Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" A1CF "ACF, ACF64, ACF65, APOBEC1CF, ASP" ENSG00000148584 "APOBEC1 complementation factor" Q9NQ94 10 50799409-50885675 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 32.5;liver: 99.7" "Cell type enhanced" "Detected in many" 17 "Cholangiocytes: 107.0;Enterocytes: 90.6;Hepatocytes: 295.0;Intestinal endocrine cells: 111.9;Paneth cells: 71.9;Proximal tubular cells: 93.2" "Cancer enriched" "Detected in some" 6 "liver cancer: 18.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "basophil: 1.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.6" "Group enriched" "Detected in some" 23 "CACO-2: 13.8;Hep G2: 35.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037779, HPA044079" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA037779: AB_10670529, HPA044079: AB_2678800" "unprognostic (3.87e-3)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (2.21e-3)" "unprognostic (2.73e-1)" "unprognostic (4.61e-3)" "unprognostic (1.71e-1)" "unprognostic (7.38e-3)" "unprognostic (1.30e-2)" "unprognostic (2.46e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-3)" "unprognostic (1.97e-2)" "unprognostic (2.77e-1)" "unprognostic (2.19e-2)" "unprognostic (8.50e-4)" 0.1 0.1 0.1 1.7 0.1 0.0 0.1 0.1 0.1 0.1 14.4 0.0 0.0 8.7 0.1 0.6 0.1 0.1 3.0 0.1 0.1 0.1 9.5 99.7 0.1 0.0 0.1 0.0 0.1 5.6 0.0 0.1 0.0 0.1 0.1 3.8 0.0 0.1 0.0 0.1 0.1 32.5 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 1.6 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 9.1 0.0 0.0 0.4 0.4 107.0 0.0 0.0 3.5 2.0 0.0 8.3 0.8 0.0 0.0 90.6 0.0 9.5 0.0 0.0 0.0 0.0 295.0 0.0 0.0 111.9 7.4 6.4 0.0 0.0 0.0 0.0 0.0 49.6 0.0 15.6 71.9 0.0 93.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 25.9 0.1 ABCA5 EST90625 ENSG00000154265 "ATP binding cassette subfamily A member 5" Q8WWZ7 17 69244311-69327244 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 52.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022032, HPA062904" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022032: AB_1844427, HPA062904: AB_2732692" "unprognostic (1.24e-2)" "unprognostic (1.49e-2)" "unprognostic (1.62e-3)" "unprognostic (7.17e-2)" "unprognostic (8.05e-4)" "unprognostic (3.05e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "prognostic favorable (9.97e-5)" "unprognostic (3.60e-2)" "unprognostic (1.09e-3)" "unprognostic (1.07e-1)" "unprognostic (1.65e-1)" "unprognostic (2.55e-1)" "unprognostic (8.52e-2)" 10.5 8.6 6.7 3.8 9.8 6.0 12.7 35.6 12.4 8.8 9.6 4.3 13.5 9.7 6.0 7.7 8.6 6.6 4.6 5.2 5.3 6.2 7.9 21.7 4.9 3.3 4.1 7.9 6.9 20.3 13.0 35.9 5.3 13.6 7.4 10.6 15.5 8.2 11.4 52.8 24.0 15.5 3.4 7.6 4.3 8.9 9.0 3.9 1.7 7.9 10.3 5.9 5.5 8.1 4.2 3.9 4.5 0.7 3.0 4.2 1.2 4.2 2.0 1.6 2.5 7.9 5.7 0.5 4.5 4.9 4.7 7.0 0.6 1.6 0.0 2.4 3.9 3.7 6.4 1.0 3.7 5.3 0.1 3.0 0.0 4.8 3.0 10.5 0.0 2.7 5.6 4.6 2.0 5.4 1.0 10.2 1.6 0.0 1.7 0.4 3.7 2.6 0.0 1.6 1.6 3.0 0.3 0.1 0.4 0.9 7.2 8.9 1.4 16.1 7.4 4.6 1.5 7.6 2.7 7.4 5.3 1.5 4.9 0.9 9.2 0.2 0.3 2.2 0.0 4.8 0.7 0.7 4.5 3.1 0.2 4.2 2.4 4.0 3.4 0.5 4.2 2.1 3.4 1.9 3.0 0.1 3.9 2.4 1.2 6.7 9.8 35.6 12.4 5.3 6.2 4.1 7.9 13.6 3.9 17.9 16.9 10.2 30.0 58.2 127.4 22.1 28.1 49.5 14.8 36.6 110.0 11.6 5.0 9.2 14.9 17.1 72.6 0.0 8.6 4.9 18.8 32.6 13.9 89.4 6.2 100.1 108.2 18.4 4.8 9.5 59.0 8.9 96.2 47.7 65.8 49.9 12.8 38.6 43.2 10.2 117.6 90.5 24.0 103.0 47.0 46.9 19.8 13.8 26.6 34.4 ABCA6 EST155051 ENSG00000154262 "ATP binding cassette subfamily A member 6" Q8N139 17 69078702-69141888 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 53.9" "Group enriched" "Detected in many" 4 "Fibroblasts: 27.1;Hepatocytes: 95.4;Leydig cells: 47.5" "Cancer enriched" "Detected in some" 7 "liver cancer: 4.8" "Group enriched" "Detected in many" 5 "basal ganglia: 6.6;midbrain: 10.9;pons and medulla: 11.2;thalamus: 9.3" "Cell type enhanced" "Detected in some" "classical monocyte: 1.0;plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 20.7;ASC TERT1: 30.0;HSkMC: 13.1;HUVEC TERT2: 27.9;RT4: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA064878, HPA067180" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064878: AB_2685380, HPA067180: AB_2685797" "unprognostic (7.76e-2)" "unprognostic (6.80e-2)" "unprognostic (2.12e-1)" "unprognostic (8.01e-2)" "unprognostic (8.47e-2)" "unprognostic (9.82e-3)" "prognostic favorable (3.29e-4)" "unprognostic (1.35e-1)" "unprognostic (6.60e-2)" "unprognostic (3.00e-2)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (7.96e-4)" "unprognostic (1.61e-4)" "unprognostic (2.10e-2)" "unprognostic (3.03e-2)" "unprognostic (1.69e-1)" 31.4 4.3 1.4 2.0 6.6 0.4 12.1 0.7 1.9 12.3 9.9 4.7 2.9 1.8 7.9 6.9 10.5 4.9 7.2 13.2 1.5 0.9 3.0 53.9 9.3 3.6 10.9 0.2 22.0 1.9 1.1 6.0 1.8 11.2 8.0 3.4 4.2 7.1 1.9 6.6 5.0 3.9 9.8 21.0 1.8 4.4 5.0 9.3 0.0 6.7 6.6 2.5 16.6 11.7 0.0 1.2 0.0 1.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 20.7 30.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 13.1 0.0 1.6 0.4 0.8 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.2 1.2 0.0 0.3 1.4 6.6 0.7 1.9 1.5 0.9 10.9 0.2 11.2 9.3 0.0 0.0 2.7 0.9 2.7 13.9 4.8 0.0 0.0 1.2 3.5 5.9 0.0 0.0 0.2 2.9 2.2 0.5 0.0 0.2 0.0 27.1 0.1 0.0 95.4 1.2 0.0 2.4 2.5 1.8 2.2 47.5 2.8 5.0 1.0 0.1 3.9 0.5 0.0 11.3 0.6 13.8 0.0 1.7 0.9 1.0 2.5 0.0 0.0 0.0 0.3 ABHD12B "BEM46L3, C14orf29" ENSG00000131969 "Abhydrolase domain containing 12B" Q7Z5M8 14 50872160-50904970 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.0;retina: 10.0;skin 1: 21.6" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 136.7" "Cancer enriched" "Detected in many" 5 "testis cancer: 7.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 2.3;neutrophil: 5.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;Hep G2: 1.4;NB-4: 2.4;NTERA-2: 1.6;RH-30: 2.0;SH-SY5Y: 1.3;SuSa: 2.9;T-47d: 1.3;THP-1: 1.9" "Region enriched" "Detected in single" 5 "thalamus: 2.3" "Low region specificity" "Detected in many" HPA002873 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA002873: AB_2220573" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (2.92e-3)" "unprognostic (1.99e-3)" "unprognostic (4.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.62e-2)" "unprognostic (2.09e-1)" "unprognostic (4.31e-2)" "unprognostic (6.27e-2)" "unprognostic (3.30e-1)" "unprognostic (3.35e-1)" "unprognostic (1.70e-3)" "unprognostic (3.16e-2)" "unprognostic (9.62e-2)" "unprognostic (3.18e-3)" "unprognostic (1.68e-1)" 1.1 0.2 2.4 0.4 10.0 2.4 2.8 0.3 5.2 0.2 1.5 5.4 0.3 0.2 0.8 0.4 0.7 2.0 0.4 0.5 1.4 1.2 0.6 0.2 0.8 0.4 2.2 2.7 0.3 1.1 1.3 0.3 0.4 2.2 0.3 2.4 10.0 0.2 0.2 0.2 21.6 0.3 0.2 0.7 0.2 0.2 1.2 3.9 0.0 0.4 0.0 0.3 0.2 0.2 0.0 0.1 5.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.4 0.5 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.9 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.9 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 2.4 10.0 0.3 5.2 1.4 1.2 2.2 2.7 2.2 3.9 0.0 0.0 0.0 0.0 0.3 3.3 1.4 0.0 14.7 0.0 1.8 2.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.8 1.1 0.0 0.0 0.0 0.9 136.7 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.2 0.2 1.3 0.2 0.0 1.6 0.1 ABHD16B "C20orf135, dJ591C20.1" ENSG00000183260 "Abhydrolase domain containing 16B" Q9H3Z7 20 63861498-63862988 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 58 "Early spermatids: 120.3;Late spermatids: 172.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 6.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 13.6;PC-3: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059272, HPA075886" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059272: AB_2683963, HPA075886: " 4.3 3.6 3.0 5.3 3.8 2.0 1.1 0.6 3.0 1.3 1.9 4.1 2.3 0.0 2.9 2.2 0.9 2.2 1.9 2.0 2.6 2.0 2.2 3.4 1.5 2.3 4.8 0.0 3.2 1.3 2.9 0.0 3.6 0.0 3.1 2.4 3.4 0.0 1.2 7.4 5.0 9.0 2.0 0.0 1.4 1.5 1.8 1.6 6.3 1.8 0.4 2.0 1.6 4.1 2.7 0.5 1.1 0.0 0.0 6.3 4.9 0.0 0.0 0.0 13.6 5.4 3.8 4.0 0.0 1.2 10.6 0.0 0.0 0.0 2.6 3.3 2.4 4.7 9.8 0.0 1.4 6.9 0.0 0.0 0.0 0.0 0.2 0.0 2.9 4.6 4.5 0.0 7.1 2.2 4.0 1.2 0.5 16.3 4.8 0.6 1.4 0.0 2.8 2.0 1.6 4.6 2.7 0.6 0.2 5.4 0.6 1.7 2.9 5.1 1.5 2.0 3.7 2.1 2.5 2.1 1.5 2.1 0.3 1.8 6.3 1.9 1.2 1.2 0.8 0.7 1.5 1.5 1.8 1.5 1.1 0.8 0.4 0.8 1.6 2.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 172.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 ABHD4 FLJ12816 ENSG00000100439 "Abhydrolase domain containing 4" Q8TB40 14 22598237-22613215 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000600 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA000600: AB_1078081" "unprognostic (5.04e-2)" "unprognostic (5.15e-2)" "unprognostic (2.68e-3)" "unprognostic (8.17e-2)" "unprognostic (1.17e-1)" "unprognostic (5.24e-2)" "unprognostic (1.19e-3)" "unprognostic (3.69e-2)" "unprognostic (1.28e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-3)" "unprognostic (3.73e-1)" "unprognostic (1.56e-2)" "unprognostic (5.18e-2)" "unprognostic (1.37e-1)" "unprognostic (4.51e-2)" "unprognostic (1.03e-2)" 17.2 24.9 12.8 6.4 14.5 10.0 20.5 12.3 13.9 19.4 14.7 21.4 37.5 13.4 26.0 26.2 28.6 14.4 22.4 16.4 14.1 10.4 23.9 17.0 13.6 8.7 18.9 12.9 15.4 11.4 14.8 12.2 15.9 15.5 19.3 12.8 22.2 13.9 35.5 17.9 14.2 26.3 22.8 18.5 11.9 18.5 45.0 16.4 5.1 25.1 11.1 14.7 23.2 20.7 3.8 2.8 18.6 4.2 4.4 6.0 3.4 7.8 13.2 5.4 4.9 44.0 16.0 5.2 3.5 18.2 8.9 16.7 8.0 12.6 0.7 9.4 15.5 9.6 15.4 3.4 9.2 7.3 5.8 1.2 2.9 9.2 26.3 20.1 0.4 10.7 20.3 7.2 11.7 10.0 18.7 9.2 5.5 2.1 14.4 8.2 4.3 0.2 0.4 6.6 32.1 9.7 2.1 4.8 3.2 10.4 8.4 0.3 1.1 23.9 8.5 9.1 11.3 3.3 0.8 6.5 3.9 5.4 6.3 1.4 15.6 8.1 0.2 2.9 0.6 3.1 18.6 4.2 6.6 6.0 3.2 5.0 3.8 3.9 3.9 2.8 2.4 1.3 2.6 17.4 4.4 2.9 0.4 2.3 3.4 12.8 14.5 12.3 13.0 14.1 10.4 18.9 12.9 15.5 16.4 11.9 3.5 3.2 5.8 2.9 3.0 5.2 15.3 0.0 2.3 3.5 3.9 5.0 8.3 10.7 3.2 5.9 9.8 0.0 10.3 1.5 5.0 6.9 4.7 7.3 6.4 7.9 5.8 8.6 4.7 3.2 5.2 3.8 1.7 13.6 6.1 7.5 8.8 10.5 7.8 4.2 3.1 6.5 6.2 0.7 0.5 2.4 22.4 5.3 2.8 9.3 AC003006.1 ENSG00000269026 19 57682045-57753575 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ: 2.1;HEK 293: 2.8;HL-60: 3.5;RT4: 2.8;U-266/84: 5.4;U-698: 2.0" HPA068553 Approved Nucleoplasm NA NA Nucleoplasm "HPA068553: AB_2686002" "unprognostic (2.74e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (3.50e-1)" "unprognostic (1.43e-2)" "unprognostic (3.61e-1)" "unprognostic (4.82e-2)" "unprognostic (1.46e-1)" 2.4 1.3 1.3 3.2 1.9 1.7 2.3 7.7 1.6 1.8 2.0 2.4 3.4 3.0 3.0 2.0 1.4 2.3 2.1 2.0 1.5 1.2 1.3 1.9 1.5 4.4 1.3 0.7 5.2 4.4 1.2 2.3 1.7 1.5 1.6 1.2 2.2 4.5 3.5 3.4 2.0 1.4 2.5 1.9 2.8 3.4 8.1 1.9 5.6 2.5 1.6 4.2 2.8 2.0 1.6 1.1 1.7 1.3 4.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.1 0.0 0.7 0.0 1.6 0.0 0.4 0.6 0.0 0.0 0.0 0.7 0.7 0.0 0.8 2.8 0.7 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.8 1.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.3 0.0 5.4 2.0 0.0 0.0 0.0 0.3 1.3 0.6 0.4 0.0 1.3 1.6 0.7 1.5 0.5 1.0 1.1 0.5 1.7 4.0 0.2 1.1 0.6 0.2 1.3 1.9 7.7 1.6 1.5 1.2 1.3 0.7 1.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008770.2 ENSG00000267179 19 11925075-11979290 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.1;HHSteC: 2.8;PC-3: 1.8;U-266/70: 2.6;U-937: 2.0" HPA047845 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (2.46e-3)" "unprognostic (9.75e-5)" "unprognostic (1.14e-2)" "unprognostic (1.80e-1)" "unprognostic (2.37e-2)" "unprognostic (2.38e-3)" "unprognostic (1.26e-1)" "unprognostic (1.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.97e-2)" "unprognostic (4.82e-3)" "unprognostic (2.69e-2)" "unprognostic (5.04e-3)" "unprognostic (2.24e-2)" "unprognostic (9.29e-2)" "unprognostic (1.67e-1)" "unprognostic (8.13e-2)" 3.8 4.6 2.3 7.9 2.7 2.1 7.7 3.0 3.3 2.5 3.4 1.2 4.4 1.4 3.7 4.0 2.4 1.8 4.5 2.1 2.3 2.0 2.8 2.9 4.4 4.9 2.3 1.0 3.6 8.5 1.4 3.9 2.9 1.8 2.8 2.7 1.8 5.3 3.5 2.3 3.6 2.2 4.7 2.0 2.7 2.4 5.9 2.3 3.0 2.3 1.6 4.0 3.2 4.3 1.5 1.5 1.4 1.3 1.1 1.9 0.8 0.6 0.0 0.7 0.0 0.0 0.8 0.0 1.3 2.1 0.9 1.0 0.0 0.4 0.8 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.7 0.8 0.0 0.0 0.5 0.2 1.8 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.6 2.6 1.2 1.7 0.4 2.0 0.0 0.0 0.5 1.4 0.7 0.6 1.9 0.7 1.1 0.6 1.5 1.5 0.3 0.6 1.0 1.1 1.3 0.6 0.2 0.8 2.3 2.7 3.0 2.5 2.3 2.0 2.3 1.0 1.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012184.2 ENSG00000260537 16 70299194-70372582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 27 "Ciliated cells: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 22.6;U-698: 22.3" "HPA046380, HPA066668" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046380: AB_2679645, HPA066668: " 12.9 11.6 2.6 10.2 4.7 10.4 7.2 12.9 6.3 4.8 7.4 5.6 5.2 9.8 5.7 5.2 9.8 4.2 7.1 10.8 2.9 2.7 7.2 14.6 6.6 8.8 3.6 3.7 4.5 13.7 0.8 7.1 4.3 4.9 4.7 7.5 7.7 8.7 5.8 23.5 15.9 7.0 6.0 3.2 7.0 7.3 2.6 4.5 6.8 8.0 6.6 13.3 13.4 5.2 8.8 14.7 12.3 16.0 12.0 17.9 11.1 1.4 4.9 4.2 9.8 0.0 4.7 8.2 4.6 5.5 7.9 8.4 9.0 12.6 8.3 5.8 4.7 1.5 5.0 0.0 3.4 6.2 2.5 6.2 5.4 4.1 0.6 5.1 8.2 4.4 3.0 0.8 8.2 0.0 2.0 5.6 2.3 3.1 2.2 3.3 3.7 0.1 0.0 5.1 0.7 1.1 22.6 1.7 15.2 2.5 6.3 5.3 5.1 11.7 2.1 2.3 1.3 4.3 2.0 5.2 5.4 5.6 2.2 2.9 7.7 5.1 22.3 0.7 5.2 9.7 12.3 13.0 9.2 13.5 16.0 11.2 8.8 11.9 13.2 14.7 8.3 10.2 9.9 1.8 12.0 11.5 3.0 17.9 11.1 2.6 4.7 12.9 6.3 2.9 2.7 3.6 3.7 4.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC058822.1 ENSG00000282278 4 53377839-54295272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 19.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.4;fHDF/TERT166: 12.7;HDLM-2: 3.4;NTERA-2: 2.9;U-2197: 2.9" HPA058202 Supported Nucleoplasm NA NA Nucleoplasm "HPA058202: AB_2683636" 4.3 2.6 3.6 9.5 5.0 2.7 3.4 4.3 19.1 4.7 4.6 3.4 2.6 2.6 5.5 2.6 3.2 2.6 2.6 4.5 2.6 3.0 3.3 5.4 3.9 3.6 5.1 7.8 6.6 2.6 5.3 5.3 3.8 4.0 2.8 2.6 3.0 3.1 3.2 2.6 7.1 6.5 3.3 4.7 4.1 4.7 4.2 9.3 4.3 3.0 4.2 4.5 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 2.0 0.0 0.2 5.4 0.0 0.1 1.0 0.0 0.0 0.0 12.7 0.0 0.0 1.1 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 1.5 0.0 2.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093668.1 ENSG00000270249 7 102541501-102592444 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 6.9" "Cell type enriched" "Detected in single" 12 "Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.7;hTERT-RPE1: 3.4;Karpas-707: 4.0" HPA046970 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" 0.4 0.7 0.6 0.8 0.6 0.7 0.4 3.1 1.1 1.0 1.0 2.5 0.9 2.5 0.4 0.6 0.0 0.3 0.6 0.5 1.4 0.1 0.7 0.5 0.3 0.7 1.2 6.9 2.9 0.4 0.5 0.6 1.1 0.2 5.4 1.7 1.4 0.0 0.3 1.3 1.1 0.2 0.3 0.1 0.4 0.7 4.0 3.5 1.3 1.0 0.7 5.3 1.2 0.1 0.0 1.0 0.2 0.2 3.7 0.5 1.1 0.7 0.6 0.0 0.0 2.1 2.3 0.7 1.6 0.4 0.8 0.0 0.0 0.0 0.7 0.0 1.3 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.4 0.0 1.2 0.0 4.0 0.0 0.4 2.6 1.3 0.5 2.3 1.0 1.4 0.0 0.5 0.3 0.8 1.5 1.2 0.0 0.0 0.2 1.7 0.5 0.0 0.0 0.0 0.1 0.3 0.0 1.8 1.5 0.4 0.4 1.0 0.0 0.0 0.7 0.4 2.9 0.9 4.1 4.0 3.8 2.9 1.7 3.1 5.3 3.0 1.3 0.7 1.0 3.5 5.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC116366.3 ENSG00000283782 5 132410832-132646079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 7.5;Ciliated cells: 22.7;Club cells: 11.4;monocytes: 10.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA052291 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA052291: AB_2681786" 4.8 4.8 2.6 11.9 4.4 1.9 5.3 4.2 6.0 6.3 6.3 4.0 6.0 5.6 4.2 7.0 3.2 4.9 7.4 4.0 3.2 5.8 6.5 10.4 9.8 4.1 2.8 8.6 3.4 5.7 6.3 3.5 3.9 5.6 4.7 6.2 4.3 5.8 4.7 1.7 8.0 6.1 4.4 9.3 4.6 1.9 4.7 7.6 5.7 2.4 9.6 4.4 8.3 5.0 3.5 7.4 3.1 5.1 9.0 3.7 3.3 0.2 1.0 1.5 8.4 8.7 4.5 3.5 3.4 6.4 6.1 0.2 7.2 2.9 2.0 4.2 11.2 2.3 4.7 0.9 5.7 6.1 0.7 4.1 0.9 0.7 12.3 2.5 2.6 4.9 1.8 4.4 9.3 6.4 4.5 3.2 0.7 7.8 7.4 0.1 7.7 3.0 2.1 2.2 1.2 7.2 3.6 9.8 1.8 0.6 1.5 1.5 2.2 1.7 3.0 2.4 0.2 3.4 5.7 2.9 1.8 2.0 1.9 11.0 5.7 3.6 3.5 8.1 1.6 3.8 1.9 7.4 9.0 3.1 5.0 5.0 4.9 6.4 1.1 5.0 5.4 6.2 4.9 5.1 2.8 3.5 5.7 3.7 20.8 7.5 0.0 0.0 0.0 0.0 0.0 0.0 22.7 11.4 3.5 0.0 0.0 1.7 2.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 10.8 0.0 0.0 1.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC126755.2 ENSG00000233024 "Nuclear pore complex-interacting protein family member A5 isoform 2 " 16 18358086-18379331 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.5" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.7;Ciliated cells: 10.7;granulocytes: 10.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 4.7" "Group enriched" "Detected in many" 6 "B-cells: 4.7;T-cells: 1.8" "Low cell line specificity" "Detected in all" HPA053611 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (9.10e-2)" "unprognostic (6.00e-3)" "unprognostic (1.66e-1)" "unprognostic (5.77e-2)" "unprognostic (8.31e-2)" "unprognostic (6.34e-2)" "unprognostic (6.34e-2)" "unprognostic (6.76e-2)" "unprognostic (1.30e-3)" "unprognostic (5.87e-2)" "unprognostic (5.79e-3)" "unprognostic (1.60e-2)" "unprognostic (1.25e-5)" "unprognostic (1.96e-1)" "unprognostic (1.90e-2)" "unprognostic (5.38e-2)" "unprognostic (6.45e-3)" 4.1 5.4 5.2 3.3 5.5 3.3 6.0 46.5 10.1 5.4 6.9 3.4 9.5 10.0 4.7 6.3 4.4 3.3 6.4 6.4 3.5 4.6 5.4 4.2 3.3 11.5 6.6 14.3 27.8 2.8 5.4 6.3 3.7 7.0 17.5 9.8 4.5 7.6 2.8 4.9 4.0 4.6 6.5 3.6 4.6 3.8 4.7 0.5 0.5 0.5 0.3 1.8 0.5 7.0 4.7 26.0 21.2 22.3 20.8 6.1 27.2 9.9 13.4 20.0 4.6 4.2 9.8 10.6 23.9 7.9 12.8 8.0 7.3 16.4 8.3 7.7 26.2 22.7 22.6 22.7 12.4 60.1 21.3 33.3 16.8 22.6 28.3 6.5 12.2 6.0 19.7 13.4 10.8 20.3 27.2 11.0 7.0 5.9 29.2 6.4 9.8 13.3 13.4 7.4 11.6 17.1 10.8 14.6 10.4 9.9 14.9 12.4 18.1 8.0 15.2 8.3 14.9 11.6 15.0 8.1 17.3 9.3 0.0 0.5 0.5 1.8 0.1 0.6 4.7 1.2 0.9 0.2 1.1 1.0 0.4 0.0 0.3 0.3 0.5 0.4 0.5 3.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 10.7 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC131097.2 ENSG00000216921 2 241893985-241902551 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "pancreas: 27.6;tongue: 59.2" "Cell type enriched" "Detected in some" 4 "Exocrine glandular cells: 7.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 3.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 4.1;MCF7: 1.8;REH: 6.3;SCLC-21H: 4.1" HPA073342 Approved Nucleoplasm NA NA Nucleoplasm "HPA073342: " "unprognostic (9.31e-2)" "unprognostic (4.59e-2)" "unprognostic (1.61e-2)" "unprognostic (1.10e-1)" "unprognostic (7.48e-2)" "unprognostic (3.12e-1)" "unprognostic (2.93e-2)" "unprognostic (4.75e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (2.04e-2)" "unprognostic (5.12e-2)" "unprognostic (5.44e-2)" "unprognostic (8.45e-2)" "unprognostic (2.44e-1)" "unprognostic (3.29e-1)" 2.7 0.3 4.9 0.6 4.4 0.2 1.6 1.7 2.4 0.8 0.6 0.6 0.6 0.1 0.6 0.6 3.8 0.5 0.9 0.6 2.1 2.3 0.6 0.6 0.6 0.6 3.9 0.6 1.4 27.6 0.0 0.6 0.6 0.6 2.6 0.0 0.6 4.4 4.0 3.7 2.6 0.6 0.6 0.6 0.6 0.1 0.8 0.6 1.1 6.4 59.2 2.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.5 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.5 0.6 0.0 1.8 1.4 0.2 0.5 0.0 0.0 6.3 0.0 0.6 0.0 0.0 4.1 0.1 0.0 0.6 0.0 0.9 0.0 0.9 1.2 0.0 0.2 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 4.4 1.7 2.4 2.1 2.3 3.9 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC138894.1 ENSG00000261832 16 28456371-28492098 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 3.5;Ciliated cells: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.0;BEWO: 1.3;hTCEpi: 3.4;NB-4: 1.4;REH: 1.0" HPA053611 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.93e-3)" "unprognostic (8.88e-3)" "unprognostic (4.33e-3)" "unprognostic (2.66e-1)" "unprognostic (3.59e-1)" "unprognostic (9.85e-2)" "unprognostic (3.82e-4)" "unprognostic (3.25e-2)" "unprognostic (3.44e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.59e-1)" "unprognostic (1.03e-1)" "unprognostic (6.85e-2)" "unprognostic (1.40e-1)" "unprognostic (2.37e-1)" "unprognostic (3.74e-1)" 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.6 0.0 0.8 0.3 0.5 0.0 0.1 0.0 0.3 0.2 0.1 0.3 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 3.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 1.4 0.4 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.5 0.3 0.3 0.0 0.0 0.2 0.0 6.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 9.4 1.2 0.0 0.0 0.8 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 AC138969.1 ENSG00000183889 "Nuclear pore complex-interacting protein family member A5 isoform 2 " 16 16317444-16350590 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Ciliated cells: 5.3;Club cells: 7.9;granulocytes: 8.1;monocytes: 2.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.3;T-cells: 2.7" "Cell line enhanced" "Detected in all" "HMC-1: 64.2" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.91e-1)" "unprognostic (3.88e-1)" "unprognostic (1.09e-1)" "unprognostic (2.18e-2)" "unprognostic (1.92e-1)" "unprognostic (8.96e-2)" "unprognostic (2.31e-2)" "unprognostic (3.69e-3)" "unprognostic (1.27e-1)" "unprognostic (1.32e-1)" "unprognostic (5.45e-7)" "unprognostic (1.22e-2)" "unprognostic (5.04e-6)" "unprognostic (6.04e-2)" "unprognostic (9.80e-2)" "unprognostic (1.79e-1)" "unprognostic (2.22e-3)" 5.2 6.4 9.8 2.9 7.1 6.5 5.5 35.6 12.6 4.6 9.3 2.7 11.3 17.9 7.0 10.9 9.9 5.5 11.0 9.0 4.6 4.5 6.3 5.3 5.9 16.4 5.6 12.2 17.9 3.3 7.4 11.0 5.4 8.5 10.1 19.0 5.0 12.5 4.4 6.2 5.0 7.4 6.6 7.3 4.4 4.9 4.3 0.8 0.4 0.7 0.2 2.7 0.7 7.9 5.7 15.7 14.8 22.5 21.4 11.0 16.3 8.0 8.6 11.5 3.9 4.8 6.5 15.6 17.9 7.0 14.1 9.9 6.7 13.1 2.6 9.4 15.1 39.2 25.9 23.1 9.5 64.2 19.8 43.1 13.5 22.7 16.9 5.6 12.2 5.5 21.9 12.6 13.5 15.4 35.4 7.2 7.4 3.9 18.7 6.5 6.6 13.7 26.7 9.9 10.3 8.0 12.0 26.0 11.9 12.8 29.2 3.8 13.6 8.1 8.4 6.1 10.1 18.2 12.4 7.7 10.3 7.0 0.0 0.7 0.4 2.7 0.1 0.8 4.3 2.0 2.3 0.1 1.1 1.5 0.6 0.0 0.2 0.6 0.8 1.1 0.7 3.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.9 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 8.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ACTRT3 ARPM1 ENSG00000184378 "Actin related protein T3" Q9BYD9 3 169766921-169769895 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 57.4" "Cell type enriched" "Detected in many" 9 "Early spermatids: 728.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.4" "Group enriched" "Detected in many" 4 "B-cells: 1.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "ASC diff: 16.0;HSkMC: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA035817, HPA035818" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035817: AB_10671938, HPA035818: AB_2674801" "unprognostic (2.35e-1)" "unprognostic (9.39e-2)" "unprognostic (2.10e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.89e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" "unprognostic (1.24e-1)" "unprognostic (7.31e-4)" "unprognostic (2.64e-1)" "unprognostic (9.16e-2)" "unprognostic (4.41e-2)" "unprognostic (8.03e-2)" "unprognostic (8.49e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-3)" "unprognostic (2.22e-1)" 1.0 0.7 0.9 0.4 1.1 0.5 1.5 2.4 1.3 1.0 0.5 0.5 1.3 0.7 0.7 1.4 0.6 1.4 0.5 0.7 0.7 0.9 1.8 1.7 0.7 0.6 1.0 0.4 1.1 0.3 0.8 1.0 0.7 1.1 1.0 0.4 0.6 0.5 1.3 0.7 0.3 0.5 1.0 0.6 0.1 0.8 57.4 0.7 0.2 1.0 0.1 0.5 1.5 3.1 1.2 0.5 0.0 0.0 0.0 3.4 0.4 3.6 2.2 0.2 1.1 16.0 5.2 0.0 4.4 2.6 2.7 2.3 0.0 4.6 0.0 6.1 4.9 1.8 2.3 1.2 2.1 2.8 2.7 1.6 8.4 1.9 0.4 2.6 0.9 0.7 10.3 0.5 3.3 0.6 1.8 4.9 1.0 0.0 0.0 4.8 1.8 0.3 0.1 3.9 3.1 4.6 0.7 0.0 0.1 2.9 0.9 2.9 2.0 5.2 1.3 0.1 0.5 2.2 3.6 2.2 0.0 0.0 2.2 0.0 0.5 0.2 0.2 1.1 0.0 0.5 0.0 0.0 0.0 0.7 0.0 3.4 1.2 0.0 1.1 0.5 1.1 0.4 0.4 0.0 0.0 0.0 0.5 0.0 0.4 0.9 1.1 2.4 1.3 0.7 0.9 1.0 0.4 1.1 0.7 0.0 1.0 0.0 0.7 0.3 1.0 0.6 0.0 2.7 2.3 0.0 2.0 1.4 1.7 2.0 728.6 0.7 0.0 0.0 1.8 1.1 1.4 0.4 1.1 1.7 1.4 3.2 0.0 1.8 0.6 82.5 8.9 0.6 1.7 0.0 0.1 1.4 1.3 0.0 5.3 2.5 1.1 12.9 1.9 5.5 4.0 0.0 0.7 0.0 0.4 0.3 ACYP2 ENSG00000170634 "Acylphosphatase 2" P14621 2 53970838-54305300 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 116.4" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 159.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035301 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA035301: AB_10670291" "unprognostic (1.19e-1)" "unprognostic (2.84e-2)" "unprognostic (3.40e-1)" "unprognostic (2.16e-1)" "unprognostic (6.90e-3)" "unprognostic (6.21e-2)" "unprognostic (2.03e-3)" "unprognostic (3.17e-1)" "unprognostic (5.22e-2)" "unprognostic (7.83e-3)" "unprognostic (3.64e-3)" "unprognostic (1.16e-1)" "unprognostic (6.66e-2)" "unprognostic (2.13e-1)" "unprognostic (1.97e-1)" "unprognostic (3.24e-1)" "unprognostic (2.24e-2)" 12.9 24.0 31.0 4.6 33.9 5.6 10.1 15.5 29.3 6.7 6.2 19.4 4.4 6.2 6.7 10.5 6.6 7.1 7.3 39.6 29.1 28.4 8.8 18.7 7.2 7.5 35.7 18.2 5.7 10.3 9.1 9.7 5.9 28.1 10.4 4.8 6.3 11.5 8.4 116.4 6.6 5.6 6.9 35.7 7.8 7.5 6.5 22.7 3.5 8.2 22.9 6.4 8.2 4.1 20.9 23.7 24.1 10.2 12.6 15.9 8.9 7.7 4.3 4.6 3.8 16.8 13.3 4.2 9.3 7.0 5.8 5.1 1.0 5.6 15.1 24.7 9.2 5.8 6.6 2.5 7.8 5.4 13.0 10.3 11.6 4.7 11.5 6.9 9.7 5.6 9.6 14.6 4.1 6.9 11.8 2.6 7.8 4.8 8.1 12.2 4.9 6.0 12.0 5.2 6.1 5.4 4.8 4.4 8.5 13.6 7.1 13.3 8.8 11.3 7.1 4.2 1.8 2.6 8.9 9.3 8.2 7.9 3.6 8.6 17.1 9.4 8.4 11.9 16.6 9.0 24.1 10.2 19.8 13.4 9.0 11.9 20.9 13.4 12.7 14.7 19.7 15.9 13.4 8.5 12.6 8.8 23.7 11.6 8.9 31.0 33.9 15.5 29.3 29.1 28.4 35.7 18.2 28.1 22.7 14.9 13.2 27.4 34.8 18.2 14.8 159.9 25.5 25.4 21.6 17.4 9.8 12.0 53.0 19.2 60.2 23.2 19.1 23.3 33.4 5.0 14.9 30.3 19.6 58.0 27.9 27.0 29.4 26.4 35.8 48.4 12.4 30.9 21.9 21.6 25.3 53.2 29.4 17.5 29.0 36.5 28.8 51.8 26.4 19.2 9.7 18.6 8.6 17.0 18.0 35.7 ADAMTS17 "FLJ16363, FLJ32769" ENSG00000140470 "ADAM metallopeptidase with thrombospondin type 1 motif 17" Q8TE56 15 99971589-100342005 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Deafness, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.1" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 111.4;Horizontal cells: 20.6;Late spermatids: 51.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HEK 293: 7.4;JURKAT: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062487 Approved Nucleoplasm "Secreted to extracellular matrix" NA NA Nucleoplasm "HPA062487: AB_2684780" "unprognostic (7.73e-2)" "unprognostic (2.38e-2)" "unprognostic (1.79e-2)" "unprognostic (9.03e-3)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (5.78e-2)" "unprognostic (1.18e-3)" "unprognostic (5.03e-3)" "unprognostic (4.70e-2)" "unprognostic (2.93e-1)" "unprognostic (1.27e-1)" "unprognostic (3.35e-2)" "unprognostic (8.48e-2)" "unprognostic (1.21e-1)" "unprognostic (7.43e-3)" "unprognostic (6.43e-2)" 1.2 2.0 3.6 2.7 3.1 1.5 1.9 0.7 4.5 1.9 2.1 2.9 6.4 2.5 4.9 1.9 5.1 2.9 1.9 2.2 3.4 1.6 2.2 15.7 10.5 2.0 1.6 1.0 3.0 12.2 0.3 3.5 1.6 1.7 1.9 2.1 2.7 8.3 4.7 13.5 5.0 2.8 6.6 2.1 2.5 3.6 4.0 2.0 20.1 1.9 2.7 2.1 2.7 2.1 0.1 0.0 1.4 0.1 0.2 0.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.1 1.3 0.2 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 25.8 0.0 0.1 0.1 0.6 2.2 0.4 0.2 1.2 1.1 0.0 0.6 2.8 0.0 0.3 2.3 0.4 0.3 2.8 3.7 0.6 0.0 0.4 0.4 0.0 0.9 0.7 0.0 0.4 0.0 0.0 0.0 0.5 3.4 1.4 0.0 0.0 0.1 0.0 0.5 0.0 0.8 0.2 0.0 0.1 0.5 0.5 0.4 0.2 0.1 0.0 0.0 0.1 3.6 3.1 0.7 4.5 3.4 1.6 1.6 1.0 1.7 2.0 0.0 0.0 0.0 0.6 0.9 0.9 3.4 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 111.4 0.7 0.1 0.0 0.7 0.0 0.8 1.7 0.0 3.9 6.1 20.6 0.0 0.0 0.6 51.8 2.0 0.0 0.0 0.0 0.3 2.3 0.4 0.0 0.0 0.0 0.5 0.0 0.1 0.9 1.4 0.5 0.1 1.3 0.3 0.8 ADAMTS5 "ADAMTS11, ADMP-2" ENSG00000154736 "ADAM metallopeptidase with thrombospondin type 1 motif 5" Q9UNA0 21 26917912-26966513 "Cancer-related genes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 21.2;placenta: 20.9" "Cell type enhanced" "Detected in many" 16 "Fibroblasts: 51.0;Leydig cells: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "classical monocyte: 1.5" "Lineage enriched" "Detected in single" 6 "monocytes: 1.5" "Cell line enhanced" "Detected in some" "ASC diff: 23.9;ASC TERT1: 10.1;fHDF/TERT166: 9.5;RH-30: 25.2;U-87 MG: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA005661, CAB025996, HPA030906, HPA030908" Approved Supported Nucleoplasm "Secreted to extracellular matrix" NA NA 18000 Nucleoplasm "CAB025996: , HPA005661: AB_1078101, HPA030906: AB_2673654, HPA030908: AB_2673655" "unprognostic (1.97e-1)" "unprognostic (2.88e-3)" "unprognostic (2.69e-2)" "unprognostic (4.01e-2)" "unprognostic (4.67e-1)" "unprognostic (2.10e-2)" "unprognostic (4.38e-8)" "unprognostic (1.11e-3)" "unprognostic (7.66e-2)" "unprognostic (6.17e-2)" "unprognostic (8.13e-2)" "unprognostic (7.76e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (6.69e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.15e-1)" 14.1 0.4 1.0 1.6 0.6 0.0 21.2 2.5 0.9 5.5 2.3 0.4 7.2 0.3 10.7 8.2 1.2 3.3 1.0 6.9 1.0 0.0 1.6 0.8 1.2 0.4 1.1 0.4 14.9 0.4 0.1 0.4 20.9 1.5 2.2 0.8 2.3 1.8 9.7 11.0 3.3 2.4 6.2 1.1 6.4 1.8 2.3 0.4 0.6 5.3 1.5 0.6 2.8 3.1 0.0 0.2 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 23.9 10.1 0.0 1.3 0.2 1.4 0.5 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 2.1 0.0 0.9 0.0 0.3 0.0 2.5 0.1 0.0 5.5 0.0 1.0 0.2 0.2 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.2 0.0 2.2 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.4 0.3 1.3 0.6 0.0 0.0 0.0 9.1 0.1 1.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.6 2.5 0.9 1.0 0.0 1.1 0.4 1.5 0.4 0.0 0.3 0.0 0.1 2.6 1.9 2.6 0.0 0.0 1.2 3.5 0.0 0.8 0.0 0.0 4.8 7.1 0.0 0.0 0.2 1.4 51.0 0.2 0.0 0.0 1.8 0.0 1.7 2.5 0.0 0.8 58.1 0.8 3.3 0.0 0.0 0.0 0.0 0.0 8.5 2.2 0.0 12.9 13.7 0.0 0.5 2.6 2.3 0.0 0.0 0.1 ADAT1 ENSG00000065457 "Adenosine deaminase, tRNA specific 1" Q9BUB4 16 75596981-75623300 "Enzymes, Predicted intracellular proteins" "tRNA processing" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 80.3;Late spermatids: 160.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040713, HPA040903" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA040713: AB_10795371, HPA040903: AB_10794071" "unprognostic (7.71e-3)" "unprognostic (5.35e-2)" "unprognostic (7.62e-2)" "unprognostic (9.00e-2)" "unprognostic (9.99e-2)" "unprognostic (4.69e-2)" "unprognostic (4.54e-2)" "unprognostic (6.65e-3)" "unprognostic (3.38e-1)" "unprognostic (1.14e-2)" "unprognostic (9.75e-2)" "unprognostic (2.97e-1)" "unprognostic (4.60e-3)" "unprognostic (7.21e-2)" "unprognostic (4.92e-1)" "unprognostic (5.58e-3)" "unprognostic (8.27e-2)" 14.8 17.1 12.5 12.6 18.2 13.0 15.1 11.0 23.3 13.5 12.4 21.4 11.8 10.1 15.1 24.4 12.0 12.6 15.8 10.4 17.2 15.1 17.2 17.8 12.8 21.2 16.7 20.5 11.1 15.3 33.5 16.7 14.0 22.3 15.3 15.1 11.8 12.2 14.2 9.0 21.2 13.6 12.6 16.0 21.3 11.7 51.8 16.8 19.4 20.6 9.2 16.7 17.1 11.3 12.5 8.6 15.0 13.0 12.1 20.5 8.3 14.1 23.2 14.0 14.5 21.1 17.3 13.1 15.7 18.0 21.4 17.1 19.2 21.7 16.8 16.7 14.2 12.1 16.1 12.9 20.2 21.3 11.0 7.6 7.4 16.1 13.5 15.5 14.3 16.7 19.1 15.9 31.8 26.0 6.7 17.9 20.7 12.4 7.6 18.8 53.0 16.6 13.5 11.5 14.5 10.0 19.7 12.0 20.8 20.9 21.8 19.8 20.5 35.5 11.1 9.7 12.9 23.0 9.5 13.0 34.4 14.2 13.8 15.0 16.1 22.6 46.9 14.9 15.3 28.4 9.6 7.2 15.0 14.7 8.4 20.5 12.5 13.8 20.0 8.0 11.8 8.5 12.0 9.5 12.1 13.0 8.6 14.0 8.3 12.5 18.2 11.0 23.3 17.2 15.1 16.7 20.5 22.3 16.8 8.9 4.3 7.6 4.6 4.0 13.4 4.8 5.1 9.4 4.5 7.0 25.5 11.0 14.9 7.4 80.3 8.5 5.9 23.3 6.7 7.7 5.4 7.1 8.1 8.7 8.8 12.7 13.8 6.7 10.4 160.0 9.2 10.2 3.3 10.8 5.3 7.2 8.0 3.5 7.4 8.6 18.9 6.5 5.7 14.0 11.7 4.6 8.1 9.6 8.0 6.5 ADAT3 TAD3 ENSG00000213638 "Adenosine deaminase, tRNA specific 3" 19 1905378-1913447 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 5.5;Suprabasal keratinocytes: 9.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 14.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 12.9" "Low region specificity" "Detected in all" HPA058899 Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA058899: AB_2683847" "unprognostic (1.79e-1)" "unprognostic (7.99e-2)" "unprognostic (1.57e-1)" "unprognostic (3.61e-3)" "unprognostic (4.43e-2)" "prognostic favorable (6.13e-4)" "unprognostic (1.48e-4)" "unprognostic (2.18e-1)" "unprognostic (1.63e-1)" "unprognostic (1.38e-1)" "unprognostic (4.78e-3)" "unprognostic (5.27e-2)" "unprognostic (2.21e-2)" "prognostic favorable (6.98e-4)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "unprognostic (9.55e-3)" 6.5 7.4 4.7 5.6 7.9 5.0 6.5 7.3 10.6 4.5 12.4 18.2 7.7 31.0 6.0 7.4 12.1 7.3 7.1 4.4 4.8 3.7 9.4 7.8 6.2 4.4 8.1 4.9 8.7 7.5 3.4 8.6 9.0 10.4 8.3 5.3 7.8 16.1 7.0 5.4 18.3 20.5 3.0 12.5 8.9 15.6 5.5 7.3 3.1 8.8 3.3 6.5 3.2 7.7 2.2 14.0 0.3 1.3 4.9 2.6 0.7 4.8 1.3 0.7 1.0 0.4 0.0 6.2 1.8 0.3 0.7 1.0 2.0 1.5 2.9 0.7 0.2 0.4 3.2 0.2 0.2 0.0 7.0 12.9 0.7 2.9 2.6 0.3 1.3 9.2 0.0 0.2 0.8 0.0 0.1 0.6 0.8 8.0 1.6 0.4 1.0 2.3 4.2 6.8 0.2 8.8 7.8 1.2 4.7 0.8 1.3 2.8 6.7 2.2 5.2 2.4 0.3 4.0 1.0 1.6 0.7 2.9 2.6 3.8 2.8 2.6 2.5 0.6 1.3 1.6 0.3 1.3 0.0 1.6 0.6 1.6 1.0 2.3 2.5 1.8 2.2 1.7 2.6 0.3 4.9 1.1 14.0 2.3 0.7 4.7 7.9 7.3 10.6 4.8 3.7 8.1 4.9 10.4 7.3 0.0 1.0 1.5 1.1 5.5 0.0 0.6 2.5 2.7 0.0 0.0 0.0 1.3 1.7 1.0 0.0 0.6 3.5 0.0 0.6 1.9 1.0 0.2 0.0 0.8 1.6 0.0 1.2 3.1 1.2 0.2 0.0 0.9 0.0 1.0 0.9 0.0 0.5 3.5 0.7 2.9 0.0 0.0 0.3 0.9 1.6 9.7 3.8 0.0 1.5 0.7 ADCK1 FLJ39600 ENSG00000063761 "AarF domain containing kinase 1" Q86TW2 14 77800083-77935012 "Enzymes, Predicted secreted proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051012, HPA055014" Uncertain Uncertain Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA051012: AB_2681310, HPA055014: AB_2682672" "unprognostic (6.36e-2)" "unprognostic (7.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.70e-4)" "prognostic favorable (4.11e-5)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (4.57e-3)" "unprognostic (1.38e-1)" "prognostic favorable (5.82e-6)" "unprognostic (6.30e-3)" "unprognostic (2.06e-1)" "unprognostic (9.57e-2)" "unprognostic (4.06e-1)" 7.2 11.0 11.0 7.0 15.2 7.4 6.9 6.8 20.5 5.6 10.3 19.0 7.7 11.2 7.7 10.3 7.7 7.1 9.1 11.1 12.4 10.4 8.8 10.5 6.2 6.0 13.5 9.4 6.6 9.8 11.3 11.3 7.8 15.0 8.2 10.3 13.8 10.6 8.9 13.7 8.5 8.5 10.5 10.6 9.7 7.5 5.5 11.5 10.8 9.1 7.8 7.5 6.9 5.0 4.0 8.9 1.4 7.2 3.4 5.3 3.1 3.3 5.4 3.3 10.8 8.1 4.6 4.3 3.4 5.7 3.1 3.8 3.0 8.0 7.3 5.5 6.0 5.7 6.4 17.8 5.4 2.0 4.2 5.6 1.9 3.4 4.9 8.3 2.8 4.1 5.8 10.1 1.2 3.9 3.2 4.4 6.4 7.0 4.5 4.0 16.8 3.4 5.6 6.4 12.3 6.4 5.6 0.5 5.8 4.4 8.5 7.2 4.0 6.6 9.3 4.0 5.1 13.3 6.2 3.9 2.9 2.3 5.9 3.1 4.6 5.0 4.2 4.4 4.9 3.8 1.4 4.7 1.3 5.3 7.2 3.5 1.7 2.2 3.1 8.9 4.0 2.5 4.6 0.4 3.4 2.8 7.0 3.7 3.1 11.0 15.2 6.8 20.5 12.4 10.4 13.5 9.4 15.0 11.5 0.0 3.0 0.8 1.8 0.8 5.0 4.8 0.0 1.4 1.2 0.0 19.6 6.8 3.3 3.6 1.2 1.2 2.1 0.0 4.3 3.6 2.0 1.3 1.1 5.8 8.2 7.9 1.7 1.8 5.1 0.4 1.4 5.4 0.0 1.0 3.6 3.2 3.0 0.0 1.8 3.3 8.8 0.0 1.9 1.7 9.7 1.3 4.5 1.8 4.9 0.9 ADNP "ADNP1, KIAA0784" ENSG00000101126 "Activity dependent neuroprotector homeobox" Q9H2P0 20 50888916-50931421 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder, Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006371 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA006371: AB_1078105" "unprognostic (3.40e-2)" "unprognostic (6.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.06e-2)" "unprognostic (1.68e-1)" "unprognostic (6.68e-2)" "prognostic unfavorable (1.65e-5)" "unprognostic (1.73e-1)" "unprognostic (1.80e-1)" "unprognostic (4.38e-2)" "unprognostic (3.11e-1)" "unprognostic (1.39e-2)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (3.63e-1)" "unprognostic (1.90e-2)" "unprognostic (1.08e-1)" 23.7 26.5 32.2 28.1 29.3 21.3 32.4 46.0 35.4 26.3 24.2 23.0 34.2 18.4 32.6 38.7 27.8 28.4 25.5 19.9 27.2 21.1 23.7 22.7 27.9 29.0 29.0 28.5 38.8 21.7 49.2 32.4 23.5 25.6 27.4 22.4 26.1 25.3 30.6 31.8 28.6 25.6 28.6 23.9 28.6 24.9 33.4 28.2 50.2 28.4 17.4 31.1 32.1 33.1 16.4 28.7 15.0 24.6 15.1 30.9 8.1 20.9 19.8 37.6 19.8 18.8 18.5 16.2 15.6 17.7 30.8 22.6 28.4 16.5 27.4 20.5 18.7 16.1 24.0 31.6 29.9 36.3 13.1 11.3 19.6 22.1 21.8 18.2 31.1 17.0 17.5 37.2 18.8 34.0 22.4 20.4 16.9 25.8 19.4 19.4 21.2 30.6 20.7 18.8 18.2 15.9 28.6 20.9 20.0 18.0 28.3 31.3 23.6 35.8 51.5 26.3 25.6 24.5 29.2 17.3 27.4 29.6 20.7 16.8 14.1 16.4 46.6 15.4 18.3 18.7 15.0 12.3 10.6 20.8 18.5 22.5 13.6 23.4 19.0 13.9 16.4 23.4 30.9 6.3 15.1 24.6 28.7 15.4 8.1 32.2 29.3 46.0 35.4 27.2 21.1 29.0 28.5 25.6 28.2 8.9 19.5 18.0 29.5 53.2 39.0 30.7 40.8 10.7 23.9 14.0 23.6 26.4 14.9 19.0 21.4 29.2 18.0 0.0 19.0 18.1 29.3 29.1 17.3 25.9 19.0 36.5 35.6 25.8 22.4 24.8 29.1 18.3 38.8 14.4 31.8 27.7 23.4 21.0 37.4 17.3 33.7 38.8 27.6 26.7 26.4 45.5 18.5 27.7 32.0 34.4 ADPRHL1 ARH2 ENSG00000153531 "ADP-ribosylhydrolase like 1" Q8NDY3 13 113399610-113453524 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 89.6;skeletal muscle: 68.1" "Cell type enriched" "Detected in many" 15 "Cardiomyocytes: 122.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.7;T-47d: 26.4" "Region enhanced" "Detected in single" "cerebellum: 2.6" "Not detected" "Not detected" "HPA066478, HPA072123" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA066478: AB_2685673, HPA072123: " "unprognostic (3.03e-1)" "unprognostic (1.38e-2)" "unprognostic (2.31e-1)" "unprognostic (8.88e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (4.88e-4)" "prognostic unfavorable (2.55e-5)" "unprognostic (1.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.35e-1)" "unprognostic (2.56e-1)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (2.14e-2)" "unprognostic (1.53e-2)" "unprognostic (4.99e-3)" "unprognostic (1.02e-1)" 1.8 1.0 0.6 0.2 1.1 0.0 0.8 0.5 3.0 0.4 1.4 0.3 0.0 0.9 0.4 4.0 2.2 1.9 0.7 89.6 0.5 0.8 0.2 0.4 0.5 0.1 0.7 1.1 0.5 1.5 0.0 1.8 1.4 0.3 0.9 0.5 0.0 1.9 0.1 68.1 0.9 3.0 0.2 0.5 0.3 1.0 1.3 0.0 0.1 0.7 21.8 0.6 0.3 0.5 1.9 2.8 1.7 1.6 1.1 2.5 1.0 4.0 9.6 1.0 3.0 3.1 5.0 2.7 1.5 0.7 0.5 0.4 2.7 9.9 1.4 5.7 1.7 2.8 2.2 3.8 0.2 0.4 1.4 1.6 4.1 2.3 0.7 1.0 0.3 1.7 1.7 2.3 3.2 0.4 0.4 0.1 3.6 1.2 0.4 4.0 8.7 0.6 2.4 2.2 10.4 5.1 6.3 2.5 3.6 1.0 0.4 14.7 3.4 1.0 4.8 1.2 1.2 26.4 0.5 0.3 0.1 1.8 4.4 0.5 1.4 1.1 4.7 2.9 0.8 2.1 0.4 1.2 0.1 0.1 1.6 1.8 1.9 0.8 2.5 2.8 0.8 1.4 1.5 1.7 1.1 1.3 0.5 1.3 1.0 0.6 1.1 0.5 3.0 0.5 0.8 0.7 1.1 0.3 0.0 0.0 5.8 0.0 1.9 1.1 1.3 122.4 0.0 8.1 4.5 0.0 0.0 3.2 0.0 2.8 1.1 1.6 3.8 0.0 2.9 2.2 1.5 2.3 0.0 1.0 0.5 1.6 4.1 1.3 0.3 1.3 0.0 0.5 1.7 0.0 5.1 2.1 1.4 5.8 1.4 0.3 1.7 0.0 0.5 1.8 2.6 2.3 2.1 0.0 3.2 2.8 ADPRHL2 "ARH3, FLJ20446" ENSG00000116863 "ADP-ribosylhydrolase like 2" Q9NX46 1 36088875-36093932 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" Hydrolase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026641, HPA027104, HPA027141" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA026641: , HPA027104: AB_10601330, HPA027141: AB_1844619" "unprognostic (3.22e-3)" "unprognostic (5.10e-2)" "unprognostic (2.95e-2)" "unprognostic (1.61e-2)" "unprognostic (5.98e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.10e-7)" "unprognostic (3.71e-2)" "unprognostic (2.63e-1)" "unprognostic (5.34e-2)" "unprognostic (3.17e-2)" "unprognostic (7.80e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (4.37e-2)" "unprognostic (9.31e-2)" "unprognostic (3.65e-2)" "unprognostic (4.74e-2)" 15.5 27.6 17.4 15.2 17.4 16.9 20.0 16.5 22.7 15.9 17.3 30.3 17.7 15.6 14.3 17.8 26.3 28.4 13.5 15.1 19.1 18.9 19.8 16.5 20.7 19.1 25.8 18.5 19.7 27.6 15.1 14.0 20.9 19.7 16.6 12.9 12.2 21.9 20.2 26.4 24.4 17.7 22.2 23.5 18.0 14.1 25.1 20.0 21.2 21.2 22.3 19.7 16.1 15.9 27.7 38.9 34.1 38.8 23.5 29.3 29.2 25.7 10.9 13.0 18.3 12.0 8.8 18.6 19.2 16.2 31.1 30.7 12.9 23.4 18.4 18.8 19.1 16.1 16.1 16.4 29.5 18.7 13.1 20.6 16.7 13.2 17.3 22.7 19.0 9.9 10.3 22.6 28.1 12.3 23.7 19.6 17.8 14.4 15.3 14.5 12.4 19.2 28.8 28.0 15.3 22.7 15.7 13.7 18.5 27.8 21.2 16.0 25.4 14.1 14.8 31.3 18.0 15.2 16.5 13.4 18.0 18.6 24.9 25.4 19.9 19.0 16.3 26.0 18.9 11.0 18.2 32.4 34.1 25.5 38.7 24.0 23.6 27.9 29.3 38.9 27.7 28.3 24.0 31.4 23.5 38.8 24.6 22.8 29.2 17.4 17.4 16.5 22.7 19.1 18.9 25.8 18.5 19.7 20.0 29.8 10.0 22.9 24.4 34.9 17.7 7.3 15.3 30.8 14.8 21.0 5.9 67.9 29.9 47.4 6.6 17.1 20.1 0.0 30.7 33.5 19.7 18.0 14.9 6.0 46.0 9.5 16.7 11.1 11.2 7.9 15.3 22.0 25.3 45.1 12.5 24.3 38.3 15.0 17.0 36.1 15.8 25.8 17.9 24.4 46.2 35.8 59.0 19.2 19.8 22.7 AEBP2 MGC17922 ENSG00000139154 "AE binding protein 2" Q6ZN18 12 19404045-19720801 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020893, HPA022282" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA020893: AB_2670528, HPA022282: AB_2670931" "unprognostic (3.28e-1)" "unprognostic (1.77e-1)" "unprognostic (2.29e-1)" "unprognostic (3.16e-2)" "unprognostic (2.74e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (3.24e-4)" "unprognostic (9.15e-2)" "unprognostic (4.56e-2)" "unprognostic (5.19e-3)" "unprognostic (1.87e-1)" "unprognostic (3.45e-2)" "unprognostic (1.68e-1)" "unprognostic (7.92e-2)" "unprognostic (1.71e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" 20.9 27.6 26.8 23.6 24.0 13.8 19.1 31.9 32.4 28.2 19.6 13.3 14.6 11.8 25.7 16.2 27.0 20.4 20.2 16.9 21.4 13.5 21.1 14.8 16.3 19.0 14.1 25.0 26.5 14.2 30.5 19.0 40.2 15.6 25.1 15.9 18.2 21.8 24.5 15.8 28.7 15.8 25.2 16.6 16.4 15.3 15.8 19.2 19.6 23.7 11.5 22.5 28.9 28.7 5.2 4.0 6.0 4.4 9.6 9.9 1.9 9.3 12.3 12.7 6.6 9.7 12.3 33.8 8.8 10.8 13.6 14.5 14.1 17.0 15.4 7.3 11.9 8.9 11.7 27.7 10.6 21.5 43.5 10.5 13.9 18.1 9.4 11.9 17.3 9.6 10.8 11.6 11.2 16.7 16.3 11.0 10.9 7.7 0.7 12.8 10.9 19.0 25.3 26.6 7.9 5.8 15.2 27.2 10.5 10.0 19.9 3.3 7.6 18.5 7.3 9.2 30.5 10.2 11.1 12.0 12.8 9.8 3.9 13.2 4.2 7.7 33.0 9.6 7.9 9.4 6.0 4.4 4.0 7.3 4.3 7.3 3.7 7.3 6.3 3.1 5.2 6.4 9.9 5.0 9.6 3.3 4.0 7.0 1.9 26.8 24.0 31.9 32.4 21.4 13.5 14.1 25.0 15.6 19.2 23.8 11.0 14.3 21.7 66.7 28.8 19.8 10.2 25.4 28.4 12.2 41.2 51.8 14.9 10.5 1.1 20.4 7.9 0.0 10.4 21.2 32.2 20.9 26.6 11.4 13.3 49.3 21.8 13.5 19.0 1.4 22.7 10.5 27.0 15.4 10.2 17.4 9.7 8.6 27.3 14.6 15.6 19.4 61.4 11.7 23.0 66.5 69.5 17.9 10.8 23.7 AES "GRG5, TLE5" ENSG00000104964 "Amino-terminal enhancer of split" Q08117 19 3052910-3063107 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 15.8;T-cells: 49.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049499 Supported Nucleoplasm NA NA Nucleoplasm "HPA049499: AB_2680795" "unprognostic (1.08e-1)" "unprognostic (3.32e-3)" "unprognostic (7.15e-2)" "prognostic favorable (3.89e-4)" "unprognostic (1.45e-1)" "unprognostic (4.07e-3)" "unprognostic (3.00e-2)" "unprognostic (1.26e-2)" "unprognostic (3.58e-1)" "unprognostic (7.58e-2)" "unprognostic (1.38e-3)" "unprognostic (2.15e-1)" "prognostic favorable (7.74e-4)" "unprognostic (7.17e-3)" "unprognostic (2.60e-1)" "unprognostic (2.08e-2)" "unprognostic (1.78e-3)" 43.9 64.7 83.7 31.4 62.1 30.7 71.9 115.4 95.8 49.7 61.4 23.4 46.9 30.3 51.6 30.9 58.3 52.5 52.1 131.7 70.9 56.0 38.9 35.4 53.9 66.7 56.7 47.7 63.1 66.5 44.1 42.2 64.1 55.1 52.9 32.3 47.7 102.4 73.2 162.7 43.8 34.4 69.9 39.7 56.4 46.9 25.6 26.2 59.2 61.4 49.8 40.3 64.2 55.7 15.8 6.0 6.7 2.3 8.1 49.4 17.6 27.6 32.6 22.6 43.6 27.9 30.7 17.9 34.6 47.5 44.8 39.2 13.7 28.1 40.8 39.8 44.3 15.9 23.8 26.7 51.3 22.3 68.7 12.3 15.1 32.7 24.9 49.9 21.9 20.6 34.2 40.9 21.4 20.1 47.7 41.7 20.9 53.0 20.7 37.3 28.0 54.3 23.9 20.5 18.9 32.4 57.8 26.0 29.6 53.1 57.4 59.3 62.3 33.1 43.8 34.7 11.6 32.8 28.8 58.7 38.8 26.0 33.6 32.5 1.1 0.2 57.2 35.6 36.1 35.6 6.7 1.4 3.6 28.5 2.3 21.9 13.0 37.5 29.7 2.6 15.8 49.4 32.3 1.0 8.1 1.8 6.0 48.5 17.6 83.7 62.1 115.4 95.8 70.9 56.0 56.7 47.7 55.1 26.2 53.6 54.2 112.4 200.3 74.8 153.7 4.5 119.8 33.5 39.8 118.7 45.2 21.8 99.5 139.0 6.8 93.1 241.4 0.0 124.8 329.2 65.0 157.5 39.2 101.0 72.4 50.9 240.5 116.0 102.1 7.0 218.3 69.7 91.1 113.6 195.4 95.4 169.1 172.3 245.8 60.7 51.8 38.8 87.6 2.8 11.5 56.7 78.6 182.7 134.1 286.4 AHDC1 "DJ159A19.3, RP1-159A19.1" ENSG00000126705 "AT-hook DNA binding motif containing 1" Q5TGY3 1 27534035-27604431 "Disease related genes, Predicted intracellular proteins" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028648, HPA028685, HPA028691" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028648: AB_10599276, HPA028685: , HPA028691: AB_10601781" "unprognostic (1.96e-1)" "unprognostic (1.73e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (4.43e-1)" "prognostic favorable (2.68e-4)" "unprognostic (9.20e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (5.21e-3)" "unprognostic (3.96e-1)" "unprognostic (1.76e-1)" "unprognostic (1.46e-1)" "unprognostic (2.30e-1)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" 10.2 17.6 16.9 6.7 12.9 4.6 7.7 40.3 21.7 15.3 8.7 5.8 6.7 5.2 16.8 6.6 20.4 13.5 7.5 9.9 15.2 7.4 7.2 5.6 6.6 5.7 8.2 12.7 19.0 7.5 4.3 16.0 8.4 13.7 8.0 3.0 8.8 15.4 13.1 41.5 21.3 5.6 11.0 14.6 18.2 9.3 8.9 12.9 9.1 12.8 10.9 10.6 9.8 14.0 0.6 1.6 0.9 0.7 2.0 1.4 0.7 7.6 7.0 9.9 5.3 3.2 5.3 10.1 7.2 5.2 5.0 4.2 2.7 7.2 1.1 5.3 4.8 3.0 7.7 1.0 9.4 1.4 2.8 3.8 6.0 6.3 3.6 3.0 1.6 3.1 5.0 3.9 3.5 2.2 5.1 2.6 3.6 7.2 0.9 8.3 3.7 5.1 8.6 7.3 1.9 8.7 22.9 11.9 0.6 3.3 1.0 17.1 6.5 5.0 8.3 2.0 3.5 4.1 1.3 4.8 8.7 7.2 6.4 2.2 2.5 1.7 1.2 7.4 4.8 4.9 0.9 0.4 0.5 1.2 0.6 0.7 0.5 1.0 1.2 0.4 0.6 1.4 1.0 0.7 2.0 0.7 1.6 1.1 0.7 16.9 12.9 40.3 21.7 15.2 7.4 8.2 12.7 13.7 12.9 6.0 6.9 8.2 7.7 44.0 32.7 14.2 2.5 5.3 9.1 17.4 0.0 9.1 3.3 9.3 0.6 11.9 5.6 0.0 11.8 4.0 19.6 9.7 0.0 9.7 11.2 33.4 9.4 14.7 2.1 1.9 48.1 4.1 15.1 2.8 6.1 11.7 12.9 5.8 59.8 4.4 1.8 38.8 15.6 2.6 4.3 49.1 4.7 4.5 6.3 11.3 AKAP5 "AKAP75, AKAP79" ENSG00000179841 "A-kinase anchoring protein 5" P24588 14 64465499-64474503 "Plasma proteins, Predicted intracellular proteins, Transporters" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 39.1" "Group enriched" "Detected in many" 4 "granulocytes: 63.8;Mucus-secreting cells: 24.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "basophil: 5.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 5.7" "Cell line enhanced" "Detected in many" "CACO-2: 14.1" "Group enriched" "Detected in all" 5 "amygdala: 34.7;basal ganglia: 98.5;cerebral cortex: 52.2;hippocampal formation: 56.3" "CAB004308, HPA053891" Enhanced Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB004308: AB_626655, HPA053891: AB_2682294" "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (3.44e-4)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-3)" "unprognostic (1.08e-1)" "unprognostic (3.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.02e-3)" "unprognostic (8.23e-2)" "unprognostic (1.42e-1)" "unprognostic (5.44e-2)" "unprognostic (4.49e-4)" "unprognostic (2.11e-1)" "unprognostic (2.42e-1)" "unprognostic (7.45e-2)" 0.7 0.8 17.3 2.2 39.1 1.0 1.1 2.9 21.8 0.7 5.9 0.2 0.0 1.1 2.3 0.6 1.0 0.8 1.6 0.6 9.9 1.4 2.4 1.2 3.0 2.9 1.3 9.2 0.7 0.5 1.5 1.3 1.8 0.9 1.0 6.1 0.0 0.7 1.0 0.6 1.0 2.4 2.2 0.7 2.0 1.1 0.7 1.3 0.1 1.1 0.0 2.5 1.4 0.7 0.7 0.4 5.7 0.3 0.9 1.0 0.2 1.7 1.4 1.7 1.0 0.6 0.1 5.7 1.3 0.6 1.6 2.1 14.1 4.4 1.3 2.7 1.0 0.2 0.6 3.7 0.3 1.6 2.6 3.1 4.3 2.6 1.2 0.1 0.5 0.6 0.6 0.1 1.1 0.0 2.9 0.6 3.2 0.5 1.0 1.0 1.0 3.4 0.3 1.3 0.2 0.7 4.2 0.8 0.3 2.6 1.6 4.4 2.0 1.5 0.1 0.4 5.5 1.3 0.3 0.8 1.9 5.8 0.2 2.2 3.0 3.3 3.2 1.3 0.5 0.3 5.7 0.3 0.2 1.0 0.1 0.2 0.5 0.3 0.9 0.2 0.7 0.4 0.5 0.7 0.9 0.1 0.4 0.1 0.2 17.3 39.1 2.9 19.9 9.9 1.4 1.3 9.2 0.9 1.3 6.0 3.7 0.5 1.3 0.8 7.0 0.9 2.5 0.0 0.0 0.0 7.9 0.5 0.0 0.5 1.6 0.8 0.9 0.0 0.2 1.4 1.5 1.0 63.8 0.8 0.4 7.9 0.0 0.6 0.8 0.5 0.0 1.3 1.7 0.0 24.0 0.5 0.6 0.0 0.0 0.7 7.9 0.0 0.4 0.5 4.3 0.6 0.6 10.2 4.6 0.7 AKAP8 "AKAP95, DKFZp586B1222" ENSG00000105127 "A-kinase anchoring protein 8" O43823 19 15353385-15379798 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Protein transport, Transcription, Transcription regulation, Transport" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004776 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA004776: AB_1078122" "unprognostic (9.04e-3)" "unprognostic (3.67e-3)" "unprognostic (1.03e-1)" "unprognostic (4.17e-2)" "unprognostic (8.03e-2)" "unprognostic (1.77e-2)" "unprognostic (4.13e-2)" "unprognostic (3.17e-2)" "unprognostic (3.34e-3)" "unprognostic (1.27e-1)" "unprognostic (2.82e-1)" "unprognostic (1.78e-3)" "unprognostic (5.04e-3)" "unprognostic (1.22e-2)" "unprognostic (3.57e-1)" "unprognostic (6.06e-2)" "unprognostic (3.83e-2)" 17.7 12.1 7.0 14.0 11.9 32.8 13.9 15.7 10.9 14.8 11.5 11.6 7.9 18.0 14.9 14.9 13.4 12.9 10.9 10.8 7.6 5.8 12.9 14.2 11.7 12.9 10.9 5.9 13.5 13.7 11.4 9.4 17.8 9.3 11.8 7.7 13.7 13.5 15.8 25.7 16.1 14.5 14.9 9.3 16.0 13.3 12.4 11.1 15.2 12.3 12.1 16.0 13.6 11.4 7.2 9.7 2.3 9.3 5.6 7.9 4.9 14.4 10.5 10.5 9.5 3.6 5.2 12.7 8.8 7.6 8.9 8.1 15.8 18.0 14.4 9.3 8.6 5.8 11.0 7.8 11.0 5.8 13.8 11.5 16.4 12.0 14.5 4.2 22.1 13.4 7.5 5.9 7.6 2.5 3.6 7.6 9.7 11.8 9.8 6.0 18.4 13.3 10.0 15.6 9.5 13.9 14.2 9.4 15.3 4.6 18.7 9.7 10.2 9.3 13.6 10.4 5.3 7.7 9.4 14.6 13.4 8.2 12.9 17.1 13.0 10.5 16.6 9.9 15.4 10.8 0.0 6.7 2.3 7.6 7.3 7.9 7.2 6.5 7.8 9.7 6.4 5.9 6.2 0.9 5.6 9.3 7.8 7.9 4.9 7.0 11.9 15.7 10.9 7.6 5.8 10.9 5.9 9.3 11.1 11.9 25.5 29.7 17.0 17.1 14.3 15.0 7.6 26.8 27.3 12.2 25.5 24.6 5.0 13.6 1.9 18.6 13.8 23.3 18.7 23.1 13.9 14.2 29.0 11.9 11.5 20.6 10.4 9.8 12.7 2.1 17.5 16.3 11.8 20.8 16.1 16.7 14.7 11.5 13.1 7.9 18.1 6.5 21.3 16.3 24.3 14.1 33.6 20.2 18.0 16.9 AKIP1 "BCA3, C11orf17" ENSG00000166452 "A-kinase interacting protein 1" Q9NQ31 11 8911139-8920084 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061391 Supported Nucleoplasm NA NA Nucleoplasm "HPA061391: AB_2684499" "unprognostic (7.79e-3)" "unprognostic (5.65e-2)" "unprognostic (1.60e-1)" "prognostic favorable (5.15e-4)" "unprognostic (6.58e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (6.24e-9)" "unprognostic (1.03e-1)" "unprognostic (5.97e-2)" "unprognostic (5.77e-2)" "unprognostic (6.63e-2)" "unprognostic (8.88e-2)" "unprognostic (6.74e-3)" "unprognostic (1.15e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-3)" "unprognostic (1.19e-1)" 13.2 26.4 18.8 12.0 19.6 10.2 11.7 16.3 19.7 13.2 14.8 16.6 13.5 14.4 19.8 19.4 23.9 14.0 17.4 26.9 16.7 17.7 15.7 13.6 16.2 10.5 17.6 22.6 17.6 14.0 14.5 14.8 17.0 15.4 17.5 12.3 15.8 16.8 16.9 35.2 9.6 16.0 22.3 16.5 20.2 12.7 22.1 11.2 12.5 20.9 13.5 10.7 15.5 14.6 4.5 20.8 1.2 15.6 5.8 25.9 8.6 32.3 30.1 13.3 12.7 12.9 16.0 10.5 23.9 19.3 14.8 14.5 16.1 20.0 5.9 19.2 17.3 16.4 21.8 6.4 11.6 10.3 28.8 16.9 10.3 16.7 14.2 15.0 13.6 12.3 13.9 16.1 7.3 26.8 11.7 13.3 12.4 20.8 6.3 27.1 10.7 10.8 12.5 10.9 16.1 23.1 11.4 9.6 7.4 15.1 13.8 9.3 9.0 27.6 12.3 12.9 8.9 14.1 11.3 21.7 20.8 18.8 35.3 23.3 9.7 24.1 1.4 21.4 16.4 21.9 1.2 15.6 0.6 7.8 13.4 8.1 4.5 9.1 8.6 19.7 4.5 6.2 10.8 0.9 5.8 6.5 20.8 25.9 8.6 18.8 19.6 16.3 19.7 16.7 17.7 17.6 22.6 15.4 11.2 17.9 6.9 4.9 12.3 9.5 14.5 11.6 15.3 16.0 12.5 19.2 9.8 35.6 21.6 35.4 43.6 20.4 5.7 0.0 31.6 34.9 17.3 8.5 48.5 11.9 57.1 23.8 2.4 19.0 20.9 16.4 20.4 20.6 15.1 45.9 8.6 27.2 29.4 17.5 45.3 15.3 14.0 19.4 19.1 37.0 32.5 6.1 9.8 14.4 14.5 7.8 AKIRIN2 "C6orf166, dJ486L4.2, FLJ10342" ENSG00000135334 "Akirin 2" Q53H80 6 87675072-87702209 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 178.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064239 Supported Nucleoplasm No Yes Nucleoplasm "HPA064239: AB_2685222" "unprognostic (9.65e-2)" "unprognostic (2.56e-1)" "unprognostic (8.25e-2)" "unprognostic (8.09e-2)" "unprognostic (3.58e-1)" "unprognostic (1.87e-2)" "unprognostic (1.07e-1)" "unprognostic (5.38e-2)" "unprognostic (6.17e-2)" "unprognostic (6.60e-3)" "unprognostic (1.62e-2)" "unprognostic (2.56e-1)" "unprognostic (1.48e-2)" "unprognostic (9.62e-2)" "unprognostic (9.55e-2)" "unprognostic (2.23e-3)" "unprognostic (1.02e-1)" 27.9 24.1 23.7 19.9 27.0 53.4 22.0 19.3 27.8 13.7 14.1 17.5 10.3 11.4 16.3 22.5 20.5 16.2 14.4 20.1 22.1 21.1 14.8 27.8 21.9 34.5 19.3 18.6 20.7 8.5 12.0 15.5 16.7 17.3 13.4 11.9 21.3 15.5 11.6 54.2 12.9 13.6 15.9 20.2 35.7 12.1 20.7 14.7 45.0 14.1 14.8 26.1 21.4 14.9 15.4 27.0 51.9 25.6 12.5 13.6 11.1 10.4 11.4 32.7 18.5 20.8 14.4 19.2 18.7 12.0 15.7 15.5 18.0 8.2 27.8 20.3 19.3 25.8 16.2 18.2 13.6 18.1 35.3 22.6 16.1 10.3 40.2 22.7 13.7 13.9 16.6 14.1 19.2 19.2 15.2 17.1 11.2 31.2 19.4 20.2 13.8 4.3 28.3 23.2 9.1 17.8 17.2 23.3 11.3 19.4 9.4 24.6 23.4 11.4 6.7 18.2 19.6 8.2 32.8 21.7 12.9 8.7 10.8 24.2 18.8 20.9 17.6 14.1 18.1 20.5 23.1 20.6 21.7 10.7 25.6 11.0 15.4 10.5 10.3 19.5 12.6 8.3 8.7 51.9 12.5 24.6 27.0 13.6 11.1 23.7 27.0 19.3 24.5 22.1 21.1 19.3 18.6 17.3 14.7 23.8 16.6 44.6 173.9 85.7 12.9 18.5 28.1 4.0 19.4 17.4 7.9 40.7 38.1 26.5 41.2 28.6 13.7 23.3 12.9 57.9 48.3 99.6 32.4 25.8 69.7 11.1 11.6 38.6 81.5 82.9 33.1 86.1 70.9 25.2 8.3 53.7 23.7 10.5 26.5 40.8 14.2 6.5 48.6 61.8 46.9 81.2 114.2 55.8 10.9 178.8 AL031777.3 ENSG00000282988 6 26195595-26199293 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 184.8" "Cell type enhanced" "Detected in some" 22 "Cytotrophoblasts: 4.4;Extravillous trophoblasts: 4.1;granulocytes: 3.5;Hofbauer cells: 7.2;Syncytiotrophoblasts: 17.3" "Cell type enriched" "Detected in many" 4 "neutrophil: 18.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 18.7" "Cell line enhanced" "Detected in some" "K-562: 7.9;SiHa: 7.5;U-2 OS: 5.7;U-266/70: 9.5;U-266/84: 6.3" HPA041189 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" 1.3 1.3 0.1 10.9 0.2 13.1 4.8 0.3 0.7 3.9 3.4 0.0 2.2 0.7 1.0 2.2 7.1 1.2 1.9 4.2 0.0 1.0 1.1 3.5 12.7 0.0 0.1 2.4 1.2 0.7 0.0 3.4 0.4 2.9 0.9 0.9 1.1 3.2 0.7 0.7 3.2 1.5 2.6 8.5 1.7 4.3 0.1 184.8 0.9 3.9 11.4 4.0 0.0 2.7 1.1 18.7 1.0 0.6 1.1 0.7 0.8 0.5 0.2 0.7 0.2 0.1 0.0 0.7 0.1 1.5 0.4 0.6 0.9 0.8 2.4 0.0 0.2 1.2 0.3 0.0 0.0 2.6 0.3 0.7 2.5 1.5 0.0 0.2 0.8 1.2 0.0 0.8 0.5 0.1 0.2 0.4 7.9 1.6 0.0 1.1 2.9 1.7 0.2 2.5 2.4 0.7 0.2 4.4 0.0 0.0 0.9 0.2 7.5 0.0 0.5 0.0 4.8 0.0 0.8 0.8 5.7 0.0 0.2 9.5 6.3 0.9 0.6 2.2 0.3 4.3 0.0 1.2 0.3 0.3 0.4 0.9 0.6 0.6 0.4 2.7 0.5 0.8 18.7 0.6 1.0 1.1 1.1 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 1.6 0.0 0.0 0.0 0.0 0.2 4.1 0.0 0.0 3.5 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 AL162417.1 ENSG00000285245 9 133098121-133163914 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.8;HUVEC TERT2: 2.1;K-562: 1.5;REH: 2.4;TIME: 2.3;U-937: 1.5" HPA025961 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA025961: AB_2671795" 2.4 1.8 2.0 5.1 1.5 3.4 6.0 2.6 2.4 1.6 1.5 1.8 1.0 3.2 2.0 1.5 1.9 0.9 2.0 2.0 2.1 1.2 0.9 2.9 8.2 1.2 0.9 6.5 4.6 0.8 0.9 7.9 2.9 2.7 1.1 6.5 2.2 2.6 1.3 1.3 1.0 3.7 2.2 3.0 1.4 0.9 1.5 0.0 2.6 0.4 4.1 2.0 3.0 0.0 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.6 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 2.1 0.1 1.5 0.5 0.0 0.0 0.6 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL512785.2 ENSG00000254706 1 162365407-162383531 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 10.3;U-266/70: 5.7" HPA074060 Approved Nucleoplasm NA NA Nucleoplasm "HPA074060: " "unprognostic (1.41e-2)" "unprognostic (2.12e-1)" "unprognostic (4.50e-1)" "unprognostic (9.12e-3)" "unprognostic (6.73e-2)" "unprognostic (2.09e-2)" "unprognostic (3.57e-1)" "unprognostic (3.42e-1)" "unprognostic (4.63e-2)" "unprognostic (2.96e-1)" "unprognostic (7.61e-3)" "unprognostic (6.07e-2)" "unprognostic (1.19e-2)" "unprognostic (6.10e-2)" 0.9 1.0 0.0 0.2 0.0 1.3 2.7 0.6 0.0 2.6 2.8 2.3 1.5 0.0 1.1 1.4 2.7 0.7 0.1 0.1 2.0 4.6 0.6 0.1 0.3 0.2 4.3 0.0 0.4 0.6 1.3 0.2 5.5 6.3 0.2 1.5 1.2 0.6 0.9 0.0 3.5 2.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.6 4.7 0.0 4.0 3.3 0.3 0.0 0.0 0.2 0.6 0.2 0.0 2.5 2.4 0.0 5.0 0.0 1.4 0.5 0.0 0.8 0.0 0.0 3.7 10.3 0.1 4.1 0.2 0.4 0.0 0.9 0.3 0.0 0.3 1.0 0.4 1.1 1.2 0.2 0.2 3.4 0.1 0.0 1.1 2.7 3.6 0.4 0.0 0.0 2.2 3.5 2.1 2.1 1.7 0.6 2.4 0.8 5.1 0.0 3.0 0.1 0.9 0.0 1.8 5.7 0.0 0.0 0.5 0.2 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALG8 MGC2840 ENSG00000159063 "ALG8, alpha-1,3-glucosyltransferase" Q9BVK2 11 78100936-78139660 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051898 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA051898: AB_2681656" "unprognostic (1.37e-1)" "unprognostic (9.24e-2)" "unprognostic (4.60e-2)" "unprognostic (2.69e-2)" "unprognostic (2.65e-1)" "unprognostic (6.49e-2)" "unprognostic (5.38e-3)" "unprognostic (5.91e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (5.29e-2)" "unprognostic (1.20e-1)" "unprognostic (1.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.34e-1)" "unprognostic (3.78e-2)" "unprognostic (6.37e-2)" 20.2 24.5 18.0 11.2 22.3 9.7 23.7 13.8 17.9 16.5 15.0 20.7 23.9 10.3 14.5 30.9 13.3 18.4 12.3 13.0 15.9 16.0 24.9 40.8 12.8 15.7 16.0 11.6 22.9 23.4 24.2 23.6 21.7 17.1 15.5 19.0 17.6 23.2 19.5 8.2 13.3 13.3 14.8 17.6 13.8 13.1 38.9 16.5 18.2 29.7 13.1 17.4 13.2 11.2 21.9 19.4 3.0 20.3 18.2 19.0 14.9 8.9 24.6 23.6 20.2 20.5 14.4 12.7 13.1 19.7 22.5 21.8 46.6 32.7 20.9 24.3 15.7 29.5 25.7 27.5 18.9 36.4 15.0 16.5 25.2 21.7 20.9 13.3 24.0 16.8 11.5 12.2 26.3 13.1 12.9 16.3 19.0 31.2 21.6 30.1 13.0 20.0 27.1 26.3 60.1 12.9 21.4 10.9 49.8 22.6 13.8 6.9 17.4 18.9 30.7 9.5 22.5 34.3 19.0 10.0 15.3 17.8 34.4 11.3 15.5 30.1 30.9 8.5 23.6 26.4 0.3 17.5 3.0 15.7 19.5 17.5 21.9 16.0 16.1 19.4 16.6 19.0 17.2 1.1 18.2 20.3 18.7 13.0 14.9 18.0 22.3 13.8 17.9 15.9 16.0 16.0 11.6 17.1 16.5 11.9 12.3 25.2 20.6 9.3 13.9 6.3 25.5 10.7 13.6 19.2 17.7 44.1 5.0 18.7 10.7 14.3 6.0 0.0 22.1 52.0 15.3 15.6 11.5 36.4 27.9 15.9 7.5 11.1 14.0 9.8 16.7 17.3 25.3 4.6 15.5 8.2 16.4 5.8 14.9 14.6 12.9 0.0 15.2 115.0 39.1 7.9 27.3 14.9 14.0 15.7 ALKBH2 "ABH2, MGC90512" ENSG00000189046 "AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase" Q6NS38 12 109088188-109093631 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011198, HPA045392, HPA051976" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB011198: AB_261971, HPA045392: AB_2679309, HPA051976: AB_2681680" "prognostic favorable (6.67e-5)" "unprognostic (3.66e-3)" "unprognostic (1.08e-1)" "unprognostic (4.64e-2)" "unprognostic (4.55e-2)" "unprognostic (4.71e-2)" "unprognostic (1.69e-1)" "unprognostic (9.60e-2)" "unprognostic (3.63e-1)" "unprognostic (1.85e-1)" "unprognostic (6.39e-2)" "unprognostic (6.43e-3)" "prognostic unfavorable (1.41e-5)" "unprognostic (1.01e-2)" "unprognostic (7.88e-2)" "unprognostic (6.24e-2)" "prognostic favorable (8.67e-4)" 16.1 12.3 13.6 16.9 13.4 8.2 22.3 12.7 20.5 12.9 11.7 15.2 14.6 9.0 18.0 14.2 14.1 18.3 12.2 12.3 13.5 12.3 12.0 25.6 9.8 17.0 14.3 8.9 23.1 18.5 7.1 7.8 8.1 15.7 15.0 10.7 10.8 18.9 18.5 20.0 25.0 10.7 15.9 15.4 12.3 12.6 14.3 13.5 11.3 13.9 19.7 16.5 15.5 13.8 16.9 13.1 1.1 6.7 9.0 18.2 6.9 13.0 22.4 12.8 28.6 9.0 12.3 20.4 8.7 5.8 9.2 10.3 23.5 9.4 20.1 8.7 5.0 4.3 9.5 21.5 8.7 5.4 17.9 19.2 10.0 12.7 21.4 12.0 13.8 9.4 12.6 19.0 8.7 22.4 11.4 3.5 19.4 14.8 12.0 6.1 23.0 12.7 27.8 17.7 13.8 22.8 11.3 12.5 21.6 12.2 18.2 13.2 22.8 9.2 30.0 18.2 5.0 18.4 8.5 3.6 10.3 11.2 9.7 12.8 16.9 19.6 43.8 8.8 12.0 16.4 1.1 5.1 0.7 8.0 6.7 14.1 16.2 12.1 11.2 5.1 16.9 18.2 10.7 0.9 9.0 4.3 13.1 9.0 6.9 13.6 13.4 12.7 20.5 13.5 12.3 14.3 8.9 15.7 13.5 8.9 4.6 11.9 40.0 45.2 4.3 5.9 10.2 13.4 18.2 8.7 2.0 14.2 13.3 16.1 10.1 14.7 2.6 0.0 20.7 22.0 18.8 11.8 5.8 19.2 9.1 4.8 8.1 4.9 7.1 4.9 24.7 7.4 25.3 3.6 10.2 10.0 18.9 2.9 16.3 14.6 6.4 0.0 27.8 8.8 28.1 52.4 4.2 11.5 14.5 23.5 ALOX5 5-LOX ENSG00000012779 "Arachidonate 5-lipoxygenase" P09917 10 45374176-45446119 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Leukotriene biosynthesis" "Dioxygenase, Hydrolase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.2;bone marrow: 39.9;lymphoid tissue: 41.8" "Cell type enhanced" "Detected in many" 13 "granulocytes: 194.3;Hofbauer cells: 78.7;Kupffer cells: 81.6;Macrophages: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 7.9;CAPAN-2: 6.1;Daudi: 22.3;HMC-1: 16.0;Karpas-707: 7.0;RT4: 10.5;U-266/70: 10.5;U-698: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071285 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA071285: AB_2686379" "unprognostic (2.57e-2)" "unprognostic (2.81e-1)" "unprognostic (4.82e-2)" "unprognostic (1.75e-2)" "unprognostic (7.98e-3)" "unprognostic (1.26e-1)" "unprognostic (5.32e-2)" "unprognostic (8.69e-2)" "unprognostic (1.86e-2)" "unprognostic (6.91e-2)" "unprognostic (5.04e-2)" "unprognostic (3.42e-1)" "prognostic unfavorable (1.80e-5)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.53e-1)" "prognostic favorable (7.18e-4)" 7.4 3.9 2.9 18.3 7.4 39.9 5.8 13.2 3.2 3.4 6.5 6.4 1.0 4.5 3.2 4.7 4.9 5.4 8.0 6.1 3.9 2.6 4.8 2.6 34.7 36.9 9.0 1.7 2.6 10.0 1.3 1.7 11.2 6.1 7.8 3.4 3.2 6.6 3.4 1.1 2.9 14.4 7.8 8.4 41.8 4.5 2.0 6.2 2.4 3.0 1.4 16.7 27.2 10.5 14.8 11.1 45.2 21.3 0.0 0.5 9.5 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 6.1 22.3 0.8 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.2 4.3 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.0 0.8 0.3 10.5 0.5 0.0 0.0 0.2 0.0 0.1 0.1 0.5 0.0 0.0 1.2 0.0 0.0 10.5 1.9 7.4 0.0 0.1 0.0 36.7 21.3 27.0 0.0 20.0 0.1 14.8 0.5 0.2 11.1 10.4 0.0 0.0 45.2 0.0 19.6 0.3 0.1 9.5 2.9 7.4 13.2 3.2 3.9 2.6 9.0 1.7 6.1 6.2 14.9 58.3 34.9 5.4 1.0 0.8 2.0 15.3 4.0 12.5 8.7 2.0 0.5 0.0 19.2 0.4 0.7 2.1 0.0 18.9 1.4 0.6 3.3 194.3 0.6 78.7 0.0 6.8 2.5 81.6 1.1 0.3 81.2 0.0 18.0 0.7 0.3 17.8 0.0 0.0 0.0 0.2 12.9 0.7 0.4 0.8 1.3 3.4 1.3 0.4 35.5 ALPK3 "KIAA1330, MAK, Midori" ENSG00000136383 "Alpha kinase 3" Q96L96 15 84816680-84873482 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 18.4;skeletal muscle: 47.6" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 52.4;Cholangiocytes: 20.4;Exocrine glandular cells: 17.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 9.5;HDLM-2: 7.1;HUVEC TERT2: 10.2;LHCN-M2: 13.9;NTERA-2: 8.5;RH-30: 25.0;THP-1: 6.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA026558 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA026558: AB_1844774" "unprognostic (2.69e-2)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (4.61e-2)" "unprognostic (2.08e-1)" "unprognostic (6.53e-2)" "unprognostic (1.44e-3)" "unprognostic (1.42e-1)" "unprognostic (1.68e-2)" "unprognostic (1.82e-1)" "unprognostic (1.74e-3)" "unprognostic (1.23e-1)" "prognostic favorable (3.95e-7)" "unprognostic (1.76e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (4.87e-2)" 3.7 1.8 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.5 1.4 0.0 0.1 1.7 0.8 0.2 0.3 18.4 0.0 0.6 1.6 1.3 1.0 0.0 0.1 0.0 2.1 8.8 6.9 0.6 0.4 0.0 0.4 0.2 47.6 0.0 0.2 0.8 0.0 0.0 1.2 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.1 0.1 0.1 0.2 0.0 9.5 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.0 7.1 1.1 1.1 0.2 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.1 10.2 0.0 0.0 0.0 13.9 0.5 0.0 0.1 8.5 0.2 0.0 0.0 25.0 0.1 0.0 2.6 0.0 0.1 0.0 1.3 0.0 1.3 0.0 6.1 0.2 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.0 2.4 0.5 0.0 0.8 3.1 52.4 20.4 0.0 1.2 8.7 15.7 0.2 0.0 3.1 0.1 4.5 0.0 0.0 17.3 0.6 1.5 0.5 1.1 1.5 7.9 0.0 8.7 2.5 0.3 0.0 0.0 1.9 3.3 8.2 0.3 0.9 13.6 0.2 0.0 1.7 3.0 0.0 8.3 0.2 3.1 0.1 0.6 0.0 0.3 0.8 ALX4 "FPP, KIAA1788, PFM, PFM2" ENSG00000052850 "ALX homeobox 4" Q9H161 11 44260444-44310166 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 10.5;retina: 14.4" "Group enriched" "Detected in some" 15 "Cardiomyocytes: 17.1;Leydig cells: 4.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.4;BJ: 4.5;HAP1: 6.3;HEK 293: 6.5;HEL: 8.8;K-562: 4.1;SiHa: 9.4" "Region enriched" "Detected in single" 8 "olfactory region: 11.1" "Region enriched" "Detected in single" 34 "olfactory region: 27.7" HPA001903 Supported Nucleoplasm NA NA Nucleoplasm "HPA001903: AB_2666495" "unprognostic (7.56e-5)" "unprognostic (1.69e-1)" "unprognostic (5.40e-2)" "unprognostic (2.74e-1)" "unprognostic (7.24e-3)" "unprognostic (2.63e-4)" "unprognostic (1.95e-1)" "unprognostic (2.89e-2)" "unprognostic (2.33e-4)" "unprognostic (5.13e-2)" "unprognostic (1.25e-1)" "unprognostic (1.55e-1)" "unprognostic (1.34e-6)" "unprognostic (3.62e-2)" "unprognostic (2.85e-1)" "unprognostic (2.02e-3)" "unprognostic (2.03e-1)" 1.6 0.1 0.6 0.0 1.6 0.0 10.5 0.7 1.6 2.0 0.1 1.4 0.0 0.0 2.4 2.4 0.5 0.8 0.3 0.9 1.3 0.7 0.3 0.0 0.5 0.0 0.4 2.2 0.2 0.1 0.2 0.3 0.0 0.3 2.0 0.0 14.4 5.6 0.1 3.1 2.8 0.0 1.1 0.2 0.1 0.1 2.5 0.5 0.0 0.4 4.2 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 0.0 4.5 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.3 0.0 0.0 1.3 6.5 8.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.7 1.6 1.3 0.7 0.4 2.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 AMD1 SAMDC ENSG00000123505 "Adenosylmethionine decarboxylase 1" P17707 6 110874770-110895713 "Enzymes, Predicted intracellular proteins" "Polyamine biosynthesis, Spermidine biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 104.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029281, HPA029282" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA029281: AB_10600101, HPA029282: AB_10599965" "prognostic unfavorable (3.87e-4)" "unprognostic (4.68e-2)" "unprognostic (1.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.91e-6)" "unprognostic (1.18e-1)" "unprognostic (2.03e-2)" "unprognostic (6.50e-2)" "unprognostic (2.25e-1)" "unprognostic (4.20e-1)" "prognostic favorable (4.28e-4)" "unprognostic (8.62e-3)" "unprognostic (1.55e-1)" "unprognostic (4.41e-2)" "unprognostic (7.71e-2)" 16.7 15.2 29.7 16.9 35.6 38.1 17.8 27.3 34.2 18.6 18.6 45.7 12.5 14.9 18.9 14.2 28.9 14.7 17.5 18.5 32.5 21.5 25.2 16.9 16.9 18.5 39.0 22.0 16.9 20.2 21.8 26.2 33.8 32.7 104.7 19.4 12.8 17.5 19.2 15.3 14.5 13.5 18.4 38.3 16.7 18.4 15.8 46.0 19.4 25.5 20.1 24.6 12.6 16.8 6.6 12.9 42.0 14.0 6.1 9.2 6.5 20.8 14.3 17.5 33.1 26.5 16.9 22.9 30.1 33.4 23.5 27.7 22.7 13.2 36.9 14.6 19.0 25.0 14.4 41.3 27.2 32.4 21.6 23.9 38.2 13.0 23.8 15.8 32.9 22.9 11.3 25.2 16.2 32.8 8.2 20.4 19.0 28.5 32.2 39.5 12.6 43.7 25.3 21.5 20.8 13.1 24.1 17.6 21.9 26.6 28.0 22.5 16.0 18.3 23.3 26.5 14.9 15.0 28.2 13.4 15.6 11.8 83.0 32.4 8.8 14.3 37.7 18.0 26.4 20.0 15.0 9.8 14.7 7.6 11.6 8.9 6.3 7.6 8.7 12.9 6.6 9.2 9.0 42.0 6.1 14.0 5.8 8.8 6.5 29.7 35.6 27.3 34.2 32.5 21.5 39.0 22.0 32.7 46.0 35.7 72.7 96.8 225.1 280.1 92.0 87.2 86.6 30.8 108.1 52.4 56.9 32.2 124.3 65.9 25.2 75.1 78.4 70.0 59.9 125.5 124.4 304.0 93.3 52.5 68.2 73.1 119.2 47.9 101.7 37.7 40.6 70.6 124.9 74.9 52.0 241.3 72.3 49.3 47.0 70.8 99.1 19.4 119.5 83.5 72.8 251.9 45.7 59.8 63.1 119.5 ANAPC2 "APC2, KIAA1406" ENSG00000176248 "Anaphase promoting complex subunit 2" Q9UJX6 9 137174784-137188549 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018692, HPA066539" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB018692: AB_2258285, HPA066539: AB_2685688" "unprognostic (5.20e-2)" "unprognostic (8.86e-3)" "unprognostic (1.43e-2)" "prognostic favorable (8.91e-5)" "unprognostic (2.29e-1)" "unprognostic (2.38e-2)" "unprognostic (4.46e-1)" "unprognostic (4.84e-2)" "unprognostic (1.07e-1)" "unprognostic (3.36e-1)" "prognostic favorable (1.07e-7)" "unprognostic (7.41e-2)" "prognostic favorable (3.67e-4)" "prognostic favorable (2.87e-4)" "unprognostic (1.35e-1)" "unprognostic (8.46e-2)" "unprognostic (9.88e-2)" 14.6 15.5 13.3 15.3 17.9 19.0 14.1 21.8 26.9 12.2 11.8 28.5 17.7 17.1 15.1 12.3 13.6 13.8 16.4 14.1 12.5 10.2 12.3 19.1 13.1 19.1 22.4 14.5 15.4 23.7 10.6 12.6 11.0 16.2 15.2 5.0 15.5 25.7 14.5 20.0 25.0 16.2 9.4 13.3 19.3 16.2 31.6 13.4 14.0 14.4 11.7 15.2 13.2 11.7 1.4 2.3 0.6 3.2 1.1 2.4 3.3 10.2 22.8 5.5 9.1 6.7 4.0 17.4 9.2 5.9 8.8 6.8 13.7 10.7 11.1 10.9 6.1 8.2 21.2 6.6 7.1 1.3 14.1 11.3 6.6 26.6 12.4 7.9 10.1 11.6 8.0 5.7 5.9 3.2 4.4 10.7 10.3 9.7 13.7 4.1 28.9 12.1 14.3 11.2 13.7 17.4 14.5 13.6 20.6 6.8 9.1 7.3 11.0 14.0 19.1 5.8 2.8 20.3 13.9 11.2 13.1 10.4 15.5 8.3 6.7 9.8 12.0 10.5 7.0 9.4 0.3 2.3 0.4 2.4 2.4 1.4 1.4 1.2 1.9 1.9 1.4 1.4 1.5 0.6 1.1 3.2 2.3 1.2 3.3 13.3 17.9 21.8 26.9 12.5 10.2 22.4 14.5 16.2 13.4 0.0 0.3 6.5 7.4 8.2 4.7 3.1 7.6 0.0 1.2 10.4 3.9 22.6 11.6 9.4 31.6 5.7 18.6 0.0 9.4 9.5 8.5 6.4 11.5 10.4 13.6 1.6 9.8 12.3 9.5 40.9 10.3 6.6 13.5 16.2 14.6 3.5 6.9 7.0 8.9 13.4 4.3 0.0 9.9 30.0 24.3 8.3 20.5 10.2 11.3 6.3 ANAPC5 APC5 ENSG00000089053 "Anaphase promoting complex subunit 5" Q9UJX4 12 121308245-121399896 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039457, HPA039801" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA039457: AB_10795676, HPA039801: AB_2676687" "unprognostic (3.41e-1)" "unprognostic (1.16e-3)" "unprognostic (5.37e-2)" "unprognostic (7.24e-3)" "unprognostic (5.35e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (2.31e-5)" "unprognostic (1.63e-1)" "unprognostic (6.91e-2)" "unprognostic (7.85e-2)" "unprognostic (1.93e-3)" "unprognostic (4.94e-2)" "prognostic unfavorable (2.01e-9)" "unprognostic (1.79e-1)" "unprognostic (1.79e-1)" "unprognostic (6.87e-2)" "unprognostic (3.28e-1)" 28.9 26.9 23.2 24.1 37.3 29.3 31.3 34.1 38.1 28.2 26.3 57.0 21.8 22.3 33.7 28.4 26.0 34.2 20.8 24.8 25.4 21.6 23.6 33.5 22.2 31.6 53.8 25.1 30.0 40.1 27.4 34.1 22.3 34.3 22.9 29.6 24.9 47.3 24.7 48.6 29.2 23.9 26.1 36.5 30.0 27.6 18.2 45.5 36.5 27.5 32.1 37.7 26.3 25.9 30.7 36.4 27.0 32.1 34.9 38.7 42.0 27.7 39.3 17.7 12.6 31.2 34.6 31.2 27.0 30.9 31.5 28.3 31.3 14.4 37.9 27.9 39.3 12.9 23.9 41.0 26.6 25.2 32.6 45.6 34.5 25.6 35.8 34.2 49.9 34.5 34.6 25.4 32.2 25.8 29.2 39.7 33.7 43.5 23.0 25.3 39.9 43.1 49.0 28.0 27.5 43.3 38.4 25.9 48.9 22.9 28.9 22.5 22.6 40.2 16.8 27.4 21.5 40.2 47.8 24.9 21.3 15.3 14.5 22.1 29.7 30.0 44.5 28.0 37.7 26.2 18.6 30.7 27.0 26.6 32.1 32.4 30.7 30.3 32.5 36.4 23.9 30.6 29.0 7.5 34.9 27.3 24.2 38.7 42.0 23.2 37.3 34.1 38.1 25.4 21.6 53.8 25.1 34.3 45.5 38.7 59.2 66.3 57.9 58.3 59.3 43.2 20.4 104.4 66.0 52.4 53.0 76.6 59.7 42.2 18.2 53.7 39.2 70.0 77.0 87.6 63.3 47.3 65.9 57.2 49.3 73.1 81.8 41.7 46.3 27.6 74.2 48.5 45.5 86.6 46.8 37.6 53.3 38.6 59.8 55.9 55.9 51.8 61.8 48.6 79.0 56.7 68.5 76.2 66.1 44.7 ANGEL1 "Ccr4e, KIAA0759" ENSG00000013523 "Angel homolog 1" Q9UNK9 14 76786178-76826246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 45.0;Late spermatids: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000948 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA000948: AB_2227189" "unprognostic (4.81e-2)" "unprognostic (2.37e-2)" "unprognostic (2.67e-1)" "unprognostic (2.46e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-1)" "unprognostic (7.33e-2)" "prognostic favorable (3.43e-4)" "unprognostic (9.24e-2)" "unprognostic (1.01e-1)" "prognostic favorable (5.46e-4)" "unprognostic (3.03e-1)" "unprognostic (6.92e-3)" "unprognostic (1.42e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-1)" "unprognostic (6.32e-2)" 7.2 13.0 14.7 8.1 16.4 4.3 9.0 10.0 16.6 7.2 7.1 17.9 3.3 6.6 11.0 18.8 5.1 9.1 8.0 11.6 15.1 10.8 7.0 11.3 10.5 8.6 22.5 11.7 15.2 35.8 13.1 18.9 7.7 14.5 6.7 8.2 11.7 10.7 6.7 8.1 4.7 6.3 9.2 16.5 18.6 11.5 27.5 14.9 6.1 9.3 4.6 7.8 7.2 5.3 9.0 9.3 1.9 8.3 6.6 10.2 6.7 9.5 10.4 11.6 10.4 9.5 8.7 10.8 5.7 8.3 6.0 7.7 9.9 13.6 17.5 8.5 5.0 8.2 12.1 11.0 10.3 10.1 7.3 9.9 10.5 6.5 7.6 6.2 5.6 6.7 9.2 12.9 5.6 11.1 8.6 15.1 18.7 10.4 4.6 6.2 18.6 10.1 8.5 13.3 15.3 13.9 12.3 7.9 10.3 9.1 13.6 16.5 7.3 8.7 12.0 5.4 11.0 23.5 5.9 7.2 7.0 6.2 5.2 4.7 12.0 9.0 10.8 6.0 9.9 8.7 0.7 5.9 1.9 7.9 6.7 9.6 9.0 7.1 7.4 9.3 7.7 10.2 7.5 1.8 6.6 8.3 6.2 5.7 6.7 14.7 16.4 10.0 15.0 15.1 10.8 22.5 11.7 14.5 14.9 6.0 10.9 4.5 1.4 1.0 2.2 6.1 10.2 0.0 2.3 3.5 9.8 1.3 0.0 2.9 45.0 5.8 1.3 0.0 2.8 2.3 1.9 2.3 1.1 8.1 6.4 0.0 4.1 6.2 4.7 52.1 2.0 4.3 1.7 0.0 4.1 4.3 2.5 0.0 4.6 1.0 8.0 6.5 1.4 17.4 3.2 0.4 1.0 2.5 3.7 1.0 ANKDD1A FLJ25870 ENSG00000166839 "Ankyrin repeat and death domain containing 1A" Q495B1 15 64911902-64958700 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Leydig cells: 57.2;Muller glia cells: 36.1;Peritubular cells: 73.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 19.2;RT4: 14.4;U-266/84: 18.6" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 29.1" HPA040757 Approved Approved Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA040757: AB_10960566" "unprognostic (3.72e-4)" "unprognostic (1.86e-1)" "unprognostic (6.07e-3)" "unprognostic (3.25e-2)" "unprognostic (4.78e-1)" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (1.22e-3)" "unprognostic (5.11e-3)" "unprognostic (5.57e-2)" "unprognostic (4.37e-2)" "unprognostic (1.60e-1)" "unprognostic (3.15e-7)" "unprognostic (1.06e-1)" "unprognostic (1.98e-1)" "unprognostic (8.04e-3)" "unprognostic (1.64e-2)" 3.9 12.4 7.9 3.7 9.5 3.2 2.3 7.9 9.4 4.3 2.2 0.6 3.5 1.9 4.7 7.6 5.1 5.9 3.9 3.6 8.3 3.9 2.0 1.3 4.4 6.3 4.2 9.8 5.8 7.6 3.5 4.4 5.4 3.5 3.3 0.5 2.4 3.3 4.2 1.5 4.9 2.4 6.5 3.0 14.2 2.6 8.6 1.1 0.0 3.8 0.9 1.6 5.1 4.0 1.0 1.5 1.4 1.9 6.8 4.0 0.8 1.0 2.9 1.4 1.3 2.2 1.7 5.7 1.3 3.5 1.4 2.0 1.6 1.4 1.3 1.5 2.9 1.2 1.4 2.9 0.2 1.1 0.7 0.8 1.4 3.0 1.1 1.6 1.1 2.3 1.3 0.4 0.9 0.5 0.8 1.0 1.3 0.2 19.2 0.4 2.7 0.5 2.1 1.7 0.5 1.3 0.8 0.8 9.1 0.1 14.4 2.9 3.5 0.7 1.0 1.3 1.3 1.1 1.1 1.4 2.6 2.7 2.3 1.3 5.3 18.6 1.0 2.9 2.6 0.8 1.0 0.9 0.1 2.1 1.9 0.8 1.0 1.1 3.2 1.5 0.7 0.8 0.8 1.4 6.8 1.8 0.0 4.0 0.8 7.9 9.5 7.9 9.4 8.3 3.9 4.2 9.8 3.5 1.1 0.0 2.2 0.0 4.9 4.9 9.4 1.2 0.0 0.0 1.2 0.0 11.8 2.7 0.0 0.7 0.8 8.0 0.0 0.0 1.9 4.6 7.0 2.2 5.7 0.0 4.9 3.2 1.2 1.3 5.4 0.9 57.2 7.9 10.1 0.0 0.0 36.1 4.2 0.0 73.9 0.0 6.6 12.9 13.9 1.4 1.1 3.1 1.8 4.1 0.0 4.1 ANKRD20A1 "ANKRD20A, DKFZp434A171" ENSG00000260691 "Ankyrin repeat domain 20 family member A1" Q5TYW2 9 67859147-67902094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3;testis: 6.5" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Cardiomyocytes: 2.6;Ciliated cells: 4.0;Spermatocytes: 6.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "eosinophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "Karpas-707: 7.1;U-266/70: 11.7;U-266/84: 3.9" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (4.92e-1)" "unprognostic (4.31e-3)" "unprognostic (3.97e-1)" "unprognostic (2.30e-2)" "unprognostic (5.94e-2)" "unprognostic (2.26e-2)" "unprognostic (1.31e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-2)" "unprognostic (7.17e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-2)" 0.1 0.0 0.0 0.3 0.1 0.8 0.3 0.2 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.9 0.2 0.1 0.0 0.4 0.1 0.3 0.8 0.0 6.5 0.5 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.3 0.0 0.2 0.4 1.4 0.6 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.3 1.8 0.0 0.0 0.4 0.9 1.0 0.4 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.2 1.8 0.4 7.1 0.0 0.0 1.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 2.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.3 0.6 1.0 11.7 3.9 0.0 0.5 0.0 1.9 0.0 0.0 2.3 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.0 1.3 0.0 0.0 0.0 0.0 2.6 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 1.1 0.0 1.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 6.3 1.9 0.0 0.0 0.0 0.9 0.0 ANKRD20A2 ENSG00000183148 "Ankyrin repeat domain 20 family member A2" Q5SQ80 9 40223285-40266392 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "testis: 7.6" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 1.7;granulocytes: 1.1;Spermatocytes: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 16.7;U-266/70: 2.8;U-266/84: 5.0" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (4.24e-3)" "unprognostic (9.19e-2)" 0.1 0.1 0.4 0.0 1.4 0.2 0.3 1.0 1.2 0.1 0.4 0.0 0.0 0.5 1.2 0.7 0.1 1.9 0.7 0.7 0.3 0.2 1.2 0.0 0.4 0.0 1.4 1.1 0.8 0.0 0.4 1.1 1.1 0.4 0.3 0.2 0.1 0.0 0.1 1.5 0.0 7.6 0.5 0.0 0.0 0.3 0.1 0.9 0.9 0.0 0.0 0.6 0.0 0.2 1.3 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.8 1.6 16.7 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.1 2.8 5.0 0.0 0.0 0.0 0.8 0.1 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.2 0.0 0.0 0.1 ANKRD20A3 ENSG00000276203 "Ankyrin repeat domain 20 family member A3" Q5VUR7 9 66106815-66153135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "esophagus: 1.1;lung: 1.3;testis: 2.0" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 5.3;Horizontal cells: 4.8;Spermatocytes: 16.4;Spermatogonia: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;HDLM-2: 5.2;RPTEC TERT1: 1.4;WM-115: 1.3" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (4.27e-2)" 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.5 0.0 0.1 0.1 0.0 5.2 0.0 0.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.2 0.8 1.8 0.0 5.3 0.0 0.0 3.9 0.0 0.0 0.0 2.0 0.0 1.0 0.0 0.9 0.0 0.0 0.6 3.5 0.0 0.1 4.8 0.0 0.6 1.3 1.8 0.3 0.0 0.0 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.1 16.4 6.5 0.1 0.0 0.0 0.2 1.0 ANKRD20A4 ENSG00000172014 "Ankyrin repeat domain 20 family member A4" Q4UJ75 9 64369394-64413142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 7 "Spermatocytes: 40.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 1.7;plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 4.4;Karpas-707: 4.3" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (3.40e-2)" "unprognostic (1.02e-1)" "unprognostic (2.69e-2)" "unprognostic (2.56e-1)" "unprognostic (9.24e-2)" "unprognostic (1.11e-2)" "unprognostic (3.97e-3)" "unprognostic (8.99e-2)" "unprognostic (2.88e-1)" "unprognostic (4.12e-1)" "unprognostic (4.01e-2)" "unprognostic (1.82e-2)" "unprognostic (1.16e-1)" "unprognostic (8.10e-2)" "unprognostic (5.84e-2)" 1.5 1.0 0.7 0.2 1.6 3.9 0.9 2.3 1.9 0.3 0.9 0.6 0.5 0.2 1.7 0.5 0.2 1.7 0.8 1.0 0.7 0.1 1.1 0.1 0.6 1.4 2.4 0.0 0.9 1.0 0.4 1.4 0.9 0.0 0.4 0.6 1.2 0.0 0.3 1.0 0.9 2.1 0.7 0.0 0.3 0.6 0.0 1.4 1.7 0.0 0.0 0.8 0.0 0.7 0.4 2.3 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 1.0 0.3 1.9 0.2 0.0 4.4 1.4 1.3 0.4 0.7 0.0 1.0 2.0 0.0 0.0 0.1 0.1 0.5 0.6 2.8 3.0 4.3 0.1 0.3 0.8 0.2 0.3 2.5 0.9 0.0 1.0 0.6 0.8 0.5 1.9 0.6 0.2 0.1 2.0 0.5 1.9 0.2 0.9 0.0 1.8 0.5 0.1 0.9 0.6 1.0 0.4 0.0 0.4 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.4 0.0 0.0 3.0 0.0 0.0 0.8 0.5 1.5 5.5 0.0 2.7 0.0 0.0 2.0 0.3 0.0 0.1 2.3 0.4 5.9 0.0 3.2 0.1 0.4 0.4 1.1 0.0 0.0 1.6 2.9 0.6 1.2 0.8 0.0 0.7 0.0 0.0 2.5 0.6 0.8 3.5 1.1 0.1 0.3 0.0 0.9 40.3 2.7 0.5 0.2 1.7 1.7 2.3 ANKRD20A8P ANKRD20B ENSG00000229089 "Ankyrin repeat domain 20 family member A8, pseudogene" Q5CZ79 2 94811046-94857282 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 3.2;thyroid gland: 5.0" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.7;Cardiomyocytes: 3.0;Club cells: 9.1;granulocytes: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "RT4: 2.8;U-2 OS: 9.8" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (3.08e-1)" "unprognostic (3.86e-1)" "unprognostic (3.79e-2)" "unprognostic (1.30e-4)" "unprognostic (2.29e-1)" "unprognostic (1.55e-1)" "unprognostic (6.38e-2)" 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 5.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.7 0.0 0.0 0.0 0.0 3.0 0.0 1.4 9.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD22 MGC22805 ENSG00000152766 "Ankyrin repeat domain 22" Q5VYY1 10 88822132-88851818 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 40.2;stomach 1: 27.6;tongue: 29.0" "Cell type enhanced" "Detected in many" 16 "Basal keratinocytes: 33.1;Suprabasal keratinocytes: 89.8;Urothelial cells: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 15.4" "Group enriched" "Detected in many" 13 "granulocytes: 15.4;monocytes: 6.8" "Cell line enhanced" "Detected in some" "A-431: 8.5;CAPAN-2: 27.2;HL-60: 8.0;OE19: 20.7;RT4: 18.4;T-47d: 12.5;U-937: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA012922 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA012922: AB_1844838" "unprognostic (1.86e-1)" "unprognostic (1.48e-3)" "unprognostic (9.73e-3)" "prognostic favorable (8.73e-6)" "unprognostic (1.18e-1)" "unprognostic (2.81e-2)" "unprognostic (2.39e-2)" "unprognostic (1.50e-1)" "unprognostic (4.57e-2)" "unprognostic (7.21e-3)" "prognostic unfavorable (6.15e-4)" "unprognostic (1.09e-3)" "unprognostic (1.05e-2)" "unprognostic (4.87e-3)" "unprognostic (4.17e-2)" "unprognostic (3.18e-3)" "unprognostic (1.01e-3)" 0.4 0.5 2.3 8.4 3.6 5.3 2.3 0.3 3.2 6.7 6.7 0.5 0.0 2.0 0.3 0.2 21.9 0.3 4.3 1.1 4.0 0.6 6.0 1.6 1.3 6.1 3.6 0.2 0.3 40.2 0.1 1.6 0.2 2.7 2.0 7.2 0.1 3.7 0.0 0.3 18.5 2.1 1.3 7.4 8.8 27.6 0.3 1.4 7.9 0.3 29.0 14.6 4.4 8.6 0.1 0.4 15.4 6.8 0.5 0.8 1.2 8.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.1 0.1 0.0 0.0 6.7 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 8.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.7 6.4 0.1 20.7 0.1 0.0 0.0 0.0 0.1 18.4 0.0 0.0 0.0 1.3 0.0 0.0 12.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.3 0.1 0.1 4.8 2.5 0.1 6.8 0.0 0.0 0.4 0.1 0.4 0.1 0.8 0.2 15.4 0.5 1.2 0.4 0.0 1.2 2.3 3.6 0.3 3.2 4.0 0.6 3.6 0.2 2.7 1.4 0.0 3.0 0.0 16.2 33.1 0.0 0.1 10.2 0.0 1.2 7.0 0.0 0.0 0.0 2.6 0.0 0.0 6.4 0.0 5.2 0.0 0.7 10.4 0.0 0.0 2.4 0.0 1.7 0.0 7.2 0.0 0.3 12.3 1.7 1.0 11.8 0.0 4.5 20.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 89.8 0.0 0.7 11.2 29.8 ANKRD61 ENSG00000157999 "Ankyrin repeat domain 61" A6NGH8 7 6031376-6036386 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "bone marrow: 8.7;testis: 9.1" "Group enriched" "Detected in some" 19 "Early spermatids: 44.1;Late spermatids: 19.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029511, HPA050732" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029511: AB_10602430, HPA050732: " "unprognostic (1.40e-1)" "unprognostic (1.03e-3)" "unprognostic (9.32e-2)" "unprognostic (5.67e-2)" "unprognostic (1.73e-1)" "unprognostic (2.56e-2)" "unprognostic (6.76e-2)" "unprognostic (2.65e-1)" "unprognostic (8.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.98e-1)" "unprognostic (6.68e-2)" "unprognostic (2.73e-2)" "unprognostic (5.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.55e-2)" "unprognostic (2.63e-1)" 0.5 0.5 0.0 0.7 0.2 8.7 0.7 0.5 0.9 0.4 0.3 0.6 0.6 0.0 0.4 0.5 0.2 0.6 0.1 0.1 0.3 0.5 0.5 1.1 0.0 0.8 1.0 0.1 0.5 0.4 0.4 0.0 0.9 0.0 0.6 2.1 0.8 0.0 0.2 0.9 0.9 9.1 0.9 0.0 0.5 0.5 0.6 1.5 0.9 1.1 0.0 0.8 0.3 2.2 6.0 1.8 2.8 0.3 0.3 2.6 1.4 0.4 0.6 0.6 3.0 5.6 1.1 0.6 0.2 2.6 2.2 1.0 0.0 0.7 0.3 0.8 1.5 12.7 0.4 0.2 1.7 2.6 0.4 1.2 0.5 1.1 1.3 0.5 1.7 2.0 1.8 0.7 3.8 0.3 1.8 0.9 0.4 0.7 1.6 0.5 0.3 0.5 2.9 1.4 2.5 1.4 1.6 0.2 2.9 3.0 1.1 1.2 2.4 4.9 2.9 1.8 1.6 1.8 0.9 0.7 1.4 1.5 0.9 1.1 0.0 0.1 1.1 0.0 0.0 0.0 0.8 1.5 0.6 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 ANKRD65 ENSG00000235098 "Ankyrin repeat domain 65" E5RJM6 1 1418420-1421769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;fallopian tube: 33.6" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "myeloid DC: 4.8;plasmacytoid DC: 10.4" "Lineage enriched" "Detected in single" 20 "dendritic cells: 10.4" "Group enriched" "Detected in some" 7 "Hep G2: 20.3;RT4: 20.0;SCLC-21H: 27.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065720 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA065720: AB_2685545" "unprognostic (2.17e-2)" "unprognostic (2.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.77e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-2)" "unprognostic (1.59e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.64e-1)" "unprognostic (4.39e-1)" "unprognostic (1.16e-1)" "unprognostic (4.43e-2)" "unprognostic (5.14e-2)" "unprognostic (3.02e-3)" "unprognostic (1.81e-2)" "unprognostic (8.04e-2)" "unprognostic (2.76e-2)" 4.6 1.1 12.4 2.8 20.8 0.4 4.2 8.0 13.3 6.7 4.8 21.0 3.7 2.2 4.0 5.6 6.7 33.6 2.7 2.2 12.0 8.6 1.9 0.9 9.9 7.1 37.8 8.2 6.9 13.3 1.1 0.6 6.3 13.7 8.9 1.8 2.1 14.0 21.2 2.8 4.8 2.1 3.8 16.7 1.4 4.3 3.1 28.0 4.2 1.8 1.0 6.3 13.2 3.3 0.5 10.4 0.3 0.3 0.0 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.5 0.0 2.6 0.2 2.5 0.0 0.3 0.2 0.0 0.0 20.3 0.5 0.0 0.0 0.2 3.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 2.7 0.0 0.0 20.0 27.7 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 4.8 0.5 0.1 0.4 0.0 0.0 0.0 10.4 0.0 0.2 12.4 20.8 8.0 13.3 12.0 8.6 37.8 8.2 13.7 28.0 20.8 25.3 0.0 11.4 1.9 8.4 0.6 12.7 56.2 20.5 1.8 0.0 21.2 8.3 12.9 0.0 5.0 0.0 0.0 27.8 0.4 3.8 7.3 8.1 0.6 2.0 7.9 1.7 1.8 0.6 0.0 19.2 2.9 3.3 1.8 0.0 16.0 12.0 0.0 27.3 0.3 2.2 0.0 2.6 0.4 0.3 2.8 14.1 0.0 0.0 7.9 ANKRD7 TSA806 ENSG00000106013 "Ankyrin repeat domain 7" Q92527 7 118214669-118496171 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "testis: 184.1" "Group enriched" "Detected in some" 4 "Early spermatids: 2368.8;Spermatocytes: 2786.2" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 5.2;JURKAT: 5.8;SCLC-21H: 9.8;U-266/70: 12.7;WM-115: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043489, HPA052941" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043489: AB_10959304, HPA052941: " "unprognostic (1.29e-1)" "unprognostic (7.22e-4)" "unprognostic (3.13e-3)" "unprognostic (6.16e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-1)" "unprognostic (5.51e-1)" "unprognostic (9.46e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (1.45e-2)" "unprognostic (1.55e-2)" "unprognostic (3.35e-2)" "unprognostic (3.57e-4)" "unprognostic (3.32e-2)" 0.1 0.1 0.5 0.0 0.8 0.0 0.1 0.1 1.0 0.1 0.1 0.0 0.0 0.1 0.1 1.3 0.1 0.1 0.0 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.9 0.0 1.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 184.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 3.1 0.4 1.0 0.0 0.0 0.8 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.2 1.6 0.0 3.1 0.0 0.1 0.3 0.1 1.4 1.0 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.4 0.7 0.0 0.4 0.0 5.8 0.0 2.2 1.4 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 2.4 0.0 0.0 1.9 0.0 0.0 1.2 0.4 0.0 1.1 0.3 0.0 12.7 0.6 0.5 1.8 0.0 4.0 0.0 0.0 1.0 0.4 0.0 0.3 3.1 0.2 0.6 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.4 0.0 0.1 0.5 0.8 0.1 1.0 0.4 0.1 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 2.5 0.0 0.0 0.0 0.0 0.1 5.0 0.1 2368.8 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 3.2 0.0 0.0 0.0 635.0 36.5 0.0 1.7 0.0 0.0 1.2 0.1 0.0 27.6 1.4 0.0 25.8 0.1 2786.2 17.7 0.1 0.0 0.0 0.0 0.0 ANXA8 ANX8 ENSG00000265190 "Annexin A8" P13928 10 47460162-47484158 "Predicted intracellular proteins" "Blood coagulation, Hemostasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 41.6;skin 1: 60.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 92.3;Ciliated cells: 25.4;Club cells: 73.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 16.1" "Cell type enhanced" "Detected in some" "myeloid DC: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 73.7;HBEC3-KT: 107.5;hTCEpi: 60.8;hTERT-HME1: 23.2;RT4: 27.0" "HPA045246, HPA047451" Approved Nucleoplasm NA NA Nucleoplasm "HPA045246: AB_2679271, HPA047451: AB_2680052" "unprognostic (8.32e-4)" "unprognostic (2.52e-1)" "unprognostic (2.44e-1)" "unprognostic (6.15e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (5.94e-2)" "unprognostic (2.88e-2)" "unprognostic (2.40e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (2.68e-4)" "unprognostic (1.19e-1)" "unprognostic (7.55e-15)" "unprognostic (1.04e-2)" "unprognostic (9.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.39e-1)" 0.1 0.0 0.1 3.7 0.1 0.0 2.3 0.1 0.1 2.9 0.4 0.1 0.1 0.0 0.1 1.3 41.6 0.2 0.1 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.1 0.4 0.1 0.0 0.1 7.7 0.1 1.2 0.0 0.3 0.1 1.8 0.1 60.7 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 2.5 9.5 10.2 0.1 0.0 5.5 1.1 2.1 0.7 0.0 0.5 20.5 2.6 0.0 0.0 0.0 0.0 6.1 0.4 0.0 0.0 0.0 1.3 5.9 0.0 0.4 0.1 0.3 73.7 0.0 107.5 0.0 4.7 0.0 0.0 6.7 0.0 4.4 0.0 0.2 0.0 60.8 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 10.7 3.1 0.0 1.6 0.0 0.5 0.0 0.0 6.4 0.1 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 92.3 8.2 0.0 9.1 1.0 0.0 1.6 5.1 25.4 73.9 3.5 0.0 5.7 0.0 3.2 0.4 0.4 0.7 0.0 0.4 7.2 0.5 1.1 1.1 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 1.8 5.1 0.0 0.0 15.7 ANXA8L1 "ANXA8L2, bA145E20.2, bA301J7.3" ENSG00000264230 "Annexin A8 like 1" Q5VT79 10 46375627-46391784 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.9;skin 1: 75.4;tongue: 34.2" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 26.8;Cholangiocytes: 17.8;Ciliated cells: 20.1;Club cells: 36.4;Extravillous trophoblasts: 14.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;myeloid DC: 5.0" "Group enriched" "Detected in many" 5 "dendritic cells: 5.0;monocytes: 3.2" "Cell line enhanced" "Detected in some" "HaCaT: 72.8;HBEC3-KT: 110.8;hTCEpi: 29.4;SiHa: 26.2" "HPA045246, HPA047451" Approved Nucleoplasm NA NA Nucleoplasm "HPA045246: AB_2679271, HPA047451: AB_2680052" "unprognostic (3.67e-3)" "unprognostic (4.56e-3)" "unprognostic (9.14e-3)" "unprognostic (3.92e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.27e-2)" "unprognostic (1.08e-2)" "unprognostic (8.05e-2)" "unprognostic (6.94e-3)" "unprognostic (8.33e-5)" "unprognostic (3.43e-1)" "unprognostic (8.26e-10)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.0 1.5 0.0 0.0 4.8 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.7 1.2 35.9 1.2 0.0 0.9 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.0 0.9 0.0 0.0 1.1 0.7 0.0 75.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 34.2 13.3 6.9 0.6 0.0 5.0 0.8 3.2 0.5 0.0 0.5 14.5 3.7 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.0 0.0 0.3 2.6 0.0 0.1 0.0 0.1 72.8 0.0 110.8 0.0 6.2 0.0 0.0 7.1 0.0 2.6 0.0 0.1 0.0 29.4 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 16.9 0.0 0.0 26.2 2.3 0.0 1.4 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 26.8 1.4 0.0 3.1 0.0 0.0 3.0 17.8 20.1 36.4 0.0 0.0 7.2 0.0 0.7 0.1 0.0 2.0 0.0 0.2 14.1 0.8 1.7 0.0 0.0 0.6 0.0 0.0 0.6 0.0 1.3 0.3 0.0 0.0 0.0 0.1 0.1 5.6 0.3 0.0 0.0 0.0 12.9 0.0 0.2 1.0 1.0 5.3 0.0 0.1 3.0 APEX1 "APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1" ENSG00000100823 "Apurinic/apyrimidinic endodeoxyribonuclease 1" P27695 14 20455191-20457772 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000956, HPA002564, CAB004294, CAB047307" Supported Supported Nucleoplasm Yes No 98000 Nucleoplasm "CAB004294: AB_626685, CAB047307: , HPA000956: AB_2666158, HPA002564: AB_1078174" "unprognostic (2.80e-3)" "unprognostic (1.39e-1)" "unprognostic (1.55e-2)" "unprognostic (4.74e-3)" "unprognostic (1.97e-2)" "unprognostic (5.88e-2)" "prognostic unfavorable (7.82e-5)" "unprognostic (4.21e-2)" "unprognostic (3.14e-2)" "unprognostic (2.46e-2)" "unprognostic (2.42e-2)" "unprognostic (1.68e-1)" "unprognostic (1.38e-1)" "unprognostic (1.22e-1)" "unprognostic (1.83e-2)" "unprognostic (2.54e-1)" "unprognostic (7.08e-2)" 43.9 52.8 30.6 33.2 32.5 55.6 43.6 24.1 44.9 38.5 41.9 37.3 28.4 44.1 53.2 30.1 40.7 42.9 46.4 34.4 28.0 27.4 44.4 61.3 31.8 44.5 30.2 31.1 64.7 48.4 31.8 21.7 29.4 34.4 36.1 39.8 36.0 35.5 38.9 53.2 41.2 37.6 40.9 30.1 51.0 41.7 20.9 28.3 73.2 51.2 38.5 48.4 41.8 32.7 35.0 53.0 1.5 23.7 20.6 32.5 38.4 44.6 54.9 49.3 45.4 34.7 50.1 42.5 42.0 45.2 62.6 54.3 40.0 44.4 86.3 37.5 32.0 33.5 47.9 58.6 44.4 58.2 38.5 25.0 34.9 32.5 66.7 36.5 110.9 36.3 51.7 49.0 40.7 40.4 50.2 52.2 35.7 40.5 28.4 50.1 43.5 71.0 46.7 48.5 50.7 49.7 79.0 55.4 36.2 52.5 60.3 59.5 37.8 45.5 56.8 45.1 36.3 34.5 50.2 33.7 33.0 55.4 33.2 39.1 38.2 66.1 58.2 14.8 70.5 41.7 0.1 23.7 1.5 19.0 20.5 25.9 35.0 23.8 22.6 46.8 31.4 32.5 28.3 1.5 20.6 12.4 53.0 14.1 38.4 30.6 32.5 24.1 44.9 28.0 27.4 30.2 31.1 34.4 28.3 59.6 45.2 101.2 74.7 94.4 52.3 42.8 86.6 72.3 79.6 64.6 39.3 161.9 127.6 119.2 16.8 57.5 33.9 0.0 91.3 165.4 86.9 49.2 78.7 65.2 158.8 27.0 115.1 39.3 80.7 4.0 74.5 109.4 60.8 100.0 78.8 68.5 83.2 73.7 60.5 126.7 45.4 51.8 136.6 6.3 43.7 84.8 84.9 76.1 136.8 42.5 APLF "C2orf13, MGC47799, Xip1, ZCCHH1" ENSG00000169621 "Aprataxin and PNKP like factor" Q8IW19 2 68467561-68655862 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 19 "Early spermatids: 110.5;Late spermatids: 132.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 9.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029396, HPA034642, HPA034643" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA029396: AB_10610285, HPA034642: AB_2674259, HPA034643: AB_10602431" "unprognostic (9.37e-2)" "unprognostic (1.04e-1)" "unprognostic (2.14e-1)" "unprognostic (4.29e-3)" "unprognostic (5.18e-3)" "unprognostic (2.39e-3)" "unprognostic (3.24e-1)" "unprognostic (1.46e-1)" "unprognostic (4.00e-2)" "unprognostic (2.78e-1)" "unprognostic (1.25e-3)" "unprognostic (3.28e-1)" "unprognostic (5.02e-3)" "unprognostic (8.44e-2)" "unprognostic (5.95e-2)" "unprognostic (1.35e-2)" "unprognostic (1.85e-3)" 5.2 4.4 3.8 7.3 6.5 2.8 8.2 1.1 5.0 8.0 5.7 3.1 3.8 2.6 8.8 4.0 10.6 3.3 4.1 3.8 4.7 2.0 3.7 5.1 3.4 5.8 3.6 2.1 4.3 3.8 4.1 5.1 6.2 3.2 8.5 2.7 2.3 6.4 4.8 5.4 9.2 3.3 9.2 5.6 5.7 3.6 4.1 6.1 5.1 4.4 7.5 5.8 6.9 6.9 1.1 1.4 9.3 1.2 1.5 2.2 0.9 3.6 0.9 4.1 4.1 5.5 7.4 2.1 3.2 5.8 1.9 2.4 2.3 3.0 6.7 2.6 2.6 4.5 1.2 0.5 4.4 4.6 6.2 0.8 5.5 0.8 1.4 2.6 1.9 4.9 4.1 3.7 2.7 4.1 4.9 1.4 4.2 1.1 4.8 1.9 0.6 2.7 5.0 2.3 3.6 1.6 3.6 1.4 3.0 3.8 2.0 1.2 2.7 3.2 0.4 3.8 6.0 0.3 1.1 3.6 6.7 1.5 3.4 2.5 4.4 2.4 5.2 2.9 2.7 4.4 9.3 0.9 3.1 0.9 1.2 1.0 1.1 1.4 1.3 1.3 1.0 1.5 0.8 0.0 1.5 0.9 1.4 2.2 0.9 3.8 6.5 1.1 5.0 4.7 2.0 3.6 2.1 3.2 6.1 3.0 1.6 0.9 2.2 2.2 0.1 2.6 0.0 1.4 3.4 0.0 2.0 5.3 0.0 2.7 110.5 2.5 0.0 0.0 1.7 2.0 2.3 1.5 0.0 0.8 1.9 3.2 3.4 2.5 0.3 132.8 4.0 1.7 0.0 6.4 0.5 0.5 0.9 0.0 1.8 1.9 0.3 0.0 2.7 5.0 3.9 2.9 4.1 0.0 0.7 1.3 APOBEC3A "ARP3, PHRBN" ENSG00000128383 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3A" P31941 22 38952741-38992778 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 113.5;bone marrow: 42.7;lymphoid tissue: 31.5" "Cell type enriched" "Detected in many" 5 "Urothelial cells: 223.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 15.8" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "intermediate monocyte: 113.5" "Lineage enriched" "Detected in many" 7 "monocytes: 113.5" "Cell line enhanced" "Detected in some" "Karpas-707: 3.5" "HPA043237, HPA056980, HPA066719" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711" "unprognostic (6.45e-3)" "unprognostic (1.44e-2)" "unprognostic (1.12e-1)" "unprognostic (5.21e-3)" "unprognostic (1.31e-1)" "unprognostic (2.72e-2)" "unprognostic (1.91e-1)" "unprognostic (1.91e-1)" "unprognostic (3.52e-1)" "unprognostic (2.59e-3)" "unprognostic (9.01e-3)" "unprognostic (2.00e-1)" "unprognostic (1.13e-2)" "unprognostic (1.76e-1)" "unprognostic (4.98e-2)" "unprognostic (3.41e-1)" "unprognostic (1.91e-1)" 4.3 0.2 0.3 11.0 0.4 42.7 0.5 0.2 0.7 1.7 0.8 0.2 0.0 0.6 1.3 1.4 7.2 3.3 3.4 0.9 0.2 0.3 0.7 1.3 16.0 15.8 1.9 0.5 0.7 0.7 0.1 0.3 4.9 0.7 0.3 0.2 2.0 5.9 0.0 1.2 0.3 0.8 0.8 1.7 31.5 0.8 0.4 0.2 1.4 0.7 22.3 29.0 2.7 6.4 0.2 1.2 15.3 113.5 0.1 0.1 15.2 0.7 0.3 0.5 2.5 0.2 0.4 1.1 0.3 0.0 0.0 0.1 0.2 1.6 0.6 1.7 0.2 0.3 2.1 0.6 0.4 0.0 0.8 0.2 0.2 1.7 0.2 0.2 0.3 1.1 0.2 0.9 0.3 0.2 0.3 0.1 0.5 0.3 3.5 0.1 1.3 0.5 0.5 1.1 0.5 0.2 0.9 0.5 0.7 0.6 1.3 1.2 0.6 0.4 1.4 0.2 0.3 1.1 0.1 1.5 1.1 0.9 0.4 0.4 0.5 0.8 1.0 1.4 2.5 1.2 3.5 26.8 0.9 0.0 113.5 0.1 0.2 0.0 0.0 1.2 0.1 0.0 0.0 15.3 0.1 31.1 0.1 0.1 15.2 0.3 0.4 0.2 0.7 0.2 0.3 1.9 0.5 0.7 0.2 26.8 47.2 0.0 9.0 1.1 0.5 0.0 0.0 14.7 33.0 1.8 3.9 0.2 0.0 0.0 0.5 0.1 4.3 23.3 0.2 0.2 0.5 4.8 24.4 0.0 15.6 0.0 0.0 0.6 18.0 0.0 0.3 11.3 15.1 0.0 0.0 0.8 0.8 0.0 0.4 0.0 0.8 0.0 0.9 0.1 0.5 5.9 0.2 1.0 0.0 223.8 APOBEC3B "FLJ21201, PHRBNL" ENSG00000179750 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3B" Q9UH17 22 38982347-38992804 "Cancer-related genes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.1" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 4.7;Ductal cells: 7.3;Melanocytes: 6.8;Pancreatic endocrine cells: 5.7;Urothelial cells: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 10.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 60.7;Karpas-707: 68.8" "HPA056980, HPA066719" Approved Nucleoplasm NA NA Nucleoplasm "HPA056980: AB_2683298, HPA066719: AB_2685711" "unprognostic (2.92e-2)" "prognostic favorable (2.58e-5)" "unprognostic (4.29e-2)" "unprognostic (1.19e-1)" "unprognostic (2.50e-1)" "unprognostic (1.35e-1)" "unprognostic (1.69e-2)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (6.36e-2)" "unprognostic (1.08e-2)" "unprognostic (5.88e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (8.47e-2)" "unprognostic (2.98e-2)" "unprognostic (2.70e-1)" "unprognostic (1.04e-1)" 1.6 2.3 0.3 4.4 2.2 20.1 1.4 0.3 1.2 2.3 9.9 0.7 0.3 5.8 2.0 2.4 4.6 1.2 2.2 1.6 0.6 0.2 3.6 0.9 2.5 4.3 0.3 0.3 1.7 5.7 0.4 0.3 6.4 0.8 2.1 10.0 1.3 4.8 0.3 4.1 1.9 8.8 1.0 0.7 10.4 3.8 2.0 0.3 5.9 3.3 0.3 12.0 2.0 2.4 10.2 0.8 1.7 5.8 2.2 3.8 5.9 60.7 6.8 2.6 16.4 0.3 1.5 4.5 5.6 4.9 10.8 14.2 13.0 11.1 0.6 5.1 5.6 15.9 26.1 0.3 1.1 10.9 21.9 0.6 17.5 1.5 3.4 0.1 14.5 10.6 0.6 0.1 11.2 0.5 2.2 4.1 0.0 9.8 68.8 16.6 1.6 0.0 8.1 0.0 5.8 6.1 0.4 26.3 21.8 2.2 10.2 0.4 0.0 0.0 0.0 3.7 0.4 8.1 4.2 2.5 11.9 20.8 1.8 0.1 15.3 4.2 0.0 8.5 16.2 24.1 0.5 1.3 0.0 0.3 5.8 0.0 10.2 0.8 0.5 0.8 3.2 0.0 0.4 1.7 2.2 1.8 0.1 3.8 5.9 0.3 2.2 0.3 1.2 0.6 0.2 0.3 0.3 0.8 0.3 0.0 1.7 0.8 2.2 4.7 0.0 0.2 0.0 1.4 2.3 0.0 0.0 0.3 0.0 7.3 0.0 0.0 0.5 0.0 1.6 1.9 0.4 1.2 0.0 0.0 1.8 0.0 0.0 0.0 1.6 0.0 0.0 1.6 6.8 1.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.7 0.0 0.6 9.5 APPBP2 "Hs.84084, KIAA0228, PAT1" ENSG00000062725 "Amyloid beta precursor protein binding protein 2" Q92624 17 60443149-60526219 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 317.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066852, HPA078370" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA066852: , HPA078370: " "unprognostic (1.43e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-3)" "unprognostic (2.97e-2)" "unprognostic (2.93e-2)" "unprognostic (4.53e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (7.67e-2)" "unprognostic (9.24e-2)" "unprognostic (2.39e-1)" "unprognostic (2.90e-3)" "unprognostic (6.87e-2)" "unprognostic (5.07e-2)" "unprognostic (1.03e-1)" "unprognostic (3.84e-1)" "unprognostic (1.31e-1)" "unprognostic (9.36e-2)" 18.8 16.0 16.1 13.2 22.6 5.3 15.9 28.1 27.3 17.5 13.9 25.4 12.9 10.1 18.5 13.8 14.5 14.5 16.1 10.1 16.6 16.0 18.4 15.0 16.4 10.9 20.8 15.4 27.9 17.1 23.4 20.4 24.3 25.1 19.4 12.8 13.4 13.0 15.0 14.5 12.6 10.8 16.7 18.5 15.4 14.5 30.8 21.2 17.9 17.8 7.2 11.0 15.8 15.3 12.7 12.0 15.7 14.2 15.6 16.7 9.3 7.0 9.7 10.2 8.5 10.9 11.6 5.7 11.2 7.8 6.3 8.0 4.7 6.2 7.4 18.9 9.4 10.8 6.1 7.2 3.9 11.1 6.6 5.5 9.4 9.1 9.6 11.7 7.7 10.4 11.3 5.2 6.6 6.4 9.8 9.7 4.6 7.0 8.6 9.1 48.1 10.8 3.9 2.2 7.8 4.3 7.2 17.0 8.6 9.7 11.7 11.1 9.5 9.7 1.6 8.0 5.9 13.6 5.3 12.5 14.2 17.4 9.7 8.5 9.3 29.2 6.2 9.4 4.6 10.0 13.5 12.0 15.0 10.2 8.7 11.7 9.7 12.0 11.2 12.0 12.7 16.7 12.2 15.7 15.6 14.2 7.2 11.5 9.3 16.1 22.6 28.1 24.1 16.6 16.0 20.8 15.4 25.1 21.2 26.8 20.0 19.3 13.1 16.0 57.6 22.2 15.3 12.0 18.2 14.0 17.7 21.5 16.6 15.5 317.9 26.3 12.3 0.0 14.7 7.2 23.0 21.2 23.0 17.1 16.8 35.0 31.8 39.3 19.2 94.9 32.8 14.8 16.9 17.2 22.0 40.8 15.2 14.4 36.7 27.2 33.4 38.8 23.1 33.4 25.1 16.2 52.9 20.6 18.9 15.3 AQR "fSAP164, IBP160, KIAA0560" ENSG00000021776 "Aquarius intron-binding spliceosomal factor" O60306 15 34851782-34969839 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 108.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040624, HPA055647" Enhanced Nucleoplasm No No Nucleoplasm "HPA040624: AB_2677050, HPA055647: AB_2682874" "unprognostic (1.73e-1)" "unprognostic (3.71e-2)" "unprognostic (2.97e-1)" "unprognostic (1.32e-2)" "unprognostic (1.03e-1)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-2)" "unprognostic (2.65e-1)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "prognostic favorable (4.83e-4)" "unprognostic (2.97e-1)" "unprognostic (2.47e-1)" "unprognostic (3.84e-1)" "unprognostic (3.13e-2)" 15.5 15.8 8.0 14.0 12.4 9.7 16.1 11.2 14.3 16.6 11.2 11.8 8.7 9.2 18.5 11.8 18.3 12.3 8.7 9.9 8.4 7.5 14.4 11.2 10.7 12.6 8.7 6.9 15.5 13.6 16.8 13.2 15.3 13.2 12.0 11.8 12.4 15.1 11.3 8.7 14.2 13.0 14.3 8.3 16.8 12.9 15.8 9.2 27.9 14.8 8.5 16.5 15.7 14.9 5.9 5.5 7.1 5.1 4.5 6.5 2.9 5.0 13.1 8.7 9.1 11.8 11.0 4.5 6.2 7.9 8.3 7.5 5.9 3.1 4.1 4.0 10.5 5.5 8.0 14.6 8.9 9.2 5.8 5.9 13.2 11.6 5.4 6.7 10.7 6.2 8.5 5.9 6.5 6.9 7.8 7.0 3.3 9.3 4.1 8.2 3.4 6.2 7.2 8.6 11.7 5.4 8.5 15.0 4.1 8.4 8.9 9.5 7.4 10.1 9.7 2.2 8.0 6.8 8.4 9.1 6.2 3.4 4.2 5.5 5.0 6.1 8.4 7.7 9.3 6.2 7.1 4.7 2.7 6.5 5.1 5.7 4.0 5.7 6.2 3.8 5.9 5.8 6.4 2.3 4.5 3.0 5.5 4.6 2.9 8.0 12.4 11.2 13.4 8.4 7.5 8.7 6.9 13.2 9.2 11.9 27.0 11.9 11.9 8.5 25.3 14.6 20.4 29.4 36.4 14.0 108.0 13.3 3.3 11.5 36.0 17.9 15.5 0.0 12.3 12.0 10.6 12.5 23.1 17.1 13.1 23.8 12.7 31.9 17.0 6.9 19.2 12.7 15.1 13.6 17.7 17.4 15.9 14.0 17.3 10.3 38.7 6.5 9.8 19.3 20.1 8.4 11.1 20.8 19.1 11.2 ARHGAP8 "BPGAP1, FLJ20185" ENSG00000241484 "Rho GTPase activating protein 8" P85298 22 44752558-44862788 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 29.3" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 18.6;Ductal cells: 23.6;Pancreatic endocrine cells: 23.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "T-reg: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 12.4;BEWO: 23.4;CACO-2: 14.8;HEK 293: 20.2;MCF7: 20.9;SK-BR-3: 20.2" HPA069694 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA069694: AB_2686173" "unprognostic (4.14e-1)" "unprognostic (1.21e-2)" "unprognostic (6.88e-2)" "unprognostic (8.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-2)" "unprognostic (5.51e-2)" "unprognostic (2.88e-1)" "unprognostic (1.50e-1)" "unprognostic (8.78e-3)" "unprognostic (9.58e-2)" "unprognostic (7.65e-6)" "unprognostic (8.59e-2)" "unprognostic (3.29e-1)" "unprognostic (2.32e-2)" "unprognostic (2.22e-2)" 0.5 0.1 1.7 5.6 0.4 0.2 7.5 0.3 0.4 2.2 10.6 0.6 29.3 1.2 2.6 13.0 5.7 6.1 11.5 0.3 0.3 0.4 18.2 0.9 3.9 0.3 0.3 0.3 0.9 14.6 4.5 5.2 22.4 1.2 10.0 5.7 1.9 28.4 24.8 0.3 1.4 3.6 1.2 0.3 6.7 4.3 3.0 0.3 0.7 15.2 2.4 4.9 2.0 1.8 0.2 0.7 0.2 0.4 0.1 2.2 0.3 12.4 0.1 0.2 0.1 0.0 0.2 23.4 0.1 1.5 0.0 0.1 14.8 6.7 0.1 0.8 0.0 0.2 9.3 4.4 10.7 0.1 0.0 20.2 0.0 0.3 0.1 0.0 0.0 0.2 0.1 4.7 0.1 0.2 0.3 0.0 0.2 0.4 0.3 0.0 20.9 0.0 0.0 3.1 9.4 0.0 0.0 0.0 0.2 5.7 8.5 1.3 0.0 0.0 20.2 0.4 5.3 8.7 0.1 0.1 0.0 0.7 0.1 0.1 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.6 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.0 0.7 2.2 0.3 1.7 0.4 0.3 0.4 0.3 0.4 0.3 0.3 1.2 0.3 3.0 12.2 0.0 18.6 0.6 0.4 0.8 5.1 4.0 6.8 17.4 3.9 16.5 0.0 23.6 2.3 1.0 2.6 0.0 9.4 0.9 1.3 16.8 0.0 0.0 2.7 0.0 6.9 0.0 0.6 2.5 0.3 0.0 0.0 0.0 7.6 0.5 23.2 3.5 0.4 1.4 0.3 0.0 0.7 0.0 3.9 0.3 5.8 1.0 12.3 15.6 ARHGEF10 "Gef10, KIAA0294" ENSG00000104728 "Rho guanine nucleotide exchange factor 10" O15013 8 1823976-1958641 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.4" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024649 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024649: AB_1845002" "unprognostic (2.51e-1)" "unprognostic (3.60e-2)" "unprognostic (2.39e-1)" "unprognostic (1.08e-2)" "unprognostic (1.02e-1)" "unprognostic (3.57e-1)" "unprognostic (1.44e-1)" "unprognostic (7.27e-2)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "unprognostic (2.43e-2)" "unprognostic (9.29e-2)" "unprognostic (3.37e-2)" "unprognostic (1.81e-2)" "unprognostic (4.42e-1)" "unprognostic (3.18e-2)" "unprognostic (4.46e-2)" 13.5 8.2 11.1 6.9 18.4 1.8 9.7 3.5 14.2 11.6 10.8 20.4 9.3 3.2 19.5 7.1 7.2 8.9 8.0 19.0 13.5 7.9 6.5 2.3 17.7 5.4 17.0 8.6 9.6 5.8 4.9 4.6 9.9 13.4 9.3 5.7 10.2 7.5 10.4 3.8 14.2 5.3 15.0 18.0 5.7 8.4 19.1 21.0 1.6 8.4 4.4 4.1 10.2 19.9 0.0 0.0 0.0 0.0 1.4 0.7 0.1 6.4 8.2 7.9 3.3 6.6 9.8 1.7 8.5 7.2 6.7 7.3 2.6 3.0 0.0 1.3 11.8 11.1 4.9 7.1 10.7 8.4 0.0 2.8 2.8 7.2 0.0 6.3 0.0 1.8 7.1 6.1 6.8 6.2 10.2 12.7 2.2 3.1 0.0 7.6 3.5 4.1 0.8 6.0 4.8 4.4 0.3 7.4 0.0 4.9 2.3 1.4 1.8 6.7 0.2 4.2 10.3 3.4 1.6 15.2 6.6 3.8 0.1 8.2 0.0 2.7 0.0 5.1 6.2 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.2 0.1 11.1 18.4 3.5 14.2 13.5 7.9 17.0 8.6 13.4 21.0 3.0 5.5 0.0 10.3 34.1 5.3 11.8 12.7 1.4 4.5 7.0 9.8 0.5 0.0 6.9 13.7 23.5 0.5 0.0 1.7 0.8 29.2 17.0 0.0 0.9 1.4 20.6 1.2 16.5 0.6 16.5 32.5 2.7 21.9 0.0 4.1 15.5 8.6 0.0 24.8 0.3 9.9 0.0 22.7 32.7 18.3 13.2 0.2 1.3 1.9 4.1 ARID1A "B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1" ENSG00000117713 "AT-rich interaction domain 1A" O14497 1 26693236-26782110 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005456, CAB016334" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB016334: AB_673396, HPA005456: AB_1078205" "unprognostic (2.83e-1)" "unprognostic (1.81e-1)" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (2.44e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (4.18e-4)" "unprognostic (3.02e-1)" "unprognostic (3.66e-2)" "unprognostic (1.34e-1)" "unprognostic (9.69e-2)" "unprognostic (7.76e-2)" "unprognostic (1.01e-2)" "unprognostic (1.62e-2)" "unprognostic (6.05e-2)" "unprognostic (2.66e-1)" "unprognostic (6.54e-2)" 18.6 18.4 17.4 24.9 17.0 33.8 27.8 23.6 19.1 20.3 23.7 21.7 23.9 15.8 24.1 17.3 23.2 20.6 21.9 15.5 14.8 12.8 13.7 15.9 18.8 35.6 20.3 19.2 24.1 23.9 27.5 15.8 19.3 17.2 16.5 16.4 18.9 21.4 23.1 22.6 20.6 20.7 18.4 15.4 25.9 19.5 16.5 19.8 57.3 24.8 14.2 24.5 24.4 20.4 4.3 5.3 7.4 3.3 4.7 5.1 3.5 19.2 18.3 25.9 27.0 7.5 7.2 12.2 9.0 7.9 12.4 8.8 13.3 13.0 27.2 7.9 11.7 7.8 11.7 22.5 10.0 14.5 33.6 8.8 23.1 11.9 8.9 6.2 34.2 7.4 8.3 7.1 14.6 10.5 6.9 10.6 19.7 27.6 30.5 8.0 9.1 28.8 13.3 27.4 12.5 8.5 30.1 17.1 15.4 7.7 13.0 24.3 20.0 15.8 13.4 10.9 15.0 3.9 19.4 18.7 13.3 12.9 12.4 14.6 14.5 19.1 12.5 8.1 21.9 11.7 0.4 3.3 2.9 4.0 2.9 5.1 4.3 3.2 4.9 3.1 4.3 4.0 4.4 7.4 4.7 2.8 5.3 1.5 3.5 17.4 17.0 23.6 19.1 14.8 12.8 20.3 19.2 17.2 19.8 56.6 36.8 33.6 18.1 65.3 60.2 31.1 28.1 25.4 28.4 36.6 49.1 31.8 1.7 31.8 14.2 37.2 28.4 0.0 32.5 32.1 42.6 39.3 56.9 53.9 43.0 69.9 45.7 51.0 93.5 7.5 35.6 45.4 38.8 34.3 56.1 31.2 40.3 31.6 39.3 14.5 37.1 51.8 27.2 46.0 55.3 82.4 30.7 41.2 46.0 27.7 ARID1B "6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R" ENSG00000049618 "AT-rich interaction domain 1B" Q8NFD5 6 156777374-157210779 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016511, HPA075291" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA016511: AB_1845008, HPA075291: AB_2686743" "prognostic unfavorable (1.04e-4)" "unprognostic (9.82e-2)" "unprognostic (1.73e-1)" "unprognostic (5.42e-2)" "unprognostic (7.47e-2)" "unprognostic (1.40e-2)" "unprognostic (2.73e-2)" "unprognostic (2.89e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (2.53e-1)" "unprognostic (5.33e-2)" "unprognostic (1.07e-3)" "unprognostic (2.46e-1)" "unprognostic (1.80e-1)" "unprognostic (3.53e-1)" "unprognostic (1.16e-1)" 18.3 15.0 20.2 18.8 20.9 25.8 19.3 42.1 32.8 20.0 17.4 26.3 21.7 15.3 23.0 14.2 18.6 20.7 15.9 16.8 20.4 11.3 14.2 10.6 17.0 18.3 19.4 16.7 30.2 18.5 47.4 29.2 12.2 17.7 17.7 13.3 24.0 20.0 20.2 30.6 27.3 17.8 21.7 14.9 21.1 15.0 10.7 24.6 24.0 23.8 13.3 26.3 23.5 21.0 9.5 11.9 5.6 3.0 2.7 5.6 1.6 7.2 11.1 16.4 22.3 13.5 12.4 11.2 7.7 10.1 10.0 10.0 9.8 10.5 22.8 4.8 13.0 12.3 9.2 14.0 12.5 9.9 22.9 9.8 16.5 11.2 11.6 9.5 13.7 12.1 14.0 10.1 15.2 13.6 10.9 13.8 14.9 19.4 17.8 7.1 8.5 15.9 15.5 8.3 9.6 5.9 36.3 7.0 12.3 6.9 13.4 15.0 19.2 15.4 16.2 9.0 9.0 10.9 21.6 14.2 12.6 13.4 11.6 15.0 12.3 11.0 29.2 11.0 16.5 16.9 5.6 3.0 2.5 5.4 2.4 5.0 6.8 4.7 3.8 2.3 9.5 4.0 5.6 5.5 2.7 2.6 11.9 4.6 1.6 20.2 20.9 42.1 32.8 20.4 11.3 19.4 16.7 17.7 24.6 44.7 46.7 59.6 18.3 42.2 35.6 27.8 28.1 28.1 36.4 120.4 27.5 10.8 6.6 33.6 12.1 27.8 19.2 0.0 29.8 6.4 27.7 23.2 38.1 23.3 12.3 44.5 39.2 37.4 29.2 13.0 52.6 28.8 28.7 72.1 38.0 23.8 39.9 21.0 59.1 12.2 30.1 45.3 28.2 6.3 14.9 48.7 14.6 23.2 34.9 20.2 ARID3B "BDP, DRIL2" ENSG00000179361 "AT-rich interaction domain 3B" Q8IVW6 15 74541177-74598131 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 41.2;Late spermatids: 48.5;Rod photoreceptor cells: 50.3;Syncytiotrophoblasts: 53.5" "Cancer enhanced" "Detected in all" "testis cancer: 10.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 33.1;SuSa: 38.1;U-266/70: 20.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 7 "cerebellum: 67.3" HPA050320 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA050320: AB_2681085" "unprognostic (2.97e-1)" "unprognostic (5.91e-2)" "unprognostic (6.41e-2)" "unprognostic (8.15e-2)" "unprognostic (8.42e-2)" "unprognostic (1.13e-1)" "unprognostic (3.33e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-1)" "unprognostic (2.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.64e-2)" "unprognostic (1.42e-2)" "unprognostic (4.71e-2)" "unprognostic (3.52e-2)" "unprognostic (9.45e-3)" "unprognostic (2.20e-1)" 2.5 2.0 2.5 5.8 2.4 21.1 2.4 8.0 4.0 3.2 5.2 2.6 5.2 4.4 2.7 2.1 5.5 2.4 8.4 3.9 2.0 2.8 3.1 3.6 6.7 11.0 2.0 0.2 1.5 5.7 1.8 8.3 17.5 3.6 4.3 4.1 9.1 5.6 6.9 6.1 2.7 6.4 1.8 2.5 9.2 7.0 19.5 2.1 7.2 3.7 1.8 10.4 3.2 8.2 3.7 2.1 14.4 2.2 4.3 6.0 3.2 2.7 1.1 15.5 3.3 0.6 0.3 16.6 0.7 0.7 0.9 1.0 18.3 1.3 0.2 0.8 0.7 5.5 3.3 18.7 2.5 0.8 17.3 4.3 10.7 1.9 4.9 0.4 1.7 7.0 0.4 1.1 1.6 1.6 0.7 1.6 4.3 9.3 6.3 0.2 0.6 4.6 5.7 33.1 1.1 1.0 2.0 0.6 4.4 0.9 2.9 3.9 7.0 0.8 1.7 3.2 38.1 2.2 3.1 1.0 1.3 1.6 1.0 2.0 20.2 12.7 1.9 0.7 2.7 0.5 2.8 2.0 7.5 6.0 1.7 3.5 3.7 3.5 4.4 1.5 1.8 2.7 3.4 14.4 4.3 2.2 2.1 4.8 3.2 2.5 2.4 8.0 4.0 2.0 2.8 2.0 0.2 3.6 2.1 3.0 6.4 12.4 4.2 4.6 20.4 1.2 0.0 1.4 1.2 0.0 41.2 29.5 0.0 2.5 34.7 2.8 6.3 0.0 2.9 15.3 3.6 6.1 2.3 2.4 7.0 11.1 5.2 3.7 7.9 48.5 2.6 7.4 3.3 3.6 6.1 5.7 4.9 7.0 2.8 1.3 50.3 0.0 1.4 17.7 13.0 2.9 53.5 10.2 4.1 6.7 ARIH2 TRIAD1 ENSG00000177479 "Ariadne RBR E3 ubiquitin protein ligase 2" O95376 3 48918821-48986382 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067381, HPA069715, HPA070963" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA067381: AB_2685827, HPA069715: AB_2686182, HPA070963: AB_2686329" "unprognostic (7.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.26e-1)" "unprognostic (2.74e-1)" "unprognostic (2.55e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.90e-2)" "unprognostic (4.01e-2)" "unprognostic (5.01e-2)" "prognostic favorable (7.31e-4)" "unprognostic (5.01e-3)" "prognostic favorable (6.60e-4)" "unprognostic (1.15e-1)" "unprognostic (7.04e-2)" "unprognostic (1.27e-2)" "unprognostic (1.39e-2)" 15.0 16.2 14.1 12.8 20.6 16.0 19.2 22.7 22.5 14.1 18.6 25.4 13.9 10.0 18.7 29.2 14.9 16.2 12.8 38.5 15.8 14.9 14.3 17.2 14.5 17.8 24.7 18.3 18.3 20.5 23.1 19.8 15.3 19.7 16.5 15.5 19.2 13.2 19.5 71.3 11.4 14.4 23.0 18.8 17.5 15.7 27.5 21.4 17.7 18.7 15.2 17.2 16.4 14.1 20.6 21.7 27.6 24.5 15.8 32.6 25.3 14.3 14.5 14.0 19.8 20.7 11.4 19.0 16.9 19.8 21.2 23.5 15.2 12.8 29.3 7.9 18.1 30.8 8.6 28.8 17.3 26.0 19.7 17.5 30.2 19.1 12.4 18.8 22.3 14.6 12.2 26.2 26.4 35.9 12.1 15.9 14.1 23.8 20.1 18.7 9.9 22.5 9.2 23.8 15.5 22.0 8.4 16.0 24.4 12.4 19.4 6.1 16.6 16.6 20.9 16.2 17.3 10.6 15.9 15.1 12.9 18.7 19.2 26.5 26.3 50.8 37.1 14.1 18.7 16.1 27.6 24.5 26.2 32.6 21.6 22.1 19.5 20.9 26.7 21.7 20.6 21.6 27.8 17.2 15.8 13.5 18.7 22.9 25.3 14.1 20.6 22.7 22.5 15.8 14.9 24.7 18.3 19.7 21.4 32.8 22.3 31.1 35.9 45.2 56.4 60.0 30.6 37.5 58.0 27.9 82.5 31.2 24.9 23.6 8.2 33.8 20.3 23.3 37.3 30.6 28.0 46.9 42.9 36.5 23.8 54.0 16.0 35.0 26.4 4.7 38.6 33.2 28.7 41.5 22.9 39.7 33.1 22.9 40.7 25.6 73.6 25.8 35.4 140.0 77.3 47.2 44.6 50.1 26.5 58.6 ARMC2 "bA787I22.1, DKFZp434P0714" ENSG00000118690 "Armadillo repeat containing 2" Q8NEN0 6 108848416-108974472 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.8" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 88.3;Early spermatids: 89.1;Late spermatids: 112.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA025809, HPA053696" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA025809: AB_1845032, HPA053696: AB_2682233" "unprognostic (4.42e-2)" "unprognostic (9.64e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.45e-2)" "unprognostic (2.11e-1)" "unprognostic (4.00e-4)" "unprognostic (1.13e-2)" "unprognostic (3.74e-2)" "unprognostic (5.71e-2)" "unprognostic (5.19e-5)" "unprognostic (7.55e-2)" "unprognostic (1.55e-3)" "unprognostic (9.38e-2)" "unprognostic (6.44e-2)" "unprognostic (4.65e-2)" "unprognostic (2.28e-1)" 6.0 5.2 13.3 5.6 19.6 7.8 7.3 9.6 14.7 7.4 4.2 7.9 2.1 2.0 8.2 11.9 3.7 21.5 5.4 9.4 12.2 7.0 4.6 2.8 8.8 4.0 4.0 11.8 6.1 3.3 9.9 20.0 7.0 16.7 4.4 4.9 5.7 3.8 5.2 3.7 5.3 3.5 4.4 6.3 5.8 4.9 31.8 7.1 2.4 11.0 2.8 4.3 4.0 5.0 2.7 4.6 9.5 4.7 4.8 7.0 1.6 3.4 2.1 10.3 6.5 5.1 6.4 2.3 2.1 2.9 5.4 7.2 3.1 3.1 5.4 2.7 3.4 8.3 3.0 5.6 4.2 9.4 1.5 4.8 5.1 4.7 3.2 2.8 7.8 2.3 7.3 5.9 6.2 1.8 7.2 5.0 16.6 2.1 8.4 5.5 2.6 6.7 7.1 3.2 3.3 2.6 7.7 8.5 4.4 4.9 4.1 14.4 5.3 7.3 1.9 5.1 6.0 3.7 4.0 2.5 4.6 2.4 3.8 2.8 3.9 5.2 4.6 7.8 5.5 5.7 4.3 3.5 0.9 3.4 4.7 3.2 1.4 2.7 3.7 2.8 2.7 1.6 3.9 9.5 4.8 3.7 4.6 7.0 1.6 13.3 19.6 9.6 14.7 12.2 7.0 4.0 11.8 16.7 7.1 8.9 3.0 0.0 1.1 0.9 1.5 4.3 2.5 88.3 18.2 0.0 0.0 1.3 0.0 0.8 89.1 1.2 0.0 0.0 0.8 1.7 1.3 0.8 0.0 0.2 3.2 1.6 1.7 0.6 3.7 112.4 6.4 1.3 5.0 0.0 0.3 1.8 0.7 0.0 9.6 1.2 5.2 0.0 2.3 27.6 5.5 1.3 0.5 2.9 0.5 0.7 ARNT2 "bHLHe1, KIAA0307" ENSG00000172379 "Aryl hydrocarbon receptor nuclear translocator 2" Q9HBZ2 15 80404350-80597937 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 73.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 29.2;Intestinal endocrine cells: 22.0;Late spermatids: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.9;BJ hTERT+ SV40 Large T+ RasG12V: 16.0;hTERT-RPE1: 16.7;LHCN-M2: 14.3;SK-MEL-30: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001056, CAB005081" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB005081: AB_2243005, HPA001056: AB_1845042" "unprognostic (2.04e-3)" "unprognostic (8.32e-2)" "unprognostic (2.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.11e-1)" "unprognostic (5.65e-2)" "unprognostic (2.61e-2)" "unprognostic (1.48e-1)" "unprognostic (2.74e-2)" "unprognostic (3.00e-1)" "prognostic favorable (1.46e-6)" "unprognostic (2.20e-1)" "prognostic favorable (7.51e-4)" "unprognostic (2.53e-1)" "unprognostic (2.31e-1)" "unprognostic (3.39e-1)" "unprognostic (3.62e-2)" 1.4 2.3 30.6 2.3 35.5 1.0 1.8 9.1 73.2 4.2 2.4 14.3 0.0 2.0 5.3 7.2 2.3 4.9 2.7 3.7 32.8 17.4 11.5 1.0 4.4 2.3 19.2 23.4 9.3 3.2 4.2 3.6 1.7 11.9 5.1 2.4 2.0 1.5 4.8 7.0 2.3 2.5 3.7 13.2 3.2 3.9 8.0 12.7 0.0 6.0 0.0 2.9 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.8 15.9 0.0 0.1 2.0 0.0 6.7 9.5 7.8 16.0 0.0 0.0 0.0 1.7 8.0 4.1 0.2 5.8 0.3 10.1 0.0 1.6 0.2 0.0 0.5 0.5 0.0 4.0 7.6 0.3 3.4 0.1 16.7 0.0 0.0 0.0 0.1 14.3 7.5 0.0 0.0 3.1 0.0 0.1 0.0 0.2 0.0 3.4 11.2 8.4 11.6 0.8 0.1 17.1 1.0 0.3 0.0 0.0 12.5 2.5 0.3 7.9 0.0 0.0 0.0 4.8 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 35.5 9.1 36.0 32.8 17.4 19.2 23.4 11.9 12.7 0.0 2.9 0.0 1.1 1.1 15.4 5.9 0.0 2.7 7.9 3.5 7.9 0.1 11.6 6.4 29.2 0.8 0.0 0.0 0.2 3.3 0.9 1.9 2.3 0.0 0.2 1.6 22.0 0.6 0.0 28.4 0.6 0.6 6.8 0.0 0.9 5.7 3.0 2.8 2.8 0.6 9.2 6.5 2.8 1.1 1.5 0.3 2.3 0.0 0.8 1.1 ARPC2 "ARC34, p34-Arc" ENSG00000163466 "Actin related protein 2/3 complex subunit 2" O15144 2 218217094-218254356 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "monocytes: 1874.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001994, HPA008352, HPA052703" Approved Supported Nucleoplasm NA NA 24000000 Nucleoplasm "CAB001994: , HPA008352: AB_1854887, HPA052703: " "unprognostic (7.42e-2)" "unprognostic (4.07e-1)" "unprognostic (1.50e-1)" "unprognostic (3.28e-3)" "unprognostic (2.77e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.23e-2)" "unprognostic (1.90e-2)" "unprognostic (4.07e-2)" "unprognostic (3.95e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (1.07e-7)" "unprognostic (1.97e-1)" "unprognostic (1.04e-1)" "unprognostic (1.01e-2)" "unprognostic (7.41e-2)" 46.9 28.8 32.6 78.6 37.9 79.5 67.1 19.3 31.4 34.1 42.5 19.9 26.3 34.0 37.2 35.8 103.4 30.2 51.2 52.3 40.7 25.0 38.2 35.1 71.8 118.3 26.4 27.8 30.7 31.2 18.9 23.0 67.1 26.8 35.6 48.6 23.7 39.0 32.7 60.1 56.2 59.2 69.1 23.9 73.7 43.8 36.5 22.3 59.0 27.2 72.7 102.5 58.5 49.7 60.6 101.2 167.7 145.0 50.0 76.2 149.4 47.6 20.9 30.1 22.4 40.4 54.4 56.0 74.6 72.0 63.0 63.4 64.8 50.8 39.0 40.7 84.7 45.6 55.6 40.7 110.3 74.3 32.4 29.0 39.6 31.6 35.5 45.3 82.5 111.9 36.1 89.3 63.0 52.3 59.3 82.2 33.4 18.7 77.1 96.5 33.0 44.8 96.8 35.8 55.1 20.4 34.1 26.6 53.0 63.4 87.0 17.7 32.3 27.2 30.2 64.0 65.2 21.8 76.0 71.5 82.1 31.5 36.8 55.8 42.0 44.4 68.0 59.5 51.9 61.7 106.1 97.2 143.7 75.0 131.3 50.2 60.6 58.9 72.7 101.2 47.6 42.1 62.0 167.7 50.0 145.0 56.1 76.2 149.4 32.6 37.9 19.3 31.4 40.7 25.0 26.4 27.8 26.8 22.3 265.0 262.5 474.2 568.5 824.8 84.9 120.6 224.2 202.1 246.9 164.0 53.0 815.9 290.1 578.5 498.2 333.2 468.4 23.3 579.0 1225.3 410.2 308.1 398.0 92.5 1003.6 55.6 306.9 268.2 655.6 636.8 198.2 927.3 393.1 1874.7 258.1 106.0 656.4 469.9 306.9 244.6 80.4 297.5 339.0 278.1 210.5 848.4 874.6 601.9 267.4 1012.4 ARPC3 "ARC21, p21-Arc" ENSG00000111229 "Actin related protein 2/3 complex subunit 3" O15145 12 110434825-110450422 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006550 Approved Uncertain Nucleoplasm NA NA 38000000 Nucleoplasm "HPA006550: AB_1854869" "unprognostic (1.83e-1)" "unprognostic (4.21e-3)" "unprognostic (4.15e-1)" "unprognostic (4.26e-3)" "unprognostic (2.89e-1)" "unprognostic (1.11e-3)" "unprognostic (1.10e-2)" "unprognostic (6.71e-2)" "unprognostic (2.89e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (9.96e-2)" "prognostic unfavorable (2.22e-11)" "unprognostic (3.00e-1)" "unprognostic (5.83e-2)" "unprognostic (2.05e-2)" "unprognostic (1.79e-3)" 47.9 50.5 47.4 65.2 50.0 123.1 65.3 21.3 61.0 40.2 58.9 29.4 31.4 47.2 35.9 56.9 88.1 32.4 49.4 39.7 44.6 39.1 64.3 54.0 86.0 143.3 41.1 38.0 27.6 51.5 23.8 41.9 58.4 34.4 34.4 63.9 23.1 51.2 37.6 23.9 35.5 52.2 40.1 49.6 93.9 47.8 29.3 35.0 65.7 38.6 49.8 99.3 61.6 47.2 59.7 83.9 136.8 111.0 33.9 50.9 102.9 48.8 39.2 35.1 21.9 36.5 69.6 46.4 55.6 60.8 66.7 65.6 42.1 39.1 70.9 41.6 61.1 41.2 38.3 37.8 57.0 72.8 40.9 46.1 61.3 17.4 40.7 59.9 60.5 96.3 48.8 61.9 42.2 39.2 83.7 82.9 49.1 38.8 19.4 82.2 38.6 72.2 149.3 34.1 57.1 47.3 56.4 20.3 60.1 115.7 62.7 39.1 39.0 37.4 52.7 46.2 53.7 85.2 102.4 69.8 40.2 22.6 35.4 38.0 38.5 55.4 99.6 52.7 61.4 47.3 89.4 83.8 134.8 32.1 97.9 29.0 59.7 32.9 35.7 83.9 52.2 24.8 32.1 136.8 33.9 111.0 53.8 50.9 102.9 47.4 50.0 21.3 61.0 44.6 39.1 41.1 38.0 34.4 35.0 175.7 264.9 449.7 241.0 141.6 37.6 43.7 229.3 270.4 177.5 254.7 11.8 446.1 490.7 567.2 84.2 191.2 402.9 140.2 470.4 667.1 173.4 288.5 473.1 161.8 1260.7 50.9 263.3 228.9 810.9 28.3 159.6 1039.3 227.7 769.2 436.5 125.5 569.7 627.8 148.2 609.1 28.3 245.8 164.8 185.1 179.4 150.3 603.5 401.3 343.1 512.2 ARRB1 ARR1 ENSG00000137486 "Arrestin beta 1" P49407 11 75264182-75351705 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 37.5" "Group enriched" "Detected in many" 5 "dendritic cells: 12.7;granulocytes: 14.7;monocytes: 37.5" "Cell line enhanced" "Detected in many" "HEL: 49.9;RH-30: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003763, HPA049318, HPA070249" Approved Supported Nucleoplasm NA NA 2100000 Nucleoplasm "CAB003763: AB_562248, HPA049318: AB_2680711, HPA070249: AB_2732151" "unprognostic (3.40e-1)" "unprognostic (8.37e-2)" "unprognostic (1.63e-1)" "unprognostic (1.88e-1)" "unprognostic (2.35e-1)" "unprognostic (3.27e-3)" "unprognostic (1.33e-2)" "unprognostic (1.15e-2)" "unprognostic (1.23e-2)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (9.35e-2)" "unprognostic (2.34e-2)" "unprognostic (2.29e-1)" "unprognostic (7.10e-2)" "unprognostic (3.90e-1)" "unprognostic (1.26e-1)" 20.9 5.4 27.7 14.7 31.7 9.6 15.9 24.4 36.7 6.9 17.8 11.2 2.0 15.4 7.6 4.5 13.8 12.1 9.2 12.2 25.0 16.0 9.1 7.4 37.3 9.7 19.1 25.7 12.5 28.8 1.8 3.3 17.7 21.8 12.0 16.9 10.1 8.5 7.5 7.2 11.6 18.5 15.9 6.4 26.5 23.1 3.1 19.0 3.8 6.4 3.9 7.2 13.2 7.9 0.1 12.7 14.7 37.5 3.9 3.6 10.9 1.5 7.0 7.3 3.5 6.4 5.5 15.1 1.5 5.2 1.9 1.3 10.3 7.2 0.6 18.0 1.4 1.4 0.3 2.9 0.0 0.7 0.0 1.6 49.9 0.9 6.1 1.6 1.4 19.3 2.7 0.3 3.2 0.0 2.3 21.6 1.8 24.2 0.0 3.7 4.0 0.9 16.8 5.4 21.0 2.1 5.5 34.8 1.9 7.7 6.2 3.8 4.0 2.6 18.5 4.5 16.2 13.6 8.1 18.0 1.4 1.9 5.8 0.1 0.0 0.0 0.0 1.0 23.3 1.7 8.3 19.8 13.0 3.6 31.3 1.3 0.1 1.7 2.0 12.7 0.0 1.5 2.1 14.7 3.9 37.5 0.2 1.5 10.9 27.7 31.7 24.4 36.7 25.0 16.0 19.1 25.7 21.8 19.0 26.8 15.0 2.7 1.7 1.6 1.8 4.0 5.1 5.3 5.7 3.5 5.9 36.0 1.7 4.3 1.6 14.3 24.1 0.0 7.4 1.2 6.0 4.6 23.1 1.8 34.3 0.0 5.2 22.7 43.2 11.6 14.7 20.6 3.3 21.6 8.2 0.2 7.3 17.5 15.6 0.0 0.9 12.9 5.3 0.0 0.6 2.6 28.1 6.9 20.0 2.6 ARRDC2 "CLONE24945, PP2703" ENSG00000105643 "Arrestin domain containing 2" Q8TBH0 19 18001132-18014102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.7" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 53.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053788, HPA074216" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053788: AB_2682262, HPA074216: " "unprognostic (8.10e-2)" "prognostic favorable (5.93e-4)" "unprognostic (2.20e-3)" "unprognostic (8.67e-2)" "unprognostic (4.81e-3)" "unprognostic (4.26e-3)" "unprognostic (1.82e-1)" "unprognostic (1.06e-1)" "unprognostic (4.40e-2)" "prognostic unfavorable (5.84e-4)" "unprognostic (1.16e-1)" "unprognostic (8.37e-2)" "unprognostic (4.87e-3)" "unprognostic (7.26e-2)" "unprognostic (1.01e-1)" "prognostic favorable (6.91e-4)" "prognostic favorable (2.92e-4)" 26.7 5.3 10.4 12.5 34.6 39.3 27.7 3.2 19.5 10.9 9.6 28.3 7.3 6.9 7.6 4.7 8.1 8.5 13.1 8.5 14.1 8.2 10.7 9.8 22.6 19.0 47.5 9.0 4.9 6.2 18.7 5.7 8.1 20.1 10.1 7.2 6.0 15.3 11.6 60.7 9.4 13.3 6.7 16.8 18.7 12.1 3.2 32.9 10.5 14.3 4.9 19.1 9.3 11.3 5.9 3.1 3.7 6.3 7.2 16.0 4.7 5.8 10.7 0.2 5.4 4.5 4.1 4.2 3.4 9.8 2.9 2.9 2.4 11.6 11.0 9.8 2.9 4.7 4.0 4.3 3.1 2.3 7.1 6.3 8.4 8.3 3.3 4.1 6.3 12.4 4.4 5.0 3.3 5.1 5.4 4.9 7.1 9.6 0.3 2.7 9.1 4.8 17.5 1.3 13.2 17.7 28.3 0.1 8.2 4.2 5.5 2.6 2.6 5.6 5.7 5.7 0.9 3.4 16.3 10.4 5.0 3.9 16.9 4.3 0.8 0.0 12.4 8.1 24.2 3.9 3.7 6.3 3.7 4.0 5.2 2.8 3.9 6.7 5.1 3.1 5.9 16.0 8.4 2.4 7.2 5.4 2.0 5.0 4.7 10.4 34.6 3.2 19.5 14.1 8.2 47.5 9.0 20.1 32.9 14.9 16.2 24.9 14.4 5.7 0.4 6.2 53.5 16.0 7.9 8.7 0.0 0.6 1.7 8.3 0.7 27.0 6.6 0.0 5.6 7.1 7.8 19.7 26.5 5.4 16.7 0.0 17.7 15.4 24.0 1.0 4.4 39.6 5.0 8.2 8.7 0.9 10.8 7.8 7.1 0.3 0.4 12.9 14.6 0.5 3.7 6.1 1.0 20.8 5.2 23.1 ASB1 ASB-1 ENSG00000065802 "Ankyrin repeat and SOCS box containing 1" Q9Y576 2 238426742-238452250 "Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003508 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA003508: AB_1845065" "unprognostic (1.02e-1)" "unprognostic (5.30e-2)" "unprognostic (9.58e-2)" "prognostic unfavorable (4.89e-5)" "unprognostic (4.04e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (5.37e-4)" "unprognostic (3.49e-2)" "unprognostic (5.81e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.56e-4)" "unprognostic (3.70e-2)" "unprognostic (2.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" "unprognostic (2.19e-1)" 9.2 8.4 17.0 10.9 19.7 3.8 7.7 9.3 18.4 7.1 8.7 16.2 7.8 5.8 12.0 5.9 7.5 9.3 7.8 22.0 16.1 14.7 8.0 6.2 7.6 10.5 18.0 12.7 15.3 6.6 15.1 8.8 4.9 15.6 9.8 7.2 9.3 5.4 12.1 26.2 8.3 7.8 11.8 18.8 7.8 7.6 14.0 11.3 9.0 8.2 9.3 11.7 7.1 6.5 5.5 4.2 1.4 1.1 3.0 6.7 1.9 4.9 7.1 9.8 7.8 6.3 6.6 7.9 13.6 9.0 8.1 9.2 3.4 3.5 4.3 1.9 12.7 18.3 5.4 9.6 21.5 13.0 10.8 7.9 5.4 6.4 8.5 14.6 7.4 7.2 7.0 9.9 23.9 32.5 12.9 3.5 7.6 11.3 2.9 15.0 3.3 4.0 7.8 10.4 4.3 6.1 5.8 19.9 2.8 5.9 6.7 7.9 10.7 4.2 3.1 7.0 6.1 2.3 7.9 7.5 14.9 9.7 11.6 26.9 10.6 6.5 7.4 23.4 2.3 7.4 0.0 0.8 1.4 6.7 1.1 3.5 5.5 4.7 6.5 0.9 3.3 4.1 4.9 0.3 3.0 0.6 4.2 5.5 1.9 17.0 19.7 9.3 18.4 16.1 14.7 18.0 12.7 15.6 11.3 8.9 3.0 14.1 23.6 7.0 10.6 40.0 20.4 14.7 6.8 8.7 3.9 11.2 1.7 15.7 27.1 3.8 5.1 23.3 18.1 23.0 14.5 14.7 16.1 9.9 23.2 9.5 12.2 4.9 14.2 15.0 7.2 9.5 6.8 14.4 5.2 8.0 22.5 17.3 13.8 10.2 5.7 25.8 12.7 37.9 35.5 5.9 4.8 15.8 6.0 11.6 ASF1A "CIA, DKFZP547E2110" ENSG00000111875 "Anti-silencing function 1A histone chaperone" Q9Y294 6 118894220-118909167 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030502, HPA071495" Enhanced Nucleoplasm No No Nucleoplasm "HPA030502: AB_2673504, HPA071495: AB_2686404" "unprognostic (7.09e-2)" "unprognostic (1.33e-1)" "unprognostic (4.78e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (5.02e-7)" "unprognostic (8.28e-2)" "unprognostic (8.42e-2)" "unprognostic (8.37e-3)" "unprognostic (3.28e-2)" "unprognostic (4.95e-1)" "unprognostic (9.07e-3)" "unprognostic (2.90e-2)" "unprognostic (7.37e-2)" "unprognostic (1.42e-2)" "unprognostic (5.09e-3)" 7.8 14.1 21.5 9.1 23.8 7.9 14.4 20.3 17.5 12.9 10.4 12.6 16.1 8.5 12.3 15.6 13.7 12.3 9.0 14.6 18.1 19.2 14.4 13.3 15.0 16.3 21.6 14.9 20.9 10.8 25.7 12.9 9.5 15.2 12.0 12.5 9.1 11.6 15.4 16.6 12.9 11.7 11.6 21.4 15.2 11.8 10.5 14.8 36.9 20.2 14.9 16.4 13.3 12.2 13.4 12.8 12.2 7.9 12.1 30.8 17.6 6.0 3.9 13.8 9.2 11.9 7.0 11.1 8.3 8.3 10.9 12.3 4.8 5.3 10.2 13.7 5.9 9.5 6.7 11.9 10.6 13.9 7.3 11.0 15.0 9.4 30.9 8.3 25.3 7.8 6.1 10.8 9.4 14.4 14.6 14.4 32.7 23.2 27.4 12.8 6.4 29.5 20.0 5.7 9.1 13.5 16.2 5.6 12.7 14.5 7.9 8.9 6.8 8.4 8.5 9.7 4.5 4.9 23.7 12.3 5.1 7.5 7.0 12.7 8.5 14.1 14.9 13.3 20.2 10.9 6.6 6.0 12.2 16.3 6.3 22.7 13.4 26.6 20.9 12.8 8.1 29.1 23.8 1.0 12.1 7.9 9.7 30.8 17.6 21.5 23.8 20.3 17.5 18.1 19.2 21.6 14.9 15.2 14.8 14.9 19.9 35.3 13.8 26.2 15.4 23.4 12.7 24.1 15.9 8.7 3.9 59.8 53.0 28.9 26.4 23.7 8.5 116.8 20.7 67.2 19.7 9.5 22.0 13.9 21.7 23.8 28.4 14.1 16.8 7.8 23.6 19.0 15.1 26.2 10.5 22.6 19.3 10.5 21.9 22.6 12.5 12.9 29.7 26.5 40.0 28.9 39.0 47.3 16.7 11.1 ASF1B FLJ10604 ENSG00000105011 "Anti-silencing function 1B histone chaperone" Q9NVP2 19 14119509-14136956 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 39.2;lymphoid tissue: 45.1;testis: 45.2" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 35.5;Extravillous trophoblasts: 30.7;Spermatocytes: 54.1;Spermatogonia: 88.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 7 "neutrophil: 39.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 39.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA054036, HPA069385" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA054036: AB_2682350, HPA069385: " "unprognostic (3.14e-1)" "prognostic favorable (4.45e-5)" "unprognostic (2.41e-3)" "unprognostic (2.40e-1)" "unprognostic (2.15e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (2.87e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (8.48e-3)" "prognostic unfavorable (2.22e-16)" "prognostic favorable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (3.92e-2)" "unprognostic (4.31e-2)" 1.3 1.6 0.7 15.1 1.3 10.0 0.9 0.3 0.8 2.0 7.2 0.8 1.1 4.9 0.9 1.9 9.3 0.7 3.0 1.2 0.6 0.4 1.5 1.4 3.1 11.5 0.9 0.3 1.0 0.8 0.0 0.9 3.8 0.9 0.9 7.6 0.7 2.0 0.3 0.7 2.9 5.2 1.5 1.0 6.4 3.1 45.2 0.6 45.1 0.7 6.4 14.0 1.9 2.9 0.8 0.8 39.2 5.2 1.0 3.3 2.0 28.6 11.1 17.5 13.3 1.7 1.6 7.6 15.2 12.5 28.6 36.2 11.5 14.1 27.4 14.0 7.7 12.1 17.6 18.6 10.6 22.5 24.3 13.4 25.9 23.5 8.0 0.1 17.4 16.2 0.3 0.7 16.0 5.5 3.2 11.1 20.0 22.3 38.4 14.0 32.6 35.3 14.8 8.0 30.2 27.1 34.1 25.9 22.6 8.9 12.4 21.4 7.8 18.0 13.3 7.6 4.9 10.0 18.0 5.4 16.6 10.3 41.9 25.1 20.6 20.8 35.0 13.2 32.0 16.1 0.4 4.0 1.0 1.4 5.2 0.8 0.8 1.2 1.5 0.8 0.8 0.7 1.3 39.2 1.0 5.1 0.3 3.3 2.0 0.7 1.3 0.3 0.8 0.6 0.4 0.9 0.3 0.9 0.6 0.0 1.1 4.5 2.3 2.3 0.0 0.4 2.5 0.0 1.2 0.0 0.0 9.2 0.0 1.3 35.5 0.1 2.9 23.3 1.1 30.7 0.4 0.8 4.6 0.0 17.8 0.0 1.2 0.6 7.1 22.9 0.0 4.2 1.7 1.8 3.4 0.4 0.8 2.9 0.7 0.0 0.7 0.0 0.2 54.1 88.8 1.0 8.7 4.4 7.1 0.9 ASXL2 "ASXH2, FLJ10898, KIAA1685" ENSG00000143970 "Additional sex combs like 2, transcriptional regulator" Q76L83 2 25733753-25878516 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034646, HPA058040" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA034646: AB_2674261, HPA058040: AB_2683586" "unprognostic (4.78e-2)" "unprognostic (3.41e-2)" "unprognostic (2.23e-2)" "unprognostic (1.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.88e-2)" "unprognostic (2.98e-2)" "unprognostic (2.80e-1)" "unprognostic (2.68e-3)" "unprognostic (3.17e-2)" "unprognostic (1.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.33e-3)" "unprognostic (1.82e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-1)" "unprognostic (3.75e-2)" 15.0 14.9 14.5 14.1 16.5 10.4 13.1 23.0 16.1 14.4 13.9 15.7 13.0 9.8 14.7 9.9 17.5 12.1 10.0 14.2 15.2 8.9 14.7 10.2 13.1 15.3 14.3 8.5 11.4 12.1 28.0 17.4 17.4 13.9 10.5 14.2 12.6 15.3 14.1 20.5 14.2 12.9 13.3 12.3 15.4 12.1 20.7 18.0 26.2 16.5 10.7 17.0 16.7 13.5 3.0 3.7 4.7 2.7 1.8 4.5 1.3 15.7 9.5 7.3 5.2 7.3 10.3 9.4 8.7 13.6 8.5 7.7 10.5 8.6 9.8 5.1 9.8 10.0 9.8 14.4 10.6 12.3 9.8 6.6 17.4 8.5 11.5 6.2 19.2 17.4 5.1 11.1 13.0 10.3 7.6 10.9 6.2 15.1 7.9 9.0 6.4 9.0 6.4 10.3 9.2 6.7 10.1 25.0 7.9 7.9 10.7 8.0 9.0 10.5 10.0 8.8 7.5 5.6 8.2 14.4 12.1 13.8 10.4 12.5 16.1 15.8 20.5 11.3 16.2 8.6 2.1 2.4 3.7 4.5 2.7 3.6 2.7 3.5 3.9 2.3 3.0 3.0 3.6 4.7 1.8 2.4 3.7 2.5 1.3 14.5 16.5 23.0 16.1 15.2 8.9 14.3 8.5 13.9 18.0 23.8 17.9 16.0 8.0 28.7 21.5 25.8 10.2 38.8 15.9 8.7 23.6 9.0 13.3 13.9 36.9 22.2 10.5 0.0 12.4 7.4 14.5 11.0 23.1 13.9 16.0 23.8 9.9 26.4 25.3 19.7 18.1 21.6 21.9 15.4 16.7 13.6 14.9 14.0 12.4 12.9 24.1 38.8 11.0 30.5 24.7 35.9 12.2 28.8 15.6 13.8 ATAD2 "ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000" ENSG00000156802 "ATPase family, AAA domain containing 2" Q6PL18 8 123319850-123416350 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 53.8" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 74.6;Spermatogonia: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 75.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029424, CAB056158" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB056158: AB_2665580, HPA029424: AB_10611680" "unprognostic (1.56e-1)" "unprognostic (4.55e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.08e-1)" "unprognostic (4.44e-2)" "unprognostic (2.98e-2)" "unprognostic (2.74e-3)" "unprognostic (2.02e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.33e-15)" "unprognostic (1.15e-2)" "unprognostic (1.82e-1)" "unprognostic (4.84e-2)" "unprognostic (6.17e-2)" 4.1 4.9 4.6 12.6 9.2 22.8 7.2 5.6 6.9 14.0 8.6 1.5 13.4 5.3 4.7 5.0 10.7 4.7 3.5 13.7 4.2 6.3 2.2 10.1 9.8 13.7 4.0 4.3 9.9 3.9 3.5 18.7 5.2 4.0 11.4 7.5 2.4 6.8 15.4 13.8 7.2 6.6 5.5 4.1 8.8 6.9 20.2 3.4 53.8 4.8 6.3 12.7 9.9 5.9 4.3 2.3 7.2 2.8 4.0 7.4 1.8 25.5 9.9 14.2 4.8 2.5 3.2 6.2 20.0 6.9 17.3 19.3 7.5 11.1 16.7 6.1 6.3 6.8 12.2 18.9 6.4 27.8 23.2 10.1 30.0 10.7 15.2 1.0 10.9 14.9 1.0 1.0 16.4 5.4 3.7 5.2 9.8 14.0 17.0 12.8 26.4 31.4 8.2 2.5 19.3 9.9 16.4 16.9 9.0 6.1 11.7 18.2 7.9 29.0 75.6 5.1 6.0 15.4 10.4 3.2 13.1 18.1 10.3 24.0 5.5 9.8 15.5 8.6 18.4 10.2 7.2 1.5 5.4 2.9 1.3 4.0 4.3 4.2 4.8 2.3 2.8 2.8 3.0 0.4 4.0 2.8 0.3 7.4 1.8 4.6 9.2 5.6 6.9 4.2 6.3 4.0 4.3 4.0 3.4 6.0 8.3 14.2 19.9 14.1 2.5 22.9 2.5 5.3 11.4 3.5 3.9 8.2 1.7 2.4 46.2 6.7 2.2 23.3 1.9 21.2 7.3 19.9 13.9 14.0 9.7 1.6 1.2 9.2 11.1 17.9 6.9 6.6 1.7 5.4 4.4 5.2 2.7 3.5 13.1 0.9 2.1 0.0 8.6 74.6 90.7 10.7 11.3 15.3 12.8 24.8 ATAD2B KIAA1240 ENSG00000119778 "ATPase family, AAA domain containing 2B" Q9ULI0 2 23748664-23927114 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034555 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA034555: AB_10601665" "unprognostic (2.40e-1)" "unprognostic (4.36e-2)" "unprognostic (2.58e-1)" "unprognostic (2.16e-1)" "unprognostic (1.62e-2)" "unprognostic (5.93e-3)" "unprognostic (5.57e-3)" "unprognostic (2.22e-2)" "unprognostic (1.85e-2)" "unprognostic (1.23e-1)" "unprognostic (9.14e-2)" "unprognostic (7.56e-3)" "prognostic unfavorable (2.35e-5)" "unprognostic (2.46e-1)" "unprognostic (2.68e-1)" "unprognostic (2.67e-2)" "unprognostic (1.98e-1)" 9.5 6.0 10.8 13.9 11.7 16.7 12.2 17.1 8.1 8.9 6.8 7.0 7.5 9.8 10.1 5.6 11.3 8.1 7.8 7.2 9.2 4.9 6.2 8.0 13.9 13.0 8.7 5.2 11.9 8.8 10.6 14.0 7.9 7.9 8.5 8.7 8.8 9.5 5.1 17.1 15.9 9.6 13.4 8.0 9.4 7.6 8.1 10.5 25.3 10.5 6.1 12.5 7.5 13.3 7.6 11.5 13.2 8.8 6.0 5.9 1.8 3.7 3.2 10.4 4.8 3.0 3.3 8.2 2.5 2.1 3.3 2.3 5.0 1.8 12.3 2.3 2.3 1.5 5.0 8.0 2.8 2.8 8.0 3.9 10.4 4.0 6.0 3.3 9.2 7.8 2.6 4.9 2.0 3.3 2.8 4.5 7.0 11.0 5.5 2.6 6.4 8.6 10.8 6.1 6.3 1.8 9.8 11.3 2.8 3.7 8.4 4.8 8.0 6.9 8.5 3.7 6.0 4.2 9.2 4.3 3.4 3.9 2.8 2.9 5.7 2.6 9.3 1.8 10.6 3.1 12.4 8.8 5.1 4.5 5.1 4.9 7.6 4.1 3.9 7.9 7.6 5.9 4.8 13.2 6.0 6.1 11.5 3.5 1.8 10.8 11.7 17.1 8.1 9.2 4.9 8.7 5.2 7.9 10.5 3.0 13.6 5.9 7.4 9.5 25.2 7.3 7.6 9.4 13.6 8.7 45.2 6.8 0.0 5.9 48.6 10.5 13.7 0.0 10.4 6.3 8.6 8.4 12.7 8.3 7.2 9.5 15.0 14.1 15.1 22.9 11.5 15.7 3.3 22.6 9.8 16.3 7.9 17.3 10.3 1.7 44.5 6.5 9.2 14.4 11.8 15.3 9.2 12.1 8.1 10.7 ATE1 ENSG00000107669 "Arginyltransferase 1" O95260 10 121740421-121928801 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038444, HPA057549" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA038444: AB_10672745, HPA057549: AB_2683463" "unprognostic (1.37e-1)" "unprognostic (5.19e-2)" "unprognostic (2.75e-3)" "unprognostic (2.40e-1)" "unprognostic (4.67e-2)" "unprognostic (6.65e-3)" "unprognostic (1.85e-1)" "unprognostic (1.42e-1)" "unprognostic (1.71e-1)" "unprognostic (1.00e-1)" "unprognostic (2.52e-1)" "unprognostic (5.69e-2)" "prognostic favorable (2.67e-4)" "unprognostic (3.20e-1)" "unprognostic (8.08e-2)" "unprognostic (2.16e-1)" "unprognostic (1.02e-1)" 15.4 16.9 14.6 16.8 18.8 14.7 16.9 23.1 20.8 17.4 18.8 17.6 12.6 13.5 14.4 14.3 15.7 13.6 14.4 27.5 15.0 18.4 23.1 23.0 14.0 11.7 17.6 14.0 14.4 13.4 23.6 22.5 15.0 15.4 16.5 20.0 19.0 14.1 16.6 33.6 12.0 16.2 25.8 15.6 12.9 12.0 18.1 14.6 21.4 22.0 11.2 14.3 22.8 15.2 14.0 14.4 17.1 11.5 9.9 16.0 8.5 10.0 17.1 13.3 11.2 9.2 11.0 9.1 8.8 15.9 10.6 11.2 22.2 12.5 12.4 7.3 10.1 7.1 10.3 12.3 8.8 10.3 20.4 10.9 4.4 7.5 17.9 9.4 18.9 10.4 8.0 8.2 11.0 23.3 12.5 11.5 8.2 6.8 25.7 8.4 6.3 10.2 7.8 6.8 10.9 8.2 10.0 14.0 7.2 13.4 8.6 3.8 12.4 12.0 8.5 18.2 8.9 6.2 4.8 14.1 6.1 6.0 9.1 15.7 22.4 30.8 15.1 9.5 13.2 5.1 17.1 11.1 14.7 16.0 11.1 15.5 13.0 13.9 13.7 9.4 14.0 15.7 14.3 8.1 9.9 11.5 14.4 13.6 8.5 14.6 18.8 23.1 20.8 15.0 18.4 17.6 14.0 15.4 14.6 8.9 15.8 7.4 11.5 7.4 21.9 62.1 7.6 12.0 14.8 19.2 11.8 6.1 14.9 9.2 5.3 13.6 18.8 0.0 11.6 8.0 10.8 18.1 11.6 23.8 8.5 22.3 21.2 26.4 14.8 5.8 19.0 10.5 13.5 6.4 14.8 18.4 12.5 14.4 24.4 29.3 31.4 0.0 11.7 23.5 33.8 15.3 7.2 10.4 15.0 14.6 ATF1 TREB36 ENSG00000123268 "Activating transcription factor 1" P18846 12 50763710-50821122 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016222, HPA055069, HPA055406" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016222: AB_2290030, HPA055069: AB_2682688, HPA055406: AB_2682807" "unprognostic (1.71e-1)" "unprognostic (1.50e-3)" "unprognostic (1.50e-1)" "unprognostic (9.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.53e-5)" "unprognostic (3.65e-1)" "unprognostic (8.17e-3)" "unprognostic (5.94e-2)" "unprognostic (4.31e-3)" "unprognostic (5.52e-2)" "unprognostic (1.73e-1)" "unprognostic (2.74e-2)" "unprognostic (2.46e-1)" "unprognostic (2.27e-1)" "unprognostic (8.75e-2)" 24.4 20.7 9.8 13.7 9.5 10.2 16.2 28.1 10.6 22.4 19.7 8.1 14.6 12.3 19.2 14.2 16.2 15.5 13.4 20.0 10.8 8.0 17.7 19.8 15.1 15.8 12.2 6.0 24.7 11.8 18.1 15.2 36.1 11.9 20.7 15.1 12.5 16.3 14.2 37.9 12.9 18.8 13.4 12.3 22.9 12.7 9.3 13.9 34.4 30.8 16.3 16.2 21.6 20.0 13.3 13.6 26.3 12.3 12.2 18.8 11.6 13.5 9.8 10.4 10.6 15.0 16.0 25.9 14.4 24.8 22.8 18.0 20.1 21.5 18.7 23.8 16.6 10.0 11.3 12.3 14.8 24.4 18.4 12.7 20.6 22.2 10.7 28.8 29.6 19.8 17.0 23.5 16.3 26.8 23.8 11.0 13.2 25.1 18.1 16.9 20.1 18.6 18.8 15.1 15.7 15.7 17.9 16.2 22.1 17.3 9.3 14.0 7.6 30.5 13.3 21.7 14.9 18.5 18.1 7.6 16.1 19.5 13.5 11.4 10.0 11.8 29.9 15.5 16.7 7.6 4.2 11.5 26.3 13.9 12.3 15.8 13.0 15.1 16.4 13.6 13.3 18.8 14.3 7.3 12.2 7.7 6.2 17.9 11.6 9.8 9.5 28.1 10.6 10.8 8.0 12.2 6.0 11.9 13.9 50.6 14.4 34.4 42.6 66.9 12.0 12.9 10.2 18.7 23.9 12.2 0.0 27.2 44.7 20.3 6.5 18.6 17.3 70.0 18.5 60.0 36.0 33.7 9.3 15.7 24.6 12.7 5.8 15.4 21.9 4.9 29.7 29.4 21.9 18.0 13.9 12.9 18.2 14.0 26.2 25.4 6.9 38.8 32.0 9.3 10.2 47.7 67.4 30.9 21.2 30.7 ATF2 "CRE-BP1, CREB2, HB16, TREB7" ENSG00000115966 "Activating transcription factor 2" P15336 2 175072250-175168382 "Enzymes, Predicted intracellular proteins, Transcription factors" "DNA damage, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 100.8;Late spermatids: 111.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003769, HPA022134" Supported Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB003769: AB_562241, HPA022134: AB_1845138" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" "unprognostic (9.81e-2)" "unprognostic (1.93e-1)" "unprognostic (9.29e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (7.08e-5)" "unprognostic (2.28e-2)" "unprognostic (3.70e-2)" "unprognostic (6.47e-2)" "unprognostic (7.17e-2)" "unprognostic (4.02e-2)" "unprognostic (4.40e-3)" "unprognostic (1.15e-2)" "unprognostic (1.50e-1)" "unprognostic (7.21e-3)" "unprognostic (6.70e-2)" 25.3 21.0 25.3 14.3 29.3 14.3 19.7 39.6 33.4 27.5 15.9 18.0 15.7 12.8 22.4 22.6 16.0 19.5 17.9 14.1 25.1 28.0 23.0 26.8 15.2 17.6 23.2 18.4 27.3 19.0 24.0 33.0 19.9 29.6 19.0 16.0 14.9 16.8 19.1 13.9 10.1 13.2 18.3 22.9 17.5 13.8 19.9 18.9 34.6 32.6 10.2 20.1 21.7 16.7 15.0 18.7 24.2 14.8 15.3 22.0 14.3 7.3 6.5 19.4 12.5 17.3 18.5 8.9 12.1 20.8 14.7 21.4 14.0 13.8 11.1 13.3 14.2 17.4 7.2 14.7 7.4 23.1 13.8 8.5 15.7 11.9 30.5 19.4 14.5 16.5 13.8 16.5 18.9 22.6 19.5 20.2 10.5 12.7 17.4 16.4 5.6 23.4 18.1 18.0 12.6 14.8 20.4 8.9 17.2 21.5 6.5 16.1 13.3 15.2 4.7 17.8 16.3 10.5 16.2 12.7 17.2 9.0 9.1 7.2 16.6 25.0 14.2 13.5 13.9 11.6 24.2 14.4 16.8 18.2 12.8 22.0 15.0 15.7 18.8 18.7 12.7 18.3 19.9 9.3 15.3 14.8 10.5 19.8 14.3 25.3 29.3 39.6 33.4 25.1 28.0 23.2 18.4 29.6 18.9 14.9 10.4 18.4 14.2 29.3 20.8 18.7 20.4 21.4 14.8 22.7 9.8 11.7 11.6 12.1 100.8 23.3 13.2 0.0 6.1 9.9 28.8 16.7 28.9 24.6 16.4 38.1 15.6 18.4 26.8 111.2 30.2 20.4 28.7 10.0 14.8 24.9 12.5 8.6 26.9 14.9 24.6 12.9 38.1 32.4 11.7 22.1 5.3 24.5 13.6 9.5 ATG16L2 "ATG16B, FLJ00012, WDR80" ENSG00000168010 "Autophagy related 16 like 2" Q8NAA4 11 72814308-72843674 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 60.9;lymphoid tissue: 52.0" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 45.9;Macrophages: 38.5;Paneth cells: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 28.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045444, HPA050312" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045444: AB_2679324, HPA050312: AB_2681082" "unprognostic (7.20e-3)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (4.26e-2)" "unprognostic (2.12e-1)" "unprognostic (1.31e-3)" "unprognostic (1.61e-2)" "unprognostic (4.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.90e-1)" "prognostic favorable (7.06e-4)" "unprognostic (2.49e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (1.74e-1)" "unprognostic (4.38e-2)" "unprognostic (1.08e-1)" "unprognostic (4.83e-2)" 7.8 6.6 7.1 20.7 8.0 60.9 7.2 7.4 6.2 9.5 9.7 10.5 7.6 5.5 11.9 7.5 10.2 8.3 11.6 5.8 7.4 4.8 7.2 6.5 16.3 16.4 10.7 7.0 10.1 8.0 5.7 11.5 5.2 8.6 7.3 8.9 11.3 10.1 5.5 3.6 35.7 13.1 10.4 7.9 52.0 6.6 2.6 8.3 3.2 6.5 8.0 19.6 8.5 8.5 2.0 4.7 28.5 7.1 2.4 2.6 1.4 1.4 1.3 4.1 3.2 4.9 4.0 2.6 3.2 3.2 1.6 2.5 1.6 3.5 9.6 2.1 4.1 2.9 2.9 0.5 10.8 2.8 7.6 1.6 7.5 6.9 2.7 3.6 9.8 31.3 3.9 1.5 3.6 4.5 17.9 4.9 17.6 1.0 13.2 1.8 4.7 11.3 16.9 0.6 6.4 1.5 5.6 2.9 4.2 5.3 4.9 3.1 2.4 1.3 7.2 3.0 3.4 3.6 13.5 6.8 4.4 1.6 7.9 2.5 6.0 1.5 4.2 1.9 8.8 2.4 2.4 7.1 18.1 1.3 3.9 1.3 1.2 1.9 2.6 4.7 2.0 1.0 1.2 28.5 2.4 4.7 0.8 1.7 1.4 7.1 8.0 7.4 6.2 7.4 4.8 10.7 7.0 8.6 8.3 6.0 18.4 16.7 5.1 14.8 2.6 4.4 5.1 6.7 3.4 5.2 2.0 6.8 0.0 3.7 0.5 7.9 8.0 0.0 0.9 3.1 5.6 2.8 23.0 2.9 15.2 4.8 12.6 12.9 45.9 0.4 9.5 38.5 3.3 16.2 9.0 4.0 2.3 43.6 7.4 1.6 3.7 0.0 6.6 1.6 7.7 15.2 10.3 23.5 10.4 4.2 ATG2B "C14orf103, FLJ10242" ENSG00000066739 "Autophagy related 2B" Q96BY7 14 96279202-96363870 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000880, HPA001427, HPA019665" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000880: AB_1078888, HPA001427: AB_1845551, HPA019665: AB_2274278" "unprognostic (9.39e-2)" "unprognostic (1.01e-1)" "unprognostic (7.28e-2)" "unprognostic (1.07e-1)" "unprognostic (1.02e-1)" "unprognostic (6.01e-2)" "unprognostic (3.19e-1)" "unprognostic (9.29e-3)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-3)" "unprognostic (1.45e-2)" "unprognostic (7.60e-3)" "unprognostic (6.66e-2)" "unprognostic (3.08e-1)" "unprognostic (3.90e-2)" "unprognostic (8.49e-2)" 3.6 3.4 2.6 2.5 4.1 4.4 5.2 9.2 4.5 3.9 3.2 3.1 4.9 4.4 2.9 4.0 3.0 2.7 3.2 3.3 4.5 6.0 3.4 3.1 3.0 5.1 8.1 9.7 4.1 2.7 4.0 3.2 3.1 3.1 5.2 9.3 4.3 3.8 2.7 3.9 3.6 6.5 4.9 3.5 3.3 3.6 1.5 1.6 2.1 1.0 2.5 3.0 0.7 4.1 5.2 6.5 5.1 11.3 10.5 5.2 6.1 8.7 6.7 7.6 2.8 2.8 9.2 5.8 9.9 4.5 5.7 8.8 6.0 10.8 8.5 4.5 4.0 5.7 2.5 7.4 7.3 4.4 8.8 6.1 9.0 7.2 7.1 8.4 7.0 4.6 8.3 5.3 6.6 6.6 6.3 3.1 4.8 5.4 6.1 14.6 6.2 7.5 5.1 6.4 7.2 9.2 3.8 4.4 7.0 6.0 4.2 11.2 3.7 1.7 9.0 3.9 8.4 6.9 8.6 7.6 5.1 3.6 0.6 1.0 1.7 1.6 0.6 3.0 1.5 1.8 1.7 1.3 1.5 1.9 2.0 2.1 2.5 1.0 1.6 2.7 0.7 11.9 10.5 7.5 2.8 12.2 24.5 11.2 7.6 2.7 6.8 8.7 25.5 4.4 3.3 5.2 31.1 9.8 8.2 0.0 5.2 2.7 7.8 11.1 6.9 23.2 3.6 30.2 7.9 13.5 10.5 36.0 11.8 8.9 1.7 3.6 11.8 8.5 4.9 10.5 9.9 6.8 19.0 6.5 8.5 15.6 13.8 24.6 13.2 6.5 8.7 3.1 ATN1 "B37, D12S755E, DRPLA" ENSG00000111676 "Atrophin 1" P54259 12 6924463-6942321 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031619 Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031619: AB_10601667" "unprognostic (3.86e-3)" "unprognostic (2.07e-1)" "unprognostic (1.80e-3)" "unprognostic (5.82e-2)" "unprognostic (1.37e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (7.20e-4)" "unprognostic (1.44e-1)" "unprognostic (6.90e-2)" "unprognostic (8.42e-3)" "unprognostic (1.86e-2)" "unprognostic (3.19e-1)" "unprognostic (7.43e-2)" "unprognostic (5.46e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-1)" "unprognostic (7.35e-2)" 37.6 38.6 34.6 20.1 28.1 4.3 25.9 57.5 45.5 33.7 30.5 27.0 38.3 22.8 35.7 17.2 21.2 34.7 28.0 25.6 32.8 22.4 21.6 8.8 26.3 11.9 24.4 33.8 72.0 28.7 37.4 43.8 27.6 29.2 28.9 14.2 29.2 44.0 40.9 26.5 28.3 20.5 33.4 29.5 19.3 22.3 8.8 29.4 2.3 42.0 7.3 9.1 30.0 57.6 2.6 2.1 2.5 0.5 0.5 2.5 0.7 15.5 20.3 22.0 44.2 20.8 18.8 36.7 18.6 16.0 19.1 13.6 20.5 18.6 4.2 5.9 22.9 15.7 10.4 13.4 18.2 10.1 49.4 13.3 19.8 18.8 9.7 32.2 4.0 30.2 30.4 13.4 23.9 18.8 33.0 18.7 6.4 16.7 8.6 16.9 22.3 8.7 3.7 45.0 7.2 8.6 18.2 11.9 3.1 14.0 22.0 6.8 21.9 19.0 22.2 13.3 22.5 8.4 11.2 24.2 22.5 29.0 17.7 28.4 6.6 2.2 2.9 17.5 5.2 23.5 1.9 0.5 2.5 2.5 0.3 2.2 2.6 1.1 1.4 0.6 2.3 1.4 1.9 0.0 0.5 0.1 2.1 1.2 0.7 34.6 28.1 57.5 45.5 32.8 22.4 24.4 33.8 29.2 29.4 14.9 18.8 2.4 11.1 26.9 27.8 12.2 15.3 10.7 21.6 27.9 17.7 23.4 13.3 16.4 1.7 28.0 25.9 0.0 26.2 12.8 25.2 15.6 9.3 7.2 10.2 23.8 20.8 27.6 11.9 2.6 59.0 9.4 20.3 7.2 23.5 15.7 23.6 19.8 49.5 9.9 25.4 19.4 22.1 5.8 7.1 21.8 31.0 7.2 18.8 15.2 ATOH8 "bHLHa21, FLJ14708, HATH6" ENSG00000168874 "Atonal bHLH transcription factor 8" Q96SQ7 2 85751344-85788066 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 41.8" "Cell type enhanced" "Detected in many" 7 "Club cells: 22.7;Hepatocytes: 31.6;Late spermatids: 19.8;Muller glia cells: 25.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 15.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 2.9;MAIT T-cell: 1.7" "Group enriched" "Detected in many" 12 "monocytes: 2.9;T-cells: 1.7" "Cell line enhanced" "Detected in many" "AN3-CA: 11.4;RH-30: 19.2;RT4: 12.3;TIME: 18.1;U-2197: 12.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA028406 Supported Nucleoplasm NA NA Nucleoplasm "HPA028406: AB_2672587" "unprognostic (7.70e-2)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (2.84e-3)" "unprognostic (2.01e-1)" "unprognostic (2.50e-2)" "unprognostic (1.78e-1)" "unprognostic (6.28e-3)" "unprognostic (1.56e-1)" "prognostic favorable (8.98e-6)" "unprognostic (3.32e-2)" "prognostic favorable (3.80e-5)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-2)" 36.4 2.4 3.7 2.4 4.3 0.8 19.9 2.9 4.9 10.5 4.0 4.3 4.5 2.7 11.5 2.2 5.0 7.6 5.7 12.9 5.0 2.0 3.6 30.8 21.1 4.5 6.3 2.1 9.7 4.3 1.0 2.3 3.2 5.4 9.0 1.3 6.4 3.5 12.1 25.2 8.4 3.2 5.8 4.1 8.1 4.4 2.0 4.6 0.3 41.8 4.2 1.1 10.4 24.5 0.0 0.2 0.0 2.9 0.0 1.7 0.4 0.0 3.6 5.1 11.4 5.0 0.3 0.1 9.5 1.0 2.9 1.3 0.0 0.0 0.0 3.6 7.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 8.5 0.5 3.3 0.0 0.0 3.7 0.0 0.0 0.0 6.0 1.9 0.0 0.0 0.0 7.8 0.1 0.0 0.0 0.1 2.5 0.1 0.0 19.2 0.1 0.0 12.3 8.5 1.8 1.8 0.0 0.6 0.0 0.0 0.0 18.1 4.5 0.2 12.5 0.0 0.0 0.0 0.0 1.5 0.0 8.9 0.0 2.9 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 3.7 4.3 2.9 4.9 5.0 2.0 6.3 2.1 5.4 4.6 8.9 16.5 0.0 6.2 2.3 0.2 11.5 7.6 2.7 22.7 1.8 0.0 0.1 0.0 7.5 11.2 11.7 0.0 0.0 2.0 0.5 9.0 5.6 1.1 31.6 2.4 0.0 4.1 5.5 2.4 19.8 3.1 3.3 1.7 0.0 1.9 25.7 0.9 0.0 0.4 0.3 0.3 0.0 9.4 1.1 0.7 1.3 0.2 0.0 0.8 1.1 ATP13A4 "DKFZp761I1011, FLJ37958" ENSG00000127249 "ATPase 13A4" Q4VNC1 3 193402077-193593111 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2" "Cell type enhanced" "Detected in many" 19 "Alveolar cells type 1: 59.6;Alveolar cells type 2: 19.6;Cholangiocytes: 12.7;Ciliated cells: 13.4;Club cells: 22.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 23.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051932 Approved Nucleoplasm NA NA Nucleoplasm "HPA051932: " "unprognostic (4.97e-2)" "unprognostic (1.50e-3)" "unprognostic (4.86e-3)" "unprognostic (2.52e-3)" "unprognostic (2.72e-2)" "prognostic favorable (3.91e-4)" "unprognostic (1.55e-1)" "unprognostic (3.99e-3)" "unprognostic (2.65e-1)" "unprognostic (1.36e-1)" "unprognostic (4.39e-2)" "unprognostic (1.34e-1)" "unprognostic (4.29e-5)" "unprognostic (1.91e-1)" "unprognostic (1.70e-1)" "unprognostic (5.75e-3)" "unprognostic (2.00e-1)" 0.6 0.7 11.2 0.6 11.1 0.6 17.8 2.6 10.1 1.8 2.2 8.4 9.0 0.9 0.6 46.4 11.8 2.7 4.3 0.6 11.1 5.1 0.8 0.7 22.0 0.8 7.5 7.7 0.8 3.9 52.5 3.5 0.6 9.0 0.6 3.2 0.5 4.5 16.7 0.6 11.2 0.6 0.7 6.1 0.7 7.6 0.8 7.5 0.0 51.2 7.8 9.5 0.6 3.7 0.4 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 1.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 9.4 0.2 0.1 1.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 1.9 1.0 1.5 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 11.2 11.1 2.6 10.1 11.1 5.1 7.5 7.7 9.0 7.5 59.6 19.6 0.0 0.0 0.1 1.9 0.4 12.7 13.4 22.7 0.0 0.0 0.8 0.0 2.1 0.3 0.0 0.0 0.0 0.2 0.1 0.2 0.0 1.1 0.0 0.2 1.6 0.0 1.8 0.8 0.8 0.0 0.6 1.7 0.0 1.5 0.6 1.2 1.7 0.4 0.2 0.9 0.0 0.0 0.7 1.2 1.4 0.6 0.8 1.7 0.0 ATP6V1D "ATP6M, VATD, VMA8" ENSG00000100554 "ATPase H+ transporting V1 subunit D" Q9Y5K8 14 67294371-67360265 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031515, HPA057316" Enhanced Approved Nucleoplasm Yes No Nucleoplasm "HPA031515: AB_10600785, HPA057316: AB_2683409" "unprognostic (1.10e-1)" "unprognostic (7.35e-2)" "unprognostic (1.59e-1)" "unprognostic (7.10e-3)" "unprognostic (1.52e-1)" "unprognostic (7.64e-2)" "unprognostic (7.78e-3)" "unprognostic (1.19e-1)" "unprognostic (2.32e-1)" "unprognostic (3.05e-2)" "unprognostic (1.13e-2)" "unprognostic (3.08e-2)" "prognostic favorable (7.60e-13)" "unprognostic (2.78e-1)" "unprognostic (3.18e-2)" "unprognostic (1.41e-2)" "unprognostic (1.44e-2)" 18.2 51.9 43.9 13.8 47.7 9.9 15.9 23.6 54.1 13.1 19.9 13.5 20.9 16.2 13.8 30.2 33.6 17.9 14.8 52.6 39.8 45.2 52.0 19.9 14.5 11.8 39.7 44.9 10.4 12.4 21.8 28.8 17.2 39.6 21.4 20.3 10.8 15.7 18.1 31.8 14.7 16.8 16.1 29.4 9.7 17.8 14.0 23.0 14.7 34.1 25.2 15.3 16.6 17.0 14.7 35.0 39.2 34.5 17.9 28.5 23.9 62.0 12.9 26.5 16.6 17.7 18.8 18.7 48.0 22.1 29.4 24.6 14.8 21.9 5.1 20.1 28.7 28.2 23.4 14.4 22.4 39.8 22.1 9.9 5.4 17.9 12.0 32.5 5.3 19.8 13.5 16.4 20.6 15.6 32.5 18.4 13.6 11.9 15.7 42.2 15.0 15.4 12.0 19.1 22.6 15.5 12.0 22.0 8.1 39.1 24.6 33.2 14.6 30.9 20.1 41.3 25.0 28.5 15.7 29.6 44.2 32.3 21.1 30.7 16.8 12.1 7.2 44.2 10.8 24.5 32.2 34.5 37.3 18.6 33.6 15.7 14.7 20.1 20.0 35.0 14.5 15.1 16.8 39.2 17.9 33.3 26.7 28.5 23.9 43.9 47.7 23.6 54.1 39.8 45.2 39.7 44.9 39.6 23.0 50.6 50.0 34.2 59.3 85.5 56.9 137.6 43.3 182.0 63.7 78.5 51.1 84.1 310.0 120.5 149.9 33.7 68.6 93.5 42.7 73.5 53.9 61.4 40.4 40.0 114.2 82.6 52.2 20.3 37.5 68.5 30.5 59.4 75.9 57.7 39.8 86.6 96.8 63.1 47.7 271.8 92.4 12.9 27.8 77.2 60.9 120.9 172.2 35.9 33.7 102.9 ATP6V1E1 "ATP6E, ATP6E2, ATP6V1E, P31, Vma4" ENSG00000131100 "ATPase H+ transporting V1 subunit E1" P36543 22 17592136-17628818 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Distal tubular cells: 391.3;Syncytiotrophoblasts: 400.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009528, CAB018699, HPA029196" Enhanced Approved Nucleoplasm NA NA 61000 Nucleoplasm "CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: AB_2672944" "unprognostic (1.53e-3)" "unprognostic (5.78e-3)" "unprognostic (1.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.24e-3)" "prognostic unfavorable (1.56e-5)" "unprognostic (2.17e-1)" "unprognostic (2.09e-1)" "unprognostic (3.37e-2)" "unprognostic (7.72e-3)" "prognostic favorable (4.18e-4)" "prognostic favorable (7.66e-8)" "unprognostic (3.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.58e-2)" "unprognostic (2.75e-1)" 32.8 45.9 59.5 20.4 69.0 24.9 31.5 48.9 90.3 30.2 26.7 34.5 25.2 17.6 27.7 44.4 37.5 26.7 26.7 67.4 58.9 55.4 71.7 26.1 31.7 24.5 54.5 52.3 27.0 15.8 48.3 29.6 46.2 69.8 31.1 32.0 24.1 21.5 42.1 48.5 26.9 19.1 38.1 53.7 23.9 23.8 20.2 32.4 17.5 31.9 26.1 32.5 32.1 22.0 24.2 26.3 55.3 34.8 22.6 29.4 30.1 21.7 19.8 18.0 17.4 59.9 32.4 19.7 29.1 38.8 37.0 43.0 24.6 18.0 13.6 25.0 38.8 47.5 34.5 28.0 25.5 33.1 26.1 31.7 24.5 19.8 32.9 87.7 28.2 42.5 40.6 50.1 35.7 26.1 41.6 31.2 17.4 30.6 28.0 63.0 22.6 24.4 20.5 13.1 48.7 28.0 14.3 26.2 8.1 61.4 34.5 13.2 23.0 26.6 18.9 62.6 36.7 18.3 32.7 26.6 26.1 13.8 32.5 21.5 27.4 48.1 17.3 42.0 13.8 35.0 45.2 32.9 55.3 21.4 30.8 20.8 24.2 21.9 20.5 26.3 19.0 20.8 21.5 44.3 22.6 34.8 25.4 29.4 30.1 59.5 69.0 48.9 90.3 58.9 55.4 54.5 52.3 69.8 32.4 71.5 74.4 66.3 65.8 37.3 53.1 103.3 86.6 80.3 53.4 130.9 25.5 202.2 391.3 124.1 6.9 68.0 66.0 23.3 104.7 118.4 63.5 55.0 86.8 40.9 161.1 50.9 40.3 70.0 71.1 12.5 87.2 106.2 75.9 170.5 45.1 93.9 121.5 73.7 91.9 264.4 32.5 58.2 83.4 71.0 67.3 45.0 400.7 65.0 28.6 80.6 ATRIP "FLJ12343, MGC20625, MGC21482, MGC26740" ENSG00000164053 "ATR interacting protein" Q8WXE1 3 48446710-48467645 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.3" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 5.3;Exocrine glandular cells: 3.3;Pancreatic endocrine cells: 3.5;Suprabasal keratinocytes: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033109, HPA047590" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB033109: AB_634993, HPA047590: AB_2680094" "unprognostic (5.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.85e-1)" "unprognostic (8.87e-2)" "unprognostic (2.34e-1)" "unprognostic (4.79e-3)" "unprognostic (4.72e-2)" "unprognostic (8.88e-3)" "unprognostic (2.66e-1)" "unprognostic (7.94e-2)" "unprognostic (2.53e-2)" "unprognostic (7.05e-2)" "unprognostic (2.01e-1)" "unprognostic (8.89e-2)" "unprognostic (2.59e-1)" "unprognostic (1.40e-2)" "unprognostic (8.52e-2)" 6.1 5.3 4.9 6.2 5.5 7.1 6.5 9.4 6.4 7.0 5.2 7.2 5.1 3.8 8.2 5.1 7.0 5.7 5.0 5.4 3.5 2.8 5.4 5.4 6.0 5.5 4.8 3.6 6.8 5.3 5.3 5.5 9.2 3.8 6.2 6.0 6.5 5.1 7.2 7.3 8.0 4.6 5.4 3.4 6.3 5.2 38.3 4.6 13.4 9.3 6.6 9.0 5.5 6.2 0.9 2.9 1.0 1.4 1.4 3.4 1.5 7.0 2.9 8.2 6.2 5.0 8.5 8.7 10.7 5.0 13.3 11.1 4.3 5.0 15.7 5.1 4.5 6.2 7.3 9.2 8.4 13.0 9.3 4.7 12.2 13.1 2.9 2.7 11.8 7.8 3.6 2.7 7.1 3.4 2.9 5.8 5.9 9.7 8.1 12.4 3.9 9.9 4.2 6.4 3.6 8.8 6.7 7.5 11.5 4.5 3.5 4.0 5.8 8.6 8.7 3.4 7.7 7.4 4.5 6.5 8.9 5.8 10.7 12.4 9.6 15.3 10.8 4.7 8.9 4.9 0.7 1.4 0.0 3.3 0.8 0.5 0.9 3.0 1.7 0.9 0.5 2.1 3.3 1.0 1.4 1.0 2.9 3.4 1.5 4.9 5.5 9.4 6.4 3.5 2.8 4.8 3.6 3.8 4.6 0.0 1.0 0.0 0.0 2.6 0.8 1.3 0.0 5.3 2.3 0.0 2.0 0.1 0.0 3.0 0.0 0.7 0.0 0.0 3.3 0.1 0.2 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.8 0.0 0.6 3.5 0.0 0.0 1.5 2.0 0.0 0.9 0.0 0.0 3.3 0.1 0.0 0.0 0.0 ATXN1L BOAT1 ENSG00000224470 "Ataxin 1 like" P0C7T5 16 71845991-71885268 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 197.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062596, HPA062789" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA062596: AB_2684802, HPA062789: AB_2684868" "unprognostic (1.51e-1)" "unprognostic (1.73e-2)" "unprognostic (1.39e-1)" "unprognostic (1.67e-1)" "unprognostic (3.01e-2)" "unprognostic (1.01e-1)" "unprognostic (1.68e-1)" "unprognostic (1.14e-1)" "unprognostic (1.00e-1)" "unprognostic (1.04e-1)" "unprognostic (8.13e-2)" "unprognostic (1.99e-1)" "prognostic favorable (5.33e-8)" "unprognostic (1.61e-1)" "unprognostic (1.42e-1)" "unprognostic (5.30e-2)" "prognostic unfavorable (8.42e-4)" 19.2 12.0 17.1 14.2 15.9 41.3 16.2 11.9 20.9 15.0 15.4 22.7 9.1 10.2 19.4 9.8 14.7 14.2 14.5 11.9 13.5 10.9 23.4 10.0 14.9 11.4 14.7 13.1 16.7 16.3 29.3 10.3 14.6 14.7 14.4 11.9 14.2 14.4 14.0 15.9 18.6 14.9 16.3 14.5 13.8 16.0 25.3 16.9 10.9 15.1 8.2 12.9 16.2 18.5 1.8 1.3 3.2 2.1 2.0 3.0 1.4 8.5 11.6 11.8 8.6 13.9 6.9 13.9 7.2 8.1 13.2 10.1 16.5 9.6 9.6 11.4 11.3 6.0 15.1 10.0 11.0 14.4 2.6 8.8 7.0 12.1 11.5 10.4 8.5 14.4 9.9 14.1 14.9 10.8 8.7 11.9 12.7 7.9 7.7 7.7 24.3 14.3 8.4 10.8 6.7 5.5 15.4 12.0 11.4 9.1 12.0 6.3 10.8 14.4 7.7 8.8 13.0 11.9 9.1 14.3 14.5 15.3 9.1 9.7 17.4 14.6 22.9 9.0 5.8 12.2 3.2 1.5 1.7 2.3 2.1 1.6 1.8 1.7 2.0 1.3 1.5 3.0 2.7 2.2 2.0 0.9 0.8 3.0 1.4 17.1 15.9 11.9 20.9 13.5 10.9 14.7 13.1 14.7 16.9 0.0 8.8 10.7 13.3 20.3 11.2 11.0 7.6 5.3 5.7 14.0 13.7 7.2 14.9 10.6 37.1 15.7 13.6 0.0 10.3 6.3 10.5 13.0 12.7 10.6 7.5 14.3 7.5 13.5 8.8 197.6 13.8 11.3 11.8 15.4 7.5 8.0 12.2 16.4 12.0 14.0 15.5 12.9 14.4 20.4 17.9 21.8 9.6 23.5 8.5 23.8 ATXN7L3B lnc-SCA7 ENSG00000253719 "Ataxin 7 like 3B" Q96GX2 12 74537827-74545430 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 170.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056612 Approved Nucleoplasm NA NA Nucleoplasm "HPA056612: AB_2683190" "unprognostic (3.43e-3)" "unprognostic (1.07e-1)" "unprognostic (4.76e-2)" "unprognostic (3.20e-2)" "unprognostic (3.68e-1)" "unprognostic (9.26e-2)" "unprognostic (1.81e-3)" "unprognostic (7.12e-2)" "unprognostic (9.55e-2)" "unprognostic (6.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.49e-1)" "prognostic favorable (2.25e-6)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (1.16e-2)" "unprognostic (1.15e-2)" 12.4 17.9 29.7 13.1 34.2 15.6 20.9 44.1 52.1 18.2 15.8 20.6 12.9 18.5 19.9 24.3 14.8 31.6 14.7 16.1 27.6 35.0 22.2 18.6 15.3 17.6 26.0 32.2 31.5 20.9 23.3 18.3 20.8 31.2 21.6 18.1 22.3 20.4 21.0 18.1 16.4 16.9 17.0 20.0 17.2 34.2 8.1 18.5 27.8 23.1 9.5 20.2 14.8 13.2 5.6 9.1 13.7 11.5 8.2 14.8 8.4 9.4 7.5 25.1 15.8 15.9 15.0 10.7 9.1 9.1 10.8 8.5 8.6 5.3 13.8 7.2 9.0 7.2 9.6 12.9 8.8 9.0 12.7 10.2 18.4 7.7 13.0 15.2 18.2 3.9 17.2 20.5 8.2 13.6 18.9 12.4 16.1 22.7 7.0 8.8 13.7 20.1 13.0 14.2 13.1 7.2 15.8 13.5 12.4 9.9 15.6 39.5 24.9 10.3 12.2 14.3 16.9 28.8 12.0 10.6 10.4 9.2 6.1 5.6 8.3 7.7 18.0 4.5 6.7 10.4 13.7 9.5 12.5 5.6 9.0 6.7 4.4 8.5 6.2 9.1 5.6 14.8 8.0 2.7 8.2 11.5 5.1 6.1 8.4 29.7 34.2 44.1 52.1 27.6 35.0 26.0 32.2 31.2 18.5 68.5 31.6 13.7 33.4 16.4 86.9 46.2 45.9 170.0 66.0 36.6 31.4 47.5 26.6 34.8 0.6 33.8 24.5 23.3 28.4 31.6 25.2 38.1 44.0 25.2 19.3 49.3 34.8 29.4 20.7 1.3 34.8 19.8 20.3 19.0 36.4 95.6 46.1 17.5 35.3 27.2 75.5 19.4 16.7 11.8 14.9 19.9 37.6 21.8 32.8 34.3 BAG1 ENSG00000107262 "BCL2 associated athanogene 1" Q99933 9 33247820-33264720 "Cancer-related genes, Predicted intracellular proteins" Apoptosis Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 1003.4;Late spermatids: 2167.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 82.4;NB-4: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002486, HPA018121" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB002486: AB_563422, HPA018121: AB_1845255" "unprognostic (4.49e-3)" "unprognostic (4.52e-2)" "unprognostic (2.33e-2)" "unprognostic (1.32e-3)" "unprognostic (5.46e-2)" "unprognostic (3.67e-3)" "unprognostic (2.10e-1)" "unprognostic (1.34e-2)" "unprognostic (4.62e-2)" "unprognostic (7.21e-2)" "unprognostic (4.24e-1)" "unprognostic (2.23e-1)" "prognostic favorable (2.22e-16)" "unprognostic (4.45e-2)" "unprognostic (4.03e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-2)" 21.5 22.1 30.0 14.6 34.3 25.2 28.6 21.2 25.0 21.4 32.0 18.3 19.5 20.8 15.5 20.4 26.9 17.4 34.8 48.6 25.0 24.3 41.9 34.5 21.2 14.1 33.8 20.1 14.4 43.2 40.9 24.9 16.6 20.0 24.7 27.7 18.2 38.5 26.4 93.2 26.7 27.2 22.2 27.7 21.4 32.5 46.0 20.5 14.9 29.7 41.9 21.2 30.8 27.3 10.2 18.8 29.4 11.6 8.2 9.0 5.1 10.6 10.6 9.0 19.8 13.8 8.1 12.6 8.6 12.3 13.3 13.6 7.4 10.3 35.2 6.5 8.7 4.7 13.4 10.4 7.1 8.8 17.8 9.9 17.5 82.4 11.5 11.7 40.0 21.4 8.2 39.9 6.2 15.0 6.2 15.7 9.1 20.2 17.7 11.0 16.6 27.3 78.8 17.5 13.8 15.5 14.4 12.9 22.6 16.8 31.0 28.9 17.4 38.5 33.9 8.7 3.7 15.4 48.9 8.3 5.9 7.6 17.4 15.0 14.1 21.8 19.1 5.0 21.7 3.3 12.2 11.5 29.4 5.8 11.6 5.2 6.8 6.6 6.9 14.0 10.2 9.0 5.4 7.0 8.2 11.2 18.8 7.8 5.1 30.0 34.3 21.2 25.0 25.0 24.3 33.8 20.1 20.0 20.5 83.4 68.2 64.1 244.9 381.9 70.1 123.1 117.2 45.5 85.3 207.6 55.0 122.0 336.5 113.1 1003.4 65.4 200.5 23.3 167.5 46.5 81.3 398.0 41.5 69.3 91.7 36.5 190.1 49.7 67.4 2167.8 79.4 97.7 155.3 55.1 184.6 65.3 112.7 159.6 83.4 221.7 93.8 97.0 133.9 99.2 59.6 490.8 205.6 67.3 143.0 386.9 BAHD1 KIAA0945 ENSG00000140320 "Bromo adjacent homology domain containing 1" Q8TBE0 15 40439721-40468242 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041196 Supported Nucleoplasm NA NA Nucleoplasm "HPA041196: AB_10803999" "prognostic unfavorable (1.55e-4)" "unprognostic (4.08e-1)" "unprognostic (3.00e-2)" "unprognostic (1.56e-2)" "unprognostic (1.35e-2)" "unprognostic (1.04e-1)" "unprognostic (7.19e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "unprognostic (2.00e-2)" "unprognostic (3.49e-3)" "unprognostic (4.81e-2)" "prognostic favorable (1.29e-10)" "unprognostic (4.95e-2)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" 12.7 24.3 11.8 15.7 13.8 10.1 19.5 11.3 16.1 12.1 12.5 10.6 19.1 13.0 15.0 15.6 13.1 15.8 13.2 12.8 12.7 8.7 13.8 13.8 14.8 13.5 12.9 13.2 26.1 16.6 19.6 15.6 14.4 10.9 13.6 8.7 10.2 14.1 16.1 13.5 13.4 13.0 11.3 9.1 14.5 13.8 21.7 12.2 18.4 23.9 8.0 12.9 15.7 22.5 2.4 1.8 3.8 3.2 3.9 4.1 1.2 10.0 5.1 9.2 15.1 7.5 5.8 20.1 8.2 6.0 9.0 8.9 14.1 4.8 7.6 11.1 7.3 11.0 20.2 14.9 6.2 5.1 14.5 9.5 19.9 8.0 6.8 7.1 8.6 15.1 7.7 6.4 5.5 5.5 8.1 7.8 9.7 19.5 6.4 5.3 9.5 9.5 13.0 9.1 11.9 9.7 16.4 10.4 6.2 10.0 12.0 14.4 8.8 5.0 26.7 5.8 6.0 21.3 13.9 9.0 9.9 11.1 13.9 8.5 9.8 10.8 8.7 10.3 13.3 6.6 1.9 0.9 3.8 4.1 1.8 2.2 1.7 2.9 2.3 1.0 2.4 3.8 3.3 1.0 3.9 3.2 1.8 0.9 1.2 11.8 13.8 11.3 16.1 12.7 8.7 12.9 13.2 10.9 12.2 17.9 6.5 2.7 3.3 7.3 3.3 9.6 7.6 2.7 9.1 10.4 2.0 4.1 1.7 4.9 0.7 6.7 10.3 0.0 6.3 5.9 4.8 4.5 9.2 10.6 4.8 15.9 7.5 9.8 7.6 2.2 9.5 3.7 0.0 2.8 8.3 4.8 5.5 10.5 5.3 4.2 3.7 6.5 3.6 6.0 10.2 6.8 3.4 4.4 6.6 3.8 BATF "B-ATF, BATF1, SFA-2" ENSG00000156127 "Basic leucine zipper ATF-like transcription factor" Q16520 14 75522425-75547015 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.1;lymphoid tissue: 26.6" "Cell type enhanced" "Detected in many" 18 "granulocytes: 226.5;T-cells: 75.6;Urothelial cells: 57.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "T-cells: 41.1" "Cell line enhanced" "Detected in some" "HDLM-2: 82.7;MCF7: 31.1;RT4: 19.5;SK-BR-3: 15.9;U-937: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059588, HPA064962" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059588: AB_2684074, HPA064962: AB_2685392" "unprognostic (3.33e-3)" "unprognostic (4.87e-3)" "prognostic unfavorable (8.30e-4)" "prognostic favorable (5.35e-6)" "unprognostic (3.02e-2)" "prognostic favorable (7.91e-5)" "unprognostic (1.14e-2)" "unprognostic (1.39e-1)" "unprognostic (2.94e-1)" "unprognostic (6.72e-2)" "unprognostic (7.17e-2)" "unprognostic (8.90e-2)" "prognostic unfavorable (3.74e-9)" "unprognostic (4.74e-2)" "unprognostic (1.90e-1)" "unprognostic (1.41e-1)" "prognostic favorable (4.30e-4)" 4.9 1.3 0.9 15.8 4.7 13.8 7.6 0.2 1.9 2.8 2.8 0.2 1.0 2.0 1.3 1.4 2.6 1.9 7.0 3.1 1.0 0.7 1.9 3.0 7.9 20.2 2.1 0.2 1.6 1.6 0.5 1.2 3.7 1.9 5.2 1.1 1.0 6.0 8.3 0.9 2.8 8.0 2.6 2.7 26.6 5.7 0.7 1.9 6.2 2.7 3.4 23.1 10.4 7.3 7.1 9.0 5.0 8.9 6.4 41.1 8.4 1.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.7 0.0 1.8 0.0 0.3 2.7 2.2 8.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 2.4 0.0 31.1 1.0 6.7 0.0 13.0 0.0 0.2 0.0 1.4 0.0 19.5 0.0 0.0 0.0 15.9 0.6 0.0 1.4 4.3 0.0 0.0 0.0 1.0 0.0 7.7 8.2 0.0 0.0 23.0 0.0 1.2 8.9 2.7 19.6 4.9 15.4 7.1 21.4 25.1 9.0 5.2 8.6 18.1 5.0 6.4 4.2 1.0 41.1 8.4 0.9 4.7 0.2 1.9 1.0 0.7 2.1 0.2 1.9 1.9 8.9 43.8 23.6 46.3 4.7 0.0 0.2 2.5 9.4 13.6 3.5 0.0 0.3 0.0 0.3 0.5 0.7 0.0 0.0 2.3 0.2 3.3 20.8 226.5 0.8 49.2 0.0 0.0 3.1 16.0 0.2 0.0 19.3 5.0 9.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.0 0.9 75.6 0.0 57.9 BCL2L2 "BCL-W, KIAA0271, PPP1R51" ENSG00000129473 "BCL2 like 2" Q92843 14 23298790-23311759 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB040539, HPA048740" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB040539: , HPA048740: " "unprognostic (8.23e-3)" "unprognostic (9.85e-2)" "unprognostic (1.71e-2)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (1.64e-1)" "unprognostic (3.47e-3)" "unprognostic (1.53e-2)" "unprognostic (1.78e-1)" "unprognostic (2.91e-3)" "unprognostic (1.50e-3)" "unprognostic (2.60e-1)" "prognostic favorable (1.99e-6)" "unprognostic (2.44e-1)" "unprognostic (2.00e-1)" "unprognostic (6.60e-2)" "unprognostic (5.38e-2)" 29.9 22.8 38.2 15.6 33.6 7.4 25.1 27.3 44.8 13.7 32.3 27.4 21.9 19.4 19.0 20.6 32.8 16.6 17.6 23.8 36.2 32.9 22.3 9.0 18.6 8.6 43.3 39.5 17.5 30.6 34.1 16.5 15.1 32.8 31.8 20.4 15.0 36.5 31.9 10.6 29.2 19.0 34.8 40.9 11.3 22.3 14.9 28.1 1.2 25.6 11.8 10.1 23.0 23.2 1.3 1.8 0.6 1.8 0.1 0.3 1.3 11.8 12.8 11.6 8.5 22.4 19.6 10.6 21.5 13.2 10.7 11.8 7.8 18.9 7.7 7.7 11.8 13.6 22.1 7.2 13.5 13.5 3.9 6.8 8.5 17.1 15.4 14.0 9.2 15.1 15.1 26.6 8.0 13.0 13.7 9.0 1.4 8.3 7.6 12.7 8.9 0.7 6.2 4.5 16.4 25.0 5.5 14.3 3.5 9.4 20.3 15.4 9.2 9.7 15.5 17.5 7.5 9.8 7.4 17.5 19.1 12.0 12.9 11.0 9.8 5.8 1.1 12.1 7.6 21.6 0.0 1.8 0.4 0.3 1.8 0.2 1.3 0.0 0.2 1.8 1.0 0.3 0.0 0.6 0.1 1.0 0.9 0.1 1.3 38.2 33.6 27.3 44.8 36.2 32.9 43.3 39.5 32.8 28.1 8.9 13.3 0.5 6.8 7.7 17.1 25.0 2.5 9.4 12.5 5.2 23.6 4.4 11.6 7.4 17.7 9.0 10.1 0.0 15.7 3.4 6.7 14.5 5.7 6.4 4.9 19.1 17.9 9.8 7.3 3.3 10.3 4.0 6.8 4.6 15.5 6.8 18.7 10.5 20.1 7.5 12.0 6.5 16.0 0.0 0.2 9.7 4.7 1.8 9.7 15.2 BCL6 "BCL5, BCL6A, LAZ3, ZBTB27, ZNF51" ENSG00000113916 "B cell CLL/lymphoma 6" P41182 3 187721377-187745727 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Immunity, Inflammatory response, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 114.3" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 96.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 63.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 63.4" "Cell line enhanced" "Detected in many" "ASC diff: 27.3;Daudi: 42.9;HSkMC: 31.1;U-698: 59.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000307, HPA004899, HPA050645" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB000307: AB_2063451, HPA004899: AB_1078273, HPA050645: AB_2681199" "unprognostic (5.36e-2)" "unprognostic (3.29e-2)" "unprognostic (1.63e-3)" "unprognostic (2.49e-1)" "unprognostic (2.85e-1)" "unprognostic (6.34e-3)" "unprognostic (2.62e-2)" "unprognostic (3.33e-3)" "unprognostic (8.75e-2)" "unprognostic (2.04e-2)" "unprognostic (1.63e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.27e-9)" "unprognostic (5.22e-2)" "unprognostic (7.82e-2)" "unprognostic (5.67e-2)" "unprognostic (2.58e-2)" 47.1 14.3 21.8 23.2 25.9 50.6 48.0 58.7 23.7 21.2 21.2 19.2 11.5 4.1 17.7 8.8 20.9 28.3 22.3 18.6 21.5 8.0 10.1 20.1 26.3 24.5 31.6 9.3 20.2 15.6 9.1 23.3 7.5 28.5 17.3 5.8 15.9 19.1 11.8 114.3 36.4 8.1 24.4 50.1 27.2 16.1 10.2 26.6 18.9 14.8 10.4 22.4 24.9 20.0 3.9 5.6 63.4 15.4 0.9 1.3 5.2 1.2 3.6 3.6 0.8 27.3 21.8 3.9 4.3 10.5 5.0 5.3 2.6 2.0 42.9 3.1 5.4 3.1 2.1 1.2 2.8 4.3 9.0 1.4 0.0 1.8 6.1 14.2 0.5 0.2 31.1 18.2 6.1 9.4 16.3 2.8 1.1 0.4 7.4 4.8 1.4 1.4 0.3 0.3 0.7 2.7 11.9 1.8 0.2 3.5 6.3 0.8 0.0 5.0 2.1 2.8 8.3 9.4 1.5 5.6 12.1 1.9 4.4 2.0 5.5 1.8 59.6 6.6 1.6 8.5 1.6 6.9 4.1 1.3 8.7 1.3 1.4 0.8 1.2 5.6 3.9 0.5 0.6 63.4 0.9 15.4 0.9 0.6 5.2 21.8 25.9 58.7 23.7 21.5 8.0 31.6 9.3 28.5 26.6 17.9 76.9 6.5 13.3 42.0 11.0 60.5 17.8 25.4 22.7 15.7 19.6 1.1 0.0 9.2 12.3 27.7 1.6 0.0 10.6 2.0 36.2 28.7 10.5 44.4 11.2 0.0 4.6 9.8 56.3 6.2 26.7 26.7 33.7 3.6 1.1 40.1 8.7 0.0 17.7 1.1 9.6 32.3 96.4 0.4 0.7 53.8 3.4 10.7 1.9 21.9 BCL7B ENSG00000106635 "BCL tumor suppressor 7B" Q9BQE9 7 73536356-73558002 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Differentiation, Wnt signaling pathway" "Allergen, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049943, HPA058069" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA049943: AB_2680963, HPA058069: AB_2683594" "unprognostic (2.79e-2)" "unprognostic (2.87e-1)" "unprognostic (1.93e-2)" "unprognostic (1.04e-1)" "unprognostic (3.54e-3)" "unprognostic (1.12e-1)" "unprognostic (2.91e-2)" "unprognostic (4.84e-2)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (5.37e-2)" "unprognostic (9.43e-2)" "prognostic favorable (4.38e-4)" "unprognostic (4.09e-1)" "unprognostic (3.55e-1)" "unprognostic (5.41e-2)" "unprognostic (1.32e-1)" 24.3 13.6 19.2 10.3 21.7 44.1 21.2 10.2 24.2 10.8 21.4 10.3 12.5 11.2 12.1 12.2 13.1 9.7 12.2 28.7 17.6 14.0 15.2 16.6 15.9 11.5 12.8 13.7 7.9 9.9 13.9 16.1 15.3 13.1 11.7 10.7 14.9 10.4 14.9 43.2 7.7 16.5 20.8 9.3 14.2 15.2 15.8 10.6 11.9 13.7 9.3 11.6 16.4 12.5 13.2 14.6 14.4 15.4 17.1 12.8 5.7 18.5 9.4 5.4 11.0 4.4 6.0 9.6 20.6 14.7 14.7 11.7 10.4 16.4 19.3 4.3 13.1 17.3 7.7 4.9 9.4 12.3 19.2 9.4 10.0 5.8 5.5 11.1 14.3 25.7 4.5 8.1 13.2 13.2 5.5 9.1 6.9 14.9 13.7 8.2 15.4 26.1 15.8 12.8 10.5 23.9 13.5 7.1 17.4 9.8 12.9 15.4 16.1 16.2 15.9 13.0 3.3 11.1 15.0 12.6 17.6 14.6 10.3 21.2 12.8 10.7 28.9 16.2 19.7 18.4 10.3 12.0 14.4 10.1 13.6 12.0 10.2 11.5 12.8 11.8 13.2 12.0 10.6 7.0 17.1 15.4 14.6 9.1 5.7 19.2 21.7 10.2 24.2 17.6 14.0 12.8 13.7 13.1 10.6 29.8 16.5 31.6 71.7 57.5 27.0 27.7 17.8 12.0 15.9 15.7 5.9 59.7 46.4 37.9 5.2 31.9 47.7 0.0 40.1 35.9 32.0 54.5 32.3 17.1 45.7 39.7 33.1 25.8 22.4 5.9 23.9 39.6 30.4 45.1 29.3 22.9 49.1 49.1 28.7 33.5 15.3 45.3 46.7 60.8 68.5 50.4 85.1 55.4 35.3 58.1 BCL7C ENSG00000099385 "BCL tumor suppressor 7C" Q8WUZ0 16 30833626-30894960 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 184.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018676, HPA052654" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018676: AB_1845322, HPA052654: AB_2681903" "unprognostic (2.27e-2)" "prognostic favorable (4.23e-4)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (1.21e-1)" "unprognostic (3.60e-1)" "unprognostic (3.18e-3)" "unprognostic (4.91e-3)" "unprognostic (2.44e-1)" "unprognostic (3.41e-2)" "unprognostic (3.84e-2)" "unprognostic (9.22e-2)" "unprognostic (2.05e-2)" "unprognostic (2.45e-1)" "unprognostic (2.97e-1)" "unprognostic (2.07e-2)" "unprognostic (2.85e-1)" 18.5 13.5 14.2 19.1 16.2 21.3 24.8 16.1 12.4 24.1 22.1 13.3 21.6 14.3 21.2 18.9 23.2 19.0 27.5 24.4 13.1 14.4 22.3 12.6 13.2 19.6 17.1 9.3 28.2 14.1 11.1 15.9 17.1 17.1 25.4 10.7 19.3 20.3 22.3 23.4 21.7 20.2 31.3 13.7 15.0 16.8 24.9 13.6 10.5 26.5 17.7 20.5 20.5 32.0 7.2 6.6 7.0 5.2 5.7 10.2 3.7 21.2 12.5 14.2 32.8 10.8 17.3 8.5 16.8 14.2 16.8 12.3 10.6 13.9 1.4 19.9 21.0 9.9 11.5 7.2 14.7 11.4 14.9 25.3 5.0 10.3 17.7 16.1 9.0 11.3 18.7 19.5 12.5 6.8 9.4 16.6 11.0 11.8 8.9 15.8 28.1 9.3 23.4 7.3 12.2 20.3 20.6 14.4 19.1 8.9 7.9 9.2 14.9 15.6 13.1 10.4 9.1 21.5 13.8 11.4 23.2 23.1 14.5 13.7 8.3 7.5 9.7 15.5 15.3 17.1 6.2 5.2 7.0 9.2 3.5 10.2 7.2 7.9 10.1 4.5 7.1 7.1 8.4 4.2 5.7 3.7 6.6 8.2 3.7 14.2 16.2 16.1 12.4 13.1 14.4 17.1 9.3 17.1 13.6 11.9 10.7 24.5 65.4 35.1 10.0 15.1 33.1 9.4 13.6 68.0 5.9 44.4 184.1 29.8 17.9 44.4 33.8 23.3 30.9 46.1 66.6 43.2 2.3 20.2 50.4 12.7 35.8 35.0 23.5 19.6 51.8 41.0 52.3 89.2 34.6 29.6 38.8 17.5 48.4 62.8 9.8 19.4 38.9 2.6 3.4 37.3 20.9 41.5 53.7 57.0 BCL9L DLNB11 ENSG00000186174 "B cell CLL/lymphoma 9 like" Q86UU0 11 118893875-118925608 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049370, HPA053421" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049370: AB_2680732, HPA053421: AB_2682145" "unprognostic (1.67e-2)" "unprognostic (1.48e-2)" "unprognostic (1.20e-1)" "unprognostic (2.71e-1)" "unprognostic (2.87e-1)" "unprognostic (1.90e-1)" "unprognostic (6.61e-3)" "unprognostic (1.17e-3)" "unprognostic (1.03e-1)" "unprognostic (4.61e-2)" "unprognostic (4.66e-3)" "unprognostic (1.39e-1)" "unprognostic (2.83e-3)" "unprognostic (4.85e-3)" "unprognostic (2.24e-2)" "unprognostic (2.14e-1)" "unprognostic (2.90e-3)" 18.4 18.9 10.2 17.2 10.0 13.3 23.8 31.7 9.9 27.4 16.4 6.7 15.8 13.2 22.3 12.8 18.9 22.2 21.2 15.6 9.0 4.1 10.9 9.0 17.1 13.8 9.5 7.7 22.2 16.4 9.0 6.5 31.9 9.1 16.1 4.1 14.5 21.5 14.7 19.1 19.9 14.6 22.8 7.9 13.9 14.0 9.0 8.6 13.0 12.2 11.9 16.7 21.9 25.6 0.6 0.6 1.1 0.5 0.7 2.2 0.8 12.3 22.5 3.2 5.9 10.5 10.2 20.7 17.1 13.2 5.4 3.2 23.9 24.7 3.4 22.9 17.9 22.2 24.0 1.5 31.4 1.4 4.1 0.8 3.3 12.6 8.2 11.9 1.1 3.2 12.9 19.6 6.5 13.1 10.5 4.8 2.0 4.3 3.9 3.7 20.8 2.5 0.9 3.8 7.4 13.0 5.3 1.4 2.3 5.7 8.6 1.7 2.6 24.1 36.6 3.4 6.0 28.8 1.4 16.0 17.5 13.3 5.2 14.5 0.8 0.0 1.0 9.4 3.9 9.9 0.0 0.5 0.0 2.2 0.0 1.5 0.3 1.2 1.3 0.1 0.6 1.9 1.5 1.1 0.7 0.0 0.6 0.2 0.8 10.2 10.0 31.7 9.9 9.0 4.1 9.5 7.7 9.1 8.6 14.9 11.5 2.4 8.8 34.5 18.4 2.0 15.3 4.0 11.4 7.0 3.9 9.8 0.0 11.8 0.1 10.1 8.0 0.0 12.7 7.0 11.6 18.2 2.3 10.0 3.8 12.7 5.2 11.1 5.2 0.0 13.6 2.6 6.8 19.8 5.0 6.9 20.3 7.0 13.4 2.2 2.8 25.8 14.7 0.5 1.0 39.5 29.6 11.8 6.3 9.1 BCLAF3 CXorf23 ENSG00000173681 "BCLAF1 and THRAP3 family member 3" A2AJT9 X 19912860-19970298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 14.2;Club cells: 13.6;Collecting duct cells: 8.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027215 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027215: AB_1847358" "unprognostic (2.46e-1)" "unprognostic (1.96e-1)" "unprognostic (3.15e-1)" "unprognostic (2.24e-1)" "unprognostic (2.27e-2)" "unprognostic (2.48e-2)" "unprognostic (3.72e-2)" "prognostic favorable (5.42e-4)" "unprognostic (1.82e-2)" "unprognostic (1.10e-1)" "unprognostic (1.43e-1)" "unprognostic (4.83e-2)" "unprognostic (2.03e-2)" "unprognostic (2.21e-1)" "unprognostic (9.38e-2)" "unprognostic (2.30e-2)" "prognostic favorable (5.56e-4)" 4.3 2.4 3.7 2.8 3.4 2.5 4.6 8.1 3.4 3.4 4.5 2.6 5.0 8.1 2.8 3.6 3.6 2.7 4.0 3.2 3.8 2.0 3.8 3.2 3.7 5.1 3.2 7.1 3.3 2.5 4.6 5.4 3.1 4.9 3.9 5.3 4.1 3.4 4.2 4.1 3.1 1.8 4.2 3.3 4.2 3.9 2.8 2.3 4.8 1.4 1.4 1.6 0.3 5.6 4.5 6.3 10.5 5.6 8.0 3.5 5.3 4.4 3.4 4.8 4.1 6.2 5.8 3.2 6.2 6.1 4.2 5.5 3.9 6.6 3.8 4.5 3.8 4.8 4.0 8.0 5.1 6.5 7.1 6.1 3.8 5.2 8.0 3.9 4.7 2.7 13.9 3.9 4.3 3.6 3.4 5.5 5.4 5.8 1.5 6.3 7.7 9.1 5.7 3.9 5.9 6.6 5.6 5.3 12.1 6.7 4.6 7.2 5.8 2.9 13.9 3.8 4.4 3.4 4.8 5.0 2.9 5.0 4.1 0.9 1.8 1.5 1.2 1.6 1.2 1.2 1.5 0.7 2.8 1.2 1.4 4.8 1.4 1.4 2.3 0.5 0.3 14.9 14.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 13.6 8.7 0.0 3.3 1.7 5.5 0.0 0.0 0.0 0.0 3.1 3.2 0.0 0.0 5.8 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 2.8 0.0 0.0 5.7 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 BCOR "FLJ20285, KIAA1575" ENSG00000183337 "BCL6 corepressor" Q6W2J9 X 40049815-40177329 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056308, HPA073591" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA056308: AB_2683095, HPA073591: AB_2732227" "unprognostic (2.75e-2)" "unprognostic (2.83e-1)" "unprognostic (2.45e-1)" "unprognostic (9.26e-2)" "unprognostic (1.55e-1)" "unprognostic (9.80e-3)" "prognostic unfavorable (1.30e-5)" "unprognostic (3.82e-3)" "unprognostic (6.86e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.91e-3)" "unprognostic (6.83e-2)" "unprognostic (9.57e-2)" "unprognostic (2.63e-1)" "unprognostic (1.55e-1)" 9.1 12.8 8.7 8.7 10.5 20.6 13.3 11.5 12.0 10.0 12.6 22.7 11.9 7.8 11.1 13.9 13.6 10.4 8.6 13.0 7.1 5.4 11.2 13.3 11.4 15.2 12.9 8.4 19.8 13.6 19.7 11.9 12.5 10.7 13.2 8.2 13.7 11.1 16.5 28.8 13.6 10.3 12.9 8.6 11.4 11.5 9.8 15.8 18.4 16.0 11.4 13.5 13.8 25.5 6.5 7.3 7.6 7.1 8.2 6.8 11.8 13.1 8.7 17.8 21.7 2.0 1.6 3.1 4.5 7.1 5.7 4.7 3.7 5.3 12.0 5.3 8.3 3.7 12.4 29.0 3.8 5.1 20.9 26.4 13.4 13.4 14.4 3.4 10.8 7.7 2.6 5.6 6.3 3.6 8.4 7.7 7.9 34.3 29.0 7.0 8.4 24.4 22.6 17.5 6.2 13.6 11.9 18.4 13.5 10.5 8.3 12.8 23.1 9.4 8.3 7.0 9.1 8.9 23.8 6.4 6.2 7.8 9.1 5.0 17.2 13.3 12.5 5.4 9.9 9.5 7.6 5.0 4.5 6.8 6.1 4.3 6.5 4.7 3.9 7.3 5.5 4.7 4.8 1.1 8.2 7.1 3.1 5.5 11.8 8.7 10.5 11.5 12.0 7.1 5.4 12.9 8.4 10.7 15.8 20.8 23.2 12.3 3.2 13.1 34.2 7.6 10.2 6.7 5.7 10.4 11.8 3.7 1.7 4.5 2.1 17.4 4.9 0.0 9.1 5.5 13.6 7.9 23.2 9.5 6.4 14.3 15.6 19.0 11.0 2.1 9.8 8.6 5.0 7.2 11.7 7.7 6.6 0.0 7.4 4.0 22.0 0.0 26.4 1.1 13.5 12.2 1.7 7.5 7.6 2.6 BDP1 "HSA238520, KIAA1241, KIAA1689, TAF3B1, TFC5, TFIIIB150, TFIIIB90, TFNR" ENSG00000145734 "B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB" A6H8Y1 5 71455615-71567820 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 7.3;TIME: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064166, HPA077984" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064166: , HPA077984: " "unprognostic (4.96e-2)" "unprognostic (2.19e-1)" "unprognostic (6.65e-2)" "unprognostic (3.01e-1)" "unprognostic (3.47e-2)" "unprognostic (1.44e-2)" "unprognostic (7.72e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (8.20e-2)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "unprognostic (3.86e-2)" "unprognostic (1.52e-1)" "unprognostic (7.83e-2)" "unprognostic (2.50e-2)" "unprognostic (5.86e-2)" 7.8 8.7 6.1 4.4 9.0 3.3 7.9 13.1 9.8 5.9 4.4 2.5 3.3 1.5 6.1 3.3 5.0 7.8 5.2 4.0 6.6 3.4 6.5 4.2 3.7 3.5 6.3 5.6 5.0 10.7 1.5 10.0 3.7 5.7 4.9 4.1 1.9 4.9 6.1 10.0 6.5 4.1 6.1 4.1 4.7 3.6 4.9 7.5 6.7 7.9 2.5 3.0 5.7 3.7 2.5 1.4 1.8 0.4 1.9 1.3 0.1 0.2 2.3 4.4 1.1 0.1 0.5 4.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.3 1.6 5.0 0.0 0.1 0.0 3.5 0.0 0.0 0.1 5.6 1.0 2.7 0.6 0.0 0.0 0.0 0.0 0.7 2.4 4.1 0.0 7.3 0.0 1.8 2.4 0.0 0.4 0.0 0.3 4.8 4.7 0.0 4.0 1.9 1.7 0.0 6.1 0.0 0.9 3.6 2.6 0.0 0.0 9.7 4.7 0.1 1.6 0.0 1.5 3.8 0.0 0.0 0.4 5.2 0.0 0.1 1.8 1.3 0.4 0.6 0.9 0.6 0.5 0.6 2.5 1.3 0.9 0.5 1.9 0.0 1.4 0.4 0.1 6.1 9.0 13.1 9.8 6.6 3.4 6.3 5.6 5.7 7.5 56.6 88.2 43.6 51.4 39.5 73.1 98.6 45.9 57.6 83.0 33.2 96.2 32.1 1.7 38.7 21.8 53.7 20.2 46.7 31.3 41.0 40.7 42.1 55.6 24.1 27.5 89.0 56.2 22.1 17.5 16.8 54.4 37.3 27.0 55.1 25.9 46.5 39.7 23.0 51.2 8.2 121.3 51.8 48.6 64.7 53.0 37.9 40.3 55.4 32.3 59.9 BEND3 KIAA1553 ENSG00000178409 "BEN domain containing 3" Q5T5X7 6 107065182-107115269 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 12.6" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 5.9;Late spermatids: 5.2" "Cancer enhanced" "Detected in all" "testis cancer: 12.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017891, HPA062067" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA017891: AB_2064595, HPA062067: AB_2684675" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "unprognostic (9.47e-3)" "unprognostic (4.25e-3)" "unprognostic (1.04e-1)" "unprognostic (2.43e-2)" "unprognostic (8.37e-8)" "unprognostic (1.59e-1)" "unprognostic (9.71e-2)" "unprognostic (3.99e-2)" "unprognostic (2.71e-2)" "unprognostic (6.89e-2)" "unprognostic (1.12e-2)" "unprognostic (8.65e-2)" "unprognostic (3.49e-1)" "unprognostic (1.09e-1)" "unprognostic (4.37e-1)" 1.8 1.9 1.4 1.8 2.5 1.8 5.6 4.0 2.2 1.6 3.6 1.3 0.8 3.0 2.4 4.2 2.5 2.3 3.6 3.8 1.1 1.3 3.1 4.4 2.0 1.5 1.8 0.8 1.9 12.6 1.8 2.3 1.5 3.3 2.6 3.9 1.3 3.4 1.0 5.0 1.4 4.1 2.5 1.8 2.8 5.0 4.6 1.5 2.4 1.9 3.9 3.6 2.2 1.2 1.5 1.3 2.0 1.0 0.8 1.7 0.4 2.8 4.1 11.3 6.4 1.3 1.0 9.3 1.1 1.5 1.5 1.8 4.6 2.1 8.4 2.9 2.9 2.6 2.8 12.2 6.3 2.5 3.3 6.1 2.3 3.0 5.1 1.1 6.0 3.0 2.5 2.6 2.2 3.2 1.2 1.9 4.0 6.3 3.5 1.9 5.7 5.1 4.6 15.8 7.1 2.6 7.0 3.3 5.5 2.4 8.4 11.5 5.6 3.6 6.1 2.3 6.0 3.6 4.8 2.2 4.1 3.9 1.9 5.4 2.4 3.2 8.6 1.4 4.7 3.2 2.0 0.8 1.5 1.2 1.0 0.9 1.5 1.1 1.1 0.5 1.1 0.8 1.7 1.6 0.8 1.0 1.3 1.2 0.4 1.4 2.5 4.0 1.8 1.1 1.3 1.8 0.8 3.3 1.5 3.0 2.4 0.0 0.8 2.6 1.4 2.8 0.0 1.4 2.3 0.0 5.9 0.8 0.0 0.8 4.2 0.8 0.4 0.0 1.5 1.2 0.6 1.0 0.0 0.6 0.6 0.0 1.2 0.0 1.0 5.2 0.9 0.5 0.0 0.0 2.2 0.2 0.9 0.0 0.0 0.8 1.4 0.0 2.1 0.6 2.5 2.6 0.7 0.0 3.0 0.7 BHMG1 HMGDC ENSG00000237452 "Basic helix-loop-helix and HMG-box containing 1" C9JSJ3 19 45733251-45764534 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 33 "testis: 17.8" "Group enriched" "Detected in some" 15 "Spermatocytes: 24.2;Spermatogonia: 22.0" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Daudi: 3.5;K-562: 8.3" "Not detected" "Not detected" HPA049521 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049521: AB_2680803" "unprognostic (4.15e-2)" "unprognostic (2.97e-2)" "unprognostic (2.64e-1)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (6.29e-2)" "unprognostic (1.70e-3)" "unprognostic (3.31e-2)" "unprognostic (3.34e-1)" "unprognostic (1.15e-2)" "unprognostic (1.08e-1)" "unprognostic (6.53e-12)" "unprognostic (2.29e-1)" "unprognostic (1.07e-1)" "unprognostic (6.11e-3)" "unprognostic (1.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.0 3.5 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 8.3 0.3 0.0 1.3 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.9 0.4 0.2 0.4 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 24.2 22.0 0.0 0.0 0.0 0.0 0.0 BICRA GLTSCR1 ENSG00000063169 "BRD4 interacting chromatin remodeling complex associated protein" Q9NZM4 19 47608196-47703277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 6.2;Collecting duct cells: 7.0;Syncytiotrophoblasts: 4.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056211 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA056211: AB_2683068" "unprognostic (2.36e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-2)" "unprognostic (9.58e-2)" "unprognostic (7.75e-2)" "prognostic favorable (1.34e-4)" "unprognostic (8.38e-2)" "unprognostic (1.36e-1)" "unprognostic (1.42e-1)" "unprognostic (1.47e-2)" "unprognostic (1.56e-3)" "unprognostic (2.21e-3)" "prognostic unfavorable (1.82e-4)" "unprognostic (9.72e-2)" "unprognostic (7.98e-2)" "unprognostic (1.61e-1)" "prognostic favorable (9.34e-4)" 12.6 8.5 11.3 14.0 12.4 12.0 10.8 19.6 13.1 13.7 12.5 16.7 8.2 15.2 17.0 7.9 10.8 14.4 10.1 9.9 11.4 5.9 7.2 7.6 10.6 11.5 13.8 12.4 16.5 7.6 17.4 9.5 12.7 9.3 13.0 10.4 8.7 11.0 12.8 30.4 14.0 12.1 15.4 11.5 10.5 9.9 7.1 12.7 12.4 11.9 4.2 9.6 14.9 13.8 0.6 1.6 1.8 0.6 0.1 0.9 0.1 7.4 8.1 16.2 11.9 8.6 8.8 8.0 6.8 6.8 9.0 6.3 8.7 4.8 8.5 3.6 9.4 7.0 7.6 10.7 5.3 9.7 8.1 6.8 5.2 5.8 4.2 10.8 6.2 8.7 7.2 7.9 9.9 8.9 7.3 9.1 7.8 7.8 10.9 5.5 5.9 9.9 15.1 10.6 11.0 6.4 10.4 5.5 2.3 3.6 5.4 9.1 11.3 17.4 10.1 4.5 14.3 4.2 4.8 9.8 7.0 12.8 5.2 9.4 7.5 14.1 8.8 1.3 4.2 9.6 0.2 0.6 1.6 0.3 0.0 0.1 0.1 0.2 0.2 0.6 0.6 0.9 0.2 1.8 0.1 0.2 1.6 0.2 0.1 11.3 12.4 19.6 13.1 11.4 5.9 13.8 12.4 9.3 12.7 8.9 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 7.0 0.0 3.7 0.0 2.8 0.0 0.0 0.0 0.0 3.3 3.1 0.0 0.0 1.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 2.8 0.0 0.0 3.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 BICRAL "GLTSCR1L, KIAA0240" ENSG00000112624 "BRD4 interacting chromatin remodeling complex associated protein like" Q6AI39 6 42746958-42868560 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 6.5;Ciliated cells: 5.3;Club cells: 7.9;Hofbauer cells: 4.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029390, HPA029391" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA029390: AB_10599730, HPA029391: AB_10599949" "unprognostic (2.30e-1)" "unprognostic (1.76e-1)" "unprognostic (2.15e-2)" "unprognostic (3.46e-2)" "unprognostic (9.25e-2)" "prognostic favorable (5.47e-4)" "unprognostic (2.74e-1)" "unprognostic (6.17e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-2)" "unprognostic (1.55e-1)" "unprognostic (7.24e-2)" "unprognostic (1.54e-3)" "unprognostic (4.71e-2)" "unprognostic (2.60e-1)" "unprognostic (1.29e-1)" "unprognostic (6.54e-2)" 12.7 7.1 9.8 11.0 10.9 8.3 12.1 39.6 14.4 12.6 10.6 16.3 10.0 7.2 14.6 9.8 8.0 13.0 8.8 8.4 8.5 9.2 7.7 6.8 9.3 17.5 9.1 12.0 20.9 9.8 17.5 16.2 6.2 10.7 11.8 11.9 17.1 10.6 10.7 9.8 12.8 10.1 12.1 9.6 12.2 9.0 10.5 10.3 17.1 14.0 6.3 14.6 13.4 11.4 2.8 1.4 7.5 1.6 2.9 4.5 1.1 5.0 4.0 3.6 5.8 7.5 8.8 3.2 4.5 4.6 4.0 3.1 1.8 3.6 11.7 4.1 7.5 6.2 4.0 3.5 4.6 6.6 8.7 2.2 8.2 4.0 5.1 4.0 6.9 7.5 5.3 9.0 3.9 7.2 7.6 4.1 7.0 7.8 10.5 4.7 6.0 1.1 4.0 4.0 19.8 2.5 7.2 2.1 11.6 4.0 3.3 12.4 6.6 5.0 7.3 5.1 3.7 6.4 8.2 4.7 5.6 5.6 3.6 4.4 9.6 5.5 18.0 3.3 8.9 3.9 3.9 1.1 5.1 4.5 0.8 4.0 2.5 2.8 4.4 0.9 2.8 2.7 3.3 7.5 2.9 1.6 1.4 3.1 1.1 9.8 10.9 39.6 14.4 8.5 9.2 9.1 12.0 10.7 10.3 8.9 6.5 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.9 3.5 0.0 1.5 0.0 3.3 0.0 0.0 0.0 0.0 3.3 1.6 0.0 0.0 1.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 2.8 0.0 0.0 3.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 BIVM FLJ20159 ENSG00000134897 "Basic, immunoglobulin-like variable motif containing" Q86UB2 13 102799049-102841535 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 3.6;NK-cells: 6.3;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050126 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA050126: AB_2681027" "unprognostic (8.86e-2)" "unprognostic (1.02e-1)" "unprognostic (3.55e-1)" "unprognostic (2.77e-1)" "unprognostic (1.19e-2)" "unprognostic (1.83e-3)" "unprognostic (1.37e-1)" "unprognostic (1.00e-1)" "unprognostic (1.91e-2)" "unprognostic (1.30e-1)" "unprognostic (6.89e-3)" "unprognostic (6.66e-2)" "unprognostic (1.97e-1)" "unprognostic (2.79e-2)" "unprognostic (2.73e-1)" "unprognostic (7.29e-2)" "unprognostic (3.33e-2)" 6.8 7.6 10.8 3.3 15.6 3.4 9.6 32.3 16.9 9.2 6.9 6.9 10.5 6.8 10.1 14.3 5.6 7.7 6.9 18.7 10.9 8.4 17.7 17.6 6.4 4.5 9.3 10.8 10.1 10.3 6.4 10.7 7.4 10.4 8.7 8.2 6.3 6.7 9.8 16.9 8.3 6.7 8.8 7.1 7.0 8.9 2.2 9.8 4.3 8.4 7.4 3.6 6.7 6.3 0.6 1.2 3.6 0.4 6.3 4.9 0.9 7.5 2.4 9.0 10.4 11.6 17.9 2.1 9.1 9.2 5.7 6.4 2.7 3.4 0.0 4.1 8.7 4.3 5.2 7.3 7.2 8.1 6.9 9.1 6.4 6.8 4.6 10.4 7.2 11.2 14.4 9.2 3.1 10.2 13.8 8.6 10.4 6.9 0.0 11.7 1.6 8.2 9.4 2.1 10.6 6.4 0.0 4.3 3.2 26.3 3.2 14.0 12.1 3.7 4.3 5.9 3.7 6.9 9.9 6.2 7.3 1.9 5.4 5.5 6.0 2.7 0.0 9.3 0.0 12.7 3.6 0.4 0.8 2.4 0.2 4.9 0.5 1.4 3.1 1.2 0.6 0.9 2.1 0.4 6.3 0.1 0.5 1.2 0.9 10.8 15.6 32.3 16.9 10.9 8.4 9.3 10.8 10.4 9.8 8.9 10.9 3.0 3.0 3.3 15.7 24.6 12.7 8.1 13.6 17.4 13.7 6.3 24.9 4.5 0.2 11.7 5.2 0.0 4.8 5.9 11.4 4.1 5.8 26.7 5.7 22.3 20.9 19.6 5.2 0.2 12.7 4.2 3.3 1.0 16.5 7.7 4.7 10.5 10.6 25.2 11.5 19.4 9.5 0.5 8.7 4.3 2.1 10.1 15.1 2.6 BIVM-ERCC5 ENSG00000270181 "BIVM-ERCC5 readthrough" 13 102799110-102875994 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 10.6" "Group enriched" "Detected in some" 28 "Alveolar cells type 2: 2.9;Ciliated cells: 1.4;Club cells: 4.5;granulocytes: 2.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "MAIT T-cell: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 3.0;HEK 293: 12.2;HeLa: 5.2;PC-3: 6.7;SCLC-21H: 3.4" "HPA045845, HPA050126, HPA050374" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106" "unprognostic (6.01e-2)" 1.0 1.0 2.7 3.7 4.5 1.1 1.4 10.6 5.7 1.0 2.9 1.3 2.6 1.0 2.1 1.1 1.0 2.6 1.0 1.9 2.7 3.2 2.4 2.3 1.5 2.2 2.7 1.0 1.9 1.0 2.7 1.3 2.6 2.0 1.0 1.1 1.0 2.7 1.0 1.0 1.0 2.6 0.6 1.8 2.6 1.2 2.3 0.3 1.7 1.5 1.0 1.0 1.0 0.0 2.8 0.0 1.4 1.3 2.9 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.7 0.0 0.1 0.6 0.0 3.0 0.3 0.0 0.0 0.0 12.2 0.0 5.2 0.0 0.5 2.5 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.4 0.1 3.4 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.6 2.9 0.0 0.7 1.0 2.8 0.0 0.2 0.1 0.0 1.3 0.0 0.0 0.3 1.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BLK MGC10442 ENSG00000136573 "BLK proto-oncogene, Src family tyrosine kinase" P51451 8 11486894-11564604 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "blood: 47.8;intestine: 23.5;lymphoid tissue: 39.8" "Cell type enriched" "Detected in some" 52 "B-cells: 93.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 47.8;naive B-cell: 33.9" "Lineage enriched" "Detected in many" 5 "B-cells: 47.8" "Cell line enhanced" "Detected in some" "Daudi: 44.0;REH: 11.9;RPMI-8226: 14.5;U-698: 21.5;U-87 MG: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB005093, HPA069571" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB005093: AB_2274756, HPA069571: AB_2732137" "unprognostic (6.50e-5)" "unprognostic (4.22e-3)" "unprognostic (5.64e-2)" "unprognostic (1.42e-1)" "unprognostic (3.45e-1)" "unprognostic (5.98e-6)" "unprognostic (1.59e-2)" "unprognostic (8.94e-4)" "unprognostic (1.02e-3)" "unprognostic (9.83e-3)" "unprognostic (1.22e-2)" "unprognostic (4.66e-2)" "unprognostic (9.05e-6)" "unprognostic (5.62e-2)" "unprognostic (5.43e-2)" "unprognostic (2.19e-1)" "unprognostic (1.16e-1)" 0.5 0.2 0.1 32.3 0.1 1.7 0.2 0.1 0.1 0.1 1.2 0.0 0.0 0.3 0.1 0.0 1.9 0.2 0.4 0.3 0.1 0.1 1.3 0.5 0.6 27.6 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.3 2.4 0.0 0.1 0.1 23.5 0.0 0.1 31.9 1.4 0.2 0.0 3.9 0.7 0.4 39.8 2.5 0.4 47.8 4.3 0.1 0.0 0.0 9.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.9 0.0 14.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.3 3.8 21.5 9.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 9.8 47.8 0.3 1.1 0.0 33.9 0.2 0.1 0.1 0.0 0.0 4.3 0.4 1.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 93.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BMF FLJ00065 ENSG00000104081 "Bcl2 modifying factor" Q96LC9 15 40087890-40108892 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 81.0" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 12.7;monocytes: 14.4;Pancreatic endocrine cells: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 19.8;HMC-1: 22.4;hTERT-RPE1: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010120 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA010120: AB_1845385" "unprognostic (2.94e-1)" "unprognostic (4.92e-3)" "unprognostic (7.63e-2)" "unprognostic (4.44e-1)" "unprognostic (1.89e-1)" "prognostic favorable (1.83e-4)" "prognostic unfavorable (6.32e-4)" "unprognostic (1.42e-2)" "unprognostic (4.26e-1)" "unprognostic (3.75e-1)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (7.06e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-2)" "unprognostic (2.35e-2)" 5.3 2.9 1.3 13.5 1.9 15.8 6.1 2.3 2.0 10.9 9.9 2.1 13.0 11.9 12.4 4.7 2.8 8.3 6.7 3.4 1.3 1.6 6.5 3.9 7.7 18.4 2.8 0.9 8.9 8.1 1.8 2.8 5.7 2.5 7.0 4.5 7.2 9.2 10.8 4.6 4.0 23.2 5.8 3.0 18.1 6.7 4.1 2.1 81.0 18.6 3.1 15.0 7.5 3.7 5.1 3.3 5.2 6.0 0.0 1.4 0.9 0.4 0.6 11.5 2.5 0.3 0.5 7.8 0.0 1.8 0.2 0.5 11.5 0.8 3.3 3.7 0.5 3.5 2.4 2.8 0.0 0.0 7.9 2.3 1.7 19.8 2.6 1.1 0.3 22.4 5.8 0.6 0.2 0.2 29.0 3.0 2.4 0.9 1.4 1.0 0.6 1.1 8.4 3.1 5.7 0.4 2.1 2.6 9.5 0.5 2.6 6.1 5.0 2.2 5.8 5.1 12.9 3.4 6.7 2.3 0.4 1.6 0.3 0.1 14.2 13.3 2.0 0.8 1.6 1.3 0.1 4.2 3.6 0.2 4.9 0.4 5.1 0.4 1.4 2.7 1.8 0.7 0.1 5.2 0.0 6.0 3.3 1.2 0.9 1.3 1.9 2.3 2.0 1.3 1.6 2.8 0.9 2.5 2.1 3.0 2.1 10.0 1.0 1.0 0.0 1.6 7.6 0.0 5.7 0.0 0.0 0.6 0.0 8.9 1.0 2.1 5.1 0.0 12.7 1.1 1.9 2.6 0.0 0.9 7.6 0.0 1.2 1.8 10.8 0.0 1.7 6.1 0.0 14.4 1.5 0.3 13.9 0.3 0.7 2.2 0.4 0.0 0.8 0.2 1.1 0.5 1.5 0.7 1.3 0.9 BNC1 "BNC, HsT19447" ENSG00000169594 "Basonuclin 1" Q01954 15 83255903-83284714 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 13.4;testis: 27.5;tongue: 20.2" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 78.8;Early spermatids: 37.3;Late spermatids: 74.8;Suprabasal keratinocytes: 51.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 16.3;HBEC3-KT: 37.1;hTCEpi: 41.7;hTERT-HME1: 40.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063183, HPA066947, HPA077428" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345" "unprognostic (1.86e-3)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (5.55e-2)" "unprognostic (4.06e-2)" "unprognostic (2.47e-2)" "unprognostic (2.45e-2)" "unprognostic (7.91e-2)" "unprognostic (8.89e-4)" "unprognostic (6.94e-2)" "unprognostic (4.13e-1)" "unprognostic (3.85e-3)" "unprognostic (8.46e-3)" "unprognostic (2.20e-1)" "unprognostic (2.95e-3)" "unprognostic (1.01e-2)" 12.7 0.1 0.0 1.6 0.1 0.0 0.9 0.0 0.4 2.7 1.5 0.1 0.0 0.0 0.4 10.8 13.4 0.8 0.1 1.4 0.1 0.0 0.1 0.1 0.7 1.3 0.2 0.2 0.6 0.0 0.0 0.0 1.9 0.5 0.4 0.0 0.7 1.7 0.2 0.1 7.9 0.2 0.3 0.3 0.1 0.0 27.5 0.0 6.0 0.2 20.2 3.7 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 1.4 2.1 0.0 0.6 0.1 7.1 10.0 0.0 0.1 0.0 0.3 4.3 0.0 16.3 0.8 37.1 12.9 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 1.8 41.7 6.3 40.7 1.5 6.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.7 0.0 0.0 4.8 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 9.7 78.8 0.0 0.4 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 37.3 0.5 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.0 0.1 0.0 0.0 1.3 0.0 74.8 0.6 0.5 8.5 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.2 16.3 5.9 51.1 0.0 0.0 0.0 4.6 BNC2 "BSN2, FLJ20043" ENSG00000173068 "Basonuclin 2" Q6ZN30 9 16409503-16870843 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 35.8;ovary: 37.0" "Group enriched" "Detected in many" 4 "granulocytes: 21.9;Leydig cells: 83.4;Peritubular cells: 63.6;Proximal tubular cells: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "gdT-cell: 5.8" "Lineage enriched" "Detected in many" 5 "T-cells: 5.8" "Cell line enhanced" "Detected in many" "HSkMC: 18.5;Karpas-707: 22.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA018525, HPA059419" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA018525: AB_1845402, HPA059419: AB_2732637" "unprognostic (2.68e-1)" "unprognostic (2.89e-1)" "unprognostic (3.64e-2)" "unprognostic (1.14e-2)" "unprognostic (1.56e-2)" "unprognostic (5.07e-2)" "unprognostic (2.81e-2)" "unprognostic (2.50e-1)" "unprognostic (1.94e-2)" "unprognostic (6.05e-2)" "unprognostic (5.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.15e-1)" "unprognostic (1.36e-2)" "unprognostic (1.62e-1)" "unprognostic (6.74e-2)" "unprognostic (1.14e-3)" 4.3 1.0 0.5 5.1 0.7 0.3 4.3 0.5 0.7 19.8 7.6 1.8 2.9 0.8 35.8 5.5 3.8 14.3 9.3 3.8 1.2 0.5 7.6 0.4 2.6 0.9 0.9 0.5 37.0 0.5 2.7 1.5 2.2 2.3 6.4 2.1 11.0 1.3 4.8 7.6 2.9 2.8 23.1 2.0 0.5 3.0 4.7 1.0 0.9 1.7 3.6 1.3 8.5 9.0 0.1 0.0 0.0 0.0 1.0 5.8 3.2 0.1 0.9 0.7 0.0 10.1 12.5 1.6 6.2 10.9 4.5 3.7 0.0 0.0 0.0 2.1 4.2 3.3 0.0 2.9 0.0 4.6 0.1 1.2 0.1 2.9 0.0 7.8 0.0 0.2 18.5 0.0 9.5 0.0 7.8 10.0 0.0 0.0 22.5 6.3 0.0 0.0 1.5 3.7 0.0 5.7 0.0 7.1 15.0 3.4 0.2 0.1 0.5 0.0 0.0 10.6 4.9 0.0 0.0 9.8 10.5 7.8 8.5 11.4 0.1 0.0 0.1 4.3 1.4 1.4 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 1.0 0.0 0.0 0.0 3.2 0.5 0.7 0.5 0.7 1.2 0.5 0.9 0.5 2.3 1.0 0.0 2.1 0.0 0.6 9.0 2.1 4.3 0.0 1.4 1.2 0.0 0.0 2.4 0.0 0.5 5.0 6.8 0.3 0.0 0.3 1.6 11.6 0.1 21.9 0.0 6.1 0.0 0.0 11.6 2.1 1.8 83.4 2.2 10.1 0.0 0.0 2.3 0.1 0.0 63.6 31.8 0.2 6.5 7.4 0.7 5.1 4.8 1.0 1.5 0.0 0.0 BOD1L1 "BOD1L, FAM44A, FLJ33215, KIAA1327" ENSG00000038219 "Biorientation of chromosomes in cell division 1 like 1" Q8NFC6 4 13568738-13627723 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Rod photoreceptor cells: 187.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 12.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036943, HPA037362, HPA041290" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036943: AB_2675397, HPA037362: AB_10670380, HPA041290: AB_2677393" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (7.73e-2)" "unprognostic (2.29e-2)" "unprognostic (5.94e-2)" "unprognostic (6.15e-2)" "unprognostic (6.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.13e-2)" "unprognostic (3.19e-1)" "unprognostic (9.02e-2)" "unprognostic (1.72e-1)" "prognostic favorable (3.48e-6)" "unprognostic (2.03e-1)" "unprognostic (1.16e-1)" "unprognostic (1.02e-2)" "unprognostic (6.60e-2)" 17.5 12.6 18.9 23.8 24.3 40.2 18.3 30.4 34.9 21.5 16.8 10.4 18.2 12.1 20.5 19.8 15.2 16.9 14.1 13.6 18.4 12.4 14.2 12.6 22.8 22.0 20.1 21.7 26.8 16.0 28.6 16.0 18.3 21.1 15.4 14.5 7.1 17.1 27.3 13.2 19.5 20.9 18.2 21.1 26.9 16.1 18.0 21.6 23.4 16.4 11.7 22.3 16.5 16.2 2.2 2.5 12.2 1.4 0.7 1.6 0.5 10.2 13.8 13.8 9.9 16.8 17.8 10.6 11.9 12.6 9.9 11.2 10.3 11.2 13.8 5.4 13.0 18.5 7.0 11.2 11.8 19.2 9.5 6.5 19.4 17.4 12.6 10.4 29.1 16.1 14.2 13.5 20.5 15.9 13.7 10.2 9.8 13.6 16.6 12.4 6.1 15.0 19.5 17.7 6.6 12.0 11.5 20.5 5.5 18.5 10.4 8.2 15.1 13.1 4.6 10.6 15.5 5.4 11.3 23.1 15.4 8.1 9.5 15.6 19.7 11.5 17.5 15.2 13.8 12.2 2.5 1.4 2.8 1.6 1.4 1.3 1.7 1.0 1.1 0.9 2.2 1.5 1.1 12.2 0.7 0.9 2.5 0.9 0.5 18.9 24.3 30.4 34.9 18.4 12.4 20.1 21.7 21.1 21.6 77.4 85.8 51.3 16.8 23.4 156.0 80.3 53.5 52.2 75.1 34.9 84.4 13.6 3.3 26.0 15.3 42.2 24.0 23.3 21.8 14.9 25.9 20.4 60.2 30.4 18.6 152.6 33.4 33.7 36.5 13.5 46.6 34.3 23.6 21.6 26.0 103.2 26.0 21.0 54.5 4.5 187.0 45.3 24.0 75.4 15.2 25.2 15.6 37.3 21.0 22.8 BOLA2 "BOLA2A, My016" ENSG00000183336 "BolA family member 2" Q9H3K6 16 29443056-29454964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.6" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 2.4;Ciliated cells: 1.4;Club cells: 2.3;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045380, HPA046696" Supported Uncertain Nucleoplasm NA NA 180000 Nucleoplasm "HPA045380: AB_2679301, HPA046696: AB_2679757" 2.3 3.6 3.6 9.0 3.6 9.5 2.2 1.3 2.0 1.4 5.6 13.5 1.6 0.0 4.6 1.2 1.5 3.1 3.3 2.7 3.2 3.5 2.7 6.6 3.4 0.6 7.2 0.7 3.6 2.9 1.8 0.8 7.1 1.2 4.6 2.5 10.7 0.5 3.6 6.0 7.2 5.5 1.8 1.2 2.3 2.3 25.6 21.4 15.8 20.7 10.4 20.1 18.1 14.2 23.4 3.9 8.4 1.5 2.2 12.4 4.7 2.3 4.5 5.9 10.7 12.9 5.2 14.8 1.4 7.2 8.3 1.9 7.8 0.3 14.6 35.6 11.8 8.9 23.5 3.8 7.7 12.8 1.9 4.4 9.2 2.6 0.9 5.0 17.2 5.3 12.3 2.5 28.7 9.7 13.3 10.7 7.6 21.8 18.0 5.8 25.8 3.8 5.8 10.0 11.1 2.6 23.2 4.4 0.8 7.5 5.5 5.0 9.2 5.8 10.2 9.9 22.6 12.0 9.4 10.4 10.8 9.9 8.2 19.3 15.8 16.5 20.7 16.0 25.6 15.6 16.7 14.8 20.6 11.9 13.7 3.7 10.4 17.4 21.4 20.1 18.1 0.0 2.4 0.0 0.2 0.1 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.2 0.0 0.4 0.5 0.0 0.5 0.0 0.7 0.1 0.0 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.2 0.0 0.2 0.3 BOLA2B ENSG00000169627 "BolA family member 2B" Q9H3K6 16 30192934-30194306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 47.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 89.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 80.0;Hep G2: 72.9;MCF7: 69.2" "HPA045380, HPA046696" Supported Uncertain Nucleoplasm NA NA 180000 Nucleoplasm "HPA045380: AB_2679301, HPA046696: AB_2679757" "unprognostic (2.49e-1)" "unprognostic (4.60e-3)" "unprognostic (8.49e-2)" "unprognostic (3.02e-3)" "unprognostic (9.80e-4)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (1.25e-1)" "unprognostic (3.08e-2)" "unprognostic (2.24e-2)" "unprognostic (1.26e-1)" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (2.94e-1)" "unprognostic (5.29e-1)" "unprognostic (2.21e-2)" "unprognostic (4.91e-3)" 5.3 6.2 10.0 8.5 8.3 17.6 4.5 6.7 8.8 5.1 13.8 6.1 3.9 14.7 5.8 5.6 9.7 3.3 6.7 11.9 8.2 6.1 7.4 5.4 4.9 15.6 8.9 3.9 5.2 8.3 1.8 6.5 5.5 4.7 4.1 8.5 5.0 7.9 3.9 5.9 7.4 11.2 4.2 8.5 10.8 9.2 7.8 5.6 9.2 3.9 7.7 13.7 7.8 24.9 47.7 32.4 24.8 33.5 25.6 33.6 26.2 15.2 49.2 4.8 11.7 1.6 1.9 15.7 3.7 2.3 3.5 4.9 29.3 15.9 4.6 18.2 1.0 6.3 8.3 2.7 7.1 0.6 14.3 80.0 9.9 28.1 72.9 3.5 6.3 13.1 1.1 4.7 6.0 2.4 1.2 6.1 14.7 6.5 15.5 3.1 69.2 17.8 18.6 14.5 7.0 51.6 15.6 7.1 34.0 4.6 24.8 14.7 14.6 2.0 21.3 4.9 1.5 9.6 9.2 4.8 8.1 6.5 14.0 14.0 26.0 16.1 16.2 11.7 16.9 12.0 14.3 25.5 24.8 28.6 33.5 29.7 47.7 30.3 31.7 21.4 38.1 22.2 31.8 4.3 25.6 29.2 32.4 33.6 26.2 10.0 8.3 6.7 8.8 8.2 6.1 8.9 3.9 4.7 5.6 14.9 16.3 3.7 2.1 5.6 0.8 89.6 33.1 42.8 39.8 22.7 2.0 6.5 39.7 11.7 27.2 8.0 36.6 0.0 21.1 4.3 5.6 3.1 27.9 18.1 10.1 1.6 27.7 15.4 27.7 21.6 2.3 10.1 6.8 13.6 24.2 4.1 21.3 25.4 1.4 21.3 2.0 6.5 5.1 4.3 6.8 9.8 3.2 17.5 23.3 3.3 BPTF "FAC1, FALZ, NURF301" ENSG00000171634 "Bromodomain PHD finger transcription factor" Q12830 17 67825524-67984378 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029069, HPA048289" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029069: AB_10602597, HPA048289: AB_2680342" "unprognostic (1.22e-1)" "unprognostic (6.53e-2)" "unprognostic (2.41e-2)" "unprognostic (3.74e-2)" "unprognostic (4.43e-2)" "unprognostic (1.10e-1)" "unprognostic (1.02e-2)" "unprognostic (2.30e-1)" "unprognostic (8.97e-2)" "unprognostic (1.54e-1)" "unprognostic (4.07e-2)" "unprognostic (9.24e-2)" "prognostic favorable (8.46e-4)" "unprognostic (1.05e-1)" "unprognostic (2.85e-1)" "unprognostic (3.01e-2)" "unprognostic (1.56e-1)" 16.1 16.2 28.0 28.6 28.7 22.3 19.5 61.9 35.3 20.7 18.5 18.9 17.0 12.1 20.1 24.0 17.9 17.8 17.4 13.9 26.6 17.7 17.1 14.7 24.1 31.7 31.6 22.2 27.1 16.3 31.3 29.7 17.2 26.0 17.3 18.0 14.5 16.9 18.4 17.9 29.5 18.2 16.5 18.4 21.1 17.4 23.6 33.5 41.4 19.0 12.3 30.1 16.7 32.5 12.6 10.4 15.1 4.8 9.7 7.3 1.4 13.3 17.5 25.7 13.0 14.3 13.7 14.1 10.5 9.8 12.6 11.0 16.1 9.6 54.9 7.8 11.7 10.0 10.5 25.1 11.3 20.6 7.7 24.2 21.1 16.8 22.0 6.8 30.7 17.0 10.0 12.8 12.6 9.6 11.5 23.6 17.6 23.8 15.8 10.9 20.5 31.3 15.3 19.6 12.5 16.0 22.6 31.1 10.8 11.1 16.8 19.4 22.2 14.4 38.9 14.8 32.6 16.4 17.8 16.5 19.3 15.1 7.0 12.9 13.0 13.0 32.6 9.1 14.9 7.4 15.1 3.9 7.5 7.3 2.2 5.9 5.7 5.9 5.7 2.8 12.6 6.2 6.4 8.9 9.7 4.8 10.4 4.2 1.4 28.0 28.7 61.9 35.3 26.6 17.7 31.6 22.2 26.0 33.5 107.2 124.1 51.4 47.2 66.7 204.4 114.1 56.0 96.4 130.8 55.8 135.5 32.0 6.6 51.8 19.7 85.7 44.6 46.7 54.5 27.7 63.0 50.8 115.8 38.4 36.7 187.5 121.0 64.4 50.9 14.5 100.7 50.8 60.8 45.1 58.7 132.3 54.5 60.4 104.7 15.3 196.3 64.7 58.2 135.4 80.7 66.0 32.4 81.2 68.6 50.4 BRAT1 "BAAT1, C7orf27, MGC22916" ENSG00000106009 "BRCA1 associated ATM activator 1" Q6PJG6 7 2537877-2555727 "Disease related genes, Predicted intracellular proteins" "DNA damage" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029455, HPA076508" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA029455: AB_10600761, HPA076508: AB_2686803" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "unprognostic (1.19e-2)" "unprognostic (7.04e-3)" "unprognostic (6.07e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (8.02e-4)" "unprognostic (2.03e-1)" "unprognostic (1.76e-1)" "unprognostic (2.46e-1)" "unprognostic (1.10e-3)" "unprognostic (4.69e-2)" "prognostic unfavorable (3.90e-4)" "unprognostic (5.37e-2)" "unprognostic (3.12e-2)" "unprognostic (8.88e-2)" "unprognostic (3.71e-2)" 16.1 19.2 12.2 13.0 14.3 12.1 10.1 20.4 12.9 11.4 9.6 14.3 9.4 16.5 12.2 11.7 10.3 11.4 15.8 8.1 13.4 9.1 9.1 13.7 15.9 11.6 14.7 9.8 13.8 17.0 9.9 12.5 11.0 8.9 14.0 3.1 12.9 20.0 13.7 12.0 19.0 13.8 8.8 11.3 14.6 14.5 17.0 10.6 19.2 14.5 5.8 12.3 10.2 10.8 14.2 23.1 18.7 22.2 10.2 17.1 14.6 15.0 13.8 3.2 12.0 3.1 2.8 11.0 5.2 2.9 4.5 3.9 9.8 9.3 11.4 8.3 3.4 8.6 15.3 3.9 5.9 0.7 4.4 20.1 5.2 10.1 6.2 4.0 7.0 8.1 4.9 4.2 4.6 1.3 2.6 5.2 8.9 16.7 4.1 3.1 21.5 4.9 33.2 15.8 3.7 21.2 12.2 9.9 10.9 2.8 4.8 8.8 13.5 7.8 13.0 5.3 1.5 11.7 14.5 5.1 6.1 19.7 12.7 9.9 9.2 7.1 8.1 6.9 14.2 14.5 3.6 22.2 12.3 16.8 20.2 14.7 14.2 15.2 17.1 23.1 12.6 12.8 13.7 18.7 10.2 17.4 16.4 13.0 14.6 12.2 14.3 20.4 12.9 13.4 9.1 14.7 9.8 8.9 10.6 11.9 5.4 8.2 16.1 6.9 10.7 5.7 15.3 5.3 12.5 8.7 11.8 18.4 13.3 9.5 15.3 10.5 12.9 0.0 11.8 11.3 10.3 7.4 13.9 12.9 27.9 3.2 10.9 18.4 13.2 6.1 21.0 12.4 6.8 18.0 12.9 11.2 11.0 13.3 20.8 13.6 10.8 6.5 9.5 27.0 39.0 5.9 12.2 13.4 13.4 7.6 BRCC3 "BRCC36, C6.1A, CXorf53" ENSG00000185515 "BRCA1/BRCA2-containing complex subunit 3" P46736 X 155071420-155123074 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Metalloprotease, Protease" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048737 Supported Nucleoplasm NA NA Nucleoplasm "HPA048737: AB_2680504" "unprognostic (1.16e-2)" "unprognostic (2.40e-2)" "unprognostic (5.99e-2)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (2.88e-2)" "unprognostic (4.48e-2)" "unprognostic (6.47e-3)" "unprognostic (1.33e-1)" "unprognostic (9.68e-2)" "unprognostic (1.35e-3)" "unprognostic (3.72e-2)" "unprognostic (3.71e-3)" "unprognostic (7.14e-3)" "unprognostic (1.57e-1)" "unprognostic (1.17e-1)" "unprognostic (1.90e-1)" 12.9 14.8 11.3 11.2 16.5 14.0 12.9 20.0 18.6 11.8 19.5 9.1 15.2 16.7 9.4 11.8 20.4 12.1 8.3 10.3 10.3 12.1 18.3 12.3 9.4 12.5 10.4 10.5 10.7 12.2 14.3 11.8 14.2 15.3 12.2 19.5 8.7 15.5 12.6 21.3 10.0 19.2 13.1 8.9 11.1 13.7 3.9 12.9 10.2 13.9 13.7 12.7 11.4 11.6 13.4 16.2 25.0 17.8 21.0 19.0 12.3 31.2 19.3 8.2 6.4 6.1 5.1 13.5 12.8 8.1 7.9 17.3 17.5 13.7 30.0 23.4 8.1 12.1 12.2 21.0 11.4 11.4 17.4 16.7 6.0 30.5 14.4 5.4 21.3 9.4 6.2 5.2 12.8 10.9 7.8 10.8 12.0 9.8 8.9 6.3 13.2 8.1 7.6 7.2 32.2 13.8 12.8 14.0 12.5 9.4 14.8 13.4 5.7 8.4 13.5 7.6 10.2 9.4 7.2 12.0 7.0 10.8 10.3 19.2 11.4 18.6 39.0 10.2 19.9 8.2 22.6 14.7 25.0 16.2 17.8 19.0 13.4 16.0 14.8 16.2 11.8 12.5 14.0 8.0 21.0 16.9 10.4 18.6 12.3 11.3 16.5 20.0 18.6 10.3 12.1 10.4 10.5 15.3 12.9 29.8 15.1 9.3 5.8 4.8 12.7 24.6 10.2 38.8 42.1 7.0 13.7 22.3 16.6 19.5 0.4 7.8 14.7 0.0 17.5 21.1 9.1 7.6 25.5 7.6 15.5 7.9 9.2 6.2 8.3 0.8 5.5 10.9 5.0 19.8 21.3 12.9 11.9 17.3 11.3 13.5 13.5 19.4 7.1 0.6 1.3 5.6 11.3 11.8 26.0 7.5 BRD4 "CAP, HUNK1, HUNKI, MCAP" ENSG00000141867 "Bromodomain containing 4" O60885 19 15235519-15332545 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015055, HPA061646, CAB068177, CAB068178" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB068177: AB_2665685, CAB068178: AB_2665686, HPA015055: AB_1845435, HPA061646: AB_2684575" "unprognostic (2.83e-3)" "unprognostic (2.39e-2)" "unprognostic (6.37e-3)" "unprognostic (3.38e-2)" "unprognostic (2.15e-1)" "unprognostic (9.53e-3)" "unprognostic (3.03e-3)" "unprognostic (6.13e-2)" "unprognostic (7.63e-2)" "unprognostic (2.72e-2)" "unprognostic (3.98e-2)" "unprognostic (5.26e-2)" "unprognostic (1.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.73e-1)" "unprognostic (1.28e-1)" "unprognostic (1.22e-1)" 23.0 20.7 27.8 25.6 30.1 25.2 20.4 32.1 29.9 20.8 19.6 17.2 18.9 17.6 23.4 12.5 22.9 18.6 15.8 21.3 20.3 12.4 18.1 25.3 22.5 22.7 14.8 17.6 27.3 31.3 19.1 18.8 34.0 17.6 20.8 10.7 18.9 22.0 19.3 47.7 27.3 21.0 20.3 13.9 26.8 20.2 20.1 16.8 34.2 21.5 11.6 23.7 20.9 24.8 6.9 4.3 11.6 4.4 4.9 3.5 2.0 20.4 20.7 12.9 24.3 12.3 8.7 15.6 15.1 12.3 11.9 12.6 21.8 30.9 25.7 25.0 16.4 11.7 20.5 15.0 14.2 10.4 25.7 9.9 24.3 18.1 19.0 18.8 24.0 27.1 12.8 14.7 14.8 29.2 7.9 11.5 17.3 41.1 26.1 7.6 26.5 22.5 17.3 26.3 9.4 24.3 28.3 13.6 16.1 9.5 22.1 15.6 14.1 19.9 14.6 17.0 11.0 14.6 16.4 18.3 31.2 14.9 27.7 23.7 21.3 18.8 13.1 17.2 19.5 24.2 5.2 3.6 3.9 3.5 4.4 2.7 5.4 3.1 2.9 2.1 6.9 3.1 2.9 11.6 4.9 3.9 4.3 2.2 2.0 27.8 30.1 32.1 29.9 20.3 12.4 14.8 17.6 17.6 16.8 59.6 53.2 59.1 104.0 104.5 62.2 73.0 56.0 22.7 28.4 24.4 78.5 177.3 21.6 46.6 107.0 73.3 66.9 93.5 57.8 59.0 72.1 110.7 34.8 77.4 51.9 74.7 109.2 55.3 67.7 148.2 71.7 51.2 42.2 43.3 47.3 38.6 55.1 44.4 75.0 28.3 85.9 71.1 85.8 52.5 37.5 125.2 212.7 56.7 51.5 128.6 BRD9 FLJ13441 ENSG00000028310 "Bromodomain containing 9" Q9H8M2 5 850291-892824 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021465, HPA023197" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021465: AB_1845441, HPA023197: AB_2671106" "unprognostic (3.10e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-3)" "unprognostic (4.61e-2)" "unprognostic (5.89e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (5.88e-7)" "unprognostic (6.28e-2)" "unprognostic (7.53e-3)" "unprognostic (3.84e-2)" "unprognostic (8.82e-2)" "unprognostic (2.28e-2)" "prognostic unfavorable (2.37e-6)" "unprognostic (6.64e-2)" "unprognostic (1.07e-1)" "unprognostic (6.62e-3)" "unprognostic (1.02e-2)" 13.7 12.3 14.5 15.2 23.8 12.7 12.9 31.8 22.0 13.0 13.0 16.1 10.9 11.7 17.9 10.0 12.8 14.9 9.1 15.3 16.2 10.9 9.1 8.5 11.9 14.3 15.1 15.0 16.3 14.6 13.2 18.2 10.9 14.4 11.2 11.1 11.1 14.7 14.7 25.8 13.1 12.5 12.7 13.9 12.5 13.6 18.5 21.1 16.8 13.3 12.0 15.9 15.6 14.4 6.5 3.1 6.2 4.7 2.7 4.8 1.1 6.2 3.8 12.0 11.9 4.3 8.8 13.7 12.5 7.3 12.5 9.2 7.9 8.5 8.0 19.3 11.8 13.3 5.8 8.1 11.3 10.5 43.9 5.5 10.4 13.8 3.9 9.4 15.0 8.9 6.6 3.3 8.8 7.7 8.8 12.2 14.3 12.7 5.7 9.4 6.4 17.3 8.6 7.2 5.7 6.5 11.0 7.3 6.8 6.3 8.2 7.1 12.6 23.9 8.4 4.4 6.6 7.5 13.2 12.1 11.2 7.5 5.8 12.1 9.2 4.2 14.2 9.4 14.4 13.6 6.2 4.7 5.4 3.5 2.4 4.6 6.5 4.2 4.8 3.1 4.9 4.8 3.0 4.1 2.7 3.1 1.8 4.5 1.1 14.5 23.8 31.8 22.0 16.2 10.9 15.1 15.0 14.4 21.1 17.9 15.6 25.2 12.1 22.6 66.5 21.2 25.5 2.7 14.8 22.7 43.2 15.1 19.9 21.0 76.4 21.8 20.0 0.0 17.1 26.0 16.9 10.8 18.5 18.4 18.2 95.3 15.6 33.7 23.0 43.5 21.0 16.9 13.5 24.4 24.0 25.2 23.6 21.6 18.4 12.6 85.2 25.8 16.5 33.9 61.3 17.8 16.5 29.9 21.8 11.5 BRMS1L "BRMS1, FLJ39177, MGC11296" ENSG00000100916 "Breast cancer metastasis-suppressor 1 like" Q5PSV4 14 35826318-35932325 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046623 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA046623: AB_2679724" "prognostic unfavorable (5.78e-4)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.69e-3)" "unprognostic (2.66e-2)" "unprognostic (2.27e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (2.56e-2)" "unprognostic (2.02e-2)" "unprognostic (8.04e-2)" "unprognostic (6.50e-2)" "unprognostic (1.66e-1)" "prognostic favorable (6.55e-5)" "unprognostic (2.06e-2)" "unprognostic (1.98e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (6.87e-6)" 8.4 14.3 15.5 5.0 18.6 3.0 8.7 18.6 21.4 8.7 6.0 7.2 5.9 4.5 9.0 8.1 9.0 6.7 5.9 15.4 13.2 13.3 12.3 8.3 6.7 3.9 11.5 16.7 10.4 4.3 14.9 7.8 9.9 15.9 9.4 5.3 3.9 5.6 9.2 16.3 8.0 3.9 9.8 11.0 4.7 5.6 7.1 11.0 2.2 10.1 5.8 5.2 7.3 9.6 2.1 2.3 0.8 3.4 1.0 4.0 2.2 7.0 7.2 12.6 7.2 11.4 14.5 18.7 7.4 7.2 11.5 11.3 4.6 6.0 5.7 7.6 10.3 5.4 9.1 9.9 13.5 16.6 6.3 12.2 5.2 7.3 20.1 8.1 2.6 4.4 10.1 9.2 8.9 7.6 6.0 8.2 3.3 2.5 4.6 12.9 9.4 3.0 4.2 5.0 10.0 10.7 3.1 13.9 4.3 9.3 8.1 3.7 9.6 8.5 10.0 8.4 10.0 11.4 3.7 5.0 11.1 6.7 6.2 7.2 4.3 5.6 3.5 2.7 5.7 6.7 0.1 1.4 0.8 2.8 3.2 2.4 2.1 3.0 3.7 0.9 1.5 4.0 3.6 0.1 1.0 3.4 2.3 3.4 2.2 15.5 18.6 18.6 17.5 13.2 13.3 11.5 16.7 15.9 11.0 8.9 8.6 6.9 7.6 16.6 16.8 16.5 2.5 6.7 12.5 7.0 3.9 16.9 6.6 4.3 2.8 10.2 1.3 0.0 6.1 13.7 12.5 9.3 14.9 3.9 4.4 15.9 4.6 4.9 1.8 1.7 10.3 3.6 8.5 9.0 3.6 16.9 4.5 3.5 9.2 16.2 16.3 19.4 18.6 4.9 16.2 14.2 18.8 7.0 3.7 4.7 BTBD6 BDPL ENSG00000184887 "BTB domain containing 6" Q96KE9 14 105248490-105251093 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031355 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031355: AB_10611812" "prognostic favorable (1.11e-4)" "unprognostic (2.01e-2)" "unprognostic (2.65e-1)" "unprognostic (1.97e-2)" "unprognostic (2.69e-1)" "unprognostic (2.58e-1)" "unprognostic (2.23e-2)" "unprognostic (4.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-1)" "prognostic favorable (2.25e-4)" "unprognostic (8.48e-3)" "prognostic favorable (6.51e-5)" "unprognostic (6.55e-2)" "unprognostic (3.22e-1)" "unprognostic (6.86e-2)" "unprognostic (9.85e-2)" 25.9 9.4 19.9 9.4 17.7 11.8 53.4 18.1 27.0 13.6 14.6 5.4 15.2 14.1 9.9 14.7 17.4 11.4 13.6 19.8 17.9 12.9 9.7 12.3 17.7 11.3 11.3 15.9 13.1 5.6 7.7 12.4 7.7 9.5 13.1 11.7 11.6 20.5 12.6 73.0 19.4 14.3 14.4 6.1 9.3 13.7 24.7 6.2 8.2 9.3 31.3 10.6 11.5 22.3 2.4 2.7 4.6 1.6 0.6 8.1 1.1 17.7 14.3 7.8 20.7 25.2 17.6 0.0 16.5 15.0 25.6 17.5 11.1 16.4 5.6 10.1 24.0 5.3 24.0 15.0 15.9 12.7 14.5 12.2 4.1 20.8 0.0 17.3 12.5 8.0 18.2 22.0 11.8 9.6 10.0 20.4 19.0 0.0 0.1 13.6 25.3 13.1 5.1 3.3 16.9 24.7 14.2 0.0 5.2 9.7 19.7 12.9 5.5 15.5 12.5 12.2 5.7 25.6 16.1 13.6 20.7 0.5 30.2 20.4 3.7 5.0 2.7 21.3 5.8 16.0 0.6 1.1 4.6 4.1 1.6 4.0 2.4 4.3 4.2 1.1 1.3 3.3 2.3 0.7 0.6 1.2 2.7 8.1 1.1 19.9 17.7 18.1 27.0 17.9 12.9 11.3 15.9 9.5 6.2 23.8 18.7 1.5 22.6 10.4 23.3 21.0 17.8 20.1 21.6 10.4 5.9 2.2 18.3 5.1 9.8 13.5 20.8 0.0 0.0 3.1 9.6 22.7 24.3 12.8 6.7 19.1 19.5 9.8 7.6 25.6 8.6 8.9 11.8 2.8 24.7 14.8 0.8 14.4 7.1 7.8 16.4 12.9 8.2 8.9 7.9 11.0 1.8 7.5 16.9 20.0 BTBD8 ENSG00000189195 "BTB domain containing 8" Q5XKL5 1 92080305-92184725 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 42.3" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.2" "Low region specificity" "Detected in all" "HPA024216, HPA035311" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA024216: AB_1852385, HPA035311: AB_10671933" "unprognostic (2.94e-1)" "unprognostic (2.97e-2)" "unprognostic (1.99e-1)" "unprognostic (3.06e-2)" "unprognostic (1.83e-1)" "unprognostic (3.17e-2)" "unprognostic (2.72e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-2)" "unprognostic (2.97e-1)" "unprognostic (2.82e-2)" "unprognostic (8.42e-2)" "unprognostic (3.73e-3)" "unprognostic (5.04e-2)" "unprognostic (9.49e-2)" "unprognostic (2.39e-2)" "unprognostic (3.15e-1)" 3.4 4.6 11.7 1.2 27.3 0.7 3.3 20.3 42.3 2.3 2.4 4.0 0.6 1.7 3.4 4.7 2.0 3.3 2.3 2.8 7.8 2.1 2.4 1.9 2.5 1.4 4.5 23.3 5.0 2.7 5.1 6.0 2.5 16.4 3.3 2.5 1.2 2.8 2.7 2.3 1.8 2.1 2.0 6.6 1.8 2.4 8.3 9.9 0.2 3.7 0.0 1.1 4.7 2.7 0.5 0.8 0.6 0.7 0.9 2.3 0.4 2.7 2.2 1.6 0.0 5.0 10.2 5.5 1.8 2.5 1.5 1.8 0.5 3.2 1.2 6.5 1.6 6.0 0.8 1.2 3.2 2.3 2.8 1.8 2.1 0.6 0.9 1.1 1.1 1.2 6.0 2.7 0.9 1.8 6.8 1.5 2.9 2.5 0.8 2.8 1.7 0.8 2.1 1.7 3.8 1.7 1.8 1.6 0.2 3.2 2.0 0.9 1.5 2.9 1.4 1.4 3.0 2.3 1.6 1.0 1.9 1.2 1.1 0.7 2.1 0.9 0.0 1.5 0.2 0.4 0.0 0.6 0.0 2.3 0.1 0.5 0.5 1.0 0.9 0.0 0.5 1.8 1.4 0.6 0.9 0.7 0.8 0.9 0.4 11.7 27.3 20.3 42.3 7.8 2.1 4.5 23.3 16.4 9.9 0.0 2.6 0.0 1.0 0.3 8.7 0.7 5.1 5.3 5.7 5.2 5.9 1.9 1.7 3.1 4.5 0.6 1.7 0.0 2.5 0.9 1.1 1.8 0.0 0.8 0.6 3.2 0.0 1.3 2.4 0.5 5.5 1.3 1.7 1.8 2.3 6.5 3.2 2.9 3.5 1.1 16.7 0.0 0.5 3.7 8.2 0.5 1.1 0.5 2.3 0.9 BTBD9 "dJ322I12.1, KIAA1880" ENSG00000183826 "BTB domain containing 9" Q96Q07 6 38168451-38640148 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041930 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041930: AB_10795270" "unprognostic (4.40e-1)" "unprognostic (1.74e-1)" "unprognostic (1.75e-3)" "unprognostic (1.64e-2)" "unprognostic (6.59e-2)" "unprognostic (3.94e-2)" "unprognostic (1.48e-1)" "unprognostic (1.76e-3)" "unprognostic (5.44e-2)" "unprognostic (6.13e-2)" "unprognostic (1.92e-2)" "unprognostic (2.74e-1)" "prognostic favorable (4.20e-13)" "unprognostic (1.35e-1)" "unprognostic (6.56e-2)" "unprognostic (8.67e-2)" "unprognostic (1.15e-2)" 5.3 6.6 17.9 5.4 23.9 9.1 5.1 9.8 20.4 5.7 6.6 7.8 7.1 6.3 7.2 5.4 7.8 13.0 7.5 9.2 15.6 11.5 8.4 3.8 12.5 7.4 8.9 13.7 11.5 4.8 28.6 12.9 5.6 10.5 6.8 7.8 7.0 5.3 6.4 7.8 7.4 8.7 6.8 6.1 5.3 5.7 10.2 7.7 4.1 8.5 3.0 7.6 7.5 5.2 5.2 3.9 12.7 5.5 5.0 5.6 2.6 5.9 5.1 8.1 10.1 6.0 8.4 5.8 6.4 8.4 7.0 7.5 6.0 3.5 3.7 4.2 9.6 9.5 4.3 4.4 9.1 8.3 10.3 8.7 7.8 5.2 2.6 4.7 7.9 16.2 6.4 6.9 9.5 9.0 6.4 12.0 6.7 3.8 6.1 7.0 3.7 5.6 2.8 2.1 6.1 4.4 3.3 5.7 7.0 6.7 15.1 10.3 7.3 6.0 5.9 5.8 6.0 6.2 5.4 7.8 6.9 4.3 7.5 6.6 3.6 3.0 4.3 5.4 4.9 7.4 12.7 2.7 4.5 3.8 3.8 5.3 3.9 3.8 3.4 2.5 5.2 4.8 4.3 6.7 5.0 5.5 3.9 5.6 2.6 17.9 23.9 9.8 20.4 15.6 11.5 8.9 13.7 10.5 7.7 3.0 13.2 1.4 2.0 4.0 11.6 10.3 10.2 2.7 9.1 8.7 7.9 2.5 5.0 3.6 14.3 3.6 11.7 0.0 5.1 1.3 3.2 2.5 0.0 2.1 2.2 4.8 4.7 9.8 3.5 18.9 2.8 3.5 1.7 0.0 4.5 5.2 4.9 3.7 3.2 5.1 5.1 0.0 3.8 2.2 2.7 5.1 3.9 5.0 5.1 2.7 BUB3 BUB3L ENSG00000154473 "BUB3, mitotic checkpoint protein" O43684 10 123154277-123170467 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003601, CAB037075" Supported Supported Nucleoplasm NA Yes 100000000 Nucleoplasm "CAB037075: AB_1078310, HPA003601: AB_1078309" "unprognostic (7.82e-2)" "prognostic favorable (2.04e-4)" "unprognostic (9.07e-2)" "unprognostic (1.83e-1)" "unprognostic (7.93e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (4.45e-5)" "unprognostic (6.04e-3)" "unprognostic (9.41e-2)" "unprognostic (6.30e-3)" "unprognostic (2.69e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (3.81e-7)" "unprognostic (8.80e-2)" "unprognostic (7.64e-2)" "unprognostic (1.51e-1)" "unprognostic (7.71e-2)" 23.8 35.1 21.1 35.3 26.6 51.0 27.9 30.4 28.3 20.2 27.7 31.3 22.3 24.5 24.5 22.7 38.2 22.1 20.7 19.6 19.8 28.3 24.1 25.1 22.4 51.8 33.3 23.6 27.4 20.5 20.7 37.3 22.6 31.3 21.8 29.6 16.8 26.5 21.4 23.4 28.9 30.3 22.2 29.1 38.8 24.4 35.4 28.2 67.8 28.1 22.8 49.0 30.3 26.5 43.0 25.8 32.7 24.3 45.6 71.6 52.4 51.7 52.2 33.7 37.3 19.2 18.2 29.1 54.2 58.0 60.4 48.1 45.3 35.8 46.6 20.3 24.7 28.8 33.6 49.8 58.7 63.5 37.8 49.7 29.3 63.3 49.6 20.0 57.1 36.4 15.1 23.1 53.6 69.0 32.6 40.5 39.8 35.5 46.9 54.1 44.6 46.9 35.4 20.7 26.9 49.3 64.4 16.8 29.9 27.5 57.5 25.2 25.5 30.6 20.7 25.9 14.6 23.5 29.6 31.7 47.5 29.1 29.8 79.8 25.1 35.4 72.5 25.9 56.8 20.0 32.7 23.6 32.4 53.5 24.3 48.1 43.0 49.1 54.2 24.2 37.5 52.9 55.7 11.7 45.6 21.2 25.8 71.6 52.4 21.1 26.6 30.4 28.3 19.8 28.3 33.3 23.6 31.3 28.2 23.8 35.1 84.1 58.3 116.0 25.8 36.7 38.2 37.5 25.0 36.6 9.8 71.6 59.7 62.8 111.8 69.4 34.1 23.3 51.2 112.6 68.6 51.7 49.7 36.7 69.7 9.5 39.1 44.8 49.9 110.6 41.7 56.4 91.1 199.2 46.1 52.8 54.3 35.1 43.5 60.0 21.6 103.5 63.6 136.5 153.0 116.6 54.3 139.0 54.0 50.5 BUD13 "Cwc26, fSAP71, MGC13125" ENSG00000137656 "BUD13 homolog" Q9BRD0 11 116748170-116772988 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038340, HPA038341" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038340: AB_2675967, HPA038341: AB_10671528" "unprognostic (1.89e-1)" "unprognostic (1.73e-1)" "unprognostic (1.01e-2)" "unprognostic (2.77e-2)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.07e-5)" "unprognostic (1.77e-1)" "unprognostic (8.39e-2)" "unprognostic (1.46e-1)" "unprognostic (4.23e-2)" "unprognostic (9.10e-2)" "unprognostic (1.81e-1)" "unprognostic (4.53e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.63e-1)" 15.1 10.0 9.7 20.4 12.4 12.9 16.1 19.0 15.5 21.2 20.6 16.1 11.6 12.8 19.4 13.8 16.3 16.8 13.7 13.2 9.5 9.4 12.4 11.3 14.4 17.5 10.8 7.8 20.4 13.8 15.7 13.3 18.0 11.0 17.1 16.3 13.5 14.7 13.4 18.5 15.1 20.8 15.5 12.4 18.1 14.7 29.8 11.9 37.9 18.1 14.0 21.2 16.6 22.6 10.8 8.5 20.1 8.7 7.1 11.9 5.7 11.0 6.1 17.2 10.3 5.5 6.6 8.6 10.9 12.2 12.6 12.3 14.3 16.8 23.5 13.9 9.0 13.2 15.6 13.8 8.5 13.9 13.7 5.6 27.4 4.4 10.8 6.7 23.0 16.4 6.0 10.0 10.6 10.9 8.1 12.2 23.4 17.5 11.7 10.3 8.7 28.0 20.4 10.3 15.8 9.7 21.2 14.8 18.1 8.9 12.8 10.2 13.6 12.8 9.4 5.0 11.4 12.9 15.3 6.9 14.5 9.2 7.3 14.5 4.8 6.0 19.4 4.7 21.3 12.8 14.3 7.8 20.1 10.9 7.8 11.9 10.8 9.4 8.6 8.5 8.8 10.8 8.8 9.5 7.1 8.7 7.5 8.0 5.7 9.7 12.4 19.0 15.5 9.5 9.4 10.8 7.8 11.0 11.9 8.9 3.5 6.9 10.0 6.8 6.6 3.7 2.5 12.0 5.7 8.7 11.8 7.2 6.6 6.8 7.7 6.6 10.2 23.3 7.2 9.4 5.1 5.1 10.5 5.4 7.0 3.2 9.2 6.7 7.9 3.2 8.3 8.1 6.8 4.6 6.4 6.9 5.1 6.8 10.3 3.9 6.5 6.5 3.6 33.2 21.3 4.3 8.2 10.0 9.7 5.8 C10orf55 bA417O11.3 ENSG00000222047 "Chromosome 10 open reading frame 55" Q5SWW7 10 73909969-73922777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 14.0" "Cell type enhanced" "Detected in some" 13 "Basal glandular cells: 6.4;Distal tubular cells: 6.6;Early spermatids: 11.8;Sertoli cells: 6.5;Urothelial cells: 5.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.1;CAPAN-2: 4.8;HaCaT: 4.9;hTERT-RPE1: 3.4;RPTEC TERT1: 7.6;U-251 MG: 3.3" HPA045739 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045739: AB_10961861" "unprognostic (5.50e-2)" "unprognostic (1.82e-1)" "unprognostic (1.84e-2)" "unprognostic (2.25e-2)" "unprognostic (4.42e-2)" "unprognostic (2.71e-2)" "unprognostic (9.68e-3)" "unprognostic (5.61e-3)" "unprognostic (4.99e-2)" "unprognostic (8.84e-2)" "unprognostic (3.62e-3)" "unprognostic (1.30e-1)" "unprognostic (2.15e-3)" "unprognostic (1.27e-1)" "unprognostic (3.90e-2)" "unprognostic (5.94e-3)" "unprognostic (3.13e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.1 0.5 1.0 0.0 0.0 0.0 0.1 0.0 14.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.1 0.3 0.0 0.0 0.0 0.1 0.0 0.3 1.6 0.4 0.3 0.0 4.8 0.0 0.3 0.2 1.5 4.9 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.4 0.6 1.0 3.4 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.1 0.0 7.6 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.4 3.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.5 11.8 0.0 0.0 0.0 0.6 0.0 0.2 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 6.5 0.3 0.0 0.2 0.1 0.0 0.0 0.0 5.4 C11orf1 FLJ23499 ENSG00000137720 "Chromosome 11 open reading frame 1" Q9H5F2 11 111878935-111885975 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 16 "Early spermatids: 375.8;Late spermatids: 825.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038410, HPA057519" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038410: AB_10672591, HPA057519: AB_2683454" "unprognostic (1.33e-2)" "unprognostic (1.61e-1)" "unprognostic (1.96e-1)" "prognostic favorable (9.32e-4)" "unprognostic (1.30e-1)" "unprognostic (1.42e-2)" "unprognostic (1.10e-1)" "unprognostic (1.14e-1)" "unprognostic (9.26e-2)" "unprognostic (3.23e-2)" "unprognostic (1.41e-2)" "unprognostic (2.86e-2)" "prognostic favorable (1.39e-4)" "unprognostic (3.76e-2)" "unprognostic (2.12e-1)" "unprognostic (1.97e-1)" "unprognostic (2.08e-1)" 11.5 21.2 20.3 12.5 34.8 8.9 29.2 8.3 13.9 12.6 15.8 11.2 21.0 11.8 10.4 39.3 17.7 17.0 19.8 20.8 16.6 18.2 40.1 31.2 15.8 12.4 20.2 12.0 17.1 47.6 19.9 18.9 8.3 14.3 16.6 15.8 12.7 22.6 29.5 8.3 16.9 15.5 10.2 17.4 10.0 15.6 31.4 12.2 10.6 24.2 15.0 10.2 14.2 9.5 14.8 19.0 5.0 8.2 9.5 22.0 6.3 8.0 10.4 13.6 15.0 15.7 12.1 14.1 4.5 11.5 3.7 4.7 17.3 15.1 29.6 21.5 7.6 10.6 9.5 5.4 16.5 5.8 13.1 7.7 10.0 2.2 13.4 9.9 14.6 7.1 22.1 26.0 13.1 25.3 16.6 4.5 31.9 14.3 22.4 12.4 7.9 19.7 23.0 15.5 28.2 15.9 10.2 14.1 41.2 22.9 14.9 12.2 11.7 2.8 10.6 9.6 13.6 21.2 10.3 3.9 13.7 9.8 6.0 6.2 13.1 19.1 44.2 7.0 17.4 8.3 3.3 4.4 5.0 8.2 8.2 15.4 14.8 13.7 10.4 6.4 10.2 22.0 16.4 1.1 9.5 5.5 19.0 9.7 6.3 20.3 34.8 8.3 13.9 16.6 18.2 20.2 12.0 14.3 12.2 23.8 17.5 18.4 55.8 21.1 6.9 48.4 20.4 42.8 31.8 33.2 5.9 24.6 170.8 16.9 375.8 13.5 15.8 46.7 23.8 20.6 13.9 36.9 28.8 31.0 21.2 14.3 25.3 9.2 7.3 825.1 25.3 19.0 23.6 19.0 36.6 26.8 21.3 17.5 23.0 138.3 12.9 19.4 12.7 47.1 30.9 25.7 17.6 12.7 46.6 52.8 C12orf10 "Gamm1, MYG, MYG1" ENSG00000139637 "Chromosome 12 open reading frame 10" Q9HB07 12 53299686-53307177 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 85.6" "Group enriched" "Detected in all" 6 "Early spermatids: 413.5;Late spermatids: 787.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038626, HPA038627" Approved Supported Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA038626: AB_10674692, HPA038627: AB_2676123" "unprognostic (5.33e-2)" "unprognostic (4.41e-2)" "unprognostic (6.77e-2)" "unprognostic (2.44e-2)" "unprognostic (3.59e-1)" "unprognostic (7.56e-2)" "unprognostic (1.61e-3)" "unprognostic (2.73e-1)" "unprognostic (1.97e-1)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (1.39e-1)" "unprognostic (2.81e-1)" "unprognostic (6.41e-2)" "unprognostic (2.18e-1)" "unprognostic (2.16e-1)" "unprognostic (1.61e-1)" 16.1 18.7 21.5 13.0 18.4 13.7 17.8 18.4 32.2 17.9 15.1 14.0 18.7 14.3 17.7 18.3 15.9 28.4 16.6 20.2 19.7 21.3 18.8 15.7 13.0 23.6 25.0 23.9 33.3 27.6 20.6 15.7 11.7 27.7 14.6 11.9 14.3 19.4 19.7 22.4 15.7 13.1 17.7 14.3 12.1 16.2 85.6 12.9 19.4 24.1 18.3 15.0 17.3 15.0 26.1 31.1 12.2 27.4 19.2 33.3 23.2 13.2 30.5 10.8 17.2 11.7 17.7 1.3 8.8 14.2 20.1 14.6 27.6 14.4 12.7 20.9 12.2 11.2 15.0 15.1 19.1 11.0 10.6 29.6 13.2 25.2 32.0 27.4 13.6 8.9 17.6 14.6 18.5 18.9 20.2 17.9 15.1 0.7 26.4 13.5 62.3 18.3 22.4 18.0 13.6 29.5 17.2 10.3 29.7 17.3 14.8 21.8 21.0 9.9 19.5 21.4 6.6 30.6 13.0 11.6 19.7 18.6 14.1 13.8 23.9 24.8 14.1 25.0 11.6 15.1 7.8 27.4 12.2 18.3 20.6 27.5 26.1 24.6 18.4 31.1 22.0 25.9 23.4 6.9 19.2 15.4 19.4 33.3 23.2 21.5 18.4 18.4 32.2 19.7 21.3 25.0 23.9 27.7 12.9 20.8 13.4 38.4 38.3 34.7 24.1 14.2 33.1 28.1 13.6 29.6 11.8 30.6 66.3 54.6 413.5 33.7 29.6 23.3 80.2 49.2 43.7 27.1 13.9 21.5 61.3 9.5 48.4 28.3 41.7 787.6 47.5 41.2 32.1 34.3 43.5 34.6 50.7 40.7 42.8 99.0 31.7 38.8 57.5 104.3 80.3 34.9 21.6 34.8 48.6 26.8 C15orf41 "FLJ22851, HH114, MGC11326" ENSG00000186073 "Chromosome 15 open reading frame 41" Q9Y2V0 15 36579611-36810248 "Disease related genes, Predicted intracellular proteins" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 79.9" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 94.8;Early spermatids: 108.6;Late spermatids: 112.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061023 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA061023: AB_2684417" "unprognostic (1.82e-1)" "unprognostic (1.14e-1)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (2.93e-3)" "unprognostic (2.27e-2)" "unprognostic (2.37e-2)" "unprognostic (2.02e-2)" "unprognostic (3.40e-2)" "unprognostic (3.29e-2)" "unprognostic (2.59e-3)" "unprognostic (9.14e-2)" "unprognostic (3.74e-6)" "unprognostic (1.22e-2)" "unprognostic (4.54e-2)" "unprognostic (1.62e-4)" "unprognostic (1.58e-1)" 2.3 4.1 3.4 4.1 8.9 0.8 2.4 4.2 4.1 5.5 4.0 2.8 3.5 4.9 8.8 2.7 7.0 3.3 4.7 79.9 2.5 2.4 2.3 2.8 2.9 1.9 3.1 2.3 3.6 1.9 2.7 3.5 1.8 2.8 5.4 2.7 2.7 3.5 5.3 7.9 4.2 3.0 16.0 3.4 2.0 2.8 4.9 3.7 2.8 2.2 7.2 3.9 7.7 6.2 3.6 2.4 0.4 2.1 4.9 7.8 2.0 13.2 7.1 9.0 3.4 9.9 12.1 3.7 6.4 3.2 8.1 6.7 9.8 5.3 2.1 6.5 15.6 6.0 24.4 9.3 5.5 9.4 1.0 6.5 6.9 6.6 7.1 9.0 6.0 5.2 9.0 6.1 6.9 3.8 6.2 7.7 6.8 8.8 2.2 11.1 6.0 1.8 3.4 4.9 6.1 3.6 5.5 2.5 1.4 5.2 18.2 5.2 3.3 4.3 4.3 3.4 7.0 4.0 9.2 5.4 8.0 4.4 5.3 1.7 5.4 7.4 9.8 10.1 10.5 7.3 0.0 0.8 0.4 4.3 2.1 3.9 3.6 3.4 4.2 2.4 3.5 4.1 3.5 0.1 4.9 0.8 1.8 7.8 2.0 3.4 8.9 4.2 4.1 2.5 2.4 3.1 2.3 2.8 3.7 0.0 0.6 0.8 16.5 9.6 7.7 94.8 5.1 2.7 2.3 0.0 31.4 6.8 5.0 3.4 108.6 4.5 1.3 0.0 1.2 5.6 4.6 5.1 0.0 2.1 1.7 7.9 1.2 4.9 2.2 112.4 2.8 1.3 1.7 0.0 2.0 2.7 3.9 0.0 3.5 1.4 15.6 0.0 6.2 4.4 4.7 8.5 9.0 2.2 2.4 22.3 C16orf87 ENSG00000155330 "Chromosome 16 open reading frame 87" Q6PH81 16 46796607-46831411 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 167.5;Spermatogonia: 106.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041179 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041179: AB_10795002" "unprognostic (2.44e-1)" "unprognostic (4.21e-1)" "unprognostic (2.91e-1)" "unprognostic (1.80e-1)" "unprognostic (1.63e-2)" "prognostic unfavorable (7.95e-5)" "unprognostic (1.74e-1)" "unprognostic (3.13e-2)" "unprognostic (3.21e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (6.57e-4)" "unprognostic (9.90e-2)" "unprognostic (1.35e-2)" "unprognostic (2.08e-2)" "unprognostic (2.66e-1)" "unprognostic (6.61e-3)" "unprognostic (1.84e-2)" 5.4 7.7 10.9 7.7 22.1 23.3 8.2 6.3 13.9 5.8 6.7 3.9 5.9 5.1 6.9 5.2 7.2 5.0 6.4 10.3 7.4 6.2 14.2 19.7 6.1 12.7 5.5 10.6 5.3 4.2 22.0 9.6 8.7 6.5 6.2 5.0 4.3 5.5 4.4 18.2 5.6 11.8 7.6 6.5 7.8 4.6 28.5 8.0 10.6 5.0 6.1 9.0 8.7 6.4 13.6 10.9 9.1 9.8 3.8 15.4 4.8 8.7 3.8 13.8 7.5 3.8 3.5 12.9 10.1 6.2 6.9 4.2 6.0 6.3 13.2 11.4 5.4 3.8 6.8 13.0 4.7 9.2 10.8 8.8 8.1 5.9 7.4 8.5 9.4 11.7 5.4 5.6 8.8 8.6 10.1 5.9 12.9 9.0 2.5 7.3 5.1 13.6 14.1 12.8 4.4 7.1 20.6 21.3 8.9 11.2 5.5 8.4 9.5 12.6 12.2 4.7 25.4 5.2 10.9 6.7 8.2 6.7 8.4 5.1 11.5 12.2 35.6 3.8 8.2 7.7 3.0 7.8 9.1 5.5 9.8 3.0 13.6 7.8 6.8 10.9 8.1 7.4 5.3 1.1 3.8 9.0 6.0 15.4 4.8 10.9 22.1 6.3 13.9 7.4 6.2 5.5 10.6 6.5 8.0 14.9 11.5 27.0 14.9 41.9 8.2 30.5 22.9 4.0 7.9 15.7 21.6 61.1 26.6 17.6 34.8 10.8 9.8 0.0 10.6 46.5 31.9 16.3 13.9 34.4 20.5 28.6 18.3 14.1 20.8 12.1 15.8 35.1 32.1 20.8 10.8 18.6 12.2 8.6 13.4 66.8 10.7 32.3 21.2 167.5 106.7 36.6 28.7 16.0 12.0 13.2 C17orf107 ENSG00000205710 "Chromosome 17 open reading frame 107" Q6ZR85 17 4899418-4902932 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 25.7;salivary gland: 26.0" "Group enriched" "Detected in many" 11 "Early spermatids: 54.2;Late spermatids: 207.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "neutrophil: 6.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.7" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 5.5;HMC-1: 7.3;hTCEpi: 6.7" "Not detected" "Not detected" HPA069713 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA069713: AB_2686181" "prognostic favorable (5.06e-5)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "unprognostic (1.51e-2)" "unprognostic (5.83e-2)" "unprognostic (1.13e-3)" "unprognostic (9.61e-2)" "unprognostic (5.03e-2)" "unprognostic (4.15e-1)" "unprognostic (2.05e-1)" "prognostic favorable (8.61e-4)" "unprognostic (1.17e-1)" "prognostic favorable (2.68e-4)" "unprognostic (9.29e-2)" "unprognostic (2.65e-1)" "unprognostic (2.71e-1)" "unprognostic (3.12e-1)" 2.4 3.7 5.0 2.3 5.1 4.2 3.0 7.7 8.7 3.9 1.4 0.2 5.9 2.1 1.9 5.9 1.3 1.8 3.3 15.3 3.8 4.3 2.2 8.8 2.9 1.0 1.6 4.2 6.4 7.7 6.2 25.7 1.5 1.7 4.5 0.9 2.1 26.0 6.4 0.6 3.3 1.6 1.2 2.2 2.1 4.6 4.7 0.6 0.1 1.9 0.6 2.7 3.3 1.9 0.0 0.0 6.7 0.2 0.0 0.9 0.1 0.7 0.8 1.0 0.3 2.2 1.7 1.5 3.9 0.5 0.2 0.6 0.7 0.7 0.4 0.6 5.5 0.0 1.4 0.1 0.5 0.3 0.1 0.8 2.1 0.6 0.8 3.1 0.0 7.3 1.8 6.7 0.1 0.4 0.2 0.2 0.2 0.1 0.1 0.1 0.7 0.1 0.6 0.3 1.9 0.8 0.3 0.2 2.9 0.3 0.3 0.1 0.5 0.6 2.3 0.3 0.5 0.7 1.1 0.5 0.3 0.7 0.6 0.5 0.6 0.6 0.1 0.5 0.1 0.3 0.0 0.2 0.8 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.8 6.7 0.0 0.1 0.0 0.0 0.1 5.0 5.1 7.7 8.7 3.8 4.3 1.6 4.2 1.7 0.6 0.0 2.2 0.9 2.5 1.5 0.5 12.3 0.0 0.0 1.2 0.0 0.0 0.3 1.7 0.3 54.2 0.7 0.0 0.0 1.1 1.6 2.2 2.2 11.5 3.4 0.9 4.8 0.0 0.6 1.5 207.3 1.4 4.3 1.7 0.0 1.6 0.0 0.8 0.0 1.1 1.6 0.6 0.0 3.1 1.0 1.1 1.1 4.3 0.7 0.2 0.9 C17orf50 ENSG00000270806 "Chromosome 17 open reading frame 50" Q8WW18 17 35760897-35765079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 63.6" "Group enriched" "Detected in some" 88 "Early spermatids: 590.0;Late spermatids: 956.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.3;dendritic cells: 3.5;T-cells: 3.7" "Cell line enriched" "Detected in some" 5 "HaCaT: 10.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA043184, HPA063464" Supported Nucleoplasm Yes NA Nucleoplasm "HPA043184: AB_2678358, HPA063464: " "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (4.36e-2)" "unprognostic (4.01e-2)" "unprognostic (5.84e-2)" "unprognostic (5.12e-3)" "unprognostic (2.04e-2)" "unprognostic (1.97e-2)" "unprognostic (7.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.14e-2)" "unprognostic (2.71e-1)" "unprognostic (6.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.54e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 3.5 0.0 0.6 0.2 3.7 0.6 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.9 2.2 0.1 0.0 0.6 0.0 0.3 0.0 0.5 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.6 1.9 2.3 2.0 1.2 0.0 1.9 3.5 3.7 0.0 0.2 0.0 3.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 590.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 956.8 7.8 0.0 0.0 0.0 0.6 1.0 0.0 0.0 5.3 0.5 0.0 6.5 0.0 8.4 6.1 0.0 0.0 0.0 0.6 0.1 C18orf54 "LAS2, MGC33382" ENSG00000166845 "Chromosome 18 open reading frame 54" Q8IYD9 18 54357917-54385218 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 21.4;testis: 25.2" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 73.3;Extravillous trophoblasts: 22.1;Late spermatids: 23.0;Spermatocytes: 34.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040704 Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA040704: AB_10959454" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (5.29e-2)" "unprognostic (8.63e-3)" "unprognostic (2.40e-1)" "unprognostic (1.05e-1)" "unprognostic (5.60e-6)" "unprognostic (1.11e-2)" "unprognostic (7.85e-3)" "unprognostic (2.55e-2)" "unprognostic (5.91e-3)" "unprognostic (1.13e-2)" "unprognostic (3.06e-5)" "unprognostic (2.29e-1)" "unprognostic (4.21e-1)" "unprognostic (1.28e-2)" "unprognostic (7.05e-2)" 2.9 1.3 2.8 4.8 7.7 2.0 2.1 4.5 4.3 4.1 2.4 3.8 1.0 1.3 3.6 1.1 2.0 1.9 2.1 2.0 3.3 2.2 1.6 0.9 2.5 4.0 10.0 3.4 2.5 1.1 1.9 1.0 21.4 5.7 1.8 2.3 0.7 1.4 1.6 1.0 1.8 2.0 2.7 5.8 4.3 1.5 25.2 6.7 9.3 1.9 1.2 4.0 2.1 3.2 1.4 0.6 1.9 4.1 0.8 2.1 0.6 5.8 3.4 14.6 6.9 3.6 6.3 4.9 9.7 4.2 9.8 12.6 2.2 3.1 4.3 2.7 3.2 4.3 6.3 10.1 5.3 12.8 14.4 3.2 4.2 3.7 3.7 0.8 4.8 4.6 2.1 1.1 13.3 6.2 4.2 11.7 5.7 4.4 9.4 14.0 1.8 5.2 3.0 7.2 1.1 6.7 4.0 10.8 3.0 4.8 4.0 8.1 4.6 4.0 1.7 2.2 8.7 2.5 4.1 10.5 18.2 8.0 3.0 5.3 5.7 6.4 6.4 4.8 8.2 12.8 1.9 0.7 0.3 1.3 0.8 1.2 0.9 1.1 0.9 0.6 1.4 1.0 1.2 0.0 0.8 4.1 0.3 2.1 0.6 2.8 7.7 4.5 4.3 3.3 2.2 10.0 3.4 5.7 6.7 0.0 1.1 0.0 0.6 0.3 1.6 1.2 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.1 73.3 2.6 0.1 0.0 0.2 22.1 1.5 0.3 0.0 0.0 2.1 0.0 0.0 4.9 2.8 23.0 1.4 1.7 1.7 1.8 0.6 2.3 0.3 0.0 0.7 0.2 0.7 0.0 1.4 34.4 16.0 0.4 1.7 0.7 0.8 0.7 C19orf47 FLJ36888 ENSG00000160392 "Chromosome 19 open reading frame 47" Q8N9M1 19 40319536-40348527 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 35.4;skeletal muscle: 118.0" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 20.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 20.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041843, HPA046309" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA041843: AB_10959886, HPA046309: AB_10960266" "prognostic favorable (6.50e-4)" "unprognostic (1.35e-3)" "unprognostic (1.80e-1)" "prognostic unfavorable (7.10e-5)" "unprognostic (2.75e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (2.26e-1)" "unprognostic (1.59e-1)" "unprognostic (1.63e-1)" "unprognostic (1.47e-2)" "unprognostic (3.25e-2)" "unprognostic (6.23e-2)" "unprognostic (1.62e-2)" "unprognostic (5.28e-2)" "unprognostic (2.77e-1)" "unprognostic (3.28e-2)" 3.2 2.9 4.5 4.2 5.7 4.7 4.4 5.8 9.1 3.5 3.3 9.2 3.6 3.8 3.8 3.1 7.4 2.8 3.5 35.4 4.2 3.8 2.9 4.4 3.4 4.5 6.2 5.0 3.6 3.8 3.7 3.7 4.8 5.6 4.5 2.5 3.6 4.9 4.6 118.0 5.2 3.6 3.7 4.8 3.7 3.0 10.0 5.3 5.0 3.8 6.4 4.7 4.1 5.0 2.1 1.6 20.2 1.6 1.7 2.3 1.3 12.9 19.9 8.4 9.1 5.0 4.5 11.6 13.4 6.2 12.7 15.4 16.5 5.4 15.1 7.5 6.3 6.7 6.5 10.2 12.3 5.3 18.5 12.5 12.3 12.4 12.5 3.7 12.4 8.0 4.5 7.3 17.1 6.1 3.4 7.7 14.1 15.0 8.9 10.7 12.6 18.5 7.0 5.4 10.4 7.6 18.4 13.8 7.6 4.1 11.4 10.8 8.8 14.4 13.6 5.2 5.2 8.1 10.3 10.1 16.0 11.2 10.8 18.3 10.7 14.7 15.0 6.8 11.9 11.0 20.2 1.6 4.7 1.3 1.4 1.6 1.6 2.3 2.1 1.6 2.1 1.6 1.2 5.7 1.7 1.6 1.6 1.6 1.3 4.5 5.7 5.8 9.1 4.2 3.8 6.2 5.0 5.6 5.3 3.0 3.2 0.0 2.4 4.2 2.9 39.1 2.5 1.4 2.3 0.0 2.0 9.1 0.0 3.2 8.0 3.7 2.9 0.0 3.9 11.7 4.7 1.6 4.6 3.8 5.8 3.2 3.5 5.5 5.6 17.1 1.7 2.6 5.0 2.8 2.8 2.9 3.3 0.0 6.3 2.4 1.8 6.5 2.1 14.9 5.5 6.0 13.3 2.2 2.3 1.4 C19orf57 MGC11271 ENSG00000132016 "Chromosome 19 open reading frame 57" Q0VDD7 19 13882348-13906452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.9" "Cell type enhanced" "Detected in many" 10 "Rod photoreceptor cells: 7.7;Spermatocytes: 16.3;Spermatogonia: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.9" "Group enriched" "Detected in many" 5 "dendritic cells: 2.6;T-cells: 4.9" "Low cell line specificity" "Detected in many" "HPA044012, HPA054615" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA044012: AB_10964782, HPA054615: AB_2682543" "unprognostic (1.71e-1)" "unprognostic (3.48e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.38e-4)" "unprognostic (2.12e-1)" "prognostic favorable (5.14e-4)" "unprognostic (5.01e-2)" "unprognostic (2.30e-1)" "unprognostic (1.06e-1)" "unprognostic (1.36e-1)" "unprognostic (7.60e-2)" "unprognostic (4.43e-2)" "unprognostic (1.57e-4)" "unprognostic (1.21e-3)" "unprognostic (2.46e-1)" "unprognostic (1.39e-1)" "unprognostic (5.73e-2)" 2.5 0.9 4.6 1.9 5.5 4.0 4.2 12.8 9.1 2.6 6.9 5.8 0.8 7.7 1.8 3.7 6.2 5.6 1.9 1.1 5.4 3.1 1.3 2.2 1.6 1.9 7.2 3.7 2.8 10.8 3.3 1.6 0.9 6.3 2.4 3.0 1.4 4.4 1.9 1.3 14.2 5.6 1.2 5.9 1.8 2.9 22.9 4.1 2.3 1.4 0.5 1.8 2.1 4.5 0.1 2.6 0.0 0.2 0.6 4.9 1.1 9.4 0.3 7.2 4.0 2.1 0.4 4.8 2.7 1.1 3.2 3.1 5.9 1.4 10.5 14.8 1.1 1.9 4.8 2.1 0.9 1.1 1.5 4.6 4.4 3.9 0.1 0.6 2.2 9.8 0.4 0.7 2.0 0.3 0.5 0.7 5.9 3.0 4.2 1.0 3.1 8.4 4.9 1.0 3.3 7.2 9.3 2.7 0.6 1.2 2.2 6.3 2.4 10.4 1.9 3.0 0.6 2.0 2.1 0.0 5.9 3.2 13.4 0.7 7.6 1.6 5.3 3.6 7.2 9.0 0.0 0.1 0.0 4.9 0.0 0.5 0.0 0.2 1.1 0.0 0.1 0.4 2.5 0.0 0.6 0.2 2.6 0.0 1.1 4.6 5.5 12.8 9.1 5.4 3.1 7.2 3.7 6.3 4.1 0.0 0.0 0.0 2.6 1.4 1.9 1.2 0.0 0.0 1.2 0.0 2.0 0.4 3.3 0.4 0.5 0.5 1.8 0.0 1.0 0.3 0.8 0.5 0.0 0.0 0.5 1.6 0.0 0.6 0.8 1.4 2.6 0.0 1.7 1.0 2.5 1.4 0.4 5.8 1.8 0.0 7.7 0.0 1.4 16.3 10.0 2.6 0.7 0.0 2.5 1.8 C1orf174 RP13-531C17.2 ENSG00000198912 "Chromosome 1 open reading frame 174" Q8IYL3 1 3889125-3900293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008270, HPA065778" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA008270: AB_1845633, HPA065778: AB_2685557" "unprognostic (4.91e-3)" "unprognostic (1.13e-1)" "unprognostic (1.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.38e-1)" "unprognostic (1.49e-2)" "prognostic unfavorable (5.84e-4)" "unprognostic (2.52e-1)" "prognostic unfavorable (7.62e-4)" "unprognostic (7.24e-2)" "unprognostic (5.36e-2)" "unprognostic (7.02e-2)" "prognostic unfavorable (2.73e-6)" "unprognostic (3.71e-2)" "unprognostic (3.95e-1)" "unprognostic (8.05e-2)" "unprognostic (1.46e-2)" 17.6 17.4 15.0 18.8 16.5 24.0 17.8 16.3 19.2 15.4 16.9 21.3 11.6 15.6 19.4 20.1 19.3 19.7 21.1 13.4 15.3 15.4 18.1 24.8 14.5 20.2 15.8 17.1 19.6 20.0 5.4 13.3 24.4 16.7 18.9 15.6 16.5 15.9 17.2 22.9 15.6 16.5 20.1 13.7 22.4 16.5 18.9 15.3 26.9 21.9 19.7 22.4 19.5 15.0 16.5 18.7 30.4 28.8 16.1 27.6 13.6 14.3 8.4 13.3 11.2 11.2 7.0 9.4 13.2 7.4 11.8 12.1 12.2 22.8 11.4 14.9 9.7 16.5 13.9 14.0 9.0 13.3 19.3 13.6 29.4 8.6 17.9 6.9 20.9 15.3 7.4 5.9 12.4 10.0 9.2 9.4 14.1 22.9 11.7 8.2 10.7 21.6 16.1 15.1 19.2 17.8 16.4 22.2 10.7 8.0 8.7 12.8 10.6 12.0 18.0 18.1 12.8 7.5 12.8 10.2 17.1 12.8 28.3 12.5 4.5 4.3 21.9 8.3 23.3 5.6 27.7 16.1 30.4 27.6 28.8 24.0 16.5 18.7 20.9 18.7 15.2 17.9 22.7 13.3 16.1 18.8 10.3 19.3 13.6 15.0 16.5 16.3 19.2 15.3 15.4 15.8 17.1 16.7 15.3 8.9 4.8 14.9 10.8 19.5 9.8 3.4 7.6 12.0 14.8 5.2 7.9 52.5 23.2 19.2 104.9 12.3 10.9 0.0 16.9 53.1 17.4 9.5 36.8 11.6 27.7 11.1 10.9 9.8 14.0 14.5 15.8 18.9 13.5 16.2 13.6 11.7 14.8 14.0 18.0 17.2 10.5 12.9 12.3 20.1 26.0 15.4 22.3 24.5 15.6 9.9 C1orf226 FLJ13137 ENSG00000239887 "Chromosome 1 open reading frame 226" A1L170 1 162366908-162386818 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 28.6" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 27.5;Early spermatids: 20.6;Hepatocytes: 22.6;Late spermatids: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 13.2;HEL: 16.9" "Low region specificity" "Detected in all" "HPA052251, HPA074060" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA052251: AB_2681775, HPA074060: " "prognostic favorable (2.60e-4)" "unprognostic (1.30e-1)" "unprognostic (2.69e-2)" "unprognostic (1.59e-2)" "unprognostic (6.71e-3)" "unprognostic (9.80e-2)" "unprognostic (8.55e-2)" "unprognostic (1.65e-1)" "unprognostic (2.05e-1)" "unprognostic (4.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-3)" "prognostic favorable (4.44e-5)" "unprognostic (9.34e-3)" "unprognostic (1.06e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.13e-4)" 1.5 8.2 1.5 3.4 1.5 1.2 7.1 4.8 2.0 3.7 18.0 1.5 1.5 4.9 1.9 1.6 4.4 2.5 3.2 1.5 1.6 2.4 5.2 15.2 3.0 1.5 1.8 1.5 2.0 3.5 1.4 6.9 18.9 1.5 3.2 8.3 2.0 8.2 7.6 1.5 3.3 28.6 2.4 2.3 2.2 5.8 2.7 1.5 1.5 1.5 7.4 5.1 2.2 1.5 0.0 0.0 0.8 0.7 0.0 0.0 0.2 13.2 0.7 10.9 8.3 0.3 0.0 0.2 1.2 1.1 0.8 0.4 1.5 6.1 0.0 9.1 0.2 4.0 9.7 3.2 0.7 0.5 0.2 4.4 16.9 0.5 7.4 0.2 0.0 0.1 1.2 0.8 0.0 0.6 3.0 3.3 1.8 1.4 0.1 0.2 4.3 0.6 0.0 6.8 11.9 6.1 0.2 1.7 0.0 9.3 5.4 4.7 3.2 4.5 1.2 2.6 4.2 4.9 0.7 2.3 0.0 1.4 0.2 3.3 6.3 0.0 0.0 1.6 0.2 0.7 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 1.5 1.5 4.8 2.0 1.6 2.4 1.8 1.5 1.5 1.5 3.0 1.6 0.0 1.4 0.7 0.7 3.3 2.5 1.4 1.2 14.0 27.5 0.0 0.0 0.8 20.6 1.1 8.0 0.0 2.0 0.1 0.6 3.7 0.0 22.6 0.1 6.4 2.4 3.7 1.0 30.4 2.0 0.0 0.0 0.0 10.3 6.5 1.7 3.5 1.8 0.0 0.3 0.0 0.2 0.7 0.7 1.3 0.1 0.0 5.6 2.0 C1orf52 "FLJ44982, gm117" ENSG00000162642 "Chromosome 1 open reading frame 52" Q8N6N3 1 85249953-85259672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036072, HPA061790" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036072: AB_10602696, HPA061790: AB_2684610" "unprognostic (1.59e-1)" "unprognostic (2.30e-1)" "unprognostic (5.97e-2)" "unprognostic (1.13e-2)" "unprognostic (4.06e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (5.37e-5)" "unprognostic (6.67e-3)" "unprognostic (2.95e-2)" "unprognostic (3.73e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (4.93e-4)" "prognostic unfavorable (1.17e-7)" "unprognostic (8.01e-2)" "unprognostic (2.54e-1)" "unprognostic (4.14e-1)" "unprognostic (2.05e-2)" 14.4 13.5 22.4 13.4 30.1 42.9 17.4 13.8 25.8 11.8 12.3 19.1 9.4 11.3 14.2 16.9 12.0 11.3 12.2 13.0 25.4 19.3 9.9 13.3 14.6 20.3 20.6 19.9 13.9 14.2 11.0 15.6 21.0 17.9 13.1 11.9 8.8 11.5 11.8 18.0 19.8 10.7 12.0 18.7 14.1 12.0 17.0 20.3 12.4 11.4 8.8 14.3 11.2 12.3 27.3 20.8 25.6 21.4 15.5 23.6 16.7 13.4 6.1 11.9 9.9 13.0 9.9 20.7 13.7 8.3 15.1 14.8 8.7 7.2 12.4 12.9 12.0 13.5 9.0 24.0 7.8 15.2 12.8 15.0 16.7 10.7 10.9 11.5 17.2 7.8 7.9 11.1 13.2 10.1 10.6 9.5 18.7 19.7 13.7 8.8 3.7 13.1 14.0 36.7 6.5 8.8 14.5 13.8 5.3 15.0 8.4 7.3 11.4 3.8 10.7 20.2 15.7 6.1 28.0 9.1 8.3 12.4 15.2 16.8 13.0 21.7 18.9 4.9 13.2 9.3 25.6 15.1 22.8 16.4 21.4 17.6 27.3 15.6 14.2 19.4 16.7 23.6 22.9 23.6 15.5 17.6 20.8 12.9 16.7 22.4 30.1 13.8 25.8 25.4 19.3 20.6 19.9 17.9 20.3 41.7 26.4 35.3 50.1 129.1 22.6 21.3 7.6 30.8 33.0 15.7 21.6 54.0 16.6 32.5 28.7 43.0 21.5 23.3 24.1 49.7 56.0 31.9 49.7 14.7 32.0 14.3 37.2 25.8 27.0 8.0 33.9 37.1 30.4 16.2 18.9 25.6 27.3 23.5 23.0 17.3 25.6 38.8 54.2 91.6 55.3 112.7 56.8 36.3 22.0 60.4 C1QTNF6 "CTRP6, ZACRP6" ENSG00000133466 "C1q and TNF related 6" Q9BXI9 22 37180167-37199385 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "endometrium 1: 23.7;placenta: 79.5" "Cell type enriched" "Detected in many" 12 "Extravillous trophoblasts: 349.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 45.0;RT4: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002042 Enhanced Approved Nucleoplasm "Secreted to blood" No No 354000000 Nucleoplasm "HPA002042: AB_1078342" "unprognostic (9.65e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.23e-3)" "unprognostic (1.25e-3)" "unprognostic (3.01e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (9.60e-6)" "unprognostic (6.96e-2)" "unprognostic (5.11e-2)" "unprognostic (2.61e-2)" "unprognostic (1.72e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.61e-2)" "unprognostic (5.36e-2)" "unprognostic (1.08e-3)" "unprognostic (1.52e-2)" 3.3 4.4 1.2 4.2 1.6 0.8 2.5 1.2 1.8 7.8 2.5 1.3 1.6 1.0 23.7 7.2 1.6 5.2 6.2 3.1 1.4 0.7 3.9 7.9 9.2 3.1 1.2 1.3 5.9 2.3 1.4 1.4 79.5 1.7 4.3 2.5 4.4 2.2 3.4 1.5 3.1 3.2 5.7 1.8 4.6 1.8 3.5 1.2 1.6 2.4 1.7 1.8 5.1 2.7 2.4 1.1 1.8 0.5 4.0 3.8 1.0 6.7 8.4 4.4 1.5 0.8 8.9 13.4 1.4 2.8 1.1 0.8 1.5 9.9 0.0 5.7 2.3 0.6 14.0 0.1 3.4 0.5 1.9 1.1 1.1 3.2 1.5 3.1 0.0 0.9 12.3 1.9 0.9 0.2 3.0 10.6 0.3 0.0 3.1 0.4 45.0 0.0 0.2 2.8 1.0 0.1 0.1 0.0 1.1 10.2 20.8 0.7 5.7 0.4 8.1 1.1 2.4 2.8 0.2 3.6 0.4 2.3 0.1 0.0 6.5 0.1 0.0 0.9 0.8 1.2 1.0 0.5 1.5 0.7 0.5 0.8 0.8 1.3 1.0 0.5 2.4 2.9 2.2 1.8 4.0 0.3 1.1 3.8 1.0 1.2 1.6 1.2 1.8 1.4 0.7 1.2 1.3 1.7 1.2 0.0 0.0 3.0 1.4 1.3 0.9 1.1 2.5 4.0 2.3 1.8 0.0 4.2 1.7 1.9 1.7 1.4 2.6 0.0 1.0 349.8 8.9 0.6 1.1 5.0 8.4 0.0 0.0 11.6 1.0 6.2 0.6 0.9 5.0 1.0 2.1 4.2 2.0 3.5 0.4 1.3 0.7 0.0 3.3 7.0 4.0 0.3 28.8 2.5 3.9 1.0 C22orf23 "EVG1, FLJ32787, LOC84645" ENSG00000128346 "Chromosome 22 open reading frame 23" Q9BZE7 22 37943050-37953669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 189.0" "Group enriched" "Detected in some" 4 "Early spermatids: 211.4;Late spermatids: 246.7;Spermatocytes: 159.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 17.1;U-138 MG: 17.6;U-87 MG: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000650 Approved Nucleoplasm NA NA Nucleoplasm "HPA000650: AB_2732391" "unprognostic (6.09e-3)" "unprognostic (3.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.99e-2)" "unprognostic (1.95e-1)" "unprognostic (1.80e-1)" "unprognostic (7.42e-5)" "unprognostic (1.50e-2)" "unprognostic (2.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.04e-1)" "unprognostic (5.80e-2)" "unprognostic (8.18e-3)" "unprognostic (4.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.82e-2)" "unprognostic (8.46e-2)" 0.9 0.9 1.3 2.0 1.8 0.7 0.8 1.7 3.3 1.2 4.1 2.8 0.8 0.8 3.7 2.8 6.1 6.0 2.5 1.8 1.7 1.7 1.2 1.1 2.7 1.0 1.9 2.0 2.2 3.4 0.1 2.2 2.0 5.5 1.8 0.0 2.0 4.1 1.4 1.8 11.3 1.2 1.2 3.2 0.8 3.8 189.0 1.2 0.8 3.4 0.9 0.9 5.2 1.6 0.7 0.3 0.9 0.2 0.1 1.4 0.2 3.5 2.8 6.2 5.7 0.1 0.2 7.6 9.8 0.3 0.3 0.4 3.3 3.2 1.8 2.9 0.2 6.4 17.1 0.2 0.1 0.3 3.5 7.3 1.0 2.3 2.3 0.2 2.8 2.5 0.2 0.1 1.1 0.1 8.6 0.0 1.4 1.2 1.1 0.0 2.2 0.1 1.7 0.9 3.5 2.5 3.3 8.8 0.7 0.1 15.6 3.1 2.3 4.6 1.7 5.5 10.4 2.1 3.9 14.9 17.6 5.9 13.7 5.2 2.5 1.1 0.9 26.5 1.3 9.9 0.9 0.1 0.0 1.3 0.2 1.4 0.7 0.3 0.1 0.0 0.7 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.2 1.3 1.8 1.7 1.8 1.7 1.7 1.9 2.0 5.5 1.2 0.0 3.7 0.0 0.1 0.2 0.1 0.0 0.0 50.9 2.3 0.0 0.0 0.1 1.7 0.3 211.4 0.0 0.0 0.0 0.3 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 246.7 6.4 0.0 0.0 0.0 0.0 2.0 0.2 0.0 4.9 1.4 0.5 0.0 0.0 159.9 4.3 0.0 0.0 0.0 0.0 0.0 C2CD2 "C21orf25, C21orf258, DKFZP586F0422, TMEM24L" ENSG00000157617 "C2 calcium dependent domain containing 2" Q9Y426 21 41885112-41953890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 56.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 51.0;Cone photoreceptor cells: 78.5;Ito cells: 42.4;Rod photoreceptor cells: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 38.7;SK-BR-3: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030922, HPA030924" Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA030922: AB_2673660, HPA030924: AB_10669873" "unprognostic (3.02e-3)" "unprognostic (3.69e-2)" "unprognostic (2.21e-2)" "unprognostic (9.63e-2)" "unprognostic (3.15e-3)" "unprognostic (2.93e-2)" "unprognostic (2.39e-2)" "unprognostic (3.44e-2)" "unprognostic (3.00e-2)" "unprognostic (4.39e-2)" "unprognostic (2.43e-1)" "unprognostic (2.38e-1)" "prognostic unfavorable (7.68e-5)" "unprognostic (1.99e-1)" "unprognostic (4.56e-2)" "unprognostic (1.06e-2)" "unprognostic (1.48e-1)" 23.9 56.9 5.4 6.1 8.0 1.1 21.0 2.7 7.0 5.8 5.8 7.6 10.9 3.5 6.3 6.1 5.4 4.9 7.8 3.6 5.9 5.1 5.3 4.2 9.6 9.1 12.8 4.5 11.7 10.7 19.4 3.8 4.2 10.9 8.8 4.3 11.8 8.1 9.4 2.7 10.1 4.4 5.6 11.7 20.7 5.7 2.7 9.1 5.7 4.8 3.9 5.3 7.0 23.9 1.1 1.4 0.9 1.3 1.9 2.8 0.7 6.1 2.6 1.8 4.2 38.7 10.7 7.2 4.3 6.8 2.7 2.5 4.0 7.0 0.1 2.4 8.4 6.7 0.7 6.5 4.5 3.5 0.4 2.9 1.1 3.2 3.2 5.2 0.4 0.0 6.8 4.2 14.5 5.7 6.0 12.8 0.3 3.8 0.0 7.2 0.5 0.9 1.2 10.2 2.6 8.9 0.6 2.7 3.7 4.0 13.0 3.0 1.3 4.7 21.3 3.8 3.8 5.6 2.7 4.4 6.5 0.9 2.1 3.5 2.4 3.5 0.5 19.0 3.6 1.3 0.0 1.3 0.0 1.3 0.8 0.5 0.5 1.2 0.5 1.4 1.1 2.8 1.6 0.9 1.9 0.7 0.2 1.5 0.7 5.4 8.0 2.7 7.0 5.9 5.1 12.8 4.5 10.9 9.1 3.0 13.3 6.4 6.8 3.7 51.0 2.0 5.1 4.0 5.7 3.5 78.5 9.6 0.0 5.0 0.1 12.0 2.3 0.0 7.1 3.7 6.1 12.9 0.0 4.5 3.2 1.6 4.7 42.4 7.8 0.0 3.4 2.9 1.7 0.0 7.3 3.5 7.9 6.8 2.1 2.8 35.1 12.9 15.6 0.0 2.3 2.3 7.8 1.7 7.1 12.4 C2orf42 FLJ20558 ENSG00000115998 "Chromosome 2 open reading frame 42" Q9NWW7 2 70149880-70248615 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.2" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 194.1;Late spermatids: 86.2;Spermatocytes: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031840, HPA031841, HPA031842" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031840: AB_2674066, HPA031841: AB_10601124, HPA031842: AB_2674068" "unprognostic (8.49e-2)" "unprognostic (2.09e-1)" "unprognostic (2.52e-1)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" "unprognostic (3.41e-1)" "unprognostic (1.92e-1)" "unprognostic (2.20e-3)" "unprognostic (2.26e-1)" "unprognostic (3.73e-1)" "prognostic favorable (5.94e-5)" "unprognostic (4.66e-2)" "unprognostic (9.41e-2)" "unprognostic (2.11e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (2.49e-3)" 6.2 5.9 6.2 4.3 8.7 3.1 6.8 10.7 11.8 6.4 4.5 11.5 6.6 3.2 6.6 8.5 5.0 8.7 5.7 4.2 7.2 6.4 6.3 11.2 4.5 8.2 7.3 6.2 8.3 5.0 8.6 8.2 5.9 6.7 5.0 4.0 7.4 4.6 5.8 4.8 4.9 4.6 5.8 6.1 6.7 4.4 41.2 8.2 9.7 6.2 2.1 8.3 6.2 7.5 12.8 6.6 8.0 6.6 17.9 14.2 9.0 4.9 8.4 8.0 7.2 15.9 9.8 9.0 12.0 8.0 10.1 8.4 6.4 4.6 6.2 7.0 7.5 16.1 7.0 8.1 6.8 10.7 11.0 7.2 7.5 5.9 6.4 14.2 6.2 7.6 11.6 13.0 9.2 11.9 10.5 9.3 8.2 6.3 24.8 12.7 4.7 8.0 8.8 5.6 8.4 9.0 7.7 10.7 11.5 8.2 6.0 6.6 6.6 6.4 11.0 12.1 5.7 4.7 7.5 7.2 8.8 6.1 8.1 9.6 13.3 13.2 6.4 7.2 10.0 7.7 1.9 6.6 8.0 11.2 6.1 14.2 12.8 11.4 13.4 6.6 11.5 13.2 13.7 7.0 17.9 6.1 6.0 12.6 9.0 6.2 8.7 10.7 11.8 7.2 6.4 7.3 6.2 6.7 8.2 0.0 2.1 11.8 2.6 2.3 6.6 2.4 0.0 5.3 1.2 5.2 0.0 7.4 6.6 3.1 194.1 2.6 2.9 0.0 2.1 3.0 4.0 2.7 2.3 5.8 3.8 0.0 1.2 5.5 3.5 86.2 6.9 2.7 3.3 1.0 2.2 7.0 1.7 2.9 7.4 5.4 3.9 0.0 3.1 42.3 11.7 3.8 8.0 6.4 2.1 1.8 C4orf46 "LOC201725, RCDG1" ENSG00000205208 "Chromosome 4 open reading frame 46" Q504U0 4 158666679-158672255 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.3" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047287, HPA052670" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047287: AB_2680011, HPA052670: " "unprognostic (2.71e-1)" "unprognostic (2.38e-1)" "unprognostic (1.41e-2)" "unprognostic (2.57e-1)" "unprognostic (2.26e-1)" "unprognostic (6.10e-2)" "unprognostic (6.27e-5)" "unprognostic (1.60e-1)" "unprognostic (4.71e-2)" "unprognostic (4.20e-2)" "unprognostic (1.35e-1)" "unprognostic (5.29e-2)" "unprognostic (4.56e-2)" "unprognostic (5.15e-2)" "unprognostic (1.19e-1)" "unprognostic (5.69e-2)" "unprognostic (9.06e-3)" 4.5 4.6 4.2 5.4 5.6 16.7 4.3 6.4 5.5 5.4 4.5 10.7 2.4 4.2 7.2 5.1 5.5 4.2 4.0 5.1 4.5 3.7 3.9 2.7 4.8 7.7 7.3 3.5 6.4 5.8 2.2 3.1 6.3 5.3 4.1 6.1 7.2 4.1 3.4 2.8 4.1 4.4 5.7 6.6 5.4 4.3 25.5 7.3 26.3 6.1 5.8 7.2 5.3 5.0 4.0 5.1 4.9 4.9 8.6 5.8 3.4 6.9 4.2 10.4 15.3 4.6 4.8 5.2 11.9 8.2 13.8 12.1 3.7 6.3 12.5 1.9 6.0 5.1 3.9 9.0 6.1 18.1 17.0 4.6 18.8 4.8 5.0 1.6 14.3 10.4 2.8 2.2 11.2 4.9 4.6 10.0 12.6 8.2 31.5 18.9 3.7 27.2 12.9 7.1 4.5 5.6 19.8 5.9 5.5 4.2 3.5 5.7 17.3 5.2 4.8 4.3 5.4 4.0 11.5 5.3 21.5 9.8 11.9 9.8 7.2 9.1 15.7 5.4 12.8 8.2 4.9 4.7 4.5 4.9 3.9 3.7 4.0 4.0 4.8 5.1 3.9 5.5 5.8 1.6 8.6 4.9 4.4 4.1 3.4 4.2 5.6 6.4 5.5 4.5 3.7 7.3 3.5 5.3 7.3 3.0 2.6 10.0 5.2 21.4 5.6 3.6 0.0 1.4 0.0 1.8 3.9 7.4 6.6 3.2 0.9 4.5 2.6 0.0 2.6 9.4 12.3 4.9 6.9 2.1 8.0 9.5 7.5 4.3 10.8 1.5 4.4 4.4 18.6 27.1 4.0 4.2 4.0 2.9 5.6 2.1 25.5 6.5 8.2 32.0 14.2 13.7 2.7 7.7 3.6 4.1 C5orf24 FLJ37562 ENSG00000181904 "Chromosome 5 open reading frame 24" Q7Z6I8 5 134845680-134859737 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057749, HPA062502" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA057749: AB_2683515, HPA062502: AB_2684785" "unprognostic (8.10e-2)" "unprognostic (1.59e-1)" "unprognostic (8.33e-3)" "unprognostic (2.03e-1)" "unprognostic (2.72e-2)" "unprognostic (9.45e-2)" "unprognostic (3.27e-2)" "unprognostic (3.31e-2)" "unprognostic (1.72e-2)" "unprognostic (2.04e-1)" "unprognostic (1.54e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (5.86e-4)" "unprognostic (6.55e-2)" "unprognostic (2.37e-1)" "unprognostic (5.04e-2)" "unprognostic (4.75e-2)" 22.8 26.7 24.1 16.7 32.6 20.8 37.7 44.8 38.2 22.0 21.5 19.8 17.0 21.7 29.7 16.7 22.8 18.3 21.5 23.2 24.9 23.8 40.7 41.8 22.6 21.3 22.2 23.0 21.0 14.9 30.2 18.5 27.9 22.7 22.6 19.0 21.4 18.0 20.4 21.0 18.9 20.2 29.8 32.5 20.3 17.6 14.6 22.4 15.4 30.0 12.1 14.2 24.6 18.5 8.4 12.9 11.1 11.3 6.4 9.3 4.4 10.4 8.8 18.2 26.5 22.8 26.8 6.6 22.4 15.9 12.5 15.0 11.7 11.9 9.7 19.6 15.9 15.8 7.1 10.3 15.5 21.7 7.2 14.7 10.9 20.9 13.6 17.3 4.7 13.0 22.0 19.0 17.9 20.6 25.0 22.8 16.2 7.5 12.1 26.9 5.9 10.2 8.2 4.1 6.5 9.1 11.8 17.4 10.9 31.6 9.7 11.4 21.7 23.3 6.2 32.7 8.5 12.8 15.4 25.0 25.2 10.9 18.3 16.0 12.7 9.1 12.0 18.4 13.4 18.6 5.0 11.3 11.1 7.3 8.5 5.9 8.4 4.9 5.8 9.4 8.2 9.3 5.6 2.2 6.4 7.0 12.9 5.7 4.4 24.1 32.6 44.8 38.2 24.9 23.8 22.2 23.0 22.7 22.4 80.4 28.5 30.5 26.6 38.2 47.6 28.9 63.7 25.4 25.0 101.2 35.3 27.3 49.7 45.6 11.7 89.4 26.4 0.0 37.8 30.6 51.2 28.9 20.8 78.4 27.7 65.2 51.8 68.2 24.8 5.4 65.3 35.6 60.8 26.2 29.8 25.5 61.7 35.1 67.1 91.2 43.2 71.1 80.9 50.1 50.3 43.2 18.5 38.9 31.6 21.1 C6orf163 ENSG00000203872 "Chromosome 6 open reading frame 163" Q5TEZ5 6 87344849-87365463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 20.2" "Group enriched" "Detected in some" 26 "Early spermatids: 164.9;Late spermatids: 171.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 4 "basal ganglia: 1.4" "Low region specificity" "Detected in all" "HPA044797, HPA052927" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044797: AB_10962365, HPA052927: AB_2681990" "unprognostic (4.98e-2)" "unprognostic (6.42e-2)" "unprognostic (1.65e-1)" "unprognostic (2.33e-2)" "unprognostic (4.18e-2)" "unprognostic (3.49e-2)" "unprognostic (7.55e-3)" "unprognostic (3.96e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-2)" "unprognostic (5.60e-4)" "unprognostic (6.66e-2)" "unprognostic (3.77e-3)" "unprognostic (1.46e-1)" "unprognostic (1.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.42e-2)" 0.7 0.8 0.5 0.5 4.3 3.2 1.3 0.7 1.0 0.8 0.8 1.5 0.5 0.0 1.4 3.0 0.5 2.3 0.5 1.0 0.9 0.4 0.6 0.9 1.7 0.9 0.5 0.5 3.3 1.1 1.7 1.8 0.5 4.6 1.2 1.2 0.5 1.2 0.5 1.5 2.4 1.1 0.5 0.5 1.7 0.8 20.2 1.2 0.5 1.1 0.5 0.8 0.6 0.6 1.4 0.7 3.4 0.9 1.2 1.8 0.4 0.2 0.6 3.0 4.5 0.5 3.3 3.6 0.0 0.0 0.6 1.0 1.3 0.9 1.8 0.5 0.4 1.9 0.8 1.2 2.6 0.0 1.6 1.8 2.3 1.0 1.0 0.0 1.1 0.6 1.6 1.5 0.8 0.8 1.3 0.5 1.9 3.5 1.6 0.4 0.7 0.3 1.5 0.7 0.1 0.2 4.0 1.0 0.1 1.9 2.9 2.3 1.2 0.3 0.5 1.2 3.2 0.6 1.3 1.0 1.8 1.4 0.9 1.4 0.5 0.8 0.3 0.2 2.1 1.1 0.5 0.7 0.3 1.8 0.4 0.9 1.3 1.8 1.2 0.7 1.4 1.7 1.8 3.4 1.2 0.9 0.4 1.0 0.4 0.5 4.3 0.7 1.0 0.9 0.4 0.5 0.5 4.6 1.2 0.0 0.3 0.0 0.3 0.3 0.6 1.7 2.5 1.4 0.0 0.0 0.0 0.4 0.0 0.1 164.9 0.0 0.2 0.0 0.0 0.3 0.4 0.4 0.0 0.2 0.2 0.0 0.0 0.0 1.2 171.0 2.3 0.0 1.7 0.0 0.3 0.0 0.1 0.0 1.8 0.4 0.5 6.5 0.4 2.1 1.6 0.1 0.7 0.0 0.2 0.3 C7orf55-LUC7L2 ENSG00000269955 "C7orf55-LUC7L2 readthrough" 7 139341360-139422599 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 80.5;Melanocytes: 75.9;Smooth muscle cells: 39.2;Suprabasal keratinocytes: 78.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045663, HPA051631" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045663: AB_2679410, HPA051631: AB_2681558" "unprognostic (2.54e-1)" "unprognostic (5.27e-2)" "unprognostic (3.21e-2)" "unprognostic (1.33e-3)" "unprognostic (1.38e-1)" "unprognostic (2.46e-3)" "unprognostic (1.68e-2)" "unprognostic (4.48e-2)" "unprognostic (2.26e-1)" "unprognostic (1.76e-3)" "unprognostic (1.10e-1)" "unprognostic (3.12e-2)" "unprognostic (6.42e-3)" 14.4 17.5 10.1 9.7 19.2 7.6 11.7 11.2 21.2 9.8 10.6 8.3 17.2 13.4 13.8 14.3 8.1 10.5 11.1 30.3 8.7 6.7 13.3 14.8 8.9 9.1 14.7 11.7 16.5 25.1 6.9 9.1 8.5 13.9 10.9 6.1 8.2 13.9 15.1 57.2 7.8 11.6 9.3 9.5 10.4 13.5 7.4 13.6 6.1 17.5 21.2 6.2 10.7 12.4 18.6 18.3 17.0 14.8 18.8 21.1 12.6 13.4 19.4 24.0 13.8 10.2 7.2 9.1 10.6 7.1 13.3 10.7 15.3 15.2 15.4 19.2 8.0 17.3 10.6 25.4 9.1 4.3 10.3 5.1 20.1 19.6 12.4 10.0 24.4 16.8 6.3 6.8 12.4 8.1 7.4 9.3 8.6 25.1 20.8 8.3 19.8 36.0 4.0 19.4 18.5 4.9 23.5 18.0 20.6 3.0 9.5 20.2 20.8 14.5 11.4 13.9 4.9 8.5 10.5 10.2 9.5 8.9 9.7 16.0 19.3 16.4 28.4 17.7 16.0 17.0 9.7 12.9 17.0 19.0 12.6 17.8 18.6 18.4 19.5 18.3 18.5 21.1 18.8 4.3 18.8 14.8 15.0 19.8 12.6 10.1 19.2 11.2 21.2 8.7 6.7 14.7 11.7 13.9 13.6 6.0 5.8 0.0 0.0 80.5 0.0 22.1 0.0 14.7 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 20.7 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 1.7 75.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 0.0 0.0 78.7 0.0 0.0 0.0 0.0 C8orf44 FLJ11267 ENSG00000213865 "Chromosome 8 open reading frame 44" Q96CB5 8 66667615-66685564 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043660, HPA054753" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043660: AB_10794889, HPA054753: AB_2682592" "unprognostic (6.19e-2)" "unprognostic (7.50e-2)" "unprognostic (3.09e-2)" "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (2.53e-1)" "unprognostic (8.61e-3)" "unprognostic (8.20e-3)" "unprognostic (4.42e-2)" "unprognostic (2.73e-2)" "prognostic favorable (4.21e-4)" "unprognostic (7.35e-2)" "prognostic unfavorable (1.08e-7)" "unprognostic (4.01e-2)" "unprognostic (9.35e-2)" "unprognostic (1.49e-1)" "prognostic favorable (2.68e-6)" 5.8 4.5 15.8 6.1 18.1 8.6 9.6 16.6 14.9 6.6 5.3 10.4 7.2 4.3 8.4 27.7 4.2 7.7 5.6 5.8 10.6 7.7 5.9 4.0 4.7 10.1 11.4 9.0 10.2 4.6 6.8 14.6 5.8 8.6 6.8 8.3 8.9 7.7 7.0 11.6 12.4 5.3 5.9 9.2 7.5 6.4 15.3 11.5 9.4 10.8 3.0 8.0 6.8 6.0 5.8 4.4 5.7 3.1 0.6 3.8 1.5 8.7 3.4 5.8 4.1 3.5 6.9 3.2 2.4 2.3 3.3 3.9 3.5 9.9 9.8 1.6 4.1 4.7 6.0 5.5 2.1 4.6 7.3 5.3 8.3 10.5 7.2 2.8 3.7 5.9 5.8 4.9 4.4 4.8 6.5 4.1 10.9 9.4 6.5 3.3 3.2 4.1 5.1 5.0 6.5 4.3 4.0 1.9 2.0 4.8 1.8 4.7 3.8 2.6 1.7 3.1 4.3 5.8 2.4 5.9 3.5 4.7 3.4 1.5 7.7 2.6 4.0 5.7 4.0 1.8 5.7 3.1 4.0 1.9 2.5 1.4 5.8 2.4 2.2 2.6 4.8 3.8 2.8 3.6 0.6 1.3 4.4 3.4 1.5 15.8 18.1 16.6 14.9 10.6 7.7 11.4 9.0 8.6 11.5 3.0 3.4 3.7 5.3 0.6 8.6 26.0 0.0 5.3 4.5 7.0 7.9 2.7 10.0 2.0 0.9 3.8 2.6 0.0 3.4 1.6 4.4 4.8 3.5 2.4 2.6 1.6 6.3 3.7 4.4 1.3 8.6 4.9 1.7 1.8 3.6 7.0 2.4 4.3 8.5 3.3 6.0 12.9 3.9 16.4 5.7 1.4 1.4 2.9 3.3 3.4 C8orf74 ENSG00000171060 "Chromosome 8 open reading frame 74" Q6P047 8 10672637-10700593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 30.2" "Group enriched" "Detected in some" 103 "Early spermatids: 154.4;Late spermatids: 281.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A549: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA027986 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA027986: AB_10600762" "unprognostic (4.24e-2)" "unprognostic (5.62e-2)" "unprognostic (4.68e-2)" "unprognostic (5.54e-2)" "unprognostic (2.37e-2)" "unprognostic (1.56e-4)" "unprognostic (6.82e-2)" "unprognostic (2.20e-2)" 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.6 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 1.4 0.0 0.1 0.0 0.2 0.1 30.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.5 0.1 0.0 0.6 1.4 0.5 0.9 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.8 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.1 0.3 0.0 0.5 0.5 0.3 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.8 0.8 0.3 0.3 0.0 0.2 0.1 0.3 0.3 0.0 0.3 0.1 0.2 0.3 0.4 0.5 0.1 0.5 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 154.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 281.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.0 C8orf82 MGC70857 ENSG00000213563 "Chromosome 8 open reading frame 82" Q6P1X6 8 144525733-144529132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 117.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034331 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB034331: AB_1565393" "unprognostic (3.56e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (1.63e-2)" "unprognostic (8.60e-2)" "unprognostic (6.31e-3)" "unprognostic (1.95e-1)" "unprognostic (4.57e-2)" "unprognostic (3.82e-1)" "unprognostic (1.22e-1)" "unprognostic (3.61e-1)" "unprognostic (4.09e-2)" "prognostic favorable (1.70e-5)" "unprognostic (5.72e-3)" "unprognostic (3.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.87e-3)" 11.1 11.4 7.9 10.6 8.1 4.2 16.1 8.6 11.6 14.2 19.4 7.8 8.1 16.8 10.2 10.4 13.3 9.3 14.7 16.3 8.1 6.1 12.7 29.1 7.9 8.9 8.8 7.8 13.4 17.5 19.7 10.2 7.1 6.3 32.8 6.4 8.2 18.0 11.4 12.2 8.9 17.7 7.4 5.1 11.0 12.2 12.7 8.0 8.5 14.8 10.3 7.0 12.4 9.6 1.7 1.5 1.7 2.1 0.9 1.2 0.3 3.6 9.4 5.6 4.5 2.3 2.0 4.7 4.0 2.2 2.2 2.2 4.6 6.3 6.5 6.5 2.5 1.9 4.5 1.2 1.3 0.8 4.9 14.6 12.6 5.4 8.5 2.4 1.9 6.1 3.0 3.1 1.4 1.4 3.6 1.5 3.7 10.2 3.3 1.6 19.5 4.7 7.7 3.0 5.5 26.6 5.4 1.9 3.1 3.4 5.6 19.2 15.6 6.1 4.4 3.9 2.0 8.1 3.9 8.1 4.3 16.7 4.7 2.8 2.4 1.5 5.1 5.7 2.4 4.1 0.8 2.1 1.7 0.6 0.8 0.7 1.4 0.2 0.6 0.9 1.7 0.6 0.7 0.0 0.9 1.7 1.5 1.2 0.3 7.9 8.1 8.6 11.6 8.1 6.1 8.8 7.8 6.3 8.0 3.0 8.6 8.8 41.8 14.2 30.4 14.5 15.3 0.0 1.2 15.7 13.7 26.9 117.7 3.8 12.7 6.7 36.0 0.0 6.5 29.6 15.4 46.1 5.7 63.1 16.7 27.0 32.8 8.0 12.0 15.6 22.5 16.8 32.1 2.8 28.3 26.3 6.6 17.3 19.1 83.0 30.6 32.3 25.4 30.2 18.1 18.2 21.1 11.4 31.0 38.8 C9orf78 "HCA59, HSPC220" ENSG00000136819 "Chromosome 9 open reading frame 78" Q9NZ63 9 129827290-129835863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021216, HPA021232, HPA021242" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "HPA021216: AB_1845836, HPA021232: AB_1845837, HPA021242: AB_1845838" "unprognostic (1.00e-1)" "unprognostic (4.23e-3)" "unprognostic (1.03e-2)" "unprognostic (1.83e-1)" "unprognostic (3.35e-2)" "unprognostic (7.03e-2)" "unprognostic (3.50e-2)" "unprognostic (6.02e-3)" "unprognostic (1.27e-1)" "unprognostic (1.26e-1)" "unprognostic (1.13e-2)" "unprognostic (1.43e-2)" "prognostic favorable (3.49e-7)" "unprognostic (5.34e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" 23.9 29.0 42.7 24.5 44.0 73.8 28.0 37.0 34.5 24.0 24.7 27.6 25.5 21.8 24.1 28.9 26.2 21.5 24.8 28.7 40.3 39.6 44.8 41.7 21.8 35.7 39.5 30.8 31.1 26.3 20.9 26.6 24.5 29.3 27.5 27.6 18.0 26.7 26.4 45.8 27.8 25.9 28.9 38.7 28.1 22.5 32.3 32.8 42.0 33.6 23.5 34.0 32.4 31.3 28.5 22.9 57.6 43.6 37.8 52.8 34.4 9.3 9.3 10.0 15.6 17.9 12.1 12.4 13.6 11.0 12.2 8.9 9.7 9.9 14.6 11.0 15.5 19.2 20.1 13.7 11.6 10.2 14.3 9.8 23.3 16.6 10.2 11.9 33.8 24.1 11.0 20.6 14.9 12.7 12.3 11.1 62.7 58.3 17.9 14.8 22.4 43.3 43.5 14.8 38.1 22.3 12.5 15.4 30.9 12.2 6.4 8.3 15.8 20.5 19.1 16.3 9.9 16.7 23.9 12.5 18.2 13.8 17.8 17.1 8.0 23.2 23.8 15.1 27.5 14.9 36.4 23.3 57.6 44.4 35.3 43.9 28.5 46.4 48.0 19.2 28.1 52.8 48.2 18.0 37.8 43.6 22.9 48.9 34.4 42.7 44.0 37.0 34.5 40.3 39.6 39.5 30.8 29.3 32.8 83.4 75.8 65.1 59.9 69.4 38.3 50.4 61.1 103.1 105.8 54.1 35.3 62.3 106.1 56.0 34.8 56.1 58.8 186.9 78.2 64.8 51.4 57.1 128.5 71.9 59.9 30.2 81.0 35.6 56.4 11.6 54.7 75.9 69.2 90.2 53.5 48.4 55.0 38.6 57.3 121.7 34.8 77.6 67.6 82.1 101.3 74.3 56.5 139.4 52.1 49.2 CACFD1 "C9orf7, D9S2135, flower" ENSG00000160325 "Calcium channel flower domain containing 1" Q9UGQ2 9 133459965-133470848 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015280 Approved Nucleoplasm NA NA Nucleoplasm "HPA015280: AB_1845833" "unprognostic (3.15e-2)" "unprognostic (4.25e-1)" "unprognostic (1.96e-3)" "unprognostic (4.48e-1)" "unprognostic (2.77e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-2)" "unprognostic (5.49e-2)" "unprognostic (3.97e-1)" "unprognostic (3.17e-1)" "unprognostic (1.67e-3)" "unprognostic (3.91e-2)" "prognostic favorable (2.83e-8)" "unprognostic (5.10e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (3.99e-3)" 2.8 7.0 7.2 7.4 6.9 3.5 11.4 8.5 9.4 5.7 14.0 9.4 5.9 18.9 6.7 16.9 8.4 7.3 15.8 9.1 6.5 5.5 19.1 33.7 9.8 8.6 12.3 6.7 7.7 16.6 10.6 12.6 5.3 8.4 8.3 8.3 6.9 9.9 10.3 5.2 3.3 17.9 6.3 8.7 5.0 22.1 13.7 8.6 4.4 13.7 3.7 3.8 8.7 12.6 4.2 1.3 7.6 1.4 2.7 1.0 1.1 0.8 3.7 8.1 5.0 1.7 0.8 5.1 2.5 3.4 2.3 0.8 8.1 6.7 1.0 8.1 3.4 3.9 1.6 2.5 2.0 0.1 1.4 3.0 0.6 5.3 5.6 4.3 0.0 1.0 1.8 5.5 1.8 1.3 6.6 3.0 1.9 1.4 2.7 2.6 9.4 1.0 1.4 4.9 8.2 3.1 2.1 2.1 7.1 4.7 3.6 10.2 11.4 3.2 13.8 2.0 3.3 15.9 1.8 1.4 5.5 5.2 1.5 0.3 4.6 5.5 3.0 2.1 0.6 1.9 3.7 1.4 7.6 0.8 1.1 0.6 3.5 0.7 1.0 1.3 4.2 0.4 0.7 0.2 2.7 0.9 0.5 0.5 1.1 7.2 6.9 8.5 9.4 6.5 5.5 12.3 6.7 8.4 8.6 17.9 15.8 1.4 4.6 2.5 4.4 7.0 28.1 1.4 6.8 19.2 11.8 1.9 3.3 17.8 10.8 2.3 46.4 0.0 28.6 3.0 5.1 9.4 4.6 38.0 2.9 3.2 27.9 6.2 5.6 6.2 7.5 1.8 5.0 4.6 36.5 6.0 22.8 42.1 7.1 14.4 9.7 0.0 4.2 12.5 6.5 1.4 2.4 1.8 12.8 5.5 CACNA2D3 HSA272268 ENSG00000157445 "Calcium voltage-gated channel auxiliary subunit alpha2delta 3" Q8IZS8 3 54122547-55074557 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;skeletal muscle: 19.5" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 28.9;Early spermatids: 77.9;Late spermatids: 41.2;Syncytiotrophoblasts: 56.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.2;HAP1: 2.8;HeLa: 14.0" "Low region specificity" "Detected in all" HPA030849 Uncertain Nucleoplasm NA NA 49000 Nucleoplasm "HPA030849: " "unprognostic (6.92e-2)" "unprognostic (1.35e-2)" "unprognostic (1.89e-1)" "unprognostic (4.34e-5)" "unprognostic (5.53e-3)" "unprognostic (2.64e-3)" "unprognostic (3.24e-1)" "unprognostic (1.17e-2)" "unprognostic (5.84e-3)" "unprognostic (7.22e-3)" "unprognostic (1.14e-2)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (1.47e-3)" "unprognostic (2.19e-1)" "unprognostic (3.62e-2)" "unprognostic (6.95e-2)" 1.5 10.3 6.4 1.3 21.9 1.0 1.5 2.4 23.2 1.5 2.0 1.4 0.2 1.4 1.4 4.0 2.1 2.1 1.6 5.1 8.9 8.0 3.8 1.1 2.2 2.2 4.8 12.8 6.7 1.2 1.1 2.4 2.1 9.0 3.4 1.7 2.4 1.9 4.4 19.5 1.2 1.7 2.4 1.7 1.6 1.9 3.9 4.2 0.0 2.1 3.6 2.1 1.0 2.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 1.7 0.2 14.0 0.0 0.8 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.2 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 6.4 21.9 2.4 16.1 8.9 8.0 4.8 12.8 9.0 4.2 0.0 0.0 0.0 0.3 0.2 9.8 28.9 0.0 1.4 1.2 0.0 7.9 8.4 6.6 0.0 77.9 0.1 0.0 0.0 0.6 2.3 2.4 0.2 0.0 0.0 5.4 0.0 0.0 0.6 7.9 41.2 2.6 10.3 0.0 0.0 0.0 4.3 0.8 0.0 1.4 0.1 1.3 6.5 1.9 5.0 2.2 0.1 56.9 0.0 0.0 0.4 CACUL1 "C10orf46, CAC1, FLJ40409, MGC33215" ENSG00000151893 "CDK2 associated cullin domain 1" Q86Y37 10 118674167-118755249 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 177.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050611 Approved Nucleoplasm NA NA Nucleoplasm "HPA050611: AB_2797238" "unprognostic (1.48e-1)" "unprognostic (1.15e-2)" "unprognostic (2.83e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (1.34e-5)" "unprognostic (3.44e-2)" "unprognostic (1.84e-1)" "unprognostic (9.35e-2)" "unprognostic (1.26e-2)" "unprognostic (3.68e-2)" "unprognostic (1.68e-1)" "unprognostic (9.75e-2)" "unprognostic (8.48e-2)" "unprognostic (3.10e-2)" "unprognostic (1.54e-1)" 19.7 20.0 18.4 13.4 19.3 28.8 23.0 13.2 19.9 20.7 20.2 14.9 22.8 13.7 27.2 21.6 20.7 14.6 14.1 17.9 15.6 16.6 15.2 19.0 19.7 11.2 15.3 17.1 14.8 16.1 23.9 18.7 25.3 15.4 22.5 16.4 13.0 15.7 23.1 26.9 17.0 13.5 26.2 15.0 16.7 17.2 23.8 13.0 20.2 15.9 14.2 15.0 25.1 20.4 3.2 6.1 15.7 11.8 3.1 5.2 3.3 11.6 6.9 5.3 9.6 12.6 8.7 5.5 5.1 13.9 7.3 9.3 7.6 9.9 8.3 3.9 8.2 6.0 10.3 10.5 9.0 9.8 3.3 5.8 7.6 7.2 9.5 8.3 7.0 5.1 6.9 10.1 9.4 14.3 11.1 8.2 9.3 3.7 8.6 8.6 9.0 6.6 11.2 5.1 5.0 3.7 3.8 21.9 5.1 10.7 9.0 2.8 9.0 4.8 12.3 15.8 6.0 6.9 5.7 7.8 5.1 5.8 6.3 8.5 7.5 8.0 5.9 6.6 13.8 3.1 15.7 6.8 12.1 4.1 11.2 4.0 3.0 3.9 4.1 6.1 3.2 4.4 5.2 15.2 3.1 11.8 2.9 2.9 3.3 18.4 19.3 13.2 19.9 15.6 16.6 15.3 17.1 15.4 13.0 56.6 20.8 39.6 27.4 66.4 32.2 38.1 33.1 20.1 13.6 34.9 68.7 58.6 19.9 44.7 177.2 36.4 21.5 23.3 51.7 27.2 35.0 40.2 15.1 24.2 42.7 87.4 65.8 29.4 69.8 24.2 27.3 54.5 27.0 31.5 35.7 37.0 45.0 17.3 22.6 31.5 51.1 12.9 24.1 52.9 83.0 68.9 85.6 33.0 36.6 45.6 CAD GATD4 ENSG00000084774 "Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase" P27708 2 27217390-27243943 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007781, HPA057266, HPA069341" Supported Supported Nucleoplasm No No 26000 Nucleoplasm "CAB007781: AB_562057, HPA057266: AB_2683387, HPA069341: AB_2686125" "unprognostic (1.69e-1)" "unprognostic (7.34e-2)" "unprognostic (1.49e-1)" "unprognostic (4.71e-3)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (1.72e-11)" "unprognostic (1.25e-1)" "unprognostic (2.22e-1)" "unprognostic (2.37e-1)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "prognostic unfavorable (1.82e-4)" "unprognostic (6.94e-2)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (5.93e-3)" 12.0 11.9 10.1 23.1 12.4 11.1 18.9 13.3 13.1 14.6 12.4 10.9 9.7 12.1 21.0 18.0 16.3 16.6 15.8 9.8 8.6 8.8 13.1 22.9 13.0 27.9 11.8 9.5 24.4 18.1 10.7 16.4 10.6 10.1 12.5 11.6 12.9 11.7 18.3 12.3 26.0 13.2 17.3 12.5 18.7 11.4 21.3 10.8 35.2 13.8 14.1 18.5 12.7 13.1 5.1 4.9 0.8 2.3 3.7 7.9 2.6 25.3 23.0 10.2 20.5 16.7 13.7 8.1 10.8 7.5 13.6 9.7 26.0 10.1 22.7 9.8 9.8 10.5 14.4 30.1 14.3 10.3 14.8 24.3 32.4 17.5 13.5 8.3 25.5 16.4 10.4 11.8 19.8 22.6 6.3 14.6 21.1 22.8 12.7 12.0 25.5 16.2 38.0 24.6 10.7 17.5 28.5 30.7 23.6 10.1 13.0 20.6 10.3 15.0 10.7 12.6 7.9 8.4 10.7 13.1 20.7 17.1 16.1 21.6 26.4 16.9 46.4 8.3 24.6 17.8 0.0 1.2 0.5 4.7 2.3 4.0 5.1 6.5 7.7 2.7 5.0 4.3 4.3 0.8 3.7 1.2 4.9 7.9 2.6 10.1 12.4 13.3 13.1 8.6 8.8 11.8 9.5 10.1 10.8 3.0 3.8 2.2 3.7 3.3 8.9 4.8 15.3 2.7 5.7 1.8 15.7 4.7 0.0 6.1 1.1 3.8 2.5 0.0 3.0 4.7 5.0 2.4 4.6 4.9 6.9 6.4 6.3 4.3 2.4 1.4 5.8 2.2 3.3 5.4 5.2 4.1 5.3 0.0 9.2 1.3 6.2 0.0 5.1 4.9 10.0 3.0 1.8 4.5 6.8 2.0 CALHM3 "bA225H22.7, FAM26A" ENSG00000183128 "Calcium homeostasis modulator 3" Q86XJ0 10 103472804-103479240 "Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Taste, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.8;pancreas: 2.8;testis: 2.0" "Cell type enhanced" "Detected in some" 23 "Cardiomyocytes: 1.1;Early spermatids: 2.2;Extravillous trophoblasts: 5.4;Late spermatids: 1.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.5" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.8;myeloid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "U-266/84: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA018205 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018205: AB_2069267" "unprognostic (2.88e-1)" "unprognostic (4.00e-1)" "unprognostic (3.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.87e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (7.42e-3)" "unprognostic (1.44e-1)" "unprognostic (4.89e-2)" "unprognostic (3.07e-1)" "unprognostic (5.05e-2)" "unprognostic (1.53e-1)" 0.2 0.1 0.5 0.0 0.6 0.0 0.0 0.2 0.7 0.3 0.1 0.8 0.3 0.9 0.0 0.3 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.4 2.8 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 2.0 0.0 0.0 0.2 0.4 0.0 1.5 0.0 1.8 0.0 0.7 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.3 3.3 0.4 1.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 17.4 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.2 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 CAMKMT "C2orf34, CLNMT" ENSG00000143919 "Calmodulin-lysine N-methyltransferase" Q7Z624 2 44361950-44772592 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067912 Supported Nucleoplasm NA NA Nucleoplasm "HPA067912: AB_2685922" "unprognostic (2.28e-1)" "unprognostic (6.15e-2)" "unprognostic (1.96e-1)" "unprognostic (2.39e-2)" "prognostic favorable (9.10e-4)" "unprognostic (1.03e-1)" "unprognostic (9.58e-3)" "unprognostic (1.46e-3)" "unprognostic (1.85e-1)" "unprognostic (7.42e-2)" "unprognostic (8.76e-2)" "unprognostic (1.37e-1)" "unprognostic (3.33e-1)" "unprognostic (4.82e-2)" "unprognostic (4.66e-2)" "unprognostic (1.70e-1)" "unprognostic (8.57e-2)" 7.1 8.0 13.9 10.8 21.7 13.9 8.2 15.4 13.1 9.8 10.8 8.2 8.7 8.7 11.0 10.5 8.8 8.1 14.8 7.3 11.8 14.8 11.4 7.0 8.2 8.1 14.1 4.3 6.7 17.6 15.7 17.6 5.2 13.7 5.8 10.9 8.4 12.0 6.4 10.9 9.7 10.8 8.2 10.5 8.4 7.8 19.0 12.6 13.7 12.1 8.1 10.7 7.9 10.0 17.7 9.9 9.3 8.5 7.7 17.2 6.9 7.0 4.4 5.4 4.8 5.7 5.8 11.5 5.9 4.1 3.0 3.9 8.1 6.4 6.8 6.6 3.8 3.9 5.9 7.3 9.1 5.3 25.4 10.5 10.0 9.3 15.2 2.2 6.5 7.1 2.4 5.6 4.1 7.8 4.5 4.4 7.3 7.9 12.1 4.9 7.3 11.8 13.2 9.9 16.7 4.7 7.0 6.4 13.6 14.5 7.9 10.5 9.6 5.6 16.8 6.1 5.3 6.1 5.5 6.0 4.1 4.8 4.9 4.3 9.6 8.0 12.3 4.5 11.5 3.1 9.3 8.5 5.9 11.7 6.7 11.7 17.7 11.2 9.7 9.5 13.4 17.2 13.5 5.1 7.7 7.1 9.9 16.0 6.9 13.9 21.7 15.4 13.1 11.8 14.8 14.1 4.3 13.7 12.6 6.0 1.9 6.5 6.4 4.6 4.2 1.5 7.6 0.0 0.0 8.7 0.0 3.2 19.9 10.2 52.0 3.5 4.7 0.0 13.8 4.1 5.1 4.8 5.7 5.1 5.2 1.6 0.0 1.3 1.8 25.7 7.5 4.0 10.1 7.2 4.8 15.5 7.3 6.5 5.3 11.2 2.3 0.0 5.1 18.0 5.4 6.5 2.2 8.7 7.4 5.2 CAPG "AFCP, MCP" ENSG00000042493 "Capping actin protein, gelsolin like" P40121 2 85394748-85418432 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 121.1" "Cell type enhanced" "Detected in many" 10 "granulocytes: 535.8;Hofbauer cells: 1102.8;monocytes: 603.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 79.0;classical monocyte: 97.4;eosinophil: 58.2;intermediate monocyte: 36.4;memory B-cell: 50.1;myeloid DC: 121.1;naive B-cell: 37.1;NK-cell: 48.3;plasmacytoid DC: 84.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 81.3;HMC-1: 116.7;SK-MEL-30: 84.8;U-937: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018843, HPA019080, HPA019092" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" Yes No 6700000 Nucleoplasm "HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980" "unprognostic (2.82e-2)" "unprognostic (1.37e-1)" "unprognostic (8.80e-2)" "unprognostic (1.28e-2)" "unprognostic (4.37e-2)" "unprognostic (7.52e-2)" "prognostic unfavorable (3.22e-5)" "unprognostic (8.83e-2)" "unprognostic (3.22e-2)" "unprognostic (1.54e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-1)" "prognostic favorable (2.96e-4)" "unprognostic (1.45e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-3)" "unprognostic (7.89e-3)" 44.3 4.9 10.1 18.3 10.8 32.4 17.6 3.3 7.6 19.9 13.8 17.6 17.7 6.8 14.0 16.0 52.3 12.9 25.2 4.1 8.5 6.5 35.4 2.9 44.3 26.9 14.7 4.8 10.6 8.9 40.3 5.2 15.6 11.9 15.0 11.0 7.6 22.5 19.3 2.6 39.2 11.5 9.9 17.6 10.9 25.9 8.4 10.0 21.2 31.5 28.1 40.2 27.0 31.1 50.1 121.1 79.0 97.4 48.3 9.7 67.5 22.8 11.0 0.0 1.0 7.8 17.0 11.8 8.7 0.9 8.6 8.5 1.3 81.3 2.9 12.4 16.3 9.1 26.7 0.0 17.1 3.7 17.6 0.6 8.2 20.2 4.8 6.1 4.6 116.7 14.7 13.2 7.8 9.7 0.4 5.6 16.9 0.9 6.8 5.9 19.3 12.3 54.3 3.4 17.1 14.6 12.3 1.3 1.3 32.6 11.4 0.1 0.1 10.9 14.7 84.8 6.3 6.1 58.0 21.6 18.4 4.0 0.6 0.3 0.1 0.6 1.2 41.7 61.9 0.2 79.0 97.4 58.2 1.1 36.4 3.4 50.1 9.7 3.7 121.1 37.1 2.8 1.3 14.1 48.3 10.3 84.1 9.6 67.5 10.1 10.8 3.3 7.6 8.5 6.5 14.7 4.8 11.9 10.0 17.9 29.8 86.2 131.0 107.6 0.5 1.1 63.7 9.4 23.9 300.1 0.0 25.0 179.1 90.0 3.2 5.8 101.1 0.0 81.2 260.0 55.7 64.5 535.8 0.9 1102.8 1.6 27.6 3.1 175.5 12.5 43.4 306.0 140.0 603.3 55.7 37.8 257.6 119.4 21.2 88.5 1.1 12.9 23.5 6.3 40.4 148.2 29.9 59.9 86.5 209.1 CAPN13 FLJ23523 ENSG00000162949 "Calpain 13" Q6MZZ7 2 30722771-30820542 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 67.3;pancreas: 20.4;stomach 1: 17.6" "Cell type enhanced" "Detected in many" 8 "Club cells: 21.6;Enterocytes: 20.8;Intestinal endocrine cells: 14.5;Undifferentiated cells: 17.1;Urothelial cells: 20.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RT4: 9.0;SK-BR-3: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA029496, HPA029497, HPA030034" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029496: AB_2673072, HPA029497: AB_2673073, HPA030034: AB_2673281" "unprognostic (7.42e-2)" "unprognostic (1.19e-1)" "unprognostic (7.01e-3)" "unprognostic (1.96e-1)" "unprognostic (8.56e-2)" "unprognostic (1.51e-1)" "unprognostic (1.68e-1)" "unprognostic (1.32e-3)" "unprognostic (2.17e-1)" "unprognostic (2.66e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-1)" "unprognostic (1.96e-2)" "unprognostic (3.64e-1)" "unprognostic (3.32e-2)" "unprognostic (5.03e-2)" "unprognostic (4.28e-3)" 0.2 0.0 0.5 0.5 0.4 0.0 4.8 0.2 0.2 6.2 39.6 0.3 0.2 13.0 1.1 0.6 1.1 0.5 7.4 0.2 0.8 0.4 2.0 0.2 9.4 0.2 0.7 0.3 0.4 20.4 0.6 1.2 0.2 0.2 5.2 16.0 0.2 1.0 0.2 0.2 0.1 67.3 1.6 1.0 0.2 17.6 0.2 0.2 0.2 0.2 0.5 1.0 3.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 9.0 0.1 0.4 0.0 21.7 0.0 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.2 0.8 0.4 0.7 0.3 0.2 0.2 6.0 1.9 0.0 7.5 0.0 0.0 1.7 0.0 8.1 21.6 1.8 0.0 0.0 0.0 0.7 0.8 0.0 20.8 0.0 4.8 0.0 0.0 1.9 1.1 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 1.5 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.1 20.1 CAPN15 SOLH ENSG00000103326 "Calpain 15" O75808 16 527717-554636 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 15.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011960 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA011960: AB_10610556" "unprognostic (4.11e-2)" "unprognostic (1.63e-1)" "unprognostic (1.14e-1)" "unprognostic (2.66e-1)" "unprognostic (7.18e-2)" "unprognostic (1.12e-2)" "unprognostic (1.54e-3)" "unprognostic (8.31e-3)" "unprognostic (1.32e-1)" "unprognostic (1.24e-1)" "unprognostic (1.86e-1)" "unprognostic (4.02e-2)" "unprognostic (2.53e-3)" "unprognostic (2.54e-3)" "unprognostic (5.91e-2)" "unprognostic (1.83e-1)" "unprognostic (9.23e-3)" 9.2 7.7 7.1 13.1 6.8 12.0 12.0 20.4 10.9 5.6 15.7 5.7 8.6 26.1 7.9 5.4 10.7 7.5 13.4 5.9 9.8 2.9 9.7 14.1 8.6 8.2 5.8 4.7 8.2 20.5 4.3 9.1 6.1 5.0 7.2 4.7 3.7 11.7 6.9 11.4 14.3 24.7 7.0 3.4 16.8 21.9 10.8 4.1 9.7 6.9 6.6 11.8 6.4 11.8 2.7 0.5 15.8 1.1 1.1 0.4 0.2 8.4 11.0 1.6 4.8 0.9 1.8 24.5 9.1 2.4 2.6 1.8 14.4 6.2 12.3 8.8 1.6 2.6 11.3 1.0 3.6 0.9 12.7 19.4 10.2 11.3 8.8 3.9 11.9 14.4 2.0 2.1 2.6 1.2 1.5 2.8 7.6 18.6 3.7 0.8 13.1 13.3 13.1 14.2 4.4 10.5 23.3 4.5 12.1 1.7 5.5 10.3 9.4 6.0 8.4 5.1 1.0 6.9 12.5 13.4 8.1 11.4 8.2 11.3 9.8 5.4 10.5 3.5 7.0 5.0 3.0 1.1 0.7 0.2 0.8 0.1 0.3 0.1 0.4 0.3 2.7 0.1 0.2 15.8 1.1 1.0 0.5 0.2 0.2 7.1 6.8 20.4 10.9 9.8 2.9 5.8 4.7 5.0 4.1 3.0 9.6 6.0 3.8 7.9 11.8 2.5 10.2 1.4 3.4 7.0 15.7 3.1 1.7 6.3 15.0 7.2 31.5 0.0 13.3 3.5 6.7 8.6 6.9 15.3 6.0 19.1 4.1 8.0 13.5 5.3 6.9 4.8 1.7 2.8 24.3 7.8 10.5 24.9 4.2 4.1 11.4 0.0 3.8 4.9 6.4 6.9 2.1 7.5 19.9 11.9 CARD8 "CARDINAL, Dakar, KIAA0955, NDPP, TUCAN" ENSG00000105483 "Caspase recruitment domain family member 8" Q9Y2G2 19 48180770-48255946 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Kupffer cells: 77.2;T-cells: 77.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 34.1;HUVEC TERT2: 44.3;NB-4: 38.3;TIME: 42.0" "HPA042071, HPA043513" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA042071: AB_2677831, HPA043513: AB_2678522" "unprognostic (3.96e-2)" "unprognostic (1.92e-1)" "unprognostic (7.84e-2)" "unprognostic (1.48e-1)" "unprognostic (3.30e-2)" "unprognostic (1.58e-2)" "unprognostic (6.95e-2)" "unprognostic (2.18e-2)" "unprognostic (9.19e-2)" "unprognostic (7.30e-2)" "unprognostic (3.79e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (1.63e-8)" "unprognostic (1.78e-1)" "unprognostic (1.69e-1)" "unprognostic (9.19e-2)" "prognostic favorable (1.72e-5)" 33.9 10.0 7.9 19.3 11.4 14.9 17.2 7.2 9.5 11.9 8.7 10.1 6.9 8.1 14.0 8.1 7.5 9.4 9.7 10.5 8.6 5.2 8.7 10.1 16.8 25.6 13.3 3.3 8.1 10.5 6.9 11.3 15.0 10.2 9.6 8.0 10.2 8.9 6.2 12.0 6.8 15.1 11.1 16.2 42.1 9.9 9.8 11.7 24.1 11.4 9.2 23.9 12.8 10.1 10.2 12.8 53.6 20.0 8.3 14.1 9.5 4.0 9.3 9.0 2.9 2.9 4.6 3.5 3.7 4.8 6.0 9.3 3.2 5.9 7.8 4.7 3.8 4.1 2.5 5.3 2.8 5.7 12.9 4.5 34.1 4.6 6.6 3.9 16.3 26.2 3.8 2.0 2.9 3.5 5.3 44.3 9.3 4.6 10.3 4.6 2.7 6.7 38.3 2.2 8.6 2.3 11.4 4.0 2.0 3.4 5.1 3.0 4.6 6.1 4.3 5.2 4.8 2.7 14.5 42.0 3.5 4.4 1.4 6.0 9.4 22.8 5.2 1.6 11.7 6.1 25.0 15.2 23.0 10.4 19.9 11.5 10.2 10.2 11.8 12.8 9.6 9.8 10.4 53.6 8.3 20.0 9.0 14.1 9.5 7.9 11.4 7.2 9.5 8.6 5.2 13.3 3.3 10.2 11.7 3.0 33.5 45.1 5.2 8.2 8.3 8.1 12.7 10.7 10.3 12.2 11.8 23.9 5.0 6.7 18.0 55.4 6.2 23.3 9.1 8.9 11.8 3.6 32.4 13.6 36.4 6.4 5.2 68.2 77.2 42.1 7.2 52.8 20.3 10.0 6.2 4.7 9.0 7.0 7.4 9.8 3.8 6.5 11.3 18.7 14.0 6.1 12.9 77.8 6.3 3.5 CARM1 PRMT4 ENSG00000142453 "Coactivator associated arginine methyltransferase 1" Q86X55 19 10871513-10923070 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 64.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032961, HPA043561, HPA048073, HPA069313" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: " "unprognostic (9.46e-2)" "unprognostic (3.61e-1)" "unprognostic (2.94e-2)" "unprognostic (2.23e-1)" "unprognostic (2.69e-2)" "unprognostic (3.13e-2)" "unprognostic (1.66e-3)" "unprognostic (3.76e-2)" "unprognostic (7.81e-2)" "unprognostic (6.18e-2)" "unprognostic (9.31e-2)" "unprognostic (7.25e-2)" "prognostic unfavorable (7.88e-6)" "unprognostic (1.71e-2)" "unprognostic (6.26e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (8.37e-4)" 12.2 8.8 12.3 12.6 16.1 13.2 9.6 12.5 17.7 15.8 14.0 9.3 9.0 11.5 19.6 9.1 20.5 14.8 12.4 14.7 11.2 7.2 9.3 14.5 8.9 12.4 7.8 10.2 13.0 16.9 8.2 6.9 15.3 9.5 12.6 10.2 12.0 11.4 13.2 64.3 12.5 12.0 15.6 6.6 9.8 11.1 17.5 8.6 9.4 10.0 12.7 15.6 15.8 15.9 1.3 1.6 0.3 1.4 0.1 2.6 0.4 22.6 16.9 24.2 32.8 20.2 27.7 23.2 16.3 28.3 24.2 23.3 26.0 8.3 31.2 19.6 28.4 12.2 21.7 24.7 24.5 15.3 34.9 20.1 9.6 11.0 31.5 17.3 14.4 12.5 18.9 16.0 16.5 20.0 13.8 30.6 24.9 22.9 28.1 14.2 40.9 25.1 12.4 29.9 15.2 28.1 35.1 12.4 36.3 14.6 11.7 17.6 16.9 11.6 14.1 15.7 12.6 14.1 12.4 18.3 29.2 16.5 27.7 19.0 27.4 21.6 27.3 19.2 23.2 12.6 0.0 1.4 0.2 1.2 1.4 0.5 1.3 0.9 2.6 1.3 1.3 1.0 0.9 0.3 0.1 0.7 1.6 0.8 0.4 12.3 16.1 12.5 17.7 11.2 7.2 7.8 10.2 9.5 8.6 8.9 13.5 11.5 4.9 6.9 31.0 0.8 17.8 8.1 6.8 8.7 49.1 16.3 6.6 11.8 25.6 5.7 28.0 46.7 16.9 26.3 10.3 10.9 1.1 23.7 22.3 42.9 26.5 11.1 17.8 13.0 26.2 7.5 5.0 28.9 25.6 10.2 20.3 25.9 18.0 7.3 19.9 6.5 9.2 25.8 16.4 6.0 10.1 4.1 21.2 9.0 CASC10 "bA418C1.3, C10orf114" ENSG00000204682 "Cancer susceptibility 10" Q5T4H9 10 21492658-21497262 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;liver: 13.6" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 5.9;Proximal tubular cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 10.3;AF22: 10.4;AN3-CA: 14.4;BEWO: 13.9;SK-BR-3: 9.1" HPA064131 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA064131: AB_2685196" "unprognostic (2.69e-2)" "unprognostic (1.46e-2)" "unprognostic (5.37e-3)" "unprognostic (1.87e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (3.22e-2)" "unprognostic (1.34e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.00e-1)" "unprognostic (8.55e-2)" "unprognostic (1.85e-1)" "unprognostic (4.04e-3)" "unprognostic (1.09e-3)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (5.86e-4)" 1.8 2.6 8.9 0.9 6.2 0.9 0.9 2.0 8.0 2.5 0.8 6.1 0.1 1.0 1.3 1.1 1.2 2.4 1.7 3.8 11.8 3.8 6.3 13.6 1.5 1.3 3.3 4.2 2.6 1.3 3.7 3.3 7.2 2.7 1.9 0.7 2.0 1.0 1.8 5.0 3.3 0.9 1.5 2.2 0.8 0.9 2.6 5.3 0.1 5.6 0.0 0.8 2.3 1.6 0.6 0.4 2.2 0.3 1.0 0.4 0.2 1.7 10.3 10.4 14.4 1.9 1.0 13.9 0.9 0.4 0.1 0.2 1.6 3.6 0.5 1.5 0.8 1.8 2.2 1.8 0.6 0.1 0.3 1.9 0.1 1.5 2.3 0.5 0.0 0.1 1.3 1.8 0.1 0.2 1.5 0.9 0.6 0.6 0.1 0.1 1.6 0.7 0.6 1.4 0.0 0.9 0.8 0.1 0.0 2.1 1.5 1.4 5.1 4.8 9.1 0.6 3.5 1.7 7.9 2.5 0.9 8.1 0.2 1.1 0.1 0.2 0.1 4.5 0.0 4.5 1.5 0.3 0.3 0.3 0.2 0.2 0.3 0.2 0.1 0.0 0.6 0.2 0.4 2.2 1.0 0.3 0.4 0.2 0.2 8.9 6.2 2.0 8.0 11.8 3.8 3.3 4.2 2.7 5.3 0.0 0.6 0.0 0.4 1.0 2.3 2.2 0.0 2.7 0.0 1.8 0.0 2.0 5.0 0.0 0.2 3.7 0.0 0.0 0.0 2.3 1.9 0.1 0.0 5.9 0.7 4.8 0.0 3.7 0.3 0.0 4.4 0.0 1.7 0.0 0.0 2.9 0.2 0.0 1.8 10.5 0.6 0.0 0.3 0.2 0.2 0.6 3.2 0.0 0.0 0.1 CASD1 "C7orf12, FLJ21213, FLJ21879" ENSG00000127995 "CAS1 domain containing 1" Q96PB1 7 94509219-94557019 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 54.4;Horizontal cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044404 Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA044404: AB_10964353" "unprognostic (4.02e-2)" "unprognostic (4.16e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (7.04e-2)" "unprognostic (7.90e-2)" "unprognostic (3.66e-2)" "unprognostic (2.18e-2)" "unprognostic (9.83e-2)" "unprognostic (4.74e-2)" "unprognostic (4.95e-3)" "unprognostic (2.16e-2)" "unprognostic (5.24e-2)" "unprognostic (4.01e-3)" "unprognostic (1.93e-1)" "unprognostic (7.07e-2)" "unprognostic (2.59e-3)" 8.6 21.6 16.6 7.1 24.2 4.1 13.2 20.5 24.8 10.0 13.2 10.9 7.5 5.0 11.7 12.5 5.1 9.2 8.1 13.6 25.9 22.2 10.2 7.1 9.0 9.2 13.1 16.6 14.1 7.8 12.7 22.8 9.8 20.0 11.8 15.9 8.4 22.6 8.2 11.3 3.7 6.3 9.7 13.7 8.0 6.0 10.1 11.5 7.3 13.2 2.9 8.3 9.0 6.3 1.8 1.1 0.2 0.7 1.8 4.7 0.7 3.0 5.9 20.3 7.5 6.2 7.5 3.4 4.2 7.4 4.6 6.1 3.7 7.6 7.8 11.0 5.6 8.3 1.7 5.1 1.4 9.2 12.4 4.1 6.9 5.0 6.7 5.3 11.4 0.0 6.8 5.4 4.2 6.1 9.1 7.3 9.2 3.7 17.2 11.4 4.5 15.8 6.5 10.4 4.3 4.7 10.9 16.5 6.0 9.4 8.5 7.7 26.3 6.5 12.1 4.1 15.4 3.1 7.2 3.8 11.6 9.2 9.5 6.0 16.5 15.4 16.3 6.3 2.7 7.5 0.0 0.6 0.2 1.9 0.7 4.7 1.8 2.8 2.3 1.1 1.7 2.9 2.2 0.0 1.8 0.6 1.0 1.7 0.7 16.6 24.2 20.5 24.8 25.9 22.2 13.1 16.6 20.0 11.5 26.8 22.9 6.9 5.2 4.0 54.4 17.1 17.8 18.7 17.0 19.2 17.7 9.7 3.3 4.5 2.7 13.3 12.0 0.0 4.8 4.6 9.3 11.8 10.3 10.9 7.4 63.5 6.9 17.2 11.5 4.7 10.6 5.6 23.6 2.8 27.6 25.0 6.1 8.6 9.2 8.8 28.9 19.4 7.1 6.3 11.9 4.0 14.1 7.2 14.1 3.7 CASP2 "ICH1, MGC2181, NEDD2, PPP1R57" ENSG00000106144 "Caspase 2" P42575 7 143288215-143307696 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 45.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012175, HPA050678" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB012175: , HPA050678: AB_2681214" "unprognostic (6.96e-2)" "prognostic favorable (7.38e-4)" "unprognostic (2.74e-2)" "unprognostic (7.51e-2)" "unprognostic (4.24e-2)" "unprognostic (2.39e-2)" "prognostic unfavorable (2.34e-4)" "unprognostic (1.74e-2)" "unprognostic (1.34e-2)" "prognostic favorable (2.89e-4)" "unprognostic (1.91e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (5.01e-6)" "unprognostic (2.66e-3)" "unprognostic (9.48e-2)" "unprognostic (1.19e-1)" "unprognostic (1.64e-1)" 10.5 6.5 6.6 10.7 6.7 26.8 10.2 9.6 10.9 9.6 8.5 9.0 8.2 8.2 10.8 7.8 14.1 8.4 5.7 6.1 5.7 4.1 7.3 5.8 9.8 15.8 6.9 6.1 8.7 8.1 12.1 6.6 11.3 7.3 7.6 10.2 10.1 11.6 5.8 4.3 14.2 14.0 7.4 6.3 18.6 7.5 8.6 6.9 45.7 8.9 8.0 23.0 7.4 10.2 18.5 11.8 33.2 17.7 13.4 21.4 7.6 10.9 10.3 11.6 20.5 6.5 7.7 6.2 11.2 5.1 10.3 11.3 10.2 12.4 20.8 10.7 7.1 7.9 10.8 11.6 8.9 13.8 18.2 8.9 12.3 16.2 7.0 3.5 23.9 15.4 5.3 7.3 12.5 4.4 4.7 8.8 16.4 10.2 13.3 10.9 10.8 41.6 25.2 14.6 10.7 10.5 30.6 6.0 12.7 6.1 9.3 12.7 14.3 22.3 9.7 7.1 8.3 10.6 9.2 9.8 9.2 6.4 16.5 11.2 11.1 10.9 24.2 10.3 28.5 16.7 33.2 10.8 9.3 14.9 11.9 14.6 15.8 20.6 15.4 9.8 18.5 15.4 17.8 12.3 13.4 17.7 11.8 21.4 7.6 6.6 6.7 9.6 10.9 5.7 4.1 6.9 6.1 7.3 6.9 8.9 8.8 17.9 5.4 13.5 4.7 5.3 25.5 2.7 3.4 7.0 7.9 16.2 3.3 7.7 35.5 13.9 6.5 0.0 6.6 12.8 8.7 5.5 9.3 4.4 8.8 6.4 10.3 14.7 15.4 38.5 10.9 12.1 20.3 11.8 10.3 4.0 7.6 3.5 7.8 3.3 14.0 0.0 8.4 10.1 29.4 12.0 4.8 20.8 13.3 6.0 CATSPERZ "C11orf20, DKFZP566E164, TEX40" ENSG00000219435 "Catsper channel auxiliary subunit zeta" Q9NTU4 11 64300391-64304770 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 105 "testis: 139.5" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.7;CACO-2: 15.6;PC-3: 9.3;T-47d: 7.6" HPA052822 Approved Nucleoplasm NA NA Nucleoplasm "HPA052822: AB_2797245" "unprognostic (1.89e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (8.23e-2)" "unprognostic (2.18e-1)" "unprognostic (1.11e-1)" "unprognostic (5.66e-4)" "unprognostic (5.96e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" 0.1 0.0 0.5 0.0 0.4 0.0 0.8 0.1 0.9 0.2 0.1 0.1 0.2 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.5 0.2 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.3 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 139.5 0.1 0.0 0.4 0.0 0.1 0.1 0.2 0.5 0.4 0.6 0.6 0.0 0.3 0.0 0.0 4.1 0.3 0.0 0.5 1.0 5.7 0.0 0.3 0.0 0.0 15.6 3.2 0.1 0.2 0.2 0.2 3.4 3.2 0.5 0.1 0.0 0.0 1.5 0.1 1.0 0.1 0.0 0.0 0.1 0.3 1.0 0.0 0.0 0.2 0.0 1.6 0.7 0.2 0.7 0.0 0.7 1.1 4.5 9.3 1.7 0.0 2.0 4.5 1.5 0.1 0.9 1.7 0.5 0.2 0.3 7.6 0.4 0.3 0.2 0.1 2.1 0.0 0.4 0.1 0.5 0.3 0.0 0.1 0.0 0.3 0.0 0.3 0.2 0.1 0.5 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.0 0.6 0.4 0.0 0.0 0.5 0.4 0.1 0.3 0.5 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 29.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 CBARP "BARP, C19orf26, DOS, MGC40084" ENSG00000099625 "CACN beta subunit associated regulatory protein" Q8N350 19 1228287-1238027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;pituitary gland: 13.1" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 18.9;Early spermatids: 35.1;Late spermatids: 59.2" "Cancer enhanced" "Detected in many" "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 8.7" HPA012777 Approved Nucleoplasm NA NA Nucleoplasm "HPA012777: AB_2067005" "unprognostic (1.31e-1)" "unprognostic (4.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" "unprognostic (3.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (2.17e-1)" "unprognostic (4.58e-2)" "unprognostic (2.86e-3)" "unprognostic (3.03e-1)" "unprognostic (5.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (7.42e-5)" 2.3 8.1 7.2 1.5 12.1 1.0 1.2 3.6 17.9 1.2 1.3 5.2 0.0 1.3 1.8 1.1 1.5 1.1 1.8 1.5 8.5 5.6 1.8 1.5 1.4 1.1 3.3 4.7 2.9 2.1 1.6 13.1 1.4 10.6 1.4 1.0 1.2 1.2 1.5 1.3 4.5 1.1 1.2 6.5 1.2 1.9 3.0 2.2 0.0 1.3 0.0 1.2 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.0 5.3 0.2 0.6 1.5 4.4 1.3 0.9 1.0 2.4 0.2 0.0 5.0 1.0 0.5 2.4 0.8 0.9 0.2 0.9 1.1 0.1 1.7 1.4 2.3 0.1 1.8 1.2 0.5 1.1 0.3 0.9 0.7 1.2 2.8 0.1 0.6 4.0 0.0 1.3 3.7 0.3 2.2 4.4 0.8 0.3 0.2 0.6 3.2 8.7 0.0 0.1 4.5 0.2 0.6 0.9 1.7 1.9 5.6 5.2 1.6 0.5 0.5 0.0 1.5 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 12.1 3.6 17.9 8.5 5.6 3.3 4.7 10.6 2.2 0.0 0.0 0.0 0.2 0.0 18.9 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.2 35.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.2 3.2 0.0 1.3 1.0 59.2 1.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.4 0.1 1.1 0.0 0.0 9.8 4.1 0.0 0.0 0.0 0.0 0.1 CBFA2T3 "ETO2, MTG16, MTGR2, RUNX1T3, ZMYND4" ENSG00000129993 "CBFA2/RUNX1 translocation partner 3" O75081 16 88874858-88977204 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 75.9" "Cell type enhanced" "Detected in many" 7 "B-cells: 11.5;Mucus-secreting cells: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 11.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 26.0" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 21.4;K-562: 37.4;MCF7: 17.3;MOLT-4: 19.0;NB-4: 23.1;REH: 37.6;T-47d: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA059931, HPA062423, HPA065890" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059931: AB_2684168, HPA062423: AB_2684758, HPA065890: AB_2685575" "unprognostic (2.47e-1)" "unprognostic (2.03e-2)" "unprognostic (9.24e-3)" "unprognostic (2.62e-1)" "unprognostic (1.98e-1)" "prognostic favorable (3.95e-4)" "unprognostic (1.13e-3)" "unprognostic (1.69e-2)" "unprognostic (1.25e-1)" "unprognostic (2.10e-1)" "unprognostic (7.30e-3)" "unprognostic (2.38e-1)" "unprognostic (7.04e-5)" "unprognostic (2.18e-1)" "unprognostic (4.08e-2)" "unprognostic (4.62e-2)" "unprognostic (9.35e-3)" 10.0 1.7 3.6 11.3 7.4 8.2 6.1 26.0 5.4 2.3 3.9 1.3 1.4 3.9 3.2 2.1 2.1 1.9 2.5 6.2 3.0 3.0 0.7 2.0 6.4 9.5 2.0 3.8 0.9 24.9 0.7 2.7 3.8 2.3 3.7 1.5 3.1 4.5 2.9 14.2 2.6 5.5 1.5 1.2 14.7 3.5 3.2 2.2 75.9 2.4 2.0 10.3 3.6 4.8 3.7 11.6 3.6 4.9 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.4 0.0 0.0 0.0 5.6 10.6 0.0 0.0 0.0 0.0 0.0 0.0 10.3 37.4 0.2 0.0 17.3 19.0 23.1 0.4 0.0 0.0 37.6 0.3 3.7 0.0 0.0 7.4 1.6 0.8 0.1 0.1 0.1 17.1 6.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 12.4 0.0 6.5 0.0 1.1 2.7 2.7 0.0 3.2 0.0 3.7 0.0 0.0 7.1 2.1 0.0 0.0 3.6 0.1 4.9 11.6 0.0 1.7 3.6 7.4 26.0 5.4 3.0 3.0 2.0 3.8 2.3 2.2 0.0 1.4 11.5 5.1 2.3 7.7 1.6 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.2 0.0 3.6 0.9 0.0 2.4 0.1 1.6 2.5 5.8 5.7 2.4 0.0 3.5 2.5 2.8 0.0 2.0 6.4 0.0 1.0 13.5 0.1 1.4 0.0 0.7 0.5 1.2 19.4 11.2 0.2 4.5 1.9 0.2 1.0 0.8 3.8 CBLN3 ENSG00000139899 "Cerebellin 3 precursor" Q6UW01 14 24426532-24430954 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 105.2" "Cell type enhanced" "Detected in some" 8 "Fibroblasts: 2.3;Leydig cells: 2.3;monocytes: 3.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 23 "cerebellum: 105.2" "Cell type enhanced" "Detected in some" "memory B-cell: 1.5;naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.9;HDLM-2: 12.7;HSkMC: 18.9;Karpas-707: 14.2;U-266/70: 9.9" "Region enriched" "Detected in some" 25 "cerebellum: 481.8" "Region enriched" "Detected in some" 47 "cerebellum: 583.0" HPA041266 Enhanced Supported Approved Nucleoplasm "Secreted in brain" NA NA Nucleoplasm "HPA041266: AB_10674430" "unprognostic (5.02e-2)" "unprognostic (3.26e-1)" "unprognostic (1.43e-3)" "prognostic unfavorable (4.22e-4)" "unprognostic (4.39e-4)" "unprognostic (5.39e-3)" "unprognostic (1.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (6.20e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (6.20e-6)" "unprognostic (2.75e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (9.02e-2)" 2.1 7.7 1.2 4.5 1.3 0.0 1.2 105.2 1.7 1.8 1.1 1.9 1.0 0.6 1.3 4.8 1.0 1.2 3.1 1.6 1.0 1.1 1.2 1.4 1.3 7.9 1.3 1.4 3.3 1.0 1.0 1.3 1.7 4.6 1.2 0.7 1.7 1.6 1.6 1.4 1.6 1.3 1.3 2.0 7.4 1.4 1.6 1.1 1.1 1.2 1.5 5.3 1.9 1.3 2.3 0.3 0.1 0.8 0.0 0.3 0.0 1.1 1.0 0.5 1.9 5.0 10.9 0.3 4.2 8.6 1.7 2.2 0.5 2.0 1.8 0.9 2.6 1.9 0.3 0.6 2.3 1.1 12.7 0.4 0.0 3.5 0.8 2.8 0.3 0.7 18.9 1.0 2.1 1.7 7.0 1.5 0.8 0.5 14.2 2.1 0.6 0.0 0.5 0.1 1.1 1.1 0.0 0.0 1.3 1.0 0.4 0.7 0.4 0.3 0.1 0.6 0.3 0.6 0.4 6.6 6.1 1.2 2.5 0.2 9.9 2.3 2.0 0.3 0.8 1.0 0.0 0.0 0.1 0.0 0.8 0.3 1.5 0.1 0.1 0.0 2.3 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.0 1.2 1.3 105.2 1.7 1.0 1.1 1.3 1.4 4.6 1.1 0.0 0.0 0.0 0.5 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.5 0.0 1.0 0.5 2.3 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 2.3 0.0 0.0 3.6 0.2 0.8 0.8 0.0 1.4 0.5 0.3 0.0 1.2 0.0 0.1 0.5 0.7 0.0 0.4 0.5 CBX2 "CDCA6, MGC10561" ENSG00000173894 "Chromobox 2" Q14781 17 79778132-79787983 "Disease related genes, Predicted intracellular proteins" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.9;testis: 16.5" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 27.9;Late spermatids: 28.1;Spermatogonia: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 32.1;SH-SY5Y: 24.4;SK-BR-3: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023083 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA023083: AB_2671063" "unprognostic (1.37e-2)" "unprognostic (1.19e-1)" "unprognostic (1.95e-1)" "unprognostic (3.80e-2)" "unprognostic (1.49e-1)" "unprognostic (9.72e-2)" "unprognostic (2.25e-11)" "unprognostic (1.05e-1)" "unprognostic (7.77e-2)" "unprognostic (6.34e-3)" "unprognostic (1.86e-3)" "unprognostic (1.66e-1)" "unprognostic (1.25e-8)" "unprognostic (1.34e-1)" "unprognostic (3.33e-2)" "unprognostic (2.37e-3)" "unprognostic (2.07e-1)" 2.1 0.6 1.6 1.3 2.5 3.4 8.1 0.5 1.5 1.7 0.8 0.6 2.9 0.6 4.0 3.4 6.0 1.7 1.1 3.3 0.8 0.7 1.3 0.9 2.2 2.2 1.8 1.1 4.1 2.2 0.4 0.5 3.9 1.3 1.3 0.4 1.0 2.1 1.5 1.3 3.4 1.0 1.2 0.8 2.5 0.9 16.5 1.8 17.9 1.7 6.8 2.4 1.5 3.5 0.8 0.4 0.0 0.6 0.0 0.4 0.2 2.5 6.9 12.8 23.3 0.1 0.2 4.6 0.9 0.4 0.4 0.8 7.1 0.5 9.9 2.0 0.1 1.6 1.3 14.8 0.4 0.3 1.4 8.0 0.5 7.5 4.7 0.5 3.0 2.1 0.2 0.9 0.2 0.6 0.5 2.6 10.7 6.8 0.8 0.4 10.4 15.5 7.3 12.7 3.4 8.1 32.1 9.6 6.0 0.5 3.5 15.7 24.4 4.0 46.6 2.7 6.4 8.4 4.5 1.8 4.6 13.7 1.4 1.7 3.0 1.5 6.1 0.2 8.1 5.4 0.0 0.1 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.6 0.4 0.0 0.2 1.6 2.5 0.5 1.5 0.8 0.7 1.8 1.1 1.3 1.8 0.0 0.0 0.0 0.2 0.9 0.6 2.0 0.0 0.0 0.0 1.8 2.0 0.2 1.7 3.5 27.9 6.7 0.0 0.0 0.8 1.1 0.8 0.8 0.0 0.5 1.1 0.0 0.0 2.5 0.6 28.1 0.6 0.0 3.3 1.0 0.4 2.3 0.9 0.0 0.7 0.5 0.2 0.0 0.0 1.1 16.1 1.3 0.2 0.0 0.0 0.5 CBX5 "HP1, HP1-ALPHA, HP1Hs-alpha" ENSG00000094916 "Chromobox 5" P45973 12 54230940-54280133 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016699, CAB017548" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB017548: AB_2071368, HPA016699: AB_1850627" "unprognostic (1.58e-2)" "unprognostic (7.99e-2)" "unprognostic (1.15e-2)" "unprognostic (5.05e-3)" "unprognostic (3.80e-1)" "unprognostic (4.59e-3)" "unprognostic (2.97e-3)" "unprognostic (6.39e-3)" "unprognostic (2.57e-2)" "unprognostic (1.41e-1)" "unprognostic (4.47e-2)" "unprognostic (1.96e-1)" "unprognostic (2.34e-1)" "unprognostic (1.70e-1)" "unprognostic (1.08e-1)" "unprognostic (6.26e-2)" "unprognostic (8.64e-2)" 9.7 18.2 26.3 16.3 28.4 17.3 16.0 22.3 32.3 13.8 12.0 25.3 10.4 8.7 11.7 18.0 11.2 18.9 10.6 22.0 22.1 28.4 20.8 10.1 11.6 19.8 22.4 18.8 22.2 12.2 42.5 26.8 13.9 20.4 13.9 13.0 19.5 10.5 16.0 14.1 19.5 10.4 12.6 25.3 11.7 11.8 26.8 20.3 37.0 27.4 9.0 23.4 10.0 11.6 11.3 18.4 3.7 6.1 6.2 8.2 3.6 8.8 26.4 41.4 19.1 5.5 12.0 9.6 13.7 9.9 11.6 12.1 10.2 28.4 24.5 18.5 13.5 13.9 7.5 29.3 8.5 19.9 38.8 6.4 21.6 30.0 3.6 4.3 11.4 9.2 5.9 5.8 19.9 17.6 13.2 12.8 22.8 24.5 24.3 19.1 15.3 36.2 11.9 33.1 3.7 3.2 35.9 23.2 13.6 12.1 8.1 20.8 32.1 25.7 5.8 3.0 17.0 22.4 19.3 16.8 19.7 17.0 7.4 16.2 6.1 6.8 47.1 12.5 11.7 20.5 0.8 4.7 3.7 6.2 4.9 5.0 9.4 6.7 5.7 7.8 11.3 6.6 6.1 0.7 6.2 6.1 18.4 8.2 3.6 26.3 28.4 22.3 27.2 22.1 28.4 22.4 18.8 20.4 20.3 35.7 44.5 47.7 38.8 41.1 105.7 135.1 56.0 92.3 52.4 78.5 43.2 45.4 89.5 54.0 84.3 46.6 14.0 70.0 51.5 49.9 48.3 35.9 29.0 27.7 32.9 173.2 25.9 32.5 22.5 38.8 59.8 30.8 33.7 55.1 34.8 65.1 38.7 7.0 75.7 47.7 56.4 32.3 42.9 202.7 89.2 28.5 21.9 35.2 33.3 23.0 CBX8 "HPC3, PC3, RC1" ENSG00000141570 "Chromobox 8" Q9HC52 17 79792132-79801683 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031462 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031462: AB_10601252" "unprognostic (4.77e-2)" "unprognostic (2.24e-1)" "unprognostic (1.34e-1)" "unprognostic (8.81e-2)" "unprognostic (3.26e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.94e-6)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (6.26e-2)" "prognostic favorable (3.84e-5)" "unprognostic (4.74e-1)" "prognostic unfavorable (5.39e-7)" "unprognostic (6.99e-3)" "unprognostic (7.18e-2)" "unprognostic (4.51e-1)" "unprognostic (5.99e-2)" 5.0 4.6 6.3 7.5 4.3 3.6 4.6 4.4 7.2 3.8 4.3 5.1 3.9 5.4 3.6 20.5 3.9 13.9 7.3 4.8 5.6 2.7 6.9 7.8 6.2 5.0 4.5 5.0 3.2 7.9 10.0 11.0 4.7 4.7 3.6 1.6 5.9 4.8 6.9 3.9 4.2 4.1 2.2 3.3 4.3 5.5 13.6 5.5 12.8 4.4 1.7 4.0 2.6 2.5 4.9 5.7 14.6 6.8 3.0 3.4 2.1 7.8 16.1 4.3 15.5 2.4 1.5 5.2 4.0 2.9 3.5 2.4 8.8 4.0 5.8 11.4 2.2 3.1 7.4 5.5 1.2 1.5 4.4 7.7 2.1 8.5 9.3 2.8 8.6 18.2 1.3 2.5 2.2 0.7 3.4 0.7 6.9 5.1 2.6 1.0 9.6 9.8 12.8 1.7 5.7 8.8 9.2 3.8 10.6 2.6 5.4 6.3 12.7 5.8 18.5 9.2 1.5 9.7 11.3 1.8 7.3 10.1 2.9 6.3 7.5 2.9 3.7 4.5 8.6 4.0 1.0 5.2 14.6 3.4 6.5 1.2 4.9 1.9 2.0 5.7 2.1 1.9 1.8 6.5 3.0 6.8 4.6 1.9 2.1 6.3 4.3 4.4 7.2 5.6 2.7 4.5 5.0 4.7 5.5 0.0 0.3 1.3 0.7 1.5 5.2 2.1 10.2 1.4 0.0 3.5 7.9 6.1 0.0 4.1 2.7 1.2 3.2 0.0 4.8 2.4 1.5 0.8 5.7 2.6 4.2 7.9 8.7 0.6 2.8 0.0 0.9 1.1 1.7 1.0 6.3 6.8 3.7 4.0 2.1 1.9 10.8 0.0 2.8 0.5 11.4 1.0 2.1 3.8 3.7 0.3 CBY3 ENSG00000204659 "Chibby family member 3" A6NI87 5 179678583-179680974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 15.8" "Group enriched" "Detected in some" 122 "Early spermatids: 194.9;Late spermatids: 243.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 2.8;BEWO: 1.9;HDLM-2: 5.3;HeLa: 3.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA069037 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA069037: AB_2686069" "unprognostic (1.33e-1)" "unprognostic (1.57e-1)" "unprognostic (1.23e-2)" "unprognostic (1.15e-2)" "unprognostic (1.76e-1)" "unprognostic (8.68e-3)" "unprognostic (7.69e-3)" "unprognostic (5.71e-2)" "unprognostic (1.56e-2)" "unprognostic (9.14e-2)" "unprognostic (6.10e-4)" "unprognostic (2.69e-2)" "unprognostic (1.67e-2)" "unprognostic (9.76e-3)" "unprognostic (7.85e-2)" "unprognostic (5.04e-3)" "unprognostic (4.98e-2)" 0.4 0.6 1.1 0.5 1.3 0.2 0.4 0.8 1.2 0.4 0.4 0.4 0.4 0.6 0.4 0.4 0.4 0.3 0.4 0.4 1.1 1.3 0.4 0.4 0.4 0.8 1.9 0.4 0.9 1.1 0.0 0.6 0.4 0.4 0.5 0.0 0.4 0.4 0.4 1.1 1.6 0.9 0.4 2.1 1.2 0.9 15.8 0.4 0.4 0.9 0.4 0.4 0.4 0.4 2.9 1.2 0.1 1.0 0.4 2.1 0.6 0.0 0.5 0.0 2.8 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.3 0.3 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.4 0.0 1.1 0.1 0.9 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.1 1.4 0.1 0.6 0.1 0.0 0.1 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.3 0.7 0.0 0.5 0.0 2.0 1.0 1.1 1.2 2.1 0.7 1.2 2.9 2.1 1.3 0.1 0.4 0.1 0.9 1.4 0.6 1.1 1.3 0.8 0.5 1.1 1.3 1.9 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 194.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 243.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 CCDC12 MGC23918 ENSG00000160799 "Coiled-coil domain containing 12" Q8WUD4 3 46921726-46982010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056814, HPA060530" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA056814: AB_2683241, HPA060530: AB_2684309" "unprognostic (1.47e-2)" "unprognostic (1.79e-3)" "unprognostic (2.27e-1)" "unprognostic (1.32e-3)" "unprognostic (1.65e-1)" "unprognostic (4.24e-2)" "unprognostic (6.15e-2)" "unprognostic (4.27e-3)" "unprognostic (1.88e-1)" "unprognostic (4.35e-2)" "unprognostic (1.50e-2)" "unprognostic (4.08e-2)" "prognostic favorable (1.15e-4)" "unprognostic (2.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.86e-3)" "unprognostic (4.65e-2)" 11.1 14.0 7.8 10.5 9.2 15.1 8.9 13.0 10.3 17.4 13.0 6.1 35.7 11.8 12.5 14.9 50.9 8.4 23.7 11.3 8.3 7.8 10.0 9.5 15.6 13.8 8.2 6.2 9.9 11.2 5.5 8.2 9.0 7.6 14.4 6.1 7.3 52.0 56.7 48.9 16.5 10.4 10.1 7.9 11.5 13.5 6.6 5.2 6.7 9.8 19.6 27.6 11.6 13.5 54.3 55.7 31.9 39.5 31.3 40.9 29.6 17.4 14.7 17.3 9.0 9.8 8.1 13.3 17.7 9.1 13.4 9.8 19.0 15.1 34.2 16.2 10.6 19.1 9.8 14.7 16.5 5.7 33.5 11.1 37.5 21.6 28.6 13.4 40.2 26.8 10.9 15.7 17.0 15.1 10.7 13.0 22.0 40.0 17.0 6.5 21.1 31.1 38.1 22.6 17.3 12.2 13.2 13.4 21.9 13.8 18.4 9.2 17.9 21.7 18.0 16.8 8.0 13.7 40.1 26.5 9.0 17.7 18.3 28.1 22.3 48.7 42.5 12.6 28.6 12.9 11.1 37.4 31.9 40.9 38.3 32.1 54.3 31.6 35.7 35.0 53.5 27.3 32.2 11.3 31.3 39.5 55.7 38.5 29.6 7.8 9.2 13.0 9.4 8.3 7.8 8.2 6.2 7.6 5.2 74.5 47.8 116.2 114.6 70.3 51.3 44.4 56.0 52.2 50.0 76.8 51.1 113.1 94.5 89.3 3.4 66.6 110.9 23.3 109.2 94.8 57.8 77.8 80.8 48.7 87.8 55.6 76.0 52.8 65.3 6.2 54.1 66.7 43.9 106.4 65.7 64.2 89.4 132.5 45.3 73.9 75.0 38.8 61.4 17.9 50.9 95.1 139.6 102.3 79.7 187.7 CCDC129 FLJ38344 ENSG00000180347 "Coiled-coil domain containing 129" Q6ZRS4 7 31514071-31658720 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 17.2;salivary gland: 10.9" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 8.2;Intestinal endocrine cells: 1.7;Late spermatids: 5.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebellum: 7.9;midbrain: 5.0;pons and medulla: 17.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 1.6;CACO-2: 1.3;RH-30: 2.1;T-47d: 2.7;U-2 OS: 5.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA024103 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA024103: AB_1846132" "unprognostic (1.11e-2)" "unprognostic (1.39e-1)" "unprognostic (1.57e-1)" "unprognostic (1.78e-5)" "unprognostic (9.72e-3)" "unprognostic (1.78e-1)" "unprognostic (3.89e-2)" "unprognostic (6.42e-3)" "unprognostic (1.01e-1)" "unprognostic (5.77e-2)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" 0.1 0.0 0.1 0.6 2.0 0.1 3.3 7.9 0.3 3.7 0.9 1.2 0.0 2.1 1.1 0.2 0.1 0.1 0.1 0.0 0.4 1.4 0.1 0.0 0.4 0.0 5.0 0.0 0.0 0.2 0.0 0.4 0.9 17.2 0.1 0.2 0.0 10.9 0.0 0.0 4.5 0.9 1.1 0.2 0.0 0.8 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.8 1.1 0.0 0.1 1.0 0.1 0.0 0.0 1.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.5 0.8 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.1 2.1 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.2 2.7 0.0 0.0 0.0 5.6 0.2 0.3 0.2 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.7 0.2 0.1 0.1 0.8 1.0 0.4 1.1 0.1 0.0 0.8 0.0 0.1 0.1 2.0 7.9 0.3 0.4 1.4 5.0 0.0 17.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 5.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 CCDC141 "CAMDI, FLJ39502" ENSG00000163492 "Coiled-coil domain containing 141" 2 178829757-179050086 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 47.5;lung: 17.6" "Cell type enhanced" "Detected in many" 22 "Alveolar cells type 2: 19.8;Cardiomyocytes: 103.0;Early spermatids: 34.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "T-reg: 12.9" "Group enriched" "Detected in many" 9 "B-cells: 7.6;T-cells: 12.9" "Cell line enhanced" "Detected in some" "CACO-2: 6.4;Daudi: 4.1;HEL: 9.5;RH-30: 5.1;U-266/70: 6.1;U-698: 8.5" HPA012718 Approved Nucleoplasm NA NA Nucleoplasm "HPA012718: AB_2072055" "unprognostic (1.58e-1)" "unprognostic (1.85e-2)" "unprognostic (3.10e-2)" "unprognostic (2.37e-1)" "unprognostic (8.62e-3)" "unprognostic (4.25e-2)" "unprognostic (2.98e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (1.74e-2)" "unprognostic (5.33e-2)" "unprognostic (8.03e-3)" "unprognostic (7.71e-8)" "unprognostic (2.50e-2)" "unprognostic (1.52e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-1)" 1.6 0.6 0.5 7.5 0.6 0.9 4.9 0.5 0.5 0.7 1.2 0.1 0.5 0.2 0.8 2.2 2.5 0.6 6.3 47.5 0.6 0.6 0.5 0.5 17.6 4.4 0.6 0.0 0.8 3.8 0.2 0.5 0.8 1.1 1.0 0.3 1.8 0.6 0.3 9.3 0.5 0.7 1.7 0.7 1.8 0.6 1.6 0.0 11.0 0.7 2.1 7.4 1.4 1.2 7.6 0.0 0.4 0.0 1.1 12.9 0.4 0.2 0.0 0.1 0.3 0.0 0.1 2.0 0.0 0.1 0.0 0.2 6.4 0.5 4.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 3.5 0.2 9.5 0.3 0.0 0.0 1.7 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.6 0.1 0.1 0.1 0.3 3.4 0.6 0.7 0.2 5.1 1.6 0.0 0.1 0.2 0.2 0.1 0.3 0.1 1.1 0.3 0.4 0.1 0.3 0.2 0.3 0.0 6.1 0.1 8.5 0.3 0.5 0.6 0.3 0.0 0.2 0.3 0.0 0.2 6.6 2.1 1.4 0.0 7.6 6.4 4.8 0.4 1.1 0.0 0.0 12.9 0.4 0.5 0.6 0.5 0.5 0.6 0.6 0.6 0.0 1.1 0.0 6.0 19.8 0.5 0.0 0.1 1.4 103.0 10.2 2.7 1.2 0.0 0.0 0.0 0.0 2.5 34.6 3.6 0.0 0.0 1.2 0.2 0.4 0.0 5.8 0.0 0.0 6.4 0.0 0.0 0.3 12.9 1.1 0.8 1.7 0.0 0.0 3.8 0.2 0.0 1.8 0.0 0.6 6.5 1.4 0.0 0.2 0.1 0.0 5.0 0.0 0.1 CCDC150 FLJ39660 ENSG00000144395 "Coiled-coil domain containing 150" Q8NCX0 2 196639554-196763490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 6.7;testis: 11.9" "Group enriched" "Detected in many" 4 "Early spermatids: 24.9;Late spermatids: 16.8;Melanocytes: 6.8;Proximal tubular cells: 9.8;Spermatocytes: 26.5;Spermatogonia: 13.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048104 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA048104: AB_2680264" "unprognostic (1.92e-1)" "unprognostic (3.75e-1)" "unprognostic (2.95e-1)" "unprognostic (2.58e-4)" "unprognostic (9.88e-2)" "unprognostic (1.42e-3)" "unprognostic (1.59e-2)" "unprognostic (1.62e-1)" "unprognostic (5.91e-4)" "unprognostic (2.01e-2)" "unprognostic (3.16e-2)" "unprognostic (9.17e-3)" "unprognostic (5.66e-4)" "unprognostic (7.29e-2)" "unprognostic (1.99e-2)" "unprognostic (4.35e-2)" "unprognostic (2.69e-5)" 0.5 0.4 1.0 2.9 5.2 1.5 0.5 2.6 3.1 0.4 1.0 2.4 0.0 0.6 0.5 0.6 1.6 0.6 0.6 0.5 1.3 0.5 6.7 3.4 0.5 0.8 3.1 0.3 0.5 0.5 0.5 1.0 0.7 2.9 0.4 0.9 0.1 0.4 0.2 0.6 0.6 0.8 1.2 3.1 0.6 0.6 11.9 3.9 3.9 0.4 2.9 2.1 0.6 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.6 0.6 7.2 4.6 0.2 0.4 3.2 1.6 0.8 1.3 3.4 2.4 1.5 1.2 0.9 1.3 1.1 2.1 2.9 1.3 3.3 6.6 4.1 2.5 3.5 3.9 0.0 1.3 1.1 0.0 0.2 1.6 0.9 0.4 0.8 2.5 3.2 3.0 0.9 0.7 1.2 2.1 4.1 0.5 1.7 2.7 1.2 0.9 0.5 0.7 7.9 1.4 1.2 0.7 0.3 4.0 1.1 0.8 1.4 2.5 2.1 2.3 1.4 1.3 1.3 2.1 1.0 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 5.2 2.6 3.1 1.3 0.5 3.1 0.3 2.9 3.9 3.0 1.7 0.8 1.5 1.3 3.9 1.6 0.0 4.0 0.0 0.0 2.0 1.1 1.7 0.3 24.9 1.1 0.0 0.0 0.3 1.7 2.5 1.4 3.5 3.9 1.0 1.6 0.0 1.3 1.0 16.8 1.4 1.5 6.8 0.0 0.7 1.6 0.4 0.2 1.8 9.8 0.7 0.0 0.9 26.5 13.8 0.9 0.6 0.8 1.1 1.1 CCDC151 MGC20983 ENSG00000198003 "Coiled-coil domain containing 151" A5D8V7 19 11420604-11435782 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.7;fallopian tube: 18.2" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 30.8;Distal tubular cells: 24.9;Kupffer cells: 37.0;Muller glia cells: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.3;memory B-cell: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 4.1;T-47d: 9.4;U-87 MG: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA044184, HPA054626" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA044184: AB_10959331, HPA054626: AB_2682547" "unprognostic (1.50e-1)" "unprognostic (6.59e-2)" "unprognostic (2.05e-3)" "unprognostic (4.41e-3)" "unprognostic (1.35e-2)" "unprognostic (6.30e-2)" "unprognostic (4.41e-3)" "unprognostic (2.32e-2)" "unprognostic (2.22e-1)" "unprognostic (5.09e-2)" "unprognostic (6.76e-4)" "unprognostic (3.01e-1)" "unprognostic (2.63e-3)" "unprognostic (4.27e-2)" "unprognostic (1.85e-1)" "unprognostic (2.35e-1)" "unprognostic (2.05e-1)" 0.8 3.1 5.7 0.6 9.9 0.6 0.6 4.4 7.7 1.6 0.6 4.0 1.4 0.6 1.0 2.8 0.6 18.2 0.6 1.2 7.7 4.3 2.0 0.8 2.7 0.6 2.3 4.6 2.5 0.6 9.8 10.4 1.4 12.7 0.8 0.6 0.7 4.0 1.8 0.5 0.5 0.6 0.6 1.7 1.9 0.9 8.5 5.4 0.0 2.1 0.0 0.7 0.6 0.4 1.5 0.7 0.1 2.3 0.0 0.0 0.1 0.5 0.1 1.2 0.1 0.1 0.4 1.0 0.5 0.1 0.6 0.7 0.1 0.0 0.3 0.5 0.2 2.3 0.2 0.9 0.5 0.0 1.0 1.0 0.4 0.6 0.0 0.5 0.0 0.5 0.3 0.0 0.6 0.0 1.0 0.0 0.2 0.0 0.9 0.2 0.8 0.0 0.1 0.5 0.3 2.2 0.4 0.1 1.4 0.7 0.0 4.1 2.7 1.2 0.2 0.1 0.5 9.4 0.4 0.0 1.5 0.3 3.5 0.1 3.4 2.7 0.2 3.7 0.6 0.1 0.0 0.6 0.0 0.0 2.3 0.0 1.5 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 5.7 9.9 4.4 7.7 7.7 4.3 2.3 4.6 12.7 5.4 0.0 0.0 3.0 0.6 0.8 0.9 1.2 2.5 30.8 3.4 12.2 0.0 0.4 24.9 0.2 9.6 0.9 0.0 0.0 0.2 0.4 4.3 0.1 4.6 0.5 4.1 1.6 0.0 12.3 37.0 11.5 2.6 3.0 6.8 0.0 0.0 30.6 0.1 0.0 0.7 0.5 2.7 6.5 5.1 15.3 2.9 0.4 1.0 0.0 0.0 0.3 CCDC174 "C3orf19, FLJ33839" ENSG00000154781 "Coiled-coil domain containing 174" Q6PII3 3 14651746-14672659 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043468, HPA060129" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043468: AB_2678493, HPA060129: AB_2684208" "unprognostic (6.10e-2)" "unprognostic (7.96e-2)" "unprognostic (2.92e-1)" "unprognostic (3.26e-2)" "unprognostic (6.58e-3)" "unprognostic (5.06e-2)" "unprognostic (6.48e-3)" "unprognostic (1.13e-1)" "unprognostic (1.52e-1)" "unprognostic (5.29e-2)" "unprognostic (3.86e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.15e-2)" "unprognostic (2.30e-3)" "unprognostic (2.04e-1)" "unprognostic (2.64e-1)" "prognostic favorable (3.81e-5)" 16.8 12.9 15.7 13.4 17.5 27.1 17.1 22.3 18.2 19.2 18.5 17.8 15.2 16.8 24.0 14.5 16.1 15.5 12.9 14.4 13.1 10.9 17.9 15.3 13.0 15.7 17.9 14.8 28.0 18.6 15.7 29.9 15.6 16.9 17.7 13.7 12.6 16.1 15.7 26.9 17.4 20.6 14.9 18.7 20.2 18.2 15.3 19.2 23.1 17.5 9.8 18.4 19.0 17.6 14.7 9.5 21.0 9.9 15.4 16.7 8.4 5.1 5.7 8.8 9.3 12.2 10.1 22.3 7.0 10.0 8.8 6.9 6.4 6.1 10.8 5.1 6.1 6.0 4.6 6.3 5.8 6.9 8.1 7.7 11.0 6.8 6.8 17.7 10.7 12.8 11.6 15.0 11.8 14.6 12.4 7.5 11.6 10.9 9.9 6.5 9.1 11.2 9.5 11.8 8.6 9.4 8.4 8.2 8.8 9.0 9.2 4.3 11.6 8.1 6.4 11.2 10.7 9.7 15.3 6.9 7.1 6.9 6.5 8.0 13.2 11.7 12.6 7.1 8.3 9.6 21.0 9.5 18.4 12.1 9.7 14.1 14.7 15.1 13.9 8.4 13.3 16.7 13.3 18.4 15.4 9.9 9.5 10.3 8.4 15.7 17.5 22.3 18.2 13.1 10.9 17.9 14.8 16.9 19.2 8.9 34.6 52.9 25.1 14.3 31.2 32.7 28.1 36.1 34.2 12.2 19.6 26.1 48.0 29.4 124.0 26.9 26.2 70.0 30.5 21.0 25.8 23.3 50.8 26.6 23.1 14.3 17.7 27.6 22.9 39.8 31.1 28.8 13.5 55.1 21.6 23.3 32.0 31.7 37.8 29.8 23.3 32.3 21.7 47.7 31.1 11.8 54.9 42.1 21.1 27.8 CCDC36 "CT74, FLJ25320" ENSG00000173421 "Coiled-coil domain containing 36" Q8IYA8 3 49198428-49258104 "Predicted intracellular proteins" "Differentiation, DNA recombination, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.4" "Group enriched" "Detected in some" 8 "Early spermatids: 51.2;Late spermatids: 32.2;Spermatocytes: 85.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 3.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.9;hTEC/SVTERT24-B: 13.3;LHCN-M2: 5.5;U-2197: 7.2;WM-115: 3.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA045690, HPA069534" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045690: AB_10964634, HPA069534: AB_2686146" "unprognostic (1.54e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.36e-2)" "unprognostic (1.49e-2)" "unprognostic (9.94e-3)" "unprognostic (2.62e-1)" "unprognostic (1.38e-1)" "unprognostic (1.36e-2)" "unprognostic (5.51e-4)" "unprognostic (3.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.59e-2)" "unprognostic (6.33e-2)" 6.5 1.7 0.8 1.8 0.8 0.4 3.6 0.8 0.7 3.7 2.2 0.7 2.1 0.4 6.3 1.2 1.1 1.3 1.4 1.9 0.9 0.4 0.5 0.4 1.4 0.5 1.1 0.1 5.0 0.4 0.2 0.4 1.4 2.0 0.6 0.4 2.6 2.0 0.8 1.6 0.8 0.6 3.9 0.4 0.7 0.6 35.4 0.3 0.0 1.3 0.3 0.6 1.2 0.9 0.9 0.6 3.6 0.3 0.8 0.5 0.2 0.0 0.2 0.1 0.2 2.8 3.1 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 3.5 0.0 0.2 2.4 0.0 13.3 0.0 0.0 1.7 0.1 0.0 0.3 5.5 0.0 0.0 0.2 3.5 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 2.5 7.2 0.1 0.1 0.1 0.1 0.0 0.2 3.6 2.1 0.3 0.6 0.4 0.2 0.3 0.8 0.4 0.3 0.1 0.9 0.4 0.5 3.6 0.8 0.2 0.6 0.3 0.2 0.8 0.8 0.8 0.7 0.9 0.4 1.1 0.1 2.0 0.3 0.0 1.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.8 5.9 0.0 0.0 0.0 51.2 2.4 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.3 0.0 0.0 0.6 0.0 32.2 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.9 0.0 0.0 85.6 6.8 0.4 0.1 0.0 0.0 0.0 CCDC61 ENSG00000104983 "Coiled-coil domain containing 61" Q9Y6R9 19 45995461-46021318 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NB-4: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040325, HPA061548" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA040325: AB_10672970, HPA061548: AB_2684559" "unprognostic (1.30e-1)" "unprognostic (1.51e-3)" "unprognostic (2.56e-1)" "unprognostic (6.23e-3)" "unprognostic (7.27e-2)" "unprognostic (5.59e-3)" "unprognostic (4.83e-2)" "unprognostic (2.81e-1)" "unprognostic (1.58e-1)" "unprognostic (2.93e-2)" "unprognostic (2.73e-2)" "unprognostic (1.34e-1)" "unprognostic (2.13e-3)" "unprognostic (2.58e-1)" "unprognostic (2.09e-1)" "unprognostic (1.40e-2)" "unprognostic (1.09e-1)" 9.0 10.7 7.8 16.9 8.0 6.3 8.5 10.5 9.3 9.2 12.4 13.1 9.3 9.4 15.2 9.5 9.4 18.3 10.7 7.5 6.0 5.0 10.1 10.6 8.8 11.7 6.6 12.4 12.0 10.2 11.2 12.7 7.3 6.3 11.1 6.0 11.8 10.2 11.3 5.5 15.1 10.2 14.5 6.6 12.6 10.6 22.6 10.1 17.8 13.8 7.0 13.0 11.0 9.4 1.9 0.6 7.8 1.0 0.6 2.0 0.4 8.6 6.3 3.3 5.7 6.3 4.6 5.1 6.2 3.2 3.7 6.3 3.9 7.6 5.4 3.1 4.3 5.2 7.3 3.6 8.3 2.8 10.2 3.4 5.7 5.0 6.2 7.0 5.4 8.0 5.0 11.4 3.2 6.7 6.4 7.5 10.4 6.3 11.2 4.8 2.7 12.4 35.3 1.2 9.2 2.7 8.4 1.1 8.7 6.1 7.2 3.6 3.3 6.1 8.0 4.7 3.4 3.4 7.9 6.3 2.7 1.1 1.3 6.9 6.9 3.3 5.4 6.1 6.1 4.5 7.8 0.9 0.8 2.0 0.8 1.1 1.4 1.0 1.2 0.4 1.9 1.5 1.2 2.8 0.6 1.0 0.6 1.0 0.4 7.8 8.0 10.5 9.3 6.0 5.0 6.6 12.4 6.3 10.1 0.0 4.1 1.4 6.2 5.6 4.4 4.2 2.5 1.4 4.5 10.4 0.0 10.1 8.3 1.3 2.6 4.0 8.5 0.0 1.6 7.0 4.3 3.7 0.0 4.0 6.8 3.2 3.5 3.7 4.4 0.9 4.9 2.1 3.3 0.0 8.4 4.8 1.6 5.8 5.3 6.7 1.5 6.5 4.7 13.4 6.1 4.5 6.5 4.4 8.0 3.1 CCDC84 DLNB14 ENSG00000186166 "Coiled-coil domain containing 84" Q86UT8 11 118998142-119015791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 18.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039906, HPA071715" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA039906: AB_2676740, HPA071715: AB_2686436" "unprognostic (5.83e-2)" "unprognostic (2.64e-1)" "unprognostic (1.36e-1)" "unprognostic (8.12e-2)" "unprognostic (1.54e-1)" "unprognostic (4.06e-2)" "unprognostic (1.15e-2)" "unprognostic (1.03e-3)" "unprognostic (3.60e-3)" "unprognostic (3.45e-2)" "unprognostic (4.64e-3)" "unprognostic (1.20e-2)" "prognostic unfavorable (2.93e-5)" "unprognostic (8.14e-2)" "unprognostic (8.24e-2)" "unprognostic (3.15e-1)" "unprognostic (2.09e-3)" 9.3 10.7 10.5 11.0 15.3 15.2 12.5 18.9 17.5 9.8 10.6 19.4 12.1 10.7 16.2 16.6 9.3 8.7 10.4 9.4 11.4 9.0 12.6 15.0 13.2 13.6 15.8 11.7 10.0 10.1 14.1 14.1 9.9 16.7 13.7 9.8 18.7 13.0 16.6 16.7 19.1 11.7 12.8 8.7 18.8 10.8 6.8 12.3 7.6 14.0 9.4 15.1 8.5 10.1 5.8 3.8 4.0 2.1 5.5 8.8 2.5 3.6 3.2 2.7 3.7 2.8 0.9 2.8 3.2 3.4 2.8 1.8 18.2 2.2 1.3 10.7 3.6 4.3 9.6 1.3 1.7 2.9 5.0 2.0 6.1 5.4 5.0 2.6 2.6 3.4 1.1 1.9 2.9 3.3 2.9 1.6 4.1 1.3 4.8 2.7 5.7 6.5 4.6 3.5 5.4 8.3 9.0 5.5 6.2 4.4 5.2 3.8 2.5 8.3 2.5 0.6 4.4 7.5 2.3 1.7 2.8 13.5 3.8 2.1 3.7 3.6 5.6 2.2 4.9 5.2 0.0 2.1 4.0 4.4 1.2 5.2 5.0 5.4 4.7 3.3 5.8 5.0 3.6 3.6 5.5 1.2 3.8 8.8 2.5 10.5 15.3 18.9 17.5 11.4 9.0 15.8 11.7 16.7 12.3 41.7 40.5 7.8 13.8 14.0 43.0 7.3 12.7 12.0 35.2 12.2 45.2 13.1 5.0 7.4 1.3 11.9 7.1 0.0 13.1 3.1 11.3 9.3 25.5 6.4 8.0 17.5 6.3 8.6 7.9 1.4 8.9 11.2 6.8 17.2 6.1 17.1 13.1 8.6 8.9 3.1 69.8 12.9 11.7 9.6 11.7 9.7 6.1 14.9 6.0 7.1 CCDC89 FLJ38159 ENSG00000179071 "Coiled-coil domain containing 89" Q8N998 11 85684866-85686277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 40.6" "Cell type enriched" "Detected in some" 11 "Early spermatids: 332.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.4;GAMG: 5.2;LHCN-M2: 6.2;SCLC-21H: 7.3;U-2197: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040628 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA040628: AB_2677053" "unprognostic (5.81e-2)" "unprognostic (1.93e-1)" "unprognostic (1.99e-1)" "unprognostic (3.04e-2)" "unprognostic (5.37e-2)" "unprognostic (6.38e-2)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" "unprognostic (8.22e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (2.00e-1)" "unprognostic (2.41e-3)" "unprognostic (7.75e-3)" "unprognostic (5.10e-2)" "unprognostic (8.47e-2)" "unprognostic (3.52e-1)" 0.7 0.9 0.9 0.1 1.8 0.0 1.3 6.4 1.3 1.5 0.6 2.0 0.9 0.1 2.8 0.9 0.3 10.5 1.1 1.0 1.2 1.2 1.4 0.3 1.2 0.6 0.9 1.2 5.9 0.2 2.7 5.2 0.7 3.7 1.7 0.7 0.9 0.4 1.9 0.7 0.5 0.5 2.6 1.2 0.4 1.1 40.6 0.9 0.1 0.4 0.2 0.0 0.7 0.7 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.1 3.8 5.0 0.2 1.4 0.0 0.0 0.1 0.2 0.0 0.1 5.4 4.2 5.2 1.9 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.3 2.6 0.0 0.0 2.8 0.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.3 0.0 0.0 0.0 0.6 0.0 0.0 4.3 0.0 0.3 2.8 7.3 1.8 0.0 0.9 0.0 0.1 0.6 0.0 0.0 3.7 0.0 8.3 3.4 0.0 3.7 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 6.4 1.3 1.2 1.2 0.9 1.2 3.7 0.9 0.0 1.1 0.0 0.0 0.2 0.1 0.0 0.0 29.4 1.2 0.0 0.0 0.0 0.0 0.0 332.2 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 1.3 6.4 0.0 0.6 1.2 13.3 2.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 4.2 1.2 0.5 0.0 0.1 3.4 0.9 0.3 0.0 0.0 0.0 0.1 CCDC94 FLJ10374 ENSG00000105248 "Coiled-coil domain containing 94" Q9BW85 19 4247079-4269090 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043606, HPA055675" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA043606: AB_10963431, HPA055675: AB_2682880" "unprognostic (1.75e-2)" "unprognostic (2.11e-3)" "unprognostic (1.81e-2)" "unprognostic (6.91e-3)" "unprognostic (1.96e-1)" "unprognostic (1.28e-3)" "unprognostic (2.91e-1)" "unprognostic (1.11e-2)" "unprognostic (1.33e-1)" "unprognostic (7.53e-2)" "unprognostic (1.01e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.32e-4)" "prognostic favorable (8.04e-4)" "unprognostic (7.61e-2)" "unprognostic (3.12e-2)" "unprognostic (9.46e-3)" 18.1 14.8 16.1 14.5 17.3 50.5 14.3 22.0 20.3 15.5 16.2 18.4 15.6 17.9 17.2 14.6 16.9 16.8 12.5 12.2 16.2 13.6 18.1 16.7 14.7 20.8 20.4 17.1 23.3 24.7 12.2 10.4 23.2 15.6 15.4 10.9 16.0 19.7 14.5 21.5 19.7 15.2 13.6 17.3 18.7 16.1 16.6 20.0 18.8 20.0 26.3 18.8 14.0 12.5 24.8 19.3 22.6 19.3 16.8 25.0 13.9 17.2 16.8 9.4 7.5 5.6 7.5 9.6 7.0 8.9 13.1 14.6 14.9 10.6 20.1 8.0 10.5 11.3 13.1 15.2 16.6 9.2 11.6 15.0 12.9 10.9 17.4 8.3 16.8 18.1 7.9 10.0 11.5 17.2 8.0 10.6 9.8 18.3 23.5 5.4 23.8 17.7 10.5 22.4 7.9 12.8 10.4 7.9 17.9 12.2 17.0 13.6 14.1 6.2 13.6 12.5 5.7 9.8 15.8 11.8 9.3 9.8 18.7 17.3 25.6 18.1 20.0 13.0 18.0 9.9 15.2 15.2 22.6 21.2 19.3 18.9 23.3 20.5 19.5 18.5 24.8 24.5 20.2 9.4 16.8 13.8 19.3 25.0 13.9 16.1 17.3 22.0 20.3 16.2 13.6 20.4 17.1 15.6 20.0 8.9 19.5 14.3 17.9 9.2 12.1 0.0 7.6 1.4 12.5 0.0 0.0 24.6 0.0 0.0 4.1 9.8 18.8 0.0 0.0 21.7 8.0 10.2 32.3 6.2 17.6 12.7 10.4 9.8 11.4 5.7 11.5 9.3 8.5 0.0 11.8 16.0 0.0 12.2 11.0 0.0 12.1 6.5 7.6 13.5 12.1 8.3 38.2 14.4 16.2 12.8 CCM2L "C20orf160, dJ310O13.5" ENSG00000101331 "CCM2 like scaffolding protein" Q9NUG4 20 32010450-32032180 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 53.0" "Group enriched" "Detected in some" 4 "Endothelial cells: 22.4;Ito cells: 20.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 10.6;HUVEC TERT2: 12.5;NTERA-2: 6.8;RH-30: 4.7;SCLC-21H: 11.6;TIME: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA008434, HPA071063" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008434: AB_1845671, HPA071063: AB_2686339" "unprognostic (1.71e-1)" "unprognostic (4.64e-2)" "unprognostic (2.43e-3)" "unprognostic (5.84e-3)" "unprognostic (1.91e-1)" "unprognostic (3.09e-3)" "unprognostic (1.27e-3)" "unprognostic (2.37e-1)" "unprognostic (2.04e-1)" "unprognostic (4.34e-2)" "unprognostic (1.00e-3)" "unprognostic (7.84e-2)" "unprognostic (4.66e-3)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" 7.2 1.8 2.1 1.8 2.0 0.2 15.0 2.1 2.2 4.4 1.4 1.7 2.1 1.2 7.1 2.3 1.9 2.6 2.4 5.4 2.0 1.7 3.1 1.0 15.1 1.3 2.3 1.5 1.8 1.0 1.4 1.4 6.7 2.5 1.9 1.2 4.9 1.4 2.0 3.5 1.5 1.6 3.2 1.4 53.0 1.4 1.6 1.6 0.2 3.0 5.2 1.0 2.0 4.6 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 12.5 1.3 0.0 0.0 0.0 3.5 0.0 0.0 6.8 0.2 0.0 0.8 4.7 0.2 0.0 0.0 11.6 1.3 0.3 0.0 0.0 1.7 3.7 0.0 6.3 0.1 2.0 0.0 0.0 0.2 0.0 0.2 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.1 2.0 2.1 2.2 2.0 1.7 2.3 1.5 2.5 1.6 0.0 0.0 0.0 0.0 0.1 0.5 3.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 20.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.5 0.3 0.0 0.0 0.0 0.0 CCND1 "BCL1, D11S287E, PRAD1, U21B31" ENSG00000110092 "Cyclin D1" P24385 11 69641087-69654474 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation" "Cyclin, Repressor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 534.1;Pancreatic endocrine cells: 367.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.0;myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 96.3;WM-115: 134.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000024, HPA027802" Uncertain Supported Nucleoplasm Yes No Nucleoplasm "CAB000024: AB_563678, HPA027802: AB_2672390" "unprognostic (4.90e-2)" "unprognostic (1.54e-1)" "unprognostic (7.62e-2)" "unprognostic (1.39e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.38e-1)" "unprognostic (2.53e-2)" "unprognostic (9.46e-2)" "unprognostic (4.84e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (4.39e-2)" "unprognostic (2.61e-3)" "unprognostic (4.38e-3)" "unprognostic (1.16e-1)" "unprognostic (6.40e-3)" "unprognostic (2.57e-1)" 52.0 11.6 9.7 6.0 9.7 0.7 22.8 3.4 7.7 15.4 8.9 15.4 19.9 8.4 18.8 23.1 37.7 11.8 31.0 23.9 10.8 8.8 14.5 68.1 22.2 3.7 12.4 5.6 6.5 31.5 83.2 16.6 38.1 10.0 30.7 6.8 24.8 25.6 21.7 2.0 43.6 10.4 16.5 12.6 12.9 19.2 4.0 7.5 9.0 17.1 23.1 23.6 21.4 22.1 3.0 3.4 0.8 0.0 0.0 0.9 0.3 48.7 19.5 6.5 0.2 20.0 21.1 14.0 77.2 28.8 9.0 5.3 21.9 37.8 0.0 35.1 40.1 15.1 35.7 0.7 21.0 16.2 0.1 3.9 0.0 4.8 22.2 4.8 0.3 0.7 11.9 4.1 12.7 4.9 21.3 15.4 0.0 0.0 0.1 71.0 20.6 0.0 2.8 11.9 20.2 21.5 0.1 20.6 1.1 41.9 30.1 1.1 25.5 0.9 18.3 48.0 16.5 11.1 1.0 64.4 44.3 12.3 19.2 52.4 96.3 57.5 0.1 37.9 0.6 134.1 0.8 0.0 0.0 0.9 0.0 0.1 3.0 0.4 0.2 3.4 2.5 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.3 9.7 9.7 3.4 7.7 10.8 8.8 12.4 5.6 10.0 7.5 169.7 99.5 5.9 202.5 179.8 2.2 68.0 124.9 78.9 155.8 118.7 2.0 6.4 26.6 534.1 0.2 134.5 22.2 0.0 128.5 1.1 63.9 195.1 27.8 148.1 60.6 0.0 54.3 108.1 18.0 0.9 3.7 17.9 49.0 3.6 40.4 66.7 367.2 54.7 54.1 42.3 2.0 129.4 220.1 0.2 19.0 306.9 2.1 7.0 62.1 326.2 CCND2 ENSG00000118971 "Cyclin D2" P30279 12 4273772-4305350 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 305.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 32.3;HBEC3-KT: 29.5;HDLM-2: 49.7;Karpas-707: 71.8;RH-30: 47.0;SuSa: 37.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049138, HPA054196" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA049138: AB_2680650, HPA054196: AB_2682412" "unprognostic (2.98e-3)" "unprognostic (1.15e-1)" "unprognostic (7.21e-2)" "unprognostic (1.65e-2)" "unprognostic (1.70e-2)" "unprognostic (4.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.01e-3)" "unprognostic (3.16e-2)" "unprognostic (1.66e-2)" "prognostic favorable (2.52e-4)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (8.23e-2)" "unprognostic (4.52e-1)" "prognostic favorable (9.76e-5)" "unprognostic (7.06e-2)" 13.7 39.3 20.8 12.0 15.9 23.6 10.4 6.1 22.3 14.4 28.3 8.1 24.3 18.5 21.9 41.9 12.2 16.5 9.1 36.9 17.5 7.3 6.0 5.7 12.8 24.5 7.9 17.0 11.6 18.4 8.3 19.2 23.5 9.3 16.4 24.2 14.1 8.3 22.4 2.0 9.2 19.6 45.5 14.0 16.5 11.1 5.2 8.6 6.2 18.5 6.9 13.6 22.3 16.3 3.9 2.1 4.6 1.0 9.1 14.8 5.4 0.0 0.0 32.3 0.0 5.6 0.8 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.2 0.0 0.0 4.1 0.9 29.5 0.0 49.7 0.8 0.3 0.0 0.2 0.1 12.6 2.7 10.8 4.9 0.0 22.3 0.2 0.0 0.9 3.4 71.8 6.3 0.0 0.0 16.6 13.3 0.2 0.0 0.0 47.0 23.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.1 2.3 0.0 9.4 0.0 0.0 1.2 12.2 0.0 0.1 9.1 0.0 4.1 1.0 4.6 9.1 0.2 13.7 3.9 13.0 11.0 2.1 1.5 8.2 9.8 1.5 9.1 0.1 1.0 14.8 5.4 20.8 15.9 6.1 22.3 17.5 7.3 7.9 17.0 9.3 8.6 56.6 49.3 25.1 24.4 94.8 6.8 305.9 0.0 9.4 43.3 12.2 0.0 2.6 0.0 2.5 0.7 38.4 26.9 46.7 59.7 1.7 135.6 5.7 54.3 0.8 12.0 3.2 62.3 17.8 13.3 0.9 48.6 38.9 37.1 6.4 146.6 155.3 32.6 35.1 116.7 1.0 3.7 25.8 50.5 0.7 3.6 34.6 5.3 61.2 109.0 7.0 CCND3 ENSG00000112576 "Cyclin D3" P30281 6 41934933-42050357 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 129.2;lymphoid tissue: 142.5" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 197.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 94.2;REH: 89.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000116, HPA042871" Approved Supported Nucleoplasm NA Yes Nucleoplasm "CAB000116: , HPA042871: " "unprognostic (4.53e-2)" "unprognostic (4.45e-2)" "unprognostic (2.45e-1)" "unprognostic (4.40e-3)" "unprognostic (1.01e-1)" "unprognostic (9.80e-2)" "unprognostic (3.40e-2)" "unprognostic (5.25e-2)" "unprognostic (7.76e-2)" "unprognostic (3.45e-1)" "unprognostic (9.17e-2)" "unprognostic (6.39e-2)" "unprognostic (2.45e-3)" "unprognostic (9.12e-2)" "unprognostic (1.71e-1)" "prognostic favorable (8.08e-6)" "unprognostic (2.11e-1)" 20.2 39.8 16.1 28.9 17.5 74.7 36.0 13.3 19.8 13.3 17.3 11.3 14.1 16.0 10.8 10.4 13.5 13.4 19.0 16.3 15.4 14.5 13.7 8.0 32.1 83.8 14.1 15.5 11.1 10.9 5.0 10.1 21.9 9.3 14.2 11.4 10.2 18.1 14.4 6.5 14.6 22.0 11.7 11.5 51.2 18.0 7.4 10.0 142.5 26.8 9.3 32.8 13.0 16.6 24.1 42.4 129.2 45.8 39.0 52.8 66.2 9.2 33.7 3.5 7.8 6.4 13.2 40.9 10.8 6.2 11.2 8.2 6.3 4.2 39.7 18.4 7.2 10.0 5.7 9.4 13.2 5.8 6.7 6.1 62.9 15.0 5.1 14.1 10.2 55.6 12.5 8.7 10.8 4.1 3.4 13.7 26.7 31.7 3.9 16.0 12.5 94.2 49.4 1.5 28.4 7.2 89.5 13.7 4.4 25.9 6.2 12.0 3.1 9.2 11.8 5.3 4.7 7.3 40.2 22.9 12.5 6.9 10.7 12.1 2.5 2.0 62.1 7.3 21.7 7.5 129.2 30.5 87.7 52.8 35.1 37.0 16.4 36.4 42.5 42.4 24.1 42.8 45.0 42.8 39.0 45.8 27.8 23.2 66.2 16.1 17.5 13.3 19.8 15.4 14.5 14.1 15.5 9.3 10.0 56.6 64.8 78.2 82.2 24.0 9.3 21.8 56.0 16.0 18.2 19.2 5.9 150.0 24.9 17.1 12.1 47.0 34.6 93.5 21.5 66.5 22.6 44.0 25.5 3.9 39.8 11.1 9.2 55.9 111.4 7.4 38.3 68.6 35.4 7.2 16.9 35.9 21.6 28.8 48.8 13.2 14.6 45.3 26.8 1.7 5.7 19.7 197.8 130.7 19.5 56.2 CCNE1 CCNE ENSG00000105173 "Cyclin E1" P24864 19 29811898-29824308 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.3;placenta: 46.7" "Cell type enriched" "Detected in many" 14 "Extravillous trophoblasts: 1526.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 81.6" "Low region specificity" "Detected in all" "CAB000308, CAB016682, HPA018169" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384" "unprognostic (2.90e-3)" "unprognostic (1.33e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (6.35e-6)" "unprognostic (5.78e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (3.89e-5)" "unprognostic (1.26e-3)" "unprognostic (3.14e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (3.29e-2)" "unprognostic (7.07e-2)" "unprognostic (1.11e-16)" "unprognostic (5.61e-2)" "unprognostic (1.92e-1)" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" 1.6 6.8 2.4 4.5 2.9 23.3 0.6 6.3 3.3 0.8 3.0 1.7 1.1 2.3 1.2 0.6 4.7 0.7 2.2 4.4 2.3 2.8 1.2 0.7 1.1 4.6 1.9 1.9 0.9 1.4 1.7 1.0 46.7 2.8 1.1 3.8 1.5 3.2 1.2 2.2 4.4 2.5 3.0 1.7 4.6 2.0 12.3 1.6 4.1 1.6 2.1 5.9 2.7 2.5 2.7 1.6 1.6 1.9 0.0 1.4 0.5 4.1 8.6 6.6 9.4 1.4 1.6 81.6 6.6 1.4 2.9 3.6 8.7 8.4 3.5 15.7 2.9 3.8 1.3 7.8 3.4 4.2 11.1 4.8 2.9 8.4 9.1 1.1 11.5 7.9 1.7 1.9 4.0 0.5 0.9 3.5 3.5 11.8 1.6 4.4 6.2 6.3 3.3 11.0 9.4 2.0 9.5 7.7 2.6 2.2 6.6 5.6 4.7 9.5 11.7 1.0 10.1 2.6 8.6 2.0 6.9 25.9 4.1 4.4 6.6 4.6 23.9 3.9 1.4 3.7 0.0 0.1 0.0 0.6 1.9 1.1 2.7 0.5 0.4 1.6 0.2 0.1 0.9 1.6 0.0 1.9 0.0 1.4 0.5 2.4 2.9 6.3 3.3 2.3 2.8 1.9 1.9 2.8 1.6 0.0 1.1 0.8 1.0 4.2 2.4 2.8 0.0 0.0 2.3 0.0 0.0 112.5 0.0 0.4 7.1 1.1 1.7 0.0 0.6 1526.8 4.8 1.9 0.0 0.0 37.5 3.2 2.9 1.3 0.3 2.6 1.1 1.1 1.7 0.0 2.7 1.8 1.0 2.9 2.1 0.2 0.8 6.5 3.1 14.1 19.5 5.3 96.8 2.2 3.8 2.4 CCNG1 CCNG ENSG00000113328 "Cyclin G1" P51959 5 163437569-163446151 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB000350 Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB000350: " "unprognostic (2.49e-2)" "unprognostic (1.64e-1)" "prognostic favorable (7.00e-4)" "unprognostic (2.92e-2)" "unprognostic (9.04e-2)" "unprognostic (2.26e-1)" "unprognostic (6.25e-2)" "unprognostic (1.58e-1)" "unprognostic (6.15e-2)" "unprognostic (1.45e-2)" "unprognostic (1.29e-2)" "unprognostic (1.20e-1)" "unprognostic (1.38e-3)" "unprognostic (1.46e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" "unprognostic (7.89e-2)" 32.3 24.8 11.1 16.0 14.6 9.6 20.5 9.0 9.7 27.9 43.5 11.0 14.1 41.4 22.3 23.6 24.7 19.4 25.8 29.8 11.5 10.3 40.4 46.6 20.7 26.0 22.5 9.1 44.1 42.5 13.5 12.6 17.9 17.0 39.3 26.9 12.6 25.6 18.1 51.7 10.2 68.7 35.8 27.1 22.7 24.6 17.0 15.8 26.5 38.3 29.7 15.6 48.1 21.4 23.2 23.3 15.9 14.0 15.4 36.5 22.8 9.6 10.8 45.2 25.4 39.1 75.4 47.6 13.4 32.8 13.6 30.9 23.4 19.8 23.7 13.7 17.8 22.5 4.0 24.9 33.5 20.2 11.3 31.5 18.7 14.4 40.6 42.8 8.6 12.7 81.8 19.4 13.5 13.9 41.0 43.8 16.3 16.0 16.9 46.2 6.0 15.1 11.7 20.7 7.1 9.8 13.2 22.2 13.1 33.1 37.5 10.7 12.1 0.0 5.5 27.2 29.9 21.1 27.7 25.4 8.8 19.1 7.4 11.7 15.1 5.9 16.0 15.7 14.6 14.7 15.9 10.3 11.8 15.1 14.0 22.3 23.2 26.6 20.6 23.3 14.5 36.5 29.8 4.2 15.4 13.0 8.9 31.3 22.8 11.1 14.6 9.0 9.7 11.5 10.3 22.5 9.1 17.0 15.8 23.8 18.3 58.8 79.1 50.8 12.2 40.5 30.6 2.7 17.0 34.9 0.0 122.0 137.6 62.2 4.0 45.6 56.4 0.0 103.1 85.5 67.2 98.8 42.7 41.4 51.3 14.3 68.1 60.2 65.1 3.1 70.2 48.0 35.4 50.5 100.4 22.6 102.5 63.1 67.8 185.4 9.0 38.8 59.7 7.2 12.8 38.6 81.4 88.8 179.5 81.8 CCNH "CycH, p34, p37" ENSG00000134480 "Cyclin H" P51946 5 87318416-87413019 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 169.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019416, HPA044138" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB019416: AB_2259936, HPA044138: AB_2678828" "unprognostic (5.65e-2)" "unprognostic (3.94e-3)" "unprognostic (4.01e-3)" "unprognostic (4.12e-1)" "unprognostic (1.10e-1)" "unprognostic (9.30e-2)" "unprognostic (3.93e-2)" "unprognostic (6.43e-2)" "unprognostic (8.79e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (4.16e-2)" "unprognostic (2.27e-2)" "prognostic unfavorable (3.92e-5)" "unprognostic (1.48e-1)" "unprognostic (2.35e-1)" "unprognostic (1.61e-1)" "unprognostic (9.62e-2)" 32.4 25.8 18.7 16.1 25.2 28.9 25.5 40.9 29.9 16.3 14.7 19.2 16.9 16.0 15.5 23.7 17.4 14.9 23.2 20.3 23.4 19.4 22.6 33.8 21.7 19.6 20.8 21.4 24.3 21.0 24.3 32.5 14.8 27.3 25.3 19.0 16.6 17.9 20.5 24.4 13.7 18.8 15.7 22.1 17.2 16.3 46.9 22.3 28.4 25.7 13.9 23.6 19.7 16.4 19.9 23.1 33.5 25.7 16.7 22.8 19.0 19.3 9.2 9.1 6.0 13.4 9.5 9.3 14.0 18.3 25.0 34.7 15.7 11.0 13.2 4.9 21.8 26.1 9.9 11.5 22.9 23.6 14.4 14.5 23.4 16.7 15.1 24.1 18.8 19.0 13.2 8.5 13.0 31.7 12.8 21.9 12.4 15.5 22.5 20.7 11.6 13.2 15.6 3.7 5.1 36.3 11.0 21.4 19.3 20.9 10.5 9.1 5.8 7.8 7.0 16.9 5.6 17.1 14.8 15.0 24.4 9.3 14.1 12.4 7.2 6.8 19.6 15.6 17.8 10.8 20.1 21.8 33.5 15.3 24.9 22.7 19.9 20.3 20.6 23.1 16.6 21.0 20.1 18.2 16.7 25.7 13.7 22.8 19.0 18.7 25.2 40.9 29.9 23.4 19.4 20.8 21.4 27.3 22.3 32.8 31.8 40.7 55.2 33.2 25.9 12.0 22.9 28.1 20.5 17.4 15.7 17.7 34.9 29.2 169.8 34.1 17.3 70.0 30.3 23.0 26.8 33.8 56.5 16.9 39.8 17.5 23.1 28.3 46.3 18.0 27.3 72.7 45.5 15.4 14.4 42.4 24.8 14.0 23.7 37.5 29.3 51.8 55.5 90.7 54.1 30.2 25.2 99.7 17.4 34.9 CCNK CPR4 ENSG00000090061 "Cyclin K" O75909 14 99481169-99535044 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" Cyclin "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000645, HPA077073" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000645: AB_1078606, HPA077073: AB_2732331" "unprognostic (8.07e-2)" "unprognostic (9.32e-3)" "unprognostic (9.52e-2)" "unprognostic (1.52e-2)" "unprognostic (5.83e-2)" "unprognostic (6.71e-2)" "unprognostic (9.22e-4)" "unprognostic (1.50e-2)" "unprognostic (2.06e-1)" "unprognostic (1.64e-1)" "unprognostic (4.78e-3)" "unprognostic (8.94e-3)" "unprognostic (7.74e-2)" "unprognostic (3.93e-1)" "unprognostic (2.73e-1)" "unprognostic (1.06e-1)" "unprognostic (6.21e-2)" 21.9 18.4 16.1 20.3 20.6 70.4 16.9 25.0 17.6 20.4 21.0 26.2 15.3 20.4 20.2 16.6 25.2 18.6 15.8 18.4 17.0 13.2 18.7 16.5 21.5 21.4 18.9 11.0 26.0 16.9 12.6 28.7 21.0 16.7 16.2 23.2 20.6 21.6 16.2 36.3 20.6 22.5 16.9 19.0 23.1 20.1 50.5 22.4 35.9 19.1 21.0 29.7 21.0 18.5 6.8 6.0 15.6 7.0 6.0 9.3 3.9 16.3 18.4 19.0 15.9 15.5 16.2 34.9 21.8 19.6 22.8 26.6 26.7 21.9 25.9 15.3 23.5 17.0 18.8 20.2 28.1 32.1 25.3 10.6 23.9 12.5 22.9 20.4 33.6 27.4 17.5 21.8 22.7 26.2 10.9 17.1 26.0 21.6 23.1 19.8 35.2 25.8 13.6 18.7 20.4 16.4 23.3 25.6 13.6 12.7 31.4 15.7 11.7 19.6 10.1 9.0 19.3 27.6 15.3 20.7 8.2 13.2 71.9 19.5 19.7 25.6 31.7 21.1 15.7 16.8 5.8 6.5 13.9 9.3 7.0 8.1 6.8 7.2 8.0 5.6 6.6 8.4 7.6 15.6 6.0 6.8 6.0 7.3 3.9 16.1 20.6 25.0 17.6 17.0 13.2 18.9 11.0 16.7 22.4 11.9 35.2 21.7 34.4 32.6 15.9 8.7 17.8 45.5 42.1 21.0 19.6 20.8 11.6 16.6 34.3 20.7 27.5 23.3 21.3 23.6 19.9 39.1 19.7 17.0 21.5 17.5 18.9 27.6 29.1 13.7 20.8 24.0 16.9 27.1 32.0 14.6 24.2 28.5 17.0 13.7 29.9 0.0 15.1 70.7 62.3 39.5 22.8 28.7 29.2 60.7 CCNL2 "ania-6b, CCNM, CCNS, HLA-ISO, PCEE, SB138" ENSG00000221978 "Cyclin L2" Q96S94 1 1385711-1399328 "Predicted intracellular proteins" "Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053137 Supported Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA053137: AB_2682053" "unprognostic (3.08e-2)" "unprognostic (2.60e-1)" "unprognostic (1.14e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.59e-3)" "unprognostic (2.06e-1)" "unprognostic (3.91e-2)" "unprognostic (1.67e-2)" "unprognostic (1.15e-1)" "unprognostic (7.08e-3)" "unprognostic (2.91e-2)" "prognostic unfavorable (1.12e-6)" "unprognostic (4.61e-2)" "unprognostic (6.17e-2)" "unprognostic (3.71e-1)" "prognostic favorable (1.46e-7)" 22.2 28.4 26.7 22.2 34.5 22.9 26.7 56.3 32.5 29.1 23.8 28.2 27.9 26.7 33.9 24.0 24.1 30.1 26.4 18.7 30.3 10.7 24.5 35.5 22.6 22.8 38.6 27.1 40.7 36.6 30.9 32.1 26.3 26.9 27.9 16.6 24.1 27.5 29.4 23.4 33.4 27.4 28.2 27.7 27.9 26.8 11.1 32.9 19.5 33.5 16.1 23.3 30.2 28.8 14.9 13.7 14.3 12.4 13.7 14.6 4.9 10.6 10.8 28.6 12.7 16.1 25.1 14.5 25.0 12.7 12.3 12.3 13.7 22.4 12.9 14.6 15.8 10.9 25.6 11.6 15.7 9.2 7.9 27.9 14.3 46.0 17.9 18.9 9.4 17.0 31.3 11.4 12.4 18.5 36.7 13.5 15.7 16.8 12.4 14.3 12.2 10.1 28.6 10.5 8.4 19.7 20.2 7.5 14.8 21.2 13.5 18.5 24.1 15.9 24.6 14.3 17.4 18.9 14.3 23.4 27.9 13.5 12.3 9.7 23.9 5.1 21.6 15.1 20.2 7.6 10.4 12.4 14.3 13.1 10.0 10.3 12.7 12.1 14.6 13.7 14.9 13.3 11.9 10.8 13.7 11.8 13.3 6.8 4.9 26.7 34.5 56.3 32.5 30.3 10.7 38.6 27.1 26.9 32.9 32.8 88.6 26.2 31.6 40.4 25.5 31.1 33.1 56.2 52.4 27.9 45.2 35.8 18.3 26.5 16.2 39.6 34.6 46.7 23.1 28.2 41.7 26.2 41.6 32.0 21.6 57.2 48.6 39.3 29.2 12.1 47.5 27.9 30.4 17.2 36.8 46.4 31.4 27.1 30.8 12.2 40.6 58.2 49.5 44.0 31.9 38.5 53.3 30.5 28.1 33.5 CCNT1 "CCNT, CYCT1, HIVE1" ENSG00000129315 "Cyclin T1" O60563 12 48688458-48716998 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 95.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004892, CAB009016, HPA072012" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009016: AB_2073888, HPA004892: AB_1078607, HPA072012: " "unprognostic (1.76e-3)" "unprognostic (3.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.76e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (5.78e-3)" "unprognostic (1.86e-1)" "unprognostic (2.80e-1)" "unprognostic (1.28e-1)" "unprognostic (3.13e-1)" "unprognostic (3.22e-1)" "unprognostic (3.43e-2)" "unprognostic (4.50e-2)" "unprognostic (1.92e-1)" 16.6 14.9 13.1 12.9 17.4 38.1 15.7 20.9 17.7 13.4 12.6 16.5 10.9 9.9 19.9 13.0 13.8 15.8 10.5 11.8 13.5 8.5 13.0 14.1 15.6 14.9 14.3 13.2 21.5 15.9 18.4 19.6 18.5 14.5 12.8 12.4 12.8 12.6 11.2 18.8 16.4 14.6 13.3 12.1 16.8 13.8 22.6 15.7 22.4 16.5 10.9 15.9 15.3 13.2 5.5 4.4 14.8 2.8 3.7 4.9 0.9 7.6 10.6 10.5 10.4 8.4 9.8 12.8 10.3 8.1 7.8 6.4 13.1 9.4 20.8 13.5 6.6 5.6 9.6 16.7 7.3 11.6 11.6 10.7 21.6 17.1 5.9 9.9 23.8 11.0 7.8 10.9 9.8 13.5 11.3 6.4 12.3 20.7 9.0 9.4 4.9 11.1 11.1 11.4 4.6 8.7 10.8 16.8 8.9 7.8 14.0 11.2 12.7 15.8 8.6 12.6 8.7 11.4 13.7 6.5 9.0 9.2 6.4 9.0 13.9 18.7 18.6 10.2 33.9 5.2 6.8 2.8 7.9 3.6 1.8 4.9 4.3 3.1 3.5 1.7 5.5 4.5 4.0 14.8 3.7 2.0 4.4 1.8 0.9 13.1 17.4 20.9 17.7 13.5 8.5 14.3 13.2 14.5 15.7 14.9 17.6 17.9 16.5 34.2 20.2 11.3 15.3 24.1 14.8 12.2 21.6 11.3 3.3 7.0 95.2 23.3 11.2 0.0 6.0 11.3 13.4 16.0 28.9 12.9 8.8 36.5 11.5 22.7 18.0 21.0 15.5 16.2 20.3 5.4 14.3 16.7 6.5 10.5 13.8 7.9 13.0 6.5 23.7 16.1 13.2 39.3 14.5 24.5 10.9 27.8 CD70 "CD27L, CD27LG, TNFSF7" ENSG00000125726 "CD70 molecule" P32970 19 6583183-6604103 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Cytokine "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.3;lymphoid tissue: 12.7" "Cell type enriched" "Detected in some" 23 "monocytes: 417.4" "Cancer enhanced" "Detected in many" "renal cancer: 24.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 13.9;T-reg: 23.3" "Group enriched" "Detected in many" 38 "B-cells: 13.9;T-cells: 23.3" "Cell line enhanced" "Detected in many" "SiHa: 36.8;THP-1: 30.2;U-251 MG: 44.7;U-266/70: 79.5;U-266/84: 57.5" HPA046582 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046582: " "unprognostic (8.71e-2)" "unprognostic (9.91e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-4)" "unprognostic (1.73e-2)" "unprognostic (1.51e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (2.57e-2)" "unprognostic (1.40e-1)" "unprognostic (2.27e-1)" "unprognostic (2.08e-1)" 5.3 0.2 0.2 9.3 0.2 1.4 2.2 0.9 0.9 1.4 4.1 0.2 0.1 1.0 0.4 1.8 4.0 0.7 0.8 0.4 0.2 0.2 1.7 0.4 1.9 6.1 0.4 0.1 0.3 0.4 0.0 0.3 0.3 0.2 0.9 3.1 0.2 3.1 1.2 1.2 3.3 5.2 0.7 0.5 11.8 1.7 1.9 0.1 3.2 0.8 1.8 12.7 3.1 1.1 13.9 0.1 0.2 0.0 0.4 23.3 0.9 0.2 7.5 0.0 14.8 0.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 14.2 0.8 0.0 16.3 10.4 9.1 0.7 0.0 0.0 0.3 0.0 11.2 0.0 0.0 0.0 0.4 0.1 0.0 8.7 6.2 2.4 0.0 0.0 0.2 0.4 0.2 0.0 0.2 17.8 0.1 0.0 13.7 3.8 0.0 3.0 4.8 0.0 0.0 0.0 36.8 0.0 0.1 0.0 0.1 30.2 0.2 0.1 6.6 0.0 44.7 79.5 57.5 25.6 8.2 4.5 2.8 0.2 0.0 0.0 1.9 0.0 4.8 13.9 3.2 5.0 0.0 4.0 0.4 1.3 0.1 0.4 0.0 0.1 23.3 0.9 0.2 0.2 0.9 0.9 0.2 0.2 0.4 0.1 0.2 0.1 0.0 0.0 18.2 0.1 5.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.1 1.1 0.0 0.3 0.0 1.7 1.3 0.0 0.0 0.0 1.7 3.3 417.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.2 4.6 0.0 10.2 0.0 0.0 CDA CDD ENSG00000158825 "Cytidine deaminase" P32320 1 20588948-20618908 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 126.5;bone marrow: 68.0" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 120.2;Hepatocytes: 94.4;Kupffer cells: 118.1;Pancreatic endocrine cells: 70.1;Paneth cells: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 126.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 126.5" "Cell line enhanced" "Detected in many" "A-431: 42.9;CAPAN-2: 28.6;HeLa: 40.6;PC-3: 20.4;SiHa: 51.0;U-937: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA064202 Enhanced Approved Nucleoplasm NA NA 3700000 Nucleoplasm "HPA064202: AB_2685211" "unprognostic (2.38e-1)" "prognostic unfavorable (5.05e-4)" "unprognostic (2.86e-1)" "unprognostic (2.56e-1)" "unprognostic (8.02e-2)" "unprognostic (3.84e-3)" "unprognostic (1.47e-1)" "unprognostic (1.68e-3)" "unprognostic (2.64e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (8.56e-5)" "unprognostic (2.94e-2)" "unprognostic (5.03e-2)" "unprognostic (8.47e-3)" "unprognostic (2.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.89e-3)" 4.0 1.4 1.5 4.0 1.5 68.0 2.2 1.1 2.4 19.0 8.6 1.7 2.0 2.6 6.7 3.5 38.3 2.9 1.8 5.9 1.7 1.6 12.5 42.1 8.4 9.1 2.0 1.3 2.9 0.8 1.2 0.7 30.8 3.5 4.2 10.2 4.5 6.9 1.5 3.2 7.0 24.7 4.3 1.9 11.8 1.2 2.9 0.9 0.9 3.0 23.3 10.5 3.1 16.5 0.0 1.3 126.5 21.7 0.0 0.1 7.1 42.9 4.2 0.0 0.0 0.0 1.3 0.0 3.3 0.9 0.8 3.4 0.2 28.6 0.0 1.6 6.8 1.8 15.1 0.8 11.2 2.2 0.0 0.8 0.0 40.6 5.4 0.3 0.0 0.0 1.9 1.8 8.1 0.0 0.1 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 5.0 20.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 51.0 0.0 0.0 0.5 0.0 1.2 0.7 0.0 1.7 3.9 0.2 0.0 0.0 0.0 0.5 18.0 0.0 16.3 21.7 43.3 0.0 11.4 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 126.5 0.0 9.3 0.2 0.0 7.1 1.5 1.5 1.1 2.4 1.7 1.6 2.0 1.3 3.5 0.9 3.0 1.4 0.9 0.2 1.3 0.1 2.8 2.5 0.0 0.0 5.2 0.0 0.2 36.5 2.4 0.6 4.4 120.2 0.0 1.3 2.7 1.0 0.9 0.0 94.4 6.1 0.0 0.0 28.8 118.1 0.8 0.3 3.7 0.0 0.0 12.5 0.0 70.1 48.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 2.1 1.5 4.9 0.3 CDADC1 NYD-SP15 ENSG00000102543 "Cytidine and dCMP deaminase domain containing 1" Q9BWV3 13 49247925-49293485 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 173.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047615, HPA058314" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA047615: AB_2680104, HPA058314: AB_2683677" "unprognostic (2.81e-1)" "unprognostic (2.64e-1)" "unprognostic (2.20e-1)" "unprognostic (2.86e-1)" "unprognostic (2.75e-1)" "unprognostic (1.11e-2)" "unprognostic (1.58e-3)" "prognostic favorable (6.03e-4)" "unprognostic (7.68e-2)" "unprognostic (6.06e-2)" "unprognostic (2.35e-3)" "unprognostic (1.89e-1)" "prognostic favorable (1.19e-5)" "unprognostic (3.35e-2)" "unprognostic (5.92e-3)" "unprognostic (5.40e-2)" "unprognostic (8.27e-3)" 9.3 13.8 11.6 6.5 10.4 11.0 8.6 14.1 12.9 8.4 8.6 7.1 8.4 6.3 9.7 12.5 6.7 7.6 6.7 8.5 9.5 9.7 18.6 15.4 7.0 5.7 9.8 11.2 9.5 5.6 8.8 12.5 4.3 10.7 8.2 6.7 7.6 6.8 9.5 7.9 4.7 6.0 8.4 14.2 8.7 8.0 23.5 8.8 5.5 18.5 7.2 5.2 6.5 7.4 1.0 1.3 10.3 2.7 1.8 3.3 1.4 2.6 3.2 2.8 3.4 14.0 7.7 1.4 6.2 3.9 3.1 3.3 3.2 2.1 3.5 1.3 2.7 3.1 4.4 5.7 2.8 4.0 7.6 4.6 4.0 3.1 3.3 6.1 7.5 2.2 5.3 6.9 3.0 3.8 5.6 4.6 7.0 2.5 2.6 3.9 0.9 7.1 6.2 1.0 4.3 2.8 4.8 3.0 3.5 4.6 0.8 1.6 1.4 4.2 2.7 3.5 1.9 1.9 6.6 3.4 1.7 3.1 4.4 2.8 0.8 2.8 2.2 1.4 8.7 4.6 10.3 1.9 1.5 2.4 1.5 2.6 0.7 1.8 3.3 1.3 1.0 1.6 2.3 2.0 1.8 2.7 1.3 2.5 1.4 11.6 10.4 14.1 12.9 9.5 9.7 9.8 11.2 10.7 8.8 6.0 11.3 3.9 7.2 7.1 12.0 13.6 5.1 24.1 7.9 17.4 11.8 4.0 8.3 4.8 173.6 8.9 5.3 23.3 9.3 7.7 10.8 5.9 24.3 11.5 5.4 3.2 6.4 8.6 9.4 52.5 14.7 8.5 6.8 2.8 7.6 23.8 6.1 5.8 13.4 16.7 12.1 0.0 16.9 32.9 4.1 4.6 2.1 14.4 6.0 5.0 CDC14B "Cdc14B1, Cdc14B2, CDC14B3, hCDC14B" ENSG00000081377 "Cell division cycle 14B" O60729 9 96490241-96619830 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.9" "Lineage enhanced" "Detected in many" "granulocytes: 9.9" "Cell line enhanced" "Detected in many" "ASC diff: 15.2;ASC TERT1: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013312, HPA064747" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA013312: AB_1846354, HPA064747: AB_2732719" "unprognostic (5.69e-2)" "unprognostic (9.09e-2)" "unprognostic (3.50e-2)" "unprognostic (8.08e-3)" "unprognostic (4.24e-1)" "unprognostic (1.19e-2)" "unprognostic (1.11e-2)" "unprognostic (4.49e-2)" "unprognostic (1.63e-2)" "unprognostic (2.27e-2)" "unprognostic (2.35e-1)" "unprognostic (2.75e-1)" "prognostic favorable (2.97e-10)" "unprognostic (2.01e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (7.40e-2)" 7.3 6.2 6.8 3.0 7.5 4.4 15.7 2.4 6.6 5.3 5.0 14.8 7.1 4.5 4.0 3.7 3.5 7.1 5.9 8.2 6.0 4.6 9.1 16.0 4.9 1.8 9.5 4.0 5.8 7.3 17.1 5.2 3.4 7.1 5.7 5.4 8.3 3.8 7.2 2.2 3.3 7.7 4.2 9.3 2.2 9.3 16.9 8.2 0.2 13.6 2.2 2.1 10.4 10.3 1.6 0.0 9.9 0.0 0.1 2.9 0.8 5.2 2.9 3.1 3.2 15.2 22.8 8.5 3.8 5.1 2.5 4.1 9.9 8.3 0.0 3.7 8.0 6.2 5.9 4.4 3.0 3.0 1.3 4.1 0.8 1.0 7.8 2.5 0.0 0.1 9.4 1.5 2.7 2.5 3.0 0.5 0.0 3.0 0.6 3.5 2.5 0.0 0.8 5.8 5.9 2.5 0.0 1.9 0.1 4.0 8.1 0.9 4.9 2.7 0.8 1.5 11.0 0.7 1.7 1.5 2.5 3.0 6.6 2.8 0.1 0.0 0.0 2.7 0.0 6.0 9.9 0.0 3.1 2.9 0.0 1.6 1.6 1.3 2.3 0.0 0.8 2.3 1.4 0.0 0.1 0.0 0.0 1.6 0.8 6.8 7.5 2.4 6.6 6.0 4.6 9.5 4.0 7.1 8.2 6.0 9.1 2.4 7.4 8.0 6.4 14.5 10.2 16.0 14.8 8.7 7.9 5.3 6.6 4.8 28.7 4.7 8.5 0.0 5.7 2.5 9.3 10.2 13.9 27.2 8.6 7.9 2.4 8.0 1.0 27.6 8.3 4.1 8.5 3.6 7.6 10.9 6.9 6.5 11.0 14.1 11.7 25.8 22.0 3.7 5.5 6.8 2.9 5.0 7.2 8.1 CDC26 "ANAPC12, APC12, C9orf17" ENSG00000176386 "Cell division cycle 26" Q8NHZ8 9 113255835-113275589 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044130 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA044130: AB_10963690" "unprognostic (9.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.47e-2)" "unprognostic (2.60e-1)" "unprognostic (1.48e-1)" "unprognostic (2.59e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (7.27e-2)" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" "unprognostic (7.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.27e-1)" "unprognostic (6.26e-2)" "unprognostic (3.79e-2)" 24.2 21.8 19.1 21.0 25.3 15.8 27.4 20.8 19.8 24.2 27.4 18.0 30.9 19.7 20.1 29.4 22.2 18.6 16.6 37.5 18.1 15.9 27.6 34.9 21.7 24.7 24.9 15.2 23.2 24.2 27.4 23.3 26.7 20.7 23.4 23.2 15.6 31.7 24.6 28.1 21.7 37.1 36.3 29.1 27.7 21.8 13.3 25.7 22.7 34.5 20.1 29.7 31.5 44.6 54.8 30.1 65.2 30.3 44.9 68.5 38.2 14.2 23.4 20.5 10.3 35.2 30.4 9.4 20.9 32.9 22.4 22.2 24.6 17.4 26.7 18.7 18.7 25.3 28.3 17.3 31.9 22.4 24.2 12.6 17.5 23.6 22.8 17.2 30.7 17.7 21.0 22.4 20.7 30.4 23.4 30.0 21.4 26.1 20.1 16.9 29.4 26.0 19.8 33.8 67.2 20.9 22.9 44.0 13.1 23.5 25.1 15.8 15.1 28.1 20.3 15.6 23.6 18.6 13.3 19.7 13.5 12.5 19.9 26.9 13.5 23.3 21.1 18.9 18.2 13.1 48.1 30.0 65.2 46.7 30.3 57.2 54.8 59.4 51.5 30.1 45.3 68.5 53.1 46.0 44.9 28.0 25.5 56.7 38.2 19.1 25.3 20.8 19.8 18.1 15.9 24.9 15.2 20.7 25.7 32.8 39.2 64.1 66.0 69.1 19.1 3.6 33.1 41.5 34.2 21.0 21.6 37.2 96.2 52.8 18.0 69.7 46.7 46.7 52.2 58.4 57.1 55.8 26.5 66.9 53.1 14.3 30.6 50.3 51.1 10.0 74.2 59.9 49.0 69.5 42.9 29.4 51.6 55.4 41.1 133.8 30.6 25.8 44.3 31.4 15.8 79.4 40.0 74.6 45.5 76.1 CDC27 "ANAPC3, APC3, D0S1430E, D17S978E, NUC2" ENSG00000004897 "Cell division cycle 27" P30260 17 47117703-47189422 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Erythroid cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016315, HPA028129, HPA052399, HPA065835" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB016315: AB_627228, HPA028129: AB_10603559, HPA052399: AB_2681814, HPA065835: " "unprognostic (2.34e-2)" "unprognostic (8.83e-3)" "prognostic favorable (1.77e-4)" "unprognostic (4.26e-2)" "unprognostic (7.99e-2)" "unprognostic (8.93e-3)" "prognostic unfavorable (4.38e-4)" "prognostic unfavorable (8.15e-4)" "unprognostic (1.98e-1)" "unprognostic (1.45e-1)" "unprognostic (4.05e-3)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.39e-5)" "unprognostic (2.64e-1)" "unprognostic (1.58e-1)" "unprognostic (7.95e-2)" "unprognostic (3.66e-2)" 29.2 18.9 19.4 18.7 25.2 23.0 23.3 26.0 33.0 23.7 17.2 14.8 13.8 14.4 23.2 19.6 17.6 17.6 18.6 22.8 18.3 22.6 16.8 23.8 20.4 21.3 19.4 23.9 19.5 14.3 27.8 26.8 25.0 31.5 17.6 18.2 14.6 15.7 16.5 31.6 15.5 15.3 24.4 17.7 24.2 16.1 23.5 17.4 25.2 42.8 15.5 22.9 23.6 17.3 9.0 7.7 9.6 10.3 12.8 11.6 5.4 23.6 25.4 21.3 17.1 14.4 22.9 12.7 33.5 30.2 32.0 32.8 16.2 12.5 31.9 22.6 28.0 20.5 11.4 22.9 18.9 44.2 45.8 23.5 37.1 26.8 14.4 15.6 21.7 16.9 16.6 9.3 28.8 22.8 15.5 33.0 18.7 29.5 17.8 26.0 20.1 26.7 9.9 10.1 13.4 20.7 14.4 54.7 14.1 19.3 15.0 14.2 17.3 16.8 5.9 18.6 19.0 17.9 15.4 35.1 33.5 29.1 21.1 24.7 18.2 31.5 28.9 18.5 13.0 23.1 9.6 4.4 6.2 8.1 10.3 7.8 6.0 6.8 8.5 6.0 9.0 6.7 7.6 5.7 12.8 7.4 7.7 11.6 5.4 19.4 25.2 26.0 33.0 18.3 22.6 19.4 23.9 31.5 17.4 8.9 22.9 28.9 16.0 23.1 20.2 34.3 22.9 10.7 28.4 19.2 15.7 24.5 13.3 23.9 23.6 38.7 10.6 163.5 23.1 29.3 36.3 14.9 25.5 25.2 24.1 33.4 13.3 37.4 24.8 22.5 26.2 19.8 6.8 31.5 13.5 19.5 24.1 10.5 28.0 17.4 13.9 19.4 33.0 88.5 35.1 23.5 9.6 21.0 14.3 13.1 CDC40 "EHB3, FLJ10564, PRP17, PRPF17" ENSG00000168438 "Cell division cycle 40" O60508 6 110180141-110254275 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 179.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046620 Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA046620: AB_2679722" "unprognostic (4.19e-3)" "unprognostic (2.41e-2)" "unprognostic (1.23e-2)" "unprognostic (1.10e-2)" "unprognostic (4.25e-2)" "unprognostic (3.64e-2)" "unprognostic (3.42e-2)" "unprognostic (5.24e-1)" "unprognostic (2.82e-1)" "unprognostic (1.08e-1)" "unprognostic (9.27e-2)" "unprognostic (1.92e-1)" "unprognostic (4.68e-2)" "unprognostic (7.36e-2)" "unprognostic (1.09e-1)" "unprognostic (3.01e-1)" "unprognostic (2.09e-1)" 13.1 20.7 13.4 13.9 32.8 36.3 15.3 15.4 34.1 15.0 12.7 12.4 11.7 12.0 13.8 12.1 13.3 12.7 11.7 11.3 18.0 11.0 19.9 19.9 12.0 19.5 12.7 12.5 18.7 14.3 17.1 34.0 11.9 14.7 14.5 13.8 11.4 13.3 11.6 16.4 11.8 14.9 13.1 11.6 21.3 12.4 13.1 13.3 29.1 18.1 12.7 19.8 14.2 12.6 23.6 19.8 18.3 17.3 12.4 14.0 7.7 6.6 6.2 11.2 19.5 11.6 12.0 9.2 13.0 16.1 13.2 16.8 13.6 6.9 22.4 14.6 11.6 14.2 9.6 17.2 10.6 18.9 18.0 13.1 18.4 8.9 7.4 15.1 23.5 24.8 10.9 10.2 13.9 11.3 9.9 13.1 14.7 18.3 13.6 13.2 6.5 17.4 8.9 11.2 9.1 6.8 15.3 13.2 7.7 9.7 14.2 12.0 11.9 9.6 8.5 9.2 10.7 7.9 22.8 14.7 7.2 7.2 16.8 14.4 6.9 9.1 20.3 11.7 19.9 10.4 18.3 15.0 15.3 11.7 15.8 11.3 23.0 11.6 11.9 12.4 23.6 14.0 12.0 16.9 12.4 17.3 19.8 12.7 7.7 13.4 32.8 15.4 34.1 18.0 11.0 12.7 12.5 14.7 13.3 29.8 29.9 51.1 24.2 23.5 87.2 18.1 22.9 29.4 31.8 26.2 41.2 28.3 48.0 32.3 179.7 34.6 21.6 0.0 32.6 26.0 25.8 20.0 48.5 50.8 33.4 89.0 25.3 38.6 28.2 63.6 62.5 41.9 10.1 21.6 26.9 50.0 24.6 31.7 42.5 58.7 77.9 77.6 20.3 18.2 18.8 23.7 24.0 42.6 31.9 17.4 CDC5L "CDC5, CEF1, hCDC5, PCDC5RP" ENSG00000096401 "Cell division cycle 5 like" Q99459 6 44387525-44450426 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 293.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006302, HPA011361, CAB012275" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012275: , HPA006302: AB_1078488, HPA011361: AB_1846379" "unprognostic (2.67e-1)" "unprognostic (9.31e-2)" "unprognostic (8.26e-3)" "unprognostic (4.17e-3)" "unprognostic (2.01e-2)" "unprognostic (2.17e-1)" "unprognostic (7.96e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (7.02e-5)" "unprognostic (1.01e-2)" "unprognostic (6.31e-2)" "unprognostic (1.63e-1)" "unprognostic (4.33e-2)" "unprognostic (3.08e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-1)" "unprognostic (1.46e-1)" 21.3 18.6 17.1 17.4 17.6 24.5 18.3 30.3 22.1 19.4 16.1 12.2 13.9 12.6 18.2 20.5 20.4 15.1 12.0 18.0 17.4 15.3 16.4 24.7 12.8 16.3 16.6 15.0 21.8 15.0 32.4 26.1 20.8 19.2 19.6 15.6 8.6 16.8 13.6 30.8 14.8 15.9 23.2 18.1 17.6 14.3 16.9 19.1 28.4 16.0 17.4 18.1 26.0 16.6 11.5 13.6 21.1 17.6 14.8 14.8 8.2 18.3 7.2 17.8 14.4 7.3 9.6 10.1 13.4 10.5 17.0 18.8 9.4 6.3 17.6 11.2 10.7 13.9 11.7 18.5 10.6 25.6 14.8 16.6 23.4 7.2 12.1 6.7 17.5 12.7 7.3 9.4 16.6 14.4 9.8 11.0 9.1 17.9 10.4 15.4 12.4 16.2 12.0 12.5 44.8 6.7 12.7 20.5 11.3 9.6 11.0 19.8 17.2 10.8 7.3 14.3 11.9 10.3 17.1 10.1 14.7 15.0 11.4 18.9 9.0 10.8 32.3 9.4 15.3 14.7 16.7 13.9 17.4 11.7 16.6 13.3 10.7 11.4 12.9 13.6 11.5 12.2 11.8 21.1 14.8 17.6 11.8 14.8 8.2 17.1 17.6 30.3 22.1 17.4 15.3 16.6 15.0 19.2 19.1 68.5 39.9 34.7 52.2 39.3 32.7 74.2 25.5 104.4 97.8 22.7 29.5 47.5 33.2 43.0 293.7 44.7 17.1 0.0 47.7 42.8 39.4 39.6 69.3 34.7 39.6 30.2 34.7 27.6 35.5 192.5 57.0 42.2 18.6 66.7 34.2 61.8 43.6 34.0 51.9 22.6 35.1 64.7 52.1 39.1 88.8 33.5 60.0 32.0 35.9 49.8 CDCA2 "PPP1R81, Repo-Man" ENSG00000184661 "Cell division cycle associated 2" Q69YH5 8 25458997-25507920 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 38.8;testis: 17.7" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 22.0;Early spermatids: 29.6;Extravillous trophoblasts: 12.3;Late spermatids: 14.4;Sertoli cells: 12.9;Spermatocytes: 45.9;Spermatogonia: 28.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.6;T-reg: 1.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026293, HPA030049" Enhanced Supported Nucleoplasm Yes Yes Nucleoplasm "HPA026293: AB_1846384, HPA030049: AB_10600862" "unprognostic (2.12e-1)" "unprognostic (4.75e-3)" "prognostic favorable (9.62e-4)" "unprognostic (2.92e-2)" "unprognostic (9.69e-2)" "unprognostic (3.56e-2)" "unprognostic (2.50e-5)" "unprognostic (1.47e-3)" "unprognostic (6.06e-2)" "unprognostic (2.91e-3)" "unprognostic (1.32e-3)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.30e-14)" "unprognostic (1.36e-2)" "unprognostic (4.02e-1)" "unprognostic (1.91e-1)" "unprognostic (5.30e-2)" 0.8 0.5 0.3 11.3 0.5 5.5 0.6 0.3 0.3 0.7 3.3 0.2 0.0 1.3 0.5 0.2 2.8 0.3 0.1 0.6 0.3 0.3 0.5 0.5 0.6 4.4 0.4 0.2 0.4 0.3 0.0 0.4 3.3 0.3 0.5 2.0 0.1 0.7 0.0 0.4 1.0 3.3 0.6 1.0 3.9 0.8 17.7 0.4 38.8 0.4 3.5 5.9 0.6 1.0 0.7 0.0 0.0 0.0 2.6 1.9 0.8 14.8 14.1 13.1 10.9 1.1 2.0 8.7 16.7 9.9 14.6 14.6 12.0 6.8 17.6 7.2 6.9 15.8 13.6 18.2 8.5 21.6 6.6 5.2 18.0 10.2 6.4 0.3 8.0 8.8 1.1 0.5 10.2 6.9 1.4 10.5 10.6 14.2 20.4 13.3 5.8 22.4 3.8 13.4 10.3 6.2 11.6 14.5 6.4 4.1 8.1 5.5 5.9 14.1 6.8 6.6 6.6 7.5 3.9 7.2 10.9 17.5 20.5 15.4 3.4 6.9 18.7 7.8 10.5 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.1 0.1 0.0 0.0 2.6 0.0 0.0 1.9 0.8 0.3 0.5 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.4 0.0 0.6 0.8 0.5 1.0 0.4 22.0 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.2 29.6 0.0 0.0 0.0 0.0 12.3 0.4 0.4 0.0 0.0 3.3 0.0 0.0 1.3 1.9 14.4 1.1 1.2 0.0 1.0 0.1 0.0 0.2 0.0 0.0 0.5 0.3 12.9 0.7 45.9 28.1 0.6 1.4 1.9 1.2 0.4 CDCA5 ENSG00000146670 "Cell division cycle associated 5" Q96FF9 11 65066300-65084164 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 39.9;testis: 27.9" "Group enriched" "Detected in many" 5 "Early spermatids: 41.6;Extravillous trophoblasts: 30.6;Late spermatids: 84.2;Spermatocytes: 40.4;Spermatogonia: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "NK-cell: 5.8;T-reg: 4.2" "Group enriched" "Detected in many" 4 "NK-cells: 5.8;T-cells: 4.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023691, HPA076007" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA023691: AB_1846392, HPA076007: " "unprognostic (3.14e-2)" "unprognostic (4.20e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.15e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.21e-6)" "unprognostic (1.41e-3)" "unprognostic (7.55e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (8.72e-6)" "unprognostic (2.16e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.55e-3)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (8.97e-2)" 1.3 1.3 1.1 12.3 1.1 27.4 4.3 1.0 2.8 1.6 3.8 0.6 0.0 3.3 0.9 1.4 7.9 0.7 1.4 1.3 1.1 0.9 1.3 1.3 1.9 9.5 1.1 0.5 0.8 0.7 0.2 0.7 5.5 1.3 0.9 4.7 0.1 1.5 0.1 0.7 2.4 3.6 1.7 0.7 5.7 2.1 27.9 0.2 39.9 0.7 6.6 9.9 1.5 2.3 1.2 0.8 0.3 0.5 5.8 4.2 1.4 30.7 17.6 16.9 14.3 1.1 1.8 14.1 22.0 9.2 25.8 20.6 18.0 18.7 28.0 12.7 7.1 30.4 21.3 27.3 12.1 25.2 28.0 11.9 25.2 12.8 15.1 0.1 26.8 20.4 0.6 1.1 24.1 11.2 2.7 7.8 33.6 28.5 51.8 15.7 25.5 37.8 27.7 26.6 15.2 21.4 33.2 18.7 26.7 5.3 11.8 22.0 16.5 14.1 20.2 14.9 11.0 26.0 13.2 4.9 23.4 24.2 24.6 24.4 26.2 41.5 45.6 9.4 16.6 24.1 0.0 0.2 0.3 0.8 0.0 0.1 0.7 1.1 0.6 0.8 1.2 0.1 0.8 0.1 5.8 0.5 0.7 4.2 1.4 1.1 1.1 1.0 2.8 1.1 0.9 1.1 0.5 1.3 0.2 0.0 0.3 0.8 0.8 3.4 0.8 0.8 0.0 0.0 1.2 0.0 2.0 3.7 1.7 0.9 41.6 0.9 0.9 0.0 0.7 30.6 1.8 0.4 3.5 0.0 9.5 1.6 0.0 1.3 2.8 84.2 2.6 1.9 0.0 3.6 2.3 0.8 0.5 0.0 1.4 0.3 0.2 0.0 0.3 40.4 22.0 0.9 3.1 1.9 2.8 1.0 CDK20 "CCRK, p42" ENSG00000156345 "Cyclin dependent kinase 20" Q8IZL9 9 87966441-87974753 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 25.4;Spermatocytes: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.2" "Group enriched" "Detected in many" 7 "NK-cells: 7.2;T-cells: 5.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.4;THP-1: 21.7" "Low region specificity" "Detected in all" "HPA007666, HPA027379, HPA027401" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA007666: AB_10600002, HPA027379: AB_10599939, HPA027401: AB_10601553" "unprognostic (4.60e-2)" "unprognostic (6.48e-2)" "unprognostic (1.69e-2)" "prognostic favorable (2.59e-4)" "unprognostic (2.32e-1)" "unprognostic (4.33e-3)" "unprognostic (2.81e-4)" "unprognostic (6.33e-2)" "unprognostic (1.45e-1)" "unprognostic (1.34e-1)" "unprognostic (2.83e-3)" "unprognostic (4.04e-2)" "prognostic favorable (2.12e-5)" "unprognostic (8.24e-3)" "unprognostic (5.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.42e-2)" 2.6 16.2 10.8 2.4 13.0 1.6 4.1 8.7 17.1 8.7 5.0 6.1 5.1 5.3 7.2 6.0 2.8 19.5 5.6 3.0 8.6 10.7 8.2 3.2 4.0 2.0 5.8 14.3 9.5 4.8 7.6 10.8 3.1 9.3 6.1 3.4 7.7 3.6 8.6 2.1 3.6 7.6 5.5 3.1 1.6 3.7 17.7 5.2 0.8 6.8 1.2 1.1 6.3 3.0 0.1 0.8 0.4 0.8 7.2 5.0 1.3 2.4 3.0 2.4 7.6 1.7 2.4 1.0 2.2 4.2 5.9 5.5 0.7 3.6 0.0 3.3 3.6 10.3 3.1 0.0 2.1 2.4 5.9 2.5 0.0 1.9 0.0 7.4 2.8 3.4 1.9 4.4 9.3 3.8 4.6 0.0 5.3 0.3 0.0 1.7 7.1 1.9 0.8 1.9 5.3 1.1 0.0 0.0 0.1 7.4 2.0 14.4 4.1 2.5 3.0 3.6 0.8 3.3 21.7 0.0 2.6 1.0 0.5 2.4 3.8 3.6 0.0 9.3 1.9 2.8 0.0 0.7 0.4 1.3 0.8 0.5 0.0 3.0 1.9 0.7 0.1 5.0 3.2 0.1 7.2 0.7 0.8 2.7 1.3 10.8 13.0 8.7 17.1 8.6 10.7 5.8 14.3 9.3 5.2 3.0 4.1 0.0 1.5 1.9 5.2 2.0 2.5 25.4 5.7 1.8 2.0 3.6 1.7 4.2 4.7 0.5 5.4 0.0 1.3 1.9 3.3 2.5 1.1 0.9 0.9 7.9 0.0 0.6 0.0 1.7 4.0 1.1 0.0 0.0 2.0 4.8 1.5 0.0 6.3 5.3 13.5 6.5 2.3 25.0 2.9 1.9 3.3 0.5 2.9 0.7 CDK2AP1 "doc-1, DOC1, DORC1, p12DOC-1, ST19" ENSG00000111328 "Cyclin dependent kinase 2 associated protein 1" O14519 12 123260971-123272334 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Late spermatids: 109.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 13.0;intermediate monocyte: 40.5;myeloid DC: 14.9;non-classical monocyte: 44.8" "Group enriched" "Detected in many" 6 "dendritic cells: 14.9;monocytes: 44.8" "Low cell line specificity" "Detected in many" "CAB019377, HPA057648, HPA068833" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB019377: , HPA057648: AB_2683488, HPA068833: AB_2686046" "unprognostic (1.56e-1)" "unprognostic (5.94e-2)" "unprognostic (1.83e-2)" "unprognostic (3.04e-2)" "unprognostic (7.77e-2)" "unprognostic (8.89e-2)" "unprognostic (4.21e-3)" "unprognostic (2.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.70e-2)" "unprognostic (3.32e-2)" "unprognostic (2.22e-1)" "prognostic unfavorable (5.27e-7)" "unprognostic (9.32e-2)" "unprognostic (6.20e-2)" "unprognostic (5.56e-2)" "unprognostic (1.18e-1)" 29.9 28.3 60.4 20.1 55.4 21.0 61.5 27.4 61.6 42.6 22.8 62.8 15.0 13.1 34.5 45.2 30.9 25.5 29.9 30.1 61.0 52.4 20.8 18.2 21.1 22.2 76.4 30.3 16.9 16.4 24.2 22.4 21.4 53.6 33.0 21.9 16.4 51.0 35.4 26.6 21.6 12.6 41.0 96.8 17.7 19.4 22.7 59.9 17.9 16.6 22.1 18.0 36.9 23.4 0.2 14.9 5.1 44.8 0.3 0.5 7.6 16.2 22.9 61.2 65.2 49.6 61.9 11.1 53.0 49.7 42.5 32.7 17.2 15.6 0.0 23.7 81.4 15.8 15.0 64.8 34.6 35.4 10.0 16.2 8.8 14.0 27.2 26.5 13.5 9.5 39.3 36.3 24.6 16.0 38.8 60.2 20.1 11.6 0.1 79.9 31.5 17.8 21.8 40.1 20.2 17.2 68.3 26.5 7.0 34.5 39.5 58.0 67.9 38.9 19.1 52.0 17.0 36.9 13.6 36.8 39.7 20.7 23.2 34.8 2.8 5.3 15.0 21.3 6.5 86.3 3.8 13.0 5.1 0.2 40.5 0.5 0.2 0.2 0.3 14.9 0.0 0.1 0.2 0.7 0.3 44.8 1.4 0.1 7.6 60.4 55.4 27.4 52.2 61.0 52.4 76.4 30.3 53.6 59.9 26.8 31.2 0.0 1.1 1.1 0.2 1.6 7.6 18.7 34.2 12.2 0.0 1.2 1.7 19.8 19.8 5.6 5.1 0.0 14.6 2.8 4.1 0.3 18.5 7.3 5.2 3.2 7.5 13.5 18.0 109.1 12.4 7.2 3.3 10.8 19.8 20.0 19.4 10.5 13.4 2.6 0.2 0.0 1.0 1.5 5.7 2.5 1.1 0.0 18.0 0.8 CDK2AP2 "DOC-1R, p14" ENSG00000167797 "Cyclin dependent kinase 2 associated protein 2" O75956 11 67506497-67508649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047599 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047599: AB_10963069" "unprognostic (2.44e-1)" "unprognostic (5.01e-2)" "unprognostic (1.42e-1)" "prognostic favorable (8.80e-4)" "unprognostic (6.24e-2)" "unprognostic (2.30e-2)" "unprognostic (8.85e-3)" "unprognostic (1.42e-1)" "unprognostic (5.65e-2)" "unprognostic (3.85e-3)" "unprognostic (4.91e-3)" "unprognostic (2.06e-1)" "prognostic unfavorable (5.20e-4)" "unprognostic (7.58e-2)" "unprognostic (3.11e-1)" "unprognostic (6.96e-2)" "unprognostic (1.73e-3)" 16.2 28.0 16.8 20.4 22.4 17.0 26.2 13.5 15.6 20.5 22.4 13.1 32.3 23.4 16.6 44.8 17.8 16.6 18.6 28.6 16.2 14.8 43.3 45.5 19.6 23.8 21.9 9.2 12.3 41.6 9.0 18.1 19.5 21.3 16.0 14.4 8.1 55.1 24.9 9.6 10.1 20.0 13.8 21.1 19.0 19.7 6.8 21.4 28.3 80.3 10.6 22.9 17.4 35.8 25.9 91.6 27.8 30.0 32.5 37.6 23.3 16.8 11.0 5.9 10.4 8.0 2.5 9.4 6.5 3.1 7.6 7.1 13.9 19.7 12.5 22.1 4.3 9.9 12.1 8.7 11.5 2.2 23.5 8.0 6.7 8.5 9.6 18.4 6.5 10.4 3.0 12.6 5.8 13.5 7.5 8.4 17.7 7.0 26.5 4.0 26.1 32.8 22.3 5.3 32.6 18.4 15.0 3.5 40.3 18.0 4.2 4.5 10.3 8.0 16.3 26.3 5.1 11.7 12.9 7.0 4.9 8.9 12.1 4.8 11.2 6.7 10.7 14.5 8.6 5.5 23.9 17.2 27.8 37.6 27.0 32.5 25.9 29.1 34.0 23.0 24.0 17.1 24.6 11.3 32.5 30.0 91.6 32.6 23.3 16.8 22.4 13.5 15.6 16.2 14.8 21.9 9.2 21.3 21.4 59.6 74.7 108.7 45.0 59.5 27.2 75.3 86.6 68.3 58.0 111.7 29.5 94.6 182.4 73.9 0.9 46.6 169.0 0.0 46.4 142.7 44.3 65.4 73.8 110.5 74.2 31.8 98.5 41.1 36.7 1.6 22.7 61.1 108.0 148.7 60.1 47.9 95.1 91.2 28.7 224.3 19.5 25.8 79.5 7.2 30.9 44.5 162.6 126.6 78.6 49.7 CDK8 K35 ENSG00000132964 "Cyclin dependent kinase 8" P49336 13 26254104-26405238 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Kinase, Repressor, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 55.8;Late spermatids: 83.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044721 Approved Nucleoplasm NA NA Nucleoplasm "HPA044721: AB_2679059" "unprognostic (3.28e-3)" "unprognostic (2.25e-3)" "unprognostic (2.08e-1)" "unprognostic (3.88e-3)" "unprognostic (2.30e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-3)" "unprognostic (1.85e-2)" "unprognostic (5.00e-2)" "unprognostic (8.57e-2)" "unprognostic (2.52e-1)" "unprognostic (3.18e-3)" "unprognostic (2.12e-1)" "prognostic favorable (9.23e-4)" "unprognostic (1.43e-2)" "unprognostic (1.88e-1)" "unprognostic (6.37e-2)" 7.6 8.8 10.1 10.4 8.5 5.2 5.6 26.9 11.3 5.9 24.0 6.0 13.8 13.8 11.2 6.5 10.0 7.0 11.2 7.6 8.3 7.3 9.4 10.4 6.7 5.2 7.8 7.9 6.1 12.7 8.4 10.2 10.6 8.2 7.8 11.2 4.6 9.0 19.2 9.7 6.1 15.0 12.7 6.0 6.4 11.7 16.3 9.9 12.8 6.4 6.9 7.2 15.5 11.0 1.9 1.7 3.4 1.6 1.0 2.1 1.3 6.9 5.7 11.6 11.8 6.2 7.6 7.2 13.4 9.2 10.0 7.2 16.6 9.7 7.4 5.9 6.9 8.0 8.6 13.3 9.0 12.6 17.1 7.4 14.1 4.6 5.7 4.3 22.0 8.1 5.5 8.7 7.5 12.7 5.5 7.3 12.1 21.8 0.0 9.0 7.4 16.8 10.3 9.2 10.5 7.1 10.6 11.5 5.1 5.8 6.5 9.9 5.8 5.7 10.9 9.8 9.6 3.9 10.1 7.4 6.4 8.2 11.7 7.3 5.7 10.1 13.6 4.0 9.3 7.6 0.4 0.9 3.4 1.1 1.6 1.9 1.0 1.5 2.1 1.7 1.9 2.1 1.7 0.0 1.0 1.2 1.0 0.6 1.3 10.1 8.5 26.9 11.3 8.3 7.3 7.8 7.9 8.2 9.9 8.9 4.1 4.5 6.7 17.5 19.1 5.0 7.6 0.0 5.7 1.8 23.6 7.2 8.3 8.5 55.8 6.8 9.7 0.0 7.2 8.3 9.3 11.0 0.0 5.4 7.1 17.5 8.1 6.2 7.5 83.1 7.2 6.6 8.5 8.2 7.8 7.1 10.6 11.5 7.8 11.5 16.6 6.5 11.3 27.8 17.5 20.8 8.1 6.9 10.5 9.1 CDKL5 "CFAP247, EIEE2, STK9" ENSG00000008086 "Cyclin dependent kinase like 5" O76039 X 18425583-18653629 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 76.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 7.7;eosinophil: 2.1;neutrophil: 4.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 7.7" "Cell line enhanced" "Detected in many" "A549: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002847, CAB011577" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB011577: AB_727019, HPA002847: AB_1080107" "unprognostic (7.01e-2)" "unprognostic (4.86e-2)" "unprognostic (1.41e-1)" "unprognostic (1.25e-4)" "unprognostic (1.17e-1)" "unprognostic (1.61e-2)" "unprognostic (1.72e-2)" "unprognostic (1.67e-1)" "unprognostic (2.07e-1)" "unprognostic (9.63e-3)" "unprognostic (2.05e-3)" "unprognostic (1.66e-1)" "prognostic favorable (5.54e-4)" "unprognostic (7.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.67e-3)" "unprognostic (1.99e-1)" 3.3 3.2 8.0 1.8 24.7 3.2 4.3 3.9 28.0 5.4 2.7 7.7 1.8 1.5 4.5 2.8 5.2 2.8 3.1 5.0 8.0 3.7 6.3 2.2 6.9 1.4 3.5 13.2 6.7 4.5 6.2 5.0 5.4 5.9 6.7 2.2 2.0 3.9 4.4 3.0 3.5 1.9 4.0 5.7 2.3 4.9 14.0 5.7 1.6 5.1 0.8 2.1 5.6 4.6 0.7 1.0 7.7 1.0 0.5 0.6 0.2 1.7 12.3 3.5 3.1 3.3 4.5 2.5 2.0 3.8 2.8 3.2 4.0 2.3 1.9 0.4 1.3 5.5 0.5 4.0 3.0 5.9 0.5 2.6 0.0 7.1 3.2 1.6 0.1 0.8 2.6 3.1 6.8 7.1 1.7 1.3 2.2 0.1 2.0 4.2 1.7 0.8 0.8 7.2 1.6 3.0 0.7 3.8 0.1 2.5 9.0 0.7 4.5 4.5 1.1 2.2 7.4 1.7 0.7 7.3 4.3 1.9 7.9 1.5 0.3 0.1 0.3 2.4 0.5 4.2 7.7 1.0 2.1 0.6 0.6 0.3 0.2 0.4 0.3 0.3 0.7 0.6 0.6 4.7 0.5 0.6 1.0 0.2 0.2 8.0 24.7 3.9 28.0 8.0 3.7 3.5 13.2 5.9 5.7 23.8 19.0 0.0 8.3 0.8 16.1 12.0 5.1 6.7 9.1 7.0 31.4 20.0 6.6 5.7 27.2 4.5 0.0 0.0 8.1 2.5 3.1 18.1 1.1 3.0 3.7 76.3 2.4 4.9 5.3 41.5 5.5 1.8 0.0 2.8 1.9 27.7 6.6 0.0 4.9 7.5 19.5 32.3 4.2 2.3 9.8 1.1 39.6 0.8 1.5 24.3 CDKN2AIP "CARF, FLJ20036" ENSG00000168564 "CDKN2A interacting protein" Q9NXV6 4 183444591-183448198 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 103.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041397, HPA062142" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA041397: AB_10794297, HPA062142: AB_2684696" "unprognostic (9.00e-2)" "unprognostic (1.14e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (7.20e-2)" "unprognostic (1.52e-2)" "unprognostic (7.65e-3)" "unprognostic (6.70e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "prognostic favorable (3.00e-5)" "unprognostic (2.93e-2)" "unprognostic (4.69e-2)" "unprognostic (2.25e-3)" "unprognostic (2.23e-2)" 14.2 14.3 13.9 13.6 15.6 32.3 15.9 20.8 13.8 18.1 18.1 15.0 10.1 18.7 17.1 13.2 27.7 13.0 13.3 15.0 13.0 12.9 18.1 17.2 17.8 17.8 15.4 10.7 24.0 18.4 15.9 21.9 16.4 14.0 21.5 14.2 13.0 15.9 15.2 11.1 14.2 18.0 14.8 13.7 16.0 17.2 20.1 12.2 24.7 23.4 20.6 27.3 16.6 24.1 8.3 4.6 28.5 5.9 8.1 14.7 8.4 5.1 2.9 8.7 6.2 7.3 5.3 6.5 8.7 7.3 9.0 6.0 4.3 5.0 17.3 1.8 5.9 3.7 4.1 7.9 6.4 9.5 7.0 4.7 17.9 14.0 5.5 5.8 13.1 7.2 6.3 6.0 5.3 7.0 4.8 7.1 6.6 8.9 18.7 6.2 2.7 14.8 10.7 6.3 1.9 6.0 12.8 4.2 6.9 60.3 4.9 8.9 7.6 6.3 26.6 10.4 5.9 3.9 11.4 4.0 3.2 4.5 2.9 7.0 9.1 3.7 8.9 5.0 11.3 5.1 28.5 4.8 10.4 9.0 5.6 9.4 7.4 11.1 9.7 4.6 8.3 14.7 13.3 5.7 8.1 5.9 3.1 10.9 8.4 13.9 15.6 20.8 13.8 13.0 12.9 15.4 10.7 14.0 12.2 14.9 30.7 18.2 22.6 31.9 21.9 15.7 22.9 33.5 27.3 15.7 9.8 20.1 14.9 11.0 103.2 21.8 25.7 0.0 13.7 12.2 23.7 35.9 61.1 12.8 13.7 20.6 29.1 17.8 8.8 51.4 19.5 18.9 20.3 11.8 19.1 18.8 13.2 20.1 16.3 10.5 19.8 12.9 21.1 32.3 36.3 34.8 15.7 34.1 17.5 48.5 CDKN2B "CDK4I, INK4B, MTS2, P15, p15INK4b, TP15" ENSG00000147883 "Cyclin dependent kinase inhibitor 2B" P42772 9 22002903-22009363 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.0" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 140.1;Pancreatic endocrine cells: 107.4;Urothelial cells: 219.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 4.6;intermediate monocyte: 3.9;non-classical monocyte: 10.9" "Lineage enriched" "Detected in single" 16 "monocytes: 10.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.7;HaCaT: 16.2;HeLa: 15.3;hTERT-RPE1: 28.4;SiHa: 20.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB000349, HPA052838, HPA063327" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB000349: , HPA052838: , HPA063327: AB_2684987" "unprognostic (2.30e-1)" "unprognostic (9.23e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (4.47e-6)" "unprognostic (2.10e-1)" "unprognostic (7.40e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (2.01e-1)" "unprognostic (3.03e-2)" "unprognostic (3.19e-2)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (9.14e-3)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.28e-2)" 22.4 1.4 1.4 7.3 1.1 0.0 25.1 0.8 1.2 6.6 35.4 1.4 1.5 14.1 2.6 0.8 27.0 1.2 1.4 1.4 1.6 0.8 0.5 0.6 9.9 2.3 2.0 0.8 0.8 1.0 3.9 7.8 3.7 3.4 3.1 13.4 0.7 5.1 3.2 6.5 8.6 47.0 3.2 1.0 4.4 3.9 3.3 1.3 1.1 0.8 9.8 12.5 2.8 16.6 0.0 0.6 0.0 10.9 0.0 0.4 1.3 0.0 0.0 0.1 0.9 13.6 18.7 0.3 0.6 0.0 2.1 5.9 1.5 4.1 0.0 1.7 1.0 0.0 16.2 0.3 3.2 2.6 1.1 5.0 0.0 15.3 0.7 6.9 0.4 2.7 3.9 0.0 2.7 12.0 28.4 2.0 0.0 0.0 7.2 3.4 1.2 0.0 0.0 0.7 0.8 9.4 0.0 0.9 0.3 4.6 0.0 2.6 0.0 20.5 5.3 14.7 12.6 1.1 0.0 5.3 0.0 0.3 0.0 0.0 6.9 3.9 0.0 0.0 0.4 0.0 0.0 4.6 0.0 0.1 3.9 0.0 0.0 0.4 0.3 0.6 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.1 1.3 1.4 1.1 0.8 1.2 1.6 0.8 2.0 0.8 3.4 1.3 62.5 7.9 0.9 16.4 4.7 1.2 2.4 2.5 4.0 3.4 5.2 0.0 0.8 0.0 50.3 4.4 2.5 140.1 0.0 34.0 0.4 7.2 41.1 0.0 0.0 1.2 0.0 7.5 2.5 14.8 1.7 0.6 4.0 3.3 1.8 21.9 3.7 107.4 49.1 1.1 0.0 6.7 0.0 6.3 13.8 3.3 21.1 2.6 0.0 11.2 219.8 CDR2 "CDR62, Yo" ENSG00000140743 "Cerebellar degeneration related protein 2" Q01850 16 22345936-22437165 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018151, HPA023870" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018151: AB_1846457, HPA023870: AB_1846459" "unprognostic (7.89e-2)" "unprognostic (1.55e-1)" "unprognostic (5.23e-2)" "unprognostic (3.09e-1)" "unprognostic (6.59e-2)" "unprognostic (1.27e-2)" "unprognostic (5.76e-2)" "unprognostic (2.75e-1)" "unprognostic (2.55e-1)" "unprognostic (1.06e-1)" "unprognostic (9.86e-2)" "unprognostic (3.04e-1)" "unprognostic (2.04e-2)" "unprognostic (3.34e-3)" "unprognostic (1.38e-2)" "unprognostic (5.78e-2)" "unprognostic (1.67e-3)" 10.6 7.2 6.9 14.3 14.2 12.0 13.3 12.0 9.1 16.6 24.6 2.2 14.2 15.9 10.4 11.7 13.2 8.9 13.4 13.1 5.6 8.0 14.7 14.1 20.1 20.3 5.4 4.9 18.3 11.3 9.0 27.4 9.0 9.2 22.9 11.6 37.1 16.9 15.2 5.3 6.5 24.5 40.5 4.2 13.7 11.7 42.9 3.4 17.9 38.2 5.8 14.7 39.8 43.4 1.4 1.5 5.9 1.1 3.1 8.4 2.0 15.4 10.9 9.7 10.4 24.6 21.3 10.2 15.5 24.3 15.9 21.3 14.2 11.1 13.7 8.0 26.4 9.6 15.3 20.9 8.9 18.9 10.3 10.9 10.2 12.0 45.1 28.6 11.3 20.9 15.7 8.2 15.9 17.7 20.4 19.8 18.2 10.1 22.2 15.2 11.4 10.7 8.2 13.6 13.5 9.4 16.1 12.7 20.2 20.1 9.9 7.6 5.3 10.4 22.2 15.4 11.7 6.6 5.5 12.4 15.5 9.9 14.7 13.2 12.0 18.7 18.4 10.2 11.3 13.3 5.9 1.1 1.5 2.4 0.9 5.1 1.4 7.6 4.8 1.1 0.9 6.0 5.0 1.0 3.1 1.1 1.5 8.4 2.0 6.9 14.2 12.0 9.1 5.6 8.0 5.4 4.9 9.2 3.4 3.0 6.1 3.7 14.4 30.2 7.7 2.8 12.7 4.0 9.1 8.7 13.7 1.4 1.7 7.7 23.9 9.0 19.5 23.3 6.1 9.4 14.1 16.6 0.0 8.2 8.0 7.9 6.3 9.2 4.1 4.7 6.4 5.4 10.1 4.6 11.6 7.2 12.0 9.3 10.3 11.2 57.8 6.5 16.5 26.0 17.0 21.2 1.1 14.1 7.5 13.2 CDX2 CDX3 ENSG00000165556 "Caudal type homeobox 2" Q99626 13 27962137-27971139 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "intestine: 21.2" "Group enriched" "Detected in some" 7 "Enterocytes: 190.4;Intestinal endocrine cells: 60.0;Mucus-secreting cells: 200.2;Paneth cells: 129.8;Undifferentiated cells: 183.4" "Cancer enriched" "Detected in many" 6 "colorectal cancer: 63.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 14.7;CAPAN-2: 4.9;HEK 293: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002221, HPA045669, HPA049580" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002221: AB_563649, HPA045669: AB_2679413, HPA049580: AB_2680823" "unprognostic (1.42e-1)" "unprognostic (2.41e-1)" "unprognostic (2.92e-1)" "unprognostic (8.11e-3)" "unprognostic (4.19e-6)" "unprognostic (1.73e-4)" "unprognostic (1.71e-1)" "unprognostic (1.58e-1)" "unprognostic (5.51e-2)" "unprognostic (6.07e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 21.2 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 14.3 0.0 0.0 0.0 0.0 16.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.7 4.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 8.1 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 20.8 0.0 0.0 190.4 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.4 0.0 60.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 200.2 0.0 1.1 129.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 183.4 0.1 CEBPB "C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5" ENSG00000172216 "CCAAT/enhancer binding protein beta" P17676 20 50190734-50192689 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 121.9" "Cell type enhanced" "Detected in many" 7 "Smooth muscle cells: 658.6;Suprabasal keratinocytes: 699.3;Syncytiotrophoblasts: 1179.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.6" "Group enriched" "Detected in many" 8 "granulocytes: 13.6;monocytes: 6.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 45.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB004213, HPA061355, HPA062267" Supported Enhanced Nucleoplasm Yes No Nucleoplasm "CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731" "unprognostic (2.30e-2)" "unprognostic (2.64e-1)" "unprognostic (1.24e-2)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "unprognostic (2.24e-2)" "unprognostic (1.32e-1)" "unprognostic (1.40e-3)" "unprognostic (1.79e-2)" "unprognostic (9.85e-3)" "unprognostic (9.26e-3)" "unprognostic (6.55e-2)" "prognostic unfavorable (2.44e-12)" "unprognostic (7.29e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-2)" "unprognostic (7.63e-2)" 56.9 54.7 7.0 35.9 9.9 21.1 34.4 1.8 6.2 22.8 25.2 6.4 8.0 8.0 19.4 11.2 19.2 21.7 20.2 33.6 8.4 4.4 15.3 92.5 51.3 20.4 9.5 3.0 33.6 18.6 4.1 7.4 75.1 7.7 21.1 5.0 14.0 14.6 11.7 121.9 23.9 19.4 12.6 9.5 40.3 15.3 14.3 8.1 1.5 46.1 25.3 10.7 30.8 30.6 0.4 1.2 13.6 6.1 0.4 0.5 0.5 7.4 3.4 0.3 4.1 19.3 7.6 33.5 10.1 16.0 7.0 6.2 3.4 6.9 4.9 19.4 4.1 34.4 10.2 1.0 9.9 4.7 3.5 2.5 1.5 4.4 5.0 23.8 2.4 9.8 8.1 26.3 8.9 15.8 14.6 0.9 5.1 7.1 9.1 4.3 2.8 1.1 5.3 2.1 7.1 9.9 3.5 1.0 5.5 2.3 1.8 2.0 1.3 8.4 20.9 45.0 2.3 5.5 13.8 1.3 14.6 11.1 12.4 9.7 19.4 8.0 4.3 26.6 5.6 6.3 5.9 3.0 9.1 0.4 5.3 0.1 0.4 0.4 0.5 1.2 0.3 0.3 0.2 13.6 0.4 6.1 0.0 0.2 0.5 7.0 9.9 1.8 6.2 8.4 4.4 9.5 3.0 7.7 8.1 32.8 78.5 51.8 281.2 643.3 2.2 40.0 84.1 21.4 31.8 43.6 0.0 157.2 26.6 27.6 4.6 30.6 66.5 0.0 11.5 550.7 468.0 220.5 50.7 350.5 326.4 3.2 64.1 81.0 362.0 5.0 120.0 403.2 205.8 1.8 77.9 46.2 16.6 52.6 90.5 50.0 3.3 155.2 658.6 0.7 9.1 699.3 1179.1 63.8 45.7 245.2 CEBPD "C/EBP-delta, CELF, CRP3, NF-IL6-beta" ENSG00000221869 "CCAAT/enhancer binding protein delta" P49716 8 47736909-47739086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 1062.9;Glandular cells: 1104.9;Smooth muscle cells: 1847.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 20.9" "Group enriched" "Detected in many" 5 "granulocytes: 20.9;monocytes: 7.8" "Cell line enhanced" "Detected in many" "BEWO: 13.5;HHSteC: 17.5;HSkMC: 17.3;NB-4: 36.7;SiHa: 15.1" "Low region specificity" "Detected in many" HPA067581 Approved Nucleoplasm NA NA Nucleoplasm "HPA067581: AB_2685865" "prognostic favorable (2.28e-5)" "unprognostic (1.43e-1)" "unprognostic (2.99e-2)" "unprognostic (1.74e-2)" "unprognostic (2.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.52e-2)" "unprognostic (2.12e-1)" "unprognostic (6.81e-2)" "unprognostic (5.16e-2)" "unprognostic (5.47e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.87e-7)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "unprognostic (4.62e-2)" "unprognostic (3.40e-2)" 27.3 14.9 4.7 14.3 4.7 6.5 12.3 4.7 7.7 7.3 9.5 4.7 4.7 6.1 5.8 4.7 5.4 12.6 4.7 9.5 4.7 1.3 8.2 25.7 10.5 4.7 4.7 4.7 21.5 7.3 0.6 8.4 11.3 4.7 11.0 2.6 7.5 6.4 4.7 9.1 6.8 9.6 4.7 4.7 13.5 8.8 9.4 4.7 4.7 7.1 14.1 4.7 11.7 9.4 0.1 2.7 20.9 7.8 1.3 2.4 0.9 2.3 1.8 0.1 0.0 10.8 11.2 13.5 6.2 4.7 1.7 3.7 3.6 3.8 0.0 4.5 1.6 1.5 2.5 0.4 3.2 0.5 0.0 0.9 0.1 1.5 1.5 17.5 1.0 0.0 17.3 8.4 0.4 4.1 1.1 0.3 0.1 1.0 1.9 0.6 0.7 0.0 36.7 0.7 1.5 0.6 0.0 1.3 0.1 5.1 1.9 0.7 0.2 15.1 2.0 1.5 0.7 1.6 8.4 1.5 0.4 1.1 4.1 0.4 0.0 0.0 0.0 2.0 0.0 0.0 0.9 7.8 3.6 0.8 3.0 2.4 0.0 0.1 0.4 2.7 0.1 0.0 0.0 20.9 1.3 1.1 0.0 0.1 0.9 4.7 4.7 4.7 7.7 4.7 1.3 4.7 4.7 4.7 4.7 95.3 155.3 27.0 1062.9 589.5 4.9 66.7 96.8 56.2 94.4 212.9 5.9 176.8 184.1 42.0 2.5 382.1 63.9 0.0 65.1 327.7 527.3 1104.9 4.7 125.8 194.7 1.6 22.4 138.7 301.2 7.0 403.3 397.2 254.8 5.4 35.9 259.0 72.6 40.7 136.2 287.1 12.7 459.2 1847.8 2.1 3.7 714.5 294.3 115.1 47.7 772.4 CEBPG "GPE1BP, IG/EBP-1" ENSG00000153879 "CCAAT/enhancer binding protein gamma" P53567 19 33373330-33382686 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012024 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA012024: AB_1846503" "unprognostic (5.56e-2)" "unprognostic (1.35e-1)" "unprognostic (3.29e-3)" "prognostic unfavorable (7.97e-5)" "unprognostic (8.12e-2)" "unprognostic (2.35e-2)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (1.19e-2)" "unprognostic (2.10e-2)" "unprognostic (1.29e-1)" "unprognostic (2.74e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (1.16e-1)" "unprognostic (5.25e-2)" "unprognostic (8.87e-2)" "unprognostic (2.01e-2)" 16.8 7.2 13.0 10.3 14.3 12.4 21.3 17.9 14.2 9.6 22.6 7.3 6.5 25.2 10.6 7.5 16.4 9.4 8.9 11.3 12.5 14.5 10.0 35.8 13.3 8.8 13.2 9.7 12.2 21.7 10.7 15.7 14.5 13.0 9.6 22.5 6.7 15.2 7.8 34.5 21.0 42.8 13.7 20.9 9.6 14.8 10.7 11.4 9.7 20.0 19.1 11.0 12.3 34.6 8.5 17.1 9.6 20.8 5.4 10.4 9.3 11.9 12.8 10.8 10.9 5.3 7.8 15.1 9.1 7.7 7.6 9.3 12.4 6.1 18.3 7.9 4.5 9.6 6.0 18.9 9.0 13.4 34.3 8.8 9.7 5.4 13.5 17.6 16.1 11.1 10.2 42.8 9.6 33.1 4.2 9.4 15.3 13.4 21.2 6.2 7.5 11.6 10.2 6.1 33.2 7.4 13.1 7.4 7.2 4.8 7.5 21.5 12.9 9.2 9.3 21.5 8.3 7.9 32.8 9.0 7.9 11.1 8.7 13.6 12.8 9.5 12.0 8.3 18.1 10.8 9.6 16.8 7.3 8.0 19.0 7.8 8.5 8.6 9.0 17.1 6.4 8.4 8.3 2.0 5.4 20.8 5.9 10.4 9.3 13.0 14.3 17.9 14.2 12.5 14.5 13.2 9.7 13.0 11.4 17.9 10.4 28.9 79.8 110.4 10.8 14.5 20.4 58.9 21.6 14.0 7.9 35.7 16.6 33.7 60.3 48.8 104.1 0.0 46.7 59.8 28.6 57.1 25.4 60.4 41.6 3.2 33.9 20.3 38.3 57.1 6.4 41.2 27.0 57.7 71.4 25.6 56.4 67.7 8.5 23.7 12.9 6.5 48.7 53.1 45.3 136.1 62.6 25.4 55.6 99.7 CEBPZOS CEBPZ-AS1 ENSG00000218739 "CEBPZ opposite strand" A8MTT3 2 37196488-37216193 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053866 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053866: AB_2682283" "unprognostic (2.13e-1)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (1.33e-1)" "unprognostic (8.05e-3)" "prognostic unfavorable (1.72e-6)" "unprognostic (2.34e-2)" "unprognostic (2.40e-2)" "unprognostic (5.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (3.46e-7)" "unprognostic (3.69e-2)" "unprognostic (4.49e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-2)" 16.5 31.3 29.5 16.2 25.4 17.9 18.5 21.0 30.2 16.9 19.8 16.3 19.1 19.0 25.9 33.0 19.3 19.5 14.4 24.5 43.8 23.8 21.5 18.2 13.8 16.5 23.6 31.3 22.8 14.9 18.6 30.2 22.1 25.4 22.3 18.9 16.1 23.9 16.7 38.4 19.0 22.0 17.1 19.4 13.8 15.3 20.3 12.7 12.9 23.7 19.8 15.1 19.4 14.0 20.9 29.4 15.3 15.3 13.1 25.2 13.7 26.2 8.8 18.9 15.3 20.1 21.9 18.3 19.5 17.6 12.7 9.3 8.2 12.0 9.1 10.5 19.4 16.5 15.5 10.3 14.8 15.6 24.6 21.3 24.5 10.2 12.8 17.4 30.5 13.7 23.2 20.5 17.1 19.1 17.2 20.2 9.8 18.4 13.7 20.6 5.3 7.6 30.0 27.8 21.2 13.6 22.8 26.0 20.9 22.3 7.2 20.3 19.9 14.9 24.9 19.0 10.8 11.1 18.6 17.8 13.7 16.9 20.0 16.8 24.6 0.2 19.8 25.5 18.4 19.5 15.3 14.1 12.1 17.7 15.3 20.4 20.9 20.1 18.5 13.5 18.0 25.2 22.4 5.7 13.1 11.5 29.4 13.7 13.7 29.5 25.4 21.0 30.2 43.8 23.8 23.6 31.3 25.4 12.7 50.6 39.2 29.4 42.0 0.0 44.4 41.1 7.6 49.5 38.7 36.6 17.7 70.8 77.9 36.3 30.8 23.3 27.4 0.0 29.4 42.0 27.8 39.9 16.2 24.1 37.6 30.2 16.8 22.1 25.3 9.5 43.7 33.7 0.0 37.9 27.6 46.1 36.7 28.8 41.8 51.9 51.6 45.3 28.5 119.8 51.1 0.0 57.8 34.5 27.5 38.8 CELF1 "BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, hNab50, NAB50, NAPOR" ENSG00000149187 "CUGBP Elav-like family member 1" Q92879 11 47465933-47565569 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016114, HPA044597, CAB069989" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016114: AB_627319, CAB069989: AB_2086153, HPA044597: AB_2679012" "unprognostic (1.05e-1)" "unprognostic (7.54e-2)" "unprognostic (3.24e-2)" "unprognostic (7.64e-2)" "unprognostic (2.69e-1)" "unprognostic (4.08e-2)" "prognostic unfavorable (7.55e-4)" "unprognostic (3.84e-2)" "unprognostic (3.41e-2)" "unprognostic (1.59e-1)" "unprognostic (2.75e-1)" "unprognostic (4.24e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-2)" "unprognostic (2.68e-1)" "unprognostic (9.58e-2)" "unprognostic (3.34e-2)" 18.4 22.8 28.3 19.9 30.8 25.8 22.7 49.5 29.8 17.8 20.7 16.6 22.9 14.7 22.9 20.1 21.5 19.0 16.5 19.3 18.7 14.1 18.5 36.5 21.0 24.0 12.8 20.2 18.9 19.2 54.3 19.6 18.2 14.6 16.3 17.7 18.4 18.0 19.7 45.4 20.1 20.1 31.4 11.9 22.3 17.9 20.4 17.7 15.8 19.5 17.0 24.6 20.6 23.8 15.4 12.4 20.6 15.5 7.0 16.1 8.0 17.9 32.0 26.6 27.3 20.9 22.4 22.7 19.3 20.1 24.4 25.6 27.1 21.4 47.5 13.5 20.8 29.5 26.9 41.1 27.4 41.2 19.8 17.9 14.6 42.0 19.4 20.4 22.8 16.2 17.1 16.9 26.5 32.3 17.3 22.2 20.6 27.3 19.4 15.6 24.0 23.5 18.3 37.2 22.4 18.9 24.3 21.3 18.6 21.0 32.2 25.0 21.1 25.7 23.9 15.7 28.5 33.7 15.1 25.5 28.0 27.6 26.7 26.1 16.7 15.1 37.9 22.6 10.9 22.7 10.9 10.8 20.6 12.8 9.6 16.1 14.6 13.5 14.5 12.4 15.4 14.7 12.1 14.6 7.0 15.5 7.7 9.2 8.0 28.3 30.8 49.5 29.8 18.7 14.1 12.8 20.2 14.6 17.7 50.6 34.1 56.8 64.7 95.7 73.0 45.8 86.6 37.5 29.6 75.0 90.3 45.7 18.3 52.0 15.0 60.9 41.1 46.7 48.3 42.8 47.4 90.8 20.8 179.6 61.2 120.8 82.1 87.2 102.7 7.0 48.9 83.5 40.5 34.3 52.3 66.2 69.1 45.6 51.9 31.8 44.1 51.8 57.1 53.7 63.4 95.4 30.1 57.3 64.3 86.4 CELF3 "BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4" ENSG00000159409 "CUGBP Elav-like family member 3" Q5SZQ8 1 151702404-151716814 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.8;brain: 44.0;pituitary gland: 31.2" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 93.5;Cone photoreceptor cells: 37.3;Horizontal cells: 19.1;Intestinal endocrine cells: 50.7" "Group enriched" "Detected in many" 5 "glioma: 4.4;pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 28.6;SH-SY5Y: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006292 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA006292: AB_10602250" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (7.67e-2)" "unprognostic (1.96e-1)" "unprognostic (1.75e-1)" "unprognostic (6.64e-2)" "unprognostic (1.38e-1)" "unprognostic (3.02e-2)" "unprognostic (3.12e-1)" "unprognostic (3.48e-3)" "unprognostic (3.49e-3)" "unprognostic (6.90e-2)" "unprognostic (1.82e-8)" "unprognostic (8.50e-2)" "unprognostic (9.01e-2)" "unprognostic (2.41e-1)" "unprognostic (3.05e-2)" 1.1 16.8 21.4 1.4 28.9 1.1 1.0 29.2 44.0 1.0 2.1 2.0 0.0 5.0 1.0 1.0 1.1 2.1 1.0 1.0 19.5 16.2 1.1 1.0 1.1 1.0 5.3 15.3 1.0 8.8 1.0 31.2 1.2 3.7 1.1 2.1 3.7 1.0 1.0 1.0 1.0 3.8 1.2 1.5 1.0 8.5 2.0 4.4 0.0 1.1 0.0 1.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 28.6 20.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 28.9 29.2 29.1 19.5 16.2 5.3 15.3 3.7 4.4 0.0 0.0 0.0 0.0 0.0 93.5 0.8 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 19.1 50.7 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.6 2.3 0.1 0.0 0.0 0.3 4.8 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 CELF4 BRUNOL4 ENSG00000101489 "CUGBP Elav-like family member 4" Q9BZC1 18 37243047-37566037 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 69.1" "Group enriched" "Detected in many" 5 "Bipolar cells: 75.9;Horizontal cells: 278.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013322, HPA037986" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA013322: , HPA037986: AB_10673035" "unprognostic (7.87e-3)" "unprognostic (2.31e-2)" "unprognostic (4.31e-3)" "unprognostic (3.42e-7)" "unprognostic (2.95e-2)" "unprognostic (2.95e-2)" "unprognostic (3.72e-3)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.92e-2)" "unprognostic (1.00e-2)" "unprognostic (3.49e-1)" "unprognostic (1.69e-2)" "unprognostic (2.48e-1)" "unprognostic (8.32e-3)" "unprognostic (6.13e-2)" 1.4 10.7 40.2 1.7 25.2 1.1 1.3 45.3 69.1 1.1 1.6 0.9 0.0 1.6 1.3 1.5 1.4 1.3 2.0 1.7 27.0 26.3 1.4 1.3 1.4 1.6 13.5 26.3 2.0 4.2 1.2 8.1 1.7 13.1 1.5 1.3 0.5 2.5 1.1 8.3 2.0 1.9 1.3 3.7 1.7 1.6 3.9 5.6 0.0 2.3 0.0 1.0 1.2 0.0 0.7 0.5 2.4 0.9 0.9 0.9 0.4 0.1 0.1 0.5 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.2 0.7 0.0 0.1 0.4 0.0 0.1 0.0 0.5 0.3 0.0 1.2 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.6 0.0 0.2 0.1 0.4 1.1 0.0 0.2 0.1 0.0 1.4 0.0 0.1 31.7 7.7 0.8 0.2 0.0 0.2 0.2 0.1 0.0 1.0 0.4 0.2 0.1 2.0 0.3 0.1 0.1 0.1 0.1 2.4 0.5 0.5 0.7 0.6 0.7 0.7 0.4 0.4 0.3 0.7 0.8 0.9 1.3 0.9 0.9 0.5 0.6 0.4 40.2 25.2 45.3 31.1 27.0 26.3 13.5 26.3 13.1 5.6 0.0 0.0 0.0 1.4 0.3 75.9 1.5 0.0 0.0 0.0 0.0 39.3 0.2 0.0 0.2 37.5 0.6 0.3 0.0 0.9 0.1 0.7 2.1 0.0 0.0 6.4 278.1 12.2 1.3 0.0 19.6 0.6 0.0 0.0 0.0 0.0 6.0 4.1 0.0 4.9 1.3 20.9 0.0 0.0 10.0 4.3 0.5 0.2 0.0 0.1 0.8 CEMP1 CP-23 ENSG00000205923 "Cementum protein 1" Q6PRD7 16 2530035-2531417 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 2.7;Early spermatids: 2.6;granulocytes: 1.1;Late spermatids: 6.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 8.7;REH: 9.3" "HPA057658, HPA075926" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA057658: AB_2683492, HPA075926: " 0.7 4.1 5.8 1.6 3.3 0.6 0.5 3.6 3.7 1.2 0.7 1.7 1.1 0.0 3.3 0.6 2.6 3.3 4.5 2.4 3.6 2.5 1.6 5.4 3.0 2.1 0.8 0.8 0.9 1.3 1.0 0.0 5.5 0.6 1.9 8.0 4.6 0.0 2.4 3.4 0.9 1.0 2.4 0.0 4.6 0.6 0.6 1.2 4.2 0.0 0.7 1.8 0.0 1.2 0.9 1.1 6.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.9 5.3 0.0 0.7 0.0 2.3 1.9 0.0 0.0 0.0 0.7 8.7 0.7 0.0 3.0 0.0 0.7 4.2 0.0 0.0 0.0 0.0 1.3 0.0 3.6 2.1 2.0 0.0 3.6 1.0 3.0 2.4 0.5 1.8 9.3 0.6 0.1 0.0 1.8 5.0 1.8 1.4 6.5 6.4 0.3 7.4 0.8 0.4 2.3 2.0 2.9 1.3 1.0 1.7 2.1 2.8 4.3 1.2 4.2 0.0 3.5 0.3 0.0 0.6 0.6 0.6 1.1 0.0 0.4 0.2 0.9 0.0 0.7 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CENPA "CenH3, CENP-A" ENSG00000115163 "Centromere protein A" P49450 2 26764289-26801067 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 53.7" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 27.3;Hofbauer cells: 12.7;Spermatogonia: 18.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.6" "Lineage enriched" "Detected in single" 16 "T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB008371, HPA073086" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB008371: AB_591074, HPA073086: AB_2686569" "unprognostic (3.94e-2)" "unprognostic (1.38e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (1.13e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (2.88e-8)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.69e-3)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.21e-3)" "unprognostic (0.00e+0)" "unprognostic (5.74e-2)" "unprognostic (1.33e-1)" "unprognostic (7.68e-2)" "unprognostic (2.07e-1)" 1.2 0.9 0.2 12.1 0.2 3.5 3.0 0.2 0.2 1.3 3.5 0.4 0.3 5.3 0.9 1.5 8.5 0.1 1.2 1.5 0.2 0.3 0.8 0.7 1.4 8.2 0.3 0.0 0.5 0.7 0.0 0.3 3.1 0.3 0.5 3.2 0.1 1.7 0.0 0.3 4.5 3.6 0.8 0.3 4.9 1.8 7.8 0.0 53.7 0.4 9.2 10.0 1.3 2.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 31.2 7.2 11.2 6.2 0.9 1.8 9.3 9.7 7.4 13.1 11.3 5.2 10.2 9.4 6.3 3.5 15.4 9.2 10.0 5.1 13.0 27.9 9.8 15.9 3.3 8.7 0.3 9.2 17.8 0.1 0.6 5.2 7.2 2.0 6.7 11.6 12.8 19.5 10.3 10.5 13.3 14.2 10.0 10.4 13.3 15.9 20.0 10.4 5.7 1.4 9.6 9.7 9.3 10.4 7.6 4.0 6.2 9.9 4.8 8.1 20.6 9.6 16.0 19.4 19.2 38.4 3.9 19.0 15.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.5 5.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.4 0.0 0.4 0.0 0.2 27.3 1.0 0.9 0.0 0.0 12.7 0.0 4.1 2.5 1.6 0.0 0.9 1.8 1.7 0.0 3.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 7.1 18.1 4.5 2.9 1.7 3.7 2.1 CENPF hcp-1 ENSG00000117724 "Centromere protein F" P49454 1 214603195-214664588 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis" "Developmental protein" "Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 19.5;lymphoid tissue: 67.5" "Cell type enhanced" "Detected in many" 20 "Erythroid cells: 303.7;Extravillous trophoblasts: 74.0;Spermatogonia: 88.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052382, HPA064308, CAB070134" Enhanced Supported Nucleoplasm Yes Yes Nucleoplasm "CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711" "unprognostic (2.80e-1)" "unprognostic (2.16e-1)" "unprognostic (2.65e-1)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (2.29e-5)" "unprognostic (1.13e-2)" "unprognostic (2.58e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.58e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" "unprognostic (1.89e-2)" "unprognostic (4.12e-1)" 1.6 1.5 1.0 10.7 1.3 19.5 1.1 0.4 0.9 2.1 5.6 0.3 0.0 4.6 1.2 1.7 9.4 0.8 0.4 1.7 0.6 0.6 1.0 0.8 3.2 6.2 0.6 0.5 1.4 0.6 0.0 0.4 6.4 0.8 0.7 4.5 0.4 1.9 0.0 0.5 4.7 6.4 1.6 1.5 3.8 2.3 9.4 0.6 67.5 0.6 7.6 7.6 1.4 2.9 0.3 0.3 0.0 0.0 0.7 1.9 0.2 32.6 18.5 39.9 20.8 1.5 2.0 15.6 20.2 8.3 12.2 12.0 14.7 20.2 31.1 12.0 11.2 11.0 20.3 24.6 13.2 20.7 27.1 15.4 25.5 28.4 20.9 0.2 36.1 14.0 0.7 1.0 17.5 20.2 3.5 12.7 14.3 23.0 18.6 21.7 12.4 21.3 14.4 35.3 9.8 8.2 22.7 56.4 10.2 11.9 8.1 18.7 25.5 27.3 18.2 10.5 22.2 21.7 13.8 16.7 22.1 26.0 18.3 41.7 14.3 15.4 29.9 9.6 26.1 19.5 0.0 0.0 0.0 0.4 0.0 0.1 0.2 1.4 0.4 0.3 0.3 1.9 0.8 0.0 0.7 0.0 0.3 1.7 0.2 1.0 1.3 0.4 0.9 0.6 0.6 0.6 0.5 0.8 0.6 0.0 1.9 40.2 1.2 8.2 3.2 1.9 2.5 26.8 14.8 0.0 0.0 9.1 0.0 1.8 32.4 2.8 1.3 303.7 0.4 74.0 7.7 1.0 1.1 1.9 26.4 1.6 0.0 9.8 11.2 9.4 1.1 9.9 1.7 0.0 5.3 1.1 0.5 0.0 2.8 0.0 2.8 0.0 0.3 20.9 88.3 4.8 4.2 10.9 15.5 0.9 CENPN "BM039, C16orf60, FLJ13607, FLJ22660" ENSG00000166451 "Centromere protein N" Q96H22 16 81006498-81033114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 70.0;Extravillous trophoblasts: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052870 Supported Nucleoplasm NA NA Nucleoplasm "HPA052870: AB_2681978" "unprognostic (1.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.15e-1)" "unprognostic (1.76e-2)" "unprognostic (2.15e-1)" "unprognostic (1.76e-2)" "unprognostic (3.69e-3)" "prognostic unfavorable (6.49e-4)" "unprognostic (1.90e-1)" "unprognostic (2.36e-3)" "prognostic unfavorable (1.46e-5)" "unprognostic (3.02e-2)" "prognostic unfavorable (4.86e-4)" "unprognostic (2.34e-2)" "unprognostic (7.42e-2)" "unprognostic (1.41e-2)" "unprognostic (7.99e-2)" 4.2 4.9 4.8 8.2 5.0 26.9 3.2 2.4 5.4 2.7 6.6 5.9 4.8 6.4 2.6 6.8 9.9 2.1 3.7 7.3 5.0 4.6 6.5 21.0 5.2 8.9 6.0 4.5 2.4 3.9 12.0 2.5 8.8 5.1 25.3 7.0 1.5 3.7 4.7 5.6 3.5 7.7 5.6 6.1 5.9 5.1 11.8 5.6 24.6 4.2 12.6 10.2 4.2 3.8 6.6 8.5 2.9 3.7 4.0 10.1 2.7 23.2 22.4 19.4 17.2 5.3 4.3 23.3 23.9 16.9 38.9 17.3 40.7 18.8 13.2 13.8 14.0 18.3 19.9 15.6 17.3 50.6 7.9 13.3 11.6 18.2 27.2 2.6 16.9 22.9 3.8 1.8 35.4 12.5 5.4 17.7 16.8 21.2 19.0 19.9 42.7 21.6 21.7 20.6 10.7 12.3 25.4 18.4 14.2 7.0 15.8 12.4 11.3 36.2 9.1 10.8 12.0 21.4 9.7 9.3 28.7 29.1 18.9 26.8 13.3 29.2 50.1 13.5 12.1 24.9 0.0 1.7 2.9 2.5 3.3 2.3 1.9 3.9 2.1 8.5 6.6 1.9 2.0 1.4 4.0 3.7 2.7 10.1 2.7 4.8 5.0 2.4 5.4 5.0 4.6 6.0 4.5 5.1 5.6 0.0 4.5 1.5 14.2 21.3 1.0 3.4 7.6 1.4 4.5 3.5 0.0 29.0 0.0 4.8 34.5 2.9 4.3 70.0 5.7 78.1 10.5 11.7 5.8 3.9 23.1 0.0 1.2 5.5 8.8 31.4 2.6 8.4 6.8 4.6 7.7 0.8 4.7 2.9 3.2 6.7 0.0 0.0 8.3 40.2 40.3 14.3 22.8 15.4 12.7 11.9 CENPQ "C6orf139, CENP-Q, FLJ10545" ENSG00000031691 "Centromere protein Q" Q7L2Z9 6 49463378-49493107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029043, HPA046634, HPA054965" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA029043: AB_2672881, HPA046634: AB_2679728, HPA054965: AB_2682653" "unprognostic (7.39e-2)" "unprognostic (7.33e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (2.49e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (2.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.76e-2)" "prognostic favorable (6.26e-4)" "unprognostic (2.89e-1)" "unprognostic (8.19e-2)" "unprognostic (1.48e-3)" "unprognostic (8.93e-2)" "unprognostic (7.47e-2)" "unprognostic (2.74e-3)" "unprognostic (2.56e-1)" 7.2 7.6 10.4 11.2 15.4 6.4 8.7 10.9 11.4 6.6 5.8 6.4 5.8 4.2 7.5 7.1 12.1 6.4 5.4 10.0 11.5 9.3 7.6 6.8 5.8 10.0 19.8 7.7 10.4 4.8 4.6 8.9 9.1 15.3 7.4 7.5 2.7 5.5 5.4 6.9 6.1 5.1 7.0 18.7 8.8 5.6 8.8 18.3 15.1 6.0 9.1 12.7 9.5 6.4 7.8 5.0 7.2 3.1 4.4 5.6 2.3 16.4 4.6 14.7 9.1 4.0 6.3 13.0 21.4 12.3 20.6 29.0 5.6 6.7 11.2 10.7 6.0 16.1 6.0 7.6 7.7 30.5 12.1 10.7 8.2 7.4 9.0 1.7 17.4 10.4 2.8 4.3 25.2 8.8 5.3 7.5 9.8 12.6 11.2 15.2 4.7 12.2 8.2 9.1 14.4 4.2 8.8 17.4 12.1 6.0 6.8 7.9 7.9 10.0 6.0 11.2 15.2 7.7 16.0 4.4 16.0 12.4 12.5 19.0 5.1 13.2 10.0 10.8 13.1 15.4 4.1 2.2 7.2 4.0 2.7 4.2 7.6 4.3 4.6 2.5 7.8 4.7 4.5 1.6 4.4 3.1 5.0 5.6 2.3 10.4 15.4 10.9 11.4 11.5 9.3 19.8 7.7 15.3 18.3 0.0 2.4 6.7 8.9 7.7 5.4 5.1 7.6 10.7 3.4 7.0 2.0 12.0 6.6 7.0 1.0 6.3 1.6 0.0 6.9 23.5 8.4 4.8 4.6 2.8 8.8 6.4 2.4 13.5 10.8 1.9 8.1 5.5 3.3 7.2 2.7 12.4 6.0 3.6 10.3 3.1 5.0 6.5 5.1 16.8 28.6 6.0 10.4 6.4 4.5 5.4 CENPW "C6orf173, CUG2" ENSG00000203760 "Centromere protein W" Q5EE01 6 126340174-126348875 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 43.2" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 184.2;Extravillous trophoblasts: 133.8;Spermatocytes: 97.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067285 Supported Nucleoplasm NA NA Nucleoplasm "HPA067285: AB_2685818" "unprognostic (3.51e-3)" "unprognostic (2.35e-1)" "unprognostic (3.26e-3)" "unprognostic (9.61e-3)" "unprognostic (3.78e-1)" "unprognostic (9.80e-3)" "prognostic unfavorable (1.21e-5)" "unprognostic (1.11e-2)" "unprognostic (2.82e-2)" "unprognostic (9.07e-2)" "unprognostic (5.86e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.07e-1)" "unprognostic (1.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.22e-1)" 5.5 3.3 3.3 14.8 2.6 27.1 5.2 1.4 4.9 9.9 9.6 1.3 7.7 5.3 17.4 12.4 16.8 5.9 3.5 2.2 5.3 1.5 2.9 2.7 4.0 9.1 1.3 4.5 4.8 1.7 0.0 2.0 4.8 1.6 4.7 11.7 1.8 6.5 2.9 2.1 5.8 7.0 10.5 1.8 5.5 5.0 43.2 0.8 28.6 2.0 21.4 17.0 4.6 7.9 5.2 14.6 2.6 15.2 5.6 8.9 5.0 20.6 14.1 26.6 23.6 3.0 3.2 23.2 16.5 11.9 23.1 28.1 42.5 13.9 24.5 15.0 10.4 36.6 25.5 21.8 26.3 32.2 28.1 40.4 23.7 36.3 44.7 0.9 34.2 17.5 1.8 3.0 19.1 14.2 6.5 24.4 33.3 39.2 15.6 19.0 33.5 27.9 56.4 16.3 17.8 21.4 29.7 18.2 17.0 10.2 9.2 28.8 12.9 14.0 12.6 18.7 22.5 12.5 33.4 13.6 21.2 23.3 29.5 45.3 11.0 21.0 43.6 12.7 43.7 25.2 2.6 13.2 1.8 1.7 15.2 0.6 5.2 3.7 3.4 12.3 2.3 2.9 2.4 2.5 5.6 10.1 14.6 8.9 5.0 3.3 2.6 1.4 4.9 5.3 1.5 1.3 4.5 1.6 0.8 0.0 1.6 16.4 7.3 33.8 1.4 0.3 10.2 0.0 4.5 1.8 2.0 26.4 5.0 14.3 184.2 5.6 11.8 70.0 15.8 133.8 19.2 8.6 13.8 5.7 55.0 3.2 7.5 11.6 18.0 15.9 17.8 25.1 8.5 12.6 13.0 2.2 12.7 11.5 8.5 0.9 1.1 0.0 9.2 97.1 73.0 25.3 17.7 4.5 21.3 31.8 CEP63 FLJ13386 ENSG00000182923 "Centrosomal protein 63" Q96MT8 3 134485743-134575017 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Mitosis" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 54.1" "Lineage enriched" "Detected in all" 7 "granulocytes: 54.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058154, HPA058313" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA058154: AB_2683624, HPA058313: " "unprognostic (1.80e-1)" "unprognostic (1.03e-2)" "unprognostic (2.13e-1)" "unprognostic (1.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-2)" "unprognostic (2.23e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (3.08e-2)" "unprognostic (5.24e-2)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-1)" 21.6 15.4 17.7 17.1 18.1 25.3 16.5 19.7 22.6 13.8 15.4 14.5 18.8 9.1 13.7 17.6 15.1 12.2 12.3 25.6 17.2 15.0 15.2 20.5 12.4 15.7 20.4 15.7 16.7 17.8 21.8 23.1 13.5 20.0 16.7 14.5 11.1 15.5 17.4 38.1 15.0 11.3 20.2 20.2 15.3 13.9 37.2 21.5 21.7 18.3 14.9 16.3 17.3 19.9 6.1 7.2 54.1 8.2 5.9 5.6 3.5 17.2 7.7 14.6 9.5 21.3 18.1 13.7 18.7 15.4 15.0 12.7 6.1 7.4 19.6 12.0 13.5 14.5 10.3 7.5 10.4 18.2 21.9 4.0 25.3 8.3 8.6 14.7 16.0 11.8 15.7 13.8 8.0 26.7 16.9 14.8 27.4 7.5 17.1 17.6 11.6 19.1 19.1 10.4 11.1 9.1 12.4 21.6 28.0 12.8 10.8 8.6 8.2 16.8 6.6 25.2 18.3 13.5 21.8 16.8 17.0 10.1 16.1 13.8 15.8 10.9 25.2 18.2 17.1 21.5 18.1 6.0 9.9 4.0 6.2 5.4 4.8 3.9 5.1 7.2 6.1 5.6 4.2 54.1 5.9 8.2 4.8 4.8 3.5 17.7 18.1 19.7 22.6 17.2 15.0 20.4 15.7 20.0 21.5 17.9 25.9 21.5 13.0 9.5 30.0 76.9 20.4 45.5 27.3 7.0 19.6 22.1 26.6 22.3 64.2 20.4 10.5 0.0 17.7 22.5 17.3 16.0 50.8 13.9 24.8 30.2 12.6 15.4 22.3 37.5 22.2 24.5 16.9 20.8 15.3 24.6 18.7 17.5 24.4 22.3 42.3 19.4 18.4 95.2 46.4 8.5 14.5 12.7 15.0 12.3 CERS3 "LASS3, MGC27091" ENSG00000154227 "Ceramide synthase 3" Q8IU89 15 100400395-100544995 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 25.6;skin 1: 29.0;testis: 37.9" "Cell type enhanced" "Detected in some" 16 "Basal keratinocytes: 16.8;Early spermatids: 19.4;Late spermatids: 12.5;Spermatocytes: 33.6;Suprabasal keratinocytes: 43.8" "Cancer enhanced" "Detected in some" "head and neck cancer: 14.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "hTCEpi: 38.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006092, HPA024356" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006092: AB_1079236, HPA024356: AB_1852721" "unprognostic (5.01e-3)" "unprognostic (3.43e-2)" "unprognostic (6.47e-4)" "unprognostic (2.35e-2)" "unprognostic (5.58e-2)" "unprognostic (1.68e-1)" "unprognostic (6.84e-3)" "unprognostic (3.23e-1)" "unprognostic (1.43e-1)" "unprognostic (2.09e-1)" "unprognostic (1.31e-5)" "unprognostic (2.65e-1)" "unprognostic (4.74e-4)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.05e-3)" 0.4 0.0 0.4 0.4 0.4 0.0 1.9 0.4 0.4 6.0 0.4 0.4 0.4 0.0 0.4 0.4 25.6 0.3 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.4 3.6 0.4 0.4 29.0 0.4 0.4 0.4 0.4 0.0 37.9 0.4 0.4 0.4 0.4 8.5 0.4 11.2 0.0 0.0 1.5 0.6 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.1 0.2 0.2 0.0 0.7 0.3 0.0 0.0 3.3 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 3.6 16.8 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 33.6 0.4 43.8 0.0 0.0 0.0 7.4 CFAP20 "C16orf80, fSAP23, GTL3" ENSG00000070761 "Cilia and flagella associated protein 20" Q9Y6A4 16 58113588-58129450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 311.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018195 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA018195: AB_1850408" "unprognostic (9.96e-2)" "unprognostic (5.44e-2)" "unprognostic (3.80e-1)" "unprognostic (7.45e-2)" "unprognostic (2.27e-1)" "unprognostic (7.14e-3)" "unprognostic (9.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-1)" "unprognostic (2.86e-2)" "unprognostic (1.42e-1)" "unprognostic (1.15e-2)" "unprognostic (9.72e-2)" "unprognostic (9.71e-2)" "unprognostic (7.58e-3)" "unprognostic (1.47e-1)" 13.5 18.4 20.7 10.8 37.3 15.8 16.1 19.4 30.2 16.8 12.5 26.0 12.1 12.8 15.4 18.2 14.6 28.0 13.4 31.4 22.7 27.2 15.5 25.0 15.1 17.0 21.6 18.1 24.9 13.2 22.1 24.4 22.8 20.2 14.5 12.3 16.8 12.8 14.4 8.1 14.9 12.0 13.3 21.7 13.3 11.9 21.6 19.8 30.6 20.2 9.7 15.6 12.5 13.4 23.0 24.6 28.1 13.5 26.9 39.8 21.8 18.0 15.0 24.5 13.1 9.2 7.3 19.2 17.1 12.0 27.2 17.7 23.3 19.6 18.7 24.8 11.5 12.3 18.7 22.6 17.0 27.0 10.7 24.4 10.5 8.8 30.2 10.7 15.9 21.1 8.3 11.8 17.2 15.8 10.4 16.5 29.6 17.5 8.9 21.3 14.0 45.1 32.1 22.5 12.5 30.4 43.8 30.6 17.8 15.0 11.3 22.4 19.8 30.6 12.0 16.7 17.7 10.3 20.0 11.4 16.8 22.0 18.2 19.4 11.0 10.4 36.1 11.0 16.7 22.7 28.1 13.5 22.9 21.9 12.9 21.0 23.0 22.9 23.3 15.0 21.2 31.0 26.2 11.3 26.9 12.7 24.6 39.8 21.8 20.7 37.3 19.4 30.2 22.7 27.2 21.6 18.1 20.2 19.8 11.9 16.9 11.1 38.7 0.0 26.1 47.4 28.1 61.6 29.6 19.2 31.4 88.8 48.0 31.1 311.7 45.8 12.3 0.0 14.6 63.4 35.6 17.8 11.6 30.5 30.2 17.5 23.4 25.2 10.0 99.3 31.4 12.1 0.0 21.6 26.1 29.4 18.1 16.1 29.4 24.8 28.5 19.4 21.5 67.4 31.1 0.0 55.2 14.9 21.3 12.8 CFAP45 "CCDC19, NESG1" ENSG00000213085 "Cilia and flagella associated protein 45" Q9UL16 1 159872364-159900163 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 35.5;testis: 29.7" "Group enriched" "Detected in many" 5 "Ciliated cells: 306.5;Early spermatids: 187.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 10.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "eosinophil: 6.0;neutrophil: 4.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.0" "Cell line enhanced" "Detected in many" "BEWO: 11.2;HEL: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042204, HPA043618" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042204: AB_10966555, HPA043618: AB_10959305" "unprognostic (1.88e-1)" "unprognostic (4.15e-2)" "unprognostic (3.95e-1)" "unprognostic (5.18e-3)" "unprognostic (4.78e-3)" "unprognostic (1.49e-1)" "unprognostic (8.80e-4)" "unprognostic (2.57e-1)" "unprognostic (1.76e-1)" "unprognostic (5.21e-2)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-12)" "unprognostic (2.95e-1)" "unprognostic (1.87e-1)" "unprognostic (3.83e-3)" "unprognostic (1.65e-1)" 0.3 0.3 2.0 0.4 7.5 0.6 0.5 0.0 0.2 2.5 0.2 11.9 0.0 0.4 1.3 10.5 0.4 35.5 0.2 0.5 3.1 2.8 0.3 0.2 6.1 0.3 0.1 0.1 7.3 0.1 0.1 0.2 3.3 12.5 0.2 0.2 0.0 0.2 0.5 0.2 0.3 0.2 0.4 0.5 0.5 0.6 29.7 3.4 0.0 0.7 0.0 0.3 0.4 0.1 0.7 0.3 6.0 0.3 0.2 0.5 0.2 2.5 0.6 0.0 0.0 0.1 0.3 11.2 1.3 1.6 2.4 1.0 1.9 3.3 1.1 0.5 0.6 1.3 1.6 0.3 0.3 1.4 0.6 0.3 14.5 0.6 0.1 0.7 1.2 0.5 1.0 0.8 2.6 0.9 3.4 1.7 0.4 1.5 0.5 0.4 3.5 0.2 1.1 0.6 2.1 1.2 0.0 1.2 0.5 0.4 0.6 1.0 0.2 1.3 3.9 0.4 3.4 3.8 0.2 2.2 1.0 3.0 2.0 2.4 1.2 0.0 0.4 5.4 0.5 0.8 0.0 0.3 6.0 0.0 0.3 0.0 0.5 0.3 0.5 0.3 0.7 0.0 0.5 4.9 0.2 0.0 0.3 0.0 0.2 2.0 7.5 0.0 0.1 3.1 2.8 0.1 0.1 12.5 3.4 0.0 3.7 0.0 0.7 0.0 0.0 0.8 0.0 306.5 54.6 5.2 0.0 1.5 0.0 1.4 187.0 2.3 0.0 0.0 2.0 6.4 0.4 0.9 3.5 0.0 0.4 0.0 0.0 1.3 1.6 33.1 2.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 1.4 0.4 0.0 0.0 0.4 19.0 2.3 0.0 0.7 0.0 0.0 1.1 CGGBP1 "CGGBP, p20-CGGBP" ENSG00000163320 "CGG triplet repeat binding protein 1" Q9UFW8 3 88051944-88149885 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 111.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035568, HPA037017" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035568: AB_10670022, HPA037017: AB_2675433" "unprognostic (2.87e-1)" "unprognostic (2.86e-1)" "unprognostic (2.43e-2)" "unprognostic (4.89e-2)" "unprognostic (1.30e-2)" "unprognostic (2.96e-2)" "unprognostic (6.76e-2)" "unprognostic (2.95e-2)" "unprognostic (8.30e-2)" "unprognostic (3.63e-1)" "unprognostic (1.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" "unprognostic (3.35e-2)" "unprognostic (3.00e-1)" "prognostic favorable (7.79e-4)" 29.6 23.9 26.1 27.5 28.6 38.5 80.0 33.3 36.9 28.7 28.3 19.4 23.7 23.1 30.7 23.6 23.5 24.2 23.6 33.8 23.1 21.6 28.4 30.8 29.1 39.4 24.4 26.4 37.1 25.9 40.6 33.2 26.4 21.2 27.3 26.0 23.7 25.2 24.9 30.8 19.2 30.0 29.7 28.9 33.9 25.1 22.4 22.0 76.0 32.7 16.7 37.4 27.7 30.9 24.8 19.9 41.6 23.0 20.8 25.1 19.8 8.0 13.8 23.0 16.4 20.3 18.1 7.4 16.1 14.6 17.0 20.2 10.1 11.9 17.6 10.9 14.4 13.3 6.4 18.1 12.2 21.0 26.6 10.0 26.9 12.1 9.0 18.1 17.8 19.2 16.3 12.7 18.7 24.2 21.0 17.3 20.1 12.7 18.4 19.2 12.8 26.7 12.7 12.6 13.5 11.6 17.3 21.6 12.6 12.7 12.3 4.5 15.1 13.6 7.8 38.0 16.9 11.8 21.6 16.7 20.6 15.2 111.3 16.8 13.5 16.3 19.3 15.7 17.4 17.6 41.6 21.2 39.4 23.3 21.7 22.7 22.5 20.7 23.9 19.9 24.8 25.1 20.5 39.8 20.8 23.0 17.9 23.0 19.8 26.1 28.6 33.3 36.9 23.1 21.6 24.4 26.4 21.2 22.0 47.6 40.0 45.5 57.2 47.3 33.0 39.5 35.7 16.0 46.6 38.4 15.7 48.1 56.3 34.4 15.7 65.2 42.3 23.3 36.4 51.7 55.0 57.7 45.1 49.4 36.3 63.5 40.2 61.4 45.7 28.6 64.5 53.4 38.8 34.3 30.1 61.7 41.1 34.9 47.0 52.9 30.4 64.7 68.9 82.4 49.4 43.7 70.1 69.0 31.8 57.8 CHAF1B "CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7" ENSG00000159259 "Chromatin assembly factor 1 subunit B" Q13112 21 36385378-36419015 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 20.7" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021679, CAB033604" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB033604: AB_2229411, HPA021679: AB_1846621" "unprognostic (2.28e-2)" "prognostic favorable (5.44e-5)" "prognostic favorable (7.92e-4)" "unprognostic (1.43e-1)" "unprognostic (3.28e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (6.14e-6)" "unprognostic (2.14e-2)" "unprognostic (1.89e-2)" "unprognostic (1.13e-2)" "unprognostic (2.84e-2)" "unprognostic (6.27e-2)" "unprognostic (7.66e-6)" "unprognostic (5.89e-2)" "unprognostic (5.00e-3)" "unprognostic (9.12e-2)" "unprognostic (1.36e-1)" 2.4 1.4 2.8 3.7 5.9 9.3 4.1 7.2 9.4 2.4 3.0 2.0 1.2 2.8 3.9 2.8 4.4 2.3 1.6 2.9 2.0 2.7 1.7 1.4 2.1 4.5 1.8 4.1 2.7 6.9 3.1 2.1 2.1 3.8 2.9 3.6 4.6 5.2 1.6 20.7 4.4 3.1 2.4 1.5 2.5 2.1 6.2 0.2 12.3 1.7 3.6 7.3 1.8 2.6 2.8 1.3 3.7 0.8 4.4 5.1 1.7 14.8 9.0 15.4 8.7 1.2 3.1 8.4 10.5 6.1 13.0 13.7 10.1 7.9 11.6 4.7 5.4 13.3 5.0 15.8 7.0 10.6 11.7 12.3 18.0 9.7 7.1 0.8 11.5 8.8 1.9 1.7 12.2 5.3 2.6 6.1 14.4 15.7 10.9 6.6 10.3 17.8 6.7 10.7 13.5 6.6 26.2 8.3 6.7 4.5 7.4 9.3 7.7 16.1 12.3 5.8 6.5 9.6 7.8 3.7 10.7 5.3 9.4 12.2 8.0 14.8 13.6 6.8 12.7 13.4 3.1 0.8 1.0 3.7 0.4 3.3 2.6 2.9 2.8 0.7 2.8 1.9 3.0 3.7 4.4 0.7 1.3 5.1 1.7 2.8 5.9 7.2 9.4 2.0 2.7 1.8 4.1 3.8 0.2 0.0 2.4 2.2 5.1 2.5 1.3 0.9 0.0 2.7 3.4 3.5 0.0 4.4 0.0 6.5 7.1 2.1 0.5 0.0 1.9 7.5 1.7 3.3 2.3 0.4 3.7 1.6 0.0 1.3 1.9 5.9 0.6 1.1 5.0 1.8 2.1 2.0 1.8 0.0 0.0 0.2 2.2 6.5 0.5 8.9 13.2 2.0 2.1 1.7 3.7 2.1 CHD1L ALC1 ENSG00000131778 "Chromodomain helicase DNA binding protein 1 like" Q86WJ1 1 147242641-147295766 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027789, HPA028670" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA027789: AB_10601099, HPA028670: AB_10601257" "unprognostic (1.07e-1)" "unprognostic (3.93e-2)" "unprognostic (1.97e-1)" "unprognostic (3.49e-1)" "unprognostic (1.78e-1)" "unprognostic (2.58e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.86e-2)" "unprognostic (7.83e-2)" "unprognostic (1.39e-2)" "unprognostic (4.97e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.31e-9)" "unprognostic (5.51e-2)" "unprognostic (3.52e-1)" "unprognostic (2.74e-2)" "unprognostic (1.16e-1)" 11.2 12.2 16.1 14.1 16.5 26.9 18.2 23.0 20.0 9.8 16.1 29.5 6.4 18.4 16.0 12.2 10.4 13.4 12.5 9.2 17.3 13.6 11.8 26.1 13.7 16.1 27.3 12.6 9.5 18.5 12.6 17.9 11.8 18.2 13.2 20.0 11.6 9.5 11.9 12.0 15.9 20.9 18.4 24.7 21.3 12.9 27.8 22.2 18.5 8.9 9.4 16.9 8.5 11.9 15.3 19.0 7.6 8.3 8.2 9.1 9.0 19.0 16.5 18.9 12.0 13.3 13.0 15.7 17.1 14.5 16.0 15.1 15.9 13.3 24.8 8.0 17.1 9.8 18.1 16.0 18.6 14.2 24.6 22.4 23.8 13.2 40.5 14.1 30.6 15.3 12.1 9.2 15.8 18.2 13.8 17.5 26.2 27.1 11.6 19.4 21.1 23.2 16.5 24.9 33.1 21.8 26.0 17.5 19.5 15.1 13.6 11.4 19.3 15.4 19.4 14.9 26.1 10.6 44.6 15.9 10.8 16.5 9.7 26.6 10.0 13.8 20.5 22.0 13.5 16.3 7.6 8.1 3.7 9.0 6.8 9.1 12.5 7.9 7.8 19.0 15.3 8.0 8.9 0.8 8.2 8.3 15.8 5.5 9.0 16.1 16.5 23.0 20.0 17.3 13.6 27.3 12.6 18.2 22.2 11.9 17.0 17.4 7.7 10.2 6.5 5.9 15.3 14.7 19.4 5.2 5.9 18.4 18.3 9.2 15.1 12.7 11.7 23.3 7.1 15.4 11.0 9.8 20.8 27.6 18.8 1.6 8.6 3.7 19.8 18.3 6.6 19.1 15.1 13.6 14.8 13.5 9.0 14.0 10.6 11.2 8.8 6.5 10.2 31.2 27.2 9.2 9.8 10.7 18.0 5.8 CHD2 "DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614" ENSG00000173575 "Chromodomain helicase DNA binding protein 2" O14647 15 92900189-93028005 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060744, HPA060960" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA060744: AB_2684353, HPA060960: AB_2684398" "unprognostic (1.65e-2)" "unprognostic (2.43e-1)" "unprognostic (2.14e-2)" "unprognostic (5.98e-2)" "unprognostic (2.12e-2)" "unprognostic (3.10e-2)" "unprognostic (2.67e-2)" "unprognostic (7.85e-2)" "unprognostic (7.51e-3)" "unprognostic (1.14e-1)" "unprognostic (2.84e-1)" "unprognostic (1.79e-2)" "unprognostic (4.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.15e-1)" "unprognostic (1.70e-2)" 23.7 16.6 18.7 23.6 21.1 66.7 21.8 35.1 22.8 24.1 19.9 19.7 17.6 15.7 26.1 31.9 20.3 18.4 16.8 15.3 18.5 15.7 17.7 17.6 30.4 25.2 22.1 13.9 26.3 20.9 27.5 41.9 33.1 19.1 22.4 16.1 22.1 21.2 19.9 24.3 25.2 24.3 20.3 30.8 26.9 20.8 20.4 22.4 39.5 28.8 11.3 37.4 34.7 19.0 25.5 17.2 34.5 6.3 8.0 17.5 4.6 10.7 5.9 16.0 7.0 10.0 24.6 12.3 10.1 10.4 6.8 8.5 7.5 14.2 2.6 8.5 8.8 11.7 16.1 9.3 10.0 9.6 0.0 5.5 12.8 11.8 6.4 13.4 13.5 10.1 15.5 12.3 8.1 16.6 14.2 11.6 19.1 13.3 30.4 10.3 6.6 7.0 7.0 10.1 5.3 6.6 10.1 14.6 14.5 7.1 14.5 8.9 9.5 17.6 6.5 13.2 16.8 7.3 11.4 18.4 5.6 7.4 4.8 6.4 29.0 11.6 11.1 8.6 8.1 4.9 14.9 6.3 15.0 12.9 3.3 11.8 25.5 12.6 10.1 3.3 23.4 17.5 12.5 34.5 8.0 5.8 17.2 12.3 4.6 18.7 21.1 35.1 22.8 18.5 15.7 22.1 13.9 19.1 22.4 65.5 165.7 52.5 97.7 146.0 66.2 34.7 25.5 105.7 153.6 43.6 86.4 24.4 3.3 30.1 45.6 46.5 39.7 23.3 32.9 20.4 79.4 107.2 94.9 29.8 22.2 54.0 56.9 23.4 43.8 28.3 32.2 70.9 91.1 47.7 34.3 34.1 46.6 37.7 35.3 8.7 80.7 32.3 55.9 14.4 10.0 158.0 50.6 94.7 35.1 111.1 CHD4 "Mi-2b, Mi2-BETA" ENSG00000111642 "Chromodomain helicase DNA binding protein 4" Q14839 12 6570082-6614524 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012008 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA012008: AB_1846633" "unprognostic (6.11e-2)" "unprognostic (2.26e-2)" "unprognostic (1.71e-2)" "unprognostic (6.40e-3)" "unprognostic (8.99e-2)" "unprognostic (3.36e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (2.66e-2)" "unprognostic (1.05e-1)" "unprognostic (6.85e-2)" "unprognostic (3.15e-1)" "unprognostic (3.94e-1)" "unprognostic (2.06e-1)" "unprognostic (3.33e-1)" "unprognostic (1.82e-1)" "unprognostic (9.84e-2)" "unprognostic (1.66e-1)" 23.5 34.9 21.9 50.0 33.5 27.2 25.9 29.4 25.1 28.1 29.5 29.3 38.5 18.6 37.2 35.4 29.1 28.0 40.3 52.8 23.5 19.2 29.5 25.0 25.5 30.9 33.6 19.4 34.6 27.4 58.4 25.3 29.5 27.2 21.5 26.0 26.5 24.8 46.2 33.7 31.1 24.4 36.6 30.3 29.4 27.2 29.7 28.9 75.7 38.4 33.7 38.4 34.7 24.3 12.6 16.8 12.8 9.1 13.5 16.7 5.8 20.4 18.7 46.4 17.4 19.0 21.4 27.3 22.7 22.2 25.1 23.2 31.2 15.9 44.1 9.0 25.7 16.4 18.3 43.5 25.0 33.9 33.0 22.4 61.6 29.1 19.4 16.5 48.3 29.6 20.7 12.4 24.3 17.0 31.7 29.3 24.7 48.4 22.0 23.8 25.6 45.8 15.8 44.4 19.0 17.7 39.3 28.5 24.1 15.9 24.2 22.0 28.3 29.2 32.6 22.6 53.2 14.9 27.5 27.2 25.7 54.7 18.8 26.5 35.7 21.2 56.3 17.0 29.5 18.7 9.0 7.7 9.2 12.2 9.1 12.0 10.5 10.3 11.1 7.9 12.6 13.0 12.3 12.8 13.5 8.1 16.8 16.7 5.8 21.9 33.5 29.4 25.1 23.5 19.2 33.6 19.4 27.2 28.9 56.6 102.0 59.1 45.6 60.9 103.2 110.8 66.2 96.4 79.6 83.7 66.8 38.6 11.6 71.4 71.8 70.5 43.4 23.3 62.1 41.7 66.9 40.2 81.1 60.6 61.2 131.9 93.2 49.7 44.2 45.3 60.9 57.6 45.5 56.9 59.2 71.6 76.6 24.6 70.0 30.3 60.2 51.8 73.5 97.0 107.1 59.1 56.9 61.8 61.8 37.3 CHD6 "CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB" ENSG00000124177 "Chromodomain helicase DNA binding protein 6" Q8TD26 20 41402101-41618494 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 143.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015543 Approved Nucleoplasm NA NA Nucleoplasm "HPA015543: " "unprognostic (5.13e-3)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (1.27e-1)" "unprognostic (6.66e-2)" "unprognostic (1.36e-1)" "unprognostic (4.72e-3)" "prognostic favorable (3.42e-4)" "unprognostic (1.17e-1)" "unprognostic (3.17e-1)" "unprognostic (4.75e-2)" "unprognostic (1.14e-1)" "unprognostic (2.12e-3)" "unprognostic (6.66e-2)" "unprognostic (3.41e-1)" "unprognostic (1.00e-1)" "unprognostic (1.14e-2)" 12.1 12.6 16.5 12.7 16.2 18.1 19.4 34.1 24.9 17.4 11.3 16.6 15.4 6.5 20.4 19.9 11.0 16.3 11.7 12.1 15.8 13.9 11.8 10.7 11.7 12.1 14.7 16.8 26.1 12.5 31.4 30.3 12.9 24.3 19.7 10.0 14.2 14.5 17.0 9.4 14.4 10.5 14.4 17.3 12.0 12.3 11.1 18.2 21.4 21.4 6.7 15.3 16.9 15.0 12.0 11.5 15.1 9.3 10.4 10.4 2.3 6.4 7.6 16.5 7.2 9.4 9.7 11.0 5.7 11.7 10.1 12.4 10.5 5.3 7.7 10.3 9.6 11.4 9.6 10.3 9.7 11.6 2.4 5.0 10.6 7.0 10.1 5.3 8.2 5.3 9.7 9.1 7.3 8.2 10.8 8.7 10.9 8.3 8.8 7.8 17.7 13.0 9.0 5.4 4.0 12.9 10.1 19.6 5.5 6.3 15.0 14.9 10.3 17.2 4.6 11.5 12.6 7.9 6.2 9.9 16.0 7.9 8.5 4.9 8.0 6.4 10.0 7.1 4.0 5.0 15.1 6.5 7.1 8.9 6.2 8.9 8.8 7.7 7.3 5.1 12.0 10.4 8.7 0.9 10.4 9.3 11.5 5.9 2.3 16.5 16.2 34.1 24.9 15.8 13.9 14.7 16.8 24.3 18.2 44.7 25.0 32.1 38.2 16.1 123.2 51.6 22.9 45.5 34.2 21.0 88.4 26.6 18.3 19.0 12.5 32.3 4.8 0.0 13.7 22.1 28.6 28.3 20.8 18.7 14.3 143.0 58.3 23.9 21.3 14.0 46.1 23.5 16.9 32.5 27.7 76.4 14.4 14.0 42.8 10.6 137.4 19.4 29.7 22.1 59.7 15.1 27.3 31.9 20.9 22.3 CHD8 "DUPLIN, HELSNF1, KIAA1564" ENSG00000100888 "Chromodomain helicase DNA binding protein 8" Q9HCK8 14 21385194-21456126 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor" "Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052186, HPA076133" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052186: AB_2681754, HPA076133: " "unprognostic (3.45e-1)" "unprognostic (9.71e-2)" "unprognostic (3.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.14e-1)" "unprognostic (3.43e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (7.31e-2)" "unprognostic (9.22e-2)" "prognostic favorable (8.35e-4)" "unprognostic (1.64e-1)" "unprognostic (2.63e-2)" "unprognostic (2.54e-3)" "unprognostic (2.88e-1)" "unprognostic (9.24e-2)" "unprognostic (2.51e-1)" "unprognostic (8.07e-3)" 13.9 14.5 13.0 14.8 21.5 34.8 17.0 28.9 25.7 15.8 14.4 26.6 14.1 11.1 18.3 13.4 17.4 15.9 11.7 12.3 13.5 13.3 14.0 11.2 15.5 18.5 15.4 15.2 20.7 19.0 34.7 25.3 15.2 20.3 16.3 14.6 19.3 15.7 14.9 16.9 24.5 16.4 17.2 13.1 19.2 16.1 15.2 18.1 29.9 17.4 10.4 24.8 16.6 14.5 12.3 7.8 12.8 7.4 8.7 8.6 3.0 16.5 21.7 24.1 11.2 15.4 13.3 13.6 13.2 15.2 20.1 20.1 18.8 14.4 27.4 8.3 17.6 15.9 20.3 29.4 18.5 25.4 20.9 13.4 24.0 14.5 22.8 14.3 33.2 22.9 17.9 15.1 22.5 16.2 15.6 17.8 21.7 16.7 14.7 15.1 17.8 23.8 13.6 18.4 16.1 18.4 22.4 18.2 9.2 14.9 30.6 17.6 16.9 20.6 16.1 11.4 22.7 11.3 16.1 20.9 16.7 12.8 9.8 15.6 16.7 19.9 27.4 6.7 12.3 16.6 12.8 4.8 12.1 7.7 5.0 8.6 5.8 6.8 7.5 3.3 12.3 7.4 6.4 11.0 8.7 7.4 7.8 5.7 3.0 13.0 21.5 28.9 25.7 13.5 13.3 15.4 15.2 20.3 18.1 35.7 52.5 15.1 10.4 11.2 32.4 18.1 20.4 36.1 43.3 31.4 25.5 12.2 1.7 19.0 1.6 18.0 11.3 23.3 20.2 10.1 9.9 12.1 26.7 12.4 15.0 22.3 26.0 14.1 20.9 2.5 15.0 13.0 10.1 19.8 16.3 19.2 21.3 14.0 16.6 6.3 22.9 0.0 13.3 26.2 22.4 14.4 10.3 22.3 14.7 11.1 CHRAC1 "CHRAC15, YCL1" ENSG00000104472 "Chromatin accessibility complex 1" Q9NRG0 8 140511298-140517137 "Predicted intracellular proteins" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059008 Approved Nucleoplasm NA NA Nucleoplasm "HPA059008: AB_2683878" "unprognostic (6.34e-2)" "unprognostic (7.32e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.29e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (4.88e-5)" "unprognostic (8.79e-3)" "unprognostic (1.86e-1)" "prognostic favorable (9.72e-4)" "prognostic unfavorable (5.43e-4)" "unprognostic (4.19e-1)" "unprognostic (6.22e-3)" "unprognostic (7.61e-2)" "unprognostic (1.01e-1)" "unprognostic (6.92e-2)" "unprognostic (1.49e-1)" 24.3 14.7 12.1 15.9 16.0 23.3 18.0 10.1 14.2 17.3 20.9 23.8 11.9 15.5 20.4 12.7 24.1 16.1 19.8 18.7 13.7 10.4 21.4 24.3 16.5 21.6 19.2 7.7 18.2 17.7 15.5 13.1 21.0 13.6 17.8 16.2 17.2 17.6 20.1 28.4 19.1 24.3 21.2 20.8 22.2 18.2 26.1 21.6 36.4 27.5 19.3 24.9 19.3 15.8 19.6 19.5 21.4 23.5 16.1 16.0 12.5 22.4 10.9 10.3 9.7 10.3 17.5 7.8 9.6 14.1 14.1 17.2 14.0 16.3 23.3 14.4 11.8 11.2 14.1 12.2 9.9 19.6 17.8 12.8 33.0 15.2 15.7 9.7 10.9 17.5 8.7 14.5 10.4 20.3 7.6 13.5 14.4 24.3 22.3 12.5 26.4 38.2 11.8 7.5 19.8 18.4 23.1 10.8 18.5 14.1 9.4 14.1 11.7 13.5 9.2 17.0 5.8 17.8 12.6 12.7 16.8 29.3 20.6 20.3 10.7 13.9 28.3 20.2 26.1 13.0 8.7 17.0 20.3 16.0 22.4 15.7 17.3 14.4 15.8 18.7 19.6 15.2 12.6 21.4 16.1 23.5 19.5 12.7 12.5 12.1 16.0 10.1 14.2 13.7 10.4 19.2 7.7 13.6 21.6 14.9 25.1 31.5 36.8 34.1 6.9 11.6 20.4 16.0 29.6 14.0 2.0 19.7 36.5 19.4 15.6 29.5 21.9 0.0 31.3 42.0 24.9 26.9 32.3 18.4 21.6 6.4 20.7 30.1 29.5 26.2 27.0 33.4 18.6 31.5 20.5 25.3 27.4 18.6 23.7 24.5 10.7 71.1 38.1 72.7 63.0 42.4 20.1 29.9 19.3 30.6 CHTF8 "CTF8, DERPC, FLJ20400" ENSG00000168802 "Chromosome transmission fidelity factor 8" "P0CG12, P0CG13" 16 69118010-69132584 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051872, HPA065522" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051872: AB_2681647, HPA065522: AB_2685503" "unprognostic (7.86e-3)" "unprognostic (1.99e-2)" "unprognostic (2.59e-2)" "unprognostic (2.46e-2)" "unprognostic (6.44e-2)" "unprognostic (1.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.86e-3)" "unprognostic (9.88e-2)" "unprognostic (7.45e-2)" "unprognostic (2.96e-1)" "unprognostic (1.02e-1)" "prognostic favorable (3.59e-9)" "unprognostic (3.74e-2)" "unprognostic (1.85e-1)" "unprognostic (3.75e-2)" "unprognostic (1.45e-1)" 27.8 29.9 20.5 25.1 26.8 12.7 34.3 18.5 24.4 29.3 27.8 18.8 36.3 18.4 33.5 40.5 33.1 38.5 26.0 25.7 18.5 15.5 42.0 46.8 27.2 32.2 24.8 23.0 30.9 60.8 37.0 27.6 38.0 17.6 31.4 26.7 31.4 38.7 30.2 22.9 30.4 30.3 30.0 18.7 37.9 30.9 32.1 20.6 51.5 56.9 23.2 37.1 27.8 32.4 35.7 32.5 46.9 35.7 26.3 32.9 32.2 34.2 31.7 42.7 27.3 35.0 34.0 33.4 30.7 29.5 49.2 41.0 34.9 48.9 35.7 40.0 28.3 27.9 41.7 45.4 52.7 41.6 24.4 24.3 36.6 23.2 20.4 29.3 36.0 37.4 29.5 36.2 38.6 28.2 34.9 50.0 28.3 40.3 15.0 41.3 30.0 41.4 35.4 41.1 45.5 24.8 59.1 22.6 46.9 40.1 26.5 36.3 29.4 43.9 19.4 35.9 37.6 34.6 45.1 31.6 30.5 28.8 17.9 27.4 29.2 37.9 53.6 27.6 25.2 34.1 46.9 32.5 28.6 27.1 35.7 30.8 30.5 27.8 31.5 32.5 35.7 28.6 27.2 18.1 26.3 34.9 29.3 32.9 32.2 20.5 26.8 18.5 24.4 18.5 15.5 24.8 23.0 17.6 20.6 14.9 13.9 29.5 17.9 12.8 11.5 12.2 25.5 13.4 7.9 22.7 3.9 56.7 51.4 34.5 5.0 19.0 27.1 0.0 41.8 56.3 18.4 24.1 6.9 34.5 37.5 6.4 27.1 29.4 28.0 14.3 19.8 22.2 11.8 45.9 27.7 18.0 36.9 23.0 25.5 53.5 7.9 6.5 14.7 22.1 41.9 15.1 55.7 20.1 28.1 16.0 CIART "BC017397, C1orf51" ENSG00000159208 "Circadian associated repressor of transcription" Q8N365 1 150282543-150287093 "Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Bipolar cells: 40.0;Cone photoreceptor cells: 96.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "MAIT T-cell: 3.4;memory CD4 T-cell: 3.8;naive CD4 T-cell: 2.4;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 38 "T-cells: 3.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.2;Karpas-707: 23.6;U-266/84: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027515, HPA054349" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA027515: AB_10600757, HPA054349: AB_2682457" "unprognostic (1.77e-1)" "unprognostic (5.63e-2)" "unprognostic (4.15e-2)" "unprognostic (4.58e-1)" "unprognostic (4.76e-2)" "unprognostic (4.42e-1)" "unprognostic (5.99e-3)" "unprognostic (2.29e-2)" "unprognostic (1.47e-1)" "unprognostic (1.31e-1)" "unprognostic (1.89e-1)" "unprognostic (4.54e-2)" "unprognostic (1.01e-2)" "unprognostic (1.16e-1)" "unprognostic (1.45e-1)" "unprognostic (1.64e-1)" "unprognostic (2.34e-2)" 4.8 10.0 6.9 2.9 18.4 0.6 6.7 14.2 26.5 9.1 11.8 6.3 11.1 3.0 7.4 8.2 7.3 6.2 4.0 23.5 5.4 7.1 8.3 11.5 3.0 2.1 4.9 5.8 11.5 4.4 7.5 10.6 2.6 8.4 7.2 2.8 20.5 14.2 21.1 40.2 19.7 4.9 12.9 3.1 2.4 7.3 6.3 4.2 0.8 16.1 19.6 6.5 10.3 5.2 0.0 0.0 0.0 0.0 0.0 3.8 0.3 0.1 0.6 4.8 2.2 1.8 0.8 4.1 2.9 7.1 3.8 5.0 1.1 16.2 0.0 5.0 6.2 8.6 2.8 0.1 2.8 5.7 0.0 0.4 0.1 0.2 0.0 6.5 0.9 2.4 2.5 4.3 9.6 2.0 8.9 0.6 0.1 0.1 23.6 2.1 12.5 0.0 0.5 5.3 2.8 11.9 0.6 0.0 0.1 3.8 0.6 2.5 0.9 4.8 0.4 8.6 1.2 4.1 0.4 1.2 10.8 0.1 0.4 6.3 5.0 16.8 0.1 9.7 0.0 6.4 0.0 0.0 0.0 0.5 0.0 3.4 0.0 3.8 0.0 0.0 0.0 2.4 1.2 0.0 0.0 0.0 0.0 0.3 0.3 6.9 18.4 14.2 26.5 5.4 7.1 4.9 5.8 8.4 4.2 0.0 1.0 0.0 5.3 0.0 40.0 5.6 5.1 1.4 2.3 0.0 96.2 0.2 8.3 2.5 0.2 1.1 1.3 0.0 1.3 0.1 0.0 3.5 0.0 3.0 1.0 6.4 2.4 0.6 0.0 1.1 4.9 0.3 0.0 1.8 0.3 18.4 3.1 0.3 8.9 2.6 18.0 0.0 2.9 4.3 7.9 0.0 0.0 0.0 0.6 1.0 CIITA "C2TA, MHC2TA, NLRA" ENSG00000179583 "Class II major histocompatibility complex transactivator" P33076 16 10866222-10943021 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, Kinase, Transferase" "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.2" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 17.9;Macrophages: 36.9;monocytes: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 23.3;REH: 40.9;U-266/70: 8.6;U-698: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016084, HPA054757" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB016084: AB_627261, HPA054757: " "unprognostic (1.45e-3)" "unprognostic (1.38e-2)" "unprognostic (8.22e-3)" "unprognostic (1.12e-2)" "unprognostic (5.66e-2)" "unprognostic (2.88e-3)" "unprognostic (2.92e-2)" "unprognostic (1.55e-2)" "unprognostic (1.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.23e-1)" "unprognostic (3.72e-1)" "unprognostic (1.64e-2)" "unprognostic (2.72e-2)" "unprognostic (6.33e-3)" "unprognostic (2.74e-1)" "unprognostic (1.05e-2)" 8.0 5.9 4.6 47.7 7.1 4.3 6.8 1.5 5.5 6.3 3.7 10.6 4.2 10.4 8.1 10.4 4.8 5.2 8.1 4.9 4.7 3.5 8.8 2.9 15.0 27.0 9.4 1.1 2.5 3.5 1.9 4.0 1.2 6.6 5.5 4.3 5.5 13.3 4.3 2.9 4.4 17.4 3.7 15.6 25.9 6.2 1.5 7.4 12.6 6.1 5.2 67.2 6.3 6.8 27.3 19.0 6.5 11.9 0.7 0.5 1.7 0.1 0.2 0.3 0.3 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.3 5.6 5.1 0.8 0.0 0.9 0.9 0.0 0.0 0.1 23.3 0.3 2.9 1.1 0.6 0.0 0.5 0.4 1.0 0.0 0.1 0.0 0.9 0.0 0.3 0.3 2.0 0.1 0.3 0.2 0.4 0.1 0.2 0.1 40.9 0.3 3.6 0.0 1.7 0.9 0.1 0.9 0.3 0.9 0.3 0.5 1.7 0.3 2.1 0.3 0.6 0.2 8.6 0.6 12.1 7.7 0.5 6.9 0.2 11.9 6.5 0.3 9.5 0.1 17.9 0.1 0.5 17.7 27.3 0.1 0.2 2.8 0.7 10.0 19.0 0.4 1.7 4.6 7.1 1.5 5.5 4.7 3.5 9.4 1.1 6.6 7.4 6.0 17.9 12.3 0.3 2.1 0.6 2.8 2.5 2.7 1.2 3.5 0.0 0.1 0.0 2.5 0.6 4.2 3.4 0.0 1.7 0.2 1.0 0.3 10.4 1.0 9.1 0.0 2.4 2.5 15.6 0.0 0.6 36.9 6.8 58.7 0.7 0.4 1.7 0.0 0.0 3.3 0.9 0.0 0.9 0.0 0.0 2.5 0.1 1.0 0.4 0.3 CIRBP CIRP ENSG00000099622 "Cold inducible RNA binding protein" Q14011 19 1259384-1274880 "Plasma proteins, Predicted intracellular proteins" "Stress response" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060537 Supported Nucleoplasm NA NA 33000 Nucleoplasm "HPA060537: AB_2684314" "unprognostic (2.77e-3)" "prognostic favorable (3.63e-4)" "unprognostic (9.80e-2)" "prognostic favorable (1.36e-4)" "unprognostic (3.95e-2)" "unprognostic (2.94e-2)" "unprognostic (3.38e-3)" "prognostic favorable (2.50e-4)" "unprognostic (6.43e-2)" "unprognostic (2.29e-2)" "prognostic favorable (2.69e-4)" "unprognostic (1.82e-1)" "prognostic favorable (3.65e-7)" "unprognostic (1.04e-1)" "unprognostic (5.76e-1)" "unprognostic (2.23e-2)" "unprognostic (1.49e-2)" 57.0 64.6 54.3 54.4 63.7 55.9 72.7 92.0 88.7 78.6 55.7 98.9 75.2 33.2 82.9 86.4 38.5 89.5 75.1 62.4 47.8 57.1 51.7 34.7 51.4 66.6 45.3 95.9 154.5 115.1 101.0 92.2 48.9 61.6 67.8 40.1 115.4 91.5 100.1 119.1 68.5 48.9 93.0 50.0 56.7 60.7 67.4 37.5 33.7 73.7 65.1 63.7 58.5 49.1 70.6 67.4 48.3 54.6 52.3 58.6 40.5 37.4 8.0 59.0 29.9 26.4 29.7 15.4 41.2 58.2 32.4 29.1 14.7 14.5 75.4 22.3 42.6 3.8 17.8 24.7 37.3 25.2 33.7 7.1 44.8 8.5 19.0 96.5 69.3 32.7 72.8 33.6 20.9 91.7 44.7 29.1 38.2 29.4 60.9 33.5 26.5 35.6 18.8 23.3 21.5 13.7 44.4 47.6 37.0 36.6 31.5 28.0 51.0 43.5 19.9 32.7 20.3 41.4 19.6 35.3 23.8 14.6 56.7 35.9 80.8 87.2 63.2 20.5 28.8 31.1 43.5 21.4 48.3 56.1 36.7 57.3 62.5 50.2 50.3 23.9 70.6 57.6 54.1 36.8 52.3 54.6 67.4 58.6 40.5 54.3 63.7 92.0 88.7 47.8 57.1 45.3 95.9 61.6 37.5 190.6 388.3 412.5 566.2 521.1 731.5 217.9 331.2 267.7 194.5 282.6 310.2 478.8 824.0 309.0 59.1 377.8 185.6 93.5 422.6 250.6 423.2 404.8 393.8 127.7 276.6 646.7 416.8 304.5 333.2 163.7 601.8 335.9 696.8 569.9 235.7 848.5 279.0 222.0 469.5 414.6 606.0 368.7 588.0 224.4 542.1 486.7 616.7 487.7 250.2 270.4 CITED2 MRG1 ENSG00000164442 "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2" Q99967 6 139371807-139374620 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Stress response, Transcription, Transcription regulation" "Activator, Developmental protein, Repressor" "Atrial septal defect, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 592.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 20.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 78.3;fHDF/TERT166: 136.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016157, CAB069879" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB016157: AB_668099, CAB069879: AB_10003446" "unprognostic (7.42e-2)" "unprognostic (2.06e-2)" "unprognostic (1.56e-2)" "unprognostic (8.34e-2)" "unprognostic (4.03e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-2)" "unprognostic (1.13e-1)" "unprognostic (4.05e-2)" "unprognostic (1.11e-2)" "unprognostic (3.61e-3)" "unprognostic (1.00e-2)" "prognostic favorable (3.40e-4)" "prognostic unfavorable (3.33e-4)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" "unprognostic (2.03e-1)" 42.8 34.5 6.8 27.1 11.2 71.7 35.4 24.2 27.9 22.2 23.6 6.0 19.0 9.3 53.3 26.5 24.1 58.1 27.0 37.7 4.7 6.6 24.9 55.2 40.6 14.3 3.7 7.2 84.0 35.3 58.5 6.0 75.7 17.4 23.3 11.4 26.1 31.4 44.6 44.5 34.8 19.6 23.3 3.7 40.6 21.4 17.7 3.0 11.2 99.7 18.7 16.6 17.6 24.4 1.9 2.9 20.0 6.6 2.3 4.7 2.2 2.9 1.7 6.0 17.7 25.7 27.5 22.7 78.3 58.3 35.8 33.7 15.5 4.4 2.1 11.5 136.2 7.6 3.5 1.8 1.8 25.5 57.8 5.8 42.9 9.8 1.2 21.0 12.6 4.7 21.9 8.4 15.6 12.1 23.4 6.5 1.2 16.0 10.3 46.4 6.4 2.1 15.8 5.6 1.8 2.7 3.0 4.4 18.6 17.2 6.6 6.7 0.1 5.6 21.5 2.5 14.6 9.2 43.6 35.7 28.7 9.1 8.5 4.3 3.0 2.7 3.2 8.8 10.9 2.0 2.1 6.6 20.0 3.0 3.7 4.3 1.0 4.7 4.3 2.9 1.9 4.1 2.1 3.3 2.3 4.9 1.3 2.7 2.2 6.8 11.2 24.2 27.9 4.7 6.6 3.7 7.2 17.4 3.0 107.2 265.7 40.2 132.0 31.8 30.0 100.1 86.6 24.1 53.4 97.7 11.8 110.8 157.5 15.3 1.5 29.2 85.3 163.5 12.7 592.3 59.2 48.6 45.1 58.7 304.1 28.6 95.8 63.8 84.7 5.3 92.0 87.1 79.2 2.8 110.2 49.6 21.5 84.2 57.3 82.4 35.3 97.0 57.9 0.9 1.3 29.5 225.2 123.7 94.5 29.9 CIZ1 "LSFR1, ZNF356" ENSG00000148337 "CDKN1A interacting zinc finger protein 1" Q9ULV3 9 128166064-128204383 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020380, HPA020387" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA020380: , HPA020387: AB_2670425" "unprognostic (1.28e-1)" "unprognostic (5.77e-2)" "unprognostic (2.81e-2)" "unprognostic (3.33e-1)" "unprognostic (1.69e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.43e-4)" "unprognostic (6.14e-2)" "unprognostic (1.63e-1)" "unprognostic (7.49e-3)" "unprognostic (3.13e-3)" "unprognostic (8.05e-3)" "unprognostic (2.30e-2)" "unprognostic (1.54e-1)" "unprognostic (2.11e-1)" "unprognostic (3.24e-1)" "unprognostic (8.47e-3)" 31.9 24.3 33.6 23.8 36.0 36.7 36.7 39.4 40.4 31.5 35.7 28.0 21.3 26.8 33.6 20.9 30.3 33.5 26.7 25.5 30.5 19.9 19.7 12.1 22.2 24.8 29.4 27.5 56.3 41.7 23.1 21.1 21.9 23.4 30.1 21.8 23.3 31.3 28.8 51.4 49.6 26.1 40.0 27.3 22.5 28.9 35.4 37.0 30.3 22.8 24.2 27.0 35.2 39.3 6.7 4.6 4.9 5.8 8.1 8.3 3.2 23.0 27.9 23.9 22.5 24.7 29.9 23.4 18.2 27.4 33.5 19.0 25.5 20.3 27.1 15.5 30.7 27.9 33.6 18.4 19.6 18.3 24.6 21.0 25.9 35.0 16.4 28.5 24.0 30.9 28.9 35.1 36.7 31.3 24.4 22.6 17.4 62.6 23.5 20.1 53.9 31.4 24.4 20.7 31.2 28.7 26.7 25.2 27.9 15.1 15.9 29.8 23.1 40.5 28.7 24.0 11.1 29.9 31.3 23.9 35.8 25.5 40.6 34.1 27.3 30.8 26.2 25.3 16.1 38.3 4.6 4.3 4.9 5.0 5.8 4.5 5.7 6.1 6.4 4.6 6.7 6.1 5.5 0.7 8.1 4.3 4.6 8.3 3.2 33.6 36.0 39.4 40.4 30.5 19.9 29.4 27.5 23.4 37.0 3.0 11.7 14.1 19.6 20.6 21.1 8.7 12.7 5.3 9.1 17.4 27.5 19.0 11.6 22.6 63.0 13.4 23.6 0.0 38.7 23.5 21.6 14.9 9.2 4.7 19.4 15.9 21.9 14.7 16.7 60.3 32.2 14.9 18.6 20.8 17.7 17.7 26.4 14.0 29.4 14.6 23.8 12.9 20.8 24.4 24.7 21.8 17.4 17.9 25.5 13.3 CLASRP "CLASP, SFRS16, SWAP2" ENSG00000104859 "CLK4 associating serine/arginine rich protein" Q8N2M8 19 45039040-45070956 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA060469, HPA062455" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA060469: AB_2684289, HPA062455: AB_2684770" "unprognostic (2.99e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (9.77e-4)" "unprognostic (9.03e-2)" "unprognostic (1.37e-1)" "unprognostic (2.76e-3)" "unprognostic (1.58e-2)" "unprognostic (2.62e-1)" "unprognostic (8.52e-2)" "unprognostic (4.01e-2)" "unprognostic (1.76e-3)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.69e-8)" "unprognostic (2.19e-1)" "unprognostic (1.74e-2)" "unprognostic (3.36e-1)" "prognostic favorable (1.02e-5)" 14.5 12.2 14.1 16.5 24.6 40.4 13.6 19.0 25.7 12.0 14.5 27.4 13.0 17.6 14.4 14.5 14.7 13.8 13.4 9.6 16.2 12.2 11.6 11.6 13.9 17.7 26.8 16.2 18.3 28.6 13.7 19.8 12.0 18.4 14.7 9.4 10.7 16.8 17.2 21.5 17.0 20.6 14.6 22.1 18.5 18.3 14.3 22.4 7.8 14.7 9.9 14.1 11.7 15.3 7.1 5.1 9.2 3.6 2.7 4.1 2.0 11.0 15.9 6.5 4.8 2.1 3.4 14.5 9.6 3.6 7.4 7.4 7.3 10.6 17.4 7.3 3.8 2.9 12.2 9.9 7.3 3.3 8.6 14.7 10.3 8.5 9.2 4.9 6.9 14.2 4.2 4.0 5.0 8.9 3.5 5.0 11.8 16.3 9.9 2.5 11.1 18.4 23.0 9.0 7.3 9.3 14.7 7.3 13.2 4.9 11.1 7.5 11.7 7.7 7.4 7.0 3.7 9.5 15.1 7.5 7.3 9.1 6.1 14.5 14.4 11.6 15.6 5.1 11.2 5.9 0.7 3.6 5.5 3.8 2.6 3.5 7.1 2.3 4.1 3.2 6.4 3.3 2.9 9.2 2.7 3.0 5.1 1.9 2.0 14.1 24.6 19.0 25.7 16.2 12.2 26.8 16.2 18.4 22.4 3.0 2.7 25.1 23.5 20.7 25.6 3.6 20.4 2.7 3.4 15.7 15.7 20.7 5.0 9.7 15.9 13.5 27.2 0.0 13.0 24.6 15.0 15.3 12.7 13.9 15.2 19.1 9.2 14.7 17.4 4.6 20.1 18.1 3.3 19.8 22.5 22.0 12.7 21.0 16.6 6.5 28.8 32.3 16.5 61.4 27.7 18.9 30.3 20.0 17.9 18.2 CLCN7 "CLC-7, CLC7, OPTA2, PPP1R63" ENSG00000103249 "Chloride voltage-gated channel 7" P51798 16 1444934-1475580 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 69.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043019, HPA043586" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA043019: AB_10964727, HPA043586: AB_10965322" "unprognostic (2.69e-1)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (5.61e-2)" "unprognostic (1.90e-2)" "prognostic favorable (5.23e-4)" "unprognostic (1.59e-2)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-2)" "unprognostic (1.41e-2)" "unprognostic (3.98e-1)" "unprognostic (3.49e-3)" "unprognostic (5.81e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (2.80e-1)" "unprognostic (2.54e-1)" 19.5 34.7 23.2 18.7 23.0 35.0 19.4 22.9 26.8 16.7 15.5 29.3 15.4 18.3 18.8 16.8 12.5 15.8 17.0 15.0 21.9 17.5 19.5 22.7 17.7 19.6 30.3 18.5 14.2 24.1 30.9 19.5 15.5 22.2 14.6 9.4 34.4 17.5 17.5 22.5 21.7 18.9 17.3 18.0 24.8 18.1 17.6 29.5 16.4 21.8 10.9 14.9 17.2 10.2 2.5 2.3 2.0 6.4 0.5 1.6 1.5 5.0 14.1 8.0 12.6 18.2 9.3 12.6 6.9 15.9 15.1 18.8 11.0 18.9 5.8 14.2 9.3 29.2 10.7 7.2 8.9 4.6 9.2 11.3 4.1 13.2 10.9 31.7 10.6 17.0 18.3 12.3 13.6 11.7 9.3 9.6 14.1 16.7 11.3 7.6 10.1 7.4 18.2 8.0 3.4 8.1 34.8 5.4 16.1 7.5 7.3 9.0 9.2 11.1 14.0 44.3 4.7 12.3 28.4 9.5 13.3 6.1 14.6 6.5 17.2 11.2 6.0 11.1 20.2 8.3 0.0 3.0 2.0 1.6 5.4 0.7 2.2 0.9 0.7 2.3 2.5 0.4 0.6 0.6 0.5 6.4 2.3 0.3 1.5 23.2 23.0 22.9 26.8 21.9 17.5 30.3 18.5 22.2 29.5 0.0 6.9 7.8 4.9 6.5 40.9 2.8 5.1 2.7 5.7 19.2 33.4 8.6 1.7 14.1 8.1 5.7 15.8 0.0 15.2 7.9 8.7 7.7 5.8 13.9 31.5 69.9 11.5 20.3 25.7 7.2 10.6 15.2 37.1 15.4 11.7 24.7 17.3 8.0 7.8 12.3 25.3 0.0 6.9 10.2 9.8 5.9 12.9 9.5 10.0 4.3 CLDND2 MGC33839 ENSG00000160318 "Claudin domain containing 2" Q8NHS1 19 51367098-51369003 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 31.4" "Cell type enriched" "Detected in many" 15 "Early spermatids: 230.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 11.7" HPA056971 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA056971: AB_2683294" "unprognostic (2.86e-1)" "unprognostic (4.29e-5)" "unprognostic (2.29e-2)" "unprognostic (3.40e-2)" "unprognostic (1.19e-1)" "unprognostic (9.42e-2)" "unprognostic (5.74e-3)" "unprognostic (1.79e-1)" "unprognostic (2.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.25e-3)" "unprognostic (1.13e-2)" "unprognostic (1.94e-9)" "unprognostic (4.00e-2)" "unprognostic (3.95e-1)" "unprognostic (1.85e-1)" "unprognostic (8.70e-2)" 7.7 7.8 6.8 3.2 11.1 13.3 3.3 10.9 16.5 2.6 3.6 1.4 8.4 7.7 3.0 2.5 2.9 2.8 4.5 2.5 9.9 4.7 2.8 3.5 4.0 3.2 19.6 5.2 6.7 9.1 1.5 2.9 1.8 7.4 3.8 2.4 1.7 7.5 6.0 11.9 1.5 7.1 3.8 10.2 7.3 3.3 31.4 10.6 0.0 2.9 2.2 1.2 3.2 3.0 1.7 3.0 5.8 2.0 5.3 4.5 0.7 2.1 6.0 2.2 3.0 3.3 2.9 1.2 1.0 0.5 1.0 1.3 0.7 7.1 5.6 1.2 0.6 0.7 2.7 0.7 0.3 0.2 3.9 9.7 4.9 9.4 11.7 1.3 1.4 1.4 2.2 1.0 0.2 0.6 1.5 0.7 2.8 3.1 4.1 0.9 1.3 1.2 8.1 0.9 6.1 7.6 1.1 5.1 2.2 1.6 1.6 1.3 1.5 2.6 0.5 2.1 1.1 1.5 0.4 1.4 2.2 4.4 2.3 0.9 3.8 4.0 2.0 5.4 5.6 1.3 5.8 0.9 4.1 3.5 2.0 2.0 1.7 0.8 4.5 1.4 1.1 0.6 1.5 0.5 5.3 0.7 3.0 1.2 0.7 6.8 11.1 10.9 16.5 9.9 4.7 19.6 5.2 7.4 10.6 0.0 5.9 7.8 5.0 1.4 5.5 3.6 12.7 9.4 1.2 15.7 0.0 1.9 3.3 0.7 230.3 1.7 6.6 0.0 0.6 1.1 2.3 4.4 15.1 13.4 2.3 3.2 9.9 7.4 2.4 9.1 5.8 4.6 1.7 1.8 14.5 2.3 0.8 5.8 6.0 3.0 1.9 0.0 2.7 2.3 1.3 2.4 0.7 4.5 10.5 4.6 CLP1 "hClp1, HEAB" ENSG00000172409 "Cleavage and polyadenylation factor I subunit 1" Q92989 11 57648992-57661868 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Kinase, Transferase" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057770 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA057770: AB_2683523" "unprognostic (1.33e-1)" "unprognostic (7.90e-2)" "unprognostic (1.11e-3)" "unprognostic (2.13e-2)" "unprognostic (4.90e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-3)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (1.66e-2)" "unprognostic (8.82e-2)" "unprognostic (7.58e-2)" "unprognostic (8.31e-3)" "unprognostic (3.71e-2)" "unprognostic (1.75e-1)" "unprognostic (8.78e-2)" "unprognostic (3.07e-1)" 10.8 11.7 7.0 11.2 8.8 23.5 9.6 7.2 10.9 8.5 9.3 5.6 7.6 9.0 12.0 10.0 13.6 10.1 6.2 8.1 6.0 4.5 9.9 12.8 8.7 9.9 6.5 5.1 7.3 11.8 7.2 6.8 17.3 6.1 10.5 9.2 5.6 10.3 8.1 16.7 11.8 11.7 11.2 5.0 15.4 11.5 11.3 6.5 15.4 11.8 10.8 13.2 8.8 6.9 16.2 19.0 23.7 19.1 12.8 20.9 11.6 14.2 14.2 14.3 15.1 15.8 10.5 13.6 14.0 15.5 21.1 17.8 13.1 12.9 23.5 17.1 11.6 16.2 17.5 19.7 22.6 23.6 15.9 11.5 12.8 10.2 14.9 12.0 19.5 15.5 11.7 16.1 17.9 12.8 8.6 19.1 11.6 20.6 8.2 17.0 10.1 14.1 22.2 21.9 15.5 15.0 15.1 23.0 25.0 11.3 10.1 7.8 15.2 11.9 12.3 19.1 15.7 22.7 15.0 13.3 11.4 15.4 19.4 11.2 13.2 16.7 25.7 12.4 10.5 12.1 23.7 19.1 19.9 17.6 16.0 20.9 16.2 15.8 17.8 19.0 14.1 18.2 16.6 22.3 12.8 15.7 11.0 16.0 11.6 7.0 8.8 7.2 10.9 6.0 4.5 6.5 5.1 6.1 6.5 8.9 6.1 4.7 9.0 17.2 2.9 2.2 5.1 5.3 9.1 0.0 5.9 13.9 8.3 10.4 21.7 6.7 4.5 0.0 10.2 12.3 8.0 3.5 8.1 4.0 9.5 4.8 2.4 4.9 4.1 1.7 5.2 6.1 8.5 17.2 3.2 3.6 8.3 5.9 8.1 9.0 3.0 6.5 11.3 6.7 13.4 12.7 11.3 7.5 4.7 8.2 CMPK1 "CMPK, UMP-CMPK" ENSG00000162368 "Cytidine/uridine monophosphate kinase 1" P30085 1 47333797-47378839 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053730, HPA058604" Approved Supported Nucleoplasm "Intracellular and membrane" NA NA 2100000 Nucleoplasm "HPA053730: AB_2682244, HPA058604: AB_2683773" "unprognostic (2.16e-2)" "unprognostic (1.16e-1)" "unprognostic (9.39e-3)" "unprognostic (1.18e-1)" "unprognostic (1.09e-3)" "unprognostic (1.50e-2)" "unprognostic (1.59e-2)" "unprognostic (9.88e-2)" "unprognostic (5.80e-2)" "unprognostic (2.90e-2)" "unprognostic (1.71e-2)" "unprognostic (2.61e-1)" "unprognostic (1.28e-2)" "unprognostic (2.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.02e-3)" "unprognostic (7.36e-2)" 35.0 17.0 28.5 30.4 24.4 14.8 72.2 18.0 35.8 26.8 44.8 17.8 20.9 53.7 16.5 19.3 42.2 13.5 39.2 28.6 28.0 31.4 26.2 88.2 36.8 46.2 35.1 16.8 16.2 42.3 19.3 16.6 16.0 25.4 32.8 48.1 16.2 50.8 18.3 30.4 22.2 64.9 46.9 33.1 21.6 35.9 8.6 18.2 25.6 31.7 26.7 28.0 34.0 39.0 11.2 10.6 23.1 12.4 15.0 17.5 12.1 30.8 17.3 22.4 20.0 40.9 47.9 31.7 54.9 33.1 33.4 34.0 15.4 21.4 45.7 28.3 37.2 31.4 21.0 16.5 28.4 45.8 69.1 13.5 35.5 23.9 26.5 26.7 50.6 26.0 26.8 34.4 27.8 31.3 31.6 34.5 17.1 33.5 36.9 43.5 11.3 41.0 23.9 14.2 40.6 24.0 25.6 38.8 34.3 32.5 34.0 20.3 10.7 39.3 45.7 31.5 30.9 11.3 30.2 32.3 41.8 24.2 39.9 45.1 26.9 37.2 31.2 33.0 31.3 28.5 23.1 10.2 18.2 13.6 10.7 17.5 11.2 15.5 16.7 10.6 10.2 14.7 14.0 4.2 15.0 12.4 8.9 16.0 12.1 28.5 24.4 18.0 35.8 28.0 31.4 35.1 16.8 25.4 18.2 65.5 42.5 120.7 103.0 155.9 32.3 44.9 101.9 57.6 33.0 71.5 15.7 70.1 147.6 156.9 1.2 74.2 219.2 46.7 158.3 115.0 53.6 209.9 94.4 215.9 69.9 41.3 112.9 68.2 97.0 4.1 55.0 98.6 241.3 77.5 273.0 40.6 127.4 150.8 65.7 149.9 26.0 84.1 148.0 8.2 27.2 170.5 99.0 139.5 184.6 187.9 CMTM1 "CKLFH, CKLFH1a, CKLFSF1" ENSG00000089505 "CKLF like MARVEL transmembrane domain containing 1" Q8IZ96 16 66566393-66579137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 80.7" "Group enriched" "Detected in some" 13 "Early spermatids: 60.6;Late spermatids: 113.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.7" "Cell line enhanced" "Detected in many" "REH: 16.8" "HPA013801, HPA017136" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA013801: AB_1846990, HPA017136: AB_1846992" "unprognostic (2.37e-2)" "unprognostic (7.48e-2)" "unprognostic (3.10e-1)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.32e-2)" "unprognostic (2.97e-3)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.68e-5)" "unprognostic (2.47e-2)" "unprognostic (1.56e-4)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (3.49e-1)" 0.9 0.8 0.8 1.9 1.2 0.0 0.5 2.2 1.3 0.7 0.9 0.5 0.5 1.7 1.3 1.1 0.6 0.8 1.5 0.7 0.8 1.1 0.8 0.5 0.9 1.2 0.8 0.6 1.7 0.5 0.3 1.1 0.9 0.7 0.7 0.2 0.5 0.6 0.5 0.6 0.6 1.2 0.5 0.9 2.8 0.9 80.7 0.7 0.8 0.7 0.5 0.6 0.9 0.6 0.3 1.9 8.7 2.1 1.3 1.9 1.1 4.2 6.7 1.2 5.6 2.4 2.3 1.2 5.6 2.7 4.5 4.7 1.4 2.9 2.0 3.0 1.6 1.4 3.4 1.9 0.3 2.4 7.4 1.3 0.7 3.0 1.4 1.1 3.9 4.9 1.9 0.5 4.0 0.5 6.9 2.3 4.0 3.5 2.8 1.9 1.6 7.4 3.8 1.0 0.6 2.5 16.8 14.4 4.6 4.0 2.0 3.2 4.3 7.8 0.6 2.0 0.2 2.0 2.8 5.7 8.0 12.7 4.8 2.4 2.8 6.7 7.3 3.8 5.3 9.3 8.7 2.1 7.1 1.9 0.6 1.6 0.2 0.6 0.9 1.9 0.3 0.5 0.6 8.4 1.3 1.2 0.5 0.6 1.1 0.8 1.2 2.2 1.0 0.8 1.1 0.8 0.6 0.7 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 113.2 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 6.5 0.0 4.8 0.4 0.3 0.1 0.0 0.0 0.0 CMTM3 "BNAS2, CKLFSF3, FLJ31762" ENSG00000140931 "CKLF like MARVEL transmembrane domain containing 3" Q96MX0 16 66603874-66613892 "Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 178.7;granulocytes: 90.0;Hofbauer cells: 108.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013870, HPA072695" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA013870: AB_1847003, HPA072695: AB_2732210" "unprognostic (1.59e-1)" "unprognostic (2.83e-2)" "unprognostic (7.63e-2)" "unprognostic (1.49e-1)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (1.80e-3)" "unprognostic (6.65e-3)" "unprognostic (7.75e-2)" "unprognostic (1.60e-2)" "unprognostic (1.22e-2)" "unprognostic (7.38e-2)" "prognostic unfavorable (4.42e-6)" "prognostic unfavorable (1.85e-4)" "unprognostic (7.56e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" 24.3 8.5 5.4 11.5 6.1 8.0 29.5 1.2 4.6 19.1 7.8 10.0 7.7 3.2 18.0 19.1 10.0 12.2 16.3 15.9 5.9 4.9 8.9 6.1 21.7 34.1 6.7 2.6 25.4 6.5 22.9 5.6 30.8 8.4 16.4 6.0 15.5 9.3 8.7 7.9 11.5 9.1 14.0 8.4 19.0 6.2 61.7 6.9 35.6 8.6 10.4 14.6 13.6 21.1 1.4 19.9 7.0 11.3 6.5 12.0 4.4 1.8 9.6 27.3 19.0 20.4 12.9 16.8 4.9 22.7 10.0 10.0 5.3 6.0 0.0 13.7 13.9 17.5 2.1 18.3 16.4 8.1 9.4 6.5 6.0 1.3 14.9 27.6 17.9 22.2 25.5 1.3 10.6 2.2 41.7 22.8 17.0 9.2 0.2 12.4 2.3 14.5 30.0 13.0 0.1 9.1 45.3 19.1 0.9 4.8 0.2 2.8 9.7 2.4 0.1 15.9 18.5 0.2 16.6 15.1 14.4 17.2 3.4 5.9 1.2 0.1 6.0 9.0 13.9 15.3 6.1 11.3 7.0 7.8 10.9 10.9 1.4 8.8 8.9 9.7 0.8 6.8 8.2 6.6 6.5 6.5 19.9 12.0 4.4 5.4 6.1 1.2 4.6 5.9 4.9 6.7 2.6 8.4 6.9 0.0 10.3 18.2 25.6 13.1 0.6 1.6 5.1 2.7 7.9 5.2 0.0 7.2 0.0 20.2 1.8 33.7 0.0 0.0 5.8 178.7 48.2 33.2 90.0 0.8 108.7 0.0 12.0 41.1 71.2 6.3 36.5 64.5 27.0 11.8 0.5 10.0 25.7 0.0 23.0 2.2 0.6 6.5 19.7 3.9 9.7 7.5 7.9 69.9 0.0 19.4 CMTM8 CKLFSF8 ENSG00000170293 "CKLF like MARVEL transmembrane domain containing 8" Q8IZV2 3 32238679-32370325 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 79.8" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 81.9;Syncytiotrophoblasts: 97.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.2;memory CD4 T-cell: 2.8" "Group enriched" "Detected in many" 7 "granulocytes: 4.2;T-cells: 2.8" "Group enriched" "Detected in many" 4 "BEWO: 68.3;SK-BR-3: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA055077, HPA073258" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA055077: AB_2682691, HPA073258: AB_2686591" "unprognostic (9.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-1)" "unprognostic (1.14e-1)" "unprognostic (3.33e-2)" "unprognostic (9.46e-2)" "unprognostic (5.67e-2)" "unprognostic (8.85e-2)" "unprognostic (1.29e-1)" "unprognostic (7.59e-2)" "unprognostic (2.56e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.78e-2)" "unprognostic (2.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" 9.7 9.9 4.3 4.1 3.5 0.9 27.0 1.5 3.4 4.7 6.8 1.3 10.8 5.2 3.4 13.4 4.2 6.3 5.7 8.2 3.6 3.2 8.8 40.0 19.9 12.6 3.9 3.3 2.1 79.8 2.8 3.1 12.4 2.5 8.8 5.5 4.4 13.5 19.2 4.3 6.2 8.1 2.0 3.1 1.5 10.0 1.1 1.6 5.5 20.7 6.0 11.2 4.7 5.6 0.1 0.0 4.2 0.1 0.4 2.8 0.3 3.3 3.5 0.6 4.3 3.1 4.9 68.3 0.0 0.1 0.3 0.4 4.7 4.8 0.0 7.1 0.0 0.0 1.8 5.5 1.1 0.3 0.0 10.1 2.1 0.7 7.9 0.2 0.8 1.7 9.6 3.5 0.4 3.4 1.7 2.7 3.6 0.0 0.0 3.4 2.4 2.7 0.3 1.4 5.1 3.2 3.9 0.8 0.6 4.2 3.8 1.2 1.0 0.5 19.3 1.7 0.8 5.5 0.4 2.4 0.0 5.2 0.0 1.0 0.1 0.1 0.0 0.0 1.5 1.1 0.0 0.1 4.2 0.3 0.0 0.4 0.0 2.8 0.8 0.0 0.1 1.8 0.3 0.0 0.4 0.0 0.0 0.0 0.3 4.3 3.5 1.5 3.4 3.6 3.2 3.9 3.3 2.5 1.6 35.7 27.6 0.8 29.9 10.3 0.0 1.7 12.7 6.7 19.4 0.0 0.0 81.9 10.0 16.6 7.5 35.8 13.1 23.3 32.2 59.6 6.9 51.8 0.0 67.6 8.5 0.0 21.4 46.1 6.0 1.8 2.3 4.1 5.0 1.0 41.2 30.7 28.4 10.5 1.1 21.6 1.7 0.0 4.7 3.4 2.1 5.6 97.1 15.0 21.1 38.8 CNOT11 "C2orf29, C40" ENSG00000158435 "CCR4-NOT transcription complex subunit 11" Q9UKZ1 2 101252802-101270316 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069823, HPA074943" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA069823: AB_2686209, HPA074943: " "unprognostic (1.72e-1)" "unprognostic (2.51e-1)" "unprognostic (5.43e-2)" "unprognostic (2.77e-2)" "unprognostic (2.02e-2)" "unprognostic (1.13e-3)" "prognostic unfavorable (1.05e-4)" "unprognostic (3.71e-2)" "unprognostic (1.09e-1)" "unprognostic (1.78e-2)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.33e-6)" "unprognostic (4.19e-2)" "unprognostic (2.35e-1)" "unprognostic (3.62e-3)" "unprognostic (2.72e-3)" 13.2 19.0 13.9 19.7 15.1 20.9 14.4 13.3 18.6 17.0 21.5 15.0 19.7 23.0 19.2 18.2 31.9 17.7 23.7 25.6 12.5 12.5 23.9 28.9 14.9 24.1 15.0 13.8 14.3 27.9 16.8 17.6 36.7 16.9 20.6 26.0 16.9 22.5 15.8 27.3 17.5 25.5 15.3 11.1 27.2 25.0 32.5 13.2 39.8 19.4 23.6 30.7 20.7 17.0 4.0 3.6 11.1 3.9 1.6 5.9 1.7 16.2 11.2 18.5 25.6 15.5 18.8 54.9 16.9 21.3 20.9 22.2 24.7 18.8 28.7 20.0 15.0 26.6 19.8 21.9 20.1 25.4 19.5 18.9 24.0 12.2 36.8 17.2 28.7 23.8 14.8 18.5 15.0 16.0 17.3 23.4 16.4 26.7 17.5 18.8 16.8 28.0 31.2 23.0 25.7 16.0 18.0 20.1 22.0 28.6 30.9 27.9 17.7 10.2 30.4 27.1 22.0 19.2 26.6 15.6 16.5 19.0 14.1 14.0 25.2 23.5 22.6 18.1 32.5 19.0 9.1 2.8 4.9 4.5 3.9 3.1 2.9 4.7 5.5 2.2 4.0 4.4 5.9 11.1 1.6 3.6 3.6 5.7 1.7 13.9 15.1 13.3 18.6 12.5 12.5 15.0 13.8 16.9 13.2 6.0 11.2 15.3 19.2 10.4 10.7 25.0 28.1 14.7 6.8 38.4 13.7 55.7 26.6 46.1 5.4 14.6 20.0 0.0 36.3 43.7 10.7 24.8 5.8 25.4 20.2 6.4 10.4 17.2 17.1 6.3 8.9 12.6 5.0 32.5 25.1 16.9 36.3 14.4 11.3 29.3 10.7 38.8 14.7 35.6 15.1 11.2 48.2 20.8 21.3 37.9 CNTNAP1 "Caspr, CNTNAP, NRXN4, p190" ENSG00000108797 "Contactin associated protein 1" P78357 17 42682613-42699814 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.7;smooth muscle: 26.7" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 12.8;Sertoli cells: 6.5;Smooth muscle cells: 4.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "TIME: 30.0;U-138 MG: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011772 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011772: AB_1079541" "unprognostic (4.04e-2)" "unprognostic (3.69e-1)" "unprognostic (2.37e-3)" "unprognostic (1.89e-1)" "unprognostic (5.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" "unprognostic (2.59e-1)" "unprognostic (9.76e-3)" "unprognostic (1.99e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.16e-14)" "unprognostic (9.52e-3)" "unprognostic (2.27e-2)" "unprognostic (3.11e-2)" "unprognostic (7.37e-3)" 6.1 2.5 35.5 5.9 18.8 1.1 1.7 31.7 48.7 4.7 8.5 2.9 1.4 2.3 12.1 7.1 2.9 7.0 7.1 4.0 29.2 14.8 1.7 0.9 3.9 2.8 10.5 23.9 8.7 6.5 1.7 7.2 5.0 18.4 4.2 4.7 2.1 2.0 7.6 3.5 2.5 2.7 26.7 11.5 3.2 3.9 2.3 13.3 0.0 1.7 0.2 2.9 5.8 3.3 0.0 0.7 0.1 0.0 0.1 1.4 0.0 1.8 2.6 5.8 1.9 9.0 18.4 0.4 10.9 19.1 8.1 7.3 0.3 0.4 0.0 0.6 11.9 8.1 2.1 2.8 0.9 6.3 4.2 0.9 0.0 10.8 2.7 4.4 0.0 0.1 17.9 0.0 7.7 1.5 12.9 10.1 0.1 0.5 3.3 3.1 0.3 0.0 1.6 2.0 0.1 2.6 0.3 0.7 1.0 2.1 0.0 1.1 3.4 3.2 0.0 2.1 5.5 2.1 0.9 30.0 34.8 5.9 8.0 3.0 4.0 2.4 0.1 9.6 0.7 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 1.4 0.0 35.5 18.8 31.7 48.7 29.2 14.8 10.5 23.9 18.4 13.3 0.0 2.6 0.0 0.1 0.5 12.8 1.1 0.0 1.4 1.2 0.0 3.9 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 2.5 0.4 0.0 0.0 0.1 1.6 0.0 2.5 0.0 0.0 1.4 0.0 0.0 1.0 0.0 0.8 0.1 0.0 0.7 0.0 2.8 6.5 4.4 0.2 0.2 0.3 0.2 0.0 0.0 0.1 COL2A1 "AOM, SEDC, STL1" ENSG00000139219 "Collagen type II alpha 1 chain" P02458 12 47972965-48004554 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 22.7;pituitary gland: 11.0;retina: 8.1;stomach 1: 11.3" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 12.7;Intestinal endocrine cells: 42.2;Muller glia cells: 19.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 55.2;HAP1: 34.6;HEK 293: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002214, HPA055753" Approved Approved Nucleoplasm "Secreted to extracellular matrix" No NA Nucleoplasm "CAB002214: AB_563666, HPA055753: AB_2682908" "unprognostic (7.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-1)" "unprognostic (2.88e-2)" "unprognostic (3.08e-2)" "unprognostic (8.63e-2)" "unprognostic (2.77e-1)" "unprognostic (1.22e-1)" "unprognostic (3.12e-2)" "unprognostic (1.31e-4)" "unprognostic (2.64e-1)" "unprognostic (3.44e-3)" "unprognostic (1.89e-1)" "unprognostic (2.93e-1)" "unprognostic (2.07e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.1 2.2 0.3 0.0 0.7 0.9 0.9 0.0 0.2 0.3 0.0 0.0 0.3 22.7 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 1.4 0.0 0.0 0.7 1.3 0.0 0.0 11.0 0.4 1.9 2.6 0.4 8.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 11.3 2.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 34.6 0.0 0.0 0.0 12.8 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.9 0.9 0.5 1.3 0.0 0.7 1.9 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.2 0.0 42.2 0.0 0.0 7.1 0.9 0.0 0.0 0.0 0.3 19.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.5 0.7 0.0 0.7 0.0 0.9 0.1 COMMD10 PTD002 ENSG00000145781 "COMM domain containing 10" Q9Y6G5 5 116084991-116412762 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045441, HPA054156" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA045441: AB_10961905, HPA054156: " "unprognostic (1.14e-1)" "unprognostic (2.15e-2)" "unprognostic (5.38e-2)" "unprognostic (5.72e-2)" "unprognostic (1.79e-1)" "unprognostic (5.72e-3)" "unprognostic (2.12e-2)" "unprognostic (1.51e-1)" "unprognostic (3.02e-2)" "unprognostic (2.64e-1)" "unprognostic (2.07e-1)" "unprognostic (3.14e-1)" "unprognostic (1.84e-3)" "prognostic unfavorable (2.99e-4)" "unprognostic (9.47e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (1.59e-1)" 20.5 26.6 18.6 22.8 20.3 13.3 21.9 17.9 20.5 20.0 16.9 15.7 26.7 12.7 18.6 31.5 18.6 13.4 16.6 28.4 16.3 16.8 33.2 22.4 15.4 19.0 23.4 15.0 18.2 23.0 15.2 29.1 22.3 18.9 20.6 19.6 15.1 27.2 24.1 15.1 11.5 20.4 18.7 19.1 25.1 19.3 12.9 17.9 19.1 27.0 14.3 20.6 18.2 17.3 12.0 23.6 12.7 21.4 15.9 10.8 13.5 16.1 16.6 17.9 9.5 12.9 18.3 19.9 12.7 13.8 17.7 14.8 13.3 20.3 8.2 15.1 17.4 36.9 9.3 10.0 19.7 26.5 23.8 7.4 9.8 5.6 10.3 14.7 7.7 18.7 11.5 13.2 11.3 13.9 14.5 17.6 11.7 6.3 5.6 23.0 10.7 14.4 18.4 15.4 12.3 7.6 14.6 18.9 23.9 24.8 10.3 9.5 12.7 15.3 13.9 17.7 13.7 17.0 29.3 10.5 15.5 19.0 7.1 21.7 6.1 8.1 21.1 15.0 29.3 17.8 7.6 18.2 12.7 7.8 21.4 10.6 12.0 10.1 9.7 23.6 8.3 9.9 10.1 3.3 15.9 19.6 17.4 10.8 13.5 18.6 20.3 17.9 20.5 16.3 16.8 23.4 15.0 18.9 17.9 8.9 18.3 20.4 27.7 19.7 15.5 37.5 12.7 4.0 11.4 22.7 5.9 38.4 77.9 24.7 1.5 21.0 12.9 0.0 13.3 43.4 28.0 28.2 46.1 11.6 42.0 15.9 10.3 20.9 26.5 2.5 19.5 32.4 30.4 16.2 22.3 29.0 16.3 14.4 19.1 83.0 19.4 0.0 27.8 8.1 16.6 22.0 41.4 22.4 21.0 24.7 COPS5 "CSN5, JAB1, MOV-34, SGN5" ENSG00000121022 "COP9 signalosome subunit 5" Q92905 8 67043079-67083783 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 275.9;Late spermatids: 320.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004242, HPA004845, HPA051531" Supported Enhanced Nucleoplasm NA NA 27000 Nucleoplasm "CAB004242: AB_627835, HPA004845: AB_1078557, HPA051531: AB_2681522" "unprognostic (1.90e-3)" "unprognostic (1.35e-1)" "unprognostic (1.61e-1)" "unprognostic (2.85e-3)" "unprognostic (2.53e-1)" "unprognostic (4.16e-2)" "unprognostic (2.04e-3)" "unprognostic (1.39e-1)" "unprognostic (2.15e-2)" "unprognostic (4.48e-2)" "unprognostic (4.74e-3)" "unprognostic (1.96e-2)" "unprognostic (1.90e-3)" "unprognostic (2.88e-2)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.18e-2)" 20.2 26.3 29.4 19.6 28.6 16.2 28.1 28.5 40.3 18.0 21.7 15.6 20.2 22.0 17.6 21.7 24.0 17.7 15.5 46.8 27.6 27.5 27.4 33.7 16.8 17.5 31.8 29.9 17.0 20.7 23.3 21.7 24.3 33.7 18.3 25.5 9.9 19.6 18.9 64.0 16.8 22.5 23.3 39.2 16.1 20.7 27.4 31.3 19.6 18.5 29.2 22.4 18.3 16.5 20.7 35.1 33.7 30.0 26.5 28.1 22.3 28.8 27.4 23.3 21.3 24.5 26.2 18.5 25.4 20.9 35.3 31.9 17.7 35.6 26.8 11.7 26.2 25.5 24.2 31.2 28.0 39.0 25.7 26.9 38.1 27.5 23.8 23.8 24.0 23.1 23.8 36.0 28.8 37.2 27.3 34.4 28.3 45.0 18.6 31.6 26.8 42.3 42.2 30.9 60.8 31.5 27.2 16.6 21.1 37.4 25.7 14.1 19.5 14.6 28.3 24.6 21.5 46.6 24.8 25.4 18.0 22.2 21.7 19.9 23.4 29.8 35.7 26.2 27.4 24.5 26.0 28.6 33.7 20.8 30.0 21.7 20.7 20.1 23.1 35.1 17.5 21.6 19.1 21.2 26.5 28.3 18.4 28.1 22.3 29.4 28.6 28.5 40.3 27.6 27.5 31.8 29.9 33.7 31.3 20.8 21.3 38.7 36.8 43.8 32.5 99.1 43.3 26.8 29.6 29.6 31.4 115.4 74.6 65.8 275.9 33.7 37.6 0.0 52.3 84.4 39.7 44.8 34.7 33.9 69.9 23.8 32.8 31.9 28.8 320.8 40.0 37.7 27.0 55.9 34.2 45.4 48.3 45.6 48.1 56.1 44.9 32.3 31.6 126.7 59.2 41.5 106.9 39.5 48.7 48.1 COPS6 "CSN6, MOV34-34KD" ENSG00000168090 "COP9 signalosome subunit 6" Q7L5N1 7 100088954-100092200 "Enzymes, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044315 Approved Supported Nucleoplasm "Intracellular and membrane" NA NA 58000 Nucleoplasm "HPA044315: AB_10959750" "unprognostic (1.48e-2)" "unprognostic (2.43e-2)" "unprognostic (6.56e-3)" "unprognostic (1.38e-1)" "unprognostic (5.84e-2)" "unprognostic (2.09e-2)" "unprognostic (3.62e-3)" "unprognostic (2.93e-2)" "unprognostic (2.00e-1)" "unprognostic (2.45e-2)" "unprognostic (4.96e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (6.72e-4)" "unprognostic (1.20e-1)" "unprognostic (3.58e-2)" "unprognostic (8.57e-2)" "unprognostic (8.77e-2)" 25.4 30.0 37.7 20.2 50.6 19.7 25.6 31.5 43.3 32.5 30.4 26.5 15.1 19.3 31.0 39.8 33.4 33.7 32.4 47.2 31.5 32.1 31.7 41.2 20.1 30.4 33.3 32.6 30.8 42.8 38.1 28.2 29.1 34.1 27.4 26.6 25.0 28.3 35.7 53.1 23.4 19.2 45.2 30.1 22.7 26.9 25.5 30.8 29.4 27.6 21.6 25.8 26.7 24.8 53.4 67.6 58.9 64.0 48.2 69.4 45.3 32.3 46.2 27.7 32.9 24.4 29.2 17.6 29.4 45.3 49.3 36.3 37.7 30.7 22.4 38.1 48.2 55.1 24.8 31.3 49.8 50.0 22.3 49.1 19.1 45.8 29.0 51.1 21.6 19.9 28.8 33.1 53.1 56.8 33.0 67.4 34.8 27.4 32.4 58.0 80.6 47.8 32.2 25.0 47.7 55.5 22.9 46.1 53.4 39.2 30.5 43.5 32.3 30.4 60.2 22.3 38.0 24.8 21.4 35.3 47.6 43.4 56.9 51.7 24.0 26.6 45.9 36.0 29.5 70.2 58.9 61.9 51.7 61.1 64.0 61.2 53.4 61.3 57.8 67.6 49.8 48.3 53.9 24.1 48.2 57.4 50.2 69.4 45.3 37.7 50.6 31.5 43.3 31.5 32.1 33.3 32.6 34.1 30.8 47.6 36.9 81.5 102.7 98.2 102.2 140.2 79.0 83.0 60.3 82.0 49.1 166.8 179.1 109.3 59.3 92.0 58.6 46.7 99.3 110.5 106.3 89.3 89.9 52.9 111.6 90.6 72.3 79.8 61.4 119.0 118.2 67.5 148.5 112.8 58.6 129.0 94.7 59.6 117.8 164.9 114.4 97.0 134.0 70.6 115.8 87.7 115.3 82.8 79.4 85.2 COPS7B CSN7B ENSG00000144524 "COP9 signalosome subunit 7B" Q9H9Q2 2 231781671-231809254 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 59.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034675, HPA034676" Uncertain Supported Nucleoplasm NA NA 33000 Nucleoplasm "HPA034675: AB_10696360, HPA034676: AB_2674274" "unprognostic (3.21e-1)" "unprognostic (1.59e-1)" "unprognostic (6.25e-3)" "unprognostic (3.59e-3)" "unprognostic (3.50e-1)" "unprognostic (4.77e-2)" "prognostic unfavorable (8.37e-6)" "unprognostic (1.19e-1)" "unprognostic (4.81e-2)" "unprognostic (1.89e-1)" "unprognostic (5.77e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.50e-6)" "unprognostic (2.37e-2)" "unprognostic (1.39e-1)" "unprognostic (6.64e-2)" "unprognostic (1.55e-3)" 11.9 19.4 17.4 13.0 25.2 12.4 14.3 20.8 35.0 16.7 17.0 31.0 19.6 8.7 18.4 13.9 15.9 19.6 11.1 13.2 17.3 14.2 14.6 16.9 14.4 20.1 29.7 18.2 18.0 14.1 29.3 40.9 18.5 23.4 18.3 19.3 17.5 17.7 19.9 15.3 20.8 15.8 21.2 21.7 21.8 18.5 24.5 24.5 19.0 17.8 11.8 26.3 15.9 16.9 13.8 12.5 10.3 12.3 15.4 14.2 10.8 11.9 10.6 15.4 17.2 11.7 14.7 17.4 10.0 9.3 16.3 19.5 17.9 13.6 11.6 10.9 12.1 18.8 9.5 23.1 18.0 24.4 19.6 21.6 22.1 9.5 24.9 12.5 23.7 12.9 10.1 18.5 18.2 13.3 14.6 18.5 28.7 24.4 9.6 14.8 15.6 22.4 19.5 24.6 11.7 11.2 26.3 19.1 12.6 12.3 10.6 16.9 14.7 9.5 7.9 17.5 24.2 10.2 19.5 11.9 11.8 11.4 13.0 13.3 15.5 12.6 32.4 11.4 17.0 11.9 10.3 8.2 4.4 13.1 9.4 12.7 13.8 10.3 11.9 12.5 13.0 14.2 10.0 2.0 15.4 12.3 9.7 10.0 10.8 17.4 25.2 20.8 35.0 17.3 14.2 29.7 18.2 23.4 24.5 14.9 9.9 9.7 11.2 11.0 13.1 6.4 5.1 1.4 10.3 15.7 9.8 19.8 11.6 12.0 38.1 8.4 8.6 0.0 8.2 16.7 10.3 10.5 5.7 6.0 13.1 12.7 22.3 16.0 12.1 10.8 16.7 8.9 11.8 13.6 13.8 8.5 10.3 7.0 19.1 7.9 16.3 12.9 10.3 36.2 59.4 7.0 14.9 16.6 12.9 10.5 CPA5 ENSG00000158525 "Carboxypeptidase A5" Q8WXQ8 7 130344816-130368730 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "blood: 25.2;testis: 30.4" "Group enriched" "Detected in some" 20 "Early spermatids: 46.3;Late spermatids: 106.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 8.0;naive CD8 T-cell: 20.3;T-reg: 25.2" "Lineage enriched" "Detected in single" 114 "T-cells: 25.2" "Cell line enhanced" "Detected in some" "RH-30: 11.2;RT4: 5.1;U-266/84: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020322 Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA020322: AB_10960562" "unprognostic (2.44e-1)" "unprognostic (3.76e-1)" "unprognostic (1.50e-1)" "unprognostic (5.94e-2)" "unprognostic (4.96e-2)" "unprognostic (7.10e-3)" "unprognostic (1.64e-2)" "unprognostic (1.41e-2)" "unprognostic (3.26e-1)" "unprognostic (5.02e-2)" "unprognostic (5.83e-4)" "unprognostic (1.43e-1)" "unprognostic (8.88e-13)" "unprognostic (5.16e-2)" "unprognostic (1.32e-1)" "unprognostic (8.81e-2)" "unprognostic (3.08e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 1.6 0.1 0.1 0.1 0.4 0.0 1.0 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.4 0.1 0.1 1.6 0.0 30.4 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.0 0.0 0.2 0.0 0.0 25.2 3.1 0.8 0.0 0.1 0.6 0.0 0.0 0.0 0.4 3.3 0.2 0.4 2.4 0.0 0.0 0.0 0.0 1.1 0.1 0.4 0.7 0.0 0.0 1.9 0.7 0.7 1.2 0.5 0.0 0.0 0.0 1.1 0.0 1.2 1.4 0.0 0.9 0.0 1.6 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 11.2 0.4 1.5 5.1 1.4 0.2 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 8.4 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 8.0 4.1 0.0 0.0 2.1 20.3 0.0 0.0 0.0 0.0 25.2 3.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 2.8 0.0 0.0 46.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 106.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.6 1.9 0.0 3.9 0.0 0.0 0.0 CPED1 "C7orf58, FLJ21986" ENSG00000106034 "Cadherin like and PC-esterase domain containing 1" A4D0V7 7 120988677-121297444 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Fibroblasts: 35.2;Ito cells: 30.7;Peritubular cells: 76.7;Smooth muscle cells: 39.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 7.6;intermediate monocyte: 7.8;myeloid DC: 17.2;non-classical monocyte: 4.8;plasmacytoid DC: 10.3" "Group enriched" "Detected in many" 9 "dendritic cells: 17.2;monocytes: 7.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 28.7;Hep G2: 16.5;K-562: 55.7;LHCN-M2: 19.7;U-138 MG: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA012058 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012058: AB_1845761" "unprognostic (7.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (4.48e-4)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (5.52e-3)" "prognostic favorable (3.00e-4)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.48e-1)" "unprognostic (8.69e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (6.28e-3)" "unprognostic (5.05e-2)" "unprognostic (3.78e-1)" "unprognostic (6.54e-4)" 21.6 8.3 3.2 8.0 3.7 0.1 7.8 1.1 2.7 19.4 16.3 4.1 15.0 3.7 21.8 15.7 10.5 12.2 14.4 10.3 2.9 1.7 3.9 19.4 9.0 1.5 5.1 1.9 36.8 2.0 0.4 4.5 10.6 3.1 20.7 6.7 18.5 2.8 17.1 24.4 2.9 10.6 48.9 8.7 9.9 8.6 7.1 3.8 0.2 4.9 15.9 1.4 34.3 14.6 1.0 17.2 1.4 7.8 0.0 0.1 2.1 1.9 0.0 0.1 0.0 4.7 13.8 0.1 8.1 28.7 2.8 7.7 0.2 0.1 0.3 0.1 4.3 3.2 0.1 0.1 0.0 7.4 0.1 0.3 2.2 0.1 16.5 8.2 0.0 0.0 5.6 0.0 6.6 0.1 2.2 1.4 0.0 55.7 4.2 19.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 11.3 5.5 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.2 0.8 16.8 0.4 14.0 7.7 1.8 0.0 0.2 1.9 0.0 0.8 1.4 7.6 0.0 0.0 7.8 0.1 1.0 0.0 0.0 17.2 0.3 0.0 0.0 0.3 0.0 4.8 10.3 0.0 2.1 3.2 3.7 1.1 2.7 2.9 1.7 5.1 1.9 3.1 3.8 17.9 0.3 1.3 0.5 2.7 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 3.6 0.0 0.0 0.0 1.5 35.2 0.8 0.0 20.2 3.9 3.2 0.0 30.7 11.5 0.0 19.5 25.2 3.3 1.0 0.0 21.5 0.0 0.0 76.7 0.0 0.2 0.0 39.2 0.3 0.4 1.8 0.3 0.0 0.0 1.3 CPSF1 CPSF160 ENSG00000071894 "Cleavage and polyadenylation specific factor 1" Q10570 8 144393229-144409349 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065167, HPA068906" Enhanced Nucleoplasm No No Nucleoplasm "HPA065167: AB_2685426, HPA068906: AB_2686055" "unprognostic (6.37e-2)" "unprognostic (7.72e-2)" "unprognostic (2.41e-2)" "unprognostic (1.21e-1)" "unprognostic (2.93e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (1.05e-1)" "unprognostic (2.00e-3)" "unprognostic (6.45e-2)" "unprognostic (7.54e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (6.54e-5)" "unprognostic (2.40e-1)" "unprognostic (1.91e-1)" "unprognostic (7.90e-2)" "unprognostic (9.66e-3)" 11.9 13.5 13.4 18.6 17.2 27.0 14.3 28.5 18.0 11.7 15.1 16.3 14.9 40.7 17.8 8.9 13.0 16.2 14.3 10.3 13.0 8.2 13.0 15.0 13.7 17.4 16.6 11.5 19.8 22.4 7.3 21.6 11.1 15.4 18.4 7.6 14.9 26.9 13.8 14.7 25.2 29.8 11.7 11.0 21.2 16.3 27.9 16.1 27.1 17.7 10.6 16.0 13.1 13.4 7.5 8.8 4.9 9.3 5.7 10.0 5.8 9.4 13.3 12.1 12.6 6.5 5.2 11.9 8.9 5.6 7.3 7.6 13.4 12.2 10.9 8.7 6.6 4.9 8.6 6.8 7.5 2.0 9.8 19.7 21.4 14.9 21.4 5.5 8.1 13.3 5.7 3.2 6.7 3.9 4.4 9.7 18.2 17.9 9.3 3.6 40.3 21.2 17.1 7.3 7.9 18.8 15.3 4.9 8.7 7.7 14.0 9.9 9.8 11.5 7.2 6.5 3.6 12.7 9.1 8.3 5.0 19.4 11.0 9.8 5.6 4.4 10.3 6.8 13.8 5.9 4.9 7.8 4.9 8.0 9.3 8.4 6.9 8.5 8.4 8.8 7.5 7.5 7.1 1.5 5.7 8.6 4.1 10.0 5.8 13.4 17.2 28.5 18.0 13.0 8.2 16.6 11.5 15.4 16.1 14.9 22.7 3.0 3.6 9.0 10.3 8.3 15.3 8.1 11.4 8.7 11.8 8.9 1.7 7.8 15.6 11.1 19.5 0.0 9.9 9.4 9.3 3.4 13.9 7.2 13.0 7.9 12.6 9.2 8.3 30.3 13.0 13.0 13.5 8.2 23.9 4.3 9.8 11.5 15.2 4.6 13.8 6.5 8.0 24.2 22.0 10.8 6.1 10.4 24.2 3.3 CREB1 ENSG00000118260 "CAMP responsive element binding protein 1" P16220 2 207529737-207603431 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Early spermatids: 355.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003803, HPA019150" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB003803: AB_562092, HPA019150: AB_1847220" "unprognostic (1.20e-1)" "unprognostic (3.15e-1)" "unprognostic (3.30e-2)" "unprognostic (2.69e-2)" "unprognostic (3.16e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (8.41e-2)" "unprognostic (1.04e-2)" "unprognostic (2.53e-1)" "unprognostic (9.58e-2)" "unprognostic (1.74e-2)" "unprognostic (4.82e-3)" "unprognostic (5.53e-3)" "unprognostic (1.06e-1)" "unprognostic (1.77e-1)" "unprognostic (8.45e-2)" 21.2 12.9 19.4 24.8 17.0 22.9 16.7 25.5 18.7 17.6 15.7 14.3 14.7 12.6 19.3 14.9 17.9 15.4 15.5 14.4 15.4 14.5 14.6 13.1 17.7 21.7 15.8 17.7 20.5 12.9 19.8 20.0 19.8 16.1 16.3 16.2 11.2 16.2 14.9 11.6 14.3 15.2 19.5 19.8 19.0 13.3 39.2 18.5 38.4 19.7 13.3 27.7 16.1 23.6 22.1 20.7 34.8 19.1 28.4 22.5 14.5 15.3 13.8 25.5 9.8 15.0 15.4 14.6 9.9 14.8 17.2 18.1 13.9 15.6 10.0 13.3 14.5 20.2 13.4 23.1 13.5 25.3 15.9 8.3 18.3 12.3 14.2 12.6 17.3 13.5 11.1 10.0 14.2 21.1 17.2 24.1 18.7 12.8 14.6 21.2 10.6 26.2 10.2 18.2 15.4 8.4 20.5 13.9 13.1 15.4 15.9 17.6 15.3 13.7 10.1 11.9 25.5 11.3 18.9 11.5 14.1 15.1 14.7 12.6 13.2 16.7 23.0 17.3 15.9 14.7 16.9 17.0 16.8 17.3 18.0 15.4 22.1 16.6 16.7 20.7 20.2 19.9 13.5 34.8 28.4 19.1 11.3 22.5 14.5 19.4 17.0 25.5 18.7 15.4 14.5 15.8 17.7 16.1 18.5 17.9 12.8 45.4 39.6 63.0 36.1 22.1 12.7 9.4 25.0 12.2 31.4 24.5 19.9 20.2 355.9 44.6 20.0 0.0 17.9 21.7 32.3 41.9 42.7 14.3 25.7 38.1 31.2 31.3 43.4 27.4 24.2 38.0 42.2 36.9 24.2 40.0 21.9 23.5 27.6 15.6 36.9 38.8 34.1 24.7 27.5 50.6 15.6 31.9 23.0 54.8 CREBRF "C5orf41, LRF" ENSG00000164463 "CREB3 regulatory factor" Q8IUR6 5 173056352-173139284 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation, Transport, Unfolded protein response" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015329 Supported Nucleoplasm NA NA Nucleoplasm "HPA015329: AB_2669192" "unprognostic (8.00e-2)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" "unprognostic (3.14e-2)" "unprognostic (5.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.35e-1)" "unprognostic (6.03e-3)" "unprognostic (1.78e-1)" "unprognostic (1.38e-1)" "unprognostic (2.17e-2)" "unprognostic (4.69e-2)" "prognostic favorable (3.20e-7)" "unprognostic (1.40e-2)" "unprognostic (1.81e-1)" "unprognostic (2.52e-1)" "prognostic favorable (9.30e-4)" 18.0 10.6 15.9 9.2 17.3 53.5 16.5 29.7 23.1 13.8 12.4 5.6 11.7 7.9 15.2 11.2 8.5 10.9 9.4 10.0 16.6 6.7 13.9 10.7 16.3 16.0 19.0 11.0 18.4 9.3 16.6 18.0 13.0 14.9 11.8 8.4 6.7 13.2 13.0 12.2 15.6 12.9 16.1 15.1 14.7 10.3 12.0 18.4 9.2 21.7 3.8 9.6 15.3 19.1 4.9 2.6 19.0 2.6 1.3 4.1 1.4 1.0 2.2 2.2 3.4 10.2 13.6 5.2 3.1 15.2 2.9 5.6 3.1 5.2 1.8 7.5 3.1 5.4 1.3 1.0 2.4 4.1 6.8 2.1 1.4 1.5 1.0 7.9 1.1 8.5 8.2 6.2 3.1 7.9 7.2 3.5 2.4 1.3 9.9 3.4 1.9 1.8 1.6 0.7 1.5 1.1 1.7 1.5 2.9 4.1 2.0 1.7 2.6 3.1 1.3 11.5 4.9 1.4 2.1 5.7 4.4 1.4 3.0 0.8 11.1 9.2 3.3 3.3 2.0 1.5 3.5 2.4 4.9 3.3 2.1 3.0 2.6 3.3 2.7 1.2 4.9 4.1 3.2 19.0 1.3 2.6 2.6 2.9 1.4 15.9 17.3 29.7 23.1 16.6 6.7 19.0 11.0 14.9 18.4 47.6 36.6 34.0 20.7 70.3 49.1 53.7 33.1 36.1 27.3 36.6 64.8 8.0 13.3 12.1 4.3 64.3 34.2 93.5 13.6 9.5 43.2 42.5 46.2 31.1 18.6 106.5 73.4 38.1 67.4 5.3 48.1 51.3 62.4 45.1 27.3 35.7 15.8 24.6 51.6 18.2 63.6 58.2 59.3 63.7 44.6 81.2 31.2 53.2 18.8 18.5 CRTC2 TORC2 ENSG00000160741 "CREB regulated transcription coactivator 2" Q53ET0 1 153947669-153958625 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028454, HPA028465" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028454: AB_10599617, HPA028465: AB_10601991" "unprognostic (4.91e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (4.32e-3)" "unprognostic (2.86e-1)" "unprognostic (4.63e-3)" "unprognostic (1.54e-3)" "unprognostic (1.20e-2)" "unprognostic (1.07e-1)" "unprognostic (2.24e-2)" "unprognostic (2.17e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (1.35e-7)" "unprognostic (7.90e-2)" "unprognostic (2.59e-1)" "unprognostic (3.35e-1)" "prognostic favorable (6.12e-5)" 22.4 19.7 21.0 23.1 26.6 28.7 21.1 31.8 22.8 21.5 18.9 29.5 15.6 13.3 24.3 20.2 17.7 22.7 18.4 17.4 20.4 11.3 21.4 22.9 26.0 31.1 25.7 16.3 32.3 20.6 22.7 19.7 24.2 18.6 20.1 15.9 21.9 20.1 22.1 24.6 24.0 23.5 21.5 19.2 39.4 18.9 18.1 28.1 22.1 23.6 10.9 29.7 23.4 21.0 6.1 4.6 10.1 5.9 4.6 5.0 1.8 14.8 11.2 10.9 12.3 18.0 13.1 16.7 8.4 17.4 16.1 13.3 11.5 15.0 14.3 13.4 14.5 10.9 17.0 13.0 16.9 9.0 18.7 17.0 7.3 11.4 8.8 18.2 11.8 12.2 17.2 16.5 17.7 14.5 12.8 14.9 8.2 11.7 17.3 11.5 23.6 12.8 19.8 8.5 16.2 13.9 9.5 7.5 12.0 17.0 12.1 9.2 15.1 13.5 27.6 20.9 11.2 13.3 23.2 11.0 13.0 11.8 13.9 14.2 28.3 18.3 9.8 12.0 10.1 9.6 5.2 3.9 8.4 4.6 5.9 3.8 4.5 4.7 5.0 3.4 6.1 3.2 3.8 10.1 4.6 4.7 4.6 3.1 1.8 21.0 26.6 31.8 22.8 20.4 11.3 25.7 16.3 18.6 28.1 6.0 10.6 4.8 7.1 21.9 5.2 5.6 10.2 2.7 4.5 12.2 3.9 8.3 1.7 8.1 1.1 11.7 10.9 0.0 8.9 8.2 11.2 9.1 8.1 10.6 9.5 1.6 15.4 10.4 10.5 1.1 11.2 12.0 3.3 11.8 12.1 4.5 11.7 2.9 14.2 2.8 6.9 6.5 11.7 11.5 11.5 19.7 10.2 12.9 7.6 9.6 CRYBB2 "CCA2, CRYB2, CRYB2A" ENSG00000244752 "Crystallin beta B2" P43320 22 25219522-25231869 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 26.9" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 23.2;Melanocytes: 11.8;Peritubular cells: 7.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 5.2;THP-1: 1.7;U-138 MG: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA043749 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA043749: AB_2678652" "unprognostic (1.28e-1)" "unprognostic (2.71e-2)" "unprognostic (4.09e-2)" "unprognostic (1.95e-1)" "unprognostic (5.06e-2)" "unprognostic (7.04e-2)" "unprognostic (8.57e-3)" "unprognostic (9.51e-3)" "unprognostic (8.55e-2)" "unprognostic (2.46e-2)" "unprognostic (4.13e-2)" "unprognostic (2.01e-1)" "unprognostic (1.73e-5)" "unprognostic (1.44e-2)" "unprognostic (1.60e-1)" "unprognostic (3.28e-1)" "unprognostic (9.89e-3)" 0.8 0.7 2.0 0.5 3.7 0.1 1.7 0.5 1.8 1.0 1.3 0.5 0.5 0.8 0.5 1.8 1.1 0.4 0.5 0.6 2.9 1.5 0.5 0.5 1.4 0.5 0.8 0.5 0.5 0.5 0.0 2.6 0.5 0.9 0.9 1.5 26.9 1.2 0.5 0.6 0.4 1.0 1.0 0.5 0.5 0.2 4.0 0.5 0.5 1.7 0.5 0.5 0.5 0.5 1.4 1.3 0.5 1.1 1.7 1.4 0.7 0.2 0.5 0.1 0.7 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.6 0.0 1.2 0.8 0.0 0.0 0.2 0.0 1.1 0.6 5.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.3 1.2 0.3 0.6 0.0 0.2 0.1 0.6 0.0 0.2 0.0 0.0 0.9 1.7 0.0 3.0 0.7 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.5 0.8 0.4 1.4 0.6 0.6 1.4 1.2 0.7 1.1 1.0 1.1 1.2 0.1 1.7 1.1 1.3 0.4 0.7 2.0 3.7 0.5 1.8 2.9 1.5 0.8 0.5 0.9 0.5 0.0 0.0 0.0 0.4 4.7 0.1 0.8 0.0 0.0 0.0 1.8 0.0 0.1 23.2 0.0 2.5 2.4 0.0 0.0 0.2 0.1 0.3 0.3 0.0 0.4 0.2 0.0 0.0 0.6 0.3 4.0 2.3 0.7 11.8 0.0 0.1 0.7 0.4 0.0 7.8 0.7 0.0 0.0 4.2 2.1 2.6 3.3 0.1 0.0 0.0 0.6 CRYBG2 "AIM1L, FLJ38020" ENSG00000176092 "Crystallin beta-gamma domain containing 2" Q8N1P7 1 26321698-26360080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.9;placenta: 55.0" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 40.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 7.1;BEWO: 15.5;CACO-2: 25.1;CAPAN-2: 16.9;HaCaT: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA029629 Approved Nucleoplasm NA NA Nucleoplasm "HPA029629: AB_10601331" "unprognostic (2.20e-1)" "unprognostic (2.07e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (5.11e-6)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (6.39e-4)" "unprognostic (1.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.94e-2)" "unprognostic (4.83e-9)" "unprognostic (9.12e-3)" "unprognostic (3.40e-1)" "unprognostic (6.44e-2)" "unprognostic (1.63e-2)" 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 8.0 4.4 0.0 0.0 4.9 0.9 0.6 43.9 0.2 2.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 55.0 0.0 0.8 1.4 0.1 5.1 0.0 0.0 13.8 10.4 0.0 0.0 0.0 0.9 1.2 0.0 0.1 0.0 22.0 19.8 4.9 16.1 0.7 0.0 2.4 0.1 0.2 1.7 0.3 7.1 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.1 25.1 16.9 0.1 5.1 0.0 0.1 6.3 0.0 4.5 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.2 4.0 0.0 0.0 0.0 0.1 0.3 1.6 0.3 0.0 0.0 3.0 0.0 1.2 4.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.1 0.5 0.7 1.7 0.7 0.0 0.6 0.5 0.5 2.4 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.9 1.7 1.8 0.0 0.0 0.0 0.0 1.2 4.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.0 0.0 0.0 CSNK2A1 "Cka1, Cka2" ENSG00000101266 "Casein kinase 2 alpha 1" P68400 20 472498-543835 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB020680, HPA059206, HPA061698, CAB069395" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB020680: , CAB069395: AB_1611912, HPA059206: AB_2683948, HPA061698: AB_2732667" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (5.44e-2)" "unprognostic (8.28e-3)" "unprognostic (3.62e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (4.11e-6)" "unprognostic (4.08e-2)" "unprognostic (3.89e-1)" "unprognostic (6.88e-2)" "unprognostic (1.94e-2)" "unprognostic (1.16e-1)" "unprognostic (8.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.47e-1)" "unprognostic (9.53e-2)" "unprognostic (7.37e-2)" 21.5 26.7 23.2 20.6 31.3 16.7 24.1 26.3 32.8 22.2 26.1 28.2 19.5 21.9 24.3 15.7 31.9 23.3 17.7 29.2 21.8 21.9 24.5 23.1 18.6 21.9 21.3 22.6 24.9 27.5 27.7 24.6 23.1 29.4 20.7 24.2 19.6 23.8 22.4 58.8 27.0 22.5 23.3 21.3 21.8 26.5 51.6 23.2 30.3 22.4 22.4 25.7 26.2 22.8 19.8 25.4 23.3 27.3 18.7 19.4 15.7 44.4 39.7 36.7 22.6 14.0 24.5 23.8 26.1 26.4 30.3 33.8 40.0 29.2 39.7 16.8 21.5 42.6 34.5 40.3 39.1 43.2 13.9 14.6 53.8 10.6 38.7 24.1 46.7 11.9 22.4 41.4 27.9 77.7 29.7 32.7 34.5 52.8 26.2 27.7 14.7 56.1 16.6 52.5 39.9 27.4 33.4 32.1 32.4 26.1 28.2 38.4 30.6 22.3 43.0 39.7 29.7 28.7 18.3 30.7 32.2 27.6 20.8 38.6 27.2 64.0 39.2 16.1 28.1 32.5 23.3 19.7 22.2 16.1 27.3 19.4 19.8 15.7 15.5 25.4 18.9 16.0 15.0 12.1 18.7 25.2 21.1 16.4 15.7 23.2 31.3 26.3 32.8 21.8 21.9 21.3 22.6 29.4 23.2 59.6 72.9 45.0 31.0 36.5 45.7 53.7 33.1 80.3 85.3 41.8 29.5 35.3 34.9 61.1 104.2 34.8 33.8 0.0 43.6 47.2 34.8 36.9 60.3 26.4 28.9 57.2 33.8 22.1 30.2 104.8 38.0 35.3 13.5 67.7 41.3 34.4 54.4 24.6 34.6 56.2 26.8 51.8 32.5 61.3 54.1 43.8 51.4 32.4 39.1 45.0 CSNK2A3 CSNK2A1P ENSG00000254598 "Casein kinase 2 alpha 3" Q8NEV1 11 11351942-11353357 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 11.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 5.6" "HPA059206, HPA061698" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059206: AB_2683948, HPA061698: AB_2732667" "unprognostic (3.10e-2)" "unprognostic (3.39e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-3)" "unprognostic (1.82e-2)" "unprognostic (1.60e-1)" "unprognostic (6.25e-4)" "unprognostic (4.36e-2)" "unprognostic (5.42e-2)" "unprognostic (1.88e-1)" "unprognostic (5.46e-3)" "unprognostic (1.07e-1)" "unprognostic (1.50e-1)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (1.42e-1)" "unprognostic (3.38e-2)" 4.6 1.6 1.3 2.8 1.3 0.6 1.9 1.6 5.5 2.8 3.8 0.5 2.1 3.4 1.8 3.8 3.4 1.1 1.6 2.3 1.5 1.2 5.4 3.0 3.7 1.0 1.1 0.7 2.0 1.4 0.6 1.7 2.9 2.0 2.2 0.7 2.1 1.7 3.6 5.3 1.9 2.9 2.9 1.2 0.9 1.3 3.5 0.3 3.6 1.6 1.8 2.7 1.8 1.3 0.7 0.9 1.1 0.6 0.8 1.0 1.2 5.6 1.2 0.2 2.1 0.0 0.0 0.7 0.5 0.3 0.3 0.3 0.0 0.3 0.0 0.4 0.0 1.6 1.9 1.0 0.8 0.0 0.2 0.3 0.0 0.2 0.5 0.0 0.2 0.4 0.6 0.4 0.0 0.6 0.1 0.0 0.8 0.4 0.8 0.7 0.6 1.3 0.7 1.7 0.4 3.0 0.9 0.2 1.0 0.6 1.0 0.5 1.2 1.6 3.2 0.6 0.2 1.2 0.4 0.7 0.9 1.2 0.4 0.6 0.5 0.9 0.8 2.6 0.2 2.6 0.7 0.5 1.1 0.6 0.6 0.9 0.7 0.4 0.7 0.9 0.7 1.0 0.3 0.1 0.8 0.6 0.7 0.7 1.2 1.3 1.3 1.6 5.5 1.5 1.2 1.1 0.7 2.0 0.3 3.0 0.3 0.0 0.8 1.5 1.0 11.1 0.0 1.4 1.2 3.5 0.0 0.6 0.0 0.7 1.7 1.6 0.4 0.0 0.7 0.4 0.5 1.0 1.1 0.0 0.2 3.2 1.2 0.6 1.0 1.4 0.6 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.0 0.6 0.5 0.0 0.7 0.6 0.9 0.9 0.8 0.8 0.4 0.5 CSTF1 ENSG00000101138 "Cleavage stimulation factor subunit 1" Q05048 20 56392371-56406369 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019270, HPA047275, HPA065000" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB019270: , HPA047275: AB_2680008, HPA065000: AB_2685400" "unprognostic (2.51e-1)" "unprognostic (1.74e-1)" "unprognostic (1.54e-3)" "unprognostic (1.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.50e-1)" "unprognostic (8.57e-3)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.62e-1)" "unprognostic (1.03e-1)" "unprognostic (4.05e-2)" "unprognostic (3.91e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (1.29e-1)" "unprognostic (3.60e-1)" 14.3 16.6 9.7 15.0 15.9 6.8 17.1 14.8 14.9 13.2 11.9 14.5 9.1 8.1 17.5 12.6 16.4 15.2 12.0 11.9 10.2 9.6 18.1 27.5 12.8 17.2 12.9 9.4 20.1 18.4 20.1 19.0 14.1 12.2 14.1 12.7 14.6 22.8 11.7 18.7 16.9 13.6 13.6 10.5 17.1 14.1 28.2 11.4 32.5 15.8 15.8 21.9 14.9 12.1 15.1 15.7 9.4 11.6 21.0 22.6 12.9 8.6 8.2 10.4 7.2 10.8 9.8 11.4 11.8 13.1 23.6 17.7 17.8 12.6 17.8 12.8 8.6 15.1 14.6 16.7 20.1 27.8 5.6 5.9 17.4 14.7 10.7 6.5 14.5 11.3 9.4 11.7 13.2 11.4 9.0 14.1 11.3 14.7 8.7 14.2 20.2 16.1 7.5 9.6 17.0 10.8 12.0 22.4 15.7 11.4 8.9 11.6 8.0 15.9 43.8 11.7 12.6 17.5 10.1 7.7 19.2 12.3 7.9 11.3 6.1 9.5 19.4 15.1 9.6 9.1 7.5 11.6 9.0 14.9 10.1 19.0 14.8 19.1 16.8 14.9 15.1 21.1 18.4 9.4 21.0 8.2 15.7 22.6 12.9 9.7 15.9 14.8 14.9 10.2 9.6 12.9 9.4 12.2 11.4 8.9 13.3 9.3 10.1 8.1 8.5 8.1 15.3 12.0 7.9 17.4 13.7 26.5 16.6 14.9 11.5 10.5 6.9 0.0 12.9 17.1 7.4 9.9 17.3 19.1 13.4 4.8 4.7 13.5 20.3 4.2 12.7 6.6 5.0 17.2 9.3 12.0 10.7 12.7 12.0 15.9 11.1 19.4 6.2 17.7 36.6 7.8 17.6 15.4 10.7 8.0 CSTF3 CstF-77 ENSG00000176102 "Cleavage stimulation factor subunit 3" Q12996 11 33077188-33162371 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039743, HPA040168" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039743: AB_10795682, HPA040168: AB_10794025" "unprognostic (2.38e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.63e-4)" "unprognostic (3.77e-1)" "unprognostic (4.04e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (8.20e-6)" "unprognostic (1.47e-1)" "unprognostic (1.67e-2)" "unprognostic (6.42e-3)" "unprognostic (9.73e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (4.64e-2)" "unprognostic (1.86e-2)" "unprognostic (1.15e-2)" "unprognostic (1.01e-3)" 9.6 16.0 27.4 16.4 38.2 11.2 16.0 30.7 35.5 12.1 13.2 11.2 14.4 16.0 16.2 50.9 16.2 13.0 13.2 11.9 24.9 23.4 15.0 19.5 12.7 20.0 17.7 22.2 17.0 12.8 21.3 45.2 15.6 17.4 18.7 16.9 12.7 13.5 13.3 12.3 21.7 14.6 12.8 20.4 15.9 15.7 21.8 19.1 20.9 19.4 15.1 16.8 13.3 15.2 9.2 11.3 9.4 11.8 9.3 13.3 5.3 18.3 18.3 34.0 22.6 8.9 15.8 25.5 18.7 11.6 20.2 27.2 14.0 15.0 19.9 12.8 11.3 13.6 24.0 29.8 17.1 32.1 20.3 50.5 20.5 39.7 22.9 10.4 26.6 12.7 11.8 12.2 15.2 15.2 16.4 25.9 15.8 27.0 14.6 26.4 13.9 25.0 13.9 16.6 13.4 22.4 20.3 33.7 15.3 21.6 26.1 26.0 14.9 21.2 12.4 14.2 22.5 22.2 17.1 16.0 16.5 21.1 27.4 23.9 13.6 19.1 17.4 20.5 26.4 16.1 5.4 7.9 9.4 9.6 9.9 11.0 9.2 11.4 9.2 11.3 8.3 12.3 12.2 4.3 9.3 11.8 8.6 13.3 5.3 27.4 38.2 30.7 35.5 24.9 23.4 17.7 22.2 17.4 19.1 17.9 16.0 27.9 37.5 16.8 33.5 18.5 25.5 72.3 43.3 55.8 5.9 56.0 53.0 20.9 31.0 22.9 14.4 23.3 14.5 25.8 32.3 29.2 13.9 51.6 24.7 12.7 30.6 12.3 21.3 9.8 27.6 20.7 27.0 28.9 26.0 29.9 17.7 14.4 28.0 36.5 25.0 25.8 21.7 72.7 51.5 16.9 28.3 20.8 31.1 52.5 CTBP1 BARS ENSG00000159692 "C-terminal binding protein 1" Q13363 4 1211448-1249953 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Oxidoreductase, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004217, HPA018987, HPA044971" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161" "unprognostic (6.19e-2)" "unprognostic (4.78e-2)" "unprognostic (9.14e-2)" "prognostic favorable (4.03e-4)" "unprognostic (3.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.52e-2)" "unprognostic (1.04e-2)" "unprognostic (9.65e-2)" "unprognostic (2.24e-2)" "unprognostic (6.35e-3)" "unprognostic (3.58e-2)" "unprognostic (3.36e-1)" "unprognostic (2.46e-2)" "unprognostic (3.00e-1)" "unprognostic (3.22e-2)" "prognostic favorable (8.94e-4)" 32.3 35.8 42.4 39.8 44.4 31.3 54.6 70.7 56.1 27.6 29.4 29.2 29.0 44.9 35.8 30.8 31.9 38.2 37.6 41.2 41.5 45.7 29.3 36.0 28.5 48.4 38.0 41.2 35.4 62.2 28.4 48.1 27.2 30.2 32.6 21.6 28.2 44.9 27.9 74.2 33.9 43.6 29.7 29.3 47.0 33.5 16.7 27.2 44.9 29.4 30.5 30.2 32.2 38.6 15.6 25.0 11.6 16.2 16.1 24.5 10.3 22.8 33.9 26.2 32.1 18.4 13.3 22.5 18.1 16.9 22.5 23.0 29.0 55.6 28.1 21.0 21.0 34.9 18.4 15.8 23.8 6.8 21.3 19.1 25.4 38.3 37.0 30.7 22.8 36.3 22.9 18.3 19.1 11.1 21.9 16.8 32.1 28.8 48.3 12.4 37.8 73.3 71.9 31.0 18.7 32.8 51.9 15.8 36.6 14.4 29.2 49.3 30.9 17.3 18.7 23.9 16.5 40.9 35.2 21.4 37.7 21.3 21.6 38.7 35.2 33.5 32.5 29.8 35.6 29.5 8.6 11.9 11.6 24.5 16.2 18.4 15.3 17.2 20.8 14.7 15.6 13.5 19.5 9.3 16.1 15.8 25.0 14.6 10.3 42.4 44.4 70.7 56.1 41.5 45.7 38.0 41.2 30.2 27.2 38.7 35.8 50.6 18.9 30.3 28.2 46.2 45.9 24.1 19.4 34.9 3.9 21.5 10.0 27.3 2.7 34.3 46.6 46.7 35.0 26.5 27.8 33.2 23.1 79.0 37.1 38.1 44.3 48.5 64.1 3.6 41.7 35.1 43.9 24.4 42.4 41.9 38.2 31.6 33.6 29.3 15.7 6.5 27.0 6.0 15.1 33.1 16.6 39.6 51.0 23.8 CTCF ENSG00000102974 "CCCTC-binding factor" P49711 16 67562407-67639185 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Chromosome partition, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004122, CAB062550, CAB068181, CAB068182" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB062550: AB_2665624, CAB068181: AB_2665625, CAB068182: AB_2665626, HPA004122: AB_2667139" "unprognostic (2.70e-1)" "unprognostic (4.21e-2)" "unprognostic (3.41e-2)" "unprognostic (4.70e-2)" "unprognostic (4.41e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (1.71e-2)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (1.36e-2)" "unprognostic (1.99e-2)" "prognostic favorable (4.06e-4)" "unprognostic (3.47e-1)" "unprognostic (5.99e-2)" "unprognostic (4.58e-2)" "unprognostic (1.11e-2)" 19.1 17.5 22.3 35.0 24.3 32.2 20.2 31.6 26.6 23.0 19.4 20.5 21.0 16.5 24.2 15.4 23.1 21.7 20.3 17.6 21.8 16.7 19.5 19.5 17.2 27.9 22.3 21.0 24.6 21.2 42.4 21.8 23.5 17.9 19.4 23.2 14.3 19.9 24.9 29.4 25.2 21.4 22.0 20.2 26.1 18.5 14.8 22.9 68.8 20.7 16.2 35.5 22.6 26.7 10.1 7.9 9.6 6.2 4.9 7.2 1.9 11.0 17.1 22.8 9.0 10.4 8.9 18.5 10.6 11.3 15.7 15.0 14.0 11.5 34.7 8.6 9.2 8.9 14.4 21.9 11.9 17.7 12.3 14.4 21.1 9.7 16.0 7.1 23.8 20.2 7.2 14.5 11.7 13.1 9.4 11.9 27.9 18.4 14.5 13.0 21.7 50.0 9.1 19.8 12.7 11.5 36.6 18.7 19.1 9.6 16.1 19.5 13.5 19.2 11.2 9.3 12.5 13.8 14.8 11.3 13.6 14.1 10.3 11.6 12.7 15.9 50.6 7.8 14.3 14.5 9.4 3.4 4.9 6.7 3.4 6.3 7.9 7.2 5.4 3.1 10.1 5.9 6.7 9.6 4.9 6.2 7.9 5.4 1.9 22.3 24.3 31.6 26.6 21.8 16.7 22.3 21.0 17.9 22.9 20.8 28.0 26.8 21.6 19.8 33.6 32.3 38.2 17.4 38.7 22.7 7.9 20.9 16.6 25.5 0.9 30.1 18.7 46.7 29.1 27.5 18.8 26.1 18.5 21.3 20.8 42.9 30.0 20.3 23.2 2.0 23.0 23.7 11.8 24.4 25.6 30.4 26.6 14.0 26.9 19.5 27.1 19.4 21.7 15.8 25.6 21.7 24.7 32.3 21.2 29.4 CTDSP1 "NLIIF, SCP1" ENSG00000144579 "CTD small phosphatase 1" Q9GZU7 2 218398256-218405941 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062654 Supported Nucleoplasm NA NA Nucleoplasm "HPA062654: AB_2684819" "unprognostic (1.97e-2)" "unprognostic (4.02e-2)" "unprognostic (1.67e-3)" "unprognostic (2.62e-2)" "unprognostic (1.49e-1)" "unprognostic (1.82e-2)" "unprognostic (3.90e-2)" "unprognostic (8.69e-2)" "unprognostic (2.98e-1)" "unprognostic (6.38e-2)" "unprognostic (3.70e-1)" "unprognostic (1.79e-1)" "unprognostic (2.58e-1)" "unprognostic (6.67e-2)" "unprognostic (2.62e-1)" "unprognostic (7.01e-2)" "unprognostic (1.57e-1)" 32.9 22.5 15.9 21.9 13.9 19.9 41.1 12.2 16.4 34.8 30.7 27.6 31.8 24.2 34.5 30.7 31.3 30.9 43.4 25.9 15.5 8.6 34.1 47.5 30.2 33.2 15.0 13.1 44.9 50.8 28.8 12.6 71.3 15.9 41.5 19.8 35.4 34.3 31.5 23.2 30.5 41.3 33.7 12.4 39.1 34.2 15.1 16.1 33.2 41.0 27.2 29.9 32.5 28.4 3.4 6.6 29.3 12.4 6.7 11.0 7.5 10.3 13.3 7.8 25.8 21.4 20.0 29.6 13.9 20.0 13.4 11.7 17.3 25.8 6.2 12.1 24.5 9.2 21.1 11.6 16.7 6.9 22.2 9.1 23.8 16.3 23.1 25.7 14.6 33.4 22.7 20.4 10.2 11.5 21.3 19.7 9.8 19.3 22.4 14.2 28.9 12.8 42.7 5.5 16.5 13.7 17.7 11.1 13.5 17.1 12.7 5.2 13.1 12.1 26.4 13.1 10.4 14.5 35.2 17.2 21.4 13.1 16.3 6.0 14.4 9.3 14.7 19.1 13.9 11.8 20.3 12.4 29.3 11.0 10.2 7.1 3.4 6.7 7.0 6.6 3.2 4.3 5.7 24.5 6.7 10.4 2.3 5.6 7.5 15.9 13.9 12.2 16.4 15.5 8.6 15.0 13.1 15.9 16.1 41.7 40.2 27.7 26.3 24.3 14.0 27.9 45.9 9.4 20.5 29.6 2.0 35.7 28.2 31.7 1.5 43.6 72.4 46.7 37.2 35.9 36.1 31.8 17.4 49.9 35.0 6.4 20.8 58.3 79.9 2.0 55.0 36.2 32.1 26.2 44.5 46.7 32.1 35.1 41.4 42.5 24.7 25.8 34.0 1.6 4.7 17.8 45.4 46.7 37.6 26.7 CTDSPL2 "FLJ10523, HSPC129" ENSG00000137770 "CTD small phosphatase like 2" Q05D32 15 44427234-44529038 "Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 155.1;Late spermatids: 125.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040763, HPA062198" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040763: AB_10960989, HPA062198: AB_2684708" "unprognostic (6.64e-2)" "unprognostic (4.30e-2)" "unprognostic (1.43e-1)" "unprognostic (2.06e-1)" "unprognostic (7.39e-3)" "unprognostic (5.20e-2)" "unprognostic (7.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.37e-2)" "unprognostic (2.54e-2)" "unprognostic (3.68e-3)" "unprognostic (5.35e-2)" "unprognostic (8.36e-3)" "unprognostic (7.49e-2)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" "unprognostic (1.16e-1)" 17.4 11.1 13.0 15.9 16.3 19.8 17.0 33.2 18.4 17.7 14.2 11.6 15.7 11.2 21.3 13.3 14.6 15.4 13.3 11.8 11.5 9.3 12.8 11.5 14.3 20.1 13.4 10.7 22.7 13.0 13.4 21.1 17.6 11.6 14.7 12.8 12.2 15.6 12.7 17.9 16.0 14.9 16.0 11.6 16.5 11.8 21.7 13.8 35.5 17.4 9.7 20.9 18.4 15.8 12.3 16.0 10.3 13.1 17.0 16.5 11.2 11.0 5.5 23.3 11.7 3.6 8.3 12.9 11.4 9.9 14.9 19.0 11.2 10.4 11.7 11.0 8.1 8.4 15.7 13.4 7.8 17.6 11.6 6.3 14.6 14.5 6.9 5.2 25.1 13.0 6.6 5.9 10.4 13.8 6.5 11.5 15.2 16.9 13.2 10.8 4.7 29.8 8.7 12.3 11.9 7.9 33.4 32.1 10.8 7.9 14.8 10.6 15.7 14.1 11.6 6.5 9.0 15.6 22.8 9.8 18.5 20.1 17.7 19.3 7.8 29.5 36.0 8.7 19.9 14.2 6.0 12.8 10.3 12.7 13.1 11.9 12.3 12.4 11.5 16.0 12.1 13.4 15.0 9.0 17.0 9.9 10.2 16.5 11.2 13.0 16.3 33.2 18.4 11.5 9.3 13.4 10.7 11.6 13.8 17.9 29.4 18.2 12.4 21.9 22.2 21.8 12.7 22.7 43.3 12.2 9.8 15.1 14.9 10.2 155.1 21.2 12.0 0.0 12.6 16.2 20.7 15.1 33.7 11.5 11.8 28.6 8.6 17.8 21.6 125.2 18.7 17.5 15.1 18.0 12.7 18.4 13.2 8.6 12.4 9.8 28.3 25.8 14.1 18.1 34.2 19.2 12.2 22.4 13.8 12.9 CTHRC1 ENSG00000164932 "Collagen triple helix repeat containing 1" Q96CG8 8 103371515-103382997 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Endothelial cells: 36.6;Fibroblasts: 168.4;Melanocytes: 47.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 2.3;NK-cell: 5.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.3;NK-cells: 5.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 56.2;fHDF/TERT166: 24.7;HHSteC: 37.4;HSkMC: 77.1;WM-115: 70.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059806, HPA061896" Approved Approved Nucleoplasm "Secreted in other tissues" NA NA 320000 Nucleoplasm "HPA059806: AB_2684130, HPA061896: AB_2684633" "unprognostic (2.04e-2)" "unprognostic (4.58e-1)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (1.67e-4)" "unprognostic (4.17e-2)" "unprognostic (3.64e-2)" "unprognostic (8.63e-2)" "unprognostic (1.12e-2)" "unprognostic (3.73e-2)" "prognostic unfavorable (1.22e-14)" "unprognostic (2.33e-3)" "unprognostic (3.21e-2)" "unprognostic (7.96e-3)" "unprognostic (2.37e-3)" 35.1 1.4 1.1 5.2 1.1 0.0 32.3 0.8 2.3 5.3 3.8 0.5 3.0 2.0 6.9 11.2 3.5 3.0 33.0 4.2 1.1 1.6 2.0 0.7 4.5 7.6 1.6 1.3 3.7 2.1 0.3 2.1 32.2 1.9 4.0 2.1 2.6 23.0 4.2 9.2 17.4 2.1 8.4 2.6 1.4 1.8 8.4 0.8 2.2 4.8 3.7 5.4 31.3 3.6 0.2 0.7 2.3 0.0 5.2 0.4 0.3 2.1 0.1 0.6 0.1 16.9 56.2 0.0 6.3 1.7 0.6 0.9 0.2 1.5 0.2 6.7 24.7 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.1 3.4 37.4 0.1 0.1 77.1 0.1 5.7 0.0 0.2 11.0 0.4 0.0 17.0 3.4 0.3 3.0 7.3 2.0 0.0 10.6 6.4 5.7 0.2 0.5 0.0 1.0 0.8 0.0 0.0 18.9 2.4 0.0 0.0 8.9 0.8 0.3 0.9 0.0 0.5 0.1 0.1 0.4 0.0 70.8 0.0 0.0 2.3 0.1 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.2 0.3 0.1 5.2 0.0 0.7 0.0 0.3 1.1 1.1 0.8 2.3 1.1 1.6 1.6 1.3 1.9 0.8 3.0 2.9 0.0 0.1 28.4 0.3 0.6 2.5 0.0 0.0 3.5 0.0 5.6 0.0 4.4 0.3 36.6 0.0 0.0 0.6 8.9 168.4 0.6 0.0 0.0 7.0 0.0 1.2 26.4 0.3 0.2 11.5 1.7 47.2 1.0 0.0 5.5 2.4 0.0 0.4 0.3 1.0 0.0 24.7 1.6 15.6 23.8 13.8 0.0 0.0 0.4 CTR9 "KIAA0155, p150TSP, SH2BP1, TSBP" ENSG00000198730 "CTR9 homolog, Paf1/RNA polymerase II complex component" Q6PD62 11 10750987-10801625 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061027, HPA068122" Supported Enhanced Nucleoplasm No No Nucleoplasm "HPA061027: AB_2684418, HPA068122: AB_2685959" "unprognostic (1.92e-1)" "unprognostic (1.82e-1)" "unprognostic (2.89e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.58e-1)" "unprognostic (6.27e-2)" "unprognostic (2.42e-1)" "unprognostic (5.26e-2)" "unprognostic (2.80e-1)" "unprognostic (2.63e-1)" "unprognostic (7.27e-2)" "prognostic favorable (3.65e-6)" "unprognostic (6.88e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" 16.7 26.7 15.9 19.9 17.4 18.4 26.1 17.5 17.1 21.5 15.8 13.0 20.3 14.2 21.4 44.1 23.7 17.7 13.7 24.2 18.8 14.8 20.5 35.0 15.6 23.8 14.3 14.0 25.4 18.8 36.5 31.4 26.7 16.0 17.5 16.4 14.0 19.1 20.2 24.0 18.3 19.2 16.6 15.7 26.6 17.6 24.4 15.8 39.1 20.9 13.1 21.9 19.6 21.1 11.9 11.9 27.2 12.1 17.5 18.5 9.5 13.0 10.2 14.7 13.9 32.2 12.9 7.2 14.6 9.7 11.8 12.5 16.8 28.1 11.9 8.0 12.0 14.4 13.6 18.0 11.9 19.3 18.3 21.6 60.8 10.8 9.5 10.3 23.8 33.8 11.9 9.8 7.5 10.3 10.9 13.5 11.6 24.5 14.6 14.2 5.9 15.2 9.3 12.2 15.8 12.8 14.1 17.9 8.2 10.2 18.0 6.7 16.1 13.2 13.1 10.2 14.7 11.6 10.5 13.2 10.0 10.3 17.5 7.8 8.0 18.8 13.1 10.7 16.1 10.2 27.2 10.0 19.8 14.1 12.1 18.5 11.6 14.9 13.6 11.9 11.9 14.7 13.8 7.5 17.5 11.2 6.0 12.4 9.5 15.9 17.4 17.5 17.1 18.8 14.8 14.3 14.0 16.0 15.8 53.6 45.6 25.3 36.7 77.4 33.6 39.1 22.9 36.1 45.5 24.4 53.0 31.1 16.6 23.4 13.7 23.9 23.8 0.0 21.3 20.2 22.3 24.0 80.1 34.2 25.0 60.4 25.8 26.4 28.9 6.8 31.1 22.9 11.8 22.6 34.5 29.0 21.5 20.3 29.4 15.6 45.5 25.8 23.6 72.8 63.9 70.9 38.2 33.1 21.5 27.6 CUL2 ENSG00000108094 "Cullin 2" Q13617 10 35008551-35090642 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 245.9;Late spermatids: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002677, HPA024578" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002677: , HPA024578: AB_1847338" "unprognostic (8.11e-3)" "unprognostic (1.12e-1)" "unprognostic (9.77e-2)" "unprognostic (1.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (8.24e-6)" "unprognostic (2.18e-1)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (4.70e-2)" "unprognostic (6.94e-2)" "prognostic unfavorable (9.32e-5)" "unprognostic (2.26e-2)" "unprognostic (2.31e-1)" "unprognostic (3.70e-1)" "unprognostic (2.29e-1)" 16.2 14.9 17.2 12.6 22.6 14.3 13.6 16.8 20.9 11.6 14.3 9.0 18.1 11.9 13.6 9.5 14.3 12.1 10.1 15.7 15.4 15.1 12.2 17.2 11.9 15.4 14.3 20.8 12.9 17.7 21.4 19.3 21.9 17.3 13.3 13.0 7.0 12.8 14.1 33.7 14.2 12.4 16.1 14.0 15.1 14.5 27.9 15.4 20.3 13.7 14.4 16.6 15.6 12.3 11.4 11.9 10.0 13.7 11.3 17.4 7.7 20.0 11.9 15.7 13.5 18.0 19.9 16.7 23.8 13.3 23.6 23.8 15.9 19.3 16.0 13.2 25.1 17.3 18.6 22.8 21.9 27.1 18.8 14.9 20.9 12.9 14.0 19.8 11.3 13.8 19.1 18.3 25.8 9.0 18.2 26.2 17.1 23.9 14.6 25.7 13.7 18.8 6.3 5.7 13.9 48.8 15.9 25.5 10.0 21.6 15.8 7.7 10.3 13.3 16.8 18.7 18.3 12.7 13.0 24.0 14.6 16.3 24.9 15.5 6.1 8.3 19.3 28.1 25.7 10.2 9.6 9.3 10.0 12.3 13.7 17.4 10.8 14.0 14.7 11.9 11.4 16.7 15.5 4.4 11.3 13.3 5.4 16.6 7.7 17.2 22.6 16.8 20.9 15.4 15.1 14.3 20.8 17.3 15.4 20.8 9.3 10.7 8.3 10.6 12.2 23.2 7.6 22.7 22.7 8.7 9.8 21.0 13.3 16.2 245.9 19.5 10.6 0.0 15.5 16.7 11.8 7.8 19.7 17.9 17.5 22.3 10.3 12.9 19.7 133.1 13.0 19.8 10.1 24.4 9.5 15.3 15.9 7.0 11.0 11.5 13.0 0.0 14.1 33.9 31.3 11.4 31.0 18.1 11.5 8.1 CUL4A ENSG00000139842 "Cullin 4A" Q13619 13 113208193-113267108 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058979 Approved Nucleoplasm NA NA Nucleoplasm "HPA058979: AB_2683868" "unprognostic (3.01e-1)" "unprognostic (5.93e-3)" "unprognostic (6.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.19e-1)" "unprognostic (2.53e-2)" "unprognostic (6.41e-3)" "unprognostic (6.77e-2)" "unprognostic (1.45e-1)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "unprognostic (5.16e-3)" "unprognostic (3.57e-3)" "prognostic favorable (2.84e-4)" "unprognostic (2.95e-1)" "unprognostic (3.91e-2)" "unprognostic (3.48e-1)" 14.6 13.5 9.7 13.9 12.0 20.7 16.5 13.2 10.0 12.0 13.6 12.6 16.1 10.5 13.5 14.4 14.7 11.9 15.0 36.8 8.6 8.4 14.1 23.6 13.3 15.8 10.1 7.0 12.6 23.8 11.2 13.4 13.3 10.6 13.7 11.8 11.2 15.8 15.6 70.5 16.8 12.8 21.7 10.7 13.8 14.0 18.0 9.7 12.8 13.3 25.7 17.4 14.3 15.7 11.7 11.9 11.8 19.3 10.8 22.8 15.4 35.1 18.1 16.7 14.9 20.3 22.8 22.4 36.1 26.0 30.2 23.2 31.2 28.8 42.9 15.7 30.1 29.6 22.5 25.5 19.1 27.4 19.1 25.7 29.0 37.9 23.7 24.3 44.2 19.6 16.4 23.1 17.7 27.3 19.8 19.8 15.8 28.6 8.4 29.2 16.3 22.7 38.7 15.9 47.5 18.2 23.5 18.0 19.9 20.2 16.0 25.5 14.9 18.3 39.1 17.0 15.0 28.7 45.8 28.3 14.9 31.3 16.4 19.8 22.4 16.8 37.8 32.8 35.9 23.1 8.4 13.2 11.8 20.1 19.1 18.6 11.7 20.3 22.8 11.9 10.6 17.1 20.4 4.8 10.8 19.3 9.1 13.2 15.4 9.7 12.0 13.2 10.0 8.6 8.4 10.1 7.0 10.6 9.7 26.8 35.5 13.4 24.4 41.2 13.9 122.7 30.6 18.7 15.9 33.2 9.8 28.7 21.6 25.7 51.2 27.4 20.6 0.0 32.1 30.6 27.2 43.5 10.5 51.3 26.9 27.0 23.0 20.9 47.0 92.3 33.1 25.6 37.1 20.8 33.3 12.5 32.0 17.5 29.7 22.8 17.7 32.3 31.5 57.1 24.5 52.4 33.2 20.6 29.3 36.0 CUL4B ENSG00000158290 "Cullin 4B" Q13620 X 120524609-120575794 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 78.2;Late spermatids: 113.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003046, HPA011880, CAB017786, HPA058979" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: AB_2683868" "unprognostic (2.34e-2)" "unprognostic (2.74e-2)" "unprognostic (2.69e-2)" "unprognostic (7.73e-3)" "unprognostic (9.66e-2)" "unprognostic (3.91e-1)" "unprognostic (3.88e-3)" "unprognostic (8.99e-2)" "unprognostic (8.12e-3)" "unprognostic (3.20e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-1)" "unprognostic (2.87e-3)" "unprognostic (3.83e-2)" "unprognostic (1.35e-1)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" 20.9 24.0 19.0 19.2 28.1 12.2 25.3 28.9 25.7 32.6 20.5 12.1 25.7 14.0 24.2 47.2 29.3 19.6 18.5 19.4 18.5 20.2 19.1 20.4 23.8 23.5 17.3 20.4 30.1 18.8 34.4 48.3 17.0 18.4 30.8 17.2 15.7 17.3 27.3 10.8 17.7 16.3 36.0 20.5 19.9 17.0 34.0 17.3 29.8 18.8 13.9 24.1 40.4 22.5 7.6 12.5 15.4 4.3 5.5 8.3 4.9 11.8 10.0 8.4 8.9 36.9 18.8 6.7 26.9 32.3 22.3 23.3 9.0 33.7 11.9 9.2 61.9 39.5 8.8 17.1 7.9 25.4 6.9 8.9 5.8 14.6 6.4 16.0 6.2 8.3 20.9 6.0 12.8 11.1 40.3 39.8 6.4 8.9 9.3 21.5 6.3 8.1 6.5 12.7 13.4 10.2 6.9 8.3 12.1 7.4 5.9 9.5 8.0 19.9 9.8 9.8 10.9 8.3 5.7 52.4 16.0 8.9 21.4 24.1 5.9 10.3 14.8 17.4 8.5 14.4 5.8 4.3 9.0 7.2 3.8 7.7 7.6 7.0 6.6 5.1 5.7 7.9 8.3 15.4 5.5 2.7 12.5 8.2 4.9 19.0 28.1 28.9 25.7 18.5 20.2 17.3 20.4 18.4 17.3 20.8 11.8 6.0 8.4 13.5 15.6 14.3 7.6 17.4 9.1 14.0 13.7 8.8 11.6 8.5 78.2 15.7 9.9 0.0 7.7 19.0 13.1 10.1 13.9 13.5 14.7 23.8 23.6 43.0 28.3 113.1 19.8 13.7 11.8 8.2 16.6 13.0 13.8 3.5 20.1 9.8 12.9 12.9 13.4 11.3 12.1 12.0 8.4 12.9 13.0 8.3 CWC27 "NY-CO-10, SDCCAG-10, SDCCAG10" ENSG00000153015 "CWC27 spliceosome associated protein homolog" Q6UX04 5 64768930-65018763 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Disease mutation, Dwarfism, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 197.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020344, HPA024149, HPA065809" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561" "unprognostic (1.71e-1)" "unprognostic (6.47e-3)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (8.91e-2)" "unprognostic (4.00e-3)" "prognostic unfavorable (5.27e-6)" "unprognostic (1.58e-2)" "unprognostic (3.43e-2)" "unprognostic (1.21e-1)" "unprognostic (1.48e-2)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (2.46e-1)" "unprognostic (2.05e-1)" "unprognostic (2.74e-1)" "unprognostic (7.45e-3)" 15.6 16.4 22.0 14.9 30.4 21.7 16.4 30.1 25.6 16.5 17.5 13.8 14.0 11.8 19.4 15.7 17.3 14.9 13.8 22.1 20.6 19.9 17.5 12.1 12.8 17.0 22.3 20.7 23.3 10.9 21.4 28.8 17.5 26.2 18.6 18.7 11.4 13.3 16.0 24.0 13.8 15.9 24.7 23.3 15.0 13.9 19.6 23.6 22.5 17.2 18.2 18.6 18.6 20.0 15.1 14.6 8.6 11.5 17.0 15.9 9.0 15.2 10.2 18.4 34.0 15.8 19.3 20.5 16.1 13.4 18.0 19.0 17.0 19.4 22.7 28.2 16.7 20.3 9.7 19.2 29.1 32.9 18.9 15.7 17.0 17.2 14.1 24.2 17.8 11.6 12.8 22.4 22.7 28.9 16.0 19.0 26.0 16.5 15.0 17.8 15.2 24.7 16.1 14.9 8.0 12.4 23.0 24.7 23.6 17.1 13.3 21.9 9.7 19.6 8.0 18.1 18.3 17.4 26.2 15.8 10.6 18.7 16.9 25.6 11.7 15.2 22.3 19.9 31.3 18.8 8.6 11.5 7.9 12.8 11.3 15.5 15.1 14.2 15.9 14.6 11.9 15.4 15.9 2.5 17.0 8.5 12.0 15.1 9.0 22.0 30.4 30.1 25.6 20.6 19.9 22.3 20.7 26.2 23.6 8.9 25.8 20.1 22.0 14.5 30.0 55.8 20.4 33.5 14.8 14.0 13.7 36.6 18.3 35.9 197.3 26.9 10.5 23.3 28.8 45.9 24.6 20.8 18.5 10.5 28.6 19.1 28.7 14.1 17.2 37.1 35.6 23.8 13.5 29.7 16.0 31.3 33.5 10.5 33.9 21.9 53.9 32.3 28.4 43.0 28.9 17.6 25.7 23.6 26.6 17.4 CXorf58 FLJ25444 ENSG00000165182 "Chromosome X open reading frame 58" Q96LI9 X 23907801-23939507 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 8.4" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 18.3;Spermatocytes: 20.0;Spermatogonia: 5.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "monocytes: 1.0;T-cells: 1.8" "Cell line enhanced" "Detected in some" "GAMG: 4.4;PC-3: 2.0;U-266/70: 1.9" "HPA031542, HPA031543, HPA031544" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031542: AB_2673927, HPA031543: AB_10603789, HPA031544: AB_2673929" "unprognostic (9.74e-2)" "unprognostic (9.17e-3)" "unprognostic (2.52e-1)" "unprognostic (3.64e-2)" "unprognostic (1.90e-2)" "unprognostic (1.24e-1)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-2)" "unprognostic (1.43e-1)" "unprognostic (4.14e-3)" "unprognostic (8.19e-2)" "unprognostic (3.82e-2)" "unprognostic (1.10e-1)" "unprognostic (3.21e-2)" "unprognostic (7.39e-2)" "unprognostic (5.06e-3)" 0.1 0.4 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.2 0.2 0.3 0.6 0.2 0.1 0.0 0.2 0.0 0.4 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.0 8.4 0.6 0.0 0.2 0.0 0.1 0.2 0.1 1.0 0.0 1.8 0.1 0.7 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.3 0.1 0.1 0.0 0.8 1.0 0.2 0.0 4.4 0.5 0.1 0.7 0.0 0.4 0.5 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.7 0.6 0.5 0.0 0.0 1.6 0.3 0.2 0.1 0.1 0.1 0.8 0.0 0.1 2.0 0.4 0.0 0.1 1.0 0.0 0.9 0.1 0.5 0.1 0.4 0.1 1.1 0.1 0.4 0.0 0.0 0.2 0.3 1.9 0.9 0.2 0.2 0.1 0.3 0.0 0.0 0.1 0.3 1.0 1.4 0.1 1.3 1.0 0.0 0.1 1.0 0.7 0.0 0.0 0.2 0.2 1.8 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 4.0 0.0 0.0 0.0 0.1 1.7 0.0 18.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 1.0 0.0 0.5 0.1 0.0 0.0 0.0 2.3 0.0 0.0 20.0 5.2 0.0 0.1 0.0 0.0 0.0 CXorf67 ENSG00000187690 "Chromosome X open reading frame 67" Q86X51 X 51406915-51408843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 14.3;testis: 21.4" "Group enriched" "Detected in some" 5 "Sertoli cells: 6.5;Spermatocytes: 4.9;Spermatogonia: 15.6" "Cancer enriched" "Detected in some" 6 "testis cancer: 11.4" "Region enriched" "Detected in single" 5 "cerebellum: 2.8" "Cell type enhanced" "Detected in some" "memory B-cell: 1.1;naive CD4 T-cell: 1.2" "Group enriched" "Detected in many" 11 "B-cells: 1.1;T-cells: 1.2" "Cell line enriched" "Detected in single" 46 "U-2 OS: 27.7" "HPA004003, HPA006128" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004003: AB_2667113, HPA006128: AB_2667517" "unprognostic (4.21e-2)" "unprognostic (6.36e-2)" "unprognostic (3.37e-2)" "unprognostic (8.58e-3)" "unprognostic (3.57e-4)" "unprognostic (1.47e-6)" "unprognostic (4.55e-2)" "unprognostic (3.06e-2)" "unprognostic (4.26e-1)" 0.1 0.2 0.3 0.2 0.6 0.1 0.1 2.8 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.4 0.1 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.2 0.2 0.2 0.1 0.7 0.1 0.0 1.5 14.3 0.1 0.4 0.1 0.1 0.9 0.2 0.1 0.2 0.2 0.1 0.4 0.7 0.1 21.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.1 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.7 1.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.6 2.8 0.4 0.3 0.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 6.5 0.0 4.9 15.6 0.0 1.6 0.0 0.0 0.0 CXXC1 "CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1" ENSG00000154832 "CXXC finger protein 1" Q9P0U4 18 50282343-50288304 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044511 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044511: AB_10963081" "unprognostic (4.47e-2)" "unprognostic (1.83e-2)" "unprognostic (1.69e-2)" "unprognostic (1.36e-2)" "unprognostic (1.99e-1)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.18e-6)" "unprognostic (3.82e-1)" "unprognostic (3.24e-1)" "unprognostic (5.08e-2)" "prognostic favorable (2.60e-4)" "unprognostic (1.10e-2)" "unprognostic (1.00e-1)" "unprognostic (3.83e-2)" "unprognostic (2.07e-1)" "unprognostic (2.12e-1)" "unprognostic (2.41e-2)" 12.1 16.9 17.5 20.0 20.3 40.3 12.4 42.4 23.1 15.7 15.2 15.7 18.7 18.3 16.8 10.2 15.5 19.8 17.5 13.6 18.2 12.2 16.5 14.9 13.9 23.6 22.6 13.1 23.6 32.8 13.7 14.3 22.4 18.7 15.6 9.1 14.1 24.7 19.4 12.1 17.2 15.1 17.7 11.7 19.3 17.3 15.5 20.3 25.8 15.5 14.0 18.6 17.5 20.1 22.0 16.6 24.5 16.9 16.0 21.1 15.0 8.3 11.3 8.6 16.2 7.0 4.9 17.8 11.0 7.6 11.0 9.7 8.3 6.3 23.7 5.7 5.0 6.5 13.7 14.3 10.4 3.1 19.4 12.7 19.1 12.4 13.1 5.0 44.7 20.8 4.8 8.1 12.0 6.2 4.0 7.4 18.7 11.8 20.3 5.5 11.8 26.5 22.0 18.9 4.2 7.6 26.7 8.9 19.1 5.9 5.0 18.1 17.4 8.6 5.6 6.9 5.1 7.1 18.9 11.2 15.4 9.8 6.8 9.3 35.0 24.6 19.5 9.7 16.6 13.1 17.7 14.1 24.5 19.2 16.9 21.1 22.0 17.7 19.3 16.6 21.7 19.6 16.2 6.2 16.0 13.1 12.1 19.6 15.0 17.5 20.3 42.4 23.1 18.2 12.2 22.6 13.1 18.7 20.3 17.9 27.2 14.9 11.2 23.8 13.6 6.3 12.7 13.4 20.5 17.4 13.7 32.2 11.6 16.2 12.1 17.9 26.6 0.0 19.0 32.2 14.6 10.7 8.1 12.8 19.3 7.9 33.9 16.0 17.5 7.0 18.4 21.2 8.5 16.2 22.0 17.1 18.2 22.4 18.4 10.6 11.7 6.5 16.4 48.7 18.1 26.3 31.0 27.4 23.1 9.4 CYB5RL LOC606495 ENSG00000215883 "Cytochrome b5 reductase like" Q6IPT4 1 54169651-54200036 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 9.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042671, HPA060463" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042671: AB_2678107, HPA060463: AB_2684286" "unprognostic (2.03e-1)" "unprognostic (1.36e-1)" "unprognostic (1.72e-2)" "unprognostic (1.84e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-3)" "unprognostic (1.90e-4)" "unprognostic (6.45e-3)" "unprognostic (9.75e-2)" "unprognostic (2.04e-1)" "unprognostic (5.93e-2)" "unprognostic (2.58e-1)" "unprognostic (2.35e-1)" "unprognostic (1.80e-2)" "unprognostic (5.08e-2)" "unprognostic (5.74e-2)" "unprognostic (2.86e-1)" 1.7 4.9 1.9 0.8 1.9 1.6 2.4 1.3 1.7 2.5 2.2 2.6 2.5 2.3 2.1 2.9 2.0 3.5 2.1 1.7 2.7 2.6 1.5 2.1 2.3 5.0 4.1 1.8 4.2 1.1 2.1 2.7 3.2 1.4 3.7 3.9 1.5 2.4 1.8 2.5 2.8 1.2 3.1 2.2 2.8 1.8 1.4 1.8 2.6 3.5 3.1 1.5 1.2 3.9 5.3 7.3 7.5 5.9 5.7 2.5 3.1 4.5 6.1 6.6 4.9 4.3 6.6 3.7 2.1 13.9 3.6 11.3 3.3 6.9 7.4 4.6 7.5 8.5 5.0 4.4 6.3 3.8 3.0 4.4 7.2 3.3 4.3 5.3 6.0 8.0 3.1 4.4 4.8 6.3 3.5 7.2 4.5 4.2 10.2 8.9 6.0 2.7 4.5 10.7 5.3 2.1 7.2 6.3 6.1 5.0 4.9 2.4 4.7 3.8 6.9 5.5 4.7 7.5 9.7 5.2 13.6 7.1 2.2 1.8 1.6 1.0 3.5 0.8 1.1 1.5 0.6 1.6 1.4 1.2 1.2 2.6 3.1 0.8 1.8 0.5 1.2 0.0 7.4 0.9 1.0 0.1 3.7 4.2 0.0 9.4 4.5 3.5 3.9 1.5 6.6 2.4 0.0 3.6 0.9 0.0 3.6 1.7 1.5 1.1 2.3 2.1 4.6 0.0 2.4 3.1 1.0 0.6 1.4 1.4 0.0 1.0 0.7 2.0 1.3 0.0 1.8 2.2 3.1 0.0 1.4 0.9 5.3 0.6 0.2 0.5 2.4 0.8 CYHR1 "CHRP, KIAA0496, MGC13010" ENSG00000187954 "Cysteine and histidine rich 1" Q6ZMK1 8 144449582-144465677 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053653, HPA059543" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053653: AB_2682219, HPA059543: AB_2684056" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.58e-2)" "unprognostic (8.28e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.90e-4)" "unprognostic (4.02e-2)" "unprognostic (2.63e-1)" "unprognostic (2.13e-1)" "unprognostic (7.08e-3)" "unprognostic (1.46e-1)" "unprognostic (5.33e-2)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (1.54e-2)" 18.7 26.9 30.3 10.9 30.2 10.3 15.8 49.5 29.5 19.4 16.6 21.4 40.6 14.7 17.1 25.3 15.3 24.3 17.2 33.4 26.4 20.3 16.4 17.2 14.1 13.9 22.0 21.5 19.3 40.2 29.1 28.2 11.2 22.3 28.3 9.5 16.9 40.4 41.6 35.3 22.9 14.5 17.2 16.1 14.7 16.3 26.9 25.6 10.1 19.5 13.8 11.7 19.6 15.8 10.1 19.1 4.8 8.7 3.3 17.4 7.0 11.4 14.8 9.5 12.1 17.0 11.9 12.3 8.4 8.5 7.9 10.6 6.5 16.3 5.3 17.1 12.5 10.3 17.6 7.8 12.7 3.2 12.7 13.1 11.8 17.3 11.3 24.7 3.1 6.5 20.9 16.3 10.2 12.7 17.2 9.3 14.8 17.9 14.6 7.8 27.4 14.9 8.6 6.4 17.9 30.2 14.4 4.0 13.9 12.1 10.6 14.3 8.6 17.8 14.2 18.7 7.8 19.5 12.8 10.8 10.4 11.4 11.3 8.5 7.4 4.9 4.2 14.8 10.8 7.8 2.1 8.7 4.8 7.2 5.6 11.6 9.7 8.9 5.9 9.0 10.1 17.4 9.6 4.4 3.3 6.2 19.1 3.5 7.0 30.3 30.2 49.5 29.5 26.4 20.3 22.0 21.5 22.3 25.6 32.8 21.6 16.6 38.3 27.1 79.2 16.5 38.2 34.8 27.3 55.8 23.6 26.6 36.5 23.2 7.8 28.7 37.7 0.0 24.8 16.3 32.4 46.0 4.7 42.0 22.3 85.8 32.4 36.8 20.6 29.7 46.9 19.0 25.3 32.5 43.9 110.9 24.4 42.1 37.4 30.5 50.8 38.8 24.7 39.5 25.6 33.9 14.0 19.5 43.5 27.8 CYYR1 C21orf95 ENSG00000166265 "Cysteine and tyrosine rich 1" Q96J86 21 26466209-26573284 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "breast: 59.8" "Group enriched" "Detected in many" 6 "Endothelial cells: 113.7;Ito cells: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 38 "plasmacytoid DC: 21.1" "Lineage enriched" "Detected in single" 73 "dendritic cells: 21.1" "Cell line enhanced" "Detected in some" "AF22: 9.0;NTERA-2: 25.2;PC-3: 6.9;RH-30: 10.7;SCLC-21H: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034921, HPA067685" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB034921: AB_2089315, HPA067685: AB_2685887" "unprognostic (5.64e-2)" "unprognostic (2.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (2.63e-2)" "unprognostic (2.88e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.46e-1)" "unprognostic (2.44e-3)" "unprognostic (9.29e-3)" "unprognostic (2.26e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" 30.9 28.9 3.8 7.7 4.4 4.0 59.8 2.1 4.3 19.0 8.4 2.7 13.4 3.5 15.1 14.7 13.1 8.6 10.8 29.1 4.7 3.9 10.6 7.1 23.8 13.4 5.6 2.5 9.8 4.5 5.1 3.5 21.7 3.9 11.7 4.0 11.6 5.4 10.5 14.5 4.8 6.8 14.6 5.0 34.1 5.9 9.2 2.5 3.6 11.2 9.1 2.7 11.2 23.9 0.0 21.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.0 0.2 0.0 3.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 25.2 0.0 6.9 0.0 10.7 0.0 1.0 0.0 21.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 21.1 0.0 0.0 3.8 4.4 2.1 4.3 4.7 3.9 5.6 2.5 3.9 2.5 0.0 1.1 0.9 1.1 10.4 0.0 5.6 0.0 1.4 2.3 14.0 0.0 0.1 3.3 0.0 0.6 113.7 0.0 0.0 0.0 0.2 6.1 0.4 0.0 0.0 0.3 0.0 0.0 60.8 2.7 0.9 2.0 1.2 6.8 1.0 0.0 0.5 0.1 0.0 0.0 2.6 0.0 0.0 3.3 0.2 1.1 4.6 0.2 0.0 0.0 0.7 DACH2 ENSG00000126733 "Dachshund family transcription factor 2" Q96NX9 X 86148458-86832604 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 29.5;epididymis: 9.3;fallopian tube: 8.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 1.3;Horizontal cells: 3.2;Muller glia cells: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HAP1: 11.5" "Low region specificity" "Detected in some" "HPA000258, HPA001367" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA000258: AB_1078618, HPA001367: " "unprognostic (5.73e-3)" "unprognostic (3.22e-1)" "unprognostic (1.54e-6)" "unprognostic (3.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.34e-1)" "unprognostic (7.71e-2)" "unprognostic (6.48e-1)" "unprognostic (3.17e-2)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-2)" "unprognostic (1.28e-1)" "unprognostic (5.74e-3)" "unprognostic (5.01e-3)" "unprognostic (2.63e-2)" 0.9 0.9 7.9 0.6 29.5 0.6 0.6 0.2 17.8 1.0 0.8 0.3 0.0 1.2 1.2 9.3 0.7 8.0 0.6 0.6 13.5 10.8 2.4 0.6 0.9 0.6 3.4 10.4 1.4 1.1 0.7 1.3 0.6 11.8 1.5 0.7 1.6 0.7 0.8 0.6 0.7 1.3 0.8 0.7 0.6 1.4 0.7 1.7 0.0 0.7 0.0 0.6 1.4 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 29.5 0.2 16.8 13.5 10.8 3.4 10.4 11.8 1.7 0.0 0.0 0.0 0.0 0.3 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DACT1 "DAPPER, DAPPER1, FRODO, HDPR1, THYEX3" ENSG00000165617 "Dishevelled binding antagonist of beta catenin 1" Q9NYF0 14 58633967-58648321 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 36.0;Peritubular cells: 26.2;Smooth muscle cells: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 1.9;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;T-cells: 1.9" "Cell line enhanced" "Detected in many" "SK-MEL-30: 9.5;SuSa: 13.4;U-138 MG: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003016, HPA074619" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA003016: AB_1078623, HPA074619: " "unprognostic (2.47e-2)" "unprognostic (2.72e-2)" "unprognostic (1.79e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-2)" "unprognostic (3.55e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-2)" "unprognostic (4.79e-2)" "unprognostic (1.93e-1)" "unprognostic (5.42e-2)" "unprognostic (6.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" 7.1 7.0 5.0 3.2 4.5 1.0 8.7 24.5 6.5 8.2 5.0 2.6 7.0 4.8 7.5 5.1 2.5 4.7 21.4 7.2 3.2 3.0 4.8 3.1 7.4 2.9 4.0 4.6 21.8 2.2 3.5 3.6 9.9 7.8 10.6 5.8 11.5 2.9 11.8 3.5 2.4 4.3 10.0 7.5 5.6 5.7 8.0 3.5 1.6 14.7 1.7 1.8 9.5 12.8 0.4 1.6 0.0 0.0 0.0 1.9 0.1 0.0 0.0 3.0 0.1 3.4 3.8 0.0 1.7 2.1 1.7 1.5 0.2 0.1 0.0 0.1 5.0 3.0 2.5 8.3 0.0 1.0 1.9 1.7 0.0 0.1 0.0 6.2 0.0 1.0 4.4 0.2 6.6 0.0 6.7 0.1 0.5 0.0 0.0 1.2 0.0 0.6 0.0 2.8 0.1 0.7 3.5 4.2 0.0 0.0 0.0 0.0 0.0 4.7 0.0 9.5 13.4 0.0 0.3 0.0 23.8 8.3 0.3 6.0 3.2 1.2 0.0 2.5 1.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 1.6 0.0 0.1 5.0 4.5 24.5 6.5 3.2 3.0 4.0 4.6 7.8 3.5 0.0 0.0 0.0 1.2 0.7 0.2 3.0 5.1 0.0 0.0 1.8 0.0 0.1 0.0 2.3 36.0 0.7 0.0 0.0 2.1 0.5 5.2 0.5 0.0 0.0 1.0 0.0 0.0 4.9 2.2 10.6 11.2 0.4 1.7 0.0 0.9 3.8 2.4 0.0 26.2 0.7 0.3 0.0 15.3 6.1 2.8 1.1 0.1 0.0 0.0 0.3 DAPK3 "ZIP, ZIPK" ENSG00000167657 "Death associated protein kinase 3" O43293 19 3958453-3971123 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation, Translation regulation" "Activator, Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028569, HPA064809" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028569: AB_10794319, HPA064809: AB_2685357" "unprognostic (5.72e-2)" "unprognostic (3.28e-2)" "unprognostic (3.34e-3)" "prognostic favorable (2.01e-5)" "unprognostic (1.83e-1)" "unprognostic (2.37e-1)" "unprognostic (7.72e-3)" "unprognostic (2.16e-1)" "unprognostic (2.46e-2)" "unprognostic (4.95e-2)" "unprognostic (1.84e-3)" "unprognostic (7.64e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (9.92e-2)" "unprognostic (1.41e-1)" "unprognostic (5.48e-2)" "unprognostic (2.14e-1)" 18.8 10.2 12.6 16.6 16.4 10.0 17.2 14.5 29.5 22.5 30.1 13.6 11.5 18.5 33.1 11.5 20.2 18.5 21.9 49.2 12.4 11.0 10.9 11.0 24.5 11.6 11.9 16.8 18.8 21.7 11.1 14.6 26.0 19.7 21.3 6.9 18.2 15.3 25.8 45.2 17.8 17.0 38.8 10.6 14.7 23.3 15.7 12.7 11.8 11.4 11.6 12.9 26.7 17.8 15.0 14.7 23.9 15.6 17.3 19.5 11.0 25.7 20.5 12.8 16.1 9.6 10.9 19.8 35.6 28.7 29.1 19.2 37.7 7.8 14.3 17.5 31.2 20.5 20.6 12.5 20.2 10.6 20.9 20.8 5.7 25.1 21.6 30.6 13.8 21.7 24.7 25.3 26.4 15.2 17.5 24.1 9.8 18.1 24.9 17.7 16.8 13.7 10.4 19.9 10.5 16.5 17.2 18.9 13.3 17.5 20.3 20.3 14.1 24.0 28.9 20.4 15.7 20.8 10.9 45.1 37.5 17.0 33.5 44.4 27.8 22.8 16.5 29.8 14.5 19.9 22.1 14.2 23.9 19.5 15.6 14.0 13.5 14.8 17.9 12.6 15.0 11.3 10.8 23.9 17.3 10.6 14.7 17.6 11.0 12.6 16.4 14.5 29.5 12.4 11.0 11.9 16.8 19.7 12.7 23.8 10.9 16.6 82.6 89.4 12.3 27.3 17.8 5.3 7.9 10.4 2.0 40.8 14.9 91.0 24.5 19.4 61.2 0.0 75.9 65.4 32.8 38.1 20.7 6.0 20.1 11.1 26.2 20.3 16.7 17.7 21.0 12.0 35.4 33.3 33.0 11.1 89.1 42.1 21.2 11.5 10.2 32.3 50.1 15.2 15.6 62.7 77.9 17.5 20.3 41.6 DBR1 ENSG00000138231 "Debranching RNA lariats 1" Q9UK59 3 138161012-138174949 "Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035365 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035365: AB_10611956" "unprognostic (1.20e-1)" "unprognostic (3.72e-2)" "unprognostic (8.48e-3)" "unprognostic (2.04e-2)" "unprognostic (2.83e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (1.36e-4)" "unprognostic (2.33e-1)" "unprognostic (5.24e-2)" "unprognostic (9.99e-2)" "unprognostic (2.60e-1)" "unprognostic (3.33e-2)" "prognostic favorable (1.36e-4)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (5.35e-2)" "unprognostic (4.79e-2)" 11.8 13.5 9.3 10.0 10.5 20.7 12.2 12.5 10.5 13.3 10.1 14.4 12.8 8.3 15.8 13.6 12.3 11.8 12.4 9.3 9.3 8.9 13.4 12.2 15.3 12.6 11.0 10.5 13.7 15.5 13.1 16.1 9.1 10.0 12.3 10.1 12.7 12.8 10.7 10.8 11.9 12.4 11.6 10.9 17.0 18.3 5.8 12.0 22.3 13.2 7.7 13.6 11.0 12.7 8.3 9.8 14.3 11.2 9.2 13.3 7.0 14.9 6.2 11.3 12.5 6.3 5.9 11.7 8.9 6.5 9.6 11.8 10.4 6.7 13.7 17.0 8.0 14.6 11.1 13.0 4.4 12.7 11.7 10.7 14.8 8.1 8.6 7.7 19.1 13.1 8.1 7.4 8.9 8.4 5.7 7.9 12.0 9.6 3.0 9.7 11.5 18.7 11.3 13.0 11.6 7.3 11.8 12.8 12.5 8.3 14.6 10.9 14.1 23.7 8.3 12.7 9.6 15.6 15.7 7.4 8.2 5.7 15.0 10.2 4.5 6.2 28.7 5.3 13.8 10.5 4.8 8.1 14.3 10.4 11.2 13.3 8.3 11.8 9.9 9.8 8.0 12.1 13.1 3.5 9.2 9.0 6.0 9.5 7.0 9.3 10.5 12.5 10.5 9.3 8.9 11.0 10.5 10.0 12.0 6.0 11.7 7.5 3.0 4.6 5.4 4.3 10.2 5.3 5.7 8.7 0.0 9.2 8.3 9.5 0.0 5.3 3.8 0.0 7.7 8.3 6.9 3.6 5.7 6.4 9.2 6.4 5.8 6.7 16.1 0.0 8.1 5.6 3.3 8.2 5.6 8.9 6.1 5.5 7.8 5.1 4.8 0.0 4.2 4.4 2.1 3.6 3.8 10.1 6.6 2.6 DCAF11 "GL014, PRO2389, WDR23" ENSG00000100897 "DDB1 and CUL4 associated factor 11" Q8TEB1 14 24114195-24125242 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003583, HPA031157" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003583: AB_2667001, HPA031157: AB_10603002" "unprognostic (1.50e-1)" "unprognostic (4.72e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (1.01e-1)" "unprognostic (9.58e-2)" "unprognostic (1.91e-3)" "unprognostic (1.48e-3)" "unprognostic (3.23e-2)" "unprognostic (4.08e-1)" "unprognostic (1.19e-1)" "unprognostic (2.01e-1)" "prognostic favorable (3.50e-13)" "unprognostic (2.58e-1)" "unprognostic (3.48e-1)" "unprognostic (6.80e-2)" "unprognostic (1.68e-1)" 7.6 20.8 14.4 12.1 15.4 21.7 10.3 14.2 23.0 8.1 14.0 11.5 18.7 23.7 8.8 14.1 13.5 10.5 13.6 13.9 14.1 10.9 15.3 56.2 9.8 13.1 12.3 15.5 11.8 42.5 21.1 12.6 8.6 10.4 11.6 11.3 12.3 18.3 19.4 26.8 8.9 25.2 9.5 9.7 14.2 14.4 13.4 9.4 13.1 17.1 13.2 10.5 10.6 7.3 12.8 18.0 20.9 16.5 23.9 17.2 14.8 6.2 10.5 5.1 4.8 5.9 4.7 9.3 5.1 7.8 9.5 8.9 6.6 10.5 11.0 4.9 6.6 6.3 9.1 8.7 7.4 6.4 11.2 5.2 10.5 11.2 33.5 8.0 13.0 14.6 5.2 8.6 4.9 9.6 6.3 6.9 14.5 6.9 11.2 5.5 19.7 12.9 11.3 3.1 17.1 9.5 12.1 9.5 13.0 6.9 16.0 10.9 7.3 4.4 15.2 7.7 5.8 8.9 11.1 3.9 7.1 5.9 5.7 6.1 17.2 16.2 13.4 5.4 10.5 7.9 15.1 15.3 20.9 15.8 16.5 13.7 12.8 14.2 14.4 18.0 12.5 14.7 13.7 13.2 23.9 13.1 9.3 17.2 14.8 14.4 15.4 14.2 23.0 14.1 10.9 12.3 15.5 10.4 9.4 26.8 50.8 26.1 16.7 7.8 34.9 33.5 33.1 20.1 22.7 36.6 45.2 27.4 39.7 34.6 15.9 12.7 79.6 93.5 40.4 26.6 14.9 21.0 11.6 112.5 32.6 15.9 27.7 18.4 19.3 20.4 8.3 16.1 16.9 40.5 34.2 28.5 29.3 33.2 13.8 39.6 26.0 25.8 13.3 12.6 10.2 9.9 42.2 37.0 39.4 17.0 DCAF17 "C2orf37, FLJ13096" ENSG00000115827 "DDB1 and CUL4 associated factor 17" Q5H9S7 2 171434217-171485052 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Deafness, Diabetes mellitus, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053339, HPA055040" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA053339: AB_2682119, HPA055040: AB_2682680" "unprognostic (1.60e-2)" "unprognostic (1.21e-1)" "unprognostic (4.05e-1)" "unprognostic (1.03e-2)" "unprognostic (1.60e-1)" "unprognostic (5.98e-2)" "unprognostic (5.60e-2)" "unprognostic (2.67e-2)" "unprognostic (2.30e-3)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.69e-1)" "unprognostic (1.12e-2)" "unprognostic (1.41e-1)" "unprognostic (4.27e-1)" "prognostic unfavorable (7.10e-4)" "unprognostic (2.79e-2)" 7.9 9.8 12.3 9.7 19.0 5.7 12.2 14.5 12.1 11.2 10.4 14.5 8.7 8.4 16.2 12.5 9.2 9.2 9.0 7.1 13.6 9.4 11.2 8.3 7.3 12.6 19.2 8.0 14.1 13.1 13.8 10.9 10.0 10.9 10.2 9.2 9.4 9.0 10.2 7.4 13.5 9.5 14.6 17.2 11.5 8.1 10.5 17.3 15.4 19.6 5.0 11.0 10.7 11.1 3.9 2.0 2.3 2.9 2.0 7.1 3.0 6.8 5.7 7.4 8.8 9.5 10.2 11.5 6.1 6.2 6.1 5.8 6.7 4.5 19.9 4.5 7.4 4.7 6.8 7.5 7.4 8.5 9.1 5.0 9.1 4.6 12.1 9.6 12.9 6.6 7.9 9.8 7.8 17.4 7.3 6.6 6.3 14.2 6.9 8.4 4.2 14.1 12.0 11.1 5.0 3.6 10.8 9.8 10.8 5.2 6.2 6.6 9.6 5.6 4.9 6.0 7.3 3.8 6.8 7.9 7.1 6.4 4.0 5.2 10.5 14.2 16.8 7.5 6.7 7.3 2.3 2.6 1.0 5.0 2.9 7.1 2.8 4.0 3.5 2.0 3.9 4.4 5.4 0.1 2.0 2.5 1.5 3.5 3.0 12.3 19.0 14.5 12.1 13.6 9.4 19.2 8.0 10.9 17.3 0.0 9.8 4.7 4.5 4.1 9.8 4.0 10.2 5.3 1.2 7.0 11.8 5.6 8.3 4.3 1.7 3.9 4.0 0.0 3.3 4.9 3.8 5.3 3.5 6.0 4.9 7.9 9.8 1.3 8.5 2.7 5.8 4.9 3.3 0.0 4.9 9.1 5.2 2.5 5.6 5.5 14.0 0.0 3.6 15.1 14.7 4.4 4.7 6.5 3.8 4.1 DCAF4 "DKFZp434K114, WDR21, WDR21A" ENSG00000119599 "DDB1 and CUL4 associated factor 4" Q8WV16 14 72926332-72959703 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047276 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047276: AB_10959615" "unprognostic (6.01e-2)" "unprognostic (1.96e-1)" "unprognostic (9.31e-2)" "unprognostic (1.78e-2)" "unprognostic (1.78e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (6.77e-4)" "unprognostic (3.93e-2)" "unprognostic (2.11e-1)" "unprognostic (1.38e-2)" "unprognostic (2.86e-1)" "unprognostic (7.56e-2)" "prognostic favorable (4.90e-4)" "unprognostic (6.80e-2)" "unprognostic (1.87e-1)" "unprognostic (9.96e-3)" "unprognostic (2.11e-2)" 9.0 10.4 6.7 10.2 11.4 7.3 10.8 6.1 19.2 8.4 10.5 12.0 7.5 6.7 14.5 9.8 10.0 8.9 9.9 6.6 7.4 9.2 12.3 9.6 6.3 9.4 9.4 10.9 15.0 17.9 9.4 6.5 14.5 15.4 9.3 10.6 9.0 13.4 8.6 18.2 18.5 8.8 9.6 6.6 9.2 10.7 14.5 6.6 7.9 17.7 7.5 12.1 9.9 9.6 12.0 3.5 1.0 4.5 9.0 7.1 3.1 12.6 6.1 1.5 6.6 6.5 8.6 12.1 7.3 7.4 9.5 11.0 6.8 5.6 16.3 5.5 13.8 8.8 9.6 10.5 11.2 16.8 8.1 5.8 6.8 2.7 8.9 9.4 4.6 11.1 15.2 11.4 10.2 19.2 6.4 3.3 16.0 9.8 10.6 7.6 20.9 7.9 11.6 3.8 12.9 12.7 5.6 8.0 9.3 14.2 7.5 7.8 3.1 4.4 23.1 9.1 6.9 7.8 6.2 5.0 5.1 12.2 14.1 3.6 14.8 14.1 10.9 7.3 3.9 3.2 0.3 1.7 0.3 4.5 2.7 6.7 12.0 5.5 5.1 3.5 10.3 6.4 6.7 1.0 9.0 4.5 2.7 7.1 3.1 6.7 11.4 6.1 19.2 7.4 9.2 9.4 10.9 15.4 6.6 6.0 4.0 9.0 6.0 5.5 2.7 3.6 2.5 2.7 11.4 3.5 3.9 16.9 3.3 5.6 2.9 4.0 1.7 0.0 4.9 16.1 6.1 2.7 0.0 4.0 5.2 0.0 4.1 0.0 2.2 1.9 3.4 1.9 1.7 3.6 3.3 1.6 4.5 6.2 5.3 5.0 3.4 0.0 5.4 6.7 19.4 5.8 4.7 3.2 6.3 3.1 DCAKD FLJ22955 ENSG00000172992 "Dephospho-CoA kinase domain containing" Q8WVC6 17 45023340-45061109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060997 Approved Nucleoplasm NA NA Nucleoplasm "HPA060997: AB_2797262" "unprognostic (1.32e-2)" "unprognostic (4.79e-3)" "unprognostic (9.71e-2)" "prognostic favorable (7.16e-6)" "unprognostic (1.13e-1)" "unprognostic (8.24e-3)" "unprognostic (7.57e-2)" "unprognostic (6.05e-3)" "unprognostic (4.10e-2)" "unprognostic (1.12e-1)" "unprognostic (2.97e-3)" "unprognostic (4.00e-2)" "unprognostic (6.55e-2)" "unprognostic (5.10e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" "unprognostic (1.82e-2)" 14.6 26.9 25.1 10.3 28.1 6.5 14.9 20.3 32.6 18.8 11.8 31.2 17.8 10.0 18.7 23.7 19.6 28.2 13.6 29.0 28.0 30.0 13.6 15.9 9.9 11.3 28.7 22.9 26.5 16.5 21.1 25.0 11.8 28.6 21.3 10.5 23.7 38.1 22.5 12.7 21.5 10.2 15.6 24.6 11.2 9.8 11.6 23.6 21.8 27.0 8.7 14.8 17.9 15.6 5.7 13.2 2.2 6.5 4.7 9.4 3.9 7.7 14.8 14.3 21.8 12.3 13.0 7.9 6.9 4.7 8.8 8.9 3.5 8.3 13.9 15.0 6.7 7.7 9.9 9.9 6.7 7.6 43.6 19.0 14.3 7.1 17.5 14.9 6.0 8.3 16.1 15.7 9.8 2.9 8.2 7.5 21.4 13.3 9.7 10.3 17.3 18.7 6.7 7.6 14.0 12.7 11.3 11.7 11.4 7.9 10.2 17.8 22.7 4.7 3.7 8.2 12.9 11.1 8.8 11.3 11.5 7.8 16.4 7.2 12.2 5.8 6.3 20.1 6.2 13.4 1.0 4.5 2.2 7.5 6.5 9.4 5.7 7.6 6.6 7.0 5.1 7.0 7.3 0.8 4.7 4.6 13.2 6.9 3.9 25.1 28.1 20.3 28.1 28.0 30.0 28.7 22.9 28.6 23.6 6.0 8.6 5.4 11.2 6.8 11.1 14.5 10.2 6.7 4.5 19.2 3.9 15.9 19.9 4.0 1.6 4.5 3.4 0.0 4.2 9.1 9.1 8.4 0.0 9.5 6.5 15.9 11.6 6.7 4.6 2.7 8.6 4.6 15.1 25.2 9.2 20.7 3.3 9.0 10.3 12.1 10.5 12.9 7.2 4.6 4.3 6.9 9.4 5.7 12.9 7.9 DCK ENSG00000156136 "Deoxycytidine kinase" P27707 4 70992538-71030914 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 80.9" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 186.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 60.9;U-698: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059609, HPA062773" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA059609: AB_2684082, HPA062773: AB_2684865" "unprognostic (9.16e-2)" "unprognostic (2.44e-1)" "unprognostic (5.24e-3)" "unprognostic (4.77e-2)" "unprognostic (3.95e-1)" "unprognostic (6.45e-2)" "prognostic unfavorable (6.90e-7)" "unprognostic (3.04e-2)" "unprognostic (7.19e-2)" "unprognostic (8.28e-2)" "unprognostic (4.51e-1)" "unprognostic (1.33e-1)" "unprognostic (3.37e-2)" "unprognostic (4.47e-2)" "unprognostic (6.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.27e-2)" 8.0 8.3 11.9 30.9 16.8 17.2 6.9 11.4 14.8 5.6 8.6 10.4 2.6 7.6 7.5 4.4 8.8 5.5 6.1 5.5 12.3 13.1 5.8 4.8 9.7 42.8 11.7 10.3 6.0 5.0 3.6 4.2 7.9 11.1 5.9 10.4 6.4 6.3 4.0 6.8 7.9 12.4 7.5 17.6 17.5 8.2 5.6 8.6 80.9 8.3 3.8 39.9 9.5 6.5 27.9 34.2 17.5 12.7 18.5 24.9 25.1 6.7 4.5 9.9 5.9 3.1 5.5 5.7 17.5 6.5 13.9 11.6 2.9 14.8 60.9 7.6 7.2 8.1 3.9 8.8 5.5 18.8 12.9 5.4 12.6 5.2 4.6 3.2 25.1 16.3 2.7 6.7 8.4 5.1 6.8 7.9 17.3 5.0 23.2 15.8 3.9 31.0 9.9 4.7 11.5 5.5 26.4 20.1 4.8 6.9 4.7 8.8 9.4 6.6 12.9 7.7 4.7 5.8 13.2 6.3 15.7 11.8 13.1 9.4 8.8 5.8 49.4 10.9 15.7 11.6 13.1 10.7 17.5 16.2 12.7 20.3 27.9 21.8 20.0 14.3 26.4 23.4 23.5 5.4 18.5 12.1 34.2 24.9 25.1 11.9 16.8 11.4 14.8 12.3 13.1 11.7 10.3 11.1 8.6 0.0 11.3 75.5 8.0 38.1 13.6 4.6 7.6 1.4 3.4 12.2 5.9 9.8 24.9 17.7 0.4 14.3 9.0 186.9 5.6 16.0 12.9 9.5 23.0 5.3 33.7 17.5 20.2 21.5 48.3 1.1 7.8 41.6 43.9 68.5 17.2 14.3 8.9 7.0 9.6 6.1 8.2 6.5 20.6 34.4 28.8 37.9 3.8 61.7 14.3 6.2 DDB1 ENSG00000167986 "Damage specific DNA binding protein 1" Q16531 11 61299451-61342596 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 331.8;Rod photoreceptor cells: 442.7;Syncytiotrophoblasts: 325.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032821, HPA045174, HPA068456" Approved Enhanced Nucleoplasm NA NA 170000 Nucleoplasm "CAB032821: AB_639050, HPA045174: AB_2679242, HPA068456: AB_2685992" "unprognostic (3.45e-1)" "unprognostic (8.38e-2)" "prognostic favorable (7.09e-4)" "unprognostic (1.21e-1)" "unprognostic (6.56e-2)" "unprognostic (1.19e-2)" "unprognostic (1.11e-2)" "unprognostic (9.33e-2)" "unprognostic (9.74e-3)" "unprognostic (1.09e-1)" "unprognostic (7.42e-3)" "unprognostic (3.11e-1)" "prognostic favorable (1.51e-8)" "unprognostic (3.44e-1)" "unprognostic (1.58e-1)" "unprognostic (7.30e-2)" "unprognostic (1.25e-3)" 19.3 83.3 19.9 14.1 24.9 16.1 19.7 22.9 33.8 21.3 16.2 24.9 33.3 18.4 23.9 30.6 19.8 26.2 17.4 21.1 18.1 20.8 21.7 26.8 16.0 21.7 18.3 23.4 31.1 23.5 107.3 22.0 80.3 27.3 19.4 17.8 33.0 23.9 27.2 57.1 24.1 19.7 20.7 16.7 17.5 19.7 36.1 14.4 33.3 22.1 20.4 21.0 22.6 17.9 19.6 30.5 17.8 23.5 22.0 32.5 23.8 39.3 42.5 41.2 36.1 39.3 37.1 62.0 37.0 47.9 45.0 34.1 45.9 33.3 59.6 33.0 50.6 26.9 36.8 60.5 44.1 48.6 30.1 32.8 34.2 40.7 47.4 27.6 48.8 29.7 43.7 30.3 44.4 38.4 31.4 48.3 25.5 68.7 32.6 39.5 47.8 60.2 23.0 54.7 24.8 36.7 49.7 52.3 62.3 31.4 43.7 36.8 37.5 40.0 46.8 36.8 38.4 58.0 20.7 39.8 32.0 30.2 36.5 26.2 37.6 39.7 52.9 35.3 26.1 30.9 17.8 20.9 17.7 24.8 23.5 32.5 19.6 22.4 24.8 30.5 17.9 20.7 23.1 2.5 22.0 21.0 16.8 24.4 23.8 19.9 24.9 22.9 33.8 18.1 20.8 18.3 23.4 27.3 14.4 26.8 65.3 45.5 43.2 46.8 67.6 79.5 38.2 42.8 48.9 50.6 331.8 218.9 14.9 38.9 12.5 47.4 47.5 0.0 36.5 109.7 39.2 49.2 29.0 61.1 65.3 82.6 71.2 47.3 39.9 13.6 78.9 30.6 40.5 42.3 50.3 62.6 44.2 28.1 58.4 41.7 442.7 32.3 39.2 87.4 115.3 52.2 325.6 38.3 51.6 46.7 DDIT3 "CHOP, CHOP10, GADD153" ENSG00000175197 "DNA damage inducible transcript 3" P35638 12 57516588-57521737 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Growth arrest, Stress response, Transcription, Transcription regulation, Unfolded protein response, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 50.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 125.3;hTERT-HME1: 63.0;SK-MEL-30: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058416, HPA068416" Uncertain Supported Nucleoplasm No No Nucleoplasm "HPA058416: AB_2683712, HPA068416: AB_2685985" "unprognostic (1.12e-1)" "unprognostic (5.33e-2)" "unprognostic (2.20e-3)" "unprognostic (4.92e-2)" "unprognostic (7.86e-3)" "unprognostic (2.28e-1)" "prognostic unfavorable (6.55e-4)" "unprognostic (8.55e-2)" "unprognostic (1.26e-3)" "unprognostic (9.40e-3)" "unprognostic (4.92e-2)" "unprognostic (4.16e-2)" "unprognostic (3.52e-2)" "unprognostic (3.70e-1)" "unprognostic (1.62e-1)" "unprognostic (2.56e-1)" "unprognostic (6.76e-2)" 19.1 25.5 15.9 8.3 29.9 82.2 21.4 16.7 25.2 14.8 13.5 20.1 15.7 10.6 19.5 55.8 13.0 13.1 16.0 25.8 18.6 19.8 28.8 26.1 17.1 8.8 34.4 15.5 27.3 13.0 13.5 26.8 18.0 32.1 22.8 13.9 27.3 20.7 13.9 18.0 16.3 10.9 15.4 21.8 11.2 14.7 14.3 35.3 2.9 88.9 12.6 9.4 30.2 17.0 13.8 4.6 50.8 5.4 9.2 10.9 5.1 2.6 2.4 1.5 5.3 14.4 9.8 8.4 7.3 16.3 10.9 10.3 8.6 7.0 3.8 7.4 2.1 29.4 3.2 5.9 1.1 11.3 3.1 2.4 2.9 2.7 6.2 125.3 4.6 4.6 27.9 23.7 18.4 63.0 12.8 2.6 4.0 12.6 14.5 4.8 1.6 3.1 6.1 3.0 5.6 5.8 1.7 34.4 3.2 3.8 3.4 3.2 2.4 2.1 2.5 58.5 6.1 5.3 12.5 1.5 7.5 3.2 7.0 6.3 25.7 8.6 4.0 9.0 4.4 13.1 27.5 5.4 13.5 8.0 4.6 7.0 13.8 5.7 7.3 3.7 13.1 10.9 9.9 50.8 9.2 5.1 4.6 6.5 5.1 15.9 29.9 16.7 25.2 18.6 19.8 34.4 15.5 32.1 35.3 17.9 66.4 36.9 73.0 50.0 111.0 146.3 38.2 24.1 25.0 21.0 86.4 37.7 97.8 32.3 4.8 25.9 67.5 0.0 13.8 18.0 63.8 157.0 198.7 17.9 39.8 52.4 221.2 23.4 24.7 5.5 25.9 50.7 84.4 8.2 36.5 118.8 35.9 70.2 35.7 34.7 135.4 12.9 94.3 83.5 13.4 40.0 90.2 46.8 32.1 42.1 DDX19A "DDX19L, FLJ11126" ENSG00000168872 "DEAD-box helicase 19A" Q9NUU7 16 70346829-70373383 "Enzymes, Predicted intracellular proteins, Transporters" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045252, HPA066668" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045252: AB_10961128, HPA066668: " "unprognostic (3.11e-2)" "unprognostic (1.93e-1)" "unprognostic (9.07e-2)" "unprognostic (3.95e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (2.38e-4)" "prognostic unfavorable (8.05e-5)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (1.67e-1)" "unprognostic (1.30e-1)" "unprognostic (5.87e-2)" "unprognostic (1.24e-1)" "unprognostic (2.01e-2)" "unprognostic (1.49e-1)" "unprognostic (3.01e-2)" "unprognostic (6.68e-3)" 18.4 20.6 14.5 15.5 19.7 9.8 18.1 16.6 19.6 16.9 19.2 19.2 17.8 9.3 22.0 14.2 19.2 17.1 16.1 22.1 18.6 13.5 16.6 24.8 14.4 18.0 17.1 15.5 21.6 22.5 31.7 17.4 21.8 15.1 15.4 14.4 14.2 14.4 21.1 51.5 15.8 13.5 25.9 15.4 14.1 17.2 9.7 13.7 17.1 19.7 14.4 18.4 19.5 15.5 8.1 14.2 7.9 11.4 8.2 10.3 8.8 13.2 15.0 15.8 16.0 23.8 16.2 15.1 16.9 17.4 26.8 20.9 22.5 9.9 22.2 16.1 17.8 12.7 15.2 28.3 16.8 22.2 7.4 15.4 11.6 12.3 27.6 21.5 20.2 9.7 19.9 12.1 24.4 19.2 13.2 17.0 16.2 27.9 5.8 16.0 19.0 22.4 16.8 25.5 15.8 9.2 27.8 10.6 30.4 16.2 8.2 13.0 17.5 43.3 9.5 12.7 17.1 17.4 12.9 11.5 18.7 14.8 11.8 16.0 16.4 24.6 48.9 12.6 18.5 18.3 7.9 11.4 5.8 10.2 10.7 9.4 7.7 8.9 10.0 14.2 8.1 9.9 10.3 0.7 8.2 9.6 7.3 7.5 8.8 14.5 19.7 16.6 19.6 18.6 13.5 17.1 15.5 15.1 13.7 14.9 20.2 21.7 15.7 8.9 31.9 16.2 28.1 13.4 22.7 10.4 31.4 18.9 8.3 11.1 1.4 13.8 6.6 23.3 12.1 13.1 12.8 16.7 17.3 15.3 12.3 22.3 13.8 14.7 14.5 1.3 24.2 11.8 10.1 17.2 8.8 18.0 11.6 8.6 11.7 10.6 31.0 25.8 15.5 12.2 16.4 8.9 14.4 12.9 11.3 15.9 DDX19B "DBP5, DDX19" ENSG00000157349 "DEAD-box helicase 19B" Q9UMR2 16 70289663-70335283 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 170.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037229, CAB037284, HPA046380, HPA066668" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: " "unprognostic (2.91e-2)" "unprognostic (5.37e-2)" "unprognostic (6.48e-2)" "unprognostic (3.55e-2)" "unprognostic (3.98e-2)" "unprognostic (4.05e-2)" "unprognostic (2.93e-2)" "unprognostic (1.98e-2)" "unprognostic (1.40e-1)" "unprognostic (1.05e-1)" "unprognostic (6.33e-2)" "unprognostic (4.07e-1)" "unprognostic (7.95e-2)" "unprognostic (2.19e-1)" "unprognostic (3.50e-1)" "unprognostic (1.04e-1)" "unprognostic (6.32e-2)" 22.2 18.6 8.8 16.6 12.7 19.4 20.1 30.4 16.3 13.1 16.7 14.6 13.8 14.4 15.0 13.9 16.0 13.2 15.2 15.0 8.3 8.3 15.9 33.9 16.6 15.3 10.5 10.7 14.6 21.6 20.3 17.9 12.0 13.2 13.8 18.2 19.3 16.8 15.2 24.8 26.9 16.6 15.7 10.1 17.8 18.5 64.3 12.3 17.4 18.0 16.9 20.8 16.2 13.9 21.1 21.1 27.0 28.6 22.1 35.4 22.5 2.0 12.4 17.7 16.0 9.8 13.1 15.3 10.0 14.2 22.0 23.0 26.4 15.3 16.2 9.5 12.6 8.9 12.2 0.1 5.7 22.8 6.7 11.3 9.6 8.1 21.6 21.1 20.5 9.3 16.1 11.3 16.7 12.7 9.1 16.8 5.0 9.7 7.0 13.4 14.2 0.0 29.7 11.1 7.7 5.2 28.4 9.6 23.4 13.1 11.5 11.6 15.3 23.6 5.4 12.7 8.1 12.1 18.2 10.2 10.4 9.3 8.6 9.2 15.1 7.8 37.7 3.4 16.8 13.4 27.0 22.1 19.0 23.2 28.6 22.3 21.1 20.9 25.3 21.1 19.0 19.0 18.0 4.1 22.1 17.7 6.5 35.4 22.5 8.8 12.7 30.4 16.3 8.3 8.3 10.5 10.7 13.2 12.3 11.9 17.9 27.3 15.3 8.4 17.8 6.6 12.7 29.4 20.5 10.4 11.8 16.5 26.6 35.6 170.5 17.5 27.5 0.0 57.8 18.6 16.1 14.9 10.5 12.4 25.9 9.5 21.1 11.6 14.6 32.4 19.2 19.7 3.3 43.3 14.6 16.0 37.9 34.5 14.9 17.4 15.7 12.9 12.3 78.8 7.4 9.2 26.4 25.5 20.3 15.7 DEDD "CASP8IP1, DEDD1, DEFT, FLDED1, KE05" ENSG00000158796 "Death effector domain containing" O75618 1 161120974-161132688 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030681, HPA073628" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA030681: AB_2797220, HPA073628: AB_2732230" "unprognostic (2.24e-1)" "unprognostic (2.38e-1)" "unprognostic (4.81e-2)" "unprognostic (5.09e-2)" "unprognostic (4.20e-3)" "unprognostic (5.94e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (2.52e-1)" "unprognostic (8.70e-2)" "unprognostic (7.66e-3)" "unprognostic (2.33e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (4.98e-7)" "unprognostic (1.53e-1)" "unprognostic (1.34e-1)" "unprognostic (4.06e-2)" "unprognostic (1.43e-2)" 24.4 15.7 15.8 17.3 16.4 24.2 20.8 19.3 24.0 16.6 20.4 19.3 16.4 19.4 19.6 14.8 24.0 18.4 20.1 18.5 14.3 12.8 16.5 26.3 20.3 17.8 12.9 11.8 22.1 18.7 14.5 14.0 36.7 18.2 17.2 13.1 17.5 18.1 16.0 39.0 21.5 17.9 20.0 13.8 21.2 16.6 35.8 14.7 19.2 18.7 24.2 19.5 20.1 18.5 16.3 21.3 33.6 23.8 16.5 24.0 18.7 13.2 13.1 15.6 13.5 12.0 12.2 10.7 11.4 16.3 13.3 14.8 9.1 23.0 14.2 11.5 17.1 9.8 12.1 11.8 17.8 8.6 14.1 12.8 13.2 15.7 12.2 21.3 9.2 20.1 15.3 19.1 14.2 22.7 17.7 21.3 19.7 11.2 21.3 15.4 20.8 22.3 10.1 25.9 26.6 13.6 18.4 10.7 18.9 13.2 16.2 16.5 25.0 11.6 30.8 19.8 17.8 18.4 18.9 14.9 14.5 15.5 16.8 16.5 29.5 18.6 25.1 17.3 10.0 10.3 33.6 23.8 32.1 19.0 21.9 16.2 16.3 19.0 18.9 21.3 15.4 21.5 17.5 26.6 16.5 22.5 18.8 24.0 18.7 15.8 16.4 19.3 24.0 14.3 12.8 12.9 11.8 18.2 14.7 23.8 9.4 6.8 11.7 22.3 6.0 8.7 12.7 5.3 7.9 8.7 5.9 16.8 19.9 11.5 30.8 18.0 10.6 0.0 16.8 16.5 15.0 8.8 16.1 9.2 13.3 12.7 10.9 14.1 18.6 37.1 10.9 15.9 13.5 17.2 8.7 5.0 11.9 11.5 9.2 11.3 9.2 6.5 18.6 15.7 14.7 21.8 22.5 8.3 9.9 13.7 DEDD2 FLAME-3 ENSG00000160570 "Death effector domain containing 2" Q8WXF8 19 42198598-42220140 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 58.6" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 135.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 22.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043419 Approved Nucleoplasm NA NA Nucleoplasm "HPA043419: AB_10960747" "unprognostic (1.59e-1)" "unprognostic (5.90e-2)" "unprognostic (3.54e-2)" "unprognostic (5.87e-2)" "unprognostic (5.57e-2)" "unprognostic (6.48e-2)" "unprognostic (1.03e-1)" "unprognostic (7.55e-3)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (6.39e-2)" "unprognostic (2.46e-1)" "unprognostic (3.59e-2)" "unprognostic (1.24e-1)" "unprognostic (5.80e-2)" "unprognostic (3.70e-2)" "prognostic favorable (3.26e-6)" 8.7 12.5 9.9 13.5 13.1 22.2 12.3 17.6 14.9 7.8 13.8 6.0 11.5 14.5 7.2 7.9 11.6 9.6 6.4 6.3 9.4 15.4 11.5 11.1 12.9 12.7 14.5 5.7 9.7 11.6 7.1 17.0 10.5 10.4 13.8 5.7 6.3 11.6 8.2 13.6 11.4 13.2 5.8 8.2 17.8 19.7 9.6 10.5 17.2 24.1 6.3 13.2 10.4 58.6 16.9 19.0 49.2 29.1 14.3 21.9 24.2 10.1 22.9 1.5 1.8 3.5 0.8 6.8 4.1 3.6 3.3 2.3 6.4 6.6 6.6 8.0 1.2 3.6 4.0 6.9 1.5 1.5 5.5 18.3 3.2 5.4 9.8 4.3 3.7 6.8 0.5 3.8 2.5 3.5 6.0 1.9 2.8 15.9 7.4 0.9 4.4 3.9 11.8 3.6 9.4 13.8 4.6 2.9 5.7 2.6 3.7 11.8 4.6 3.7 10.9 2.1 2.2 2.0 4.3 3.3 2.5 7.9 1.0 7.4 13.9 6.3 2.1 3.8 5.8 2.6 27.5 21.5 34.5 20.1 27.0 21.9 16.9 18.6 19.2 13.5 16.4 16.8 17.3 49.2 14.3 29.1 19.0 17.4 24.2 9.9 13.1 17.6 14.9 9.4 15.4 14.5 5.7 10.4 10.5 6.0 6.9 42.9 43.3 41.2 27.1 5.5 5.1 21.4 3.4 14.0 11.8 24.7 10.0 21.5 27.8 12.7 56.1 0.0 21.3 35.2 14.6 62.6 72.3 7.4 33.6 14.3 88.4 6.2 27.4 2.8 12.4 48.4 37.1 35.1 33.2 17.2 32.9 38.6 12.0 13.6 18.4 6.5 24.7 15.9 12.6 46.9 135.5 55.4 23.8 77.9 DEF6 "IBP, SLAT, SWAP70L" ENSG00000023892 "DEF6, guanine nucleotide exchange factor" Q9H4E7 6 35297852-35321771 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.5;lymphoid tissue: 51.7" "Cell type enhanced" "Detected in many" 10 "Hofbauer cells: 76.8;Late spermatids: 127.4;T-cells: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 27.3;MOLT-4: 23.7;NB-4: 31.6;REH: 21.9;THP-1: 25.3;U-937: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038975, HPA038976" Enhanced Enhanced Nucleoplasm Yes NA Nucleoplasm "HPA038975: AB_10697544, HPA038976: AB_10673409" "prognostic favorable (3.02e-6)" "prognostic favorable (1.08e-4)" "prognostic unfavorable (1.71e-4)" "prognostic favorable (2.37e-4)" "unprognostic (1.93e-1)" "unprognostic (3.63e-3)" "unprognostic (2.24e-1)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (2.12e-1)" "unprognostic (2.14e-1)" "unprognostic (6.21e-3)" "prognostic unfavorable (1.02e-8)" "unprognostic (1.78e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (1.45e-3)" 2.9 2.0 4.5 34.8 4.6 30.3 3.4 0.9 3.1 4.3 4.7 6.9 4.7 5.3 3.1 11.1 15.3 2.7 6.8 2.6 3.8 2.7 3.1 2.5 7.5 42.7 5.3 1.0 2.0 16.5 0.7 5.1 4.2 4.8 10.6 4.0 2.9 14.1 6.7 0.9 14.4 15.2 2.4 7.1 32.6 8.3 6.7 5.0 42.6 4.7 9.3 51.7 6.7 8.6 13.9 21.0 43.5 13.8 25.9 31.5 20.7 7.5 0.0 0.2 0.2 0.0 0.1 9.6 0.8 1.2 0.2 0.2 0.4 3.2 9.0 2.7 0.4 0.0 5.0 0.0 6.4 0.1 0.3 0.3 10.1 0.1 4.0 0.2 18.2 13.3 1.5 8.2 0.1 7.4 0.0 0.0 27.3 4.5 21.7 0.0 3.9 23.7 31.6 0.4 0.9 0.9 21.9 0.2 12.1 0.8 5.7 0.1 0.0 0.6 1.9 1.7 0.4 5.2 25.3 1.2 0.1 0.2 0.0 0.1 12.4 11.4 7.5 0.0 37.9 0.0 16.3 13.8 43.5 31.5 11.0 25.8 13.9 25.7 31.0 21.0 12.5 27.1 26.1 26.7 25.9 9.9 13.9 26.9 20.7 4.5 4.6 0.9 3.1 3.8 2.7 5.3 1.0 4.8 5.0 6.0 10.1 30.6 16.6 10.5 2.3 0.5 5.1 2.7 6.8 5.2 0.0 20.5 0.0 0.7 44.9 1.7 2.9 0.0 8.6 14.6 1.5 5.8 17.3 0.5 76.8 3.2 4.1 3.7 28.3 127.4 2.6 28.4 6.8 7.2 8.5 0.8 5.8 10.5 1.8 0.2 1.6 0.0 1.2 4.2 0.7 10.3 10.5 75.9 7.2 12.7 DEK D6S231E ENSG00000124795 "DEK proto-oncogene" P35659 6 18223868-18264823 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB015226, HPA054505, HPA057799" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530" "unprognostic (6.35e-2)" "unprognostic (6.11e-2)" "unprognostic (5.04e-3)" "unprognostic (1.40e-2)" "unprognostic (3.66e-1)" "unprognostic (5.02e-3)" "prognostic unfavorable (9.65e-4)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (1.61e-3)" "unprognostic (6.49e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (2.31e-1)" "unprognostic (3.78e-1)" 30.9 20.0 22.9 41.8 29.5 50.8 28.9 41.5 30.2 31.0 35.8 11.4 24.0 28.2 32.9 19.7 31.0 23.8 19.2 33.5 26.8 14.1 19.3 23.8 29.2 42.7 30.7 17.6 28.3 19.3 20.5 27.8 24.3 27.7 33.9 29.9 11.0 26.8 21.4 40.2 23.2 35.9 51.3 28.1 29.8 24.2 12.6 32.9 58.8 44.9 33.9 38.4 45.1 43.3 40.0 40.2 57.7 49.3 34.0 46.3 35.0 60.9 18.0 47.6 39.7 9.6 16.7 27.7 56.2 31.0 50.7 68.8 29.4 22.9 69.4 59.6 25.3 40.8 36.6 35.2 27.9 85.4 46.7 33.6 42.9 32.3 34.2 9.3 65.3 34.9 8.2 13.9 35.0 27.7 24.0 24.2 25.6 52.1 0.0 32.3 21.9 47.1 29.3 29.2 24.3 20.1 62.8 63.2 40.7 24.4 35.3 29.2 26.8 50.7 44.1 30.6 32.6 39.6 26.9 24.6 59.5 33.0 33.1 69.9 4.2 10.2 73.2 14.2 33.3 55.1 51.1 49.3 21.9 41.4 39.3 46.3 40.0 42.1 42.5 40.2 33.2 33.5 32.0 57.7 34.0 43.9 31.0 40.6 35.0 22.9 29.5 41.5 30.2 26.8 14.1 30.7 17.6 27.7 32.9 113.2 133.1 112.0 157.1 241.0 64.8 174.2 152.8 109.7 146.7 75.0 76.6 208.5 69.6 136.5 15.9 140.0 115.1 443.9 150.2 201.0 139.1 206.8 105.4 107.1 166.8 25.4 84.9 75.5 163.3 15.6 175.4 212.2 96.2 259.7 117.1 119.5 110.8 110.4 180.0 82.7 127.2 207.0 187.2 63.1 177.2 204.1 90.8 150.3 203.5 166.1 DENND2C "dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1" ENSG00000175984 "DENN domain containing 2C" Q68D51 1 114582848-114670422 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.7;skeletal muscle: 31.1" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 99.0;Basal keratinocytes: 97.0;Suprabasal keratinocytes: 150.2;Urothelial cells: 270.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 6.1;eosinophil: 2.1" "Lineage enriched" "Detected in single" 9 "granulocytes: 6.1" "Cell line enhanced" "Detected in many" "U-2197: 10.3;U-266/70: 22.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA029935, HPA054955" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029935: AB_10601208, HPA054955: AB_2682648" "unprognostic (2.25e-1)" "unprognostic (1.08e-1)" "unprognostic (9.97e-2)" "unprognostic (4.89e-4)" "unprognostic (1.52e-1)" "unprognostic (2.46e-1)" "unprognostic (2.53e-1)" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (6.61e-2)" "unprognostic (2.20e-2)" "unprognostic (7.43e-2)" "unprognostic (2.77e-2)" "unprognostic (2.24e-2)" "unprognostic (6.11e-2)" "unprognostic (3.64e-2)" "unprognostic (1.57e-2)" 1.9 0.7 1.5 0.7 1.5 0.8 1.7 1.4 1.1 8.6 1.1 0.5 0.8 0.6 4.2 1.7 28.7 1.0 1.1 1.5 1.3 0.5 0.8 2.1 1.7 1.7 0.6 0.3 1.1 4.0 2.4 3.6 0.3 1.9 2.5 0.6 1.6 3.0 1.4 31.1 10.6 0.6 2.4 0.6 0.5 0.8 4.5 0.2 0.0 1.3 16.0 10.4 6.2 6.6 0.6 0.1 6.1 0.2 0.3 0.5 0.3 1.7 0.0 0.1 1.2 1.5 1.7 0.3 0.5 0.9 0.6 0.9 0.2 0.0 0.0 0.8 3.5 1.2 6.5 1.2 4.0 0.6 0.0 1.6 1.0 0.4 0.1 0.5 0.0 1.6 1.7 3.9 2.4 2.0 0.1 0.2 0.4 0.1 0.3 2.1 5.1 0.2 0.1 0.8 0.0 0.9 0.0 5.5 0.1 0.1 4.9 0.0 0.0 3.9 0.1 0.4 1.1 0.8 0.3 0.2 0.9 1.3 10.3 0.1 22.5 4.0 0.0 0.9 0.0 0.7 6.1 0.2 2.1 0.5 0.0 0.5 0.6 0.1 0.4 0.0 0.4 0.3 0.2 0.5 0.3 0.1 0.1 0.2 0.3 1.5 1.5 1.4 1.1 1.3 0.5 0.6 0.3 1.9 0.2 26.8 2.1 0.0 99.0 97.0 21.6 6.9 12.7 20.1 4.5 7.0 19.6 0.1 0.0 5.6 23.7 8.7 0.0 0.0 6.4 0.0 5.3 46.7 2.3 11.0 0.2 0.0 0.0 13.5 3.4 9.1 4.6 1.6 6.8 1.0 0.8 2.0 20.3 0.0 2.1 0.6 8.7 0.0 8.5 23.4 49.0 150.2 0.0 0.7 0.5 270.3 DERA "CGI-26, DEOC" ENSG00000023697 "Deoxyribose-phosphate aldolase" Q9Y315 12 15911172-16037282 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055897 Supported Nucleoplasm NA NA 180000 Nucleoplasm "HPA055897: AB_2682963" "unprognostic (3.05e-1)" "unprognostic (1.26e-1)" "unprognostic (1.06e-2)" "unprognostic (7.26e-2)" "unprognostic (8.12e-2)" "unprognostic (7.74e-2)" "unprognostic (1.36e-1)" "unprognostic (1.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "unprognostic (8.74e-2)" "unprognostic (2.17e-2)" "prognostic favorable (3.64e-5)" "unprognostic (3.66e-2)" 20.3 12.0 10.5 10.8 10.8 7.5 11.5 5.2 7.7 11.3 30.3 11.4 12.7 20.2 21.5 14.7 20.0 8.2 11.1 11.7 10.1 9.1 40.9 51.5 13.6 14.1 12.5 6.5 5.8 16.9 6.6 27.5 12.3 11.3 9.2 21.2 11.0 11.4 11.3 15.3 12.4 46.7 10.4 14.6 14.6 10.5 5.5 11.0 13.8 26.6 16.7 14.3 10.1 13.1 12.4 30.2 14.1 28.2 17.1 14.9 15.7 19.0 15.8 12.4 10.9 8.4 19.2 25.4 11.1 10.5 15.2 19.5 19.0 35.4 13.0 9.9 14.2 13.7 13.5 13.4 14.3 27.0 21.7 7.8 11.5 7.9 17.9 12.1 12.1 7.8 12.8 16.6 12.4 25.5 12.9 21.9 11.1 1.6 4.0 27.6 7.0 9.0 10.1 27.0 10.7 7.8 13.8 27.2 8.1 38.1 6.9 9.0 15.3 21.0 7.0 21.9 51.1 37.9 15.2 21.6 16.2 10.7 7.4 11.9 4.3 6.3 22.4 20.8 12.2 11.9 5.4 24.4 14.1 7.2 27.1 7.9 12.4 7.8 7.7 30.2 11.4 8.6 6.9 6.5 17.1 28.2 16.5 14.9 15.7 10.5 10.8 5.2 7.7 10.1 9.1 12.5 6.5 11.3 11.0 41.7 25.0 18.6 24.3 26.1 5.0 11.4 22.9 21.4 22.7 12.2 13.7 54.5 92.9 55.2 33.8 25.2 49.7 0.0 52.2 57.8 21.3 17.5 8.1 44.5 53.2 3.2 25.4 30.7 32.6 3.0 22.7 32.0 69.2 55.9 43.0 20.9 60.6 45.0 28.7 104.3 25.2 6.5 18.6 5.0 14.7 22.6 59.6 10.0 39.9 24.7 DHX16 "DBP2, DDX16, Prp2, PRPF2" ENSG00000204560 "DEAH-box helicase 16" O60231 6 30653119-30673037 "Enzymes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051455 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA051455: AB_2681491" "unprognostic (7.04e-2)" "unprognostic (1.37e-1)" "unprognostic (7.29e-2)" "unprognostic (7.46e-2)" "unprognostic (1.48e-1)" "unprognostic (1.94e-1)" "unprognostic (4.36e-3)" "unprognostic (1.13e-1)" "unprognostic (2.66e-2)" "unprognostic (3.11e-1)" "unprognostic (8.58e-2)" "unprognostic (1.24e-2)" "unprognostic (9.77e-3)" "unprognostic (4.42e-2)" "unprognostic (1.51e-1)" "unprognostic (2.64e-1)" "unprognostic (8.73e-3)" 12.8 15.8 12.7 16.8 14.0 12.1 14.4 16.8 14.9 13.3 16.2 12.3 15.8 19.3 16.3 13.3 14.9 14.4 14.6 12.4 11.4 7.1 18.0 19.2 13.9 18.2 13.6 8.6 15.6 19.1 24.3 16.6 11.3 13.5 16.4 13.6 14.4 18.0 18.2 23.2 18.4 19.8 16.4 11.0 22.6 14.9 36.8 14.9 18.8 21.6 12.1 16.5 13.2 15.3 4.5 5.9 8.7 7.6 7.1 5.8 4.4 9.7 4.1 6.0 9.3 6.8 4.7 7.1 8.1 6.5 11.7 9.1 9.2 4.0 7.4 7.6 7.2 8.8 9.4 9.8 7.3 9.4 10.4 8.1 7.3 7.4 5.1 6.0 18.4 9.8 4.2 7.1 9.5 8.2 4.7 3.6 9.4 12.1 7.3 5.8 8.1 5.2 9.3 5.7 5.2 5.7 8.8 6.4 7.9 6.2 7.7 7.1 5.8 9.0 9.5 6.6 5.6 7.2 5.6 3.9 7.5 5.2 7.3 11.8 8.7 13.4 7.2 3.6 10.1 9.6 6.0 6.0 8.7 5.8 7.5 5.3 4.4 5.3 4.8 5.9 4.5 4.4 5.0 5.8 7.1 7.6 4.8 5.1 4.4 12.7 14.0 16.8 14.9 11.4 7.1 13.6 8.6 13.5 14.9 20.8 18.1 15.7 10.1 9.6 11.0 13.3 7.6 41.5 26.1 5.2 37.3 16.9 8.3 15.7 71.1 9.2 13.9 23.3 16.1 16.8 9.6 8.3 39.5 7.5 12.3 4.8 5.8 9.8 10.5 36.4 13.3 13.6 5.0 22.6 11.7 9.8 18.4 24.6 11.7 7.8 49.9 19.4 12.2 73.1 30.6 9.4 16.0 16.6 10.1 9.1 DHX38 "DDX38, hPrp16, KIAA0224, PRP16, PRPF16" ENSG00000140829 "DEAH-box helicase 38" Q92620 16 72093562-72112912 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041347, HPA041604" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA041347: AB_10796571, HPA041604: AB_2677577" "unprognostic (2.38e-1)" "unprognostic (1.89e-1)" "unprognostic (1.24e-2)" "unprognostic (3.25e-2)" "unprognostic (1.07e-1)" "unprognostic (1.01e-1)" "unprognostic (6.32e-3)" "unprognostic (8.50e-3)" "unprognostic (6.97e-2)" "unprognostic (1.45e-1)" "unprognostic (7.92e-2)" "unprognostic (1.28e-3)" "unprognostic (4.20e-3)" "unprognostic (2.68e-1)" "unprognostic (9.46e-2)" "unprognostic (2.40e-1)" "unprognostic (2.40e-2)" 21.8 16.5 21.1 22.2 25.0 35.1 20.5 36.0 29.4 18.6 19.5 23.5 19.4 20.1 24.1 13.5 21.1 19.9 18.1 19.2 24.1 13.7 17.3 20.8 20.6 26.1 24.1 20.7 29.0 17.3 36.6 18.7 19.3 20.9 18.3 17.2 17.9 20.4 16.4 33.0 27.2 23.0 23.5 22.5 27.3 19.4 17.5 27.8 24.6 20.8 23.2 23.1 20.5 21.4 10.4 8.1 8.3 10.6 11.8 14.9 6.3 14.5 21.7 15.7 8.8 13.7 10.6 20.7 13.2 12.9 19.7 15.2 26.2 14.6 19.4 11.8 19.8 11.0 19.2 18.2 18.1 15.3 9.7 19.6 14.9 18.4 35.7 12.8 17.5 27.0 14.7 16.7 26.5 19.2 10.5 17.0 14.1 22.0 9.2 12.1 44.8 16.7 19.9 19.8 9.3 12.5 21.6 10.9 19.2 9.5 13.9 14.2 15.6 16.9 8.1 9.3 9.5 14.7 14.6 19.2 19.0 16.9 13.8 14.3 22.8 18.0 37.3 17.9 12.2 14.8 7.4 7.9 8.3 14.9 10.6 13.7 10.4 9.3 10.7 8.1 8.2 10.4 10.8 8.2 11.8 6.6 7.4 10.9 6.3 21.1 25.0 36.0 29.4 24.1 13.7 24.1 20.7 20.9 27.8 23.8 30.1 24.7 9.7 10.9 28.0 7.5 15.3 21.4 30.7 14.0 15.7 11.7 0.0 11.7 6.6 18.0 21.3 0.0 17.7 11.6 13.5 9.4 40.6 11.6 12.9 28.6 29.3 14.1 13.9 9.1 26.7 18.7 8.5 14.4 20.2 18.0 18.2 15.8 23.7 6.5 35.4 19.4 13.3 22.7 15.8 11.2 17.0 23.5 17.1 9.9 DHX40 "ARG147, DDX40, FLJ22060, PAD" ENSG00000108406 "DEAH-box helicase 40" Q8IX18 17 59565525-59608345 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044350 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA044350: AB_10960560" "unprognostic (1.58e-2)" "unprognostic (3.10e-1)" "prognostic favorable (4.05e-5)" "unprognostic (4.09e-2)" "unprognostic (5.23e-2)" "unprognostic (2.84e-1)" "unprognostic (4.57e-3)" "unprognostic (7.53e-3)" "unprognostic (2.86e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (3.08e-1)" "unprognostic (9.48e-3)" "unprognostic (2.22e-1)" "unprognostic (1.25e-2)" "unprognostic (1.11e-1)" "unprognostic (3.10e-1)" 22.4 24.2 16.2 14.0 18.1 19.5 24.8 21.7 18.4 21.4 16.5 17.5 23.7 12.8 27.0 25.0 19.3 24.8 16.5 19.8 17.1 19.5 29.5 13.1 16.7 16.8 17.9 14.7 29.7 21.0 51.3 45.8 21.9 19.0 21.6 15.4 13.7 19.3 27.8 20.4 21.3 12.3 18.9 19.9 15.6 17.2 28.4 16.8 26.1 28.2 16.0 15.5 26.0 19.7 5.4 6.9 18.8 6.6 4.2 10.6 6.1 11.7 21.6 27.5 17.8 16.8 17.4 15.2 10.6 20.4 16.3 18.5 8.4 11.7 15.4 30.0 15.3 17.3 8.7 19.6 15.0 25.3 12.2 28.6 14.1 16.2 9.4 13.1 16.9 6.6 13.3 13.8 13.7 13.4 26.8 17.3 15.2 11.8 14.3 11.0 21.3 20.8 10.5 10.4 14.5 15.8 20.0 19.3 16.8 16.4 9.5 19.5 48.2 19.2 7.6 19.5 14.0 24.7 10.0 14.1 19.7 24.5 7.0 10.4 17.7 19.4 9.9 23.1 11.8 13.4 8.5 6.6 10.5 8.1 6.5 10.6 5.1 5.9 5.8 6.9 5.4 5.9 6.9 18.8 4.2 4.4 3.5 6.0 6.1 16.2 18.1 21.7 18.4 17.1 19.5 17.9 14.7 19.0 16.8 8.9 18.1 9.6 9.0 17.2 11.9 20.3 22.9 61.6 30.7 45.4 17.7 6.9 10.0 15.3 32.5 20.4 12.2 0.0 14.6 7.3 13.9 12.6 3.5 23.8 7.9 47.7 17.7 24.5 16.1 12.2 23.3 12.4 18.6 2.8 17.7 18.8 12.6 11.5 25.1 25.0 13.4 32.3 13.2 56.5 50.9 19.3 10.5 16.6 15.8 9.2 DIP2A "C21orf106, Dip2, KIAA0184" ENSG00000160305 "Disco interacting protein 2 homolog A" Q14689 21 46458899-46569852 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 110.0;Rod photoreceptor cells: 214.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052516 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052516: AB_2681859" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (6.52e-2)" "unprognostic (3.88e-2)" "unprognostic (7.30e-2)" "prognostic favorable (9.35e-5)" "unprognostic (1.37e-1)" "unprognostic (1.34e-1)" "unprognostic (1.24e-1)" "unprognostic (1.09e-1)" "unprognostic (3.86e-2)" "unprognostic (1.70e-2)" "unprognostic (6.05e-3)" "unprognostic (1.05e-1)" "unprognostic (8.08e-2)" "unprognostic (2.46e-1)" "unprognostic (1.78e-3)" 10.8 12.6 9.8 18.1 15.0 16.7 13.1 17.1 14.6 10.5 10.3 20.6 8.6 12.5 11.8 7.6 14.3 11.7 9.0 15.4 11.0 7.5 7.5 5.9 10.5 12.5 14.1 10.7 12.1 13.0 10.8 12.6 10.9 14.7 13.7 7.8 15.1 14.1 9.1 18.3 12.9 13.6 9.5 11.4 15.8 13.8 16.9 13.3 16.0 10.2 7.4 11.3 14.9 11.4 4.0 10.4 11.5 6.5 9.3 15.7 4.0 12.5 8.2 16.0 7.5 7.6 7.0 9.9 8.7 6.9 8.7 7.2 14.4 9.7 5.3 8.3 9.1 8.8 6.6 7.0 11.7 5.1 20.5 10.1 18.0 13.4 8.8 5.0 6.5 9.4 6.2 8.0 9.1 9.8 6.6 12.6 10.3 11.6 12.2 7.2 11.3 10.0 9.9 8.7 11.0 8.7 10.2 6.6 10.6 5.3 11.4 8.6 5.5 13.4 8.8 7.7 4.4 9.4 6.4 17.1 7.1 5.1 10.1 6.5 12.6 6.3 5.0 7.7 11.0 11.9 8.1 5.4 11.5 15.7 6.3 9.9 3.2 6.9 10.4 2.9 4.0 5.0 9.7 10.4 9.3 6.5 10.4 5.6 4.0 9.8 15.0 17.1 14.6 11.0 7.5 14.1 10.7 14.7 13.3 38.7 19.2 13.7 8.6 13.1 54.6 23.8 12.7 6.7 20.5 14.0 110.0 8.3 8.3 9.1 14.6 29.2 18.8 0.0 9.4 6.6 14.1 16.4 12.7 9.5 15.0 17.5 23.1 31.9 37.8 18.2 22.2 16.5 6.8 11.8 21.1 15.4 14.7 14.4 20.8 6.8 214.6 25.8 9.0 36.4 28.8 15.4 9.4 23.6 20.0 12.9 DIRC1 ENSG00000174325 "Disrupted in renal carcinoma 1" Q969H9 2 188734155-188790104 "Disease related genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 5.9;gallbladder: 2.1" "Group enriched" "Detected in some" 7 "Early spermatids: 1.8;Late spermatids: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC TERT1: 24.7;HSkMC: 9.0" HPA068508 Approved Nucleoplasm NA NA Nucleoplasm "HPA068508: AB_2732783" "unprognostic (3.11e-2)" "unprognostic (1.69e-1)" "unprognostic (3.80e-2)" "unprognostic (2.77e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-2)" "unprognostic (2.07e-1)" "unprognostic (1.00e-1)" "unprognostic (7.39e-4)" "unprognostic (6.95e-2)" 1.4 0.0 0.0 0.4 0.0 0.0 5.9 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.7 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 24.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 DLL1 ENSG00000198719 "Delta like canonical Notch ligand 1" O00548 6 170282206-170306565 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.9" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 59.4;Intestinal endocrine cells: 49.7;Mucus-secreting cells: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 7.3" "Lineage enriched" "Detected in single" 8 "NK-cells: 7.3" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;HBEC3-KT: 10.8;NB-4: 17.8;THP-1: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078298 Uncertain Nucleoplasm NA NA 210000 Nucleoplasm "HPA078298: " "unprognostic (1.03e-1)" "unprognostic (9.22e-2)" "unprognostic (2.17e-3)" "unprognostic (1.95e-1)" "unprognostic (2.89e-2)" "unprognostic (6.35e-2)" "unprognostic (1.63e-2)" "unprognostic (1.89e-1)" "unprognostic (9.22e-2)" "unprognostic (1.14e-2)" "unprognostic (1.39e-2)" "unprognostic (2.64e-2)" "unprognostic (5.23e-3)" "unprognostic (3.50e-1)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.66e-1)" 8.9 5.7 4.1 5.5 9.0 3.2 8.6 2.5 13.8 7.4 10.3 18.5 2.6 8.1 6.0 3.0 11.1 5.7 11.4 7.2 5.2 4.0 5.8 13.5 6.8 5.6 5.5 5.2 2.5 13.8 2.2 3.1 5.0 10.0 14.5 5.2 14.3 8.9 7.1 3.8 14.3 13.1 3.9 4.6 36.9 5.9 1.6 7.3 0.9 6.1 5.3 6.3 4.5 11.0 0.0 0.0 0.1 0.9 7.3 0.5 0.2 0.9 0.1 4.3 2.7 0.3 0.2 2.3 0.2 0.6 0.3 0.5 1.1 0.1 0.0 0.2 0.1 0.7 7.0 2.7 10.8 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 3.1 0.1 2.0 0.0 1.1 0.2 1.1 0.1 0.0 0.0 0.4 3.0 0.0 17.8 0.6 0.4 0.0 0.8 4.3 0.1 0.0 1.3 1.9 0.1 0.3 0.0 0.0 1.6 0.7 14.7 0.5 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.8 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.3 0.1 7.3 0.9 0.0 0.0 0.2 4.1 9.0 2.5 11.2 5.2 4.0 5.5 5.2 10.0 7.3 0.0 0.3 0.0 15.5 59.4 0.7 4.6 0.0 10.7 10.3 1.8 21.6 2.4 0.0 0.3 0.3 18.9 1.6 0.0 1.5 5.2 8.9 3.8 5.7 0.0 1.0 0.0 49.7 20.9 3.9 1.2 0.3 2.5 6.8 0.0 76.5 1.0 0.9 2.9 1.1 0.0 0.6 12.9 9.0 0.5 1.9 11.2 3.1 0.0 2.6 0.9 DLX4 "BP1, DLX7, DLX8, DLX9" ENSG00000108813 "Distal-less homeobox 4" Q92988 17 49968970-49974959 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 14.7;skin 1: 6.0" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 67.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 18.6;CACO-2: 13.1;GAMG: 12.4;HAP1: 9.0;K-562: 10.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059933 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA059933: AB_2684169" "unprognostic (8.12e-2)" "unprognostic (2.48e-1)" "unprognostic (1.26e-2)" "unprognostic (2.29e-3)" "unprognostic (7.49e-2)" "unprognostic (2.71e-1)" "unprognostic (9.35e-3)" "unprognostic (2.85e-2)" "unprognostic (8.73e-2)" "unprognostic (5.93e-2)" "unprognostic (1.29e-2)" "unprognostic (4.34e-2)" "unprognostic (2.88e-13)" "unprognostic (8.79e-3)" "unprognostic (2.77e-1)" "unprognostic (5.00e-2)" "unprognostic (6.86e-2)" 0.4 0.3 0.2 1.2 0.7 0.4 0.7 0.3 0.8 0.8 0.6 0.8 0.2 0.2 0.2 0.6 1.5 0.5 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.5 0.2 0.2 0.2 0.7 0.1 0.2 14.7 1.4 0.5 0.3 0.5 2.7 0.6 0.2 6.0 1.5 0.2 0.2 0.8 0.3 0.5 0.2 0.2 0.6 3.8 1.2 0.4 0.8 0.1 0.9 0.0 1.3 1.0 0.8 0.3 0.4 1.1 0.0 0.1 0.1 0.0 18.6 0.1 0.1 0.0 0.3 13.1 0.8 0.5 2.7 0.2 12.4 1.8 9.0 0.3 0.0 3.5 4.7 0.3 4.5 1.3 0.0 0.7 3.1 0.0 2.3 0.1 0.0 0.1 0.0 2.7 10.3 0.0 0.0 2.2 0.3 4.7 0.2 2.4 0.0 0.0 4.2 0.4 0.1 0.6 1.5 0.0 0.3 1.6 0.8 2.9 3.3 3.1 0.0 0.0 0.9 0.2 0.0 0.7 0.1 0.0 0.3 2.4 0.0 0.0 0.3 0.0 0.8 1.3 0.0 0.0 0.0 0.4 0.7 0.1 0.2 0.0 0.0 1.0 1.3 0.9 0.0 0.3 0.2 0.7 0.3 0.8 0.2 0.2 0.2 0.2 1.4 0.2 6.0 0.0 0.0 0.3 2.3 0.0 2.0 0.0 2.7 0.0 0.0 0.0 10.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 67.1 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.5 14.1 0.0 0.0 0.3 DLX5 ENSG00000105880 "Distal-less homeobox 5" P56178 7 97020392-97024950 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Osteogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 17.7;placenta: 44.5;skin 1: 20.6" "Cell type enhanced" "Detected in some" 19 "Cytotrophoblasts: 128.5;Extravillous trophoblasts: 203.8;Sertoli cells: 58.2;Syncytiotrophoblasts: 263.3" "Cancer enriched" "Detected in many" 11 "endometrial cancer: 81.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 32.9;HAP1: 16.5;SuSa: 8.6" "Group enriched" "Detected in many" 4 "basal ganglia: 13.5;olfactory region: 36.5" "Region enhanced" "Detected in many" "olfactory region: 24.3" HPA005670 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA005670: AB_1078681" "unprognostic (3.99e-1)" "unprognostic (1.05e-1)" "unprognostic (2.96e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (2.86e-2)" "unprognostic (6.14e-2)" "unprognostic (2.46e-2)" "unprognostic (5.89e-2)" "unprognostic (6.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.01e-2)" "unprognostic (7.43e-8)" "unprognostic (1.39e-2)" "unprognostic (3.73e-1)" "unprognostic (1.16e-1)" "unprognostic (2.55e-1)" 1.5 0.6 2.7 0.5 11.5 0.3 1.5 0.1 3.9 10.0 0.6 0.3 1.4 0.7 17.7 1.7 5.8 2.0 0.8 1.2 2.2 4.5 0.4 0.2 0.4 1.9 0.5 2.5 2.1 0.2 0.4 1.9 44.5 0.0 1.8 0.3 0.1 3.6 3.9 0.6 20.6 0.3 1.4 0.2 0.3 0.3 1.2 3.1 2.5 1.6 6.5 2.7 1.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 3.7 16.5 0.0 0.0 0.0 2.8 0.0 0.3 0.2 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 2.1 0.9 1.3 0.1 0.0 0.0 8.6 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.0 0.0 2.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 11.5 0.1 3.9 2.2 4.5 0.5 2.5 0.0 3.1 0.0 0.0 0.0 0.7 8.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 128.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 203.8 2.2 1.1 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 58.2 7.1 1.8 6.0 18.1 263.3 0.0 0.0 1.4 DMC1 LIM15 ENSG00000100206 "DNA meiotic recombinase 1" Q14565 22 38518949-38570286 "Predicted intracellular proteins" "Cell cycle, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.1" "Cell type enhanced" "Detected in many" 21 "Erythroid cells: 23.3;Sertoli cells: 12.9;Spermatocytes: 61.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 17.7;hTEC/SVTERT24-B: 12.6;U-266/84: 14.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA001232, CAB015397" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB015397: AB_629406, HPA001232: AB_1078683" "unprognostic (1.29e-2)" "unprognostic (3.11e-3)" "unprognostic (4.48e-3)" "unprognostic (5.71e-2)" "unprognostic (6.43e-2)" "unprognostic (2.22e-1)" "unprognostic (8.22e-2)" "unprognostic (2.61e-2)" "unprognostic (4.23e-2)" "unprognostic (3.99e-3)" "unprognostic (7.40e-3)" "unprognostic (1.00e-2)" "unprognostic (2.16e-4)" "unprognostic (3.94e-1)" "unprognostic (2.79e-1)" "unprognostic (7.27e-2)" "unprognostic (2.99e-1)" 1.7 0.6 1.6 4.7 2.0 3.1 4.4 2.2 2.0 2.5 1.3 0.7 1.2 0.4 3.7 2.6 1.5 1.6 1.8 3.3 2.5 1.1 1.0 0.5 1.1 3.9 2.8 1.5 1.8 0.8 0.8 1.1 1.0 3.2 2.9 1.6 2.7 1.0 1.3 1.8 2.5 1.1 3.4 4.4 0.9 1.0 24.1 2.3 8.2 0.8 3.2 4.5 2.0 3.8 1.2 0.8 3.3 1.0 2.5 1.5 0.4 4.9 1.9 3.7 0.1 0.3 1.5 0.2 5.3 0.7 8.5 5.9 0.2 0.6 2.5 0.2 1.4 0.0 0.9 1.4 0.2 9.7 17.7 0.3 9.5 1.4 0.1 0.1 0.8 2.1 0.4 0.0 12.6 0.0 0.0 0.7 8.0 7.1 2.6 3.0 2.8 1.9 7.2 6.5 2.4 0.1 4.2 0.0 3.6 1.1 0.7 7.2 0.4 8.9 0.8 0.1 0.9 1.6 2.1 0.2 0.1 0.5 0.1 0.1 7.1 14.7 4.5 1.5 2.0 0.7 2.2 1.0 0.5 1.5 0.3 0.3 0.5 1.3 0.6 0.8 1.2 1.2 0.5 3.3 2.5 0.6 0.7 0.7 0.4 1.6 2.0 2.2 2.0 2.5 1.1 2.8 1.5 3.2 2.3 0.0 2.9 0.0 0.7 2.1 0.6 2.0 0.0 1.4 4.5 3.5 0.0 0.8 1.7 0.2 1.9 0.6 0.0 23.3 0.0 1.3 1.2 0.2 1.1 0.0 0.8 0.0 0.0 0.6 0.0 1.6 1.4 0.8 0.0 0.0 0.8 2.3 0.1 0.0 1.4 0.0 0.3 12.9 0.8 61.6 8.3 0.5 0.7 1.0 2.1 0.0 DMTF1 "DMP1, DMTF, hDMP1, MRUL" ENSG00000135164 "Cyclin D binding myb like transcription factor 1" Q9Y222 7 87152361-87196337 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023846 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA023846: AB_1847779" "unprognostic (3.86e-2)" "unprognostic (1.88e-1)" "unprognostic (9.82e-2)" "unprognostic (8.54e-2)" "unprognostic (3.13e-1)" "unprognostic (2.26e-3)" "unprognostic (9.77e-3)" "unprognostic (2.53e-3)" "unprognostic (6.89e-2)" "unprognostic (2.56e-3)" "unprognostic (1.15e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (6.39e-2)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (1.09e-3)" 16.8 14.2 22.5 17.8 27.2 24.3 19.1 35.2 24.2 19.2 17.8 19.2 22.3 15.0 23.7 35.0 12.3 19.6 14.0 14.1 23.0 15.1 14.5 10.6 18.4 17.2 28.9 20.0 27.1 14.8 24.9 41.6 16.4 23.1 17.0 18.3 14.3 13.4 16.9 10.0 17.9 17.7 19.9 23.6 17.5 13.5 42.0 32.4 29.4 25.0 7.0 16.6 18.2 17.0 10.3 5.9 13.6 5.1 6.6 10.0 3.5 12.2 6.3 27.6 22.8 7.9 13.7 11.5 15.3 6.0 9.1 14.6 5.5 11.4 15.4 11.1 9.7 10.7 6.9 19.5 10.7 17.7 8.1 9.9 11.2 17.2 8.3 7.8 10.4 12.2 12.8 8.5 17.8 17.5 14.9 11.6 16.9 19.2 18.0 14.6 11.4 18.5 12.9 21.6 8.0 11.4 16.1 14.9 10.0 8.2 10.8 18.9 23.5 19.7 7.5 12.0 35.9 11.2 6.5 14.8 16.8 8.3 21.4 13.7 14.2 19.9 28.2 9.4 8.3 14.6 13.6 4.4 8.8 10.0 4.8 9.2 10.3 7.7 7.0 3.6 9.3 9.2 8.2 6.8 6.6 5.1 5.9 9.1 3.5 22.5 27.2 35.2 24.2 23.0 15.1 28.9 20.0 23.1 32.4 20.8 24.8 18.9 14.2 11.6 25.0 9.4 12.7 25.4 20.5 3.5 35.3 12.2 3.3 8.7 19.4 19.5 16.6 0.0 7.0 7.4 11.3 19.7 34.8 8.6 9.4 17.5 18.9 20.9 19.6 9.9 21.6 16.0 0.0 10.8 12.8 11.9 8.1 17.5 21.2 3.0 25.8 32.3 12.0 53.4 18.6 11.0 6.4 27.7 10.3 18.4 DNAJB1 "Hsp40, HSPF1, RSPH16B, Sis1" ENSG00000132002 "DnaJ heat shock protein family (Hsp40) member B1" P25685 19 14514770-14529770 "Cancer-related genes, Predicted intracellular proteins" "Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 291.1" "Cell type enhanced" "Detected in many" 4 "Smooth muscle cells: 802.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017450, HPA063247" Enhanced Supported Nucleoplasm NA Yes 9600 Nucleoplasm "CAB017450: AB_10631418, HPA063247: AB_2684971" "unprognostic (3.75e-2)" "unprognostic (2.23e-1)" "unprognostic (1.46e-1)" "unprognostic (2.12e-1)" "unprognostic (1.60e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "unprognostic (1.74e-2)" "unprognostic (3.83e-1)" "unprognostic (1.85e-1)" "unprognostic (7.91e-3)" "unprognostic (2.17e-1)" "prognostic favorable (5.96e-4)" "unprognostic (2.20e-2)" "unprognostic (4.44e-2)" "unprognostic (2.00e-2)" "unprognostic (6.77e-2)" 29.2 76.9 28.5 13.2 30.0 36.2 67.0 41.4 29.4 19.3 15.5 21.5 14.5 10.5 20.4 11.8 72.3 21.7 56.4 23.5 28.2 31.6 23.4 37.7 35.7 10.7 53.4 12.0 32.3 22.6 18.3 25.0 33.5 45.8 29.6 13.1 12.2 18.4 40.8 16.1 25.3 9.5 24.0 40.2 9.4 19.1 37.5 37.9 15.0 28.9 18.0 31.1 19.2 291.1 19.7 15.2 28.2 31.6 23.0 61.6 56.7 36.9 39.3 14.2 15.1 26.2 21.1 8.9 24.6 18.3 39.0 29.5 23.2 20.9 10.2 28.2 20.9 25.5 28.1 29.1 17.7 27.7 10.7 14.4 16.3 26.0 48.6 17.9 11.5 15.5 11.7 42.4 15.1 13.2 20.4 12.8 6.9 24.1 110.7 21.4 23.4 18.5 10.7 15.1 48.9 42.4 14.2 20.0 23.0 17.7 12.7 13.1 9.7 22.3 44.2 24.2 16.6 12.1 11.2 13.3 31.7 19.1 36.5 51.6 49.3 30.2 13.4 22.6 19.9 28.2 11.5 18.9 22.3 36.6 31.1 38.9 19.4 52.5 45.4 15.2 19.7 61.6 47.6 28.2 23.0 31.6 9.1 51.8 56.7 28.5 30.0 41.4 29.4 28.2 31.6 53.4 12.0 45.8 37.9 145.9 105.3 114.6 695.7 378.2 47.1 335.7 48.4 87.0 71.7 22.7 111.9 123.3 34.9 105.0 377.6 275.7 133.0 0.0 143.2 142.5 617.3 678.1 342.8 50.4 134.5 49.3 390.0 73.1 71.9 368.9 58.7 232.5 477.5 35.1 126.4 109.5 97.8 108.7 34.6 43.9 149.2 25.8 802.9 139.1 31.8 418.7 229.9 251.4 123.6 238.8 DNAJC17 FLJ10634 ENSG00000104129 "DnaJ heat shock protein family (Hsp40) member C17" Q9NVM6 15 40765155-40807478 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chaperone, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040914, HPA041187" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040914: AB_10794072, HPA041187: AB_10794192" "unprognostic (9.79e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.65e-1)" "unprognostic (2.84e-1)" "unprognostic (1.94e-1)" "unprognostic (5.98e-2)" "unprognostic (5.37e-2)" "unprognostic (2.72e-1)" "unprognostic (4.78e-1)" "unprognostic (2.64e-2)" "unprognostic (6.58e-2)" 17.0 15.7 19.5 13.0 18.5 7.5 19.8 38.0 22.1 18.3 17.8 20.5 12.7 11.0 20.1 15.4 19.7 19.7 15.2 12.6 14.0 10.3 16.7 23.6 14.7 16.6 16.0 17.3 23.7 16.2 19.4 12.6 18.4 17.2 15.9 15.6 16.2 19.1 16.0 13.6 18.2 15.1 17.2 13.9 19.1 14.1 7.7 19.0 12.1 17.3 11.8 21.2 13.7 17.9 14.8 17.1 19.5 20.0 8.5 26.1 9.2 5.9 5.5 13.9 13.4 6.3 15.8 5.9 11.4 11.3 19.2 15.8 4.4 8.7 9.4 12.6 13.6 8.8 12.7 14.1 18.6 17.0 17.2 8.8 15.8 11.1 4.2 17.8 8.1 14.1 15.6 12.0 15.1 27.3 10.7 17.6 16.1 11.0 5.0 14.6 7.7 11.9 11.0 5.0 14.2 8.1 8.8 11.5 4.8 19.3 11.1 8.8 5.6 8.3 7.7 6.0 10.3 9.8 16.5 17.2 10.9 9.4 12.3 9.6 5.6 16.5 20.5 7.0 21.2 9.2 17.6 15.8 19.5 18.6 20.0 13.1 14.0 15.9 17.3 17.1 14.8 17.3 16.5 5.7 8.5 11.3 13.9 26.1 9.2 19.5 18.5 38.0 22.1 14.0 10.3 16.0 17.3 17.2 19.0 11.9 16.0 10.0 17.1 4.9 14.0 4.7 15.3 18.7 23.9 24.4 11.8 20.3 16.6 15.7 2.0 10.5 21.4 0.0 15.5 13.7 11.3 11.6 20.9 12.5 20.2 12.7 7.5 20.9 9.5 1.4 14.1 15.4 6.8 13.6 12.5 6.6 14.8 20.7 15.2 17.7 9.8 0.0 10.3 4.7 3.9 4.5 14.4 17.8 15.1 19.5 DNAJC8 SPF31 ENSG00000126698 "DnaJ heat shock protein family (Hsp40) member C8" O75937 1 28199456-28233025 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026275, HPA026283" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA026275: AB_2671823, HPA026283: AB_10600907" "unprognostic (1.42e-1)" "unprognostic (2.44e-2)" "unprognostic (5.71e-2)" "prognostic favorable (6.95e-5)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (4.71e-4)" "unprognostic (2.54e-1)" "unprognostic (3.07e-3)" "unprognostic (9.57e-2)" "unprognostic (3.93e-1)" "unprognostic (1.65e-1)" "unprognostic (1.23e-1)" "unprognostic (1.72e-1)" "unprognostic (5.50e-2)" "prognostic favorable (2.39e-4)" "unprognostic (4.84e-2)" 27.3 26.9 35.9 27.8 40.1 27.5 27.7 33.6 40.7 26.3 27.2 33.6 15.8 22.6 33.1 25.9 24.5 23.6 22.5 30.5 31.2 31.7 29.0 29.1 23.4 38.5 34.2 32.5 32.0 15.0 20.0 23.8 32.4 38.2 30.0 25.4 21.4 20.7 26.1 26.4 21.8 21.8 36.0 33.0 30.3 22.3 15.7 36.0 30.8 35.1 19.9 42.8 29.6 27.7 31.9 34.8 29.6 30.8 29.6 37.0 44.0 24.9 12.9 20.4 23.4 24.7 20.3 18.2 20.8 26.0 42.0 38.6 13.5 20.4 28.7 21.6 23.1 20.8 15.5 29.9 20.4 44.6 22.5 22.2 36.8 19.8 23.9 22.3 36.2 30.4 15.5 18.3 26.5 14.0 19.8 27.8 23.9 34.3 20.2 30.6 14.5 27.5 25.4 36.9 15.6 15.0 31.3 30.2 27.5 26.7 20.6 7.4 19.1 27.3 11.7 24.6 15.8 16.8 29.6 21.3 18.8 20.4 41.9 30.9 19.2 25.1 45.1 25.2 44.3 25.4 29.6 30.5 27.8 37.0 29.3 37.0 31.9 33.5 36.1 33.1 30.7 33.6 34.1 16.2 29.6 30.8 34.8 35.1 44.0 35.9 40.1 33.6 40.7 31.2 31.7 34.2 32.5 38.2 36.0 71.5 77.9 119.9 114.0 115.2 95.1 130.7 76.5 89.7 100.1 101.2 23.6 164.5 228.8 122.3 29.6 126.6 51.6 70.0 85.7 129.7 132.6 93.6 134.3 64.5 156.1 65.2 44.2 86.5 68.5 31.5 111.7 136.1 97.8 171.3 45.8 156.0 94.7 57.5 135.4 133.6 90.4 84.1 106.1 126.5 83.5 96.4 187.4 117.7 62.3 94.7 DNM1 DNM ENSG00000106976 "Dynamin 1" Q05193 9 128191655-128255248 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, Motor protein" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 133.5" "Group enriched" "Detected in many" 10 "Bipolar cells: 113.1;Cone photoreceptor cells: 84.4;Horizontal cells: 47.7;Rod photoreceptor cells: 70.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 49.8;U-87 MG: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005920, HPA049910, HPA061801" Enhanced Supported Nucleoplasm NA NA 440000 Nucleoplasm "CAB005920: , HPA049910: AB_2680948, HPA061801: AB_2797266" "unprognostic (3.25e-2)" "unprognostic (5.49e-2)" "unprognostic (1.34e-3)" "unprognostic (3.95e-2)" "unprognostic (4.57e-2)" "unprognostic (1.16e-1)" "unprognostic (3.60e-3)" "unprognostic (1.20e-1)" "unprognostic (5.53e-2)" "unprognostic (6.53e-2)" "unprognostic (6.62e-3)" "unprognostic (6.30e-1)" "unprognostic (9.58e-2)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (3.07e-3)" "unprognostic (1.10e-3)" 5.9 6.1 31.5 3.3 36.9 2.3 4.6 57.7 133.5 11.7 3.0 2.5 0.0 2.4 4.6 2.7 3.3 6.3 9.0 2.7 33.4 24.0 2.9 1.8 2.5 2.5 18.3 33.0 1.6 4.7 3.2 5.5 2.7 33.0 2.9 2.9 4.3 2.6 3.1 2.3 4.6 3.3 4.4 5.1 1.6 2.6 4.0 1.8 0.0 1.9 0.4 2.3 3.6 3.7 0.3 0.4 0.5 0.3 0.0 0.3 0.7 3.3 49.8 4.5 1.1 1.4 15.2 0.2 3.1 7.5 6.3 2.6 0.6 1.0 0.0 4.3 6.5 0.2 6.0 0.7 0.3 3.5 0.0 4.8 3.1 7.1 0.2 1.0 0.4 2.2 4.0 0.1 4.9 0.0 6.1 0.0 2.9 1.1 0.2 0.0 1.4 0.2 1.0 4.8 0.8 9.1 5.9 0.1 1.5 0.9 0.0 6.5 10.9 10.6 0.3 0.4 0.6 0.1 4.3 0.2 0.2 14.4 14.5 6.3 0.4 0.1 0.3 19.0 0.1 1.0 0.0 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.4 0.2 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.7 31.5 36.9 57.7 71.8 33.4 24.0 18.3 33.0 33.0 1.8 0.0 0.0 0.0 1.6 7.0 113.1 2.0 7.6 1.4 1.2 0.0 84.4 0.2 1.7 0.7 0.5 1.5 0.6 0.0 0.7 0.2 3.9 0.7 1.1 0.5 8.0 47.7 0.0 0.0 0.8 0.4 2.6 1.9 3.3 1.0 0.1 8.1 1.0 2.9 1.4 3.4 70.6 0.0 4.1 0.3 1.3 6.6 0.7 0.7 0.6 0.5 DNMT1 "CXXC9, DNMT, MCMT" ENSG00000130816 "DNA methyltransferase 1" P26358 19 10133345-10231286 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Deafness, Disease mutation, FDA approved drug targets, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Cytotrophoblasts: 329.4;Spermatocytes: 249.6;Syncytiotrophoblasts: 270.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002694, CAB005876" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB005876: AB_731983, HPA002694: AB_1847810" "unprognostic (3.51e-1)" "unprognostic (1.20e-2)" "unprognostic (1.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.62e-1)" "unprognostic (7.59e-3)" "prognostic unfavorable (1.46e-4)" "unprognostic (2.90e-1)" "unprognostic (4.23e-3)" "unprognostic (1.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.28e-3)" "unprognostic (7.81e-3)" "unprognostic (1.73e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" 12.1 7.6 9.8 20.2 10.8 31.9 11.5 27.1 14.4 12.0 8.6 10.0 4.3 8.1 12.1 8.0 12.0 11.5 7.8 8.0 9.3 8.1 6.9 9.2 11.8 29.7 12.5 7.9 11.1 6.2 10.2 8.8 32.5 8.7 8.3 10.7 7.8 9.3 6.5 6.8 10.8 11.3 11.2 9.1 11.0 9.0 19.9 12.6 31.4 9.5 8.8 28.8 11.4 9.7 12.6 19.0 10.2 13.4 25.0 18.2 6.8 24.3 15.4 19.7 16.7 7.3 7.5 42.3 16.5 13.1 23.8 23.9 14.9 13.3 40.8 10.4 10.1 12.0 16.1 21.7 12.9 24.4 16.0 32.3 59.1 13.8 7.7 3.2 24.0 24.0 5.0 2.5 20.8 8.2 7.2 12.9 12.6 23.4 25.2 17.7 16.2 35.1 32.8 25.9 11.0 22.5 35.6 20.7 22.4 7.5 15.4 21.0 16.3 20.0 9.0 6.4 12.6 9.4 12.2 9.7 40.0 13.7 24.2 24.4 20.6 21.5 48.3 11.6 22.4 31.0 10.2 13.4 3.3 18.2 13.2 15.9 7.9 14.6 12.5 11.3 12.6 16.6 12.3 3.1 25.0 7.9 19.0 12.9 6.8 9.8 10.8 27.1 14.4 9.3 8.1 12.5 7.9 8.7 12.6 6.0 24.5 38.8 19.1 26.3 66.8 11.9 7.6 48.2 29.6 21.0 53.0 329.4 11.6 20.3 42.9 33.0 4.7 93.5 12.4 56.3 25.7 12.5 34.8 12.1 68.9 62.0 15.1 24.5 28.2 38.6 25.9 51.5 13.5 45.1 16.3 39.9 15.7 11.5 26.9 7.6 50.4 12.9 22.0 249.6 179.2 19.6 270.7 54.2 37.6 14.1 DNMT3A ENSG00000119772 "DNA methyltransferase 3 alpha" Q9Y6K1 2 25227855-25342590 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 119.8;Horizontal cells: 90.6;Rod photoreceptor cells: 144.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 25.7;REH: 25.4;SH-SY5Y: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009469, HPA026588" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009469: AB_2093990, HPA026588: AB_1847812" "unprognostic (2.38e-1)" "unprognostic (2.94e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (8.38e-2)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (7.25e-2)" "unprognostic (2.72e-1)" "prognostic favorable (1.18e-4)" "unprognostic (2.35e-2)" "prognostic unfavorable (2.49e-4)" "unprognostic (1.43e-1)" "unprognostic (1.87e-1)" "unprognostic (1.14e-1)" "unprognostic (2.70e-2)" 7.8 12.4 13.7 12.7 15.5 10.8 8.6 21.6 20.1 9.0 12.7 14.5 7.6 9.1 13.0 12.2 8.0 9.6 8.9 8.2 12.3 6.7 9.4 6.9 9.5 13.6 15.3 10.1 18.3 12.1 6.3 12.6 20.8 10.7 9.3 9.2 12.0 8.5 9.2 29.1 6.6 11.4 11.3 7.9 17.5 11.6 6.6 15.2 20.8 9.1 10.5 11.8 9.8 8.4 3.0 4.1 4.9 4.1 8.7 8.3 2.3 1.1 3.5 14.9 3.6 1.6 1.2 19.5 1.0 0.9 2.0 1.6 8.8 5.7 0.0 2.2 1.9 1.6 1.0 1.6 2.2 1.2 3.7 2.6 6.4 5.3 10.5 3.9 1.3 4.1 3.6 1.1 2.6 0.9 3.9 8.3 14.5 7.3 1.4 1.5 8.5 13.9 15.1 25.7 5.9 1.9 25.4 16.4 2.1 1.2 1.5 8.8 31.3 1.2 8.4 2.6 13.4 1.0 6.7 2.8 2.5 3.3 0.6 1.3 3.2 2.2 8.6 0.9 3.8 2.6 4.7 1.8 3.1 5.2 3.0 7.0 2.3 3.4 4.9 2.0 3.0 8.3 6.6 4.9 8.7 4.1 4.1 2.8 2.3 13.7 15.5 21.6 20.1 12.3 6.7 15.3 10.1 10.7 15.2 6.0 13.3 10.0 8.3 4.6 74.9 13.7 5.1 9.4 12.5 19.2 119.8 30.2 5.0 13.8 1.5 14.6 5.3 0.0 8.5 9.4 14.7 11.7 36.9 5.5 19.8 90.6 12.6 6.2 10.5 1.1 17.8 11.9 6.8 4.6 11.5 22.7 9.2 10.5 14.5 5.6 144.9 19.4 8.2 2.3 13.4 2.3 26.9 18.7 11.0 6.7 DNMT3B ENSG00000088305 "DNA methyltransferase 3 beta" Q9UBC3 20 32762385-32809356 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Activator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.7;testis: 23.3" "Cell type enhanced" "Detected in some" 7 "Cytotrophoblasts: 3.7;Extravillous trophoblasts: 3.8;Horizontal cells: 4.8;Sertoli cells: 6.5;Syncytiotrophoblasts: 4.0" "Cancer enriched" "Detected in all" 25 "testis cancer: 111.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 55.3;CACO-2: 20.8;HEL: 21.7;K-562: 20.8;NTERA-2: 74.7;SuSa: 41.2" "Low region specificity" "Detected in some" "HPA001595, HPA001803, CAB069896" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: " "unprognostic (7.65e-3)" "unprognostic (3.52e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (5.04e-4)" "unprognostic (3.42e-1)" "unprognostic (7.27e-2)" "unprognostic (4.39e-4)" "unprognostic (4.18e-3)" "unprognostic (8.60e-3)" "unprognostic (8.48e-2)" "unprognostic (6.79e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.87e-7)" "unprognostic (6.62e-2)" "unprognostic (1.00e-1)" "unprognostic (1.50e-1)" "unprognostic (6.55e-2)" 1.1 0.8 0.9 2.5 0.9 4.7 2.4 4.5 1.4 1.6 2.1 0.7 0.5 0.9 1.3 4.7 1.6 1.1 1.6 1.8 0.8 0.7 2.7 1.2 1.2 1.9 0.9 0.5 1.2 7.5 2.5 1.1 2.8 0.8 1.1 0.8 1.2 3.5 1.6 0.5 5.5 0.8 1.0 0.5 1.3 1.1 23.3 0.8 17.7 2.6 1.7 2.5 2.7 2.2 0.7 1.0 0.0 0.2 0.9 1.3 0.1 0.8 1.1 6.0 1.4 0.1 0.5 55.3 0.7 0.5 0.8 0.8 20.8 0.9 2.1 2.2 0.3 0.9 0.5 3.9 0.3 0.6 0.2 3.1 21.7 0.7 3.9 0.2 0.9 2.2 0.5 0.4 1.2 0.2 0.4 1.4 1.3 20.8 0.6 0.3 3.3 3.3 18.4 74.7 1.9 0.7 3.3 1.0 0.5 2.0 0.9 1.9 1.2 1.3 1.9 0.5 41.2 1.2 1.1 0.3 1.2 2.8 0.6 0.5 1.3 0.6 0.8 0.5 5.9 0.5 0.0 0.2 0.0 0.1 0.1 0.1 0.7 0.2 0.0 1.0 0.0 1.3 0.0 0.0 0.9 0.1 0.9 0.0 0.1 0.9 0.9 4.5 1.4 0.8 0.7 0.9 0.5 0.8 0.8 0.0 1.0 0.0 0.1 0.8 1.4 1.1 0.0 0.0 1.2 0.0 2.0 3.7 0.0 0.9 0.0 0.4 0.0 0.0 0.5 3.8 0.9 0.6 0.0 0.0 0.6 4.8 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.8 1.1 0.0 0.4 0.6 2.1 6.5 0.4 0.0 2.5 1.1 4.0 0.0 0.8 0.0 DOCK1 "ced5, DOCK180" ENSG00000150760 "Dedicator of cytokinesis 1" Q14185 10 126905409-127452517 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 1.5;plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004378, HPA048692, HPA053277" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004378: AB_2094604, HPA048692: AB_2680495, HPA053277: AB_2682097" "unprognostic (4.27e-2)" "unprognostic (4.22e-3)" "unprognostic (1.49e-3)" "unprognostic (8.98e-3)" "unprognostic (2.57e-2)" "unprognostic (3.31e-1)" "unprognostic (4.12e-1)" "unprognostic (4.80e-2)" "unprognostic (6.85e-2)" "unprognostic (1.55e-1)" "unprognostic (2.75e-2)" "unprognostic (2.42e-1)" "unprognostic (2.61e-3)" "unprognostic (1.87e-1)" "unprognostic (3.85e-2)" "unprognostic (1.18e-1)" "unprognostic (4.83e-2)" 17.1 7.7 27.4 8.1 36.8 1.0 17.4 6.9 25.4 23.5 12.5 27.4 14.3 12.2 18.3 18.0 13.8 17.6 16.2 12.9 24.4 17.8 18.9 9.0 12.8 8.0 34.5 11.4 24.2 12.1 38.6 5.3 17.9 25.0 16.1 13.0 9.4 15.4 18.3 9.7 30.0 13.6 21.2 25.4 8.7 11.0 6.6 32.3 2.2 25.1 9.1 5.5 14.5 18.5 0.0 2.3 0.0 0.7 0.8 0.0 0.0 6.4 12.3 24.0 17.0 12.3 16.6 5.3 12.9 27.3 9.2 9.8 7.6 7.4 0.0 4.3 19.0 8.4 7.3 7.6 9.6 10.8 0.1 7.3 4.0 8.1 8.9 12.1 0.0 6.0 13.4 2.9 9.5 20.7 22.0 21.1 0.0 0.0 0.0 13.8 6.4 0.0 0.0 5.9 4.9 5.5 0.0 15.7 0.1 9.1 7.1 1.4 10.2 13.5 7.6 12.0 17.7 1.9 0.0 22.0 16.6 6.6 4.2 12.3 0.0 0.0 0.0 13.3 0.0 10.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 0.0 2.3 0.0 0.0 27.4 36.8 6.9 25.4 24.4 17.8 34.5 11.4 25.0 32.3 29.8 16.9 0.0 12.4 15.2 0.0 10.1 7.6 25.4 23.9 21.0 0.0 12.0 0.0 11.0 9.3 21.5 15.7 0.0 6.2 10.1 12.7 11.5 0.0 7.3 4.9 0.0 5.2 27.0 4.5 18.9 30.2 4.9 6.8 3.6 14.8 7.1 11.6 7.0 34.3 7.8 1.3 12.9 13.4 1.8 7.9 14.2 10.5 0.5 11.7 8.8 DOT1L "DOT1, KIAA1814, KMT4" ENSG00000104885 "DOT1 like histone lysine methyltransferase" Q8TEK3 19 2164149-2232578 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.7" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011875, HPA071217, HPA074977" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA011875: AB_2668552, HPA071217: AB_2686364, HPA074977: " "unprognostic (1.41e-2)" "unprognostic (1.44e-1)" "unprognostic (2.26e-1)" "prognostic favorable (1.69e-4)" "unprognostic (1.08e-1)" "prognostic favorable (6.00e-4)" "unprognostic (2.53e-3)" "unprognostic (2.21e-1)" "unprognostic (1.57e-2)" "unprognostic (1.67e-2)" "unprognostic (5.25e-3)" "unprognostic (8.18e-3)" "unprognostic (2.56e-1)" "unprognostic (1.73e-3)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" 7.3 8.8 7.0 10.7 11.7 20.1 5.1 20.6 11.7 4.5 7.9 9.8 6.0 13.5 6.4 4.9 8.3 5.4 6.9 5.7 7.0 3.6 9.5 8.5 10.0 8.4 11.9 5.3 6.5 10.8 3.6 8.3 11.6 7.1 5.7 4.9 9.5 6.1 7.4 9.8 9.9 13.0 4.2 6.7 10.4 13.3 64.7 9.7 10.5 9.2 7.0 9.1 4.8 5.3 0.7 1.0 3.0 0.9 2.8 1.4 0.6 12.2 6.6 22.4 12.2 1.7 2.5 29.5 7.0 1.5 3.8 3.1 8.4 4.6 14.4 3.4 4.5 3.3 11.0 7.4 3.9 1.8 7.3 9.3 13.2 10.8 8.2 2.7 18.9 24.4 2.4 2.9 7.4 3.8 3.1 3.1 8.2 16.0 15.1 3.0 7.0 15.1 20.9 17.3 7.8 11.8 15.6 6.3 9.9 2.1 5.8 15.0 11.6 4.9 14.6 9.2 6.2 6.7 14.5 4.4 10.7 9.8 15.8 13.4 14.0 18.3 10.0 10.6 13.1 6.2 0.5 0.7 3.0 0.9 0.3 1.4 0.7 0.8 0.2 0.9 0.7 0.5 0.3 0.3 2.8 0.9 1.0 0.1 0.6 7.0 11.7 20.6 11.7 7.0 3.6 11.9 5.3 7.1 9.7 29.8 18.9 9.9 9.3 15.8 25.0 5.2 20.4 6.7 6.8 8.7 62.8 5.3 3.3 10.1 25.8 7.1 25.4 0.0 10.4 11.3 11.0 12.4 5.8 13.1 9.3 12.7 20.0 6.7 11.9 11.9 2.8 14.6 11.8 5.4 10.8 7.3 14.1 14.0 3.2 2.2 26.6 0.0 8.1 28.3 23.5 17.3 13.6 4.9 11.7 14.2 DPF2 "BAF45d, REQ, ubi-d4" ENSG00000133884 "Double PHD fingers 2" Q92785 11 65333754-65353249 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020880, HPA056786" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA020880: AB_1847845, HPA056786: AB_2683235" "unprognostic (2.06e-1)" "unprognostic (2.13e-1)" "unprognostic (3.45e-2)" "unprognostic (2.90e-3)" "unprognostic (1.40e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (2.04e-1)" "unprognostic (3.29e-2)" "unprognostic (3.07e-1)" "unprognostic (2.43e-1)" "unprognostic (1.33e-1)" "unprognostic (6.93e-2)" "unprognostic (3.04e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" 18.5 16.3 22.5 14.3 26.4 23.0 17.0 29.4 28.6 26.3 24.8 41.7 16.9 14.1 31.5 25.5 19.5 34.9 20.8 27.1 21.4 20.4 14.7 12.2 17.3 21.4 30.4 18.6 46.3 18.1 21.9 17.7 19.8 23.2 22.9 15.9 21.7 19.7 30.5 27.6 14.2 17.9 31.2 27.3 23.3 18.9 27.0 30.3 40.6 26.1 10.8 25.8 25.2 21.3 36.9 26.4 56.1 26.5 41.8 35.2 33.7 13.6 17.3 21.9 19.1 19.7 20.0 12.3 11.8 16.8 26.2 19.0 17.0 16.5 18.6 19.6 16.1 22.5 14.5 25.1 15.2 18.8 21.9 11.0 23.5 12.3 17.2 30.6 21.4 17.4 17.6 14.8 23.3 42.8 19.4 20.9 22.2 22.2 24.3 17.1 22.0 27.0 22.0 24.3 14.7 17.7 29.5 14.3 21.5 16.2 11.4 14.3 13.0 15.3 21.6 20.6 15.0 28.1 11.8 12.2 17.0 15.1 18.5 11.9 29.9 35.1 23.7 10.4 14.1 18.9 53.0 26.5 46.9 29.4 23.9 31.7 36.7 28.6 28.5 26.4 36.9 30.0 27.1 56.1 41.8 26.1 24.2 35.2 33.7 22.5 26.4 29.4 28.6 21.4 20.4 30.4 18.6 23.2 30.3 6.0 8.5 27.4 19.8 20.1 38.5 12.4 43.3 6.7 11.4 31.4 45.2 23.2 16.6 18.4 4.1 25.2 13.2 0.0 15.1 19.3 25.3 18.7 16.1 10.5 16.8 28.6 16.7 19.6 19.3 9.5 54.4 16.4 18.6 24.4 18.2 23.6 16.0 7.0 50.2 15.9 47.0 32.3 28.1 50.6 56.1 20.3 22.2 33.3 15.8 14.8 DPF3 "BAF45c, cer-d4, Cerd4, FLJ14079" ENSG00000205683 "Double PHD fingers 3" Q92784 14 72619296-72894116 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.3;skeletal muscle: 28.4" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 33.3;Cone photoreceptor cells: 102.1;Early spermatids: 36.1;Rod photoreceptor cells: 86.0" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Region enriched" "Detected in all" 5 "cerebellum: 56.3" "Cell type enhanced" "Detected in some" "memory B-cell: 1.1;naive B-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 13.7;BJ hTERT+ SV40 Large T+: 9.4;HEL: 23.3;Karpas-707: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA066790, HPA070601" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA066790: AB_2685724, HPA070601: AB_2686284" "unprognostic (2.38e-2)" "unprognostic (2.96e-1)" "unprognostic (3.25e-1)" "unprognostic (1.56e-2)" "unprognostic (1.55e-1)" "unprognostic (9.98e-2)" "unprognostic (4.80e-2)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (3.54e-2)" "unprognostic (9.71e-3)" "unprognostic (1.02e-1)" "unprognostic (2.02e-1)" "unprognostic (3.85e-3)" "unprognostic (4.08e-2)" "unprognostic (4.80e-2)" "unprognostic (1.96e-1)" 0.7 2.2 6.2 1.1 10.3 3.2 0.8 56.3 7.6 0.9 2.7 8.4 0.0 0.8 0.8 0.5 1.2 0.7 1.0 16.8 6.4 2.5 2.2 4.3 0.8 1.5 8.9 4.5 17.8 0.7 8.4 0.9 0.9 10.4 0.7 2.4 3.4 0.8 0.7 28.4 1.1 1.7 1.2 10.1 1.4 1.1 6.6 10.7 0.0 0.8 6.3 1.8 0.8 0.7 1.9 0.0 0.0 0.3 0.4 0.8 0.2 1.5 0.0 1.2 0.1 0.2 2.3 13.7 4.1 3.9 9.4 3.6 0.0 0.1 0.2 0.2 1.2 0.2 0.1 1.3 0.6 5.8 0.2 0.5 23.3 0.1 0.0 0.3 0.1 0.4 0.6 0.2 2.2 1.6 1.6 3.0 2.5 2.0 9.5 3.0 0.1 1.9 0.2 0.0 0.0 1.3 5.1 0.6 0.3 1.6 0.0 0.9 0.5 0.0 0.1 0.0 0.4 0.0 0.0 6.5 4.6 0.0 1.7 0.5 3.4 0.9 0.3 0.4 0.9 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.2 6.2 10.3 56.3 7.6 6.4 2.5 8.9 4.5 10.4 10.7 0.0 0.0 0.9 0.0 0.6 4.7 33.3 0.0 0.0 0.0 0.0 102.1 2.2 1.7 0.0 36.1 1.8 3.9 23.3 0.3 1.2 0.8 0.1 4.6 4.2 0.4 6.4 0.0 0.6 1.5 22.2 0.3 0.9 0.0 0.0 3.3 8.1 0.5 4.0 4.6 9.9 86.0 0.0 0.8 1.7 0.7 0.3 0.1 2.5 6.3 0.0 DPH2 DPH2L2 ENSG00000132768 "DPH2 homolog" Q9BQC3 1 43970000-43973369 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045796 Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA045796: AB_2679456" "unprognostic (2.41e-1)" "unprognostic (1.15e-1)" "unprognostic (4.20e-3)" "unprognostic (9.13e-3)" "unprognostic (3.83e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.17e-8)" "unprognostic (1.38e-1)" "unprognostic (1.81e-1)" "unprognostic (3.72e-1)" "unprognostic (2.49e-1)" "unprognostic (3.42e-3)" "unprognostic (2.60e-1)" "prognostic favorable (1.37e-4)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (6.37e-2)" 9.6 12.7 13.5 12.4 14.1 7.5 9.8 7.9 18.8 8.3 12.0 12.4 5.9 8.9 9.4 7.5 15.2 10.8 11.5 11.6 11.6 6.3 11.5 21.7 8.5 14.1 13.6 9.3 9.1 21.1 10.4 10.6 8.3 9.7 9.8 11.9 5.8 11.6 9.2 33.4 13.1 9.9 11.2 7.6 13.7 10.6 14.7 12.3 10.8 8.9 14.6 13.5 10.3 7.8 9.0 10.2 0.5 9.2 9.8 10.1 5.8 9.9 11.5 5.2 11.0 3.9 4.1 17.5 5.3 5.8 13.9 11.4 14.6 9.8 16.8 9.1 5.5 7.2 11.5 17.4 15.1 7.5 11.5 15.2 17.3 14.4 15.1 10.3 19.9 9.8 6.3 16.9 16.4 9.1 4.2 9.6 13.4 21.8 9.5 6.9 11.6 17.6 11.0 35.9 16.7 13.2 15.2 11.9 27.2 8.7 8.0 17.9 20.7 7.0 17.8 12.9 7.3 7.5 13.8 6.2 6.7 15.4 11.8 21.1 23.3 38.5 17.2 6.0 22.2 9.8 0.0 6.6 0.3 6.7 9.2 9.9 9.0 6.8 6.9 10.2 8.8 7.0 10.1 0.5 9.8 4.7 8.5 6.6 5.8 13.5 14.1 7.9 18.8 11.6 6.3 13.6 9.3 9.7 12.3 0.0 3.7 17.1 9.7 20.4 6.3 8.5 10.2 6.7 3.4 1.8 9.8 12.3 5.0 14.8 0.3 6.0 2.5 0.0 16.3 12.3 7.0 9.4 4.6 4.2 7.7 3.2 11.5 3.1 1.8 0.9 7.8 5.0 5.0 10.8 6.5 4.5 11.7 0.0 3.5 7.3 5.5 0.0 11.2 8.6 27.1 23.7 7.2 6.9 11.8 8.0 DPPA2 "CT100, PESCRG1" ENSG00000163530 "Developmental pluripotency associated 2" Q7Z7J5 3 109293788-109316517 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 4.9;testis: 9.0" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 2.7;Extravillous trophoblasts: 9.2" "Cancer enriched" "Detected in some" 41 "testis cancer: 35.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Group enriched" "Detected in some" 5 "BEWO: 7.6;EFO-21: 14.5;SuSa: 8.7" HPA036134 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036134: AB_10601547" "unprognostic (2.23e-1)" "unprognostic (2.79e-1)" "unprognostic (1.81e-2)" "unprognostic (3.50e-2)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 14.5 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 8.7 0.5 0.1 0.1 0.1 2.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 DR1 "NC2-BETA, NC2B, NCB2" ENSG00000117505 "Down-regulator of transcription 1" Q01658 1 93345888-93369498 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050785, HPA055308" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA050785: AB_2681237, HPA055308: AB_2682779" "unprognostic (1.46e-1)" "unprognostic (9.62e-2)" "prognostic favorable (4.79e-4)" "unprognostic (1.03e-2)" "unprognostic (2.08e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (9.95e-7)" "unprognostic (8.70e-2)" "unprognostic (6.71e-2)" "unprognostic (1.44e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (4.30e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (4.97e-1)" "unprognostic (1.60e-1)" 18.5 15.2 14.6 19.4 17.9 37.2 16.9 20.1 18.7 19.2 19.0 17.5 12.6 19.4 20.7 9.7 26.7 13.6 17.0 19.0 14.5 13.9 17.0 17.8 19.0 28.2 15.0 10.1 17.1 14.3 14.4 17.6 25.9 14.2 17.6 12.2 16.7 18.2 10.9 32.2 27.0 21.4 15.4 15.9 21.8 21.8 44.4 14.9 63.4 17.8 17.8 25.4 20.5 22.1 19.0 28.0 39.8 26.0 16.5 27.9 18.7 33.0 10.4 16.7 21.5 15.5 17.7 20.6 26.8 16.5 18.3 19.6 12.0 12.0 35.1 31.1 19.7 24.9 17.6 20.0 18.5 27.0 29.5 18.8 29.5 21.9 13.1 24.7 34.6 21.8 12.3 22.4 25.4 37.0 19.1 16.2 21.1 30.3 34.0 21.6 10.2 32.8 10.9 27.8 11.5 25.5 28.6 36.9 35.8 12.9 20.2 16.2 20.7 22.8 21.2 28.1 15.8 15.0 27.4 25.1 33.1 26.4 32.3 40.0 19.7 21.8 36.3 9.5 27.7 13.4 36.8 22.8 39.8 19.0 26.0 21.1 19.0 21.0 21.6 28.0 16.1 21.2 20.6 31.9 16.5 22.1 22.9 27.9 18.7 14.6 17.9 20.1 18.7 14.5 13.9 15.0 10.1 14.2 14.9 26.8 23.2 41.0 28.2 152.1 30.2 28.2 22.9 12.0 25.0 34.9 23.6 62.2 38.1 30.0 119.9 35.9 27.5 46.7 24.1 58.0 36.2 39.6 48.4 24.3 46.8 47.7 20.0 32.5 46.7 83.6 26.2 41.6 42.2 63.1 37.3 14.2 36.5 23.0 24.8 31.0 24.1 32.3 43.2 95.6 40.9 140.4 91.9 44.7 23.4 63.0 DSCC1 "DCC1, hDCC1, MGC5528" ENSG00000136982 "DNA replication and sister chromatid cohesion 1" Q9BVC3 8 119833976-119856010 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 34.2" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 15.8;Spermatogonia: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA023780, HPA024401" Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA023780: AB_2671311, HPA024401: AB_2671557" "unprognostic (7.36e-3)" "unprognostic (8.24e-2)" "unprognostic (1.56e-1)" "unprognostic (4.71e-3)" "unprognostic (9.91e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.92e-6)" "prognostic unfavorable (3.93e-4)" "prognostic unfavorable (5.73e-4)" "unprognostic (3.24e-3)" "unprognostic (8.12e-3)" "unprognostic (2.72e-2)" "unprognostic (2.32e-9)" "unprognostic (2.75e-2)" "unprognostic (5.01e-1)" "unprognostic (4.40e-2)" "unprognostic (8.18e-2)" 4.3 4.7 3.6 8.5 3.9 9.2 5.4 9.4 5.0 5.1 4.6 3.3 3.5 4.1 6.2 2.4 5.8 3.0 4.7 3.4 3.9 2.6 2.1 2.5 3.3 11.5 4.0 2.0 4.1 7.0 1.3 1.6 4.0 5.3 4.1 6.4 2.1 11.4 4.3 3.9 4.5 4.0 4.9 4.2 4.1 4.0 4.8 5.1 34.2 2.4 5.7 9.5 3.4 5.1 1.4 0.8 0.2 0.2 2.4 3.3 0.9 11.9 5.9 11.7 10.6 1.7 3.1 5.0 8.2 1.7 5.9 6.2 5.3 7.3 21.6 7.2 2.4 3.7 8.8 13.2 5.1 6.4 14.6 11.9 27.5 6.0 6.2 0.5 10.7 9.7 1.4 0.8 7.3 3.5 1.4 1.7 14.5 9.3 9.7 7.1 11.7 28.2 6.7 17.1 31.7 14.6 10.1 11.1 10.3 4.6 7.5 10.5 6.4 4.4 35.1 5.5 9.5 6.5 5.9 1.1 6.5 17.7 6.2 11.9 13.3 19.8 22.9 3.3 17.3 9.4 0.0 0.2 0.2 3.3 0.0 2.5 1.4 0.7 1.6 0.2 0.6 0.4 1.4 0.0 2.4 0.0 0.8 1.1 0.9 3.6 3.9 9.4 5.0 3.9 2.6 4.0 2.0 5.3 5.1 0.0 0.3 0.0 1.9 3.1 0.4 0.7 0.0 2.7 0.0 0.0 0.0 1.8 0.0 1.6 0.1 2.4 0.1 0.0 2.1 15.8 3.5 1.4 4.6 0.0 4.1 0.0 0.0 6.2 1.3 0.0 1.1 0.0 3.3 0.0 0.4 1.3 0.5 0.0 2.5 1.1 0.2 0.0 2.8 1.1 22.6 2.9 1.1 1.3 1.5 0.9 DUSP12 "DUSP1, YVH1" ENSG00000081721 "Dual specificity phosphatase 12" Q9UNI6 1 161749758-161757238 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008840 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008840: AB_1847884" "unprognostic (3.51e-2)" "unprognostic (2.62e-1)" "unprognostic (1.05e-1)" "unprognostic (2.01e-2)" "unprognostic (2.11e-1)" "unprognostic (4.04e-2)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.86e-1)" "unprognostic (1.06e-2)" "unprognostic (2.25e-3)" "unprognostic (9.52e-2)" "unprognostic (2.42e-3)" "prognostic unfavorable (1.55e-7)" "unprognostic (1.17e-1)" "unprognostic (1.84e-1)" "unprognostic (3.25e-2)" "unprognostic (2.42e-1)" 15.6 12.1 15.0 16.0 17.2 37.8 21.2 27.2 20.3 14.0 14.2 13.9 16.6 11.7 19.5 14.0 12.7 15.6 12.1 11.9 12.6 12.7 14.0 11.4 14.1 18.5 18.6 13.1 18.4 16.7 10.7 18.7 16.4 14.7 13.6 16.0 15.2 13.8 15.1 8.6 12.6 14.4 16.5 12.0 17.4 13.8 8.2 19.4 11.1 15.9 9.4 18.4 14.4 14.1 16.0 17.8 18.7 15.4 23.1 19.4 10.6 18.2 17.3 18.9 12.7 10.1 11.0 17.9 14.6 19.1 22.6 17.5 24.5 16.1 11.1 15.3 17.7 14.2 13.2 14.7 17.9 22.0 14.5 13.0 9.9 15.7 15.9 21.4 21.1 9.9 14.8 19.7 19.6 35.3 12.8 15.7 15.6 17.6 12.2 16.2 17.0 12.3 24.0 30.2 19.4 25.1 18.1 18.5 18.2 12.7 22.5 12.1 25.7 12.4 20.8 24.2 21.7 18.1 24.4 10.9 19.5 18.2 15.2 31.1 20.6 17.0 26.5 12.1 21.4 19.2 18.7 13.9 10.2 16.1 15.4 19.4 15.5 18.1 15.3 17.8 16.0 17.5 19.1 5.5 23.1 9.2 8.2 15.3 10.6 15.0 17.2 27.2 20.3 12.6 12.7 18.6 13.1 14.7 19.4 17.9 10.9 26.6 12.4 12.0 14.1 4.4 7.6 4.0 12.5 7.0 7.9 18.4 18.3 17.8 3.2 19.6 5.3 0.0 21.0 18.7 16.5 15.2 17.4 6.6 17.6 9.5 10.9 16.5 25.1 0.5 8.1 14.3 10.1 19.0 9.7 11.1 16.9 5.8 16.6 14.6 15.6 0.0 20.0 10.6 12.0 11.4 14.8 20.1 11.8 10.7 DUSP16 "KIAA1700, MKP-7, MKP7" ENSG00000111266 "Dual specificity phosphatase 16" Q9BY84 12 12474210-12562383 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 56.3;Intestinal endocrine cells: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 6.9" "Lineage enriched" "Detected in many" 5 "T-cells: 6.9" "Cell line enhanced" "Detected in many" "NTERA-2: 23.7;RT4: 21.6;SuSa: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020326 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA020326: AB_1847890" "unprognostic (8.05e-2)" "unprognostic (9.47e-2)" "unprognostic (1.49e-3)" "unprognostic (4.14e-2)" "unprognostic (9.86e-2)" "prognostic favorable (1.01e-4)" "unprognostic (1.75e-2)" "unprognostic (3.52e-2)" "unprognostic (1.13e-2)" "unprognostic (2.11e-1)" "unprognostic (1.78e-1)" "unprognostic (2.82e-1)" "unprognostic (2.34e-3)" "unprognostic (6.35e-3)" "unprognostic (2.42e-1)" "unprognostic (1.46e-1)" "unprognostic (5.76e-2)" 6.4 32.8 6.3 14.8 7.5 3.4 12.5 16.4 7.1 8.8 13.1 6.7 9.5 13.6 11.0 9.1 9.5 6.8 12.3 5.8 6.7 5.4 6.6 34.2 17.0 13.2 8.0 3.6 8.5 13.9 11.6 31.4 21.3 7.7 13.9 11.7 9.2 17.4 9.5 8.3 7.9 20.1 5.7 9.1 12.2 9.9 8.6 9.2 40.7 10.8 6.8 16.7 10.9 13.4 0.1 0.2 1.4 0.1 0.1 6.9 0.5 2.7 4.0 5.1 2.7 1.8 2.3 8.5 1.6 3.7 4.1 5.9 11.9 5.2 0.2 0.9 1.8 7.2 1.8 9.0 1.5 5.8 8.7 4.5 0.4 4.3 13.3 3.8 0.8 1.8 1.8 4.5 3.3 10.7 4.6 3.1 4.6 2.3 7.3 0.3 5.9 1.0 0.6 23.7 7.1 1.3 1.2 1.7 4.9 2.5 21.6 7.8 7.4 6.5 8.7 4.3 19.7 3.3 1.5 2.8 1.8 5.4 1.1 1.9 5.2 6.0 0.9 2.5 1.8 2.5 0.0 0.0 0.0 1.1 0.1 4.6 0.1 3.2 1.5 0.2 0.1 1.1 0.7 1.4 0.1 0.0 0.0 6.9 0.5 6.3 7.5 16.4 7.1 6.7 5.4 8.0 3.6 7.7 9.2 26.8 56.3 2.9 13.7 2.5 4.2 11.2 17.8 16.0 14.8 3.5 2.0 8.1 0.0 11.0 1.1 6.3 28.9 0.0 21.0 2.7 4.1 30.4 23.1 28.4 4.4 6.4 47.6 6.7 8.3 2.0 5.5 2.6 5.0 4.6 7.1 37.1 19.9 17.6 6.3 4.1 4.8 0.0 3.1 1.6 5.8 1.6 25.2 13.4 16.1 12.8 DUSP18 DUSP20 ENSG00000167065 "Dual specificity phosphatase 18" Q8NEJ0 22 30652051-30667890 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 103.5;Late spermatids: 252.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034070, HPA051349" Uncertain Supported Nucleoplasm Yes No Nucleoplasm "CAB034070: AB_2094867, HPA051349: AB_2681450" "unprognostic (1.11e-1)" "unprognostic (2.34e-2)" "unprognostic (3.49e-3)" "unprognostic (4.88e-3)" "unprognostic (1.88e-1)" "unprognostic (9.12e-2)" "unprognostic (3.77e-4)" "unprognostic (1.83e-1)" "unprognostic (1.61e-1)" "unprognostic (3.53e-2)" "unprognostic (9.62e-2)" "unprognostic (4.87e-2)" "unprognostic (1.23e-3)" "unprognostic (6.55e-2)" "unprognostic (1.97e-1)" "unprognostic (4.56e-2)" "unprognostic (1.02e-1)" 5.2 3.9 10.1 7.1 9.7 4.9 5.3 4.1 8.3 5.6 10.1 11.4 4.6 7.8 6.1 8.4 7.5 18.5 8.0 3.8 8.7 7.8 5.5 2.3 9.9 7.2 8.4 3.9 4.4 6.6 5.2 19.5 3.6 9.5 4.6 11.5 4.7 6.1 4.3 2.0 7.9 11.0 6.4 9.0 6.9 8.3 30.8 10.2 8.0 5.8 3.4 7.6 6.0 6.1 6.4 11.2 21.7 13.9 4.3 8.1 4.7 5.3 5.8 2.6 6.5 6.6 13.1 2.5 5.1 5.9 5.2 5.6 3.1 5.7 3.5 3.6 6.4 6.6 4.0 1.6 4.1 5.8 10.0 6.4 1.8 2.0 2.0 2.8 7.5 5.9 3.7 5.8 8.6 3.1 5.8 15.9 4.3 1.8 3.2 5.6 4.6 4.1 1.8 1.0 6.6 3.5 3.0 1.7 1.3 6.3 3.7 6.7 3.8 5.3 2.1 3.7 3.6 4.7 2.1 11.4 10.7 5.8 2.7 2.9 2.3 2.7 1.8 12.1 1.3 5.4 18.3 10.4 19.4 5.9 12.5 4.6 6.4 6.8 5.4 11.2 6.2 4.6 5.5 21.7 4.3 13.9 6.4 8.1 4.7 10.1 9.7 4.1 8.3 8.7 7.8 8.4 3.9 9.5 10.2 17.9 4.8 6.0 10.2 19.1 2.6 1.9 7.6 64.3 11.4 5.2 43.2 1.0 3.3 7.4 103.5 9.0 14.8 0.0 8.2 3.0 9.3 7.5 6.9 0.9 7.3 1.6 34.1 9.8 12.7 252.1 7.8 16.2 8.5 6.4 18.0 9.2 7.0 14.0 6.3 3.0 16.3 6.5 7.2 68.7 18.8 18.6 0.8 8.6 18.5 6.4 DUSP19 "DUSP17, SKRP1" ENSG00000162999 "Dual specificity phosphatase 19" Q8WTR2 2 183078559-183100005 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 20.1;Early spermatids: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021501 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA021501: AB_1847892" "unprognostic (1.24e-1)" "unprognostic (2.13e-2)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (5.18e-2)" "unprognostic (2.44e-1)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (8.30e-2)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (6.53e-2)" "unprognostic (5.80e-3)" "unprognostic (6.97e-2)" "unprognostic (2.91e-2)" "unprognostic (2.16e-2)" "unprognostic (2.75e-2)" 2.8 4.6 9.2 2.0 16.3 1.0 3.0 2.9 9.6 3.4 4.7 2.2 3.8 3.5 6.8 9.2 4.2 8.4 3.5 7.4 17.4 3.4 4.7 3.0 3.4 2.3 3.3 6.8 4.4 4.3 7.7 10.6 2.7 3.7 4.2 3.0 3.0 2.8 5.4 3.8 3.4 3.0 8.6 2.9 4.0 9.1 10.4 4.7 6.2 4.6 1.1 1.9 4.0 2.7 4.1 1.5 2.0 0.8 2.2 3.2 1.3 0.1 2.4 2.9 1.4 3.9 2.2 0.0 1.1 1.8 4.6 1.6 2.3 3.0 1.0 6.0 1.2 3.3 0.3 5.7 0.8 3.5 5.8 3.2 10.6 1.8 1.6 1.7 2.6 6.5 1.7 0.5 2.3 1.1 2.9 2.6 0.0 3.1 1.6 2.7 1.0 5.0 2.5 2.4 1.0 2.0 4.9 4.5 0.3 1.0 1.1 3.6 1.5 4.0 1.7 2.9 0.2 0.8 1.0 2.0 2.5 2.1 1.7 0.9 2.0 2.4 0.1 3.1 0.4 3.7 2.0 0.5 1.9 2.3 0.8 2.3 4.1 2.1 3.1 0.6 2.2 2.7 2.7 1.3 2.2 0.4 1.5 3.2 1.3 9.2 16.3 2.9 9.6 17.4 3.4 3.3 6.8 3.7 4.7 0.0 2.7 1.7 1.2 0.9 1.7 6.5 2.5 20.1 2.3 1.8 2.0 2.0 5.0 0.6 10.4 1.0 1.6 0.0 0.6 1.2 1.3 0.9 1.1 1.0 0.6 1.6 2.4 1.8 0.6 4.6 1.7 0.1 0.0 1.8 2.0 4.5 0.5 2.5 2.5 2.3 1.0 0.0 1.4 4.7 3.1 1.4 0.6 0.0 2.1 1.3 DUSP23 "DUSP25, FLJ20442" ENSG00000158716 "Dual specificity phosphatase 23" Q9BVJ7 1 159780932-159782543 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 88.0" "Cell type enhanced" "Detected in many" 8 "Exocrine glandular cells: 394.0;Proximal tubular cells: 620.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028211, HPA045792" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028211: AB_2672522, HPA045792: AB_10961133" "unprognostic (1.52e-1)" "unprognostic (4.12e-1)" "unprognostic (1.40e-3)" "unprognostic (3.33e-2)" "unprognostic (4.36e-2)" "unprognostic (3.22e-1)" "prognostic unfavorable (3.06e-4)" "unprognostic (3.16e-1)" "unprognostic (4.62e-1)" "unprognostic (3.33e-3)" "unprognostic (4.72e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (2.59e-5)" "unprognostic (8.58e-2)" "unprognostic (2.84e-2)" "unprognostic (7.47e-2)" "unprognostic (1.39e-1)" 25.0 28.0 7.6 9.3 10.5 11.2 27.3 4.4 9.0 15.5 15.9 5.9 6.6 17.2 12.2 15.0 21.2 10.9 12.6 14.9 7.8 5.2 88.0 80.8 12.1 15.4 8.5 4.6 12.3 21.5 12.5 4.3 7.4 9.6 18.0 9.1 9.5 37.8 10.9 32.8 15.8 16.1 7.7 9.6 8.7 11.0 9.7 7.3 5.7 27.0 17.4 11.4 10.5 19.1 13.6 59.7 49.9 43.2 21.3 24.0 24.0 12.2 13.2 0.1 0.0 12.9 11.1 0.1 5.0 4.1 5.9 4.6 5.4 14.1 0.0 30.0 5.5 1.3 0.5 3.4 4.5 3.2 3.0 1.5 16.9 4.8 0.0 19.3 10.2 13.0 46.8 12.3 3.8 13.9 4.3 22.6 0.0 7.7 6.2 8.3 22.2 1.0 0.4 22.9 22.1 18.9 0.0 0.0 5.8 7.2 2.1 5.8 12.8 9.1 20.0 23.4 2.4 12.9 16.0 16.5 4.9 0.2 0.6 0.0 4.4 10.3 0.1 8.3 8.2 3.7 20.0 43.2 49.9 24.0 33.4 13.3 13.6 18.1 22.5 59.7 9.8 11.0 16.4 43.2 21.3 22.1 13.6 15.7 24.0 7.6 10.5 4.4 9.0 7.8 5.2 8.5 4.6 9.6 7.3 38.7 65.7 25.0 97.5 66.2 8.4 26.4 94.3 38.8 83.0 48.8 5.9 13.5 222.2 148.8 39.6 154.1 106.2 0.0 394.0 20.1 31.9 94.9 53.1 219.9 155.2 1.6 34.0 66.3 86.6 5.5 24.5 94.8 40.5 32.5 101.6 59.7 258.6 101.7 14.9 620.9 7.1 12.9 32.0 3.2 13.0 65.1 4.8 43.7 91.6 102.1 DUSP26 "DUSP24, MGC1136" ENSG00000133878 "Dual specificity phosphatase 26" Q9BV47 8 33591332-33600106 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 147.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 76.1;Cardiomyocytes: 54.3;Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 58.5" "Cancer enhanced" "Detected in some" "glioma: 6.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 16 "B-cells: 1.5" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018221 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA018221: AB_2669813" "unprognostic (2.77e-4)" "unprognostic (2.70e-2)" "unprognostic (2.70e-3)" "unprognostic (5.47e-3)" "unprognostic (2.01e-1)" "unprognostic (1.24e-1)" "unprognostic (1.62e-1)" "unprognostic (2.53e-2)" "unprognostic (2.81e-1)" "unprognostic (1.39e-1)" "unprognostic (4.10e-3)" "unprognostic (1.78e-2)" "unprognostic (2.28e-1)" "unprognostic (1.52e-2)" "unprognostic (1.14e-1)" "unprognostic (8.15e-2)" "unprognostic (5.80e-2)" 1.3 9.3 11.5 1.4 13.1 1.1 1.2 18.2 14.8 1.1 1.7 4.2 0.0 2.4 1.5 3.4 3.0 2.3 1.5 20.1 9.1 15.9 1.6 1.0 1.7 1.1 10.6 8.8 15.1 2.2 1.0 14.0 1.0 7.6 2.6 1.5 4.4 1.5 1.3 147.1 1.0 1.9 2.0 10.0 1.2 2.6 1.6 3.8 0.0 1.1 27.0 1.3 1.4 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 46.2 11.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 13.1 18.2 14.8 9.1 15.9 10.6 8.8 7.6 3.8 0.0 0.0 0.0 0.2 0.0 76.1 54.3 0.0 0.0 0.0 0.0 39.3 0.0 18.3 0.3 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 23.8 24.6 0.0 0.0 4.4 0.0 0.0 1.7 0.0 0.0 13.3 1.6 0.0 5.6 0.8 58.5 0.0 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 DUSP27 ENSG00000198842 "Dual specificity phosphatase 27, atypical" Q5VZP5 1 167094045-167129165 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 131.1" "Group enriched" "Detected in many" 6 "colorectal cancer: 12.8;stomach cancer: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RH-30: 18.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA012912 Approved Nucleoplasm NA NA Nucleoplasm "HPA012912: AB_2668767" "unprognostic (1.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.44e-3)" "unprognostic (1.22e-1)" "unprognostic (2.10e-3)" "unprognostic (4.65e-2)" "unprognostic (1.53e-1)" "unprognostic (8.19e-2)" "unprognostic (1.07e-2)" "unprognostic (1.48e-1)" "unprognostic (2.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.72e-1)" "unprognostic (7.65e-2)" "unprognostic (8.23e-2)" "unprognostic (3.39e-1)" 2.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.1 46.8 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.8 0.0 0.0 0.9 0.0 64.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.5 18.2 0.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 131.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 DUSP4 "HVH2, MKP-2, TYP" ENSG00000120875 "Dual specificity phosphatase 4" Q13115 8 29333064-29350668 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 46.7;pancreas: 78.6;seminal vesicle: 63.5" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 94.6;monocytes: 131.7;Pancreatic endocrine cells: 166.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "T-reg: 9.6" "Lineage enriched" "Detected in single" 18 "T-cells: 9.6" "Cell line enhanced" "Detected in many" "A549: 29.9;OE19: 27.1;SK-MEL-30: 46.1;WM-115: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061967 Supported Nucleoplasm NA NA Nucleoplasm "HPA061967: AB_2684648" "unprognostic (1.92e-1)" "unprognostic (5.97e-3)" "unprognostic (3.24e-1)" "unprognostic (6.54e-2)" "unprognostic (2.18e-2)" "unprognostic (7.66e-3)" "unprognostic (7.30e-2)" "unprognostic (7.08e-2)" "unprognostic (1.83e-2)" "unprognostic (9.73e-3)" "unprognostic (9.60e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (4.19e-4)" "unprognostic (6.88e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-2)" "unprognostic (6.07e-2)" 10.9 3.4 1.2 3.6 1.1 3.4 17.1 4.8 2.7 4.6 1.7 1.0 46.7 0.8 3.2 0.7 1.6 1.3 13.1 1.5 4.6 0.8 0.7 0.4 3.7 1.8 0.8 0.8 1.2 78.6 0.1 3.7 17.7 0.7 4.3 0.9 17.1 8.9 63.5 2.7 3.5 1.3 1.5 1.1 0.6 20.6 1.7 0.2 3.9 1.2 2.0 4.7 7.4 3.0 0.0 0.5 0.0 0.0 0.2 9.6 0.1 11.1 29.9 17.8 0.8 2.2 0.0 1.5 2.3 12.7 7.0 3.1 0.3 5.7 0.0 6.3 1.0 4.9 3.6 0.2 7.7 4.2 0.3 0.6 0.0 1.0 0.2 0.0 0.1 14.6 1.4 5.1 2.1 13.1 15.4 5.7 0.1 0.1 1.3 14.0 12.6 0.0 2.0 3.1 27.1 18.4 0.3 0.5 2.3 16.1 5.9 0.1 9.8 3.2 15.2 46.1 0.3 3.2 0.3 16.0 5.1 0.0 0.0 1.6 3.5 0.4 0.0 15.6 2.6 37.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 9.6 0.1 1.2 1.1 4.8 2.7 4.6 0.8 0.8 0.8 0.7 0.2 0.0 3.2 1.4 94.6 10.8 34.2 1.9 28.1 29.4 15.9 0.0 11.8 2.7 0.0 64.0 3.5 10.8 0.4 0.0 66.9 37.5 8.4 20.9 5.8 0.0 19.5 41.3 93.8 19.6 5.0 19.7 0.3 25.0 62.4 131.7 7.6 0.9 166.3 0.0 0.0 0.0 2.8 12.9 12.2 0.6 0.4 10.5 14.9 8.5 2.2 92.0 DUT dUTPase ENSG00000128951 "Deoxyuridine triphosphatase" P33316 15 48331011-48343373 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054422, HPA060360" Enhanced Supported Nucleoplasm No Yes Nucleoplasm "HPA054422: AB_2682483, HPA060360: AB_2684262" "unprognostic (1.82e-1)" "unprognostic (3.49e-2)" "unprognostic (7.89e-2)" "unprognostic (5.27e-2)" "unprognostic (2.20e-1)" "unprognostic (7.17e-2)" "unprognostic (1.65e-1)" "unprognostic (1.16e-2)" "unprognostic (4.42e-3)" "unprognostic (1.87e-2)" "unprognostic (4.25e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-2)" "unprognostic (4.23e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-2)" "unprognostic (1.71e-2)" 26.9 32.9 23.2 51.1 31.8 69.0 31.9 31.7 27.6 26.8 26.3 24.4 27.2 14.5 29.8 31.8 33.7 26.9 28.2 35.5 23.2 26.5 25.4 19.8 25.7 44.7 25.3 23.6 33.4 22.2 23.7 30.7 26.0 22.5 30.3 24.3 28.1 27.5 26.1 25.6 27.3 22.6 25.6 23.9 30.1 25.8 31.9 20.7 120.3 40.5 37.7 43.2 23.5 28.4 34.5 32.3 17.0 24.5 22.2 40.2 24.3 26.1 8.2 20.1 19.0 14.1 15.0 12.0 27.8 17.7 25.7 31.9 9.5 18.1 73.0 15.0 15.2 21.0 36.0 21.1 19.0 25.2 51.4 21.8 59.6 21.7 12.9 7.8 62.4 28.4 9.2 12.9 17.4 9.2 16.7 17.0 43.7 32.2 41.5 18.9 10.6 55.8 73.5 12.7 26.7 15.9 45.5 44.0 76.7 16.9 17.8 29.2 29.7 20.6 16.7 23.8 21.4 23.6 49.8 14.1 26.9 26.0 32.0 36.4 33.5 69.7 71.9 20.3 107.2 29.5 11.3 19.5 17.0 21.7 19.3 28.1 34.5 38.9 34.2 28.2 31.6 40.2 26.5 11.1 22.2 24.5 32.3 34.4 24.3 23.2 31.8 31.7 27.6 23.2 26.5 25.3 23.6 22.5 20.7 50.6 29.3 108.7 177.4 159.5 41.9 99.9 84.1 24.1 61.4 99.5 13.7 138.0 172.5 82.7 26.1 112.3 21.0 140.2 40.7 245.0 140.4 116.4 84.1 71.8 150.1 77.9 92.4 100.1 85.2 25.7 171.2 102.9 146.8 57.7 93.4 81.1 44.6 42.1 166.9 204.1 36.1 155.2 162.6 380.2 218.4 147.3 81.2 113.3 168.7 147.0 DYNLT1 TCTEL1 ENSG00000146425 "Dynein light chain Tctex-type 1" P63172 6 158636474-158644739 "Predicted intracellular proteins" "Cell cycle, Cell division, Cytoplasmic inwards viral transport, Host-virus interaction, Microtubular inwards viral transport, Mitosis, Neurogenesis, Transport, Virus entry into host cell" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046559 Approved Nucleoplasm NA Yes Nucleoplasm "HPA046559: AB_2679698" "unprognostic (1.80e-3)" "unprognostic (3.09e-1)" "unprognostic (3.69e-2)" "unprognostic (2.22e-3)" "unprognostic (5.31e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (5.62e-2)" "unprognostic (1.83e-1)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (9.58e-2)" "unprognostic (2.72e-3)" "unprognostic (2.61e-1)" "unprognostic (1.74e-1)" "unprognostic (4.73e-2)" "unprognostic (2.92e-2)" 20.2 34.2 20.2 16.6 23.6 8.2 29.6 16.0 22.0 29.3 33.5 17.4 31.1 27.0 30.8 38.5 44.2 42.7 28.7 36.0 18.4 15.1 45.6 25.5 32.3 23.9 26.5 16.9 24.7 19.5 14.2 27.6 25.6 32.5 28.8 33.6 16.0 37.8 31.0 44.9 14.1 55.5 42.4 29.3 27.2 26.7 52.5 22.8 15.7 32.8 30.8 28.9 32.1 27.7 10.8 27.7 99.5 56.5 12.0 20.3 30.9 31.9 22.8 37.7 36.8 39.1 39.9 15.6 33.3 26.9 41.2 48.8 27.0 29.0 7.7 13.9 69.1 31.0 29.5 23.6 35.9 50.1 11.0 32.9 12.2 22.3 31.0 41.3 5.6 8.6 34.3 38.9 33.9 34.1 35.8 52.0 10.9 23.3 9.3 60.4 28.5 2.5 14.7 20.6 57.8 18.7 5.0 20.3 7.0 57.3 22.0 75.6 37.8 46.9 38.4 13.5 33.5 26.1 12.7 45.1 20.5 25.8 21.9 29.8 5.6 7.0 12.9 29.1 23.6 22.1 17.9 56.5 5.4 16.4 52.5 18.1 10.8 17.6 18.5 27.7 6.6 14.6 15.2 99.5 12.0 38.9 13.6 20.3 30.9 20.2 23.6 16.0 22.0 18.4 15.1 26.5 16.9 32.5 22.8 89.3 87.3 54.4 206.4 48.0 16.8 146.9 173.3 546.0 134.2 200.7 11.8 189.7 353.1 366.9 70.1 71.6 286.6 0.0 241.4 159.7 112.4 234.5 58.9 73.1 140.1 22.3 165.8 125.2 101.8 42.1 99.8 99.9 108.0 154.1 199.8 78.6 342.5 284.0 120.2 447.2 40.3 135.8 134.9 320.2 181.7 53.3 179.9 79.1 152.2 375.2 E2F4 E2F-4 ENSG00000205250 "E2F transcription factor 4" Q16254 16 67192169-67198918 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054128 Supported Nucleoplasm NA NA Nucleoplasm "HPA054128: AB_2682392" "unprognostic (1.74e-1)" "unprognostic (1.81e-1)" "unprognostic (4.73e-2)" "unprognostic (1.01e-1)" "unprognostic (2.76e-1)" "unprognostic (4.39e-3)" "unprognostic (1.05e-3)" "unprognostic (7.50e-3)" "unprognostic (1.37e-1)" "unprognostic (3.55e-2)" "unprognostic (1.06e-1)" "unprognostic (4.21e-2)" "unprognostic (3.60e-2)" "unprognostic (3.04e-2)" "unprognostic (8.44e-2)" "unprognostic (5.50e-2)" "unprognostic (1.17e-1)" 19.9 20.4 19.0 23.1 22.5 51.1 24.9 15.9 22.0 17.0 21.7 15.5 17.2 19.8 23.4 14.6 24.8 20.5 16.8 18.7 14.6 10.9 18.4 16.7 20.8 29.1 20.9 13.4 21.6 26.4 21.5 22.3 27.2 17.6 20.3 20.3 18.6 16.6 18.6 25.2 17.5 22.8 20.8 11.5 31.1 21.4 19.5 20.3 21.1 18.7 15.4 26.0 19.9 17.8 6.9 15.5 10.6 12.5 8.5 11.0 7.5 19.2 15.6 13.3 16.2 19.5 17.0 47.9 14.5 21.6 26.7 25.8 27.6 21.2 24.0 17.6 15.3 18.4 28.3 20.6 20.4 17.5 10.1 21.8 16.2 8.9 28.0 23.7 31.7 34.2 20.0 16.2 21.2 23.7 10.1 23.1 18.6 30.4 8.0 14.0 33.2 36.2 26.2 32.7 20.8 14.1 44.0 28.0 31.8 12.5 14.9 16.2 19.4 39.6 14.9 16.6 11.1 15.1 31.9 16.5 19.0 18.0 13.8 22.6 19.9 17.1 61.5 22.3 21.9 18.0 1.2 12.5 10.6 9.6 11.1 8.1 6.9 8.8 11.0 15.5 6.8 7.2 6.5 8.0 8.5 8.2 6.9 4.2 7.5 19.0 22.5 15.9 22.0 14.6 10.9 20.9 13.4 17.6 20.3 11.9 16.8 20.8 26.3 37.0 21.6 14.4 17.8 8.1 10.3 12.2 3.9 94.8 16.6 22.1 41.8 27.0 20.0 70.0 32.7 70.6 24.4 26.4 26.5 8.5 39.2 20.6 21.9 26.4 17.7 61.9 25.0 26.4 13.5 45.1 22.7 12.4 28.2 14.4 22.3 9.9 17.5 45.3 27.6 29.4 38.5 40.1 66.7 34.9 27.5 33.6 E2F6 E2F-6 ENSG00000169016 "E2F transcription factor 6" O75461 2 11444375-11466177 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "basophil: 8.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 8.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075185 Supported Nucleoplasm NA NA Nucleoplasm "HPA075185: AB_2732282" "unprognostic (7.13e-2)" "unprognostic (2.44e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (7.13e-4)" "unprognostic (4.18e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.90e-1)" "unprognostic (3.05e-3)" "unprognostic (7.58e-2)" "unprognostic (3.17e-3)" "unprognostic (3.64e-3)" "unprognostic (2.08e-3)" "unprognostic (2.72e-2)" "unprognostic (1.02e-1)" "unprognostic (9.01e-2)" "unprognostic (2.13e-1)" 8.4 6.6 4.4 5.0 5.9 5.0 6.2 7.8 8.0 4.1 4.9 7.4 4.7 4.2 8.4 6.6 3.6 7.4 5.0 8.9 4.3 4.9 4.0 6.2 4.5 3.3 5.6 3.8 6.7 5.3 3.9 12.4 5.4 5.0 5.3 3.5 4.7 4.7 6.5 17.7 3.9 4.8 10.6 9.0 5.0 5.7 4.2 7.3 2.9 6.7 4.4 3.7 6.3 4.9 0.0 0.3 8.3 0.3 0.0 0.8 0.2 3.1 4.0 8.5 4.7 3.8 3.1 6.4 3.1 5.5 3.6 3.3 7.8 4.6 7.1 3.6 3.5 7.4 2.3 5.9 4.6 3.8 7.9 8.6 11.3 3.0 9.8 7.6 11.5 11.6 5.3 4.3 3.9 4.7 3.1 3.3 5.5 8.4 11.9 2.9 7.6 6.6 12.7 12.0 3.9 5.3 11.8 9.5 6.3 3.9 2.9 7.2 15.3 3.5 5.2 13.8 3.8 4.8 5.8 2.8 5.3 6.7 3.3 6.9 17.3 12.8 15.4 5.8 11.0 8.0 8.3 0.3 0.1 0.2 0.0 0.8 0.0 0.1 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 4.4 5.9 7.8 8.0 4.3 4.9 5.6 3.8 5.0 7.3 6.0 3.7 5.1 18.6 21.6 12.6 8.0 7.6 4.0 6.8 3.5 15.7 15.4 6.6 10.1 1.0 8.9 3.9 0.0 9.6 11.6 14.7 14.9 0.0 7.3 10.7 12.7 6.4 9.2 3.3 1.5 8.1 8.1 16.9 4.6 4.6 9.1 7.3 3.5 10.6 7.6 11.5 0.0 15.1 14.1 45.7 19.2 18.5 5.7 5.2 12.9 E4F1 E4F ENSG00000167967 "E4F transcription factor 1" Q66K89 16 2223566-2235742 "Enzymes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, Growth regulation, Host-virus interaction, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052042, HPA069007, HPA071325, HPA072309" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052042: AB_2681705, HPA069007: , HPA071325: AB_2686390, HPA072309: " "unprognostic (3.05e-1)" "prognostic favorable (9.13e-4)" "unprognostic (7.31e-2)" "unprognostic (4.57e-3)" "unprognostic (2.89e-1)" "prognostic favorable (1.10e-4)" "unprognostic (9.16e-2)" "unprognostic (4.23e-2)" "unprognostic (3.08e-1)" "unprognostic (1.87e-1)" "unprognostic (1.29e-2)" "unprognostic (8.49e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (1.85e-1)" "unprognostic (1.03e-1)" "unprognostic (5.12e-1)" "unprognostic (8.93e-3)" 12.4 12.8 18.1 13.8 15.4 21.0 21.0 26.1 18.9 10.8 10.7 11.9 9.3 13.4 14.8 10.4 11.4 10.9 13.5 9.8 14.3 10.7 11.7 12.9 10.0 13.4 16.7 16.4 13.8 17.0 11.6 14.8 12.0 12.8 15.5 5.0 8.7 20.7 13.7 26.7 23.2 14.7 10.3 9.8 18.8 15.9 14.6 17.2 13.3 17.3 9.3 10.6 10.5 13.4 11.5 11.6 15.2 14.2 8.5 14.7 9.3 6.1 11.8 5.0 9.7 2.9 2.7 11.9 8.6 4.0 6.0 4.0 18.9 9.5 9.0 9.3 3.3 3.3 8.4 4.1 4.4 1.1 9.7 14.6 6.4 19.0 10.2 5.7 8.1 11.3 4.0 5.1 5.4 2.5 3.4 4.0 7.9 14.9 6.3 2.2 17.1 10.6 17.3 11.1 3.8 11.0 19.7 5.4 15.5 3.7 4.4 12.6 9.2 10.5 13.1 6.0 1.9 11.4 11.6 7.1 7.1 9.4 7.1 7.2 12.3 5.9 18.2 3.0 5.8 7.2 7.5 10.7 14.6 14.7 13.1 12.5 11.5 12.0 13.6 11.6 11.5 13.2 11.9 15.2 8.5 14.2 7.0 14.1 9.3 18.1 15.4 26.1 18.9 14.3 10.7 16.7 16.4 12.8 17.2 14.9 8.0 14.5 6.7 6.4 13.9 3.5 5.1 4.0 12.5 10.4 35.3 16.5 10.0 9.5 11.4 7.8 14.4 0.0 9.1 14.7 8.0 8.1 2.3 8.9 11.0 28.6 24.8 6.7 6.1 3.3 10.6 7.6 6.8 9.0 15.3 9.1 9.7 10.5 15.2 6.8 14.0 12.9 9.2 14.8 15.2 7.9 11.2 8.7 11.8 6.0 ECPAS "ECM29, FLJ22036, KIAA0368" ENSG00000136813 "Ecm29 proteasome adaptor and scaffold" Q5VYK3 9 111360692-111484745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 92.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 52.8;Ciliated cells: 44.2;Club cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021646, HPA059795" Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA021646: AB_2670788, HPA059795: AB_2684127" "unprognostic (1.64e-1)" "unprognostic (1.57e-1)" "unprognostic (7.42e-2)" "unprognostic (5.72e-2)" "unprognostic (3.81e-1)" "unprognostic (1.79e-1)" "unprognostic (1.80e-2)" "unprognostic (5.12e-2)" "unprognostic (2.02e-1)" "unprognostic (2.17e-1)" "unprognostic (9.99e-2)" "unprognostic (1.67e-1)" "unprognostic (3.72e-3)" "unprognostic (2.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.09e-1)" "unprognostic (1.05e-1)" 21.0 17.2 16.4 12.9 29.0 13.2 19.4 18.4 18.1 16.6 16.6 14.1 20.8 17.1 18.9 17.2 13.6 14.3 13.2 19.9 27.4 13.7 16.0 16.6 12.7 13.8 15.1 12.8 17.9 19.2 28.5 20.8 12.8 15.7 19.2 16.4 13.7 14.9 23.3 92.6 15.3 17.8 19.5 11.5 13.9 15.7 18.3 11.5 8.7 17.7 23.7 14.5 17.8 18.5 5.6 11.6 4.0 8.6 6.6 8.2 3.6 20.7 19.2 12.9 13.8 30.8 30.9 21.2 25.6 22.0 21.1 14.6 17.8 12.9 21.0 12.1 22.4 17.3 30.3 16.4 17.1 19.7 23.1 10.3 12.9 23.2 25.5 22.9 24.1 14.2 28.0 18.0 21.1 31.5 24.0 21.4 5.3 29.7 29.8 17.2 17.6 0.1 14.1 25.2 26.6 16.1 11.8 39.6 12.6 17.9 18.7 24.7 11.8 21.9 23.6 16.0 14.6 18.5 12.9 23.3 14.2 16.3 21.2 23.4 26.4 49.2 25.8 20.8 10.0 13.1 4.0 8.2 2.7 6.9 8.6 8.2 5.6 7.4 8.0 11.6 5.3 4.5 7.6 2.6 6.6 6.2 5.3 5.8 3.6 16.4 29.0 18.4 18.1 27.4 13.7 15.1 12.8 15.7 11.5 53.6 52.8 0.0 0.0 0.0 0.0 0.0 0.0 44.2 60.3 12.2 0.0 13.8 8.3 18.8 0.0 0.0 0.0 0.0 18.6 9.6 0.0 0.0 22.1 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 19.0 0.0 0.0 20.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 EED "HEED, WAIT-1" ENSG00000074266 "Embryonic ectoderm development" O75530 11 86244544-86278813 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012211, HPA060089, HPA061140" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012211: AB_2262066, HPA060089: AB_2684201, HPA061140: AB_2684437" "unprognostic (7.46e-2)" "unprognostic (4.40e-2)" "unprognostic (1.65e-1)" "unprognostic (1.02e-2)" "unprognostic (1.33e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (1.80e-5)" "unprognostic (2.90e-1)" "unprognostic (1.32e-2)" "unprognostic (2.39e-1)" "unprognostic (2.31e-1)" "unprognostic (9.19e-3)" "prognostic unfavorable (1.36e-7)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (1.33e-2)" "prognostic favorable (2.27e-5)" 10.9 12.0 20.1 20.6 19.8 9.7 14.0 33.4 26.5 13.4 14.4 10.4 19.2 15.6 20.0 20.1 16.7 13.5 14.5 10.8 17.7 12.7 13.7 15.1 13.0 31.1 18.3 17.7 16.9 14.1 16.2 21.6 17.6 17.7 15.5 15.0 9.8 13.7 13.8 11.8 14.6 14.6 12.5 18.2 19.5 13.7 12.5 20.5 17.0 14.6 11.9 36.2 14.9 22.8 21.5 6.7 11.3 7.6 8.9 27.3 9.2 11.7 13.5 14.2 6.1 7.9 6.6 16.5 17.4 7.3 15.4 15.6 42.4 22.6 26.5 18.4 4.9 15.9 14.7 16.8 9.2 14.7 27.4 8.0 17.8 13.5 12.6 6.9 18.3 11.9 4.3 6.1 16.4 6.9 6.4 7.0 11.9 19.5 5.7 13.1 19.2 17.0 18.5 10.5 37.6 6.6 18.8 17.6 12.9 10.0 19.4 9.9 8.0 22.3 10.5 4.9 11.0 17.6 7.8 6.9 17.0 16.1 25.0 15.1 3.3 10.6 21.5 4.8 16.1 12.7 11.3 4.5 7.1 13.3 7.2 11.6 21.5 17.4 16.6 6.7 18.8 14.0 15.8 1.9 8.9 7.6 4.4 27.3 9.2 20.1 19.8 33.4 26.5 17.7 12.7 18.3 17.7 17.7 20.5 6.0 9.4 18.2 10.8 22.8 23.0 8.1 7.6 10.7 2.3 7.0 17.7 38.3 16.6 13.6 4.9 15.2 11.5 0.0 8.8 28.8 17.9 8.0 16.1 10.9 14.9 30.2 6.9 14.1 13.6 2.3 21.0 11.3 18.6 36.9 11.2 9.9 10.4 11.4 16.3 6.2 17.7 6.5 14.3 12.7 18.8 14.6 20.8 28.4 11.8 18.4 EEF2K eEF-2K ENSG00000103319 "Eukaryotic elongation factor 2 kinase" O00418 16 22206282-22288732 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 4.0;HMC-1: 4.8;NB-4: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007818, HPA056061" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB007818: AB_598150, HPA056061: AB_2683021" "unprognostic (4.79e-2)" "unprognostic (6.10e-1)" "unprognostic (3.89e-2)" "unprognostic (3.49e-1)" "unprognostic (1.94e-2)" "unprognostic (5.09e-3)" "unprognostic (1.40e-1)" "unprognostic (2.24e-2)" "unprognostic (1.74e-1)" "unprognostic (8.50e-2)" "unprognostic (2.01e-2)" "unprognostic (9.07e-3)" "prognostic unfavorable (2.38e-4)" "unprognostic (2.86e-1)" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" 16.8 5.5 5.3 8.6 3.7 7.6 12.4 17.5 4.8 14.3 10.7 1.3 9.4 5.6 13.2 8.3 6.1 8.2 12.5 9.0 3.2 3.3 3.7 5.5 9.2 6.7 2.4 4.9 6.4 8.1 3.3 3.0 6.4 4.9 12.5 4.6 4.4 12.4 20.5 16.2 37.5 5.1 15.5 1.6 6.1 6.4 4.6 3.1 4.0 4.4 11.5 6.7 13.3 14.2 0.7 2.3 2.2 0.9 1.3 1.6 0.1 0.1 0.0 0.0 0.0 1.1 1.3 1.0 0.0 0.0 0.2 0.0 0.7 0.0 1.0 0.4 0.0 0.0 4.0 0.6 0.0 0.0 0.4 0.0 1.6 0.7 2.7 0.0 3.8 4.8 0.0 1.0 0.3 0.3 0.9 0.2 0.2 0.5 3.4 0.0 0.0 0.2 4.1 0.4 1.1 0.0 1.0 2.6 0.7 1.2 0.0 1.0 1.6 0.0 0.0 0.4 0.3 0.6 1.2 1.3 2.4 0.9 3.7 0.1 0.8 0.4 1.1 2.8 2.8 0.4 1.5 0.8 0.6 0.5 0.9 0.7 0.4 0.3 0.2 0.2 0.7 0.7 0.3 2.2 1.3 0.5 2.3 1.6 0.1 5.3 3.7 17.5 4.8 3.2 3.3 2.4 4.9 4.9 3.1 20.8 14.1 9.5 7.8 11.2 47.9 16.2 15.3 18.7 12.5 8.7 13.7 15.1 0.0 4.0 41.4 9.5 8.5 0.0 11.6 10.1 9.3 6.6 28.8 14.5 16.0 1.6 2.9 16.0 11.5 60.9 13.3 8.1 8.5 7.2 10.9 7.7 9.6 25.9 14.9 3.0 19.6 6.5 10.3 0.9 3.6 20.1 6.5 7.5 6.8 3.9 EFCAB6 "dJ185D5.1, DJBP, FLJ23588, HSCBCIP1, KIAA1672" ENSG00000186976 "EF-hand calcium binding domain 6" Q5THR3 22 43528744-43812337 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.2;testis: 32.2" "Group enriched" "Detected in many" 13 "Early spermatids: 263.3;Late spermatids: 334.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 5.6;RPTEC TERT1: 3.8" "Low region specificity" "Detected in some" HPA003098 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003098: AB_1079087" "unprognostic (1.85e-1)" "unprognostic (8.85e-3)" "unprognostic (4.45e-2)" "unprognostic (1.04e-5)" "unprognostic (1.00e-1)" "unprognostic (4.25e-2)" "unprognostic (4.96e-2)" "unprognostic (8.82e-3)" "unprognostic (2.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.91e-3)" "unprognostic (3.66e-2)" "unprognostic (1.71e-3)" "unprognostic (4.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.65e-3)" "unprognostic (1.33e-2)" 1.2 1.8 3.3 0.8 4.8 0.6 2.1 1.2 4.7 2.2 1.3 3.0 8.9 1.0 2.3 9.3 1.2 11.5 2.2 1.3 2.3 2.6 2.7 1.1 2.6 0.8 1.4 2.4 4.0 2.3 5.2 17.2 0.8 5.7 1.9 0.9 5.2 1.7 4.8 1.0 1.2 0.9 1.3 1.3 0.8 1.8 32.2 1.3 0.0 5.0 0.5 0.8 1.3 1.2 0.3 0.0 0.0 1.3 0.0 0.6 0.1 0.3 0.8 1.2 1.7 1.5 5.6 0.0 1.3 1.0 0.3 0.6 0.0 0.3 0.0 0.8 0.6 2.3 1.6 0.0 0.4 1.2 0.0 0.4 0.0 0.0 0.0 3.3 0.1 0.0 1.9 2.0 1.4 0.4 1.3 0.4 0.5 0.1 0.1 0.9 3.5 0.1 0.3 1.5 1.0 0.5 0.1 0.0 0.1 3.8 0.7 2.3 0.9 3.3 0.1 1.8 1.0 0.6 0.0 0.4 1.0 0.3 1.3 0.3 0.2 0.2 0.0 2.3 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.2 0.0 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 3.3 4.8 1.2 4.7 2.3 2.6 1.4 2.4 5.7 1.3 3.0 2.6 0.0 0.8 0.2 4.0 1.4 0.0 22.7 3.4 0.0 5.9 0.0 0.0 0.5 263.3 0.0 0.0 0.0 0.6 0.1 0.3 0.5 1.1 0.0 0.2 6.4 0.0 0.6 0.0 334.9 2.8 0.0 0.0 1.0 0.4 2.0 1.1 0.0 1.4 1.0 12.9 6.5 1.0 23.2 4.7 0.1 0.1 0.0 0.2 0.1 EGLN2 "HIFPH1, PHD1" ENSG00000269858 "Egl-9 family hypoxia inducible factor 2" Q96KS0 19 40798996-40808433 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 208.8;Late spermatids: 575.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056649 Supported Nucleoplasm NA NA Nucleoplasm "HPA056649: AB_2683203" "unprognostic (1.11e-2)" "prognostic favorable (2.88e-4)" "unprognostic (9.40e-3)" "unprognostic (6.01e-2)" "unprognostic (6.03e-2)" "unprognostic (6.47e-3)" "unprognostic (1.51e-2)" "unprognostic (4.74e-2)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "prognostic favorable (4.81e-4)" "unprognostic (7.10e-2)" "unprognostic (7.48e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (9.99e-2)" "unprognostic (1.38e-3)" 27.4 24.3 24.8 24.7 28.5 23.3 33.5 22.6 28.9 22.2 21.2 21.9 26.4 17.8 24.2 17.8 16.7 18.6 23.4 18.6 25.5 18.7 18.4 19.1 31.6 29.0 21.8 25.7 22.8 16.6 10.6 16.9 42.5 16.9 20.9 15.3 16.5 19.4 25.7 15.5 13.4 16.8 28.1 15.0 42.4 18.0 74.1 18.0 14.4 29.7 17.2 22.7 19.6 25.1 25.1 16.3 68.2 21.5 15.1 30.2 26.5 16.6 45.3 21.0 20.4 27.4 20.1 13.7 18.2 15.3 26.1 28.7 37.4 16.9 14.9 15.5 21.8 23.7 10.8 26.5 20.8 14.0 18.6 15.0 19.8 26.4 14.1 29.5 15.2 27.0 24.6 22.2 24.9 14.3 16.5 32.0 16.4 28.0 14.0 27.4 11.9 28.0 25.2 18.2 26.4 15.8 26.2 10.4 10.1 28.1 25.7 19.4 17.7 29.8 23.6 24.1 18.8 31.1 41.5 29.6 32.7 23.7 13.4 21.4 7.0 10.2 26.2 23.9 22.2 24.2 20.9 19.1 46.8 24.1 21.5 25.3 23.2 28.5 24.9 16.3 25.1 30.2 25.2 68.2 15.1 19.9 11.9 25.6 26.5 24.8 28.5 22.6 28.9 25.5 18.7 21.8 25.7 16.9 18.0 20.8 12.6 13.6 49.3 43.4 36.7 18.6 28.1 2.7 14.8 3.5 13.7 50.5 0.0 14.1 208.8 56.4 58.0 23.3 8.8 21.0 50.6 59.3 17.3 25.1 58.5 20.6 43.0 62.6 37.2 575.5 58.4 26.7 38.8 20.8 28.8 16.5 12.3 49.1 49.1 1.1 12.9 38.8 30.7 124.4 56.4 33.5 110.9 40.2 33.0 59.3 EGR1 "AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225" ENSG00000120738 "Early growth response 1" P18146 5 138465490-138469315 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 923.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.5;intermediate monocyte: 5.1;neutrophil: 9.9" "Group enriched" "Detected in many" 8 "granulocytes: 9.9;monocytes: 5.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 39.7;hTCEpi: 57.8;U-266/84: 87.2" "Group enriched" "Detected in all" 6 "amygdala: 88.4;basal ganglia: 148.1;cerebral cortex: 237.4;hippocampal formation: 138.8;olfactory region: 126.1" "Low region specificity" "Detected in all" "CAB019427, HPA029937, HPA029938" Supported Enhanced Nucleoplasm No No Nucleoplasm "CAB019427: AB_2097038, HPA029937: AB_2673258, HPA029938: AB_2673259" "unprognostic (5.47e-2)" "unprognostic (4.09e-1)" "unprognostic (1.57e-1)" "unprognostic (7.74e-2)" "unprognostic (6.32e-2)" "unprognostic (2.66e-1)" "unprognostic (1.80e-1)" "unprognostic (2.96e-1)" "unprognostic (7.36e-2)" "unprognostic (2.97e-3)" "unprognostic (1.75e-1)" "unprognostic (2.94e-2)" "unprognostic (3.51e-3)" "unprognostic (3.57e-2)" "unprognostic (1.03e-1)" "unprognostic (1.67e-1)" "unprognostic (1.98e-3)" 78.7 47.9 5.5 114.3 23.3 18.3 28.7 23.7 25.0 61.8 40.5 31.6 8.0 6.8 51.7 15.6 47.2 187.3 158.4 42.9 7.0 8.1 22.0 68.8 39.7 18.6 4.9 7.0 130.9 23.0 15.8 43.3 24.3 17.8 45.2 21.7 56.1 18.7 100.5 19.4 54.2 29.8 60.8 4.4 8.8 46.1 14.7 2.8 19.4 76.6 67.5 26.6 43.2 20.3 0.9 0.9 9.9 5.1 0.1 0.2 0.4 4.1 0.1 9.0 13.4 24.5 39.7 1.0 7.2 4.5 9.7 7.9 5.1 3.7 0.2 1.1 15.6 33.4 1.9 0.5 14.6 4.5 0.2 0.6 0.5 1.7 1.4 3.1 1.5 11.6 3.1 57.8 8.6 1.9 7.6 0.8 10.6 21.2 5.1 2.8 20.8 0.6 6.5 0.8 15.5 0.0 0.1 1.3 0.7 7.4 2.5 11.3 1.3 8.7 24.2 18.7 9.1 0.3 1.2 0.3 3.5 4.6 1.7 2.7 12.1 87.2 1.7 4.1 19.8 1.0 0.0 3.5 0.4 0.2 5.1 0.0 0.9 0.1 0.1 0.9 0.3 0.2 0.2 9.9 0.1 1.4 0.0 0.2 0.4 5.5 23.3 23.7 25.0 7.0 8.1 4.9 7.0 17.8 2.8 256.1 658.4 51.0 240.2 161.5 44.6 590.3 183.4 53.5 87.6 27.9 60.9 127.7 6.6 145.2 1.2 175.3 431.9 0.0 86.9 88.6 317.5 418.7 343.2 161.3 107.4 3.2 923.5 169.4 153.0 1.8 152.5 134.7 101.3 10.0 629.1 114.5 132.3 391.8 49.8 5.0 87.7 219.9 490.3 2.3 1.9 175.0 108.5 55.8 355.8 76.3 EGR2 KROX20 ENSG00000122877 "Early growth response 2" P11161 10 62811996-62919900 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 57.1" "Cell type enhanced" "Detected in many" 10 "Intestinal endocrine cells: 70.2;Macrophages: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5;non-classical monocyte: 5.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "U-87 MG: 22.9" "Group enriched" "Detected in many" 10 "amygdala: 2.5;basal ganglia: 3.8;cerebral cortex: 4.9;hippocampal formation: 4.1;olfactory region: 3.0" "Group enriched" "Detected in many" 4 "basal ganglia: 3.7;cerebral cortex: 6.6;hippocampal formation: 5.1;midbrain: 3.0;olfactory region: 9.8" HPA031165 Supported Nucleoplasm NA NA Nucleoplasm "HPA031165: AB_2673768" "prognostic favorable (7.30e-5)" "unprognostic (1.86e-3)" "unprognostic (1.45e-2)" "unprognostic (8.72e-2)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (2.70e-1)" "unprognostic (1.75e-1)" "unprognostic (9.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (2.47e-3)" "unprognostic (6.54e-2)" "unprognostic (1.74e-2)" "unprognostic (3.46e-1)" "unprognostic (1.11e-3)" 9.4 4.7 1.8 8.3 9.2 2.7 7.8 1.2 9.9 8.5 2.9 18.7 0.5 0.7 5.8 25.5 3.5 6.1 13.1 16.1 3.3 1.6 3.0 5.2 15.7 5.3 6.0 1.2 7.6 2.2 3.9 10.6 4.9 7.5 7.6 1.5 7.8 3.1 1.3 1.2 15.9 3.1 6.7 3.1 3.6 3.0 4.3 0.7 22.7 57.1 5.0 11.5 8.2 2.4 1.2 1.1 1.5 5.5 0.5 0.4 0.6 0.0 0.2 2.5 1.0 1.8 2.5 0.4 0.5 0.2 0.6 0.8 0.0 0.3 0.6 0.0 0.6 0.7 0.3 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.6 3.9 0.3 0.6 1.3 0.2 0.8 0.1 0.3 0.2 0.8 0.1 1.2 0.0 1.7 0.2 0.1 1.3 0.1 0.3 0.4 0.0 0.2 0.1 0.3 0.2 0.8 4.0 0.5 0.0 0.5 0.1 0.6 0.4 0.2 0.3 1.4 0.6 0.3 22.9 0.5 0.4 0.0 1.1 0.4 0.4 5.5 0.0 1.0 0.0 0.2 1.1 1.2 0.0 0.4 1.5 0.5 5.3 0.0 0.0 0.6 1.8 9.2 1.2 9.9 3.3 1.6 6.0 1.2 7.5 0.7 0.0 18.8 0.5 8.5 18.9 0.9 4.8 0.0 4.0 0.0 0.0 0.0 1.3 0.0 0.9 6.3 2.1 6.9 0.0 0.6 1.1 14.4 7.8 19.7 1.5 22.6 0.0 70.2 5.5 12.4 3.1 1.7 30.3 8.5 1.0 16.6 1.7 0.8 5.8 6.7 0.0 0.5 6.5 4.4 0.1 1.1 10.9 0.9 4.4 14.3 0.8 EID1 "C15orf3, CRI1, EID-1" ENSG00000255302 "EP300 interacting inhibitor of differentiation 1" Q9Y6B2 15 48877886-48880183 "Predicted intracellular proteins" "Cell cycle, Differentiation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051122, HPA051123" Approved Supported Nucleoplasm NA Yes Nucleoplasm "HPA051122: AB_2681350, HPA051123: AB_2681351" "unprognostic (1.38e-1)" "unprognostic (6.69e-2)" "unprognostic (1.64e-1)" "unprognostic (3.18e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (9.99e-4)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.41e-1)" "unprognostic (6.75e-3)" "unprognostic (2.46e-1)" "unprognostic (3.62e-3)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.04e-2)" "unprognostic (2.13e-1)" "unprognostic (2.09e-1)" 42.6 75.4 69.7 33.0 66.6 18.4 38.1 65.0 77.2 56.1 47.9 36.9 33.6 30.4 58.1 46.0 41.2 46.8 52.9 95.4 63.4 73.2 53.0 42.5 35.1 35.1 58.6 63.7 71.7 38.3 42.0 71.7 32.7 67.6 56.2 24.6 44.9 34.4 53.3 92.7 19.9 29.1 55.3 59.8 39.6 33.4 26.9 44.4 32.8 48.3 38.0 26.9 57.1 35.0 36.4 72.7 55.3 62.9 43.9 65.0 73.4 20.8 17.8 40.6 38.1 35.9 47.9 2.7 55.2 45.7 33.7 44.4 15.4 9.5 28.1 51.3 31.4 24.9 18.9 19.5 19.6 36.6 77.3 20.2 48.2 39.5 0.6 28.1 29.0 22.1 41.8 16.8 22.7 13.6 32.8 37.9 24.6 28.6 27.0 37.3 30.1 20.9 24.4 0.0 14.9 15.7 29.5 50.5 45.8 41.7 23.1 38.7 38.8 34.4 13.1 62.5 33.1 23.9 38.3 42.9 53.7 29.9 50.9 48.1 34.9 95.2 20.0 44.4 64.1 37.7 55.3 62.9 53.7 47.8 56.6 45.1 34.0 54.6 49.5 72.7 36.4 39.9 36.6 8.3 43.9 56.0 72.2 65.0 73.4 69.7 66.6 65.0 77.2 63.4 73.2 58.6 63.7 67.6 44.4 360.3 149.9 104.9 122.0 155.9 338.8 422.3 160.5 255.6 306.0 247.7 113.9 301.2 514.0 334.6 14.7 353.4 52.3 116.8 234.2 122.3 472.2 84.6 181.5 144.0 183.1 225.6 224.3 276.2 202.2 21.3 650.4 211.2 462.2 264.3 93.9 629.6 172.4 94.5 612.4 325.8 264.9 316.9 445.7 102.8 59.4 127.2 91.7 198.0 88.5 76.7 EID2 "CRI2, EID-2, MGC20452" ENSG00000176396 "EP300 interacting inhibitor of differentiation 2" Q8N6I1 19 39538705-39540333 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045477 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA045477: AB_10959785" "unprognostic (5.91e-2)" "unprognostic (6.37e-3)" "prognostic favorable (9.73e-4)" "unprognostic (5.93e-2)" "unprognostic (6.50e-2)" "unprognostic (1.39e-1)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (6.02e-2)" "unprognostic (3.43e-1)" "unprognostic (6.88e-3)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.21e-1)" "unprognostic (2.79e-2)" "unprognostic (2.25e-2)" "unprognostic (1.55e-1)" "unprognostic (1.51e-1)" 12.1 19.8 18.0 10.1 18.9 6.5 10.6 16.7 24.5 10.1 9.2 9.5 7.7 8.2 10.9 10.3 8.7 8.9 7.9 9.7 17.8 20.8 15.4 12.8 10.1 9.9 16.2 17.9 10.8 9.3 13.6 14.4 20.6 24.0 11.3 8.2 9.2 8.6 10.5 10.3 8.5 9.3 11.8 10.9 10.5 9.1 9.2 9.4 13.1 12.9 6.0 9.7 8.0 8.6 1.9 1.4 1.8 1.5 0.8 4.2 1.1 13.1 17.8 17.1 11.5 13.8 8.6 2.5 15.8 11.9 12.3 12.8 11.2 4.1 13.4 13.0 10.9 8.4 5.7 15.7 11.4 16.0 12.9 19.7 6.0 10.0 13.3 13.8 10.4 8.9 10.0 7.3 10.2 7.9 9.8 14.3 26.5 9.7 9.4 10.7 8.6 15.0 9.1 9.6 15.9 7.5 14.0 16.3 6.2 15.5 12.1 16.0 11.3 17.1 6.9 10.7 12.0 9.3 6.8 10.3 7.9 28.1 10.5 11.7 14.9 17.3 16.8 7.4 9.8 6.4 0.0 1.2 1.8 2.4 1.5 2.5 1.4 3.0 3.1 1.3 1.9 3.1 4.2 0.5 0.8 1.2 1.4 0.6 1.1 18.0 18.9 16.7 24.5 17.8 20.8 16.2 17.9 24.0 9.4 17.9 8.6 5.2 3.4 9.0 20.6 15.5 12.7 6.7 5.7 14.0 9.8 40.9 1.7 4.4 1.9 12.1 4.0 0.0 4.1 2.1 9.4 4.4 1.1 11.9 9.4 25.4 6.9 9.8 8.6 0.4 9.5 5.1 8.5 1.8 6.0 29.2 4.8 7.0 12.4 9.1 17.3 6.5 9.2 9.8 9.1 6.6 16.2 7.5 6.5 2.1 EIF4A3 "DDX48, EIF4AIII, Fal1, KIAA0111" ENSG00000141543 "Eukaryotic translation initiation factor 4A3" P38919 17 80135214-80147183 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport" "Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021878 Supported Supported Nucleoplasm NA NA 73000 Nucleoplasm "HPA021878: AB_1848090" "unprognostic (7.24e-2)" "unprognostic (7.33e-3)" "prognostic favorable (3.57e-5)" "unprognostic (1.29e-2)" "unprognostic (2.95e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.68e-5)" "prognostic unfavorable (1.87e-4)" "unprognostic (3.71e-1)" "unprognostic (5.06e-2)" "unprognostic (4.64e-2)" "unprognostic (2.64e-2)" "unprognostic (9.78e-3)" "unprognostic (5.81e-2)" "unprognostic (9.20e-2)" "unprognostic (1.38e-2)" "unprognostic (2.91e-3)" 27.3 37.0 19.6 23.6 21.5 71.7 22.0 20.3 19.8 24.2 23.8 16.9 19.2 16.2 24.9 18.0 41.5 29.4 17.1 24.2 17.8 12.3 24.5 20.3 21.6 25.4 16.8 19.7 37.5 16.8 17.1 21.9 38.3 13.1 24.7 20.9 14.7 22.1 31.2 19.8 31.2 18.6 18.5 13.7 25.5 20.4 35.1 19.3 30.7 26.9 26.4 30.6 28.9 25.8 38.7 80.4 33.1 41.9 30.2 38.9 48.3 48.1 43.2 28.6 21.1 22.0 13.4 25.0 25.6 18.2 36.3 29.2 46.0 22.5 44.1 17.2 22.3 26.0 32.1 39.1 27.3 40.4 16.2 41.0 27.6 34.2 49.6 21.7 49.7 29.0 20.5 14.0 30.4 24.7 14.7 29.6 25.8 36.7 28.6 21.4 36.8 44.8 25.3 30.7 44.4 40.0 37.1 57.9 34.8 17.7 41.2 39.8 21.7 35.2 68.9 29.5 28.1 45.0 33.5 20.3 22.5 28.9 33.1 40.3 25.1 21.6 81.4 18.2 31.4 23.0 25.7 41.1 33.1 26.7 41.9 34.5 38.7 34.5 30.8 50.3 31.6 32.0 30.7 24.4 30.2 32.9 80.4 38.9 48.3 19.6 21.5 20.3 19.8 17.8 12.3 16.8 19.7 13.1 19.3 38.7 49.5 57.4 240.8 251.5 20.3 50.7 30.6 36.1 62.6 27.9 15.7 121.7 54.7 70.9 25.8 58.9 51.0 23.3 101.3 178.8 96.2 78.8 91.1 26.0 94.7 6.4 57.8 30.7 62.3 10.0 62.2 81.9 97.8 83.8 45.6 43.1 73.7 52.7 46.7 47.7 27.1 84.1 170.0 87.7 109.4 261.3 219.0 53.3 56.0 264.3 EIF6 "b(2)gcn, EIF3A, ITGB4BP, p27BBP" ENSG00000242372 "Eukaryotic translation initiation factor 6" P56537 20 35278911-35284985 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Ribosome biogenesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA040873 Enhanced Supported Nucleoplasm NA NA 150000 Nucleoplasm "HPA040873: AB_2677182" "unprognostic (9.00e-2)" "unprognostic (2.65e-1)" "unprognostic (2.06e-1)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (2.24e-1)" "prognostic unfavorable (7.25e-5)" "unprognostic (9.94e-3)" "unprognostic (4.97e-2)" "unprognostic (1.14e-1)" "unprognostic (4.55e-3)" "unprognostic (2.63e-1)" "unprognostic (3.51e-2)" "unprognostic (1.53e-1)" "unprognostic (2.17e-1)" "unprognostic (9.18e-2)" "unprognostic (8.15e-2)" 21.5 24.9 13.7 21.7 13.1 14.3 21.4 12.4 20.3 26.9 29.5 13.4 15.7 33.7 22.5 19.4 59.9 25.2 29.7 14.4 13.1 14.3 39.9 63.7 18.3 27.9 13.1 15.8 22.1 35.6 17.7 15.6 30.8 13.7 21.2 29.0 14.7 27.0 22.7 14.9 40.6 43.2 22.8 11.1 21.4 20.6 24.1 10.9 31.0 30.7 49.7 43.8 24.1 29.8 51.3 64.0 70.4 60.4 47.4 39.3 60.5 37.3 54.7 13.7 15.6 17.1 20.5 17.6 24.9 29.9 52.6 40.0 101.5 35.1 26.8 29.3 30.6 37.4 29.5 28.2 79.4 33.3 6.4 18.8 43.5 21.6 73.0 32.4 22.9 21.2 20.7 51.4 41.0 80.5 22.3 36.0 15.5 28.2 13.3 55.3 36.6 13.3 30.4 16.4 40.3 46.0 18.6 22.6 23.4 68.0 26.5 23.0 19.5 19.1 75.8 27.1 10.5 36.8 17.9 28.3 57.3 24.4 29.1 33.2 14.5 15.5 22.2 28.3 24.6 31.7 70.4 55.8 46.1 36.7 55.8 39.2 51.3 35.6 39.3 64.0 49.7 29.1 34.2 18.8 47.4 60.4 59.6 38.1 60.5 13.7 13.1 12.4 20.3 13.1 14.3 13.1 15.8 13.7 10.9 59.6 54.1 84.3 174.7 249.8 33.4 22.5 127.4 52.2 64.8 157.1 9.8 204.4 167.5 366.1 53.7 83.1 285.9 0.0 331.2 176.5 88.5 134.5 98.0 185.9 157.7 23.8 101.4 49.1 74.5 76.7 75.6 97.4 101.3 301.2 121.5 59.3 490.4 210.5 62.9 381.3 23.8 64.7 103.2 80.7 67.6 302.9 214.1 74.6 166.1 311.8 ELAC2 "FLJ10530, HPC2" ENSG00000006744 "ElaC ribonuclease Z 2" Q9BQ52 17 12992391-13018187 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Endonuclease, Hydrolase, Nuclease" "Disease mutation, Primary mitochondrial disease, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 96.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019535 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019535: AB_1848106" "unprognostic (4.24e-3)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "prognostic favorable (3.24e-6)" "unprognostic (8.64e-2)" "unprognostic (1.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.47e-1)" "unprognostic (2.22e-1)" "unprognostic (3.98e-1)" "unprognostic (5.31e-3)" "unprognostic (3.09e-1)" "unprognostic (5.31e-3)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (8.09e-2)" "unprognostic (3.70e-2)" 20.3 35.9 15.2 17.2 23.5 13.8 18.6 16.9 30.0 17.5 21.2 24.6 17.9 15.8 22.1 13.1 25.9 19.5 19.6 28.1 14.2 14.3 23.5 34.8 14.2 19.4 18.2 19.5 20.3 24.5 27.5 14.0 21.2 20.5 20.7 25.1 19.4 19.1 26.2 49.2 20.7 18.7 26.6 15.6 25.5 22.8 29.5 17.1 28.1 20.7 20.1 25.9 23.0 16.3 19.9 23.5 9.4 20.4 24.0 25.1 20.9 14.7 23.6 16.3 18.2 13.1 12.8 9.9 16.2 13.0 26.5 17.9 18.9 7.9 26.8 17.7 15.4 10.0 20.0 29.6 18.8 26.6 13.9 29.9 15.7 18.4 12.4 9.7 13.4 21.7 11.4 16.0 20.6 19.2 11.9 18.5 15.9 21.4 8.2 20.1 13.1 23.6 13.4 13.5 28.3 15.8 16.6 28.0 16.8 15.0 13.3 8.4 12.3 20.6 13.4 8.3 96.8 13.3 5.8 18.0 32.8 10.9 13.0 23.8 5.1 9.5 10.8 13.0 14.3 11.9 9.4 14.7 9.3 21.4 20.1 23.0 19.9 20.7 21.3 23.5 17.4 21.5 19.2 2.2 24.0 20.4 13.3 25.1 20.9 15.2 23.5 16.9 30.0 14.2 14.3 18.2 19.5 20.5 17.1 6.0 13.3 13.7 8.6 9.2 10.1 22.9 15.3 10.7 5.7 15.7 2.0 52.4 16.6 22.1 5.2 12.0 10.9 0.0 22.4 24.6 15.4 8.8 9.2 21.8 24.4 11.1 8.1 12.3 14.6 4.2 9.8 10.2 13.5 18.0 10.0 13.8 23.0 16.1 20.1 15.6 10.9 51.8 13.3 25.0 27.4 12.7 28.0 13.8 16.6 7.1 ELF1 ENSG00000120690 "E74 like ETS transcription factor 1" P32519 13 40932028-41061440 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 129.5" "Cell type enhanced" "Detected in all" 5 "granulocytes: 307.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 65.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001755, CAB005172" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB005172: AB_631428, HPA001755: AB_1078732" "unprognostic (1.21e-1)" "unprognostic (8.73e-3)" "unprognostic (4.20e-2)" "unprognostic (8.45e-2)" "unprognostic (2.01e-1)" "unprognostic (1.65e-1)" "unprognostic (1.02e-1)" "unprognostic (3.28e-1)" "unprognostic (2.11e-2)" "unprognostic (5.78e-2)" "unprognostic (3.38e-2)" "unprognostic (2.17e-1)" "unprognostic (6.02e-3)" "unprognostic (2.96e-1)" "unprognostic (4.11e-2)" "unprognostic (8.98e-2)" "unprognostic (3.72e-2)" 27.7 11.5 6.0 37.9 12.5 51.4 22.6 3.4 7.7 19.9 23.4 9.0 12.0 14.5 20.9 15.6 25.1 17.0 19.3 15.8 7.0 4.5 16.6 13.8 28.0 34.8 14.9 3.4 16.7 20.0 12.7 13.9 15.9 11.1 17.4 14.0 10.9 22.0 16.8 13.0 23.8 34.6 14.8 15.1 44.8 15.2 8.5 11.1 129.5 19.4 18.6 44.4 26.7 23.4 20.1 17.1 64.6 26.3 20.7 27.2 20.6 8.0 4.7 3.7 3.6 16.8 17.8 13.7 8.3 20.3 11.6 13.5 12.0 21.4 46.5 5.3 14.0 8.7 18.5 0.7 10.6 7.4 10.2 5.6 41.6 3.9 8.1 12.6 23.6 65.4 18.4 18.6 7.9 15.2 7.7 16.4 22.2 10.1 12.3 7.7 7.3 30.7 13.7 2.8 27.2 3.7 41.3 6.0 13.2 12.1 12.7 1.4 5.0 7.2 7.2 14.7 5.3 5.1 30.6 14.6 5.0 3.0 4.1 2.9 5.7 3.2 30.6 7.0 15.1 10.7 64.6 17.7 38.1 21.9 19.5 23.1 19.1 25.1 24.2 17.1 20.1 27.2 24.0 28.8 20.7 26.3 11.3 24.7 20.6 6.0 12.5 3.4 7.7 7.0 4.5 14.9 3.4 11.1 11.1 71.5 71.4 100.3 182.5 96.7 2.4 28.3 40.8 78.9 75.1 54.1 9.8 29.1 16.6 56.5 37.6 98.4 56.1 46.7 60.7 47.9 62.5 133.5 307.0 22.1 83.5 3.2 55.8 63.3 93.8 11.4 39.7 135.9 114.7 64.1 49.8 7.5 56.2 45.6 40.7 23.7 3.6 38.8 56.7 7.6 8.5 100.4 44.7 171.1 49.4 185.4 ELF3 "EPR-1, ERT, ESE-1, ESX" ENSG00000163435 "E74 like ETS transcription factor 3" P78545 1 202007945-202017188 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Inflammatory response, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 100.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 1511.9;Glandular cells: 1015.6;Paneth cells: 1043.9;Urothelial cells: 1629.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 40.5;CAPAN-2: 57.8;OE19: 37.3;RT4: 41.5;SK-BR-3: 80.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003316, HPA003479" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003316: AB_1078757, HPA003479: AB_1078756" "unprognostic (9.90e-3)" "unprognostic (1.72e-1)" "unprognostic (7.50e-2)" "unprognostic (1.12e-1)" "unprognostic (2.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.38e-2)" "unprognostic (1.83e-1)" "unprognostic (1.69e-1)" "unprognostic (5.05e-3)" "unprognostic (7.67e-3)" "unprognostic (7.07e-2)" "unprognostic (9.92e-3)" "unprognostic (4.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-1)" "unprognostic (3.37e-3)" 0.3 0.1 0.1 16.0 0.2 0.0 34.0 0.2 0.2 13.2 80.7 0.2 12.5 34.4 3.8 8.9 59.3 8.6 67.7 1.1 0.1 0.1 38.1 33.3 24.6 0.1 0.1 0.1 5.8 38.4 1.1 1.7 16.7 0.3 39.9 31.3 0.7 37.9 11.3 0.7 3.5 100.8 9.5 0.3 0.2 29.9 1.9 0.1 0.6 5.7 25.5 43.5 44.7 22.7 0.3 0.8 2.0 0.3 0.2 0.3 0.0 10.6 40.5 0.0 0.0 0.0 0.0 12.6 0.0 1.5 0.0 0.0 9.0 57.8 0.0 4.8 0.0 0.3 10.5 0.0 0.0 0.0 1.2 0.0 0.0 7.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.1 0.6 37.3 3.4 0.0 0.0 0.5 15.4 41.5 0.0 0.0 0.4 80.2 0.0 1.9 5.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.8 0.3 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.8 0.3 0.2 0.1 2.0 0.2 0.3 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.3 0.1 273.9 377.1 5.4 575.3 4.5 1.7 1.2 448.4 586.2 343.5 312.3 17.7 60.7 34.9 553.5 0.0 1.1 1511.9 0.0 565.5 107.5 4.2 1015.6 40.3 30.4 7.8 0.0 434.4 0.6 1.3 0.0 0.0 12.0 8.5 25.2 963.0 2.0 453.3 1043.9 0.0 114.1 63.9 0.0 0.4 0.0 0.2 7.3 215.1 2.2 773.6 1629.9 ELF5 ENSG00000135374 "E74 like ETS transcription factor 5" Q9UKW6 11 34478793-34513805 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "breast: 48.8;ductus deferens: 72.2;salivary gland: 85.1;seminal vesicle: 86.9" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 2: 29.3;Collecting duct cells: 96.0;Cytotrophoblasts: 17.5;Melanocytes: 16.9" "Cancer enhanced" "Detected in many" "breast cancer: 8.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "RT4: 17.8;T-47d: 34.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA062706 Approved Nucleoplasm NA NA Nucleoplasm "HPA062706: AB_2684841" "unprognostic (1.13e-1)" "unprognostic (1.48e-1)" "unprognostic (7.55e-2)" "unprognostic (3.31e-2)" "unprognostic (2.41e-4)" "unprognostic (6.90e-2)" "unprognostic (3.93e-1)" "prognostic favorable (3.64e-4)" "unprognostic (1.12e-1)" "unprognostic (3.40e-2)" "unprognostic (8.15e-2)" "unprognostic (3.15e-2)" "unprognostic (1.78e-3)" "unprognostic (3.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (2.86e-1)" 0.1 0.0 0.0 0.0 0.1 0.0 48.8 0.0 0.0 0.5 0.0 0.0 72.2 0.6 0.0 0.1 0.6 0.0 1.1 0.0 0.0 0.0 6.5 0.0 2.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.8 0.0 1.4 0.0 0.0 85.1 86.9 0.0 3.5 0.0 1.0 0.0 0.3 0.1 0.1 0.0 0.2 0.0 3.5 1.0 5.8 1.2 0.5 0.5 2.0 1.8 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 17.8 0.0 0.0 0.0 3.1 0.0 0.1 34.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.0 0.3 0.2 0.5 1.8 0.3 0.2 0.3 0.4 0.3 0.5 0.4 0.4 0.9 0.7 1.8 0.5 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 29.3 0.0 2.5 0.2 0.0 0.3 0.0 5.3 9.1 96.0 0.0 17.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.3 1.9 0.0 0.0 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 9.6 0.0 0.0 5.8 ELK1 ENSG00000126767 "ELK1, ETS transcription factor" P19419 X 47635521-47650604 "Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003808, HPA036084, HPA064381" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB003808: AB_562282, HPA036084: AB_2674931, HPA064381: AB_2685250" "unprognostic (2.25e-1)" "unprognostic (1.83e-2)" "unprognostic (4.77e-2)" "unprognostic (1.40e-2)" "unprognostic (2.31e-1)" "unprognostic (2.73e-1)" "unprognostic (1.16e-2)" "unprognostic (1.69e-1)" "unprognostic (1.47e-1)" "unprognostic (2.59e-3)" "unprognostic (1.17e-1)" "unprognostic (8.39e-2)" "prognostic unfavorable (3.25e-5)" "unprognostic (1.02e-1)" "unprognostic (2.03e-1)" "unprognostic (1.79e-2)" "unprognostic (1.67e-2)" 12.1 20.9 37.2 10.8 52.2 11.5 8.2 32.6 32.9 11.1 9.4 4.9 14.6 8.1 11.4 17.5 8.5 13.1 9.9 12.4 23.3 11.6 7.7 19.0 8.9 10.4 5.7 22.7 37.7 9.8 12.0 7.5 13.7 6.7 9.3 9.8 7.4 9.8 11.3 17.9 8.6 8.5 10.8 4.4 14.3 7.5 19.1 11.2 8.7 6.9 8.3 11.5 8.9 6.7 7.4 11.7 3.9 9.5 4.2 12.7 6.3 17.2 13.6 7.0 19.4 12.1 14.7 9.7 14.5 17.3 17.8 18.5 9.5 13.1 13.6 8.0 15.7 28.8 10.5 18.4 15.5 16.9 15.1 17.5 11.3 12.5 8.5 26.9 12.3 19.9 14.1 14.1 28.5 19.2 14.9 10.2 19.4 23.4 16.1 14.5 22.8 13.0 14.1 16.2 8.5 28.8 14.2 17.6 21.3 9.5 7.5 15.1 12.6 24.4 8.7 20.5 16.6 22.1 7.9 8.1 20.4 21.2 26.5 13.5 26.7 36.7 14.2 22.6 22.4 12.7 2.0 8.1 3.4 7.4 9.5 8.6 7.4 9.5 8.6 11.7 6.7 8.4 6.8 3.9 4.2 7.8 8.2 12.7 6.3 37.2 52.2 32.6 32.9 23.3 11.6 5.7 22.7 6.7 11.2 0.0 7.0 7.4 10.8 14.9 13.3 7.5 5.1 1.4 4.5 7.0 3.9 6.8 5.0 6.9 2.9 8.0 4.5 0.0 6.4 8.2 8.2 10.6 8.1 11.9 9.0 4.8 9.8 18.4 6.5 0.9 13.0 9.0 6.8 20.8 7.7 8.2 6.0 3.5 28.0 4.4 6.8 6.5 11.3 1.9 7.8 13.9 7.4 7.2 10.5 9.5 ELK4 SAP1 ENSG00000158711 "ELK4, ETS transcription factor" P28324 1 205597556-205631962 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 95.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028863 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA028863: AB_10602492" "unprognostic (2.08e-1)" "unprognostic (2.71e-2)" "unprognostic (1.98e-1)" "unprognostic (1.59e-1)" "unprognostic (2.15e-1)" "prognostic favorable (4.65e-4)" "unprognostic (2.97e-1)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (3.53e-1)" "unprognostic (1.27e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (2.94e-6)" "unprognostic (2.21e-2)" "unprognostic (1.26e-1)" "unprognostic (1.08e-1)" "unprognostic (5.58e-3)" 14.1 7.1 10.0 14.7 12.7 12.0 13.8 16.2 10.4 10.1 8.9 10.4 8.6 7.3 11.3 9.2 11.7 9.5 11.4 10.8 10.6 5.0 15.2 15.6 13.8 19.1 10.0 6.9 13.1 12.4 13.6 16.8 9.5 9.5 32.6 8.7 12.2 12.4 8.2 14.7 17.6 13.5 10.5 8.2 18.3 9.4 8.4 11.0 24.4 10.8 8.3 19.6 15.1 13.2 2.2 1.5 8.7 1.1 1.2 3.1 0.6 8.2 7.5 2.9 7.7 7.1 9.1 7.5 5.6 5.8 4.4 5.2 3.2 8.4 17.6 5.3 6.9 3.3 10.4 6.2 6.8 7.7 20.0 4.4 7.6 12.2 6.8 9.7 14.2 30.3 8.0 8.5 7.0 14.4 8.6 18.6 8.4 6.9 14.8 6.2 11.2 11.7 5.3 4.9 1.9 4.5 8.7 18.3 14.3 5.9 18.2 3.5 4.1 14.4 7.9 9.5 5.4 7.3 4.8 13.4 9.0 10.6 8.0 10.5 11.1 10.1 11.9 7.8 5.8 10.5 8.7 0.8 1.2 1.6 1.1 2.1 1.4 1.8 2.1 1.1 2.2 2.2 3.1 0.4 1.2 0.6 1.5 1.8 0.6 10.0 12.7 16.2 10.4 10.6 5.0 10.0 6.9 9.5 11.0 8.9 11.5 21.4 29.2 34.9 95.4 18.7 28.1 17.4 15.9 29.6 11.8 11.3 3.3 12.9 11.6 35.7 9.8 0.0 15.6 5.2 25.6 62.3 27.7 28.9 8.9 23.8 12.6 25.8 20.0 14.0 23.6 18.5 28.7 5.4 15.8 10.6 12.9 3.5 14.5 13.9 26.7 25.8 23.4 20.0 9.8 42.4 15.3 37.4 17.3 61.0 ELL2 MRCCAT1 ENSG00000118985 "Elongation factor for RNA polymerase II 2" O00472 5 95885098-95962071 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "granulocytes: 168.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 65.4;HDLM-2: 57.6;U-266/84: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013569 Supported Nucleoplasm No No Nucleoplasm "HPA013569: AB_2668853" "unprognostic (1.18e-2)" "unprognostic (1.88e-2)" "unprognostic (3.41e-2)" "unprognostic (2.94e-2)" "unprognostic (1.93e-1)" "unprognostic (5.82e-2)" "unprognostic (9.14e-2)" "unprognostic (3.21e-2)" "unprognostic (1.29e-1)" "unprognostic (8.05e-2)" "unprognostic (9.16e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (1.31e-4)" "prognostic unfavorable (1.61e-4)" "unprognostic (6.27e-2)" "unprognostic (1.37e-2)" "unprognostic (1.74e-2)" 24.4 9.1 7.1 12.2 13.5 18.1 16.4 5.2 19.3 9.8 7.5 11.5 26.0 6.3 4.2 3.7 27.5 6.4 16.3 17.2 10.5 8.1 7.5 37.1 14.3 10.0 11.4 8.3 11.8 41.3 9.4 14.3 12.5 15.8 18.2 6.0 2.8 43.9 55.7 14.0 25.9 6.8 9.1 13.3 14.9 18.3 6.5 11.9 1.4 7.7 15.4 9.3 12.3 14.8 5.3 0.6 8.7 1.6 2.2 1.5 0.9 6.2 2.4 0.8 0.1 9.5 11.9 0.9 65.4 11.2 21.8 18.6 4.7 1.4 0.2 1.4 34.7 5.1 8.1 2.0 20.8 26.8 57.6 1.5 4.0 10.7 10.3 6.0 0.9 6.9 11.5 14.4 13.2 40.0 13.1 3.4 0.7 2.2 24.8 20.3 0.6 0.0 1.1 1.0 0.9 3.4 0.6 3.9 4.9 4.1 6.0 1.3 0.4 24.0 1.2 1.4 3.2 0.7 0.7 7.1 28.8 5.8 6.6 11.8 17.5 41.5 0.3 14.9 0.4 1.9 8.7 1.1 7.6 0.9 1.6 1.5 5.3 1.3 1.3 0.6 2.6 0.9 0.7 2.5 2.2 1.1 0.4 1.4 0.9 7.1 13.5 5.2 19.3 10.5 8.1 11.4 8.3 15.8 11.9 26.8 88.8 34.3 115.9 162.7 0.3 27.0 5.1 29.4 69.4 17.4 0.0 1.7 5.0 25.9 1.8 31.6 13.4 46.7 78.5 13.7 30.4 143.0 168.5 135.2 36.5 0.0 103.5 21.5 54.4 2.5 7.2 36.9 43.9 38.7 15.1 1.2 61.0 14.4 6.7 13.4 0.1 12.9 55.1 12.8 7.7 149.8 21.6 32.4 12.1 81.4 ELMSAN1 "C14orf117, C14orf43, LSR68" ENSG00000156030 "ELM2 and Myb/SANT domain containing 1" Q6PJG2 14 73715122-73790285 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003111 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003111: AB_1078329" "unprognostic (1.54e-3)" "unprognostic (2.69e-1)" "unprognostic (2.83e-1)" "unprognostic (9.69e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.03e-2)" "unprognostic (1.12e-1)" "unprognostic (8.55e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (2.02e-1)" "unprognostic (2.89e-1)" "unprognostic (3.36e-3)" "unprognostic (7.35e-2)" "unprognostic (2.44e-1)" "unprognostic (1.11e-1)" "unprognostic (1.96e-1)" 17.8 8.1 11.2 18.7 10.1 18.8 17.4 17.8 9.9 17.3 13.7 14.5 9.7 11.2 16.8 11.1 14.0 12.7 15.8 11.2 8.3 6.3 7.7 7.8 13.9 12.9 7.6 8.2 18.6 8.7 21.4 7.6 12.8 9.4 14.2 6.0 16.8 13.1 13.1 13.4 26.1 14.1 13.9 7.6 18.8 12.6 8.2 11.8 8.8 11.0 9.5 20.0 16.1 15.0 2.9 4.4 3.1 1.9 2.1 1.8 1.3 6.8 7.7 2.8 5.2 2.6 4.5 5.4 2.8 4.8 3.9 3.5 6.7 8.2 10.0 3.2 3.8 4.1 10.6 4.6 7.9 1.6 13.2 2.8 16.0 6.6 2.4 4.3 2.7 34.9 5.9 4.9 3.4 4.3 3.4 6.2 3.5 8.2 9.3 1.9 16.0 6.3 4.4 0.9 3.4 6.4 7.4 15.2 2.6 5.9 7.4 3.6 3.0 10.6 14.7 5.9 1.6 11.3 5.9 12.3 8.1 9.4 6.0 3.0 7.3 3.4 11.1 6.6 3.4 9.4 2.1 1.9 0.7 1.2 0.9 1.8 1.8 0.6 1.3 2.1 2.9 0.7 0.8 3.1 2.1 1.1 4.4 1.4 1.3 11.2 10.1 17.8 9.9 8.3 6.3 7.6 8.2 9.4 11.8 23.8 22.4 64.8 25.5 78.6 20.9 18.6 20.4 13.4 10.3 17.4 49.1 32.2 13.3 17.8 1.6 26.4 41.7 0.0 14.9 23.4 29.6 22.2 22.0 17.1 23.3 11.1 39.2 43.6 34.2 2.2 25.0 22.4 69.2 28.9 30.4 17.8 17.2 28.8 29.4 12.9 33.8 32.3 25.0 1.1 18.8 54.5 24.6 26.7 20.2 5.8 ELOA2 "HsT832, TCEB3B, TCEB3L" ENSG00000206181 "Elongin A2" Q8IYF1 18 47032572-47035621 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 30 "testis: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.8;WM-115: 1.2" "HPA041009, HPA043501, HPA048971, HPA049178, HPA050086, HPA053158" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA041009: AB_10959881, HPA043501: AB_10960403, HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " "unprognostic (2.38e-1)" "unprognostic (4.47e-1)" "unprognostic (2.54e-4)" "unprognostic (2.39e-1)" "unprognostic (8.75e-2)" "unprognostic (5.34e-2)" "unprognostic (3.64e-1)" "unprognostic (5.25e-2)" "unprognostic (1.81e-1)" "unprognostic (1.38e-2)" "unprognostic (3.97e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.6 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOA3 "ELOA3A, HsT829, TCEB3C, TCEB3L2" ENSG00000183791 "Elongin A3" Q8NG57 18 47028202-47030078 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.7" "HPA048971, HPA049178, HPA050086, HPA053158" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.1 0.1 0.3 0.1 0.8 0.1 0.1 0.6 0.3 0.4 0.1 0.1 0.6 0.1 0.1 0.6 0.1 0.1 0.5 0.4 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.6 0.9 0.6 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOA3B "HsT828, TCEB3CL" ENSG00000278674 "Elongin A3 family member B" Q3SY89 18 47022287-47023927 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.0" "HPA048971, HPA049178, HPA050086, HPA053158" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOA3C ENSG00000275553 "Elongin A3 family member C" 18 46968695-46969912 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049178, HPA050086, HPA053158" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOA3D TCEB3CL2 ENSG00000274744 "Elongin A3 family member D" A6NLF2 18 46962768-46964408 "Predicted intracellular proteins" "Transcription, Transcription regulation" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;U-2 OS: 1.6" "HPA048971, HPA049178, HPA050086, HPA053158" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELP4 "C11orf19, PAXNEB" ENSG00000109911 "Elongator acetyltransferase complex subunit 4" Q96EB1 11 31509700-31790328 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038572, HPA038573" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA038572: AB_2676090, HPA038573: AB_2676091" "unprognostic (7.25e-2)" "unprognostic (5.40e-2)" "unprognostic (7.81e-2)" "unprognostic (1.61e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-3)" "unprognostic (1.67e-2)" "unprognostic (1.87e-1)" "unprognostic (6.73e-2)" "unprognostic (8.13e-2)" "unprognostic (1.01e-1)" "unprognostic (5.33e-2)" "unprognostic (1.09e-2)" "unprognostic (2.15e-1)" "unprognostic (1.48e-1)" "unprognostic (8.38e-2)" "unprognostic (3.63e-2)" 14.7 14.6 19.8 12.0 19.6 12.9 12.2 55.1 17.6 13.9 15.3 15.2 8.5 8.1 13.9 15.3 15.7 12.5 12.8 17.0 18.5 13.2 18.6 16.0 12.5 15.1 15.7 13.2 13.6 17.5 16.5 19.0 13.3 16.2 12.1 13.8 15.2 11.6 13.6 13.9 16.7 11.1 13.2 17.8 14.6 11.5 14.5 19.1 28.0 11.8 12.3 13.8 13.1 12.2 12.6 12.8 10.2 12.3 9.5 13.6 8.7 8.6 7.6 8.4 10.1 7.8 10.7 2.9 7.8 8.5 11.7 12.9 7.0 7.9 11.9 6.7 7.0 14.2 15.9 10.8 9.8 12.9 9.8 12.5 4.0 9.7 10.4 8.0 8.3 7.9 10.6 6.1 5.0 13.8 9.0 14.0 15.7 17.8 10.8 7.4 13.9 14.1 9.9 4.8 25.5 9.4 8.6 18.0 8.1 17.5 8.8 9.7 4.6 14.3 9.4 6.4 8.5 17.7 12.2 5.7 10.8 9.4 17.5 10.1 4.3 8.1 14.5 7.6 11.8 9.2 7.7 11.1 10.2 9.5 12.3 12.1 12.6 11.2 11.4 12.8 9.0 12.5 11.1 3.3 9.5 12.0 11.2 13.6 8.7 19.8 19.6 55.1 17.6 18.5 13.2 15.7 13.2 16.2 19.1 11.9 8.0 6.3 10.0 7.3 4.3 6.7 2.5 8.1 12.5 7.0 3.9 16.6 24.9 7.1 5.2 4.8 3.4 0.0 9.8 13.2 6.4 3.2 10.4 4.9 10.3 14.3 6.4 3.7 4.7 1.8 4.6 5.6 3.3 8.2 5.2 14.1 5.3 3.5 6.0 22.3 5.9 6.5 7.2 12.1 10.0 7.2 15.8 8.5 7.0 5.0 EMC7 "C11orf3, C15orf24" ENSG00000134153 "ER membrane protein complex subunit 7" Q9NPA0 15 34084017-34101948 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010029, HPA047572" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA010029: AB_1078335, HPA047572: AB_2680090" "unprognostic (2.16e-1)" "unprognostic (8.16e-3)" "unprognostic (5.28e-2)" "prognostic favorable (4.68e-5)" "unprognostic (7.75e-2)" "prognostic unfavorable (9.25e-5)" "unprognostic (1.35e-1)" "unprognostic (3.68e-2)" "unprognostic (1.18e-1)" "unprognostic (5.65e-3)" "unprognostic (4.67e-2)" "unprognostic (3.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.31e-1)" "unprognostic (2.58e-1)" "unprognostic (2.49e-2)" "unprognostic (2.47e-3)" 31.2 45.1 36.8 22.4 41.6 31.8 29.7 22.5 36.8 25.1 30.1 30.9 38.2 25.1 27.1 53.1 25.0 23.0 24.5 36.5 34.0 45.3 52.5 62.3 26.5 24.4 44.0 38.7 24.1 46.7 35.5 33.5 57.6 35.2 31.8 32.3 29.8 29.6 46.0 44.8 28.2 28.1 29.0 42.2 28.5 28.5 39.3 30.8 18.8 35.3 26.7 21.8 26.3 26.2 37.8 68.8 66.6 54.7 32.6 53.7 49.1 14.3 39.6 14.4 18.3 56.4 32.3 15.1 41.2 43.0 38.6 40.1 36.0 17.3 8.5 42.8 40.2 40.1 28.0 20.9 20.7 28.9 20.9 20.7 21.1 59.2 30.7 51.6 21.1 30.1 35.7 39.5 27.6 40.1 26.3 24.2 16.4 20.5 57.0 37.2 16.6 11.7 24.1 12.8 33.8 26.3 14.8 16.7 29.4 40.6 25.5 23.6 17.5 24.5 33.2 20.4 17.9 24.0 34.2 20.3 41.4 16.0 27.3 30.7 38.6 46.6 19.0 41.8 32.4 33.5 66.6 47.3 49.0 42.7 51.0 41.6 37.8 42.9 43.4 43.1 28.9 31.6 39.0 41.3 32.6 54.7 68.8 53.7 49.1 36.8 41.6 22.5 36.8 34.0 45.3 44.0 38.7 35.2 30.8 26.8 26.0 38.7 50.2 77.2 49.7 83.2 45.9 48.2 40.9 97.7 43.2 105.5 33.2 106.2 83.3 62.5 52.0 0.0 149.7 127.4 78.3 46.4 44.9 78.4 102.1 28.6 43.8 56.4 57.1 65.1 83.4 60.8 97.8 64.1 51.6 111.7 112.9 52.6 97.9 61.9 46.3 116.4 76.2 178.6 21.7 75.5 133.9 64.0 55.9 50.3 EMP1 "CL-20, TMP" ENSG00000134531 "Epithelial membrane protein 1" P54849 12 13196716-13219939 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 240.9;lymphoid tissue: 129.3" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 616.6;Fibroblasts: 489.5;Melanocytes: 448.7;Suprabasal keratinocytes: 601.1;Urothelial cells: 926.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 28.6" "Cell type enriched" "Detected in some" 7 "myeloid DC: 7.0" "Lineage enriched" "Detected in single" 14 "dendritic cells: 7.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 132.0;fHDF/TERT166: 91.8;HaCaT: 82.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA051931, HPA056250" Approved Nucleoplasm NA NA Nucleoplasm "HPA051931: , HPA056250: " "unprognostic (1.40e-2)" "unprognostic (7.30e-2)" "unprognostic (8.01e-2)" "unprognostic (1.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (8.41e-3)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" "prognostic unfavorable (2.26e-8)" "prognostic unfavorable (7.46e-4)" "unprognostic (2.98e-1)" "unprognostic (4.84e-2)" "unprognostic (3.05e-2)" "unprognostic (3.45e-2)" "unprognostic (3.25e-1)" "prognostic unfavorable (9.69e-8)" 63.3 5.0 2.7 8.0 10.4 2.1 20.8 0.8 3.9 51.3 11.6 5.5 4.0 4.6 14.0 10.4 240.9 9.9 25.2 16.1 7.3 2.8 8.9 4.4 18.1 5.9 5.3 0.9 5.7 10.2 2.9 2.8 10.6 28.6 6.3 6.9 17.8 45.4 2.8 12.0 16.8 10.7 17.6 9.7 8.5 6.0 5.2 3.0 0.6 22.5 99.1 129.3 14.1 80.6 0.0 7.0 0.0 0.5 0.1 0.1 0.0 38.9 2.0 1.0 0.2 63.1 132.0 0.1 28.8 52.9 14.9 19.0 0.2 66.0 0.2 20.6 91.8 6.5 82.1 1.1 3.8 20.2 0.7 0.0 0.1 6.9 0.0 15.2 0.2 0.2 41.4 5.6 47.3 13.9 11.8 34.0 0.0 0.2 0.6 35.0 0.1 0.0 0.8 0.7 7.3 6.7 0.1 4.0 0.3 43.5 0.4 0.0 0.0 12.9 1.9 21.5 7.7 0.3 0.2 37.2 33.5 11.8 31.4 15.5 0.1 0.4 0.2 48.8 0.2 39.3 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.1 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 2.7 10.4 0.8 3.9 7.3 2.8 5.3 0.9 28.6 3.0 190.6 90.0 2.7 198.6 616.6 0.0 9.5 2.5 87.0 247.9 17.4 0.0 0.8 13.3 17.9 0.7 293.7 59.6 0.0 3.9 1.5 489.5 352.1 46.5 2.0 41.5 0.0 45.6 127.7 32.1 0.5 64.5 93.9 448.7 7.2 4.0 2.5 37.6 27.1 102.9 0.2 0.0 6.5 173.1 0.7 0.5 601.1 0.9 5.1 5.6 926.6 EMSY C11orf30 ENSG00000158636 "EMSY, BRCA2 interacting transcriptional repressor" Q7Z589 11 76444923-76553025 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012234, HPA050777" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012234: AB_449325, HPA050777: AB_2681232" "unprognostic (1.69e-2)" "unprognostic (8.15e-2)" "unprognostic (1.51e-3)" "unprognostic (3.66e-2)" "unprognostic (2.60e-2)" "unprognostic (1.54e-2)" "unprognostic (3.32e-2)" "unprognostic (3.87e-2)" "unprognostic (2.01e-2)" "unprognostic (7.70e-2)" "unprognostic (8.47e-2)" "unprognostic (5.37e-2)" "unprognostic (2.99e-2)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (6.64e-2)" "unprognostic (8.74e-2)" 14.5 12.1 13.7 12.8 22.7 19.7 15.6 39.4 22.2 17.7 14.3 17.2 12.6 9.0 21.7 14.0 11.5 15.8 11.4 17.2 13.6 10.6 13.1 10.7 17.8 14.3 23.8 10.8 20.9 15.3 23.2 23.1 25.8 16.2 14.6 15.7 14.7 14.0 14.4 18.3 11.6 13.5 18.0 24.8 14.7 13.9 14.4 26.7 22.6 15.1 8.5 14.3 14.2 17.1 7.0 6.2 11.8 5.1 5.0 8.4 4.4 4.9 7.0 16.2 9.9 6.1 6.1 7.1 8.0 8.0 10.5 11.6 11.9 6.9 6.8 7.8 8.7 8.7 10.0 13.1 7.7 16.3 10.8 4.9 10.6 10.3 5.1 3.9 11.5 9.6 5.5 5.2 12.0 10.0 6.7 9.4 11.7 7.3 12.0 8.4 13.3 15.4 6.9 7.0 15.7 9.4 9.9 29.8 9.6 7.2 5.9 10.2 4.4 11.2 7.7 2.4 10.5 15.5 7.1 7.0 9.9 13.5 25.4 5.6 6.7 7.3 19.6 3.3 7.1 7.2 11.8 5.1 10.3 7.2 4.8 6.7 6.4 6.7 8.4 3.8 7.0 6.3 5.8 10.8 5.0 3.8 6.2 6.5 4.4 13.7 22.7 39.4 22.2 13.6 10.6 23.8 10.8 16.2 26.7 14.9 5.6 2.2 6.3 0.0 18.9 0.0 5.1 12.0 11.4 12.2 33.4 13.7 11.6 5.0 0.9 7.1 4.2 0.0 3.7 6.9 8.2 11.7 2.3 5.9 7.4 14.3 7.0 8.0 6.0 1.5 10.6 6.9 0.0 1.0 15.1 10.8 5.6 0.0 11.7 7.7 22.3 12.9 0.0 25.6 7.0 0.0 17.6 8.7 10.4 7.4 EMX2 ENSG00000170370 "Empty spiracles homeobox 2" Q04743 10 117542444-117549546 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 46.8;epididymis: 53.9;seminal vesicle: 76.3" "Cell type enhanced" "Detected in many" 17 "Collecting duct cells: 226.8;Distal tubular cells: 76.3;Leydig cells: 55.8;Proximal tubular cells: 156.2" "Group enriched" "Detected in many" 13 "endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 17.2;fHDF/TERT166: 19.0;RPTEC TERT1: 19.2;RT4: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003497, HPA065294" Enhanced Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA003497: , HPA065294: AB_2685455" "unprognostic (1.53e-1)" "prognostic favorable (2.80e-4)" "unprognostic (7.21e-3)" "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (3.53e-2)" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (7.33e-2)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "prognostic favorable (2.28e-13)" "unprognostic (3.65e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.88e-2)" 4.6 0.5 11.5 0.6 10.3 0.5 1.4 0.5 12.5 23.5 0.7 7.3 46.8 0.5 40.5 53.9 0.7 25.4 1.2 0.6 14.7 2.1 25.5 0.5 0.5 0.7 1.8 10.4 5.7 0.5 0.6 1.1 0.6 2.5 1.9 0.5 3.4 1.3 76.3 5.1 4.7 0.5 22.6 0.6 0.5 0.5 3.6 6.2 0.0 0.5 1.2 0.7 4.2 2.4 0.7 0.5 2.4 0.9 1.0 0.7 0.1 0.0 0.0 0.0 1.9 0.0 0.2 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 17.2 19.0 0.0 0.1 0.4 0.0 0.0 0.0 1.8 0.5 0.1 0.1 0.0 0.1 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.1 19.2 6.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.5 0.6 0.5 0.6 0.7 0.4 0.4 0.4 0.4 0.7 0.6 0.5 1.1 1.0 0.9 0.5 0.6 0.1 11.5 10.3 0.5 12.5 14.7 2.1 1.8 10.4 2.5 6.2 0.0 0.0 0.0 1.9 9.5 0.0 1.1 0.0 0.0 0.0 226.8 0.0 0.0 76.3 0.0 1.2 0.8 0.0 0.0 0.0 0.3 13.4 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 55.8 1.8 20.3 0.0 0.0 0.0 0.0 0.0 38.5 156.2 0.0 51.8 12.2 0.1 0.2 6.6 0.1 0.0 0.0 1.1 ENTPD7 "FLJ30978, LALP1" ENSG00000198018 "Ectonucleoside triphosphate diphosphohydrolase 7" Q9NQZ7 10 99659506-99706240 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 46.1" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 14.1;Urothelial cells: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014351 Uncertain Approved Nucleoplasm NA NA 24000 Nucleoplasm "HPA014351: AB_1848183" "unprognostic (1.82e-1)" "unprognostic (7.26e-2)" "unprognostic (1.11e-2)" "unprognostic (6.01e-3)" "unprognostic (6.22e-2)" "unprognostic (3.32e-3)" "unprognostic (9.35e-2)" "unprognostic (3.77e-3)" "unprognostic (3.83e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (5.59e-2)" "unprognostic (2.98e-1)" "unprognostic (1.22e-1)" "unprognostic (2.99e-2)" "unprognostic (3.39e-1)" 3.1 5.6 2.2 5.1 2.1 6.4 2.7 2.4 3.3 4.4 15.7 1.3 11.3 18.6 3.9 5.7 9.1 3.1 9.1 3.2 2.0 1.7 6.0 14.5 4.2 7.1 1.4 1.9 3.2 23.9 3.6 8.6 8.5 1.5 5.6 4.9 3.4 9.0 13.2 1.6 4.4 46.1 5.6 1.4 5.4 5.1 3.5 0.5 2.5 3.5 6.0 6.3 11.4 5.0 0.9 7.7 3.7 2.2 2.7 2.2 1.3 5.2 6.0 8.0 14.8 4.0 4.0 9.7 9.9 20.6 12.9 10.8 11.0 5.9 4.5 5.8 13.3 3.9 13.9 6.7 4.0 10.6 1.9 5.3 3.4 4.7 10.1 6.0 12.0 7.8 3.7 6.9 16.2 15.4 15.0 13.0 4.8 6.4 4.4 5.1 4.7 2.4 2.5 4.7 6.5 2.6 0.0 6.2 2.4 14.1 17.0 3.3 6.4 6.9 2.6 8.6 5.7 7.2 6.1 8.2 11.2 7.2 7.2 8.3 4.5 7.5 4.1 10.9 3.7 3.0 0.3 2.2 3.7 2.2 2.2 2.0 0.9 0.8 1.8 5.0 0.3 1.4 0.9 2.0 2.7 1.2 7.7 0.6 1.3 2.2 2.1 2.4 3.3 2.0 1.7 1.4 1.9 1.5 0.5 0.0 0.0 0.0 14.1 7.2 0.4 0.6 0.0 4.0 2.3 5.2 2.0 4.5 0.0 1.9 1.4 1.0 6.5 0.0 4.3 4.4 1.5 1.8 0.0 3.4 1.7 0.0 5.2 0.6 1.2 2.2 0.9 1.3 0.0 6.4 2.7 0.7 3.4 2.9 0.7 1.3 1.8 0.0 1.4 1.4 0.7 6.5 4.2 0.0 1.4 22.1 EP300 "KAT3B, p300" ENSG00000100393 "E1A binding protein p300" Q09472 22 41091786-41180079 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000146, HPA003128, HPA004112" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746" "unprognostic (7.67e-2)" "unprognostic (5.56e-2)" "unprognostic (2.29e-1)" "unprognostic (2.52e-1)" "unprognostic (6.10e-3)" "unprognostic (1.66e-1)" "unprognostic (2.21e-2)" "unprognostic (2.13e-1)" "unprognostic (1.54e-1)" "unprognostic (8.97e-2)" "unprognostic (1.74e-2)" "unprognostic (8.54e-2)" "prognostic favorable (7.45e-5)" "unprognostic (7.97e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-1)" "unprognostic (8.66e-2)" 16.8 14.8 19.1 13.9 15.5 45.3 14.5 33.0 20.6 14.8 16.8 15.6 18.9 11.1 18.1 11.6 16.8 15.7 16.5 10.7 16.6 8.3 11.5 12.2 14.1 12.9 16.9 12.7 20.2 15.7 26.4 14.5 27.7 13.8 13.2 12.2 12.3 15.3 17.9 19.5 18.2 17.4 13.8 12.7 15.9 14.7 20.6 18.6 29.3 16.9 10.9 14.1 18.7 22.5 4.3 4.4 9.8 3.9 5.7 3.9 2.3 15.7 11.3 19.2 11.9 12.2 13.2 17.2 7.6 11.0 11.4 11.0 14.4 5.8 16.4 6.7 15.0 10.5 12.7 27.7 10.4 12.7 15.9 18.4 12.3 13.0 11.2 13.9 29.2 13.9 12.9 10.9 16.5 13.8 10.0 12.6 9.5 13.0 22.6 9.0 5.8 8.4 9.1 13.8 19.8 7.9 17.3 9.0 10.2 10.8 20.9 6.1 6.5 26.9 13.7 13.1 16.7 9.7 17.0 16.3 11.4 13.8 8.1 10.8 15.5 7.3 25.6 8.4 9.0 10.8 5.0 3.2 3.0 3.7 3.9 3.2 4.3 3.6 3.9 4.4 2.9 3.1 2.6 9.8 5.7 2.1 3.0 2.6 2.3 19.1 15.5 33.0 20.6 16.6 8.3 16.9 12.7 13.8 18.6 62.5 45.1 44.7 19.0 21.9 43.6 25.4 53.5 29.4 18.2 24.4 33.4 15.3 3.3 13.2 12.6 27.2 22.2 46.7 16.0 15.4 23.4 24.1 24.3 24.1 15.9 23.8 23.7 34.4 59.8 3.4 26.7 31.6 8.5 20.8 23.1 31.8 20.2 26.6 28.7 9.2 31.1 25.8 15.6 20.6 29.9 22.6 25.3 26.6 20.3 30.6 EP400 "CAGH32, DKFZP434I225, KIAA1498, KIAA1818, P400, TNRC12" ENSG00000183495 "E1A binding protein p400" Q96L91 12 131949920-132081102 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 6.7;dendritic cells: 7.3;T-cells: 2.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016704, HPA049013" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA016704: AB_1854888, HPA049013: AB_2680598" "unprognostic (2.28e-1)" "unprognostic (4.04e-1)" "unprognostic (4.33e-1)" "unprognostic (8.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (3.10e-1)" "unprognostic (1.37e-2)" "unprognostic (4.90e-2)" "unprognostic (2.05e-2)" "unprognostic (2.35e-1)" "unprognostic (1.13e-2)" "unprognostic (2.33e-1)" "unprognostic (4.36e-1)" "unprognostic (2.46e-2)" "unprognostic (2.24e-1)" 14.1 15.5 19.3 23.9 21.9 20.0 16.5 27.4 24.0 17.3 15.6 17.6 13.4 11.4 19.2 25.8 14.0 17.1 18.0 11.1 16.6 12.6 12.3 11.9 13.9 18.9 15.6 17.6 24.6 14.0 24.6 17.9 13.3 13.7 15.6 13.2 14.4 16.1 22.6 19.2 27.9 14.7 16.3 12.0 19.4 13.4 27.0 16.8 22.5 18.0 11.8 16.9 16.0 20.9 6.7 7.3 1.0 1.2 0.8 2.8 0.9 14.7 19.6 18.6 9.2 11.1 11.1 14.6 8.3 6.4 6.4 5.6 11.6 4.6 12.6 7.8 10.3 7.3 11.3 8.9 8.4 8.7 5.2 13.3 18.0 6.6 13.1 9.2 19.3 14.1 9.4 8.0 11.9 10.8 11.1 10.9 8.2 17.4 3.6 9.2 18.6 14.5 26.4 14.8 8.1 17.0 15.4 12.4 5.0 8.6 18.1 15.0 12.6 9.7 6.8 9.4 14.0 11.3 15.2 16.2 10.4 16.1 11.5 12.0 9.2 7.1 12.9 10.8 10.8 10.4 1.0 1.2 0.9 1.9 0.9 2.0 6.7 1.7 1.5 0.9 6.4 2.0 2.8 1.0 0.8 0.8 7.3 1.1 0.9 19.3 21.9 27.4 24.0 16.6 12.6 15.6 17.6 13.7 16.8 3.0 13.2 27.5 9.4 8.9 32.0 12.5 2.5 32.1 13.6 15.7 37.3 10.3 1.7 8.7 9.0 15.0 8.0 0.0 9.0 9.5 10.2 8.9 5.8 9.7 13.2 23.8 13.8 13.5 10.7 6.5 15.3 9.1 6.8 14.4 10.2 14.3 11.8 12.2 15.9 2.9 40.1 19.4 10.3 37.1 33.4 11.4 14.9 14.9 12.1 10.7 EPHA6 FLJ35246 ENSG00000080224 "EPH receptor A6" Q9UF33 3 96814581-97752460 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.9;ovary: 13.2;testis: 15.5" "Group enriched" "Detected in some" 67 "Early spermatids: 305.1;Late spermatids: 156.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEK 293: 8.2;U-266/70: 24.9" "Low region specificity" "Detected in many" "HPA007397, HPA058047" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA007397: AB_2667821, HPA058047: AB_2683588" "unprognostic (9.87e-2)" "unprognostic (1.67e-2)" "unprognostic (3.42e-4)" "unprognostic (7.21e-5)" "unprognostic (8.51e-2)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (3.14e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (1.71e-4)" "unprognostic (1.93e-3)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (7.14e-3)" 0.8 0.5 8.7 0.5 9.8 0.3 0.8 27.9 9.9 2.2 5.8 1.1 0.3 0.6 2.2 1.0 2.1 4.2 2.1 1.1 15.4 1.3 1.3 0.5 0.5 0.4 1.1 6.8 13.2 1.4 0.7 0.6 0.5 5.7 2.5 1.8 0.2 0.6 1.7 0.4 0.5 1.1 3.2 0.8 0.4 1.7 15.5 2.8 0.0 4.3 0.0 0.5 2.1 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 8.2 0.0 2.1 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.8 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 2.1 0.0 0.8 24.9 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 9.8 27.9 9.9 15.4 1.3 1.1 6.8 5.7 2.8 0.0 0.0 0.0 0.1 0.2 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 305.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 156.3 2.8 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.4 0.6 0.2 0.0 0.1 3.4 2.3 0.0 0.1 0.0 0.0 0.0 EPHX3 "ABHD9, FLJ22408" ENSG00000105131 "Epoxide hydrolase 3" Q9H6B9 19 15226919-15233435 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 34.8;lymphoid tissue: 29.6;skin 1: 33.1;tongue: 39.6" "Group enriched" "Detected in many" 4 "Suprabasal keratinocytes: 37.9;Urothelial cells: 18.6" "Cancer enhanced" "Detected in many" "cervical cancer: 30.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2;non-classical monocyte: 4.9" "Group enriched" "Detected in many" 18 "dendritic cells: 2.8;monocytes: 4.9" "Cell line enhanced" "Detected in some" "EFO-21: 4.0;NTERA-2: 3.7;OE19: 12.9;SuSa: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012842 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA012842: AB_10601648" "unprognostic (1.39e-1)" "unprognostic (1.16e-2)" "unprognostic (1.54e-2)" "unprognostic (1.74e-1)" "unprognostic (8.24e-2)" "prognostic favorable (2.27e-5)" "unprognostic (8.83e-3)" "unprognostic (1.50e-1)" "unprognostic (3.90e-1)" "unprognostic (4.36e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.43e-1)" "unprognostic (3.68e-2)" "unprognostic (1.48e-1)" "unprognostic (1.30e-2)" "unprognostic (6.01e-2)" 0.2 0.1 0.1 0.2 0.3 0.1 1.0 0.1 0.3 12.5 0.2 0.2 0.4 0.1 0.9 0.3 34.8 1.1 1.7 0.1 0.5 0.1 1.6 0.2 1.6 0.0 0.2 0.0 0.6 0.0 2.2 2.4 0.2 0.4 1.5 0.1 0.6 3.4 0.6 0.2 33.1 0.2 0.2 0.2 1.2 0.5 2.7 0.2 2.4 0.2 39.6 29.6 2.8 13.6 0.0 2.8 0.2 4.9 0.0 0.0 0.5 0.1 0.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.5 0.3 4.0 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.6 0.0 0.5 3.7 12.9 0.5 0.0 0.0 0.0 0.1 0.8 1.6 0.2 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.1 0.0 1.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 4.9 2.8 0.0 0.5 0.1 0.3 0.1 0.3 0.5 0.1 0.2 0.0 0.4 0.2 0.0 0.6 0.0 1.5 6.3 0.2 0.3 2.5 1.4 0.0 5.2 0.0 1.5 1.7 0.5 0.3 0.1 0.0 0.0 0.0 2.5 0.7 2.0 0.0 0.0 0.6 0.0 0.0 1.3 1.3 0.0 0.0 1.4 0.0 1.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 1.2 2.1 2.1 37.9 2.2 0.0 0.0 18.6 EPM2A "LD, LDE" ENSG00000112425 "EPM2A, laforin glucan phosphatase" O95278 6 145382535-145736023 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Carbohydrate metabolism, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Disease mutation, Epilepsy, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.9" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 23.5;Early spermatids: 28.2;Horizontal cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 20.3" "Low region specificity" "Detected in all" "HPA053643, HPA055468" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053643: AB_2797247, HPA055468: AB_2797252" "unprognostic (2.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (3.34e-3)" "unprognostic (2.92e-3)" "unprognostic (1.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.63e-1)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" "unprognostic (1.52e-4)" "unprognostic (2.28e-1)" "prognostic favorable (4.08e-7)" "unprognostic (4.12e-4)" "unprognostic (2.17e-1)" "unprognostic (2.99e-3)" "unprognostic (1.23e-1)" 5.4 6.0 8.8 1.9 9.0 2.2 3.6 4.0 8.9 3.9 11.1 8.6 2.5 3.4 4.8 4.8 8.9 4.3 3.9 19.4 9.6 8.7 8.0 5.7 3.5 3.4 11.9 5.5 5.9 2.9 5.5 3.3 2.0 9.6 6.2 3.4 5.6 3.1 9.2 60.9 2.4 3.3 13.9 13.6 2.5 4.6 3.3 7.1 3.7 4.2 15.7 2.9 10.4 6.0 1.4 1.0 0.3 1.4 5.4 2.4 1.0 1.1 1.7 3.3 6.3 8.2 2.5 1.4 3.0 3.5 2.8 3.4 1.5 1.7 20.3 2.5 3.5 3.4 1.8 1.2 1.3 2.5 7.9 1.7 3.3 2.4 2.5 5.0 11.3 2.0 2.1 6.8 1.7 0.6 3.7 2.0 4.8 1.4 5.2 3.5 2.6 7.5 2.4 3.4 3.0 1.7 4.3 3.0 5.9 2.5 1.7 6.1 6.1 5.3 3.2 7.0 3.1 1.8 6.5 4.3 2.8 1.4 2.6 2.3 3.8 3.8 8.2 2.4 2.7 4.4 0.0 0.1 0.1 0.4 1.4 1.1 1.3 1.1 0.9 1.0 1.4 1.2 2.4 0.3 5.4 0.3 0.9 0.2 1.0 8.8 9.0 4.0 8.9 9.6 8.7 11.9 5.5 9.6 7.1 6.0 1.0 3.2 0.8 0.8 7.9 23.5 5.1 2.7 3.4 1.8 5.9 0.7 10.0 0.9 28.2 1.5 0.3 0.0 2.0 0.6 1.2 1.3 2.3 5.8 2.0 28.6 1.2 1.3 1.5 14.1 2.8 3.1 6.8 0.0 1.5 7.5 1.1 1.1 2.1 6.3 6.7 0.0 2.0 1.6 1.3 0.4 0.3 0.0 1.0 0.3 ERCC1 RAD10 ENSG00000012061 "ERCC excision repair 1, endonuclease non-catalytic subunit" P07992 19 45407333-45478828 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cataract" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004390, HPA029773, HPA050182, CAB072859, CAB072860" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004390: AB_2278023, CAB072859: AB_2665703, CAB072860: AB_2665704, HPA029773: AB_10602129, HPA050182: AB_2681044" "unprognostic (1.54e-3)" "unprognostic (5.99e-2)" "unprognostic (1.58e-1)" "unprognostic (1.34e-1)" "unprognostic (1.41e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (9.69e-4)" "unprognostic (2.57e-1)" "unprognostic (5.80e-2)" "unprognostic (7.37e-2)" "unprognostic (1.93e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (9.00e-5)" "unprognostic (6.19e-2)" "unprognostic (1.96e-1)" "unprognostic (1.60e-1)" "unprognostic (1.43e-1)" 25.0 28.2 25.9 20.2 27.5 20.8 30.6 28.4 34.8 26.4 21.5 35.4 20.6 20.8 27.4 34.6 28.6 30.9 24.0 63.5 24.7 24.4 22.9 24.2 21.3 26.3 28.3 25.0 37.6 42.9 31.6 32.0 20.3 27.4 29.1 17.1 29.1 53.8 24.4 43.3 43.5 20.4 26.1 23.5 24.3 22.4 21.6 26.7 22.6 28.4 25.7 25.1 22.0 26.0 16.6 69.0 5.3 29.7 12.6 14.2 17.9 13.9 24.1 20.5 29.9 14.1 26.8 6.5 21.0 28.1 25.5 34.0 2.6 13.7 8.3 5.9 22.3 13.6 10.8 6.5 66.9 15.8 18.0 6.6 12.3 9.2 8.2 29.4 12.4 23.2 19.9 14.4 26.6 24.1 22.3 27.7 9.6 7.5 16.6 40.0 9.4 11.7 10.0 4.8 12.7 9.6 17.7 9.6 11.1 18.7 8.9 8.8 18.5 13.3 11.4 18.3 7.1 13.8 23.8 15.9 23.0 22.0 14.0 21.1 12.3 9.9 8.9 26.5 10.7 69.4 4.7 29.2 5.3 14.2 29.7 9.6 16.4 8.7 11.0 29.3 16.6 7.0 11.3 4.0 12.6 21.8 69.0 10.2 17.9 25.9 27.5 28.4 34.8 24.7 24.4 28.3 25.0 27.4 26.7 20.8 37.2 34.7 96.6 63.0 0.0 31.4 35.7 49.5 35.2 19.2 0.0 32.3 76.3 41.3 22.9 40.9 32.2 0.0 57.1 27.9 72.1 73.7 48.5 24.1 86.0 0.0 38.1 33.2 64.8 84.9 73.4 73.4 64.1 25.2 36.0 0.0 64.4 35.1 53.7 53.0 0.0 45.3 61.7 21.5 39.8 46.2 29.7 37.4 38.3 82.3 ERCC3 "BTF2, GTF2H, RAD25, TFIIH, XPB" ENSG00000163161 "ERCC excision repair 3, TFIIH core complex helicase subunit" P19447 2 127257290-127294176 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037153, HPA046077" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB037153: AB_796181, HPA046077: AB_2679527" "unprognostic (2.31e-1)" "unprognostic (1.15e-1)" "unprognostic (3.03e-2)" "unprognostic (1.07e-3)" "unprognostic (1.05e-1)" "unprognostic (8.85e-2)" "prognostic unfavorable (1.62e-7)" "unprognostic (2.74e-1)" "unprognostic (9.13e-3)" "unprognostic (9.25e-2)" "unprognostic (1.25e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (4.30e-6)" "unprognostic (3.71e-1)" "unprognostic (8.50e-2)" "unprognostic (5.73e-2)" "unprognostic (3.92e-2)" 17.4 20.0 26.1 23.8 28.9 20.5 21.0 35.9 32.0 22.1 19.4 19.7 17.1 11.5 21.6 15.7 19.1 23.6 20.4 20.4 23.2 18.8 17.5 17.4 19.4 23.1 19.7 25.8 23.3 22.4 32.0 26.4 16.3 21.5 20.1 17.1 18.3 18.0 21.8 30.1 19.7 17.3 26.1 16.0 24.5 17.4 39.5 20.1 24.1 19.3 15.8 25.9 22.4 20.8 11.8 13.9 7.2 9.7 18.8 16.2 11.7 22.2 15.3 19.0 20.1 21.1 14.5 23.5 20.5 26.6 33.2 32.2 23.4 16.3 16.9 17.0 18.7 21.5 20.0 28.9 21.6 28.9 26.4 25.9 21.2 18.7 24.6 15.7 18.4 23.1 15.0 20.3 38.3 16.4 21.2 21.3 22.2 20.6 11.1 20.9 22.0 26.2 19.8 27.6 14.5 23.9 21.6 21.8 14.0 18.5 20.8 23.0 24.8 17.5 26.7 26.8 22.7 14.4 21.1 16.9 20.0 22.9 18.1 24.3 19.9 38.8 26.5 17.7 8.9 21.3 6.6 9.5 7.2 16.0 9.7 16.2 11.5 11.8 13.5 13.9 11.8 15.8 10.9 3.1 18.8 7.9 11.3 16.1 11.7 26.1 28.9 35.9 32.0 23.2 18.8 19.7 25.8 21.5 20.1 20.8 13.4 8.2 8.1 6.8 0.0 10.5 5.1 32.1 22.7 7.0 0.0 15.9 1.7 12.0 3.5 14.3 4.9 0.0 13.1 10.3 12.0 6.2 9.3 7.8 12.5 0.0 5.8 12.3 12.6 3.1 15.3 9.2 8.5 12.6 8.2 0.0 12.9 5.8 12.0 7.0 0.0 12.9 8.5 34.7 27.5 8.3 12.2 13.8 9.9 5.6 ERCC5 "ERCM2, XPGC" ENSG00000134899 "ERCC excision repair 5, endonuclease" P28715 13 102807146-102876001 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045845, HPA050126, HPA050374" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106" "unprognostic (1.28e-3)" "unprognostic (1.32e-3)" "unprognostic (1.86e-2)" "unprognostic (9.28e-3)" "unprognostic (6.19e-2)" "unprognostic (8.73e-2)" "unprognostic (1.23e-1)" "unprognostic (8.72e-2)" "unprognostic (2.52e-1)" "unprognostic (2.55e-1)" "unprognostic (7.77e-3)" "unprognostic (5.76e-3)" "prognostic unfavorable (2.96e-6)" "unprognostic (3.56e-2)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "prognostic favorable (6.82e-4)" 22.3 19.1 15.9 16.1 17.8 23.7 20.1 26.4 20.8 19.7 27.0 17.9 27.0 25.0 22.1 25.7 21.0 15.1 21.1 15.4 14.6 13.1 18.7 28.1 19.9 26.4 17.1 16.2 22.9 22.3 15.7 25.6 17.9 19.0 20.1 23.1 15.9 20.5 24.7 14.6 25.8 31.1 17.0 19.4 30.6 21.9 14.0 17.8 40.8 21.8 16.6 26.0 22.4 19.6 10.1 10.8 23.4 17.4 17.7 17.5 12.0 14.8 5.4 10.8 6.8 21.7 20.4 6.6 15.1 20.0 8.7 11.4 8.3 20.8 9.3 7.6 15.2 6.1 15.5 9.6 13.8 9.1 14.1 5.4 13.9 15.7 7.2 10.6 28.3 18.2 19.4 13.3 10.1 15.7 13.8 15.2 19.7 6.5 8.5 15.3 4.0 15.2 19.6 4.7 17.9 7.6 8.3 8.1 9.4 18.0 8.3 7.3 10.8 7.9 13.3 8.0 8.7 11.9 26.4 15.3 6.8 3.4 5.7 9.4 12.5 3.8 4.7 26.4 11.5 8.4 23.4 9.8 18.3 16.7 12.3 15.5 9.6 15.5 17.5 10.8 10.1 16.6 16.1 7.2 17.7 17.4 7.7 16.6 12.0 15.9 17.8 26.4 20.8 14.6 13.1 17.1 16.2 19.0 17.8 3.0 7.4 14.6 5.7 6.4 0.0 25.5 7.6 6.7 13.6 0.0 0.0 7.7 0.0 1.0 44.4 9.0 18.4 0.0 1.1 6.6 8.2 3.7 18.5 17.1 9.3 0.0 4.7 10.4 14.3 23.3 20.4 9.9 6.8 1.0 19.0 0.0 1.4 16.4 14.9 1.2 0.0 19.4 6.1 10.6 6.4 6.0 4.8 25.4 16.6 4.3 ERF "PE-2, PE2" ENSG00000105722 "ETS2 repressor factor" P50548 19 42247572-42255157 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 139.4;Suprabasal keratinocytes: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058532, HPA067952" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA058532: AB_2683744, HPA067952: AB_2685932" "prognostic favorable (8.07e-4)" "unprognostic (2.86e-1)" "unprognostic (1.47e-2)" "unprognostic (9.07e-2)" "unprognostic (5.21e-2)" "unprognostic (6.66e-2)" "unprognostic (2.21e-1)" "unprognostic (7.27e-3)" "unprognostic (3.61e-2)" "unprognostic (2.20e-1)" "unprognostic (8.63e-3)" "unprognostic (3.24e-1)" "unprognostic (6.41e-2)" "unprognostic (1.63e-1)" "unprognostic (2.85e-1)" "unprognostic (1.91e-2)" "unprognostic (1.54e-2)" 29.0 18.1 17.8 17.5 22.0 11.2 20.4 8.3 29.6 27.0 23.5 48.3 14.9 28.4 29.8 15.5 18.4 34.6 42.1 21.5 17.6 12.0 20.2 27.2 22.8 15.2 26.7 13.7 41.0 24.1 14.1 25.0 15.5 22.7 21.0 8.8 23.7 15.2 15.7 10.1 23.3 28.1 17.4 17.7 19.0 17.5 20.8 25.2 18.0 22.9 18.4 16.2 25.0 18.1 0.6 1.0 3.1 0.2 0.0 0.5 0.1 18.4 44.9 19.4 21.8 4.3 11.2 5.4 17.5 12.5 18.1 18.4 20.3 21.6 15.3 11.1 16.1 16.2 20.3 14.0 40.9 13.3 7.5 9.6 9.2 25.2 25.8 11.8 10.6 15.3 12.6 13.9 13.9 15.4 23.6 15.0 12.5 19.5 12.8 9.8 37.4 12.0 8.0 16.2 17.6 9.7 15.0 7.0 6.4 11.1 16.0 8.9 18.3 19.6 14.5 20.2 13.8 14.5 19.1 17.8 26.7 38.5 9.2 32.2 14.6 16.3 12.2 26.0 11.4 36.0 0.0 0.2 1.7 0.2 0.1 0.2 0.0 0.1 0.1 1.0 0.6 0.3 0.3 3.1 0.0 0.0 0.1 0.5 0.1 17.8 22.0 8.3 29.6 17.6 12.0 26.7 13.7 22.7 25.2 3.0 1.7 8.3 24.0 139.4 14.4 6.5 25.5 1.4 1.2 8.7 21.6 6.2 6.6 16.4 8.0 29.2 22.0 0.0 13.8 4.2 11.4 20.6 11.5 25.3 10.2 9.5 25.3 41.7 13.2 3.1 10.3 15.5 52.3 2.8 21.1 23.4 12.4 25.8 9.6 19.2 11.9 12.9 30.3 2.6 15.6 95.9 12.4 14.9 19.1 12.2 ESRP2 "FLJ21918, RBM35B" ENSG00000103067 "Epithelial splicing regulatory protein 2" Q9H6T0 16 68229111-68238102 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.2;pancreas: 41.5" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 63.6;Syncytiotrophoblasts: 48.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 18.4;MCF7: 36.1;RT4: 19.4;SK-BR-3: 19.4;T-47d: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040751, HPA048597, HPA048618" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040751: AB_2677115, HPA048597: AB_2680458, HPA048618: AB_2680463" "unprognostic (3.55e-2)" "unprognostic (1.18e-1)" "unprognostic (1.19e-1)" "unprognostic (3.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.62e-2)" "unprognostic (1.54e-1)" "unprognostic (1.33e-1)" "unprognostic (1.50e-1)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "unprognostic (8.80e-2)" "prognostic favorable (1.30e-6)" "unprognostic (1.24e-1)" "unprognostic (3.16e-1)" "unprognostic (9.04e-3)" "unprognostic (8.75e-3)" 0.4 0.2 0.2 7.6 0.5 0.0 3.9 0.6 0.3 4.7 8.0 0.6 4.1 4.6 1.2 10.2 30.1 2.1 12.4 0.6 0.3 0.1 13.4 45.2 15.6 0.2 0.2 0.2 1.3 41.5 7.0 2.5 11.3 0.7 6.6 5.6 0.8 17.3 5.0 0.3 17.6 8.5 0.6 0.2 0.2 12.8 7.0 0.3 3.0 18.4 25.7 17.1 6.4 9.4 0.0 0.0 0.0 0.8 0.0 0.8 0.0 12.4 0.0 0.0 0.0 0.0 0.0 18.4 0.1 0.0 0.0 0.1 11.7 6.2 0.0 0.5 0.0 0.0 12.9 0.0 9.6 0.0 0.0 8.5 0.0 3.5 9.3 0.2 0.0 0.1 0.0 13.6 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 1.3 9.3 4.2 0.0 0.0 0.0 4.8 19.4 1.3 0.0 6.2 19.4 0.0 1.6 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.6 0.3 0.3 0.1 0.2 0.2 0.7 0.3 17.9 12.1 0.0 4.0 5.7 0.5 1.0 15.3 2.7 10.3 22.7 0.0 27.4 0.0 10.0 23.1 0.4 10.3 0.0 12.2 3.2 0.8 6.9 0.0 28.2 2.4 0.0 8.1 0.0 1.5 63.6 0.9 0.0 1.7 1.0 23.1 0.2 11.0 7.0 0.0 3.5 0.2 0.0 0.3 5.7 1.5 7.4 48.9 0.0 15.1 7.1 ESRRG NR3B3 ENSG00000196482 "Estrogen related receptor gamma" P62508 1 216503246-217137755 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5;parathyroid gland: 37.2;placenta: 40.8" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 55.0;Syncytiotrophoblasts: 179.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "pons and medulla: 49.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "RPMI-8226: 15.4;SH-SY5Y: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044678 Uncertain Approved Nucleoplasm No NA Nucleoplasm "HPA044678: AB_10963215" "unprognostic (6.48e-2)" "unprognostic (1.11e-1)" "unprognostic (7.06e-2)" "unprognostic (7.32e-2)" "unprognostic (2.34e-1)" "unprognostic (5.48e-2)" "unprognostic (1.66e-1)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (2.88e-1)" "unprognostic (2.35e-1)" "unprognostic (1.79e-2)" "prognostic favorable (1.13e-11)" "unprognostic (3.04e-1)" "unprognostic (2.55e-1)" "unprognostic (3.65e-4)" "unprognostic (2.05e-1)" 0.5 5.1 2.8 0.4 3.3 0.2 2.9 6.9 10.3 1.4 0.7 0.7 2.2 4.0 0.5 1.5 1.4 2.1 0.8 8.3 3.2 2.6 22.0 0.8 0.7 0.4 6.8 1.7 0.8 4.4 37.2 9.9 40.8 49.5 2.6 0.4 10.7 11.0 2.4 6.3 1.5 3.7 0.9 2.6 1.0 22.2 1.0 1.5 0.0 4.6 7.2 0.4 1.0 0.7 0.4 0.2 1.5 0.0 0.2 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 15.4 2.4 1.7 5.5 29.5 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.1 0.1 1.5 0.2 0.0 0.2 0.0 0.0 2.8 3.3 6.9 10.3 3.2 2.6 6.8 1.7 49.5 1.5 0.0 2.6 0.0 3.3 0.2 26.3 45.0 7.6 18.7 1.2 22.7 55.0 29.1 46.4 3.1 4.5 0.3 0.0 0.0 2.1 3.1 1.5 8.3 0.0 0.8 3.8 46.1 7.9 0.6 0.8 4.6 0.3 0.0 8.5 0.0 0.7 12.3 0.6 0.2 0.7 23.0 34.7 0.0 1.0 1.4 0.1 0.3 179.8 0.0 0.2 1.4 ESS2 "bis1, DGCR13, DGCR14, DGS-H, DGSI, ES2, Es2el, ESS-2" ENSG00000100056 "Ess-2 splicing factor homolog" Q96DF8 22 19130279-19144684 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 13.0;monocytes: 18.0;Pancreatic endocrine cells: 12.5;Syncytiotrophoblasts: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 11.7;RH-30: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001221, HPA001222" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA001221: AB_1078645, HPA001222: AB_1078647" "unprognostic (8.31e-2)" "unprognostic (1.81e-3)" "unprognostic (2.26e-1)" "unprognostic (2.83e-1)" "unprognostic (5.75e-3)" "unprognostic (4.70e-2)" "unprognostic (2.43e-2)" "unprognostic (6.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (5.89e-2)" "unprognostic (9.36e-2)" "unprognostic (3.04e-2)" "unprognostic (1.71e-3)" 4.5 4.0 6.3 5.1 7.2 2.5 4.2 18.9 11.8 5.2 7.9 6.3 3.8 3.6 6.8 4.4 6.4 7.3 4.1 5.9 6.0 6.1 3.9 2.9 4.7 4.9 5.7 6.8 9.4 3.7 5.4 5.2 4.9 5.6 6.4 4.2 5.0 4.4 9.6 6.3 9.3 4.1 6.9 5.0 5.6 5.0 7.2 5.8 6.1 5.0 5.5 6.0 7.2 5.5 1.2 1.5 1.7 1.1 1.8 1.4 1.1 2.1 3.9 2.2 2.6 3.6 0.6 1.0 2.0 1.2 3.4 2.8 3.0 0.7 2.7 0.7 0.9 0.8 3.7 6.6 1.1 1.7 4.3 7.5 0.8 3.3 0.5 0.9 3.4 2.6 0.5 3.9 2.4 0.7 0.9 0.6 2.1 11.7 0.3 1.5 2.1 2.1 2.0 1.9 2.3 3.1 3.2 11.0 0.0 0.9 1.6 5.5 1.2 0.9 1.7 2.4 1.5 1.1 1.3 0.5 3.0 4.4 2.9 1.5 1.5 3.2 1.1 1.0 2.1 2.0 0.3 1.1 1.7 0.9 0.4 0.4 0.4 1.2 0.6 0.7 1.2 1.3 1.4 0.9 1.8 0.5 1.5 0.6 1.1 6.3 7.2 18.9 11.8 6.0 6.1 5.7 6.8 5.6 5.8 6.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 3.4 8.7 0.0 13.0 11.6 11.7 0.0 0.0 0.0 0.0 9.1 10.4 0.0 0.0 4.7 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 18.0 0.0 0.0 12.5 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 ETNPPL AGXT2L1 ENSG00000164089 "Ethanolamine-phosphate phospho-lyase" Q8TBG4 4 108742040-108763054 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 53.5;liver: 111.0" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 9.4;Hepatocytes: 22.6;Muller glia cells: 6.4" "Group enriched" "Detected in some" 23 "glioma: 7.9;liver cancer: 21.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 11.0;Hep G2: 4.3;NTERA-2: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044546, HPA072938" Approved Approved Nucleoplasm Yes NA Nucleoplasm "HPA044546: AB_10962867, HPA072938: AB_2686560" "unprognostic (5.20e-3)" "unprognostic (1.33e-1)" "unprognostic (3.93e-1)" "prognostic favorable (9.52e-5)" "unprognostic (5.93e-3)" "unprognostic (3.91e-2)" "unprognostic (2.82e-1)" "unprognostic (6.32e-2)" "unprognostic (2.70e-2)" "unprognostic (1.30e-1)" "unprognostic (3.40e-2)" "unprognostic (1.93e-1)" "unprognostic (1.59e-1)" "unprognostic (1.42e-2)" "unprognostic (9.48e-2)" 1.2 1.9 50.8 1.3 51.3 1.2 1.3 7.9 53.5 1.3 1.2 13.4 0.0 1.3 1.4 1.2 1.3 1.2 1.4 3.2 37.5 20.1 6.2 111.0 1.2 1.2 26.0 28.7 1.3 1.2 1.4 0.1 1.2 15.7 1.2 1.2 0.5 19.9 1.3 1.6 1.2 1.2 1.2 7.3 1.6 10.4 1.5 18.7 0.0 1.9 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 0.1 11.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 2.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.9 0.1 0.2 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 51.3 7.9 24.9 37.5 20.1 26.0 28.7 15.7 18.7 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.6 1.0 1.3 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ETS1 "ETS-1, EWSR2, FLJ10768" ENSG00000134954 "ETS proto-oncogene 1, transcription factor" P14921 11 128458761-128587558 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Immunity, Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 122.5" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 159.3;Ito cells: 228.3;T-cells: 181.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 59.4;JURKAT: 62.5;U-698: 79.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002575, HPA063230" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002575: AB_563721, HPA063230: AB_2684965" "unprognostic (1.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.18e-3)" "unprognostic (6.22e-2)" "unprognostic (3.07e-1)" "unprognostic (2.56e-1)" "unprognostic (1.24e-2)" "unprognostic (1.57e-1)" "unprognostic (1.35e-2)" "unprognostic (7.17e-2)" "unprognostic (2.46e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.30e-5)" "unprognostic (2.02e-1)" "unprognostic (3.08e-2)" "unprognostic (1.38e-1)" "unprognostic (5.48e-3)" 33.2 6.3 4.1 45.9 4.7 6.4 24.0 1.6 3.3 13.3 15.0 3.1 4.9 5.3 18.0 9.3 12.6 8.1 13.6 19.1 4.2 3.7 12.4 9.9 36.7 53.9 4.7 2.9 14.1 6.2 6.7 4.1 11.6 4.2 11.7 6.6 12.7 11.7 5.7 12.9 7.5 19.1 7.9 4.3 68.0 8.8 6.0 2.3 122.5 16.7 9.2 51.4 17.5 18.8 6.0 3.0 20.5 0.4 12.5 17.3 4.7 14.5 2.6 12.7 0.0 5.5 8.9 0.0 11.3 24.2 14.2 13.7 0.8 15.8 52.7 11.6 18.6 32.6 5.1 1.2 32.6 30.0 11.1 0.2 59.4 1.1 0.0 14.8 6.1 0.7 17.4 2.6 12.2 44.7 8.1 11.7 62.5 0.1 11.0 17.0 0.0 30.6 4.5 4.7 1.3 9.5 8.4 20.8 4.1 11.2 16.3 0.1 0.8 5.9 0.1 12.5 8.9 0.0 3.0 21.5 32.0 10.0 6.2 18.5 8.2 1.4 79.5 5.7 11.5 28.0 20.5 0.0 3.0 10.4 0.1 14.6 6.0 14.0 12.6 0.1 4.9 17.3 13.5 0.5 12.5 0.4 3.0 15.5 4.7 4.1 4.7 1.6 3.3 4.2 3.7 4.7 2.9 4.2 2.3 23.8 31.1 40.2 29.1 102.1 0.0 6.2 2.5 2.7 35.2 10.4 0.0 0.2 0.0 33.5 2.0 159.3 6.7 0.0 19.5 0.3 45.7 17.2 18.5 3.8 5.6 0.0 14.9 228.3 20.9 0.9 13.0 5.0 65.8 10.0 13.3 0.1 65.1 5.8 14.5 2.9 0.0 103.5 62.6 0.9 1.5 55.3 0.3 181.5 4.0 30.3 ETV1 ER81 ENSG00000006468 "ETS variant 1" P50549 7 13891228-13991425 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 90.0;salivary gland: 45.8" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 2: 112.4;Cardiomyocytes: 72.8;Intestinal endocrine cells: 190.4" "Cancer enhanced" "Detected in all" "glioma: 22.5" "Region enriched" "Detected in all" 8 "cerebellum: 90.0" "Cell type enriched" "Detected in single" 5 "T-reg: 3.1" "Lineage enriched" "Detected in single" 5 "T-cells: 3.1" "Cell line enhanced" "Detected in many" "AN3-CA: 22.2;hTERT-RPE1: 25.6;SCLC-21H: 26.3;U-87 MG: 51.8;WM-115: 25.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 418.9" "HPA068389, HPA077249" Supported Approved Nucleoplasm No No Nucleoplasm "HPA068389: , HPA077249: AB_2686829" "unprognostic (2.45e-1)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-2)" "unprognostic (2.13e-2)" "unprognostic (1.64e-7)" "unprognostic (7.08e-3)" "unprognostic (7.21e-2)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (3.02e-1)" "unprognostic (1.51e-3)" "unprognostic (2.21e-2)" "unprognostic (2.05e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-2)" 2.5 12.4 8.1 1.1 11.7 0.2 4.4 90.0 35.2 1.4 2.4 3.1 0.1 1.2 2.4 1.3 1.5 1.1 9.2 18.0 7.0 4.5 2.1 2.0 14.9 0.7 4.5 6.9 1.0 1.6 11.4 7.4 1.9 8.3 3.1 2.4 0.9 45.8 7.1 0.9 1.5 1.9 2.0 3.5 4.5 1.7 4.5 2.9 0.3 6.5 0.9 4.7 1.8 1.3 0.0 0.0 0.0 0.6 0.0 3.1 0.2 0.0 1.6 11.6 22.2 4.1 12.2 0.0 1.0 3.9 0.6 2.6 0.0 5.3 0.0 1.2 1.8 3.2 0.1 0.4 1.2 1.4 0.3 0.5 0.6 1.0 0.0 2.4 3.8 1.5 3.6 0.0 7.6 0.6 25.6 5.0 0.3 3.4 0.1 4.7 0.0 0.0 0.0 17.5 0.6 11.8 0.0 7.1 0.9 7.9 0.1 26.3 5.1 0.0 0.4 6.3 4.2 0.4 0.1 2.7 2.3 0.7 4.5 4.3 4.0 1.2 0.0 51.8 0.2 25.6 0.0 0.2 0.0 0.1 0.6 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 8.1 11.7 90.0 10.9 7.0 4.5 4.5 6.9 8.3 2.9 17.9 112.4 0.0 2.5 0.9 4.2 72.8 38.2 1.4 1.2 3.5 0.0 0.4 5.0 2.7 18.7 5.2 0.0 0.0 0.8 0.3 4.2 0.2 2.3 11.0 2.6 4.8 190.4 1.8 6.0 6.6 1.4 0.8 11.8 0.0 0.7 12.2 0.9 0.0 32.5 2.7 0.4 19.4 8.2 0.5 1.0 1.1 0.2 0.7 1.1 0.3 ETV5 ERM ENSG00000244405 "ETS variant 5" P41161 3 186046308-186110318 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 55.3" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 62.8;Syncytiotrophoblasts: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 56.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009590, HPA063065, HPA073889" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009590: AB_2101008, HPA063065: AB_2684936, HPA073889: " "unprognostic (3.85e-1)" "unprognostic (5.81e-2)" "unprognostic (1.54e-2)" "unprognostic (3.30e-1)" "unprognostic (9.00e-2)" "unprognostic (2.56e-3)" "prognostic unfavorable (7.85e-9)" "unprognostic (3.52e-3)" "unprognostic (2.97e-1)" "unprognostic (1.22e-2)" "unprognostic (4.18e-2)" "unprognostic (1.48e-1)" "unprognostic (1.57e-3)" "unprognostic (6.80e-2)" "unprognostic (1.57e-1)" "unprognostic (3.58e-2)" "unprognostic (3.84e-3)" 5.8 30.3 13.2 5.5 21.7 1.6 11.3 12.1 35.2 4.7 3.0 15.7 1.3 5.1 6.8 6.2 3.8 4.6 4.8 8.8 13.6 9.4 7.1 6.2 21.9 8.9 9.9 11.0 2.5 25.4 55.3 28.1 24.3 11.5 6.3 3.1 7.4 5.5 5.1 9.8 5.3 2.8 6.1 9.6 10.0 11.9 7.2 6.1 2.0 16.6 1.7 3.6 3.6 3.6 0.6 1.8 0.9 3.1 0.1 0.3 0.5 13.0 9.0 11.6 25.3 7.2 7.4 0.8 11.2 12.6 8.9 9.6 9.9 8.0 0.3 15.1 10.8 13.4 2.2 0.2 8.5 13.2 2.8 0.3 3.8 0.3 11.1 11.9 9.5 7.1 6.5 1.4 14.2 17.4 10.6 13.0 1.3 3.5 4.7 15.1 6.0 1.2 14.5 17.3 3.7 10.2 26.7 11.6 8.7 7.3 3.1 0.5 14.9 2.7 0.1 56.7 4.8 0.0 5.3 12.6 4.9 8.0 12.3 21.9 3.6 14.7 0.1 14.9 7.6 29.1 0.0 0.3 0.1 0.3 3.1 0.0 0.6 0.0 0.0 1.8 0.1 0.0 0.0 0.9 0.1 1.5 1.6 0.0 0.5 13.2 21.7 12.1 31.7 13.6 9.4 9.9 11.0 11.5 6.1 3.0 55.6 4.2 10.8 14.0 15.6 4.7 20.4 1.4 2.3 0.0 11.8 53.9 3.3 8.2 19.2 8.3 1.0 0.0 8.0 16.2 11.4 2.6 8.1 8.5 45.7 4.8 10.3 14.7 47.8 37.8 8.3 13.5 15.1 2.8 0.3 62.8 9.4 0.0 14.5 11.8 15.8 0.0 15.7 17.4 9.3 4.5 74.3 0.9 0.4 1.6 ETV7 "TEL-2, TEL2" ENSG00000010030 "ETS variant 7" Q9Y603 6 36354091-36387800 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.2" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 17.9;Cytotrophoblasts: 25.0;Exocrine glandular cells: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 15.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 16.1;BJ hTERT+ SV40 Large T+: 8.4;BJ hTERT+ SV40 Large T+ RasG12V: 16.0;HDLM-2: 33.3" "Low region specificity" "Detected in all" HPA029033 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA029033: AB_10601375" "unprognostic (1.67e-2)" "prognostic favorable (5.16e-4)" "unprognostic (9.48e-2)" "unprognostic (1.57e-2)" "unprognostic (1.51e-1)" "unprognostic (2.62e-3)" "unprognostic (9.08e-2)" "unprognostic (4.11e-2)" "unprognostic (2.08e-2)" "prognostic favorable (5.32e-4)" "unprognostic (6.81e-3)" "unprognostic (1.11e-1)" "unprognostic (1.69e-3)" "unprognostic (5.54e-2)" "unprognostic (4.93e-1)" "unprognostic (1.27e-2)" "prognostic favorable (2.95e-6)" 2.3 2.5 1.7 7.9 1.7 0.9 1.8 0.9 1.5 2.3 15.1 0.9 2.1 14.4 2.0 2.1 4.7 1.9 7.5 0.9 0.9 1.0 3.0 3.6 7.5 4.2 1.1 1.7 3.7 2.4 3.1 9.9 7.2 3.0 5.3 2.2 3.0 8.1 1.5 0.8 15.1 22.2 4.5 1.5 3.3 5.5 1.1 1.3 3.7 5.3 5.5 8.0 4.3 9.8 2.8 0.7 15.4 4.4 0.4 12.0 1.8 2.1 0.3 0.5 1.3 0.0 0.1 16.1 0.2 5.3 8.4 16.0 1.1 4.7 0.7 0.8 0.1 1.4 2.7 0.2 0.9 0.4 33.3 0.6 1.1 0.3 1.2 1.1 0.5 0.6 0.7 1.4 0.4 0.1 0.4 0.2 0.4 0.3 1.0 0.2 0.4 0.7 0.6 1.2 0.7 0.1 3.5 0.3 0.3 0.1 1.3 0.8 0.5 0.8 1.8 0.5 0.8 2.9 1.0 0.7 0.8 0.9 0.4 0.5 0.3 0.5 0.7 0.3 1.9 0.9 0.0 2.9 0.2 1.4 4.4 3.3 2.8 4.5 1.8 0.7 1.1 0.9 1.2 15.4 0.4 1.4 0.0 12.0 1.8 1.7 1.7 0.9 1.5 0.9 1.0 1.1 1.7 3.0 1.3 17.9 17.9 0.0 1.9 1.8 0.2 0.3 0.0 1.4 7.9 0.0 0.0 25.0 0.0 12.2 0.4 0.7 9.3 0.0 20.9 4.3 2.4 3.4 2.3 0.2 2.5 0.0 3.5 0.0 0.8 0.0 1.4 0.5 3.3 10.0 4.6 2.2 12.8 5.8 1.1 0.8 0.6 0.0 8.2 0.9 16.6 3.1 7.1 0.0 4.5 4.3 EVX1 ENSG00000106038 "Even-skipped homeobox 1" P49640 7 27242700-27250493 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 6.5;prostate: 6.4;seminal vesicle: 6.7;urinary bladder: 8.9" "Group enriched" "Detected in some" 29 "Early spermatids: 49.8;Late spermatids: 47.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 26 "pons and medulla: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "OE19: 21.4;RT4: 13.3" "Group enriched" "Detected in some" 15 "midbrain: 1.0;pons and medulla: 1.0" "Not detected" "Not detected" HPA055132 Approved Nucleoplasm NA NA Nucleoplasm "HPA055132: AB_2682707" "unprognostic (2.73e-2)" "unprognostic (3.59e-1)" "unprognostic (4.31e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-3)" "unprognostic (2.08e-2)" "unprognostic (8.48e-3)" "unprognostic (5.94e-2)" "unprognostic (1.26e-8)" "unprognostic (2.94e-1)" "unprognostic (1.39e-1)" "unprognostic (9.12e-2)" "unprognostic (1.83e-2)" 0.1 6.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.2 0.6 0.1 0.1 0.0 0.9 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.5 3.0 6.4 0.7 0.1 0.1 6.7 0.1 0.0 0.1 1.9 0.1 0.1 0.0 1.7 0.1 0.1 0.1 0.1 0.1 8.9 5.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.2 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 3.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 47.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 EXOSC3 "CGI-102, hRrp-40, hRrp40p, p10, RRP40, Rrp40p" ENSG00000107371 "Exosome component 3" Q9NQT5 9 37766978-37801437 "Disease related genes, Predicted intracellular proteins" "rRNA processing" RNA-binding "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020485 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA020485: AB_10960685" "unprognostic (7.07e-2)" "unprognostic (4.51e-2)" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (3.69e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (7.01e-5)" "unprognostic (3.06e-1)" "prognostic unfavorable (7.39e-4)" "unprognostic (1.71e-3)" "unprognostic (5.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.20e-2)" "unprognostic (9.25e-3)" "unprognostic (2.07e-1)" "unprognostic (1.64e-1)" "unprognostic (1.04e-1)" 14.5 18.2 14.9 18.8 16.3 11.5 16.7 29.2 19.2 14.2 14.0 14.3 12.9 16.1 14.8 13.2 20.6 12.2 8.6 11.5 13.5 13.2 13.2 16.3 10.8 20.6 17.4 8.2 16.0 11.3 13.0 18.1 13.6 14.1 15.9 13.0 13.2 13.5 14.6 14.9 11.9 12.0 17.9 11.7 16.0 15.8 26.9 18.7 23.1 14.6 13.3 22.5 12.9 15.7 34.5 32.6 22.9 33.7 24.4 32.9 33.7 25.9 18.6 10.0 12.8 6.9 5.4 13.3 15.1 5.9 12.6 11.9 24.3 4.4 20.2 11.4 5.6 14.6 10.1 11.1 10.5 14.6 28.2 18.3 16.3 22.6 22.3 7.8 24.8 15.0 3.9 5.5 9.8 6.2 4.1 6.6 14.8 40.3 9.4 9.0 15.8 22.1 19.9 27.1 23.9 20.9 20.1 12.4 10.9 7.1 8.9 14.6 14.7 8.6 7.1 9.5 8.5 9.4 18.2 7.6 10.3 18.7 12.6 23.5 6.6 16.6 26.8 10.2 19.5 11.3 17.8 29.8 22.9 25.0 33.7 31.9 34.5 30.3 32.9 27.7 30.5 30.6 29.5 18.2 24.4 29.8 32.6 32.1 33.7 14.9 16.3 29.2 19.2 13.5 13.2 17.4 8.2 14.1 18.7 20.8 14.5 32.3 25.9 48.1 6.6 6.4 22.9 12.0 10.3 7.0 0.0 51.2 28.2 35.4 50.5 14.0 12.0 0.0 30.2 64.9 23.2 12.7 28.8 10.4 39.7 6.4 10.3 12.9 23.1 7.4 15.5 17.5 18.6 24.4 15.3 8.9 29.5 17.5 12.4 22.3 6.8 25.8 24.7 99.1 59.2 47.3 26.3 20.0 21.5 22.7 EYA3 DKFZp686C132 ENSG00000158161 "EYA transcriptional coactivator and phosphatase 3" Q99504 1 27970344-28088696 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052432, HPA062889" Uncertain Supported Nucleoplasm Yes No Nucleoplasm "HPA052432: AB_2681831, HPA062889: AB_2684895" "unprognostic (3.57e-1)" "unprognostic (2.61e-1)" "unprognostic (2.85e-1)" "unprognostic (8.74e-2)" "unprognostic (1.39e-1)" "prognostic favorable (5.11e-4)" "unprognostic (1.39e-3)" "unprognostic (2.21e-1)" "unprognostic (4.81e-2)" "unprognostic (1.00e-1)" "unprognostic (9.13e-2)" "unprognostic (8.98e-2)" "prognostic favorable (3.15e-6)" "unprognostic (5.17e-2)" "unprognostic (2.79e-1)" "unprognostic (7.60e-2)" "unprognostic (6.11e-2)" 12.8 10.0 14.9 24.0 12.9 8.6 13.3 21.9 13.8 14.7 10.2 14.4 12.8 10.7 14.4 12.4 19.4 11.8 8.1 11.7 10.6 11.8 21.6 11.3 12.5 15.6 11.1 8.8 12.4 12.9 20.9 29.2 13.8 12.9 11.8 11.7 16.4 11.8 13.1 14.5 16.3 12.2 10.5 10.1 14.2 10.0 20.6 13.7 17.4 17.3 12.2 25.0 10.7 13.8 8.6 12.4 10.5 11.2 10.4 12.1 2.6 10.5 4.4 9.0 6.7 10.6 8.2 5.1 7.7 7.4 9.1 9.0 4.3 6.5 16.7 8.6 5.2 3.4 10.4 16.6 6.4 10.8 8.8 9.3 19.0 9.0 7.7 6.3 18.3 17.5 5.0 5.8 10.0 6.8 7.9 11.6 6.2 17.4 6.5 8.1 4.6 11.7 12.3 18.9 8.4 5.9 8.9 16.6 10.6 10.7 5.9 10.4 5.7 8.3 5.2 7.4 7.6 4.3 4.9 11.1 11.0 5.9 10.1 6.3 9.7 9.7 15.5 7.9 17.9 4.8 7.5 11.2 10.5 12.1 10.4 10.8 8.6 9.5 8.7 12.4 7.6 8.3 9.4 9.7 10.4 8.3 7.7 8.2 2.6 14.9 12.9 21.9 13.8 10.6 11.8 11.1 8.8 12.9 13.7 8.9 9.6 18.4 9.6 15.9 17.4 7.5 2.5 1.4 5.7 24.4 15.7 11.8 13.3 9.9 72.6 10.8 8.6 0.0 7.9 11.4 10.4 8.5 11.5 6.8 8.8 17.5 19.7 15.4 12.3 29.7 9.5 14.3 11.8 10.0 9.2 9.1 11.2 10.2 5.6 11.6 18.9 12.9 8.5 40.6 26.0 19.9 9.2 25.4 8.9 9.9 EYA4 "CMD1J, DFNA10" ENSG00000112319 "EYA transcriptional coactivator and phosphatase 4" O95677 6 133240598-133532120 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 65.6" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 11.9;Cardiomyocytes: 13.7;Collecting duct cells: 43.6;monocytes: 12.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 12.7;GAMG: 13.2;HeLa: 35.6;RH-30: 12.1;U-87 MG: 12.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA004805, HPA038771, HPA038772" Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119" "unprognostic (1.60e-1)" "unprognostic (3.34e-1)" "unprognostic (1.27e-1)" "unprognostic (2.04e-9)" "unprognostic (1.64e-1)" "unprognostic (3.08e-2)" "unprognostic (3.44e-2)" "unprognostic (7.21e-2)" "unprognostic (9.07e-2)" "unprognostic (2.04e-2)" "unprognostic (2.80e-1)" "unprognostic (2.29e-1)" "unprognostic (8.27e-4)" "unprognostic (1.82e-3)" "unprognostic (6.67e-2)" "unprognostic (9.55e-2)" "unprognostic (2.51e-2)" 1.6 3.0 1.2 0.2 1.3 0.1 2.4 0.4 1.2 9.7 0.6 2.5 11.1 0.4 2.6 1.9 0.7 8.3 0.7 6.2 1.5 1.2 6.1 0.4 2.0 0.2 2.1 0.8 1.6 0.4 0.2 7.2 0.2 3.5 6.6 0.4 2.7 0.8 13.9 65.6 0.4 0.5 1.9 3.5 0.6 0.7 7.4 1.4 1.8 2.5 5.5 0.7 2.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 1.2 0.0 0.0 0.0 0.0 0.0 10.2 0.2 1.5 0.0 0.0 0.0 10.0 0.0 13.2 0.0 7.7 3.3 0.0 0.0 10.0 1.3 35.6 0.0 0.3 0.0 3.5 2.6 0.0 7.3 2.3 1.7 0.0 0.0 0.0 5.4 4.1 0.0 0.0 0.0 0.0 0.1 0.7 0.1 12.1 0.0 0.0 1.9 1.9 2.0 0.1 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.1 3.7 1.6 0.0 12.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.4 1.2 1.5 1.2 2.1 0.8 3.5 1.4 11.9 2.6 0.0 0.1 0.1 0.0 13.7 0.0 0.0 3.4 43.6 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 1.7 0.6 1.3 2.0 0.6 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.6 6.6 0.0 0.0 0.0 0.0 0.1 EZH1 "KIAA0388, KMT6B" ENSG00000108799 "Enhancer of zeste 1 polycomb repressive complex 2 subunit" Q92800 17 42700275-42745049 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Rod photoreceptor cells: 268.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005478, HPA077684" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA005478: AB_1848340, HPA077684: AB_2732356" "unprognostic (1.01e-1)" "unprognostic (6.02e-2)" "unprognostic (2.19e-2)" "unprognostic (8.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.84e-3)" "unprognostic (1.76e-2)" "unprognostic (1.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.55e-3)" "unprognostic (5.22e-3)" "unprognostic (4.11e-3)" "unprognostic (1.48e-2)" "unprognostic (4.60e-2)" "unprognostic (3.29e-1)" "unprognostic (5.39e-2)" "unprognostic (4.74e-2)" 21.7 10.4 15.0 10.1 25.0 9.9 18.7 39.6 26.1 18.4 15.1 21.4 10.0 9.7 29.8 21.2 10.6 18.8 9.7 17.2 19.0 11.2 13.6 5.3 12.6 14.0 13.7 22.0 38.2 8.1 20.0 19.1 9.3 25.6 13.1 12.1 21.5 10.7 19.3 25.4 16.0 14.0 16.4 19.9 16.0 10.6 8.6 16.7 11.9 15.0 7.5 14.9 16.0 15.9 6.2 6.0 18.8 5.4 4.8 8.3 2.3 5.5 5.8 8.0 5.5 32.1 19.4 6.8 8.9 8.2 7.4 7.6 2.7 6.9 8.4 5.6 9.4 7.3 12.6 5.2 5.9 10.7 9.3 9.3 2.9 10.8 3.3 11.0 6.2 7.0 11.1 10.8 5.6 13.6 13.0 6.0 8.5 7.6 11.9 6.5 2.3 10.1 8.0 2.2 5.1 3.0 6.6 8.2 8.9 7.7 5.9 5.5 4.4 4.9 2.4 5.9 11.9 8.5 4.0 6.2 8.0 3.3 9.3 5.6 12.5 6.3 5.0 5.7 6.5 4.0 10.2 5.2 6.9 5.9 5.4 8.3 5.7 5.2 6.0 1.9 6.2 7.7 5.7 18.8 4.8 3.3 6.0 5.7 2.3 15.0 25.0 39.6 26.1 19.0 11.2 13.7 22.0 25.6 16.7 8.9 17.3 10.7 12.1 4.6 67.2 34.7 17.8 38.8 17.0 12.2 62.8 6.1 8.3 9.2 0.4 12.2 6.7 46.7 6.4 2.6 7.5 7.2 19.7 6.7 7.7 44.5 12.5 15.4 11.6 1.1 28.7 10.6 1.7 20.8 4.2 32.0 9.4 6.0 32.2 8.1 268.1 51.8 13.3 9.3 8.8 5.4 9.0 15.9 6.8 7.6 EZH2 "ENX-1, EZH1, KMT6, KMT6A" ENSG00000106462 "Enhancer of zeste 2 polycomb repressive complex 2 subunit" Q15910 7 148807383-148884321 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.5;lymphoid tissue: 44.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 72.2;Spermatocytes: 126.7;Spermatogonia: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009589 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009589: " "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.57e-1)" "unprognostic (3.30e-3)" "unprognostic (1.33e-1)" "unprognostic (3.85e-3)" "prognostic unfavorable (2.11e-6)" "unprognostic (2.21e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (2.32e-3)" "unprognostic (1.58e-3)" "unprognostic (1.69e-3)" "prognostic unfavorable (8.18e-12)" "prognostic favorable (6.97e-4)" "unprognostic (1.83e-1)" "unprognostic (2.12e-1)" "unprognostic (6.67e-2)" 2.0 1.7 1.8 10.6 1.6 25.5 1.4 4.9 2.7 2.6 4.8 1.1 0.1 3.8 1.7 2.8 11.0 0.9 3.0 0.9 0.8 0.6 1.7 3.3 2.3 12.6 1.3 0.3 2.2 3.8 0.6 1.7 3.4 1.4 1.4 5.1 1.8 3.2 1.6 3.7 6.4 4.8 1.5 1.2 5.8 2.7 19.6 1.3 44.1 0.9 5.5 12.4 2.6 3.5 1.5 4.7 1.3 3.9 8.5 10.3 1.7 17.0 8.0 27.3 18.2 0.8 1.4 14.9 13.3 5.4 11.0 11.1 12.0 19.7 30.2 6.5 5.0 10.0 10.5 14.0 4.6 14.0 43.2 14.0 12.9 9.9 9.3 2.2 28.6 10.6 1.2 2.6 8.2 4.4 3.3 6.4 29.3 27.3 20.1 9.8 19.3 55.6 23.9 21.7 15.0 10.8 34.4 15.3 18.7 5.1 8.2 26.1 16.6 16.7 12.7 4.4 7.3 9.3 12.3 3.9 11.7 5.4 23.3 23.8 18.0 19.6 30.4 10.7 19.6 22.9 0.5 2.2 1.3 1.7 1.5 1.3 1.5 3.4 2.9 4.7 0.8 1.9 1.2 0.2 8.5 3.9 1.0 10.3 1.7 1.8 1.6 4.9 2.7 0.8 0.6 1.3 0.3 1.4 1.3 0.0 7.9 6.7 5.7 23.6 4.8 6.5 2.5 14.7 7.9 7.0 33.4 13.6 3.3 9.1 72.2 7.1 6.7 23.3 7.4 29.5 10.8 4.4 21.8 1.3 10.4 14.3 8.6 4.3 8.9 19.2 2.8 10.9 13.5 19.0 10.2 2.0 10.1 9.3 0.7 1.0 21.1 6.5 9.9 126.7 62.4 25.3 25.5 18.7 18.6 4.0 FAF1 "CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A" ENSG00000185104 "Fas associated factor 1" Q9UNN5 1 50437028-50960263 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 92.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018253, CAB072814" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB072814: , HPA018253: AB_1848351" "unprognostic (1.52e-1)" "unprognostic (1.25e-2)" "unprognostic (6.49e-3)" "unprognostic (4.69e-2)" "unprognostic (6.35e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (1.87e-5)" "unprognostic (2.51e-1)" "unprognostic (1.02e-1)" "unprognostic (1.82e-1)" "unprognostic (9.52e-2)" "unprognostic (1.58e-1)" "unprognostic (1.58e-1)" "unprognostic (1.17e-1)" "unprognostic (9.00e-2)" "unprognostic (2.01e-3)" "unprognostic (6.42e-3)" 16.0 13.6 11.6 18.0 13.4 17.4 16.7 20.0 16.3 14.1 14.6 19.1 14.5 12.2 17.2 12.9 16.9 13.3 12.2 22.3 11.1 10.8 13.2 14.7 13.3 14.9 16.4 13.3 17.0 21.3 22.8 21.5 12.0 13.1 13.9 13.0 12.5 18.0 17.3 58.4 19.0 15.8 17.3 13.1 10.6 14.5 29.7 15.7 29.6 15.6 19.6 17.8 19.4 14.0 5.6 5.4 7.3 5.0 6.1 9.1 2.4 14.5 10.8 9.4 15.9 9.4 8.9 13.9 14.3 12.9 22.2 20.3 12.0 10.5 23.7 10.6 12.1 19.6 10.9 15.1 13.3 19.0 15.7 13.6 19.6 14.3 12.4 15.3 21.1 11.7 8.3 12.0 23.4 28.8 11.5 11.9 18.0 22.8 0.0 11.4 5.8 21.8 16.8 12.5 19.5 7.8 20.4 20.7 0.0 22.4 13.2 0.1 11.7 12.9 26.5 21.7 13.7 8.3 25.3 7.2 12.6 15.4 15.4 0.1 18.5 19.3 27.5 0.0 30.8 14.4 1.4 3.4 7.3 6.6 4.1 8.7 4.0 5.9 6.4 5.4 5.6 7.0 4.7 1.2 6.1 5.0 4.5 9.1 2.4 11.6 13.4 20.0 16.3 11.1 10.8 16.4 13.3 13.1 15.7 6.0 12.8 13.6 31.6 19.1 19.0 40.5 5.1 21.4 29.6 15.7 25.5 12.7 24.9 7.5 59.2 12.6 15.8 23.3 9.8 23.2 11.1 17.4 5.7 15.1 10.0 15.9 10.9 8.0 9.4 92.2 10.3 9.9 15.1 5.4 16.2 18.8 7.4 8.6 10.3 23.7 31.5 6.5 12.9 31.6 13.9 24.6 12.8 19.5 18.0 32.0 FAM103A1 "C15orf18, HsT19360, MGC2560, RAM" ENSG00000169612 "Family with sequence similarity 103 member A1" Q9BTL3 15 82986207-82991057 "Predicted intracellular proteins" "mRNA capping, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041923, HPA041948" Enhanced Supported Nucleoplasm No No Nucleoplasm "HPA041923: AB_10796467, HPA041948: AB_10797270" "unprognostic (1.51e-1)" "unprognostic (1.16e-2)" "unprognostic (5.30e-2)" "unprognostic (1.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (1.96e-1)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (3.63e-3)" "unprognostic (2.09e-2)" "unprognostic (4.72e-2)" "unprognostic (7.46e-3)" "unprognostic (9.57e-2)" "unprognostic (2.72e-2)" "unprognostic (9.47e-2)" "unprognostic (2.45e-1)" 16.1 16.2 16.7 12.8 19.5 21.8 23.2 18.9 25.4 16.4 15.4 11.6 18.9 12.0 16.6 27.8 27.5 17.4 13.1 13.3 15.7 17.9 22.1 23.2 10.9 17.5 16.0 14.4 18.9 21.4 12.5 21.7 29.0 22.7 16.3 17.1 16.3 20.9 14.1 27.0 21.8 18.9 14.6 12.4 16.2 17.6 17.0 11.3 25.8 20.8 19.9 23.9 16.7 17.1 24.9 21.7 46.3 23.4 26.4 26.3 22.5 13.5 18.4 18.0 11.4 11.8 8.8 14.1 14.3 14.4 16.5 13.5 20.5 18.2 7.1 19.1 12.0 18.7 15.9 31.7 13.6 18.1 16.9 23.9 22.1 9.8 24.0 15.5 15.1 19.3 15.3 26.9 12.7 16.8 12.1 10.3 11.7 26.3 14.4 17.3 14.7 11.2 20.0 22.1 17.6 9.4 13.5 15.9 11.1 21.0 26.7 18.0 18.4 14.6 15.6 33.8 30.7 25.1 20.2 7.8 12.2 14.6 11.2 19.8 21.5 40.4 16.7 10.8 21.1 14.3 40.4 23.4 36.3 20.1 22.2 21.8 24.9 23.3 22.0 21.7 21.6 23.3 23.2 46.3 26.4 22.2 20.1 26.3 22.5 16.7 19.5 18.9 25.4 15.7 17.9 16.0 14.4 22.7 11.3 6.0 4.8 34.0 39.0 59.2 23.3 0.0 30.6 18.7 10.3 0.0 23.6 92.6 0.0 0.0 21.7 23.0 29.6 46.7 0.0 69.1 37.1 39.6 35.7 45.7 61.4 27.0 21.9 31.9 31.9 12.7 32.5 19.4 40.5 0.0 26.3 26.1 0.0 52.6 31.8 0.0 27.7 32.3 26.9 59.7 58.6 72.4 77.7 47.3 27.1 48.8 FAM117A ENSG00000121104 "Family with sequence similarity 117 member A" Q9C073 17 49710332-49789180 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 24.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 35.4;U-266/84: 24.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA022531 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022531: AB_2101087" "prognostic favorable (5.30e-5)" "unprognostic (8.06e-3)" "unprognostic (2.82e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-1)" "unprognostic (3.90e-3)" "unprognostic (1.69e-1)" "prognostic favorable (8.25e-7)" "unprognostic (4.05e-1)" "unprognostic (3.58e-1)" "prognostic favorable (1.81e-4)" "unprognostic (1.99e-2)" "unprognostic (3.73e-2)" "unprognostic (9.12e-2)" "unprognostic (1.45e-1)" "unprognostic (4.07e-2)" "unprognostic (4.66e-2)" 9.9 5.7 7.6 15.5 9.4 42.9 9.6 12.4 5.7 17.4 15.8 5.6 12.2 7.2 21.2 9.6 11.3 12.4 13.3 12.5 5.6 3.7 8.3 10.0 9.0 14.2 2.8 5.4 16.0 17.6 8.6 11.9 4.4 10.8 16.4 6.0 24.3 11.9 21.3 4.0 13.6 13.7 20.7 2.1 26.7 10.3 18.4 3.6 30.0 14.2 6.5 24.1 21.8 8.5 13.9 2.1 24.3 0.9 6.7 5.5 1.8 3.0 0.7 4.9 0.0 2.2 0.4 8.8 1.0 1.7 1.8 3.1 21.7 5.0 14.3 5.4 0.6 8.3 1.7 3.8 3.6 1.4 1.0 6.2 15.8 0.0 6.9 2.4 2.4 12.6 2.1 3.0 3.1 1.7 1.9 3.3 12.4 19.2 12.2 1.7 8.1 15.2 12.7 7.3 4.1 2.4 4.8 4.1 7.5 2.8 2.7 4.9 3.2 1.0 0.4 3.5 5.0 7.2 9.1 0.3 1.8 1.5 1.9 0.8 35.4 24.3 9.5 1.6 3.5 1.5 24.3 0.9 4.9 5.0 0.6 5.5 13.9 3.3 4.2 0.7 9.3 2.7 3.7 1.9 6.7 0.1 2.1 3.2 1.8 7.6 9.4 12.4 5.7 5.6 3.7 2.8 5.4 10.8 3.6 6.0 5.7 11.0 1.2 8.0 12.6 16.1 2.5 1.4 5.7 7.0 13.7 0.9 5.0 1.3 2.3 6.5 0.9 93.5 3.1 1.6 6.1 2.6 2.3 5.0 1.1 4.8 10.3 6.7 3.2 4.5 13.3 3.4 6.8 11.8 4.4 3.9 3.2 0.0 14.5 2.8 3.1 0.0 7.2 17.2 12.4 12.3 0.7 13.1 2.6 0.9 FAM122B "DKFZp686L20116, RP11-308B5.5" ENSG00000156504 "Family with sequence similarity 122B" Q7Z309 X 134769566-134797232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000266 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA000266: AB_1078801" "unprognostic (2.10e-3)" "unprognostic (1.55e-2)" "unprognostic (4.53e-3)" "prognostic unfavorable (7.19e-5)" "unprognostic (1.67e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-2)" "unprognostic (3.07e-2)" "unprognostic (1.50e-2)" "unprognostic (2.15e-1)" "unprognostic (7.64e-2)" "unprognostic (1.53e-3)" "unprognostic (2.26e-3)" "unprognostic (2.60e-2)" "unprognostic (7.96e-2)" "unprognostic (2.11e-2)" "unprognostic (3.19e-3)" 13.4 18.5 24.5 18.4 41.5 27.1 14.8 20.9 29.6 15.7 15.4 22.3 13.4 15.5 23.0 27.7 16.2 20.3 13.6 13.9 22.5 21.8 15.2 9.8 15.5 27.2 22.9 24.7 29.3 15.9 29.0 27.8 17.4 21.3 17.3 23.6 13.3 18.8 17.4 10.3 19.4 19.5 20.3 21.8 26.1 18.5 34.5 20.5 21.4 20.7 11.1 26.5 16.3 16.3 1.6 3.8 5.9 1.2 2.7 3.3 1.1 17.8 16.5 13.3 9.4 6.8 8.9 9.3 14.2 12.5 16.1 15.3 14.6 16.0 17.5 28.2 10.3 22.6 12.0 19.5 11.7 29.4 21.6 13.5 17.6 33.0 4.7 4.2 32.3 22.5 5.8 11.6 17.7 7.8 10.5 9.3 18.0 11.4 22.6 16.9 24.1 20.0 28.1 7.2 20.6 17.8 20.4 14.4 15.3 9.8 18.6 12.1 8.6 7.6 10.3 5.1 11.9 5.5 16.7 6.6 13.5 8.8 34.1 30.8 12.5 14.4 22.7 14.4 37.6 16.7 0.1 1.2 5.9 2.1 0.5 2.8 1.6 2.0 2.8 1.2 1.5 2.4 3.3 1.3 2.7 1.1 3.8 2.0 1.1 24.5 41.5 20.9 29.6 22.5 21.8 22.9 24.7 21.3 20.5 11.9 7.2 13.9 12.1 11.9 4.2 9.0 5.1 2.7 11.4 15.7 11.8 7.4 14.9 6.3 1.2 11.9 10.4 23.3 11.9 8.9 11.3 12.7 24.1 6.8 12.5 12.7 5.8 8.0 18.8 3.3 9.8 11.4 16.9 8.2 13.7 3.9 9.6 17.5 6.0 5.9 5.4 0.0 8.2 2.3 3.6 9.8 7.3 24.9 13.2 16.3 FAM122C RP3-473B4.1 ENSG00000156500 "Family with sequence similarity 122C" Q6P4D5 X 134796395-134854835 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 41.5;Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 14.9" HPA059961 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA059961: AB_2684181" "unprognostic (1.32e-2)" "unprognostic (3.50e-2)" "unprognostic (7.63e-2)" "unprognostic (3.38e-3)" "unprognostic (1.08e-1)" "unprognostic (5.25e-2)" "unprognostic (1.85e-1)" "unprognostic (3.76e-3)" "unprognostic (3.50e-2)" "unprognostic (7.20e-3)" "unprognostic (2.28e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-2)" "unprognostic (5.93e-2)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" "unprognostic (4.16e-3)" 4.2 3.8 4.1 4.7 6.0 8.7 4.1 2.9 5.0 4.6 3.8 7.9 3.8 1.8 11.5 4.2 3.5 4.7 3.4 3.9 4.0 4.2 3.6 3.2 5.6 7.1 6.3 4.6 22.0 2.1 2.9 5.5 2.9 5.3 4.4 3.2 11.5 6.6 3.2 2.9 3.3 4.0 7.9 6.2 6.4 4.7 12.0 5.2 9.1 3.8 2.1 6.5 5.9 3.5 4.8 7.0 7.3 5.8 4.5 3.8 2.1 1.1 1.4 4.4 4.5 1.2 1.7 2.6 3.7 3.3 3.4 4.7 3.2 4.5 1.5 5.7 1.6 7.4 1.7 3.7 1.3 2.5 3.7 1.4 2.6 14.9 1.4 1.3 3.9 2.3 1.8 0.7 3.3 2.1 2.3 2.8 11.6 10.9 8.7 2.4 6.8 4.0 3.2 2.4 1.2 3.3 6.9 3.0 3.2 1.1 1.0 1.8 3.0 2.3 0.7 3.8 3.3 1.1 1.1 0.9 2.0 1.3 3.1 2.4 3.3 2.9 6.5 2.9 4.4 2.2 2.7 2.8 7.3 2.6 3.1 2.7 4.8 3.0 3.8 1.9 4.1 3.7 3.3 5.3 4.5 5.8 7.0 2.7 2.1 4.1 6.0 2.9 5.0 4.0 4.2 6.3 4.6 5.3 5.2 6.0 5.0 0.0 2.1 1.1 4.2 1.9 0.0 13.4 3.4 1.8 13.7 1.3 1.7 1.0 41.5 5.7 2.3 23.3 1.6 2.2 2.0 1.3 12.7 0.5 1.9 3.2 1.2 4.9 1.9 4.5 3.7 2.7 3.3 3.6 1.7 4.6 2.0 1.1 2.1 1.1 13.0 0.0 2.3 10.7 1.9 1.0 1.6 8.7 1.7 2.2 FAM13B "ARHGAP49, C5orf5, FAM13B1, KHCHP, N61" ENSG00000031003 "Family with sequence similarity 13 member B" Q9NYF5 5 137937960-138051961 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036525, HPA041819, HPA071936" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036525: AB_10696655, HPA041819: AB_2677690, HPA071936: AB_2686474" "unprognostic (8.09e-2)" "unprognostic (1.27e-1)" "unprognostic (2.34e-3)" "unprognostic (9.61e-2)" "unprognostic (1.44e-1)" "unprognostic (3.95e-2)" "unprognostic (1.44e-2)" "unprognostic (2.02e-3)" "unprognostic (6.51e-2)" "unprognostic (6.31e-2)" "unprognostic (1.69e-2)" "unprognostic (3.60e-1)" "prognostic favorable (3.55e-5)" "unprognostic (9.56e-2)" "unprognostic (4.46e-1)" "unprognostic (1.98e-1)" "unprognostic (3.06e-2)" 12.8 27.1 19.7 18.3 22.0 19.1 14.6 29.4 22.6 15.2 16.4 15.8 18.4 8.9 21.1 13.7 13.3 14.6 13.8 18.3 17.0 21.9 13.1 7.9 13.5 17.8 18.5 15.5 23.7 9.3 14.9 17.7 14.6 26.3 23.4 11.6 14.2 12.3 34.4 5.8 10.1 13.5 29.6 13.4 15.3 12.4 29.4 21.5 13.5 14.1 5.7 20.5 21.2 15.2 7.9 3.7 11.9 6.6 7.6 6.2 1.8 9.3 4.7 14.2 11.6 19.0 6.0 11.1 20.8 17.0 15.9 18.6 12.6 8.5 21.2 7.0 18.1 20.4 7.3 8.7 6.5 20.9 16.0 9.4 9.5 11.5 3.9 6.4 15.5 13.2 7.6 3.9 12.1 7.1 8.4 5.4 7.8 5.4 10.9 14.6 6.9 15.5 8.6 5.6 7.3 5.7 11.2 14.1 4.2 9.6 16.8 16.1 14.2 16.2 5.0 20.4 21.4 13.6 15.8 7.1 17.1 7.5 12.6 15.6 8.9 21.0 20.3 9.7 12.7 14.6 11.9 2.9 10.5 6.2 3.9 5.2 6.5 4.4 5.4 2.1 7.9 4.6 5.9 9.1 7.6 6.6 3.7 4.1 1.8 19.7 22.0 29.4 22.6 17.0 21.9 18.5 15.5 26.3 21.5 20.8 13.7 26.1 14.6 13.7 20.6 41.1 12.7 12.0 19.4 5.2 19.6 10.0 3.3 5.4 31.0 13.8 6.7 0.0 2.9 3.6 16.9 10.5 29.0 5.0 12.1 11.1 9.9 18.4 22.1 22.6 15.0 22.6 11.8 3.6 9.8 7.8 5.3 5.5 24.1 3.3 16.2 25.8 24.0 31.0 22.2 12.0 4.3 30.0 7.9 10.7 FAM149B1 KIAA0974 ENSG00000138286 "Family with sequence similarity 149 member B1" Q96BN6 10 73168166-73244504 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039189, HPA039859" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA039189: AB_10805355, HPA039859: AB_2676712" "unprognostic (2.23e-1)" "unprognostic (7.04e-2)" "unprognostic (1.52e-1)" "unprognostic (4.88e-2)" "unprognostic (6.21e-2)" "unprognostic (1.45e-1)" "unprognostic (2.34e-1)" "unprognostic (4.66e-2)" "unprognostic (3.01e-1)" "unprognostic (5.25e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (5.13e-2)" "unprognostic (1.96e-3)" "unprognostic (1.22e-1)" "unprognostic (9.21e-3)" "unprognostic (2.68e-1)" "unprognostic (5.24e-2)" 9.3 8.9 21.3 7.3 17.0 5.4 10.1 7.7 15.1 12.2 13.4 14.9 10.3 5.4 9.1 10.6 10.5 11.4 12.8 15.7 19.2 14.2 17.5 15.2 7.9 6.3 20.8 9.8 12.6 9.3 12.9 10.8 10.3 13.6 10.5 8.0 8.1 9.0 9.1 9.4 5.8 9.5 9.3 22.8 5.9 7.2 16.6 13.2 6.2 9.8 13.4 7.3 8.3 7.3 2.7 2.7 5.0 1.8 4.6 3.4 1.3 6.9 5.3 11.9 10.9 26.1 16.3 7.7 8.0 15.7 5.4 9.6 3.3 12.2 5.2 3.1 13.9 6.2 6.7 6.9 10.0 6.5 6.3 3.5 6.6 4.1 5.6 13.6 9.1 4.4 13.9 7.4 7.0 27.3 24.0 13.6 8.3 5.9 9.7 9.8 6.3 6.0 8.6 5.1 15.0 13.9 4.0 7.5 5.3 14.6 7.0 2.6 11.3 6.2 16.7 9.6 11.1 9.6 5.8 7.2 5.3 5.4 5.3 10.0 10.7 4.8 4.6 9.1 9.1 4.2 5.0 0.7 2.5 2.2 1.8 2.8 2.7 2.2 2.1 1.5 2.2 3.4 3.1 1.5 4.6 1.0 2.7 2.5 1.3 21.3 17.0 7.7 15.1 19.2 14.2 20.8 9.8 13.6 13.2 3.0 1.9 3.7 3.0 1.8 6.6 10.2 5.1 10.7 5.7 1.8 5.9 5.8 1.7 3.8 17.7 5.8 4.7 0.0 3.1 4.8 4.3 4.0 2.3 3.4 4.8 3.2 7.5 5.5 4.5 19.6 7.8 2.5 1.7 1.8 5.8 4.2 4.0 0.0 4.2 6.8 12.1 12.9 5.2 10.9 3.8 3.1 6.9 2.1 5.2 3.7 FAM168A "KIAA0280, TCRP1" ENSG00000054965 "Family with sequence similarity 168 member A" Q92567 11 73400487-73598189 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037580 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA037580: AB_10672906" "unprognostic (2.65e-1)" "unprognostic (2.10e-1)" "unprognostic (1.15e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (4.60e-2)" "unprognostic (3.24e-2)" "unprognostic (3.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.64e-1)" "unprognostic (2.18e-2)" "unprognostic (3.07e-1)" "unprognostic (1.58e-1)" "prognostic favorable (6.41e-5)" "unprognostic (2.10e-1)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (9.70e-4)" 12.4 10.3 32.0 9.7 28.5 9.9 12.3 29.1 54.7 15.3 10.1 28.2 7.9 7.9 14.6 16.3 9.3 14.0 13.6 11.8 30.3 22.5 11.8 7.9 9.9 7.8 30.1 29.2 16.9 10.3 34.0 9.2 9.5 34.3 12.7 9.4 9.6 11.3 16.2 16.1 8.0 9.8 17.4 35.3 8.5 8.2 6.4 22.4 5.5 14.5 4.3 7.6 9.9 8.5 1.1 2.6 7.5 4.1 0.9 1.5 0.6 8.3 9.3 20.1 11.5 14.3 16.5 3.2 12.0 14.0 14.1 13.3 9.9 10.4 8.9 11.0 22.1 12.6 7.2 12.5 12.5 16.6 7.0 8.4 10.3 9.6 4.9 5.6 5.7 19.4 16.0 7.9 14.7 7.5 17.2 8.5 14.3 2.7 7.0 13.1 11.7 13.4 4.8 7.1 14.9 12.0 18.4 33.5 4.7 7.3 7.2 13.9 20.7 14.2 10.2 21.3 7.4 17.3 6.3 10.9 15.8 13.5 19.7 9.6 15.6 11.0 16.0 7.8 6.6 14.1 7.5 2.7 1.5 1.5 4.1 0.8 1.0 0.8 1.3 2.1 1.1 1.1 1.3 6.3 0.9 2.9 2.6 1.2 0.6 32.0 28.5 29.1 42.4 30.3 22.5 30.1 29.2 34.3 22.4 3.0 10.9 4.5 1.7 3.4 21.0 18.2 20.4 5.3 11.4 7.0 43.2 1.8 0.0 3.1 18.3 6.3 4.9 0.0 2.3 3.2 6.1 2.6 23.0 15.5 8.6 3.2 12.2 9.8 15.1 18.1 6.9 6.9 5.0 2.8 7.8 24.9 3.6 3.5 12.0 3.1 22.1 6.5 13.3 3.7 4.1 3.3 2.3 2.5 6.6 1.4 FAM180A "HWKM1940, UNQ1940" ENSG00000189320 "Family with sequence similarity 180 member A" Q6UWF9 7 135728348-135748846 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.0" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 6.6;Cardiomyocytes: 5.2;Fibroblasts: 5.8;Ito cells: 8.0;Leydig cells: 2.6;Melanocytes: 6.8;Peritubular cells: 3.9;Smooth muscle cells: 2.8;Suprabasal keratinocytes: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "basophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "U-2197: 74.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021224 Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA021224: AB_1851352" "unprognostic (3.85e-2)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.33e-2)" "unprognostic (6.85e-2)" "unprognostic (1.27e-1)" "unprognostic (5.05e-2)" "unprognostic (1.97e-3)" "unprognostic (5.62e-2)" "unprognostic (7.55e-2)" "unprognostic (8.88e-4)" "unprognostic (3.14e-3)" "unprognostic (1.82e-1)" "unprognostic (4.35e-4)" "unprognostic (6.62e-4)" 9.3 2.6 0.1 1.7 0.5 0.0 5.6 0.1 1.0 7.8 5.7 0.3 0.5 0.7 9.4 2.0 5.1 3.0 21.2 14.7 0.1 0.1 8.7 23.0 4.6 0.0 0.1 0.0 8.1 1.1 0.0 0.3 1.4 0.5 6.1 1.8 1.9 2.2 0.1 3.5 5.5 3.2 8.1 0.4 0.9 1.6 3.9 0.1 0.0 4.6 4.8 0.9 6.6 8.3 0.6 0.2 2.0 0.3 0.4 0.5 0.1 0.0 0.0 0.0 0.0 8.1 8.4 0.0 4.2 16.1 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 10.3 1.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 16.7 0.0 74.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.0 0.1 0.1 0.3 0.1 0.2 0.2 0.3 0.2 0.0 0.6 0.4 0.5 0.8 0.4 0.3 0.2 0.2 0.1 0.1 0.5 0.1 1.0 0.1 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 6.6 0.0 5.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 2.6 0.0 6.8 0.0 0.0 0.0 0.1 0.0 3.9 0.0 0.0 0.0 2.8 0.0 0.0 4.3 0.6 0.0 0.0 0.0 FAM182B ENSG00000175170 "Family with sequence similarity 182 member B" Q5T319 20 25763466-25868225 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.6;testis: 9.9" "Group enriched" "Detected in some" 37 "Early spermatids: 201.1;Late spermatids: 281.2" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "SCLC-21H: 17.4" HPA050100 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA050100: AB_2681014" "unprognostic (8.05e-2)" "unprognostic (1.48e-2)" "unprognostic (1.29e-2)" "unprognostic (3.63e-1)" "unprognostic (2.68e-1)" "unprognostic (1.50e-2)" "unprognostic (1.88e-4)" "unprognostic (1.61e-1)" "unprognostic (3.15e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-2)" "unprognostic (3.30e-1)" "unprognostic (2.47e-9)" "unprognostic (2.36e-1)" "unprognostic (4.40e-2)" "unprognostic (6.54e-2)" "unprognostic (3.18e-1)" 0.4 0.9 2.9 0.2 3.8 0.0 0.8 7.6 5.9 0.6 0.2 0.1 1.2 0.3 0.6 6.4 0.2 0.3 3.0 3.7 0.4 0.0 1.2 0.2 2.0 1.7 0.8 0.5 2.7 4.4 1.7 0.1 0.8 0.5 1.2 5.2 0.7 0.4 1.2 0.8 0.6 9.9 1.4 0.0 0.0 0.4 0.2 0.2 2.1 0.1 0.7 1.2 0.4 2.2 1.0 1.2 1.2 0.6 0.1 0.5 0.3 0.0 0.1 0.4 0.0 3.0 0.2 1.3 1.5 1.0 4.1 0.0 0.4 0.0 0.0 0.4 0.0 0.7 0.0 0.3 0.2 1.1 0.9 0.1 0.0 1.1 0.0 0.1 1.4 1.0 2.8 0.0 0.1 1.4 0.7 0.1 1.7 1.6 0.1 0.1 0.6 0.4 0.0 17.4 1.1 0.7 0.2 1.2 1.2 0.5 0.6 0.3 0.2 3.7 0.8 0.5 1.8 0.3 0.8 0.2 0.5 1.5 0.0 0.1 1.7 0.6 0.0 0.6 0.1 1.0 0.3 0.2 0.2 0.9 1.2 2.1 0.7 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 3.0 0.6 0.4 0.0 0.0 0.0 1.8 5.9 0.5 1.7 0.0 201.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 6.4 0.0 0.0 0.0 281.2 2.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.5 6.5 1.4 5.1 1.3 2.5 0.0 0.0 0.0 0.0 FAM189A1 "KIAA0574, TMEM228" ENSG00000104059 "Family with sequence similarity 189 member A1" O60320 15 29120254-29570723 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.3;parathyroid gland: 6.5" "Cell type enhanced" "Detected in some" 7 "Cardiomyocytes: 3.1;Ductal cells: 3.7;Enterocytes: 2.3;Intestinal endocrine cells: 2.9;Paneth cells: 3.5;Undifferentiated cells: 2.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;HDLM-2: 15.6;Karpas-707: 2.0;REH: 3.7" "Low region specificity" "Detected in many" "HPA009410, HPA010637" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA009410: AB_1852332, HPA010637: AB_1852333" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (5.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.71e-2)" "unprognostic (4.85e-3)" "unprognostic (2.21e-1)" "unprognostic (1.27e-1)" "unprognostic (3.39e-1)" "unprognostic (7.97e-2)" "unprognostic (5.00e-1)" "unprognostic (6.70e-3)" "unprognostic (2.39e-2)" "unprognostic (9.03e-2)" "unprognostic (2.50e-2)" "unprognostic (3.12e-1)" 0.8 1.5 12.8 0.6 7.9 0.4 0.6 4.2 9.5 0.4 4.0 1.5 0.0 1.0 1.1 0.8 0.6 1.5 0.5 0.7 15.3 4.7 1.7 0.5 1.5 0.5 3.5 3.4 0.4 3.3 6.5 0.0 0.7 4.0 0.8 3.0 0.0 1.1 0.5 0.4 0.8 3.2 1.0 0.7 1.3 0.6 2.3 0.3 0.0 1.9 0.0 1.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.3 0.0 0.0 0.0 0.2 15.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 2.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 3.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 12.8 7.9 4.2 9.5 15.3 4.7 3.5 3.4 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.7 0.0 2.3 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.5 0.9 0.0 0.0 0.0 1.7 0.1 0.2 3.5 1.4 0.8 0.3 0.0 0.2 0.5 1.2 0.0 0.0 0.0 2.9 0.5 FAM189B "C1orf2, cote1" ENSG00000160767 "Family with sequence similarity 189 member B" P81408 1 155247205-155255483 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006659, HPA050674" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA006659: AB_1078339, HPA050674: AB_2681213" "unprognostic (1.56e-2)" "prognostic unfavorable (4.98e-4)" "unprognostic (1.44e-2)" "prognostic unfavorable (9.59e-5)" "unprognostic (1.46e-2)" "unprognostic (4.86e-3)" "prognostic unfavorable (3.43e-4)" "unprognostic (2.70e-2)" "unprognostic (3.49e-2)" "unprognostic (2.73e-1)" "unprognostic (5.15e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.43e-7)" "unprognostic (4.16e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-3)" "unprognostic (3.25e-2)" 18.7 13.5 18.8 12.0 17.3 6.4 20.1 18.3 18.4 11.2 16.9 5.6 16.6 14.4 14.8 6.9 14.7 10.9 13.9 10.3 15.2 11.0 11.0 10.1 10.1 7.8 10.1 16.3 11.6 11.8 15.9 13.2 11.0 19.7 12.3 8.1 7.2 13.9 18.7 41.1 12.9 12.5 17.1 13.0 9.7 13.6 10.3 11.2 3.8 8.9 10.8 7.2 18.6 19.3 0.2 0.2 0.1 0.3 1.2 0.8 0.3 12.6 9.5 8.6 16.2 8.2 11.3 2.5 10.8 8.1 8.1 7.0 10.7 6.8 10.9 16.8 8.2 4.7 12.8 10.2 10.3 3.8 15.5 23.0 7.8 8.0 6.2 11.0 2.5 9.1 10.4 6.5 8.2 7.7 9.4 10.7 6.6 6.5 4.6 6.3 6.8 11.2 3.9 10.8 10.6 23.0 11.6 6.4 12.3 5.5 3.4 12.3 16.5 5.0 18.0 12.6 5.5 14.8 9.8 9.1 7.5 10.4 8.6 11.6 9.9 9.8 5.8 9.1 4.6 6.2 0.0 0.3 0.0 0.1 0.3 0.8 0.1 0.4 0.2 0.2 0.2 0.0 0.2 0.1 1.2 0.0 0.2 0.0 0.3 18.8 17.3 18.3 18.4 15.2 11.0 10.1 16.3 19.7 11.2 3.0 2.1 7.5 10.8 5.4 15.2 10.7 5.1 5.3 2.3 12.2 17.7 10.6 1.7 12.3 3.2 12.6 7.1 0.0 9.0 13.3 7.3 10.3 5.7 5.9 6.9 38.1 6.4 14.1 9.7 4.2 8.9 4.0 6.8 4.6 8.6 7.2 9.9 3.5 8.5 4.8 16.5 0.0 9.8 17.7 6.6 7.2 12.0 3.8 9.2 10.4 FAM208A "C3orf63, KIAA1105, RAP140, se89-1, TASOR" ENSG00000163946 "Family with sequence similarity 208 member A" Q9UK61 3 56620133-56683237 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006735, HPA017142" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006735: AB_1852384, HPA017142: AB_1852382" "unprognostic (1.46e-1)" "unprognostic (7.97e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-2)" "unprognostic (2.30e-3)" "unprognostic (9.31e-2)" "unprognostic (3.91e-2)" "unprognostic (5.93e-2)" "unprognostic (1.51e-1)" "unprognostic (8.84e-2)" "unprognostic (1.73e-1)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (1.67e-1)" "unprognostic (2.74e-1)" 10.3 11.6 11.4 10.9 14.7 8.0 9.8 13.8 11.6 9.9 10.1 14.3 10.5 7.3 12.6 5.8 11.2 11.1 9.0 9.9 9.2 5.4 8.1 5.8 8.5 14.6 15.2 7.1 11.9 12.6 22.9 19.2 7.0 10.5 7.6 9.6 8.6 11.4 7.6 7.4 8.2 10.4 16.9 11.6 10.5 10.2 21.1 13.0 13.8 14.6 4.1 14.2 14.3 12.9 4.1 3.3 3.7 2.6 2.9 4.4 2.0 23.1 9.2 14.4 11.3 7.8 13.7 7.2 10.4 10.7 10.0 10.5 7.6 17.4 36.8 3.9 10.4 16.8 9.3 14.3 12.2 14.6 18.1 7.2 14.4 13.5 3.4 5.5 15.1 22.9 6.5 10.3 9.7 17.6 11.8 12.9 14.0 13.9 21.3 12.7 8.1 18.5 3.0 8.0 12.3 14.2 9.9 14.3 12.2 9.6 17.1 9.6 11.9 22.7 9.1 11.4 8.6 15.0 17.5 13.8 13.0 12.0 11.7 15.8 19.4 27.0 18.7 15.0 22.4 17.1 1.8 2.6 3.7 4.3 2.0 2.8 2.8 3.8 4.4 3.3 4.1 4.1 4.2 0.8 2.9 2.3 2.5 3.3 2.0 11.4 14.7 13.8 11.6 9.2 5.4 15.2 7.1 10.5 13.0 14.9 33.1 18.2 14.9 17.5 31.9 22.6 28.1 33.5 21.6 14.0 21.6 11.6 8.3 12.5 13.8 28.2 12.7 23.3 14.7 7.4 19.2 13.4 17.4 13.0 18.1 35.0 17.9 31.3 45.6 6.3 34.5 23.3 13.5 17.2 17.4 26.0 14.8 10.5 21.5 14.1 25.8 45.3 22.9 72.1 46.0 20.3 7.7 26.1 17.2 10.9 FAM214A "FLJ10980, KIAA1370" ENSG00000047346 "Family with sequence similarity 214 member A" Q32MH5 15 52581317-52709817 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 27.1;U-698: 30.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039369, HPA040180" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039369: AB_10795250, HPA040180: AB_10794736" "unprognostic (1.75e-1)" "unprognostic (6.40e-2)" "unprognostic (4.54e-1)" "prognostic favorable (7.27e-6)" "unprognostic (1.08e-2)" "unprognostic (5.96e-3)" "unprognostic (1.32e-3)" "prognostic favorable (8.68e-4)" "unprognostic (6.84e-2)" "unprognostic (2.62e-1)" "unprognostic (2.91e-2)" "unprognostic (2.20e-1)" "unprognostic (2.26e-2)" "unprognostic (1.63e-1)" "unprognostic (3.22e-1)" "unprognostic (3.79e-2)" "unprognostic (6.94e-3)" 21.7 17.1 11.6 15.3 16.2 12.1 18.8 41.3 18.5 11.9 12.0 8.7 32.0 8.8 12.7 6.7 21.1 10.9 8.8 10.5 11.6 5.6 7.7 24.5 9.9 14.5 14.0 14.1 10.4 16.8 24.4 26.0 6.5 11.9 10.1 10.9 9.4 17.3 27.9 47.7 11.9 14.2 13.9 7.1 11.9 12.9 14.9 16.1 12.1 16.4 13.4 18.9 16.4 17.7 7.7 10.0 6.1 0.7 5.4 5.3 1.4 2.4 3.2 3.4 5.8 10.4 6.3 3.9 6.0 10.5 3.2 4.2 1.8 2.6 16.6 7.3 5.6 1.5 4.9 2.4 5.5 2.9 13.3 3.4 4.2 7.2 1.5 3.6 2.0 2.2 14.8 8.9 3.2 3.5 6.1 10.6 5.2 2.4 17.6 4.5 9.5 3.1 5.1 0.6 4.1 3.9 7.6 3.5 12.6 5.3 11.3 3.8 6.7 6.0 11.4 4.5 10.8 17.8 4.4 7.8 3.3 1.0 3.6 1.3 27.1 16.2 30.5 5.6 2.7 1.1 0.8 0.7 6.1 4.7 0.2 5.0 7.7 3.4 3.1 0.9 6.9 3.9 3.6 4.5 5.4 0.3 10.0 5.3 1.4 11.6 16.2 41.3 18.5 11.6 5.6 14.0 14.1 11.9 16.1 41.7 21.9 37.7 12.6 14.4 19.7 22.9 28.1 41.5 25.0 3.5 58.9 2.5 3.3 8.4 2.0 16.5 14.4 0.0 12.8 2.2 16.0 25.3 3.5 34.2 6.1 25.4 27.9 26.4 12.6 2.1 26.2 9.4 25.3 2.8 23.5 29.0 13.2 14.1 30.1 5.6 26.4 12.9 14.1 26.0 8.5 12.5 16.9 27.7 11.5 22.8 FAM217B "C20orf177, dJ551D2.5" ENSG00000196227 "Family with sequence similarity 217 member B" Q9NTX9 20 59933764-59948680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041021, HPA056698" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA041021: AB_10959734, HPA056698: AB_2683212" "unprognostic (1.78e-1)" "unprognostic (2.92e-2)" "unprognostic (2.88e-2)" "unprognostic (1.32e-2)" "unprognostic (9.43e-2)" "unprognostic (5.05e-2)" "unprognostic (9.04e-8)" "unprognostic (2.78e-3)" "unprognostic (4.51e-2)" "unprognostic (1.56e-1)" "unprognostic (1.17e-1)" "unprognostic (9.89e-2)" "unprognostic (1.13e-2)" "unprognostic (5.51e-2)" "unprognostic (1.55e-1)" "unprognostic (1.76e-1)" "unprognostic (2.63e-2)" 5.5 5.2 17.7 7.2 18.2 14.7 6.2 18.7 29.6 6.4 5.4 10.7 5.0 6.2 8.6 7.3 5.9 7.2 5.1 11.7 15.5 14.3 6.8 2.8 6.5 10.3 14.4 19.1 13.7 4.0 5.9 14.3 7.7 14.1 9.6 4.6 4.7 5.8 11.8 16.5 4.3 7.1 5.8 10.7 7.4 5.6 10.8 11.6 8.5 8.5 4.9 10.4 7.0 6.8 7.2 8.0 13.8 7.0 9.3 13.5 6.9 5.3 3.7 8.6 5.9 4.1 6.2 6.9 7.7 6.6 8.5 6.2 19.1 11.8 11.9 13.0 3.2 6.8 13.3 9.3 6.4 8.4 6.5 5.8 11.1 9.2 10.9 2.7 17.6 15.1 3.6 7.9 6.2 2.0 3.5 2.5 14.4 7.9 5.1 5.5 9.8 30.7 9.7 8.4 5.0 7.6 7.5 8.5 11.6 3.3 8.4 8.8 10.5 10.3 13.4 11.3 8.4 12.9 12.6 3.5 7.1 8.3 7.3 4.0 8.6 14.6 14.1 9.9 11.6 4.6 9.6 7.0 9.5 11.0 4.6 13.5 6.6 10.6 10.0 8.0 7.2 11.0 11.6 13.8 9.3 4.3 6.4 9.1 6.9 17.7 18.2 18.7 29.6 15.5 14.3 14.4 19.1 14.1 11.6 14.9 14.2 20.3 4.0 4.7 30.9 27.4 10.2 16.0 10.3 10.4 21.6 18.9 14.9 4.7 19.0 13.4 14.2 0.0 7.0 8.9 11.7 8.1 27.8 4.9 15.8 57.2 8.1 13.5 31.8 16.0 16.1 16.4 11.8 10.0 6.2 23.6 7.1 5.8 9.6 11.8 29.6 32.3 16.5 51.9 14.7 4.6 5.7 22.4 9.2 4.3 FAM222B "C17orf63, FLJ10700" ENSG00000173065 "Family with sequence similarity 222 member B" Q8WU58 17 28755978-28855232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051840, HPA062239" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051840: AB_2681633, HPA062239: AB_2684722" "unprognostic (4.11e-2)" "unprognostic (9.72e-2)" "unprognostic (9.12e-2)" "unprognostic (2.40e-3)" "unprognostic (1.57e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.18e-2)" "unprognostic (1.05e-1)" "unprognostic (8.28e-3)" "unprognostic (1.63e-1)" "unprognostic (1.79e-1)" "unprognostic (3.70e-2)" "unprognostic (2.37e-2)" "unprognostic (1.46e-1)" "unprognostic (3.61e-2)" "unprognostic (7.18e-2)" 9.6 7.6 12.0 11.5 13.4 7.9 9.4 25.4 15.3 10.6 14.0 12.3 9.2 15.3 9.7 10.5 13.9 9.4 11.1 10.6 11.6 9.5 11.6 8.7 9.3 7.6 11.5 10.3 11.4 9.2 15.0 15.2 12.4 13.9 10.5 13.0 16.4 16.8 12.2 42.4 8.5 13.4 9.7 9.5 7.8 10.5 39.4 10.9 10.1 11.1 4.4 9.2 13.3 12.5 7.8 5.7 13.6 8.5 4.1 10.2 4.2 7.7 15.4 13.1 15.2 11.4 8.0 14.4 5.6 5.3 7.9 8.0 19.7 7.7 7.9 11.2 6.2 9.8 10.0 11.0 12.6 6.6 11.0 14.5 8.9 7.7 14.9 13.1 5.6 14.5 8.3 12.5 11.2 10.0 7.9 15.6 9.3 16.7 5.7 16.7 9.9 9.9 4.7 15.0 10.4 5.8 4.7 12.5 8.0 14.0 10.0 14.5 10.1 7.7 15.0 19.6 29.0 11.7 5.5 17.4 5.2 10.8 5.7 8.7 11.6 14.1 5.1 7.2 4.0 9.4 13.6 4.2 11.1 8.2 5.9 10.2 7.8 6.8 8.3 5.6 6.4 9.6 7.9 6.1 4.1 8.5 5.7 5.9 4.2 12.0 13.4 25.4 15.3 11.6 9.5 11.5 10.3 13.9 10.9 3.0 8.2 7.3 7.0 8.4 13.6 11.4 25.5 4.0 5.7 7.0 25.5 6.9 3.3 16.7 45.8 13.1 17.3 46.7 11.5 8.3 7.2 11.3 9.3 11.0 7.6 23.8 24.9 32.5 6.9 35.2 11.5 6.6 6.8 8.2 21.2 5.6 17.4 10.5 7.4 7.8 7.2 0.0 5.6 40.0 32.9 5.8 5.0 5.1 18.4 8.7 FAM227A ENSG00000184949 "Family with sequence similarity 227 member A" F5H4B4 22 38578120-38656629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 26.2;testis: 15.6" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 80.3;Cone photoreceptor cells: 37.3;Early spermatids: 62.3;Late spermatids: 43.0;Rod photoreceptor cells: 33.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HDLM-2: 11.4;Karpas-707: 21.5" HPA003077 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003077: AB_1079264" "unprognostic (7.52e-2)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "unprognostic (8.14e-2)" "unprognostic (5.85e-2)" "unprognostic (2.91e-3)" "unprognostic (4.79e-5)" "unprognostic (5.91e-2)" "unprognostic (3.04e-2)" "unprognostic (4.04e-2)" "unprognostic (1.85e-2)" "unprognostic (4.62e-2)" "unprognostic (6.46e-6)" "unprognostic (3.74e-1)" "unprognostic (3.47e-2)" "unprognostic (2.65e-3)" "unprognostic (1.35e-2)" 0.5 1.2 4.7 0.9 7.0 1.5 2.8 0.9 3.1 2.6 0.8 5.0 5.5 0.7 2.3 7.8 0.7 9.3 2.2 0.8 4.2 3.4 2.0 0.5 2.4 0.7 1.9 2.5 1.6 1.5 2.3 26.2 0.6 6.7 1.5 1.0 2.7 1.1 1.8 0.5 2.4 0.6 1.5 0.9 0.7 1.3 15.6 3.0 0.8 3.5 0.1 0.6 1.1 0.7 1.4 1.0 2.3 0.7 1.0 1.3 0.3 0.4 1.2 1.8 2.4 0.4 1.2 0.4 0.2 0.2 0.3 0.2 0.0 1.1 0.2 0.5 0.2 0.5 1.1 0.8 0.2 0.4 11.4 1.1 0.1 3.3 0.2 0.2 0.5 0.5 0.6 0.7 1.3 0.4 1.8 0.2 1.6 0.4 21.5 0.1 0.5 0.5 0.5 0.8 0.2 0.7 1.1 0.1 0.6 0.8 0.3 2.3 0.6 1.5 0.1 0.1 0.7 1.4 0.2 0.4 0.6 0.5 0.5 0.1 2.0 1.0 0.1 0.8 0.2 0.3 2.0 0.7 0.7 0.7 0.6 0.5 0.8 0.7 0.6 0.3 1.4 0.9 1.3 2.3 1.0 0.6 1.0 0.7 0.3 4.7 7.0 0.9 3.1 4.2 3.4 1.9 2.5 6.7 3.0 3.0 1.6 0.0 2.3 2.2 5.7 1.6 5.1 80.3 10.3 5.2 37.3 0.2 0.0 2.9 62.3 1.4 0.0 0.0 2.2 0.2 1.9 2.1 0.0 0.0 0.2 4.8 4.6 0.6 0.0 43.0 2.0 1.0 0.0 0.0 0.4 12.4 1.8 0.0 1.1 0.9 33.1 0.0 1.0 15.4 13.8 3.0 0.1 0.0 1.2 1.4 FAM46C FLJ20202 ENSG00000183508 "Family with sequence similarity 46 member C" Q5VWP2 1 117605934-117628372 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction" "Nucleotidyltransferase, RNA-binding, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 114.0" "Group enriched" "Detected in many" 9 "Early spermatids: 418.3;Late spermatids: 1175.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 16.3" "Group enriched" "Detected in many" 17 "B-cells: 9.7;granulocytes: 16.3;T-cells: 9.2" "Cell line enhanced" "Detected in some" "Karpas-707: 74.8;RPMI-8226: 44.6;U-266/70: 20.8;U-266/84: 17.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054049 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA054049: AB_2682356" "unprognostic (3.76e-2)" "unprognostic (3.85e-3)" "unprognostic (3.24e-3)" "prognostic favorable (3.75e-5)" "unprognostic (1.17e-1)" "unprognostic (1.55e-3)" "unprognostic (3.29e-1)" "unprognostic (2.88e-2)" "unprognostic (5.75e-2)" "unprognostic (1.36e-3)" "unprognostic (9.41e-3)" "unprognostic (3.91e-2)" "prognostic favorable (2.77e-5)" "unprognostic (6.26e-2)" "unprognostic (3.16e-2)" "unprognostic (3.08e-2)" "unprognostic (1.10e-2)" 3.2 1.8 1.2 24.5 1.1 28.9 4.4 1.1 1.1 8.1 16.1 1.8 8.4 5.6 4.8 16.6 6.9 3.3 9.7 6.4 1.2 1.1 5.0 5.5 11.2 16.3 1.2 0.1 8.3 114.0 7.2 5.3 10.6 3.9 6.4 9.5 4.4 37.8 11.9 10.0 1.8 10.6 4.7 1.4 19.1 12.2 34.0 0.2 1.5 10.3 10.9 37.0 9.5 8.6 9.7 0.2 16.3 0.0 0.6 9.2 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 6.7 0.1 0.0 0.4 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 4.2 0.4 9.2 0.0 0.0 0.0 5.4 11.9 0.0 0.0 0.1 0.0 0.0 0.0 2.5 1.2 74.8 0.0 0.9 0.0 5.5 0.9 1.1 0.6 0.0 0.0 44.6 0.0 0.9 0.5 0.0 0.4 0.6 0.4 0.1 0.4 0.0 0.1 0.0 0.5 0.0 0.1 20.8 17.2 0.4 0.4 1.9 0.6 16.3 0.0 10.5 2.5 0.0 2.2 9.7 2.5 3.1 0.0 8.0 0.3 1.4 1.1 0.6 0.0 0.2 9.2 2.1 1.2 1.1 1.1 1.1 1.2 1.1 1.2 0.1 3.9 0.2 6.0 42.9 52.6 7.5 7.6 0.0 0.0 5.1 21.4 36.4 0.0 0.0 1.9 0.0 0.0 418.3 2.8 12.0 93.5 0.0 2.0 7.3 6.6 7.0 4.3 1.1 0.0 19.0 0.0 1.5 1175.9 13.3 2.0 45.5 0.0 35.3 1.1 0.0 8.6 8.5 0.0 0.0 6.5 9.2 12.5 8.5 5.6 1.8 32.0 26.4 7.9 FAM49A "DKFZP566A1524, FLJ11080" ENSG00000197872 "Family with sequence similarity 49 member A" Q9H0Q0 2 16549459-16666331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.8;brain: 39.5" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 90.0;Kupffer cells: 96.6;monocytes: 191.2;Syncytiotrophoblasts: 125.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 23.3;HUVEC TERT2: 18.6;RH-30: 41.7;SK-BR-3: 12.2;TIME: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017847, HPA060398" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB017847: , HPA060398: AB_2684275" "unprognostic (3.45e-1)" "unprognostic (1.83e-2)" "unprognostic (6.50e-2)" "unprognostic (1.94e-3)" "unprognostic (1.88e-1)" "unprognostic (7.78e-2)" "unprognostic (8.61e-2)" "unprognostic (3.83e-2)" "unprognostic (2.61e-1)" "unprognostic (2.00e-2)" "unprognostic (5.74e-2)" "unprognostic (8.38e-2)" "prognostic unfavorable (1.83e-6)" "unprognostic (1.32e-2)" "unprognostic (3.43e-2)" "unprognostic (3.82e-2)" "prognostic unfavorable (4.46e-4)" 10.8 9.1 22.7 15.6 28.0 15.3 7.0 6.6 39.5 13.7 5.3 7.0 1.2 2.9 8.2 2.1 4.3 6.2 8.7 3.3 17.2 14.1 1.9 6.1 9.6 13.4 10.2 25.2 10.0 2.4 1.1 4.8 15.3 9.9 6.9 5.3 2.9 3.2 7.3 6.0 2.9 4.6 8.6 6.0 20.1 3.4 1.8 6.3 1.9 31.8 1.1 13.6 7.7 7.4 8.9 15.5 45.8 34.4 13.4 5.3 8.5 0.2 0.0 2.6 0.1 2.8 0.8 7.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 1.8 1.6 0.6 1.0 0.0 2.8 0.1 1.6 0.0 0.0 1.4 0.0 23.3 1.3 1.0 0.2 0.0 2.1 18.6 0.0 0.1 2.0 1.6 0.1 0.0 5.4 1.1 0.1 0.0 0.9 41.7 0.1 2.2 10.3 0.4 1.5 0.0 12.2 0.0 3.4 0.4 0.7 14.5 0.2 2.4 0.0 0.0 1.2 0.0 1.4 6.1 1.2 0.8 0.0 23.6 31.4 5.3 29.8 0.6 8.9 0.2 2.7 15.5 6.1 0.2 2.1 45.8 13.4 34.4 7.7 0.1 8.5 22.7 28.0 6.6 33.3 17.2 14.1 10.2 25.2 9.9 6.3 3.0 17.3 26.5 17.4 10.0 3.2 1.4 0.0 1.4 9.1 0.0 2.0 40.6 0.0 2.9 0.8 6.0 0.0 23.3 0.8 90.0 12.5 8.1 11.5 1.0 31.7 0.0 0.0 29.4 96.6 0.0 2.0 70.2 28.7 191.2 0.0 22.8 0.2 0.0 1.8 0.0 2.4 12.9 14.1 0.0 2.1 7.3 125.4 11.7 0.0 24.3 FAM50A "9F, DXS9928E, HXC-26, XAP5" ENSG00000071859 "Family with sequence similarity 50 member A" Q14320 X 154444126-154450654 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003585 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003585: AB_1080603" "unprognostic (1.95e-1)" "prognostic favorable (2.05e-4)" "prognostic unfavorable (9.52e-5)" "unprognostic (5.39e-2)" "unprognostic (4.73e-2)" "unprognostic (3.32e-1)" "prognostic unfavorable (3.15e-5)" "unprognostic (2.56e-1)" "unprognostic (4.62e-2)" "unprognostic (1.40e-1)" "unprognostic (3.64e-3)" "unprognostic (6.35e-2)" "unprognostic (3.28e-2)" "unprognostic (9.78e-2)" "unprognostic (1.18e-1)" "unprognostic (1.97e-2)" "unprognostic (4.14e-1)" 33.0 29.9 31.4 23.3 46.1 21.7 22.6 42.7 45.3 23.0 27.0 25.6 22.2 24.8 22.2 38.1 18.9 16.4 17.4 31.9 32.6 23.5 24.7 23.2 23.1 16.6 43.5 29.5 20.3 25.1 32.1 41.3 30.5 35.6 23.1 20.2 24.3 27.9 26.6 54.7 16.1 22.9 26.5 31.4 24.1 23.1 7.0 42.9 11.7 25.6 12.4 16.9 24.8 39.9 16.5 24.5 19.4 35.1 19.6 30.3 14.6 26.0 32.5 10.8 15.5 40.6 29.3 21.5 33.9 30.8 33.2 50.8 29.6 12.3 1.3 35.3 35.8 48.5 10.3 25.6 23.7 25.8 19.0 16.3 8.3 39.0 18.6 59.4 7.5 24.9 33.5 17.1 51.1 26.3 24.0 27.2 10.0 10.8 21.3 32.2 17.8 8.9 10.0 7.3 23.1 20.4 13.1 27.3 18.8 21.0 26.4 19.6 13.9 12.3 20.0 40.6 19.5 17.4 14.8 33.0 22.9 18.8 37.5 41.5 49.5 28.4 9.3 31.0 26.5 25.5 14.2 26.6 19.4 22.5 33.9 30.3 16.5 23.4 21.5 24.5 14.0 13.2 18.0 14.4 19.6 35.1 18.8 24.9 14.6 31.4 46.1 42.7 45.3 32.6 23.5 43.5 29.5 35.6 42.9 32.8 52.0 32.9 35.3 23.1 61.4 79.5 50.9 10.7 15.9 27.9 25.5 56.8 48.0 42.2 0.8 43.0 99.3 93.5 58.5 92.1 57.0 45.1 47.2 37.6 125.0 44.5 60.7 39.9 53.7 2.6 72.2 73.5 30.4 61.3 64.6 70.3 63.3 77.2 75.0 89.7 62.4 32.3 59.0 7.2 15.7 22.6 101.7 53.3 49.8 41.4 FAM71F2 FAM137B ENSG00000205085 "Family with sequence similarity 71 member F2" Q6NXP2 7 128672288-128687872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "testis: 28.1" "Group enriched" "Detected in many" 7 "Early spermatids: 138.1;Late spermatids: 512.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA020513, HPA024248" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA020513: AB_1853077, HPA024248: AB_2671497" "unprognostic (1.01e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (9.83e-2)" "unprognostic (8.29e-3)" "unprognostic (6.22e-2)" "unprognostic (2.67e-2)" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (3.65e-4)" "unprognostic (3.17e-2)" "unprognostic (3.85e-4)" "unprognostic (3.00e-2)" "unprognostic (2.79e-2)" "unprognostic (2.40e-4)" "unprognostic (2.47e-2)" 1.4 1.1 0.7 0.7 1.2 1.3 0.7 1.8 1.1 0.7 0.7 0.7 0.7 0.4 0.7 1.6 0.7 0.5 0.8 0.9 0.7 0.7 0.9 0.7 0.7 0.7 0.7 0.7 0.9 0.7 0.2 2.5 0.7 0.7 0.9 0.5 0.7 1.6 0.7 1.6 1.3 0.7 1.0 0.7 1.2 1.0 28.1 0.7 0.7 0.9 0.7 0.7 0.7 0.7 1.4 1.3 4.2 0.8 1.2 0.9 0.2 0.8 1.3 1.5 2.9 2.6 2.0 0.7 1.7 0.4 0.4 1.0 0.3 1.4 0.9 0.8 2.8 1.0 2.0 0.2 0.7 0.7 0.9 1.3 0.5 2.7 0.2 0.7 0.7 1.9 1.7 0.7 3.0 0.5 2.0 0.4 0.9 0.4 1.4 1.2 1.3 0.4 1.4 0.9 0.3 1.9 1.1 0.3 0.4 1.0 3.5 1.2 0.8 0.7 0.8 2.2 1.9 1.1 0.4 4.3 1.9 0.7 3.9 1.6 2.9 2.5 0.9 1.0 1.2 1.3 3.9 0.8 0.6 0.5 0.4 0.5 0.8 0.6 0.5 0.3 1.4 0.6 0.6 4.2 1.2 0.5 1.3 0.9 0.2 0.7 1.2 1.8 1.1 0.7 0.7 0.7 0.7 0.7 0.7 3.0 2.1 0.0 1.4 0.0 12.1 1.1 0.0 0.0 0.0 3.5 49.1 0.4 0.0 1.3 138.1 0.7 0.3 0.0 0.6 0.7 0.8 1.6 2.3 0.6 0.8 0.0 1.2 1.8 2.2 512.3 3.7 0.2 0.0 1.0 1.3 2.9 1.0 1.5 2.8 0.0 17.9 0.0 0.9 10.2 2.7 0.1 2.1 0.0 1.4 0.8 FAM83A "BJ-TSA-9, MGC14128" ENSG00000147689 "Family with sequence similarity 83 member A" Q86UY5 8 123178960-123210079 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.8;lymphoid tissue: 28.6" "Cell type enhanced" "Detected in some" 14 "Pancreatic endocrine cells: 16.6;Suprabasal keratinocytes: 13.2;Urothelial cells: 19.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 52.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A-431: 24.3;HBEC3-KT: 37.9;hTCEpi: 20.3;K-562: 59.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052615 Approved Nucleoplasm NA NA Nucleoplasm "HPA052615: AB_2797244" "unprognostic (4.48e-2)" "unprognostic (2.03e-3)" "unprognostic (1.78e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.49e-1)" "unprognostic (2.68e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (2.98e-9)" "unprognostic (2.62e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (4.99e-6)" "unprognostic (2.04e-1)" "unprognostic (2.22e-16)" "unprognostic (2.76e-1)" "unprognostic (1.33e-2)" "unprognostic (2.24e-1)" "unprognostic (6.07e-2)" 0.1 0.3 0.0 0.1 0.0 0.1 0.3 0.0 0.1 15.6 0.4 0.0 8.3 0.6 0.8 2.0 44.8 2.8 1.2 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.7 0.1 0.0 0.1 2.7 0.0 1.3 0.0 0.0 3.1 13.6 0.1 4.4 2.5 0.2 0.0 0.1 0.1 0.3 0.0 0.1 0.3 13.4 28.6 3.1 18.4 0.4 0.3 0.7 0.2 0.3 0.4 0.0 24.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 3.2 0.0 0.0 7.8 0.0 37.9 0.0 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.0 20.3 0.0 5.2 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 4.3 2.9 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.4 0.1 0.3 0.1 0.2 0.1 0.0 0.4 0.1 0.2 0.7 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.4 0.0 0.6 0.0 4.0 4.5 1.8 0.0 0.0 0.0 0.3 0.6 0.0 0.5 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 1.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 13.2 0.0 0.0 0.4 19.7 FAM84A "FLJ35392, NSE1" ENSG00000162981 "Family with sequence similarity 84 member A" Q96KN4 2 14632686-14650814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.0" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 143.9;Mucus-secreting cells: 133.7;Syncytiotrophoblasts: 173.8;Undifferentiated cells: 210.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.1;hTCEpi: 12.0;RT4: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047703 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047703: AB_2680123" "unprognostic (1.05e-2)" "unprognostic (9.22e-2)" "unprognostic (2.24e-3)" "unprognostic (1.13e-1)" "unprognostic (4.28e-2)" "unprognostic (7.38e-2)" "unprognostic (2.62e-2)" "unprognostic (1.23e-1)" "unprognostic (1.48e-1)" "unprognostic (4.44e-2)" "unprognostic (1.20e-1)" "unprognostic (9.27e-2)" "unprognostic (3.52e-2)" "unprognostic (1.13e-1)" "unprognostic (1.58e-1)" "unprognostic (5.57e-3)" "unprognostic (1.36e-1)" 0.9 1.8 22.0 9.1 14.8 0.6 2.7 3.1 31.8 9.9 34.0 1.7 0.9 22.4 3.0 29.0 22.6 2.8 5.6 2.1 7.7 7.7 3.3 1.8 5.6 0.8 3.6 11.2 7.9 3.3 2.0 3.0 5.9 2.4 11.1 31.9 1.6 15.9 2.5 1.3 14.4 21.3 3.0 2.5 0.8 3.0 20.0 3.9 0.6 2.2 10.4 3.8 9.5 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 1.6 0.4 0.3 0.0 0.2 0.0 0.0 0.2 0.0 6.1 0.6 2.7 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.4 12.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.8 4.9 0.0 0.1 0.5 0.0 2.6 0.0 0.0 0.1 4.6 31.9 2.8 1.3 0.0 1.2 0.0 0.2 0.0 0.0 1.9 5.5 0.4 0.0 2.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 14.8 3.1 31.8 7.7 7.7 3.6 11.2 2.4 3.9 0.0 1.4 2.4 19.6 10.0 1.7 1.5 2.5 8.1 5.7 29.6 0.0 143.9 10.0 2.2 8.0 14.9 93.2 0.0 6.4 16.6 4.4 47.3 10.3 0.9 10.6 0.0 47.6 30.7 3.8 9.6 4.6 1.1 6.8 1.0 133.7 13.7 5.4 57.5 2.8 0.8 1.1 0.0 11.3 0.5 0.9 23.1 173.8 1.7 210.4 69.9 FAM84B "BCMP101, NSE2" ENSG00000168672 "Family with sequence similarity 84 member B" Q96KN1 8 126552442-126558393 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 21.6;AN3-CA: 31.3;MCF7: 31.6;PC-3: 21.5;SuSa: 50.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050782, HPA062115" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA050782: AB_2681235, HPA062115: AB_2684686" "unprognostic (2.46e-3)" "unprognostic (6.37e-2)" "unprognostic (7.36e-2)" "prognostic unfavorable (9.71e-4)" "unprognostic (2.75e-3)" "unprognostic (1.54e-1)" "unprognostic (1.79e-1)" "unprognostic (4.52e-2)" "unprognostic (1.32e-1)" "unprognostic (4.49e-2)" "unprognostic (2.42e-3)" "unprognostic (1.07e-2)" "prognostic favorable (1.96e-8)" "unprognostic (2.04e-3)" "unprognostic (1.58e-1)" "unprognostic (1.18e-1)" "prognostic favorable (1.75e-5)" 8.1 3.0 6.0 6.5 8.2 2.2 20.0 8.7 6.8 10.0 8.0 10.8 11.4 10.7 10.5 11.2 20.9 7.2 16.4 4.8 7.7 5.1 23.5 10.2 10.7 4.7 13.9 3.8 3.7 13.8 9.0 5.6 7.8 11.0 7.3 7.0 18.6 33.3 13.2 2.0 7.5 6.3 4.0 6.2 2.8 14.1 2.7 10.3 1.9 8.3 5.4 8.1 6.3 11.2 1.6 0.1 2.7 0.1 1.9 5.3 1.6 21.6 2.8 1.7 31.3 0.0 0.0 2.1 0.3 0.8 0.2 0.3 0.8 13.0 0.0 14.4 0.0 2.4 9.8 0.9 4.2 0.4 0.0 18.7 0.0 0.0 0.1 0.4 0.0 0.4 0.1 6.0 0.0 2.6 5.2 1.8 5.6 0.0 0.0 0.1 31.6 0.7 0.0 1.6 18.4 21.5 0.0 0.7 0.2 12.8 9.4 8.6 0.0 0.7 10.3 9.3 50.8 15.5 0.2 0.0 0.1 2.9 0.0 0.6 0.4 0.0 0.0 0.2 1.4 5.8 2.5 0.1 2.7 2.7 0.0 2.5 0.6 3.6 5.3 0.0 1.6 3.9 4.0 0.3 1.9 0.0 0.1 4.7 1.6 6.0 8.2 8.7 5.3 7.7 5.1 13.9 3.8 11.0 10.3 11.9 29.5 3.2 9.0 14.9 1.9 5.3 15.3 4.0 13.6 40.1 62.8 4.4 6.6 23.9 0.6 22.7 7.9 0.0 11.6 1.6 8.5 16.8 0.0 20.3 1.3 52.4 26.5 22.7 4.1 1.0 0.6 2.9 33.7 0.0 16.0 31.4 26.7 10.5 0.4 32.9 6.5 0.0 3.9 0.7 0.7 15.3 2.4 5.7 17.5 22.1 FAM9B TEX39B ENSG00000177138 "Family with sequence similarity 9 member B" Q8IZU0 X 9024232-9164639 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.4;liver: 3.7;testis: 11.4" "Group enriched" "Detected in some" 7 "Spermatocytes: 32.2;Spermatogonia: 62.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.4" "Group enriched" "Detected in some" 49 "U-266/70: 21.2;U-266/84: 22.8" HPA035135 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA035135: AB_10669999" "unprognostic (3.95e-1)" "unprognostic (4.49e-1)" "unprognostic (3.76e-2)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (2.62e-1)" "unprognostic (6.08e-10)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" 0.1 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.2 0.1 2.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.5 0.5 0.1 0.0 1.1 0.2 11.4 0.1 0.0 0.2 0.6 0.8 0.7 3.4 0.7 0.7 0.4 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 21.2 22.8 0.1 0.0 0.1 0.0 1.0 0.7 0.4 0.3 0.3 0.3 0.5 0.4 0.3 0.2 0.8 0.4 0.4 3.4 0.7 0.4 0.7 0.3 0.4 0.0 0.6 0.0 0.2 0.2 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.9 0.2 1.6 0.0 0.6 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 6.5 0.3 32.2 62.0 0.3 0.0 0.0 0.0 0.1 FANCA "FA-H, FAA, FACA, FAH, FANCH" ENSG00000187741 "Fanconi anemia complementation group A" O15360 16 89737549-89816657 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.6;testis: 28.8" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;Spermatocytes: 22.3;Spermatogonia: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063236 Supported Nucleoplasm NA Yes Nucleoplasm "HPA063236: AB_2684966" "unprognostic (5.99e-2)" "unprognostic (5.68e-2)" "unprognostic (2.36e-1)" "unprognostic (5.12e-2)" "unprognostic (1.87e-1)" "unprognostic (7.11e-2)" "unprognostic (1.45e-4)" "unprognostic (9.21e-2)" "unprognostic (1.58e-2)" "unprognostic (2.05e-1)" "unprognostic (4.82e-3)" "unprognostic (8.48e-4)" "unprognostic (7.82e-10)" "unprognostic (3.67e-2)" "unprognostic (2.05e-1)" "unprognostic (2.94e-1)" "unprognostic (1.62e-1)" 2.1 2.0 2.2 16.5 3.7 17.1 1.7 5.7 6.6 1.7 5.1 1.1 0.6 5.0 1.7 3.1 6.6 1.9 1.6 1.7 1.8 1.4 2.1 5.8 3.3 11.1 1.3 2.7 1.6 1.8 2.3 1.9 11.2 2.4 1.7 6.3 1.5 2.2 0.5 0.7 5.0 5.4 2.0 1.6 6.9 3.5 28.8 0.8 20.6 1.7 4.6 17.6 2.9 2.5 7.4 6.5 9.9 9.2 7.5 9.5 4.2 9.3 14.4 17.3 15.1 1.1 2.2 13.2 11.7 6.4 19.8 8.3 12.6 15.6 23.1 5.5 4.0 6.6 14.5 11.6 8.7 20.9 5.4 19.5 6.8 18.5 25.8 0.7 6.9 7.5 0.7 0.9 16.0 5.1 2.8 6.2 11.7 16.3 7.1 10.3 21.7 13.8 30.0 11.2 12.9 9.0 25.2 13.9 4.2 4.9 8.9 15.5 8.4 17.5 5.2 2.2 10.4 9.4 12.5 4.6 15.9 16.8 8.8 12.2 6.4 7.5 22.9 7.5 15.5 15.1 2.6 7.9 9.9 4.7 8.8 3.3 7.4 2.8 4.1 6.5 5.5 0.7 3.0 9.8 7.5 9.2 0.4 9.5 4.2 2.2 3.7 5.7 6.6 1.8 1.4 1.3 2.7 2.4 0.8 0.0 0.6 13.1 1.4 3.1 8.8 1.6 0.0 1.4 3.4 15.7 9.8 10.9 1.7 1.6 5.3 0.8 2.0 23.3 1.4 7.5 1.3 0.5 2.3 4.0 7.7 3.2 1.7 7.4 4.3 3.5 1.4 6.3 0.0 0.0 6.1 1.4 1.5 0.0 0.0 6.8 7.2 0.0 1.0 22.3 33.2 1.6 21.2 3.2 6.3 2.1 FANCC "FA3, FAC, FACC" ENSG00000158169 "Fanconi anemia complementation group C" Q00597 9 95099054-95426796 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 29.7" "Group enriched" "Detected in many" 5 "Early spermatids: 190.4;Late spermatids: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 10.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.4" "Cell line enhanced" "Detected in all" "RH-30: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017793, HPA030771" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB017793: , HPA030771: AB_2673604" "unprognostic (1.48e-2)" "unprognostic (4.33e-2)" "unprognostic (1.10e-1)" "unprognostic (2.63e-1)" "unprognostic (2.14e-1)" "unprognostic (1.32e-2)" "unprognostic (3.41e-3)" "unprognostic (1.26e-2)" "unprognostic (7.45e-3)" "unprognostic (1.37e-1)" "unprognostic (8.00e-3)" "unprognostic (3.19e-2)" "prognostic favorable (6.03e-6)" "unprognostic (2.35e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (5.71e-2)" 4.9 2.7 4.3 8.6 7.0 3.6 4.6 29.7 7.7 4.6 6.4 4.9 5.1 7.1 6.3 4.1 4.5 3.6 5.2 3.2 4.0 2.7 10.0 25.7 6.7 3.7 7.3 1.6 3.3 5.4 2.9 12.1 4.3 6.7 4.4 6.1 4.0 4.0 4.2 4.5 7.7 8.1 2.9 6.4 3.4 4.4 19.6 7.3 7.9 4.3 3.2 6.0 3.5 4.0 1.0 1.3 10.4 1.7 0.3 1.5 0.7 13.6 9.2 12.2 10.6 1.2 3.2 7.7 5.9 3.9 9.5 8.8 10.5 5.8 7.8 4.2 4.3 7.3 16.7 12.3 5.2 5.2 7.4 5.8 6.1 10.4 5.4 2.0 6.1 6.8 2.7 2.2 7.6 3.4 2.6 5.2 7.6 9.1 3.4 6.8 9.6 5.7 3.5 5.8 14.5 5.2 12.2 31.5 3.6 3.9 3.5 17.7 9.4 11.3 4.0 3.4 6.4 4.2 5.1 2.5 8.3 12.2 9.1 8.4 3.6 6.6 4.1 4.5 5.6 9.8 10.4 0.4 0.0 1.3 0.8 1.3 1.0 0.7 1.5 0.4 1.0 1.2 1.0 0.1 0.3 1.7 1.3 1.3 0.7 4.3 7.0 29.7 7.7 4.0 2.7 7.3 1.6 6.7 7.3 3.0 2.1 0.0 2.3 2.3 5.4 1.6 5.1 1.4 3.4 0.0 3.9 2.3 1.7 4.1 190.4 4.3 3.3 0.0 3.6 4.0 2.0 2.5 5.7 25.1 1.8 9.5 0.0 4.3 2.7 63.3 6.1 1.3 1.7 3.6 4.5 2.6 3.4 0.0 2.1 7.7 4.2 0.0 1.6 13.0 10.6 2.4 1.9 1.0 3.8 2.5 FANCE "FACE, FAE" ENSG00000112039 "Fanconi anemia complementation group E" Q9HB96 6 35452361-35467103 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 82.2;Syncytiotrophoblasts: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB014893 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB014893: " "unprognostic (2.66e-1)" "unprognostic (8.01e-3)" "unprognostic (7.73e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (1.99e-1)" "unprognostic (2.80e-3)" "prognostic unfavorable (2.08e-9)" "unprognostic (8.90e-2)" "unprognostic (5.70e-3)" "unprognostic (8.41e-2)" "unprognostic (1.52e-1)" "unprognostic (2.91e-2)" "unprognostic (1.28e-1)" "unprognostic (1.70e-1)" "unprognostic (3.05e-1)" "unprognostic (2.44e-2)" "unprognostic (5.14e-2)" 7.2 2.1 2.6 7.0 3.8 7.2 8.5 5.5 3.9 6.7 4.1 4.8 1.5 3.1 6.1 4.7 10.0 4.9 5.4 4.1 2.8 3.2 2.4 1.7 5.5 5.4 2.4 1.8 10.8 6.9 2.7 4.0 21.3 3.9 6.7 4.1 3.7 5.3 4.0 20.8 16.8 4.7 4.1 3.7 4.6 3.8 12.1 3.5 3.0 5.9 10.1 8.5 6.7 15.0 2.4 1.8 1.0 1.0 2.6 3.6 0.9 5.7 2.8 7.9 17.6 5.7 10.2 21.1 6.9 5.9 9.1 7.9 6.7 3.3 19.6 4.6 4.3 6.9 4.3 8.8 5.9 8.8 6.6 7.6 13.7 6.9 4.3 3.1 8.0 5.6 6.4 17.8 11.1 17.1 2.4 5.3 7.6 12.6 7.3 7.6 6.7 3.7 10.0 3.2 6.2 4.5 11.1 7.5 7.4 2.0 6.3 7.8 7.3 4.0 5.6 6.2 7.6 5.5 26.3 3.2 11.0 9.2 7.0 10.8 4.9 16.9 7.1 2.4 14.8 10.3 0.7 1.0 1.0 2.2 0.6 3.0 0.7 2.8 3.6 0.6 2.4 1.9 1.9 0.6 2.6 0.6 1.8 1.7 0.9 2.6 3.8 5.5 3.9 2.8 3.2 2.4 1.8 3.9 3.5 6.0 0.0 0.8 3.9 7.8 0.5 1.7 0.0 0.0 1.2 0.0 0.0 17.8 0.0 1.2 0.2 2.5 0.9 0.0 0.7 82.2 3.8 2.4 0.0 0.0 5.2 0.0 1.2 1.8 1.2 0.0 1.4 1.3 1.7 0.0 2.9 1.5 1.0 0.0 0.7 0.2 1.7 0.0 2.5 6.9 10.4 6.1 39.0 1.0 3.3 2.7 FANCF FAF ENSG00000183161 "Fanconi anemia complementation group F" Q9NPI8 11 22622519-22626787 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 123.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008899 Supported Nucleoplasm NA NA Nucleoplasm "HPA008899: " "unprognostic (1.16e-2)" "unprognostic (4.10e-2)" "unprognostic (2.33e-2)" "unprognostic (1.37e-2)" "unprognostic (4.55e-2)" "unprognostic (8.84e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (4.29e-2)" "unprognostic (1.11e-1)" "unprognostic (2.74e-3)" "unprognostic (3.95e-1)" "unprognostic (1.67e-1)" "unprognostic (2.29e-1)" "unprognostic (3.73e-2)" "unprognostic (1.81e-1)" "unprognostic (9.14e-2)" "unprognostic (7.64e-3)" 1.2 4.1 2.9 3.1 2.8 1.1 3.2 1.0 2.7 3.1 3.4 5.3 3.0 6.0 3.0 6.1 1.7 1.9 2.9 3.9 3.2 4.2 1.8 4.9 3.3 4.2 9.0 3.4 4.5 1.5 2.9 3.7 3.8 3.1 0.4 3.1 4.9 1.1 3.5 5.4 4.6 4.3 3.6 4.8 2.6 2.0 15.2 9.7 11.5 5.7 10.0 15.1 7.3 1.4 4.3 5.6 6.1 2.9 3.5 2.3 2.8 3.3 3.2 3.5 2.8 2.2 7.1 0.7 2.8 5.8 6.1 4.5 4.6 1.6 11.6 2.1 2.7 1.7 4.9 3.4 4.9 2.9 3.3 8.9 1.1 4.9 5.5 5.0 10.3 6.8 9.3 2.0 4.5 12.5 4.6 6.4 12.0 5.4 10.8 2.6 8.0 6.0 5.6 20.9 9.8 1.5 4.9 4.8 6.2 9.9 4.5 3.6 3.3 3.5 5.9 3.9 5.4 6.9 2.1 5.4 2.0 7.6 5.7 5.4 11.5 11.5 5.5 13.5 11.8 10.8 10.8 6.4 15.2 15.1 12.4 0.8 10.0 5.7 9.7 7.3 7.3 3.0 2.1 10.5 5.3 3.0 15.7 4.4 10.2 22.7 2.3 3.5 9.8 9.4 38.1 15.4 123.7 4.7 9.6 0.0 16.2 7.1 3.8 3.9 2.3 8.1 6.0 15.9 3.4 1.8 5.9 13.7 8.9 5.3 5.0 9.0 16.2 11.8 10.5 10.5 9.2 15.4 17.2 6.5 3.1 21.0 15.8 1.9 1.9 11.4 15.5 2.3 FANCI "FLJ10719, KIAA1794" ENSG00000140525 "Fanconi anemia complementation group I" Q9NVI1 15 89243949-89317261 "Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.4;testis: 28.3" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 46.7;Spermatocytes: 45.0;Spermatogonia: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039972, HPA040379" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039972: AB_10673265, HPA040379: AB_2676951" "unprognostic (6.88e-2)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (2.99e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (6.82e-3)" "unprognostic (1.15e-2)" "unprognostic (4.59e-3)" "prognostic unfavorable (3.59e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.71e-13)" "unprognostic (2.40e-2)" "unprognostic (2.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.12e-1)" 3.7 3.2 1.7 11.1 3.3 16.5 3.3 1.8 5.6 3.8 5.9 3.0 2.7 3.3 3.3 3.3 10.7 2.1 1.8 2.8 2.5 1.5 2.4 2.0 3.5 13.4 5.0 2.6 3.1 2.3 1.8 1.5 7.1 2.9 2.8 7.6 2.3 4.0 1.7 1.3 5.4 4.9 3.8 2.8 6.7 4.6 28.3 3.2 44.4 1.7 9.2 15.4 3.9 4.6 3.8 3.9 17.7 3.8 4.6 10.6 3.0 24.5 28.2 30.2 20.3 2.7 3.9 18.7 23.6 13.6 29.6 36.2 22.3 22.4 45.5 12.8 7.8 18.9 33.7 46.1 16.0 27.9 29.0 28.8 45.1 41.5 10.4 0.4 32.5 23.0 2.1 1.6 20.8 10.6 4.3 12.0 28.1 31.1 33.6 19.7 14.0 33.9 11.2 23.7 16.1 10.4 29.5 44.0 19.5 6.8 45.4 22.5 19.3 24.4 17.3 11.0 21.3 19.1 14.8 8.2 24.6 25.1 22.5 35.8 22.3 46.3 35.1 9.2 29.0 24.6 17.7 2.4 2.8 5.2 3.0 2.9 3.5 5.0 6.8 2.1 3.8 4.1 6.0 3.7 4.6 3.8 3.9 10.6 3.0 1.7 3.3 1.8 5.6 2.5 1.5 5.0 2.6 2.9 3.2 3.0 1.0 3.7 1.8 3.8 2.1 2.7 0.0 8.1 4.5 1.8 0.0 8.3 0.0 1.7 5.9 1.6 1.3 46.7 2.5 15.5 2.7 1.4 2.3 0.8 6.8 1.6 1.2 9.2 3.1 5.3 3.1 4.3 1.7 3.6 4.5 9.5 2.2 0.0 1.4 1.0 1.7 6.5 1.9 45.0 68.0 2.0 10.4 5.2 4.4 1.7 FANCM "FAAP250, KIAA1596" ENSG00000187790 "Fanconi anemia complementation group M" Q8IYD8 14 45135940-45200890 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 55.9;Late spermatids: 151.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055144 Supported Nucleoplasm NA NA Nucleoplasm "HPA055144: AB_2682715" "unprognostic (8.40e-2)" "unprognostic (6.70e-2)" "unprognostic (3.99e-2)" "unprognostic (4.32e-2)" "unprognostic (2.15e-1)" "unprognostic (2.31e-3)" "unprognostic (2.66e-2)" "unprognostic (1.18e-1)" "unprognostic (1.57e-2)" "unprognostic (8.52e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-2)" "unprognostic (7.55e-2)" "unprognostic (2.90e-1)" "unprognostic (1.71e-1)" "unprognostic (8.94e-2)" "unprognostic (1.13e-2)" 4.7 3.9 3.9 4.4 8.4 9.8 5.7 8.2 7.9 5.7 3.5 4.9 4.9 2.6 6.7 4.8 4.5 4.2 3.7 3.8 3.4 3.3 4.1 3.1 3.3 6.6 3.2 3.6 6.2 3.3 4.5 4.5 4.4 9.3 3.5 3.8 4.8 4.1 4.8 4.2 5.2 3.5 3.8 3.4 8.9 3.2 15.4 4.2 15.2 3.3 2.9 6.4 3.8 4.3 6.7 3.2 7.6 3.6 2.0 4.1 1.1 7.8 6.8 8.1 7.5 6.4 4.0 6.5 10.3 4.0 8.1 10.5 11.0 6.0 10.3 5.9 2.4 4.6 10.6 9.5 4.4 11.1 7.5 5.2 4.7 7.7 6.0 1.2 12.3 6.1 2.3 1.6 8.1 5.1 1.8 6.9 6.7 8.5 9.1 6.7 7.8 9.0 8.8 3.2 6.0 11.5 8.4 12.6 4.7 3.3 5.6 7.4 1.9 9.1 7.5 3.8 5.4 8.0 5.7 5.4 11.8 11.1 10.8 7.7 4.6 8.3 10.3 2.3 7.6 7.0 7.6 1.3 4.6 4.0 3.6 2.2 6.7 2.5 1.5 1.0 4.2 4.1 3.5 2.1 2.0 1.7 3.2 1.7 1.1 3.9 8.4 8.2 7.9 3.4 3.3 3.2 3.6 9.3 4.2 0.0 1.9 1.5 1.2 2.4 5.2 6.7 2.5 0.0 3.4 1.8 2.0 6.7 0.0 1.6 55.9 2.7 1.0 0.0 2.3 2.8 2.3 0.8 1.1 1.7 3.0 3.2 0.0 5.5 3.7 151.5 8.3 2.7 3.3 4.6 1.6 4.4 1.5 0.0 4.9 1.5 6.1 6.5 4.1 23.6 14.4 1.6 1.9 3.3 2.6 0.3 FANK1 ENSG00000203780 "Fibronectin type III and ankyrin repeat domains 1" Q8TC84 10 125896539-126009592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.3;fallopian tube: 24.7;testis: 44.7" "Group enriched" "Detected in many" 5 "Ciliated cells: 171.3;Early spermatids: 463.3;Late spermatids: 423.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 14 "T-reg: 28.3" "Lineage enriched" "Detected in single" 284 "T-cells: 28.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.7;hTCEpi: 8.6;hTERT-RPE1: 11.4;RPTEC TERT1: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038413 Supported Nucleoplasm NA NA Nucleoplasm "HPA038413: AB_10697249" "unprognostic (4.25e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.83e-4)" "unprognostic (1.17e-3)" "unprognostic (4.02e-2)" "unprognostic (6.29e-2)" "unprognostic (1.44e-1)" "unprognostic (3.12e-3)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (3.42e-2)" "unprognostic (9.53e-3)" "unprognostic (2.84e-2)" "unprognostic (1.17e-2)" "unprognostic (1.10e-2)" "unprognostic (1.44e-1)" 0.5 2.4 4.1 1.3 8.3 0.7 3.4 0.8 1.8 2.5 2.2 4.0 3.8 1.6 2.3 18.5 2.2 24.7 4.9 0.5 4.9 6.4 4.5 0.1 4.0 0.8 2.7 1.3 5.6 3.1 2.3 7.8 2.0 14.1 1.5 3.3 2.0 1.5 2.9 0.2 3.9 1.9 1.3 2.1 0.3 3.5 44.7 2.4 0.4 5.8 1.1 1.7 1.7 1.4 0.0 0.0 0.0 0.0 0.0 28.3 0.1 6.0 2.1 0.5 3.5 2.7 2.7 3.9 2.4 1.7 0.6 0.5 0.1 16.7 0.0 0.4 1.7 0.9 8.1 0.0 2.9 0.5 0.2 0.1 0.0 0.7 0.0 1.0 0.3 0.6 0.8 8.6 2.3 0.8 11.4 0.9 0.0 0.3 0.0 1.0 5.1 0.0 1.2 0.4 5.5 0.2 0.0 0.2 0.5 11.9 1.7 0.4 1.8 1.8 3.9 0.4 6.7 0.6 0.3 0.8 1.2 2.0 1.6 0.1 0.0 0.3 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.1 4.1 8.3 0.8 1.8 4.9 6.4 2.7 1.3 14.1 2.4 11.9 4.6 0.0 3.4 4.5 1.5 0.4 2.5 171.3 28.4 12.2 31.4 1.9 11.6 9.8 463.3 2.1 2.0 0.0 7.7 4.4 1.3 3.6 3.5 0.0 0.8 3.2 0.0 1.8 0.3 423.7 3.4 2.2 1.7 0.0 13.0 5.8 9.3 6.8 4.2 6.7 9.5 0.0 1.0 66.4 16.4 3.0 4.2 1.3 4.1 3.3 FAXC "C6orf168, dJ273F20, MGC2817" ENSG00000146267 "Failed axon connections homolog" Q5TGI0 6 99271169-99350062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 17.5;Bipolar cells: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 16.2;HAP1: 14.5;SCLC-21H: 21.3;SH-SY5Y: 14.8;SK-MEL-30: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039106 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA039106: AB_10697546" "unprognostic (8.03e-2)" "unprognostic (4.91e-2)" "unprognostic (5.04e-3)" "unprognostic (6.44e-2)" "unprognostic (3.80e-1)" "unprognostic (5.00e-3)" "unprognostic (7.56e-2)" "unprognostic (7.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.34e-2)" "unprognostic (2.79e-3)" "unprognostic (2.47e-3)" "unprognostic (6.70e-4)" "unprognostic (1.13e-2)" "unprognostic (1.71e-1)" "unprognostic (4.86e-2)" "unprognostic (3.49e-3)" 0.7 3.3 9.4 2.1 12.2 0.4 4.6 11.0 19.7 1.8 13.3 1.8 5.1 2.3 4.5 15.3 8.6 2.4 3.5 1.3 7.7 10.3 2.5 0.3 2.3 0.4 9.1 9.9 3.4 2.2 9.3 10.4 1.4 7.5 10.1 4.3 1.4 5.8 15.1 0.9 0.4 2.1 19.1 4.8 0.8 5.2 2.8 1.6 0.0 2.0 0.2 0.5 13.6 1.7 1.2 0.6 1.4 0.6 0.8 0.4 0.0 2.3 1.9 6.4 8.8 0.0 0.0 2.3 3.0 1.9 5.0 4.4 1.1 0.7 0.0 0.3 0.6 16.2 0.1 14.5 2.8 4.4 0.0 7.2 0.0 1.2 0.4 0.4 0.0 0.0 0.3 4.6 0.1 2.3 3.7 0.0 1.2 0.3 0.0 1.6 4.1 0.0 0.0 7.5 0.0 2.9 0.0 0.6 0.0 2.7 0.1 21.3 14.8 2.7 2.0 13.0 2.7 6.1 0.0 0.6 1.6 2.9 0.0 9.2 0.0 0.0 0.0 0.1 0.0 11.9 0.8 0.6 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.2 1.2 0.3 0.4 1.4 0.8 0.3 0.6 0.2 0.0 9.4 12.2 11.0 17.4 7.7 10.3 9.1 9.9 7.5 1.6 23.8 17.5 0.0 3.4 0.3 12.6 0.8 0.0 2.7 10.3 1.8 9.8 0.8 8.3 1.7 2.1 0.6 0.0 0.0 0.6 0.1 0.4 4.1 3.5 0.0 0.2 3.2 0.0 1.3 0.8 3.6 0.0 0.4 1.7 0.0 0.2 3.1 1.3 0.0 1.8 0.8 11.6 0.0 0.7 0.9 9.0 0.3 0.2 0.0 0.2 1.0 FBRS "FBS, FBS1, FLJ11618" ENSG00000156860 Fibrosin Q9HAH7 16 30658431-30670814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 79.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044117 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA044117: AB_10794394" "unprognostic (1.87e-1)" "unprognostic (8.48e-3)" "unprognostic (2.41e-2)" "unprognostic (9.52e-3)" "unprognostic (1.03e-1)" "unprognostic (4.80e-2)" "unprognostic (2.07e-3)" "unprognostic (7.01e-3)" "unprognostic (6.32e-2)" "unprognostic (7.65e-2)" "unprognostic (4.57e-3)" "unprognostic (1.01e-1)" "unprognostic (1.25e-2)" "unprognostic (2.13e-1)" "unprognostic (4.16e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" 13.4 13.0 14.2 19.8 15.4 41.0 9.9 22.6 16.4 12.1 13.6 18.5 12.2 18.3 15.5 8.7 21.5 14.7 10.8 9.4 16.7 8.2 13.1 12.9 13.6 17.1 20.0 10.5 14.3 14.6 16.5 23.8 23.6 13.8 14.6 6.0 13.1 17.5 18.5 16.8 21.3 19.0 10.0 13.0 21.7 13.6 52.9 19.3 22.7 14.8 8.1 19.7 13.8 12.3 2.3 2.9 5.6 2.9 1.2 2.8 2.5 12.4 13.3 7.0 5.8 7.1 7.2 17.9 9.3 7.6 8.0 6.0 7.8 11.5 11.7 15.5 7.5 7.2 10.4 7.4 8.8 3.8 31.4 18.6 15.7 12.4 14.2 17.4 11.4 23.8 10.7 12.0 15.5 7.6 9.0 9.8 10.9 13.6 22.6 5.8 25.6 14.4 22.3 2.0 5.6 8.5 21.0 5.3 12.7 8.4 9.3 9.9 11.1 7.3 14.0 9.8 3.2 31.6 15.1 15.2 18.3 11.2 11.3 12.1 26.6 12.8 11.2 17.6 11.2 10.7 0.0 2.9 2.3 2.4 1.2 2.3 1.9 2.0 2.3 1.5 2.3 0.6 2.8 5.6 1.2 1.7 2.9 0.2 2.5 14.2 15.4 22.6 16.4 16.7 8.2 20.0 10.5 13.8 19.3 14.9 27.4 15.9 13.0 16.7 19.3 7.5 10.2 12.0 4.5 7.0 31.4 7.8 5.0 9.2 62.2 11.7 30.0 0.0 12.8 7.8 12.1 15.9 18.5 7.3 12.3 41.3 16.1 22.1 14.8 79.8 15.8 15.8 10.1 18.0 19.3 13.0 15.7 24.5 15.2 7.2 24.1 0.0 10.3 63.0 21.5 21.2 27.6 17.5 15.3 20.7 FBXL17 "DKFZP434C1715, Fbl17, Fbx13, FBXO13" ENSG00000145743 "F-box and leucine rich repeat protein 17" Q9UF56 5 107859035-108382098 "Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036410, HPA036411" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA036410: AB_2675109, HPA036411: AB_10669603" "unprognostic (8.15e-2)" "unprognostic (3.77e-2)" "unprognostic (2.18e-2)" "unprognostic (1.21e-1)" "unprognostic (4.58e-2)" "unprognostic (2.72e-2)" "unprognostic (2.08e-2)" "unprognostic (2.65e-1)" "unprognostic (6.67e-2)" "unprognostic (3.08e-2)" "unprognostic (5.98e-2)" "unprognostic (6.30e-2)" "prognostic favorable (4.60e-8)" "unprognostic (1.86e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (3.35e-2)" 13.7 13.8 22.2 7.8 27.4 5.4 13.3 18.0 27.4 11.5 9.8 7.9 12.0 10.3 10.1 9.3 12.0 9.3 10.4 25.1 18.5 19.0 16.8 13.6 9.8 12.0 16.8 17.1 9.7 9.8 27.5 12.5 6.1 11.7 12.0 10.5 12.4 9.6 14.4 46.1 9.6 10.5 11.6 12.3 10.4 9.6 8.2 8.9 16.8 23.8 9.7 10.0 10.8 9.0 2.0 1.9 3.3 1.3 1.0 2.3 0.5 6.5 6.5 7.5 13.7 12.6 13.3 5.0 8.0 18.1 6.6 9.0 1.3 13.9 7.3 12.7 12.9 10.2 2.9 6.0 9.2 10.3 7.3 5.4 6.9 7.6 3.2 6.6 4.6 8.0 9.5 13.8 6.1 4.5 12.9 7.8 3.0 1.0 9.5 14.4 4.9 4.0 5.9 1.0 5.0 6.1 5.7 10.1 9.4 9.2 9.1 6.5 11.1 10.4 9.3 9.8 5.5 7.3 11.1 8.4 15.0 4.7 4.6 10.3 7.5 10.4 5.5 13.3 7.1 9.7 0.4 0.9 3.3 2.1 1.3 2.2 1.1 1.9 2.3 1.1 2.0 2.0 1.6 1.7 1.0 0.7 1.9 1.3 0.5 22.2 27.4 18.0 27.4 18.5 19.0 16.8 17.1 11.7 8.9 17.9 16.4 11.5 6.7 14.9 34.9 31.5 10.2 2.7 6.8 27.9 53.0 3.9 14.9 5.4 3.7 11.2 14.7 0.0 11.2 5.4 7.7 10.1 16.1 18.4 7.4 28.6 28.7 21.5 18.4 2.9 13.0 9.7 15.1 1.0 24.2 19.3 10.7 17.3 15.6 11.2 49.7 0.0 7.8 8.6 4.3 21.5 3.8 12.1 14.3 7.0 FBXL19 "CXXC11, DKFZp434K0410, Fbl19, JHDM1C" ENSG00000099364 "F-box and leucine rich repeat protein 19" Q6PCT2 16 30923055-30948783 "Predicted intracellular proteins" "Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074250 Approved Nucleoplasm NA No Nucleoplasm "HPA074250: " "unprognostic (1.37e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.03e-1)" "unprognostic (3.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (3.54e-4)" "unprognostic (3.61e-2)" "unprognostic (2.52e-1)" "unprognostic (2.89e-1)" "unprognostic (1.48e-1)" "unprognostic (6.95e-3)" "unprognostic (1.37e-3)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (2.45e-2)" "unprognostic (2.38e-2)" 5.5 6.7 17.4 9.8 15.3 8.3 3.8 13.2 23.5 6.8 9.6 3.4 9.5 11.2 7.5 4.4 10.5 6.0 9.4 4.9 17.6 10.5 6.1 3.1 5.8 9.8 9.6 11.6 6.9 6.6 11.0 8.3 11.2 9.5 6.9 4.1 5.2 8.4 7.1 4.5 12.7 9.8 6.2 4.8 9.9 9.3 19.6 8.4 7.3 5.8 4.7 6.7 9.7 7.0 2.1 2.8 1.9 1.7 3.6 1.5 0.4 6.3 17.6 16.8 14.1 3.0 3.1 15.4 8.9 4.8 7.2 6.8 9.2 9.6 10.2 10.6 5.2 5.3 9.3 13.4 9.5 5.3 27.6 41.8 10.9 27.5 13.2 3.8 12.0 27.5 3.2 7.6 8.5 6.1 6.0 11.1 14.2 29.4 9.9 3.8 17.2 13.1 16.6 17.3 4.7 5.8 27.4 5.3 10.0 6.6 8.7 11.9 22.3 3.2 20.4 5.0 9.9 12.5 12.8 11.0 8.4 10.3 5.1 6.3 8.8 7.0 6.0 9.8 18.3 11.7 0.0 1.7 1.9 1.5 0.8 1.2 2.1 0.4 0.6 0.9 0.8 0.2 1.2 1.8 3.6 0.2 2.8 0.7 0.4 17.4 15.3 13.2 23.5 17.6 10.5 9.6 11.6 9.5 8.4 0.0 1.4 0.0 2.0 7.3 5.2 1.4 5.1 0.0 2.3 3.5 11.8 4.8 0.0 4.8 3.5 3.8 5.1 0.0 6.1 4.6 3.0 4.7 0.0 2.1 4.4 1.6 2.4 3.1 2.8 4.5 1.4 2.7 0.0 2.8 5.2 2.6 6.4 3.5 2.5 3.4 5.3 6.5 1.9 4.1 2.5 7.9 7.8 0.9 4.7 6.5 FBXO27 "Fbg5, Fbx27" ENSG00000161243 "F-box protein 27" Q8NI29 19 38990714-39032785 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 19.6;Cytotrophoblasts: 20.2;Syncytiotrophoblasts: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 16.6" "Low region specificity" "Detected in all" "HPA046800, HPA062242" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046800: AB_2679813, HPA062242: AB_2684723" "prognostic favorable (2.15e-4)" "unprognostic (7.32e-2)" "unprognostic (2.03e-2)" "prognostic unfavorable (3.53e-5)" "unprognostic (1.48e-3)" "unprognostic (4.38e-3)" "unprognostic (1.02e-1)" "unprognostic (8.95e-2)" "unprognostic (1.67e-1)" "unprognostic (7.31e-3)" "unprognostic (6.80e-2)" "unprognostic (9.31e-2)" "unprognostic (2.25e-2)" "unprognostic (8.72e-3)" "unprognostic (6.04e-2)" "unprognostic (7.51e-2)" "unprognostic (3.21e-2)" 8.9 3.1 11.8 2.0 7.9 2.3 21.3 18.5 14.1 4.5 5.2 4.7 5.2 2.0 3.9 2.3 11.6 4.4 4.4 14.1 8.8 8.8 5.1 5.8 3.9 3.5 7.3 10.5 8.1 3.8 1.4 3.3 3.1 6.4 7.2 6.7 5.1 5.5 6.4 1.5 26.7 3.9 5.8 6.7 2.5 2.8 3.6 4.1 2.9 3.7 6.0 5.6 9.3 7.1 1.6 1.1 4.0 0.7 2.7 0.9 0.3 4.2 5.4 0.2 3.5 7.6 0.4 1.6 0.6 3.3 2.6 2.4 1.8 1.6 0.6 8.6 4.8 4.4 7.4 0.3 3.1 1.7 0.4 0.2 0.2 1.4 0.2 1.3 0.4 1.3 2.7 5.0 2.6 0.2 4.1 1.5 0.2 2.4 0.6 3.6 3.8 0.3 0.6 3.9 1.4 9.9 0.1 0.0 0.6 1.6 16.6 0.3 5.3 8.4 1.1 0.0 2.5 4.4 0.8 1.9 0.3 0.2 0.2 0.4 1.7 3.9 0.9 4.4 0.1 0.1 1.8 0.7 0.4 0.8 0.6 0.5 0.8 0.5 0.6 0.5 1.6 0.9 0.7 4.0 2.7 0.4 1.1 0.5 0.3 11.8 7.9 18.5 14.1 8.8 8.8 7.3 10.5 6.4 4.1 3.0 19.6 0.0 4.6 5.3 7.4 8.3 2.5 6.7 10.3 1.8 0.0 20.2 1.7 1.4 2.5 0.7 0.0 0.0 0.7 3.1 2.1 2.6 7.0 2.5 3.9 7.9 0.0 0.6 0.0 1.7 2.6 1.0 0.0 1.8 0.0 4.0 0.5 0.0 3.9 5.3 2.9 0.0 1.4 5.7 1.3 15.6 22.5 1.3 0.1 4.2 FBXO33 Fbx33 ENSG00000165355 "F-box protein 33" Q7Z6M2 14 39397669-39432500 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 49.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046657 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046657: AB_10960398" "unprognostic (8.84e-3)" "unprognostic (6.72e-2)" "unprognostic (3.65e-2)" "unprognostic (2.79e-1)" "unprognostic (1.08e-1)" "unprognostic (3.20e-2)" "unprognostic (1.19e-1)" "prognostic favorable (4.94e-4)" "unprognostic (1.24e-1)" "unprognostic (2.70e-2)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "prognostic favorable (4.58e-4)" "unprognostic (9.61e-2)" "unprognostic (4.54e-1)" "unprognostic (4.41e-2)" "unprognostic (8.58e-3)" 8.9 13.3 8.9 8.9 12.1 49.1 8.4 12.3 19.7 10.1 7.0 7.1 10.0 8.2 8.5 12.0 7.5 8.8 8.6 6.1 10.4 11.7 8.5 8.8 9.0 12.8 9.1 11.0 9.4 7.8 18.4 19.0 8.8 9.3 9.1 6.9 9.4 10.8 12.0 4.4 6.7 8.0 7.7 7.2 10.4 8.2 12.8 7.5 16.6 14.9 5.7 10.6 8.6 8.7 2.5 1.6 7.8 2.2 5.5 4.8 1.3 9.7 6.1 5.6 8.6 20.2 9.5 9.3 9.8 13.3 5.5 6.5 3.6 8.7 11.0 12.2 15.3 5.5 5.0 14.4 9.7 10.0 10.5 9.3 4.3 8.9 9.3 5.7 16.4 16.7 8.8 10.5 9.4 3.0 9.6 4.6 11.0 3.8 10.0 10.8 10.4 14.6 10.3 5.7 8.8 9.2 12.7 9.1 9.9 10.5 12.5 9.7 4.4 8.9 9.4 10.7 8.7 6.9 10.6 5.8 9.4 8.4 13.9 7.8 13.6 16.0 17.3 7.2 7.8 6.9 1.6 1.7 3.7 3.4 2.1 3.2 2.5 3.4 3.7 1.6 2.3 4.8 4.5 7.8 5.5 2.2 1.5 3.4 1.3 8.9 12.1 12.3 19.7 10.4 11.7 9.1 11.0 9.3 7.5 8.9 19.0 17.1 12.7 30.7 22.6 5.9 2.5 1.4 5.7 8.7 41.2 7.0 6.6 7.2 32.0 14.3 14.7 0.0 8.2 7.7 16.9 17.3 10.3 9.0 9.3 27.0 23.0 9.8 19.6 8.0 7.8 14.0 18.6 6.4 12.6 12.4 11.0 7.0 4.9 2.7 16.1 0.0 17.9 19.6 10.2 49.3 17.7 17.5 12.4 20.9 FBXO4 FBX4 ENSG00000151876 "F-box protein 4" Q9UKT5 5 41925254-41941743 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003362 Approved Nucleoplasm NA NA Nucleoplasm "HPA003362: AB_2666918" "unprognostic (1.43e-1)" "unprognostic (2.10e-2)" "unprognostic (9.25e-3)" "unprognostic (2.65e-2)" "unprognostic (2.50e-1)" "unprognostic (7.32e-2)" "unprognostic (6.15e-2)" "unprognostic (1.48e-2)" "unprognostic (1.62e-3)" "unprognostic (5.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (1.28e-4)" "unprognostic (8.57e-2)" "unprognostic (1.51e-1)" "unprognostic (5.39e-2)" "unprognostic (8.27e-2)" 15.5 13.3 6.6 9.4 9.8 8.5 14.9 7.1 10.3 11.1 9.2 7.8 14.4 9.2 10.0 19.6 10.0 10.5 12.3 8.6 6.3 6.5 9.2 19.9 10.2 12.9 8.9 7.3 12.1 19.3 9.7 9.4 8.6 8.7 11.2 9.7 10.8 11.7 11.7 7.6 11.2 9.9 10.6 7.8 14.8 9.2 11.0 8.2 11.1 16.2 9.9 15.1 11.0 8.9 11.5 9.6 2.6 15.9 8.0 9.9 6.7 5.6 4.1 0.7 10.6 5.7 9.4 6.4 4.8 9.0 8.1 11.1 2.0 15.4 14.5 6.5 6.6 1.8 1.4 2.5 1.6 6.8 5.0 1.0 7.6 15.0 5.3 11.1 12.3 4.9 5.6 3.6 4.1 15.5 3.0 6.1 6.6 7.0 4.6 9.3 2.3 7.8 2.5 0.3 8.1 3.6 1.4 1.6 3.7 5.5 5.5 1.7 3.2 19.0 1.4 7.0 0.4 9.5 13.9 4.3 9.1 2.6 6.1 3.8 7.2 6.2 0.9 9.2 13.7 4.7 2.6 5.1 1.1 8.5 7.4 9.9 11.5 9.5 8.9 9.6 11.1 9.7 8.9 0.3 8.0 15.9 8.5 7.4 6.7 6.6 9.8 7.1 10.3 6.3 6.5 8.9 7.3 8.7 8.2 8.9 11.0 9.3 9.0 11.2 5.8 3.0 15.3 13.4 4.5 10.4 0.0 22.5 10.0 11.5 0.6 7.0 3.6 0.0 14.4 23.5 15.5 4.4 4.7 16.4 14.6 3.2 1.7 8.6 4.0 0.9 9.8 11.5 18.6 4.6 8.4 8.3 9.2 7.0 9.9 17.3 7.1 6.5 9.2 21.8 17.9 12.4 10.4 17.0 10.1 5.4 FBXO42 "Fbx42, KIAA1332" ENSG00000037637 "F-box protein 42" Q6P3S6 1 16246839-16352454 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025071 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA025071: AB_1848461" "unprognostic (1.08e-1)" "unprognostic (2.38e-1)" "unprognostic (1.25e-1)" "unprognostic (3.09e-2)" "unprognostic (1.40e-1)" "unprognostic (1.11e-2)" "prognostic unfavorable (3.72e-4)" "unprognostic (3.22e-2)" "unprognostic (4.00e-2)" "unprognostic (4.22e-2)" "unprognostic (3.96e-2)" "unprognostic (4.61e-2)" "unprognostic (1.22e-2)" "unprognostic (1.13e-1)" "unprognostic (2.53e-1)" "unprognostic (5.78e-3)" "unprognostic (3.91e-2)" 18.2 15.0 18.2 13.0 18.7 11.3 16.1 37.3 23.9 19.1 15.8 17.1 16.1 10.4 24.3 18.5 23.0 18.5 16.3 19.7 16.2 15.9 13.4 15.7 15.2 15.3 16.1 13.4 22.2 22.6 21.2 19.6 16.2 19.5 21.6 15.0 19.0 18.2 22.0 24.3 33.6 12.5 24.9 13.1 15.9 14.3 16.5 17.7 20.1 18.2 10.4 18.9 19.9 22.1 12.2 14.4 18.5 16.8 12.4 12.9 7.9 10.6 5.8 14.2 14.3 17.3 11.2 6.2 11.1 16.9 16.1 15.8 5.4 9.9 11.4 10.0 15.4 11.1 9.8 14.3 10.6 13.3 13.1 6.7 10.6 8.8 6.1 20.6 12.5 13.9 12.0 24.4 14.1 20.5 14.7 16.1 14.4 11.3 16.0 11.4 7.3 12.0 11.0 6.1 14.3 6.6 13.7 8.7 10.1 10.6 3.1 13.4 8.8 12.6 10.6 13.1 13.6 8.6 9.9 10.0 8.2 7.2 13.4 8.6 7.9 8.0 11.6 10.8 16.5 11.2 7.1 12.3 18.5 12.9 16.8 9.7 8.2 9.8 8.2 14.4 12.2 11.3 9.6 10.9 12.4 12.5 6.4 12.2 7.9 18.2 18.7 37.3 23.9 16.2 15.9 16.1 13.4 19.5 17.7 11.9 10.2 12.2 5.3 23.0 20.2 17.1 10.2 2.7 4.5 12.2 43.2 9.2 0.0 6.7 7.2 9.2 7.1 0.0 6.6 11.9 12.2 9.8 2.3 8.6 11.8 27.0 10.3 10.4 12.7 7.2 13.8 14.6 1.7 8.2 5.8 12.5 7.7 7.0 10.6 2.8 21.7 12.9 10.5 13.6 8.8 30.4 22.0 14.4 8.2 4.4 FBXO44 "FBG3, FBX30, Fbx44, Fbxo6a, MGC14140" ENSG00000132879 "F-box protein 44" Q9H4M3 1 11654375-11663327 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 61.7" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003363 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003363: AB_1078831" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (9.59e-2)" "unprognostic (5.34e-2)" "unprognostic (2.82e-1)" "unprognostic (2.97e-2)" "unprognostic (2.44e-1)" "unprognostic (1.31e-2)" "unprognostic (3.32e-1)" "unprognostic (1.93e-1)" "prognostic favorable (2.63e-4)" "unprognostic (2.57e-2)" "prognostic favorable (6.29e-5)" "unprognostic (1.34e-2)" "unprognostic (5.45e-1)" "unprognostic (1.77e-1)" "unprognostic (3.02e-3)" 6.6 21.1 26.6 8.3 39.0 5.3 7.0 61.7 45.0 6.5 5.0 12.3 8.9 14.2 8.5 10.3 7.7 12.1 10.5 13.7 28.7 26.4 12.2 7.7 8.1 16.3 20.7 27.4 11.3 17.8 21.7 19.5 2.4 23.1 13.7 3.4 9.9 25.5 15.4 6.4 22.1 7.8 6.2 14.2 13.4 8.1 8.5 15.3 3.2 13.0 3.3 9.9 7.4 7.5 10.9 5.1 1.5 2.5 1.5 11.7 6.1 7.5 12.2 4.5 17.2 6.7 7.0 6.1 6.1 7.4 6.7 5.8 8.9 14.3 0.2 13.6 6.7 11.2 1.9 9.0 20.3 2.8 8.6 11.0 0.2 6.6 14.8 9.3 0.2 1.1 9.0 13.5 6.3 4.8 13.9 5.2 14.1 4.6 1.9 1.7 4.7 12.6 1.4 4.7 6.8 8.7 5.1 0.2 2.5 10.8 2.7 13.7 11.3 16.0 6.2 27.0 5.8 11.1 6.9 6.4 4.9 11.9 6.5 4.8 12.7 7.1 4.6 11.3 3.2 11.6 1.1 2.1 0.6 11.7 2.4 9.0 10.0 8.0 8.9 3.3 10.9 10.9 7.5 1.5 1.5 2.5 5.1 7.1 6.1 26.6 39.0 61.7 45.0 28.7 26.4 20.7 27.4 23.1 15.3 0.0 9.0 9.1 10.8 16.4 20.1 3.6 5.1 2.7 5.7 15.7 13.7 1.3 26.6 8.0 3.6 3.8 0.8 0.0 5.7 2.4 10.1 9.3 3.5 3.9 5.1 38.1 4.1 5.5 6.2 9.9 21.3 5.0 10.1 5.4 2.0 14.8 6.5 1.1 27.3 9.1 6.8 0.0 6.6 11.1 7.2 14.9 0.7 20.0 2.1 4.7 FBXO5 "EMI1, FBX5, Fbxo31" ENSG00000112029 "F-box protein 5" Q9UKT4 6 152970519-152983579 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "bone marrow: 29.3;lymphoid tissue: 69.0" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 70.0;Spermatogonia: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB008106, HPA029048" Approved Supported Nucleoplasm NA Yes Nucleoplasm "CAB008106: AB_828450, HPA029048: AB_10602132" "unprognostic (1.22e-2)" "unprognostic (7.21e-2)" "unprognostic (4.61e-3)" "unprognostic (1.24e-2)" "unprognostic (5.92e-2)" "unprognostic (2.94e-2)" "unprognostic (2.43e-8)" "unprognostic (2.46e-2)" "unprognostic (1.55e-2)" "unprognostic (7.32e-2)" "unprognostic (2.89e-1)" "unprognostic (5.86e-2)" "unprognostic (1.25e-9)" "prognostic favorable (8.65e-4)" "unprognostic (1.20e-1)" "unprognostic (1.72e-1)" "unprognostic (1.51e-1)" 4.2 2.9 2.7 13.7 3.1 29.3 3.5 6.6 3.3 5.3 6.1 1.8 1.8 3.5 5.8 3.7 6.1 4.4 3.0 2.4 2.8 2.3 3.0 4.1 3.8 10.8 4.4 1.6 5.1 3.1 2.0 3.4 8.2 3.5 3.9 4.1 1.6 6.9 2.4 1.6 3.3 5.0 3.9 2.4 10.6 3.5 4.2 3.9 69.0 5.6 4.8 11.2 3.5 4.5 6.8 5.3 0.0 3.5 8.8 7.9 3.2 11.1 5.8 24.6 16.5 1.9 3.9 7.8 27.2 12.2 20.5 23.1 11.9 6.7 27.4 8.4 7.2 13.8 10.7 19.4 9.1 24.7 14.6 17.3 27.4 8.6 12.9 3.6 24.5 17.0 2.7 1.7 13.8 10.9 5.0 9.3 14.4 28.9 25.8 18.6 8.5 27.9 15.8 14.3 8.6 8.6 23.6 19.7 17.7 7.2 6.1 16.1 16.7 19.3 10.4 5.1 9.0 7.5 23.0 7.0 15.4 20.1 17.7 31.7 8.6 9.5 40.5 11.2 18.2 18.6 0.0 2.4 0.0 3.8 3.0 5.4 6.8 6.3 6.9 4.6 6.0 6.2 6.4 0.0 8.8 3.5 5.3 7.9 3.2 2.7 3.1 6.6 3.3 2.8 2.3 4.4 1.6 3.5 3.9 0.0 0.6 13.7 3.5 8.9 2.8 1.4 2.5 2.7 5.7 1.8 5.9 6.7 3.3 2.7 0.5 4.5 1.0 70.0 1.4 24.6 7.2 2.7 2.3 1.7 6.5 1.6 4.6 6.2 1.0 0.0 4.0 4.8 1.7 2.8 2.7 4.0 1.3 0.0 5.6 2.9 3.0 12.9 6.6 8.8 32.4 4.5 4.9 7.0 4.3 1.7 FBXW10 "C17orf1, C17orf1A, Fbw10, HREP, SM2SH2" ENSG00000171931 "F-box and WD repeat domain containing 10" Q5XX13 17 18744024-18779349 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 15.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 8.1;Early spermatids: 30.2;Late spermatids: 8.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.8;ASC diff: 2.1;CAPAN-2: 3.1;HaCaT: 4.3;HeLa: 3.4" HPA047457 Approved Nucleoplasm NA NA Nucleoplasm "HPA047457: " "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (9.59e-2)" "unprognostic (7.47e-2)" "unprognostic (4.54e-1)" "unprognostic (5.08e-2)" "unprognostic (6.67e-2)" "unprognostic (3.89e-1)" "unprognostic (2.30e-1)" "unprognostic (6.30e-2)" "unprognostic (5.65e-2)" "unprognostic (3.49e-2)" "unprognostic (2.20e-7)" "unprognostic (3.16e-1)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (1.05e-1)" 0.1 0.7 0.1 0.1 0.7 0.0 0.1 1.9 0.6 0.6 0.1 0.1 0.1 0.4 0.1 2.1 0.2 0.8 0.4 0.1 0.6 0.3 0.2 1.1 0.3 0.1 0.1 0.8 0.1 0.1 0.1 0.4 0.1 1.6 0.1 0.0 0.4 0.3 0.2 0.8 0.1 0.4 0.1 0.1 0.1 0.3 15.9 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 5.8 0.0 0.1 2.1 1.3 0.1 0.0 0.2 0.0 0.3 0.1 3.1 0.1 0.1 0.4 0.2 4.3 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.4 1.5 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.9 0.6 0.6 0.3 0.1 0.8 1.6 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.4 0.4 0.1 0.0 0.0 0.0 0.1 FBXW2 "FBW2, Fwd2, Md6" ENSG00000119402 "F-box and WD repeat domain containing 2" Q9UKT8 9 120751978-120793412 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067878 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA067878: AB_2685913" "unprognostic (1.08e-1)" "unprognostic (1.45e-1)" "unprognostic (5.06e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" "unprognostic (6.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.57e-1)" "unprognostic (8.06e-3)" "unprognostic (1.40e-1)" "unprognostic (2.95e-1)" "unprognostic (3.88e-3)" "prognostic favorable (1.38e-6)" "unprognostic (1.66e-1)" "unprognostic (2.75e-1)" "unprognostic (2.86e-1)" "unprognostic (3.83e-2)" 26.4 31.7 17.4 22.9 25.8 35.6 29.7 27.0 30.3 26.0 22.6 22.6 17.4 18.1 28.8 25.2 25.5 22.7 24.2 25.3 18.1 16.1 20.4 25.5 27.4 25.0 15.1 19.8 20.9 27.3 30.7 23.4 18.8 18.8 22.8 22.3 23.8 25.6 23.2 20.2 27.2 20.9 29.7 16.8 30.1 24.5 23.0 16.7 32.9 22.8 15.7 26.6 25.2 23.8 10.6 11.7 17.7 13.2 15.4 19.3 9.6 14.1 18.0 13.5 22.8 25.6 21.1 12.5 19.1 21.9 21.1 20.7 14.2 17.2 21.3 10.1 24.8 21.4 31.3 19.4 19.0 26.4 28.5 8.4 13.8 30.4 20.6 14.5 30.7 19.1 15.3 23.8 23.3 25.0 19.9 24.7 22.2 18.3 23.3 18.3 22.7 22.0 9.2 20.1 24.2 17.2 17.0 21.6 21.3 14.6 16.1 10.8 16.4 26.8 19.9 13.8 16.7 32.5 8.9 18.3 18.1 14.5 29.1 23.5 16.9 33.9 18.6 19.2 13.7 18.5 13.3 12.6 17.7 19.3 12.0 14.7 10.6 14.1 18.1 11.7 6.9 11.7 15.8 13.4 15.4 13.2 10.3 13.4 9.6 17.4 25.8 27.0 30.3 18.1 16.1 15.1 19.8 18.8 16.7 23.8 49.9 14.5 22.8 20.1 19.5 19.1 17.8 17.4 29.6 10.4 11.8 15.7 18.3 22.8 36.2 31.5 18.9 0.0 29.7 24.2 25.1 28.8 15.1 28.7 22.4 31.8 26.6 34.4 30.8 127.2 24.5 23.2 45.5 33.3 21.9 14.7 25.6 22.9 33.6 21.1 23.1 6.5 25.0 40.3 58.2 28.0 14.9 30.5 21.3 22.6 FCF1 "Bka, C14orf111, CGI-35, UTP24" ENSG00000119616 "FCF1, rRNA-processing protein" Q9Y324 14 74713144-74738620 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 87.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046681 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046681: AB_10960541" "unprognostic (1.39e-2)" "unprognostic (1.54e-1)" "unprognostic (5.74e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (7.94e-3)" "prognostic unfavorable (5.54e-6)" "unprognostic (3.17e-1)" "unprognostic (3.43e-2)" "unprognostic (7.36e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (7.79e-2)" "prognostic favorable (2.26e-4)" "unprognostic (3.30e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-1)" "unprognostic (1.47e-1)" 23.9 26.0 19.5 18.4 23.0 18.3 27.1 15.7 21.6 25.6 21.6 24.6 25.9 14.4 29.5 18.5 30.4 30.6 17.8 21.9 17.7 18.2 24.6 25.1 21.1 24.2 25.2 17.5 32.7 18.3 23.1 34.5 24.4 23.8 22.8 23.2 20.8 22.7 25.4 26.3 20.3 19.3 23.8 34.9 21.4 19.8 19.4 21.6 28.3 37.8 23.3 30.5 26.6 24.0 19.0 25.2 15.8 14.5 12.1 18.1 6.8 36.1 26.7 19.3 21.8 30.8 27.3 25.5 31.8 24.5 31.8 28.5 29.6 29.9 32.4 20.8 27.7 15.4 26.7 32.2 30.0 56.4 30.0 14.0 22.4 16.8 19.3 22.3 27.3 20.7 21.3 26.6 33.7 35.5 25.3 29.6 28.2 26.8 19.6 28.5 25.8 31.7 9.8 25.9 21.1 31.1 24.2 38.0 15.4 16.2 29.7 13.6 19.8 40.8 21.7 18.1 22.4 27.7 19.1 26.9 25.5 27.3 24.0 36.3 17.3 45.3 50.4 24.2 26.1 28.2 10.0 14.5 15.8 16.6 12.3 18.1 19.0 16.0 14.2 11.2 18.7 17.4 17.8 12.1 12.1 14.2 25.2 15.4 6.8 19.5 23.0 15.7 21.6 17.7 18.2 25.2 17.5 23.8 21.6 6.0 19.4 22.2 6.5 2.7 6.9 18.9 43.3 62.9 18.2 12.2 5.9 10.3 13.3 15.2 17.6 13.6 14.2 46.7 16.3 12.5 7.3 6.1 25.4 87.3 11.2 11.1 9.8 34.4 35.1 8.8 14.4 12.0 0.0 8.2 14.0 14.5 15.2 8.6 15.9 10.7 6.3 12.9 5.2 10.6 11.9 4.3 7.3 13.8 14.2 5.5 FEM1C "EUROIMAGE686608, EUROIMAGE783647, FEM1A, KIAA1785" ENSG00000145780 "Fem-1 homolog C" Q96JP0 5 115520908-115544894 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 58.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059919, HPA060977" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059919: AB_2684161, HPA060977: AB_2684402" "unprognostic (1.14e-2)" "unprognostic (3.02e-1)" "prognostic favorable (1.83e-4)" "unprognostic (1.28e-1)" "unprognostic (3.31e-1)" "unprognostic (7.56e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (4.67e-2)" "unprognostic (5.52e-3)" "unprognostic (1.99e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.64e-1)" "unprognostic (3.37e-1)" "unprognostic (1.37e-2)" "unprognostic (1.05e-2)" 18.2 6.8 15.9 8.6 19.4 58.5 14.6 21.1 19.6 15.1 14.2 12.2 10.7 12.1 11.3 7.5 16.4 8.7 13.8 28.6 13.9 8.6 8.7 16.8 15.3 7.3 12.9 17.1 10.7 12.1 6.9 8.2 7.2 14.9 11.5 13.7 6.4 8.5 9.9 24.3 13.1 17.4 12.2 15.3 9.0 14.2 14.1 14.5 4.1 9.5 15.4 7.4 16.5 10.2 3.3 6.1 6.4 10.9 3.0 5.5 3.6 8.3 5.0 7.3 11.3 13.1 18.5 5.9 13.3 10.6 10.0 11.7 5.5 7.5 8.6 9.1 9.7 11.6 6.6 5.8 11.1 14.8 13.2 5.5 4.5 7.2 4.2 8.7 3.0 6.1 12.1 9.4 12.5 11.4 9.4 9.8 7.2 2.8 11.3 15.1 3.6 7.7 5.0 5.1 5.3 6.4 6.6 13.3 9.3 11.2 15.9 6.0 4.8 8.6 6.0 14.3 6.1 7.8 6.0 17.2 17.3 9.0 15.8 11.8 9.0 6.5 6.9 10.1 8.4 6.9 2.5 6.1 6.4 3.8 9.4 5.5 3.3 4.0 2.8 6.1 1.9 4.6 3.7 6.4 3.0 10.9 1.6 4.4 3.6 15.9 19.4 21.1 19.6 13.9 8.6 12.9 17.1 14.9 14.5 20.8 9.9 10.7 13.5 23.6 14.9 28.2 20.4 13.4 11.4 10.4 19.6 3.5 5.0 10.4 38.8 19.0 31.9 46.7 7.2 6.7 26.4 18.1 12.7 36.5 6.8 4.8 16.0 17.2 16.7 59.6 8.1 16.4 28.7 5.4 24.9 18.7 16.0 17.6 6.3 9.1 26.4 0.0 24.7 6.9 6.1 21.7 4.2 6.9 17.8 26.6 FGF1 "AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1" ENSG00000113578 "Fibroblast growth factor 1" P05230 5 142592178-142698070 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 65.0;heart muscle: 35.5;kidney: 41.5" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 49.6;Collecting duct cells: 19.2;Cone photoreceptor cells: 15.7;Muller glia cells: 68.6" "Cancer enriched" "Detected in many" 12 "glioma: 33.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 19.8;BJ hTERT+: 14.8;BJ hTERT+ SV40 Large T+: 16.3;BJ hTERT+ SV40 Large T+ RasG12V: 20.6;HBF TERT88: 29.5;hTEC/SVTERT24-B: 20.6;LHCN-M2: 13.7;U-2 OS: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003265, CAB017519" Enhanced Supported Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "CAB017519: AB_629473, HPA003265: AB_1848522" "unprognostic (1.25e-2)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (3.41e-3)" "unprognostic (2.55e-2)" "unprognostic (3.52e-1)" "unprognostic (2.77e-1)" "unprognostic (2.39e-1)" "unprognostic (3.63e-1)" "unprognostic (1.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.54e-1)" "prognostic favorable (2.59e-5)" "unprognostic (3.72e-4)" "unprognostic (2.49e-1)" "prognostic favorable (3.45e-5)" "unprognostic (3.01e-4)" 7.3 3.5 44.2 2.0 43.1 1.5 9.7 10.5 59.9 1.8 1.7 65.0 0.0 1.6 3.1 8.7 2.3 2.1 2.7 35.5 47.4 33.0 41.5 2.0 2.9 1.4 62.6 13.8 1.5 1.4 3.4 1.6 2.3 36.3 2.2 1.8 0.8 5.8 2.6 2.3 2.0 1.7 2.6 57.7 5.5 1.1 2.2 48.6 0.0 4.9 0.8 2.2 1.7 0.4 1.2 1.0 1.8 0.6 0.1 2.3 0.2 2.4 0.1 0.1 0.7 0.5 1.5 0.8 19.8 14.8 16.3 20.6 0.1 0.1 0.5 1.4 6.8 0.9 0.3 0.0 1.5 29.5 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.2 0.7 0.5 20.6 1.2 4.4 0.0 0.1 0.0 0.7 13.7 0.3 0.0 0.4 0.6 0.0 0.6 0.1 0.7 0.2 0.6 0.1 0.5 1.0 0.0 0.4 0.2 3.9 0.0 0.1 0.4 2.6 14.7 0.3 9.3 0.3 0.1 0.1 3.7 0.1 0.7 0.3 0.3 1.8 2.3 0.1 1.8 0.4 0.8 0.9 0.2 1.2 0.9 1.9 1.7 0.1 0.6 1.0 0.5 0.2 44.2 43.1 10.5 22.6 47.4 33.0 62.6 13.8 36.3 48.6 0.0 0.0 0.0 3.4 0.3 1.6 49.6 0.0 0.0 3.4 19.2 15.7 0.5 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.4 1.8 1.4 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.4 0.0 0.0 3.3 0.0 0.0 68.6 0.7 0.0 0.4 0.0 9.6 6.5 4.7 0.0 0.1 0.0 0.7 0.0 0.0 0.3 FHL3 SLIM2 ENSG00000183386 "Four and a half LIM domains 3" Q13643 1 37996770-38005606 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "blood: 67.9;skeletal muscle: 247.1;tongue: 100.1" "Cell type enhanced" "Detected in many" 7 "granulocytes: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 9 "eosinophil: 67.9" "Lineage enriched" "Detected in many" 12 "granulocytes: 67.9" "Cell line enhanced" "Detected in many" "HEL: 29.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA045723 Approved Nucleoplasm NA NA Nucleoplasm "HPA045723: AB_10966278" "prognostic favorable (5.62e-4)" "unprognostic (1.12e-1)" "unprognostic (3.02e-3)" "unprognostic (6.97e-2)" "unprognostic (2.26e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.59e-5)" "unprognostic (1.02e-3)" "unprognostic (1.80e-1)" "unprognostic (1.36e-1)" "unprognostic (9.05e-2)" "unprognostic (5.05e-2)" "prognostic unfavorable (4.20e-11)" "unprognostic (8.88e-3)" "unprognostic (2.38e-1)" "unprognostic (4.94e-2)" "unprognostic (2.77e-2)" 7.0 2.0 1.2 3.3 2.1 3.9 4.5 0.6 1.4 5.5 6.4 1.3 2.4 1.1 7.5 8.1 6.9 4.4 3.6 2.3 1.6 1.1 1.7 1.3 2.9 5.0 2.4 0.9 7.6 2.0 1.4 1.1 2.1 2.1 4.8 1.6 2.2 5.5 3.6 247.1 2.6 1.9 12.0 2.2 2.5 2.7 1.7 1.0 0.3 1.8 100.1 4.0 15.5 5.7 0.1 3.8 67.9 5.7 3.0 3.4 2.3 6.2 2.3 6.2 6.3 5.8 23.6 3.9 5.0 9.8 9.4 7.0 5.2 5.0 0.0 8.4 11.2 4.5 2.4 4.0 6.0 4.7 2.3 7.2 29.5 5.1 5.9 22.8 2.3 21.7 20.8 6.9 10.8 6.1 20.1 13.2 3.1 24.8 0.1 17.6 3.3 0.8 10.0 8.1 0.4 1.6 4.0 5.2 0.4 6.2 1.1 0.7 3.2 4.5 0.4 7.2 12.1 1.9 2.0 9.3 4.2 9.5 1.1 4.5 1.6 5.7 0.7 1.9 13.8 4.3 1.3 5.7 67.9 3.2 3.7 3.4 0.0 0.7 1.6 3.8 0.1 0.5 0.7 7.4 3.0 2.4 0.1 1.6 2.3 1.2 2.1 0.6 1.3 1.6 1.1 2.4 0.9 2.1 1.0 0.0 4.0 0.5 16.0 18.5 0.3 3.9 5.1 0.0 4.5 7.0 0.0 7.1 1.7 16.8 0.6 9.3 0.0 0.0 24.2 26.2 19.0 5.1 73.7 0.9 25.9 0.0 0.0 15.4 14.3 0.9 20.8 24.2 5.0 8.2 0.0 2.4 24.2 0.0 30.1 2.5 0.3 25.8 30.6 1.1 14.7 14.2 8.1 12.2 0.0 8.4 FICD "HIP13, HYPE" ENSG00000198855 "FIC domain containing" Q9BVA6 12 108515185-108525837 "Enzymes, Predicted intracellular proteins" "Unfolded protein response" "Hydrolase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 65.6;Late spermatids: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021390, HPA071134" Approved Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA021390: AB_1851340, HPA071134: AB_2686347" "unprognostic (1.00e-1)" "unprognostic (8.76e-2)" "unprognostic (1.76e-2)" "prognostic favorable (4.61e-5)" "unprognostic (6.92e-2)" "unprognostic (2.68e-2)" "unprognostic (5.73e-2)" "unprognostic (2.84e-2)" "unprognostic (8.68e-2)" "unprognostic (2.57e-1)" "unprognostic (3.15e-2)" "unprognostic (1.19e-1)" "unprognostic (7.66e-2)" "unprognostic (1.56e-2)" "unprognostic (6.22e-2)" "unprognostic (3.12e-2)" "unprognostic (3.65e-2)" 4.2 9.6 5.6 6.1 8.2 3.0 4.5 4.0 6.7 8.5 3.8 7.3 10.5 3.9 4.6 15.8 2.3 4.1 4.1 3.5 5.4 5.9 5.2 16.4 5.0 4.9 8.9 5.1 4.8 27.9 4.8 15.3 7.9 6.0 6.1 3.6 10.2 19.7 7.9 2.6 3.4 3.3 4.6 7.5 4.8 5.1 8.5 6.6 5.4 13.6 1.0 6.2 4.1 4.5 5.0 15.2 10.9 5.4 3.1 8.0 1.8 1.9 4.8 2.0 3.9 4.7 3.3 5.4 12.7 6.7 6.0 4.2 3.0 1.9 2.7 4.8 6.0 7.1 2.5 2.1 1.4 5.3 4.5 3.1 1.5 3.7 4.2 18.5 2.2 5.7 1.5 3.0 8.4 12.1 7.4 4.3 2.5 1.0 9.1 5.3 4.4 2.9 2.3 2.1 2.0 8.0 1.7 2.6 6.5 2.8 3.8 1.9 1.3 5.7 2.7 6.2 3.0 4.2 2.2 4.8 6.2 2.2 10.8 4.8 18.2 2.9 0.9 8.5 2.0 4.3 10.9 2.8 4.2 6.8 4.8 8.0 5.0 5.0 6.2 2.7 3.3 2.9 5.6 5.5 3.1 5.4 15.2 3.1 1.8 5.6 8.2 4.0 6.7 5.4 5.9 8.9 5.1 6.0 6.6 0.0 3.0 1.5 2.9 0.7 5.2 1.7 5.1 2.7 0.0 7.0 2.0 4.9 5.0 3.7 65.6 3.7 1.6 0.0 8.1 3.9 4.7 7.7 13.8 4.9 5.7 12.7 1.7 4.9 1.8 37.2 3.1 4.7 6.8 3.6 2.5 14.7 7.6 0.8 9.2 1.8 8.3 12.9 2.7 7.2 6.8 2.9 26.0 4.5 1.6 4.2 FIP1L1 "DKFZp586K0717, FIP1" ENSG00000145216 "Factor interacting with PAPOLA and CPSF1" Q6UN15 4 53377643-53460861 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "mRNA processing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037475, HPA058202" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037475: AB_10696933, HPA058202: AB_2683636" "unprognostic (3.80e-1)" "unprognostic (5.46e-2)" "unprognostic (5.60e-3)" "unprognostic (1.40e-1)" "unprognostic (7.18e-2)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.51e-4)" "unprognostic (1.87e-1)" "unprognostic (9.00e-3)" "unprognostic (1.14e-2)" "unprognostic (5.48e-2)" "unprognostic (1.42e-1)" "unprognostic (4.07e-1)" "unprognostic (1.10e-1)" "unprognostic (8.66e-3)" "unprognostic (3.10e-2)" "unprognostic (1.39e-1)" 25.7 24.4 20.2 27.6 25.8 35.8 24.0 23.0 25.1 24.5 18.0 19.4 16.1 16.0 27.4 17.7 23.4 22.4 16.2 19.7 17.1 16.6 19.7 19.0 20.3 24.5 20.1 26.0 32.2 16.9 26.6 26.6 28.2 20.9 21.7 21.0 16.2 21.5 18.0 33.9 24.5 20.0 23.5 19.4 24.5 20.4 40.2 22.4 42.4 22.7 17.8 29.2 26.6 22.6 26.5 32.7 36.5 24.0 33.7 32.4 21.3 18.3 12.1 22.2 13.3 16.8 17.1 28.4 23.3 29.3 19.0 14.7 17.6 17.1 33.7 18.1 24.8 17.8 11.6 24.1 17.3 24.7 11.7 13.1 26.6 10.0 16.2 26.7 39.5 22.8 19.6 15.8 24.0 24.6 18.4 14.0 20.4 30.6 15.8 14.9 13.5 35.6 18.2 14.6 23.5 11.9 32.0 10.1 14.8 15.4 16.6 17.3 18.7 16.3 18.8 26.7 21.8 10.7 14.7 14.7 19.5 17.0 18.1 27.9 19.8 11.5 42.6 16.9 24.8 34.7 25.8 16.9 36.5 25.7 17.8 29.2 26.5 25.8 25.1 22.6 24.2 28.9 25.4 20.7 33.7 24.0 32.7 32.4 21.3 20.2 25.8 23.0 25.1 17.1 16.6 20.1 26.0 20.9 22.4 23.8 20.1 45.5 37.4 34.5 40.5 13.1 17.8 45.5 27.3 26.2 17.7 52.0 31.5 34.1 7.4 26.3 21.3 0.0 30.6 43.6 38.6 25.4 47.4 18.7 28.6 73.1 35.2 33.2 19.4 8.8 61.9 27.7 30.4 46.9 24.6 45.2 30.3 31.7 50.2 19.6 28.8 38.8 24.7 112.4 78.8 29.7 72.2 41.5 25.5 30.3 FIZ1 "FLJ14768, ZNF798" ENSG00000179943 "FLT3 interacting zinc finger 1" Q96SL8 19 55591371-55601970 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074026 Approved Nucleoplasm NA NA Nucleoplasm "HPA074026: AB_2686653" "unprognostic (1.97e-2)" "unprognostic (6.59e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-1)" "unprognostic (6.43e-2)" "unprognostic (8.33e-3)" "unprognostic (4.51e-3)" "unprognostic (8.69e-2)" "unprognostic (1.15e-1)" "unprognostic (1.30e-1)" "prognostic favorable (8.42e-4)" "unprognostic (7.02e-2)" "unprognostic (7.28e-2)" "unprognostic (1.87e-2)" "unprognostic (6.92e-2)" "unprognostic (3.03e-1)" "prognostic favorable (2.02e-4)" 10.9 8.6 13.9 9.3 16.6 5.8 12.4 17.0 17.8 10.2 10.9 13.6 10.4 10.4 14.5 13.0 8.0 10.9 11.1 10.0 13.7 11.2 11.5 8.1 9.7 8.0 14.2 9.1 12.1 15.4 21.1 13.9 8.6 9.2 11.7 8.7 14.7 14.3 15.5 18.2 10.6 10.7 16.0 12.3 10.5 13.7 9.4 10.8 9.5 14.4 8.6 9.4 9.4 17.6 2.5 3.4 1.9 3.0 2.1 2.6 0.9 7.2 15.5 10.7 7.6 6.2 4.3 12.2 6.1 4.2 7.0 5.3 8.6 8.2 12.7 5.7 3.8 3.8 7.3 7.4 7.7 6.9 10.0 19.4 9.8 10.5 7.5 6.3 8.3 9.3 5.0 12.6 6.0 7.2 6.7 3.5 8.0 12.0 5.9 5.1 6.4 14.7 6.2 11.7 8.8 11.1 15.4 10.0 6.9 7.0 13.4 14.3 16.3 9.6 7.0 6.4 6.6 7.2 9.9 5.5 6.6 10.8 2.4 7.4 15.5 22.8 8.3 9.4 7.9 7.2 0.1 1.7 0.2 1.0 3.0 1.0 2.5 2.6 1.5 1.2 1.5 1.3 1.9 1.9 2.1 1.1 3.4 1.0 0.9 13.9 16.6 17.0 17.8 13.7 11.2 14.2 9.1 9.2 10.8 8.9 0.6 1.4 3.0 3.0 13.9 4.8 10.2 8.1 3.4 5.2 3.9 3.4 0.0 3.4 0.5 3.2 4.8 0.0 3.4 3.0 2.8 3.1 0.0 5.1 4.0 12.7 9.7 3.7 3.0 0.6 2.8 3.4 0.0 1.8 4.2 8.8 4.7 3.5 3.2 4.1 13.7 0.0 2.3 2.6 2.2 1.9 2.9 2.2 5.1 2.7 FKBP5 "FKBP51, FKBP54, P54, PPIase, Ptg-10" ENSG00000096060 "FK506 binding protein 5" Q13451 6 35573585-35728583 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Chaperone, Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 277.2" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 325.8;Peritubular cells: 205.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 103.4;ASC TERT1: 64.4;HHSteC: 81.0;HSkMC: 97.8;hTCEpi: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009315, HPA031092, HPA031093, HPA031095" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734" "unprognostic (2.09e-3)" "unprognostic (1.70e-1)" "unprognostic (1.44e-2)" "unprognostic (1.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.93e-1)" "unprognostic (4.72e-1)" "unprognostic (6.30e-3)" "unprognostic (3.70e-3)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "unprognostic (1.73e-1)" "unprognostic (7.48e-3)" "unprognostic (2.18e-3)" "unprognostic (8.31e-2)" "unprognostic (4.22e-2)" "unprognostic (6.90e-3)" 78.8 20.7 9.5 14.2 15.6 4.9 36.7 2.4 10.9 16.5 29.0 5.1 29.8 2.2 18.6 16.9 29.2 19.4 17.9 26.3 10.6 4.2 44.9 30.7 19.7 55.9 15.7 3.6 27.2 43.7 8.6 33.8 6.0 13.1 18.3 8.2 11.8 30.4 25.1 277.2 20.2 36.7 18.6 18.2 32.3 25.0 14.3 12.4 20.1 24.2 9.8 16.8 22.5 18.4 4.0 30.6 24.9 31.2 11.8 42.3 39.9 5.0 2.2 9.7 14.4 103.4 64.4 0.1 2.7 0.1 1.8 4.1 3.8 0.9 25.0 2.6 0.5 1.5 0.0 5.7 12.1 4.3 9.8 5.5 10.7 1.9 5.3 81.0 6.7 1.1 97.8 49.2 3.1 29.7 1.9 10.5 5.0 11.4 10.2 19.0 3.2 27.9 12.6 2.5 1.1 1.6 12.4 2.5 12.2 8.0 3.0 3.7 2.2 2.2 2.6 0.5 2.2 14.3 7.9 23.2 2.6 2.3 0.3 3.8 4.6 5.3 31.7 0.8 13.2 1.0 13.7 31.2 19.4 20.0 27.0 23.8 3.0 28.2 20.8 30.6 4.0 42.3 30.2 24.9 11.8 12.0 9.2 10.3 39.9 9.5 15.6 2.4 10.9 10.6 4.2 15.7 3.6 13.1 12.4 11.9 9.9 41.7 52.1 15.7 1.7 110.1 79.0 21.4 13.6 5.2 0.0 0.6 19.9 0.5 8.8 66.1 19.7 163.5 6.9 0.9 22.2 38.7 36.0 165.7 28.8 0.0 20.1 130.8 325.8 11.8 149.0 56.5 6.8 91.0 17.5 3.7 3.3 9.3 205.4 16.3 18.2 142.3 28.8 11.6 19.2 18.6 0.3 117.1 19.5 19.5 FLYWCH2 ENSG00000162076 "FLYWCH family member 2" Q96CP2 16 2883186-2899382 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041354 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041354: AB_10795007" "unprognostic (3.57e-2)" "prognostic favorable (9.38e-4)" "unprognostic (7.33e-2)" "unprognostic (8.53e-3)" "unprognostic (4.40e-1)" "unprognostic (3.81e-2)" "unprognostic (4.83e-3)" "unprognostic (8.35e-3)" "unprognostic (8.92e-2)" "unprognostic (1.62e-1)" "prognostic favorable (1.87e-5)" "unprognostic (5.50e-2)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (2.65e-1)" 19.7 33.9 20.8 13.0 24.6 9.3 14.9 28.5 29.5 15.7 15.0 14.7 19.4 20.8 16.8 13.7 20.8 18.3 22.0 23.8 19.8 27.1 20.2 8.3 15.7 12.6 22.8 16.4 19.5 13.9 17.6 21.7 10.3 22.9 22.4 7.4 22.9 25.4 19.6 34.6 15.9 14.6 13.2 18.2 31.4 17.6 22.3 10.4 19.8 27.0 18.6 17.0 14.2 12.6 15.3 25.3 10.1 18.4 9.8 19.3 12.7 8.7 17.6 7.4 17.3 7.4 10.5 10.7 6.8 5.2 7.4 5.0 8.0 11.0 8.6 26.2 6.3 7.1 5.6 4.0 9.5 1.3 14.4 11.0 9.0 17.2 6.3 20.8 5.4 9.2 14.6 7.3 5.9 3.0 9.2 5.7 15.5 6.5 9.5 5.1 40.9 13.9 23.7 8.0 8.3 18.1 27.1 7.8 18.6 5.2 2.6 11.4 14.8 19.0 20.6 13.7 2.9 24.4 18.0 7.8 12.7 10.3 19.7 6.9 15.6 13.6 11.8 7.4 8.0 9.2 5.6 13.0 10.1 15.1 18.4 16.5 15.3 17.5 14.5 18.4 14.3 19.3 16.5 5.6 9.8 17.8 25.3 16.3 12.7 20.8 24.6 28.5 29.5 19.8 27.1 22.8 16.4 22.9 10.4 11.9 12.8 16.0 36.2 18.1 19.5 13.3 12.7 13.4 7.9 41.8 7.9 17.9 71.3 38.9 8.4 30.8 27.6 0.0 48.7 37.6 34.7 40.7 13.9 5.5 30.2 14.3 32.3 13.5 6.5 8.7 19.5 22.5 40.5 23.4 36.2 46.1 36.0 31.6 23.7 43.4 14.1 32.3 33.0 47.7 38.1 24.8 10.1 21.7 32.4 26.3 FN3KRP "FLJ12171, FN3KL" ENSG00000141560 "Fructosamine 3 kinase related protein" Q9HA64 17 82716683-82730328 "Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cytotrophoblasts: 80.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056172, HPA065831" Approved Approved Nucleoplasm NA NA 14000 Nucleoplasm "HPA056172: AB_2683055, HPA065831: AB_2685565" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (1.54e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (2.31e-1)" "unprognostic (1.25e-2)" "unprognostic (8.67e-2)" "unprognostic (1.26e-1)" "unprognostic (1.99e-1)" "unprognostic (8.84e-2)" "unprognostic (4.32e-3)" "unprognostic (1.60e-2)" "unprognostic (1.31e-1)" "unprognostic (2.23e-2)" "unprognostic (3.97e-2)" "unprognostic (3.71e-2)" 17.6 18.3 27.9 10.8 26.3 12.3 15.7 19.5 27.3 15.3 17.4 27.4 10.0 11.8 18.4 16.7 16.4 16.6 13.0 12.7 26.1 20.8 18.8 23.1 12.8 12.9 25.7 23.0 21.9 15.3 10.8 11.4 17.1 22.2 17.1 14.4 13.2 17.2 20.0 7.3 16.1 13.6 20.3 30.7 13.7 12.6 8.8 21.6 8.2 15.1 9.8 17.5 12.1 12.9 16.5 23.2 18.5 15.5 18.5 23.0 17.1 10.9 44.3 12.1 16.0 5.9 11.3 10.0 20.6 11.5 19.9 16.3 23.4 7.7 9.0 13.8 16.6 18.4 12.6 11.0 15.6 18.0 6.0 19.5 15.1 24.8 26.9 10.5 10.5 8.5 10.4 18.5 18.9 10.4 12.2 14.3 12.8 14.5 5.7 25.4 20.8 20.5 15.6 5.5 24.1 19.3 15.4 30.8 14.0 14.1 21.1 10.1 21.5 34.0 15.4 16.6 21.9 25.7 15.3 12.6 38.7 13.3 27.3 30.3 11.7 12.8 22.4 18.0 13.4 17.8 17.0 14.2 18.5 20.4 15.5 20.0 15.7 19.9 19.5 11.7 16.5 23.0 16.7 2.1 18.5 8.4 23.2 18.6 17.1 27.9 26.3 19.5 27.3 26.1 20.8 25.7 23.0 22.2 21.6 11.9 12.0 13.7 25.9 13.4 17.8 5.2 20.4 10.7 12.5 10.4 7.9 80.4 19.9 17.2 1.3 11.7 9.5 23.3 9.9 35.3 15.1 14.6 12.7 9.0 28.7 3.2 7.5 11.6 9.4 2.3 26.2 11.8 21.9 28.9 13.3 29.2 14.9 17.3 29.7 15.8 14.3 12.9 17.6 9.7 22.6 13.4 52.3 14.9 16.9 21.3 FOS "AP-1, c-fos" ENSG00000170345 "Fos proto-oncogene, AP-1 transcription factor subunit" P01100 14 75278774-75282230 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 84.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 84.5" "Cell line enhanced" "Detected in many" "hTCEpi: 98.8;OE19: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA018531 Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA018531: AB_1846576" "unprognostic (1.18e-2)" "unprognostic (8.70e-2)" "unprognostic (1.61e-1)" "unprognostic (3.80e-1)" "unprognostic (3.08e-2)" "unprognostic (4.82e-2)" "unprognostic (2.09e-1)" "unprognostic (3.30e-1)" "unprognostic (9.55e-3)" "unprognostic (4.20e-3)" "unprognostic (1.04e-1)" "prognostic favorable (7.81e-4)" "unprognostic (3.20e-2)" "unprognostic (1.52e-2)" "unprognostic (3.22e-1)" "unprognostic (1.43e-1)" "unprognostic (2.66e-2)" 104.8 58.4 17.0 143.7 30.0 157.6 40.7 24.0 21.3 132.3 48.7 52.3 22.1 17.4 79.7 50.5 93.6 239.5 271.8 56.8 17.5 21.4 22.7 47.9 70.7 31.0 23.9 10.6 94.5 32.7 40.9 52.9 130.2 44.6 60.6 49.3 64.4 42.8 255.8 37.5 156.2 44.1 98.1 43.7 18.5 60.7 33.2 26.8 10.1 77.5 226.7 28.1 60.8 54.0 0.0 11.6 84.5 12.3 0.7 0.1 3.3 0.4 0.3 1.5 2.2 13.2 4.0 9.1 1.3 0.5 0.9 0.7 0.9 2.6 0.1 0.4 9.2 9.2 0.6 0.7 15.9 0.2 0.2 0.2 0.2 3.8 0.3 6.1 0.5 9.3 9.9 98.8 0.8 6.0 1.3 0.5 1.9 0.4 4.2 0.2 5.4 0.1 2.6 1.6 35.5 0.5 0.4 0.3 4.8 4.1 4.3 11.4 0.7 2.0 18.3 7.8 4.9 0.3 1.9 1.3 0.1 1.2 0.8 0.4 11.4 11.9 2.0 0.6 1.6 1.2 6.0 12.3 14.6 0.0 3.5 0.0 0.0 0.0 0.1 11.6 0.0 0.0 0.0 84.5 0.7 0.4 0.2 0.0 3.3 17.0 30.0 24.0 21.3 17.5 21.4 23.9 10.6 44.6 26.8 1024.3 2295.6 355.2 364.1 763.7 85.4 943.0 545.2 294.5 662.0 181.5 121.7 1104.1 14.9 389.9 11.8 1089.3 1251.6 70.0 471.9 2288.8 1942.6 1138.8 1518.7 136.0 1546.5 33.4 1566.3 439.5 1852.6 21.7 873.9 1719.6 811.4 159.7 1650.2 515.9 381.7 1444.9 167.6 15.8 410.8 1190.0 1600.6 4.1 8.0 954.8 1909.4 705.6 1252.5 275.6 FOSL1 fra-1 ENSG00000175592 "FOS like 1, AP-1 transcription factor subunit" P15407 11 65892049-65900573 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.2;tongue: 46.8" "Group enriched" "Detected in many" 7 "Basal glandular cells: 279.5;Basal keratinocytes: 300.3;Glandular cells: 139.2;Suprabasal keratinocytes: 296.9;Urothelial cells: 386.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "myeloid DC: 6.9" "Lineage enriched" "Detected in many" 4 "dendritic cells: 6.9" "Cell line enhanced" "Detected in many" "PC-3: 94.2;U-2197: 63.2;WM-115: 142.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004396, HPA030728" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB004396: AB_627632, HPA030728: " "unprognostic (2.88e-2)" "unprognostic (1.56e-1)" "unprognostic (9.46e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.80e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (9.26e-5)" "unprognostic (7.85e-2)" "prognostic unfavorable (6.40e-6)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (2.28e-1)" "unprognostic (2.82e-2)" 22.4 3.7 1.5 8.2 3.1 17.9 3.6 1.1 2.8 5.4 2.8 1.5 0.2 0.8 2.1 2.0 35.2 4.4 24.4 5.8 2.3 1.3 2.2 4.4 7.7 1.7 2.6 0.5 2.6 9.9 0.4 2.0 3.2 6.5 3.1 1.7 0.6 5.4 1.0 6.6 9.2 2.0 3.6 3.5 1.6 8.7 1.5 2.3 0.3 2.1 46.8 16.5 16.6 4.6 0.0 6.9 1.0 1.6 0.0 0.6 1.1 36.6 5.4 0.6 2.4 5.5 5.5 5.3 34.3 31.5 29.7 16.7 1.7 30.5 0.0 7.5 23.7 46.9 6.9 2.2 27.6 25.5 1.1 0.0 2.2 0.5 4.0 6.9 1.4 0.8 2.3 2.8 23.3 35.2 14.5 9.5 0.0 5.3 0.2 38.9 1.5 0.0 3.0 2.5 3.1 94.2 0.1 3.0 0.1 13.8 2.4 0.0 0.0 2.0 0.0 25.7 1.6 0.1 1.3 23.7 35.2 7.2 63.2 50.2 0.0 0.1 0.1 49.5 0.6 142.9 0.0 1.6 0.0 0.3 1.1 0.2 0.0 0.6 0.3 6.9 0.0 0.6 0.0 1.0 0.0 0.5 0.8 0.0 1.1 1.5 3.1 1.1 2.7 2.3 1.3 2.6 0.5 6.5 2.3 6.0 4.1 0.0 279.5 300.3 0.0 0.6 0.0 9.4 19.4 0.0 0.0 1.1 0.0 14.2 0.1 11.3 2.8 0.0 3.1 3.8 23.0 139.2 9.2 0.0 1.8 0.0 10.9 8.0 0.6 0.0 0.3 9.0 42.2 1.8 1.2 0.0 23.7 0.2 0.0 0.0 0.0 0.0 40.8 0.2 0.7 296.9 14.8 0.0 0.7 386.7 FOSL2 "FLJ23306, FRA2" ENSG00000075426 "FOS like 2, AP-1 transcription factor subunit" P15408 2 28392448-28417312 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 255.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 23.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004817, CAB013460, HPA061417" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013460: , HPA004817: AB_1849014, HPA061417: AB_2684509" "unprognostic (1.21e-1)" "unprognostic (3.60e-1)" "unprognostic (1.21e-1)" "unprognostic (8.55e-2)" "unprognostic (1.28e-3)" "unprognostic (3.41e-2)" "unprognostic (7.24e-2)" "unprognostic (3.78e-3)" "unprognostic (1.08e-1)" "unprognostic (7.73e-3)" "unprognostic (1.40e-2)" "unprognostic (2.08e-1)" "unprognostic (2.38e-1)" "unprognostic (2.38e-1)" "unprognostic (1.72e-2)" "unprognostic (1.99e-2)" "unprognostic (2.79e-2)" 62.8 66.9 7.3 24.6 11.2 74.5 22.5 5.4 11.9 34.4 35.4 7.0 15.0 11.4 43.8 16.3 49.6 26.6 42.0 30.3 12.0 4.7 17.2 12.6 32.2 4.4 10.2 3.6 62.0 14.1 4.1 14.2 20.8 15.9 36.4 15.9 11.4 16.2 22.1 56.3 31.1 37.2 40.8 20.0 20.4 25.4 13.8 8.0 2.1 13.6 16.2 14.5 47.1 79.7 0.0 2.5 23.0 6.2 2.7 5.1 2.8 12.5 8.6 0.5 6.7 7.1 12.6 18.2 10.8 11.0 17.3 15.1 10.2 10.0 0.0 15.9 13.8 17.6 12.1 0.7 14.2 15.6 2.9 0.9 1.3 16.1 1.7 11.2 2.2 5.5 20.0 36.4 20.2 17.9 14.6 9.0 0.4 0.1 3.6 11.5 2.0 0.2 6.8 1.0 12.8 4.3 0.5 16.8 1.2 27.7 43.6 4.6 0.6 17.5 10.3 3.1 5.2 1.1 10.1 26.9 36.4 24.6 21.1 15.6 5.6 2.0 0.0 24.1 12.3 6.2 8.8 6.2 5.4 5.1 4.7 5.0 0.0 1.1 2.5 2.5 0.0 0.3 1.7 23.0 2.7 3.8 0.8 0.7 2.8 7.3 11.2 5.4 11.9 12.0 4.7 10.2 3.6 15.9 8.0 29.8 69.6 2.4 72.6 127.2 0.5 23.8 50.9 13.4 25.0 158.7 0.0 19.1 16.6 56.4 1.1 60.9 113.3 0.0 51.5 108.4 60.6 59.1 105.2 12.4 34.3 0.0 26.9 49.7 65.1 2.2 20.8 81.0 81.0 38.7 56.3 0.5 55.4 66.6 23.0 25.4 1.0 25.8 255.1 1.7 2.5 131.7 42.0 34.6 44.8 118.3 FOXA3 HNF3G ENSG00000170608 "Forkhead box A3" P55318 19 45863989-45873797 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 36.7;pancreas: 63.3" "Cell type enhanced" "Detected in many" 19 "Intestinal endocrine cells: 79.9;Mucus-secreting cells: 184.0;Paneth cells: 49.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 10 "T-cells: 3.2" "Cell line enhanced" "Detected in some" "HDLM-2: 5.5;Hep G2: 12.9;K-562: 10.3;OE19: 45.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB015154, HPA054034" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB015154: AB_647545, HPA054034: AB_2682349" "unprognostic (2.88e-1)" "unprognostic (6.95e-2)" "unprognostic (2.37e-1)" "unprognostic (2.34e-1)" "unprognostic (1.07e-1)" "unprognostic (2.27e-1)" "unprognostic (2.39e-2)" "unprognostic (1.42e-1)" "unprognostic (6.87e-3)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (1.17e-2)" "unprognostic (2.57e-2)" "unprognostic (1.91e-2)" "unprognostic (3.55e-1)" "unprognostic (3.75e-1)" "unprognostic (2.11e-1)" 0.3 0.0 0.2 5.9 0.2 0.0 0.1 0.1 0.3 0.5 9.7 0.3 0.7 4.7 0.2 0.1 0.2 0.1 13.7 0.5 0.1 0.0 0.9 36.7 0.6 0.1 0.1 0.1 0.1 63.3 0.7 0.1 0.1 0.2 0.3 8.0 0.1 1.0 0.8 0.1 0.1 9.0 0.1 0.1 0.1 17.1 0.7 0.3 0.2 0.1 0.5 0.7 0.1 0.1 0.3 0.0 0.0 0.0 0.0 3.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.7 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.5 0.5 0.1 0.0 12.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 10.3 0.0 0.0 0.1 0.0 0.0 5.2 45.3 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.0 0.0 0.7 3.2 0.0 0.3 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.2 0.3 0.0 4.5 1.4 0.5 0.2 0.0 0.4 10.2 0.0 0.0 1.8 0.0 0.0 0.0 9.7 0.1 0.6 22.2 0.0 21.3 0.0 0.1 6.3 4.6 31.7 0.0 0.0 79.9 0.6 2.1 0.0 0.0 0.0 1.7 0.0 184.0 0.0 26.3 49.1 0.0 0.2 0.0 0.0 0.5 2.3 6.4 0.3 0.0 0.0 36.6 0.9 FOXD4 "FKHL9, FOXD4a, FREAC5" ENSG00000170122 "Forkhead box D4" Q12950 9 116231-118204 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.7;testis: 3.1" "Cell type enriched" "Detected in single" 7 "monocytes: 4.6" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "THP-1: 8.9" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (8.27e-2)" "unprognostic (1.09e-2)" "unprognostic (2.38e-3)" "unprognostic (4.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-3)" "unprognostic (1.22e-1)" "unprognostic (4.20e-2)" "unprognostic (9.46e-2)" "unprognostic (2.52e-4)" "unprognostic (3.66e-4)" "unprognostic (7.06e-3)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "unprognostic (6.26e-2)" "unprognostic (1.02e-3)" 0.6 0.6 1.2 0.5 1.4 0.1 0.1 5.7 1.5 0.4 0.2 0.4 0.7 0.1 0.1 0.3 0.1 0.2 1.3 1.5 1.6 0.2 0.6 0.7 0.8 0.3 0.5 0.2 0.7 0.6 0.7 0.3 0.3 0.5 1.4 0.3 0.6 0.4 0.4 1.0 0.6 3.1 0.2 0.2 0.2 0.1 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.6 0.5 0.0 0.4 0.8 0.4 3.7 0.2 0.4 0.0 0.3 1.0 0.2 3.7 0.6 0.0 0.1 0.0 0.9 0.2 0.3 3.6 3.0 0.0 0.5 0.3 0.2 2.6 1.9 0.5 0.0 0.0 0.1 0.6 0.0 0.2 1.2 1.6 0.1 1.4 0.3 2.1 0.1 0.5 1.8 0.3 0.8 0.5 0.9 1.9 1.8 1.4 1.0 0.6 0.0 0.3 0.9 8.9 0.5 1.1 1.1 0.7 1.3 0.1 0.4 0.8 0.8 2.0 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 FOXD4L1 FOXD5 ENSG00000184492 "Forkhead box D4 like 1" Q9NU39 2 113498665-113501155 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.2;bone marrow: 3.0;brain: 3.3;lymphoid tissue: 1.2;testis: 3.1" "Cell type enriched" "Detected in single" 134 "monocytes: 54.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 22 "naive B-cell: 2.2" "Lineage enriched" "Detected in single" 22 "B-cells: 2.2" "Cell line enhanced" "Detected in some" "RH-30: 5.3;THP-1: 3.7" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" "unprognostic (3.02e-2)" "unprognostic (6.61e-2)" "unprognostic (3.22e-1)" "unprognostic (6.41e-4)" "unprognostic (2.54e-1)" "unprognostic (5.77e-3)" "unprognostic (5.93e-2)" "unprognostic (4.21e-2)" "unprognostic (9.54e-4)" "unprognostic (3.98e-2)" "unprognostic (1.18e-8)" "unprognostic (1.57e-2)" "unprognostic (4.14e-2)" "unprognostic (9.57e-2)" "unprognostic (5.91e-4)" 0.2 0.5 0.4 1.2 1.2 3.0 0.1 3.3 0.8 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.6 0.6 0.4 0.1 0.4 0.4 0.3 0.0 0.2 0.0 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.2 3.1 0.2 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.6 0.7 1.1 0.0 1.5 0.0 0.6 0.0 0.1 0.3 0.0 2.0 0.9 0.1 0.2 0.1 0.6 0.0 0.1 1.9 1.4 0.8 1.0 1.0 0.0 2.1 1.6 0.0 0.7 0.2 0.0 0.8 0.0 0.9 1.2 1.7 0.3 0.1 0.3 0.9 0.0 0.2 0.7 0.6 5.3 0.7 0.1 0.6 0.7 0.4 0.5 0.1 0.3 0.0 0.4 3.7 0.4 1.7 1.5 0.6 1.3 1.4 1.4 0.7 0.3 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FOXD4L3 FOXD6 ENSG00000187559 "Forkhead box D4 like 3" Q6VB84 9 68302867-68304905 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.6;fallopian tube: 2.4;lymphoid tissue: 2.0" "Cell type enriched" "Detected in single" 12 "monocytes: 1.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 7 "B-cells: 1.0" "Cell line enhanced" "Detected in some" "HDLM-2: 1.7;NB-4: 1.2;THP-1: 1.9" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (7.93e-4)" "unprognostic (8.71e-2)" "unprognostic (7.04e-2)" "unprognostic (4.75e-2)" 0.0 0.1 0.7 1.4 1.3 0.0 0.0 2.1 2.3 0.3 0.1 0.0 0.0 0.0 0.0 2.4 0.4 0.0 2.6 0.7 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 2.0 0.0 0.9 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.3 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.4 0.0 0.9 0.1 0.1 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.2 0.5 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.6 0.1 0.8 0.5 0.4 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L4 "bA460E7.2, FOXD4L2" ENSG00000184659 "Forkhead box D4 like 4" Q8WXT5 9 65736555-65738784 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.4" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (6.92e-2)" "unprognostic (5.48e-2)" "unprognostic (5.19e-2)" "unprognostic (7.78e-2)" "unprognostic (7.93e-3)" "unprognostic (7.14e-2)" 0.4 0.6 0.3 1.0 1.2 0.0 0.2 1.5 1.3 0.7 0.2 0.0 0.2 0.0 0.2 0.2 0.1 0.4 1.0 0.7 0.2 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.2 0.2 0.2 0.1 0.4 0.1 0.4 0.0 0.4 0.1 0.2 0.5 0.1 0.5 0.0 0.2 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.5 1.4 0.0 0.2 0.3 0.7 0.0 0.0 0.2 1.0 0.0 0.5 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.2 1.1 0.2 0.5 0.0 0.2 0.2 0.7 0.3 0.2 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.5 0.2 0.7 0.0 0.1 0.3 0.2 0.0 0.0 0.3 0.8 1.0 0.4 0.0 0.1 0.2 0.7 0.0 0.1 0.5 0.0 0.4 1.0 0.5 0.7 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L5 bA15J10.2 ENSG00000204779 "Forkhead box D4 like 5" Q5VV16 9 65282101-65285209 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (8.26e-2)" "unprognostic (6.95e-3)" "unprognostic (1.58e-1)" "unprognostic (5.76e-2)" "unprognostic (2.57e-1)" 0.7 1.1 0.3 0.1 0.5 0.0 0.7 0.6 2.2 0.3 0.1 0.1 0.1 1.1 0.4 0.7 0.1 0.2 1.0 0.5 0.5 0.2 0.3 0.2 0.3 0.2 0.2 0.0 0.2 0.5 0.3 0.0 1.2 0.1 0.5 2.0 0.3 0.0 0.2 0.2 0.4 1.0 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.2 1.1 0.7 2.8 0.5 0.3 3.5 0.6 0.2 0.0 0.0 0.7 0.3 2.0 0.4 0.2 0.3 0.0 1.5 0.2 0.2 2.8 1.7 1.8 0.8 0.9 0.0 1.5 2.7 0.2 0.8 0.2 0.6 1.0 0.0 0.2 2.7 1.1 0.3 0.6 0.3 1.0 0.8 0.3 0.9 0.6 2.2 0.7 0.7 1.4 1.4 2.6 0.6 0.3 0.2 1.8 0.9 3.5 0.4 0.4 2.1 1.2 1.1 0.8 1.7 0.5 0.3 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L6 ENSG00000273514 "Forkhead box D4 like 6" Q3SYB3 9 41126430-41128463 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 1.8;lymphoid tissue: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.8" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (2.41e-1)" "unprognostic (3.41e-1)" "unprognostic (3.61e-1)" 0.0 0.0 1.5 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.7 0.2 0.0 0.5 1.0 0.0 0.1 0.1 0.2 0.0 0.0 0.7 0.1 0.0 0.1 0.1 1.0 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.0 0.3 0.0 0.0 0.1 0.6 0.4 0.6 0.2 0.6 0.5 0.3 0.3 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.7 0.3 0.0 0.8 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXF1 "FKHL5, FREAC1" ENSG00000103241 "Forkhead box F1" Q12946 16 86510527-86515418 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 54.7;urinary bladder: 48.5" "Cell type enhanced" "Detected in some" 22 "Endothelial cells: 4.7;Fibroblasts: 7.2;Ito cells: 4.9;Smooth muscle cells: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BJ: 9.4;BJ hTERT+: 20.7;HHSteC: 20.3;U-2197: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA028886 Approved Nucleoplasm NA NA Nucleoplasm "HPA028886: AB_10601652" "unprognostic (7.91e-2)" "unprognostic (3.02e-3)" "unprognostic (1.23e-1)" "unprognostic (4.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.62e-3)" "unprognostic (2.37e-2)" "unprognostic (1.08e-1)" "unprognostic (8.22e-2)" "unprognostic (6.07e-3)" "unprognostic (1.06e-1)" "unprognostic (1.91e-2)" "unprognostic (1.29e-2)" "unprognostic (4.89e-2)" "unprognostic (4.20e-2)" "unprognostic (7.11e-2)" "unprognostic (2.44e-1)" 2.2 0.3 2.5 15.4 2.9 0.0 0.8 2.3 4.2 7.9 34.6 1.3 1.6 7.2 2.1 0.9 17.9 1.2 39.7 0.6 3.4 1.9 1.2 2.4 33.1 2.4 3.5 1.0 0.6 0.9 1.1 0.4 18.5 3.5 35.7 9.2 0.5 0.9 4.8 0.3 0.4 18.4 54.7 3.0 0.5 18.4 0.6 3.7 0.0 3.6 2.6 3.3 48.5 25.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 20.7 2.9 1.0 0.0 0.1 0.0 0.0 0.8 2.0 0.0 1.6 0.0 2.5 0.0 1.1 0.0 1.5 0.0 20.3 0.0 1.7 2.1 0.0 3.3 0.4 0.3 3.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 3.1 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 8.9 0.0 0.0 0.0 0.0 1.9 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.5 2.9 2.3 4.2 3.4 1.9 3.5 1.0 3.5 3.7 0.0 1.1 0.0 0.2 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 4.7 0.0 0.0 0.0 0.3 7.2 0.7 0.0 0.0 0.3 0.0 0.0 4.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 19.6 0.0 0.4 0.3 1.0 0.0 0.0 0.2 FOXO3 "AF6q21, FKHRL1, FOXO2, FOXO3A" ENSG00000118689 "Forkhead box O3" O43524 6 108559835-108684774 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Erythroid cells: 210.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004074, HPA063104" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004074: AB_2106672, HPA063104: AB_2684941" "unprognostic (3.42e-2)" "unprognostic (3.76e-2)" "unprognostic (4.28e-2)" "unprognostic (1.96e-2)" "unprognostic (6.68e-2)" "unprognostic (4.63e-2)" "unprognostic (4.08e-3)" "unprognostic (1.73e-1)" "unprognostic (3.81e-2)" "unprognostic (5.18e-2)" "unprognostic (1.98e-2)" "unprognostic (1.75e-1)" "unprognostic (2.54e-2)" "unprognostic (9.09e-2)" "unprognostic (1.13e-1)" "unprognostic (5.81e-2)" "unprognostic (5.68e-2)" 29.6 7.7 11.5 12.2 12.6 36.7 35.4 28.0 18.1 19.9 16.1 12.6 9.8 7.8 17.4 16.1 22.3 16.5 18.0 12.9 9.7 7.7 10.7 14.0 21.1 16.8 12.4 14.0 28.8 52.3 14.3 8.8 13.1 10.3 13.8 11.0 14.3 21.2 10.5 54.7 20.3 11.3 13.9 7.9 14.2 14.8 13.1 13.2 11.6 13.1 12.7 10.2 17.1 20.3 1.8 2.7 15.7 4.6 3.4 4.0 1.0 9.1 3.3 6.0 9.7 18.6 22.3 7.5 7.6 8.0 6.7 9.2 5.9 8.3 5.9 6.5 8.9 9.8 6.7 6.2 9.3 10.0 5.3 9.0 14.7 2.9 4.4 21.7 3.5 10.8 25.4 18.8 13.7 18.8 9.3 5.0 5.4 9.8 40.1 12.1 5.2 4.9 5.4 3.9 4.4 5.0 5.7 17.1 19.7 13.3 7.0 10.6 27.6 6.5 5.3 7.6 11.0 5.8 11.7 8.0 11.4 6.4 7.0 9.8 0.7 6.9 5.6 6.2 7.1 7.8 6.7 2.9 5.7 3.6 1.5 4.0 1.0 1.9 3.0 1.7 1.8 1.7 2.3 15.7 3.4 4.6 2.7 1.8 1.0 11.5 12.6 28.0 18.1 9.7 7.7 12.4 14.0 10.3 13.2 41.7 39.5 22.4 61.6 60.1 55.0 28.2 73.9 44.2 46.6 24.4 66.8 19.2 14.9 43.0 12.5 63.2 36.2 210.2 26.5 31.0 67.9 115.8 15.0 60.6 39.1 49.3 64.2 66.9 66.3 12.1 98.7 35.8 54.0 43.3 49.3 89.6 53.0 33.6 94.4 15.9 67.1 32.3 89.8 7.2 18.1 40.7 34.4 35.5 29.9 108.9 FOXP1 "12CC4, hFKH1B, HSPC215, QRF1" ENSG00000114861 "Forkhead box P1" Q9H334 3 70952817-71583993 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 40.2" "HPA003876, CAB011501" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB011501: AB_732428, HPA003876: AB_1078907" "unprognostic (2.31e-1)" "unprognostic (4.35e-3)" "unprognostic (2.09e-2)" "unprognostic (3.54e-2)" "unprognostic (2.69e-1)" "unprognostic (2.81e-3)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (1.23e-1)" "unprognostic (2.03e-1)" "unprognostic (4.38e-3)" "unprognostic (3.40e-1)" "unprognostic (6.14e-2)" "unprognostic (1.05e-1)" "unprognostic (8.65e-2)" "unprognostic (1.27e-1)" "unprognostic (6.05e-2)" 24.6 5.1 7.0 30.2 19.2 32.7 21.9 7.2 13.1 16.3 29.3 8.7 10.3 10.1 19.8 9.9 19.6 13.1 19.3 15.5 8.4 5.9 7.6 12.9 26.1 34.0 7.6 10.2 30.3 14.7 7.2 25.7 11.4 7.4 21.6 21.6 11.3 24.6 11.2 12.7 12.2 16.7 34.3 7.9 18.6 20.4 11.7 10.1 38.1 19.8 13.1 27.0 28.5 31.8 29.9 8.4 14.4 9.9 9.2 29.6 11.2 3.8 2.9 7.1 4.8 3.3 9.6 3.4 11.4 13.1 10.0 7.3 21.3 4.5 10.3 1.7 5.1 7.2 2.6 13.1 9.8 16.9 3.1 5.4 5.3 7.1 20.0 8.3 9.9 13.1 9.8 4.0 40.2 17.8 7.0 14.9 6.1 5.3 15.1 4.5 16.8 4.9 3.9 8.7 2.7 18.6 14.9 12.3 1.8 8.2 12.1 6.0 10.9 11.9 3.3 0.7 7.1 2.3 7.3 18.8 13.9 6.0 19.3 15.7 3.8 2.8 14.6 8.8 12.7 2.9 14.4 5.7 6.0 8.3 5.7 9.3 25.8 18.3 10.3 5.3 29.9 29.6 18.9 8.3 9.2 9.9 8.4 15.9 11.2 7.0 19.2 7.2 13.1 8.4 5.9 7.6 10.2 7.4 10.1 68.5 106.7 181.2 154.9 162.6 27.9 38.3 114.7 87.0 93.3 31.4 17.7 37.3 26.6 65.8 141.2 159.5 75.9 70.0 81.8 13.6 54.0 219.0 213.7 53.9 43.0 6.4 260.7 120.9 97.8 57.5 38.9 86.3 35.4 111.0 226.3 20.3 98.8 101.7 23.3 15.6 38.0 90.5 74.6 10.8 6.4 88.7 43.8 126.3 146.7 116.8 FOXP2 "CAGH44, SPCH1, TNRC10" ENSG00000128573 "Forkhead box P2" O15409 7 114086327-114693772 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 48.4;urinary bladder: 31.5" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 27.2;Muller glia cells: 42.1;Suprabasal keratinocytes: 22.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 15.0;RH-30: 27.6;THP-1: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000382, HPA000383, HPA001679" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000382: AB_1078908, HPA000383: AB_1078909, HPA001679: AB_2666415" "unprognostic (1.21e-1)" "unprognostic (7.85e-2)" "unprognostic (4.89e-2)" "unprognostic (8.83e-3)" "unprognostic (4.66e-1)" "unprognostic (3.69e-4)" "unprognostic (2.04e-2)" "unprognostic (6.22e-2)" "unprognostic (2.17e-1)" "unprognostic (6.70e-3)" "unprognostic (1.22e-1)" "unprognostic (1.77e-1)" "unprognostic (8.04e-2)" "unprognostic (4.16e-3)" "unprognostic (2.84e-1)" "unprognostic (9.81e-2)" "unprognostic (4.19e-2)" 1.7 1.5 0.9 9.4 2.9 0.0 2.0 0.6 2.8 9.4 20.4 0.7 3.6 2.7 18.1 2.1 12.4 3.5 7.7 1.2 0.7 2.9 1.5 2.9 1.4 0.6 2.0 1.0 11.1 4.5 0.0 0.9 0.7 1.8 13.3 5.7 1.4 2.8 1.5 4.6 3.3 4.2 48.4 0.9 0.6 4.6 0.9 0.9 0.6 5.3 3.2 1.2 31.5 5.4 9.4 16.5 11.1 7.2 6.3 10.3 16.3 0.2 2.2 15.0 0.0 3.5 4.7 0.9 2.4 2.6 0.5 0.3 1.0 0.2 0.2 0.6 0.8 0.1 0.3 0.6 0.0 0.1 0.1 5.1 5.6 3.4 4.6 0.0 0.3 0.3 1.2 0.6 0.0 0.0 0.9 0.6 0.0 1.2 2.1 0.5 1.1 1.2 0.8 0.8 0.2 0.7 0.4 27.6 5.3 0.3 6.0 3.9 1.6 0.0 0.9 0.7 1.0 0.7 8.2 1.1 1.0 0.4 1.4 0.4 5.4 0.4 0.6 1.1 0.5 0.4 7.5 5.2 11.1 6.2 7.2 6.3 9.4 7.0 6.8 6.8 7.3 7.2 8.1 5.6 6.3 5.9 16.5 10.3 16.3 0.9 2.9 0.6 2.7 0.7 2.9 2.0 1.0 1.8 0.9 0.0 5.1 0.0 1.7 27.2 0.0 1.4 7.6 12.0 7.9 3.5 2.0 0.1 0.0 0.0 8.1 2.2 4.3 0.0 4.8 0.0 7.2 3.1 0.0 10.6 0.2 12.7 4.1 9.8 1.9 4.5 4.9 0.7 3.3 0.0 11.9 42.1 2.0 16.1 0.7 2.2 1.0 0.0 1.0 0.1 0.2 22.3 0.2 0.0 12.1 2.4 FOXP3 "AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID" ENSG00000049768 "Forkhead box P3" Q9BZS1 X 49250436-49264826 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.9;lymphoid tissue: 23.3" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 1.1;granulocytes: 1.1;Horizontal cells: 3.2;Melanocytes: 1.7;T-cells: 2.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 11 "T-reg: 25.9" "Lineage enriched" "Detected in single" 260 "T-cells: 25.9" "Cell line enhanced" "Detected in some" "MCF7: 8.3;SiHa: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026301, HPA045943" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB026301: , HPA045943: AB_2679508" "unprognostic (2.46e-2)" "prognostic favorable (1.91e-4)" "unprognostic (4.95e-3)" "prognostic favorable (7.02e-4)" "unprognostic (2.55e-4)" "prognostic favorable (4.90e-4)" "unprognostic (2.42e-2)" "unprognostic (3.46e-1)" "unprognostic (1.04e-2)" "unprognostic (1.99e-3)" "unprognostic (8.77e-3)" "unprognostic (1.94e-1)" "unprognostic (2.73e-14)" "unprognostic (5.93e-2)" "unprognostic (4.55e-2)" "unprognostic (1.98e-1)" "unprognostic (1.39e-1)" 0.4 0.4 1.4 20.2 1.3 1.4 0.6 2.2 1.2 0.7 0.8 0.5 1.0 0.6 1.1 7.2 2.6 0.3 3.3 0.4 1.3 1.0 1.1 4.7 1.9 23.3 0.9 0.4 0.6 0.4 0.1 1.2 0.4 0.4 0.9 0.6 0.6 4.0 0.6 0.4 2.5 4.0 0.4 0.7 4.7 1.8 2.7 0.4 23.3 0.8 1.8 20.6 4.9 0.6 0.0 0.0 0.0 0.0 0.0 25.9 0.4 0.3 0.5 0.5 1.2 0.3 0.0 1.5 0.4 0.0 0.4 0.1 0.4 0.3 0.9 0.4 0.4 0.6 0.4 1.0 0.0 0.3 3.1 0.5 0.4 0.6 0.1 0.7 0.7 0.9 0.3 0.5 0.7 0.8 0.0 0.0 1.6 1.5 0.9 0.1 8.3 0.3 0.6 1.3 0.3 0.8 0.6 0.3 0.6 0.4 0.5 0.7 0.4 4.9 0.5 3.0 0.7 1.8 0.7 0.1 0.1 1.6 0.8 0.2 0.9 1.6 1.0 0.5 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 25.9 0.4 1.4 1.3 2.2 1.2 1.3 1.0 0.9 0.4 0.4 0.4 0.0 1.1 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 0.0 2.5 0.0 0.0 FOXQ1 HFH1 ENSG00000164379 "Forkhead box Q1" Q9C009 6 1312440-1314748 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 65.5;vagina: 39.9" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 53.7;Collecting duct cells: 38.4;Suprabasal keratinocytes: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 14.0;HaCaT: 16.4;Hep G2: 34.5;OE19: 46.8;RT4: 14.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA059700 Supported Nucleoplasm Yes NA Nucleoplasm "HPA059700: AB_2684107" "unprognostic (2.04e-3)" "unprognostic (3.44e-1)" "unprognostic (1.10e-1)" "unprognostic (7.18e-2)" "unprognostic (1.50e-3)" "unprognostic (2.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.15e-3)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "unprognostic (7.65e-3)" "prognostic favorable (6.68e-4)" "unprognostic (1.49e-2)" "unprognostic (3.16e-3)" "unprognostic (2.82e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-2)" 0.6 0.5 2.3 0.6 4.0 0.5 1.4 1.6 5.9 7.1 1.9 3.2 0.0 6.9 1.1 0.7 7.2 3.2 31.8 0.5 2.2 1.9 7.1 3.6 5.8 0.5 2.7 1.5 0.5 10.1 0.5 1.8 1.2 3.8 18.2 0.8 7.5 35.8 1.3 0.6 16.8 0.8 6.6 1.9 0.5 65.5 0.6 0.8 0.8 3.1 7.8 11.7 26.3 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 5.6 0.0 0.0 14.0 8.5 0.0 0.2 0.0 0.0 16.4 0.0 0.7 0.0 0.0 0.4 0.0 3.0 34.5 0.0 0.0 0.9 0.0 6.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.2 0.0 0.0 0.0 0.1 14.5 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 4.0 1.6 5.9 2.2 1.9 2.7 1.5 3.8 0.8 14.9 8.8 0.0 2.1 53.7 0.0 0.8 0.0 2.7 13.6 38.4 0.0 0.0 1.7 2.4 0.0 0.0 0.0 0.0 12.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.0 0.0 6.9 0.0 0.0 3.7 0.0 0.0 0.5 0.0 0.0 39.6 0.0 0.0 0.0 3.1 FOXR2 "FOXN6, MGC21658" ENSG00000189299 "Forkhead box R2" Q6PJQ5 X 55623400-55625325 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 6.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 117 "NTERA-2: 11.7;SH-SY5Y: 10.3;U-266/70: 6.8;U-266/84: 17.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA034487, HPA057358" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA034487: AB_10795354, HPA057358: AB_2683418" "unprognostic (3.81e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 FRS3 "FRS2B, FRS2beta, SNT-2" ENSG00000137218 "Fibroblast growth factor receptor substrate 3" O43559 6 41770176-41786542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 12.7;Spermatocytes: 8.6;Spermatogonia: 10.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030162, HPA030174" Enhanced Uncertain Nucleoplasm NA NA Nucleoplasm "HPA030162: AB_10599976, HPA030174: AB_10602093" "unprognostic (2.52e-2)" "unprognostic (1.31e-1)" "unprognostic (4.30e-2)" "unprognostic (8.91e-2)" "unprognostic (8.13e-2)" "unprognostic (1.67e-2)" "unprognostic (3.79e-2)" "unprognostic (8.47e-3)" "unprognostic (2.96e-1)" "unprognostic (1.83e-1)" "prognostic favorable (3.87e-4)" "unprognostic (4.23e-2)" "unprognostic (3.29e-3)" "unprognostic (2.96e-2)" "unprognostic (8.48e-2)" "unprognostic (5.10e-2)" "unprognostic (3.29e-3)" 6.4 7.0 12.1 4.5 13.6 4.2 3.7 20.4 22.2 4.4 5.1 9.1 2.7 5.4 7.1 3.6 5.4 6.9 5.1 8.2 12.3 15.2 4.0 3.1 5.6 6.0 12.2 12.9 7.5 5.9 4.9 4.9 5.2 13.1 5.5 3.4 5.3 8.1 9.3 13.3 2.5 5.3 5.0 8.0 6.4 5.3 18.5 7.0 3.4 7.4 1.7 3.5 4.7 5.0 1.0 1.7 2.3 1.7 1.4 1.4 0.3 3.1 2.7 4.5 6.3 3.7 4.0 9.5 3.4 4.9 4.0 4.1 3.6 1.9 5.4 3.8 2.9 5.3 2.1 2.9 3.6 3.4 5.5 2.8 3.3 5.0 5.7 4.6 2.7 4.9 3.9 4.3 3.9 3.6 5.3 4.2 13.1 3.6 4.5 3.5 5.1 7.9 6.0 2.3 6.9 2.7 7.5 4.1 3.8 3.5 6.0 6.6 9.9 2.4 3.4 6.9 3.5 4.2 5.4 3.6 7.1 7.5 4.6 3.4 8.0 6.5 8.8 1.9 4.6 2.1 0.0 1.7 2.3 0.9 0.5 0.9 0.3 1.4 0.6 1.1 1.0 0.7 0.3 0.3 1.4 0.4 1.7 0.6 0.3 12.1 13.6 20.4 22.2 12.3 15.2 12.2 12.9 13.1 7.0 0.0 3.0 0.9 1.0 0.9 5.8 2.4 12.7 1.4 1.2 0.0 0.0 1.5 0.0 1.5 0.5 2.8 0.4 0.0 1.2 0.8 1.9 0.9 0.0 0.8 1.7 4.8 1.7 1.3 1.3 0.0 2.3 1.3 3.3 0.0 1.6 2.7 1.0 1.5 4.2 0.5 4.0 0.0 1.2 8.6 10.1 0.5 0.5 0.0 1.4 1.3 FSBP ENSG00000265817 "Fibrinogen silencer binding protein" O95073 8 94372170-94436952 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 3.0;Club cells: 1.2;Ito cells: 1.8;Rod photoreceptor cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.3;naive CD4 T-cell: 3.7" "Lineage enriched" "Detected in single" 22 "T-cells: 5.3" "Cell line enhanced" "Detected in many" "AF22: 10.5;hTERT-HME1: 11.0;SK-MEL-30: 10.5" "HPA025059, HPA026509" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA025059: AB_2671718, HPA026509: AB_10602307" 2.2 3.7 3.4 1.6 5.6 2.1 4.1 7.1 7.6 6.7 2.0 2.7 11.0 1.5 3.7 9.6 4.3 14.1 3.1 4.6 3.0 2.4 5.1 4.2 2.6 1.8 3.4 3.6 7.7 4.3 3.2 23.7 2.9 6.4 5.3 2.4 16.4 4.7 15.4 4.4 3.7 1.8 5.3 2.9 1.9 4.6 5.6 3.7 2.3 3.2 3.2 2.6 8.7 4.2 0.2 0.0 0.0 0.0 0.1 5.3 0.7 0.0 1.8 10.5 4.5 1.6 2.8 0.0 0.3 2.3 0.2 2.8 2.5 3.4 0.1 9.2 1.0 0.8 1.9 4.6 1.7 0.9 0.0 2.8 1.4 0.8 3.5 4.7 0.0 0.9 2.8 1.9 2.4 11.0 3.7 3.1 1.4 1.7 4.3 2.5 1.9 0.9 0.7 4.9 2.5 2.2 0.4 0.0 2.8 6.1 7.7 0.1 2.1 0.0 0.0 10.5 8.9 2.6 1.7 2.3 1.9 0.1 0.0 0.3 0.0 2.3 0.4 2.1 1.9 4.0 0.0 0.0 0.0 1.0 0.0 5.3 0.2 1.3 0.3 0.0 0.1 3.7 2.8 0.0 0.1 0.0 0.0 0.2 0.7 3.4 5.6 7.1 7.6 3.0 2.4 3.4 3.6 6.4 3.7 3.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FSIP1 FLJ35989 ENSG00000150667 "Fibrous sheath interacting protein 1" Q8NA03 15 39588357-39782830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 17.8;pituitary gland: 11.8;testis: 13.9" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 17.4;Early spermatids: 47.1;Late spermatids: 39.8;Spermatocytes: 27.4" "Cancer enriched" "Detected in some" 8 "breast cancer: 6.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 7.3" "Low region specificity" "Detected in many" HPA041002 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA041002: AB_10796565" "unprognostic (1.55e-2)" "unprognostic (1.49e-1)" "unprognostic (9.12e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-2)" "unprognostic (1.43e-3)" "unprognostic (5.17e-3)" "unprognostic (5.37e-2)" "unprognostic (9.22e-2)" "unprognostic (1.60e-1)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.81e-2)" "unprognostic (2.01e-1)" "unprognostic (1.81e-1)" 0.8 0.7 2.9 0.7 9.3 1.1 1.9 1.0 5.7 0.8 11.7 1.5 0.8 0.5 1.4 2.5 0.6 2.3 0.7 0.8 3.1 3.0 1.6 0.7 0.9 0.5 1.2 4.1 0.7 0.6 1.7 11.8 0.8 4.5 0.8 17.8 0.6 0.5 0.7 0.9 1.7 0.6 0.9 1.1 0.6 1.1 13.9 1.4 0.5 1.0 0.0 0.5 1.0 0.9 1.0 1.0 1.8 1.3 1.5 3.4 1.4 0.6 2.3 6.2 0.9 1.1 2.1 0.1 7.3 1.5 1.2 2.2 1.7 0.6 0.5 0.6 2.1 3.1 1.5 1.0 1.2 1.9 2.5 0.6 4.5 1.7 0.1 0.6 0.9 5.0 1.4 5.2 2.8 1.2 1.6 1.3 2.5 0.2 0.6 1.9 0.3 0.6 0.4 0.7 0.3 1.2 0.6 1.2 0.1 2.4 2.7 1.6 4.7 1.5 0.2 0.3 0.5 2.1 0.5 1.0 3.0 1.7 1.6 0.8 1.3 2.7 0.3 6.2 1.7 1.4 1.8 1.3 1.5 3.4 0.8 2.7 0.8 1.8 2.1 1.0 1.0 1.1 0.9 1.1 1.5 1.0 0.0 0.4 1.4 2.9 9.3 1.0 5.7 3.1 3.0 1.2 4.1 4.5 1.4 0.0 0.3 0.5 0.3 0.6 1.0 0.6 2.5 17.4 3.4 1.8 11.8 0.7 1.7 0.6 47.1 0.1 4.9 0.0 0.4 0.1 0.9 0.7 15.1 0.0 0.1 0.0 0.0 0.6 0.0 39.8 1.1 0.1 0.0 0.0 2.2 1.5 0.1 0.0 0.7 2.4 4.9 0.0 0.2 27.4 7.8 0.0 4.7 1.0 1.5 0.3 FSTL3 "FLRG, FSRP" ENSG00000070404 "Follistatin like 3" O95633 19 676365-683399 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Osteogenesis, Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "placenta: 201.0" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 2939.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 36.2;hTCEpi: 40.0;SiHa: 73.8;U-2197: 38.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB024899, HPA045378" Approved Supported Nucleoplasm "Secreted in other tissues" NA Yes 6800000 Nucleoplasm "CAB024899: , HPA045378: AB_2679300" "unprognostic (9.86e-3)" "unprognostic (1.32e-3)" "prognostic unfavorable (3.01e-4)" "prognostic unfavorable (3.03e-4)" "unprognostic (2.19e-3)" "unprognostic (1.51e-3)" "unprognostic (8.64e-3)" "prognostic unfavorable (4.61e-7)" "unprognostic (9.50e-2)" "prognostic unfavorable (1.65e-4)" "unprognostic (3.50e-2)" "unprognostic (5.91e-2)" "unprognostic (1.03e-3)" "unprognostic (7.22e-3)" "unprognostic (3.07e-1)" "unprognostic (3.75e-1)" "unprognostic (5.89e-3)" 19.9 29.1 4.0 10.7 6.2 5.6 24.7 1.3 4.2 13.1 14.9 3.8 8.1 3.8 12.8 15.6 12.7 14.1 13.1 27.0 5.0 2.0 13.7 5.1 26.9 8.7 7.3 4.5 16.8 11.7 1.4 5.3 201.0 6.0 14.3 3.1 12.0 4.5 11.0 4.1 6.2 6.5 20.6 10.4 3.9 9.1 34.5 4.9 0.7 7.2 5.5 1.4 16.7 18.3 0.9 2.2 0.1 4.4 0.6 2.6 2.0 1.9 15.9 1.1 0.8 5.0 12.8 36.2 27.0 4.0 6.8 2.5 5.8 3.1 0.8 10.9 18.2 3.9 13.9 0.9 23.0 2.2 1.6 1.9 0.7 22.2 4.7 21.6 1.4 2.6 16.0 40.0 7.5 31.3 17.6 1.2 0.8 1.7 1.1 10.2 7.0 0.5 0.8 1.3 13.1 5.5 1.5 0.7 1.8 9.4 0.3 0.7 1.2 73.8 1.5 0.8 1.4 1.3 0.7 16.2 6.8 23.5 38.1 9.9 1.8 0.8 0.4 1.0 4.2 3.1 0.0 4.4 0.0 1.0 4.4 0.2 0.3 1.4 1.1 2.2 0.9 2.6 1.6 0.1 0.6 3.2 0.9 0.2 2.0 4.0 6.2 1.3 4.2 5.0 2.0 7.3 4.5 6.0 4.9 17.9 3.4 2.2 19.6 12.9 1.6 12.8 30.6 2.7 1.2 8.7 0.0 22.7 6.6 69.7 5.6 4.5 0.9 0.0 56.0 2939.6 52.2 21.7 0.0 0.9 68.4 3.2 1.2 22.1 3.8 6.5 56.7 4.0 5.0 11.8 0.9 7.8 198.1 0.0 25.1 5.6 0.5 45.3 32.5 2.3 7.7 6.8 662.4 2.9 1.7 20.7 FUBP1 "FBP, FUBP" ENSG00000162613 "Far upstream element binding protein 1" Q96AE4 1 77944055-77979110 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006149 Supported Enhanced Nucleoplasm NA NA 200000 Nucleoplasm "HPA006149: AB_1849172" "unprognostic (4.17e-2)" "unprognostic (2.83e-2)" "unprognostic (3.35e-3)" "unprognostic (3.89e-2)" "unprognostic (3.77e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.83e-9)" "unprognostic (2.32e-2)" "unprognostic (2.16e-1)" "unprognostic (1.69e-1)" "unprognostic (3.31e-3)" "unprognostic (9.80e-3)" "unprognostic (9.02e-3)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (6.24e-2)" "unprognostic (9.46e-2)" 23.9 35.5 21.8 42.4 26.9 56.8 27.0 34.0 31.8 24.3 19.6 18.1 23.0 21.8 29.4 35.0 23.5 25.2 18.4 27.5 22.0 22.3 26.6 16.3 27.2 37.6 17.5 28.8 44.4 31.6 36.0 41.5 27.3 26.3 22.4 28.3 22.0 28.2 35.6 27.4 21.3 24.0 22.7 31.3 28.6 22.6 17.6 19.9 64.9 35.0 26.2 40.3 24.0 29.1 16.1 11.3 10.8 16.1 23.5 22.2 12.8 22.3 19.7 46.6 18.5 7.2 9.1 38.2 23.1 13.8 22.2 16.2 19.9 25.0 40.0 10.8 17.1 26.3 22.3 31.2 25.4 29.7 44.0 15.9 25.6 32.7 29.2 15.7 43.8 10.8 11.9 21.0 23.7 18.9 18.2 17.7 27.0 29.3 17.8 17.5 22.5 34.7 21.2 36.4 22.0 14.1 42.7 36.9 15.3 23.0 22.0 24.6 23.2 21.5 20.4 18.2 26.0 24.8 15.9 22.7 21.5 31.3 6.1 27.6 17.1 18.4 51.9 9.3 19.3 21.9 3.8 9.6 10.8 18.7 15.7 22.2 16.1 18.3 19.4 8.7 13.1 17.9 20.9 4.0 23.5 16.1 11.3 21.3 12.8 21.8 26.9 34.0 31.8 22.0 22.3 17.5 28.8 26.3 19.9 68.5 47.3 43.1 67.8 75.3 41.1 65.5 30.6 96.4 89.9 31.4 39.3 42.2 36.5 50.0 27.8 42.8 20.6 0.0 62.7 54.9 40.0 39.3 75.2 20.7 29.1 17.5 52.9 33.7 27.2 15.1 44.5 34.8 37.1 55.9 32.7 36.4 54.2 30.6 28.3 19.7 37.0 32.3 42.4 33.8 40.6 55.2 29.9 54.8 35.4 54.0 FUS "ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS" ENSG00000089280 "FUS RNA binding protein" P35637 16 31180110-31194871 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008784, CAB033036, CAB058691" Supported Enhanced Nucleoplasm NA NA 190000 Nucleoplasm "CAB033036: AB_2105208, CAB058691: AB_2665583, HPA008784: AB_1849181" "unprognostic (3.06e-2)" "unprognostic (2.53e-1)" "unprognostic (1.86e-2)" "unprognostic (8.68e-2)" "unprognostic (1.44e-1)" "unprognostic (8.03e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (5.22e-3)" "unprognostic (1.01e-1)" "unprognostic (1.01e-3)" "unprognostic (1.12e-3)" "unprognostic (1.87e-1)" "unprognostic (5.27e-1)" "unprognostic (1.66e-1)" "unprognostic (1.49e-2)" 44.0 24.2 35.0 47.1 43.3 41.7 29.9 64.1 59.0 39.7 32.4 48.6 22.6 28.0 54.5 44.7 29.6 48.6 35.9 32.0 32.7 34.6 30.3 24.4 27.7 51.3 31.1 39.0 66.7 28.8 41.7 24.8 44.1 39.2 29.1 30.2 39.3 27.6 30.5 43.6 24.3 28.7 46.5 33.7 36.2 27.7 40.7 30.7 66.3 29.1 40.1 49.6 30.3 31.4 16.4 22.3 24.2 29.0 14.2 24.8 9.4 48.3 42.0 55.3 35.9 13.6 11.6 58.9 65.2 23.7 29.8 22.8 56.6 32.6 74.6 46.5 32.9 36.9 21.1 55.1 42.2 28.5 44.3 35.8 63.0 31.7 57.0 22.8 67.0 43.4 23.5 11.6 43.0 29.2 14.3 28.4 44.4 66.8 25.4 37.0 59.2 48.6 59.3 84.2 29.4 46.1 79.9 73.7 42.7 33.3 35.5 36.1 64.8 42.8 30.2 32.3 36.7 36.4 74.6 35.2 47.8 48.0 31.5 68.8 23.6 45.2 105.0 26.7 45.6 57.7 5.6 17.5 24.2 24.8 29.0 24.0 12.8 17.4 21.8 19.3 16.4 20.3 21.1 14.9 14.2 25.1 22.3 13.9 9.4 35.0 43.3 64.1 59.0 32.7 34.6 31.1 39.0 39.2 30.7 95.3 108.8 163.2 313.8 128.6 263.0 87.0 94.3 111.1 129.7 99.5 123.7 234.5 58.0 142.1 94.6 197.5 188.3 46.7 133.2 323.0 212.4 178.2 227.1 52.9 180.4 190.7 203.5 174.3 132.4 22.8 284.5 176.9 156.9 172.3 132.7 214.0 132.4 175.4 202.6 57.5 247.1 161.7 222.6 158.2 225.3 134.9 246.8 262.6 169.5 255.7 FZD10 CD350 ENSG00000111432 "Frizzled class receptor 10" Q9ULW2 12 130162459-130165740 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 26.9;lymphoid tissue: 18.6" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 3.9;Basal keratinocytes: 7.4;Smooth muscle cells: 14.4;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 8.6;BEWO: 9.9;hTCEpi: 5.7;RPTEC TERT1: 3.0;RT4: 4.8" "Region enhanced" "Detected in some" "thalamus: 7.6" "Low region specificity" "Detected in many" "HPA014484, HPA014485" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA014484: AB_1849132, HPA014485: AB_1849134" "unprognostic (2.41e-3)" "unprognostic (3.29e-1)" "unprognostic (4.74e-2)" "prognostic favorable (5.05e-7)" "unprognostic (2.81e-2)" "unprognostic (4.63e-2)" "unprognostic (8.62e-3)" "unprognostic (6.33e-2)" "unprognostic (5.41e-2)" "unprognostic (3.77e-2)" "unprognostic (2.70e-1)" "unprognostic (2.24e-3)" "unprognostic (2.66e-9)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (1.49e-2)" "unprognostic (1.07e-1)" 1.1 0.4 1.0 0.5 1.9 0.2 1.5 5.4 2.1 11.6 0.6 2.1 1.6 0.4 5.1 3.4 26.9 2.2 7.1 0.5 1.0 1.0 0.4 0.2 2.0 0.9 1.6 1.2 3.4 1.1 0.2 1.4 9.2 1.9 3.7 0.6 3.0 5.4 3.1 1.2 10.2 0.7 0.9 1.2 0.3 1.0 0.7 2.0 0.6 1.7 9.0 18.6 5.1 7.2 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 8.6 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 1.5 0.7 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 3.0 4.8 0.1 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 1.9 5.4 2.1 1.0 1.0 1.6 1.2 1.9 2.0 0.0 0.3 0.0 3.9 7.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 1.1 0.0 0.0 0.2 0.3 2.5 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 14.4 0.0 0.4 7.4 0.7 0.0 0.0 1.1 GABPA "E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A" ENSG00000154727 "GA binding protein transcription factor alpha subunit" Q06546 21 25734570-25772460 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003258, CAB004411, HPA028791" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004411: AB_627648, HPA003258: AB_1078928, HPA028791: AB_10602598" "unprognostic (5.50e-2)" "unprognostic (2.40e-1)" "unprognostic (3.74e-2)" "unprognostic (2.68e-1)" "unprognostic (3.98e-2)" "unprognostic (1.17e-2)" "unprognostic (3.01e-1)" "unprognostic (2.73e-1)" "unprognostic (2.56e-2)" "unprognostic (1.76e-1)" "unprognostic (4.07e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (3.97e-5)" "unprognostic (1.62e-1)" "unprognostic (1.77e-1)" "unprognostic (5.70e-2)" "unprognostic (2.73e-3)" 25.3 15.2 11.6 17.0 16.9 13.6 18.3 15.9 15.4 17.6 17.1 11.4 18.8 12.7 19.5 15.9 15.1 15.4 13.6 18.6 12.5 9.5 14.6 18.8 13.3 18.8 12.9 9.0 20.4 13.3 19.4 20.3 34.5 12.5 18.0 14.2 10.8 14.2 15.4 18.2 11.5 17.0 15.8 18.4 20.0 12.3 19.5 16.3 37.7 27.3 10.3 19.0 18.4 35.3 8.9 6.6 12.0 8.2 10.8 10.3 6.1 12.8 5.3 15.8 11.2 16.2 22.0 12.2 10.3 11.6 8.6 8.5 6.7 11.0 27.6 8.2 11.9 8.3 5.9 17.5 10.5 14.3 15.6 16.2 19.2 7.2 6.4 11.0 20.4 13.0 16.0 10.3 11.4 10.8 14.1 15.8 15.1 17.5 16.7 14.3 6.4 22.0 8.9 21.8 14.0 7.4 18.4 22.7 16.9 10.0 8.6 9.7 13.1 18.5 11.8 12.6 10.0 10.5 15.8 15.5 10.4 9.6 11.3 8.5 13.4 11.5 24.5 10.8 15.7 12.5 12.0 6.8 11.5 7.4 8.2 9.9 8.9 8.6 8.7 6.6 8.4 10.3 8.7 8.7 10.8 6.0 3.4 8.6 6.1 11.6 16.9 15.9 15.4 12.5 9.5 12.9 9.0 12.5 16.3 8.9 11.8 14.7 10.4 10.3 6.6 6.7 15.3 6.7 13.6 21.0 0.0 14.8 3.3 6.9 5.5 20.4 9.0 0.0 7.0 10.8 11.7 9.2 5.8 17.5 10.8 12.7 8.6 22.7 19.7 2.1 16.4 11.5 6.8 7.2 13.3 20.9 7.5 8.6 20.8 8.5 9.4 19.4 12.0 27.7 17.4 11.0 21.1 13.1 11.2 11.6 GALM ENSG00000143891 "Galactose mutarotase" Q96C23 2 38665910-38741237 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 54.2" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 102.0;Proximal tubular cells: 198.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 29.7" "Group enriched" "Detected in all" 5 "granulocytes: 13.2;T-cells: 29.7" "Cell line enhanced" "Detected in many" "Karpas-707: 27.8;U-266/70: 31.3" "Low region specificity" "Detected in all" "HPA035472, HPA035473, HPA064835" Enhanced Approved Nucleoplasm NA NA 570000 Nucleoplasm "HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723" "unprognostic (5.02e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (9.20e-2)" "unprognostic (1.88e-2)" "unprognostic (9.99e-3)" "unprognostic (1.63e-2)" "unprognostic (2.80e-3)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (6.65e-2)" "unprognostic (6.45e-2)" "prognostic favorable (9.06e-5)" "unprognostic (1.70e-2)" "unprognostic (1.62e-1)" "unprognostic (4.34e-1)" "prognostic favorable (1.32e-4)" 11.2 54.2 3.1 10.4 2.5 0.7 4.6 1.9 2.7 5.9 28.4 2.5 44.3 22.7 6.8 11.8 3.4 11.6 13.3 7.7 2.5 1.8 39.1 28.8 5.8 6.4 2.4 1.9 6.4 7.9 10.4 2.4 3.1 2.9 8.1 10.7 15.3 7.9 29.1 4.6 2.2 39.8 5.4 3.3 4.1 5.0 4.7 2.1 6.4 7.4 3.3 9.3 6.5 5.2 2.8 4.5 13.2 2.1 2.3 29.7 5.3 0.0 10.6 3.3 0.0 11.1 6.5 5.9 1.3 4.0 3.0 4.9 11.9 5.6 4.1 7.9 5.9 6.0 1.7 4.6 0.3 6.0 18.7 7.7 2.2 2.9 23.7 4.0 0.9 0.1 4.5 0.1 6.8 0.0 4.2 3.4 0.0 6.3 27.8 5.5 0.3 9.1 14.8 5.0 22.6 3.5 5.7 0.2 8.0 3.9 18.4 0.6 4.7 0.0 7.6 5.4 4.4 3.6 2.1 1.3 1.0 0.2 7.3 0.4 31.3 21.1 0.1 6.9 2.6 0.1 13.2 2.1 1.8 10.2 1.5 15.0 2.8 16.0 14.8 4.5 2.5 5.8 5.0 5.1 2.3 0.2 0.4 29.7 5.3 3.1 2.5 1.9 2.7 2.5 1.8 2.4 1.9 2.9 2.1 26.8 11.2 12.5 6.5 6.0 2.9 17.3 22.9 24.1 9.1 66.3 0.0 17.0 21.6 9.1 0.8 9.3 102.0 0.0 13.3 25.1 14.3 6.4 6.9 40.4 91.8 3.2 12.7 6.2 12.3 0.5 18.7 36.1 16.9 12.6 36.5 34.6 10.1 63.0 91.9 198.6 7.1 6.5 9.6 1.0 2.1 5.3 5.3 24.5 72.8 4.7 GATA1 "ERYF1, GATA-1, GF1, NF-E1, NFE1" ENSG00000102145 "GATA binding protein 1" P15976 X 48786554-48794311 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "blood: 78.3;bone marrow: 37.0" "Group enriched" "Detected in some" 10 "Early spermatids: 11.8;Erythroid cells: 23.3;granulocytes: 35.9;Late spermatids: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "eosinophil: 78.3" "Lineage enriched" "Detected in single" 784 "granulocytes: 78.3" "Group enriched" "Detected in some" 9 "HEL: 50.8;HMC-1: 52.4;K-562: 54.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000232, HPA000233, CAB009195" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951" "unprognostic (1.93e-1)" "unprognostic (7.54e-2)" "unprognostic (8.95e-3)" "unprognostic (3.84e-3)" "unprognostic (2.25e-1)" "unprognostic (3.00e-4)" "unprognostic (4.87e-2)" "unprognostic (3.48e-2)" "unprognostic (4.44e-2)" "unprognostic (1.95e-2)" "unprognostic (6.04e-2)" "unprognostic (7.71e-3)" "unprognostic (4.13e-2)" "unprognostic (2.24e-1)" "unprognostic (2.78e-1)" "unprognostic (9.10e-2)" "unprognostic (2.71e-2)" 0.7 0.2 0.1 2.4 0.7 37.0 0.3 0.0 0.3 0.7 0.3 0.0 0.0 0.6 4.9 2.4 0.4 0.3 0.6 2.3 0.1 0.3 0.4 0.8 5.6 0.2 0.6 0.0 0.1 0.1 0.1 0.5 2.8 0.3 1.4 0.4 1.6 0.3 0.2 0.1 0.6 0.8 2.4 0.3 4.9 0.5 3.1 0.0 1.5 0.6 1.1 0.6 0.9 0.6 0.0 0.0 78.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.0 0.0 52.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.1 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 78.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.1 0.7 0.0 0.3 0.1 0.3 0.6 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 23.3 0.0 0.7 0.0 0.0 35.9 0.0 0.5 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 GATA2 NFE1B ENSG00000179348 "GATA binding protein 2" P23769 3 128479427-128493185 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Phagocytosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.2;ductus deferens: 85.8;seminal vesicle: 209.1" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 226.1;granulocytes: 616.3;Syncytiotrophoblasts: 268.8" "Cancer enhanced" "Detected in all" "prostate cancer: 36.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 339 "basophil: 81.2" "Lineage enriched" "Detected in single" 813 "granulocytes: 81.2" "Cell line enhanced" "Detected in many" "BEWO: 57.0;HEL: 70.3;HMC-1: 38.1;SH-SY5Y: 66.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA005633, CAB024847" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB024847: , HPA005633: AB_1078954" "unprognostic (1.71e-1)" "unprognostic (8.90e-2)" "unprognostic (1.12e-1)" "unprognostic (8.61e-2)" "unprognostic (8.67e-2)" "unprognostic (4.17e-2)" "unprognostic (5.96e-3)" "unprognostic (7.30e-2)" "unprognostic (3.98e-2)" "unprognostic (4.12e-2)" "unprognostic (3.58e-2)" "unprognostic (3.04e-1)" "prognostic favorable (2.04e-4)" "unprognostic (2.50e-1)" "unprognostic (8.07e-2)" "unprognostic (2.08e-1)" "prognostic favorable (5.22e-5)" 7.0 6.2 2.1 1.5 2.4 2.5 7.9 1.2 1.9 22.4 2.8 1.4 85.8 2.5 20.6 5.4 3.2 23.0 9.7 4.8 1.5 1.0 7.6 0.6 16.1 2.2 1.8 1.1 4.6 5.8 3.4 4.5 51.8 2.4 27.8 1.8 6.1 1.9 209.1 3.5 4.1 3.4 8.4 1.4 5.1 2.9 2.7 1.5 0.4 3.3 2.7 1.5 22.4 12.4 0.0 0.0 81.2 0.0 0.0 0.0 0.4 4.7 1.1 0.2 3.1 0.4 0.1 57.0 10.6 9.1 3.6 1.3 1.9 2.1 0.1 3.0 6.3 0.3 5.0 2.9 0.0 1.5 0.0 1.6 70.3 7.8 3.1 0.8 7.1 38.1 0.0 0.0 0.1 0.0 0.5 5.7 0.0 18.4 0.1 0.0 1.7 0.0 14.4 0.2 0.0 0.3 0.0 1.4 0.0 0.1 4.2 4.4 66.4 2.7 14.1 0.4 3.0 2.7 2.9 10.2 0.2 0.1 2.5 1.4 0.0 0.0 0.0 0.1 0.4 0.7 81.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.1 2.4 1.2 1.9 1.5 1.0 1.8 1.1 2.4 1.5 6.0 48.7 0.5 16.6 4.2 0.2 6.1 0.0 1.4 3.4 71.5 0.0 50.4 1.7 0.3 5.8 56.9 0.0 0.0 12.6 226.1 5.8 36.8 616.3 0.0 9.5 0.0 2.9 34.4 0.8 4.0 0.6 2.9 8.5 0.0 0.0 0.0 1.3 0.0 0.4 0.1 0.2 0.0 7.6 0.5 2.8 2.0 268.8 0.0 0.1 10.0 GATA3 HDR ENSG00000107485 "GATA binding protein 3" P23771 10 8045378-8075203 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 97.8;skin 1: 61.7" "Cell type enhanced" "Detected in many" 19 "Cytotrophoblasts: 243.8;Extravillous trophoblasts: 651.3;Syncytiotrophoblasts: 949.1" "Group enriched" "Detected in many" 24 "breast cancer: 190.0;urothelial cancer: 87.0" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 42 "gdT-cell: 9.7;MAIT T-cell: 13.3;memory CD4 T-cell: 18.2;memory CD8 T-cell: 14.1;naive CD4 T-cell: 10.0;naive CD8 T-cell: 9.0;NK-cell: 16.6;T-reg: 18.9" "Group enriched" "Detected in many" 54 "NK-cells: 16.6;T-cells: 18.9" "Cell line enhanced" "Detected in some" "BEWO: 33.3;MCF7: 79.6;RT4: 32.6;SH-SY5Y: 28.0;T-47d: 103.7" "Region enriched" "Detected in single" 6 "midbrain: 7.3" "Group enriched" "Detected in some" 38 "midbrain: 25.5;pons and medulla: 17.5;thalamus: 20.0" "CAB016217, HPA029730" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB016217: AB_2108591, HPA029730: AB_10601907" "unprognostic (1.70e-1)" "unprognostic (7.23e-2)" "unprognostic (3.58e-2)" "unprognostic (2.00e-1)" "unprognostic (7.03e-3)" "unprognostic (4.68e-3)" "unprognostic (4.23e-2)" "unprognostic (9.65e-2)" "unprognostic (2.06e-1)" "unprognostic (2.55e-1)" "unprognostic (3.83e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (6.31e-2)" "unprognostic (1.82e-3)" 2.0 2.0 0.3 3.4 0.3 0.9 17.8 0.3 0.3 1.8 0.5 0.1 44.4 0.1 0.4 13.5 0.8 0.4 0.4 0.9 0.3 0.4 12.9 0.7 1.6 2.7 0.8 0.0 0.3 0.4 55.0 3.8 53.4 1.4 8.1 0.0 1.8 8.9 97.8 0.8 61.7 1.2 3.4 0.4 2.7 0.5 0.8 0.1 42.4 3.3 0.6 3.4 26.9 16.4 0.2 0.0 0.3 0.0 16.6 18.9 3.0 5.5 1.3 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 0.0 2.0 5.0 0.0 0.0 0.0 0.0 4.9 0.5 0.1 0.0 16.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.3 0.1 2.6 7.8 0.0 0.0 0.0 79.6 8.7 0.0 0.6 1.0 0.7 0.4 0.4 0.1 0.0 32.6 1.6 28.0 0.0 4.5 0.0 6.1 103.7 0.0 0.0 0.4 1.0 0.2 0.7 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 9.7 0.0 13.3 0.2 18.2 14.1 0.0 0.0 10.0 9.0 0.3 16.6 0.0 0.0 18.9 3.0 0.3 0.3 0.3 0.3 0.3 0.4 0.8 0.0 1.4 0.1 0.0 8.9 0.5 60.9 84.1 0.0 1.2 0.0 0.0 1.2 169.3 0.0 243.8 0.0 0.2 0.0 4.9 0.0 0.0 0.3 651.3 6.9 27.0 2.3 0.5 27.7 0.0 0.0 9.8 4.0 0.0 0.0 2.2 8.5 1.0 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.2 173.9 949.1 56.1 0.0 68.0 GATA6 ENSG00000141448 "GATA binding protein 6" Q92908 18 22169443-22202528 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Atrial septal defect, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 77.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 78.9;Mucus-secreting cells: 48.1;Undifferentiated cells: 48.1" "Cancer enhanced" "Detected in many" "stomach cancer: 26.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "basophil: 5.7" "Lineage enriched" "Detected in single" 13 "granulocytes: 5.7" "Cell line enhanced" "Detected in many" "BEWO: 26.8;CACO-2: 32.6;hTERT-RPE1: 12.5;OE19: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB011581, HPA066629" Approved Supported Nucleoplasm Yes No Nucleoplasm "CAB011581: AB_732529, HPA066629: AB_2685695" "unprognostic (1.90e-1)" "unprognostic (1.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (1.51e-1)" "unprognostic (1.72e-2)" "unprognostic (2.16e-1)" "unprognostic (9.43e-2)" "unprognostic (4.36e-2)" "unprognostic (3.47e-1)" "unprognostic (2.61e-1)" "unprognostic (8.45e-3)" "prognostic unfavorable (1.92e-9)" "unprognostic (8.75e-3)" "unprognostic (2.07e-1)" "unprognostic (1.91e-1)" "unprognostic (2.12e-2)" 9.7 26.6 0.2 8.4 0.2 0.0 9.4 0.2 0.2 9.8 24.7 0.9 1.5 12.5 19.5 10.3 3.3 15.3 51.3 40.4 0.2 0.2 3.9 15.5 14.9 11.1 0.2 0.1 77.2 52.2 0.1 0.5 5.2 0.7 24.3 6.0 0.4 1.5 1.1 1.5 0.9 43.5 32.2 0.4 18.9 26.9 9.7 0.0 0.1 6.3 0.7 0.6 30.3 16.5 0.0 0.0 5.7 0.0 0.0 0.4 0.0 4.7 0.7 0.0 0.0 1.0 0.5 26.8 0.1 0.1 0.4 0.4 32.6 1.8 0.0 1.6 0.5 1.7 5.2 0.2 2.1 0.7 0.0 6.5 0.0 2.0 2.8 7.1 0.2 0.3 0.2 4.2 5.9 4.4 12.5 4.5 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 17.4 4.6 0.0 0.5 0.1 0.2 1.3 0.4 0.0 5.0 2.9 1.3 1.4 0.8 0.0 0.3 0.7 0.8 5.5 0.8 0.0 0.0 0.0 3.0 0.1 4.7 5.7 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.7 0.0 41.7 27.5 0.0 3.5 0.8 0.0 78.9 25.5 2.7 7.9 0.0 0.0 0.5 0.0 22.6 47.7 6.2 29.3 0.0 16.9 9.5 20.0 2.8 4.7 8.3 1.4 0.0 25.0 17.8 0.3 5.9 3.1 0.8 0.0 0.0 48.1 0.0 30.5 17.5 9.6 0.0 0.0 32.3 5.5 0.9 1.0 0.6 1.6 0.0 48.1 2.1 GATAD1 "FLJ22489, ODAG, RG083M05.2" ENSG00000157259 "GATA zinc finger domain containing 1" Q8WUU5 7 92447448-92459432 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 125.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006105, HPA072785" Enhanced Nucleoplasm Yes No Nucleoplasm "HPA006105: AB_1078956, HPA072785: AB_2686556" "unprognostic (8.37e-2)" "unprognostic (1.01e-1)" "unprognostic (7.31e-3)" "unprognostic (6.24e-2)" "unprognostic (6.03e-2)" "unprognostic (1.36e-1)" "unprognostic (8.65e-3)" "unprognostic (6.43e-2)" "unprognostic (5.16e-2)" "unprognostic (4.30e-2)" "unprognostic (2.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.91e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-1)" "unprognostic (3.44e-2)" "unprognostic (1.98e-3)" 20.1 20.9 14.7 13.7 32.1 8.7 21.1 19.5 23.5 23.1 18.2 32.9 20.8 17.6 23.2 29.8 13.7 21.7 20.0 14.9 18.3 13.4 21.5 17.5 22.5 12.4 37.7 21.4 32.9 27.3 19.7 22.5 19.3 22.1 21.7 18.3 19.5 17.0 21.2 10.4 15.3 16.9 22.2 28.9 18.9 21.1 11.5 31.8 6.5 28.1 8.0 11.3 21.4 18.7 4.5 3.8 7.3 3.8 3.1 3.0 1.1 8.6 5.5 11.3 11.8 14.7 17.0 9.1 8.7 13.0 9.2 12.7 6.0 13.5 6.5 12.1 6.4 21.6 10.4 7.7 5.9 9.8 11.3 8.4 8.3 5.5 8.3 20.5 9.9 22.5 12.8 14.2 7.0 20.6 16.6 10.3 4.8 16.8 14.0 10.0 12.5 3.8 14.1 15.2 14.0 10.6 5.1 13.4 8.5 9.9 9.8 10.1 16.0 11.4 12.1 16.3 14.7 6.8 13.4 9.4 14.8 11.3 22.3 11.1 11.3 3.9 7.2 12.4 6.5 20.2 7.3 3.8 3.4 2.6 2.3 2.5 2.8 2.0 1.6 2.0 4.5 2.1 3.0 3.9 3.1 2.5 3.8 2.0 1.1 14.7 32.1 19.5 23.5 18.3 13.4 37.7 21.4 22.1 31.8 44.7 54.7 23.8 32.5 11.7 77.4 13.2 20.4 45.5 33.0 45.4 66.8 21.8 3.3 18.5 3.3 25.3 24.9 0.0 19.1 19.7 20.3 33.0 50.9 19.5 21.7 58.8 16.1 30.1 26.3 3.4 42.0 29.9 20.3 10.8 35.4 86.9 22.4 33.6 32.9 13.5 125.5 19.4 26.7 10.7 7.0 15.6 17.3 18.5 29.9 26.0 GATAD2A p66alpha ENSG00000167491 "GATA zinc finger domain containing 2A" Q86YP4 19 19385826-19508931 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006759, HPA024373" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006759: AB_1079549, HPA024373: AB_1849522" "unprognostic (1.07e-1)" "unprognostic (2.79e-2)" "unprognostic (1.40e-1)" "unprognostic (5.64e-3)" "unprognostic (3.41e-1)" "unprognostic (1.86e-1)" "unprognostic (9.04e-3)" "unprognostic (9.53e-2)" "unprognostic (2.12e-1)" "unprognostic (2.58e-2)" "unprognostic (6.62e-3)" "unprognostic (4.69e-2)" "unprognostic (3.06e-3)" "unprognostic (4.50e-2)" "unprognostic (2.43e-1)" "unprognostic (3.30e-2)" "unprognostic (9.84e-2)" 19.2 16.1 14.7 24.4 15.3 30.5 25.9 11.1 14.2 12.9 22.2 12.2 20.4 24.8 16.7 16.1 23.3 13.1 17.4 16.3 16.2 11.3 21.2 28.7 22.3 29.9 12.8 10.1 16.0 28.5 13.8 16.2 26.9 15.3 11.7 13.0 18.1 16.7 20.2 17.9 29.9 26.4 13.1 14.8 28.1 19.5 42.0 11.4 34.1 16.1 15.3 24.6 16.3 23.0 3.2 4.9 12.3 4.9 3.7 5.2 2.7 18.7 16.1 15.0 22.2 6.2 6.5 31.6 14.8 10.1 15.5 14.8 29.1 19.9 36.8 22.6 14.8 10.3 15.7 14.0 13.1 9.0 12.5 15.2 27.0 16.1 16.0 15.3 29.9 23.4 10.3 9.7 16.1 13.1 5.1 15.4 21.3 43.0 11.9 8.9 21.2 35.3 11.9 31.6 17.4 14.7 37.7 15.1 17.1 8.0 24.8 28.5 15.9 12.8 15.6 18.7 10.2 14.1 12.6 30.0 29.5 14.2 34.4 27.6 14.9 18.7 39.4 18.4 25.3 17.1 5.6 4.9 4.5 5.2 2.3 3.1 3.1 3.1 4.2 2.1 3.2 2.3 2.6 12.3 3.7 4.5 4.9 2.1 2.7 14.7 15.3 11.1 14.2 16.2 11.3 12.8 10.1 15.3 11.4 11.9 16.3 12.4 16.8 49.5 14.4 10.6 10.2 9.4 12.5 14.0 17.7 20.2 11.6 19.7 14.7 28.5 34.2 0.0 26.2 27.9 19.3 19.6 16.2 25.1 23.4 22.3 15.0 25.2 24.1 13.3 14.4 19.3 30.4 16.2 28.2 17.4 36.9 32.3 13.1 22.5 18.5 19.4 21.7 12.1 33.7 48.6 30.7 35.5 26.9 23.0 GATAD2B P66beta ENSG00000143614 "GATA zinc finger domain containing 2B" Q8WXI9 1 153789030-153923360 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017015 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA017015: AB_1854905" "unprognostic (1.90e-1)" "unprognostic (5.02e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.43e-2)" "unprognostic (2.59e-3)" "unprognostic (1.07e-1)" "unprognostic (3.79e-2)" "unprognostic (4.37e-2)" "unprognostic (2.02e-2)" "unprognostic (3.29e-1)" "unprognostic (1.28e-1)" "unprognostic (6.40e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.53e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-1)" "unprognostic (5.17e-2)" 12.9 9.6 16.5 16.2 19.8 22.2 13.6 33.2 24.4 12.0 12.4 22.2 10.5 10.7 15.7 9.0 14.6 13.1 9.6 19.3 16.3 11.0 8.8 10.5 15.9 18.4 15.1 12.3 17.1 16.0 19.4 11.1 14.4 14.7 10.8 9.6 12.3 10.7 14.6 20.2 17.2 11.9 17.6 13.9 14.6 11.6 24.6 17.9 29.5 19.1 7.6 17.7 12.1 14.4 1.3 2.9 6.7 1.1 1.5 1.4 0.7 4.8 9.2 8.2 9.0 1.7 5.4 4.9 3.0 7.3 9.6 11.3 4.4 7.6 9.5 7.2 6.8 5.1 9.8 11.4 5.9 7.9 8.6 7.9 9.3 10.0 1.8 5.6 5.6 13.3 4.2 4.2 10.7 21.3 4.6 9.1 13.4 6.9 13.1 1.9 9.0 20.1 1.5 3.6 3.8 4.5 20.5 4.1 10.4 1.9 6.8 9.5 10.0 11.2 13.8 5.9 6.3 12.7 4.8 8.1 9.4 8.4 5.2 6.4 17.8 12.0 14.6 5.3 3.7 8.1 6.7 1.1 0.9 1.3 0.5 1.3 0.7 0.6 1.4 0.3 1.3 0.5 0.6 6.4 1.5 0.5 2.9 1.1 0.7 16.5 19.8 33.2 24.4 16.3 11.0 15.1 12.3 14.7 17.9 8.9 11.8 11.8 11.6 38.9 43.4 14.5 22.9 12.0 9.1 24.4 37.3 8.2 6.6 10.9 12.5 23.4 7.9 23.3 12.3 5.5 12.9 16.7 24.3 19.5 11.9 33.4 22.8 24.5 27.8 5.2 25.0 17.4 13.5 34.3 19.5 18.6 14.4 20.9 32.9 7.9 35.5 6.5 19.8 25.5 19.8 41.5 8.2 24.5 14.0 16.0 GATD1 "FLJ34283, PDDC1" ENSG00000177225 "Glutamine amidotransferase like class 1 domain containing 1" Q8NB37 11 767220-777488 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 41.7;Alveolar cells type 2: 23.2;Collecting duct cells: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 50.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008812 Uncertain Supported Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA008812: AB_10962724" "unprognostic (3.39e-1)" "unprognostic (2.48e-2)" "unprognostic (1.31e-1)" "unprognostic (3.58e-2)" "unprognostic (2.82e-2)" "unprognostic (3.03e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (3.50e-2)" "unprognostic (2.19e-1)" "unprognostic (5.67e-2)" "unprognostic (5.23e-3)" "unprognostic (4.89e-3)" "prognostic favorable (3.79e-5)" "unprognostic (2.84e-2)" "unprognostic (8.40e-2)" "unprognostic (6.11e-2)" "unprognostic (6.61e-3)" 16.7 36.5 26.6 16.3 24.9 10.6 19.1 30.9 29.8 15.1 15.0 20.7 19.8 23.3 17.7 22.4 16.6 18.8 20.0 16.7 27.0 26.2 19.8 18.6 15.3 15.6 25.8 19.4 21.9 16.6 15.5 22.9 16.4 22.0 18.6 10.5 15.8 20.0 23.8 19.2 27.2 21.5 12.6 21.7 17.2 19.1 17.5 21.5 12.8 17.0 13.0 11.5 11.9 14.3 4.0 9.5 1.3 8.7 1.7 4.7 2.8 16.8 9.8 9.4 10.1 4.4 6.8 9.1 10.0 4.4 9.3 8.3 7.0 26.4 9.2 3.7 6.6 10.1 18.1 7.0 8.9 4.7 11.7 50.6 5.6 14.7 14.8 7.6 10.5 12.0 9.7 9.9 4.0 6.1 8.6 7.1 10.7 13.7 8.4 5.2 4.9 11.8 11.3 9.0 5.5 18.0 13.0 6.4 11.5 8.2 3.8 24.4 9.6 9.7 13.9 6.8 2.6 12.0 6.9 13.0 10.1 7.6 5.4 7.7 10.1 5.1 11.7 15.3 14.0 8.2 1.3 7.0 1.3 4.7 8.7 3.4 4.0 4.5 4.4 9.5 3.5 3.9 2.6 0.7 1.7 3.5 5.5 2.1 2.8 26.6 24.9 30.9 27.7 27.0 26.2 25.8 19.4 22.0 21.5 41.7 23.2 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.6 21.0 0.0 11.0 5.0 9.7 0.0 0.0 0.0 0.0 6.5 6.9 0.0 0.0 5.8 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 8.2 0.0 0.0 11.7 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 GBX2 ENSG00000168505 "Gastrulation brain homeobox 2" P52951 2 236165236-236168369 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 11.9" "Cell type enhanced" "Detected in single" 26 "Early spermatids: 1.8" "Group enriched" "Detected in some" 6 "glioma: 1.7;testis cancer: 6.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 32.5;BEWO: 5.6;PC-3: 9.6;TIME: 5.1" "Group enriched" "Detected in some" 6 "basal ganglia: 0.7;thalamus: 1.4" "Region enhanced" "Detected in many" "thalamus: 6.3" HPA067809 Approved Nucleoplasm Yes NA Nucleoplasm "HPA067809: AB_2685900" "unprognostic (5.30e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.91e-1)" "unprognostic (8.13e-2)" "unprognostic (6.99e-2)" "unprognostic (3.55e-4)" "unprognostic (8.69e-7)" "unprognostic (2.08e-1)" "unprognostic (1.01e-2)" "unprognostic (5.47e-2)" "unprognostic (9.39e-4)" 0.1 0.1 0.3 0.4 5.8 0.1 0.1 11.9 3.6 0.1 0.2 4.2 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.4 0.6 3.8 0.2 0.3 0.1 0.1 1.2 0.3 0.1 0.1 0.1 0.2 1.4 6.3 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.2 0.3 4.6 0.1 0.1 1.3 2.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 32.5 1.2 0.0 0.0 5.6 0.4 0.0 0.9 0.0 0.7 0.0 0.0 0.6 0.0 1.0 0.0 0.2 0.1 0.2 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.6 0.0 2.1 0.0 0.4 0.8 0.0 0.2 0.8 0.0 9.6 0.0 3.5 0.0 0.3 0.0 0.4 0.2 1.1 0.0 0.3 1.0 0.0 0.0 5.1 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.8 11.9 0.0 0.6 3.8 1.2 0.3 6.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 GCFC2 "C2orf3, DNABF, GCF, TCF9" ENSG00000005436 "GC-rich sequence DNA-binding factor 2" P16383 2 75652000-75710989 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077882 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA077882: AB_2686864" "unprognostic (1.98e-1)" "unprognostic (5.18e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (9.59e-4)" "unprognostic (5.67e-3)" "unprognostic (2.75e-1)" "unprognostic (2.34e-2)" "unprognostic (3.74e-2)" "unprognostic (8.80e-2)" "unprognostic (4.21e-2)" "unprognostic (1.63e-1)" "unprognostic (5.71e-2)" "unprognostic (3.20e-2)" "unprognostic (8.37e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (6.07e-2)" 13.7 10.0 10.3 10.8 11.2 9.7 14.8 12.7 12.2 17.6 9.9 11.2 11.9 5.6 14.7 16.8 14.9 12.9 8.8 15.4 10.7 10.2 15.5 24.3 8.6 11.1 10.2 12.0 16.9 13.8 9.0 14.9 12.2 10.4 13.5 5.9 8.8 11.8 13.7 34.0 22.1 11.9 9.7 10.9 11.8 9.5 10.9 11.4 20.9 15.9 11.7 9.7 13.5 10.6 14.3 11.0 3.0 7.3 3.9 12.7 7.5 8.8 8.9 5.4 6.5 3.1 4.3 8.2 5.8 4.9 6.2 5.9 10.5 6.5 8.7 8.7 4.0 7.4 3.4 7.6 4.1 8.1 12.8 16.2 6.7 8.6 27.7 5.5 11.5 6.5 4.4 5.2 3.0 9.0 6.2 7.5 11.0 10.0 5.0 5.8 7.1 11.9 19.7 9.8 6.2 10.0 14.1 12.9 21.5 10.5 9.5 11.2 14.7 8.0 8.5 10.0 3.9 6.7 5.2 7.2 5.2 7.9 8.4 11.7 6.1 10.3 6.7 5.6 7.0 12.7 0.5 6.7 3.0 9.1 4.3 10.5 14.3 8.8 10.6 7.8 9.9 12.7 11.6 0.4 3.9 7.3 11.0 9.3 7.5 10.3 11.2 12.7 12.2 10.7 10.2 10.2 12.0 10.4 11.4 14.9 9.1 14.6 16.9 24.6 11.5 17.6 10.2 16.0 25.0 12.2 0.0 30.8 18.3 11.2 25.1 14.5 5.2 0.0 16.4 17.8 18.4 14.5 12.8 22.2 11.1 15.9 15.5 16.5 12.4 55.1 15.5 10.3 13.5 4.6 6.8 10.0 11.5 7.0 9.2 13.6 8.7 12.9 17.6 11.4 19.4 21.7 19.8 5.7 9.6 14.4 GCHFR "GFRP, HsT16933" ENSG00000137880 "GTP cyclohydrolase I feedback regulator" P30047 15 40764020-40767710 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.4" "Group enriched" "Detected in many" 4 "Hepatocytes: 655.3;Hofbauer cells: 541.0;Proximal tubular cells: 464.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 32.6;RPTEC TERT1: 41.8;SCLC-21H: 37.5;SK-BR-3: 26.8" "Group enriched" "Detected in many" 5 "cerebellum: 11.6;midbrain: 14.1;pons and medulla: 9.8" HPA046258 Enhanced Supported Nucleoplasm NA NA 59000 Nucleoplasm "HPA046258: AB_10967205" "unprognostic (2.50e-1)" "unprognostic (1.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.72e-2)" "unprognostic (9.89e-3)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "prognostic favorable (5.62e-4)" "unprognostic (4.63e-2)" "unprognostic (1.67e-1)" "unprognostic (3.81e-1)" "unprognostic (2.31e-1)" "unprognostic (7.03e-3)" "unprognostic (9.28e-3)" "unprognostic (2.91e-2)" "unprognostic (1.84e-1)" "unprognostic (2.55e-1)" 9.0 4.9 3.8 6.6 6.0 7.9 37.6 9.7 5.0 7.2 16.5 1.5 0.9 18.3 2.0 2.7 13.4 5.1 6.2 8.1 4.6 4.1 16.3 73.4 16.4 10.5 2.8 2.3 7.1 3.9 1.5 5.1 4.7 8.8 5.0 3.4 6.5 6.0 1.7 1.9 7.3 31.7 1.3 3.1 3.5 4.4 3.4 1.3 10.3 5.0 4.0 12.6 4.4 6.1 13.0 25.4 27.1 21.0 33.1 38.6 27.0 0.1 2.2 1.8 9.4 2.7 1.0 4.8 0.6 2.2 1.1 2.1 24.9 14.1 12.7 9.0 0.5 0.7 1.7 4.5 0.8 0.2 9.8 7.7 12.4 18.8 32.6 2.3 8.1 4.3 2.3 1.1 0.5 0.1 0.8 4.1 1.0 6.2 3.9 0.3 4.6 2.2 16.4 4.6 2.3 16.2 17.8 0.1 7.7 41.8 6.6 37.5 0.5 5.6 26.8 2.8 2.4 7.2 8.3 0.0 0.1 0.3 0.6 0.1 0.2 1.6 7.8 1.4 18.0 1.1 4.3 21.0 27.1 22.7 6.4 38.0 13.0 20.1 21.0 13.6 9.6 20.8 13.5 3.3 33.1 5.6 25.4 38.6 27.0 3.8 6.0 9.7 5.0 4.6 4.1 2.8 2.3 8.8 1.3 3.0 49.6 29.9 20.8 12.9 2.5 0.1 86.6 49.5 36.4 61.1 11.8 137.3 64.6 36.4 0.5 12.7 72.2 0.0 28.6 23.2 12.4 34.2 43.8 655.3 541.0 0.0 58.3 19.0 74.4 0.0 16.4 34.2 64.1 7.2 41.6 11.7 22.0 106.6 8.1 464.4 18.1 0.0 4.2 0.4 10.0 13.0 30.6 47.3 99.7 27.8 GCNA "ACRC, NAAR1" ENSG00000147174 "Germ cell nuclear acidic peptidase" Q96QF7 X 71578411-71613583 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 29.4" "Cell type enhanced" "Detected in some" 20 "Collecting duct cells: 3.5;granulocytes: 2.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA023476, HPA030870" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA023476: AB_1844530, HPA030870: " "unprognostic (6.01e-2)" "unprognostic (2.30e-1)" "unprognostic (1.43e-2)" "unprognostic (4.37e-3)" "unprognostic (1.39e-1)" "unprognostic (2.35e-4)" "unprognostic (5.84e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-1)" "unprognostic (1.68e-1)" "unprognostic (1.03e-2)" "unprognostic (2.06e-1)" "unprognostic (5.07e-10)" "unprognostic (2.30e-1)" "unprognostic (5.06e-2)" "unprognostic (4.74e-1)" "unprognostic (1.15e-5)" 1.4 6.9 1.2 1.7 1.7 1.6 1.2 3.7 1.7 1.2 1.2 1.2 1.2 1.0 1.2 1.4 1.2 0.9 1.2 1.2 1.3 2.5 1.2 1.8 1.4 2.6 1.2 1.2 1.5 1.7 0.4 1.2 1.2 1.7 1.2 1.0 1.2 1.2 1.2 3.1 1.7 1.5 1.2 1.2 3.9 0.9 29.4 1.2 1.2 1.6 1.2 1.4 1.2 1.2 1.4 0.6 1.1 0.6 1.4 3.3 0.5 0.6 1.1 2.2 2.0 4.5 4.2 1.3 3.6 1.9 1.2 2.1 2.0 1.3 5.5 2.7 1.9 1.2 2.6 4.3 0.2 1.8 0.9 2.9 1.1 4.9 0.5 1.2 1.0 5.1 1.6 6.9 1.0 1.0 4.6 0.8 4.3 1.5 3.5 2.5 0.7 0.4 3.9 2.2 2.5 2.6 1.0 0.1 4.0 2.8 1.6 1.3 0.2 1.2 0.6 3.0 2.4 0.4 3.5 1.4 1.3 2.6 1.8 1.0 1.0 2.5 2.2 2.5 2.1 2.2 0.6 0.6 0.1 0.7 0.3 1.3 1.4 1.7 3.3 0.3 0.5 1.0 1.1 1.1 1.4 0.1 0.6 3.0 0.5 1.2 1.7 3.7 1.7 1.3 2.5 1.2 1.2 1.7 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GCOM1 "FLJ30973, GRINL1A, MYZAP-POLR2M" ENSG00000137878 "GRINL1A complex locus 1" 15 57591908-57714745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 107.1;smooth muscle: 42.3" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 3.0;Cardiomyocytes: 2.8;Paneth cells: 3.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebellum: 10.4;pons and medulla: 3.9" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6;naive CD4 T-cell: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 3.6;monocytes: 1.5;T-cells: 4.0" "Cell line enhanced" "Detected in some" "HEL: 25.3;RH-30: 7.1;RT4: 8.0;TIME: 10.9" "HPA039827, HPA068141" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039827: AB_10673364, HPA068141: AB_2685962" "unprognostic (1.10e-1)" "unprognostic (3.62e-4)" "unprognostic (1.10e-1)" "unprognostic (5.43e-3)" "unprognostic (1.31e-3)" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (7.69e-4)" "unprognostic (1.22e-1)" "unprognostic (3.22e-3)" "unprognostic (3.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (7.44e-2)" "unprognostic (1.67e-1)" "unprognostic (5.78e-2)" 6.7 4.6 1.2 1.9 1.4 2.9 10.3 10.4 1.3 4.1 3.6 0.1 2.3 3.6 5.2 1.2 9.9 1.3 2.3 107.1 1.2 1.6 1.2 0.9 7.6 1.7 1.2 0.0 2.3 5.6 0.4 1.0 9.1 3.9 10.2 1.3 0.0 4.6 2.7 7.3 2.6 5.8 42.3 1.0 2.6 3.3 2.5 0.0 0.0 1.1 5.0 4.8 25.3 9.5 3.6 0.5 0.4 1.5 0.0 4.0 4.5 3.3 0.6 0.0 3.3 0.0 0.0 0.8 0.6 2.3 1.1 1.0 2.4 3.3 0.0 0.5 0.0 2.9 2.1 0.0 2.0 0.9 0.0 0.1 25.3 0.7 0.1 0.0 0.1 0.1 0.1 0.1 0.3 5.0 0.1 1.0 0.1 1.3 0.0 0.2 0.4 0.0 0.0 0.1 4.6 0.1 0.0 7.1 0.0 0.0 8.0 0.0 0.8 0.7 0.7 0.0 0.5 3.2 0.0 10.9 0.3 2.1 0.3 0.2 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 1.2 0.7 0.0 0.5 3.6 4.0 0.0 0.4 0.0 1.5 0.0 0.3 4.5 1.2 1.4 10.4 1.3 1.2 1.6 1.2 0.0 3.9 0.0 3.0 0.3 0.0 0.2 0.0 0.0 2.8 0.0 1.4 1.2 0.0 0.0 0.1 0.0 1.4 0.0 0.3 1.3 0.0 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.0 0.0 1.3 3.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.3 GDA ENSG00000119125 "Guanine deaminase" Q9Y2T3 9 72114595-72257193 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;intestine: 54.5;liver: 27.6" "Group enriched" "Detected in many" 7 "Enterocytes: 113.2;Hepatocytes: 49.7;Paneth cells: 91.2;Proximal tubular cells: 84.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 11.1;EFO-21: 44.1;HeLa: 15.4;hTCEpi: 20.6;OE19: 50.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "amygdala: 39.7;basal ganglia: 31.5;cerebral cortex: 63.2;hippocampal formation: 79.5;olfactory region: 28.4" "HPA019352, HPA024099, HPA030387" Enhanced Approved Nucleoplasm No NA 1300000 Nucleoplasm "HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351" "unprognostic (2.64e-2)" "unprognostic (7.10e-2)" "unprognostic (2.83e-2)" "unprognostic (2.92e-1)" "unprognostic (4.35e-2)" "unprognostic (8.45e-2)" "unprognostic (2.00e-1)" "unprognostic (5.60e-2)" "unprognostic (3.26e-1)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (5.56e-2)" "prognostic favorable (2.66e-5)" "unprognostic (2.23e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (8.30e-4)" 0.5 1.7 26.7 1.8 27.7 0.5 0.5 0.4 33.8 1.0 20.6 0.9 7.7 47.4 2.4 0.6 0.5 4.7 13.1 0.5 25.7 15.0 21.4 27.6 0.5 0.5 2.9 27.4 0.4 1.7 10.8 1.7 10.3 0.8 0.4 5.5 0.0 0.4 4.1 1.1 1.6 54.5 0.5 0.6 0.5 2.0 1.0 0.2 0.0 0.4 1.0 2.6 3.4 0.5 1.4 0.5 3.0 0.7 1.0 1.0 0.1 11.1 1.4 0.0 0.0 0.0 0.0 0.2 0.0 8.1 0.0 0.0 1.0 6.3 0.0 44.1 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 50.0 0.0 0.0 0.0 0.3 0.3 2.5 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.0 0.7 0.3 1.0 0.6 0.3 0.6 0.5 0.4 0.3 1.4 0.7 0.7 1.9 1.0 0.4 0.5 0.5 0.1 26.7 27.7 0.4 33.8 25.7 15.0 2.9 27.4 0.8 0.2 0.0 0.3 1.7 0.5 0.0 0.0 0.6 12.7 0.0 0.0 0.0 0.0 0.1 3.3 9.2 1.0 0.0 113.2 0.0 9.7 1.0 0.4 0.6 0.0 49.7 0.2 0.0 4.6 1.3 1.0 0.0 0.3 0.0 0.0 1.0 11.2 0.0 4.4 91.2 0.0 84.2 0.0 0.0 0.3 0.4 4.2 0.1 1.6 0.0 7.8 0.8 GEN1 "FLJ40869, Gen" ENSG00000178295 "GEN1, Holliday junction 5' flap endonuclease" Q17RS7 2 17753858-17788941 "Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.5" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA020078, HPA021141" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA020078: AB_2670352, HPA021141: AB_2670599" "unprognostic (2.25e-1)" "unprognostic (2.33e-1)" "unprognostic (1.52e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (8.64e-2)" "unprognostic (1.67e-3)" "unprognostic (7.90e-4)" "unprognostic (4.53e-2)" "unprognostic (1.70e-3)" "unprognostic (8.60e-3)" "unprognostic (8.04e-2)" "unprognostic (6.99e-2)" "unprognostic (1.89e-12)" "unprognostic (3.97e-3)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" "unprognostic (1.49e-3)" 3.0 3.0 2.8 15.6 4.0 14.9 3.9 2.3 5.1 3.2 5.9 3.7 4.3 3.3 2.1 11.1 9.0 2.4 4.7 2.8 2.9 2.5 3.4 11.2 3.3 11.9 2.3 3.2 1.8 3.8 2.6 8.6 4.4 4.8 4.6 7.6 7.3 8.8 3.7 2.7 8.8 6.9 1.6 2.8 8.5 3.4 27.5 2.2 24.3 3.4 11.3 13.7 2.6 5.2 5.1 2.2 1.1 1.4 1.2 2.1 1.0 16.3 8.6 9.6 7.4 2.3 3.3 14.0 11.8 4.4 7.4 8.0 10.4 8.6 19.7 4.6 4.8 6.4 11.5 9.5 8.6 10.8 11.6 6.1 10.6 9.6 5.9 1.6 12.1 10.9 2.2 3.3 9.5 5.8 2.3 4.8 9.1 11.7 13.0 12.1 9.7 9.4 11.3 6.7 6.8 4.3 10.8 22.0 7.2 4.3 10.8 10.4 13.8 5.9 10.3 4.7 7.1 6.7 5.4 5.6 15.5 7.1 8.5 12.5 8.0 14.1 30.0 6.9 12.7 10.0 0.3 1.4 1.1 1.1 1.1 0.9 5.1 1.2 2.1 2.0 2.9 1.3 1.4 0.7 1.2 1.3 2.2 1.7 1.0 2.8 4.0 2.3 5.1 2.9 2.5 2.3 3.2 4.8 2.2 6.0 2.2 6.5 2.3 2.5 5.5 3.9 2.5 6.7 11.4 3.5 11.8 3.1 0.0 1.9 3.9 1.4 6.4 23.3 2.0 3.6 3.9 2.5 1.1 4.2 3.3 3.2 1.7 1.3 3.5 2.7 1.7 2.6 1.7 2.8 4.8 3.8 2.0 3.5 0.7 2.1 3.2 6.5 3.8 12.3 9.0 1.6 2.7 1.0 4.3 2.6 GINS1 "KIAA0186, PSF1" ENSG00000101003 "GINS complex subunit 1" Q14691 20 25407727-25452628 "Predicted intracellular proteins" "DNA replication" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.1;testis: 21.4" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 43.6;Extravillous trophoblasts: 14.7;Late spermatids: 17.2;Spermatogonia: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051185 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051185: AB_2681378" "unprognostic (6.10e-3)" "unprognostic (2.58e-1)" "unprognostic (5.37e-3)" "unprognostic (1.74e-3)" "unprognostic (2.00e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (4.61e-7)" "unprognostic (5.86e-3)" "unprognostic (1.42e-2)" "unprognostic (1.32e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.42e-11)" "unprognostic (5.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.60e-2)" "unprognostic (2.55e-1)" 1.5 1.9 4.1 11.7 4.2 4.5 2.2 7.4 4.3 2.2 4.5 1.3 0.0 4.3 2.2 1.0 8.5 1.4 2.3 1.0 2.2 2.2 2.2 2.0 1.4 7.2 1.9 2.1 1.7 1.8 1.1 0.8 5.5 2.2 1.4 5.9 1.3 2.1 0.7 0.7 5.3 4.1 2.8 1.8 3.4 2.9 21.4 0.9 20.1 1.0 6.4 10.5 2.6 3.2 2.6 2.3 1.3 1.0 1.9 3.5 0.9 18.0 16.4 20.2 13.1 1.1 1.6 20.4 8.0 3.9 15.5 16.5 14.2 18.1 22.3 9.2 3.3 11.5 21.0 17.6 14.8 18.0 5.9 6.1 15.3 6.0 17.2 0.4 20.0 7.0 0.7 0.8 14.7 3.0 2.1 8.2 12.8 14.7 14.7 9.2 19.5 30.7 15.0 13.7 12.6 8.6 22.0 23.3 15.1 5.9 12.2 8.5 8.9 8.2 19.6 6.9 11.9 18.6 10.1 3.7 12.2 13.2 7.9 14.6 5.9 16.7 17.6 3.2 19.6 13.7 0.8 0.8 0.5 1.5 1.0 0.9 2.6 1.1 0.5 2.1 1.7 0.8 1.4 1.3 1.9 1.0 2.3 3.5 0.9 4.1 4.2 7.4 4.3 2.2 2.2 1.9 2.1 2.2 0.9 0.0 1.1 0.8 0.4 2.9 1.3 0.3 0.0 2.7 2.3 1.8 0.0 5.0 0.0 1.3 43.6 0.1 0.5 0.0 0.6 14.7 1.4 0.4 1.1 0.0 4.8 0.0 1.2 1.3 1.3 17.2 0.6 1.5 0.0 0.0 1.2 1.3 0.4 0.0 1.1 1.8 0.1 0.0 0.9 8.9 20.9 1.3 2.1 0.0 2.8 0.4 GINS2 "Pfs2, PSF2" ENSG00000131153 "GINS complex subunit 2" Q9Y248 16 85676198-85690073 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.2;testis: 21.3" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 65.9;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 11.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 72.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA057285 Uncertain Approved Nucleoplasm No Yes Nucleoplasm "HPA057285: AB_2683398" "unprognostic (3.22e-2)" "unprognostic (1.13e-3)" "unprognostic (2.04e-3)" "unprognostic (2.09e-1)" "unprognostic (2.64e-1)" "unprognostic (1.30e-1)" "unprognostic (2.45e-3)" "unprognostic (2.58e-2)" "unprognostic (1.67e-2)" "unprognostic (2.52e-3)" "unprognostic (2.19e-2)" "unprognostic (5.82e-3)" "unprognostic (5.70e-3)" "unprognostic (4.54e-2)" "unprognostic (6.30e-2)" "unprognostic (5.44e-3)" "unprognostic (1.60e-1)" 0.9 1.5 3.5 15.9 3.7 13.2 3.6 3.8 2.1 1.9 6.5 1.9 1.5 4.7 1.8 2.6 7.1 0.9 2.2 1.6 4.8 1.5 1.3 3.3 1.4 8.7 2.2 1.5 1.9 4.4 2.6 1.4 4.6 1.6 2.6 7.4 1.9 2.0 0.7 3.2 3.1 5.9 1.5 2.3 7.6 2.1 21.3 1.8 25.2 1.8 8.0 13.3 1.9 3.0 1.4 1.7 1.5 3.3 4.3 11.1 2.4 13.4 9.7 19.0 7.9 0.5 1.9 5.0 9.3 3.7 13.7 8.5 12.8 9.0 15.9 5.1 3.2 7.2 10.3 20.0 7.6 13.3 5.5 17.3 7.8 7.4 14.4 0.1 5.4 4.3 0.5 0.9 8.2 3.2 1.7 5.8 12.9 21.4 3.8 7.9 28.2 19.1 20.5 10.6 11.9 7.4 26.8 11.5 8.8 4.4 5.6 26.2 8.3 13.4 2.7 2.7 7.9 27.6 7.4 3.5 9.0 12.1 8.4 10.6 7.1 12.5 72.1 5.2 11.5 10.2 0.7 0.3 1.5 1.4 1.3 0.2 1.4 4.7 3.1 1.7 1.0 2.2 1.6 1.2 4.3 3.3 1.0 11.1 2.4 3.5 3.7 3.8 2.1 4.8 1.5 2.2 1.5 1.6 1.8 3.0 0.0 6.7 6.6 8.1 7.1 1.1 0.0 2.7 4.5 3.5 2.0 17.0 3.3 6.0 8.2 0.6 1.6 23.3 1.3 22.7 3.1 2.7 1.1 1.7 19.7 7.9 2.9 0.0 0.6 22.2 1.1 2.8 0.0 1.0 8.2 3.4 1.5 5.8 1.8 0.3 8.0 19.4 3.1 65.9 96.9 3.3 10.6 5.1 29.9 1.6 GINS3 "FLJ13912, PSF3" ENSG00000181938 "GINS complex subunit 3" Q9BRX5 16 58295080-58406144 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 53.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041216, HPA048209" Uncertain Enhanced Nucleoplasm No No Nucleoplasm "HPA041216: AB_10794989, HPA048209: AB_2680314" "unprognostic (3.12e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-3)" "unprognostic (6.34e-2)" "unprognostic (4.70e-2)" "unprognostic (2.82e-1)" "unprognostic (1.75e-4)" "unprognostic (7.76e-2)" "unprognostic (1.76e-3)" "unprognostic (7.19e-2)" "unprognostic (4.50e-2)" "unprognostic (2.67e-3)" "unprognostic (1.14e-7)" "unprognostic (9.76e-3)" "unprognostic (5.34e-2)" "unprognostic (8.23e-2)" "unprognostic (1.07e-2)" 5.5 10.6 3.3 5.6 11.4 9.9 4.4 20.4 4.7 5.9 6.6 3.2 13.2 4.3 5.6 5.5 11.5 3.4 3.3 8.2 3.5 3.6 5.3 4.2 6.1 10.0 5.8 1.5 2.8 2.3 6.0 4.2 6.3 4.5 3.5 6.0 3.3 4.8 10.0 3.9 5.4 5.0 5.1 4.1 11.9 3.4 8.0 4.9 17.5 4.9 14.3 13.1 3.8 7.9 4.7 10.9 0.5 2.4 5.0 4.1 2.1 7.3 8.3 10.0 5.4 1.1 1.4 5.0 8.4 3.7 13.4 10.2 6.1 7.4 12.8 6.7 2.8 10.1 7.0 9.2 7.0 15.2 7.1 11.3 7.5 4.7 7.4 0.6 9.5 12.9 1.6 1.3 6.9 2.4 3.0 9.1 10.7 11.9 5.5 5.6 7.5 17.3 8.7 9.4 6.3 17.1 30.1 11.1 16.3 4.9 4.7 11.6 7.7 13.9 9.2 4.6 4.2 4.8 7.8 3.8 9.1 10.6 5.4 10.4 5.5 7.1 53.9 6.3 9.6 11.0 0.2 2.4 0.2 2.9 2.2 2.1 3.5 2.4 4.1 5.5 4.7 2.3 3.6 0.5 5.0 1.2 10.9 3.2 2.1 3.3 11.4 20.4 4.3 3.5 3.6 5.8 1.5 4.5 4.9 0.0 1.6 5.2 3.9 1.5 1.3 3.0 0.0 1.4 1.2 0.0 2.0 4.9 0.0 3.1 15.8 2.8 0.5 0.0 1.8 6.7 1.0 1.5 1.1 0.8 2.4 4.8 0.0 2.5 2.1 7.1 1.4 1.1 1.7 2.8 0.6 1.5 1.5 0.0 1.1 0.4 1.8 6.5 1.5 4.2 8.1 2.0 2.6 2.5 2.2 5.4 GLIS2 NPHP7 ENSG00000126603 "GLIS family zinc finger 2" Q9BZE0 16 4314761-4339597 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Ciliopathy, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 31.8;Smooth muscle cells: 30.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062755, HPA065406" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA062755: , HPA065406: " "unprognostic (2.86e-1)" "unprognostic (3.27e-2)" "unprognostic (5.96e-2)" "prognostic unfavorable (1.59e-5)" "unprognostic (3.76e-1)" "unprognostic (5.15e-2)" "unprognostic (8.13e-2)" "unprognostic (6.65e-2)" "unprognostic (3.94e-1)" "unprognostic (2.37e-3)" "unprognostic (3.59e-1)" "unprognostic (2.48e-1)" "prognostic favorable (8.06e-6)" "unprognostic (1.59e-3)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (4.40e-3)" 3.6 6.0 1.5 2.3 1.6 0.0 2.4 4.3 2.4 5.0 4.4 1.2 5.8 1.0 1.2 4.3 7.4 8.4 0.9 1.2 11.5 0.3 7.8 1.4 1.4 8.0 3.2 2.2 5.3 5.7 5.6 0.2 3.0 5.8 1.1 1.5 1.2 4.3 0.2 0.8 2.7 1.9 5.3 0.5 5.6 2.7 0.3 0.0 0.2 0.0 0.0 0.1 0.0 4.0 10.6 1.7 3.9 1.4 5.7 3.6 4.5 4.3 1.6 1.2 2.9 3.0 0.0 7.9 4.9 1.9 2.6 1.0 4.5 0.1 4.7 0.0 0.0 8.1 1.5 6.2 0.0 0.8 3.3 1.1 1.5 0.7 2.3 1.5 0.1 0.3 1.8 1.1 2.6 0.1 0.9 3.8 0.6 1.8 6.8 2.3 4.8 0.0 0.1 0.8 3.7 5.2 2.2 1.0 0.6 6.3 0.7 3.4 2.4 3.9 28.0 1.4 0.8 0.5 1.3 0.9 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.9 9.8 0.0 6.2 4.9 10.4 4.9 20.4 2.7 4.5 12.2 3.9 0.1 16.6 10.0 0.1 6.0 0.0 0.0 7.4 0.9 20.7 2.6 0.0 0.6 0.3 6.4 0.0 5.5 0.0 0.4 20.4 1.2 3.3 1.8 0.0 9.4 7.6 0.0 31.8 19.5 6.5 0.0 30.9 0.0 3.4 2.5 0.9 0.0 0.0 1.7 GLIS3 "MGC33662, ZNF515" ENSG00000107249 "GLIS family zinc finger 3" Q8NEA6 9 3824127-4348392 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Congenital hypothyroidism, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 57.8" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 45.9;Collecting duct cells: 66.3;Ductal cells: 42.5;Intestinal endocrine cells: 42.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 15.4;HSkMC: 23.4;RPTEC TERT1: 14.5;U-251 MG: 12.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056426 Approved Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA056426: AB_2683128" "unprognostic (6.24e-2)" "unprognostic (2.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.63e-3)" "unprognostic (4.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.81e-2)" "unprognostic (7.14e-2)" "unprognostic (4.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.17e-1)" "unprognostic (2.63e-1)" "unprognostic (1.91e-3)" "unprognostic (6.88e-3)" "unprognostic (8.54e-2)" "unprognostic (1.04e-1)" "unprognostic (6.35e-2)" 5.6 2.8 5.6 4.4 7.4 1.0 2.9 3.5 9.5 13.4 2.9 10.7 33.5 1.6 6.1 6.5 1.5 15.0 14.7 4.7 8.9 4.5 11.4 5.1 5.7 2.6 7.7 3.8 10.4 17.3 6.4 8.8 2.8 16.3 5.3 4.0 4.6 5.2 57.8 2.1 1.4 2.2 5.1 26.7 3.8 3.2 4.6 10.2 0.0 29.3 1.4 1.7 5.6 8.8 0.0 0.0 1.8 0.9 0.3 0.7 0.0 0.6 6.7 2.0 0.0 2.7 7.4 0.2 5.1 15.4 2.3 3.4 1.1 2.4 0.0 4.0 3.7 7.7 0.0 1.3 0.0 4.8 1.5 1.0 0.0 0.3 0.0 8.1 0.7 0.0 23.4 0.0 7.1 0.7 4.2 0.4 0.0 0.0 0.1 1.9 0.2 0.0 0.9 0.1 0.0 0.9 0.0 4.6 0.0 14.5 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 5.1 2.6 0.6 2.7 12.1 0.0 0.0 0.0 7.1 0.0 3.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.7 1.1 0.3 0.9 0.0 0.1 0.0 5.6 7.4 3.5 9.5 8.9 4.5 7.7 3.8 16.3 10.2 8.9 20.0 0.9 6.4 1.6 0.2 1.1 45.9 29.4 30.7 66.3 0.0 2.0 0.0 42.5 3.6 5.8 2.0 0.0 20.0 2.7 6.6 10.3 1.1 6.6 2.1 0.0 42.0 6.2 1.0 1.8 12.7 2.7 3.3 3.6 1.1 22.1 34.5 2.9 10.6 17.0 0.2 0.0 10.3 0.7 4.3 1.1 3.5 1.0 3.5 3.9 GMEB1 "P96PIF, PIF96" ENSG00000162419 "Glucocorticoid modulatory element binding protein 1" Q9Y692 1 28668732-28719353 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044811, HPA052975" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044811: AB_10959666, HPA052975: AB_2682003" "unprognostic (1.52e-1)" "unprognostic (3.55e-2)" "unprognostic (2.49e-2)" "prognostic favorable (1.94e-4)" "unprognostic (2.71e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.91e-7)" "unprognostic (1.42e-2)" "unprognostic (1.41e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (3.38e-2)" "unprognostic (8.41e-2)" "unprognostic (4.79e-3)" "unprognostic (3.44e-1)" "unprognostic (1.75e-1)" "unprognostic (1.13e-2)" 8.3 6.6 8.0 14.0 6.5 21.1 8.7 13.5 9.0 8.8 8.0 8.4 6.4 5.4 10.9 8.0 10.4 8.5 8.0 6.8 7.8 4.9 6.6 7.3 8.7 11.3 5.8 7.0 12.1 7.5 8.6 8.8 16.4 5.8 7.2 8.4 8.0 7.4 6.8 10.3 9.3 8.6 9.1 6.3 11.5 7.4 11.4 6.4 25.3 7.5 7.0 14.1 7.9 12.4 10.8 9.7 14.4 12.7 10.6 12.8 6.3 9.3 6.8 11.6 10.4 3.8 7.1 8.2 10.0 7.3 6.5 9.7 2.1 7.6 17.3 5.3 9.3 3.9 3.7 10.3 7.8 8.5 19.7 6.3 16.1 7.1 4.1 5.8 13.3 8.3 5.7 5.6 15.7 10.2 5.7 8.9 8.7 9.6 13.9 7.8 8.2 8.3 4.4 15.4 6.3 4.6 5.6 7.9 8.0 4.9 7.7 8.5 7.0 9.5 6.5 6.5 8.1 4.9 6.9 9.0 4.5 10.8 7.6 13.5 6.2 10.5 9.7 5.4 12.5 7.0 10.0 8.2 14.4 11.1 10.2 8.4 6.6 10.6 12.8 9.7 10.8 8.8 9.3 11.8 10.6 12.7 7.2 8.9 6.3 8.0 6.5 13.5 9.0 7.8 4.9 5.8 7.0 5.8 6.4 6.0 24.8 13.5 13.9 15.0 22.8 4.2 5.1 5.3 12.5 14.0 11.8 11.6 5.0 9.2 8.0 10.6 9.6 23.3 9.5 13.6 7.3 9.8 27.7 5.6 9.4 23.8 7.5 17.8 12.9 2.2 8.9 11.7 1.7 8.2 11.1 17.5 9.5 10.4 7.4 4.9 23.9 19.4 7.6 14.4 27.4 14.6 27.0 15.9 9.2 15.6 GMNN Gem ENSG00000112312 "Geminin, DNA replication inhibitor" O75496 6 24774931-24786099 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "DNA replication inhibitor" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 95.0" "Cell type enhanced" "Detected in many" 8 "Paneth cells: 272.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011458, CAB047327, CAB047328, HPA049977, HPA054597" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538" "unprognostic (1.37e-1)" "unprognostic (3.43e-3)" "unprognostic (3.91e-3)" "unprognostic (1.52e-2)" "unprognostic (1.28e-1)" "unprognostic (4.37e-2)" "unprognostic (2.90e-3)" "unprognostic (8.29e-2)" "unprognostic (1.23e-3)" "prognostic favorable (4.13e-4)" "prognostic unfavorable (9.77e-4)" "unprognostic (1.33e-2)" "prognostic unfavorable (7.82e-5)" "unprognostic (2.25e-1)" "unprognostic (7.92e-2)" "unprognostic (3.63e-2)" "unprognostic (5.90e-3)" 4.5 3.9 10.7 11.2 19.0 24.1 10.7 15.6 9.4 4.9 17.1 3.2 9.7 7.6 5.3 6.3 8.0 7.3 4.7 3.7 11.0 10.2 10.8 8.4 4.4 12.0 13.6 9.8 7.2 95.0 2.6 7.5 7.9 10.7 18.4 18.9 3.4 4.2 11.6 3.7 17.3 7.4 5.7 7.9 12.6 9.7 19.6 11.9 26.1 13.2 11.0 9.7 15.2 7.4 8.5 9.2 15.8 6.7 5.3 15.2 5.6 24.9 14.8 37.6 15.5 5.3 5.7 25.1 24.5 13.0 29.5 32.4 28.7 9.0 25.1 31.3 7.9 21.7 14.7 32.5 18.1 31.8 9.3 34.0 34.4 26.4 47.0 5.0 26.7 12.6 4.6 5.9 17.9 7.0 6.1 14.5 19.6 43.2 13.4 20.8 19.5 50.1 28.9 20.5 20.4 11.7 29.2 29.4 32.2 12.4 21.8 30.2 18.6 11.0 18.2 21.6 22.1 19.1 16.4 7.1 18.1 18.3 20.8 41.5 14.9 45.7 47.1 5.5 50.4 25.9 5.3 5.3 15.8 4.6 6.7 5.8 8.5 8.9 7.1 7.4 4.5 6.6 7.3 3.0 5.3 4.7 9.2 15.2 5.6 10.7 19.0 15.6 9.4 11.0 10.2 13.6 9.8 10.7 11.9 6.0 14.1 15.7 25.3 29.3 8.9 9.4 15.3 33.5 52.4 41.8 2.0 52.0 8.3 78.3 58.9 14.3 21.2 0.0 100.1 110.5 15.8 27.7 12.7 15.3 45.0 11.1 24.9 9.8 9.2 17.5 8.9 12.4 21.9 19.8 24.9 29.4 43.9 272.7 10.3 14.6 12.1 19.4 12.3 132.2 59.4 55.6 40.7 17.5 87.0 19.7 GMPPA ENSG00000144591 "GDP-mannose pyrophosphorylase A" Q96IJ6 2 219498867-219506989 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035512, HPA035513" Approved Approved Nucleoplasm NA NA 17000 Nucleoplasm "HPA035512: AB_2674660, HPA035513: AB_10671934" "unprognostic (3.43e-1)" "unprognostic (3.95e-2)" "unprognostic (7.75e-3)" "unprognostic (1.40e-3)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (5.57e-1)" "unprognostic (2.39e-1)" "unprognostic (2.25e-1)" "unprognostic (1.17e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.90e-10)" "prognostic favorable (5.24e-4)" "unprognostic (1.28e-1)" "unprognostic (2.01e-1)" "unprognostic (2.28e-1)" 12.0 15.8 10.3 13.6 14.7 9.9 12.9 10.2 14.6 21.1 17.7 16.5 23.2 17.1 16.7 44.3 14.8 14.6 12.0 16.2 10.4 7.0 22.5 54.1 12.8 11.0 15.8 11.5 12.7 39.8 17.6 28.8 21.4 12.2 21.2 20.0 12.6 37.4 20.3 12.6 10.2 23.6 16.0 13.2 21.1 17.6 9.6 14.3 8.9 24.8 8.1 18.4 13.7 13.5 16.6 21.8 29.2 27.0 17.2 18.4 16.0 14.2 11.7 7.3 12.8 28.1 25.0 19.4 24.9 33.4 29.3 36.5 21.5 13.6 7.7 17.7 35.9 18.9 13.5 13.4 21.5 25.5 15.0 11.6 15.1 12.0 38.1 25.4 7.8 17.8 19.1 17.5 27.5 31.3 15.3 17.9 10.0 26.7 22.6 22.7 17.8 7.7 14.8 7.5 17.5 12.8 6.1 7.8 13.8 16.8 9.7 9.4 8.2 10.4 15.8 17.0 16.0 10.5 12.7 10.3 17.0 11.8 30.6 13.5 15.6 6.2 9.3 34.8 8.8 19.0 29.2 26.5 17.7 15.8 26.7 18.4 16.6 12.6 16.6 21.7 10.4 9.4 8.7 5.9 17.2 27.0 21.8 16.3 16.0 10.3 14.7 10.2 14.6 10.4 7.0 15.8 11.5 12.2 14.3 14.9 15.6 10.0 10.6 4.9 6.1 11.8 10.2 6.7 11.4 15.7 5.9 32.0 29.9 19.9 0.5 6.3 37.6 0.0 26.4 64.3 15.8 14.8 18.5 33.8 30.0 1.6 10.4 13.5 17.8 1.9 17.0 17.9 11.8 13.6 41.5 10.3 19.7 34.5 12.7 28.1 3.5 12.9 7.2 4.6 6.4 7.4 39.5 8.5 23.6 11.6 GP6 GPVI ENSG00000088053 "Glycoprotein VI platelet" Q9HCN6 19 55013705-55038264 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.9" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 5.9;Early spermatids: 10.5;Late spermatids: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "HEL: 13.9;K-562: 5.9;U-2 OS: 4.0" HPA066482 Approved Approved Nucleoplasm "Intracellular and membrane" NA NA 28000000 Nucleoplasm "HPA066482: AB_2685674" "unprognostic (3.06e-3)" "unprognostic (4.58e-2)" "unprognostic (1.74e-5)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (7.50e-4)" "unprognostic (2.81e-1)" "unprognostic (1.00e-1)" "unprognostic (4.18e-2)" "unprognostic (3.04e-1)" "unprognostic (1.12e-1)" "unprognostic (1.53e-1)" "unprognostic (2.62e-1)" "unprognostic (3.32e-2)" "unprognostic (5.44e-3)" "unprognostic (2.70e-2)" 0.3 0.3 0.8 0.4 1.4 4.4 0.9 4.6 1.6 1.3 0.4 0.3 0.3 0.1 1.1 0.3 2.1 0.5 0.5 5.4 0.7 0.9 0.4 1.5 1.4 0.3 0.3 0.3 0.6 0.3 0.6 0.3 2.8 0.3 0.6 0.4 2.0 0.7 3.0 0.3 3.2 0.3 0.3 0.3 8.9 0.1 4.2 1.0 0.3 0.6 0.3 0.3 0.7 1.8 0.0 0.3 1.3 0.2 0.0 0.1 4.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.6 0.2 0.0 0.2 0.2 0.5 13.9 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.3 5.9 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.4 0.2 0.2 0.1 4.0 0.1 0.0 0.3 0.0 0.4 0.1 0.4 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 4.0 0.8 1.4 4.6 1.6 0.7 0.9 0.3 0.3 0.3 1.0 0.0 0.0 0.0 0.1 0.0 1.5 0.4 0.0 1.4 0.0 0.0 5.9 0.1 0.0 0.0 10.5 0.3 0.3 0.0 0.3 0.2 0.2 0.3 1.1 0.0 0.1 3.2 0.0 2.5 1.2 6.4 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 2.4 0.0 0.0 1.1 0.9 0.1 0.5 0.0 0.0 0.7 GPATCH11 "CCDC75, CENP-Y, CENPY, FLJ38348" ENSG00000152133 "G-patch domain containing 11" Q8N954 2 37084451-37099244 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038231, HPA038232" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA038231: AB_2675904, HPA038232: AB_10675788" "unprognostic (1.28e-2)" "unprognostic (1.58e-1)" "unprognostic (2.45e-1)" "unprognostic (1.80e-1)" "unprognostic (3.88e-2)" "unprognostic (2.23e-2)" "unprognostic (4.58e-3)" "unprognostic (2.40e-2)" "unprognostic (2.44e-2)" "unprognostic (4.39e-2)" "unprognostic (1.16e-1)" "unprognostic (1.26e-1)" "unprognostic (8.64e-3)" "unprognostic (4.31e-2)" "unprognostic (4.44e-2)" "unprognostic (3.40e-2)" "unprognostic (7.16e-2)" 26.0 8.5 14.4 9.4 15.8 11.0 11.1 16.0 17.5 9.9 6.0 10.7 4.0 6.2 7.3 5.2 6.8 5.1 5.9 6.9 14.3 13.9 7.3 7.3 8.0 14.8 16.1 16.2 8.2 4.4 6.6 11.2 7.3 15.3 5.6 6.6 4.9 5.2 5.8 7.3 7.6 6.4 5.7 22.7 9.7 6.2 14.1 15.5 8.6 8.5 2.8 14.3 8.0 8.2 9.3 12.9 5.9 2.8 7.3 4.9 1.5 6.4 3.9 6.7 5.1 14.3 6.6 7.1 11.7 4.7 7.1 5.8 4.9 2.8 7.5 6.6 4.3 6.1 4.6 7.8 2.8 10.6 12.7 8.6 13.6 5.3 4.9 4.6 16.2 14.9 4.3 5.0 9.7 5.5 4.7 6.2 4.7 12.7 35.5 8.2 3.2 10.4 9.0 2.8 10.7 5.5 8.7 14.2 20.9 3.1 2.8 8.0 7.5 6.1 3.9 5.7 5.6 4.1 7.5 6.8 12.9 7.1 9.3 12.8 13.9 14.3 11.5 9.2 13.7 11.3 5.9 2.8 2.3 4.9 2.0 4.9 9.3 3.7 4.1 3.8 7.8 4.0 4.1 0.9 7.3 0.8 12.9 2.6 1.5 14.4 15.8 16.0 17.5 14.3 13.9 16.1 16.2 15.3 15.5 11.9 7.2 15.2 2.2 3.8 24.7 12.0 10.2 14.7 4.5 10.4 23.6 7.4 10.0 6.9 21.3 12.8 9.6 23.3 12.4 22.3 6.4 1.9 11.5 12.1 11.4 12.7 2.9 17.8 11.9 3.6 15.0 15.8 3.3 9.0 5.2 28.4 10.9 3.6 20.8 7.1 47.4 12.9 5.7 69.5 41.8 4.6 3.2 9.6 5.2 1.8 GPCPD1 "GDE5, GDPD6, KIAA1434" ENSG00000125772 "Glycerophosphocholine phosphodiesterase 1" Q9NPB8 20 5544404-5611026 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 145.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042987 Approved Nucleoplasm NA NA Nucleoplasm "HPA042987: AB_2678254" "unprognostic (2.25e-2)" "unprognostic (2.45e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.30e-4)" "unprognostic (2.93e-2)" "unprognostic (8.10e-2)" "unprognostic (1.63e-1)" "unprognostic (1.39e-2)" "unprognostic (3.76e-2)" "unprognostic (1.67e-1)" "unprognostic (1.46e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.56e-1)" "unprognostic (1.22e-1)" "unprognostic (1.51e-1)" "unprognostic (2.30e-2)" 12.9 12.9 10.6 21.8 17.6 56.7 12.7 29.6 28.2 12.2 8.8 9.1 36.7 7.4 12.5 10.5 10.6 12.6 13.2 12.6 12.2 10.1 8.1 8.1 43.6 30.6 13.1 8.9 18.1 8.9 4.5 10.3 13.4 19.4 9.6 10.6 11.0 34.2 31.2 31.8 9.1 15.1 21.5 14.6 24.9 8.8 8.1 4.0 12.1 13.4 17.0 17.5 13.7 9.8 4.2 4.5 16.2 7.1 3.6 4.6 3.4 3.8 7.3 5.0 4.0 3.3 3.9 5.7 6.1 4.9 3.5 2.4 3.8 3.0 8.6 1.1 3.4 3.2 1.3 6.2 12.1 3.4 1.8 2.0 11.8 0.8 4.4 16.0 7.2 5.4 8.3 15.8 2.1 26.1 3.6 3.7 5.4 6.7 4.5 3.2 2.1 6.5 3.9 2.7 6.8 4.2 4.7 6.0 3.1 4.8 3.2 1.9 2.5 2.7 11.9 5.7 5.2 2.8 20.3 4.1 3.0 2.2 8.2 3.9 4.3 7.4 9.2 0.9 8.9 3.3 2.6 7.1 9.0 4.0 5.5 3.1 4.2 3.0 3.3 4.5 3.8 4.6 3.1 16.2 3.6 5.5 2.0 2.4 3.4 10.6 17.6 29.6 28.2 12.2 10.1 13.1 8.9 19.4 4.0 20.8 56.2 34.4 13.7 14.7 16.4 35.1 15.3 13.4 31.8 21.0 5.9 24.1 3.3 10.4 145.3 24.3 12.0 70.0 7.9 13.9 20.4 21.1 42.7 15.3 42.6 11.1 18.9 20.9 80.0 39.0 5.2 52.4 10.1 10.0 20.3 9.1 6.0 8.6 3.2 6.3 19.4 6.5 35.6 39.0 9.5 24.0 40.7 32.0 10.4 44.4 GPKOW "GPATC5, GPATCH5, Spp2, T54" ENSG00000068394 "G-patch domain and KOW motifs" Q92917 X 49113389-49123801 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000287, HPA001894" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000287: AB_1079015, HPA001894: AB_1079014" "unprognostic (3.34e-2)" "unprognostic (9.54e-3)" "unprognostic (8.95e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (1.19e-1)" "unprognostic (2.03e-3)" "unprognostic (1.02e-1)" "unprognostic (9.29e-2)" "unprognostic (7.96e-2)" "unprognostic (4.32e-1)" "unprognostic (7.08e-2)" "unprognostic (1.14e-2)" "unprognostic (3.17e-1)" "unprognostic (2.73e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-2)" 14.9 14.6 20.1 11.8 23.1 15.0 13.8 24.3 25.3 14.5 14.8 22.6 11.7 15.3 15.5 13.4 14.7 17.0 11.3 17.0 17.6 20.1 12.3 15.8 12.8 14.1 22.9 28.9 14.3 11.5 22.4 15.8 14.7 20.0 13.8 13.9 12.1 13.4 19.3 31.9 16.9 14.1 15.3 20.3 14.0 13.5 8.0 22.3 15.7 14.2 9.0 14.9 14.8 12.1 21.3 17.0 20.7 24.8 17.8 29.5 14.6 20.5 21.9 14.7 12.3 13.0 11.3 16.0 13.4 15.1 21.3 22.7 15.9 20.7 8.6 10.3 16.4 21.9 14.6 16.2 15.8 14.0 18.1 17.3 9.0 18.4 11.2 15.6 10.6 19.1 12.3 20.2 17.0 17.4 12.6 15.9 17.5 11.0 13.6 13.8 33.5 14.5 17.7 10.4 11.1 17.5 18.2 16.2 23.4 10.9 26.3 12.3 14.3 15.5 14.8 14.3 16.2 28.4 13.9 17.7 12.4 18.8 17.9 12.6 21.0 14.3 11.7 15.9 17.7 19.0 19.3 16.8 20.7 29.5 23.1 24.0 15.4 23.2 22.0 17.0 21.3 19.7 18.5 13.3 17.8 24.8 15.5 22.7 14.6 20.1 23.1 24.3 25.3 17.6 20.1 22.9 28.9 20.0 22.3 17.9 8.3 11.7 11.1 7.1 14.9 10.4 28.1 6.7 17.0 7.0 3.9 23.1 13.3 22.4 0.8 10.8 14.9 23.3 22.2 16.9 13.4 9.1 11.5 13.0 14.5 4.8 7.5 9.8 7.0 1.3 14.4 10.8 5.0 15.4 10.8 15.8 21.4 21.0 14.2 17.0 11.7 38.8 14.4 5.2 17.9 8.7 36.6 14.4 10.7 10.8 GPS2 ENSG00000132522 "G protein pathway suppressor 2" Q13227 17 7311324-7315564 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Erythroid cells: 116.8;Late spermatids: 206.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067540 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA067540: AB_2685860" "unprognostic (1.53e-2)" "unprognostic (3.43e-1)" "unprognostic (3.33e-2)" "unprognostic (1.71e-3)" "unprognostic (1.55e-1)" "unprognostic (1.53e-4)" "unprognostic (1.37e-2)" "unprognostic (1.33e-1)" "unprognostic (3.18e-2)" "unprognostic (2.84e-1)" "prognostic favorable (7.50e-5)" "unprognostic (1.37e-2)" "prognostic unfavorable (3.42e-5)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (6.87e-2)" "unprognostic (1.28e-3)" 21.8 22.8 21.1 17.6 20.9 27.8 25.0 18.2 25.4 18.5 23.4 19.1 14.4 14.4 20.0 15.5 24.6 19.9 15.5 35.3 19.9 17.1 28.7 30.1 18.5 15.2 19.5 16.9 20.9 23.0 26.6 21.1 21.9 16.5 17.5 20.2 14.3 19.7 21.5 72.4 23.0 25.7 18.2 21.2 20.6 18.0 45.8 22.1 21.2 22.4 21.0 21.1 19.2 25.0 55.2 48.3 58.1 46.4 28.2 57.0 38.8 19.8 38.5 12.3 16.8 24.6 13.9 14.2 14.4 17.0 29.1 25.1 26.7 10.2 22.4 10.9 19.7 20.8 27.2 15.6 28.0 22.6 27.3 24.5 20.7 36.6 33.0 17.5 12.4 24.2 13.1 19.4 40.1 10.7 13.1 17.0 20.2 12.5 5.3 30.2 16.8 24.1 13.1 16.8 20.9 16.1 18.5 22.8 22.9 21.6 22.4 16.4 27.5 23.4 15.0 19.7 14.4 14.8 12.1 10.2 13.7 14.1 18.9 33.4 17.5 24.8 14.9 20.5 14.6 23.8 44.1 35.3 58.1 40.8 43.0 38.4 55.2 45.5 45.8 29.5 43.3 42.5 38.5 56.4 28.2 46.4 48.3 57.0 38.8 21.1 20.9 18.2 25.4 19.9 17.1 19.5 16.9 16.5 22.1 11.9 9.6 21.7 8.7 14.1 27.6 1.0 15.3 18.7 21.6 19.2 62.8 11.4 21.6 17.7 78.1 12.8 48.4 116.8 23.3 9.1 9.8 7.6 18.5 9.5 8.9 36.5 16.1 9.8 14.9 206.1 19.5 12.6 18.6 19.8 16.9 17.6 18.7 21.0 14.5 19.3 44.7 19.4 13.6 30.3 47.1 14.8 16.4 27.7 17.5 7.3 GRHL2 "BOM, DFNA28, FLJ13782, TFCP2L3" ENSG00000083307 "Grainyhead like transcription factor 2" Q6ISB3 8 101492432-101669726 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Corneal dystrophy, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 47.9;seminal vesicle: 42.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 29.8;Ciliated cells: 40.2;Club cells: 27.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.2" "Cell line enhanced" "Detected in some" "A-431: 15.6;CACO-2: 11.4;HaCaT: 19.1;hTCEpi: 14.9;MCF7: 13.1;OE19: 15.3;RT4: 28.1;T-47d: 33.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004820, HPA062839" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004820: AB_1857928, HPA062839: AB_2684878" "prognostic unfavorable (6.43e-4)" "unprognostic (2.54e-2)" "unprognostic (4.09e-2)" "unprognostic (2.95e-2)" "unprognostic (2.68e-1)" "unprognostic (4.79e-2)" "unprognostic (1.90e-1)" "unprognostic (2.66e-1)" "unprognostic (1.64e-1)" "unprognostic (8.59e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (2.61e-2)" "unprognostic (8.29e-4)" "unprognostic (4.54e-3)" "unprognostic (2.64e-1)" "unprognostic (1.08e-1)" "unprognostic (1.03e-2)" 0.4 0.3 0.4 3.3 0.4 0.0 11.3 0.3 0.4 6.0 9.9 0.0 34.7 2.1 1.6 16.4 18.7 5.2 10.3 0.4 0.4 0.4 6.4 0.7 11.3 0.0 0.4 0.0 1.5 22.1 7.1 1.5 47.9 0.1 15.2 5.6 0.1 15.0 42.4 0.4 18.0 8.6 1.6 0.4 0.4 5.9 0.6 0.0 1.7 12.7 14.3 12.2 7.4 8.4 0.0 0.0 0.0 0.0 1.2 0.2 0.0 15.6 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 11.4 7.8 0.0 0.0 0.0 0.0 19.1 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 28.1 0.5 0.0 0.0 6.2 0.0 1.9 33.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.0 0.1 0.0 29.8 8.8 0.0 9.3 21.6 0.0 0.4 10.2 40.2 27.3 10.4 0.0 12.4 5.0 6.5 2.2 0.4 5.9 0.0 4.8 5.9 0.8 10.0 0.0 0.0 1.3 0.0 1.2 0.0 0.0 4.1 0.0 0.0 1.7 1.0 10.0 0.0 7.4 7.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 22.7 16.6 0.0 7.6 5.1 GRHL3 "SOM, TFCP2L4" ENSG00000158055 "Grainyhead like transcription factor 3" Q8TE85 1 24319322-24364482 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 59.0;lymphoid tissue: 60.1;tongue: 51.5" "Group enriched" "Detected in some" 5 "Suprabasal keratinocytes: 86.8;Urothelial cells: 72.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 28.9" "Region enhanced" "Detected in some" "pons and medulla: 3.6" "Group enriched" "Detected in some" 12 "eosinophil: 1.0;neutrophil: 1.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 21.4;HaCaT: 16.8;MCF7: 25.9;OE19: 9.4;RT4: 29.6;SuSa: 16.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA059960 Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA059960: AB_2684180" "unprognostic (8.99e-2)" "unprognostic (1.23e-1)" "unprognostic (3.95e-2)" "unprognostic (7.83e-3)" "unprognostic (7.58e-3)" "unprognostic (6.28e-3)" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (9.01e-3)" "unprognostic (4.03e-2)" "unprognostic (1.24e-1)" "unprognostic (7.36e-2)" "unprognostic (8.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.83e-1)" "unprognostic (6.97e-3)" "unprognostic (7.42e-2)" 0.1 0.1 0.1 0.1 0.9 0.0 1.0 0.2 0.9 9.0 0.1 0.2 0.0 0.2 0.6 0.8 59.0 0.2 0.6 0.1 1.1 0.3 0.6 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.9 0.1 1.1 3.6 3.6 0.1 0.0 5.9 0.9 0.2 21.7 0.1 0.5 3.0 0.0 0.2 1.1 0.1 0.5 0.1 51.5 60.1 12.3 11.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.5 1.2 0.4 0.0 0.0 0.0 21.4 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 16.8 0.0 1.5 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.6 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 25.9 0.0 0.1 1.1 9.4 0.0 0.0 0.0 0.1 2.1 29.6 0.1 0.0 0.0 2.9 0.0 16.3 1.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.2 0.1 1.1 0.3 0.1 0.0 3.6 0.1 0.0 1.1 0.0 8.8 12.8 0.0 0.4 0.0 2.7 2.3 1.8 0.0 3.5 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.3 9.1 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.0 86.8 15.4 0.0 0.0 72.5 GSDMD "DF5L, FLJ12150, GSDMDC1" ENSG00000104518 "Gasdermin D" P57764 8 143553207-143563062 "Predicted intracellular proteins, Transporters" "Immunity, Inflammatory response, Innate immunity, Necrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 225.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004656, HPA044487" Uncertain Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB004656: AB_426076, HPA044487: AB_2678957" "unprognostic (1.11e-2)" "unprognostic (8.44e-2)" "unprognostic (6.72e-2)" "unprognostic (4.00e-2)" "unprognostic (4.38e-2)" "unprognostic (1.10e-1)" "unprognostic (1.66e-1)" "unprognostic (2.65e-1)" "unprognostic (7.20e-2)" "unprognostic (6.36e-2)" "unprognostic (4.66e-2)" "unprognostic (8.90e-2)" "prognostic unfavorable (1.43e-4)" "unprognostic (8.51e-3)" "unprognostic (1.60e-1)" "unprognostic (1.96e-1)" "unprognostic (6.77e-3)" 15.1 13.3 4.8 19.7 5.9 18.6 19.2 2.2 4.6 12.1 25.4 3.9 17.2 23.3 13.9 15.6 14.5 13.7 22.4 11.6 5.1 2.6 21.7 64.6 19.0 28.1 6.8 2.8 14.8 18.3 6.9 6.9 17.0 6.8 13.6 7.2 10.9 17.9 15.0 8.7 5.8 31.7 13.0 5.3 42.9 13.2 4.1 5.0 17.2 20.0 9.8 15.9 11.5 13.1 19.6 22.9 20.8 32.3 19.6 30.4 21.6 11.5 6.7 0.1 0.0 4.2 4.7 8.7 5.4 11.3 14.4 13.8 3.4 15.4 5.3 9.4 5.6 6.5 4.6 0.2 8.8 4.4 15.3 1.0 11.0 2.2 6.5 5.1 3.1 0.5 9.9 0.8 5.2 3.1 5.7 11.6 11.2 0.5 13.8 0.6 0.4 23.5 3.9 0.1 8.2 20.9 10.6 1.3 14.1 6.2 15.1 0.2 0.2 17.3 10.7 11.5 2.6 19.8 7.0 5.4 0.1 17.9 1.2 6.9 4.6 7.0 0.1 8.5 7.1 5.9 20.8 21.9 20.0 26.5 32.3 22.8 19.6 24.5 26.5 22.9 17.2 18.9 20.9 18.9 19.6 26.7 13.2 30.4 21.6 4.8 5.9 2.2 4.6 5.1 2.6 6.8 2.8 6.8 5.0 11.9 26.1 49.1 34.0 9.6 0.2 9.7 45.9 20.1 18.2 29.6 0.0 56.0 51.4 54.3 1.8 43.6 225.0 0.0 80.6 77.0 30.7 33.5 27.6 63.6 55.5 0.0 38.1 73.1 50.7 3.2 21.9 36.3 16.9 82.0 83.9 26.1 56.4 154.3 21.2 93.5 1.1 58.2 23.5 0.9 6.6 7.9 34.9 68.6 85.6 32.7 GSK3B ENSG00000082701 "Glycogen synthase kinase 3 beta" P49841 3 119821323-120094417 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Carbohydrate metabolism, Differentiation, Glycogen metabolism, Neurogenesis, Wnt signaling pathway" "Developmental protein, Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase" "Alzheimer disease, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 135.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016263, HPA028017" Approved Supported Nucleoplasm No No 81000 Nucleoplasm "CAB016263: AB_2279451, HPA028017: AB_10600708" "unprognostic (1.09e-2)" "unprognostic (2.62e-1)" "unprognostic (1.40e-1)" "unprognostic (2.17e-3)" "unprognostic (1.15e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (8.20e-5)" "unprognostic (3.39e-2)" "unprognostic (1.11e-1)" "unprognostic (1.67e-2)" "unprognostic (1.05e-3)" "unprognostic (6.79e-2)" "prognostic favorable (1.52e-4)" "unprognostic (2.39e-1)" "unprognostic (2.58e-1)" "unprognostic (1.28e-2)" "unprognostic (1.16e-1)" 17.6 17.6 17.4 13.8 21.3 25.0 13.7 32.7 28.3 15.8 16.0 15.6 7.1 15.5 14.5 12.6 20.3 12.4 14.4 20.8 17.1 22.4 15.7 21.7 17.1 17.5 17.0 22.6 14.0 14.9 25.0 19.2 24.1 18.1 13.9 17.9 14.9 18.5 11.7 23.9 21.6 18.2 17.1 13.4 26.3 13.3 30.8 14.4 46.5 17.4 8.4 14.1 14.2 15.7 1.7 2.0 10.6 3.1 1.4 3.0 1.0 28.7 13.9 23.3 13.5 15.5 15.8 22.6 16.2 31.2 15.6 14.3 15.0 11.8 11.7 10.0 23.1 18.1 19.7 11.0 31.5 24.3 7.9 3.1 17.0 10.4 11.2 17.7 17.5 22.9 15.9 21.2 16.6 34.0 12.7 17.1 15.5 7.2 22.8 20.4 15.6 18.5 4.9 12.7 11.0 14.4 7.4 19.9 11.2 11.3 20.6 17.6 10.9 19.1 13.9 18.7 23.8 17.2 11.8 21.9 22.4 25.3 7.0 9.6 15.1 13.9 22.6 13.9 11.7 17.8 4.3 2.9 7.5 2.4 2.6 2.1 1.1 2.0 3.0 2.0 1.7 2.0 1.5 10.6 1.4 3.1 1.6 1.3 1.0 17.4 21.3 32.7 28.3 17.1 22.4 17.0 22.6 18.1 14.4 29.8 26.1 16.6 27.4 45.2 58.2 34.8 17.8 13.4 17.0 17.4 56.9 22.4 10.0 21.7 114.4 21.8 32.1 0.0 28.0 43.2 22.6 25.0 17.3 20.3 19.0 135.1 25.8 23.9 27.9 40.1 12.0 22.7 33.7 24.4 23.3 27.6 35.4 22.6 18.7 11.5 40.3 12.9 20.0 34.2 22.5 35.9 35.9 24.1 20.4 35.8 GSS ENSG00000100983 "Glutathione synthetase" P48637 20 34928433-34956027 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054508, HPA059315" Enhanced Supported Nucleoplasm NA NA 23000000 Nucleoplasm "HPA054508: AB_2682509, HPA059315: AB_2683976" "unprognostic (5.80e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (7.21e-2)" "unprognostic (3.63e-2)" "unprognostic (5.68e-2)" "prognostic unfavorable (7.21e-5)" "unprognostic (2.90e-2)" "unprognostic (8.52e-2)" "unprognostic (3.64e-1)" "unprognostic (6.49e-2)" "unprognostic (1.50e-1)" "prognostic favorable (7.31e-6)" "unprognostic (3.35e-3)" "unprognostic (1.96e-1)" "unprognostic (1.42e-3)" "unprognostic (1.52e-1)" 12.9 29.8 14.7 13.2 21.0 16.0 16.2 9.2 27.6 12.7 26.9 17.2 28.9 20.0 11.5 47.5 25.6 18.5 18.3 14.6 15.0 15.9 30.5 30.9 12.1 11.7 15.1 15.1 11.6 10.3 17.5 15.6 27.2 15.3 18.6 27.6 15.4 19.1 19.4 10.7 19.1 21.4 12.9 13.3 13.3 15.7 16.8 9.2 17.0 18.0 12.0 21.0 14.4 13.9 7.3 24.3 7.9 21.3 15.2 18.3 14.9 18.2 22.2 10.9 15.3 12.7 13.2 15.5 15.6 14.4 24.6 20.4 40.7 22.3 12.9 20.8 16.0 23.8 17.4 15.9 39.7 20.8 6.0 9.0 51.0 14.1 40.4 17.9 12.8 18.0 13.9 42.5 23.1 39.1 11.0 17.4 17.6 24.6 10.6 29.8 20.1 20.4 18.2 6.4 24.1 28.7 18.8 21.9 30.7 35.2 18.7 21.4 12.5 27.5 25.8 20.5 6.2 31.7 11.7 13.7 28.3 16.1 18.6 13.4 10.8 10.0 14.2 24.1 14.1 16.8 7.9 20.3 4.6 18.0 21.3 16.1 7.3 14.5 18.3 24.3 5.2 16.9 14.3 5.3 15.2 19.0 13.5 17.5 14.9 14.7 21.0 9.2 27.6 15.0 15.9 15.1 15.1 15.3 9.2 17.9 8.0 10.4 28.7 23.4 20.6 14.0 30.6 8.1 12.5 24.4 9.8 69.5 21.6 40.0 44.5 14.6 44.5 0.0 41.7 42.0 15.3 18.9 17.3 23.3 52.3 33.4 22.5 5.5 16.2 108.3 9.5 20.4 15.1 40.5 44.4 26.6 32.4 28.8 17.3 95.3 15.4 25.8 12.2 16.4 14.7 21.1 41.0 20.3 70.9 22.9 GSTCD FLJ13273 ENSG00000138780 "Glutathione S-transferase C-terminal domain containing" Q8NEC7 4 105708778-105847728 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 93.7;Late spermatids: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 11.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 11.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046160, HPA061782" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA046160: AB_10961048, HPA061782: AB_2797265" "unprognostic (4.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.06e-3)" "unprognostic (4.44e-3)" "unprognostic (6.44e-2)" "unprognostic (6.43e-2)" "unprognostic (1.84e-3)" "unprognostic (4.30e-2)" "unprognostic (2.43e-1)" "unprognostic (1.53e-1)" "unprognostic (1.38e-2)" "unprognostic (5.46e-2)" "unprognostic (8.67e-2)" "unprognostic (8.59e-2)" "unprognostic (2.68e-1)" "unprognostic (1.32e-2)" "unprognostic (7.02e-2)" 6.5 6.1 7.6 7.2 10.1 9.3 11.2 11.0 9.7 8.2 7.3 8.4 5.7 5.2 9.3 10.0 10.0 8.8 7.7 5.6 7.4 7.8 10.3 5.7 6.3 9.4 7.5 6.5 7.2 6.3 7.6 13.1 7.2 10.0 8.2 8.3 14.4 7.4 7.6 5.6 6.9 5.9 8.4 10.5 6.9 6.6 20.5 6.4 15.1 10.7 5.4 9.8 7.1 7.1 2.0 1.9 11.4 1.9 1.9 2.2 0.9 7.7 7.0 16.1 14.0 4.1 5.5 12.1 10.9 5.6 13.6 12.4 6.5 14.9 9.3 5.7 4.6 7.9 6.4 18.3 11.5 19.2 13.8 5.5 7.8 6.8 8.8 1.9 14.3 5.4 2.9 5.8 12.4 9.6 5.1 8.3 9.5 14.9 8.5 11.4 6.3 14.9 5.3 8.8 11.4 8.9 10.3 9.5 5.3 14.8 5.7 13.1 5.8 8.5 12.1 4.7 14.8 10.9 5.8 6.2 10.1 10.6 6.2 8.5 3.2 6.7 5.2 6.3 7.4 13.8 0.9 1.4 0.6 1.3 1.7 1.5 1.5 1.2 0.4 1.4 2.0 1.4 2.2 11.4 1.9 1.9 1.9 0.2 0.9 7.6 10.1 11.0 9.7 7.4 7.8 7.5 6.5 10.0 6.4 6.0 3.8 1.5 3.4 2.3 19.6 2.2 10.2 1.4 1.2 8.7 25.5 4.9 3.3 4.6 93.7 3.6 2.9 0.0 4.3 6.8 3.5 4.0 2.3 5.3 6.3 20.6 4.1 3.1 4.7 41.2 7.8 3.0 5.0 4.6 3.5 7.2 5.2 0.0 4.2 3.7 22.0 0.0 4.2 7.2 4.7 3.8 2.7 2.5 4.4 1.7 GTF2A2 "HsT18745, TFIIA" ENSG00000140307 "General transcription factor IIA subunit 2" P52657 15 59638062-59657541 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 117.1" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 673.0;Late spermatids: 563.9;Spermatocytes: 832.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056239 Supported Nucleoplasm NA NA Nucleoplasm "HPA056239: AB_2683074" "unprognostic (2.18e-2)" "unprognostic (3.21e-1)" "unprognostic (9.37e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (1.53e-2)" "unprognostic (3.06e-2)" "unprognostic (1.31e-2)" "unprognostic (7.35e-2)" "unprognostic (6.29e-2)" "unprognostic (3.47e-1)" "unprognostic (7.13e-2)" "unprognostic (1.58e-1)" "unprognostic (2.79e-1)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" 20.7 25.7 19.3 22.6 27.5 26.3 35.2 19.1 21.8 17.4 26.6 14.3 18.3 17.5 20.6 24.3 27.0 18.3 18.6 38.6 21.0 20.3 22.3 24.2 24.1 28.3 22.5 18.3 21.4 23.8 13.0 26.1 18.6 24.9 18.2 22.6 16.1 26.3 25.3 26.7 14.6 18.2 20.0 28.8 19.4 18.2 117.1 15.9 20.8 21.8 26.3 21.2 18.2 24.7 41.1 65.0 53.2 44.1 36.2 41.8 39.2 31.2 44.5 29.8 28.6 18.2 15.2 34.4 35.3 16.3 28.9 29.2 48.0 12.7 29.0 33.0 22.6 43.5 26.9 30.0 21.2 21.3 50.4 24.6 33.0 34.6 30.2 24.2 35.9 29.7 14.5 20.5 24.4 20.8 21.0 18.9 22.4 47.1 29.7 23.7 21.9 23.3 27.6 40.0 10.5 26.1 22.0 31.5 35.5 28.2 37.0 32.3 34.7 32.8 37.7 32.9 41.8 26.2 38.0 26.0 28.1 49.9 31.3 63.2 29.6 85.8 63.1 32.0 60.5 34.0 45.3 44.0 53.2 31.0 44.1 32.2 41.1 36.3 34.3 56.6 33.0 31.3 34.1 22.9 36.2 40.8 65.0 41.8 39.2 19.3 27.5 19.1 21.8 21.0 20.3 22.5 18.3 24.9 15.9 38.7 50.9 81.9 137.1 87.6 47.3 113.7 63.7 109.7 76.2 61.1 45.2 183.6 179.1 136.5 673.0 78.8 67.4 93.5 130.5 166.8 100.9 133.1 78.7 71.5 131.0 47.7 78.8 68.2 95.2 563.9 116.5 102.0 75.9 159.7 82.6 100.0 143.4 101.9 129.0 103.7 52.7 64.7 97.3 832.7 160.9 93.3 127.0 86.6 107.2 228.6 GTF2E1 "FE, TFIIE-A" ENSG00000153767 "General transcription factor IIE subunit 1" P29083 3 120742637-120783069 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009884, HPA056359, HPA066881" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009884: AB_2279381, HPA056359: AB_2683106, HPA066881: AB_2685740" "unprognostic (3.19e-1)" "unprognostic (1.40e-1)" "unprognostic (2.05e-1)" "unprognostic (1.05e-2)" "unprognostic (8.94e-2)" "unprognostic (3.23e-1)" "unprognostic (4.36e-3)" "unprognostic (2.62e-1)" "unprognostic (2.64e-2)" "unprognostic (1.59e-1)" "unprognostic (4.38e-2)" "unprognostic (9.34e-3)" "unprognostic (5.10e-2)" "unprognostic (8.29e-3)" "unprognostic (4.94e-1)" "unprognostic (3.19e-2)" "unprognostic (2.97e-1)" 11.1 18.0 8.6 10.7 9.9 6.6 10.0 9.1 9.9 9.2 8.5 11.6 7.3 7.8 13.3 8.1 9.4 7.6 6.4 8.5 8.8 8.3 12.9 12.7 8.4 14.0 9.3 7.6 10.5 14.5 8.4 12.9 11.9 9.1 8.2 10.4 7.9 18.7 10.2 12.8 7.8 9.8 10.0 11.9 14.0 7.8 16.3 8.9 25.6 9.6 10.0 14.9 9.2 9.5 10.9 10.5 16.8 12.9 11.9 12.0 8.7 9.2 13.0 16.3 9.9 12.3 5.7 14.2 6.2 5.7 9.8 10.6 15.5 6.7 15.2 11.0 4.6 7.6 11.2 15.0 8.2 13.8 10.5 3.5 19.6 9.5 12.9 9.6 17.6 11.9 7.5 8.9 7.3 10.4 6.7 15.0 13.1 13.6 8.0 10.3 10.6 14.5 8.9 15.5 9.0 12.1 12.0 19.2 11.3 9.7 6.0 3.5 10.8 9.4 8.2 8.4 15.4 10.4 13.6 13.1 9.2 10.1 2.9 7.0 7.1 7.7 21.8 9.7 17.9 8.8 16.8 8.5 13.0 8.5 12.9 11.1 10.9 10.1 12.0 10.5 9.1 11.1 10.7 6.2 11.9 11.7 4.9 11.4 8.7 8.6 9.9 9.1 9.9 8.8 8.3 9.3 7.6 9.1 8.9 3.0 4.1 11.0 2.7 1.6 4.5 4.5 10.2 2.7 6.8 7.0 0.0 7.7 5.0 4.5 5.6 3.6 2.6 0.0 3.9 7.0 3.1 2.6 12.7 3.8 8.1 15.9 1.2 6.2 6.5 2.0 2.0 6.3 3.3 12.6 3.2 5.2 4.3 0.0 4.6 4.8 4.1 0.0 1.9 12.6 21.5 2.3 7.3 5.0 3.5 2.8 GTF2H1 "BTF2, P62, TFIIH" ENSG00000110768 "General transcription factor IIH subunit 1" P32780 11 18322295-18367044 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004637, HPA046660" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004637: AB_425470, HPA046660: AB_2679743" "unprognostic (2.25e-1)" "unprognostic (2.33e-1)" "unprognostic (9.78e-2)" "unprognostic (2.38e-1)" "unprognostic (2.63e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (5.98e-9)" "unprognostic (7.71e-2)" "unprognostic (4.24e-2)" "unprognostic (2.81e-1)" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (7.42e-3)" "unprognostic (8.31e-2)" "unprognostic (1.24e-1)" "unprognostic (7.90e-2)" "unprognostic (2.94e-1)" 27.1 26.4 24.1 18.2 28.8 10.5 33.0 32.6 35.7 21.5 21.6 19.3 24.1 18.0 23.5 23.1 26.2 18.6 22.9 21.4 24.1 20.4 25.9 25.0 19.1 23.7 19.6 22.2 27.2 24.3 27.1 32.4 24.3 27.4 22.5 20.9 21.2 25.8 26.0 20.8 32.4 21.7 20.6 21.1 23.4 20.5 38.5 23.3 22.7 29.3 21.7 25.7 22.9 22.2 12.0 11.8 20.3 12.1 15.9 13.9 8.8 12.3 11.4 9.6 13.7 22.1 17.6 12.1 18.5 20.0 16.5 19.0 11.9 4.9 20.7 7.4 19.0 23.8 17.2 15.8 17.0 21.4 9.1 15.6 13.4 11.7 12.0 31.5 25.7 14.6 19.8 20.4 10.2 32.4 13.6 14.5 11.0 20.5 11.0 23.7 11.5 12.9 20.5 8.4 20.8 16.5 13.3 20.5 9.6 13.6 17.0 11.0 11.9 15.3 14.8 22.8 8.7 7.7 15.1 10.7 22.3 10.8 39.8 15.0 5.6 13.3 15.2 19.2 20.2 21.1 20.3 10.9 11.3 9.1 11.0 9.8 11.7 11.5 10.1 11.8 12.0 13.9 11.1 7.9 15.9 12.1 6.5 11.0 8.8 24.1 28.8 32.6 35.7 24.1 20.4 19.6 22.2 27.4 23.3 14.9 12.8 15.4 18.2 42.8 16.7 22.8 22.9 28.1 22.7 10.4 19.6 21.2 6.6 19.7 33.7 20.4 13.9 0.0 26.5 23.5 19.3 19.1 17.4 11.4 21.7 20.6 7.5 21.5 18.0 32.8 15.8 23.4 21.9 24.4 11.2 20.1 23.7 8.6 15.2 18.8 19.3 6.5 26.4 48.3 30.1 45.2 23.6 15.3 15.5 21.4 GTF2H3 "BTF2, P34, TFIIH" ENSG00000111358 "General transcription factor IIH subunit 3" Q13889 12 123633739-123662606 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004844, HPA053562" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004844: AB_2667265, HPA053562: AB_2682191" "unprognostic (1.07e-1)" "unprognostic (1.36e-1)" "unprognostic (6.02e-2)" "unprognostic (6.13e-3)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (6.72e-8)" "unprognostic (1.02e-1)" "unprognostic (1.22e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-1)" "unprognostic (1.10e-1)" "unprognostic (5.68e-3)" "unprognostic (4.71e-2)" "unprognostic (1.22e-1)" "unprognostic (7.49e-2)" "unprognostic (2.80e-2)" 15.8 15.8 17.4 15.2 22.0 12.2 19.7 23.2 23.8 16.1 17.2 21.4 9.3 13.0 18.4 18.1 22.5 19.4 12.3 13.5 16.9 17.3 15.8 25.3 12.1 18.8 16.7 19.8 16.9 10.8 16.1 24.0 16.1 24.6 17.1 21.1 14.8 15.6 15.4 16.1 16.1 13.7 18.2 17.9 17.3 14.6 17.9 16.1 23.6 17.2 23.1 19.4 15.7 15.2 7.4 8.6 10.5 8.6 12.8 11.7 5.2 18.7 10.0 12.9 16.5 16.0 17.9 18.3 14.3 17.7 22.1 15.0 10.5 9.7 21.9 17.6 19.6 8.9 12.8 21.3 25.9 26.6 18.5 15.0 17.9 9.3 15.1 22.5 36.0 11.9 19.0 19.8 17.9 40.7 16.7 15.8 27.4 26.7 7.3 19.9 12.2 17.9 12.2 16.6 13.3 18.5 18.5 19.7 12.3 11.4 18.3 11.6 10.3 18.9 9.2 14.3 14.8 25.8 21.8 10.4 13.9 10.6 21.5 22.9 13.5 18.3 21.6 16.0 18.4 15.9 10.5 5.6 7.2 9.9 8.6 10.0 7.4 8.1 10.4 8.6 7.3 11.7 10.5 0.8 12.8 7.8 7.3 8.1 5.2 17.4 22.0 23.2 23.8 16.9 17.3 16.7 19.8 24.6 16.1 20.8 22.4 7.5 9.7 10.4 16.0 5.6 12.7 24.1 26.1 12.2 9.8 22.3 3.3 8.5 5.3 7.0 6.5 0.0 9.5 18.5 12.9 9.2 24.2 14.7 16.0 15.9 6.4 9.8 7.9 1.9 10.9 9.5 1.7 16.2 10.5 21.6 8.9 12.4 10.6 12.5 13.5 12.9 7.9 18.7 24.9 11.5 19.8 6.9 15.1 10.0 GTF2I "BAP-135, BTKAP1, DIWS, IB291, SPIN, TFII-I, WBSCR6" ENSG00000263001 "General transcription factor IIi" P78347 7 74657667-74760692 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004595, HPA026638" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004595: AB_628345, HPA026638: AB_1857959" "unprognostic (3.47e-1)" "unprognostic (2.26e-2)" "unprognostic (3.63e-1)" "unprognostic (1.61e-1)" "unprognostic (3.21e-1)" "unprognostic (1.11e-1)" "unprognostic (7.08e-2)" "unprognostic (2.53e-2)" "unprognostic (1.15e-2)" "unprognostic (1.63e-1)" "unprognostic (8.80e-3)" "unprognostic (1.28e-1)" "prognostic favorable (6.35e-6)" "unprognostic (7.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.19e-1)" "unprognostic (5.88e-2)" 10.2 14.3 12.6 10.2 14.3 4.0 11.5 13.1 15.2 11.3 8.6 15.4 6.0 9.1 10.5 9.6 9.9 12.5 10.8 8.6 12.8 13.5 10.2 10.2 8.8 18.1 9.7 12.1 8.5 29.0 12.4 9.8 12.9 12.1 6.9 12.1 11.7 10.3 13.4 10.9 7.9 11.1 8.8 7.5 12.0 4.3 16.0 21.2 22.3 6.3 11.6 10.3 7.1 16.8 14.8 10.9 6.9 14.2 13.2 5.8 29.6 24.5 50.8 49.8 28.1 25.0 10.6 18.8 17.3 20.8 20.7 17.0 36.2 35.8 7.6 23.0 27.7 26.1 49.7 22.6 26.9 26.9 26.3 18.2 29.1 23.6 16.9 34.5 27.3 23.1 19.5 15.7 16.2 30.5 27.8 12.1 35.5 17.1 25.0 27.6 28.7 30.9 54.4 63.3 15.3 31.6 17.6 29.3 27.3 51.7 42.6 54.4 34.2 51.5 17.2 44.6 26.3 22.9 24.8 28.6 15.4 14.3 23.9 20.2 17.8 56.9 16.3 20.9 28.5 5.1 6.9 10.9 8.3 5.1 13.2 14.6 11.3 12.9 10.5 16.8 13.1 12.9 2.8 14.2 4.2 14.8 5.7 5.8 74.5 52.9 73.0 73.2 53.3 262.6 25.7 193.6 52.2 54.6 113.4 267.0 84.7 48.0 123.3 33.9 79.4 49.7 0.0 72.6 51.4 66.4 111.8 12.7 84.7 68.3 236.8 108.4 117.2 104.4 29.3 141.5 49.6 52.3 67.7 67.6 192.8 108.5 76.4 181.4 83.8 173.7 84.1 49.5 22.3 38.3 80.4 60.4 45.7 63.2 92.7 GTF2IRD2 "FLJ37938, GTF2IRD2A" ENSG00000196275 "GTF2I repeat domain containing 2" Q86UP8 7 74796144-74851551 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 35.0" "HPA056679, HPA056680" Approved Nucleoplasm NA NA Nucleoplasm "HPA056679: AB_2683205, HPA056680: AB_2683206" "unprognostic (7.91e-5)" "unprognostic (3.90e-3)" "unprognostic (1.43e-2)" "unprognostic (5.35e-2)" "unprognostic (2.02e-1)" "unprognostic (1.85e-2)" "unprognostic (5.47e-2)" "unprognostic (6.80e-3)" "unprognostic (1.22e-1)" "unprognostic (6.11e-2)" "unprognostic (4.43e-5)" "unprognostic (3.18e-2)" "unprognostic (8.97e-3)" "unprognostic (2.58e-1)" "unprognostic (6.35e-2)" "unprognostic (1.19e-1)" "unprognostic (1.59e-4)" 3.9 4.3 3.1 2.1 2.0 4.0 5.6 2.1 2.1 6.0 5.6 3.2 5.6 3.1 3.1 6.0 2.5 4.6 2.8 2.7 4.6 6.4 4.3 2.8 2.8 9.3 6.6 4.3 5.6 1.9 6.5 3.8 4.9 4.3 21.6 3.2 3.8 4.5 2.7 3.4 5.3 2.6 6.0 2.9 4.5 4.2 14.9 12.4 10.4 6.8 5.0 9.8 6.6 9.7 3.4 4.4 6.6 6.4 4.2 4.0 3.3 3.4 4.0 4.4 0.7 8.1 2.6 0.9 5.4 6.7 2.0 0.1 2.1 3.3 1.2 0.8 2.5 5.0 4.6 6.0 3.4 0.4 3.9 3.2 1.1 3.1 4.8 3.9 1.9 6.0 5.3 3.6 9.0 1.3 9.7 7.3 10.4 2.3 2.5 1.5 9.1 9.2 8.5 3.3 10.3 13.6 35.0 7.5 3.9 7.4 6.5 3.7 5.9 1.5 1.0 5.3 4.1 1.7 2.6 5.1 2.4 12.6 10.4 6.8 7.2 3.4 3.9 5.0 14.9 7.6 9.8 7.0 10.0 9.2 5.9 1.1 5.0 3.3 12.4 6.5 6.6 17.9 20.6 19.7 9.7 2.9 23.8 10.1 22.9 25.4 21.6 12.2 53.0 5.5 3.3 17.6 17.8 5.8 12.5 0.0 24.7 5.1 9.3 11.3 13.9 8.1 3.9 35.0 25.9 16.5 5.1 3.8 40.6 6.9 10.1 8.2 20.3 16.6 22.6 21.0 24.4 4.2 42.7 12.9 8.6 2.7 2.0 3.8 5.4 12.9 24.0 6.8 GTF2IRD2B ENSG00000174428 "GTF2I repeat domain containing 2B" Q6EKJ0 7 75092573-75149817 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 12.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA056679, HPA056680" Approved Nucleoplasm NA NA Nucleoplasm "HPA056679: AB_2683205, HPA056680: AB_2683206" "prognostic favorable (3.27e-4)" "unprognostic (1.32e-2)" "unprognostic (1.07e-1)" "unprognostic (2.70e-1)" "unprognostic (1.25e-1)" "unprognostic (1.53e-2)" "unprognostic (2.19e-2)" "unprognostic (6.28e-2)" "unprognostic (1.32e-1)" "unprognostic (2.86e-1)" "unprognostic (8.90e-4)" "unprognostic (1.54e-2)" "unprognostic (7.21e-3)" "unprognostic (2.31e-1)" "unprognostic (3.61e-1)" "unprognostic (3.18e-3)" "unprognostic (2.65e-5)" 7.3 6.7 6.3 9.2 13.4 7.5 9.9 5.9 9.4 11.2 11.0 11.4 4.6 2.7 13.4 4.4 5.4 12.7 9.2 12.3 7.9 4.5 8.7 9.5 8.2 7.3 11.0 6.7 21.7 10.4 10.5 7.5 4.2 10.8 12.9 5.7 9.8 7.2 8.4 18.8 4.7 5.6 11.3 5.8 4.4 8.7 3.5 14.1 6.3 7.8 4.0 7.1 13.0 6.7 12.8 1.5 5.1 1.9 1.6 3.3 0.5 12.1 5.6 8.7 9.8 7.0 9.8 6.6 6.7 10.1 3.2 8.2 2.5 9.8 8.1 6.6 6.9 12.3 4.4 4.1 4.3 3.9 9.8 3.8 6.0 7.2 5.1 13.6 8.8 8.6 9.0 9.0 2.6 11.6 11.2 4.6 3.0 7.6 17.1 10.4 8.7 6.2 20.5 8.7 11.1 8.2 12.0 2.8 11.3 9.0 9.3 8.5 14.9 13.4 14.8 14.3 2.5 14.4 8.9 7.2 8.1 5.4 7.6 8.5 6.7 4.0 20.7 4.2 9.0 17.8 0.5 1.3 5.1 1.2 1.9 2.0 12.8 2.1 2.6 1.2 5.7 3.3 1.3 1.7 1.6 1.1 1.5 2.7 0.5 6.3 13.4 5.9 9.4 7.9 4.5 11.0 6.7 10.8 14.1 0.0 9.6 11.3 4.4 3.9 8.5 20.6 12.7 9.4 2.3 7.0 11.8 1.7 0.0 10.5 11.1 6.6 8.1 0.0 11.3 1.6 8.2 4.5 3.5 11.1 2.2 12.7 18.5 8.0 8.9 3.6 25.3 3.5 20.3 4.6 13.8 4.8 12.0 14.0 15.9 2.9 12.7 12.9 10.3 2.3 1.3 3.8 2.5 5.7 13.8 3.4 GTF3A "AP2, TFIIIA" ENSG00000122034 "General transcription factor IIIA" Q92664 13 27424544-27435823 "Predicted intracellular proteins, Transcription factors" "Ribosome biogenesis, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007990 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA007990: AB_1857960" "unprognostic (9.88e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-1)" "unprognostic (1.36e-1)" "unprognostic (2.87e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-2)" "unprognostic (8.64e-2)" "unprognostic (7.53e-2)" "unprognostic (1.21e-1)" "unprognostic (1.39e-1)" "unprognostic (3.41e-1)" "prognostic unfavorable (3.43e-6)" "unprognostic (1.98e-1)" "unprognostic (1.33e-1)" "unprognostic (3.26e-1)" "unprognostic (1.41e-1)" 28.1 19.5 33.8 23.4 32.4 36.9 39.1 20.4 29.4 16.7 21.0 13.6 17.5 14.0 14.5 27.1 20.4 16.6 21.5 88.6 30.6 19.3 23.6 59.9 19.2 42.5 26.0 12.6 13.0 53.5 8.3 15.6 13.5 16.2 16.5 20.2 14.6 35.2 19.0 60.2 14.0 17.4 19.1 22.5 36.8 20.9 11.5 18.0 50.6 15.9 39.7 42.1 21.6 16.9 58.8 57.7 29.0 33.7 45.2 72.2 82.3 17.9 14.4 14.3 28.4 20.2 22.6 18.1 19.0 18.6 25.4 16.5 21.0 28.7 52.9 13.3 23.5 15.7 12.6 28.5 27.6 35.7 55.5 16.0 43.9 14.4 23.2 23.3 81.6 30.3 18.0 29.2 23.4 30.8 19.3 22.6 53.8 34.0 19.1 29.4 30.7 64.9 89.2 24.0 61.7 36.8 30.3 33.3 50.1 28.5 7.2 32.2 16.7 13.1 19.9 27.9 18.5 15.1 42.9 12.8 13.2 13.6 9.9 19.8 12.0 21.3 60.8 14.0 52.6 23.9 18.9 33.4 29.0 53.0 33.7 72.2 58.8 54.7 57.5 42.8 48.0 42.4 48.0 7.3 45.2 30.9 57.7 66.5 82.3 33.8 32.4 20.4 29.4 30.6 19.3 26.0 12.6 16.2 18.0 41.7 33.6 153.3 47.9 56.1 40.6 185.2 79.0 29.4 37.5 26.2 27.5 70.6 127.6 132.7 27.3 76.8 14.6 23.3 165.6 158.6 74.3 71.7 74.9 132.8 192.6 33.4 33.5 33.2 126.7 60.5 59.0 122.2 92.8 166.9 56.5 34.4 144.7 24.6 54.8 167.8 27.4 84.1 74.1 27.7 142.9 56.2 35.2 149.5 64.4 57.8 GTF3C2 "KIAA0011, TFIIIC110" ENSG00000115207 "General transcription factor IIIC subunit 2" Q8WUA4 2 27325849-27357034 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008274, HPA035836" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008274: , HPA035836: AB_10601813" "unprognostic (1.76e-1)" "unprognostic (9.64e-2)" "unprognostic (9.89e-2)" "prognostic unfavorable (8.25e-5)" "unprognostic (1.33e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (1.21e-8)" "unprognostic (1.57e-1)" "unprognostic (1.77e-2)" "unprognostic (1.47e-1)" "unprognostic (2.59e-2)" "unprognostic (7.39e-2)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.94e-1)" "unprognostic (7.97e-2)" "unprognostic (3.00e-1)" 16.5 23.7 15.4 21.9 19.8 17.0 18.1 22.5 22.5 19.4 22.1 25.0 25.3 18.7 19.8 25.1 30.6 21.3 21.7 19.0 13.3 11.9 21.7 17.9 20.5 20.5 15.5 12.5 19.5 27.4 30.8 19.0 22.8 19.4 18.6 24.1 26.3 26.5 19.2 28.8 27.9 24.5 20.2 12.4 25.2 20.9 24.8 15.2 28.3 25.3 21.6 30.1 20.0 18.4 12.7 14.9 23.2 17.1 12.0 15.6 17.4 29.7 26.8 22.6 21.7 13.4 13.1 33.1 10.9 14.9 14.4 12.3 19.9 19.1 26.2 19.7 15.1 14.9 18.0 33.2 20.9 13.9 20.6 28.9 22.0 18.1 26.2 12.3 23.9 22.0 16.4 18.9 16.4 21.2 13.8 18.4 17.9 30.6 19.7 13.9 24.5 22.1 17.5 42.5 24.2 17.0 27.4 25.0 29.3 20.4 22.5 21.0 37.1 11.7 28.3 19.9 20.2 15.1 13.7 14.2 17.6 19.3 13.3 20.3 21.9 23.9 58.8 17.6 19.4 19.2 23.2 16.0 13.3 14.4 14.8 15.6 12.7 12.8 15.3 14.9 12.7 13.2 12.4 8.6 12.0 17.1 9.5 8.2 17.4 15.4 19.8 22.5 22.5 13.3 11.9 15.5 12.5 19.4 15.2 17.9 16.6 6.0 8.4 8.8 10.7 9.8 12.7 9.4 13.6 5.2 21.6 16.1 8.3 13.6 56.2 5.8 12.4 23.3 19.6 19.5 8.6 8.8 17.4 9.3 14.2 9.5 3.4 11.1 14.6 49.8 8.6 9.8 5.0 11.8 20.6 8.8 16.8 3.5 7.4 10.2 16.7 6.5 8.2 7.9 18.8 11.0 16.7 10.2 17.1 11.6 GTF3C5 "TFiiiC2-63, TFIIIC63, TFIIICepsilon" ENSG00000148308 "General transcription factor IIIC subunit 5" Q9Y5Q8 9 133030675-133058503 "Predicted intracellular proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067063, HPA069805" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA067063: AB_2685773, HPA069805: AB_2686201" "unprognostic (1.07e-2)" "unprognostic (1.78e-3)" "unprognostic (5.58e-2)" "unprognostic (2.35e-1)" "unprognostic (1.62e-1)" "unprognostic (1.27e-1)" "unprognostic (7.97e-3)" "unprognostic (4.01e-2)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (1.10e-2)" "unprognostic (1.58e-2)" "unprognostic (1.45e-3)" "unprognostic (4.55e-3)" "unprognostic (1.13e-2)" "unprognostic (1.33e-1)" "unprognostic (8.73e-2)" 21.2 24.6 20.1 18.2 30.4 33.3 21.8 38.7 30.6 21.9 25.0 39.6 20.6 24.7 23.1 21.9 28.0 25.7 16.2 24.5 20.8 17.3 20.9 25.1 18.8 23.1 31.9 19.9 41.3 24.6 24.4 26.0 24.9 22.7 24.0 18.5 21.3 26.4 20.1 36.7 31.2 23.6 20.6 23.0 23.9 20.4 24.2 30.8 43.5 22.1 29.3 29.2 19.5 22.5 11.2 12.0 28.4 13.2 13.8 17.0 11.5 11.7 22.0 19.2 17.9 10.5 9.1 25.6 11.5 13.0 22.2 15.7 23.1 19.6 19.8 10.9 12.7 17.9 28.8 22.9 20.8 12.6 20.1 19.0 22.6 25.2 21.3 16.1 18.4 48.7 12.8 13.9 23.3 16.2 10.9 19.5 65.7 29.2 19.5 11.5 39.3 29.4 25.6 24.9 27.4 22.1 31.2 19.2 25.0 14.6 13.8 23.0 17.0 19.0 21.1 12.1 12.2 27.0 26.3 11.9 26.7 20.7 16.4 19.0 7.5 15.2 21.5 13.3 13.6 18.0 28.4 11.0 14.9 11.8 13.2 17.0 11.2 12.2 15.3 12.0 10.8 14.0 12.4 6.6 13.8 10.7 11.6 13.4 11.5 20.1 30.4 38.7 30.6 20.8 17.3 31.9 19.9 22.7 30.8 8.9 14.7 20.4 14.8 11.0 14.4 27.1 7.6 10.7 13.6 15.7 7.9 34.8 24.9 20.8 3.0 14.3 26.2 23.3 26.2 32.0 16.6 10.9 16.1 15.3 19.8 14.3 13.8 20.9 15.5 3.6 16.1 10.8 15.1 16.2 14.6 20.6 22.9 23.0 20.1 10.2 17.1 45.3 15.6 17.2 28.4 14.4 34.8 19.1 21.2 15.3 GTSF1 "FAM112B, FLJ32942" ENSG00000170627 "Gametocyte specific factor 1" Q8WW33 12 54455950-54473602 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 20.3;testis: 62.3" "Cell type enhanced" "Detected in many" 24 "Early spermatids: 927.5;Late spermatids: 1408.5;Spermatocytes: 345.5" "Cancer enriched" "Detected in many" 5 "testis cancer: 23.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 47.4;HMC-1: 35.4;K-562: 46.4;NB-4: 71.8;THP-1: 66.2;U-266/84: 53.1;U-937: 35.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA038876, HPA038877" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA038876: AB_10670911, HPA038877: AB_2676251" "unprognostic (1.17e-1)" "unprognostic (2.15e-2)" "unprognostic (2.12e-2)" "unprognostic (1.59e-1)" "unprognostic (1.11e-2)" "unprognostic (6.74e-3)" "unprognostic (2.56e-2)" "unprognostic (3.94e-2)" "unprognostic (9.93e-2)" "unprognostic (1.16e-1)" "unprognostic (1.45e-1)" "unprognostic (7.59e-2)" "unprognostic (3.97e-5)" "unprognostic (4.16e-3)" "unprognostic (1.92e-1)" "unprognostic (2.77e-1)" "unprognostic (9.18e-2)" 0.3 0.2 0.3 1.5 0.4 1.8 0.5 0.1 0.2 0.1 0.2 0.2 0.0 0.3 0.1 0.5 0.3 0.2 0.3 0.3 0.4 0.2 0.3 0.4 0.7 1.7 0.3 0.0 0.2 0.2 0.0 0.2 9.9 0.2 0.2 0.6 0.1 0.2 0.0 0.4 0.2 0.6 0.0 0.3 3.3 0.2 62.3 0.0 3.0 0.2 0.0 3.5 0.5 0.2 19.7 19.7 13.5 6.1 17.6 20.3 9.7 0.1 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 18.7 8.9 0.0 0.0 0.0 25.3 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 47.4 35.4 0.0 0.0 0.0 0.0 0.0 0.0 14.2 46.4 19.2 0.0 0.0 0.0 71.8 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 66.2 0.2 0.0 1.7 0.0 0.1 19.3 53.1 0.1 0.0 35.4 0.0 13.5 5.9 10.5 14.4 5.6 17.9 19.7 17.0 20.3 9.7 16.5 15.8 16.6 2.7 17.6 6.1 19.7 17.6 9.7 0.3 0.4 0.1 0.2 0.4 0.2 0.3 0.0 0.2 0.0 0.0 1.1 3.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 927.5 0.0 0.0 0.0 0.0 96.3 0.2 0.0 1.1 0.0 10.8 0.0 0.0 0.0 2.4 1408.5 14.7 3.3 3.3 15.4 0.0 0.0 0.0 0.0 9.6 0.0 0.0 12.9 0.3 345.5 99.5 0.3 22.5 7.5 0.0 0.0 GUCD1 "C22orf13, LLN4, MGC1842" ENSG00000138867 "Guanylyl cyclase domain containing 1" Q96NT3 22 24540423-24555935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 73.3" "Cell type enhanced" "Detected in all" 4 "Enterocytes: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022786 Approved Nucleoplasm NA NA Nucleoplasm "HPA022786: AB_1845711" "unprognostic (1.58e-1)" "prognostic favorable (6.84e-4)" "unprognostic (2.83e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-2)" "unprognostic (1.61e-1)" "unprognostic (3.96e-2)" "unprognostic (1.89e-1)" "prognostic favorable (7.26e-4)" "unprognostic (1.28e-1)" "unprognostic (3.55e-2)" "unprognostic (1.76e-2)" "unprognostic (4.36e-2)" "unprognostic (8.63e-2)" "unprognostic (1.59e-1)" "unprognostic (3.01e-2)" 16.7 12.8 7.6 13.6 7.2 25.8 19.0 5.1 7.5 9.0 37.4 8.7 9.7 23.3 7.8 9.8 14.3 7.4 19.7 35.7 7.0 5.6 29.3 73.3 12.2 11.9 8.0 5.3 10.2 30.0 7.0 6.7 11.3 6.8 11.7 12.8 9.0 8.7 8.7 28.9 8.8 59.9 13.5 8.0 14.9 15.8 9.1 5.7 13.4 10.6 14.5 13.8 14.3 8.0 23.3 6.5 23.7 7.0 3.3 4.4 5.5 13.9 13.1 11.7 14.3 24.6 23.1 9.3 13.9 22.4 24.4 23.9 19.9 10.9 26.5 9.1 18.9 15.1 18.6 13.4 16.2 13.1 25.4 16.2 11.3 13.0 18.1 19.9 29.3 22.4 23.3 13.0 24.3 11.2 15.0 25.7 13.3 11.3 26.6 18.3 16.5 16.9 12.6 11.0 35.2 11.3 19.5 19.0 26.0 19.1 15.5 12.2 12.0 16.7 22.8 11.9 9.5 18.0 20.9 17.1 52.6 21.7 16.3 11.7 25.9 17.7 18.6 21.6 16.5 17.7 7.8 7.0 23.7 3.8 7.0 4.4 18.6 3.6 3.9 6.5 23.3 3.5 3.9 7.4 3.3 6.6 4.7 3.4 5.5 7.6 7.2 5.1 7.5 7.0 5.6 8.0 5.3 6.8 5.7 14.9 23.9 38.4 10.3 11.0 4.9 45.6 94.3 2.7 10.3 5.2 5.9 15.8 44.7 22.0 10.3 15.4 117.4 46.7 56.9 16.4 16.6 31.1 15.0 103.6 23.7 3.2 19.0 20.9 20.4 5.8 17.5 13.3 16.9 33.3 46.5 13.7 39.7 66.2 15.2 65.8 12.4 25.8 17.9 20.5 32.8 9.7 13.6 9.5 37.7 15.7 GUCY1A1 "GC-SA3, GUC1A3, GUCY1A3" ENSG00000164116 "Guanylate cyclase 1 soluble subunit alpha 1" Q02108 4 155666711-155732349 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "cGMP biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 55.2" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 2: 41.4;Club cells: 12.5;Collecting duct cells: 10.4;Distal tubular cells: 16.6;Ductal cells: 15.1;Proximal tubular cells: 10.2" "Cancer enhanced" "Detected in all" "prostate cancer: 24.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 7.6;non-classical monocyte: 9.2;plasmacytoid DC: 11.6" "Group enriched" "Detected in many" 27 "dendritic cells: 11.6;monocytes: 9.2;NK-cells: 7.6" "Cell line enhanced" "Detected in some" "HAP1: 6.1;HEK 293: 5.0;Karpas-707: 8.7;MOLT-4: 15.9;RPTEC TERT1: 10.9;RT4: 12.7;SH-SY5Y: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010887, HPA056004, HPA058617" Uncertain Supported Nucleoplasm NA NA 6100 Nucleoplasm "CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624" "unprognostic (4.81e-3)" "unprognostic (2.60e-1)" "unprognostic (3.03e-1)" "unprognostic (2.15e-1)" "unprognostic (1.99e-2)" "unprognostic (7.77e-3)" "unprognostic (1.07e-1)" "prognostic favorable (2.38e-4)" "unprognostic (1.85e-3)" "unprognostic (6.46e-2)" "unprognostic (3.42e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.59e-4)" "unprognostic (1.60e-2)" "prognostic unfavorable (3.59e-4)" "unprognostic (2.27e-1)" "unprognostic (6.55e-3)" 10.9 5.3 12.4 10.2 19.9 0.9 11.1 3.4 11.6 13.7 31.2 7.3 2.8 5.6 14.7 6.0 7.0 6.8 8.3 21.0 9.0 7.2 11.6 5.1 13.2 7.3 4.7 12.5 5.4 8.5 55.2 5.8 16.3 6.3 17.2 6.9 39.7 7.0 9.8 4.5 3.6 10.1 18.8 6.6 8.5 12.9 2.1 8.5 4.5 8.1 7.3 5.9 6.4 10.6 0.1 11.6 0.3 9.2 7.6 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 6.1 0.0 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 3.3 0.0 8.7 0.0 0.0 15.9 0.0 0.0 0.0 0.2 3.5 0.0 2.6 10.9 12.7 2.2 8.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.3 0.0 2.3 0.1 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 7.6 9.2 11.6 0.0 1.0 12.4 19.9 3.4 11.6 9.0 7.2 4.7 12.5 6.3 8.5 8.9 41.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 12.5 10.4 0.0 0.4 16.6 15.1 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 3.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 H2AFJ "FLJ10903, MGC921" ENSG00000246705 "H2A histone family member J" Q9BTM1 12 14774383-14778002 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 148.5" "Group enriched" "Detected in all" 5 "Early spermatids: 2365.3;Late spermatids: 2711.3" "Cancer enhanced" "Detected in all" "prostate cancer: 151.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 52.0;MCF7: 67.2;RT4: 48.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (9.38e-2)" "unprognostic (8.49e-2)" "unprognostic (9.15e-2)" "unprognostic (7.06e-2)" "unprognostic (2.43e-3)" "unprognostic (4.70e-2)" "unprognostic (3.92e-2)" "unprognostic (7.67e-2)" "unprognostic (1.16e-1)" "unprognostic (1.14e-1)" "unprognostic (5.37e-2)" "unprognostic (4.05e-2)" "unprognostic (3.32e-3)" "unprognostic (3.43e-2)" "unprognostic (8.66e-3)" "unprognostic (5.22e-3)" "unprognostic (3.87e-3)" 37.8 27.6 3.6 15.0 11.6 14.6 36.7 2.2 5.2 19.1 27.3 9.9 21.7 16.0 15.4 26.7 29.9 13.9 34.0 24.8 4.3 3.8 22.2 16.7 22.7 16.9 9.0 5.1 12.7 47.7 4.8 5.0 25.5 6.8 49.2 8.6 18.2 67.6 25.7 20.4 26.8 18.7 18.6 11.8 15.7 17.8 148.5 5.8 14.4 19.3 25.3 17.4 26.5 29.3 7.2 39.1 23.8 44.5 19.8 25.1 24.2 21.2 52.0 2.0 0.0 23.7 15.8 33.9 16.0 8.9 6.5 6.3 10.2 35.1 0.0 10.1 7.7 0.0 20.4 1.2 12.1 1.7 1.1 0.9 0.8 18.4 8.6 34.1 0.0 8.1 20.5 13.3 8.9 8.3 2.6 12.9 0.0 0.0 0.0 3.2 67.2 0.1 5.6 3.3 15.5 11.9 8.4 0.0 4.1 10.3 48.2 0.6 0.2 20.3 25.2 0.0 7.5 38.4 6.5 12.7 0.0 6.2 9.5 3.1 5.2 7.5 0.0 1.8 0.0 5.1 23.8 44.5 9.3 18.0 24.5 16.3 5.8 17.8 13.4 39.1 7.2 12.7 13.7 15.4 19.8 21.4 19.4 25.1 24.2 3.6 11.6 2.2 5.2 4.3 3.8 9.0 5.1 6.8 5.8 41.7 33.7 49.1 304.8 105.8 15.7 27.9 175.8 202.1 68.2 136.1 21.6 108.3 127.6 141.6 2365.3 89.2 383.6 303.7 335.4 99.7 141.6 500.9 63.4 107.1 207.7 11.1 230.0 119.7 205.3 2711.3 162.8 122.0 217.6 210.2 226.5 28.4 179.6 287.5 91.9 223.3 35.9 265.1 186.8 506.4 29.2 123.0 134.1 87.3 219.6 347.8 H2AFY macroH2A1.2 ENSG00000113648 "H2A histone family member Y" O75367 5 135333900-135399914 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041189, HPA050962" Supported Supported Nucleoplasm NA NA 4700000 Nucleoplasm "HPA041189: AB_2677357, HPA050962: AB_2681292" "unprognostic (1.05e-1)" "unprognostic (3.63e-2)" "unprognostic (1.60e-3)" "unprognostic (2.78e-2)" "unprognostic (1.27e-1)" "unprognostic (7.88e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (3.17e-1)" "unprognostic (3.34e-2)" "unprognostic (2.53e-3)" "unprognostic (9.43e-2)" "unprognostic (2.21e-1)" "unprognostic (8.89e-3)" "unprognostic (8.34e-2)" "unprognostic (5.96e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" 34.9 26.0 24.8 32.2 27.2 75.1 21.7 37.6 27.6 22.5 40.0 19.7 14.0 40.2 22.0 21.8 60.7 22.4 38.8 41.9 21.4 28.8 23.8 24.1 36.7 39.4 24.1 26.5 21.8 16.6 24.2 25.8 30.0 21.0 20.2 43.2 24.4 28.3 14.0 34.9 33.4 52.0 21.9 21.8 33.8 28.5 21.4 16.9 76.9 22.2 40.7 47.2 28.7 29.6 16.0 51.8 23.8 45.6 21.5 15.9 30.1 45.6 32.2 49.7 34.0 23.3 13.9 44.7 19.2 20.7 34.2 24.2 50.6 45.9 54.2 32.8 15.5 29.0 31.2 37.2 81.4 25.7 29.3 37.1 64.7 38.0 34.0 17.1 30.7 28.5 14.7 22.1 28.5 30.7 21.0 21.9 37.1 22.4 22.3 19.4 39.9 88.2 58.5 19.4 54.7 17.2 79.8 28.3 38.3 42.4 52.2 70.0 44.1 37.4 36.4 30.8 27.2 43.2 85.1 17.6 30.0 25.3 22.0 39.1 10.7 43.5 50.8 25.0 69.3 21.1 4.1 45.6 20.5 10.8 30.1 9.1 11.7 14.0 13.4 51.8 16.0 13.6 11.2 23.8 21.5 19.0 37.3 15.9 30.1 24.8 27.2 37.6 27.6 21.4 28.8 24.1 26.5 21.0 16.9 89.3 73.9 95.3 103.9 115.3 133.0 49.8 99.3 112.4 113.7 75.0 90.3 125.6 61.3 217.9 39.7 83.0 188.9 46.7 110.7 116.9 69.9 135.3 50.8 51.0 384.3 322.6 171.4 63.8 399.4 18.3 56.7 337.9 86.0 166.9 190.1 115.6 179.5 156.5 77.4 76.7 166.8 71.1 91.4 52.4 75.0 139.4 153.4 97.8 202.7 196.4 H2AFY2 macroH2A2 ENSG00000099284 "H2A histone family member Y2" Q9P0M6 10 70052796-70112280 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ductal cells: 38.2;Intestinal endocrine cells: 62.8;monocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 9 "dendritic cells: 12.6;monocytes: 5.4;T-cells: 6.4" "Cell line enhanced" "Detected in many" "AF22: 49.3;AN3-CA: 28.6;SCLC-21H: 36.5;SH-SY5Y: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035865, HPA041189" Enhanced Supported Nucleoplasm No No Nucleoplasm "HPA035865: AB_10672099, HPA041189: AB_2677357" "unprognostic (1.62e-2)" "unprognostic (9.62e-2)" "unprognostic (1.46e-2)" "unprognostic (1.46e-2)" "unprognostic (7.71e-3)" "unprognostic (1.85e-1)" "unprognostic (3.44e-2)" "unprognostic (5.37e-2)" "unprognostic (1.67e-1)" "unprognostic (9.17e-2)" "unprognostic (7.32e-2)" "unprognostic (1.80e-2)" "unprognostic (1.31e-2)" "unprognostic (3.27e-2)" "unprognostic (4.58e-2)" "unprognostic (8.78e-2)" "unprognostic (4.66e-2)" 4.7 3.7 9.3 9.0 9.8 2.0 11.3 21.8 12.1 16.1 10.9 12.2 26.0 9.8 22.5 14.8 18.7 18.1 17.9 13.9 7.3 9.8 12.6 10.2 6.3 5.9 6.6 9.2 18.3 12.5 14.3 18.8 2.6 6.3 19.7 12.1 10.6 11.7 23.5 15.6 11.4 10.6 16.7 9.3 3.4 9.2 18.9 7.4 6.9 15.3 11.7 9.9 14.1 12.5 0.0 12.6 0.4 5.4 0.9 6.4 3.1 1.3 7.3 49.3 28.6 0.6 1.5 0.0 2.2 0.0 4.3 3.0 0.2 14.7 0.0 6.2 0.8 2.6 7.5 3.7 11.9 1.3 19.2 17.8 0.0 0.0 15.1 3.0 0.5 0.4 1.9 8.7 1.5 2.4 6.6 0.0 2.1 0.0 0.0 4.1 10.2 0.0 0.0 20.4 0.0 12.5 0.0 0.0 0.0 8.8 9.1 36.5 35.5 7.5 0.0 0.1 10.7 11.0 5.6 0.0 0.0 8.6 3.5 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 3.6 5.4 4.5 0.0 4.8 4.3 12.6 0.0 5.0 6.4 0.4 0.9 3.3 0.1 3.4 3.1 9.3 9.8 21.8 12.1 7.3 9.8 6.6 9.2 6.3 7.4 0.0 2.7 0.0 17.3 7.2 11.3 6.0 7.6 8.1 2.3 14.0 0.0 0.4 21.6 38.2 0.8 2.8 2.6 0.0 7.0 0.3 4.8 11.1 2.3 3.6 4.8 0.0 62.8 3.7 3.2 1.8 3.4 6.3 1.7 46.9 11.0 2.4 11.8 3.5 4.6 5.7 2.6 6.5 0.5 2.3 3.8 9.5 0.8 4.3 19.4 15.3 H2AFZ "H2A.Z, H2AZ" ENSG00000164032 "H2A histone family member Z" P0C0S5 4 99948086-99950388 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 1666.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022549, HPA057236" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022549: , HPA057236: AB_2683377" "unprognostic (1.21e-2)" "unprognostic (2.97e-3)" "unprognostic (1.03e-3)" "unprognostic (7.60e-2)" "unprognostic (1.97e-1)" "unprognostic (8.74e-3)" "prognostic unfavorable (1.02e-5)" "unprognostic (2.29e-3)" "unprognostic (1.98e-1)" "unprognostic (4.99e-3)" "unprognostic (9.70e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (3.02e-1)" "unprognostic (1.33e-1)" "unprognostic (6.34e-2)" "unprognostic (1.52e-1)" 23.5 22.5 28.9 40.7 40.4 113.9 31.1 39.5 38.0 26.3 45.0 13.9 26.9 33.2 40.4 23.1 53.5 24.0 27.9 32.1 28.6 28.1 37.1 26.9 32.4 70.6 32.9 26.2 32.6 19.8 14.5 30.3 32.0 26.1 30.2 43.2 29.5 29.4 27.2 28.3 30.1 34.0 46.2 26.7 46.1 37.4 32.2 31.3 139.8 29.7 47.9 81.0 51.6 29.9 46.7 54.1 139.3 87.0 41.3 80.9 120.4 86.8 61.2 127.7 65.7 26.4 22.3 42.0 92.3 66.6 95.4 89.9 62.8 101.6 154.7 33.6 46.9 63.9 31.7 111.5 90.0 103.5 67.9 77.6 79.3 72.4 71.2 15.9 141.2 66.9 17.5 39.4 73.4 41.2 27.5 94.0 94.3 78.0 94.3 108.8 120.7 116.9 117.5 73.7 98.6 58.7 100.9 93.5 64.7 53.0 52.9 83.3 64.3 57.0 108.9 106.4 45.4 55.6 109.4 49.1 61.6 117.5 42.1 117.8 54.5 80.5 184.7 69.0 94.5 96.4 61.8 63.2 120.2 38.1 68.7 42.2 46.7 60.5 49.8 54.1 39.3 56.9 47.2 139.3 41.3 87.0 36.1 80.9 120.4 28.9 40.4 39.5 38.0 28.6 28.1 32.9 26.2 26.1 31.3 59.6 72.1 223.6 636.0 1666.4 166.9 102.6 150.3 116.4 97.8 188.5 51.1 382.0 321.7 310.6 14.8 301.1 184.6 210.2 358.1 1168.3 589.6 472.9 172.9 101.8 614.7 60.4 273.0 216.0 285.6 36.7 187.6 455.0 843.5 1029.8 227.7 128.4 329.3 211.3 212.2 354.3 185.1 187.5 662.3 476.9 167.0 1432.4 337.2 318.1 419.3 624.2 H3F3A "H3.3A, H3F3" ENSG00000163041 "H3 histone family member 3A" P84243 1 226061851-226072001 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 258.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 258.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 258.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011481, CAB037178, HPA042570" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB011481: AB_880446, CAB037178: AB_532248, HPA042570: AB_2678056" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-1)" "unprognostic (2.19e-3)" "unprognostic (2.83e-2)" "unprognostic (3.74e-1)" "unprognostic (9.83e-3)" "unprognostic (4.71e-2)" "unprognostic (1.77e-3)" "unprognostic (3.69e-2)" "unprognostic (1.29e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (3.66e-2)" "unprognostic (8.03e-3)" "unprognostic (2.21e-3)" "unprognostic (6.03e-2)" 39.0 43.4 37.2 83.4 33.4 126.8 67.9 45.0 42.8 44.6 54.0 31.6 62.9 47.9 43.4 60.6 66.3 42.4 49.6 59.4 36.1 31.2 45.9 59.2 73.2 217.9 37.8 23.2 44.4 79.7 30.8 34.8 59.1 29.2 38.4 59.4 42.7 49.0 49.7 37.0 47.1 50.0 42.0 48.6 71.9 41.4 87.6 31.7 148.9 38.5 71.0 84.1 43.5 47.6 39.2 44.6 258.7 56.9 23.6 34.9 60.5 53.9 30.8 120.2 67.8 33.4 38.9 90.3 25.6 31.1 41.6 32.9 32.1 90.0 51.9 56.9 31.4 20.7 51.8 59.4 46.6 40.9 32.1 102.6 64.2 45.6 42.9 33.1 65.9 78.0 35.6 54.0 29.1 38.3 56.4 61.5 67.9 90.4 88.9 47.3 31.2 136.8 122.6 163.0 137.1 61.1 92.6 87.8 133.8 86.0 57.7 117.4 174.5 73.0 92.4 63.2 71.8 104.7 154.7 34.6 30.3 42.3 40.9 74.1 39.6 50.7 90.7 28.9 63.0 64.7 40.0 56.9 80.8 23.1 44.9 23.6 39.2 25.0 24.9 44.6 36.0 23.7 25.7 258.7 23.6 50.8 36.6 34.9 60.5 37.2 33.4 45.0 42.8 36.1 31.2 37.8 23.2 29.2 31.7 485.3 628.9 1112.7 1421.3 1190.0 539.7 34.4 1036.9 1187.2 831.4 919.5 155.1 1193.7 1374.4 1195.9 1414.0 1038.4 1355.7 2359.5 1184.4 1689.1 947.0 1270.6 649.3 699.9 1338.0 554.6 1437.2 842.8 2198.6 1327.8 1016.5 1622.8 1010.6 1191.2 1707.9 908.2 1197.9 2104.2 985.0 1310.8 429.3 976.6 889.6 588.0 858.5 1210.5 1352.2 961.6 1983.9 1893.1 H3F3B H3.3B ENSG00000132475 "H3 histone family member 3B" P84243 17 75776434-75785893 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 570.8;bone marrow: 441.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 570.8" "Lineage enriched" "Detected in all" 6 "granulocytes: 570.8" "Low cell line specificity" "Detected in all" "CAB037166, CAB037187, CAB037221, HPA042570" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: AB_2678056" "unprognostic (1.66e-1)" "unprognostic (8.42e-3)" "unprognostic (3.42e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.95e-1)" "unprognostic (2.41e-1)" "unprognostic (2.43e-3)" "unprognostic (3.37e-2)" "unprognostic (1.64e-1)" "unprognostic (5.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.26e-3)" "unprognostic (9.20e-2)" "unprognostic (4.81e-2)" "unprognostic (2.33e-1)" "unprognostic (1.99e-1)" 57.2 41.2 38.1 58.9 48.6 441.9 71.4 60.2 47.0 86.6 44.6 65.9 42.7 37.9 60.5 77.7 93.2 70.2 75.8 35.1 38.5 33.9 42.8 48.1 64.2 62.3 50.4 41.2 141.0 90.9 33.0 41.5 58.5 42.7 60.5 26.6 65.8 58.4 55.4 71.1 114.0 58.0 63.7 51.8 65.9 45.1 66.9 46.2 78.6 58.9 69.1 55.7 78.5 71.9 78.9 88.1 570.8 98.4 80.0 77.2 203.5 117.9 104.8 43.8 43.2 25.0 39.2 60.6 55.9 49.5 68.7 55.2 112.2 84.0 59.1 53.4 32.5 48.6 46.5 34.6 77.3 39.1 32.2 78.0 52.7 55.9 94.9 56.5 87.5 67.9 42.8 47.9 70.4 90.8 30.6 51.6 38.6 74.6 106.3 35.3 173.6 125.6 73.5 35.1 38.2 117.1 93.6 80.2 64.4 54.2 70.1 88.9 98.7 56.7 83.2 120.0 24.4 65.2 94.6 48.1 123.3 109.1 53.2 148.0 128.6 76.0 71.0 65.2 83.5 67.2 182.8 98.4 259.3 74.4 86.9 70.2 78.9 71.8 70.5 86.7 65.3 77.2 64.5 570.8 80.0 78.9 88.1 76.0 203.5 38.1 48.6 60.2 47.0 38.5 33.9 50.4 41.2 42.7 46.2 851.6 868.5 887.7 3350.2 2457.1 1722.8 361.5 690.4 1184.5 958.9 922.9 382.9 1428.6 1080.9 1926.0 2467.5 1156.8 1059.1 327.1 1563.3 1285.8 1898.2 1719.4 1592.3 352.8 1655.2 575.2 1610.5 672.8 901.1 452.7 934.0 1810.8 1808.5 1233.6 1221.5 2460.8 1745.6 1627.3 545.9 699.9 1161.2 983.1 2751.1 2035.3 943.0 3026.0 2929.8 1269.9 852.2 2611.9 HASPIN GSG2 ENSG00000177602 "Histone H3 associated protein kinase" Q8TF76 17 3723903-3726699 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 7.5;lymphoid tissue: 26.7;testis: 26.7" "Cell type enriched" "Detected in single" 5 "Extravillous trophoblasts: 2.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027422, HPA030698" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA027422: AB_10601812, HPA030698: AB_2673575" "unprognostic (1.15e-2)" "unprognostic (2.78e-2)" "unprognostic (7.06e-2)" "unprognostic (2.14e-2)" "unprognostic (8.05e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-4)" "unprognostic (1.57e-2)" "unprognostic (6.60e-2)" "unprognostic (1.77e-1)" "unprognostic (2.75e-3)" "unprognostic (3.82e-3)" "unprognostic (0.00e+0)" "unprognostic (5.65e-3)" "unprognostic (3.09e-2)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" 1.2 0.3 0.3 11.8 0.6 7.5 1.8 0.5 0.3 0.5 1.5 0.2 0.0 2.2 0.3 0.4 2.8 0.6 1.3 0.6 0.2 0.2 0.8 0.4 2.6 5.8 0.4 0.0 0.4 0.5 0.0 0.3 1.3 0.2 0.7 1.5 0.2 1.0 0.0 1.2 0.9 3.6 0.4 1.2 4.9 1.7 26.7 0.3 26.7 0.7 1.7 7.3 0.8 1.0 2.8 1.5 2.1 0.6 0.0 1.2 0.4 7.5 8.3 7.7 8.6 0.5 1.0 6.4 7.0 5.3 13.8 13.6 6.5 3.1 18.6 4.0 3.8 5.5 12.3 13.8 6.7 13.2 0.1 11.5 9.2 6.7 3.8 0.3 5.3 9.5 0.6 0.5 10.3 6.4 1.6 6.3 14.8 8.1 16.4 6.9 3.9 10.7 3.1 6.7 5.8 5.7 11.2 9.7 5.0 2.0 5.3 3.1 4.5 6.1 4.2 2.4 7.0 4.2 5.0 3.2 6.1 7.0 6.8 12.1 3.1 3.5 9.0 3.6 7.7 7.3 0.4 0.6 2.1 0.2 0.5 0.2 0.7 0.8 0.0 1.1 2.8 1.2 0.2 0.2 0.0 0.0 1.5 0.1 0.4 0.3 0.6 0.5 0.3 0.2 0.2 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 HAT1 KAT1 ENSG00000128708 "Histone acetyltransferase 1" O14929 2 171922448-171983682 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036788, CAB037191" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB037191: AB_477070, HPA036788: AB_10672267" "unprognostic (1.76e-1)" "unprognostic (1.01e-2)" "unprognostic (7.39e-3)" "unprognostic (8.24e-3)" "unprognostic (2.76e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (5.72e-5)" "unprognostic (2.71e-2)" "unprognostic (9.08e-3)" "unprognostic (3.69e-2)" "unprognostic (1.56e-2)" "unprognostic (1.24e-1)" "unprognostic (3.23e-2)" "unprognostic (6.89e-2)" "unprognostic (1.80e-1)" "unprognostic (3.97e-2)" "unprognostic (6.69e-2)" 24.3 23.7 14.3 20.8 21.4 30.9 25.7 18.4 16.7 17.6 18.2 14.0 17.7 11.8 20.7 15.6 21.3 17.7 14.8 26.2 16.7 13.0 27.5 22.1 18.8 26.9 21.2 12.9 21.8 23.0 22.3 32.2 21.1 21.4 20.8 19.3 13.1 25.5 15.6 53.9 18.6 15.8 22.9 20.5 22.5 20.2 15.9 21.5 35.4 26.1 31.8 27.8 22.1 16.9 21.0 16.0 29.9 32.1 25.9 28.1 19.2 34.2 16.4 29.0 26.5 15.4 16.0 20.5 35.8 23.9 39.6 41.4 38.0 23.8 38.5 23.2 21.6 33.6 27.3 31.4 29.3 61.2 21.7 31.1 33.9 27.1 34.3 7.5 42.8 21.3 9.5 17.0 52.2 17.5 12.5 24.9 26.9 35.1 25.3 44.9 23.9 33.5 39.2 24.1 41.8 17.2 26.9 36.6 26.1 23.5 34.6 18.6 15.3 30.0 16.8 30.4 23.4 23.4 43.5 12.6 35.6 27.5 29.9 36.0 11.1 25.6 45.3 24.0 30.7 30.8 23.8 21.1 29.9 20.8 24.5 25.8 21.0 22.1 21.3 16.0 18.4 22.2 24.2 24.0 25.9 32.1 8.2 28.1 19.2 14.3 21.4 18.4 16.7 16.7 13.0 21.2 12.9 21.4 21.5 32.8 31.1 44.9 101.4 65.9 23.1 47.4 17.8 45.5 30.7 26.2 31.4 65.0 69.6 36.4 42.5 37.9 16.0 23.3 40.9 71.6 41.6 50.0 40.3 18.4 45.8 27.0 13.7 28.3 32.7 8.9 28.4 37.8 30.4 19.0 18.1 49.8 25.8 18.2 34.6 35.3 35.7 38.8 59.0 45.9 63.7 46.0 48.7 40.6 27.7 61.2 HCFC1R1 "FLJ20568, HPIP" ENSG00000103145 "Host cell factor C1 regulator 1" Q9NWW0 16 3022620-3024286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 204.8" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 247.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 84.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059647 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059647: AB_2684094" "unprognostic (2.24e-2)" "unprognostic (8.13e-2)" "unprognostic (9.85e-3)" "unprognostic (6.03e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (1.61e-2)" "unprognostic (2.12e-1)" "unprognostic (3.43e-3)" "unprognostic (2.23e-1)" "unprognostic (2.96e-2)" "unprognostic (1.17e-1)" "unprognostic (1.30e-3)" "unprognostic (4.89e-2)" "unprognostic (1.49e-1)" "unprognostic (2.02e-1)" "unprognostic (1.23e-1)" 19.7 28.9 49.3 10.2 61.0 7.8 23.9 25.4 37.5 30.4 17.5 13.5 17.7 14.3 20.5 18.4 20.7 19.4 28.0 27.8 37.2 38.6 24.9 11.1 19.1 10.6 40.9 23.9 24.3 10.4 19.9 19.5 16.5 23.0 22.8 10.0 11.5 15.1 42.4 204.8 25.0 13.9 28.7 23.2 9.1 11.2 11.4 14.7 7.5 13.5 37.0 9.1 24.7 17.2 14.1 26.2 8.4 21.6 13.7 20.2 9.6 12.4 32.9 6.6 8.0 27.1 35.7 6.3 3.9 24.9 12.3 33.8 6.9 15.0 8.7 13.5 23.3 10.7 16.4 6.6 24.2 5.7 11.9 15.6 3.8 26.2 11.5 22.2 6.3 7.5 44.1 15.7 12.8 14.0 84.8 17.1 6.6 5.2 17.4 13.7 11.2 3.8 9.9 14.4 7.2 6.9 13.7 5.9 24.3 43.8 2.5 11.4 9.6 9.6 15.4 15.5 16.8 10.2 5.8 4.9 20.3 56.9 17.2 10.6 10.6 10.3 7.6 8.6 3.9 4.6 2.7 21.6 8.4 12.3 15.5 11.6 14.1 15.9 13.3 26.2 13.5 11.8 14.2 4.5 13.7 13.5 13.0 20.2 9.6 49.3 61.0 25.4 37.5 37.2 38.6 40.9 23.9 23.0 14.7 53.6 12.9 28.9 60.6 75.9 26.6 39.3 50.9 16.0 18.2 188.5 5.9 91.7 203.9 41.6 3.8 35.9 68.0 0.0 23.5 101.8 139.4 33.1 39.3 41.9 104.8 19.1 42.0 61.4 66.0 10.1 89.2 41.2 60.8 50.5 33.1 31.3 26.9 48.9 167.6 247.7 19.7 122.9 137.0 14.0 37.3 57.5 45.1 20.8 42.9 31.5 HDAC1 "GON-10, HD1, RPD3L1" ENSG00000116478 "Histone deacetylase 1" Q13547 1 32292086-32333635 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005017, HPA029693, CAB068191" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659" "unprognostic (2.51e-2)" "unprognostic (9.10e-2)" "unprognostic (2.92e-1)" "unprognostic (2.98e-1)" "unprognostic (9.15e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (5.76e-7)" "unprognostic (9.57e-2)" "unprognostic (5.02e-2)" "unprognostic (3.47e-2)" "unprognostic (7.06e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (6.86e-2)" "unprognostic (3.78e-1)" "unprognostic (7.16e-2)" "unprognostic (1.72e-1)" 13.8 22.8 12.8 33.5 14.8 15.0 21.1 5.1 13.0 21.9 35.7 16.0 34.8 22.2 24.6 17.5 40.6 21.0 43.8 12.4 12.5 8.5 21.1 21.5 17.2 33.3 14.7 8.6 27.7 20.5 17.2 27.1 24.4 12.2 25.2 33.9 18.0 27.8 31.3 6.6 16.9 32.7 22.1 13.3 32.6 27.8 20.0 16.7 59.4 36.8 21.2 51.1 26.0 25.1 47.7 32.1 59.8 44.6 42.4 49.2 54.7 29.4 18.0 11.6 23.0 6.8 8.1 24.1 20.9 23.4 28.0 25.9 32.9 53.1 45.4 38.8 23.0 28.5 34.4 35.5 28.4 31.1 42.4 35.3 31.3 21.6 25.2 16.0 55.4 45.4 14.6 15.6 21.7 14.4 22.0 21.2 59.5 41.0 18.1 12.3 22.4 63.1 31.2 26.8 35.2 46.1 43.6 27.5 20.2 30.3 42.6 9.1 11.5 34.8 23.5 43.8 47.7 27.7 43.1 24.5 18.7 21.9 5.7 50.8 11.0 23.7 62.3 15.4 46.0 24.2 37.0 27.7 59.8 43.2 35.5 35.4 47.7 42.4 46.1 32.1 44.3 49.2 45.7 19.9 42.4 44.6 20.1 42.5 54.7 12.8 14.8 5.1 13.0 12.5 8.5 14.7 8.6 12.2 16.7 23.8 38.4 50.1 48.1 22.0 15.5 18.2 56.0 80.3 48.9 64.6 15.7 81.3 81.2 57.2 10.0 40.9 97.1 0.0 65.1 93.0 21.5 29.1 29.0 28.2 38.0 11.1 82.9 63.8 40.8 5.9 38.0 31.0 27.0 42.3 101.3 32.1 65.7 108.7 41.8 25.9 13.9 58.2 37.7 45.1 76.2 22.2 78.1 50.7 115.8 49.8 HDAC2 "RPD3, YAF1" ENSG00000196591 "Histone deacetylase 2" Q92769 6 113933028-114011308 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005054, HPA011727" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB005054: AB_562295, HPA011727: AB_1850540" "prognostic unfavorable (7.07e-4)" "unprognostic (1.44e-1)" "unprognostic (2.67e-1)" "unprognostic (2.56e-2)" "unprognostic (2.61e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (5.39e-10)" "unprognostic (2.03e-1)" "unprognostic (2.63e-2)" "unprognostic (9.00e-2)" "unprognostic (2.01e-1)" "unprognostic (3.92e-1)" "unprognostic (1.84e-2)" "unprognostic (1.96e-1)" "unprognostic (2.42e-1)" "unprognostic (9.80e-2)" "unprognostic (3.51e-1)" 25.8 33.8 25.8 30.1 31.3 34.9 58.7 32.8 36.5 32.1 30.7 25.6 32.2 22.0 38.7 36.7 36.3 32.7 23.3 27.6 26.5 26.9 31.6 22.2 29.9 41.5 29.6 26.5 39.2 31.5 31.7 45.1 38.1 27.9 32.1 36.1 17.5 29.3 39.0 33.9 30.8 26.1 36.1 31.1 30.7 29.9 47.4 27.4 64.0 35.1 31.3 32.5 33.1 47.3 27.0 35.7 28.2 32.6 26.3 32.6 24.3 24.6 17.0 79.6 45.7 20.5 23.5 33.3 29.5 24.1 34.8 41.7 45.1 18.2 20.4 24.6 26.5 35.8 19.4 54.0 29.8 58.7 29.0 37.3 49.1 22.1 26.0 27.4 49.8 22.2 18.9 20.1 37.0 34.8 34.1 40.5 36.1 63.1 20.7 57.6 20.7 44.6 45.1 45.0 26.4 23.5 30.3 39.7 18.7 35.9 29.8 53.3 45.2 23.3 22.0 24.5 50.0 16.0 58.1 32.7 22.2 25.5 23.2 48.8 16.5 21.7 48.8 18.8 48.0 37.6 23.1 27.6 28.2 21.1 26.6 28.1 27.0 25.9 22.7 35.7 22.3 32.6 29.7 16.3 26.3 32.6 30.9 24.5 24.3 25.8 31.3 32.8 36.5 26.5 26.9 29.6 26.5 27.9 27.4 53.6 49.8 31.2 71.8 170.6 26.7 56.1 33.1 81.7 79.6 50.6 3.9 139.9 36.5 140.8 72.3 70.5 33.4 140.2 91.3 114.1 97.6 61.7 53.2 30.8 91.5 14.3 96.4 47.9 63.7 84.2 76.8 67.2 79.2 128.0 68.7 30.1 115.2 49.1 63.3 52.8 23.5 38.8 84.5 123.0 166.8 168.8 173.7 50.7 90.3 79.6 HDAC6 "FLJ16239, HD6, JM21, KIAA0901, PPP1R90" ENSG00000094631 "Histone deacetylase 6" Q9UBN7 X 48801377-48824982 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Actin-binding, Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003714, CAB004236, HPA026321" Supported Supported Nucleoplasm NA NA 39000 Nucleoplasm "CAB004236: AB_627708, HPA003714: AB_1850544, HPA026321: AB_1850546" "unprognostic (9.53e-2)" "unprognostic (1.59e-1)" "unprognostic (2.66e-2)" "unprognostic (2.42e-2)" "unprognostic (2.82e-2)" "unprognostic (4.11e-3)" "unprognostic (2.17e-2)" "unprognostic (1.16e-1)" "unprognostic (7.68e-2)" "unprognostic (2.83e-1)" "unprognostic (1.16e-3)" "unprognostic (2.33e-2)" "unprognostic (6.10e-2)" "unprognostic (1.47e-1)" "unprognostic (6.60e-2)" "unprognostic (2.34e-1)" "prognostic favorable (3.34e-4)" 14.6 13.7 23.4 12.8 29.8 19.0 14.4 34.2 30.1 12.7 14.1 24.4 14.9 16.9 16.0 14.7 13.1 15.7 11.7 11.9 21.7 24.8 32.8 43.3 15.1 13.9 27.2 22.4 18.7 15.5 26.7 24.4 15.1 27.0 12.3 15.9 15.1 12.2 15.3 18.2 11.3 16.1 15.0 20.9 15.3 14.2 24.7 22.4 19.0 15.7 9.5 14.0 11.7 12.1 5.7 9.7 6.3 12.4 4.0 5.8 5.0 15.1 12.9 25.3 9.6 10.2 9.3 17.1 7.2 6.2 14.0 13.8 12.4 13.0 14.6 7.0 8.2 17.9 10.8 15.3 7.7 12.1 13.6 9.7 20.0 15.4 12.7 9.6 9.2 31.0 13.5 12.6 10.9 13.2 12.5 11.6 18.5 21.9 16.2 8.8 5.3 13.0 14.4 9.4 6.9 12.3 11.2 27.2 15.0 8.0 6.6 13.0 12.8 14.6 4.4 8.7 34.3 18.3 8.6 9.4 10.9 14.1 14.9 6.9 14.9 14.8 10.6 11.1 11.9 10.8 0.0 5.8 6.3 5.8 9.7 4.1 4.3 4.0 4.2 8.6 5.7 3.9 3.7 2.9 4.0 12.4 9.7 4.4 5.0 23.4 29.8 34.2 30.1 21.7 24.8 27.2 22.4 27.0 22.4 17.9 30.9 11.7 10.4 6.6 37.4 9.5 12.7 9.4 20.5 17.4 47.1 9.6 16.6 6.3 37.4 7.7 17.6 0.0 6.4 10.4 8.4 7.6 5.8 45.7 9.7 38.1 13.8 11.6 10.0 14.2 13.0 9.2 5.0 15.4 11.6 26.8 6.8 11.5 10.6 39.4 33.8 12.9 8.0 31.5 13.0 5.1 8.1 6.7 13.6 6.4 HDAC9 "HD7, HDAC, HDAC7B, KIAA0744, MITR" ENSG00000048052 "Histone deacetylase 9" Q9UKV0 7 18086949-19002416 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 197.2;Late spermatids: 49.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 29.5" "Group enriched" "Detected in many" 9 "B-cells: 21.8;dendritic cells: 29.5;monocytes: 9.7" "Cell line enhanced" "Detected in many" "HAP1: 55.1;hTERT-HME1: 26.4;SH-SY5Y: 22.0;U-698: 21.8;WM-115: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028926 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA028926: AB_10602327" "unprognostic (2.06e-2)" "unprognostic (2.67e-1)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.74e-1)" "unprognostic (5.54e-2)" "unprognostic (2.20e-2)" "unprognostic (2.32e-1)" "unprognostic (2.21e-1)" "unprognostic (2.45e-1)" "unprognostic (5.01e-1)" "unprognostic (7.58e-2)" "unprognostic (1.29e-1)" "unprognostic (3.94e-2)" "unprognostic (1.32e-1)" "unprognostic (1.02e-1)" "unprognostic (6.87e-3)" 10.7 13.5 12.6 10.7 16.2 5.9 8.4 19.1 16.9 11.6 7.4 11.3 7.5 3.8 17.8 6.7 4.7 10.5 7.5 14.9 13.1 12.0 3.9 3.1 5.7 18.9 13.9 14.9 3.0 2.7 3.0 17.7 6.8 11.2 12.5 6.2 9.7 6.9 16.5 15.5 3.8 8.4 14.4 17.6 17.4 9.1 8.7 18.2 2.9 5.5 5.4 19.3 7.1 9.6 21.8 29.5 0.5 9.7 2.0 2.1 4.5 12.5 0.0 2.1 0.0 0.3 2.8 0.0 0.7 7.4 3.1 5.3 0.1 4.1 5.4 13.9 8.3 17.1 1.9 55.1 1.0 8.1 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 1.0 1.0 9.8 26.4 2.7 0.1 0.8 0.0 8.4 4.3 0.0 0.5 1.1 6.7 0.0 1.2 1.5 0.8 3.1 1.7 3.3 3.9 22.0 0.1 0.1 4.0 3.3 0.2 4.9 0.5 11.4 3.6 0.6 7.1 9.7 4.1 21.8 3.0 0.5 22.5 0.1 9.7 0.0 1.7 6.7 1.7 21.8 0.6 0.8 29.5 16.3 0.0 0.9 0.5 2.0 3.8 6.4 2.1 4.5 12.6 16.2 19.1 16.9 13.1 12.0 13.9 14.9 11.2 18.2 6.0 3.2 26.4 0.4 2.2 32.0 12.1 0.0 1.4 4.5 0.0 15.7 0.1 3.3 6.6 197.2 11.1 0.0 0.0 0.6 0.1 5.7 1.4 1.1 0.8 10.5 19.1 6.9 13.5 45.7 49.8 1.4 31.1 15.1 0.0 0.4 5.0 7.0 0.2 0.7 0.0 27.3 6.5 6.9 10.3 8.8 1.8 0.1 8.7 0.0 2.0 HDGF HMG1L2 ENSG00000143321 "Heparin binding growth factor" P51858 1 156742107-156766925 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Growth factor, Heparin-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026035, HPA048728, HPA053422" Enhanced Enhanced Nucleoplasm NA NA 300000 Nucleoplasm "CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146" "unprognostic (2.80e-1)" "unprognostic (9.63e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (9.06e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (2.43e-8)" "unprognostic (9.80e-3)" "unprognostic (2.34e-2)" "prognostic favorable (9.84e-4)" "unprognostic (2.45e-3)" "unprognostic (3.67e-2)" "unprognostic (1.40e-3)" "unprognostic (8.66e-3)" "unprognostic (2.14e-1)" "unprognostic (2.06e-1)" "unprognostic (3.86e-2)" 27.6 24.0 24.4 26.4 24.6 78.7 51.5 26.7 22.1 29.7 57.9 22.4 23.9 40.6 22.1 22.9 53.0 34.9 38.1 41.7 23.5 18.3 64.5 92.6 38.0 32.6 23.7 12.9 29.0 35.3 25.6 19.0 49.1 20.4 21.3 37.5 15.9 26.5 30.6 57.2 39.2 83.1 21.7 25.5 30.0 25.6 11.8 22.4 79.0 38.3 64.8 44.0 30.9 29.6 7.5 14.5 10.4 12.3 6.1 9.7 7.8 72.9 36.2 41.6 19.8 24.1 33.2 46.0 24.2 61.9 56.8 37.2 40.9 78.0 49.4 47.9 48.2 25.3 51.7 61.9 54.4 56.6 40.0 43.9 42.2 52.6 35.7 32.1 61.8 35.7 23.8 52.2 44.4 86.8 45.3 41.8 39.1 55.2 41.4 46.2 53.7 50.9 68.5 73.5 117.0 51.4 57.5 24.9 65.9 62.4 24.7 62.2 67.6 57.8 76.5 29.1 53.8 61.1 96.1 36.9 28.8 44.7 36.4 61.4 55.9 69.4 86.0 38.3 49.2 36.6 6.0 12.3 10.4 8.5 10.4 6.3 6.7 7.3 7.5 14.1 7.5 6.6 6.2 7.1 6.1 11.4 14.5 9.7 7.8 24.4 24.6 26.7 22.1 23.5 18.3 23.7 12.9 20.4 22.4 65.5 86.4 36.5 146.2 130.9 60.7 81.8 79.0 123.1 80.8 68.0 25.5 38.8 68.0 89.5 37.7 46.6 109.5 70.0 112.1 90.8 73.3 173.1 30.0 144.0 46.2 50.9 119.7 27.6 33.2 33.1 37.7 55.8 37.1 37.9 83.0 56.2 134.0 51.8 43.2 94.2 31.4 19.4 48.5 28.7 24.6 139.4 45.9 41.5 82.1 206.9 HDGFL3 "Hdgfrp3, HRP-3" ENSG00000166503 "HDGF like 3" Q9Y3E1 15 83112738-83208018 "Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 6 "Alveolar cells type 2: 16.2;Ciliated cells: 17.4;Club cells: 19.4;Collecting duct cells: 19.2;Ductal cells: 17.4;Exocrine glandular cells: 20.2;monocytes: 18.0;Pancreatic endocrine cells: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 5.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040719 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA040719: AB_2677097" "unprognostic (1.28e-3)" "unprognostic (1.13e-1)" "unprognostic (3.52e-2)" "unprognostic (3.38e-2)" "unprognostic (1.53e-1)" "unprognostic (2.55e-2)" "unprognostic (1.91e-2)" "unprognostic (2.95e-2)" "unprognostic (2.99e-2)" "unprognostic (4.68e-2)" "unprognostic (1.93e-3)" "unprognostic (3.39e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-2)" "unprognostic (3.55e-1)" "unprognostic (1.25e-1)" "unprognostic (1.85e-1)" 9.5 12.9 30.0 6.8 18.8 5.4 9.3 16.0 28.8 11.0 10.6 11.6 4.8 3.7 13.2 17.9 8.5 9.7 9.1 11.8 25.1 24.2 7.9 2.9 8.1 6.3 20.0 19.0 11.3 4.4 42.3 12.9 7.1 13.1 11.2 6.7 7.7 4.3 10.9 5.7 5.0 4.5 11.6 20.2 7.5 5.2 18.5 12.3 5.4 13.9 4.3 5.5 12.3 14.4 0.7 0.7 2.6 0.9 5.1 1.6 0.4 4.5 4.0 11.8 6.1 5.0 6.9 4.0 4.4 7.7 4.6 4.8 0.3 8.6 0.1 5.4 1.1 5.0 1.8 13.0 6.6 6.8 21.5 6.8 7.4 2.1 0.1 7.0 0.2 1.2 4.1 5.6 5.3 9.3 7.2 11.0 8.1 5.6 0.2 8.6 4.7 4.4 0.4 8.8 0.0 2.3 0.1 11.6 0.0 6.9 9.4 15.0 11.4 6.6 1.6 5.6 9.0 1.8 0.8 9.6 9.7 7.3 1.9 13.3 1.4 0.5 5.6 4.5 3.5 6.5 1.6 0.9 2.6 1.6 0.4 0.2 0.3 0.5 0.3 0.5 0.7 0.6 0.7 2.4 5.1 0.3 0.7 0.1 0.4 30.0 18.8 16.0 28.8 25.1 24.2 20.0 19.0 13.1 12.3 11.9 16.2 0.0 0.0 0.0 0.0 0.0 0.0 17.4 19.4 19.2 0.0 0.3 13.3 17.4 0.0 0.0 0.0 0.0 20.2 0.4 0.0 0.0 4.7 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 18.0 0.0 0.0 18.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 HECTD2 FLJ37306 ENSG00000165338 "HECT domain E3 ubiquitin protein ligase 2" Q5U5R9 10 91409280-91514829 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 25.5;Horizontal cells: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "NK-cell: 6.7" "Lineage enriched" "Detected in many" 7 "NK-cells: 6.7" "Cell line enhanced" "Detected in many" "AF22: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037767 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA037767: AB_10671378" "unprognostic (6.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.26e-2)" "unprognostic (3.34e-1)" "unprognostic (6.65e-3)" "unprognostic (1.10e-2)" "unprognostic (9.37e-4)" "unprognostic (1.42e-1)" "unprognostic (1.59e-1)" "unprognostic (2.31e-1)" "unprognostic (2.54e-3)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.67e-5)" "unprognostic (6.98e-3)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (5.84e-2)" 8.7 8.8 16.5 6.9 17.9 2.4 10.8 20.3 19.5 14.3 10.1 5.1 9.1 4.6 17.2 16.6 8.3 12.1 11.4 8.1 11.9 8.7 7.3 4.7 8.7 4.7 5.8 11.3 16.8 7.4 14.4 18.6 10.2 6.5 24.8 7.6 7.5 7.7 24.3 7.7 6.8 6.0 18.4 6.8 5.3 7.5 9.7 6.4 2.9 9.8 5.1 3.6 13.7 10.5 0.6 0.4 0.1 0.8 6.7 1.0 0.5 4.1 2.1 21.4 8.8 4.7 5.2 3.8 3.4 4.5 6.9 6.3 0.2 3.9 0.0 2.9 3.4 4.0 0.3 5.8 2.4 8.5 4.4 7.2 2.4 15.0 1.3 2.4 0.4 1.6 5.3 2.2 5.0 4.3 9.7 5.1 5.1 3.1 10.7 10.6 1.9 2.5 1.3 8.9 0.4 2.1 6.4 14.1 2.4 4.8 1.2 5.0 5.4 6.6 1.5 6.7 6.9 9.7 1.4 5.4 6.9 4.8 0.5 6.3 0.7 1.4 5.9 6.1 0.0 4.0 0.0 0.1 0.0 1.0 0.8 0.6 0.2 0.5 0.7 0.4 0.6 0.5 0.6 0.1 6.7 0.2 0.0 0.1 0.5 16.5 17.9 20.3 19.5 11.9 8.7 5.8 11.3 6.5 6.4 0.0 3.2 0.0 7.0 5.5 21.3 6.5 5.1 5.3 5.7 5.2 25.5 0.3 18.3 2.4 1.5 8.3 0.7 0.0 3.0 0.3 11.3 4.2 3.5 0.8 5.3 27.0 8.6 9.2 7.0 1.5 11.2 3.8 6.8 3.6 3.0 12.0 2.5 0.6 13.4 1.3 8.2 12.9 7.6 6.7 8.1 3.9 0.3 1.5 1.3 3.0 HEMGN "CT155, EDAG, NDR" ENSG00000136929 Hemogen Q9BXL5 9 97926791-97944856 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 71.1;placenta: 20.2;testis: 32.5" "Group enriched" "Detected in some" 149 "Early spermatids: 1388.7;Erythroid cells: 724.2;Late spermatids: 1114.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.2" "Group enriched" "Detected in many" 27 "granulocytes: 2.1;NK-cells: 2.9;T-cells: 8.2" "Cell line enriched" "Detected in some" 4 "K-562: 77.0" "Region enriched" "Detected in all" 5 "cerebellum: 55.9" "HPA019572, HPA019604, HPA019606" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (2.50e-2)" "unprognostic (9.00e-3)" "unprognostic (2.12e-3)" "unprognostic (2.48e-1)" "unprognostic (6.45e-4)" "unprognostic (2.77e-1)" "unprognostic (5.74e-2)" "unprognostic (2.25e-1)" 0.3 0.2 0.2 0.4 0.2 71.1 0.2 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.3 1.0 0.2 0.2 0.3 0.9 5.4 0.5 0.2 0.0 0.6 0.2 0.0 0.3 20.2 1.1 0.2 0.0 0.1 0.2 0.0 0.2 0.2 0.2 0.0 0.3 2.8 0.2 32.5 0.0 17.1 0.3 0.2 0.5 1.4 4.8 0.0 0.1 2.1 0.1 2.9 8.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 77.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.1 0.8 0.0 2.3 1.1 0.1 0.0 8.2 3.3 1.0 2.9 0.0 0.0 1.2 4.4 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 1388.7 0.0 0.0 724.2 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.3 1114.5 5.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 6.5 0.0 7.2 3.3 0.0 0.5 0.0 0.0 0.0 HES1 "bHLHb39, FLJ20408, HES-1, Hes1, HRY" ENSG00000114315 "Hes family bHLH transcription factor 1" Q14469 3 194136145-194138732 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 883.9;Paneth cells: 936.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "eosinophil: 19.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 19.5" "Cell line enhanced" "Detected in many" "EFO-21: 26.2;hTCEpi: 32.9;OE19: 32.2;SK-BR-3: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066929 Supported Nucleoplasm NA NA Nucleoplasm "HPA066929: AB_2732753" "unprognostic (1.79e-2)" "unprognostic (2.41e-1)" "unprognostic (1.79e-2)" "unprognostic (4.44e-2)" "unprognostic (1.00e-1)" "unprognostic (1.46e-1)" "unprognostic (3.01e-2)" "unprognostic (1.05e-1)" "unprognostic (4.64e-1)" "unprognostic (2.62e-2)" "unprognostic (2.04e-2)" "unprognostic (1.40e-2)" "unprognostic (1.71e-2)" "unprognostic (1.44e-1)" "unprognostic (1.74e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.04e-5)" 31.0 10.9 8.4 7.9 9.3 0.6 30.1 5.5 8.1 28.4 18.9 14.1 36.1 17.2 21.2 15.9 47.8 9.9 11.5 21.2 9.5 6.0 22.1 27.4 37.9 3.7 6.3 8.8 15.7 21.2 19.7 15.1 23.5 8.8 35.1 20.5 58.7 31.0 89.6 32.8 56.0 12.6 9.7 8.4 10.7 23.9 11.7 8.0 2.3 36.3 29.7 40.3 26.3 39.8 0.5 0.1 19.5 4.8 0.0 0.0 0.1 3.0 0.9 7.2 9.3 2.2 0.0 1.8 1.4 4.2 0.3 0.1 12.3 8.9 0.4 26.2 0.5 4.4 17.6 1.3 8.3 0.1 2.5 15.1 11.1 1.1 3.1 0.0 0.0 10.5 0.8 32.9 0.2 3.8 5.0 9.9 0.6 5.3 0.4 0.0 14.6 15.6 15.2 6.7 32.2 6.1 0.0 0.5 0.3 9.7 24.2 0.4 0.5 7.1 27.4 12.3 8.6 7.7 0.8 7.6 0.8 7.8 0.1 10.5 0.0 0.0 0.0 0.5 0.0 15.0 0.0 0.1 19.5 0.0 3.1 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 4.8 0.0 0.0 0.1 8.4 9.3 5.5 8.1 9.5 6.0 6.3 8.8 8.8 8.0 23.8 99.8 66.4 291.3 109.2 14.2 64.5 387.3 165.9 238.8 186.7 15.7 27.9 160.8 197.9 1.4 288.1 452.8 0.0 176.3 4.8 322.5 246.0 301.9 136.4 23.9 9.5 153.8 713.3 61.6 4.3 54.4 73.1 75.9 37.9 274.4 883.9 162.1 936.3 17.7 69.0 39.9 161.7 297.1 1.1 1.5 259.2 174.9 9.6 593.0 248.6 HES3 bHLHb43 ENSG00000173673 "Hes family bHLH transcription factor 3" Q5TGS1 1 6244192-6245578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 6.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 28 "testis cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 16.1" "Region enriched" "Detected in single" 30 "cerebellum: 39.0" "Low region specificity" "Detected in many" "HPA047927, HPA072697" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047927: AB_2680213, HPA072697: " "unprognostic (7.42e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HESX1 "ANF, RPX" ENSG00000163666 "HESX homeobox 1" Q9UBX0 3 57197843-57226521 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 14.7;lymphoid tissue: 15.2" "Cell type enhanced" "Detected in some" 11 "Spermatocytes: 10.7;Spermatogonia: 5.8" "Cancer enhanced" "Detected in many" "testis cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.0;plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 40.4;U-266/84: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024187 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024187: AB_1850620" "unprognostic (6.47e-2)" "unprognostic (1.66e-3)" "unprognostic (5.50e-2)" "unprognostic (1.19e-3)" "unprognostic (5.04e-2)" "unprognostic (2.83e-2)" "unprognostic (3.96e-1)" "unprognostic (3.21e-2)" "unprognostic (1.93e-1)" "unprognostic (3.46e-3)" "unprognostic (9.48e-2)" "unprognostic (2.79e-3)" "unprognostic (1.39e-3)" "unprognostic (4.17e-2)" "unprognostic (3.15e-2)" "unprognostic (4.50e-3)" "unprognostic (1.14e-1)" 1.5 2.6 2.1 1.4 2.0 4.2 3.5 1.4 2.3 1.4 1.4 1.4 14.7 1.0 1.4 5.7 1.4 1.2 2.1 1.4 2.2 2.3 2.7 4.8 1.5 15.2 3.3 2.4 2.1 2.5 3.4 2.6 3.4 1.4 1.9 0.8 2.3 1.5 7.0 1.4 5.7 1.4 1.4 5.1 4.6 2.1 8.7 2.0 3.0 3.3 1.4 1.8 1.4 1.4 1.5 4.6 0.3 4.0 1.1 0.3 0.5 0.7 0.6 1.4 2.7 0.2 1.0 0.4 0.0 0.2 0.4 0.8 0.2 2.4 1.9 0.4 0.0 0.6 0.1 0.7 0.7 0.5 1.1 1.5 2.7 0.7 0.1 1.8 1.0 0.2 2.5 0.7 0.2 1.5 1.3 0.4 4.3 0.4 2.5 0.1 0.1 1.2 5.1 40.4 0.5 0.5 0.4 0.9 1.0 1.9 0.2 0.6 2.0 0.6 0.8 1.5 0.8 0.6 4.1 0.3 1.8 0.7 0.6 0.8 7.4 12.5 6.0 0.7 1.7 1.0 0.0 2.1 0.3 0.3 4.0 0.0 1.5 0.1 0.0 1.1 1.1 0.2 0.0 0.3 1.1 0.3 4.6 0.0 0.5 2.1 2.0 1.4 2.3 2.2 2.3 3.3 2.4 1.4 2.0 0.0 0.3 0.0 0.8 0.3 0.2 0.5 2.5 0.0 0.0 1.8 0.0 1.4 0.0 0.2 0.3 1.6 0.8 0.0 0.2 1.0 0.6 0.7 0.0 0.9 1.7 1.6 0.0 0.6 1.8 0.0 0.9 1.3 0.0 1.0 0.0 2.0 0.6 0.0 0.4 1.0 2.4 0.0 0.3 10.7 5.8 1.0 0.5 0.5 0.4 0.0 HHIP "FLJ20992, HIP" ENSG00000164161 "Hedgehog interacting protein" Q96QV1 4 144646021-144745271 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.5;lung: 29.7" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 2: 177.0;Leydig cells: 126.0;Peritubular cells: 41.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.6" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 69.8;TIME: 80.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012616 Uncertain Approved Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "HPA012616: AB_1850687" "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (7.12e-3)" "unprognostic (8.18e-2)" "unprognostic (2.43e-2)" "unprognostic (1.02e-1)" "unprognostic (3.60e-1)" "unprognostic (1.95e-2)" "unprognostic (4.20e-1)" "unprognostic (1.90e-2)" "unprognostic (1.89e-1)" "unprognostic (9.66e-3)" "unprognostic (7.13e-3)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (2.38e-1)" 4.0 5.2 9.9 1.7 22.2 2.3 1.1 2.3 16.0 3.4 6.5 31.5 0.0 5.5 4.1 8.1 1.0 1.2 3.0 1.1 16.0 6.3 2.4 12.7 29.7 1.0 21.6 9.9 2.2 4.8 1.0 1.1 1.0 17.5 9.8 6.8 4.4 1.3 6.2 1.3 1.1 8.2 1.3 12.3 1.0 11.2 3.7 26.5 2.3 1.6 0.0 1.0 7.1 1.0 0.1 2.6 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.7 3.8 69.8 6.2 0.0 0.0 1.0 0.0 9.8 0.0 0.9 0.0 0.6 0.1 14.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.5 0.0 0.8 0.0 0.5 0.4 0.0 2.1 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 2.6 0.0 0.0 9.9 22.2 2.3 16.0 16.0 6.3 21.6 9.9 17.5 26.5 11.9 177.0 0.0 0.0 0.0 1.4 1.1 0.0 8.1 6.8 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.4 0.0 16.1 0.0 0.1 0.0 0.0 16.0 0.0 1.8 126.0 1.0 1.7 0.0 0.0 0.2 0.1 0.0 41.4 0.0 3.5 0.0 0.4 0.2 0.2 0.5 0.0 0.0 0.0 0.0 HIC2 "HRG22, KIAA1020, ZBTB30, ZNF907" ENSG00000169635 "HIC ZBTB transcriptional repressor 2" Q96JB3 22 21417404-21451463 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 31.5;Extravillous trophoblasts: 34.4;Syncytiotrophoblasts: 33.1" "Cancer enriched" "Detected in all" 5 "testis cancer: 17.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 28.6;K-562: 49.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031884, HPA059399" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA031884: AB_10602234, HPA059399: AB_2684003" "unprognostic (2.37e-1)" "unprognostic (2.73e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.42e-5)" "unprognostic (1.83e-1)" "unprognostic (3.83e-1)" "unprognostic (3.62e-2)" "unprognostic (3.11e-1)" "unprognostic (1.05e-1)" "unprognostic (1.49e-2)" "unprognostic (1.21e-4)" "unprognostic (1.28e-1)" "unprognostic (4.83e-3)" "unprognostic (7.34e-3)" "unprognostic (3.33e-1)" "unprognostic (3.86e-2)" "unprognostic (5.64e-2)" 4.0 2.8 3.7 5.2 9.1 8.1 8.1 4.9 6.3 4.0 4.1 4.3 5.0 3.7 6.5 5.6 4.4 3.7 2.5 3.0 3.5 3.8 2.8 2.9 3.3 3.9 2.7 6.8 6.2 5.9 4.3 5.9 15.1 4.3 2.7 2.6 3.2 6.1 2.3 12.3 2.4 4.3 2.3 4.4 4.6 4.7 11.4 3.1 2.2 4.2 3.0 2.6 2.3 4.9 1.3 2.2 0.7 1.1 0.6 1.5 0.4 0.8 1.0 5.9 1.7 0.5 0.4 28.6 0.5 0.2 0.6 0.5 10.8 0.3 2.0 0.6 0.3 0.4 2.3 4.1 0.3 0.3 1.3 6.1 2.7 1.4 5.9 0.5 2.3 1.2 0.4 0.2 0.8 0.3 0.3 0.4 0.8 49.3 0.8 0.3 0.8 1.0 2.4 6.2 1.9 0.8 2.6 2.6 0.3 0.3 1.4 1.6 2.9 0.7 0.8 1.0 6.4 0.5 3.6 0.8 0.9 2.2 0.8 0.6 1.7 1.3 2.2 0.7 1.0 0.6 0.0 0.8 0.4 0.3 0.5 1.5 1.3 1.3 0.5 0.5 0.5 1.5 0.8 0.7 0.6 1.1 2.2 0.3 0.4 3.7 9.1 4.9 6.3 3.5 3.8 2.7 6.8 4.3 3.1 3.0 0.6 3.2 4.5 4.8 13.2 2.8 7.6 0.0 1.2 1.8 13.7 31.5 0.0 2.1 11.9 4.7 7.7 0.0 2.1 34.4 6.5 5.5 1.1 2.4 8.7 7.9 5.8 2.5 1.8 22.9 5.2 2.8 5.0 1.0 6.1 2.5 2.2 2.9 9.6 1.1 6.5 6.5 3.8 8.6 27.4 4.0 33.1 4.9 8.5 6.0 HIPK2 ENSG00000064393 "Homeodomain interacting protein kinase 2" Q9H2X6 7 139561570-139777778 "Enzymes, Plasma proteins, Predicted membrane proteins" "Apoptosis, DNA damage, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.1" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 209.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 17.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 17.8" "Cell line enhanced" "Detected in many" "HDLM-2: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007611 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA007611: AB_1850730" "unprognostic (1.35e-3)" "unprognostic (1.49e-2)" "unprognostic (1.65e-1)" "unprognostic (7.65e-2)" "unprognostic (5.50e-2)" "unprognostic (9.44e-2)" "unprognostic (2.76e-1)" "unprognostic (4.66e-2)" "unprognostic (1.44e-1)" "unprognostic (2.76e-2)" "unprognostic (3.42e-3)" "unprognostic (4.58e-2)" "prognostic favorable (9.99e-4)" "unprognostic (1.38e-1)" "unprognostic (7.82e-2)" "unprognostic (3.93e-3)" "unprognostic (1.03e-2)" 19.6 9.8 58.8 7.4 53.6 14.4 12.6 8.5 39.8 5.5 7.4 54.5 5.2 8.2 4.7 5.2 10.2 9.9 5.5 30.5 60.0 39.9 28.2 17.5 8.6 5.3 66.1 16.4 6.6 12.3 17.2 7.6 10.8 26.4 10.7 5.8 9.4 11.5 7.1 21.6 3.2 6.2 4.8 56.2 7.3 15.4 2.6 38.6 1.7 10.4 2.8 4.9 6.8 7.4 0.6 0.5 17.8 2.9 0.2 1.4 0.5 4.1 18.5 8.6 5.2 21.0 15.1 1.0 2.3 2.3 2.6 2.7 1.3 2.3 0.0 5.3 4.3 16.0 0.2 3.9 6.0 6.5 42.6 1.6 19.0 3.0 6.5 11.8 5.2 5.2 22.9 3.9 11.8 17.8 6.1 6.4 3.6 11.0 5.2 19.8 3.1 6.5 3.7 2.2 2.3 12.7 7.8 4.7 0.5 11.7 0.7 5.2 4.8 5.2 0.1 2.6 1.6 2.9 2.1 21.5 9.1 4.3 10.5 11.3 25.8 15.3 3.7 18.6 2.8 4.9 17.8 1.1 2.7 0.2 0.9 0.3 0.6 0.5 0.1 0.5 0.3 1.4 0.4 1.5 0.2 2.9 0.2 0.0 0.5 58.8 53.6 8.5 25.2 60.0 39.9 66.1 16.4 26.4 38.6 14.9 31.1 34.2 22.5 8.2 100.5 179.2 58.6 29.4 29.6 61.1 143.3 6.0 29.9 26.8 2.4 43.9 23.1 0.0 58.5 1.5 18.6 91.5 42.8 127.8 14.7 209.7 64.5 159.0 115.1 3.1 12.0 28.9 42.2 32.5 35.2 61.0 53.9 17.5 17.7 62.8 59.6 45.3 63.6 0.9 1.7 8.3 8.0 30.2 23.3 40.0 HIRA "DGCR1, TUP1, TUPLE1" ENSG00000100084 "Histone cell cycle regulator" P54198 22 19330698-19447450 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 50.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 74.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB039243, CAB039244, HPA050714, HPA052902" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB039243: , CAB039244: , HPA050714: AB_2681219, HPA052902: AB_2681984" "unprognostic (1.32e-1)" "unprognostic (1.74e-3)" "unprognostic (2.45e-3)" "unprognostic (1.11e-1)" "unprognostic (4.59e-2)" "unprognostic (2.46e-1)" "unprognostic (2.42e-2)" "unprognostic (2.17e-2)" "unprognostic (2.50e-1)" "prognostic favorable (8.11e-4)" "prognostic favorable (3.97e-4)" "unprognostic (9.05e-2)" "prognostic favorable (5.18e-6)" "unprognostic (4.84e-2)" "unprognostic (8.57e-2)" "unprognostic (6.36e-2)" "unprognostic (1.32e-3)" 9.9 9.8 14.8 10.0 13.6 19.9 7.4 16.7 16.3 8.0 11.7 10.9 9.4 12.4 11.9 8.4 9.7 11.5 10.0 9.2 13.4 11.6 12.8 15.0 9.1 11.4 11.3 10.0 10.8 11.3 25.6 11.4 7.6 9.8 7.6 9.4 8.9 8.6 8.7 15.3 10.8 12.1 10.3 8.3 10.2 10.1 10.5 10.6 20.3 50.0 4.6 10.0 8.9 18.2 8.2 2.9 6.1 1.2 3.6 2.4 1.2 8.1 7.1 10.1 10.4 9.9 6.5 7.1 6.8 7.9 11.3 11.2 16.2 4.7 15.7 3.4 8.8 6.8 9.6 14.3 8.6 7.3 9.8 16.6 14.6 7.7 14.8 10.8 33.7 10.8 7.9 8.4 8.8 8.7 6.1 8.1 15.9 74.9 8.4 6.4 10.0 16.5 12.0 9.2 19.2 7.2 13.2 14.4 4.6 6.5 9.0 14.8 9.9 7.8 7.9 9.4 5.3 5.0 11.8 9.4 7.8 11.6 7.9 8.0 9.0 8.9 16.5 9.0 10.9 6.4 6.1 1.2 5.0 2.3 1.2 2.4 3.7 1.3 2.3 1.5 8.2 0.6 1.7 2.2 3.6 0.6 2.9 0.6 1.2 14.8 13.6 16.7 16.3 13.4 11.6 11.3 10.0 9.8 10.6 6.0 0.3 6.9 1.9 8.1 8.5 2.0 5.1 0.0 0.0 5.2 2.0 3.2 5.0 5.3 5.7 3.6 7.0 0.0 7.7 3.0 4.1 3.8 0.0 18.1 5.6 15.9 2.4 7.4 10.8 1.6 4.6 2.5 10.1 3.6 8.5 4.5 6.6 10.8 6.3 9.3 4.0 6.5 4.2 7.1 7.5 9.3 2.5 3.3 13.3 1.8 HIRIP3 ENSG00000149929 "HIRA interacting protein 3" Q9BW71 16 29992321-29996436 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 94.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051897, HPA063205" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA051897: AB_2681655, HPA063205: AB_2684963" "unprognostic (6.99e-2)" "prognostic favorable (2.74e-5)" "unprognostic (4.75e-2)" "unprognostic (2.83e-1)" "unprognostic (1.08e-1)" "unprognostic (4.48e-2)" "unprognostic (9.55e-2)" "unprognostic (1.80e-2)" "unprognostic (3.58e-2)" "unprognostic (8.53e-3)" "unprognostic (3.85e-2)" "unprognostic (2.07e-1)" "unprognostic (4.26e-3)" "unprognostic (5.22e-2)" "unprognostic (1.69e-1)" "unprognostic (1.97e-2)" "unprognostic (2.35e-2)" 9.4 11.3 16.8 9.2 26.8 15.0 10.0 23.4 17.9 10.9 11.3 20.7 10.0 9.6 11.3 10.8 9.5 12.5 9.0 17.6 16.4 14.6 10.6 13.6 12.8 12.7 22.9 13.6 18.2 11.4 20.0 14.2 8.4 15.3 10.1 7.5 11.5 12.8 15.5 29.0 13.3 9.2 13.3 20.1 10.8 8.5 34.0 23.9 21.0 11.8 9.0 11.9 10.3 12.4 13.9 14.6 10.8 13.9 9.7 16.6 8.3 11.0 11.8 18.2 12.3 5.8 6.3 6.3 8.8 7.2 9.6 8.1 9.9 12.1 19.6 18.6 5.8 6.5 8.3 11.9 10.8 6.3 19.4 14.3 21.0 15.7 11.1 5.4 18.6 18.5 3.4 8.2 9.1 13.6 5.1 5.5 22.6 10.9 25.0 5.0 8.1 26.9 11.8 6.0 7.2 7.5 29.4 20.3 22.5 6.1 4.8 13.2 15.8 8.4 7.5 6.2 4.6 10.6 13.3 5.4 12.9 9.6 9.0 8.6 17.3 12.1 13.4 11.9 17.5 17.3 3.5 5.9 10.8 13.4 9.2 9.3 13.9 15.3 12.4 4.9 11.7 16.1 14.9 2.7 9.7 13.9 14.6 16.6 8.3 16.8 26.8 23.4 17.9 16.4 14.6 22.9 13.6 15.3 23.9 62.5 22.9 6.7 16.0 11.3 36.1 27.0 10.2 26.8 20.5 8.7 13.7 21.2 24.9 8.4 13.9 14.6 13.6 0.0 10.7 25.6 12.2 5.7 30.1 12.3 16.1 14.3 9.2 8.6 9.9 8.2 19.0 13.5 5.0 10.0 9.1 34.7 6.1 10.5 21.2 15.3 39.9 12.9 19.6 94.0 51.7 9.9 9.6 19.2 13.3 4.2 HIST1H1A "H1.1, H1a, H1F1" ENSG00000124610 "Histone cluster 1 H1 family member a" Q02539 6 26017085-26017732 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 57.2" "Cell type enriched" "Detected in some" 9 "Spermatogonia: 131.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "T-reg: 4.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 2.1;REH: 4.4;RPTEC TERT1: 1.5;U-2 OS: 3.9" "Not detected" "Not detected" "HPA043753, HPA056830" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA043753: AB_2678654, HPA056830: " "unprognostic (3.80e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (1.96e-1)" "unprognostic (1.21e-1)" "unprognostic (3.05e-1)" 0.8 1.4 1.0 3.9 0.9 1.1 0.8 0.9 3.3 3.5 0.8 0.0 0.4 0.7 3.6 3.9 6.2 1.1 3.4 2.8 1.0 0.8 3.7 5.3 0.7 1.3 0.8 0.6 7.9 0.8 0.7 1.0 0.7 0.6 0.9 0.9 0.9 0.7 1.5 0.7 2.0 0.8 0.7 0.7 0.9 0.8 57.2 0.0 15.1 2.7 10.6 12.4 1.2 0.8 1.4 1.2 0.0 0.1 0.0 4.9 0.4 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.6 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 0.0 0.2 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.4 0.0 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 3.9 0.5 0.0 0.2 0.5 0.0 0.5 0.0 0.5 0.0 0.0 0.0 1.5 0.1 0.0 1.4 2.8 0.3 0.6 0.0 1.7 0.1 0.0 0.0 0.0 1.2 4.9 0.4 1.0 0.9 0.9 3.3 1.0 0.8 0.8 0.6 0.6 0.0 0.0 0.3 0.0 1.0 0.1 0.0 3.4 0.0 1.4 1.2 0.0 0.0 0.1 14.9 0.0 0.3 0.0 0.0 0.0 0.2 3.6 0.6 0.2 1.1 2.1 1.6 0.0 0.0 4.3 0.3 0.9 0.9 0.2 1.7 0.0 0.0 0.5 0.2 0.0 1.8 0.3 1.0 0.0 0.4 4.9 131.8 0.4 0.3 0.0 0.0 0.3 HIST1H1B "H1.5, H1b, H1F5, H1s-3" ENSG00000184357 "Histone cluster 1 H1 family member b" P16401 6 27866849-27867529 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 342.6" "Cell type enhanced" "Detected in some" 10 "Extravillous trophoblasts: 3.8;Hofbauer cells: 2.6;Kupffer cells: 2.2;Macrophages: 1.8;T-cells: 1.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 4.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 13.0;dendritic cells: 12.7;T-cells: 3.4" "Cell line enhanced" "Detected in many" "MOLT-4: 14.0;NB-4: 7.7;U-698: 6.0" "CAB012241, HPA055907, HPA060331" Supported Supported Nucleoplasm NA NA 510000 Nucleoplasm "CAB012241: , HPA055907: AB_2682966, HPA060331: " "unprognostic (2.34e-1)" "unprognostic (3.75e-4)" "unprognostic (2.12e-2)" "unprognostic (3.63e-2)" "unprognostic (1.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.91e-2)" "unprognostic (4.93e-2)" "unprognostic (1.20e-1)" "unprognostic (8.47e-2)" "unprognostic (6.23e-3)" "unprognostic (5.85e-2)" "unprognostic (5.68e-4)" "unprognostic (2.10e-1)" "unprognostic (9.79e-2)" "unprognostic (1.35e-1)" 1.1 0.4 0.4 22.9 0.5 18.2 2.1 0.5 0.4 1.7 7.3 0.0 0.0 0.3 0.5 1.0 10.2 0.3 1.9 0.6 0.5 0.5 0.4 0.6 3.9 10.7 0.5 0.0 0.4 0.4 0.3 0.4 6.4 0.0 0.4 0.5 0.0 0.8 0.3 0.4 1.4 7.0 0.3 1.7 14.4 1.3 1.7 0.0 342.6 0.6 10.5 26.0 2.0 0.7 13.0 12.7 0.7 1.1 1.8 3.4 2.1 2.2 0.0 0.8 0.0 0.0 0.0 1.7 0.7 0.6 1.0 0.6 0.7 1.5 2.7 0.4 0.8 0.7 0.8 0.0 0.0 0.1 0.8 1.0 3.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.9 1.9 2.7 1.9 0.1 0.4 14.0 7.7 2.1 2.1 0.0 4.2 0.0 0.0 0.4 0.0 1.9 1.1 2.4 0.3 0.0 0.8 1.0 2.5 0.8 1.4 0.1 1.4 1.1 2.9 0.0 6.0 2.0 0.9 1.3 0.0 0.9 0.0 3.3 0.9 1.7 4.8 3.1 3.4 5.1 13.0 1.7 1.8 0.7 1.8 1.1 12.7 3.4 2.1 0.4 0.5 0.5 0.4 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.3 0.1 0.0 0.0 2.6 0.0 0.0 0.6 2.2 0.0 0.3 1.8 0.0 0.0 0.3 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.6 1.8 0.9 0.1 HIST1H2AA "bA317E16.2, H2AFR" ENSG00000164508 "Histone cluster 1 H2A family member a" Q96QV6 6 25726132-25726527 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 518 "testis: 453.1" "Group enriched" "Detected in some" 15 "Spermatocytes: 219.3;Spermatogonia: 217.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "HEK 293: 3.0" "Not detected" "Not detected" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (4.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 453.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 219.3 217.6 0.0 0.0 0.0 0.0 0.0 HIST1H2AB "H2A/m, H2AFM" ENSG00000278463 "Histone cluster 1 H2A family member b" P04908 6 26033176-26033568 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "lymphoid tissue: 133.2" "Cell type enhanced" "Detected in some" 9 "B-cells: 2.2;Early spermatids: 2.6;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 9.2" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (9.53e-3)" "unprognostic (3.93e-2)" "unprognostic (5.40e-2)" "unprognostic (5.96e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (7.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.49e-1)" "unprognostic (1.04e-3)" "unprognostic (3.28e-1)" "unprognostic (7.78e-2)" "unprognostic (1.47e-1)" "unprognostic (1.47e-3)" 0.7 0.3 0.2 7.6 0.0 9.6 2.6 0.2 0.6 0.5 1.7 0.0 0.0 0.3 0.5 0.3 5.0 0.3 0.7 2.6 0.0 0.6 0.3 1.7 5.9 0.0 0.0 0.3 0.3 0.3 0.0 2.6 0.0 0.5 0.3 0.2 0.3 0.3 0.3 0.3 2.2 0.3 0.1 8.2 0.7 8.3 0.0 133.2 0.3 1.5 12.2 0.3 0.0 4.2 1.8 3.4 1.5 1.4 2.4 0.3 0.2 1.0 0.5 3.6 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.0 0.3 1.8 0.9 0.0 0.1 0.6 0.5 0.0 0.6 0.9 2.2 1.1 0.5 9.2 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.4 1.0 0.0 1.4 2.0 2.0 3.6 0.0 3.5 1.2 0.7 1.5 0.0 3.0 0.4 0.1 2.1 0.0 0.1 0.1 0.6 1.0 0.0 0.3 4.0 0.3 0.2 1.5 2.5 0.1 0.6 3.7 0.3 0.0 0.1 3.4 0.8 1.5 0.0 4.2 1.5 2.4 1.8 3.1 0.6 0.8 0.7 1.4 0.1 0.2 0.6 0.3 0.0 0.0 2.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.9 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.6 0.3 1.0 0.0 0.0 1.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 1.1 0.0 0.5 0.0 0.4 0.5 HIST1H2AC H2AFL ENSG00000180573 "Histone cluster 1 H2A family member c" Q93077 6 26124145-26139116 "Cancer-related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 116.1;lymphoid tissue: 202.5" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 177.7;Urothelial cells: 208.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 116.1" "Lineage enriched" "Detected in all" 17 "granulocytes: 116.1" "Cell line enhanced" "Detected in many" "HSkMC: 31.4;OE19: 26.8;SiHa: 26.9;U-2 OS: 27.1;U-266/84: 27.0" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (4.89e-2)" "unprognostic (1.97e-1)" "unprognostic (7.15e-3)" "unprognostic (1.34e-1)" "unprognostic (4.70e-1)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (1.37e-1)" "unprognostic (8.16e-2)" "unprognostic (2.57e-1)" "unprognostic (1.61e-3)" "unprognostic (1.75e-1)" "unprognostic (1.19e-2)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.20e-1)" "unprognostic (5.89e-3)" 13.6 14.5 13.6 22.5 16.4 19.0 29.9 7.3 9.8 35.6 21.0 12.2 17.9 18.1 13.2 32.8 27.5 23.6 13.9 12.6 18.5 12.4 21.4 34.1 29.2 28.5 18.6 8.5 23.8 15.7 3.7 13.4 26.2 8.5 37.2 15.0 21.1 10.4 17.0 17.5 15.4 21.6 14.4 27.0 26.4 26.9 16.3 10.4 202.5 24.5 9.2 34.9 29.6 25.8 6.6 4.5 116.1 3.6 1.9 2.1 48.3 5.5 1.6 1.9 0.6 16.1 8.8 0.8 2.8 1.7 8.5 7.3 2.1 1.4 0.2 13.8 5.6 5.7 6.7 1.5 2.9 6.1 5.3 0.9 0.9 0.7 0.3 12.6 0.9 6.4 31.4 5.0 1.8 5.5 10.8 0.5 0.7 13.9 10.2 3.7 4.6 0.9 1.0 2.3 26.8 0.5 0.6 1.0 16.3 8.1 0.6 2.9 1.2 26.9 5.7 8.8 8.2 13.1 1.4 1.8 5.2 27.1 2.3 1.2 13.3 27.0 1.5 1.9 14.0 2.2 36.0 2.0 24.4 1.4 1.5 1.2 3.3 1.5 1.0 1.4 6.6 2.1 1.1 116.1 1.9 3.6 4.5 2.0 48.3 13.6 16.4 7.3 9.8 18.5 12.4 18.6 8.5 8.5 10.4 32.8 12.8 27.7 117.6 2.6 22.0 22.6 15.3 24.1 12.5 68.0 7.9 13.9 23.2 18.9 3.5 18.0 86.9 0.0 11.7 21.5 13.7 177.7 10.4 51.3 13.8 17.5 93.4 16.0 10.5 0.5 13.0 8.0 5.0 12.6 30.9 10.9 33.5 129.8 7.1 77.4 22.6 19.4 16.5 2.4 2.2 7.3 63.5 18.7 26.1 208.4 HIST1H2AD "H2A.3, H2A/g, H2AFG" ENSG00000196866 "Histone cluster 1 H2A family member d" P20671 6 26198851-26199243 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 14 "lymphoid tissue: 225.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 16.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "U-266/70: 21.2;U-266/84: 6.9" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (5.03e-2)" "unprognostic (1.11e-2)" "unprognostic (7.27e-2)" "unprognostic (3.56e-1)" "unprognostic (9.17e-2)" "unprognostic (1.45e-1)" "unprognostic (9.09e-3)" "unprognostic (6.72e-2)" "unprognostic (1.92e-1)" "unprognostic (4.34e-1)" "unprognostic (1.81e-1)" "unprognostic (2.88e-2)" "unprognostic (1.10e-9)" "unprognostic (2.00e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (2.14e-2)" 2.6 1.8 0.9 13.8 1.1 14.7 6.3 0.8 1.3 8.0 4.6 0.0 3.2 1.5 2.0 3.1 9.2 1.3 2.8 5.5 1.2 1.3 2.3 3.6 4.8 15.9 1.1 0.5 3.4 1.9 1.1 1.5 4.6 1.0 6.8 2.2 1.5 2.5 4.3 1.2 3.2 4.3 2.3 3.6 10.8 1.8 5.7 0.6 225.6 1.4 5.1 14.3 5.3 8.6 7.0 5.7 16.0 1.8 1.1 3.8 0.8 0.8 0.0 0.3 0.3 0.0 0.0 0.0 0.6 0.3 1.9 0.0 2.4 0.3 0.0 1.7 0.3 0.2 0.4 0.0 0.3 0.2 0.1 1.3 0.2 1.6 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 3.5 1.7 0.0 0.1 2.9 1.3 1.7 0.0 0.3 1.5 0.5 1.5 0.4 0.1 1.5 0.3 0.7 1.4 0.1 0.0 0.5 0.5 0.0 1.5 4.1 0.0 1.1 21.2 6.9 2.5 0.8 1.8 0.7 2.2 0.2 3.2 1.1 1.8 1.1 2.0 1.5 3.8 1.0 7.0 1.4 1.1 16.0 1.1 1.3 5.7 2.0 0.8 0.9 1.1 0.8 1.3 1.2 1.3 1.1 0.5 1.0 0.6 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 HIST1H2AE "H2A.1, H2A/a, H2AFA" ENSG00000277075 "Histone cluster 1 H2A family member e" P04908 6 26216975-26217483 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 139.6" "Group enriched" "Detected in many" 7 "Basal glandular cells: 99.4;Glandular cells: 104.2;Urothelial cells: 88.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 26.7" "CAB012242, HPA041189" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012242: AB_470265, HPA041189: AB_2677357" "unprognostic (4.26e-2)" "unprognostic (1.55e-2)" "unprognostic (4.66e-2)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (1.50e-1)" "unprognostic (2.48e-2)" "unprognostic (7.22e-2)" "unprognostic (1.24e-2)" "unprognostic (6.99e-2)" "unprognostic (1.21e-3)" "unprognostic (1.30e-2)" "unprognostic (7.64e-2)" "unprognostic (1.15e-1)" "unprognostic (2.41e-1)" "unprognostic (2.20e-1)" "unprognostic (9.36e-2)" 0.3 1.8 0.9 19.1 0.9 13.5 33.8 4.9 6.2 3.7 3.8 0.2 3.2 2.8 2.2 13.6 7.2 3.0 2.4 2.2 0.5 0.8 1.5 1.9 11.4 0.0 3.0 2.0 1.1 0.4 0.0 2.9 0.5 10.6 1.6 1.4 2.7 2.5 0.1 2.4 3.4 2.0 3.5 5.9 2.0 5.1 0.0 139.6 2.0 7.4 11.4 2.3 0.0 6.1 15.4 11.4 2.1 4.0 4.2 10.1 2.8 0.0 2.1 0.0 3.5 0.7 0.5 0.9 1.4 3.1 2.1 1.4 2.3 0.1 7.8 0.3 2.8 2.4 1.0 1.4 1.2 3.1 2.6 1.9 4.2 1.8 0.6 0.2 2.9 6.2 0.7 1.3 0.1 0.9 1.5 0.5 7.7 2.1 0.2 5.2 6.3 5.4 2.5 9.8 2.6 5.0 1.7 9.9 1.3 1.6 8.6 3.6 7.7 2.6 1.7 1.5 10.6 2.8 0.0 0.1 0.6 1.3 1.2 26.7 0.0 0.0 1.1 3.8 1.9 11.4 2.0 6.3 2.7 2.1 3.8 4.3 3.0 4.2 5.0 6.1 1.6 2.1 9.4 4.0 1.2 15.4 3.6 10.1 3.0 13.0 11.1 99.4 1.3 3.3 0.4 0.0 0.0 2.3 1.8 0.0 6.5 1.7 2.8 2.5 0.5 13.7 0.0 0.0 4.1 2.1 104.2 2.3 2.1 14.1 3.2 10.4 1.8 1.5 1.8 0.9 5.7 0.0 2.8 12.1 1.7 0.3 10.8 0.4 4.0 0.1 0.0 0.2 0.7 9.1 1.3 11.6 10.0 8.1 88.8 HIST1H2AG "H2A.1b, H2A/p, H2AFP, pH2A/f" ENSG00000196787 "Histone cluster 1 H2A family member g" P0C0S8 6 27133042-27135291 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 305.4" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 16.3;Enterocytes: 7.3;Late spermatids: 10.6;Paneth cells: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 9.7" "Group enriched" "Detected in many" 4 "B-cells: 4.4;granulocytes: 9.7;T-cells: 3.8" "Cell line enhanced" "Detected in many" "K-562: 9.9;SiHa: 11.5;U-266/84: 31.2" HPA041189 Supported Approved Nucleoplasm NA Yes Nucleoplasm "HPA041189: AB_2677357" "unprognostic (4.86e-2)" "unprognostic (6.89e-2)" "unprognostic (1.66e-1)" "unprognostic (3.94e-1)" "unprognostic (8.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.95e-1)" "unprognostic (5.78e-2)" "unprognostic (2.41e-1)" "unprognostic (2.37e-1)" "unprognostic (2.14e-3)" "unprognostic (1.53e-2)" "unprognostic (7.36e-2)" "unprognostic (5.98e-2)" "unprognostic (6.48e-2)" "unprognostic (8.22e-3)" "unprognostic (9.54e-2)" 2.4 1.6 1.1 25.1 1.2 6.3 8.7 0.7 1.0 3.3 9.7 0.0 1.0 3.8 2.0 3.7 15.7 1.0 3.2 2.7 1.3 1.6 1.1 2.6 6.0 13.5 2.3 0.0 1.4 0.9 0.3 1.0 8.7 0.3 2.5 2.3 0.3 2.1 1.5 1.1 1.4 7.1 0.9 2.3 20.2 1.8 16.1 0.0 305.4 1.5 12.3 28.9 2.4 2.0 4.4 1.3 9.7 0.8 1.1 3.8 7.7 1.3 1.8 1.6 1.4 4.9 1.0 1.0 0.5 0.7 1.6 0.2 0.8 1.4 0.4 2.0 0.5 1.5 2.8 1.9 0.8 1.1 2.4 1.1 0.7 3.6 0.0 1.0 0.7 1.5 1.8 0.4 0.5 0.5 0.8 0.5 1.3 9.9 4.7 0.1 1.7 1.8 1.1 0.9 2.0 1.2 1.2 1.5 5.1 0.3 0.3 6.1 1.5 11.5 1.8 0.6 0.7 0.0 0.4 0.6 1.8 4.0 1.4 0.7 8.4 31.2 3.2 0.3 1.1 1.1 9.7 0.4 0.7 0.6 0.3 1.3 3.0 2.3 1.6 0.6 4.4 2.2 1.8 3.5 1.1 0.8 1.3 3.8 7.7 1.1 1.2 0.7 0.9 1.3 1.6 2.3 0.0 0.3 0.0 0.0 1.4 2.2 1.4 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 16.3 0.3 7.3 0.0 0.0 2.9 0.3 1.4 0.0 0.4 2.1 4.8 1.2 0.0 0.6 10.6 0.0 1.0 0.0 1.0 3.1 1.2 0.1 10.5 0.0 0.0 0.0 0.0 0.3 2.2 3.0 0.4 2.5 2.5 2.9 1.0 HIST1H2AH "dJ86C11.1, H2A/S, H2AFALii" ENSG00000274997 "Histone cluster 1 H2A family member h" Q96KK5 6 27147129-27147515 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "lymphoid tissue: 301.1" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive B-cell: 16.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 9.0;MOLT-4: 9.3;NB-4: 10.2" "CAB004030, HPA041189" Supported Approved Nucleoplasm NA Yes Nucleoplasm "CAB004030: AB_2118804, HPA041189: AB_2677357" "unprognostic (4.07e-1)" "unprognostic (2.73e-3)" "unprognostic (4.04e-2)" "unprognostic (4.01e-1)" "unprognostic (2.02e-1)" "unprognostic (5.35e-3)" "unprognostic (3.90e-2)" "unprognostic (3.20e-1)" "unprognostic (2.36e-1)" "unprognostic (2.38e-3)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (9.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.26e-4)" 0.8 0.7 0.0 26.0 0.0 20.2 1.5 0.0 0.4 3.1 6.6 0.0 0.6 1.0 1.8 2.6 6.4 1.0 2.7 1.3 0.0 0.5 0.4 4.1 5.4 0.0 0.0 2.4 0.5 0.4 0.0 9.0 0.0 0.6 0.9 0.1 1.7 0.6 0.4 0.6 6.5 0.9 0.0 13.9 0.7 23.5 0.0 301.1 0.6 9.0 27.3 1.9 0.0 16.2 2.2 0.0 2.4 5.1 4.7 2.3 2.6 3.5 1.1 4.9 0.0 0.0 0.7 0.3 0.6 0.6 0.0 2.6 1.0 3.8 0.9 0.0 0.6 0.3 1.0 0.0 0.0 2.1 9.0 4.7 3.0 0.0 0.0 3.2 1.8 0.0 0.0 1.2 0.0 0.0 0.9 1.8 4.8 2.4 0.9 0.4 9.3 10.2 3.2 0.9 1.2 3.4 3.1 5.0 0.0 0.3 2.5 0.6 1.4 0.5 0.2 0.1 1.0 1.5 0.0 0.8 2.8 0.2 2.7 2.9 2.9 6.1 1.3 4.6 0.8 0.0 0.9 0.0 2.6 2.4 1.2 3.8 4.7 4.2 2.2 16.2 2.4 1.6 0.0 5.1 1.5 1.5 0.8 2.3 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.7 0.0 0.3 1.7 0.1 1.6 23.3 0.3 1.9 0.3 0.8 1.1 0.0 0.7 0.0 1.7 1.8 1.2 4.3 0.6 0.6 0.0 0.0 0.3 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.5 0.2 2.5 1.0 0.6 HIST1H2AI "H2A/c, H2AFC" ENSG00000196747 "Histone cluster 1 H2A family member i" P0C0S8 6 27808199-27808701 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "lymphoid tissue: 349.3" "Cell type enhanced" "Detected in single" 10 "T-cells: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 17.7;U-266/84: 48.6" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (1.23e-1)" "unprognostic (6.21e-3)" "unprognostic (6.82e-2)" "unprognostic (5.57e-3)" "unprognostic (1.38e-1)" "unprognostic (4.48e-2)" "unprognostic (9.11e-3)" "unprognostic (1.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (9.54e-5)" "unprognostic (5.50e-2)" "unprognostic (1.50e-5)" "unprognostic (1.43e-1)" "unprognostic (1.85e-1)" "unprognostic (1.89e-1)" "unprognostic (6.24e-2)" 1.7 1.2 0.7 36.2 0.9 10.7 2.8 0.6 0.7 1.5 6.3 0.0 0.5 2.3 1.1 1.4 14.2 1.4 2.8 4.8 1.1 1.1 1.0 1.3 3.5 25.8 0.6 0.0 1.2 0.4 1.4 0.6 5.4 0.0 1.3 5.8 0.0 1.3 0.3 0.5 1.1 7.1 0.5 4.3 21.9 2.2 4.3 0.0 349.3 1.0 15.2 26.8 2.3 2.0 3.0 2.6 4.8 0.8 2.5 4.0 2.0 0.9 3.7 0.9 0.6 0.4 0.2 0.3 0.7 0.1 1.2 0.9 1.1 0.6 1.0 2.2 0.3 0.6 0.7 0.0 0.6 0.5 3.6 4.8 1.5 5.9 3.1 0.4 0.4 0.8 1.7 0.2 0.4 0.1 1.0 0.2 1.2 17.7 4.2 0.0 4.6 2.6 2.8 0.9 3.1 1.3 1.3 0.0 6.9 1.4 0.7 5.2 1.0 10.3 1.5 0.3 0.3 6.3 0.4 0.2 0.5 2.0 0.4 0.4 3.9 48.6 2.0 0.4 4.1 0.3 0.0 0.5 3.6 0.9 0.8 0.7 2.1 3.2 0.9 2.3 3.0 0.7 0.4 4.8 2.5 0.8 2.6 4.0 2.0 0.7 0.9 0.6 0.7 1.1 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.2 0.4 HIST1H2AJ "H2A/E, H2AFE" ENSG00000276368 "Histone cluster 1 H2A family member j" Q99878 6 27814354-27814740 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "lymphoid tissue: 357.7" "Cell type enriched" "Detected in some" 29 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 10.0;Karpas-707: 12.1;MCF7: 16.8" "Low region specificity" "Detected in some" HPA041189 Supported Approved Nucleoplasm NA Yes Nucleoplasm "HPA041189: AB_2677357" "unprognostic (8.95e-3)" "unprognostic (4.08e-3)" "unprognostic (3.28e-2)" "unprognostic (5.72e-3)" "unprognostic (2.29e-2)" "unprognostic (2.69e-2)" "unprognostic (6.06e-2)" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" "unprognostic (9.39e-3)" "unprognostic (3.43e-1)" "unprognostic (9.35e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-2)" 0.6 0.1 0.0 7.2 0.0 16.5 0.2 0.0 0.2 1.0 5.2 0.0 0.0 0.3 0.3 0.6 6.6 0.3 0.8 0.2 0.0 0.3 0.4 2.2 3.1 0.0 0.0 0.1 0.1 0.1 0.0 3.6 0.0 0.2 0.4 0.0 0.1 0.1 0.1 0.4 3.9 0.1 0.0 10.5 0.8 5.2 0.0 357.7 0.1 7.9 23.1 1.5 0.0 4.2 2.7 2.5 0.5 0.4 5.9 5.0 4.0 0.0 1.2 0.0 0.0 0.0 1.0 1.2 1.2 1.1 2.6 2.1 0.2 3.9 0.4 0.7 0.1 1.1 0.0 1.1 0.6 1.9 0.6 5.6 0.5 10.0 0.3 0.0 2.1 0.0 0.3 0.5 0.3 0.0 1.5 2.1 0.0 12.1 0.3 16.8 6.7 6.1 2.0 1.7 3.5 6.0 0.0 2.3 0.2 2.4 0.5 0.8 1.1 1.2 0.5 0.3 0.4 4.1 0.0 0.0 2.4 0.4 0.2 6.2 3.9 3.8 1.3 4.5 2.8 0.0 0.1 0.0 0.7 0.5 0.9 0.7 3.4 3.1 2.7 4.2 1.1 0.4 2.5 0.4 0.2 0.3 5.9 5.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 46.7 0.0 1.6 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.0 0.4 0.3 HIST1H2AK "H2A/d, H2AFD" ENSG00000275221 "Histone cluster 1 H2A family member k" P0C0S8 6 27837947-27838339 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 115.7" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 1.4;granulocytes: 1.1;Melanocytes: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.3;AN3-CA: 4.9;HeLa: 5.1;SCLC-21H: 4.8;U-266/84: 7.2" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" 1.5 4.1 0.0 11.1 0.5 3.2 3.5 0.9 1.3 2.8 2.3 0.2 0.5 1.0 1.7 1.6 4.4 2.7 4.1 2.5 0.0 0.2 0.4 4.4 8.4 0.8 0.0 3.3 0.0 0.0 0.1 1.7 0.3 2.3 0.4 0.9 1.7 1.1 0.7 0.0 1.5 0.3 1.6 7.0 1.3 3.9 0.5 115.7 1.6 2.8 12.3 2.1 0.0 6.0 1.2 0.0 0.6 1.1 3.8 5.1 0.0 4.3 0.0 4.9 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.4 0.0 0.2 0.2 0.8 0.5 2.2 1.0 0.0 0.6 1.4 1.2 1.7 5.1 0.6 0.7 0.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.6 1.9 0.0 0.0 0.7 1.6 0.0 0.0 0.2 0.0 0.6 0.4 0.0 1.0 0.3 4.8 0.8 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.5 0.5 0.0 0.3 1.9 7.2 1.0 0.0 0.3 0.5 0.0 0.1 0.0 2.3 0.0 1.8 5.8 2.6 2.4 0.0 6.0 3.8 2.8 0.0 1.1 0.6 1.2 2.7 5.1 0.0 0.3 0.5 0.3 0.1 0.7 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.8 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.0 HIST1H2AL "dJ193B12.9, H2A/i, H2AFI" ENSG00000276903 "Histone cluster 1 H2A family member l" P0C0S8 6 27865355-27865747 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 288.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 7.2;MOLT-4: 8.9" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (2.45e-2)" "unprognostic (2.94e-2)" "unprognostic (5.88e-2)" "unprognostic (2.46e-3)" "unprognostic (3.17e-1)" "unprognostic (1.82e-1)" "unprognostic (3.86e-2)" "unprognostic (2.08e-2)" "unprognostic (4.18e-1)" "unprognostic (2.38e-1)" "unprognostic (4.01e-2)" "unprognostic (4.29e-1)" "unprognostic (2.41e-2)" "unprognostic (2.12e-1)" "unprognostic (6.21e-2)" 1.1 0.5 0.0 24.8 0.0 16.4 1.3 0.0 0.5 1.1 4.5 0.0 0.0 1.1 0.8 1.7 7.6 0.3 1.8 1.5 0.0 0.4 0.4 3.4 10.2 0.0 0.0 0.3 0.3 1.5 0.0 5.2 0.0 0.3 0.3 0.0 0.7 0.3 0.3 0.5 4.4 0.3 0.0 12.9 0.7 13.1 0.0 288.3 0.3 9.6 26.4 0.5 0.0 9.6 4.7 8.8 3.6 0.1 2.0 1.1 4.2 1.7 0.9 0.0 0.0 0.0 1.1 1.7 0.7 1.4 1.7 0.0 1.4 3.2 1.2 0.0 1.0 1.2 0.0 0.0 0.4 3.1 7.2 1.2 0.0 1.2 0.0 0.8 1.5 0.0 0.0 0.4 0.0 0.0 0.0 1.7 5.5 3.3 0.5 3.8 8.9 6.4 2.9 1.7 1.3 4.6 0.0 0.5 0.7 2.6 2.1 2.0 1.2 0.0 0.8 0.0 0.4 1.2 0.0 0.2 0.0 1.4 3.0 5.6 0.0 6.5 1.4 4.1 1.3 2.4 2.0 1.3 0.1 1.7 0.0 3.3 1.7 2.0 4.7 9.6 0.7 1.0 8.8 0.1 3.6 3.4 1.7 1.1 0.0 0.0 0.0 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.9 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.1 0.0 0.4 0.5 HIST1H2AM "H2A.1, H2A/n, H2AFN" ENSG00000278677 "Histone cluster 1 H2A family member m" P0C0S8 6 27892757-27893149 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "lymphoid tissue: 315.3" "Cell type enhanced" "Detected in some" 11 "B-cells: 2.2;Ciliated cells: 4.0;granulocytes: 2.3;T-cells: 3.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 25.2" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (6.05e-2)" "unprognostic (4.03e-1)" "unprognostic (2.04e-1)" "unprognostic (2.79e-1)" "unprognostic (1.26e-1)" "unprognostic (1.11e-2)" "unprognostic (6.48e-2)" "unprognostic (2.70e-1)" "unprognostic (6.36e-2)" "unprognostic (4.64e-3)" "unprognostic (2.65e-3)" "unprognostic (4.24e-1)" "unprognostic (8.85e-6)" "unprognostic (2.44e-1)" "unprognostic (3.18e-1)" "unprognostic (8.80e-2)" "unprognostic (1.30e-1)" 1.2 1.5 0.0 30.7 0.0 9.3 2.3 0.2 0.2 2.1 6.1 0.1 2.3 1.4 1.3 2.6 10.7 0.3 3.9 2.2 0.0 0.6 1.7 4.7 12.7 0.0 0.0 0.4 1.2 0.0 0.0 10.4 0.3 0.9 1.8 0.0 1.3 2.2 0.7 1.0 6.5 0.0 1.1 15.3 1.7 4.8 0.0 315.3 1.3 11.4 28.9 2.5 0.0 10.3 14.7 28.7 6.2 4.8 8.5 7.0 3.2 2.7 2.1 5.1 0.3 0.3 4.5 0.9 0.7 2.6 3.5 1.0 1.3 5.4 3.7 0.8 2.5 2.2 1.6 1.7 1.7 3.5 1.3 2.7 3.4 3.6 0.0 1.6 2.2 1.3 0.0 1.8 0.0 0.2 2.6 3.9 11.6 7.5 0.4 5.3 11.0 7.8 3.8 2.0 1.3 6.7 3.5 9.6 1.3 0.7 8.1 1.5 5.6 0.6 0.7 1.1 4.9 1.6 0.0 1.1 0.1 1.2 1.7 8.1 25.2 12.6 1.5 9.5 1.0 28.7 3.4 12.5 6.8 3.8 4.1 8.9 5.9 5.7 11.4 10.3 2.5 2.8 11.5 4.8 6.2 14.7 8.5 7.0 0.0 0.0 2.2 0.1 0.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.1 2.3 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 3.2 0.4 0.0 HIST2H2AA3 "H2A.2, H2A/q, H2AFO, HIST2H2AA" ENSG00000203812 "Histone cluster 2 H2A family member a3" Q6FI13 1 149842188-149842736 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 67.4" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 76.9;Ciliated cells: 64.3;granulocytes: 22.1" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 19.8;U-266/70: 96.9;U-266/84: 53.8" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (2.41e-2)" "unprognostic (3.79e-1)" "unprognostic (1.53e-1)" "unprognostic (2.89e-1)" "unprognostic (2.20e-1)" 6.1 2.7 3.7 6.8 3.7 67.4 7.8 3.7 5.4 10.1 4.0 3.7 3.7 4.2 3.7 3.7 6.5 5.4 5.0 4.5 3.7 1.6 5.6 9.9 14.6 4.4 3.7 3.7 5.1 3.7 0.4 3.7 8.9 3.7 35.8 1.7 3.7 22.4 3.7 4.5 11.7 3.7 3.7 8.0 12.8 9.6 11.2 3.7 18.9 3.7 3.7 5.4 3.7 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.3 0.6 0.0 5.3 2.5 3.6 3.0 0.0 1.0 1.5 3.8 2.3 0.0 0.9 0.3 1.1 0.4 2.5 0.0 0.7 7.0 0.9 2.4 0.0 0.7 11.8 2.0 0.9 1.0 0.0 0.9 0.0 7.8 19.8 1.2 0.0 0.0 5.9 0.0 2.9 4.2 0.8 0.0 7.4 1.4 1.8 0.0 0.0 6.7 0.0 0.2 0.0 5.2 2.0 2.0 0.7 8.9 0.0 0.5 96.9 53.8 2.1 5.6 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.7 3.7 5.4 3.7 1.6 3.7 3.7 3.7 3.7 17.9 76.9 0.0 7.4 10.5 0.0 2.8 0.0 64.3 13.6 1.8 0.0 0.2 0.0 0.1 1.4 0.0 0.0 0.0 0.2 0.1 2.8 4.2 22.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 9.3 10.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.2 13.7 1.8 1.9 0.0 4.1 HIST2H2AA4 H2A/r ENSG00000272196 "Histone cluster 2 H2A family member a4" Q6FI13 1 149851061-149851624 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 164.8;lymphoid tissue: 101.1" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 89.0;Ciliated cells: 155.2;Club cells: 42.1;granulocytes: 40.7" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.5" "Cell type enriched" "Detected in all" 5 "neutrophil: 164.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 164.8" "Cell line enhanced" "Detected in many" "SiHa: 27.3;U-266/70: 68.1;U-266/84: 60.4" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (1.63e-1)" "unprognostic (1.77e-1)" "unprognostic (1.76e-1)" "unprognostic (8.47e-2)" 4.5 6.5 0.0 9.8 1.2 9.0 2.5 0.3 2.6 5.2 5.7 1.5 2.5 5.7 5.5 3.4 9.1 2.4 4.2 4.0 0.7 3.0 2.5 8.8 7.1 0.1 0.0 4.3 5.0 0.0 0.5 6.5 1.6 9.5 0.0 2.1 4.2 2.6 3.5 5.8 5.4 0.9 0.8 8.4 4.2 21.6 0.1 101.1 1.9 4.8 11.5 5.8 2.3 9.3 17.2 164.8 17.9 3.5 4.2 18.8 3.8 9.7 1.3 2.2 0.0 1.2 3.1 8.2 0.0 0.0 0.0 6.6 3.9 0.0 9.3 0.0 2.6 5.3 0.0 0.0 0.0 5.3 12.8 1.2 8.0 4.3 0.0 1.2 7.5 0.0 0.0 0.0 0.0 2.3 0.0 4.4 8.3 19.7 0.0 24.7 4.2 1.2 3.7 21.0 10.2 3.7 1.5 6.7 0.0 2.0 9.8 4.1 27.3 7.5 2.1 1.3 13.0 2.7 0.0 2.7 20.9 3.8 1.0 68.1 60.4 4.6 0.0 6.2 3.1 24.2 17.9 32.8 3.2 10.5 3.3 5.9 2.8 3.0 12.0 9.3 2.2 2.0 164.8 3.5 12.4 17.2 4.2 18.8 23.8 89.0 0.0 6.7 0.0 0.0 22.0 0.0 155.2 42.1 3.5 0.0 0.3 0.0 0.6 1.5 0.0 0.0 0.0 0.3 0.2 0.3 5.6 40.7 1.6 0.9 0.0 0.0 0.0 0.6 1.0 0.3 0.7 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.2 0.0 2.2 0.9 0.1 4.8 HIST2H2AB ENSG00000184270 "Histone cluster 2 H2A family member b" Q8IUE6 1 149887524-149887916 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 126.3" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 2.4;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Horizontal cells: 1.6;Intestinal endocrine cells: 1.7;Muller glia cells: 4.3;Rod photoreceptor cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 8.0;U-266/70: 4.9;U-266/84: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011483, HPA041189" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB011483: AB_732909, HPA041189: AB_2677357" "unprognostic (6.31e-2)" "unprognostic (6.63e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.09e-1)" "unprognostic (3.34e-1)" "unprognostic (2.42e-3)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" "unprognostic (2.03e-1)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (9.97e-3)" "unprognostic (5.33e-2)" "unprognostic (2.00e-2)" "unprognostic (4.36e-2)" 2.4 1.6 1.2 6.4 1.6 21.1 2.9 2.6 2.4 6.8 2.6 0.6 0.6 1.2 1.9 1.6 5.1 1.5 2.2 1.5 1.4 1.3 1.6 1.8 4.2 3.0 1.2 1.9 7.4 3.0 2.2 1.4 2.3 0.0 4.2 2.0 3.9 1.9 1.9 2.5 4.7 2.9 4.0 2.7 4.8 1.9 2.1 0.1 126.3 1.7 2.1 9.0 7.1 2.4 10.2 4.3 11.6 2.0 4.3 4.5 0.8 1.3 0.0 0.7 0.7 0.0 0.0 1.1 0.9 0.0 0.0 1.4 0.0 1.0 0.8 0.6 0.0 0.0 1.0 1.0 0.0 0.0 0.3 1.5 0.0 0.8 0.7 0.0 0.0 1.5 0.0 0.0 0.6 0.0 0.2 0.0 1.1 1.1 1.1 0.7 0.0 8.0 3.4 0.9 0.8 1.7 1.7 0.5 1.3 0.0 0.5 2.3 1.0 2.3 0.0 0.2 0.2 0.3 3.5 0.0 1.0 3.4 0.0 0.7 4.9 5.3 1.4 2.1 0.3 0.6 1.3 1.6 0.8 2.7 2.0 2.7 3.8 4.5 4.0 2.3 10.2 2.7 2.7 11.6 4.3 1.9 4.3 2.6 0.8 1.2 1.6 2.6 2.4 1.4 1.3 1.2 1.9 0.0 0.1 0.0 0.0 0.0 0.5 0.0 2.4 0.4 0.0 0.0 0.0 1.8 2.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.2 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 HIST2H2AC "H2A, H2A/q, H2AFQ" ENSG00000184260 "Histone cluster 2 H2A family member c" Q16777 1 149886975-149887364 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 47.7;bone marrow: 86.5;lymphoid tissue: 80.6" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "MCF7: 45.3" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (5.50e-3)" "unprognostic (4.97e-2)" "unprognostic (9.34e-2)" "unprognostic (6.95e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-3)" "unprognostic (1.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.81e-1)" "unprognostic (3.24e-2)" "unprognostic (4.25e-2)" "unprognostic (7.87e-2)" "prognostic unfavorable (1.20e-10)" "unprognostic (1.42e-1)" "unprognostic (1.73e-1)" "unprognostic (4.89e-2)" "prognostic favorable (7.86e-5)" 10.5 8.5 4.2 6.5 4.2 86.5 8.6 3.1 4.1 13.8 7.5 2.8 5.4 4.6 8.1 6.0 10.9 6.4 8.1 13.2 3.9 3.1 8.2 6.1 10.5 12.5 2.9 3.7 15.3 15.8 3.6 7.6 8.4 2.3 10.6 4.3 13.8 6.0 10.1 7.2 10.1 6.4 9.7 7.6 10.7 5.8 4.9 2.4 80.6 6.0 8.1 10.5 16.2 8.9 15.8 11.6 47.7 15.9 7.9 11.0 10.8 2.6 3.2 3.7 11.2 0.0 0.6 5.5 0.7 0.9 1.8 2.7 1.9 0.7 5.5 0.1 0.2 0.3 1.2 0.2 1.2 0.0 0.3 4.4 1.3 0.4 9.4 0.0 3.2 2.9 0.7 0.2 0.1 0.4 0.1 1.3 1.4 1.1 6.7 0.4 45.3 3.8 3.2 4.8 3.1 7.8 1.2 1.5 1.0 0.7 1.9 1.1 5.2 1.5 0.8 2.5 0.3 0.4 3.2 1.1 0.8 7.4 1.4 1.9 3.1 1.9 2.8 2.0 4.4 1.6 17.0 15.9 8.1 11.0 10.6 10.0 6.2 9.7 8.7 8.1 15.8 6.8 6.7 47.7 7.9 10.6 11.6 7.3 10.8 4.2 4.2 3.1 4.1 3.9 3.1 2.9 3.7 2.3 2.4 6.0 6.4 11.2 15.2 3.3 9.8 1.6 7.6 2.7 5.7 1.8 9.8 4.0 8.3 12.0 3.7 6.8 8.0 46.7 11.6 15.4 4.3 7.6 8.1 6.4 8.1 7.9 9.1 6.2 7.6 2.1 7.5 12.4 3.3 19.0 6.1 13.7 11.0 4.3 6.0 3.9 14.1 0.0 6.2 0.4 1.6 5.5 7.3 11.7 6.3 11.2 HIST3H2A MGC3165 ENSG00000181218 "Histone cluster 3 H2A" Q7L7L0 1 228456979-228457873 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.8;lymphoid tissue: 62.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 35.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 18.7;SCLC-21H: 15.8;U-266/70: 18.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (3.65e-3)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (2.71e-1)" "prognostic favorable (3.73e-4)" "unprognostic (1.84e-3)" "unprognostic (2.49e-2)" "unprognostic (4.51e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-2)" "unprognostic (3.20e-2)" "unprognostic (1.96e-1)" "unprognostic (6.67e-3)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (7.76e-2)" 2.5 20.5 4.3 7.0 8.3 11.1 5.8 35.8 8.1 9.9 3.8 2.4 2.0 7.7 5.0 4.4 7.0 4.2 3.8 4.9 5.4 4.6 1.6 1.0 2.5 5.1 5.6 5.3 8.3 4.5 3.5 5.0 3.4 6.5 7.0 2.8 13.9 6.6 3.9 1.0 6.4 4.2 1.5 5.2 6.6 4.7 3.5 4.8 62.3 1.9 5.6 9.3 2.9 9.3 3.4 3.4 5.1 7.1 6.8 11.7 4.3 3.6 1.9 2.6 3.5 2.1 2.2 3.1 1.8 1.7 5.2 3.6 1.9 3.0 1.6 2.2 0.4 0.0 8.9 1.8 0.8 1.2 2.6 18.7 2.6 2.5 0.0 5.0 1.8 5.2 4.8 5.3 1.0 2.2 2.1 2.2 3.4 9.0 0.0 0.0 5.1 2.3 0.0 3.9 2.1 4.8 0.0 0.0 13.6 0.8 2.2 15.8 11.1 6.3 5.6 12.1 0.4 9.9 1.3 0.8 0.0 0.0 7.0 1.6 18.8 13.4 0.0 1.8 1.8 1.3 5.1 1.7 0.0 7.1 3.1 5.1 3.4 6.8 5.3 3.4 2.0 5.3 5.2 0.7 6.8 7.1 0.6 11.7 4.3 4.3 8.3 35.8 5.9 5.4 4.6 5.6 5.3 6.5 4.8 0.0 0.3 7.5 21.8 1.1 18.2 5.5 5.1 18.7 13.6 3.5 45.2 11.8 6.6 3.3 0.6 1.0 6.0 23.3 2.7 9.5 3.1 30.8 13.9 0.0 23.0 39.7 35.1 1.3 8.0 1.1 19.2 14.3 3.3 25.2 26.6 24.1 9.7 17.3 8.1 1.1 6.4 0.0 4.6 0.5 2.7 5.1 45.0 41.5 17.4 32.1 HIST3H3 "H3.4, H3/g, H3FT, H3t" ENSG00000168148 "Histone cluster 3 H3" Q16695 1 228424845-228425325 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 194 "testis: 107.8" "Cell type enhanced" "Detected in some" 29 "Early spermatids: 2.8;Late spermatids: 13.2;Spermatocytes: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;MCF7: 1.3;THP-1: 1.8" "CAB001386, CAB003812, HPA042570" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB001386: , CAB003812: AB_365490, HPA042570: AB_2678056" "unprognostic (4.45e-1)" "unprognostic (4.66e-2)" "unprognostic (1.36e-1)" "unprognostic (3.78e-3)" "unprognostic (1.75e-2)" "unprognostic (4.04e-2)" "unprognostic (1.39e-2)" "unprognostic (2.26e-2)" 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.1 107.8 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 1.8 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.2 0.0 0.8 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.4 0.0 0.0 0.0 0.0 0.0 HIST4H4 MGC24116 ENSG00000197837 "Histone cluster 4 H4" P62805 12 14767999-14771131 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 36.7" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 9.8;Enterocytes: 9.5;Rod photoreceptor cells: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.1" "CAB011503, CAB037279, HPA042201" Supported Supported Nucleoplasm NA NA 30000000 Nucleoplasm "CAB011503: AB_873863, CAB037279: AB_1079064, HPA042201: AB_2677898" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.16e-2)" "unprognostic (4.86e-2)" "unprognostic (3.67e-2)" "unprognostic (9.69e-3)" "unprognostic (4.54e-2)" "unprognostic (3.25e-2)" "unprognostic (5.35e-2)" "unprognostic (6.62e-3)" "unprognostic (4.38e-2)" "unprognostic (1.02e-2)" "unprognostic (1.33e-3)" "unprognostic (2.01e-1)" "unprognostic (1.28e-3)" 7.1 4.6 2.3 7.4 7.6 2.5 4.7 6.7 4.9 6.9 6.2 1.1 3.3 5.0 5.4 7.1 8.9 6.0 5.4 5.9 2.8 2.5 11.0 3.3 6.3 7.2 2.5 2.1 8.3 36.7 2.1 5.1 7.1 2.1 16.0 4.8 6.1 12.7 5.5 2.8 6.4 8.9 3.3 3.1 21.8 10.1 6.6 1.7 16.9 9.9 6.8 18.6 6.6 6.8 5.5 3.6 19.7 2.1 2.1 3.4 1.1 2.1 0.8 0.1 2.6 2.9 0.0 1.5 1.3 0.1 1.1 0.9 1.4 8.1 2.0 0.5 0.7 0.0 1.4 0.0 1.0 0.6 2.5 1.1 0.0 5.2 2.1 0.8 0.5 2.0 2.0 0.6 0.2 1.2 0.0 0.0 0.6 0.0 2.6 0.1 1.1 0.5 0.7 2.8 0.7 0.3 2.2 0.0 3.9 0.0 5.8 1.0 1.4 5.3 1.4 0.3 0.6 1.0 1.0 1.8 0.5 4.2 1.1 1.6 2.8 1.7 5.8 1.9 0.0 1.3 0.0 1.9 0.2 2.0 2.1 3.4 4.1 2.3 2.2 2.1 5.5 2.0 2.2 19.7 2.1 0.7 3.6 3.2 1.1 2.3 7.6 6.7 4.9 2.8 2.5 2.5 2.1 2.1 1.7 0.0 0.0 2.2 1.3 0.5 6.2 2.0 0.0 1.4 1.2 1.8 9.8 0.8 0.0 0.7 0.0 0.6 9.5 0.0 1.0 0.3 0.9 0.6 0.0 0.9 1.4 0.0 1.7 0.6 2.1 0.0 1.1 0.6 0.0 1.8 1.4 2.3 0.8 2.0 0.7 0.8 18.8 0.0 1.3 0.2 0.5 1.0 1.4 4.5 1.4 0.5 HIVEP2 "HIV-EP2, MBP-2, MIBP1, Schnurri-2, ZAS2, ZNF40B" ENSG00000010818 "Human immunodeficiency virus type I enhancer binding protein 2" P31629 6 142751467-142956698 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 83.8;Suprabasal keratinocytes: 82.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 23.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055954 Supported Nucleoplasm NA NA Nucleoplasm "HPA055954: " "unprognostic (1.35e-2)" "unprognostic (1.61e-2)" "unprognostic (8.48e-2)" "unprognostic (2.03e-2)" "unprognostic (2.55e-1)" "unprognostic (1.20e-2)" "unprognostic (7.71e-2)" "unprognostic (8.44e-2)" "unprognostic (1.50e-1)" "unprognostic (1.34e-2)" "unprognostic (1.19e-2)" "unprognostic (1.93e-1)" "unprognostic (8.09e-3)" "unprognostic (1.25e-2)" "unprognostic (5.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.10e-1)" 11.3 9.7 13.9 13.6 17.4 4.2 9.2 29.8 30.1 6.3 7.2 5.9 3.8 6.1 8.6 7.3 11.7 15.9 13.5 10.5 15.7 10.4 8.5 7.7 10.6 14.9 9.3 12.8 18.5 13.4 19.0 8.7 9.6 12.7 7.3 6.3 7.1 10.9 8.6 24.3 10.6 8.0 10.1 13.5 10.4 6.5 2.7 8.5 18.6 11.2 9.6 15.5 12.5 12.0 2.1 1.1 2.3 0.6 1.7 3.9 1.2 3.7 0.7 0.9 3.3 7.3 8.2 2.6 5.4 13.8 3.4 4.1 0.3 3.1 5.9 3.4 23.7 6.4 2.4 1.5 11.0 8.3 2.2 1.7 1.6 2.4 1.4 5.5 5.1 0.0 7.5 11.0 13.8 15.9 7.8 1.8 4.7 0.1 5.4 5.7 4.2 6.7 2.2 0.8 0.9 5.4 8.9 6.0 0.5 3.1 6.5 9.0 3.8 7.1 5.9 4.0 1.6 1.0 3.0 1.9 11.4 2.8 9.5 4.7 11.3 1.8 12.7 3.2 4.0 5.3 0.0 0.3 0.0 1.6 0.6 3.6 2.1 3.9 3.2 1.1 1.3 3.9 3.0 2.3 1.7 0.5 0.5 2.9 1.2 13.9 17.4 29.8 30.1 15.7 10.4 9.3 12.8 12.7 8.5 20.8 27.5 3.2 41.6 83.8 14.1 18.3 10.2 30.8 39.8 7.0 23.6 1.9 0.0 10.2 1.5 14.3 3.8 0.0 12.9 1.0 34.3 37.8 3.5 4.3 2.3 28.6 3.4 6.7 3.4 0.9 10.9 11.1 23.6 5.4 4.5 2.3 17.1 7.0 14.9 2.3 2.3 0.0 30.9 0.5 0.9 82.7 3.9 12.8 2.9 53.2 HIVEP3 "FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C" ENSG00000127124 "Human immunodeficiency virus type I enhancer binding protein 3" Q5T1R4 1 41506365-42035925 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3;lymphoid tissue: 16.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 17.9;hTEC/SVTERT24-B: 9.3;Karpas-707: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005728 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA005728: AB_10612117" "unprognostic (2.87e-3)" "unprognostic (2.38e-2)" "unprognostic (4.65e-2)" "unprognostic (2.56e-1)" "unprognostic (1.55e-2)" "unprognostic (6.50e-2)" "unprognostic (2.70e-3)" "unprognostic (3.73e-1)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "unprognostic (2.07e-8)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (1.13e-2)" "unprognostic (3.21e-1)" 4.2 1.5 7.5 5.4 5.7 3.8 3.6 20.3 11.7 1.2 1.4 5.1 0.0 1.2 1.1 1.1 3.2 1.3 2.0 2.1 6.1 3.0 1.4 1.2 4.6 4.1 4.8 4.7 1.6 2.4 2.3 8.3 1.8 6.5 2.2 1.5 0.5 3.7 1.1 1.6 11.7 1.3 2.2 5.0 2.9 1.9 1.4 5.1 16.6 2.9 1.8 5.4 1.9 1.6 1.0 1.5 0.1 3.7 0.2 2.1 1.1 1.8 0.6 0.2 1.7 2.3 1.0 0.0 0.9 0.2 2.3 4.0 0.1 0.3 3.8 0.6 0.9 1.4 2.6 0.4 0.4 3.1 17.9 0.5 0.2 0.8 0.0 0.4 0.3 0.3 5.6 0.4 9.3 1.1 0.6 0.5 1.3 0.0 10.8 1.7 1.1 2.8 0.8 0.6 0.6 2.2 1.9 2.8 2.0 1.5 0.3 2.0 0.6 2.5 0.7 0.5 1.1 0.8 3.2 3.3 2.0 2.2 0.6 4.4 3.2 1.3 2.6 8.1 0.2 7.3 0.1 1.7 0.0 2.1 3.7 0.5 0.6 0.9 1.0 1.5 1.0 0.2 0.8 0.1 0.2 3.1 0.3 0.3 1.1 7.5 5.7 20.3 11.7 6.1 3.0 4.8 4.7 6.5 5.1 6.0 8.0 2.2 24.6 21.1 15.2 5.1 0.0 1.4 12.5 1.8 2.0 0.3 1.7 3.1 7.6 4.3 2.1 23.3 2.4 2.8 11.6 16.0 1.1 2.8 6.1 23.8 3.5 13.5 5.1 18.7 8.1 10.5 5.0 0.0 1.1 15.6 2.3 0.0 3.9 2.2 3.5 6.5 9.0 8.6 8.3 7.5 0.7 17.0 0.8 7.3 HLF MGC33822 ENSG00000108924 "HLF, PAR bZIP transcription factor" Q16534 17 55265012-55325065 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 78.8" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 122.6;Hepatocytes: 152.5;Horizontal cells: 87.4" "Cancer enhanced" "Detected in many" "liver cancer: 13.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 2.4;T-reg: 2.1" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enriched" "Detected in some" 6 "Hep G2: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068156, HPA071210" Enhanced Nucleoplasm Yes NA Nucleoplasm "HPA068156: AB_2685963, HPA071210: AB_2686361" "unprognostic (1.24e-1)" "unprognostic (1.19e-3)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "prognostic favorable (1.88e-4)" "unprognostic (5.30e-3)" "prognostic favorable (2.71e-7)" "unprognostic (1.42e-1)" "unprognostic (3.44e-2)" "unprognostic (1.24e-3)" "unprognostic (2.19e-1)" "prognostic favorable (3.55e-6)" "unprognostic (8.47e-2)" "unprognostic (1.64e-1)" "unprognostic (6.85e-2)" "unprognostic (1.60e-2)" 9.5 15.2 13.3 2.0 26.2 1.0 10.8 15.2 38.0 10.5 10.6 6.4 2.4 1.7 10.3 8.5 18.1 9.3 6.1 15.9 12.6 6.9 9.2 78.8 9.5 2.1 6.6 24.5 34.6 2.7 2.8 8.0 1.5 12.3 9.9 3.1 23.7 15.9 9.5 5.3 11.6 3.0 14.3 5.5 5.7 4.7 3.4 6.3 0.0 23.4 7.1 5.6 9.2 5.2 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 10.0 0.2 0.0 0.0 60.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.1 0.1 5.0 0.0 4.2 0.2 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 1.9 1.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 13.3 26.2 15.2 38.0 12.6 6.9 6.6 24.5 12.3 6.3 3.0 36.8 0.0 4.7 19.8 122.6 31.9 15.3 1.4 11.4 7.0 9.8 0.1 10.0 1.5 0.9 8.6 0.0 0.0 0.8 0.0 6.0 1.2 0.0 152.5 0.1 87.4 2.9 4.9 4.1 2.7 26.2 1.0 10.1 0.0 0.1 54.5 0.3 0.0 36.7 18.9 13.0 12.9 6.2 0.3 2.7 24.1 1.0 2.2 0.0 0.5 HLTF "HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3" ENSG00000071794 "Helicase like transcription factor" Q14527 3 149030127-149086554 "Enzymes, Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 88.3;Spermatocytes: 110.2;Spermatogonia: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015284, HPA049001" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015284: AB_1857263, HPA049001: AB_2680594" "unprognostic (3.21e-2)" "unprognostic (3.46e-2)" "unprognostic (6.81e-2)" "unprognostic (1.95e-3)" "unprognostic (4.29e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (3.01e-2)" "unprognostic (2.13e-2)" "unprognostic (2.27e-1)" "unprognostic (4.78e-2)" "unprognostic (9.00e-3)" "unprognostic (1.39e-1)" "unprognostic (2.94e-1)" "unprognostic (3.42e-1)" "unprognostic (2.83e-2)" "unprognostic (1.07e-2)" 10.2 22.1 12.6 8.4 17.6 9.0 12.4 29.3 23.8 11.1 11.0 12.4 6.2 4.8 12.4 9.6 7.1 10.8 8.6 16.5 15.8 16.6 15.6 16.3 7.1 9.8 15.7 19.0 17.6 12.0 16.5 25.1 7.3 29.9 14.7 7.0 11.3 9.3 11.1 9.7 5.1 6.6 12.7 19.0 7.5 8.7 37.7 14.0 17.1 19.0 4.8 9.6 10.0 7.8 8.4 9.2 8.8 2.3 5.4 10.4 3.5 24.6 12.0 17.2 13.4 11.5 14.9 1.7 16.7 10.0 12.4 14.5 9.7 17.2 15.9 20.5 7.7 24.3 0.7 23.0 6.6 20.8 8.8 11.2 38.2 9.4 3.9 7.2 10.0 15.9 9.4 3.6 9.2 5.4 19.0 7.1 26.0 13.3 10.4 16.9 12.4 20.5 15.4 12.9 12.5 15.1 23.8 19.3 2.5 10.2 8.0 17.0 10.0 25.4 11.8 23.0 9.5 35.2 9.8 5.0 14.6 8.8 20.5 18.2 15.4 8.6 20.8 14.3 13.7 5.6 8.8 1.3 4.0 5.6 2.1 10.4 8.4 4.9 7.2 3.9 5.4 7.2 7.4 0.2 5.4 2.3 9.2 4.4 3.5 12.6 17.6 29.3 23.8 15.8 16.6 15.7 19.0 29.9 14.0 23.8 14.8 13.8 7.6 4.9 88.3 34.8 17.8 30.8 21.6 29.6 39.3 6.6 29.9 7.9 9.5 10.8 1.3 0.0 7.3 8.2 10.6 11.9 53.2 14.9 7.6 44.5 4.7 15.4 4.0 5.8 31.4 7.5 5.0 3.6 6.2 35.2 6.8 2.8 30.4 15.6 75.2 12.9 14.1 110.2 89.0 3.8 1.4 13.8 6.6 4.3 HMCES "C3orf37, DC12, SRAPD1" ENSG00000183624 "5-hydroxymethylcytosine binding, ES cell specific" Q96FZ2 3 129278828-129306186 "Predicted intracellular proteins" "DNA damage" "DNA-binding, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044968 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA044968: AB_2679160" "unprognostic (9.18e-3)" "unprognostic (1.11e-3)" "unprognostic (4.16e-2)" "unprognostic (2.80e-2)" "unprognostic (2.93e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.41e-4)" "unprognostic (1.87e-1)" "unprognostic (2.29e-1)" "unprognostic (3.00e-1)" "unprognostic (4.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.46e-2)" "unprognostic (1.71e-2)" "unprognostic (1.74e-1)" "unprognostic (1.25e-2)" "unprognostic (9.08e-3)" 16.4 10.8 15.9 29.8 23.1 15.1 15.2 19.2 22.8 13.2 16.3 9.3 18.1 13.3 13.4 11.8 19.6 12.8 13.9 27.9 13.6 16.7 13.1 24.6 12.5 42.6 14.9 18.6 14.4 7.3 62.2 11.2 10.5 14.4 12.7 14.8 12.2 13.0 13.0 24.9 16.2 13.2 15.5 10.4 14.4 11.9 17.8 9.7 36.5 14.3 14.3 57.5 12.8 15.1 33.3 14.9 32.9 19.7 13.3 24.4 15.5 33.6 15.2 17.5 20.2 21.8 9.0 15.8 11.9 9.6 17.3 13.5 23.8 15.9 65.4 12.9 10.6 13.5 24.7 22.1 25.5 20.1 13.1 11.8 13.5 12.3 16.9 9.4 11.7 10.0 8.6 13.3 14.4 14.2 8.4 10.4 14.6 13.6 57.8 9.5 44.5 16.7 10.1 11.3 24.6 9.9 15.0 15.0 11.4 18.2 20.2 17.5 10.8 26.5 16.7 16.1 11.3 28.5 11.9 8.4 8.7 15.3 20.7 15.2 32.2 19.0 65.8 10.4 9.5 9.6 14.8 13.8 32.9 17.1 14.2 17.7 19.1 20.9 20.1 13.8 33.3 20.8 22.7 27.7 13.3 19.7 14.9 24.4 15.5 15.9 23.1 19.2 22.8 13.6 16.7 14.9 18.6 14.4 9.7 29.8 24.6 19.3 61.1 51.7 17.8 29.9 35.7 14.7 10.3 21.0 9.8 34.4 31.5 32.8 6.8 25.4 21.3 23.3 41.3 29.6 19.4 28.9 21.9 24.3 17.4 25.4 20.2 17.2 6.9 7.8 22.7 20.3 55.6 19.8 13.3 37.7 25.1 17.5 29.4 15.1 10.3 12.9 33.2 68.2 65.8 38.3 29.3 37.3 28.7 50.3 HMG20A "FLJ10739, HMGX1, HMGXB1" ENSG00000140382 "High mobility group 20A" Q9NP66 15 77420412-77485607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008126 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA008126: AB_1079072" "unprognostic (2.04e-1)" "unprognostic (6.87e-2)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" "unprognostic (2.56e-1)" "unprognostic (1.70e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-2)" "unprognostic (1.75e-1)" "unprognostic (9.74e-3)" "unprognostic (3.40e-1)" "unprognostic (1.58e-1)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" 12.5 17.5 19.7 14.7 27.3 8.6 13.0 24.7 28.8 16.8 14.0 21.0 12.6 11.6 20.7 12.5 12.9 12.8 14.3 22.9 18.5 19.5 13.2 22.3 14.3 21.6 17.3 16.7 21.4 11.8 14.2 21.5 19.8 19.8 11.9 16.0 19.4 12.4 13.5 31.9 12.0 12.4 15.1 17.4 31.2 12.0 18.7 14.7 30.5 15.1 10.3 19.6 16.9 13.7 17.7 16.1 9.4 13.7 27.6 21.2 13.8 7.6 12.5 24.1 16.8 10.1 12.6 9.6 10.2 15.2 12.2 13.4 7.7 11.7 13.0 11.9 11.6 9.3 10.5 33.8 12.9 12.5 11.6 16.5 27.0 11.1 10.1 15.0 19.6 16.2 14.0 9.1 10.6 11.9 15.9 23.9 17.1 20.1 11.0 10.6 5.6 15.6 12.6 17.3 6.7 6.0 20.6 23.3 14.6 13.6 13.4 9.4 20.5 16.4 10.1 30.6 24.1 9.7 20.5 15.0 14.2 12.8 6.7 12.3 15.0 31.9 26.1 11.0 28.1 17.0 4.6 12.4 9.4 18.1 12.1 21.2 17.7 14.2 16.7 16.1 16.0 19.2 17.2 2.2 27.6 13.7 12.2 13.2 13.8 19.7 27.3 24.7 28.8 18.5 19.5 17.3 16.7 19.8 14.7 11.9 7.8 11.5 5.2 7.8 19.1 33.9 20.4 1.4 11.4 10.4 23.6 12.0 5.0 8.8 21.4 15.8 8.5 23.3 7.0 7.7 12.4 4.3 12.7 28.8 14.0 36.5 17.2 25.2 32.4 61.1 11.8 12.6 13.5 19.0 17.1 16.2 8.0 14.0 13.1 7.7 19.4 19.4 7.6 21.3 13.7 6.5 11.6 11.5 11.4 4.7 HMG20B "BRAF25, BRAF35, HMGX2, HMGXB2, SMARCE1r, SOXL" ENSG00000064961 "High mobility group 20B" Q9P0W2 19 3572777-3579088 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 228.6;Melanocytes: 217.6;Syncytiotrophoblasts: 254.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 81.6;WM-115: 84.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050220, HPA053157, HPA069832" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA050220: AB_2681056, HPA053157: AB_2682061, HPA069832: AB_2686210" "unprognostic (2.97e-1)" "unprognostic (1.84e-2)" "unprognostic (2.57e-1)" "prognostic favorable (1.72e-7)" "unprognostic (2.18e-2)" "unprognostic (1.77e-2)" "unprognostic (1.12e-1)" "unprognostic (2.97e-1)" "unprognostic (1.66e-1)" "unprognostic (4.62e-2)" "unprognostic (3.19e-2)" "unprognostic (1.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.91e-3)" "unprognostic (2.78e-2)" "unprognostic (1.84e-1)" "prognostic favorable (2.89e-5)" 22.2 19.0 14.4 19.2 17.1 18.7 22.8 7.1 15.0 23.7 24.5 18.5 28.3 20.4 27.0 22.6 26.0 20.6 28.9 17.4 16.3 8.2 25.0 23.3 17.4 13.0 20.3 9.9 19.0 21.7 19.3 9.8 35.2 14.8 33.6 12.9 18.8 36.6 23.5 12.5 25.9 24.6 22.6 14.6 18.6 24.2 19.0 16.2 44.8 29.4 14.0 25.0 24.0 24.4 18.6 32.7 31.1 35.2 27.7 22.9 24.8 18.6 8.0 7.2 17.3 9.1 8.2 13.3 12.1 8.8 11.0 8.4 2.9 6.8 10.2 11.4 8.7 10.0 9.1 4.2 8.2 6.6 9.0 9.6 5.0 26.2 7.6 5.8 6.8 24.7 7.0 9.9 6.3 4.2 11.3 11.1 9.2 8.3 17.0 7.2 25.3 12.7 12.3 8.3 16.0 16.2 8.5 12.7 13.9 8.2 12.0 4.5 13.8 16.9 29.4 81.6 7.2 22.2 18.4 15.9 5.9 13.3 20.8 10.2 16.0 8.4 7.1 15.3 17.3 84.1 19.1 34.5 31.1 21.2 33.6 18.9 18.6 18.3 22.9 32.7 15.9 19.7 18.9 19.0 27.7 35.2 29.5 19.9 24.8 14.4 17.1 7.1 15.0 16.3 8.2 20.3 9.9 14.8 16.2 26.8 17.1 34.9 44.6 62.6 3.3 5.9 22.9 17.4 19.4 17.4 9.8 97.1 77.9 53.0 20.8 36.2 53.8 0.0 39.7 228.6 45.8 57.3 38.0 17.4 72.0 7.9 64.1 27.0 24.0 36.4 34.5 48.2 217.6 123.6 117.2 30.7 48.6 54.6 42.1 56.9 17.4 32.3 56.2 38.7 15.6 69.8 254.0 28.8 59.7 56.3 HMGB1 "DKFZp686A04236, HMG1, HMG3, SBP-1" ENSG00000189403 "High mobility group box 1" P09429 13 30456704-30617597 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Autophagy, Chemotaxis, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003506, CAB005873" Supported Supported Nucleoplasm "Intracellular and membrane" NA NA 2000000 Nucleoplasm "CAB005873: AB_444360, HPA003506: AB_1079070" "unprognostic (9.56e-2)" "unprognostic (1.34e-1)" "unprognostic (1.97e-2)" "unprognostic (1.07e-1)" "unprognostic (4.44e-2)" "unprognostic (4.29e-2)" "unprognostic (3.16e-2)" "unprognostic (4.33e-2)" "unprognostic (5.73e-2)" "unprognostic (1.73e-1)" "unprognostic (2.64e-2)" "unprognostic (2.30e-2)" "unprognostic (4.28e-3)" "unprognostic (5.22e-3)" "unprognostic (4.67e-1)" "unprognostic (9.13e-3)" "unprognostic (1.97e-2)" 52.0 40.0 71.2 57.0 86.8 147.8 57.6 69.6 66.1 56.0 55.0 59.6 45.1 47.6 69.7 48.8 58.5 50.2 39.4 40.3 71.2 58.7 42.4 61.1 43.6 104.8 90.3 57.3 56.1 34.5 28.4 53.3 42.7 70.6 47.5 67.3 40.0 43.0 51.7 62.6 41.2 51.6 70.3 85.8 53.8 44.8 27.1 91.2 68.8 48.9 48.3 120.9 51.0 79.5 90.8 78.1 133.2 74.8 87.6 102.9 132.3 51.7 40.1 93.3 69.6 26.2 26.1 36.7 66.1 36.0 64.0 43.4 63.5 87.2 105.3 34.5 59.8 58.9 58.0 97.5 53.3 110.6 55.3 40.9 110.6 29.2 58.2 14.3 158.7 67.6 17.2 28.4 47.5 44.2 33.4 85.5 88.4 73.3 37.9 56.4 96.1 202.3 170.6 78.5 91.5 45.0 170.5 128.5 61.9 59.9 51.4 84.5 76.4 60.6 45.1 33.7 47.0 44.2 119.3 53.0 42.9 62.2 45.9 76.6 34.3 44.2 225.8 17.6 105.2 90.0 127.3 74.8 133.2 75.5 60.7 84.2 87.9 86.6 84.5 78.1 90.8 78.6 74.9 96.4 87.6 57.4 77.3 102.9 132.3 71.2 86.8 69.6 66.1 71.2 58.7 90.3 57.3 70.6 91.2 425.8 414.0 667.0 861.1 702.7 391.2 150.7 517.2 421.6 417.5 572.3 123.7 686.8 649.9 789.1 90.9 697.7 331.0 1354.9 842.5 1201.1 600.0 601.9 525.2 664.2 641.9 185.9 406.1 530.3 511.2 73.5 666.8 690.7 639.4 489.7 477.4 551.6 916.3 480.9 626.9 664.3 236.9 640.3 823.7 170.6 1295.4 604.9 389.5 703.9 724.3 741.7 HMGN1 "FLJ27265, FLJ31471, HMG14, MGC104230, MGC117425" ENSG00000205581 "High mobility group nucleosome binding domain 1" P05114 21 39342315-39349647 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Rod photoreceptor cells: 1229.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012260, HPA048694" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012260: AB_304786, HPA048694: AB_2680496" "unprognostic (4.49e-2)" "unprognostic (5.52e-2)" "unprognostic (4.85e-2)" "unprognostic (6.28e-2)" "unprognostic (2.20e-1)" "unprognostic (5.21e-3)" "unprognostic (8.50e-3)" "unprognostic (1.32e-1)" "unprognostic (2.46e-3)" "unprognostic (5.68e-2)" "unprognostic (3.02e-2)" "unprognostic (5.24e-2)" "prognostic unfavorable (8.74e-7)" "unprognostic (3.20e-1)" "unprognostic (3.72e-2)" "unprognostic (3.84e-2)" "unprognostic (8.98e-3)" 16.8 24.5 18.1 56.3 18.0 37.4 27.0 11.1 21.3 27.3 28.5 14.4 30.6 26.3 21.4 38.9 46.4 21.3 28.2 25.5 17.0 17.5 33.0 30.4 42.3 76.6 15.8 13.6 28.7 44.1 26.9 29.1 30.9 19.1 27.7 28.9 36.4 37.1 27.1 10.1 25.6 32.0 27.4 23.4 41.7 26.0 42.5 15.9 58.5 31.2 24.4 63.1 23.3 26.7 46.9 60.2 55.0 16.5 33.8 43.9 42.2 52.7 12.4 44.5 29.5 8.1 15.8 31.3 27.9 19.8 27.2 25.1 23.3 42.8 117.2 26.7 25.4 32.7 11.2 32.6 39.2 36.2 48.1 34.7 90.1 18.5 29.9 21.1 79.6 31.3 17.5 37.2 27.2 33.4 22.5 41.8 50.5 70.6 20.2 43.5 64.5 78.6 67.8 83.1 69.7 25.6 85.6 24.3 46.2 45.6 24.6 41.5 36.5 60.9 36.3 31.7 20.4 48.6 79.8 24.8 13.3 13.9 10.4 28.1 24.9 39.6 72.7 18.9 85.8 35.3 14.6 16.5 55.0 30.1 14.0 33.6 46.9 38.6 31.3 45.3 41.6 43.6 38.0 11.0 33.8 12.9 60.2 43.9 42.2 18.1 18.0 11.1 21.3 17.0 17.5 15.8 13.6 19.1 15.9 86.4 145.9 405.1 420.9 247.4 248.1 51.9 242.0 123.1 138.8 270.4 312.2 505.6 625.1 409.9 439.9 204.9 244.5 70.0 307.2 777.0 197.4 519.9 214.8 146.7 471.8 227.2 331.4 117.2 150.3 120.6 162.8 266.2 231.2 589.7 353.2 267.5 330.8 252.6 188.1 435.0 1229.1 32.3 110.2 66.2 129.4 274.3 503.6 343.9 504.7 585.4 HMGN4 "HMG17L3, NHC" ENSG00000182952 "High mobility group nucleosomal binding domain 4" O00479 6 26538405-26546254 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077364 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA077364: AB_2686835" "unprognostic (1.91e-1)" "unprognostic (2.48e-2)" "unprognostic (5.88e-2)" "unprognostic (8.81e-2)" "unprognostic (4.10e-2)" "unprognostic (6.02e-2)" "unprognostic (4.00e-3)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (3.22e-1)" "unprognostic (7.81e-3)" "unprognostic (2.09e-1)" "unprognostic (3.06e-2)" "unprognostic (1.64e-1)" "unprognostic (8.02e-3)" "unprognostic (9.01e-2)" "unprognostic (6.07e-3)" 26.3 26.8 16.8 28.9 20.8 16.6 32.0 21.8 26.5 29.0 34.0 16.2 27.5 21.1 42.0 31.7 28.1 32.0 28.6 29.4 14.3 18.2 31.0 10.7 25.5 50.3 15.5 18.3 33.0 24.1 24.4 18.5 23.7 15.9 35.3 31.4 21.1 24.7 36.6 30.8 21.0 32.7 45.3 16.7 33.2 23.1 26.8 15.6 38.2 36.2 24.0 38.1 35.1 34.4 31.8 25.9 57.0 22.1 30.6 39.7 37.7 23.3 9.7 17.2 23.2 23.6 35.9 11.7 20.6 35.1 31.5 42.9 9.2 14.9 28.5 31.4 29.0 29.8 11.1 30.4 25.9 34.6 35.2 28.1 30.0 13.5 16.9 25.9 24.4 30.4 27.0 35.1 24.8 40.7 26.1 29.1 34.8 27.0 46.6 27.9 12.2 40.5 27.7 10.4 18.6 15.9 15.0 20.8 48.6 22.1 16.7 28.9 25.4 17.6 13.4 38.1 21.2 14.7 11.7 22.1 21.4 15.7 19.2 17.5 29.6 79.7 24.5 10.1 56.4 27.3 57.0 19.1 34.9 39.2 18.0 37.5 31.8 39.7 39.6 25.9 27.3 33.6 32.1 28.3 30.6 22.1 20.8 39.4 37.7 16.8 20.8 21.8 26.5 14.3 18.2 15.5 18.3 15.9 15.6 3.0 4.3 10.9 3.3 6.6 0.2 1.2 10.2 1.4 12.5 1.8 0.0 3.0 5.0 1.6 0.3 2.2 2.6 0.0 1.2 8.5 3.7 1.8 8.1 1.0 3.8 0.0 0.0 3.7 3.2 0.0 1.4 9.2 8.5 8.2 1.5 1.9 1.9 1.7 2.5 6.1 0.2 0.0 3.1 0.2 1.1 4.4 6.8 8.5 1.2 1.7 HMGXB4 "HMG2L1, THC211630" ENSG00000100281 "HMG-box containing 4" Q9UGU5 22 35257452-35295807 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000725, HPA076681" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA000725: AB_1079073, HPA076681: " "unprognostic (2.22e-1)" "unprognostic (1.12e-1)" "prognostic favorable (3.24e-5)" "unprognostic (4.81e-2)" "unprognostic (1.93e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (4.79e-4)" "unprognostic (2.85e-2)" "unprognostic (8.25e-3)" "unprognostic (6.67e-3)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.62e-1)" "unprognostic (8.71e-3)" "unprognostic (1.13e-1)" "unprognostic (1.98e-1)" "unprognostic (1.20e-1)" "unprognostic (8.54e-2)" 13.6 11.6 11.4 11.4 17.6 28.6 13.6 17.4 15.1 14.4 10.9 17.2 9.5 10.6 17.4 8.4 14.4 14.5 10.8 9.8 10.0 8.6 8.6 8.0 10.2 10.5 14.4 13.8 21.7 10.9 9.4 7.6 20.2 12.4 12.4 12.2 8.7 11.9 12.7 17.2 14.4 13.1 15.0 12.6 10.0 10.3 12.1 16.9 20.0 10.6 10.2 11.6 14.8 13.5 11.8 9.4 22.6 12.5 7.4 13.1 4.7 13.1 2.9 20.6 10.3 5.0 9.9 5.9 13.7 18.0 13.4 12.5 2.2 4.9 15.8 6.1 13.5 8.5 8.1 8.9 9.6 15.6 13.8 10.0 14.5 3.9 2.9 6.8 30.4 14.8 9.0 8.4 11.2 8.6 8.1 9.2 12.1 11.3 13.1 9.9 6.0 18.3 7.3 9.5 9.1 8.8 14.7 19.4 5.5 7.5 9.7 13.0 12.8 12.2 8.9 9.8 6.8 6.1 9.5 8.5 12.2 27.0 14.1 11.2 14.1 13.7 19.7 10.3 9.3 17.3 22.6 11.1 13.8 12.6 12.5 10.8 8.9 12.1 13.1 8.8 11.8 8.1 9.2 16.8 7.4 11.5 9.4 10.1 4.7 11.4 17.6 17.4 15.1 10.0 8.6 14.4 13.8 12.4 16.9 11.9 14.4 20.9 45.0 18.5 60.2 11.2 38.2 10.7 25.0 26.2 33.4 42.1 24.9 34.2 7.5 26.4 25.5 23.3 25.8 44.6 29.1 49.7 52.9 21.9 26.9 63.5 16.3 35.6 29.7 7.7 49.8 31.0 8.5 24.4 24.8 21.2 29.9 24.5 53.4 18.1 66.1 38.8 27.8 50.4 77.1 19.7 54.1 24.1 26.6 46.9 HNF1A "HNF1, LFB1, MODY3, TCF1" ENSG00000135100 "HNF1 homeobox A" 12 120978543-121002512 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 24.2;kidney: 17.2;liver: 15.6" "Cell type enhanced" "Detected in some" 8 "Enterocytes: 16.0;Hepatocytes: 13.9;Paneth cells: 14.4;Proximal tubular cells: 13.2;Undifferentiated cells: 8.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A549: 6.2;CACO-2: 20.5;Hep G2: 22.4;OE19: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010430, HPA035231" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB010430: AB_2116746, HPA035231: AB_2674528" "unprognostic (5.92e-3)" "unprognostic (8.47e-2)" "unprognostic (4.12e-3)" "unprognostic (6.18e-3)" "unprognostic (3.72e-1)" "unprognostic (1.27e-2)" "unprognostic (9.18e-2)" "unprognostic (9.18e-2)" "unprognostic (2.99e-1)" "unprognostic (2.01e-1)" "unprognostic (9.77e-3)" "unprognostic (5.21e-2)" "unprognostic (6.25e-3)" "unprognostic (5.55e-2)" "unprognostic (2.48e-1)" "unprognostic (6.93e-3)" 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.1 17.3 0.1 0.1 13.7 0.1 1.5 0.1 0.8 5.1 0.1 0.1 0.0 17.2 15.6 0.1 0.1 0.1 0.1 0.2 6.3 0.0 0.1 0.1 0.1 0.1 2.1 0.1 0.1 0.1 0.1 0.0 24.2 0.5 0.1 0.1 3.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.5 1.8 0.3 0.3 0.4 0.2 0.0 6.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.2 0.2 0.3 0.2 0.3 0.4 0.4 0.1 0.5 0.4 0.4 1.6 0.3 0.3 0.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.6 0.8 2.5 0.0 0.0 1.8 0.0 0.0 0.0 2.3 0.0 0.0 16.0 0.0 4.6 0.1 0.0 0.4 0.0 13.9 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 6.7 0.5 3.2 14.4 0.0 13.2 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 8.9 0.2 HNF4A "HNF4, MODY, MODY1, NR2A1, TCF14" ENSG00000101076 "Hepatocyte nuclear factor 4 alpha" P41235 20 44355700-44434596 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 65.5;kidney: 30.5;liver: 57.3" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 146.5;Hepatocytes: 160.5;Paneth cells: 94.8;Proximal tubular cells: 115.9;Undifferentiated cells: 91.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 48.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "CACO-2: 52.3;Hep G2: 38.5;OE19: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004712, CAB019417" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB019417: AB_2295208, HPA004712: AB_1079075" "unprognostic (2.47e-1)" "unprognostic (3.08e-1)" "unprognostic (2.34e-1)" "unprognostic (2.29e-1)" "unprognostic (8.54e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-2)" "unprognostic (4.79e-3)" "unprognostic (2.59e-2)" "unprognostic (3.77e-2)" "unprognostic (2.45e-2)" "unprognostic (1.05e-1)" "unprognostic (2.75e-2)" "unprognostic (8.40e-3)" "unprognostic (2.12e-1)" "unprognostic (2.70e-2)" 0.2 0.2 0.2 13.4 0.2 0.0 0.2 0.2 0.3 0.2 54.0 0.2 0.1 33.0 0.2 6.2 0.2 0.4 15.7 0.2 0.2 0.2 30.5 57.3 0.3 0.1 0.2 0.1 0.3 22.7 0.0 0.2 0.1 0.2 0.2 14.4 0.2 0.2 0.1 0.2 0.2 65.5 0.3 0.2 0.2 7.1 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.4 0.4 0.6 1.2 0.8 0.8 0.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 52.3 2.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.4 0.4 0.4 0.7 0.8 0.8 0.6 0.3 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.5 0.3 0.0 0.0 1.1 43.3 0.0 0.0 12.2 0.0 0.0 13.3 6.8 3.1 0.0 146.5 0.0 19.4 0.0 0.0 0.3 4.6 160.5 0.0 0.0 34.4 3.7 5.1 16.4 0.3 0.0 0.0 1.8 62.7 0.0 17.5 94.8 0.4 115.9 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 91.6 0.1 HNRNPA0 "hnRNPA0, HNRPA0" ENSG00000177733 "Heterogeneous nuclear ribonucleoprotein A0" Q13151 5 137745651-137754376 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036569, HPA059404" Enhanced Enhanced Nucleoplasm No No 110000 Nucleoplasm "HPA036569: AB_10670840, HPA059404: AB_2684004" "unprognostic (5.51e-2)" "unprognostic (4.86e-2)" "unprognostic (2.00e-2)" "unprognostic (3.78e-1)" "unprognostic (8.99e-2)" "unprognostic (2.52e-1)" "unprognostic (2.65e-3)" "unprognostic (1.06e-1)" "unprognostic (1.77e-1)" "unprognostic (1.23e-1)" "prognostic favorable (3.74e-4)" "unprognostic (6.86e-2)" "prognostic favorable (1.99e-4)" "unprognostic (2.34e-1)" "unprognostic (4.57e-1)" "unprognostic (2.66e-2)" "unprognostic (7.39e-2)" 25.6 30.9 18.1 31.8 21.4 40.7 62.9 35.2 43.8 27.0 21.2 11.5 17.2 21.0 38.1 26.3 25.7 29.3 29.5 29.1 15.7 18.0 17.4 18.5 40.4 61.2 16.5 22.5 42.7 34.8 15.1 20.4 30.7 16.6 22.1 17.2 20.0 18.6 20.8 38.1 23.2 23.1 33.4 16.8 24.2 24.3 25.7 13.6 50.1 26.2 22.5 21.6 24.8 24.2 5.2 6.1 8.0 4.4 7.8 7.1 1.5 14.4 14.5 28.2 28.4 13.9 8.9 29.0 11.1 9.2 10.0 11.6 27.0 11.4 26.3 16.1 9.5 11.0 13.3 15.2 17.3 12.2 13.2 21.2 17.0 9.3 16.3 12.8 15.5 18.1 14.3 12.2 7.9 9.2 11.0 13.8 23.9 13.8 17.7 10.0 18.8 29.0 20.9 22.0 6.9 10.6 34.9 20.6 13.2 9.8 16.7 35.8 29.1 14.3 10.0 18.8 32.3 12.7 18.0 13.4 16.0 13.7 8.8 21.1 17.9 14.4 18.7 10.4 18.0 15.8 4.2 2.4 8.0 5.9 4.1 7.1 4.2 5.6 5.9 4.2 5.2 6.1 6.0 2.6 7.8 4.4 6.1 3.2 1.5 18.1 21.4 35.2 43.8 15.7 18.0 16.5 22.5 16.6 13.6 80.4 53.0 188.3 346.9 489.4 73.3 31.1 99.3 37.5 62.6 96.0 35.3 296.0 145.9 218.1 24.7 188.8 85.5 70.0 128.8 402.7 254.2 247.7 94.6 65.2 171.4 79.4 226.9 148.0 122.8 31.9 146.2 137.9 266.6 273.3 165.1 127.6 167.3 162.1 141.8 99.3 53.7 84.1 348.8 141.2 79.6 423.3 305.8 240.4 208.3 323.0 HNRNPA1 "ALS20, hnRNP-A1, hnRNPA1, HNRPA1" ENSG00000135486 "Heterogeneous nuclear ribonucleoprotein A1" P09651 12 54280193-54287088 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001609, HPA001666, HPA005812, HPA007185, CAB010894" Supported Enhanced Nucleoplasm NA NA 10000000 Nucleoplasm "CAB010894: AB_261962, HPA001609: AB_2666383, HPA001666: AB_1850836, HPA005812: AB_2667441, HPA007185: AB_2667768" "unprognostic (1.38e-3)" "unprognostic (1.90e-1)" "unprognostic (1.59e-2)" "unprognostic (5.98e-3)" "unprognostic (2.82e-2)" "unprognostic (2.46e-1)" "unprognostic (1.22e-2)" "unprognostic (9.71e-2)" "unprognostic (3.34e-2)" "unprognostic (2.91e-2)" "unprognostic (3.72e-2)" "unprognostic (3.51e-2)" "unprognostic (6.88e-3)" "unprognostic (2.32e-2)" "unprognostic (1.14e-1)" "unprognostic (1.48e-1)" "unprognostic (9.54e-3)" 36.4 33.3 31.7 55.6 37.4 99.5 45.1 48.3 43.0 52.2 38.9 38.4 33.9 35.2 54.1 41.6 41.3 39.5 20.4 31.9 29.7 28.5 40.5 76.2 29.7 51.7 33.1 23.1 123.6 46.1 34.4 36.7 49.9 42.6 35.3 38.7 28.1 33.4 31.5 40.5 37.3 35.6 34.9 40.1 59.5 34.1 69.6 33.3 88.7 42.1 62.0 62.7 37.5 45.8 61.6 72.5 17.9 51.1 86.6 98.1 105.8 84.3 77.7 166.2 131.5 51.4 82.2 90.4 77.8 89.3 86.3 73.2 116.3 93.1 222.9 76.5 53.9 27.9 76.2 111.0 111.6 104.9 87.1 84.5 123.7 111.5 200.3 27.3 175.9 81.5 73.2 43.2 57.0 85.0 82.0 94.4 100.5 136.9 94.0 71.9 109.4 191.5 190.3 175.1 58.7 55.2 186.9 132.7 108.5 93.5 127.5 93.3 128.0 57.7 118.8 86.2 92.3 74.2 110.4 79.7 64.4 86.5 64.9 99.6 84.4 85.3 149.4 42.2 111.0 56.3 12.0 39.5 17.9 61.9 51.1 96.1 61.6 82.7 72.3 72.5 55.2 98.1 89.4 4.2 86.6 41.3 55.9 70.9 105.8 31.7 37.4 48.3 43.0 29.7 28.5 33.1 23.1 42.6 33.3 282.9 416.9 979.2 866.3 1257.9 240.2 144.8 512.1 277.1 532.3 279.2 88.4 1846.9 626.6 1015.4 131.7 691.4 446.7 116.8 1834.6 2353.9 905.7 556.1 513.1 175.1 878.1 103.3 791.7 392.3 666.2 95.5 972.8 726.1 558.5 1333.7 1093.4 203.6 1143.2 522.5 697.3 587.0 150.2 446.3 924.5 196.6 318.3 1103.1 1822.1 976.0 1319.8 750.5 HNRNPA1P48 ENSG00000224578 "Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48" 16 51553436-51647132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 74.5;Exocrine glandular cells: 119.5;granulocytes: 106.3;Intestinal endocrine cells: 64.6;monocytes: 100.0;Pancreatic endocrine cells: 81.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.0" "HPA001666, HPA005812" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA001666: AB_1850836, HPA005812: AB_2667441" "unprognostic (2.61e-2)" "unprognostic (2.08e-1)" "unprognostic (3.22e-2)" "unprognostic (2.07e-3)" "unprognostic (7.23e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.48e-1)" "unprognostic (2.86e-1)" "unprognostic (6.09e-2)" "unprognostic (1.55e-3)" "unprognostic (7.66e-2)" "unprognostic (5.84e-2)" "unprognostic (2.17e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-3)" "unprognostic (2.11e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 26.2 13.4 0.0 0.0 0.0 8.9 0.0 26.8 40.9 1.8 0.0 0.0 10.0 74.5 0.0 0.0 0.0 0.0 119.5 0.0 0.0 0.0 106.3 0.0 0.0 0.0 64.6 0.0 0.0 0.0 0.0 11.0 0.0 100.0 0.0 0.0 81.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HNRNPA2B1 HNRPA2B1 ENSG00000122566 "Heterogeneous nuclear ribonucleoprotein A2/B1" P22626 7 26189927-26201529 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001666, HPA005812, CAB012403, HPA065537" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 11000000 Nucleoplasm "CAB012403: , HPA001666: AB_1850836, HPA005812: AB_2667441, HPA065537: AB_2685507" "unprognostic (1.19e-1)" "unprognostic (4.45e-1)" "unprognostic (2.33e-1)" "unprognostic (6.39e-2)" "unprognostic (5.64e-2)" "unprognostic (8.04e-3)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.25e-2)" "unprognostic (9.12e-3)" "unprognostic (4.35e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.12e-4)" "prognostic unfavorable (8.01e-5)" "unprognostic (6.74e-2)" "unprognostic (3.36e-2)" "unprognostic (2.02e-1)" "unprognostic (1.56e-2)" 82.2 97.4 85.1 105.3 106.3 90.9 74.4 123.3 87.4 77.1 85.7 89.4 68.7 87.5 92.6 71.9 90.4 75.1 51.7 87.9 82.4 71.8 113.4 103.7 76.2 127.7 118.6 57.0 121.0 75.7 107.2 121.2 100.7 96.3 75.5 98.6 64.4 71.4 66.5 167.2 58.7 94.8 73.7 139.7 116.5 74.1 73.1 135.4 180.3 81.9 104.4 140.7 74.2 128.8 33.7 46.5 35.1 52.4 32.1 42.5 36.0 124.0 105.9 154.2 115.6 39.7 36.3 71.4 79.6 62.1 88.0 79.7 97.8 90.4 226.9 76.1 73.8 105.0 86.6 164.9 104.0 124.0 70.5 100.5 137.5 127.8 116.9 33.3 148.0 94.2 34.3 54.5 83.7 76.4 46.4 90.8 104.9 161.7 74.2 88.8 100.4 158.3 173.1 136.6 95.1 81.7 147.2 125.3 95.0 101.6 108.6 90.1 110.5 95.7 94.3 58.1 98.3 105.7 128.9 78.4 49.5 102.5 67.0 135.8 98.6 195.4 215.9 63.8 168.7 93.2 17.4 38.7 35.1 42.5 52.4 38.6 33.7 35.5 36.6 46.5 29.2 35.6 35.6 13.0 32.1 48.4 43.6 36.1 36.0 85.1 106.3 123.3 87.4 82.4 71.8 118.6 57.0 96.3 135.4 452.6 512.0 456.4 620.8 656.0 459.5 635.5 267.5 721.4 702.9 326.2 280.8 790.3 391.3 484.7 96.5 561.1 396.4 280.4 392.8 789.3 528.7 417.7 617.9 353.4 530.6 295.6 471.8 332.7 355.7 124.0 380.5 569.8 372.8 501.4 392.2 570.4 369.1 357.7 366.7 366.6 518.1 433.4 564.3 596.8 448.9 524.9 905.5 489.7 465.4 566.2 HNRNPA3 HNRPA3 ENSG00000170144 "Heterogeneous nuclear ribonucleoprotein A3" P51991 2 177212563-177223958 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001666, HPA005812, HPA066381" Supported Enhanced Nucleoplasm NA NA 1500000 Nucleoplasm "HPA001666: AB_1850836, HPA005812: AB_2667441, HPA066381: AB_2685666" "unprognostic (2.85e-2)" "prognostic favorable (4.87e-4)" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (2.14e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.95e-5)" "unprognostic (2.46e-1)" "unprognostic (3.15e-3)" "unprognostic (2.80e-3)" "unprognostic (3.65e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (9.57e-7)" "unprognostic (6.95e-2)" "unprognostic (3.04e-1)" "unprognostic (4.55e-2)" "unprognostic (1.10e-2)" 22.9 17.6 24.7 29.5 28.0 29.8 19.5 22.3 29.3 24.3 24.8 16.1 13.7 18.0 26.5 26.9 33.8 20.8 20.9 16.7 20.8 14.2 23.9 20.3 23.7 29.9 40.4 17.7 35.6 19.3 20.6 20.1 27.0 26.5 19.0 28.7 14.9 20.0 28.4 28.0 23.2 23.5 23.4 35.0 24.8 19.7 22.2 27.3 23.0 30.7 18.4 40.6 20.5 28.2 15.2 26.4 7.4 15.8 15.6 18.7 9.3 63.7 43.0 94.5 48.2 25.0 22.3 72.5 48.9 23.0 38.5 36.7 85.5 33.0 128.6 37.3 37.7 51.6 36.8 93.3 61.1 72.5 59.0 56.9 95.8 65.2 169.2 26.9 102.9 59.7 24.8 27.4 57.3 42.7 21.4 52.5 57.2 68.4 44.3 48.8 85.9 71.7 41.5 51.6 73.5 40.5 91.9 80.2 40.2 53.7 126.1 55.4 49.9 72.7 22.7 29.5 71.3 32.8 64.7 58.1 49.4 55.1 34.3 70.4 40.3 71.5 110.0 29.4 68.4 31.9 4.9 15.3 7.4 18.7 15.8 15.0 13.9 15.0 16.5 16.4 15.2 13.8 13.9 6.6 15.6 14.9 26.4 17.3 9.3 24.7 28.0 22.3 29.3 20.8 14.2 40.4 17.7 26.5 27.3 154.9 215.2 221.2 361.3 312.4 188.7 56.1 86.6 283.7 291.2 151.8 92.3 425.0 102.8 195.6 26.3 270.9 149.7 46.7 236.9 457.8 255.4 219.8 270.4 155.4 295.4 139.8 263.9 182.3 180.4 26.3 189.6 227.7 182.2 276.9 212.7 161.7 237.6 169.9 197.0 126.2 152.7 148.8 302.8 280.0 218.2 288.8 414.8 248.4 249.1 343.8 HNRNPAB "ABBP1, FLJ40338, HNRPAB" ENSG00000197451 "Heterogeneous nuclear ribonucleoprotein A/B" Q99729 5 178204507-178211163 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046688 Approved Enhanced Nucleoplasm NA NA 380000 Nucleoplasm "HPA046688: AB_10964924" "unprognostic (2.23e-1)" "unprognostic (6.21e-2)" "unprognostic (2.61e-2)" "unprognostic (1.96e-2)" "unprognostic (8.69e-2)" "unprognostic (1.17e-1)" "unprognostic (1.22e-3)" "unprognostic (4.09e-2)" "unprognostic (6.17e-3)" "prognostic favorable (9.79e-4)" "unprognostic (9.12e-3)" "unprognostic (4.23e-2)" "prognostic unfavorable (1.35e-7)" "unprognostic (3.47e-2)" "unprognostic (1.82e-1)" "unprognostic (3.53e-1)" "unprognostic (2.08e-1)" 34.9 41.7 16.5 47.8 18.4 44.6 32.5 17.9 19.1 30.0 54.0 20.4 24.9 37.0 33.9 23.0 50.9 27.3 38.6 44.4 15.4 17.8 50.0 72.4 29.8 36.5 20.6 12.4 39.1 39.1 25.5 20.5 36.7 16.8 26.8 47.1 19.4 31.3 26.7 53.3 43.4 55.0 38.7 18.9 53.5 31.9 26.5 15.9 75.6 34.6 46.3 41.3 38.7 36.8 5.9 11.4 15.1 7.2 5.7 6.6 2.2 46.1 38.5 59.4 57.4 22.0 19.4 85.9 52.0 24.1 41.6 44.9 70.9 34.7 74.8 48.0 27.8 50.8 30.6 51.4 70.6 51.7 115.6 60.6 47.0 31.0 43.3 22.0 59.4 40.1 19.1 33.4 37.3 37.6 17.2 37.2 30.0 38.3 34.2 41.7 124.3 71.6 57.4 54.4 47.6 55.5 58.5 35.8 44.3 35.1 49.5 54.7 42.6 40.5 56.6 36.6 38.8 33.9 36.4 33.3 50.9 43.0 35.8 71.0 40.1 46.8 88.0 20.6 65.8 41.2 2.8 4.8 15.1 5.5 7.2 6.2 5.9 4.6 6.6 4.6 5.0 4.5 5.3 0.9 5.7 7.1 11.4 4.8 2.2 16.5 18.4 17.9 19.1 15.4 17.8 20.6 12.4 16.8 15.9 29.8 43.7 80.2 123.5 250.0 24.2 39.9 48.4 25.4 44.3 47.1 17.7 71.8 43.1 103.9 4.5 77.1 177.1 93.5 130.6 169.9 80.3 113.7 44.9 96.2 90.6 15.9 114.3 57.1 60.6 7.9 68.4 88.9 64.1 41.5 155.2 31.3 147.7 149.7 82.7 85.7 26.4 77.6 138.6 57.6 139.0 297.1 95.7 42.1 166.2 201.2 HNRNPC "hnRNPC, HNRPC" ENSG00000092199 "Heterogeneous nuclear ribonucleoprotein C (C1/C2)" P07910 14 21209136-21269494 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005223, HPA051075, CAB075755, CAB075756" Supported Enhanced Nucleoplasm NA NA 1400000 Nucleoplasm "CAB005223: AB_2117508, CAB075755: AB_2665761, CAB075756: AB_2665762, HPA051075: AB_2681335" "unprognostic (1.92e-3)" "unprognostic (1.02e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.42e-2)" "unprognostic (5.21e-3)" "prognostic unfavorable (7.72e-5)" "unprognostic (8.66e-3)" "unprognostic (5.96e-3)" "prognostic favorable (1.19e-4)" "unprognostic (3.31e-3)" "unprognostic (5.30e-3)" "prognostic unfavorable (7.29e-5)" "unprognostic (7.36e-2)" "unprognostic (3.73e-3)" "unprognostic (2.28e-3)" "unprognostic (5.42e-2)" 41.1 53.9 51.8 51.1 64.0 71.6 55.1 72.1 65.5 49.6 41.9 45.3 47.3 35.3 51.0 51.1 53.4 54.3 38.0 41.1 47.9 45.1 50.0 51.9 43.0 76.7 54.8 42.1 72.8 57.8 38.3 63.3 54.7 43.7 45.2 47.8 43.9 36.0 44.5 44.5 39.8 39.5 57.6 54.8 55.8 37.4 62.4 52.4 49.3 53.0 37.9 75.6 45.3 45.9 78.3 104.6 119.0 73.3 64.8 89.1 142.9 94.7 79.3 119.5 68.1 79.4 73.5 84.2 60.5 73.6 102.2 87.3 74.7 72.0 168.5 38.5 76.1 66.5 71.7 164.3 102.5 139.5 109.7 87.7 84.5 62.6 111.4 90.3 129.2 70.6 76.1 83.8 75.4 180.2 89.4 107.3 95.6 129.7 72.0 80.8 91.1 154.1 122.9 124.3 95.0 73.9 123.6 95.3 83.0 109.0 86.1 66.3 61.6 73.5 71.0 67.0 110.2 66.7 116.1 69.4 36.8 66.4 43.6 86.9 65.3 97.8 164.4 34.3 105.3 72.0 57.8 73.3 71.2 65.9 63.5 86.1 78.3 78.0 70.2 104.6 68.7 89.1 75.0 119.0 64.8 59.7 67.5 80.3 142.9 51.8 64.0 72.1 65.5 47.9 45.1 54.8 42.1 43.7 52.4 142.9 216.7 293.4 537.0 476.4 166.6 113.3 191.1 426.9 343.5 261.7 186.5 541.0 240.4 270.5 104.5 231.5 115.2 93.5 187.7 622.0 348.5 363.8 401.3 193.0 344.7 109.7 214.8 160.2 259.6 47.1 249.9 333.4 197.4 316.6 194.2 147.6 213.3 119.3 217.1 276.6 280.5 148.8 296.7 355.3 259.1 471.9 731.7 329.0 278.1 447.5 HNRNPD "AUF1, HNRPD" ENSG00000138668 "Heterogeneous nuclear ribonucleoprotein D" Q14103 4 82352498-82374503 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004911 Supported Enhanced Nucleoplasm NA NA 550000 Nucleoplasm "HPA004911: AB_1078250" "unprognostic (9.60e-3)" "unprognostic (1.01e-2)" "unprognostic (9.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (1.77e-1)" "unprognostic (1.03e-3)" "unprognostic (1.75e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-2)" "unprognostic (1.40e-2)" "unprognostic (5.93e-2)" "unprognostic (1.08e-1)" "unprognostic (2.81e-1)" "unprognostic (1.31e-2)" 45.5 40.0 35.4 58.8 46.1 88.0 49.4 49.1 40.6 55.2 49.8 37.2 40.5 45.1 56.2 39.1 55.5 47.9 48.5 40.8 28.4 27.4 36.4 40.6 43.2 72.2 26.5 37.1 64.5 48.9 51.6 38.7 51.9 32.9 44.9 45.8 41.5 52.9 48.6 51.6 49.5 49.9 53.1 27.9 61.4 46.7 30.4 30.7 136.1 41.5 53.7 80.4 58.2 49.9 17.8 21.8 18.0 11.9 12.4 17.5 5.9 60.1 23.9 103.1 32.7 13.6 17.8 48.7 47.4 36.6 54.7 47.2 42.7 53.5 123.3 34.4 32.1 29.1 29.8 81.9 35.5 86.0 22.9 42.3 88.3 32.9 57.8 27.8 117.0 45.5 21.7 15.9 44.1 44.7 28.1 49.4 60.3 97.1 42.7 46.4 23.2 142.4 81.3 85.7 45.1 22.2 105.5 104.8 51.1 45.6 36.9 52.1 56.2 46.7 40.7 23.6 50.2 30.4 46.7 41.7 42.3 57.7 32.5 60.9 45.3 35.6 143.5 32.5 60.5 48.1 18.0 10.8 10.8 13.2 11.3 14.5 17.8 15.9 16.5 12.3 14.4 17.5 14.5 13.1 12.4 11.9 21.8 17.2 5.9 35.4 46.1 49.1 40.6 28.4 27.4 26.5 37.1 32.9 30.7 95.3 129.9 97.5 173.8 232.1 125.8 176.6 81.5 117.8 162.7 106.4 58.9 238.7 59.7 146.2 21.6 142.9 61.9 93.5 181.6 291.7 117.2 144.5 88.0 106.3 135.9 101.7 140.7 111.1 121.5 16.8 115.6 129.0 86.0 133.5 128.6 156.0 133.5 42.1 96.2 65.2 99.6 109.9 139.4 99.7 128.2 200.9 227.5 109.0 142.2 181.5 HNRNPDL "HNRPDL, JKTBP, laAUF1" ENSG00000152795 "Heterogeneous nuclear ribonucleoprotein D like" O14979 4 82422564-82430408 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056820, HPA063147" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA056820: AB_2683246, HPA063147: AB_2684950" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (1.38e-1)" "unprognostic (3.29e-3)" "unprognostic (1.11e-1)" "unprognostic (3.13e-1)" "unprognostic (6.30e-3)" "unprognostic (7.19e-2)" "unprognostic (4.05e-2)" "unprognostic (3.59e-1)" "unprognostic (3.46e-1)" "unprognostic (5.56e-3)" "unprognostic (4.07e-2)" "unprognostic (1.72e-1)" "unprognostic (2.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.03e-2)" 60.5 43.9 52.0 58.8 82.9 98.2 58.8 67.6 79.7 50.1 51.9 60.4 42.9 41.8 73.7 57.8 45.3 53.5 42.4 47.7 49.0 44.7 43.0 37.4 52.9 64.4 86.9 74.2 101.7 66.0 43.5 41.0 46.2 79.0 49.8 44.5 31.6 46.4 52.3 89.7 46.0 47.8 60.6 69.4 55.7 51.1 32.8 80.8 48.3 49.0 59.2 51.3 44.9 51.5 27.7 20.3 14.4 31.1 17.6 35.6 19.9 52.6 27.9 104.1 20.6 39.1 21.4 34.2 57.1 62.1 50.9 48.5 38.3 43.7 98.3 36.4 61.8 26.3 41.1 78.4 52.7 59.8 21.6 56.8 56.9 45.2 68.6 18.4 96.7 42.4 37.7 15.3 56.9 51.0 40.3 40.3 62.8 73.7 40.8 49.3 22.0 90.3 67.9 71.4 47.8 33.0 81.1 84.1 44.9 59.3 34.5 44.3 76.6 35.5 45.9 33.5 49.0 48.0 55.0 33.8 51.4 63.5 33.6 68.1 48.0 45.9 108.2 45.0 56.6 43.2 14.4 15.7 13.2 28.5 25.7 23.3 27.7 25.5 26.0 12.6 26.8 35.6 30.6 6.7 17.6 31.1 20.3 19.4 19.9 52.0 82.9 67.6 79.7 49.0 44.7 86.9 74.2 79.0 80.8 253.1 256.3 276.8 560.8 585.3 217.8 173.8 101.9 365.4 381.1 144.8 100.1 445.7 252.0 241.5 42.1 260.0 120.7 23.3 220.9 513.8 334.8 344.9 370.4 124.1 286.8 166.8 226.5 117.9 193.0 32.1 196.8 307.6 295.3 348.1 161.4 241.5 205.1 122.8 190.6 215.4 158.8 161.7 311.0 158.6 399.4 484.4 435.7 307.9 180.7 425.7 HNRNPF HNRPF ENSG00000169813 "Heterogeneous nuclear ribonucleoprotein F" P52597 10 43385617-43409166 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016884, HPA069667" Supported Enhanced Nucleoplasm NA NA 2500000 Nucleoplasm "HPA016884: AB_1856444, HPA069667: AB_2686166" "unprognostic (9.93e-2)" "unprognostic (2.26e-2)" "unprognostic (1.81e-1)" "unprognostic (3.65e-2)" "unprognostic (6.39e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (1.51e-2)" "unprognostic (6.37e-2)" "unprognostic (6.33e-3)" "unprognostic (4.89e-3)" "unprognostic (1.07e-2)" "unprognostic (1.95e-2)" "unprognostic (3.77e-3)" "unprognostic (3.35e-1)" "unprognostic (3.71e-1)" "unprognostic (2.22e-1)" 48.1 34.0 19.9 41.2 34.9 43.3 56.1 23.2 22.3 31.1 44.5 31.6 26.9 41.1 34.9 32.6 50.4 39.2 35.7 26.2 21.7 18.3 42.3 68.3 40.4 55.9 33.7 13.9 54.2 39.7 22.5 28.1 37.5 32.5 35.4 37.8 26.2 36.9 25.0 40.0 40.6 57.5 41.6 27.5 58.7 39.2 66.4 31.2 77.5 40.6 42.3 56.9 46.2 57.4 58.3 59.7 52.0 62.5 63.2 75.8 89.4 46.3 49.3 30.7 46.4 37.6 41.3 45.0 36.4 61.2 51.2 60.6 46.1 64.9 93.5 23.4 39.3 30.1 65.8 81.9 59.4 42.2 39.1 49.0 59.5 30.7 59.2 46.5 87.2 60.5 50.1 47.2 39.7 73.3 29.8 43.9 46.2 60.1 42.5 38.6 72.4 85.2 47.8 23.1 70.6 41.7 71.7 28.8 44.3 52.3 71.9 37.9 38.1 37.0 68.1 55.1 34.9 75.8 42.7 32.7 23.6 44.9 38.6 57.4 38.3 64.5 56.7 38.3 83.9 23.0 38.5 54.4 52.0 62.3 62.5 75.8 58.3 65.5 68.6 59.7 48.1 55.7 52.5 36.5 63.2 55.5 33.4 72.6 89.4 19.9 34.9 23.2 22.3 21.7 18.3 33.7 13.9 32.5 31.2 125.0 101.0 151.2 286.6 298.4 46.3 53.4 129.9 188.7 104.6 106.4 45.2 238.4 149.2 179.9 260.2 132.4 146.6 93.5 123.9 343.0 154.8 203.1 114.2 201.4 197.1 46.1 121.7 118.4 187.9 81.6 135.2 151.7 94.5 200.2 160.4 105.7 142.1 149.4 110.7 162.5 134.4 97.0 151.4 223.4 171.5 288.8 176.0 209.8 206.2 283.8 HNRNPH1 "hnRNPH, HNRPH1" ENSG00000169045 "Heterogeneous nuclear ribonucleoprotein H1" P31943 5 179614178-179634784 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Basal keratinocytes: 688.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000914, HPA001359, HPA016884, CAB032820" Supported Enhanced Nucleoplasm NA NA 2100000 Nucleoplasm "CAB032820: AB_2248257, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444" "unprognostic (9.01e-2)" "unprognostic (3.83e-1)" "unprognostic (3.45e-3)" "unprognostic (8.82e-2)" "unprognostic (1.01e-1)" "prognostic favorable (7.85e-4)" "prognostic unfavorable (3.29e-7)" "unprognostic (7.99e-2)" "unprognostic (6.22e-3)" "unprognostic (1.56e-1)" "unprognostic (8.65e-3)" "unprognostic (8.64e-3)" "prognostic unfavorable (3.46e-4)" "unprognostic (1.40e-2)" "unprognostic (1.54e-1)" "unprognostic (2.40e-3)" "unprognostic (1.72e-3)" 40.1 36.2 26.8 86.3 31.0 90.5 45.4 73.4 33.2 55.6 38.2 26.6 54.7 30.2 52.4 44.3 41.7 37.7 45.3 30.3 25.6 23.3 36.5 42.3 37.0 59.8 33.0 30.3 60.1 41.3 24.4 46.1 43.6 28.9 40.8 34.7 34.4 53.5 60.3 51.3 44.3 43.0 61.6 31.3 65.2 34.4 42.5 34.3 113.2 47.5 61.5 62.0 57.3 54.4 26.3 34.7 18.4 27.7 24.3 36.8 13.8 51.6 39.4 62.4 40.8 22.4 12.3 50.5 30.8 16.0 40.3 26.6 53.4 34.4 86.0 27.9 22.4 34.2 33.1 58.1 36.3 36.2 72.0 41.7 46.8 65.0 67.0 26.3 61.1 45.1 12.9 26.4 39.3 24.8 25.1 21.9 36.5 58.7 45.5 23.9 35.4 93.0 56.9 72.3 28.9 29.0 82.9 71.0 51.0 20.7 61.6 59.6 50.7 59.8 40.9 53.8 34.7 38.9 79.3 35.9 59.1 42.0 26.9 69.6 37.4 80.9 90.1 32.0 58.5 69.0 18.4 18.0 17.5 26.0 27.7 34.3 26.3 27.8 27.9 26.6 22.7 35.5 36.8 3.5 24.3 20.8 34.7 31.7 13.8 26.8 31.0 73.4 33.2 25.6 23.3 33.0 30.3 28.9 34.3 107.2 244.9 156.8 156.9 688.7 112.1 115.5 160.5 113.8 153.6 148.3 123.7 142.0 66.3 86.3 122.9 189.6 133.1 303.7 106.4 163.6 207.4 153.7 235.1 192.4 96.7 66.7 245.0 179.2 181.7 67.9 103.3 177.8 317.2 101.0 168.3 82.9 89.4 147.3 110.3 55.5 160.3 181.1 190.5 157.9 116.9 627.7 161.0 200.5 170.7 155.5 HNRNPH2 "FTP3, hnRNPH', HNRPH', HNRPH2" ENSG00000126945 "Heterogeneous nuclear ribonucleoprotein H2" P55795 X 101408295-101414133 "Disease related genes, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 253.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000914, HPA001359, CAB004436, HPA016884" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004436: AB_627737, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444" "unprognostic (1.00e-1)" "unprognostic (5.57e-2)" "unprognostic (2.10e-1)" "unprognostic (2.70e-1)" "unprognostic (5.48e-2)" "unprognostic (1.71e-2)" "unprognostic (3.83e-2)" "unprognostic (1.47e-2)" "unprognostic (3.88e-1)" "unprognostic (3.04e-1)" "unprognostic (2.22e-1)" "unprognostic (2.99e-1)" "prognostic favorable (7.37e-4)" "unprognostic (8.09e-2)" "unprognostic (1.04e-2)" "unprognostic (3.66e-1)" "unprognostic (6.68e-2)" 49.5 44.2 43.4 34.6 51.9 38.3 42.7 49.1 53.9 37.0 32.2 33.8 33.3 34.1 36.6 39.7 36.7 32.7 28.2 35.9 40.3 42.4 49.8 46.1 34.5 30.1 37.1 46.4 47.8 28.4 77.5 50.0 44.9 48.8 37.9 35.9 25.0 30.4 45.2 54.8 40.0 43.6 39.7 36.7 42.2 30.6 18.9 34.2 44.0 44.1 39.9 39.9 41.7 34.4 16.7 28.8 65.9 32.1 22.1 19.4 22.6 31.1 21.7 42.6 25.5 37.6 32.8 20.4 26.7 37.2 25.2 51.6 18.3 28.0 32.1 27.3 37.3 34.7 28.7 48.5 36.9 34.6 31.2 23.8 23.8 52.7 24.8 32.2 29.5 23.4 33.3 34.0 24.9 24.5 30.5 34.2 17.7 24.1 46.5 38.2 39.9 24.2 26.0 26.8 51.0 21.3 23.2 45.4 31.2 54.3 41.6 19.6 35.8 39.8 19.0 30.1 31.5 24.2 28.2 37.1 14.1 25.9 40.1 10.9 15.7 22.5 22.7 29.0 34.3 17.5 29.3 29.4 43.2 18.1 32.1 19.4 16.7 17.7 18.2 28.8 15.6 18.7 19.2 65.9 22.1 30.4 12.1 16.3 22.6 43.4 51.9 49.1 53.9 40.3 42.4 37.1 46.4 48.8 34.2 26.8 63.6 43.1 84.4 63.0 39.8 45.6 33.1 44.2 47.8 85.5 11.8 120.9 84.6 83.4 2.9 54.0 50.2 23.3 64.4 53.5 57.5 42.3 80.8 70.6 73.2 15.9 58.3 47.3 65.5 4.3 51.2 73.1 65.8 105.6 41.2 38.4 56.0 48.0 55.5 110.9 28.7 77.6 49.5 8.0 21.3 63.0 253.0 48.5 42.5 60.2 HNRNPH3 "2H9, HNRPH3" ENSG00000096746 "Heterogeneous nuclear ribonucleoprotein H3" P31942 10 68331174-68343191 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038264 Supported Nucleoplasm NA NA 560000 Nucleoplasm "HPA038264: AB_10697246" "unprognostic (1.72e-1)" "unprognostic (3.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.85e-1)" "unprognostic (7.25e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (6.17e-2)" "unprognostic (8.29e-2)" "unprognostic (1.75e-1)" "unprognostic (2.32e-1)" "unprognostic (9.81e-3)" "unprognostic (2.75e-3)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-1)" "unprognostic (1.06e-3)" 44.9 41.8 47.1 37.9 53.2 51.3 42.8 57.3 48.1 45.1 39.2 49.8 33.2 33.4 58.2 29.2 38.2 42.4 27.8 40.3 45.0 42.3 42.7 34.4 34.6 43.7 57.3 42.2 71.4 27.0 41.2 61.5 50.4 45.6 53.1 40.4 30.4 28.1 39.7 50.4 38.5 41.9 61.1 81.9 38.0 33.7 40.5 65.3 48.9 60.5 31.6 45.8 55.4 78.7 13.6 17.4 29.0 19.3 17.5 22.7 10.6 42.4 41.2 66.0 20.5 25.9 16.1 42.6 37.5 19.7 35.2 29.2 70.3 37.6 67.3 20.6 24.7 27.9 28.5 53.0 36.1 54.5 41.3 28.0 52.1 37.2 42.4 22.7 59.5 28.8 10.5 33.1 40.0 71.3 29.2 26.6 36.1 64.4 23.4 38.9 58.8 52.5 64.6 43.8 31.2 49.0 44.0 55.3 21.8 28.2 35.3 29.8 32.5 39.8 27.5 39.1 39.5 29.2 30.4 28.9 32.5 54.8 17.1 50.4 28.4 38.3 68.7 18.2 29.5 25.5 14.7 15.3 29.0 15.0 17.0 15.5 13.2 17.8 17.2 17.4 13.6 22.7 18.6 19.8 17.5 19.3 14.3 15.8 10.6 47.1 53.2 57.3 48.1 45.0 42.3 57.3 42.2 45.6 65.3 95.3 107.8 84.3 251.6 289.4 114.7 95.6 43.3 145.9 130.8 69.8 90.3 123.5 51.4 76.1 15.9 108.9 62.8 23.3 72.3 174.4 129.1 149.0 135.4 36.5 84.8 82.6 103.3 67.5 62.9 15.8 89.2 95.2 123.2 90.2 71.6 97.7 64.9 83.4 113.1 58.5 138.2 129.4 182.3 279.8 178.3 233.2 160.4 86.3 75.4 187.4 HNRNPK "CSBP, HNRPK, TUNP" ENSG00000165119 "Heterogeneous nuclear ribonucleoprotein K" P61978 9 83968083-83980616 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004435, HPA007644, CAB016225, HPA044105" Supported Enhanced Nucleoplasm NA NA 5000000 Nucleoplasm "CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: AB_2678812" "unprognostic (4.84e-2)" "unprognostic (4.69e-1)" "unprognostic (1.15e-2)" "unprognostic (8.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.83e-3)" "prognostic unfavorable (6.68e-5)" "unprognostic (3.46e-3)" "unprognostic (8.11e-2)" "unprognostic (1.47e-1)" "unprognostic (8.85e-3)" "unprognostic (2.81e-2)" "unprognostic (2.76e-3)" "unprognostic (2.23e-3)" "unprognostic (6.50e-2)" "unprognostic (4.59e-1)" "unprognostic (2.82e-1)" 79.0 92.0 70.0 80.7 81.7 146.9 97.2 88.0 104.8 77.9 70.0 68.8 80.9 74.5 96.3 69.0 95.8 79.6 67.5 80.4 68.2 71.5 76.0 90.9 77.7 125.0 80.9 72.9 96.5 102.8 91.4 74.5 92.3 67.3 69.4 75.2 58.6 76.5 104.6 101.4 78.7 76.7 100.9 86.3 96.1 72.5 60.3 78.6 162.5 79.9 80.8 106.9 81.0 77.1 59.7 76.1 92.7 71.0 75.6 73.2 136.4 122.3 84.6 145.5 86.1 69.9 77.5 116.9 86.6 107.7 108.5 102.2 70.8 87.7 145.4 59.6 90.6 94.1 94.1 145.4 105.1 132.5 99.9 85.6 102.0 74.2 100.3 92.6 126.4 101.3 78.8 80.4 92.5 123.1 81.8 110.4 82.7 103.7 74.7 106.7 107.3 156.7 86.7 129.2 124.4 82.4 136.9 116.0 96.9 105.1 101.0 94.4 112.1 91.1 97.2 86.3 105.3 96.2 107.5 90.3 75.6 89.1 76.6 112.8 78.7 103.0 105.6 72.2 102.4 106.8 77.4 71.0 90.1 53.9 69.2 67.3 59.7 62.5 61.2 76.1 56.8 65.1 59.3 92.7 75.6 65.8 45.2 73.2 136.4 70.0 81.7 88.0 104.8 68.2 71.5 80.9 72.9 67.3 78.6 190.6 233.2 308.4 456.1 449.4 175.4 171.5 206.4 338.6 282.1 249.5 84.4 518.7 334.9 379.2 22.5 338.4 245.6 163.5 321.8 621.5 373.1 281.2 324.9 300.6 341.5 147.8 371.7 237.6 349.5 31.1 309.8 311.8 310.4 423.8 309.1 344.3 335.2 270.0 301.9 310.5 156.5 271.7 398.2 345.1 248.3 392.2 609.3 308.9 346.3 397.3 HNRNPL HNRPL ENSG00000104824 "Heterogeneous nuclear ribonucleoprotein L" P14866 19 38836388-38852347 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016326, HPA051748, HPA052661" Supported Enhanced Nucleoplasm NA NA 130000 Nucleoplasm "CAB016326: AB_627736, HPA051748: AB_2681588, HPA052661: AB_2681905" "unprognostic (5.33e-2)" "unprognostic (4.58e-2)" "unprognostic (2.27e-1)" "unprognostic (9.67e-3)" "unprognostic (8.99e-3)" "unprognostic (4.90e-3)" "prognostic unfavorable (3.25e-6)" "unprognostic (1.45e-1)" "unprognostic (8.85e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (9.69e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (1.96e-11)" "unprognostic (2.17e-2)" "unprognostic (4.23e-2)" "unprognostic (1.58e-2)" "unprognostic (4.39e-2)" 44.1 43.3 32.8 47.1 37.1 102.7 40.6 48.9 47.6 38.9 46.2 42.5 35.9 43.7 47.8 34.8 50.1 36.2 42.0 39.7 31.8 31.9 39.9 52.9 43.2 48.0 36.2 32.5 41.6 41.6 36.1 28.1 47.9 34.7 34.6 49.1 35.6 37.5 39.8 44.7 50.7 48.1 49.4 34.3 44.8 38.2 34.9 39.4 102.8 53.0 36.8 67.6 37.9 40.5 3.1 6.2 3.5 3.8 2.2 3.6 1.9 46.2 36.6 46.5 29.9 18.5 21.8 43.9 38.5 26.6 35.8 34.1 39.2 35.6 73.5 31.5 24.7 27.2 28.4 57.3 43.2 53.3 56.6 31.1 60.7 23.3 34.9 19.7 56.0 41.1 23.7 20.5 36.1 35.7 20.5 39.5 32.5 58.8 38.1 37.3 36.6 57.9 34.6 54.7 32.5 25.4 75.3 53.2 46.2 40.1 34.8 39.0 36.2 38.7 30.4 15.5 33.8 39.8 31.2 35.3 35.9 40.9 31.5 55.3 36.6 49.1 82.7 23.1 49.6 39.2 1.1 2.6 1.7 3.5 3.8 2.7 2.2 2.5 2.1 3.5 3.1 2.7 2.2 3.5 2.2 2.8 6.2 3.6 1.9 32.8 37.1 48.9 47.6 31.8 31.9 36.2 32.5 34.7 39.4 20.8 57.5 59.4 53.2 31.5 76.3 16.1 20.4 25.4 36.4 21.0 60.9 36.1 6.6 30.0 12.1 37.0 50.9 0.0 38.1 29.7 32.6 50.4 38.1 62.1 23.8 31.8 60.4 42.4 60.8 8.9 26.2 37.5 25.3 31.5 62.4 41.8 34.9 35.1 21.2 17.8 69.2 19.4 36.3 19.1 19.6 41.5 43.7 49.8 62.6 36.9 HNRNPM "CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1" ENSG00000099783 "Heterogeneous nuclear ribonucleoprotein M" P52272 19 8444767-8489114 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016113, HPA024344" Supported Enhanced Nucleoplasm NA NA 170000 Nucleoplasm "CAB016113: AB_627739, HPA024344: AB_1850879" "unprognostic (2.12e-1)" "unprognostic (8.59e-2)" "unprognostic (2.51e-2)" "unprognostic (2.06e-2)" "unprognostic (1.27e-1)" "unprognostic (1.52e-3)" "prognostic unfavorable (1.80e-6)" "unprognostic (2.44e-1)" "unprognostic (2.59e-2)" "unprognostic (6.91e-3)" "unprognostic (4.70e-3)" "unprognostic (7.34e-2)" "unprognostic (3.62e-2)" "unprognostic (1.22e-3)" "unprognostic (1.02e-1)" "unprognostic (2.17e-1)" "unprognostic (1.73e-1)" 41.1 38.3 43.2 57.1 44.8 83.6 39.3 66.1 56.7 41.0 45.8 32.8 45.7 42.0 51.5 35.5 54.5 40.7 41.2 38.3 40.4 29.0 38.9 53.9 37.9 55.7 36.4 35.5 56.3 36.0 57.6 42.2 44.8 37.5 37.9 41.1 35.7 40.4 52.4 98.8 43.4 40.8 48.7 39.6 50.1 38.3 41.0 45.4 91.7 41.4 40.0 64.7 37.9 64.3 26.0 32.4 16.5 35.0 30.6 36.6 28.2 61.8 42.0 79.8 31.9 18.3 20.4 50.8 37.4 28.1 46.6 35.5 59.8 19.0 91.4 49.9 33.7 33.5 38.2 81.3 46.7 58.7 57.0 67.1 81.1 42.7 57.2 19.0 82.8 43.4 21.0 23.7 39.5 16.5 13.7 41.7 34.4 81.3 26.3 36.9 42.1 79.5 71.8 68.6 34.1 51.2 89.7 69.2 43.2 24.5 60.0 43.9 48.8 62.8 33.9 35.0 39.8 40.3 49.4 48.4 40.7 49.3 42.7 69.7 38.6 71.1 106.1 30.5 67.6 44.2 6.9 28.2 16.5 36.0 35.0 36.6 26.0 31.4 35.9 32.2 24.6 34.0 33.0 7.7 30.6 25.7 32.4 31.6 28.2 43.2 44.8 66.1 56.7 40.4 29.0 36.4 35.5 37.5 45.4 119.1 188.2 159.3 181.9 147.8 207.0 80.6 96.8 250.3 285.5 111.7 66.8 237.5 82.9 166.9 9.2 145.2 70.1 116.8 237.4 247.6 125.5 75.8 253.7 134.1 152.1 130.3 182.7 108.6 128.8 17.2 105.0 125.4 104.6 223.6 109.3 163.0 169.0 103.7 133.7 73.2 167.9 207.0 191.9 152.3 129.3 119.7 219.3 156.9 140.9 130.8 HNRNPR "hnRNP-R, HNRPR" ENSG00000125944 "Heterogeneous nuclear ribonucleoprotein R" O43390 1 23303771-23344336 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011687, HPA026092" Supported Enhanced Nucleoplasm NA NA 50000 Nucleoplasm "CAB011687: AB_2295532, HPA026092: AB_1850885" "unprognostic (1.86e-1)" "unprognostic (2.12e-1)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.92e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.29e-2)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" "unprognostic (1.15e-3)" "unprognostic (3.28e-2)" "unprognostic (7.65e-2)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.14e-2)" "unprognostic (4.12e-1)" 27.1 30.4 31.2 36.1 34.7 33.8 31.2 41.0 32.2 32.4 27.4 34.3 29.5 26.5 42.2 23.7 33.2 32.7 20.3 25.6 29.1 27.9 25.1 25.1 28.1 39.6 35.0 27.9 44.3 32.8 40.5 40.9 40.9 27.5 27.3 31.3 26.5 28.1 27.7 31.1 27.8 26.8 41.0 34.1 28.8 24.9 20.3 40.0 68.3 29.9 29.7 40.9 29.0 29.4 21.9 23.6 20.8 23.2 26.1 28.5 19.8 36.7 22.9 47.0 27.8 16.8 16.8 22.2 25.0 25.5 35.3 25.5 15.7 25.5 45.0 12.3 30.3 21.3 21.2 48.5 32.4 46.3 31.2 32.9 43.0 30.3 28.3 17.0 53.2 29.0 18.7 20.0 33.1 26.8 18.0 26.2 34.8 38.6 31.4 27.1 21.1 60.7 15.5 26.5 25.4 21.1 43.5 45.9 31.7 23.8 18.0 30.0 31.3 32.8 27.8 20.2 27.0 22.3 23.8 26.5 23.7 32.4 29.0 29.6 19.9 29.6 60.7 17.9 45.5 25.8 8.7 18.5 20.8 25.4 22.5 27.7 21.9 24.3 25.2 23.6 20.1 26.3 24.4 6.6 26.1 23.2 13.9 28.5 19.8 31.2 34.7 41.0 32.2 29.1 27.9 35.0 27.9 27.5 40.0 110.2 90.3 90.8 156.4 113.3 122.1 64.1 76.5 147.2 144.5 83.7 41.2 198.0 77.9 84.8 12.3 105.1 51.1 23.3 109.3 227.4 125.2 131.2 163.3 64.4 93.4 119.2 111.7 58.3 74.5 13.1 111.9 91.5 79.2 159.7 84.5 155.0 99.5 59.6 109.6 54.2 110.8 84.1 129.6 143.8 153.0 113.4 172.9 111.0 103.7 158.3 HNRNPU "C1orf199, FLJ30202, FLJ37978, hnRNPU, HNRNPU-AS1, HNRPU, NCRNA00201, SAF-A" ENSG00000153187 "Heterogeneous nuclear ribonucleoprotein U" Q00839 1 244840638-244864560 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Cell division, Differentiation, Host-virus interaction, Mitosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011532, HPA041057, HPA058707" Supported Enhanced Nucleoplasm NA NA 840000 Nucleoplasm "CAB011532: AB_732983, HPA041057: AB_2677278, HPA058707: AB_2683796" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.31e-2)" "unprognostic (1.99e-1)" "unprognostic (3.63e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.88e-5)" "unprognostic (2.26e-2)" "unprognostic (4.09e-3)" "unprognostic (1.87e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (7.45e-2)" "unprognostic (1.21e-1)" "unprognostic (3.01e-2)" "unprognostic (2.98e-1)" "unprognostic (4.62e-1)" 55.6 57.5 55.3 55.3 68.1 87.3 60.9 80.2 61.7 53.4 47.9 57.7 49.6 38.9 61.4 74.9 53.3 55.9 48.0 47.4 53.3 51.5 68.5 61.2 45.1 52.2 60.5 51.8 76.0 51.7 85.9 48.6 55.4 47.2 56.5 51.1 43.9 49.0 54.3 69.7 43.9 50.3 58.0 55.4 62.3 49.4 47.8 64.5 121.5 61.7 41.5 64.3 57.5 97.9 17.3 25.1 17.0 11.7 15.1 21.7 7.3 47.9 38.6 51.3 40.2 26.9 23.3 50.4 34.4 22.2 31.6 28.2 36.9 32.0 75.9 32.3 29.0 30.3 37.8 68.6 39.0 50.3 31.9 46.0 65.4 34.2 56.3 28.3 74.8 39.8 26.2 23.6 34.4 36.6 28.4 32.3 47.9 85.1 28.2 42.6 34.3 79.6 77.8 89.0 36.0 35.2 79.9 64.0 41.2 50.9 35.4 42.9 42.3 54.2 35.9 41.6 39.1 49.4 84.4 38.9 31.7 46.7 33.7 60.7 46.6 50.8 74.0 26.0 64.2 45.3 14.1 11.7 15.5 15.3 10.1 16.2 17.3 18.6 18.4 12.4 17.0 21.7 18.3 17.0 15.1 11.0 25.1 15.8 7.3 55.3 68.1 80.2 50.4 53.3 51.5 60.5 51.8 47.2 64.5 303.7 307.6 169.4 272.6 241.0 145.0 162.6 101.9 311.8 396.9 183.2 172.8 181.9 82.9 177.3 334.5 193.4 127.0 0.0 156.7 227.3 175.2 162.2 346.3 111.1 161.8 133.5 190.1 114.8 193.9 392.9 142.4 255.5 116.4 215.6 139.7 150.4 156.6 124.3 134.0 103.9 204.8 142.3 205.0 166.3 161.8 209.2 211.3 200.3 159.5 244.9 HNRNPUL1 "E1B-AP5, E1BAP5, FLJ12944, HNRPUL1" ENSG00000105323 "Heterogeneous nuclear ribonucleoprotein U like 1" Q9BUJ2 19 41262496-41307598 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046290, CAB046477, HPA049475" Enhanced Enhanced Nucleoplasm NA NA 20000 Nucleoplasm "CAB046477: AB_2120664, HPA046290: AB_2679616, HPA049475: AB_2680783" "unprognostic (5.52e-2)" "unprognostic (6.37e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.39e-1)" "unprognostic (4.29e-2)" "unprognostic (3.45e-3)" "unprognostic (1.94e-1)" "unprognostic (6.08e-2)" "unprognostic (2.86e-1)" "unprognostic (1.76e-1)" "unprognostic (3.59e-2)" "unprognostic (5.78e-2)" "unprognostic (2.32e-1)" "unprognostic (1.66e-1)" "unprognostic (8.05e-2)" "unprognostic (2.39e-1)" 44.8 37.1 31.0 40.7 32.2 72.3 40.4 35.9 40.3 48.9 48.0 47.3 38.1 38.6 50.3 33.3 43.6 41.4 43.6 52.9 28.9 24.6 29.1 28.4 39.0 45.5 30.8 26.7 58.8 44.9 34.3 33.7 27.9 28.8 38.3 35.8 40.8 45.4 44.7 50.9 48.4 40.1 55.5 29.7 41.2 39.6 54.3 34.5 85.2 39.6 45.9 50.2 52.7 44.1 9.4 13.0 13.2 6.7 11.5 19.3 4.8 58.1 77.5 46.0 42.4 22.7 27.1 17.6 35.6 40.8 44.3 40.6 45.1 44.8 52.2 24.3 42.5 24.8 19.2 43.4 40.1 50.3 51.0 37.7 57.7 35.8 35.0 26.5 53.8 53.6 29.0 25.3 39.5 36.7 39.8 41.1 39.4 41.1 49.4 39.1 44.4 68.4 31.6 35.1 55.6 28.3 44.7 37.4 29.0 32.4 61.6 36.8 33.6 78.4 45.1 20.2 32.9 34.6 59.9 40.8 49.9 48.6 22.7 65.8 58.2 37.4 49.1 31.6 43.9 65.7 9.0 5.9 9.4 12.3 6.2 19.3 8.6 14.9 12.6 6.7 9.4 10.1 8.0 13.2 11.5 6.7 13.0 9.8 4.8 31.0 32.2 35.9 40.3 28.9 24.6 30.8 26.7 28.8 34.5 74.5 69.5 91.1 39.9 49.9 61.0 56.5 33.1 53.5 34.2 29.6 68.7 44.1 38.1 50.3 36.2 49.6 41.7 93.5 54.0 50.7 57.7 39.1 56.7 37.5 55.7 46.1 73.6 58.9 80.2 56.6 80.0 61.8 33.7 61.3 60.4 65.5 55.5 31.6 67.1 24.6 98.2 77.6 60.1 100.8 116.2 52.7 44.6 105.4 68.9 37.6 HNRNPUL2 "DKFZp762N1910, HNRPUL2" ENSG00000214753 "Heterogeneous nuclear ribonucleoprotein U like 2" Q1KMD3 11 62712630-62727349 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041632, HPA056696, HPA067699" Supported Enhanced Nucleoplasm NA NA 23000 Nucleoplasm "HPA041632: AB_10960896, HPA056696: AB_2683211, HPA067699: AB_2685891" "unprognostic (3.06e-3)" "unprognostic (2.31e-1)" "unprognostic (7.48e-2)" "unprognostic (9.27e-3)" "unprognostic (4.38e-2)" "unprognostic (1.95e-1)" "unprognostic (1.91e-2)" "unprognostic (2.21e-1)" "unprognostic (2.83e-1)" "unprognostic (4.99e-3)" "unprognostic (2.35e-1)" "unprognostic (6.43e-2)" "unprognostic (2.50e-1)" "unprognostic (3.92e-2)" "unprognostic (2.17e-1)" "unprognostic (2.33e-2)" "unprognostic (6.45e-2)" 26.6 17.3 35.3 24.5 42.1 22.1 25.8 52.1 42.3 28.1 32.2 23.5 22.9 26.8 27.6 37.0 28.5 23.7 27.2 23.7 31.9 29.6 24.2 19.5 24.0 30.1 32.8 35.2 26.3 25.3 33.1 19.5 26.9 27.7 26.3 27.8 21.6 28.0 31.2 38.8 35.1 28.6 34.2 26.7 29.5 24.0 17.1 28.4 36.6 20.8 14.8 34.6 26.6 31.3 4.0 5.0 4.4 3.8 2.6 5.1 1.7 35.9 17.1 28.9 17.3 16.3 20.0 4.8 23.2 14.3 18.6 14.4 11.8 12.6 42.4 11.9 19.8 15.7 20.3 18.0 22.9 25.0 17.9 9.3 39.8 22.2 13.3 14.5 41.6 26.7 15.5 18.1 17.5 21.9 14.4 22.6 11.0 15.0 16.2 21.3 21.6 41.3 37.8 13.6 13.7 13.8 29.1 26.4 20.2 23.2 22.6 17.1 19.1 24.0 20.4 24.4 14.5 14.9 18.1 24.5 21.6 9.5 26.7 24.4 20.3 16.8 42.0 19.4 20.1 19.7 3.2 2.9 4.4 5.1 1.9 3.7 3.4 3.7 4.3 1.7 4.0 2.9 3.6 3.8 2.6 3.8 5.0 3.3 1.7 35.3 42.1 52.1 42.3 31.9 29.6 32.8 35.2 27.7 28.4 26.8 8.9 31.2 12.6 26.2 27.8 37.2 33.1 8.1 13.6 50.6 9.8 21.3 5.0 24.6 5.7 28.7 53.9 0.0 31.1 22.2 25.3 20.4 15.0 34.6 32.7 39.7 36.9 39.3 58.6 5.2 38.9 27.8 13.5 22.6 52.8 16.6 29.1 47.2 43.2 21.9 17.9 32.3 27.8 12.9 20.1 28.1 21.1 24.9 53.4 15.9 HOXA11 "HOX1, HOX1I" ENSG00000005073 "Homeobox A11" P31270 7 27181510-27185223 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 35.7;endometrium 1: 60.9;smooth muscle: 27.3" "Cell type enhanced" "Detected in some" 10 "Distal tubular cells: 5.0;Fibroblasts: 4.3;Intestinal endocrine cells: 5.1;Smooth muscle cells: 2.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 14.7;BJ hTERT+: 17.8;HEK 293: 25.0;THP-1: 17.9;U-937: 23.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006770, HPA035623" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA006770: AB_2667672, HPA035623: AB_10601576" "unprognostic (5.95e-2)" "unprognostic (9.23e-2)" "unprognostic (3.07e-2)" "unprognostic (2.70e-2)" "unprognostic (6.29e-2)" "unprognostic (9.78e-2)" "unprognostic (2.82e-3)" "unprognostic (4.36e-2)" "unprognostic (1.61e-2)" "unprognostic (3.05e-2)" "unprognostic (2.08e-3)" "unprognostic (1.73e-2)" "prognostic unfavorable (2.57e-5)" "unprognostic (2.17e-2)" "unprognostic (6.90e-2)" "unprognostic (2.03e-2)" "unprognostic (2.56e-1)" 1.5 0.4 0.0 1.7 0.0 0.0 2.0 0.0 0.0 35.7 9.3 0.0 5.7 0.0 60.9 8.8 0.0 0.7 0.0 0.2 0.0 0.0 3.6 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 9.0 0.0 16.5 2.4 0.0 0.1 6.3 4.9 0.7 0.2 27.3 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 20.1 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 0.1 0.0 6.8 8.4 5.9 0.0 14.7 17.8 10.5 7.5 0.1 0.8 0.0 3.4 12.5 0.0 1.6 8.7 0.0 7.7 0.8 25.0 3.1 6.1 0.3 0.5 6.2 0.9 3.7 0.3 0.0 0.0 0.0 7.6 0.6 0.2 0.0 1.1 0.1 0.0 4.8 0.0 2.1 7.4 0.4 0.0 0.1 5.0 4.3 3.2 0.0 3.6 0.0 1.0 2.1 0.6 17.9 0.0 0.1 7.2 1.6 0.7 0.0 0.0 0.0 0.1 23.4 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 4.3 2.0 0.0 0.0 0.3 0.0 5.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.6 0.7 HOXA3 "HOX1, HOX1E" ENSG00000105997 "Homeobox A3" O43365 7 27106184-27152581 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ito cells: 9.2;Mucus-secreting cells: 14.6;Proximal tubular cells: 11.0;Undifferentiated cells: 13.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "pons and medulla: 6.6" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 19.1;CACO-2: 12.3;CAPAN-2: 32.9;HEK 293: 14.7;WM-115: 17.6" "Region enriched" "Detected in single" 31 "pons and medulla: 2.9" "Region enriched" "Detected in single" 34 "pons and medulla: 5.0" HPA029157 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA029157: AB_10601020" "unprognostic (1.32e-1)" "unprognostic (3.71e-2)" "unprognostic (1.58e-1)" "unprognostic (3.85e-3)" "unprognostic (2.94e-2)" "unprognostic (5.48e-2)" "unprognostic (2.81e-2)" "unprognostic (2.05e-2)" "unprognostic (8.61e-2)" "unprognostic (6.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.09e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (1.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.65e-2)" "unprognostic (5.82e-2)" 5.3 2.6 0.5 11.0 0.5 0.0 8.9 0.5 0.5 3.9 13.7 0.7 9.8 3.9 7.5 7.2 6.9 16.0 4.7 4.7 0.5 0.0 9.9 1.5 5.2 3.5 1.3 0.5 5.5 0.6 5.4 0.5 0.5 6.6 5.6 4.9 0.5 0.5 4.2 7.2 3.8 7.8 3.6 4.7 2.5 6.3 2.7 0.5 6.7 2.5 9.8 2.7 9.4 6.0 0.5 1.3 3.8 1.1 1.3 0.5 0.3 5.7 6.8 0.0 19.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 12.3 32.9 0.9 9.5 0.5 2.6 7.7 0.3 0.8 0.0 0.2 14.7 0.2 0.1 9.9 0.6 0.3 0.3 1.2 0.0 1.5 1.8 0.0 1.8 0.8 0.6 0.1 0.7 0.3 0.0 0.5 0.0 1.6 4.2 6.8 2.2 0.0 5.6 2.6 2.8 0.0 1.0 0.0 2.7 0.3 0.5 0.4 8.1 0.0 1.0 2.0 1.5 0.0 0.0 0.3 0.6 1.2 17.6 1.7 0.2 0.7 0.5 0.2 0.0 0.5 0.3 0.5 1.3 0.1 0.0 0.3 3.8 1.3 1.1 0.1 0.5 0.3 0.5 0.5 0.5 0.5 0.5 0.0 1.3 0.5 6.6 0.5 0.0 0.0 0.0 3.0 1.0 0.0 0.6 0.0 0.0 0.0 3.5 0.0 0.0 5.0 0.0 6.5 1.4 5.0 0.0 0.0 0.0 1.1 2.2 1.1 0.0 0.1 0.0 4.1 9.2 0.3 7.3 0.6 0.0 3.3 0.0 14.6 0.0 0.0 7.0 0.0 11.0 0.0 0.0 4.2 1.2 0.4 1.1 0.0 0.0 13.6 2.6 HOXA9 "HOX1, HOX1G" ENSG00000078399 "Homeobox A9" P31269 7 27162435-27175180 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 35.1" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 46.4;Intestinal endocrine cells: 37.7;Proximal tubular cells: 60.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basophil: 5.4;myeloid DC: 6.0;NK-cell: 11.7" "Group enriched" "Detected in many" 5 "dendritic cells: 6.0;granulocytes: 5.4;NK-cells: 11.7" "Cell line enhanced" "Detected in some" "HEK 293: 43.6;PC-3: 15.2;RPTEC TERT1: 15.0;SCLC-21H: 40.5;U-937: 14.5" "HPA061982, HPA076200" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA061982: AB_2684651, HPA076200: " "unprognostic (4.72e-1)" "unprognostic (1.23e-2)" "unprognostic (2.86e-1)" "unprognostic (5.24e-3)" "unprognostic (2.36e-1)" "unprognostic (2.02e-1)" "unprognostic (8.35e-2)" "unprognostic (8.44e-3)" "unprognostic (5.50e-2)" "unprognostic (5.71e-2)" "unprognostic (9.87e-3)" "unprognostic (4.42e-2)" "unprognostic (2.80e-3)" "unprognostic (6.45e-2)" "unprognostic (7.58e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" 3.2 3.4 0.2 8.8 0.1 2.4 8.7 0.1 0.2 15.5 12.8 0.2 4.1 0.0 10.4 16.8 1.4 12.2 0.3 0.1 0.1 0.0 35.1 0.1 0.8 0.7 0.1 0.1 2.0 0.1 0.0 0.1 1.4 0.4 16.6 4.5 0.2 0.5 5.6 21.0 13.3 8.2 13.1 0.7 1.0 0.0 2.4 0.1 2.6 0.3 0.3 0.3 16.2 11.4 0.5 6.0 5.4 1.0 11.7 1.5 0.5 12.7 0.0 0.0 6.4 2.1 1.6 0.0 5.1 4.1 0.4 0.4 0.8 0.5 0.1 0.5 2.7 0.0 11.9 8.2 0.0 0.4 0.0 43.6 0.1 0.3 0.0 0.2 0.0 0.1 2.2 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 15.2 2.7 0.0 0.0 15.0 0.2 40.5 0.0 5.4 0.0 0.1 0.2 0.0 10.7 0.4 0.0 4.0 4.9 0.0 0.0 0.0 0.0 0.0 14.5 0.0 5.4 1.0 0.0 1.5 0.2 0.2 0.2 0.0 0.1 6.0 0.5 0.3 0.1 0.9 11.7 0.4 1.9 0.2 0.5 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.8 10.6 22.2 0.0 0.6 0.0 0.0 0.0 17.4 0.0 0.3 46.4 0.0 0.0 0.2 7.9 0.0 0.0 0.3 10.8 14.2 0.0 0.0 0.3 0.0 37.7 0.0 4.8 0.0 0.0 1.6 5.0 0.0 19.1 0.0 0.0 18.4 0.0 60.8 0.0 0.0 3.6 0.0 0.6 24.1 0.2 4.4 19.4 11.5 HOXB13 ENSG00000159184 "Homeobox B13" Q92826 17 48724763-48729178 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 18.6;prostate: 38.3" "Cell type enhanced" "Detected in some" 17 "Glandular cells: 62.7;Intestinal endocrine cells: 187.8;Mucus-secreting cells: 92.1;Paneth cells: 66.2;Undifferentiated cells: 64.4" "Cancer enriched" "Detected in many" 17 "prostate cancer: 187.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.3" "Cell line enriched" "Detected in some" 13 "PC-3: 59.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004438, HPA062852, HPA065019" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004438: AB_627744, HPA062852: AB_2684880, HPA065019: AB_2685406" "unprognostic (4.81e-2)" "unprognostic (2.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.33e-2)" "unprognostic (5.85e-3)" "unprognostic (1.88e-2)" "unprognostic (1.19e-2)" "unprognostic (3.19e-2)" "unprognostic (1.17e-2)" "unprognostic (6.65e-2)" "unprognostic (1.74e-1)" "unprognostic (4.27e-2)" "unprognostic (4.73e-11)" "unprognostic (1.39e-2)" "unprognostic (4.50e-2)" "unprognostic (1.12e-1)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 2.4 10.8 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.4 0.1 38.3 18.6 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 3.6 2.4 0.1 0.2 1.3 0.1 0.1 0.1 0.0 0.6 2.0 0.0 4.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.9 1.0 0.0 1.0 0.0 0.5 0.0 3.0 0.0 0.0 0.3 1.4 0.9 0.6 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.7 59.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.9 0.0 1.4 0.2 0.0 0.2 0.0 0.2 1.7 1.7 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 37.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 40.4 0.0 0.0 0.2 0.3 62.7 0.0 0.0 0.1 0.0 187.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 92.1 0.0 0.0 66.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 64.4 6.4 HOXB2 "HOX2, HOX2H" ENSG00000173917 "Homeobox B2" P14652 17 48540894-48544989 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 53.1" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 50.6;Distal tubular cells: 132.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 6 "pons and medulla: 12.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 21.0;EFO-21: 20.3;HEK 293: 23.0;HMC-1: 45.9;WM-115: 20.1" "Region enriched" "Detected in single" 34 "pons and medulla: 4.7" "Region enriched" "Detected in single" 29 "pons and medulla: 5.4" HPA047857 Supported Nucleoplasm NA NA Nucleoplasm "HPA047857: AB_2680184" "unprognostic (8.58e-3)" "unprognostic (4.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (3.16e-1)" "unprognostic (2.12e-2)" "unprognostic (7.72e-2)" "unprognostic (3.57e-1)" "unprognostic (1.75e-2)" "unprognostic (2.60e-1)" "unprognostic (3.24e-1)" "unprognostic (3.04e-3)" "unprognostic (4.12e-1)" "unprognostic (5.75e-2)" "unprognostic (5.29e-2)" "unprognostic (2.89e-1)" 9.2 11.0 0.2 6.3 0.3 1.9 24.2 0.3 0.2 14.5 15.4 0.4 53.1 2.4 6.9 32.5 19.3 12.2 12.8 4.5 0.5 0.1 25.6 2.8 6.4 4.4 2.0 0.3 6.4 1.6 8.9 0.9 1.7 12.9 8.2 1.7 0.8 0.6 33.2 6.1 3.7 6.4 7.5 19.4 6.8 6.7 2.7 0.2 2.4 3.0 3.9 2.6 7.9 16.3 0.8 6.0 5.0 0.4 2.2 9.5 1.3 0.0 0.7 21.0 0.0 4.8 5.6 0.0 1.9 0.0 0.0 0.0 0.3 0.1 0.0 20.3 5.8 0.0 0.0 3.1 0.0 0.0 0.1 23.0 7.9 0.8 0.0 8.5 0.0 45.9 3.5 0.0 9.1 3.6 0.2 3.3 0.0 15.5 0.0 12.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 10.4 0.0 15.0 1.8 0.0 0.0 1.5 0.0 12.0 1.5 11.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.0 0.0 8.2 0.0 20.1 5.0 0.4 0.0 4.2 0.4 1.3 0.2 6.2 4.7 1.9 0.8 9.5 3.9 0.0 2.2 0.3 6.0 7.3 1.3 0.2 0.3 0.3 0.2 0.5 0.1 2.0 0.3 12.9 0.2 3.0 1.4 5.2 6.2 6.3 0.0 0.8 0.0 1.4 2.3 50.6 0.0 14.4 132.6 0.8 0.6 5.6 0.0 0.0 0.2 23.9 18.1 7.9 20.7 0.0 6.8 0.0 2.4 21.5 12.6 0.9 0.0 11.9 11.8 6.4 1.3 0.0 0.1 1.1 0.0 17.2 0.0 0.0 30.9 1.7 6.8 5.0 20.8 27.4 0.7 21.3 HOXB3 "HOX2, HOX2G" ENSG00000120093 "Homeobox B3" P14651 17 48548870-48604912 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 56.7;epididymis: 44.9;seminal vesicle: 68.4" "Group enriched" "Detected in many" 5 "Collecting duct cells: 94.2;Early spermatids: 27.9;Ito cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.7;EFO-21: 18.1;HEK 293: 21.9;RPTEC TERT1: 17.0;U-251 MG: 19.5" "Region enriched" "Detected in single" 40 "pons and medulla: 9.3" "Region enriched" "Detected in single" 29 "pons and medulla: 12.9" "CAB009860, HPA064990" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009860: AB_2119262, HPA064990: AB_2685398" "unprognostic (5.88e-2)" "unprognostic (1.01e-1)" "unprognostic (5.61e-2)" "unprognostic (7.04e-2)" "unprognostic (8.39e-3)" "unprognostic (1.72e-1)" "unprognostic (1.52e-1)" "unprognostic (2.88e-2)" "unprognostic (3.09e-2)" "unprognostic (4.32e-3)" "unprognostic (8.14e-2)" "unprognostic (8.27e-2)" "unprognostic (3.17e-1)" "unprognostic (7.60e-2)" "unprognostic (7.85e-2)" "unprognostic (2.32e-1)" "prognostic favorable (8.45e-6)" 8.3 4.5 1.0 7.3 1.1 0.2 8.0 1.0 1.0 11.3 16.4 1.0 56.7 2.3 10.1 44.9 5.5 17.7 3.6 1.7 1.0 0.0 16.3 1.6 4.8 1.6 1.0 1.0 2.8 1.7 6.7 1.0 3.8 2.6 4.1 4.9 1.0 1.0 68.4 4.0 2.9 11.3 3.5 4.8 6.5 7.8 3.7 1.0 1.0 1.8 1.0 1.1 6.4 5.2 0.1 2.8 1.7 0.9 1.4 1.1 0.4 3.3 7.0 4.7 2.2 3.9 5.5 1.2 0.1 0.0 0.1 0.1 3.2 20.7 1.7 18.1 14.8 2.3 0.1 1.0 0.3 0.0 5.3 21.9 5.1 3.1 0.0 6.4 0.0 13.6 6.4 0.0 6.1 0.4 2.8 6.4 6.7 6.9 0.1 3.8 0.1 0.3 0.1 0.1 6.7 0.7 0.0 3.4 0.7 17.0 3.1 0.0 0.0 0.7 0.0 3.3 3.8 6.6 1.4 7.2 2.2 7.1 1.2 19.5 1.8 2.1 0.1 4.6 0.0 3.8 1.7 0.1 0.0 0.9 0.1 0.4 0.0 0.5 1.1 0.3 0.1 0.8 1.0 0.0 1.4 0.9 2.8 1.1 0.4 1.0 1.1 1.0 1.0 1.0 0.0 1.0 1.0 2.6 1.0 0.0 3.4 0.0 2.3 2.3 0.0 0.8 0.0 0.0 1.2 94.2 0.0 2.5 6.6 0.2 27.9 7.7 7.4 0.0 0.0 0.7 5.1 3.6 8.1 0.2 0.6 0.0 2.4 27.6 2.1 7.9 0.3 1.0 5.0 0.0 6.3 0.0 0.4 3.5 0.4 0.6 0.0 0.0 3.3 4.5 9.2 1.3 0.3 1.3 9.7 4.7 HOXB8 "HOX2, HOX2D" ENSG00000120068 "Homeobox B8" P17481 17 48611377-48614939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6" "Group enriched" "Detected in some" 7 "Collecting duct cells: 83.7;Distal tubular cells: 61.3;Intestinal endocrine cells: 42.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 33.3" "Region enriched" "Detected in single" 82 "pons and medulla: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 20.9;HDLM-2: 9.4;HEK 293: 21.6;LHCN-M2: 11.0;RPTEC TERT1: 23.0" "Region enriched" "Detected in single" 48 "pons and medulla: 6.8" "Low region specificity" "Detected in many" HPA075905 Supported Nucleoplasm NA NA Nucleoplasm "HPA075905: AB_2686767" "unprognostic (4.44e-1)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (2.13e-1)" "unprognostic (1.94e-2)" "unprognostic (9.07e-5)" "unprognostic (6.63e-3)" "unprognostic (1.40e-3)" "unprognostic (6.00e-2)" "unprognostic (5.66e-3)" "unprognostic (2.93e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.30e-7)" "unprognostic (1.77e-2)" "unprognostic (6.64e-2)" "unprognostic (4.57e-2)" "unprognostic (2.88e-3)" 3.5 4.3 0.0 1.6 0.0 0.0 2.5 0.0 0.0 7.7 2.1 0.0 45.4 0.0 2.1 39.2 0.0 0.9 0.0 0.0 0.0 0.0 16.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.4 0.2 0.2 8.2 1.9 0.8 0.0 0.1 34.6 0.2 0.4 4.0 1.1 49.3 0.0 4.3 2.8 0.0 0.1 0.1 0.0 0.0 5.0 6.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.1 3.3 0.0 0.4 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 20.9 3.3 0.4 0.0 0.0 0.0 0.0 9.4 21.6 0.5 0.0 0.0 0.2 0.0 3.1 0.6 0.0 0.0 0.0 0.4 1.4 0.1 6.2 0.0 11.0 0.0 0.0 0.2 0.0 7.0 0.0 0.0 2.1 0.0 23.0 0.6 0.0 0.0 0.3 0.0 3.1 0.0 0.2 0.0 5.2 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 83.7 0.0 0.0 61.3 0.0 0.1 0.5 1.3 0.0 0.0 0.7 0.4 0.2 0.0 0.0 0.2 0.0 42.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.3 0.5 9.6 0.0 0.0 0.0 4.1 0.0 HOXB9 "HOX2, HOX2E" ENSG00000170689 "Homeobox B9" P17482 17 48621159-48626356 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 27.3;epididymis: 42.8;intestine: 16.6;kidney: 15.3;seminal vesicle: 23.5" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 55.8;Distal tubular cells: 33.2;Intestinal endocrine cells: 169.5;Mucus-secreting cells: 37.2;Undifferentiated cells: 43.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 79.2;HEK 293: 30.5;HMC-1: 31.3;K-562: 33.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA004928 Supported Nucleoplasm NA No Nucleoplasm "HPA004928: " "unprognostic (2.16e-2)" "unprognostic (1.46e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (4.47e-4)" "unprognostic (1.38e-4)" "prognostic unfavorable (6.64e-5)" "unprognostic (3.15e-2)" "unprognostic (1.60e-3)" "unprognostic (6.30e-3)" "unprognostic (3.41e-2)" "unprognostic (5.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.28e-3)" "unprognostic (1.43e-1)" "unprognostic (5.34e-2)" "unprognostic (1.85e-1)" "unprognostic (6.00e-2)" 0.5 0.8 0.1 1.9 0.2 0.0 0.4 0.1 0.3 5.3 16.6 0.1 27.3 0.0 1.4 42.8 0.1 0.4 0.1 0.1 0.1 0.1 15.3 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.4 0.3 0.5 0.2 1.1 10.4 0.1 0.1 23.5 0.2 0.2 11.3 1.0 3.5 0.2 0.2 2.0 0.1 0.1 0.1 0.1 0.1 2.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 4.1 1.4 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 1.7 0.0 8.5 0.2 0.9 0.0 1.3 0.0 0.0 79.2 30.5 13.8 0.5 0.0 0.5 0.2 31.3 0.0 0.0 0.0 0.8 2.4 0.0 0.6 33.6 0.0 1.3 0.0 0.0 0.1 0.0 1.8 1.3 0.0 5.3 0.4 13.8 0.0 0.0 0.0 1.0 0.0 8.7 0.1 0.1 0.0 0.1 0.0 7.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 55.8 0.0 0.0 33.2 0.0 0.1 0.2 12.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 169.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 37.2 0.0 0.1 11.5 0.0 0.7 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.0 43.2 0.1 HOXC4 "HOX3, HOX3E" ENSG00000198353 "Homeobox C4" P09017 12 54016931-54056030 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.7;ovary: 31.6" "Cell type enhanced" "Detected in some" 12 "Early spermatids: 3.5;Leydig cells: 2.8;Proximal tubular cells: 2.4;Sertoli cells: 6.5;Spermatocytes: 2.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 27 "pons and medulla: 29.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 14.1;HDLM-2: 18.1;HEK 293: 19.9;SH-SY5Y: 16.9" "Region enriched" "Detected in single" 24 "pons and medulla: 9.9" "Region enriched" "Detected in single" 13 "pons and medulla: 3.7" HPA053910 Supported Nucleoplasm NA NA Nucleoplasm "HPA053910: AB_2682305" "unprognostic (2.78e-2)" "unprognostic (8.51e-2)" "unprognostic (2.96e-6)" "unprognostic (3.30e-2)" "unprognostic (6.27e-2)" "unprognostic (1.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.63e-3)" "unprognostic (6.42e-2)" "unprognostic (1.42e-1)" "unprognostic (8.83e-3)" "unprognostic (4.37e-2)" "unprognostic (7.81e-2)" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (2.11e-4)" "unprognostic (9.82e-2)" 16.2 4.4 0.7 3.2 0.7 0.0 17.9 0.7 0.7 1.3 2.3 0.6 1.4 0.9 11.5 17.8 6.0 20.9 1.0 1.0 0.7 0.7 15.4 0.8 0.9 3.2 1.1 0.0 31.6 0.7 0.0 0.7 5.8 29.7 2.4 0.0 0.3 0.7 1.3 8.1 4.2 9.2 4.4 10.5 1.2 2.6 8.3 0.9 0.0 1.0 0.0 1.8 2.1 3.4 1.1 0.5 0.0 0.0 0.0 1.1 0.0 3.0 3.1 0.0 14.1 5.9 3.0 0.0 1.4 1.5 1.4 1.0 0.1 2.6 12.2 0.1 10.7 0.0 2.7 0.2 0.3 0.9 18.1 19.9 0.1 1.4 0.0 0.7 1.4 0.4 7.8 1.4 8.5 1.4 0.0 0.2 4.0 0.6 0.0 5.4 0.1 1.7 0.3 0.1 0.5 0.0 3.9 4.5 0.0 6.1 0.0 0.0 16.9 2.2 0.7 7.9 0.7 10.6 0.7 0.0 7.4 4.2 0.6 7.5 3.2 3.5 6.3 0.4 1.3 7.7 0.0 0.0 0.0 0.8 0.0 0.8 1.1 0.0 0.8 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.5 0.6 0.0 0.7 0.7 0.7 0.7 0.7 0.7 1.1 0.0 29.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 1.8 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 2.4 0.0 6.5 0.0 2.8 0.4 0.0 0.2 0.7 0.0 0.0 HOXC9 "HOX3, HOX3B" ENSG00000180806 "Homeobox C9" P31274 12 53994895-54003337 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 18.9;skeletal muscle: 28.3" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 34.9;Fibroblasts: 20.8;Melanocytes: 37.1;Proximal tubular cells: 16.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 14.7;HDLM-2: 18.7;HEK 293: 22.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063965, HPA072160" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063965: AB_2685162, HPA072160: AB_2686491" "unprognostic (2.38e-1)" "unprognostic (1.03e-1)" "unprognostic (3.19e-5)" "unprognostic (1.23e-1)" "unprognostic (4.09e-3)" "unprognostic (7.12e-2)" "unprognostic (6.92e-3)" "unprognostic (1.06e-3)" "unprognostic (4.32e-1)" "unprognostic (1.58e-2)" "unprognostic (7.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.01e-1)" "unprognostic (2.74e-2)" "unprognostic (1.53e-1)" 18.9 2.5 0.0 1.2 0.0 0.1 12.8 0.0 0.1 0.5 0.2 0.0 0.4 0.1 1.7 7.8 0.3 6.3 0.1 0.1 0.0 0.0 12.2 0.1 0.1 4.3 0.0 0.0 5.6 1.0 0.1 0.0 2.0 0.0 0.9 0.1 0.0 0.5 0.2 28.3 5.7 4.4 1.2 0.5 0.1 0.1 4.3 0.0 0.1 0.2 0.2 0.3 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 2.2 0.0 14.7 5.9 4.9 1.0 1.5 1.4 1.9 1.3 0.6 2.2 0.0 1.1 5.8 0.3 2.6 0.3 1.5 1.7 18.7 22.8 0.4 3.3 0.5 0.6 0.0 3.4 5.5 2.5 2.8 1.3 0.0 1.8 0.1 4.6 0.0 3.9 1.6 0.0 1.3 0.0 1.1 0.2 0.2 2.8 0.0 4.4 1.4 0.0 4.3 5.3 2.8 5.8 0.4 4.4 0.2 0.0 3.5 6.3 1.0 1.8 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.3 34.9 0.0 3.4 0.1 0.0 0.0 0.3 10.4 20.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.6 4.4 0.3 37.1 0.0 0.0 0.0 0.3 0.0 7.4 16.7 0.0 6.5 2.5 7.6 8.9 8.3 0.3 0.0 0.0 0.0 HOXD1 "HOX4, HOX4G" ENSG00000128645 "Homeobox D1" Q9GZZ0 2 176188579-176190907 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9;epididymis: 14.1;seminal vesicle: 20.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 21.0;Distal tubular cells: 21.6;Enterocytes: 18.8;Mucus-secreting cells: 16.6;Undifferentiated cells: 20.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 6.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.9;Hep G2: 6.0;RPTEC TERT1: 18.8;RT4: 14.4;SCLC-21H: 5.0" "Region enriched" "Detected in single" 5 "pons and medulla: 1.2" "Low region specificity" "Detected in many" "HPA040062, HPA056900" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040062: AB_2676826, HPA056900: AB_2683270" "unprognostic (8.78e-2)" "unprognostic (9.97e-2)" "unprognostic (7.11e-3)" "unprognostic (1.06e-3)" "unprognostic (2.70e-1)" "unprognostic (3.19e-2)" "unprognostic (7.33e-2)" "unprognostic (4.10e-2)" "unprognostic (2.85e-1)" "unprognostic (2.44e-1)" "unprognostic (9.64e-2)" "unprognostic (4.02e-1)" "unprognostic (1.54e-5)" "unprognostic (4.33e-3)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" 2.4 0.6 1.5 1.1 3.5 0.3 2.0 0.6 3.9 0.5 5.2 18.8 11.8 0.7 0.8 14.1 0.9 8.8 1.4 0.3 4.1 2.2 6.8 0.2 5.7 0.9 9.8 1.3 1.2 0.5 0.2 0.2 0.3 15.5 1.7 3.7 0.3 1.0 20.4 0.3 1.2 4.4 0.9 18.9 1.5 0.7 2.2 6.3 0.0 0.4 0.0 0.5 4.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 5.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 18.8 14.4 5.0 0.9 0.0 0.0 0.9 0.8 0.0 0.0 3.3 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.5 0.6 3.2 4.1 2.2 9.8 1.3 15.5 6.3 3.0 21.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 4.5 7.0 0.0 0.0 21.6 0.0 0.0 2.9 18.8 0.0 0.0 0.0 0.1 0.5 2.3 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 3.3 0.0 16.6 0.0 0.1 11.5 0.4 2.9 0.0 0.0 0.1 2.6 6.4 2.3 0.0 0.0 20.6 1.8 HOXD11 "HOX4, HOX4F" ENSG00000128713 "Homeobox D11" P31277 2 176104216-176109754 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 15.8" "Group enriched" "Detected in some" 4 "Basal glandular cells: 21.0;Collecting duct cells: 21.0;Distal tubular cells: 8.3;Glandular cells: 6.3;Intestinal endocrine cells: 19.9;Mucus-secreting cells: 8.7;Undifferentiated cells: 6.0;Urothelial cells: 11.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 20.8;RPTEC TERT1: 2.6;SCLC-21H: 6.3;SiHa: 2.5;U-251 MG: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA055155 Supported Nucleoplasm NA NA Nucleoplasm "HPA055155: AB_2682719" "unprognostic (1.99e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (9.05e-2)" "unprognostic (1.85e-3)" "unprognostic (2.48e-1)" "unprognostic (1.93e-2)" "unprognostic (2.13e-2)" "unprognostic (6.73e-2)" "unprognostic (5.00e-2)" "unprognostic (2.11e-8)" "unprognostic (2.09e-3)" "unprognostic (2.49e-2)" "unprognostic (2.27e-3)" 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 5.4 4.2 0.0 0.0 0.0 15.8 0.4 0.3 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.6 0.3 5.7 0.9 0.0 0.0 2.9 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 1.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 1.3 0.0 0.0 0.1 0.0 20.8 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 6.3 0.3 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 21.0 0.3 0.0 0.2 0.0 0.0 0.0 21.0 0.0 0.0 8.3 0.0 0.0 0.2 1.0 0.0 0.0 0.1 0.9 6.3 0.0 0.0 0.3 0.0 19.9 0.0 0.0 0.0 0.9 0.0 1.7 0.0 8.7 0.0 0.1 2.9 1.1 0.2 0.0 0.0 0.1 0.0 0.3 0.6 0.0 0.0 6.0 11.2 HOXD13 "HOX4I, SPD" ENSG00000128714 "Homeobox D13" P35453 2 176092891-176095938 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 14.0;intestine: 13.1;prostate: 13.8;seminal vesicle: 19.0;vagina: 15.0" "Cell type enhanced" "Detected in some" 20 "Basal glandular cells: 10.8;Intestinal endocrine cells: 28.0;Mucus-secreting cells: 11.6;Undifferentiated cells: 8.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 9.8;HEK 293: 28.1;HL-60: 31.2;JURKAT: 8.8;NB-4: 18.6;SCLC-21H: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA064064 Approved Nucleoplasm NA NA Nucleoplasm "HPA064064: AB_2685186" "unprognostic (2.04e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.95e-5)" "unprognostic (2.52e-3)" "unprognostic (7.25e-2)" "unprognostic (2.08e-2)" "unprognostic (4.62e-2)" "unprognostic (1.77e-1)" "unprognostic (4.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.82e-4)" "unprognostic (4.95e-2)" "unprognostic (3.70e-2)" "unprognostic (9.98e-3)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 14.0 13.1 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 13.8 8.8 0.1 0.1 19.0 0.6 0.0 0.1 3.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 3.8 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 1.2 2.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 9.8 0.0 1.5 0.0 28.1 4.2 0.0 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 2.0 0.0 0.0 0.0 0.0 18.6 1.0 0.0 1.5 0.0 0.1 0.0 0.0 0.2 8.2 2.0 1.9 0.0 4.5 0.1 0.0 0.0 0.0 1.0 0.0 0.4 2.6 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 10.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 8.3 5.5 HR "ALUNC, AU" ENSG00000168453 "HR, lysine demethylase and nuclear receptor corepressor" O43593 8 22114415-22133384 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Oxidoreductase" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 50.5;tongue: 23.8" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 93.6;Cone photoreceptor cells: 31.4;Paneth cells: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.9;HaCaT: 38.1;OE19: 18.4;SiHa: 13.2;T-47d: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054888 Supported Nucleoplasm NA NA Nucleoplasm "HPA054888: AB_2682630" "unprognostic (9.11e-2)" "unprognostic (2.12e-2)" "unprognostic (7.32e-2)" "unprognostic (4.68e-3)" "unprognostic (6.49e-2)" "unprognostic (2.80e-1)" "unprognostic (1.53e-2)" "unprognostic (2.45e-1)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" "unprognostic (1.75e-1)" "unprognostic (2.27e-2)" "unprognostic (8.00e-3)" "unprognostic (1.81e-1)" "unprognostic (2.32e-1)" "unprognostic (2.28e-2)" 2.6 1.8 3.8 3.2 6.1 0.8 4.7 19.8 17.0 2.1 7.5 9.6 0.1 5.5 1.5 0.9 12.1 1.9 6.7 1.9 5.3 4.0 0.9 0.8 1.2 1.0 6.1 6.8 0.8 1.3 0.7 1.7 0.9 4.9 2.3 4.0 6.7 3.4 5.4 1.1 50.5 5.3 2.3 3.8 1.1 8.4 5.2 6.6 0.0 2.6 23.8 4.4 3.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 9.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 9.8 0.7 0.5 38.1 0.0 0.9 0.0 0.0 0.0 0.0 8.0 0.0 2.2 0.0 0.0 1.9 6.2 0.0 0.6 0.6 0.0 1.0 0.0 0.1 0.0 5.7 0.6 0.1 0.0 18.4 7.6 0.8 0.0 0.2 0.1 2.6 0.4 2.2 13.2 3.0 3.0 0.1 14.1 0.0 0.0 0.2 8.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 6.1 19.8 17.0 5.3 4.0 6.1 6.8 4.9 6.6 0.0 0.0 0.0 4.2 10.6 93.6 2.4 0.0 0.0 0.0 1.8 31.4 0.0 0.0 0.1 0.1 0.4 16.7 0.0 0.6 0.1 1.3 2.3 0.0 0.0 0.0 9.5 7.5 0.6 0.0 1.1 3.1 0.0 20.3 0.0 10.4 3.9 0.2 28.1 6.7 0.0 6.6 0.0 5.1 0.0 0.3 15.6 0.7 0.0 12.0 3.9 HRCT1 "LGLL338, PRO537, UNQ338" ENSG00000196196 "Histidine rich carboxyl terminus 1" Q6UXD1 9 35906192-35907141 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 25.3" "Cell type enhanced" "Detected in many" 22 "Enterocytes: 63.2;Mucus-secreting cells: 49.5;Paneth cells: 238.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 13.8;HBEC3-KT: 7.6;HeLa: 11.3;Hep G2: 8.5;U-2197: 20.4;U-251 MG: 9.5" "Low region specificity" "Detected in all" HPA067038 Approved Nucleoplasm NA NA Nucleoplasm "HPA067038: AB_2685767" "unprognostic (2.48e-2)" "unprognostic (4.88e-2)" "unprognostic (2.43e-2)" "unprognostic (2.49e-1)" "unprognostic (5.69e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (6.63e-2)" "unprognostic (2.53e-2)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.80e-1)" "unprognostic (1.18e-1)" "unprognostic (2.00e-1)" "unprognostic (9.41e-2)" "unprognostic (2.80e-1)" "unprognostic (9.43e-2)" 25.3 1.9 1.9 3.6 2.8 0.4 21.4 0.9 3.4 5.3 16.8 1.8 1.4 11.2 4.2 3.9 6.6 3.5 2.1 7.6 2.6 1.6 17.6 1.8 5.2 5.0 2.4 2.3 2.2 1.6 0.3 0.7 4.7 3.6 3.6 14.8 5.8 4.6 4.0 6.1 4.2 14.3 6.5 1.5 0.8 2.5 5.3 1.4 0.0 3.5 1.2 1.5 4.6 3.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.6 4.6 0.0 0.2 0.4 0.1 0.0 0.1 1.2 0.0 13.8 0.3 2.6 0.0 0.0 7.6 0.0 0.0 0.0 0.0 11.3 8.5 1.8 0.0 0.0 4.5 3.9 1.5 0.9 0.6 4.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 3.5 1.8 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 3.9 0.2 4.1 20.4 9.5 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.8 0.9 3.4 2.6 1.6 2.4 2.3 3.6 1.4 6.0 1.0 0.0 0.4 1.9 1.5 0.6 2.5 1.4 3.4 0.0 0.0 20.6 1.7 0.8 0.0 21.2 63.2 0.0 0.2 6.6 4.2 0.6 0.0 0.4 1.6 0.0 1.2 35.0 0.8 0.0 10.0 0.9 1.7 0.0 49.5 7.5 2.7 238.4 8.9 9.3 2.6 12.9 4.6 0.0 0.2 1.6 2.2 0.0 18.6 0.1 HS6ST1 HS6ST ENSG00000136720 "Heparan sulfate 6-O-sulfotransferase 1" O60243 2 128236716-128318577 "Disease related genes, Predicted intracellular proteins" Transferase "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 71.5;granulocytes: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 39.5;HMC-1: 62.8;SCLC-21H: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044586 Approved Nucleoplasm "Intracellular and membrane" NA NA 27000 Nucleoplasm "HPA044586: AB_10963057" "unprognostic (9.94e-2)" "unprognostic (8.93e-3)" "unprognostic (4.94e-3)" "unprognostic (6.69e-3)" "unprognostic (1.99e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (4.28e-2)" "unprognostic (1.21e-2)" "unprognostic (2.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" 13.2 32.0 22.4 8.0 16.2 4.1 9.2 17.2 33.2 16.2 9.6 13.5 23.8 8.3 8.8 6.4 19.3 17.1 20.1 8.1 17.3 13.9 22.8 29.5 9.1 7.1 17.8 18.8 16.2 24.2 8.9 7.5 11.5 16.5 13.1 6.9 10.5 12.2 23.9 20.1 14.2 11.3 6.4 14.9 18.2 6.3 14.7 15.6 10.9 7.0 6.7 8.0 19.1 11.1 2.0 5.5 5.8 3.0 0.5 2.6 1.2 3.5 5.2 14.0 8.0 5.4 10.2 7.5 4.4 5.7 4.5 2.5 2.6 2.4 3.5 39.5 5.7 2.1 9.6 5.3 8.7 1.7 5.7 5.4 3.0 1.9 25.6 6.6 5.3 62.8 13.7 10.3 3.6 1.1 1.5 2.4 9.5 1.9 3.6 1.6 7.5 14.1 23.5 16.7 1.4 3.2 4.6 3.8 18.0 4.1 10.8 34.4 8.6 3.6 9.1 2.0 9.8 3.7 2.0 2.8 4.0 8.9 14.8 3.5 2.1 2.1 0.7 2.4 3.8 2.9 5.8 1.6 1.4 2.6 1.0 0.4 1.9 1.0 1.6 1.1 2.0 1.0 1.0 0.5 0.5 3.0 5.5 0.5 1.2 22.4 16.2 17.2 33.2 17.3 13.9 17.8 18.8 16.5 15.6 23.8 12.8 5.2 10.5 14.3 8.1 6.1 7.6 10.7 9.1 71.5 29.5 7.4 5.0 10.2 0.8 7.7 7.1 0.0 5.1 34.4 11.6 6.8 54.4 15.1 8.6 20.6 2.9 30.7 11.7 2.0 10.9 6.2 6.8 6.4 5.2 7.8 7.9 8.2 15.9 2.8 33.7 6.5 5.1 1.1 3.1 14.9 19.5 2.5 4.1 7.8 HS6ST2 ENSG00000171004 "Heparan sulfate 6-O-sulfotransferase 2" Q96MM7 X 132626016-132961395 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5;kidney: 17.3;ovary: 18.2" "Cell type enhanced" "Detected in some" 16 "Cytotrophoblasts: 31.0;Leydig cells: 58.1;Peritubular cells: 33.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 29.5" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Lineage enhanced" "Detected in single" "NK-cells: 1.8" "Cell line enhanced" "Detected in some" "HEK 293: 19.6;HeLa: 13.3;RH-30: 28.4;RT4: 14.1;SH-SY5Y: 35.5" "Low region specificity" "Detected in all" "HPA034625, HPA034626" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA034625: AB_10612119, HPA034626: AB_2674252" "unprognostic (7.62e-3)" "unprognostic (4.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.41e-1)" "unprognostic (3.24e-1)" "unprognostic (5.54e-2)" "unprognostic (1.44e-1)" "unprognostic (1.71e-2)" "unprognostic (1.14e-2)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-1)" "unprognostic (8.39e-5)" "unprognostic (1.36e-3)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.03e-4)" 0.4 3.2 6.5 0.9 29.5 0.1 2.6 3.0 6.7 1.0 0.8 0.8 0.6 0.3 4.5 3.2 5.0 2.5 0.5 0.4 4.1 9.1 17.3 0.2 1.0 0.3 3.5 0.9 18.2 6.5 0.1 1.3 9.9 3.3 5.4 1.2 0.0 1.1 1.6 6.7 0.3 0.2 2.0 3.3 0.2 1.1 7.9 0.7 0.7 0.6 1.7 2.7 2.3 0.6 0.0 0.0 0.0 0.0 1.8 0.6 0.0 4.3 0.0 6.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.1 0.0 0.0 6.5 0.0 0.0 0.2 9.2 0.0 0.0 0.0 19.6 0.0 13.3 0.0 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.2 0.1 0.0 5.0 3.0 0.2 0.0 28.4 0.0 5.7 14.1 0.7 35.5 6.2 0.0 0.0 10.7 0.0 0.0 0.0 0.0 1.1 4.1 9.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.5 29.5 3.0 5.8 4.1 9.1 3.5 0.9 3.3 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.0 13.4 7.9 3.5 0.0 31.0 5.0 0.0 0.4 0.4 0.0 0.0 1.6 1.3 2.2 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 58.1 0.0 0.0 0.0 0.0 5.3 1.2 0.0 33.2 0.0 0.0 0.0 0.3 0.2 1.2 0.3 14.5 0.0 0.0 0.2 HSBP1L1 "FLJ10967, MGC189743" ENSG00000226742 "Heat shock factor binding protein 1 like 1" C9JCN9 18 79964561-79970822 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "granulocytes: 17.0;T-cells: 17.4" "Cell line enhanced" "Detected in many" "HHSteC: 51.5;SK-MEL-30: 29.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA048273 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA048273: AB_2680337" "unprognostic (2.08e-1)" "unprognostic (2.14e-1)" "unprognostic (1.14e-2)" "unprognostic (5.85e-2)" "unprognostic (2.71e-2)" "unprognostic (3.70e-2)" "unprognostic (8.15e-3)" "unprognostic (8.86e-2)" "unprognostic (1.47e-1)" "unprognostic (1.16e-1)" "unprognostic (2.53e-3)" "unprognostic (7.41e-2)" "unprognostic (4.70e-2)" "unprognostic (1.67e-1)" "unprognostic (2.12e-1)" "unprognostic (8.28e-2)" "unprognostic (1.76e-2)" 7.2 15.4 10.7 4.8 9.9 2.9 18.2 15.2 13.3 10.9 16.3 3.0 14.2 6.9 7.0 11.5 14.4 9.3 8.3 5.8 11.4 7.8 15.2 37.9 11.1 3.8 9.4 5.9 5.7 21.2 8.3 8.2 11.0 15.5 8.9 13.0 8.9 18.5 19.9 12.4 12.1 5.6 6.3 7.1 5.3 10.5 2.1 9.7 0.7 15.2 14.3 6.4 6.6 9.7 1.8 2.0 17.0 4.2 3.1 17.4 3.9 9.1 2.2 0.0 0.1 1.3 4.5 3.9 4.4 9.5 4.4 3.8 4.6 6.0 0.0 1.1 5.3 0.0 5.2 8.0 5.1 1.9 9.3 2.1 0.0 2.3 2.2 51.5 0.0 0.0 5.1 14.4 0.4 3.2 9.2 0.1 1.3 0.0 0.0 0.2 7.4 0.0 0.0 0.0 5.1 9.8 0.1 0.0 0.0 15.6 2.0 0.1 0.4 4.7 5.8 29.1 0.4 3.3 2.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.0 2.4 0.1 17.0 4.2 5.2 3.8 2.7 4.6 1.5 6.6 4.1 1.7 1.8 17.4 9.3 0.2 3.1 0.9 2.0 2.9 3.9 10.7 9.9 15.2 13.3 11.4 7.8 9.4 5.9 15.5 9.7 50.6 25.1 0.9 60.6 35.3 8.5 11.5 38.2 46.8 43.3 47.1 21.6 106.1 58.0 53.9 0.9 19.8 71.4 23.3 54.4 55.1 20.9 68.1 18.5 107.1 37.6 19.1 11.1 22.7 19.6 0.7 18.4 16.9 37.1 1.0 74.8 21.2 100.9 96.8 23.0 57.9 28.4 0.0 11.6 1.4 0.6 50.6 98.2 12.5 87.5 81.2 HSF2 ENSG00000025156 "Heat shock transcription factor 2" Q03933 6 122399546-122433119 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatogonia: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016067, HPA031455" Approved Supported Nucleoplasm No No Nucleoplasm "CAB016067: AB_627754, HPA031455: AB_10670702" "unprognostic (1.62e-2)" "unprognostic (1.23e-1)" "unprognostic (1.55e-1)" "unprognostic (5.42e-2)" "unprognostic (2.27e-3)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.51e-6)" "unprognostic (3.40e-3)" "unprognostic (2.60e-1)" "unprognostic (2.58e-1)" "unprognostic (1.25e-3)" "unprognostic (3.03e-1)" "prognostic unfavorable (7.65e-4)" "unprognostic (9.27e-2)" "unprognostic (5.44e-2)" "unprognostic (1.89e-1)" "unprognostic (2.42e-1)" 9.6 13.7 9.0 6.7 14.7 20.6 11.4 17.8 19.4 12.7 9.3 9.9 9.2 6.3 14.4 9.8 8.7 11.1 6.9 20.3 9.2 11.3 6.4 4.9 7.7 11.5 9.7 15.5 14.3 5.9 13.5 18.5 7.3 18.0 10.4 6.5 9.7 7.7 12.1 37.9 10.2 7.8 12.6 9.2 8.5 8.5 31.7 9.3 14.3 8.3 15.9 10.7 13.1 8.6 6.6 3.8 4.0 4.2 7.0 21.3 7.7 4.3 4.5 23.6 19.2 10.6 8.5 6.6 7.8 18.6 14.3 22.5 6.7 3.7 16.6 6.8 9.7 16.6 5.5 15.7 7.5 20.2 16.7 19.1 16.2 4.4 13.8 10.8 11.9 8.3 10.7 11.5 11.8 13.6 13.4 8.6 15.2 17.3 8.3 13.5 5.8 19.5 15.6 7.2 6.4 6.5 18.1 9.6 5.3 10.8 4.9 25.2 16.9 8.1 6.6 7.5 18.2 5.7 13.1 5.1 7.8 9.0 8.6 11.7 12.1 11.5 21.2 8.4 7.9 10.1 3.4 2.7 4.0 8.5 3.2 9.1 6.6 8.1 7.4 3.8 5.4 21.3 16.0 0.4 7.0 4.2 2.6 8.8 7.7 9.0 14.7 17.8 19.4 9.2 11.3 9.7 15.5 18.0 9.3 17.9 9.3 5.2 10.6 28.2 20.9 21.0 5.1 22.7 12.5 0.0 25.5 13.0 10.0 6.1 46.7 10.5 2.4 0.0 3.7 6.2 14.4 6.6 8.1 4.3 6.7 20.6 6.3 6.2 4.5 14.0 9.5 7.3 18.6 1.8 5.7 13.8 4.2 4.3 9.2 6.1 32.6 25.8 13.7 42.8 81.2 22.5 2.6 11.4 4.6 5.8 HSPA12B "C20orf60, dJ1009E24.2" ENSG00000132622 "Heat shock protein family A (Hsp70) member 12B" Q96MM6 20 3732667-3753111 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 17 "Endothelial cells: 38.3;Ito cells: 12.3;Late spermatids: 10.5;Peritubular cells: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 11 "monocytes: 3.1" "Cell line enhanced" "Detected in some" "CACO-2: 6.4;EFO-21: 6.7;HUVEC TERT2: 12.8;TIME: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013659, HPA015639" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA013659: AB_1234541, HPA015639: AB_1851192" "unprognostic (1.00e-1)" "unprognostic (1.14e-1)" "unprognostic (1.30e-1)" "unprognostic (6.99e-2)" "unprognostic (4.53e-2)" "unprognostic (2.09e-1)" "unprognostic (1.21e-1)" "unprognostic (6.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.07e-2)" "unprognostic (6.45e-2)" "unprognostic (8.74e-2)" "unprognostic (2.61e-2)" "unprognostic (1.75e-2)" "unprognostic (1.47e-1)" "unprognostic (4.05e-1)" "unprognostic (1.66e-2)" 22.7 3.4 2.6 4.6 4.9 1.8 19.4 1.5 5.5 11.0 4.3 3.9 4.3 2.6 11.7 8.1 6.2 6.2 10.7 14.6 3.1 2.7 5.7 3.0 26.8 2.3 4.1 2.8 6.4 4.8 2.1 1.8 13.9 5.1 5.1 2.0 7.2 5.3 5.4 13.5 4.8 3.6 6.1 2.8 21.2 3.2 5.2 1.8 0.4 6.1 9.6 2.1 4.7 7.5 0.1 0.2 0.0 3.1 0.0 0.2 0.0 0.6 2.3 1.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 6.4 0.2 0.3 6.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.1 0.0 3.4 0.2 0.1 0.1 0.2 0.0 0.1 0.0 2.0 12.8 0.5 0.4 0.2 0.0 1.4 0.5 1.2 1.4 0.0 1.1 2.3 0.3 0.7 0.0 0.0 1.2 1.0 0.4 0.2 0.1 0.2 0.2 0.7 7.1 0.2 3.0 1.0 0.5 0.5 0.4 0.7 0.2 1.1 0.6 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 2.6 4.9 1.5 5.5 3.1 2.7 4.1 2.8 5.1 1.8 0.0 0.0 0.0 0.0 1.6 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.2 38.3 0.0 0.0 0.0 0.1 8.6 0.0 0.0 0.0 0.4 0.0 0.0 12.3 2.7 10.5 6.9 0.0 0.0 0.0 0.0 2.5 0.0 0.0 14.5 0.0 0.6 0.0 0.4 1.4 1.1 1.0 0.3 0.0 0.0 0.1 HSPB7 cvHSP ENSG00000173641 "Heat shock protein family B (small) member 7" Q9UBY9 1 16014028-16019594 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "heart muscle: 524.6;skeletal muscle: 551.1" "Cell type enriched" "Detected in many" 48 "Cardiomyocytes: 2261.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "fHDF/TERT166: 83.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA027639 Approved Approved Nucleoplasm NA NA 43000 Nucleoplasm "HPA027639: AB_10601756" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (1.28e-3)" "unprognostic (7.44e-3)" "unprognostic (8.35e-2)" "prognostic unfavorable (5.29e-4)" "unprognostic (1.02e-1)" "unprognostic (5.32e-2)" "unprognostic (2.47e-3)" "unprognostic (3.19e-3)" "unprognostic (6.94e-2)" "unprognostic (1.55e-1)" "unprognostic (1.20e-2)" "unprognostic (1.18e-2)" "unprognostic (1.51e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (1.26e-4)" 32.3 9.6 0.1 3.3 0.1 0.1 9.0 0.9 0.2 7.0 8.4 0.3 1.3 0.7 12.6 8.0 15.7 4.5 8.2 524.6 0.1 0.0 4.1 0.2 1.2 2.7 0.2 0.3 4.8 1.0 1.1 0.2 0.7 0.9 4.7 0.9 1.7 4.4 2.7 551.1 1.0 2.1 20.1 0.4 0.3 6.1 1.3 0.0 0.0 9.6 70.1 7.2 12.0 4.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 19.6 0.8 0.4 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 83.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.4 0.0 3.0 0.0 0.3 0.0 0.3 0.0 3.9 0.1 0.4 0.0 2.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.2 0.1 0.0 0.2 0.3 0.9 0.0 0.0 0.0 0.0 0.1 2.9 0.2 2261.8 0.0 0.0 0.0 3.5 0.0 2.4 11.6 1.1 29.5 0.7 0.0 0.0 0.2 1.4 11.2 0.3 0.0 0.0 1.4 1.6 0.0 0.0 0.0 47.4 13.3 0.3 0.0 0.0 0.0 3.0 0.0 0.0 6.3 0.0 0.4 0.0 43.4 1.7 1.0 2.3 2.7 0.0 0.0 0.1 HTATSF1 TAT-SF1 ENSG00000102241 "HIV-1 Tat specific factor 1" O43719 X 136497079-136512346 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000504 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000504: AB_10752094" "unprognostic (3.56e-2)" "prognostic favorable (3.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.56e-2)" "unprognostic (6.72e-2)" "unprognostic (3.70e-1)" "unprognostic (3.32e-3)" "unprognostic (3.27e-1)" "unprognostic (2.09e-2)" "unprognostic (1.49e-1)" "unprognostic (1.73e-2)" "unprognostic (3.37e-2)" "prognostic favorable (8.13e-8)" "unprognostic (7.12e-2)" "unprognostic (2.67e-2)" "unprognostic (2.25e-2)" "unprognostic (4.05e-1)" 14.5 40.9 26.2 11.8 24.7 18.3 19.6 29.5 22.2 15.2 13.4 19.4 12.9 9.6 15.9 24.7 12.3 14.5 11.5 25.2 23.8 29.9 17.5 12.7 10.4 12.1 26.9 17.6 25.5 10.9 25.6 71.7 21.2 21.4 15.1 14.2 11.9 10.6 16.6 72.2 13.6 9.8 14.4 28.1 10.2 12.4 15.8 19.0 14.5 19.4 22.6 13.3 12.7 12.9 17.1 14.1 19.2 16.1 23.6 24.9 13.1 42.0 22.5 28.5 20.2 21.3 16.1 25.2 19.5 17.4 16.7 16.3 13.3 18.9 31.6 47.5 18.9 19.4 18.2 34.5 14.6 21.7 24.1 29.3 19.7 28.5 16.3 11.8 37.0 16.0 14.2 19.1 18.3 11.3 11.7 16.9 47.6 18.1 23.4 21.4 31.3 36.8 31.9 16.4 37.9 33.5 29.1 35.5 28.8 17.9 29.8 20.2 31.4 18.5 15.5 15.3 25.2 11.5 26.7 16.3 20.4 15.4 23.1 34.9 13.7 18.8 26.3 13.0 52.9 14.3 19.2 10.1 16.4 21.9 10.5 24.4 17.1 24.1 22.2 14.1 15.9 24.9 22.2 3.4 23.6 16.1 10.3 24.0 13.1 26.2 24.7 29.5 22.2 23.8 29.9 26.9 17.6 21.4 19.0 47.6 40.5 17.9 31.9 26.3 49.7 142.2 15.3 58.9 68.2 47.1 9.8 79.5 41.4 30.5 4.9 27.0 20.7 0.0 29.6 57.8 33.4 28.5 33.5 20.4 33.5 39.7 77.9 10.4 19.3 9.9 41.7 26.7 30.4 26.2 34.6 55.0 26.0 14.0 50.5 24.8 43.9 45.3 33.5 21.8 87.9 23.2 97.7 40.6 29.3 30.6 HTR2B "5-HT(2B), 5-HT2B" ENSG00000135914 "5-hydroxytryptamine receptor 2B" P41595 2 231108230-231125118 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 26.0" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 3.9;Ito cells: 5.5;monocytes: 10.8;Peritubular cells: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 3.8;T-reg: 2.9" "Group enriched" "Detected in many" 29 "granulocytes: 3.8;T-cells: 2.9" "Group enriched" "Detected in some" 4 "HHSteC: 7.0;HSkMC: 13.3;SK-MEL-30: 24.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012867, HPA063658" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA012867: AB_1856710, HPA063658: AB_2685079" "unprognostic (1.86e-1)" "unprognostic (3.55e-2)" "unprognostic (1.20e-3)" "unprognostic (1.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.53e-2)" "unprognostic (1.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.15e-4)" "unprognostic (3.59e-1)" "unprognostic (2.17e-2)" "unprognostic (1.42e-3)" "unprognostic (7.44e-4)" "unprognostic (1.81e-1)" "unprognostic (1.17e-1)" "unprognostic (1.14e-2)" 2.3 17.9 0.2 5.8 0.3 0.7 4.1 0.3 0.6 17.8 7.3 0.2 1.7 1.0 14.9 9.5 5.7 1.9 0.8 4.6 0.3 0.3 5.6 2.5 1.8 0.5 0.3 0.4 4.3 0.3 0.3 0.4 26.0 0.9 2.6 1.5 1.8 0.5 1.0 0.2 0.2 6.3 12.8 0.3 0.4 5.2 3.3 0.3 2.4 6.8 1.0 0.4 4.9 0.8 0.0 0.1 3.8 0.0 0.0 2.9 0.0 0.1 0.2 0.0 0.1 0.4 3.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.0 0.1 0.3 13.3 0.0 0.0 0.0 0.0 2.5 1.1 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 24.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 2.9 0.0 0.2 0.3 0.3 0.6 0.3 0.3 0.3 0.4 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 2.7 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.9 2.6 1.6 0.0 5.5 1.2 0.0 0.6 0.0 0.0 10.8 0.0 0.0 0.1 0.0 4.9 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 IAH1 ENSG00000134330 "Isoamyl acetate hydrolyzing esterase 1 (putative)" Q2TAA2 2 9473658-9496543 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 336.0;Late spermatids: 365.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040523, HPA076040" Approved Approved Nucleoplasm NA NA 160000 Nucleoplasm "HPA040523: AB_2677021, HPA076040: " "unprognostic (1.51e-2)" "unprognostic (1.19e-2)" "unprognostic (1.27e-1)" "unprognostic (9.41e-2)" "unprognostic (9.35e-2)" "unprognostic (2.06e-2)" "unprognostic (5.40e-2)" "unprognostic (2.28e-2)" "unprognostic (2.98e-2)" "unprognostic (5.40e-2)" "unprognostic (7.39e-2)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.26e-1)" "unprognostic (1.44e-1)" "unprognostic (2.42e-2)" "unprognostic (3.91e-2)" 27.3 34.5 27.3 21.0 27.0 19.6 28.7 19.6 35.3 26.7 25.6 21.9 19.9 18.3 22.3 30.5 22.8 24.2 24.2 46.2 24.5 25.1 31.4 40.4 20.9 24.6 23.7 24.6 27.0 24.7 24.1 23.0 21.2 25.5 23.2 27.0 19.7 20.8 28.0 28.7 15.4 25.2 30.3 25.9 18.6 20.7 49.9 17.9 21.2 26.9 23.7 27.6 24.6 20.8 27.2 36.4 20.2 25.5 23.2 30.4 15.8 12.3 12.6 1.3 0.1 23.4 43.9 0.2 11.0 23.6 15.6 14.6 0.1 13.8 6.4 5.2 31.8 10.2 8.4 4.6 9.3 15.0 25.7 12.7 8.2 5.0 7.1 43.9 0.0 6.2 26.2 28.0 11.0 13.1 27.0 14.7 11.1 0.1 4.0 30.6 12.1 30.1 0.9 1.8 14.8 12.2 7.5 0.0 1.9 23.5 6.6 9.0 18.3 8.3 10.9 15.2 0.6 11.8 13.9 12.0 11.9 5.2 5.3 16.3 3.2 0.2 2.2 16.7 5.0 13.1 13.9 25.5 20.2 22.7 23.2 24.0 27.2 25.9 24.9 33.9 22.4 20.8 23.5 13.9 23.2 25.3 36.4 30.4 15.8 27.3 27.0 19.6 35.3 24.5 25.1 23.7 24.6 25.5 17.9 29.8 25.8 55.8 83.9 79.8 31.5 39.7 33.1 32.1 21.6 47.1 11.8 63.9 77.9 59.8 336.0 31.5 41.6 46.7 67.5 89.5 85.0 53.7 35.8 48.9 77.7 39.7 24.6 34.4 61.8 365.3 86.9 75.3 87.7 139.7 25.4 36.5 72.8 31.6 68.6 109.3 51.1 97.0 76.9 214.7 46.8 83.7 37.2 66.0 46.0 86.6 IBTK "BTBD26, BTKI, DKFZP564B116" ENSG00000005700 "Inhibitor of Bruton tyrosine kinase" Q9P2D0 6 82169983-82247754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023826, HPA048438" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA023826: AB_1851378, HPA048438: AB_2680392" "unprognostic (3.13e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (2.72e-2)" "unprognostic (1.75e-2)" "unprognostic (2.48e-1)" "unprognostic (2.78e-1)" "unprognostic (5.93e-2)" "unprognostic (1.97e-2)" "unprognostic (6.18e-2)" "unprognostic (1.90e-2)" "unprognostic (8.81e-2)" "unprognostic (3.02e-2)" "unprognostic (1.08e-2)" "unprognostic (7.33e-2)" "unprognostic (1.09e-1)" "unprognostic (7.27e-2)" "unprognostic (9.78e-2)" 12.8 26.4 8.7 11.0 13.3 4.8 13.2 15.9 16.0 13.9 12.0 14.9 16.7 11.7 14.3 10.9 14.7 12.9 8.9 13.9 8.8 8.7 16.3 39.1 12.1 15.5 11.8 7.7 13.9 20.4 19.9 22.2 9.0 14.5 11.5 15.1 11.2 14.6 17.6 30.9 7.2 16.5 15.1 12.9 12.7 15.8 6.2 10.8 13.6 14.9 14.5 10.0 13.5 10.1 3.9 4.3 3.0 4.6 2.2 6.0 1.9 5.6 11.8 8.6 7.2 10.5 14.4 3.8 13.3 14.7 11.1 12.0 6.2 6.7 11.2 8.5 15.7 14.5 6.1 6.9 7.4 13.3 15.0 5.1 12.0 6.3 9.6 14.6 13.8 7.3 12.4 12.5 10.5 26.1 10.2 10.8 7.8 11.0 7.0 11.6 8.7 4.8 4.5 3.8 8.8 6.3 7.0 18.2 4.4 16.7 13.1 5.8 6.4 9.0 11.3 7.0 7.9 10.6 8.5 8.7 6.4 4.8 8.0 10.6 7.3 11.3 5.2 7.1 9.2 8.2 3.0 2.7 2.1 4.4 2.5 6.0 3.9 4.3 3.9 4.3 2.6 4.4 4.0 0.0 2.2 4.6 3.2 5.9 1.9 8.7 13.3 15.9 16.0 8.8 8.7 11.8 7.7 14.5 10.8 38.7 33.8 23.8 28.4 12.0 54.8 60.8 53.5 34.8 47.8 36.6 51.1 20.9 13.3 28.0 2.7 24.4 34.5 46.7 44.8 13.7 23.6 45.7 35.8 65.2 23.9 49.3 37.3 24.5 29.4 1.3 23.9 31.7 21.9 38.7 34.6 33.5 42.5 29.1 19.8 27.2 36.7 25.8 20.6 19.7 24.7 10.2 7.9 21.8 28.8 63.3 ID1 "bHLHb24, dJ857M17.1.2" ENSG00000125968 "Inhibitor of DNA binding 1, HLH protein" P41134 20 31605283-31606515 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 163.1" "Cell type enhanced" "Detected in many" 8 "Ito cells: 1636.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 3.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.9" "Cell line enhanced" "Detected in many" "EFO-21: 75.9;HaCaT: 72.3;PC-3: 75.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025915, HPA051456, HPA058518" Approved Enhanced Nucleoplasm "Intracellular and membrane" Yes No Nucleoplasm "CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740" "unprognostic (3.89e-2)" "unprognostic (3.45e-2)" "unprognostic (2.62e-2)" "unprognostic (3.19e-2)" "unprognostic (1.27e-2)" "unprognostic (1.74e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (2.29e-1)" "unprognostic (1.58e-1)" "unprognostic (2.14e-2)" "unprognostic (7.83e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.97e-1)" "unprognostic (6.17e-3)" "unprognostic (3.41e-3)" 28.6 12.3 8.2 15.2 9.1 4.4 33.2 5.6 13.8 36.3 33.3 15.4 38.5 36.4 25.9 11.6 78.0 25.1 19.0 33.5 8.7 8.4 22.3 23.4 57.4 17.9 10.0 7.9 12.3 5.8 4.0 25.7 22.1 14.3 56.4 13.1 34.9 10.5 163.1 23.0 16.5 40.6 16.9 8.1 15.3 48.6 7.8 4.0 2.4 78.8 36.2 21.0 80.0 26.4 0.4 0.7 3.9 0.7 0.3 0.5 0.5 10.7 35.5 0.4 7.2 4.7 2.1 27.7 45.5 1.8 8.4 0.9 18.7 16.2 0.0 75.9 12.1 9.9 72.3 5.9 2.5 1.3 0.8 3.7 5.9 30.8 60.2 6.4 0.1 0.3 8.7 10.4 0.0 0.6 14.0 5.1 4.0 13.0 0.3 16.1 14.0 1.6 0.2 25.5 48.0 75.7 0.1 29.7 0.5 1.6 29.7 13.8 12.9 37.8 13.6 0.3 20.1 8.3 1.0 27.1 22.6 44.0 7.2 30.5 0.8 0.8 0.6 26.3 5.6 3.0 0.0 0.6 0.9 0.1 0.2 0.0 0.1 0.1 0.0 0.7 0.4 0.0 0.5 3.9 0.3 0.7 0.0 0.0 0.5 8.2 9.1 5.6 13.8 8.7 8.4 10.0 7.9 14.3 4.0 220.3 143.7 26.8 631.9 90.9 1.0 20.7 76.5 89.7 271.8 216.3 3.9 104.2 31.5 429.0 5.6 483.5 528.2 0.0 472.2 442.0 137.2 501.4 21.9 90.9 22.4 0.0 550.7 1636.4 76.9 5.9 26.4 25.7 86.0 13.6 450.7 80.6 190.0 770.0 0.4 2.7 4.0 12.9 193.3 1.9 2.2 76.9 74.5 24.9 241.9 477.9 ID3 "bHLHb25, HEIR-1" ENSG00000117318 "Inhibitor of DNA binding 3, HLH protein" Q02535 1 23557918-23559794 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Myogenesis, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 117.9" "Cell type enhanced" "Detected in many" 6 "Ito cells: 1041.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 47.4;naive B-cell: 42.9" "Group enriched" "Detected in many" 37 "B-cells: 47.4;T-cells: 24.9" "Cell line enhanced" "Detected in many" "U-698: 84.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021353, HPA024677" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB021353: , HPA024677: AB_2671647" "unprognostic (6.73e-2)" "unprognostic (2.48e-1)" "unprognostic (5.19e-2)" "prognostic favorable (1.27e-5)" "unprognostic (5.58e-3)" "unprognostic (1.46e-1)" "unprognostic (8.98e-2)" "unprognostic (7.76e-2)" "unprognostic (3.89e-2)" "unprognostic (6.47e-3)" "unprognostic (2.42e-1)" "unprognostic (1.50e-1)" "unprognostic (2.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.01e-1)" "unprognostic (4.37e-3)" "unprognostic (8.36e-2)" 33.5 12.2 13.3 18.9 15.5 6.0 41.6 2.4 14.4 22.0 25.9 16.6 31.4 18.9 21.7 17.8 20.6 33.8 22.9 42.2 21.1 12.4 21.3 11.1 25.8 15.3 16.6 9.1 27.2 10.2 4.2 31.1 31.3 17.7 38.9 13.0 42.6 9.1 117.9 17.0 14.2 17.0 13.3 16.9 12.4 21.6 6.9 20.7 20.5 82.8 19.3 10.7 35.0 72.1 47.4 0.9 0.5 0.2 0.0 24.9 6.1 3.3 20.4 7.0 24.5 3.2 0.4 8.2 24.6 2.1 13.8 1.7 1.2 0.1 21.8 25.4 9.2 2.9 28.2 8.6 3.2 1.4 0.1 9.0 0.3 26.6 11.0 9.9 0.0 0.0 10.3 17.3 0.3 0.2 12.1 12.2 8.7 0.1 0.2 12.5 8.0 2.9 0.0 6.1 16.3 5.1 27.2 13.0 0.7 0.1 7.7 10.3 8.1 23.5 17.4 1.7 5.5 4.5 0.6 25.3 19.6 10.5 9.7 12.8 6.8 6.2 84.2 4.3 0.2 11.4 0.0 0.2 0.0 0.6 0.2 0.2 47.4 10.9 2.1 0.7 42.9 18.2 7.2 0.5 0.0 0.2 0.9 24.9 6.1 13.3 15.5 2.4 14.4 21.1 12.4 16.6 9.1 17.7 20.7 107.2 66.6 152.0 308.3 182.4 2.9 23.8 20.4 28.1 46.6 198.9 9.8 146.2 19.9 195.6 1.1 558.2 223.7 0.0 376.5 627.5 200.0 250.3 15.0 3.4 67.3 4.8 415.6 1041.7 65.7 1.8 38.0 95.2 236.2 34.3 461.1 365.1 130.9 345.5 0.7 5.7 12.4 511.0 604.0 0.5 0.6 165.7 233.5 45.9 226.0 105.9 ID4 bHLHb27 ENSG00000172201 "Inhibitor of DNA binding 4, HLH protein" P47928 6 19837386-19840684 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "thyroid gland: 154.6" "Group enriched" "Detected in many" 4 "Basal glandular cells: 188.3;Muller glia cells: 371.8;Smooth muscle cells: 607.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 17.2;AN3-CA: 22.6;EFO-21: 51.6;HEK 293: 28.9;SCLC-21H: 46.6;SuSa: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075639 Supported Nucleoplasm NA NA Nucleoplasm "HPA075639: " "unprognostic (3.25e-3)" "unprognostic (7.37e-3)" "unprognostic (1.80e-1)" "unprognostic (6.34e-3)" "unprognostic (4.17e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-1)" "unprognostic (2.87e-1)" "unprognostic (1.65e-2)" "prognostic favorable (2.49e-4)" "unprognostic (7.26e-2)" "unprognostic (1.66e-3)" "unprognostic (2.41e-2)" "unprognostic (3.13e-2)" "unprognostic (1.03e-3)" "unprognostic (2.57e-3)" 33.1 2.1 29.3 5.3 29.6 1.1 16.9 13.2 31.1 21.1 5.1 29.0 7.2 4.9 22.9 7.0 12.1 34.1 6.8 25.2 32.3 20.6 11.7 2.4 14.6 3.5 14.5 19.0 22.9 11.8 2.0 13.1 13.2 24.9 18.7 4.6 5.7 16.0 26.6 1.8 31.3 4.0 14.2 12.5 11.4 11.9 10.8 20.0 0.0 154.6 4.4 3.5 10.5 11.5 1.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 17.2 22.6 0.5 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 51.6 5.8 0.1 8.8 0.0 0.0 0.2 0.0 28.9 0.0 0.0 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.4 2.4 0.0 0.0 0.0 0.0 3.0 6.1 46.6 0.6 0.0 0.8 3.0 15.0 1.4 0.0 0.0 0.1 2.7 0.0 0.7 0.0 0.0 0.5 0.7 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 29.3 29.6 13.2 19.2 32.3 20.6 14.5 19.0 24.9 20.0 89.3 35.7 0.0 188.3 73.7 10.2 30.8 0.0 10.7 26.1 64.6 2.0 7.6 43.1 14.4 1.3 5.8 7.9 0.0 2.9 6.2 57.9 86.7 0.0 0.0 2.5 3.2 87.7 17.2 0.3 4.4 7.5 4.1 84.4 0.0 4.8 371.8 2.1 31.7 0.0 61.2 12.2 0.0 607.2 0.9 0.6 68.6 4.9 0.0 2.8 35.0 IER2 ETR101 ENSG00000160888 "Immediate early response 2" Q9BTL4 19 13150415-13154908 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 120.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 57.5;U-266/84: 73.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055387, HPA060574" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055387: AB_2682802, HPA060574: AB_2684324" "unprognostic (3.09e-2)" "unprognostic (1.78e-1)" "unprognostic (1.99e-1)" "unprognostic (4.86e-2)" "unprognostic (3.86e-2)" "unprognostic (2.47e-2)" "unprognostic (2.10e-1)" "unprognostic (3.31e-1)" "unprognostic (2.35e-2)" "unprognostic (7.05e-2)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (5.69e-2)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" "unprognostic (2.86e-1)" "unprognostic (1.01e-1)" 34.1 24.4 11.5 13.4 16.1 68.2 19.1 13.3 16.8 16.4 20.3 10.1 28.7 12.6 20.3 13.0 22.3 66.8 16.4 16.2 14.1 5.9 16.8 19.9 25.4 14.0 19.2 13.7 33.9 21.6 15.1 17.0 19.9 14.9 26.4 10.0 11.6 34.4 27.1 4.2 45.6 13.7 24.1 15.3 17.1 25.3 7.0 14.2 6.7 29.0 6.7 11.9 18.3 26.4 23.8 14.3 120.1 27.5 28.4 38.4 30.3 14.0 8.4 6.6 10.0 4.4 5.9 14.6 10.9 5.9 7.5 4.4 7.1 8.5 8.3 11.1 7.9 12.7 9.5 3.0 6.3 3.8 4.9 5.7 10.9 14.3 5.9 5.4 13.7 12.2 3.0 15.7 8.1 5.1 9.2 8.8 8.7 27.5 11.2 2.9 23.0 8.2 57.5 12.6 15.2 36.4 16.0 6.7 9.9 6.8 8.3 8.2 11.8 12.2 37.7 24.7 5.4 4.4 8.3 15.8 16.0 10.9 13.2 31.4 33.1 73.6 8.6 8.6 27.4 12.3 40.5 23.4 37.6 38.4 27.5 33.1 21.3 27.0 30.7 14.3 23.8 18.1 22.7 120.1 28.4 24.7 6.5 25.3 30.3 11.5 16.1 13.3 16.8 14.1 5.9 19.2 13.7 14.9 14.2 163.8 583.5 268.0 446.3 283.3 80.9 53.2 336.3 91.0 145.6 90.7 33.4 412.8 44.7 562.1 8.3 433.3 636.2 23.3 334.1 457.3 546.3 696.8 470.7 72.3 507.9 14.3 939.8 260.9 263.5 8.1 127.8 482.9 224.4 162.3 744.6 230.0 421.9 589.0 36.4 32.7 128.3 633.8 468.1 4.5 8.9 386.1 765.7 449.7 550.7 402.2 IER5L bA247A12.2 ENSG00000188483 "Immediate early response 5 like" Q5T953 9 129175552-129178262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 15.5;SiHa: 21.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021327 Approved Nucleoplasm NA NA Nucleoplasm "HPA021327: AB_2121674" "unprognostic (2.46e-1)" "unprognostic (3.73e-3)" "unprognostic (3.90e-3)" "unprognostic (8.49e-3)" "unprognostic (1.21e-1)" "unprognostic (5.65e-2)" "unprognostic (3.37e-3)" "prognostic unfavorable (1.48e-6)" "unprognostic (6.91e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.99e-2)" "unprognostic (1.08e-3)" "unprognostic (7.23e-3)" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (2.29e-1)" 12.6 11.3 6.0 6.4 9.0 3.3 31.3 2.1 15.3 29.6 8.2 3.5 14.9 5.0 17.4 10.8 13.0 11.0 14.3 14.9 6.4 5.0 14.8 15.0 9.4 8.1 5.5 3.9 35.0 5.4 3.2 8.0 9.8 7.9 15.2 3.7 6.1 8.1 30.1 8.4 8.0 5.3 10.5 11.8 5.7 11.1 6.2 4.1 1.2 9.4 4.9 3.8 20.7 25.5 0.0 0.3 2.1 1.1 0.4 0.8 0.2 5.2 15.5 4.4 8.4 3.3 5.2 13.4 7.9 0.7 1.2 1.2 0.8 8.7 0.1 3.2 1.8 3.6 11.5 0.2 0.9 0.2 0.7 1.1 0.0 3.3 1.4 2.5 0.1 0.1 5.7 1.2 0.9 0.1 7.0 0.5 0.1 0.4 2.8 0.2 13.5 0.1 0.6 0.4 1.3 8.2 0.7 0.3 2.2 4.7 0.7 2.0 2.6 21.8 7.1 8.9 1.9 2.2 1.4 3.2 7.6 4.5 5.1 11.2 1.5 1.0 0.1 9.6 1.5 3.3 0.0 1.1 0.0 0.3 0.6 0.0 0.0 0.1 0.8 0.3 0.0 0.0 0.0 2.1 0.4 0.2 0.1 0.0 0.2 6.0 9.0 2.1 9.0 6.4 5.0 5.5 3.9 7.9 4.1 14.9 1.7 2.9 5.9 6.1 6.0 1.4 20.4 2.7 4.5 45.4 0.0 3.5 8.3 10.6 0.7 11.1 16.9 0.0 22.8 5.4 12.9 12.2 0.0 9.7 25.2 3.2 10.3 29.4 15.4 1.1 10.0 9.2 13.5 3.6 14.6 14.0 18.0 9.3 6.7 14.3 2.7 25.8 20.8 0.0 1.7 4.0 6.8 1.0 8.4 6.7 IFI44 "MTAP44, p44, TLDC5" ENSG00000137965 "Interferon induced protein 44" Q8TCB0 1 78649796-78664078 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 36.8;Ito cells: 48.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 46.1;BJ hTERT+ SV40 Large T+ RasG12V: 57.0;GAMG: 46.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA027148, HPA043858" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027148: AB_1851411, HPA043858: AB_2678702" "unprognostic (1.20e-1)" "unprognostic (6.53e-2)" "unprognostic (5.70e-2)" "unprognostic (4.13e-3)" "unprognostic (1.63e-1)" "unprognostic (8.81e-2)" "unprognostic (5.52e-2)" "unprognostic (8.30e-2)" "unprognostic (1.88e-1)" "unprognostic (1.78e-2)" "unprognostic (2.72e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.37e-8)" "unprognostic (1.71e-1)" "unprognostic (2.07e-3)" "unprognostic (8.89e-2)" "unprognostic (4.90e-2)" 35.2 12.6 10.2 16.2 11.7 47.8 13.0 4.3 8.2 10.0 8.1 6.6 10.5 10.5 13.6 29.9 15.2 8.3 24.9 10.7 10.8 9.8 26.9 11.2 18.6 16.5 11.9 10.5 10.9 5.2 3.0 19.6 11.4 10.5 11.0 5.3 11.3 35.4 13.2 7.5 5.5 8.8 10.2 15.1 32.3 11.2 4.8 11.0 22.3 13.8 11.3 8.1 13.6 8.0 2.2 5.9 3.7 13.0 6.1 12.4 5.5 1.9 0.0 0.3 0.0 1.4 9.6 0.0 1.2 16.8 46.1 57.0 0.0 5.6 2.6 13.1 1.2 46.6 1.0 0.0 0.7 7.5 5.6 0.0 6.7 4.9 0.0 1.9 0.0 0.0 6.0 0.0 19.9 0.2 3.6 8.6 1.7 0.0 9.0 10.9 0.0 5.5 0.4 0.0 0.0 3.7 4.3 13.9 0.3 1.3 1.2 0.1 0.3 0.4 0.1 19.7 0.0 0.0 0.2 10.5 8.5 3.6 0.9 8.4 0.7 0.9 0.0 13.1 7.6 2.3 0.3 13.0 0.1 6.2 12.3 12.4 2.2 9.1 5.9 5.9 1.6 3.9 5.0 3.7 6.1 6.3 1.7 4.3 5.5 10.2 11.7 4.3 8.2 10.8 9.8 11.9 10.5 10.5 11.0 26.8 23.9 0.5 8.9 3.2 0.0 4.5 5.1 21.4 15.9 8.7 0.0 0.2 0.0 9.9 0.4 36.8 0.8 0.0 10.8 0.2 9.8 3.6 17.4 2.4 27.7 0.0 6.4 48.5 34.5 0.5 12.4 26.5 5.0 4.6 1.5 0.8 8.5 0.0 16.3 2.1 0.2 19.4 9.5 0.0 0.4 4.0 0.0 12.5 1.5 11.7 IFI44L "C1orf29, GS3686" ENSG00000137959 "Interferon induced protein 44 like" Q53G44 1 78619922-78646145 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 70.0;Peritubular cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 25.6;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;GAMG: 9.2;HSkMC: 14.9;SK-MEL-30: 11.7" "Low region specificity" "Detected in all" "HPA053247, HPA060372" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053247: AB_2682088, HPA060372: AB_2684267" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "unprognostic (9.99e-3)" "prognostic unfavorable (2.95e-4)" "prognostic favorable (3.82e-4)" "unprognostic (1.35e-1)" "unprognostic (4.52e-3)" "unprognostic (1.44e-2)" "unprognostic (2.54e-1)" "unprognostic (3.26e-2)" "unprognostic (3.33e-3)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (7.58e-2)" "unprognostic (1.10e-3)" "unprognostic (2.24e-1)" "unprognostic (9.03e-2)" 33.6 5.3 9.4 6.2 10.6 36.2 7.6 3.3 10.4 3.8 4.0 12.3 2.7 3.5 10.6 19.7 3.8 4.9 15.0 7.4 9.2 11.0 15.7 4.9 9.5 5.1 10.6 9.4 6.6 2.2 1.9 5.6 8.6 21.6 5.4 3.1 14.4 26.3 5.2 3.5 2.7 3.8 7.0 17.2 23.1 3.7 5.0 12.2 21.6 10.0 4.9 5.2 10.4 3.2 3.6 2.2 2.3 5.6 4.4 2.2 1.5 0.0 0.0 1.0 0.0 0.5 6.9 0.0 0.2 5.3 25.6 27.8 0.0 0.3 5.7 3.1 0.1 9.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.6 0.1 0.1 14.9 0.1 1.9 0.3 4.8 0.2 0.0 0.0 0.8 0.5 0.0 0.3 0.1 0.0 0.0 2.6 0.0 0.0 0.0 1.3 0.1 0.0 0.0 6.9 0.0 11.7 0.0 0.0 0.1 0.2 0.2 0.4 0.5 0.7 1.2 0.2 0.0 4.2 0.0 0.0 0.1 5.0 0.3 0.5 5.6 1.6 3.6 2.2 1.7 1.6 1.6 0.8 0.8 2.3 4.4 2.1 2.2 0.5 1.5 9.4 10.6 3.3 10.4 9.2 11.0 10.6 9.4 21.6 12.2 0.0 9.0 7.2 2.5 3.5 0.0 1.7 2.5 17.4 9.1 7.0 0.0 0.1 0.0 4.0 0.6 70.0 0.0 0.0 7.5 0.1 6.1 1.5 2.3 0.0 22.8 0.0 0.0 22.1 13.0 1.8 21.9 14.1 3.3 2.8 0.0 1.2 1.6 0.0 45.3 0.6 0.2 6.5 4.2 0.3 0.0 1.8 0.2 6.2 0.0 3.1 IFRD2 "IFNRP, SKMc15, SM15" ENSG00000214706 "Interferon related developmental regulator 2" Q12894 3 50287732-50292918 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068560 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA068560: AB_2686005" "prognostic favorable (7.22e-4)" "unprognostic (5.19e-2)" "unprognostic (2.08e-2)" "unprognostic (8.61e-3)" "unprognostic (3.88e-1)" "unprognostic (2.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.24e-1)" "unprognostic (1.62e-1)" "unprognostic (2.01e-1)" "unprognostic (1.91e-2)" "unprognostic (7.78e-3)" "prognostic favorable (2.50e-4)" "unprognostic (3.07e-2)" "unprognostic (1.03e-1)" "unprognostic (1.58e-1)" "unprognostic (1.13e-1)" 11.0 10.0 5.2 10.8 7.7 6.9 15.4 9.0 6.6 7.9 13.7 6.4 21.2 10.7 6.9 7.7 11.8 8.0 17.0 23.9 4.9 4.5 11.1 41.1 8.4 6.5 7.8 3.5 9.8 34.7 10.2 7.6 6.7 7.1 15.6 8.3 8.0 23.7 22.3 39.2 7.8 12.0 8.5 4.9 9.4 18.4 9.9 6.9 7.4 15.8 24.3 8.5 7.8 7.5 17.5 17.8 3.9 16.9 18.5 25.2 15.2 22.8 23.6 6.5 20.5 6.7 7.8 15.1 17.6 9.6 21.7 15.4 19.4 23.5 15.7 13.0 12.1 18.6 13.4 13.6 28.2 11.2 14.9 27.3 22.6 31.2 22.8 13.3 22.9 14.3 7.2 24.3 22.6 28.4 7.2 18.3 14.1 14.3 12.9 12.7 21.5 14.9 26.9 16.4 28.5 46.0 9.8 9.5 35.7 12.9 13.8 11.6 11.2 11.1 30.8 11.1 6.6 14.6 22.0 13.2 18.1 22.8 31.2 35.5 9.1 15.5 13.4 14.4 30.1 26.4 3.9 12.5 1.7 17.9 16.9 25.2 17.5 18.9 17.1 17.8 17.3 20.2 18.3 1.1 18.5 9.3 17.5 14.9 15.2 5.2 7.7 9.0 6.6 4.9 4.5 7.8 3.5 7.1 6.9 17.9 27.7 30.0 43.2 59.8 16.6 1.6 33.1 2.7 15.9 19.2 19.6 29.0 24.9 47.3 66.9 24.8 23.6 0.0 77.7 36.7 26.6 71.8 7.0 44.0 28.7 17.5 15.0 9.8 9.4 95.0 12.7 14.5 33.7 19.0 24.8 13.0 62.8 21.0 13.4 43.7 11.7 0.0 48.6 17.2 16.2 60.0 25.4 20.8 46.4 75.9 ILF2 NF45 ENSG00000143621 "Interleukin enhancer binding factor 2" Q12905 1 153661788-153671048 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007484 Supported Supported Nucleoplasm No No 3800000 Nucleoplasm "HPA007484: AB_1079137" "unprognostic (1.97e-3)" "unprognostic (8.68e-2)" "unprognostic (3.44e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-3)" "unprognostic (9.70e-2)" "prognostic unfavorable (5.71e-8)" "unprognostic (2.64e-1)" "unprognostic (4.66e-2)" "unprognostic (3.22e-3)" "unprognostic (1.94e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (2.61e-1)" "unprognostic (4.17e-2)" "unprognostic (2.65e-1)" "unprognostic (2.09e-1)" 35.9 39.2 26.3 32.8 27.1 58.1 43.7 25.6 32.8 34.8 33.8 32.7 23.5 24.2 37.8 39.6 46.0 33.9 27.8 32.0 24.7 28.4 64.1 45.4 35.3 38.1 33.2 29.2 46.5 52.8 38.4 36.8 53.3 30.8 29.9 40.4 25.0 50.4 28.3 49.1 38.5 27.7 34.3 26.7 39.8 33.9 58.0 28.5 117.0 58.5 45.5 54.0 32.1 30.9 49.5 55.4 34.5 39.9 52.4 52.5 76.4 48.8 38.1 67.4 47.3 28.3 26.7 53.9 36.5 41.5 65.9 47.6 56.1 39.9 67.7 56.3 36.3 31.9 37.5 80.2 38.8 63.9 36.7 52.1 50.8 31.1 48.0 26.0 78.6 37.6 24.3 22.3 50.3 54.7 27.7 61.3 40.5 63.6 32.2 54.8 65.1 105.0 35.2 96.2 72.1 58.1 76.5 58.4 63.9 31.6 47.4 60.6 56.3 42.5 53.0 43.1 66.3 57.9 68.1 37.3 34.0 43.6 30.5 60.1 55.9 77.9 136.6 28.5 48.7 51.3 34.5 39.9 28.7 39.8 38.3 50.1 49.5 46.4 42.9 55.4 40.7 52.5 45.6 3.7 52.4 30.3 53.6 51.0 76.4 26.3 27.1 25.6 32.8 24.7 28.4 33.2 29.2 30.8 28.5 53.6 62.2 87.8 197.1 175.8 35.7 58.5 71.4 62.9 69.4 36.6 25.5 182.2 111.0 167.4 37.9 93.1 44.0 0.0 137.2 213.8 109.6 107.7 92.3 28.6 110.7 27.0 102.4 40.5 43.7 25.3 55.5 80.0 106.3 135.3 65.7 79.9 127.2 65.6 61.9 162.5 27.6 64.7 108.0 316.3 160.4 138.9 217.7 99.4 100.9 173.0 ILKAP "DKFZP434J2031, FLJ10181, PPM1O" ENSG00000132323 "ILK associated serine/threonine phosphatase" Q9H0C8 2 238170401-238203729 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004752, HPA056099" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004752: AB_1851753, HPA056099: AB_2797255" "unprognostic (1.50e-1)" "unprognostic (1.62e-1)" "unprognostic (1.23e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" "unprognostic (9.75e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.60e-1)" "unprognostic (3.07e-2)" "unprognostic (3.88e-2)" "unprognostic (1.37e-3)" "unprognostic (7.03e-2)" "prognostic unfavorable (9.89e-6)" "unprognostic (6.24e-2)" "unprognostic (6.63e-2)" "unprognostic (2.63e-2)" "unprognostic (1.20e-1)" 17.0 17.1 19.4 31.3 22.2 34.6 24.2 34.1 23.4 18.7 23.4 29.5 22.0 20.5 23.0 22.7 19.4 19.0 21.8 20.9 20.6 19.8 17.8 20.8 27.1 25.7 23.9 21.4 22.1 24.1 17.5 24.7 18.1 22.7 21.5 18.9 20.2 19.0 24.9 32.8 19.4 19.0 26.5 19.8 22.2 18.1 21.2 25.5 23.9 22.6 19.0 24.8 18.1 26.1 18.9 20.7 24.1 18.1 17.4 23.8 16.2 17.9 11.7 17.3 16.9 13.5 9.0 17.7 19.0 12.9 19.3 16.8 10.8 9.6 11.5 4.9 13.7 23.1 15.4 22.3 15.8 19.6 20.5 22.2 29.8 11.6 23.7 20.8 19.0 23.6 9.4 10.9 20.5 20.7 9.5 14.4 15.7 22.9 7.5 16.4 21.6 19.1 25.9 16.1 17.0 11.3 23.4 35.4 10.6 14.2 8.6 25.5 12.6 12.8 13.8 30.4 13.8 10.8 19.8 12.9 18.8 17.2 25.2 20.2 13.4 13.4 20.7 15.4 21.4 15.9 24.1 15.1 19.6 22.5 18.1 20.1 18.9 20.0 21.0 20.7 18.5 23.8 18.6 5.3 17.4 15.1 15.8 22.4 16.2 19.4 22.2 34.1 23.4 20.6 19.8 23.9 21.4 22.7 25.5 11.9 22.4 26.5 25.9 24.0 27.2 20.9 5.1 17.4 13.6 24.4 27.5 31.9 36.5 21.9 7.1 20.3 20.0 23.3 24.8 34.9 21.1 24.0 33.4 14.1 30.1 36.5 18.3 17.2 12.7 9.1 26.2 19.1 28.7 35.1 21.4 23.4 21.2 17.5 27.6 24.2 27.2 32.3 28.0 48.7 60.2 25.1 33.8 27.1 22.5 19.3 IMPACT RWDD5 ENSG00000154059 "Impact RWD domain protein" Q9P2X3 18 24426616-24453535 "Predicted intracellular proteins" "Differentiation, Neurogenesis, Stress response, Translation regulation" "Actin-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 84.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 28.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041045, HPA041968" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA041045: AB_10793866, HPA041968: AB_10795603" "unprognostic (1.13e-1)" "unprognostic (8.59e-2)" "unprognostic (1.15e-2)" "unprognostic (1.62e-1)" "unprognostic (5.12e-2)" "unprognostic (7.94e-2)" "unprognostic (3.29e-2)" "unprognostic (6.14e-2)" "unprognostic (2.94e-2)" "unprognostic (2.15e-1)" "unprognostic (8.20e-2)" "unprognostic (1.22e-1)" "prognostic favorable (7.90e-4)" "unprognostic (5.60e-3)" "unprognostic (9.27e-2)" "unprognostic (1.99e-3)" "unprognostic (5.60e-3)" 16.2 23.9 18.7 12.0 24.4 11.5 21.1 6.1 17.0 14.0 14.5 14.4 16.8 13.3 16.1 23.9 18.7 12.2 14.7 17.7 15.6 28.8 21.0 18.5 12.9 13.5 19.9 12.0 15.9 16.9 22.8 28.5 17.1 22.8 15.6 12.6 13.8 23.6 19.1 15.0 12.2 13.5 20.4 26.9 11.9 13.0 40.3 10.7 10.9 27.7 14.1 11.7 16.3 11.8 3.2 6.7 28.4 6.7 4.9 4.4 3.2 10.3 5.9 10.2 12.7 10.0 15.3 16.8 13.9 16.6 7.8 7.8 2.0 9.1 6.3 14.1 14.7 4.8 12.2 3.4 15.4 11.7 0.0 3.1 9.3 6.3 3.3 15.2 36.7 9.0 13.1 11.8 5.2 32.3 9.5 14.9 0.0 7.8 0.0 12.7 9.6 0.0 6.4 17.0 18.3 6.6 0.0 20.1 3.1 8.5 16.4 8.5 10.6 19.7 8.7 14.2 8.5 12.3 12.4 18.2 31.8 4.2 5.9 5.8 12.1 15.5 0.1 12.8 4.6 13.6 28.4 5.3 9.7 2.5 6.7 3.3 2.2 3.2 2.4 6.7 3.2 3.4 2.9 0.8 4.9 4.7 4.7 4.4 3.2 18.7 24.4 6.1 17.0 15.6 28.8 19.9 12.0 22.8 10.7 17.9 9.3 4.5 10.1 10.1 10.9 23.6 20.4 25.4 20.5 14.0 2.0 25.1 31.5 14.4 11.8 15.3 11.3 0.0 19.5 18.0 20.0 11.5 19.7 29.8 23.9 4.8 15.0 19.6 14.8 14.8 15.0 15.2 18.6 17.2 28.0 35.3 16.5 0.0 25.5 38.3 11.1 12.9 18.5 84.6 69.0 12.7 13.7 10.0 20.0 9.0 ING2 "ING1L, p33ING2" ENSG00000168556 "Inhibitor of growth family member 2" Q9H160 4 183504994-183511096 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019486, HPA021517" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA019486: AB_1851780, HPA021517: AB_10601914" "prognostic favorable (5.43e-4)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (3.74e-2)" "unprognostic (3.89e-3)" "unprognostic (4.56e-2)" "prognostic unfavorable (8.87e-4)" "unprognostic (7.47e-3)" "unprognostic (2.27e-1)" "unprognostic (1.09e-3)" "unprognostic (1.65e-2)" "unprognostic (1.97e-1)" "unprognostic (2.30e-3)" "unprognostic (6.19e-2)" "unprognostic (4.43e-1)" "unprognostic (5.52e-2)" "unprognostic (7.82e-2)" 6.1 28.5 7.8 4.4 12.2 20.0 7.6 8.3 10.3 6.2 13.0 6.0 5.9 10.1 4.2 11.6 15.7 8.0 8.1 5.0 8.0 8.9 10.4 9.4 6.1 6.0 9.9 6.0 34.4 17.3 6.3 18.8 11.5 9.5 6.0 6.3 6.5 6.8 6.7 16.2 7.4 23.1 6.8 11.0 7.2 7.5 16.9 7.2 11.5 9.1 10.9 6.8 10.3 9.4 11.4 7.4 21.8 7.9 3.5 10.7 3.9 14.8 7.8 12.8 10.4 20.3 13.3 11.1 16.6 14.1 13.0 11.9 7.6 15.0 11.5 3.7 12.1 9.5 6.3 7.6 14.1 18.7 8.0 6.9 17.0 9.1 9.1 5.9 13.2 19.3 10.1 11.3 13.6 5.3 9.5 6.7 9.6 10.4 40.8 10.4 14.5 18.4 15.8 9.2 4.8 10.5 8.6 6.4 17.8 15.0 7.3 12.1 8.3 9.7 13.6 4.0 8.3 6.4 9.9 4.6 8.7 14.8 6.8 9.6 8.7 5.7 7.2 16.9 12.0 6.1 13.1 6.2 21.8 3.6 6.3 5.5 11.4 7.6 6.5 7.4 8.1 10.7 9.0 7.4 3.5 7.9 7.0 5.6 3.9 7.8 12.2 8.3 10.3 8.0 8.9 9.9 6.0 9.5 7.2 6.0 16.0 25.2 16.6 43.8 23.5 7.6 25.5 54.9 15.9 15.7 11.8 20.8 63.0 17.7 41.4 15.0 33.7 46.7 30.8 78.8 23.6 23.6 39.3 19.2 26.7 23.8 17.9 10.4 16.1 27.5 76.5 29.3 25.3 8.2 19.6 27.5 27.8 28.1 50.5 28.3 21.0 19.4 21.1 80.2 75.2 40.4 17.7 18.3 20.5 27.7 ING3 "Eaf4, FLJ20089, MEAF4, p47ING3" ENSG00000071243 "Inhibitor of growth family member 3" Q9NXR8 7 120950749-120977216 "Disease related genes, Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004762, HPA067388, HPA067575" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004762: , HPA067388: AB_2685831, HPA067575: AB_2685863" "unprognostic (1.35e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.78e-1)" "unprognostic (3.03e-1)" "unprognostic (1.39e-2)" "unprognostic (4.26e-2)" "unprognostic (7.09e-3)" "unprognostic (4.07e-2)" "unprognostic (5.18e-2)" "unprognostic (8.04e-3)" "unprognostic (2.86e-1)" "unprognostic (6.90e-2)" "unprognostic (3.96e-2)" "unprognostic (1.52e-1)" "unprognostic (1.72e-1)" "unprognostic (5.64e-2)" 9.6 9.1 7.4 8.8 9.9 57.7 9.6 21.5 13.8 9.0 9.6 5.5 11.1 7.3 11.1 9.7 8.0 9.7 7.7 7.6 7.3 7.3 8.8 8.4 12.3 11.9 7.6 12.2 11.9 12.1 7.9 17.7 13.0 11.1 9.5 10.6 6.7 10.0 11.5 7.7 6.1 12.9 11.4 8.8 16.4 10.4 8.6 9.6 19.0 12.6 10.4 11.2 8.3 8.4 15.8 15.0 32.7 19.5 18.5 16.9 9.8 9.3 2.8 12.7 7.1 4.8 3.8 4.3 6.4 5.1 9.3 10.9 3.6 10.9 15.2 2.9 5.6 9.8 4.6 12.2 5.0 10.7 10.6 21.4 11.0 10.6 2.1 6.6 21.2 13.1 2.8 2.6 8.2 5.8 4.5 14.5 9.6 24.6 24.7 8.9 3.2 17.4 12.7 15.3 5.3 5.2 8.6 9.1 12.6 9.4 9.7 11.5 12.5 6.6 13.7 6.9 8.2 3.1 8.3 5.1 9.5 3.5 20.4 11.6 11.3 7.2 22.9 4.8 14.3 7.9 22.3 19.1 16.5 13.9 19.5 13.4 14.4 14.1 12.6 15.0 15.8 14.4 13.1 32.7 18.5 19.1 11.2 16.9 9.8 7.4 9.9 21.5 13.8 7.3 7.3 7.6 12.2 11.1 9.6 17.9 13.6 22.2 20.2 6.8 20.4 12.6 7.6 13.4 7.9 7.0 3.9 33.3 18.3 10.3 4.0 18.5 17.3 23.3 15.7 21.2 19.3 14.2 33.4 11.1 15.3 25.4 11.5 19.6 26.6 3.9 12.7 19.0 15.1 15.4 14.0 17.3 12.9 14.8 9.2 9.7 17.2 19.4 22.6 15.0 13.9 9.8 38.2 21.8 12.4 13.9 ING4 "my036, p29ING4" ENSG00000111653 "Inhibitor of growth family member 4" Q9UNL4 12 6650280-6663148 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Chromatin regulator" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031817, HPA057338" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA031817: AB_2674056, HPA057338: AB_2683412" "unprognostic (2.95e-1)" "unprognostic (1.92e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (9.44e-2)" "unprognostic (5.76e-3)" "unprognostic (1.65e-2)" "prognostic favorable (5.16e-4)" "unprognostic (3.67e-2)" "unprognostic (1.80e-1)" "unprognostic (7.66e-3)" "unprognostic (1.52e-1)" "unprognostic (4.32e-2)" "unprognostic (1.31e-1)" "unprognostic (9.88e-2)" "unprognostic (2.17e-1)" "unprognostic (1.42e-2)" 15.0 17.7 30.7 13.0 27.6 9.3 25.9 36.7 34.3 20.0 20.2 22.3 18.9 16.2 23.8 29.5 17.1 25.5 16.3 18.9 27.9 21.0 19.0 20.7 16.6 22.2 30.2 24.8 26.7 17.9 21.1 18.7 19.5 29.9 21.1 20.3 15.5 20.2 22.5 15.6 26.2 16.9 21.4 25.0 24.9 17.6 13.3 29.0 29.5 24.2 10.2 21.3 20.0 18.3 29.4 23.9 19.4 33.1 25.1 29.1 25.2 4.3 5.9 17.6 8.3 13.7 13.7 11.3 5.8 9.4 9.7 11.7 2.6 19.9 7.6 3.8 8.1 7.7 6.9 8.6 6.8 10.8 14.6 12.7 10.8 10.8 5.4 8.0 4.2 5.1 13.7 15.8 5.1 6.6 31.5 14.5 14.8 5.0 4.3 9.2 3.1 15.4 6.5 25.9 9.6 5.7 14.6 9.2 7.9 12.0 5.0 7.3 19.0 9.0 3.0 10.7 26.6 4.0 11.8 10.9 4.0 8.1 4.5 3.7 5.3 7.2 10.0 10.7 6.6 4.0 19.4 22.0 17.7 25.0 29.3 22.7 21.9 20.8 21.0 23.9 29.4 29.1 24.8 14.1 25.1 33.1 18.5 20.7 25.2 30.7 27.6 36.7 34.3 27.9 21.0 30.2 24.8 29.9 29.0 20.8 14.7 22.9 10.7 7.2 29.6 9.0 10.2 14.7 18.2 17.4 17.7 33.6 24.9 19.0 1.7 21.5 11.8 0.0 7.1 11.0 15.1 13.3 27.6 6.0 21.9 33.4 24.2 18.4 14.5 4.2 31.9 20.8 10.1 36.1 19.7 32.7 10.9 18.6 35.3 17.9 26.3 32.3 19.8 20.0 16.4 8.8 25.6 32.4 17.1 7.0 INIP "C9orf80, HSPC043, hSSBIP1, MISE, SOSS-C" ENSG00000148153 "INTS3 and NABP interacting protein" Q9NRY2 9 112683926-112718236 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020382 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA020382: AB_1845840" "prognostic unfavorable (7.08e-4)" "unprognostic (1.67e-1)" "unprognostic (9.64e-2)" "unprognostic (2.35e-1)" "unprognostic (8.05e-2)" "unprognostic (8.56e-2)" "unprognostic (1.01e-2)" "unprognostic (6.29e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.11e-2)" "unprognostic (4.47e-3)" "prognostic favorable (2.00e-8)" "prognostic favorable (2.53e-4)" "unprognostic (2.28e-1)" "unprognostic (3.50e-2)" "unprognostic (1.26e-1)" 9.0 11.3 16.1 9.8 17.3 11.4 14.7 18.7 22.9 10.9 12.4 21.0 4.4 12.8 9.6 11.2 12.6 10.4 11.0 9.3 16.8 15.6 15.1 13.7 10.5 16.6 18.6 14.4 11.0 8.1 11.1 18.4 7.5 20.6 8.9 14.8 7.8 10.2 8.6 7.6 11.4 13.4 9.7 19.3 12.5 8.7 8.2 18.2 17.3 13.6 6.1 17.1 12.6 9.2 15.0 21.2 25.1 23.0 13.1 19.5 14.8 8.5 8.4 11.6 16.6 10.1 10.8 11.9 12.1 6.7 10.7 10.7 10.0 7.0 23.0 7.6 8.3 7.7 12.2 11.4 5.3 14.3 27.3 6.7 9.5 10.0 9.4 6.5 19.2 7.2 5.3 8.0 11.2 9.2 5.2 9.9 11.7 16.3 15.0 11.6 13.9 17.0 9.9 6.0 15.5 15.6 19.1 24.7 9.9 12.1 11.7 15.2 11.4 15.2 9.8 7.8 8.1 14.6 12.0 8.1 8.6 13.5 16.7 11.6 7.5 31.3 19.4 11.0 11.2 14.4 17.7 19.7 25.1 13.4 23.0 17.5 12.5 17.2 19.5 21.2 15.0 19.0 16.3 16.0 13.1 19.8 7.5 15.8 14.8 16.1 17.3 18.7 22.9 16.8 15.6 18.6 14.4 20.6 18.2 20.8 17.0 13.2 16.0 32.5 16.5 12.9 22.9 8.1 18.2 14.0 15.7 18.3 48.0 20.2 1.5 17.9 14.2 0.0 14.2 26.5 13.3 15.6 25.5 15.3 22.8 41.3 21.5 13.5 17.4 1.5 13.0 29.0 18.6 36.9 17.3 19.3 18.3 8.6 11.3 21.9 15.7 0.0 14.1 12.9 18.3 36.5 12.4 21.8 18.0 24.0 INSM2 "IA-6, Mlt1" ENSG00000168348 "INSM transcriptional repressor 2" Q96T92 14 35534042-35537054 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.3;brain: 5.2;salivary gland: 1.6;testis: 2.9" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 2.0;Rod photoreceptor cells: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 134 "SH-SY5Y: 50.5" "Region enhanced" "Detected in single" "hypothalamus: 1.3" "Low region specificity" "Detected in some" "HPA044885, HPA051925" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044885: AB_10794779, HPA051925: AB_2681664" "unprognostic (9.88e-2)" "unprognostic (8.74e-2)" "unprognostic (2.35e-1)" "unprognostic (1.08e-3)" "unprognostic (3.29e-3)" "unprognostic (1.72e-1)" "unprognostic (2.51e-1)" "unprognostic (2.26e-3)" "unprognostic (2.60e-3)" "unprognostic (7.51e-2)" "unprognostic (1.75e-2)" "unprognostic (2.36e-3)" "unprognostic (5.00e-1)" 0.3 2.3 1.0 0.5 2.8 0.2 0.3 0.5 5.2 0.2 0.2 1.0 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.8 5.0 0.2 0.2 0.3 0.2 1.9 1.2 0.2 0.2 0.2 0.1 0.2 2.7 0.2 0.2 0.7 1.6 0.2 0.2 0.4 0.2 0.2 0.4 0.2 0.2 2.9 0.2 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 50.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.8 0.5 4.6 0.8 5.0 1.9 1.2 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 INTS1 "DKFZp586J0619, INT1, KIAA1440, NET28" ENSG00000164880 "Integrator complex subunit 1" Q8N201 7 1470277-1504367 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021658, HPA053009" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA021658: AB_1852402, HPA053009: AB_2682016" "unprognostic (3.20e-2)" "unprognostic (2.85e-2)" "unprognostic (2.47e-2)" "unprognostic (2.08e-1)" "unprognostic (1.97e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (7.72e-3)" "unprognostic (3.11e-1)" "unprognostic (1.90e-2)" "prognostic favorable (4.83e-4)" "unprognostic (4.30e-1)" "unprognostic (5.10e-3)" "unprognostic (1.81e-1)" "unprognostic (1.51e-1)" "unprognostic (1.56e-2)" "unprognostic (1.81e-3)" 15.4 14.6 17.8 16.1 17.2 28.5 15.2 26.5 28.1 12.2 14.5 19.2 10.1 19.0 15.0 11.0 15.8 13.3 14.4 13.0 13.5 11.0 13.8 13.8 12.0 18.2 13.5 10.1 18.2 23.0 11.6 15.8 12.6 15.2 14.7 6.0 15.6 25.6 14.5 43.3 20.4 17.6 15.1 10.0 19.3 17.9 27.3 14.0 18.0 15.9 10.8 14.9 13.7 14.8 6.0 3.7 4.4 2.7 3.1 4.8 2.1 20.6 18.0 7.0 18.2 5.2 4.0 24.5 8.8 4.9 6.8 6.0 19.8 16.1 11.1 9.3 6.3 13.7 21.4 3.9 10.4 1.9 5.4 21.7 7.9 25.6 13.0 6.0 13.7 11.9 5.4 4.9 7.0 5.0 4.1 7.4 15.9 22.0 8.9 4.1 25.0 7.7 37.6 38.5 7.6 16.2 19.6 8.0 11.3 3.2 15.7 13.3 32.8 12.6 23.2 8.0 4.2 18.4 13.8 13.6 11.2 32.2 9.3 14.3 18.7 9.8 10.8 12.6 11.9 22.9 4.4 2.7 2.9 4.8 2.1 3.0 2.7 3.5 3.8 3.7 6.0 2.2 2.8 2.2 3.1 1.8 2.1 4.2 2.1 17.8 17.2 26.5 28.1 13.5 11.0 13.5 10.1 15.2 14.0 11.9 29.1 6.0 4.2 5.3 30.1 38.9 20.4 4.0 9.1 10.4 23.6 10.7 0.0 14.5 18.4 11.3 33.3 0.0 19.9 8.3 10.3 8.7 1.1 21.2 12.9 46.1 17.3 16.5 23.4 32.2 12.4 11.6 5.0 8.2 18.2 15.8 17.3 15.6 14.5 12.9 36.0 25.8 8.2 19.4 11.0 6.9 12.7 10.1 20.1 5.4 INTS8 "C8orf52, FLJ20530, INT8, MGC131633" ENSG00000164941 "Integrator complex subunit 8" Q75QN2 8 94813311-94881746 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057299 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA057299: AB_2683403" "unprognostic (1.08e-2)" "unprognostic (3.12e-2)" "unprognostic (1.28e-1)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (4.81e-2)" "prognostic unfavorable (2.54e-6)" "unprognostic (3.07e-2)" "unprognostic (6.87e-2)" "unprognostic (9.77e-3)" "unprognostic (4.84e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.24e-1)" "unprognostic (5.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.96e-2)" 10.5 10.0 12.7 19.3 16.1 16.6 14.3 17.1 16.0 19.2 15.4 9.1 12.5 9.4 14.4 8.3 15.9 10.6 9.2 15.2 11.6 12.6 10.2 10.8 11.5 19.3 12.4 9.5 15.0 20.1 14.7 22.9 11.4 11.1 14.0 18.2 9.7 12.9 13.7 15.6 12.5 15.1 16.7 12.5 17.0 14.6 35.1 10.7 31.9 13.3 7.6 16.1 17.1 13.2 13.0 9.7 14.4 9.8 10.9 13.0 4.5 22.1 14.1 21.5 18.8 7.8 18.8 11.5 12.4 11.1 15.6 14.5 9.4 16.2 22.4 11.5 8.7 19.5 14.0 26.3 12.4 20.9 25.1 14.0 19.8 8.5 9.2 9.5 10.5 14.6 7.5 5.9 15.0 12.9 17.9 17.1 15.1 18.9 16.9 9.4 14.3 22.4 8.7 12.7 48.5 24.5 18.8 8.7 12.7 13.0 11.4 16.1 8.9 11.7 3.2 10.6 18.4 16.1 13.4 11.9 7.3 8.5 13.6 10.7 10.5 18.1 19.2 9.4 21.1 13.9 2.1 9.8 14.4 5.2 6.8 8.4 13.0 12.2 13.0 9.7 10.4 12.2 7.2 9.9 10.9 6.6 5.7 9.9 4.5 12.7 16.1 17.1 16.0 11.6 12.6 12.4 9.5 11.1 10.7 14.9 7.5 11.3 9.5 5.3 13.4 7.3 5.1 18.7 10.3 7.0 31.4 8.3 3.3 7.1 14.4 9.0 7.4 0.0 11.7 10.7 9.0 7.2 12.7 5.3 8.6 27.0 17.2 9.8 13.5 3.4 15.0 12.4 6.8 16.2 11.4 7.0 10.0 11.5 15.2 3.5 19.6 6.5 8.9 48.8 29.4 6.0 7.1 10.1 9.9 6.7 INTS9 "CPSF2L, FLJ10871, RC-74" ENSG00000104299 "Integrator complex subunit 9" Q9NV88 8 28767661-28890242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051615, HPA066822" Enhanced Nucleoplasm Yes No Nucleoplasm "HPA051615: AB_2681552, HPA066822: AB_2685729" "unprognostic (2.19e-2)" "unprognostic (1.45e-2)" "unprognostic (1.79e-2)" "prognostic favorable (9.45e-4)" "unprognostic (2.46e-1)" "unprognostic (1.56e-3)" "unprognostic (6.91e-3)" "prognostic favorable (7.71e-4)" "unprognostic (3.64e-2)" "unprognostic (5.01e-2)" "unprognostic (4.72e-2)" "unprognostic (2.48e-3)" "prognostic favorable (1.91e-5)" "unprognostic (2.51e-2)" "unprognostic (2.73e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" 10.8 28.8 10.5 14.1 13.4 8.1 11.0 14.2 16.5 11.3 11.7 15.5 7.7 9.3 16.4 16.1 14.1 13.7 9.1 13.0 9.5 7.6 12.8 9.3 11.4 17.9 15.2 8.1 11.4 12.5 13.4 24.0 11.4 12.1 11.6 12.9 17.9 15.5 10.6 14.1 12.4 11.9 12.8 13.5 20.4 11.7 15.2 13.3 28.4 17.2 8.5 23.1 13.2 11.2 17.6 24.3 15.5 19.3 19.9 17.0 9.3 13.2 9.4 11.3 12.0 14.0 6.6 5.0 6.1 8.4 10.7 11.9 6.5 7.5 13.2 8.6 6.2 9.6 11.1 21.8 12.5 15.0 5.5 8.9 13.2 5.3 11.3 10.2 6.6 10.3 7.5 9.0 12.9 9.3 5.8 13.2 19.1 27.8 7.7 7.1 7.3 30.5 12.0 15.3 15.6 6.1 19.7 13.1 6.9 7.5 9.2 8.2 15.0 6.3 8.3 11.1 9.5 8.0 7.5 7.7 6.2 16.0 10.5 7.7 4.0 2.7 16.4 9.6 11.1 8.8 12.1 17.7 15.5 15.4 19.3 14.3 15.4 13.7 17.0 24.3 17.6 12.5 13.1 7.2 19.9 13.7 12.8 16.3 9.3 10.5 13.4 14.2 16.5 9.5 7.6 15.2 8.1 12.1 13.3 6.0 3.4 4.7 2.4 2.1 2.1 4.6 7.6 1.4 2.3 3.5 5.9 6.7 1.7 3.0 6.1 2.9 2.3 0.0 4.5 3.8 3.8 1.4 0.0 1.6 6.7 1.6 5.8 2.5 4.1 3.3 7.2 2.9 3.3 4.6 4.0 2.0 4.7 0.0 4.2 3.3 5.5 0.0 2.8 3.0 3.3 2.6 4.0 3.2 3.3 1.4 IPMK ENSG00000151151 "Inositol polyphosphate multikinase" Q8NFU5 10 58191517-58267934 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 48.0;Suprabasal keratinocytes: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.4" "Group enriched" "Detected in many" 4 "granulocytes: 6.4;monocytes: 2.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037837, HPA057542" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037837: AB_10670166, HPA057542: AB_2683460" "unprognostic (4.52e-2)" "unprognostic (3.29e-2)" "unprognostic (4.22e-3)" "unprognostic (6.85e-2)" "unprognostic (2.41e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-3)" "unprognostic (2.10e-1)" "unprognostic (9.39e-2)" "unprognostic (2.23e-1)" "unprognostic (1.55e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (9.96e-7)" "unprognostic (1.79e-1)" "unprognostic (4.33e-1)" "unprognostic (1.27e-3)" "unprognostic (9.02e-3)" 12.2 4.1 5.4 6.8 5.6 2.8 6.7 8.7 5.6 5.9 19.4 3.5 2.1 9.5 3.2 5.6 10.8 3.8 8.6 7.4 5.2 5.5 5.3 21.3 11.0 13.8 4.9 3.3 4.8 6.0 22.5 6.1 13.8 4.3 4.4 7.5 4.8 6.4 4.4 9.8 9.0 28.1 4.9 6.0 14.1 4.4 2.9 3.8 11.7 5.9 4.9 5.9 10.4 12.3 0.7 1.0 6.4 2.1 0.4 0.9 0.4 14.7 3.8 5.6 5.4 5.5 6.5 4.9 3.9 8.4 3.4 6.8 7.6 9.5 11.8 8.0 4.6 3.2 4.6 4.7 5.2 10.8 5.4 3.6 2.9 3.8 7.2 3.3 4.6 6.7 7.1 4.7 5.7 11.5 3.8 7.2 3.5 1.9 6.1 5.9 3.7 6.2 8.9 3.5 6.0 3.6 0.4 12.1 5.5 6.2 3.8 3.9 6.8 5.1 13.6 3.9 9.6 11.3 5.6 6.2 3.7 7.1 7.7 4.9 13.1 7.7 9.4 6.9 4.9 1.4 2.3 1.5 3.3 0.4 1.6 0.4 0.7 0.4 0.2 1.0 0.4 0.9 0.3 6.4 0.4 2.1 0.4 0.1 0.4 5.4 5.6 8.7 5.6 5.2 5.5 4.9 3.3 4.3 3.8 6.0 3.4 9.7 9.1 48.0 9.1 2.4 5.1 17.4 7.9 1.8 5.9 8.5 3.3 3.2 1.9 3.2 22.2 0.0 4.2 17.8 16.0 7.8 6.9 11.4 9.0 12.7 8.1 8.6 27.1 1.0 2.6 17.3 25.3 1.0 11.7 3.7 6.2 16.4 1.8 7.3 5.4 6.5 12.2 9.8 4.3 50.7 7.9 4.3 9.0 14.3 IPO8 "IMP8, RANBP8" ENSG00000133704 "Importin 8" O15397 12 30628988-30695986 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018439, HPA023765" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018439: AB_1851771, HPA023765: AB_1851773" "unprognostic (1.63e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (5.14e-2)" "unprognostic (2.15e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.35e-4)" "unprognostic (2.66e-2)" "unprognostic (5.42e-2)" "unprognostic (1.20e-1)" "unprognostic (2.97e-1)" "unprognostic (1.38e-1)" "prognostic favorable (8.62e-5)" "unprognostic (9.75e-2)" "unprognostic (2.95e-1)" "unprognostic (3.14e-3)" "unprognostic (2.24e-1)" 15.7 20.9 21.2 17.3 22.5 10.0 15.4 19.8 22.6 17.4 25.2 12.3 15.9 17.9 22.4 16.0 22.9 17.2 18.3 18.9 17.9 14.5 22.5 23.3 15.6 17.5 14.8 20.3 21.1 23.9 54.4 27.8 17.2 19.0 18.4 22.6 11.9 16.7 18.5 19.8 16.6 22.6 21.3 15.9 20.4 17.8 27.5 14.6 24.8 22.1 13.1 18.0 21.6 20.4 8.0 3.6 7.3 6.0 6.0 7.5 2.8 16.9 19.9 19.1 14.0 18.0 20.7 26.8 18.8 18.1 15.0 17.7 13.6 17.7 21.9 16.5 23.0 15.9 11.0 21.1 20.3 21.9 25.5 14.9 17.9 23.9 12.4 11.8 25.9 14.1 16.7 12.8 23.9 20.4 27.1 24.7 15.4 15.9 16.5 21.2 8.6 19.5 16.0 37.2 23.4 7.6 16.0 40.1 17.7 18.9 23.5 11.8 14.5 19.7 14.4 10.4 35.5 23.0 9.4 22.0 14.4 12.7 31.0 16.3 16.3 22.1 33.2 17.6 15.6 24.9 7.2 4.5 5.4 4.8 6.0 7.1 5.6 5.4 5.2 3.3 8.0 5.9 7.5 7.3 6.0 5.5 3.6 6.1 2.8 21.2 22.5 19.8 22.6 17.9 14.5 14.8 20.3 19.0 14.6 8.9 18.9 11.0 5.4 8.5 11.5 16.9 10.2 8.1 21.6 10.4 11.8 9.8 3.3 8.6 29.2 13.9 11.7 23.3 11.9 6.0 9.1 6.7 11.5 22.4 13.9 7.9 6.4 24.5 22.2 6.4 8.1 12.1 8.5 3.6 13.0 12.1 11.0 5.8 12.4 12.9 14.6 12.9 11.2 9.1 3.2 8.2 15.0 7.7 13.0 7.5 IQCA1 "DRC11, FLJ22527, IQCA" ENSG00000132321 "IQ motif containing with AAA domain 1" Q86XH1 2 236324147-236507542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 27.8;thyroid gland: 30.0" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 163.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 9.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 4.4" "Group enriched" "Detected in many" 4 "NK-cells: 1.2;T-cells: 4.4" "Cell line enhanced" "Detected in some" "EFO-21: 4.0;HBEC3-KT: 3.7;HeLa: 4.4;hTERT-RPE1: 8.7;SuSa: 5.5;U-2 OS: 15.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA057320 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA057320: " "unprognostic (1.73e-2)" "unprognostic (6.38e-2)" "unprognostic (3.75e-3)" "unprognostic (1.62e-2)" "unprognostic (6.27e-3)" "unprognostic (1.73e-2)" "unprognostic (3.23e-5)" "unprognostic (1.55e-1)" "unprognostic (7.23e-3)" "unprognostic (1.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.62e-1)" "prognostic favorable (2.54e-4)" "unprognostic (1.19e-3)" "unprognostic (1.67e-3)" "unprognostic (1.91e-3)" "unprognostic (5.30e-2)" 1.8 2.7 13.4 1.4 19.2 0.8 3.5 3.8 11.6 2.2 1.0 6.7 0.4 0.9 3.4 9.1 1.6 17.8 3.5 1.1 12.9 10.0 6.6 0.8 5.1 1.3 8.8 9.3 4.7 2.4 0.9 27.8 1.1 13.0 3.1 1.0 2.7 2.6 2.8 0.8 0.9 1.2 1.5 3.2 5.5 1.1 7.4 8.0 1.4 30.0 0.0 1.6 3.0 1.0 0.7 0.0 0.0 0.0 1.2 4.4 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.1 0.0 0.0 4.0 0.0 1.1 0.0 0.0 3.7 0.0 0.0 0.1 0.0 4.4 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.0 8.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.1 0.0 15.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.2 0.8 0.0 0.7 1.1 4.4 0.0 1.2 0.0 0.0 0.3 0.1 13.4 19.2 3.8 10.0 12.9 10.0 8.8 9.3 13.0 8.0 14.9 15.9 0.0 6.7 0.5 20.3 0.8 12.7 163.3 30.7 3.5 15.7 0.4 0.0 10.2 19.7 3.8 0.0 0.0 1.4 3.6 0.9 1.1 1.1 0.0 0.3 0.0 0.0 1.3 0.0 11.0 2.0 0.5 0.0 0.0 0.0 0.2 1.7 0.0 5.6 7.9 1.8 0.0 0.3 23.3 27.1 0.3 0.2 0.0 0.0 2.6 IQCD "CFAP84, DRC10" ENSG00000166578 "IQ motif containing D" Q96DY2 12 113195441-113221094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 22.4;testis: 33.8" "Group enriched" "Detected in many" 7 "Ciliated cells: 124.5;Early spermatids: 118.9;Late spermatids: 69.7;Spermatocytes: 74.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.6;classical monocyte: 2.8;myeloid DC: 2.1;plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 5 "dendritic cells: 3.7;granulocytes: 3.6;monocytes: 2.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 22.4;GAMG: 8.9;RPTEC TERT1: 11.1;U-698: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046810, HPA048782" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA046810: AB_2679818, HPA048782: AB_2680519" "unprognostic (3.90e-2)" "unprognostic (4.61e-2)" "unprognostic (4.97e-2)" "unprognostic (4.28e-3)" "unprognostic (1.81e-1)" "unprognostic (7.11e-2)" "unprognostic (2.26e-5)" "unprognostic (2.23e-1)" "unprognostic (3.38e-2)" "unprognostic (3.04e-1)" "prognostic favorable (3.90e-4)" "unprognostic (1.54e-1)" "unprognostic (3.48e-3)" "unprognostic (4.09e-2)" "unprognostic (3.22e-2)" "unprognostic (1.79e-1)" "unprognostic (5.20e-2)" 1.2 1.2 2.8 1.3 6.4 0.6 1.8 2.0 3.8 2.6 1.1 6.8 1.7 0.6 2.3 6.3 1.8 22.4 1.4 1.6 3.8 3.2 3.4 0.6 3.0 1.3 4.8 1.5 2.5 1.4 5.4 8.7 1.2 11.4 1.1 1.2 1.6 1.2 1.7 0.7 0.9 0.7 1.4 2.5 0.6 1.0 33.8 6.4 0.0 4.0 1.1 3.3 1.6 1.0 0.6 3.7 3.6 2.8 0.0 0.1 0.5 2.7 3.2 1.1 0.8 1.2 1.3 0.7 0.4 22.4 1.1 1.5 0.5 8.7 3.0 2.4 0.6 8.9 0.5 0.5 0.9 1.8 0.2 0.9 1.0 1.1 0.5 0.7 0.3 0.7 0.5 0.7 3.5 1.1 6.1 0.7 1.2 0.2 0.2 0.2 3.2 0.2 5.8 0.2 1.4 0.8 0.2 0.5 0.8 11.1 3.4 2.5 1.0 0.7 1.1 3.5 0.9 4.0 1.7 0.3 0.5 1.7 1.1 0.6 0.9 0.7 12.0 1.6 0.1 1.9 3.6 2.8 0.0 0.1 0.2 0.0 0.6 0.0 0.0 2.1 0.2 0.0 0.1 0.1 0.0 0.0 3.7 0.0 0.5 2.8 6.4 2.0 3.8 3.8 3.2 4.8 1.5 11.4 6.4 3.0 1.7 0.0 2.7 2.2 0.4 3.4 5.1 124.5 11.4 5.2 13.7 1.2 11.6 2.3 118.9 0.1 1.3 0.0 0.7 0.2 2.4 1.7 0.0 0.4 1.9 0.0 6.3 1.8 0.0 69.7 2.0 1.3 3.3 2.8 0.6 6.5 0.7 0.3 4.9 11.8 4.8 0.0 1.4 74.6 4.7 1.5 1.6 0.8 0.0 3.5 IRF2BP1 "DKFZP434M154, IRF-2BP1" ENSG00000170604 "Interferon regulatory factor 2 binding protein 1" Q8IU81 19 45883607-45886170 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042164, HPA049480" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA042164: AB_2677882, HPA049480: AB_2680785" "unprognostic (5.90e-2)" "unprognostic (1.34e-1)" "unprognostic (8.86e-2)" "unprognostic (9.49e-2)" "unprognostic (1.78e-1)" "unprognostic (2.61e-2)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (3.03e-1)" "unprognostic (1.01e-1)" "prognostic favorable (2.32e-4)" "unprognostic (2.60e-1)" "prognostic favorable (3.85e-5)" "unprognostic (1.33e-2)" "unprognostic (6.99e-2)" "unprognostic (2.66e-1)" "unprognostic (5.07e-3)" 14.2 11.9 12.2 9.0 14.1 6.7 8.7 23.1 26.2 12.7 11.2 12.6 10.6 14.4 15.3 8.1 8.2 12.4 12.6 10.8 11.8 11.7 12.0 14.8 10.0 9.5 13.2 12.8 20.3 18.5 12.4 15.6 8.6 12.5 13.5 4.8 12.6 19.6 15.2 33.4 13.4 12.4 9.3 8.7 15.6 16.4 8.0 12.8 17.4 13.7 8.0 8.6 12.0 8.7 2.7 2.0 1.4 1.7 2.4 3.6 1.6 8.3 12.8 3.2 7.0 2.7 1.7 5.2 6.2 3.6 5.0 4.4 4.8 4.0 6.8 4.7 3.1 2.9 7.9 2.2 2.3 1.4 8.5 22.3 6.8 3.6 6.0 5.5 7.0 6.4 2.4 3.2 2.6 1.9 3.1 3.0 8.5 10.7 5.4 1.9 6.5 14.2 38.4 5.9 3.1 11.4 16.4 3.7 5.8 3.5 4.7 9.5 16.2 6.5 8.6 7.8 1.2 7.1 13.1 4.3 4.3 8.7 3.3 8.7 14.8 16.3 4.0 5.8 6.7 6.2 0.0 1.2 0.4 2.8 1.7 2.8 2.7 2.5 2.3 1.1 2.3 3.6 2.2 1.4 2.4 0.7 2.0 2.3 1.6 12.2 14.1 23.1 26.2 11.8 11.7 13.2 12.8 12.5 12.8 0.0 1.4 10.4 5.2 9.5 13.2 0.9 5.1 1.4 0.0 10.4 0.0 9.7 11.6 6.7 1.3 4.7 7.9 0.0 8.1 6.2 7.3 7.0 0.0 7.6 4.2 9.5 9.2 5.5 2.6 1.0 17.3 3.9 8.5 2.8 9.8 12.0 6.1 10.5 10.3 10.1 6.4 19.4 7.3 3.6 1.9 9.8 7.3 4.8 8.0 2.6 IRF2BP2 IRF-2BP2 ENSG00000168264 "Interferon regulatory factor 2 binding protein 2" Q7Z5L9 1 234604269-234609525 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 396.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 75.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027815, HPA062269" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027815: AB_10609994, HPA062269: AB_2684732" "unprognostic (1.15e-3)" "unprognostic (1.02e-1)" "unprognostic (3.90e-1)" "unprognostic (2.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.74e-3)" "unprognostic (1.97e-2)" "unprognostic (8.77e-2)" "unprognostic (2.19e-1)" "unprognostic (3.69e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (1.25e-1)" "unprognostic (2.70e-1)" "unprognostic (3.14e-1)" "unprognostic (3.77e-1)" 17.9 14.5 11.3 21.1 12.9 48.0 29.9 16.5 17.6 19.8 19.3 13.8 10.9 13.9 20.3 13.1 17.3 17.1 31.6 19.6 12.7 11.5 12.3 20.4 35.0 30.3 11.1 10.6 25.3 22.6 15.9 10.8 11.1 13.9 18.5 18.1 16.8 19.6 12.9 18.8 25.2 20.0 11.6 15.0 16.2 17.0 23.9 11.3 28.6 21.1 14.6 19.5 17.4 19.4 4.0 17.4 8.9 4.5 2.8 5.1 2.3 7.5 11.7 8.4 12.9 17.7 14.1 10.1 6.1 5.2 3.7 4.1 6.7 9.4 0.0 14.4 5.8 12.3 10.5 4.5 8.0 5.7 12.4 10.6 7.3 9.2 19.8 14.4 26.9 25.7 16.5 18.6 8.1 15.3 21.0 9.1 6.9 6.3 15.6 9.3 2.2 6.8 28.7 7.6 17.8 4.5 13.4 3.9 17.9 7.0 6.3 16.9 11.9 9.8 13.1 19.1 8.7 12.6 75.3 10.2 13.1 5.5 9.7 11.4 34.7 9.0 2.5 6.5 24.6 17.7 8.9 4.5 7.6 4.1 3.4 4.2 4.0 5.0 4.8 4.5 3.9 5.1 4.3 2.3 2.8 1.8 17.4 3.7 2.3 11.3 12.9 16.5 17.6 12.7 11.5 11.1 10.6 13.9 11.3 125.0 159.6 51.3 373.3 289.5 29.7 48.7 129.9 73.6 138.8 48.8 9.8 34.2 11.6 50.2 20.2 107.9 65.6 70.0 43.0 37.5 72.0 119.8 103.0 148.0 75.7 55.6 139.8 102.5 119.4 18.0 64.5 110.8 104.6 13.6 101.3 95.4 59.9 66.6 76.4 35.8 18.6 77.6 123.6 20.5 17.0 346.3 66.4 45.8 141.3 396.8 IRF2BPL "C14orf4, EAP1, KIAA1865" ENSG00000119669 "Interferon regulatory factor 2 binding protein like" Q9H1B7 14 77024543-77028699 "Plasma proteins, Predicted intracellular proteins" Transferase "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050862, HPA061333" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA050862: AB_2681258, HPA061333: AB_2684481" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.99e-3)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.78e-3)" "unprognostic (1.57e-2)" "unprognostic (2.70e-1)" "unprognostic (1.81e-1)" "unprognostic (5.74e-2)" "unprognostic (2.53e-2)" "unprognostic (2.51e-3)" "unprognostic (5.39e-2)" "unprognostic (1.03e-3)" "unprognostic (2.55e-1)" "unprognostic (9.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" 24.2 21.6 12.7 13.7 13.0 7.9 24.4 20.3 17.9 21.0 21.0 9.8 18.2 11.0 19.3 13.3 16.3 26.3 23.4 21.3 12.9 12.3 19.7 16.3 15.6 12.7 13.8 7.4 36.9 18.2 35.8 17.2 13.7 15.7 20.2 6.0 19.7 26.2 20.2 15.9 17.0 11.1 18.4 13.5 18.4 13.9 15.3 13.4 27.4 27.6 7.1 9.8 21.8 24.6 2.1 12.2 9.9 2.4 6.5 3.4 0.7 6.8 6.0 14.9 16.7 4.5 4.2 21.3 7.2 5.9 2.0 2.7 2.8 11.3 2.4 5.3 6.1 5.8 10.7 2.5 5.3 1.7 11.4 8.8 3.0 5.9 3.8 5.9 0.8 13.8 5.6 4.2 3.6 3.2 16.3 2.7 5.0 4.5 27.4 2.6 18.7 9.2 6.4 6.7 2.9 31.3 1.9 4.2 5.6 7.1 10.1 11.6 16.8 10.2 10.7 17.8 4.2 7.4 1.5 4.7 9.5 9.3 3.1 4.6 10.6 11.3 4.1 14.7 2.1 11.8 1.5 1.6 1.4 3.4 2.2 3.2 1.7 3.0 3.1 1.4 2.1 2.5 2.6 9.9 6.5 2.4 12.2 2.9 0.7 12.7 13.0 20.3 14.1 12.9 12.3 13.8 7.4 15.7 13.4 20.8 14.7 25.3 28.2 65.5 56.8 14.7 38.2 8.1 9.1 61.1 27.5 17.1 31.5 19.5 1.2 24.8 5.6 0.0 16.4 44.6 44.5 25.7 25.5 42.3 28.3 9.5 45.8 48.5 47.9 2.7 27.9 17.0 33.7 0.0 13.5 45.5 16.0 3.5 32.2 19.3 10.0 38.8 33.3 1.7 28.8 44.3 38.4 25.5 11.9 17.6 IRF8 "ICSBP, ICSBP1, IRF-8" ENSG00000140968 "Interferon regulatory factor 8" Q02556 16 85898803-85922609 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Autophagy, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 197.4;lymphoid tissue: 64.4" "Cell type enhanced" "Detected in many" 13 "B-cells: 159.1;Hofbauer cells: 61.3;Kupffer cells: 76.1;Macrophages: 82.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 197.4" "Lineage enriched" "Detected in many" 6 "dendritic cells: 197.4" "Cell line enhanced" "Detected in some" "Daudi: 35.6;THP-1: 60.1;U-698: 140.9;U-937: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002267, HPA002531, CAB013480" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904" "unprognostic (2.09e-3)" "unprognostic (7.51e-2)" "unprognostic (5.16e-2)" "unprognostic (1.19e-1)" "unprognostic (7.54e-2)" "unprognostic (3.46e-3)" "unprognostic (3.19e-2)" "unprognostic (5.31e-3)" "unprognostic (1.23e-1)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (5.31e-2)" "unprognostic (3.14e-3)" "unprognostic (3.97e-2)" "unprognostic (9.66e-3)" "unprognostic (4.04e-1)" "unprognostic (1.10e-2)" 12.4 4.0 6.8 36.1 8.8 19.2 6.7 2.6 5.3 2.3 7.8 8.3 6.8 12.3 2.3 3.0 3.7 2.9 5.6 2.9 5.8 3.3 5.6 9.9 11.7 60.4 9.3 3.1 2.1 3.1 0.2 2.2 2.7 6.7 3.3 10.0 2.2 6.1 8.9 1.5 2.6 36.4 3.6 10.9 64.4 6.5 2.2 8.8 18.4 3.6 2.3 63.3 8.3 2.1 31.8 197.4 0.7 10.8 8.9 0.3 9.8 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 3.8 0.0 35.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.2 0.0 1.1 0.1 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 60.1 0.0 0.0 1.6 0.0 0.1 0.0 0.0 140.9 0.0 19.9 0.0 0.5 10.7 0.2 0.2 10.8 0.3 29.3 0.1 0.1 23.7 31.8 0.3 0.2 0.7 8.9 7.2 197.4 0.0 9.8 6.8 8.8 2.6 5.3 5.8 3.3 9.3 3.1 6.7 8.8 0.0 6.2 159.1 1.1 9.3 0.0 1.2 2.5 0.0 2.3 0.0 0.0 0.5 1.7 0.4 1.4 3.9 16.1 0.0 1.2 4.7 6.4 0.9 2.3 5.6 61.3 0.0 27.5 3.1 76.1 3.7 0.3 82.3 42.2 7.2 5.8 0.4 0.2 11.9 0.0 2.2 0.0 6.5 4.4 0.5 5.5 8.2 0.9 13.8 19.3 2.5 ISG20L2 FLJ12671 ENSG00000143319 "Interferon stimulated exonuclease gene 20 like 2" Q9H9L3 1 156721891-156728799 "Predicted intracellular proteins" "Ribosome biogenesis" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 98.1" "Group enriched" "Detected in many" 29 "Early spermatids: 725.4;Late spermatids: 2397.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028005, HPA054285" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028005: AB_2126319, HPA054285: " "unprognostic (1.67e-2)" "unprognostic (7.87e-2)" "unprognostic (2.80e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (3.52e-1)" "unprognostic (1.65e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (1.02e-1)" "unprognostic (9.55e-2)" "unprognostic (6.05e-2)" "unprognostic (2.40e-1)" "unprognostic (8.17e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (5.11e-2)" "unprognostic (2.68e-1)" "unprognostic (3.82e-3)" "unprognostic (2.32e-1)" 8.0 7.9 8.5 9.5 10.5 12.1 9.7 15.4 11.2 8.6 8.9 10.2 8.9 7.7 10.6 8.5 13.8 9.3 7.9 8.2 7.9 6.1 8.6 10.1 7.9 11.1 8.5 7.6 11.1 9.3 8.4 10.6 10.5 8.3 8.8 11.3 7.5 8.8 9.0 7.2 10.6 10.5 11.6 7.9 10.6 9.2 98.1 9.4 14.1 8.4 7.6 14.3 9.8 9.2 9.5 8.0 20.4 10.6 11.9 9.9 5.5 13.5 10.2 9.5 10.1 9.9 7.7 14.6 9.7 9.2 13.4 9.3 14.0 10.8 25.6 12.3 7.9 6.0 18.8 22.0 16.3 10.3 13.3 13.8 13.8 7.9 7.9 9.8 33.1 15.1 7.7 16.1 12.4 13.6 8.2 12.1 11.8 22.1 12.0 8.6 18.5 15.0 8.6 30.1 29.2 17.6 18.5 10.8 16.9 9.2 10.6 18.6 23.5 11.7 32.0 9.3 14.7 20.6 21.3 7.2 7.6 11.0 8.7 18.8 15.9 24.6 33.3 6.8 16.8 9.8 20.4 8.3 15.5 8.5 10.1 9.9 7.7 7.0 8.7 8.0 9.5 6.8 8.3 16.0 11.9 10.6 5.1 6.2 5.5 8.5 10.5 15.4 11.2 7.9 6.1 8.5 7.6 8.3 9.4 26.8 40.8 21.7 36.3 47.1 22.4 9.3 25.5 21.4 35.2 7.0 23.6 30.5 14.9 20.2 725.4 23.9 29.3 0.0 15.0 33.1 22.9 32.1 26.6 16.8 18.7 22.3 30.6 18.4 19.8 2397.2 27.0 25.7 21.9 10.8 28.3 18.4 18.3 21.0 24.4 10.9 18.9 25.8 24.7 35.8 26.8 53.1 31.4 27.7 23.0 34.6 ISM2 "FLJ32147, TAIL1, THSD3" ENSG00000100593 "Isthmin 2" Q6H9L7 14 77474394-77498850 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "placenta: 193.8" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 240.2;Extravillous trophoblasts: 440.1;Syncytiotrophoblasts: 148.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "basal ganglia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "BEWO: 91.4" "Not detected" "Not detected" "HPA039314, HPA039742" Supported Supported Nucleoplasm "Secreted in female reproductive system" NA NA Nucleoplasm "HPA039314: AB_10673239, HPA039742: AB_10673427" "unprognostic (5.69e-2)" "unprognostic (9.17e-3)" "unprognostic (2.58e-2)" "unprognostic (1.41e-3)" "unprognostic (3.73e-2)" "unprognostic (2.34e-1)" "unprognostic (2.16e-2)" "unprognostic (3.09e-3)" "unprognostic (2.11e-1)" "unprognostic (4.13e-1)" "unprognostic (8.10e-2)" "unprognostic (1.42e-2)" "unprognostic (9.36e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (3.95e-1)" 0.7 0.0 0.2 0.2 4.2 0.0 0.1 0.1 0.3 1.1 0.2 0.1 0.3 0.1 2.7 0.9 0.2 0.5 0.1 0.1 0.1 0.8 0.6 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.5 193.8 0.2 3.2 0.0 0.2 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.2 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.1 0.3 0.1 0.8 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 240.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 440.1 0.3 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 148.4 0.0 0.0 0.0 ITGB3BP "CENPR, HSU37139, NRIF3, TAP20" ENSG00000142856 "Integrin subunit beta 3 binding protein" Q13352 1 63440770-63593721 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028463 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028463: AB_10601435" "unprognostic (4.98e-2)" "unprognostic (5.88e-3)" "unprognostic (6.28e-3)" "unprognostic (3.96e-2)" "unprognostic (4.58e-1)" "prognostic favorable (4.32e-4)" "prognostic unfavorable (7.24e-5)" "unprognostic (2.68e-2)" "unprognostic (7.89e-3)" "unprognostic (2.15e-2)" "unprognostic (1.35e-1)" "unprognostic (4.97e-3)" "prognostic unfavorable (8.45e-6)" "unprognostic (1.34e-2)" "unprognostic (5.24e-2)" "unprognostic (7.34e-3)" "unprognostic (6.14e-2)" 8.3 11.3 10.9 11.2 14.2 8.3 12.8 17.6 16.3 11.8 8.6 3.1 4.4 6.5 10.1 13.8 13.6 11.3 9.0 6.5 12.5 3.6 13.2 7.1 8.1 13.8 17.6 3.6 15.5 12.6 15.1 29.4 8.3 13.7 10.7 8.9 4.5 12.5 6.4 6.1 8.6 8.7 9.6 16.5 12.0 9.6 17.1 15.0 17.6 11.6 9.0 13.6 11.0 11.5 13.5 6.8 7.1 3.3 11.6 10.2 5.7 24.2 11.6 13.7 11.3 3.3 10.5 12.8 11.8 7.1 20.6 25.3 6.5 11.2 22.1 9.1 2.9 10.3 17.5 10.9 11.3 25.3 16.4 26.1 16.8 16.4 13.1 3.6 23.0 11.1 2.5 8.9 11.5 9.4 9.6 10.5 12.9 19.4 29.5 2.7 10.1 24.7 21.3 18.0 9.2 13.1 16.1 24.7 32.7 13.5 7.0 18.3 11.0 13.5 7.7 18.7 21.5 7.8 7.7 6.4 7.0 10.4 14.5 17.7 14.9 24.0 20.8 11.5 28.9 10.8 7.1 3.3 0.9 5.8 2.4 9.5 13.5 9.0 8.7 4.0 12.8 10.2 8.7 1.0 11.6 2.9 6.8 9.5 5.7 10.9 14.2 17.6 16.3 12.5 3.6 17.6 3.6 13.7 15.0 8.9 8.6 52.6 43.2 30.1 9.4 9.9 28.1 37.5 35.2 24.4 9.8 31.6 24.9 34.7 65.0 20.2 5.0 70.0 29.7 49.0 20.3 18.0 23.1 7.9 25.3 6.4 16.7 20.3 24.1 95.1 19.8 17.0 20.3 27.1 16.7 21.1 28.9 0.0 24.4 21.0 14.0 32.3 21.7 117.9 61.4 28.5 16.0 26.2 24.8 25.4 ITPKB "IP3-3KB, IP3KB" ENSG00000143772 "Inositol-trisphosphate 3-kinase B" P27987 1 226631690-226739323 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.1" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 35.8;Ito cells: 27.0;Smooth muscle cells: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030273, HPA072923" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA030273: AB_10601127, HPA072923: AB_2686558" "unprognostic (4.54e-2)" "unprognostic (3.85e-2)" "unprognostic (8.41e-3)" "unprognostic (9.37e-3)" "unprognostic (1.53e-1)" "prognostic favorable (1.72e-5)" "unprognostic (1.24e-1)" "prognostic favorable (6.65e-4)" "unprognostic (2.29e-1)" "unprognostic (9.57e-2)" "unprognostic (1.41e-2)" "unprognostic (1.75e-2)" "unprognostic (3.23e-3)" "unprognostic (2.90e-2)" "unprognostic (7.46e-2)" "unprognostic (6.54e-3)" "unprognostic (7.87e-2)" 23.8 4.2 34.7 13.0 35.1 14.8 15.2 11.1 33.6 14.3 19.7 32.4 8.5 6.0 27.1 15.6 12.6 15.3 8.9 7.8 27.9 24.8 9.7 3.2 13.4 22.7 50.4 16.3 8.8 4.8 10.1 4.2 13.5 40.0 13.1 6.3 20.8 24.9 21.3 9.8 10.5 12.5 32.6 63.1 19.0 12.4 3.2 34.0 20.0 5.9 4.3 17.1 19.6 8.5 3.1 0.9 7.7 3.5 3.0 7.9 2.6 2.8 3.0 4.9 5.7 3.9 2.5 1.3 0.8 3.4 1.6 3.7 0.5 3.6 13.1 4.7 0.7 0.3 4.2 6.3 2.5 0.8 1.8 4.3 5.8 3.4 0.0 1.5 5.4 10.3 2.8 3.7 1.7 1.6 4.4 10.7 6.7 0.0 1.8 0.2 2.7 9.9 7.3 10.9 2.1 4.9 3.8 8.9 2.9 11.5 4.6 2.9 3.8 2.3 1.7 28.6 5.1 7.3 6.1 7.4 2.1 1.6 1.8 4.6 0.1 4.6 16.0 0.5 4.9 7.5 1.2 1.4 7.7 4.4 2.1 3.9 1.9 5.3 4.5 0.9 3.1 7.9 5.7 5.4 3.0 3.5 0.8 3.0 2.6 34.7 35.1 11.1 27.9 27.9 24.8 50.4 16.3 40.0 34.0 0.0 6.1 11.1 3.8 10.9 0.3 5.6 0.0 2.7 5.7 7.0 0.0 0.5 3.3 2.0 2.0 35.8 1.3 0.0 2.0 1.1 8.5 6.5 9.3 0.9 16.4 0.0 4.1 27.0 17.7 16.5 6.6 8.6 18.6 2.8 2.6 1.4 2.3 3.2 8.9 0.5 0.0 0.0 32.0 0.9 2.3 8.8 0.3 22.3 2.9 2.1 IWS1 "DKFZp761G0123, FLJ10006, FLJ14655, FLJ32319" ENSG00000163166 "IWS1, SUPT6H interacting protein" Q96ST2 2 127436207-127526886 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035719, HPA061866" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035719: AB_10669527, HPA061866: AB_2684628" "unprognostic (3.11e-2)" "unprognostic (1.31e-1)" "unprognostic (1.80e-2)" "unprognostic (3.07e-2)" "unprognostic (1.44e-1)" "unprognostic (1.17e-2)" "unprognostic (8.49e-2)" "unprognostic (1.05e-1)" "unprognostic (4.27e-2)" "unprognostic (2.25e-1)" "unprognostic (4.32e-2)" "unprognostic (9.96e-2)" "unprognostic (1.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.10e-2)" "unprognostic (9.01e-2)" "unprognostic (9.81e-2)" 18.6 16.5 21.7 24.5 30.8 25.4 22.9 32.7 25.3 19.6 18.6 23.6 19.1 21.2 21.7 23.1 19.6 18.3 17.8 30.8 24.3 21.4 18.9 27.0 19.1 24.2 32.4 21.8 16.7 18.8 26.8 30.6 35.6 24.9 21.1 22.6 13.4 19.9 19.1 40.5 17.2 20.1 21.0 27.9 23.4 18.4 20.3 32.3 31.4 18.8 24.8 25.2 19.1 23.0 15.7 13.6 18.3 16.4 15.0 13.2 9.2 21.9 15.0 30.3 19.7 23.3 19.4 31.7 32.1 22.0 29.9 25.2 35.0 16.9 20.7 17.0 25.6 22.8 18.1 29.0 25.1 35.7 21.4 19.7 29.0 21.7 38.8 27.4 32.6 24.1 19.0 19.3 31.6 28.6 15.9 25.4 26.1 30.5 16.4 28.3 20.4 32.2 26.7 40.5 18.3 20.2 29.2 23.8 19.0 30.0 26.8 23.7 15.4 23.0 28.9 25.3 34.2 12.9 22.8 28.9 29.7 22.5 17.9 18.8 12.7 13.9 28.2 16.5 23.2 19.6 3.8 13.8 18.3 11.2 14.9 13.2 12.0 12.5 13.0 13.6 15.7 11.8 12.3 14.5 15.0 16.4 12.2 11.1 9.2 21.7 30.8 32.7 25.3 24.3 21.4 32.4 21.8 24.9 32.3 104.2 66.6 34.3 45.4 14.0 26.6 62.9 25.5 52.2 72.8 15.7 25.5 33.4 16.6 32.9 6.5 24.3 27.5 0.0 22.1 44.1 25.5 45.0 39.5 22.2 23.7 20.6 27.0 20.3 16.5 6.2 36.2 28.8 10.1 35.1 19.7 28.4 33.6 21.5 29.7 17.7 43.7 32.3 38.3 56.6 54.1 14.9 77.6 32.4 22.5 80.0 JADE2 "JADE-2, KIAA0239, PHF15" ENSG00000043143 "Jade family PHD finger 2" Q9NQC1 5 134524312-134583230 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025959, HPA055789" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA025959: AB_1855289, HPA055789: AB_2682922" "unprognostic (8.98e-2)" "unprognostic (1.38e-1)" "unprognostic (1.10e-2)" "unprognostic (1.29e-1)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (7.69e-2)" "unprognostic (5.56e-2)" "unprognostic (8.25e-2)" "prognostic unfavorable (4.42e-4)" "unprognostic (1.58e-2)" "unprognostic (3.49e-2)" "prognostic favorable (5.36e-6)" "unprognostic (3.73e-1)" "unprognostic (1.76e-3)" "unprognostic (2.68e-1)" "unprognostic (2.87e-2)" 15.6 19.8 16.7 16.1 22.0 9.7 13.9 22.8 21.7 16.0 13.4 15.3 9.2 12.7 13.9 8.4 11.8 20.6 13.2 13.4 17.8 14.5 14.8 4.7 15.0 25.8 30.8 16.0 28.4 14.0 30.9 14.4 8.5 20.1 12.8 8.2 16.4 15.0 16.9 12.0 11.5 17.8 13.0 16.8 22.9 12.9 8.1 30.8 13.0 20.6 6.0 19.2 20.0 22.7 7.3 2.0 6.8 3.0 3.1 6.2 2.4 28.7 20.5 0.6 0.8 7.2 8.7 9.4 5.2 13.7 9.6 11.3 15.6 22.4 31.7 11.6 6.7 9.7 6.1 3.6 27.5 4.8 19.1 1.4 7.4 14.3 4.2 7.2 8.1 1.1 5.8 13.3 11.7 14.8 7.6 7.2 9.5 4.6 11.9 5.8 10.3 14.0 7.3 6.8 8.8 10.7 12.6 0.6 12.4 9.0 8.0 4.4 2.9 12.8 0.4 18.4 5.8 5.6 10.1 10.1 6.8 6.1 19.1 12.9 5.5 23.0 29.3 10.5 14.6 9.5 6.8 1.2 4.4 6.2 1.1 6.0 7.3 5.7 5.6 2.0 5.5 5.6 5.6 1.3 3.1 3.0 1.2 5.8 2.4 16.7 22.0 22.8 21.7 17.8 14.5 30.8 16.0 20.1 30.8 8.9 9.1 20.8 6.1 3.8 21.4 10.1 10.2 6.7 4.5 7.0 33.4 6.4 6.6 4.6 0.2 9.2 8.4 0.0 14.6 8.4 8.1 4.3 2.3 3.0 4.0 9.5 11.1 15.4 30.1 0.0 19.0 8.0 1.7 22.6 9.7 6.0 8.8 3.5 18.0 9.1 21.8 0.0 10.8 0.2 1.5 3.1 6.1 20.2 11.9 3.4 JMJD6 "KIAA0585, PTDSR, PTDSR1" ENSG00000070495 "Arginine demethylase and lysine hydroxylase" Q6NYC1 17 76712832-76726799 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 80.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004548, HPA059156" Supported Supported Nucleoplasm No No Nucleoplasm "CAB004548: AB_628185, HPA059156: AB_2683934" "unprognostic (1.26e-1)" "unprognostic (6.27e-2)" "unprognostic (8.06e-2)" "unprognostic (9.46e-2)" "unprognostic (5.95e-2)" "unprognostic (4.14e-3)" "prognostic unfavorable (5.75e-6)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (2.56e-2)" "prognostic favorable (5.71e-4)" "unprognostic (5.66e-2)" "prognostic unfavorable (7.59e-7)" "unprognostic (1.15e-1)" "unprognostic (1.31e-1)" "unprognostic (8.86e-2)" "unprognostic (3.82e-1)" 14.9 15.9 10.7 12.6 14.9 80.6 14.3 20.5 18.7 9.9 17.5 8.5 10.5 11.7 12.2 6.6 12.2 11.5 14.7 26.0 11.9 7.3 9.7 11.1 14.6 11.0 17.8 7.8 16.7 13.7 10.6 13.3 12.3 16.9 11.9 8.6 8.3 9.7 10.2 19.6 8.6 10.5 13.7 13.8 12.7 14.7 11.2 18.6 5.4 11.0 8.6 10.0 16.1 57.5 13.4 17.3 25.2 24.8 8.6 20.4 12.8 16.4 22.7 8.0 10.4 10.4 9.0 7.8 15.2 11.8 22.1 21.6 22.9 8.2 10.8 6.7 16.4 32.5 12.6 25.3 7.5 21.4 7.7 20.1 16.1 15.9 23.1 16.7 8.4 24.7 10.6 11.9 24.3 8.2 14.1 18.4 5.9 23.9 20.2 16.4 10.3 14.5 12.0 7.0 15.9 27.5 11.5 15.1 16.7 7.5 5.2 13.9 13.7 13.2 19.6 18.1 14.4 17.5 12.5 11.8 25.9 15.1 13.3 28.1 22.4 11.9 10.0 25.0 7.4 14.3 25.1 19.4 25.2 17.6 24.8 17.0 13.4 20.4 19.5 17.3 9.2 17.0 15.8 15.4 8.6 23.7 14.9 19.5 12.8 10.7 14.9 20.5 18.7 11.9 7.3 17.8 7.8 16.9 18.6 23.8 25.1 29.2 77.6 73.8 14.6 19.8 20.4 12.0 22.7 8.7 47.1 25.1 14.9 26.0 22.7 26.3 38.4 0.0 23.8 37.8 34.9 35.0 63.6 8.6 28.6 6.4 37.7 27.0 17.6 8.6 15.0 33.2 55.6 37.9 18.1 14.1 24.5 19.9 16.6 6.7 34.5 12.9 62.8 45.9 25.9 64.4 25.5 38.3 20.4 33.1 JMY "FLJ37870, WHAMM2" ENSG00000152409 "Junction mediating and regulatory protein, p53 cofactor" Q8N9B5 5 79236189-79327215 "Predicted intracellular proteins" "DNA damage, DNA repair" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 17.4;Karpas-707: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037508, HPA043308" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037508: , HPA043308: AB_10806502" "unprognostic (1.87e-2)" "unprognostic (2.12e-3)" "unprognostic (4.28e-1)" "unprognostic (1.79e-1)" "unprognostic (4.30e-2)" "unprognostic (5.28e-3)" "unprognostic (2.10e-2)" "unprognostic (1.16e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "prognostic favorable (3.03e-5)" "unprognostic (7.21e-2)" "unprognostic (3.22e-1)" "unprognostic (1.85e-1)" "unprognostic (4.15e-1)" 8.6 9.2 13.4 5.8 17.0 14.8 10.3 21.7 15.8 13.6 17.8 10.1 13.0 5.8 20.3 12.9 10.0 9.2 8.4 8.5 11.2 8.9 11.5 9.1 7.1 7.6 13.6 13.4 24.7 15.9 24.8 12.5 5.8 11.7 13.5 7.9 9.2 11.9 11.0 15.4 11.9 8.2 13.0 9.7 8.1 9.5 12.0 14.1 10.4 17.7 5.1 7.2 13.5 10.2 0.9 0.8 0.4 0.4 3.7 1.7 0.1 2.4 2.4 1.8 4.8 5.2 4.7 6.5 2.4 6.1 2.2 3.6 1.1 2.7 1.7 17.4 2.6 2.5 2.7 6.5 3.1 3.5 7.5 6.0 3.4 3.8 2.4 7.9 1.5 2.2 4.4 8.5 1.0 9.6 4.5 2.7 4.7 2.0 29.8 1.8 3.3 3.2 3.2 3.0 0.5 1.6 3.2 5.9 7.2 4.7 2.6 7.4 4.0 3.0 3.3 5.5 3.3 2.7 3.2 2.8 0.9 1.6 0.5 1.5 8.5 7.3 1.7 1.9 1.5 1.6 0.0 0.4 0.1 1.4 0.4 0.9 0.9 1.4 1.4 0.1 0.8 1.7 1.2 0.4 3.7 0.3 0.8 1.2 0.1 13.4 17.0 21.7 15.8 11.2 8.9 13.6 13.4 11.7 14.1 8.9 12.2 7.5 10.3 26.6 32.0 32.7 17.8 20.1 14.8 15.7 41.2 5.1 1.7 6.5 23.3 13.0 4.7 0.0 8.5 4.7 16.9 16.5 8.1 13.9 4.0 38.1 23.0 4.9 5.4 15.4 22.5 9.9 21.9 1.0 8.4 17.3 13.0 10.4 33.6 6.5 38.4 12.9 25.5 22.9 41.1 34.8 16.9 17.0 7.3 9.2 JPH1 JP-1 ENSG00000104369 "Junctophilin 1" Q9HDC5 8 74234700-74321328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 97.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 35.7;Basal glandular cells: 27.1;Cardiomyocytes: 31.6;Glandular cells: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 10.1;OE19: 12.1;SK-BR-3: 24.2;T-47d: 17.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008996, HPA009413, CAB013461" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163" "unprognostic (2.91e-3)" "unprognostic (3.01e-1)" "unprognostic (8.85e-2)" "unprognostic (8.73e-6)" "unprognostic (2.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.63e-2)" "prognostic favorable (5.77e-5)" "unprognostic (8.97e-2)" "unprognostic (1.30e-1)" "unprognostic (2.38e-1)" "unprognostic (5.99e-2)" "unprognostic (9.80e-2)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-2)" 1.7 0.6 1.8 0.7 5.7 0.5 0.8 13.7 3.1 0.8 1.9 0.8 0.4 0.8 1.5 1.7 1.8 0.6 0.6 3.3 2.1 0.7 0.8 0.5 2.2 0.5 1.0 4.2 0.5 3.5 1.1 0.4 1.1 2.4 1.8 2.8 0.0 1.3 0.8 97.2 0.7 0.9 1.4 2.4 0.5 0.9 0.9 2.3 2.4 1.2 21.5 1.4 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.4 0.1 3.1 0.0 1.0 0.0 0.7 4.5 3.9 3.1 1.0 0.0 5.9 0.0 3.6 0.0 0.5 2.0 0.2 0.6 2.6 0.0 2.9 0.0 0.0 7.8 0.5 0.0 0.2 2.8 10.1 0.0 6.8 12.1 2.0 5.1 3.9 0.0 0.1 9.0 5.2 0.7 0.0 24.2 1.2 1.2 17.2 0.1 0.0 1.2 1.7 0.4 1.0 0.0 0.0 0.0 2.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 5.7 13.7 3.1 2.1 0.7 1.0 4.2 2.4 2.3 35.7 8.0 0.0 27.1 2.5 0.0 31.6 0.0 8.1 15.9 1.8 5.9 0.0 0.0 0.2 2.1 0.4 1.3 0.0 1.2 0.0 2.1 24.9 0.0 0.0 0.1 0.0 12.1 0.0 0.0 0.4 0.9 0.2 1.7 0.0 10.1 0.2 3.4 8.0 0.0 0.7 0.0 0.0 2.3 0.1 3.6 1.8 0.0 0.0 5.6 16.6 JUN "AP-1, c-Jun" ENSG00000177606 "Jun proto-oncogene, AP-1 transcription factor subunit" P05412 1 58780788-58784327 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 71.6" "Low region specificity" "Detected in all" "CAB003801, CAB007780, HPA031174, HPA059474" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030" "unprognostic (2.06e-2)" "unprognostic (1.76e-2)" "unprognostic (1.34e-1)" "unprognostic (7.85e-2)" "unprognostic (1.60e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" "unprognostic (5.21e-2)" "unprognostic (1.24e-1)" "unprognostic (5.00e-2)" "unprognostic (2.14e-1)" "unprognostic (2.82e-1)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.83e-1)" "unprognostic (2.37e-1)" "unprognostic (2.81e-3)" 64.5 29.4 26.7 33.7 17.2 68.4 61.7 19.5 20.6 60.0 32.7 30.8 28.4 13.3 40.5 21.8 34.1 72.6 48.5 31.3 20.2 12.4 21.2 39.3 55.1 14.3 15.3 12.0 49.8 48.7 15.0 16.7 21.6 24.1 48.6 16.7 40.5 59.4 39.3 32.2 51.3 28.6 40.7 17.6 22.9 47.0 18.2 18.1 9.0 61.0 35.2 23.3 41.5 33.1 7.4 1.3 4.0 5.1 3.2 2.5 1.2 16.1 2.3 5.2 1.0 8.3 9.5 0.1 20.6 7.5 14.6 8.9 4.2 1.2 0.6 9.9 12.8 31.6 5.6 0.4 6.7 9.3 12.8 37.5 0.2 0.9 4.7 6.9 1.1 3.7 10.2 17.3 18.8 7.9 6.6 10.9 0.7 5.7 9.4 5.6 3.0 1.0 9.0 4.2 7.8 14.7 0.4 71.6 3.2 13.7 1.5 14.5 4.2 14.3 15.0 6.0 5.9 5.3 0.6 19.1 33.3 15.1 12.0 25.8 20.9 3.3 1.2 34.8 2.1 9.5 1.2 5.1 2.0 2.4 1.1 1.3 4.1 1.2 2.5 1.3 7.4 0.3 1.7 4.0 3.2 0.4 0.2 0.9 1.2 26.7 17.2 19.5 20.6 20.2 12.4 15.3 12.0 24.1 18.1 500.2 627.8 505.0 717.3 1097.5 107.5 1349.5 494.3 76.3 282.1 99.5 247.4 529.1 43.1 569.2 40.2 960.8 1411.6 46.7 449.9 86.5 867.7 1920.0 529.9 118.4 560.4 82.6 1440.1 352.4 430.2 18.1 1136.5 481.3 718.7 237.2 1907.1 688.6 543.7 1520.1 243.3 25.0 400.6 1513.4 1714.3 15.6 13.8 843.0 347.6 518.9 938.7 449.9 JUNB ENSG00000171223 "JunB proto-oncogene, AP-1 transcription factor subunit" P17275 19 12791496-12793315 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Smooth muscle cells: 2844.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 101.1" "Group enriched" "Detected in all" 5 "granulocytes: 101.1;monocytes: 27.0" "Cell line enhanced" "Detected in many" "HDLM-2: 106.6;U-266/70: 45.7;U-266/84: 67.8" "Group enriched" "Detected in many" 5 "amygdala: 25.2;basal ganglia: 16.8;cerebral cortex: 31.3;hippocampal formation: 24.3;olfactory region: 15.1" "Region enriched" "Detected in single" 20 "cerebellum: 17.1" "CAB004464, HPA019149" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB004464: AB_2130023, HPA019149: AB_1852053" "unprognostic (1.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.04e-1)" "unprognostic (7.17e-2)" "unprognostic (1.77e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.79e-1)" "unprognostic (9.78e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (7.20e-2)" "unprognostic (7.06e-2)" "unprognostic (3.77e-1)" "unprognostic (1.02e-1)" 83.4 95.3 8.7 57.2 16.6 153.1 29.0 8.3 16.0 57.6 33.1 29.2 13.0 20.7 26.6 23.7 84.8 128.6 103.5 46.4 10.2 9.9 20.4 54.5 76.2 23.1 10.3 7.1 108.1 25.0 10.5 43.8 44.4 21.5 63.8 9.7 47.3 37.8 84.3 54.3 66.0 32.9 33.6 15.7 25.7 39.7 15.3 11.6 12.2 27.1 71.9 53.3 71.7 37.9 4.7 12.7 101.1 27.0 2.6 6.5 12.7 8.9 1.8 0.5 1.1 2.0 5.0 1.8 3.9 3.4 1.9 1.8 1.1 5.3 3.1 13.8 1.4 5.9 17.0 0.4 5.9 0.2 106.6 1.7 3.0 6.8 1.5 2.7 4.1 14.3 6.3 17.4 1.7 1.3 3.9 0.9 2.2 8.0 5.7 0.6 26.9 2.8 24.9 0.3 6.1 7.0 3.8 1.3 6.4 1.3 11.3 4.2 6.4 17.1 10.5 4.9 0.3 1.8 4.6 3.0 5.7 3.3 11.4 4.9 45.7 67.8 2.8 6.7 10.6 1.5 3.5 17.4 18.5 5.2 27.0 5.3 4.7 5.7 6.5 12.7 4.4 4.1 4.3 101.1 2.6 24.7 1.1 5.5 12.7 8.7 16.6 8.3 16.0 10.2 9.9 10.3 7.1 21.5 11.6 107.2 621.9 699.4 682.5 1300.3 80.0 296.2 231.8 71.0 126.3 146.5 37.3 100.9 41.4 570.4 6.9 1195.0 682.0 70.0 486.4 175.7 1823.6 1011.1 495.7 64.4 1063.7 20.6 1445.6 268.2 528.1 10.3 754.8 1027.7 848.6 461.7 904.4 381.1 718.1 736.4 247.5 63.6 159.5 1144.8 2844.2 7.1 9.8 1577.0 368.2 643.4 570.8 396.1 JUND AP-1 ENSG00000130522 "JunD proto-oncogene, AP-1 transcription factor subunit" P17535 19 18279760-18281622 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 204.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005268, HPA063029" Supported Supported Nucleoplasm No No Nucleoplasm "CAB005268: AB_2130177, HPA063029: AB_2684925" "prognostic favorable (6.15e-5)" "unprognostic (4.18e-3)" "unprognostic (8.89e-2)" "unprognostic (2.52e-1)" "unprognostic (3.70e-1)" "unprognostic (6.39e-2)" "unprognostic (1.63e-2)" "unprognostic (6.35e-2)" "unprognostic (3.48e-2)" "unprognostic (2.00e-1)" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (3.35e-2)" "unprognostic (1.22e-1)" "unprognostic (3.99e-1)" "unprognostic (5.37e-2)" "unprognostic (1.49e-1)" 75.7 52.7 35.4 38.9 32.4 204.7 51.5 34.7 56.5 42.4 49.5 42.6 21.1 35.7 43.4 31.0 31.7 55.7 43.5 35.9 31.5 32.1 26.9 66.5 55.7 17.2 21.6 22.6 78.1 64.3 21.7 47.8 80.3 27.0 45.5 21.0 35.2 39.0 33.3 29.2 44.5 61.8 34.4 31.5 39.3 46.2 34.9 19.2 32.0 27.2 33.7 23.1 41.7 30.8 8.6 10.7 19.0 7.8 4.5 6.3 1.7 22.3 9.5 9.5 10.6 7.5 8.4 41.9 9.4 11.3 5.3 7.2 10.2 20.2 11.6 11.1 9.6 8.9 12.2 2.3 2.2 2.7 23.0 20.6 17.1 7.8 22.2 16.8 8.0 22.3 8.1 9.6 5.7 7.4 12.8 4.2 5.2 23.3 33.9 1.4 29.8 23.5 24.9 19.7 6.2 13.7 8.7 5.9 24.4 7.7 3.5 51.6 21.2 11.6 12.8 30.5 11.2 10.7 12.0 14.6 3.2 15.4 20.7 5.7 47.5 18.8 9.3 11.5 12.1 7.6 8.0 6.4 5.8 4.9 7.8 3.8 7.4 6.3 4.4 4.6 8.6 4.7 4.9 19.0 4.5 7.4 10.7 5.1 1.7 35.4 32.4 34.7 56.5 31.5 32.1 21.6 22.6 27.0 19.2 166.7 583.1 114.2 384.1 281.7 132.7 131.9 277.7 40.2 80.8 244.3 74.6 62.1 26.6 75.1 45.5 195.4 591.7 0.0 119.6 99.8 176.3 381.2 256.9 414.0 90.7 131.9 546.1 198.2 227.2 34.1 114.2 233.6 236.2 46.9 344.1 497.9 140.1 270.0 83.4 55.0 167.8 129.4 254.4 4.4 18.5 344.5 137.4 102.3 148.5 185.6 KANSL1 "CENP-36, DKFZP727C091, KIAA1267, MSL1v1, NSL1" ENSG00000120071 "KAT8 regulatory NSL complex subunit 1" Q7Z3B3 17 46029916-46225389 "Predicted intracellular proteins" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 157.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006874, HPA007208" Approved Supported Nucleoplasm No No Nucleoplasm "HPA006874: AB_1852393, HPA007208: AB_1852395" "unprognostic (2.46e-1)" "unprognostic (2.55e-1)" "unprognostic (2.11e-1)" "unprognostic (1.37e-1)" "unprognostic (2.33e-2)" "unprognostic (4.45e-2)" "prognostic unfavorable (3.74e-4)" "unprognostic (1.54e-2)" "unprognostic (9.28e-2)" "unprognostic (7.79e-3)" "unprognostic (2.01e-1)" "unprognostic (1.16e-1)" "unprognostic (2.84e-2)" "unprognostic (6.13e-2)" "unprognostic (1.29e-1)" "unprognostic (5.76e-2)" "unprognostic (1.33e-2)" 14.2 11.0 8.9 11.3 12.6 18.2 17.2 24.6 12.1 15.3 11.7 19.6 7.7 6.5 20.3 14.9 14.7 14.0 11.0 9.7 8.1 8.3 13.9 7.8 13.0 18.8 13.2 6.5 19.5 16.8 13.9 11.4 13.4 14.7 13.7 13.3 13.6 12.6 7.8 15.9 17.8 15.6 16.2 18.2 18.8 13.3 25.6 14.6 42.8 14.2 5.5 14.2 16.8 26.6 2.1 1.1 1.8 0.6 1.7 2.6 0.7 1.7 1.4 6.5 3.2 0.9 2.5 4.2 1.4 2.5 3.2 3.8 6.5 0.5 6.3 2.5 6.9 9.7 3.8 13.2 4.8 6.4 7.1 6.5 0.9 2.7 8.2 10.7 0.7 2.3 2.5 10.2 7.1 10.9 3.4 7.9 11.0 2.5 7.2 6.9 2.5 23.7 1.2 2.0 0.5 8.4 13.7 11.9 11.4 4.5 4.1 3.3 8.1 8.8 0.3 5.7 19.9 10.1 13.0 6.8 14.0 8.2 5.4 1.7 12.4 8.2 10.0 3.8 3.5 9.7 0.1 0.6 1.7 1.6 0.4 1.6 2.1 1.6 2.6 0.2 1.0 1.6 1.3 1.8 1.7 0.6 1.1 1.8 0.7 8.9 12.6 24.6 12.1 8.1 8.3 13.2 6.5 14.7 14.6 29.8 36.7 32.2 16.0 24.2 64.8 10.4 15.3 12.0 12.5 45.4 96.2 13.0 1.7 34.3 157.2 31.5 27.5 0.0 22.2 16.9 22.4 23.4 23.1 18.7 18.2 65.2 30.6 31.3 37.1 106.7 32.2 26.2 20.3 43.3 28.8 31.9 35.1 24.6 28.3 7.9 84.7 25.8 19.4 24.0 44.5 26.3 12.2 30.5 26.9 23.3 KAT5 "cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5" ENSG00000172977 "Lysine acetyltransferase 5" Q92993 11 65711996-65719604 "Enzymes, Predicted intracellular proteins, Transcription factors" "Growth regulation, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016953 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA016953: AB_1851277" "unprognostic (2.20e-1)" "unprognostic (3.58e-1)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "unprognostic (9.61e-2)" "unprognostic (7.16e-2)" "unprognostic (1.29e-3)" "unprognostic (1.20e-1)" "unprognostic (2.01e-1)" "unprognostic (2.74e-1)" "unprognostic (2.13e-1)" "unprognostic (2.54e-1)" "prognostic favorable (1.10e-13)" "unprognostic (1.37e-1)" "unprognostic (2.55e-1)" "unprognostic (1.85e-1)" "unprognostic (8.54e-2)" 18.5 19.5 21.2 16.0 27.4 34.3 21.6 29.4 37.1 22.1 24.1 28.2 22.3 16.5 30.1 24.8 21.2 32.9 24.5 21.1 18.3 19.2 22.6 16.1 20.8 18.3 19.0 25.7 29.5 23.2 38.8 22.0 32.7 24.6 21.2 19.4 29.3 23.6 27.5 24.6 27.6 19.2 25.2 20.1 22.0 21.9 30.7 22.8 26.9 26.5 19.1 22.1 24.4 22.0 25.0 24.0 40.4 23.6 24.8 28.6 23.3 19.1 23.4 21.3 16.2 16.9 17.9 22.4 13.9 22.7 23.3 20.3 17.0 22.9 17.6 19.9 24.3 25.7 16.2 26.5 23.3 14.1 22.9 17.0 25.8 19.3 20.1 24.3 28.1 31.0 19.0 26.1 15.3 31.5 18.0 14.6 20.7 26.6 27.6 22.0 34.9 23.8 32.9 18.6 13.7 15.1 19.6 14.1 32.2 21.3 29.1 19.9 21.0 13.2 25.0 26.5 11.6 24.5 18.2 18.7 18.9 16.7 14.9 14.9 21.2 21.8 25.9 16.3 13.8 15.4 23.4 23.6 40.4 25.7 22.3 22.1 21.1 22.5 25.5 24.0 25.0 28.6 23.3 26.1 24.8 23.3 14.5 21.5 23.3 21.2 27.4 29.4 37.1 18.3 19.2 19.0 25.7 24.6 22.8 11.9 13.7 18.8 38.6 18.8 41.0 0.6 17.8 24.1 14.8 27.9 29.5 43.8 29.9 35.7 7.2 16.8 22.2 0.0 44.9 35.8 24.2 20.6 33.4 9.3 32.0 36.5 29.1 16.5 14.9 9.4 25.9 18.3 40.5 53.3 18.0 36.1 31.7 25.9 36.4 25.6 34.3 45.3 33.0 35.4 22.7 18.6 85.7 25.5 24.7 24.6 KAT8 "FLJ14040, hMOF, MOF, MYST1, ZC2HC8" ENSG00000103510 "Lysine acetyltransferase 8" Q9H7Z6 16 31115754-31131393 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 17.8;neutrophil: 17.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066324 Supported Nucleoplasm NA NA Nucleoplasm "HPA066324: AB_2685658" "unprognostic (8.58e-2)" "unprognostic (9.53e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "unprognostic (8.59e-2)" "unprognostic (1.06e-1)" "unprognostic (3.22e-1)" "prognostic favorable (6.34e-4)" "unprognostic (3.13e-2)" "unprognostic (3.05e-1)" "unprognostic (5.50e-2)" "unprognostic (9.77e-2)" "unprognostic (7.33e-2)" "unprognostic (2.97e-1)" "unprognostic (1.29e-1)" "unprognostic (5.00e-1)" "unprognostic (1.41e-1)" 18.4 21.7 22.7 29.4 23.6 26.6 29.7 48.9 30.8 28.0 24.8 18.3 27.5 15.7 29.8 48.3 16.7 35.0 28.2 32.7 23.0 21.2 20.8 18.9 26.3 29.0 20.2 21.0 52.8 31.4 38.0 22.2 31.5 16.8 21.2 17.7 22.1 35.1 26.2 39.8 22.1 19.7 25.9 20.5 27.4 18.6 27.3 18.4 30.2 31.7 22.6 22.2 20.2 26.6 2.1 4.1 17.8 4.6 1.7 2.9 1.9 7.7 12.0 15.0 4.5 17.8 13.4 15.4 6.9 13.3 11.2 12.3 6.0 17.0 18.3 11.0 8.6 10.2 9.3 23.9 11.6 11.1 15.3 16.2 7.9 8.8 19.0 16.0 13.1 14.4 12.6 23.4 8.3 24.2 14.7 10.6 19.4 21.1 15.1 5.7 22.6 20.2 24.8 16.9 18.8 7.3 32.6 12.3 21.5 9.0 4.6 15.8 16.1 4.2 11.7 5.8 9.6 12.7 21.8 6.3 4.7 10.1 5.3 5.0 14.4 14.5 10.4 7.2 17.5 7.1 3.9 4.4 17.8 1.9 2.4 2.4 2.1 2.2 2.6 4.1 1.8 2.9 2.1 17.4 1.7 4.6 1.4 1.3 1.9 22.7 23.6 48.9 30.8 23.0 21.2 20.2 21.0 16.8 18.4 17.9 15.6 17.9 35.9 18.4 17.8 15.2 12.7 4.0 14.8 8.7 13.7 25.5 18.3 19.6 99.8 18.5 18.6 23.3 23.2 17.7 24.7 25.4 27.6 11.1 26.6 30.2 23.6 16.5 29.2 102.1 49.8 22.4 23.6 22.6 19.7 36.9 14.8 17.5 50.9 12.4 23.7 25.8 17.5 30.4 18.8 13.7 38.0 20.0 20.7 22.1 KCND1 Kv4.1 ENSG00000102057 "Potassium voltage-gated channel subfamily D member 1" Q9NSA2 X 48961378-48971569 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in some" 8 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Intestinal endocrine cells: 3.4;Leydig cells: 1.7;Peritubular cells: 3.5;Rod photoreceptor cells: 2.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 13.2;NB-4: 10.5;SuSa: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000524, HPA001066" Supported Uncertain Nucleoplasm Yes No Nucleoplasm "HPA000524: AB_2666013, HPA001066: AB_1079662" "unprognostic (6.00e-2)" "unprognostic (2.58e-1)" "unprognostic (1.01e-4)" "unprognostic (2.19e-4)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" "unprognostic (2.79e-1)" "unprognostic (8.13e-3)" "unprognostic (1.13e-2)" "unprognostic (2.41e-3)" "prognostic favorable (2.66e-6)" "unprognostic (2.61e-1)" "unprognostic (4.30e-11)" "unprognostic (3.13e-2)" "unprognostic (3.49e-1)" "unprognostic (7.64e-2)" "unprognostic (2.22e-3)" 4.9 2.4 4.2 3.4 4.7 6.0 2.2 16.8 7.8 5.1 2.2 6.3 1.9 2.0 5.0 3.8 1.4 7.4 6.3 2.9 6.9 2.5 2.5 1.8 3.0 3.1 3.1 3.5 4.6 1.4 1.8 3.0 2.5 10.4 3.3 2.1 2.6 1.2 6.0 0.7 1.6 2.6 6.6 6.5 4.2 2.5 3.0 2.7 1.1 2.3 0.5 3.6 3.0 3.0 0.6 1.3 1.4 0.1 0.0 0.8 0.1 0.4 1.9 0.8 4.7 6.4 5.1 1.6 1.0 4.0 2.8 1.9 1.2 0.6 1.6 3.4 3.1 0.8 0.6 0.8 0.4 2.7 2.6 3.1 1.4 1.9 0.1 2.4 0.4 2.9 13.2 1.8 5.2 0.6 4.7 0.9 2.2 1.1 3.6 2.0 3.5 0.4 10.5 2.5 0.3 0.7 1.3 0.9 1.5 3.1 1.5 0.5 2.1 0.9 0.0 2.1 10.2 2.0 1.5 2.4 0.6 2.6 0.6 0.2 2.9 3.8 3.8 1.7 3.7 2.1 0.0 0.1 0.0 0.5 0.0 0.3 0.6 0.2 0.8 0.0 0.1 0.2 0.0 1.4 0.0 0.0 1.3 0.0 0.1 4.2 4.7 16.8 7.8 6.9 2.5 3.1 3.5 10.4 2.7 0.0 1.4 0.0 0.0 0.7 0.2 0.4 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 3.4 0.6 0.8 0.0 1.7 0.0 0.0 0.0 0.2 0.3 0.1 0.0 3.5 0.0 2.8 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.1 KCNK5 "K2p5.1, TASK-2" ENSG00000164626 "Potassium two pore domain channel subfamily K member 5" O95279 6 39188973-39229450 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 48.4;intestine: 74.2;kidney: 46.3" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 43.3;Enterocytes: 50.9;Proximal tubular cells: 29.1;Syncytiotrophoblasts: 38.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 18.0;OE19: 14.7;T-47d: 14.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059148 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059148: AB_2683929" "unprognostic (1.46e-1)" "prognostic favorable (3.29e-4)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (8.09e-4)" "unprognostic (3.97e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-3)" "unprognostic (7.14e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (2.98e-1)" "prognostic favorable (4.98e-7)" "unprognostic (2.34e-1)" "unprognostic (7.13e-2)" "unprognostic (1.03e-2)" "prognostic favorable (4.45e-4)" 2.2 1.3 0.3 4.5 0.4 4.5 3.9 0.4 0.5 4.3 25.5 0.8 2.6 16.1 5.6 4.0 4.3 1.4 48.4 1.5 0.3 0.0 46.3 12.6 3.6 1.1 0.8 0.4 4.0 15.3 1.2 1.0 15.2 0.8 2.3 4.7 3.6 16.0 1.6 0.5 15.8 74.2 1.3 0.6 1.2 9.4 0.9 0.3 2.0 9.0 2.2 4.1 2.2 3.8 0.0 0.9 0.2 0.1 0.0 1.4 0.5 3.4 3.2 4.3 1.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 18.8 7.8 0.0 5.7 0.0 0.4 7.2 3.3 0.1 0.0 0.0 2.4 19.3 1.5 0.1 0.0 3.9 17.8 0.0 0.0 0.1 0.0 0.0 0.0 4.3 18.0 0.0 0.0 6.1 8.7 4.3 7.9 14.7 0.0 0.0 0.8 7.3 3.0 2.9 1.0 0.8 3.1 4.0 0.0 1.7 14.3 6.5 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.9 1.4 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.9 0.2 0.5 0.3 0.4 0.4 0.5 0.3 0.0 0.8 0.4 0.8 0.3 0.0 19.2 0.0 1.8 3.3 0.0 0.4 43.3 0.0 6.8 1.8 0.0 22.6 5.0 13.0 0.0 0.2 50.9 0.0 10.8 3.9 1.9 1.8 0.0 23.1 1.8 0.0 0.0 0.0 0.3 0.0 0.6 0.7 1.7 1.0 10.8 0.0 7.5 10.5 0.0 29.1 0.0 0.0 0.4 0.0 0.7 2.4 38.1 1.0 6.4 10.7 KCNN3 "hSK3, KCa2.3, SKCA3" ENSG00000143603 "Potassium calcium-activated channel subfamily N member 3" Q9UGI6 1 154697455-154870280 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.7" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 11.9;Ciliated cells: 32.1;Endothelial cells: 16.9" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.8;memory B-cell: 4.8" "Group enriched" "Detected in many" 9 "B-cells: 4.8;granulocytes: 5.8;monocytes: 2.7" "Cell line enhanced" "Detected in some" "Daudi: 18.1;HMC-1: 12.5;Karpas-707: 31.0;RPMI-8226: 8.4;U-266/70: 29.9;U-698: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057127 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA057127: AB_2683345" "unprognostic (2.09e-1)" "unprognostic (2.91e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (7.22e-2)" "unprognostic (4.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (9.51e-2)" "unprognostic (4.07e-3)" "unprognostic (4.89e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (1.71e-2)" "unprognostic (1.54e-1)" "unprognostic (6.93e-2)" "unprognostic (1.80e-2)" 1.7 2.5 20.6 6.5 21.7 1.0 1.8 5.7 26.7 9.3 9.1 12.4 1.1 5.4 12.6 1.7 3.5 10.3 3.1 4.0 21.6 8.0 3.5 1.0 3.1 5.8 12.0 10.9 2.1 1.0 1.5 2.6 0.7 13.3 3.4 4.6 0.1 2.7 2.7 8.5 1.1 3.9 10.6 8.1 5.0 4.4 1.3 15.5 0.2 3.7 3.5 9.2 8.3 4.9 4.8 0.4 5.8 2.7 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 31.0 0.3 0.0 0.1 0.0 0.4 0.0 1.2 0.0 7.7 8.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 29.9 3.9 10.0 0.3 0.0 2.9 5.8 0.0 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.4 20.6 21.7 5.7 10.3 21.6 8.0 12.0 10.9 13.3 15.5 11.9 2.4 0.0 0.5 1.1 0.2 2.2 0.0 32.1 3.4 0.0 2.0 0.0 3.3 0.2 2.6 16.9 0.0 0.0 0.2 0.0 2.3 0.4 0.0 0.0 0.4 0.0 4.1 5.5 0.0 6.2 0.3 0.8 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.5 0.1 1.5 0.0 0.0 0.0 0.1 KCTD11 "C17orf36, KCASH1, REN" ENSG00000213859 "Potassium channel tetramerization domain containing 11" Q693B1 17 7351889-7354944 "Predicted intracellular proteins" "Cell cycle, Growth regulation, Ubl conjugation pathway" "Developmental protein, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 29.2;hTCEpi: 21.5" "Not detected" "Not detected" HPA052035 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA052035: AB_2681704" "unprognostic (1.98e-1)" "unprognostic (5.67e-2)" "unprognostic (1.08e-1)" "prognostic favorable (9.55e-4)" "unprognostic (6.78e-3)" "unprognostic (1.92e-2)" "unprognostic (2.38e-2)" "unprognostic (1.59e-3)" "unprognostic (3.91e-1)" "prognostic unfavorable (5.02e-4)" "unprognostic (7.93e-2)" "unprognostic (3.62e-1)" "unprognostic (1.99e-1)" "unprognostic (2.03e-1)" "unprognostic (8.03e-2)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" 7.4 5.7 4.7 5.3 6.5 0.9 16.2 5.8 5.7 20.1 6.9 7.6 5.1 5.2 8.9 7.5 32.9 8.0 9.8 4.9 3.6 3.6 5.2 5.1 8.6 9.4 10.2 3.4 8.6 10.5 8.2 5.2 15.2 6.0 10.5 5.2 6.5 11.1 9.8 4.3 23.0 6.5 7.1 5.0 8.1 7.9 4.0 5.5 1.5 17.2 23.3 17.0 19.2 22.0 1.8 2.5 8.8 6.0 1.6 2.3 2.5 10.2 4.1 3.1 2.3 13.3 7.8 3.3 6.6 10.7 7.2 6.3 3.7 4.5 1.5 3.7 11.2 6.7 17.9 0.4 29.2 6.1 6.1 1.2 0.1 2.9 0.6 7.0 0.1 5.9 6.1 21.5 7.7 4.2 14.4 2.2 1.2 1.3 1.7 5.3 4.4 0.9 1.4 1.0 4.5 2.4 1.3 2.8 1.4 7.3 4.0 0.1 1.7 4.7 4.7 0.7 4.0 6.7 0.6 4.3 5.8 5.2 3.9 3.4 1.2 0.6 0.4 7.1 3.3 4.3 8.8 3.6 2.4 2.3 6.0 0.8 1.8 1.1 1.0 2.5 1.4 0.6 1.6 0.5 1.6 4.3 0.1 0.2 2.5 4.7 6.5 5.8 5.7 3.6 3.6 10.2 3.4 6.0 5.5 8.9 0.6 1.7 16.0 1.5 3.3 0.4 2.5 10.7 4.5 5.2 2.0 4.2 3.3 11.3 12.7 2.7 7.7 0.0 8.4 5.3 11.4 7.7 4.6 2.4 4.2 1.6 6.9 6.7 3.7 5.3 16.4 5.4 1.7 8.2 4.3 3.9 21.3 4.8 20.5 2.7 1.4 19.4 17.2 0.7 1.0 3.9 8.2 4.3 3.3 17.4 KDELC1 "EP58, MGC5302" ENSG00000134901 "KDEL motif containing 1" Q6UW63 13 102784281-102799007 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 20.1;Peritubular cells: 10.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 6.5" "Group enriched" "Detected in many" 4 "NK-cells: 6.5;T-cells: 4.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020780, HPA043946, HPA064398" Approved Supported Nucleoplasm "Intracellular and membrane" NA NA 7400 Nucleoplasm "CAB020780: , HPA043946: AB_2678743, HPA064398: AB_2685256" "unprognostic (1.97e-2)" "unprognostic (2.34e-1)" "unprognostic (3.21e-1)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (6.68e-3)" "prognostic unfavorable (4.81e-4)" "unprognostic (4.34e-3)" "unprognostic (2.75e-2)" "unprognostic (7.26e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.11e-2)" "unprognostic (1.17e-1)" "unprognostic (2.46e-1)" "unprognostic (2.60e-3)" 7.0 4.6 6.7 4.0 8.2 1.9 7.1 14.8 8.6 8.8 5.6 4.5 6.1 1.8 18.8 5.9 4.9 7.0 10.9 8.4 6.1 2.6 10.0 10.1 5.8 2.9 8.4 3.2 9.8 3.2 2.5 10.5 15.8 5.7 6.0 3.9 5.7 3.4 7.1 1.7 3.3 3.5 16.4 6.3 4.7 4.4 2.6 7.1 3.0 5.2 1.9 2.5 9.0 6.2 0.4 1.2 0.0 0.0 6.5 4.5 0.5 3.8 2.8 18.2 17.4 18.7 14.5 4.4 10.3 8.0 9.7 16.8 8.2 5.5 0.0 8.3 8.5 4.9 6.4 12.9 5.3 9.8 1.6 10.8 4.7 8.7 8.8 16.3 11.9 17.1 13.7 6.1 7.3 7.1 14.5 21.0 5.9 7.6 0.0 5.1 4.2 5.3 9.6 11.6 5.5 8.7 0.0 13.0 4.5 26.5 0.3 2.7 16.8 10.2 2.7 5.7 15.8 7.9 5.2 6.4 6.4 4.7 7.2 10.3 3.6 6.6 0.0 12.5 0.0 11.0 0.0 0.0 0.0 2.7 0.0 4.5 0.4 1.5 2.2 1.2 0.0 0.5 1.4 0.0 6.5 0.0 0.0 1.7 0.5 6.7 8.2 14.8 8.6 6.1 2.6 8.4 3.2 5.7 7.1 3.0 0.3 0.0 0.6 1.0 0.6 0.8 2.5 0.0 0.0 0.0 2.0 4.8 0.0 2.1 0.0 3.4 0.0 0.0 0.3 20.1 7.0 0.2 6.9 2.8 2.7 0.0 1.2 6.2 0.6 0.0 4.6 0.2 0.0 0.0 0.3 0.9 0.5 0.0 10.3 1.0 0.7 6.5 3.1 0.0 1.1 0.9 3.1 1.5 0.5 0.1 KDM1B "AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2" ENSG00000165097 "Lysine demethylase 1B" Q8NB78 6 18155329-18223853 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 4.2;granulocytes: 7.6;monocytes: 9.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031269, HPA055597" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA031269: AB_10601587, HPA055597: " "unprognostic (1.93e-1)" "unprognostic (7.53e-2)" "prognostic favorable (6.94e-4)" "unprognostic (2.57e-2)" "unprognostic (7.25e-2)" "unprognostic (1.08e-1)" "unprognostic (5.57e-3)" "unprognostic (1.32e-2)" "unprognostic (8.41e-2)" "unprognostic (6.84e-2)" "unprognostic (2.16e-1)" "unprognostic (3.17e-2)" "unprognostic (6.68e-2)" "unprognostic (3.02e-2)" "unprognostic (2.90e-1)" "unprognostic (7.36e-2)" "unprognostic (3.53e-1)" 7.3 10.5 19.1 12.2 17.8 27.9 13.4 13.5 14.6 8.6 15.6 10.6 7.2 9.8 7.5 8.2 11.7 17.5 7.5 8.1 13.8 9.6 10.0 8.9 12.1 11.4 15.1 12.0 8.8 7.8 3.9 9.8 5.5 13.5 7.0 15.9 7.1 7.6 6.4 19.1 13.3 10.3 10.0 13.0 10.5 7.1 18.7 13.8 16.0 33.5 7.6 11.5 9.2 10.0 1.6 4.2 7.6 9.6 0.3 0.8 1.2 8.4 5.1 7.2 14.9 9.5 15.3 14.2 7.9 8.4 5.2 7.4 8.7 4.9 21.4 19.3 13.1 16.3 10.3 12.1 14.4 11.6 17.9 9.6 10.4 5.6 9.0 4.8 14.5 11.5 7.5 16.8 13.2 12.5 8.5 5.5 10.7 24.7 3.0 9.0 7.7 8.3 6.2 2.2 21.6 8.4 16.6 14.0 15.5 7.5 11.2 19.8 7.6 6.4 15.6 14.8 8.7 15.4 11.8 4.2 10.5 5.5 7.6 9.2 3.0 8.4 12.0 4.2 11.0 24.3 1.3 5.3 7.6 0.6 9.6 0.4 1.3 0.6 0.6 4.2 1.6 0.6 0.2 5.6 0.3 7.5 1.8 0.8 1.2 19.1 17.8 13.5 14.6 13.8 9.6 15.1 12.0 13.5 13.8 0.0 8.0 4.7 3.6 11.3 4.6 9.4 5.1 17.4 14.8 1.8 9.8 2.3 1.7 4.9 0.6 2.4 14.4 0.0 3.8 4.4 3.8 5.9 2.3 6.0 6.8 4.8 6.4 4.9 30.8 0.2 3.4 16.9 6.8 7.2 9.9 6.6 4.9 15.6 6.3 9.1 14.4 0.0 4.7 0.4 12.4 13.9 1.1 4.5 9.7 5.2 KDM2A "CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA" ENSG00000173120 "Lysine demethylase 2A" Q9Y2K7 11 67119269-67258087 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012272, HPA044251" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012272: , HPA044251: " "unprognostic (7.43e-2)" "unprognostic (1.84e-1)" "unprognostic (4.09e-1)" "unprognostic (8.66e-2)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (6.05e-2)" "unprognostic (2.84e-1)" "unprognostic (4.46e-1)" "unprognostic (2.04e-3)" "unprognostic (3.27e-2)" "unprognostic (5.08e-2)" "unprognostic (2.67e-2)" "unprognostic (3.30e-1)" "unprognostic (1.05e-1)" "unprognostic (5.61e-2)" "unprognostic (9.45e-3)" 19.6 14.6 18.6 25.3 23.9 38.1 21.0 36.5 22.8 20.0 21.9 17.8 20.7 15.3 32.0 18.6 32.7 20.2 19.3 18.8 17.4 12.7 16.8 20.3 24.3 30.1 17.9 14.9 27.4 15.3 26.1 21.1 26.0 17.5 23.3 17.1 21.0 22.2 20.5 32.8 28.7 24.1 25.0 14.6 29.0 19.8 27.6 18.6 32.2 19.9 20.3 37.3 24.9 25.9 7.2 1.9 5.0 1.9 4.6 5.2 2.8 25.5 15.4 9.4 14.6 9.3 13.6 7.1 11.2 13.0 20.1 13.8 24.1 13.4 19.7 19.7 15.7 12.4 25.0 15.5 11.1 16.3 33.0 6.9 14.5 18.4 6.0 9.9 12.3 20.1 11.2 13.6 19.7 13.8 11.1 14.6 11.5 13.4 27.8 9.7 17.0 15.9 8.9 19.0 15.9 13.2 20.3 15.8 11.0 8.4 16.1 12.8 10.2 35.9 20.7 21.3 11.6 31.1 12.6 19.5 13.5 9.1 18.5 9.5 15.5 17.0 12.5 11.9 8.9 9.3 0.6 1.9 0.5 4.8 1.5 5.2 6.4 3.6 4.2 1.2 7.2 3.8 3.5 5.0 4.6 1.0 1.9 4.3 2.8 18.6 23.9 36.5 22.8 17.4 12.7 17.9 14.9 17.5 18.6 35.7 36.8 25.7 19.5 36.6 73.1 27.1 38.2 25.4 28.4 15.7 129.6 18.9 0.0 15.1 20.3 31.6 30.8 0.0 12.5 11.7 30.7 26.1 26.5 32.7 19.2 90.6 30.5 27.0 41.3 10.2 19.8 42.0 18.6 31.5 24.9 25.1 20.3 23.0 21.5 9.1 113.7 19.4 25.9 56.1 34.8 41.8 27.0 45.7 23.2 39.3 KDM2B "CXXC2, Fbl10, FBXL10, JHDM1B, PCCX2" ENSG00000089094 "Lysine demethylase 2B" Q8NHM5 12 121429097-121581015 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071257 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA071257: " "unprognostic (7.67e-2)" "unprognostic (3.72e-3)" "unprognostic (2.15e-1)" "unprognostic (1.69e-1)" "unprognostic (1.37e-1)" "prognostic favorable (6.74e-6)" "unprognostic (1.16e-1)" "unprognostic (5.45e-2)" "unprognostic (1.01e-2)" "unprognostic (1.95e-1)" "prognostic favorable (8.64e-4)" "unprognostic (1.77e-1)" "unprognostic (4.44e-3)" "unprognostic (1.44e-2)" "unprognostic (3.90e-2)" "unprognostic (7.07e-2)" "unprognostic (4.82e-2)" 6.2 6.3 13.9 20.1 15.7 14.9 7.0 31.1 25.1 9.2 7.6 12.3 5.2 8.2 9.9 7.3 14.4 10.8 7.9 5.8 11.8 7.2 6.6 10.2 9.5 21.3 14.3 15.1 14.1 8.2 13.0 8.2 7.2 12.2 6.6 7.7 8.1 9.1 6.8 11.7 18.9 13.1 8.1 13.2 16.3 7.4 9.8 14.5 27.0 8.2 5.5 20.9 11.1 11.6 11.5 5.0 4.2 3.6 2.6 8.3 4.0 6.7 8.6 17.0 5.2 4.7 4.9 17.4 6.7 9.1 9.8 8.3 11.7 3.8 33.1 9.9 6.1 5.2 5.9 18.1 6.6 7.4 13.7 11.7 19.1 7.8 10.4 5.2 22.3 14.8 3.9 4.0 8.8 6.7 9.8 7.0 16.6 14.4 4.7 5.0 10.0 24.2 26.8 27.3 5.4 7.0 27.9 8.6 16.3 5.4 13.1 18.6 11.0 11.5 6.8 6.8 14.8 12.8 24.5 8.8 10.2 7.6 9.7 6.5 11.0 9.7 32.3 9.3 17.5 6.3 4.2 3.6 2.8 8.3 3.2 6.3 11.5 6.6 4.8 5.0 10.6 5.9 7.5 0.5 2.6 1.9 4.8 5.5 4.0 13.9 15.7 31.1 25.1 11.8 7.2 14.3 15.1 12.2 14.5 0.0 11.7 22.7 5.0 15.0 19.7 13.0 15.3 2.7 4.5 10.4 11.8 5.7 10.0 6.6 41.3 7.3 4.7 0.0 5.0 9.1 9.4 5.4 13.9 12.2 21.8 14.3 5.2 8.0 16.4 37.2 7.2 21.0 15.1 64.1 4.7 3.9 5.1 5.9 6.7 3.3 13.8 19.4 9.9 5.1 13.9 13.2 5.5 17.8 6.6 5.4 KDM3A "JHMD2A, JMJD1, JMJD1A, KIAA0742, TSGA" ENSG00000115548 "Lysine demethylase 3A" Q9Y4C1 2 86440647-86492716 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055543, HPA065162" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055543: AB_2682842, HPA065162: AB_2685424" "unprognostic (1.97e-2)" "unprognostic (3.03e-3)" "unprognostic (1.32e-2)" "unprognostic (4.04e-2)" "unprognostic (5.06e-2)" "unprognostic (5.24e-2)" "prognostic unfavorable (2.15e-6)" "unprognostic (2.01e-1)" "unprognostic (3.35e-3)" "unprognostic (9.50e-3)" "unprognostic (4.44e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (2.17e-1)" "unprognostic (2.24e-1)" "unprognostic (1.24e-1)" "unprognostic (2.66e-2)" 21.5 12.5 21.5 14.6 27.2 52.9 18.5 17.2 18.7 18.9 25.9 19.6 17.3 17.0 21.2 24.8 20.3 16.8 14.7 21.3 22.7 11.4 13.2 11.9 17.2 14.8 17.8 15.2 20.6 15.7 16.3 20.3 19.5 17.8 19.7 14.9 14.6 19.2 19.1 20.7 34.7 19.1 21.0 22.1 15.7 14.5 42.9 23.6 30.1 18.6 12.8 17.3 29.0 22.1 4.8 4.9 14.4 3.4 4.9 9.1 4.1 18.4 7.4 17.6 4.6 9.1 9.3 16.5 9.0 8.9 8.5 10.5 9.4 7.9 10.8 17.1 7.5 17.5 11.8 13.1 9.0 16.6 14.5 10.9 17.4 6.8 13.3 6.8 13.8 11.1 10.2 13.7 7.6 14.1 29.3 10.4 10.2 11.1 17.8 8.9 4.7 19.2 19.4 15.8 11.1 11.3 13.1 23.8 23.3 7.6 10.5 13.7 14.5 11.9 8.6 16.4 16.2 5.0 9.1 11.6 17.3 7.2 17.8 10.2 18.6 17.5 16.1 21.9 14.4 21.1 11.9 3.2 5.9 7.6 3.4 8.0 4.8 8.4 7.3 4.9 4.1 9.1 7.8 14.4 4.9 2.3 4.4 8.6 4.1 21.5 27.2 17.2 18.7 22.7 11.4 17.8 15.2 17.8 23.6 32.8 13.4 6.9 20.9 27.1 22.7 22.6 10.2 36.1 23.9 5.2 49.1 3.7 0.0 12.1 58.0 19.8 15.9 23.3 8.6 5.9 16.9 16.0 37.0 6.8 9.0 52.4 15.0 14.7 11.3 20.1 16.1 15.1 20.3 5.4 11.4 35.1 10.0 9.7 16.3 4.2 33.6 6.5 14.4 32.1 10.2 35.0 9.7 17.0 9.3 11.7 KDM3B "C5orf7, JMJD1B, KIAA1082, NET22" ENSG00000120733 "Lysine demethylase 3B" Q7LBC6 5 138352596-138437028 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016610, HPA057202" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA016610: AB_1852004, HPA057202: AB_2683367" "unprognostic (1.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-3)" "unprognostic (1.34e-1)" "unprognostic (6.72e-2)" "unprognostic (1.72e-1)" "unprognostic (5.21e-2)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (4.68e-2)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "prognostic favorable (6.67e-4)" "unprognostic (1.73e-1)" "unprognostic (3.05e-1)" "unprognostic (1.43e-1)" "unprognostic (7.60e-2)" 13.5 12.8 10.0 10.9 12.6 12.2 14.9 20.2 14.9 14.0 14.2 18.4 13.5 9.9 20.0 18.0 13.0 14.7 12.5 11.8 14.7 8.6 12.8 8.4 11.4 11.5 12.0 9.6 19.8 17.4 27.9 15.1 11.7 11.3 13.6 14.4 18.5 16.3 16.3 29.6 16.5 14.0 21.5 10.7 13.3 12.6 10.4 12.2 25.2 16.1 9.0 16.4 21.9 19.4 4.1 5.1 9.3 4.6 7.4 5.7 2.2 10.6 15.0 28.3 25.9 13.1 10.9 21.9 7.4 12.0 13.2 14.8 16.7 11.8 21.3 13.4 14.0 18.1 11.0 23.0 16.5 15.1 14.0 14.1 18.3 13.3 12.6 11.7 14.7 20.0 13.0 18.0 10.2 12.2 10.4 15.7 12.4 14.3 11.4 15.8 13.7 19.2 18.2 14.0 14.5 6.2 23.4 21.8 13.9 18.9 14.8 15.0 16.4 12.6 12.4 10.9 43.9 11.8 18.6 15.1 7.9 8.2 8.3 12.8 15.8 7.5 18.9 5.2 20.8 11.2 0.3 4.6 6.5 4.2 3.6 5.7 4.1 5.0 5.2 4.1 3.9 4.4 4.2 9.3 7.4 3.6 5.1 2.8 2.2 10.0 12.6 20.2 14.9 14.7 8.6 12.0 9.6 11.3 12.2 14.9 14.9 8.8 12.1 14.2 19.4 29.7 25.5 10.7 13.6 21.0 27.5 10.5 0.0 12.9 5.9 12.7 15.8 0.0 14.4 8.0 12.8 16.3 12.7 18.3 15.1 22.3 20.2 17.8 45.4 2.2 19.5 16.7 15.1 17.2 28.8 20.6 16.4 26.8 21.5 12.6 29.9 25.8 12.7 12.3 13.9 18.9 9.2 11.4 23.0 17.3 KDM4C "GASC1, JMJD2C, KIAA0780, TDRD14C" ENSG00000107077 "Lysine demethylase 4C" Q9H3R0 9 6720863-7175648 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 73.8;Late spermatids: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 32.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069357 Approved Nucleoplasm NA NA Nucleoplasm "HPA069357: AB_2686128" "unprognostic (1.56e-2)" "unprognostic (1.91e-2)" "unprognostic (4.38e-2)" "unprognostic (1.38e-1)" "unprognostic (3.52e-1)" "unprognostic (4.36e-2)" "unprognostic (2.50e-2)" "unprognostic (6.89e-3)" "unprognostic (2.37e-1)" "unprognostic (2.34e-2)" "unprognostic (3.65e-2)" "unprognostic (2.03e-2)" "unprognostic (1.92e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" "unprognostic (2.23e-2)" "unprognostic (1.64e-3)" 12.1 12.1 13.3 21.5 15.0 27.5 12.7 51.2 14.3 12.4 14.9 18.0 14.6 14.2 14.7 13.9 12.5 12.0 11.9 10.0 11.1 11.9 9.9 12.2 16.1 21.1 15.1 10.5 13.5 18.9 26.0 24.0 10.6 13.7 11.5 18.5 15.3 15.1 13.9 9.7 16.9 16.6 15.4 13.8 15.2 16.2 10.4 16.0 29.0 14.9 7.9 25.7 13.5 14.2 13.8 8.4 13.0 11.1 10.8 11.8 6.9 9.4 5.6 2.4 3.5 8.2 9.2 6.8 4.3 5.9 5.2 5.0 6.6 5.4 11.1 2.7 6.0 5.1 2.9 5.2 7.5 6.7 32.0 3.8 15.5 8.0 8.9 7.8 5.9 10.7 7.9 5.2 4.1 8.8 13.1 6.2 9.7 2.4 7.6 5.4 4.9 9.7 23.1 4.0 10.4 2.1 5.8 2.1 6.8 7.6 5.6 8.2 4.9 4.0 7.8 3.8 6.9 3.8 10.2 6.6 5.1 2.4 5.8 4.1 5.7 4.1 11.2 5.0 5.7 1.9 7.2 6.4 13.0 9.8 6.9 10.8 11.9 10.9 10.7 8.4 13.8 11.8 8.8 1.5 10.8 11.1 3.4 9.2 6.9 13.3 15.0 51.2 14.3 11.1 11.9 15.1 10.5 13.7 16.0 6.0 11.8 5.3 5.9 17.6 22.2 7.0 12.7 8.1 6.8 7.0 43.2 4.3 3.3 5.7 73.8 7.9 11.1 0.0 5.5 4.6 6.2 5.5 8.1 9.0 5.8 11.1 9.4 8.0 9.1 64.8 8.9 15.0 6.8 8.2 13.0 5.6 6.5 12.4 8.9 3.1 30.6 12.9 7.6 5.4 3.7 20.8 4.9 17.3 9.3 6.5 KDM4D "FLJ10251, JMJD2D" ENSG00000186280 "Lysine demethylase 4D" Q6B0I6 11 94973681-94999518 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 37.5" "Group enriched" "Detected in many" 4 "Early spermatids: 69.2;Late spermatids: 28.4;Spermatocytes: 52.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 5.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA055854, HPA064037" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA055854: AB_2682944, HPA064037: AB_2685180" "unprognostic (1.98e-1)" "unprognostic (5.71e-2)" "unprognostic (1.83e-1)" "unprognostic (9.65e-3)" "unprognostic (3.19e-1)" "unprognostic (5.12e-2)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (5.62e-2)" "unprognostic (4.49e-2)" "unprognostic (8.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.45e-1)" "unprognostic (2.88e-1)" 0.6 0.8 1.2 0.4 2.0 0.1 0.8 1.4 2.1 0.6 0.3 1.2 1.7 0.2 0.6 0.9 0.4 1.0 0.5 1.0 0.7 0.7 0.6 0.4 0.4 0.7 0.6 1.3 1.3 0.4 1.4 2.1 0.5 1.1 0.6 0.4 1.2 0.7 0.7 1.0 0.7 0.5 0.6 0.9 0.7 0.4 37.5 1.0 0.3 0.8 0.6 0.6 0.6 0.4 1.3 1.2 0.0 5.1 0.1 1.4 0.2 0.9 1.4 5.6 4.1 1.2 1.4 2.6 1.9 2.1 5.2 4.6 1.5 1.8 2.1 6.1 1.6 5.0 1.7 3.6 3.9 4.0 2.3 3.7 1.8 0.6 2.1 1.1 0.9 0.6 2.7 2.1 5.2 4.7 0.8 2.0 7.4 2.0 1.0 2.0 1.7 3.1 2.1 2.5 1.4 6.8 4.3 2.4 1.5 1.2 0.6 3.3 4.0 2.2 2.0 1.5 3.2 2.1 0.6 1.5 3.6 2.1 5.5 2.8 1.3 4.1 0.3 1.2 1.1 3.9 0.0 0.3 0.0 0.3 0.2 0.2 1.3 0.6 1.0 0.0 0.2 0.8 0.1 0.0 0.1 5.1 1.2 1.4 0.2 1.2 2.0 1.4 2.1 0.7 0.7 0.6 1.3 1.1 1.0 0.0 0.0 0.0 0.2 0.0 6.6 0.8 2.5 1.4 0.0 0.0 2.0 0.8 3.3 0.6 69.2 0.4 0.0 0.0 0.5 0.7 0.3 0.1 0.0 1.0 0.5 3.2 0.0 1.8 0.3 28.4 2.0 0.7 0.0 1.0 0.0 4.3 0.2 0.0 1.1 1.0 2.9 0.0 0.9 52.0 12.4 0.0 0.2 0.0 0.2 0.1 KHDC4 "BLOM7, KIAA0907, SNORA80EHG" ENSG00000132680 "KH domain containing 4, pre-mRNA splicing factor" Q7Z7F0 1 155913043-155934400 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 22.7;Club cells: 22.7;Collecting duct cells: 54.1;monocytes: 23.4;Syncytiotrophoblasts: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008796 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA008796: AB_1079369" "unprognostic (6.31e-2)" "unprognostic (1.32e-1)" "unprognostic (4.52e-2)" "unprognostic (5.22e-3)" "unprognostic (7.68e-3)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.01e-6)" "unprognostic (3.79e-2)" "unprognostic (2.44e-2)" "unprognostic (7.88e-2)" "unprognostic (3.66e-2)" "prognostic unfavorable (3.87e-4)" "prognostic unfavorable (2.78e-10)" "unprognostic (1.04e-1)" "unprognostic (2.37e-1)" "unprognostic (9.10e-2)" "prognostic favorable (4.36e-5)" 15.6 17.9 22.5 18.4 24.6 9.3 20.0 42.2 26.7 23.0 19.0 19.5 25.2 20.4 24.4 42.5 16.3 17.2 17.4 15.8 22.7 11.0 20.1 16.2 19.1 23.5 25.0 13.3 29.8 18.8 19.5 39.4 20.5 20.2 23.1 25.0 18.9 22.3 19.9 21.9 25.7 20.4 23.8 21.7 22.3 24.3 15.8 24.8 21.8 20.4 7.1 25.6 21.5 20.8 6.5 3.6 7.6 6.1 5.1 7.2 2.4 12.3 9.5 20.2 12.2 10.9 15.3 12.6 10.7 8.5 16.3 16.9 9.8 27.5 15.4 12.0 6.0 11.7 23.0 18.5 7.5 16.2 12.2 38.7 13.8 28.9 11.7 7.6 16.2 12.0 9.9 20.0 11.4 8.9 19.3 11.7 17.6 16.6 17.8 14.8 5.9 15.5 16.0 22.3 11.7 13.7 18.5 11.0 13.6 14.4 6.8 14.1 14.1 7.9 8.4 11.4 17.4 17.6 27.4 9.8 15.9 11.0 5.1 14.3 29.0 12.5 13.7 11.4 15.2 11.9 7.6 3.5 6.5 5.3 4.6 6.8 6.1 5.6 6.8 3.4 6.5 7.2 6.5 4.5 5.1 6.1 3.6 4.6 2.4 22.5 24.6 42.2 26.7 22.7 11.0 25.0 13.3 20.2 24.8 11.9 16.3 0.0 0.0 0.0 0.0 0.0 0.0 22.7 22.7 54.1 0.0 20.8 3.3 9.5 0.0 0.0 0.0 0.0 6.2 17.7 0.0 0.0 5.8 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 23.4 0.0 0.0 13.6 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 KHDRBS1 "FLJ34027, p62, Sam68" ENSG00000121774 "KH RNA binding domain containing, signal transduction associated 1" Q07666 1 32013829-32060850 "Predicted intracellular proteins" "Cell cycle, mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005355, HPA051280, HPA056813" Supported Enhanced Nucleoplasm NA NA 20000 Nucleoplasm "CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240" "unprognostic (1.31e-1)" "unprognostic (3.01e-2)" "unprognostic (1.22e-2)" "unprognostic (1.55e-1)" "unprognostic (2.09e-1)" "unprognostic (6.55e-2)" "prognostic unfavorable (3.68e-5)" "unprognostic (5.01e-2)" "unprognostic (2.51e-3)" "unprognostic (4.03e-2)" "unprognostic (2.17e-2)" "unprognostic (1.91e-3)" "prognostic unfavorable (9.32e-4)" "unprognostic (1.08e-1)" "unprognostic (1.45e-1)" "unprognostic (1.26e-1)" "unprognostic (7.03e-2)" 34.5 31.7 31.1 49.7 34.2 42.0 35.9 56.6 41.5 42.0 38.8 35.1 30.1 33.3 51.5 37.8 37.0 39.5 51.2 34.9 29.7 30.1 30.0 30.9 38.3 52.5 27.3 35.9 63.2 31.3 40.4 29.5 33.9 25.9 36.5 31.7 32.2 31.1 35.5 39.0 30.6 32.4 44.2 31.4 36.0 31.0 42.7 23.7 69.9 35.1 41.0 50.0 40.2 34.4 11.4 10.2 6.4 10.2 8.2 14.4 3.5 44.4 27.1 62.1 45.6 21.6 27.2 36.5 27.0 34.4 50.8 42.9 30.1 40.0 66.7 30.3 34.1 29.5 31.2 50.0 37.0 52.1 39.7 42.7 42.0 26.7 41.0 28.5 55.6 28.3 29.8 21.2 38.6 30.7 33.4 47.9 41.1 54.1 30.6 38.9 29.0 81.8 47.6 63.0 28.1 32.6 65.7 52.6 56.3 35.4 45.2 42.5 55.6 39.3 33.7 33.9 46.2 40.1 40.5 35.9 33.1 35.9 35.3 45.1 32.2 34.8 65.6 34.4 44.5 25.2 4.6 6.7 6.4 9.6 10.2 14.4 11.4 11.5 9.9 9.0 9.3 12.5 11.8 5.9 8.2 8.2 10.2 10.3 3.5 31.1 34.2 56.6 41.5 29.7 30.1 27.3 35.9 25.9 23.7 35.7 61.9 121.1 181.3 131.1 88.3 92.4 79.0 108.4 116.0 66.3 47.1 161.4 71.3 89.2 18.7 98.3 69.3 23.3 88.7 198.7 113.7 105.9 126.8 57.1 105.8 60.4 113.1 87.8 125.1 11.5 102.9 123.6 102.9 84.8 92.4 126.7 86.6 57.5 116.7 98.2 71.0 90.5 113.7 152.3 117.7 114.2 145.1 101.2 124.2 156.2 KHDRBS3 "Etle, etoile, SALP, SLM-2, SLM2, T-STAR" ENSG00000131773 "KH RNA binding domain containing, signal transduction associated 3" O75525 8 135457457-135656722 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4;testis: 79.1" "Group enriched" "Detected in many" 7 "Bipolar cells: 168.5;Early spermatids: 282.4;Late spermatids: 91.3;Spermatocytes: 308.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "eosinophil: 4.1" "Lineage enriched" "Detected in single" 25 "granulocytes: 4.1" "Cell line enhanced" "Detected in many" "REH: 31.4;RPTEC TERT1: 28.3;WM-115: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000275, HPA000500, HPA000981" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA000275: AB_1079183, HPA000500: AB_1079184, HPA000981: AB_2666164" "unprognostic (1.36e-1)" "unprognostic (1.61e-1)" "unprognostic (1.98e-1)" "unprognostic (6.55e-3)" "unprognostic (2.75e-1)" "unprognostic (2.43e-1)" "unprognostic (1.31e-3)" "unprognostic (9.36e-2)" "unprognostic (2.00e-2)" "unprognostic (2.66e-1)" "unprognostic (1.91e-2)" "unprognostic (1.21e-1)" "prognostic favorable (7.16e-6)" "unprognostic (6.63e-2)" "unprognostic (7.85e-2)" "unprognostic (1.07e-1)" "unprognostic (1.33e-3)" 8.0 9.6 16.4 3.3 16.6 1.7 5.8 7.1 34.4 10.3 5.3 8.0 0.9 2.7 4.3 13.4 3.9 4.2 6.8 5.6 16.7 9.8 11.0 7.0 4.5 1.9 11.1 21.7 5.8 5.4 3.5 4.2 1.6 8.7 5.2 5.4 2.6 6.4 7.6 14.7 3.1 3.6 5.1 12.5 1.9 3.7 79.1 7.9 0.9 3.1 1.5 2.7 6.8 4.5 0.1 0.0 4.1 0.0 0.0 0.1 0.0 0.1 0.6 11.5 0.6 2.4 4.6 4.6 7.5 10.5 7.2 3.7 4.0 1.6 0.0 4.1 7.2 0.1 1.0 7.2 7.6 9.8 1.5 12.4 0.0 4.2 8.2 1.9 2.0 26.2 1.0 1.0 3.9 6.0 8.7 5.8 13.5 0.9 19.0 12.7 2.6 0.7 0.4 2.3 6.1 12.5 31.4 15.7 8.1 28.3 0.2 14.8 12.5 0.5 1.6 8.1 7.6 0.5 0.6 0.4 8.9 15.3 0.1 16.2 6.7 0.0 0.0 5.4 0.0 31.3 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 16.6 7.1 34.4 16.7 9.8 11.1 21.7 8.7 7.9 26.8 4.0 1.4 11.3 13.4 168.5 11.4 5.1 1.4 6.8 7.0 0.0 0.4 21.6 11.4 282.4 14.6 2.4 0.0 19.1 1.0 19.3 16.7 4.6 16.3 0.7 6.4 22.5 6.2 2.4 91.3 15.0 2.8 13.5 2.8 7.8 5.3 25.6 2.9 8.1 21.6 13.0 0.0 26.9 308.0 29.7 8.2 1.1 0.0 5.2 6.5 KHSRP "FBP2, FUBP2, KSRP" ENSG00000088247 "KH-type splicing regulatory protein" Q92945 19 6413348-6424794 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034739, HPA056518" Supported Enhanced Nucleoplasm NA NA 740000 Nucleoplasm "HPA034739: AB_10601582, HPA056518: AB_2683162" "unprognostic (2.16e-1)" "unprognostic (3.98e-2)" "unprognostic (2.41e-1)" "unprognostic (4.27e-1)" "unprognostic (4.57e-2)" "unprognostic (1.77e-2)" "unprognostic (2.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.25e-1)" "unprognostic (7.12e-2)" "unprognostic (1.74e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.45e-2)" "unprognostic (1.50e-1)" "unprognostic (9.38e-2)" "unprognostic (2.84e-2)" 40.3 34.3 31.4 34.5 37.2 49.9 27.6 53.8 54.2 38.9 35.6 51.4 23.9 49.5 48.0 27.5 41.5 39.2 33.3 27.4 31.3 27.7 31.0 49.2 27.0 39.3 31.7 29.8 51.0 45.3 18.4 31.4 43.4 28.1 35.0 25.6 39.2 44.4 35.9 43.7 41.8 44.8 30.3 30.3 37.9 36.1 56.3 29.2 73.9 37.8 35.0 33.4 37.7 33.7 8.9 11.5 4.9 7.6 3.1 6.3 3.5 72.0 36.3 34.7 33.7 15.1 16.5 60.4 29.7 19.6 35.2 36.3 73.6 19.7 71.5 46.5 17.2 21.1 39.0 39.5 28.0 28.1 0.3 74.1 46.1 22.5 50.9 26.4 51.6 44.5 21.3 12.7 28.9 23.7 14.6 27.3 33.0 85.6 30.3 21.2 46.0 63.3 51.0 67.5 17.9 51.3 66.9 34.0 45.8 16.3 37.1 41.1 45.5 36.5 25.4 32.2 24.2 30.3 48.2 29.7 28.9 36.2 61.1 58.2 60.6 47.1 54.6 25.4 73.5 33.9 3.2 6.9 4.5 5.7 7.6 6.0 5.9 6.0 6.3 6.4 8.9 4.2 4.5 4.9 3.1 6.3 11.5 4.1 3.5 31.4 37.2 53.8 54.2 31.3 27.7 31.7 29.8 28.1 29.2 8.9 20.3 40.4 19.2 52.2 42.6 12.6 40.8 12.0 25.0 29.6 47.1 31.6 5.0 24.6 57.0 30.1 34.2 23.3 26.5 36.8 31.4 26.2 18.4 39.5 33.0 47.7 55.3 38.1 29.9 19.6 46.9 22.9 25.3 16.2 44.5 35.1 29.9 24.6 43.5 20.3 58.4 25.8 22.3 68.6 52.6 63.2 33.4 16.0 55.7 28.8 KIAA0040 ENSG00000235750 KIAA0040 Q15053 1 175156987-175192999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Syncytiotrophoblasts: 315.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 32.8;RPMI-8226: 23.3;U-698: 42.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA016895, HPA068812" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA016895: AB_2669476, HPA068812: AB_2686041" "unprognostic (5.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "unprognostic (2.99e-2)" "unprognostic (1.01e-2)" "unprognostic (8.54e-3)" "unprognostic (2.91e-1)" "unprognostic (2.87e-2)" "unprognostic (3.83e-1)" "unprognostic (1.21e-1)" "unprognostic (2.66e-2)" "unprognostic (1.63e-1)" "unprognostic (2.53e-2)" "unprognostic (1.49e-1)" "unprognostic (2.57e-1)" "unprognostic (2.28e-2)" "unprognostic (3.05e-1)" 25.7 4.0 2.7 18.4 7.4 5.1 16.0 2.0 3.9 8.0 7.7 1.8 3.5 5.2 8.6 7.9 7.0 9.2 11.0 16.3 3.2 2.9 17.8 12.1 25.3 16.1 6.9 1.0 5.0 17.9 4.6 13.6 45.6 7.6 7.9 5.6 12.2 15.2 4.1 11.1 5.1 10.2 6.0 5.4 27.6 9.8 3.4 3.5 14.8 9.6 7.2 18.6 6.6 10.7 16.5 5.4 26.4 6.1 3.3 9.6 5.4 3.1 0.1 0.1 0.0 0.0 0.0 0.0 1.4 3.8 0.0 0.0 1.6 4.6 32.8 7.8 0.0 0.1 13.2 2.3 15.4 0.0 11.1 1.9 3.5 7.2 0.2 0.4 0.2 0.4 0.0 4.2 0.0 5.9 0.0 5.1 4.8 2.8 5.5 0.0 0.7 4.1 0.0 1.0 2.7 2.8 3.5 1.7 23.3 5.0 7.9 0.2 1.2 2.4 12.9 0.3 8.4 8.2 0.7 2.0 0.0 1.5 0.0 0.3 13.6 16.5 42.2 0.6 0.0 3.5 12.8 6.1 1.0 5.9 3.3 5.3 16.2 6.5 4.9 5.4 16.5 6.9 5.9 26.4 3.3 1.2 1.2 9.6 5.4 2.7 7.4 2.0 3.9 3.2 2.9 6.9 1.0 7.6 3.5 35.7 5.6 53.8 61.7 23.7 0.0 3.1 12.7 20.1 15.9 12.2 0.0 57.4 11.6 11.3 0.5 20.2 11.2 0.0 20.8 5.6 39.4 46.5 10.5 6.0 10.4 0.0 4.1 13.5 10.6 1.2 15.5 16.9 6.8 10.0 5.5 4.3 17.8 14.2 9.9 4.7 0.0 25.8 65.9 0.3 3.3 9.7 315.3 25.4 10.3 30.7 KIAA0355 ENSG00000166398 KIAA0355 O15063 19 34254537-34355586 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Ito cells: 122.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014570 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA014570: AB_1852307" "unprognostic (1.88e-2)" "unprognostic (8.90e-2)" "unprognostic (1.08e-1)" "unprognostic (1.75e-2)" "unprognostic (2.17e-2)" "unprognostic (1.48e-3)" "unprognostic (9.05e-2)" "unprognostic (8.27e-2)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.98e-2)" "unprognostic (3.83e-2)" "unprognostic (1.34e-1)" "unprognostic (7.73e-3)" "unprognostic (2.96e-2)" "unprognostic (1.86e-1)" "unprognostic (1.16e-1)" "unprognostic (1.67e-1)" 19.8 7.2 9.3 10.8 14.7 4.4 19.5 16.3 15.0 12.3 8.5 22.1 9.3 7.5 16.6 9.4 11.3 11.8 13.1 14.0 9.0 8.9 10.2 8.8 14.9 11.7 15.6 11.1 12.5 14.5 18.9 21.8 31.0 15.7 11.2 8.1 16.6 9.4 9.7 17.4 12.2 9.8 12.3 16.2 20.7 8.2 22.2 13.5 8.4 14.1 5.4 12.7 10.7 12.1 6.3 2.0 4.4 3.4 2.6 5.8 1.4 2.3 6.9 6.2 3.2 4.3 4.1 8.2 5.2 4.3 4.0 6.0 5.5 2.8 5.2 11.6 4.8 5.0 1.6 4.6 2.4 4.4 7.4 4.0 3.2 2.7 4.2 5.5 1.4 2.6 4.8 4.3 5.2 7.8 15.9 16.3 2.9 9.5 2.6 4.3 1.2 0.9 1.2 4.7 3.1 2.6 2.3 4.3 2.7 3.3 2.6 7.2 5.9 6.0 23.5 7.6 9.5 1.8 2.6 13.5 13.8 5.2 3.5 5.4 4.5 6.2 1.6 2.6 0.5 6.7 0.0 1.2 0.0 1.8 2.7 2.7 4.7 3.8 1.6 1.5 6.3 3.2 2.0 4.4 2.6 3.4 2.0 5.8 1.4 9.3 14.7 16.3 15.0 9.0 8.9 15.6 11.1 15.7 13.5 23.8 18.8 27.0 6.6 16.5 44.8 10.9 30.6 10.7 7.9 26.2 37.3 18.8 11.6 15.4 3.0 69.9 15.4 23.3 14.6 22.0 19.0 14.8 13.9 29.8 9.5 25.4 60.6 122.2 18.6 3.1 13.8 10.8 18.6 10.8 22.6 16.9 15.1 24.5 14.9 6.9 78.9 12.9 16.5 29.2 43.4 17.1 28.5 20.3 18.0 8.6 KIAA1191 "FLJ21022, p33MONOX, p60MONOX" ENSG00000122203 KIAA1191 Q96A73 5 176346061-176361968 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Proximal tubular cells: 207.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044701, HPA048145" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044701: AB_2679053, HPA048145: AB_2680283" "unprognostic (7.59e-3)" "unprognostic (1.08e-1)" "unprognostic (3.85e-2)" "unprognostic (4.94e-2)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (2.46e-1)" "unprognostic (1.48e-2)" "unprognostic (4.39e-1)" "unprognostic (7.10e-2)" "unprognostic (8.93e-2)" "unprognostic (1.73e-1)" "prognostic favorable (9.94e-5)" "unprognostic (5.02e-3)" "unprognostic (1.69e-1)" "unprognostic (2.52e-1)" "unprognostic (1.73e-2)" 16.7 22.0 31.3 11.0 35.5 12.0 19.6 32.4 43.0 22.5 20.6 21.2 19.2 20.8 22.3 24.1 26.6 29.5 17.8 34.3 25.9 28.1 84.1 29.3 20.4 10.9 24.6 28.8 41.6 25.1 24.0 22.9 16.1 30.5 24.5 20.0 24.0 29.3 29.1 29.1 17.8 23.1 24.0 18.9 14.0 25.5 7.5 18.6 10.8 28.5 14.0 17.5 26.4 18.4 17.9 16.1 22.3 19.7 19.1 27.7 19.1 17.1 16.7 30.8 40.1 27.3 20.5 23.6 24.9 24.0 27.7 30.2 33.1 17.4 6.5 33.2 29.7 41.3 15.1 18.8 43.9 33.1 34.5 20.7 7.6 11.7 17.4 31.2 6.7 13.9 20.2 31.3 24.4 20.8 31.3 33.7 10.8 11.5 14.8 29.9 21.9 9.6 4.0 13.3 17.5 21.8 7.2 19.4 5.6 25.9 16.9 23.8 25.7 26.6 13.0 29.5 28.0 18.8 7.1 31.6 25.5 11.7 18.1 29.7 9.6 13.0 7.8 20.4 12.8 19.7 20.1 16.7 22.3 21.8 19.7 24.2 17.9 20.8 20.9 16.1 14.6 22.1 23.1 8.0 19.1 19.0 13.2 27.7 19.1 31.3 35.5 32.4 43.0 25.9 28.1 24.6 28.8 30.5 18.6 50.6 37.1 20.7 37.8 30.2 29.8 54.8 30.6 33.5 39.8 31.4 23.6 18.8 79.6 31.8 1.9 28.9 32.5 0.0 23.9 12.1 24.7 29.2 17.3 41.4 13.8 46.1 41.5 22.1 19.1 5.9 28.7 20.9 20.3 36.1 28.0 25.8 29.8 33.7 36.0 207.7 29.3 12.9 29.2 7.5 6.4 27.7 27.9 17.5 27.1 40.6 KIDINS220 ARMS ENSG00000134313 "Kinase D interacting substrate 220" Q9ULH0 2 8721081-8837630 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014790 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA014790: AB_1852460" "unprognostic (3.58e-1)" "unprognostic (1.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.78e-3)" "unprognostic (2.05e-1)" "unprognostic (2.01e-1)" "unprognostic (1.33e-2)" "prognostic favorable (9.64e-4)" "unprognostic (1.68e-1)" "unprognostic (9.21e-2)" "unprognostic (9.74e-2)" "unprognostic (7.39e-2)" "prognostic favorable (9.29e-6)" "unprognostic (4.12e-2)" "unprognostic (1.47e-1)" "unprognostic (9.27e-2)" "unprognostic (1.15e-1)" 16.5 16.4 21.6 9.4 26.9 14.7 14.7 35.3 30.3 16.9 17.2 21.9 7.2 7.8 23.2 11.2 13.0 15.7 12.3 14.7 16.6 8.1 16.0 10.7 16.1 8.2 25.6 15.9 27.5 12.8 45.8 20.2 14.5 25.5 14.5 11.7 11.1 14.8 13.3 17.4 12.7 11.6 17.5 30.3 11.1 14.0 7.1 24.3 11.2 14.9 6.3 8.3 19.6 16.7 3.6 5.1 10.0 8.1 5.7 7.2 3.7 7.1 11.6 23.2 14.8 29.3 19.4 12.2 14.3 11.8 9.1 8.5 11.5 7.4 13.5 14.6 21.3 17.6 12.3 20.8 8.8 13.5 19.3 14.1 12.0 9.0 12.1 20.7 12.4 16.7 20.1 13.9 14.5 19.0 14.1 14.2 11.8 23.4 16.9 16.1 7.9 12.6 6.7 12.6 11.9 10.3 12.1 17.1 6.7 12.1 13.8 19.7 33.2 11.3 11.4 12.8 12.7 7.3 14.3 18.7 20.3 10.7 20.2 15.3 12.5 10.9 18.3 11.8 16.8 15.4 7.4 6.2 7.5 7.2 7.4 5.4 3.6 5.3 6.0 5.1 3.6 5.5 6.1 10.0 5.7 8.1 3.4 4.3 3.7 21.6 26.9 35.3 30.3 16.6 8.1 25.6 15.9 25.5 24.3 92.3 90.8 17.1 22.8 29.1 86.9 34.8 17.8 34.8 60.3 27.9 131.6 14.0 0.0 28.3 1.0 42.5 22.2 46.7 20.3 8.6 44.1 27.7 33.6 26.8 24.5 146.2 41.6 47.9 43.5 3.9 64.5 42.8 23.6 19.0 21.7 76.6 23.5 27.7 61.5 10.9 56.2 6.5 32.3 23.7 25.5 25.7 9.2 27.4 21.8 32.3 KIF12 ENSG00000136883 "Kinesin family member 12" Q96FN5 9 114086126-114099291 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 33.1;kidney: 51.5;pancreas: 42.1" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 101.9;Collecting duct cells: 85.5;Distal tubular cells: 68.0;Intestinal endocrine cells: 61.7;Proximal tubular cells: 57.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.5;OE19: 11.2;RPTEC TERT1: 30.9;SCLC-21H: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA020192, HPA024127" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA020192: AB_1852467, HPA024127: AB_1852469" "unprognostic (5.29e-2)" "unprognostic (5.03e-2)" "unprognostic (3.34e-1)" "unprognostic (1.84e-2)" "unprognostic (5.80e-2)" "unprognostic (8.38e-2)" "unprognostic (9.81e-2)" "unprognostic (4.41e-2)" "unprognostic (1.90e-1)" "unprognostic (3.98e-2)" "unprognostic (1.69e-2)" "unprognostic (3.33e-2)" "unprognostic (1.10e-2)" "unprognostic (4.51e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" 0.4 0.0 0.8 0.8 1.2 0.0 9.1 0.8 0.6 3.3 5.8 0.4 3.3 11.8 4.7 18.0 0.5 3.8 33.1 0.4 0.4 0.2 51.5 9.8 1.0 0.4 0.4 0.5 1.1 42.1 0.0 0.6 1.3 0.4 2.4 1.7 0.8 1.8 4.2 0.4 0.4 7.3 0.4 0.4 0.4 5.5 1.5 0.4 1.0 11.6 0.4 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 6.5 0.1 0.0 3.6 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.3 0.1 11.2 0.4 0.0 0.0 0.0 30.9 0.1 4.5 0.1 0.0 0.6 0.0 0.1 3.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.8 0.6 0.4 0.2 0.4 0.5 0.4 0.4 0.0 4.1 0.8 0.8 0.0 0.0 0.4 101.9 0.0 0.0 85.5 0.0 0.1 68.0 28.9 5.4 0.0 7.1 0.0 10.4 6.4 0.2 2.2 0.0 7.4 0.3 0.0 61.7 0.0 0.0 9.5 0.6 0.0 0.0 1.8 22.5 0.0 8.1 20.9 0.0 57.8 0.0 0.0 0.0 1.5 4.5 0.0 0.5 0.0 23.4 0.1 KIN "KIN17, Rts2" ENSG00000151657 "Kin17 DNA and RNA binding protein" O60870 10 7750962-7787981 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication, Host-virus interaction, mRNA processing, Stress response" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016339, HPA038700" Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016339: AB_627860, HPA038700: AB_2676159" "unprognostic (4.33e-3)" "unprognostic (1.24e-2)" "unprognostic (1.66e-2)" "unprognostic (1.40e-2)" "unprognostic (2.94e-2)" "unprognostic (1.31e-1)" "unprognostic (3.17e-3)" "unprognostic (1.30e-2)" "unprognostic (2.58e-1)" "unprognostic (5.59e-2)" "unprognostic (1.11e-1)" "unprognostic (5.40e-3)" "prognostic unfavorable (1.44e-7)" "unprognostic (3.98e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-1)" "prognostic favorable (3.23e-5)" 8.5 8.6 9.0 8.2 9.7 9.4 9.0 19.8 11.9 9.5 7.0 10.2 9.1 7.8 11.3 9.9 6.5 8.1 7.2 8.6 7.5 7.8 10.1 12.9 7.4 10.4 9.7 8.2 10.8 10.2 7.7 15.5 10.0 10.6 10.0 7.7 8.4 8.4 8.6 9.1 11.5 10.0 9.1 9.0 10.8 8.1 6.9 9.7 13.6 11.1 7.7 9.7 8.8 8.3 7.0 6.9 13.8 5.1 5.9 5.0 1.8 6.9 4.4 6.8 4.3 5.6 6.8 5.5 6.2 2.8 7.5 8.1 8.5 7.0 5.4 3.3 3.8 2.3 6.7 5.7 3.8 8.7 6.1 6.6 8.5 4.5 8.1 8.0 3.0 6.9 5.6 4.3 5.7 3.8 6.3 5.6 6.9 8.4 5.2 5.8 6.2 6.0 4.7 6.6 7.2 2.7 7.7 4.9 4.9 6.3 3.9 3.0 6.4 4.9 5.0 9.9 6.8 9.1 6.1 4.0 4.9 5.5 8.6 5.0 6.8 7.3 6.7 6.2 4.7 3.3 13.8 4.8 8.0 4.7 5.1 4.7 6.5 4.2 3.9 3.6 7.0 4.8 5.0 10.8 5.9 4.6 6.9 3.4 1.8 9.0 9.7 19.8 11.9 7.5 7.8 9.7 8.2 10.6 9.7 32.8 25.6 13.0 13.7 15.3 52.4 11.1 22.9 30.8 18.2 17.4 37.3 31.0 11.6 26.4 4.2 24.1 15.8 23.3 18.7 21.8 20.6 11.9 15.1 12.4 27.3 60.4 22.3 24.5 18.0 4.3 25.6 22.4 15.1 19.0 17.1 29.5 18.4 20.1 29.0 14.6 53.1 12.9 17.6 28.6 16.7 12.5 32.2 25.4 13.3 13.3 KLF1 EKLF ENSG00000105610 "Kruppel like factor 1" Q13351 19 12884422-12887199 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 30.6;lymphoid tissue: 7.0;placenta: 9.0" "Cell type enriched" "Detected in some" 146 "Erythroid cells: 350.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 1.7;intermediate monocyte: 4.7;non-classical monocyte: 2.9" "Lineage enriched" "Detected in single" 8 "monocytes: 4.7" "Group enriched" "Detected in some" 28 "HEL: 23.1;K-562: 55.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA051850 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA051850: AB_2616460" "unprognostic (1.17e-1)" "unprognostic (1.38e-4)" "unprognostic (2.96e-1)" "unprognostic (1.17e-3)" "unprognostic (7.13e-2)" "unprognostic (3.90e-4)" "unprognostic (3.25e-2)" "unprognostic (3.19e-2)" "unprognostic (1.97e-1)" "unprognostic (1.08e-2)" "unprognostic (6.51e-2)" "unprognostic (7.71e-2)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (3.76e-1)" "unprognostic (2.44e-1)" 0.0 0.0 0.5 0.0 0.3 30.6 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 1.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.2 9.0 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 7.0 0.0 0.1 0.0 0.0 0.8 1.2 0.0 0.6 0.0 0.3 0.5 0.5 4.7 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 23.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.4 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.2 4.7 0.0 0.3 0.0 0.1 0.5 0.1 0.1 0.2 0.5 0.0 2.9 0.0 0.0 1.6 0.5 0.3 0.1 0.4 0.2 0.1 0.2 0.0 0.3 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 350.4 0.0 1.2 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 KLF16 "BTEB4, DRRF, NSLP2" ENSG00000129911 "Kruppel like factor 16" Q9BXK1 19 1852399-1863568 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 56.1;Rod photoreceptor cells: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052481 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA052481: AB_2681845" "unprognostic (3.24e-2)" "unprognostic (4.66e-2)" "unprognostic (2.48e-1)" "unprognostic (3.74e-2)" "unprognostic (4.12e-2)" "unprognostic (1.37e-1)" "unprognostic (9.68e-3)" "unprognostic (1.46e-1)" "unprognostic (2.92e-3)" "unprognostic (7.15e-2)" "unprognostic (3.23e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.93e-5)" "unprognostic (5.85e-3)" "unprognostic (2.31e-1)" "unprognostic (1.98e-1)" "unprognostic (3.76e-2)" 10.5 9.2 19.5 11.8 32.2 20.3 5.7 7.0 20.8 3.9 12.9 6.2 5.0 15.8 5.8 4.1 9.9 5.1 10.1 4.8 20.6 8.8 7.1 15.1 8.6 14.8 7.8 10.2 10.8 10.1 6.2 10.2 7.0 7.3 5.0 5.6 5.3 6.0 4.7 4.9 9.2 14.2 6.2 6.6 15.9 12.8 6.4 5.8 7.7 3.5 10.1 11.8 4.4 4.2 2.5 9.1 4.8 2.3 0.2 2.1 1.1 16.6 8.9 4.5 9.4 2.7 3.2 9.9 12.8 2.9 5.4 4.8 7.1 7.4 12.4 11.1 8.3 4.9 15.4 6.9 11.6 3.4 18.9 12.1 12.9 4.6 8.4 6.1 12.3 21.9 4.9 7.0 8.8 11.1 6.6 4.6 8.3 15.8 9.7 4.5 12.6 11.4 15.2 14.8 11.0 12.8 17.8 4.2 13.4 5.6 5.7 19.8 16.7 4.5 6.9 14.5 4.4 6.5 15.5 11.2 8.8 13.3 19.9 17.4 13.7 15.6 13.9 9.0 10.7 9.2 1.7 2.3 2.2 1.5 1.9 1.8 2.2 1.8 0.9 1.8 2.5 1.6 1.1 4.8 0.2 1.8 9.1 2.1 1.1 19.5 32.2 7.0 19.3 20.6 8.8 7.8 10.2 7.3 5.8 0.0 7.2 8.7 10.0 23.8 56.1 1.5 5.1 4.0 4.5 3.5 21.6 3.2 1.7 6.2 38.5 10.5 23.9 23.3 7.0 2.5 5.2 8.9 4.6 14.1 11.5 14.3 31.6 10.4 11.4 26.9 4.6 7.5 11.8 5.4 20.1 9.6 9.4 24.6 3.2 4.8 50.1 0.0 4.2 0.9 4.3 23.7 3.3 2.5 15.8 12.3 KLF2 LKLF ENSG00000127528 "Kruppel like factor 2" Q9Y5W3 19 16324817-16327874 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 353.6;Ito cells: 251.0;Smooth muscle cells: 179.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 33.3;U-266/70: 22.9;U-266/84: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055964 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA055964: AB_2682989" "unprognostic (3.22e-3)" "unprognostic (1.89e-2)" "unprognostic (3.13e-2)" "unprognostic (1.72e-3)" "unprognostic (1.04e-1)" "unprognostic (7.91e-3)" "prognostic favorable (8.55e-4)" "unprognostic (1.74e-1)" "unprognostic (3.09e-2)" "unprognostic (4.28e-2)" "unprognostic (4.90e-1)" "unprognostic (1.52e-1)" "unprognostic (9.76e-3)" "unprognostic (7.80e-2)" "unprognostic (1.76e-1)" "unprognostic (3.50e-1)" "unprognostic (7.56e-2)" 59.2 17.9 4.4 35.3 6.4 51.2 33.6 3.1 8.7 33.7 16.3 8.5 15.6 6.4 46.3 30.8 28.2 35.3 35.9 29.5 5.2 4.3 12.3 8.1 58.9 64.6 6.3 4.2 54.4 6.6 5.4 9.4 15.9 10.2 26.8 4.9 38.3 10.3 11.1 43.7 19.5 14.4 42.6 7.6 35.6 46.1 23.2 2.5 10.9 16.7 39.4 24.1 50.2 36.1 19.4 1.3 32.0 12.4 10.6 23.5 7.1 3.4 1.1 0.1 0.8 0.2 0.5 1.4 8.3 1.2 3.1 1.3 0.1 11.5 0.3 1.8 4.3 0.6 1.2 0.3 0.0 1.0 0.3 1.4 0.0 0.6 0.1 3.0 0.0 6.0 0.8 0.1 1.0 0.1 4.8 6.9 7.3 0.2 7.5 1.6 0.2 0.7 1.5 0.1 4.9 1.1 0.2 2.2 12.2 0.1 0.2 0.2 0.1 0.6 6.0 4.5 0.0 0.2 4.0 33.3 6.3 4.5 0.4 11.2 22.9 22.0 0.8 2.8 0.0 2.8 21.6 3.3 9.4 17.8 12.4 14.4 17.4 23.5 18.0 1.3 19.4 22.7 18.6 32.0 10.6 10.5 0.2 22.1 7.1 4.4 6.4 3.1 8.7 5.2 4.3 6.3 4.2 10.2 2.5 32.8 89.9 111.6 9.0 21.2 4.3 39.3 7.6 4.0 7.9 3.5 7.9 3.9 0.0 6.4 1.8 353.6 13.6 0.0 5.1 6.9 75.5 10.2 32.4 7.6 71.7 0.0 44.5 251.0 130.3 3.5 82.8 76.1 60.8 0.0 41.9 5.2 38.7 3.5 68.6 1.3 5.9 64.7 179.5 0.9 1.3 23.1 5.5 58.6 4.9 13.1 KLF3 BKLF ENSG00000109787 "Kruppel like factor 3" P57682 4 38664196-38701042 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 244.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049512, HPA065054" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049512: AB_2680799, HPA065054: AB_2685415" "unprognostic (4.20e-1)" "unprognostic (2.08e-2)" "unprognostic (4.70e-3)" "unprognostic (3.77e-2)" "unprognostic (1.36e-1)" "unprognostic (3.02e-2)" "unprognostic (3.20e-2)" "unprognostic (2.33e-1)" "unprognostic (2.57e-2)" "unprognostic (2.15e-1)" "unprognostic (1.02e-3)" "unprognostic (4.10e-2)" "prognostic favorable (4.36e-4)" "unprognostic (9.01e-2)" "unprognostic (1.70e-1)" "unprognostic (1.99e-1)" "unprognostic (3.10e-3)" 23.0 14.3 11.1 14.7 14.4 41.7 25.6 8.9 13.7 20.2 31.2 21.7 10.4 21.0 20.0 14.1 51.9 14.6 39.3 12.0 11.9 8.1 13.2 25.2 21.4 16.6 16.2 8.2 36.1 18.6 21.6 11.4 20.4 13.8 19.0 27.6 12.4 24.0 17.6 12.5 43.1 40.3 18.7 16.7 22.3 25.6 7.9 18.2 6.5 16.4 25.7 34.9 26.1 28.3 4.0 3.1 14.3 10.9 2.7 9.4 2.1 9.5 6.6 25.0 5.0 11.5 17.2 7.9 5.3 15.5 3.6 4.5 6.2 17.7 0.0 7.5 11.5 10.4 10.5 7.1 9.3 5.8 0.1 5.2 9.1 9.7 13.0 11.8 2.2 0.0 15.5 25.8 5.2 9.7 6.8 13.8 3.6 25.9 4.5 5.7 2.2 2.4 4.0 5.8 19.8 4.8 3.2 12.1 10.4 12.8 23.1 7.2 9.3 5.8 4.6 11.1 10.5 2.8 3.2 21.8 12.0 6.8 20.3 5.7 6.3 2.0 0.0 4.9 6.9 5.1 8.8 4.0 14.3 6.3 6.9 4.3 3.7 7.0 5.6 3.1 4.0 9.4 5.6 12.8 2.7 10.9 0.7 7.2 2.1 11.1 14.4 8.9 13.7 11.9 8.1 16.2 8.2 13.8 18.2 20.8 25.6 15.7 113.6 107.8 41.2 15.3 63.7 21.4 23.9 29.6 29.5 23.5 10.0 75.6 0.6 80.0 132.1 140.2 75.2 17.8 67.1 127.0 19.6 48.4 47.0 33.4 83.1 51.0 71.6 1.9 48.1 51.1 47.2 34.3 132.6 51.1 83.4 132.3 45.3 18.4 36.2 25.8 29.9 0.7 0.9 194.5 22.9 35.8 87.7 244.9 KLF4 "EZF, GKLF" ENSG00000136826 "Kruppel like factor 4" O43474 9 107484852-107490482 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 92.1" "Cell type enhanced" "Detected in many" 6 "Mucus-secreting cells: 685.3;Suprabasal keratinocytes: 589.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 5.2;intermediate monocyte: 7.4;myeloid DC: 4.4;non-classical monocyte: 2.9" "Group enriched" "Detected in many" 12 "dendritic cells: 4.4;monocytes: 7.4" "Cell line enhanced" "Detected in many" "hTCEpi: 32.8;hTERT-HME1: 20.3;OE19: 17.5;U-2197: 49.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA002926 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA002926: AB_1852541" "unprognostic (2.06e-1)" "unprognostic (1.42e-2)" "unprognostic (1.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.55e-1)" "unprognostic (6.58e-3)" "unprognostic (3.44e-2)" "unprognostic (6.49e-2)" "unprognostic (3.45e-1)" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (1.08e-1)" "prognostic favorable (3.93e-5)" "unprognostic (2.55e-1)" "unprognostic (1.67e-1)" "unprognostic (8.13e-2)" "unprognostic (8.32e-2)" 29.2 8.5 2.7 23.8 3.9 14.4 23.7 1.8 3.5 39.1 28.9 5.6 5.5 10.2 17.8 18.6 34.9 22.0 32.4 18.6 2.4 2.2 4.8 5.1 35.6 4.4 2.7 2.2 18.6 2.3 2.7 2.8 41.0 6.2 11.3 29.6 11.7 11.9 6.5 13.6 92.1 39.4 16.0 3.3 21.8 22.2 11.2 2.0 1.9 7.8 81.1 30.7 16.8 24.1 0.0 4.4 0.4 7.4 0.1 0.0 1.3 5.7 2.3 0.2 0.0 6.0 15.5 2.2 2.0 10.6 2.7 3.2 0.8 7.3 0.0 0.3 2.6 9.4 4.2 2.6 1.5 1.0 0.0 1.1 0.0 4.0 0.1 9.0 0.0 0.0 2.0 32.8 5.5 20.3 0.6 0.2 0.1 0.2 0.0 1.5 3.7 0.0 0.7 1.8 17.5 11.5 0.1 0.6 0.1 0.8 1.6 0.1 0.1 1.6 4.8 6.0 4.8 0.7 2.5 1.2 1.6 0.0 49.8 0.8 0.0 0.0 0.0 1.6 1.0 2.8 0.0 5.2 0.0 0.0 7.4 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.1 2.9 0.4 0.0 1.3 2.7 3.9 1.8 3.5 2.4 2.2 2.7 2.2 6.2 2.0 11.9 47.4 12.3 228.3 387.3 0.4 56.5 17.8 18.7 29.6 1.8 7.9 33.0 1.7 21.1 201.9 242.7 430.0 0.0 34.8 55.7 240.7 170.1 55.2 3.9 80.6 0.0 118.8 142.4 148.1 123.4 133.2 214.3 195.7 12.6 685.3 1.7 32.1 447.5 57.0 1.2 1.8 38.8 108.2 4.1 15.1 589.1 90.3 5.3 253.4 169.8 KLF8 "BKLF3, DXS741, ZNF741" ENSG00000102349 "Kruppel like factor 8" O95600 X 56232421-56287889 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Ito cells: 18.4;Leydig cells: 34.8;Peritubular cells: 25.8;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTCEpi: 12.1;RT4: 10.5;SK-BR-3: 9.3;SuSa: 6.0;T-47d: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071740 Supported Nucleoplasm NA NA Nucleoplasm "HPA071740: AB_2686440" "unprognostic (2.32e-1)" "unprognostic (1.56e-1)" "unprognostic (3.60e-2)" "unprognostic (1.50e-8)" "unprognostic (2.96e-1)" "prognostic favorable (3.32e-4)" "unprognostic (6.56e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (6.13e-2)" "unprognostic (3.15e-1)" "unprognostic (6.83e-2)" "unprognostic (1.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.15e-1)" "unprognostic (7.68e-2)" "unprognostic (2.60e-2)" 15.1 2.0 2.9 7.9 7.4 0.4 15.0 6.7 5.5 12.9 5.0 0.8 5.2 1.2 19.2 8.6 24.8 6.8 4.8 4.3 2.4 1.8 8.8 0.9 8.3 2.7 1.3 3.3 10.3 2.0 4.0 2.0 7.9 2.9 5.3 4.0 5.2 8.8 4.7 3.3 28.4 4.9 11.6 1.9 5.0 3.4 5.3 0.9 0.7 5.5 16.6 14.3 9.7 14.3 5.0 2.1 0.6 0.2 4.1 1.4 0.5 2.2 0.0 0.1 0.0 1.9 0.5 1.3 0.2 2.3 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 5.2 0.0 0.0 0.0 4.0 5.0 1.4 0.0 0.0 0.1 0.0 0.0 0.1 12.1 0.0 1.8 0.0 0.0 0.0 1.3 0.6 0.4 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 5.7 10.5 0.0 0.0 4.5 9.3 0.0 6.0 17.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.3 0.2 0.4 5.0 1.2 1.4 2.1 4.6 0.3 0.3 0.5 4.1 0.1 0.8 0.5 0.5 2.9 7.4 6.7 5.5 2.4 1.8 1.3 3.3 2.9 0.9 0.0 2.6 9.7 4.4 6.2 0.1 1.4 0.0 1.4 1.2 14.0 2.0 4.2 0.0 0.8 0.1 5.5 0.5 0.0 0.9 12.7 5.0 5.2 1.1 0.0 1.2 0.0 0.0 18.4 1.2 1.5 34.8 7.0 5.0 3.6 0.9 0.5 0.6 0.0 25.8 5.0 0.0 19.4 8.9 0.9 0.7 10.2 3.8 0.7 0.8 4.8 KLHDC10 "KIAA0265, slim" ENSG00000128607 "Kelch domain containing 10" Q6PID8 7 130070510-130135720 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020119 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020119: AB_2249467" "unprognostic (2.83e-1)" "unprognostic (6.26e-2)" "unprognostic (1.13e-1)" "unprognostic (8.16e-3)" "unprognostic (3.22e-1)" "unprognostic (1.80e-2)" "unprognostic (5.55e-2)" "unprognostic (8.70e-2)" "unprognostic (7.97e-2)" "unprognostic (1.42e-2)" "unprognostic (8.69e-2)" "unprognostic (2.43e-1)" "unprognostic (1.24e-2)" "unprognostic (8.22e-2)" "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (1.64e-2)" 11.7 18.6 15.5 9.1 21.1 7.2 14.8 27.1 24.1 13.4 12.6 16.9 13.6 11.0 13.4 14.4 13.0 15.5 9.7 14.9 14.2 24.8 21.3 22.8 11.8 7.9 17.0 18.6 15.2 15.3 37.4 25.1 13.6 23.4 13.4 13.0 15.0 10.7 17.1 23.2 13.1 11.7 11.9 14.1 11.0 11.9 35.3 10.2 9.8 18.3 8.9 11.6 9.6 12.3 3.3 1.9 1.8 2.5 0.6 3.4 0.6 11.3 10.6 7.3 40.0 9.7 10.8 3.4 10.8 8.3 8.2 8.6 5.7 8.6 9.6 7.7 9.9 13.8 8.9 11.7 6.9 10.4 7.8 7.0 5.6 11.9 6.7 7.7 10.3 6.9 6.7 11.9 12.7 8.0 10.3 11.5 6.7 27.2 6.1 9.2 9.5 8.9 10.0 1.2 8.3 6.9 7.3 13.8 6.9 11.3 7.8 11.9 9.5 17.4 31.1 8.8 9.4 7.6 7.7 13.0 10.6 4.6 14.1 12.9 8.0 10.4 8.9 22.2 10.0 14.3 0.0 1.8 1.8 2.4 2.5 2.0 1.7 1.7 2.8 1.9 3.3 1.5 2.8 1.6 0.6 1.9 1.6 3.4 0.6 15.5 21.1 27.1 24.1 14.2 24.8 17.0 18.6 23.4 10.2 17.9 13.2 6.0 6.4 20.6 19.5 19.4 33.1 16.0 20.5 33.2 37.3 10.1 3.3 15.5 51.3 15.6 11.8 23.3 20.5 7.9 20.1 11.2 5.8 37.5 10.8 33.4 19.1 32.5 22.9 12.4 14.1 11.7 16.9 13.6 15.5 18.1 18.9 3.5 23.0 23.2 21.6 0.0 10.3 29.7 4.5 25.5 9.4 7.5 18.2 11.5 KLHDC3 "dJ20C7.3, hPeas, PEAS" ENSG00000124702 "Kelch domain containing 3" Q9BQ90 6 43014103-43021298 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.7" "Group enriched" "Detected in all" 9 "Early spermatids: 436.9;Late spermatids: 1305.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030131, HPA030132, HPA030133, HPA030134" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350" "unprognostic (3.85e-2)" "prognostic favorable (9.15e-4)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.52e-4)" "unprognostic (9.97e-3)" "unprognostic (2.80e-1)" "unprognostic (2.09e-3)" "unprognostic (1.05e-2)" "unprognostic (5.09e-2)" "unprognostic (1.58e-3)" "prognostic favorable (9.08e-4)" "unprognostic (6.34e-2)" "unprognostic (2.88e-2)" "unprognostic (8.73e-2)" "unprognostic (9.78e-2)" "unprognostic (2.88e-1)" "unprognostic (1.52e-1)" 16.1 19.0 37.2 11.6 41.6 14.7 17.6 38.0 68.2 15.2 16.7 14.6 15.4 14.4 12.8 21.2 16.1 19.9 13.6 34.0 34.2 25.7 14.8 20.2 14.4 14.4 26.7 41.6 20.3 15.2 15.6 17.6 20.9 29.6 16.3 15.0 13.5 21.3 18.5 122.7 15.1 14.7 15.9 14.6 14.1 15.4 47.0 15.3 17.4 19.3 17.6 15.6 13.7 11.2 19.5 39.4 41.6 36.3 21.6 31.5 29.8 26.4 8.2 27.3 45.6 18.8 14.2 19.6 12.0 15.5 23.5 25.8 23.5 13.9 26.3 13.7 17.5 8.8 14.1 29.0 15.5 16.1 14.0 39.5 32.7 23.6 24.4 18.5 19.2 23.4 22.8 15.6 18.1 10.6 18.3 22.7 30.1 39.7 18.8 8.8 32.9 31.4 33.1 35.5 66.8 8.8 30.6 20.0 31.5 14.4 15.4 50.6 39.5 12.7 14.6 20.4 18.5 25.4 55.7 13.4 10.7 20.0 11.8 11.8 20.6 25.8 38.2 4.7 27.6 9.0 14.9 36.3 41.6 28.5 33.8 24.0 19.2 23.8 25.8 39.4 19.5 31.5 24.5 17.7 21.6 25.8 21.8 25.1 29.8 37.2 41.6 38.0 68.2 34.2 25.7 26.7 41.6 29.6 15.3 11.9 17.1 31.9 30.7 16.7 29.1 32.5 30.6 5.3 6.8 17.4 13.7 84.7 72.9 52.9 436.9 20.2 33.8 23.3 48.1 97.9 40.2 39.5 13.8 24.5 56.1 30.2 50.3 24.5 35.6 1305.6 41.4 26.0 32.1 61.3 43.7 33.2 40.4 43.6 55.5 45.1 21.9 51.8 26.8 102.4 30.2 18.1 89.5 30.2 50.7 28.0 KLHL8 KIAA1378 ENSG00000145332 "Kelch like family member 8" Q9P2G9 4 87160103-87240314 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 56.2" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 205.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013856, HPA017762" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA013856: AB_1852594, HPA017762: AB_2669660" "unprognostic (2.93e-2)" "unprognostic (4.91e-3)" "unprognostic (3.44e-2)" "unprognostic (4.66e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (2.12e-1)" "unprognostic (4.46e-3)" "unprognostic (3.27e-2)" "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (3.46e-1)" "prognostic favorable (1.53e-5)" "unprognostic (4.24e-3)" "unprognostic (3.05e-1)" "unprognostic (3.57e-3)" "unprognostic (1.57e-3)" 6.8 7.3 6.9 5.6 8.1 3.0 12.0 10.0 10.7 9.2 7.5 5.3 3.8 7.3 8.3 56.2 5.3 5.4 5.0 7.4 7.7 7.2 11.4 10.3 9.0 8.1 6.3 5.6 6.1 6.3 7.1 14.2 6.6 7.3 5.7 8.5 4.6 6.5 7.7 23.4 4.8 8.2 6.6 8.0 6.9 5.5 4.2 6.5 7.0 17.3 2.9 4.7 6.8 10.9 3.8 10.3 8.6 12.1 8.7 4.9 5.0 6.5 5.8 10.5 4.7 9.6 7.0 5.6 8.4 4.5 5.6 6.6 9.2 5.0 9.5 6.8 6.2 4.6 2.8 11.1 8.3 12.2 9.1 7.0 11.6 4.4 5.4 8.2 19.0 7.3 8.8 6.0 8.6 8.7 5.5 6.7 7.3 14.9 8.7 5.8 7.2 22.7 9.6 2.6 14.8 2.3 8.6 9.0 5.8 9.5 6.8 22.0 7.7 5.5 13.5 6.2 4.1 4.7 14.1 6.2 7.2 8.8 7.6 7.0 13.1 8.5 16.9 5.4 9.1 7.8 1.9 12.1 7.3 3.0 9.2 4.9 3.3 2.4 2.5 10.3 3.8 4.4 4.3 8.6 8.7 9.0 2.7 0.9 5.0 6.9 8.1 10.0 10.7 7.7 7.2 6.3 5.6 7.3 6.5 3.0 18.5 11.3 9.5 12.2 18.4 11.7 5.1 6.7 10.3 41.8 39.3 3.2 10.0 4.5 2.8 9.5 12.2 0.0 3.9 4.6 8.6 10.5 7.0 17.1 8.6 22.3 8.6 5.5 30.8 2.4 8.9 13.4 10.1 2.8 12.0 205.6 5.0 8.6 7.8 16.5 44.7 12.9 9.2 11.2 19.4 12.9 19.9 7.7 13.3 9.8 KLRG2 "CLEC15B, FLJ44186" ENSG00000188883 "Killer cell lectin like receptor G2" A4D1S0 7 139452690-139483712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 9.7;thyroid gland: 22.1" "Group enriched" "Detected in some" 6 "Collecting duct cells: 7.0;Extravillous trophoblasts: 1.8;Syncytiotrophoblasts: 6.4" "Cancer enriched" "Detected in many" 11 "testis cancer: 42.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 11.2;HAP1: 11.8;NTERA-2: 6.2;SCLC-21H: 5.6;SK-BR-3: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018199 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA018199: AB_2133260" "unprognostic (2.50e-2)" "unprognostic (3.05e-2)" "unprognostic (9.82e-2)" "unprognostic (5.38e-8)" "unprognostic (2.41e-1)" "unprognostic (1.97e-2)" "unprognostic (3.13e-2)" "prognostic favorable (8.61e-4)" "unprognostic (2.14e-2)" "unprognostic (2.92e-1)" "unprognostic (5.19e-2)" "unprognostic (8.83e-2)" "unprognostic (1.10e-3)" "unprognostic (5.66e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-2)" "unprognostic (2.34e-2)" 0.2 0.1 0.0 0.0 0.3 0.0 2.4 0.0 0.8 1.0 0.0 0.2 0.0 0.0 0.2 0.7 7.3 0.2 0.0 0.0 0.0 0.0 4.5 0.0 6.2 0.0 0.1 0.0 0.0 0.2 6.5 0.9 0.7 0.3 0.2 0.1 0.3 9.7 0.3 0.1 4.7 0.0 1.5 1.4 0.0 0.2 2.3 0.0 0.9 22.1 2.6 2.3 0.8 2.4 0.4 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.3 0.0 0.0 1.7 11.8 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.1 0.0 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.0 1.8 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.4 0.1 5.6 0.3 1.7 23.9 0.0 4.8 5.3 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.3 0.0 0.0 0.0 7.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 6.4 0.0 0.0 0.3 KMT2C "HALR, KIAA1506, MLL3" ENSG00000055609 "Lysine methyltransferase 2C" Q8NEZ4 7 152134922-152436005 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074736 Approved Nucleoplasm NA NA Nucleoplasm "HPA074736: AB_2686709" "unprognostic (7.75e-2)" "unprognostic (3.10e-1)" "unprognostic (2.83e-1)" "unprognostic (1.33e-2)" "unprognostic (1.31e-1)" "unprognostic (5.23e-3)" "unprognostic (1.09e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.45e-1)" "unprognostic (1.06e-1)" "prognostic favorable (8.01e-6)" "unprognostic (1.78e-1)" "unprognostic (3.83e-1)" "unprognostic (3.04e-2)" "unprognostic (2.64e-1)" 13.9 12.6 11.7 16.7 18.6 29.7 14.5 24.8 14.1 18.4 12.6 15.5 21.4 9.7 20.2 20.6 14.4 12.8 12.7 10.8 13.4 9.5 10.3 11.4 13.0 12.1 17.7 9.4 18.8 18.4 18.8 18.9 38.0 12.6 14.0 11.8 12.6 15.8 22.9 30.3 25.2 13.1 13.6 16.0 14.6 14.9 13.6 19.6 22.6 16.9 9.3 16.8 17.8 31.6 5.6 3.5 16.1 3.9 5.5 2.9 0.6 9.7 4.9 9.1 9.7 16.5 10.0 10.7 5.1 3.9 4.1 5.0 9.3 5.9 15.5 7.4 9.2 5.6 5.6 9.8 7.4 6.9 9.8 5.0 9.2 7.4 6.4 8.0 15.5 11.3 8.4 10.3 5.8 7.8 6.6 5.8 8.1 14.8 13.4 8.9 13.6 11.2 14.1 5.5 7.6 4.9 7.6 8.3 8.1 7.0 10.0 13.3 10.5 8.4 15.0 5.5 9.9 4.9 12.8 7.3 6.8 3.6 7.3 7.2 14.1 6.9 16.7 8.9 12.8 7.0 8.8 3.5 4.3 2.1 2.2 2.9 5.6 1.7 1.7 1.7 3.8 2.7 1.8 16.1 5.5 3.9 3.5 1.3 0.6 11.7 18.6 24.8 14.1 13.4 9.5 17.7 9.4 12.6 19.6 71.5 66.6 54.7 36.1 79.1 82.8 58.2 45.9 44.2 92.1 43.6 163.0 29.7 5.0 30.2 18.6 49.2 41.0 23.3 28.7 45.7 47.0 48.1 62.5 36.6 29.6 76.3 65.1 41.7 48.8 11.0 62.5 61.0 40.5 25.2 44.5 62.2 33.0 43.8 56.6 15.7 75.2 25.8 50.1 33.5 31.5 84.2 106.4 50.4 30.3 55.0 KMT5B "CGI-85, SUV420H1" ENSG00000110066 "Lysine methyltransferase 5B" Q4FZB7 11 68154863-68213828 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 52.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063648 Supported Nucleoplasm NA NA Nucleoplasm "HPA063648: AB_2685073" "unprognostic (5.82e-2)" "unprognostic (4.25e-2)" "unprognostic (2.54e-1)" "unprognostic (5.36e-3)" "unprognostic (3.52e-1)" "unprognostic (2.94e-1)" "unprognostic (1.83e-2)" "unprognostic (1.08e-1)" "unprognostic (3.16e-2)" "unprognostic (1.71e-1)" "unprognostic (5.54e-2)" "unprognostic (1.21e-1)" "unprognostic (3.79e-3)" "unprognostic (2.62e-1)" "unprognostic (4.26e-2)" "unprognostic (3.21e-2)" "prognostic favorable (9.30e-4)" 17.6 19.1 20.9 23.4 22.5 23.7 27.3 38.8 26.7 22.4 21.2 19.9 32.3 21.8 26.2 22.7 19.7 20.4 18.2 15.1 23.8 15.3 19.1 21.5 17.4 16.9 18.6 22.2 27.4 24.0 27.4 28.1 26.6 17.0 24.9 21.5 15.4 25.2 30.4 18.8 20.8 24.0 23.4 18.4 19.6 19.7 19.1 23.6 38.0 30.9 17.5 19.1 20.5 22.5 4.5 5.5 16.0 5.2 8.9 5.9 2.7 10.3 7.8 16.0 10.3 3.7 9.4 17.3 7.5 5.2 9.3 5.5 24.6 16.6 8.5 13.0 10.1 9.2 5.4 11.0 8.6 13.6 9.5 6.4 8.0 9.2 10.1 13.6 11.2 11.0 9.3 17.8 11.2 11.8 8.6 9.2 8.5 11.8 9.9 7.9 21.3 7.9 11.8 17.1 20.7 5.9 13.1 12.5 22.6 6.9 10.0 14.0 16.7 11.5 11.6 52.3 9.1 14.9 7.4 9.6 12.6 16.8 9.6 7.5 12.7 5.5 17.9 7.9 7.1 13.4 7.8 3.7 16.0 4.7 5.2 3.3 3.4 5.1 5.7 3.6 4.5 5.9 5.2 11.3 8.9 4.8 5.5 4.0 2.7 20.9 22.5 38.8 26.7 23.8 15.3 18.6 22.2 17.0 23.6 56.6 48.3 13.8 31.8 0.0 45.8 0.0 22.9 58.9 46.6 24.4 11.8 24.2 18.3 24.2 13.7 24.8 22.7 0.0 28.3 24.3 18.6 34.9 20.9 32.7 15.6 60.4 24.6 25.2 31.0 17.2 25.9 18.9 0.0 34.3 38.9 26.9 30.1 24.6 29.7 19.2 39.1 32.3 0.0 34.9 59.5 0.0 43.3 17.5 31.2 40.1 KMT5C "MGC2705, SUV420H2" ENSG00000133247 "Lysine methyltransferase 5C" Q86Y97 19 55339853-55348120 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 47.4;Cone photoreceptor cells: 47.1;Horizontal cells: 63.5;Rod photoreceptor cells: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 16.6;SCLC-21H: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052294 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052294: AB_2681788" "unprognostic (4.02e-2)" "unprognostic (3.45e-2)" "unprognostic (2.92e-3)" "unprognostic (6.77e-3)" "unprognostic (2.48e-1)" "unprognostic (8.27e-2)" "unprognostic (2.29e-2)" "unprognostic (1.27e-1)" "unprognostic (8.69e-2)" "unprognostic (3.04e-1)" "unprognostic (9.48e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.05e-8)" "unprognostic (7.39e-2)" "unprognostic (2.96e-1)" "unprognostic (9.41e-2)" "unprognostic (2.39e-2)" 5.0 5.6 8.5 7.3 15.7 13.4 5.4 20.0 10.7 5.1 7.5 11.2 4.9 11.9 7.0 5.4 4.6 11.0 7.4 4.2 11.2 4.5 5.1 4.4 5.5 4.6 17.1 5.3 6.1 8.5 6.2 11.7 6.5 9.6 6.6 3.8 6.3 7.7 6.3 6.6 13.5 8.5 3.6 6.2 6.2 9.8 7.0 14.7 10.1 5.1 2.3 3.5 6.3 4.6 0.3 0.8 0.9 0.6 1.1 0.8 0.3 5.0 3.5 3.3 2.8 0.7 0.9 9.3 1.4 0.6 0.5 1.3 2.2 4.3 5.0 1.8 1.1 0.2 2.8 2.1 1.8 0.6 4.5 16.6 4.0 2.5 2.2 1.2 2.3 4.8 0.8 2.5 1.7 0.9 0.7 1.1 5.5 9.8 2.8 0.6 5.8 6.6 5.2 6.0 3.0 5.2 9.8 3.9 4.9 0.8 1.3 16.2 6.9 0.7 3.7 2.0 1.9 4.2 2.9 1.2 1.6 4.0 0.5 1.0 8.3 4.1 3.2 0.8 5.6 2.2 0.3 0.6 0.3 0.7 0.4 0.0 0.1 0.5 0.7 0.6 0.3 0.3 0.8 0.9 1.1 0.0 0.8 0.2 0.3 8.5 15.7 20.0 10.7 11.2 4.5 17.1 5.3 9.6 14.7 6.0 5.5 1.9 11.9 0.0 47.4 0.0 10.2 6.7 5.7 3.5 47.1 25.7 1.7 5.8 1.6 2.2 8.4 23.3 2.6 16.4 3.1 9.2 2.3 1.0 8.3 63.5 7.0 4.9 3.1 1.5 6.9 4.9 0.0 1.0 14.9 28.9 6.1 15.3 6.0 2.1 46.0 6.5 0.0 8.4 11.1 0.0 16.6 9.6 13.3 9.8 KPNA4 "IPOA3, MGC12217, MGC26703, QIP1, SRP3" ENSG00000186432 "Karyopherin subunit alpha 4" O00629 3 160494995-160565588 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034336, HPA043154, HPA045500" Enhanced Enhanced Nucleoplasm NA NA 250000 Nucleoplasm "CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351" "unprognostic (1.58e-1)" "unprognostic (7.65e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (8.59e-4)" "unprognostic (7.56e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (6.24e-7)" "unprognostic (7.71e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.20e-1)" "unprognostic (1.21e-1)" "unprognostic (3.98e-2)" "unprognostic (2.21e-1)" "unprognostic (2.17e-3)" "unprognostic (1.48e-1)" 18.0 9.4 12.6 12.9 12.7 15.2 25.1 13.1 14.1 14.8 14.4 8.6 11.1 7.3 13.1 10.8 22.1 8.9 13.9 45.0 12.0 12.1 11.0 12.6 11.4 12.4 11.6 10.8 15.0 10.7 12.5 6.9 17.5 11.1 11.0 9.7 7.1 10.9 13.1 66.1 10.6 9.5 20.4 10.4 12.1 10.8 13.5 6.3 13.8 11.4 22.2 10.2 21.8 25.2 2.9 2.9 6.8 11.5 8.3 5.6 3.2 33.8 12.0 12.4 16.7 14.3 13.2 16.3 21.1 15.1 15.5 13.2 15.3 17.8 18.0 25.3 21.6 23.2 15.8 13.9 13.6 23.4 22.3 7.8 15.2 10.7 9.1 18.6 21.2 13.7 13.5 14.4 15.0 30.6 12.5 20.4 8.9 11.4 14.6 22.0 9.5 19.1 8.8 25.2 15.3 11.2 12.8 18.5 18.2 12.5 13.0 10.1 9.8 20.4 20.5 29.3 14.4 17.8 11.6 22.7 17.8 15.3 17.7 33.9 26.8 17.7 41.3 16.2 22.2 15.7 6.8 3.6 6.0 3.1 6.7 5.6 2.9 4.5 4.5 2.7 2.5 3.6 4.7 5.4 8.3 11.5 2.9 4.2 3.2 12.6 12.7 13.1 13.3 12.0 12.1 11.6 10.8 11.1 6.3 35.7 24.3 27.5 63.0 109.9 56.4 153.2 20.4 40.2 43.3 10.4 74.6 22.7 29.9 33.3 19.9 45.0 51.2 0.0 32.4 20.6 50.3 69.0 30.1 26.1 35.0 50.9 27.5 29.4 41.9 14.3 31.4 45.8 42.2 26.2 29.9 52.1 57.1 33.4 32.5 31.4 60.8 32.3 42.2 40.3 21.8 110.2 34.0 29.9 30.5 94.6 KRBA2 ENSG00000184619 "KRAB-A domain containing 2" Q6ZNG9 17 8368637-8376711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 28.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA022849 Approved Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA022849: AB_1852996" "unprognostic (9.17e-2)" "unprognostic (1.81e-1)" "unprognostic (1.92e-1)" "unprognostic (3.10e-2)" "unprognostic (2.98e-2)" "unprognostic (8.35e-3)" "unprognostic (7.44e-2)" "unprognostic (1.07e-1)" "unprognostic (2.80e-2)" "unprognostic (2.13e-1)" "unprognostic (7.61e-4)" "unprognostic (6.14e-2)" "unprognostic (5.02e-7)" "unprognostic (1.82e-1)" "unprognostic (2.55e-1)" "unprognostic (3.52e-2)" "unprognostic (1.08e-1)" 10.2 6.5 7.2 3.9 9.7 1.6 6.1 7.8 7.6 6.4 4.5 9.9 4.1 3.7 6.6 5.1 3.9 5.0 3.9 27.5 8.2 4.4 9.6 2.7 4.0 4.0 9.9 6.4 7.1 5.0 11.2 8.8 4.7 7.6 6.9 4.0 11.0 7.7 4.9 11.0 6.4 4.2 4.6 9.1 3.9 4.5 6.2 8.7 6.3 7.5 6.0 3.4 7.5 5.7 5.0 2.8 12.7 3.8 1.8 6.0 0.7 0.6 6.2 7.1 6.6 3.9 5.8 3.9 0.9 2.6 3.1 3.8 0.1 2.4 0.6 4.5 1.0 1.8 1.5 2.6 1.0 4.1 3.1 2.2 1.0 4.0 2.8 1.4 0.4 1.8 4.5 0.0 2.6 1.3 2.1 4.8 4.0 0.0 0.8 2.3 1.0 2.7 0.3 0.7 0.2 2.2 5.0 4.5 0.6 2.0 4.3 2.4 4.9 6.3 2.1 1.6 5.8 3.1 0.4 2.9 2.2 3.8 0.9 0.9 2.6 1.5 0.4 2.8 0.0 5.1 12.7 2.3 3.5 3.4 1.8 3.2 2.9 3.4 2.6 1.2 5.0 6.0 3.3 2.2 1.8 3.8 2.8 3.2 0.7 7.2 9.7 7.8 7.6 8.2 4.4 9.9 6.4 7.6 8.7 0.0 0.6 0.0 1.2 0.2 2.0 0.4 0.0 4.0 0.0 1.8 15.7 2.0 3.3 2.4 0.3 1.5 1.0 0.0 1.0 0.5 0.9 0.5 4.7 0.0 0.8 3.2 4.1 2.5 1.0 0.0 1.4 1.1 1.7 0.0 1.0 2.4 1.6 0.0 2.8 0.9 28.5 0.0 1.2 1.8 1.5 0.6 1.0 1.3 1.2 0.3 KRBOX4 "FLJ20344, ZNF673" ENSG00000147121 "KRAB box domain containing 4" Q5JUW0 X 46446857-46497422 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA065295 Approved Nucleoplasm NA NA Nucleoplasm "HPA065295: AB_2685456" "unprognostic (4.12e-1)" "unprognostic (6.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.64e-2)" "unprognostic (1.17e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (2.87e-6)" "prognostic favorable (4.67e-5)" "unprognostic (1.73e-2)" "unprognostic (2.61e-3)" "unprognostic (3.27e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (1.98e-7)" "unprognostic (7.94e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.17e-4)" 17.8 11.3 16.9 10.5 22.3 6.8 17.0 24.9 21.0 14.4 14.2 19.9 11.7 7.9 25.6 27.9 8.5 16.0 14.1 10.6 13.6 16.6 12.0 16.4 13.5 15.5 16.1 16.8 22.4 14.0 17.3 24.5 20.3 22.2 16.8 11.1 13.2 9.8 14.6 8.7 13.4 10.5 18.1 17.2 19.7 10.3 6.4 19.0 12.6 17.0 9.3 14.5 14.3 12.9 17.4 12.5 13.7 8.8 13.8 17.8 8.2 14.8 8.5 13.7 10.4 13.5 14.2 8.3 14.5 13.3 13.5 12.4 7.5 13.7 8.5 9.7 12.4 22.1 10.6 16.9 8.1 16.0 8.3 7.2 7.0 17.6 7.1 14.6 10.3 11.5 15.8 9.0 18.5 15.4 12.0 12.6 13.1 7.5 9.4 12.1 8.6 10.6 5.2 12.3 5.8 15.6 7.5 12.7 10.5 8.7 6.2 5.0 9.7 12.5 6.1 13.9 24.3 10.1 10.4 11.3 15.2 15.1 19.7 11.8 10.3 11.6 12.2 13.0 0.5 13.6 12.2 6.7 13.7 12.7 8.2 13.3 13.2 13.7 12.2 6.6 17.4 17.8 12.7 5.1 13.8 8.8 12.5 11.6 8.2 16.9 22.3 24.9 21.0 13.6 16.6 16.1 16.8 22.2 19.0 6.0 6.7 12.3 3.7 1.9 5.7 6.3 10.2 5.3 4.5 5.2 3.9 11.8 8.3 7.0 0.2 12.3 2.0 0.0 4.0 6.6 7.5 4.3 7.0 4.0 8.1 9.5 1.2 16.5 6.5 0.9 7.2 4.6 6.8 3.6 3.6 10.1 3.1 4.3 10.6 4.5 7.8 12.9 5.1 1.9 5.1 2.4 11.3 8.7 4.3 1.4 KY FLJ33207 ENSG00000174611 "Kyphoscoliosis peptidase" Q8NBH2 3 134603138-134651636 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease" "Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 19.5;tongue: 36.2" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 3.0;Late spermatids: 5.2;Muller glia cells: 2.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 7.4" "Lineage enriched" "Detected in single" 75 "granulocytes: 7.4" "Cell line enhanced" "Detected in some" "Karpas-707: 3.4;U-2197: 4.6;U-87 MG: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036492, HPA036668" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036492: AB_10672222, HPA036668: AB_2675239" "unprognostic (1.40e-2)" "unprognostic (2.05e-2)" "unprognostic (4.24e-2)" "unprognostic (2.81e-2)" "unprognostic (2.72e-2)" "unprognostic (1.65e-2)" "unprognostic (2.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.27e-1)" "unprognostic (3.86e-2)" "unprognostic (9.87e-2)" "unprognostic (2.83e-2)" "unprognostic (3.82e-1)" "unprognostic (4.62e-2)" "unprognostic (2.29e-1)" "unprognostic (8.98e-2)" "unprognostic (1.47e-1)" 0.3 5.7 3.5 0.4 2.3 0.5 1.4 2.5 4.6 2.2 1.7 2.1 1.7 0.9 3.9 2.3 3.1 3.7 0.9 4.8 4.9 2.1 0.7 0.2 0.3 0.2 1.7 6.9 1.7 0.2 8.5 6.8 0.2 3.2 3.6 0.6 3.3 1.7 2.8 19.5 12.6 0.5 7.4 2.0 0.3 1.7 0.7 3.6 0.5 5.2 36.2 1.1 1.3 1.4 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 13.9 0.7 0.0 7.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.5 2.3 2.5 4.6 4.9 2.1 1.7 6.9 3.2 3.6 0.0 0.0 0.0 0.0 0.6 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 L3MBTL2 "dJ756G23.3, DKFZP761I141, H-l(3)mbt-l" ENSG00000100395 "L3MBTL2, polycomb repressive complex 1 subunit" Q969R5 22 41205205-41231271 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000815 Approved Nucleoplasm NA NA Nucleoplasm "HPA000815: AB_1079220" "unprognostic (2.42e-1)" "prognostic favorable (6.39e-5)" "unprognostic (3.98e-2)" "prognostic favorable (4.37e-4)" "unprognostic (3.48e-1)" "unprognostic (1.19e-2)" "unprognostic (4.16e-3)" "unprognostic (1.03e-2)" "unprognostic (2.19e-1)" "unprognostic (2.26e-1)" "unprognostic (7.95e-3)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (2.07e-3)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" "unprognostic (2.19e-1)" 10.8 15.8 15.2 13.5 26.4 11.1 12.9 20.6 32.7 15.5 12.8 16.8 17.9 10.1 15.0 15.2 12.6 24.0 11.4 14.3 15.6 16.6 12.4 16.9 13.9 18.5 14.5 19.2 18.7 15.9 23.6 22.6 12.4 15.4 15.1 12.5 15.2 15.8 17.9 11.6 15.6 11.8 16.9 12.6 16.9 13.2 14.5 16.0 16.7 14.7 9.3 20.4 13.8 10.9 13.1 13.2 7.2 13.3 14.5 17.7 15.2 9.8 9.9 8.3 17.2 10.6 7.9 9.9 9.5 11.2 18.7 15.5 6.2 7.2 16.1 7.6 13.0 11.3 9.7 20.2 12.7 12.0 20.0 25.7 6.3 17.9 15.0 11.2 30.7 15.0 10.8 4.9 14.9 14.0 8.0 13.3 12.7 11.4 13.3 8.8 17.3 15.3 10.3 11.7 36.2 11.6 15.8 6.7 19.0 9.3 10.1 7.0 4.9 16.7 12.4 9.9 8.8 8.2 17.2 10.6 9.9 9.3 7.9 10.5 10.8 19.8 13.5 11.6 14.1 12.7 6.5 10.4 7.2 17.7 12.9 16.3 13.1 14.1 13.9 13.2 9.3 16.9 15.9 1.1 14.5 13.3 9.8 13.5 15.2 15.2 26.4 20.6 32.7 15.6 16.6 14.5 19.2 15.4 16.0 14.9 18.7 6.0 5.1 2.4 23.9 9.2 17.8 26.8 22.7 10.4 15.7 14.9 10.0 8.4 10.3 6.8 7.1 23.3 6.7 16.3 5.7 5.8 10.5 12.3 11.1 15.9 14.5 8.0 9.1 23.9 6.6 9.9 3.3 10.8 7.5 14.1 7.2 5.8 8.9 6.7 14.2 6.5 8.2 18.4 12.4 3.3 14.3 12.5 8.0 5.3 LCAT ENSG00000213398 "Lecithin-cholesterol acyltransferase" P04180 16 67939750-67944131 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Hydrolase, Transferase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "brain: 64.4;liver: 154.2" "Cell type enriched" "Detected in many" 16 "Hepatocytes: 204.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 64.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 35.6;Hep G2: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044767 Approved Nucleoplasm "Secreted to blood" NA NA 6470000000 9500000000 Nucleoplasm "HPA044767: AB_2756312" "unprognostic (3.34e-2)" "unprognostic (3.56e-2)" "prognostic unfavorable (8.50e-4)" "unprognostic (5.43e-3)" "unprognostic (1.25e-2)" "unprognostic (2.16e-1)" "prognostic favorable (4.21e-8)" "unprognostic (6.42e-2)" "unprognostic (4.26e-1)" "unprognostic (4.12e-1)" "unprognostic (1.50e-2)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (9.93e-2)" "unprognostic (1.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.90e-3)" 4.4 3.6 6.3 2.2 3.7 0.9 4.3 64.4 9.6 4.5 4.4 7.3 1.4 1.3 5.3 3.0 1.8 3.5 3.5 4.5 8.4 1.8 3.9 154.2 5.6 1.9 5.5 6.3 4.7 2.5 5.9 2.7 5.5 9.2 6.4 1.3 1.8 2.4 6.2 3.4 9.9 2.4 3.8 7.5 3.9 2.3 2.2 6.1 1.4 7.6 1.6 1.4 2.6 4.5 1.8 0.8 5.0 1.1 1.3 1.4 0.1 2.5 4.0 6.0 6.8 5.2 7.4 35.6 9.9 4.3 6.7 4.7 13.3 3.1 1.3 1.9 14.3 2.4 8.8 1.4 13.6 4.2 0.6 3.6 1.7 8.9 27.7 7.2 0.3 4.7 12.8 12.9 13.9 4.8 9.1 4.9 4.0 3.8 0.6 4.7 4.1 1.6 4.2 3.9 0.4 2.2 1.7 6.5 1.4 1.9 4.3 0.2 3.1 15.0 0.7 1.7 12.9 8.5 2.7 9.3 8.7 13.6 9.5 3.5 8.2 2.2 3.7 4.1 1.1 7.5 2.4 1.1 5.0 0.9 0.1 1.3 1.2 0.7 0.8 0.2 1.8 1.4 0.4 2.8 1.3 0.5 0.8 0.0 0.1 6.3 3.7 64.4 9.6 8.4 1.8 5.5 6.3 9.2 6.1 8.9 4.5 0.0 4.1 8.4 0.2 4.2 7.6 2.7 3.4 3.5 2.0 6.0 0.0 1.6 0.0 4.3 0.0 0.0 0.9 2.7 7.1 2.9 1.1 204.0 2.1 0.0 1.2 12.3 3.2 0.5 8.1 1.6 6.8 2.8 0.0 7.5 1.4 0.0 8.1 0.0 0.5 12.9 7.1 1.0 1.5 2.3 10.2 0.0 0.0 1.4 LCOR "C10orf12, DKFZP564P1916, FLJ13022, FLJ38026, KIAA1795, MLR2" ENSG00000196233 "Ligand dependent nuclear receptor corepressor" Q96JN0 10 96832282-96995959 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031429, HPA057621, HPA077000" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031429: AB_2673879, HPA057621: AB_2732616, HPA077000: AB_2686824" "unprognostic (5.61e-2)" "unprognostic (1.59e-1)" "unprognostic (2.11e-1)" "unprognostic (2.23e-1)" "unprognostic (1.49e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (2.19e-1)" "unprognostic (2.40e-1)" "unprognostic (1.54e-1)" "unprognostic (4.93e-2)" "unprognostic (5.61e-3)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (4.40e-2)" "unprognostic (1.24e-1)" "prognostic favorable (2.16e-4)" 7.5 6.4 9.9 9.2 11.6 35.5 8.6 25.7 10.5 7.8 13.8 12.6 9.4 17.4 8.9 8.1 12.9 8.3 8.3 7.8 7.3 6.9 9.1 10.0 9.4 9.7 13.6 7.5 13.1 16.9 10.3 20.3 25.9 10.8 8.7 14.1 9.5 12.1 7.4 11.9 7.1 24.2 9.4 11.4 9.9 10.9 7.6 11.7 13.2 10.5 6.6 13.2 12.5 9.7 6.8 4.8 12.2 4.2 3.4 5.4 1.9 11.2 7.4 13.0 6.0 3.7 4.2 6.7 5.7 5.0 6.5 7.1 10.0 7.8 11.9 6.0 5.5 5.5 6.5 12.6 6.9 11.5 5.6 6.5 12.2 4.3 11.8 7.3 11.5 7.1 3.8 5.9 9.6 16.7 6.5 7.0 6.4 10.2 6.2 9.5 5.4 6.7 6.1 4.3 5.8 3.4 9.1 10.3 3.5 6.5 25.1 6.0 5.2 5.5 3.4 7.3 6.2 7.4 5.1 9.7 5.3 10.7 4.2 9.3 5.9 5.1 13.9 5.1 11.9 2.4 2.1 3.8 6.4 4.8 4.2 4.6 3.8 4.0 5.4 3.1 6.8 4.7 4.7 12.2 3.4 2.5 4.8 2.4 1.9 9.9 11.6 25.7 10.5 7.3 6.9 13.6 7.5 10.8 11.7 17.9 23.2 11.8 15.3 13.7 43.1 12.4 48.4 50.9 29.6 29.6 72.6 11.6 10.0 25.1 0.8 17.3 59.9 0.0 29.4 6.5 12.3 29.5 25.5 19.5 12.0 38.1 45.1 24.5 25.9 1.1 9.5 27.5 20.3 19.0 30.3 10.3 34.4 42.1 13.1 21.3 55.5 19.4 20.8 19.2 25.0 11.3 32.3 23.0 29.6 29.7 LDB1 "CLIM2, NLI" ENSG00000198728 "LIM domain binding 1" Q86U70 10 102107560-102120453 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034488 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA034488: AB_10669783" "unprognostic (8.83e-2)" "unprognostic (3.71e-2)" "unprognostic (1.97e-3)" "unprognostic (4.54e-2)" "unprognostic (1.35e-1)" "unprognostic (5.01e-3)" "unprognostic (1.55e-2)" "unprognostic (1.04e-3)" "unprognostic (2.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-3)" "unprognostic (8.25e-2)" "unprognostic (2.54e-1)" "unprognostic (3.19e-1)" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (1.26e-2)" 18.6 18.7 20.6 20.7 31.1 46.3 21.3 23.2 43.0 35.5 30.4 26.5 24.5 14.0 37.4 19.4 25.2 31.8 27.3 26.9 20.1 13.1 20.7 9.5 21.1 25.1 19.5 24.5 58.0 13.5 24.6 25.5 22.0 20.4 27.6 12.7 36.3 28.8 37.5 21.1 64.3 23.3 31.2 13.9 29.0 20.5 15.3 22.0 27.4 24.2 20.5 27.4 32.2 33.9 4.6 2.4 8.5 7.8 3.0 4.4 2.0 11.4 14.1 27.4 34.0 10.7 12.4 14.2 11.9 19.1 13.4 11.6 9.6 9.9 17.8 17.4 14.7 6.3 22.9 13.0 22.8 7.2 15.4 11.9 53.0 14.4 9.4 13.0 14.5 18.8 26.1 18.1 10.8 12.6 47.0 13.8 15.4 32.4 19.4 10.3 10.7 26.3 20.8 13.9 5.1 6.9 29.8 18.0 12.5 12.1 12.3 11.4 28.1 7.8 9.5 13.4 19.1 46.0 9.4 13.6 8.3 17.5 7.3 9.9 17.0 14.4 12.0 13.6 31.9 7.5 3.1 4.1 3.3 4.4 4.8 2.7 3.4 3.0 4.1 2.3 4.6 4.0 3.0 8.5 3.0 7.8 2.4 2.4 2.0 20.6 31.1 23.2 43.0 20.1 13.1 19.5 24.5 20.4 22.0 29.8 8.3 11.6 2.8 20.3 17.8 7.3 2.5 5.3 9.1 3.5 3.9 4.0 0.0 7.1 1.7 4.2 1.8 23.3 4.9 5.1 5.8 2.4 9.2 2.0 7.9 14.3 7.9 3.1 3.8 2.0 5.8 5.9 3.3 1.8 1.3 10.4 6.0 2.0 6.0 1.4 5.7 0.0 5.3 6.7 6.6 18.4 6.5 6.9 1.9 1.8 LEF1 "TCF10, TCF1ALPHA, TCF7L3" ENSG00000138795 "Lymphoid enhancer binding factor 1" Q9UJU2 4 108047545-108168956 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 231.5" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 11.6;Melanocytes: 32.1;Spermatocytes: 21.3;T-cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 42.2" "Lineage enriched" "Detected in many" 5 "T-cells: 42.2" "Group enriched" "Detected in many" 5 "JURKAT: 98.3;MOLT-4: 93.3;REH: 72.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002087, CAB019405" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB019405: AB_823558, HPA002087: AB_1079245" "unprognostic (1.03e-3)" "unprognostic (7.36e-3)" "unprognostic (2.97e-2)" "prognostic favorable (1.37e-5)" "unprognostic (9.08e-2)" "unprognostic (5.24e-2)" "unprognostic (3.81e-2)" "unprognostic (1.10e-2)" "unprognostic (1.77e-1)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.47e-6)" "unprognostic (1.12e-1)" "unprognostic (5.22e-2)" "unprognostic (7.88e-2)" "unprognostic (8.91e-2)" 0.9 13.5 3.5 9.3 5.4 7.6 2.0 1.6 3.4 3.6 1.0 2.9 0.8 0.4 6.0 3.5 3.4 5.0 2.8 0.5 4.7 5.2 2.7 0.3 2.4 25.3 4.9 1.9 1.8 0.8 0.0 1.1 7.8 3.1 2.8 1.0 1.6 3.1 0.7 0.5 2.4 3.9 2.9 4.4 7.0 0.9 8.2 2.3 231.5 2.7 1.3 20.6 4.8 3.2 0.3 0.1 0.5 0.0 8.9 42.2 9.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.7 4.1 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.5 0.0 2.9 1.0 0.0 0.0 0.0 3.6 0.5 0.0 0.1 0.0 0.1 0.6 0.0 98.3 2.1 0.0 0.4 0.1 93.3 0.0 0.2 1.0 0.2 72.0 1.4 0.0 0.3 0.2 0.4 0.8 0.0 0.0 13.8 1.1 0.3 0.0 0.0 1.9 1.6 0.0 2.4 6.0 2.5 16.5 1.2 0.0 7.9 0.0 0.0 0.0 2.6 0.0 0.5 0.1 19.7 8.8 0.0 0.3 42.2 29.2 0.5 8.9 0.0 0.1 25.7 9.5 3.5 5.4 1.6 3.4 4.7 5.2 4.9 1.9 3.1 2.3 3.0 3.4 0.0 1.1 3.0 0.0 1.2 0.0 4.0 1.2 0.0 0.0 0.1 11.6 0.0 3.1 3.6 0.0 0.0 0.0 0.1 1.8 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.9 0.6 0.8 32.1 0.0 0.0 0.4 0.2 0.0 0.0 0.3 0.0 0.0 5.9 21.3 9.6 1.1 0.3 13.1 0.1 0.3 LGALS13 "PLAC8, PP13" ENSG00000105198 "Galectin 13" Q9UHV8 19 39602501-39607476 "Predicted intracellular proteins" Apoptosis Hemagglutinin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "placenta: 58.9" "Cell type enriched" "Detected in some" 19 "Syncytiotrophoblasts: 267.5" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Group enriched" "Detected in some" 7 "cerebellum: 1.5;hypothalamus: 1.2;midbrain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 73 "SuSa: 7.3" HPA046803 Supported Nucleoplasm NA NA Nucleoplasm "HPA046803: AB_10965990" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 58.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.2 0.0 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 14.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 267.5 0.0 0.0 0.0 LGALS14 "CLC2, PPL13" ENSG00000006659 "Galectin 14" Q8TCE9 19 39704306-39709444 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "placenta: 110.8" "Cell type enriched" "Detected in some" 72 "Syncytiotrophoblasts: 74.1" "Cancer enriched" "Detected in single" 16 "liver cancer: 5.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Group enriched" "Detected in some" 5 "EFO-21: 5.5;U-266/70: 12.8" HPA065180 Supported Nucleoplasm NA NA Nucleoplasm "HPA065180: " "unprognostic (1.95e-1)" 0.0 0.2 0.1 0.1 0.1 0.2 1.1 0.1 0.3 1.5 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.2 0.0 0.2 110.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.2 0.0 0.3 0.3 0.1 1.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.6 0.0 0.0 3.2 0.6 0.3 0.0 0.4 0.7 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.3 0.5 0.0 5.5 0.1 0.1 0.8 0.1 0.0 0.3 1.9 0.2 0.1 1.0 0.4 0.0 0.2 1.2 0.0 0.3 0.3 0.4 0.7 0.0 0.5 0.1 1.4 0.0 0.5 0.2 0.3 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.4 0.3 0.1 0.4 0.2 0.8 0.1 0.2 0.0 0.6 0.8 1.0 0.3 12.8 0.7 0.1 0.4 0.3 0.3 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.1 3.2 0.2 0.6 0.0 0.0 0.3 0.0 0.6 0.1 0.1 0.1 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.1 0.0 0.0 0.0 LGALSL "GRP, HSPC159" ENSG00000119862 "Galectin like" Q3ZCW2 2 64453969-64461381 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 50.8;tongue: 90.3" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 124.1;Suprabasal keratinocytes: 119.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "eosinophil: 3.7;MAIT T-cell: 1.9;neutrophil: 4.1" "Group enriched" "Detected in many" 8 "granulocytes: 4.1;T-cells: 1.9" "Cell line enhanced" "Detected in many" "AN3-CA: 25.0;HAP1: 36.4" "Low region specificity" "Detected in all" HPA046079 Approved Approved Nucleoplasm NA NA 9700000 Nucleoplasm "HPA046079: AB_10967075" "unprognostic (1.34e-1)" "unprognostic (3.43e-1)" "unprognostic (7.18e-2)" "unprognostic (3.77e-2)" "unprognostic (3.12e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.25e-2)" "unprognostic (8.43e-2)" "unprognostic (3.57e-3)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (4.34e-2)" "unprognostic (6.57e-2)" "unprognostic (6.20e-2)" "unprognostic (9.19e-2)" "unprognostic (2.77e-2)" 6.5 9.2 4.8 3.4 6.2 3.5 12.0 11.0 7.2 6.9 11.5 2.7 2.4 5.0 4.2 6.4 12.7 3.5 4.9 8.1 4.6 5.0 5.6 4.8 18.0 2.9 3.8 3.9 5.7 5.5 10.0 6.3 5.3 4.3 8.2 6.1 14.7 6.4 3.9 30.7 50.8 13.4 5.2 2.8 4.0 4.4 4.0 1.2 0.8 3.1 90.3 13.6 5.1 6.2 0.3 0.1 4.1 0.3 0.0 1.9 3.8 5.8 3.7 10.6 25.0 0.3 0.1 3.1 1.6 4.0 3.1 3.0 17.4 1.2 0.0 2.4 0.8 6.1 7.0 36.4 6.7 2.5 6.6 9.5 0.1 1.9 8.5 3.2 1.6 2.4 1.6 4.3 1.3 4.8 2.8 1.9 3.9 0.0 1.7 0.0 4.5 2.4 0.3 8.3 3.4 4.4 2.7 6.5 1.9 3.7 4.2 1.7 7.0 5.2 3.5 3.0 6.6 2.5 0.2 0.8 2.0 6.4 1.3 3.1 7.4 3.5 4.9 0.0 1.0 2.7 0.0 0.3 3.7 0.0 0.0 1.9 0.3 0.4 0.4 0.1 0.2 0.0 0.0 4.1 0.0 0.0 0.0 0.0 3.8 4.8 6.2 11.0 7.2 4.6 5.0 3.8 3.9 4.3 1.2 20.8 55.7 0.8 19.8 60.0 27.5 11.8 5.1 0.0 3.4 10.4 31.4 1.2 13.3 5.6 9.7 11.7 35.4 0.0 11.7 2.3 9.3 20.9 1.1 9.5 0.9 12.7 8.7 12.9 4.8 1.5 7.5 2.8 10.1 1.8 29.0 68.8 14.0 20.1 4.2 10.2 124.1 19.4 32.3 4.7 1.3 119.7 1.3 0.0 16.6 28.5 LHX2 "hLhx2, LH-2" ENSG00000106689 "LIM homeobox 2" P50458 9 124001670-124033301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 44.7;retina: 17.0" "Cell type enriched" "Detected in some" 9 "Muller glia cells: 245.9" "Group enriched" "Detected in many" 5 "cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5" "Group enriched" "Detected in many" 6 "amygdala: 30.7;basal ganglia: 20.5;cerebral cortex: 26.6;hippocampal formation: 23.6;olfactory region: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 15.7;GAMG: 12.3;HAP1: 15.7;HeLa: 10.9;NTERA-2: 19.5;U-138 MG: 10.2" "Group enriched" "Detected in many" 5 "amygdala: 41.7;basal ganglia: 25.3;cerebral cortex: 46.8;hippocampal formation: 47.4;olfactory region: 19.7" "Group enriched" "Detected in many" 6 "amygdala: 55.6;basal ganglia: 46.4;cerebral cortex: 70.9;hippocampal formation: 73.5;olfactory region: 35.5" HPA000838 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA000838: AB_2666109" "unprognostic (3.60e-3)" "prognostic favorable (9.52e-4)" "unprognostic (3.52e-1)" "unprognostic (9.97e-2)" "unprognostic (1.29e-1)" "unprognostic (1.12e-2)" "unprognostic (6.37e-3)" "unprognostic (1.07e-1)" "unprognostic (4.59e-2)" "unprognostic (3.24e-1)" "unprognostic (2.96e-1)" "unprognostic (1.32e-2)" "unprognostic (4.66e-15)" "unprognostic (1.72e-1)" "unprognostic (2.92e-1)" "unprognostic (2.46e-2)" "unprognostic (1.77e-1)" 0.9 1.0 30.7 1.1 20.5 0.9 1.1 0.0 44.7 0.8 0.9 4.7 0.0 1.0 0.8 0.8 0.8 0.8 1.0 0.8 23.6 2.4 0.8 6.1 0.9 1.1 1.5 16.1 1.1 0.8 0.8 4.6 5.1 0.0 0.8 1.1 17.0 1.1 0.8 0.8 2.2 0.9 0.8 0.2 0.9 0.9 4.0 4.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 4.9 0.1 15.7 0.0 0.2 1.6 0.4 0.2 1.2 0.1 4.9 0.0 0.1 2.1 0.9 12.3 0.1 15.7 0.0 0.6 0.0 3.4 0.0 10.9 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 7.8 0.0 0.1 19.5 0.0 4.6 4.2 0.0 0.0 0.0 0.0 6.4 0.0 4.0 0.0 0.0 0.1 5.6 2.0 0.0 10.2 0.4 2.9 0.7 0.2 3.2 0.0 0.6 2.2 1.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 30.7 20.5 0.0 26.6 23.6 2.4 1.5 16.1 0.0 4.2 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 3.0 7.9 0.0 6.7 0.0 16.0 0.0 0.0 0.0 0.0 0.0 245.9 0.0 0.0 0.0 0.0 6.2 0.0 0.0 1.0 0.6 0.0 0.1 0.0 0.0 0.0 LHX9 ENSG00000143355 "LIM homeobox 9" Q9NQ69 1 197911902-197935478 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "ovary: 22.1;retina: 24.3;testis: 17.5" "Group enriched" "Detected in some" 10 "Leydig cells: 145.9;Peritubular cells: 47.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "fHDF/TERT166: 78.9" "Group enriched" "Detected in many" 4 "hippocampal formation: 6.9;midbrain: 20.7;thalamus: 13.3" "Group enriched" "Detected in many" 5 "midbrain: 38.1;pons and medulla: 11.9;thalamus: 24.4" HPA009695 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA009695: AB_1079251" "unprognostic (8.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.38e-4)" "unprognostic (1.43e-1)" "unprognostic (5.68e-3)" "unprognostic (3.55e-1)" "unprognostic (1.12e-2)" "unprognostic (5.52e-2)" "unprognostic (2.63e-2)" "unprognostic (3.26e-2)" "unprognostic (5.15e-2)" "unprognostic (2.62e-3)" "unprognostic (6.35e-3)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" 0.3 0.2 1.7 0.1 1.0 0.1 0.1 0.1 0.5 1.1 0.3 0.7 0.4 0.2 0.8 4.1 0.1 0.4 0.2 1.5 0.7 2.6 0.1 1.2 2.7 0.1 0.8 0.0 22.1 0.1 0.1 1.4 0.1 3.1 0.1 0.2 24.3 0.1 0.2 0.9 0.1 0.2 0.1 0.5 0.1 0.1 17.5 0.5 0.0 0.1 0.0 0.1 0.1 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.2 2.2 0.1 0.0 0.0 0.0 0.0 78.9 0.0 0.0 1.9 0.0 0.6 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 2.4 2.3 0.9 0.0 0.0 0.0 0.0 1.9 0.0 0.7 0.4 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.1 0.5 0.7 2.6 0.8 0.0 3.1 0.5 3.0 9.6 0.0 0.0 0.0 0.0 1.4 0.0 1.4 1.2 0.0 0.0 0.0 1.7 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.8 145.9 0.0 0.0 0.0 0.0 2.6 0.0 0.0 47.4 0.0 0.3 0.0 0.0 2.3 0.3 0.0 0.1 0.0 0.0 0.0 LIG3 LIG2 ENSG00000005156 "DNA ligase 3" P49916 17 34980494-35009743 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006723 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA006723: AB_1847781" "unprognostic (6.05e-3)" "unprognostic (2.98e-1)" "unprognostic (1.24e-1)" "unprognostic (2.83e-1)" "unprognostic (1.57e-1)" "unprognostic (8.76e-2)" "unprognostic (2.40e-2)" "unprognostic (2.78e-1)" "unprognostic (2.25e-1)" "unprognostic (1.02e-2)" "unprognostic (8.77e-3)" "unprognostic (1.31e-1)" "unprognostic (6.67e-3)" "unprognostic (3.39e-1)" "unprognostic (3.28e-1)" "unprognostic (3.29e-2)" "unprognostic (4.71e-2)" 8.8 11.5 10.7 9.8 17.0 9.2 12.5 15.9 18.3 14.7 11.5 15.8 11.4 8.4 21.5 12.3 14.2 17.3 7.9 11.0 14.2 8.0 9.8 11.8 9.8 9.6 9.1 11.7 17.8 15.4 22.9 13.3 16.5 9.3 16.5 13.1 11.8 14.3 13.9 17.0 13.9 9.8 14.7 8.0 14.3 11.6 27.8 10.9 20.8 14.5 9.7 13.9 13.6 12.7 4.6 10.1 4.8 6.3 11.1 8.4 4.5 7.9 15.8 19.1 16.8 3.8 4.7 14.6 7.7 5.6 10.4 10.5 7.6 4.3 13.0 6.4 10.0 10.3 7.4 21.6 9.9 13.5 6.1 14.5 13.6 7.6 11.0 6.0 21.2 24.1 3.5 8.7 7.7 12.1 5.2 12.6 20.0 21.3 14.9 7.5 8.9 26.7 6.8 18.3 9.9 6.7 14.5 17.5 13.7 5.1 8.6 15.6 11.2 11.5 9.4 7.4 29.3 17.0 10.7 6.0 6.8 8.5 8.3 12.3 13.4 14.4 16.8 4.9 10.1 13.0 0.6 3.8 4.8 5.9 6.3 8.4 4.6 4.0 5.2 10.1 4.0 5.4 3.8 0.3 11.1 3.2 6.0 2.5 4.5 10.7 17.0 15.9 18.3 14.2 8.0 9.1 11.7 9.3 10.9 3.0 10.1 1.5 8.9 4.4 16.2 8.7 10.2 4.0 13.6 12.2 15.7 12.3 8.3 5.8 35.6 3.9 6.2 0.0 5.2 15.3 5.4 10.6 9.2 7.3 7.0 15.9 6.4 3.7 5.9 51.3 6.6 4.5 3.3 3.6 8.2 8.5 3.7 7.0 7.4 5.7 16.8 6.5 3.9 29.6 15.8 4.5 18.1 4.9 9.7 8.4 LIN37 "F25965, lin-37, ZK418.4" ENSG00000267796 "Lin-37 DREAM MuvB core complex component" Q96GY3 19 35748361-35754519 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 9.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043253, HPA047809" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA043253: AB_2678391, HPA047809: AB_2680162" "unprognostic (7.10e-2)" "unprognostic (1.32e-1)" "unprognostic (7.07e-2)" "unprognostic (2.45e-3)" "unprognostic (7.77e-3)" "unprognostic (5.85e-3)" "unprognostic (1.62e-2)" "unprognostic (1.07e-1)" "unprognostic (2.93e-1)" "unprognostic (2.56e-1)" "prognostic favorable (1.67e-4)" "unprognostic (9.88e-3)" "prognostic unfavorable (1.62e-6)" "unprognostic (2.53e-2)" "unprognostic (8.89e-2)" "unprognostic (4.35e-1)" "unprognostic (5.14e-2)" 12.0 13.1 15.7 6.4 18.6 13.5 10.0 22.9 20.6 12.9 11.4 10.1 9.4 8.4 15.3 11.5 10.5 15.5 10.2 17.3 12.2 12.7 8.8 9.3 10.6 11.4 10.6 13.1 21.5 13.5 7.9 13.5 15.3 11.9 9.7 7.1 10.3 10.3 13.5 16.8 15.2 8.5 11.8 10.4 10.0 8.7 13.7 13.4 11.2 11.1 7.4 11.2 10.6 10.7 11.5 11.3 16.9 4.3 9.2 13.7 7.2 5.6 13.8 4.5 5.6 9.7 7.4 6.4 6.4 8.1 12.1 13.8 4.9 1.9 4.4 6.7 9.1 8.1 2.0 4.2 6.4 4.2 12.4 6.1 5.1 5.9 5.7 23.6 3.8 6.8 6.4 11.9 10.3 19.8 7.1 8.5 11.6 5.1 5.0 7.7 13.5 4.9 4.5 1.3 11.7 6.6 2.3 3.5 3.3 8.1 3.4 4.4 4.7 6.9 11.2 5.6 4.2 5.0 6.4 7.1 5.8 3.4 6.6 8.7 7.8 8.3 3.5 6.9 5.5 4.7 7.9 4.3 13.8 11.2 4.1 10.4 10.9 12.7 13.2 4.9 11.5 13.7 12.4 16.9 9.2 4.3 11.3 13.1 7.2 15.7 18.6 22.9 20.6 12.2 12.7 10.6 13.1 11.9 13.4 0.0 0.6 3.2 0.6 3.4 1.7 0.1 2.5 0.0 0.0 3.5 2.0 4.0 3.3 1.0 4.7 0.6 3.2 0.0 1.0 2.5 2.5 0.6 4.6 0.9 1.6 1.6 1.2 0.0 3.4 3.1 3.7 2.1 5.0 1.8 0.5 0.8 2.0 1.7 3.2 2.7 2.2 6.5 2.2 6.5 1.9 4.6 9.6 2.5 1.3 0.1 LIN9 TGS ENSG00000183814 "Lin-9 DREAM MuvB core complex component" Q5TKA1 1 226231149-226309869 "Predicted intracellular proteins" "Cell cycle, DNA synthesis" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 34.4;Spermatogonia: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030241 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA030241: AB_10601542" "unprognostic (9.90e-2)" "unprognostic (8.00e-2)" "unprognostic (1.23e-1)" "unprognostic (8.82e-3)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" "unprognostic (3.51e-5)" "unprognostic (2.80e-2)" "unprognostic (9.84e-3)" "unprognostic (2.65e-2)" "unprognostic (3.59e-3)" "unprognostic (1.17e-1)" "unprognostic (1.09e-3)" "unprognostic (8.08e-2)" "unprognostic (1.79e-1)" "unprognostic (3.22e-1)" "unprognostic (8.26e-2)" 3.7 3.0 3.9 5.9 3.9 6.9 4.3 17.5 5.6 5.0 7.9 2.6 3.3 5.1 4.1 2.1 6.0 3.2 2.9 15.9 4.2 2.8 4.3 2.4 5.1 5.8 2.4 1.9 6.6 3.1 2.3 3.1 5.0 4.5 4.6 5.0 2.3 3.8 3.0 4.6 4.7 7.8 3.6 3.7 5.0 4.0 11.6 4.6 22.0 4.8 5.8 5.8 4.3 4.3 4.3 1.3 6.2 5.1 2.9 6.8 2.0 9.0 5.7 9.6 6.9 0.9 2.5 18.9 6.7 4.3 11.7 10.6 6.3 12.0 8.6 8.7 2.9 5.2 8.5 9.2 3.4 10.6 8.1 16.6 5.4 7.4 4.5 0.8 10.3 5.8 0.9 2.5 6.0 6.2 2.8 5.8 8.0 18.4 10.4 7.1 3.2 11.0 7.1 15.6 11.5 10.5 10.8 16.6 11.3 3.8 4.6 8.6 12.2 11.9 14.2 8.7 6.2 7.9 13.8 2.7 6.8 10.1 9.3 17.1 4.9 11.3 18.2 4.0 9.7 15.9 6.2 2.0 1.8 2.5 2.6 3.7 4.3 4.3 5.5 0.8 3.7 6.8 5.0 0.3 2.9 5.1 1.3 5.5 2.0 3.9 3.9 17.5 5.6 4.2 2.8 2.4 1.9 4.5 4.6 8.9 3.2 0.0 1.1 3.0 0.8 12.7 0.0 5.3 2.3 0.0 0.0 11.3 1.7 1.7 9.0 3.0 1.6 0.0 2.7 5.9 2.1 1.0 1.1 0.8 2.3 3.2 2.4 1.8 3.4 2.2 4.0 0.6 0.0 0.0 2.2 1.7 2.6 3.5 4.2 1.0 0.9 0.0 2.8 34.4 15.6 1.6 12.9 1.3 3.9 1.3 LINS1 "LINS, WINS1" ENSG00000140471 "Lines homolog 1" Q8NG48 15 100559369-100603230 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038578, HPA038579" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA038578: AB_2676095, HPA038579: AB_10697393" "unprognostic (9.87e-2)" "unprognostic (3.32e-3)" "unprognostic (2.93e-1)" "unprognostic (2.00e-1)" "unprognostic (7.37e-2)" "unprognostic (6.16e-2)" "unprognostic (7.14e-2)" "unprognostic (1.06e-1)" "unprognostic (2.48e-2)" "unprognostic (3.36e-2)" "unprognostic (1.65e-1)" "unprognostic (1.71e-3)" "unprognostic (1.14e-2)" "unprognostic (2.93e-1)" "unprognostic (2.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.28e-2)" 10.0 10.2 12.2 13.2 13.4 8.1 13.6 16.9 13.8 13.7 10.2 10.1 13.3 6.8 13.5 16.7 14.9 12.0 7.7 8.6 11.2 6.8 10.4 9.2 10.3 17.6 8.2 11.1 13.1 9.4 12.8 19.8 11.4 9.6 10.9 12.1 10.2 14.1 13.2 11.4 15.7 11.6 10.6 10.7 13.4 10.4 11.8 10.4 16.6 14.7 9.2 15.9 13.3 12.8 7.7 5.1 6.9 5.0 9.0 23.3 6.6 4.1 6.6 8.2 8.1 6.1 8.2 7.1 6.8 7.3 7.5 8.2 6.0 8.2 11.1 4.0 6.1 5.7 18.2 7.6 8.5 8.0 3.8 11.0 10.0 10.0 4.7 4.9 8.4 6.1 7.3 7.4 5.8 9.3 7.5 8.9 6.3 15.9 8.9 4.7 5.5 5.0 7.2 9.3 16.1 8.1 7.5 13.1 10.4 6.5 11.6 4.2 5.5 6.4 6.1 9.9 10.8 10.3 6.5 6.4 9.6 8.7 6.7 8.6 9.7 12.4 10.0 6.1 11.0 7.6 6.9 5.0 6.9 10.9 4.6 15.2 7.7 17.0 11.6 5.1 6.8 23.3 16.6 6.4 9.0 3.8 4.1 10.2 6.6 12.2 13.4 16.9 13.8 11.2 6.8 8.2 11.1 9.6 10.4 17.9 5.1 2.4 8.9 0.0 15.5 0.0 5.1 13.4 4.5 12.2 17.7 6.7 5.0 4.9 5.4 2.9 7.8 0.0 4.5 4.5 3.1 7.3 1.1 7.4 12.3 15.9 4.7 4.9 5.7 1.1 11.2 3.2 0.0 4.6 7.0 10.0 4.0 0.0 6.7 3.6 14.0 12.9 0.0 16.4 11.1 0.0 10.4 10.2 5.3 6.8 LKAAEAR1 C20orf201 ENSG00000171695 "LKAAEAR motif containing 1" Q8TD35 20 64083380-64084359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 12.5;testis: 18.0" "Group enriched" "Detected in some" 36 "Early spermatids: 401.3;Late spermatids: 525.6" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 9 "intermediate monocyte: 7.9;non-classical monocyte: 12.5" "Lineage enriched" "Detected in many" 11 "monocytes: 12.5" "Group enriched" "Detected in some" 4 "REH: 9.3;SCLC-21H: 9.6" "Low region specificity" "Detected in many" HPA056463 Approved Nucleoplasm NA NA Nucleoplasm "HPA056463: AB_2683139" "unprognostic (5.47e-3)" "unprognostic (1.18e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-1)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.19e-1)" "unprognostic (2.58e-1)" "unprognostic (7.93e-2)" "unprognostic (3.78e-3)" "unprognostic (6.74e-2)" "unprognostic (3.16e-4)" "unprognostic (3.07e-2)" "unprognostic (1.41e-1)" "unprognostic (3.12e-1)" "unprognostic (2.30e-2)" 0.5 0.0 3.4 0.3 2.9 0.6 0.1 1.5 2.9 0.0 0.2 0.6 0.1 0.0 0.0 1.8 0.0 0.0 1.7 3.1 0.1 0.0 0.3 0.2 1.2 0.0 0.7 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.3 0.5 0.3 18.0 0.1 0.0 0.0 0.0 0.1 1.0 0.8 12.5 0.0 0.8 0.8 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 1.8 0.7 0.3 0.0 1.5 9.3 0.0 0.2 0.0 0.0 9.6 2.3 0.0 0.1 0.1 0.0 0.2 0.5 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.8 0.1 7.9 0.6 0.1 0.7 0.2 1.0 0.0 0.8 0.2 0.0 0.0 12.5 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 401.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 1.5 0.0 0.0 1.3 2.4 525.6 3.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 2.8 0.0 0.7 12.9 0.5 3.7 5.5 0.0 0.1 0.0 0.0 0.0 LMO2 "RBTN2, RBTNL1, RHOM2, TTG2" ENSG00000135363 "LIM domain only 2" P25791 11 33858576-33892289 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 121.0;Erythroid cells: 46.7;Ito cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 1.5;classical monocyte: 1.1;eosinophil: 3.0;intermediate monocyte: 3.1;myeloid DC: 4.3;neutrophil: 1.6;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 7 "dendritic cells: 4.3;granulocytes: 3.0;monocytes: 3.6" "Cell line enhanced" "Detected in some" "HEL: 23.3;HL-60: 23.2;K-562: 23.6;NB-4: 9.9;THP-1: 30.8;U-937: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016258, HPA029285, HPA070901, HPA070910" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016258: AB_2136572, HPA029285: AB_2672978, HPA070901: , HPA070910: " "unprognostic (1.60e-1)" "unprognostic (1.47e-2)" "unprognostic (6.03e-2)" "unprognostic (1.71e-3)" "unprognostic (1.89e-1)" "unprognostic (1.14e-3)" "prognostic favorable (3.12e-4)" "unprognostic (1.73e-3)" "unprognostic (8.95e-2)" "unprognostic (5.76e-2)" "unprognostic (7.86e-3)" "unprognostic (3.69e-1)" "unprognostic (7.10e-2)" "unprognostic (9.65e-2)" "unprognostic (3.90e-1)" "unprognostic (1.45e-1)" "unprognostic (4.46e-2)" 18.2 6.1 13.8 13.6 15.6 28.8 14.5 5.2 18.4 9.4 5.5 10.3 6.4 6.2 9.7 9.9 6.9 8.6 9.1 6.4 15.8 12.2 12.9 5.5 15.9 22.2 14.2 7.2 5.1 3.9 4.2 8.3 8.5 11.9 8.3 2.7 14.6 4.5 4.0 25.0 4.2 5.5 6.6 13.9 22.0 4.4 3.6 11.1 1.0 10.7 8.1 13.3 11.1 14.8 0.5 4.3 3.0 3.6 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.9 0.5 5.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 23.3 0.0 0.0 0.1 23.2 8.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 23.6 0.0 0.0 0.1 2.1 9.9 0.4 0.0 0.0 6.6 0.3 0.0 0.0 0.3 1.9 0.0 0.1 0.2 0.0 0.1 0.0 30.8 0.3 0.0 0.1 0.7 0.0 0.0 0.1 0.2 2.1 10.9 0.1 1.5 1.1 3.0 0.0 3.1 0.1 0.5 0.0 0.0 4.3 0.0 0.0 0.0 1.6 0.0 3.6 0.3 0.0 0.5 13.8 15.6 5.2 9.5 15.8 12.2 14.2 7.2 11.9 11.1 3.0 10.3 7.6 7.8 7.4 1.4 1.7 7.6 5.3 0.0 5.2 2.0 0.3 0.0 2.9 0.2 121.0 0.0 46.7 1.7 1.7 8.4 4.1 7.0 1.0 33.2 0.0 0.0 110.5 41.7 0.7 3.7 42.5 10.1 0.0 0.0 1.0 0.9 0.0 0.0 5.6 1.9 0.0 2.8 0.2 2.7 5.3 18.0 0.5 0.4 19.5 LMX1B NPS1 ENSG00000136944 "LIM homeobox transcription factor 1 beta" O60663 9 126614443-126701032 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 16.5;salivary gland: 35.3" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 1.4;Early spermatids: 1.1" "Cancer enriched" "Detected in some" 14 "breast cancer: 12.9" "Region enriched" "Detected in single" 4 "pons and medulla: 2.9" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 17.2;OE19: 10.9;T-47d: 10.6" "Region enhanced" "Detected in some" "pons and medulla: 2.4" "Region enhanced" "Detected in some" "midbrain: 7.9" HPA073716 Approved Nucleoplasm NA NA Nucleoplasm "HPA073716: AB_2686630" "unprognostic (4.17e-1)" "unprognostic (4.72e-2)" "unprognostic (2.81e-2)" "unprognostic (2.53e-4)" "unprognostic (1.73e-1)" "unprognostic (1.50e-4)" "unprognostic (1.86e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-1)" "unprognostic (2.26e-1)" "unprognostic (1.34e-2)" "unprognostic (3.51e-3)" "unprognostic (1.63e-5)" "unprognostic (1.69e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-6)" "unprognostic (1.13e-2)" 1.3 0.1 0.0 0.1 0.0 0.1 7.5 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 1.9 0.1 0.2 1.4 0.0 0.1 0.0 0.6 0.0 0.1 0.8 0.0 0.6 0.0 2.9 0.1 0.0 16.5 35.3 0.0 0.4 1.5 0.2 0.0 2.4 0.0 0.1 3.1 0.0 0.0 0.9 0.1 0.0 0.2 0.1 0.6 0.4 1.2 0.3 0.9 0.5 0.0 2.4 1.1 0.4 3.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.2 1.3 0.0 0.5 0.0 2.8 1.2 3.8 0.0 0.0 0.0 4.6 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.5 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 17.2 0.0 0.0 0.0 10.9 0.2 0.0 3.2 0.0 0.0 0.3 0.0 1.5 0.3 0.1 0.4 0.1 10.6 0.2 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.3 0.3 0.3 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.5 0.4 1.2 0.9 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 LONRF2 "FLJ45273, RNF192" ENSG00000170500 "LON peptidase N-terminal domain and ring finger 2" Q1L5Z9 2 100273291-100322733 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9;epididymis: 32.6" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 74.2;Cardiomyocytes: 34.4;Horizontal cells: 104.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 15.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 6.5;GAMG: 8.1;HAP1: 6.4;HEK 293: 6.9;HMC-1: 5.7;PC-3: 5.9;SCLC-21H: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057366 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA057366: AB_2683420" "unprognostic (9.81e-2)" "unprognostic (4.97e-2)" "unprognostic (2.68e-2)" "unprognostic (3.20e-2)" "unprognostic (7.10e-2)" "unprognostic (7.72e-2)" "unprognostic (9.50e-2)" "unprognostic (9.86e-3)" "unprognostic (6.33e-2)" "unprognostic (1.32e-1)" "prognostic favorable (6.42e-5)" "unprognostic (1.14e-1)" "unprognostic (6.06e-2)" "unprognostic (3.45e-2)" "unprognostic (2.50e-2)" "unprognostic (2.66e-3)" "unprognostic (6.34e-2)" 1.6 23.0 8.4 0.6 32.9 0.2 2.2 21.1 15.4 5.1 1.7 1.3 2.3 0.5 19.0 32.6 2.0 17.8 1.7 4.3 5.6 9.9 1.3 0.7 1.5 0.5 3.9 7.0 10.5 4.4 9.6 7.8 0.6 6.4 3.2 0.7 1.6 1.5 3.2 4.6 0.4 0.5 19.8 4.5 0.5 1.5 1.8 4.3 0.4 3.5 0.8 0.4 1.4 1.3 0.7 0.5 1.7 0.4 0.7 0.5 0.1 0.0 6.5 2.0 2.4 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 1.2 0.0 1.1 0.0 8.1 0.0 6.4 0.0 0.0 0.5 6.9 0.0 0.4 0.0 0.2 0.1 5.7 0.0 0.0 0.3 0.0 0.4 0.0 1.8 3.7 0.1 0.0 4.2 0.0 0.3 0.4 1.2 5.9 0.0 0.0 0.0 1.6 0.2 14.0 3.8 0.0 0.0 1.0 2.3 3.5 0.1 0.1 0.1 0.8 0.0 0.4 0.0 0.0 0.0 2.8 0.0 0.3 1.1 0.4 0.4 0.3 0.3 0.3 0.4 0.3 0.3 0.2 0.7 0.4 0.5 1.7 0.7 0.3 0.5 0.2 0.1 8.4 32.9 21.1 9.7 5.6 9.9 3.9 7.0 6.4 4.3 0.0 13.2 0.0 1.2 0.7 74.2 34.4 5.1 5.3 5.7 5.2 29.5 1.7 5.0 2.4 0.4 1.0 0.0 0.0 1.8 0.2 1.5 5.8 5.7 0.5 0.4 104.9 10.9 0.0 0.0 1.5 3.1 0.3 1.7 0.0 0.1 10.0 2.1 0.0 11.0 0.3 18.2 6.5 3.3 0.5 0.2 0.1 2.4 0.0 0.4 0.5 LOXL2 "LOR, WS9-14" ENSG00000134013 "Lysyl oxidase like 2" Q9Y4K0 8 23297189-23425328 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "Chromatin regulator, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Endothelial cells: 15.5;Extravillous trophoblasts: 20.1;Fibroblasts: 16.6;Ito cells: 23.4;Sertoli cells: 25.8;Smooth muscle cells: 22.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 8 "pons and medulla: 22.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 109.9;BJ hTERT+ SV40 Large T+ RasG12V: 63.6;fHDF/TERT166: 71.2;TIME: 59.3;U-87 MG: 110.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025848, HPA036257, HPA056542" Approved Enhanced Nucleoplasm "Secreted to extracellular matrix" NA NA Nucleoplasm "CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168" "unprognostic (9.48e-2)" "prognostic unfavorable (9.83e-6)" "unprognostic (2.03e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (5.55e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (1.46e-7)" "unprognostic (2.91e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (9.05e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.91e-7)" "unprognostic (1.51e-2)" "unprognostic (7.07e-2)" "unprognostic (4.93e-2)" "unprognostic (3.68e-3)" 37.8 2.7 1.2 14.5 1.6 0.6 22.4 2.9 1.6 16.9 18.4 1.0 12.2 5.8 11.8 9.1 11.5 4.1 5.4 7.2 1.2 1.3 4.3 4.1 6.2 7.5 1.9 0.7 15.6 4.4 1.3 2.2 38.0 22.7 8.4 3.8 1.6 5.6 9.7 6.2 4.3 10.7 27.3 10.9 8.3 7.7 4.1 0.7 1.6 4.3 8.0 8.6 19.1 6.4 1.9 1.3 3.0 0.7 2.1 2.8 0.7 6.3 17.0 5.1 4.1 14.0 23.1 2.2 109.9 35.6 50.4 63.6 0.1 0.4 1.2 0.8 71.2 23.4 5.3 0.2 9.4 26.7 0.2 0.9 0.0 2.3 0.1 28.3 0.0 0.4 20.4 0.4 18.8 2.5 33.6 42.1 0.2 0.0 0.2 16.6 3.4 0.0 0.1 3.3 0.0 2.6 0.2 4.2 0.0 14.6 0.0 0.1 1.4 13.7 0.7 1.0 16.8 0.1 0.1 59.3 46.9 12.4 19.1 14.4 0.4 0.0 3.3 110.2 0.1 48.8 1.9 0.7 3.0 1.6 0.3 0.8 1.9 0.6 1.3 0.5 0.9 0.8 2.8 1.6 2.1 0.6 1.3 0.2 0.7 1.2 1.6 2.9 1.0 1.2 1.3 1.9 0.7 22.7 0.7 0.0 4.0 0.5 0.4 2.3 1.7 1.7 0.0 1.4 0.0 0.0 0.0 2.0 0.0 1.5 0.5 15.5 0.0 0.0 1.3 20.1 16.6 0.5 0.0 0.0 1.1 1.6 0.0 23.4 0.3 0.0 0.9 0.5 3.3 0.0 0.0 0.8 3.4 0.0 0.4 0.0 3.1 25.8 22.6 0.9 0.9 2.8 0.8 0.0 0.0 0.1 LRP5L DKFZp434O0213 ENSG00000100068 "LDL receptor related protein 5 like" A4QPB2 22 25351418-25405377 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 6.3;NK-cell: 10.7" "Group enriched" "Detected in many" 7 "granulocytes: 6.3;NK-cells: 10.7" "Low cell line specificity" "Detected in many" HPA028717 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA028717: AB_10601767" "unprognostic (5.90e-2)" "unprognostic (2.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.34e-3)" "unprognostic (2.22e-1)" "unprognostic (5.98e-2)" "unprognostic (1.13e-1)" "unprognostic (5.98e-3)" "unprognostic (5.11e-1)" "unprognostic (9.64e-2)" "unprognostic (9.78e-2)" "unprognostic (4.38e-2)" "unprognostic (8.51e-2)" "unprognostic (1.15e-1)" "unprognostic (1.59e-1)" "unprognostic (3.44e-1)" "prognostic favorable (6.93e-6)" 6.0 4.7 4.8 8.0 3.8 17.6 18.5 1.5 6.2 10.0 7.0 4.1 11.4 4.1 8.2 8.1 3.9 6.3 8.0 5.3 3.9 2.0 9.1 17.4 5.9 8.5 8.1 1.7 7.7 8.0 6.3 3.8 2.1 4.1 8.9 4.7 6.5 11.0 12.2 2.7 6.1 5.7 7.7 3.4 8.4 4.8 5.0 3.6 3.7 15.5 4.3 6.7 6.3 7.5 1.1 0.2 6.3 0.5 10.7 1.0 0.3 2.0 3.1 1.2 6.2 2.3 1.0 2.2 1.8 2.8 2.4 2.6 2.9 1.0 0.8 2.4 2.0 1.9 4.0 2.2 3.1 1.5 2.9 7.0 4.0 5.1 7.3 2.8 7.7 8.2 4.1 3.0 2.7 11.5 3.9 1.0 3.6 2.5 2.5 1.6 6.9 1.4 7.2 2.8 6.5 4.5 6.9 2.7 3.0 2.8 4.8 4.0 4.7 1.4 2.2 2.2 1.3 2.6 2.8 1.8 2.7 11.7 1.8 3.0 6.4 1.3 1.7 1.6 4.7 1.4 6.3 0.5 2.1 1.0 0.4 0.9 0.2 0.3 0.3 0.1 1.1 0.1 0.3 0.2 10.7 0.2 0.2 0.0 0.3 4.8 3.8 1.5 6.2 3.9 2.0 8.1 1.7 4.1 3.6 0.0 2.7 0.9 3.4 6.0 1.7 1.4 2.5 2.7 6.8 1.8 0.0 0.4 0.0 2.5 0.5 2.9 2.6 0.0 1.0 0.4 1.1 3.7 0.0 4.4 2.2 9.5 3.5 2.5 4.3 0.0 3.7 4.0 1.7 1.8 5.2 1.5 2.6 5.8 1.8 0.3 1.5 12.9 5.2 0.9 3.4 3.4 0.2 4.4 4.3 2.8 LRRC29 "FBL9, FBXL9" ENSG00000125122 "Leucine rich repeat containing 29" Q8WV35 16 67207139-67227048 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034998 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA034998: AB_10601938" "unprognostic (5.16e-3)" "unprognostic (1.55e-1)" "unprognostic (2.55e-3)" "prognostic favorable (4.33e-4)" "unprognostic (1.80e-1)" "unprognostic (2.49e-1)" "unprognostic (2.10e-1)" "unprognostic (5.29e-2)" "unprognostic (1.92e-1)" "unprognostic (2.45e-1)" "prognostic favorable (5.20e-4)" "unprognostic (1.88e-1)" "unprognostic (4.32e-3)" "unprognostic (3.44e-3)" "unprognostic (4.92e-2)" "unprognostic (1.00e-1)" "unprognostic (1.21e-1)" 2.4 4.9 8.2 1.6 10.3 2.7 3.0 7.4 8.2 2.0 1.7 7.1 3.6 3.1 2.4 2.7 1.5 4.5 3.8 2.4 8.3 4.2 5.6 3.8 3.7 2.7 7.0 6.0 3.1 5.1 4.2 8.1 2.7 5.0 5.4 1.4 3.9 6.6 4.1 4.0 5.0 3.8 3.2 5.0 2.5 2.9 4.3 5.9 2.6 6.3 0.6 1.8 2.1 1.6 1.4 2.3 3.6 2.9 3.9 4.5 2.3 1.0 3.0 0.9 0.4 1.8 1.3 0.2 0.8 1.7 1.6 1.8 0.4 0.6 0.8 2.4 2.2 0.8 0.2 0.4 2.0 0.6 1.0 0.8 0.7 0.2 1.6 2.0 0.1 2.7 1.7 2.1 2.4 1.4 1.2 1.0 0.5 0.6 0.4 3.2 0.1 0.3 1.6 0.4 0.0 1.1 1.4 0.8 2.2 2.0 0.1 1.1 1.4 1.1 1.1 1.8 0.4 3.0 1.3 0.4 3.1 0.9 0.6 0.2 4.4 0.9 1.3 2.2 0.8 0.9 0.0 2.6 3.6 0.9 2.9 1.0 0.8 2.5 3.6 2.3 1.4 4.5 1.9 3.4 3.9 2.7 1.6 0.5 2.3 8.2 10.3 7.4 8.2 8.3 4.2 7.0 6.0 5.0 5.9 0.0 1.3 0.8 2.7 0.5 2.9 1.0 5.1 1.4 0.0 8.7 3.9 3.1 3.3 2.0 4.0 2.4 2.4 0.0 0.8 0.9 3.1 2.8 1.1 0.8 3.4 6.4 2.9 0.0 3.1 6.7 0.9 2.2 3.3 4.6 1.1 1.4 1.2 0.3 1.4 7.7 1.8 0.0 1.9 7.7 2.3 1.3 0.8 0.0 0.7 0.8 LRRC32 "D11S833E, GARP" ENSG00000137507 "Leucine rich repeat containing 32" Q14392 11 76657524-76670747 "Predicted intracellular proteins, Predicted membrane proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 91.0;Extravillous trophoblasts: 149.6;Fibroblasts: 48.9;Ito cells: 70.6;Sertoli cells: 38.8;Smooth muscle cells: 74.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "neutrophil: 1.0;T-reg: 3.1" "Group enriched" "Detected in many" 7 "granulocytes: 1.0;T-cells: 3.1" "Group enriched" "Detected in some" 6 "ASC diff: 42.0;ASC TERT1: 25.9;HSkMC: 16.1;HUVEC TERT2: 18.2;U-2197: 38.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA055775, HPA058434" Enhanced Nucleoplasm "Intracellular and membrane" NA NA 19000 Nucleoplasm "HPA055775: AB_2732600, HPA058434: AB_2732622" "unprognostic (3.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (4.19e-3)" "unprognostic (1.16e-1)" "unprognostic (8.84e-2)" "unprognostic (1.39e-2)" "unprognostic (2.24e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.58e-1)" "unprognostic (9.86e-2)" "prognostic unfavorable (3.93e-5)" "unprognostic (7.99e-3)" "unprognostic (1.15e-2)" "unprognostic (5.22e-3)" "prognostic unfavorable (2.64e-4)" 50.5 16.5 5.4 8.0 11.3 1.9 35.1 4.6 9.1 19.8 12.4 4.4 3.5 7.0 15.2 10.4 11.1 10.8 22.6 18.0 7.6 3.5 19.5 8.5 51.8 4.7 10.2 4.3 19.9 8.7 7.9 7.0 40.5 10.1 12.6 5.1 16.6 5.2 9.4 29.0 9.9 7.7 13.0 5.7 21.2 8.1 8.6 8.7 0.6 16.6 9.7 2.1 19.8 25.1 0.2 0.0 1.0 0.0 0.0 3.1 9.6 0.0 0.0 0.4 0.0 42.0 25.9 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.2 0.0 0.8 0.0 0.0 16.1 0.0 1.4 0.0 0.3 18.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 4.8 2.7 0.3 38.6 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 3.1 9.6 5.4 11.3 4.6 9.1 7.6 3.5 10.2 4.3 10.1 8.7 0.0 7.0 3.4 0.2 12.9 0.0 3.4 0.0 1.4 2.3 0.0 0.0 1.3 0.0 0.1 1.3 91.0 0.0 0.0 0.0 149.6 48.9 1.2 2.3 0.8 3.3 0.0 0.0 70.6 4.4 1.1 8.3 5.2 16.9 0.0 0.2 0.4 0.0 2.9 8.5 0.1 0.0 38.8 74.8 0.5 2.7 10.9 7.0 1.3 0.0 1.1 LRRC42 MGC8974 ENSG00000116212 "Leucine rich repeat containing 42" Q9Y546 1 53946077-53968168 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047458, HPA050537, HPA064581" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA047458: , HPA050537: AB_2681161, HPA064581: AB_2685292" "unprognostic (3.13e-1)" "unprognostic (1.32e-1)" "unprognostic (5.88e-2)" "unprognostic (9.97e-3)" "unprognostic (4.01e-2)" "unprognostic (7.95e-3)" "prognostic unfavorable (3.88e-5)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (1.11e-1)" "unprognostic (1.13e-1)" "unprognostic (2.24e-2)" "unprognostic (9.08e-2)" "unprognostic (7.36e-3)" "unprognostic (1.67e-2)" 12.0 27.1 11.8 9.8 14.7 8.7 20.3 8.8 10.5 15.1 13.1 7.9 18.5 10.7 17.5 19.4 18.8 15.1 16.6 14.0 9.1 8.3 16.1 23.1 13.1 12.9 7.7 10.0 17.9 11.5 12.4 23.1 32.3 10.5 15.8 11.9 17.9 15.0 21.2 14.9 18.0 10.2 16.1 13.6 10.2 14.4 24.0 9.9 16.6 21.8 14.9 13.1 18.3 17.8 6.5 10.5 7.6 4.5 6.4 8.9 4.1 25.3 9.5 24.0 14.1 12.6 17.2 16.3 20.1 28.2 26.9 36.8 31.2 17.2 14.2 16.2 24.7 32.0 22.5 20.3 28.8 31.5 11.3 12.2 13.2 15.2 20.2 23.0 8.2 12.7 15.5 40.1 23.2 25.7 19.9 17.1 13.4 16.5 3.9 26.1 8.8 15.1 11.5 20.4 18.8 14.8 26.2 25.4 10.0 19.4 19.2 14.4 15.4 26.9 15.4 22.1 39.6 22.7 9.9 13.8 20.6 26.3 18.2 12.5 10.7 12.3 21.4 20.0 8.6 10.9 0.1 4.5 7.6 7.6 4.4 6.4 6.5 6.5 8.9 5.6 4.1 6.9 5.0 6.8 6.4 3.3 10.5 7.0 4.1 11.8 14.7 8.8 10.5 9.1 8.3 7.7 10.0 10.5 9.9 11.9 4.3 5.6 28.2 45.8 3.6 8.3 20.4 12.0 11.4 10.4 3.9 38.1 16.6 32.6 2.2 8.7 8.5 0.0 14.7 26.4 20.6 35.2 0.0 11.9 15.2 9.5 65.5 8.6 5.6 2.7 22.2 8.6 10.1 10.8 8.5 20.7 26.6 13.5 16.6 12.2 3.2 12.9 14.1 24.6 45.1 34.3 48.1 6.5 13.6 35.8 LRRC61 "FLJ31392, HSPC295, MGC3036" ENSG00000127399 "Leucine rich repeat containing 61" Q9BV99 7 150322639-150338150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 41.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 31.1;Hep G2: 20.7;NTERA-2: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019355 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA019355: AB_1853339" "unprognostic (4.05e-2)" "unprognostic (9.50e-2)" "unprognostic (1.61e-3)" "unprognostic (5.91e-3)" "prognostic unfavorable (1.11e-5)" "unprognostic (1.46e-2)" "unprognostic (4.43e-3)" "unprognostic (1.82e-1)" "unprognostic (1.76e-2)" "unprognostic (4.22e-2)" "unprognostic (2.53e-2)" "unprognostic (1.56e-1)" "unprognostic (1.66e-2)" "prognostic favorable (2.85e-4)" "unprognostic (1.21e-1)" "unprognostic (3.27e-1)" "unprognostic (1.69e-3)" 2.8 14.7 6.7 9.0 9.3 2.3 4.1 7.5 7.3 6.7 6.0 3.5 4.5 5.8 7.0 4.0 6.4 20.8 8.0 3.3 5.4 13.1 10.8 18.3 4.8 9.1 5.0 3.4 18.5 12.7 12.2 10.9 7.3 5.1 6.4 2.9 10.6 6.2 6.7 3.0 5.4 7.9 3.8 3.0 10.1 6.6 6.6 3.9 41.0 16.4 3.0 11.8 4.2 9.0 9.5 15.1 11.6 2.4 6.5 10.5 4.2 7.8 0.2 0.2 0.0 0.0 0.0 3.7 0.0 0.0 1.0 3.2 14.8 7.8 2.4 3.3 0.1 0.0 7.1 0.0 0.0 0.5 31.1 10.1 2.8 9.5 20.7 5.7 0.0 1.5 0.6 3.2 0.0 0.0 0.2 0.0 16.2 9.8 4.6 0.0 14.2 14.3 1.2 27.3 5.3 0.0 0.0 0.0 6.4 2.3 5.1 14.1 13.8 13.2 2.9 5.4 2.3 2.2 1.7 0.0 0.0 0.0 0.0 0.0 5.1 1.6 0.0 0.0 0.0 0.0 2.3 2.4 6.7 9.5 1.0 7.6 8.0 6.8 7.3 2.6 9.5 6.7 7.7 11.6 6.5 1.0 15.1 10.5 4.2 6.7 9.3 7.5 7.3 5.4 13.1 5.0 3.4 5.1 3.9 6.0 1.0 6.5 4.0 1.0 7.7 2.1 10.2 20.1 4.5 15.7 0.0 22.6 16.6 22.1 4.7 2.1 9.6 0.0 24.7 21.2 2.4 4.0 1.1 18.3 5.5 12.7 18.6 1.3 1.3 12.9 9.5 1.8 3.3 24.4 7.6 13.0 27.0 13.9 5.3 27.2 4.7 0.0 0.8 20.4 22.8 2.4 22.5 8.7 9.5 2.6 LSM2 "C6orf28, G7b, YBL026W" ENSG00000204392 "LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated" Q9Y333 6 31797396-31806984 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052805, HPA066718" Supported Enhanced Nucleoplasm NA NA 26000 Nucleoplasm "HPA052805: , HPA066718: AB_2685710" "unprognostic (1.69e-1)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "unprognostic (1.24e-1)" "unprognostic (5.10e-2)" "unprognostic (1.50e-1)" "unprognostic (1.36e-3)" "unprognostic (6.14e-2)" "unprognostic (1.03e-1)" "unprognostic (2.34e-3)" "unprognostic (1.51e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (5.59e-9)" "unprognostic (2.23e-1)" "unprognostic (8.48e-2)" "unprognostic (4.49e-2)" "unprognostic (9.59e-2)" 20.3 17.4 15.7 21.7 19.4 21.0 18.7 14.4 17.7 21.1 19.5 14.0 11.8 17.9 23.6 15.2 21.8 21.5 20.7 17.5 14.4 12.8 17.5 15.1 18.0 33.5 20.7 17.5 19.4 20.3 9.6 15.1 17.9 20.3 19.7 21.3 10.8 12.8 14.0 19.5 17.1 15.3 21.5 26.7 22.1 16.7 16.5 19.4 51.8 23.4 19.5 26.9 21.8 20.9 18.2 10.8 8.7 5.7 12.3 15.3 10.1 10.2 5.0 8.8 11.3 5.0 6.9 9.3 6.4 4.1 9.2 8.2 5.7 3.9 10.9 9.0 5.3 8.5 4.1 11.6 10.9 8.3 11.5 14.9 12.5 3.1 5.8 6.1 12.4 4.5 5.2 5.0 8.5 8.8 4.3 9.6 11.2 16.3 7.1 6.5 7.4 14.9 28.4 8.1 7.7 10.9 9.2 7.0 16.0 7.6 3.0 8.9 7.7 6.9 6.2 12.5 4.8 6.8 9.9 5.0 5.5 9.6 6.3 10.3 7.4 12.6 13.9 2.8 14.8 8.5 8.7 5.7 3.6 9.4 5.2 12.4 18.2 10.1 10.6 9.5 16.1 9.7 11.9 1.2 12.3 4.4 10.8 15.3 10.1 15.7 19.4 14.4 17.7 14.4 12.8 20.7 17.5 20.3 19.4 20.8 23.4 106.9 62.3 51.7 30.5 12.2 40.8 18.7 22.7 52.4 5.9 114.2 96.2 89.8 18.3 82.4 26.4 70.0 118.6 172.4 68.7 55.0 82.9 52.9 122.6 28.6 51.9 62.0 59.2 20.0 46.1 69.2 87.7 110.0 89.7 34.6 82.0 49.1 46.3 86.4 26.4 45.3 57.7 49.6 178.0 56.1 57.7 108.4 103.8 39.9 LTBP2 "C14orf141, LTBP3" ENSG00000119681 "Latent transforming growth factor beta binding protein 2" Q14767 14 74498170-74612378 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding, Heparin-binding" "Disease mutation, Dwarfism, Glaucoma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 18 "Fibroblasts: 19.4;Peritubular cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 44.9;HUVEC TERT2: 24.5;LHCN-M2: 24.4;TIME: 107.9" "Group enriched" "Detected in some" 10 "cerebellum: 5.9;olfactory region: 3.0" "Region enriched" "Detected in some" 5 "olfactory region: 31.6" HPA003415 Approved Approved Nucleoplasm "Secreted to extracellular matrix" NA NA 13000000 Nucleoplasm "HPA003415: AB_1079284" "unprognostic (1.24e-1)" "unprognostic (3.09e-2)" "unprognostic (5.10e-2)" "unprognostic (3.92e-3)" "unprognostic (2.08e-3)" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (4.43e-2)" "unprognostic (1.08e-1)" "unprognostic (1.61e-1)" "unprognostic (2.80e-2)" "unprognostic (3.77e-1)" "unprognostic (1.98e-3)" "unprognostic (2.22e-3)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.94e-4)" 25.0 1.7 0.8 8.0 1.3 0.0 21.5 1.0 1.0 50.3 5.0 1.2 4.8 1.2 18.0 11.8 16.2 6.2 20.1 20.3 0.8 0.8 2.4 1.4 29.5 4.8 1.6 1.9 32.1 3.9 0.4 4.2 19.0 3.1 15.7 0.9 51.8 13.6 9.7 20.5 6.0 3.2 8.6 2.6 2.5 4.3 12.2 0.4 2.2 44.8 14.4 6.0 14.7 11.6 0.4 1.7 0.3 0.2 0.0 1.2 0.2 0.5 0.9 0.2 0.0 7.2 13.3 0.0 9.0 3.1 1.7 1.1 0.0 3.3 0.0 2.7 44.9 0.8 0.9 0.0 3.3 0.7 0.0 0.1 0.1 0.4 0.3 1.7 0.0 0.1 13.7 1.4 9.6 5.6 13.3 24.5 0.0 0.0 0.0 24.4 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.0 2.1 1.2 0.2 0.6 6.4 0.0 0.2 0.6 0.2 0.0 107.9 0.6 10.8 3.3 3.3 0.1 0.1 0.0 2.4 0.0 0.3 0.1 0.1 0.1 1.2 0.1 1.0 0.2 0.6 0.2 0.2 0.4 0.7 0.6 0.3 0.0 0.2 1.7 0.0 0.2 0.8 1.3 1.0 1.0 0.8 0.8 1.6 1.9 3.1 0.4 0.0 2.1 0.0 14.7 4.9 2.3 5.0 0.0 0.0 10.3 0.0 0.0 0.3 5.0 1.2 1.2 3.5 0.0 0.0 0.3 0.4 19.4 1.6 1.1 0.2 4.1 3.2 0.0 12.9 0.0 4.5 15.3 1.5 0.0 0.0 0.0 0.4 2.8 0.0 77.4 0.0 0.6 6.5 6.2 0.7 2.7 0.9 1.0 0.0 0.0 1.7 LUC7L2 "CGI-59, CGI-74, FLJ10657, H_NH0792N18.3, hLuc7B2, LUC7B2" ENSG00000146963 "LUC7 like 2, pre-mRNA splicing factor" Q9Y383 7 139340359-139423457 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051631 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA051631: AB_2681558" "unprognostic (1.07e-3)" "unprognostic (2.71e-2)" "unprognostic (8.26e-3)" "unprognostic (2.91e-1)" "unprognostic (2.84e-1)" "unprognostic (1.00e-2)" "unprognostic (4.54e-3)" "unprognostic (2.05e-2)" "unprognostic (1.12e-2)" "unprognostic (1.48e-3)" "unprognostic (3.54e-1)" "unprognostic (2.20e-2)" "prognostic unfavorable (4.92e-4)" "unprognostic (1.23e-2)" "unprognostic (1.97e-1)" "unprognostic (1.39e-1)" "unprognostic (4.28e-3)" 27.2 24.7 32.2 34.7 35.0 59.3 41.3 35.6 33.9 35.1 34.7 41.6 28.0 22.6 35.7 36.8 33.1 32.7 29.3 35.0 33.3 30.4 29.7 33.3 26.6 39.0 33.2 30.5 41.3 34.7 47.7 29.0 31.6 33.8 39.8 31.4 27.3 29.5 40.1 58.4 41.8 27.5 35.2 37.3 32.0 29.0 37.0 32.4 66.3 53.3 23.6 44.8 34.0 33.7 14.3 11.3 15.0 13.7 13.5 20.8 10.6 18.9 10.9 22.8 21.4 15.9 13.1 17.6 21.7 20.8 20.8 21.9 12.1 18.0 31.3 13.3 17.0 13.1 13.7 27.7 21.6 29.7 14.8 27.4 26.8 16.6 12.0 13.4 42.8 22.5 11.3 27.6 19.6 24.2 14.5 16.6 16.2 34.0 16.6 22.6 17.6 50.9 39.0 18.7 24.7 15.8 30.9 23.3 28.2 23.8 21.0 20.2 19.7 23.8 24.1 20.9 17.8 16.8 16.8 16.3 16.4 9.8 18.4 20.0 26.1 24.3 68.5 18.0 41.4 22.0 8.0 8.1 15.0 16.7 12.5 18.7 14.3 16.3 17.5 11.1 13.1 20.8 17.4 8.2 13.5 13.7 11.3 16.3 10.6 32.2 35.0 35.6 33.9 33.3 30.4 33.2 30.5 33.8 32.4 50.6 46.2 14.9 66.6 0.0 52.0 0.0 38.2 68.3 72.8 36.6 49.1 65.1 46.4 37.4 8.6 43.3 25.3 0.0 33.9 61.0 40.1 52.5 55.8 49.7 38.8 41.3 21.1 33.2 38.6 4.2 49.2 33.4 0.0 42.3 38.2 40.5 31.1 21.0 63.6 30.1 47.3 58.2 0.0 57.2 71.0 0.1 68.9 66.1 33.4 47.7 LY6G6E "C6orf22, G6e" ENSG00000255552 "Lymphocyte antigen 6 family member G6E" 6 31711771-31714065 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 111 "HEL: 23.1" HPA056234 Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA056234: AB_2732601" "unprognostic (1.77e-1)" "unprognostic (1.58e-2)" "unprognostic (2.25e-1)" "unprognostic (6.88e-2)" 0.3 0.0 2.9 0.0 0.5 4.3 0.0 0.0 5.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.3 0.2 1.7 0.1 0.0 0.3 3.9 0.0 0.0 0.0 0.6 0.0 0.2 0.2 0.6 0.7 0.2 0.0 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.6 2.2 0.0 0.1 0.2 0.4 0.4 0.8 1.1 0.4 0.1 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.4 0.4 0.4 0.7 0.4 0.0 0.2 0.3 0.4 1.1 0.1 0.3 0.8 0.7 1.0 2.9 0.5 0.0 5.2 1.7 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LYSMD1 "MGC35223, RP11-68I18.5, SB145" ENSG00000163155 "LysM domain containing 1" Q96S90 1 151159748-151165948 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028055, HPA064537" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028055: AB_10601912, HPA064537: AB_2685281" "unprognostic (1.71e-1)" "unprognostic (1.45e-2)" "unprognostic (1.19e-2)" "unprognostic (3.60e-3)" "unprognostic (2.59e-3)" "unprognostic (8.26e-2)" "unprognostic (7.24e-3)" "unprognostic (7.31e-3)" "unprognostic (1.77e-1)" "unprognostic (1.53e-2)" "unprognostic (1.88e-1)" "unprognostic (2.24e-2)" "unprognostic (8.72e-3)" "unprognostic (1.80e-1)" "unprognostic (2.07e-1)" "unprognostic (8.47e-3)" "unprognostic (6.33e-2)" 8.2 11.2 9.0 4.7 11.2 2.1 10.0 20.8 13.4 11.0 9.3 13.0 10.7 10.6 12.1 7.9 8.6 11.4 8.7 13.2 8.8 9.1 9.4 9.3 5.9 5.2 8.5 9.9 19.8 10.9 13.8 14.8 13.2 11.0 10.6 9.8 11.1 9.0 15.4 20.6 9.2 8.7 12.4 9.3 6.3 8.2 7.3 10.6 8.2 11.1 6.4 5.7 10.0 8.8 3.6 3.3 7.2 2.1 3.1 3.5 0.7 4.1 4.5 9.7 7.6 5.7 6.4 7.6 6.1 5.3 7.2 6.5 2.8 5.0 5.5 7.4 3.9 3.7 7.3 7.6 4.2 5.3 10.5 8.4 3.1 7.4 3.0 9.0 3.2 5.1 8.9 9.4 6.7 9.7 9.8 3.0 12.6 6.2 5.3 5.0 6.6 8.3 4.1 6.2 4.2 5.8 6.0 7.1 3.2 5.3 1.9 11.8 14.4 4.5 13.9 7.8 12.9 8.5 11.2 3.0 5.6 3.1 3.5 7.8 16.9 12.9 2.6 4.8 1.3 5.2 3.8 2.1 3.0 2.1 1.3 2.4 1.7 2.5 1.4 1.6 3.6 3.3 3.5 7.2 3.1 1.7 3.3 3.3 0.7 9.0 11.2 20.8 13.2 8.8 9.1 8.5 9.9 11.0 10.6 0.0 0.3 0.0 0.8 0.8 4.1 7.5 0.0 4.0 4.5 5.2 5.9 3.4 3.3 1.8 0.3 0.9 3.4 0.0 0.5 2.3 2.7 1.0 0.0 3.2 0.5 1.6 4.1 2.5 0.0 0.0 4.0 0.0 1.7 0.0 1.9 3.4 1.9 0.0 5.6 4.3 7.9 0.0 3.0 1.6 2.5 1.0 2.4 0.0 2.7 0.9 MAB21L1 CAGR1 ENSG00000180660 "Mab-21 like 1" Q13394 13 35474182-35477209 "Predicted intracellular proteins" "Developmental protein, Nucleotidyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 24.0;skeletal muscle: 8.5" "Group enriched" "Detected in some" 38 "Bipolar cells: 51.8;Cone photoreceptor cells: 47.1;Horizontal cells: 82.6;Muller glia cells: 136.9;Rod photoreceptor cells: 120.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 12.9;BJ hTERT+: 10.5;BJ hTERT+ SV40 Large T+: 14.9;HBF TERT88: 16.2;hTERT-RPE1: 31.2;SH-SY5Y: 48.0" "Group enriched" "Detected in some" 9 "cerebellum: 45.8;midbrain: 22.3;pons and medulla: 12.9" "Low region specificity" "Detected in all" "HPA049324, HPA059864" Approved Nucleoplasm NA NA Nucleoplasm "HPA049324: AB_2680712, HPA059864: AB_2684147" "unprognostic (4.44e-2)" "unprognostic (2.82e-2)" "unprognostic (2.79e-3)" "unprognostic (3.87e-4)" "unprognostic (5.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.71e-1)" "unprognostic (4.12e-3)" "unprognostic (1.64e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (3.19e-2)" "unprognostic (6.93e-3)" "unprognostic (1.14e-1)" "unprognostic (3.72e-1)" "unprognostic (2.86e-1)" 2.9 6.4 0.3 0.5 0.0 0.0 6.3 24.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.8 0.6 1.1 0.0 0.0 0.0 0.0 1.8 0.5 3.7 0.2 8.5 1.2 1.1 0.0 0.8 0.0 0.3 0.0 0.6 0.2 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.9 10.5 14.9 8.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 16.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.2 48.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 51.8 0.3 0.0 0.0 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.2 2.3 0.0 0.1 82.6 0.0 1.3 0.0 0.0 0.3 0.0 1.7 0.0 0.0 136.9 0.0 0.0 0.4 0.0 120.3 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.2 MAB21L2 ENSG00000181541 "Mab-21 like 2" Q9Y586 4 150581922-150584693 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.2;intestine: 59.8;smooth muscle: 15.2" "Cell type enhanced" "Detected in some" 24 "Cholangiocytes: 12.7;Horizontal cells: 23.8;Muller glia cells: 5.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.3" "Region enriched" "Detected in some" 18 "pons and medulla: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "hTERT-RPE1: 46.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049324, HPA059864" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049324: AB_2680712, HPA059864: AB_2684147" "unprognostic (1.12e-1)" "unprognostic (3.67e-2)" "unprognostic (4.03e-2)" "unprognostic (2.63e-1)" "unprognostic (2.32e-1)" "unprognostic (3.85e-2)" "unprognostic (8.99e-2)" "unprognostic (2.76e-2)" "unprognostic (2.75e-1)" "unprognostic (6.60e-2)" "unprognostic (4.78e-3)" "unprognostic (1.18e-1)" "unprognostic (6.81e-2)" "unprognostic (1.68e-1)" 0.6 3.1 0.2 8.6 0.4 0.0 0.1 0.2 0.2 0.2 59.8 0.1 0.0 6.8 0.1 0.9 0.9 0.2 0.5 0.7 0.2 0.6 0.1 0.5 0.1 0.6 1.0 0.0 0.1 0.2 0.0 0.3 0.0 19.2 0.2 8.1 9.0 2.2 0.0 0.3 0.2 14.7 15.2 4.5 0.1 0.3 0.1 0.0 0.2 1.4 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.0 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.6 1.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.8 12.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MAB21L3 "C1orf161, FLJ38716" ENSG00000173212 "Mab-21 like 3" Q8N8X9 1 116111755-116135240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.9;skin 1: 8.7" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 41.7;Alveolar cells type 2: 51.9;Ciliated cells: 24.1;Club cells: 33.0;granulocytes: 16.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 15.7;RT4: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039551 Approved Nucleoplasm NA NA Nucleoplasm "HPA039551: AB_2676565" "unprognostic (9.25e-3)" "unprognostic (3.47e-3)" "unprognostic (1.44e-3)" "unprognostic (5.23e-5)" "unprognostic (2.22e-1)" "unprognostic (2.06e-2)" "unprognostic (5.36e-2)" "unprognostic (3.75e-3)" "unprognostic (1.21e-1)" "unprognostic (7.01e-2)" "unprognostic (2.49e-1)" "unprognostic (4.84e-2)" "unprognostic (1.16e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (2.52e-1)" "unprognostic (4.61e-2)" 0.3 0.0 0.3 2.7 0.3 0.8 0.5 0.3 0.3 2.8 2.1 0.3 0.3 0.2 0.3 0.3 9.9 0.0 0.3 0.3 0.3 0.2 2.0 3.1 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 2.2 0.3 1.1 1.8 0.3 1.3 0.7 0.6 8.7 3.4 0.3 0.3 0.3 0.4 0.7 0.3 0.3 0.3 2.5 1.7 2.1 4.2 2.6 1.3 5.5 1.2 4.4 0.7 0.0 3.4 0.1 0.8 0.6 0.1 0.0 5.3 0.6 0.2 0.0 0.0 0.3 1.3 2.1 15.7 0.1 0.3 2.9 0.1 0.1 0.1 0.7 0.1 0.9 0.4 2.8 0.0 0.9 0.5 0.0 0.4 0.1 0.3 0.1 0.0 0.5 0.9 2.4 0.0 0.3 0.5 0.5 2.2 0.7 1.0 0.8 0.8 0.4 0.6 15.1 0.5 0.8 2.4 2.0 0.6 2.5 2.5 0.4 0.5 1.0 2.5 0.7 0.6 2.3 4.0 1.0 0.5 0.3 1.0 2.6 1.2 0.3 0.6 0.6 0.5 0.8 0.4 0.5 0.3 2.6 0.7 0.7 5.5 4.4 0.7 1.3 0.2 0.0 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 41.7 51.9 0.0 2.3 0.6 0.0 0.4 0.0 24.1 33.0 3.5 0.0 3.8 1.7 0.0 0.1 0.0 0.7 0.0 0.2 0.5 0.0 0.7 16.3 0.6 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 1.5 11.4 0.0 1.0 0.6 MACROD1 LRP16 ENSG00000133315 "MACRO domain containing 1" Q9BQ69 11 63998558-64166106 "Disease related genes, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 142.5" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 116.0;Proximal tubular cells: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 27.0;RPMI-8226: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041031, HPA071075" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA041031: AB_10794435, HPA071075: AB_2686341" "unprognostic (1.19e-2)" "unprognostic (2.15e-1)" "unprognostic (1.38e-1)" "unprognostic (3.14e-2)" "unprognostic (3.88e-2)" "unprognostic (6.03e-2)" "unprognostic (1.95e-2)" "unprognostic (2.82e-1)" "unprognostic (2.44e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.15e-1)" "prognostic favorable (4.68e-6)" "unprognostic (2.45e-2)" "unprognostic (9.92e-2)" "unprognostic (2.36e-1)" "unprognostic (2.86e-2)" 4.9 3.0 2.9 2.8 3.3 2.5 3.9 6.2 4.6 3.6 6.9 2.8 7.0 4.3 3.4 6.5 7.8 3.2 3.9 29.0 2.2 3.4 10.6 10.4 3.0 1.8 3.0 3.1 5.2 16.6 2.5 2.7 2.1 3.1 6.1 1.9 4.6 16.4 8.1 142.5 5.5 3.9 6.2 2.4 2.7 5.6 1.9 2.7 0.8 12.7 25.0 3.3 4.6 4.5 0.6 0.7 0.0 1.2 0.0 2.0 0.4 4.0 2.1 0.6 3.8 0.6 0.4 3.7 2.3 1.1 1.9 1.8 2.0 11.0 15.4 8.5 0.2 0.6 10.4 0.5 0.0 0.1 1.1 7.2 5.5 8.8 10.9 2.3 4.6 0.6 0.9 1.2 0.2 0.5 1.3 0.7 4.8 5.0 3.1 0.3 27.0 6.4 15.9 1.8 1.4 8.2 5.7 4.3 51.0 0.6 0.2 5.3 11.0 2.1 15.9 14.5 0.0 11.4 0.1 1.0 1.7 2.6 2.6 0.2 6.2 0.9 2.5 1.2 4.7 1.6 0.0 0.2 0.0 2.0 1.2 1.9 0.6 1.8 1.1 0.4 0.4 0.9 0.8 0.0 0.0 0.0 0.7 0.0 0.4 2.9 3.3 6.2 4.6 2.2 3.4 3.0 3.1 3.1 2.7 0.0 5.8 10.9 30.6 24.8 13.1 30.8 30.6 0.0 4.5 40.1 0.0 25.1 116.0 16.5 5.8 9.0 17.2 0.0 34.7 10.9 13.7 23.2 0.0 42.3 9.7 11.1 22.0 7.4 2.5 15.9 23.0 1.8 37.1 2.8 52.9 14.3 17.6 28.8 13.4 164.4 15.8 19.4 18.4 2.9 28.5 32.4 20.0 6.1 65.5 30.1 MAD2L1 "HSMAD2, MAD2" ENSG00000164109 "Mitotic arrest deficient 2 like 1" Q13257 4 120055608-120067074 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.3" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 100.5;Spermatocytes: 142.5;Spermatogonia: 91.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003348 Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA003348: AB_10603014" "unprognostic (4.08e-3)" "unprognostic (7.31e-2)" "unprognostic (5.17e-3)" "unprognostic (1.10e-2)" "unprognostic (1.27e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (5.15e-5)" "prognostic unfavorable (2.17e-4)" "unprognostic (6.74e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "unprognostic (3.87e-3)" "prognostic unfavorable (3.07e-11)" "unprognostic (3.06e-2)" "unprognostic (4.05e-1)" "unprognostic (1.03e-1)" "unprognostic (9.70e-2)" 1.4 1.8 2.4 4.2 5.7 10.3 2.4 4.4 4.1 1.9 4.4 1.2 0.3 3.8 1.7 1.4 6.5 2.9 1.1 1.7 2.7 2.7 1.2 1.2 1.5 7.6 2.3 3.6 1.7 1.2 0.7 1.0 3.5 2.4 1.6 5.5 0.7 2.4 1.2 1.2 2.3 4.2 1.8 2.8 3.8 1.9 13.7 1.2 27.3 1.2 8.2 7.3 2.1 2.4 1.8 2.2 2.0 0.8 2.5 3.9 1.7 14.7 6.4 15.2 9.9 1.6 2.0 6.5 11.7 6.6 12.2 9.5 8.6 9.1 21.7 3.9 4.2 5.4 4.0 15.1 8.9 17.2 10.2 10.6 12.0 6.3 8.1 0.5 19.5 6.9 1.1 1.3 8.3 5.2 3.1 7.0 9.3 14.3 12.4 6.4 6.5 18.7 8.5 10.4 7.7 7.4 9.7 20.4 8.9 5.0 5.7 16.2 11.5 5.8 7.2 3.6 7.8 4.8 7.2 4.4 8.3 9.4 8.3 14.7 11.6 12.4 14.2 7.7 10.1 10.8 2.0 0.5 0.4 1.6 0.5 2.1 1.8 3.8 3.0 0.4 1.4 3.5 3.5 1.3 2.5 0.8 2.2 3.9 1.7 2.4 5.7 4.4 4.1 2.7 2.7 2.3 3.6 2.4 1.2 0.0 2.2 6.0 6.3 15.3 8.5 3.0 2.5 6.7 2.3 7.0 2.0 18.3 0.0 2.9 1.8 3.1 2.9 23.3 1.4 100.5 6.1 4.5 15.0 1.6 23.3 19.1 1.7 2.5 6.3 3.6 4.4 6.2 8.5 4.6 8.1 10.6 1.7 2.9 1.4 4.3 3.6 12.9 6.6 142.5 91.0 7.9 9.0 17.9 16.2 4.5 MAEA "EMP, GID9" ENSG00000090316 "Macrophage erythroblast attacher" Q7L5Y9 4 1289851-1340147 "Predicted intracellular proteins" "Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway" "Actin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036886, HPA058185" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA036886: , HPA058185: AB_2683633" "unprognostic (2.70e-2)" "unprognostic (1.52e-1)" "unprognostic (1.78e-2)" "unprognostic (1.11e-1)" "unprognostic (2.03e-2)" "prognostic favorable (5.34e-4)" "unprognostic (3.10e-3)" "unprognostic (3.89e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-1)" "unprognostic (6.94e-3)" "unprognostic (4.65e-3)" "prognostic favorable (1.90e-4)" "unprognostic (1.17e-2)" "unprognostic (2.49e-1)" "unprognostic (1.97e-1)" "unprognostic (4.51e-2)" 23.6 35.4 25.5 26.3 28.4 19.5 20.9 34.0 35.8 24.4 33.3 21.7 26.8 39.9 27.3 23.8 34.7 26.0 29.2 36.6 23.7 33.1 33.2 27.9 19.1 26.1 23.3 32.0 33.4 32.0 21.9 30.3 27.6 34.0 23.6 17.2 22.3 36.7 28.0 27.3 29.0 38.2 20.9 17.7 31.0 30.3 23.3 26.7 26.5 26.1 28.5 26.5 26.3 25.4 19.7 18.9 48.2 28.0 17.0 35.8 21.9 22.7 27.0 19.2 19.0 12.8 12.8 25.0 23.3 12.2 18.8 17.3 28.0 29.3 20.7 18.2 16.7 34.9 16.9 18.4 28.5 7.8 16.6 20.5 19.5 29.8 26.7 15.3 21.9 21.0 15.9 15.6 15.2 9.6 13.1 15.2 20.0 27.1 16.6 16.5 24.1 32.5 33.6 25.3 24.7 29.1 31.7 15.4 18.7 20.1 27.5 34.5 24.1 20.8 15.7 15.8 11.2 29.0 19.1 21.3 35.1 15.1 16.0 38.5 20.9 32.0 22.8 24.5 20.2 19.3 23.9 20.2 27.2 25.5 20.7 35.8 19.7 20.5 24.1 18.9 16.5 18.3 18.8 48.2 17.0 28.0 13.3 23.1 21.9 25.5 28.4 34.0 35.8 23.7 33.1 23.3 32.0 34.0 26.7 17.9 23.5 19.1 12.9 16.7 25.9 30.8 12.7 14.7 21.6 15.7 19.6 42.4 39.7 39.2 5.8 20.4 33.8 0.0 26.5 43.0 21.1 18.9 10.4 15.3 34.2 20.6 19.5 18.4 22.3 8.2 32.8 16.9 27.0 55.9 30.8 20.6 33.1 32.0 35.0 28.1 18.6 12.9 16.5 25.9 41.2 17.3 79.6 27.4 32.9 18.6 MAFK "NFE2U, P18" ENSG00000198517 "MAF bZIP transcription factor K" O60675 7 1530714-1543043 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 62.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026820, HPA060841" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB026820: , HPA060841: AB_2684377" "unprognostic (6.82e-2)" "unprognostic (3.71e-3)" "unprognostic (1.49e-2)" "unprognostic (2.55e-1)" "unprognostic (6.44e-3)" "unprognostic (1.19e-1)" "unprognostic (9.44e-2)" "unprognostic (2.28e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-2)" "unprognostic (2.81e-1)" "unprognostic (1.40e-1)" "unprognostic (2.83e-2)" "unprognostic (1.08e-2)" "unprognostic (1.24e-1)" "unprognostic (5.59e-2)" "unprognostic (2.14e-1)" 15.7 14.3 12.6 12.4 20.1 16.3 13.0 4.2 12.5 9.3 18.0 13.5 6.7 18.2 14.7 5.0 10.1 10.2 12.7 30.9 13.2 11.8 10.5 10.9 18.7 8.7 19.7 11.0 7.2 34.9 6.0 8.7 62.4 14.5 16.1 5.1 6.7 11.0 12.0 26.8 12.8 16.8 26.1 12.1 11.3 13.2 4.1 13.1 22.8 9.1 9.7 7.5 13.7 19.0 1.9 5.1 3.6 1.7 1.5 2.6 1.4 20.0 14.4 0.5 2.1 1.6 2.0 11.0 13.3 7.6 3.2 2.3 10.3 5.5 4.7 4.9 3.3 21.9 15.6 1.2 3.8 1.4 7.2 10.5 2.7 18.4 7.5 3.7 6.4 8.7 2.0 5.0 5.4 4.1 4.0 2.9 14.8 7.0 2.6 1.5 13.2 7.2 23.1 4.6 4.9 14.6 10.9 0.5 7.9 3.0 8.3 6.2 2.3 8.0 23.8 5.8 3.3 9.2 8.6 6.9 5.0 34.8 25.0 7.2 5.0 1.5 7.8 6.6 8.9 7.0 1.7 1.6 3.6 2.1 0.8 2.3 1.4 1.2 2.5 0.7 1.9 2.6 2.0 2.2 1.5 1.7 5.1 2.2 1.4 12.6 20.1 4.2 12.5 13.2 11.8 19.7 11.0 14.5 13.1 38.7 21.2 5.1 38.8 56.7 1.8 2.4 12.7 9.4 15.9 29.6 2.0 7.9 1.7 12.6 2.8 17.5 32.5 0.0 12.9 7.1 20.6 51.3 9.2 11.6 9.5 11.1 22.2 10.4 16.3 3.8 4.4 14.9 18.6 5.4 21.7 7.5 30.7 26.8 2.8 2.1 0.6 12.9 22.7 0.5 4.7 50.4 65.2 8.6 13.4 64.3 MAGEB17 ENSG00000182798 "MAGE family member B17" A8MXT2 X 16167481-16171464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 4.4;testis: 5.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 3.3;U-2 OS: 7.2;U-266/70: 17.8" HPA003756 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003756: AB_2250114" "unprognostic (1.94e-2)" "unprognostic (2.23e-1)" "unprognostic (3.57e-1)" "unprognostic (4.04e-4)" "unprognostic (2.75e-1)" "unprognostic (5.11e-1)" "unprognostic (3.56e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (1.88e-2)" "unprognostic (2.49e-2)" "unprognostic (1.50e-1)" "unprognostic (7.05e-2)" "unprognostic (2.88e-1)" "unprognostic (5.45e-2)" "unprognostic (6.44e-2)" 0.1 0.0 0.1 0.4 0.0 0.0 0.6 0.1 0.0 0.6 0.4 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 1.2 5.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 1.8 0.0 0.0 3.3 7.2 0.0 0.2 17.8 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGOH "MAGOH1, MAGOHA" ENSG00000162385 "Mago homolog, exon junction complex core component" P61326 1 53226892-53238610 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015425, HPA043036, HPA047754" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB015425: AB_629914, HPA043036: AB_2678279, HPA047754: AB_2680148" "prognostic favorable (1.85e-4)" "unprognostic (2.61e-2)" "unprognostic (5.39e-2)" "unprognostic (2.33e-1)" "unprognostic (3.59e-1)" "unprognostic (6.34e-3)" "unprognostic (3.07e-3)" "unprognostic (2.18e-1)" "unprognostic (5.17e-2)" "unprognostic (1.46e-2)" "unprognostic (8.54e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (1.45e-5)" "unprognostic (2.01e-2)" "unprognostic (1.63e-1)" "unprognostic (3.60e-2)" "unprognostic (6.75e-3)" 31.5 31.3 25.7 32.9 28.9 70.7 33.8 23.0 36.8 26.9 33.9 17.4 33.5 30.2 37.5 33.7 37.5 31.4 25.6 27.6 30.3 25.6 35.9 42.5 33.2 43.2 23.5 28.8 36.7 35.6 18.9 46.6 43.4 31.4 24.6 31.9 22.8 31.2 31.1 40.9 30.7 35.7 35.3 32.6 36.9 28.5 28.1 24.3 50.3 37.4 37.2 46.0 28.0 30.0 29.8 35.2 31.3 30.9 29.8 33.0 18.2 33.1 16.0 28.2 24.5 14.6 9.4 32.6 24.9 14.6 32.9 33.4 36.5 15.9 47.4 29.1 14.5 41.7 20.5 36.8 21.8 39.3 31.4 40.9 43.2 20.9 39.4 23.4 74.9 24.2 10.1 15.7 29.9 24.6 12.9 21.7 43.8 43.3 10.9 17.8 25.8 61.4 52.0 52.1 27.3 35.2 42.0 53.9 25.1 17.5 33.2 24.2 19.6 33.3 27.1 39.0 35.3 14.0 53.9 19.9 20.5 28.1 28.9 56.9 16.0 28.6 74.0 18.6 47.7 20.9 17.0 21.6 31.3 32.3 30.9 31.1 29.8 31.2 33.0 30.5 29.0 28.8 29.5 26.0 29.8 28.1 35.2 32.3 18.2 25.7 28.9 23.0 36.8 30.3 25.6 23.5 28.8 31.4 24.3 47.6 37.5 73.4 102.0 128.2 31.7 45.8 56.0 76.3 62.6 54.1 13.7 170.1 150.9 70.5 11.4 70.8 46.6 0.0 74.0 157.5 82.2 60.3 80.9 46.1 101.6 22.3 52.2 54.6 49.1 8.4 69.9 77.4 77.6 102.8 70.6 51.5 72.6 70.2 64.0 112.9 28.8 58.2 90.6 80.9 69.2 105.6 202.3 78.8 80.9 86.6 MAML1 "KIAA0200, Mam-1" ENSG00000161021 "Mastermind like transcriptional coactivator 1" Q92585 5 179732850-179777286 "Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "granulocytes: 57.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.6;BJ hTERT+ SV40 Large T+: 8.9;hTCEpi: 9.0;SK-MEL-30: 15.6;SuSa: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037687, HPA057531" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA037687: AB_10672604, HPA057531: AB_2683458" "unprognostic (2.64e-1)" "unprognostic (2.06e-1)" "unprognostic (3.01e-2)" "unprognostic (5.41e-3)" "unprognostic (5.79e-2)" "unprognostic (2.45e-1)" "unprognostic (1.75e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (9.70e-4)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (3.44e-1)" "unprognostic (6.05e-2)" "unprognostic (1.06e-1)" "unprognostic (6.69e-2)" 8.5 8.9 8.5 9.5 9.6 15.8 8.2 27.2 9.3 35.4 9.3 10.6 3.9 12.5 11.2 18.8 8.8 9.5 6.8 6.4 7.9 3.3 7.5 5.8 11.9 9.7 9.9 5.8 13.0 8.8 2.3 9.2 11.7 8.6 9.2 10.9 10.4 7.8 4.7 13.1 9.2 25.1 13.4 6.4 10.1 8.0 5.6 10.6 20.8 10.8 3.4 9.1 9.9 9.6 2.4 0.8 3.3 2.0 1.1 1.7 0.9 0.0 0.0 0.0 0.0 7.6 7.5 0.0 4.6 8.6 8.9 6.6 0.0 0.0 5.5 6.6 0.0 0.0 0.3 0.0 0.0 5.6 0.0 0.0 0.0 6.6 0.0 6.7 0.0 0.1 0.0 9.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.2 0.1 0.0 0.0 0.1 15.6 8.5 7.1 0.0 7.0 0.1 1.1 0.2 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.3 1.7 1.2 0.8 2.4 0.9 1.4 0.6 2.4 1.0 0.8 3.0 1.1 2.0 0.8 0.5 0.9 8.5 9.6 27.2 9.3 7.9 3.3 9.9 5.8 8.6 10.6 14.9 9.4 3.9 11.0 22.1 12.9 6.2 17.8 4.0 3.4 8.7 17.7 8.9 1.7 6.0 1.8 20.3 6.7 23.3 5.7 9.5 10.8 9.5 57.4 8.6 11.1 20.6 8.6 31.9 21.5 1.6 16.1 11.4 5.0 10.0 13.5 10.0 5.8 7.0 23.7 3.3 9.3 12.9 10.3 5.7 9.4 26.1 7.8 13.1 13.3 12.7 MAMLD1 "CG1, CXorf6, F18" ENSG00000013619 "Mastermind like domain containing 1" Q13495 X 150361422-150514178 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Horizontal cells: 12.7;Leydig cells: 31.4;Peritubular cells: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 15.6;U-2197: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003923 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA003923: AB_10602034" "unprognostic (4.18e-3)" "unprognostic (1.74e-1)" "unprognostic (1.63e-1)" "unprognostic (4.29e-2)" "unprognostic (4.16e-2)" "unprognostic (5.09e-2)" "unprognostic (2.31e-1)" "unprognostic (7.68e-2)" "unprognostic (2.08e-2)" "unprognostic (9.74e-2)" "unprognostic (9.86e-3)" "unprognostic (4.82e-2)" "unprognostic (1.86e-1)" "unprognostic (3.33e-2)" "unprognostic (3.58e-2)" "unprognostic (1.41e-3)" "unprognostic (9.76e-3)" 7.6 4.6 9.1 2.6 15.5 2.6 10.0 5.2 11.7 5.8 3.7 5.7 5.7 1.8 9.0 5.9 3.2 7.8 4.2 3.9 9.3 9.5 2.6 3.2 5.9 2.8 3.5 6.9 21.8 6.0 3.0 6.0 3.2 5.7 5.6 2.3 6.4 3.2 11.7 6.6 2.4 1.8 5.6 5.6 2.5 2.6 15.3 5.2 0.0 1.6 1.7 2.1 2.9 3.5 2.2 0.1 0.8 0.1 0.6 3.0 0.8 4.6 1.8 2.5 5.0 7.3 2.7 0.0 4.4 9.3 6.8 15.6 0.0 0.2 0.0 2.3 10.5 5.4 0.1 2.8 2.1 9.3 7.0 0.2 0.1 5.9 0.1 5.4 0.2 0.0 3.7 0.5 7.7 0.9 3.4 1.4 0.4 0.1 0.1 6.4 0.9 0.0 0.1 0.5 0.0 3.5 0.3 9.7 0.2 1.1 0.1 0.7 0.5 1.5 0.1 2.5 0.6 0.1 0.0 1.8 3.6 4.5 24.2 7.8 0.3 0.3 0.1 10.1 1.8 4.9 0.0 0.0 0.2 1.1 0.0 1.6 2.2 1.8 1.5 0.1 0.9 1.7 3.0 0.8 0.6 0.1 0.1 2.0 0.8 9.1 15.5 5.2 11.0 9.3 9.5 3.5 6.9 5.7 5.2 0.0 0.3 0.0 0.8 3.1 1.0 2.0 5.1 0.0 0.0 0.0 9.8 0.0 1.7 2.8 1.1 4.5 0.0 0.0 2.2 0.0 1.1 1.2 0.0 3.4 0.5 12.7 3.5 3.7 0.6 2.4 31.4 2.6 3.3 1.0 0.4 2.0 2.1 0.0 22.6 0.1 0.4 6.5 8.0 0.0 0.4 3.6 0.0 0.0 0.0 0.4 MAN2C1 "MANA, MANA1" ENSG00000140400 "Mannosidase alpha class 2C member 1" Q9NTJ4 15 75355207-75368630 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040627, HPA067407" Uncertain Enhanced Nucleoplasm NA NA 9000 Nucleoplasm "HPA040627: AB_10795490, HPA067407: AB_2685834" "unprognostic (4.68e-2)" "unprognostic (1.95e-1)" "unprognostic (3.84e-3)" "unprognostic (3.48e-2)" "unprognostic (3.85e-1)" "unprognostic (3.00e-2)" "unprognostic (1.26e-2)" "unprognostic (6.26e-2)" "unprognostic (2.47e-1)" "unprognostic (5.02e-2)" "unprognostic (1.06e-2)" "unprognostic (3.40e-2)" "unprognostic (4.87e-3)" "unprognostic (9.56e-2)" "unprognostic (1.33e-1)" "unprognostic (2.91e-1)" "unprognostic (1.39e-3)" 29.9 28.8 22.6 20.4 26.0 30.0 24.6 27.5 25.5 25.1 25.1 26.8 23.8 22.9 27.8 27.5 20.2 24.2 23.3 28.2 18.3 12.9 22.9 21.4 25.2 17.0 23.0 28.3 32.8 22.3 28.2 30.6 22.4 18.3 24.9 14.2 30.8 25.6 20.2 37.9 30.9 27.7 20.0 15.0 28.1 23.0 28.8 19.9 21.0 34.7 15.3 19.5 21.1 21.3 2.3 15.7 2.6 16.2 3.9 7.3 8.5 5.5 13.3 11.1 8.0 12.7 11.0 13.8 12.9 12.2 6.8 5.7 9.2 19.1 2.7 7.6 9.4 6.2 17.2 6.1 8.7 4.4 15.2 13.4 17.5 25.2 9.1 18.8 11.2 2.8 13.1 8.8 6.4 8.1 14.4 15.8 8.0 10.0 14.4 5.5 10.8 5.5 12.7 4.7 6.6 5.6 7.8 5.6 16.6 8.9 25.9 6.6 12.0 8.2 12.5 5.8 8.3 12.4 13.1 30.9 14.3 10.0 9.9 12.7 14.4 3.5 4.4 9.2 12.9 14.2 2.6 13.3 2.0 7.2 16.2 6.8 2.3 5.3 5.2 15.7 2.0 7.3 5.1 1.4 3.9 12.4 6.4 7.0 8.5 22.6 26.0 27.5 25.5 18.3 12.9 23.0 28.3 18.3 19.9 20.8 52.5 12.9 13.4 11.9 32.1 2.0 5.1 16.0 18.2 8.7 51.1 14.5 3.3 9.4 8.2 17.2 21.3 0.0 7.7 8.8 15.0 13.8 31.1 21.5 17.5 27.0 32.8 33.2 37.8 10.6 21.6 24.1 15.1 19.8 21.0 18.6 9.2 14.4 11.7 12.3 52.0 25.8 10.4 18.6 10.9 7.4 17.7 12.7 20.7 11.9 MAP3K3 "MAPKKK3, MEKK3" ENSG00000198909 "Mitogen-activated protein kinase kinase kinase 3" Q99759 17 63622415-63696303 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007764, HPA035410, HPA035411" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB007764: AB_562314, HPA035410: AB_2674614, HPA035411: AB_2674615" "unprognostic (9.65e-3)" "unprognostic (1.33e-1)" "unprognostic (5.14e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.16e-1)" "unprognostic (4.12e-2)" "unprognostic (1.03e-2)" "unprognostic (1.33e-1)" "unprognostic (1.36e-1)" "unprognostic (9.37e-2)" "unprognostic (1.46e-3)" "unprognostic (5.51e-2)" "unprognostic (2.35e-1)" "unprognostic (2.79e-2)" "unprognostic (4.68e-2)" "unprognostic (1.09e-1)" "unprognostic (3.08e-2)" 23.9 11.8 10.5 20.5 15.0 24.8 19.1 26.8 14.9 22.2 21.8 15.0 14.0 8.0 24.5 13.2 16.6 18.3 20.6 37.4 11.3 8.4 17.1 12.4 23.1 21.4 14.4 9.6 21.6 11.4 16.9 12.3 21.0 11.9 18.4 8.3 21.7 12.8 18.5 19.6 15.4 14.7 20.4 13.2 30.4 16.4 26.5 12.3 12.9 15.5 12.8 15.4 19.0 26.8 1.9 3.5 18.3 8.5 1.1 2.6 2.3 10.2 7.7 9.8 9.6 18.9 15.2 4.5 10.2 11.2 12.7 10.3 3.5 2.1 11.1 7.2 19.9 9.3 3.8 6.4 7.2 8.1 9.7 14.1 9.0 10.5 5.0 9.9 6.9 9.7 10.9 5.0 15.8 8.3 8.1 30.8 8.2 5.5 14.7 10.1 7.3 12.4 7.3 6.1 2.1 8.3 6.6 25.2 7.2 4.6 4.7 5.0 12.1 6.9 8.3 8.5 12.9 8.3 6.9 27.7 32.5 8.6 17.6 12.3 14.7 14.8 4.1 7.0 5.6 8.4 8.8 8.5 10.4 2.2 8.3 2.3 1.5 2.6 2.1 3.5 1.9 2.5 2.5 18.3 1.1 8.2 1.3 1.9 2.3 10.5 15.0 26.8 14.9 11.3 8.4 14.4 9.6 11.9 12.3 17.9 12.6 8.8 5.9 6.9 13.9 9.9 2.5 4.0 5.7 15.7 13.7 2.7 8.3 3.7 7.1 33.7 2.1 0.0 6.9 2.9 7.4 8.9 3.5 8.3 13.8 17.5 4.1 39.3 38.3 4.4 13.8 15.3 21.9 8.2 3.3 7.5 4.9 0.0 12.4 2.1 15.0 19.4 11.4 18.0 6.1 9.8 1.1 8.7 4.4 3.7 MAP3K7CL "C21orf7, TAK1L, TAKL, TAKL-1, TAKL-2, TAKL-4" ENSG00000156265 "MAP3K7 C-terminal like" P57077 21 29077471-29175889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.9;skeletal muscle: 50.4;tongue: 28.8" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 17.1;Sertoli cells: 19.4;Smooth muscle cells: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 7.6;granulocytes: 12.0;monocytes: 5.7" "Cell line enhanced" "Detected in many" "HBF TERT88: 17.4;LHCN-M2: 18.5;RH-30: 74.0" "HPA030079, HPA042439" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030079: AB_2673299, HPA042439: AB_10794422" "unprognostic (2.23e-1)" "unprognostic (2.06e-1)" "unprognostic (9.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.98e-2)" "unprognostic (7.00e-3)" "unprognostic (3.40e-3)" "unprognostic (1.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.93e-2)" "unprognostic (1.28e-3)" "unprognostic (4.39e-3)" "prognostic unfavorable (8.31e-6)" "unprognostic (2.68e-3)" "unprognostic (1.57e-1)" "unprognostic (1.12e-1)" "unprognostic (8.10e-2)" 6.9 5.1 1.6 4.6 2.2 1.4 2.5 1.2 1.7 4.0 4.6 2.4 1.7 0.9 8.6 11.7 3.4 3.0 5.2 16.2 1.4 1.9 4.4 3.2 6.6 5.2 1.8 1.9 4.7 4.3 2.5 2.9 1.7 2.7 4.4 1.8 2.4 1.8 2.6 50.4 2.7 3.1 3.8 3.1 3.9 1.7 3.2 1.4 2.3 2.7 28.8 7.8 3.6 2.1 7.6 0.8 12.0 5.7 0.6 1.5 37.9 0.9 0.2 0.1 0.3 0.1 5.7 0.1 1.3 3.7 3.4 9.3 1.5 0.4 8.0 0.5 5.3 0.1 0.0 0.1 4.2 17.4 1.6 0.0 0.8 0.6 0.1 0.8 0.0 0.0 2.0 8.1 11.9 11.3 1.7 0.6 0.2 0.5 3.3 18.5 0.2 0.1 0.0 0.4 0.7 0.3 0.0 74.0 0.2 0.5 0.2 0.5 0.3 0.0 0.0 0.4 1.5 0.0 0.4 0.6 7.3 6.2 1.6 0.2 1.4 0.2 0.3 1.1 0.6 1.5 12.0 5.7 1.1 0.6 4.2 1.5 7.6 0.4 0.6 0.7 5.3 0.7 1.1 8.6 0.6 1.9 0.8 1.1 37.9 1.6 2.2 1.2 1.7 1.4 1.9 1.8 1.9 2.7 1.4 0.0 4.0 3.7 5.5 7.6 2.3 1.4 2.5 1.4 0.0 0.0 2.0 0.2 0.0 1.1 1.1 3.6 1.3 0.0 1.4 0.2 3.4 3.0 1.1 4.0 3.3 0.0 4.6 1.3 17.1 0.6 0.6 5.5 5.0 1.8 2.2 1.3 2.6 2.9 4.2 2.1 1.2 19.4 26.7 1.1 1.4 8.3 0.3 2.6 1.3 2.1 MAPK3 "ERK1, p44erk1, p44mapk, PRKM3" ENSG00000102882 "Mitogen-activated protein kinase 3" P27361 16 30114105-30123506 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle, Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 255.2;Enterocytes: 275.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 25.1;neutrophil: 11.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 25.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002683, HPA003995, HPA005700, HPA030069" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB002683: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035" "unprognostic (5.03e-2)" "unprognostic (4.62e-2)" "unprognostic (3.46e-2)" "unprognostic (1.60e-1)" "unprognostic (4.70e-3)" "unprognostic (2.75e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (2.09e-2)" "unprognostic (3.59e-2)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (3.51e-2)" "unprognostic (8.78e-2)" "unprognostic (1.45e-1)" "unprognostic (3.01e-2)" "unprognostic (2.38e-1)" "unprognostic (1.19e-2)" 24.9 18.5 63.3 15.3 43.2 15.6 21.1 24.8 52.0 21.3 45.1 30.4 6.3 39.7 24.2 11.4 44.1 28.7 25.6 21.2 37.1 34.0 13.4 8.8 23.3 13.1 33.8 27.4 32.7 13.0 26.1 15.2 27.6 27.6 20.1 36.7 26.2 17.1 18.3 13.9 18.7 49.2 24.0 27.8 15.9 33.7 11.6 19.5 8.4 20.5 18.7 26.0 18.2 22.2 1.4 1.5 25.1 2.7 0.8 3.1 1.4 14.0 7.7 16.4 9.2 41.2 54.6 9.2 10.5 26.0 16.6 19.9 9.1 28.2 14.1 10.4 29.3 19.2 5.2 13.7 12.3 16.3 26.7 15.9 4.3 8.5 15.3 41.4 3.2 12.1 33.7 7.2 19.0 8.6 25.3 42.2 15.5 5.9 18.2 22.0 36.8 14.5 5.0 4.3 28.6 6.7 17.2 9.7 31.7 15.2 8.9 14.5 10.3 6.0 21.1 6.1 13.8 13.8 7.7 29.9 11.0 9.5 12.5 3.6 20.7 9.4 7.2 22.0 6.8 7.7 2.4 2.7 25.1 0.9 1.9 1.4 1.3 2.1 1.6 1.4 1.4 1.5 1.6 11.3 0.8 1.0 1.5 3.1 1.4 63.3 43.2 24.8 52.0 37.1 34.0 33.8 27.4 27.6 19.5 20.8 20.3 9.0 19.0 8.8 28.0 12.7 15.3 20.1 7.9 8.7 21.6 66.6 19.9 31.0 255.2 49.5 275.3 0.0 54.5 107.4 25.7 11.8 2.3 6.4 38.5 7.9 52.6 52.8 25.3 107.0 30.0 18.9 21.9 27.9 135.6 38.1 77.0 98.1 25.8 18.2 32.7 19.4 18.6 10.5 17.5 11.5 28.3 13.1 63.5 18.0 MAPKAPK3 "3pK, MAPKAP3" ENSG00000114738 "Mitogen-activated protein kinase-activated protein kinase 3" Q16644 3 50611520-50649297 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 86.7;skeletal muscle: 70.1" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 193.9;Hofbauer cells: 91.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 30.2;eosinophil: 23.0;intermediate monocyte: 50.0;myeloid DC: 27.1;neutrophil: 20.5;non-classical monocyte: 61.4;plasmacytoid DC: 16.9" "Group enriched" "Detected in all" 5 "dendritic cells: 27.1;granulocytes: 23.0;monocytes: 61.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058275 Supported Nucleoplasm NA NA Nucleoplasm "HPA058275: AB_2683663" "unprognostic (6.46e-3)" "unprognostic (1.84e-1)" "prognostic favorable (8.08e-5)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (9.96e-2)" "unprognostic (8.77e-3)" "unprognostic (7.68e-3)" "unprognostic (1.11e-1)" "unprognostic (5.87e-2)" "unprognostic (2.19e-3)" "unprognostic (1.01e-1)" "prognostic favorable (1.90e-8)" "unprognostic (2.15e-2)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.69e-1)" 8.9 16.1 5.6 9.3 7.2 30.4 6.3 1.9 6.2 5.5 9.5 7.1 7.5 9.9 5.5 8.6 16.8 5.1 8.5 86.7 4.8 3.7 17.9 11.9 11.0 15.1 7.2 4.1 8.7 24.2 11.2 9.0 9.0 6.0 7.6 6.7 10.9 12.4 9.2 70.1 17.6 12.0 5.2 5.9 12.5 9.0 4.0 5.2 25.9 22.6 40.9 14.3 6.1 7.5 3.0 27.1 23.0 61.4 7.3 6.4 19.5 23.4 7.3 3.0 8.6 4.6 11.7 6.9 5.7 8.2 8.8 7.5 11.3 21.9 9.4 5.8 19.1 21.9 8.4 20.9 22.5 7.9 20.8 5.0 49.5 10.3 10.2 9.3 35.6 26.4 9.3 14.0 20.5 28.0 8.8 7.8 16.8 13.9 6.2 18.5 9.5 15.1 35.9 11.4 8.2 30.0 6.7 7.3 14.2 41.0 13.5 5.7 4.0 5.1 14.5 6.5 5.3 9.1 22.1 5.6 7.0 16.0 36.0 14.1 4.2 7.7 7.8 37.0 56.1 2.8 6.4 30.2 23.0 5.5 50.0 5.4 3.0 6.2 6.4 27.1 1.8 4.9 5.5 20.5 7.3 61.4 16.9 5.2 19.5 5.6 7.2 1.9 6.2 4.8 3.7 7.2 4.1 6.0 5.2 8.9 9.4 7.5 19.5 10.1 0.9 193.9 10.2 6.7 6.8 10.4 0.0 5.0 54.7 35.3 28.4 6.7 23.1 0.0 26.4 5.7 11.0 21.5 35.7 10.9 91.5 0.0 5.8 4.9 48.9 60.2 6.6 40.9 6.8 46.9 13.9 10.8 54.8 8.6 3.2 28.5 2.3 25.8 11.7 3.4 4.3 17.7 4.2 18.7 27.9 30.1 MAPRE2 "EB1, EB2, RP1" ENSG00000166974 "Microtubule associated protein RP/EB family member 2" Q15555 18 34976928-35143470 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.4" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 93.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016738, HPA016739" Enhanced Uncertain Nucleoplasm NA NA 24000000 Nucleoplasm "HPA016738: AB_1853571, HPA016739: AB_1853570" "unprognostic (2.01e-1)" "unprognostic (3.48e-1)" "unprognostic (2.55e-2)" "unprognostic (5.30e-3)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-2)" "unprognostic (8.53e-2)" "unprognostic (1.09e-2)" "unprognostic (2.29e-1)" "unprognostic (2.93e-2)" "unprognostic (5.40e-2)" "unprognostic (2.22e-3)" "unprognostic (5.83e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (3.99e-3)" 12.3 33.8 38.9 15.3 35.5 10.4 9.6 34.6 61.8 11.6 13.4 30.4 3.1 8.3 8.1 11.3 10.1 6.5 22.7 47.9 43.7 29.8 10.6 18.5 15.1 18.4 39.0 43.3 14.8 7.3 7.6 8.6 15.7 32.1 9.4 14.0 8.7 10.5 10.2 24.6 12.8 10.7 14.4 71.4 14.6 16.7 3.8 22.1 31.9 12.3 8.6 17.5 15.7 8.4 27.4 23.1 25.1 22.8 34.0 32.8 32.8 0.2 8.8 9.9 5.2 6.0 5.6 0.7 6.3 15.0 7.5 13.0 0.6 3.3 28.9 7.4 13.8 8.1 11.9 7.7 5.1 13.9 16.9 7.2 29.4 9.6 16.9 4.4 16.1 24.7 6.7 1.4 10.5 3.6 7.1 42.1 20.8 9.1 13.0 9.8 0.5 34.1 5.4 7.7 9.6 1.7 13.7 12.1 6.6 3.9 0.1 12.4 8.2 4.7 0.2 5.2 9.7 1.0 9.5 7.0 8.3 4.7 4.9 4.2 6.8 16.2 17.0 14.4 21.7 12.9 25.1 14.7 22.2 32.8 18.2 25.4 27.4 23.2 29.8 16.0 25.9 26.8 32.6 10.6 34.0 22.8 23.1 23.5 32.8 38.9 35.5 34.6 41.2 43.7 29.8 39.0 43.3 32.1 22.1 20.8 19.4 20.7 4.8 21.1 74.9 93.6 17.8 9.4 6.8 5.2 23.6 0.4 5.0 7.3 8.0 22.0 9.6 0.0 11.4 8.9 21.6 2.9 26.5 22.2 22.9 49.3 28.2 36.2 41.5 5.5 17.8 20.3 28.7 4.6 27.1 43.5 8.6 19.2 19.8 4.6 10.1 77.6 52.6 1.5 11.3 24.1 0.7 35.5 9.9 3.0 MASTL "FLJ14813, Gwl, THC2" ENSG00000120539 "Microtubule associated serine/threonine kinase like" Q96GX5 10 27154824-27186924 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027175, HPA054273" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA027175: AB_1853591, HPA054273: AB_2682433" "unprognostic (4.10e-2)" "unprognostic (6.89e-2)" "unprognostic (1.22e-2)" "unprognostic (3.14e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (2.19e-2)" "unprognostic (4.00e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (4.81e-5)" "unprognostic (3.78e-2)" "prognostic unfavorable (1.71e-6)" "unprognostic (1.55e-3)" "unprognostic (2.27e-1)" "unprognostic (2.66e-1)" "unprognostic (1.79e-1)" 9.1 7.0 3.6 8.9 6.1 21.1 8.3 4.0 7.5 7.4 7.6 3.8 5.7 5.7 6.0 6.7 12.3 5.4 5.3 5.6 6.8 4.5 6.5 7.1 10.2 14.8 5.4 5.7 7.0 12.7 6.7 6.3 14.2 6.7 5.5 7.1 5.6 8.0 4.7 4.0 10.1 10.0 6.1 5.6 8.7 6.2 11.3 2.3 21.1 6.5 4.3 12.3 8.7 7.5 3.9 2.6 5.6 4.9 2.3 4.0 1.8 11.9 9.6 18.4 6.8 2.8 4.2 10.9 17.9 7.5 29.7 36.6 11.6 12.0 9.6 6.8 7.5 14.4 11.6 11.7 7.1 21.1 8.1 11.3 11.3 6.7 6.7 1.6 4.3 8.5 2.5 3.2 17.9 3.5 3.9 6.4 7.8 8.6 21.6 18.0 7.9 14.0 4.7 13.7 6.7 3.9 9.0 30.7 7.9 7.3 4.5 8.2 11.8 11.3 7.6 7.9 12.7 7.6 9.1 5.5 7.4 15.6 18.9 15.7 2.6 4.2 14.1 8.1 13.1 6.1 0.1 4.4 3.8 2.0 4.3 3.0 2.6 2.5 1.8 2.5 3.9 2.5 2.3 5.6 2.3 4.9 2.6 4.0 1.8 3.6 6.1 4.0 7.5 6.8 4.5 5.4 5.7 6.7 2.3 6.0 8.5 7.2 4.0 9.7 1.9 1.6 0.0 4.0 9.1 1.8 0.0 3.3 0.0 3.2 1.7 3.6 3.0 0.0 2.2 20.7 5.8 3.3 12.7 1.7 5.1 3.2 4.1 2.5 12.0 1.5 2.8 5.6 0.0 1.8 3.4 1.5 3.6 1.9 2.5 1.4 0.9 0.0 5.9 11.2 16.4 8.7 5.1 8.7 3.5 5.9 MATR3 "KIAA0723, MGC9105, MPD2, VCPDM" ENSG00000015479 "Matrin 3" P43243 5 139293648-139331677 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" RNA-binding "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 12 "Cytotrophoblasts: 1.0;Hofbauer cells: 1.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB033552, HPA036564, HPA036565" Supported Approved Nucleoplasm "Intracellular and membrane" NA NA 140000 Nucleoplasm "CAB033552: AB_2281755, HPA036564: AB_10669907, HPA036565: AB_10673623" "unprognostic (9.33e-2)" "unprognostic (6.57e-2)" "unprognostic (8.37e-2)" "unprognostic (7.53e-2)" "unprognostic (7.20e-2)" "unprognostic (4.32e-3)" "unprognostic (1.03e-1)" "unprognostic (3.56e-2)" "unprognostic (2.96e-2)" "unprognostic (1.93e-1)" "unprognostic (1.23e-1)" "unprognostic (9.36e-2)" "unprognostic (1.08e-3)" "unprognostic (1.73e-1)" "unprognostic (1.93e-1)" "unprognostic (3.86e-2)" "unprognostic (7.90e-2)" 32.9 39.7 62.4 25.8 77.3 82.2 49.0 103.4 81.6 46.9 32.2 35.3 27.1 22.4 50.6 38.6 31.4 40.5 34.6 36.1 61.5 62.0 46.3 33.3 34.0 42.0 50.1 58.5 62.6 30.2 61.7 61.0 36.1 59.0 40.7 32.6 28.8 28.4 43.3 44.3 23.7 27.5 43.5 51.3 35.0 25.5 32.7 36.8 64.8 58.0 23.9 48.5 36.7 30.4 36.6 28.3 45.5 30.4 45.4 44.8 42.9 36.9 34.7 104.5 47.9 36.7 40.7 52.9 31.6 55.5 56.2 65.6 49.4 38.6 62.4 44.2 44.1 53.2 24.6 69.0 49.1 75.8 49.3 33.8 42.3 41.1 51.6 35.0 45.9 32.5 41.9 37.8 45.6 42.4 46.3 54.3 39.9 38.0 31.4 57.6 33.6 87.3 51.4 56.4 37.0 33.1 54.0 78.2 38.9 52.1 57.7 52.3 65.8 45.5 33.1 46.4 83.5 36.2 45.4 35.0 51.5 33.7 33.7 44.2 32.0 52.0 76.0 35.9 40.3 49.5 45.5 20.9 33.9 36.3 25.1 44.8 36.6 38.2 40.9 28.3 30.7 42.3 38.8 10.4 45.4 30.4 15.7 40.8 42.9 62.4 77.3 103.4 81.6 61.5 62.0 50.1 58.5 59.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 MATR3 ENSG00000280987 "Matrin 3" 5 139273752-139331671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 101.8;Ciliated cells: 112.4;Club cells: 72.8;granulocytes: 100.2;Intestinal endocrine cells: 79.9;Melanocytes: 97.8;Suprabasal keratinocytes: 97.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA036564, HPA036565" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA036564: AB_10669907, HPA036565: AB_10673623" "unprognostic (3.08e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-2)" "unprognostic (2.37e-2)" "unprognostic (3.64e-1)" "unprognostic (1.10e-1)" "unprognostic (8.69e-9)" "unprognostic (1.10e-1)" "unprognostic (9.33e-3)" "unprognostic (3.09e-1)" "unprognostic (2.08e-1)" "unprognostic (5.51e-2)" "unprognostic (9.91e-10)" "unprognostic (2.91e-2)" "unprognostic (9.21e-3)" "unprognostic (2.24e-1)" "unprognostic (9.89e-2)" 1.9 3.5 4.4 5.4 11.1 4.3 5.5 3.0 14.5 2.0 4.4 3.9 1.2 3.6 3.6 5.3 3.0 4.4 1.6 9.6 4.6 1.9 2.0 1.1 7.6 3.8 6.8 4.0 4.2 1.8 1.1 2.1 10.1 3.7 6.3 0.7 6.1 1.8 12.8 3.1 2.4 3.2 3.3 4.0 3.9 4.7 4.5 2.2 1.5 5.2 6.7 2.8 5.3 5.8 4.9 0.5 1.8 1.6 4.3 2.2 14.5 10.7 6.9 32.8 17.5 19.8 12.3 9.6 7.6 13.4 16.4 16.5 13.4 56.3 14.1 13.8 9.4 17.5 51.4 27.3 25.6 11.3 23.7 33.7 14.4 12.8 14.2 33.6 14.2 21.4 19.3 17.3 21.6 9.7 13.4 21.2 28.7 9.7 15.3 6.3 21.8 9.4 27.0 7.6 7.5 43.2 21.7 23.4 6.9 8.9 21.8 12.3 12.3 13.1 24.7 16.8 10.9 17.3 10.3 11.3 17.2 9.3 13.6 5.0 5.3 31.0 9.5 29.0 13.8 0.1 1.4 0.2 0.9 1.8 2.1 5.8 2.9 3.4 4.9 3.6 4.3 3.3 0.5 1.6 0.8 0.2 1.5 2.2 41.7 33.3 0.0 0.6 101.8 1.8 0.0 0.0 112.4 72.8 0.0 2.0 0.3 0.0 0.0 0.2 0.7 2.3 0.0 0.0 0.2 0.8 0.7 100.2 0.0 0.7 1.6 79.9 0.0 0.0 0.4 0.6 23.2 97.8 0.0 2.0 0.5 0.1 0.8 0.7 0.0 0.9 0.0 0.3 1.4 0.4 97.2 0.2 0.0 1.5 0.9 MAZ "Pur-1, ZF87, Zif87, ZNF801" ENSG00000103495 "MYC associated zinc finger protein" P56270 16 29806106-29811164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 128.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048315, HPA059495, HPA065930" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA048315: AB_2680353, HPA059495: AB_2684039, HPA065930: AB_2685579" "unprognostic (1.05e-1)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" "unprognostic (3.83e-1)" "unprognostic (3.25e-3)" "unprognostic (6.16e-2)" "unprognostic (1.27e-1)" "unprognostic (5.12e-2)" "unprognostic (2.00e-1)" "unprognostic (6.39e-3)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.20e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.22e-4)" "unprognostic (7.08e-2)" 23.9 32.2 49.3 34.0 37.9 86.3 62.2 57.3 49.0 31.7 51.5 25.5 30.8 34.8 33.1 26.5 31.1 34.9 31.4 21.3 43.3 30.1 22.8 33.0 31.3 52.5 30.5 32.4 38.4 39.8 44.5 30.2 24.2 22.1 48.1 38.8 29.0 32.3 31.2 41.0 35.8 34.6 29.1 22.9 34.5 28.7 28.4 25.4 141.5 30.2 26.7 40.8 30.6 39.4 5.7 8.4 9.5 9.9 16.4 28.6 8.7 28.1 37.6 38.9 42.3 21.1 20.1 35.1 20.6 16.9 32.2 23.4 48.0 40.7 50.6 26.9 40.2 15.9 25.7 63.8 26.9 11.5 41.2 102.1 33.5 81.7 65.4 29.7 82.8 41.8 21.4 38.1 27.0 30.6 30.1 32.1 71.6 49.0 44.6 15.2 116.4 79.3 70.6 39.4 30.9 29.4 78.5 36.7 58.9 26.2 30.7 59.8 46.6 19.7 42.8 25.8 26.1 36.8 80.0 22.0 35.5 28.6 13.5 32.0 32.6 41.0 55.9 17.4 54.8 29.3 6.8 6.3 9.5 26.1 9.9 28.6 5.7 17.5 24.8 8.0 4.2 14.6 21.4 5.0 16.4 6.2 8.4 18.4 8.7 49.3 37.9 57.3 49.0 43.3 30.1 30.5 32.4 22.1 25.4 6.0 4.8 31.8 14.3 29.2 60.4 0.3 33.1 9.4 6.8 10.4 11.8 21.0 24.9 29.7 2.1 30.0 41.1 0.0 35.5 46.9 42.8 30.2 33.4 34.2 49.7 44.5 128.1 28.8 32.4 3.4 25.9 25.0 43.9 13.6 101.5 21.1 32.8 59.6 34.6 17.0 30.3 32.3 47.4 17.7 20.5 31.0 14.0 40.1 104.1 11.3 MBD3 ENSG00000071655 "Methyl-CpG binding domain protein 3" O95983 19 1573596-1592801 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 101.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013265 Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB013265: " "unprognostic (1.41e-1)" "unprognostic (2.12e-2)" "unprognostic (3.44e-2)" "prognostic favorable (5.08e-4)" "unprognostic (1.85e-1)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.99e-4)" "unprognostic (2.50e-1)" "unprognostic (3.12e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.76e-5)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (4.42e-2)" "unprognostic (5.89e-2)" "unprognostic (3.17e-1)" "unprognostic (4.24e-2)" 19.4 14.8 27.3 18.2 21.0 19.9 19.7 18.9 25.1 11.8 14.9 12.7 18.8 17.1 14.4 12.0 14.8 13.4 18.3 21.5 26.5 16.5 17.2 19.1 13.1 18.2 18.2 16.9 17.2 25.4 17.7 18.1 27.3 13.1 19.5 7.5 12.5 28.0 17.1 41.4 28.5 14.5 11.4 14.9 18.3 14.1 21.1 11.0 23.9 17.2 14.3 15.4 12.3 26.8 3.1 7.0 2.3 3.7 1.2 3.7 2.0 27.5 31.3 13.1 22.5 10.8 9.4 19.5 17.0 10.3 18.2 17.0 29.2 12.6 27.8 13.4 12.4 6.3 22.9 14.6 16.4 4.9 37.2 30.2 16.3 33.8 21.6 15.6 20.8 23.2 13.4 14.0 17.6 8.0 9.1 16.6 20.4 30.0 23.8 8.9 31.3 25.0 28.9 21.9 8.4 20.7 29.8 16.3 20.8 9.2 26.8 36.8 29.9 17.0 14.9 12.7 4.7 16.7 25.7 16.5 25.6 18.7 37.9 40.1 23.2 19.3 25.4 20.7 29.1 26.2 1.2 3.7 2.3 3.7 2.0 3.3 1.6 3.0 2.0 3.4 3.1 3.3 2.8 1.5 1.2 1.7 7.0 0.7 2.0 27.3 21.0 18.9 25.1 26.5 16.5 18.2 16.9 13.1 11.0 11.9 28.2 15.2 7.7 9.6 22.9 17.3 7.6 2.7 10.3 10.4 13.7 42.8 5.0 14.0 2.5 16.5 27.6 46.7 22.3 36.6 14.2 12.7 3.5 37.6 23.2 17.5 14.3 28.8 26.1 4.7 20.8 11.9 5.0 10.0 22.7 30.6 17.9 14.7 24.1 15.8 10.7 38.8 11.6 5.7 11.0 11.2 101.6 7.5 25.3 7.4 MBD6 KIAA1887 ENSG00000166987 "Methyl-CpG binding domain protein 6" Q96DN6 12 57520710-57530148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "neutrophil: 14.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 14.7" "Cell line enhanced" "Detected in all" "RH-30: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038948, HPA038949" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038948: AB_2676285, HPA038949: AB_10671868" "unprognostic (2.56e-1)" "unprognostic (4.15e-2)" "unprognostic (1.64e-2)" "unprognostic (3.12e-2)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (2.84e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.19e-1)" "unprognostic (1.83e-2)" "unprognostic (6.65e-2)" "unprognostic (1.28e-3)" "unprognostic (1.13e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-1)" "unprognostic (1.01e-2)" 16.0 21.1 15.2 22.1 18.4 35.0 18.7 20.2 15.2 22.3 22.1 19.6 35.2 27.9 24.9 22.6 18.0 21.7 25.2 13.1 15.2 7.6 21.0 21.6 17.6 16.3 18.0 11.1 24.3 22.4 24.2 60.6 35.1 14.0 19.9 14.3 34.8 23.7 37.0 22.5 25.1 22.8 14.6 16.1 34.4 28.6 31.1 18.7 16.1 48.2 14.0 21.9 19.0 20.3 1.4 0.5 14.7 1.1 0.7 1.3 0.6 8.7 12.5 9.7 10.3 6.7 4.8 13.6 10.1 6.1 6.5 4.9 12.9 13.9 8.8 7.8 5.4 6.5 12.3 8.8 7.6 4.6 17.4 8.9 15.5 12.1 8.7 8.2 9.2 40.2 8.4 13.4 7.0 10.0 10.2 8.7 7.5 9.8 23.4 5.2 9.0 9.5 9.2 9.3 6.4 9.2 9.5 46.8 6.7 5.6 17.3 13.4 8.1 8.1 16.2 9.9 6.1 18.2 14.9 8.6 7.2 11.9 7.3 6.8 24.4 8.2 6.1 9.4 5.8 12.1 0.0 1.1 0.4 1.3 0.9 0.6 1.4 0.2 0.4 0.5 1.0 0.6 0.6 14.7 0.7 0.4 0.4 0.2 0.6 15.2 18.4 20.2 15.2 15.2 7.6 18.0 11.1 14.0 18.7 6.0 16.2 6.7 12.6 9.7 56.0 5.2 33.1 12.0 10.3 8.7 25.5 9.5 5.0 7.2 6.7 12.7 14.9 0.0 10.4 6.7 8.2 11.5 18.5 24.3 12.2 23.8 15.0 15.4 20.2 7.8 13.6 15.0 11.8 1.0 19.5 28.3 8.8 17.5 12.0 3.7 67.0 19.4 7.6 39.1 29.6 10.8 18.9 13.1 15.7 14.9 MBNL2 "MBLL, MBLL39" ENSG00000139793 "Muscleblind like splicing regulator 2" Q5VZF2 13 97221434-97394120 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062685 Supported Nucleoplasm NA NA Nucleoplasm "HPA062685: AB_2684834" "unprognostic (8.02e-2)" "unprognostic (7.78e-2)" "unprognostic (6.37e-2)" "unprognostic (5.46e-2)" "unprognostic (1.37e-1)" "unprognostic (1.58e-1)" "unprognostic (3.54e-1)" "unprognostic (1.44e-3)" "unprognostic (1.08e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (1.00e-1)" "unprognostic (5.26e-3)" "unprognostic (1.01e-2)" "unprognostic (1.48e-1)" "unprognostic (2.73e-1)" "unprognostic (9.17e-2)" 38.4 43.3 26.5 12.9 38.6 5.0 23.2 31.2 41.0 27.8 21.6 45.9 9.5 13.8 23.9 11.2 25.6 14.8 29.7 23.4 31.0 22.6 24.6 59.6 19.3 12.3 46.5 22.4 40.8 28.9 16.9 35.9 33.5 49.8 21.8 16.4 16.6 24.6 27.0 28.9 13.3 12.2 27.4 52.3 12.4 19.0 9.7 46.9 11.1 24.2 17.2 15.3 25.6 28.0 9.2 6.5 13.3 8.4 5.5 12.9 7.1 11.0 3.9 4.3 4.5 23.9 12.7 0.3 25.4 12.8 11.8 12.0 4.5 16.5 3.7 10.6 35.0 13.2 15.7 2.0 11.2 15.4 9.9 1.9 4.6 8.9 11.2 35.2 0.5 4.1 13.0 19.2 9.6 18.6 13.5 22.3 5.1 5.6 2.0 5.9 2.8 2.6 1.6 0.1 1.3 6.7 1.2 9.3 3.1 15.7 12.5 5.5 9.4 14.5 15.0 25.1 10.6 6.1 0.6 7.0 1.7 5.5 3.3 5.3 5.4 1.3 1.0 11.3 1.3 31.1 13.3 6.2 8.9 10.1 8.4 12.9 9.2 9.2 9.0 6.5 7.6 8.1 10.8 1.0 5.5 5.8 5.5 9.6 7.1 26.5 38.6 31.2 41.0 31.0 22.6 46.5 22.4 49.8 46.9 77.4 33.1 17.2 23.5 62.4 22.9 62.9 28.1 78.9 59.1 27.9 45.2 19.3 16.6 21.2 2.1 46.8 13.1 0.0 36.5 66.4 35.8 27.2 17.3 61.0 12.9 44.5 46.7 42.4 25.3 6.4 65.3 18.4 54.0 7.2 27.1 73.1 48.9 10.5 42.1 24.9 104.0 45.3 43.8 0.5 0.7 42.4 20.9 22.7 16.6 26.3 MCM2 "BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030" ENSG00000073111 "Minichromosome maintenance complex component 2" P49736 3 127598223-127622436 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 69.9" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 45.7;Extravillous trophoblasts: 22.4;Spermatogonia: 27.1;Syncytiotrophoblasts: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000303, HPA031450, HPA031495, HPA031496" Enhanced Enhanced Nucleoplasm Yes Yes 8600 Nucleoplasm "CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905" "unprognostic (2.43e-1)" "prognostic favorable (4.66e-4)" "unprognostic (4.44e-2)" "unprognostic (3.12e-3)" "unprognostic (1.68e-1)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.51e-7)" "unprognostic (8.43e-3)" "unprognostic (1.92e-2)" "unprognostic (1.79e-1)" "unprognostic (1.41e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-2)" "unprognostic (8.16e-3)" "unprognostic (1.56e-1)" "unprognostic (3.29e-2)" "unprognostic (2.82e-1)" 2.9 3.7 2.1 24.3 4.0 32.5 3.5 6.7 3.2 4.7 7.1 3.3 2.2 4.7 4.7 5.9 11.2 4.8 5.4 3.6 2.0 2.3 3.9 3.4 3.4 14.6 2.2 3.5 5.1 3.0 2.4 2.4 26.4 3.0 3.2 6.0 2.5 4.7 1.9 7.0 6.0 7.1 2.9 2.9 13.3 3.8 20.3 3.9 69.9 4.1 16.6 20.7 3.4 5.1 10.4 3.6 0.9 1.4 5.8 10.6 3.4 25.1 21.4 23.5 20.5 1.4 3.0 23.0 13.2 8.5 26.6 29.0 35.5 16.7 27.1 12.9 6.5 22.8 20.3 41.9 15.2 16.6 22.4 26.2 44.9 28.7 25.8 0.9 41.9 19.6 1.6 1.7 18.0 2.7 3.2 8.3 29.6 22.3 24.9 9.8 33.3 38.8 30.7 34.4 21.6 18.9 43.6 33.7 38.8 5.5 19.5 29.3 22.2 33.9 10.1 3.5 9.9 21.7 32.9 4.2 20.7 17.7 25.5 17.8 25.8 29.2 67.4 14.3 31.7 7.9 0.0 0.6 0.2 4.7 1.4 5.9 10.4 4.1 5.5 2.8 9.2 3.9 5.0 0.9 5.8 0.3 3.6 10.6 3.4 2.1 4.0 6.7 3.2 2.0 2.3 2.2 3.5 3.0 3.9 3.0 1.3 6.7 1.7 4.0 2.2 7.6 0.0 10.7 5.7 0.0 0.0 45.7 0.0 4.1 0.7 1.7 1.0 0.0 1.6 22.4 3.3 0.7 1.1 1.7 15.2 0.0 3.5 1.3 1.6 0.7 1.7 1.6 1.7 15.4 5.1 1.5 1.7 0.0 1.4 0.5 1.7 0.0 2.8 6.2 27.1 2.6 28.0 3.2 12.0 0.6 MCM3 ENSG00000112118 "Minichromosome maintenance complex component 3" P25205 6 52264009-52284881 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 82.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002162, HPA004789, HPA004790" Supported Supported Nucleoplasm NA Yes 29000 Nucleoplasm "CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335" "unprognostic (9.14e-2)" "prognostic favorable (1.89e-4)" "unprognostic (2.37e-1)" "unprognostic (1.53e-2)" "unprognostic (2.14e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.40e-5)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.15e-1)" "unprognostic (8.35e-2)" "unprognostic (1.16e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.13e-5)" "unprognostic (1.34e-2)" 17.3 10.9 8.5 29.7 10.5 22.3 15.3 10.7 9.7 15.9 17.2 9.5 20.2 9.0 21.2 13.0 21.7 15.5 15.8 15.4 7.4 6.6 16.1 12.6 13.7 30.1 8.9 5.8 20.0 13.8 16.0 7.4 24.7 10.0 15.9 19.2 12.7 12.6 23.4 12.1 15.0 17.8 17.7 9.5 23.2 15.3 16.1 10.5 82.5 12.9 20.1 35.7 19.1 15.3 21.1 12.9 11.4 13.3 22.2 29.4 18.6 30.2 20.1 35.1 33.0 7.6 6.8 23.0 22.5 17.3 38.4 39.4 41.1 16.5 33.0 22.6 13.1 25.1 24.1 46.2 27.5 38.8 37.1 43.7 62.4 40.4 57.9 2.0 61.2 25.6 4.1 6.4 28.2 7.9 9.4 19.5 40.0 50.7 76.2 19.7 19.9 61.6 47.3 29.1 60.3 14.2 54.7 53.7 44.1 17.0 32.2 35.6 27.3 23.6 13.6 20.4 51.4 26.8 43.4 10.0 26.2 28.2 27.1 33.5 22.6 25.8 58.8 22.5 53.1 30.7 11.1 8.0 11.4 22.9 13.3 19.7 21.1 23.3 23.0 12.9 19.2 22.6 24.0 1.1 22.2 7.4 8.3 29.4 18.6 8.5 10.5 10.7 9.7 7.4 6.6 8.9 5.8 10.0 10.5 20.8 10.5 30.5 14.0 17.1 13.8 13.9 12.7 22.7 20.5 21.0 3.9 85.3 11.6 21.3 0.6 24.8 4.9 23.3 17.7 53.2 16.0 7.5 36.9 9.3 30.8 0.0 7.0 14.7 8.9 2.3 25.0 13.8 6.8 10.8 16.7 19.0 13.0 10.5 19.8 6.5 11.2 6.5 24.7 21.7 59.4 8.8 22.9 27.7 31.0 11.2 MCM4 "CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21" ENSG00000104738 "Minichromosome maintenance complex component 4" P33991 8 47960185-47978160 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.6" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 117.9;Late spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004497, HPA004873, HPA031052" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712" "unprognostic (4.55e-2)" "unprognostic (3.16e-3)" "prognostic favorable (2.19e-4)" "prognostic unfavorable (2.84e-5)" "unprognostic (7.71e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.12e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.65e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (5.16e-2)" "prognostic unfavorable (2.61e-4)" "unprognostic (3.53e-2)" "unprognostic (2.90e-1)" "unprognostic (1.70e-2)" "unprognostic (1.40e-1)" 4.9 8.7 6.7 18.4 12.6 33.1 9.3 13.9 14.8 6.7 11.9 6.9 3.6 8.3 4.7 7.8 21.6 5.9 6.8 8.3 6.6 7.1 8.0 6.6 4.4 20.3 5.9 7.7 5.3 5.5 4.3 4.1 29.2 7.7 4.2 13.2 5.3 9.0 3.1 8.7 16.2 10.3 5.9 6.4 10.1 6.3 39.0 4.1 56.6 4.0 21.8 23.7 8.0 9.5 5.1 4.9 3.4 4.3 4.9 12.9 4.5 34.5 21.5 39.9 14.6 3.9 6.9 17.6 26.4 17.3 33.3 37.7 22.8 31.5 37.5 14.8 13.1 25.0 25.5 50.3 21.4 37.6 11.8 33.2 64.3 25.8 25.3 1.1 34.3 14.1 4.1 4.3 26.5 9.5 5.1 11.7 25.3 35.4 31.2 22.9 21.4 75.8 25.0 43.3 41.1 9.3 48.2 31.3 24.4 12.0 31.0 38.4 18.4 53.4 22.3 7.9 23.8 26.6 18.1 7.8 25.4 24.7 28.5 24.2 10.3 24.6 76.5 20.4 31.9 22.7 3.4 2.1 1.5 5.5 3.7 2.7 5.1 5.0 6.8 4.9 2.1 4.6 3.4 0.1 4.9 4.3 1.7 12.9 4.5 6.7 12.6 13.9 14.8 6.6 7.1 5.9 7.7 7.7 4.1 0.0 4.6 3.0 9.5 19.3 11.6 22.4 0.0 17.4 10.3 5.2 9.8 26.7 3.3 6.0 117.9 5.2 5.0 46.7 5.2 33.9 7.4 4.3 1.1 3.4 10.4 15.9 6.4 1.3 3.5 57.7 4.9 9.9 3.3 2.8 9.6 6.5 4.1 3.5 2.8 2.2 15.3 0.0 8.0 45.2 31.3 16.7 24.9 3.8 20.2 8.2 MCM5 CDC46 ENSG00000100297 "Minichromosome maintenance complex component 5" P33992 22 35400063-35425430 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.0;lymphoid tissue: 60.6" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 115.2;monocytes: 225.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000101, HPA000845, HPA052880" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979" "unprognostic (6.71e-2)" "prognostic favorable (2.81e-6)" "unprognostic (5.29e-3)" "unprognostic (7.94e-2)" "unprognostic (1.83e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.78e-4)" "prognostic unfavorable (3.95e-4)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" "unprognostic (1.37e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (3.26e-2)" "unprognostic (1.01e-1)" "unprognostic (1.77e-3)" "unprognostic (1.53e-1)" 12.1 4.9 6.1 27.5 9.0 57.0 9.1 6.7 5.7 10.4 11.5 12.3 5.0 9.5 10.8 10.8 15.8 8.7 9.4 5.2 4.4 3.4 6.8 8.0 9.3 31.1 8.8 3.7 17.9 10.8 6.2 3.6 19.3 5.8 7.2 8.3 6.5 8.9 5.1 8.8 10.3 16.7 6.0 7.8 31.2 8.4 16.4 8.8 60.6 9.0 17.7 33.0 8.7 9.6 46.8 30.9 19.0 26.0 21.3 32.9 24.0 39.3 28.6 22.6 23.0 2.2 4.5 19.9 26.3 14.0 39.4 37.5 19.0 19.7 26.1 15.3 13.4 16.3 19.7 22.6 20.9 12.6 21.0 41.5 37.2 28.7 38.0 0.8 76.8 33.7 2.4 1.9 23.5 6.4 3.6 17.4 23.9 23.0 39.0 14.9 32.5 62.5 25.6 30.1 26.9 17.0 70.8 32.1 32.8 7.7 22.9 17.5 18.6 36.2 14.5 8.1 12.4 15.2 29.4 10.3 39.8 30.2 24.7 27.1 21.7 26.8 49.1 25.8 29.1 30.3 19.0 20.7 14.5 18.4 24.1 13.1 46.8 16.1 19.4 27.1 37.0 13.1 14.8 9.9 21.3 26.0 30.9 32.9 24.0 6.1 9.0 6.7 5.7 4.4 3.4 8.8 3.7 5.8 8.8 6.0 8.2 53.6 8.0 9.4 1.5 3.4 12.7 5.3 4.5 7.0 0.0 115.2 5.0 14.8 1.9 7.5 3.8 70.0 11.1 61.5 6.2 3.3 15.0 5.1 47.1 1.6 3.4 13.5 21.1 3.6 10.0 25.5 6.8 225.4 9.2 4.5 9.4 7.0 5.6 3.7 3.2 19.4 6.4 11.2 52.2 5.5 68.8 20.8 32.2 4.7 MCM6 Mis5 ENSG00000076003 "Minichromosome maintenance complex component 6" Q14566 2 135839626-135876426 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 66.3" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 46.7;Spermatogonia: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004818, CAB009577" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB009577: AB_2266309, HPA004818: AB_1079339" "unprognostic (6.73e-2)" "unprognostic (6.68e-3)" "unprognostic (1.22e-3)" "unprognostic (3.60e-3)" "unprognostic (8.98e-2)" "unprognostic (4.34e-2)" "prognostic unfavorable (5.70e-7)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (2.36e-2)" "unprognostic (1.36e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (8.29e-12)" "unprognostic (2.84e-1)" "unprognostic (9.02e-2)" "unprognostic (7.42e-2)" "unprognostic (1.68e-1)" 11.3 6.3 7.2 17.7 8.4 23.1 9.5 12.3 9.4 9.1 11.9 5.1 2.9 8.7 10.4 8.8 12.6 8.7 7.6 6.0 5.0 5.5 6.8 7.0 8.5 23.9 4.9 8.0 10.9 4.3 6.2 3.4 10.9 5.9 8.6 12.2 6.2 6.9 6.7 8.2 8.9 16.7 10.4 7.2 14.1 8.0 13.2 3.7 66.3 5.1 11.4 27.5 10.8 9.8 5.5 9.4 5.3 4.0 7.0 13.9 5.6 23.3 14.3 31.3 19.9 6.7 8.8 12.3 17.0 12.9 19.8 22.1 29.3 17.9 40.8 12.5 12.3 8.7 13.9 31.6 15.5 21.2 20.9 21.8 40.5 21.3 9.2 3.1 48.5 18.1 5.2 2.0 14.4 4.4 4.0 13.4 32.2 28.9 34.5 14.5 23.8 59.2 35.7 28.2 20.6 14.4 29.4 37.5 37.3 9.9 20.6 19.7 16.8 22.4 10.7 10.7 23.4 12.3 30.6 6.6 13.8 11.5 14.8 12.8 20.7 33.7 53.7 19.3 37.2 16.4 5.3 1.4 0.9 7.6 4.0 7.1 5.5 10.5 9.2 4.6 3.2 9.6 11.8 0.8 7.0 3.6 9.4 13.9 5.6 7.2 8.4 12.3 9.4 5.0 5.5 4.9 8.0 5.9 3.7 0.0 2.4 2.2 3.8 6.0 2.2 3.2 2.5 4.0 6.8 3.5 0.0 26.1 0.0 4.4 2.1 7.1 1.3 46.7 5.8 20.9 11.3 1.5 9.2 3.0 20.4 3.2 2.4 9.8 4.0 1.6 8.6 5.8 5.0 3.6 9.2 2.3 2.8 3.5 15.9 1.0 0.5 0.0 4.2 15.6 41.4 3.6 8.9 17.5 9.7 1.0 MCM7 "CDC47, MCM2, PPP1R104" ENSG00000166508 "Minichromosome maintenance complex component 7" P33993 7 100092728-100101940 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002163, HPA003898, CAB016312" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632" "unprognostic (1.87e-1)" "prognostic favorable (1.28e-4)" "unprognostic (1.36e-1)" "unprognostic (5.20e-2)" "unprognostic (1.94e-1)" "unprognostic (7.03e-2)" "prognostic unfavorable (2.18e-4)" "unprognostic (2.08e-2)" "unprognostic (5.79e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-1)" "unprognostic (9.34e-3)" "unprognostic (3.83e-2)" "unprognostic (5.41e-2)" "unprognostic (1.76e-1)" "unprognostic (1.32e-2)" "unprognostic (2.38e-1)" 8.6 5.2 17.5 13.6 21.7 37.3 11.2 20.0 20.6 8.2 14.2 19.2 15.0 10.4 16.0 6.3 10.7 8.6 9.9 5.1 18.1 12.4 5.5 8.5 7.4 22.4 23.7 9.5 12.6 13.1 7.5 10.3 10.7 15.5 10.0 15.7 7.2 9.2 9.2 11.5 10.1 10.3 11.7 23.5 10.7 7.8 14.9 22.3 7.5 9.4 4.1 28.2 10.3 10.0 7.3 5.7 1.9 5.7 7.6 9.0 6.0 24.9 28.8 31.8 24.0 3.1 4.1 16.3 15.2 18.4 42.5 45.3 22.0 26.4 42.3 14.5 10.8 27.1 19.8 46.7 22.1 35.9 21.6 39.9 26.9 16.2 15.2 1.7 45.7 17.5 2.8 4.2 31.1 18.7 5.4 16.1 24.4 51.5 34.7 21.5 53.3 77.6 18.7 27.9 23.2 20.9 41.8 46.7 51.6 8.2 15.1 20.8 31.7 24.0 22.3 7.5 18.6 10.2 19.2 6.8 16.0 29.1 31.4 30.1 14.5 24.8 76.1 11.1 36.7 28.6 1.8 2.5 1.9 8.1 4.1 6.2 5.3 5.7 7.9 5.5 7.3 5.9 5.7 1.6 7.6 5.7 5.7 9.0 6.0 17.5 21.7 20.0 20.6 18.1 12.4 23.7 9.5 15.5 22.3 8.9 17.0 23.7 20.7 41.4 8.7 7.9 15.3 24.1 9.1 3.5 13.7 90.8 8.3 17.6 40.0 14.5 15.8 70.0 22.4 78.1 17.3 11.3 24.2 10.4 34.4 6.4 16.7 8.0 10.8 22.7 19.5 16.5 18.6 17.2 34.7 10.1 16.0 20.1 14.5 9.1 11.9 12.9 22.7 83.2 67.3 30.9 60.2 28.7 60.9 12.3 MCM8 "C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC" ENSG00000125885 "Minichromosome maintenance 8 homologous recombination repair factor" Q9UJA3 20 5950652-5998977 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 43.2;Spermatogonia: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045141, HPA066433" Supported Nucleoplasm NA NA Nucleoplasm "HPA045141: AB_2679230, HPA066433: " "unprognostic (6.55e-2)" "unprognostic (2.46e-2)" "unprognostic (4.43e-1)" "unprognostic (2.22e-3)" "unprognostic (1.90e-1)" "unprognostic (5.78e-2)" "prognostic unfavorable (9.30e-8)" "unprognostic (5.21e-2)" "unprognostic (5.14e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (6.74e-2)" "unprognostic (1.11e-2)" "unprognostic (5.53e-2)" "unprognostic (2.76e-1)" "unprognostic (2.66e-2)" "unprognostic (3.47e-1)" 4.9 5.4 7.3 11.0 7.6 11.2 9.3 17.9 12.7 5.4 6.2 3.1 12.0 5.4 5.9 3.9 6.6 4.3 2.7 11.3 4.8 2.2 4.3 3.1 6.3 9.6 10.6 5.1 5.0 5.6 5.1 4.8 5.4 7.1 5.9 6.0 3.5 5.1 7.2 11.2 6.1 6.1 7.0 8.3 6.1 5.6 21.9 7.7 8.8 4.4 7.0 9.5 6.0 6.1 1.8 1.7 3.3 0.7 1.9 3.0 0.4 19.1 15.0 12.9 13.0 3.4 4.2 11.5 15.7 6.4 12.4 14.9 16.3 12.1 19.5 4.7 5.2 22.3 20.6 21.4 12.4 22.3 5.3 8.7 21.6 7.2 15.9 0.5 22.7 3.4 1.9 2.0 20.8 8.6 3.2 5.7 12.5 22.0 19.3 12.6 5.4 11.7 11.9 17.3 11.8 8.8 14.3 21.9 7.9 3.1 7.6 9.6 10.2 16.0 17.9 9.6 14.5 11.5 8.1 3.8 21.9 18.3 11.8 22.8 8.3 20.7 33.2 4.4 14.7 18.0 3.3 0.5 1.7 1.8 0.5 3.0 1.8 1.1 2.1 0.1 1.7 1.1 1.7 2.1 1.9 0.7 1.7 2.0 0.4 7.3 7.6 17.9 12.7 4.8 2.2 10.6 5.1 7.1 7.7 0.0 4.1 10.0 2.6 2.1 6.9 8.5 7.6 4.0 2.3 12.2 15.7 5.2 0.0 1.2 6.5 3.0 3.8 0.0 2.3 4.7 2.7 4.2 1.1 1.6 3.6 6.4 4.1 1.8 2.1 2.3 3.4 3.5 1.7 0.0 2.9 4.0 2.7 3.5 2.8 2.4 10.7 6.5 2.7 43.2 32.6 2.3 3.3 3.9 5.2 1.8 MCM9 "C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304" ENSG00000111877 "Minichromosome maintenance 9 homologous recombination repair factor" Q9NXL9 6 118813442-118935162 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031137 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031137: AB_10602027" "unprognostic (3.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.33e-3)" "unprognostic (2.90e-1)" "unprognostic (2.78e-2)" "unprognostic (2.82e-1)" "unprognostic (3.00e-2)" "unprognostic (2.29e-1)" "unprognostic (3.61e-2)" "unprognostic (7.76e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (8.30e-2)" "unprognostic (2.16e-1)" "unprognostic (3.95e-1)" "unprognostic (2.26e-1)" "unprognostic (8.79e-2)" 8.6 7.2 5.9 11.9 8.4 14.5 17.7 5.2 6.9 9.4 11.2 8.2 9.8 7.3 9.0 16.0 10.2 8.6 8.2 6.6 5.9 4.0 9.3 7.6 15.6 12.1 11.5 4.7 8.7 12.2 11.9 11.2 13.8 6.3 10.5 8.4 7.0 11.8 8.7 4.2 9.8 12.6 10.9 5.7 10.2 7.3 7.9 8.1 27.0 13.1 7.1 9.9 9.6 10.5 3.1 5.2 8.0 5.3 10.2 6.4 3.9 4.6 7.4 11.9 12.8 5.4 5.3 9.1 4.4 7.9 6.5 8.3 6.1 8.4 14.1 5.5 7.6 4.3 14.0 8.3 4.8 9.2 8.3 11.4 11.2 8.8 5.9 3.2 12.0 7.6 5.8 5.7 6.7 7.7 4.1 6.2 8.8 13.5 6.5 4.3 9.8 10.6 9.7 5.8 7.7 3.4 8.4 7.5 3.7 6.6 9.3 10.3 7.4 7.8 5.7 4.1 3.2 8.5 17.0 6.3 5.2 4.6 3.7 6.5 8.7 7.2 16.7 6.6 9.8 6.0 7.2 4.5 8.0 4.9 5.3 3.8 3.1 3.0 5.0 5.2 3.0 3.6 3.5 5.4 10.2 3.2 3.7 6.4 3.9 5.9 8.4 5.2 6.9 5.9 4.0 11.5 4.7 6.3 8.1 6.0 4.1 4.4 3.1 2.6 3.5 3.9 2.5 12.0 4.5 7.0 9.8 9.1 3.3 2.3 1.5 4.4 5.1 0.0 2.5 2.9 2.8 3.4 6.9 2.4 3.0 1.6 6.9 3.7 5.3 1.9 3.4 4.5 0.0 2.8 5.9 2.1 2.1 5.8 3.9 2.9 5.4 0.0 2.1 4.8 2.7 1.8 6.1 5.3 4.1 4.1 MCRS1 "ICP22BP, INO80Q, MCRS2, MSP58, P78" ENSG00000187778 "Microspherule protein 1" Q96EZ8 12 49556544-49568153 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039057 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA039057: AB_10794085" "unprognostic (2.60e-3)" "unprognostic (5.23e-2)" "unprognostic (1.46e-1)" "unprognostic (1.89e-2)" "unprognostic (1.68e-1)" "unprognostic (4.60e-2)" "prognostic unfavorable (2.30e-4)" "unprognostic (2.26e-2)" "unprognostic (2.83e-3)" "unprognostic (6.11e-2)" "unprognostic (9.94e-3)" "unprognostic (1.23e-1)" "prognostic favorable (2.70e-4)" "unprognostic (2.28e-1)" "unprognostic (1.69e-1)" "unprognostic (4.35e-2)" "unprognostic (3.26e-2)" 16.3 20.3 20.2 19.5 23.3 24.4 16.0 20.1 41.7 19.8 21.0 28.3 16.5 19.1 21.7 20.6 22.5 23.2 22.7 47.6 20.0 15.5 25.0 21.5 17.3 19.7 19.0 24.7 17.8 25.3 23.8 16.6 25.7 21.6 19.7 19.4 24.1 26.8 21.0 32.3 19.9 29.0 20.4 21.8 22.2 20.6 33.2 23.1 30.2 29.9 30.2 22.7 19.4 17.6 22.8 38.6 38.6 39.0 41.0 34.8 31.7 15.6 23.3 24.2 22.9 13.0 15.1 27.7 15.2 15.0 35.7 19.9 39.2 27.9 27.2 29.8 27.1 16.3 18.7 38.8 34.9 15.9 21.8 35.1 28.5 17.3 13.2 24.6 32.3 30.2 18.9 26.0 26.6 21.8 22.1 28.0 25.4 34.5 18.9 21.1 22.4 21.3 18.2 36.2 15.9 18.1 27.3 20.5 31.9 25.4 11.5 24.9 24.6 16.3 20.2 13.1 18.2 33.8 32.8 20.6 18.6 22.4 16.8 21.0 18.9 18.7 26.7 24.7 17.3 11.8 38.6 29.9 34.7 33.0 39.0 25.3 22.7 28.6 34.8 38.6 22.8 25.5 27.1 15.4 41.0 29.2 26.5 28.7 31.7 20.2 23.3 20.1 41.7 20.0 15.5 19.0 24.7 21.6 23.1 32.8 14.4 21.6 19.8 9.5 12.0 21.6 28.1 18.7 6.8 22.7 7.9 43.3 44.7 33.3 22.1 14.6 30.2 0.0 31.4 42.6 16.5 23.3 27.6 9.6 35.7 22.3 26.4 12.9 19.2 31.3 25.3 19.4 27.0 45.9 22.8 19.7 32.7 29.6 25.5 31.9 14.0 6.5 15.5 38.5 60.3 11.0 49.5 34.5 30.6 22.5 MDFI I-mfa ENSG00000112559 "MyoD family inhibitor" Q99750 6 41636882-41654246 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 196.5;Extravillous trophoblasts: 103.1;Pancreatic endocrine cells: 86.6;Syncytiotrophoblasts: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 23.6;HBEC3-KT: 29.3;OE19: 24.7;REH: 77.3" "Region enriched" "Detected in single" 8 "cerebellum: 19.0" "Low region specificity" "Detected in all" HPA049973 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA049973: AB_2680975" "unprognostic (9.74e-3)" "unprognostic (4.25e-2)" "unprognostic (6.82e-2)" "unprognostic (6.26e-3)" "unprognostic (9.18e-2)" "unprognostic (1.07e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (1.32e-5)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.66e-1)" "unprognostic (3.27e-2)" "unprognostic (4.04e-2)" "prognostic unfavorable (2.85e-6)" "unprognostic (2.66e-2)" "unprognostic (6.06e-2)" "unprognostic (1.57e-1)" "unprognostic (8.22e-2)" 29.5 2.1 2.9 5.3 3.1 0.4 10.5 0.9 10.8 14.0 3.2 2.5 3.5 1.9 4.8 4.6 20.5 4.1 12.3 4.0 2.3 2.1 2.5 2.3 10.1 4.5 2.4 1.3 15.7 1.6 0.9 4.2 17.8 3.4 13.3 0.6 6.3 10.1 4.7 1.0 6.7 1.3 2.9 2.0 0.7 3.2 4.6 1.3 0.8 7.0 31.0 19.6 8.4 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 12.9 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.0 0.0 7.1 0.0 5.4 0.0 0.0 13.6 3.5 29.3 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.0 0.0 0.9 13.6 0.1 6.4 0.0 9.7 4.0 0.0 0.0 0.0 0.0 10.1 0.1 8.8 24.7 0.5 77.3 7.4 0.1 0.8 2.2 2.4 5.9 0.1 11.0 0.0 9.3 0.0 0.9 10.7 0.0 12.6 0.1 0.4 0.0 0.0 0.0 0.1 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.1 0.9 2.0 2.3 2.1 2.4 1.3 3.4 1.3 0.0 0.0 0.0 26.4 21.8 0.0 0.8 0.0 0.0 0.0 5.2 0.0 196.5 0.0 24.1 0.5 3.0 0.0 0.0 44.9 103.1 11.5 36.3 0.0 0.0 16.7 0.0 0.0 3.7 0.0 0.0 36.2 0.5 0.0 1.0 0.0 0.0 86.6 0.0 5.6 0.0 0.0 0.0 1.9 0.1 1.5 8.0 116.0 0.0 0.0 51.1 MDM2 "HDM2, MGC5370" ENSG00000135679 "MDM2 proto-oncogene" Q00987 12 68808176-68850686 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 95.6;U-698: 91.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000086, CAB016303" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB000086: AB_563872, CAB016303: AB_627920" "unprognostic (1.16e-1)" "prognostic favorable (3.23e-4)" "unprognostic (6.16e-2)" "prognostic favorable (4.51e-7)" "unprognostic (7.25e-2)" "unprognostic (6.91e-2)" "unprognostic (3.77e-2)" "unprognostic (1.72e-1)" "unprognostic (2.45e-2)" "unprognostic (3.23e-1)" "unprognostic (1.80e-3)" "unprognostic (2.36e-1)" "unprognostic (4.22e-2)" "unprognostic (4.59e-2)" "unprognostic (1.81e-1)" "unprognostic (2.68e-1)" "unprognostic (8.95e-2)" 16.6 15.3 11.1 12.5 10.8 23.1 12.5 12.0 11.3 13.1 16.6 13.6 11.9 5.2 8.8 9.4 14.2 12.6 12.3 9.0 8.8 8.6 11.2 25.7 15.9 13.3 14.2 7.1 11.0 21.4 11.4 10.4 24.5 11.9 12.6 21.5 7.8 10.5 11.1 19.5 9.8 7.2 10.8 10.8 15.3 9.8 6.5 11.5 29.5 13.6 10.8 14.1 13.5 12.6 4.9 4.0 19.3 6.4 3.6 4.4 3.0 3.1 7.5 7.9 3.9 10.2 9.5 40.2 8.9 8.9 4.7 7.6 4.5 1.4 33.3 2.5 5.8 1.3 1.9 5.4 95.6 7.6 8.8 3.7 6.1 6.3 20.2 10.0 5.4 5.6 14.6 8.2 18.7 12.8 4.7 13.2 5.8 6.2 8.1 9.0 5.1 7.1 1.8 6.6 1.6 1.4 25.3 5.4 2.7 2.9 26.6 6.0 3.5 5.6 4.4 1.9 16.7 10.4 3.6 14.1 3.6 6.8 2.9 3.1 12.3 7.8 91.9 5.5 2.1 14.7 5.3 5.4 4.8 4.4 4.0 3.9 4.7 3.7 4.1 2.8 4.9 4.0 3.7 19.3 3.6 6.4 4.0 3.8 3.0 11.1 10.8 12.0 11.3 8.8 8.6 14.2 7.1 11.9 11.5 29.8 48.8 22.9 24.5 13.9 27.9 17.8 25.5 97.7 62.6 24.4 31.4 43.9 11.6 18.1 1.1 20.2 16.6 0.0 20.8 23.6 22.4 34.7 31.3 38.4 16.5 28.6 24.1 22.1 44.9 1.8 17.8 21.8 11.8 31.5 23.5 26.4 19.8 20.1 14.2 15.3 34.5 19.4 21.7 13.9 20.6 19.3 78.8 25.4 19.7 74.5 MDM4 "HDMX, MDMX" ENSG00000198625 "MDM4, p53 regulator" O15151 1 204516379-204558120 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018919, HPA048821" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA018919: AB_1853694, HPA048821: AB_2680531" "unprognostic (4.63e-2)" "unprognostic (3.73e-1)" "unprognostic (6.38e-2)" "unprognostic (1.50e-1)" "unprognostic (3.84e-2)" "unprognostic (1.68e-3)" "unprognostic (2.33e-1)" "unprognostic (1.29e-1)" "unprognostic (1.51e-2)" "unprognostic (2.34e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (9.87e-4)" "prognostic unfavorable (7.06e-6)" "unprognostic (1.20e-1)" "unprognostic (1.73e-1)" "unprognostic (2.49e-2)" "prognostic favorable (2.49e-4)" 12.7 8.8 14.4 21.1 18.0 59.1 14.6 19.7 16.4 12.2 10.6 20.4 15.8 7.6 12.5 23.6 10.4 12.3 10.3 11.3 13.7 8.0 11.1 12.3 15.4 21.0 20.5 9.5 19.0 16.7 11.1 19.0 12.4 13.4 13.1 12.4 14.2 11.3 15.4 12.0 23.7 15.2 18.5 13.5 19.9 11.9 19.6 19.4 55.8 15.1 9.5 21.0 13.9 12.7 15.1 9.0 8.1 4.8 4.9 7.8 2.4 3.6 7.1 7.2 9.9 5.0 5.6 34.0 2.7 2.8 3.5 5.2 3.7 4.9 12.4 2.6 3.8 2.9 3.9 4.8 4.0 4.7 3.7 3.4 9.8 15.8 4.3 3.8 7.7 9.8 5.7 2.6 5.7 10.2 3.7 3.4 8.0 5.6 18.1 3.0 12.0 4.7 6.8 9.9 1.3 3.0 5.6 5.9 4.1 3.4 17.5 3.2 7.2 2.7 5.4 5.1 7.5 10.2 4.5 3.4 4.0 7.1 2.6 4.4 9.1 3.2 10.3 2.8 3.3 5.7 8.1 4.7 6.2 7.2 4.8 6.0 9.0 5.4 5.0 4.1 15.1 7.8 6.5 7.8 4.9 4.3 9.0 3.0 2.4 14.4 18.0 19.7 16.4 13.7 8.0 20.5 9.5 13.4 19.4 26.8 49.9 72.9 46.9 54.7 91.7 33.5 40.8 20.1 61.4 66.3 159.0 39.1 11.6 25.4 65.9 50.6 37.1 93.5 23.0 23.0 48.1 52.9 63.6 48.4 30.6 39.7 62.4 94.5 85.6 124.4 74.2 75.3 40.5 23.4 44.0 44.1 23.4 40.8 50.9 12.8 196.4 51.8 36.2 60.6 71.3 59.7 50.9 73.9 39.6 40.0 MDP1 "FN6Pase, MGC5987" ENSG00000213920 "Magnesium dependent phosphatase 1" Q86V88 14 24213937-24216070 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003064, HPA070338" Uncertain Approved Nucleoplasm NA NA 34000 Nucleoplasm "HPA003064: AB_10602350, HPA070338: AB_2686256" "unprognostic (2.70e-1)" "unprognostic (3.68e-1)" "unprognostic (2.51e-1)" "unprognostic (2.11e-1)" "unprognostic (3.09e-1)" "unprognostic (5.46e-2)" "unprognostic (5.48e-2)" "unprognostic (1.12e-1)" "unprognostic (6.27e-2)" "unprognostic (8.02e-2)" "unprognostic (2.00e-3)" "unprognostic (1.02e-1)" "prognostic favorable (5.96e-4)" "unprognostic (6.39e-2)" "unprognostic (1.32e-1)" "unprognostic (3.82e-1)" "unprognostic (3.19e-2)" 12.2 17.6 18.5 8.3 15.0 8.1 18.7 18.6 18.3 13.3 10.2 13.1 21.0 6.7 10.6 19.0 8.9 14.3 12.0 17.8 13.8 13.9 16.6 14.7 8.7 13.5 15.1 14.5 12.9 20.2 14.8 18.3 9.4 16.6 13.3 8.6 13.5 14.3 16.3 11.4 10.6 9.8 10.9 13.9 10.4 10.0 6.6 17.0 14.3 14.6 10.6 10.8 10.0 9.6 10.1 23.0 12.2 11.1 9.0 11.9 7.9 3.1 7.9 6.0 3.9 6.0 5.6 0.2 3.4 7.4 6.9 7.2 4.2 9.1 12.8 8.8 3.5 2.1 3.1 2.9 6.8 4.3 4.3 3.2 4.9 2.9 9.6 5.8 6.2 3.6 3.9 6.3 4.2 8.0 7.1 4.9 9.3 1.5 9.6 6.2 17.2 8.8 10.2 1.7 6.3 14.2 6.3 4.2 10.1 6.7 4.6 7.4 7.2 5.4 11.6 7.2 3.4 7.0 3.3 2.9 7.6 7.3 3.2 3.4 15.6 6.2 9.3 7.1 3.1 5.8 3.1 10.9 12.2 6.3 11.1 5.9 10.1 8.1 7.3 12.4 9.5 9.9 8.2 3.8 9.0 9.4 23.0 11.9 7.9 18.5 15.0 18.6 18.3 13.8 13.9 15.1 14.5 16.6 17.0 6.0 11.7 7.5 2.8 4.0 3.4 0.0 5.1 21.4 0.0 5.2 0.0 3.1 11.6 10.4 3.0 5.2 8.1 0.0 17.0 4.4 5.6 2.4 4.7 5.0 7.0 3.2 11.1 6.2 2.2 2.9 5.8 11.0 16.9 29.7 11.1 3.1 12.6 2.9 7.1 15.7 2.7 12.9 7.2 1.9 3.2 4.0 2.1 5.1 10.7 2.0 MECP2 "MRX16, MRX79, RTT" ENSG00000169057 "Methyl-CpG binding protein 2" P51608 X 154021573-154137103 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 194.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000593, HPA001341, CAB037264" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB037264: AB_477252, HPA000593: AB_1079348, HPA001341: AB_1079347" "unprognostic (1.27e-3)" "unprognostic (2.60e-3)" "unprognostic (2.16e-3)" "prognostic unfavorable (8.35e-5)" "unprognostic (2.35e-1)" "unprognostic (3.66e-1)" "unprognostic (6.12e-2)" "unprognostic (1.18e-2)" "unprognostic (8.81e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-3)" "unprognostic (4.22e-1)" "prognostic favorable (7.32e-9)" "unprognostic (7.63e-2)" "unprognostic (1.00e-1)" "unprognostic (9.08e-2)" "unprognostic (6.05e-2)" 18.6 21.4 29.2 17.0 27.1 33.8 17.6 39.1 33.5 20.2 19.2 17.6 15.9 13.9 20.0 15.1 18.8 21.1 19.5 23.1 22.5 14.0 17.1 16.4 22.8 19.7 22.5 26.7 29.0 21.2 24.3 22.9 13.9 25.4 23.0 8.0 20.8 18.7 23.7 31.6 14.1 15.3 16.2 21.1 23.3 15.0 9.7 24.4 13.8 19.1 8.7 14.3 18.7 28.6 5.6 4.2 22.4 4.9 2.9 6.8 1.8 19.4 11.6 9.8 12.2 8.4 6.0 8.3 9.8 11.0 12.0 19.6 8.9 9.5 23.4 23.2 8.6 19.0 9.3 14.7 11.5 6.1 17.7 17.7 9.0 10.6 5.6 10.3 11.3 18.9 6.1 6.5 11.2 13.2 9.5 9.3 11.5 9.7 20.0 7.2 11.6 13.6 13.0 7.6 14.7 13.0 11.8 10.7 7.7 8.5 8.9 13.8 8.0 7.6 8.9 18.7 5.5 5.8 14.7 9.7 9.1 18.1 18.5 19.7 24.0 17.8 26.6 13.2 22.3 15.6 22.4 3.5 13.3 6.8 3.2 4.8 5.6 4.8 5.5 2.4 4.9 4.6 4.4 16.9 2.9 4.9 4.2 5.0 1.8 29.2 27.1 39.1 33.5 22.5 14.0 22.5 26.7 25.4 24.4 6.0 33.8 38.3 36.3 27.4 82.7 40.4 30.6 17.4 33.0 43.6 194.4 13.1 56.3 31.6 0.5 36.8 24.4 0.0 27.0 13.6 26.3 29.6 50.8 30.8 23.4 93.8 35.1 60.8 37.0 2.1 49.5 41.8 28.7 60.5 17.4 46.1 29.3 28.1 69.3 21.9 81.7 32.3 40.0 7.7 36.0 25.3 15.4 82.9 16.4 29.4 MED1 "CRSP1, CRSP200, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2" ENSG00000125686 "Mediator complex subunit 1" Q15648 17 39404285-39451286 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 87.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017696, HPA052818" Approved Supported Nucleoplasm NA NA 170000 Nucleoplasm "CAB017696: AB_1128703, HPA052818: AB_2681962" "unprognostic (1.77e-1)" "unprognostic (1.63e-1)" "unprognostic (9.26e-2)" "unprognostic (1.21e-1)" "unprognostic (2.18e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.50e-1)" "unprognostic (7.86e-2)" "unprognostic (1.95e-3)" "unprognostic (4.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.78e-2)" "unprognostic (2.00e-1)" "unprognostic (5.94e-2)" "unprognostic (9.40e-2)" "unprognostic (5.79e-2)" 16.4 13.8 11.8 14.8 13.7 15.5 15.1 19.8 16.5 16.9 14.6 18.8 9.3 10.3 17.9 9.7 15.0 14.3 10.9 12.8 11.6 10.5 13.0 13.3 12.3 17.7 12.0 10.3 22.2 16.2 34.5 21.1 16.5 14.5 12.5 14.2 16.5 13.4 11.6 19.5 16.1 14.1 17.1 14.0 20.4 13.0 15.1 12.1 34.1 13.2 12.1 22.5 16.6 13.4 6.6 4.9 4.4 4.0 5.0 6.1 2.7 8.1 11.0 13.8 9.4 10.1 10.3 11.1 10.0 10.9 13.8 13.5 10.5 8.1 22.0 11.4 12.4 15.8 16.2 16.5 9.9 21.9 21.2 13.8 13.8 10.4 10.5 10.9 24.6 14.6 9.7 10.1 16.9 24.7 8.5 11.7 12.6 17.7 11.9 11.2 4.6 22.9 9.3 8.9 7.9 6.5 17.2 18.6 9.4 8.1 9.5 8.8 10.0 13.2 87.5 11.5 12.3 16.2 14.1 10.4 10.7 13.4 11.9 17.6 10.9 14.6 22.7 10.6 12.1 13.1 3.2 4.0 4.4 5.2 3.9 5.8 6.6 5.5 5.8 4.0 6.4 5.4 6.1 3.3 5.0 2.6 4.9 3.3 2.7 11.8 13.7 19.8 16.5 11.6 10.5 12.0 10.3 14.5 12.1 23.8 11.5 11.9 11.5 24.2 13.6 16.9 10.2 17.4 26.1 8.7 13.7 14.5 3.3 10.8 5.0 19.6 9.5 0.0 10.3 10.6 16.0 13.2 9.2 17.0 12.9 11.1 13.2 17.8 21.9 6.6 13.6 14.7 20.3 10.0 14.1 12.3 11.8 10.5 17.0 7.2 10.5 19.4 13.7 18.4 18.1 28.5 18.5 20.0 16.0 14.0 MED10 "L6, MGC5309, NUT2, TRG20" ENSG00000133398 "Mediator complex subunit 10" Q9BTT4 5 6371881-6378594 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042795, HPA054188" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042795: AB_10796679, HPA054188: AB_2682410" "unprognostic (2.33e-3)" "unprognostic (3.31e-1)" "unprognostic (1.50e-2)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.65e-5)" "unprognostic (3.38e-2)" "prognostic unfavorable (1.62e-6)" "unprognostic (3.26e-1)" "unprognostic (5.16e-2)" "unprognostic (4.92e-3)" "unprognostic (4.32e-2)" "unprognostic (2.16e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (3.85e-2)" "unprognostic (3.78e-2)" "unprognostic (3.11e-1)" "unprognostic (2.14e-1)" 19.8 15.8 28.8 16.9 23.2 37.2 16.2 20.6 31.4 13.9 22.7 19.3 17.1 15.8 15.1 20.3 22.2 16.7 16.6 24.6 29.9 31.2 14.7 17.2 16.2 25.1 27.7 21.1 17.7 31.4 10.6 13.8 16.5 23.9 15.9 10.4 13.7 17.1 19.6 21.5 21.3 18.7 24.0 26.6 17.4 16.9 21.1 17.5 15.1 16.4 12.3 21.6 19.6 22.9 34.4 24.4 37.4 17.2 24.9 40.0 35.2 17.5 19.5 7.8 14.4 12.4 13.7 22.2 22.2 20.0 23.6 17.3 29.5 14.1 22.7 18.0 18.5 34.2 13.1 13.4 16.4 21.2 37.6 15.6 15.0 30.5 14.7 38.3 18.0 13.3 15.6 21.6 22.4 32.1 14.5 18.7 13.1 22.0 13.5 18.0 22.0 26.2 27.2 13.3 12.2 51.3 15.1 13.8 9.5 16.0 18.5 14.9 22.2 42.3 17.5 33.6 10.1 12.2 16.2 20.6 23.6 26.1 21.6 23.4 22.0 21.7 32.6 21.2 28.5 17.5 37.4 15.8 33.1 28.7 16.4 35.2 34.4 36.2 30.9 13.3 31.5 40.0 33.6 11.4 24.9 17.2 24.4 31.8 35.2 28.8 23.2 20.6 31.4 29.9 31.2 27.7 21.1 23.9 17.5 20.8 20.0 57.8 71.8 81.7 63.0 37.5 28.1 26.8 20.5 43.6 27.5 70.4 49.7 97.6 4.0 72.4 44.3 23.3 79.7 67.2 66.6 65.2 50.7 21.5 57.0 69.9 42.4 66.9 26.4 8.0 65.0 44.9 59.1 114.6 40.5 50.4 108.8 43.2 42.5 39.7 47.1 32.3 76.8 57.9 89.6 61.6 66.4 95.9 40.4 66.0 MED12 "CAGH45, FGS1, HOPA, KIAA0192, OKS, OPA1, TNRC11, TRAP230" ENSG00000184634 "Mediator complex subunit 12" Q93074 X 71118556-71142454 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003184, HPA003185" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA003184: AB_1079349, HPA003185: AB_1079350" "unprognostic (1.39e-1)" "unprognostic (2.23e-1)" "unprognostic (5.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.89e-3)" "unprognostic (7.14e-2)" "unprognostic (1.68e-2)" "unprognostic (1.15e-2)" "unprognostic (2.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (2.50e-1)" "unprognostic (1.22e-3)" "unprognostic (1.28e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.16e-2)" 18.2 31.3 12.3 15.3 14.7 16.6 18.1 18.0 15.1 16.8 12.8 19.8 21.3 10.2 21.7 16.5 13.1 17.7 14.2 12.9 12.9 8.5 13.3 9.8 14.0 15.3 15.7 10.7 28.8 14.2 20.1 17.9 23.0 11.6 16.5 11.8 18.6 14.6 20.3 14.9 17.6 14.8 16.4 11.2 27.3 14.2 15.3 12.9 33.1 17.8 12.6 15.9 15.4 16.4 4.0 5.1 9.7 3.7 5.0 7.4 3.6 8.7 10.3 16.3 9.7 12.0 10.7 24.1 6.2 8.9 9.9 7.1 12.4 8.3 11.5 8.2 10.7 6.8 8.7 19.0 7.8 7.9 12.1 14.7 19.1 23.2 16.7 9.4 17.5 16.9 12.4 8.5 12.9 15.0 12.7 15.2 14.7 17.7 20.2 9.7 14.7 18.4 10.0 9.3 11.2 13.5 17.3 18.2 8.7 7.5 17.4 9.1 11.0 14.3 7.3 8.1 17.5 8.8 8.7 13.2 10.8 12.8 9.9 4.3 10.0 5.5 8.4 6.3 9.8 7.2 9.7 3.7 7.2 5.9 3.6 5.0 4.0 4.1 5.4 3.9 4.0 4.6 3.9 7.7 5.0 2.4 5.1 7.4 3.6 12.3 14.7 18.0 15.1 12.9 8.5 15.7 10.7 11.6 12.9 8.9 3.4 5.2 5.2 5.4 7.1 8.1 15.3 2.7 6.8 8.7 5.9 17.0 1.7 5.4 0.2 8.7 6.8 0.0 5.4 6.2 7.8 5.7 9.2 3.4 8.0 12.7 7.5 14.1 6.7 0.9 13.0 9.2 5.0 6.4 7.8 5.8 8.6 8.4 12.7 2.2 4.5 0.0 5.0 6.4 7.4 5.0 22.8 6.4 6.4 6.8 MED13 "KIAA0593, THRAP1, TRAP240" ENSG00000108510 "Mediator complex subunit 13" Q9UHV7 17 61942605-62065282 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067939 Supported Nucleoplasm NA NA Nucleoplasm "HPA067939: AB_2685928" "unprognostic (7.26e-2)" "unprognostic (4.50e-2)" "prognostic favorable (1.43e-4)" "unprognostic (8.79e-2)" "unprognostic (1.69e-2)" "unprognostic (3.56e-1)" "unprognostic (1.33e-1)" "unprognostic (5.69e-2)" "unprognostic (1.18e-1)" "unprognostic (1.97e-1)" "unprognostic (1.88e-1)" "unprognostic (3.92e-2)" "unprognostic (2.63e-2)" "unprognostic (2.53e-1)" "unprognostic (1.21e-1)" "unprognostic (4.51e-3)" "unprognostic (2.30e-1)" 10.4 7.6 6.3 6.6 9.1 19.3 8.8 8.8 7.5 8.7 9.0 13.8 6.8 7.1 13.6 9.0 9.7 6.8 8.2 8.4 12.6 5.3 9.0 14.3 12.7 7.3 8.2 3.5 9.9 8.6 15.3 5.9 9.6 15.6 7.1 8.3 6.4 21.6 5.9 31.8 10.0 8.1 12.0 13.8 6.7 7.4 11.9 8.3 15.1 10.4 12.4 8.9 10.7 8.4 3.2 5.6 7.9 5.0 2.7 3.5 0.7 13.1 15.8 12.2 9.9 11.2 12.3 9.3 7.3 10.6 14.8 14.4 11.9 7.2 14.1 6.9 11.4 11.2 8.2 15.5 9.5 20.8 9.1 9.1 23.0 11.5 7.6 11.8 20.1 10.8 9.5 11.1 16.1 18.4 10.7 11.1 11.1 18.8 24.3 10.1 22.3 18.1 6.1 6.5 15.5 8.1 15.0 31.3 8.6 10.4 15.6 9.6 18.2 15.2 4.4 9.5 12.7 15.9 14.3 13.9 17.0 25.1 8.8 13.7 11.8 13.4 19.4 9.0 9.0 9.6 1.6 2.1 2.5 2.8 1.0 3.5 2.0 2.7 2.9 2.1 3.2 1.9 3.5 7.9 2.7 5.0 5.6 3.0 0.7 6.3 9.1 8.8 7.5 12.6 5.3 8.2 3.5 15.6 8.3 59.6 43.0 14.7 44.8 69.3 52.4 21.4 68.8 17.4 40.9 22.7 43.2 15.6 8.3 15.0 36.5 37.9 41.2 46.7 17.2 9.5 48.8 53.4 25.4 34.1 16.6 58.8 42.5 35.0 34.5 46.0 28.4 34.0 30.4 18.0 37.0 37.9 22.3 34.5 30.8 15.6 39.0 32.3 40.6 39.0 13.6 71.4 36.3 22.4 25.2 74.9 MED14 "CRSP150, CRSP2, CSRP, CXorf4, EXLM1, RGR1, TRAP170" ENSG00000180182 "Mediator complex subunit 14" O60244 X 40648306-40735858 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064182 Approved Nucleoplasm NA NA Nucleoplasm "HPA064182: AB_2685204" "unprognostic (5.21e-2)" "unprognostic (2.82e-1)" "unprognostic (8.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.07e-1)" "unprognostic (2.34e-1)" "unprognostic (2.08e-3)" "unprognostic (2.16e-1)" "unprognostic (7.95e-3)" "unprognostic (4.38e-2)" "unprognostic (5.05e-2)" "unprognostic (7.78e-2)" "unprognostic (1.16e-1)" "unprognostic (4.89e-2)" "unprognostic (8.54e-2)" "unprognostic (2.32e-1)" "unprognostic (1.64e-1)" 11.0 11.4 12.0 18.5 14.7 19.6 10.5 19.2 16.8 12.9 17.7 20.5 11.4 18.1 14.4 21.9 15.0 10.0 11.1 14.6 13.8 12.5 13.0 15.5 12.4 16.2 12.4 11.5 14.9 12.9 21.5 15.9 13.5 15.1 12.0 15.6 14.7 10.6 12.2 53.8 16.7 19.8 16.2 12.8 13.5 12.8 5.7 11.7 31.7 16.2 18.4 20.9 17.5 12.8 4.0 5.7 6.0 7.3 7.7 5.2 2.4 22.2 11.0 17.8 15.7 7.9 10.3 3.6 8.8 11.1 12.8 16.3 10.1 11.1 12.9 6.0 11.1 27.4 17.0 30.1 14.0 19.2 11.7 22.7 13.0 13.5 9.1 8.5 13.6 13.5 7.4 8.6 18.6 16.3 15.1 15.3 8.6 8.8 12.6 13.3 11.5 12.5 12.2 19.6 14.2 12.9 6.3 19.0 12.9 12.2 10.3 11.5 10.1 20.9 9.6 9.7 34.7 14.0 8.2 13.9 13.1 13.7 16.4 10.8 11.8 12.0 12.8 12.7 9.4 9.4 4.3 3.6 6.0 4.5 7.3 5.2 3.9 4.3 4.4 5.7 4.0 4.9 3.8 1.9 7.7 3.9 3.1 3.9 2.4 12.0 14.7 19.2 16.8 13.8 12.5 12.4 11.5 15.1 11.7 14.9 11.8 11.3 8.1 21.1 15.3 12.9 12.7 2.7 11.4 12.2 17.7 5.5 5.0 7.0 0.4 8.3 15.8 0.0 8.7 4.4 10.9 12.9 10.4 18.7 8.0 17.5 19.7 8.0 16.7 0.8 8.1 14.9 11.8 11.8 20.8 6.5 10.3 14.4 8.1 8.6 15.6 25.8 11.4 11.4 3.2 26.5 5.5 8.7 15.3 25.3 MED15 "Arc105, CAG7A, PCQAP, TIG-1, TNRC7" ENSG00000099917 "Mediator complex subunit 15" Q96RN5 22 20495913-20587632 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 71.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003179 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA003179: AB_1079581" "unprognostic (7.98e-2)" "unprognostic (2.26e-1)" "unprognostic (1.70e-1)" "prognostic favorable (7.30e-5)" "unprognostic (2.53e-1)" "unprognostic (1.76e-3)" "prognostic unfavorable (3.71e-4)" "unprognostic (3.73e-2)" "unprognostic (1.12e-3)" "unprognostic (3.46e-1)" "prognostic unfavorable (9.09e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.32e-2)" "unprognostic (2.50e-1)" "unprognostic (3.60e-2)" "unprognostic (5.57e-2)" 26.2 28.3 26.4 29.5 32.0 41.6 23.4 28.5 31.4 23.9 25.3 27.4 17.6 34.8 35.6 15.0 25.8 23.4 25.9 21.9 23.4 15.4 20.6 12.2 28.6 31.4 22.8 22.4 23.6 24.9 17.9 24.1 32.2 22.0 22.0 13.8 29.5 22.7 23.2 40.7 27.9 30.1 20.8 19.3 32.9 24.5 19.9 23.9 19.2 20.3 16.4 29.2 29.7 24.3 4.9 6.8 9.1 13.9 13.6 19.8 8.8 22.1 11.9 7.6 9.2 8.0 7.9 14.0 22.6 16.6 17.9 16.6 18.1 10.1 9.0 10.4 15.9 8.1 22.9 6.9 16.8 7.2 12.8 12.3 17.1 12.8 13.1 13.4 15.5 15.8 9.6 13.2 14.1 14.4 10.2 13.8 6.9 71.5 8.5 11.3 14.9 6.5 8.8 8.2 9.8 8.1 11.4 17.3 3.6 10.8 16.2 7.2 12.4 17.0 17.3 24.0 5.2 9.7 8.7 24.8 28.9 21.8 15.4 18.1 11.2 9.9 6.9 20.9 9.6 25.7 4.1 7.6 6.5 17.8 8.4 8.4 4.2 12.2 19.8 6.8 4.9 7.2 12.0 9.1 13.6 13.9 6.1 19.0 8.8 26.4 32.0 28.5 31.4 23.4 15.4 22.8 22.4 22.0 23.9 47.6 28.6 11.2 22.3 26.6 19.3 3.9 7.6 26.8 25.0 24.4 17.7 42.4 13.3 28.7 32.9 22.4 35.0 0.0 24.9 35.8 18.8 29.4 19.7 7.4 27.6 14.3 17.2 23.9 25.0 18.1 13.3 27.1 23.6 31.5 22.7 12.8 47.2 23.2 13.8 10.1 14.7 45.3 24.7 20.4 15.4 24.1 51.7 31.2 19.6 31.9 MED18 "FLJ20045, p28b, SRB5" ENSG00000130772 "Mediator complex subunit 18" Q9BUE0 1 28329002-28335967 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027429 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA027429: AB_10610137" "unprognostic (2.72e-2)" "unprognostic (2.00e-1)" "unprognostic (2.78e-3)" "prognostic favorable (3.93e-4)" "unprognostic (2.40e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (4.30e-2)" "unprognostic (1.53e-1)" "unprognostic (3.54e-1)" "unprognostic (7.49e-2)" "unprognostic (2.13e-1)" "prognostic favorable (8.38e-5)" "prognostic favorable (6.72e-4)" "unprognostic (9.20e-2)" "unprognostic (3.08e-2)" "unprognostic (7.69e-2)" 9.8 11.2 6.2 9.2 6.7 5.9 7.9 5.5 12.1 7.7 11.4 7.1 8.9 9.7 8.1 9.1 13.3 9.9 9.5 8.4 6.6 6.7 11.6 19.2 6.7 11.8 8.5 6.6 7.0 12.3 5.7 7.1 12.4 8.6 8.6 10.3 7.8 10.2 7.3 10.9 9.1 13.0 6.9 6.0 14.3 9.9 8.5 6.9 17.0 11.0 6.1 18.5 8.4 6.6 8.3 8.3 11.6 8.3 5.4 7.5 7.1 13.2 6.6 6.6 5.6 8.9 8.6 7.4 7.9 9.5 10.4 9.0 3.7 12.5 16.5 8.2 8.1 6.3 8.3 10.5 9.8 8.1 11.2 7.4 12.7 6.0 8.2 12.3 7.6 13.6 9.2 12.1 8.1 12.5 6.2 8.9 8.3 12.0 4.4 9.6 6.4 9.6 9.7 7.8 7.4 3.8 7.0 9.5 8.7 9.1 6.7 6.7 6.7 8.0 8.1 11.0 7.3 6.9 7.3 10.7 6.3 7.2 10.4 8.2 7.6 10.1 9.2 9.3 16.2 4.5 6.2 7.5 10.4 7.5 7.4 5.5 8.3 5.9 6.2 6.2 6.7 7.4 7.3 11.6 5.4 8.3 8.3 7.5 7.1 6.2 6.7 5.5 12.1 6.6 6.7 8.5 6.6 8.6 6.9 8.9 4.5 6.0 3.4 0.7 3.2 4.1 2.5 4.0 5.7 1.8 11.8 9.8 6.6 6.2 0.4 2.3 6.3 23.3 5.2 11.1 2.1 2.5 1.1 3.4 6.8 9.5 3.4 4.3 3.2 0.7 4.4 3.3 1.7 6.4 4.8 4.6 5.0 6.8 4.9 6.4 4.6 19.4 3.1 7.2 6.3 1.1 12.4 5.1 4.1 5.3 MED22 "Med24, SRB6, SURF5" ENSG00000148297 "Mediator complex subunit 22" Q15528 9 133338323-133348131 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020391, HPA063694" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA020391: AB_1857668, HPA063694: AB_2685093" "unprognostic (2.62e-2)" "unprognostic (1.15e-1)" "unprognostic (2.68e-1)" "unprognostic (7.53e-2)" "unprognostic (5.56e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (5.16e-6)" "unprognostic (4.99e-3)" "unprognostic (3.23e-2)" "unprognostic (1.66e-1)" "prognostic favorable (6.46e-4)" "unprognostic (3.99e-1)" "prognostic favorable (3.76e-11)" "unprognostic (9.25e-3)" "unprognostic (2.66e-1)" "unprognostic (1.66e-2)" "unprognostic (1.62e-1)" 12.6 14.4 15.2 15.9 16.5 11.9 11.3 19.6 26.0 19.0 16.6 15.5 12.6 14.3 18.4 12.6 13.4 16.2 14.3 15.4 13.7 14.3 14.0 10.6 13.8 15.6 14.5 16.2 19.7 15.0 19.3 13.0 16.2 15.7 18.1 8.7 14.6 14.7 21.7 14.5 14.9 14.4 20.4 15.4 16.9 12.2 8.3 12.7 11.4 20.4 7.5 13.4 14.5 12.3 4.6 4.8 6.3 4.9 1.6 2.9 2.4 7.0 8.3 13.0 9.3 2.9 4.9 15.2 8.6 6.0 10.7 7.2 18.1 6.6 14.2 5.1 6.1 9.4 14.0 9.7 8.3 4.4 11.1 5.6 7.5 18.1 5.0 4.9 9.6 7.8 3.8 6.6 9.6 6.4 5.0 5.2 8.3 10.9 6.9 5.1 9.7 13.6 8.1 18.2 8.8 10.0 18.7 10.5 13.0 4.4 5.2 10.6 8.6 10.0 12.7 7.5 5.6 14.4 3.4 6.8 14.0 9.8 9.5 11.2 4.7 6.3 13.7 8.0 7.5 11.5 2.2 3.9 6.3 2.0 3.7 2.6 3.4 2.4 2.6 3.0 4.6 2.9 2.2 6.0 1.6 4.9 4.8 2.0 2.4 15.2 16.5 19.6 26.0 13.7 14.3 14.5 16.2 15.7 12.7 20.8 13.2 5.1 9.2 7.3 12.8 7.5 10.2 0.0 2.3 15.7 0.0 5.2 3.3 5.2 1.7 7.2 7.4 0.0 4.5 4.4 10.1 7.1 7.0 5.0 6.7 12.7 6.4 5.5 6.9 1.6 10.9 7.5 1.7 1.0 6.7 8.4 6.1 0.0 15.6 4.9 10.9 25.8 21.5 7.1 10.4 5.6 4.6 5.0 5.6 3.6 MED25 "ACID1, ARC92, DKFZp434K0512, TCBAP0758" ENSG00000104973 "Mediator complex subunit 25" Q71SY5 19 49818279-49840383 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 19.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 19.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068802 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA068802: AB_2686039" "unprognostic (1.72e-1)" "unprognostic (5.22e-3)" "unprognostic (6.67e-2)" "unprognostic (8.16e-2)" "unprognostic (2.20e-1)" "prognostic favorable (9.85e-4)" "unprognostic (1.02e-3)" "unprognostic (2.10e-1)" "unprognostic (3.59e-2)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "unprognostic (1.38e-2)" "unprognostic (1.04e-2)" "unprognostic (9.85e-2)" "unprognostic (1.65e-1)" "unprognostic (1.39e-1)" "unprognostic (3.04e-3)" 13.2 45.2 16.3 17.0 16.5 30.4 13.1 22.7 25.1 15.1 18.1 19.3 14.2 14.8 21.0 18.2 20.6 28.6 20.5 24.9 16.1 15.6 16.8 13.9 18.2 16.3 16.3 16.0 29.3 21.6 15.9 25.3 22.1 16.5 13.4 14.2 20.9 15.1 22.7 49.3 20.0 14.9 15.6 14.0 18.2 21.2 58.8 16.4 24.9 23.9 21.1 17.9 17.7 14.3 4.2 3.1 19.8 2.6 1.0 2.2 1.7 23.7 32.2 19.3 21.1 13.4 13.3 17.4 15.5 17.4 24.1 24.4 27.3 29.5 26.9 9.6 19.7 15.2 21.1 22.8 17.7 19.0 16.4 33.0 18.1 28.5 21.2 14.8 20.8 27.1 14.6 17.2 19.5 14.3 22.1 20.2 16.8 33.1 21.0 16.2 13.0 17.7 39.5 14.8 23.5 24.2 22.8 19.5 27.3 24.5 35.8 34.0 31.2 21.8 25.9 9.9 17.7 15.9 17.1 22.8 24.9 18.2 11.9 16.7 22.3 32.1 28.4 20.4 18.5 13.7 1.1 2.6 3.9 2.2 2.4 1.9 3.0 1.7 2.1 2.3 4.2 1.6 1.2 19.8 1.0 1.7 3.1 1.8 1.7 16.3 16.5 22.7 25.1 16.1 15.6 16.3 16.0 16.5 16.4 32.8 18.5 7.0 12.0 4.9 10.9 4.9 7.6 78.9 15.9 19.2 41.2 22.6 1.7 20.2 42.0 7.1 27.9 46.7 21.3 19.4 8.2 7.8 7.0 5.4 18.8 7.9 42.5 5.5 13.8 84.9 14.7 13.7 3.3 26.2 16.6 10.1 24.3 16.7 10.6 14.6 25.2 12.9 7.2 40.9 34.9 4.5 28.3 13.1 15.6 13.9 MED28 "DKFZP434N185, EG1, magicin" ENSG00000118579 "Mediator complex subunit 28" Q9H204 4 17614631-17634105 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Actin-binding, Activator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035900, HPA035901" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA035900: AB_10673223, HPA035901: AB_2674853" "unprognostic (1.14e-3)" "unprognostic (6.97e-2)" "unprognostic (1.95e-1)" "unprognostic (6.08e-3)" "unprognostic (8.22e-3)" "unprognostic (3.90e-1)" "unprognostic (1.55e-2)" "unprognostic (5.47e-2)" "unprognostic (5.71e-2)" "unprognostic (2.43e-1)" "unprognostic (2.27e-2)" "unprognostic (7.00e-2)" "unprognostic (1.16e-2)" "unprognostic (6.30e-2)" "unprognostic (8.46e-2)" "unprognostic (1.14e-1)" "unprognostic (5.07e-3)" 12.8 12.4 16.5 15.3 18.2 22.7 20.1 23.6 19.4 18.9 15.8 20.2 17.4 13.1 25.1 22.0 15.0 19.7 11.9 11.3 16.4 15.7 13.0 10.9 16.7 21.4 18.7 17.4 30.2 16.5 14.1 20.4 18.3 15.1 18.5 15.6 17.0 16.5 17.1 27.8 22.0 16.5 16.4 16.1 20.0 15.0 16.7 17.9 27.3 18.9 14.9 23.2 16.4 17.7 9.5 10.1 14.9 10.7 8.4 11.2 10.7 3.3 2.1 17.1 8.6 7.6 6.0 7.0 4.8 5.6 6.4 5.8 5.8 8.0 9.0 3.3 4.3 5.6 3.3 10.3 5.1 6.5 3.5 5.1 15.8 6.9 8.7 5.3 11.0 8.0 5.7 7.1 3.9 3.4 6.7 5.5 13.1 13.9 8.3 5.6 3.2 16.2 19.1 11.8 6.5 3.5 12.6 6.3 4.1 6.1 4.9 12.3 6.2 4.1 3.6 4.0 10.5 6.8 11.4 6.7 4.2 3.0 3.0 4.4 6.3 2.8 11.7 3.8 10.7 4.4 6.7 10.7 9.8 7.6 8.0 7.5 9.0 8.4 7.0 10.1 9.5 11.2 8.6 14.9 8.4 6.5 7.0 6.5 10.7 16.5 18.2 23.6 19.4 16.4 15.7 18.7 17.4 15.1 17.9 17.9 25.9 61.1 99.1 81.9 38.0 16.5 33.1 24.1 37.5 21.0 15.7 101.0 71.3 52.8 8.7 68.0 25.0 23.3 46.6 148.4 70.1 83.1 58.8 24.9 81.0 31.8 42.5 41.1 73.2 17.0 52.3 65.7 57.3 101.0 38.4 49.8 50.1 40.3 44.2 44.5 33.7 32.3 50.1 82.8 93.7 81.8 112.6 68.2 42.3 82.7 MED29 "DKFZp434H247, IXL, MED2" ENSG00000063322 "Mediator complex subunit 29" Q9NX70 19 39391303-39400637 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055956 Supported Nucleoplasm NA NA Nucleoplasm "HPA055956: AB_2682986" "unprognostic (3.30e-2)" "unprognostic (3.51e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (2.68e-1)" "unprognostic (1.92e-1)" "unprognostic (2.85e-2)" "unprognostic (1.71e-1)" "unprognostic (5.36e-3)" "unprognostic (1.46e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-2)" "prognostic favorable (5.15e-5)" "unprognostic (9.51e-2)" "unprognostic (4.84e-2)" "unprognostic (2.17e-1)" "unprognostic (1.87e-2)" 17.4 22.2 39.7 15.0 39.1 15.7 17.8 24.8 38.1 21.1 16.0 25.7 15.8 17.0 18.3 22.5 15.9 29.9 20.1 21.1 34.4 35.4 22.2 22.0 17.6 17.4 36.4 31.9 34.6 23.9 41.9 21.5 17.1 28.5 21.4 13.5 19.3 22.6 25.8 25.7 16.0 16.5 18.7 32.6 18.5 16.9 15.1 17.9 16.4 30.8 14.2 16.3 18.0 13.1 28.2 22.2 35.7 41.9 21.8 27.8 25.8 14.5 38.6 11.7 11.9 17.3 13.4 9.4 15.8 17.5 15.1 12.1 19.0 14.2 10.8 21.2 14.5 13.0 7.7 10.9 13.7 8.8 21.0 19.8 13.9 15.3 12.8 14.0 13.2 12.3 14.0 11.0 15.7 17.3 15.9 12.1 21.2 9.2 13.7 14.9 19.0 12.9 4.0 8.9 17.9 13.6 21.3 16.0 15.2 14.1 24.7 18.1 16.3 32.2 21.2 13.8 7.4 16.5 14.5 13.2 12.8 13.1 15.6 15.9 17.6 19.9 18.4 17.7 10.0 20.4 26.0 28.6 24.0 24.5 34.4 23.9 28.2 22.8 21.9 22.2 26.2 27.8 26.1 35.7 21.8 41.9 17.8 26.3 25.8 39.7 39.1 24.8 38.1 34.4 35.4 36.4 31.9 28.5 17.9 26.8 35.0 25.3 26.4 19.7 21.9 29.7 30.6 28.1 25.0 29.6 11.8 31.6 44.7 23.3 42.3 29.3 65.9 23.3 24.7 25.8 28.9 19.9 42.7 41.4 35.2 22.3 31.4 32.5 37.8 44.0 35.6 33.2 27.0 39.7 30.7 32.2 23.2 60.4 30.4 46.2 15.8 51.8 25.9 24.4 15.1 17.8 24.1 32.0 23.6 16.2 MED30 "THRAP6, TRAP25" ENSG00000164758 "Mediator complex subunit 30" Q96HR3 8 117520713-117540262 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 151.0;Suprabasal keratinocytes: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045767 Approved Nucleoplasm NA NA Nucleoplasm "HPA045767: AB_2679446" "unprognostic (1.15e-1)" "unprognostic (1.90e-1)" "unprognostic (3.86e-2)" "unprognostic (1.57e-2)" "unprognostic (1.46e-1)" "unprognostic (3.20e-2)" "unprognostic (2.00e-2)" "unprognostic (3.33e-2)" "unprognostic (8.41e-2)" "unprognostic (4.02e-2)" "unprognostic (1.51e-2)" "unprognostic (7.73e-2)" "prognostic unfavorable (1.70e-6)" "unprognostic (5.38e-3)" "unprognostic (2.80e-1)" "unprognostic (1.05e-1)" "unprognostic (4.62e-2)" 18.5 12.5 10.8 16.1 12.1 46.7 18.8 12.9 14.8 16.8 14.9 15.4 12.0 11.9 17.8 21.0 15.8 18.3 9.2 14.9 11.1 10.0 9.9 19.0 16.2 19.7 13.7 8.6 23.0 10.1 4.2 14.5 14.3 12.1 16.1 15.2 10.5 11.1 14.2 12.2 16.9 12.9 15.8 14.1 17.0 12.4 18.9 13.1 34.3 19.3 12.9 18.5 17.5 16.1 28.7 34.8 45.4 27.3 16.9 24.3 17.5 22.2 2.3 9.0 5.9 6.3 5.9 9.9 6.7 7.3 10.3 12.9 4.2 11.1 17.8 10.8 3.6 7.9 10.1 7.9 5.2 13.3 23.7 9.8 14.4 1.4 5.5 6.9 11.4 12.5 5.4 6.0 5.3 12.0 3.8 6.3 25.9 8.0 10.9 4.8 5.2 35.0 29.3 5.0 21.1 16.6 13.0 11.3 7.8 5.2 3.9 12.7 10.8 7.9 18.3 10.1 8.5 4.4 14.6 3.0 5.0 13.2 9.2 11.6 9.5 6.4 20.5 4.7 13.0 8.4 24.7 16.7 45.4 21.3 18.8 22.3 24.0 21.6 20.9 18.1 28.7 24.3 23.0 38.8 16.9 27.3 34.8 22.8 17.5 10.8 12.1 12.9 14.8 11.1 10.0 13.7 8.6 12.1 13.1 8.9 17.1 45.0 68.1 151.0 5.5 5.1 17.8 60.2 15.9 8.7 5.9 43.1 10.0 19.7 20.7 26.7 20.8 0.0 19.7 56.3 56.7 49.8 20.8 20.4 27.1 0.0 36.1 33.2 28.6 10.4 55.3 33.3 38.8 17.2 32.4 7.8 16.3 30.8 35.0 14.3 4.5 32.3 41.0 32.1 36.6 133.1 51.5 58.0 37.7 53.3 MED31 "CGI-125, Soh1" ENSG00000108590 "Mediator complex subunit 31" Q9Y3C7 17 6643315-6651634 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035947 Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA035947: AB_10696646" "unprognostic (1.42e-1)" "unprognostic (4.39e-1)" "unprognostic (6.87e-2)" "unprognostic (4.40e-3)" "unprognostic (1.71e-1)" "unprognostic (3.99e-1)" "unprognostic (6.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.03e-2)" "unprognostic (1.39e-2)" "unprognostic (5.79e-2)" "unprognostic (6.46e-3)" "unprognostic (1.58e-2)" "unprognostic (1.54e-1)" "unprognostic (1.30e-1)" "unprognostic (2.22e-3)" "unprognostic (1.89e-1)" 9.7 19.7 18.7 9.6 21.6 9.4 16.2 25.3 25.5 12.1 10.0 10.2 8.9 9.4 11.9 30.5 20.8 14.3 13.9 16.0 19.0 21.4 15.4 15.9 10.1 14.1 16.0 15.1 14.0 9.5 9.1 22.3 12.5 19.4 11.3 9.7 10.5 14.3 10.4 11.4 21.8 11.3 13.6 13.7 14.5 10.0 17.6 11.5 17.5 16.3 13.4 15.4 16.9 11.9 12.5 13.4 33.3 12.2 11.8 15.7 11.0 18.0 20.3 18.3 11.6 16.6 14.2 6.5 14.2 14.6 21.9 28.7 10.0 9.5 2.4 18.0 6.9 16.3 19.9 14.4 17.3 19.1 13.1 24.2 4.4 18.6 15.4 12.5 5.0 9.5 7.6 19.1 19.8 6.8 11.8 16.2 9.6 7.8 4.7 15.8 6.6 9.6 13.1 6.5 8.2 11.8 7.2 8.1 6.6 18.2 9.0 7.1 8.0 7.2 5.9 15.4 9.0 6.1 5.5 7.3 10.9 9.4 13.7 14.1 4.3 5.5 6.0 15.0 6.0 7.7 28.6 12.2 19.5 14.7 8.3 13.9 12.0 13.6 14.1 10.4 12.5 12.4 13.1 33.3 11.8 10.0 13.4 15.7 11.0 18.7 21.6 25.3 25.5 19.0 21.4 16.0 15.1 19.4 11.5 14.9 19.3 37.2 41.8 94.9 7.5 4.5 43.3 61.6 19.4 31.4 9.8 37.0 46.4 32.6 26.3 32.3 17.8 0.0 27.5 35.1 31.5 42.1 26.5 51.9 29.6 12.7 12.1 38.6 27.8 40.6 41.1 29.6 38.8 27.9 17.2 16.7 35.8 14.0 24.8 41.8 10.6 38.8 32.0 75.1 83.7 105.0 40.0 35.4 18.3 56.1 MED4 "DRIP36, HSPC126, TRAP36, VDRIP" ENSG00000136146 "Mediator complex subunit 4" Q9NPJ6 13 48053323-48095131 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006232 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006232: AB_1079351" "unprognostic (1.10e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-1)" "unprognostic (2.80e-1)" "unprognostic (5.79e-1)" "unprognostic (2.56e-2)" "unprognostic (4.09e-1)" "unprognostic (7.97e-2)" "unprognostic (7.34e-3)" "unprognostic (3.21e-1)" "unprognostic (2.35e-1)" "unprognostic (2.45e-1)" "unprognostic (1.28e-1)" "unprognostic (1.86e-3)" "unprognostic (6.54e-3)" "unprognostic (1.94e-2)" "unprognostic (1.84e-1)" 31.3 25.9 29.1 23.1 33.4 43.8 31.8 28.9 31.8 27.4 32.3 23.2 24.3 26.4 32.1 30.3 31.5 24.4 21.9 36.6 28.5 24.1 28.6 33.3 24.1 27.7 29.4 34.1 26.0 21.2 18.0 27.8 40.2 29.5 27.9 31.6 19.0 26.3 27.2 58.8 29.2 33.3 35.6 30.7 29.2 25.2 34.7 26.7 39.7 28.9 29.7 35.0 26.4 26.4 33.9 32.8 52.1 35.3 41.4 50.0 41.7 13.7 9.0 31.0 17.1 20.7 26.7 21.5 20.2 25.3 24.3 17.4 17.1 23.8 22.8 5.8 21.3 15.0 21.1 22.7 19.4 31.8 29.4 18.6 29.8 17.7 26.7 19.2 43.9 27.6 18.4 27.4 14.3 21.3 23.8 22.5 23.1 21.1 14.6 27.1 13.9 41.2 41.9 30.7 44.8 12.0 30.1 21.0 18.3 31.5 21.5 13.7 22.3 16.5 20.8 21.4 21.1 17.7 33.2 18.1 13.6 15.8 17.0 18.3 14.2 20.7 34.9 11.7 23.1 25.8 42.9 34.6 52.1 41.0 35.2 45.2 33.9 46.6 41.3 32.8 30.7 45.3 42.9 36.5 41.4 35.3 29.8 50.0 41.7 29.1 33.4 28.9 31.8 28.5 24.1 29.4 34.1 29.5 26.7 89.3 48.5 58.1 61.8 81.1 51.2 87.3 58.6 60.2 102.4 54.1 15.7 104.5 129.3 69.3 65.3 77.3 49.0 46.7 55.2 88.3 76.1 49.7 94.8 58.7 61.5 35.0 25.8 46.1 48.8 142.9 71.1 63.1 74.2 169.5 41.9 46.1 53.9 60.4 72.9 63.7 43.3 51.8 73.1 126.5 140.6 85.1 112.8 80.4 51.2 61.0 MED6 NY-REN-28 ENSG00000133997 "Mediator complex subunit 6" O75586 14 70581257-70600690 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030764, HPA069039" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030764: AB_2673601, HPA069039: AB_2686070" "unprognostic (1.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (6.93e-2)" "unprognostic (2.86e-1)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (3.15e-2)" 16.7 19.7 20.3 16.5 30.7 22.7 21.9 42.0 30.4 17.6 15.7 19.3 16.6 14.2 23.6 22.9 24.5 19.7 14.8 17.1 20.1 19.5 14.7 20.2 15.5 26.9 17.4 23.0 25.7 15.6 13.5 30.0 22.9 21.9 15.2 16.5 20.5 17.4 17.4 29.9 24.1 16.2 18.9 19.6 21.6 16.4 16.6 20.5 21.0 19.4 18.9 30.2 18.5 18.8 19.9 18.5 23.5 21.1 21.3 24.8 14.2 36.9 20.7 26.8 11.6 14.7 15.5 21.4 18.8 19.9 28.9 28.3 20.3 23.0 28.4 11.1 15.9 17.3 17.9 31.3 18.9 31.2 19.8 16.6 20.6 16.0 27.4 18.0 18.0 16.6 17.6 22.2 20.7 19.2 12.8 22.1 21.7 18.9 18.0 20.9 27.6 25.7 24.4 19.9 26.3 25.2 21.5 25.0 14.7 18.0 19.8 18.3 19.8 19.6 21.0 21.8 16.3 32.8 22.7 17.5 23.8 34.6 12.0 17.2 19.1 28.4 39.8 20.8 15.7 16.5 17.4 16.2 23.5 18.7 18.2 22.2 18.9 24.8 21.3 18.5 19.9 23.1 23.3 15.8 21.3 21.1 13.9 23.1 14.2 20.3 30.7 42.0 30.4 20.1 19.5 17.4 23.0 21.9 20.5 17.9 21.7 37.3 31.2 17.2 71.1 5.6 10.2 25.4 18.2 17.4 74.6 34.1 5.0 27.0 5.8 22.4 13.9 23.3 20.3 35.6 20.0 28.9 45.1 12.5 22.6 25.4 21.2 26.4 19.2 4.4 25.0 20.6 16.9 27.1 10.5 47.4 22.6 17.6 27.6 12.5 92.2 25.8 18.6 20.6 39.9 17.6 41.0 40.8 14.6 27.6 MEF2A "RSRFC4, RSRFC9" ENSG00000068305 "Myocyte enhancer factor 2A" Q02078 15 99565417-99716466 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004499, HPA046597" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB004499: AB_627921, HPA046597: AB_2679714" "unprognostic (1.89e-1)" "unprognostic (8.82e-2)" "unprognostic (5.91e-2)" "unprognostic (8.04e-2)" "unprognostic (8.68e-2)" "unprognostic (2.05e-1)" "unprognostic (2.25e-1)" "unprognostic (6.26e-2)" "unprognostic (1.93e-2)" "unprognostic (1.91e-2)" "unprognostic (7.08e-3)" "unprognostic (1.46e-1)" "prognostic favorable (6.93e-4)" "prognostic unfavorable (7.96e-4)" "unprognostic (4.69e-2)" "unprognostic (1.32e-1)" "unprognostic (1.69e-3)" 28.9 17.4 17.4 19.1 24.3 12.0 20.1 22.9 31.6 21.9 19.7 20.1 18.2 9.5 30.5 24.7 16.6 20.5 16.6 62.0 14.9 12.7 18.8 17.5 26.0 16.7 14.0 21.9 23.0 11.7 32.0 10.2 18.8 16.1 19.9 11.4 14.5 15.5 18.4 46.1 38.4 16.3 31.2 23.6 22.2 16.3 10.7 15.8 17.6 15.2 19.6 17.3 25.2 15.9 12.8 10.7 11.3 14.2 5.6 4.5 4.3 8.5 4.8 8.2 4.1 10.5 13.5 4.1 8.7 20.0 7.1 9.8 4.9 11.9 10.7 12.3 18.6 11.0 9.4 8.3 6.8 9.3 7.2 12.2 21.6 10.9 4.5 18.0 8.5 10.6 8.9 11.5 9.6 19.9 29.8 13.0 8.9 7.6 20.6 13.3 3.5 13.9 12.7 4.5 5.7 7.1 20.5 18.0 8.7 14.7 12.1 5.3 7.4 13.2 5.7 24.4 9.1 5.4 7.8 21.2 20.0 11.0 9.8 10.4 11.3 12.8 23.4 13.9 9.5 19.0 6.2 10.3 11.3 3.4 12.8 2.9 12.8 3.2 3.0 10.7 10.4 4.5 3.4 10.2 5.6 14.2 6.6 2.1 4.3 17.4 24.3 22.9 31.6 14.9 12.7 14.0 21.9 16.1 15.8 74.5 34.5 30.5 27.2 78.8 48.1 137.9 20.4 69.6 51.2 27.9 47.1 6.7 21.6 16.0 6.0 83.9 18.4 23.3 16.2 2.9 42.7 21.5 30.1 37.6 35.1 28.6 12.2 52.8 98.7 3.6 51.8 62.9 33.7 33.3 16.2 25.2 20.7 23.0 60.8 15.3 40.4 71.1 67.0 25.6 25.6 44.2 7.7 19.7 12.4 21.3 MEIS1 ENSG00000143995 "Meis homeobox 1" O00470 2 66433452-66573869 "Disease related genes, Predicted intracellular proteins, Transcription factors" Transcription "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 104.1;Horizontal cells: 77.9;Paneth cells: 51.8;Rod photoreceptor cells: 125.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.3;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 4 "dendritic cells: 2.9;granulocytes: 1.9;NK-cells: 3.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 25.4;HeLa: 15.9;HHSteC: 19.0;SH-SY5Y: 16.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB011521, HPA056000" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB011521: AB_776272, HPA056000: AB_2683004" "unprognostic (6.84e-2)" "unprognostic (1.08e-1)" "unprognostic (3.43e-2)" "unprognostic (1.34e-1)" "unprognostic (4.22e-1)" "prognostic favorable (2.70e-5)" "unprognostic (2.45e-2)" "unprognostic (7.78e-3)" "unprognostic (2.36e-2)" "unprognostic (5.91e-2)" "unprognostic (1.07e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (6.52e-2)" "unprognostic (9.71e-2)" "unprognostic (4.13e-2)" "unprognostic (2.01e-2)" 7.9 21.2 2.5 14.1 5.1 1.1 9.0 27.5 5.1 52.6 24.0 6.8 13.1 3.0 49.3 15.6 18.2 30.5 15.5 9.0 2.0 1.5 4.7 1.8 14.7 5.3 8.9 3.6 25.4 33.8 4.4 1.4 8.0 9.4 14.8 7.0 10.8 26.4 20.2 2.6 4.8 7.7 31.9 7.7 7.2 14.1 5.9 5.6 0.7 2.7 6.6 6.2 20.6 22.7 0.1 2.9 1.9 0.4 3.3 0.6 5.3 0.1 0.9 7.5 1.5 9.8 6.4 1.0 9.8 25.4 8.4 8.8 0.8 7.1 0.0 2.5 7.5 0.5 1.2 4.4 4.4 8.4 0.0 4.3 12.4 15.9 1.8 19.0 0.0 3.3 5.8 5.1 3.4 1.5 6.8 3.9 2.0 1.1 0.0 0.3 0.5 0.9 0.2 0.2 0.9 1.0 0.0 2.0 1.8 0.7 2.3 2.4 16.2 1.8 0.5 0.7 5.9 0.7 1.4 1.2 1.8 3.0 1.3 2.7 1.9 0.6 0.1 1.6 10.9 0.5 1.9 0.1 0.0 0.5 0.4 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.6 1.4 3.3 0.0 2.9 0.2 5.3 2.5 5.1 27.5 5.1 2.0 1.5 8.9 3.6 9.4 5.6 0.0 0.3 0.0 11.4 2.9 10.6 16.1 0.0 2.7 6.8 0.0 104.1 4.1 0.0 16.5 8.7 3.8 0.9 0.0 15.3 1.6 11.0 1.7 0.0 1.6 2.0 77.9 1.2 16.5 1.9 10.4 31.9 0.5 3.3 0.0 0.3 19.9 16.8 51.8 26.5 2.9 125.2 19.4 10.6 1.4 0.9 1.9 1.6 0.0 0.9 13.7 MEIS3 "DKFZp547H236, MRG2" ENSG00000105419 "Meis homeobox 3" Q99687 19 47403124-47419523 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 35.3;endometrium 1: 28.8" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 22.3;Horizontal cells: 42.9;Late spermatids: 47.6;Muller glia cells: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 28.4;HMC-1: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046699 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046699: AB_2616456" "unprognostic (3.27e-3)" "unprognostic (2.98e-1)" "unprognostic (2.13e-2)" "unprognostic (4.49e-1)" "unprognostic (3.16e-1)" "unprognostic (4.67e-2)" "unprognostic (2.12e-2)" "unprognostic (5.93e-3)" "unprognostic (1.21e-1)" "unprognostic (2.73e-2)" "unprognostic (1.58e-2)" "unprognostic (9.76e-2)" "prognostic unfavorable (1.78e-6)" "unprognostic (9.29e-3)" "unprognostic (9.21e-3)" "unprognostic (4.36e-2)" "unprognostic (3.80e-3)" 5.6 3.9 35.3 4.7 10.6 0.0 5.0 11.0 25.3 8.4 4.7 2.4 3.8 3.5 28.8 2.2 6.0 14.2 6.0 3.7 23.2 11.6 1.5 1.1 3.1 1.2 2.6 14.6 7.4 1.7 1.1 4.9 7.4 3.8 7.0 2.1 4.1 3.6 6.4 1.4 1.6 3.8 22.5 1.7 2.4 2.6 3.3 2.0 0.5 3.4 1.6 1.4 6.1 4.7 0.0 0.2 0.5 0.7 0.0 0.1 0.4 0.3 12.1 28.4 0.1 15.4 13.3 0.4 12.7 19.4 9.9 17.5 1.1 1.9 0.0 1.4 20.8 8.2 1.4 2.9 3.5 3.4 18.9 4.3 0.0 4.4 0.1 10.0 0.2 24.6 9.8 0.7 3.9 2.1 3.5 0.0 0.0 0.2 2.8 1.1 11.5 0.0 0.1 8.3 0.3 0.7 0.0 2.1 0.3 0.6 0.9 1.1 23.0 10.9 0.9 5.2 11.8 0.6 3.5 0.0 7.6 19.3 5.5 1.7 0.0 0.0 0.0 21.2 1.1 15.2 0.1 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.1 0.4 35.3 10.6 11.0 25.3 23.2 11.6 2.6 14.6 3.8 2.0 0.0 2.7 0.0 1.0 0.7 4.8 0.8 0.0 2.7 3.4 3.5 5.9 0.1 0.0 0.0 22.3 0.5 0.0 0.0 0.0 0.2 9.9 3.2 0.0 0.0 0.5 42.9 0.0 1.8 0.0 47.6 10.6 1.1 6.8 0.0 0.0 18.0 0.1 0.0 3.9 0.0 2.7 12.9 6.9 2.6 4.7 0.9 0.7 0.0 0.0 0.7 METTL1 "C12orf1, TRM8, TRMT8" ENSG00000037897 "Methyltransferase like 1" Q9UBP6 12 57768471-57772793 "Enzymes, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 6 "RH-30: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020914, HPA050450" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA020914: AB_1853830, HPA050450: AB_2681130" "unprognostic (5.24e-2)" "unprognostic (2.60e-1)" "unprognostic (9.43e-2)" "unprognostic (3.46e-1)" "unprognostic (9.01e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (4.25e-6)" "unprognostic (5.67e-2)" "unprognostic (6.19e-2)" "unprognostic (1.14e-3)" "unprognostic (1.78e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (3.55e-6)" "unprognostic (7.75e-2)" "unprognostic (1.96e-1)" "unprognostic (5.01e-2)" "unprognostic (2.22e-1)" 12.2 16.6 6.7 13.8 8.8 8.4 12.3 2.2 6.9 7.6 7.6 4.5 10.8 3.3 9.4 21.2 10.3 9.0 10.7 8.1 5.8 5.0 20.9 15.3 7.7 8.8 7.4 4.6 17.6 34.9 10.9 10.6 8.3 6.5 11.0 10.3 5.3 17.9 17.2 20.4 8.5 5.7 10.5 5.0 8.2 7.3 11.4 5.4 4.5 15.1 15.6 9.8 8.8 7.8 6.1 12.6 0.7 6.7 7.3 18.6 5.1 6.1 11.2 4.7 4.3 6.4 4.4 6.4 6.6 6.0 11.1 6.0 7.8 8.6 7.4 12.3 8.0 6.3 7.3 7.2 10.2 10.8 4.4 8.4 8.6 4.3 9.5 4.5 9.3 4.5 3.9 9.3 12.4 8.7 5.4 5.9 4.8 7.9 7.4 5.6 11.9 6.5 11.1 11.1 8.2 11.3 5.8 78.7 10.9 9.7 7.7 5.0 4.5 6.9 7.6 6.1 4.9 10.0 8.8 4.4 4.5 5.0 7.9 8.7 3.4 2.5 9.0 6.4 6.7 9.3 0.0 4.7 0.0 5.3 6.7 18.6 4.7 6.9 6.5 10.3 6.1 9.5 9.2 0.7 7.3 1.1 12.6 3.3 5.1 6.7 8.8 2.2 6.9 5.8 5.0 7.4 4.6 6.5 5.4 8.9 3.5 8.9 11.4 9.3 2.9 3.6 2.5 1.4 17.0 5.2 0.0 15.0 21.6 15.2 11.3 7.1 1.3 0.0 20.6 19.6 12.0 7.7 12.7 9.0 22.2 3.2 6.3 4.3 1.0 8.6 10.3 9.0 6.8 27.1 5.6 1.6 12.8 0.0 4.6 53.6 5.5 0.0 14.7 4.8 14.7 9.2 8.1 4.3 9.1 10.5 METTL14 KIAA1627 ENSG00000145388 "Methyltransferase like 14" Q9HCE5 4 118685368-118715433 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 64.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038002 Supported Supported Nucleoplasm Yes No Nucleoplasm "HPA038002: AB_10672401" "unprognostic (4.48e-1)" "unprognostic (5.13e-2)" "unprognostic (5.98e-3)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.83e-1)" "unprognostic (3.75e-2)" "unprognostic (4.40e-1)" "unprognostic (9.97e-2)" "unprognostic (2.40e-2)" "unprognostic (3.64e-2)" "unprognostic (3.33e-3)" "prognostic favorable (1.46e-5)" "unprognostic (1.05e-1)" "unprognostic (1.32e-1)" "unprognostic (1.76e-3)" "unprognostic (7.76e-3)" 17.3 16.4 15.5 12.4 19.2 25.8 18.0 25.9 19.4 21.8 16.1 12.8 11.7 13.4 19.1 17.2 16.4 15.9 12.0 12.3 13.3 11.3 17.4 22.0 13.9 15.9 16.4 16.0 22.6 14.6 17.1 34.5 13.6 16.0 20.0 13.0 12.3 13.7 14.9 13.5 16.4 15.4 14.5 17.3 17.3 14.2 26.6 18.4 24.1 18.7 10.6 16.2 23.0 16.1 18.9 12.3 24.1 17.5 17.1 18.4 10.7 14.7 6.8 14.9 14.0 9.4 11.9 10.9 13.2 10.1 10.0 11.5 9.8 17.7 16.8 7.9 9.2 10.0 7.3 12.6 10.9 12.8 13.2 7.7 14.0 8.6 10.9 10.8 22.6 16.8 10.5 12.6 11.5 7.7 13.1 9.0 13.5 14.9 14.3 13.6 9.9 22.1 19.0 12.8 12.7 6.0 12.7 18.7 8.4 10.8 9.8 12.3 13.8 9.3 17.3 12.5 14.3 7.8 21.6 12.1 14.5 13.3 12.9 10.4 12.0 12.5 19.1 10.3 12.7 11.7 24.1 10.6 22.3 14.7 15.6 16.6 18.9 15.4 15.1 12.3 18.1 18.4 16.6 8.5 17.1 17.5 9.8 16.2 10.7 15.5 19.2 25.9 19.4 13.3 11.3 16.4 16.0 16.0 18.4 23.8 23.4 4.8 15.3 9.6 15.8 13.7 15.3 13.4 27.3 22.7 21.6 15.0 10.0 9.5 64.5 14.8 10.9 0.0 13.6 8.9 10.1 14.5 20.9 29.7 10.5 7.9 11.6 14.7 15.5 9.0 17.3 12.0 6.8 7.2 14.1 12.0 12.0 15.0 13.1 18.2 24.7 12.9 11.7 18.9 16.8 10.5 12.8 17.5 13.0 13.2 METTL17 "FLJ20859, METT11D1" ENSG00000165792 "Methyltransferase like 17" Q9H7H0 14 20989770-20997035 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002955, HPA059802" Uncertain Enhanced Nucleoplasm "Intracellular and membrane" No No Nucleoplasm "HPA002955: AB_2144183, HPA059802: AB_2684129" "unprognostic (1.90e-2)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (2.88e-1)" "unprognostic (1.28e-1)" "unprognostic (1.00e-2)" "unprognostic (2.23e-3)" "unprognostic (1.90e-1)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (4.02e-2)" "unprognostic (3.06e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (2.11e-1)" "unprognostic (3.29e-2)" 11.4 35.7 15.8 15.8 18.4 25.4 14.4 24.9 16.6 16.4 22.1 14.2 25.6 19.7 14.9 15.8 23.4 15.2 12.2 20.6 17.3 10.0 20.7 20.4 17.5 18.5 21.1 11.8 15.6 19.8 11.6 18.9 16.0 16.1 13.4 25.0 14.2 23.1 26.1 20.2 16.0 21.6 21.0 16.3 25.0 17.6 21.9 20.2 17.9 15.1 22.1 22.3 12.7 15.2 7.9 10.3 17.6 5.3 6.2 9.2 4.3 14.4 17.9 18.8 7.1 11.6 5.2 14.5 9.6 13.5 29.3 24.2 14.1 18.9 31.0 9.8 12.5 18.1 24.2 23.8 18.8 21.2 10.9 19.7 16.2 13.2 18.4 10.9 27.1 18.8 10.8 16.6 15.0 11.2 10.4 11.7 27.8 14.9 14.9 13.9 10.7 18.0 28.2 18.7 23.1 22.7 23.1 16.5 20.4 15.6 14.2 13.5 15.9 12.7 16.7 9.6 14.4 11.6 23.9 6.5 10.2 29.9 9.9 13.1 12.9 20.9 22.1 5.9 19.5 12.3 17.6 5.3 5.0 8.6 4.9 4.8 7.3 9.1 8.4 10.3 7.9 8.9 9.2 0.0 6.2 3.2 6.2 7.1 4.3 15.8 18.4 24.9 16.6 17.3 10.0 21.1 11.8 16.1 20.2 8.9 12.4 26.4 18.4 16.8 36.1 4.8 17.8 24.1 12.5 10.4 41.2 27.0 5.0 17.2 37.8 9.0 22.4 0.0 13.4 14.1 13.0 10.5 27.8 22.7 16.0 20.6 11.7 12.3 9.9 5.6 31.1 17.5 3.3 19.8 20.1 26.1 13.4 30.0 20.1 13.6 49.5 12.9 13.9 18.2 14.0 15.6 10.6 18.7 30.4 24.6 MGLL "HU-K5, MGL" ENSG00000074416 "Monoglyceride lipase" Q99685 3 127689062-127823250 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 404.8;Pancreatic endocrine cells: 322.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.6;intermediate monocyte: 28.5;non-classical monocyte: 18.3;plasmacytoid DC: 30.4" "Group enriched" "Detected in many" 13 "dendritic cells: 30.4;granulocytes: 11.6;monocytes: 28.5" "Cell line enhanced" "Detected in many" "BJ: 46.5;BJ hTERT+: 53.6;LHCN-M2: 42.8;RPTEC TERT1: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011348, HPA011993, HPA011994" Enhanced Enhanced Nucleoplasm NA NA 4300000 Nucleoplasm "HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916" "unprognostic (1.84e-2)" "unprognostic (1.80e-2)" "unprognostic (2.14e-1)" "unprognostic (8.19e-2)" "unprognostic (1.15e-2)" "unprognostic (1.69e-1)" "unprognostic (5.83e-2)" "unprognostic (3.61e-2)" "unprognostic (1.45e-1)" "unprognostic (8.83e-2)" "prognostic unfavorable (6.41e-4)" "unprognostic (7.63e-3)" "unprognostic (1.44e-1)" "unprognostic (1.68e-1)" "unprognostic (1.90e-2)" "unprognostic (2.51e-1)" "unprognostic (2.11e-3)" 72.2 6.7 29.4 22.6 29.7 7.5 39.0 32.8 36.9 13.3 36.3 8.3 8.4 16.5 8.7 10.8 63.8 16.3 24.1 35.5 23.6 10.2 22.6 32.1 32.4 6.0 15.4 17.8 3.9 3.6 1.7 5.0 18.9 10.2 10.6 27.6 10.0 31.4 13.6 40.9 11.9 22.3 13.6 12.2 19.2 17.5 3.2 15.5 2.4 6.4 33.4 19.7 14.4 14.5 1.8 30.4 11.6 28.5 0.6 0.9 6.0 11.2 10.1 0.0 0.0 17.8 21.0 1.3 46.5 53.6 10.3 16.6 0.3 4.6 2.9 12.9 15.7 3.1 0.4 0.0 6.1 5.7 5.0 0.1 0.3 7.2 0.0 6.4 0.0 0.3 7.8 3.6 19.3 21.1 5.8 21.8 0.1 0.0 0.5 42.8 1.1 0.0 0.1 0.0 7.3 16.0 0.0 5.5 23.8 38.6 1.2 6.0 0.4 8.0 15.8 2.7 0.4 0.7 0.4 27.9 11.3 3.3 27.2 6.3 0.0 0.0 9.5 23.4 0.6 35.0 4.2 2.8 11.6 0.2 28.5 0.9 1.8 0.2 0.3 3.1 0.2 0.0 0.0 0.5 0.6 18.3 30.4 0.0 6.0 29.4 29.7 32.8 36.9 23.6 10.2 15.4 17.8 10.2 15.5 181.7 90.0 5.2 8.0 20.3 16.7 42.0 119.8 56.2 34.2 40.1 0.0 68.4 142.6 90.3 3.6 101.2 167.0 23.3 144.8 129.8 47.2 9.2 8.1 126.2 122.7 0.0 85.0 14.7 24.4 4.0 30.2 33.6 20.3 404.8 177.1 46.3 322.3 129.8 65.4 60.0 6.1 84.1 176.1 0.2 1.1 19.4 60.8 10.2 49.8 4.2 MGMT ENSG00000170430 "O-6-methylguanine-DNA methyltransferase" P16455 10 129467184-129768007 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Hepatocytes: 419.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002786, HPA032135, HPA032136, HPA069497, CAB069881" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002786: , CAB069881: AB_10002128, HPA032135: AB_2674171, HPA032136: AB_2674172, HPA069497: AB_2732134" "unprognostic (1.10e-1)" "prognostic favorable (9.42e-4)" "unprognostic (1.48e-1)" "unprognostic (5.81e-2)" "unprognostic (7.84e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.54e-4)" "unprognostic (6.54e-3)" "unprognostic (4.71e-2)" "unprognostic (2.03e-1)" "unprognostic (1.26e-1)" "unprognostic (6.32e-1)" "unprognostic (4.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" 11.7 11.3 7.4 15.5 7.6 7.1 11.3 3.5 9.1 8.3 12.2 10.0 19.6 10.8 15.3 17.1 9.9 15.2 14.1 10.5 7.1 7.1 12.6 45.6 7.5 11.6 8.6 6.6 12.3 16.5 5.7 5.8 4.5 9.2 11.2 3.4 11.8 14.9 24.5 14.4 9.2 9.6 10.9 8.1 8.6 9.9 11.7 3.9 16.0 10.2 14.9 14.7 12.6 13.0 20.3 17.7 6.5 15.3 18.2 21.2 16.6 0.0 2.5 2.7 13.0 5.7 11.8 10.2 5.7 6.4 4.2 4.1 15.8 16.9 11.8 9.2 7.4 0.0 7.7 1.7 6.1 1.9 0.0 1.0 2.3 5.8 10.1 8.8 0.2 6.8 7.5 0.0 2.4 0.0 0.0 0.0 20.0 0.0 8.3 5.1 21.3 9.3 12.1 0.6 10.9 10.2 10.8 0.0 4.6 7.8 5.8 2.7 6.8 6.9 2.8 0.0 2.2 11.2 9.2 0.0 5.5 2.8 0.0 0.0 0.0 0.0 6.0 0.0 3.8 0.0 2.6 15.3 6.5 19.1 14.8 18.6 20.3 17.5 17.8 15.8 19.9 17.6 18.9 1.8 18.2 13.7 17.7 21.2 16.6 7.4 7.6 3.5 9.1 7.1 7.1 8.6 6.6 9.2 3.9 11.9 14.7 57.0 56.4 45.4 15.7 37.8 86.6 57.6 15.9 97.7 7.9 41.1 107.8 40.8 70.9 48.0 68.8 23.3 51.1 53.2 48.9 49.8 64.5 419.1 76.3 14.3 52.4 98.2 75.3 90.6 62.5 39.9 62.4 45.9 56.4 33.9 74.4 47.0 51.9 227.8 39.0 45.3 55.7 43.1 97.3 37.3 22.4 67.1 59.6 48.8 MGST3 GST-III ENSG00000143198 "Microsomal glutathione S-transferase 3" O14880 1 165630861-165661796 "Enzymes, Predicted membrane proteins" "Lyase, Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cytotrophoblasts: 1846.4;Syncytiotrophoblasts: 1983.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 88.9;HDLM-2: 94.3;OE19: 97.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053311, HPA077929" Enhanced Approved Nucleoplasm NA NA 40000 Nucleoplasm "HPA053311: AB_2682108, HPA077929: " "unprognostic (1.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.65e-2)" "unprognostic (1.22e-2)" "unprognostic (2.67e-1)" "unprognostic (7.78e-2)" "unprognostic (3.09e-1)" "unprognostic (2.06e-2)" "unprognostic (2.16e-1)" "unprognostic (1.90e-1)" "unprognostic (3.96e-1)" "unprognostic (3.34e-2)" "unprognostic (1.12e-2)" "unprognostic (7.60e-2)" "unprognostic (8.88e-2)" "unprognostic (1.89e-1)" "unprognostic (1.90e-1)" 42.8 30.8 52.5 9.7 30.5 19.0 51.2 17.9 56.0 18.4 39.7 18.4 19.1 65.2 19.5 101.8 19.7 20.6 26.5 133.6 38.1 33.9 45.2 29.5 20.8 11.0 44.2 37.6 22.7 17.7 11.1 18.3 30.9 39.6 21.2 40.4 20.3 29.8 20.6 87.2 15.6 53.4 24.7 38.7 12.4 29.8 19.4 23.3 2.7 25.7 41.8 8.2 19.9 17.3 21.3 35.1 20.7 47.0 15.7 38.0 40.7 22.2 16.3 17.7 13.9 62.1 37.3 88.9 18.6 30.0 14.5 25.3 17.0 29.0 1.4 14.7 22.7 14.3 27.2 4.3 18.2 14.7 94.3 11.1 3.4 12.8 7.7 17.5 5.3 7.5 31.8 14.7 20.0 7.7 28.6 23.6 6.1 8.3 8.5 27.1 4.9 5.9 12.3 38.7 97.4 21.0 5.6 7.6 2.8 76.5 20.9 13.7 16.8 18.7 24.3 37.0 37.1 18.5 26.2 21.4 18.0 10.7 12.4 13.4 6.3 4.3 0.7 33.4 14.1 11.6 10.4 45.7 20.7 30.1 37.0 30.3 21.3 38.0 33.5 35.1 19.9 24.4 26.7 9.8 15.7 47.0 15.1 32.3 40.7 52.5 30.5 17.9 56.0 38.1 33.9 44.2 37.6 39.6 23.3 95.3 125.6 83.1 202.5 202.9 129.1 591.8 331.2 242.2 134.2 528.7 251.3 1846.4 848.8 339.3 13.2 253.1 716.8 630.8 371.6 1154.8 298.4 174.8 89.0 248.3 760.5 123.9 146.8 184.8 114.8 21.3 359.3 238.2 492.6 405.8 197.9 162.7 335.4 599.7 375.8 841.2 122.6 498.0 374.9 15.6 33.3 203.4 1983.2 87.4 339.8 197.4 MIDN ENSG00000167470 Midnolin Q504T8 19 1248553-1259140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 13.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 13.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042018, HPA049432" Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA042018: AB_2677800, HPA049432: AB_2680765" "unprognostic (1.82e-2)" "unprognostic (6.21e-2)" "unprognostic (2.27e-2)" "unprognostic (2.18e-2)" "unprognostic (2.40e-1)" "unprognostic (2.24e-3)" "unprognostic (1.06e-2)" "unprognostic (2.04e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (3.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.49e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-1)" "unprognostic (3.56e-1)" "unprognostic (1.19e-2)" 28.0 32.6 9.7 22.7 16.1 59.4 16.6 8.9 19.5 19.5 24.7 17.6 12.6 19.0 14.1 14.2 38.7 28.3 40.8 27.8 10.4 9.8 17.9 19.3 28.7 19.9 10.2 6.5 36.7 20.0 8.2 32.7 19.7 22.3 20.1 11.1 19.5 18.8 22.2 48.2 26.6 31.6 14.6 14.6 30.7 21.9 10.5 9.2 28.6 14.0 31.3 34.5 19.4 20.1 0.4 0.5 13.5 1.2 1.4 1.2 0.6 5.2 11.6 19.9 9.2 4.2 7.3 14.6 9.1 5.5 4.7 3.3 15.1 5.9 8.4 10.0 6.8 2.5 10.8 6.0 9.7 1.8 11.7 11.0 11.7 7.6 11.8 8.7 11.8 17.5 11.2 9.1 5.6 5.4 7.3 7.7 10.0 15.0 8.8 4.9 21.0 15.7 4.8 43.7 10.3 7.7 24.5 5.6 3.8 8.8 6.2 16.0 20.9 19.3 18.6 12.0 10.8 7.4 13.5 9.5 8.6 9.6 39.5 9.8 8.4 4.5 11.4 16.5 5.3 29.2 1.1 1.2 1.2 1.2 1.2 0.8 0.3 0.4 0.8 0.5 0.4 0.2 0.6 13.5 1.4 1.2 0.5 0.1 0.6 9.7 16.1 8.9 15.5 10.4 9.8 10.2 6.5 22.3 9.2 35.7 74.9 43.3 105.5 87.8 56.5 71.4 104.4 30.8 33.0 127.4 29.5 12.3 16.6 100.6 27.2 122.8 266.9 0.0 134.4 37.6 65.2 167.2 60.0 71.2 67.2 20.6 157.9 183.5 91.3 20.0 46.1 71.9 40.5 13.6 163.9 48.5 185.5 221.8 31.1 33.6 32.7 38.8 178.2 2.7 14.0 129.5 68.0 56.7 123.5 150.3 MIER1 "hMI-ER1, KIAA1610, MI-ER1" ENSG00000198160 "MIER1 transcriptional regulator" Q8N108 1 66924895-66988619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019589, HPA050306" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA019589: AB_1853953, HPA050306: AB_2681080" "unprognostic (3.38e-3)" "unprognostic (1.34e-1)" "prognostic favorable (4.96e-4)" "unprognostic (1.63e-1)" "prognostic favorable (3.44e-8)" "unprognostic (1.61e-1)" "unprognostic (3.15e-3)" "unprognostic (1.32e-1)" "unprognostic (1.05e-1)" "unprognostic (3.92e-3)" "unprognostic (4.48e-3)" "unprognostic (2.57e-2)" "unprognostic (2.81e-2)" "unprognostic (2.25e-2)" "unprognostic (2.73e-1)" "unprognostic (5.15e-2)" "unprognostic (2.45e-2)" 23.5 20.0 13.9 23.2 14.8 70.3 19.9 15.9 14.9 22.2 22.9 10.8 18.8 13.2 19.3 17.9 16.0 15.0 19.0 12.5 13.3 12.9 16.0 20.7 19.4 22.2 14.8 10.9 22.9 11.8 11.2 20.2 18.5 13.3 19.9 20.7 10.8 12.6 22.5 14.0 14.1 22.3 25.6 15.0 23.0 16.1 15.9 13.9 30.4 17.4 13.9 16.3 23.9 34.3 8.5 7.6 24.3 12.2 9.6 14.9 5.3 14.1 8.4 10.3 18.4 21.2 14.6 11.5 15.0 17.0 15.4 16.7 6.8 8.9 14.3 5.7 16.9 13.7 9.5 12.7 16.2 22.0 16.8 9.8 31.4 22.5 10.5 17.2 24.7 18.7 14.5 12.3 17.1 17.8 17.6 16.5 17.9 16.5 13.0 17.6 4.4 35.8 9.0 14.4 6.5 5.4 15.7 24.8 9.9 12.8 16.3 6.2 11.9 22.4 13.8 14.6 10.4 7.4 16.4 19.3 17.6 12.5 17.2 13.8 16.1 14.9 20.9 14.3 10.9 10.6 21.6 7.4 16.6 12.8 8.0 14.9 7.5 11.6 11.3 5.5 8.5 12.0 11.7 24.3 9.6 12.2 7.6 9.5 5.3 13.9 14.8 15.9 14.9 13.3 12.9 14.8 10.9 13.3 13.9 14.9 43.7 34.7 30.9 42.8 36.6 29.9 20.4 36.1 34.2 26.2 23.6 32.0 38.1 31.5 37.6 46.8 73.5 0.0 35.1 21.8 47.2 42.0 89.1 45.1 20.1 38.1 40.5 35.0 36.9 40.6 75.4 43.8 13.5 51.3 46.9 62.0 40.3 63.2 87.7 24.9 46.9 77.6 49.2 49.7 56.8 30.4 28.7 56.8 35.4 56.7 MIER3 "DKFZp686L09111, DKFZp781I1119, FLJ35954" ENSG00000155545 "MIER family member 3" Q7Z3K6 5 56919602-56971675 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058349, HPA065946" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA058349: AB_2683688, HPA065946: AB_2685583" "unprognostic (1.01e-1)" "unprognostic (2.71e-1)" "unprognostic (4.07e-3)" "unprognostic (1.81e-1)" "unprognostic (2.22e-2)" "unprognostic (1.29e-1)" "unprognostic (2.82e-2)" "unprognostic (2.47e-1)" "unprognostic (1.61e-2)" "unprognostic (3.36e-1)" "unprognostic (1.88e-2)" "unprognostic (5.66e-2)" "unprognostic (9.31e-3)" "unprognostic (5.53e-2)" "unprognostic (3.76e-1)" "unprognostic (2.63e-2)" "unprognostic (4.84e-3)" 7.5 7.3 5.6 8.0 7.7 8.0 10.9 23.0 10.7 10.9 25.9 7.7 5.4 19.4 15.3 8.0 7.1 8.4 5.5 6.5 5.9 5.4 6.7 9.5 6.1 6.6 9.2 7.4 13.5 14.7 12.1 12.5 8.7 9.2 8.2 19.5 9.6 7.9 8.7 8.2 6.2 14.1 8.0 8.5 6.4 6.9 15.0 8.1 12.4 8.6 7.7 6.6 7.4 12.2 4.1 4.4 4.4 4.1 3.8 6.0 3.4 6.4 9.4 13.2 24.8 8.8 7.0 18.3 6.1 7.9 11.6 13.0 14.9 5.5 7.0 7.4 7.1 10.5 8.2 16.5 6.5 12.5 3.6 7.6 6.0 11.3 7.1 6.6 8.1 12.4 8.1 8.2 8.6 7.2 7.2 7.5 8.6 7.7 12.1 6.7 7.1 12.2 9.3 10.4 2.9 5.5 20.6 12.4 7.2 5.5 12.9 11.0 17.6 18.5 6.9 9.1 11.0 10.0 7.7 7.2 3.3 10.4 5.9 10.9 7.5 10.1 17.6 6.3 6.3 7.2 0.6 2.4 4.4 3.3 4.1 4.9 4.1 2.6 6.0 3.8 4.0 4.8 3.3 2.3 3.8 3.3 4.4 2.5 3.4 5.6 7.7 23.0 10.7 5.9 5.4 9.2 7.4 9.2 8.1 14.9 4.8 1.9 4.4 11.9 7.1 7.1 10.2 4.0 6.8 3.5 13.7 3.2 5.0 3.5 11.5 5.8 44.2 0.0 5.0 2.9 8.2 7.4 4.6 8.5 3.5 9.5 11.5 8.0 5.1 5.6 5.5 4.8 1.7 7.2 14.2 6.6 6.3 12.7 8.1 4.2 13.2 12.9 6.6 11.7 4.1 8.5 5.7 4.9 8.9 5.4 MINDY1 "FAM63A, FLJ11280, MINDY-1" ENSG00000143409 "MINDY lysine 48 deubiquitinase 1" Q8N5J2 1 150996086-151008375 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 33.2;Ductal cells: 11.3;Proximal tubular cells: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 26.3;eosinophil: 19.1;neutrophil: 30.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 30.4" "Cell line enhanced" "Detected in many" "T-47d: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028351, HPA028358, HPA061086" Approved Enhanced Nucleoplasm NA NA 240000 Nucleoplasm "HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425" "unprognostic (5.73e-2)" "unprognostic (2.86e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-1)" "unprognostic (3.39e-2)" "unprognostic (6.90e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-1)" "unprognostic (1.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.22e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.43e-8)" "unprognostic (2.30e-1)" "unprognostic (7.95e-2)" "unprognostic (2.50e-2)" "unprognostic (6.06e-2)" 9.2 9.7 14.0 6.7 31.1 5.6 13.0 18.4 21.2 13.1 13.5 53.8 14.8 14.0 14.7 6.5 24.1 14.4 11.8 24.5 17.6 10.1 26.6 12.2 10.9 5.2 37.5 13.5 19.3 37.3 26.2 12.3 5.9 25.0 11.7 14.8 16.9 25.3 21.0 11.9 17.1 12.1 13.7 34.1 10.7 15.9 14.7 35.7 0.9 39.9 7.9 10.3 12.3 13.0 0.6 4.0 30.4 3.2 1.5 2.2 3.4 6.1 4.0 4.3 6.1 7.8 6.5 3.6 2.0 5.1 2.8 4.5 8.6 14.7 0.4 4.8 2.6 0.9 3.1 3.4 3.7 1.3 4.6 5.1 6.0 7.4 7.3 1.7 1.8 2.4 5.3 3.4 5.1 1.4 9.6 7.2 2.1 3.7 15.5 2.9 9.5 0.3 4.0 2.0 1.9 1.4 4.5 0.8 18.9 13.4 12.2 7.5 5.5 3.8 7.0 4.2 2.1 27.9 6.1 6.7 2.4 3.2 1.2 1.7 5.7 5.2 20.6 5.8 4.0 11.4 26.3 3.2 19.1 0.1 1.5 0.1 0.3 1.3 0.3 4.0 0.6 2.2 0.7 30.4 1.5 0.9 0.6 1.6 3.4 14.0 31.1 18.4 21.2 17.6 10.1 37.5 13.5 25.0 35.7 8.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 4.0 6.8 3.5 0.0 3.4 33.2 11.3 0.0 0.0 0.0 0.0 6.1 0.6 0.0 0.0 3.5 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 7.3 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 MINDY2 "FAM63B, KIAA1164" ENSG00000128923 "MINDY lysine 48 deubiquitinase 2" Q8NBR6 15 58771192-58861900 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 137.0;Collecting duct cells: 78.5;Extravillous trophoblasts: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 40.6" "Low region specificity" "Detected in all" "HPA051103, HPA063669" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA051103: AB_2681345, HPA063669: AB_2685082" "unprognostic (4.71e-2)" "unprognostic (8.92e-3)" "unprognostic (4.63e-2)" "unprognostic (4.13e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "unprognostic (8.60e-2)" "unprognostic (7.23e-2)" "unprognostic (7.09e-2)" "unprognostic (2.36e-3)" "unprognostic (4.74e-2)" "prognostic favorable (3.00e-8)" "unprognostic (2.53e-1)" "unprognostic (3.59e-1)" "unprognostic (6.76e-2)" "unprognostic (4.77e-2)" 14.0 9.2 15.5 8.8 14.7 5.6 11.1 41.0 15.4 12.4 8.8 12.4 11.8 5.8 13.0 8.0 11.8 11.7 10.4 16.7 14.6 12.6 16.9 5.8 12.5 6.1 16.2 15.5 11.7 6.4 15.5 12.5 21.9 14.9 15.0 6.6 11.7 7.7 11.8 6.1 11.4 6.5 13.6 16.9 9.4 7.8 6.2 15.8 8.6 15.8 5.4 6.0 13.1 9.1 4.6 2.9 5.5 3.1 1.9 5.5 1.4 5.8 2.9 4.1 2.5 6.2 11.4 6.5 5.4 11.5 1.7 2.4 4.6 2.9 3.0 5.9 6.5 3.0 5.7 7.5 4.3 2.6 3.0 2.7 4.2 3.2 4.1 3.8 3.1 3.9 5.0 7.3 2.0 4.5 6.4 4.1 3.2 7.2 3.4 3.9 0.7 3.9 2.4 8.7 0.8 1.5 1.7 11.8 3.2 5.0 6.6 3.7 2.8 3.9 5.5 9.8 9.1 1.7 6.7 4.8 2.4 2.1 40.6 2.3 3.0 4.3 3.0 5.3 5.2 5.7 5.5 1.8 3.3 3.2 1.6 5.5 2.7 2.8 3.5 0.6 4.6 2.4 3.3 3.9 1.9 3.1 2.9 2.2 1.4 15.5 14.7 41.0 15.4 14.6 12.6 16.2 15.5 14.9 15.8 137.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 52.2 33.0 78.5 0.0 54.4 39.7 36.7 0.0 0.0 0.0 0.0 18.8 84.1 0.0 0.0 10.5 0.0 28.7 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 16.2 0.0 0.0 23.8 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 44.5 0.0 0.0 0.0 MIXL1 "MILD1, MIXL" ENSG00000185155 "Mix paired-like homeobox" Q9H2W2 1 226223618-226227054 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 23.9;lymphoid tissue: 8.9" "Cell type enhanced" "Detected in single" 17 "Melanocytes: 1.7" "Cancer enriched" "Detected in some" 9 "testis cancer: 6.3" "Group enriched" "Detected in some" 5 "cerebellum: 5.1;cerebral cortex: 1.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HAP1: 2.7;Hep G2: 13.3;SuSa: 3.1;U-698: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA005662 Approved Nucleoplasm NA NA Nucleoplasm "HPA005662: AB_2667382" "unprognostic (4.09e-2)" "unprognostic (2.84e-2)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (6.34e-2)" "unprognostic (1.03e-2)" "unprognostic (3.18e-2)" "unprognostic (5.66e-2)" "unprognostic (5.05e-2)" "unprognostic (7.40e-3)" "unprognostic (2.78e-2)" "unprognostic (2.70e-1)" "unprognostic (2.71e-13)" "unprognostic (1.54e-1)" "unprognostic (1.29e-2)" "unprognostic (1.67e-1)" "unprognostic (8.47e-2)" 0.6 0.2 0.6 8.9 0.4 0.3 0.3 5.1 1.8 0.7 1.4 0.4 0.0 2.7 0.4 0.1 0.6 0.3 0.2 0.4 0.6 0.6 0.3 0.6 0.5 8.2 0.6 0.0 1.2 0.2 2.3 0.3 0.3 0.6 1.0 1.1 0.2 4.9 0.4 0.2 0.3 1.3 0.0 0.5 7.8 1.4 2.2 0.0 1.0 0.4 0.7 7.0 2.6 0.3 7.5 7.7 23.9 12.2 14.6 9.5 4.0 0.1 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.1 2.7 0.0 0.2 0.0 0.1 0.2 0.2 13.3 0.7 0.0 0.1 0.2 0.1 0.7 0.0 0.0 0.2 1.9 0.0 0.1 0.1 0.0 0.1 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 3.1 0.1 0.7 0.2 0.1 0.0 0.1 0.0 0.4 0.0 3.5 0.0 0.0 0.0 23.9 4.7 8.4 4.8 7.1 9.5 7.5 5.6 5.4 4.8 7.2 7.4 7.3 12.9 14.6 12.2 7.7 7.1 4.0 0.6 0.4 5.1 1.8 0.6 0.6 0.6 0.0 0.6 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 MKNK1 MNK1 ENSG00000079277 "MAP kinase interacting serine/threonine kinase 1" Q9BUB5 1 46557408-46616843 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 72.3" "Cell type enhanced" "Detected in all" 6 "Hofbauer cells: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB027355, CAB037310, HPA071293" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: AB_2686382" "unprognostic (4.05e-3)" "prognostic favorable (7.05e-4)" "unprognostic (5.28e-2)" "unprognostic (3.47e-2)" "unprognostic (1.64e-1)" "unprognostic (7.38e-2)" "prognostic unfavorable (1.24e-5)" "unprognostic (3.50e-2)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (1.50e-1)" "unprognostic (2.14e-2)" "prognostic unfavorable (1.51e-5)" "unprognostic (7.02e-2)" "unprognostic (3.19e-2)" "unprognostic (4.67e-1)" "unprognostic (5.67e-3)" 17.6 12.0 10.7 16.2 10.5 16.8 12.1 13.7 12.3 9.2 12.6 11.0 9.6 9.7 11.9 13.3 12.2 11.1 11.4 12.3 10.8 7.0 9.4 10.8 16.1 16.3 9.9 9.8 10.7 72.3 8.6 11.3 15.4 11.0 9.9 13.3 11.9 10.6 7.7 12.8 10.2 12.7 13.3 8.1 25.6 11.7 7.6 8.7 12.5 8.8 15.8 10.9 10.9 14.5 4.9 6.0 33.3 12.1 5.0 22.0 6.1 19.5 13.2 8.8 9.7 7.9 11.7 11.7 9.9 9.9 12.0 16.4 15.3 8.0 12.9 12.2 9.9 13.5 23.7 14.7 16.2 12.9 22.2 13.0 27.3 15.2 13.0 12.3 14.6 22.2 15.4 11.2 15.6 8.6 6.5 14.0 15.9 14.2 9.5 6.5 12.8 10.4 13.0 6.0 11.3 15.7 9.6 18.4 12.9 12.9 20.5 6.2 5.5 19.1 17.3 16.0 18.3 11.7 16.3 11.4 4.4 0.9 13.6 11.0 8.1 13.5 11.0 8.5 18.8 8.0 3.9 12.1 14.3 7.5 11.5 22.0 4.6 6.6 6.8 6.0 4.9 4.8 7.0 33.3 5.0 8.1 4.4 4.4 6.1 10.7 10.5 13.7 12.3 10.8 7.0 9.9 9.8 11.0 8.7 11.9 22.1 17.5 15.7 12.4 17.9 15.5 15.3 10.7 18.2 21.0 2.0 19.4 6.6 16.1 13.0 14.3 23.5 23.3 32.1 29.7 19.5 15.8 11.5 20.2 113.5 17.5 16.1 18.4 71.2 17.5 19.8 58.2 10.1 16.2 11.9 6.5 28.0 14.0 34.3 10.2 4.6 6.5 14.4 16.8 15.5 9.7 15.4 24.9 14.7 19.5 MLH1 "COCA2, FCC2, HNPCC, HNPCC2" ENSG00000076242 "MutL homolog 1" P40692 3 36993332-37050918 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013294, HPA052707, HPA060714, CAB070868" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348" "unprognostic (1.26e-2)" "unprognostic (3.88e-3)" "unprognostic (2.36e-2)" "unprognostic (1.82e-1)" "unprognostic (3.33e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (8.24e-5)" "unprognostic (3.36e-2)" "unprognostic (2.18e-1)" "unprognostic (1.32e-1)" "unprognostic (8.54e-2)" "unprognostic (8.63e-3)" "unprognostic (2.10e-3)" "unprognostic (4.37e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (8.86e-2)" 16.3 20.7 18.2 19.4 21.4 24.4 18.7 19.7 19.6 15.3 17.3 28.8 19.6 12.4 18.7 23.6 15.1 16.2 14.4 32.0 17.3 17.7 18.8 20.5 17.8 22.8 19.9 16.0 17.6 18.1 26.0 29.4 17.3 19.2 18.5 17.7 16.7 15.6 18.1 46.4 14.2 14.1 21.1 21.6 20.7 16.5 27.6 21.5 29.0 22.2 19.5 24.5 16.9 21.4 12.0 12.9 13.2 23.2 6.7 13.4 9.0 14.2 22.5 28.1 0.0 12.5 15.7 12.6 21.3 17.0 24.8 26.4 17.0 15.9 35.3 10.6 17.3 14.0 9.8 24.2 18.0 26.6 16.0 12.5 24.7 20.8 23.8 13.9 30.3 17.2 11.7 12.7 23.1 28.8 9.8 15.3 23.9 31.6 16.9 25.1 11.5 31.6 12.4 20.6 14.5 12.4 3.1 34.4 14.9 15.7 15.5 6.0 14.2 21.6 23.0 14.2 16.4 33.2 21.6 12.1 19.5 21.0 19.1 25.0 13.4 36.6 33.1 15.1 28.7 17.5 10.9 11.7 13.2 13.4 19.5 9.7 12.0 8.4 10.7 12.9 10.3 9.6 9.7 3.4 6.7 23.2 6.1 12.5 9.0 18.2 21.4 19.7 19.6 17.3 17.7 19.9 16.0 19.2 21.5 23.8 12.0 16.0 10.7 6.4 19.2 37.1 15.3 16.0 13.6 10.4 9.8 27.1 16.6 12.5 20.3 11.2 5.3 0.0 13.0 23.0 13.4 8.0 7.0 14.5 17.5 3.2 5.2 12.3 14.3 9.5 10.3 11.4 8.5 19.8 7.2 14.3 8.6 7.0 13.1 9.2 17.9 12.9 9.5 37.0 25.4 4.8 16.7 13.1 7.6 3.4 MLH3 ENSG00000119684 "MutL homolog 3" Q9UHC1 14 75013764-75051532 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Disease mutation, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060570 Approved Nucleoplasm NA NA Nucleoplasm "HPA060570: AB_2684323" "unprognostic (2.94e-1)" "unprognostic (6.70e-3)" "unprognostic (7.14e-3)" "unprognostic (7.35e-2)" "unprognostic (7.38e-2)" "unprognostic (1.55e-1)" "unprognostic (1.49e-2)" "unprognostic (1.62e-2)" "unprognostic (3.77e-2)" "unprognostic (6.68e-2)" "unprognostic (1.93e-2)" "unprognostic (8.42e-2)" "unprognostic (3.53e-1)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.64e-1)" "unprognostic (7.11e-2)" 13.6 15.6 10.3 9.0 14.4 3.3 13.4 15.2 18.6 13.7 11.8 17.3 17.0 8.4 13.1 12.9 9.4 10.9 10.7 11.0 11.2 10.6 12.8 11.7 8.6 10.3 18.5 15.4 13.3 9.4 24.6 33.6 10.3 16.6 13.4 11.0 8.4 9.2 19.4 13.6 8.0 13.3 12.0 15.6 9.9 7.9 10.7 18.5 7.7 19.2 5.7 12.6 12.0 9.6 8.1 4.1 4.6 3.8 9.8 7.0 8.3 10.4 10.4 7.4 1.3 8.3 13.9 7.9 3.3 3.2 6.2 5.5 8.1 12.5 12.1 3.2 4.0 7.2 7.7 0.1 3.8 8.8 11.5 0.1 7.4 6.8 5.0 6.8 3.4 5.1 5.6 7.8 6.1 0.4 6.4 10.0 0.0 7.5 9.4 13.4 7.9 4.8 3.2 6.8 7.8 5.8 9.3 4.9 2.3 13.4 10.9 12.0 9.2 11.2 8.1 0.6 8.4 10.9 6.8 5.3 2.6 4.9 3.5 3.6 11.1 10.9 11.7 9.2 0.3 11.4 4.6 3.8 2.4 7.0 2.9 5.8 4.8 4.1 6.4 4.1 8.1 6.4 5.1 1.9 9.8 2.0 3.5 4.5 8.3 10.3 14.4 15.2 18.6 11.2 10.6 18.5 15.4 16.6 18.5 23.8 15.9 16.4 20.6 7.0 53.7 15.9 20.4 20.1 17.0 34.9 41.2 12.8 6.6 12.4 5.2 13.7 11.6 0.0 9.6 5.6 12.6 11.4 23.1 13.7 8.8 33.4 12.6 12.9 6.5 4.7 36.8 9.4 15.1 6.4 13.1 35.6 11.0 13.1 48.1 13.2 58.1 45.3 14.6 21.5 8.9 7.5 8.5 12.2 16.4 10.0 MLIP "C6orf142, CIP, MGC18257" ENSG00000146147 "Muscular LMNA interacting protein" Q5VWP3 6 53929982-54266280 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 61.7;liver: 47.4;skeletal muscle: 101.9;tongue: 31.6" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 190.6" "Cancer enhanced" "Detected in some" "liver cancer: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HUVEC TERT2: 18.1;SK-MEL-30: 17.4" "Low region specificity" "Detected in many" "HPA029252, HPA046654" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA029252: AB_2732446, HPA046654: " "unprognostic (7.95e-3)" "unprognostic (4.39e-2)" "unprognostic (2.36e-1)" "unprognostic (1.06e-4)" "unprognostic (2.38e-2)" "unprognostic (1.26e-2)" "unprognostic (5.60e-2)" "unprognostic (2.74e-2)" "unprognostic (1.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (1.91e-5)" "unprognostic (7.49e-2)" "unprognostic (2.65e-2)" "unprognostic (5.27e-2)" "unprognostic (3.29e-3)" 5.7 1.9 4.2 0.2 5.2 0.1 1.6 0.8 11.5 0.8 0.5 0.0 0.0 0.3 0.4 3.5 4.9 0.5 0.8 61.7 1.8 0.8 0.5 47.4 0.4 0.2 7.2 8.3 0.4 0.6 0.3 0.5 0.2 1.8 0.8 0.4 1.3 2.6 0.3 101.9 6.5 1.1 0.3 2.9 0.3 0.4 0.5 0.0 0.0 2.7 31.6 2.2 0.6 1.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.4 2.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.0 0.0 18.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.2 0.0 0.1 0.6 1.3 0.0 0.0 0.5 17.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 5.2 0.8 11.5 1.8 0.8 7.2 8.3 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 190.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 11.7 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 18.3 0.0 12.7 0.0 0.6 1.5 8.2 0.3 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.2 0.1 1.8 0.0 0.0 0.0 0.1 MLLT1 "ENL, LTG19, YEATS1" ENSG00000130382 "MLLT1, super elongation complex subunit" Q03111 19 6210379-6279948 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 13 "Cytotrophoblasts: 494.9;Syncytiotrophoblasts: 951.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031166 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA031166: AB_10601874" "unprognostic (3.21e-1)" "unprognostic (2.75e-3)" "unprognostic (4.84e-2)" "unprognostic (3.36e-2)" "unprognostic (2.47e-1)" "prognostic favorable (6.03e-5)" "unprognostic (1.30e-3)" "unprognostic (1.44e-2)" "unprognostic (1.56e-1)" "unprognostic (1.98e-1)" "unprognostic (3.93e-3)" "unprognostic (4.76e-2)" "unprognostic (3.65e-3)" "unprognostic (1.14e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-2)" "unprognostic (7.99e-3)" 20.1 13.7 21.8 17.1 23.4 8.8 12.9 32.7 28.6 17.7 16.8 16.8 17.7 13.4 22.1 15.5 13.1 25.5 19.3 18.2 16.9 14.3 10.7 12.8 16.7 10.9 13.0 18.5 29.8 22.4 26.2 10.7 45.2 14.6 17.2 6.8 18.7 21.7 18.8 23.5 18.8 13.1 15.0 10.6 13.9 15.1 10.7 13.7 10.8 18.9 12.1 10.2 20.6 23.6 1.5 5.2 4.9 3.5 1.9 2.5 1.6 24.6 12.1 15.0 17.7 11.7 10.2 17.5 15.3 10.0 12.9 13.3 20.0 8.3 17.9 20.1 20.1 14.5 15.4 11.9 15.0 7.8 15.1 18.6 22.3 32.9 15.0 22.7 14.4 20.5 16.5 13.2 12.3 10.1 14.3 14.6 16.2 21.5 21.0 8.5 13.6 24.6 13.9 18.2 12.4 25.6 21.2 11.2 14.3 7.0 15.3 26.1 23.7 15.8 17.6 19.0 7.8 15.8 17.1 15.2 18.1 14.1 28.0 21.1 25.8 19.9 14.1 21.0 24.8 25.7 0.2 1.9 0.4 1.8 3.0 2.5 1.5 1.3 1.7 1.4 1.4 1.1 1.5 4.9 1.9 3.5 5.2 0.5 1.6 21.8 23.4 32.7 28.6 16.9 14.3 13.0 18.5 14.6 13.7 20.8 37.8 0.0 10.7 0.1 27.3 17.8 5.1 8.1 15.9 12.2 17.7 494.9 6.6 11.4 24.3 22.4 5.5 0.0 14.2 17.8 8.9 15.8 9.3 16.8 52.2 55.6 4.7 18.4 16.7 43.4 17.5 7.0 0.0 5.4 11.7 31.9 12.0 0.0 17.3 5.6 14.4 25.8 7.3 8.2 5.5 0.1 951.9 4.3 11.7 11.9 MLLT10 AF10 ENSG00000078403 "MLLT10, histone lysine methyltransferase DOT1L cofactor" P55197 10 21524675-21743630 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 158.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005747 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA005747: AB_1079393" "unprognostic (6.58e-2)" "unprognostic (1.57e-1)" "unprognostic (7.32e-2)" "unprognostic (1.47e-2)" "unprognostic (1.31e-2)" "prognostic favorable (8.75e-4)" "unprognostic (1.03e-3)" "unprognostic (9.56e-3)" "unprognostic (9.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.69e-2)" "unprognostic (7.85e-2)" "unprognostic (6.57e-2)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" 16.3 12.1 11.7 18.4 14.3 21.9 12.8 25.4 13.6 19.0 17.0 12.0 13.6 8.5 26.3 12.8 14.7 14.5 13.7 15.8 10.2 8.5 12.3 13.5 12.3 11.6 10.5 9.9 21.4 12.3 16.6 23.2 20.3 11.8 12.6 11.3 14.6 13.2 16.3 13.4 18.7 12.1 18.7 11.2 10.6 11.4 71.2 14.3 14.6 18.1 9.7 15.2 18.5 19.6 5.5 6.9 12.0 6.8 5.3 7.2 2.8 14.5 12.4 19.1 13.2 12.1 15.3 21.0 9.2 5.8 11.6 11.3 13.1 15.5 17.4 5.1 10.2 10.0 13.7 21.0 12.4 11.6 12.0 12.2 27.0 10.8 18.9 15.0 0.6 17.4 11.4 14.8 9.6 11.1 11.8 15.3 18.3 28.8 13.6 9.1 11.3 20.9 12.6 7.8 8.1 3.9 18.3 10.2 14.6 11.1 6.9 6.7 18.6 12.2 14.7 20.7 17.7 6.9 18.7 13.8 7.3 12.7 14.5 9.1 11.8 13.6 19.5 8.4 10.4 5.6 10.6 6.8 12.0 5.3 4.6 5.2 5.0 6.2 5.7 5.6 5.5 7.2 6.7 5.8 5.3 5.2 6.9 4.6 2.8 11.7 14.3 25.4 13.6 10.2 8.5 10.5 9.9 11.8 14.3 26.8 36.0 13.7 13.7 33.5 31.4 23.5 20.4 17.4 20.5 17.4 41.2 28.7 11.6 12.4 52.7 20.3 15.5 0.0 11.2 48.3 23.9 18.2 23.3 17.8 25.1 28.6 3.4 27.0 30.5 78.0 36.5 23.5 45.5 20.8 15.6 19.7 11.6 14.0 45.3 17.5 50.9 38.8 19.4 158.1 57.1 38.3 42.0 23.5 18.3 10.1 MLLT6 "AF17, FLJ23480" ENSG00000275023 "MLLT6, PHD finger containing" 17 38705542-38729803 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 244.7;Cone photoreceptor cells: 192.4;Rod photoreceptor cells: 215.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004021 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA004021: AB_1853995" "prognostic favorable (4.18e-4)" "unprognostic (1.50e-1)" "unprognostic (2.53e-1)" "unprognostic (1.44e-2)" "unprognostic (1.29e-1)" "prognostic favorable (3.98e-4)" "unprognostic (4.98e-2)" "unprognostic (1.79e-2)" "unprognostic (1.77e-1)" "unprognostic (7.12e-3)" "prognostic favorable (7.41e-4)" "unprognostic (1.78e-1)" "unprognostic (1.84e-2)" "unprognostic (9.12e-2)" "unprognostic (1.12e-1)" "unprognostic (2.05e-1)" "unprognostic (2.46e-3)" 6.5 7.6 10.0 10.3 10.6 7.3 6.3 14.1 16.9 6.2 6.8 7.2 11.1 7.2 9.2 8.6 5.5 10.3 9.2 7.5 9.7 5.8 1.2 8.5 11.8 8.5 9.6 13.0 9.0 12.8 10.1 4.8 7.2 7.3 5.7 10.0 10.3 12.5 22.3 8.5 8.9 8.2 8.1 11.7 6.7 4.1 9.2 6.3 7.2 4.8 10.1 5.5 11.5 1.4 0.9 2.0 0.8 2.8 6.0 1.7 5.8 6.5 6.6 14.4 7.3 6.6 3.4 3.6 6.7 4.5 5.4 2.4 11.5 16.6 5.3 4.3 6.4 15.2 4.2 7.5 4.0 17.7 11.5 6.1 10.8 10.6 3.5 9.3 8.3 6.7 7.7 3.9 8.9 10.9 7.3 12.6 10.1 14.0 3.8 4.9 18.2 9.0 0.8 5.0 3.4 10.8 9.0 15.3 5.2 13.5 14.8 16.4 3.8 12.6 10.7 4.3 12.4 6.8 9.6 5.2 7.8 7.3 6.6 23.9 7.8 11.2 7.7 8.6 5.5 1.7 0.8 0.4 6.0 0.5 4.6 1.4 3.2 4.2 0.4 1.4 3.1 4.1 2.0 2.8 0.3 0.9 1.7 1.7 44.7 51.0 32.0 22.5 27.1 244.7 23.4 30.6 14.7 36.4 31.4 192.4 15.0 10.0 20.0 2.7 38.7 26.1 0.0 35.9 4.1 20.2 29.7 35.9 9.4 12.0 112.8 47.7 31.9 18.3 3.1 43.4 18.1 18.6 23.4 30.0 32.6 28.3 21.0 39.6 13.5 215.1 32.3 25.4 16.1 23.5 25.5 32.0 48.9 37.7 23.0 MLXIPL "bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH" ENSG00000009950 "MLX interacting protein like" Q9NP71 7 73593194-73624543 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 103.6" "Group enriched" "Detected in many" 6 "Cholangiocytes: 71.4;Hepatocytes: 220.3;Intestinal endocrine cells: 86.4" "Cancer enriched" "Detected in many" 6 "liver cancer: 60.9" "Region enhanced" "Detected in many" "cerebellum: 20.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 30.1;K-562: 9.0;SCLC-21H: 16.2;T-47d: 7.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064640 Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA064640: AB_2685309" "unprognostic (1.11e-1)" "unprognostic (1.14e-1)" "unprognostic (2.18e-2)" "unprognostic (4.86e-2)" "unprognostic (5.04e-1)" "unprognostic (1.06e-3)" "unprognostic (3.46e-3)" "unprognostic (9.12e-2)" "unprognostic (1.30e-1)" "unprognostic (1.43e-1)" "unprognostic (6.13e-3)" "unprognostic (4.91e-2)" "unprognostic (2.25e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-2)" "unprognostic (2.46e-2)" "unprognostic (7.72e-3)" 30.0 18.0 4.2 0.8 3.9 0.5 10.9 20.4 6.8 1.1 16.5 0.4 2.6 33.2 0.4 22.1 1.0 3.5 5.5 1.8 3.2 1.7 11.6 103.6 0.9 0.4 1.2 4.0 2.0 6.5 4.0 3.9 0.4 5.0 0.9 1.3 1.1 2.7 0.9 24.7 1.2 27.1 0.7 1.2 0.4 3.5 5.7 0.0 0.0 2.0 7.7 0.4 0.8 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.6 0.0 3.7 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.3 0.0 0.1 0.0 0.3 0.7 0.0 0.0 0.0 0.1 4.6 0.0 2.5 30.1 0.8 0.1 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 3.5 0.0 0.0 0.4 4.8 0.7 0.0 0.0 0.7 0.0 0.0 16.2 0.4 0.5 2.5 0.0 0.0 7.3 3.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.2 3.9 20.4 6.8 3.2 1.7 1.2 4.0 5.0 0.0 0.0 14.4 0.0 4.4 1.0 3.5 2.1 71.4 5.3 7.9 3.5 19.6 0.1 1.7 1.8 1.7 1.5 5.2 0.0 0.9 0.1 2.5 2.1 0.0 220.3 0.4 1.6 86.4 12.3 11.6 0.2 2.6 1.7 6.8 0.0 7.7 2.8 2.2 4.2 1.1 9.9 7.4 0.0 1.9 3.6 0.9 0.6 0.5 2.9 10.3 2.5 MMS19 "hMMS19, MET18, MMS19L" ENSG00000155229 "MMS19 homolog, cytosolic iron-sulfur assembly component" Q96T76 10 97458324-97498794 "Predicted intracellular proteins" "Chromosome partition, DNA damage, DNA repair, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051936, HPA056299" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051936: AB_2681668, HPA056299: AB_2683091" "unprognostic (8.57e-2)" "unprognostic (2.38e-3)" "unprognostic (9.34e-3)" "unprognostic (1.84e-1)" "unprognostic (2.04e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (4.40e-1)" "unprognostic (1.99e-2)" "unprognostic (4.90e-2)" "unprognostic (1.17e-1)" "unprognostic (9.06e-3)" "unprognostic (6.79e-2)" "unprognostic (6.49e-2)" "unprognostic (4.06e-1)" "unprognostic (3.51e-2)" "prognostic unfavorable (3.39e-4)" 17.5 16.4 26.5 16.6 25.5 17.1 23.0 38.0 35.7 18.9 18.2 26.2 17.1 16.8 20.8 23.4 23.1 23.7 15.9 25.6 24.8 18.4 22.8 16.2 20.2 24.2 21.0 24.8 28.3 20.6 19.3 31.4 24.5 22.3 17.3 21.8 23.1 19.5 20.6 26.7 38.2 18.4 22.0 18.6 23.7 17.8 33.7 24.7 27.6 19.2 19.4 26.4 18.0 21.9 8.1 11.0 9.8 8.5 6.7 12.7 7.7 15.2 14.7 17.8 24.8 17.5 21.1 10.7 12.4 25.0 18.9 22.3 19.5 20.1 23.7 13.6 16.8 12.6 17.5 29.1 33.5 17.9 10.2 22.1 12.4 12.2 20.3 13.2 16.4 12.2 17.4 14.6 16.7 35.7 36.8 31.8 17.9 17.7 13.3 18.3 13.9 15.6 30.2 10.0 15.6 12.1 12.6 13.6 10.6 22.4 11.1 7.2 11.9 7.1 9.6 18.4 23.2 19.4 15.0 18.0 8.6 11.0 5.9 13.9 12.0 13.4 13.7 13.0 24.8 7.0 9.8 7.2 5.8 7.5 8.5 12.7 8.1 10.1 9.4 11.0 7.0 12.2 9.5 1.6 6.7 6.5 8.3 10.0 7.7 26.5 25.5 38.0 35.7 24.8 18.4 21.0 24.8 22.3 24.7 20.8 16.5 8.0 5.3 9.3 10.5 15.3 7.6 4.0 5.7 5.2 17.7 11.8 10.0 9.9 7.2 10.8 8.7 0.0 6.9 15.6 8.7 5.0 3.5 12.8 11.1 9.5 9.8 14.7 13.8 6.4 14.4 7.8 13.5 17.2 13.1 5.6 8.4 2.9 10.6 5.5 22.4 12.9 9.2 20.9 29.6 10.0 7.3 7.0 12.0 4.1 MMS22L "C6orf167, dJ39B17.2" ENSG00000146263 "MMS22 like, DNA repair protein" Q6ZRQ5 6 97142161-97283217 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 21.4" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 39.3;Early spermatids: 45.4;Spermatocytes: 34.8;Spermatogonia: 44.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA067042 Supported Nucleoplasm NA NA Nucleoplasm "HPA067042: AB_2685768" "unprognostic (3.61e-2)" "unprognostic (2.80e-1)" "unprognostic (2.26e-2)" "unprognostic (1.97e-3)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (1.00e-5)" "unprognostic (9.63e-2)" "unprognostic (5.81e-3)" "unprognostic (8.21e-3)" "unprognostic (9.39e-2)" "unprognostic (6.58e-2)" "unprognostic (1.34e-6)" "unprognostic (3.48e-2)" "unprognostic (2.00e-1)" "unprognostic (1.66e-1)" "unprognostic (1.29e-1)" 3.1 3.3 3.0 8.0 4.6 12.7 7.1 2.0 3.2 4.2 3.4 5.5 3.6 2.7 5.2 2.8 4.9 3.1 3.0 3.7 3.6 3.3 2.7 2.1 6.0 11.0 5.1 1.8 3.7 3.2 5.0 4.3 4.1 4.0 4.6 5.0 4.6 3.9 3.5 1.6 5.9 5.1 3.9 8.1 4.5 2.8 13.1 3.1 21.4 2.5 4.0 6.8 3.5 4.0 3.0 4.1 3.1 4.8 2.1 3.9 1.4 4.9 5.6 9.4 10.2 1.5 2.9 7.4 10.2 4.7 9.7 14.2 7.7 5.9 11.0 6.3 3.8 11.2 9.1 11.8 5.6 19.3 9.4 8.8 11.1 8.1 4.8 0.9 17.0 7.9 1.5 3.0 13.6 6.3 2.0 4.1 10.4 15.1 17.7 9.0 5.9 6.2 6.9 3.6 8.1 4.2 10.5 8.9 3.9 4.1 6.6 5.3 4.6 6.7 3.4 2.8 5.5 5.2 10.5 3.1 9.8 9.4 8.1 13.9 2.2 6.6 12.4 5.6 10.8 10.8 1.6 1.5 3.1 2.4 2.4 3.6 1.8 3.2 3.5 3.6 3.0 3.0 3.9 1.5 2.1 4.8 4.1 2.8 1.4 3.0 4.6 2.0 3.2 3.6 3.3 5.1 1.8 4.0 3.1 3.0 7.5 10.7 4.6 8.1 10.7 3.6 5.1 4.0 9.1 3.5 39.3 7.5 1.7 2.3 45.4 5.3 2.6 0.0 3.6 9.4 6.4 2.3 7.0 2.6 5.3 3.2 1.2 11.1 8.7 11.8 9.2 5.2 6.8 1.8 7.5 6.9 2.1 0.0 5.3 0.3 29.7 6.5 3.1 34.8 44.9 7.2 3.0 12.1 7.0 1.8 MN1 "MGCR, MGCR1, MGCR1-PEN" ENSG00000169184 "MN1 proto-oncogene, transcriptional regulator" Q10571 22 27748277-27801498 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 62.7" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 9.8;Early spermatids: 22.6;Fibroblasts: 10.0;Late spermatids: 12.6;Peritubular cells: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 8 "monocytes: 1.7" "Cell line enhanced" "Detected in some" "AF22: 22.1;HeLa: 8.9;hTERT-RPE1: 9.9;RH-30: 8.9;TIME: 14.0;U-2 OS: 12.1;U-2197: 12.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003072 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003072: AB_1079399" "unprognostic (5.64e-2)" "unprognostic (2.48e-2)" "unprognostic (1.09e-2)" "unprognostic (1.26e-1)" "unprognostic (2.88e-2)" "unprognostic (2.52e-2)" "unprognostic (7.01e-2)" "unprognostic (3.03e-2)" "unprognostic (4.17e-2)" "unprognostic (1.64e-1)" "unprognostic (4.00e-2)" "unprognostic (7.33e-2)" "unprognostic (5.13e-7)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" "unprognostic (5.28e-3)" "unprognostic (2.21e-4)" 3.7 2.0 3.4 4.2 17.3 2.4 1.9 1.3 5.6 5.9 4.2 2.6 2.5 2.1 3.0 9.0 7.0 3.4 11.1 5.1 2.5 2.7 1.6 1.4 4.3 1.3 3.3 3.5 12.4 1.5 1.3 2.3 2.6 4.5 3.1 2.2 10.8 2.1 2.7 62.7 2.9 2.1 5.8 1.0 1.5 3.5 2.0 5.4 0.0 1.8 14.8 2.1 5.0 4.7 0.0 0.2 0.0 1.7 0.0 0.1 0.0 0.0 1.0 22.1 0.6 0.4 0.9 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 2.2 3.9 0.9 1.8 1.1 1.3 0.0 0.0 0.6 0.0 8.9 0.0 0.5 0.0 0.2 0.0 2.5 0.5 2.2 9.9 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.2 2.9 0.0 2.0 3.6 8.9 0.0 0.3 0.0 0.0 0.3 1.9 0.0 0.0 5.6 0.2 0.0 14.0 0.7 12.1 12.7 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 3.4 17.3 1.3 4.2 2.5 2.7 3.3 3.5 4.5 5.4 3.0 2.9 0.5 0.1 3.8 9.8 3.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 22.6 4.1 0.0 0.0 0.9 0.1 10.0 0.1 0.0 0.4 0.2 0.0 0.0 0.6 0.3 12.6 4.6 0.7 0.0 0.0 0.0 4.3 1.7 0.0 9.6 0.0 0.6 0.0 2.1 0.5 0.9 2.4 0.0 0.0 0.0 0.1 MNAT1 "MAT1, RNF66" ENSG00000020426 "MNAT1, CDK activating kinase assembly factor" P51948 14 60734742-60969953 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000701, HPA001154, CAB004495" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004495: AB_670057, HPA000701: AB_1079400, HPA001154: AB_2666212" "unprognostic (4.10e-2)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (6.11e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.17e-2)" "unprognostic (2.73e-1)" "unprognostic (2.62e-2)" "unprognostic (3.52e-2)" "unprognostic (3.48e-2)" "unprognostic (6.34e-2)" "prognostic favorable (3.46e-4)" "unprognostic (2.68e-1)" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "unprognostic (7.14e-3)" 15.3 14.9 14.6 10.1 18.9 9.4 19.6 29.2 20.2 16.9 11.4 11.8 12.2 6.8 17.3 15.0 13.7 18.9 10.8 15.2 14.0 14.2 19.8 17.0 10.7 9.4 13.8 15.4 16.2 10.3 42.8 33.2 13.7 18.7 16.3 9.9 11.6 18.4 12.8 53.0 8.4 7.1 14.6 15.0 9.2 11.5 8.8 11.8 11.8 14.0 15.9 12.5 13.6 12.3 14.7 25.7 11.6 5.1 18.9 10.8 3.9 60.9 11.8 14.7 10.4 17.2 19.0 16.1 22.5 24.3 27.5 22.3 9.4 21.5 14.7 17.1 16.4 14.9 19.5 16.4 25.8 39.6 18.3 17.1 9.9 11.5 13.8 21.4 22.9 5.3 11.5 19.0 17.7 19.7 26.6 26.2 21.5 14.6 14.1 30.6 20.9 14.2 14.4 8.0 11.6 26.4 14.8 40.2 9.2 32.3 28.8 13.2 9.0 17.2 14.5 20.8 17.8 22.5 11.2 19.9 21.2 22.4 9.9 16.8 6.2 5.2 21.1 17.1 3.9 15.3 4.7 3.6 11.6 8.5 4.6 8.8 14.7 9.1 8.9 6.6 11.3 10.8 10.7 0.3 18.9 5.1 25.7 7.5 3.9 14.6 18.9 29.2 20.2 14.0 14.2 13.8 15.4 18.7 11.8 29.8 18.0 15.9 49.9 22.0 39.8 44.5 28.1 66.9 35.2 27.9 29.5 43.5 68.0 30.1 2.7 27.0 2.9 0.0 38.3 30.0 22.1 39.3 31.3 19.1 17.5 22.3 16.7 15.4 4.5 4.9 27.9 11.3 13.5 13.6 13.8 46.7 45.6 11.8 28.7 46.9 58.0 51.8 35.9 54.6 50.7 15.8 30.1 25.5 14.2 38.2 MNT "bHLHd3, MAD6, MXD6, ROX" ENSG00000070444 "MAX network transcriptional repressor" Q99583 17 2384060-2401118 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059532, HPA067578" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059532: AB_2684053, HPA067578: AB_2685864" "unprognostic (3.72e-1)" "unprognostic (3.42e-2)" "unprognostic (1.57e-1)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (5.30e-3)" "unprognostic (1.31e-2)" "unprognostic (4.49e-2)" "unprognostic (1.27e-1)" "unprognostic (4.97e-2)" "unprognostic (3.47e-3)" "unprognostic (2.27e-3)" "unprognostic (1.81e-2)" "unprognostic (3.52e-2)" "unprognostic (5.09e-1)" "unprognostic (9.32e-2)" "unprognostic (1.98e-2)" 18.0 14.7 12.6 15.2 15.2 29.8 11.8 13.3 22.8 17.3 16.8 12.1 9.9 14.9 16.9 11.3 19.5 15.9 14.4 9.0 12.1 11.6 11.2 9.1 11.9 13.2 8.6 13.6 17.9 15.8 14.2 18.9 15.1 12.0 13.8 8.4 15.8 12.4 17.2 10.7 15.3 13.6 13.4 11.4 14.5 13.1 16.2 9.3 14.2 13.3 11.5 14.4 25.5 13.8 1.0 1.1 4.1 1.7 0.6 1.2 0.6 7.2 9.0 7.8 9.9 9.8 11.1 7.1 4.8 6.4 2.7 3.1 5.9 7.1 10.0 5.1 7.4 6.0 11.5 5.6 10.6 2.1 5.4 8.1 7.1 14.8 5.0 6.4 3.0 13.2 17.6 10.0 5.8 7.8 8.8 4.7 8.0 6.0 9.2 3.1 5.2 7.0 5.2 3.7 5.3 5.9 8.1 3.7 6.6 5.1 10.3 8.3 12.0 5.6 5.5 12.9 4.2 4.5 5.8 8.5 6.7 4.6 10.5 3.9 7.9 3.9 4.0 13.6 6.1 4.3 1.5 1.2 2.9 0.6 1.7 1.2 1.0 0.8 1.0 0.5 0.7 1.0 1.0 4.1 0.6 1.3 1.1 0.1 0.6 12.6 15.2 13.3 21.6 12.1 11.6 8.6 13.6 12.0 9.3 6.0 25.0 11.3 14.7 16.6 15.7 5.6 5.1 8.1 15.9 14.0 21.6 5.6 1.7 8.7 6.8 10.5 16.7 0.0 8.9 7.9 12.4 16.5 12.8 8.9 12.2 25.4 19.0 12.9 24.0 12.2 10.3 15.4 10.1 1.8 20.9 10.6 10.9 20.1 12.4 2.4 10.6 6.5 12.2 10.4 19.6 22.5 7.8 12.8 22.3 51.0 MORC4 "FLJ11565, ZCW4, ZCWCC2" ENSG00000133131 "MORC family CW-type zinc finger 4" Q8TE76 X 106813871-107000244 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 94.5" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 122.1;Alveolar cells type 2: 98.4;Ciliated cells: 111.1;Club cells: 109.2;Cytotrophoblasts: 213.9;granulocytes: 61.5;Syncytiotrophoblasts: 215.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 44.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA000395, HPA015547, HPA050250" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063" "prognostic unfavorable (3.56e-5)" "unprognostic (3.30e-3)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (1.40e-1)" "unprognostic (6.29e-3)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.30e-2)" "unprognostic (5.56e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.60e-2)" "unprognostic (6.57e-2)" "unprognostic (4.89e-2)" "unprognostic (8.69e-2)" 8.7 20.0 3.2 6.0 4.8 5.1 6.2 4.9 3.6 8.0 5.3 4.6 12.7 4.6 8.8 8.5 6.8 7.3 6.7 5.3 4.3 2.8 4.9 9.7 6.0 2.2 4.9 2.2 12.3 9.1 6.0 4.9 94.5 5.8 7.7 4.9 4.2 8.7 8.8 9.4 8.6 4.9 7.4 5.4 2.6 5.6 12.5 5.0 2.3 7.6 7.5 5.2 6.3 15.1 6.0 4.6 10.5 3.8 2.8 4.0 0.7 11.0 44.0 4.4 10.1 13.4 15.5 22.9 10.7 11.4 5.4 7.0 23.3 5.0 1.7 5.6 11.0 9.3 8.7 14.7 9.4 6.5 2.5 8.5 2.7 14.9 9.8 9.9 1.9 5.6 8.2 9.1 7.4 10.8 32.3 4.8 1.7 1.5 16.7 12.1 9.7 4.0 2.7 3.9 29.5 16.7 1.9 8.8 1.9 17.5 8.8 3.8 4.8 13.0 12.8 8.4 6.5 7.6 1.9 5.0 8.7 8.8 17.2 5.9 4.7 6.1 4.3 9.3 1.7 6.3 10.5 3.8 3.1 3.7 3.0 3.2 3.3 3.6 2.8 1.6 6.0 4.0 3.4 8.2 2.8 3.6 4.6 2.6 0.7 3.2 4.8 4.9 3.6 4.3 2.8 4.9 2.2 5.8 5.0 122.1 98.4 2.2 12.9 15.5 4.5 2.2 7.6 111.1 109.2 5.2 3.9 213.9 18.3 8.8 0.8 5.0 3.9 0.0 6.4 21.9 23.8 19.4 61.5 16.2 20.2 1.6 1.7 8.6 1.3 0.9 10.3 4.8 11.8 0.0 8.8 5.8 6.7 4.9 11.0 9.0 7.5 25.8 8.6 5.4 24.3 14.1 215.6 6.4 8.4 11.7 MORF4L2 "KIAA0026, MRGX" ENSG00000123562 "Mortality factor 4 like 2" Q15014 X 103675496-103688158 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 931.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031872, HPA054102" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031872: AB_2674081, HPA054102: AB_2682379" "prognostic unfavorable (9.83e-4)" "unprognostic (2.04e-1)" "unprognostic (1.81e-1)" "unprognostic (7.14e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (4.29e-5)" "unprognostic (5.27e-2)" "unprognostic (6.34e-3)" "unprognostic (2.41e-1)" "unprognostic (4.49e-3)" "unprognostic (1.88e-1)" "unprognostic (1.10e-2)" "prognostic unfavorable (7.86e-7)" "unprognostic (8.54e-2)" "unprognostic (2.65e-2)" "unprognostic (1.78e-1)" "unprognostic (4.05e-1)" 33.3 51.4 50.4 26.6 53.5 23.9 51.6 52.8 66.8 76.2 32.9 29.7 62.9 25.8 74.0 63.4 40.2 55.2 39.5 38.5 50.0 71.2 44.0 76.5 34.3 19.3 45.5 48.8 99.8 36.2 38.6 81.8 77.4 63.5 47.4 40.3 23.4 35.2 57.8 44.9 27.4 27.8 93.7 46.1 25.9 31.5 33.5 34.7 21.5 46.8 35.6 29.9 55.5 45.3 21.6 40.7 24.7 24.7 25.4 29.1 21.9 61.5 41.8 56.2 24.8 83.8 63.0 75.5 82.5 72.2 68.6 70.7 42.8 55.5 42.1 67.7 78.4 84.4 41.9 70.3 61.1 86.0 19.3 31.9 22.4 71.9 48.4 91.9 30.6 21.3 68.4 54.5 58.4 77.1 58.7 75.2 21.9 36.7 58.2 83.9 62.3 27.3 30.2 53.4 74.4 47.6 27.7 52.8 44.5 68.5 37.5 53.7 41.8 62.2 46.2 61.5 62.5 30.6 29.8 62.7 40.1 26.9 69.4 44.0 29.0 35.4 37.4 71.7 62.2 60.0 24.7 23.3 18.4 25.4 24.7 29.1 21.6 24.3 23.9 24.3 19.1 26.9 23.1 9.5 25.4 24.6 40.7 19.7 21.9 50.4 53.5 52.8 66.8 50.0 71.2 45.5 48.8 63.5 34.7 116.1 147.5 88.8 414.6 322.8 43.3 119.2 122.3 420.3 177.5 104.7 9.8 369.7 208.9 242.9 24.0 127.8 101.6 93.5 114.3 931.5 289.9 258.5 150.3 162.2 144.9 55.6 171.3 128.3 54.0 17.4 306.3 110.7 178.8 79.4 116.9 105.8 160.2 115.2 540.3 206.2 33.5 142.3 300.8 27.0 40.2 277.8 488.0 71.4 94.4 332.6 MORN2 MOPT ENSG00000188010 "MORN repeat containing 2" Q502X0 2 38875962-38929072 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 88.7" "Cell type enhanced" "Detected in many" 21 "Ciliated cells: 638.4;Early spermatids: 1599.5;Late spermatids: 2860.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057815 Approved Nucleoplasm NA NA Nucleoplasm "HPA057815: AB_2683537" "unprognostic (7.28e-3)" "unprognostic (3.84e-2)" "unprognostic (8.65e-2)" "unprognostic (1.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.48e-1)" "unprognostic (1.24e-3)" "unprognostic (1.66e-2)" "unprognostic (6.01e-2)" "unprognostic (2.60e-2)" "unprognostic (2.93e-1)" "unprognostic (2.21e-1)" "unprognostic (8.37e-3)" "unprognostic (2.35e-1)" "unprognostic (1.09e-2)" "unprognostic (3.55e-1)" "unprognostic (8.80e-2)" 5.9 14.4 20.5 3.1 22.7 4.1 10.2 6.8 14.8 14.9 6.5 10.3 13.8 3.4 8.3 34.6 5.0 43.7 9.1 10.7 16.4 18.6 31.4 8.6 8.6 2.9 16.5 12.7 9.6 9.5 22.7 27.1 4.0 30.1 8.4 6.8 8.3 11.4 9.7 7.1 3.6 3.3 5.7 11.1 3.1 6.9 88.7 9.5 2.0 21.9 7.2 2.9 6.1 4.4 3.6 7.5 2.0 11.0 3.1 4.8 4.8 23.4 12.4 15.2 18.5 16.7 25.2 8.5 10.9 17.2 17.5 16.9 7.2 13.4 1.5 9.2 16.2 17.5 6.5 6.8 14.1 26.0 9.9 13.1 5.1 14.0 19.1 14.6 8.2 3.7 15.0 17.4 21.4 7.8 22.0 16.0 4.7 8.7 3.5 14.3 23.5 3.7 15.8 11.6 15.6 13.0 2.0 16.0 5.3 32.6 14.1 15.3 20.1 16.2 10.8 23.1 9.2 14.8 11.4 10.7 12.2 12.2 19.3 17.3 6.9 9.9 0.9 28.2 2.4 21.9 2.0 11.0 1.5 2.2 8.4 4.1 3.4 2.6 3.3 7.5 3.6 4.4 4.6 0.9 3.1 6.9 3.8 4.8 4.8 20.5 22.7 6.8 14.8 16.4 18.6 16.5 12.7 30.1 9.5 14.9 16.4 6.4 23.2 8.7 14.8 36.7 38.2 638.4 66.0 57.6 9.8 13.2 228.8 53.3 1599.5 11.8 8.3 0.0 38.9 19.6 23.9 32.1 9.2 17.9 21.0 15.9 22.0 14.1 7.8 2860.4 49.5 14.9 21.9 5.4 18.5 60.4 35.0 28.8 48.4 323.7 28.1 25.8 13.4 365.9 74.1 9.3 6.4 4.1 23.9 21.4 MORN3 ENSG00000139714 "MORN repeat containing 3" Q6PF18 12 121648742-121672631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "placenta: 30.1;testis: 51.5" "Cell type enriched" "Detected in many" 5 "Late spermatids: 1766.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "BEWO: 12.6;CACO-2: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038709, HPA038710" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA038709: AB_2676164, HPA038710: AB_2676165" "prognostic favorable (1.16e-4)" "unprognostic (2.70e-3)" "unprognostic (5.56e-2)" "unprognostic (5.13e-2)" "unprognostic (7.38e-3)" "unprognostic (3.46e-3)" "unprognostic (7.44e-2)" "unprognostic (3.70e-2)" "unprognostic (4.31e-2)" "unprognostic (3.09e-2)" "unprognostic (3.65e-3)" "unprognostic (3.11e-2)" "unprognostic (1.39e-2)" "unprognostic (3.06e-1)" "unprognostic (2.21e-1)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" 0.3 0.2 1.2 0.5 1.4 0.9 0.3 0.3 1.6 0.4 0.3 0.3 0.3 0.2 0.3 1.4 0.3 5.6 0.4 0.3 1.4 1.2 0.4 0.3 1.0 1.4 0.3 0.3 0.3 0.4 3.4 0.7 30.1 0.3 0.3 0.0 0.3 0.3 0.3 0.3 2.5 0.3 0.3 0.3 0.8 0.8 51.5 0.3 0.3 0.5 0.3 0.6 0.3 0.3 1.2 1.2 3.1 0.6 2.2 2.3 0.6 0.1 0.2 0.4 0.2 0.0 0.3 12.6 0.2 0.0 0.1 0.1 6.8 0.3 0.2 0.2 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.5 0.3 0.4 0.3 0.4 0.9 0.1 0.3 0.3 0.0 0.1 0.2 0.8 0.2 0.3 0.1 0.2 0.8 0.6 0.2 0.0 0.1 0.3 0.0 0.1 0.4 0.2 1.1 1.1 0.1 0.2 0.0 0.5 0.9 0.1 0.1 0.2 0.2 0.3 0.1 0.2 0.1 0.4 0.9 0.3 0.1 2.3 0.6 0.4 2.1 0.3 2.0 0.8 2.3 1.3 0.2 1.2 2.1 1.4 3.1 2.2 0.5 1.2 2.0 0.6 1.2 1.4 0.3 1.2 1.4 1.2 0.3 0.3 0.3 0.3 3.0 2.2 0.5 1.1 2.9 1.1 1.1 5.1 50.9 11.4 1.8 0.0 0.2 6.6 3.3 357.0 1.5 0.0 0.0 1.2 0.4 1.3 0.3 2.3 0.0 0.8 0.0 0.0 0.6 0.0 1766.8 8.6 0.1 0.0 1.8 0.0 3.7 1.7 0.0 8.9 0.8 1.7 0.0 0.0 7.0 5.6 3.4 6.1 3.3 0.1 1.0 MRE11 "ATLD, MRE11A" ENSG00000020922 "MRE11 homolog, double strand break repair nuclease" P49959 11 94415578-94493908 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Meiosis" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes, Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 26.8;Ciliated cells: 21.4;Cytotrophoblasts: 31.8;Syncytiotrophoblasts: 23.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002691, CAB004081" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004081: AB_2145100, HPA002691: AB_1079409" "unprognostic (5.59e-3)" "unprognostic (4.35e-2)" "unprognostic (8.55e-2)" "unprognostic (2.76e-2)" "unprognostic (9.82e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (7.14e-4)" "unprognostic (2.85e-1)" "unprognostic (1.03e-2)" "unprognostic (1.34e-1)" "unprognostic (8.66e-3)" "unprognostic (6.96e-3)" "unprognostic (1.57e-3)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.22e-1)" "unprognostic (8.06e-3)" 14.7 11.0 10.7 15.2 12.5 24.0 16.6 21.2 12.0 17.5 11.0 10.8 13.9 8.0 17.4 11.2 13.9 13.2 8.9 9.4 8.7 6.5 8.8 8.9 11.4 13.8 13.3 7.9 16.7 15.5 8.2 12.8 14.2 9.8 12.7 14.1 10.4 14.1 10.8 9.3 18.3 12.8 12.8 13.5 17.2 11.8 9.9 13.0 25.3 12.7 7.4 18.4 14.3 13.3 8.7 14.8 7.9 13.1 10.3 11.8 7.9 10.0 10.3 19.3 2.4 6.6 9.2 11.1 14.2 9.2 12.8 15.2 18.7 20.7 26.4 23.1 7.4 16.0 19.4 16.4 10.6 17.0 17.4 9.7 23.0 14.7 10.7 3.0 15.0 16.6 6.4 6.6 16.6 10.4 5.8 11.2 12.9 16.0 17.1 10.2 7.3 15.2 14.3 6.2 23.4 11.3 13.6 17.3 13.2 8.4 14.1 6.8 9.8 19.6 12.3 3.8 17.1 21.1 9.1 8.1 19.2 14.1 16.6 10.1 4.3 15.2 25.9 5.1 24.0 15.3 5.4 11.1 7.9 11.2 13.1 11.0 8.5 8.4 11.8 14.8 8.7 7.1 11.5 4.8 10.3 9.8 10.5 10.9 7.9 10.7 12.5 21.2 12.0 8.7 6.5 13.3 7.9 9.8 13.0 26.8 14.7 0.0 0.0 0.0 0.0 0.0 0.0 21.4 17.0 8.7 0.0 31.8 3.3 10.1 0.0 0.0 0.0 0.0 6.9 13.1 0.0 0.0 16.3 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 16.2 0.0 0.0 8.6 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 MRFAP1 "PAM14, PGR1" ENSG00000179010 "Morf4 family associated protein 1" Q9Y605 4 6640091-6642745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB042447, HPA056367" Approved Supported Nucleoplasm No No Nucleoplasm "CAB042447: AB_2145271, HPA056367: AB_2683107" "unprognostic (1.28e-1)" "unprognostic (1.67e-1)" "unprognostic (3.82e-2)" "unprognostic (1.31e-2)" "unprognostic (7.03e-2)" "unprognostic (9.55e-2)" "unprognostic (1.14e-3)" "unprognostic (1.86e-3)" "unprognostic (1.30e-1)" "unprognostic (5.51e-2)" "unprognostic (7.78e-3)" "unprognostic (1.02e-1)" "prognostic favorable (2.90e-7)" "unprognostic (1.24e-1)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" 52.8 77.4 88.5 32.3 81.7 24.6 51.2 64.5 87.7 53.9 43.6 57.8 42.4 39.3 57.5 59.3 41.5 54.0 36.6 67.1 77.3 83.7 60.7 65.9 40.2 31.3 87.2 95.9 69.0 39.9 64.2 65.6 52.0 59.7 54.5 37.0 38.4 43.0 60.5 82.3 33.0 39.2 59.1 91.6 45.9 37.7 51.0 69.1 19.1 54.2 57.2 34.4 45.5 58.4 34.3 62.7 71.1 65.3 46.4 49.6 58.2 52.6 58.6 49.9 57.4 61.4 55.7 39.4 69.6 64.5 64.6 64.7 57.7 57.3 33.0 54.1 64.3 73.4 30.2 67.2 72.7 78.4 13.4 48.7 49.2 68.4 62.4 57.6 36.7 24.8 57.6 66.8 59.3 60.4 61.5 71.6 29.3 64.5 21.7 63.6 66.4 27.6 86.6 62.1 46.0 75.3 36.1 90.4 27.9 78.0 40.0 78.7 61.6 45.1 32.6 64.5 45.6 90.8 45.0 63.8 56.9 38.2 42.2 91.3 32.2 39.7 54.9 58.9 78.6 55.0 60.1 65.3 55.3 47.4 52.8 47.8 33.0 47.4 47.4 62.7 34.3 49.3 48.1 71.1 46.4 49.6 50.5 49.6 58.2 88.5 81.7 64.5 87.0 77.3 83.7 87.2 95.9 59.7 69.1 148.9 130.0 79.5 227.3 167.4 108.6 201.1 155.4 147.2 116.0 83.7 15.7 451.0 185.6 196.0 36.0 186.5 82.1 70.0 177.2 244.5 165.5 214.4 148.7 169.8 172.2 104.9 170.8 146.1 121.9 44.4 290.8 105.8 119.8 143.3 103.2 214.1 184.1 109.1 286.4 178.7 82.2 213.4 216.5 343.0 235.0 151.9 269.5 109.0 123.5 202.6 MRGBP "C20orf20, Eaf7, FLJ10914, MRG15BP" ENSG00000101189 "MRG domain binding protein" Q9NV56 20 62796453-62801738 "Plasma proteins, Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 55.3" "Group enriched" "Detected in many" 8 "Early spermatids: 101.9;Late spermatids: 283.4;Spermatocytes: 115.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017012 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA017012: AB_1845679" "unprognostic (1.90e-1)" "unprognostic (1.60e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (8.56e-2)" "unprognostic (1.80e-3)" "prognostic unfavorable (3.80e-6)" "unprognostic (2.02e-2)" "unprognostic (3.06e-1)" "unprognostic (1.45e-1)" "unprognostic (1.17e-1)" "unprognostic (8.79e-2)" "prognostic unfavorable (2.48e-6)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "unprognostic (2.25e-1)" "unprognostic (6.01e-3)" 5.7 6.7 6.3 6.1 6.6 6.6 5.8 7.8 9.1 5.4 7.7 6.8 4.4 9.2 5.7 4.6 6.2 5.2 5.4 8.9 5.6 5.3 6.5 9.4 5.6 8.0 6.5 5.5 10.5 10.6 5.9 6.6 8.4 5.1 5.7 4.9 6.5 8.4 7.3 8.5 6.3 9.7 8.4 4.0 8.5 6.7 55.3 6.0 8.3 6.2 6.2 6.1 6.6 7.5 1.7 2.0 2.8 3.7 0.6 3.8 1.2 14.3 9.1 7.5 11.5 4.1 6.3 7.3 8.3 10.8 32.5 14.2 32.4 11.5 13.2 16.7 6.4 16.1 12.2 8.5 14.1 18.4 4.1 7.3 9.6 9.8 18.6 6.5 11.2 18.2 5.4 10.4 8.8 9.4 6.9 7.7 12.8 13.0 7.3 8.1 21.8 21.1 21.3 6.3 15.1 16.5 19.0 14.3 9.8 4.9 5.9 10.6 8.6 11.9 10.7 15.0 4.3 13.1 16.4 7.9 20.3 21.2 13.7 17.6 9.8 6.0 15.7 20.0 11.2 11.3 0.0 2.2 2.8 2.0 3.7 2.7 1.5 2.5 2.7 1.5 1.7 1.9 3.8 2.4 0.6 1.5 2.0 2.7 1.2 6.3 6.6 7.8 9.1 5.6 5.3 6.5 5.5 5.1 6.0 0.0 2.1 8.2 13.4 13.1 10.5 8.1 7.6 1.4 3.4 12.2 7.9 9.6 16.6 19.6 101.9 10.3 9.8 0.0 19.2 21.5 10.4 13.1 1.1 12.7 12.6 12.7 2.4 7.4 8.4 283.4 11.2 12.2 6.8 14.4 10.2 10.6 18.6 7.0 7.4 13.8 12.6 0.0 8.9 115.6 17.2 11.4 12.2 10.9 11.8 16.5 MROH6 C8orf73 ENSG00000204839 "Maestro heat like repeat family member 6" A6NGR9 8 143566187-143572971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 11.8;HaCaT: 10.0;OE19: 10.2;SK-BR-3: 21.4;U-937: 12.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA068049 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA068049: AB_2685945" "unprognostic (2.10e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-3)" "unprognostic (2.26e-3)" "unprognostic (8.04e-2)" "unprognostic (8.96e-2)" "unprognostic (2.28e-1)" "unprognostic (1.73e-1)" "unprognostic (5.97e-2)" "unprognostic (2.81e-2)" "unprognostic (1.09e-2)" "unprognostic (9.04e-2)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (1.44e-1)" "unprognostic (9.16e-3)" "unprognostic (1.18e-1)" 1.8 2.3 3.4 2.3 2.8 15.8 1.5 7.6 3.9 5.8 2.7 2.0 3.6 5.7 1.9 2.6 17.4 1.6 11.0 1.3 2.4 0.9 3.1 5.3 2.8 5.4 1.1 1.2 2.6 1.2 2.1 1.4 8.7 2.4 3.7 1.2 4.8 3.1 3.3 1.2 10.1 4.7 4.1 2.6 3.6 6.7 4.1 1.5 0.7 1.2 7.8 15.0 3.2 6.3 0.1 0.8 1.6 1.0 0.0 0.4 0.1 11.8 2.7 0.2 0.5 0.6 0.5 1.3 0.3 0.3 0.2 0.1 0.8 6.5 1.2 0.6 0.1 0.1 10.0 0.3 3.4 0.0 1.6 2.0 1.2 3.7 0.4 0.4 0.4 1.6 0.6 0.9 0.3 0.2 0.0 0.1 1.3 0.9 1.0 0.0 6.7 0.5 1.1 0.3 10.2 2.0 1.1 0.2 2.0 0.5 1.2 0.5 0.2 0.4 21.4 1.0 0.1 2.3 0.8 0.0 0.2 7.5 0.8 1.8 1.0 0.7 0.2 0.4 12.2 0.3 0.0 1.0 0.0 0.1 0.4 0.1 0.0 0.2 0.1 0.8 0.1 0.3 0.4 1.6 0.0 0.6 0.4 0.0 0.1 3.4 2.8 7.6 3.9 2.4 0.9 1.1 1.2 2.4 1.5 0.0 6.6 1.4 1.9 2.5 1.5 1.2 5.1 0.0 2.3 8.7 0.0 0.8 1.7 1.2 0.0 2.1 8.3 0.0 0.6 2.7 2.1 1.4 1.1 10.4 4.6 1.6 1.7 1.3 9.1 0.5 4.4 3.0 3.3 1.0 4.0 3.8 4.3 4.0 2.5 1.9 0.2 0.0 2.3 0.7 2.1 2.3 0.8 1.9 4.9 2.1 MROH8 "C20orf131, C20orf132, dJ621N11.3, dJ621N11.4" ENSG00000101353 "Maestro heat like repeat family member 8" Q9H579 20 37101226-37179588 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.7" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 27.0;Late spermatids: 25.0;Spermatocytes: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" HPA060298 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA060298: AB_2684246" "unprognostic (1.16e-2)" "unprognostic (6.65e-3)" "unprognostic (5.88e-3)" "unprognostic (1.04e-2)" "unprognostic (2.17e-2)" "unprognostic (6.92e-2)" "unprognostic (3.31e-3)" "unprognostic (2.50e-4)" "unprognostic (1.98e-1)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (9.70e-3)" "unprognostic (5.00e-9)" "unprognostic (1.39e-1)" "unprognostic (1.01e-1)" "unprognostic (3.10e-2)" "unprognostic (1.62e-1)" 3.6 3.1 4.0 1.8 5.9 2.7 2.9 6.6 7.7 3.4 3.4 4.6 2.4 2.1 4.3 9.5 2.0 4.0 2.2 4.9 3.6 5.0 3.6 4.0 1.7 5.5 3.8 5.0 3.7 4.5 4.8 7.3 1.9 4.1 3.4 2.1 6.2 4.7 5.9 12.0 3.4 1.9 4.1 3.4 2.6 2.5 33.7 2.7 3.1 4.8 2.4 3.7 2.8 2.0 2.6 7.2 8.0 2.2 1.0 2.0 1.1 1.3 3.6 8.9 2.2 3.5 3.6 1.4 1.3 5.0 3.1 3.8 2.3 1.8 7.7 0.4 1.3 5.8 2.2 2.3 1.0 2.5 1.3 0.2 2.4 1.9 1.9 3.1 2.5 3.8 2.1 2.2 1.2 0.1 2.6 2.4 3.6 3.2 1.6 2.0 0.7 6.9 7.0 1.0 1.0 2.2 5.9 1.9 1.5 1.7 1.4 3.1 4.2 2.3 0.9 1.5 2.5 2.2 2.7 2.8 9.5 1.5 0.5 0.6 2.9 2.2 4.8 3.2 1.6 3.1 1.9 2.1 0.7 1.8 2.2 2.0 2.6 1.2 2.0 1.0 2.5 0.6 1.4 8.0 1.0 1.0 7.2 0.7 1.1 4.0 5.9 6.6 7.7 3.6 5.0 3.8 5.0 4.1 2.7 3.0 1.1 0.0 0.8 0.6 5.7 2.8 0.0 1.4 0.0 0.0 7.9 3.5 0.0 0.1 27.0 2.4 1.3 0.0 0.2 0.9 3.1 0.8 0.0 3.4 2.4 0.0 1.2 1.3 2.6 25.0 1.4 0.2 1.7 1.0 1.0 3.3 0.1 0.8 2.8 1.7 4.2 0.0 1.0 18.2 3.7 0.4 1.1 0.7 1.3 0.3 MSANTD3 "C9orf30, MGC17337" ENSG00000066697 "Myb/SANT DNA binding domain containing 3" Q96H12 9 100427156-100451711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062662 Approved Nucleoplasm NA NA Nucleoplasm "HPA062662: AB_2684826" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (5.51e-2)" "unprognostic (1.51e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.66e-5)" "prognostic unfavorable (3.23e-6)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.51e-1)" "unprognostic (2.61e-3)" "unprognostic (5.52e-2)" "unprognostic (3.38e-1)" "prognostic unfavorable (3.22e-7)" "unprognostic (1.95e-1)" "unprognostic (1.18e-1)" "unprognostic (2.28e-1)" "unprognostic (2.16e-2)" 11.4 12.5 17.0 16.8 17.5 14.7 21.2 22.7 22.6 15.1 13.2 15.8 5.5 8.8 16.4 12.2 12.6 8.6 19.3 21.5 16.9 14.9 13.0 15.1 15.5 9.3 19.6 18.2 11.1 15.0 10.4 11.3 16.7 20.1 11.6 10.1 9.7 10.9 14.9 21.5 10.9 7.9 20.4 17.6 7.2 11.6 7.8 14.5 5.4 18.2 11.6 11.0 17.3 13.0 3.7 1.5 9.0 0.6 5.7 6.2 2.7 14.9 13.6 9.9 9.7 15.5 18.2 11.2 21.7 24.5 21.3 16.0 8.5 14.1 9.0 11.1 21.3 47.7 17.1 6.7 22.8 25.1 13.2 4.6 4.2 10.9 7.1 16.2 6.0 5.3 8.0 9.8 19.1 37.8 20.1 24.3 7.7 7.5 3.4 31.5 10.7 8.0 4.4 14.6 16.3 23.6 9.5 26.1 2.7 22.0 4.2 11.7 14.6 7.8 6.9 18.5 12.0 2.9 6.8 26.4 27.5 34.8 21.4 32.3 4.9 9.1 4.1 38.4 4.1 20.7 9.0 0.6 3.3 4.2 0.3 6.2 3.6 3.6 5.0 1.5 3.7 4.4 4.0 0.5 5.7 0.2 0.8 2.9 2.7 17.0 17.5 22.7 22.6 16.9 14.9 19.6 18.2 20.1 14.5 14.9 3.4 1.4 7.5 5.3 16.0 13.3 10.2 9.4 9.1 7.0 2.0 28.2 26.6 24.5 1.5 10.5 1.3 0.0 21.1 11.6 8.9 7.2 3.5 8.3 9.9 19.1 9.2 8.0 1.6 3.0 6.9 6.6 6.8 39.7 4.4 6.3 36.9 5.7 8.1 5.3 7.9 6.5 8.2 2.3 11.7 3.8 9.0 6.9 5.8 4.3 MSANTD4 KIAA1826 ENSG00000170903 "Myb/SANT DNA binding domain containing 4 with coiled-coils" Q8NCY6 11 105995623-106022403 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Muller glia cells: 124.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014411 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA014411: AB_2668995" "prognostic unfavorable (4.95e-4)" "unprognostic (1.64e-1)" "unprognostic (1.74e-1)" "unprognostic (1.30e-1)" "unprognostic (7.04e-3)" "unprognostic (8.21e-3)" "unprognostic (1.41e-2)" "unprognostic (2.13e-2)" "unprognostic (8.84e-3)" "unprognostic (1.09e-1)" "unprognostic (3.14e-2)" "unprognostic (1.83e-1)" "prognostic favorable (1.26e-5)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.78e-2)" "unprognostic (2.90e-1)" 8.5 11.3 15.4 8.5 16.5 2.9 9.0 21.6 20.7 13.8 8.6 12.6 6.0 5.4 12.8 7.7 9.6 8.3 7.7 17.0 19.2 14.2 10.6 7.4 9.0 9.6 17.1 18.2 12.4 10.2 12.1 20.6 7.7 15.9 10.9 6.9 7.8 7.3 13.9 14.6 4.8 6.9 11.6 13.1 8.5 7.5 10.6 17.9 7.2 14.7 6.0 10.4 10.9 9.0 8.9 8.5 3.6 10.0 9.2 11.8 6.1 4.3 6.5 14.6 0.1 16.0 17.7 0.1 12.5 17.2 9.8 12.6 11.3 8.6 9.6 21.2 10.5 10.8 11.3 16.3 8.0 12.2 17.5 7.9 18.8 7.6 6.9 24.1 14.6 14.9 11.9 9.9 13.2 26.3 12.2 8.7 10.4 8.7 6.2 14.3 1.8 13.9 7.3 5.6 6.5 13.3 9.3 19.0 13.7 13.5 5.4 9.7 18.6 3.3 11.4 9.1 9.5 9.0 7.5 12.4 14.5 11.4 7.5 12.5 6.2 7.1 4.9 6.7 5.8 10.5 2.8 6.9 3.6 10.7 10.0 10.5 8.3 10.0 7.7 8.5 8.9 11.8 10.1 1.7 9.2 5.9 7.3 7.1 6.1 15.4 16.5 21.6 20.7 19.2 14.2 17.1 18.2 15.9 17.9 14.9 12.5 2.2 2.9 4.7 41.7 20.2 15.3 10.7 22.7 3.5 19.6 1.4 1.7 5.8 26.9 8.3 1.7 0.0 5.1 1.2 8.5 1.1 5.8 5.7 4.5 35.0 8.1 6.2 6.9 11.1 13.0 7.1 11.8 6.4 2.7 124.6 5.9 0.0 9.2 7.3 19.5 0.0 6.3 9.1 5.6 5.1 0.2 5.0 2.9 1.4 MSC "ABF-1, bHLHa22" ENSG00000178860 Musculin O60682 8 71841549-71844468 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 56.3" "Cell type enhanced" "Detected in many" 12 "Exocrine glandular cells: 35.3;Leydig cells: 39.4;monocytes: 88.4;Peritubular cells: 38.9;Smooth muscle cells: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 18.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 14 "HDLM-2: 132.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062878 Supported Nucleoplasm NA NA Nucleoplasm "HPA062878: AB_2684891" "unprognostic (2.58e-2)" "unprognostic (1.62e-1)" "unprognostic (1.86e-1)" "unprognostic (1.35e-3)" "prognostic unfavorable (5.21e-4)" "unprognostic (3.70e-2)" "prognostic unfavorable (4.83e-5)" "unprognostic (3.95e-2)" "unprognostic (7.92e-2)" "unprognostic (3.75e-2)" "unprognostic (3.73e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.07e-13)" "unprognostic (1.65e-2)" "unprognostic (1.45e-1)" "unprognostic (7.48e-2)" "unprognostic (1.40e-2)" 9.9 7.6 2.0 10.1 1.3 2.8 56.3 0.6 4.4 4.8 1.6 0.8 0.4 1.9 4.8 2.9 3.3 3.4 10.5 16.3 5.5 0.2 5.2 3.0 6.6 14.1 0.8 1.2 7.3 4.7 0.0 2.6 15.1 1.9 4.8 0.9 15.9 3.7 3.1 2.6 3.0 3.8 3.8 0.9 5.6 3.8 3.1 0.6 1.8 3.6 3.4 4.8 10.3 6.5 5.0 4.3 0.1 0.2 0.0 18.5 2.1 0.0 1.0 0.0 0.0 4.8 0.8 0.0 0.2 3.9 0.1 0.2 0.0 0.0 0.0 0.0 0.7 4.8 0.2 0.0 0.2 0.0 132.2 0.0 0.0 0.0 0.0 8.6 0.0 0.4 1.9 0.0 8.3 5.1 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.1 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 7.2 0.0 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.0 3.5 0.0 5.7 0.0 0.0 0.0 3.9 0.0 5.2 5.0 6.8 18.5 0.1 2.8 0.1 6.4 0.1 0.0 0.2 4.3 8.6 2.1 2.0 1.3 0.6 4.4 5.5 0.2 0.8 1.2 1.9 0.6 0.0 0.0 1.5 0.1 4.5 0.0 1.6 0.0 0.0 0.0 1.8 0.0 0.1 0.0 14.0 0.3 2.2 0.0 0.0 35.3 0.1 17.8 0.4 0.0 0.0 1.9 0.0 0.0 1.8 0.8 0.6 39.4 3.8 25.3 88.4 0.0 0.0 22.7 0.0 38.9 0.8 0.0 25.8 40.6 0.2 0.2 2.9 0.0 5.0 0.0 0.2 MSL1 "DKFZp686P24239, hMSL1, MSL-1" ENSG00000188895 "Male specific lethal 1 homolog" Q68DK7 17 40122298-40136916 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 11.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 95.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022800, HPA023567" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA022800: AB_1853057, HPA023567: AB_1853059" "unprognostic (1.94e-1)" "unprognostic (6.28e-2)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (4.71e-2)" "unprognostic (5.39e-2)" "unprognostic (2.33e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-2)" "unprognostic (2.24e-1)" "unprognostic (3.46e-1)" "unprognostic (7.48e-3)" "prognostic unfavorable (3.06e-6)" "unprognostic (2.92e-2)" "unprognostic (7.91e-2)" "unprognostic (5.80e-2)" "unprognostic (2.61e-2)" 27.2 26.0 31.4 26.6 31.6 29.9 56.5 36.0 45.1 44.6 31.7 25.8 42.7 30.2 39.3 35.1 29.6 38.7 31.9 22.2 31.6 20.3 27.5 21.7 29.3 27.2 31.4 36.7 32.0 28.6 40.5 39.9 28.4 27.2 32.6 28.7 20.3 27.2 32.9 29.2 35.4 28.7 32.5 24.5 43.6 27.0 32.8 33.8 22.1 39.3 23.9 29.4 34.0 52.7 1.7 1.9 11.7 1.3 0.9 2.3 0.8 9.1 10.9 23.5 15.3 21.4 18.6 12.1 16.1 17.2 20.4 18.5 10.9 9.9 20.3 12.4 16.9 13.0 17.1 19.7 10.6 21.1 17.3 15.9 11.2 15.0 12.9 11.2 15.1 21.9 15.5 17.0 15.0 12.5 20.8 18.7 12.4 17.6 16.6 16.2 5.7 24.0 16.8 10.0 10.1 7.2 19.8 13.0 18.3 14.8 10.1 21.8 12.9 15.1 95.0 12.0 22.4 22.2 21.0 15.3 13.8 15.4 10.0 13.5 26.5 14.8 20.3 14.0 11.3 16.0 0.0 1.3 1.0 2.3 0.7 1.2 1.7 1.3 1.8 0.9 1.1 1.3 1.2 11.7 0.9 1.0 1.9 0.8 0.8 31.4 31.6 36.0 45.1 31.6 20.3 31.4 36.7 27.2 33.8 26.8 38.4 15.6 33.7 44.4 55.0 22.6 22.9 26.8 22.7 10.4 11.8 12.6 3.3 16.7 12.4 38.4 28.0 0.0 18.0 11.4 35.5 45.8 3.5 31.4 21.1 49.3 30.0 38.6 33.5 19.8 54.1 27.8 30.4 5.4 31.8 34.6 19.9 23.0 37.4 6.0 28.4 38.8 36.3 69.6 48.1 57.5 14.2 15.2 28.5 42.5 MSL3 MSL3L1 ENSG00000005302 "MSL complex subunit 3" Q8N5Y2 X 11758159-11775753 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034535, HPA034536" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA034535: AB_10603878, HPA034536: AB_10670973" "unprognostic (2.58e-1)" "unprognostic (1.76e-3)" "unprognostic (1.04e-1)" "unprognostic (9.56e-2)" "unprognostic (5.36e-2)" "prognostic favorable (3.28e-4)" "prognostic unfavorable (4.93e-4)" "unprognostic (8.36e-2)" "unprognostic (2.48e-2)" "unprognostic (4.88e-3)" "unprognostic (2.13e-1)" "unprognostic (5.04e-2)" "prognostic unfavorable (3.14e-9)" "unprognostic (1.20e-1)" "unprognostic (2.06e-1)" "unprognostic (4.35e-1)" "prognostic favorable (2.17e-4)" 11.4 8.1 11.7 23.4 13.3 19.0 10.7 11.9 18.8 7.8 9.3 10.0 6.4 8.6 9.6 7.5 11.9 9.4 10.9 7.7 11.1 11.2 9.9 9.2 14.4 32.5 11.8 10.5 8.6 7.5 7.0 7.9 12.3 15.7 9.7 10.5 4.6 9.9 8.9 24.0 13.7 16.2 10.1 11.3 34.1 9.5 10.5 10.0 49.1 10.1 9.4 30.2 13.9 15.5 25.7 27.1 39.0 33.4 24.5 37.1 30.9 11.5 12.5 16.6 14.5 13.8 19.1 7.1 14.8 13.3 16.2 19.5 7.7 11.7 16.5 15.3 14.1 11.4 9.6 19.7 12.1 19.7 10.6 13.9 8.8 14.3 3.9 12.6 13.4 17.1 11.8 15.5 19.5 8.5 15.2 27.6 21.2 16.0 10.5 16.2 11.8 10.7 15.2 13.6 12.2 20.7 7.8 16.9 20.0 11.3 14.4 10.9 13.1 16.0 6.9 9.6 16.7 11.6 8.8 26.4 15.7 11.0 25.5 13.6 8.3 9.9 19.1 11.4 7.6 13.0 26.7 31.1 22.4 24.2 27.5 23.0 25.7 28.6 27.8 24.0 25.3 37.1 34.5 39.0 24.5 33.4 27.1 33.6 30.9 11.7 13.3 11.9 18.8 11.1 11.2 11.8 10.5 15.7 10.0 8.9 16.3 29.8 12.1 11.7 9.9 13.3 22.9 26.8 13.6 7.0 7.9 18.5 8.3 14.7 38.4 20.4 9.2 0.0 14.8 27.4 15.3 10.0 25.5 14.1 20.2 7.9 6.4 27.0 54.7 16.2 11.5 37.3 13.5 14.4 14.3 7.2 19.6 11.5 15.6 9.8 7.3 6.5 13.7 32.0 11.7 16.2 9.8 32.0 12.4 10.9 MSRB1 "SelR, SelX, SepR, SEPX1" ENSG00000198736 "Methionine sulfoxide reductase B1" Q9NZV6 16 1938210-1943326 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 195.6;liver: 94.8;pancreas: 107.2" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 236.4;monocytes: 165.9;Proximal tubular cells: 237.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 85.8;neutrophil: 195.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 195.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008650, HPA043463, HPA069557" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153" "unprognostic (3.93e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (9.61e-2)" "unprognostic (1.76e-2)" "unprognostic (1.15e-1)" "unprognostic (2.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.88e-2)" "unprognostic (4.90e-2)" "unprognostic (5.29e-2)" "unprognostic (3.60e-1)" "unprognostic (4.27e-2)" "unprognostic (8.46e-2)" "unprognostic (4.92e-2)" "unprognostic (7.31e-2)" "unprognostic (4.59e-3)" 7.9 4.0 5.2 9.0 6.3 27.3 5.1 3.2 6.1 5.2 13.1 5.6 7.5 8.7 7.9 13.5 16.9 9.6 13.5 13.7 4.7 4.1 24.9 94.8 9.6 15.6 5.5 4.1 7.3 107.2 2.9 3.9 11.6 4.1 11.0 5.1 6.2 4.7 9.4 20.5 8.0 17.0 14.3 4.3 18.2 9.6 8.1 3.6 3.7 5.5 19.8 4.5 14.8 4.8 1.7 10.9 195.6 26.2 2.4 2.8 12.2 6.8 17.3 6.4 15.2 12.0 5.3 11.0 8.4 10.6 12.3 10.7 27.7 7.5 6.6 27.5 9.7 10.8 11.2 10.7 7.4 3.8 37.0 12.2 5.1 6.4 44.1 11.0 14.4 12.2 9.8 6.5 8.9 1.7 3.9 12.3 8.6 8.0 3.7 6.5 37.5 8.1 23.6 8.8 12.3 9.9 11.8 8.9 31.0 19.2 11.4 6.2 8.2 9.5 10.6 5.1 4.3 11.5 25.5 7.3 3.7 10.4 7.4 4.9 9.8 15.5 12.6 3.9 13.6 6.5 26.0 26.2 85.8 2.2 12.0 2.1 1.7 1.8 1.8 10.9 1.7 1.4 1.6 195.6 2.4 10.7 4.6 2.8 12.2 5.2 6.3 3.2 6.1 4.7 4.1 5.5 4.1 4.1 3.6 8.9 14.9 11.5 10.5 5.8 6.0 32.4 38.2 20.1 3.4 31.4 3.9 30.0 79.6 56.2 3.3 12.0 75.5 23.3 97.0 102.6 13.1 12.7 4.6 236.4 55.0 7.9 57.8 19.0 79.6 10.4 8.6 26.2 15.1 165.9 31.9 17.1 66.7 63.3 21.5 237.9 3.0 0.0 19.8 35.7 9.1 8.3 32.3 20.3 27.8 18.7 MSX1 "HOX7, HYD1, OFC5" ENSG00000163132 "Msh homeobox 1" P28360 4 4859666-4863936 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 47.2" "Cell type enhanced" "Detected in some" 11 "Endothelial cells: 14.6;Fibroblasts: 22.2;Melanocytes: 15.1;Smooth muscle cells: 26.1" "Cancer enriched" "Detected in all" 17 "endometrial cancer: 246.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 29.5;EFO-21: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026198, HPA063895, HPA073604" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB026198: , HPA063895: AB_2685145, HPA073604: AB_2686617" "unprognostic (1.12e-1)" "unprognostic (1.93e-2)" "unprognostic (3.39e-2)" "prognostic favorable (1.64e-7)" "unprognostic (9.13e-2)" "unprognostic (1.16e-3)" "unprognostic (4.07e-3)" "unprognostic (3.81e-2)" "unprognostic (1.48e-2)" "unprognostic (2.21e-3)" "unprognostic (4.78e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.18e-5)" "unprognostic (4.35e-2)" "unprognostic (2.06e-1)" "unprognostic (2.34e-3)" "unprognostic (1.33e-2)" 9.0 3.8 4.6 1.5 2.9 1.0 11.4 1.4 8.6 47.2 1.4 6.0 1.0 1.4 17.9 1.2 1.5 4.5 2.2 2.5 8.7 2.2 1.4 1.3 2.1 1.4 4.2 1.6 2.5 2.0 1.2 11.5 5.1 14.0 3.9 0.9 1.7 3.7 4.9 18.3 2.5 1.2 4.3 3.6 3.3 1.3 1.4 3.8 0.0 4.7 2.6 1.2 5.9 18.8 0.5 0.4 1.9 0.8 0.7 0.6 0.2 1.5 0.9 0.3 1.8 5.2 3.3 5.6 3.8 1.8 2.2 1.1 29.5 9.6 0.1 13.7 2.7 10.9 0.0 6.6 0.0 0.8 1.2 7.7 0.0 5.1 10.5 0.4 0.1 0.9 0.6 0.5 1.7 0.5 0.7 0.5 2.5 4.7 0.2 1.1 0.7 0.8 1.5 0.1 0.4 7.0 3.9 4.1 0.3 0.1 0.9 0.3 0.1 3.4 0.1 2.3 0.5 0.6 1.3 1.2 2.6 5.8 8.3 6.0 0.6 0.5 3.4 1.7 1.9 2.5 1.9 0.4 0.5 0.3 0.5 0.4 0.5 0.3 0.4 0.3 0.4 0.6 0.4 1.4 0.7 0.8 0.4 0.5 0.2 4.6 2.9 1.4 8.6 8.7 2.2 4.2 1.6 14.0 3.8 0.0 0.0 0.0 1.9 6.4 0.7 4.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.2 0.4 14.6 0.7 0.0 0.8 0.1 22.2 3.2 0.0 0.0 0.4 0.0 0.0 6.7 0.6 0.0 1.1 0.9 15.1 0.0 0.1 0.3 0.4 0.0 0.4 0.4 0.8 0.0 26.1 0.7 1.5 4.1 0.2 0.0 1.5 1.5 MT1E "MT1, MTD" ENSG00000169715 "Metallothionein 1E" P04732 16 56625475-56627112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 248.5" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 3009.6;Hepatocytes: 2806.6;Mucus-secreting cells: 2755.2;Paneth cells: 3720.3;Proximal tubular cells: 4546.8;Undifferentiated cells: 2435.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 3.9;T-cells: 14.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 124.0;LHCN-M2: 94.5;RPTEC TERT1: 107.0;U-2 OS: 60.4" HPA041152 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA041152: AB_2732490" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.59e-1)" "unprognostic (1.55e-1)" "unprognostic (2.77e-2)" "unprognostic (1.19e-2)" "unprognostic (3.63e-1)" "unprognostic (9.80e-2)" "unprognostic (7.85e-2)" "unprognostic (3.45e-2)" "unprognostic (2.78e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (5.06e-5)" "unprognostic (1.86e-1)" "unprognostic (9.53e-2)" "unprognostic (1.97e-1)" "unprognostic (3.78e-2)" 68.4 71.5 38.0 18.4 104.6 2.5 47.7 13.8 42.3 10.1 75.3 20.0 10.7 36.2 7.3 18.4 27.1 33.1 44.2 19.6 40.0 27.0 66.1 248.5 21.1 13.7 66.0 27.4 13.4 145.0 4.5 5.1 7.8 94.3 22.6 64.3 13.9 9.1 9.1 28.0 16.4 114.5 29.8 58.6 5.4 47.0 4.1 24.5 0.0 110.7 21.3 4.9 9.4 11.8 0.3 3.9 0.0 2.0 0.1 14.2 1.9 11.2 0.0 0.0 0.0 18.2 21.1 0.1 29.8 32.0 8.2 9.6 0.1 15.1 0.0 2.3 10.3 1.2 24.5 27.5 124.0 11.3 11.3 0.0 0.4 16.4 1.9 8.2 0.0 0.0 14.5 42.1 21.4 24.7 49.8 4.9 0.0 0.0 0.0 94.5 0.0 0.0 7.4 10.8 0.0 0.1 0.0 0.0 0.3 107.0 0.0 1.6 0.0 0.0 0.0 0.1 2.1 0.0 13.8 12.2 0.0 60.4 9.5 5.7 0.0 0.2 0.2 34.7 18.9 0.1 0.0 2.0 0.0 10.5 1.4 3.7 0.3 5.9 14.2 3.9 0.0 2.7 10.7 0.0 0.1 1.2 0.2 13.7 1.9 38.0 104.6 13.8 42.3 40.0 27.0 66.0 27.4 94.3 24.5 366.3 115.6 55.5 220.6 158.7 0.0 67.5 448.4 238.3 298.0 471.1 0.0 12.9 1188.7 375.5 1.5 49.3 3009.6 93.5 167.4 775.1 142.5 750.7 27.7 2806.6 30.0 0.0 233.0 171.2 56.5 2.4 138.4 87.0 104.6 99.2 2755.2 0.0 423.2 3720.3 48.1 4546.8 0.0 213.4 278.2 0.2 2.7 129.5 66.7 38.7 2435.9 51.9 MTA2 "MTA1-L1, MTA1L1" ENSG00000149480 "Metastasis associated 1 family member 2" O94776 11 62593214-62601840 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005315, HPA006214, CAB017522, HPA072727" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: " "unprognostic (5.97e-3)" "unprognostic (1.63e-2)" "unprognostic (1.23e-1)" "unprognostic (3.04e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" "prognostic unfavorable (4.82e-5)" "unprognostic (3.32e-3)" "unprognostic (1.95e-1)" "unprognostic (5.38e-3)" "unprognostic (3.09e-2)" "unprognostic (1.59e-1)" "unprognostic (1.16e-3)" "unprognostic (3.16e-3)" "unprognostic (9.84e-2)" "unprognostic (2.23e-1)" "unprognostic (2.50e-2)" 26.3 20.4 16.6 28.0 17.9 28.7 20.5 21.6 24.8 23.9 22.0 31.5 15.6 17.1 23.8 16.9 45.1 19.9 23.7 18.8 15.8 12.4 19.0 23.6 21.8 35.5 19.7 12.7 35.0 13.7 22.5 19.8 22.3 20.9 21.9 27.3 21.2 22.3 22.1 12.7 41.1 23.5 25.0 23.8 39.4 19.9 25.7 18.9 64.6 19.3 20.3 49.1 21.7 27.8 12.9 12.0 8.4 13.2 10.4 17.3 4.4 24.8 21.8 34.8 45.5 15.6 14.7 24.0 21.1 29.7 42.4 31.1 20.6 21.8 35.5 22.8 27.7 22.7 33.6 46.9 58.4 36.1 35.1 23.5 37.8 23.6 20.7 24.3 42.6 48.7 16.4 32.9 29.8 44.6 20.2 39.2 37.1 41.7 28.3 30.3 48.3 54.0 54.4 30.0 23.7 25.5 51.9 24.8 41.5 30.0 37.4 27.8 25.5 22.0 31.5 17.8 28.8 36.9 29.3 27.4 23.9 22.0 26.9 24.3 21.2 27.4 50.2 17.4 31.2 23.0 5.6 6.4 8.4 17.3 11.0 14.6 12.9 14.4 12.5 10.2 9.8 13.7 13.5 2.9 10.4 13.2 12.0 11.6 4.4 16.6 17.9 21.6 24.8 15.8 12.4 19.7 12.7 20.9 18.9 3.0 3.8 13.4 3.6 11.8 0.0 3.4 2.5 0.0 5.7 1.8 0.0 11.3 5.0 4.9 0.4 6.2 7.9 23.3 8.1 8.8 6.6 3.3 10.4 8.2 7.3 0.0 11.5 14.1 16.4 0.4 4.6 5.3 1.7 7.2 10.5 0.0 6.9 5.8 3.9 2.1 0.0 0.0 5.7 5.1 5.3 9.8 15.8 7.5 11.5 3.9 MTF1 ENSG00000188786 "Metal regulatory transcription factor 1" Q14872 1 37809567-37859620 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028604, HPA028689" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA028604: AB_10600304, HPA028689: AB_10611384" "unprognostic (5.74e-2)" "unprognostic (2.10e-1)" "unprognostic (2.56e-2)" "unprognostic (2.89e-1)" "unprognostic (8.33e-2)" "unprognostic (8.15e-3)" "unprognostic (1.34e-2)" "unprognostic (5.07e-2)" "unprognostic (1.91e-1)" "unprognostic (4.58e-2)" "unprognostic (3.20e-2)" "unprognostic (2.30e-2)" "unprognostic (3.70e-2)" "unprognostic (4.37e-3)" "unprognostic (2.98e-1)" "unprognostic (6.32e-2)" "unprognostic (2.19e-1)" 7.8 7.1 9.9 8.1 11.8 28.4 6.9 12.4 10.8 8.4 7.2 10.0 6.7 4.8 9.6 4.8 16.1 9.5 6.0 4.9 9.4 6.5 6.5 5.3 7.3 8.2 10.7 7.0 9.5 8.6 12.7 12.1 10.5 8.3 6.4 7.7 5.3 7.1 8.3 10.5 7.7 6.2 7.8 8.9 8.4 6.4 10.5 13.4 4.9 6.5 7.1 10.0 6.8 7.8 2.9 3.9 6.3 9.1 1.6 3.1 2.7 6.6 4.1 4.1 3.6 10.5 7.3 7.8 6.6 6.8 7.9 7.5 4.4 3.8 7.1 5.1 7.4 5.1 6.2 6.9 5.5 9.2 24.4 4.3 6.7 5.6 3.4 6.0 7.8 7.5 6.7 9.7 11.1 11.3 5.6 5.0 5.1 4.3 5.8 5.8 3.8 3.9 4.0 5.8 3.5 4.0 4.2 9.7 4.3 5.2 6.6 6.3 4.6 7.9 6.4 5.7 5.9 3.9 6.6 7.0 4.9 5.6 5.6 8.6 10.6 12.0 4.1 6.7 8.2 4.3 4.4 6.1 3.9 3.1 5.9 2.7 2.4 2.7 2.4 3.9 2.9 2.9 2.4 6.3 1.6 9.1 1.4 1.8 2.7 9.9 11.8 12.4 10.8 9.4 6.5 10.7 7.0 8.3 13.4 8.9 9.3 12.9 9.3 18.3 0.0 10.9 5.1 25.4 3.4 7.0 0.0 8.4 1.7 9.7 42.8 11.7 10.2 0.0 13.7 20.3 7.8 10.8 16.1 5.5 9.3 0.0 22.8 12.3 17.3 15.0 8.9 16.2 6.8 11.8 7.8 0.0 10.7 7.0 11.0 5.6 0.0 6.5 7.6 28.7 21.3 26.0 14.3 12.5 8.1 12.7 MTF2 "M96, PCL2, TDRD19A" ENSG00000143033 "Metal response element binding transcription factor 2" Q9Y483 1 93079235-93139081 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 43.4" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 122.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069047, HPA069066" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA069047: AB_2686073, HPA069066: AB_2686078" "unprognostic (1.84e-2)" "unprognostic (1.45e-1)" "unprognostic (5.56e-2)" "unprognostic (7.88e-3)" "unprognostic (7.12e-2)" "unprognostic (2.26e-3)" "prognostic unfavorable (8.90e-7)" "unprognostic (1.26e-2)" "unprognostic (9.22e-3)" "unprognostic (3.98e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (1.05e-4)" "prognostic unfavorable (2.47e-7)" "unprognostic (7.19e-3)" "unprognostic (2.48e-1)" "unprognostic (2.48e-1)" "unprognostic (1.26e-2)" 6.8 8.0 8.5 19.7 18.4 21.9 10.3 24.3 12.2 9.8 8.0 8.6 4.9 8.0 9.0 8.5 7.2 7.6 7.4 5.3 9.0 8.2 7.6 7.3 8.6 19.9 8.1 9.8 12.0 7.0 6.7 13.9 13.0 9.2 7.0 8.4 6.7 6.7 6.8 7.1 8.1 9.5 6.8 8.5 12.7 7.2 17.3 9.2 43.4 9.6 7.1 19.4 7.9 8.3 11.7 12.0 14.7 10.6 13.0 14.3 6.2 7.4 3.6 12.5 8.2 2.2 2.1 14.5 4.8 3.8 8.3 10.4 6.1 4.1 24.1 8.8 3.0 7.1 4.0 11.5 5.0 12.3 9.3 8.4 16.6 5.5 8.2 3.3 21.6 7.1 2.6 2.7 7.8 4.7 3.8 7.9 18.8 18.7 7.6 5.1 3.1 31.0 18.0 21.3 3.3 4.8 25.2 15.4 6.5 7.7 8.1 7.8 9.5 7.9 9.4 9.6 13.8 5.6 15.3 4.5 5.5 8.2 5.2 7.1 5.9 6.7 42.8 1.1 12.9 3.5 9.4 9.4 14.7 11.3 10.6 12.9 10.0 11.7 14.3 12.0 11.7 13.9 12.4 7.2 13.0 6.3 11.4 12.9 6.2 8.5 18.4 24.3 12.2 9.0 8.2 8.1 9.8 9.2 9.2 26.8 27.2 56.4 25.5 41.3 0.0 11.7 7.6 17.4 28.4 36.6 0.0 60.2 6.6 29.9 3.7 39.3 25.4 23.3 16.9 56.8 29.0 28.2 57.8 13.4 30.0 0.0 30.9 35.0 26.7 5.0 30.2 40.6 16.9 42.3 29.2 0.0 27.2 31.6 22.3 12.9 0.0 38.8 23.6 122.6 74.3 37.8 50.8 48.4 30.8 32.0 MTREX "Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2" ENSG00000039123 "Mtr4 exosome RNA helicase" P42285 5 55307760-55425581 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, rRNA processing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 39.4;Ciliated cells: 48.2;Club cells: 39.8;Exocrine glandular cells: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037379 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA037379: AB_10601713" "unprognostic (7.71e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-3)" "unprognostic (1.32e-1)" "unprognostic (1.50e-1)" "unprognostic (2.08e-1)" "unprognostic (1.79e-2)" "unprognostic (5.08e-1)" "unprognostic (4.17e-2)" "unprognostic (1.46e-2)" "unprognostic (5.05e-2)" "unprognostic (7.67e-2)" "unprognostic (1.11e-2)" "unprognostic (2.09e-1)" "unprognostic (3.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.11e-1)" 23.6 23.6 26.1 24.9 24.0 18.7 24.1 40.6 31.2 22.0 19.3 15.2 28.8 27.6 26.2 17.8 23.3 20.0 22.4 24.3 22.0 16.0 21.2 22.7 19.7 24.7 21.1 21.5 25.9 25.8 35.8 45.0 19.0 26.6 25.6 21.7 10.4 21.8 28.7 71.3 23.8 24.3 20.9 37.5 20.9 20.6 22.3 21.5 29.7 29.3 19.2 21.7 24.4 23.4 9.8 10.9 5.8 10.3 5.9 10.4 4.0 14.2 20.0 14.6 15.5 12.4 13.1 19.6 13.1 10.0 14.8 18.9 21.4 18.7 27.7 15.5 11.5 19.6 9.9 28.4 18.0 22.2 4.9 23.5 18.9 18.9 16.3 11.4 11.1 12.6 10.3 12.3 15.6 19.1 11.6 12.8 10.4 22.3 16.0 14.3 13.0 11.9 14.7 13.2 5.9 19.4 14.6 16.3 12.2 16.0 20.9 18.0 11.1 14.9 8.5 12.8 14.6 20.4 16.1 11.5 3.8 9.7 10.7 22.0 11.8 12.4 23.9 9.7 25.5 14.7 4.9 6.6 5.8 10.4 6.1 10.0 8.8 7.7 9.7 7.9 9.8 8.1 8.3 1.9 5.9 10.3 10.9 7.5 4.0 26.1 24.0 40.6 31.2 22.0 16.0 21.1 21.5 26.6 21.5 29.8 39.4 0.0 0.0 0.0 0.0 0.0 0.0 48.2 39.8 19.2 0.0 21.8 10.0 23.4 0.0 0.0 0.0 0.0 35.5 18.3 0.0 0.0 23.3 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 24.4 0.0 0.0 29.8 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 MUTYH MYH ENSG00000132781 "MutY DNA glycosylase" Q9UIF7 1 45329163-45340470 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosidase, Hydrolase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008732 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008732: AB_1854219" "unprognostic (6.30e-3)" "unprognostic (7.12e-2)" "unprognostic (6.29e-2)" "unprognostic (8.80e-2)" "unprognostic (3.43e-1)" "unprognostic (5.16e-3)" "prognostic unfavorable (4.76e-8)" "unprognostic (2.80e-2)" "unprognostic (7.12e-3)" "unprognostic (3.05e-2)" "unprognostic (7.80e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (7.25e-5)" "unprognostic (3.50e-3)" "unprognostic (1.62e-1)" "unprognostic (5.57e-2)" "unprognostic (5.49e-3)" 7.7 8.4 10.3 12.7 14.8 11.1 8.3 31.6 12.4 10.5 10.1 15.1 11.0 11.1 11.5 9.8 8.3 11.0 10.0 6.1 10.9 7.3 9.7 9.0 7.2 14.0 13.6 10.1 12.9 8.4 7.5 12.5 12.5 11.6 9.1 11.0 12.6 9.5 11.7 8.5 11.1 9.8 7.5 12.6 12.8 11.8 4.9 16.6 14.1 11.9 7.4 12.0 9.3 9.2 7.2 6.5 1.9 8.9 6.6 15.4 6.3 4.9 4.3 10.1 6.9 7.2 5.4 17.6 3.4 4.7 7.4 6.1 9.1 7.0 13.9 6.1 2.3 5.9 7.6 5.3 6.3 3.4 11.5 4.0 6.8 6.9 6.5 6.7 5.8 5.0 3.6 6.5 9.9 16.6 1.9 5.3 18.3 10.5 5.4 3.1 8.0 15.9 5.5 25.5 11.7 5.3 21.6 7.8 7.5 3.8 9.3 9.2 7.2 7.4 5.8 11.5 13.6 4.6 6.7 3.3 6.5 4.0 5.0 5.4 8.2 9.4 8.5 5.6 8.8 4.9 1.5 5.6 1.9 9.8 8.9 15.4 7.2 10.2 9.9 6.5 7.2 11.3 11.0 0.9 6.6 6.8 5.5 10.3 6.3 10.3 14.8 31.6 12.4 10.9 7.3 13.6 10.1 11.6 16.6 0.0 6.4 7.0 10.7 6.2 14.7 3.1 0.0 9.4 6.8 7.0 2.0 33.3 3.3 5.7 0.8 5.2 13.7 0.0 4.6 11.1 7.0 7.0 10.4 3.9 8.7 4.8 7.5 6.7 6.4 0.6 10.0 6.9 6.8 9.0 12.3 11.8 3.3 14.0 11.3 7.0 18.5 12.9 7.1 7.1 11.1 4.6 18.5 12.9 12.5 6.4 MYBL1 "A-myb, AMYB" ENSG00000185697 "MYB proto-oncogene like 1" P10243 8 66562175-66614247 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.6" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 23.3;Spermatocytes: 32.1;T-cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.9;MAIT T-cell: 3.5" "Group enriched" "Detected in many" 32 "NK-cells: 1.4;T-cells: 4.9" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 29.1;BJ hTERT+ SV40 Large T+ RasG12V: 24.7;Daudi: 29.7;HBF TERT88: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA008791 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008791: AB_1078540" "unprognostic (1.11e-1)" "unprognostic (2.47e-2)" "unprognostic (2.57e-1)" "unprognostic (7.23e-4)" "unprognostic (2.26e-1)" "unprognostic (1.89e-2)" "unprognostic (6.67e-3)" "unprognostic (2.38e-1)" "unprognostic (1.25e-1)" "unprognostic (3.78e-2)" "unprognostic (1.13e-2)" "unprognostic (3.74e-3)" "prognostic unfavorable (2.03e-8)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (5.87e-2)" 2.1 1.1 2.6 25.6 5.1 2.5 2.2 6.5 3.8 1.6 2.1 4.0 2.6 1.7 1.6 2.9 1.5 1.8 3.3 3.9 3.4 2.2 1.4 2.4 4.5 21.7 6.4 2.8 1.2 0.7 1.3 1.2 4.1 6.3 2.6 1.9 1.8 1.2 2.2 1.3 1.6 3.9 2.7 6.5 11.0 2.2 12.7 4.4 4.7 1.5 1.0 18.0 2.2 1.9 0.0 0.0 0.0 0.0 1.4 4.9 0.3 11.8 4.1 1.3 3.5 0.3 0.7 0.9 16.4 7.6 29.1 24.7 0.5 12.1 29.7 1.5 13.8 10.9 3.4 1.2 1.3 40.3 3.5 1.9 0.6 4.5 0.5 0.0 0.2 1.2 0.2 0.1 8.0 6.7 5.2 0.9 2.2 0.1 9.9 17.7 1.0 1.9 0.4 1.0 1.1 5.5 0.6 4.9 0.7 6.8 0.4 2.9 1.1 2.9 1.0 2.9 2.1 17.6 0.8 5.0 17.5 4.0 3.9 15.0 2.9 3.9 8.8 4.6 1.8 6.9 0.0 0.0 0.0 4.9 0.0 3.5 0.0 0.9 2.0 0.0 0.0 0.1 0.8 0.0 1.4 0.0 0.0 0.0 0.3 2.6 5.1 6.5 3.8 3.4 2.2 6.4 2.8 6.3 4.4 0.0 2.9 0.9 0.4 1.5 9.2 8.1 0.0 2.7 0.0 0.0 2.0 1.2 0.0 0.6 3.0 0.7 0.0 23.3 0.0 0.6 1.3 0.2 0.0 0.8 0.5 4.8 0.0 3.1 0.6 3.2 0.9 1.4 1.7 1.0 0.1 10.3 0.1 0.0 0.0 0.6 9.3 0.0 2.1 32.1 5.7 0.4 1.3 50.3 0.2 0.1 MYC "bHLHe39, c-Myc, MYCC" ENSG00000136997 "MYC proto-oncogene, bHLH transcription factor" P01106 8 127735434-127741434 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 812.6;Basal keratinocytes: 900.0;Smooth muscle cells: 529.5;Suprabasal keratinocytes: 935.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 132.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000084, CAB010307, HPA055893, HPA066556" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000084: , CAB010307: AB_631274, HPA055893: AB_2682960, HPA066556: AB_2685691" "unprognostic (1.45e-2)" "unprognostic (4.00e-3)" "unprognostic (3.94e-3)" "unprognostic (2.41e-3)" "unprognostic (8.14e-2)" "unprognostic (3.36e-3)" "unprognostic (5.80e-2)" "unprognostic (4.94e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.19e-3)" "unprognostic (9.86e-3)" "prognostic unfavorable (5.49e-8)" "unprognostic (7.85e-2)" "unprognostic (4.66e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (4.96e-5)" 67.4 20.8 3.2 46.6 7.1 16.3 36.0 1.2 5.0 23.9 23.3 3.8 11.8 11.1 23.8 14.4 47.6 59.5 32.4 23.7 5.8 2.2 11.2 36.6 16.0 40.5 5.8 1.2 38.7 64.6 2.1 7.4 14.9 9.8 20.6 11.3 6.1 14.4 21.8 69.6 78.5 17.2 21.3 12.0 38.3 24.7 16.3 3.8 40.2 9.0 48.4 27.1 28.9 37.3 25.5 8.8 1.0 10.3 20.9 55.2 22.0 7.2 14.0 1.2 12.5 20.4 24.1 3.7 8.7 3.8 10.9 9.1 19.2 19.1 74.3 12.3 5.2 10.7 15.8 65.1 28.3 7.2 17.5 22.7 44.7 23.8 25.0 18.8 31.2 7.2 16.8 62.6 7.3 58.0 8.8 12.5 26.2 66.0 39.3 5.4 20.8 51.0 68.1 3.5 31.3 28.1 28.4 5.3 132.1 9.1 7.5 86.4 8.2 4.0 34.1 22.6 2.1 13.9 20.5 15.2 8.2 9.8 6.3 10.9 0.7 1.2 35.9 7.2 35.0 4.1 0.7 10.3 0.1 8.6 9.1 43.4 25.5 31.1 18.6 8.8 20.6 55.2 34.8 1.0 20.9 6.1 0.3 24.8 22.0 3.2 7.1 1.2 3.6 5.8 2.2 5.8 1.2 9.8 3.8 53.6 68.5 50.1 812.6 900.0 0.0 10.2 28.1 18.7 83.0 12.2 0.0 20.0 1.7 71.3 0.9 89.5 6.3 0.0 37.0 51.5 149.4 176.0 54.4 27.1 25.9 0.0 12.0 96.3 42.9 1.1 91.5 19.1 160.3 3.6 66.1 1.0 60.5 11.5 63.3 5.3 0.2 45.3 529.5 0.5 0.7 935.3 4.9 39.5 82.4 301.8 MYEF2 "FLJ11213, HsT18564, KIAA1341, MEF-2" ENSG00000104177 "Myelin expression factor 2" 15 48134631-48178517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 75.7;Cone photoreceptor cells: 74.6;Horizontal cells: 77.9;Spermatocytes: 104.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 34.5;SCLC-21H: 30.8;SK-MEL-30: 30.1" "Low region specificity" "Detected in all" HPA004883 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA004883: AB_1079436" "unprognostic (4.30e-2)" "unprognostic (8.59e-2)" "unprognostic (5.01e-2)" "unprognostic (2.17e-1)" "unprognostic (2.02e-2)" "unprognostic (7.18e-3)" "unprognostic (2.76e-3)" "unprognostic (6.81e-2)" "unprognostic (2.35e-1)" "unprognostic (4.09e-2)" "unprognostic (1.55e-5)" "unprognostic (1.32e-2)" "unprognostic (3.76e-3)" "unprognostic (7.94e-2)" "unprognostic (2.51e-2)" "unprognostic (7.26e-2)" "unprognostic (4.05e-1)" 5.2 17.0 18.7 6.5 18.7 2.0 8.7 23.1 31.9 2.6 9.6 12.7 15.7 4.3 6.7 11.6 3.3 13.6 7.9 9.5 18.3 17.8 19.9 1.1 6.6 7.3 19.0 18.5 2.6 15.3 19.3 26.5 2.1 19.3 10.3 5.9 8.6 6.9 14.9 2.0 5.1 4.6 8.8 20.8 6.6 8.7 28.2 11.4 7.6 6.4 0.9 8.3 5.0 2.2 1.8 1.1 0.0 0.0 1.9 1.4 0.2 0.1 9.9 34.5 21.4 0.3 0.0 0.0 10.4 2.8 5.3 2.3 3.9 4.2 7.2 13.7 2.3 3.7 0.0 14.4 0.6 7.1 19.5 5.5 4.4 0.0 1.6 1.8 5.0 3.5 0.1 0.4 0.0 0.7 16.2 9.5 10.1 0.7 10.2 4.3 5.6 7.6 0.0 14.8 2.4 1.7 0.0 2.7 0.2 17.3 1.9 30.8 23.7 0.0 3.1 30.1 16.9 16.5 6.4 6.1 1.7 8.3 6.4 24.1 4.6 17.3 0.0 3.2 0.0 6.7 0.0 0.0 0.0 0.8 0.0 0.0 1.8 0.5 0.5 1.0 0.2 1.4 0.5 0.0 1.9 0.0 1.1 1.0 0.2 18.7 18.7 23.1 24.0 18.3 17.8 19.0 18.5 19.3 11.4 11.9 12.6 6.1 1.9 0.7 75.7 6.5 10.2 50.9 19.4 47.1 74.6 0.3 26.6 18.1 69.2 6.1 0.5 0.0 9.8 0.1 1.1 11.2 4.6 0.0 0.4 77.9 50.1 4.3 1.3 27.3 2.0 5.4 10.1 6.4 7.8 34.0 12.9 7.0 1.1 18.2 56.1 0.0 6.2 104.9 27.4 0.9 0.0 7.9 6.0 1.4 MYF5 bHLHc2 ENSG00000111049 "Myogenic factor 5" P13349 12 80716912-80719673 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "skeletal muscle: 23.1;tongue: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "LHCN-M2: 104.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041691 Supported Nucleoplasm NA NA Nucleoplasm "HPA041691: AB_10796780" "unprognostic (2.65e-2)" 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 13.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYH14 "DFNA4, FLJ13881, KIAA2034, MHC16, MYH17" ENSG00000105357 "Myosin heavy chain 14" Q7Z406 19 50188186-50310544 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 78.6;skeletal muscle: 53.1" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 373.2;Paneth cells: 214.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 15.2;CAPAN-2: 19.2;HaCaT: 38.2;MCF7: 18.5;OE19: 19.5;RT4: 47.4;SK-BR-3: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062391, HPA067889, HPA070260" Enhanced Approved Nucleoplasm NA NA 59000000 Nucleoplasm "HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243" "unprognostic (2.52e-1)" "unprognostic (5.81e-2)" "unprognostic (9.63e-2)" "unprognostic (3.73e-3)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "unprognostic (1.71e-1)" "unprognostic (3.48e-2)" "unprognostic (1.93e-2)" "unprognostic (1.01e-1)" "prognostic favorable (3.97e-8)" "prognostic favorable (7.83e-4)" "unprognostic (8.50e-2)" "unprognostic (3.12e-1)" "unprognostic (2.77e-1)" 5.5 0.5 6.1 8.4 6.1 0.1 2.7 4.6 9.4 3.4 63.9 10.5 3.5 38.7 1.1 4.6 14.7 7.5 9.2 16.2 6.4 5.4 4.3 8.7 11.5 0.2 8.5 3.9 1.1 7.5 7.3 4.5 0.7 7.8 3.2 9.4 4.6 12.0 3.1 53.1 20.3 78.6 0.8 11.1 0.2 21.0 0.7 4.2 0.4 16.7 11.4 9.5 4.9 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 1.6 0.0 8.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 10.5 19.2 0.0 9.9 0.0 1.2 38.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 8.0 0.0 0.0 5.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 18.5 0.0 0.1 0.2 19.5 0.2 0.0 9.6 0.2 0.0 47.4 0.0 0.0 0.9 16.9 0.0 0.0 3.1 0.5 0.0 0.0 3.9 0.0 0.0 0.3 3.4 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 6.1 4.6 9.4 6.4 5.4 8.5 3.9 7.8 4.2 74.5 32.2 4.7 15.0 3.0 4.6 18.6 50.9 42.8 37.5 54.1 2.0 0.0 0.0 46.2 0.9 0.7 373.2 0.0 24.4 0.1 0.9 28.7 14.9 41.5 0.1 15.9 49.7 3.7 1.2 0.4 0.3 1.7 5.0 0.0 88.8 19.2 45.9 214.0 0.0 6.4 10.8 0.0 2.8 0.4 4.1 18.3 0.0 0.8 86.0 79.7 MYNN "SBBIZ1, ZBTB31, ZNF902" ENSG00000085274 Myoneurin Q9NPC7 3 169772831-169789716 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045149 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA045149: AB_10960839" "unprognostic (7.13e-2)" "unprognostic (2.28e-2)" "unprognostic (3.67e-2)" "unprognostic (2.19e-2)" "unprognostic (1.17e-2)" "unprognostic (2.02e-1)" "unprognostic (3.09e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-2)" "unprognostic (2.77e-1)" "unprognostic (8.25e-3)" "unprognostic (1.25e-3)" "unprognostic (1.34e-3)" "unprognostic (1.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.36e-3)" 20.3 10.3 10.3 10.6 13.3 22.4 16.4 29.7 15.3 18.4 12.3 8.9 17.7 8.8 17.7 10.9 15.4 15.1 10.5 12.1 13.0 9.0 13.5 13.7 11.4 13.6 12.9 13.7 22.4 15.8 16.2 18.4 17.5 16.0 16.7 12.0 7.7 12.5 11.6 17.9 13.0 16.4 14.3 12.4 16.3 14.3 16.1 15.8 17.5 15.4 13.1 15.9 15.3 12.9 8.2 5.2 19.0 5.0 10.0 10.6 7.6 9.5 4.3 5.3 10.3 10.8 9.3 6.7 6.8 9.2 9.8 10.9 5.4 9.9 14.7 11.8 6.9 8.0 7.7 9.3 8.0 13.0 13.2 7.3 13.9 6.4 5.2 9.3 12.4 10.0 8.2 10.4 6.0 17.5 8.0 8.6 6.4 5.7 14.8 9.6 8.0 7.3 6.4 7.9 11.7 5.0 8.0 7.3 15.2 6.4 16.4 7.4 8.9 7.9 17.7 10.7 7.1 21.7 9.0 6.6 9.0 4.4 8.5 12.3 17.5 12.1 20.0 7.3 7.8 8.9 19.0 5.0 11.9 7.6 5.0 10.2 8.2 8.7 7.2 5.1 8.1 10.6 8.4 13.5 10.0 4.1 5.2 8.4 7.6 10.3 13.3 29.7 15.3 13.0 9.0 12.9 13.7 16.0 15.8 26.8 16.3 8.3 27.3 36.7 10.7 10.9 17.8 20.1 19.4 10.4 21.6 13.1 11.6 8.7 32.8 15.7 8.8 0.0 8.2 14.2 14.2 14.5 7.0 6.4 7.1 9.5 13.7 11.1 9.1 8.9 15.8 9.1 15.1 10.8 7.6 12.0 9.1 9.3 17.7 10.4 30.3 6.5 15.7 28.4 16.8 33.5 17.4 15.4 8.3 23.0 MYO1A "DFNA48, MYHL" ENSG00000166866 "Myosin IA" Q9UBC5 12 57028517-57051198 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "intestine: 148.0" "Cell type enhanced" "Detected in some" 25 "Enterocytes: 221.7;Mucus-secreting cells: 59.5;Paneth cells: 51.8;Undifferentiated cells: 76.4" "Group enriched" "Detected in many" 13 "colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8" "Region enhanced" "Detected in single" "pons and medulla: 1.3" "Group enriched" "Detected in some" 5 "classical monocyte: 1.2;intermediate monocyte: 1.1;myeloid DC: 2.9" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;monocytes: 1.2" "Cell line enriched" "Detected in some" 5 "OE19: 30.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA053490 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA053490: AB_2682168" "unprognostic (2.77e-2)" "unprognostic (2.00e-3)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (7.31e-2)" "unprognostic (7.11e-2)" "unprognostic (4.57e-2)" "unprognostic (1.57e-1)" "unprognostic (6.04e-2)" "unprognostic (4.26e-2)" "unprognostic (8.96e-2)" "unprognostic (2.14e-1)" "unprognostic (2.38e-2)" "unprognostic (6.89e-2)" "unprognostic (5.01e-1)" "unprognostic (5.81e-2)" "unprognostic (8.72e-2)" 0.1 0.1 0.1 5.2 0.2 0.0 0.1 0.1 0.2 0.1 57.2 0.3 0.1 70.0 0.1 0.1 0.1 0.1 5.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.2 1.3 0.1 14.1 0.1 0.2 0.1 0.1 0.1 148.0 0.4 4.7 0.1 3.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 2.9 0.0 1.2 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 1.1 0.0 30.9 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.5 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.4 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 221.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 23.7 0.0 0.3 0.2 0.0 0.9 0.0 0.0 59.5 0.0 0.2 51.8 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.0 76.4 0.0 MYO6 "DFNA22, DFNB37, KIAA0389" ENSG00000196586 "Myosin VI" Q9UM54 6 75749192-75919537 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Hearing, Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 333.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "gdT-cell: 8.6;MAIT T-cell: 4.0;memory CD4 T-cell: 2.7;memory CD8 T-cell: 4.9;naive CD8 T-cell: 4.8;NK-cell: 3.3" "Group enriched" "Detected in many" 20 "NK-cells: 3.3;T-cells: 8.6" "Cell line enhanced" "Detected in many" "RT4: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010762, HPA035482, HPA035483" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647" "unprognostic (6.29e-2)" "unprognostic (6.34e-2)" "unprognostic (3.63e-3)" "unprognostic (1.30e-1)" "unprognostic (8.98e-2)" "unprognostic (2.73e-2)" "unprognostic (3.41e-3)" "unprognostic (1.23e-2)" "unprognostic (1.23e-2)" "unprognostic (2.66e-2)" "unprognostic (7.78e-2)" "unprognostic (2.78e-2)" "prognostic favorable (1.27e-12)" "unprognostic (1.57e-1)" "unprognostic (1.72e-1)" "unprognostic (1.41e-1)" "unprognostic (2.49e-2)" 8.4 9.1 18.2 9.0 27.0 0.9 26.9 17.1 24.1 16.2 18.9 26.8 28.7 30.0 7.5 25.9 28.1 10.0 23.1 4.9 19.1 12.2 44.0 13.8 20.5 4.5 24.0 17.9 4.6 18.5 42.2 24.2 7.1 19.0 16.0 17.3 11.9 23.3 33.7 4.2 14.1 27.7 8.0 21.2 6.7 23.9 14.3 28.2 0.9 13.4 9.1 10.9 16.1 13.1 0.2 0.0 0.1 0.1 3.3 8.6 1.2 22.7 6.1 4.9 3.5 11.9 9.6 19.6 8.1 8.6 6.0 7.8 9.2 20.5 0.0 7.9 9.1 6.9 18.0 5.8 11.6 6.9 9.6 11.9 6.5 2.0 5.6 10.2 0.0 9.5 6.8 8.4 8.1 6.4 10.0 16.6 3.3 8.5 3.3 6.1 21.9 0.0 0.2 3.3 17.1 1.6 0.4 11.8 0.4 22.3 43.4 10.2 6.7 2.0 20.4 3.5 11.6 8.7 13.3 24.3 6.6 5.7 0.3 7.3 6.9 7.0 0.0 4.1 0.0 2.3 0.1 0.0 0.0 8.6 0.0 4.0 0.2 2.7 4.9 0.0 0.0 0.6 4.8 0.1 3.3 0.1 0.0 0.1 1.2 18.2 27.0 17.1 24.1 19.1 12.2 24.0 17.9 19.0 28.2 131.0 218.3 7.6 88.9 26.8 74.9 7.3 35.7 75.0 79.6 143.1 113.9 27.1 46.4 104.1 3.9 45.8 95.7 0.0 104.0 18.4 24.2 142.1 25.4 28.2 5.5 90.6 81.6 42.4 3.8 5.6 27.9 6.0 28.7 4.6 66.2 333.7 145.6 80.7 40.7 83.4 184.9 12.9 16.9 10.9 13.8 29.7 65.6 12.1 54.2 164.0 MYOCD MYCD ENSG00000141052 Myocardin Q8IZQ8 17 12665890-12768949 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 63.4" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 26.6;Peritubular cells: 94.7;Sertoli cells: 25.8;Smooth muscle cells: 30.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 6.3;BJ hTERT+: 6.4;HBF TERT88: 10.6;hTEC/SVTERT24-B: 11.7;REH: 8.0;SuSa: 13.5" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "cerebellum: 6.4" "CAB046485, HPA071528, HPA072582" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB046485: AB_10600720, HPA071528: , HPA072582: " "unprognostic (2.82e-1)" "unprognostic (1.69e-1)" "unprognostic (2.36e-2)" "unprognostic (1.90e-1)" "unprognostic (3.79e-2)" "unprognostic (5.33e-2)" "unprognostic (2.15e-4)" "unprognostic (2.71e-2)" "unprognostic (1.61e-2)" "unprognostic (2.31e-1)" "unprognostic (1.76e-1)" "unprognostic (4.83e-2)" "unprognostic (1.01e-4)" "unprognostic (2.88e-2)" "unprognostic (1.07e-1)" "unprognostic (5.45e-2)" "unprognostic (1.91e-2)" 3.1 0.8 0.6 5.1 1.0 0.0 1.9 0.3 0.5 19.6 19.9 0.2 17.6 2.1 16.6 10.9 14.4 7.4 12.2 18.6 0.4 0.4 0.9 0.4 2.5 0.0 0.5 0.8 10.6 0.4 0.0 0.5 2.6 0.6 17.2 4.2 5.1 0.4 18.7 1.2 1.5 6.6 63.4 0.6 0.5 6.7 3.7 0.1 0.0 1.0 1.2 0.0 33.4 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.3 6.4 2.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 13.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.3 0.5 0.4 0.4 0.5 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 1.1 0.1 0.0 0.0 0.1 0.0 7.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.7 0.0 0.0 25.8 30.6 0.2 0.7 0.6 0.5 0.0 0.0 0.0 MYOD1 "bHLHc1, MYF3, MYOD, PUM" ENSG00000129152 "Myogenic differentiation 1" P15172 11 17719568-17722131 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 31.8" "Cell type enriched" "Detected in single" 7 "Spermatogonia: 3.0" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "RH-30: 103.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055436, HPA078647" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055436: , HPA078647: " "unprognostic (1.07e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.5 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 4.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.0 0.0 MYOG "bHLHc3, MYF4" ENSG00000122180 Myogenin P15173 1 203083132-203086036 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 60.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "head and neck cancer: 3.9;testis cancer: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 200 "HSkMC: 18.0;RH-30: 34.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA028336 Supported Nucleoplasm NA NA Nucleoplasm "HPA028336: AB_2672562" "unprognostic (1.71e-1)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (2.22e-1)" "unprognostic (2.79e-9)" "unprognostic (3.96e-1)" "unprognostic (2.56e-1)" 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.3 0.0 0.0 2.4 0.0 60.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.7 13.3 1.7 0.0 0.0 0.8 0.8 2.3 1.3 1.8 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.4 0.8 0.4 0.7 1.0 0.8 0.5 0.6 0.3 0.6 0.9 1.0 1.4 1.8 1.3 0.8 0.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYPOP P42pop ENSG00000176182 "Myb related transcription factor, partner of profilin" Q86VE0 19 45890020-45902604 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 36.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 19.2;NB-4: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065307 Approved Nucleoplasm NA NA Nucleoplasm "HPA065307: AB_2685460" "unprognostic (5.13e-2)" "unprognostic (2.68e-2)" "unprognostic (1.70e-1)" "unprognostic (4.52e-2)" "unprognostic (2.68e-2)" "unprognostic (4.87e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.94e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (8.67e-5)" "unprognostic (1.28e-3)" "unprognostic (1.42e-2)" "unprognostic (4.08e-2)" "unprognostic (8.19e-3)" "unprognostic (3.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-3)" 7.6 9.4 15.7 7.9 14.3 4.2 8.0 15.1 25.9 6.5 7.5 6.8 5.9 11.4 7.2 7.0 6.4 6.1 7.1 8.0 15.9 9.2 9.5 6.1 5.9 8.3 8.5 7.7 6.5 8.5 7.0 12.9 6.1 11.3 7.7 6.0 6.3 9.5 8.2 36.4 10.1 10.1 6.5 9.0 12.3 8.5 6.8 8.7 5.3 5.0 4.3 7.0 6.8 10.7 1.0 1.5 2.7 1.4 0.6 1.1 0.4 4.2 6.8 2.6 5.3 3.4 2.2 5.2 3.2 3.3 3.5 4.6 2.7 2.7 4.1 3.1 1.6 3.4 3.6 1.9 1.4 2.5 19.2 11.1 1.9 3.8 4.4 3.7 1.9 6.2 2.1 4.1 1.9 1.8 3.7 2.8 7.0 2.6 3.7 2.2 1.8 10.1 26.2 2.9 5.5 6.9 8.1 1.1 2.3 2.0 2.4 5.4 4.1 3.1 3.4 3.3 2.0 2.3 7.1 3.6 3.3 5.5 3.0 5.0 10.9 7.8 2.7 4.8 5.2 3.9 0.0 1.4 2.7 1.1 0.6 0.3 1.0 0.8 0.6 1.5 0.3 0.6 0.7 1.6 0.6 0.7 1.0 0.7 0.4 15.7 14.3 15.1 25.9 15.9 9.2 8.5 7.7 11.3 8.7 3.0 1.3 3.7 4.4 10.2 10.1 11.8 5.1 1.4 0.0 5.2 7.9 4.5 19.9 7.0 5.2 3.8 7.8 0.0 7.9 14.2 6.6 2.9 0.0 3.2 5.1 6.4 8.6 3.7 4.9 1.0 6.6 5.3 3.3 6.4 4.5 3.2 6.0 5.9 7.1 5.1 11.4 19.4 4.5 2.4 4.9 8.5 4.5 6.9 4.6 2.0 MZF1 "MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6" ENSG00000099326 "Myeloid zinc finger 1" P28698 19 58561931-58573575 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 27.9;HeLa: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001757 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA001757: AB_1080718" "unprognostic (8.25e-3)" "unprognostic (2.33e-1)" "unprognostic (5.12e-2)" "unprognostic (5.16e-3)" "unprognostic (7.15e-2)" "unprognostic (4.29e-3)" "unprognostic (1.84e-2)" "unprognostic (4.62e-1)" "unprognostic (8.10e-2)" "unprognostic (7.03e-2)" "prognostic favorable (7.97e-4)" "unprognostic (2.87e-2)" "prognostic unfavorable (2.83e-8)" "unprognostic (1.47e-1)" "unprognostic (1.80e-1)" "unprognostic (4.64e-2)" "prognostic favorable (4.09e-5)" 7.8 14.2 16.9 10.9 17.4 9.4 8.1 20.3 18.8 12.5 9.4 12.4 24.8 19.6 13.6 13.4 8.7 16.6 13.5 6.7 15.4 9.7 11.7 9.8 12.5 9.9 13.9 14.8 15.9 15.2 17.5 26.0 6.8 13.7 13.8 7.8 12.4 16.7 21.5 9.7 11.6 17.0 9.6 9.6 11.7 14.7 9.0 16.1 8.3 18.1 5.2 9.4 11.0 9.8 3.5 2.3 2.3 1.2 6.6 9.0 3.4 4.7 12.4 5.1 3.2 3.0 2.7 6.1 4.3 2.3 0.8 1.6 2.6 5.9 3.4 2.1 1.2 3.7 5.4 1.3 3.1 0.4 5.9 27.9 3.6 21.4 1.4 1.8 2.7 6.3 1.8 8.0 1.1 3.5 5.0 2.7 4.0 3.0 4.4 1.1 5.3 1.5 1.5 1.8 2.9 4.9 4.2 1.2 6.1 2.7 10.4 4.9 6.9 2.1 4.2 2.7 1.0 4.3 3.6 3.0 8.2 2.6 1.4 2.2 7.5 8.5 2.8 6.5 2.9 1.9 0.0 1.2 0.6 3.3 0.9 4.9 3.2 5.4 3.8 2.3 3.5 9.0 5.6 2.3 6.6 0.9 0.6 3.2 3.4 16.9 17.4 20.3 18.8 15.4 9.7 13.9 14.8 13.7 16.1 11.9 14.2 12.3 10.5 7.1 36.2 5.5 12.7 13.4 2.3 10.4 31.4 5.0 3.3 6.8 16.9 6.4 15.4 0.0 4.8 3.0 6.1 9.5 4.6 8.3 4.1 28.6 16.1 7.4 3.5 19.1 9.8 3.3 10.1 1.0 10.7 18.1 5.6 8.5 12.4 7.9 46.3 19.4 3.2 8.9 3.4 7.2 5.4 12.8 10.5 6.0 N4BP2L2 "CG005, PFAAP5" ENSG00000244754 "NEDD4 binding protein 2 like 2" Q92802 13 32432417-32538885 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039338, HPA039434, HPA059327" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039338: AB_2676453, HPA039434: AB_10673143, HPA059327: AB_2683981" "unprognostic (1.13e-1)" "unprognostic (1.72e-1)" "unprognostic (3.15e-1)" "unprognostic (5.81e-2)" "unprognostic (6.83e-2)" "unprognostic (6.51e-2)" "unprognostic (8.95e-2)" "unprognostic (6.29e-3)" "unprognostic (6.04e-2)" "unprognostic (1.87e-1)" "unprognostic (2.71e-3)" "unprognostic (2.67e-2)" "unprognostic (4.73e-3)" "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (4.03e-3)" 24.4 22.6 22.8 27.3 28.0 17.4 29.7 43.4 34.0 34.1 25.2 18.0 31.6 13.9 38.3 25.8 19.5 26.3 22.1 30.3 23.7 18.8 23.7 25.4 26.2 20.1 30.2 23.3 38.5 19.5 19.1 75.7 20.6 24.6 28.1 23.3 15.5 22.4 27.3 49.3 23.0 21.4 28.7 39.8 24.3 23.1 14.7 29.6 31.4 27.8 21.1 20.4 29.4 27.1 12.7 10.2 23.0 12.5 14.2 17.7 7.7 7.7 5.4 17.6 12.4 14.8 18.5 14.4 15.0 14.7 12.5 11.7 10.0 20.4 9.8 8.5 15.1 21.3 13.4 17.1 14.0 15.9 20.8 7.6 19.6 12.1 10.9 22.6 21.0 9.5 19.4 18.7 10.9 14.0 21.8 18.7 16.0 14.1 9.8 18.2 9.1 17.7 18.4 17.2 34.6 7.2 13.4 16.4 9.6 15.4 9.7 6.8 14.8 10.9 12.0 21.4 18.9 12.7 24.7 14.8 7.9 8.1 7.2 7.5 7.5 7.8 8.0 9.1 14.7 11.8 23.0 8.6 19.7 12.4 9.6 17.0 12.7 14.4 12.4 7.7 11.4 17.7 15.2 15.4 14.2 12.5 10.2 13.3 7.7 22.8 28.0 43.4 34.0 23.7 18.8 30.2 23.3 24.6 29.6 160.8 148.3 169.0 254.9 122.5 229.6 159.8 99.3 147.2 134.2 205.9 233.7 140.7 77.9 107.5 102.8 157.2 207.2 93.5 65.1 67.9 132.2 215.5 205.8 114.9 103.8 235.2 168.7 154.7 146.4 89.3 342.6 171.5 118.1 247.1 126.1 127.5 94.1 273.5 283.5 60.3 318.6 310.4 155.5 171.9 86.9 120.3 160.2 246.8 107.6 246.1 NAA38 "LSMD1, MGC14151, PFAAP2" ENSG00000183011 "N(alpha)-acetyltransferase 38, NatC auxiliary subunit" Q9BRA0 17 7856685-7885238 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 1093.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059189 Supported Nucleoplasm "Intracellular and membrane" No No Nucleoplasm "HPA059189: " "unprognostic (6.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.30e-2)" "unprognostic (1.85e-3)" "unprognostic (2.76e-2)" "unprognostic (3.35e-1)" "unprognostic (4.72e-2)" "unprognostic (1.05e-1)" "unprognostic (2.27e-1)" "unprognostic (7.28e-3)" "unprognostic (1.48e-3)" "unprognostic (3.31e-1)" "unprognostic (5.83e-3)" "unprognostic (1.58e-1)" "unprognostic (6.02e-2)" "unprognostic (2.66e-1)" "unprognostic (9.75e-2)" 24.4 38.7 55.9 20.5 51.0 41.8 23.8 25.1 60.7 22.1 27.0 18.7 16.2 20.1 17.2 22.9 19.8 30.1 28.1 34.2 41.4 37.2 26.1 27.6 18.4 26.3 45.9 36.2 15.8 33.3 17.9 21.3 15.0 32.1 26.7 18.1 19.7 37.5 33.2 74.5 16.5 18.2 23.8 34.2 22.3 22.2 26.6 25.6 14.6 18.7 39.8 20.0 18.0 15.9 66.0 84.4 68.7 71.8 35.5 52.1 70.5 27.7 51.1 28.7 29.3 16.0 17.9 9.9 13.0 15.1 24.1 20.2 19.2 11.9 19.2 22.0 13.7 15.4 22.9 15.3 24.0 6.0 28.4 69.8 29.2 57.9 27.7 15.6 8.1 22.7 25.9 13.4 15.7 10.3 16.7 23.3 44.1 6.0 21.0 13.9 33.5 29.3 19.4 6.4 21.1 59.6 30.2 13.2 12.7 22.0 15.7 12.8 24.6 10.1 24.5 18.4 4.3 15.1 21.5 12.5 16.2 11.7 13.1 36.3 8.7 8.8 7.0 27.3 33.9 15.8 68.7 71.8 47.6 47.7 59.1 43.6 66.0 50.9 48.6 84.4 57.1 46.1 47.8 51.7 35.5 56.4 76.8 52.1 70.5 55.9 51.0 25.1 60.7 41.4 37.2 45.9 36.2 32.1 25.6 71.5 116.4 99.9 74.2 83.6 100.6 294.9 109.5 131.2 75.1 240.8 47.1 142.9 439.3 87.9 575.0 132.2 186.5 70.0 137.1 98.8 70.4 99.2 97.1 325.3 181.0 38.1 217.8 193.3 210.1 1093.0 108.1 113.0 72.6 165.1 179.4 108.6 125.9 144.0 106.4 289.2 88.8 109.9 82.5 94.0 121.8 86.9 76.9 96.9 261.5 96.2 NAALAD2 "GCPIII, NAALADASE2" ENSG00000077616 "N-acetylated alpha-linked acidic dipeptidase 2" Q9Y3Q0 11 90131515-90192894 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 44.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 15.8;Early spermatids: 37.5;Horizontal cells: 66.7" "Cancer enhanced" "Detected in some" "testis cancer: 1.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 2.4" "Lineage enriched" "Detected in single" 12 "monocytes: 2.4" "Cell line enhanced" "Detected in some" "CACO-2: 20.0;SH-SY5Y: 6.7;SuSa: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060820, HPA065419" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA060820: AB_2684373, HPA065419: AB_2685487" "unprognostic (1.68e-1)" "unprognostic (2.66e-3)" "unprognostic (1.49e-1)" "unprognostic (4.52e-3)" "unprognostic (4.73e-3)" "unprognostic (2.97e-1)" "unprognostic (3.82e-3)" "unprognostic (1.77e-2)" "unprognostic (2.44e-1)" "unprognostic (2.30e-1)" "unprognostic (3.30e-2)" "unprognostic (8.00e-2)" "unprognostic (9.97e-4)" "unprognostic (1.52e-2)" "unprognostic (2.54e-1)" "unprognostic (1.63e-2)" "unprognostic (2.93e-1)" 7.7 13.0 5.3 1.8 9.9 1.1 3.1 2.1 9.8 7.8 2.1 3.7 2.8 1.3 10.3 5.4 1.8 4.7 3.7 2.5 5.5 7.4 2.7 1.7 2.8 1.6 6.5 5.0 12.9 2.5 0.9 44.1 8.8 11.9 5.2 2.2 5.8 1.9 3.7 2.1 1.5 2.1 3.5 6.2 4.4 1.8 16.6 7.4 0.0 1.7 1.7 1.2 1.8 3.8 0.0 0.1 0.0 2.4 0.0 0.1 0.1 0.1 0.2 1.9 0.1 0.6 0.1 2.4 0.1 0.1 0.1 0.0 20.0 0.7 0.3 0.2 0.0 0.3 0.3 1.4 0.0 0.0 0.0 0.4 1.9 0.4 1.8 0.2 0.1 0.1 2.3 0.0 0.0 0.0 0.6 0.4 0.2 0.1 0.0 0.0 0.0 0.3 0.3 1.9 0.5 0.2 0.3 0.0 0.2 0.0 0.0 0.2 6.7 0.0 0.2 0.0 4.9 0.2 0.4 2.6 0.1 1.6 0.4 0.3 1.1 0.3 0.3 0.7 0.3 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.1 0.1 5.3 9.9 2.1 9.8 5.5 7.4 6.5 5.0 11.9 7.4 0.0 0.0 0.0 0.1 0.2 15.8 0.8 2.5 0.0 1.2 0.0 0.0 0.8 0.0 0.0 37.5 0.7 0.0 0.0 0.0 0.5 3.4 0.2 0.0 0.0 0.3 66.7 0.0 1.3 5.4 13.2 10.3 0.2 0.0 0.0 0.0 10.1 0.0 0.0 13.8 0.0 2.3 0.0 4.7 0.3 4.4 0.0 0.7 0.0 0.0 0.0 NAALADL2 ENSG00000177694 "N-acetylated alpha-linked acidic dipeptidase like 2" Q58DX5 3 174438573-175810552 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 29.3" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 60.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.7;BJ hTERT+: 4.2;fHDF/TERT166: 4.9;WM-115: 4.5" "Low region specificity" "Detected in many" "HPA012413, HPA017425, CAB025586" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275" "unprognostic (7.28e-3)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (1.60e-1)" "unprognostic (2.56e-1)" "unprognostic (2.56e-1)" "unprognostic (2.29e-4)" "unprognostic (3.44e-3)" "unprognostic (5.70e-2)" "unprognostic (7.42e-2)" "unprognostic (7.85e-3)" "unprognostic (9.49e-2)" "unprognostic (3.66e-6)" "unprognostic (7.11e-2)" "unprognostic (1.48e-1)" "unprognostic (9.05e-2)" "unprognostic (2.22e-2)" 4.9 2.3 2.2 4.6 3.7 0.8 7.0 1.9 2.7 8.3 8.3 5.4 23.8 2.4 9.7 10.5 2.3 5.0 8.9 5.4 2.5 1.8 7.0 3.7 3.3 1.3 2.3 2.0 5.4 3.9 20.6 3.0 6.4 4.0 9.6 3.3 4.4 17.0 29.3 1.8 3.2 6.6 6.0 3.6 2.6 4.5 1.9 2.9 4.9 3.5 2.6 1.7 8.7 5.0 0.1 1.7 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.2 0.0 3.5 11.7 0.1 2.3 4.2 0.6 0.7 0.2 1.3 0.0 0.5 4.9 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 3.2 0.6 0.1 0.0 3.0 0.4 0.0 0.0 0.1 2.3 0.4 0.2 0.0 0.0 1.6 0.0 0.0 0.2 0.1 1.7 0.2 0.0 0.0 0.2 0.2 0.9 0.3 3.1 0.1 0.5 2.3 0.1 0.1 0.5 0.0 0.0 0.0 1.5 0.0 4.5 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.1 0.0 1.7 0.0 0.0 2.2 3.7 1.9 2.7 2.5 1.8 2.3 2.0 4.0 2.9 0.0 11.5 0.0 7.2 2.1 7.6 2.8 10.2 18.7 6.8 12.2 11.8 16.3 6.6 6.8 60.1 2.1 11.1 0.0 2.3 1.5 7.8 18.3 4.6 2.4 1.6 0.0 8.6 3.1 0.3 28.0 14.1 0.7 3.3 0.0 1.1 7.7 2.5 3.5 11.3 1.7 6.6 0.0 2.3 3.2 1.9 1.6 10.3 0.0 14.9 13.7 NABP2 "hSSB1, MGC2731, OBFC2B, SOSS-B1, SSB1" ENSG00000139579 "Nucleic acid binding protein 2" Q9BQ15 12 56222015-56229854 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 187.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044615, HPA057213" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044615: AB_10795884, HPA057213: AB_2683371" "unprognostic (1.45e-1)" "prognostic favorable (8.35e-6)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (7.44e-6)" "unprognostic (4.00e-1)" "unprognostic (1.11e-1)" "unprognostic (6.96e-3)" "unprognostic (6.52e-2)" "unprognostic (4.72e-2)" "prognostic unfavorable (2.69e-5)" "unprognostic (1.28e-1)" "unprognostic (1.92e-1)" "unprognostic (1.28e-1)" "unprognostic (3.01e-2)" 14.0 26.7 27.7 16.7 33.3 16.2 15.7 23.6 32.6 16.2 19.5 17.6 14.9 22.8 16.3 19.4 15.0 16.0 23.0 16.2 25.8 25.2 21.0 17.7 11.7 18.0 26.4 24.4 23.1 25.8 17.2 17.0 8.6 24.0 15.8 19.9 17.6 15.9 19.6 51.8 14.0 22.4 16.7 20.2 14.9 17.0 18.6 20.5 10.6 20.6 21.7 18.7 15.9 14.7 17.1 13.5 15.3 14.9 25.9 21.0 10.2 25.4 26.4 25.1 27.9 10.9 11.9 4.8 15.4 12.9 22.4 13.4 15.8 23.0 19.6 31.4 14.1 16.0 20.4 23.3 19.4 17.1 36.9 21.9 32.7 18.5 12.1 11.8 23.3 31.9 10.1 15.5 26.7 21.7 19.2 14.3 24.3 16.8 33.8 16.1 23.1 31.5 26.1 18.4 15.2 25.3 28.6 23.5 29.2 10.6 10.6 32.0 23.7 24.7 30.6 20.9 4.1 35.0 20.8 10.1 15.8 15.0 33.1 28.2 22.9 34.9 12.5 29.4 21.8 29.2 15.3 9.9 8.6 17.5 13.8 19.4 17.1 14.7 15.8 13.4 12.6 9.2 15.3 1.9 25.9 14.9 13.5 21.0 10.2 27.7 33.3 23.6 32.6 25.8 25.2 26.4 24.4 24.0 20.5 14.9 17.6 19.2 18.9 16.6 15.5 8.1 12.7 12.0 3.4 22.7 2.0 25.5 41.4 27.1 73.7 17.5 25.1 0.0 61.7 33.3 19.1 11.3 17.3 18.5 27.5 14.3 17.3 16.5 16.1 187.0 21.9 20.4 30.4 36.9 24.4 24.4 31.4 24.6 32.2 28.4 11.8 19.4 19.4 9.9 24.7 14.9 12.7 27.7 34.4 9.3 NANS SAS ENSG00000095380 "N-acetylneuraminate synthase" Q9NR45 9 98056739-98083075 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019223 Approved Enhanced Nucleoplasm No No 200000 Nucleoplasm "HPA019223: AB_1854298" "unprognostic (2.95e-1)" "unprognostic (5.10e-3)" "unprognostic (2.24e-2)" "prognostic favorable (1.71e-4)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (2.08e-1)" "unprognostic (7.98e-2)" "unprognostic (2.28e-1)" "unprognostic (1.54e-2)" "unprognostic (1.12e-1)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (7.36e-2)" "unprognostic (3.62e-3)" "unprognostic (1.79e-1)" 17.2 10.1 8.8 20.2 11.4 22.2 16.4 7.0 11.7 20.2 47.6 6.4 17.0 19.4 11.0 15.1 18.6 10.4 25.0 20.9 14.4 12.4 15.0 49.6 17.1 20.1 11.5 10.6 14.1 59.2 6.1 16.3 15.8 12.1 37.2 49.6 9.4 80.0 18.3 11.9 10.3 18.9 11.0 9.0 22.2 28.3 11.5 9.8 10.6 19.7 15.2 25.0 15.7 14.8 12.3 41.9 16.4 49.8 7.4 12.1 18.3 73.9 21.9 6.5 18.7 13.1 14.2 14.1 23.7 18.6 19.4 15.9 26.1 10.6 22.8 11.5 26.0 20.5 26.3 12.0 20.3 16.2 18.3 18.0 13.5 24.5 52.1 36.3 15.2 11.1 11.9 13.9 20.6 23.6 22.6 20.6 11.4 24.5 23.8 14.1 50.8 10.2 22.0 11.2 53.6 28.4 19.8 17.8 23.2 15.4 22.7 13.2 6.9 15.2 82.5 20.1 7.5 27.3 16.5 53.6 15.1 14.7 38.7 24.2 22.2 18.4 8.7 17.9 18.5 11.7 5.3 42.1 6.0 8.0 49.8 12.1 12.3 10.5 8.3 41.9 10.1 11.5 7.8 16.4 7.4 43.0 38.4 11.9 18.3 8.8 11.4 7.0 11.7 14.4 12.4 11.5 10.6 12.1 9.8 26.8 52.4 47.0 107.6 62.3 8.1 21.5 53.5 151.3 77.3 21.0 17.7 73.6 59.7 41.8 35.3 57.3 177.1 0.0 89.0 121.2 62.1 166.7 43.8 28.6 139.8 9.5 62.4 25.2 52.6 53.6 30.0 94.4 123.2 58.7 195.9 13.3 63.2 189.8 24.8 47.7 7.0 12.9 96.2 7.2 16.9 54.0 126.1 27.7 245.2 195.9 NAP1L4 NAP2 ENSG00000205531 "Nucleosome assembly protein 1 like 4" Q99733 11 2944431-2992377 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011567 Approved Supported Nucleoplasm NA NA 5700000 Nucleoplasm "CAB011567: AB_776638" "unprognostic (1.61e-1)" "prognostic favorable (9.77e-4)" "unprognostic (8.99e-2)" "unprognostic (9.64e-3)" "unprognostic (2.96e-3)" "unprognostic (2.24e-2)" "prognostic unfavorable (1.68e-7)" "unprognostic (1.80e-1)" "unprognostic (6.44e-2)" "unprognostic (1.77e-1)" "unprognostic (6.73e-2)" "unprognostic (2.31e-1)" "unprognostic (6.10e-3)" "unprognostic (1.19e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.55e-4)" "unprognostic (1.54e-1)" 21.6 17.2 36.4 21.9 41.0 27.5 21.1 31.7 34.8 22.9 23.4 37.8 19.1 13.3 23.3 18.7 29.8 18.7 21.8 58.2 34.6 40.1 30.8 22.2 20.3 37.7 50.5 28.7 26.7 18.9 63.0 25.3 24.1 33.7 22.7 22.8 22.3 27.2 22.4 51.5 19.3 24.8 27.5 49.5 23.5 25.1 36.6 34.9 32.2 23.6 32.1 46.8 29.8 21.6 12.3 12.4 28.2 13.1 24.7 30.6 19.4 17.7 11.9 19.5 15.4 20.3 22.6 8.9 37.1 24.3 34.5 31.7 29.7 48.6 34.0 22.8 22.6 3.6 32.4 5.1 31.6 40.1 36.0 12.7 24.3 36.0 38.2 14.0 19.8 26.3 18.8 15.4 18.6 13.5 2.8 20.8 15.6 31.1 35.5 29.9 16.8 46.0 0.8 47.1 22.6 17.3 21.3 23.2 26.6 3.0 30.4 29.0 24.9 18.7 27.8 17.9 20.1 1.7 1.6 15.7 27.0 25.1 36.0 3.2 18.9 30.0 45.8 1.9 14.2 17.6 28.2 10.3 13.4 19.7 11.2 19.4 11.7 24.8 25.5 12.4 12.3 22.0 25.4 7.0 24.7 13.1 11.2 30.6 19.4 36.4 41.0 31.7 34.8 34.6 40.1 50.5 28.7 33.7 34.9 41.7 36.7 40.2 54.8 62.3 78.5 179.1 53.5 109.7 70.5 71.5 43.2 87.0 82.9 68.3 75.9 55.4 32.8 70.0 44.0 90.2 52.2 59.8 70.7 42.9 41.1 62.0 43.6 45.4 20.1 108.1 44.5 38.9 33.7 73.9 37.6 64.0 62.3 21.0 47.0 52.8 59.4 45.3 37.9 136.3 123.0 58.5 76.3 103.8 47.2 75.7 NASP "DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999" ENSG00000132780 "Nuclear autoantigenic sperm protein" P49321 1 45583846-45618904 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Spermatocytes: 344.6;Spermatogonia: 575.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028136, HPA030518, HPA030520" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510" "unprognostic (5.59e-2)" "unprognostic (1.34e-3)" "unprognostic (5.02e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (5.36e-3)" "prognostic unfavorable (4.96e-6)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (1.56e-2)" "unprognostic (1.15e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (1.91e-8)" "unprognostic (1.62e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" "unprognostic (5.32e-2)" 20.7 15.2 19.3 33.4 32.0 64.0 21.2 20.1 24.0 22.8 21.9 30.2 26.4 15.9 22.3 19.8 20.1 23.0 12.5 18.1 22.4 17.3 17.5 21.0 17.6 39.0 40.2 17.8 28.3 17.4 21.9 22.9 28.5 24.2 18.9 24.7 12.6 17.8 21.8 14.3 16.1 20.5 21.3 30.3 31.7 17.5 35.8 40.2 49.1 17.7 28.2 43.0 18.5 19.6 16.9 11.8 8.1 9.7 7.3 17.5 6.9 24.6 14.6 70.1 24.8 11.8 6.2 33.0 20.0 14.9 31.1 39.1 26.9 17.9 46.5 14.1 8.6 34.2 23.9 46.7 21.3 39.9 21.2 29.6 60.1 26.3 42.1 4.1 62.7 25.3 7.2 5.2 34.3 11.9 8.1 21.2 39.2 50.5 27.5 21.0 16.8 71.4 57.5 101.9 24.6 12.4 90.3 61.5 44.7 15.4 24.9 26.9 32.6 32.9 18.8 20.3 55.3 13.5 49.1 11.4 14.4 44.2 27.6 32.5 16.9 31.8 80.7 14.7 40.1 14.3 4.9 7.3 8.1 12.3 9.7 14.2 13.5 13.9 14.0 11.5 16.9 12.3 11.8 3.1 7.3 5.7 11.8 17.5 6.9 19.3 32.0 20.1 24.0 22.4 17.3 40.2 17.8 24.2 40.2 53.6 89.6 88.0 115.5 69.4 46.4 46.2 35.7 160.6 146.7 34.9 35.3 265.5 26.6 48.1 12.2 85.7 26.9 23.3 32.6 179.3 75.1 49.2 111.0 32.6 90.0 41.3 49.2 76.1 37.0 19.1 87.8 52.1 38.8 54.1 39.4 64.0 29.7 41.2 73.6 27.1 77.6 84.1 71.5 344.6 575.6 49.8 224.3 87.3 90.3 75.0 NAT16 "C7orf52, FLJ39237" ENSG00000167011 "N-acetyltransferase 16 (putative)" Q8N8M0 7 101170493-101180276 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6" "Cell type enriched" "Detected in some" 45 "Horizontal cells: 276.5" "Cancer enhanced" "Detected in some" "melanoma: 2.1" "Group enriched" "Detected in many" 4 "amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 4.6;SH-SY5Y: 6.9;SK-MEL-30: 5.2;U-2 OS: 6.1;U-87 MG: 3.4" HPA021918 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA021918: AB_1848922" "unprognostic (4.32e-2)" "unprognostic (1.75e-1)" "unprognostic (2.69e-3)" "unprognostic (4.58e-3)" "unprognostic (2.93e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" "unprognostic (1.40e-2)" "unprognostic (2.25e-3)" "unprognostic (2.35e-2)" "unprognostic (4.23e-2)" "unprognostic (2.62e-2)" "unprognostic (5.53e-5)" "unprognostic (7.65e-2)" "unprognostic (2.48e-1)" "unprognostic (5.02e-5)" "unprognostic (1.59e-1)" 0.2 0.4 3.1 0.2 9.1 0.7 0.1 0.4 8.2 0.1 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.1 0.1 0.9 4.8 0.1 0.5 0.1 0.2 0.7 0.6 0.1 6.0 0.2 5.8 0.1 0.8 0.2 0.3 0.5 0.3 0.1 0.3 0.4 0.2 0.2 0.4 0.3 1.2 0.4 1.2 0.0 4.6 0.0 0.0 0.1 0.0 1.2 0.7 2.2 0.6 1.3 0.8 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.3 0.5 0.5 0.1 0.1 0.8 0.0 0.6 0.2 0.1 4.6 0.1 0.5 0.1 6.9 0.0 0.3 5.2 0.5 0.3 0.0 0.0 0.4 6.1 0.5 0.1 0.1 0.0 0.1 3.4 0.0 1.6 0.4 0.6 0.3 0.3 0.4 0.3 0.2 0.2 0.1 0.2 1.2 0.8 0.4 2.2 1.3 0.3 0.7 0.3 0.0 3.1 9.1 0.4 2.9 0.9 4.8 0.7 0.6 0.8 1.2 0.0 0.0 0.0 0.0 0.0 1.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 276.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NAT9 DKFZP564C103 ENSG00000109065 "N-acetyltransferase 9 (putative)" Q9BTE0 17 74770547-74776367 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021820, HPA057149" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA021820: AB_1847958, HPA057149: AB_2683350" "unprognostic (7.53e-2)" "unprognostic (1.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.40e-1)" "unprognostic (2.18e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.25e-5)" "unprognostic (1.27e-1)" "unprognostic (5.77e-2)" "unprognostic (1.41e-1)" "prognostic favorable (3.21e-5)" "unprognostic (6.50e-3)" "prognostic unfavorable (6.26e-6)" "prognostic favorable (7.80e-4)" "unprognostic (8.50e-2)" "unprognostic (8.64e-2)" "unprognostic (1.03e-3)" 9.4 31.6 20.1 11.3 17.8 11.8 13.5 20.0 20.6 13.6 11.2 9.9 21.7 8.0 11.6 24.5 9.1 16.8 12.9 11.3 18.4 12.1 12.9 16.6 10.5 12.0 18.1 17.8 21.5 14.5 18.5 25.1 13.8 23.1 15.8 9.9 11.6 18.1 13.2 9.5 10.9 8.5 11.2 17.0 12.1 11.2 12.2 20.7 7.9 14.9 7.0 10.8 11.3 10.3 19.6 13.7 9.7 16.7 10.9 21.5 8.4 9.5 13.9 8.9 8.1 14.6 18.3 10.7 18.1 16.2 19.4 16.8 24.0 10.6 26.1 7.0 14.5 12.5 10.5 12.0 20.1 12.5 5.4 18.0 16.7 10.3 21.3 17.0 8.6 10.8 16.7 15.0 19.3 29.5 16.2 21.1 16.9 20.8 8.3 14.1 9.1 17.2 7.0 6.9 18.6 20.4 11.5 26.2 15.1 14.0 15.6 12.8 17.1 7.6 22.5 35.1 12.8 20.9 11.6 12.1 22.4 18.2 9.7 17.1 11.5 4.1 14.6 9.3 5.9 14.2 9.7 11.5 4.6 6.9 16.7 13.7 14.0 12.3 10.1 13.7 19.6 21.5 15.5 2.9 10.9 9.4 10.3 6.5 8.4 20.1 17.8 20.0 20.6 18.4 12.1 18.1 17.8 23.1 20.7 6.0 12.6 22.2 30.8 31.1 35.9 5.0 5.1 5.3 6.8 17.4 45.2 18.9 6.6 13.9 4.5 17.4 10.0 0.0 17.0 16.5 18.5 26.9 1.1 8.5 15.7 42.9 25.3 7.4 8.3 2.9 27.3 15.2 10.1 19.0 12.9 12.4 16.5 16.9 15.9 9.8 39.2 6.5 18.6 17.9 24.3 26.0 18.5 12.9 16.4 31.4 NAV2 "FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1" ENSG00000166833 "Neuron navigator 2" Q8IVL1 11 19350724-20121598 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 64.6" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 34.8;SH-SY5Y: 31.8;TIME: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011755, HPA011891" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA011755: AB_1854319, HPA011891: AB_1854318" "unprognostic (7.71e-2)" "unprognostic (2.37e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (1.76e-3)" "unprognostic (3.01e-2)" "unprognostic (3.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.00e-1)" "unprognostic (3.53e-3)" "unprognostic (1.84e-1)" "unprognostic (2.83e-2)" "unprognostic (3.85e-2)" "unprognostic (1.08e-1)" "unprognostic (6.43e-2)" "unprognostic (3.28e-2)" 14.8 3.1 7.9 4.7 12.5 3.1 13.8 13.8 16.1 10.2 17.6 16.1 8.6 5.1 9.3 13.4 7.8 5.7 3.2 64.6 9.9 7.0 12.3 18.7 11.2 3.0 16.5 11.5 4.7 10.8 10.1 6.6 16.2 23.5 7.9 6.3 8.6 16.5 11.8 3.4 7.9 4.7 13.0 32.2 2.5 9.9 2.1 12.6 0.0 20.1 1.8 5.3 6.0 8.6 0.3 1.9 0.0 0.5 0.0 0.3 0.0 5.9 1.7 3.9 0.4 13.2 8.5 4.2 5.0 8.6 6.6 5.0 6.7 0.8 0.0 0.2 7.5 10.8 0.7 0.2 3.9 7.8 1.0 0.4 0.1 8.8 7.6 2.4 0.0 0.2 5.5 10.2 3.1 34.8 4.9 8.8 0.0 0.7 3.0 19.1 6.3 0.0 0.0 9.2 1.6 5.0 0.0 18.0 0.9 5.7 1.7 6.8 31.8 3.8 3.0 5.7 21.5 0.1 0.0 24.5 15.5 2.3 18.3 4.7 1.0 0.5 0.0 5.3 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.5 1.9 0.0 0.0 7.9 12.5 13.8 16.1 9.9 7.0 16.5 11.5 23.5 12.6 59.6 16.9 0.8 19.9 3.8 1.7 12.3 10.2 25.4 25.0 19.2 0.0 22.2 11.6 17.9 2.4 10.8 1.0 0.0 18.3 18.1 14.6 23.3 1.1 33.0 8.6 25.4 10.4 11.1 1.5 5.6 0.9 2.3 15.1 1.8 7.7 32.7 26.8 0.0 3.9 0.4 2.1 0.0 9.0 1.5 0.5 3.1 12.2 0.0 8.0 15.2 NCAPD3 "CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056" ENSG00000151503 "Non-SMC condensin II complex subunit D3" P42695 11 134150119-134225454 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 82.1" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 8 "prostate cancer: 50.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040286 Supported Nucleoplasm NA NA Nucleoplasm "HPA040286: AB_2676918" "unprognostic (4.27e-2)" "unprognostic (6.05e-2)" "unprognostic (7.78e-3)" "unprognostic (8.22e-3)" "unprognostic (2.79e-1)" "unprognostic (4.29e-2)" "unprognostic (2.15e-3)" "unprognostic (2.56e-1)" "unprognostic (4.32e-2)" "unprognostic (4.75e-1)" "unprognostic (2.79e-3)" "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.93e-2)" "unprognostic (3.35e-2)" "unprognostic (3.94e-1)" "unprognostic (3.48e-1)" 4.9 6.4 4.9 8.3 7.4 13.7 5.4 8.9 6.2 4.0 5.4 8.5 5.0 5.4 4.7 5.9 7.8 4.2 5.4 4.5 5.5 4.3 4.3 12.1 5.3 7.6 9.0 3.3 4.1 5.9 6.8 9.2 6.0 6.1 82.1 6.1 4.9 6.0 6.6 3.8 9.0 5.6 5.4 6.8 8.5 5.3 14.8 7.1 30.7 6.6 5.3 9.8 4.5 5.4 6.9 11.2 2.6 5.6 5.8 10.4 3.8 13.1 11.7 12.9 19.4 5.2 3.9 8.5 15.5 9.9 14.3 15.8 22.8 20.8 24.4 20.9 7.9 14.8 22.0 24.0 13.4 15.6 22.1 20.8 41.9 11.8 10.1 2.5 25.9 22.8 2.7 2.2 18.9 6.2 4.1 9.3 23.2 22.3 14.5 10.7 11.0 29.8 16.8 8.8 24.7 20.7 17.5 15.2 14.1 5.5 16.9 25.8 12.1 22.5 18.0 3.6 10.5 28.5 14.8 7.4 18.5 7.8 12.5 19.3 6.2 6.2 23.0 5.3 30.9 15.5 1.7 5.6 2.6 9.5 5.0 5.6 3.7 6.4 7.2 5.1 6.9 8.9 10.4 2.2 5.8 4.1 11.2 9.4 3.8 4.9 7.4 8.9 6.2 5.5 4.3 9.0 3.3 6.1 7.1 3.0 7.2 9.0 3.7 8.1 18.5 7.0 5.1 4.0 9.1 12.2 9.8 8.7 0.0 2.5 5.0 4.2 2.4 0.0 2.3 8.8 5.9 9.1 2.3 8.9 7.6 11.1 7.5 4.9 5.1 7.5 4.4 7.7 1.7 20.8 4.3 10.6 2.7 0.0 3.9 2.8 22.1 0.0 6.4 17.4 13.7 8.0 3.8 7.9 7.1 2.5 NCBP2 "Cbc2, CBP20, NIP1" ENSG00000114503 "Nuclear cap binding protein subunit 2" P52298 3 196935402-196942597 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044850, HPA062483" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044850: AB_10961012, HPA062483: AB_2684779" "unprognostic (1.82e-2)" "unprognostic (1.09e-1)" "unprognostic (4.04e-2)" "unprognostic (5.12e-3)" "unprognostic (3.17e-1)" "unprognostic (5.13e-3)" "prognostic unfavorable (2.37e-7)" "unprognostic (2.86e-2)" "unprognostic (9.63e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.28e-3)" "unprognostic (6.38e-2)" "unprognostic (1.97e-1)" "unprognostic (4.30e-2)" "unprognostic (5.04e-3)" 27.6 34.5 39.4 26.8 42.1 11.4 35.6 33.4 37.8 28.0 25.4 17.9 25.2 21.8 26.6 32.1 23.1 24.9 22.5 22.6 37.5 33.3 31.9 21.6 20.3 37.6 33.5 28.9 30.8 27.8 28.3 30.4 25.4 31.4 28.3 26.1 18.7 19.8 27.8 41.8 20.1 19.9 33.7 39.0 24.3 21.3 20.4 31.3 24.9 29.8 19.3 30.5 27.5 23.7 26.1 19.1 9.7 20.8 19.6 28.9 17.6 35.7 11.6 26.9 34.0 30.8 27.0 19.3 27.0 20.1 17.1 17.8 25.4 13.0 23.9 60.4 18.8 22.1 21.8 34.5 29.3 26.7 12.6 22.7 31.2 13.5 21.1 27.3 36.4 21.8 21.6 25.3 12.4 35.0 25.6 26.2 26.3 17.6 25.5 28.6 41.6 27.0 22.4 34.3 33.9 37.6 21.3 20.6 22.6 24.8 25.0 15.2 40.3 16.9 32.5 47.1 22.4 72.1 29.0 24.8 17.7 18.8 21.8 48.5 39.3 36.3 41.1 24.1 41.2 26.9 3.8 18.1 9.7 19.2 20.8 28.9 26.1 23.5 22.5 19.1 20.5 27.3 24.4 2.3 19.6 20.1 15.5 20.8 17.6 39.4 42.1 33.4 35.7 37.5 33.3 33.5 28.9 31.4 31.3 23.8 35.0 86.4 59.4 46.6 55.7 35.2 20.4 37.5 50.0 40.1 55.0 50.6 82.9 57.9 91.7 48.0 33.3 0.0 43.2 65.3 43.0 45.0 51.9 29.2 58.3 42.9 43.3 31.9 50.5 46.4 34.8 49.6 30.4 71.3 40.2 72.8 56.6 43.0 48.4 59.3 55.3 25.8 53.0 32.3 58.0 39.1 44.5 49.8 42.2 83.5 NCOA6 "AIB3, ASC2, KIAA0181, NRC, PRIP, RAP250, TRBP" ENSG00000198646 "Nuclear receptor coactivator 6" Q14686 20 34689097-34825649 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004198, HPA050211" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA004198: AB_1078228, HPA050211: AB_2681052" "unprognostic (2.48e-1)" "unprognostic (4.81e-2)" "unprognostic (1.72e-1)" "unprognostic (1.37e-2)" "unprognostic (1.23e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.65e-4)" "unprognostic (2.05e-1)" "unprognostic (2.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.87e-2)" "unprognostic (1.51e-1)" "prognostic favorable (8.78e-5)" "unprognostic (9.04e-2)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (4.42e-2)" 13.7 13.4 14.7 12.8 23.0 15.8 17.7 31.9 17.3 14.9 16.9 28.5 17.5 16.4 16.7 16.3 17.1 14.9 14.2 11.8 16.2 11.7 13.6 10.8 13.2 10.8 18.7 12.6 15.5 15.8 35.1 17.7 18.1 14.4 13.1 18.8 14.4 16.4 18.4 17.6 18.4 21.2 19.8 21.8 11.2 14.6 22.6 22.6 16.9 17.7 9.7 13.2 16.6 14.6 2.7 3.1 6.5 2.1 2.1 2.7 1.3 14.3 8.6 19.5 11.7 10.7 12.0 12.7 7.0 9.0 12.7 10.2 21.9 10.1 10.2 7.8 12.5 15.5 17.6 17.3 11.8 14.5 5.1 7.8 23.9 9.5 12.9 11.8 13.3 17.7 9.0 21.9 11.9 14.8 8.8 11.9 11.8 12.1 14.1 10.4 9.3 21.2 8.4 4.0 12.1 12.5 14.2 23.5 9.1 9.3 9.6 16.3 11.1 12.8 31.2 12.0 9.4 13.1 10.8 11.6 20.6 12.6 15.2 11.6 16.2 13.5 11.8 13.6 7.9 9.1 3.0 1.7 6.5 2.7 1.6 2.6 2.7 2.5 2.3 3.1 2.1 2.3 1.5 4.4 2.1 2.1 2.8 1.4 1.3 14.7 23.0 31.9 17.3 16.2 11.7 18.7 12.6 14.4 22.6 23.8 13.6 9.7 8.2 15.0 26.7 16.7 22.9 16.0 9.1 15.7 27.5 9.8 5.0 11.3 21.4 11.1 16.8 23.3 10.7 10.0 11.1 13.7 5.8 11.4 9.4 31.8 10.4 13.5 12.9 13.4 16.7 10.1 10.1 9.0 18.4 10.0 12.8 8.6 12.7 8.1 27.6 25.8 13.2 22.1 23.7 18.2 13.3 11.7 16.2 13.9 NCOR2 "CTG26, SMRT, SMRTE, TNRC14, TRAC-1" ENSG00000196498 "Nuclear receptor corepressor 2" Q9Y618 12 124324415-124567589 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001928 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA001928: AB_1079454" "unprognostic (9.51e-3)" "unprognostic (7.37e-3)" "unprognostic (4.66e-2)" "unprognostic (2.55e-3)" "unprognostic (2.14e-1)" "unprognostic (7.37e-2)" "unprognostic (3.19e-2)" "unprognostic (8.86e-2)" "unprognostic (2.21e-2)" "unprognostic (2.90e-3)" "unprognostic (6.42e-3)" "unprognostic (1.96e-1)" "unprognostic (9.86e-2)" "unprognostic (6.26e-2)" "unprognostic (1.59e-1)" "unprognostic (7.56e-2)" "unprognostic (8.90e-2)" 24.0 22.0 21.3 21.3 19.0 16.8 18.3 33.8 33.5 24.5 17.2 24.3 17.7 16.4 21.3 19.0 15.7 16.3 21.5 18.2 22.0 14.8 16.0 11.2 23.4 11.9 19.0 15.6 28.6 30.0 13.8 39.5 13.2 28.3 21.3 7.6 32.7 29.2 24.5 62.4 22.8 22.2 17.4 12.2 17.4 24.0 10.8 22.0 9.3 16.7 25.0 7.6 16.3 14.7 0.6 1.7 8.1 4.0 0.2 1.9 0.4 19.7 37.2 10.6 10.1 6.2 8.4 31.8 20.5 10.2 12.0 5.3 19.7 14.6 20.0 15.2 16.7 10.7 18.8 4.2 21.8 4.9 21.1 8.2 16.1 35.1 12.0 12.4 12.1 20.5 13.5 8.2 14.9 8.9 18.4 11.4 9.2 20.6 6.0 10.7 17.0 43.4 14.0 14.8 7.5 36.2 14.1 17.7 10.1 5.7 23.1 28.1 20.5 25.2 21.3 12.9 8.3 17.3 15.3 54.6 27.9 48.3 27.5 43.4 11.5 11.5 12.2 15.9 9.0 26.1 8.1 0.7 1.6 1.9 0.4 0.5 0.6 0.5 1.5 0.3 0.4 0.6 0.5 1.6 0.2 4.0 1.7 0.0 0.4 21.3 19.0 33.8 28.4 22.0 14.8 19.0 15.6 28.3 22.0 107.2 54.1 4.5 21.5 29.7 63.3 27.7 20.4 18.7 56.9 17.4 37.3 6.7 3.3 19.2 1.6 21.0 23.6 0.0 24.0 33.5 32.5 20.3 39.5 16.3 25.4 114.4 18.0 14.7 40.3 4.8 57.5 32.4 15.1 18.0 18.7 30.6 26.9 17.3 61.2 7.0 57.9 6.5 30.6 1.7 10.3 21.3 10.5 13.1 20.4 17.9 NEDD8-MDP1 ENSG00000255526 "NEDD8-MDP1 readthrough" 14 24213955-24232352 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 24 "Alveolar cells type 2: 1.9;Ciliated cells: 4.0;granulocytes: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 7.8;U-266/70: 5.0" "Low region specificity" "Detected in all" "HPA003064, HPA060254" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA003064: AB_10602350, HPA060254: AB_2732644" "unprognostic (2.72e-3)" "unprognostic (1.82e-1)" "unprognostic (3.64e-1)" "unprognostic (6.44e-2)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (6.04e-3)" "unprognostic (1.04e-1)" "unprognostic (1.92e-2)" "unprognostic (1.32e-3)" "unprognostic (2.33e-1)" "unprognostic (1.99e-2)" "unprognostic (1.64e-1)" "unprognostic (4.43e-2)" "unprognostic (2.60e-2)" "unprognostic (1.92e-1)" "unprognostic (1.83e-2)" 4.8 6.0 6.6 5.6 9.0 5.0 4.5 5.7 8.5 4.0 8.8 3.2 4.3 3.0 4.1 5.0 5.2 4.7 4.1 7.6 5.3 5.2 6.2 6.1 4.6 4.7 4.9 8.3 4.1 4.5 11.2 5.9 5.6 6.6 4.8 5.2 3.3 5.1 4.5 20.1 6.7 8.6 4.4 4.2 4.2 5.5 16.4 4.6 3.3 5.2 6.5 3.8 4.0 4.1 0.7 1.9 1.0 0.9 0.4 2.3 1.0 3.3 0.0 0.8 0.5 0.8 0.0 0.0 4.1 0.1 0.2 0.2 0.4 1.0 0.2 1.7 1.2 0.3 1.4 0.6 1.0 0.5 2.2 0.4 1.1 0.0 0.0 0.0 1.5 0.0 0.6 1.5 0.0 0.4 0.6 0.0 1.5 0.3 0.0 0.2 3.0 7.8 0.6 0.4 1.9 0.0 0.5 0.0 2.1 0.2 0.0 1.0 0.5 0.0 1.3 1.4 0.3 0.6 1.1 0.0 0.0 3.6 0.0 1.3 5.0 3.7 3.4 0.5 0.0 0.6 0.8 0.3 1.0 0.6 0.8 0.2 0.7 2.3 0.0 0.2 0.5 1.8 0.5 0.4 0.4 0.9 1.9 1.4 1.0 6.6 9.0 5.7 8.5 5.3 5.2 4.9 8.3 6.6 4.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEIL1 "FLJ22402, FPG1, hFPG1, NEI1" ENSG00000140398 "Nei like DNA glycosylase 1" Q96FI4 15 75346955-75357114 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.7;memory B-cell: 4.0;naive B-cell: 6.5;NK-cell: 14.1" "Group enriched" "Detected in many" 12 "B-cells: 6.5;NK-cells: 14.1;T-cells: 4.7" "Cell line enhanced" "Detected in many" "Daudi: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054084 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA054084: AB_2682372" "unprognostic (9.84e-3)" "unprognostic (1.19e-1)" "unprognostic (1.15e-2)" "unprognostic (4.62e-3)" "unprognostic (3.21e-2)" "unprognostic (1.81e-2)" "unprognostic (2.24e-2)" "unprognostic (1.17e-3)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "prognostic favorable (2.09e-4)" "unprognostic (3.50e-3)" "unprognostic (8.60e-2)" "unprognostic (9.24e-2)" "unprognostic (2.05e-1)" "unprognostic (3.03e-1)" "unprognostic (2.27e-3)" 7.1 14.8 12.9 28.2 14.5 6.8 9.3 24.4 15.4 10.8 8.3 4.9 23.2 10.1 8.4 11.6 6.4 10.0 10.2 5.3 12.8 5.7 7.9 9.1 9.3 9.8 6.0 9.8 11.0 10.8 9.1 9.0 4.6 8.0 10.4 2.4 7.1 25.0 24.2 13.6 11.7 9.5 4.3 5.9 6.8 9.9 3.8 7.0 15.4 8.2 5.2 13.3 7.5 8.5 6.5 0.2 0.7 0.5 14.1 4.7 1.0 2.2 3.7 2.4 1.5 0.7 0.8 4.6 1.3 0.0 0.5 0.1 0.6 4.0 11.6 2.2 0.2 1.1 6.4 1.4 0.4 0.0 5.6 9.5 1.9 10.0 1.8 1.0 2.2 2.7 0.3 1.8 0.6 0.0 6.0 1.5 1.1 1.2 3.4 0.4 2.9 0.4 6.3 2.1 0.4 0.9 2.2 1.5 0.5 2.2 2.4 1.4 2.8 2.3 1.0 3.2 1.3 4.3 3.3 6.3 1.3 2.5 1.9 1.1 5.4 5.2 9.4 1.2 9.4 1.2 0.0 0.5 0.0 4.7 0.1 1.3 4.0 0.8 1.0 0.2 6.5 1.4 1.4 0.7 14.1 0.1 0.2 0.2 1.0 12.9 14.5 24.4 15.4 12.8 5.7 6.0 9.8 8.0 7.0 20.8 19.2 9.3 14.9 5.7 20.2 2.5 2.5 38.8 23.9 14.0 9.8 8.7 1.7 7.2 21.8 13.4 15.5 0.0 7.4 3.1 7.8 12.0 10.5 10.5 2.8 9.5 20.7 24.5 6.9 1.1 17.5 5.8 8.5 0.0 18.2 21.4 6.1 14.7 12.7 5.8 5.9 6.5 4.1 1.4 0.7 5.1 4.0 13.1 11.3 5.8 NEIL3 "FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3" ENSG00000109674 "Nei like DNA glycosylase 3" Q8TAT5 4 177309836-177362943 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 70.8" "Cell type enhanced" "Detected in some" 8 "Club cells: 2.3;Extravillous trophoblasts: 2.9;Kupffer cells: 2.2;Spermatocytes: 1.9;Spermatogonia: 3.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 26.6;HL-60: 29.0;Karpas-707: 38.1;MOLT-4: 29.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065761 Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA065761: AB_2685555" "unprognostic (6.03e-2)" "unprognostic (5.79e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (5.45e-4)" "unprognostic (4.91e-2)" "unprognostic (2.05e-1)" "unprognostic (3.64e-7)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.09e-3)" "unprognostic (7.67e-2)" "unprognostic (6.51e-4)" "unprognostic (2.82e-3)" "unprognostic (0.00e+0)" "unprognostic (3.25e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (1.04e-2)" 0.5 0.4 0.2 7.4 0.2 9.3 0.7 0.1 0.2 0.8 1.5 0.1 0.1 1.5 0.5 0.1 5.6 0.2 0.3 0.5 0.2 0.2 0.4 0.4 0.9 5.1 0.2 0.1 0.3 0.2 0.0 0.2 1.6 0.2 0.2 2.1 0.2 0.8 0.1 0.2 3.4 1.7 0.5 0.7 1.5 0.8 3.5 0.3 70.8 0.2 1.1 5.0 0.7 1.3 0.2 0.3 0.8 0.0 1.6 1.6 0.2 7.1 5.9 6.3 3.1 0.7 1.3 3.1 8.8 3.3 9.8 5.8 2.1 6.3 7.9 1.3 2.3 9.7 3.3 6.6 3.5 14.3 26.6 4.3 5.4 4.7 5.6 0.2 29.0 3.7 0.1 0.2 10.1 2.2 2.0 3.7 20.5 5.6 38.1 6.3 3.1 29.3 11.1 2.9 2.1 4.4 6.0 4.3 2.5 2.5 0.9 5.0 3.4 4.4 5.1 2.4 2.9 4.2 7.6 1.7 5.9 4.6 3.0 8.9 2.6 1.7 12.5 3.9 10.3 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 0.2 0.0 1.1 0.8 1.6 0.0 0.3 1.6 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.6 2.2 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.9 3.0 1.1 0.2 0.5 0.4 0.1 NEK11 FLJ23495 ENSG00000114670 "NIMA related kinase 11" Q8NG66 3 131026850-131350465 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.9" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 148.5;Early spermatids: 122.2;Late spermatids: 80.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016908 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA016908: AB_1854364" "unprognostic (9.15e-3)" "prognostic favorable (7.10e-4)" "unprognostic (1.05e-1)" "unprognostic (1.08e-1)" "unprognostic (9.96e-2)" "unprognostic (4.85e-3)" "unprognostic (2.48e-5)" "unprognostic (5.38e-2)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" "prognostic favorable (5.92e-6)" "unprognostic (2.46e-2)" "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.58e-1)" 3.9 5.8 9.3 2.7 11.1 0.5 8.7 2.7 7.6 7.3 2.8 11.2 8.4 2.0 6.5 16.0 3.2 26.9 6.0 2.9 9.1 10.0 8.2 1.1 5.5 1.7 7.8 5.4 8.7 2.8 5.0 9.3 4.6 17.3 4.0 3.3 3.0 3.8 6.7 1.7 2.8 2.6 4.3 7.3 1.8 2.3 17.8 5.5 0.2 12.3 2.5 1.7 4.2 3.0 0.9 1.0 1.1 1.3 0.3 2.9 0.3 5.9 2.4 1.8 5.2 7.0 10.5 1.0 2.9 5.5 4.5 3.4 2.2 8.3 0.3 2.1 5.2 4.3 3.3 0.5 5.1 6.3 0.6 0.7 0.8 0.4 1.0 2.3 0.6 1.5 4.4 8.5 4.8 2.2 4.8 0.9 2.6 0.2 0.9 7.5 4.2 0.1 0.5 0.5 0.9 2.3 0.0 0.2 0.1 10.3 2.3 2.2 2.5 1.4 0.1 2.0 0.8 4.9 0.1 0.9 4.7 2.3 3.6 1.4 1.4 2.3 0.1 3.2 0.2 0.8 0.0 0.3 1.1 0.6 1.3 1.2 0.9 2.9 2.6 0.5 0.6 1.0 0.8 0.9 0.3 0.9 1.0 1.5 0.3 9.3 11.1 2.7 7.6 9.1 10.0 7.8 5.4 17.3 5.5 14.9 2.7 0.0 3.4 3.8 2.7 1.1 2.5 148.5 29.6 1.8 5.9 0.5 5.0 4.7 122.2 2.4 1.7 0.0 2.2 1.0 5.4 1.4 0.0 0.0 1.8 0.0 2.4 2.5 0.0 80.8 6.4 1.4 0.0 1.0 2.7 5.7 2.9 3.7 5.6 8.4 6.9 6.5 2.2 30.5 4.9 1.8 1.4 0.0 1.7 1.8 NEK7 ENSG00000151414 "NIMA related kinase 7" Q8TDX7 1 198156963-198322420 "Enzymes, Predicted intracellular proteins, Transporters" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 150.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 85.5;fHDF/TERT166: 115.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015520, HPA018193" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA015520: AB_1854371, HPA018193: AB_1854372" "unprognostic (2.08e-1)" "unprognostic (2.98e-2)" "unprognostic (1.65e-1)" "unprognostic (5.38e-2)" "unprognostic (4.26e-2)" "unprognostic (3.00e-2)" "unprognostic (2.14e-2)" "unprognostic (5.47e-2)" "unprognostic (4.77e-2)" "unprognostic (3.21e-1)" "unprognostic (1.46e-3)" "unprognostic (2.82e-1)" "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.74e-1)" "unprognostic (2.05e-2)" "unprognostic (1.56e-1)" 31.7 31.4 24.9 15.2 23.0 5.6 23.7 7.8 15.6 19.3 20.6 25.5 13.7 11.3 24.5 11.4 18.7 12.8 15.1 74.7 23.9 20.4 16.1 16.0 22.3 14.9 26.8 13.4 17.2 11.1 14.6 17.6 40.5 18.0 20.0 13.2 11.8 13.5 21.3 29.9 10.6 15.8 30.9 34.9 16.4 11.7 9.5 22.6 18.0 14.9 12.8 12.5 27.4 20.7 1.6 2.1 6.1 2.2 3.8 14.7 1.4 7.1 1.9 2.3 0.9 6.0 6.9 2.7 85.5 35.8 34.8 16.5 3.5 7.1 2.6 6.2 115.4 2.0 4.4 3.5 4.6 35.2 8.1 5.0 3.5 8.2 1.4 7.2 5.9 7.3 4.3 4.0 22.9 6.9 13.0 6.6 21.6 2.7 6.4 15.9 2.2 5.1 3.5 1.2 5.7 1.4 2.7 5.7 4.5 5.9 3.7 1.4 2.7 14.2 8.2 9.5 3.4 6.0 5.4 14.5 9.8 8.3 28.0 8.9 4.5 4.1 1.7 4.2 5.4 7.5 1.9 2.2 3.0 3.2 1.9 14.7 1.3 3.6 4.6 2.1 1.6 2.9 3.6 6.1 3.8 1.7 1.4 6.0 1.4 24.9 23.0 7.8 15.6 23.9 20.4 26.8 13.4 18.0 22.6 26.8 24.2 12.3 15.3 45.6 9.4 150.0 10.2 25.4 21.6 17.4 13.7 11.6 10.0 8.8 2.1 26.3 19.8 46.7 16.9 13.3 24.9 20.4 8.1 19.2 15.2 3.2 19.0 35.0 42.5 1.7 27.0 23.7 28.7 16.2 19.6 10.0 34.6 17.3 36.0 11.6 25.0 19.4 44.2 7.5 5.7 43.0 53.8 20.1 14.9 22.4 NELFB "COBRA1, KIAA1182, NELF-B" ENSG00000188986 "Negative elongation factor complex member B" Q8WX92 9 137255173-137273546 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020259 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA020259: AB_1847072" "unprognostic (2.56e-2)" "unprognostic (5.14e-2)" "unprognostic (1.26e-1)" "unprognostic (1.14e-2)" "unprognostic (3.27e-1)" "unprognostic (4.06e-1)" "unprognostic (5.58e-3)" "unprognostic (7.74e-3)" "unprognostic (2.04e-1)" "unprognostic (1.46e-1)" "unprognostic (5.03e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.31e-6)" "unprognostic (6.74e-3)" "unprognostic (1.01e-1)" "unprognostic (2.66e-2)" "unprognostic (4.04e-2)" 21.9 16.5 28.2 20.1 27.8 21.2 17.1 20.2 41.6 19.2 20.6 20.6 17.0 23.7 19.6 10.6 24.7 21.8 17.9 28.8 25.8 21.8 20.1 17.9 19.9 25.8 23.0 27.6 27.3 33.7 14.8 14.6 19.4 24.0 20.6 12.6 19.2 29.6 18.4 29.3 29.0 24.9 26.9 17.3 22.6 22.6 19.1 21.1 17.7 21.5 13.0 23.1 20.7 34.2 6.8 8.3 9.2 6.1 7.1 8.0 3.6 18.4 32.1 16.2 21.1 14.3 10.6 23.4 15.4 11.9 20.1 14.3 33.4 22.3 26.7 23.0 16.1 21.9 35.7 17.0 19.0 6.2 25.6 21.3 17.2 39.5 26.4 14.5 25.2 21.1 12.4 19.5 18.4 10.7 11.5 18.5 17.2 29.3 23.1 11.7 44.9 18.4 32.3 25.1 33.2 31.8 30.3 29.6 43.1 11.1 17.7 24.0 21.4 21.5 23.5 14.4 9.2 31.5 28.7 23.0 28.9 21.2 44.3 24.4 11.7 20.5 22.1 22.7 18.2 25.3 2.3 6.1 9.2 8.0 4.8 5.4 6.4 6.8 6.0 5.2 6.8 6.3 6.6 3.2 7.1 4.4 8.3 7.2 3.6 28.2 27.8 20.2 41.6 25.8 21.8 23.0 27.6 24.0 21.1 6.0 19.9 13.0 10.8 13.3 19.3 11.8 15.3 4.0 15.9 22.7 17.7 19.9 11.6 24.1 3.1 14.1 26.2 0.0 33.2 23.2 13.5 16.6 18.4 17.9 22.7 41.3 27.1 22.7 9.5 4.0 21.6 16.4 6.8 50.5 33.3 24.7 26.8 17.3 19.4 12.4 13.9 38.8 13.7 11.9 24.7 12.2 13.0 13.1 29.0 11.3 NEMP1 "KIAA0286, TMEM194, TMEM194A" ENSG00000166881 "Nuclear envelope integral membrane protein 1" O14524 12 57055643-57088063 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 20.8;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014394 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA014394: AB_2204899" "unprognostic (9.24e-2)" "unprognostic (1.78e-1)" "unprognostic (1.18e-1)" "unprognostic (4.97e-2)" "unprognostic (1.43e-1)" "unprognostic (4.57e-3)" "prognostic unfavorable (1.93e-4)" "unprognostic (8.36e-2)" "unprognostic (2.42e-3)" "unprognostic (2.11e-1)" "unprognostic (1.64e-1)" "unprognostic (6.61e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (2.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.63e-2)" "unprognostic (7.05e-2)" 9.5 7.3 7.6 16.7 7.8 7.8 8.6 10.6 8.5 8.1 12.2 8.1 3.6 4.9 14.8 7.6 8.8 9.4 5.8 4.8 6.6 3.8 6.0 8.1 9.7 15.1 7.7 5.8 12.3 6.4 5.9 12.7 20.6 6.2 9.6 9.4 8.2 7.2 7.5 3.6 14.3 11.0 12.8 8.3 11.4 8.5 15.4 6.9 26.6 8.7 4.1 15.1 9.3 8.9 4.6 2.2 5.5 3.5 5.4 4.7 2.0 8.1 6.9 15.9 17.1 5.3 5.3 9.1 12.6 7.2 17.6 14.3 8.2 15.6 19.3 16.3 4.3 15.0 12.0 21.1 5.4 20.3 10.2 9.6 11.4 8.0 4.3 2.3 14.1 13.1 1.8 5.2 14.4 9.0 7.3 4.8 17.6 23.1 38.6 14.7 4.4 15.4 12.0 8.9 7.7 7.7 15.7 22.6 8.8 3.8 5.0 9.5 6.4 10.7 9.0 10.1 11.8 16.2 14.2 3.4 16.8 9.8 15.4 11.7 17.4 33.1 17.0 9.9 13.6 17.2 5.5 1.1 1.9 2.8 3.5 3.7 4.6 3.1 3.6 1.2 3.6 4.7 3.9 0.5 5.4 2.0 2.2 2.8 2.0 7.6 7.8 10.6 8.5 6.6 3.8 7.7 5.8 6.2 6.9 20.8 1.6 0.0 2.9 0.0 2.3 1.2 0.0 5.3 3.4 5.2 3.9 3.2 0.0 1.7 1.0 2.9 0.4 0.0 0.7 3.1 2.1 3.6 0.0 3.9 4.8 1.6 0.0 5.5 5.3 0.2 5.8 5.9 0.0 3.6 1.7 2.9 2.1 0.0 4.9 0.6 3.9 12.9 1.9 10.1 6.9 0.0 2.5 3.2 1.8 2.0 NEMP2 TMEM194B ENSG00000189362 "Nuclear envelope integral membrane protein 2" A6NFY4 2 190504342-190534722 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 27.3" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" HPA057719 Approved Nucleoplasm NA NA Nucleoplasm "HPA057719: AB_2683510" "unprognostic (3.51e-1)" "unprognostic (9.99e-2)" "unprognostic (1.11e-3)" "unprognostic (1.05e-2)" "unprognostic (2.06e-2)" "unprognostic (1.03e-1)" "unprognostic (8.65e-3)" "unprognostic (5.70e-2)" "unprognostic (1.06e-1)" "unprognostic (5.61e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (5.82e-2)" "unprognostic (7.76e-3)" "unprognostic (4.75e-3)" "unprognostic (1.32e-1)" 7.8 4.9 2.9 14.5 2.9 4.5 4.3 7.5 3.6 6.0 3.6 4.3 2.2 2.5 8.5 6.8 4.4 3.3 3.0 4.3 3.5 2.9 5.7 5.7 9.3 11.3 3.8 3.2 5.6 3.2 2.6 4.0 3.7 3.4 3.9 2.6 6.6 9.3 4.8 1.7 5.1 4.5 3.4 3.4 12.3 5.1 8.1 2.4 27.3 5.4 3.5 15.8 4.4 4.3 3.6 3.4 0.2 0.8 2.4 5.6 2.2 5.2 2.8 1.9 2.4 1.1 3.0 5.1 3.8 3.3 3.8 4.7 4.2 7.3 7.6 2.5 1.9 2.7 9.3 3.0 8.1 7.6 5.6 2.6 5.5 2.8 2.9 2.9 5.9 1.9 3.1 3.4 17.3 4.5 3.5 1.7 8.5 4.7 9.0 7.3 2.4 6.4 2.8 2.1 2.9 3.1 2.7 4.2 3.5 3.4 3.9 3.5 3.0 5.9 0.6 5.7 3.4 1.5 6.4 3.1 8.5 6.6 1.6 4.1 4.9 5.3 4.1 6.5 6.2 6.1 0.1 0.8 0.1 3.0 0.7 3.9 2.7 3.3 2.7 0.9 3.6 5.4 4.6 0.2 2.4 0.6 3.4 5.6 2.2 2.9 2.9 7.5 3.6 3.5 2.9 3.8 3.2 3.4 2.4 0.0 1.1 2.4 1.3 0.0 4.5 1.6 0.0 0.0 0.0 1.8 0.0 2.1 0.0 1.5 2.5 3.8 0.0 0.0 1.7 2.8 1.3 1.5 1.1 2.5 2.6 3.2 0.0 3.1 5.4 4.2 2.6 2.3 0.0 1.8 1.2 3.3 0.6 1.5 1.1 2.1 2.1 0.0 2.5 16.7 5.9 0.0 1.0 5.7 1.8 1.3 NFATC2IP "ESC2, FLJ14639, NIP45, RAD60" ENSG00000176953 "Nuclear factor of activated T cells 2 interacting protein" Q8NCF5 16 28950807-28967097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053587 Approved Nucleoplasm NA NA Nucleoplasm "HPA053587: AB_2682202" "unprognostic (6.01e-2)" "unprognostic (1.41e-2)" "unprognostic (8.48e-2)" "unprognostic (1.33e-1)" "unprognostic (4.90e-1)" "unprognostic (7.09e-2)" "unprognostic (8.82e-3)" "unprognostic (1.15e-2)" "unprognostic (8.95e-2)" "unprognostic (5.80e-2)" "unprognostic (5.32e-2)" "prognostic unfavorable (5.23e-4)" "prognostic unfavorable (1.03e-5)" "unprognostic (8.00e-2)" "unprognostic (3.85e-2)" "unprognostic (3.25e-1)" "unprognostic (5.94e-2)" 14.0 11.9 16.6 26.5 15.0 32.5 16.1 29.9 16.8 14.6 23.6 12.7 19.0 16.1 17.8 11.8 20.4 17.5 15.8 15.6 13.0 7.8 15.9 18.9 18.1 26.0 16.5 18.0 18.6 16.2 21.9 11.2 14.0 12.0 17.1 25.7 15.7 17.1 12.9 20.7 24.8 25.1 19.4 12.2 32.7 17.8 27.1 15.3 37.7 16.3 6.9 28.6 19.8 16.0 3.5 6.3 8.7 3.7 5.8 4.9 1.3 18.0 13.1 17.8 17.9 10.9 11.5 22.6 17.6 13.3 20.7 26.6 15.1 22.6 19.3 13.4 12.5 12.6 21.5 21.4 19.3 28.2 16.4 15.7 17.6 34.0 18.7 6.9 15.9 27.0 8.1 15.8 22.5 13.7 10.3 16.5 19.7 15.9 24.1 18.3 22.4 20.6 28.2 17.5 14.6 15.5 36.1 15.9 17.7 14.8 16.3 13.8 9.8 11.8 18.4 6.8 15.2 19.0 11.9 18.2 23.0 13.0 17.9 13.2 17.9 23.4 23.6 12.7 26.3 13.4 8.7 3.2 3.2 4.1 3.7 3.8 3.2 3.1 4.7 1.8 3.5 4.9 4.4 2.4 5.8 2.3 6.3 4.5 1.3 16.6 15.0 29.9 16.8 13.0 7.8 16.5 18.0 12.0 15.3 32.8 50.0 43.4 20.5 28.2 62.9 14.8 22.9 17.4 35.2 27.9 94.2 24.6 16.6 19.0 3.9 28.0 38.7 70.0 20.0 25.0 22.1 29.7 34.8 17.9 20.3 41.3 39.3 39.3 30.1 4.3 27.3 31.4 21.9 35.1 53.9 16.0 32.1 31.7 19.1 14.0 87.9 38.8 18.4 64.9 95.4 26.5 21.9 40.1 47.3 40.4 NFIA "KIAA1439, NFI-L" ENSG00000162599 "Nuclear factor I A" Q12857 1 60865259-61462793 "Disease related genes, Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Leydig cells: 378.6;Peritubular cells: 412.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 37.8;T-47d: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006111, HPA008884" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006111: AB_1854422, HPA008884: AB_1854421" "unprognostic (1.50e-3)" "unprognostic (1.32e-1)" "unprognostic (2.06e-1)" "unprognostic (1.05e-1)" "unprognostic (3.44e-2)" "prognostic favorable (7.30e-4)" "unprognostic (2.55e-1)" "unprognostic (1.22e-2)" "unprognostic (9.12e-2)" "unprognostic (9.38e-2)" "unprognostic (2.85e-2)" "unprognostic (5.20e-2)" "prognostic favorable (7.01e-4)" "unprognostic (2.11e-1)" "unprognostic (1.20e-1)" "unprognostic (2.23e-2)" "prognostic unfavorable (2.03e-4)" 29.1 17.7 21.9 17.0 19.1 15.9 28.5 42.1 16.9 23.1 20.1 17.1 19.2 9.1 17.1 16.3 27.9 20.4 18.7 25.7 18.2 13.7 13.7 48.4 11.3 8.7 16.9 13.0 22.1 17.2 24.5 14.1 6.5 21.9 26.0 12.8 16.4 25.3 26.5 30.8 11.6 12.3 44.0 25.8 11.7 14.9 11.1 15.9 2.9 36.6 14.9 8.8 35.6 30.9 1.3 2.4 5.2 5.0 0.7 5.6 2.8 3.4 3.3 0.4 37.8 15.9 10.5 0.1 0.8 2.6 0.8 1.6 0.2 2.6 5.8 2.7 1.6 0.8 4.5 1.4 9.3 0.4 13.4 3.0 0.3 8.5 2.7 3.6 0.7 1.2 13.2 7.6 3.7 15.4 2.8 9.9 1.8 3.6 10.9 0.7 1.7 0.1 0.1 1.7 3.5 3.3 0.5 3.9 9.6 2.0 6.9 3.7 2.8 2.0 15.9 5.2 0.5 20.1 0.2 9.4 0.6 5.4 8.7 1.6 0.9 1.6 0.0 0.9 0.0 0.8 5.2 5.0 2.3 3.7 3.4 5.5 1.3 4.5 5.6 2.4 0.5 4.4 5.3 0.2 0.7 4.3 1.7 0.1 2.8 21.9 19.1 42.1 16.9 18.2 13.7 16.9 13.0 21.9 15.9 32.8 33.6 5.4 59.0 75.6 33.8 159.5 142.7 66.9 62.6 45.4 2.0 4.7 23.2 26.4 20.8 92.6 15.2 140.2 42.1 1.3 154.1 78.8 26.5 273.8 12.6 39.7 24.2 171.2 52.2 9.9 378.6 13.7 43.9 16.2 43.1 155.3 21.3 31.6 412.3 88.5 5.8 142.3 149.4 6.0 8.1 66.7 1.4 11.4 64.6 44.8 NFIX NF1A ENSG00000008441 "Nuclear factor I X" Q14938 19 12995608-13098796 "Disease related genes, Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 139.7" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 103.9;Peritubular cells: 118.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 37.3;fHDF/TERT166: 50.2;U-138 MG: 47.9;U-2197: 45.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007533 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA007533: AB_2667855" "unprognostic (3.32e-1)" "unprognostic (1.37e-2)" "unprognostic (2.84e-1)" "unprognostic (2.20e-1)" "unprognostic (2.29e-1)" "unprognostic (8.12e-2)" "prognostic favorable (4.66e-4)" "prognostic favorable (2.35e-4)" "unprognostic (1.26e-1)" "unprognostic (2.01e-2)" "unprognostic (3.25e-1)" "unprognostic (2.63e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.92e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-2)" 28.6 6.6 21.3 8.0 23.8 5.8 15.5 57.0 60.8 25.1 17.9 41.0 8.9 9.2 29.9 12.4 29.2 29.2 21.8 24.1 27.3 15.0 4.6 8.9 20.3 3.1 21.6 29.8 31.8 10.2 6.8 7.0 5.3 22.1 35.4 8.7 19.5 56.6 26.1 139.7 39.7 10.1 27.6 28.3 5.0 14.6 7.2 23.4 1.2 12.8 29.1 8.1 15.6 17.7 1.1 0.6 0.6 0.8 0.1 2.6 0.5 9.2 3.8 0.2 29.4 27.9 37.3 0.3 11.6 16.5 11.1 7.9 0.3 0.8 0.1 3.4 50.2 7.6 4.2 3.1 9.0 4.9 6.1 4.9 4.7 1.9 4.0 13.4 1.9 2.6 24.9 2.6 10.8 6.0 19.8 2.9 2.0 1.5 1.4 7.0 2.9 3.4 1.5 0.1 2.0 32.3 10.0 5.5 5.3 0.1 2.0 4.4 11.8 8.6 0.0 10.7 0.0 5.5 4.1 3.0 47.9 6.1 45.6 16.2 1.1 0.4 0.0 12.3 2.9 14.9 0.6 0.4 0.0 2.4 0.8 2.6 0.1 0.1 0.0 0.1 1.1 0.9 0.2 0.5 0.1 0.2 0.6 0.0 0.5 21.3 23.8 57.0 60.8 27.3 15.0 21.6 29.8 22.1 23.4 11.9 53.6 3.7 37.7 52.2 7.5 30.5 28.1 20.1 20.5 14.0 3.9 0.2 1.7 21.7 42.2 15.7 8.9 93.5 10.9 0.2 43.1 67.6 3.5 26.3 0.9 0.0 11.6 14.7 2.9 29.0 103.9 3.6 25.3 1.0 24.1 87.7 12.8 14.0 118.5 8.8 2.0 6.5 26.2 12.9 13.2 44.9 0.2 0.7 26.2 27.1 NFKBIL1 "IKBL, NFKBIL" ENSG00000204498 "NFKB inhibitor like 1" Q9UBC1 6 31546870-31558829 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 4.9;ASC TERT1: 5.1;HEK 293: 21.0;JURKAT: 8.6;U-266/70: 9.4;U-266/84: 7.8;U-698: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006298 Supported Nucleoplasm NA NA Nucleoplasm "HPA006298: AB_1079480" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.21e-1)" "unprognostic (3.63e-1)" "unprognostic (2.51e-2)" "unprognostic (6.29e-2)" "unprognostic (5.41e-2)" "unprognostic (5.97e-3)" "unprognostic (5.54e-2)" "unprognostic (1.33e-1)" "unprognostic (2.16e-1)" "unprognostic (8.73e-2)" "unprognostic (9.92e-2)" "unprognostic (3.15e-1)" "unprognostic (7.50e-2)" 19.3 20.7 7.9 8.8 8.8 4.9 16.4 9.8 13.7 9.8 13.0 7.4 11.4 4.9 9.2 23.0 15.1 24.5 12.8 6.5 7.1 6.9 8.5 8.7 16.1 9.8 7.4 7.3 16.1 18.6 4.9 10.1 6.8 6.7 11.5 4.9 7.0 11.8 13.9 24.3 28.8 8.8 11.2 6.8 19.1 16.7 12.9 8.3 6.3 12.7 7.6 5.1 13.8 11.3 0.3 2.0 1.6 1.7 1.5 0.9 0.5 0.0 3.6 0.0 0.1 4.9 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.4 0.0 0.0 4.1 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 7.8 4.9 0.0 0.0 0.0 0.6 1.7 0.6 0.9 0.4 0.5 0.3 0.1 0.5 1.6 0.3 0.3 0.7 1.6 1.5 1.3 2.0 0.6 0.5 7.9 8.8 9.8 13.7 7.1 6.9 7.4 7.3 6.7 8.3 6.0 5.1 17.7 22.5 18.4 15.6 4.4 25.5 8.1 2.3 24.4 2.0 18.5 33.2 23.3 5.5 16.2 28.0 0.0 27.6 23.3 18.1 21.9 6.9 13.6 21.3 6.4 7.5 16.5 21.6 5.3 23.6 15.1 8.5 25.2 22.6 24.7 28.1 22.1 24.4 18.5 15.2 25.8 20.2 11.2 9.2 16.4 24.7 13.1 21.7 15.9 NFRKB "DKFZp547B2013, INO80G" ENSG00000170322 "Nuclear factor related to kappaB binding protein" Q6P4R8 11 129863636-129895590 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007082, HPA007128" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA007082: AB_1079481, HPA007128: AB_1079482" "unprognostic (1.22e-1)" "unprognostic (3.42e-2)" "unprognostic (2.12e-1)" "unprognostic (9.41e-2)" "unprognostic (6.56e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (6.36e-3)" "unprognostic (1.68e-2)" "unprognostic (1.82e-1)" "unprognostic (2.00e-1)" "unprognostic (5.31e-2)" "unprognostic (9.22e-2)" "unprognostic (4.15e-2)" "unprognostic (6.57e-2)" "unprognostic (7.14e-2)" "unprognostic (3.93e-2)" 5.8 7.8 10.1 7.8 13.7 13.4 7.3 17.0 11.2 7.8 9.2 7.6 7.0 8.5 12.7 12.4 8.7 12.5 6.3 4.5 8.4 5.2 7.4 6.6 7.1 8.8 7.5 9.1 14.6 11.4 10.3 10.2 8.4 7.4 9.6 6.7 9.2 9.9 9.6 10.4 14.6 9.0 11.8 5.5 7.0 8.3 27.0 7.0 13.6 18.8 6.6 10.6 10.5 9.5 7.8 8.5 11.1 9.8 3.7 11.5 6.9 7.8 7.5 17.1 9.2 7.3 7.3 10.8 5.4 5.0 6.5 6.4 23.4 13.6 18.8 15.0 4.2 9.6 20.2 16.5 10.7 6.1 7.4 14.4 37.1 13.6 9.7 5.3 9.4 12.6 4.6 11.9 10.7 11.3 7.5 11.2 12.7 21.6 14.4 6.5 7.1 8.0 16.3 8.7 11.6 17.8 11.9 7.4 8.6 8.2 24.8 8.8 9.2 12.3 12.2 3.4 13.3 28.4 8.8 8.8 9.8 9.7 7.2 6.8 4.6 5.6 17.3 4.1 18.7 8.4 11.1 8.4 10.0 10.9 9.8 11.5 5.9 11.1 9.1 8.5 7.8 9.3 7.5 10.0 3.7 8.5 7.7 7.4 6.9 10.1 13.7 17.0 11.2 8.4 5.2 7.5 9.1 7.4 7.0 8.9 15.9 5.2 15.5 26.1 9.3 7.3 7.6 12.0 13.6 7.0 9.8 16.8 6.6 9.6 8.2 7.0 9.7 0.0 8.8 13.2 10.4 9.4 10.4 10.4 9.0 7.9 8.2 8.6 8.1 5.8 13.6 7.3 13.5 10.0 8.8 9.7 8.9 7.0 9.9 6.9 10.6 32.3 8.4 39.3 45.3 30.7 19.5 10.0 10.6 15.4 NFXL1 HOZFP ENSG00000170448 "Nuclear transcription factor, X-box binding like 1" Q6ZNB6 4 47847233-47914667 "Predicted membrane proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 100.7;Spermatocytes: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059132 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059132: AB_2683917" "unprognostic (5.37e-2)" "unprognostic (2.89e-1)" "unprognostic (5.14e-3)" "unprognostic (6.13e-2)" "unprognostic (1.81e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (1.13e-2)" "unprognostic (6.26e-3)" "unprognostic (8.48e-3)" "unprognostic (8.34e-2)" "unprognostic (4.47e-2)" "unprognostic (4.72e-3)" "unprognostic (8.89e-2)" "unprognostic (3.15e-1)" "unprognostic (6.67e-2)" "unprognostic (8.01e-2)" 8.3 5.8 7.8 7.2 8.7 6.5 10.8 19.1 9.4 10.1 7.4 6.2 12.2 7.8 13.3 19.2 9.7 9.6 6.9 5.5 6.7 5.5 7.4 9.5 7.4 6.5 7.0 9.6 10.9 12.8 11.9 19.6 8.7 7.6 9.0 8.6 5.3 12.4 10.2 7.1 9.3 7.4 8.8 8.8 7.5 8.2 21.3 7.0 5.9 17.2 4.4 7.7 9.2 10.9 2.5 1.9 5.6 2.3 1.5 3.5 1.7 5.5 3.5 3.9 8.1 7.5 12.4 13.4 3.8 5.4 6.2 7.8 5.9 12.7 4.4 7.3 2.5 12.1 5.7 10.1 7.6 7.4 3.4 3.9 4.7 6.5 10.8 9.7 11.5 9.5 8.1 10.2 4.3 25.6 7.4 5.4 9.3 8.4 5.5 6.4 5.3 9.0 5.4 9.5 7.6 5.5 8.1 7.6 7.3 7.9 10.6 12.5 6.0 2.8 8.0 5.5 7.9 5.5 3.4 4.4 8.2 5.1 3.8 8.4 8.9 5.4 8.9 4.7 6.5 7.1 0.0 1.7 1.7 2.3 2.3 2.8 2.2 3.2 2.5 1.6 2.5 3.5 3.4 5.6 1.5 1.1 1.9 2.0 1.7 7.8 8.7 19.1 9.4 6.7 5.5 7.0 9.6 7.6 7.0 6.0 8.3 1.5 4.0 4.7 19.0 100.7 15.3 8.1 13.6 7.0 9.8 5.0 10.0 7.2 28.3 7.3 5.8 0.0 6.0 9.5 8.0 6.1 2.3 7.2 4.3 7.9 10.9 4.3 3.5 12.4 11.8 6.2 1.7 4.6 7.4 9.1 6.3 3.5 9.6 3.1 16.0 0.0 3.6 72.2 24.3 3.8 5.6 4.9 6.9 5.1 NFYA "CBF-B, HAP2, NF-YA" ENSG00000001167 "Nuclear transcription factor Y subunit alpha" P23511 6 41072945-41099976 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009250, HPA050779" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009250: AB_2152107, HPA050779: AB_2681234" "unprognostic (2.56e-1)" "unprognostic (4.48e-2)" "unprognostic (1.33e-1)" "unprognostic (1.95e-2)" "unprognostic (4.57e-1)" "unprognostic (1.94e-2)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.97e-2)" "unprognostic (2.24e-2)" "unprognostic (5.23e-3)" "unprognostic (5.62e-3)" "unprognostic (1.03e-1)" "unprognostic (1.92e-3)" "unprognostic (3.11e-1)" "unprognostic (5.98e-2)" "unprognostic (1.03e-1)" "unprognostic (1.92e-3)" 14.0 10.8 20.5 16.2 27.1 34.0 14.7 20.9 19.7 11.6 11.0 15.2 8.5 9.2 14.2 14.4 12.7 11.3 11.8 10.5 17.7 10.3 9.8 13.1 13.4 16.6 24.7 13.0 18.3 12.8 15.8 15.2 12.6 17.8 13.3 13.9 9.3 11.2 14.0 10.7 10.6 11.1 12.9 17.7 13.4 11.4 34.0 19.9 32.4 18.2 9.7 18.3 11.6 25.9 6.2 5.9 10.8 5.0 8.6 11.1 4.1 12.9 10.7 20.4 34.1 8.4 8.3 8.7 9.8 9.2 15.5 13.2 13.9 9.5 15.8 8.2 6.4 8.2 8.6 12.4 11.8 17.2 11.2 15.6 20.6 9.0 19.7 6.0 21.7 18.1 5.2 10.2 12.4 16.8 7.6 13.4 26.4 20.1 19.2 15.2 12.9 24.5 8.7 9.1 38.4 10.6 20.0 11.2 11.8 11.4 17.7 20.8 14.3 8.6 7.8 15.1 13.6 7.3 22.1 13.0 27.7 15.1 5.4 18.7 7.6 7.6 26.3 5.4 18.6 10.9 3.7 4.0 6.3 8.6 5.0 11.1 5.2 8.0 9.2 4.5 6.2 8.6 9.2 10.8 8.6 4.5 5.9 8.8 4.1 20.5 27.1 20.9 19.7 17.7 10.3 24.7 13.0 17.8 19.9 8.9 3.8 9.4 9.6 12.9 4.4 4.1 7.6 6.7 4.5 10.4 3.9 6.5 1.7 8.7 34.4 5.4 6.9 0.0 6.5 8.9 6.6 9.5 2.3 6.4 8.7 0.0 4.6 8.0 5.3 25.1 3.4 5.2 6.8 5.4 3.9 3.1 7.5 7.2 2.8 2.1 5.2 0.0 7.2 21.4 7.9 13.9 9.0 10.2 5.8 19.3 NFYB "CBF-A, HAP3, NF-YB" ENSG00000120837 "Nuclear transcription factor Y subunit beta" P25208 12 104117077-104138289 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 107.1" "Cell type enriched" "Detected in all" 4 "Syncytiotrophoblasts: 362.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 60.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004211, HPA065646" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB004211: AB_628018, HPA065646: " "unprognostic (5.82e-2)" "unprognostic (2.44e-3)" "unprognostic (4.90e-2)" "unprognostic (7.10e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "unprognostic (2.10e-2)" "unprognostic (2.44e-1)" "unprognostic (7.36e-2)" "unprognostic (2.63e-1)" "unprognostic (9.39e-2)" "unprognostic (8.51e-2)" "prognostic unfavorable (9.28e-5)" "unprognostic (1.62e-3)" "unprognostic (4.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.81e-3)" 16.1 23.4 22.2 13.9 21.3 10.8 17.5 18.5 17.5 16.1 28.2 13.6 107.1 9.9 16.8 25.8 13.7 16.0 13.7 20.0 22.6 16.9 15.4 21.8 16.0 17.4 21.9 12.4 15.9 11.3 17.3 19.0 16.3 15.6 23.5 14.4 10.1 10.3 53.7 18.5 11.2 10.6 20.0 24.9 10.1 13.8 13.7 20.4 21.4 19.2 13.5 18.5 20.2 27.9 15.6 7.4 22.8 10.2 15.1 21.1 10.7 13.7 11.9 22.7 13.8 15.3 16.7 21.4 13.8 11.4 15.3 10.5 8.8 6.5 18.5 6.7 12.3 10.0 9.1 18.2 8.8 16.6 12.6 5.7 11.2 13.3 8.1 16.1 15.9 7.8 24.1 12.0 6.2 12.0 27.8 9.9 16.8 10.8 7.5 12.7 15.6 20.0 16.0 21.4 10.0 12.9 18.8 13.1 8.1 10.8 14.0 13.6 11.2 24.2 60.4 7.8 17.6 22.6 16.4 7.4 9.0 6.1 8.1 9.9 14.4 12.3 20.6 5.7 9.8 9.2 17.3 7.5 22.8 16.3 9.5 21.1 15.6 15.7 17.1 7.4 11.3 17.5 17.4 10.5 15.1 10.2 6.8 20.5 10.7 22.2 21.3 18.5 17.5 22.6 16.9 21.9 12.4 15.6 20.4 50.6 26.1 11.9 86.4 33.2 21.7 32.7 10.2 25.4 27.3 17.4 3.9 51.6 31.5 20.9 2.8 30.3 11.3 23.3 15.8 71.2 32.7 42.2 20.8 28.0 20.2 14.3 11.5 52.2 13.0 4.5 31.7 23.0 27.0 18.0 15.1 27.5 22.7 14.4 28.7 28.6 23.3 19.4 31.9 67.7 31.1 32.4 362.3 27.7 13.4 49.2 NFYC "CBF-C, NF-YC" ENSG00000066136 "Nuclear transcription factor Y subunit gamma" Q13952 1 40691648-40771603 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 90.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055011 Supported Nucleoplasm NA NA Nucleoplasm "HPA055011: AB_2682671" "unprognostic (1.20e-3)" "unprognostic (1.51e-2)" "unprognostic (9.77e-2)" "unprognostic (1.37e-3)" "unprognostic (8.53e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.24e-4)" "unprognostic (1.47e-2)" "unprognostic (5.66e-3)" "unprognostic (3.53e-3)" "unprognostic (2.75e-1)" "unprognostic (2.60e-2)" "prognostic favorable (1.24e-4)" "unprognostic (2.25e-2)" "unprognostic (3.63e-1)" "unprognostic (3.12e-1)" "unprognostic (7.75e-3)" 25.5 22.1 18.8 32.5 24.0 27.8 23.1 35.8 39.7 23.3 22.0 24.1 22.2 22.0 27.8 22.9 25.8 23.7 20.1 45.4 18.7 15.9 25.2 24.8 19.8 25.7 15.9 22.5 33.0 31.3 26.1 18.0 35.1 18.6 23.7 18.5 30.5 35.3 22.8 49.2 30.7 23.5 23.5 17.1 32.2 22.8 33.4 16.6 37.2 27.7 33.3 33.9 23.0 23.3 20.7 25.3 43.8 31.2 16.8 18.7 15.6 9.0 12.2 18.2 13.7 7.3 6.8 18.2 7.5 8.4 13.4 12.7 17.2 22.8 21.7 11.8 7.1 11.9 10.9 14.6 11.2 13.9 13.1 15.4 23.4 9.4 15.5 8.8 12.4 20.1 7.4 12.2 13.2 14.0 10.4 8.7 16.6 10.3 13.9 6.3 12.3 22.1 12.2 15.7 10.8 9.6 16.6 19.4 19.4 12.5 11.0 12.4 11.5 9.0 19.8 20.4 22.0 8.9 90.8 7.9 6.3 21.5 10.9 11.0 12.9 20.7 17.8 14.6 15.9 16.7 20.2 26.1 26.2 12.9 29.0 13.1 20.7 17.2 14.5 25.3 19.0 18.7 14.0 43.8 16.8 31.2 19.5 17.8 15.6 18.8 24.0 35.8 39.7 18.7 15.9 15.9 22.5 18.6 16.6 17.9 17.6 27.3 24.3 26.0 17.2 30.7 7.6 9.4 18.2 10.4 9.8 62.7 31.5 24.9 6.0 25.1 20.3 0.0 32.8 41.1 20.4 17.2 36.9 21.5 46.7 23.8 15.6 22.1 25.7 4.9 25.6 29.2 16.9 42.3 22.2 26.2 23.2 14.0 20.1 18.3 11.5 19.4 30.0 28.6 34.1 28.2 63.6 25.4 26.0 20.2 NHLRC2 "DKFZp779F115, FLJ20147, FLJ25621, FLJ33312, MGC45492" ENSG00000196865 "NHL repeat containing 2" Q8NBF2 10 113854661-113917194 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 67.2;Sertoli cells: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038493, HPA057564" Approved Approved Nucleoplasm NA NA 73000 Nucleoplasm "HPA038493: AB_10672519, HPA057564: AB_2683469" "unprognostic (7.09e-2)" "unprognostic (7.33e-2)" "unprognostic (3.00e-1)" "unprognostic (4.74e-2)" "unprognostic (5.15e-2)" "unprognostic (1.03e-1)" "unprognostic (9.70e-2)" "unprognostic (1.66e-1)" "unprognostic (3.49e-1)" "unprognostic (1.36e-1)" "unprognostic (4.88e-2)" "unprognostic (8.98e-2)" "unprognostic (1.05e-1)" "unprognostic (8.99e-2)" "unprognostic (2.52e-1)" "unprognostic (8.60e-2)" "unprognostic (1.68e-2)" 11.2 10.3 7.7 8.1 8.4 5.2 10.3 10.5 8.7 10.2 11.7 7.0 14.7 7.5 10.5 10.2 8.9 8.9 10.5 24.8 8.0 4.1 8.1 12.0 10.9 7.6 8.1 6.6 12.3 13.1 17.0 17.9 12.3 7.3 13.1 8.5 11.4 12.5 10.3 18.7 9.8 13.1 9.8 8.4 9.7 9.4 5.3 9.3 8.7 10.9 6.1 7.6 10.8 10.7 3.6 3.9 3.9 3.9 3.2 3.7 1.4 10.2 6.5 13.0 10.6 4.7 8.6 8.2 7.2 8.6 6.3 6.9 4.5 10.1 5.5 5.2 7.2 5.5 9.2 10.6 5.9 10.7 6.6 5.3 5.8 5.3 6.4 7.2 8.4 6.8 5.9 7.4 7.0 14.4 12.1 7.5 4.0 6.9 6.4 8.4 4.8 4.8 6.6 3.8 6.3 3.3 4.4 18.6 3.2 7.7 5.7 3.4 6.9 5.6 7.2 8.7 6.3 5.3 6.3 9.5 7.6 7.6 4.7 10.8 4.4 2.2 5.6 6.2 13.4 5.0 3.9 2.7 3.1 3.3 2.2 3.1 3.4 2.6 3.7 3.2 3.6 2.3 3.0 2.1 3.2 3.9 3.9 2.3 1.4 7.7 8.4 10.5 8.7 8.0 4.1 8.1 6.6 7.3 9.3 17.9 17.6 9.2 11.1 7.0 18.4 67.2 25.5 5.3 25.0 34.9 13.7 13.8 6.6 9.2 4.0 16.4 8.4 23.3 10.6 10.9 9.2 19.7 10.4 22.7 8.6 27.0 9.9 20.3 15.9 6.0 16.7 9.0 6.8 11.8 16.3 22.5 8.9 12.4 24.8 9.8 25.3 64.7 5.7 13.3 11.4 7.3 15.2 8.7 11.7 11.2 NICN1 MGC12936 ENSG00000145029 "Nicolin 1" Q9BSH3 3 49422946-49429326 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 25.0;Erythroid cells: 23.3;Late spermatids: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA058014 Supported Nucleoplasm NA NA Nucleoplasm "HPA058014: AB_2683579" "unprognostic (4.10e-2)" "unprognostic (1.08e-2)" "unprognostic (7.31e-2)" "unprognostic (1.33e-3)" "unprognostic (1.14e-1)" "unprognostic (1.31e-2)" "unprognostic (1.31e-2)" "unprognostic (4.50e-3)" "unprognostic (1.04e-2)" "unprognostic (2.88e-2)" "prognostic favorable (1.11e-4)" "unprognostic (2.46e-1)" "prognostic favorable (8.81e-7)" "unprognostic (3.11e-2)" "unprognostic (2.37e-1)" "unprognostic (1.03e-2)" "unprognostic (2.96e-2)" 9.6 12.1 19.3 5.7 23.4 3.6 10.5 21.5 27.9 9.2 9.7 8.4 12.8 7.8 12.0 12.8 5.3 10.7 8.7 16.9 12.7 10.9 16.8 10.9 10.4 8.5 9.6 21.6 13.7 12.6 10.1 10.2 6.1 12.5 10.9 5.8 10.3 13.0 10.2 14.4 8.6 8.3 9.7 8.1 9.7 10.0 13.5 10.6 7.0 13.7 7.0 8.8 9.5 8.9 9.2 8.1 8.1 8.5 6.7 10.9 7.3 2.5 8.5 8.8 6.2 3.7 4.5 3.3 3.0 2.9 2.9 3.5 1.9 7.9 8.2 3.2 6.6 6.3 2.3 5.1 4.0 2.8 14.7 3.2 7.9 8.8 9.5 6.9 3.5 5.3 9.2 4.8 6.4 2.1 14.0 4.0 17.0 4.9 0.2 3.2 2.6 5.7 5.6 3.4 3.3 2.6 4.2 2.8 10.3 5.3 1.4 2.1 3.5 2.3 2.5 6.1 19.1 4.4 2.3 10.5 2.0 2.3 2.1 1.6 9.1 3.7 2.8 7.1 8.6 3.8 8.1 7.3 6.9 8.0 5.4 5.3 9.2 5.0 9.4 5.9 5.6 6.2 7.6 2.1 6.7 8.5 8.1 10.9 7.3 19.3 23.4 21.5 26.2 12.7 10.9 9.6 21.6 12.5 10.6 0.0 0.6 0.5 5.0 3.7 6.1 10.7 5.1 1.4 1.2 0.0 9.8 5.3 0.0 0.0 25.0 3.8 4.0 23.3 0.0 1.7 4.6 2.6 1.1 4.5 4.9 3.2 11.6 1.8 4.7 27.9 8.9 1.5 3.3 0.0 3.4 5.8 0.0 1.4 5.6 0.0 6.3 6.5 3.1 12.2 2.3 2.9 2.7 5.2 2.3 4.2 NIPAL3 "DJ462O23.2, NPAL3" ENSG00000001461 "NIPA like domain containing 3" Q6P499 1 24415794-24472976 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.4" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 104.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039978 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039978: AB_10697712" "unprognostic (9.36e-2)" "unprognostic (7.63e-2)" "unprognostic (2.88e-2)" "unprognostic (1.19e-2)" "unprognostic (5.96e-2)" "unprognostic (5.38e-2)" "unprognostic (3.72e-3)" "unprognostic (3.60e-2)" "unprognostic (2.43e-1)" "unprognostic (6.66e-2)" "unprognostic (2.79e-1)" "unprognostic (3.14e-1)" "prognostic favorable (3.03e-7)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic favorable (3.95e-4)" "unprognostic (2.85e-1)" 5.3 5.1 21.4 5.2 21.8 4.9 8.3 41.2 29.4 6.9 8.9 42.4 5.6 7.1 4.2 7.4 10.3 10.4 6.3 9.2 25.5 21.3 9.4 2.3 9.2 7.1 32.9 14.7 5.5 11.3 14.0 6.5 2.8 31.5 38.4 9.3 7.1 9.9 5.7 3.5 7.7 8.5 8.1 34.8 4.8 9.6 3.1 22.5 5.8 20.7 2.3 7.9 7.8 5.4 12.9 8.4 8.9 3.6 9.2 26.0 9.7 12.8 5.2 0.5 1.7 7.9 8.8 1.9 41.7 29.9 15.3 11.3 1.8 14.7 6.0 13.4 23.0 3.1 12.6 5.1 15.5 15.0 12.2 15.9 6.6 8.7 2.1 7.3 5.8 6.0 8.8 14.4 10.1 30.9 13.9 5.2 11.8 3.8 3.8 9.2 2.8 4.7 2.4 3.2 6.2 14.7 2.2 0.0 6.8 16.2 4.1 19.4 1.8 5.6 7.9 11.2 3.6 10.8 4.4 7.5 13.7 2.9 4.5 9.1 11.9 9.7 2.1 9.2 10.6 12.2 8.9 3.6 4.7 10.8 3.4 10.7 12.9 18.2 14.0 6.5 10.9 26.0 16.1 1.6 9.2 2.3 8.4 17.6 9.7 21.4 21.8 41.2 24.6 25.5 21.3 32.9 14.7 31.5 22.5 44.7 28.0 14.5 11.0 8.1 52.0 21.5 17.8 9.4 19.4 38.4 104.1 3.0 3.3 11.5 2.8 8.5 24.1 46.7 13.4 4.0 8.5 26.1 12.7 3.2 4.2 12.7 18.0 7.4 3.8 5.6 3.7 7.1 13.5 6.4 14.9 15.3 17.2 14.4 4.9 3.6 53.0 0.0 6.2 2.4 5.5 14.3 3.5 20.8 16.3 16.1 NKX3-2 "BAPX1, NKX3.2, NKX3B" ENSG00000109705 "NK3 homeobox 2" P78367 4 13540830-13545050 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 18.3;lymphoid tissue: 6.5" "Cell type enriched" "Detected in single" 31 "Cardiomyocytes: 3.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.6;NB-4: 12.7;NTERA-2: 7.2;THP-1: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA027564 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027564: AB_10601973" "unprognostic (3.26e-2)" "unprognostic (1.26e-1)" "unprognostic (7.42e-3)" "unprognostic (5.97e-2)" "unprognostic (9.15e-3)" "unprognostic (5.72e-2)" "unprognostic (2.24e-5)" "unprognostic (3.49e-2)" "unprognostic (1.12e-1)" "unprognostic (4.06e-2)" "unprognostic (9.95e-2)" "unprognostic (1.80e-1)" "unprognostic (1.93e-8)" "unprognostic (5.81e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.15e-1)" 1.7 0.0 0.1 6.5 0.1 0.0 0.1 0.1 0.1 1.1 18.3 0.1 0.1 1.6 0.9 0.1 2.3 0.2 0.4 1.8 0.1 0.0 0.4 0.1 0.1 2.0 0.1 0.1 2.9 0.2 0.0 0.9 0.1 0.1 0.6 2.4 0.1 1.5 0.6 0.1 0.1 2.0 3.2 0.1 5.3 2.8 0.9 0.1 0.1 0.3 0.9 0.1 0.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 1.9 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.8 0.8 0.0 0.0 0.0 1.0 0.0 4.6 0.0 0.0 0.0 2.6 0.6 1.7 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 1.9 0.0 0.7 1.7 0.0 0.7 0.0 0.4 12.7 7.2 0.0 0.5 0.0 0.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 2.3 1.0 7.6 0.0 0.5 3.0 0.1 0.5 2.2 0.0 0.0 0.4 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX6-1 "Nkx6.1, NKX6A" ENSG00000163623 "NK6 homeobox 1" P78426 4 84491987-84498450 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 6.0;esophagus: 11.0;pancreas: 10.8" "Cell type enhanced" "Detected in some" 19 "Ductal cells: 7.1;Early spermatids: 2.5;Spermatocytes: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.6;HAP1: 8.1;HEK 293: 7.1;HMC-1: 5.5;PC-3: 4.8;U-2197: 9.0" "Region enhanced" "Detected in single" "pons and medulla: 1.7" "Low region specificity" "Detected in many" "HPA036774, CAB070169" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB070169: AB_10011794, HPA036774: AB_10673664" "unprognostic (2.26e-1)" "unprognostic (2.12e-2)" "unprognostic (9.13e-2)" "unprognostic (3.19e-1)" "unprognostic (1.38e-2)" "unprognostic (1.30e-1)" "unprognostic (2.71e-2)" "unprognostic (2.46e-1)" "unprognostic (2.75e-2)" "unprognostic (3.82e-2)" "unprognostic (1.82e-3)" "unprognostic (1.85e-1)" "unprognostic (5.41e-2)" "unprognostic (7.13e-3)" "unprognostic (3.68e-1)" 0.2 0.0 0.3 0.2 2.2 0.0 6.0 1.0 1.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 11.0 0.0 0.2 0.2 0.4 1.3 0.2 0.2 0.2 0.2 2.5 0.2 0.2 10.8 0.0 0.2 0.2 0.9 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 1.3 0.2 1.5 2.1 0.2 0.2 3.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 5.6 0.9 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.2 2.3 0.0 8.1 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.1 4.8 0.0 2.4 0.0 0.0 0.3 1.5 0.0 0.7 0.0 0.0 1.5 0.0 0.8 0.1 0.0 2.5 9.0 2.3 0.0 0.0 0.0 1.5 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 1.0 1.1 0.4 1.3 2.5 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 2.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.0 0.0 0.0 0.0 0.0 0.0 NMRAL1 "FLJ25918, HSCARG, SDR48A1" ENSG00000153406 "NmrA like redox sensor 1" Q9HBL8 16 4461680-4495763 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041353, HPA062287" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA041353: AB_10796343, HPA062287: AB_2684738" "unprognostic (2.56e-1)" "prognostic favorable (3.33e-7)" "unprognostic (4.16e-1)" "unprognostic (4.04e-3)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (2.20e-1)" "unprognostic (3.90e-1)" "unprognostic (1.28e-1)" "unprognostic (2.86e-1)" "unprognostic (5.52e-2)" "unprognostic (8.48e-2)" "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (5.79e-2)" "unprognostic (2.21e-1)" 10.0 20.6 19.2 8.4 23.3 11.0 17.8 7.0 31.5 16.9 14.1 23.5 19.2 17.1 12.9 18.1 17.0 20.7 17.3 17.0 19.6 16.1 18.1 26.2 12.8 14.8 20.2 23.8 20.1 30.7 14.5 14.2 16.7 17.7 18.9 10.0 14.6 28.7 17.6 3.2 25.3 13.6 12.4 20.1 13.6 19.9 7.0 14.2 14.6 18.1 10.0 12.9 12.4 11.7 13.3 19.5 11.6 19.2 8.9 23.5 17.3 10.2 14.8 2.3 8.2 4.9 4.7 12.4 7.5 2.5 8.5 6.7 15.9 17.4 0.3 15.1 8.2 2.3 11.9 6.6 9.6 3.7 9.2 3.8 9.0 10.9 7.6 11.0 10.7 7.0 7.3 11.5 9.3 3.5 6.7 8.4 32.8 11.5 0.2 3.9 32.7 21.7 10.4 10.3 12.3 13.9 23.7 0.1 12.7 8.9 5.9 3.5 9.6 12.8 21.7 8.2 1.8 20.1 9.7 5.0 5.1 0.3 3.8 0.1 0.3 0.1 18.0 2.3 9.6 9.9 4.7 19.2 2.0 23.5 11.3 18.3 13.3 15.9 22.4 18.2 11.2 17.0 17.7 11.6 8.9 8.7 19.5 14.0 17.3 19.2 23.3 7.0 31.5 19.6 16.1 20.2 23.8 17.7 14.2 23.8 27.0 25.1 32.1 24.3 10.5 20.4 35.7 28.1 29.6 40.1 0.0 90.4 44.7 30.4 11.9 19.4 26.6 0.0 43.3 84.8 27.7 25.0 19.7 67.4 56.7 4.8 19.5 29.4 28.9 21.1 27.0 24.5 33.7 22.6 34.7 36.1 32.0 33.6 28.7 68.0 9.4 25.8 22.8 4.1 40.1 26.7 53.7 27.4 39.1 17.1 NOL4 "CT125, HRIHFB2255, NOLP" ENSG00000101746 "Nucleolar protein 4" O94818 18 33851100-34224952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 12.5;testis: 14.5" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 203.4;Intestinal endocrine cells: 70.9;Late spermatids: 68.6" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 28.9;SH-SY5Y: 7.7;U-698: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046740 Supported Nucleoplasm No NA Nucleoplasm "HPA046740: AB_10960527" "unprognostic (7.86e-2)" "unprognostic (1.58e-1)" "unprognostic (3.61e-1)" "unprognostic (5.43e-7)" "unprognostic (5.76e-2)" "unprognostic (1.56e-2)" "unprognostic (7.19e-2)" "unprognostic (3.45e-1)" "unprognostic (1.12e-2)" "unprognostic (4.78e-2)" "unprognostic (3.52e-2)" "unprognostic (1.23e-1)" "unprognostic (1.39e-1)" "unprognostic (7.77e-2)" "unprognostic (7.71e-2)" 0.0 2.4 3.3 0.0 6.2 0.0 0.0 8.9 12.5 0.7 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.8 5.3 1.0 2.8 0.2 0.2 1.2 0.0 2.0 0.0 3.2 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 14.5 2.1 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 0.1 0.0 0.0 0.0 28.9 7.7 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.4 0.0 0.0 0.0 0.0 2.0 0.1 1.7 0.0 203.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 30.2 70.9 0.0 0.0 68.6 2.3 0.0 0.0 0.0 0.0 12.9 0.2 0.0 2.1 2.2 2.0 0.0 0.0 1.0 1.5 0.0 0.0 0.0 0.2 0.0 NOL4L "C20orf112, C20orf113, dJ1184F4.2, dJ1184F4.4, DKFZP566G1424" ENSG00000197183 "Nucleolar protein 4 like" Q96MY1 20 32443059-32585074 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 78.2;Late spermatids: 112.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 32.2;HEL: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041768, HPA043600" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA041768: AB_10964172, HPA043600: AB_10961001" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (4.03e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.10e-1)" "unprognostic (7.88e-2)" "unprognostic (2.75e-3)" "unprognostic (1.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (3.88e-2)" "unprognostic (9.32e-2)" "unprognostic (3.42e-1)" "unprognostic (6.08e-3)" "prognostic favorable (2.63e-4)" 7.7 8.0 13.1 9.0 14.9 18.9 8.7 19.4 14.8 6.5 16.3 35.6 8.7 19.9 6.5 13.8 2.8 9.9 11.0 5.0 13.9 11.7 9.8 5.7 10.6 8.0 20.5 8.7 3.7 12.1 5.0 19.9 12.1 16.3 7.5 15.0 12.5 11.0 9.8 1.9 3.8 20.7 7.4 17.9 11.3 14.3 33.2 20.1 16.7 8.5 2.6 6.5 10.0 8.7 1.9 2.2 7.2 11.7 8.9 8.7 4.7 3.9 12.1 7.6 5.2 1.6 2.5 1.0 2.5 2.1 3.2 2.2 32.2 9.2 0.2 7.5 3.3 5.0 1.1 2.4 7.0 1.4 0.9 1.9 25.3 5.9 23.0 4.3 0.3 1.5 6.3 1.0 2.3 1.5 7.3 19.2 5.5 7.5 3.4 1.5 2.2 8.2 7.7 4.4 12.0 11.3 3.5 0.9 1.3 5.3 0.7 10.1 8.2 7.9 0.2 4.3 8.2 1.6 7.7 20.1 3.0 10.5 2.7 2.6 2.5 0.8 1.7 3.3 13.7 9.0 3.0 2.2 1.1 6.6 4.9 5.8 1.9 4.4 3.8 2.2 1.4 8.7 7.1 7.2 8.9 11.7 0.3 7.0 4.7 13.1 14.9 19.4 14.8 13.9 11.7 20.5 8.7 16.3 20.1 6.0 3.5 1.7 9.0 0.0 34.0 7.4 5.1 4.0 2.3 12.2 62.8 0.2 8.3 6.4 78.2 21.3 50.9 0.0 6.9 1.6 5.0 14.5 11.5 3.9 8.2 7.9 16.8 26.4 3.0 112.0 5.2 4.7 0.0 5.4 33.1 14.8 10.1 34.5 4.6 17.7 55.8 19.4 6.3 53.6 3.9 0.0 0.3 12.8 28.2 20.1 NOSIP CGI-25 ENSG00000142546 "Nitric oxide synthase interacting protein" Q9Y314 19 49555711-49590262 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 119.4" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 645.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043464, HPA062132" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043464: AB_10794284, HPA062132: AB_2684693" "unprognostic (2.27e-1)" "unprognostic (4.69e-2)" "unprognostic (1.39e-1)" "unprognostic (4.17e-2)" "unprognostic (1.59e-2)" "unprognostic (9.46e-2)" "unprognostic (1.47e-2)" "unprognostic (9.42e-2)" "unprognostic (3.79e-1)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (9.73e-2)" "unprognostic (3.97e-2)" "unprognostic (2.15e-1)" "unprognostic (9.76e-2)" "unprognostic (1.02e-1)" "unprognostic (2.95e-3)" 13.4 13.9 14.2 14.0 14.0 14.3 11.5 12.1 14.2 11.3 15.9 12.3 13.1 17.3 12.5 8.1 12.7 11.1 11.7 14.9 12.3 11.4 13.2 14.5 12.6 24.6 18.3 10.8 12.9 39.7 7.1 13.6 15.6 14.3 11.6 7.9 11.3 19.2 11.4 66.9 11.9 16.5 11.0 13.1 18.0 13.9 40.2 16.3 20.6 15.5 17.6 16.3 11.7 15.0 20.4 21.5 31.8 16.8 29.7 119.4 69.2 66.5 36.1 14.1 31.0 12.6 9.2 13.5 15.7 13.9 26.5 24.4 25.2 11.8 17.9 27.6 13.2 11.1 14.9 13.8 27.6 11.6 20.4 39.9 22.6 20.8 28.0 19.9 18.3 19.1 12.0 19.2 20.1 10.9 10.8 15.9 28.8 25.0 14.3 13.8 17.8 18.6 39.4 19.1 25.0 31.4 24.4 23.4 15.9 12.3 20.1 17.6 22.9 21.2 18.1 15.8 6.7 14.7 19.4 23.5 23.0 19.5 8.0 30.0 26.9 50.8 24.2 8.7 25.2 17.7 28.0 16.8 23.5 35.1 15.7 45.4 20.4 71.4 40.2 16.6 19.8 119.4 65.8 31.8 29.7 14.3 21.5 37.5 69.2 14.2 14.0 12.1 14.2 12.3 11.4 18.3 10.8 14.3 16.3 17.9 37.0 70.7 51.2 64.7 22.7 33.5 58.6 30.8 14.8 48.8 21.6 81.7 72.9 76.5 286.4 75.9 124.9 46.7 245.7 72.4 65.6 38.9 66.9 45.0 63.5 11.1 56.3 82.3 64.5 645.6 66.4 58.6 59.1 85.6 76.3 39.5 185.4 94.7 67.8 92.9 31.4 58.2 62.7 203.6 46.2 66.7 114.0 101.0 98.9 47.7 NOTCH1 TAN1 ENSG00000148400 "Notch 1" P46531 9 136494433-136545786 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Endothelial cells: 41.3;Ito cells: 68.2;Muller glia cells: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.8" "Group enriched" "Detected in many" 4 "granulocytes: 8.8;NK-cells: 2.7" "Cell line enhanced" "Detected in many" "HaCaT: 25.0;HMC-1: 21.7;hTCEpi: 24.0;MOLT-4: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008112, CAB022466, HPA067168" Supported Approved Nucleoplasm NA NA 8100000 Nucleoplasm "CAB008112: AB_2153490, CAB022466: , HPA067168: AB_2685795" "unprognostic (1.77e-1)" "unprognostic (2.65e-2)" "unprognostic (2.16e-1)" "unprognostic (8.38e-3)" "unprognostic (3.04e-1)" "unprognostic (1.13e-1)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (5.74e-3)" "unprognostic (5.50e-3)" "unprognostic (8.78e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (2.14e-2)" "unprognostic (1.92e-1)" "unprognostic (5.65e-2)" "unprognostic (8.84e-2)" 20.0 4.0 10.0 14.5 10.4 14.6 12.8 3.8 18.8 12.8 14.2 19.9 8.2 9.8 11.2 5.1 13.3 9.6 13.1 9.6 10.7 5.8 9.4 7.2 17.4 13.7 11.6 7.5 9.2 17.8 3.7 5.6 8.5 9.3 12.1 5.7 10.4 14.2 11.8 8.2 32.3 10.8 7.7 6.6 20.7 8.6 4.1 9.9 34.8 9.4 10.2 10.9 12.3 22.2 0.6 1.1 8.8 1.0 2.7 1.3 0.9 4.4 7.5 6.2 3.1 0.2 0.5 7.8 2.2 0.6 1.3 0.4 1.1 0.5 6.1 4.7 1.7 1.6 25.0 2.0 10.3 0.2 13.8 1.1 3.4 3.0 0.4 3.4 3.6 21.7 0.4 24.0 1.8 3.8 1.5 8.0 2.7 1.5 1.1 0.9 8.1 38.1 5.8 5.2 3.2 3.4 7.9 5.0 11.2 0.9 3.8 0.0 0.4 3.3 3.5 1.4 1.9 2.1 5.8 11.8 3.3 4.8 3.2 2.4 1.3 1.1 2.4 2.2 2.5 16.9 0.7 1.0 2.8 1.3 0.4 0.8 0.4 0.6 1.0 0.6 0.6 0.4 1.1 8.8 2.7 0.4 1.1 0.4 0.9 10.0 10.4 3.8 11.7 10.7 5.8 11.6 7.5 9.3 9.9 8.9 28.2 13.8 10.6 22.0 0.3 7.3 7.6 0.0 6.8 1.8 2.0 0.7 0.0 4.8 0.3 41.3 4.9 0.0 3.4 1.8 4.8 6.6 34.6 6.8 8.0 1.6 2.4 68.2 10.5 0.0 1.1 17.1 6.8 1.0 11.0 50.6 2.2 7.0 0.7 4.1 1.7 6.5 11.5 0.2 3.2 26.1 0.9 12.9 24.7 14.1 NOX4 "KOX, KOX-1" ENSG00000086991 "NADPH oxidase 4" Q9NPH5 11 89324356-89498187 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 65.2" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 119.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 8.5;HUVEC TERT2: 15.6;TIME: 34.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015475 Approved Nucleoplasm NA NA Nucleoplasm "HPA015475: AB_1854574" "unprognostic (2.91e-2)" "unprognostic (1.08e-1)" "unprognostic (1.74e-3)" "unprognostic (6.58e-3)" "unprognostic (1.92e-1)" "unprognostic (2.33e-1)" "unprognostic (8.83e-3)" "unprognostic (8.95e-3)" "unprognostic (3.80e-1)" "unprognostic (6.88e-2)" "unprognostic (1.56e-2)" "unprognostic (1.73e-1)" "prognostic favorable (6.14e-4)" "unprognostic (1.99e-4)" "unprognostic (9.71e-2)" "unprognostic (5.69e-2)" "unprognostic (3.03e-3)" 7.5 0.6 0.2 0.6 0.6 0.3 6.5 0.3 0.5 1.2 0.9 1.1 0.4 0.3 7.3 2.5 1.5 0.8 1.3 6.9 0.6 0.2 65.2 0.3 1.2 0.3 0.3 0.2 0.7 1.1 3.8 0.8 1.7 1.0 2.6 0.4 0.8 2.6 0.9 5.1 1.1 0.5 3.5 1.2 0.4 0.4 1.0 0.0 0.0 1.7 1.7 0.4 2.1 1.1 0.4 0.3 1.7 0.3 0.8 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 8.5 15.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.2 4.3 0.3 0.0 34.8 0.1 2.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.4 0.3 0.3 1.7 0.8 0.2 0.3 0.2 0.0 0.2 0.6 0.3 0.5 0.6 0.2 0.3 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 4.1 1.1 0.0 0.0 0.0 10.4 5.9 1.2 13.3 0.0 0.8 1.1 0.0 0.0 0.0 0.6 1.1 0.1 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.4 0.3 0.0 0.0 0.0 0.0 3.7 0.1 0.0 1.1 119.8 19.3 0.0 0.3 0.5 0.1 0.3 2.1 0.0 0.0 0.0 NPAS1 "bHLHe11, MOP5, PASD5" ENSG00000130751 "Neuronal PAS domain protein 1" Q99742 19 47019820-47045775 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.2;skin 1: 10.5;stomach 1: 8.0" "Cell type enhanced" "Detected in some" 17 "Cone photoreceptor cells: 15.7;Muller glia cells: 5.6;Rod photoreceptor cells: 5.1" "Cancer enhanced" "Detected in many" "testis cancer: 5.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 2.2" "Lineage enhanced" "Detected in single" "B-cells: 2.2" "Cell line enhanced" "Detected in many" "BJ: 8.9;Daudi: 9.1;HEK 293: 10.0;HMC-1: 8.3;NB-4: 15.9;U-266/84: 9.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA043364, HPA072259" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043364: , HPA072259: AB_2686500" "unprognostic (2.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.32e-4)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-3)" "unprognostic (2.21e-2)" "unprognostic (1.09e-1)" "unprognostic (3.75e-1)" "unprognostic (5.91e-2)" "unprognostic (2.64e-1)" "unprognostic (2.14e-8)" "unprognostic (8.82e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (4.20e-2)" 0.6 0.6 9.5 1.3 4.1 0.9 1.3 0.4 14.2 0.4 0.9 0.4 0.0 0.5 0.6 0.4 0.8 1.2 0.5 0.9 9.0 5.2 1.2 0.8 0.9 1.7 3.0 4.1 0.4 1.5 0.7 1.1 0.8 5.1 0.6 0.5 3.4 0.7 0.5 0.5 10.5 0.4 0.7 0.8 3.9 8.0 0.8 0.2 0.0 0.6 0.0 1.3 0.5 0.4 2.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 2.2 0.2 0.4 0.2 0.2 0.0 8.9 0.2 0.1 0.4 0.7 0.5 9.1 2.0 7.2 0.4 0.2 1.9 0.2 0.1 0.6 10.0 0.7 0.8 2.2 0.0 4.8 8.3 0.8 0.4 0.0 0.1 0.5 0.2 1.2 3.1 0.8 1.2 0.7 0.3 15.9 2.2 0.4 1.5 0.8 0.3 0.7 0.5 0.5 0.7 0.6 0.8 0.3 2.1 0.7 1.9 1.5 0.1 0.1 0.9 0.1 0.2 5.0 9.7 1.9 1.1 1.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 9.5 4.1 0.4 14.2 9.0 5.2 3.0 4.1 5.1 0.2 0.0 1.1 0.0 1.2 0.7 0.7 0.8 0.0 2.7 0.0 0.0 15.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.5 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.6 0.8 0.0 0.0 0.5 5.1 0.0 0.3 0.0 2.0 1.9 0.0 0.0 0.5 0.9 NPAS2 "bHLHe9, MOP4, PASD4" ENSG00000170485 "Neuronal PAS domain protein 2" Q99743 2 100820152-100996829 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 49.7;Urothelial cells: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Cell line enhanced" "Detected in many" "GAMG: 45.0;PC-3: 34.2;RT4: 27.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019674 Uncertain Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA019674: AB_10601275" "unprognostic (2.74e-1)" "unprognostic (8.89e-2)" "unprognostic (4.66e-2)" "unprognostic (5.06e-3)" "unprognostic (4.39e-2)" "unprognostic (3.05e-1)" "prognostic unfavorable (2.07e-4)" "unprognostic (5.47e-3)" "unprognostic (4.48e-1)" "unprognostic (1.56e-1)" "unprognostic (1.59e-3)" "unprognostic (2.13e-1)" "prognostic unfavorable (3.55e-7)" "unprognostic (7.03e-2)" "unprognostic (6.58e-2)" "unprognostic (7.71e-3)" "unprognostic (1.34e-3)" 6.6 11.5 16.8 8.2 24.8 1.2 10.1 7.6 23.0 11.9 14.4 4.3 1.3 26.7 8.8 4.9 32.4 8.2 13.6 27.3 15.3 6.8 15.9 14.1 5.3 3.6 6.2 14.1 3.3 32.5 1.7 12.7 14.2 10.3 12.2 15.1 6.5 23.7 7.0 12.7 18.5 20.2 17.9 11.0 5.7 19.1 9.9 8.5 0.5 6.3 6.0 13.4 22.4 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 4.0 22.7 0.0 0.2 22.4 9.7 3.3 7.5 22.4 3.1 6.7 0.4 1.8 0.0 9.0 1.2 45.0 0.1 3.3 5.5 3.2 0.2 1.3 0.0 4.0 10.3 10.6 0.0 0.9 8.2 9.0 7.5 12.1 12.6 12.6 2.4 0.1 0.0 2.4 8.1 1.5 0.2 0.4 6.6 34.2 0.1 0.5 0.2 16.0 27.5 0.0 0.4 0.0 1.3 16.8 0.2 0.2 0.2 4.8 2.3 3.1 4.5 3.2 0.0 0.0 0.0 24.5 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 2.0 1.3 0.0 0.0 0.0 0.0 1.3 0.0 16.8 24.8 7.6 23.0 15.3 6.8 6.2 14.1 10.3 8.5 0.0 10.7 0.0 7.4 3.4 4.4 13.2 20.4 2.7 10.3 12.2 0.0 0.5 0.0 11.2 49.7 6.5 22.4 0.0 13.3 0.8 5.6 17.5 0.0 12.9 0.1 27.0 8.7 15.4 0.3 7.9 6.6 0.7 3.3 1.0 9.9 3.6 12.8 11.0 4.9 12.1 0.4 0.0 4.4 0.4 1.7 5.6 0.2 0.0 9.9 36.3 NPAS3 "bHLHe12, MOP6, PASD6" ENSG00000151322 "Neuronal PAS domain protein 3" Q8IXF0 14 32934933-33804176 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.8" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 7.8;Early spermatids: 16.1;Horizontal cells: 9.5;Late spermatids: 12.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 6.4;glioma: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 9.0;U-266/70: 22.3;U-266/84: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075337 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA075337: " "unprognostic (6.02e-3)" "unprognostic (2.37e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-2)" "unprognostic (3.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-2)" "unprognostic (5.65e-2)" "unprognostic (2.74e-1)" "unprognostic (3.12e-3)" "unprognostic (5.29e-3)" "unprognostic (1.38e-1)" "unprognostic (3.18e-3)" "unprognostic (2.65e-3)" "unprognostic (1.50e-1)" "unprognostic (2.69e-3)" "unprognostic (3.27e-1)" 1.8 2.4 17.4 1.4 14.4 1.0 2.7 8.5 29.8 14.0 1.8 15.8 0.7 1.5 9.1 2.6 1.6 8.5 2.2 1.6 18.7 10.3 2.4 1.3 1.3 1.3 11.7 13.0 6.4 2.2 2.5 1.6 2.0 16.2 2.5 1.7 0.8 2.7 3.6 2.0 1.4 1.6 2.2 13.8 3.1 2.8 3.5 16.3 0.0 4.4 0.0 1.5 1.1 1.4 0.0 0.6 0.1 0.2 0.0 0.2 0.0 0.0 0.0 9.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.5 0.0 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 22.3 6.4 0.0 0.3 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.6 0.0 0.0 17.4 14.4 8.5 15.3 18.7 10.3 11.7 13.0 16.2 16.3 0.0 0.0 0.0 0.7 0.9 7.8 2.0 0.0 2.7 0.0 1.8 0.0 1.2 1.7 0.1 16.1 1.9 0.0 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.4 9.5 1.2 6.2 0.0 12.4 6.6 0.0 0.0 0.0 0.0 5.8 0.3 0.0 4.9 0.6 0.3 0.0 3.1 0.2 0.1 0.4 0.2 0.0 0.0 0.4 NPEPL1 "bA261P9.2, FLJ11583" ENSG00000215440 "Aminopeptidase like 1" Q8NDH3 20 58689131-58719238 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 12.2;classical monocyte: 13.4;eosinophil: 4.9;intermediate monocyte: 8.9;myeloid DC: 8.2;neutrophil: 9.6;non-classical monocyte: 11.9" "Group enriched" "Detected in all" 5 "dendritic cells: 8.2;granulocytes: 12.2;monocytes: 13.4" "Cell line enhanced" "Detected in many" "MCF7: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004986, CAB017025, HPA036356" Approved Approved Nucleoplasm NA NA 16000 Nucleoplasm "CAB004986: AB_426073, CAB017025: , HPA036356: AB_2675082" "unprognostic (1.68e-1)" "unprognostic (5.87e-3)" "unprognostic (8.28e-2)" "unprognostic (2.78e-1)" "unprognostic (5.42e-2)" "unprognostic (1.47e-3)" "unprognostic (2.86e-3)" "unprognostic (3.11e-2)" "unprognostic (4.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.62e-3)" "unprognostic (3.78e-2)" "prognostic unfavorable (1.87e-9)" "unprognostic (7.97e-2)" "unprognostic (1.64e-1)" "unprognostic (2.21e-1)" "prognostic favorable (5.73e-4)" 17.2 10.3 9.9 9.7 15.3 15.8 25.0 24.2 10.1 9.6 14.9 10.2 17.2 14.4 11.9 23.5 17.9 12.5 24.5 19.4 10.1 8.6 16.7 11.9 14.5 12.6 12.9 7.2 12.5 15.6 13.6 11.4 11.2 13.1 15.0 4.5 15.7 19.1 17.2 51.8 15.2 13.7 25.8 10.0 16.5 12.8 13.0 9.0 5.6 16.5 20.4 11.8 15.3 20.4 1.0 8.2 12.2 13.4 2.0 2.3 4.1 9.3 13.1 2.4 1.9 5.3 9.8 0.7 3.4 0.3 11.8 6.6 7.5 7.1 0.4 19.6 6.7 0.1 10.1 3.2 4.4 1.1 8.2 2.9 3.1 10.0 3.3 13.4 3.3 5.6 9.6 14.0 4.1 0.0 4.3 9.9 2.6 0.4 1.5 4.6 43.7 1.3 8.8 3.5 5.5 13.7 2.7 1.1 5.1 4.8 6.0 4.4 1.4 9.5 2.6 17.6 1.4 10.2 6.5 10.4 3.0 2.4 5.9 1.8 4.5 1.6 0.3 4.3 6.4 1.2 12.2 13.4 4.9 1.9 8.9 2.3 1.0 1.1 1.3 8.2 0.7 0.7 1.3 9.6 2.0 11.9 0.4 2.3 4.1 9.9 15.3 24.2 10.1 10.1 8.6 12.9 7.2 13.1 9.0 8.9 14.1 0.8 7.2 8.1 14.8 13.3 7.6 14.7 12.5 26.2 23.6 11.6 11.6 13.1 1.3 12.2 10.9 0.0 8.0 6.9 9.0 5.9 2.3 7.3 10.0 7.9 11.5 14.7 15.1 6.4 20.4 9.9 6.8 8.2 9.9 20.9 8.6 15.3 13.8 17.3 8.6 19.4 11.8 2.1 3.3 9.8 7.4 10.1 12.0 4.7 NPIPA1 "morpheus, NPIP" ENSG00000183426 "Nuclear pore complex interacting protein family member A1" Q9UND3 16 14922802-14952060 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.1" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 54.9;Early spermatids: 43.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 16 "B-cells: 2.3;granulocytes: 1.7;T-cells: 1.3" "Cell line enhanced" "Detected in many" "HHSteC: 34.1" HPA053611 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.77e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-2)" "unprognostic (2.29e-2)" "unprognostic (9.21e-2)" "unprognostic (1.65e-2)" "unprognostic (5.12e-2)" "unprognostic (1.08e-1)" "unprognostic (8.82e-3)" "unprognostic (3.65e-2)" "unprognostic (1.74e-7)" "unprognostic (2.28e-1)" "unprognostic (8.76e-2)" "unprognostic (1.73e-2)" "unprognostic (2.66e-5)" 5.1 6.0 5.9 3.8 4.9 4.2 4.8 33.1 8.3 5.0 5.8 1.8 15.6 0.0 3.0 16.3 2.7 4.6 7.0 6.2 6.6 3.0 4.3 5.4 3.7 25.2 4.7 1.1 13.6 3.0 7.8 3.3 2.5 11.7 7.9 16.3 3.0 12.4 3.8 5.0 3.2 6.5 6.1 4.1 5.0 4.0 2.3 0.0 1.7 0.1 0.1 1.3 0.7 0.1 5.3 24.6 9.5 0.0 0.4 4.2 9.3 6.5 8.6 7.7 3.7 5.8 1.5 13.4 12.9 10.3 4.3 11.3 1.3 8.9 4.8 4.3 0.0 8.3 19.6 34.1 11.7 2.8 18.9 18.5 7.2 13.1 5.1 4.1 8.1 1.3 6.5 9.7 11.3 0.0 6.3 0.2 0.0 0.2 4.6 0.1 2.1 13.8 11.3 1.0 9.3 5.0 0.6 10.6 3.1 1.9 10.3 0.8 11.5 0.5 0.2 2.9 3.9 2.8 3.1 0.4 0.7 5.8 1.7 0.0 0.0 0.8 0.0 1.3 2.3 0.3 1.2 0.0 1.3 0.6 0.4 0.0 0.1 0.1 0.0 0.7 0.7 6.0 18.3 0.0 1.1 8.2 7.4 2.0 0.0 54.9 29.6 8.7 5.9 1.8 0.0 5.2 43.7 3.6 2.6 0.0 1.7 1.2 6.2 1.3 20.9 2.9 2.0 6.4 4.7 6.7 5.2 17.6 19.8 4.0 0.0 6.4 4.5 3.0 4.9 3.5 18.0 1.0 4.8 19.4 3.9 12.2 10.4 3.4 1.0 5.0 7.5 0.9 NPIPA2 ENSG00000254852 "Nuclear pore complex interacting protein family member A2" E9PIF3 16 14748066-14765413 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 11.8" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.5;Club cells: 3.4;granulocytes: 9.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 12.2;NB-4: 4.1" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" 1.6 1.2 1.3 1.1 1.5 0.9 1.8 11.8 3.8 0.6 3.2 0.6 1.7 2.7 1.1 2.4 0.8 1.3 1.8 1.5 0.6 0.5 1.6 0.9 1.0 2.6 1.2 2.3 4.1 1.1 2.2 2.6 3.1 1.0 4.2 4.1 1.0 0.8 1.3 0.9 1.6 5.9 1.2 0.8 3.3 1.5 1.6 0.0 0.1 0.1 0.0 0.5 0.0 0.4 0.4 0.3 0.0 0.4 0.3 12.2 1.0 0.5 0.1 0.3 0.4 1.7 0.0 1.1 0.9 0.2 1.4 0.3 0.0 0.1 1.0 0.7 0.8 1.0 0.2 0.4 0.2 2.9 0.1 1.6 1.6 1.2 0.1 0.3 1.6 0.8 0.8 0.2 2.4 1.3 4.1 0.8 0.0 0.5 1.3 0.8 0.2 0.7 0.6 1.1 0.6 0.4 0.7 1.7 1.8 0.0 1.0 0.9 0.4 0.3 0.0 0.5 0.4 0.3 0.3 1.5 0.7 1.0 0.1 0.1 0.0 0.5 0.0 0.3 0.7 0.5 0.1 0.0 1.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.0 4.5 0.0 0.0 2.1 0.0 0.4 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 NPIPA3 ENSG00000224712 "Nuclear pore complex interacting protein family member A3" F8WFD2 16 14708944-14726338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 13.2" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 3.0;Cardiomyocytes: 4.1;Ciliated cells: 4.0" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HSkMC: 5.0;hTERT-RPE1: 7.1;NB-4: 11.2;SK-MEL-30: 16.1" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.44e-1)" "unprognostic (7.83e-3)" "unprognostic (8.12e-3)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" "unprognostic (5.69e-3)" "unprognostic (3.11e-2)" "unprognostic (4.58e-3)" "unprognostic (4.87e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (1.67e-3)" "unprognostic (1.20e-3)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" "unprognostic (1.71e-2)" 1.3 1.4 1.8 2.3 1.3 1.9 1.2 13.2 5.0 0.8 2.9 0.5 2.4 2.2 1.1 2.8 6.4 1.0 2.2 1.8 1.1 0.8 1.2 1.0 1.1 2.8 1.5 7.2 4.1 1.3 2.3 2.6 1.9 2.9 5.3 3.2 3.4 1.2 1.0 1.0 1.3 1.8 1.4 1.0 1.9 1.6 0.1 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.6 0.1 0.3 0.0 0.1 1.5 0.5 0.0 0.4 0.4 0.0 2.1 3.5 0.2 1.3 0.8 0.1 0.1 2.3 0.3 0.1 0.0 0.4 0.7 0.4 0.2 0.1 0.5 5.0 0.7 1.3 0.2 7.1 0.1 0.7 0.1 0.3 0.3 1.3 0.0 11.2 0.9 0.0 0.0 0.1 0.0 0.0 3.1 1.0 0.5 0.5 0.0 0.2 16.1 0.7 0.2 0.0 0.5 0.6 0.1 0.0 0.1 0.0 0.2 0.1 1.9 0.1 2.0 1.6 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.5 0.0 4.1 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.2 0.1 0.3 0.0 1.1 0.0 0.1 0.0 1.2 0.0 0.3 0.2 0.6 0.0 0.0 0.0 0.6 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.5 0.0 NPIPA5 ENSG00000183793 "Nuclear pore complex interacting protein family member A5" E9PKD4 16 15363624-15381047 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 25.3" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 13.4;Early spermatids: 15.7;granulocytes: 10.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "THP-1: 15.7" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (4.19e-4)" "unprognostic (5.85e-2)" "unprognostic (5.92e-2)" "unprognostic (7.85e-2)" "unprognostic (6.58e-2)" "unprognostic (9.02e-3)" "unprognostic (1.57e-2)" "unprognostic (4.34e-3)" "unprognostic (1.85e-1)" "unprognostic (2.85e-1)" "unprognostic (9.18e-2)" "unprognostic (4.02e-2)" 2.0 2.7 4.9 0.8 4.0 3.2 3.3 25.3 6.6 3.2 4.5 2.4 8.0 8.4 4.0 5.8 4.8 4.2 5.5 5.7 1.9 2.5 4.5 2.4 3.6 5.5 4.0 7.6 8.9 1.0 3.3 2.4 1.6 2.5 4.6 13.9 2.1 2.6 2.5 2.7 2.3 8.8 2.9 1.0 2.8 2.5 0.8 0.3 0.1 0.1 1.1 0.7 0.1 0.9 1.4 4.9 0.7 9.3 9.9 0.7 1.9 4.6 6.4 6.6 2.0 0.8 2.1 0.5 4.9 2.0 2.1 1.7 4.9 3.3 3.9 1.9 2.6 5.9 9.8 1.4 0.7 3.7 1.9 8.5 2.5 3.4 2.9 3.4 7.7 2.8 1.5 6.2 1.0 2.1 3.2 6.9 4.0 0.9 0.7 0.7 0.6 5.5 1.9 0.0 0.7 5.5 2.4 6.1 0.6 2.4 15.7 7.8 0.0 2.5 7.6 0.4 4.3 6.0 7.3 0.9 3.8 1.4 0.1 0.1 0.0 0.1 0.0 0.7 0.8 0.4 0.2 0.3 0.4 0.2 0.1 0.0 1.1 0.1 0.1 0.1 0.1 0.0 3.0 0.0 0.2 4.2 1.7 2.8 0.0 13.4 3.4 1.8 0.0 0.5 0.0 0.1 15.7 2.1 0.3 0.0 0.2 0.2 7.3 0.3 10.5 1.0 0.3 1.6 0.0 1.3 1.5 2.2 1.4 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 2.7 0.0 5.7 3.9 0.9 4.0 0.2 0.0 0.0 0.1 NPIPA7 ENSG00000214967 "Nuclear pore complex interacting protein family member A7" E9PJI5 16 16379055-16393954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 1: 3.0;Cardiomyocytes: 13.4;Ciliated cells: 4.0;granulocytes: 5.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "B-cells: 1.7;T-cells: 1.9" "Cell line enhanced" "Detected in all" "HMC-1: 39.4;THP-1: 33.7" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.17e-2)" 3.6 5.7 3.0 2.8 3.0 3.7 2.9 19.7 4.0 3.2 5.1 3.1 3.7 10.1 5.3 5.5 6.2 1.9 3.8 3.4 4.4 5.9 3.8 5.2 1.7 5.1 8.8 12.4 18.0 3.2 6.1 9.0 6.6 3.2 2.6 13.8 4.2 3.9 1.6 6.3 4.2 6.1 6.8 4.3 4.1 3.3 1.7 0.1 0.2 0.1 0.4 1.9 0.2 3.1 6.9 8.3 3.2 5.0 4.0 5.5 6.5 2.5 7.5 3.9 7.2 5.0 7.9 5.3 6.8 4.6 9.6 5.8 6.7 5.6 2.3 1.7 7.8 21.3 10.5 4.7 2.7 39.4 7.2 26.0 4.1 8.9 9.4 3.8 13.1 4.6 10.2 8.2 13.3 6.3 16.2 5.7 11.4 2.3 9.4 5.6 4.4 12.3 13.4 10.8 5.8 5.2 12.0 5.5 10.7 8.7 33.7 3.3 7.2 3.5 3.2 5.5 2.1 7.7 6.5 4.1 8.7 3.1 0.2 0.1 0.0 1.9 0.0 0.4 1.5 1.2 1.9 0.0 1.7 0.2 0.3 0.0 0.4 0.1 0.1 0.4 0.2 3.0 1.6 0.0 0.0 1.4 0.0 13.4 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 NPIPA8 LCR16a9 ENSG00000214940 "Nuclear pore complex interacting protein family member A8" P0DM63 16 18317942-18336736 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 14.1" "Cell type enhanced" "Detected in single" 28 "granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 18.2;EFO-21: 18.3;HMC-1: 67.5;SCLC-21H: 16.5;THP-1: 18.2" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.68e-1)" "unprognostic (3.60e-2)" "unprognostic (2.81e-1)" 2.6 7.9 2.0 1.3 2.8 3.9 2.3 14.1 10.8 1.4 5.5 0.0 0.6 0.0 0.9 5.1 0.0 2.6 3.4 1.9 1.1 1.0 2.4 1.5 0.5 6.0 1.1 7.6 6.6 4.8 2.3 1.3 1.5 6.5 1.5 4.6 1.7 0.0 0.2 4.4 1.4 2.1 1.6 0.0 3.8 0.5 1.8 0.5 1.7 0.6 0.1 1.1 0.3 0.0 0.7 0.1 0.1 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.1 3.2 18.2 18.3 0.1 0.0 0.0 7.2 2.1 0.0 0.0 0.0 0.0 0.5 0.5 3.0 0.0 67.5 0.1 0.0 0.0 0.0 0.0 1.3 4.4 7.1 0.0 0.0 0.0 0.0 0.0 5.0 7.4 0.0 0.7 11.2 0.5 0.1 0.0 16.5 5.2 0.0 0.1 0.1 3.6 0.0 18.2 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 5.8 5.0 0.4 0.0 0.6 0.0 0.6 0.0 1.1 1.8 0.5 0.2 0.3 0.2 0.7 0.4 1.7 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 NPIPB11 ENSG00000254206 "Nuclear pore complex interacting protein family member B11" E5RHQ5 16 29381354-29404029 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 8.9;Early spermatids: 12.3" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (6.82e-2)" "unprognostic (2.99e-1)" "unprognostic (1.93e-3)" "unprognostic (1.42e-1)" "unprognostic (1.14e-1)" "unprognostic (6.92e-3)" "unprognostic (3.06e-1)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (1.36e-1)" "unprognostic (5.57e-4)" "unprognostic (7.41e-2)" "unprognostic (2.94e-6)" "unprognostic (2.79e-1)" "unprognostic (1.98e-1)" "unprognostic (5.96e-3)" "unprognostic (4.79e-5)" 2.0 1.0 1.9 3.2 2.5 5.3 1.9 5.9 2.4 1.6 1.8 2.3 2.1 4.2 1.7 2.9 2.1 1.8 2.4 1.9 2.7 3.5 1.9 7.4 1.5 4.4 1.6 0.7 2.3 1.2 2.3 2.0 2.8 0.5 5.1 8.8 3.1 0.9 1.7 5.5 3.2 4.5 2.9 1.0 1.0 1.9 3.1 0.7 1.4 0.5 0.4 1.1 0.2 1.9 1.6 2.9 4.1 2.1 1.7 3.9 1.7 0.8 1.5 0.7 2.1 3.7 12.1 2.8 0.9 0.7 3.3 2.2 2.7 1.6 2.8 3.1 2.6 4.9 3.5 1.1 3.3 6.4 1.0 2.1 1.7 2.3 3.3 0.8 3.2 3.3 3.5 1.4 4.2 2.6 10.3 5.0 1.1 3.5 4.2 1.1 3.7 1.7 1.4 3.7 1.9 0.5 2.6 1.4 9.3 1.4 4.1 3.7 4.0 1.7 2.9 2.4 3.3 2.0 9.9 2.2 4.1 2.9 0.2 0.5 0.1 1.0 0.0 0.2 0.5 0.5 0.8 0.7 3.1 1.1 1.1 1.4 0.4 0.4 0.2 0.0 0.2 8.9 6.4 2.2 0.0 0.0 0.0 1.8 0.0 4.0 4.5 0.0 0.0 0.3 0.0 0.9 12.3 0.6 3.9 0.0 0.7 0.2 0.0 0.1 4.7 0.0 0.3 4.8 6.9 0.0 0.0 4.5 0.3 0.7 0.0 1.0 6.2 0.1 1.5 5.8 0.7 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.3 0.0 4.8 0.0 NPIPB12 ENSG00000169203 "Nuclear pore complex interacting protein family, member B12" 16 29483642-29505999 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 1: 3.0;Club cells: 1.2;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 59.4" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (3.83e-2)" "unprognostic (1.08e-1)" "unprognostic (2.09e-2)" "unprognostic (1.77e-1)" "unprognostic (7.92e-2)" "unprognostic (1.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.20e-2)" "unprognostic (2.42e-1)" "unprognostic (6.08e-2)" "unprognostic (1.28e-2)" "unprognostic (6.28e-7)" "unprognostic (3.32e-2)" "unprognostic (4.11e-2)" "unprognostic (2.33e-1)" "unprognostic (2.14e-4)" 4.4 2.8 3.2 7.5 4.2 11.3 3.7 10.1 6.3 4.1 5.0 4.4 4.3 7.9 2.9 3.3 4.7 4.3 3.9 3.4 4.7 8.2 5.3 10.8 2.9 5.6 3.8 4.7 5.8 3.5 4.6 4.9 7.8 3.7 8.1 23.7 6.2 3.5 4.0 9.0 4.2 5.3 6.7 5.3 3.1 4.0 9.0 2.2 14.5 3.0 12.6 3.7 0.9 9.3 9.5 7.6 19.8 9.3 5.5 14.4 5.7 1.6 2.9 2.5 8.1 19.5 15.7 10.4 4.6 5.7 12.3 13.0 9.1 3.9 10.1 9.7 11.7 10.9 16.0 8.6 12.6 23.0 8.7 7.2 6.3 6.8 7.4 3.2 8.8 11.7 13.6 4.6 15.5 9.0 59.4 11.8 6.3 6.9 22.0 3.3 15.2 7.0 6.8 8.4 5.8 3.2 14.1 8.2 3.4 6.9 15.9 8.2 19.1 7.2 13.1 10.7 7.5 7.2 15.5 7.8 22.9 8.7 14.5 3.0 1.1 3.7 1.0 0.9 3.4 2.1 2.4 2.0 9.0 2.9 1.9 8.1 12.6 2.3 2.2 1.5 0.9 3.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPB13 ENSG00000198064 "Nuclear pore complex interacting protein family, member B13" A6NJU9 16 30222937-30254510 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 8 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 8.8;Ciliated cells: 18.7;Club cells: 13.6;granulocytes: 11.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (7.11e-3)" "unprognostic (4.08e-2)" "unprognostic (1.83e-1)" "unprognostic (1.89e-3)" "unprognostic (4.87e-2)" "unprognostic (2.49e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (7.69e-2)" "unprognostic (3.67e-1)" "unprognostic (1.41e-1)" "unprognostic (3.09e-7)" "unprognostic (1.86e-2)" "unprognostic (2.98e-1)" "unprognostic (3.17e-1)" "unprognostic (2.58e-2)" 1.8 1.1 1.9 2.3 2.0 6.5 2.3 7.6 3.3 2.3 2.3 1.7 2.4 6.2 2.0 1.9 1.7 1.5 2.4 1.6 1.6 2.3 2.7 4.2 1.5 2.7 1.4 4.8 2.9 1.7 2.8 2.5 2.8 1.7 3.5 9.0 3.3 0.4 1.4 3.9 3.5 1.8 2.8 2.1 1.4 2.2 1.3 0.6 0.8 1.6 1.9 3.2 0.5 3.3 7.8 2.0 6.8 2.0 2.4 3.9 0.6 0.0 0.7 0.3 0.9 4.5 4.7 3.4 1.4 0.7 3.9 4.3 1.9 1.1 2.9 1.7 5.0 8.7 4.1 0.9 6.9 4.4 3.0 2.7 3.0 1.9 1.0 1.3 2.2 2.1 7.2 1.6 7.0 3.0 6.4 2.7 0.7 2.0 6.1 1.0 2.7 2.2 5.5 2.4 2.4 0.9 2.7 1.2 2.9 2.2 1.9 3.4 4.1 3.9 3.6 2.0 2.8 3.2 6.2 3.8 3.0 1.9 0.1 1.6 0.2 3.2 0.4 1.6 0.4 1.3 1.3 0.5 1.3 1.4 0.4 0.8 1.9 1.6 0.6 0.4 0.5 14.9 8.8 0.0 0.0 0.0 0.0 0.0 0.0 18.7 13.6 1.8 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 11.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 NPIPB15 "LOC440348, NPIPL2" ENSG00000196436 "Nuclear pore complex interacting protein family member B15" A6NHN6 16 74377878-74392080 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 18.6" "Group enriched" "Detected in many" 8 "Early spermatids: 335.7;Late spermatids: 195.5" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "memory B-cell: 4.0" "Lineage enriched" "Detected in single" 5 "B-cells: 4.0" "Cell line enhanced" "Detected in many" "T-47d: 13.5" "HPA011188, HPA053611" Supported Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (2.23e-2)" "unprognostic (3.48e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-1)" "unprognostic (9.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.56e-2)" "unprognostic (5.53e-2)" "unprognostic (2.41e-2)" "unprognostic (7.73e-2)" "unprognostic (4.58e-3)" "unprognostic (1.53e-1)" "unprognostic (2.81e-2)" "unprognostic (1.97e-1)" "unprognostic (7.34e-3)" "unprognostic (2.53e-1)" "unprognostic (1.14e-3)" 1.8 1.2 0.8 0.5 1.3 2.9 3.8 4.5 1.5 2.1 6.2 4.1 1.1 0.0 3.0 2.1 2.1 1.1 1.1 0.8 3.1 8.4 2.4 2.6 0.8 1.8 6.1 4.4 5.2 2.7 7.1 11.2 6.1 1.1 3.0 4.1 5.3 1.5 0.9 3.1 4.3 18.6 4.4 2.2 1.4 1.8 4.0 0.2 0.8 0.3 0.6 0.6 0.5 2.8 0.1 2.7 1.6 3.3 2.3 0.6 1.9 2.6 2.1 5.9 1.6 0.1 4.7 0.0 3.7 0.0 5.3 0.0 2.2 1.7 0.0 3.0 0.1 6.2 2.7 1.5 1.9 9.5 3.2 4.8 4.3 3.3 3.2 0.0 0.1 0.4 1.9 1.8 4.3 1.0 0.0 0.6 1.4 0.0 1.0 2.7 3.1 0.0 1.8 3.8 0.0 7.0 0.0 4.5 0.0 13.5 2.2 0.2 2.0 5.6 0.0 1.0 6.5 1.8 1.1 2.7 1.3 1.4 0.0 0.3 0.2 0.6 0.0 0.0 4.0 0.2 0.6 0.2 0.7 0.2 0.0 0.8 0.6 0.1 0.1 0.0 0.5 3.0 5.1 3.7 1.6 1.8 2.8 1.1 7.6 4.0 7.9 7.0 7.9 1.0 0.0 1.2 335.7 2.9 12.4 0.0 3.3 0.9 3.4 5.9 0.0 2.1 1.0 0.0 16.8 3.1 4.0 195.5 10.6 1.2 3.3 1.0 35.4 1.1 2.1 28.1 7.1 0.5 1.7 0.0 2.8 7.2 5.3 2.4 2.1 4.5 15.8 5.5 NPIPB2 ENSG00000234719 "Nuclear pore complex interacting protein family, member B2" A6NJ64 16 11927373-11976643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Ciliated cells: 4.0;Collecting duct cells: 1.8;Distal tubular cells: 5.0;granulocytes: 2.3;monocytes: 1.8;Proximal tubular cells: 2.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.5;U-266/70: 22.0" HPA053611 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (8.80e-2)" "unprognostic (4.83e-1)" "unprognostic (5.20e-2)" "unprognostic (8.24e-2)" "unprognostic (2.45e-1)" "unprognostic (4.34e-2)" "unprognostic (1.37e-1)" "unprognostic (2.73e-1)" "unprognostic (5.92e-2)" "unprognostic (3.01e-3)" "unprognostic (2.80e-2)" "unprognostic (2.21e-1)" "unprognostic (4.89e-3)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (2.25e-1)" "unprognostic (2.58e-2)" 3.4 3.8 3.8 3.6 5.0 1.8 3.0 4.6 8.2 3.6 2.7 4.9 13.8 3.4 4.9 10.3 1.6 3.3 4.2 2.7 8.2 2.9 4.9 2.3 4.0 4.9 3.0 1.7 4.5 6.6 11.0 3.5 2.4 3.6 3.3 2.9 3.8 6.1 13.2 3.1 6.8 3.9 4.8 3.5 2.7 2.2 17.4 2.4 10.2 6.1 1.8 1.9 2.1 2.8 2.7 2.2 0.7 3.1 3.5 2.7 1.0 0.1 1.4 1.7 1.0 3.7 6.5 2.4 1.9 3.1 0.8 0.4 1.0 1.4 0.9 0.6 1.8 0.3 0.3 1.1 1.4 1.7 0.9 1.5 0.5 1.4 1.5 6.5 0.9 0.4 0.3 3.3 1.8 4.0 0.3 0.2 0.2 0.1 4.2 0.5 2.0 0.2 0.5 0.4 1.1 1.3 1.8 0.1 12.5 0.6 0.8 2.3 0.0 4.3 0.2 0.0 1.7 0.3 2.7 0.4 0.3 0.2 0.4 0.2 22.0 7.1 1.0 2.6 0.3 1.0 0.0 3.1 0.6 1.0 0.2 0.2 2.7 1.7 1.3 2.2 1.6 2.7 0.6 0.7 3.5 0.5 2.2 0.0 1.0 3.8 5.0 4.6 8.2 8.2 2.9 3.0 1.7 3.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.8 0.0 0.6 5.0 0.4 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 NPIPB3 "KIAA0220, NPIPL3" ENSG00000169246 "Nuclear pore complex interacting protein family member B3" Q92617 16 21402237-21448567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 10 "Basal keratinocytes: 2.5;Ciliated cells: 2.7;Club cells: 2.3;Melanocytes: 1.7;Suprabasal keratinocytes: 1.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 54.1" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.68e-2)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.38e-1)" "unprognostic (8.01e-2)" "unprognostic (9.97e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-2)" "unprognostic (3.14e-1)" "unprognostic (3.91e-1)" "unprognostic (1.65e-1)" "unprognostic (4.66e-5)" "unprognostic (1.50e-7)" "unprognostic (1.30e-1)" "unprognostic (3.02e-2)" "unprognostic (5.94e-2)" "unprognostic (9.00e-4)" 7.3 5.0 8.2 8.6 9.8 32.4 8.8 15.5 8.8 6.4 7.6 6.9 5.2 12.4 6.2 6.4 6.8 5.5 9.6 7.2 8.2 9.6 7.9 18.1 6.7 6.7 5.9 4.0 9.5 5.0 9.8 8.2 11.7 5.6 19.7 36.9 9.6 6.1 7.6 14.6 7.1 7.3 9.7 7.9 5.2 6.6 5.3 9.0 6.5 3.6 3.4 5.7 0.4 13.7 12.5 8.6 14.9 11.5 6.6 25.5 9.5 3.4 5.1 5.7 19.3 17.0 20.0 9.6 13.0 6.2 15.7 5.6 14.1 4.7 11.2 7.9 8.8 17.2 54.1 10.4 16.0 16.9 3.5 6.1 12.2 15.6 7.3 6.7 18.2 15.9 26.6 6.9 24.7 16.9 39.2 15.8 7.5 14.7 26.9 8.9 11.8 10.2 8.0 10.9 8.3 5.5 13.1 10.0 16.4 12.9 7.8 11.0 24.2 13.3 2.3 13.8 14.1 9.9 18.1 9.6 14.1 12.7 6.5 3.6 2.6 5.7 2.7 2.3 4.4 3.0 2.9 2.2 5.3 3.9 2.6 3.9 3.4 2.0 9.0 2.0 0.4 0.0 0.0 0.0 0.4 2.5 0.0 0.8 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.1 NPIPB4 ENSG00000185864 "Nuclear pore complex interacting protein family member B4" C9JG80 16 21834569-21880827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skin 1: 31.2" "Cell type enriched" "Detected in many" 7 "Early spermatids: 92.2" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (3.09e-3)" "unprognostic (3.51e-3)" "unprognostic (4.01e-2)" "unprognostic (1.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-3)" "unprognostic (2.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.82e-2)" "unprognostic (3.66e-1)" "unprognostic (1.76e-1)" "unprognostic (4.05e-3)" "unprognostic (6.04e-8)" "unprognostic (3.37e-1)" "unprognostic (7.78e-2)" "unprognostic (2.32e-1)" "unprognostic (5.46e-3)" 5.5 3.7 4.4 7.0 4.6 23.5 6.1 10.4 5.4 5.1 6.5 4.5 5.4 22.4 4.5 5.7 4.9 4.2 5.0 4.0 5.4 6.6 6.0 10.7 3.8 5.9 5.3 3.3 5.4 3.8 6.6 8.2 5.5 3.2 7.1 31.2 8.6 3.5 4.4 10.1 7.3 4.3 7.9 7.5 4.1 5.4 6.3 3.7 4.7 2.5 5.2 2.3 0.3 7.1 9.7 9.3 7.3 6.7 9.7 15.7 8.8 2.7 3.0 4.9 20.6 10.2 13.8 6.8 7.6 2.8 8.2 5.2 7.4 6.0 5.6 4.7 5.5 24.8 27.2 4.5 22.6 14.6 7.2 9.2 8.0 13.3 6.1 6.5 11.3 11.8 12.2 4.5 20.9 8.5 14.2 11.3 2.3 5.4 13.0 5.6 8.0 3.4 7.1 9.4 5.7 5.9 6.8 4.8 9.3 9.0 6.8 14.2 16.0 8.0 7.6 7.6 6.3 5.8 14.7 5.0 10.8 7.4 4.7 2.5 0.7 1.8 1.0 1.3 2.2 2.3 1.1 0.4 6.3 1.8 1.9 3.0 5.2 1.2 3.7 0.6 0.3 3.0 12.6 2.0 1.0 6.8 4.7 1.5 0.0 6.7 10.3 0.0 3.9 0.4 0.0 0.9 92.2 4.2 1.1 0.0 0.5 0.2 5.9 0.4 10.4 1.0 0.6 1.6 1.2 1.8 0.8 13.6 0.3 3.0 0.0 2.8 1.1 1.9 1.2 2.3 0.4 0.0 7.1 0.0 2.9 1.6 0.5 7.3 0.7 2.2 1.7 0.5 NPIPB5 ENSG00000243716 "Nuclear pore complex interacting protein family member B5" A8MRT5 16 22479121-22536521 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 44.9;Ciliated cells: 54.9;Club cells: 89.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (7.52e-4)" "unprognostic (2.08e-1)" "unprognostic (2.32e-2)" "unprognostic (9.43e-3)" "unprognostic (3.96e-1)" "unprognostic (2.64e-3)" "unprognostic (2.40e-3)" "unprognostic (4.20e-2)" "unprognostic (1.65e-1)" "unprognostic (4.19e-2)" "unprognostic (1.09e-1)" "unprognostic (3.87e-2)" "unprognostic (1.90e-10)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (3.86e-2)" "unprognostic (3.76e-5)" 10.8 7.0 13.4 34.7 12.0 30.6 10.4 18.3 13.4 9.6 10.8 9.6 12.5 7.7 8.6 33.3 7.2 8.4 6.6 8.4 24.1 6.1 8.7 6.1 13.6 19.3 17.5 16.7 9.9 10.1 6.4 8.7 7.2 13.7 10.5 12.1 14.6 12.2 22.9 17.8 54.2 17.1 6.8 9.7 16.3 8.9 10.6 11.8 7.0 14.4 6.8 14.2 8.0 10.0 11.7 7.0 8.3 3.5 4.4 5.9 1.3 10.9 9.6 6.1 7.8 10.4 9.8 14.5 6.7 2.4 4.2 5.3 13.5 18.5 15.1 12.5 8.9 4.0 9.8 14.2 9.6 7.5 18.6 5.2 5.8 25.2 26.0 10.1 31.6 9.8 11.9 7.3 10.3 19.0 7.7 7.4 17.5 16.1 24.6 5.1 18.6 14.0 42.3 17.0 2.0 4.1 15.3 4.4 18.0 7.6 6.4 6.8 5.7 8.3 11.7 5.6 15.1 6.9 10.9 25.2 13.5 6.1 11.2 11.3 13.6 6.4 19.7 5.6 23.0 6.0 6.7 3.5 2.7 5.5 1.7 2.3 8.6 5.2 3.7 2.0 11.7 5.9 4.9 8.3 4.4 3.2 7.0 2.4 1.3 13.4 12.0 18.3 13.4 24.1 6.1 17.5 16.7 13.7 11.8 26.8 44.9 3.7 11.4 12.8 13.0 28.7 2.5 54.9 89.9 5.2 9.8 3.6 0.0 3.1 4.7 11.9 2.6 0.0 1.2 2.3 8.9 9.1 9.3 1.6 3.7 6.4 1.2 6.7 4.6 1.8 9.5 11.0 5.0 9.0 3.0 5.0 4.0 4.9 6.0 0.7 24.7 0.0 17.6 3.0 2.6 10.0 4.9 11.4 3.9 9.2 NPIPB6 ENSG00000198156 "Nuclear pore complex interacting protein family member B6" E9PJ23 16 28342555-28363508 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 26.8" "Group enriched" "Detected in some" 15 "Early spermatids: 188.9;Late spermatids: 89.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 3.1;naive B-cell: 1.8" "Lineage enriched" "Detected in single" 5 "B-cells: 3.1" "Cell line enhanced" "Detected in many" "A549: 6.0;BEWO: 5.6;hTCEpi: 5.8;NB-4: 5.8;RPMI-8226: 6.0" "HPA011188, HPA053611" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (1.99e-1)" "unprognostic (1.81e-2)" "unprognostic (7.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.86e-2)" "unprognostic (2.43e-1)" "unprognostic (3.21e-1)" "unprognostic (1.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.31e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-1)" "unprognostic (6.79e-4)" "unprognostic (3.20e-1)" "unprognostic (8.36e-2)" "unprognostic (4.78e-1)" "unprognostic (1.04e-3)" 0.2 0.0 0.9 0.3 1.4 0.5 0.6 1.8 0.9 0.4 0.5 0.3 0.7 1.0 0.1 0.9 0.1 0.1 1.1 0.7 0.1 0.1 0.2 0.4 0.7 1.2 0.2 0.4 0.9 0.2 0.7 0.6 0.2 0.5 0.6 1.8 0.3 0.4 0.9 0.6 0.6 26.8 0.6 0.2 0.2 0.3 3.1 0.1 0.1 0.0 0.1 0.6 0.5 0.2 6.0 2.9 0.6 1.4 0.3 5.6 0.3 0.5 0.1 0.5 0.2 2.4 1.9 0.5 0.2 0.6 0.7 0.3 0.5 0.3 1.3 0.5 1.4 1.1 0.0 0.0 1.7 0.4 1.0 5.8 0.4 1.3 1.0 0.1 3.2 0.2 4.8 0.0 1.4 0.5 5.8 1.6 0.5 0.3 3.1 2.5 6.0 0.1 0.1 0.7 1.3 0.2 0.3 0.6 3.4 1.2 0.4 0.6 0.7 2.3 0.5 0.4 2.2 2.3 0.7 0.2 0.9 0.2 0.0 0.0 0.0 0.3 0.0 0.0 3.1 0.6 0.5 0.0 1.8 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.6 0.0 0.2 0.5 0.3 0.4 0.0 9.4 1.2 0.0 0.0 0.5 0.0 0.0 188.9 0.1 0.2 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.0 89.0 1.1 0.1 0.0 0.0 0.1 1.0 0.1 0.3 1.8 0.0 0.1 0.0 0.0 4.4 1.1 1.1 1.1 0.0 0.5 0.4 NPIPB7 "LOC440350, NPIPL1" ENSG00000233232 "Nuclear pore complex interacting protein family member B7" O75200 16 28456372-28471175 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 14.9" "Cell type enriched" "Detected in some" 6 "Early spermatids: 117.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 6.2;hTCEpi: 2.5;U-266/70: 1.6" "HPA011188, HPA053611" Approved Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "unprognostic (8.35e-2)" "unprognostic (1.94e-1)" "unprognostic (1.94e-1)" "unprognostic (7.43e-2)" "unprognostic (3.07e-3)" "unprognostic (3.35e-2)" "unprognostic (3.44e-1)" "unprognostic (2.78e-2)" "unprognostic (3.62e-2)" "unprognostic (3.04e-2)" "unprognostic (4.40e-1)" "unprognostic (2.22e-1)" "unprognostic (7.73e-2)" "unprognostic (2.03e-2)" 0.0 0.0 0.5 0.2 0.9 0.1 0.1 2.3 0.5 0.1 0.3 0.3 0.3 0.3 0.0 0.2 0.1 0.1 0.5 0.8 0.0 0.0 0.2 0.4 0.3 0.5 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.8 0.2 0.1 0.2 0.1 0.1 14.9 0.4 0.1 0.1 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 6.2 0.0 0.2 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.5 0.4 0.2 0.1 0.0 1.2 0.0 0.1 0.0 0.9 0.1 1.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.4 0.1 0.0 1.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 117.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 NPIPB8 ENSG00000255524 "Nuclear pore complex interacting protein family member B8" E9PQR5 16 28637654-28658682 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 14.4" "Group enriched" "Detected in some" 12 "Early spermatids: 12.1;Late spermatids: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "hTCEpi: 22.2" "HPA011188, HPA053611" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (8.28e-2)" "unprognostic (1.88e-1)" "unprognostic (1.10e-1)" "unprognostic (5.78e-2)" "unprognostic (1.05e-2)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" 0.4 0.7 0.0 0.6 0.3 0.5 0.5 1.6 0.4 0.3 0.9 2.2 0.6 0.7 0.5 0.3 0.1 0.1 0.1 0.0 0.3 1.1 0.6 0.3 0.1 1.1 1.1 0.1 1.3 0.2 1.1 0.4 1.3 0.4 0.9 0.7 2.2 0.2 0.1 0.6 0.7 14.4 1.0 0.4 0.5 0.6 0.6 0.3 0.1 0.1 0.5 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.6 0.3 22.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPB9 ENSG00000196993 "Nuclear pore complex interacting protein family member B9" F8W1W9 16 28751787-28772807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "testis: 13.6" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 5.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 8.0;U-266/70: 6.7" "HPA011188, HPA053611" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (7.38e-2)" "unprognostic (6.63e-4)" "unprognostic (6.63e-2)" "unprognostic (5.05e-2)" "unprognostic (5.53e-2)" "unprognostic (4.44e-2)" "unprognostic (1.53e-1)" "unprognostic (9.36e-2)" "unprognostic (7.52e-2)" "unprognostic (2.84e-1)" "unprognostic (2.86e-1)" "unprognostic (2.31e-1)" "unprognostic (4.71e-2)" 0.6 0.3 1.7 0.9 1.8 1.6 0.4 2.7 1.4 0.4 1.0 0.0 1.1 2.4 0.4 1.5 0.6 0.2 2.2 1.3 0.4 0.4 0.4 1.5 1.7 1.4 0.2 0.5 1.4 0.4 1.2 0.8 0.9 0.9 1.1 2.8 0.8 0.8 2.2 1.1 0.5 13.6 1.7 1.0 0.3 0.7 3.1 0.1 0.5 0.2 1.8 0.7 0.3 0.4 4.0 1.1 0.6 0.5 1.3 3.3 0.0 0.1 0.0 0.0 0.4 2.1 1.6 1.1 0.0 0.5 0.4 0.7 0.2 0.1 0.4 1.9 0.7 0.0 0.8 0.1 2.5 2.7 0.2 8.0 0.6 1.5 0.8 0.0 2.9 0.4 2.5 0.2 3.0 0.9 3.3 1.6 0.2 0.9 3.3 0.0 1.6 0.0 0.4 0.1 0.0 0.2 0.4 0.2 2.2 2.2 1.1 0.0 0.0 2.8 1.9 0.6 6.7 2.9 2.0 0.1 0.9 0.5 0.0 0.2 0.0 0.7 0.0 0.2 3.1 0.4 0.1 0.1 1.2 0.3 0.1 0.5 1.8 0.2 0.0 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 5.3 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.0 NR1D2 "BD73, EAR-1r, Hs.37288, HZF2, RVR" ENSG00000174738 "Nuclear receptor subfamily 1 group D member 2" Q14995 3 23945260-23980618 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 90.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053868, HPA054798" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053868: AB_2682284, HPA054798: AB_2616453" "unprognostic (8.64e-2)" "unprognostic (9.96e-3)" "unprognostic (2.27e-1)" "unprognostic (2.46e-1)" "unprognostic (8.67e-2)" "unprognostic (2.09e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (2.60e-1)" "unprognostic (6.79e-3)" "unprognostic (2.21e-1)" "unprognostic (5.73e-2)" "prognostic favorable (4.47e-7)" "unprognostic (2.36e-3)" "unprognostic (1.23e-1)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" 15.2 12.5 15.2 7.9 17.1 9.5 15.9 40.9 31.9 21.1 13.3 14.0 20.9 10.0 19.0 11.0 12.2 13.3 11.0 22.5 15.0 13.4 16.8 22.1 10.6 9.6 14.4 16.1 24.3 12.7 41.6 15.8 10.0 16.1 15.1 9.0 16.3 22.2 23.1 35.4 14.2 10.4 15.6 14.6 13.1 10.9 5.6 15.1 5.5 40.7 23.2 10.5 13.0 14.3 2.4 0.9 0.2 2.5 1.1 6.1 1.0 9.9 2.2 5.3 5.0 5.6 6.0 3.3 14.8 19.5 8.2 9.2 1.7 9.8 7.1 5.0 20.7 12.9 6.7 6.6 9.7 17.3 2.5 7.7 1.1 5.3 2.0 11.7 3.7 1.1 8.0 10.3 10.0 25.9 15.4 5.6 4.2 2.5 25.9 6.5 5.7 2.0 1.2 5.7 8.1 11.3 1.8 8.6 4.8 4.6 13.8 5.5 12.2 10.8 6.2 12.8 9.0 5.5 3.3 11.1 21.6 22.0 14.0 16.8 12.7 17.1 3.3 12.3 5.7 12.5 0.0 0.8 0.1 3.3 2.5 6.1 2.4 3.7 3.1 0.9 1.9 2.6 2.6 0.2 1.1 1.4 0.9 2.2 1.0 15.2 17.1 40.9 31.9 15.0 13.4 14.4 16.1 16.1 15.1 11.9 6.9 16.2 30.6 29.7 80.4 32.7 15.3 6.7 17.0 19.2 37.3 8.9 6.6 10.1 8.3 26.1 10.7 0.0 12.9 2.0 40.4 34.0 8.1 27.7 8.5 90.6 27.3 8.6 9.9 9.0 31.7 16.9 27.0 5.4 16.8 58.7 15.8 8.6 40.0 8.8 48.7 32.3 40.9 7.7 10.4 29.4 5.7 18.5 12.4 26.4 NR1H4 "FXR, HRR-1, HRR1, RIP14" ENSG00000012504 "Nuclear receptor subfamily 1 group H member 4" Q96RI1 12 100473708-100564413 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Disease mutation, FDA approved drug targets, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 109.4" "Cell type enhanced" "Detected in some" 15 "Cholangiocytes: 79.0;Distal tubular cells: 36.5;Hepatocytes: 90.4;Proximal tubular cells: 116.5" "Group enriched" "Detected in some" 11 "liver cancer: 18.7;renal cancer: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "Hep G2: 18.4;HHSteC: 11.1;RPTEC TERT1: 29.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA047699 Approved Nucleoplasm NA NA Nucleoplasm "HPA047699: AB_10965320" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (6.68e-2)" "unprognostic (2.49e-1)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (2.01e-1)" "unprognostic (1.88e-2)" "unprognostic (1.16e-1)" "unprognostic (2.43e-1)" "unprognostic (3.77e-3)" 0.1 11.3 0.1 1.4 0.4 0.0 0.2 0.1 0.2 0.2 5.8 0.4 0.1 11.3 0.1 0.4 0.1 0.1 7.0 0.1 0.1 0.0 25.0 109.4 0.6 2.4 0.1 0.1 7.7 2.7 0.0 2.9 0.2 0.3 0.5 0.4 0.6 0.1 0.1 0.1 0.0 19.5 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.3 0.3 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 79.0 0.0 0.0 21.0 0.0 0.0 36.5 6.3 0.2 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 90.4 0.0 0.0 0.0 14.7 1.9 1.3 0.9 0.0 0.0 0.0 0.1 0.0 0.6 2.9 0.0 116.5 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.3 0.9 NR1I2 "BXR, ONR1, PAR2, PXR, SXR" ENSG00000144852 "Nuclear receptor subfamily 1 group I member 2" O75469 3 119780484-119818485 "FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 7.1;intestine: 15.4;liver: 22.2" "Group enriched" "Detected in some" 4 "Enterocytes: 29.0;Hepatocytes: 28.7" "Group enriched" "Detected in some" 24 "colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7" "Cell type enriched" "Detected in single" 18 "NK-cell: 7.1" "Lineage enriched" "Detected in single" 18 "NK-cells: 7.1" "Cell line enriched" "Detected in some" 4 "Hep G2: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029309, HPA055121, HPA073926" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643" "unprognostic (6.76e-3)" "unprognostic (2.25e-1)" "unprognostic (5.84e-2)" "unprognostic (1.24e-4)" "unprognostic (4.51e-2)" "unprognostic (4.52e-2)" "unprognostic (4.03e-3)" "unprognostic (3.97e-2)" "unprognostic (5.78e-2)" "unprognostic (5.05e-2)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (5.51e-6)" "unprognostic (4.86e-1)" "unprognostic (6.95e-2)" "unprognostic (3.13e-1)" "unprognostic (6.12e-3)" 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 5.6 15.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.0 22.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 7.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.8 2.5 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.0 0.0 29.0 0.0 0.2 0.0 0.0 0.0 0.0 28.7 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.6 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 NR1I3 "CAR, CAR1, MB67" ENSG00000143257 "Nuclear receptor subfamily 1 group I member 3" Q14994 1 161229666-161238302 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "liver: 63.1" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 124.3" "Cancer enriched" "Detected in single" 67 "liver cancer: 17.6" "Region enriched" "Detected in single" 6 "basal ganglia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA051365 Approved Nucleoplasm NA NA Nucleoplasm "HPA051365: AB_2616454" "unprognostic (2.59e-3)" "unprognostic (1.06e-2)" "unprognostic (9.33e-2)" "unprognostic (6.92e-4)" "unprognostic (2.55e-1)" "unprognostic (1.88e-2)" "unprognostic (1.91e-2)" "unprognostic (5.51e-2)" "unprognostic (8.69e-2)" "unprognostic (1.85e-1)" "unprognostic (6.23e-2)" "unprognostic (5.63e-3)" "unprognostic (2.71e-1)" "unprognostic (5.79e-2)" "unprognostic (6.44e-2)" "unprognostic (5.48e-3)" "unprognostic (2.62e-2)" 0.1 0.0 0.2 0.1 1.9 0.1 0.1 0.1 0.2 0.1 0.7 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 3.5 63.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.3 2.3 0.1 0.1 0.1 0.0 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.7 0.3 0.0 0.6 0.3 0.3 0.9 1.1 0.6 0.0 0.0 0.9 0.4 0.0 0.0 0.0 9.4 0.3 1.0 0.6 0.0 0.3 0.6 0.0 0.0 0.0 1.0 0.9 0.0 0.2 2.2 0.0 1.7 1.7 0.0 0.0 0.0 0.0 0.6 0.0 0.9 1.2 0.4 0.0 0.8 0.3 0.6 1.7 1.8 1.3 0.9 0.8 0.6 0.0 1.8 2.3 1.4 0.3 2.9 0.4 1.4 2.1 1.2 2.2 0.7 0.7 1.5 0.2 1.5 2.2 1.3 0.5 2.9 0.5 0.7 0.2 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.3 0.2 1.9 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.3 20.8 16.0 2.2 1.1 0.6 0.7 0.3 2.5 8.1 9.1 3.5 0.0 0.1 3.3 0.1 1.7 0.3 0.0 0.0 0.0 0.1 0.4 0.4 12.7 124.3 0.3 0.0 0.0 3.1 5.3 1.2 0.3 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.4 28.7 1.7 0.0 0.4 0.2 0.0 0.0 0.0 0.5 0.0 0.8 NR2C2 "hTAK1, TAK1, TR2R1, TR4" ENSG00000177463 "Nuclear receptor subfamily 2 group C member 2" P49116 3 14947584-15053600 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006313 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006313: AB_1079503" "unprognostic (1.32e-1)" "unprognostic (3.87e-1)" "unprognostic (3.98e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "prognostic favorable (1.51e-5)" "unprognostic (1.03e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-1)" "unprognostic (1.29e-1)" "unprognostic (5.95e-2)" "unprognostic (1.02e-1)" "unprognostic (2.26e-1)" "unprognostic (1.25e-1)" "unprognostic (2.82e-2)" "unprognostic (5.82e-3)" 13.2 13.1 22.5 17.0 17.5 17.1 16.1 30.5 26.4 11.9 14.0 12.8 14.1 18.5 17.8 11.0 13.6 12.6 12.3 14.5 18.3 12.0 12.4 12.6 18.7 16.9 12.6 20.4 18.8 14.2 18.0 23.2 11.9 13.1 12.3 12.2 13.7 13.0 21.5 31.5 19.6 18.1 15.7 13.5 18.8 14.7 29.2 13.3 26.0 19.4 9.0 15.5 15.5 17.8 5.1 4.2 6.2 3.4 2.7 4.9 1.5 10.1 11.5 13.2 10.2 9.4 11.3 30.3 14.7 11.9 11.9 12.4 7.4 10.0 15.7 7.7 13.1 10.5 10.2 12.1 7.5 12.4 20.6 17.2 20.5 24.6 6.6 7.9 15.0 15.9 8.9 10.0 15.0 7.9 10.0 13.4 15.5 14.5 10.8 10.5 9.0 23.0 11.8 8.7 4.8 11.9 18.5 15.7 10.4 5.7 15.4 8.4 21.1 13.3 11.2 13.5 10.9 11.2 15.0 17.3 18.5 22.1 16.8 20.0 16.5 21.3 17.0 13.3 14.4 16.2 6.2 2.5 1.9 4.9 3.4 4.4 2.3 2.7 2.9 2.6 5.1 3.9 3.5 3.5 2.7 3.0 4.2 2.5 1.5 22.5 17.5 30.5 26.4 18.3 12.0 12.6 20.4 13.1 13.3 20.8 9.8 10.9 9.5 3.3 15.5 5.1 12.7 24.1 7.9 7.0 13.7 6.7 5.0 6.1 46.1 6.4 10.7 0.0 6.3 6.3 5.8 13.8 9.2 7.8 6.7 12.7 24.1 20.3 20.9 49.4 17.8 7.7 5.0 7.2 10.7 13.3 9.4 11.8 19.4 5.7 16.3 0.0 4.8 30.9 16.3 2.8 12.5 13.6 10.6 10.7 NR2C2AP TRA16 ENSG00000184162 "Nuclear receptor 2C2 associated protein" Q86WQ0 19 19201416-19203424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042054, HPA055653" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA042054: AB_10965022, HPA055653: AB_2682877" "unprognostic (9.54e-2)" "unprognostic (2.93e-3)" "prognostic unfavorable (8.53e-4)" "unprognostic (2.36e-2)" "unprognostic (6.81e-2)" "unprognostic (6.26e-3)" "prognostic unfavorable (5.63e-5)" "unprognostic (1.60e-2)" "unprognostic (1.53e-1)" "unprognostic (8.77e-2)" "unprognostic (3.65e-3)" "unprognostic (5.89e-2)" "unprognostic (7.62e-3)" "unprognostic (1.17e-2)" "unprognostic (5.99e-2)" "prognostic favorable (1.65e-4)" "unprognostic (2.10e-2)" 15.8 9.9 10.5 13.5 12.3 7.5 16.8 9.6 12.1 11.4 13.5 11.6 6.5 9.2 14.4 16.5 16.8 17.5 10.9 9.3 9.1 7.0 10.6 11.4 10.0 14.1 15.2 5.5 19.0 18.1 7.0 7.8 11.4 13.9 19.4 12.8 7.2 17.5 13.0 10.8 19.6 10.3 13.3 12.0 15.2 11.8 6.2 13.5 10.0 16.0 15.4 14.8 15.7 12.8 20.2 11.2 1.2 9.5 11.3 21.1 12.1 18.7 11.0 5.2 11.1 4.4 4.4 20.5 10.7 6.1 14.7 14.0 7.4 23.1 10.2 30.2 5.6 10.3 16.8 13.8 14.2 9.0 9.0 14.9 5.8 6.5 8.1 5.1 11.2 9.1 4.5 17.4 10.2 13.9 4.1 5.8 11.8 10.3 13.5 8.7 48.3 18.6 10.2 9.4 27.2 22.6 13.5 8.5 19.8 9.0 9.9 17.6 8.0 9.2 18.1 13.6 6.7 9.8 7.1 4.7 9.6 9.1 23.9 20.3 8.0 11.6 13.2 11.2 19.1 12.7 1.2 7.0 0.6 15.3 9.5 20.1 20.2 20.1 14.8 5.8 19.8 21.1 19.7 1.2 11.3 7.5 11.2 16.1 12.1 10.5 12.3 9.6 12.1 9.1 7.0 15.2 5.5 13.9 13.5 0.0 6.5 12.3 33.5 28.2 3.8 2.2 2.5 12.0 12.5 7.0 0.0 19.0 6.6 17.5 0.4 10.8 5.3 0.0 13.9 27.8 10.8 27.1 13.9 3.9 16.5 7.9 4.6 3.7 4.9 0.8 15.3 9.3 10.1 21.6 10.3 4.7 15.5 3.5 12.7 7.7 3.4 0.0 9.5 4.2 14.1 22.0 10.5 15.0 13.8 31.4 NR3C2 "MLR, MR" ENSG00000151623 "Nuclear receptor subfamily 3 group C member 2" P08235 4 148078762-148444698 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 47.2;Mucus-secreting cells: 43.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 4.8" "Lineage enriched" "Detected in single" 6 "T-cells: 4.8" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 11.1;HUVEC TERT2: 6.8;Karpas-707: 7.3;PC-3: 6.8;RPTEC TERT1: 9.1;TIME: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009155, HPA074979" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009155: AB_2155949, HPA074979: AB_2686724" "unprognostic (2.75e-3)" "unprognostic (2.63e-2)" "unprognostic (6.70e-3)" "unprognostic (1.52e-1)" "unprognostic (4.09e-1)" "unprognostic (7.82e-3)" "unprognostic (1.04e-2)" "unprognostic (1.11e-2)" "unprognostic (1.14e-1)" "unprognostic (4.35e-2)" "unprognostic (4.97e-2)" "unprognostic (2.39e-1)" "prognostic favorable (3.10e-11)" "unprognostic (1.42e-1)" "unprognostic (1.87e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" 7.0 5.6 9.0 12.9 9.5 1.5 7.2 16.8 14.5 8.2 23.4 8.2 6.5 9.7 7.2 4.8 3.8 7.1 10.2 9.7 12.7 6.5 13.8 9.6 8.2 4.2 7.5 7.7 17.0 8.6 22.5 16.7 2.4 5.7 5.9 28.4 12.1 16.9 9.6 12.1 4.6 26.5 8.6 6.5 5.7 9.0 4.8 6.5 2.2 21.7 7.6 5.0 10.7 5.6 0.8 0.0 0.0 0.4 0.1 4.8 0.4 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.0 0.1 0.0 0.5 0.0 0.1 1.5 2.9 1.1 0.2 0.0 1.6 0.8 0.1 0.3 2.8 0.3 0.7 0.0 0.0 1.8 0.4 0.1 0.0 0.1 0.0 11.1 6.8 1.1 0.0 7.3 2.3 0.0 0.0 0.0 0.1 1.3 6.8 0.6 0.0 0.1 9.1 0.1 0.1 0.1 0.0 1.6 0.7 0.1 0.8 0.0 8.9 4.8 2.8 0.2 0.9 0.0 0.0 0.1 1.6 0.6 1.2 0.0 0.0 0.0 1.5 0.0 4.8 0.4 1.8 1.2 0.0 0.8 2.9 2.9 0.0 0.1 0.4 0.0 0.5 0.4 9.0 9.5 16.8 14.5 12.7 6.5 7.5 7.7 5.7 6.5 26.8 11.5 3.5 1.7 1.8 8.9 17.5 10.2 5.3 10.3 10.4 17.7 0.7 8.3 3.1 47.2 4.9 35.4 0.0 5.1 0.2 3.1 1.8 5.7 4.0 0.5 12.7 17.3 6.2 3.7 30.6 4.0 0.9 6.8 1.0 43.5 7.3 3.7 23.4 3.5 1.7 9.3 0.0 3.1 1.2 4.9 1.5 0.1 0.0 20.3 1.8 NRDC "hNRD1, hNRD2, NRD1" ENSG00000078618 "Nardilysin convertase" O43847 1 51789191-51878937 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.4" "Group enriched" "Detected in many" 8 "Early spermatids: 492.5;Late spermatids: 1318.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053661 Approved Nucleoplasm NA NA Nucleoplasm "HPA053661: AB_2682221" "unprognostic (1.22e-1)" "unprognostic (6.52e-2)" "unprognostic (2.14e-2)" "unprognostic (5.62e-2)" "unprognostic (2.61e-1)" "unprognostic (3.25e-2)" "prognostic unfavorable (5.49e-6)" "unprognostic (1.42e-1)" "unprognostic (4.17e-2)" "unprognostic (1.67e-1)" "unprognostic (5.86e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.12e-9)" "unprognostic (2.75e-1)" "unprognostic (2.35e-2)" "unprognostic (9.54e-2)" "unprognostic (5.53e-3)" 16.4 15.9 13.4 15.8 17.5 14.5 11.7 14.7 16.9 12.2 13.7 11.0 9.9 11.2 11.8 12.1 14.4 10.9 10.9 25.7 13.1 13.3 12.4 28.5 12.0 13.6 16.2 10.6 11.7 15.9 19.3 21.4 14.2 15.7 13.8 12.1 9.8 11.9 11.3 96.4 19.1 10.3 13.3 14.0 13.6 11.9 32.3 14.5 19.4 11.7 21.5 15.1 13.0 16.0 13.8 18.5 36.3 19.1 15.8 15.1 16.2 46.9 26.5 26.6 38.1 28.0 43.3 30.9 47.5 41.1 34.6 36.7 18.5 18.6 31.0 25.4 35.7 46.4 27.4 39.0 36.8 43.8 36.7 19.2 37.0 36.0 16.1 28.7 32.3 28.2 34.4 28.2 50.4 46.8 29.8 35.9 33.0 48.7 20.8 43.2 17.2 29.2 11.2 47.2 19.4 28.5 28.6 31.8 34.2 25.5 27.3 25.5 19.2 43.3 34.9 25.7 53.9 23.3 39.3 29.8 30.4 28.2 33.1 40.3 31.1 46.9 29.0 35.9 40.7 34.8 19.3 18.1 26.0 13.7 19.1 13.7 13.8 12.7 15.1 18.5 9.3 12.5 13.4 36.3 15.8 14.5 15.0 14.4 16.2 13.4 17.5 14.7 16.9 13.1 13.3 16.2 10.6 15.7 14.5 32.8 55.9 17.8 35.3 0.0 67.0 0.0 17.8 108.4 63.7 26.2 76.6 47.3 26.6 38.1 492.5 33.3 18.8 70.0 55.1 37.0 33.6 42.0 32.5 52.9 39.9 58.8 17.5 28.3 38.2 1318.0 61.2 53.3 0.0 60.5 26.4 53.0 45.7 14.0 55.5 15.1 68.3 58.2 0.0 37.6 20.9 0.0 69.0 40.6 27.9 33.4 NRG1 "GGF, HGL, HRG, NDF, NRG1-IT2" ENSG00000157168 "Neuregulin 1" Q02297 8 31639386-32767959 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.3" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 35.7;Basal glandular cells: 36.6;Early spermatids: 31.2;Horizontal cells: 27.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "classical monocyte: 22.8" "Lineage enriched" "Detected in many" 5 "monocytes: 22.8" "Cell line enhanced" "Detected in many" "A549: 38.0;BJ: 26.0;fHDF/TERT166: 29.1;GAMG: 40.0;HBF TERT88: 25.6;hTEC/SVTERT24-B: 27.3;hTERT-HME1: 28.6" "Low region specificity" "Detected in all" HPA010964 Uncertain Approved Nucleoplasm "Secreted to blood" NA NA Nucleoplasm "HPA010964: AB_1854641" "unprognostic (5.76e-3)" "unprognostic (8.60e-2)" "unprognostic (1.96e-4)" "unprognostic (2.67e-1)" "unprognostic (1.94e-4)" "unprognostic (4.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.72e-2)" "unprognostic (2.98e-1)" "unprognostic (5.65e-2)" "unprognostic (7.99e-2)" "unprognostic (8.49e-2)" "unprognostic (4.47e-2)" "unprognostic (1.31e-1)" "unprognostic (2.88e-1)" "unprognostic (5.40e-2)" "unprognostic (7.83e-2)" 0.7 2.1 4.6 5.0 3.3 1.2 8.8 14.8 8.1 10.6 4.2 0.3 2.1 3.5 2.5 1.1 3.7 2.0 4.8 2.2 4.7 15.4 11.5 23.6 5.7 0.6 6.2 3.5 2.9 0.9 0.8 23.9 0.2 28.3 3.2 5.4 3.6 2.5 1.6 0.2 4.3 5.7 1.1 2.5 1.7 3.1 6.4 0.8 0.2 13.8 7.2 2.2 7.2 3.5 0.0 4.9 0.8 22.8 0.0 0.0 4.6 0.1 38.0 0.6 0.0 0.3 0.7 0.0 26.0 18.4 21.6 16.6 0.0 0.8 0.0 4.8 29.1 40.0 20.5 0.1 10.4 25.6 0.0 0.2 0.5 0.5 0.5 0.1 0.0 0.0 0.3 1.1 27.3 28.6 1.9 12.4 0.0 0.0 0.1 7.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 16.0 1.1 1.1 1.3 1.9 0.0 0.0 2.1 0.0 0.0 9.0 15.0 4.6 23.9 14.5 0.0 0.0 0.2 7.7 0.0 1.8 0.0 22.8 0.2 0.0 2.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.6 4.6 3.3 14.8 8.1 4.7 15.4 6.2 3.5 28.3 0.8 35.7 2.4 0.5 36.6 23.1 11.2 1.7 10.2 4.0 13.6 3.5 7.9 0.0 8.3 1.8 31.2 1.4 0.0 0.0 0.2 0.0 0.7 14.3 1.1 6.6 0.5 27.0 0.0 6.7 16.0 14.6 0.3 1.8 1.7 0.0 0.0 4.8 0.8 0.0 0.4 14.6 3.0 0.0 0.9 1.4 1.0 5.4 0.0 0.0 0.0 5.6 NSD2 "KMT3G, MMSET, WHSC1" ENSG00000109685 "Nuclear receptor binding SET domain protein 2" O96028 4 1871424-1982207 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 17.3;Ciliated cells: 13.4;Club cells: 14.8;Collecting duct cells: 12.2;Hofbauer cells: 11.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015801, CAB068246, CAB068247" Enhanced Supported Nucleoplasm No No Nucleoplasm "CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830" "unprognostic (3.70e-1)" "unprognostic (9.80e-2)" "unprognostic (3.33e-2)" "unprognostic (1.77e-1)" "unprognostic (4.01e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (2.61e-4)" "unprognostic (3.24e-2)" "unprognostic (6.22e-2)" "unprognostic (7.66e-2)" "unprognostic (2.09e-1)" "unprognostic (9.25e-3)" "prognostic unfavorable (7.19e-4)" "unprognostic (3.89e-2)" "unprognostic (2.95e-1)" "unprognostic (1.31e-1)" "unprognostic (6.15e-2)" 8.7 7.6 17.6 11.5 16.2 35.1 8.5 20.6 18.2 7.0 14.8 12.4 6.3 14.0 9.5 7.4 12.7 6.8 6.9 11.9 15.1 10.9 8.4 7.5 11.1 18.8 14.7 16.1 7.0 11.7 10.7 11.8 9.8 14.6 8.7 17.7 9.4 10.2 7.4 11.8 12.1 14.6 10.5 15.3 13.5 11.0 26.3 13.4 46.7 13.8 5.5 17.7 8.6 9.4 4.9 3.9 4.1 1.8 2.7 4.3 0.6 27.7 14.0 42.3 18.5 4.6 6.8 12.3 22.4 19.9 27.5 30.8 12.4 33.0 29.9 7.7 18.5 36.0 12.1 27.3 18.5 47.3 14.3 11.3 35.6 19.4 7.3 5.8 21.8 18.7 2.6 4.7 24.1 23.2 15.2 21.6 30.2 19.3 31.4 22.5 10.9 58.1 22.9 17.8 14.1 16.2 33.2 27.6 10.3 11.3 13.2 26.3 21.0 18.4 6.9 8.4 19.2 16.3 14.6 16.7 27.5 20.5 17.4 45.1 14.7 15.5 27.1 16.5 21.6 25.5 2.1 1.7 1.7 2.9 1.8 3.2 1.8 3.2 3.2 1.5 4.9 2.8 2.3 4.1 2.7 1.4 3.9 4.3 0.6 17.6 16.2 20.6 18.2 15.1 10.9 14.7 16.1 14.6 13.4 11.9 17.3 0.0 0.0 0.0 0.0 0.0 0.0 13.4 14.8 12.2 0.0 10.0 3.3 10.2 0.0 0.0 0.0 0.0 6.1 7.3 0.0 0.0 2.3 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 10.0 0.0 0.0 10.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 NSMCE4A "bA500G22.3, C10orf86, FLJ20003, NSE4A" ENSG00000107672 "NSE4 homolog A, SMC5-SMC6 complex component" Q9NXX6 10 121957088-121975217 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037459, HPA038412, HPA044872" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037459: AB_10696932, HPA038412: AB_2676005, HPA044872: AB_2679124" "unprognostic (1.16e-3)" "unprognostic (2.86e-2)" "unprognostic (1.56e-1)" "unprognostic (3.73e-2)" "unprognostic (4.09e-3)" "unprognostic (2.18e-2)" "unprognostic (1.64e-1)" "prognostic favorable (2.72e-5)" "unprognostic (3.16e-2)" "unprognostic (7.47e-2)" "unprognostic (1.08e-1)" "unprognostic (6.44e-3)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.64e-1)" "unprognostic (8.13e-2)" "unprognostic (1.35e-1)" "unprognostic (7.01e-3)" 21.8 17.7 11.1 27.1 17.6 16.2 26.0 14.0 12.5 23.7 26.6 14.0 14.3 22.8 20.8 17.1 22.3 18.0 16.7 17.8 11.0 8.2 15.4 23.0 22.3 22.2 18.5 12.6 20.0 24.3 13.3 10.5 15.5 12.2 21.1 20.3 15.2 24.5 23.0 15.9 14.6 26.1 26.9 12.2 20.0 23.7 6.5 16.8 23.3 21.8 15.8 20.6 26.7 16.8 24.0 24.9 8.8 17.6 18.7 22.4 17.2 16.8 20.8 22.3 19.9 7.9 10.4 16.5 9.5 17.1 16.4 22.9 16.0 13.2 22.5 7.4 7.5 9.0 14.7 13.1 10.4 13.0 27.0 30.9 14.8 7.1 29.9 6.7 16.6 10.4 7.0 8.0 9.6 15.7 9.2 17.3 20.7 13.5 16.3 9.1 13.7 30.2 24.5 11.7 12.1 16.4 26.1 17.4 24.2 11.2 14.1 6.1 12.0 10.8 7.4 14.7 9.4 8.1 15.9 14.0 6.5 11.7 10.9 19.6 21.8 23.1 34.7 8.1 22.7 6.9 0.1 15.4 8.8 15.3 17.6 17.7 24.0 20.6 19.8 15.9 21.7 21.8 17.7 1.4 18.7 17.1 24.9 22.4 17.2 11.1 17.6 14.0 12.5 11.0 8.2 18.5 12.6 12.2 16.8 20.8 27.8 29.6 39.9 15.0 20.2 17.1 25.5 17.4 20.5 12.2 31.4 41.8 29.9 24.3 0.3 29.5 27.6 46.7 53.2 31.1 22.0 38.1 11.5 31.4 31.1 25.4 20.7 17.2 18.3 0.4 32.8 19.0 20.3 55.1 31.7 29.1 29.2 37.6 31.5 30.2 36.0 25.8 24.5 6.1 11.7 18.9 55.4 25.8 40.3 43.9 NSMF NELF ENSG00000165802 "NMDA receptor synaptonuclear signaling and neuronal migration factor" Q6X4W1 9 137447573-137459334 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 96.4" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 12.1;non-classical monocyte: 10.5" "Group enriched" "Detected in many" 5 "dendritic cells: 6.0;granulocytes: 3.1;monocytes: 12.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044316 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA044316: AB_10964877" "unprognostic (1.48e-1)" "unprognostic (4.03e-2)" "unprognostic (5.40e-2)" "unprognostic (3.92e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-1)" "unprognostic (7.96e-2)" "unprognostic (3.26e-2)" "unprognostic (2.38e-3)" "unprognostic (2.34e-3)" "prognostic favorable (1.85e-6)" "unprognostic (1.97e-2)" "unprognostic (4.14e-2)" "unprognostic (4.61e-2)" "unprognostic (3.97e-2)" 8.8 8.8 61.7 6.9 34.4 6.1 5.3 6.4 67.3 6.0 8.1 18.2 2.1 16.9 8.6 6.6 6.6 7.2 5.7 5.0 96.4 21.8 15.3 6.2 5.2 6.9 20.4 30.2 5.0 14.7 10.8 13.7 4.2 12.1 9.0 6.3 5.4 11.5 8.7 4.0 9.7 13.7 8.2 9.6 6.8 9.6 7.8 15.0 2.4 5.1 1.3 5.8 6.4 3.8 0.2 6.0 3.1 12.1 0.0 1.5 1.4 7.7 6.3 11.1 16.6 26.2 12.4 9.6 7.5 9.9 7.1 5.5 16.7 4.6 9.6 10.1 11.0 16.0 23.6 16.4 10.0 4.3 12.6 17.6 7.5 14.8 22.1 14.2 5.1 17.2 14.1 19.2 8.3 19.5 16.2 7.5 0.2 17.2 1.6 9.6 17.9 0.2 22.1 14.2 31.2 16.9 4.6 17.7 21.5 4.9 3.9 46.9 38.2 17.9 10.0 11.2 4.8 7.1 10.6 19.0 12.7 10.4 30.7 12.6 3.4 5.2 14.7 7.2 6.8 11.6 1.5 2.0 3.1 1.5 12.1 0.2 0.2 0.5 0.9 6.0 0.1 0.6 0.7 0.3 0.0 10.5 0.2 0.7 1.4 61.7 34.4 6.4 62.9 96.4 21.8 20.4 30.2 12.1 15.0 0.0 4.6 5.1 6.4 12.0 7.2 4.4 15.3 1.4 0.0 10.4 7.9 0.3 5.0 7.8 6.1 9.9 41.2 0.0 18.2 1.0 8.2 16.2 2.3 18.3 5.6 27.0 18.4 11.6 8.9 11.4 22.2 5.9 15.1 4.6 15.7 10.4 18.9 17.5 67.1 26.7 13.1 12.9 13.0 2.5 5.3 12.8 1.3 5.7 11.5 13.9 NSRP1 "CCDC55, DKFZP434K1421, NSrp70" ENSG00000126653 "Nuclear speckle splicing regulatory protein 1" Q9H0G5 17 30115521-30186475 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015593, HPA015603" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA015593: AB_2072217, HPA015603: AB_1846157" "unprognostic (3.96e-1)" "unprognostic (2.16e-2)" "unprognostic (5.45e-2)" "unprognostic (1.69e-1)" "unprognostic (1.34e-1)" "unprognostic (1.89e-1)" "unprognostic (7.76e-2)" "unprognostic (1.83e-1)" "unprognostic (5.93e-3)" "unprognostic (6.12e-2)" "unprognostic (2.21e-1)" "unprognostic (3.08e-2)" "unprognostic (1.31e-3)" "unprognostic (2.02e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (2.43e-1)" 25.7 21.2 26.4 25.7 36.7 25.7 23.5 28.8 28.2 22.2 25.0 24.3 28.1 18.1 25.1 25.5 21.8 21.3 21.9 26.6 25.7 23.2 23.0 21.3 20.4 22.0 33.9 20.5 26.0 28.3 31.9 37.4 23.6 28.9 23.2 20.2 16.2 22.6 23.4 43.5 27.9 19.6 34.7 52.1 21.7 21.2 21.2 36.0 18.6 28.4 19.2 20.5 34.3 27.2 28.9 31.4 31.0 21.2 16.1 19.4 7.3 13.9 12.5 12.2 9.9 17.1 16.4 8.8 19.3 19.9 14.9 16.2 13.2 9.1 25.4 15.7 18.4 18.3 20.6 19.2 14.9 24.5 6.2 26.3 11.6 19.6 9.4 27.4 17.9 14.2 18.6 20.0 23.7 31.0 17.6 14.1 9.6 18.3 17.1 20.7 10.4 11.9 17.8 8.2 15.5 10.4 14.0 20.1 17.2 15.5 15.1 11.7 10.2 14.6 39.7 17.4 13.2 20.8 20.4 15.1 18.0 12.7 18.8 30.5 12.2 16.3 20.7 22.2 16.4 20.5 25.8 21.2 16.1 17.2 19.0 19.1 28.2 19.4 16.8 10.6 28.9 19.1 17.2 31.0 16.1 20.1 31.4 16.9 7.3 26.4 36.7 28.8 28.2 25.7 23.2 33.9 20.5 28.9 36.0 71.5 85.0 35.0 70.6 60.0 57.9 124.7 79.0 97.7 79.6 80.3 33.4 52.8 82.9 60.8 192.3 96.7 47.9 116.8 65.5 55.1 58.2 56.2 78.8 122.8 48.3 69.9 30.1 86.5 53.4 93.6 71.4 64.6 47.2 68.5 45.6 77.5 57.2 49.1 67.1 60.4 53.0 71.1 86.5 132.5 80.5 45.5 92.7 37.4 46.3 48.7 NSUN2 "FLJ20303, Misu, MRT5, TRM4" ENSG00000037474 "NOP2/Sun RNA methyltransferase family member 2" Q08J23 5 6599239-6633291 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis, tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037896 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA037896: AB_10670532" "unprognostic (3.99e-2)" "unprognostic (5.73e-2)" "unprognostic (1.44e-1)" "unprognostic (7.66e-3)" "unprognostic (8.56e-2)" "unprognostic (5.21e-2)" "unprognostic (1.44e-3)" "unprognostic (5.12e-2)" "unprognostic (4.48e-2)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (2.48e-2)" "prognostic unfavorable (5.69e-5)" "unprognostic (1.98e-1)" "unprognostic (1.47e-1)" "unprognostic (4.30e-3)" "unprognostic (1.70e-2)" 19.0 19.1 11.3 20.4 17.4 16.7 28.1 13.4 16.0 17.4 17.9 20.2 18.2 15.4 21.5 20.6 27.0 19.3 17.1 20.1 12.7 9.7 15.0 34.9 15.0 22.5 13.6 16.5 17.2 18.7 19.5 22.3 18.2 16.1 15.5 21.2 14.3 20.0 15.8 42.3 22.9 20.9 19.1 15.9 23.7 19.9 15.8 13.2 26.7 14.3 17.1 29.5 19.2 17.1 18.1 16.7 15.6 17.3 17.6 22.7 12.7 27.2 23.7 13.9 12.3 8.9 9.9 32.9 21.4 13.0 22.8 19.8 30.8 20.5 47.1 21.9 17.1 28.7 21.0 28.8 24.9 31.0 32.1 23.3 28.0 56.2 17.9 12.8 48.3 22.7 11.3 18.4 25.8 22.6 9.2 16.1 19.8 36.1 17.3 21.1 19.1 26.4 20.9 23.1 18.4 31.0 34.4 14.6 14.5 16.0 30.3 13.3 18.9 52.8 26.8 20.6 18.8 23.4 21.6 18.8 18.2 24.0 18.8 31.8 14.3 26.8 45.2 14.6 38.5 20.9 9.7 14.6 15.6 17.5 17.3 22.7 18.1 18.4 20.7 16.7 16.5 20.4 20.6 2.9 17.6 15.2 16.5 13.0 12.7 11.3 17.4 13.4 16.0 12.7 9.7 13.6 16.5 16.1 13.2 17.9 14.5 12.9 11.7 33.5 5.3 16.1 17.8 17.4 39.8 17.4 13.7 17.1 8.3 18.8 2.2 12.1 10.5 0.0 13.1 17.7 12.1 13.9 19.7 28.4 12.9 3.2 14.3 9.8 22.4 2.2 12.0 14.6 15.1 19.0 15.5 6.8 19.7 14.1 13.4 8.4 6.8 6.5 13.0 13.5 18.7 26.7 19.3 14.1 17.8 12.8 NUDT13 DKFZp586P2219 ENSG00000166321 "Nudix hydrolase 13" Q86X67 10 73110375-73131828 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040636 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA040636: AB_10960360" "unprognostic (3.75e-1)" "unprognostic (3.85e-1)" "unprognostic (1.07e-1)" "unprognostic (2.48e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.33e-1)" "unprognostic (2.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.60e-1)" "unprognostic (9.40e-2)" "unprognostic (5.07e-4)" "unprognostic (1.91e-1)" "unprognostic (3.82e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (5.96e-2)" 4.3 7.4 3.7 9.9 8.9 5.0 6.3 3.5 5.1 3.4 8.1 7.2 9.5 7.0 6.5 13.8 3.8 4.5 7.0 7.0 5.9 3.0 7.1 12.8 5.1 5.3 7.3 4.5 4.4 7.8 7.4 4.1 3.6 5.8 5.2 4.7 3.7 5.0 8.8 8.6 7.2 5.8 5.2 11.8 5.8 6.0 5.6 7.2 2.4 4.6 2.8 4.8 6.8 3.7 6.2 1.9 2.5 3.4 4.9 3.7 1.1 5.1 3.7 6.0 7.5 3.8 3.2 1.3 4.6 4.1 2.4 2.7 9.7 10.8 2.5 2.3 2.8 3.9 6.1 0.6 4.3 2.4 1.9 10.5 7.0 6.0 5.3 0.3 3.9 2.9 2.3 4.7 3.1 1.7 6.4 1.8 4.6 5.9 4.0 2.4 2.4 2.3 5.6 2.3 3.3 11.9 5.1 1.0 0.2 3.3 2.4 2.7 3.9 2.5 6.2 2.0 2.7 3.4 2.5 3.4 2.1 8.2 0.8 1.7 2.9 3.3 3.4 5.9 7.2 2.0 0.1 2.6 2.5 1.8 2.5 2.1 3.0 1.5 1.6 1.9 6.2 2.3 2.4 1.0 4.9 3.4 0.6 3.7 1.1 3.7 8.9 3.5 5.1 5.9 3.0 7.3 4.5 5.8 7.2 6.0 1.3 2.2 2.3 0.8 1.3 6.2 0.0 6.7 2.3 3.5 3.9 3.0 3.3 1.6 2.6 1.0 1.2 0.0 0.6 0.7 1.3 1.4 0.0 3.2 1.5 0.0 1.2 0.6 1.3 3.4 0.9 1.5 0.0 1.8 1.8 0.8 1.2 2.9 0.7 4.1 1.7 0.0 1.0 3.2 0.5 1.3 0.9 0.0 1.3 0.9 NUDT15 "FLJ10956, MTH2" ENSG00000136159 "Nudix hydrolase 15" Q9NV35 13 48037567-48047222 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038968, HPA038969" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA038968: AB_10697402, HPA038969: AB_2676295" "unprognostic (9.48e-2)" "unprognostic (5.91e-3)" "unprognostic (2.64e-2)" "unprognostic (9.00e-3)" "unprognostic (4.99e-2)" "unprognostic (2.50e-3)" "unprognostic (2.29e-2)" "unprognostic (7.47e-3)" "prognostic unfavorable (1.25e-5)" "unprognostic (1.04e-1)" "unprognostic (8.50e-2)" "unprognostic (3.69e-1)" "unprognostic (4.63e-2)" "unprognostic (1.84e-3)" "unprognostic (3.35e-1)" "unprognostic (9.58e-2)" "unprognostic (8.93e-3)" 15.0 15.2 11.4 16.6 14.6 16.5 18.0 14.1 17.7 14.8 21.1 9.5 14.3 22.1 11.1 15.5 23.8 12.8 13.5 13.3 10.5 15.7 20.3 21.3 11.1 7.4 12.8 11.1 13.0 13.8 6.1 18.6 14.2 15.8 16.9 24.1 8.2 14.1 12.6 15.9 10.8 20.5 11.3 11.9 9.6 13.9 22.2 10.6 11.6 22.3 24.1 12.0 12.1 14.2 4.7 7.0 4.6 9.9 3.8 9.2 4.1 19.6 11.9 22.4 9.9 9.2 13.4 16.5 16.0 15.1 17.7 17.2 17.6 19.1 14.6 9.1 12.6 15.9 23.2 21.7 23.5 27.4 7.6 18.7 14.2 11.7 19.1 8.6 21.2 13.6 9.2 15.1 14.3 20.2 8.0 19.1 14.7 12.5 5.8 28.4 9.6 16.7 20.1 35.9 30.1 14.2 11.5 14.5 9.5 19.7 15.0 13.6 14.5 10.9 18.8 12.4 20.1 9.6 16.1 9.8 12.5 15.2 15.6 22.0 3.1 5.1 18.3 6.5 16.7 20.1 2.1 7.3 4.6 4.6 9.9 4.5 4.7 7.4 5.8 7.0 4.7 8.8 9.2 1.6 3.8 6.7 5.6 5.0 4.1 11.4 14.6 14.1 17.7 10.5 15.7 12.8 11.1 15.8 10.6 11.9 11.2 7.5 29.2 14.7 7.3 10.8 15.3 12.0 20.5 7.0 2.0 29.2 41.4 15.1 13.5 11.7 22.0 0.0 15.4 67.2 13.0 26.5 9.2 14.7 14.6 36.5 8.1 8.0 6.7 7.2 15.5 9.6 10.1 10.8 19.4 7.7 12.6 11.5 11.7 33.4 7.1 0.0 21.2 5.8 30.2 17.9 31.8 5.7 29.5 30.3 NUDT2 APAH1 ENSG00000164978 "Nudix hydrolase 2" P50583 9 34329506-34343713 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004684, HPA044903, HPA058623, HPA067639" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB004684: AB_425306, HPA044903: AB_2679139, HPA058623: AB_2683780, HPA067639: AB_2685877" "unprognostic (2.74e-3)" "unprognostic (2.58e-2)" "unprognostic (3.37e-1)" "unprognostic (2.05e-3)" "unprognostic (3.08e-1)" "unprognostic (2.39e-1)" "unprognostic (1.24e-1)" "unprognostic (6.55e-2)" "unprognostic (7.06e-2)" "unprognostic (3.05e-3)" "unprognostic (1.18e-2)" "unprognostic (2.80e-1)" "unprognostic (2.77e-2)" "unprognostic (6.24e-2)" "unprognostic (1.72e-1)" "unprognostic (1.23e-1)" "unprognostic (1.91e-1)" 12.0 18.0 21.6 9.6 21.9 10.2 20.6 14.0 25.5 14.9 14.9 26.0 15.4 12.8 15.7 30.2 14.5 20.5 12.3 16.0 17.3 18.6 10.7 17.5 11.2 12.2 19.5 19.0 28.3 20.9 12.0 19.0 14.1 20.5 16.5 15.3 15.7 16.1 13.0 30.8 13.9 10.1 14.7 20.7 11.3 13.0 8.6 19.1 18.6 3.8 13.2 13.8 14.4 12.1 16.6 15.8 14.3 12.2 14.3 22.2 11.2 23.8 9.8 12.8 4.5 8.8 16.3 9.2 11.5 26.1 13.3 14.0 6.7 11.3 6.6 9.6 14.3 5.1 10.5 11.5 28.4 13.6 24.8 10.3 14.3 18.5 12.6 25.6 11.0 5.9 16.5 18.4 17.2 32.4 18.2 27.5 23.2 4.0 27.1 19.5 14.8 11.4 10.3 7.9 10.6 28.3 14.8 8.0 16.7 13.1 7.8 2.6 10.4 18.7 7.1 10.8 12.0 5.7 11.9 17.7 11.5 10.4 7.5 11.9 6.1 9.9 11.7 14.4 10.6 14.3 14.3 12.2 9.7 11.7 10.3 16.7 16.6 19.2 15.2 15.8 15.0 22.2 19.6 4.5 14.3 10.7 14.7 19.7 11.2 21.6 21.9 14.0 25.5 17.3 18.6 19.5 19.0 20.5 19.1 3.0 5.5 15.9 17.8 25.0 13.1 18.6 43.3 17.4 11.4 15.7 5.9 33.9 74.6 22.6 9.7 21.5 18.6 0.0 34.7 35.6 23.1 17.1 12.7 31.0 32.5 7.9 21.4 30.1 38.4 21.8 25.3 23.9 21.9 32.5 29.1 16.2 26.1 26.9 18.0 39.6 12.8 25.8 23.6 35.8 17.5 27.6 15.8 25.3 31.4 15.7 NUDT22 MGC13045 ENSG00000149761 "Nudix hydrolase 22" Q9BRQ3 11 64225941-64230686 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039334, HPA053464" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA039334: AB_10795174, HPA053464: AB_2682160" "unprognostic (2.72e-1)" "unprognostic (3.77e-1)" "unprognostic (1.86e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (9.75e-2)" "unprognostic (1.73e-3)" "unprognostic (1.98e-1)" "unprognostic (1.15e-1)" "unprognostic (1.43e-1)" "unprognostic (7.65e-2)" "unprognostic (6.61e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.76e-2)" "unprognostic (1.50e-1)" "unprognostic (1.71e-1)" "unprognostic (8.54e-2)" 9.2 16.8 8.1 16.0 9.2 14.3 9.8 7.3 12.8 9.2 24.2 9.1 30.9 29.6 9.1 16.9 17.8 9.0 16.7 23.4 8.3 7.0 21.1 30.1 10.2 15.9 10.5 8.4 7.9 26.4 13.8 12.2 14.7 8.6 12.3 8.5 9.0 28.6 35.2 24.9 12.9 23.7 11.4 7.8 20.5 18.5 7.8 7.7 19.5 15.4 15.7 19.6 13.5 9.4 30.0 49.1 20.0 33.9 19.2 25.0 20.1 14.7 9.4 2.4 9.9 3.6 4.4 9.0 6.2 6.5 4.5 4.2 6.1 12.6 7.0 16.5 6.2 6.8 15.5 1.4 9.9 0.6 9.0 4.0 9.4 6.9 6.3 10.8 6.0 15.7 6.8 7.4 4.8 5.1 3.4 7.3 8.4 4.6 7.7 5.3 22.1 8.4 11.2 3.7 9.1 19.9 10.4 4.0 26.0 7.8 8.2 5.5 8.8 5.5 20.9 24.8 0.9 21.3 6.9 6.7 7.6 7.2 23.8 5.3 28.9 11.4 4.4 26.1 7.1 8.8 13.8 28.7 20.0 23.0 33.9 20.5 25.3 20.3 22.4 29.1 30.0 18.0 19.6 17.3 19.2 31.8 49.1 25.0 20.1 8.1 9.2 7.3 12.8 8.3 7.0 10.5 8.4 8.6 7.7 3.0 13.4 41.3 23.3 10.6 12.3 3.1 61.1 4.0 6.8 38.4 11.8 92.1 139.3 53.1 12.7 17.7 92.0 0.0 76.6 42.4 24.2 26.6 14.0 47.8 50.9 28.6 35.7 27.0 50.0 6.5 18.7 38.1 32.1 73.9 66.5 25.6 56.4 92.1 18.4 113.9 16.8 12.9 20.6 4.9 8.3 15.3 56.4 39.2 56.2 28.8 NUP37 "FLJ22618, MGC5585" ENSG00000075188 "Nucleoporin 37" Q8NFH4 12 102073103-102120124 "Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Extravillous trophoblasts: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056300, HPA073708" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA056300: AB_2683092, HPA073708: AB_2686629" "unprognostic (1.42e-3)" "unprognostic (5.39e-2)" "unprognostic (3.31e-2)" "unprognostic (1.03e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.72e-4)" "prognostic unfavorable (7.70e-6)" "unprognostic (2.48e-3)" "unprognostic (2.37e-3)" "unprognostic (7.77e-2)" "unprognostic (2.90e-3)" "unprognostic (1.67e-2)" "unprognostic (7.47e-2)" "unprognostic (5.55e-2)" "unprognostic (1.88e-1)" "unprognostic (3.06e-1)" "unprognostic (3.64e-1)" 11.1 18.4 6.0 17.5 7.7 12.6 12.8 8.1 7.4 12.4 12.8 8.7 14.9 8.1 13.0 14.7 22.0 12.6 7.8 12.3 5.7 5.4 11.4 8.6 9.0 16.4 6.0 5.1 12.6 11.7 12.6 15.2 17.6 10.6 13.7 16.0 11.2 11.7 9.6 18.0 11.3 14.5 11.4 9.3 16.5 11.5 17.8 6.2 28.4 16.4 18.5 20.8 13.6 11.0 19.4 18.1 30.6 17.2 13.2 26.7 13.0 32.0 23.7 20.9 9.5 17.3 23.0 46.3 20.7 19.5 32.7 22.4 30.2 17.5 21.8 14.8 16.0 22.6 23.8 36.5 32.0 41.1 30.7 20.8 23.4 12.8 27.0 22.1 33.0 7.4 17.7 14.1 25.4 18.9 21.9 26.6 29.1 41.4 8.3 30.2 22.3 24.5 27.4 20.6 30.2 37.9 16.2 29.6 16.5 25.7 24.2 10.9 7.8 15.6 16.8 14.8 24.6 29.4 19.2 8.6 11.8 12.9 16.5 28.3 12.6 23.8 37.4 13.5 27.0 19.7 30.6 14.7 16.4 13.8 17.2 15.0 19.4 16.9 14.0 18.1 17.7 15.3 17.3 4.3 13.2 14.2 15.3 26.7 13.0 6.0 7.7 8.1 7.4 5.7 5.4 6.0 5.1 10.6 6.2 6.0 11.0 22.6 21.0 10.1 7.4 7.9 22.9 28.1 11.4 15.7 7.9 61.2 21.6 20.4 2.3 14.2 9.2 23.3 17.3 79.0 11.7 10.2 7.0 8.6 31.3 3.2 5.8 10.4 14.3 4.0 18.1 16.9 6.8 19.8 15.7 17.6 16.1 10.5 17.7 18.0 17.2 19.4 10.3 50.2 37.0 8.3 33.6 17.3 20.7 10.6 NUP54 ENSG00000138750 "Nucleoporin 54" Q7Z3B4 4 76114659-76148515 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035929, HPA058122" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035929: AB_10671236, HPA058122: AB_2683613" "unprognostic (6.70e-2)" "unprognostic (3.51e-2)" "prognostic favorable (8.80e-4)" "unprognostic (3.02e-1)" "unprognostic (3.58e-2)" "unprognostic (4.24e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (1.51e-3)" "unprognostic (3.05e-2)" "unprognostic (1.62e-1)" "unprognostic (2.49e-3)" "unprognostic (3.36e-2)" "unprognostic (2.10e-2)" "unprognostic (1.22e-1)" "unprognostic (2.01e-1)" "unprognostic (1.83e-1)" "unprognostic (3.65e-3)" 23.7 14.5 13.5 18.2 15.2 28.4 25.7 26.0 17.2 23.1 20.0 14.6 17.9 15.3 22.9 18.2 21.4 22.5 15.1 17.0 12.2 10.8 16.4 20.3 17.8 22.8 20.5 13.1 25.3 19.3 13.3 16.8 22.8 14.9 19.8 19.7 12.2 20.0 24.1 17.8 21.2 18.4 24.7 14.7 23.6 19.2 19.6 20.0 36.1 19.8 18.1 22.1 24.1 21.8 10.0 11.4 7.7 10.0 21.6 16.5 7.5 17.1 6.8 21.8 15.7 18.6 17.8 19.2 17.4 25.1 25.8 26.6 16.0 24.6 26.0 14.7 17.3 14.0 11.6 23.4 19.4 32.4 17.1 13.7 15.7 8.5 15.2 17.6 30.4 19.0 16.2 14.0 20.4 21.7 11.4 22.1 17.1 26.9 16.4 18.6 15.0 32.0 14.3 34.9 20.9 6.1 25.1 34.4 9.9 15.3 16.5 13.2 11.0 16.1 19.1 14.0 17.8 8.1 18.7 14.7 20.8 18.6 24.7 21.1 10.7 3.9 24.8 14.8 17.9 18.2 6.5 7.5 7.7 12.2 9.0 16.5 9.0 12.9 11.7 11.4 10.0 13.8 13.0 3.5 21.6 10.0 8.4 12.5 7.5 13.5 15.2 26.0 17.2 12.2 10.8 20.5 13.1 14.9 20.0 20.8 11.8 23.1 37.0 31.3 13.7 9.9 7.6 18.7 12.5 10.4 19.6 36.3 24.9 18.9 7.9 20.4 11.5 0.0 24.2 38.9 30.9 23.1 23.1 11.9 19.3 7.9 13.8 18.4 18.3 5.6 25.3 17.0 16.9 30.7 18.4 11.8 15.9 21.0 24.4 17.2 19.1 32.3 26.8 38.4 40.1 25.5 32.7 27.7 21.7 29.4 NUP88 MGC8530 ENSG00000108559 "Nucleoporin 88" Q99567 17 5360963-5420160 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 103.0;Spermatocytes: 115.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002209, HPA021816" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB002209: AB_564128, HPA021816: AB_1854725" "unprognostic (3.46e-2)" "unprognostic (1.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.83e-2)" "unprognostic (1.05e-1)" "unprognostic (2.03e-1)" "unprognostic (3.38e-2)" "unprognostic (3.94e-1)" "unprognostic (4.72e-2)" "unprognostic (4.94e-2)" "unprognostic (2.04e-2)" "unprognostic (5.75e-3)" "unprognostic (1.49e-1)" "unprognostic (1.10e-1)" "unprognostic (9.03e-2)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" 10.8 12.4 8.1 17.2 8.8 13.2 14.1 15.0 9.2 9.0 12.5 6.6 8.1 7.4 10.1 12.2 13.1 10.5 7.7 15.3 8.0 5.6 11.3 25.7 9.1 17.8 6.9 6.9 9.9 11.1 11.9 12.4 10.0 7.5 9.6 14.3 6.9 11.7 12.5 33.4 11.8 12.4 10.2 7.7 20.0 11.4 34.4 8.4 28.9 15.8 10.3 23.1 10.9 10.5 24.2 7.4 3.5 8.6 12.2 10.5 7.4 20.6 22.8 18.4 15.5 8.8 9.0 19.9 15.8 14.2 29.2 26.7 19.5 8.7 37.6 6.5 15.4 16.8 20.9 31.7 18.7 32.5 10.4 21.8 16.4 20.4 14.2 12.4 13.4 17.3 6.7 13.6 21.6 33.3 10.4 19.9 15.1 18.7 9.9 20.3 10.0 20.5 9.2 19.4 19.6 11.5 20.2 20.8 18.0 13.4 9.5 8.0 15.5 19.4 9.4 11.8 15.2 10.5 15.6 12.2 12.4 14.1 13.0 28.8 6.4 8.4 18.6 14.7 15.1 19.1 3.5 4.9 2.2 8.2 7.3 8.1 24.2 9.1 9.8 6.9 23.2 9.5 10.1 0.5 12.2 8.6 7.4 10.5 7.4 8.1 8.8 15.0 9.2 8.0 5.6 6.9 6.9 7.5 8.4 11.9 16.2 36.6 23.6 19.7 12.9 8.9 12.7 13.4 19.4 15.7 15.7 27.0 10.0 20.2 103.0 8.5 8.8 0.0 22.2 20.9 10.1 18.0 7.0 15.8 10.5 9.5 13.2 8.0 4.1 21.6 14.1 11.5 3.3 18.0 9.1 8.9 19.4 14.0 10.3 7.0 10.4 12.9 13.2 115.8 53.5 14.9 30.1 18.1 16.8 38.1 NUPL2 "CG1, H_RG271G13.9, hCG1, NLP_1" ENSG00000136243 "Nucleoporin like 2" O15504 7 23181827-23201011 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Early spermatids: 230.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049036, HPA057251" Supported Nucleoplasm No No Nucleoplasm "HPA049036: , HPA057251: " "unprognostic (3.81e-2)" "unprognostic (2.53e-1)" "unprognostic (3.97e-1)" "unprognostic (3.87e-1)" "unprognostic (4.16e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-3)" "unprognostic (2.16e-1)" "unprognostic (1.09e-2)" "unprognostic (1.42e-2)" "unprognostic (1.30e-3)" "unprognostic (2.07e-2)" "unprognostic (4.74e-3)" "unprognostic (1.32e-1)" "unprognostic (2.00e-3)" "unprognostic (3.59e-1)" "unprognostic (1.32e-2)" 13.3 21.1 19.4 27.0 17.1 23.3 14.4 25.9 30.4 15.4 16.4 12.3 26.8 15.4 19.5 26.5 17.9 17.7 18.7 24.3 16.1 16.1 17.8 16.2 14.7 23.2 14.9 19.9 16.7 14.6 22.3 19.7 10.8 15.2 16.5 16.9 12.5 20.3 20.8 16.9 21.6 14.9 19.1 14.6 20.1 15.2 32.2 16.9 19.7 20.8 16.8 19.6 17.7 16.7 16.4 13.8 22.9 8.7 13.9 12.3 9.8 12.1 7.0 9.0 17.0 8.9 11.4 6.6 10.1 7.6 10.8 11.4 9.0 13.6 20.4 9.0 7.0 24.3 14.7 15.5 8.8 13.5 5.9 16.4 14.1 14.9 8.9 11.1 28.7 17.2 5.5 10.7 10.3 6.6 8.3 11.3 11.5 23.7 14.4 10.7 3.5 13.7 16.7 17.1 14.9 10.0 12.6 8.1 15.3 11.9 9.3 11.9 11.4 10.6 5.6 15.6 15.1 7.1 31.4 11.5 7.8 9.8 13.4 16.2 19.0 28.6 22.5 7.3 21.5 17.8 22.9 8.7 7.6 11.4 8.4 10.2 16.4 12.2 11.3 11.5 14.0 11.5 12.3 8.5 13.9 7.1 13.8 12.3 9.8 19.4 17.1 25.9 30.4 16.1 16.1 14.9 19.9 15.2 16.9 14.9 8.6 15.3 14.1 11.9 20.9 15.4 5.1 17.4 12.5 22.7 19.6 14.9 33.2 19.5 230.4 12.2 7.4 0.0 11.6 11.0 12.2 10.0 13.9 5.0 23.6 22.3 15.0 14.1 16.5 25.9 23.3 16.2 8.5 24.4 10.9 16.0 15.1 14.4 19.4 22.3 23.0 12.9 19.8 24.4 11.8 11.8 5.5 20.2 16.8 11.9 NXF1 "DKFZp667O0311, Mex67, TAP" ENSG00000162231 "Nuclear RNA export factor 1" Q9UBU9 11 62792123-62806302 "Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016327, HPA061593" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB016327: AB_627608, HPA061593: AB_2684565" "unprognostic (2.45e-2)" "unprognostic (1.15e-3)" "unprognostic (2.34e-1)" "unprognostic (1.68e-3)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (5.40e-3)" "unprognostic (7.21e-3)" "unprognostic (2.54e-2)" "unprognostic (2.64e-1)" "prognostic favorable (4.08e-4)" "unprognostic (4.33e-3)" "unprognostic (8.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.38e-1)" "unprognostic (3.66e-3)" "unprognostic (1.25e-2)" 24.8 28.6 23.6 38.3 23.5 85.9 24.5 27.7 25.8 25.9 28.9 29.2 44.2 18.8 45.7 28.9 24.7 26.0 25.6 22.4 23.8 18.3 29.9 37.3 23.9 30.2 27.0 18.6 31.4 28.6 47.3 55.0 44.3 22.7 33.4 22.7 30.3 33.2 32.6 28.1 40.1 26.4 33.2 25.5 42.4 27.5 23.0 29.6 35.9 34.6 26.9 35.7 22.7 30.8 14.4 20.6 19.7 22.5 17.1 20.6 12.8 19.6 21.9 38.4 25.9 32.9 24.0 23.2 30.6 27.5 41.2 24.5 29.8 15.9 31.1 18.3 24.5 16.5 24.5 40.8 19.1 37.4 24.6 27.9 23.5 35.3 25.1 25.0 29.0 34.2 35.4 27.8 30.2 14.6 31.0 26.8 27.7 30.1 23.4 29.3 26.9 35.1 37.8 23.1 24.4 19.0 34.2 21.2 33.0 28.5 23.5 20.2 17.0 30.0 24.2 21.8 29.0 27.6 26.0 27.3 24.0 19.4 29.9 27.2 28.4 24.4 31.5 18.5 24.6 24.0 6.0 17.4 19.7 17.9 22.5 19.2 14.4 17.2 17.2 20.6 12.9 18.8 17.2 14.7 17.1 19.2 16.0 20.6 12.8 23.6 23.5 27.7 25.8 23.8 18.3 27.0 18.6 22.7 29.6 35.7 44.2 24.1 23.4 74.0 12.3 19.4 17.8 14.7 18.2 21.0 29.5 40.9 8.3 14.4 17.8 29.2 26.6 0.0 10.6 21.6 30.5 19.0 47.5 18.4 25.3 4.8 30.3 22.7 38.2 10.4 33.9 42.4 30.4 11.8 21.5 11.6 13.1 16.7 24.4 9.6 16.2 25.8 35.9 20.6 19.6 61.2 83.0 29.4 19.6 12.9 NXF3 ENSG00000147206 "Nuclear RNA export factor 3" Q9H4D5 X 103075810-103093125 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 18.0;gallbladder: 16.4;testis: 50.0" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 5.1;Ito cells: 2.5;Kupffer cells: 3.7;Late spermatids: 3.4;Paneth cells: 2.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 16.8;HL-60: 15.9;NB-4: 14.8;THP-1: 11.5;U-2197: 48.8;U-937: 35.6" "HPA003132, HPA046757" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA003132: AB_1079514, HPA046757: AB_2679789" "unprognostic (1.20e-3)" "unprognostic (6.72e-2)" "unprognostic (2.74e-1)" "unprognostic (3.05e-2)" "unprognostic (6.75e-4)" "unprognostic (1.72e-1)" "unprognostic (1.21e-1)" "unprognostic (8.86e-2)" "unprognostic (6.19e-2)" "unprognostic (3.13e-2)" "unprognostic (3.63e-2)" "unprognostic (1.88e-1)" "unprognostic (2.21e-10)" "unprognostic (1.90e-2)" "unprognostic (4.51e-2)" "unprognostic (3.99e-2)" "unprognostic (1.56e-1)" 1.3 0.5 0.1 0.0 0.3 2.4 0.2 0.1 0.2 0.9 0.3 0.0 1.0 0.2 0.2 8.2 0.6 18.0 16.4 1.1 0.2 0.1 0.7 2.1 5.7 1.3 0.3 0.0 4.4 0.7 0.0 0.1 0.2 0.1 0.3 0.6 0.4 4.2 0.3 0.1 0.1 1.9 0.2 0.3 0.4 0.2 50.0 0.0 0.0 0.2 0.9 0.2 0.2 0.3 0.0 0.0 0.5 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 16.8 0.1 0.0 0.0 15.9 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.7 0.0 3.0 0.3 0.0 0.0 14.8 0.0 0.1 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 48.8 0.0 0.0 0.0 0.0 0.2 35.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.9 0.1 0.3 0.1 0.2 0.2 0.1 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.5 3.7 3.4 0.3 0.0 0.0 0.0 0.3 0.0 0.3 2.9 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.8 0.0 OAF MGC52117 ENSG00000184232 "Out at first homolog" Q86UD1 11 120210767-120230332 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 187.7;Muller glia cells: 261.4;Urothelial cells: 195.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 6.2;intermediate monocyte: 2.9;myeloid DC: 4.6" "Group enriched" "Detected in many" 12 "dendritic cells: 4.6;monocytes: 6.2" "Cell line enhanced" "Detected in many" "EFO-21: 35.0;Hep G2: 54.7;NB-4: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047412 Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA 65000000 Nucleoplasm "HPA047412: AB_10960631" "unprognostic (1.59e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" "unprognostic (2.80e-1)" "unprognostic (5.69e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.11e-1)" "unprognostic (3.98e-3)" "unprognostic (5.09e-2)" "unprognostic (3.90e-2)" "unprognostic (3.28e-2)" "unprognostic (1.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.12e-2)" "unprognostic (7.15e-2)" "unprognostic (2.13e-1)" "unprognostic (1.95e-1)" 16.2 22.5 8.6 6.9 15.4 3.5 24.9 1.2 10.3 18.7 16.8 4.0 8.0 19.4 14.3 17.2 10.7 13.4 20.6 13.7 8.7 1.4 21.5 93.4 5.6 8.1 5.4 6.4 26.2 43.7 2.4 7.4 4.6 3.2 10.3 13.5 18.2 26.5 5.8 3.7 3.0 22.1 11.7 3.3 15.3 9.9 5.5 5.5 1.2 6.8 8.6 3.6 11.2 10.9 0.1 4.6 0.3 6.2 0.0 0.4 1.3 7.0 2.2 8.4 4.2 13.1 14.8 0.5 13.8 14.3 5.6 8.2 2.2 11.0 0.0 35.0 9.3 9.2 7.4 2.3 3.5 2.2 5.1 5.7 5.8 1.4 54.7 11.7 12.8 2.3 18.4 2.1 5.3 14.9 10.8 16.0 3.5 3.7 6.7 1.3 2.6 0.0 36.7 3.4 1.9 11.2 3.3 0.2 6.8 8.4 3.9 0.4 3.0 4.0 4.5 11.4 2.4 1.4 21.3 9.7 12.0 4.4 12.2 1.3 0.2 0.1 0.1 9.2 21.4 4.1 0.0 6.2 0.0 0.2 2.9 0.1 0.1 0.0 0.0 4.6 0.0 0.1 0.4 0.3 0.0 0.6 0.9 0.3 1.3 8.6 15.4 1.2 10.3 8.7 1.4 5.4 6.4 3.2 5.5 0.0 1.1 1.5 19.1 8.4 3.2 3.6 33.1 0.0 2.3 68.0 2.0 1.8 23.2 14.3 0.1 24.8 97.4 23.3 24.3 4.7 46.2 12.2 1.1 187.7 5.5 0.0 21.9 11.1 10.6 0.0 15.5 9.7 15.1 1.8 55.8 261.4 23.5 41.9 4.2 64.1 8.0 51.8 45.3 0.5 6.7 8.9 5.1 3.2 42.0 195.3 OAZ3 ENSG00000143450 "Ornithine decarboxylase antizyme 3" Q9UMX2 1 151762899-151771334 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 102.2" "Cell type enriched" "Detected in many" 4 "Late spermatids: 9340.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030136, HPA045808" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030136: AB_2673331, HPA045808: " "unprognostic (2.12e-1)" "unprognostic (3.86e-1)" "unprognostic (1.53e-1)" "unprognostic (5.44e-3)" "unprognostic (1.71e-1)" "unprognostic (1.01e-2)" "unprognostic (1.48e-3)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (1.01e-4)" "unprognostic (1.57e-2)" "unprognostic (2.89e-1)" "unprognostic (8.05e-6)" "unprognostic (3.94e-2)" "unprognostic (1.32e-1)" "unprognostic (2.50e-2)" "unprognostic (8.36e-2)" 0.4 0.3 0.5 0.7 0.5 0.0 0.6 0.6 0.6 0.3 0.4 0.4 0.7 0.1 0.3 2.0 0.4 0.2 0.3 0.6 0.5 0.5 0.5 0.8 0.6 0.8 0.5 0.5 0.3 0.6 1.4 0.6 0.3 0.4 4.0 0.5 0.3 3.1 0.7 1.0 0.3 0.3 0.5 0.6 0.6 0.2 102.2 0.2 0.3 0.8 0.7 0.4 0.4 0.6 1.4 3.2 2.2 5.0 2.6 2.4 1.6 1.2 2.3 1.4 3.3 1.1 3.3 2.9 2.3 0.6 2.2 1.0 1.3 3.1 1.0 2.0 0.7 1.6 1.2 1.3 2.3 0.7 7.3 6.9 1.1 4.4 1.8 1.3 0.6 1.3 5.1 1.4 2.6 3.5 1.4 3.4 3.0 1.4 3.7 2.3 9.7 0.9 1.6 3.3 4.6 2.5 0.4 1.1 1.7 0.4 2.9 1.5 3.6 1.0 5.2 4.6 3.2 10.4 2.7 3.0 1.3 0.7 2.6 1.3 5.1 9.5 2.6 1.7 1.6 3.5 2.2 3.0 0.6 1.4 1.5 1.3 1.4 1.3 2.4 3.2 1.2 1.5 2.2 2.1 2.6 5.0 1.3 2.2 1.6 0.5 0.5 0.6 0.4 0.5 0.5 0.5 0.5 0.4 0.2 0.0 1.7 0.0 2.1 0.7 0.6 1.2 0.0 2.7 1.2 0.0 2.0 1.4 1.7 1.8 2210.4 2.7 3.0 0.0 2.7 2.3 1.1 27.3 1.1 2.6 4.0 0.0 3.5 1.8 4.0 9340.9 42.6 1.1 1.7 2.8 7.2 1.6 2.5 4.2 40.0 2.8 1.6 0.0 0.8 57.9 27.9 0.5 1.3 0.0 1.8 3.1 OGFOD3 "C17orf101, FLJ22222" ENSG00000181396 "2-oxoglutarate and iron dependent oxygenase domain containing 3" Q6PK18 17 82389223-82418637 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052099 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052099: AB_2681725" "unprognostic (1.12e-2)" "unprognostic (5.85e-2)" "unprognostic (9.66e-2)" "unprognostic (9.69e-2)" "unprognostic (4.11e-3)" "unprognostic (2.09e-1)" "unprognostic (2.80e-2)" "unprognostic (1.99e-1)" "unprognostic (5.41e-2)" "unprognostic (7.15e-2)" "unprognostic (8.05e-3)" "unprognostic (2.95e-1)" "prognostic favorable (5.72e-4)" "unprognostic (7.43e-2)" "unprognostic (1.40e-1)" "unprognostic (7.08e-2)" "unprognostic (1.02e-1)" 12.9 18.0 7.6 11.3 10.4 10.2 12.1 15.4 13.7 12.0 11.1 14.3 21.8 11.5 14.7 24.9 10.7 15.0 19.0 20.9 7.2 8.5 13.7 16.8 14.4 12.3 9.1 11.9 15.1 30.0 15.3 20.4 12.8 9.0 13.8 6.6 13.9 21.8 22.9 24.4 11.3 11.6 13.4 10.7 10.5 13.0 9.8 8.6 6.9 18.8 17.0 12.8 11.6 12.0 10.1 18.5 3.1 10.3 5.2 10.9 5.2 12.6 15.9 5.3 17.8 10.4 13.2 9.3 13.0 12.1 13.4 13.9 17.0 17.3 8.6 10.4 10.0 13.7 9.5 4.6 10.8 5.6 6.8 14.2 13.3 12.2 21.5 9.3 15.2 15.6 10.5 8.1 6.2 5.4 9.8 14.0 9.7 16.6 6.8 3.9 11.9 10.3 15.8 5.0 13.3 19.4 7.0 10.4 13.2 7.6 11.8 11.6 23.1 22.3 20.4 10.4 4.7 12.1 20.0 10.8 25.4 16.0 9.9 16.4 12.1 1.0 8.2 15.8 8.9 13.1 0.1 10.3 3.1 5.4 9.4 6.1 10.1 7.8 10.9 18.5 8.8 9.4 7.8 1.3 5.2 6.3 9.6 2.9 5.2 7.6 10.4 15.4 13.7 7.2 8.5 9.1 11.9 9.0 8.6 23.8 13.9 24.6 17.8 10.1 21.1 15.3 17.8 8.1 12.5 21.0 9.8 33.4 8.3 22.5 21.6 17.6 23.8 0.0 27.3 50.7 23.5 29.8 9.2 23.5 34.2 28.6 27.6 5.5 19.2 32.5 19.2 14.7 13.5 28.9 21.9 11.9 20.3 31.6 17.7 21.4 14.4 6.5 15.6 10.7 9.1 11.2 26.5 11.7 28.7 25.3 OGFR 7-60 ENSG00000060491 "Opioid growth factor receptor" Q9NZT2 20 62804835-62814000 "Predicted intracellular proteins" "Growth regulation" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 13.0;neutrophil: 3.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017899 Supported Approved Nucleoplasm NA NA 11000 Nucleoplasm "HPA017899: AB_1854774" "unprognostic (1.33e-2)" "unprognostic (3.28e-2)" "unprognostic (2.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.76e-1)" "unprognostic (3.04e-1)" "unprognostic (1.23e-2)" "unprognostic (5.87e-2)" "unprognostic (5.39e-3)" "unprognostic (2.16e-1)" "unprognostic (4.58e-2)" "unprognostic (4.21e-2)" "unprognostic (2.46e-3)" "unprognostic (1.60e-2)" "unprognostic (4.53e-2)" "unprognostic (3.49e-1)" "prognostic favorable (5.19e-4)" 21.8 15.9 25.9 30.4 18.4 33.0 16.8 18.7 34.6 18.2 24.4 13.9 22.1 30.5 17.8 16.3 14.1 17.8 22.4 21.0 23.6 19.3 19.7 38.8 27.4 27.9 14.5 18.1 23.4 23.0 15.1 20.8 22.3 17.5 22.0 11.3 15.1 31.3 18.3 25.6 23.2 29.2 19.5 13.1 38.7 23.4 10.3 16.3 21.0 22.2 12.6 20.2 18.3 29.3 1.6 1.1 13.0 1.8 0.7 1.1 0.4 18.6 12.6 7.7 10.0 7.7 8.6 21.4 11.9 12.5 44.9 19.8 28.5 13.9 23.0 21.9 9.7 22.9 21.8 9.0 14.3 11.0 7.0 14.1 11.2 15.9 25.7 12.7 13.9 26.6 10.7 10.5 10.9 4.6 12.5 9.5 14.2 10.4 11.7 7.1 27.8 28.8 25.4 5.0 9.6 24.5 22.8 13.7 10.1 6.2 10.1 7.7 11.5 16.4 22.6 17.9 7.4 11.4 20.9 12.9 23.8 20.9 18.4 16.8 14.8 4.2 12.3 19.0 14.7 9.1 1.8 1.8 13.0 0.8 1.6 0.5 1.1 1.1 1.0 1.1 1.6 1.1 0.7 3.8 0.7 1.5 0.9 0.6 0.4 25.9 18.4 18.7 34.6 23.6 19.3 14.5 18.1 17.5 16.3 8.9 16.7 30.8 28.9 24.0 59.6 4.1 35.7 6.7 6.8 15.7 88.4 23.2 10.0 31.3 1.7 20.7 32.0 0.0 28.4 42.5 25.4 26.6 0.0 43.1 51.9 41.3 17.2 23.4 71.5 1.9 30.2 39.0 15.1 42.3 24.4 31.6 29.0 31.7 17.7 21.2 39.1 19.4 20.6 1.4 4.1 20.5 23.3 37.0 21.0 27.5 OGG1 "HMMH, HOGG1, MUTM, OGH1" ENSG00000114026 "8-oxoguanine DNA glycosylase" O15527 3 9749944-9788219 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027514, CAB047301" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB047301: , HPA027514: AB_10602189" "unprognostic (6.95e-2)" "unprognostic (7.82e-3)" "unprognostic (7.19e-2)" "unprognostic (1.24e-3)" "unprognostic (9.69e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (7.83e-2)" "unprognostic (2.45e-2)" "unprognostic (3.43e-3)" "unprognostic (9.66e-3)" "unprognostic (4.23e-2)" "prognostic favorable (2.65e-4)" "unprognostic (2.06e-2)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.59e-1)" 10.4 12.9 15.4 28.5 16.2 12.7 11.5 22.0 17.7 16.7 18.8 16.2 10.5 22.0 16.2 13.1 10.0 14.7 12.1 10.7 14.7 10.8 30.1 17.8 9.9 28.5 12.3 14.1 22.5 12.0 5.8 10.2 10.3 15.3 14.4 10.2 14.6 14.3 13.2 7.4 11.5 28.2 12.1 13.6 14.1 10.8 7.3 15.6 19.8 12.2 6.3 25.5 12.2 13.3 12.2 11.9 15.4 8.5 19.4 15.4 8.3 5.7 10.8 10.9 6.8 10.7 12.3 20.2 7.5 7.8 11.6 13.9 10.3 5.7 35.2 5.0 9.5 18.5 5.6 6.4 8.2 4.9 12.5 9.2 17.5 17.4 14.8 11.3 6.8 11.2 12.2 10.6 20.0 8.5 9.4 14.3 5.0 5.5 5.7 11.0 10.8 5.4 6.7 5.8 5.2 15.5 4.0 7.4 11.4 6.5 2.9 4.9 8.6 9.7 7.9 5.8 5.9 12.4 11.6 9.2 11.8 12.4 9.2 12.3 5.7 8.2 18.1 9.5 19.6 7.2 11.3 8.5 15.4 15.1 6.6 14.6 10.4 13.0 12.3 7.6 12.2 10.2 9.6 2.1 19.4 5.3 11.9 15.4 8.3 15.4 16.2 22.0 17.7 14.7 10.8 12.3 14.1 15.3 15.6 0.0 4.3 24.5 8.6 4.8 19.3 2.0 7.6 4.0 2.3 8.7 33.4 5.4 10.0 7.2 0.6 8.3 10.4 23.3 5.9 8.2 9.7 5.0 2.3 8.5 15.7 7.9 17.2 6.7 6.7 0.9 13.3 8.2 6.8 12.6 7.6 10.3 7.1 10.1 12.7 65.4 29.4 25.8 9.0 8.3 15.3 4.0 3.3 13.8 12.2 4.3 OLFM2 "NOE2, OlfC" ENSG00000105088 "Olfactomedin 2" O95897 19 9853718-9936552 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.4;skin 1: 60.2" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 111.0;Late spermatids: 38.1;Muller glia cells: 72.1;Suprabasal keratinocytes: 103.3" "Cancer enhanced" "Detected in all" "glioma: 96.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 24.9" "Group enriched" "Detected in many" 27 "granulocytes: 24.9;T-cells: 8.9" "Cell line enhanced" "Detected in many" "AN3-CA: 15.7;ASC diff: 14.9;BJ hTERT+: 11.3;SH-SY5Y: 15.2;U-2 OS: 18.2;WM-115: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049961, HPA057771" Uncertain Approved Nucleoplasm "Secreted in other tissues" NA NA 2300000 Nucleoplasm "HPA049961: AB_2680972, HPA057771: AB_2683524" "unprognostic (1.42e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.99e-2)" "unprognostic (5.91e-2)" "unprognostic (3.39e-2)" "unprognostic (8.78e-2)" "unprognostic (4.47e-2)" "unprognostic (8.04e-2)" "unprognostic (4.03e-2)" "unprognostic (1.41e-3)" "unprognostic (2.77e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.23e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" 20.9 12.2 37.2 2.7 39.7 0.8 5.8 9.1 51.4 4.5 1.9 11.6 0.3 2.1 7.9 3.8 3.9 6.6 4.9 3.9 26.2 21.6 1.8 23.5 3.2 5.0 19.6 17.9 3.5 7.9 1.1 4.4 5.2 15.4 5.2 1.4 3.2 7.1 10.3 1.7 60.2 2.0 5.1 9.0 2.2 1.4 5.2 4.6 16.0 8.4 1.1 3.7 2.6 3.2 0.0 0.0 24.9 0.0 0.6 8.9 1.7 0.0 2.2 1.8 15.7 14.9 9.2 1.0 3.4 11.3 0.8 0.9 0.1 1.5 0.0 1.4 2.5 1.3 0.9 6.0 1.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.0 2.7 4.8 0.9 0.1 0.1 0.4 0.0 2.9 0.1 0.2 0.0 4.9 0.1 0.1 9.7 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.1 15.2 0.6 0.0 3.1 6.3 0.6 0.0 0.1 6.6 18.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 15.7 9.6 0.0 24.9 3.5 0.0 3.8 0.0 4.1 3.1 0.0 0.0 8.0 5.1 0.3 0.6 0.0 0.0 8.9 1.7 37.2 39.7 9.1 38.0 26.2 21.6 19.6 17.9 15.4 4.6 0.0 0.0 0.0 4.6 111.0 2.9 0.6 5.1 0.0 0.0 7.0 0.0 0.1 1.7 0.6 6.8 0.5 0.0 0.0 2.0 0.0 9.6 5.0 4.6 16.1 0.2 1.6 1.2 0.6 0.3 38.1 12.7 0.3 16.9 0.0 0.0 72.1 6.6 0.0 9.2 0.0 2.5 0.0 18.7 2.1 9.3 103.3 0.1 7.5 0.0 2.3 ONECUT3 ENSG00000205922 "One cut homeobox 3" O60422 19 1752373-1780988 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "stomach 1: 9.4;testis: 3.8" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 295.6" "Group enriched" "Detected in some" 7 "pancreatic cancer: 3.5;stomach cancer: 3.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 8 "HaCaT: 7.6;OE19: 10.1;PC-3: 17.1" "Low region specificity" "Detected in single" "Region enhanced" "Detected in some" "hypothalamus: 1.3" HPA059936 Supported Nucleoplasm NA NA Nucleoplasm "HPA059936: AB_2684172" "unprognostic (9.43e-2)" "unprognostic (1.36e-1)" "unprognostic (6.28e-2)" "unprognostic (1.36e-3)" "unprognostic (2.27e-1)" "unprognostic (1.09e-2)" "unprognostic (2.21e-1)" "unprognostic (3.61e-3)" "unprognostic (2.02e-1)" "unprognostic (1.84e-1)" "unprognostic (3.87e-2)" "unprognostic (3.64e-1)" "unprognostic (3.08e-10)" "unprognostic (1.18e-1)" "unprognostic (9.86e-2)" "unprognostic (4.62e-1)" "unprognostic (1.21e-2)" 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.1 0.0 1.3 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 9.4 3.8 0.1 0.0 0.0 0.0 0.6 0.4 1.6 0.4 0.4 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.0 10.1 17.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.5 0.3 0.2 0.3 0.1 0.2 0.3 0.2 0.2 0.1 0.6 0.3 0.3 1.6 0.4 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.7 73.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.1 295.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.4 0.0 2.3 0.0 0.0 1.8 0.6 0.3 0.0 0.0 0.0 0.4 OPN3 "ECPN, encephalopsin, ERO, NMO-1, PPP1R116" ENSG00000054277 "Opsin 3" Q9H1Y3 1 241590102-241677376 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 211.3;Syncytiotrophoblasts: 143.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 12.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 12.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 35.8" "Low region specificity" "Detected in all" "CAB013682, HPA064443" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB013682: , HPA064443: AB_2685267" "unprognostic (2.41e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (1.75e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (7.12e-2)" "unprognostic (5.10e-3)" "unprognostic (1.24e-2)" "unprognostic (2.39e-1)" "unprognostic (4.96e-1)" "unprognostic (2.66e-2)" "unprognostic (3.44e-1)" "unprognostic (9.13e-2)" "unprognostic (9.15e-3)" "unprognostic (2.61e-2)" "unprognostic (7.12e-2)" "unprognostic (9.44e-3)" 5.3 4.2 5.1 4.5 8.8 1.7 6.4 1.9 22.1 4.4 9.0 2.4 1.0 2.6 6.2 6.7 7.9 6.7 4.6 3.5 5.2 4.9 6.2 18.1 11.8 8.4 5.0 11.1 6.8 4.2 1.8 6.9 26.4 3.4 2.3 8.0 1.4 4.1 2.3 2.6 4.1 4.4 2.9 3.2 7.8 5.6 4.7 1.7 12.5 9.3 1.7 7.1 6.2 5.1 2.5 12.1 0.9 1.4 0.5 0.5 0.6 2.1 7.0 5.1 0.4 18.8 35.8 3.9 3.7 2.8 2.7 2.7 0.5 5.8 0.3 0.2 4.5 3.0 12.2 1.6 2.6 2.7 7.6 0.4 0.0 1.6 4.3 9.5 1.7 4.0 18.1 7.4 1.6 4.1 18.2 5.4 6.3 3.5 1.0 4.3 1.1 0.6 2.2 13.9 8.9 3.8 2.9 0.3 6.7 18.3 3.1 1.4 5.2 2.4 7.4 2.0 10.8 0.4 6.8 6.5 0.6 0.5 1.0 3.9 2.5 3.9 0.3 2.0 5.7 7.8 0.0 1.1 0.9 0.1 1.4 0.1 2.2 0.2 0.2 2.7 2.5 0.3 0.5 0.3 0.5 1.2 12.1 0.2 0.6 5.1 8.8 1.9 22.1 5.2 4.9 5.0 11.1 3.4 1.7 6.0 4.8 15.9 11.0 13.1 2.3 0.6 15.3 1.4 3.4 12.2 0.0 62.4 11.6 13.0 80.4 5.8 7.3 0.0 8.9 211.3 7.6 6.9 2.3 20.3 25.1 0.0 4.1 6.7 25.6 64.2 10.3 41.2 27.0 30.7 9.0 2.1 20.4 8.2 15.6 15.4 2.1 0.0 9.0 7.7 9.1 10.8 143.5 2.6 8.2 11.6 ORAI2 "C7orf19, CBCIP2, FLJ12474, FLJ14733, H_NH0514P08.8, TMEM142B" ENSG00000160991 "ORAI calcium release-activated calcium modulator 2" Q96SN7 7 102433106-102456821 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "B-cells: 169.1;Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 30.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 46.5;RPMI-8226: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055137, HPA065937" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055137: AB_2682712, HPA065937: AB_2685581" "unprognostic (5.09e-3)" "unprognostic (1.23e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (5.07e-3)" "unprognostic (8.56e-2)" "unprognostic (3.82e-2)" "unprognostic (7.07e-2)" "unprognostic (7.61e-2)" "unprognostic (1.47e-1)" "prognostic favorable (8.49e-5)" "unprognostic (7.16e-2)" "unprognostic (1.57e-3)" "unprognostic (7.97e-2)" "unprognostic (1.88e-1)" "prognostic favorable (6.65e-4)" "unprognostic (2.46e-1)" 6.3 7.2 13.8 28.1 15.8 24.3 8.0 18.6 15.9 4.7 5.7 5.0 5.6 5.6 7.7 6.2 2.7 7.7 6.6 4.1 11.9 17.1 6.9 1.5 6.2 25.9 9.3 4.8 5.0 4.8 13.9 24.8 4.1 10.3 4.3 2.8 4.3 5.1 7.6 1.8 1.6 10.3 4.6 7.0 21.9 7.7 1.8 5.1 9.9 10.9 1.3 20.3 10.0 4.4 14.4 2.5 30.9 2.7 7.4 2.3 2.5 6.4 14.7 5.7 10.9 5.2 5.9 0.4 6.3 7.0 7.0 6.1 8.4 6.8 46.5 17.6 10.7 14.0 2.5 2.2 1.6 2.4 5.0 4.1 6.6 6.9 2.5 7.9 15.8 8.9 5.5 1.1 11.4 1.9 7.3 12.5 6.3 8.2 37.3 5.4 13.5 23.4 7.3 7.1 2.2 6.9 9.6 5.1 45.7 4.1 4.8 9.7 24.2 6.2 2.6 3.4 3.1 3.8 6.2 11.9 16.5 18.4 11.3 8.3 36.4 25.5 34.0 12.3 9.6 8.4 4.9 2.7 30.9 2.0 2.4 2.3 13.3 1.8 1.6 1.6 14.4 1.2 1.4 25.6 7.4 1.4 2.5 0.8 2.5 13.8 15.8 18.6 11.2 11.9 17.1 9.3 4.8 10.3 5.1 3.0 11.1 169.1 8.0 3.5 25.3 2.6 12.7 20.1 15.9 15.7 62.8 1.0 5.0 18.0 2.6 20.1 0.3 0.0 10.3 1.5 12.6 8.4 25.4 0.8 14.7 41.3 16.6 23.4 19.4 4.9 7.5 17.5 10.1 29.7 2.0 11.8 9.9 0.0 9.6 7.9 21.1 0.0 5.9 3.2 9.4 2.8 2.5 25.5 1.3 5.8 ORAOV1 TAOS1 ENSG00000149716 "Oral cancer overexpressed 1" Q8WV07 11 69653076-69675416 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062696 Approved Nucleoplasm NA NA Nucleoplasm "HPA062696: AB_2684837" "unprognostic (2.15e-1)" "unprognostic (1.37e-2)" "unprognostic (3.63e-1)" "unprognostic (1.60e-1)" "unprognostic (2.20e-1)" "unprognostic (2.09e-2)" "unprognostic (6.76e-3)" "unprognostic (4.65e-2)" "unprognostic (9.87e-3)" "unprognostic (1.82e-1)" "unprognostic (6.51e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (1.51e-5)" "unprognostic (1.10e-1)" "unprognostic (1.54e-1)" "unprognostic (2.77e-1)" "unprognostic (5.19e-3)" 11.3 14.8 19.0 14.0 20.2 13.5 12.2 24.0 24.0 11.1 11.3 19.6 14.1 16.0 13.8 33.8 15.6 12.1 9.8 9.4 17.7 13.5 12.6 11.7 11.1 16.3 22.5 16.8 14.5 18.6 12.8 15.7 10.1 16.7 14.1 12.6 11.6 14.4 20.0 15.5 25.4 13.1 15.1 16.2 17.8 13.6 14.7 21.0 9.3 14.1 10.3 15.6 12.4 12.5 8.0 8.0 5.3 9.9 4.1 9.9 4.2 38.2 8.3 5.8 6.7 5.9 5.2 7.1 12.8 7.1 9.8 5.7 13.7 12.5 8.8 6.8 7.7 7.4 15.9 8.1 6.8 12.1 5.1 10.6 9.2 15.5 8.7 9.2 6.8 5.8 6.0 8.8 10.8 11.0 5.7 7.1 8.2 9.3 6.1 9.5 12.7 6.3 13.0 6.2 16.9 16.1 5.9 10.0 7.5 6.4 6.1 7.0 6.4 8.8 6.8 29.7 5.2 10.2 7.3 7.7 10.6 8.7 16.7 10.3 8.2 5.4 6.9 16.6 7.6 9.9 2.3 5.2 3.9 8.8 4.2 6.6 8.0 8.0 5.9 5.5 7.6 9.9 8.7 5.3 4.1 9.9 8.0 8.7 4.2 19.0 20.2 24.0 24.0 17.7 13.5 22.5 16.8 16.7 21.0 20.8 6.4 9.5 9.1 3.9 10.9 2.0 7.6 12.0 2.3 12.2 9.8 6.5 11.6 6.7 2.1 5.9 8.1 0.0 4.8 2.6 6.2 12.3 4.7 2.9 5.7 3.2 12.2 6.2 5.7 0.9 8.6 6.3 3.3 9.0 10.0 13.8 6.6 7.0 10.3 8.7 12.0 6.5 7.3 7.6 10.5 7.3 4.8 7.5 6.8 9.2 ORC1 "HSORC1, ORC1L, PARC1" ENSG00000085840 "Origin recognition complex subunit 1" Q13415 1 52372829-52404459 "Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.9;lymphoid tissue: 29.1" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 4.6;Extravillous trophoblasts: 8.3;Spermatogonia: 7.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "NK-cell: 7.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027439, HPA027450" Approved Supported Nucleoplasm NA Yes Nucleoplasm "HPA027439: , HPA027450: AB_10602041" "unprognostic (3.28e-1)" "unprognostic (4.42e-3)" "prognostic favorable (1.74e-5)" "unprognostic (1.29e-2)" "unprognostic (7.29e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (3.77e-3)" "prognostic unfavorable (3.69e-4)" "unprognostic (3.86e-2)" "unprognostic (2.70e-3)" "unprognostic (8.39e-2)" "unprognostic (1.25e-10)" "unprognostic (4.56e-3)" "unprognostic (1.05e-1)" "unprognostic (2.45e-1)" "unprognostic (1.57e-2)" 0.9 1.2 0.2 9.9 0.4 22.9 0.8 1.4 1.1 1.1 3.4 0.4 0.1 1.4 0.6 1.5 5.3 0.5 0.8 0.9 0.3 0.4 1.0 1.1 1.4 5.7 0.3 0.4 1.0 0.7 0.2 0.9 1.6 0.9 0.8 3.8 0.5 1.4 0.8 0.9 2.0 3.0 0.7 0.4 4.2 1.2 8.7 0.5 29.1 0.5 8.0 11.3 1.0 1.7 1.0 1.3 0.7 0.4 7.5 2.3 0.7 7.4 8.2 13.3 8.7 0.3 1.1 12.8 5.3 4.9 15.8 16.4 10.1 4.2 17.2 4.7 3.3 7.2 10.3 19.5 6.7 13.8 7.3 11.2 20.6 12.2 10.0 0.0 27.6 11.8 0.6 0.3 15.4 1.7 1.1 4.6 10.9 23.9 8.4 5.1 5.5 21.6 13.1 29.4 4.5 11.8 23.3 20.7 16.8 2.7 9.8 7.5 6.3 12.3 7.5 4.2 13.0 4.1 11.1 2.1 6.4 9.3 10.0 13.2 4.4 11.7 21.3 6.3 20.6 7.8 0.1 0.2 0.0 0.5 0.3 0.6 0.4 0.8 0.8 1.3 1.0 0.3 0.7 0.7 7.5 0.4 0.1 2.3 0.7 0.2 0.4 1.4 1.1 0.3 0.4 0.3 0.4 0.9 0.5 0.0 0.0 0.8 0.2 0.8 0.5 0.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.2 4.6 0.1 0.0 0.0 0.2 8.3 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 2.8 0.6 0.2 0.0 0.0 0.7 0.2 0.1 0.0 0.4 3.3 0.9 0.0 0.1 3.2 7.3 1.0 1.5 0.5 1.9 0.1 ORC3 "IMAGE50150, LATHEO, ORC3L" ENSG00000135336 "Origin recognition complex subunit 3" Q9UBD5 6 87590067-87667453 "Predicted intracellular proteins, Predicted membrane proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039553, HPA053748" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA039553: AB_2676566, HPA053748: AB_2682247" "unprognostic (9.38e-3)" "unprognostic (2.38e-1)" "unprognostic (3.74e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (8.63e-2)" "unprognostic (1.28e-1)" "unprognostic (1.39e-2)" "unprognostic (2.15e-1)" "unprognostic (1.16e-1)" "unprognostic (2.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.07e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (1.33e-1)" "unprognostic (2.92e-2)" "unprognostic (3.38e-3)" "unprognostic (1.09e-1)" 16.9 22.6 17.6 11.4 23.1 8.9 18.7 33.9 24.4 18.1 10.7 12.1 12.4 8.1 16.5 19.6 11.0 18.1 11.2 21.7 17.8 19.6 16.7 17.3 12.4 15.2 17.6 19.4 24.8 11.8 27.8 30.0 17.6 28.5 16.4 12.9 11.5 11.0 14.2 23.6 12.2 11.4 13.8 19.8 15.4 10.0 26.8 19.4 29.0 18.6 15.3 15.3 17.0 11.1 15.1 9.7 14.9 17.1 15.1 20.6 11.1 8.5 11.4 21.4 16.1 16.5 17.5 15.9 17.4 15.5 20.4 28.8 15.8 10.7 17.1 23.4 11.7 17.2 15.6 23.9 13.8 28.2 20.8 16.3 15.7 17.1 16.2 8.9 17.6 5.4 15.5 11.1 23.1 20.2 11.7 12.4 17.8 35.4 18.1 19.2 10.8 7.4 9.3 15.0 12.0 12.9 17.2 28.8 10.3 15.7 12.3 15.4 11.2 13.6 8.2 13.1 23.2 11.3 15.3 10.1 10.4 10.0 21.1 20.4 8.8 19.0 11.7 13.7 18.0 15.6 14.9 8.8 9.5 11.4 14.2 16.8 15.1 16.3 14.2 7.2 12.9 20.6 17.2 5.9 15.1 17.1 9.7 15.4 11.1 17.6 23.1 33.9 24.4 17.8 19.6 17.6 19.4 28.5 19.4 11.9 11.2 14.1 9.3 4.4 18.3 27.8 12.7 24.1 13.6 7.0 11.8 19.8 18.3 9.5 43.1 9.0 17.6 23.3 9.0 20.3 13.2 8.4 11.5 8.5 16.9 6.4 9.9 12.3 7.1 19.9 17.3 9.7 8.5 7.2 13.7 18.1 8.4 9.9 14.5 20.3 29.1 12.9 7.8 43.9 30.9 3.9 12.2 13.8 10.4 6.3 OVOL1 HOVO1 ENSG00000172818 "Ovo like transcriptional repressor 1" O14753 11 65787022-65797219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.6;tongue: 37.4" "Cell type enhanced" "Detected in many" 16 "Syncytiotrophoblasts: 291.8;Urothelial cells: 75.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "A-431: 10.1;BEWO: 29.1;CACO-2: 7.3;HaCaT: 17.2;RT4: 16.9;SK-BR-3: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA003984 Uncertain Approved Nucleoplasm Yes NA Nucleoplasm "HPA003984: AB_1854854" "unprognostic (4.26e-3)" "unprognostic (3.39e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (3.37e-1)" "unprognostic (1.26e-2)" "unprognostic (1.95e-1)" "unprognostic (2.31e-2)" "unprognostic (2.01e-3)" "unprognostic (1.91e-1)" "prognostic favorable (1.00e-13)" "unprognostic (4.26e-2)" "unprognostic (3.51e-2)" "unprognostic (2.42e-1)" "unprognostic (9.04e-3)" 0.2 0.1 0.2 3.3 0.3 0.0 2.2 0.4 0.2 7.2 11.5 0.0 3.0 9.6 0.4 0.7 42.6 0.3 4.2 0.1 0.2 0.2 4.7 0.2 1.7 0.0 0.2 0.0 0.1 5.6 5.0 0.2 14.4 0.0 2.3 5.1 1.1 13.9 6.1 0.5 24.1 14.2 0.8 0.2 0.2 0.8 17.3 0.0 0.6 1.8 37.4 25.3 8.3 9.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 10.1 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 7.3 2.7 0.0 0.1 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.8 16.9 0.1 0.0 0.0 13.4 0.1 3.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 3.5 0.0 33.3 23.7 0.0 0.4 10.2 8.1 2.3 3.5 0.0 20.8 0.0 2.2 61.4 0.4 47.4 0.0 3.4 12.0 1.1 21.2 2.3 0.0 1.8 0.0 30.3 0.0 0.0 65.1 1.1 1.3 0.0 0.0 49.6 0.0 3.6 38.6 1.8 4.2 0.0 0.0 0.4 13.7 5.4 50.2 291.8 0.0 42.1 75.8 OXNAD1 MGC15763 ENSG00000154814 "Oxidoreductase NAD binding domain containing 1" Q96HP4 3 16265160-16350299 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "T-cells: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 33.0" "Lineage enriched" "Detected in all" 5 "T-cells: 33.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036830, HPA059160" Approved Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA036830: AB_2675338, HPA059160: AB_2683936" "unprognostic (4.49e-2)" "unprognostic (7.41e-3)" "unprognostic (2.71e-3)" "unprognostic (2.38e-3)" "unprognostic (4.65e-2)" "unprognostic (3.23e-2)" "unprognostic (1.46e-1)" "unprognostic (2.31e-2)" "unprognostic (1.23e-2)" "unprognostic (8.05e-2)" "unprognostic (1.46e-1)" "unprognostic (8.08e-2)" "prognostic favorable (1.00e-7)" "unprognostic (2.22e-2)" "unprognostic (1.03e-1)" "unprognostic (6.95e-3)" "prognostic favorable (7.63e-4)" 8.1 8.8 7.5 14.1 11.1 10.9 8.1 9.1 13.6 5.4 11.4 9.1 7.3 16.3 7.7 4.3 10.8 6.2 7.1 12.0 7.1 5.9 15.5 22.4 6.6 20.7 10.9 7.9 6.9 7.4 6.5 12.4 5.2 9.5 5.4 10.2 6.8 9.4 9.3 18.1 8.2 18.4 4.2 8.9 9.2 9.4 9.3 12.1 8.2 8.0 7.0 16.0 7.8 6.6 1.9 2.2 1.3 2.0 6.4 33.0 7.5 5.6 8.2 5.4 8.5 6.4 5.7 21.1 6.1 4.5 8.4 6.8 11.8 5.7 8.0 3.8 3.8 4.6 4.1 11.1 9.9 8.0 14.6 7.3 11.8 7.0 6.3 6.6 19.0 7.2 4.2 7.4 13.6 6.6 2.6 6.5 8.3 16.1 19.3 3.6 10.0 11.0 10.0 11.5 8.4 9.7 9.9 6.6 14.1 5.7 6.8 3.8 5.4 6.8 11.5 9.4 6.1 7.3 11.0 2.9 5.5 7.0 6.0 9.8 7.0 12.6 13.0 6.5 16.6 7.3 0.0 1.4 1.1 9.0 2.0 11.9 1.9 13.8 9.7 2.2 1.5 33.0 24.4 1.3 6.4 1.8 1.7 7.3 7.5 7.5 11.1 9.1 13.6 7.1 5.9 10.9 7.9 9.5 12.1 0.0 10.4 12.0 4.7 2.2 5.7 12.3 5.1 9.4 3.4 7.0 5.9 9.1 26.6 7.6 32.8 3.5 9.2 0.0 5.5 6.7 4.7 4.5 19.7 18.3 7.5 3.2 2.9 3.7 3.3 24.8 2.8 3.8 5.0 10.8 6.9 5.0 6.3 2.9 1.8 12.6 11.0 6.5 3.4 6.6 10.0 3.0 4.2 39.9 10.3 4.8 PAF1 "F23149_1, FLJ11123, PD2" ENSG00000006712 "PAF1 homolog, Paf1/RNA polymerase II complex component" Q8N7H5 19 39385852-39391195 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041875, HPA043637" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA041875: AB_2677720, HPA043637: AB_2678592" "unprognostic (5.33e-3)" "unprognostic (3.57e-1)" "unprognostic (1.70e-1)" "unprognostic (1.14e-1)" "unprognostic (1.92e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (6.65e-2)" "unprognostic (4.21e-1)" "unprognostic (8.37e-2)" "prognostic favorable (8.66e-4)" "unprognostic (2.28e-1)" "unprognostic (2.35e-1)" "unprognostic (1.05e-1)" "unprognostic (2.32e-1)" "unprognostic (4.60e-1)" "unprognostic (2.73e-1)" 28.9 33.2 30.7 30.6 32.9 33.7 34.1 35.1 40.0 28.5 25.4 39.5 25.8 23.5 27.3 31.0 30.0 30.1 27.1 32.6 31.1 28.3 27.9 47.9 23.7 27.6 32.7 29.9 42.2 26.0 45.0 35.1 27.1 34.9 32.7 22.0 22.7 27.1 41.0 50.9 22.4 24.4 26.3 36.2 32.7 26.5 59.1 28.5 31.5 32.1 25.4 31.7 28.1 24.7 31.5 16.5 24.5 21.1 21.8 25.1 15.4 35.8 46.6 30.7 16.3 19.8 16.8 12.5 29.9 28.3 35.6 34.5 38.1 19.4 28.8 21.1 24.7 21.1 12.6 33.1 25.1 29.3 32.3 38.8 28.3 29.4 24.9 21.4 24.0 27.0 16.9 17.3 29.5 19.3 22.5 26.0 25.4 21.9 23.9 29.2 40.7 27.2 15.9 10.8 30.0 15.7 27.7 30.2 20.1 26.6 41.0 26.0 17.5 32.3 21.4 16.2 16.0 20.4 20.6 24.3 21.5 28.3 22.1 32.9 26.0 23.4 24.7 21.3 21.1 19.7 21.1 15.0 24.5 24.0 21.1 25.1 31.5 20.1 23.8 16.5 29.3 23.0 20.7 24.1 21.8 18.7 15.7 19.4 15.4 30.7 32.9 35.1 40.0 31.1 28.3 32.7 29.9 34.9 28.5 20.8 44.0 34.7 55.8 47.6 13.9 30.2 10.2 87.0 37.5 21.0 7.9 33.0 11.6 21.6 22.6 17.9 21.4 0.0 23.8 24.7 29.8 29.1 49.7 23.6 21.5 7.9 25.3 12.9 13.1 25.1 32.5 25.7 21.9 25.2 18.0 21.4 21.3 14.1 26.2 19.5 14.2 12.9 34.0 84.6 24.5 43.0 53.5 23.5 16.1 30.6 PAK5 "KIAA1264, PAK7" ENSG00000101349 "P21 (RAC1) activated kinase 5" Q9P286 20 9537389-9839041 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 30.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "SCLC-21H: 10.2;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020444 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020444: AB_1854947" "unprognostic (5.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.05e-1)" "unprognostic (8.63e-2)" "unprognostic (3.21e-1)" "unprognostic (3.04e-1)" "unprognostic (2.25e-4)" "unprognostic (3.76e-1)" "unprognostic (2.56e-2)" "unprognostic (3.83e-1)" "unprognostic (3.35e-2)" "unprognostic (6.04e-2)" "unprognostic (4.58e-1)" 0.5 5.2 5.7 0.6 11.7 0.5 1.6 30.3 19.6 0.8 0.6 0.8 0.0 0.7 1.0 2.2 1.0 0.7 3.4 0.6 4.0 3.3 1.0 2.3 0.7 0.6 1.6 8.8 0.6 3.5 0.5 2.0 0.6 5.3 1.6 0.6 0.6 1.2 1.6 0.6 1.6 0.6 0.6 1.2 0.6 1.2 1.0 1.7 0.0 0.6 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 3.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 5.7 11.7 30.3 13.6 4.0 3.3 1.6 8.8 5.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PALB2 "FANCN, FLJ21816" ENSG00000083093 "Partner and localizer of BRCA2" Q86YC2 16 23603160-23641310 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB014895, HPA057000" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB014895: , HPA057000: AB_2683307" "unprognostic (1.11e-1)" "unprognostic (5.67e-3)" "prognostic favorable (2.83e-5)" "unprognostic (1.43e-2)" "unprognostic (6.22e-2)" "unprognostic (1.61e-2)" "unprognostic (2.00e-3)" "unprognostic (5.18e-2)" "unprognostic (2.46e-2)" "unprognostic (2.00e-2)" "prognostic unfavorable (2.35e-5)" "unprognostic (2.05e-2)" "unprognostic (1.04e-2)" "unprognostic (2.72e-1)" "unprognostic (1.25e-1)" "unprognostic (7.20e-2)" "unprognostic (3.21e-1)" 12.4 9.9 10.7 19.6 11.9 6.8 15.2 16.5 14.1 12.4 14.0 10.8 9.1 14.8 10.9 13.5 17.6 9.6 7.8 10.5 10.0 10.6 13.7 16.1 9.2 13.4 9.7 12.5 15.3 10.6 13.7 16.1 9.1 14.9 10.9 12.7 8.6 11.0 14.7 10.3 17.0 14.1 12.8 10.8 14.1 11.0 16.9 10.5 12.9 12.1 12.0 15.3 13.6 13.3 3.7 3.9 7.2 7.7 3.9 5.5 2.0 12.0 9.3 11.3 7.9 9.4 7.4 10.1 8.7 13.4 14.4 17.5 7.9 12.6 12.7 6.4 6.1 11.1 10.8 10.0 14.7 17.2 7.5 5.8 7.8 12.9 22.4 8.7 14.3 12.7 8.4 15.0 13.6 15.5 8.0 7.6 12.3 16.0 6.9 12.6 11.9 14.7 14.9 25.1 8.8 5.5 17.1 13.8 17.4 11.0 10.8 8.3 8.3 8.9 10.2 11.4 10.3 9.4 9.8 5.5 17.3 6.6 8.5 9.3 8.1 13.1 13.0 11.3 10.5 10.3 7.2 3.3 3.0 4.4 4.2 5.3 3.7 4.9 5.3 3.9 3.1 5.5 4.3 0.2 3.9 7.7 2.8 3.1 2.0 10.7 11.9 16.5 14.1 10.0 10.6 9.7 12.5 14.9 10.5 11.9 3.4 9.4 3.5 0.8 6.2 4.2 5.1 12.0 10.3 3.5 3.9 2.3 3.3 4.3 3.0 2.3 2.6 0.0 4.4 1.7 1.4 1.5 4.7 4.7 3.2 1.6 1.2 3.1 7.0 2.9 4.4 4.0 1.7 9.0 2.6 4.7 6.9 3.4 6.0 4.6 7.1 6.5 2.1 20.2 14.4 2.4 1.0 2.5 4.3 3.7 PAPLN MGC50452 ENSG00000100767 "Papilin, proteoglycan like sulfated glycoprotein" O95428 14 73237497-73274640 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Leydig cells: 31.9;Muller glia cells: 21.2;Peritubular cells: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "neutrophil: 4.4;plasmacytoid DC: 8.8" "Group enriched" "Detected in many" 6 "dendritic cells: 8.8;granulocytes: 4.4" "Cell line enhanced" "Detected in many" "HHSteC: 13.1;HSkMC: 24.7;hTCEpi: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA048682, HPA053453" Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA 46000000 Nucleoplasm "HPA048682: AB_2680492, HPA053453: AB_2682155" "unprognostic (1.97e-3)" "unprognostic (3.27e-2)" "unprognostic (1.88e-1)" "unprognostic (3.56e-3)" "unprognostic (7.42e-2)" "unprognostic (7.91e-3)" "unprognostic (2.01e-2)" "unprognostic (2.46e-3)" "unprognostic (9.13e-3)" "unprognostic (3.69e-2)" "unprognostic (1.41e-1)" "unprognostic (4.87e-2)" "unprognostic (1.89e-2)" "unprognostic (2.14e-2)" "unprognostic (3.05e-3)" "unprognostic (2.69e-2)" "unprognostic (5.58e-2)" 9.3 6.1 13.6 11.8 14.8 2.9 11.0 4.1 11.1 10.8 7.0 6.0 3.8 4.1 14.2 19.5 4.6 12.1 8.0 4.8 15.7 3.0 24.9 1.9 7.8 23.3 4.1 9.7 10.9 2.7 1.0 11.1 5.2 5.7 8.1 6.2 14.9 4.7 10.2 1.8 16.2 10.3 8.6 6.0 17.6 7.4 6.5 8.9 5.1 15.3 2.2 16.5 6.8 5.6 1.1 8.8 4.4 0.8 0.5 0.5 0.2 2.0 2.0 0.8 0.3 1.5 1.9 4.6 0.4 0.0 0.1 0.1 2.6 0.6 0.4 2.1 0.0 0.1 3.3 2.1 1.5 0.2 2.3 3.1 0.9 3.2 0.3 13.1 0.3 1.7 24.7 9.1 0.4 1.4 0.1 0.4 1.9 0.6 0.3 0.0 1.0 0.2 2.2 0.5 0.2 0.6 0.3 0.3 2.1 1.8 0.4 0.2 0.4 4.8 5.5 0.9 6.6 0.1 3.7 0.4 0.6 1.9 0.2 0.2 1.1 0.1 0.2 1.1 1.1 0.5 1.1 0.8 0.6 0.4 0.5 0.2 0.7 0.3 0.5 0.2 1.1 0.5 0.5 4.4 0.5 0.4 8.8 0.5 0.2 13.6 14.8 4.1 11.1 15.7 3.0 4.1 9.7 5.7 8.9 0.0 1.6 0.0 0.5 1.8 1.0 1.3 2.5 1.4 5.7 5.2 7.9 0.5 0.0 3.0 0.3 1.1 0.1 0.0 0.0 0.9 6.1 1.7 0.0 0.0 1.2 0.0 0.0 1.8 0.3 1.4 31.9 0.9 1.7 2.8 0.0 21.2 0.4 0.0 41.4 13.4 3.0 6.5 1.0 0.6 0.1 2.6 0.3 0.0 0.9 0.4 PAPOLA PAP ENSG00000090060 "Poly(A) polymerase alpha" P51003 14 96501433-96567111 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 866.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001788 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA001788: AB_1079564" "unprognostic (3.18e-1)" "unprognostic (1.30e-1)" "unprognostic (9.69e-2)" "unprognostic (7.26e-2)" "unprognostic (9.10e-2)" "unprognostic (5.10e-3)" "prognostic unfavorable (2.41e-5)" "unprognostic (2.12e-2)" "unprognostic (2.82e-2)" "unprognostic (1.38e-3)" "unprognostic (3.13e-1)" "unprognostic (1.22e-3)" "unprognostic (3.37e-1)" "unprognostic (1.65e-1)" "unprognostic (1.77e-1)" "unprognostic (1.08e-2)" "unprognostic (4.05e-1)" 35.8 43.4 49.1 45.7 51.6 54.5 39.7 61.2 60.5 41.0 45.1 25.2 45.6 34.9 43.8 48.3 42.0 38.7 35.6 71.8 46.3 39.6 40.0 50.2 37.1 44.7 48.1 39.7 58.2 52.9 50.2 68.7 54.5 45.6 45.1 45.8 24.0 39.2 45.5 46.4 35.5 45.5 38.9 41.9 50.9 40.4 53.0 55.7 53.0 54.8 34.8 49.6 44.9 119.5 26.4 23.0 39.0 23.5 25.2 23.4 19.8 32.2 31.1 40.0 40.1 29.0 32.8 91.1 29.5 31.9 35.1 33.8 35.9 33.3 43.6 34.0 34.5 31.2 27.9 13.0 40.6 63.0 36.0 21.2 35.2 23.6 35.2 30.0 46.0 35.7 29.9 35.6 39.2 35.1 34.3 39.2 22.1 33.0 40.0 33.8 46.9 36.1 23.3 27.3 52.6 35.4 38.5 48.8 25.3 35.0 51.4 41.2 27.3 39.4 30.9 28.7 47.0 43.8 40.6 31.2 24.8 19.8 27.9 35.9 31.6 47.2 38.5 40.1 35.3 41.5 39.0 19.7 32.7 15.5 23.5 20.4 23.8 19.6 22.6 23.0 26.4 23.4 21.8 27.4 25.2 22.6 15.2 18.7 19.8 49.1 51.6 61.2 60.5 46.3 39.6 48.1 39.7 45.6 55.7 74.5 97.8 147.6 322.5 204.0 74.0 149.1 91.7 188.7 112.6 80.3 90.3 292.7 155.9 102.9 458.6 132.1 96.5 93.5 118.9 339.8 138.5 332.8 134.9 110.0 138.1 60.4 112.4 76.1 123.0 196.9 89.2 135.9 160.3 140.7 124.7 87.2 118.9 101.7 75.7 103.9 102.5 103.5 150.3 203.7 195.7 216.4 866.4 116.1 134.7 394.8 PAPOLB PAPT ENSG00000218823 "Poly(A) polymerase beta" Q9NRJ5 7 4857733-4861994 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 33.0" "Group enriched" "Detected in some" 4 "Early spermatids: 67.3;Late spermatids: 69.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.7" "Not detected" "Not detected" HPA047285 Approved Nucleoplasm NA NA Nucleoplasm "HPA047285: " "unprognostic (7.58e-2)" "unprognostic (1.25e-1)" "unprognostic (1.68e-2)" "unprognostic (1.78e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.3 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.3 0.3 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.0 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.7 0.0 0.5 16.1 2.3 0.6 0.2 0.0 0.0 0.3 PAPOLG FLJ12972 ENSG00000115421 "Poly(A) polymerase gamma" Q9BWT3 2 60756230-60802085 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017795, HPA035349, HPA035350" Approved Enhanced Nucleoplasm No No Nucleoplasm "CAB017795: , HPA035349: AB_2674583, HPA035350: AB_2674584" "unprognostic (1.83e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "unprognostic (3.39e-2)" "unprognostic (5.56e-2)" "unprognostic (3.54e-1)" "unprognostic (6.72e-4)" "unprognostic (2.49e-1)" "unprognostic (6.97e-3)" "unprognostic (6.83e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (2.62e-2)" 12.3 9.5 11.6 11.6 11.9 5.8 9.9 19.4 15.3 10.2 8.2 9.8 7.8 6.8 12.1 6.2 10.1 9.0 10.2 8.5 15.1 10.1 8.6 6.9 9.4 14.8 10.9 11.3 17.1 9.9 13.3 18.9 11.8 12.5 9.6 9.2 7.7 11.1 8.7 13.1 11.7 9.7 9.9 21.0 15.0 9.1 14.2 11.0 23.1 27.5 6.6 14.3 10.9 11.1 6.1 3.7 13.2 6.9 9.4 9.7 4.1 5.2 4.9 9.2 7.4 11.8 8.9 8.8 5.8 5.7 5.0 5.3 8.3 4.5 7.5 6.1 4.4 6.6 8.9 13.0 5.5 9.4 13.0 6.9 9.6 4.7 5.8 7.1 10.0 6.6 6.7 6.5 6.0 12.7 7.6 8.0 7.8 9.4 7.2 5.6 4.2 11.5 6.9 14.5 7.7 4.5 9.4 16.3 6.8 5.4 5.0 5.4 7.5 9.3 5.8 5.2 10.7 3.8 6.1 7.5 6.4 7.7 4.8 5.4 7.1 4.2 18.3 5.2 11.4 4.6 13.2 4.1 8.7 6.7 4.3 8.3 5.9 7.2 6.0 3.7 6.1 7.9 7.3 10.6 9.4 6.9 3.3 9.7 4.1 11.6 11.9 19.4 15.3 15.1 10.1 10.9 11.3 12.5 11.0 11.9 9.8 4.5 13.0 11.1 5.7 6.3 5.1 8.1 10.3 8.7 23.6 5.3 3.3 3.9 4.3 9.2 4.3 0.0 3.7 3.5 8.2 12.6 12.7 4.0 6.5 4.8 2.4 10.4 11.6 3.3 6.9 12.4 11.8 7.2 5.1 5.1 3.6 5.8 8.1 2.4 10.1 25.8 8.2 23.3 14.7 13.9 7.3 15.8 3.2 12.0 PARP12 "FLJ22693, PARP-12, ZC3H1, ZC3HDC1" ENSG00000059378 "Poly(ADP-ribose) polymerase family member 12" Q9H0J9 7 140023744-140063721 "Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003584, HPA063872" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003584: AB_1079568, HPA063872: AB_2685139" "unprognostic (1.46e-3)" "unprognostic (2.93e-2)" "unprognostic (1.73e-1)" "unprognostic (2.71e-2)" "unprognostic (6.74e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (1.63e-4)" "unprognostic (2.30e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (7.51e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (4.12e-7)" "unprognostic (3.31e-2)" "unprognostic (2.76e-1)" "unprognostic (1.75e-2)" "unprognostic (6.01e-2)" 3.1 1.8 1.0 3.7 0.9 6.1 2.5 0.1 0.7 2.1 2.2 4.2 2.8 4.2 2.1 2.5 3.1 1.7 1.0 1.0 3.1 3.0 5.2 3.8 1.0 3.2 2.7 2.5 3.3 3.4 2.8 3.9 4.3 1.4 0.9 8.6 4.4 1.5 1.3 6.0 2.3 5.7 3.2 2.7 1.9 3.1 1.0 1.3 3.4 2.0 2.3 3.3 2.4 3.7 2.3 0.0 0.4 1.1 0.5 3.9 0.6 0.5 4.7 8.0 2.7 3.5 1.7 2.8 1.1 4.8 3.8 1.5 4.4 1.3 4.7 4.7 1.4 1.4 1.8 2.1 0.4 1.4 1.6 2.6 2.0 4.3 3.3 5.0 2.7 4.1 2.3 0.0 2.9 4.5 12.1 0.2 1.8 7.0 2.0 0.0 0.0 2.1 2.3 1.4 0.0 2.4 1.1 3.5 0.6 0.6 0.9 9.6 1.5 2.2 0.5 3.5 0.1 0.1 0.4 0.9 6.0 0.8 0.7 2.0 2.2 2.9 1.7 1.1 0.3 1.9 2.9 1.3 1.0 0.6 1.9 3.4 2.3 1.9 0.7 3.3 2.4 6.0 11.7 6.0 6.5 5.8 3.0 4.2 10.2 5.3 5.7 10.4 2.0 4.5 1.7 10.9 0.6 11.7 32.5 0.0 22.8 16.4 5.3 10.8 19.6 9.6 21.5 0.0 23.1 6.2 10.2 0.4 6.6 13.9 6.8 12.6 13.2 2.6 27.2 25.9 6.7 5.6 2.2 0.0 5.9 28.7 11.9 8.7 1.7 8.7 8.0 9.2 PARPBP "C12orf48, FLJ20641, PARI" ENSG00000185480 "PARP1 binding protein" Q9NWS1 12 102120185-102197520 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.6" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 23.3;Spermatocytes: 14.6;Spermatogonia: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA039677 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA039677: AB_10673426" "unprognostic (7.84e-3)" "unprognostic (1.34e-2)" "unprognostic (4.54e-3)" "unprognostic (3.03e-2)" "unprognostic (1.84e-1)" "unprognostic (3.03e-1)" "unprognostic (1.30e-5)" "unprognostic (2.52e-3)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.38e-1)" "unprognostic (3.95e-3)" "unprognostic (2.83e-1)" "unprognostic (5.61e-8)" "unprognostic (3.50e-3)" "unprognostic (2.34e-1)" "unprognostic (9.16e-3)" "unprognostic (6.14e-2)" 1.8 1.5 1.7 6.3 1.9 11.0 2.4 2.0 2.8 1.8 4.0 1.0 1.4 3.3 2.4 1.9 6.7 0.9 1.4 2.4 1.6 4.8 3.1 1.0 1.8 5.4 1.8 2.2 1.8 1.1 0.3 1.0 4.1 4.4 2.9 5.5 0.4 2.2 1.1 1.2 2.6 3.7 2.2 1.7 5.6 2.4 14.5 0.4 26.6 1.4 5.9 6.7 3.3 2.7 3.0 1.9 6.2 1.5 1.2 4.5 1.9 7.4 15.9 13.4 7.6 2.2 2.0 9.4 11.5 6.3 18.4 16.4 8.2 5.6 13.8 6.6 4.1 9.3 8.1 21.8 6.5 19.5 14.1 13.0 17.5 9.5 7.4 0.6 18.5 5.3 1.8 1.4 12.8 7.8 4.6 12.0 10.5 16.2 8.5 11.8 5.8 16.4 17.0 17.8 9.8 14.7 11.1 21.9 8.9 5.7 11.6 9.1 8.7 7.6 9.3 6.6 14.7 15.1 6.6 4.6 9.4 9.2 11.7 14.0 6.6 13.1 12.3 6.5 18.8 12.3 6.2 1.2 2.4 1.6 1.5 0.4 3.0 2.5 2.2 1.9 1.5 1.4 1.6 0.0 1.2 1.2 1.7 4.5 1.9 1.7 1.9 2.0 2.8 1.6 4.8 1.8 2.2 4.4 0.4 0.0 0.0 5.2 1.6 3.3 1.7 0.4 0.0 1.4 2.3 1.8 0.0 6.2 5.0 1.0 1.5 1.9 0.9 23.3 1.1 11.1 3.6 0.5 5.7 0.0 5.5 3.2 1.7 2.5 4.5 1.6 1.1 3.2 0.0 2.8 1.6 0.2 0.8 0.0 0.4 1.1 0.7 0.0 0.5 14.6 13.9 1.4 3.0 3.2 5.0 1.0 PATZ1 "dJ400N23, MAZR, PATZ, RIAZ, ZBTB19, ZNF278, ZSG" ENSG00000100105 "POZ/BTB and AT hook containing zinc finger 1" Q9HBE1 22 31325804-31346232 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047893, HPA048315" Approved Supported Nucleoplasm No No Nucleoplasm "HPA047893: AB_2680201, HPA048315: AB_2680353" "unprognostic (3.25e-1)" "unprognostic (8.72e-2)" "unprognostic (1.77e-1)" "unprognostic (2.88e-3)" "prognostic favorable (1.06e-4)" "unprognostic (1.77e-1)" "unprognostic (8.34e-3)" "prognostic favorable (8.71e-5)" "unprognostic (1.14e-1)" "unprognostic (1.41e-2)" "unprognostic (1.99e-3)" "unprognostic (1.76e-1)" "prognostic favorable (8.54e-8)" "unprognostic (9.22e-2)" "unprognostic (2.15e-1)" "unprognostic (1.51e-1)" "prognostic favorable (7.79e-6)" 9.6 11.2 13.0 12.7 12.9 12.9 12.1 16.8 16.0 14.2 13.0 21.7 21.8 9.4 19.6 14.4 7.3 22.2 14.1 10.4 14.0 11.8 11.4 11.0 17.4 30.3 15.3 13.4 27.7 16.6 25.4 11.0 8.9 13.6 14.0 6.8 17.5 17.5 17.8 9.1 7.5 11.9 15.6 12.5 14.3 10.5 13.0 15.5 38.5 18.9 8.2 13.8 17.4 14.2 4.7 7.1 4.8 1.8 3.5 5.7 2.0 8.4 10.6 21.8 12.8 5.8 5.3 11.4 2.6 6.6 10.6 9.7 7.4 8.2 18.1 9.4 4.8 3.7 6.6 14.7 7.9 5.4 10.5 13.5 7.6 7.4 15.1 9.5 25.5 10.3 8.3 9.6 6.7 7.5 8.4 8.3 8.9 3.2 7.3 6.7 25.8 16.3 17.5 14.6 15.5 12.6 27.6 9.3 5.9 7.1 18.0 28.5 22.9 6.5 7.9 14.2 7.5 15.7 16.3 5.8 7.1 13.4 4.4 8.7 9.5 6.2 16.5 3.0 3.3 12.1 0.0 1.8 4.8 3.4 1.1 3.5 4.7 2.6 4.4 2.5 3.8 5.7 4.1 0.8 3.5 0.6 7.1 3.7 2.0 13.0 12.9 16.8 16.0 14.0 11.8 15.3 13.4 13.6 15.5 3.0 12.2 2.9 5.4 1.4 15.6 12.2 10.2 10.7 10.3 19.2 7.9 4.3 16.6 11.3 0.4 4.5 2.9 0.0 5.2 1.4 4.9 8.2 5.8 11.3 7.6 20.6 19.7 9.2 6.4 1.3 8.9 5.0 3.3 3.6 9.1 13.3 7.4 3.5 8.1 6.8 14.2 6.5 3.3 0.7 7.2 1.4 0.7 7.4 10.8 5.6 PAX2 ENSG00000075891 "Paired box 2" Q02962 10 100735603-100829941 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 30.5;epididymis: 93.7;kidney: 43.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 137.9;Distal tubular cells: 41.4" "Group enriched" "Detected in some" 19 "endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5" "Group enriched" "Detected in some" 6 "cerebellum: 1.0;pons and medulla: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AN3-CA: 14.6;EFO-21: 20.2;RPTEC TERT1: 14.5" "Group enriched" "Detected in some" 9 "cerebellum: 1.5;pons and medulla: 3.5" "Region enhanced" "Detected in single" "pons and medulla: 8.1" "CAB013024, HPA047704, HPA070751" Enhanced Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305" "unprognostic (3.98e-2)" "unprognostic (9.55e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (4.56e-4)" "unprognostic (4.85e-2)" "unprognostic (5.54e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.24e-2)" "unprognostic (6.59e-2)" "unprognostic (9.18e-2)" "unprognostic (3.30e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-1)" "unprognostic (6.34e-2)" "unprognostic (8.26e-2)" 0.1 0.1 0.2 0.0 0.1 0.0 0.1 1.0 0.1 3.1 0.1 0.0 30.5 0.0 1.5 93.7 0.1 9.1 0.0 0.1 0.1 0.1 43.1 0.1 0.1 0.0 0.2 0.0 1.5 0.3 0.6 0.7 0.0 1.8 0.8 0.0 0.5 0.1 19.4 0.1 0.1 0.1 0.0 1.7 0.1 0.1 2.4 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.2 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 14.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.0 0.1 0.1 0.1 0.2 0.0 1.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.0 0.0 137.9 0.0 0.0 41.4 0.0 8.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.0 0.0 18.8 0.4 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 PAX3 "HUP2, WS1" ENSG00000135903 "Paired box 3" P23760 2 222199888-222298996 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Deafness, Disease mutation, Proto-oncogene, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.1;retina: 39.6" "Group enriched" "Detected in some" 8 "Early spermatids: 10.9;Late spermatids: 19.5;Melanocytes: 32.1" "Cancer enriched" "Detected in some" 24 "melanoma: 20.3" "Group enriched" "Detected in some" 6 "cerebellum: 19.1;pons and medulla: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 7.6;BJ hTERT+ SV40 Large T+ RasG12V: 9.1;HBF TERT88: 6.7;RH-30: 13.1;SK-MEL-30: 23.1" "Group enriched" "Detected in some" 7 "cerebellum: 3.9;midbrain: 1.6;pons and medulla: 1.4" "Group enriched" "Detected in many" 5 "cerebellum: 10.0;midbrain: 11.7;pons and medulla: 3.5" "HPA063659, HPA069000" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063659: AB_2685080, HPA069000: AB_2686067" "unprognostic (2.57e-2)" "unprognostic (1.48e-2)" "unprognostic (1.27e-2)" "unprognostic (1.65e-1)" "unprognostic (2.61e-2)" "unprognostic (3.70e-1)" "unprognostic (6.18e-2)" "unprognostic (1.41e-1)" "unprognostic (2.26e-1)" "unprognostic (9.70e-2)" 0.8 0.1 0.0 0.1 0.8 0.1 2.9 19.1 0.2 0.3 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.2 2.2 0.0 0.1 0.2 0.1 0.0 0.1 7.8 0.4 0.1 39.6 7.9 0.2 8.6 7.9 0.1 0.1 4.2 0.1 0.2 2.9 0.8 0.0 0.1 3.9 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 5.2 5.1 7.6 9.1 0.0 0.5 0.0 0.0 3.5 0.1 0.0 0.0 0.0 6.7 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.4 0.1 0.0 0.0 0.0 13.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 23.1 5.9 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.9 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.8 19.1 0.1 0.0 0.2 2.2 0.0 7.8 0.8 0.0 0.0 0.0 0.0 2.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.9 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.3 0.4 0.0 0.0 0.0 0.0 PAX6 "AN, AN2, D11S812E, WAGR" ENSG00000007372 "Paired box 6" P26367 11 31784779-31818062 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.3;retina: 29.4" "Group enriched" "Detected in some" 5 "Horizontal cells: 249.5;Muller glia cells: 410.0" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Region enriched" "Detected in all" 5 "cerebellum: 78.3" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 9.4;AN3-CA: 12.1;HEK 293: 11.3;hTERT-RPE1: 32.3;U-251 MG: 9.9" "Group enriched" "Detected in many" 5 "cerebellum: 61.0;olfactory region: 41.2" "Low region specificity" "Detected in all" "HPA030775, CAB034143" Enhanced Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034143: AB_1127044, HPA030775: AB_10601243" "unprognostic (2.89e-1)" "unprognostic (2.98e-2)" "unprognostic (8.34e-2)" "unprognostic (3.85e-2)" "unprognostic (4.42e-2)" "unprognostic (7.82e-2)" "unprognostic (2.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.24e-3)" "unprognostic (1.68e-1)" "unprognostic (1.20e-2)" "unprognostic (3.91e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" 0.8 2.0 12.6 0.8 10.4 1.1 1.0 78.3 23.5 0.8 1.1 9.3 0.0 3.5 0.8 1.8 0.8 0.8 0.8 0.8 16.0 3.7 0.9 0.9 0.7 0.9 3.9 9.1 0.8 15.8 0.8 4.6 0.8 10.8 0.8 1.4 29.4 0.8 0.9 1.9 1.6 2.0 0.8 16.1 0.8 19.4 2.8 9.8 0.0 0.8 0.0 1.0 1.1 0.3 0.2 0.2 1.6 0.4 0.4 0.5 0.1 0.0 0.1 9.4 12.1 2.9 4.0 3.6 0.0 0.0 0.1 0.0 0.7 2.2 0.0 3.8 1.2 5.5 0.2 1.0 0.0 0.2 0.0 11.3 5.3 8.8 5.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 32.3 0.0 3.3 4.2 0.0 0.1 0.0 2.2 0.3 0.2 0.0 6.1 0.0 4.4 0.0 0.5 0.3 0.4 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 3.2 0.2 0.0 9.9 0.0 0.1 0.0 5.0 0.0 0.0 1.6 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.2 0.2 0.2 0.3 1.0 0.4 0.4 0.2 0.1 0.1 12.6 10.4 78.3 12.2 16.0 3.7 3.9 9.1 10.8 9.8 0.0 0.0 0.0 0.0 0.5 15.4 4.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 249.5 71.5 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.1 410.0 4.1 0.6 0.0 0.0 27.5 0.0 0.3 3.7 2.9 0.0 0.0 0.0 0.0 0.0 PAX8 ENSG00000125618 "Paired box 8" Q06710 2 113215997-113278950 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 69.3;thyroid gland: 120.5" "Group enriched" "Detected in many" 4 "Collecting duct cells: 233.8;Proximal tubular cells: 100.4" "Group enriched" "Detected in many" 12 "endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "EFO-21: 27.1;GAMG: 16.8;RPTEC TERT1: 63.8" "Region enriched" "Detected in some" 4 "pons and medulla: 5.8" "HPA030062, CAB055097, CAB061888, HPA064554" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283" "unprognostic (2.63e-3)" "unprognostic (3.80e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.75e-5)" "unprognostic (7.24e-2)" "unprognostic (5.16e-5)" "unprognostic (1.56e-2)" "unprognostic (3.29e-2)" "unprognostic (1.03e-1)" "unprognostic (2.16e-1)" "unprognostic (4.13e-2)" "unprognostic (4.00e-2)" "unprognostic (3.37e-2)" "unprognostic (3.27e-1)" "unprognostic (2.37e-1)" "unprognostic (8.93e-3)" "unprognostic (1.02e-1)" 0.9 1.4 1.1 0.5 0.4 0.0 0.6 0.2 0.8 3.8 0.4 0.2 11.7 0.1 2.2 15.2 0.6 9.6 0.8 0.6 0.5 0.5 69.3 0.4 0.5 0.7 0.4 0.3 3.8 0.6 0.1 0.7 0.8 1.5 1.1 0.1 0.5 0.5 10.0 0.3 0.5 0.6 0.4 0.8 0.3 0.4 1.9 0.2 0.4 120.5 0.0 0.2 0.8 1.9 4.4 2.8 1.5 3.4 1.9 2.5 1.1 2.9 0.2 0.1 0.0 0.1 0.0 1.0 0.8 2.7 0.2 0.4 1.8 0.5 0.5 27.1 0.2 16.8 0.0 0.5 0.8 0.2 1.2 0.0 0.4 0.2 1.0 0.3 0.0 0.0 0.7 0.1 0.2 0.6 3.3 0.0 0.0 0.4 2.0 0.8 0.6 0.3 1.2 0.1 0.7 1.8 0.0 0.2 0.6 63.8 4.7 0.5 0.0 3.4 0.0 1.8 0.0 0.0 1.1 0.9 4.6 0.1 0.8 2.3 0.4 1.4 0.1 4.0 0.6 0.0 1.5 3.4 0.0 0.6 1.8 1.5 4.4 1.5 1.1 2.8 1.9 2.5 1.5 0.5 1.9 1.3 1.1 0.8 1.1 1.1 0.4 0.2 0.8 0.5 0.5 0.4 0.3 1.5 0.2 3.0 1.3 0.8 1.7 0.6 0.6 0.8 2.5 0.0 4.5 233.8 0.0 2.1 39.7 9.6 1.5 0.5 5.8 0.0 2.6 2.0 1.9 1.0 0.0 0.0 4.5 0.0 4.6 1.3 1.3 3.1 4.6 2.6 0.0 2.8 2.3 3.3 17.3 7.0 0.4 100.4 0.7 6.5 0.1 4.2 5.8 0.6 0.7 1.0 3.7 1.7 PAXX "C9orf142, XLS" ENSG00000148362 "PAXX, non-homologous end joining factor" Q9BUH6 9 136992418-136993984 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 112.4;Distal tubular cells: 111.0;Extravillous trophoblasts: 180.6;Syncytiotrophoblasts: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045268 Uncertain Supported Nucleoplasm NA NA 77000 Nucleoplasm "HPA045268: AB_10963079" "unprognostic (1.85e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.14e-3)" "unprognostic (9.88e-3)" "unprognostic (1.95e-1)" "unprognostic (2.15e-1)" "unprognostic (2.13e-3)" "unprognostic (3.22e-1)" "unprognostic (3.10e-1)" "unprognostic (1.00e-2)" "prognostic favorable (6.71e-4)" "unprognostic (3.54e-2)" "unprognostic (1.75e-2)" "unprognostic (9.64e-3)" "unprognostic (3.66e-1)" "unprognostic (9.31e-2)" "unprognostic (8.97e-3)" 14.0 10.2 20.7 17.2 18.4 28.0 15.6 14.7 25.4 11.9 17.8 16.4 10.3 22.0 10.6 12.9 14.1 11.8 14.3 12.4 19.4 16.9 14.2 18.2 12.9 24.2 20.7 12.5 10.1 25.9 9.4 17.1 17.1 16.0 16.0 4.9 9.9 24.8 15.7 15.8 19.5 18.1 7.1 25.3 27.8 28.0 6.4 14.7 34.5 16.4 11.5 15.0 11.5 10.3 8.3 56.3 4.1 12.6 19.1 36.2 13.5 10.2 11.5 1.8 7.0 3.3 3.0 27.5 7.9 4.8 5.3 2.9 5.0 7.5 9.3 13.9 2.0 2.0 16.4 0.6 5.9 0.4 23.7 16.4 7.2 5.9 4.2 5.0 10.3 16.1 2.2 5.6 1.8 2.3 0.9 4.8 17.0 10.7 2.7 1.1 22.6 10.8 16.8 11.1 11.9 35.3 14.1 3.8 26.2 3.5 5.3 8.8 11.0 6.8 16.9 9.0 0.3 20.2 8.7 6.3 2.5 7.8 12.0 9.3 5.1 4.5 6.2 4.5 11.8 9.4 4.1 10.8 4.1 36.2 12.6 31.1 8.3 20.2 31.2 11.0 7.8 11.2 25.6 3.7 19.1 6.4 56.3 15.1 13.5 20.7 18.4 14.7 25.4 19.4 16.9 20.7 12.5 16.0 14.7 14.9 25.1 0.0 0.0 0.0 0.0 0.0 0.0 21.4 13.6 38.4 0.0 112.4 111.0 40.3 0.0 0.0 0.0 0.0 37.7 180.6 0.0 0.0 11.6 0.0 69.5 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 61.3 0.0 0.0 33.7 0.0 0.0 58.6 0.0 0.0 0.0 0.0 0.0 0.0 74.1 0.0 0.0 0.0 PBRM1 "BAF180, PB1" ENSG00000163939 "Polybromo 1" Q86U86 3 52545352-52685917 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015629, HPA059373" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015629: AB_1855012, HPA059373: AB_2683994" "unprognostic (1.87e-1)" "unprognostic (1.73e-1)" "unprognostic (1.91e-2)" "unprognostic (2.00e-1)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-2)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (1.99e-2)" "unprognostic (4.32e-2)" "unprognostic (2.89e-3)" "unprognostic (3.06e-1)" "unprognostic (1.96e-1)" "unprognostic (1.53e-2)" "unprognostic (1.06e-1)" 24.3 14.8 13.8 20.6 15.9 17.2 24.4 19.1 13.8 18.9 18.5 14.0 22.9 12.2 25.9 13.9 19.9 18.9 13.7 15.9 11.1 10.0 11.7 14.5 14.9 16.5 16.5 8.2 25.1 15.4 14.4 30.6 28.0 14.7 16.1 15.3 12.7 17.5 16.2 21.8 17.2 14.3 21.1 15.6 19.1 14.8 13.1 13.7 51.0 22.0 10.5 17.1 22.4 23.0 6.6 10.7 11.1 8.7 4.6 7.4 1.9 12.5 8.1 29.0 14.2 14.3 14.6 20.3 17.3 11.9 20.0 17.6 9.1 8.5 30.4 2.4 20.3 16.6 8.6 25.1 13.1 24.4 32.5 13.5 28.8 15.3 7.0 20.5 24.0 21.9 13.6 15.2 22.4 14.5 15.8 19.3 24.1 16.4 16.7 20.1 4.2 39.5 7.2 17.6 8.5 13.3 20.7 18.2 15.5 8.3 24.5 19.7 21.8 20.8 5.0 16.5 18.4 9.4 13.9 22.2 18.8 14.3 16.2 21.1 12.1 19.0 28.9 11.6 19.5 18.7 10.1 5.0 11.1 4.8 3.2 4.9 3.6 4.8 5.3 4.8 6.6 7.4 4.7 2.7 4.6 8.7 10.7 4.5 1.9 13.8 15.9 19.1 13.8 11.1 10.0 16.5 8.2 14.7 13.7 38.7 54.1 19.5 31.0 35.9 42.0 48.4 28.1 53.5 38.7 22.7 45.2 31.3 16.6 31.4 28.7 40.3 25.3 23.3 40.4 28.9 31.5 35.3 27.8 37.0 45.9 28.6 33.8 35.0 63.3 14.7 31.7 46.6 45.5 50.5 30.6 28.5 42.9 28.1 54.8 13.9 43.3 25.8 45.3 41.9 32.8 45.0 42.6 34.1 34.5 33.3 PBX2 "G17, HOX12, PBX2MHC" ENSG00000204304 "PBX homeobox 2" P40425 6 32184741-32190186 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061478 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA061478: AB_2684535" "unprognostic (9.73e-3)" "unprognostic (2.16e-2)" "unprognostic (1.40e-2)" "prognostic unfavorable (8.90e-5)" "unprognostic (4.98e-1)" "unprognostic (2.68e-2)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (1.81e-2)" "prognostic favorable (6.84e-4)" "unprognostic (3.84e-2)" "unprognostic (3.08e-1)" "unprognostic (3.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.06e-1)" "unprognostic (2.52e-2)" "unprognostic (2.27e-1)" 15.3 17.7 14.1 14.9 14.8 8.1 12.3 19.3 16.4 17.0 20.8 16.4 36.2 13.7 23.0 39.1 19.7 21.9 19.1 13.6 15.9 10.7 14.8 14.6 26.4 24.0 13.7 10.0 25.0 12.3 10.8 24.3 30.7 12.9 18.4 15.3 15.0 14.6 29.1 17.2 22.0 17.2 22.3 12.2 29.6 22.4 9.9 17.7 17.1 25.6 14.4 20.6 17.4 18.4 0.2 1.8 0.7 0.2 0.0 0.2 0.1 2.3 2.4 12.3 9.5 13.2 16.7 6.9 2.0 4.7 5.4 5.5 3.3 3.7 10.8 12.4 7.2 0.9 6.8 3.8 14.0 5.4 8.0 15.6 8.8 4.3 2.6 11.4 6.1 9.5 22.0 7.7 4.0 11.7 6.7 9.6 17.7 13.3 5.2 2.1 10.7 6.7 13.1 0.1 1.3 1.5 9.0 2.6 12.5 11.8 4.0 4.6 6.4 1.6 3.4 13.4 8.5 8.7 12.6 2.5 4.1 10.6 1.7 2.1 27.7 18.1 13.8 8.7 5.0 6.9 0.0 0.2 0.7 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.4 0.0 0.1 1.8 0.0 0.1 14.1 14.8 19.3 16.4 15.9 10.7 13.7 10.0 12.9 17.7 6.0 14.1 14.8 16.4 16.3 17.4 2.4 25.5 2.7 5.7 15.7 7.9 25.3 3.3 14.4 0.6 11.3 9.8 0.0 11.9 23.0 14.3 16.8 15.0 19.2 16.1 25.4 29.2 25.8 34.2 1.8 18.7 18.4 8.5 9.0 15.8 19.8 12.1 14.0 18.4 7.7 4.6 6.5 18.9 0.7 3.4 16.9 39.5 15.0 14.4 15.7 PCDHB2 PCDH-BETA2 ENSG00000112852 "Protocadherin beta 2" Q9Y5E7 5 141094578-141098703 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 9 "Melanocytes: 3.3;Spermatocytes: 7.1;Spermatogonia: 4.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 13.7;AN3-CA: 29.4;EFO-21: 16.7;U-138 MG: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007548 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA007548: AB_2667859" "unprognostic (2.94e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-4)" "unprognostic (1.31e-1)" "unprognostic (3.03e-3)" "unprognostic (7.01e-2)" "unprognostic (5.52e-2)" "unprognostic (2.24e-1)" "unprognostic (3.99e-1)" "unprognostic (2.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (6.99e-4)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (4.84e-4)" 7.3 3.0 3.4 1.6 8.6 0.8 5.5 5.7 13.3 3.9 4.4 7.0 0.0 2.1 6.7 2.1 4.0 2.8 4.4 4.3 4.1 1.9 2.9 0.8 6.2 1.0 3.2 5.1 4.3 2.7 0.9 5.3 2.4 4.8 5.9 2.8 4.0 3.8 1.7 1.9 4.3 2.6 4.3 8.4 1.6 1.9 12.1 5.0 0.0 2.8 1.2 0.9 4.4 2.6 0.2 0.2 0.8 0.1 0.5 0.4 0.3 0.2 1.9 13.7 29.4 3.8 1.8 6.3 0.5 2.1 0.0 0.0 0.3 0.1 0.5 16.7 0.9 3.3 0.0 0.6 0.1 0.0 0.2 0.4 0.0 0.0 3.8 0.0 0.0 1.4 0.9 0.0 0.0 0.2 0.6 0.3 1.6 0.4 0.4 4.0 0.1 3.7 0.0 6.0 0.2 3.9 0.0 10.1 0.1 1.5 0.0 7.5 2.1 0.0 1.8 4.3 8.0 8.3 2.4 1.5 12.9 3.9 6.0 1.9 0.2 0.0 0.1 2.8 0.1 7.7 0.5 0.1 0.0 0.4 0.1 0.0 0.1 0.4 0.1 0.0 0.2 0.1 0.2 0.8 0.5 0.1 0.2 0.0 0.3 3.4 8.6 5.7 11.0 4.1 1.9 3.2 5.1 4.8 5.0 0.0 0.3 0.0 0.9 0.7 2.9 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.5 1.4 1.3 0.0 0.0 0.3 0.0 1.6 0.9 0.0 0.0 0.1 1.6 1.2 0.0 0.0 0.4 1.1 0.0 3.3 0.0 0.2 2.6 0.3 0.0 1.4 0.4 1.2 0.0 0.8 7.1 4.7 0.4 0.0 0.0 0.0 0.4 PCDHB6 PCDH-BETA6 ENSG00000113211 "Protocadherin beta 6" Q9Y5E3 5 141150022-141153287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 13.4" "Cell type enriched" "Detected in some" 7 "Spermatocytes: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 16.9;SH-SY5Y: 7.2;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029566, HPA075308" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029566: AB_10601385, HPA075308: " "unprognostic (3.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.81e-1)" "unprognostic (8.05e-2)" "unprognostic (7.65e-3)" "unprognostic (2.82e-1)" "unprognostic (1.73e-3)" "unprognostic (9.64e-3)" "unprognostic (8.62e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (6.33e-2)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.60e-4)" "unprognostic (2.31e-2)" "unprognostic (7.08e-3)" "unprognostic (6.52e-2)" 2.5 2.4 3.9 1.0 5.1 0.4 2.5 4.2 8.4 2.3 1.5 2.6 0.0 0.6 4.5 3.7 0.7 2.1 1.4 1.6 3.5 1.9 1.6 1.4 1.7 0.7 2.6 3.6 3.7 1.5 13.4 6.4 1.5 2.9 1.5 0.9 0.7 2.5 1.5 1.4 2.4 1.0 3.0 3.3 1.5 0.9 5.4 3.1 0.0 1.1 1.0 0.7 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 16.9 0.2 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 7.2 0.0 0.1 3.6 0.4 5.4 2.2 0.0 0.6 1.3 7.6 0.0 0.0 0.0 0.0 3.9 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.1 4.2 8.4 3.5 1.9 2.6 3.6 2.9 3.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.0 0.2 0.0 1.2 9.9 0.1 0.4 0.0 0.0 0.0 0.0 PCGF1 "MGC10882, NSPC1, RNF68" ENSG00000115289 "Polycomb group ring finger 1" Q9BSM1 2 74505043-74508580 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011356, HPA069156" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA011356: AB_1855063, HPA069156: AB_2686095" "unprognostic (2.41e-1)" "unprognostic (5.97e-2)" "unprognostic (1.11e-3)" "unprognostic (2.71e-2)" "unprognostic (4.25e-2)" "unprognostic (2.73e-2)" "unprognostic (2.32e-2)" "unprognostic (4.18e-3)" "unprognostic (2.26e-1)" "unprognostic (2.14e-1)" "unprognostic (1.57e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.69e-4)" "unprognostic (1.00e-1)" "unprognostic (5.09e-2)" "unprognostic (1.21e-1)" "unprognostic (2.13e-1)" 3.8 3.1 2.5 2.5 6.1 4.8 4.5 5.6 7.4 4.2 4.6 4.1 2.5 4.0 5.2 2.5 3.0 4.4 2.5 2.9 2.5 2.3 3.4 3.3 3.5 4.0 2.5 6.2 5.4 4.1 4.4 4.2 3.1 5.4 3.1 3.4 2.5 3.6 2.5 2.5 4.3 3.2 3.0 5.7 3.1 3.4 5.1 2.5 2.5 5.1 2.5 4.1 2.6 3.4 7.5 8.5 2.9 7.7 4.1 8.1 3.9 4.0 2.9 2.4 3.5 2.2 3.5 4.3 4.5 4.9 4.2 2.5 7.5 2.0 6.0 2.1 4.3 7.5 2.2 4.3 5.8 2.9 5.2 8.4 2.5 3.5 5.5 3.8 7.8 4.2 6.4 4.2 2.5 12.9 5.9 2.4 6.4 7.2 4.3 2.6 6.1 5.7 8.1 3.9 5.8 2.8 4.4 6.1 2.9 5.3 5.4 3.2 10.7 3.7 4.5 6.4 3.1 1.7 7.3 3.1 4.8 4.3 7.8 4.1 3.5 3.1 5.0 4.2 3.9 5.4 1.7 7.7 2.9 5.4 5.5 6.0 7.2 7.0 6.8 8.5 7.5 5.7 5.6 2.7 4.1 6.1 4.8 8.1 3.9 2.5 6.1 5.6 7.4 2.5 2.3 2.5 6.2 5.4 2.5 3.0 2.6 4.2 8.8 11.1 5.1 2.8 12.7 1.4 3.4 3.5 3.9 9.9 26.6 9.7 14.5 5.8 10.3 0.0 9.0 14.2 11.1 8.8 10.3 5.4 12.1 4.8 1.2 6.2 8.7 2.3 7.2 11.0 6.8 13.6 11.7 6.0 10.0 17.3 4.6 13.2 8.7 6.5 8.3 13.5 7.4 16.6 15.3 8.5 8.1 6.4 PCGF2 "MEL-18, RNF110, ZNF144" ENSG00000277258 "Polycomb group ring finger 2" P35227 17 38733897-38749817 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047732, HPA063531" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA047732: AB_2680138, HPA063531: AB_2685031" "unprognostic (1.56e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (2.45e-1)" "unprognostic (1.37e-1)" "unprognostic (1.31e-3)" "unprognostic (2.47e-2)" "unprognostic (7.78e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (5.10e-3)" "unprognostic (8.18e-2)" "unprognostic (6.12e-2)" "unprognostic (7.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" "unprognostic (1.79e-1)" 5.7 7.2 6.6 2.9 6.7 0.0 12.2 11.6 7.7 9.0 3.6 1.1 8.7 2.6 8.9 9.5 4.4 8.8 7.8 7.0 6.9 10.7 1.8 7.9 2.2 2.4 4.4 11.4 4.7 10.1 12.0 8.3 3.9 6.7 3.8 11.4 7.8 7.6 3.3 4.1 4.2 5.9 2.9 5.3 5.2 2.7 3.7 0.0 7.7 3.9 1.6 6.3 18.6 0.8 0.3 0.3 0.4 0.0 0.5 0.1 8.1 19.2 14.2 25.5 7.9 6.4 5.9 6.5 10.1 10.4 9.6 11.8 9.3 0.6 7.2 8.2 10.6 13.2 7.2 6.2 7.4 5.0 10.4 3.9 9.9 28.6 8.5 0.6 4.9 6.2 5.5 7.7 7.6 13.6 13.4 4.7 7.2 10.8 7.0 21.7 0.8 0.1 11.5 4.2 7.7 6.5 8.1 1.6 8.5 11.9 8.4 16.0 6.3 4.6 13.5 14.3 18.0 0.9 14.3 13.2 14.3 12.7 11.4 6.5 1.9 2.0 10.3 1.0 12.2 0.0 0.4 0.0 0.5 0.0 0.5 0.8 0.3 0.0 0.3 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.1 3.0 13.6 2.0 9.8 12.6 56.6 1.6 17.8 1.4 5.7 19.2 9.8 11.6 44.7 21.9 5.9 29.3 17.1 0.0 12.0 21.3 20.7 13.2 1.1 1.0 4.0 33.4 12.7 46.1 3.8 3.2 34.2 4.0 13.5 5.4 12.8 17.7 16.9 7.0 27.6 39.6 14.2 0.0 14.2 4.1 14.0 14.8 18.5 0.0 12.4 7.8 PCGF3 "DONG1, FLJ36550, MGC40413, RNF3, RNF3A" ENSG00000185619 "Polycomb group ring finger 3" Q3KNV8 4 705748-770640 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061879 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA061879: AB_2684631" "unprognostic (1.24e-1)" "unprognostic (2.77e-1)" "unprognostic (2.62e-1)" "unprognostic (1.06e-2)" "unprognostic (1.66e-1)" "prognostic favorable (3.73e-4)" "unprognostic (2.76e-2)" "unprognostic (4.21e-2)" "unprognostic (9.52e-2)" "unprognostic (1.47e-2)" "prognostic favorable (1.44e-4)" "unprognostic (2.36e-2)" "unprognostic (6.84e-3)" "unprognostic (2.53e-1)" "unprognostic (2.20e-1)" "unprognostic (1.96e-1)" "prognostic favorable (5.25e-4)" 17.3 29.0 18.2 22.0 18.8 28.0 18.9 31.4 21.8 17.7 15.2 12.4 21.4 24.3 20.9 19.1 17.9 17.5 18.1 14.0 16.5 11.2 14.6 15.3 17.8 18.2 17.2 17.5 28.6 15.3 6.5 20.0 21.3 15.3 20.5 11.9 15.1 20.4 15.8 15.5 55.8 22.5 15.2 11.8 26.4 20.8 18.0 16.9 20.8 21.3 19.2 17.6 15.3 20.0 7.3 7.2 6.9 11.6 6.9 5.4 3.5 11.4 10.4 19.2 21.9 8.8 9.1 23.7 15.6 8.6 12.9 13.1 11.4 12.7 8.3 10.5 15.0 13.1 8.0 8.9 12.7 9.8 10.8 9.6 11.8 12.2 20.0 10.8 8.0 15.8 11.4 17.0 11.2 5.1 8.5 16.4 15.2 16.2 6.8 12.5 12.8 21.5 28.5 12.7 7.8 18.9 21.4 12.2 5.2 7.6 18.9 27.5 20.7 8.1 8.7 8.3 13.0 17.0 11.5 19.6 12.6 10.2 10.4 20.0 16.5 13.9 12.9 9.9 12.9 23.2 5.5 11.6 4.7 5.4 7.5 4.8 6.7 3.4 3.4 5.1 7.3 4.3 3.0 6.9 6.9 3.5 7.2 5.0 3.5 18.2 18.8 31.4 21.8 16.5 11.2 17.2 17.5 15.3 16.9 11.9 30.3 15.9 14.9 22.6 11.8 16.7 22.9 9.4 18.2 8.7 11.8 11.7 3.3 18.4 44.6 21.8 17.2 0.0 17.2 22.3 17.3 17.4 16.1 12.1 10.7 6.4 18.5 25.8 11.0 39.8 15.3 17.1 21.9 10.0 21.7 9.2 26.4 14.4 14.5 8.8 7.9 6.5 16.9 20.1 24.3 25.1 19.8 13.8 18.7 25.2 PCNA ENSG00000132646 "Proliferating cell nuclear antigen" P12004 20 5114953-5126626 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction" DNA-binding "Cancer-related genes, Deafness, Disease mutation, Dwarfism, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 115.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB000148, HPA030521, HPA030522, HPA030523" Enhanced Enhanced Nucleoplasm No Yes Nucleoplasm "CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199" "unprognostic (5.21e-2)" "prognostic favorable (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (2.43e-1)" "unprognostic (3.17e-1)" "unprognostic (5.60e-3)" "prognostic unfavorable (2.61e-4)" "unprognostic (1.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.89e-2)" "unprognostic (1.01e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (3.03e-6)" "unprognostic (2.12e-2)" "unprognostic (2.29e-1)" "unprognostic (7.11e-3)" "unprognostic (7.46e-2)" 13.9 21.4 11.1 31.8 15.8 87.2 13.7 17.2 14.6 13.7 23.1 15.6 13.7 18.9 15.7 13.7 36.0 12.7 17.5 13.6 11.6 9.8 21.7 14.9 17.8 41.6 18.8 10.8 14.4 14.3 14.0 13.9 24.0 14.3 10.8 26.1 18.7 17.7 15.6 11.0 16.5 20.5 12.8 16.1 24.5 15.7 40.5 17.4 115.8 18.1 40.7 38.7 17.3 17.2 16.9 16.0 8.7 11.6 19.6 24.4 16.9 74.2 58.5 59.3 25.5 14.1 13.2 41.6 48.9 28.8 46.1 65.6 45.6 59.4 75.5 15.9 17.4 40.4 55.8 35.0 58.9 42.3 22.4 38.7 53.0 22.5 106.2 6.0 72.5 23.8 9.6 14.0 39.2 9.3 9.7 26.3 50.4 47.2 63.8 44.9 26.8 138.7 80.3 44.4 58.0 32.4 76.6 52.2 60.9 20.8 43.4 51.0 34.6 34.3 53.0 33.6 22.8 37.4 37.0 17.5 33.3 38.3 46.8 55.8 32.4 92.5 127.9 15.0 69.1 42.6 2.4 11.6 8.7 19.2 10.9 23.8 16.9 24.4 19.3 16.0 13.6 22.4 20.1 3.8 19.6 11.4 14.7 23.3 16.9 11.1 15.8 17.2 14.6 11.6 9.8 18.8 10.8 14.3 17.4 41.7 27.0 42.4 43.7 60.1 36.0 11.2 17.8 34.8 43.3 55.8 25.5 92.8 51.4 37.7 137.5 25.2 25.5 46.7 34.8 161.2 34.6 21.0 20.9 24.7 83.0 30.2 19.1 35.6 27.3 83.6 33.4 41.7 35.4 67.7 35.2 57.6 24.8 21.0 37.8 36.6 74.2 51.8 33.9 133.4 89.3 43.4 55.5 43.6 63.4 25.0 PCNX1 "KIAA0805, KIAA0995, PCNX, PCNXL1, pecanex" ENSG00000100731 "Pecanex homolog 1" Q96RV3 14 70907405-71115382 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 27.5;Ciliated cells: 17.4;granulocytes: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053532 Approved Nucleoplasm NA NA Nucleoplasm "HPA053532: AB_2682180" "unprognostic (1.96e-1)" "unprognostic (2.46e-1)" "unprognostic (2.01e-1)" "unprognostic (2.62e-1)" "unprognostic (2.21e-1)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-2)" "unprognostic (4.16e-2)" "unprognostic (5.56e-2)" "prognostic favorable (4.05e-5)" "unprognostic (9.01e-3)" "unprognostic (2.90e-1)" "unprognostic (8.11e-2)" "unprognostic (7.37e-2)" 18.2 32.2 14.0 18.8 19.8 20.0 17.4 16.3 21.2 15.7 18.5 14.5 8.8 10.2 18.7 10.3 12.2 14.5 13.2 16.2 11.4 8.1 16.1 14.7 20.2 21.4 14.1 13.1 27.1 12.3 26.3 22.3 11.5 12.0 12.8 10.3 16.8 11.7 12.3 22.8 12.0 18.7 17.1 12.4 22.2 14.1 26.4 13.3 16.4 16.1 10.2 16.7 16.6 17.3 2.3 4.1 11.2 2.0 1.9 10.5 1.6 12.6 8.9 10.3 6.4 17.5 11.8 5.7 13.5 13.6 10.6 14.9 8.8 5.7 9.1 4.7 13.8 8.3 12.7 11.0 10.9 16.1 27.7 4.2 1.7 5.7 9.3 10.6 13.7 4.7 12.1 9.7 10.6 19.1 13.2 10.5 9.4 0.7 13.2 12.2 10.2 6.5 12.5 5.2 5.6 4.9 5.9 11.8 2.7 7.3 9.5 4.3 6.7 10.3 6.2 7.6 11.0 5.5 13.1 12.4 19.6 21.9 6.3 9.7 8.0 4.1 7.6 12.1 11.3 6.8 2.8 2.0 1.8 4.0 1.1 5.5 1.6 6.9 4.1 0.5 2.3 3.0 4.6 11.2 1.9 0.7 4.1 10.5 1.6 14.0 19.8 16.3 21.2 11.4 8.1 14.1 13.1 12.0 13.3 14.9 27.5 0.0 0.0 0.0 0.0 0.0 0.0 17.4 11.4 8.7 0.0 5.1 1.7 7.9 0.0 0.0 0.0 0.0 4.6 5.3 0.0 0.0 14.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 7.2 0.0 0.0 7.4 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 PDCD4 H731 ENSG00000150593 "Programmed cell death 4" Q53EL6 10 110871795-110900006 "Predicted intracellular proteins" Apoptosis RNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 153.1" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 657.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 59.4;U-266/70: 65.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001032, HPA027214, CAB037024" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB037024: AB_1841089, HPA001032: AB_1079586, HPA027214: AB_1855107" "unprognostic (4.22e-3)" "unprognostic (1.23e-1)" "unprognostic (5.39e-2)" "unprognostic (1.00e-2)" "unprognostic (2.49e-1)" "unprognostic (1.78e-1)" "unprognostic (6.37e-2)" "unprognostic (3.79e-2)" "unprognostic (1.64e-2)" "unprognostic (1.64e-2)" "unprognostic (1.41e-1)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (1.62e-1)" "unprognostic (1.69e-1)" "unprognostic (2.07e-2)" "unprognostic (4.25e-1)" 14.9 9.1 9.4 20.6 9.8 11.8 28.1 15.6 8.1 20.0 46.7 9.1 64.0 18.0 19.1 18.1 40.6 12.3 11.9 8.1 8.4 8.1 6.5 30.6 9.9 13.8 7.8 6.4 27.8 153.1 61.2 30.3 51.4 8.5 18.7 26.1 16.2 81.7 61.7 5.8 37.3 47.1 13.2 8.6 24.0 27.6 10.1 9.5 22.6 55.4 18.8 27.8 15.1 22.7 18.5 12.6 50.9 9.0 26.9 33.1 11.2 5.2 5.1 8.3 8.7 12.4 23.0 4.9 6.1 18.0 3.0 5.2 3.2 13.0 50.2 17.2 8.4 2.3 24.2 5.0 15.5 6.5 43.4 10.0 25.3 29.8 5.3 5.6 12.6 27.6 18.3 49.8 3.1 16.9 13.6 5.6 8.0 6.7 23.8 7.4 13.3 4.6 14.5 2.1 3.7 9.0 2.0 14.8 26.6 4.9 7.3 3.6 15.2 11.7 6.3 21.3 9.2 59.4 23.9 14.3 4.7 3.5 3.4 2.3 65.3 31.6 28.9 4.4 17.6 4.9 50.9 6.1 15.9 18.5 8.3 33.1 18.5 17.1 20.2 7.3 14.3 14.9 18.1 12.0 26.9 9.0 12.6 9.2 11.2 9.4 9.8 15.6 8.1 8.4 8.1 7.8 6.4 8.5 9.5 17.9 50.8 79.3 72.6 118.1 53.9 14.6 22.9 45.5 69.4 24.4 29.5 205.4 29.9 41.5 11.1 69.1 177.9 0.0 89.4 54.3 62.3 50.5 127.3 20.3 49.3 20.6 32.3 79.2 72.9 9.0 134.3 49.5 276.7 41.5 157.6 33.5 61.9 230.3 209.3 20.9 191.1 38.8 44.8 44.6 64.0 144.5 657.3 161.3 172.4 52.3 PDE1A ENSG00000115252 "Phosphodiesterase 1A" P54750 2 182140036-182523192 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.0;kidney: 37.1" "Group enriched" "Detected in many" 6 "Distal tubular cells: 157.5;Early spermatids: 314.8;Late spermatids: 455.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "ASC diff: 22.8;HHSteC: 13.5;HSkMC: 28.9" "Group enriched" "Detected in many" 6 "amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8" "Low region specificity" "Detected in all" HPA022151 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022151: AB_1855118" "unprognostic (3.63e-1)" "unprognostic (7.21e-2)" "unprognostic (1.32e-1)" "unprognostic (8.61e-2)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (3.84e-1)" "unprognostic (3.82e-1)" "unprognostic (1.02e-1)" "unprognostic (5.38e-2)" "unprognostic (2.78e-1)" "unprognostic (2.86e-1)" "unprognostic (5.55e-3)" "unprognostic (2.50e-3)" "unprognostic (5.96e-2)" "unprognostic (1.37e-1)" "unprognostic (1.40e-3)" 7.6 3.9 13.8 3.6 11.5 0.5 4.1 66.0 25.3 11.5 8.8 6.2 1.7 2.6 7.3 6.7 4.7 7.4 18.2 11.8 12.6 4.1 37.1 3.2 3.1 1.8 7.1 15.7 9.2 2.0 1.3 2.3 1.3 6.9 3.8 5.6 3.0 1.8 4.8 2.4 2.1 4.6 11.8 10.1 2.6 4.6 24.6 9.0 0.0 35.1 2.6 1.1 8.3 9.0 0.0 1.4 0.8 0.2 0.0 0.0 0.0 0.0 0.1 2.3 0.0 22.8 1.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.2 0.0 13.5 0.0 0.0 28.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 3.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 13.8 11.5 66.0 25.3 12.6 4.1 7.1 15.7 6.9 9.0 0.0 1.6 0.0 2.2 1.1 12.6 3.6 0.0 0.0 2.3 26.2 0.0 0.1 157.5 0.3 314.8 5.8 0.0 0.0 0.3 0.0 1.9 2.0 0.0 0.0 0.1 0.0 0.0 8.0 0.0 455.7 13.8 0.2 0.0 0.0 0.6 0.2 0.2 0.0 7.8 1.4 1.1 51.8 47.4 4.4 3.9 1.1 0.0 0.0 0.0 0.7 PDE1C Hcam3 ENSG00000154678 "Phosphodiesterase 1C" Q14123 7 31751179-32299329 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.6;heart muscle: 56.2" "Group enriched" "Detected in some" 7 "Bipolar cells: 55.0;Cardiomyocytes: 112.6;Cone photoreceptor cells: 49.1;Early spermatids: 40.4;Late spermatids: 38.3" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 15.2;fHDF/TERT166: 49.0;hTERT-RPE1: 15.0;U-251 MG: 26.5;WM-115: 35.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052375 Approved Nucleoplasm NA NA Nucleoplasm "HPA052375: AB_2681802" "unprognostic (1.29e-2)" "unprognostic (2.20e-5)" "unprognostic (1.68e-2)" "unprognostic (1.20e-3)" "unprognostic (2.29e-1)" "unprognostic (5.65e-2)" "unprognostic (4.06e-3)" "unprognostic (2.75e-1)" "unprognostic (6.79e-3)" "unprognostic (6.49e-2)" "unprognostic (3.88e-5)" "unprognostic (7.03e-2)" "unprognostic (3.09e-3)" "unprognostic (5.76e-2)" "unprognostic (5.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.06e-3)" 2.9 2.7 10.6 3.2 27.7 0.9 5.1 2.4 17.1 1.2 2.7 30.1 0.0 2.3 3.1 6.8 7.4 8.4 2.4 56.2 14.8 7.5 4.0 1.0 5.0 1.4 31.1 12.0 4.9 2.7 1.3 1.3 4.0 16.3 2.9 2.7 7.9 2.6 4.2 1.4 0.9 2.8 10.4 17.1 1.4 3.8 4.2 33.6 0.0 3.9 0.2 1.0 7.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 5.2 0.0 0.2 0.1 0.0 15.2 6.2 7.2 5.9 0.0 0.0 0.0 0.0 49.0 0.0 0.4 0.0 0.0 9.3 0.0 0.0 0.4 0.4 0.0 0.0 0.0 10.9 0.6 0.0 1.5 0.1 15.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 7.4 0.0 2.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 8.1 3.0 0.1 26.5 0.0 0.0 0.0 0.7 0.1 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 27.7 2.4 17.1 14.8 7.5 31.1 12.0 16.3 33.6 0.0 0.0 0.0 0.8 0.0 55.0 112.6 0.0 4.0 1.2 1.8 49.1 0.0 0.0 5.6 40.4 2.9 0.0 0.0 0.4 0.0 0.0 0.2 8.1 0.0 0.1 3.2 0.0 0.0 0.0 38.3 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.4 0.0 4.4 0.0 2.1 1.1 0.7 0.0 0.0 0.0 0.0 0.0 PDE7B ENSG00000171408 "Phosphodiesterase 7B" Q9NP56 6 135851696-136195574 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 21.0;Endothelial cells: 18.2;Ito cells: 35.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 7.3;ASC TERT1: 8.6;EFO-21: 13.4;HeLa: 7.8;HSkMC: 18.7;HUVEC TERT2: 8.7;U-2197: 9.3" "Region enriched" "Detected in all" 5 "basal ganglia: 112.3" "Low region specificity" "Detected in all" HPA023967 Uncertain Approved Nucleoplasm No NA Nucleoplasm "HPA023967: AB_1855128" "unprognostic (3.18e-1)" "unprognostic (3.47e-1)" "unprognostic (2.34e-1)" "unprognostic (1.79e-3)" "unprognostic (3.34e-1)" "unprognostic (3.22e-4)" "unprognostic (1.37e-2)" "unprognostic (3.00e-1)" "unprognostic (2.80e-1)" "unprognostic (6.73e-3)" "unprognostic (1.11e-2)" "unprognostic (7.85e-2)" "prognostic favorable (1.59e-4)" "unprognostic (3.14e-3)" "unprognostic (2.68e-2)" "unprognostic (1.43e-1)" "unprognostic (3.34e-2)" 5.8 4.3 7.3 4.0 21.9 0.8 3.6 1.6 12.8 6.2 4.0 2.3 25.2 3.6 14.2 4.9 2.8 4.2 6.1 7.9 5.1 7.4 9.6 6.4 3.3 2.8 6.4 4.2 22.7 1.6 3.7 8.7 2.2 5.9 6.8 5.0 5.4 5.0 28.5 7.2 1.5 3.7 13.5 5.3 2.3 5.2 2.9 7.1 7.7 8.3 6.1 1.9 10.6 5.1 4.3 2.6 0.6 0.9 0.7 1.8 0.3 0.0 4.5 0.1 0.0 7.3 8.6 0.0 0.4 2.3 1.7 0.9 0.0 0.0 0.0 13.4 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 7.8 0.0 3.1 0.1 0.0 18.7 0.0 3.4 0.0 0.7 8.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.0 0.5 3.2 3.0 0.1 0.1 0.0 0.0 1.5 0.0 1.9 0.0 9.3 0.0 0.1 0.0 0.0 0.5 0.0 0.7 0.2 0.9 0.6 0.2 0.2 0.1 1.5 0.4 0.2 2.6 4.3 1.8 1.0 0.3 0.7 0.1 0.2 0.2 0.3 7.3 21.9 1.6 12.8 5.1 7.4 6.4 4.2 5.9 7.1 0.0 0.3 3.0 0.2 0.3 2.3 8.5 2.5 0.0 0.0 21.0 0.0 0.1 0.0 0.1 0.4 18.2 0.0 0.0 1.5 0.0 3.3 0.3 10.3 4.7 0.3 6.4 7.0 35.0 1.5 0.0 11.2 0.5 0.0 0.0 0.0 13.8 0.1 0.0 7.4 1.2 0.7 12.9 3.1 0.1 0.2 1.3 0.0 0.0 0.0 0.1 PDIK1L CLIK1L ENSG00000175087 "PDLIM1 interacting kinase 1 like" Q8N165 1 26111165-26125543 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064157 Supported Nucleoplasm NA NA Nucleoplasm "HPA064157: " "unprognostic (1.09e-1)" "unprognostic (1.81e-3)" "unprognostic (2.99e-3)" "unprognostic (2.52e-2)" "unprognostic (2.54e-1)" "unprognostic (1.34e-3)" "unprognostic (3.93e-2)" "unprognostic (1.72e-3)" "unprognostic (7.29e-3)" "unprognostic (1.08e-1)" "unprognostic (2.42e-2)" "unprognostic (3.59e-1)" "unprognostic (1.34e-2)" "unprognostic (4.24e-3)" "unprognostic (2.94e-1)" "unprognostic (4.47e-1)" "unprognostic (1.78e-2)" 7.0 6.0 8.6 6.2 12.3 19.9 11.5 17.8 15.9 8.6 8.9 7.1 7.6 9.5 7.8 6.4 11.4 7.5 5.8 4.8 8.5 10.6 8.5 11.3 6.7 8.0 9.3 9.9 10.2 15.3 10.7 9.9 5.6 11.5 6.8 10.6 6.1 10.2 8.9 7.7 9.4 9.7 6.5 8.3 8.3 10.2 7.8 9.3 19.1 22.2 6.7 8.8 8.8 8.0 6.7 9.3 11.0 6.1 5.6 10.4 5.2 5.5 2.1 5.9 7.4 2.3 3.1 1.9 1.4 2.0 3.8 2.5 1.4 8.0 11.7 4.3 2.1 3.0 4.1 7.8 2.9 3.6 4.2 5.2 10.4 3.3 1.5 3.4 10.9 6.3 1.6 4.2 3.4 6.7 2.6 3.4 11.4 12.3 11.7 1.3 3.1 15.8 4.9 2.7 6.8 3.2 8.4 5.4 14.0 2.5 4.4 9.4 8.0 5.6 7.1 7.2 1.6 4.1 3.7 3.1 4.1 3.6 5.2 4.6 17.5 17.2 8.9 4.3 13.6 3.9 11.0 5.0 4.2 6.7 4.6 6.2 6.7 9.4 7.4 9.3 5.6 10.0 8.0 0.5 5.6 6.1 3.5 10.4 5.2 8.6 12.3 17.8 15.9 8.5 10.6 9.3 9.9 11.5 9.3 8.9 3.4 4.5 1.8 2.9 17.8 1.6 10.2 9.4 7.9 1.8 0.0 3.2 0.0 2.7 0.9 3.5 3.9 0.0 3.5 0.4 2.6 3.1 6.9 9.7 3.4 22.3 12.6 3.1 6.5 0.0 2.3 4.2 3.3 0.0 9.1 10.1 3.0 0.0 2.8 6.0 9.8 0.0 1.4 8.1 4.3 6.5 1.4 4.9 10.0 2.4 PDS5A "KIAA0648, PIG54, SCC-112" ENSG00000121892 "PDS5 cohesin associated factor A" Q29RF7 4 39822863-39977956 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036661, HPA036662" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036661: AB_2675233, HPA036662: AB_10696783" "unprognostic (4.18e-2)" "unprognostic (1.42e-1)" "unprognostic (1.62e-3)" "unprognostic (6.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (9.97e-3)" "unprognostic (2.97e-1)" "unprognostic (6.67e-3)" "unprognostic (3.19e-2)" "unprognostic (2.59e-2)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (1.94e-1)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.81e-2)" 24.9 18.7 15.8 34.7 17.3 22.6 44.9 25.9 19.2 20.5 23.8 12.7 22.9 17.5 20.7 19.8 28.3 17.2 17.4 18.3 17.0 16.6 21.1 29.6 26.8 35.1 16.5 13.1 26.3 23.7 34.0 18.7 30.3 15.5 19.9 22.0 12.2 23.2 21.4 22.3 21.6 21.9 18.7 19.3 26.9 18.1 12.1 15.4 61.3 26.0 18.6 29.9 21.3 41.7 5.2 4.6 3.7 3.4 6.3 6.7 2.2 19.6 14.7 18.9 19.9 18.3 18.4 15.1 15.9 15.2 18.9 18.9 14.2 22.3 38.4 17.6 18.8 30.1 10.8 32.2 18.6 27.3 12.8 12.2 26.3 18.5 14.9 18.3 32.1 22.6 12.1 21.1 20.0 29.7 16.8 24.0 23.0 31.1 16.4 19.3 13.8 40.0 28.2 10.7 18.6 9.9 37.4 33.7 14.0 18.1 20.0 26.2 15.5 22.0 15.2 14.1 14.8 15.4 28.5 22.5 21.4 22.3 15.5 26.9 13.9 24.2 41.3 15.3 33.0 16.8 3.7 2.5 3.7 5.2 3.4 6.7 4.5 5.1 5.7 3.8 5.2 6.2 4.7 1.0 6.3 2.2 4.6 4.2 2.2 15.8 17.3 25.9 19.2 17.0 16.6 16.5 13.1 15.5 15.4 80.4 55.3 32.7 32.4 50.4 33.3 34.7 12.7 17.4 53.4 21.0 56.9 26.4 6.6 19.2 7.4 38.6 26.7 0.0 22.5 31.3 29.0 40.9 27.8 51.6 26.8 12.7 29.3 43.0 40.7 5.0 30.5 41.3 43.9 22.6 36.1 14.1 31.8 24.6 31.1 22.3 25.8 32.3 25.8 28.7 44.7 59.6 32.4 34.1 34.7 50.3 PDS5B "APRIN, AS3, CG008, FLJ23236, KIAA0979" ENSG00000083642 "PDS5 cohesin associated factor B" Q9NTI5 13 32586427-32778019 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039513, HPA040015" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039513: AB_10671999, HPA040015: AB_10671047" "unprognostic (3.52e-2)" "unprognostic (1.21e-1)" "unprognostic (4.25e-2)" "unprognostic (6.19e-2)" "unprognostic (2.00e-1)" "unprognostic (2.30e-1)" "unprognostic (8.98e-2)" "unprognostic (3.29e-1)" "unprognostic (4.17e-2)" "unprognostic (1.28e-2)" "unprognostic (3.96e-2)" "unprognostic (6.29e-2)" "unprognostic (5.47e-2)" "unprognostic (9.62e-3)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (3.91e-2)" 14.8 11.2 18.9 11.8 20.5 25.8 17.0 21.2 27.5 21.8 16.2 8.0 10.2 8.1 25.4 18.3 9.8 16.1 10.6 9.8 17.2 16.0 13.6 12.6 14.1 15.9 12.6 22.9 22.0 9.9 15.4 17.8 14.2 14.7 17.7 11.3 8.6 11.3 13.9 14.0 13.6 13.6 16.5 12.5 16.6 12.7 15.3 14.3 29.1 14.0 7.7 13.7 16.9 24.2 9.2 7.7 8.3 6.5 5.6 8.3 3.3 6.2 3.8 17.3 9.2 8.3 6.0 4.8 10.7 7.2 9.1 9.2 5.2 10.5 23.0 3.8 5.2 9.1 8.4 12.4 6.7 10.8 18.3 4.7 20.7 6.9 7.2 4.9 18.9 12.8 4.6 3.4 7.5 6.8 5.9 6.8 9.3 7.1 15.5 8.3 8.0 22.6 14.2 12.7 13.2 4.6 23.1 23.9 7.8 5.8 5.2 4.5 10.9 12.2 12.2 4.5 11.0 11.7 12.7 13.4 8.7 8.5 6.2 6.3 4.8 5.3 19.6 3.7 12.9 12.6 5.8 6.0 8.3 7.2 4.9 8.3 7.8 8.3 7.4 7.7 9.2 8.2 7.9 7.5 5.6 6.5 5.3 5.9 3.3 18.9 20.5 21.2 27.5 17.2 16.0 12.6 22.9 14.7 14.3 14.9 24.6 19.1 19.2 25.6 41.6 22.1 25.5 36.1 31.8 26.2 23.6 19.7 5.0 12.7 12.2 37.9 13.5 0.0 13.6 15.6 29.2 22.6 23.1 24.9 15.6 44.5 30.6 23.4 34.4 9.8 62.2 26.6 33.7 24.4 20.0 17.5 12.0 12.5 58.7 9.6 20.1 71.1 56.1 46.6 59.4 25.6 5.1 28.9 16.3 11.2 PDX1 "IDX-1, IPF1, MODY4, PDX-1, STF-1" ENSG00000139515 "Pancreatic and duodenal homeobox 1" P52945 13 27920020-27926231 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 10.4;intestine: 33.0;pancreas: 24.2" "Group enriched" "Detected in some" 10 "Cholangiocytes: 5.1;Ductal cells: 7.6;Exocrine glandular cells: 8.8;Intestinal endocrine cells: 13.3;Pancreatic endocrine cells: 3.3" "Group enriched" "Detected in many" 11 "colorectal cancer: 8.4;liver cancer: 1.9;pancreatic cancer: 8.6;stomach cancer: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.2;HEK 293: 3.7;HeLa: 9.4;OE19: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025873, HPA059146" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB025873: , HPA059146: AB_2683927" "unprognostic (2.79e-2)" "unprognostic (2.22e-1)" "unprognostic (1.92e-1)" "unprognostic (2.65e-1)" "unprognostic (6.84e-2)" "unprognostic (3.89e-2)" "unprognostic (6.75e-3)" "unprognostic (7.10e-3)" "unprognostic (3.83e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 33.0 0.0 0.0 31.1 0.1 0.0 0.1 0.1 10.4 0.1 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.0 0.1 24.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 17.6 0.0 0.2 0.1 4.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 6.2 3.7 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 PDXK "C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79" ENSG00000160209 "Pyridoxal kinase" O00764 21 43719094-43762307 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 68.9" "Group enriched" "Detected in all" 7 "Early spermatids: 1421.5;Late spermatids: 3146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030196, HPA030197, HPA030198, CAB033918" Enhanced Enhanced Nucleoplasm NA NA 870000 Nucleoplasm "CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570" "unprognostic (1.01e-1)" "unprognostic (1.99e-1)" "unprognostic (5.88e-2)" "unprognostic (1.87e-1)" "unprognostic (8.29e-2)" "unprognostic (4.31e-3)" "unprognostic (3.64e-3)" "unprognostic (1.32e-1)" "unprognostic (8.66e-2)" "unprognostic (9.34e-2)" "unprognostic (2.10e-1)" "unprognostic (3.54e-1)" "unprognostic (3.70e-2)" "unprognostic (1.31e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.51e-3)" 28.1 13.2 37.4 8.7 36.6 13.3 13.3 21.9 38.5 9.7 13.8 11.0 15.7 16.7 9.0 13.2 11.0 12.9 8.8 11.4 26.1 30.4 22.8 17.4 20.4 9.5 24.1 22.7 16.4 17.6 25.7 20.7 12.6 20.3 10.6 11.8 7.8 18.3 13.9 5.8 14.3 22.1 8.8 10.1 7.8 15.2 68.9 10.7 3.9 13.6 7.0 11.0 9.7 8.6 2.7 2.5 1.3 7.7 1.9 3.3 2.4 17.4 21.4 3.4 6.5 8.4 11.9 4.2 6.3 9.9 6.1 5.2 17.4 27.3 5.9 6.7 9.0 8.5 13.2 6.6 17.9 4.1 6.6 5.7 6.0 23.4 12.8 16.5 5.6 8.7 16.8 17.2 6.4 7.2 10.0 2.9 2.6 10.4 13.6 5.8 11.8 0.8 10.1 9.3 17.0 8.2 6.7 2.0 16.3 26.6 21.4 3.3 3.9 26.1 24.2 9.3 1.5 8.0 7.9 5.1 4.5 8.8 6.0 5.8 8.3 3.9 3.4 18.4 16.2 4.3 1.3 4.8 0.2 1.7 4.4 3.3 1.4 1.7 1.9 2.5 2.7 2.0 1.4 1.3 1.9 7.7 1.2 1.5 2.4 37.4 36.6 21.9 38.5 26.1 30.4 24.1 22.7 20.3 10.7 74.5 71.3 17.5 132.2 25.2 41.8 39.3 25.5 21.4 31.8 96.0 21.6 37.3 152.5 146.7 1421.5 25.3 96.0 46.7 174.9 62.9 26.6 143.6 32.2 46.0 193.8 49.3 28.9 18.4 44.0 3146.3 46.3 89.3 40.5 27.1 42.8 10.9 164.5 30.9 50.9 69.5 40.4 6.5 25.8 332.6 27.9 24.8 103.8 22.4 42.8 203.8 PDZD7 "bA108L7.8, DFNB57, FLJ23209, PDZK7" ENSG00000186862 "PDZ domain containing 7" Q9H5P4 10 101007683-101032295 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;intestine: 25.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 13.1;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.1;THP-1: 17.7" "Low region specificity" "Detected in many" HPA074542 Supported Nucleoplasm NA NA Nucleoplasm "HPA074542: " "unprognostic (1.46e-1)" "unprognostic (2.85e-3)" "unprognostic (3.96e-2)" "unprognostic (2.10e-1)" "unprognostic (2.15e-2)" "unprognostic (2.83e-2)" "unprognostic (1.38e-2)" "unprognostic (5.31e-2)" "unprognostic (2.52e-2)" "unprognostic (2.95e-2)" "unprognostic (2.45e-1)" "unprognostic (1.87e-3)" "unprognostic (3.54e-3)" "unprognostic (3.89e-1)" "unprognostic (1.79e-1)" "unprognostic (3.51e-2)" "unprognostic (2.80e-1)" 2.4 2.3 7.0 1.7 10.7 2.4 0.9 15.9 11.6 0.8 3.4 2.4 0.0 17.4 2.5 1.9 1.0 1.1 3.0 1.2 6.3 7.8 2.2 0.7 1.9 1.6 12.5 8.3 1.4 1.7 3.8 6.2 1.8 17.7 1.5 0.7 1.1 2.1 1.2 1.4 3.8 25.3 2.0 9.1 2.6 1.9 2.1 4.8 0.0 2.2 0.0 0.6 1.3 1.0 1.3 0.7 6.9 2.1 2.3 1.5 0.6 7.4 1.1 0.6 0.9 1.0 0.2 2.5 1.3 0.7 0.0 0.4 1.7 1.9 3.7 3.6 0.3 1.0 2.3 0.2 0.7 0.0 1.0 2.5 0.2 3.6 2.4 0.6 0.6 3.3 0.4 0.3 0.2 0.2 4.3 0.3 3.4 0.6 0.9 0.1 1.9 0.5 1.4 0.6 1.5 2.7 1.7 1.0 0.5 1.8 0.8 12.1 5.6 0.8 0.4 1.2 1.2 2.5 17.7 0.5 1.2 2.6 1.5 1.1 1.6 0.1 0.3 6.6 1.3 0.7 2.9 2.1 1.5 1.0 1.3 1.0 1.1 0.9 1.3 0.4 1.3 1.5 0.8 6.9 2.3 0.8 0.7 0.6 0.6 7.0 10.7 15.9 11.6 6.3 7.8 12.5 8.3 17.7 4.8 0.0 0.0 0.0 0.6 0.5 13.1 1.4 5.1 0.0 0.0 1.8 21.6 0.1 1.7 0.7 1.4 0.3 0.3 0.0 0.3 4.7 0.7 0.5 0.0 0.0 1.8 1.6 0.0 0.6 1.2 1.0 0.3 0.8 0.0 0.0 0.0 0.8 0.9 0.0 1.1 1.3 7.6 0.0 0.8 2.8 2.3 0.4 1.6 0.0 0.0 0.1 PEG3 "KIAA0287, ZKSCAN22, ZNF904, ZSCAN24" ENSG00000198300 "Paternally expressed 3" Q9GZU2 19 56810083-56840728 "Predicted intracellular proteins, Transcription factors" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.0;ovary: 106.4;placenta: 49.8" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 267.6;Horizontal cells: 139.8;Peritubular cells: 103.3;Syncytiotrophoblasts: 399.0" "Cancer enhanced" "Detected in many" "testis cancer: 9.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 1.3;plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.3" "Group enriched" "Detected in some" 5 "BEWO: 32.2;Hep G2: 65.4;RH-30: 22.4" "Low region specificity" "Detected in all" HPA026070 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA026070: AB_10603328" "unprognostic (1.38e-2)" "unprognostic (1.90e-2)" "unprognostic (1.20e-1)" "unprognostic (7.12e-2)" "unprognostic (1.58e-1)" "unprognostic (4.84e-2)" "unprognostic (4.84e-2)" "unprognostic (4.44e-2)" "unprognostic (9.16e-2)" "unprognostic (1.21e-1)" "unprognostic (1.82e-3)" "unprognostic (9.92e-2)" "unprognostic (2.48e-5)" "unprognostic (6.92e-3)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.56e-4)" "unprognostic (6.68e-3)" 2.0 29.8 10.1 1.0 51.0 0.5 4.5 9.8 22.4 4.1 2.4 5.9 0.0 0.7 9.1 2.6 1.7 5.8 1.2 2.3 9.7 9.6 1.8 2.1 1.7 0.7 3.5 16.0 106.4 1.9 7.3 24.6 49.8 21.3 1.8 1.2 0.4 2.3 2.5 1.7 1.8 1.7 4.1 4.8 1.6 2.0 12.3 7.3 0.0 2.7 0.0 2.7 2.6 2.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.1 0.0 22.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 10.1 51.0 9.8 22.4 9.7 9.6 3.5 16.0 21.3 7.3 0.0 5.8 0.0 1.7 4.2 19.4 12.3 2.5 4.0 3.4 1.8 7.9 267.6 1.7 0.7 24.4 2.6 0.0 0.0 0.0 33.5 7.8 1.7 0.0 2.9 29.8 139.8 0.0 4.9 0.6 15.2 54.4 1.0 13.5 0.0 0.0 18.1 0.5 0.0 103.3 0.8 11.8 12.9 7.3 26.9 17.4 2.3 399.0 0.0 0.0 0.7 PEPD ENSG00000124299 "Peptidase D" P12955 19 33386950-33521794 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Collagen degradation" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 92.9;kidney: 106.0" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 1020.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015599, HPA072045" Enhanced Approved Nucleoplasm NA NA 1000000000 Nucleoplasm "HPA015599: AB_1855192, HPA072045: AB_2732194" "unprognostic (1.39e-1)" "unprognostic (2.62e-2)" "unprognostic (2.27e-1)" "unprognostic (4.01e-2)" "unprognostic (2.98e-1)" "unprognostic (6.77e-2)" "unprognostic (2.82e-1)" "unprognostic (3.64e-2)" "unprognostic (3.96e-1)" "unprognostic (5.10e-2)" "unprognostic (1.11e-2)" "unprognostic (1.99e-1)" "prognostic favorable (6.50e-9)" "unprognostic (4.38e-2)" "unprognostic (1.99e-1)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" 23.5 17.2 9.8 8.9 10.4 4.1 21.8 7.6 14.9 9.8 60.1 18.7 6.9 58.1 14.3 11.5 14.9 9.6 13.6 8.0 10.8 9.1 106.0 48.6 11.1 10.6 16.0 7.7 12.6 9.0 9.6 12.5 10.4 13.0 9.2 6.6 13.3 9.6 9.0 9.7 11.4 92.9 10.4 17.4 13.4 9.3 8.4 11.5 8.4 15.0 9.7 10.6 11.9 11.9 17.1 32.3 27.5 39.1 16.8 25.8 32.6 13.3 36.3 10.7 17.3 45.7 17.6 24.8 11.9 24.4 15.2 17.3 31.6 11.8 5.4 17.8 29.8 11.7 3.5 15.4 9.7 12.5 15.4 15.2 34.7 7.4 32.1 31.3 10.1 42.1 21.7 9.2 13.8 8.6 11.2 20.3 10.7 6.6 15.8 16.5 16.3 7.7 3.4 14.7 26.6 14.8 15.2 14.6 15.0 13.1 35.3 13.2 33.8 22.2 11.0 17.9 9.4 7.6 11.0 16.9 14.7 15.9 19.0 13.7 14.5 21.5 4.8 15.7 14.6 20.9 27.5 36.1 2.5 25.8 39.1 22.6 17.1 25.7 23.8 32.3 16.3 16.9 19.6 1.9 16.8 27.2 9.9 23.6 32.6 9.8 10.4 7.6 14.9 10.8 9.1 16.0 7.7 13.0 11.5 20.8 24.3 20.2 26.1 17.2 33.9 11.7 43.3 26.8 11.4 69.8 3.9 19.3 167.5 63.4 7.6 44.9 37.6 0.0 38.3 59.7 34.6 21.4 55.5 161.7 189.6 58.8 16.6 35.0 46.9 8.9 45.8 63.2 64.1 131.7 14.5 69.3 37.3 28.5 57.0 1020.8 23.8 38.8 38.8 11.4 48.3 17.8 25.4 31.0 16.7 18.0 PEX10 RNF69 ENSG00000157911 "Peroxisomal biogenesis factor 10" O60683 1 2403964-2413797 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 144.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049458, HPA049755" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA049458: AB_2680775, HPA049755: AB_2680867" "prognostic favorable (4.50e-6)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (1.81e-2)" "unprognostic (2.91e-1)" "unprognostic (9.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (1.95e-1)" "prognostic favorable (4.16e-6)" "unprognostic (4.78e-2)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (1.42e-1)" 14.6 18.7 20.5 6.2 19.9 5.6 16.3 7.6 24.6 9.8 9.2 23.1 6.6 10.1 7.6 13.6 10.6 11.4 8.3 12.9 17.8 15.5 12.0 12.1 8.3 7.6 19.2 13.5 13.0 19.4 12.5 12.2 10.2 16.0 15.4 7.0 11.4 17.4 12.3 22.1 10.8 9.0 6.6 21.3 8.9 10.1 17.3 12.6 6.0 10.5 11.8 9.0 8.1 6.8 7.4 11.5 2.2 10.7 4.5 6.4 4.8 12.2 10.2 8.0 8.9 5.8 6.7 7.4 6.5 7.5 10.8 7.8 16.3 18.5 6.4 17.2 8.5 7.1 9.5 7.3 12.0 5.0 10.3 14.1 4.8 10.5 32.4 11.2 8.6 2.6 6.6 6.3 7.9 10.9 6.8 9.1 7.7 5.9 8.0 9.5 16.0 8.0 4.1 6.8 6.7 20.5 6.6 8.2 13.3 11.6 4.2 12.5 9.6 7.7 11.6 21.1 4.9 10.1 3.4 8.8 9.9 4.4 15.1 8.6 11.7 4.8 5.8 11.4 6.7 7.8 1.9 6.9 2.2 5.2 10.7 6.0 7.4 4.5 6.4 11.5 6.9 5.2 3.9 1.6 4.5 8.7 9.8 2.5 4.8 20.5 19.9 7.6 24.6 17.8 15.5 19.2 13.5 16.0 12.6 3.0 4.1 5.4 10.8 7.8 15.7 0.7 10.2 8.1 4.5 14.0 0.0 22.0 29.9 19.3 42.4 9.2 9.3 0.0 26.3 21.1 10.8 12.5 0.0 8.2 20.4 12.7 12.7 4.9 10.5 144.2 9.8 10.3 21.9 26.2 9.1 39.6 17.3 3.5 12.7 20.2 9.7 0.0 8.5 24.9 16.2 5.4 23.0 4.4 14.9 9.1 PFKFB2 ENSG00000123836 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2" O60825 1 207034366-207081024 "Enzymes, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 70.2;Late spermatids: 128.8;Rod photoreceptor cells: 111.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 13.9;plasmacytoid DC: 16.7" "Group enriched" "Detected in many" 8 "dendritic cells: 16.7;granulocytes: 13.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049975, HPA063575" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049975: AB_2680977, HPA063575: AB_2685046" "unprognostic (1.30e-1)" "unprognostic (6.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.75e-2)" "unprognostic (2.27e-1)" "unprognostic (3.76e-2)" "unprognostic (9.96e-3)" "unprognostic (9.74e-2)" "unprognostic (7.27e-2)" "unprognostic (2.27e-2)" "unprognostic (6.01e-2)" "unprognostic (1.30e-1)" "prognostic favorable (3.23e-7)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.63e-4)" "unprognostic (1.86e-2)" 3.3 6.1 9.8 5.8 16.6 15.7 5.1 2.1 14.6 7.3 16.0 19.5 5.3 23.2 4.0 9.1 7.7 4.5 9.1 22.8 14.1 7.7 22.0 3.6 10.9 5.3 13.4 15.1 4.3 11.9 6.2 27.5 3.0 25.3 3.9 18.1 22.4 6.3 3.5 34.9 6.4 18.7 4.0 17.4 12.5 10.7 6.1 15.1 6.5 38.4 8.8 5.0 3.4 3.6 1.6 16.7 13.9 1.9 1.1 0.4 0.4 9.7 4.3 2.8 4.9 5.9 2.9 4.7 1.4 1.7 2.4 1.3 10.5 14.1 1.7 2.2 2.2 7.4 13.9 2.1 5.2 1.4 0.3 2.1 13.8 10.8 3.9 4.9 0.0 9.7 4.1 8.0 2.3 13.2 2.9 0.5 5.8 9.4 0.1 1.3 2.9 2.3 0.4 3.9 4.7 6.5 0.0 0.0 0.2 3.3 10.1 4.5 2.7 9.1 15.4 11.4 3.2 10.6 1.1 0.2 0.0 5.3 7.5 1.3 4.5 4.4 0.9 6.1 0.0 2.6 1.0 0.9 13.9 0.2 1.9 0.3 1.3 0.1 0.3 0.8 1.6 0.3 0.4 2.6 1.1 1.3 16.7 0.0 0.4 9.8 16.6 2.1 14.6 14.1 7.7 13.4 15.1 25.3 15.1 6.0 42.0 4.5 3.4 13.5 7.3 70.2 5.1 14.7 5.7 15.7 0.0 0.5 21.6 4.0 47.4 2.7 43.0 0.0 6.7 0.4 2.5 6.5 9.2 4.9 4.9 3.2 5.8 1.3 11.3 128.8 2.6 6.0 20.3 1.8 18.9 8.1 10.5 27.7 2.8 30.6 111.9 0.0 3.2 3.1 3.3 10.2 1.3 1.0 27.6 11.2 PFKFB3 ENSG00000170525 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3" Q16875 10 6144934-6254644 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 105.6;skeletal muscle: 135.7" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 184.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 20.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 72.7;RPTEC TERT1: 45.9;T-47d: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008266, CAB020795, HPA043889" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717" "unprognostic (1.61e-1)" "unprognostic (5.08e-3)" "unprognostic (2.89e-2)" "unprognostic (6.18e-2)" "unprognostic (2.29e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (1.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.04e-1)" "unprognostic (3.30e-2)" "unprognostic (7.34e-2)" "prognostic unfavorable (1.87e-7)" "unprognostic (1.89e-2)" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.74e-1)" 105.6 9.0 16.4 25.7 17.9 77.0 43.4 8.5 29.4 6.6 8.8 29.1 10.6 7.4 9.4 6.3 13.0 14.4 22.4 5.7 16.6 13.2 22.1 11.2 15.1 12.1 19.2 12.9 8.0 8.1 4.0 10.2 7.5 20.7 5.4 3.8 19.3 9.1 20.0 135.7 11.8 6.9 6.5 36.0 12.4 6.7 4.6 16.8 3.3 2.9 4.7 10.3 10.3 10.1 1.5 3.6 20.5 7.1 0.8 4.7 2.9 5.2 72.7 5.8 4.7 21.9 2.7 3.0 7.7 5.5 5.8 9.0 3.4 19.3 9.0 5.1 3.3 4.5 17.0 6.2 12.3 6.7 10.7 4.3 5.3 3.7 1.2 1.8 5.1 8.1 1.9 4.1 9.9 2.4 14.8 11.1 6.3 3.9 3.4 4.6 8.6 3.6 4.8 5.6 7.5 5.1 8.2 2.8 3.5 45.9 2.7 5.5 2.2 5.6 6.2 11.0 10.4 47.8 6.1 14.0 6.1 5.6 0.7 9.3 7.0 2.4 8.1 16.7 6.0 9.2 2.2 5.6 5.5 1.8 7.1 4.7 1.5 3.4 2.3 3.6 1.4 2.5 2.4 20.5 0.8 4.1 2.2 3.2 2.9 16.4 17.9 8.5 16.9 16.6 13.2 19.2 12.9 20.7 16.8 71.5 75.9 13.7 14.3 91.1 7.8 17.3 15.3 13.4 42.1 184.9 49.1 0.2 0.0 42.7 5.1 29.2 7.4 0.0 22.5 4.6 29.8 4.3 41.7 11.6 19.4 6.4 8.2 9.2 79.2 6.1 2.6 37.7 43.9 23.4 5.2 0.4 46.2 5.8 6.7 2.4 1.6 0.0 21.1 0.7 1.6 55.8 0.8 21.3 5.4 9.9 PGAM1 "PGAM-B, PGAMA" ENSG00000171314 "Phosphoglycerate mutase 1" P18669 10 97426160-97433441 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Extravillous trophoblasts: 698.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042528, HPA060483" Approved Supported Nucleoplasm NA NA 200000000 Nucleoplasm "HPA042528: AB_2678039, HPA060483: AB_2684292" "prognostic unfavorable (2.04e-4)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.64e-1)" "unprognostic (5.64e-2)" "unprognostic (1.16e-1)" "unprognostic (9.47e-3)" "unprognostic (7.60e-3)" "unprognostic (1.74e-3)" "unprognostic (3.22e-1)" "unprognostic (1.05e-1)" "unprognostic (4.37e-3)" "unprognostic (2.48e-2)" "unprognostic (1.48e-1)" "unprognostic (5.74e-2)" "unprognostic (4.94e-2)" "unprognostic (1.19e-1)" "unprognostic (2.61e-3)" 26.5 46.1 42.8 28.9 50.3 30.2 19.0 32.6 90.0 26.5 27.6 24.9 14.2 29.8 24.3 20.6 63.5 17.7 21.2 54.1 47.4 44.9 32.7 35.7 18.5 29.5 45.7 61.1 22.9 14.3 27.8 23.2 30.8 72.4 21.9 29.2 30.4 24.5 33.7 8.4 30.0 27.4 35.6 25.7 21.7 20.3 26.1 21.0 26.6 17.4 27.0 43.7 31.0 31.9 22.5 49.7 88.0 65.3 22.8 41.2 72.8 119.7 57.0 39.4 75.1 37.3 34.4 53.7 76.8 100.5 90.3 126.0 61.8 35.8 63.5 52.7 65.2 36.3 75.2 68.4 111.7 109.5 58.7 65.4 41.0 44.7 69.1 27.6 58.7 54.9 33.6 45.8 60.0 44.8 122.3 65.3 47.7 26.8 36.0 94.7 49.5 52.4 72.5 60.3 34.7 68.4 39.9 36.1 50.3 69.7 45.5 8.6 40.3 41.3 24.7 39.4 64.5 67.2 49.5 49.1 48.4 42.6 42.7 88.1 54.3 59.8 57.9 112.5 98.2 22.3 30.4 65.3 88.0 37.0 57.2 32.7 22.5 31.8 36.6 49.7 18.8 20.7 28.9 50.3 22.8 62.8 17.6 41.2 72.8 42.8 50.3 32.6 90.0 47.4 44.9 45.7 61.1 72.4 21.0 41.7 37.7 99.1 98.5 166.1 402.1 21.4 81.5 34.8 53.4 101.2 72.6 433.1 303.4 278.9 11.6 112.3 222.3 46.7 180.1 698.3 148.4 67.2 102.6 165.4 366.0 365.5 46.3 103.7 173.5 17.6 138.4 127.2 124.9 317.4 104.7 280.3 240.1 115.6 220.3 200.3 232.1 200.5 123.6 31.0 121.7 178.9 311.6 142.2 136.4 230.0 PGAM4 "dJ1000K24.1, PGAM-B, PGAM1, PGAM3" ENSG00000226784 "Phosphoglycerate mutase family member 4" Q8N0Y7 X 77968874-77969638 "Enzymes, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 2.1;Melanocytes: 3.3;Suprabasal keratinocytes: 2.0" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 5.4" "HPA042528, HPA060483" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA042528: AB_2678039, HPA060483: AB_2684292" "unprognostic (3.10e-2)" "unprognostic (2.41e-2)" "unprognostic (5.25e-2)" "unprognostic (3.18e-2)" "unprognostic (4.37e-2)" "unprognostic (4.21e-2)" "unprognostic (7.71e-2)" "unprognostic (1.89e-2)" "unprognostic (1.78e-1)" "unprognostic (7.52e-3)" "unprognostic (3.19e-2)" "unprognostic (1.14e-1)" "unprognostic (4.20e-2)" "unprognostic (1.20e-1)" "unprognostic (4.15e-2)" "unprognostic (1.10e-1)" "unprognostic (2.76e-3)" 0.9 2.1 0.9 2.6 1.5 3.0 0.4 0.8 2.1 1.9 0.6 2.4 1.4 0.7 2.9 1.3 0.0 1.3 1.0 1.5 0.9 1.2 0.4 1.2 1.5 1.0 0.1 0.7 0.7 0.7 0.5 0.7 0.6 0.2 1.1 0.8 2.0 1.3 0.4 1.0 1.3 0.5 0.3 0.7 1.6 1.2 0.7 1.9 3.7 2.4 0.8 1.6 3.5 5.4 3.1 0.3 0.9 0.4 0.0 2.7 0.5 0.1 0.6 0.8 0.0 0.5 0.8 1.5 0.3 0.0 2.3 0.2 0.0 0.8 0.6 0.3 0.0 1.1 0.7 0.0 1.6 0.9 0.4 0.2 0.2 0.0 0.1 0.5 0.3 0.0 0.6 0.8 1.0 2.7 3.9 1.1 0.3 0.8 0.8 1.0 2.0 0.0 0.7 0.1 2.7 0.3 0.0 1.3 0.3 1.0 0.6 0.0 1.0 1.8 1.6 3.1 2.8 1.4 0.7 3.7 1.6 0.5 0.6 2.4 3.7 1.4 2.2 1.1 0.7 1.1 1.3 1.9 0.7 0.6 0.9 1.5 0.8 2.1 0.5 1.6 3.5 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.0 0.0 PGBD5 "DKFZp761A0620, FLJ11413" ENSG00000177614 "PiggyBac transposable element derived 5" Q8N414 1 230314482-230426371 "Disease related genes, Predicted intracellular proteins" Transposition "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.0;cervix, uterine: 21.9;pancreas: 21.6" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 23.0;Cone photoreceptor cells: 19.6;Horizontal cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 18.0;GAMG: 9.2;NTERA-2: 18.3;RH-30: 10.0;SCLC-21H: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065010 Supported Nucleoplasm NA NA Nucleoplasm "HPA065010: AB_2685402" "unprognostic (2.00e-2)" "unprognostic (4.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.61e-2)" "prognostic unfavorable (8.78e-5)" "unprognostic (1.44e-2)" "unprognostic (4.66e-2)" "unprognostic (4.91e-2)" "unprognostic (3.97e-1)" "unprognostic (1.15e-1)" "unprognostic (7.48e-3)" "unprognostic (2.57e-1)" "unprognostic (3.29e-2)" "unprognostic (6.69e-2)" "unprognostic (2.12e-1)" "unprognostic (3.13e-3)" "unprognostic (2.51e-1)" 0.8 10.8 16.0 0.8 14.1 0.6 0.7 17.9 27.0 21.9 1.5 6.0 0.1 1.0 5.8 0.5 1.8 5.6 2.2 13.3 20.0 8.0 1.5 2.8 1.8 0.9 7.1 8.9 0.9 21.6 0.9 4.0 2.6 8.0 1.4 1.3 1.0 3.2 1.2 2.8 0.9 1.0 3.0 5.0 2.6 1.6 5.8 4.6 0.5 6.0 0.6 5.1 1.6 1.5 0.8 0.6 1.5 0.6 0.6 0.6 0.2 0.0 0.0 4.6 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 4.0 0.0 18.0 1.7 0.1 9.2 3.4 1.4 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.1 0.9 0.1 3.6 18.3 0.0 0.1 0.0 10.0 2.8 2.1 0.0 25.3 4.7 0.6 0.0 0.2 0.4 0.2 6.1 0.0 0.0 1.5 0.0 1.4 7.7 5.8 0.0 0.0 1.5 0.3 1.5 0.6 1.2 0.6 0.6 0.5 0.4 0.5 0.4 0.4 0.8 0.6 0.6 1.2 0.6 0.6 0.6 0.4 0.2 16.0 14.1 17.9 23.8 20.0 8.0 7.1 8.9 8.0 4.6 0.0 3.4 0.0 0.6 0.1 23.0 5.5 0.0 1.4 0.0 0.0 19.6 0.0 0.0 6.1 0.6 0.1 0.0 0.0 5.1 0.1 0.4 1.3 10.4 4.0 8.7 20.6 8.7 0.0 3.7 0.4 0.0 0.6 1.7 0.0 0.0 2.4 4.9 0.0 0.0 0.6 9.3 0.0 0.7 0.7 1.5 0.0 0.2 0.0 0.0 0.9 PGC ENSG00000096088 Progastricsin P20142 6 41736711-41754109 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Digestion "Aspartyl protease, Hydrolase, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "ductus deferens: 249.6;pancreas: 798.6;stomach 1: 963.7" "Cell type enhanced" "Detected in some" 28 "Alveolar cells type 2: 270.0;Cholangiocytes: 150.3;Pancreatic endocrine cells: 843.0" "Cancer enhanced" "Detected in many" "stomach cancer: 1050.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "intermediate monocyte: 1.9" "Lineage enriched" "Detected in single" 7 "monocytes: 1.9" "Group enriched" "Detected in some" 11 "Hep G2: 69.6;OE19: 42.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031717, HPA031718" Enhanced Approved Nucleoplasm "Secreted to digestive system" NA NA Nucleoplasm "HPA031717: AB_10670130, HPA031718: AB_10610148" "unprognostic (9.18e-2)" "unprognostic (1.87e-1)" "unprognostic (9.83e-2)" "unprognostic (2.27e-1)" "unprognostic (7.18e-2)" "unprognostic (2.74e-1)" "unprognostic (1.47e-1)" "unprognostic (8.50e-2)" "unprognostic (1.86e-1)" "unprognostic (9.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.33e-2)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "unprognostic (8.74e-2)" 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.3 0.1 3.0 249.6 41.7 0.1 0.0 3.3 0.3 16.8 0.1 0.1 0.1 0.1 0.3 139.4 0.0 0.1 0.0 0.1 798.6 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.1 35.9 0.1 0.1 0.1 0.0 0.1 0.1 963.7 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.6 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 1.6 42.3 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 1.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 23.8 270.0 0.0 3.1 0.3 0.0 0.2 150.3 5.3 9.1 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 117.5 1.0 0.1 95.4 9.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.6 0.0 0.0 843.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 3.4 0.0 0.0 2.6 PHACTR3 "C20orf101, PPP1R123" ENSG00000087495 "Phosphatase and actin regulator 3" Q96KR7 20 59577509-59847711 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 56.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 11.9;Bipolar cells: 9.8;Cardiomyocytes: 7.3;Cholangiocytes: 10.2;Club cells: 6.8" "Group enriched" "Detected in some" 5 "glioma: 3.8;lung cancer: 1.6;pancreatic cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 2.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "THP-1: 53.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051834, HPA054847" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051834: AB_2681629, HPA054847: " "unprognostic (7.14e-2)" "unprognostic (1.22e-1)" "unprognostic (3.72e-2)" "unprognostic (1.43e-7)" "unprognostic (1.99e-1)" "unprognostic (2.87e-2)" "unprognostic (5.83e-3)" "unprognostic (8.92e-2)" "unprognostic (5.02e-2)" "unprognostic (2.30e-2)" "unprognostic (7.71e-2)" "unprognostic (7.22e-2)" "unprognostic (1.74e-2)" "unprognostic (1.66e-1)" "unprognostic (5.43e-2)" "unprognostic (2.53e-3)" "unprognostic (1.32e-1)" 1.6 2.7 31.3 1.8 29.2 2.0 1.4 15.9 56.1 1.5 1.9 20.0 0.0 2.1 1.3 2.0 2.8 1.4 3.3 3.0 27.3 14.6 2.0 2.1 5.3 1.4 28.3 19.4 6.9 1.5 1.4 0.5 1.9 21.3 1.4 1.8 0.0 1.3 1.3 1.4 2.6 2.1 1.5 25.4 8.0 1.8 1.8 29.8 0.0 1.4 0.0 1.4 1.6 0.0 0.0 2.5 0.1 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.8 0.0 0.0 0.0 10.4 0.0 0.7 2.7 0.0 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 31.3 29.2 15.9 34.1 27.3 14.6 28.3 19.4 21.3 29.8 11.9 0.3 0.0 1.0 0.6 9.8 7.3 10.2 1.4 6.8 3.5 0.0 0.0 1.7 0.1 0.9 0.1 0.0 0.0 0.0 0.0 1.1 1.9 0.0 0.0 0.2 4.8 1.2 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.8 1.8 0.0 0.0 0.0 1.6 0.0 0.7 0.0 0.7 0.4 0.0 0.0 0.8 3.0 PHAX "FLJ13193, RNUXA" ENSG00000164902 "Phosphorylated adaptor for RNA export" Q9H814 5 126600268-126627252 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059630, HPA070326" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059630: AB_2684088, HPA070326: AB_2686253" "unprognostic (1.06e-3)" "unprognostic (4.77e-2)" "unprognostic (1.35e-2)" "unprognostic (2.64e-2)" "unprognostic (6.11e-2)" "unprognostic (1.22e-1)" "unprognostic (4.59e-3)" "unprognostic (9.20e-2)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (4.91e-3)" "unprognostic (7.21e-2)" "unprognostic (1.32e-1)" "unprognostic (2.13e-2)" "unprognostic (3.07e-2)" 3.9 4.9 7.9 3.2 7.6 1.5 4.2 8.9 8.2 3.7 3.2 2.1 4.9 3.9 4.8 4.2 3.6 5.0 7.2 6.5 3.8 4.0 3.1 5.2 6.9 6.6 3.5 4.6 3.0 3.5 4.5 3.0 3.5 3.2 5.7 5.7 2.3 4.3 6.6 3.2 2.9 2.5 4.6 5.3 3.8 3.0 10.4 8.2 8.8 7.2 13.1 11.2 6.6 9.6 9.7 8.6 16.9 12.6 12.5 12.3 13.8 10.2 11.3 10.7 13.7 9.8 9.7 12.6 17.5 13.9 7.9 12.2 18.9 16.6 15.8 13.3 8.1 11.4 5.5 7.5 6.6 9.0 12.3 10.6 11.2 10.1 10.6 9.6 5.5 6.5 11.4 17.3 8.3 9.3 8.4 11.0 6.5 8.1 7.6 12.2 8.0 10.5 11.4 11.5 13.1 12.2 10.9 14.1 8.8 14.3 9.4 15.0 19.2 10.8 10.6 20.8 8.9 8.4 11.0 13.7 11.2 13.8 8.8 6.3 8.1 9.6 7.2 10.9 10.4 9.5 9.9 6.2 9.5 10.8 11.2 5.3 13.1 7.2 8.2 8.0 6.6 23.8 31.5 43.5 29.2 25.3 57.1 47.0 15.3 76.3 38.7 33.2 37.3 44.7 63.0 45.9 31.1 34.6 15.3 0.0 29.2 41.6 31.9 25.6 45.1 25.4 26.2 71.5 26.4 21.5 16.8 8.7 38.9 26.7 20.3 55.1 22.5 88.5 34.5 22.8 38.9 39.8 65.9 45.3 24.7 51.1 80.1 22.6 43.0 27.7 23.4 25.1 PHC1 "EDR1, HPH1, RAE28" ENSG00000111752 "Polyhomeotic homolog 1" P78364 12 8913896-8941467 "Disease related genes, Predicted intracellular proteins" "Developmental protein, DNA-binding" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 37.6" "Cancer enriched" "Detected in many" 7 "testis cancer: 32.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "BEWO: 31.7;NTERA-2: 114.0;SuSa: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006973 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006973: AB_1855278" "unprognostic (4.00e-2)" "unprognostic (1.79e-1)" "unprognostic (2.57e-1)" "unprognostic (1.73e-1)" "unprognostic (4.21e-3)" "unprognostic (7.46e-2)" "unprognostic (1.33e-1)" "unprognostic (1.59e-1)" "unprognostic (2.52e-1)" "unprognostic (1.47e-1)" "unprognostic (4.79e-3)" "unprognostic (1.69e-1)" "unprognostic (1.34e-2)" "unprognostic (7.55e-2)" "unprognostic (2.47e-1)" "unprognostic (9.27e-2)" "unprognostic (3.63e-2)" 7.9 10.0 23.5 12.1 27.7 4.4 9.6 37.1 20.7 15.0 11.9 10.6 19.9 4.9 23.3 11.1 12.6 18.4 12.2 11.0 18.4 10.2 11.0 3.0 10.8 11.1 9.8 20.6 23.5 10.2 26.2 34.5 10.3 13.9 14.2 7.1 18.3 15.5 16.3 8.0 4.0 8.2 17.1 9.1 9.9 9.2 26.5 12.3 7.8 18.9 5.5 10.5 11.5 13.5 2.4 2.9 1.5 5.9 2.1 3.8 1.9 1.4 2.7 10.5 9.6 3.0 3.3 31.7 1.4 3.0 2.6 3.4 1.4 2.3 3.7 1.2 2.4 3.8 1.1 2.8 3.4 3.2 12.3 1.6 4.9 2.6 1.6 3.5 2.4 8.4 4.1 2.1 4.2 4.1 7.9 3.0 4.2 0.9 1.3 2.7 1.6 3.5 4.2 114.0 0.5 0.7 5.1 6.7 0.1 2.6 5.5 1.9 6.9 2.2 5.2 3.7 41.2 0.7 2.5 1.8 4.4 7.5 3.0 2.0 2.6 1.6 5.3 2.1 1.3 3.1 1.5 0.5 0.0 2.1 2.5 1.3 2.4 3.5 3.8 0.3 2.4 3.1 2.5 0.1 2.1 5.9 2.9 1.9 1.9 23.5 27.7 37.1 20.7 18.4 10.2 9.8 20.6 13.9 12.3 14.9 20.3 1.7 4.9 2.2 21.8 0.4 10.2 20.1 20.5 8.7 25.5 4.9 1.7 4.7 19.5 9.0 0.5 0.0 4.5 9.0 6.9 5.1 18.5 1.7 3.8 15.9 10.9 7.4 2.5 14.4 13.3 3.4 6.8 1.8 2.2 16.3 4.7 2.3 11.3 4.7 37.6 0.0 6.6 13.5 23.0 2.0 4.2 6.9 1.1 4.1 PHC2 "EDR2, HPH2" ENSG00000134686 "Polyhomeotic homolog 2" Q8IXK0 1 33323623-33431052 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 12 "neutrophil: 37.3" "Lineage enriched" "Detected in many" 13 "granulocytes: 37.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047403 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA047403: AB_10964220" "unprognostic (8.58e-3)" "unprognostic (2.10e-1)" "unprognostic (9.51e-2)" "unprognostic (3.69e-1)" "unprognostic (2.00e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.28e-6)" "unprognostic (1.04e-1)" "unprognostic (2.40e-1)" "unprognostic (7.91e-2)" "unprognostic (3.08e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (2.35e-4)" "unprognostic (2.16e-1)" "unprognostic (1.57e-1)" "unprognostic (3.65e-2)" "unprognostic (1.72e-1)" 58.8 32.6 16.9 32.5 30.5 27.9 38.7 22.8 25.6 28.4 31.0 32.4 20.0 16.6 31.5 19.4 27.9 27.9 32.1 49.8 19.3 16.7 46.5 52.6 46.3 45.5 36.6 13.5 32.4 32.9 18.4 24.0 29.5 28.0 25.4 18.5 37.9 23.7 31.1 90.9 21.8 20.0 39.4 28.1 47.9 30.7 25.9 31.9 24.3 43.6 12.3 17.8 45.3 25.6 0.6 1.5 37.3 2.9 0.7 1.1 0.8 11.2 7.4 32.3 12.3 34.0 39.1 9.6 11.2 24.5 15.6 17.2 4.6 25.3 10.1 9.5 17.6 12.7 6.0 6.4 19.2 15.2 4.8 5.8 6.7 3.6 11.6 52.5 8.2 6.5 63.7 11.9 28.1 22.3 29.9 20.6 9.8 5.9 7.7 40.7 4.6 17.8 8.4 7.3 19.2 21.6 20.3 13.4 5.6 28.6 8.5 19.7 18.1 8.7 8.8 44.2 14.2 4.4 10.6 20.4 15.6 7.9 13.3 21.0 5.4 3.7 7.6 37.3 8.7 42.9 3.1 2.6 1.2 0.8 2.5 0.7 0.6 0.9 0.7 1.3 0.5 1.1 0.6 37.3 0.7 2.9 1.5 0.6 0.8 16.9 30.5 22.8 25.6 19.3 16.7 36.6 13.5 28.0 31.9 14.9 11.5 7.5 25.5 12.6 66.5 26.6 7.6 9.4 11.4 33.2 64.8 9.4 14.9 29.6 50.7 26.3 10.9 0.0 37.8 7.7 14.4 19.3 5.8 45.0 19.5 58.8 36.1 56.4 64.7 50.1 27.0 29.7 20.3 3.6 21.9 52.1 60.6 14.4 28.0 23.7 74.9 12.9 21.3 10.7 7.0 9.5 9.6 8.7 15.7 26.5 PHC3 "EDR3, FLJ12729, FLJ12967, HPH3" ENSG00000173889 "Polyhomeotic homolog 3" Q8NDX5 3 170086732-170181749 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039162, HPA062031" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA039162: AB_10671038, HPA062031: AB_2684666" "unprognostic (4.57e-2)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.85e-3)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (5.04e-2)" "unprognostic (1.19e-2)" "unprognostic (8.71e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-3)" "unprognostic (3.26e-2)" "unprognostic (3.70e-1)" "unprognostic (1.54e-1)" "unprognostic (1.92e-1)" "unprognostic (9.58e-3)" "unprognostic (2.76e-2)" 17.9 11.7 12.0 13.1 19.2 50.9 17.4 28.2 16.7 14.9 16.1 18.8 13.8 12.8 19.1 10.1 14.6 14.4 15.0 14.2 14.8 7.6 12.0 11.2 18.7 19.2 15.4 11.7 19.0 13.5 23.3 26.3 11.5 14.7 15.4 13.3 19.1 18.4 16.0 17.3 15.9 17.0 20.4 16.5 15.0 16.0 14.6 17.7 16.4 19.2 8.6 17.1 20.9 15.4 15.7 19.7 18.6 8.7 8.9 14.5 5.3 16.9 16.0 3.5 5.8 9.9 10.2 6.5 7.2 8.1 7.5 9.4 10.6 8.5 8.1 17.8 10.1 10.0 8.5 7.6 6.9 13.5 18.6 7.1 13.7 14.4 4.8 5.9 17.0 7.5 7.3 4.1 11.2 15.9 5.4 5.6 6.3 3.3 22.6 6.9 15.6 7.8 3.6 3.6 5.4 6.0 5.8 15.0 11.6 3.8 19.1 3.8 2.3 24.0 15.1 5.0 2.3 17.4 13.2 11.1 10.4 6.3 8.6 12.4 21.8 17.6 23.8 6.6 6.5 6.3 6.6 5.5 18.6 12.7 8.7 10.7 13.1 12.3 11.1 5.9 15.7 12.7 11.2 7.5 8.9 5.4 19.7 14.5 5.3 12.0 19.2 28.2 16.7 14.8 7.6 15.4 11.7 14.7 17.7 20.8 26.4 22.3 15.2 12.6 33.3 19.6 20.4 21.4 19.4 26.2 56.9 12.6 0.0 6.9 4.8 19.6 11.4 23.3 6.4 8.0 18.8 19.0 12.7 13.4 9.8 50.9 7.5 17.8 14.8 2.7 27.3 20.3 18.6 11.8 13.9 21.0 9.1 19.0 26.2 8.2 131.7 6.5 19.8 19.1 19.0 13.9 15.3 30.6 12.9 14.3 PHF1 "MTF2L2, PCL1, TDRD19C" ENSG00000112511 "PHD finger protein 1" O43189 6 33410399-33416453 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 144.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031038 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031038: AB_10671365" "unprognostic (1.96e-3)" "unprognostic (4.77e-2)" "prognostic unfavorable (9.64e-5)" "unprognostic (1.66e-1)" "unprognostic (4.71e-2)" "unprognostic (2.43e-3)" "unprognostic (2.31e-2)" "unprognostic (8.87e-3)" "unprognostic (1.41e-1)" "unprognostic (1.97e-1)" "unprognostic (2.42e-3)" "unprognostic (4.25e-2)" "unprognostic (1.21e-1)" "unprognostic (2.48e-2)" "unprognostic (1.29e-1)" "unprognostic (1.90e-1)" "prognostic favorable (1.72e-4)" 10.7 10.2 12.0 15.5 15.2 23.5 29.0 14.2 12.5 29.7 14.6 9.4 26.4 11.0 18.2 30.7 10.0 16.3 18.3 15.4 13.2 13.3 13.0 10.5 19.7 16.7 16.9 12.0 31.5 24.9 21.1 26.6 7.7 14.6 16.9 6.2 14.6 17.6 28.5 12.9 7.7 12.1 18.9 12.3 18.8 12.7 26.7 12.8 5.0 22.4 9.3 21.3 20.7 29.2 1.5 0.5 3.2 0.4 1.1 4.6 0.9 1.5 2.1 4.8 3.1 2.1 1.2 9.6 3.3 5.2 2.5 2.8 2.9 1.4 0.6 2.0 7.8 16.8 0.5 1.0 1.7 0.6 1.9 1.0 4.5 3.5 1.3 0.4 2.6 11.2 2.5 2.2 4.9 4.4 3.7 1.6 1.6 1.7 3.9 2.0 1.2 0.8 1.6 1.7 0.4 1.5 1.9 0.6 1.6 0.3 2.0 3.2 3.4 1.7 1.8 2.7 0.9 1.3 3.2 3.1 5.0 1.4 2.9 3.5 2.6 4.3 5.2 3.6 2.8 2.9 0.2 0.3 0.7 1.4 0.4 4.6 1.2 2.8 3.5 0.5 1.5 3.3 1.7 3.2 1.1 0.4 0.3 0.9 0.9 12.0 15.2 14.2 12.5 13.2 13.3 16.9 12.0 14.6 12.8 17.9 22.7 25.1 75.0 30.1 69.3 17.0 2.5 12.0 10.3 22.7 35.3 14.3 29.9 11.6 144.2 27.0 13.3 0.0 15.8 11.3 18.6 51.5 69.1 6.2 10.6 42.9 11.5 27.6 8.6 57.2 40.0 15.1 35.4 13.6 13.8 32.4 13.9 11.2 38.5 20.3 62.8 77.6 51.5 61.1 42.1 21.0 31.4 46.8 9.6 66.3 PHF10 "BAF45a, FLJ10975, XAP135" ENSG00000130024 "PHD finger protein 10" Q8WUB8 6 169703905-169725566 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055649 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA055649: AB_2682875" "unprognostic (1.74e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (4.25e-2)" "unprognostic (4.45e-2)" "unprognostic (6.76e-3)" "prognostic unfavorable (3.42e-4)" "unprognostic (1.28e-1)" "unprognostic (1.11e-1)" "unprognostic (2.48e-1)" "prognostic favorable (1.12e-5)" "unprognostic (5.92e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (2.63e-1)" "unprognostic (6.82e-2)" "unprognostic (2.43e-1)" "unprognostic (2.76e-2)" 19.2 34.3 19.9 21.2 39.0 18.7 19.8 18.3 22.4 17.1 20.8 23.1 26.1 12.9 16.7 17.0 26.5 17.9 21.6 20.1 23.2 10.5 18.6 27.9 20.3 23.3 35.3 13.1 33.5 23.6 25.8 22.1 17.7 28.5 22.1 14.6 21.6 22.2 19.8 30.0 23.1 20.3 23.8 29.0 27.0 21.7 23.3 28.3 26.9 23.0 13.6 24.4 22.7 33.5 4.8 3.0 6.3 3.3 2.4 6.2 1.8 8.8 8.9 35.7 37.3 12.5 7.6 14.7 12.1 11.0 15.0 16.5 25.8 9.3 26.3 7.4 8.4 9.5 11.3 27.4 13.2 21.8 21.0 24.4 26.2 15.7 33.6 12.8 38.2 1.6 5.7 13.9 9.6 8.9 24.9 23.6 19.0 29.0 17.1 10.7 15.2 7.2 32.9 11.2 19.7 5.6 34.7 25.3 21.1 18.6 9.5 17.1 22.8 16.5 5.5 11.8 15.6 10.8 45.9 15.8 8.5 14.3 10.8 15.3 15.2 12.9 32.8 11.1 25.7 13.5 3.0 3.0 6.3 3.4 3.2 3.3 4.8 6.0 4.8 3.0 4.2 5.9 6.2 0.5 2.4 3.3 2.8 3.7 1.8 19.9 39.0 18.3 22.4 23.2 10.5 35.3 13.1 28.5 28.3 23.8 26.7 23.0 19.5 26.6 11.6 51.3 40.8 18.7 27.3 10.4 39.3 11.2 11.6 11.6 10.8 27.7 12.3 0.0 11.1 7.8 24.4 23.2 5.8 23.7 10.0 11.1 24.9 23.9 10.0 6.1 20.8 11.8 18.6 5.4 23.0 27.0 14.2 19.5 19.8 9.5 24.7 19.4 41.5 16.3 19.4 20.6 14.5 15.0 18.0 25.0 PHF12 "KIAA1523, PF1" ENSG00000109118 "PHD finger protein 12" Q96QT6 17 28905250-28951771 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 25.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 25.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021410, HPA021452" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021410: AB_1855287, HPA021452: AB_2670708" "unprognostic (9.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.11e-2)" "unprognostic (1.21e-2)" "unprognostic (2.81e-1)" "unprognostic (1.46e-2)" "unprognostic (1.69e-2)" "unprognostic (3.10e-2)" "unprognostic (8.73e-2)" "unprognostic (5.38e-2)" "unprognostic (1.02e-3)" "unprognostic (6.71e-2)" "prognostic unfavorable (1.24e-5)" "unprognostic (2.16e-2)" "unprognostic (3.11e-1)" "unprognostic (3.24e-1)" "unprognostic (1.08e-3)" 14.0 12.0 16.7 16.5 17.9 38.4 15.6 30.7 18.4 17.1 17.4 18.5 25.4 13.2 21.0 16.4 11.4 18.1 16.1 11.3 13.0 10.5 14.2 14.8 17.2 17.7 18.6 15.2 20.7 20.3 18.6 18.7 12.2 14.0 23.4 12.9 18.9 16.6 24.5 15.6 16.5 18.0 16.2 10.2 25.2 15.4 17.5 18.2 22.1 18.9 7.3 18.0 19.2 16.6 4.5 4.9 25.6 2.7 3.5 4.3 1.5 10.2 16.4 22.5 13.5 13.7 9.8 10.6 10.1 14.9 15.5 14.9 10.9 9.6 11.4 12.6 11.6 12.7 10.6 14.4 8.5 15.1 18.9 15.6 12.0 18.2 8.6 12.4 12.9 15.0 10.8 9.3 14.2 13.1 14.6 11.1 14.9 10.2 11.9 9.7 10.5 24.6 17.5 13.1 22.0 7.3 24.2 18.5 11.3 10.3 12.6 15.3 13.2 15.1 24.1 12.1 12.3 13.1 18.3 6.7 12.9 11.9 12.4 12.0 14.8 13.1 13.4 9.9 10.1 13.2 9.6 2.7 3.9 3.9 2.2 3.9 2.7 3.1 4.3 1.5 4.5 3.0 3.3 25.6 3.5 2.4 4.9 1.7 1.5 16.7 17.9 30.7 18.4 13.0 10.5 18.6 15.2 14.0 18.2 14.9 7.5 13.3 7.2 13.6 20.8 5.9 7.6 4.0 13.6 3.5 13.7 6.2 1.7 7.6 7.2 14.3 7.8 0.0 9.1 6.3 8.7 17.0 13.9 9.6 8.0 23.8 10.3 16.0 11.3 4.1 15.8 11.6 11.8 17.2 15.4 12.3 8.3 7.0 15.6 3.8 21.0 25.8 11.8 14.4 11.1 14.3 5.0 17.5 9.8 11.9 PHF21A "BHC80, BM-006, KIAA1696" ENSG00000135365 "PHD finger protein 21A" Q96BD5 11 45929323-46121178 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 20.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 20.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023253, HPA023580" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA023253: , HPA023580: AB_10962727" "unprognostic (5.30e-3)" "unprognostic (8.93e-2)" "prognostic unfavorable (6.15e-4)" "unprognostic (1.93e-2)" "unprognostic (1.05e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (1.66e-6)" "unprognostic (2.20e-2)" "unprognostic (3.10e-1)" "unprognostic (5.35e-2)" "unprognostic (1.25e-3)" "unprognostic (3.84e-1)" "prognostic unfavorable (2.59e-8)" "unprognostic (1.89e-1)" "unprognostic (1.97e-1)" "unprognostic (9.53e-2)" "unprognostic (1.21e-1)" 14.6 17.9 18.4 19.1 22.2 25.6 12.8 24.9 20.3 16.6 18.9 15.1 9.0 6.9 17.3 11.2 11.7 12.5 13.2 21.4 16.3 10.5 8.1 9.5 20.5 14.4 17.7 10.7 25.2 8.5 27.5 28.7 13.0 13.6 15.6 10.0 14.4 10.0 14.2 15.7 12.8 10.1 17.2 19.4 17.8 10.1 23.5 18.9 18.3 13.1 5.0 14.6 16.7 13.9 3.2 2.8 20.9 5.0 3.6 4.2 2.1 3.7 10.2 19.3 18.6 8.0 12.5 2.6 7.7 13.4 6.7 11.3 2.0 5.9 15.7 5.4 7.5 10.5 4.3 11.7 4.9 6.9 17.5 8.0 9.0 10.1 4.0 9.6 6.3 13.8 11.1 11.4 3.9 11.2 15.7 9.8 10.7 10.6 26.2 7.9 3.6 6.8 10.2 16.6 4.7 6.0 11.5 9.9 5.1 6.7 6.3 12.5 15.6 11.4 5.7 8.0 13.2 10.3 11.8 9.6 11.1 9.0 9.0 6.2 28.0 22.8 10.3 8.7 6.9 8.6 16.5 5.0 2.5 4.2 2.6 3.6 3.2 3.2 3.6 2.8 3.0 2.0 3.4 20.9 3.6 4.2 1.9 3.8 2.1 18.4 22.2 24.9 20.3 16.3 10.5 17.7 10.7 13.6 18.9 11.9 15.3 13.4 8.2 9.2 26.8 20.9 7.6 14.7 10.3 3.5 25.5 3.9 1.7 7.6 6.3 12.5 3.9 0.0 5.5 2.6 11.9 9.3 16.1 4.3 9.0 14.3 22.5 12.3 24.3 6.3 24.2 13.1 10.1 18.0 7.9 9.4 5.0 7.4 13.8 2.9 23.6 12.9 11.6 13.6 11.2 7.8 3.5 14.6 5.8 4.4 PHF23 "FLJ16355, MGC2941" ENSG00000040633 "PHD finger protein 23" Q9BUL5 17 7235028-7239722 "Disease related genes, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052410 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052410: AB_2681822" "unprognostic (1.76e-2)" "unprognostic (6.12e-2)" "unprognostic (4.72e-2)" "unprognostic (6.44e-3)" "unprognostic (1.50e-1)" "unprognostic (2.96e-2)" "unprognostic (2.41e-3)" "unprognostic (2.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.19e-1)" "unprognostic (2.67e-3)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "unprognostic (4.40e-1)" "unprognostic (1.61e-1)" "unprognostic (3.48e-2)" 13.5 29.9 16.8 17.6 20.6 6.4 14.6 13.9 18.1 16.7 28.2 15.5 22.2 16.8 18.4 18.3 24.9 15.6 19.5 17.1 18.1 15.1 26.6 30.7 13.4 20.2 19.7 11.2 22.0 15.4 14.8 15.7 21.3 11.6 18.7 13.2 13.4 14.3 18.3 15.1 13.2 21.7 17.2 11.1 21.3 14.2 16.6 16.3 36.1 18.4 15.7 24.7 19.8 15.8 14.1 15.5 17.0 7.8 9.0 17.6 7.2 18.3 28.9 33.1 21.5 21.5 22.0 12.9 25.0 27.5 30.6 26.0 15.9 13.0 27.1 15.6 26.6 21.6 17.9 30.9 20.5 25.3 27.2 25.1 20.3 19.7 17.4 34.7 9.7 32.3 30.0 19.8 26.4 17.8 32.1 28.8 13.2 22.3 6.6 35.4 13.8 16.7 19.8 31.3 13.3 12.7 23.0 16.1 13.1 32.3 10.2 10.9 34.8 17.8 14.7 28.1 20.7 17.7 11.8 26.4 27.0 19.0 15.9 30.9 12.4 12.7 13.8 24.2 16.0 23.1 17.0 7.7 13.5 15.9 6.0 13.8 12.1 12.2 17.6 8.6 14.1 10.3 12.7 14.9 9.0 7.8 15.5 10.0 7.2 16.8 20.6 13.9 18.1 18.1 15.1 19.7 11.2 11.6 16.3 6.0 8.6 11.8 18.1 74.8 11.8 13.7 15.3 6.7 9.1 21.0 5.9 27.6 33.2 33.9 15.8 25.1 18.0 0.0 18.6 18.0 27.7 20.4 17.3 11.9 31.6 15.9 17.9 17.8 17.0 16.2 23.0 18.9 32.1 40.5 16.6 15.1 31.0 25.9 16.3 22.4 8.4 38.8 40.1 27.7 18.5 72.8 64.2 15.2 15.5 25.0 PHF3 ENSG00000118482 "PHD finger protein 3" Q92576 6 63635820-63779336 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024676, HPA025763" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024676: AB_10599736, HPA025763: AB_10600987" "unprognostic (4.33e-1)" "unprognostic (2.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.23e-2)" "unprognostic (2.89e-1)" "unprognostic (6.17e-2)" "unprognostic (1.44e-1)" "unprognostic (3.19e-2)" "unprognostic (1.76e-2)" "unprognostic (1.84e-2)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (2.30e-1)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (3.37e-1)" 23.7 19.6 17.1 22.9 20.0 33.0 23.5 44.4 19.4 32.6 23.5 9.4 21.9 14.9 22.7 23.4 18.8 16.9 15.9 16.2 19.1 13.3 19.5 26.7 21.0 21.5 20.0 18.5 34.1 17.4 30.3 43.5 23.0 18.7 25.6 17.5 8.5 19.1 21.5 24.5 19.4 19.2 18.1 26.8 21.9 17.1 16.8 24.9 36.3 26.0 12.9 16.9 30.5 26.6 10.3 7.5 16.2 11.5 5.5 12.2 4.5 19.4 9.4 16.3 9.5 16.5 17.5 16.0 12.8 18.4 9.6 13.0 13.0 9.1 23.8 11.1 11.4 14.0 8.6 15.6 13.5 16.2 18.9 12.7 28.5 12.1 20.6 14.7 24.3 11.6 12.6 12.1 13.7 19.7 17.2 11.2 12.8 31.0 22.5 9.8 11.5 10.3 13.0 9.2 12.7 5.8 18.2 14.6 11.3 11.6 11.6 17.5 13.0 15.4 6.9 11.4 18.6 11.9 22.5 15.7 14.9 17.7 11.3 15.2 19.0 19.8 22.8 6.8 19.5 11.4 14.4 6.8 7.3 9.0 8.9 8.9 8.4 8.5 7.0 6.0 10.3 12.2 8.9 16.2 5.5 11.5 7.5 5.9 4.5 17.1 20.0 44.4 19.4 19.1 13.3 20.0 18.5 18.7 24.9 145.9 104.5 56.7 61.6 48.8 64.2 90.4 33.1 103.1 129.7 43.6 45.2 38.2 13.3 36.1 24.3 50.4 43.4 23.3 32.7 26.7 39.3 56.1 97.4 41.4 24.8 47.7 41.3 30.7 43.8 20.2 75.1 40.6 21.9 35.1 41.1 50.4 28.8 39.5 53.4 29.6 63.6 58.2 33.0 87.4 63.1 37.5 26.1 46.8 42.8 35.3 PHF5A "bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7" ENSG00000100410 "PHD finger protein 5A" Q7RTV0 22 41459717-41468725 "Predicted intracellular proteins, Transcription factors" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028885 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028885: AB_10602079" "unprognostic (4.38e-2)" "unprognostic (3.58e-1)" "unprognostic (2.12e-3)" "unprognostic (2.64e-2)" "unprognostic (1.07e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (3.02e-8)" "unprognostic (3.39e-3)" "unprognostic (3.97e-3)" "unprognostic (4.46e-2)" "unprognostic (6.95e-3)" "unprognostic (2.12e-1)" "unprognostic (5.25e-3)" "unprognostic (4.11e-2)" "unprognostic (1.75e-1)" "unprognostic (1.67e-1)" "unprognostic (6.91e-2)" 24.5 20.8 21.4 21.4 24.9 47.6 27.8 21.3 27.3 20.7 24.0 27.6 18.2 22.0 24.4 26.8 28.8 22.2 21.9 18.3 22.0 20.8 26.1 28.9 20.0 30.9 32.4 23.8 21.9 25.9 18.1 24.5 29.7 23.0 20.1 29.0 21.5 22.4 20.0 32.4 25.3 26.9 22.3 29.5 27.1 24.8 27.3 28.8 38.0 23.4 30.4 38.4 21.3 22.8 33.8 34.2 39.5 33.5 30.4 35.0 40.0 21.8 15.9 27.2 17.9 20.1 15.3 18.9 22.5 18.3 29.4 24.9 21.6 13.1 31.7 13.1 16.6 20.7 17.0 36.8 26.6 33.4 19.5 38.3 19.7 24.0 25.0 21.0 51.5 15.7 14.6 20.8 23.2 29.0 12.3 20.7 22.8 26.2 20.4 21.1 29.3 41.6 34.3 27.2 60.8 23.4 31.6 24.2 22.2 19.4 17.4 13.4 11.3 24.6 16.3 24.2 20.0 13.1 26.8 14.1 15.8 27.5 12.5 26.9 16.9 29.6 53.3 15.1 22.6 16.6 21.4 33.5 38.9 27.0 30.8 35.0 33.8 31.2 33.6 34.2 30.4 30.9 30.1 39.5 30.4 28.4 28.8 32.5 40.0 21.4 24.9 21.3 27.3 22.0 20.8 32.4 23.8 23.0 28.8 20.8 11.5 67.5 63.0 68.6 23.0 9.7 35.7 20.1 7.9 10.4 3.9 79.5 39.7 49.1 6.3 40.0 29.3 46.7 48.8 96.5 39.8 40.0 33.4 19.2 51.8 12.7 14.5 31.9 30.2 8.9 39.1 48.0 32.1 76.7 29.2 30.1 53.9 31.6 39.3 31.5 20.3 97.0 45.3 54.3 80.0 80.0 91.3 58.6 39.3 89.1 PHF8 "JHDM1F, KDM7B, KIAA1111, ZNF422" ENSG00000172943 "PHD finger protein 8" Q9UPP1 X 53936676-54048958 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038779, HPA062015" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA038779: AB_10675950, HPA062015: AB_2684658" "unprognostic (6.35e-2)" "unprognostic (2.16e-2)" "unprognostic (1.70e-2)" "unprognostic (1.04e-1)" "unprognostic (8.76e-2)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "unprognostic (2.66e-3)" "unprognostic (1.97e-3)" "unprognostic (1.22e-1)" "unprognostic (5.64e-2)" "unprognostic (1.02e-1)" "unprognostic (5.17e-2)" "unprognostic (1.22e-1)" "unprognostic (9.94e-2)" "unprognostic (1.85e-2)" "prognostic favorable (3.74e-5)" 8.8 6.8 8.2 11.5 9.4 10.7 11.1 12.5 9.2 10.3 8.2 12.9 27.4 7.9 12.2 54.0 10.7 11.1 9.8 7.8 7.2 5.4 8.8 21.7 10.5 11.2 11.3 7.0 16.8 14.1 10.6 14.6 9.8 9.4 12.8 7.5 10.3 10.3 14.7 8.4 9.6 11.1 8.9 8.5 11.8 9.7 30.6 10.4 19.6 11.1 8.1 13.0 12.8 16.1 6.2 5.1 10.7 7.9 5.4 9.5 5.1 8.8 7.7 11.7 11.3 7.3 5.7 19.2 6.7 5.9 7.5 6.7 8.7 7.2 13.0 4.0 6.1 8.1 9.3 29.1 5.8 8.0 20.3 13.9 7.8 10.0 8.8 5.7 12.2 14.7 6.4 8.2 8.6 11.8 5.7 6.9 13.8 10.3 19.1 4.3 8.9 16.6 9.4 21.3 6.2 11.6 16.4 13.0 12.7 5.1 10.8 17.2 8.5 17.9 12.0 5.9 19.0 11.8 8.5 8.0 6.0 8.6 11.0 5.5 14.5 13.4 15.8 7.1 15.5 6.4 10.7 4.5 7.2 6.2 7.9 9.5 4.3 6.2 7.1 5.1 6.2 4.6 5.0 7.7 5.4 5.2 4.0 9.2 5.1 8.2 9.4 12.5 9.2 7.2 5.4 11.3 7.0 9.4 10.4 8.9 9.3 9.3 8.2 7.9 12.4 6.6 10.2 17.4 2.3 8.7 11.8 10.6 0.0 4.1 34.1 10.8 6.8 0.0 4.0 3.9 5.3 10.8 13.9 34.6 5.8 7.9 5.2 8.6 12.4 22.6 8.6 9.1 3.3 2.8 8.3 8.6 3.9 9.0 6.0 2.9 15.1 6.5 8.1 22.6 48.0 8.5 10.2 7.5 7.1 11.5 PHIP "BRWD2, DCAF14, FLJ20705, ndrp, WDR11" ENSG00000146247 "Pleckstrin homology domain interacting protein" Q8WWQ0 6 78935867-79078236 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019140, HPA019838" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA019140: AB_2670073, HPA019838: AB_2670287" "unprognostic (1.58e-1)" "unprognostic (1.60e-1)" "unprognostic (9.43e-2)" "unprognostic (8.47e-3)" "unprognostic (1.05e-1)" "unprognostic (2.01e-3)" "unprognostic (3.50e-3)" "unprognostic (5.03e-2)" "unprognostic (4.03e-2)" "unprognostic (6.40e-3)" "unprognostic (1.72e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (2.76e-1)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.55e-2)" 14.7 9.6 13.3 14.9 16.9 40.2 19.4 30.1 14.6 19.1 13.9 11.8 15.0 9.4 18.1 14.1 11.6 16.1 12.3 12.2 11.0 9.7 10.4 7.9 15.4 16.8 15.8 11.0 19.8 15.5 20.6 28.4 14.2 12.8 14.7 12.8 11.0 15.6 18.3 16.6 14.1 13.8 17.1 13.7 14.9 12.9 10.2 17.9 27.8 13.4 8.8 14.4 17.1 22.6 8.3 6.2 17.3 6.1 5.1 7.3 2.2 9.0 7.4 17.8 17.2 6.8 9.9 10.3 9.8 7.8 8.4 10.8 9.1 5.7 15.1 7.8 6.1 7.1 8.4 13.2 6.2 14.3 21.7 9.6 16.9 13.9 6.7 3.1 18.8 10.8 6.0 5.6 10.1 10.2 7.1 8.8 9.6 16.9 14.7 8.1 6.1 7.2 13.5 11.1 4.7 8.1 12.7 22.7 6.5 9.0 12.4 17.4 11.1 13.1 10.0 6.1 11.8 7.8 25.2 10.4 9.8 7.0 4.7 16.1 10.0 9.8 8.6 4.1 12.2 14.6 10.2 5.0 8.4 5.6 3.3 6.0 6.8 6.6 6.1 3.3 8.3 7.3 5.8 17.3 5.1 6.1 6.2 5.4 2.2 13.3 16.9 30.1 14.6 11.0 9.7 15.8 11.0 12.8 17.9 65.5 95.2 80.9 77.1 56.1 179.4 47.2 53.5 178.0 106.9 52.4 143.3 72.7 1.7 63.5 24.5 73.6 39.6 0.0 40.8 78.5 66.7 73.6 111.0 16.3 44.0 171.6 69.9 57.1 82.9 10.5 93.7 72.3 47.2 116.4 56.3 84.3 48.2 48.9 82.4 15.3 178.7 51.8 78.3 100.9 50.8 49.3 85.4 74.6 53.5 73.7 PHKA2 "PHK, PYK" ENSG00000044446 "Phosphorylase kinase regulatory subunit alpha 2" P46019 X 18892300-18984598 "Disease related genes, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" Calmodulin-binding "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002912 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA002912: AB_10961321" "unprognostic (3.90e-2)" "unprognostic (2.06e-2)" "unprognostic (5.10e-2)" "unprognostic (1.43e-2)" "unprognostic (1.90e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.07e-2)" "unprognostic (3.42e-1)" "unprognostic (1.82e-1)" "prognostic favorable (7.68e-4)" "unprognostic (7.51e-2)" "prognostic unfavorable (1.55e-5)" "unprognostic (2.05e-1)" "unprognostic (1.58e-2)" "unprognostic (7.16e-2)" "prognostic favorable (2.96e-5)" 9.5 8.6 4.0 9.8 8.3 10.8 7.9 10.9 5.9 8.7 7.7 7.8 4.5 10.1 8.5 5.4 5.8 8.3 10.9 8.6 4.2 3.7 6.2 29.4 5.4 14.1 7.1 3.6 14.5 13.1 8.8 16.9 11.6 6.9 8.3 5.2 9.5 7.4 12.4 6.0 6.9 10.1 4.9 6.6 8.5 6.9 12.4 5.4 29.6 9.2 3.4 9.1 7.2 10.4 3.0 3.2 9.9 5.6 4.2 3.4 2.6 8.4 7.9 4.6 7.7 6.3 5.9 13.0 3.7 3.1 5.4 6.0 8.3 5.5 9.8 2.8 4.7 8.6 7.8 8.3 9.5 5.9 4.9 8.7 11.8 12.3 10.0 4.5 11.0 15.2 9.8 6.4 6.6 9.6 9.0 5.6 10.4 3.9 6.1 3.7 8.6 11.5 18.4 5.7 3.8 8.7 9.2 9.6 10.9 3.5 3.7 4.0 6.2 11.3 11.5 5.0 16.2 14.4 6.4 9.9 7.4 4.3 7.9 5.7 6.0 5.0 7.5 4.2 6.0 4.0 5.1 4.6 9.9 3.2 5.6 3.4 2.5 2.6 2.3 3.2 3.0 3.2 3.0 8.2 4.2 3.6 1.7 3.2 2.6 4.0 8.3 10.9 5.9 4.2 3.7 7.1 3.6 6.9 5.4 8.9 14.6 6.2 5.3 5.8 9.7 19.0 15.3 1.4 4.5 8.7 9.8 14.3 0.0 5.1 4.3 5.8 7.7 23.3 4.4 14.6 5.1 5.9 1.1 44.0 6.8 4.8 4.1 19.0 17.6 4.7 6.9 6.4 5.0 1.0 6.5 23.5 6.5 9.5 7.4 3.9 12.4 0.0 3.4 5.4 7.2 4.1 8.8 4.6 11.9 3.3 PHOX2A "ARIX, CFEOM2, FEOM2, PMX2A" ENSG00000165462 "Paired like homeobox 2a" O14813 11 72239077-72245664 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7" "Cell type enriched" "Detected in single" 9 "Spermatogonia: 3.6" "Cancer enriched" "Detected in some" 9 "ovarian cancer: 9.3" "Region enriched" "Detected in single" 96 "pons and medulla: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 228 "SH-SY5Y: 115.5" "Region enriched" "Detected in single" 9 "pons and medulla: 0.8" "Not detected" "Not detected" "HPA053810, HPA065621, HPA078004" Enhanced Supported Nucleoplasm No NA Nucleoplasm "HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367" "unprognostic (5.84e-2)" "unprognostic (8.51e-2)" "unprognostic (5.07e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "unprognostic (9.92e-4)" "unprognostic (3.03e-2)" 0.4 24.6 0.0 9.7 0.0 0.0 0.0 0.0 0.1 0.2 3.3 0.5 0.0 0.4 0.1 0.0 1.4 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 12.1 0.9 0.7 1.7 0.7 3.7 0.0 0.0 3.2 0.3 2.1 0.1 1.6 5.2 0.0 0.0 0.0 0.0 0.0 2.6 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 115.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 PHOX2B "NBPhox, Phox2b, PMX2B" ENSG00000109132 "Paired like homeobox 2b" Q99453 4 41744082-41748970 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 14.5;brain: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 99 "pons and medulla: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 91 "SH-SY5Y: 53.6" "Region enriched" "Detected in single" 17 "pons and medulla: 5.9" "Region enriched" "Detected in single" 27 "pons and medulla: 2.0" "HPA074325, HPA074941" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA074325: AB_2686678, HPA074941: AB_2732272" "unprognostic (1.01e-1)" "unprognostic (2.47e-1)" "unprognostic (5.27e-2)" 0.0 14.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 24.8 0.2 1.4 0.8 0.0 0.0 0.0 0.0 3.2 0.5 0.4 0.0 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 53.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIANP "C12orf53, DKFZp547D2210, PANP" ENSG00000139200 "PILR alpha associated neural protein" Q8IYJ0 12 6693792-6700800 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.7" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 13.9;Horizontal cells: 17.5;Peritubular cells: 13.1" "Cancer enhanced" "Detected in many" "glioma: 14.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 7 "T-cells: 2.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 7.9;HAP1: 7.8;hTERT-RPE1: 13.1;NTERA-2: 16.5;SH-SY5Y: 15.6;U-2 OS: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010631 Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA010631: AB_10603680" "unprognostic (1.82e-1)" "unprognostic (9.21e-3)" "unprognostic (1.62e-2)" "unprognostic (7.65e-2)" "unprognostic (1.34e-1)" "unprognostic (3.03e-2)" "unprognostic (6.58e-2)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (6.41e-3)" "unprognostic (1.92e-2)" "unprognostic (3.89e-1)" "unprognostic (3.30e-3)" "unprognostic (3.26e-3)" "unprognostic (1.16e-1)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" 1.5 8.3 28.0 2.2 55.7 1.2 1.5 27.4 52.8 7.2 2.7 2.6 0.5 1.9 11.6 4.1 1.8 2.2 3.3 1.5 19.5 26.2 1.5 1.1 1.5 2.4 11.0 20.9 1.8 1.7 1.2 4.0 1.5 9.0 3.4 2.0 1.7 2.2 8.7 1.3 1.7 2.2 8.1 4.6 1.6 2.1 4.4 8.3 0.0 1.4 0.0 1.7 1.8 2.5 0.3 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.4 5.9 1.1 0.2 0.3 0.2 1.5 7.9 4.1 3.7 0.1 0.2 0.1 0.0 2.8 0.6 0.2 7.8 0.2 2.0 0.2 1.0 0.3 0.2 0.0 0.2 0.3 0.2 1.0 0.0 1.6 0.0 13.1 0.0 2.4 0.0 0.2 0.3 0.2 0.2 0.2 16.5 0.0 0.0 1.1 0.0 0.1 0.1 0.1 2.1 15.6 0.0 0.1 0.0 1.1 0.0 0.0 0.0 4.3 8.7 4.4 1.1 0.2 0.0 0.3 5.8 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.7 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.0 55.7 27.4 27.8 19.5 26.2 11.0 20.9 9.0 8.3 0.0 0.0 0.0 0.0 0.2 13.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 17.5 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 13.1 0.0 3.0 0.0 1.4 0.1 4.5 0.1 0.1 0.0 0.0 0.0 PIAS2 "ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4" ENSG00000078043 "Protein inhibitor of activated STAT 2" O75928 18 46803224-46920160 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 61.6" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 405.0;Late spermatids: 431.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068792 Enhanced Supported Nucleoplasm Yes No Nucleoplasm "HPA068792: AB_2686037" "unprognostic (9.59e-3)" "unprognostic (2.14e-1)" "unprognostic (1.63e-1)" "unprognostic (2.75e-2)" "unprognostic (1.25e-1)" "unprognostic (6.39e-2)" "unprognostic (1.05e-3)" "unprognostic (3.67e-2)" "unprognostic (1.05e-1)" "unprognostic (3.71e-3)" "unprognostic (1.77e-3)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.58e-1)" "unprognostic (6.92e-2)" "prognostic unfavorable (1.27e-4)" "unprognostic (1.71e-1)" 5.6 6.7 9.8 4.7 12.7 7.0 6.1 16.7 13.5 4.7 5.6 8.1 8.0 3.7 6.0 8.8 4.7 5.3 5.5 7.5 8.4 8.1 7.4 6.6 4.9 6.5 7.9 8.5 5.8 5.0 19.3 10.4 4.8 12.1 7.7 8.1 8.2 5.9 7.9 15.6 8.5 4.8 5.7 7.6 6.5 5.3 61.6 9.1 7.5 9.2 4.1 5.8 5.3 4.6 6.8 5.1 2.9 4.4 4.8 6.7 2.1 11.9 4.9 5.6 7.9 5.6 7.1 2.6 6.3 5.1 5.5 5.1 5.8 4.5 12.1 3.5 4.7 5.6 4.1 11.1 6.7 7.9 5.9 4.2 7.4 4.7 6.7 5.5 12.3 5.4 7.3 4.1 4.8 5.2 9.0 4.9 10.6 5.5 3.2 10.8 6.4 7.2 7.3 6.1 2.2 3.2 13.2 12.0 0.1 5.1 9.2 10.7 8.3 5.7 3.7 4.1 6.6 5.5 5.6 6.2 11.9 5.1 4.1 4.7 9.4 4.6 15.4 8.8 13.4 11.6 1.5 4.4 2.8 5.4 3.4 3.8 4.1 4.8 6.1 5.0 6.8 6.7 5.7 2.9 4.8 3.0 5.1 4.2 2.1 9.8 12.7 16.7 13.5 8.4 8.1 7.9 8.5 12.1 9.1 17.9 18.7 15.8 17.1 18.3 46.7 26.5 12.7 10.7 6.8 24.4 84.4 1.9 16.6 11.8 405.0 21.0 11.6 23.3 7.7 1.9 16.5 28.6 13.9 17.9 22.7 30.2 27.3 35.6 40.4 431.0 31.1 16.5 11.8 31.5 14.1 27.0 7.6 17.5 32.9 18.9 39.4 6.5 16.4 130.6 70.9 13.4 1.1 15.0 21.8 15.3 PIAS3 "FLJ14651, ZMIZ5" ENSG00000131788 "Protein inhibitor of activated STAT 3" Q9Y6X2 1 145848522-145859836 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006389, HPA067383" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006389: AB_2667576, HPA067383: AB_2685828" "unprognostic (1.23e-1)" "unprognostic (2.21e-1)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.79e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (2.30e-2)" "unprognostic (5.92e-2)" "unprognostic (2.50e-1)" "unprognostic (2.77e-3)" "unprognostic (5.06e-1)" "prognostic unfavorable (1.21e-7)" "unprognostic (5.14e-2)" "unprognostic (4.98e-2)" "unprognostic (5.66e-2)" "unprognostic (2.11e-2)" 15.2 9.8 10.7 12.8 12.7 4.5 17.4 19.1 16.3 29.1 16.2 17.9 16.5 7.5 25.5 15.0 26.4 36.7 20.2 14.1 11.5 9.7 13.9 6.4 13.6 8.2 11.6 11.9 21.2 11.7 14.7 13.8 10.5 11.9 20.3 8.4 28.8 20.9 26.8 17.4 28.6 10.3 23.1 10.7 10.2 15.9 10.0 12.1 7.3 11.4 19.2 22.7 22.6 24.2 6.1 8.6 10.7 11.9 15.1 12.6 6.8 12.8 8.9 9.2 8.1 14.2 26.9 5.6 12.1 16.7 13.8 15.4 7.2 8.5 6.6 13.1 20.7 5.8 13.3 4.7 19.2 11.7 7.2 7.0 3.0 6.1 3.8 14.2 5.4 15.1 21.9 12.5 12.7 7.3 17.9 19.9 6.0 4.8 9.2 28.6 21.4 5.8 2.8 14.3 36.4 14.5 9.1 6.3 4.3 10.9 7.7 3.1 14.7 11.6 6.5 5.9 11.0 30.0 8.3 30.6 18.5 13.8 12.2 7.7 12.7 5.7 4.3 18.0 4.1 9.1 8.5 9.5 10.7 11.7 8.8 12.5 6.1 7.7 12.6 7.0 4.3 7.1 6.7 2.2 15.1 11.9 8.6 8.2 6.8 10.7 12.7 19.1 16.3 11.5 9.7 11.6 11.9 11.9 12.1 20.8 11.5 3.7 7.5 9.5 8.8 0.8 5.1 40.2 21.6 15.7 11.8 3.3 1.7 7.0 2.0 8.7 1.6 0.0 6.7 5.8 11.0 7.0 10.4 3.8 4.5 9.5 4.1 9.8 6.2 2.9 13.3 5.9 5.0 15.4 5.1 3.9 8.8 2.0 12.4 1.2 11.2 25.8 13.3 3.0 10.0 14.3 3.3 4.4 2.5 8.9 PIF1 "C15orf20, FLJ22692" ENSG00000140451 "PIF1 5'-to-3' DNA helicase" Q9H611 15 64815632-64825668 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.3" "Group enriched" "Detected in many" 5 "Early spermatids: 22.3;Erythroid cells: 70.0" "Cancer enhanced" "Detected in many" "testis cancer: 10.2" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" CAB018701 Supported Supported Nucleoplasm NA Yes Nucleoplasm "CAB018701: AB_2164654" "unprognostic (1.99e-1)" "unprognostic (6.11e-2)" "unprognostic (1.34e-1)" "unprognostic (3.12e-2)" "unprognostic (1.62e-1)" "unprognostic (8.33e-3)" "unprognostic (8.66e-4)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (6.68e-2)" "unprognostic (2.38e-2)" "unprognostic (3.27e-2)" "unprognostic (0.00e+0)" "unprognostic (2.96e-3)" "unprognostic (1.78e-1)" "unprognostic (9.61e-2)" "unprognostic (5.95e-2)" 1.8 1.1 0.6 12.9 0.6 6.0 0.6 0.6 1.2 1.2 5.2 0.6 0.6 3.3 2.0 1.3 4.6 0.8 1.4 0.9 0.6 1.8 0.7 0.6 1.9 7.5 0.9 0.6 0.6 0.6 0.0 0.6 1.4 1.0 2.5 1.8 0.9 0.8 1.2 0.6 1.6 3.7 2.1 0.6 7.0 2.7 3.3 0.6 14.3 0.6 5.1 6.0 1.8 1.9 0.7 0.3 0.0 0.0 0.0 3.2 0.4 5.2 6.1 15.0 6.0 2.7 3.2 5.5 5.1 2.8 5.2 4.0 9.6 8.8 6.3 2.1 2.5 4.8 14.5 15.3 4.3 1.9 10.0 5.6 7.3 17.1 6.9 1.4 2.9 6.0 1.8 0.0 2.3 1.9 1.3 5.3 9.5 4.8 12.7 4.9 4.6 3.1 12.2 12.2 6.6 4.2 6.5 5.0 8.9 2.9 2.9 6.2 4.0 3.9 4.4 2.3 6.9 4.9 3.2 3.6 3.1 16.4 5.0 9.4 10.2 9.4 6.0 3.0 12.9 4.4 0.0 0.0 0.0 1.5 0.0 0.5 0.7 0.1 1.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.3 3.2 0.4 0.6 0.6 0.6 1.2 0.6 1.8 0.9 0.6 1.0 0.6 0.0 1.4 0.8 0.6 1.6 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 22.3 1.5 0.3 70.0 0.0 5.6 2.6 0.9 0.0 0.0 4.8 0.0 0.0 7.4 2.2 1.3 1.4 3.1 0.0 0.0 0.8 0.6 0.2 0.0 2.1 0.0 0.8 6.5 2.7 0.1 1.9 0.9 0.9 8.9 0.9 1.1 PIMREG "CATS, FAM64A, FLJ10156, FLJ10491, RCS1" ENSG00000129195 "PICALM interacting mitotic regulator" Q9BSJ6 17 6444415-6451469 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.3" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 50.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA043783, HPA049934" Uncertain Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA043783: AB_2678669, HPA049934: AB_2680959" "unprognostic (5.32e-3)" "unprognostic (1.14e-2)" "unprognostic (2.33e-1)" "unprognostic (4.37e-3)" "unprognostic (1.46e-1)" "unprognostic (1.24e-2)" "unprognostic (6.55e-3)" "unprognostic (1.23e-3)" "unprognostic (1.80e-1)" "unprognostic (5.88e-2)" "unprognostic (1.47e-3)" "unprognostic (1.50e-2)" "unprognostic (0.00e+0)" "unprognostic (8.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 1.9 4.5 1.2 1.6 1.1 3.1 2.2 1.0 0.8 1.3 4.7 0.6 0.4 4.3 1.6 1.7 6.0 0.3 2.5 1.6 0.5 0.5 0.8 0.9 2.1 1.7 0.6 0.4 1.6 0.4 0.0 1.0 0.9 1.2 0.8 6.2 0.4 1.3 0.4 0.4 3.7 4.5 2.7 1.0 9.5 1.8 1.0 0.4 27.3 0.4 3.9 3.6 2.3 2.0 0.4 0.0 0.8 0.4 3.3 1.5 1.2 12.6 17.1 50.8 22.8 0.4 1.5 3.9 14.9 9.2 24.5 16.6 10.1 5.5 0.0 6.0 12.1 12.1 9.3 25.6 6.6 13.2 19.5 10.2 0.0 10.2 12.2 0.0 0.5 15.5 0.8 0.4 10.1 3.9 2.3 7.7 11.3 3.0 7.2 15.3 9.1 2.7 0.1 22.2 10.2 11.2 22.7 20.4 8.9 4.0 1.9 11.6 16.3 12.9 13.4 12.6 6.4 6.2 1.2 3.6 19.2 15.6 11.3 24.3 2.6 9.2 0.0 7.5 6.2 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 0.0 0.4 0.2 0.7 0.8 3.3 0.4 0.0 1.3 1.2 1.2 1.1 1.0 0.7 0.5 0.5 0.6 0.4 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PIP4K2B "PIP5K2B, PIP5KIIB, PIP5KIIbeta" ENSG00000276293 "Phosphatidylinositol-5-phosphate 4-kinase type 2 beta" P78356 17 38765689-38800126 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 23.6" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 41.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062220 Supported Nucleoplasm NA NA Nucleoplasm "HPA062220: AB_2684715" "unprognostic (7.77e-2)" "unprognostic (8.37e-2)" "unprognostic (3.74e-2)" "unprognostic (1.13e-1)" "unprognostic (2.67e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (4.54e-4)" "unprognostic (2.64e-1)" "unprognostic (2.33e-1)" "unprognostic (1.50e-2)" "unprognostic (6.10e-3)" "unprognostic (3.79e-1)" "unprognostic (4.82e-3)" "unprognostic (3.38e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.36e-4)" "unprognostic (2.48e-1)" 5.1 6.5 12.4 3.3 12.9 1.1 5.0 8.8 17.4 6.8 2.7 7.0 4.2 2.2 7.2 5.9 3.5 7.4 3.6 7.1 9.6 4.1 2.2 5.0 4.2 5.4 13.3 13.3 3.0 5.1 2.7 5.4 7.5 5.1 3.2 4.1 3.8 6.5 23.6 5.8 2.3 7.3 4.7 5.1 2.5 2.8 6.5 2.0 4.7 2.2 4.5 3.7 5.9 3.3 3.1 2.4 2.4 3.4 5.0 3.7 5.7 12.7 21.2 22.0 18.5 14.7 4.3 10.8 12.0 13.6 11.2 8.6 5.7 14.8 6.8 18.4 11.9 12.4 14.0 8.9 13.1 10.2 9.0 12.8 8.2 12.6 8.4 14.6 7.9 12.9 10.9 10.6 7.9 19.2 11.3 15.4 11.2 7.0 14.6 4.3 13.4 10.7 11.8 6.4 5.9 14.6 20.9 8.1 10.0 7.2 11.8 17.1 10.9 4.4 11.0 23.1 14.0 13.8 11.9 11.5 7.6 9.9 9.3 9.2 11.5 6.7 13.7 11.6 10.4 1.6 2.4 0.8 4.8 2.2 5.0 3.1 4.1 4.6 3.1 3.3 4.7 4.2 2.4 3.4 1.8 3.0 3.9 3.7 17.9 10.7 3.7 3.7 5.5 33.8 18.9 7.6 4.0 9.1 5.2 9.8 6.3 1.7 4.7 8.7 14.6 3.9 0.0 4.2 4.1 8.5 4.5 1.1 9.8 7.5 41.3 11.1 20.3 8.3 13.7 14.1 5.7 1.7 1.8 6.9 12.9 5.4 3.5 15.6 6.7 13.4 6.5 7.2 4.6 8.1 3.9 2.1 7.2 7.3 1.8 PITX2 "ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS" ENSG00000164093 "Paired like homeodomain 2" Q99697 4 110617423-110642123 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 30.4;retina: 53.5;skeletal muscle: 28.8" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 12.7;Cytotrophoblasts: 5.5;Enterocytes: 6.5;Extravillous trophoblasts: 5.4;Hofbauer cells: 6.6;Spermatogonia: 5.6;Syncytiotrophoblasts: 8.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 16 "hypothalamus: 2.1;midbrain: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 18.1;HEK 293: 8.0;LHCN-M2: 18.6;RH-30: 15.7" "Region enhanced" "Detected in single" "hypothalamus: 9.8" "Region enhanced" "Detected in single" "hypothalamus: 5.1" "HPA050074, HPA062728" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA050074: AB_2681005, HPA062728: AB_2684851" "unprognostic (1.08e-1)" "unprognostic (1.23e-2)" "unprognostic (9.29e-2)" "unprognostic (9.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-2)" "unprognostic (9.61e-4)" "unprognostic (3.22e-2)" "unprognostic (1.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.16e-1)" "unprognostic (2.77e-1)" "unprognostic (1.11e-15)" "unprognostic (6.97e-3)" "unprognostic (1.43e-1)" "unprognostic (5.98e-2)" "unprognostic (9.91e-2)" 0.6 0.1 0.0 18.6 0.0 0.1 0.3 0.0 0.1 1.1 3.0 0.0 0.3 0.1 0.1 1.3 2.7 0.2 1.1 3.5 0.0 2.1 0.3 0.1 0.1 0.1 1.1 0.0 0.1 0.5 0.1 12.5 30.4 0.0 8.3 0.3 53.5 9.3 0.2 28.8 0.9 3.4 15.9 0.0 0.1 0.5 0.3 0.0 0.0 0.1 16.8 0.4 19.4 5.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 1.9 0.0 0.7 1.9 1.6 3.0 0.6 0.3 2.0 1.5 18.1 0.0 0.0 3.9 3.7 2.4 0.3 0.1 0.0 1.1 0.0 8.0 0.0 1.4 0.0 6.7 0.0 3.8 2.1 0.1 0.3 0.0 0.6 0.0 2.0 0.5 0.0 18.6 0.5 2.0 0.0 0.3 0.0 0.3 0.0 15.7 0.0 0.3 2.5 0.0 0.0 1.4 2.5 0.2 0.3 0.1 0.0 0.0 2.5 5.9 0.0 2.9 0.0 0.1 0.8 1.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 12.7 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 6.5 0.0 0.3 5.4 4.5 0.2 0.0 0.0 6.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.9 0.0 1.3 0.0 0.0 1.7 1.2 5.6 0.1 8.8 0.0 1.2 0.0 PKNOX1 PREP1 ENSG00000160199 "PBX/knotted 1 homeobox 1" P55347 21 42974510-43033931 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004285, HPA057215, HPA065017" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB004285: AB_2164128, HPA057215: AB_2683372, HPA065017: AB_2685405" "unprognostic (1.68e-2)" "unprognostic (2.64e-1)" "unprognostic (1.59e-1)" "unprognostic (8.39e-2)" "unprognostic (1.90e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (4.54e-8)" "unprognostic (2.03e-1)" "unprognostic (8.03e-2)" "unprognostic (3.67e-2)" "prognostic favorable (6.71e-4)" "unprognostic (9.45e-2)" "unprognostic (3.94e-2)" "unprognostic (1.85e-1)" "unprognostic (1.21e-2)" "unprognostic (6.16e-2)" "unprognostic (4.31e-3)" 6.8 6.4 7.9 8.7 9.2 3.9 7.3 24.2 9.1 12.3 8.3 9.9 9.0 5.0 14.3 9.8 7.4 10.0 8.4 6.1 7.2 7.9 6.7 6.6 6.9 8.1 10.7 5.4 14.4 15.7 6.9 13.3 11.9 8.6 8.7 6.9 5.4 7.1 12.4 11.7 9.2 6.1 15.2 7.6 7.5 6.6 42.9 10.1 12.2 16.4 5.8 7.6 9.3 18.2 4.9 3.3 10.1 4.9 4.0 7.6 4.1 8.7 3.1 4.1 3.9 7.7 11.7 5.1 11.3 7.8 6.9 5.9 5.3 6.8 12.3 9.4 9.8 5.4 4.7 9.3 7.1 9.0 8.4 7.6 7.3 5.9 5.0 8.0 6.5 5.8 8.9 11.8 8.5 6.9 7.2 6.5 4.3 5.7 9.2 15.5 5.2 6.1 7.3 6.3 12.5 6.8 9.8 18.5 6.7 13.5 7.1 13.1 7.9 8.0 5.8 7.7 4.9 4.9 8.3 7.7 10.8 5.4 5.9 7.2 5.4 6.0 6.4 13.5 11.7 5.6 0.4 3.7 2.7 7.2 4.9 7.6 4.9 5.2 5.9 3.3 4.1 6.4 5.6 10.1 4.0 3.3 3.0 5.3 4.1 7.9 9.2 24.2 9.1 7.2 7.9 10.7 5.4 8.6 10.1 6.0 14.9 6.0 71.8 15.5 22.3 5.6 12.7 20.1 20.5 15.7 3.9 12.4 8.3 14.2 104.0 11.7 9.1 23.3 10.9 24.3 19.4 19.9 5.8 6.8 10.9 12.7 14.3 9.2 8.3 26.8 17.3 17.5 13.5 18.0 9.6 9.7 13.8 5.8 27.6 5.9 11.2 32.3 22.6 61.7 24.3 12.0 24.3 15.8 9.3 44.5 PLAC8L1 ENSG00000173261 "PLAC8 like 1" A1L4L8 5 146084386-146104369 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 20.4" "Group enriched" "Detected in some" 78 "Early spermatids: 401.3;Late spermatids: 218.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA074266 Approved Nucleoplasm NA NA Nucleoplasm "HPA074266: AB_2686676" "unprognostic (6.38e-3)" "unprognostic (1.90e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-1)" "unprognostic (1.62e-2)" "unprognostic (7.48e-2)" "unprognostic (4.13e-2)" "unprognostic (3.79e-1)" "unprognostic (6.45e-2)" "unprognostic (5.05e-2)" "unprognostic (1.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.21e-6)" "unprognostic (9.72e-2)" "unprognostic (1.79e-1)" "unprognostic (1.89e-1)" "unprognostic (4.18e-2)" 0.4 0.1 0.9 0.4 1.0 0.1 1.0 1.6 0.8 0.4 0.4 0.4 0.4 0.0 0.5 0.5 0.4 0.6 0.4 0.4 1.0 1.0 0.4 0.5 0.4 0.4 1.1 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.9 3.1 0.6 0.5 1.9 0.4 0.1 20.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.2 1.3 0.0 0.0 0.0 0.5 0.0 0.9 2.7 2.6 9.8 0.7 1.1 0.6 1.0 0.4 4.2 2.7 0.4 1.2 1.5 2.2 1.1 0.9 0.7 4.0 0.0 3.5 3.2 5.6 2.2 0.9 1.1 0.5 0.9 1.8 0.0 6.3 3.2 2.5 0.5 1.5 3.3 0.2 2.0 1.1 0.0 0.9 2.9 0.5 0.3 3.8 0.9 0.5 0.0 0.3 0.0 2.4 1.2 1.1 0.4 2.3 0.8 0.2 0.9 1.1 0.0 3.7 1.1 1.9 1.2 3.2 1.3 0.8 1.6 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.9 1.0 1.6 0.8 1.0 1.0 1.1 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 401.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.6 0.0 0.6 0.0 218.3 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.4 0.0 0.2 3.2 1.5 0.0 0.1 0.0 0.1 0.0 PLCXD2 FLJ31579 ENSG00000240891 "Phosphatidylinositol specific phospholipase C X domain containing 2" Q0VAA5 3 111674676-111846447 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 16.0" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 57.6;Distal tubular cells: 135.9;Hepatocytes: 132.8;Proximal tubular cells: 94.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.2" "Group enriched" "Detected in many" 5 "dendritic cells: 7.2;NK-cells: 2.1;T-cells: 3.6" "Cell line enhanced" "Detected in many" "HBF TERT88: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055947 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055947: AB_2682981" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (7.26e-2)" "unprognostic (2.42e-1)" "unprognostic (3.09e-2)" "unprognostic (2.76e-2)" "unprognostic (1.36e-1)" "unprognostic (4.64e-1)" "unprognostic (3.47e-1)" "unprognostic (1.99e-2)" "unprognostic (3.38e-2)" "unprognostic (2.04e-1)" "prognostic favorable (1.23e-7)" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.99e-4)" 1.5 1.0 1.9 3.4 5.8 9.6 1.2 5.8 10.9 1.6 2.8 0.4 0.0 6.1 1.0 0.6 1.8 1.2 1.9 1.5 3.6 2.5 2.5 4.1 2.0 5.9 2.9 6.8 1.1 2.3 0.4 4.1 16.0 10.3 1.5 3.6 4.1 2.0 0.7 1.2 1.5 5.9 0.9 2.9 3.5 2.1 4.2 1.1 3.1 3.2 0.5 4.8 1.9 1.6 0.9 7.2 0.6 0.0 2.1 3.6 0.6 3.0 2.7 2.6 1.2 0.1 0.1 0.8 5.3 2.5 5.0 4.4 1.9 1.5 2.2 2.7 0.2 1.6 7.5 1.1 5.1 9.7 0.6 1.3 0.5 5.0 1.7 0.4 0.7 2.6 0.0 1.0 1.6 3.0 4.7 2.8 2.9 0.1 5.4 0.6 0.3 1.5 0.5 0.9 2.0 6.8 1.4 3.8 2.0 2.4 3.1 0.6 4.6 1.1 0.7 1.1 3.1 0.4 0.2 2.6 1.1 6.8 0.5 1.0 6.5 0.9 0.4 0.5 0.4 0.3 0.6 0.0 0.0 3.6 0.0 3.5 0.5 1.9 3.5 0.3 0.9 0.9 2.0 0.2 2.1 0.0 7.2 1.7 0.6 1.9 5.8 5.8 10.9 3.6 2.5 2.9 6.8 10.3 1.1 17.9 2.1 0.5 6.9 0.1 0.7 1.9 28.1 0.0 1.2 57.6 3.9 0.0 135.9 36.1 11.5 0.0 1.3 0.0 43.6 0.0 0.1 3.8 0.0 132.8 0.0 6.4 24.1 0.0 1.6 8.9 0.3 0.0 0.0 0.0 4.9 0.0 45.8 0.0 0.4 94.0 3.7 0.0 0.0 0.5 0.4 0.1 0.0 2.2 1.1 12.2 PLEKHG1 "ARHGEF41, KIAA1209" ENSG00000120278 "Pleckstrin homology and RhoGEF domain containing G1" Q9ULL1 6 150599883-150843665 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.7" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 43.2;Ito cells: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 28 "memory B-cell: 14.7;naive B-cell: 15.9" "Lineage enriched" "Detected in single" 29 "B-cells: 15.9" "Cell line enhanced" "Detected in many" "AF22: 12.5;HAP1: 18.4;Karpas-707: 16.4;U-698: 11.4" "Region enriched" "Detected in many" 5 "thalamus: 56.1" "Low region specificity" "Detected in all" "HPA027128, HPA027319, HPA028270" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388" "unprognostic (2.93e-1)" "unprognostic (3.44e-1)" "unprognostic (3.04e-3)" "unprognostic (2.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.80e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (2.10e-1)" "unprognostic (1.60e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (4.62e-3)" "unprognostic (3.63e-1)" "unprognostic (4.30e-2)" "unprognostic (3.83e-1)" "unprognostic (2.15e-2)" 27.5 2.2 7.3 10.6 7.3 2.3 10.0 2.4 7.1 8.3 5.8 10.1 4.8 4.8 7.8 14.1 9.6 8.9 8.1 5.9 7.7 6.7 4.5 5.1 12.1 13.5 10.5 3.0 4.7 2.8 8.2 5.1 13.9 11.1 4.1 6.2 3.4 3.5 5.4 6.4 8.9 6.0 5.7 19.6 28.9 4.5 7.3 7.7 39.7 6.0 5.8 13.3 7.4 8.5 15.9 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 12.5 0.1 0.0 0.0 8.9 0.0 0.0 0.0 0.0 6.9 3.0 4.9 4.8 0.0 1.2 1.8 18.4 1.6 0.0 7.7 2.0 0.3 0.9 0.0 0.0 0.0 1.4 0.8 4.7 0.0 0.1 0.0 7.7 4.1 0.0 16.4 0.0 0.2 1.5 0.0 0.9 4.8 0.5 0.8 0.0 0.0 3.6 8.2 0.4 0.1 0.0 2.2 1.5 1.4 0.0 0.0 7.7 0.0 1.7 0.0 3.3 0.0 0.0 11.4 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.5 14.7 0.3 0.4 0.0 15.9 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.4 7.3 7.3 2.4 7.1 7.7 6.7 10.5 3.0 11.1 7.7 0.0 3.8 8.1 0.6 3.8 0.2 1.6 2.5 5.3 3.4 7.0 0.0 4.2 3.3 2.3 2.7 43.2 4.3 0.0 1.0 1.3 9.9 0.7 0.0 3.0 0.5 0.0 5.2 39.9 6.1 1.3 0.3 0.8 5.0 8.2 9.0 8.3 6.3 10.5 0.4 2.8 0.5 0.0 2.3 1.0 0.9 3.1 2.4 3.2 4.2 2.4 PLEKHG4B KIAA1909 ENSG00000153404 "Pleckstrin homology and RhoGEF domain containing G4B" Q96PX9 5 92151-189972 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 25.4;Club cells: 19.4;Collecting duct cells: 10.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "pons and medulla: 8.5" "Cell type enriched" "Detected in single" 21 "plasmacytoid DC: 5.4" "Lineage enriched" "Detected in single" 21 "dendritic cells: 5.4" "Cell line enhanced" "Detected in some" "AN3-CA: 10.4;HAP1: 9.3;NTERA-2: 9.6;REH: 21.7;SCLC-21H: 9.7;SH-SY5Y: 8.7;SK-BR-3: 9.2;SuSa: 9.5;T-47d: 13.0" "HPA036274, HPA058157" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036274: AB_10669668, HPA058157: AB_2683625" "unprognostic (3.60e-2)" "unprognostic (8.52e-2)" "unprognostic (5.44e-3)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (3.91e-1)" "unprognostic (3.59e-1)" "prognostic favorable (3.47e-4)" "unprognostic (5.96e-2)" "unprognostic (7.08e-2)" "unprognostic (2.56e-2)" "unprognostic (1.58e-1)" "unprognostic (9.98e-7)" "unprognostic (1.43e-2)" "unprognostic (7.00e-2)" "unprognostic (1.63e-3)" "unprognostic (1.08e-3)" 0.1 0.2 1.7 0.3 0.5 1.4 3.9 1.5 0.6 4.4 1.0 3.1 0.0 0.6 3.6 1.0 0.6 3.1 0.0 0.1 1.3 0.9 1.4 0.1 1.3 1.5 0.8 0.0 3.3 2.5 0.2 8.2 7.9 8.5 5.4 0.1 5.1 4.5 1.2 0.4 0.9 0.9 0.7 0.4 0.2 2.1 4.8 1.1 5.2 8.2 0.6 1.6 0.3 0.8 0.0 5.4 0.2 0.0 0.1 0.2 0.0 0.0 0.9 6.9 10.4 0.0 0.0 0.1 0.7 0.2 0.7 1.5 1.2 0.1 0.1 2.3 0.9 0.6 0.4 9.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 2.8 0.0 0.0 0.0 0.2 0.1 0.0 9.6 0.0 0.1 21.7 4.9 5.6 0.8 0.0 9.7 8.7 5.3 9.2 0.0 9.5 13.0 0.0 0.0 0.2 2.6 0.0 0.2 0.1 0.0 0.4 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 5.4 0.0 0.0 1.7 0.5 1.5 0.6 1.3 0.9 0.8 0.0 8.5 1.1 0.0 4.3 0.0 2.9 0.3 0.4 1.6 0.0 25.4 19.4 10.4 0.0 4.2 0.0 0.4 0.2 0.0 0.0 0.0 0.2 3.8 0.6 2.5 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.2 5.7 0.3 1.5 0.0 0.0 0.7 PLEKHG5 "GEF720, KIAA0720, Syx, Tech" ENSG00000171680 "Pleckstrin homology and RhoGEF domain containing G5" O94827 1 6466092-6520061 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.8;skin 1: 60.0" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 12.9;Suprabasal keratinocytes: 12.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 17.5" "Group enriched" "Detected in many" 4 "amygdala: 18.7;basal ganglia: 13.2;cerebral cortex: 26.7;hippocampal formation: 40.2" "Low region specificity" "Detected in all" HPA049570 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049570: AB_2680818" "unprognostic (5.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.47e-1)" "unprognostic (2.81e-1)" "unprognostic (1.50e-3)" "unprognostic (5.10e-2)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (4.40e-2)" "unprognostic (1.02e-2)" "unprognostic (4.85e-1)" "unprognostic (2.70e-2)" "unprognostic (1.28e-3)" "unprognostic (4.85e-1)" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (4.85e-2)" 10.6 9.7 8.7 2.9 6.3 0.7 4.1 59.8 11.6 3.9 3.0 1.2 2.5 3.3 3.8 4.5 7.1 3.9 6.5 5.4 7.7 2.9 2.3 0.8 3.6 2.7 1.8 6.7 2.6 3.1 4.0 15.2 7.6 4.4 3.4 2.8 4.9 4.2 5.3 3.4 60.0 4.3 2.7 1.8 16.9 2.6 2.6 1.4 0.0 2.4 6.5 4.8 2.3 4.4 0.5 0.6 2.1 0.5 0.3 1.0 0.4 4.0 1.1 8.1 4.7 0.8 2.8 1.4 5.5 3.1 1.7 1.0 2.3 8.0 0.1 12.6 1.8 3.1 13.7 0.9 12.0 0.9 7.9 1.6 0.0 5.6 1.4 1.2 0.0 0.7 2.9 6.4 5.9 6.9 10.5 12.3 0.9 0.0 1.0 0.4 3.4 0.1 15.6 2.5 1.2 12.2 0.1 1.0 1.1 4.3 1.3 5.2 14.9 0.6 4.1 0.3 4.1 5.4 0.1 17.5 4.2 3.0 0.0 3.3 0.1 0.0 0.9 4.6 0.0 0.3 1.8 0.5 0.3 0.4 0.4 1.0 0.2 0.8 0.7 0.1 0.5 0.5 0.6 2.1 0.3 0.2 0.6 0.2 0.4 8.7 6.3 59.8 11.6 7.7 2.9 1.8 6.7 4.4 1.4 0.0 1.0 0.0 2.1 6.5 0.6 3.2 2.5 1.4 2.3 3.5 2.0 2.2 0.0 1.1 8.6 4.5 3.3 0.0 1.2 3.3 1.8 1.4 0.0 0.0 4.0 1.6 3.4 5.5 1.2 2.6 1.7 0.0 0.0 0.0 5.2 9.2 3.3 5.8 8.1 0.6 1.5 12.9 1.0 1.9 3.2 12.7 1.6 0.0 2.7 5.5 PLPPR1 "FLJ20300, LPPR1, MGC26189, PRG-3" ENSG00000148123 "Phospholipid phosphatase related 1" Q8TBJ4 9 101028709-101325135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 38.5;kidney: 24.4" "Group enriched" "Detected in some" 4 "Distal tubular cells: 31.5;Proximal tubular cells: 27.8" "Group enriched" "Detected in some" 5 "glioma: 11.1;liver cancer: 5.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Hep G2: 5.8;SCLC-21H: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014760, HPA014968, HPA014979" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130" "unprognostic (1.08e-2)" "unprognostic (2.79e-1)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (7.33e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.37e-4)" "unprognostic (2.09e-1)" "unprognostic (1.14e-1)" "unprognostic (9.86e-4)" "unprognostic (1.44e-1)" "unprognostic (1.65e-6)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (4.83e-2)" 0.8 0.9 12.6 0.7 38.5 0.7 1.4 1.7 24.4 1.0 0.9 7.6 0.0 0.8 0.8 5.2 0.8 1.0 0.9 0.8 12.7 7.0 24.4 5.0 2.8 0.7 7.5 5.5 0.7 1.1 0.7 0.1 0.8 5.3 1.0 1.0 0.1 1.1 0.8 0.8 0.8 0.8 0.8 10.2 0.7 0.9 1.5 9.3 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.9 10.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 38.5 1.7 6.4 12.7 7.0 7.5 5.5 5.3 9.3 0.0 4.6 0.0 0.0 0.0 2.2 0.0 2.5 0.0 1.2 0.0 0.0 0.0 31.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.4 0.1 0.0 1.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 27.8 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PLPPR2 "LPPR2, PRG-4" ENSG00000105520 "Phospholipid phosphatase related 2" Q96GM1 19 11355386-11365698 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 32.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 32.3" "Cell line enhanced" "Detected in many" "U-2197: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048973 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA048973: AB_2680580" "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.90e-1)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (7.10e-2)" "unprognostic (1.37e-1)" "unprognostic (9.60e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.82e-4)" "unprognostic (2.23e-1)" "prognostic unfavorable (7.46e-11)" "unprognostic (1.99e-2)" "unprognostic (1.46e-1)" "unprognostic (4.37e-2)" "unprognostic (1.17e-1)" 12.0 17.1 32.5 10.5 39.9 14.1 6.6 17.7 51.2 14.0 11.1 10.8 5.1 6.0 12.7 8.4 8.4 9.7 13.7 10.4 37.0 22.3 5.5 18.0 10.0 5.4 11.8 17.9 15.2 12.4 11.7 22.7 11.5 12.3 18.5 5.1 11.8 13.1 15.1 23.1 16.2 5.7 16.8 10.5 10.6 9.3 7.6 9.4 0.5 7.7 4.4 3.3 9.8 8.1 0.0 2.9 32.3 7.2 0.0 0.3 2.3 8.8 5.5 3.0 12.6 12.8 12.3 0.8 15.8 14.7 9.8 10.1 1.0 1.6 1.7 9.4 20.1 2.0 1.6 1.7 4.7 5.3 4.6 3.2 0.5 3.8 1.0 6.7 0.5 18.0 11.0 8.6 8.4 1.6 14.2 6.6 2.8 8.5 14.1 8.2 13.1 0.2 2.4 3.3 3.0 30.7 0.2 0.4 4.8 4.6 4.2 3.3 10.9 6.6 5.7 3.3 1.0 8.2 11.3 7.6 22.2 4.7 37.5 8.3 8.8 5.4 0.6 21.6 8.1 8.7 0.8 7.2 3.7 0.3 6.7 0.0 0.0 0.1 0.0 2.9 0.0 0.1 0.0 32.3 0.0 4.4 0.1 0.3 2.3 32.5 39.9 17.7 51.2 37.0 22.3 11.8 17.9 12.3 9.4 6.0 8.8 0.5 5.5 0.0 5.1 0.0 7.6 2.7 2.3 3.5 11.8 0.5 1.7 6.2 11.0 6.9 0.0 0.0 7.6 2.1 2.1 16.2 2.3 6.7 4.0 7.9 16.4 8.0 9.7 8.2 13.3 3.9 0.0 0.0 2.5 15.3 7.5 0.0 15.6 1.3 6.3 6.5 0.0 1.8 4.9 0.0 2.4 0.0 0.8 4.1 PM20D2 "ACY1L2, bA63L7.3" ENSG00000146281 "Peptidase M20 domain containing 2" Q8IYS1 6 89146050-89165565 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030325, HPA030326, HPA030327" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030325: , HPA030326: AB_2673429, HPA030327: AB_10603129" "unprognostic (3.60e-2)" "unprognostic (1.40e-1)" "unprognostic (6.36e-2)" "unprognostic (3.18e-3)" "unprognostic (3.22e-2)" "unprognostic (2.73e-1)" "unprognostic (1.13e-3)" "unprognostic (8.60e-2)" "unprognostic (1.04e-1)" "unprognostic (5.86e-2)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (9.99e-2)" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (1.32e-1)" "unprognostic (1.31e-1)" 6.8 5.0 4.8 11.4 6.9 6.5 7.6 11.2 4.9 11.9 13.4 4.4 9.3 7.0 11.3 7.1 14.2 11.0 9.1 16.9 5.1 5.5 9.6 9.7 6.2 8.3 3.7 3.1 21.0 11.3 12.5 23.8 6.9 8.6 23.5 8.5 17.6 8.6 8.7 38.5 10.2 8.0 27.7 4.8 5.2 7.6 4.0 2.9 16.6 23.0 10.6 12.1 19.5 8.5 4.1 2.4 3.0 1.0 4.8 4.0 1.5 11.9 5.3 4.8 7.4 1.6 1.0 0.3 6.0 6.0 9.0 11.6 6.2 5.9 34.9 7.4 1.3 7.7 4.6 9.8 4.8 20.6 10.8 12.5 7.0 3.2 5.8 1.8 20.2 5.7 1.6 3.6 3.4 7.3 7.4 2.1 10.5 2.7 18.7 2.8 1.8 12.7 16.0 1.9 10.4 5.3 21.2 23.8 25.3 10.1 2.3 13.5 9.4 3.6 5.8 5.9 6.5 0.0 17.9 3.5 0.2 5.5 1.9 12.6 10.0 14.6 7.4 2.5 17.5 0.8 1.9 1.0 2.9 2.2 0.6 3.5 4.1 2.7 3.7 1.6 3.1 4.0 3.5 3.0 4.8 0.6 2.4 0.5 1.5 4.8 6.9 11.2 3.9 5.1 5.5 3.7 3.1 8.6 2.9 8.9 9.3 11.5 19.6 26.9 19.1 18.2 28.1 10.7 14.8 15.7 29.5 2.0 5.0 11.3 4.3 10.5 4.9 0.0 9.0 1.9 14.7 40.0 5.8 7.3 3.0 7.9 10.4 7.4 8.2 7.0 22.7 3.2 16.9 19.8 16.1 10.3 16.0 3.5 18.0 13.2 21.1 6.5 17.6 4.5 6.1 27.7 1.0 10.0 24.9 14.4 PMS2 "H_DJ0042M02.9, HNPCC4, MLH4, PMSL2" ENSG00000122512 "PMS1 homolog 2, mismatch repair system component" P54278 7 5973239-6009125 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010235, HPA066490, HPA070310" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB010235: AB_2167281, HPA066490: AB_2685677, HPA070310: AB_2686250" "unprognostic (5.13e-2)" "unprognostic (6.55e-3)" "unprognostic (1.54e-1)" "unprognostic (1.43e-3)" "unprognostic (5.14e-2)" "unprognostic (1.29e-1)" "unprognostic (7.36e-2)" "unprognostic (1.02e-1)" "unprognostic (7.43e-2)" "unprognostic (2.35e-1)" "unprognostic (1.86e-1)" "unprognostic (7.38e-2)" "prognostic favorable (1.23e-5)" "unprognostic (5.31e-2)" "unprognostic (2.01e-2)" "unprognostic (3.67e-2)" "unprognostic (2.81e-2)" 6.3 7.4 8.7 6.0 19.8 3.6 8.1 15.5 21.2 6.2 6.0 11.5 6.9 6.4 6.4 6.3 7.5 7.5 5.0 5.3 9.0 10.3 14.2 5.8 5.5 9.1 8.4 9.5 7.5 7.1 16.6 7.1 5.9 16.2 7.0 6.2 8.0 7.1 7.8 5.7 14.8 6.8 7.1 7.5 6.9 6.1 4.8 5.8 7.5 12.4 5.7 10.7 7.7 6.5 6.2 5.8 7.2 7.9 4.0 9.3 6.3 9.7 10.6 8.5 21.2 6.7 9.9 7.3 5.2 4.0 5.1 4.1 9.2 7.0 18.3 6.2 7.5 11.5 13.4 12.7 3.4 5.5 7.2 5.2 8.0 8.6 6.6 11.4 9.8 5.5 10.4 9.7 4.0 15.2 7.3 9.4 8.7 14.9 8.9 8.4 9.0 2.9 7.0 8.6 4.4 6.5 10.0 10.3 9.3 10.7 7.3 7.8 16.8 10.2 14.9 11.2 13.2 18.5 6.9 8.0 6.5 14.5 9.5 9.4 12.0 20.0 18.5 4.5 9.7 14.8 7.2 5.4 3.1 8.4 7.9 9.3 6.2 6.6 7.2 5.8 5.6 8.8 6.2 2.4 4.0 3.2 5.3 6.4 6.3 8.7 19.8 15.5 21.2 9.0 10.3 8.4 9.5 16.2 5.8 11.9 5.1 17.2 8.2 4.4 12.6 2.8 5.1 6.7 7.9 10.4 21.6 7.8 29.9 4.7 6.9 7.4 2.0 0.0 2.9 5.4 5.5 8.4 4.7 9.6 4.5 28.6 5.2 7.4 7.3 5.6 11.8 4.9 6.8 5.4 2.3 5.2 3.5 2.9 9.6 32.0 14.2 25.8 6.6 24.2 10.2 7.0 10.6 8.5 2.6 10.2 POC5 "C5orf37, FLJ35779, hPOC5, MGC120442, MGC120443, MGC120444" ENSG00000152359 "POC5 centriolar protein" Q8NA72 5 75674124-75717481 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 63.9;Late spermatids: 39.9;Rod photoreceptor cells: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037509, HPA037510, HPA061521" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037509: AB_2797227, HPA037510: AB_10672349, HPA061521: AB_2797263" "unprognostic (1.33e-1)" "unprognostic (4.35e-2)" "unprognostic (1.97e-1)" "unprognostic (8.62e-2)" "unprognostic (1.26e-1)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.60e-7)" "unprognostic (1.99e-1)" "unprognostic (6.38e-2)" "unprognostic (2.97e-1)" "unprognostic (4.62e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (6.74e-5)" "unprognostic (1.02e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "prognostic favorable (1.09e-4)" 8.3 8.9 9.3 9.2 17.0 12.4 13.5 12.7 11.5 9.8 7.1 10.1 6.4 6.2 10.9 12.0 6.1 12.8 6.2 5.4 8.6 8.3 9.8 6.6 8.2 14.1 13.8 8.7 16.2 7.8 8.6 6.5 10.5 16.2 9.8 9.1 10.2 6.7 7.7 5.6 8.9 8.6 10.4 13.6 15.1 7.6 25.5 11.1 27.2 8.3 5.3 14.6 8.5 8.4 15.6 15.2 20.4 9.9 14.9 18.5 7.6 9.0 7.1 11.9 11.9 5.2 4.2 8.8 8.6 5.1 15.2 11.5 10.4 8.2 12.0 16.8 4.5 20.5 8.4 10.6 8.4 11.4 12.5 6.9 7.8 5.3 5.6 7.0 9.0 15.6 4.7 8.3 11.4 19.4 5.1 6.0 12.4 7.5 22.1 7.0 10.5 14.7 11.4 5.1 2.0 6.2 9.2 9.9 14.3 6.9 4.4 9.5 10.5 8.0 4.4 9.1 6.2 8.4 10.2 2.6 5.1 11.4 8.9 17.2 13.9 28.7 17.5 7.7 11.8 12.2 7.1 9.3 20.4 13.7 9.9 12.0 13.4 14.0 14.8 13.6 15.6 14.7 14.0 8.8 14.9 7.6 15.2 18.5 7.6 9.3 17.0 12.7 11.5 8.6 8.3 13.8 8.7 16.2 11.1 6.0 12.0 8.0 2.7 2.4 12.5 3.6 5.1 21.4 5.7 7.0 11.8 5.9 8.3 6.5 63.9 5.3 2.3 23.3 6.0 6.6 3.7 1.9 2.3 1.8 5.3 9.5 4.7 6.2 3.7 39.9 5.8 5.0 3.3 1.0 4.5 4.6 4.8 2.9 6.7 4.2 37.8 6.5 3.1 29.3 15.1 2.5 3.4 7.5 4.5 1.3 POGK "BASS2, KIAA15131, KRBOX2, LST003" ENSG00000143157 "Pogo transposable element derived with KRAB domain" Q9P215 1 166839447-166856344 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007838, HPA031630, HPA075919" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA007838: AB_1079651, HPA031630: AB_10601490, HPA075919: " "unprognostic (3.48e-2)" "unprognostic (2.03e-2)" "unprognostic (4.31e-2)" "unprognostic (3.18e-3)" "unprognostic (4.20e-2)" "unprognostic (2.59e-1)" "prognostic unfavorable (5.93e-4)" "unprognostic (4.85e-1)" "unprognostic (6.09e-2)" "unprognostic (1.02e-2)" "unprognostic (2.19e-2)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (3.22e-1)" "unprognostic (9.74e-2)" "unprognostic (2.70e-1)" "unprognostic (2.11e-2)" 12.1 10.3 24.3 15.1 27.3 10.4 24.2 18.4 23.6 17.6 13.1 27.6 8.4 10.2 17.6 12.6 16.1 13.5 12.4 11.1 24.4 18.4 15.7 12.0 20.9 13.5 27.7 17.7 19.9 14.8 30.0 10.0 15.1 21.1 12.0 15.4 12.2 12.9 15.2 6.6 20.2 12.1 16.8 30.5 14.5 14.9 6.8 25.6 9.2 13.0 5.2 17.7 16.9 24.2 9.4 10.0 6.3 10.8 9.9 7.3 5.6 15.8 13.5 14.8 18.2 15.7 13.1 8.4 11.0 11.3 14.2 10.8 10.2 13.6 17.9 16.6 11.4 12.1 15.9 18.4 14.7 13.0 21.7 12.6 7.0 12.3 7.2 13.4 25.1 19.8 9.9 23.2 15.9 22.9 12.6 12.6 16.8 24.1 12.1 13.5 7.6 15.5 6.3 24.2 18.6 15.6 17.8 8.1 15.8 14.8 38.9 19.4 23.4 15.7 21.8 20.3 23.0 20.7 23.4 11.6 15.1 15.0 11.8 19.9 17.2 22.1 23.4 8.4 12.6 14.2 2.8 7.7 6.3 6.7 9.9 7.3 9.4 6.5 7.1 10.0 5.8 6.1 6.3 1.1 9.9 10.8 5.0 5.6 5.6 24.3 27.3 18.4 23.6 24.4 18.4 27.7 17.7 21.1 25.6 50.6 15.0 10.2 22.1 19.5 30.6 7.9 15.3 12.0 23.9 12.2 9.8 9.2 1.7 15.3 2.2 16.8 7.4 0.0 13.9 10.1 12.1 19.9 23.1 12.1 14.0 46.1 8.6 12.3 18.1 0.7 10.0 16.1 8.5 10.0 12.1 14.5 12.4 14.0 17.0 7.4 27.0 12.9 13.4 0.9 2.1 21.0 7.6 7.5 15.2 25.1 POGZ "KIAA0461, ZNF280E, ZNF635m" ENSG00000143442 "Pogo transposable element derived with ZNF domain" Q7Z3K3 1 151402724-151459465 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division" DNA-binding "Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006800, HPA008781" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006800: AB_1855516, HPA008781: AB_1855517" "unprognostic (2.87e-1)" "unprognostic (7.16e-2)" "unprognostic (7.47e-2)" "prognostic unfavorable (8.67e-4)" "unprognostic (2.87e-2)" "unprognostic (1.11e-2)" "unprognostic (2.30e-2)" "unprognostic (1.41e-1)" "unprognostic (7.99e-3)" "unprognostic (2.99e-1)" "unprognostic (1.00e-2)" "unprognostic (9.69e-2)" "prognostic unfavorable (3.92e-5)" "unprognostic (2.32e-1)" "unprognostic (2.92e-2)" "unprognostic (3.29e-1)" "prognostic favorable (4.40e-4)" 11.6 15.2 18.3 15.6 20.1 23.5 18.2 40.6 24.8 16.1 17.8 22.2 21.9 10.0 24.2 39.0 11.0 23.9 17.7 12.4 15.4 13.5 16.9 14.4 13.9 12.7 18.7 20.7 37.4 13.2 33.0 26.8 10.4 17.3 17.8 14.5 17.1 15.4 17.6 15.4 24.1 13.0 19.3 20.3 16.7 13.1 21.2 21.8 20.3 21.6 7.4 13.9 15.0 17.6 5.2 4.0 7.8 2.6 2.9 5.6 1.8 9.8 12.9 32.4 18.3 14.5 14.1 11.1 8.7 8.0 10.0 10.4 14.4 10.3 20.8 15.1 10.9 7.9 8.7 18.7 9.3 13.1 17.6 10.4 12.7 17.6 8.3 10.7 17.5 13.0 12.5 7.6 11.0 13.3 18.7 15.8 15.7 11.9 20.1 9.7 25.3 19.3 11.4 22.9 10.2 7.8 18.9 15.6 10.6 10.7 16.2 17.7 18.1 14.7 12.5 14.4 27.6 16.3 23.0 13.2 12.1 14.5 10.0 12.5 14.6 12.5 40.3 8.7 9.3 10.2 7.8 2.5 5.5 4.2 2.1 3.6 5.0 4.2 5.6 2.2 5.2 4.3 4.2 4.8 2.9 2.6 4.0 2.9 1.8 18.3 20.1 40.6 24.8 15.4 13.5 18.7 20.7 17.3 21.8 56.6 41.2 14.7 23.8 40.2 81.8 15.1 35.7 18.7 28.4 61.1 78.5 13.4 3.3 19.4 12.1 41.3 27.5 0.0 12.8 9.3 31.4 29.8 26.6 38.4 18.3 74.7 55.9 49.7 22.8 6.9 49.8 26.0 49.0 19.8 30.0 52.4 20.1 26.4 69.3 9.8 57.4 64.7 32.5 27.9 57.7 29.7 9.6 25.9 33.7 23.5 POLD1 "CDC2, POLD" ENSG00000062822 "DNA polymerase delta 1, catalytic subunit" P28340 19 50384204-50418016 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Paneth cells: 38.7;Spermatogonia: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004375, HPA046524" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB004375: AB_675487, HPA046524: AB_2679684" "unprognostic (2.45e-1)" "unprognostic (7.02e-3)" "unprognostic (1.59e-1)" "unprognostic (4.35e-2)" "unprognostic (2.55e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (2.87e-6)" "unprognostic (4.12e-2)" "unprognostic (1.16e-2)" "unprognostic (2.83e-1)" "unprognostic (5.08e-1)" "unprognostic (3.92e-3)" "unprognostic (4.01e-3)" "unprognostic (1.28e-2)" "unprognostic (1.61e-1)" "unprognostic (2.89e-1)" "unprognostic (3.70e-2)" 7.9 5.7 5.4 18.3 9.9 31.6 6.6 9.4 5.4 8.2 10.0 6.1 5.9 6.8 9.5 7.2 11.3 6.9 5.2 5.5 4.4 3.2 7.6 9.3 10.9 15.7 7.0 3.6 8.2 8.4 5.2 5.1 10.9 6.7 6.3 5.2 4.9 8.1 5.4 7.2 13.1 9.9 6.2 7.7 14.1 6.5 13.2 6.5 27.4 12.1 8.1 14.2 5.9 7.8 9.3 10.5 2.1 8.5 5.4 7.3 5.6 18.2 25.2 13.8 7.9 1.8 1.5 14.2 11.4 5.0 14.1 17.9 13.7 14.5 26.2 6.4 3.4 6.3 15.0 16.3 12.4 4.8 22.1 43.8 22.8 24.4 18.0 1.6 21.7 20.1 2.9 3.8 12.7 3.8 3.0 7.2 22.0 24.5 20.4 5.8 12.3 33.5 33.9 16.3 11.8 18.3 33.3 23.2 23.0 4.5 17.5 14.4 13.0 11.3 13.9 2.6 5.2 7.6 20.6 5.6 7.1 23.2 7.7 20.0 19.2 31.6 28.0 7.8 24.5 7.0 1.6 6.2 2.1 7.3 7.8 6.2 7.8 6.5 5.9 5.7 9.3 6.5 5.9 1.1 5.4 8.5 10.5 4.5 5.6 5.4 9.9 9.4 5.4 4.4 3.2 7.0 3.6 6.7 6.5 3.0 3.8 3.7 1.7 5.7 3.3 2.8 2.5 2.7 3.4 3.5 5.9 12.2 0.0 4.4 1.7 2.6 4.6 0.0 3.4 11.7 4.1 1.3 0.0 2.1 13.6 0.0 6.9 1.8 6.3 1.1 2.8 5.0 5.0 3.6 5.3 1.2 3.9 38.7 4.9 2.2 4.1 0.0 2.1 10.9 26.7 4.5 6.4 4.3 10.0 0.6 POLD2 ENSG00000106628 "DNA polymerase delta 2, accessory subunit" P49005 7 44114681-44124358 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 217.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026745 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA026745: AB_1855520" "unprognostic (9.09e-2)" "unprognostic (1.41e-1)" "unprognostic (9.89e-2)" "unprognostic (1.84e-3)" "unprognostic (1.55e-1)" "unprognostic (2.10e-3)" "unprognostic (1.50e-3)" "unprognostic (4.94e-3)" "unprognostic (8.17e-2)" "unprognostic (1.01e-3)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.72e-2)" "unprognostic (2.14e-1)" "unprognostic (5.18e-2)" "unprognostic (1.03e-1)" "unprognostic (4.44e-3)" 17.2 19.1 17.5 14.3 16.7 16.3 33.9 14.3 25.9 15.8 15.4 17.1 12.6 13.9 16.1 9.7 27.5 34.5 14.5 35.9 16.3 13.8 15.9 43.6 15.3 16.2 15.2 14.7 24.4 49.0 18.9 17.9 12.9 15.0 15.9 12.9 17.4 19.9 14.3 42.6 19.3 11.5 15.7 13.7 11.9 16.0 14.4 14.8 27.7 20.3 25.1 15.8 13.4 16.7 28.1 37.0 3.2 13.7 13.3 29.3 21.3 26.5 35.1 19.6 41.0 17.4 18.7 19.4 16.4 16.5 22.5 16.9 29.6 25.6 61.5 21.0 23.5 45.1 36.8 32.0 44.7 14.7 17.4 37.6 13.5 37.7 25.0 19.9 41.3 16.6 17.0 27.4 34.8 33.9 23.7 18.8 41.6 49.5 29.6 24.8 43.3 50.3 78.1 30.8 38.3 34.5 33.9 26.3 87.2 19.5 17.2 38.9 30.4 20.4 73.7 14.0 13.2 42.6 53.3 14.7 29.9 37.7 36.6 51.2 46.5 68.7 58.9 26.8 41.9 42.2 0.5 13.7 3.2 17.9 12.4 26.8 28.1 21.6 18.2 23.2 27.3 29.3 21.4 1.1 13.3 11.8 37.0 17.0 21.3 17.5 16.7 14.3 25.9 16.3 13.8 15.2 14.7 15.0 14.8 6.0 35.1 22.3 62.4 43.8 38.9 57.0 38.2 60.2 37.5 27.9 29.5 61.7 87.9 57.0 88.9 29.0 11.8 0.0 52.0 69.9 44.0 51.0 25.5 84.6 40.8 50.9 40.3 20.3 12.3 217.8 38.6 15.8 47.2 10.0 53.1 37.9 39.5 14.0 50.2 78.7 48.2 19.4 68.0 59.4 64.6 52.9 29.6 23.3 71.7 63.1 POLD3 "KIAA0039, P66, P68, PPP1R128" ENSG00000077514 "DNA polymerase delta 3, accessory subunit" Q15054 11 74493851-74669117 "Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058846 Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA058846: AB_2683833" "unprognostic (3.68e-1)" "unprognostic (3.22e-2)" "unprognostic (2.05e-3)" "unprognostic (3.28e-1)" "unprognostic (1.74e-1)" "unprognostic (3.49e-1)" "prognostic unfavorable (9.17e-4)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.48e-4)" "unprognostic (3.99e-3)" "unprognostic (1.54e-3)" "unprognostic (9.21e-3)" "prognostic unfavorable (7.90e-6)" "unprognostic (7.92e-3)" "unprognostic (2.65e-1)" "unprognostic (9.11e-2)" "unprognostic (1.23e-1)" 12.6 8.2 11.3 12.8 17.5 8.3 12.7 10.3 16.4 13.8 15.6 12.5 10.3 14.5 18.1 11.7 14.1 15.6 14.1 9.6 10.2 7.8 40.3 10.0 12.7 14.0 12.1 13.1 15.9 17.5 9.3 16.0 12.4 12.3 13.2 17.2 9.9 13.0 11.8 10.4 10.8 17.1 18.2 9.1 13.9 14.5 19.8 13.9 15.2 14.2 8.0 13.5 15.9 13.7 8.1 14.7 16.5 19.0 8.7 11.0 9.6 12.0 11.0 17.0 11.6 5.3 9.1 12.1 16.4 9.2 17.2 14.6 14.4 15.7 17.2 12.2 7.8 10.0 15.8 14.1 10.7 21.7 12.9 9.0 11.0 17.1 4.8 3.8 20.9 10.0 4.0 6.8 20.0 10.8 5.4 6.6 15.3 9.9 13.9 9.8 9.5 23.5 9.4 10.2 36.0 11.3 22.6 42.9 14.3 7.8 11.7 11.4 7.7 19.5 9.8 19.0 10.8 11.5 13.4 6.3 17.0 12.3 19.1 12.9 9.8 20.5 38.6 9.7 13.3 12.8 6.0 19.0 12.5 8.2 15.1 8.1 8.1 10.4 7.2 14.7 6.7 10.4 8.5 16.5 8.7 14.8 4.3 11.0 9.6 11.3 17.5 10.3 16.4 10.2 7.8 12.1 13.1 12.3 13.9 11.9 18.3 8.2 6.3 5.3 11.8 5.6 7.6 53.5 23.9 8.7 7.9 13.0 5.0 14.6 22.4 11.1 10.3 23.3 28.4 23.6 8.2 7.5 18.5 3.4 13.9 22.3 5.2 6.2 8.5 19.4 11.5 15.5 3.3 22.6 9.2 14.6 17.7 8.5 8.1 23.8 17.1 6.5 4.7 34.3 31.1 4.6 10.9 8.2 16.6 10.5 POLH "RAD30A, XP-V" ENSG00000170734 "DNA polymerase eta" Q9Y253 6 43576150-43615660 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;Spermatocytes: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006721, HPA026762" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA006721: AB_1847785, HPA026762: AB_10601248" "unprognostic (1.79e-1)" "unprognostic (7.29e-2)" "unprognostic (2.25e-1)" "unprognostic (7.28e-2)" "unprognostic (3.61e-1)" "unprognostic (5.11e-3)" "unprognostic (9.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.18e-1)" "unprognostic (7.75e-2)" "unprognostic (4.11e-3)" "unprognostic (2.24e-1)" "unprognostic (9.50e-2)" "unprognostic (6.73e-2)" "unprognostic (8.77e-2)" "unprognostic (7.91e-2)" "unprognostic (6.02e-2)" 7.4 9.4 7.5 9.7 10.4 4.6 7.2 10.5 10.5 8.5 8.4 12.7 8.0 5.7 9.6 7.1 11.4 7.8 6.2 6.7 5.3 4.4 7.2 7.5 9.8 16.3 8.9 8.1 7.4 13.0 7.1 9.7 5.1 7.9 6.9 10.1 8.9 8.6 5.6 9.5 11.7 7.9 11.8 6.9 9.2 7.6 24.7 6.8 22.1 9.9 6.2 18.3 8.6 8.4 8.6 4.3 4.5 2.6 6.8 7.2 3.2 20.5 4.7 6.4 9.3 9.1 15.1 15.2 22.0 6.9 12.9 14.8 5.4 3.6 22.8 5.5 8.9 3.7 5.2 6.4 13.8 16.1 11.5 4.9 6.7 13.3 15.6 6.8 11.4 9.0 10.1 17.0 10.5 5.7 5.2 12.1 7.0 10.5 13.7 16.2 6.8 10.3 3.0 1.9 15.7 3.6 11.3 6.6 5.7 4.9 15.4 7.2 2.5 7.0 5.8 3.5 7.4 8.3 5.1 16.4 11.9 11.6 5.6 11.1 12.9 8.9 41.2 5.7 6.7 12.9 4.5 2.6 4.1 7.2 2.5 6.4 7.8 6.0 5.2 2.1 8.6 5.0 5.2 2.0 6.8 1.9 4.3 7.0 3.2 7.5 10.4 10.5 10.5 5.3 4.4 8.9 8.1 7.9 6.8 11.9 5.1 4.9 2.6 4.1 6.3 2.4 2.5 5.3 7.9 3.5 9.8 1.7 5.0 2.0 7.6 2.1 2.6 23.3 0.7 2.4 2.6 2.1 0.0 2.1 1.5 0.0 5.2 0.6 1.5 6.0 3.1 1.7 1.7 2.8 2.2 2.3 1.6 2.9 2.8 1.4 8.5 0.0 3.1 17.9 5.9 2.6 1.6 2.9 3.1 2.5 POLK "DINB1, DINP, POLQ" ENSG00000122008 "DNA polymerase kappa" Q9UBT6 5 75511756-75601144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 167.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012035, HPA057303, HPA068117, HPA069375" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA012035: AB_2668606, HPA057303: AB_2683406, HPA068117: AB_2685957, HPA069375: AB_2686131" "unprognostic (9.66e-2)" "unprognostic (5.29e-2)" "unprognostic (5.37e-2)" "unprognostic (2.70e-1)" "unprognostic (1.86e-1)" "unprognostic (1.66e-1)" "unprognostic (1.73e-2)" "unprognostic (7.76e-2)" "unprognostic (1.65e-2)" "unprognostic (6.29e-3)" "unprognostic (2.42e-1)" "unprognostic (5.93e-2)" "unprognostic (1.80e-2)" "unprognostic (9.96e-3)" "unprognostic (1.58e-1)" "unprognostic (9.64e-2)" "unprognostic (2.02e-1)" 14.7 12.7 10.1 8.6 12.9 6.3 13.4 17.0 13.4 18.1 10.7 8.8 13.6 6.3 21.3 12.1 11.7 10.5 9.5 11.4 14.1 10.5 12.6 12.3 12.2 9.2 14.1 12.9 15.5 11.1 18.5 23.9 15.2 17.2 13.9 8.1 6.5 10.2 10.5 15.2 10.3 9.2 15.4 16.9 13.1 9.0 9.8 12.4 12.1 18.8 9.3 8.9 12.7 10.2 7.0 7.5 6.0 13.3 4.6 4.5 2.5 6.4 6.6 4.1 5.3 5.5 10.9 3.5 12.3 8.8 9.6 10.0 4.2 5.2 6.6 10.2 8.1 6.3 2.5 3.8 4.2 11.6 7.3 4.5 6.0 5.8 2.0 10.4 3.9 5.0 5.1 5.3 7.7 5.3 7.7 8.0 4.4 5.3 3.9 9.1 0.5 7.5 3.1 1.5 0.7 3.9 3.2 10.6 4.6 5.8 2.2 4.2 4.6 9.3 2.5 3.3 2.9 3.6 3.7 10.1 7.1 3.6 3.3 7.0 4.6 4.1 6.0 4.7 6.1 12.1 5.7 7.1 3.4 3.3 7.9 2.9 7.0 3.7 4.0 6.1 5.4 4.5 3.0 6.0 4.6 13.3 7.5 4.1 2.5 10.1 12.9 17.0 13.4 14.1 10.5 14.1 12.9 17.2 12.4 29.8 39.4 38.7 18.4 13.1 33.6 17.1 30.6 18.7 29.6 27.9 19.6 14.0 19.9 16.1 167.0 32.1 9.2 23.3 13.7 11.0 21.7 14.6 49.8 20.9 18.7 62.0 14.3 49.7 37.8 38.8 34.8 32.2 21.9 27.9 12.4 23.5 16.5 11.5 36.0 17.0 40.7 6.5 16.5 43.4 16.6 11.3 5.6 18.5 10.6 10.5 POLL ENSG00000166169 "DNA polymerase lambda" Q9UGP5 10 101578882-101588270 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076828 Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA076828: " "unprognostic (3.71e-3)" "unprognostic (6.93e-3)" "unprognostic (1.73e-2)" "unprognostic (2.47e-2)" "unprognostic (9.52e-2)" "unprognostic (1.80e-2)" "unprognostic (2.11e-2)" "unprognostic (1.24e-1)" "unprognostic (8.11e-2)" "unprognostic (1.71e-2)" "unprognostic (1.12e-2)" "unprognostic (7.19e-2)" "unprognostic (4.74e-2)" "unprognostic (1.06e-2)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" "unprognostic (1.64e-3)" 11.0 15.1 14.4 16.0 17.1 9.2 13.4 11.2 22.1 13.7 12.6 16.4 15.6 14.3 15.1 22.1 15.4 18.1 17.7 12.3 11.1 10.4 16.4 16.5 11.8 13.0 9.6 13.0 20.9 30.7 21.7 23.7 11.7 12.7 17.2 15.0 19.5 17.8 14.7 26.1 12.8 11.9 12.7 9.4 15.6 16.7 53.2 11.2 4.6 18.3 10.2 14.2 14.8 11.6 8.5 10.7 1.1 8.5 8.4 11.9 7.1 11.7 10.7 8.5 11.8 8.6 16.0 11.9 7.8 13.5 11.9 12.6 7.8 14.2 2.9 12.3 7.0 6.7 14.8 9.3 11.5 9.7 10.3 12.7 9.2 10.1 8.9 15.9 9.5 8.4 14.6 15.7 13.2 27.4 33.6 12.8 5.7 10.2 10.2 7.5 9.3 0.0 10.4 4.5 6.5 6.4 0.0 7.5 4.8 10.0 7.1 5.9 8.7 4.8 8.1 13.3 13.0 24.5 5.6 6.8 4.3 8.7 4.9 8.5 14.7 7.4 4.4 9.3 8.3 3.2 0.5 8.5 1.1 6.7 5.9 10.6 8.5 7.4 6.8 10.7 7.1 11.9 7.9 0.9 8.4 5.7 0.2 8.9 7.1 14.4 17.1 11.2 22.1 11.1 10.4 9.6 13.0 12.7 11.2 6.0 11.7 10.2 7.5 3.3 15.9 6.7 12.7 4.0 5.7 7.0 45.2 14.0 5.0 8.6 16.4 5.6 10.5 0.0 18.3 7.2 6.9 5.2 13.9 8.1 10.0 20.6 12.6 4.9 12.3 39.9 13.0 8.8 10.1 15.4 12.0 9.9 11.4 7.0 10.6 8.4 22.0 12.9 5.7 23.8 9.1 1.8 9.6 9.6 12.8 5.2 POLM Tdt-N ENSG00000122678 "DNA polymerase mu" Q9NP87 7 44072247-44082540 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 31.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 31.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 38.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058900, HPA066007" Approved Nucleoplasm NA NA Nucleoplasm "HPA058900: AB_2683848, HPA066007: AB_2685595" "unprognostic (2.44e-2)" "unprognostic (8.18e-2)" "unprognostic (2.21e-3)" "unprognostic (3.93e-2)" "unprognostic (5.40e-2)" "unprognostic (1.83e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-1)" "unprognostic (5.12e-2)" "unprognostic (3.91e-1)" "unprognostic (9.36e-2)" "unprognostic (8.26e-2)" "unprognostic (2.46e-3)" "unprognostic (6.31e-2)" "unprognostic (1.47e-1)" "unprognostic (2.87e-1)" "unprognostic (3.87e-3)" 10.7 8.7 7.0 18.0 7.1 7.6 12.2 11.9 8.8 13.8 11.2 11.1 11.7 12.2 10.1 12.0 11.7 11.8 11.8 10.8 6.8 4.4 13.0 12.5 10.1 20.9 9.9 7.0 13.8 12.3 10.0 9.0 8.1 8.2 11.8 7.1 12.4 13.5 14.3 11.2 12.0 12.6 8.9 9.0 18.7 12.0 6.8 8.1 30.1 15.4 8.3 17.6 12.4 10.7 5.9 4.8 31.6 2.1 3.5 4.2 1.3 1.1 1.5 1.5 3.5 2.2 2.6 5.0 3.5 4.0 2.7 1.6 1.9 2.6 11.3 3.6 3.0 3.4 3.4 1.6 38.3 1.6 3.9 3.6 1.3 1.6 0.7 3.1 3.5 5.1 4.0 3.7 2.3 2.8 5.6 4.9 11.3 1.6 5.5 2.3 2.6 7.1 3.1 3.3 3.4 8.2 5.7 0.9 4.4 3.0 1.8 1.6 3.0 1.7 7.3 3.7 2.7 4.6 6.0 3.4 1.9 2.8 1.9 5.1 9.0 4.5 8.8 3.5 3.2 4.6 8.6 1.8 5.1 3.3 2.1 3.3 4.0 2.9 3.0 1.6 5.9 4.2 3.4 31.6 3.5 1.6 4.8 2.7 1.3 7.0 7.1 11.9 8.8 6.8 4.4 9.9 7.0 8.2 8.1 3.0 8.5 24.9 9.9 3.9 18.3 5.5 15.3 4.0 9.1 12.2 27.5 10.7 1.7 6.4 0.4 6.4 12.3 0.0 8.2 8.5 5.0 11.9 24.2 8.9 9.0 17.5 5.2 12.9 10.8 0.4 13.0 9.1 10.1 10.0 7.3 7.2 6.9 15.6 9.6 3.8 38.8 0.0 13.0 10.8 11.5 4.4 8.1 14.4 10.1 10.7 POLN ENSG00000130997 "DNA polymerase nu" Q7Z5Q5 4 2071918-2242121 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 9.2;Spermatocytes: 17.6;Spermatogonia: 10.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035939, HPA035940" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035939: AB_2674875, HPA035940: AB_2674876" "unprognostic (8.52e-3)" "unprognostic (1.55e-1)" "unprognostic (4.87e-2)" "unprognostic (1.32e-1)" "unprognostic (2.53e-1)" "unprognostic (1.45e-2)" "unprognostic (3.46e-1)" "unprognostic (2.70e-1)" "unprognostic (5.83e-2)" "unprognostic (2.23e-1)" "unprognostic (2.02e-3)" "unprognostic (1.25e-1)" "unprognostic (1.49e-3)" "unprognostic (9.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.66e-1)" "unprognostic (1.82e-2)" 13.6 3.9 6.1 2.5 5.7 1.8 5.2 11.1 5.5 2.8 2.9 3.5 2.9 2.7 4.0 5.8 2.6 3.6 3.3 2.8 4.4 2.9 3.6 3.4 3.0 2.7 4.3 4.0 2.8 3.1 2.4 7.6 2.3 3.8 4.6 1.8 1.7 4.7 3.5 2.7 2.7 2.4 3.3 5.6 3.5 2.9 12.3 5.2 8.5 2.4 0.9 2.6 2.5 2.6 0.2 0.1 2.4 0.0 0.0 0.9 0.1 0.3 2.7 0.5 2.0 5.7 2.2 0.0 2.0 1.0 1.1 1.6 0.1 0.2 1.2 0.6 1.7 1.0 0.4 2.2 0.8 1.6 0.3 2.9 0.1 2.0 0.0 0.7 0.2 2.6 3.1 0.8 1.7 1.4 2.6 0.6 0.5 0.2 2.3 3.1 0.3 0.2 0.2 0.2 0.1 0.6 0.0 3.8 0.9 0.8 0.5 2.5 0.0 0.2 0.0 0.2 1.0 0.1 0.7 0.3 0.1 1.9 1.1 0.6 0.6 0.7 0.0 0.6 1.9 1.1 0.0 0.0 2.4 0.2 0.0 0.9 0.2 0.2 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.1 6.1 5.7 11.1 5.5 4.4 2.9 4.3 4.0 3.8 5.2 0.0 0.0 0.0 1.0 0.8 3.2 1.6 2.5 1.4 2.3 0.0 0.0 0.2 3.3 0.4 6.8 0.8 0.0 0.0 0.9 0.2 1.7 1.1 0.0 0.6 0.5 3.2 4.6 4.9 1.0 9.2 4.0 1.4 0.0 0.0 0.0 2.6 0.4 0.0 3.5 0.5 3.6 0.0 1.3 17.6 10.0 1.4 0.0 0.7 0.2 1.3 POLR1C "RPA39, RPA40, RPA5, RPAC1" ENSG00000171453 "RNA polymerase I subunit C" O15160 6 43509702-43562419 "Disease related genes, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031010 Supported Nucleoplasm NA NA Nucleoplasm "HPA031010: AB_10603131" "unprognostic (2.84e-1)" "unprognostic (1.67e-1)" "unprognostic (3.15e-1)" "unprognostic (6.57e-2)" "unprognostic (7.01e-2)" "unprognostic (3.59e-1)" "unprognostic (6.69e-3)" "unprognostic (1.09e-3)" "unprognostic (2.00e-3)" "unprognostic (1.90e-2)" "unprognostic (2.05e-1)" "unprognostic (7.32e-2)" "prognostic unfavorable (4.17e-4)" "unprognostic (1.20e-2)" "unprognostic (4.69e-2)" "unprognostic (3.01e-1)" "unprognostic (6.41e-2)" 16.2 20.8 11.8 15.6 18.6 7.4 22.1 11.8 19.2 19.1 19.1 16.4 14.1 14.0 22.5 18.0 24.0 23.3 14.5 12.7 11.7 13.3 26.9 26.6 12.4 13.5 12.4 10.3 22.9 30.7 14.2 20.5 18.5 13.4 19.3 17.4 19.1 24.1 15.4 17.5 21.9 12.8 16.2 9.9 21.3 16.1 20.9 11.4 17.4 35.2 18.3 27.9 16.3 16.8 23.0 18.6 2.1 13.4 17.5 26.2 14.7 19.8 16.6 7.3 19.7 11.2 12.2 11.5 12.1 9.0 13.7 11.7 21.9 6.7 22.5 13.3 11.8 11.7 12.1 17.5 15.5 16.0 11.9 18.3 15.3 16.7 30.3 14.1 23.4 10.8 10.8 15.0 18.7 23.7 8.1 10.7 9.5 35.3 6.6 11.9 28.0 12.2 17.0 13.4 80.8 14.4 8.4 11.4 15.1 16.4 27.8 13.5 9.0 10.6 9.2 16.0 5.6 10.0 20.7 12.7 9.8 13.2 10.5 19.1 9.6 21.2 37.6 6.6 16.1 10.8 2.1 13.4 1.9 16.0 10.3 21.7 21.6 19.0 15.8 18.6 23.0 26.2 23.5 1.3 17.5 8.3 16.9 13.6 14.7 11.8 18.6 11.8 19.2 11.7 13.3 12.4 10.3 13.4 11.4 11.9 15.3 11.0 39.5 55.0 7.2 4.5 17.8 44.2 26.1 5.2 5.9 25.7 13.3 23.9 7.2 21.5 4.9 0.0 21.0 14.4 16.4 14.9 13.9 11.1 11.7 4.8 12.5 15.4 7.0 5.6 10.6 9.4 20.3 6.4 11.2 8.1 16.9 14.0 11.0 20.8 14.5 6.5 25.3 27.7 39.0 35.8 11.3 14.1 15.2 34.1 POLR2B RPB2 ENSG00000047315 "RNA polymerase II subunit B" P30876 4 56977722-57031168 "Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037506 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA037506: AB_10672597" "unprognostic (9.88e-3)" "unprognostic (4.38e-2)" "unprognostic (1.83e-3)" "unprognostic (7.51e-2)" "unprognostic (2.30e-2)" "unprognostic (4.21e-3)" "unprognostic (1.24e-3)" "unprognostic (3.51e-1)" "unprognostic (6.39e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-1)" "unprognostic (1.95e-1)" "prognostic favorable (7.17e-4)" "unprognostic (1.91e-1)" "unprognostic (1.51e-1)" "unprognostic (3.43e-1)" "unprognostic (7.35e-2)" 24.5 34.3 31.1 34.6 31.0 21.4 24.8 43.8 33.3 25.9 26.0 18.8 24.9 22.5 35.1 21.4 27.4 28.3 21.2 32.9 29.3 21.7 26.2 21.4 21.2 32.4 28.0 30.2 26.4 28.1 40.7 37.3 25.4 28.3 24.8 26.5 18.4 30.5 28.2 61.8 24.4 27.3 27.6 26.4 27.1 28.8 26.6 26.8 33.4 27.0 34.7 35.1 31.5 22.4 19.8 15.2 27.8 13.9 18.0 23.8 12.7 25.3 21.1 38.2 32.3 31.6 28.5 20.5 33.7 34.3 33.8 31.7 26.9 25.5 39.5 32.0 31.2 24.3 18.0 45.9 25.6 48.4 18.7 20.6 29.7 23.6 23.4 36.6 51.0 34.3 30.7 25.8 38.6 23.5 28.1 40.2 31.8 44.0 33.7 38.9 18.5 48.0 19.7 31.4 32.8 24.8 35.1 25.2 21.7 23.1 28.9 31.9 35.7 21.0 39.9 29.0 32.0 21.4 28.4 29.3 24.6 33.1 25.7 44.2 27.2 25.9 57.5 28.1 27.5 30.4 27.8 12.2 16.8 20.7 12.4 22.0 19.8 20.3 21.4 15.2 14.4 19.9 23.8 11.3 18.0 13.9 12.9 20.9 12.7 31.1 31.0 43.8 33.3 29.3 21.7 28.0 30.2 28.3 26.8 26.8 41.7 44.7 39.5 36.7 45.8 30.9 38.2 57.6 45.5 34.9 41.2 41.3 16.6 52.1 4.5 31.4 29.1 0.0 47.4 25.1 30.5 50.4 55.6 27.2 25.9 42.9 28.7 35.6 42.2 5.4 53.2 38.7 42.2 44.1 31.2 30.4 47.4 30.2 35.7 26.9 48.2 71.1 26.2 79.4 64.2 34.9 34.3 61.0 31.7 71.1 POLR2E "hRPB25, hsRPB5, RPABC1, RPB5, XAP4" ENSG00000099817 "RNA polymerase II subunit E" P19388 19 1086579-1095380 "Predicted intracellular proteins, RNA polymerase related proteins" "Host-virus interaction, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "monocytes: 562.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063030, HPA068992" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA063030: AB_2684926, HPA068992: AB_2686065" "unprognostic (2.52e-1)" "unprognostic (3.73e-2)" "unprognostic (2.49e-1)" "unprognostic (1.51e-2)" "unprognostic (2.14e-1)" "unprognostic (6.42e-2)" "unprognostic (2.59e-3)" "unprognostic (1.60e-1)" "unprognostic (2.08e-1)" "unprognostic (2.05e-1)" "unprognostic (2.03e-3)" "unprognostic (3.03e-2)" "prognostic favorable (3.21e-6)" "unprognostic (3.22e-1)" "unprognostic (1.47e-1)" "unprognostic (1.72e-3)" "unprognostic (4.77e-2)" 41.4 26.2 29.6 22.8 27.9 19.8 27.6 19.0 36.9 20.1 26.5 18.6 18.4 20.1 21.4 22.6 34.1 26.3 25.8 27.6 29.6 26.3 34.0 57.9 25.1 25.1 30.1 22.6 22.0 21.0 39.7 13.0 26.4 33.4 24.3 29.5 20.3 17.9 18.9 33.2 23.7 26.9 25.7 22.1 23.1 21.5 29.3 15.5 31.9 30.6 21.1 36.7 22.1 20.6 12.8 28.2 17.9 30.4 16.7 17.5 20.9 14.3 13.3 18.7 14.9 25.7 16.0 8.7 10.7 14.8 17.6 10.4 15.6 5.3 12.1 4.8 31.5 2.7 11.7 35.0 11.7 33.0 12.5 10.6 15.8 16.5 14.3 10.2 23.1 11.9 11.7 7.7 12.3 23.4 18.4 16.2 6.4 17.7 13.8 19.8 11.9 12.7 7.2 15.0 10.4 10.2 13.6 18.5 11.5 18.1 16.7 9.5 10.8 17.8 12.4 7.4 17.5 13.1 10.8 22.0 8.9 9.9 16.2 12.3 21.3 28.4 21.0 14.7 15.0 10.2 12.1 30.4 17.9 16.4 20.5 17.5 11.7 15.5 17.2 28.2 12.8 12.4 12.7 16.1 16.7 22.2 19.6 14.7 20.9 29.6 27.9 19.0 36.9 29.6 26.3 30.1 22.6 33.4 15.5 29.8 62.4 90.1 75.3 92.6 50.5 67.4 50.9 58.9 45.5 52.4 39.3 221.3 147.6 142.7 13.0 69.6 118.5 23.3 122.2 211.1 104.5 73.3 70.3 80.1 223.7 52.4 67.8 65.7 94.1 29.8 64.2 133.4 94.5 562.7 71.8 57.9 139.5 77.7 58.4 154.9 42.3 25.8 93.9 81.4 85.2 95.9 196.2 79.8 97.1 90.4 POLR2G "hRPB19, hsRPB7, RPB7" ENSG00000168002 "RNA polymerase II subunit G" P62487 11 62761544-62766710 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053000 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA053000: AB_2682010" "unprognostic (7.58e-3)" "unprognostic (2.75e-1)" "unprognostic (2.37e-2)" "prognostic favorable (8.23e-4)" "unprognostic (1.39e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (6.02e-5)" "unprognostic (8.50e-2)" "unprognostic (6.01e-2)" "unprognostic (6.26e-3)" "unprognostic (9.41e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" "unprognostic (2.46e-1)" "unprognostic (2.21e-1)" 27.9 34.6 39.4 28.7 37.7 29.4 37.2 18.6 33.5 28.0 25.4 39.9 25.0 17.3 27.0 44.0 27.4 32.3 25.2 25.0 35.0 27.7 30.6 32.1 29.8 47.5 41.4 27.6 28.1 29.0 29.6 20.4 29.0 30.7 28.3 32.9 31.4 22.3 27.2 18.9 27.5 19.5 32.6 45.4 30.7 22.6 18.7 33.6 47.7 28.2 26.3 49.2 25.4 23.2 48.9 61.3 51.5 54.1 46.4 47.4 64.6 25.3 45.3 48.9 30.6 25.6 24.9 12.1 18.0 22.9 43.5 34.6 27.4 29.6 36.9 42.0 27.4 19.2 24.9 22.2 34.0 38.8 70.3 27.9 24.3 36.1 32.1 36.0 32.3 22.3 24.3 34.5 20.2 41.2 23.3 33.9 34.7 30.4 24.4 30.8 79.7 46.8 42.5 30.3 27.3 46.4 38.5 44.8 48.4 32.1 21.7 20.5 34.7 30.8 23.5 45.0 19.4 67.6 27.9 13.4 21.9 23.6 42.5 20.9 19.2 35.5 40.2 22.3 20.7 28.9 46.9 49.0 51.5 45.2 51.7 43.5 48.5 39.0 43.9 57.6 48.9 37.1 45.7 21.6 46.4 54.1 61.3 47.4 64.6 39.4 37.7 18.6 33.5 35.0 27.7 41.4 27.6 30.7 33.6 35.7 53.8 83.6 47.8 40.0 39.2 42.0 71.4 26.8 27.3 73.3 7.9 194.5 119.3 105.3 6.0 64.2 28.4 0.0 97.0 114.7 79.8 30.5 88.8 64.4 164.9 36.5 56.2 66.3 73.0 11.5 65.6 81.3 84.4 189.4 51.6 114.6 76.4 55.7 58.4 119.9 42.6 77.6 50.4 42.6 40.8 52.8 116.3 115.1 66.7 30.2 POLR2H RPB8 ENSG00000163882 "RNA polymerase II subunit H" P52434 3 184361718-184368596 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037745, HPA055813" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA037745: AB_10672914, HPA055813: AB_2797254" "unprognostic (3.21e-1)" "unprognostic (4.96e-3)" "unprognostic (3.61e-3)" "unprognostic (7.15e-2)" "unprognostic (1.17e-2)" "unprognostic (6.72e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (8.82e-3)" "unprognostic (2.84e-1)" "unprognostic (4.02e-3)" "unprognostic (4.24e-2)" "unprognostic (1.27e-3)" "prognostic unfavorable (1.65e-10)" "unprognostic (1.34e-1)" "unprognostic (4.01e-1)" "unprognostic (1.71e-1)" "unprognostic (2.93e-3)" 18.1 32.6 19.6 19.2 17.5 14.8 24.5 24.2 24.6 28.8 29.9 13.8 19.8 32.0 19.9 23.5 26.7 23.1 26.7 16.3 17.8 16.3 34.1 41.0 17.8 21.7 16.4 17.0 21.8 46.4 15.8 20.7 27.2 17.0 19.2 33.6 19.7 26.0 17.0 19.9 20.7 38.8 20.0 13.2 21.5 25.6 20.6 12.5 28.1 29.7 23.1 26.3 18.5 16.2 17.4 18.2 7.7 15.3 14.6 26.6 11.5 49.5 17.4 18.8 27.8 21.0 14.9 23.4 18.7 19.7 25.7 33.1 44.5 23.8 28.1 47.0 14.6 39.1 20.1 33.6 33.6 22.9 27.4 44.4 26.9 20.5 27.8 19.0 28.3 15.7 19.2 19.2 16.7 30.3 23.1 26.5 28.2 20.7 18.6 20.3 58.8 27.9 37.9 20.4 62.1 36.4 16.4 17.3 38.0 30.5 22.5 28.5 20.3 15.8 49.1 27.2 19.0 61.4 22.8 13.8 12.2 19.4 16.3 49.8 37.5 38.8 52.5 19.4 30.3 16.3 3.4 9.6 7.7 15.2 15.3 18.4 17.4 18.0 16.2 18.0 16.4 26.6 19.7 0.7 14.6 9.6 18.2 18.7 11.5 19.6 17.5 24.2 24.6 17.8 16.3 16.4 17.0 17.0 12.5 35.7 40.3 38.7 63.2 100.7 21.3 13.7 53.5 36.1 31.8 41.8 15.7 88.4 119.3 59.7 14.9 50.9 83.1 0.0 78.5 122.8 54.6 65.8 31.1 57.8 53.4 23.8 53.5 32.5 21.4 9.6 42.6 31.5 49.0 30.7 62.9 23.6 80.3 69.9 26.2 102.6 23.4 38.8 60.4 72.4 110.1 64.7 102.3 28.8 72.3 83.9 POLR2I "hRPB14.5, RPB9" ENSG00000105258 "RNA polymerase II subunit I" P36954 19 36113710-36115346 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 926.9;Late spermatids: 1719.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035632, HPA045156" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035632: AB_2674711, HPA045156: AB_10964748" "unprognostic (1.95e-2)" "unprognostic (7.88e-3)" "unprognostic (3.54e-1)" "unprognostic (7.41e-3)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (1.24e-2)" "unprognostic (4.12e-2)" "unprognostic (7.39e-2)" "unprognostic (4.69e-3)" "unprognostic (2.86e-2)" "unprognostic (8.16e-2)" "unprognostic (1.83e-1)" "unprognostic (3.36e-2)" "unprognostic (3.84e-3)" "unprognostic (1.08e-1)" "unprognostic (1.16e-1)" 9.6 10.7 27.4 6.1 26.7 10.7 14.3 17.5 29.3 15.1 12.4 24.5 9.8 12.4 9.2 10.7 11.5 18.2 10.4 21.6 25.8 23.7 10.7 19.8 8.6 10.1 29.0 17.1 14.0 25.9 9.7 14.0 8.3 16.2 10.9 6.6 7.4 18.4 18.5 30.3 14.8 7.1 9.4 37.8 10.3 11.4 26.8 16.6 9.7 11.4 15.9 9.3 8.3 7.9 13.5 22.0 6.9 10.2 9.2 13.7 10.3 7.4 23.6 4.0 4.1 2.9 2.4 8.9 6.7 3.6 9.5 5.4 14.6 5.4 15.9 13.9 2.4 3.5 4.9 6.6 9.7 2.0 14.5 24.7 18.2 6.9 11.1 6.8 15.3 7.8 3.6 5.4 5.4 5.6 2.8 4.2 8.9 11.4 7.1 3.0 21.2 8.0 16.4 9.2 22.7 20.4 14.6 5.9 10.4 7.6 4.5 25.8 14.7 7.8 14.0 4.0 3.0 6.7 5.1 4.1 6.4 11.0 4.2 9.0 6.7 13.0 11.2 8.7 9.9 6.8 6.9 10.2 5.9 9.0 7.2 11.8 13.5 11.2 12.3 13.2 13.3 13.7 12.7 0.6 9.2 8.7 22.0 10.7 10.3 27.4 26.7 17.5 29.1 25.8 23.7 29.0 17.1 16.2 16.6 77.4 63.0 61.4 82.8 70.2 62.0 215.0 145.2 326.6 109.2 155.3 23.6 129.0 298.4 131.5 926.9 106.7 149.5 140.2 208.3 142.1 97.5 103.1 80.8 234.2 108.6 31.8 101.9 92.7 71.3 1719.1 128.9 73.2 160.3 125.4 134.4 86.3 165.9 201.5 144.9 353.5 48.4 109.9 114.1 313.9 161.1 95.2 86.8 65.0 140.6 77.0 POLR2J "hRPB14, POLR2J1, RPB11, RPB11A, RPB11m" ENSG00000005075 "RNA polymerase II subunit J" P52435 7 102473118-102478907 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046970 Approved Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" "unprognostic (1.11e-1)" "unprognostic (1.24e-2)" "unprognostic (1.46e-2)" "unprognostic (1.62e-1)" "unprognostic (1.90e-2)" "unprognostic (4.80e-2)" "unprognostic (6.47e-2)" "unprognostic (4.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.53e-3)" "unprognostic (4.46e-2)" "unprognostic (7.32e-2)" "unprognostic (7.13e-2)" "unprognostic (2.45e-1)" "unprognostic (4.23e-2)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" 19.0 28.1 30.9 16.5 28.9 37.0 52.2 17.9 27.6 20.0 20.6 15.1 22.7 22.2 16.3 27.9 20.0 19.6 27.9 65.7 26.1 25.1 21.0 40.9 21.2 31.9 28.5 17.8 21.7 50.2 16.0 23.4 15.6 22.3 18.4 16.7 19.4 28.2 23.9 75.9 19.1 24.3 28.1 35.9 18.6 20.7 18.1 23.1 20.8 24.9 38.8 18.6 19.9 18.3 42.8 42.3 63.4 40.1 25.5 44.8 38.1 31.5 32.3 22.2 29.2 21.1 16.3 16.3 17.5 18.8 25.8 22.0 29.3 24.7 14.6 33.9 24.4 37.2 17.0 20.5 21.6 15.9 27.2 36.6 14.6 23.2 28.3 25.8 28.2 21.9 21.2 27.1 23.1 13.0 16.9 23.0 31.4 34.1 43.7 21.1 97.3 46.3 50.4 20.5 31.5 41.7 22.1 21.8 43.0 20.6 21.0 18.9 31.5 21.1 40.4 24.9 23.6 18.1 34.6 18.5 29.2 37.2 45.7 34.2 27.0 39.2 37.8 26.0 35.2 33.9 48.3 40.1 63.4 32.1 39.1 30.4 42.8 34.5 35.6 31.3 37.6 29.8 30.0 58.5 25.5 35.5 42.3 44.8 38.1 30.9 28.9 17.9 27.6 26.1 25.1 28.5 17.8 22.3 23.1 32.8 37.7 101.2 100.0 84.3 36.9 165.4 71.4 69.6 36.4 118.7 11.8 175.6 232.1 122.3 40.3 90.9 189.8 140.2 173.5 165.1 101.3 117.4 42.7 165.1 176.1 33.4 98.9 85.3 97.5 33.8 117.6 117.2 135.0 153.3 115.9 97.7 155.7 164.9 104.0 180.9 34.8 51.8 107.2 95.4 243.8 101.5 152.3 76.2 104.4 130.5 POLR2J2 RPB11b1 ENSG00000228049 "RNA polymerase II subunit J2" Q9GZM3 7 102665368-102671629 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.6" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 18.1;RT4: 13.0;U-2 OS: 12.8" HPA046970 Approved Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" 3.8 3.9 12.0 9.5 10.0 5.4 6.6 10.6 32.6 7.2 4.6 6.5 3.4 7.9 6.9 6.5 4.8 4.6 7.4 4.3 12.5 5.5 5.8 6.1 6.1 7.8 10.1 7.7 9.0 3.7 3.2 6.1 5.7 7.8 4.6 5.2 4.5 11.2 3.4 11.9 9.9 10.3 9.8 9.3 7.5 6.6 3.5 6.2 4.2 5.8 1.3 11.0 4.7 5.1 7.9 6.0 11.3 4.0 2.9 6.5 1.3 2.5 2.2 1.5 1.9 3.4 4.8 3.0 2.8 0.6 1.7 1.8 1.6 5.1 2.6 0.5 1.9 1.0 2.4 1.1 0.7 4.3 1.8 3.0 1.4 3.1 1.0 1.5 6.1 2.8 0.9 0.5 1.3 2.4 0.8 0.6 1.6 2.6 6.6 1.3 1.0 18.1 1.8 1.1 0.9 0.6 2.3 0.4 2.4 1.0 13.0 1.4 1.7 2.4 1.3 1.1 2.4 0.8 1.0 1.0 3.9 12.8 0.6 2.1 2.9 2.1 2.3 1.6 2.7 1.3 11.3 4.0 2.9 5.9 2.3 3.9 5.5 6.0 4.2 1.9 7.9 6.5 5.0 3.2 2.9 3.6 6.0 3.5 1.3 12.0 10.0 10.6 32.6 12.5 5.5 10.1 7.7 7.8 6.2 6.0 1.6 10.0 3.2 1.4 6.1 0.0 2.5 4.0 1.2 8.7 9.8 6.1 5.0 2.9 0.0 3.1 2.9 23.3 0.7 3.5 2.4 2.0 1.1 1.7 3.2 4.8 3.5 5.5 3.2 0.0 8.3 3.8 0.0 8.2 1.9 1.3 1.5 0.0 3.2 2.9 4.1 0.0 2.2 8.6 10.7 1.1 6.5 4.3 2.3 2.7 POLR2J3 ENSG00000168255 "RNA polymerase II subunit J3" 7 102537918-102572653 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 12.3" "Group enriched" "Detected in some" 635 "Cytotrophoblasts: 71.6;Extravillous trophoblasts: 52.6;Hofbauer cells: 37.9;Syncytiotrophoblasts: 92.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 21.5" "HPA011403, HPA046970" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA011403: AB_2668503, HPA046970: AB_2679882" "unprognostic (3.55e-2)" "unprognostic (2.04e-4)" "unprognostic (4.55e-3)" "unprognostic (5.85e-2)" "unprognostic (1.71e-1)" "unprognostic (9.26e-2)" "unprognostic (2.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.12e-3)" "unprognostic (1.23e-1)" "unprognostic (2.41e-2)" "unprognostic (1.00e-1)" "unprognostic (5.90e-4)" "unprognostic (3.04e-1)" "unprognostic (7.43e-2)" "unprognostic (1.07e-1)" "unprognostic (1.04e-2)" 2.8 3.0 0.9 1.7 1.4 2.3 1.9 4.0 4.7 3.1 2.4 3.6 4.5 0.1 2.3 4.9 0.3 1.3 1.1 1.1 2.2 2.8 2.2 1.0 1.5 4.5 1.7 2.9 2.3 1.7 2.5 2.1 4.1 0.2 1.0 5.0 3.5 1.8 1.6 3.9 2.2 0.8 4.0 3.5 4.1 2.2 4.9 5.9 12.3 5.6 4.4 4.4 3.4 8.5 4.1 1.7 0.1 0.2 0.7 0.7 5.1 1.5 3.3 3.8 3.2 2.4 1.2 0.3 0.0 4.8 4.1 2.7 2.1 3.6 21.5 4.7 2.4 3.2 1.0 0.9 3.0 2.2 0.3 1.8 1.7 1.7 6.5 5.2 2.1 2.7 1.5 0.5 6.9 7.5 0.4 0.0 3.0 5.2 0.3 2.9 2.0 0.8 1.1 1.7 0.3 9.4 0.9 5.0 2.1 0.0 1.4 4.2 3.1 8.3 0.0 1.3 0.2 0.6 3.6 5.2 2.4 3.4 9.0 5.6 7.8 3.3 2.0 1.7 4.7 3.1 4.4 5.9 4.9 3.8 3.6 12.3 4.4 3.5 4.3 4.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.6 0.0 0.0 0.0 0.0 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.0 0.0 0.0 0.0 POLR2J3 ENSG00000285437 "RNA polymerase II subunit J3" 7 102562133-102572583 "Predicted intracellular proteins, RNA polymerase related proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.2;skeletal muscle: 14.6" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 246.4;Cone photoreceptor cells: 333.8;Rod photoreceptor cells: 291.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA046970 Approved Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" 0.5 2.3 1.9 5.5 1.3 5.7 0.0 3.9 2.0 2.7 3.7 1.7 0.0 0.5 0.0 2.9 2.7 0.5 1.9 1.3 0.3 0.0 0.5 0.5 2.0 0.0 0.6 14.6 2.0 1.6 0.0 2.1 1.6 1.2 0.5 1.1 0.5 22.4 26.8 29.2 25.2 16.5 23.5 14.4 14.4 1.8 20.7 18.4 1.1 4.3 7.8 20.3 0.7 4.4 1.3 6.8 11.5 6.7 10.1 3.5 10.7 8.9 2.7 4.8 13.4 0.9 3.1 15.4 26.1 20.2 2.9 25.7 15.2 4.7 6.0 2.4 1.8 12.0 5.9 12.3 13.3 39.1 1.9 7.3 36.5 11.4 6.2 18.4 0.5 17.1 18.6 19.3 5.8 18.4 9.9 14.8 16.1 16.2 14.2 24.5 6.2 14.8 6.5 27.6 12.5 24.2 16.3 17.6 25.9 40.6 15.4 18.1 16.6 26.8 19.9 29.2 17.7 18.0 16.1 22.4 23.5 20.0 17.9 20.2 20.4 19.5 21.1 16.5 25.2 26.8 21.8 14.4 6.0 1.6 68.9 89.5 10.9 246.4 14.3 89.2 9.4 5.7 7.0 333.8 0.0 1.7 0.3 6.1 20.5 47.8 23.3 0.3 0.0 14.6 61.1 13.8 37.1 0.0 168.5 56.1 102.5 57.8 5.0 84.0 10.8 23.6 1.8 38.2 55.9 0.9 59.6 48.4 2.2 291.4 25.8 24.7 93.1 107.3 12.9 0.0 90.0 43.8 82.1 POLR2L "hRPB7.6, hsRPB10b, RBP10, RPABC5, RPB10beta, RPB7.6" ENSG00000177700 "RNA polymerase II subunit L" P62875 11 837356-842545 "Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 87.6;PC-3: 112.2" "Low region specificity" "Detected in all" HPA073614 Supported Nucleoplasm NA NA Nucleoplasm "HPA073614: " "unprognostic (2.65e-2)" "unprognostic (6.56e-3)" "unprognostic (1.40e-1)" "unprognostic (5.71e-2)" "unprognostic (3.49e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (2.37e-4)" "unprognostic (6.17e-3)" "unprognostic (1.34e-1)" "unprognostic (7.51e-3)" "unprognostic (2.37e-2)" "unprognostic (6.77e-2)" "prognostic favorable (5.56e-4)" "unprognostic (3.60e-2)" "unprognostic (1.32e-1)" "unprognostic (4.03e-3)" "unprognostic (1.73e-1)" 42.9 27.7 22.4 18.4 18.3 16.9 63.3 10.1 18.8 16.6 28.3 9.9 29.7 18.7 14.1 23.8 37.5 15.0 28.5 86.7 19.2 17.3 32.9 43.3 26.3 21.2 18.8 10.7 16.6 88.3 14.8 21.1 21.0 12.5 19.3 11.5 23.0 41.6 35.4 44.8 17.3 18.9 21.5 13.5 19.2 17.1 18.3 9.3 18.7 37.9 41.8 15.7 17.6 21.0 28.6 52.3 43.0 44.1 41.7 38.6 42.2 16.0 87.6 8.3 10.3 23.9 17.4 7.5 20.7 14.5 20.5 13.7 25.6 15.0 10.1 5.7 25.7 17.4 10.8 12.3 24.8 6.5 9.3 60.4 9.6 26.1 32.3 14.2 9.2 7.8 28.6 11.2 11.6 5.8 12.5 16.2 10.7 10.2 11.2 24.1 40.5 9.3 9.7 13.0 18.7 112.2 9.1 6.7 15.4 24.7 12.4 16.8 5.3 20.6 21.2 15.9 4.7 12.7 5.5 18.0 13.9 11.0 7.6 12.8 6.8 7.8 9.8 21.0 9.1 12.2 26.4 44.1 43.0 36.1 38.4 38.6 28.6 34.4 35.7 41.7 26.0 29.5 35.6 11.5 41.7 25.9 52.3 33.0 42.2 22.4 18.3 10.1 18.8 19.2 17.3 18.8 10.7 12.5 9.3 381.2 358.3 236.7 203.3 543.4 62.5 432.3 639.5 250.3 323.0 499.0 23.6 587.7 1090.9 434.7 67.7 336.6 720.6 350.4 588.2 345.4 532.7 243.7 259.8 1459.1 606.2 47.7 482.2 661.1 436.0 177.8 283.0 301.5 624.2 530.2 452.3 186.9 631.2 462.9 239.7 1293.9 56.1 155.2 446.5 174.7 248.7 608.9 376.0 284.4 422.8 251.0 POLR2M "GCOM1, Gdown, Gdown1, GRINL1A" ENSG00000255529 "RNA polymerase II subunit M" "P0CAP2, Q6EEV4" 15 57706629-57782762 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068141 Approved Nucleoplasm NA NA Nucleoplasm "HPA068141: AB_2685962" "unprognostic (3.07e-1)" "unprognostic (1.08e-1)" "unprognostic (2.63e-1)" "unprognostic (3.73e-1)" "unprognostic (1.11e-2)" "unprognostic (1.38e-1)" "unprognostic (9.80e-2)" "unprognostic (7.30e-2)" "unprognostic (4.30e-2)" "unprognostic (9.25e-2)" "unprognostic (2.81e-1)" "unprognostic (3.56e-2)" "unprognostic (6.61e-2)" "unprognostic (1.39e-1)" "unprognostic (3.25e-2)" "unprognostic (2.43e-1)" "unprognostic (1.07e-1)" 17.0 16.3 22.9 8.5 26.5 25.2 33.5 15.3 25.1 18.1 11.5 21.0 14.0 9.6 28.0 15.5 12.1 16.1 13.1 22.2 22.7 21.9 15.8 12.0 14.7 19.5 29.9 15.8 27.0 14.8 23.6 12.3 14.4 19.7 21.1 11.5 19.2 12.6 20.5 25.3 11.8 9.6 21.5 25.0 13.2 10.2 10.8 24.0 11.7 19.0 7.1 12.5 18.9 15.1 15.2 14.3 16.2 13.9 22.4 19.5 13.5 9.4 15.9 11.2 28.1 19.6 20.5 10.6 15.7 24.8 16.5 15.7 11.7 7.2 15.2 15.8 10.7 13.7 15.8 12.5 11.8 22.1 15.8 8.5 18.4 12.5 7.4 21.6 17.0 17.6 18.3 19.2 9.3 27.0 18.6 12.7 16.4 18.6 13.3 13.9 6.0 15.4 10.8 18.2 13.0 8.1 15.3 24.8 11.5 12.4 9.5 8.3 14.5 12.0 12.2 18.4 15.3 14.0 24.2 11.6 24.9 20.9 37.3 18.4 15.3 15.7 20.1 15.0 25.5 17.4 16.2 13.9 15.4 15.8 13.5 19.4 15.2 17.2 16.1 14.3 14.7 19.5 17.2 1.6 22.4 11.1 9.9 18.9 13.5 22.9 26.5 15.3 25.1 22.7 21.9 29.9 15.8 19.7 24.0 20.8 7.8 22.9 18.9 14.9 13.6 24.3 10.2 13.4 14.8 24.4 3.9 10.8 21.6 11.0 32.2 19.0 10.3 0.0 13.2 15.2 21.1 25.2 11.6 11.6 15.8 11.1 22.4 17.8 17.8 9.0 20.4 15.3 23.6 13.6 17.7 17.1 17.6 14.0 26.5 13.3 6.5 19.4 28.8 17.9 21.4 12.5 10.1 27.4 19.2 14.5 POLR3A "hRPC155, RPC1, RPC155" ENSG00000148606 "RNA polymerase III subunit A" O14802 10 77969251-78029545 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Nucleotidyltransferase, Transferase" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 40.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037926 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA037926: AB_10672400" "unprognostic (6.83e-2)" "unprognostic (3.41e-2)" "unprognostic (4.54e-2)" "unprognostic (2.76e-2)" "unprognostic (6.41e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.64e-6)" "unprognostic (3.25e-1)" "unprognostic (1.07e-1)" "unprognostic (1.73e-1)" "unprognostic (6.64e-2)" "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (1.34e-1)" "unprognostic (3.19e-1)" "unprognostic (1.30e-1)" "unprognostic (4.11e-2)" 7.1 10.2 10.3 8.3 21.7 5.9 10.6 22.2 29.7 9.2 8.1 12.8 7.4 8.6 9.4 13.3 8.6 8.5 7.4 7.4 9.4 9.6 9.3 9.3 6.8 8.7 8.1 11.0 11.5 10.7 13.8 17.3 10.1 20.4 10.2 10.7 10.4 8.6 8.2 17.6 11.2 7.8 9.7 6.6 8.9 8.2 11.7 9.8 12.6 9.6 4.4 13.4 7.9 8.0 7.5 5.4 8.0 6.4 6.5 8.8 3.6 7.4 8.9 9.5 15.7 6.3 8.0 6.3 8.6 11.2 11.1 11.0 11.7 5.4 9.3 5.3 7.4 6.3 8.8 16.4 9.4 13.6 6.8 12.0 7.5 7.1 14.4 5.9 12.8 6.3 6.8 6.8 19.7 18.3 10.7 9.7 7.6 13.8 5.8 10.7 5.6 9.6 8.1 10.3 6.1 40.8 9.2 6.0 6.0 5.6 4.9 8.7 11.0 8.2 15.4 8.8 8.9 11.4 6.7 10.6 7.2 7.0 7.7 17.0 9.0 9.5 11.3 12.8 13.5 3.5 8.0 5.2 2.9 7.8 6.4 7.6 5.6 6.0 7.2 4.8 7.5 5.7 6.6 3.3 6.5 5.4 5.4 8.8 3.6 10.3 21.7 22.2 29.7 9.4 9.6 8.1 11.0 20.4 9.8 0.0 7.8 6.1 4.6 8.9 27.0 10.4 7.6 14.7 12.5 0.0 60.9 6.7 1.7 5.4 1.2 7.3 6.3 0.0 5.3 5.6 5.7 3.5 5.8 9.2 4.8 14.3 6.9 6.2 5.7 0.0 12.0 4.5 1.7 3.6 9.8 15.5 7.1 7.0 7.8 3.8 32.8 6.5 6.6 10.9 17.0 8.0 3.4 4.9 8.6 3.2 POLR3C "RPC3, RPC62" ENSG00000186141 "RNA polymerase III subunit C" Q9BUI4 1 145824088-145842505 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 15 "Early spermatids: 260.3;Late spermatids: 416.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027508, HPA027516" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027508: AB_10600091, HPA027516: AB_10600894" "unprognostic (1.43e-2)" "unprognostic (1.70e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (6.87e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.48e-4)" "unprognostic (2.51e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.13e-1)" "unprognostic (1.41e-2)" "unprognostic (4.46e-1)" "prognostic unfavorable (1.85e-5)" "unprognostic (2.34e-1)" "unprognostic (4.95e-2)" "unprognostic (1.07e-2)" "unprognostic (1.38e-1)" 21.1 11.9 13.5 21.2 13.4 16.9 21.7 28.3 16.4 18.0 14.2 12.2 11.1 9.4 19.2 16.2 15.1 16.9 14.6 12.7 12.1 9.9 15.7 15.3 13.3 25.4 14.7 15.8 21.9 23.1 16.7 10.9 13.9 12.6 15.7 15.9 11.9 16.9 13.0 18.3 20.3 14.9 17.5 11.0 20.5 14.9 29.3 15.0 26.5 15.9 11.4 21.3 17.5 15.8 21.1 23.6 29.5 23.9 20.6 20.7 15.9 16.1 13.4 11.2 9.2 14.7 18.0 11.9 15.3 18.8 21.8 20.9 19.3 8.7 27.9 15.5 20.9 11.9 16.0 18.1 16.3 22.7 11.4 14.2 14.9 15.7 11.5 26.6 30.6 19.3 17.1 12.0 24.4 43.5 12.5 13.5 13.4 18.7 16.5 23.0 22.4 15.8 13.9 16.0 16.9 18.0 14.9 14.0 18.3 14.2 11.6 10.4 15.7 13.7 20.2 20.7 18.5 15.5 28.6 14.1 19.2 15.3 10.4 21.3 25.8 25.0 32.4 7.0 15.9 14.8 29.5 20.9 21.1 15.9 23.9 20.7 20.1 17.6 16.4 22.0 21.1 18.0 16.4 1.7 20.6 17.3 23.6 14.9 15.9 13.5 13.4 28.3 16.4 12.1 9.9 14.7 15.8 12.6 15.0 6.0 9.6 9.0 6.7 4.4 3.1 15.7 5.1 8.1 10.3 3.5 3.9 9.9 10.0 9.4 260.3 6.8 4.7 23.3 18.5 10.2 9.0 4.8 8.1 4.5 12.4 1.6 4.1 7.4 9.7 416.7 9.5 9.1 1.7 11.8 6.5 3.6 14.3 7.0 13.8 10.2 3.7 19.4 11.3 18.9 17.0 3.8 8.0 8.7 7.3 8.1 POLR3D "BN51T, RPC4, TSBN51" ENSG00000168495 "RNA polymerase III subunit D" P05423 8 22245104-22254600 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061331, HPA067875, HPA068461, HPA069089" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA061331: AB_2684480, HPA067875: AB_2685912, HPA068461: AB_2685993, HPA069089: AB_2686081" "unprognostic (2.33e-1)" "unprognostic (2.27e-1)" "unprognostic (9.38e-3)" "unprognostic (9.33e-3)" "unprognostic (1.24e-1)" "unprognostic (8.02e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.02e-1)" "unprognostic (2.19e-2)" "unprognostic (3.27e-1)" "unprognostic (8.03e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (9.15e-6)" "unprognostic (1.15e-1)" "unprognostic (3.13e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (2.12e-4)" 14.7 12.9 10.3 14.0 13.6 9.8 18.4 8.8 15.7 13.9 11.9 13.9 8.2 9.3 14.3 9.3 16.5 11.9 13.9 16.6 10.0 8.3 11.7 11.2 12.7 13.4 16.5 13.7 18.1 20.8 10.5 16.3 20.2 13.2 14.5 11.9 9.7 14.5 11.2 34.4 11.9 9.6 17.5 13.5 13.2 12.2 29.4 12.0 8.0 12.6 10.8 13.1 14.7 15.9 9.1 13.6 1.6 5.7 11.2 10.7 5.3 6.7 20.2 11.0 12.4 10.8 15.8 11.9 18.2 11.3 15.6 13.4 14.3 5.7 22.2 15.5 11.5 16.6 11.8 25.2 8.4 12.6 7.3 9.5 19.4 10.2 19.4 17.2 6.0 15.3 13.1 17.1 19.7 23.0 16.8 13.1 16.4 25.6 14.6 12.7 10.1 22.1 12.8 27.8 15.0 11.5 17.4 14.7 17.0 7.4 6.0 12.7 23.4 7.3 8.4 25.3 14.8 6.5 8.5 14.3 15.3 14.3 18.9 17.9 16.8 15.5 13.7 10.2 11.2 20.1 0.1 5.6 1.6 8.5 5.6 10.4 8.3 9.1 10.3 7.4 9.1 10.7 9.4 0.2 11.2 5.7 13.6 5.9 5.3 10.3 13.6 8.8 15.7 10.0 8.3 16.5 13.7 13.2 12.0 8.9 6.2 12.3 29.1 17.3 11.2 10.2 2.5 12.0 11.4 10.4 15.7 13.5 10.0 17.8 33.8 11.9 5.9 0.0 10.2 25.8 15.8 23.9 18.4 4.9 12.5 3.2 20.6 12.9 8.4 31.7 14.7 7.7 8.5 14.4 13.3 4.3 19.8 5.8 12.0 10.6 11.4 19.4 15.5 36.2 50.0 16.8 22.5 12.9 11.2 32.9 POLR3E "FLJ10509, RPC5, SIN" ENSG00000058600 "RNA polymerase III subunit E" Q9NVU0 16 22297375-22335103 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041419, HPA041477" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA041419: AB_2677468, HPA041477: AB_10796345" "unprognostic (3.09e-2)" "unprognostic (8.59e-2)" "unprognostic (8.23e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "unprognostic (7.28e-2)" "unprognostic (2.42e-2)" "unprognostic (7.73e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (1.74e-4)" "unprognostic (8.14e-2)" "unprognostic (1.91e-1)" "unprognostic (8.96e-2)" "unprognostic (8.19e-3)" "unprognostic (3.41e-2)" 10.8 15.8 8.9 10.4 11.1 9.8 15.5 11.7 12.9 11.7 10.7 12.0 13.0 9.7 12.4 9.3 13.1 11.1 8.5 13.9 10.9 7.0 9.5 14.0 9.5 12.7 11.1 9.8 11.0 21.2 15.7 15.8 8.9 10.7 12.7 6.6 11.8 15.0 15.2 50.7 12.7 8.9 9.2 10.0 9.5 12.4 9.6 10.7 10.4 12.3 9.1 14.0 11.4 10.4 5.9 5.7 1.9 3.8 5.3 7.2 4.8 6.6 9.3 2.7 6.7 5.3 4.0 9.2 5.4 2.8 3.6 2.5 11.7 4.7 13.8 7.1 3.8 2.5 6.4 13.3 7.5 2.9 9.1 19.0 7.0 10.1 22.3 6.5 10.9 7.8 3.9 8.3 7.7 9.4 1.7 9.1 5.8 19.9 5.6 4.1 10.8 10.9 4.5 13.7 7.4 7.9 14.3 6.0 17.7 3.7 4.0 9.9 7.4 5.1 9.5 5.2 2.3 5.5 6.3 5.7 3.6 4.1 3.1 5.9 7.6 13.5 12.7 4.1 8.4 6.7 0.0 3.3 1.9 6.5 3.8 7.2 5.9 7.2 6.8 5.7 5.1 7.0 5.8 0.3 5.3 3.1 3.3 7.2 4.8 8.9 11.1 11.7 12.9 10.9 7.0 11.1 9.8 10.7 10.7 3.0 14.3 16.6 20.1 28.8 22.8 16.2 7.6 16.0 11.4 17.4 29.5 19.3 5.0 10.9 31.0 13.1 10.9 0.0 11.0 16.4 14.4 22.7 27.6 11.1 11.5 19.1 14.5 5.5 12.3 13.9 11.5 9.4 13.5 7.2 16.4 10.6 13.0 11.5 8.5 9.1 38.3 12.9 16.5 18.4 16.2 34.6 23.7 19.2 15.0 23.8 POLR3F "RPC39, RPC6" ENSG00000132664 "RNA polymerase III subunit F" Q9H1D9 20 18467127-18484643 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049441, HPA050173, HPA072298" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049441: AB_2680768, HPA050173: AB_2681042, HPA072298: AB_2686510" "unprognostic (4.59e-2)" "unprognostic (1.83e-1)" "unprognostic (3.44e-1)" "unprognostic (1.69e-2)" "unprognostic (1.55e-1)" "unprognostic (7.39e-2)" "prognostic unfavorable (8.87e-9)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.20e-1)" "prognostic favorable (6.48e-4)" "unprognostic (3.04e-1)" "unprognostic (4.01e-1)" "unprognostic (3.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.88e-3)" "unprognostic (4.98e-3)" 8.6 7.8 8.1 6.0 11.9 4.4 8.0 24.6 15.3 9.9 7.5 8.7 8.5 5.6 11.6 6.5 11.0 9.6 6.7 14.2 8.7 10.1 11.2 7.3 5.9 8.8 7.8 12.9 12.5 7.3 4.5 9.8 8.0 13.9 9.2 6.4 6.7 7.5 7.4 12.0 6.2 5.0 9.0 8.5 6.3 6.7 10.0 7.7 6.3 16.3 7.2 9.1 10.7 6.5 3.1 3.2 1.9 4.5 3.3 6.4 4.1 6.5 6.7 7.0 8.8 5.7 6.9 12.6 9.7 6.8 12.5 9.6 8.4 6.7 5.1 4.1 9.4 8.3 9.0 9.2 8.0 8.2 5.0 7.7 3.7 2.6 3.6 8.1 11.0 6.3 4.4 5.2 18.7 8.6 6.0 5.6 4.5 9.4 4.5 8.6 7.1 9.2 4.7 9.9 6.7 15.3 6.5 15.3 5.6 5.6 2.8 14.6 9.6 7.5 12.6 15.7 4.9 5.8 7.4 5.4 12.9 6.3 9.6 13.6 2.3 15.3 4.0 5.4 5.1 9.3 0.1 2.1 1.9 4.3 4.5 6.4 2.8 3.9 1.2 2.2 3.1 4.1 2.1 0.8 3.3 1.9 3.2 3.4 4.1 8.1 11.9 24.6 15.3 8.7 10.1 7.8 12.9 13.9 7.7 8.9 3.7 5.4 3.0 7.9 17.3 7.3 2.5 12.0 4.5 1.8 9.8 8.6 8.3 7.0 15.9 6.5 2.9 0.0 5.9 10.3 6.7 3.5 5.7 4.5 6.7 11.1 6.4 6.7 7.0 4.1 5.8 6.9 5.0 11.8 3.1 12.5 6.4 0.0 9.6 9.8 17.4 12.9 5.5 17.7 22.0 9.9 6.1 8.5 3.9 2.7 POT1 "DKFZp586D211, hPot1" ENSG00000128513 "Protection of telomeres 1" Q9NUX5 7 124822386-124929983 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA068538 Supported Nucleoplasm NA NA Nucleoplasm "HPA068538: AB_2686001" "unprognostic (1.39e-3)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" "unprognostic (5.71e-2)" "unprognostic (1.69e-1)" "unprognostic (1.49e-1)" "unprognostic (1.38e-3)" "unprognostic (7.88e-2)" "unprognostic (2.26e-2)" "unprognostic (1.51e-1)" "unprognostic (2.48e-2)" "unprognostic (9.89e-2)" "unprognostic (1.42e-1)" "unprognostic (2.92e-1)" "unprognostic (1.75e-2)" "unprognostic (4.77e-3)" "unprognostic (7.42e-2)" 12.0 13.2 11.1 8.3 14.3 6.2 15.8 13.0 16.6 13.4 10.1 16.0 12.0 7.8 17.0 13.4 10.1 12.6 11.3 11.2 15.5 11.3 16.6 14.7 9.9 14.0 15.0 12.4 15.7 9.4 15.5 29.6 11.1 16.4 12.0 9.7 12.2 8.7 10.1 9.5 8.0 8.8 13.1 16.4 13.6 9.5 15.8 14.8 17.9 21.5 9.3 12.9 13.6 9.8 4.8 3.6 2.7 3.3 5.2 7.4 2.7 12.9 5.5 8.2 6.3 5.5 10.3 5.8 7.3 8.6 8.3 12.6 4.5 13.1 11.7 5.9 5.5 11.6 5.1 9.0 7.4 13.2 15.1 13.1 11.4 5.5 4.8 12.4 11.0 6.8 7.3 8.9 7.7 12.1 9.6 10.5 4.8 20.2 28.1 9.3 2.5 14.6 11.6 9.3 8.4 9.1 8.7 8.6 16.7 7.2 7.2 8.8 11.7 7.4 9.9 10.3 13.2 4.4 10.6 3.4 10.0 4.4 12.1 9.6 15.6 15.9 16.6 10.1 12.6 12.4 0.9 3.1 2.7 4.3 3.3 6.3 4.8 4.5 5.0 3.1 3.4 7.4 5.5 0.7 5.2 3.0 3.6 4.4 2.7 11.1 14.3 13.0 16.6 15.5 11.3 15.0 12.4 16.4 14.8 6.0 5.5 4.2 5.9 4.0 7.0 8.2 7.6 2.7 2.3 12.2 9.8 5.8 16.6 4.2 13.5 4.3 0.8 0.0 3.9 6.8 6.0 3.8 3.5 10.4 5.6 7.9 8.6 6.2 10.0 6.8 8.1 6.1 15.1 4.6 3.2 12.6 3.0 0.0 4.2 8.6 9.3 0.0 8.2 27.5 12.0 2.3 3.8 6.2 4.0 1.8 POU3F1 "OCT6, OTF6, SCIP" ENSG00000185668 "POU class 3 homeobox 1" Q03052 1 38044611-38046794 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 10.5;skin 1: 31.0" "Cell type enhanced" "Detected in some" 15 "Basal keratinocytes: 24.3;Cone photoreceptor cells: 21.6;Muller glia cells: 14.6;Rod photoreceptor cells: 19.3;Suprabasal keratinocytes: 48.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.1;HDLM-2: 19.2;NTERA-2: 5.3;SCLC-21H: 3.8;SK-MEL-30: 15.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 7.0;cerebral cortex: 3.5;hippocampal formation: 9.7" "HPA055980, HPA073824" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055980: AB_2682995, HPA073824: AB_2686635" "unprognostic (9.99e-2)" "unprognostic (1.63e-1)" "unprognostic (1.69e-1)" "unprognostic (1.43e-2)" "unprognostic (7.46e-3)" "unprognostic (1.96e-2)" "unprognostic (1.33e-2)" "unprognostic (2.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.40e-1)" "unprognostic (4.61e-4)" "unprognostic (2.79e-2)" "unprognostic (1.97e-1)" "unprognostic (3.61e-2)" "unprognostic (2.67e-3)" 0.8 2.1 4.0 0.9 10.5 0.7 0.8 1.2 6.8 0.6 0.7 1.1 0.0 0.6 0.7 0.8 3.4 0.7 0.7 0.7 7.7 0.9 0.7 0.6 0.6 1.7 3.9 2.9 0.7 0.8 0.6 0.0 0.6 1.4 3.6 0.6 1.6 0.6 0.7 1.3 31.0 0.7 2.5 0.6 0.7 0.7 1.5 2.6 0.0 0.7 1.3 1.7 1.5 0.4 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 11.1 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 19.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.1 0.0 0.7 3.8 0.0 0.0 0.0 15.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 10.5 1.2 6.8 7.7 0.9 3.9 2.9 1.4 2.6 0.0 0.0 0.0 1.7 24.3 7.4 4.3 0.0 0.0 0.0 0.0 21.6 0.1 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.1 0.9 0.8 0.0 0.0 0.2 1.6 1.7 0.0 0.0 0.0 0.3 0.0 6.8 0.0 0.6 14.6 0.0 0.0 0.0 0.0 19.3 0.0 2.0 0.2 1.7 48.8 0.1 0.0 0.4 2.1 POU3F2 "BRN2, OCT7, OTF7, POUF3" ENSG00000184486 "POU class 3 homeobox 2" P20265 6 98834592-98839470 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "brain: 28.0" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 12.3" "Cancer enriched" "Detected in some" 11 "glioma: 16.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 52.2;SK-MEL-30: 7.1;U-251 MG: 15.9;WM-115: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047081, HPA056261" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA047081: , HPA056261: AB_2683081" "unprognostic (5.94e-4)" "unprognostic (7.80e-2)" "unprognostic (3.07e-3)" "unprognostic (1.83e-1)" "unprognostic (3.57e-1)" "unprognostic (1.38e-1)" "unprognostic (1.17e-3)" "unprognostic (1.84e-1)" "unprognostic (1.16e-1)" "unprognostic (1.60e-1)" "unprognostic (1.63e-3)" "unprognostic (4.77e-1)" "unprognostic (9.38e-11)" "unprognostic (4.77e-2)" "unprognostic (2.84e-2)" "unprognostic (8.47e-3)" "unprognostic (4.04e-1)" 0.9 1.0 9.0 0.9 10.8 0.9 0.9 3.4 28.0 0.9 0.9 10.3 0.0 0.9 0.9 0.9 0.9 0.9 0.9 0.9 9.8 7.1 0.9 0.9 0.9 0.9 10.7 6.8 0.9 0.9 0.9 0.0 0.9 9.7 0.9 0.9 0.0 0.9 0.9 0.9 1.0 0.9 0.9 8.4 0.9 0.9 1.2 9.0 0.0 0.9 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 52.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 2.2 1.7 0.4 0.0 0.0 0.0 2.9 1.5 0.0 0.0 7.1 0.0 0.4 0.0 0.0 0.3 0.0 0.1 15.9 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.0 10.8 3.4 12.5 9.8 7.1 10.7 6.8 9.7 9.0 0.0 0.0 0.0 0.2 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.4 0.1 0.0 0.0 0.0 0.2 POU3F3 "BRN1, OTF8" ENSG00000198914 "POU class 3 homeobox 3" P20264 2 104855511-104858574 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "brain: 18.9;epididymis: 27.2;kidney: 23.7;seminal vesicle: 12.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 55.8;Distal tubular cells: 23.2" "Group enriched" "Detected in some" 6 "glioma: 21.5;renal cancer: 24.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 27.6;AN3-CA: 26.4;HEK 293: 10.2;RPTEC TERT1: 31.4;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052792, HPA056039, HPA067151" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790" "unprognostic (3.05e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (4.26e-5)" "unprognostic (9.66e-2)" "unprognostic (1.97e-1)" "unprognostic (4.69e-1)" "unprognostic (1.16e-1)" "unprognostic (7.28e-2)" "unprognostic (1.15e-3)" "unprognostic (7.15e-2)" 0.2 0.2 9.0 0.1 8.6 0.0 0.1 4.3 18.9 0.0 0.3 0.0 0.0 27.2 0.0 0.0 0.0 0.0 9.9 6.0 23.7 0.0 0.0 0.1 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.5 0.0 0.0 10.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.9 0.2 0.3 0.2 0.0 0.0 0.0 27.6 26.4 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.9 0.6 0.0 31.4 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.8 1.0 0.0 0.0 0.0 55.8 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 POU3F4 "BRN4, DFN3, DFNX2, OTF9" ENSG00000196767 "POU class 3 homeobox 4" P49335 X 83508261-83512127 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "brain: 39.0" "Cell type enriched" "Detected in some" 6 "Collecting duct cells: 10.4" "Cancer enriched" "Detected in single" 21 "glioma: 5.6" "Region enriched" "Detected in all" 6 "basal ganglia: 39.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 145 "AF22: 15.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062295 Supported Nucleoplasm NA NA Nucleoplasm "HPA062295: AB_2732681" "unprognostic (5.73e-2)" "unprognostic (2.00e-1)" 0.5 0.5 3.3 0.5 39.0 0.6 0.5 5.0 15.2 0.5 0.7 2.4 0.0 0.5 0.5 0.5 0.5 0.5 1.3 0.5 2.8 1.6 2.5 0.5 0.5 0.5 2.4 3.7 1.1 0.5 0.5 0.1 0.5 2.4 0.5 0.6 0.0 0.5 0.5 0.5 0.5 0.5 0.6 1.7 0.5 0.5 0.5 6.6 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 39.0 5.0 4.2 2.8 1.6 2.4 3.7 2.4 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POU4F3 "BRN3C, DFNA15, DFNA42, DFNA52" ENSG00000091010 "POU class 4 homeobox 3" Q15319 5 146338839-146341722 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Region enhanced" "Detected in single" "cerebellum: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.0;SCLC-21H: 1.9;U-2 OS: 1.9" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 0.5" HPA038215 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA038215: AB_10697245" "unprognostic (8.41e-3)" "unprognostic (9.46e-2)" "unprognostic (1.84e-1)" "unprognostic (6.26e-4)" "unprognostic (1.86e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-1)" "unprognostic (9.54e-2)" "unprognostic (1.61e-1)" "unprognostic (2.09e-3)" "unprognostic (1.20e-3)" "unprognostic (1.24e-3)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (8.84e-2)" "unprognostic (7.82e-2)" 0.6 0.1 0.4 0.4 0.6 1.0 0.4 2.8 0.9 0.3 0.2 0.2 0.2 0.1 0.6 0.7 0.2 0.4 0.3 0.2 0.7 0.4 0.3 0.2 0.3 0.2 0.7 0.2 0.6 0.2 0.0 0.2 1.8 0.2 0.2 0.2 0.2 1.1 0.4 0.2 0.8 0.2 0.8 2.4 0.6 0.2 0.4 0.2 1.5 0.5 0.2 0.2 0.6 0.2 0.7 0.4 0.0 0.0 0.0 0.4 0.0 0.2 1.0 0.2 0.4 0.2 0.3 0.0 0.0 0.0 0.2 0.4 0.9 0.2 0.3 0.2 0.3 0.1 0.5 0.3 0.0 0.9 0.4 0.5 0.0 0.1 0.0 0.1 0.1 0.8 0.4 1.6 0.4 0.1 0.0 0.3 0.2 0.2 0.5 0.1 0.1 0.4 2.0 0.1 0.0 0.3 0.8 0.0 0.1 0.4 0.5 1.9 1.6 0.6 0.5 0.1 0.3 0.4 0.1 0.0 0.0 1.9 0.0 0.6 0.6 0.9 0.7 0.0 0.6 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.8 0.2 0.7 0.4 0.7 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POU5F1B "OTF3C, OTF3P1, POU5F1P1" ENSG00000212993 "POU class 5 homeobox 1B" Q06416 8 127322183-127420066 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 3.9;Enterocytes: 2.6;Paneth cells: 2.9" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.5;EFO-21: 3.4;hTERT-HME1: 8.5;NTERA-2: 4.2" HPA058267 Supported Nucleoplasm NA NA Nucleoplasm "HPA058267: AB_2683659" "unprognostic (1.74e-2)" "unprognostic (2.27e-2)" "unprognostic (2.58e-2)" "unprognostic (8.22e-3)" "unprognostic (1.65e-1)" "unprognostic (5.85e-2)" "unprognostic (9.31e-4)" "unprognostic (2.21e-3)" "unprognostic (1.13e-1)" "unprognostic (3.25e-1)" "unprognostic (6.56e-2)" "unprognostic (5.11e-2)" "unprognostic (5.60e-10)" "unprognostic (1.21e-1)" "unprognostic (7.05e-3)" "unprognostic (1.37e-1)" "unprognostic (7.33e-3)" 1.0 0.2 0.2 0.2 0.2 0.6 2.0 0.0 0.4 1.0 0.9 0.0 2.6 1.7 0.9 1.5 0.5 0.3 0.4 0.3 2.8 0.7 0.6 0.7 0.1 0.5 1.2 2.5 0.9 0.6 2.5 1.4 5.1 0.9 0.0 1.6 0.5 0.2 0.0 1.1 0.7 0.4 1.7 0.4 0.8 1.2 0.5 0.1 3.0 0.2 0.0 1.4 0.1 0.5 0.1 0.1 1.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.5 1.2 0.0 3.4 0.0 0.0 0.5 0.4 0.2 0.1 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.1 0.8 0.4 0.0 8.5 0.3 0.1 0.5 0.0 0.2 0.0 0.3 0.1 0.1 4.2 0.5 0.1 0.0 0.0 0.0 0.3 0.3 1.3 0.1 0.0 0.5 0.2 1.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 3.0 0.1 0.3 1.0 0.1 1.4 0.1 0.3 0.4 0.0 0.5 0.7 0.9 2.6 0.0 0.2 0.1 1.4 0.1 0.0 0.3 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.0 3.9 0.0 1.7 1.3 0.2 0.7 2.6 0.0 1.5 0.0 0.2 0.2 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.6 2.9 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 1.5 0.3 POU5F2 "FLJ25680, SPRM-1" ENSG00000248483 "POU domain class 5, transcription factor 2" Q8N7G0 5 93733220-93741637 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 26.8" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 15.9;Rod photoreceptor cells: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "U-2 OS: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA077615 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA077615: " "unprognostic (1.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.53e-1)" "unprognostic (1.17e-1)" "unprognostic (3.03e-1)" "unprognostic (9.17e-3)" "unprognostic (3.72e-2)" "unprognostic (5.87e-3)" "unprognostic (4.58e-1)" "unprognostic (1.49e-1)" "unprognostic (3.53e-2)" "unprognostic (3.84e-1)" "unprognostic (6.16e-9)" "unprognostic (1.87e-1)" "unprognostic (2.01e-1)" "unprognostic (2.21e-1)" "unprognostic (1.44e-3)" 0.2 0.2 0.2 0.2 0.2 1.2 0.8 0.2 0.9 0.2 0.2 0.2 0.2 0.6 0.2 0.6 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.1 0.2 0.2 0.2 0.2 1.4 0.6 0.2 0.2 0.3 0.5 26.8 0.2 0.2 0.5 0.2 0.2 0.2 0.2 2.0 0.5 2.7 0.6 1.1 1.3 0.3 0.4 0.6 1.1 0.5 0.2 0.4 0.5 0.2 0.0 0.3 0.1 0.3 0.5 0.9 0.4 0.2 0.7 0.6 0.9 0.3 0.5 0.6 0.7 0.8 0.7 0.7 0.2 0.8 0.8 0.5 0.7 0.5 0.4 0.5 0.2 0.8 0.6 1.1 0.4 0.4 0.7 1.0 0.7 0.3 0.3 0.5 1.2 0.9 0.2 0.3 1.0 0.9 0.6 0.7 0.2 0.5 0.5 0.7 0.7 0.6 8.5 0.7 0.7 0.8 0.5 0.8 0.5 0.9 0.4 1.4 0.6 0.3 1.0 0.4 1.0 0.8 0.7 0.6 0.1 2.0 0.7 1.1 2.7 1.1 0.4 0.5 1.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 3.0 2.1 3.0 2.1 1.9 10.5 0.4 2.5 1.4 0.0 1.8 5.9 0.7 0.0 1.5 1.7 1.4 1.4 0.0 0.8 0.9 1.4 2.0 8.1 0.8 1.0 15.9 2.9 2.5 1.3 4.5 4.4 2.9 1.7 2.8 0.5 5.4 1.7 0.0 1.4 0.1 15.8 0.0 0.9 6.9 2.3 2.4 0.5 5.4 1.0 2.0 PPARA "hPPAR, NR1C1, PPAR" ENSG00000186951 "Peroxisome proliferator activated receptor alpha" Q07869 22 46150521-46243756 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 93.5;Hepatocytes: 134.7;Rod photoreceptor cells: 152.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 12.1;plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;granulocytes: 12.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058901, HPA067049, CAB075701" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB075701: , HPA058901: AB_2683849, HPA067049: AB_2685770" "unprognostic (1.96e-1)" "unprognostic (2.19e-1)" "unprognostic (1.02e-1)" "unprognostic (4.76e-2)" "unprognostic (3.94e-3)" "unprognostic (4.30e-2)" "unprognostic (1.24e-1)" "unprognostic (4.94e-2)" "unprognostic (2.95e-1)" "unprognostic (5.52e-3)" "unprognostic (4.50e-2)" "unprognostic (1.01e-1)" "prognostic favorable (4.39e-9)" "unprognostic (4.84e-2)" "unprognostic (2.76e-1)" "unprognostic (1.23e-1)" "unprognostic (3.18e-2)" 5.7 6.6 5.8 6.0 6.2 4.2 6.9 2.6 4.5 3.8 11.8 5.9 9.9 13.9 4.8 6.6 6.3 3.9 9.1 19.6 5.1 4.1 17.8 30.9 3.8 3.4 6.1 4.9 9.1 13.4 6.6 3.5 3.1 7.8 6.2 7.1 13.5 8.1 8.2 17.1 5.8 19.7 5.0 4.7 3.5 5.7 2.7 7.1 1.3 5.4 10.4 4.8 7.3 12.3 1.5 3.8 12.1 1.4 0.9 1.5 0.3 6.9 1.7 2.2 7.7 12.4 8.0 4.9 6.1 12.1 6.6 6.8 3.4 3.4 2.5 3.1 14.1 6.0 3.1 6.5 8.0 5.9 7.2 8.3 7.7 4.4 7.1 7.7 5.3 13.3 6.3 6.4 4.8 11.1 5.6 1.4 5.7 2.8 5.8 6.1 1.8 6.0 1.9 0.3 5.8 1.7 7.1 8.0 3.2 4.5 4.1 2.2 6.6 2.3 2.2 7.7 3.2 2.5 4.1 2.3 6.8 7.4 6.2 2.6 5.9 3.4 1.0 10.7 6.0 2.1 1.7 1.0 12.1 1.4 1.4 1.2 1.0 0.7 0.7 0.7 1.5 0.8 0.6 0.8 0.9 0.8 3.8 1.5 0.3 5.8 6.2 2.6 4.5 5.1 4.1 6.1 4.9 7.8 7.1 3.0 9.9 5.2 13.1 20.7 14.7 84.0 25.5 2.7 7.9 7.0 58.9 6.8 8.3 7.2 0.4 16.1 66.1 93.5 14.3 5.4 13.0 13.9 4.7 134.7 7.4 4.8 19.1 20.9 22.5 0.4 18.1 9.6 3.3 11.8 34.6 15.2 11.6 24.6 28.3 36.9 152.6 6.5 14.4 0.7 1.7 29.9 2.5 7.5 31.6 17.9 PPARGC1A "PGC-1alpha, PGC1, PGC1A, PPARGC1" ENSG00000109819 "PPARG coactivator 1 alpha" Q9UBK2 4 23755041-23904089 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Activator, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 49.5;liver: 49.7;skeletal muscle: 55.6" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 81.8;Cholangiocytes: 66.2;Early spermatids: 52.7;Hepatocytes: 48.9;Late spermatids: 51.4" "Cancer enhanced" "Detected in many" "renal cancer: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "A-431: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063136 Supported Nucleoplasm NA NA Nucleoplasm "HPA063136: AB_2684948" "unprognostic (1.08e-1)" "unprognostic (7.47e-2)" "unprognostic (6.85e-3)" "unprognostic (2.28e-6)" "unprognostic (5.00e-2)" "unprognostic (1.15e-1)" "prognostic favorable (3.35e-6)" "unprognostic (3.04e-1)" "unprognostic (1.79e-1)" "unprognostic (1.69e-1)" "unprognostic (6.77e-2)" "unprognostic (4.58e-2)" "prognostic favorable (1.49e-14)" "unprognostic (3.62e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (5.80e-4)" "unprognostic (3.07e-3)" 5.7 2.4 3.1 2.4 4.2 0.3 1.3 4.7 5.5 2.6 9.4 4.2 1.8 5.7 0.9 4.8 3.0 1.2 2.2 24.6 3.3 3.1 49.5 49.7 2.5 0.4 3.1 1.8 1.3 2.8 14.6 7.6 0.3 7.8 2.6 6.6 14.0 30.4 3.0 55.6 5.5 14.2 1.6 3.2 0.8 3.1 3.4 3.4 0.3 17.4 18.2 1.5 1.7 1.0 0.0 0.0 0.2 0.6 0.0 0.0 0.3 43.9 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 2.1 5.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 3.5 0.0 0.0 0.3 0.0 6.3 0.0 2.1 0.1 1.4 0.0 1.8 2.2 0.2 0.7 0.0 0.4 0.4 0.0 0.8 3.9 0.0 0.0 0.8 0.7 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.1 4.2 4.7 5.5 3.3 3.1 3.1 1.8 7.8 3.4 17.9 1.6 1.7 5.5 0.8 3.8 81.8 66.2 8.1 6.8 34.9 37.3 0.0 44.7 6.6 52.7 0.3 26.8 0.0 0.0 0.0 0.2 1.4 1.1 48.9 0.0 0.0 25.6 1.8 2.4 51.4 0.9 0.0 6.8 0.0 13.0 5.8 0.9 7.0 2.1 22.6 0.7 0.0 5.1 0.7 0.2 1.0 0.0 1.0 10.8 0.4 PPIL2 "CYC4, Cyp-60, UBOX7" ENSG00000100023 "Peptidylprolyl isomerase like 2" Q13356 22 21666009-21700015 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "K-562: 71.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035344, HPA055637" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035344: AB_10672863, HPA055637: AB_2682869" "unprognostic (1.97e-3)" "unprognostic (3.61e-2)" "unprognostic (2.70e-2)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (2.90e-3)" "unprognostic (5.16e-3)" "unprognostic (3.77e-2)" "unprognostic (9.46e-2)" "unprognostic (1.54e-1)" "unprognostic (2.33e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-3)" "unprognostic (5.46e-2)" "unprognostic (5.39e-2)" "unprognostic (5.39e-2)" "unprognostic (1.54e-3)" 15.0 21.5 19.4 20.9 24.6 16.6 13.5 24.1 30.9 17.7 17.4 25.3 19.1 18.6 21.8 17.0 22.3 15.7 16.5 20.0 17.2 17.1 21.2 20.3 14.6 23.7 15.6 20.9 16.6 31.4 23.6 30.2 31.4 19.0 19.5 17.6 23.6 22.0 16.5 25.5 17.5 19.1 15.2 15.0 21.3 19.5 18.4 17.6 32.8 27.0 13.6 33.5 17.4 16.2 8.7 11.7 4.8 17.3 12.8 13.2 9.1 6.6 6.9 8.1 8.5 8.3 7.1 7.3 8.7 6.2 10.7 9.2 7.0 4.4 11.5 5.3 9.7 5.4 9.8 10.8 7.5 6.4 7.1 11.1 10.7 6.9 8.3 6.0 16.9 10.1 7.7 6.8 7.6 5.8 6.5 9.2 7.3 71.2 8.3 7.6 10.4 7.6 4.6 7.8 12.4 4.3 9.8 12.0 2.3 5.4 6.7 12.7 6.9 7.9 12.7 2.9 5.0 9.1 5.7 11.1 6.7 11.0 7.9 5.5 9.6 7.0 8.7 7.6 6.4 8.1 1.0 8.6 4.7 9.5 13.9 11.4 7.0 11.1 12.0 11.7 8.7 9.8 8.9 4.8 12.8 17.3 11.1 13.2 9.1 19.4 24.6 24.1 30.9 17.2 17.1 15.6 20.9 19.0 17.6 8.9 25.6 20.6 7.3 2.9 22.7 4.0 30.6 6.7 17.0 14.0 31.4 13.2 11.6 10.6 57.9 5.4 16.9 0.0 14.6 12.4 5.7 12.9 16.2 16.6 13.2 17.5 10.9 11.1 24.4 67.5 11.2 14.4 1.7 10.0 20.5 12.3 15.0 17.3 12.7 7.0 29.8 0.0 4.4 18.6 16.3 5.0 18.5 15.9 18.4 10.3 PPM1G "PP2CG, PP2Cgamma" ENSG00000115241 "Protein phosphatase, Mg2+/Mn2+ dependent 1G" O15355 2 27381194-27409687 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 93.3" "Cell type enhanced" "Detected in all" 17 "Early spermatids: 1236.5;Late spermatids: 2467.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035530, HPA035531" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035530: AB_10670021, HPA035531: AB_10610283" "unprognostic (7.50e-2)" "unprognostic (8.89e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-1)" "unprognostic (2.27e-1)" "unprognostic (4.15e-2)" "prognostic unfavorable (3.14e-7)" "unprognostic (9.36e-3)" "unprognostic (7.73e-2)" "prognostic favorable (6.08e-5)" "unprognostic (3.74e-2)" "unprognostic (1.23e-1)" "unprognostic (7.46e-3)" "unprognostic (1.06e-2)" "unprognostic (5.33e-2)" "unprognostic (1.78e-1)" "unprognostic (7.83e-2)" 12.7 17.0 9.9 19.9 9.2 19.4 30.2 10.9 19.3 17.9 14.6 9.1 16.9 12.1 26.8 12.5 19.4 19.2 17.7 13.6 8.8 7.6 12.6 18.6 14.7 20.2 9.4 8.0 13.4 18.6 13.8 13.2 11.4 8.7 10.2 16.4 9.1 16.4 18.7 24.1 10.9 12.2 14.9 6.7 14.7 14.1 93.3 8.4 25.8 14.1 19.1 22.5 25.2 17.3 20.2 40.3 24.5 29.1 22.7 38.3 19.0 50.9 42.1 30.9 23.7 19.7 16.1 28.5 31.8 20.9 38.2 30.7 64.8 27.0 60.2 23.4 22.5 32.5 27.9 51.9 35.7 34.4 25.1 42.2 58.6 30.7 68.4 17.8 57.8 24.8 17.4 20.7 38.9 31.4 18.2 36.5 29.9 49.0 18.7 28.9 45.6 42.9 62.8 44.9 35.4 30.4 44.4 64.8 31.6 25.8 35.6 41.6 47.1 28.5 31.6 22.8 25.6 17.5 19.0 29.3 28.6 34.6 25.0 48.2 40.8 45.7 95.2 22.4 47.4 21.4 22.1 17.8 24.5 26.9 22.3 26.5 20.2 28.7 27.9 28.5 18.0 21.7 22.4 9.1 22.7 29.1 40.3 38.3 19.0 9.9 9.2 10.9 19.3 8.8 7.6 9.4 8.0 8.7 8.4 59.6 43.5 61.1 65.0 72.0 42.0 33.6 50.9 61.6 66.0 66.3 27.5 71.4 28.2 97.8 1236.5 66.3 54.6 23.3 120.2 139.9 42.7 66.0 58.8 37.8 76.1 46.1 77.4 35.6 49.4 2467.5 65.0 65.1 23.6 147.9 59.6 64.9 122.3 42.1 66.8 48.3 34.6 45.3 45.8 594.3 323.3 70.4 44.4 79.7 83.2 121.2 PPM1H "ARHCL1, FLJ13253, KIAA1157, NERPP-2C" ENSG00000111110 "Protein phosphatase, Mg2+/Mn2+ dependent 1H" Q9ULR3 12 62643982-62935037 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.1;parathyroid gland: 36.6" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.3" "Group enriched" "Detected in many" 11 "dendritic cells: 2.3;granulocytes: 5.3;monocytes: 1.7" "Cell line enhanced" "Detected in many" "CACO-2: 35.9;HMC-1: 29.0;SK-BR-3: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020694, HPA044244, HPA058777" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB020694: , HPA044244: AB_2678871, HPA058777: AB_2683816" "unprognostic (3.41e-2)" "unprognostic (1.94e-1)" "unprognostic (9.51e-2)" "unprognostic (8.61e-3)" "unprognostic (1.44e-1)" "unprognostic (1.23e-1)" "unprognostic (1.86e-2)" "unprognostic (5.85e-2)" "unprognostic (3.17e-1)" "unprognostic (1.78e-2)" "unprognostic (5.53e-3)" "unprognostic (2.19e-1)" "prognostic favorable (2.72e-5)" "unprognostic (3.90e-2)" "unprognostic (1.73e-1)" "unprognostic (8.04e-3)" "unprognostic (1.14e-1)" 2.6 2.1 10.6 1.6 12.4 3.1 5.7 37.1 16.3 8.5 2.8 14.0 12.4 3.6 6.9 7.7 1.1 7.5 9.1 2.2 13.0 12.2 11.7 3.9 3.2 1.5 14.3 9.0 9.4 4.9 36.6 13.3 7.1 8.5 15.0 3.6 7.7 10.2 11.6 1.5 1.2 2.1 2.2 8.9 1.3 6.2 1.4 15.0 0.5 3.8 0.1 2.1 3.4 1.2 0.0 2.3 5.3 1.7 0.2 0.0 0.3 0.5 5.6 1.0 0.0 0.2 0.0 12.2 1.3 1.3 0.8 0.2 35.9 2.6 0.0 1.2 0.6 0.8 0.7 3.9 0.1 0.5 0.1 1.9 6.7 1.0 8.1 0.0 2.0 29.0 0.0 0.1 0.0 0.3 0.8 0.1 1.2 1.7 0.0 0.6 4.1 0.6 0.9 7.3 1.8 2.7 0.9 2.5 10.0 8.3 12.7 3.2 0.0 2.2 16.4 5.3 4.1 8.9 1.2 0.1 0.2 0.7 0.1 0.4 1.5 9.2 1.8 0.1 0.0 0.5 5.3 1.7 3.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.2 0.2 1.4 0.0 0.0 0.3 10.6 12.4 37.1 16.3 13.0 12.2 14.3 9.0 8.5 15.0 6.0 6.6 0.0 0.1 0.1 7.9 1.4 15.3 5.3 1.2 15.7 25.5 18.6 3.3 4.1 8.8 1.4 0.1 0.0 5.5 1.3 1.1 4.6 13.9 4.9 5.4 11.1 8.6 12.3 3.0 8.0 0.9 0.7 3.3 1.8 2.2 6.0 4.6 2.5 1.4 5.7 10.6 0.0 0.0 0.0 0.1 0.1 5.7 0.0 2.4 0.4 PPP1R26 KIAA0649 ENSG00000196422 "Protein phosphatase 1 regulatory subunit 26" Q5T8A7 9 135479079-135488893 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044686, HPA063817" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044686: AB_10795987, HPA063817: " "unprognostic (1.79e-1)" "unprognostic (8.80e-3)" "prognostic unfavorable (3.98e-4)" "prognostic favorable (9.91e-4)" "unprognostic (2.67e-1)" "unprognostic (1.21e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-2)" "unprognostic (1.50e-1)" "unprognostic (2.38e-1)" "prognostic favorable (6.93e-4)" "unprognostic (9.23e-2)" "prognostic favorable (6.20e-13)" "unprognostic (4.46e-3)" "unprognostic (8.31e-2)" "unprognostic (3.94e-1)" "unprognostic (2.07e-3)" 5.2 6.2 13.8 3.0 10.1 1.0 8.4 3.0 18.2 6.0 6.4 6.9 12.4 7.9 5.0 6.4 5.1 9.0 8.1 11.3 13.2 10.2 8.1 6.6 8.9 2.1 8.3 9.6 7.5 12.5 22.9 11.9 5.4 9.1 7.4 4.4 8.9 13.3 10.8 6.9 4.0 8.0 8.1 5.7 4.7 11.4 6.1 7.3 1.1 8.2 2.8 4.5 7.4 3.7 0.6 1.7 3.0 1.3 2.6 0.6 0.4 6.7 10.2 5.5 5.6 2.3 2.0 0.0 3.7 5.1 5.1 3.4 9.9 11.8 0.0 7.1 3.6 13.0 25.3 5.0 4.8 1.7 0.3 5.6 0.1 15.4 7.3 5.5 3.3 12.6 1.4 9.0 2.5 6.3 5.6 3.2 0.0 6.7 0.0 2.9 15.4 0.1 1.0 8.0 13.9 14.1 0.0 9.6 11.2 4.9 9.1 8.4 12.4 6.6 9.3 6.9 4.5 7.1 3.0 3.8 1.9 8.6 9.1 4.2 5.2 12.3 0.2 4.0 0.6 4.8 0.0 1.3 3.0 0.4 0.4 0.0 0.6 0.2 0.0 1.7 0.4 0.0 0.0 0.3 2.6 0.6 0.3 0.6 0.4 13.8 10.1 3.0 18.2 13.2 10.2 8.3 9.6 9.1 7.3 3.0 4.8 0.0 2.0 1.9 10.1 7.3 17.8 2.7 2.3 7.0 7.9 0.4 5.0 5.2 0.2 2.3 5.2 0.0 2.9 0.7 2.3 4.1 2.3 4.9 4.8 1.6 6.3 4.3 2.4 0.0 1.1 1.1 3.3 0.0 9.7 7.2 6.1 7.0 1.8 3.9 7.7 0.0 1.7 0.3 3.6 1.5 0.2 0.0 6.5 2.3 PPP1R35 "C7orf47, MGC22793" ENSG00000160813 "Protein phosphatase 1 regulatory subunit 35" Q8TAP8 7 100435282-100436565 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 129.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021604, HPA051607" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA021604: AB_2670774, HPA051607: AB_2681548" "unprognostic (2.17e-3)" "unprognostic (2.17e-1)" "unprognostic (7.40e-3)" "unprognostic (1.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.15e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (6.99e-2)" "unprognostic (1.20e-1)" "unprognostic (6.77e-2)" "unprognostic (5.17e-2)" "unprognostic (1.85e-3)" "unprognostic (1.40e-1)" "unprognostic (9.51e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.97e-4)" 5.3 12.0 4.4 12.5 5.6 8.8 5.9 9.7 8.7 9.9 9.6 3.6 7.2 12.8 7.1 6.1 7.4 6.3 7.2 5.4 4.2 4.1 7.4 11.1 5.6 14.4 3.9 7.1 10.6 12.4 7.4 7.9 7.9 4.8 7.7 2.8 7.4 10.6 6.8 7.0 7.7 11.2 6.8 3.6 20.8 8.8 32.2 2.6 20.3 8.6 4.5 10.7 7.6 6.1 4.6 6.8 12.1 2.0 2.7 6.8 2.5 16.0 6.9 4.9 8.6 1.6 1.6 6.3 4.4 4.8 3.7 4.3 2.6 16.5 5.2 7.9 2.6 18.8 5.2 2.5 4.3 0.7 11.4 6.4 5.2 4.9 6.2 6.8 4.5 6.9 3.1 7.7 3.3 5.0 6.0 7.6 18.4 7.4 10.7 4.7 15.3 13.3 21.9 9.6 7.4 9.3 3.6 1.8 15.7 4.8 4.4 4.6 11.5 4.0 28.0 12.7 3.0 8.4 12.9 5.9 5.5 6.5 6.3 11.2 12.4 6.9 6.9 6.1 7.9 11.0 12.1 2.0 4.5 5.2 0.8 5.6 3.5 5.3 6.0 1.7 4.6 3.1 3.0 9.3 2.7 0.5 6.8 6.8 2.5 4.4 5.6 9.7 8.7 4.2 4.1 3.9 7.1 4.8 2.6 14.9 8.1 24.8 32.5 18.7 33.7 1.6 20.4 10.7 2.3 45.4 7.9 56.3 44.7 6.8 7.0 20.0 21.1 0.0 8.7 34.2 11.4 31.9 8.1 13.9 14.4 46.1 17.9 8.0 6.5 4.7 16.7 17.8 16.9 13.6 25.2 25.5 9.8 26.8 8.9 33.9 36.2 12.9 13.3 129.2 24.3 29.2 28.4 28.7 24.7 37.5 PPP2CB PP2Abeta ENSG00000104695 "Protein phosphatase 2 catalytic subunit beta" P62714 8 30774457-30814314 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 248.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018600, HPA043236" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB018600: AB_675841, HPA043236: AB_2678379" "unprognostic (9.77e-2)" "unprognostic (1.30e-1)" "unprognostic (2.51e-2)" "unprognostic (3.82e-1)" "unprognostic (6.70e-2)" "unprognostic (7.79e-2)" "unprognostic (1.13e-2)" "unprognostic (3.51e-1)" "unprognostic (2.28e-1)" "unprognostic (2.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.89e-2)" "prognostic favorable (5.82e-7)" "unprognostic (9.24e-2)" "unprognostic (2.04e-1)" "unprognostic (1.39e-1)" "unprognostic (2.65e-3)" 26.7 21.0 61.3 11.9 54.9 2.6 28.7 32.0 46.2 28.8 24.1 30.7 19.4 21.7 34.5 37.5 29.7 28.2 23.1 27.2 57.3 43.7 41.0 35.7 27.7 8.4 52.6 39.8 48.0 22.9 33.7 14.8 27.4 47.7 23.7 24.5 12.5 19.5 29.1 27.4 18.0 31.2 39.0 49.7 15.0 18.9 18.8 48.2 6.3 44.5 14.0 14.0 17.7 34.3 5.8 7.9 5.1 6.5 7.3 4.8 1.7 22.1 19.4 33.9 12.9 33.9 30.9 18.9 29.7 27.8 30.8 32.3 20.3 16.3 10.8 29.2 39.5 29.5 13.4 20.2 34.1 41.6 6.7 10.6 14.4 13.2 20.4 38.9 6.4 8.2 27.2 39.0 26.0 29.2 31.3 36.9 18.1 22.3 11.5 51.9 10.9 17.5 8.2 24.7 33.5 11.2 12.3 13.6 8.0 41.2 18.0 32.6 13.5 13.7 14.6 28.6 39.5 8.0 11.0 38.7 26.6 20.0 8.7 24.5 5.9 7.7 12.8 22.8 6.0 34.0 4.8 5.0 3.3 4.2 6.5 4.8 5.8 3.8 4.2 3.5 2.7 3.8 4.6 5.1 7.3 3.0 7.9 2.8 1.7 61.3 54.9 32.0 46.2 57.3 43.7 52.6 39.8 47.7 48.2 65.5 53.8 13.8 81.2 92.5 34.5 71.2 40.8 34.8 50.0 82.0 29.5 36.8 39.7 34.2 13.3 49.6 112.3 0.0 42.0 43.1 62.0 108.1 17.3 81.5 48.8 44.5 31.0 101.3 52.3 13.4 67.9 30.8 38.8 16.2 51.0 105.4 64.5 41.8 248.2 63.4 21.1 45.3 59.7 30.2 35.8 83.6 59.0 14.0 32.4 132.7 PPP4R1 PP4R1 ENSG00000154845 "Protein phosphatase 4 regulatory subunit 1" Q8TF05 18 9546791-9615240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 23.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 23.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040905, HPA041089" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA040905: AB_10794869, HPA041089: AB_10805836" "unprognostic (1.76e-1)" "unprognostic (5.33e-2)" "unprognostic (1.40e-2)" "unprognostic (5.14e-2)" "unprognostic (3.74e-1)" "unprognostic (3.63e-1)" "unprognostic (1.14e-3)" "unprognostic (9.36e-2)" "unprognostic (1.16e-2)" "unprognostic (4.00e-3)" "unprognostic (3.13e-3)" "unprognostic (4.15e-1)" "unprognostic (7.06e-3)" "unprognostic (1.45e-1)" "unprognostic (2.76e-1)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" 18.0 11.1 9.6 10.7 11.4 16.5 25.1 11.6 12.4 17.7 22.0 13.0 15.5 13.7 16.1 14.5 46.2 13.1 14.3 12.2 9.9 8.9 13.5 12.9 26.7 14.8 9.9 7.8 12.1 20.5 15.9 9.3 28.1 10.3 13.1 12.2 10.1 15.8 13.8 12.8 16.3 25.5 18.1 11.1 15.3 14.4 24.2 11.9 9.4 12.1 28.2 25.3 16.8 21.6 2.5 4.6 23.9 3.9 2.5 3.5 2.0 23.5 16.6 40.3 11.0 8.0 12.2 20.5 23.0 15.5 22.8 22.1 15.1 13.7 11.4 16.9 22.5 19.4 10.1 18.6 34.1 30.9 13.3 7.5 10.8 12.3 10.8 12.5 27.6 16.4 10.8 22.1 19.7 18.7 17.1 26.0 7.7 15.7 10.4 24.6 11.9 19.2 10.6 16.1 32.9 10.5 24.0 24.3 7.1 19.2 33.2 11.8 14.0 27.3 12.3 8.9 27.0 6.7 10.6 27.8 40.3 25.0 20.7 28.2 9.3 12.9 20.8 15.1 11.5 18.2 7.2 3.9 6.7 2.7 3.1 3.5 2.5 2.9 2.7 4.6 1.4 1.0 2.3 23.9 2.5 3.0 1.9 3.0 2.0 9.6 11.4 11.6 12.4 9.9 8.9 9.9 7.8 10.3 11.9 92.3 66.2 7.2 26.1 35.8 18.3 18.2 5.1 53.5 71.7 21.0 9.8 21.9 5.0 21.0 75.8 28.5 19.5 0.0 30.2 13.6 16.7 18.7 3.5 11.5 14.4 31.8 16.7 28.8 16.5 46.4 16.1 14.5 13.5 9.0 14.6 11.2 35.6 10.5 11.0 7.9 20.2 12.9 14.0 13.7 10.7 37.1 19.2 9.5 13.1 57.2 PPP4R2 ENSG00000163605 "Protein phosphatase 4 regulatory subunit 2" Q9NY27 3 72996785-73069199 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034695, HPA039837, HPA073758" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA034695: AB_10671231, HPA039837: AB_2676707, HPA073758: AB_2686632" "unprognostic (4.60e-2)" "unprognostic (2.75e-1)" "unprognostic (3.98e-3)" "unprognostic (5.62e-2)" "unprognostic (8.86e-2)" "unprognostic (4.64e-2)" "unprognostic (2.38e-1)" "unprognostic (1.95e-1)" "unprognostic (1.11e-1)" "unprognostic (2.13e-3)" "unprognostic (1.87e-2)" "unprognostic (2.86e-3)" "unprognostic (1.67e-2)" "unprognostic (4.63e-2)" "unprognostic (1.71e-1)" "unprognostic (1.23e-1)" "unprognostic (3.35e-1)" 16.7 19.6 18.3 17.2 25.9 57.7 17.7 18.0 23.4 19.7 17.5 15.7 10.7 16.1 18.0 13.2 15.9 18.7 15.6 24.5 18.6 14.2 15.8 34.0 17.6 15.8 30.8 14.8 24.0 15.1 21.0 20.2 28.5 20.5 14.3 16.2 13.4 16.1 12.0 27.2 12.1 18.1 15.9 20.8 17.1 14.0 17.0 25.8 28.4 17.1 9.8 16.5 14.4 18.8 7.1 14.3 17.7 4.7 8.5 13.6 3.2 12.6 14.8 31.7 19.3 17.0 15.0 19.2 25.3 17.9 23.1 24.2 21.6 15.2 23.7 14.8 15.2 22.0 9.0 24.6 14.1 30.0 36.1 9.2 26.9 16.7 25.5 18.6 39.0 28.1 16.1 21.0 27.8 22.8 16.1 16.4 24.5 23.7 27.4 19.0 18.3 32.4 17.4 29.1 18.8 12.3 30.5 17.9 22.0 19.4 33.8 7.6 18.9 29.5 19.5 23.4 24.1 17.8 22.2 17.9 20.8 25.0 23.8 21.5 17.1 35.0 46.9 14.6 30.2 23.2 5.4 4.7 10.7 10.6 2.6 11.7 5.5 10.9 10.9 4.0 7.1 9.6 8.7 17.7 8.5 4.1 14.3 13.6 3.2 18.3 25.9 18.0 23.4 18.6 14.2 30.8 14.8 20.5 25.8 53.6 23.0 41.6 103.2 104.1 49.6 47.9 48.4 57.6 52.4 26.2 13.7 62.2 16.6 53.0 36.6 47.4 48.4 46.7 46.6 59.6 54.0 103.0 29.0 63.5 37.8 47.7 51.6 33.2 36.2 6.8 49.5 45.3 54.0 37.9 52.8 50.0 57.3 56.9 45.6 38.3 34.0 38.8 45.8 101.1 66.9 95.4 115.7 31.6 45.2 114.6 PPRC1 "KIAA0595, MGC74642, PRC" ENSG00000148840 "Peroxisome proliferator-activated receptor gamma, coactivator-related 1" Q5VV67 10 102132994-102150331 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 39.4;Suprabasal keratinocytes: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038511, HPA057571" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038511: AB_10672521, HPA057571: AB_2683472" "unprognostic (2.27e-1)" "unprognostic (7.66e-2)" "unprognostic (2.35e-2)" "unprognostic (4.77e-2)" "unprognostic (1.63e-1)" "unprognostic (4.96e-2)" "unprognostic (4.29e-3)" "unprognostic (6.31e-2)" "unprognostic (3.95e-2)" "unprognostic (1.26e-1)" "unprognostic (2.33e-1)" "unprognostic (2.86e-1)" "prognostic unfavorable (6.71e-7)" "unprognostic (8.65e-2)" "unprognostic (4.22e-1)" "unprognostic (1.12e-1)" "unprognostic (4.93e-2)" 18.9 12.0 10.0 20.2 12.3 18.1 14.2 13.1 12.2 13.4 15.6 9.5 9.7 9.1 17.4 10.1 18.4 16.2 14.2 14.4 9.3 6.1 10.3 18.0 18.9 14.2 15.0 7.8 25.4 35.6 13.5 13.1 15.3 10.4 14.2 9.8 10.0 12.6 9.7 32.8 19.6 11.3 17.0 9.7 14.7 14.8 11.5 11.4 13.2 12.2 15.9 19.3 14.2 15.4 4.0 4.6 0.3 2.4 7.6 4.6 2.2 13.3 20.0 12.3 24.6 11.0 11.3 15.8 12.0 16.2 17.3 14.4 22.4 15.4 29.2 10.1 18.0 10.9 25.2 25.0 23.8 15.3 11.9 19.5 27.7 14.3 21.5 14.8 21.8 12.1 15.0 21.4 20.2 38.5 11.5 10.7 12.0 20.6 17.3 13.6 22.9 17.4 30.5 21.1 12.7 11.9 24.4 17.5 12.4 14.8 13.3 8.5 12.4 10.2 11.4 14.3 12.4 18.4 11.5 11.7 13.8 17.5 14.0 26.9 14.5 10.2 26.3 15.6 27.4 6.9 0.0 2.1 0.3 3.6 2.4 4.6 3.1 2.8 4.4 4.6 4.0 3.3 4.1 0.1 7.6 2.3 1.9 1.7 2.2 10.0 12.3 13.1 12.2 9.3 6.1 15.0 7.8 10.4 11.4 26.8 10.4 12.2 29.1 39.4 4.5 7.4 5.1 2.7 12.5 5.2 3.9 6.7 1.7 7.4 0.7 10.5 3.3 0.0 8.3 10.5 11.3 19.5 10.4 7.3 7.7 1.6 8.1 8.6 3.5 1.8 5.8 8.5 8.5 2.8 9.1 2.0 10.6 5.8 6.0 2.2 3.4 6.5 17.6 6.4 11.8 38.0 4.2 5.3 8.1 30.1 PQLC1 FLJ22378 ENSG00000122490 "PQ loop repeat containing 1" Q8N2U9 18 79902420-79951664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 150.7;Late spermatids: 119.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051666 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051666: AB_2681567" "unprognostic (6.03e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-1)" "unprognostic (6.45e-2)" "unprognostic (3.94e-2)" "unprognostic (2.07e-2)" "unprognostic (1.39e-1)" "unprognostic (2.47e-1)" "unprognostic (2.50e-1)" "unprognostic (4.58e-2)" "unprognostic (1.02e-2)" "unprognostic (4.34e-1)" "unprognostic (1.40e-3)" "unprognostic (2.00e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.70e-2)" 31.3 12.5 17.4 12.4 16.6 28.3 23.0 12.5 27.0 9.4 16.9 12.3 9.6 8.9 13.4 12.0 20.0 10.8 13.2 13.8 21.3 12.6 16.5 56.7 14.3 14.2 13.0 13.8 9.9 23.8 8.0 8.5 9.5 14.2 10.8 7.1 19.9 21.4 10.1 29.6 19.2 10.0 12.4 7.5 14.0 10.1 22.9 9.7 8.7 25.8 14.4 13.6 11.7 15.8 1.7 7.2 3.8 3.8 2.0 2.5 1.9 16.5 5.7 5.8 11.3 13.1 8.5 8.0 10.9 7.5 8.8 8.3 7.5 9.0 6.9 4.3 9.8 5.1 17.0 8.0 11.6 2.3 21.5 11.7 8.8 8.0 20.2 15.7 20.9 22.3 9.4 11.6 8.0 3.1 4.5 7.5 7.7 3.3 5.7 4.5 12.6 10.3 22.5 1.9 2.2 15.5 18.5 6.1 11.6 5.9 11.9 17.3 7.8 8.2 10.5 12.0 1.6 6.2 23.0 9.4 13.4 13.8 7.1 8.2 3.0 4.6 9.0 10.3 25.5 5.9 0.7 3.8 3.8 1.7 3.8 1.0 1.7 1.7 0.8 4.0 1.5 2.1 2.5 2.5 2.0 3.1 7.2 1.5 1.9 17.4 16.6 12.5 27.0 21.3 12.6 13.0 13.8 14.2 9.7 23.8 16.5 28.9 22.8 35.4 28.8 10.5 15.3 4.0 6.8 5.2 70.7 11.6 1.7 8.6 85.6 20.5 37.1 0.0 12.8 11.6 14.5 23.0 19.5 150.7 31.2 87.4 15.5 18.4 32.9 119.4 18.4 20.5 18.6 7.2 29.7 21.7 13.1 35.1 22.3 16.5 33.4 6.5 19.8 8.6 10.2 44.2 17.4 8.6 26.2 38.7 PRAMEF12 ENSG00000116726 "PRAME family member 12" O95522 1 12774841-12777906 "Plasma proteins, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.8" "HPA045286, HPA051704" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045286: AB_10794782, HPA051704: AB_2681581" "unprognostic (6.60e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRDM12 ENSG00000130711 "PR/SET domain 12" Q9H4Q4 9 130664594-130682981 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "RH-30: 19.4" "Region enriched" "Detected in single" 7 "basal ganglia: 11.2" "Group enriched" "Detected in some" 33 "basal ganglia: 6.1;hypothalamus: 2.0" HPA043143 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA043143: AB_10806379" "unprognostic (3.25e-2)" "unprognostic (2.32e-1)" "unprognostic (3.40e-1)" "unprognostic (1.81e-4)" "unprognostic (7.90e-2)" "unprognostic (4.75e-3)" "unprognostic (2.48e-3)" "unprognostic (4.18e-2)" "unprognostic (4.61e-1)" "unprognostic (2.70e-1)" "unprognostic (6.43e-2)" "unprognostic (7.58e-2)" "unprognostic (4.03e-3)" "unprognostic (3.01e-2)" "unprognostic (4.79e-2)" "unprognostic (6.30e-4)" "unprognostic (1.40e-1)" 0.1 0.7 1.0 0.3 1.5 0.0 0.1 1.1 2.2 0.0 0.1 0.3 0.0 0.9 0.0 0.0 0.0 0.0 1.0 3.7 0.0 0.2 0.0 0.0 0.5 0.0 0.8 0.1 0.2 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.4 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.1 0.0 0.2 0.3 0.2 0.1 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.9 0.0 0.8 0.0 0.1 0.1 0.0 19.4 0.5 0.0 0.0 0.9 0.3 0.4 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 PRDM14 ENSG00000147596 "PR/SET domain 14" Q9GZV8 8 70051651-70071693 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 658 "testis cancer: 34.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 57 "NTERA-2: 33.7;SuSa: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019094, HPA057070" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA019094: AB_1855686, HPA057070: AB_2683327" "unprognostic (5.86e-2)" "unprognostic (9.32e-2)" "unprognostic (6.14e-3)" "unprognostic (1.37e-2)" "unprognostic (8.62e-2)" 0.2 0.2 0.2 0.2 0.2 1.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.4 1.1 0.2 0.3 0.2 1.1 0.2 0.2 0.5 0.2 0.5 0.2 0.2 0.2 0.5 0.2 0.3 0.3 0.2 0.2 0.2 0.1 1.7 0.3 0.2 0.4 1.2 0.2 0.2 0.2 0.6 0.3 5.4 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.6 1.0 1.4 1.6 1.0 2.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 9.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.5 0.6 1.0 0.4 0.8 1.4 1.1 0.7 0.3 1.6 2.5 1.9 1.4 1.0 1.6 1.0 0.4 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 PRDM16 "KIAA1675, KMT8F, MEL1, MGC166915, PFM13" ENSG00000142611 "PR/SET domain 16" Q9HAZ2 1 3069168-3438621 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 32.8;Cholangiocytes: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "NK-cell: 5.4" "Lineage enriched" "Detected in single" 13 "NK-cells: 5.4" "Cell line enhanced" "Detected in some" "AN3-CA: 2.5;HEK 293: 2.9;HHSteC: 3.4;hTERT-RPE1: 11.5;MCF7: 2.6;OE19: 5.7" "Region enriched" "Detected in many" 5 "basal ganglia: 16.1" "Low region specificity" "Detected in many" "HPA050343, HPA060467" Supported Nucleoplasm NA NA Nucleoplasm "HPA050343: AB_2681099, HPA060467: AB_2684287" "unprognostic (2.44e-1)" "unprognostic (1.44e-1)" "unprognostic (5.31e-4)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "unprognostic (3.95e-2)" "unprognostic (9.15e-3)" "unprognostic (5.68e-4)" "unprognostic (2.58e-1)" "unprognostic (2.07e-2)" "unprognostic (5.21e-2)" "unprognostic (1.71e-1)" "unprognostic (7.80e-6)" "unprognostic (2.14e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (4.70e-5)" "unprognostic (4.06e-2)" 2.7 0.7 5.3 1.4 5.6 0.5 1.6 0.5 4.7 2.1 6.2 3.3 12.8 14.1 1.5 4.5 1.1 2.0 11.7 5.1 5.2 1.9 7.0 0.6 4.2 1.4 2.9 3.1 3.6 12.7 1.2 1.1 0.6 3.3 1.1 0.9 16.1 1.3 15.0 1.2 0.9 8.0 1.5 2.5 4.2 14.8 1.4 4.8 0.0 10.7 0.0 0.9 1.1 1.5 0.3 0.1 0.0 0.0 5.4 0.4 0.0 0.0 0.0 0.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.4 0.5 0.0 0.4 0.0 0.4 0.0 2.2 0.0 0.0 0.2 2.9 0.0 0.0 0.5 3.4 0.0 1.2 0.0 0.0 0.0 0.0 11.5 0.0 0.2 0.0 0.0 0.0 2.6 0.2 0.0 0.3 5.7 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 5.4 0.0 0.0 0.0 0.0 5.3 5.6 0.5 4.7 5.2 1.9 2.9 3.1 3.3 4.8 32.8 8.0 0.0 0.2 0.6 0.0 4.8 17.8 2.7 9.1 7.0 0.0 0.0 5.0 7.6 0.0 0.7 0.0 0.0 4.3 2.9 0.0 0.3 0.0 0.0 0.0 1.6 5.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 1.3 5.3 0.0 1.8 0.2 0.0 0.0 5.3 0.2 1.1 0.0 0.0 0.0 1.2 0.1 PRDM4 PFM1 ENSG00000110851 "PR/SET domain 4" Q9UKN5 12 107732866-107761272 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024322, HPA067437" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA024322: AB_1855691, HPA067437: AB_2685839" "unprognostic (4.64e-2)" "unprognostic (3.16e-3)" "unprognostic (1.73e-3)" "unprognostic (2.35e-1)" "unprognostic (1.94e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.86e-4)" "unprognostic (1.11e-3)" "prognostic unfavorable (7.66e-4)" "unprognostic (9.64e-2)" "unprognostic (9.06e-3)" "unprognostic (5.31e-2)" "prognostic favorable (3.15e-7)" "unprognostic (9.24e-2)" "unprognostic (1.09e-1)" "unprognostic (1.59e-1)" "unprognostic (2.62e-3)" 13.5 9.6 14.6 10.4 18.0 13.5 12.3 21.2 20.6 12.1 15.2 12.7 13.3 12.1 15.4 13.1 16.3 11.4 10.6 9.1 11.5 11.3 19.5 6.8 11.9 10.5 13.3 15.4 14.6 11.4 53.6 9.5 12.8 15.8 11.3 15.5 12.4 12.9 12.1 12.9 13.1 14.8 13.1 9.3 12.1 11.6 10.3 14.6 10.4 13.2 7.4 13.5 12.8 28.1 5.1 4.5 2.6 7.5 2.1 4.2 1.4 11.4 12.7 13.9 14.4 15.1 15.6 10.7 15.6 20.4 15.9 12.1 8.9 5.0 14.8 6.6 16.5 14.8 8.2 14.5 11.4 17.3 10.8 14.8 11.7 9.3 9.4 19.5 16.6 12.1 19.0 22.1 17.9 30.9 17.4 20.6 13.9 14.1 18.0 18.9 12.0 9.3 14.8 7.3 7.4 17.4 7.6 13.9 14.5 16.4 17.6 17.3 16.2 11.8 8.4 14.1 9.9 10.2 8.5 20.8 12.2 8.9 16.2 13.0 12.7 12.5 10.5 8.9 7.9 9.0 2.2 1.7 2.6 4.0 5.8 2.8 5.1 2.1 3.6 4.5 4.5 3.5 4.2 0.7 2.1 7.5 2.4 4.0 1.4 14.6 18.0 21.2 20.6 11.5 11.3 13.3 15.4 15.8 14.6 8.9 5.4 9.9 7.4 12.9 12.4 5.6 2.5 8.1 6.8 12.2 13.7 5.6 8.3 13.0 18.9 9.2 10.8 0.0 9.9 6.4 9.7 9.1 3.5 3.9 10.0 31.8 12.1 9.2 11.0 19.5 5.8 8.7 8.5 14.4 9.3 7.2 13.0 5.8 4.6 7.1 10.1 6.5 10.3 5.9 10.3 14.8 4.0 10.2 10.9 9.1 PRDM6 "KMT8C, PRISM" ENSG00000061455 "PR/SET domain 6" Q9NQX0 5 123089121-123194266 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 19.7;smooth muscle: 29.7;urinary bladder: 18.4;vagina: 18.7" "Cell type enhanced" "Detected in some" 8 "Early spermatids: 2.9;Fibroblasts: 6.0;Late spermatids: 4.1;Melanocytes: 3.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "pons and medulla: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.0;HEK 293: 9.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA030324 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030324: AB_10670032" "unprognostic (2.33e-1)" "unprognostic (1.39e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (3.12e-1)" "unprognostic (5.44e-2)" "unprognostic (2.22e-1)" "unprognostic (1.54e-2)" "unprognostic (4.66e-2)" "unprognostic (7.66e-3)" "unprognostic (1.23e-1)" "unprognostic (1.92e-2)" "unprognostic (1.02e-7)" "unprognostic (9.30e-4)" "unprognostic (1.10e-1)" "unprognostic (3.43e-4)" "unprognostic (1.27e-1)" 1.3 0.3 0.3 0.6 0.3 0.0 1.4 0.4 0.5 1.6 6.7 0.4 0.3 0.4 1.8 0.6 1.2 0.6 19.7 0.9 0.4 0.3 0.6 0.3 10.6 0.0 0.5 0.4 3.8 0.5 0.3 0.5 8.1 3.6 14.1 1.9 0.0 0.3 0.8 0.2 0.4 1.0 29.7 0.8 0.1 1.1 0.5 0.0 0.0 1.4 0.2 0.6 18.4 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.6 0.9 7.0 0.1 0.0 0.0 0.1 0.1 0.3 0.1 0.2 0.5 0.2 0.0 1.4 0.0 0.0 0.3 9.8 2.1 0.9 0.0 2.0 0.0 0.3 0.1 0.1 0.2 0.1 0.3 0.0 0.1 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.2 1.1 0.4 0.1 1.5 0.0 0.0 0.5 0.6 0.0 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.5 0.4 0.3 0.5 0.4 3.6 0.0 0.0 0.0 0.0 0.1 1.6 0.8 1.1 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.1 2.9 0.5 0.0 0.0 0.2 0.2 6.0 0.1 0.0 0.5 0.7 0.0 0.0 0.0 0.3 4.1 2.0 0.7 3.3 0.0 0.0 0.2 0.1 0.0 1.1 0.3 0.8 0.0 1.4 1.9 1.9 1.1 0.3 0.0 0.0 0.0 PRELID2 "FLJ38376, MGC21644" ENSG00000186314 "PRELI domain containing 2" Q8N945 5 145471799-145835369 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 31.2" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 377.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 15.8;myeloid DC: 5.2" "Group enriched" "Detected in all" 5 "dendritic cells: 5.2;granulocytes: 15.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042486 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA042486: AB_10797498" "unprognostic (9.45e-3)" "unprognostic (1.95e-1)" "unprognostic (7.58e-3)" "unprognostic (2.71e-5)" "unprognostic (1.96e-3)" "unprognostic (6.53e-4)" "unprognostic (6.62e-5)" "unprognostic (2.27e-1)" "unprognostic (4.21e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (3.83e-1)" "prognostic unfavorable (9.65e-6)" "unprognostic (2.65e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-4)" "unprognostic (6.42e-3)" 6.6 2.4 1.6 5.3 2.0 3.9 4.4 0.7 2.9 4.9 16.4 2.3 2.8 10.6 5.2 2.9 2.4 3.0 14.5 6.4 1.4 1.4 2.6 2.7 2.4 2.7 2.3 1.1 5.2 15.9 1.3 2.8 0.9 2.0 4.2 16.2 9.2 4.3 2.7 1.3 3.0 31.2 6.2 2.5 2.1 7.8 2.5 1.5 0.8 4.1 2.4 1.9 4.3 11.6 1.8 5.2 15.8 1.9 1.8 2.0 0.9 10.8 3.6 3.4 5.4 0.8 1.9 0.0 3.6 6.3 6.8 9.6 11.6 17.9 0.0 6.2 4.3 15.6 3.3 2.6 8.2 10.1 3.1 4.2 12.5 4.0 6.0 2.1 1.6 13.3 1.1 3.5 7.8 6.9 9.5 7.6 0.0 6.8 5.0 3.3 1.8 0.0 1.9 1.7 12.6 2.4 0.0 0.0 1.7 3.2 1.7 1.5 3.0 4.6 0.6 7.2 1.6 5.5 2.4 7.0 5.9 3.2 10.4 8.1 0.2 0.0 0.0 10.6 0.0 2.4 15.8 1.3 0.4 0.8 1.9 0.4 1.7 1.6 1.2 5.2 1.8 0.2 1.2 0.5 1.8 1.3 0.6 2.0 0.9 1.6 2.0 0.7 2.9 1.4 1.4 2.3 1.1 2.0 1.5 0.0 2.4 1.9 11.1 3.7 19.4 7.7 5.1 2.7 6.8 0.0 377.0 0.1 0.0 11.6 3.4 5.8 91.5 0.0 11.4 2.4 5.3 2.7 17.3 2.1 2.4 4.8 9.2 3.1 2.1 1.0 3.1 4.3 0.0 3.6 27.5 7.5 15.0 48.0 4.2 2.4 47.8 0.0 4.7 0.9 1.0 2.9 0.2 3.2 32.3 8.0 PRELID3B "C20orf45, dJ543J19.5, SLMO2" ENSG00000101166 "PRELI domain containing 3B" Q9Y3B1 20 59033145-59042909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 91.2" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 165.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047721 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047721: AB_2680131" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (5.04e-4)" "unprognostic (1.37e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (6.96e-5)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-2)" "unprognostic (1.71e-2)" "unprognostic (2.47e-2)" "unprognostic (1.20e-3)" "unprognostic (5.84e-2)" "unprognostic (2.64e-1)" "unprognostic (2.61e-2)" "unprognostic (8.96e-2)" 18.6 17.0 14.1 17.0 13.9 13.7 20.4 10.3 14.1 10.0 45.2 8.7 11.2 41.3 9.6 9.6 26.7 8.8 10.3 13.3 12.9 13.4 20.5 30.1 13.5 19.1 15.4 10.0 11.1 24.2 12.7 34.3 28.8 12.3 10.5 30.0 6.1 15.3 12.6 17.2 14.0 91.2 11.6 16.7 19.9 19.3 11.5 12.1 21.4 18.9 25.5 21.2 13.9 14.4 25.8 17.5 26.6 21.0 27.1 27.6 20.2 25.9 12.8 12.5 16.3 9.3 13.2 17.6 19.2 17.1 36.1 19.3 35.7 22.0 41.3 34.0 14.7 27.9 28.4 25.4 30.6 38.0 24.4 15.9 28.6 21.8 7.6 19.8 37.3 26.6 11.7 40.4 20.7 48.3 11.9 11.7 34.3 11.2 18.1 15.4 33.3 42.0 16.6 6.2 42.2 35.6 21.9 28.4 23.4 17.9 22.2 22.6 21.7 30.8 52.4 44.3 9.6 26.5 29.2 13.7 13.1 12.7 23.9 10.1 12.3 17.5 33.4 14.3 18.4 14.6 26.6 13.6 13.5 21.4 17.9 25.9 25.8 26.1 24.0 17.5 18.6 23.6 24.8 11.7 27.1 21.0 14.7 27.6 20.2 14.1 13.9 10.3 14.1 12.9 13.4 15.4 10.0 12.3 12.1 20.8 31.8 13.4 46.7 0.0 8.1 0.0 25.5 41.5 28.4 21.0 5.9 58.5 58.0 57.9 52.0 18.0 96.3 0.0 49.8 92.9 28.8 59.3 15.1 23.2 49.1 11.1 26.9 12.3 34.8 17.4 13.8 30.9 0.0 55.9 65.9 14.3 59.9 56.1 14.9 41.1 6.5 25.8 0.0 62.2 36.7 0.0 103.8 36.2 68.2 165.6 PRICKLE1 "EPM1B, FLJ31937, RILP" ENSG00000139174 "Prickle planar cell polarity protein 1" Q96MT3 12 42456757-42590355 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 71.4;Peritubular cells: 23.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 8.1;naive B-cell: 13.3" "Lineage enriched" "Detected in many" 5 "B-cells: 13.3" "Cell line enriched" "Detected in many" 18 "HBEC3-KT: 152.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001379, HPA050037" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA001379: AB_1855703, HPA050037: " "unprognostic (2.44e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.22e-1)" "unprognostic (2.34e-4)" "unprognostic (3.53e-1)" "unprognostic (1.69e-2)" "unprognostic (5.89e-2)" "unprognostic (5.29e-2)" "unprognostic (7.77e-2)" "unprognostic (1.21e-3)" "unprognostic (2.29e-4)" "unprognostic (1.12e-1)" "unprognostic (8.95e-3)" "unprognostic (5.33e-4)" 9.1 4.1 8.8 6.1 12.6 2.1 17.2 6.6 27.0 16.6 6.1 2.0 5.2 3.4 15.7 8.4 3.2 10.1 17.5 16.4 7.5 5.8 6.4 2.3 11.7 5.4 4.5 10.5 16.3 2.9 2.3 3.9 6.5 5.5 7.1 3.1 11.2 12.6 7.4 4.5 7.2 3.9 16.0 4.4 16.7 3.8 7.2 1.5 0.1 9.9 3.7 4.4 8.6 12.4 13.3 1.7 2.6 1.8 0.6 0.8 0.8 1.1 0.6 2.6 0.0 1.9 2.1 0.1 1.6 0.7 0.4 0.8 0.0 2.4 0.0 4.8 0.2 0.0 0.4 1.8 152.5 0.5 0.0 0.9 2.5 0.1 0.0 0.2 0.0 0.0 3.0 1.1 1.9 0.2 0.2 6.0 0.0 0.2 0.4 0.4 0.0 0.0 0.0 8.5 0.0 2.7 0.0 0.1 0.0 3.2 0.1 0.6 0.4 0.0 0.1 0.1 2.2 0.0 5.2 0.4 0.1 2.1 2.1 2.1 0.1 0.0 0.9 0.0 1.6 0.1 1.8 1.8 0.4 0.3 1.0 0.8 8.1 0.3 0.3 1.0 13.3 0.5 0.3 2.6 0.6 0.6 1.7 0.2 0.8 8.8 12.6 6.6 27.0 7.5 5.8 4.5 10.5 5.5 1.5 14.9 5.1 3.7 4.6 2.4 11.8 4.9 20.4 0.0 3.4 1.8 2.0 0.4 0.0 3.7 71.4 5.2 0.0 0.0 2.2 0.2 9.7 0.5 1.1 0.0 0.6 7.9 0.0 14.1 1.2 16.6 9.2 0.0 6.8 0.0 0.0 2.3 2.8 0.0 23.3 2.5 4.0 0.0 3.0 3.0 4.7 1.3 0.6 0.0 0.0 0.6 PRIM2 PRIM2A ENSG00000146143 "DNA primase subunit 2" P49643 6 57314805-57646849 "Plasma proteins, Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 21.7;prostate: 22.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046566 Supported Nucleoplasm NA NA Nucleoplasm "HPA046566: AB_2679701" "unprognostic (1.24e-1)" "unprognostic (1.55e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (6.98e-4)" "unprognostic (3.08e-1)" "unprognostic (6.24e-2)" "prognostic unfavorable (3.44e-5)" "unprognostic (2.31e-1)" "unprognostic (1.00e-2)" "prognostic favorable (3.00e-5)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.89e-1)" "prognostic unfavorable (7.34e-6)" "unprognostic (2.04e-2)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-1)" 5.4 1.6 1.7 9.0 2.3 7.8 4.1 6.5 3.3 5.3 3.9 2.5 2.4 3.0 9.7 3.7 5.6 3.7 2.7 3.1 2.8 3.5 2.7 2.7 7.1 3.6 1.5 4.3 2.2 2.4 5.4 5.9 1.7 22.6 5.0 3.5 7.3 3.4 1.1 3.4 3.7 5.8 3.6 6.7 2.4 5.3 3.1 21.7 4.6 4.5 8.7 4.7 2.7 5.0 7.3 2.5 5.4 5.6 7.9 2.7 15.4 6.3 12.6 14.6 7.2 12.8 10.5 19.1 18.7 21.3 28.6 10.0 7.4 14.1 10.6 23.8 14.5 10.5 11.3 10.9 26.4 15.4 9.2 16.7 8.6 16.7 2.9 16.1 10.6 4.8 4.1 23.5 8.2 5.2 9.6 15.2 15.8 37.6 17.7 9.7 16.9 12.8 8.0 13.2 6.3 12.9 17.5 11.3 7.7 8.0 9.3 7.1 12.4 5.9 7.7 14.6 12.6 13.9 6.6 21.7 21.4 39.7 16.1 5.1 9.8 16.4 9.9 17.0 11.6 0.3 2.4 2.5 5.5 5.1 6.2 5.0 5.0 7.5 4.1 4.9 3.6 7.9 1.0 5.6 5.4 7.3 5.9 2.7 0.0 2.4 5.1 5.5 3.5 5.0 0.9 2.5 2.7 3.4 3.5 11.8 13.3 3.3 3.7 7.2 2.9 3.5 23.3 4.5 19.3 5.2 5.5 11.5 3.8 7.9 6.4 1.2 4.9 4.8 2.8 6.1 5.1 0.0 5.4 6.1 4.9 3.9 5.3 6.3 1.4 4.5 19.4 5.2 10.6 12.1 2.6 4.8 12.8 7.5 5.0 PRKAG2 "AAKG, AAKG2, CMH6, H91620p, WPWS" ENSG00000106617 "Protein kinase AMP-activated non-catalytic subunit gamma 2" Q9UGJ0 7 151556111-151877125 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Cardiomyopathy, Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 77.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 58.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004246, CAB018641" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB018641: AB_2170355, HPA004246: AB_1078151" "unprognostic (4.11e-2)" "unprognostic (2.82e-1)" "unprognostic (1.46e-2)" "unprognostic (9.29e-2)" "unprognostic (1.76e-1)" "unprognostic (4.33e-3)" "unprognostic (7.13e-2)" "unprognostic (8.09e-2)" "unprognostic (1.77e-1)" "unprognostic (1.18e-1)" "unprognostic (2.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (3.80e-1)" "unprognostic (3.61e-2)" "unprognostic (4.52e-1)" 12.8 5.5 15.3 8.7 28.8 6.3 9.7 31.1 19.2 8.8 11.5 7.5 9.4 16.7 10.4 10.9 10.8 8.6 12.0 77.2 15.1 13.5 15.4 18.5 8.6 7.7 12.3 14.3 6.8 6.2 6.7 5.1 20.0 18.3 17.5 13.5 7.8 11.9 14.8 21.5 6.9 17.8 32.8 8.5 12.8 13.8 9.7 9.5 2.3 12.6 5.2 7.1 22.4 12.4 7.9 7.8 18.4 6.0 3.1 6.1 3.5 15.5 4.5 3.0 3.6 13.9 11.8 5.4 7.1 6.4 7.7 7.6 2.9 19.9 0.0 11.8 9.5 58.6 5.0 1.9 8.3 12.5 3.7 2.1 4.1 0.5 0.3 20.7 3.1 4.0 5.7 17.8 7.7 8.2 12.8 13.2 4.7 1.4 1.9 23.3 5.8 1.6 2.2 3.1 6.8 13.2 1.5 2.2 3.2 14.7 3.7 13.7 2.1 4.2 7.8 3.1 8.3 2.5 4.1 17.6 1.8 1.5 0.9 4.5 1.4 1.6 0.0 21.9 9.6 17.3 18.4 6.0 10.5 5.1 5.4 3.7 7.9 4.5 4.5 4.3 3.8 4.2 6.1 13.6 3.1 5.4 7.8 2.4 3.5 15.3 28.8 31.1 19.2 15.1 13.5 12.3 14.3 18.3 9.5 6.0 17.5 17.5 32.5 9.4 15.4 84.3 7.6 14.7 13.6 43.6 7.9 2.9 54.7 13.4 39.3 19.4 29.8 0.0 19.9 19.0 16.6 41.6 21.9 55.7 17.5 3.2 12.6 19.6 50.9 26.6 6.9 39.9 15.1 42.3 27.6 18.6 19.6 17.5 7.4 14.7 4.4 12.9 29.1 3.5 19.8 9.5 42.3 26.1 25.4 38.3 PRKDC "DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, p350, XRCC7" ENSG00000253729 "Protein kinase, DNA-activated, catalytic polypeptide" P78527 8 47773108-47960183 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, Ribosome biogenesis" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005167, HPA035174" Supported Enhanced Nucleoplasm NA NA 1100000 Nucleoplasm "CAB005167: AB_2172845, HPA035174: AB_2674504" "unprognostic (3.14e-2)" "unprognostic (3.02e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (8.95e-2)" "unprognostic (1.34e-1)" "unprognostic (7.70e-3)" "unprognostic (5.74e-2)" "unprognostic (1.12e-2)" "unprognostic (1.60e-2)" "unprognostic (7.76e-3)" "unprognostic (7.77e-2)" "unprognostic (2.84e-2)" "unprognostic (2.32e-1)" "unprognostic (2.20e-1)" "unprognostic (6.76e-3)" "unprognostic (2.15e-2)" 21.3 20.5 16.0 22.3 22.0 27.4 30.2 16.5 23.1 19.6 20.6 17.3 18.1 12.0 26.2 14.5 27.4 24.4 13.0 21.1 20.8 15.2 16.7 18.4 17.0 33.6 16.6 18.2 24.6 23.8 33.4 29.4 20.5 17.3 17.9 20.3 17.8 17.9 17.8 34.0 23.9 18.4 27.0 20.3 24.4 19.1 20.5 15.9 44.4 20.8 15.9 27.9 21.3 19.1 17.0 13.9 7.1 11.5 11.5 11.3 2.3 32.9 28.2 27.5 26.1 17.1 18.2 11.6 14.0 13.8 19.8 19.5 18.4 10.9 31.5 12.2 17.2 14.7 18.8 36.3 19.2 31.0 6.9 22.5 61.8 25.4 22.5 7.4 23.5 12.9 13.1 6.3 31.1 32.7 7.6 20.3 21.9 41.1 13.3 21.8 15.5 33.1 19.4 30.2 23.1 8.6 16.2 21.6 11.1 9.9 28.4 13.8 17.5 43.3 14.1 13.6 17.7 20.2 16.2 23.5 25.9 22.0 20.4 28.1 11.6 14.8 45.3 14.6 26.7 20.9 6.7 8.1 3.5 8.7 6.3 10.9 12.6 10.8 8.8 5.9 17.0 11.3 10.3 7.1 11.5 11.5 13.9 7.4 2.3 16.0 22.0 16.5 23.1 20.8 15.2 16.6 18.2 17.3 15.9 35.7 26.0 39.5 30.4 34.1 100.6 65.8 25.5 52.2 39.8 40.1 117.8 48.3 14.9 34.6 26.1 40.5 10.5 0.0 30.9 53.5 37.0 37.2 43.9 39.8 32.1 98.5 24.8 33.7 41.6 10.8 52.6 32.7 18.6 29.7 26.8 69.1 30.3 14.0 65.4 18.7 102.0 51.8 28.8 106.0 117.5 35.5 27.6 38.3 45.0 27.8 PRKX PKX1 ENSG00000183943 "Protein kinase, X-linked" P51817 X 3604370-3713608 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 38.8" "Low region specificity" "Detected in all" HPA015324 Supported Supported Nucleoplasm No No Nucleoplasm "HPA015324: AB_1855715" "unprognostic (1.07e-1)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (3.63e-1)" "unprognostic (2.45e-1)" "unprognostic (3.33e-2)" "unprognostic (1.47e-1)" "unprognostic (1.33e-2)" "unprognostic (4.14e-1)" "unprognostic (1.68e-1)" "unprognostic (2.68e-1)" "unprognostic (2.92e-1)" "unprognostic (1.07e-3)" "unprognostic (2.15e-2)" "unprognostic (9.91e-2)" "unprognostic (2.52e-1)" "unprognostic (1.70e-2)" 4.3 1.3 12.3 7.5 15.8 5.4 11.2 4.4 12.3 6.9 5.2 5.4 11.5 4.1 7.3 8.4 13.6 16.5 3.9 4.0 14.0 7.4 14.2 2.0 8.4 9.5 27.9 5.6 4.8 4.1 3.2 2.3 6.6 22.7 3.7 5.2 3.1 6.5 5.3 1.6 9.9 6.0 3.0 17.6 10.0 3.1 6.1 22.7 6.1 28.8 3.2 8.0 3.7 11.2 2.5 2.8 12.2 4.1 3.3 3.8 1.7 4.5 4.2 11.6 8.6 2.2 3.0 10.6 2.7 1.0 1.3 1.8 6.2 3.1 0.4 2.7 2.1 2.8 3.1 10.7 8.1 2.3 5.0 7.5 5.0 3.2 0.1 2.3 6.4 38.8 2.0 8.7 1.4 5.3 3.7 13.1 6.3 5.8 6.5 4.4 3.9 7.3 5.7 7.7 3.5 4.8 13.7 11.1 8.5 10.7 3.8 7.8 5.0 2.8 1.8 2.7 19.0 1.4 5.1 7.1 1.2 2.0 1.9 1.8 0.1 0.3 5.8 0.7 5.8 3.0 12.2 3.1 1.8 3.5 3.3 3.8 2.5 3.7 3.3 2.3 2.4 3.1 3.3 0.8 3.3 4.1 2.8 2.5 1.7 12.3 15.8 4.4 12.3 14.0 7.4 27.9 5.6 22.7 22.7 3.0 13.1 6.5 16.9 19.1 0.6 1.4 25.5 17.4 9.1 5.2 0.0 17.4 11.6 10.4 7.2 17.0 7.7 0.0 2.7 3.8 9.7 9.1 85.2 1.7 15.1 1.6 4.6 11.1 19.0 34.3 18.4 20.8 5.0 6.4 11.4 2.1 4.7 10.5 20.5 5.1 0.7 32.3 22.0 1.6 21.7 23.5 6.5 25.5 22.2 16.5 PRMT1 "ANM1, HCP1, HRMT1L2" ENSG00000126457 "Protein arginine methyltransferase 1" Q99873 19 49675786-49689029 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022550, HPA069769, HPA072136" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022550: , HPA069769: AB_2686193, HPA072136: AB_2686490" "unprognostic (1.88e-2)" "unprognostic (1.28e-2)" "unprognostic (3.00e-2)" "unprognostic (3.84e-1)" "unprognostic (4.13e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (8.04e-5)" "unprognostic (3.43e-2)" "unprognostic (1.82e-1)" "unprognostic (1.77e-1)" "unprognostic (3.59e-2)" "unprognostic (1.05e-1)" "unprognostic (7.19e-3)" "unprognostic (2.21e-1)" "unprognostic (3.66e-2)" "unprognostic (4.73e-2)" "unprognostic (1.10e-2)" 21.3 31.5 27.4 28.1 29.7 21.8 22.0 29.4 35.9 31.8 25.5 26.9 27.8 21.4 36.0 22.5 28.9 45.4 24.5 56.4 25.2 28.6 23.4 20.8 22.0 34.9 32.0 23.8 43.4 35.0 20.0 31.7 27.9 25.6 33.3 18.4 34.1 20.9 31.5 83.8 21.9 19.8 38.3 20.9 33.3 20.3 24.9 28.0 25.0 32.9 31.3 32.0 29.8 23.8 51.9 41.2 9.2 23.6 38.7 35.5 31.8 38.2 87.7 60.8 73.3 16.5 18.8 32.0 24.6 43.0 71.2 61.3 65.3 30.6 63.0 18.4 28.8 28.0 28.3 51.2 52.0 31.2 48.9 87.9 45.9 24.1 70.8 40.5 55.2 33.0 26.2 25.9 39.8 57.3 24.0 42.1 51.1 48.3 44.8 27.6 57.9 71.3 68.4 64.1 48.1 57.1 50.7 49.1 57.5 40.1 80.8 67.8 52.8 28.4 29.5 15.1 20.5 22.3 32.6 26.1 41.9 40.8 19.2 58.6 43.1 64.9 62.2 25.7 40.0 43.9 5.8 20.2 9.2 28.6 23.6 35.5 51.9 26.6 30.5 34.2 41.9 29.9 29.1 3.9 38.7 17.1 41.2 24.2 31.8 27.4 29.7 29.4 35.9 25.2 28.6 32.0 23.8 25.6 28.0 3.0 15.9 80.4 187.9 183.9 238.6 13.0 28.1 1.4 7.9 41.8 100.1 170.7 107.8 159.3 3.5 104.4 27.5 0.0 117.3 137.0 110.0 82.0 55.2 18.3 92.0 122.3 110.5 96.3 30.9 13.2 96.4 65.7 106.3 237.2 61.8 106.4 105.3 52.0 83.8 63.8 130.7 90.5 132.8 70.0 132.2 138.9 196.7 52.4 83.7 157.1 PROB1 C5orf65 ENSG00000228672 "Proline rich basic protein 1" E7EW31 5 139390592-139395713 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 37.7" "Cell type enhanced" "Detected in some" 26 "Cardiomyocytes: 25.4;Ito cells: 4.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.1;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HDLM-2: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA053354, HPA060103" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053354: , HPA060103: AB_2684205" "unprognostic (4.14e-2)" "prognostic favorable (9.26e-4)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.53e-2)" "unprognostic (9.27e-3)" "unprognostic (4.72e-2)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (3.21e-2)" "unprognostic (4.84e-4)" "unprognostic (7.10e-2)" "unprognostic (1.75e-2)" "unprognostic (9.05e-2)" "unprognostic (3.62e-2)" "unprognostic (5.89e-2)" "unprognostic (8.24e-2)" 0.6 1.6 0.7 0.3 0.8 0.0 0.3 0.0 0.3 0.3 0.3 0.6 0.5 0.1 0.3 0.7 0.1 6.6 0.7 0.6 0.7 0.0 0.0 0.4 0.5 0.0 0.0 1.8 0.8 0.2 1.3 0.0 0.7 0.6 37.7 0.0 0.8 0.1 0.2 0.3 0.6 0.0 0.1 0.1 0.3 0.1 0.5 1.1 0.0 0.1 0.0 1.1 0.0 0.6 0.4 0.1 0.1 0.0 0.2 0.2 0.5 0.1 0.5 0.5 2.0 1.3 3.0 0.5 1.6 0.0 0.3 0.2 0.0 0.1 48.1 0.6 0.7 1.2 0.2 1.3 0.0 1.6 0.4 0.4 1.2 0.3 0.4 0.1 2.0 0.2 3.0 1.7 0.5 2.5 1.2 0.6 0.3 1.2 7.7 0.2 5.8 0.1 0.0 0.6 0.3 2.8 3.0 0.1 0.7 1.1 1.6 0.2 0.1 0.1 0.1 0.2 0.4 0.8 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.1 1.1 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.2 0.0 0.0 0.0 0.2 0.5 0.4 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.3 0.2 0.0 1.1 1.4 0.0 6.5 1.7 0.1 0.3 0.0 2.2 0.0 0.2 0.3 PRPF3 "hPrp3, Prp3, RP18, SNRNP90" ENSG00000117360 "Pre-mRNA processing factor 3" O43395 1 150321476-150353195 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027226, HPA067116" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027226: AB_1855770, HPA067116: AB_2685783" "unprognostic (2.75e-1)" "unprognostic (3.00e-1)" "unprognostic (2.20e-1)" "unprognostic (2.77e-1)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.59e-5)" "unprognostic (7.89e-2)" "unprognostic (7.13e-3)" "unprognostic (1.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.04e-2)" "prognostic unfavorable (3.19e-5)" "unprognostic (6.77e-3)" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.78e-3)" 21.9 18.6 22.1 28.6 24.0 38.4 23.3 37.8 27.5 21.2 20.0 25.6 27.8 16.7 35.7 27.9 18.6 21.5 17.4 17.3 18.9 12.3 17.6 19.7 20.9 26.2 19.6 19.5 32.7 17.4 22.5 41.9 23.5 17.0 22.0 20.3 27.7 18.9 23.2 19.2 21.6 20.1 22.5 23.6 26.8 16.2 18.9 24.0 27.6 27.7 18.1 27.3 20.7 20.9 13.2 9.3 12.4 19.1 9.9 15.6 7.7 16.0 17.4 17.7 11.3 11.9 13.0 24.1 16.8 11.8 26.1 18.1 13.3 15.1 21.3 11.3 13.7 24.4 19.0 32.0 11.8 23.5 10.6 14.8 18.4 25.3 12.6 11.9 22.6 11.9 9.4 16.4 22.2 19.2 12.4 15.8 14.4 21.8 12.9 18.5 23.9 18.5 19.7 25.4 41.4 15.8 27.0 14.4 14.0 10.7 9.7 15.3 13.5 14.1 16.6 12.7 25.0 19.7 54.5 12.5 16.4 12.7 13.8 27.6 12.4 22.2 23.9 10.9 20.5 17.0 6.9 8.6 12.4 15.6 11.4 15.0 13.2 11.3 10.1 9.3 10.2 11.7 12.1 5.2 9.9 19.1 7.5 8.5 7.7 22.1 24.0 37.8 27.5 18.9 12.3 19.6 19.5 17.0 24.0 32.8 22.6 8.6 11.5 10.4 29.6 10.9 5.1 22.7 21.6 10.4 17.7 13.9 11.6 12.9 7.7 17.9 12.4 0.0 10.1 13.5 9.9 9.7 22.0 8.9 10.6 30.2 2.4 12.9 9.1 3.2 18.7 11.2 10.1 11.8 13.3 29.6 11.0 8.6 17.3 4.4 42.9 12.9 14.1 41.1 14.0 8.8 16.7 14.9 10.1 8.8 PRPF31 "hPrp31, NY-BR-99, PRP31, RP11, SNRNP61" ENSG00000105618 "Pre-mRNA processing factor 31" Q8WWY3 19 54115410-54131719 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041939, HPA061873" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA041939: AB_10793938, HPA061873: AB_2684630" "unprognostic (1.32e-1)" "unprognostic (1.73e-2)" "unprognostic (1.26e-2)" "unprognostic (7.98e-2)" "unprognostic (1.28e-1)" "unprognostic (3.28e-2)" "prognostic unfavorable (7.33e-4)" "unprognostic (9.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.66e-1)" "unprognostic (5.26e-3)" "unprognostic (1.81e-2)" "unprognostic (2.06e-1)" "unprognostic (2.16e-1)" "unprognostic (5.94e-2)" "unprognostic (2.53e-1)" "unprognostic (7.04e-2)" 22.8 24.5 23.8 26.3 25.8 24.2 22.1 29.0 33.2 22.2 24.4 24.1 29.5 24.0 33.1 23.3 25.1 26.9 25.9 23.3 23.3 20.3 22.5 27.2 21.0 30.1 24.8 31.6 27.3 21.1 34.2 22.2 24.1 22.0 23.4 18.6 22.9 39.9 27.1 50.0 24.7 21.8 25.9 23.3 26.2 22.9 26.0 22.7 25.8 25.8 25.4 25.4 24.5 26.8 16.2 18.6 10.1 18.2 17.9 21.2 15.9 18.9 31.1 12.8 18.7 8.5 8.2 11.7 16.3 11.8 16.6 15.5 15.6 13.5 20.9 12.2 10.7 8.0 9.5 17.6 16.7 12.7 18.6 50.4 17.0 23.8 18.3 9.2 31.9 13.8 10.6 8.0 13.5 11.5 9.8 17.0 14.8 21.0 9.6 10.6 14.8 21.2 8.9 11.5 15.8 34.7 18.9 18.9 16.0 11.1 24.8 14.5 16.4 22.8 17.2 8.7 6.7 11.0 13.2 19.2 21.5 17.2 10.4 24.5 12.8 22.3 23.5 16.5 17.5 13.2 7.4 15.2 10.1 18.0 18.2 18.9 16.2 17.3 18.9 18.6 16.0 15.3 15.3 3.3 17.9 15.8 15.7 21.2 15.9 23.8 25.8 29.0 33.2 23.3 20.3 24.8 31.6 22.0 22.7 32.8 26.1 31.5 36.9 37.9 29.7 29.9 33.1 34.8 31.8 24.4 13.7 82.0 51.4 55.7 4.0 43.0 25.4 23.3 54.9 75.7 41.4 31.7 31.1 24.6 59.1 28.6 33.5 23.4 18.4 5.9 35.4 37.7 38.8 88.4 33.7 49.2 51.2 30.2 46.0 44.9 29.3 38.8 49.1 65.0 61.3 36.8 63.7 44.1 40.9 22.4 PRPF38A "FLJ14936, Prp38" ENSG00000134748 "Pre-mRNA processing factor 38A" Q8NAV1 1 52404564-52420839 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053099, HPA058407" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053099: AB_2682044, HPA058407: AB_2683709" "unprognostic (1.29e-1)" "unprognostic (6.12e-2)" "prognostic favorable (7.16e-4)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (2.15e-3)" "prognostic unfavorable (3.83e-5)" "unprognostic (3.83e-2)" "unprognostic (7.84e-3)" "unprognostic (7.06e-2)" "unprognostic (1.62e-1)" "unprognostic (9.69e-2)" "prognostic unfavorable (7.41e-5)" "unprognostic (6.54e-3)" "unprognostic (3.35e-1)" "unprognostic (1.89e-1)" "unprognostic (2.82e-1)" 13.5 13.2 21.5 16.9 19.2 25.4 20.6 30.5 18.5 17.3 17.2 20.7 12.9 12.9 22.1 16.0 15.0 18.0 11.3 11.5 19.1 16.8 15.4 12.1 15.1 22.1 20.3 14.0 28.1 12.6 19.2 19.9 15.9 16.6 17.6 19.1 17.2 13.4 15.1 10.0 17.4 16.2 14.5 19.3 17.8 12.9 18.8 22.1 36.4 19.3 13.7 22.1 14.1 20.1 9.1 9.7 12.5 8.8 13.3 15.3 6.6 8.3 4.1 14.7 7.0 5.9 5.8 8.8 5.7 3.9 9.5 9.2 7.5 4.2 17.3 6.0 3.9 7.4 6.2 20.9 6.2 12.4 9.4 16.0 23.2 15.4 7.7 7.2 25.8 8.6 4.4 5.6 10.4 10.1 7.2 8.0 12.6 21.3 4.5 5.6 4.7 19.9 15.5 18.1 8.9 9.7 19.6 22.3 14.5 8.4 5.0 9.8 12.0 11.6 9.6 11.2 10.4 6.7 21.0 6.2 5.4 8.1 8.0 11.2 8.7 12.4 17.5 8.0 22.6 6.8 12.5 7.5 10.5 9.8 8.8 13.3 9.1 11.0 11.8 9.7 8.5 15.3 11.6 6.0 13.3 8.6 5.4 10.7 6.6 21.5 19.2 30.5 18.5 19.1 16.8 20.3 14.0 16.6 22.1 38.7 27.2 33.7 76.8 47.2 31.2 23.5 15.3 17.4 30.7 15.7 88.4 53.1 29.9 28.6 65.9 47.2 52.0 23.3 25.7 65.9 30.1 36.9 57.8 15.5 35.1 23.8 34.3 22.7 35.1 11.0 23.9 30.8 28.7 23.4 38.6 45.7 21.8 45.6 31.5 26.9 42.6 51.8 41.1 111.6 55.6 48.9 86.5 62.3 47.3 64.1 PRPF39 "FLJ11128, FLJ20666" ENSG00000185246 "Pre-mRNA processing factor 39" Q86UA1 14 45084099-45116282 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001176 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA001176: AB_2171026" "unprognostic (1.79e-1)" "unprognostic (2.75e-1)" "unprognostic (1.03e-1)" "unprognostic (2.19e-1)" "unprognostic (1.91e-2)" "unprognostic (6.75e-3)" "prognostic unfavorable (3.84e-5)" "unprognostic (9.51e-3)" "prognostic unfavorable (6.51e-4)" "prognostic favorable (8.48e-4)" "unprognostic (4.34e-3)" "prognostic unfavorable (4.04e-4)" "unprognostic (5.02e-3)" "unprognostic (1.83e-1)" "unprognostic (9.04e-2)" "unprognostic (8.93e-2)" "prognostic favorable (2.99e-4)" 11.9 8.6 15.3 13.3 19.1 12.8 12.4 34.0 21.4 10.5 11.9 11.2 12.6 9.1 14.3 11.6 8.3 13.4 6.4 8.7 12.5 11.5 13.1 10.6 9.1 11.2 14.5 14.4 15.2 9.4 12.9 22.3 9.7 11.4 13.9 8.1 7.0 9.5 13.5 14.2 9.5 11.0 12.2 14.2 10.6 10.1 10.2 15.6 9.5 10.8 6.7 10.4 9.8 13.8 8.7 7.6 7.7 7.4 6.5 11.0 4.9 11.8 9.0 14.8 7.7 9.8 6.7 9.7 11.8 6.6 10.6 10.8 6.2 9.9 9.3 8.4 7.0 7.5 8.7 15.6 10.0 16.2 12.5 8.9 12.6 10.5 9.3 8.0 16.8 6.1 4.4 7.1 6.5 8.2 6.5 8.3 9.8 13.6 11.6 13.4 12.6 16.0 12.2 10.0 11.3 9.4 15.9 14.5 10.5 8.7 12.0 12.4 3.8 9.0 11.3 12.9 9.2 7.0 11.3 10.5 7.0 10.4 7.7 12.7 9.4 16.4 19.2 5.0 11.7 7.4 7.7 4.3 6.6 8.3 7.0 10.8 8.7 7.6 8.2 7.6 8.2 10.0 11.0 3.0 6.5 7.4 3.2 8.7 4.9 15.3 19.1 34.0 21.4 12.5 11.5 14.5 14.4 11.4 15.6 23.8 22.7 8.3 14.7 24.3 18.8 13.7 10.2 6.7 17.0 7.0 13.7 10.3 8.3 7.2 1.2 12.1 8.0 0.0 8.2 9.1 12.7 12.1 15.1 6.6 6.6 15.9 9.2 10.4 5.1 3.3 13.8 10.2 13.5 7.2 8.6 9.4 7.0 5.8 13.8 4.4 22.7 6.5 11.3 10.6 11.8 22.1 10.1 10.2 7.9 8.9 PRPF8 "hPrp8, Prp8, PRPC8, RP13, SNRNP220" ENSG00000174231 "Pre-mRNA processing factor 8" Q6P2Q9 17 1650629-1684882 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Cancer-related genes, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 237.6;Rod photoreceptor cells: 234.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009941, CAB015457" Supported Enhanced Nucleoplasm NA NA 240000 Nucleoplasm "CAB009941: AB_2171185, CAB015457: AB_831685" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (2.76e-2)" "unprognostic (3.13e-2)" "unprognostic (1.56e-1)" "unprognostic (4.94e-2)" "unprognostic (6.58e-2)" "unprognostic (1.56e-1)" "unprognostic (4.19e-2)" "unprognostic (1.77e-1)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (2.45e-3)" "unprognostic (2.00e-1)" "unprognostic (2.66e-1)" "unprognostic (1.16e-1)" "unprognostic (1.23e-1)" 30.0 37.4 23.1 25.7 40.3 39.0 26.2 43.1 57.2 31.2 28.0 36.5 29.5 19.4 35.6 28.4 29.4 35.4 28.1 34.0 22.2 24.3 23.3 35.5 27.9 30.7 21.3 23.9 47.7 25.9 66.5 45.4 31.1 32.5 30.7 27.2 45.1 30.5 33.1 46.3 30.7 27.5 36.3 17.9 34.1 26.4 45.9 19.6 63.4 30.9 22.2 41.2 32.2 27.9 14.5 20.1 10.0 12.3 10.1 17.1 5.4 18.7 41.0 24.7 20.0 21.4 16.8 19.9 14.1 18.0 27.6 22.4 38.0 9.3 27.6 15.0 25.3 21.4 26.2 60.2 24.2 31.9 17.4 38.7 21.9 35.6 32.5 12.5 25.9 24.4 15.9 15.5 35.6 24.9 14.3 24.2 19.6 21.6 22.0 19.8 20.5 18.7 32.4 17.0 16.2 15.2 36.7 14.1 13.2 10.6 20.9 12.7 19.1 28.4 10.3 13.9 21.6 15.2 17.4 22.3 16.9 14.5 25.7 32.1 8.0 8.3 19.5 14.0 18.8 20.8 10.0 6.5 6.7 15.7 8.9 17.1 13.3 14.7 15.7 9.7 14.5 13.0 16.4 7.1 10.1 12.3 20.1 14.8 5.4 23.1 40.3 43.1 57.2 22.2 24.3 21.3 23.9 32.5 19.6 56.6 70.5 44.4 25.5 26.8 124.9 33.1 56.0 34.8 56.9 45.4 237.6 37.8 6.6 32.2 9.5 43.6 40.3 23.3 35.2 22.6 31.1 25.8 50.8 34.2 34.2 68.3 35.1 36.8 40.3 8.9 67.9 32.5 18.6 38.7 37.2 56.5 35.5 37.6 49.1 15.8 234.7 71.1 36.0 74.1 83.3 24.3 33.1 38.7 42.3 27.4 PRR13 "DKFZP564J157, FLJ23818" ENSG00000205352 "Proline rich 13" Q9NZ81 12 53441605-53446645 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 190.5" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 1157.2;Enterocytes: 1047.2;Proximal tubular cells: 808.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039396, HPA046219" Uncertain Supported Nucleoplasm NA Yes Nucleoplasm "HPA039396: AB_2676484, HPA046219: AB_10963936" "unprognostic (1.09e-1)" "prognostic favorable (9.08e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-1)" "unprognostic (8.97e-3)" "unprognostic (4.88e-3)" "unprognostic (1.86e-3)" "unprognostic (7.23e-2)" "unprognostic (1.23e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-2)" "unprognostic (5.41e-2)" "unprognostic (6.81e-3)" "unprognostic (1.81e-1)" "unprognostic (1.08e-1)" "unprognostic (2.34e-1)" "prognostic favorable (7.55e-4)" 31.9 48.0 29.7 38.3 36.4 64.0 29.3 19.5 38.3 23.8 81.1 27.0 26.6 117.5 24.2 34.4 31.2 35.0 40.1 31.1 30.9 30.1 88.2 51.4 35.5 49.3 34.3 39.2 30.2 29.3 16.1 26.5 32.5 31.3 30.0 70.6 27.1 26.1 44.9 33.3 22.9 110.7 24.5 32.5 53.6 51.9 15.7 28.7 41.6 34.3 21.6 45.6 35.8 25.3 79.6 60.1 190.5 86.5 50.8 72.9 117.1 25.3 51.2 12.7 14.1 21.8 27.9 27.8 21.2 31.0 27.3 26.7 92.6 59.7 39.9 72.5 30.7 33.6 22.9 25.8 33.5 33.5 38.5 19.2 58.1 28.2 43.4 53.8 86.6 80.1 36.9 34.0 51.0 35.1 29.5 29.1 24.1 49.9 40.1 42.8 68.7 48.5 85.1 20.9 32.4 34.7 43.0 10.8 42.4 60.7 44.0 11.4 8.4 31.5 45.1 38.0 27.4 63.6 67.2 29.9 18.5 18.2 33.0 20.8 29.8 36.2 58.5 24.8 52.5 34.8 63.6 75.8 142.7 50.7 84.6 49.4 79.6 56.9 53.8 60.1 70.8 53.5 57.5 190.5 50.8 86.5 49.7 72.9 117.1 29.7 36.4 19.5 38.3 30.9 30.1 34.3 39.2 31.3 28.7 77.4 108.7 131.7 128.0 42.2 6.7 20.7 178.3 136.5 72.8 177.9 27.5 204.3 1157.2 205.4 8.6 70.6 1047.2 0.0 224.1 275.8 70.2 205.1 179.3 136.2 316.3 17.5 163.2 59.5 331.1 4.2 53.8 241.9 102.9 348.1 279.4 63.8 250.2 733.0 43.2 808.7 20.6 77.6 60.4 33.7 20.1 48.9 243.4 192.8 262.9 167.7 PRR14 MGC3121 ENSG00000156858 "Proline rich 14" Q9BWN1 16 30650717-30656440 "Predicted intracellular proteins" Myogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052022, HPA060265, HPA075914" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052022: AB_2681698, HPA060265: AB_2684236, HPA075914: " "unprognostic (1.57e-1)" "prognostic favorable (8.19e-5)" "unprognostic (3.74e-3)" "unprognostic (1.42e-2)" "unprognostic (5.18e-2)" "unprognostic (5.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.42e-2)" "unprognostic (5.75e-2)" "unprognostic (1.82e-2)" "unprognostic (1.61e-2)" "unprognostic (5.69e-2)" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (4.54e-1)" "unprognostic (9.10e-2)" "unprognostic (2.31e-3)" 17.7 13.8 15.1 18.2 14.1 24.4 16.1 27.4 17.2 19.5 18.8 19.2 16.4 19.3 21.7 11.1 18.1 17.2 16.7 10.1 14.5 9.1 16.5 15.1 15.8 18.9 16.4 7.8 18.2 19.6 18.6 15.3 13.9 10.6 17.8 9.8 14.8 22.1 22.6 13.6 24.5 18.4 15.6 13.6 23.4 23.2 9.3 13.7 31.2 17.7 10.0 19.3 16.4 19.6 8.8 5.8 18.1 8.2 6.1 8.4 4.5 8.7 10.9 9.2 7.1 8.1 5.6 6.2 9.3 5.3 9.2 8.3 5.0 7.3 15.1 8.0 5.6 4.6 8.9 7.1 10.3 2.7 21.4 20.8 8.7 11.2 9.9 11.5 7.2 20.9 5.3 11.0 6.0 5.5 9.8 11.3 4.0 11.3 9.9 4.8 21.8 16.3 12.5 2.9 5.1 5.8 12.3 4.2 20.7 5.3 3.7 7.0 16.5 3.6 12.7 8.2 1.9 15.5 4.1 8.2 7.9 8.8 7.3 9.3 23.2 14.7 9.0 5.3 15.8 6.9 8.6 4.9 17.8 8.4 4.8 6.4 6.3 6.9 8.4 4.6 8.8 6.4 6.5 18.1 6.1 8.2 5.8 8.2 4.5 15.1 14.1 27.4 17.2 14.5 9.1 16.4 7.8 10.6 13.7 8.9 7.2 15.2 22.4 20.3 13.4 5.0 25.5 6.7 5.7 12.2 13.7 12.9 13.3 19.0 5.3 18.6 21.3 0.0 19.2 12.8 16.3 19.2 11.5 9.0 16.1 1.6 12.1 19.6 12.7 1.8 17.8 17.0 8.5 37.9 14.8 12.0 18.0 14.0 19.8 11.8 12.8 19.4 20.8 17.0 22.6 20.1 11.8 24.9 16.6 14.9 PRR14L "C22orf30, MGC50372" ENSG00000183530 "Proline rich 14 like" Q5THK1 22 31676256-31750140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062645 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA062645: AB_2684817" "unprognostic (2.87e-1)" "unprognostic (1.34e-1)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.42e-2)" "unprognostic (2.13e-1)" "unprognostic (1.37e-2)" "unprognostic (4.10e-2)" "unprognostic (8.86e-3)" "unprognostic (1.80e-1)" "unprognostic (2.10e-1)" "unprognostic (4.90e-2)" "prognostic favorable (3.00e-4)" "unprognostic (1.73e-1)" "unprognostic (1.95e-1)" "unprognostic (7.48e-2)" "unprognostic (4.14e-3)" 10.9 10.6 9.8 13.9 12.0 15.1 10.8 18.2 14.0 9.7 11.9 9.9 8.9 8.1 10.0 8.4 14.4 10.4 8.3 9.0 10.1 7.2 8.6 9.8 10.3 12.0 9.4 9.3 13.9 9.7 18.7 21.5 13.5 11.2 8.7 13.6 7.6 11.6 11.9 8.0 13.0 16.4 9.8 10.6 12.8 11.1 11.0 11.8 20.3 10.3 5.8 13.3 11.1 12.1 4.2 4.4 10.0 12.2 3.2 3.8 1.9 9.5 9.3 10.2 10.0 9.4 8.8 10.6 5.2 6.3 8.3 7.8 8.5 3.5 10.9 5.1 10.3 6.2 9.5 19.9 7.9 8.7 14.5 8.4 6.6 7.8 6.7 8.0 20.3 14.3 7.8 8.0 11.5 10.0 7.2 11.5 8.7 9.9 7.3 8.6 9.1 7.1 6.5 11.7 13.8 3.6 10.8 16.3 6.3 6.9 11.0 14.1 8.3 12.3 7.4 6.9 12.6 6.6 8.2 10.9 5.1 10.3 6.7 7.2 11.4 13.4 8.4 7.9 10.0 7.8 9.2 5.3 6.1 3.8 6.4 3.3 3.9 2.3 3.1 3.9 4.2 3.5 3.5 10.0 3.2 12.2 4.4 3.0 1.9 9.8 12.0 18.2 14.0 10.1 7.2 9.4 9.3 11.2 11.8 20.8 16.9 13.0 8.1 6.6 11.4 17.3 15.3 21.4 35.2 10.4 19.6 14.7 8.3 16.4 4.8 9.5 22.2 0.0 14.8 12.9 10.6 11.8 25.5 17.0 12.5 14.3 9.8 12.9 18.1 4.0 13.8 15.1 1.7 15.4 18.6 13.8 18.9 14.0 7.8 9.2 11.0 12.9 7.2 11.6 14.0 8.4 18.5 10.2 16.9 15.9 PRRX1 "PHOX1, PMX1" ENSG00000116132 "Paired related homeobox 1" P54821 1 170662728-170739419 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 327.5;Late spermatids: 303.2;Leydig cells: 237.3;Peritubular cells: 98.3;Smooth muscle cells: 139.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 73.9;ASC TERT1: 59.0;BJ: 20.9;BJ hTERT+: 41.3;HSkMC: 30.1;U-138 MG: 29.0;U-2197: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051084, HPA063566" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA051084: AB_2681338, HPA063566: AB_2732702" "unprognostic (2.03e-1)" "unprognostic (2.00e-1)" "unprognostic (1.09e-1)" "unprognostic (7.00e-2)" "unprognostic (1.24e-1)" "unprognostic (4.97e-2)" "unprognostic (2.52e-2)" "unprognostic (1.88e-2)" "unprognostic (2.94e-3)" "unprognostic (1.13e-1)" "unprognostic (1.98e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (6.60e-10)" "unprognostic (4.23e-3)" "unprognostic (4.48e-2)" "unprognostic (2.68e-3)" "unprognostic (1.69e-3)" 44.8 4.4 5.2 7.2 6.3 0.0 21.0 4.0 9.2 58.5 4.1 6.7 10.6 0.4 31.4 19.4 10.8 17.9 14.5 19.5 6.8 4.5 1.8 0.7 10.4 13.0 6.1 5.3 27.6 1.9 3.4 3.1 2.7 7.7 17.3 2.5 17.4 18.4 34.1 58.6 11.9 2.2 23.0 6.6 1.0 2.3 17.6 6.8 5.0 21.7 28.7 14.9 19.4 31.2 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 73.9 59.0 0.0 20.9 41.3 2.9 2.9 0.0 0.0 0.0 0.0 17.2 0.0 0.0 3.6 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 30.1 0.0 14.4 0.0 5.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 29.0 0.5 27.6 3.2 0.0 0.0 0.0 15.2 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 5.2 6.3 4.0 3.9 6.8 4.5 6.1 5.3 7.7 6.8 0.0 0.3 0.0 0.4 14.4 0.0 29.7 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.9 327.5 6.4 0.0 0.0 0.2 0.2 42.1 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 303.2 237.3 3.9 13.5 0.0 0.0 0.3 0.9 0.0 98.3 0.0 0.1 51.8 139.5 6.0 1.4 10.3 0.1 0.0 0.0 1.3 PRSS22 "BSSP-4, hBSSP-4, SP001LA" ENSG00000005001 "Serine protease 22" Q9GZN4 16 2852727-2858170 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.4;lymphoid tissue: 40.1;tongue: 36.5" "Cell type enhanced" "Detected in many" 18 "Basal glandular cells: 187.4;Pancreatic endocrine cells: 242.0;Urothelial cells: 517.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 16 "cerebellum: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.6;MCF7: 12.7;RT4: 5.9;SK-BR-3: 13.4" "Region enhanced" "Detected in single" "cerebral cortex: 2.6" "Low region specificity" "Detected in all" HPA049161 Approved Approved Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "HPA049161: AB_2680660" "unprognostic (1.45e-1)" "unprognostic (9.80e-2)" "unprognostic (3.50e-2)" "unprognostic (4.48e-1)" "unprognostic (2.29e-4)" "unprognostic (2.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-2)" "unprognostic (5.06e-1)" "unprognostic (7.52e-2)" "unprognostic (3.74e-3)" "unprognostic (4.12e-1)" "unprognostic (2.32e-4)" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (2.75e-1)" 0.4 0.7 0.0 0.4 0.0 0.6 1.3 1.5 0.4 9.9 1.0 0.0 8.6 1.5 3.0 0.6 40.4 3.0 6.8 0.4 0.0 0.0 2.4 0.7 3.0 0.4 0.0 0.0 0.4 7.5 0.4 1.1 4.3 0.0 5.1 0.6 0.0 13.4 10.6 2.3 1.3 0.4 0.7 0.0 0.4 3.5 0.4 0.0 0.0 1.5 36.5 40.1 5.2 9.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 13.4 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.4 0.0 187.4 20.6 0.0 0.2 33.1 8.1 23.9 15.7 0.0 30.9 1.7 101.8 0.0 0.0 4.2 0.0 86.5 19.4 0.8 63.4 0.0 0.0 2.0 0.0 3.5 0.0 0.0 0.0 0.0 0.9 6.8 1.8 5.3 0.0 242.0 10.5 0.0 0.0 0.0 0.0 1.0 0.0 0.1 24.1 8.8 0.0 5.2 517.3 PSEN2 "AD3L, AD4, PS2, STM2" ENSG00000143801 "Presenilin 2" P49810 1 226870184-226896105 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013634, HPA038005" Supported Nucleoplasm NA NA Nucleoplasm "CAB013634: , HPA038005: " "unprognostic (3.40e-2)" "unprognostic (4.73e-3)" "unprognostic (2.94e-1)" "unprognostic (3.86e-2)" "unprognostic (6.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.72e-2)" "unprognostic (1.31e-1)" "unprognostic (9.98e-2)" "unprognostic (2.73e-2)" "unprognostic (8.25e-3)" "unprognostic (8.53e-3)" "unprognostic (8.45e-2)" "unprognostic (1.17e-1)" "unprognostic (8.36e-2)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" 8.9 13.2 9.5 5.9 7.9 1.2 8.1 16.6 10.7 9.2 9.2 5.9 7.3 9.4 16.4 9.0 9.4 8.7 12.0 9.7 6.5 10.8 7.8 7.7 9.0 11.6 8.1 9.3 13.1 31.6 14.0 15.2 7.6 14.8 12.8 6.9 15.9 9.6 13.4 22.1 6.8 12.2 17.0 4.9 10.6 7.1 21.8 5.3 1.4 6.0 7.2 7.0 9.0 7.2 5.1 7.7 19.4 18.7 12.3 3.4 3.1 9.0 13.6 4.0 12.6 5.5 1.8 6.7 7.7 15.1 9.6 7.4 10.6 11.7 0.1 10.4 9.8 6.6 4.6 7.1 7.3 3.9 9.7 13.1 6.1 9.6 6.9 9.3 4.8 10.1 5.4 8.2 11.5 6.3 6.8 4.4 0.0 10.5 4.1 5.6 7.6 0.1 5.5 12.4 11.3 11.2 0.1 14.8 14.5 8.5 7.7 7.1 11.8 6.2 17.1 30.5 11.8 14.7 6.1 4.8 6.8 5.8 6.2 9.6 16.6 24.4 0.4 12.2 1.5 9.0 19.4 5.7 12.1 3.2 6.5 3.4 5.1 1.1 2.9 7.7 2.6 0.6 1.7 1.2 12.3 18.7 0.6 1.4 3.1 9.5 7.9 16.6 10.7 6.5 10.8 8.1 9.3 14.8 5.3 14.9 13.3 3.0 4.2 1.4 6.0 7.5 12.7 2.7 3.4 5.2 0.0 12.2 1.7 11.0 1.9 7.7 6.7 0.0 15.7 4.3 7.6 4.8 13.9 6.8 16.3 15.9 5.8 23.4 5.3 0.9 6.6 8.3 32.1 30.7 4.3 20.0 11.9 5.8 12.4 6.0 5.4 6.5 4.7 0.7 4.5 1.6 38.3 2.5 4.1 3.9 PSIP1 "DFS70, LEDGF, p52, p75, PSIP2" ENSG00000164985 "PC4 and SFRS1 interacting protein 1" O75475 9 15464066-15511019 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 273.8;Spermatogonia: 282.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 132.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013718, HPA019697" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013718: , HPA019697: AB_1852779" "unprognostic (8.54e-2)" "unprognostic (3.70e-2)" "unprognostic (1.31e-1)" "unprognostic (3.29e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (2.89e-3)" "unprognostic (5.10e-2)" "unprognostic (5.93e-2)" "unprognostic (2.53e-2)" "unprognostic (6.49e-3)" "unprognostic (5.49e-2)" "unprognostic (6.98e-2)" "unprognostic (2.04e-1)" "unprognostic (2.99e-1)" "unprognostic (7.14e-2)" "unprognostic (1.39e-1)" 15.1 20.3 42.7 20.8 48.8 24.9 12.2 65.3 49.4 22.6 16.1 19.0 11.5 10.8 27.9 18.2 12.9 20.0 14.9 16.0 38.7 42.7 16.1 10.5 15.6 35.4 34.1 30.2 43.6 8.1 18.8 24.9 18.7 32.4 18.3 15.3 12.3 9.0 21.1 16.3 12.3 14.2 21.3 37.7 24.6 12.5 37.2 29.3 70.4 18.1 6.5 31.9 17.0 16.1 11.4 2.6 8.5 4.3 8.0 16.4 1.9 17.9 11.9 40.7 29.8 8.8 10.7 9.1 21.7 15.5 19.5 23.3 5.0 9.3 38.3 5.0 11.4 10.9 5.0 25.3 11.7 28.3 25.1 15.3 132.4 31.3 9.3 10.7 15.4 14.7 8.9 3.4 16.3 12.0 19.5 17.0 18.1 21.8 21.3 12.6 6.5 31.9 38.4 63.1 0.4 18.6 29.8 22.2 7.7 10.9 6.3 25.9 28.5 19.4 8.6 10.1 26.5 8.6 20.8 12.0 14.2 14.4 10.6 20.5 9.1 12.8 34.5 11.4 15.6 8.1 8.5 2.1 4.2 5.5 1.6 6.7 8.4 11.0 7.6 2.4 11.4 16.4 10.1 7.2 8.0 4.3 2.6 9.8 1.9 42.7 48.8 65.3 46.6 38.7 42.7 34.1 30.2 32.4 29.3 50.6 32.2 51.9 42.9 28.3 223.7 37.1 20.4 58.9 36.4 45.4 62.8 99.5 53.0 8.4 62.0 69.9 10.7 46.7 7.5 66.4 50.7 20.2 15.0 16.3 26.7 130.3 36.5 55.3 27.7 44.5 116.5 31.1 38.8 43.3 27.2 149.7 3.6 23.2 126.2 41.8 252.4 122.9 61.2 273.8 282.5 18.4 34.6 73.4 41.7 15.4 PSMA1 "HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30" ENSG00000129084 "Proteasome subunit alpha 1" P25786 11 14504874-14643635 "Enzymes, Predicted intracellular proteins" Immunity "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB033765, HPA037646, HPA043891" Supported Enhanced Nucleoplasm NA NA 27000000 Nucleoplasm "CAB033765: AB_2253026, HPA037646: AB_10670386, HPA043891: AB_2678718" "unprognostic (1.72e-2)" "unprognostic (4.97e-2)" "unprognostic (7.33e-2)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (6.66e-3)" "prognostic unfavorable (3.79e-5)" "unprognostic (3.28e-3)" "unprognostic (7.44e-2)" "unprognostic (3.43e-3)" "unprognostic (8.27e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (4.03e-11)" "unprognostic (1.93e-1)" "unprognostic (1.69e-1)" "unprognostic (4.66e-2)" "unprognostic (1.23e-2)" 46.6 46.3 33.7 36.0 40.2 45.7 39.0 28.3 42.7 33.4 35.5 23.1 37.4 37.3 42.1 43.1 43.7 33.0 32.2 55.4 31.7 34.1 47.8 61.0 38.8 42.3 32.0 32.4 34.0 35.6 28.2 39.4 55.2 36.9 35.6 42.4 32.9 34.9 37.1 86.6 35.3 42.7 39.0 26.7 45.8 37.3 31.6 25.9 53.0 45.5 62.8 42.2 41.5 31.7 24.2 55.4 20.9 42.3 30.5 35.7 45.2 67.4 47.7 40.0 47.9 39.9 40.2 33.4 39.9 52.5 60.9 50.1 41.3 85.2 59.0 44.2 42.1 55.8 50.9 45.6 49.5 57.7 57.3 67.7 36.8 31.7 48.7 52.4 61.0 48.1 38.9 29.5 33.0 69.2 44.5 59.5 47.6 69.0 49.8 54.1 44.7 55.5 45.9 33.4 57.6 71.2 37.6 59.3 36.7 52.9 47.9 33.0 20.8 42.5 47.7 35.6 43.1 28.4 37.3 47.0 39.9 37.5 69.8 48.7 21.8 58.3 52.8 59.0 48.6 50.9 20.9 42.3 11.0 24.3 31.1 32.3 24.2 28.3 27.2 55.4 20.6 25.7 25.0 9.4 30.5 29.4 31.3 35.7 45.2 33.7 40.2 28.3 42.7 31.7 34.1 32.0 32.4 36.9 25.9 77.4 91.8 78.9 188.2 127.0 44.8 0.0 73.9 65.6 95.5 83.7 17.7 398.7 217.2 193.4 40.4 121.2 89.1 70.0 203.0 301.8 137.7 149.4 72.1 111.7 261.1 54.0 38.6 87.8 164.2 23.5 107.9 156.0 136.7 273.3 81.1 94.3 195.2 111.4 119.9 182.7 40.0 84.1 135.9 126.7 65.4 132.7 524.5 142.0 111.1 217.3 PSMA6 "IOTA, MGC22756, MGC2333, MGC23846, p27K, PROS27" ENSG00000100902 "Proteasome subunit alpha 6" P60900 14 35278633-35317493 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Late spermatids: 395.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003049 Approved Supported Nucleoplasm NA NA 19000000 Nucleoplasm "HPA003049: AB_1079703" "unprognostic (9.68e-3)" "unprognostic (5.91e-2)" "unprognostic (1.90e-2)" "unprognostic (8.07e-2)" "unprognostic (3.42e-2)" "unprognostic (4.11e-3)" "unprognostic (7.48e-2)" "unprognostic (1.25e-1)" "unprognostic (1.16e-1)" "prognostic favorable (3.27e-4)" "unprognostic (1.29e-3)" "unprognostic (2.63e-1)" "unprognostic (1.52e-2)" "unprognostic (2.05e-1)" "unprognostic (5.45e-2)" "unprognostic (3.49e-1)" "unprognostic (5.08e-2)" 33.8 42.7 26.7 31.4 38.8 37.1 38.7 24.2 35.0 28.0 35.8 19.4 24.5 32.2 31.0 30.2 37.9 24.7 20.3 54.2 30.5 27.6 47.3 49.0 37.3 36.4 30.1 36.8 31.1 36.7 14.2 35.8 61.2 31.8 22.5 38.6 18.1 27.3 25.5 94.6 31.8 39.5 27.3 25.2 35.7 28.9 67.5 26.5 86.2 26.0 37.2 38.1 28.8 24.5 37.9 68.5 41.4 65.1 49.9 54.8 104.8 59.7 44.2 33.1 33.6 27.3 29.2 66.2 31.3 38.3 47.4 43.1 41.1 43.3 40.0 60.3 30.4 28.5 42.8 38.6 35.7 56.8 40.2 21.1 31.4 32.2 122.9 31.0 65.3 29.4 22.2 29.7 33.1 42.2 23.6 40.0 68.7 33.5 28.0 38.2 63.3 99.9 55.8 31.6 49.2 50.4 148.9 33.6 32.0 40.5 76.8 35.2 29.8 34.9 51.5 32.9 29.2 61.6 43.3 33.3 30.5 30.2 31.0 34.6 29.9 65.4 73.1 24.8 41.4 34.4 32.8 65.1 41.4 46.3 59.4 46.2 37.9 44.8 47.1 66.8 29.9 35.9 43.0 23.5 49.9 56.6 68.5 54.8 104.8 26.7 38.8 24.2 35.0 30.5 27.6 30.1 36.8 31.8 26.5 41.7 28.9 14.5 10.6 29.7 14.3 1.2 15.3 83.0 59.1 14.0 23.6 27.2 18.3 26.4 121.5 28.7 25.7 23.3 31.8 22.0 14.4 12.4 53.1 20.3 20.7 23.8 17.2 30.7 36.5 395.6 21.0 54.6 23.6 27.1 17.6 8.7 26.5 21.0 16.3 18.9 17.8 12.9 22.1 22.9 17.9 29.0 34.6 29.4 22.2 15.3 PSMB1 "HC5, PMSB1" ENSG00000008018 "Proteasome subunit beta 1" P20618 6 170535117-170553341 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029635, HPA029637, CAB033911" Enhanced Supported Nucleoplasm NA NA 14000000 Nucleoplasm "CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793" "unprognostic (2.78e-2)" "unprognostic (3.10e-2)" "unprognostic (6.73e-2)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (5.41e-3)" "unprognostic (2.36e-2)" "unprognostic (3.32e-2)" "unprognostic (8.39e-2)" "unprognostic (4.28e-2)" "unprognostic (3.07e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.76e-6)" "unprognostic (3.63e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-3)" "unprognostic (9.62e-2)" 60.8 59.3 38.5 40.4 53.7 53.2 55.0 31.4 46.4 40.5 48.6 37.9 49.9 45.1 56.8 90.6 51.7 49.8 43.1 71.9 40.9 40.1 56.4 93.2 46.9 66.7 40.8 41.1 43.7 67.3 35.4 48.4 80.6 48.4 40.6 52.7 43.8 43.6 50.0 109.3 56.1 46.0 59.7 44.9 51.4 46.9 47.1 38.1 47.1 47.9 75.2 60.4 50.1 42.0 71.0 98.1 51.9 81.9 71.6 79.3 104.1 43.1 40.6 57.9 74.7 51.8 40.7 61.7 41.3 60.8 69.0 70.5 88.7 37.3 63.2 54.0 55.3 63.5 43.7 64.1 65.7 72.0 64.2 72.2 54.0 41.2 111.2 60.8 63.2 48.1 46.4 40.4 66.5 43.2 47.5 58.8 40.0 106.5 54.3 62.8 116.2 47.3 88.3 52.8 78.8 55.9 45.9 45.9 80.1 71.5 26.0 57.9 47.3 39.7 61.8 31.6 53.9 42.2 91.6 44.7 28.1 45.1 68.3 76.3 46.5 61.4 78.4 65.6 71.7 60.2 40.1 81.9 51.9 53.2 75.8 62.1 71.0 62.2 57.7 98.1 53.4 59.2 57.2 47.5 71.6 67.6 55.8 79.3 104.1 38.5 53.7 31.4 46.4 40.9 40.1 40.8 41.1 48.4 38.1 104.2 145.5 160.9 308.1 192.9 104.7 211.7 249.7 199.4 117.2 134.3 39.3 748.5 339.8 368.1 245.5 214.1 220.2 116.8 565.6 684.7 208.1 230.0 184.8 268.0 350.5 112.8 158.7 149.8 159.1 57.7 237.3 212.8 219.4 422.0 169.6 196.7 419.2 227.4 221.7 419.5 99.6 187.5 291.5 198.6 166.3 188.6 1001.7 194.1 216.2 303.9 PSMB2 HC7-I ENSG00000126067 "Proteasome subunit beta 2" P49721 1 35599544-35641844 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026322, HPA026324" Approved Enhanced Nucleoplasm NA NA 15000000 Nucleoplasm "HPA026322: AB_1855821, HPA026324: AB_1855822" "unprognostic (3.54e-2)" "unprognostic (8.53e-2)" "unprognostic (1.63e-3)" "unprognostic (6.93e-2)" "unprognostic (6.41e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.49e-7)" "unprognostic (2.81e-2)" "unprognostic (5.23e-2)" "unprognostic (3.34e-3)" "unprognostic (7.87e-2)" "unprognostic (4.45e-1)" "prognostic unfavorable (2.80e-6)" "unprognostic (1.65e-1)" "unprognostic (2.83e-1)" "unprognostic (3.77e-2)" "unprognostic (2.93e-2)" 26.5 30.5 29.4 28.0 35.1 37.2 25.3 20.1 50.9 23.2 26.1 35.9 15.4 27.5 27.8 25.0 30.4 26.5 20.7 23.8 30.6 33.4 27.9 63.8 24.6 30.4 30.6 24.8 22.7 24.6 22.0 21.8 37.5 32.6 23.1 27.8 22.8 23.0 24.9 54.7 28.2 27.0 28.7 32.5 29.3 22.8 23.5 21.5 42.8 22.7 29.1 34.0 23.9 22.4 24.6 30.2 19.4 35.3 25.1 28.1 25.4 40.9 25.7 28.1 19.1 14.9 17.9 35.5 19.4 22.9 40.1 32.7 30.4 49.3 40.9 45.7 22.9 24.5 25.5 36.1 32.2 33.8 33.3 33.5 37.1 28.1 29.7 26.9 38.9 21.9 19.5 20.4 47.9 23.2 16.4 31.5 33.9 44.2 23.4 25.8 18.8 50.6 29.1 37.5 18.2 27.4 31.4 28.6 28.8 27.8 22.2 24.9 18.3 22.3 21.1 30.1 33.5 15.5 17.7 21.6 20.1 23.7 18.9 45.9 20.2 32.4 41.5 29.7 41.0 34.8 17.4 27.0 19.4 23.1 33.0 23.4 24.6 23.1 24.2 29.7 19.3 16.7 20.9 9.7 25.1 35.3 30.2 28.1 25.4 29.4 35.1 20.1 50.9 30.6 33.4 30.6 24.8 32.6 21.5 59.6 61.8 70.7 120.5 98.8 48.7 51.8 71.4 68.3 47.8 62.8 15.7 342.2 122.7 240.6 77.0 88.7 69.5 23.3 197.3 290.1 75.1 97.6 33.6 136.0 195.7 55.6 94.4 84.7 99.4 12.8 93.2 93.1 72.6 231.8 76.2 58.8 222.8 74.6 85.9 183.0 36.4 90.5 72.1 168.5 124.8 97.5 369.7 82.8 96.1 159.8 PSMC3IP "GT198, Hop2, HUMGT198A, TBPIP" ENSG00000131470 "PSMC3 interacting protein" Q9P2W1 17 42572315-42577831 "Disease related genes, Predicted intracellular proteins" "DNA recombination, Meiosis" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.8" "Cell type enhanced" "Detected in many" 14 "Spermatocytes: 109.9;Spermatogonia: 37.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044439 Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA044439: AB_10964210" "unprognostic (2.98e-1)" "unprognostic (3.66e-1)" "unprognostic (1.33e-1)" "unprognostic (2.87e-1)" "unprognostic (6.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.28e-7)" "unprognostic (6.22e-2)" "unprognostic (6.14e-2)" "unprognostic (2.47e-1)" "unprognostic (7.26e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (9.41e-4)" "unprognostic (6.03e-2)" "unprognostic (3.68e-1)" "unprognostic (1.39e-2)" "unprognostic (1.82e-1)" 4.0 2.0 6.6 4.2 12.1 9.2 5.2 5.0 7.7 3.4 4.3 7.0 4.1 1.7 5.2 5.5 3.9 8.6 2.4 2.1 7.4 6.3 2.8 1.2 3.1 4.7 9.7 4.1 4.8 2.7 8.5 2.1 5.4 8.7 5.5 4.3 2.4 2.5 5.7 1.9 4.1 1.9 6.9 12.7 2.3 2.8 29.8 9.9 3.1 2.5 1.5 7.1 4.2 3.3 2.4 6.2 2.2 0.5 0.2 1.9 0.3 6.4 9.7 16.2 11.8 3.8 5.4 3.6 25.2 8.0 22.1 27.4 9.6 4.2 6.9 5.6 7.4 8.8 9.8 12.5 9.6 25.5 9.5 10.5 4.1 21.8 11.4 0.5 14.6 4.7 1.8 2.2 34.9 11.7 3.0 6.4 9.1 14.0 12.6 19.2 7.5 9.8 9.1 9.9 7.2 9.2 10.4 16.5 6.2 5.0 5.3 21.6 13.7 10.1 3.7 10.2 8.4 9.0 6.4 3.0 24.0 13.7 17.9 41.6 9.9 16.8 9.9 11.2 6.9 25.9 0.0 0.2 1.8 1.9 0.3 1.9 2.4 0.9 1.7 0.2 0.8 0.3 0.9 2.2 0.2 0.5 6.2 1.2 0.3 6.6 12.1 5.0 7.7 7.4 6.3 9.7 4.1 8.7 9.9 3.0 3.0 3.0 2.5 4.7 5.8 0.8 2.5 22.7 3.4 3.5 9.8 7.6 0.0 3.4 9.2 3.2 0.0 23.3 2.8 16.4 4.3 1.3 1.1 0.9 6.3 0.0 0.0 2.5 3.8 9.4 4.9 2.4 5.0 9.0 0.7 4.6 1.6 0.0 8.1 1.9 13.3 19.4 9.2 109.9 37.9 3.6 4.3 1.9 2.6 0.7 PSMD14 "pad1, POH1, Rpn11" ENSG00000115233 "Proteasome 26S subunit, non-ATPase 14" O00487 2 161308038-161411717 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002114, HPA003828" Approved Supported Nucleoplasm NA NA 9400 Nucleoplasm "HPA002114: AB_1855850, HPA003828: AB_2667057" "unprognostic (3.50e-3)" "unprognostic (1.48e-1)" "unprognostic (9.61e-2)" "unprognostic (6.63e-2)" "unprognostic (2.57e-1)" "unprognostic (7.61e-3)" "prognostic unfavorable (2.66e-8)" "unprognostic (3.11e-2)" "unprognostic (4.04e-2)" "unprognostic (3.90e-3)" "unprognostic (9.84e-3)" "unprognostic (3.02e-1)" "prognostic unfavorable (3.10e-6)" "unprognostic (2.86e-2)" "unprognostic (4.70e-2)" "unprognostic (3.54e-1)" "unprognostic (1.66e-1)" 18.2 26.3 24.8 19.9 25.0 16.8 19.8 21.0 36.9 14.7 17.9 13.5 11.0 15.0 15.6 16.3 23.7 14.4 12.2 22.3 24.8 26.1 23.5 33.7 16.2 24.9 26.2 16.1 11.8 15.0 18.6 24.3 21.5 27.9 16.8 21.9 13.0 15.1 16.7 60.8 16.7 14.3 20.6 26.0 20.2 13.6 19.0 15.3 22.1 18.2 21.6 25.6 15.2 13.1 22.9 27.2 13.1 24.6 23.6 29.6 24.7 35.5 30.9 34.8 30.5 25.4 21.7 42.6 37.4 36.0 53.6 43.7 45.4 30.3 42.2 57.1 27.2 31.8 27.4 37.9 39.6 53.6 43.9 28.5 42.1 25.0 50.9 31.2 40.8 25.1 16.5 30.0 60.5 56.6 20.8 39.8 25.3 45.6 30.4 44.5 33.9 30.1 30.8 48.3 26.2 46.9 26.0 33.8 41.2 47.2 30.5 30.3 22.3 25.4 28.7 34.6 30.2 19.5 26.2 31.4 36.0 33.8 24.4 40.8 18.2 49.2 39.6 38.6 27.2 39.4 13.1 17.9 8.8 25.3 24.6 26.5 22.9 27.4 27.0 27.2 19.1 22.2 26.5 1.9 23.6 19.1 26.7 29.6 24.7 24.8 25.0 21.0 36.9 24.8 26.1 26.2 16.1 27.9 15.3 47.6 33.9 44.7 39.4 44.0 40.0 76.7 63.7 42.8 47.8 22.7 17.7 140.9 76.3 104.7 52.8 33.7 43.3 116.8 102.6 127.3 45.3 47.7 48.7 107.7 92.8 44.5 50.4 38.6 35.5 24.8 25.6 45.0 45.5 84.8 42.0 72.5 114.5 46.3 32.2 81.6 54.2 32.3 39.1 93.8 67.0 48.9 184.2 43.6 58.4 43.1 PSMD7 "MOV34, P40, Rpn8, S12" ENSG00000103035 "Proteasome 26S subunit, non-ATPase 7" P51665 16 74296775-74306288 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 498.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019379, HPA049824, HPA056069" Enhanced Enhanced Nucleoplasm NA NA 340000 Nucleoplasm "CAB019379: , HPA049824: AB_2680899, HPA056069: AB_2683025" "unprognostic (4.75e-3)" "unprognostic (1.30e-1)" "unprognostic (2.84e-2)" "unprognostic (6.95e-2)" "unprognostic (7.62e-2)" "prognostic unfavorable (6.64e-5)" "prognostic unfavorable (7.71e-6)" "unprognostic (1.97e-2)" "unprognostic (6.51e-2)" "unprognostic (1.91e-2)" "unprognostic (9.34e-3)" "unprognostic (1.34e-2)" "unprognostic (2.52e-2)" "unprognostic (5.06e-3)" "unprognostic (7.04e-2)" "unprognostic (2.12e-1)" "unprognostic (1.86e-2)" 26.5 30.3 23.6 20.8 32.8 45.7 21.7 21.7 34.4 17.7 26.6 22.4 17.0 19.8 24.3 26.1 31.5 16.9 17.6 59.0 22.0 21.7 25.0 47.8 20.3 23.5 24.9 22.9 17.1 18.8 23.2 17.4 44.1 36.1 30.3 28.3 16.7 22.8 27.1 88.8 30.6 22.3 26.4 25.1 27.1 21.8 20.3 22.4 30.7 18.2 34.4 28.4 34.6 22.3 50.3 71.0 64.7 60.8 44.6 56.5 58.1 27.2 45.4 33.7 17.2 24.4 25.3 42.6 38.4 32.4 47.3 43.9 60.1 38.0 37.4 42.7 31.1 20.9 35.4 26.9 34.8 42.3 22.1 29.6 28.9 35.3 45.8 32.2 46.7 49.3 23.2 35.1 42.6 42.8 21.1 41.4 23.7 42.7 16.6 30.1 67.6 26.8 44.2 36.6 27.9 22.8 38.8 21.8 49.7 25.0 41.2 21.5 24.3 37.3 14.0 22.0 26.9 29.7 32.2 37.5 28.4 23.8 30.9 28.7 35.6 45.7 109.0 38.7 34.2 29.3 45.6 58.4 64.7 49.8 60.8 48.5 50.3 49.7 52.0 71.0 36.1 48.7 49.9 34.8 44.6 60.2 59.6 56.5 58.1 23.6 32.8 21.7 34.4 22.0 21.7 24.9 22.9 36.1 22.4 62.5 54.4 81.1 136.0 92.7 50.9 45.6 63.7 85.6 83.0 43.6 7.9 286.0 68.0 118.6 92.9 69.2 93.5 70.0 165.2 180.6 80.2 157.1 101.6 127.1 167.8 54.0 82.1 71.8 72.2 15.2 52.3 110.5 94.5 141.5 71.9 64.7 136.6 87.7 61.5 80.1 48.3 90.5 77.3 113.4 94.9 113.0 498.5 82.8 82.9 180.5 PSME2 PA28beta ENSG00000100911 "Proteasome activator subunit 2" Q9UL46 14 24143362-24147570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 120.2" "Cell type enhanced" "Detected in many" 6 "monocytes: 1118.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA062661 Approved Nucleoplasm NA NA 8000000 Nucleoplasm "HPA062661: AB_2684825" "prognostic favorable (1.27e-4)" "unprognostic (7.55e-3)" "unprognostic (2.84e-1)" "unprognostic (8.72e-2)" "unprognostic (2.69e-1)" "unprognostic (1.50e-1)" "unprognostic (3.71e-1)" "unprognostic (1.02e-1)" "unprognostic (2.30e-2)" "unprognostic (2.90e-3)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.47e-5)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (6.43e-3)" "unprognostic (3.07e-3)" 15.4 43.4 14.9 33.9 17.1 16.4 17.1 14.2 14.3 17.5 42.7 9.9 33.5 63.3 17.6 30.2 24.4 17.6 31.3 15.8 13.1 14.7 36.3 64.6 27.5 38.7 13.9 11.0 20.7 26.4 14.6 30.1 25.9 15.3 22.2 35.5 14.3 28.2 36.8 13.6 15.1 102.2 18.6 12.3 61.5 21.4 12.5 13.8 32.7 27.5 27.9 35.9 20.0 18.5 38.8 48.9 20.0 112.2 49.9 45.1 120.2 18.7 19.5 12.6 28.5 9.4 13.7 18.7 11.1 25.9 35.3 44.2 15.1 43.7 25.6 6.5 12.4 36.0 16.9 7.6 19.5 21.2 40.5 6.5 14.9 10.9 60.3 30.4 21.0 22.5 13.6 6.0 24.4 9.9 14.3 17.3 17.1 7.3 32.3 13.5 41.6 41.0 31.0 4.3 31.1 26.5 38.7 19.3 27.9 23.9 44.0 7.7 10.2 20.3 34.6 14.4 7.0 17.7 25.1 13.2 17.6 16.2 8.1 20.2 30.1 39.2 28.4 12.9 23.0 21.9 8.3 60.5 20.0 43.6 112.2 45.1 38.8 43.6 42.8 48.9 29.4 32.8 39.9 19.4 49.9 71.7 35.8 41.7 120.2 14.9 17.1 14.2 14.3 13.1 14.7 13.9 11.0 15.3 13.8 47.6 112.2 196.6 142.5 137.6 37.8 61.3 160.5 129.8 102.4 111.7 21.6 275.9 253.7 303.1 9.6 150.1 574.8 0.0 494.7 240.1 145.1 162.7 140.6 195.6 314.2 27.0 94.0 60.2 127.5 9.7 68.4 275.5 129.9 1118.1 171.6 43.0 283.1 252.6 73.2 281.2 17.2 45.3 111.2 53.1 17.4 122.2 190.9 197.9 289.3 191.8 PSME3 "Ki, PA28-gamma, PA28G, REG-GAMMA" ENSG00000131467 "Proteasome activator subunit 3" P61289 17 42824385-42843758 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 225.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008388, HPA012510" Supported Enhanced Nucleoplasm NA NA 260000 Nucleoplasm "CAB008388: AB_592552, HPA012510: AB_1855752" "unprognostic (4.22e-2)" "unprognostic (2.38e-2)" "unprognostic (1.63e-3)" "unprognostic (2.65e-1)" "unprognostic (1.36e-1)" "unprognostic (8.30e-3)" "prognostic unfavorable (5.41e-5)" "unprognostic (6.02e-3)" "unprognostic (2.30e-1)" "unprognostic (1.26e-2)" "unprognostic (1.89e-2)" "unprognostic (2.41e-1)" "unprognostic (5.17e-2)" "unprognostic (4.09e-2)" "unprognostic (1.17e-1)" "unprognostic (5.41e-3)" "unprognostic (1.02e-1)" 29.8 32.4 31.7 27.8 37.6 28.2 25.9 22.7 52.7 25.3 28.6 25.3 16.7 26.3 28.4 18.8 44.9 24.8 22.1 32.1 24.8 25.9 47.9 48.5 24.8 32.5 28.7 28.3 27.1 31.0 38.1 21.3 31.3 34.9 23.9 32.0 26.8 29.2 27.5 49.7 32.3 30.1 28.9 21.0 32.8 30.5 32.7 20.4 34.5 29.7 20.4 39.5 31.1 24.8 26.2 38.0 50.4 43.3 32.4 32.3 38.4 39.0 64.8 29.8 31.7 27.3 27.9 40.6 44.9 34.2 62.0 43.8 54.0 29.7 60.0 35.2 38.7 33.8 35.3 48.2 47.4 72.9 30.7 48.3 32.0 33.8 38.6 30.9 70.3 37.1 27.3 32.6 46.8 46.9 17.6 37.9 32.5 62.6 21.4 41.9 22.7 66.0 24.5 44.1 56.4 35.4 43.5 54.3 47.8 32.8 55.4 37.4 38.3 27.4 23.0 34.7 46.2 53.2 30.3 36.5 48.7 34.1 40.2 65.2 33.5 51.6 75.8 34.3 40.6 49.6 22.9 38.2 35.0 30.1 43.3 32.3 26.2 24.8 28.9 38.0 24.1 23.1 26.1 50.4 32.4 35.2 21.3 28.9 38.4 31.7 37.6 22.7 52.7 24.8 25.9 28.7 28.3 34.9 20.4 17.9 22.9 26.1 27.0 26.9 12.0 31.9 25.5 17.4 18.2 27.9 13.7 38.0 23.2 57.0 225.1 19.7 27.4 0.0 45.8 61.2 19.5 29.4 21.9 24.5 43.4 12.7 23.7 17.2 29.8 99.0 14.4 20.8 15.1 42.3 22.2 16.0 52.4 20.9 18.7 37.0 18.5 19.4 21.9 30.2 45.8 41.3 63.7 17.0 27.9 49.5 PSME4 "KIAA0077, PA200" ENSG00000068878 "Proteasome activator subunit 4" Q14997 2 53864067-53970840 "Predicted intracellular proteins" "Differentiation, DNA damage, DNA repair, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 49.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060922 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA060922: AB_2684386" "unprognostic (2.77e-2)" "unprognostic (1.57e-1)" "unprognostic (5.00e-2)" "prognostic unfavorable (8.99e-4)" "unprognostic (7.26e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (4.84e-4)" "unprognostic (4.76e-2)" "unprognostic (6.67e-2)" "unprognostic (5.65e-2)" "unprognostic (3.72e-3)" "unprognostic (1.38e-1)" "unprognostic (1.80e-3)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (1.60e-1)" "unprognostic (2.89e-1)" 11.3 8.4 5.2 10.1 7.8 9.9 8.5 4.2 8.3 12.2 8.0 9.1 7.0 3.9 11.2 5.9 8.8 7.5 10.6 30.9 6.2 3.4 4.9 12.2 11.3 7.9 8.7 5.1 6.6 7.0 7.4 8.4 6.1 6.7 6.8 6.2 6.1 14.2 8.6 49.8 7.1 6.8 11.6 4.1 6.4 9.5 23.8 9.4 8.6 9.0 11.7 8.6 11.5 10.1 4.3 2.0 2.4 1.3 2.3 3.3 0.8 15.6 11.0 17.2 4.9 5.8 12.4 10.5 16.5 15.7 18.2 14.9 17.2 6.5 22.6 14.9 17.9 8.8 10.8 19.5 14.5 31.8 15.8 9.9 33.8 11.2 23.0 7.5 17.7 10.0 9.3 8.9 20.7 16.8 7.6 18.7 6.1 27.3 14.7 16.3 6.5 10.7 7.3 15.6 8.2 9.3 12.8 23.9 14.8 9.9 16.5 12.1 13.8 10.6 14.8 8.9 11.3 11.1 7.5 21.6 16.0 12.9 11.6 15.2 9.1 9.0 14.1 12.5 15.2 9.7 2.2 0.8 2.4 3.3 1.3 1.8 3.2 2.2 2.0 1.2 4.3 2.4 3.0 2.2 2.3 1.1 2.0 1.6 0.8 5.2 7.8 4.2 8.3 6.2 3.4 8.7 5.1 6.7 9.4 14.9 34.9 28.3 54.9 67.3 19.7 59.7 22.9 26.8 46.6 21.0 43.2 13.9 3.3 18.5 73.6 25.2 13.7 23.3 31.7 10.5 30.0 89.0 27.7 30.6 17.2 23.8 38.9 19.6 21.4 71.5 19.5 25.3 27.0 19.0 15.2 14.6 36.2 11.6 9.9 8.4 28.4 12.9 26.9 21.4 18.5 57.7 24.8 27.7 11.9 88.5 PSORS1C1 "C6orf16, SEEK1" ENSG00000204540 "Psoriasis susceptibility 1 candidate 1" Q9UIG5 6 31114750-31140092 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "testis: 52.2" "Group enriched" "Detected in many" 5 "Early spermatids: 289.3;Late spermatids: 996.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;hTCEpi: 5.5;JURKAT: 2.4;U-2 OS: 1.7" HPA045049 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045049: " "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.72e-1)" "unprognostic (9.23e-2)" "unprognostic (4.77e-3)" "unprognostic (8.48e-2)" "unprognostic (3.05e-3)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "unprognostic (9.56e-2)" "unprognostic (5.72e-3)" "unprognostic (4.80e-2)" "unprognostic (1.59e-1)" "unprognostic (6.33e-2)" "unprognostic (1.30e-1)" 0.9 0.7 1.1 0.7 2.8 0.7 0.8 0.5 1.5 3.4 6.9 2.2 2.6 0.7 7.7 6.4 2.1 1.1 7.5 0.7 0.7 0.6 1.0 0.7 3.7 0.7 4.4 0.0 1.9 1.5 0.7 0.4 1.7 3.0 1.7 1.1 0.2 0.9 1.8 0.7 2.0 6.0 6.5 3.4 0.7 1.1 52.2 0.9 0.0 1.8 1.1 0.7 3.6 3.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 5.5 0.6 1.0 0.0 0.0 2.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.8 0.5 1.5 0.7 0.6 4.4 0.0 3.0 0.9 17.9 2.7 0.0 3.6 7.8 0.0 2.0 17.8 0.0 3.4 8.7 0.0 0.1 0.0 13.8 289.3 3.6 20.7 0.0 1.9 0.4 8.0 2.6 0.0 0.0 0.3 0.0 2.9 3.7 0.0 996.1 8.6 0.0 3.3 1.0 4.6 0.5 9.4 8.0 6.3 0.7 0.0 6.5 1.4 117.0 17.9 9.3 0.1 0.0 4.7 2.3 PTBP1 "HNRNP-I, HNRPI, pPTB, PTB, PTB-1, PTB2, PTB3, PTB4" ENSG00000011304 "Polypyrimidine tract binding protein 1" P26599 19 797075-812327 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013507 Supported Supported Nucleoplasm NA NA 3100000 Nucleoplasm "CAB013507: AB_2533082" "unprognostic (2.82e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-2)" "unprognostic (1.24e-1)" "unprognostic (6.01e-2)" "unprognostic (6.22e-2)" "prognostic unfavorable (2.71e-4)" "unprognostic (4.06e-3)" "unprognostic (2.08e-2)" "unprognostic (1.92e-2)" "unprognostic (5.47e-2)" "unprognostic (4.62e-3)" "unprognostic (2.41e-2)" "unprognostic (7.91e-3)" "unprognostic (4.28e-2)" "unprognostic (8.31e-2)" "unprognostic (3.72e-2)" 38.7 31.3 13.2 37.5 16.9 43.5 38.4 13.5 16.2 36.4 35.9 19.1 32.5 34.9 42.9 32.7 49.7 31.8 39.0 24.0 13.9 9.5 45.3 68.8 37.7 56.2 20.2 9.6 47.5 47.5 37.5 31.8 65.0 15.9 35.3 24.7 35.5 51.9 31.0 15.9 43.6 41.0 26.2 13.8 49.2 31.2 34.1 18.2 94.9 49.4 43.7 62.7 31.5 36.2 19.2 26.3 14.6 27.7 22.8 24.7 23.4 78.2 68.9 40.2 34.3 13.7 17.4 60.7 47.9 24.2 39.9 31.8 66.7 37.9 66.1 30.9 32.8 14.9 46.7 55.2 45.6 37.9 69.0 61.0 54.2 65.4 67.0 25.8 72.9 58.0 17.3 31.9 49.6 27.6 14.2 37.9 30.1 82.8 34.5 64.4 68.9 87.5 35.6 69.6 30.2 37.0 99.1 30.2 39.2 24.7 76.6 45.0 51.4 59.8 33.3 27.3 27.9 35.3 42.8 57.5 43.5 45.5 47.8 83.4 38.1 69.5 89.0 24.9 53.2 52.3 8.2 21.6 14.6 24.0 27.7 24.7 18.6 19.5 22.2 26.3 19.2 19.6 19.2 9.5 22.8 24.6 15.0 21.1 23.4 13.2 16.9 13.5 16.2 13.9 9.5 20.2 9.6 15.9 18.2 38.7 73.7 72.2 83.2 68.2 18.2 29.1 81.5 36.1 37.5 45.4 33.4 94.3 29.9 71.2 12.0 74.4 107.3 23.3 75.4 150.8 59.6 69.1 91.0 71.0 69.1 31.8 97.0 74.3 54.3 15.3 73.9 56.8 37.1 42.3 112.0 29.8 77.8 95.3 61.9 37.2 21.6 58.2 60.8 38.7 59.9 71.6 111.6 50.7 106.6 94.3 PTBP2 "brPTB, nPTB, PTB, PTBLP" ENSG00000117569 "Polypyrimidine tract binding protein 2" Q9UKA9 1 96721665-96823738 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 48.7;Spermatocytes: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047420 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047420: AB_10962353" "unprognostic (2.14e-2)" "unprognostic (3.01e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (7.80e-4)" "unprognostic (1.70e-2)" "unprognostic (1.25e-2)" "unprognostic (2.41e-5)" "unprognostic (2.26e-3)" "unprognostic (1.50e-2)" "unprognostic (6.83e-3)" "unprognostic (1.70e-2)" "unprognostic (3.31e-2)" "unprognostic (5.48e-3)" "unprognostic (3.01e-2)" "unprognostic (1.75e-1)" "unprognostic (5.24e-2)" "unprognostic (1.27e-2)" 12.5 10.5 17.1 9.9 21.2 34.4 15.3 22.0 25.8 16.7 26.6 20.0 11.3 7.6 23.6 11.2 12.8 11.9 10.7 7.8 18.8 18.4 12.0 8.1 7.3 9.8 17.9 18.9 14.6 7.3 6.1 22.0 8.1 21.7 16.3 13.0 9.0 7.4 17.3 15.4 8.3 11.0 28.1 18.6 10.3 11.6 35.4 19.9 16.6 14.7 6.8 8.4 21.1 12.8 3.6 1.6 1.4 1.8 4.1 4.2 0.7 3.5 1.9 16.7 8.8 4.0 4.9 9.4 3.2 3.5 5.5 5.1 2.4 3.5 12.2 3.7 2.1 12.1 2.3 10.0 2.6 8.0 2.0 3.0 6.7 5.6 3.1 2.3 3.4 3.5 2.7 1.6 6.9 2.9 4.4 2.7 5.9 4.9 3.3 7.2 1.2 11.0 11.1 10.2 1.4 4.4 6.5 39.6 1.8 5.6 2.0 9.6 9.9 4.1 2.7 4.7 8.7 2.6 7.0 2.6 3.8 7.5 3.1 4.1 2.7 2.0 14.2 1.8 5.5 1.6 0.9 1.4 0.9 2.7 1.7 2.0 3.5 3.5 2.5 0.8 3.6 4.2 2.9 1.4 4.1 1.8 1.6 3.2 0.7 17.1 21.2 22.0 24.7 18.8 18.4 17.9 18.9 21.7 19.9 8.9 11.5 10.8 8.8 12.4 26.4 10.8 5.1 8.1 5.7 19.2 13.7 4.6 11.6 5.9 3.7 14.6 4.0 0.0 4.4 3.6 9.3 8.6 7.0 8.2 2.9 28.6 23.5 8.0 11.3 5.3 8.3 7.7 13.5 6.4 6.2 48.7 4.2 3.5 7.4 6.2 21.7 6.5 27.8 71.4 31.7 6.1 1.7 8.7 4.7 4.8 PTBP3 "DKFZp781I1117, ROD1" ENSG00000119314 "Polypyrimidine tract binding protein 3" O95758 9 112217716-112333667 "Predicted intracellular proteins" "Differentiation, Erythrocyte maturation, mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048374 Approved Nucleoplasm NA NA Nucleoplasm "HPA048374: AB_2680376" "unprognostic (6.12e-2)" "unprognostic (3.05e-1)" "unprognostic (2.77e-2)" "unprognostic (1.33e-1)" "unprognostic (2.44e-1)" "unprognostic (2.12e-1)" "unprognostic (4.38e-3)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.39e-2)" "unprognostic (6.23e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (1.17e-1)" "prognostic favorable (2.51e-4)" "unprognostic (1.72e-2)" "unprognostic (4.99e-2)" "unprognostic (3.04e-2)" "unprognostic (5.10e-2)" 22.4 9.4 7.2 24.5 9.2 22.9 26.3 9.5 6.8 17.2 21.7 5.6 18.9 17.7 14.3 18.9 38.4 10.0 17.2 11.6 6.1 8.7 26.8 12.7 25.1 37.2 6.2 4.5 13.0 17.9 9.0 17.8 25.8 6.6 13.8 22.1 9.0 20.2 22.6 8.0 25.0 32.4 12.8 11.4 23.9 20.9 22.6 6.6 41.7 12.6 30.7 38.4 22.1 21.5 7.0 11.8 23.9 9.5 4.3 8.7 4.5 20.0 21.3 8.1 7.0 7.2 7.9 41.5 8.2 6.7 10.1 10.5 24.2 30.1 23.0 9.2 10.6 8.0 28.5 11.2 23.4 13.5 25.6 3.9 23.3 8.8 17.0 9.1 30.5 28.4 8.9 15.9 13.5 18.7 6.4 17.1 17.9 31.1 21.6 11.5 18.7 30.1 8.3 12.8 31.0 7.3 19.6 27.7 11.6 14.9 26.6 10.2 6.5 16.3 21.4 7.9 18.2 25.3 13.8 13.2 8.9 12.2 12.8 10.1 11.1 27.4 20.9 7.7 15.6 8.7 14.2 6.3 11.8 8.4 7.7 8.7 5.5 6.3 6.8 7.2 7.0 5.0 6.0 23.9 4.3 9.5 11.8 6.5 4.5 7.2 9.2 9.5 6.8 6.1 8.7 6.2 4.5 6.6 6.6 26.8 59.3 29.8 34.2 71.2 7.7 6.7 63.7 69.6 70.5 108.2 17.7 29.6 24.9 37.2 53.1 41.4 73.5 46.7 61.6 89.7 27.7 65.8 62.5 27.0 49.5 7.9 86.8 43.6 100.8 105.3 20.1 76.6 27.0 63.1 73.2 3.5 88.0 63.3 17.7 25.4 15.7 19.4 25.9 17.2 19.8 90.8 29.3 57.3 69.2 200.8 PTF1A "bHLHa29, PTF1-p48" ENSG00000168267 "Pancreas specific transcription factor, 1a" Q7RTS3 10 23192327-23194252 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 154 "pancreas: 129.8" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 1.3;Exocrine glandular cells: 4.2;Pancreatic endocrine cells: 1.3;Spermatocytes: 3.3" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "U-2 OS: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" CAB022612 Approved Nucleoplasm NA NA Nucleoplasm "CAB022612: " "unprognostic (2.02e-1)" "unprognostic (1.85e-1)" "unprognostic (4.49e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 129.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.7 0.0 0.0 0.0 0.0 0.0 PTOV1 ENSG00000104960 "Prostate tumor overexpressed 1" Q86YD1 19 49850735-49860744 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 255.0;Late spermatids: 494.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051812, HPA075125" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA051812: , HPA075125: AB_2732280" "unprognostic (2.70e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (6.64e-4)" "unprognostic (4.68e-2)" "unprognostic (1.37e-1)" "unprognostic (6.31e-2)" "unprognostic (1.94e-2)" "unprognostic (1.40e-1)" "unprognostic (2.70e-1)" "unprognostic (9.08e-2)" "prognostic favorable (9.20e-4)" "unprognostic (4.65e-2)" "unprognostic (3.22e-2)" "unprognostic (2.47e-1)" "unprognostic (1.26e-2)" "unprognostic (5.27e-2)" "unprognostic (6.70e-2)" 24.1 49.1 31.6 23.7 33.6 26.8 27.3 37.8 47.1 23.7 20.9 32.5 28.4 25.0 29.9 28.1 16.3 24.9 24.6 23.5 31.1 34.1 24.9 29.3 19.1 22.5 32.2 30.3 34.3 39.3 26.9 40.1 24.5 28.5 32.6 7.3 19.5 44.6 27.4 70.2 23.6 28.8 14.3 29.0 28.9 27.3 27.4 27.9 24.8 33.0 18.6 11.4 18.9 30.4 7.9 9.9 9.5 3.5 6.0 5.1 1.5 11.8 24.7 25.1 26.9 3.5 5.8 15.4 14.7 13.1 13.8 14.5 13.4 20.7 12.9 14.1 7.3 9.4 13.3 9.3 11.4 3.3 33.6 62.0 8.3 19.2 20.8 9.1 6.8 17.1 11.0 7.4 5.8 2.4 9.3 11.4 18.4 19.4 15.7 6.3 14.7 30.7 31.1 16.1 8.6 22.6 37.4 10.2 18.0 11.9 21.0 32.6 35.6 12.6 14.8 6.2 6.6 14.4 7.6 16.4 16.5 27.3 9.8 11.9 16.6 9.9 16.9 17.0 9.7 20.8 7.9 3.5 5.0 3.6 3.0 4.7 7.9 4.0 3.1 2.4 7.8 5.1 4.7 9.5 6.0 1.7 9.9 1.6 1.5 31.6 33.6 37.8 47.1 31.1 34.1 32.2 30.3 28.5 27.9 35.7 25.5 28.4 70.8 32.4 46.5 25.7 61.1 32.1 27.3 41.8 17.7 90.7 76.3 25.5 255.0 32.2 66.7 23.3 22.8 72.7 56.7 80.2 15.0 50.8 43.9 33.4 95.7 33.7 24.0 494.5 59.5 28.7 42.2 10.8 58.5 74.1 33.9 46.3 75.7 105.6 42.1 58.2 48.4 33.9 59.8 31.7 128.5 22.4 50.2 60.4 PTPDC1 "FLJ37312, PTP9Q22" ENSG00000158079 "Protein tyrosine phosphatase domain containing 1" A2A3K4 9 94030794-94109856 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.3" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0" "Group enriched" "Detected in many" 5 "B-cells: 1.1;T-cells: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016747, HPA026832" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA016747: AB_1855908, HPA026832: AB_10602917" "unprognostic (3.99e-2)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (4.91e-2)" "unprognostic (1.94e-1)" "unprognostic (3.64e-2)" "unprognostic (1.90e-3)" "unprognostic (4.71e-1)" "unprognostic (2.43e-1)" "unprognostic (2.56e-1)" "unprognostic (3.49e-2)" "unprognostic (3.55e-2)" "unprognostic (2.48e-2)" "unprognostic (2.45e-2)" "unprognostic (2.17e-1)" "unprognostic (1.28e-1)" "unprognostic (2.61e-2)" 7.0 12.0 7.6 4.4 32.3 1.5 6.4 4.7 16.4 4.7 4.9 25.3 1.4 3.1 6.2 4.9 4.4 4.4 4.7 10.0 12.1 6.9 5.1 2.4 6.8 3.7 13.9 8.9 6.3 12.2 6.8 8.9 3.7 19.9 5.6 5.9 4.1 4.3 4.4 7.0 6.2 3.6 8.3 20.5 3.0 7.1 15.0 13.0 1.6 5.1 1.3 3.9 4.9 3.6 1.1 0.3 0.0 0.2 0.0 2.0 0.1 6.1 2.7 4.9 6.3 6.1 8.5 6.5 4.5 3.2 4.6 3.9 2.6 5.2 5.2 3.1 3.4 10.6 4.9 5.0 2.9 4.5 7.0 1.4 1.2 7.2 2.8 8.0 1.4 4.0 8.4 10.5 7.0 9.8 2.8 4.9 8.6 3.0 0.0 8.6 3.3 5.2 2.2 3.4 5.0 5.1 5.6 9.7 0.0 2.6 1.5 4.3 5.5 6.2 5.8 9.7 6.8 3.1 2.5 6.9 6.2 3.8 9.5 5.4 7.6 8.4 0.7 4.6 2.5 8.6 0.0 0.2 0.0 0.1 0.0 0.1 0.4 1.1 0.0 0.3 1.1 2.0 0.7 0.0 0.0 0.2 0.2 0.0 0.1 7.6 32.3 4.7 16.4 12.1 6.9 13.9 8.9 19.9 13.0 0.0 7.7 1.9 2.6 4.2 10.5 8.4 2.5 1.4 1.2 5.2 9.8 0.3 3.3 2.9 8.0 5.7 0.9 0.0 2.5 1.6 5.0 1.9 5.7 0.8 2.7 4.8 3.4 6.2 0.3 3.8 3.4 2.7 3.3 0.0 2.4 2.3 5.0 1.1 13.4 1.0 9.8 19.4 4.8 12.0 15.9 3.8 0.2 2.5 2.3 1.7 PTPN14 PEZ ENSG00000152104 "Protein tyrosine phosphatase, non-receptor type 14" Q15678 1 214348696-214552449 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB011469, HPA053864, CAB069441" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "CAB011469: AB_299202, CAB069441: , HPA053864: AB_2682281" "unprognostic (1.54e-1)" "unprognostic (8.19e-2)" "unprognostic (5.42e-5)" "unprognostic (1.42e-1)" "unprognostic (2.91e-1)" "unprognostic (5.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.58e-1)" "unprognostic (2.84e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.29e-4)" "unprognostic (7.43e-2)" "unprognostic (8.34e-3)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.16e-1)" "unprognostic (2.21e-1)" "unprognostic (4.81e-3)" 13.6 10.0 3.0 6.5 2.4 0.2 15.0 0.8 3.7 13.6 8.5 2.6 11.0 1.0 15.4 8.0 8.6 9.2 9.7 7.0 3.5 1.9 11.2 2.0 12.2 6.6 2.4 1.3 11.8 5.0 6.3 4.0 13.2 4.9 10.6 2.9 7.2 9.2 23.4 21.6 18.8 3.5 9.4 4.3 5.3 5.7 8.3 2.4 1.4 8.1 6.9 3.7 12.4 17.7 1.0 0.5 1.9 0.4 1.0 0.6 0.1 8.8 3.9 3.2 4.7 5.6 9.6 9.5 10.1 9.4 7.7 6.5 7.9 4.6 0.0 11.2 23.4 4.4 7.9 4.4 11.2 13.2 0.1 3.3 0.8 11.3 1.5 10.2 0.1 0.4 7.1 11.8 13.4 21.6 12.7 14.9 0.3 0.0 0.1 18.6 0.9 0.1 0.1 7.0 1.6 4.3 0.1 16.2 0.0 13.9 4.5 0.0 0.7 12.5 8.2 5.1 11.9 8.1 0.3 26.5 18.1 7.1 6.4 14.2 0.5 0.0 0.0 9.7 0.1 15.0 1.3 0.4 0.3 0.5 0.3 0.6 0.5 0.5 0.4 0.1 1.0 0.5 0.6 1.9 1.0 0.4 0.5 0.6 0.1 3.0 2.4 0.8 3.7 3.5 1.9 2.4 1.3 4.9 2.4 68.5 15.9 0.5 27.7 50.3 0.4 17.5 2.5 21.4 44.3 27.9 0.0 30.2 6.6 12.0 8.1 42.7 0.4 0.0 9.4 11.6 27.8 19.5 1.1 0.8 4.0 0.0 3.4 36.8 1.2 4.0 24.2 2.5 10.1 0.0 5.0 3.3 20.7 0.0 27.6 12.5 1.3 19.4 20.6 0.7 7.2 31.6 20.3 1.8 2.9 24.0 PTPN2 "PTPT, TC-PTP, TCELLPTP, TCPTP" ENSG00000175354 "Protein tyrosine phosphatase, non-receptor type 2" P17706 18 12785478-12929643 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015004, HPA046176" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA015004: AB_2669131, HPA046176: AB_2679569" "unprognostic (5.83e-3)" "unprognostic (8.50e-2)" "unprognostic (5.85e-2)" "unprognostic (7.21e-3)" "unprognostic (8.94e-3)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (1.68e-1)" "unprognostic (2.37e-3)" "prognostic favorable (1.37e-4)" "unprognostic (1.06e-2)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.20e-8)" "unprognostic (3.19e-1)" "unprognostic (6.84e-3)" "unprognostic (2.17e-1)" "unprognostic (4.61e-3)" 16.7 12.5 12.6 27.0 14.3 33.7 19.9 32.6 19.2 14.7 15.0 7.8 17.8 12.9 12.2 14.9 17.0 13.7 15.7 12.8 13.1 6.8 13.6 20.5 21.6 30.3 15.3 10.3 22.1 28.2 10.4 27.2 13.3 13.8 14.4 17.1 7.9 26.3 16.0 13.1 16.0 15.3 11.8 24.7 24.2 13.1 9.4 15.9 61.3 14.7 11.7 28.9 16.5 15.8 29.1 32.8 19.9 28.0 31.7 29.2 19.6 12.0 7.4 8.6 2.8 9.9 17.8 8.4 8.1 18.0 17.4 15.6 16.0 17.5 19.0 13.7 8.3 19.5 7.3 14.0 22.2 22.9 7.3 8.4 13.4 6.4 16.6 13.6 31.5 12.8 14.9 21.1 15.8 31.4 10.7 8.8 20.8 13.0 25.9 13.9 13.8 31.4 26.0 10.3 49.8 8.6 10.6 13.6 21.5 14.6 19.4 15.5 8.0 16.4 9.7 14.0 9.6 8.1 18.1 6.7 22.1 21.3 16.4 17.4 8.3 8.3 27.5 10.4 17.3 9.2 11.5 28.0 19.9 21.0 24.6 28.2 29.1 24.8 23.1 32.8 20.3 18.3 20.0 10.2 31.7 22.8 28.0 29.2 19.6 12.6 14.3 32.6 19.2 13.1 6.8 15.3 10.3 13.8 15.9 32.8 62.4 68.6 84.1 53.1 42.4 13.2 38.2 33.5 60.3 14.0 98.2 46.3 11.6 47.9 16.6 28.1 29.6 23.3 59.5 44.8 31.3 89.2 55.4 27.0 47.0 14.3 31.0 16.5 81.8 19.2 27.0 82.9 21.9 111.8 30.9 14.8 39.1 38.6 24.1 17.3 84.6 19.4 21.1 15.4 50.3 43.8 67.9 68.2 36.2 140.6 PTRHD1 "C2orf79, LOC391356" ENSG00000184924 "Peptidyl-tRNA hydrolase domain containing 1" Q6GMV3 2 24789734-24793382 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019951 Approved Approved Nucleoplasm NA NA 55000 Nucleoplasm "HPA019951: AB_1853109" "unprognostic (1.28e-2)" "unprognostic (5.79e-2)" "unprognostic (6.34e-2)" "unprognostic (1.34e-2)" "unprognostic (2.61e-2)" "unprognostic (3.99e-1)" "unprognostic (8.84e-3)" "unprognostic (1.26e-1)" "unprognostic (3.69e-1)" "unprognostic (8.31e-3)" "unprognostic (1.58e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (2.93e-1)" "unprognostic (1.55e-1)" "unprognostic (1.51e-1)" "unprognostic (5.76e-2)" 8.2 20.0 19.4 10.8 16.2 20.4 13.3 4.6 13.0 6.7 13.6 8.5 7.8 16.1 5.6 11.9 12.7 8.2 10.2 15.8 15.6 14.4 11.3 16.0 9.2 17.6 16.9 8.8 8.5 28.1 2.7 8.4 12.2 10.4 11.0 9.4 7.6 25.9 7.5 30.1 10.3 15.0 5.6 15.5 10.4 11.7 25.2 6.9 17.5 15.6 19.9 12.9 8.3 8.4 29.1 44.1 8.2 27.9 14.5 23.7 26.1 8.2 19.7 6.4 2.8 3.6 8.1 11.0 6.0 5.7 7.9 5.1 19.4 7.8 6.9 2.5 6.4 4.9 5.5 5.3 5.6 2.6 9.3 35.5 12.4 9.5 21.1 7.5 10.1 11.7 7.7 4.6 3.7 4.1 6.3 7.3 6.3 12.4 5.5 5.8 17.9 8.3 18.9 13.4 5.0 11.9 6.8 19.5 11.4 9.2 15.4 10.0 15.4 6.6 8.9 7.7 3.1 8.6 7.8 12.0 6.7 10.5 3.2 5.0 4.3 13.3 7.4 6.3 6.4 4.5 8.2 27.9 5.9 16.6 19.0 8.5 29.1 16.4 14.5 42.9 22.1 15.3 17.8 3.2 14.5 13.7 44.1 23.7 26.1 19.4 16.2 4.6 13.0 15.6 14.4 16.9 8.8 10.4 6.9 47.6 55.7 79.8 66.2 106.5 9.2 71.1 66.2 88.3 51.2 62.8 5.9 158.8 97.8 80.3 89.5 45.2 101.8 0.0 123.7 124.1 73.0 66.7 40.4 82.2 114.7 1.6 84.6 51.0 98.7 121.2 43.7 98.5 64.1 162.3 129.2 35.2 108.6 131.0 37.4 119.9 11.8 71.1 48.3 75.3 38.1 124.0 140.3 64.8 148.8 111.1 PTTG1IP "C21orf1, C21orf3, PBF" ENSG00000183255 "PTTG1 interacting protein" P53801 21 44849585-44873903 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034146, HPA061827" Uncertain Supported Nucleoplasm NA NA 380000 Nucleoplasm "CAB034146: AB_1568894, HPA061827: AB_2684620" "unprognostic (1.78e-2)" "prognostic unfavorable (8.61e-4)" "unprognostic (5.24e-3)" "unprognostic (3.18e-2)" "unprognostic (1.68e-2)" "unprognostic (2.03e-2)" "unprognostic (3.59e-2)" "unprognostic (1.22e-2)" "unprognostic (1.98e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (9.30e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (5.40e-4)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.90e-1)" 47.1 52.1 46.7 33.6 48.7 29.6 53.3 20.9 38.7 50.1 47.2 57.0 29.3 43.6 53.2 47.6 36.2 40.4 50.9 59.9 51.8 31.0 75.6 71.9 58.2 38.8 59.6 30.2 49.6 39.8 23.4 27.3 111.6 43.0 40.5 41.4 50.0 46.0 57.7 30.8 32.1 72.8 51.8 45.8 38.8 58.9 35.2 52.6 19.8 62.4 25.1 25.3 48.2 60.0 5.3 40.5 58.1 35.6 12.5 16.8 37.2 31.0 17.5 20.8 19.7 40.8 23.8 16.9 28.5 40.6 23.1 22.3 37.7 42.7 4.2 108.8 44.3 55.5 14.4 9.5 18.2 22.3 7.3 10.5 33.1 11.0 33.0 39.8 12.6 11.3 36.6 30.0 25.1 17.5 46.3 49.6 11.6 16.6 11.2 71.3 13.4 9.1 12.9 22.0 45.1 22.1 9.1 21.3 20.5 99.6 10.9 15.7 24.3 31.6 34.8 61.6 26.4 26.9 21.2 68.0 29.3 17.1 22.7 43.6 10.7 10.0 5.4 19.7 28.4 26.2 58.1 35.6 20.8 10.3 28.9 16.8 5.3 13.4 10.8 40.5 5.0 13.0 8.9 49.4 12.5 30.4 18.4 16.8 37.2 46.7 48.7 20.9 35.7 51.8 31.0 59.6 30.2 43.0 52.6 366.3 135.9 29.8 68.7 45.1 14.1 137.7 73.9 242.2 240.0 137.9 5.9 181.6 41.4 311.5 36.3 156.9 223.5 0.0 105.1 61.5 84.2 101.0 76.5 97.8 96.5 11.1 76.1 106.2 71.4 76.2 66.7 89.8 82.7 81.2 82.0 66.8 225.0 140.3 93.0 67.3 14.0 64.7 78.7 66.8 49.6 37.5 306.6 30.5 75.0 159.3 PUF60 "FIR, RoBPI, SIAHBP1" ENSG00000179950 "Poly(U) binding splicing factor 60" Q9UHX1 8 143816344-143829859 "Disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 73.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045733, HPA052096, HPA059714" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045733: AB_10960503, HPA052096: AB_2681722, HPA059714: AB_2684110" "unprognostic (3.49e-2)" "unprognostic (8.78e-2)" "unprognostic (2.66e-1)" "unprognostic (4.05e-2)" "unprognostic (1.81e-2)" "unprognostic (3.47e-2)" "unprognostic (1.51e-2)" "unprognostic (4.34e-3)" "unprognostic (2.64e-2)" "unprognostic (1.07e-2)" "unprognostic (1.75e-1)" "unprognostic (5.45e-2)" "unprognostic (2.36e-2)" "unprognostic (2.64e-2)" "unprognostic (7.00e-2)" "unprognostic (2.28e-2)" "unprognostic (3.42e-2)" 35.4 21.1 28.5 19.1 29.5 51.1 20.8 22.8 40.0 19.5 28.4 37.3 16.7 41.2 25.6 21.3 23.8 30.8 23.8 26.7 29.8 25.5 21.7 34.4 18.0 28.7 29.9 30.9 23.9 24.4 13.3 21.6 33.0 24.3 22.8 11.2 22.8 39.1 31.4 47.5 36.6 23.8 21.0 29.4 26.2 28.5 28.9 27.9 28.7 23.2 24.2 21.9 20.2 21.3 40.9 42.9 28.3 44.6 41.4 50.9 53.3 21.2 49.5 7.5 7.2 4.0 3.6 12.4 17.1 6.3 16.5 16.7 21.6 24.1 18.6 16.3 13.4 12.8 18.8 20.3 21.2 0.9 20.4 32.7 23.9 26.2 22.8 14.7 7.8 16.8 10.1 13.3 21.7 6.7 4.8 15.9 20.8 19.3 8.3 4.9 73.0 35.7 5.3 18.6 13.7 44.1 19.4 10.3 19.6 4.6 21.1 14.5 17.2 21.8 9.3 17.5 2.0 26.4 3.6 18.1 17.0 41.3 20.1 22.1 15.5 21.8 24.5 17.1 11.6 16.4 24.1 37.9 28.3 45.6 43.3 50.9 38.6 38.3 45.2 42.9 40.9 35.8 41.7 21.1 41.4 44.6 26.2 44.9 53.3 28.5 29.5 22.8 40.0 29.8 25.5 29.9 30.9 24.3 27.9 35.7 45.6 62.1 84.0 95.7 56.5 52.6 38.2 66.9 47.8 27.9 27.5 127.5 77.9 88.5 14.8 59.5 85.2 0.0 78.5 109.1 67.7 50.1 55.3 71.2 88.1 41.3 64.2 39.3 46.1 34.6 59.2 57.1 86.0 133.5 53.5 174.2 79.1 97.9 55.5 90.1 46.1 64.7 74.1 92.1 123.9 93.6 145.0 64.0 69.8 74.0 PURB PURBETA ENSG00000146676 "Purine rich element binding protein B" Q96QR8 7 44876293-44885361 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048766 Supported Nucleoplasm NA NA 13000 Nucleoplasm "HPA048766: " "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (3.21e-2)" "unprognostic (9.49e-2)" "unprognostic (4.96e-2)" "unprognostic (2.18e-1)" "unprognostic (8.44e-3)" "unprognostic (1.53e-1)" "unprognostic (1.72e-1)" "unprognostic (1.88e-3)" "unprognostic (2.01e-1)" "unprognostic (4.12e-1)" "unprognostic (5.66e-2)" "unprognostic (4.29e-2)" "unprognostic (7.96e-2)" "unprognostic (1.41e-1)" "unprognostic (3.22e-2)" 12.1 9.6 19.1 12.0 20.3 13.5 14.2 30.8 22.0 13.7 14.2 11.1 6.6 8.7 13.1 9.4 13.9 11.6 11.6 9.1 18.5 9.2 11.3 10.0 12.4 11.1 15.6 13.4 12.5 10.1 17.4 10.4 15.4 12.9 12.8 9.0 11.0 11.3 11.6 14.3 16.7 10.7 18.5 12.4 10.8 10.8 7.8 15.0 12.3 13.9 7.8 11.9 11.7 11.8 1.5 1.6 3.3 1.2 1.5 2.0 0.6 8.9 5.0 9.0 16.9 8.4 13.5 6.0 12.4 9.8 9.3 9.1 7.5 7.0 13.4 10.9 14.3 22.1 16.6 8.4 11.0 18.5 10.8 6.9 6.7 12.4 4.2 8.4 10.5 10.7 11.0 14.1 17.8 13.1 10.0 9.8 11.1 11.7 12.6 19.5 12.4 8.7 13.2 14.1 6.0 8.8 7.2 27.4 8.7 7.7 15.4 9.0 12.7 12.3 25.8 7.6 11.4 17.2 12.1 16.5 16.4 18.0 10.6 20.7 22.2 19.3 4.3 12.2 12.3 21.7 1.6 1.2 1.7 1.9 1.1 2.0 0.9 1.6 1.5 0.6 1.5 1.5 1.7 3.3 1.5 0.9 1.6 1.2 0.6 19.1 20.3 30.8 22.0 18.5 9.2 15.6 13.4 12.9 15.0 35.7 36.3 18.8 30.6 62.0 57.4 16.5 20.4 30.8 31.8 17.4 31.4 16.0 8.3 16.9 16.5 32.7 14.2 0.0 19.4 11.1 24.9 35.8 35.8 11.6 15.0 50.9 19.5 36.8 19.7 14.0 19.2 30.9 16.9 10.0 18.0 38.9 23.0 7.0 18.7 9.2 51.0 45.3 32.7 16.8 12.2 75.3 15.8 20.0 21.5 37.3 PUS7 FLJ20485 ENSG00000091127 "Pseudouridylate synthase 7 (putative)" Q96PZ0 7 105439661-105522267 "Predicted intracellular proteins" "tRNA processing" Isomerase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024116 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024116: AB_1848754" "unprognostic (3.07e-1)" "unprognostic (1.52e-3)" "unprognostic (9.03e-2)" "unprognostic (4.94e-2)" "unprognostic (8.91e-2)" "unprognostic (7.95e-2)" "prognostic unfavorable (4.89e-6)" "unprognostic (2.86e-2)" "prognostic unfavorable (7.58e-5)" "unprognostic (1.87e-1)" "unprognostic (5.64e-3)" "unprognostic (4.14e-2)" "prognostic unfavorable (1.03e-8)" "unprognostic (2.76e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (6.28e-4)" "unprognostic (4.90e-2)" 12.7 6.9 7.7 13.0 12.5 5.8 14.1 12.2 12.9 10.2 9.6 8.5 4.6 7.0 11.4 5.6 14.7 9.8 6.0 9.4 8.3 7.0 7.5 11.8 8.8 8.3 12.3 8.0 10.0 11.9 17.0 8.1 9.8 11.4 8.6 11.6 5.3 9.3 11.0 19.5 13.3 6.3 13.2 9.0 5.4 8.0 8.5 13.8 4.3 14.6 13.5 10.0 8.0 11.0 5.9 3.3 0.4 5.0 2.7 5.4 2.0 15.4 10.4 9.2 14.2 6.6 7.8 10.0 7.7 6.7 13.8 11.8 13.7 5.9 9.0 12.9 7.9 11.7 12.0 17.4 9.2 21.4 6.4 13.3 13.7 8.8 12.4 8.2 21.1 4.9 7.7 10.1 11.6 14.7 4.8 13.7 8.0 30.7 7.3 8.7 20.5 23.2 16.5 22.3 18.3 12.2 14.5 14.9 38.5 14.2 11.7 15.0 14.8 15.3 24.9 9.5 11.1 9.0 4.3 8.4 19.3 13.3 24.2 16.1 5.7 10.9 25.7 6.5 17.7 16.0 0.0 2.1 0.4 2.6 5.0 5.4 5.9 3.5 2.8 3.3 3.6 2.9 3.8 0.2 2.7 4.2 0.1 2.2 2.0 7.7 12.5 12.2 12.9 8.3 7.0 12.3 8.0 11.4 13.8 6.0 7.0 1.5 6.8 11.8 4.1 3.1 0.0 5.3 7.9 1.8 2.0 4.0 1.7 6.5 0.9 6.0 0.9 0.0 6.2 7.8 5.1 7.2 11.5 3.9 3.7 0.0 6.9 3.7 1.3 1.2 3.7 3.5 0.0 5.4 3.4 1.5 6.0 2.9 1.8 4.4 2.9 0.0 10.8 1.4 10.9 8.5 2.9 0.7 6.0 6.4 PWWP2B "bA432J24.1, FLJ46823, PWWP2" ENSG00000171813 "PWWP domain containing 2B" Q6NUJ5 10 132397168-132417863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 29.8;MCF7: 22.5;SK-BR-3: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038056, HPA038502, HPA078118" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038056: AB_10697093, HPA038502: AB_2676048, HPA078118: " "unprognostic (2.28e-1)" "unprognostic (5.47e-2)" "unprognostic (1.11e-2)" "unprognostic (1.30e-2)" "unprognostic (5.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.67e-2)" "unprognostic (8.82e-2)" "unprognostic (2.66e-1)" "unprognostic (2.40e-1)" "unprognostic (1.33e-1)" "unprognostic (2.00e-1)" "prognostic favorable (5.75e-4)" "unprognostic (4.77e-2)" "unprognostic (1.46e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-2)" 7.3 14.1 5.1 4.2 14.7 3.0 6.6 1.8 13.4 5.1 10.0 2.0 9.0 6.4 4.3 3.3 8.9 5.1 8.4 3.8 6.4 4.3 4.1 2.3 5.5 3.7 4.1 6.9 4.7 23.4 8.9 6.3 12.6 4.3 5.5 3.3 5.1 14.0 5.9 19.5 6.2 5.7 5.4 1.1 14.9 14.7 6.5 7.1 2.1 5.7 4.8 6.9 5.8 4.5 4.9 2.1 3.7 7.2 7.2 2.0 1.0 10.9 6.7 0.8 4.3 0.6 0.5 29.8 1.3 1.3 0.8 0.7 2.9 6.5 0.0 4.6 0.8 1.7 11.8 1.2 1.6 0.1 8.1 3.3 1.3 5.9 2.8 3.2 3.6 4.9 0.4 4.2 0.4 1.2 0.7 0.6 1.5 2.1 0.9 0.5 22.5 0.1 13.6 1.3 4.3 4.9 2.6 0.0 2.5 0.3 8.3 5.5 6.8 0.8 17.4 3.4 0.9 5.3 8.9 2.2 0.4 2.4 2.1 0.9 0.2 0.1 2.3 2.7 3.3 0.8 0.0 2.4 3.7 2.0 5.0 1.6 1.5 1.1 1.3 2.1 4.9 0.9 0.8 0.4 7.2 7.2 1.3 0.0 1.0 5.1 14.7 1.8 13.4 6.4 4.3 4.1 6.9 4.3 7.1 20.8 11.2 11.2 12.6 15.7 5.9 4.9 12.7 22.7 5.7 8.7 7.9 27.4 11.6 13.6 28.6 8.5 17.3 0.0 18.8 44.1 7.2 13.6 2.3 1.1 11.5 14.3 24.3 12.3 10.5 53.6 3.4 7.7 13.5 3.6 29.5 1.9 10.0 23.0 2.1 1.3 11.8 0.0 2.4 0.9 0.9 17.8 44.3 2.5 18.4 25.5 PYURF PreY ENSG00000145337 "PIGY upstream reading frame" Q96I23 4 88520985-88523813 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036455 Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA036455: AB_10673388" "unprognostic (8.25e-2)" "unprognostic (9.14e-2)" "unprognostic (6.61e-2)" "unprognostic (2.03e-1)" "unprognostic (5.03e-2)" "unprognostic (7.23e-2)" "unprognostic (1.10e-2)" "unprognostic (8.84e-3)" "unprognostic (3.64e-1)" "unprognostic (1.48e-2)" "unprognostic (1.20e-2)" "unprognostic (2.35e-2)" "unprognostic (9.04e-3)" "unprognostic (1.59e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" 40.4 48.3 47.3 29.2 43.9 44.2 63.2 28.2 43.4 40.6 38.4 31.2 35.2 35.8 47.4 56.4 40.9 41.0 36.4 62.5 45.4 45.1 48.7 59.1 33.5 43.1 47.6 35.3 44.9 61.8 40.7 42.6 39.0 43.2 42.7 37.7 31.6 48.6 42.9 54.0 37.1 37.5 44.7 51.4 36.9 33.8 28.5 38.4 28.3 47.7 40.5 33.0 41.7 51.4 45.3 50.8 35.0 43.3 47.3 54.1 74.3 29.4 9.9 19.9 23.6 40.3 41.5 13.5 21.8 30.7 27.4 23.2 7.7 23.5 0.1 24.6 30.8 18.6 12.7 18.0 27.4 34.6 36.0 31.3 32.7 13.2 29.3 30.6 54.0 21.1 28.6 41.5 17.6 36.1 26.0 44.7 10.2 36.7 33.2 39.5 22.3 32.8 33.1 16.7 34.5 19.1 33.5 18.6 34.3 22.5 16.7 24.1 23.6 27.6 25.3 57.4 20.6 11.7 27.2 30.4 29.2 26.9 28.4 20.0 23.6 19.1 3.6 25.6 27.5 32.0 30.9 43.3 35.0 45.0 42.0 50.2 45.3 52.0 48.5 50.8 35.5 54.1 51.6 8.6 47.3 41.0 31.9 51.8 74.3 47.3 43.9 28.2 43.4 45.4 45.1 47.6 35.3 43.2 38.4 47.6 58.8 74.6 136.8 204.7 28.0 4.5 68.8 84.3 85.3 82.0 9.8 205.8 243.7 96.5 35.0 121.7 71.5 23.3 113.5 97.9 127.4 138.8 102.8 109.9 125.1 25.4 110.1 92.7 113.8 79.3 116.5 112.4 330.7 100.0 88.2 79.4 90.7 113.1 112.8 171.4 25.3 58.2 140.4 100.3 65.3 252.6 137.1 99.2 113.0 120.5 QKI QK3 ENSG00000112531 "QKI, KH domain containing RNA binding" Q96PU8 6 163414000-163578596 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, mRNA transport, Translation regulation, Transport" "Developmental protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 100.3" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 308.9" "Cancer enriched" "Detected in all" 6 "glioma: 42.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 64.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019123, CAB022602" Enhanced Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022602: , HPA019123: AB_1855980" "unprognostic (2.42e-1)" "unprognostic (5.81e-2)" "unprognostic (1.31e-1)" "unprognostic (1.06e-2)" "unprognostic (8.57e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.27e-4)" "unprognostic (1.34e-1)" "unprognostic (7.06e-2)" "unprognostic (1.76e-3)" "unprognostic (1.08e-1)" "unprognostic (5.15e-2)" "prognostic unfavorable (2.31e-5)" "prognostic unfavorable (3.69e-4)" "unprognostic (1.16e-1)" "unprognostic (3.86e-1)" "unprognostic (4.09e-2)" 32.4 12.4 37.5 16.2 63.5 27.1 14.6 15.1 100.3 14.9 12.2 83.9 3.7 4.0 14.7 4.9 16.0 12.3 15.7 64.0 43.7 18.1 11.1 18.4 24.9 11.4 72.5 31.9 18.4 7.6 7.8 4.7 23.4 46.5 7.9 8.4 7.1 10.2 11.1 59.9 12.4 7.1 21.1 68.8 16.9 8.9 20.5 74.3 5.0 10.4 10.8 11.4 15.8 17.7 1.7 7.3 10.8 8.4 7.4 3.8 1.3 4.3 18.2 64.8 21.5 19.6 21.9 15.1 11.8 27.9 19.3 23.4 12.3 4.0 5.2 9.9 29.5 13.2 6.5 34.3 12.2 31.4 10.5 11.1 20.6 10.1 13.8 24.0 11.0 6.3 25.6 5.0 20.7 32.9 18.9 26.6 7.8 30.2 12.4 12.4 8.2 7.3 2.3 8.3 4.3 9.2 11.3 40.4 10.5 10.6 13.7 1.3 7.5 12.6 6.8 5.2 27.5 2.6 18.0 27.0 13.4 11.3 14.4 21.6 7.9 9.6 6.4 11.5 9.7 31.4 3.4 8.4 3.8 2.3 5.4 3.8 1.4 1.6 2.0 4.3 1.7 1.5 2.5 10.8 7.4 5.5 7.3 1.1 1.3 37.5 63.5 15.1 41.4 43.7 18.1 72.5 31.9 46.5 74.3 140.0 54.6 32.8 29.3 136.6 56.8 308.9 40.8 21.4 36.4 19.2 55.0 41.8 18.3 21.6 45.5 100.3 0.0 46.7 10.3 40.7 66.9 33.8 60.0 61.0 75.9 30.2 0.0 146.1 189.4 77.1 80.3 114.7 108.0 31.5 0.0 113.1 17.4 0.0 92.6 25.9 30.1 45.3 91.7 34.4 14.6 118.9 46.1 25.8 0.0 35.3 QRICH1 FLJ20259 ENSG00000198218 "Glutamine rich 1" Q2TAL8 3 49029707-49094363 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037677, HPA037678" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037677: AB_10671883, HPA037678: AB_2675603" "unprognostic (2.38e-2)" "unprognostic (2.05e-1)" "unprognostic (8.29e-2)" "unprognostic (1.67e-1)" "unprognostic (2.41e-1)" "unprognostic (3.14e-2)" "unprognostic (2.77e-3)" "unprognostic (6.94e-2)" "unprognostic (2.82e-2)" "prognostic favorable (7.46e-4)" "unprognostic (1.12e-1)" "unprognostic (1.40e-2)" "unprognostic (2.17e-3)" "unprognostic (5.06e-2)" "unprognostic (3.84e-1)" "unprognostic (1.76e-1)" "unprognostic (1.06e-1)" 28.9 27.6 20.4 23.6 26.8 43.1 27.8 38.9 35.0 26.2 23.3 27.0 21.2 21.0 30.7 22.0 28.4 26.7 23.7 21.5 20.9 16.7 20.3 22.1 26.0 30.3 17.8 22.1 30.5 23.3 30.7 27.3 32.1 23.6 22.6 21.4 28.4 26.4 26.0 32.3 34.1 30.0 24.6 15.9 35.2 25.8 53.9 21.8 40.3 25.9 20.2 37.1 28.1 23.6 15.5 16.0 15.9 26.0 15.8 20.1 11.1 18.6 17.9 35.6 16.4 23.4 22.5 22.2 21.1 27.7 35.4 32.3 19.5 23.7 29.9 13.6 27.5 28.6 14.9 32.6 29.5 30.8 25.6 19.6 29.3 24.8 16.1 21.1 25.5 33.8 25.5 22.5 35.4 22.7 21.6 27.4 27.6 19.8 27.4 24.0 13.8 37.1 17.5 29.1 19.6 22.5 18.6 18.6 24.7 22.1 29.1 13.6 27.4 24.0 22.4 17.4 29.4 20.0 28.9 23.8 23.2 26.4 20.5 30.1 24.7 28.7 36.2 21.2 24.6 26.5 14.0 13.2 15.9 16.8 16.5 19.9 15.4 16.2 18.6 16.0 15.5 17.5 20.1 9.9 15.8 26.0 11.4 16.6 11.1 20.4 26.8 38.9 35.0 20.9 16.7 17.8 22.1 23.6 21.8 8.9 13.9 26.2 11.9 19.7 13.5 17.6 17.8 12.0 17.0 19.2 21.6 22.0 1.7 13.7 8.6 15.8 13.1 0.0 11.9 22.9 14.2 14.3 16.1 18.7 17.0 11.1 24.9 18.4 24.3 7.9 20.8 21.5 11.8 17.2 21.2 10.6 16.0 7.0 29.0 9.7 17.1 6.5 17.0 40.7 25.1 19.7 30.8 18.4 16.9 13.5 R3HDM2 KIAA1002 ENSG00000179912 "R3H domain containing 2" Q9Y2K5 12 57253762-57431005 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038327, HPA038328" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA038327: AB_10674681, HPA038328: AB_2675962" "unprognostic (9.46e-2)" "unprognostic (1.40e-1)" "unprognostic (2.93e-2)" "unprognostic (3.48e-1)" "unprognostic (7.41e-2)" "unprognostic (2.20e-1)" "unprognostic (8.17e-2)" "unprognostic (1.90e-1)" "unprognostic (2.46e-1)" "unprognostic (2.25e-1)" "unprognostic (1.09e-2)" "unprognostic (8.89e-2)" "unprognostic (1.67e-2)" "unprognostic (1.42e-1)" "unprognostic (1.92e-1)" "unprognostic (2.15e-1)" "unprognostic (7.49e-2)" 15.9 16.6 33.7 15.7 26.3 18.0 15.6 44.0 35.0 16.2 14.6 21.6 16.5 19.2 20.5 13.2 17.6 20.8 17.2 28.2 26.4 18.8 15.1 18.6 20.6 17.9 21.4 28.1 28.7 16.9 20.4 33.1 15.0 19.5 25.1 14.6 17.8 13.6 14.7 32.0 18.7 17.0 15.5 25.5 19.4 16.9 17.0 20.7 15.1 17.7 10.0 15.0 17.7 14.5 6.6 3.3 8.7 8.3 5.2 5.3 1.3 10.0 14.1 11.7 14.5 19.2 27.2 8.1 10.5 12.9 7.5 6.9 4.6 12.2 11.1 13.2 14.8 8.6 13.1 6.9 13.3 8.7 15.4 9.0 13.7 5.5 5.8 14.3 9.0 17.5 18.4 21.0 12.9 27.3 32.6 10.4 19.9 9.4 14.7 12.6 13.1 12.6 6.7 3.0 6.1 10.3 7.7 9.7 7.2 6.6 10.9 11.9 12.9 10.0 13.4 10.8 7.0 11.7 16.7 12.1 7.8 6.0 17.7 10.8 8.8 4.3 4.5 16.4 9.5 13.9 5.3 4.3 3.2 2.8 3.6 3.6 6.6 5.0 2.6 2.1 3.5 5.3 3.2 8.7 5.2 8.3 3.3 2.0 1.3 33.7 26.3 44.0 35.0 26.4 18.8 21.4 28.1 19.5 20.7 29.8 32.5 21.7 22.9 38.6 106.3 25.4 30.6 24.1 12.5 36.6 74.6 18.0 43.1 12.7 13.7 17.5 28.5 23.3 9.6 16.3 27.9 25.6 24.4 64.2 17.0 103.3 23.7 28.8 59.2 25.8 55.3 28.4 25.3 8.2 28.8 35.9 11.0 34.5 45.3 34.8 68.5 32.3 28.9 44.9 50.2 44.9 20.4 34.1 28.8 22.4 RABGGTA PTAR3 ENSG00000100949 "Rab geranylgeranyltransferase alpha subunit" Q92696 14 24265538-24271739 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043488 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043488: AB_10794887" "unprognostic (2.00e-1)" "unprognostic (8.37e-2)" "unprognostic (2.61e-3)" "unprognostic (1.13e-1)" "unprognostic (8.34e-2)" "unprognostic (1.39e-1)" "unprognostic (2.78e-1)" "unprognostic (5.78e-2)" "unprognostic (3.89e-2)" "unprognostic (7.11e-2)" "unprognostic (3.12e-2)" "unprognostic (1.12e-1)" "prognostic favorable (5.44e-4)" "unprognostic (1.77e-1)" "unprognostic (1.84e-1)" "prognostic favorable (1.51e-4)" "unprognostic (2.01e-1)" 6.9 9.9 8.6 7.1 9.4 8.7 7.5 9.4 16.2 8.2 9.8 8.4 13.6 7.2 6.4 11.6 37.2 12.3 8.1 10.9 6.9 8.0 12.5 15.0 10.6 10.7 7.7 8.5 8.0 16.4 15.7 10.2 14.1 10.6 8.0 8.0 7.2 12.8 9.2 11.1 13.3 12.1 6.9 6.1 11.5 9.4 11.3 7.0 7.3 9.4 20.3 18.2 8.4 11.4 6.5 12.7 6.7 16.8 6.9 6.3 6.3 3.5 6.0 2.3 3.2 3.8 7.0 12.8 5.4 5.2 8.8 7.6 6.1 5.3 5.5 4.0 6.6 3.5 7.1 2.9 12.5 3.5 7.0 7.3 3.2 5.1 21.0 7.2 6.7 12.2 7.4 14.3 4.3 5.8 5.0 7.3 6.1 2.8 4.3 6.8 15.6 3.6 5.0 1.4 5.2 8.8 3.1 2.2 3.8 8.0 6.9 6.3 3.7 4.1 8.4 4.4 3.6 4.2 4.8 5.3 4.1 3.1 1.9 2.9 5.8 4.4 3.5 2.9 4.3 6.4 3.1 10.0 6.7 5.9 16.8 5.1 6.5 5.7 5.1 12.7 4.2 5.0 4.4 2.6 6.9 12.4 4.0 6.3 6.3 8.6 9.4 9.4 16.2 6.9 8.0 7.7 8.5 10.6 7.0 8.9 12.3 17.9 17.1 15.8 6.9 10.1 25.5 12.0 9.1 5.2 5.9 32.5 13.3 22.0 2.6 7.4 21.7 0.0 23.8 25.8 10.7 12.8 35.7 5.9 24.6 11.1 12.6 7.4 15.6 5.6 8.3 17.3 15.1 18.0 13.1 8.2 28.8 21.0 6.7 18.0 4.1 6.5 12.8 3.0 24.9 10.8 47.9 18.7 15.8 17.4 RABL3 MGC23920 ENSG00000144840 "RAB, member of RAS oncogene family like 3" Q5HYI8 3 120686681-120742993 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Cone photoreceptor cells: 110.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035150, HPA035151" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA035150: AB_2674493, HPA035151: AB_10601154" "unprognostic (1.69e-2)" "unprognostic (5.10e-2)" "unprognostic (8.32e-2)" "unprognostic (3.96e-2)" "unprognostic (1.88e-1)" "unprognostic (7.22e-2)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (7.19e-2)" "unprognostic (2.94e-1)" "unprognostic (2.11e-3)" "unprognostic (2.78e-1)" "prognostic favorable (2.79e-5)" "unprognostic (2.33e-1)" "unprognostic (6.15e-2)" "unprognostic (8.44e-3)" "unprognostic (3.65e-1)" 21.5 26.7 16.5 9.3 19.5 8.8 14.8 15.7 19.9 12.2 14.1 16.6 13.6 10.6 11.8 12.2 16.6 11.0 9.9 11.9 14.6 16.6 19.7 20.5 10.3 10.3 19.2 16.2 18.7 13.9 23.3 14.7 13.4 20.9 14.4 15.1 12.8 11.2 14.9 19.6 10.3 13.0 11.6 22.5 11.3 11.4 8.2 14.0 11.2 22.9 12.6 11.8 13.8 11.9 7.8 11.4 5.7 11.8 13.1 10.9 5.6 16.6 12.9 11.6 3.7 12.6 17.1 9.7 15.0 11.3 8.7 8.1 8.8 6.9 13.5 7.8 13.2 13.7 6.8 11.7 8.2 16.5 11.3 5.5 13.7 9.2 11.3 8.1 24.0 8.7 8.9 15.8 7.4 8.9 11.6 13.0 8.8 11.1 9.1 11.4 14.4 18.4 6.3 7.1 18.9 7.7 8.6 14.2 7.5 11.4 7.5 5.5 7.4 7.1 6.4 8.3 4.7 11.8 15.7 17.7 6.7 6.0 4.9 15.7 6.7 6.3 11.4 19.0 23.8 8.2 5.6 5.8 4.2 10.9 11.8 9.0 7.8 9.7 10.3 10.7 6.8 9.3 10.8 5.7 13.1 6.6 11.4 10.3 5.6 16.5 19.5 15.7 19.9 14.6 16.6 19.2 16.2 20.9 14.0 8.9 9.4 9.3 14.5 5.7 16.9 11.6 20.4 17.4 14.8 8.7 110.0 11.8 6.6 14.2 16.2 11.9 9.8 0.0 13.9 15.5 8.2 11.6 8.1 14.7 12.8 7.9 5.2 4.3 8.3 6.9 5.5 9.5 10.1 10.8 12.2 15.7 13.4 13.6 5.6 20.3 18.0 0.0 5.9 9.7 7.5 9.7 18.4 6.9 10.2 13.1 RACGAP1 MgcRacGAP ENSG00000161800 "Rac GTPase activating protein 1" Q9H0H5 12 49976923-50033136 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 46.7;Extravillous trophoblasts: 40.9;Spermatocytes: 65.3;Spermatogonia: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025859, HPA039427, HPA043912" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728" "prognostic unfavorable (1.51e-4)" "unprognostic (1.91e-1)" "unprognostic (3.74e-3)" "unprognostic (1.53e-2)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "prognostic unfavorable (1.86e-6)" "unprognostic (1.15e-3)" "unprognostic (3.07e-3)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.12e-6)" "unprognostic (5.56e-2)" "prognostic unfavorable (3.98e-8)" "unprognostic (3.13e-2)" "unprognostic (4.94e-1)" "unprognostic (6.16e-2)" "unprognostic (2.15e-1)" 3.7 2.6 4.9 10.0 11.3 21.0 4.2 6.3 7.8 4.2 10.1 4.7 1.5 6.5 3.3 1.9 17.7 2.7 4.0 2.7 4.8 4.5 5.9 2.8 5.6 13.7 7.8 5.0 2.5 2.0 3.3 1.4 8.4 5.4 2.4 11.9 2.0 4.7 2.1 3.8 8.7 7.5 7.6 5.9 5.9 6.8 29.4 6.6 40.9 2.4 8.7 17.8 6.0 6.5 6.3 2.2 16.5 3.5 8.8 14.8 4.8 44.6 40.8 32.5 20.8 6.0 7.2 27.8 47.4 22.8 49.7 34.0 40.7 34.2 24.8 21.2 25.1 24.3 30.3 32.4 22.0 53.0 47.5 20.4 31.9 40.4 13.3 2.2 33.6 26.4 3.9 4.1 33.7 26.9 14.6 16.8 22.7 23.0 38.1 46.4 31.3 27.7 16.8 23.2 25.3 27.0 26.4 39.8 18.2 13.2 22.3 27.4 23.7 38.7 24.6 13.1 17.3 47.8 15.2 15.3 32.9 29.7 21.0 34.1 20.2 49.9 29.4 16.6 23.0 19.2 16.5 2.6 3.9 5.7 3.5 4.9 6.3 6.9 7.8 2.2 3.9 4.2 5.5 0.5 8.8 1.9 1.5 14.8 4.8 4.9 11.3 6.3 7.8 4.8 4.5 7.8 5.0 5.4 6.6 6.0 5.4 8.5 2.4 11.4 1.6 1.2 2.5 2.7 3.4 5.2 3.9 6.2 16.6 1.5 9.3 1.7 1.5 46.7 1.8 40.9 4.1 2.1 2.3 1.8 11.4 1.6 0.0 6.2 11.7 11.4 1.4 8.0 1.7 3.6 2.6 1.7 1.6 0.0 3.5 1.9 0.7 12.9 2.8 65.3 40.1 11.3 7.2 4.4 4.1 1.1 RAD17 "CCYC, RAD17Sp, Rad24" ENSG00000152942 "RAD17 checkpoint clamp loader component" O75943 5 69369293-69414801 "Predicted intracellular proteins" "Cell cycle, DNA damage" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 97.3;Spermatocytes: 125.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004551, HPA005448" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004551: AB_628195, HPA005448: AB_1079738" "unprognostic (1.25e-1)" "unprognostic (1.46e-1)" "unprognostic (3.28e-3)" "unprognostic (2.21e-1)" "unprognostic (2.30e-1)" "unprognostic (6.04e-2)" "unprognostic (7.75e-3)" "unprognostic (6.09e-2)" "unprognostic (1.66e-2)" "unprognostic (2.42e-2)" "unprognostic (1.59e-2)" "unprognostic (5.74e-2)" "prognostic favorable (5.79e-6)" "unprognostic (1.02e-1)" "unprognostic (1.92e-1)" "unprognostic (3.09e-1)" "unprognostic (2.24e-2)" 11.8 12.6 10.6 15.3 15.3 9.3 16.5 13.9 14.2 11.0 10.9 12.3 13.7 7.0 12.9 12.2 10.0 9.9 7.8 11.5 11.1 12.8 18.6 16.1 13.2 24.6 11.6 10.7 11.7 18.3 15.1 32.0 12.9 14.7 12.2 13.3 10.0 12.8 18.8 15.7 9.6 11.9 10.5 13.4 14.5 11.6 37.7 11.6 17.0 15.1 10.0 17.0 10.5 13.6 10.5 4.4 4.9 3.6 7.6 7.5 3.1 7.6 3.4 10.7 12.6 0.0 0.1 13.1 7.6 9.6 10.4 14.8 8.1 8.4 33.8 8.3 4.4 20.9 3.6 10.6 4.4 16.2 0.0 5.8 8.2 8.3 8.1 12.9 0.2 10.8 7.6 7.4 7.7 7.6 0.0 9.0 8.9 7.9 10.3 13.1 0.0 15.0 5.6 6.6 3.2 4.3 13.1 9.8 7.5 12.5 7.0 11.2 7.9 7.0 2.2 0.3 11.9 10.4 10.1 2.7 0.0 9.5 4.8 4.9 13.3 20.5 11.5 10.7 16.1 6.9 1.4 3.0 4.9 6.0 3.6 5.7 10.5 5.4 6.4 4.4 7.2 7.5 6.3 1.2 7.6 1.7 2.2 7.2 3.1 10.6 15.3 13.9 14.2 11.1 12.8 11.6 10.7 14.7 11.6 29.8 13.2 13.4 4.7 4.8 17.0 29.6 15.3 44.2 27.3 5.2 19.6 15.1 21.6 10.9 97.3 7.1 8.1 0.0 11.2 14.1 10.3 7.8 29.0 9.7 8.9 6.4 14.6 13.5 10.7 61.1 13.3 11.4 5.0 10.8 9.8 18.3 10.4 7.0 10.3 17.0 44.8 6.5 8.0 125.0 69.7 5.1 11.8 11.4 11.1 4.3 RAD21 "hHR21, KIAA0078, SCC1" ENSG00000164754 "RAD21 cohesin complex component" O60216 8 116845935-116874866 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Activator, Developmental protein, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020044, CAB022065" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB022065: , HPA020044: AB_1856035" "unprognostic (7.85e-2)" "unprognostic (4.92e-1)" "unprognostic (3.05e-1)" "unprognostic (5.43e-3)" "unprognostic (9.56e-2)" "unprognostic (3.50e-1)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.86e-3)" "unprognostic (8.99e-2)" "unprognostic (8.80e-2)" "unprognostic (5.58e-3)" "unprognostic (3.56e-2)" "unprognostic (4.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.82e-1)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" 31.6 40.9 48.2 30.5 52.2 78.5 37.7 58.8 55.3 24.2 36.3 37.5 21.5 24.8 30.5 25.3 32.1 23.1 22.0 37.8 45.6 44.1 30.5 27.9 29.6 49.2 54.3 35.4 33.5 18.2 29.1 30.0 38.9 45.5 26.5 37.3 19.0 25.3 31.0 37.8 24.0 26.0 33.4 49.7 31.2 31.5 37.6 56.2 58.3 41.9 20.9 50.4 37.1 36.0 8.7 5.4 17.9 7.1 8.0 25.4 6.2 41.6 20.5 40.2 22.5 20.2 17.5 18.0 29.0 27.5 32.2 29.8 16.8 39.3 61.6 16.0 20.6 17.2 23.3 34.2 18.7 37.8 81.7 21.9 62.8 25.2 21.3 12.7 20.1 37.0 14.9 15.4 18.8 22.8 21.3 25.1 89.9 25.2 86.3 27.7 25.1 92.1 11.9 23.6 53.8 25.9 33.8 29.2 30.9 19.2 24.5 50.8 26.2 30.4 82.1 19.6 22.0 34.4 24.9 18.4 22.8 33.4 23.8 30.3 45.7 52.5 55.5 19.5 29.0 27.2 17.2 4.5 15.5 11.0 5.3 11.2 8.7 12.9 13.0 5.4 8.3 13.5 13.0 17.9 8.0 7.1 4.5 25.4 6.2 48.2 52.2 58.8 55.3 45.6 44.1 54.3 35.4 45.5 56.2 238.2 123.7 70.9 67.0 84.9 73.4 149.3 48.4 87.0 138.8 52.4 29.5 106.6 36.5 47.5 247.8 88.8 56.4 70.0 38.8 119.7 73.7 80.6 143.9 61.8 58.9 63.5 81.0 64.4 91.5 303.2 107.9 82.3 65.8 97.4 62.9 99.6 49.1 57.5 100.0 50.1 60.7 71.1 54.7 31.6 81.6 87.8 95.1 93.8 69.2 65.3 RAD50 "hRad50, RAD50-2" ENSG00000113522 "RAD50 double strand break repair protein" Q92878 5 132556019-132646344 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB022103, CAB024979, HPA052291" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022103: , CAB024979: , HPA052291: AB_2681786" "unprognostic (3.46e-3)" "prognostic unfavorable (3.77e-4)" "unprognostic (7.50e-3)" "unprognostic (4.22e-3)" "unprognostic (6.71e-2)" "unprognostic (5.98e-2)" "unprognostic (2.76e-2)" "unprognostic (1.06e-1)" "unprognostic (6.84e-2)" "unprognostic (2.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.62e-1)" "prognostic favorable (1.95e-4)" "unprognostic (1.86e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-2)" "unprognostic (2.40e-1)" 11.3 8.4 10.2 8.7 11.2 10.4 11.7 8.2 11.9 8.4 11.2 4.1 8.6 6.7 13.0 20.6 15.0 8.2 7.6 11.9 8.3 5.0 11.0 12.4 11.2 6.0 9.1 9.7 11.8 10.8 14.9 16.2 11.2 10.7 9.7 8.4 3.6 11.4 11.4 13.5 19.8 11.7 8.0 7.6 10.1 8.8 12.8 9.9 11.4 13.9 7.2 6.5 9.6 12.8 6.9 3.6 6.7 4.9 9.8 8.0 3.1 5.3 14.9 1.4 8.5 10.1 9.9 4.5 3.6 6.6 3.9 6.7 14.1 10.1 13.9 2.2 6.2 9.7 7.7 6.8 8.4 5.9 4.7 9.1 5.3 9.3 8.8 8.5 6.9 5.5 7.9 16.7 7.4 17.3 4.2 2.9 4.8 8.4 2.5 6.2 5.3 5.1 9.6 6.8 7.0 6.3 3.5 1.9 5.1 6.4 9.8 7.4 10.0 8.0 3.3 1.2 4.0 7.3 4.7 3.6 2.6 3.9 8.2 5.3 4.1 4.8 15.8 6.4 8.8 3.9 6.7 4.6 0.5 5.9 4.3 8.0 6.9 7.5 5.8 3.6 6.1 6.5 6.6 0.2 9.8 4.9 3.2 3.5 3.1 10.2 11.2 8.2 11.8 8.3 5.0 9.1 9.7 10.7 9.9 35.7 21.9 41.2 33.0 23.1 53.5 114.6 48.4 50.9 33.0 7.0 84.4 59.3 1.7 4.9 12.4 22.2 32.6 23.3 5.3 46.8 38.4 21.5 30.0 33.4 33.1 35.0 35.6 22.7 24.7 8.5 56.1 12.7 15.1 1.0 39.7 45.9 3.7 28.1 50.2 3.4 62.5 32.3 27.4 96.8 76.8 23.3 27.7 21.9 45.4 23.3 RAD51AP1 PIR51 ENSG00000111247 "RAD51 associated protein 1" Q96B01 12 4538798-4560048 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.8" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 33.7;Erythroid cells: 46.7;Extravillous trophoblasts: 30.1;Hofbauer cells: 34.3;Late spermatids: 50.0;Spermatocytes: 35.8;Spermatogonia: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051499 Approved Nucleoplasm Yes Yes Nucleoplasm "HPA051499: AB_2681508" "unprognostic (1.03e-1)" "unprognostic (5.44e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (6.30e-2)" "unprognostic (5.25e-3)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.15e-2)" "unprognostic (2.26e-2)" "unprognostic (6.29e-3)" "prognostic unfavorable (1.22e-5)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.44e-15)" "unprognostic (2.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.88e-2)" "unprognostic (3.75e-2)" 3.0 2.0 1.7 9.2 3.6 15.4 2.7 4.5 2.6 1.8 5.4 1.4 3.8 5.4 1.5 3.2 7.6 1.1 2.2 1.9 1.5 1.2 1.7 1.7 2.6 8.8 2.1 1.7 1.5 1.2 0.5 1.2 4.2 1.8 1.7 7.1 1.5 2.8 1.0 1.2 3.2 6.2 1.9 2.9 5.8 2.9 9.2 2.5 29.8 1.4 4.7 8.2 2.1 3.1 4.5 9.7 0.9 3.1 1.9 1.5 0.9 13.0 4.6 16.5 8.2 1.0 2.1 19.3 17.2 7.6 19.2 25.4 12.5 12.7 17.1 2.5 3.7 9.0 8.3 11.4 5.1 29.5 13.4 9.7 21.5 8.0 8.6 0.2 19.5 10.9 0.4 0.5 11.5 11.2 2.7 7.7 11.8 13.4 19.7 12.1 4.7 15.9 7.1 40.1 12.7 5.2 16.0 19.8 6.7 5.8 6.5 5.5 6.1 12.8 10.0 4.1 17.4 4.0 11.4 3.4 13.1 13.4 14.1 18.3 3.0 3.4 32.7 4.9 14.1 10.5 0.0 0.8 0.9 0.2 3.1 0.8 4.2 0.6 1.5 0.6 4.5 0.2 0.4 0.0 1.9 2.7 9.7 1.4 0.9 1.7 3.6 4.5 2.6 1.5 1.2 2.1 1.7 1.8 2.5 0.0 0.3 7.5 1.7 4.6 3.0 1.2 2.5 0.0 5.7 0.0 3.9 6.8 0.0 2.0 33.7 0.7 1.3 46.7 2.3 30.1 2.9 1.1 1.1 1.0 34.3 0.0 2.4 1.8 4.7 50.0 1.1 6.6 0.0 10.8 2.8 2.6 1.1 0.0 1.4 1.2 4.9 0.0 1.9 35.8 29.9 2.3 3.9 3.8 7.7 0.9 RAD54L "hHR54, hRAD54, RAD54A" ENSG00000085999 "RAD54 like" Q92698 1 46247688-46278473 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 41.9;testis: 56.6" "Cell type enhanced" "Detected in some" 11 "Extravillous trophoblasts: 7.8;granulocytes: 4.6;Spermatocytes: 8.0;Spermatogonia: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 4.1" "Lineage enriched" "Detected in single" 4 "T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA028954, HPA051537" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA028954: AB_2672840, HPA051537: AB_2681525" "unprognostic (2.12e-2)" "prognostic favorable (6.67e-4)" "unprognostic (5.12e-2)" "unprognostic (5.36e-3)" "unprognostic (3.24e-1)" "unprognostic (1.08e-2)" "unprognostic (9.75e-6)" "unprognostic (3.91e-2)" "unprognostic (2.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.77e-4)" "unprognostic (5.58e-2)" "unprognostic (1.11e-16)" "unprognostic (6.76e-3)" "unprognostic (1.66e-1)" "unprognostic (2.67e-1)" "unprognostic (1.74e-1)" 1.9 0.6 1.5 12.9 4.7 9.4 1.3 3.0 1.9 1.1 4.8 0.7 0.5 2.8 1.2 2.1 5.2 0.3 1.2 1.5 1.8 1.5 1.4 0.5 1.5 6.0 1.9 0.7 0.8 1.4 0.6 0.5 4.2 0.9 1.1 5.8 0.6 1.4 1.0 1.4 3.0 3.6 1.8 3.2 4.1 1.7 56.6 0.6 41.9 1.7 3.8 9.6 1.0 1.7 0.5 0.3 0.0 0.1 0.9 4.1 0.7 9.0 6.8 20.5 12.5 1.5 1.0 19.1 10.7 4.7 18.1 18.6 14.5 6.0 17.8 8.2 4.5 16.5 9.4 18.9 6.0 16.0 9.7 19.1 21.8 18.2 14.4 0.0 21.8 12.8 0.6 0.5 18.0 5.3 3.0 5.6 20.7 15.6 18.2 9.9 8.6 27.1 24.2 18.3 8.0 11.2 21.7 11.4 7.8 4.4 7.8 9.8 7.0 7.8 10.8 2.6 17.4 3.8 15.9 2.4 19.5 11.6 10.0 18.0 7.7 4.4 19.2 5.2 14.5 7.8 0.0 0.1 0.0 1.2 0.1 0.2 0.5 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.9 0.1 0.0 4.1 0.7 1.5 4.7 3.0 1.9 1.8 1.5 1.9 0.7 0.9 0.6 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 1.8 0.1 0.2 0.0 0.0 7.8 0.4 0.3 4.6 0.0 2.2 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.0 4.2 0.3 1.4 0.0 1.2 0.4 RAD9A RAD9 ENSG00000172613 "RAD9 checkpoint clamp component A" Q99638 11 67317871-67398410 "Enzymes, Predicted intracellular proteins" "DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006725, HPA048155" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA006725: AB_1856041, HPA048155: AB_2680290" "unprognostic (7.64e-2)" "prognostic favorable (6.95e-4)" "unprognostic (8.83e-3)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (2.12e-3)" "unprognostic (9.64e-3)" "unprognostic (1.05e-2)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (9.19e-2)" "unprognostic (2.50e-2)" "prognostic unfavorable (2.82e-5)" "unprognostic (6.16e-2)" "unprognostic (3.72e-3)" "unprognostic (2.19e-1)" "prognostic favorable (7.52e-6)" 5.4 5.2 7.0 10.6 8.4 10.8 6.1 7.7 6.3 6.7 11.8 8.5 5.1 14.2 7.1 4.1 8.2 12.1 6.3 6.1 3.8 3.5 6.9 9.4 9.5 9.0 7.8 2.5 6.8 20.1 3.7 7.2 10.2 5.5 8.6 3.3 4.9 12.8 8.1 7.8 12.8 17.5 5.5 4.1 10.7 11.3 7.2 6.0 18.2 11.7 7.2 16.8 6.2 7.1 6.7 5.1 8.9 3.9 4.7 9.0 3.2 6.7 11.0 5.8 8.3 1.7 0.8 7.8 4.3 2.9 5.0 4.3 13.1 12.9 8.1 8.1 0.9 7.9 11.4 3.4 3.3 0.7 7.7 9.5 10.9 5.9 6.5 2.4 7.1 14.4 2.1 3.3 4.3 1.8 3.1 3.3 15.3 8.8 9.0 1.0 20.9 13.8 13.8 8.8 9.4 8.3 11.5 7.9 9.2 1.3 5.4 6.7 7.2 6.0 16.4 13.6 1.3 11.6 6.8 2.5 7.2 9.4 14.6 5.1 9.6 8.9 7.0 4.8 7.0 5.9 8.0 3.2 8.9 9.0 3.6 6.4 6.7 7.2 7.3 2.1 5.3 4.9 5.7 4.7 4.7 3.9 5.1 3.9 3.2 7.0 8.4 7.7 6.3 3.8 3.5 7.8 2.5 5.5 6.0 20.8 17.9 32.3 16.6 15.1 18.1 0.8 12.7 29.4 23.9 19.2 66.8 21.0 11.6 10.1 18.0 13.7 57.3 0.0 11.5 18.5 14.7 20.0 19.7 5.9 13.4 20.6 13.7 8.6 7.1 9.4 9.8 22.6 18.6 4.6 18.9 14.0 9.0 24.6 11.7 6.9 31.2 12.9 9.7 27.6 15.0 15.2 34.0 41.5 24.0 11.9 RAG1 "MGC43321, RNF74" ENSG00000166349 "Recombination activating 1" P15918 11 36510709-36593156 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA recombination, Ubl conjugation pathway" "Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase" "Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 62 "lymphoid tissue: 462.4" "Cell type enhanced" "Detected in some" 12 "Distal tubular cells: 3.3;Ito cells: 9.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "MOLT-4: 67.2;REH: 64.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA043939 Supported Nucleoplasm NA NA Nucleoplasm "HPA043939: AB_2732512" "unprognostic (7.35e-2)" "unprognostic (1.57e-3)" "unprognostic (8.75e-2)" "unprognostic (3.44e-1)" "unprognostic (2.14e-1)" "unprognostic (1.46e-2)" "unprognostic (2.30e-1)" "unprognostic (1.70e-2)" "unprognostic (1.43e-1)" "unprognostic (1.54e-2)" "unprognostic (5.98e-3)" "unprognostic (1.28e-1)" "unprognostic (1.16e-9)" "unprognostic (2.16e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-4)" "unprognostic (1.53e-1)" 0.7 2.3 0.5 0.5 0.5 7.4 0.7 0.5 0.5 0.5 0.6 0.5 0.5 1.2 0.5 1.3 0.5 0.6 0.5 0.6 0.5 0.2 2.4 1.2 0.8 0.5 0.5 0.5 0.6 1.1 1.9 0.5 0.8 0.5 0.5 0.4 0.5 1.5 0.5 0.5 0.2 1.5 0.5 0.5 4.4 0.8 0.9 0.5 462.4 4.5 0.5 0.8 0.7 0.5 0.2 0.3 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 13.4 0.0 0.0 0.1 0.0 67.2 0.0 0.5 0.0 0.0 64.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.8 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.5 0.5 0.5 0.5 0.2 0.5 0.5 0.5 0.5 0.0 0.0 0.0 1.0 0.1 1.2 0.8 0.0 0.0 0.0 1.8 0.0 0.2 3.3 0.4 1.7 1.5 1.4 0.0 0.4 0.1 0.2 0.3 0.0 1.7 0.3 0.0 0.0 9.2 1.6 1.3 0.0 0.0 0.0 1.8 0.6 0.1 0.7 0.0 0.0 2.1 0.8 0.0 0.4 1.2 0.7 0.4 0.3 0.0 0.4 0.5 RAG2 ENSG00000175097 "Recombination activating 2" P55895 11 36575574-36598279 "Disease related genes, Predicted intracellular proteins" "DNA recombination" "Chromatin regulator" "Disease mutation, SCID" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 165.8" "Cell type enriched" "Detected in single" 6 "Early spermatids: 1.4" "Cancer enriched" "Detected in single" 21 "thyroid cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 14.0;MOLT-4: 15.6;REH: 62.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065704 Approved Nucleoplasm NA NA Nucleoplasm "HPA065704: AB_2732737" "unprognostic (4.30e-2)" "unprognostic (9.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (4.58e-2)" "unprognostic (2.17e-1)" "unprognostic (8.11e-2)" "unprognostic (1.68e-3)" 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 165.8 24.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 62.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 RAI1 "DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS" ENSG00000108557 "Retinoic acid induced 1" Q7Z5J4 17 17681473-17811453 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023898, HPA054906" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA023898: AB_10971089, HPA054906: AB_2682637" "unprognostic (7.57e-2)" "unprognostic (3.83e-2)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-2)" "unprognostic (3.85e-2)" "unprognostic (3.02e-3)" "unprognostic (1.30e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (2.61e-2)" "unprognostic (5.29e-2)" "unprognostic (4.20e-2)" "unprognostic (6.97e-2)" "unprognostic (1.35e-1)" "unprognostic (1.50e-2)" "unprognostic (8.28e-2)" 8.0 13.8 13.8 12.6 17.6 8.1 10.1 21.5 22.9 18.1 12.2 14.2 13.3 11.3 17.8 11.8 12.1 20.3 16.8 13.6 11.3 11.9 10.3 5.8 11.2 9.7 11.1 11.3 17.3 17.2 22.4 19.6 8.4 11.3 17.7 5.4 23.3 24.0 18.2 8.2 19.1 9.5 16.7 6.6 18.5 16.6 8.8 15.7 10.4 15.6 7.7 11.2 19.6 30.0 1.0 3.0 0.7 1.2 2.8 1.0 0.7 15.7 21.4 13.6 11.2 1.8 3.8 2.3 5.4 5.9 4.6 4.5 11.1 6.7 5.1 7.5 7.0 3.9 18.6 4.7 10.8 1.9 5.0 10.6 9.3 12.9 5.6 6.1 3.7 5.9 4.3 5.3 4.1 6.2 5.4 5.6 6.5 3.9 4.1 2.3 14.1 7.8 3.6 0.9 8.2 6.3 18.4 10.6 7.2 3.8 18.9 9.5 16.9 8.6 7.6 17.6 16.4 10.2 4.7 10.7 7.3 9.4 11.6 7.6 3.7 0.8 3.2 7.1 4.6 19.8 0.0 1.0 0.7 0.8 0.8 0.5 0.1 0.4 0.6 0.5 1.0 0.3 1.0 0.1 2.8 1.2 3.0 0.0 0.7 13.8 17.6 21.5 22.9 11.3 11.9 11.1 11.3 11.3 15.7 11.9 28.1 1.9 9.0 10.8 24.9 3.6 10.2 1.4 11.4 14.0 21.6 0.1 0.0 13.7 2.5 7.8 2.4 0.0 8.0 0.5 8.8 11.5 13.9 5.6 2.1 22.3 10.9 14.1 2.2 3.1 6.4 6.3 8.5 2.8 6.9 5.8 9.6 0.0 5.6 1.8 12.0 6.5 6.4 1.4 12.4 7.8 0.3 2.9 6.3 11.1 RALGDS "RalGEF, RGDS, RGF" ENSG00000160271 "Ral guanine nucleotide dissociation stimulator" Q12967 9 133097720-133149334 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 88.7;Urothelial cells: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 16.7;MAIT T-cell: 6.6;memory CD4 T-cell: 7.6;memory CD8 T-cell: 12.0;naive CD8 T-cell: 6.5;NK-cell: 5.7;T-reg: 13.1" "Group enriched" "Detected in many" 9 "NK-cells: 5.7;T-cells: 16.7" "Cell line enhanced" "Detected in all" "HDLM-2: 53.1;SH-SY5Y: 33.7" "HPA025961, CAB032582" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB032582: AB_2238105, HPA025961: AB_2671795" "unprognostic (1.01e-1)" "prognostic favorable (4.19e-4)" "unprognostic (1.35e-2)" "unprognostic (7.92e-3)" "unprognostic (8.20e-2)" "unprognostic (7.95e-2)" "unprognostic (5.09e-2)" "unprognostic (2.20e-1)" "unprognostic (8.91e-2)" "unprognostic (2.88e-1)" "unprognostic (2.69e-3)" "unprognostic (5.03e-2)" "unprognostic (9.54e-3)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" 18.9 19.8 28.2 14.5 43.2 26.3 16.8 33.1 38.1 14.8 11.1 43.6 12.8 13.0 10.3 10.4 28.7 18.8 23.9 18.7 30.4 23.0 6.3 5.7 19.9 18.8 45.6 19.2 26.6 17.4 11.5 31.8 8.2 38.0 11.8 8.0 8.0 21.6 16.7 13.1 24.8 15.3 10.6 44.3 13.4 13.3 3.8 48.0 5.5 12.2 14.5 13.6 17.1 12.7 1.1 0.5 1.3 0.4 5.7 16.7 3.5 2.6 3.8 8.1 10.0 3.1 4.5 6.8 3.1 4.7 3.2 2.1 3.3 5.7 3.9 2.9 5.3 4.9 12.4 8.2 5.7 1.1 53.1 5.8 3.4 7.6 4.7 4.0 5.3 6.2 5.3 8.1 1.7 3.6 8.8 6.6 7.8 6.6 24.8 2.9 8.5 7.6 5.1 5.5 11.7 10.0 7.8 1.9 6.6 3.9 4.5 25.6 33.7 3.7 5.5 4.9 3.3 5.7 5.6 3.5 3.6 3.8 2.7 2.1 1.1 3.0 4.7 3.2 6.1 4.0 1.3 0.4 0.5 16.7 0.2 6.6 1.1 7.6 12.0 0.5 0.3 1.7 6.5 0.2 5.7 0.1 0.5 13.1 3.5 28.2 43.2 33.1 38.1 30.4 23.0 45.6 19.2 38.0 48.0 29.8 13.7 6.9 42.4 49.2 12.3 5.9 12.7 12.0 17.0 8.7 11.8 3.6 3.3 9.9 0.4 26.3 24.7 0.0 5.8 3.4 9.1 38.3 15.1 3.0 11.6 58.8 35.5 37.4 8.3 1.5 12.4 18.0 21.9 1.8 13.4 20.5 10.0 13.5 8.5 2.2 8.5 0.0 11.2 2.3 3.8 88.7 4.9 23.0 15.8 86.8 RALYL HNRPCL3 ENSG00000184672 "RALY RNA binding protein like" Q86SE5 8 84182787-84921844 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 25.6;brain: 54.9;kidney: 23.5" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 38.5;Distal tubular cells: 150.9;Horizontal cells: 31.8;Muller glia cells: 33.3" "Cancer enhanced" "Detected in single" "glioma: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 26.8" "Low region specificity" "Detected in all" "HPA055868, HPA059112" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055868: AB_2682950, HPA059112: AB_2683908" "unprognostic (1.13e-5)" "unprognostic (1.62e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (5.04e-2)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (4.82e-5)" "unprognostic (2.74e-2)" "unprognostic (2.52e-1)" 1.1 25.6 14.0 1.1 23.0 1.2 1.1 54.9 38.2 0.9 1.3 1.1 0.0 1.4 1.1 1.8 0.9 1.7 7.1 3.7 14.9 22.6 23.5 1.3 1.1 1.0 14.7 20.0 1.0 3.7 1.0 7.6 2.4 9.8 1.2 1.5 0.4 1.1 3.4 1.1 1.2 1.8 1.1 4.6 3.8 1.6 1.4 3.5 0.0 1.1 0.0 1.0 1.0 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 26.8 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 14.0 23.0 54.9 23.0 14.9 22.6 14.7 20.0 9.8 3.5 0.0 0.0 0.0 0.0 0.0 38.5 4.4 22.9 0.0 0.0 7.0 2.0 0.0 150.9 0.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 31.8 1.7 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 14.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAN "ARA24, Gsp1, TC4" ENSG00000132341 "RAN, member RAS oncogene family" P62826 12 130871879-130877678 "Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Host-virus interaction, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA063353 Enhanced Nucleoplasm No No 2100000 Nucleoplasm "HPA063353: " "unprognostic (2.22e-2)" "unprognostic (5.16e-2)" "unprognostic (2.30e-2)" "unprognostic (3.34e-2)" "unprognostic (1.75e-1)" "unprognostic (3.39e-3)" "prognostic unfavorable (9.99e-8)" "unprognostic (2.81e-3)" "unprognostic (1.28e-1)" "unprognostic (5.41e-3)" "unprognostic (2.76e-2)" "prognostic unfavorable (7.86e-5)" "prognostic unfavorable (1.46e-7)" "unprognostic (6.55e-2)" "unprognostic (2.79e-1)" "unprognostic (4.62e-1)" "unprognostic (3.16e-2)" 52.3 68.3 46.9 75.7 62.7 80.6 53.4 42.1 62.6 38.1 61.9 32.5 41.4 41.7 47.9 59.9 96.4 44.0 36.1 55.2 53.9 59.7 52.6 65.9 50.1 90.3 48.9 61.0 46.9 51.3 31.8 43.8 57.0 50.8 37.0 65.6 28.6 43.7 40.2 84.2 45.5 45.1 59.6 42.1 60.1 47.8 87.2 31.0 84.8 51.7 89.6 108.3 44.7 49.5 94.1 69.3 34.3 62.3 60.5 96.5 110.2 97.8 134.7 116.7 67.5 53.7 66.3 90.1 129.3 67.8 126.1 87.2 144.7 104.3 161.8 87.4 92.9 79.3 63.5 169.6 134.3 137.0 54.2 133.5 95.0 102.8 146.3 65.7 164.3 81.9 62.1 84.0 108.7 158.0 84.2 121.8 116.3 140.0 48.2 123.7 120.3 160.2 198.5 136.9 101.7 215.5 125.3 100.2 90.7 117.6 171.0 107.1 65.5 74.8 67.6 90.7 100.9 133.2 119.1 84.2 72.9 111.4 73.9 120.3 67.4 109.7 227.3 74.9 101.7 101.2 29.6 51.5 34.3 69.6 62.3 84.7 94.1 95.5 79.9 69.3 78.5 87.0 82.5 10.7 60.5 58.0 65.7 96.5 110.2 46.9 62.7 42.1 62.6 53.9 59.7 48.9 61.0 50.8 31.0 169.7 129.5 266.6 518.3 564.3 160.2 103.4 160.5 183.4 197.9 160.5 35.3 577.4 328.3 654.2 67.6 212.9 137.7 233.6 391.9 1042.2 424.8 302.9 190.4 172.1 550.1 131.9 193.7 150.4 155.0 125.0 197.6 285.4 315.5 519.4 219.7 197.5 494.0 152.6 217.1 304.7 106.2 161.7 425.8 567.1 580.4 478.1 512.7 322.1 399.9 542.5 RANBP3 ENSG00000031823 "RAN binding protein 3" Q9H6Z4 19 5916139-5978142 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043375, HPA043389" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043375: AB_10959889, HPA043389: AB_10963696" "unprognostic (1.81e-1)" "unprognostic (1.18e-3)" "unprognostic (3.61e-1)" "prognostic favorable (1.22e-5)" "unprognostic (4.24e-2)" "unprognostic (1.42e-3)" "unprognostic (5.44e-2)" "unprognostic (3.90e-2)" "unprognostic (3.58e-1)" "unprognostic (1.08e-1)" "prognostic favorable (4.14e-4)" "unprognostic (2.27e-1)" "unprognostic (3.80e-2)" "unprognostic (2.91e-1)" "unprognostic (5.15e-2)" "prognostic favorable (8.14e-4)" "unprognostic (1.06e-2)" 19.5 30.2 24.8 25.2 31.5 20.9 18.6 38.2 40.9 21.2 29.8 31.6 18.3 24.7 28.2 16.5 23.4 23.9 20.3 30.8 25.0 26.5 19.3 24.6 21.9 26.7 24.3 21.2 29.2 33.1 22.4 26.1 22.3 28.8 25.6 14.2 30.1 27.9 28.0 33.9 21.2 25.1 27.9 25.0 24.9 24.9 36.7 28.0 33.5 21.9 14.7 27.7 28.0 20.9 20.7 21.3 25.0 21.4 14.9 28.7 20.1 30.2 21.3 18.1 20.2 13.7 13.9 12.9 19.4 18.3 22.7 24.7 26.9 10.7 28.6 21.8 15.0 14.3 18.9 16.1 18.9 14.0 29.2 26.3 15.3 16.7 31.9 14.9 22.4 22.6 13.6 13.1 14.2 16.2 10.6 16.5 15.7 27.7 27.1 12.8 12.7 37.2 10.9 33.2 13.2 27.0 27.6 17.4 26.0 14.7 23.5 20.0 22.5 17.2 18.2 17.1 11.1 13.9 17.0 17.1 19.2 14.1 33.5 28.4 28.1 28.3 24.6 24.3 28.2 23.6 13.2 20.8 25.0 22.7 21.4 23.3 17.0 22.0 22.7 21.3 20.7 19.6 25.1 24.0 14.9 20.6 20.2 28.7 20.1 24.8 31.5 38.2 40.9 25.0 26.5 24.3 21.2 28.8 28.0 23.8 18.7 17.9 17.1 10.9 15.9 13.3 17.8 20.1 13.6 7.0 23.6 23.8 36.5 25.9 39.7 15.2 15.8 23.3 18.2 26.3 16.4 14.7 17.3 9.5 21.6 22.3 12.7 6.7 14.3 57.9 15.5 17.0 20.3 44.1 14.6 18.9 18.6 10.5 23.3 14.7 16.8 19.4 13.7 51.1 37.9 10.3 29.6 21.7 13.3 20.9 RANBP3L FLJ25422 ENSG00000164188 "RAN binding protein 3 like" Q86VV4 5 36248434-36302114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;kidney: 33.8" "Cell type enhanced" "Detected in some" 23 "Collecting duct cells: 8.7;Distal tubular cells: 39.7;Muller glia cells: 12.8;Sertoli cells: 12.9" "Cancer enhanced" "Detected in some" "prostate cancer: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "ASC diff: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037471, HPA037472, HPA061526" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-3)" "unprognostic (5.52e-3)" "unprognostic (2.85e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-2)" "unprognostic (9.56e-2)" "unprognostic (2.66e-1)" "unprognostic (2.81e-1)" "unprognostic (1.28e-1)" "unprognostic (3.76e-4)" "unprognostic (1.68e-2)" "unprognostic (9.13e-2)" "unprognostic (8.87e-3)" "unprognostic (5.71e-2)" 4.6 2.8 25.7 1.0 27.5 0.8 10.7 8.5 24.5 2.4 1.1 5.6 0.6 1.0 1.4 3.1 1.4 2.3 3.0 2.5 30.3 5.6 33.8 12.2 3.2 1.1 8.2 16.5 3.4 1.2 1.1 5.3 7.0 12.2 18.6 1.3 1.0 1.5 4.7 0.9 0.9 1.0 6.6 21.4 1.0 2.7 6.4 18.4 0.0 3.6 0.0 1.5 8.2 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 16.9 0.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 27.5 8.5 21.2 30.3 5.6 8.2 16.5 12.2 18.4 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 8.7 0.0 0.0 39.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.2 0.0 1.3 1.4 0.0 0.0 0.6 0.0 0.0 2.0 0.0 1.7 0.0 0.0 12.8 0.0 0.0 2.1 0.1 0.5 12.9 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RARB "HAP, NR1B2, RRB2" ENSG00000077092 "Retinoic acid receptor beta" P10826 3 25174332-25597932 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Microphthalmia, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 39.1" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 17.9;Cone photoreceptor cells: 23.6;Ito cells: 20.3;Muller glia cells: 27.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 22.6" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 7.0;HEK 293: 7.9;hTERT-RPE1: 41.7;WM-115: 18.1" "Region enriched" "Detected in many" 9 "basal ganglia: 97.9" "Low region specificity" "Detected in all" "CAB002617, HPA004174" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002617: , HPA004174: AB_1079744" "unprognostic (2.04e-2)" "unprognostic (3.53e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (2.70e-2)" "unprognostic (2.43e-1)" "unprognostic (4.71e-2)" "unprognostic (1.62e-1)" "unprognostic (2.86e-1)" "prognostic favorable (3.43e-5)" "unprognostic (9.24e-3)" "unprognostic (2.28e-1)" "unprognostic (9.99e-2)" "unprognostic (6.56e-3)" 3.9 7.1 2.4 2.3 22.6 0.0 6.8 1.5 9.1 13.4 6.0 2.2 6.8 1.7 14.4 7.5 8.1 6.2 5.3 13.6 2.6 2.2 17.5 6.2 5.6 5.6 2.0 3.7 12.2 1.5 12.8 18.9 13.9 3.2 13.0 2.3 39.1 13.7 11.8 2.5 1.4 2.4 14.7 4.6 7.7 4.8 1.7 4.8 0.0 10.0 2.9 4.6 12.1 10.2 1.0 0.4 0.1 0.6 0.1 0.8 0.0 0.0 0.9 0.6 3.1 7.0 1.8 0.0 0.8 0.4 0.0 0.3 0.1 0.0 0.0 0.1 1.2 0.1 0.2 0.0 0.1 0.0 0.0 7.9 0.0 0.0 0.5 0.1 0.1 0.0 3.7 0.0 0.0 0.0 41.7 6.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 4.2 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.5 0.0 1.1 3.4 0.1 0.0 0.0 2.8 0.1 18.1 0.0 0.6 0.0 0.8 0.1 0.3 0.3 0.5 0.5 0.4 1.0 0.6 0.8 0.1 0.1 0.1 0.4 0.0 0.0 2.4 22.6 1.5 9.1 2.6 2.2 2.0 3.7 3.2 4.8 0.0 0.3 0.0 17.9 0.1 4.2 9.3 7.6 6.7 12.5 10.4 23.6 0.1 0.0 1.4 1.3 3.8 0.0 0.0 0.8 0.1 3.1 5.5 0.0 2.0 0.3 4.8 0.0 20.3 4.1 0.4 0.0 0.0 0.0 0.0 0.0 27.5 1.1 0.0 0.0 0.5 6.1 0.0 9.2 0.2 1.1 0.1 0.2 0.0 0.0 7.1 RARG "NR1B3, RARC" ENSG00000172819 "Retinoic acid receptor gamma" P13631 12 53210567-53232980 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 49.4;skin 1: 52.1" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 30.3;Suprabasal keratinocytes: 48.8;Urothelial cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 17.0" "Group enriched" "Detected in all" 4 "dendritic cells: 5.6;T-cells: 17.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 33.3;MCF7: 35.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053883 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA053883: AB_2682292" "unprognostic (7.29e-2)" "unprognostic (1.95e-2)" "unprognostic (6.11e-2)" "prognostic unfavorable (3.68e-6)" "unprognostic (2.53e-1)" "unprognostic (5.43e-2)" "unprognostic (2.28e-1)" "unprognostic (1.08e-2)" "unprognostic (3.54e-3)" "unprognostic (7.21e-3)" "unprognostic (3.78e-3)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.08e-6)" "unprognostic (5.41e-3)" "unprognostic (1.98e-2)" "unprognostic (5.94e-3)" "unprognostic (7.41e-2)" 4.8 5.0 2.7 7.0 3.6 1.3 10.8 6.3 3.8 26.8 6.3 1.8 7.3 1.0 14.6 6.0 49.4 10.6 8.6 6.9 3.0 1.4 3.7 1.9 7.4 6.7 2.4 2.3 12.6 2.7 4.2 2.8 4.4 1.6 11.3 3.4 10.3 9.5 10.6 2.6 52.1 3.0 9.7 1.5 4.7 6.0 3.9 1.7 2.3 7.3 30.6 26.8 10.9 19.8 1.8 5.6 1.5 2.5 1.7 17.0 2.9 7.2 8.0 1.8 16.9 18.9 16.2 0.5 7.6 16.6 10.0 7.9 2.7 33.3 0.1 4.2 30.6 5.4 24.5 6.1 14.6 2.5 1.9 3.1 1.0 6.1 2.3 8.0 0.0 3.0 12.0 21.5 9.5 2.1 25.3 4.2 1.5 0.2 3.2 3.9 35.1 0.4 0.3 5.4 9.8 14.2 2.3 0.6 5.8 3.0 12.0 1.5 7.6 15.5 16.8 10.2 2.4 14.5 0.4 4.5 12.0 5.7 7.9 0.4 1.5 0.8 0.5 14.8 1.2 17.0 1.5 2.5 0.7 6.6 0.8 17.0 1.8 5.7 4.8 5.6 0.6 4.8 4.1 0.0 1.7 0.0 0.4 1.5 2.9 2.7 3.6 6.3 3.8 3.0 1.4 2.4 2.3 1.6 1.7 3.0 6.5 0.0 19.4 30.3 0.7 2.8 5.1 0.0 2.3 3.5 2.0 7.2 0.0 8.7 0.0 6.9 0.4 0.0 4.5 0.7 19.6 11.9 1.1 0.0 2.3 0.0 1.7 20.9 5.2 0.2 4.9 2.8 8.5 1.8 1.6 2.9 9.8 3.5 4.9 0.6 4.9 6.5 12.2 0.4 4.1 48.8 1.5 5.7 5.2 33.4 RAVER1 KIAA1978 ENSG00000161847 "Ribonucleoprotein, PTB binding 1" Q8IY67 19 10316212-10333640 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 11.7;Intestinal endocrine cells: 15.6;monocytes: 10.8;Undifferentiated cells: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 67.4" "Low region specificity" "Detected in all" "HPA043575, HPA049457" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA043575: AB_2678562, HPA049457: AB_2680774" "unprognostic (2.04e-1)" "unprognostic (3.15e-2)" "unprognostic (1.54e-1)" "unprognostic (2.34e-2)" "unprognostic (2.36e-1)" "unprognostic (1.80e-2)" "unprognostic (1.59e-1)" "unprognostic (4.22e-2)" "unprognostic (2.01e-2)" "unprognostic (7.20e-2)" "unprognostic (2.64e-2)" "unprognostic (3.22e-2)" "unprognostic (3.40e-2)" "unprognostic (1.14e-2)" "unprognostic (1.53e-1)" "unprognostic (8.98e-2)" "unprognostic (2.97e-1)" 11.8 11.3 7.0 24.3 8.5 25.5 14.1 11.1 10.1 14.1 15.1 10.3 11.2 27.3 19.8 9.4 12.6 17.5 15.0 8.3 8.1 5.6 11.0 7.4 14.0 18.7 9.2 7.2 17.8 16.6 6.5 15.4 10.6 9.0 13.0 5.8 10.2 17.9 13.5 8.3 9.7 27.8 9.1 8.8 19.4 14.7 15.0 8.2 46.9 12.3 8.9 16.4 15.8 16.1 4.3 3.7 2.9 5.7 3.6 8.6 2.8 16.3 10.5 3.8 5.9 1.5 2.0 8.6 8.7 3.9 6.8 6.1 11.5 4.7 17.4 12.2 2.8 5.5 8.5 4.3 5.7 1.3 14.6 25.7 26.8 7.1 12.8 3.5 16.7 17.4 2.3 2.0 4.6 1.7 2.2 4.4 13.3 21.1 15.4 2.0 15.3 22.4 67.4 15.2 3.4 20.3 20.7 5.6 15.2 1.9 6.5 11.2 13.0 9.4 6.1 5.0 1.4 8.7 8.1 6.1 17.8 9.1 15.6 14.5 34.1 28.1 14.7 11.7 11.7 11.5 0.5 2.1 2.9 6.2 2.6 3.4 2.7 5.1 8.6 3.7 4.3 3.7 3.0 2.1 3.6 5.7 1.7 1.9 2.8 7.0 8.5 11.1 9.2 8.1 5.6 9.2 7.2 9.0 8.2 0.0 1.4 0.5 0.3 0.7 0.7 0.3 0.0 1.4 0.0 0.0 0.0 1.7 0.0 3.4 0.3 0.2 11.7 0.0 3.7 1.7 0.8 0.2 4.6 0.4 1.1 0.0 15.6 0.6 0.0 0.0 0.0 0.0 0.0 10.8 6.9 0.5 4.4 7.0 0.7 0.3 0.9 0.0 0.4 0.5 0.2 0.1 1.3 2.5 14.2 0.1 RAVER2 "FLJ10770, KIAA1579" ENSG00000162437 "Ribonucleoprotein, PTB binding 2" Q9HCJ3 1 64745095-64833232 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 31.0;Mucus-secreting cells: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "basophil: 7.8" "Lineage enriched" "Detected in single" 9 "granulocytes: 7.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045785 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045785: AB_10964058" "unprognostic (8.02e-2)" "unprognostic (5.23e-2)" "unprognostic (4.23e-3)" "unprognostic (2.73e-1)" "unprognostic (2.32e-1)" "unprognostic (2.89e-2)" "unprognostic (2.22e-3)" "unprognostic (1.23e-2)" "unprognostic (3.14e-1)" "unprognostic (1.47e-1)" "unprognostic (6.56e-2)" "unprognostic (1.09e-1)" "prognostic favorable (5.14e-6)" "unprognostic (1.74e-1)" "unprognostic (3.50e-2)" "unprognostic (1.41e-1)" "unprognostic (5.09e-2)" 5.2 9.6 13.2 9.2 14.0 7.8 9.0 17.4 9.3 11.5 21.8 7.2 13.9 22.3 9.1 5.9 10.8 7.5 15.2 17.1 13.4 8.1 7.5 1.7 7.9 1.9 8.6 6.1 8.2 7.3 15.2 27.7 6.9 9.1 12.0 25.7 12.6 15.3 15.1 18.5 6.5 41.4 9.1 9.5 4.6 11.8 2.6 7.4 7.0 7.2 10.7 6.8 8.4 8.4 0.2 0.9 7.8 0.1 0.2 0.4 0.0 10.3 3.2 9.9 10.7 1.8 1.5 2.7 2.3 4.2 4.8 5.4 8.5 4.6 0.0 5.4 2.4 10.8 7.9 10.0 6.9 5.8 0.0 11.1 12.6 8.6 7.6 3.4 16.9 0.1 4.5 6.4 0.3 4.9 11.1 7.8 10.6 2.7 10.5 0.4 3.8 5.6 3.5 12.2 8.2 8.6 19.3 15.5 4.2 5.1 7.8 7.4 16.7 10.4 0.0 10.1 9.7 8.1 2.7 2.9 4.4 7.2 4.4 8.1 8.0 9.0 4.4 2.7 0.0 4.1 7.8 0.1 0.1 0.2 0.0 0.4 0.2 0.2 0.1 0.9 0.1 0.1 0.1 0.0 0.2 0.0 0.4 0.1 0.0 13.2 14.0 17.4 9.3 13.4 8.1 8.6 6.1 9.1 7.4 6.0 9.1 0.0 5.5 7.1 5.8 21.8 10.2 5.3 11.4 1.8 13.7 0.1 0.0 2.5 6.3 6.9 31.0 0.0 4.5 0.3 5.3 5.9 1.1 0.0 0.5 0.0 17.3 4.3 4.0 10.7 6.1 0.7 3.3 0.0 30.2 24.7 3.0 14.4 7.8 1.6 3.5 0.0 8.1 1.2 0.9 5.1 0.2 1.5 25.1 6.3 RB1 "OSRC, PPP1R130, RB" ENSG00000139687 "RB transcriptional corepressor 1" P06400 13 48303726-48599436 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 58.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000095, CAB016687, HPA050082" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB000095: , CAB016687: AB_1622010, HPA050082: AB_2681008" "unprognostic (4.24e-3)" "unprognostic (1.00e-1)" "unprognostic (3.62e-2)" "unprognostic (4.67e-2)" "unprognostic (2.04e-2)" "unprognostic (3.86e-1)" "unprognostic (4.69e-2)" "unprognostic (7.08e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.92e-4)" "unprognostic (4.06e-2)" "unprognostic (9.40e-2)" "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (9.99e-2)" "unprognostic (2.31e-1)" "unprognostic (1.70e-1)" 19.6 21.5 14.9 23.2 18.4 14.7 28.1 25.6 19.4 18.0 13.2 11.5 19.0 12.3 16.8 19.5 27.9 12.7 15.3 19.5 15.4 15.3 18.1 12.1 25.4 30.1 17.0 11.8 15.2 11.6 12.8 17.2 21.5 16.0 15.5 15.3 11.6 20.0 17.4 27.9 20.3 14.3 16.8 23.6 29.4 13.7 14.4 15.3 39.1 19.9 15.8 25.3 17.4 23.6 20.5 10.3 13.2 12.2 3.6 4.6 4.0 9.1 4.9 13.5 14.5 6.7 7.8 6.1 18.0 15.0 19.0 16.2 4.2 16.2 11.8 4.2 12.0 10.5 12.7 17.5 14.5 29.0 16.5 6.7 21.7 10.2 7.2 7.1 18.6 20.6 4.3 8.9 12.3 15.8 15.9 13.1 29.2 7.2 9.7 21.7 4.3 58.2 9.4 6.6 20.8 5.4 25.0 13.5 13.5 19.7 8.9 0.6 13.8 17.8 8.9 14.7 12.5 9.7 24.3 10.1 11.8 7.7 14.3 16.2 4.3 1.2 0.1 6.2 11.7 15.9 11.0 9.7 5.0 4.6 12.2 3.7 17.4 3.8 4.6 9.3 20.5 3.2 3.8 13.2 3.6 12.1 10.3 4.5 4.0 14.9 18.4 25.6 19.4 15.4 15.3 17.0 11.8 16.0 15.3 3.0 18.7 56.5 18.3 25.2 14.4 15.9 17.8 20.1 14.8 29.6 27.5 5.9 13.3 15.8 20.6 33.6 15.9 0.0 10.4 8.0 15.4 21.4 11.5 14.7 64.6 17.5 16.8 38.6 83.9 10.6 24.2 88.8 25.3 107.4 18.5 21.8 13.3 9.9 26.9 21.1 18.5 19.4 20.6 27.9 14.3 33.4 3.7 20.8 15.0 14.4 RBAK ZNF769 ENSG00000146587 "RB associated KRAB zinc finger" Q9NYW8 7 5045821-5069488 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071231 Supported Nucleoplasm NA NA Nucleoplasm "HPA071231: AB_2686370" "unprognostic (2.82e-2)" "unprognostic (1.98e-2)" "unprognostic (7.40e-2)" "unprognostic (1.85e-2)" "unprognostic (5.04e-1)" "unprognostic (4.32e-1)" "unprognostic (2.62e-1)" "unprognostic (2.32e-1)" "unprognostic (4.67e-2)" "unprognostic (5.91e-2)" "unprognostic (6.84e-2)" "unprognostic (5.10e-2)" "unprognostic (1.28e-1)" "unprognostic (2.50e-1)" "unprognostic (3.66e-2)" "unprognostic (6.12e-3)" "unprognostic (5.75e-2)" 7.6 7.3 7.1 15.0 11.6 5.8 10.7 19.0 10.6 9.2 8.3 5.9 12.0 7.9 9.6 9.7 14.4 8.4 7.5 7.7 9.4 8.3 8.8 12.0 7.7 16.5 8.8 11.6 9.7 11.0 17.5 11.6 8.1 8.7 9.1 9.1 6.2 11.0 14.2 7.9 10.7 9.8 8.9 7.9 10.6 8.8 6.0 11.0 20.0 10.3 15.1 11.7 11.1 10.0 1.7 1.9 1.7 1.8 2.0 3.0 0.6 7.7 6.1 8.5 15.7 6.2 5.8 7.0 4.9 3.9 4.9 5.8 7.4 5.0 9.4 4.2 5.7 9.3 9.8 9.4 7.7 7.6 2.0 6.7 6.7 7.8 6.2 6.6 11.6 8.2 5.7 9.3 4.8 11.0 7.2 4.8 5.5 14.1 3.4 6.1 13.9 2.8 10.5 13.4 2.7 6.3 4.6 13.8 6.9 5.8 10.2 8.7 14.4 7.0 11.7 10.3 11.4 7.1 13.7 4.0 5.9 9.4 6.7 8.1 10.5 8.3 8.4 5.9 8.5 7.6 0.0 0.9 1.7 2.4 1.8 3.0 1.7 1.8 1.7 1.5 1.3 2.2 1.8 0.1 2.0 0.4 1.9 1.2 0.6 7.1 11.6 19.0 10.6 9.4 8.3 8.8 11.6 8.7 11.0 0.0 5.1 5.4 3.1 3.8 7.7 11.5 5.1 4.0 6.8 0.0 9.8 2.2 1.7 5.3 0.8 4.3 4.9 23.3 5.1 1.8 4.2 4.6 5.7 4.0 3.1 20.6 4.7 9.2 7.9 1.0 7.5 2.5 3.3 1.8 5.2 5.0 5.2 3.6 8.1 3.7 7.4 0.0 5.2 4.1 3.3 6.0 1.6 6.9 5.6 3.5 RBBP4 "lin-53, NURF55, RbAp48" ENSG00000162521 "RB binding protein 4, chromatin remodeling factor" Q09028 1 32651142-32686211 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006264, HPA060710, HPA060724" Supported Enhanced Nucleoplasm NA NA 27000 Nucleoplasm "CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350" "unprognostic (1.18e-3)" "unprognostic (1.79e-3)" "unprognostic (2.96e-3)" "unprognostic (1.82e-2)" "prognostic favorable (9.23e-4)" "unprognostic (1.62e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (1.24e-2)" "prognostic unfavorable (6.45e-4)" "unprognostic (1.57e-2)" "unprognostic (1.30e-1)" "unprognostic (2.69e-1)" "unprognostic (1.36e-3)" "unprognostic (3.05e-2)" "unprognostic (1.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.88e-2)" 23.8 33.6 28.2 34.3 27.8 23.4 29.1 30.5 35.1 32.2 24.1 32.0 42.3 20.5 36.0 29.2 26.0 35.4 21.3 24.0 27.9 24.8 25.2 25.4 23.0 43.9 30.6 29.0 37.6 31.3 27.0 32.9 26.2 26.9 24.2 35.5 31.2 30.1 43.1 31.8 24.9 26.8 32.6 26.9 27.6 28.8 53.4 31.4 73.3 35.8 20.5 65.2 32.5 26.6 33.7 45.4 26.7 39.4 33.1 32.4 48.4 15.6 13.7 39.2 28.6 12.1 11.5 15.9 11.9 10.4 24.4 23.8 19.6 32.2 47.5 13.2 14.1 14.1 10.1 42.9 12.4 26.3 18.5 20.6 44.3 27.7 25.7 17.5 41.8 19.2 12.6 15.8 18.4 12.0 19.0 18.0 32.9 31.1 34.1 20.8 10.9 53.5 13.1 43.6 15.5 16.0 52.0 41.3 41.2 17.1 33.5 37.5 22.3 28.2 10.1 19.3 40.4 17.3 19.3 14.9 14.8 15.1 18.7 16.0 27.0 28.3 53.3 17.7 33.8 22.7 26.4 38.8 26.7 31.1 39.4 32.4 33.7 29.7 31.4 45.4 26.6 26.7 28.8 10.2 33.1 35.3 38.3 30.3 48.4 28.2 27.8 30.5 35.1 27.9 24.8 30.6 29.0 26.9 31.4 38.7 41.4 104.6 60.7 63.4 104.9 19.4 79.0 50.9 46.6 69.8 135.5 102.1 71.3 72.0 18.9 58.2 40.2 23.3 50.7 69.8 69.6 53.3 47.4 69.1 71.5 100.1 93.2 70.6 73.4 13.7 73.6 63.2 47.2 72.1 69.7 74.5 62.2 28.8 83.1 53.7 104.1 97.0 47.5 120.2 77.3 67.8 71.5 85.3 75.6 47.1 RBBP7 RbAp46 ENSG00000102054 "RB binding protein 7, chromatin remodeling factor" Q16576 X 16839283-16870414 "Predicted intracellular proteins" "DNA replication, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 376.6;Syncytiotrophoblasts: 445.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037084, HPA060710, HPA060724" Supported Enhanced Nucleoplasm NA NA 25000 Nucleoplasm "CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350" "unprognostic (5.18e-1)" "unprognostic (3.29e-2)" "unprognostic (6.68e-3)" "unprognostic (1.09e-2)" "unprognostic (8.85e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (5.55e-4)" "unprognostic (3.64e-1)" "unprognostic (1.87e-2)" "unprognostic (3.00e-2)" "unprognostic (7.82e-2)" "unprognostic (1.10e-1)" "unprognostic (6.07e-2)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "prognostic favorable (2.43e-4)" "unprognostic (5.65e-2)" 16.0 81.2 16.6 21.1 26.7 20.3 15.5 13.3 16.2 34.6 22.8 15.3 103.2 13.1 32.3 77.3 20.9 24.5 19.7 36.2 15.1 13.1 17.3 18.5 14.3 19.7 13.7 15.5 41.6 19.0 47.8 16.0 28.7 12.2 26.2 18.1 16.5 19.0 87.6 78.2 16.4 17.9 25.9 15.9 16.0 23.5 31.6 13.6 30.8 18.1 18.2 24.5 24.3 18.5 36.6 29.4 23.7 41.2 32.8 37.7 27.3 54.1 40.3 30.7 40.4 19.3 22.8 19.5 27.0 27.1 39.8 45.1 23.6 35.9 59.9 41.5 26.1 45.8 28.7 54.7 40.1 52.8 33.9 75.1 25.3 49.0 28.0 16.4 38.2 30.7 17.7 14.8 45.8 33.6 25.6 39.8 25.3 25.3 32.0 31.4 36.4 42.7 35.4 34.5 26.2 37.5 37.5 56.5 70.7 28.9 36.5 28.6 21.2 50.9 24.5 23.9 45.1 81.3 23.2 18.3 19.2 19.7 50.6 29.9 22.4 32.0 78.7 24.7 25.8 23.3 16.6 18.3 23.7 36.4 31.3 34.8 36.6 30.4 37.7 25.4 31.0 32.2 35.9 7.4 32.8 41.2 29.4 27.9 27.3 16.6 26.7 13.3 16.2 15.1 13.1 13.7 15.5 12.2 13.6 47.6 54.2 48.2 88.5 66.4 28.9 94.0 30.6 84.3 85.3 52.4 27.5 376.6 66.3 71.3 10.8 45.8 40.0 0.0 65.2 134.7 86.4 63.3 56.6 33.9 93.5 23.8 58.3 39.9 27.6 22.8 105.3 44.7 79.2 75.7 53.5 73.6 61.9 31.6 176.0 51.2 38.7 135.8 87.2 52.9 107.5 53.3 445.1 67.8 67.4 67.3 RBBP8 "COM1, CtIP, RIM, SCKL2" ENSG00000101773 "RB binding protein 8, endonuclease" Q99708 18 22798261-23026488 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 21.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039890, HPA052946" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA039890: AB_10794756, HPA052946: AB_2681996" "unprognostic (1.55e-3)" "unprognostic (4.10e-3)" "unprognostic (7.89e-2)" "unprognostic (1.01e-1)" "unprognostic (2.44e-1)" "unprognostic (7.28e-2)" "unprognostic (3.60e-3)" "unprognostic (1.87e-1)" "prognostic unfavorable (7.21e-4)" "unprognostic (2.29e-2)" "unprognostic (1.58e-3)" "unprognostic (1.04e-2)" "prognostic favorable (1.71e-5)" "unprognostic (3.91e-3)" "unprognostic (2.42e-2)" "unprognostic (1.01e-2)" "unprognostic (4.48e-1)" 9.0 6.2 6.0 10.8 6.4 9.4 19.4 4.2 5.9 16.4 13.4 4.1 22.5 5.4 13.1 18.6 17.1 17.6 8.7 8.3 4.9 6.8 49.6 12.3 17.0 7.8 6.6 3.6 12.2 14.3 17.4 29.2 11.5 11.5 13.4 8.0 5.3 14.8 29.1 3.8 17.4 14.0 10.3 4.5 9.8 7.8 16.7 3.8 24.2 14.7 10.8 10.0 10.4 13.0 4.3 5.1 7.8 21.0 5.0 2.8 2.2 9.6 7.4 11.0 12.7 5.7 6.1 8.6 13.3 9.4 12.4 17.5 13.6 10.9 28.1 6.2 8.3 11.9 20.3 12.4 27.0 24.4 20.0 10.0 12.3 10.1 12.9 7.0 44.1 13.5 4.3 26.2 18.7 32.6 7.3 5.0 19.8 7.2 21.1 12.6 14.3 32.6 14.8 10.4 17.7 12.6 16.9 20.2 17.3 35.8 10.4 25.9 12.3 22.2 6.8 11.4 6.6 39.3 11.6 3.6 33.3 15.3 16.0 23.1 28.6 30.7 30.9 15.2 21.4 17.8 7.8 4.0 2.3 0.8 14.8 0.3 4.3 1.1 1.4 5.1 3.3 0.6 1.0 1.5 5.0 21.0 5.1 2.8 2.2 6.0 6.4 4.2 5.9 4.9 6.8 6.6 3.6 11.5 3.8 32.8 33.1 14.7 39.9 24.4 4.5 8.5 20.4 34.8 53.4 27.9 3.9 9.7 36.5 26.8 13.1 13.4 13.5 0.0 28.8 8.0 9.5 23.1 66.7 17.3 10.0 1.6 7.5 6.7 6.0 10.6 6.1 14.7 21.9 3.6 8.1 1.3 35.0 10.2 4.9 19.4 7.3 0.0 12.8 82.6 71.3 17.2 12.7 7.1 12.1 45.5 RBBP9 Bog ENSG00000089050 "RB binding protein 9, serine hydrolase" O75884 20 18486540-18497243 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015830, HPA049005" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA015830: AB_1845410, HPA049005: AB_2680597" "unprognostic (1.17e-2)" "unprognostic (2.51e-2)" "unprognostic (2.37e-2)" "unprognostic (1.32e-1)" "unprognostic (4.27e-2)" "unprognostic (1.26e-3)" "unprognostic (2.14e-1)" "unprognostic (7.63e-2)" "unprognostic (1.52e-1)" "unprognostic (4.71e-2)" "unprognostic (2.28e-1)" "unprognostic (1.03e-1)" "unprognostic (2.14e-2)" "unprognostic (3.93e-3)" "unprognostic (1.08e-1)" "unprognostic (2.21e-1)" "unprognostic (6.21e-2)" 8.6 18.4 10.7 7.1 11.6 3.6 11.0 11.4 11.2 16.1 7.4 15.4 9.1 7.7 10.7 8.0 9.3 7.0 11.9 9.0 9.0 9.6 19.8 39.3 9.6 8.6 11.5 7.4 9.5 7.2 15.3 14.4 6.6 12.8 10.1 8.8 12.8 13.2 10.8 4.4 14.1 10.2 9.2 13.0 10.1 8.1 5.1 9.4 9.0 27.5 9.9 9.8 8.9 7.8 3.6 3.3 10.8 3.8 2.8 4.6 3.1 7.4 8.8 8.2 11.5 5.9 9.8 8.4 8.6 8.4 11.2 11.6 6.3 6.8 9.4 3.5 6.0 7.8 8.5 6.5 14.2 13.5 2.8 7.9 4.9 2.9 19.3 3.7 7.1 3.0 5.0 5.7 9.2 5.5 5.6 14.0 7.9 3.1 7.4 9.7 4.2 7.4 5.0 5.4 10.4 16.7 7.3 24.4 5.9 10.1 8.2 7.1 12.0 11.6 14.0 5.9 5.8 11.2 2.0 8.0 18.9 6.2 11.8 7.6 8.4 20.8 6.5 7.4 3.4 6.0 10.8 3.0 0.9 3.2 3.8 4.6 3.6 3.8 2.2 3.3 3.1 3.4 2.7 0.5 2.8 2.8 0.6 4.5 3.1 10.7 11.6 11.4 11.2 9.0 9.6 11.5 7.4 12.8 9.4 20.8 16.5 0.0 2.9 6.5 4.3 7.0 0.0 12.0 9.1 10.4 0.0 2.9 13.3 5.3 2.4 5.3 5.8 0.0 2.4 3.4 4.3 2.7 0.0 16.3 4.7 3.2 5.2 4.9 5.1 0.5 4.9 4.4 5.0 6.4 4.2 8.8 3.8 0.0 6.7 18.4 5.9 0.0 4.1 0.3 4.3 5.4 2.1 3.9 5.8 3.3 RBFOX3 "FOX-3, HRNBP3, NeuN" ENSG00000167281 "RNA binding fox-1 homolog 3" A6NFN3 17 79089345-79516148 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.4;seminal vesicle: 21.5" "Cell type enhanced" "Detected in many" 12 "Glandular cells: 12.8;Peritubular cells: 9.9;Spermatogonia: 21.3" "Cancer enhanced" "Detected in some" "prostate cancer: 1.1" "Region enhanced" "Detected in all" "cerebellum: 60.4" "Cell type enhanced" "Detected in single" "gdT-cell: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A549: 13.2;NTERA-2: 11.9;SCLC-21H: 19.2;U-2 OS: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030790, HPA075862, CAB078782" Enhanced Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB078782: , HPA030790: AB_10602305, HPA075862: " "unprognostic (2.84e-1)" "unprognostic (1.88e-1)" "unprognostic (4.10e-2)" "unprognostic (9.23e-3)" "unprognostic (8.85e-2)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (1.09e-1)" "unprognostic (7.72e-2)" "unprognostic (1.50e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (3.22e-15)" "unprognostic (8.92e-3)" "unprognostic (1.92e-1)" "unprognostic (1.61e-1)" "unprognostic (1.88e-1)" 0.5 1.0 10.2 0.6 23.5 0.6 0.2 60.4 33.2 0.5 15.2 0.3 0.2 1.5 9.3 3.0 8.3 1.0 0.3 0.3 8.6 3.3 0.4 0.2 0.3 0.4 1.8 3.5 0.3 0.5 0.2 0.9 0.3 5.5 13.2 2.2 0.2 0.2 21.5 0.3 0.3 1.3 8.1 2.3 0.4 0.5 7.2 5.6 0.2 0.3 0.2 0.2 15.2 1.0 0.7 0.2 0.0 0.7 0.0 1.4 0.2 0.0 13.2 0.2 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 11.9 0.0 0.2 0.2 0.5 0.0 0.0 0.0 19.2 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 9.0 0.5 0.0 0.8 0.0 0.3 0.4 0.3 0.0 0.0 0.7 0.0 1.4 0.3 0.0 0.7 0.1 0.4 0.2 0.7 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.2 10.2 23.5 60.4 19.5 8.6 3.3 1.8 3.5 5.5 5.6 0.0 0.0 0.0 4.7 1.8 2.5 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.8 0.4 0.0 0.0 0.0 0.1 1.0 12.8 0.0 0.0 0.1 4.8 0.0 0.0 0.8 7.1 0.3 0.7 5.0 0.0 0.0 1.0 0.0 0.0 9.9 0.0 3.3 0.0 2.3 0.7 21.3 1.3 0.1 2.1 0.0 2.0 RBL1 "cp107, p107, PRB1" ENSG00000080839 "RB transcriptional corepressor like 1" P28749 20 36996349-37095995 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 14.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA054962, HPA056525" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054962: AB_2682652, HPA056525: AB_2683165" "unprognostic (1.97e-1)" "unprognostic (2.47e-2)" "unprognostic (1.30e-2)" "unprognostic (3.70e-3)" "unprognostic (2.13e-1)" "unprognostic (1.51e-1)" "unprognostic (6.25e-5)" "unprognostic (6.91e-2)" "unprognostic (7.19e-3)" "unprognostic (1.20e-1)" "unprognostic (4.49e-3)" "unprognostic (3.23e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (3.15e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-2)" "unprognostic (1.26e-1)" 5.0 4.3 4.9 12.3 7.1 20.4 4.8 16.6 7.8 5.1 5.6 5.5 5.9 4.0 8.1 3.0 7.7 4.4 3.6 4.0 4.0 3.6 3.3 3.0 4.5 11.1 6.5 2.2 7.8 6.0 5.9 5.9 8.3 5.7 4.4 6.1 5.3 4.8 2.7 10.2 5.3 5.9 5.9 7.1 6.9 4.6 8.2 5.5 19.6 5.3 6.1 11.4 4.7 7.1 5.0 5.1 2.2 1.9 3.6 7.4 1.6 12.2 7.9 10.0 6.7 2.5 3.4 6.4 14.3 6.4 12.4 12.9 8.4 6.9 13.7 4.1 5.9 7.3 12.1 8.9 9.2 20.7 4.7 4.8 13.5 9.5 7.1 1.5 17.3 9.4 1.6 1.3 16.3 5.8 2.1 6.9 9.1 9.8 13.3 7.0 5.2 16.1 5.7 2.9 6.2 7.8 10.5 29.8 10.4 2.8 6.1 2.4 6.0 15.6 9.0 4.1 3.3 5.8 12.5 4.5 21.9 8.4 20.0 12.4 4.4 7.8 13.9 15.7 12.2 10.8 1.4 1.2 2.2 5.0 1.4 4.2 5.0 5.6 4.5 2.2 3.9 6.0 4.8 0.6 3.6 1.9 5.1 7.4 1.6 4.9 7.1 16.6 7.8 4.0 3.6 6.5 2.2 5.7 5.5 6.0 14.1 9.2 1.4 2.2 5.2 2.4 0.0 1.4 10.3 0.0 2.0 4.7 0.0 1.3 1.3 2.1 0.8 0.0 1.0 4.2 2.5 0.6 8.1 1.0 4.0 3.2 1.2 1.8 2.8 0.2 2.0 3.2 1.7 4.6 1.1 4.0 1.1 2.8 2.8 0.6 12.8 6.5 1.2 8.7 6.6 1.1 3.2 5.4 2.3 0.7 RBM11 ENSG00000185272 "RNA binding motif protein 11" P57052 21 14216130-14228372 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 20.6;epididymis: 55.3" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.1" "Lineage enriched" "Detected in single" 11 "T-cells: 4.1" "Cell line enhanced" "Detected in some" "HEL: 3.6;NTERA-2: 2.8;REH: 2.8;SK-BR-3: 3.1;SuSa: 3.4;U-266/70: 2.8;WM-115: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045885 Supported Nucleoplasm NA NA Nucleoplasm "HPA045885: AB_10963937" "unprognostic (1.95e-2)" "unprognostic (1.35e-1)" "unprognostic (3.57e-1)" "unprognostic (5.44e-4)" "unprognostic (2.18e-1)" "unprognostic (7.97e-2)" "unprognostic (3.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.41e-1)" "unprognostic (3.23e-2)" "unprognostic (9.92e-4)" "unprognostic (5.74e-2)" "unprognostic (1.16e-4)" "unprognostic (3.45e-2)" "unprognostic (4.81e-2)" "unprognostic (2.69e-1)" "unprognostic (9.24e-3)" 1.2 1.8 5.0 1.4 5.8 1.5 1.5 2.3 7.3 1.0 1.2 1.9 0.6 1.3 1.8 55.3 1.6 2.1 1.2 1.3 5.9 6.1 1.4 1.0 1.2 1.3 6.1 4.3 3.5 1.4 2.2 5.4 1.1 9.7 1.6 1.1 2.8 1.5 2.2 1.0 1.1 1.0 1.4 20.6 1.5 1.3 2.5 6.1 0.0 2.4 0.0 1.2 1.1 0.9 0.3 0.0 0.0 0.1 0.0 4.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.4 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 1.5 1.1 0.0 2.8 0.0 0.0 2.8 0.0 0.0 0.7 1.1 0.3 0.0 0.4 3.1 0.0 3.4 0.6 0.6 0.0 0.0 1.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.6 0.0 0.0 0.3 4.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 5.8 2.3 7.3 5.9 6.1 6.1 4.3 9.7 6.1 3.0 2.4 0.0 5.9 1.5 6.8 0.0 0.0 1.4 1.2 1.8 0.0 2.0 13.3 2.3 6.7 0.1 0.0 0.0 1.1 0.7 0.7 5.9 2.3 0.0 0.7 4.8 7.5 0.0 0.0 3.6 0.6 0.0 0.0 1.0 0.7 8.1 1.0 0.0 0.7 0.6 4.3 0.0 3.3 3.9 6.9 1.0 1.0 0.0 0.2 4.3 RBM12 "HRIHFB2091, KIAA0765, SWAN" ENSG00000244462 "RNA binding motif protein 12" Q9NTZ6 20 35648925-35664956 "Disease related genes, Predicted intracellular proteins" RNA-binding "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043258, HPA043621" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043258: AB_2678395, HPA043621: AB_2678584" "unprognostic (8.94e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-3)" "unprognostic (7.57e-2)" "unprognostic (1.04e-1)" "unprognostic (4.19e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (7.96e-2)" "unprognostic (8.56e-2)" "unprognostic (1.28e-1)" "unprognostic (7.47e-2)" "unprognostic (3.34e-2)" "unprognostic (3.67e-1)" "unprognostic (3.29e-1)" "unprognostic (4.44e-1)" "unprognostic (3.92e-1)" "unprognostic (6.87e-2)" 23.3 26.1 18.6 26.6 20.6 22.5 23.1 28.1 19.9 26.7 20.8 19.3 21.2 17.5 31.1 21.3 27.9 29.4 22.4 21.1 17.8 12.5 19.5 18.7 23.8 32.2 17.7 20.0 39.5 18.9 24.4 25.7 31.4 15.6 22.7 21.6 22.1 25.6 18.6 24.4 22.1 25.7 25.2 15.4 28.5 21.7 20.6 18.6 52.8 29.3 21.9 37.6 28.0 22.8 15.1 14.9 9.9 13.8 11.5 17.3 11.7 25.1 16.9 36.4 22.2 8.9 17.7 22.4 14.0 16.6 19.7 19.5 23.4 17.8 45.5 15.7 28.1 20.6 17.9 43.0 35.9 25.3 21.5 15.5 38.1 16.8 15.6 15.4 41.3 20.5 25.2 18.6 22.6 15.1 12.7 21.9 24.8 36.2 22.1 17.2 18.5 49.0 11.7 26.4 16.4 17.5 30.0 44.8 22.2 14.3 41.6 19.3 25.0 25.0 19.7 18.8 31.3 25.4 15.3 30.8 16.7 24.7 16.3 20.7 24.0 26.0 48.2 14.6 16.2 21.6 6.0 11.9 9.9 14.8 13.8 17.3 15.1 13.1 17.0 14.9 14.4 14.0 12.1 9.2 11.5 11.1 9.6 12.0 11.7 18.6 20.6 28.1 19.9 17.8 12.5 17.7 20.0 15.6 18.6 23.8 20.8 19.8 17.7 26.3 14.7 19.0 22.9 24.1 18.2 3.5 25.5 18.2 1.7 13.5 3.2 15.7 13.7 0.0 15.3 15.3 17.9 15.2 25.5 11.9 15.6 7.9 23.6 22.1 23.9 3.6 13.6 19.9 15.1 14.4 21.7 11.6 16.5 14.0 15.6 10.2 13.9 6.5 18.6 15.7 14.9 25.7 14.6 20.3 18.5 23.8 RBM12B ENSG00000183808 "RNA binding motif protein 12B" Q8IXT5 8 93729356-93741017 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 41.2;Horizontal cells: 42.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024398, HPA053050" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA024398: AB_1856109, HPA053050: AB_2682026" "unprognostic (4.57e-2)" "unprognostic (7.72e-2)" "unprognostic (3.39e-1)" "unprognostic (3.57e-2)" "unprognostic (1.78e-1)" "unprognostic (2.66e-2)" "unprognostic (2.40e-3)" "unprognostic (3.05e-1)" "unprognostic (3.92e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "unprognostic (2.54e-2)" "unprognostic (1.84e-3)" "unprognostic (9.15e-2)" "unprognostic (4.82e-1)" "unprognostic (4.34e-2)" "unprognostic (2.62e-2)" 10.0 10.6 14.1 15.5 14.5 9.3 13.2 22.9 15.1 18.1 10.8 16.2 11.0 10.1 24.3 11.4 11.4 13.6 9.5 14.8 12.3 7.3 10.7 10.0 12.3 20.6 13.3 12.3 28.0 11.4 15.3 21.1 14.8 11.7 15.2 10.8 13.4 15.3 10.2 12.6 9.4 13.1 16.6 14.5 14.3 11.8 18.9 14.2 22.0 18.1 7.4 18.2 13.2 16.6 3.4 3.9 13.4 3.2 3.7 6.1 2.7 12.5 9.5 24.4 17.3 6.0 11.6 11.9 10.6 7.9 12.1 12.8 7.1 17.2 22.1 16.9 5.9 12.9 12.9 21.1 5.6 13.7 15.6 10.9 28.7 22.2 6.1 7.1 10.6 14.6 7.5 7.3 7.9 7.9 8.1 8.1 13.2 23.5 18.6 10.7 7.3 19.7 8.4 0.1 9.5 10.2 14.6 17.3 7.3 6.2 10.8 16.1 12.7 11.4 3.6 8.9 17.5 13.8 8.2 15.8 11.4 17.2 8.2 10.8 21.8 16.0 18.8 8.1 15.2 19.0 13.4 3.0 5.8 3.5 2.9 5.0 2.2 4.4 3.4 3.1 3.4 6.1 5.0 4.5 3.7 3.2 3.9 4.9 2.7 14.1 14.5 22.9 15.1 12.3 7.3 13.3 12.3 11.7 14.2 6.0 7.2 8.6 7.2 3.5 28.2 11.2 12.7 12.0 4.5 12.2 41.2 6.5 3.3 5.2 0.8 10.3 4.1 0.0 4.0 3.9 7.2 7.5 0.0 6.4 3.9 42.9 15.1 12.3 11.5 0.9 11.5 6.7 5.0 10.0 8.2 19.2 6.1 6.6 9.6 4.1 29.5 19.4 7.2 18.6 8.9 3.8 3.3 10.2 7.3 4.1 RBM15 "OTT, OTT1" ENSG00000162775 "RNA binding motif protein 15" Q96T37 1 110338506-110346681 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015201, HPA019824, HPA049642" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB015201: , HPA019824: AB_1856113, HPA049642: AB_2680839" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (9.39e-2)" "unprognostic (7.57e-3)" "unprognostic (2.43e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (7.61e-4)" "unprognostic (1.13e-1)" "unprognostic (1.84e-2)" "unprognostic (4.91e-2)" "unprognostic (9.67e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (1.37e-4)" "prognostic favorable (7.97e-4)" "unprognostic (2.88e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-1)" 8.5 7.6 6.3 12.2 7.6 48.7 7.9 18.6 8.3 6.6 8.8 7.6 8.3 7.3 8.5 7.2 8.0 7.3 6.6 8.8 5.2 4.3 6.3 11.0 10.5 13.7 8.3 6.0 8.6 7.5 7.1 8.1 7.1 5.9 5.7 5.7 8.1 7.4 6.4 17.2 7.2 11.3 5.5 5.0 12.5 8.3 14.0 7.9 21.8 7.0 5.3 13.4 6.5 8.6 10.5 4.8 9.8 6.9 5.0 9.9 5.5 7.1 7.8 7.0 7.2 4.5 4.7 11.1 3.8 5.0 6.0 7.9 9.5 6.5 13.5 6.1 4.3 4.9 10.1 11.0 9.5 8.9 14.0 10.1 10.9 11.8 6.9 6.2 11.8 11.6 4.3 6.6 8.3 7.8 3.1 6.3 10.3 15.4 23.7 6.0 7.3 10.6 9.3 15.0 6.3 4.4 12.6 10.6 9.2 4.9 7.2 8.5 4.3 8.3 10.5 8.0 7.9 7.2 14.3 4.4 5.7 10.4 6.2 6.9 18.3 9.2 29.3 8.6 12.0 7.1 8.2 6.9 9.4 7.0 6.0 9.9 10.5 7.7 6.0 4.8 10.0 6.8 8.2 9.8 5.0 6.4 4.7 7.5 5.5 6.3 7.6 18.6 8.3 5.2 4.3 8.3 6.0 5.9 7.9 6.0 3.0 15.3 8.2 29.5 5.4 10.8 7.6 9.4 2.3 3.5 13.7 7.6 0.0 3.4 6.2 9.8 7.5 0.0 3.1 6.2 8.9 8.6 28.8 13.5 5.6 0.0 9.2 10.4 5.7 4.1 3.7 5.5 8.5 1.8 8.4 5.6 4.2 2.9 4.9 3.3 7.1 0.0 13.3 24.4 14.5 29.5 3.9 12.5 7.6 6.7 RBM15B "HUMAGCGB, OTT3" ENSG00000259956 "RNA binding motif protein 15B" Q8NDT2 3 51391268-51397908 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036645, HPA058136" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036645: AB_10671965, HPA058136: AB_2683618" "unprognostic (2.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (1.39e-1)" "unprognostic (5.29e-1)" "unprognostic (5.28e-2)" "unprognostic (3.13e-3)" "unprognostic (1.70e-1)" "unprognostic (5.25e-2)" "unprognostic (3.11e-1)" "unprognostic (3.39e-1)" "unprognostic (3.01e-2)" "prognostic favorable (1.84e-5)" "unprognostic (1.35e-1)" "unprognostic (1.69e-1)" "unprognostic (1.89e-1)" "unprognostic (3.84e-1)" 8.6 3.8 4.9 5.6 6.3 5.2 7.1 4.4 9.0 8.0 7.5 6.1 6.3 5.9 7.4 6.5 8.4 7.2 10.1 5.6 5.2 4.8 9.4 6.7 11.6 4.9 4.1 9.3 9.8 9.2 3.3 7.3 4.1 8.3 7.1 5.1 7.2 7.0 4.9 9.9 9.3 7.4 2.2 7.8 6.4 9.1 4.1 23.0 8.2 5.4 7.3 6.8 9.3 4.5 4.9 1.5 5.7 3.4 5.0 3.1 10.9 9.8 22.9 23.8 20.7 16.2 14.0 10.2 19.1 16.4 13.6 12.1 8.0 15.9 8.5 18.4 18.1 10.2 13.1 18.4 7.9 12.7 10.2 13.7 15.3 10.3 12.1 17.8 7.8 17.6 22.9 15.0 17.9 17.9 16.9 26.2 10.2 10.8 14.0 11.7 31.0 11.3 18.2 10.1 15.4 11.1 10.1 13.5 14.6 26.6 14.9 21.4 13.2 17.6 11.7 15.9 13.9 21.2 15.2 16.8 14.7 14.1 19.2 16.0 14.4 17.7 13.7 14.4 17.8 0.0 4.1 1.5 4.0 5.7 4.4 2.4 5.0 4.2 4.5 4.5 5.0 3.1 0.8 3.4 5.3 4.9 2.3 3.1 3.0 4.8 10.7 31.2 22.6 18.0 15.1 5.1 8.1 7.9 14.0 9.8 13.5 10.0 18.2 18.6 17.5 15.0 23.3 19.7 17.7 12.1 26.3 4.7 18.3 15.9 14.3 12.1 12.3 26.2 8.6 14.7 10.5 6.8 4.6 19.4 12.3 25.8 8.6 14.2 14.3 12.9 25.8 18.7 11.4 6.4 24.6 16.5 11.7 20.8 29.3 RBM17 "MGC14439, SPF45" ENSG00000134453 "RNA binding motif protein 17" Q96I25 10 6088987-6117457 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037477, HPA037478" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA037477: AB_10671372, HPA037478: AB_2675494" "unprognostic (8.55e-2)" "unprognostic (2.41e-1)" "unprognostic (3.11e-3)" "unprognostic (6.23e-2)" "unprognostic (1.05e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (4.57e-8)" "unprognostic (3.78e-2)" "unprognostic (6.39e-2)" "unprognostic (3.47e-3)" "unprognostic (1.44e-1)" "unprognostic (8.32e-2)" "prognostic unfavorable (4.31e-5)" "unprognostic (1.82e-1)" "unprognostic (5.53e-2)" "unprognostic (1.26e-2)" "unprognostic (3.01e-2)" 36.5 28.0 36.2 40.7 43.1 67.9 52.5 37.2 35.8 31.4 31.9 38.2 25.2 36.4 40.0 29.9 31.3 32.7 30.5 28.9 35.5 24.6 28.5 25.8 44.9 46.0 37.0 29.2 34.1 37.1 30.2 23.4 42.6 35.1 25.2 38.5 24.7 30.2 28.7 50.5 25.9 40.3 37.4 39.2 47.6 30.2 35.7 41.0 49.3 38.2 20.5 46.8 29.9 53.3 47.9 33.6 41.4 34.0 31.4 41.2 22.8 41.3 24.4 31.7 27.4 17.2 15.8 38.9 27.8 12.4 28.4 30.9 39.8 33.4 49.3 19.8 20.2 10.8 41.2 28.0 30.0 30.9 48.6 27.8 42.5 24.4 33.8 21.4 23.0 20.9 16.1 22.8 29.2 16.1 15.2 34.5 36.2 44.7 25.0 18.2 47.5 41.0 14.4 19.8 48.4 17.0 44.5 17.5 25.6 20.7 26.0 13.2 17.5 26.5 24.5 20.6 28.1 32.3 23.6 20.9 17.4 34.6 37.2 29.3 24.8 28.3 83.1 16.1 30.1 11.1 28.2 34.0 41.4 33.4 33.4 34.1 43.7 33.0 33.0 29.4 47.9 33.7 31.5 17.5 31.4 24.6 33.6 41.2 22.8 36.2 43.1 37.2 35.8 35.5 24.6 37.0 29.2 35.1 41.0 83.4 50.1 84.5 77.4 114.8 68.7 69.4 53.5 33.5 73.9 62.8 47.1 106.5 76.3 75.8 45.6 96.7 64.3 23.3 62.1 156.6 84.9 66.1 92.6 61.0 86.0 87.4 69.9 72.4 62.5 13.9 61.2 71.7 49.0 197.4 77.6 73.3 72.9 86.2 57.0 58.5 61.1 71.1 88.6 166.4 204.4 95.0 81.1 76.2 87.4 89.1 RBM22 "Cwc2, FLJ10290, fSAP47, ZC3H16" ENSG00000086589 "RNA binding motif protein 22" Q9NW64 5 150690794-150701107 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001634 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA001634: AB_1079746" "unprognostic (1.94e-1)" "unprognostic (1.17e-3)" "unprognostic (6.86e-3)" "unprognostic (1.00e-2)" "unprognostic (1.49e-1)" "unprognostic (3.04e-2)" "prognostic unfavorable (5.50e-6)" "unprognostic (7.08e-2)" "unprognostic (2.51e-1)" "unprognostic (4.58e-2)" "unprognostic (8.71e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (7.29e-2)" "unprognostic (2.37e-1)" "unprognostic (7.82e-2)" "unprognostic (9.87e-3)" 26.2 17.5 20.3 16.3 26.3 50.1 21.2 29.4 29.5 20.6 20.1 37.4 16.7 17.4 28.0 18.5 18.8 23.8 20.5 18.5 19.7 19.1 20.0 18.8 20.5 23.5 25.7 16.9 29.2 19.6 21.5 18.0 37.8 23.5 20.9 21.5 19.1 18.3 19.2 30.4 21.5 19.1 19.7 28.0 23.0 17.8 13.5 24.6 38.6 23.8 16.3 27.6 20.3 19.2 25.8 24.9 36.3 28.8 28.4 26.7 20.8 14.9 16.3 25.1 29.2 17.0 16.0 35.5 15.3 17.6 31.0 35.1 26.4 22.2 22.2 24.5 15.0 29.4 15.8 32.5 28.2 32.4 24.6 25.7 17.6 16.2 11.1 16.4 31.1 20.8 13.3 22.5 25.7 16.9 13.6 21.8 18.3 18.6 22.4 19.3 17.4 28.7 20.7 15.0 18.4 17.2 29.4 20.7 19.7 15.3 15.4 23.6 17.9 17.2 28.6 28.2 15.7 29.7 27.9 14.4 25.0 19.8 10.9 27.9 20.8 23.4 32.0 19.7 28.4 18.7 17.6 20.8 33.5 24.4 24.9 26.7 25.8 22.6 22.7 24.9 25.3 24.6 22.9 36.3 28.4 28.8 13.3 24.2 20.8 20.3 26.3 29.4 29.5 19.7 19.1 25.7 16.9 23.5 24.6 26.8 26.2 37.5 47.4 23.1 34.3 26.9 28.1 28.1 39.8 15.7 23.6 46.8 21.6 29.7 5.0 41.2 27.1 0.0 29.8 38.5 28.7 21.3 62.3 15.1 38.1 28.6 24.9 27.0 25.1 2.6 40.0 33.7 21.9 45.9 27.2 34.4 23.2 35.1 42.8 16.5 16.9 32.3 29.3 21.3 28.8 19.1 60.8 45.7 30.2 34.3 RBM3 IS1-RNPL ENSG00000102317 "RNA binding motif protein 3" P98179 X 48574449-48579066 "Predicted intracellular proteins" "Stress response" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Exocrine glandular cells: 1250.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003624, CAB062559" Enhanced Enhanced Nucleoplasm NA NA 24000 Nucleoplasm "CAB062559: AB_2665621, HPA003624: AB_10602123" "unprognostic (1.07e-2)" "unprognostic (1.14e-3)" "prognostic favorable (3.07e-7)" "unprognostic (1.65e-3)" "unprognostic (2.87e-1)" "unprognostic (4.05e-2)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (9.37e-2)" "unprognostic (1.63e-2)" "unprognostic (2.65e-2)" "unprognostic (2.02e-2)" "unprognostic (6.18e-2)" "unprognostic (1.10e-1)" "unprognostic (5.05e-2)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 71.2 25.5 12.6 43.0 13.9 59.0 52.2 16.4 22.5 44.7 32.7 20.9 16.4 23.9 38.5 58.2 46.4 32.9 36.4 44.8 12.2 12.3 53.5 32.9 36.8 115.8 15.0 15.2 38.6 43.2 15.2 19.1 62.2 30.5 21.0 36.0 43.4 39.7 25.0 59.1 56.2 37.8 33.0 23.6 48.4 27.2 27.2 7.4 73.6 24.0 76.8 67.6 46.4 30.1 32.9 56.5 6.4 44.2 29.9 31.8 45.7 20.2 28.4 30.9 32.3 7.7 40.7 19.3 26.4 46.1 66.0 46.1 28.5 53.7 41.8 8.4 53.4 12.9 17.7 26.9 36.0 52.9 38.8 35.7 21.0 46.5 25.4 28.2 57.6 42.9 31.4 25.7 22.2 21.5 8.5 58.5 22.3 11.7 32.5 45.6 34.2 47.8 31.5 17.0 5.4 40.0 46.2 31.6 31.7 28.4 33.7 12.3 30.5 26.4 34.7 28.8 15.5 45.9 57.3 78.8 21.6 35.0 74.7 43.9 16.1 17.6 47.0 32.4 34.6 43.9 5.8 38.4 6.2 27.0 44.2 31.8 32.9 27.6 26.7 56.5 20.5 28.2 27.4 6.4 29.9 37.5 39.1 28.6 45.7 12.6 13.9 16.4 22.5 12.2 12.3 15.0 15.2 30.5 7.4 154.9 140.4 318.0 135.2 461.5 60.5 71.4 114.7 91.0 153.6 50.6 45.2 435.3 149.2 258.9 4.9 222.6 136.8 70.0 1250.6 594.7 406.0 86.3 255.6 72.3 381.7 39.7 237.4 173.7 454.7 10.5 227.6 401.8 496.0 551.0 243.6 125.2 635.6 224.5 138.6 113.6 76.3 129.4 465.6 25.6 174.8 443.8 409.2 335.1 293.7 176.9 RBM33 "DKFZp434D1319, DKFZp686F102, MGC20460, PRR8" ENSG00000184863 "RNA binding motif protein 33" Q96EV2 7 155644451-155781485 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Horizontal cells: 125.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019232, HPA021497, HPA021768" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA019232: AB_1856121, HPA021497: AB_2176261, HPA021768: AB_1856123" "unprognostic (1.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (3.04e-2)" "unprognostic (2.06e-1)" "prognostic favorable (9.63e-5)" "unprognostic (3.48e-2)" "unprognostic (2.07e-2)" "unprognostic (6.85e-2)" "unprognostic (3.89e-2)" "unprognostic (8.90e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.98e-1)" "unprognostic (2.42e-1)" "unprognostic (4.46e-2)" "prognostic favorable (4.29e-4)" 16.8 14.1 18.6 24.5 20.9 65.0 16.2 46.1 27.6 14.8 15.1 24.1 13.4 17.2 16.3 21.9 16.4 11.9 14.1 13.2 16.3 12.5 15.6 21.0 19.8 21.1 22.8 14.9 19.3 20.5 14.3 29.1 13.2 16.4 15.7 16.2 13.8 15.9 13.6 33.0 26.9 20.8 14.0 25.5 21.4 17.1 16.0 20.8 28.5 17.3 10.2 19.7 13.8 18.7 5.7 5.7 23.9 6.8 5.0 5.6 2.5 16.8 19.8 12.4 11.5 6.6 8.8 12.6 10.6 7.5 6.5 9.6 18.0 16.1 18.6 14.4 7.8 17.9 12.1 11.3 8.9 8.8 17.6 16.3 17.7 20.7 11.7 7.4 24.9 17.9 8.5 10.6 10.5 15.0 9.7 11.5 20.9 22.5 15.4 9.3 16.2 25.6 21.6 13.4 11.3 13.0 20.7 13.9 15.3 9.5 18.1 12.8 13.1 17.8 12.0 10.0 9.8 9.0 13.2 13.5 11.2 6.7 20.1 14.1 27.3 20.6 27.7 18.4 16.6 14.3 16.3 6.8 13.7 4.5 6.3 3.6 5.7 4.5 5.4 5.6 5.3 4.1 5.2 23.9 5.0 4.9 5.7 5.6 2.5 18.6 20.9 46.1 27.6 16.3 12.5 22.8 14.9 16.4 20.8 29.8 28.4 44.1 18.2 17.4 54.2 25.2 12.7 17.4 12.5 3.5 78.5 15.9 6.6 16.4 18.4 20.7 29.0 23.3 15.5 14.0 14.9 26.2 37.1 25.1 14.0 125.5 25.2 16.0 26.6 29.8 24.2 26.3 11.8 30.7 25.7 29.4 19.7 26.2 16.6 13.8 96.9 12.9 19.6 29.3 22.4 20.6 21.9 32.0 21.8 22.2 RBM45 "DRB1, FLJ44612" ENSG00000155636 "RNA binding motif protein 45" Q8IUH3 2 178112424-178139011 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020448 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA020448: AB_1856133" "unprognostic (3.11e-2)" "unprognostic (1.91e-1)" "unprognostic (6.56e-2)" "unprognostic (2.79e-1)" "unprognostic (1.34e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (5.74e-9)" "unprognostic (1.66e-1)" "unprognostic (4.25e-2)" "unprognostic (2.71e-2)" "unprognostic (2.42e-1)" "unprognostic (5.79e-2)" "prognostic unfavorable (5.34e-9)" "unprognostic (3.26e-1)" "unprognostic (2.68e-1)" "unprognostic (1.05e-1)" "unprognostic (2.94e-1)" 9.5 13.7 15.7 12.4 18.1 7.3 17.3 15.3 15.4 12.2 16.2 10.4 19.7 11.8 13.9 19.3 12.3 14.7 10.3 10.5 14.8 13.1 13.4 15.6 11.0 14.4 15.2 16.2 12.2 16.1 16.2 24.0 6.9 14.6 12.1 19.1 11.1 17.0 14.1 11.2 16.1 13.2 12.0 11.9 16.5 12.4 13.4 16.3 21.6 14.0 7.0 18.7 11.1 10.2 10.8 8.1 4.4 9.5 11.8 11.5 5.6 8.8 9.5 15.2 6.2 13.7 15.4 9.1 11.8 13.7 12.2 13.6 10.0 7.4 14.9 8.2 14.0 12.0 8.0 12.5 16.0 15.6 11.7 10.6 11.6 6.9 14.5 13.9 13.9 11.1 12.2 13.6 12.9 10.8 11.9 13.2 7.8 10.5 12.4 16.2 14.1 14.0 9.4 10.8 12.9 12.0 10.9 10.9 14.8 18.1 20.6 9.4 10.0 8.8 8.7 11.2 18.1 12.4 13.0 11.2 9.2 8.5 10.5 11.6 11.6 13.0 18.5 8.9 11.0 12.4 4.4 5.6 1.8 6.9 8.5 8.4 10.8 7.5 7.5 7.5 8.4 6.7 8.2 1.2 11.8 9.5 8.1 11.5 5.6 15.7 18.1 15.3 15.4 14.8 13.1 15.2 16.2 14.6 16.3 3.0 3.4 1.5 2.6 2.3 5.5 3.6 7.6 6.7 3.4 1.8 9.8 5.2 6.6 6.2 2.6 6.7 4.5 0.0 5.8 8.4 4.7 1.9 8.1 3.4 7.3 9.5 5.8 4.3 9.4 3.1 4.0 5.0 1.7 7.2 5.4 8.0 4.7 4.3 5.3 5.9 7.6 6.5 5.2 8.4 5.1 3.0 1.5 2.9 5.0 2.5 RBM48 "C7orf64, DKFZp564O0523, HSPC304" ENSG00000127993 "RNA binding motif protein 48" Q5RL73 7 92528773-92538005 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021777, HPA025306" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021777: AB_1845763, HPA025306: AB_1845764" "unprognostic (2.79e-2)" "unprognostic (2.15e-1)" "unprognostic (2.12e-1)" "unprognostic (1.30e-2)" "unprognostic (2.81e-2)" "unprognostic (5.04e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.86e-2)" "unprognostic (2.37e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-3)" "unprognostic (3.38e-2)" "unprognostic (1.72e-1)" "unprognostic (6.51e-2)" "unprognostic (7.79e-2)" "unprognostic (2.43e-2)" "unprognostic (8.04e-2)" 11.1 13.0 23.9 10.8 36.0 24.6 14.1 28.3 34.2 11.7 9.0 18.4 7.1 10.3 12.0 12.4 9.9 10.9 8.9 12.1 22.8 15.2 12.4 10.5 9.9 17.1 42.4 15.1 17.0 10.6 11.1 18.3 10.6 20.7 11.5 11.0 9.0 13.0 8.9 16.5 10.8 10.7 9.7 28.0 14.5 9.8 12.5 36.9 13.6 14.5 6.6 13.9 10.2 10.1 20.1 10.6 37.5 12.1 18.1 25.8 14.0 7.5 5.6 9.7 15.2 11.9 12.4 7.6 9.1 9.4 12.1 11.5 6.5 10.4 10.8 16.5 7.7 15.2 7.8 9.9 7.3 13.5 12.2 12.2 8.5 12.2 7.4 10.1 14.9 10.2 9.5 14.4 11.9 12.7 13.9 12.1 14.1 16.8 19.2 11.2 8.9 19.2 15.2 8.6 10.8 9.4 8.9 8.5 14.6 9.6 7.3 11.5 16.2 9.1 17.6 12.7 13.3 5.5 14.7 6.2 17.1 9.3 13.5 13.0 11.4 15.1 18.5 8.1 13.1 15.6 37.5 10.1 21.0 18.5 12.1 20.2 20.1 20.3 18.9 9.7 18.5 25.8 22.1 13.4 18.1 9.9 10.6 18.3 14.0 23.9 36.0 28.3 34.2 22.8 15.2 42.4 15.1 20.7 36.9 11.9 6.9 15.6 11.1 7.6 12.2 14.6 5.1 9.4 11.4 3.5 0.0 8.8 6.6 6.9 6.1 9.3 5.8 23.3 5.2 4.8 8.7 8.9 29.0 3.8 5.4 11.1 0.0 4.9 6.5 5.7 5.5 8.9 5.0 8.2 3.8 12.5 4.1 6.6 6.0 7.4 12.5 12.9 8.3 21.2 15.6 9.9 12.8 14.1 5.2 10.3 RBM5 "H37, LUCA15" ENSG00000003756 "RNA binding motif protein 5" P52756 3 50088908-50119021 "Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017335, HPA018011" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA017335: AB_1856134, HPA018011: AB_1856135" "unprognostic (4.11e-3)" "unprognostic (1.19e-1)" "unprognostic (6.12e-2)" "unprognostic (4.00e-2)" "unprognostic (2.07e-1)" "unprognostic (2.61e-3)" "prognostic unfavorable (9.77e-4)" "prognostic favorable (6.46e-4)" "unprognostic (1.16e-2)" "unprognostic (2.85e-1)" "prognostic favorable (7.58e-4)" "unprognostic (5.58e-2)" "unprognostic (1.49e-2)" "unprognostic (1.93e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-1)" "unprognostic (3.89e-3)" 33.8 25.9 34.1 43.7 37.8 37.7 37.0 51.2 38.9 38.5 33.1 47.7 41.3 25.1 53.2 45.9 28.9 40.5 27.6 28.5 31.1 25.0 30.4 26.9 30.3 41.2 38.1 38.4 63.5 36.3 37.7 58.6 40.3 30.3 41.5 33.5 40.4 35.7 37.9 45.9 54.5 34.7 37.9 41.1 47.0 30.9 36.4 39.5 41.4 42.0 28.5 45.5 31.8 36.6 14.3 12.2 29.6 14.4 14.0 20.1 10.3 9.7 12.1 43.8 19.0 18.3 26.7 10.3 29.8 18.0 22.2 15.7 12.1 11.3 23.0 10.3 19.4 21.9 8.6 29.6 14.4 23.9 21.4 10.8 28.9 41.2 10.8 22.7 26.4 23.4 23.7 16.4 24.1 23.8 38.3 23.5 23.7 19.7 15.5 20.8 8.7 26.8 17.9 15.7 16.7 13.8 14.6 19.2 11.8 16.1 49.1 6.3 14.6 24.5 10.7 14.8 31.2 9.9 25.4 26.6 14.8 15.5 20.4 17.2 21.5 31.4 24.4 11.0 16.2 17.0 29.6 14.0 18.5 17.5 14.4 16.6 13.7 15.8 18.1 12.2 14.3 20.1 15.8 26.1 14.0 14.0 9.3 18.4 10.3 34.1 37.8 51.2 38.9 31.1 25.0 38.1 38.4 30.3 39.5 65.5 105.1 31.8 36.7 28.4 88.7 39.5 17.8 100.4 86.4 36.6 172.8 40.3 10.0 22.5 120.2 50.7 39.5 0.0 18.1 21.2 40.9 41.1 64.9 37.6 27.8 89.0 70.6 55.3 39.9 150.2 59.5 45.4 42.2 37.9 45.1 49.6 24.7 36.8 54.5 7.6 131.6 32.3 43.2 48.9 34.1 29.6 68.3 55.8 33.6 34.9 RBM7 ENSG00000076053 "RNA binding motif protein 7" Q9Y580 11 114400030-114414203 "Predicted intracellular proteins" Meiosis RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 146.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA013993, HPA048003" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA013993: AB_1856137, HPA048003: AB_2680231" "unprognostic (2.90e-3)" "unprognostic (8.21e-3)" "prognostic favorable (6.14e-4)" "unprognostic (1.03e-2)" "unprognostic (1.43e-1)" "unprognostic (2.58e-2)" "unprognostic (1.93e-2)" "unprognostic (2.89e-1)" "unprognostic (9.38e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (1.05e-1)" "unprognostic (3.62e-2)" "unprognostic (5.49e-2)" "unprognostic (4.74e-2)" "unprognostic (1.84e-1)" "unprognostic (8.30e-2)" 21.6 13.0 11.4 12.9 14.9 39.9 20.2 15.1 13.0 19.9 17.2 11.9 8.4 11.0 20.2 13.9 19.2 18.2 15.4 13.9 12.1 7.3 14.7 28.6 18.2 18.7 15.5 8.7 26.3 14.9 14.4 17.7 23.8 11.9 20.9 16.8 8.4 18.1 12.1 17.2 13.9 17.7 18.7 15.8 20.0 16.6 16.7 16.1 22.0 21.5 12.5 15.8 24.3 20.5 13.4 15.4 36.2 16.5 17.5 18.6 12.7 12.8 8.6 11.3 10.7 14.8 20.1 12.4 21.1 28.6 24.8 28.7 18.7 29.1 15.5 29.5 19.6 22.8 11.7 13.7 15.4 32.6 14.3 7.5 18.5 9.8 15.4 25.1 12.1 12.9 19.9 20.6 20.7 29.2 22.3 22.0 12.9 18.0 2.9 19.1 3.7 14.1 12.4 14.1 12.1 14.3 11.1 20.6 14.8 20.7 14.3 9.2 8.8 18.3 8.6 9.6 22.4 8.4 8.3 19.7 7.5 17.7 9.5 22.1 7.6 7.8 13.7 5.3 21.5 12.7 36.2 16.2 18.2 13.0 16.5 18.6 13.4 14.0 12.3 15.4 11.9 17.5 15.0 15.6 17.5 16.0 14.8 14.9 12.7 11.4 14.9 15.1 13.0 12.1 7.3 15.5 8.7 11.9 16.1 14.9 18.8 43.6 71.5 59.9 11.2 12.8 10.2 24.1 19.4 27.9 11.8 43.4 56.3 42.2 146.5 38.3 29.0 0.0 30.7 67.9 54.3 61.6 39.3 23.2 27.3 7.9 45.5 34.4 25.7 16.1 29.1 22.4 40.5 31.5 26.8 21.6 37.8 33.2 15.9 28.4 11.6 0.0 60.8 29.2 15.2 60.0 77.2 40.5 34.3 73.7 RBMX "hnRNP-G, HNRNPG, RNMX" ENSG00000147274 "RNA binding motif protein, X-linked" P38159 X 136848004-136880764 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Cancer-related genes, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057707 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA057707: AB_2683508" "unprognostic (1.53e-1)" "unprognostic (1.52e-3)" "unprognostic (2.12e-3)" "unprognostic (1.14e-2)" "unprognostic (2.62e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (5.16e-6)" "unprognostic (5.59e-2)" "unprognostic (1.05e-2)" "unprognostic (1.68e-2)" "unprognostic (4.87e-2)" "unprognostic (2.32e-2)" "unprognostic (2.94e-2)" "unprognostic (1.57e-1)" "unprognostic (7.65e-2)" "unprognostic (6.27e-2)" "unprognostic (4.64e-3)" 31.0 25.0 30.6 57.1 41.1 48.0 40.6 28.7 33.0 44.2 28.3 32.5 32.7 24.6 45.9 31.7 26.7 38.9 22.1 31.4 26.5 18.0 25.6 20.9 34.4 64.6 34.0 29.3 81.9 39.1 30.1 30.1 25.3 30.5 28.4 33.4 27.5 29.9 29.4 50.0 27.6 27.3 43.0 44.2 27.4 30.1 23.6 29.2 70.1 31.5 34.4 44.8 36.1 33.4 47.1 41.9 25.0 44.9 39.4 60.7 62.9 40.4 44.2 81.1 36.0 20.3 34.4 47.3 40.4 44.0 56.0 59.5 47.2 40.7 73.7 41.8 28.8 35.2 27.1 86.0 42.2 64.9 31.8 40.5 56.4 43.6 50.3 17.8 61.4 51.9 28.2 20.5 43.5 61.1 43.1 45.1 69.9 50.6 37.8 45.5 51.5 89.7 41.5 51.5 43.3 37.1 74.6 54.3 45.5 41.5 48.5 47.4 51.3 32.2 29.2 37.4 50.1 33.5 41.5 28.6 31.8 34.5 21.9 51.4 27.1 36.2 78.0 22.6 44.9 43.3 25.0 37.5 20.8 36.4 44.9 50.3 47.1 47.4 43.1 41.9 45.0 60.7 49.6 6.0 39.4 39.2 25.4 46.8 62.9 30.6 41.1 28.7 33.0 26.5 18.0 34.0 29.3 30.5 29.2 104.2 138.2 258.8 161.8 135.0 109.2 87.6 155.4 174.0 208.1 83.7 90.3 148.4 131.0 128.6 6.7 123.5 81.3 233.6 127.9 222.2 130.2 86.5 255.9 103.0 103.4 87.4 194.8 214.2 240.2 4.3 159.0 111.5 91.1 117.2 164.5 89.1 96.1 94.7 125.2 73.8 131.7 90.5 161.3 27.3 77.1 107.0 93.3 214.2 203.4 130.2 RBMXL1 KAT3 ENSG00000213516 "RNA binding motif protein, X-linked like 1" Q96E39 1 88979456-88992960 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA057707 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA057707: AB_2683508" "prognostic favorable (7.60e-4)" "unprognostic (2.22e-1)" "unprognostic (2.87e-2)" "unprognostic (1.75e-1)" "unprognostic (1.00e-1)" "unprognostic (5.84e-2)" "unprognostic (1.17e-3)" "unprognostic (2.89e-1)" "unprognostic (2.09e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (2.55e-1)" "unprognostic (1.74e-2)" "unprognostic (2.75e-1)" "unprognostic (2.35e-1)" "unprognostic (1.17e-1)" "unprognostic (1.04e-1)" 13.3 9.8 18.5 11.7 15.3 23.8 13.4 12.0 18.0 18.2 12.2 15.3 9.7 9.8 18.5 16.2 20.9 16.7 11.5 14.0 17.1 15.2 17.4 18.3 13.0 13.5 17.1 17.0 22.8 14.5 25.0 14.1 16.7 17.9 16.3 9.5 14.8 11.8 14.3 8.9 12.1 12.2 16.9 17.4 14.4 13.9 14.2 13.0 11.7 16.2 10.1 14.0 19.3 12.4 8.8 8.6 12.3 10.1 6.3 10.8 8.4 10.7 3.2 9.2 12.0 10.9 11.1 17.6 4.6 10.7 9.4 11.1 5.3 7.3 9.1 9.2 5.5 21.9 6.3 17.4 11.5 10.5 8.3 7.7 10.8 11.2 7.0 6.3 8.5 5.9 6.4 6.7 8.4 7.5 4.1 6.0 6.5 15.0 6.0 5.6 4.0 9.0 4.4 16.9 7.0 7.3 8.3 22.6 4.5 6.2 12.5 6.7 10.3 5.0 11.3 11.6 12.9 8.2 8.9 4.4 6.1 12.5 7.1 7.8 9.5 8.9 9.4 4.3 5.2 5.6 2.5 6.6 5.9 6.9 8.9 9.3 6.7 9.7 7.3 8.6 8.8 10.8 6.6 12.3 6.3 10.1 4.4 7.6 8.4 18.5 15.3 12.0 18.0 17.1 15.2 17.1 17.0 17.9 13.0 32.8 34.6 13.7 48.3 27.2 18.9 17.1 20.4 24.1 29.6 12.2 13.7 25.6 3.3 7.6 1.2 18.0 9.7 0.0 7.6 24.9 16.5 19.0 33.5 28.7 10.2 23.8 27.6 14.1 21.3 1.5 15.8 13.8 20.3 19.0 9.4 26.1 8.1 5.8 14.2 4.3 16.8 6.5 23.1 10.1 15.4 21.2 28.5 20.8 10.5 30.8 RBPJ "CBF1, IGKJRB, IGKJRB1, KBF2, RBP-J, RBPJK, RBPSUH, SUH" ENSG00000168214 "Recombination signal binding protein for immunoglobulin kappa J region" Q06330 4 26163455-26435131 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000251, HPA060647" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA000251: , HPA060647: AB_2684337" "unprognostic (2.68e-1)" "unprognostic (2.71e-3)" "unprognostic (2.61e-1)" "prognostic favorable (2.98e-4)" "unprognostic (3.78e-2)" "unprognostic (1.37e-1)" "unprognostic (3.64e-3)" "unprognostic (1.66e-1)" "unprognostic (1.22e-1)" "unprognostic (3.01e-1)" "unprognostic (5.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-2)" "unprognostic (1.15e-3)" 37.7 16.2 23.9 25.7 37.0 35.9 26.3 28.0 34.1 27.5 30.4 37.2 19.4 16.3 37.0 20.9 24.0 22.7 21.7 18.5 27.3 22.4 18.3 13.3 29.6 19.9 33.4 23.5 30.6 21.8 25.3 21.2 44.3 28.3 24.8 23.1 14.1 20.4 20.1 21.5 26.1 21.6 32.3 36.5 22.1 21.0 24.3 38.9 21.9 21.3 15.8 20.6 35.7 36.1 11.8 43.7 70.6 29.8 23.1 21.0 18.0 19.1 6.0 18.4 11.5 27.9 37.9 13.6 16.5 13.9 15.4 18.3 5.0 10.8 16.0 11.2 10.8 12.1 3.5 16.4 8.6 30.3 9.2 8.9 12.6 8.2 8.7 13.4 23.3 11.2 17.9 8.1 30.4 11.1 20.8 8.1 10.6 12.9 6.3 28.4 6.5 15.7 22.9 48.7 5.8 8.7 14.9 35.1 7.4 8.2 7.3 26.7 11.1 7.4 6.3 7.2 17.9 6.5 16.2 9.8 15.6 8.3 25.0 15.6 12.2 14.0 17.3 36.6 26.0 13.6 6.4 29.8 35.8 10.5 24.1 13.5 11.8 16.4 11.4 43.7 11.2 14.2 12.1 70.6 23.1 21.7 10.0 21.0 18.0 23.9 37.0 28.0 34.1 27.3 22.4 33.4 23.5 28.3 38.9 44.7 63.4 40.1 72.5 135.8 91.7 36.3 58.6 66.9 85.3 43.6 121.7 84.8 63.0 58.7 33.2 75.2 26.5 23.3 57.8 61.5 101.0 92.3 55.4 49.9 286.2 81.0 75.2 51.0 181.5 46.8 125.4 205.8 75.9 86.6 45.2 97.1 64.6 38.6 79.2 44.7 103.8 84.1 99.8 114.2 139.3 95.5 70.1 63.8 45.2 45.7 RBX1 "BA554C12.1, RNF75, ROC1" ENSG00000100387 "Ring-box 1" P62877 22 40951347-40973309 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003038 Supported Nucleoplasm NA NA Nucleoplasm "HPA003038: AB_1079827" "unprognostic (2.34e-1)" "unprognostic (1.54e-2)" "unprognostic (1.31e-1)" "unprognostic (1.60e-3)" "unprognostic (2.30e-1)" "unprognostic (2.92e-2)" "unprognostic (1.82e-3)" "unprognostic (1.74e-1)" "unprognostic (6.61e-2)" "prognostic favorable (6.63e-4)" "unprognostic (5.01e-3)" "unprognostic (2.19e-1)" "unprognostic (4.99e-3)" "unprognostic (2.22e-2)" "unprognostic (1.34e-1)" "unprognostic (4.57e-2)" "unprognostic (3.05e-2)" 24.1 27.9 41.6 22.2 35.3 37.6 32.9 28.0 35.7 23.0 22.7 27.4 15.8 18.4 19.4 43.7 27.6 21.2 16.6 39.2 38.3 37.4 34.2 28.3 23.6 28.1 40.4 22.3 18.5 15.6 12.3 19.5 54.1 32.4 20.3 23.9 22.1 21.3 20.8 46.5 21.8 23.0 23.2 45.2 26.4 21.4 16.4 24.8 31.7 31.1 37.4 34.4 19.5 19.4 33.4 60.7 32.2 41.5 23.9 38.5 62.6 31.4 18.0 34.0 16.9 24.2 29.0 19.2 25.4 23.3 38.3 33.9 29.1 15.2 27.6 17.2 24.9 15.4 18.0 32.3 29.0 40.5 32.1 51.5 17.1 26.4 35.5 20.8 41.7 22.2 24.0 23.5 27.7 20.1 21.9 32.4 16.9 20.2 28.1 33.7 38.6 25.0 48.1 18.7 62.3 19.0 32.9 23.6 34.7 43.7 20.4 16.1 10.4 22.3 22.4 22.7 19.9 19.3 28.7 21.5 23.3 24.1 19.5 24.1 23.9 21.9 40.9 29.3 21.3 25.9 32.2 37.2 29.9 24.7 37.0 23.1 33.4 30.9 26.0 37.6 29.4 27.0 29.2 12.6 23.9 41.5 60.7 38.5 62.6 41.6 35.3 28.0 35.7 38.3 37.4 40.4 22.3 32.4 24.8 214.4 129.3 179.4 176.3 267.3 89.0 482.7 183.4 214.2 152.4 212.9 23.6 426.2 431.0 299.7 34.9 245.1 200.1 537.3 290.2 543.9 259.5 193.3 126.0 227.4 379.6 84.2 155.8 166.3 230.6 64.7 172.0 279.5 323.9 596.9 175.3 142.8 316.2 192.9 166.6 432.2 119.9 116.4 233.8 222.2 235.9 324.0 565.2 152.3 178.9 211.6 RCBTB1 "CLLD7, CLLL7, FLJ10716" ENSG00000136144 "RCC1 and BTB domain containing protein 1" Q8NDN9 13 49531946-49585583 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 41.7;Cone photoreceptor cells: 60.9;Rod photoreceptor cells: 37.8;Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056783 Approved Nucleoplasm NA NA Nucleoplasm "HPA056783: AB_2683234" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (1.49e-1)" "unprognostic (5.70e-2)" "unprognostic (2.34e-2)" "unprognostic (2.40e-1)" "unprognostic (7.52e-2)" "prognostic favorable (5.51e-5)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.21e-5)" "unprognostic (1.17e-3)" "unprognostic (1.52e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.29e-1)" "unprognostic (1.42e-1)" "unprognostic (1.82e-1)" "unprognostic (5.49e-2)" 7.4 17.6 16.9 6.5 19.7 8.8 10.3 9.4 16.9 7.0 5.0 27.5 21.3 4.5 12.2 15.1 4.1 9.6 7.0 11.1 18.3 16.5 13.7 6.2 9.3 9.4 26.5 11.2 5.8 8.2 30.9 15.3 9.2 15.8 8.4 6.3 15.1 6.0 14.6 5.0 5.8 5.6 10.8 22.7 9.9 7.4 6.4 22.3 10.9 32.0 4.1 7.7 8.5 6.5 4.6 7.4 15.3 8.1 2.5 8.7 3.2 3.0 7.1 15.8 14.2 21.1 18.4 9.2 11.8 11.8 8.9 9.2 6.0 7.8 10.5 2.6 9.7 7.8 4.4 11.7 18.1 15.5 15.3 9.0 12.5 5.7 15.3 25.3 10.0 10.0 16.3 11.2 7.4 11.9 11.8 15.5 20.8 5.5 4.6 17.9 2.8 14.4 5.8 16.4 10.4 4.4 18.8 11.9 6.6 11.2 8.5 8.3 11.0 6.0 4.6 11.7 13.9 6.2 7.3 10.8 6.7 5.4 14.0 5.7 4.7 5.7 17.1 6.0 10.0 9.4 15.3 5.8 6.1 2.9 7.2 3.4 4.6 4.8 2.3 7.4 3.2 3.0 2.8 2.9 2.5 8.1 1.0 8.7 3.2 16.9 19.7 9.4 14.3 18.3 16.5 26.5 11.2 15.8 22.3 41.7 9.6 6.5 2.3 3.3 8.3 14.8 12.7 16.0 14.8 1.8 60.9 2.5 6.6 6.4 0.3 7.4 0.7 0.0 4.3 2.5 3.5 4.2 2.3 7.3 7.5 9.5 15.5 5.5 12.0 0.4 3.1 8.4 8.5 7.2 2.5 5.8 4.9 0.0 5.3 7.9 37.8 38.8 7.1 1.7 3.6 2.0 0.9 4.9 1.9 1.8 RCL1 "RNAC, RPCL1" ENSG00000120158 "RNA terminal phosphate cyclase like 1" Q9Y2P8 9 4792869-4885917 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "liver: 108.1;pancreas: 37.5" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 4 "HDLM-2: 35.1;HEL: 90.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071308 Approved Nucleoplasm NA NA Nucleoplasm "HPA071308: AB_2686384" "prognostic favorable (5.48e-4)" "unprognostic (7.60e-3)" "unprognostic (7.55e-2)" "unprognostic (4.19e-2)" "unprognostic (1.07e-2)" "unprognostic (3.29e-1)" "prognostic favorable (8.02e-4)" "unprognostic (3.55e-1)" "unprognostic (1.47e-1)" "unprognostic (2.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.59e-2)" "prognostic favorable (2.40e-7)" "unprognostic (1.01e-1)" "unprognostic (1.06e-1)" "unprognostic (2.27e-1)" "unprognostic (3.66e-2)" 15.9 6.8 4.2 6.7 5.9 17.2 12.9 5.5 6.3 5.6 3.8 6.2 6.3 2.4 5.5 5.4 5.5 5.6 3.8 3.7 4.1 3.6 5.7 108.1 6.9 9.1 5.8 4.2 9.0 37.5 3.8 5.1 6.8 5.6 3.6 4.2 4.5 4.8 9.1 10.9 10.5 4.1 5.2 7.1 5.0 5.2 6.8 5.6 5.7 4.5 8.1 7.2 5.3 6.8 10.4 6.8 12.9 2.3 10.8 9.1 3.5 5.6 6.7 2.6 4.1 3.9 2.6 6.8 2.6 2.9 5.0 4.2 3.4 3.3 10.9 1.9 2.4 5.6 3.6 11.9 8.0 5.8 35.1 6.1 90.1 8.1 6.7 5.6 8.1 7.3 5.8 4.6 4.8 7.4 2.7 4.9 8.0 9.2 7.1 3.0 7.3 6.6 14.0 8.9 6.8 2.7 8.2 3.4 5.7 6.1 6.4 7.4 6.1 3.4 5.0 3.9 5.3 4.7 9.6 3.4 3.0 3.3 4.1 8.2 2.9 8.2 11.7 5.4 5.0 1.9 12.9 1.5 3.8 5.6 2.3 6.8 8.0 6.6 7.6 4.0 10.4 8.9 9.1 0.6 10.8 1.2 6.8 5.5 3.5 4.2 5.9 5.5 6.3 4.1 3.6 5.8 4.2 5.6 5.6 6.0 5.0 10.0 14.8 22.7 4.8 10.1 5.1 16.0 6.8 3.5 0.0 33.2 21.6 11.0 59.1 7.7 2.2 0.0 9.9 10.9 10.3 6.4 13.9 135.7 15.5 4.8 2.9 16.0 8.8 39.4 21.3 5.8 3.3 15.4 6.4 7.8 9.2 2.9 35.3 12.1 6.5 12.9 14.6 17.7 19.5 18.4 29.6 10.1 7.2 12.6 RCOR1 "COREST, KIAA0071, RCOR" ENSG00000089902 "REST corepressor 1" Q9UKL0 14 102592661-102730576 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 102.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001956, HPA049327, HPA054241" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB001956: , HPA049327: AB_2680715, HPA054241: AB_2682426" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.01e-3)" "unprognostic (1.25e-1)" "unprognostic (2.18e-1)" "unprognostic (9.96e-3)" "unprognostic (1.72e-2)" "unprognostic (1.87e-2)" "unprognostic (4.98e-2)" "unprognostic (1.46e-2)" "unprognostic (6.05e-3)" "unprognostic (7.23e-2)" "unprognostic (1.39e-1)" "unprognostic (2.02e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (3.72e-4)" 8.0 5.9 4.2 15.2 4.5 25.2 6.2 8.8 4.4 9.8 14.6 3.8 9.7 7.0 9.7 9.7 16.4 5.8 10.4 6.0 4.4 4.4 5.3 6.0 15.1 8.1 4.1 2.6 7.3 5.3 8.9 6.0 12.5 3.6 7.1 6.7 6.3 8.5 7.6 11.2 9.5 16.1 6.5 4.5 8.6 7.9 18.4 3.8 21.2 5.4 10.4 12.9 8.7 10.3 0.8 2.8 7.0 3.1 1.3 1.1 0.9 10.5 9.9 8.9 9.8 7.2 10.0 18.9 10.9 7.8 10.3 9.8 9.0 12.9 11.9 9.0 9.5 5.2 16.7 13.4 7.8 15.5 5.0 4.9 22.1 9.0 8.8 9.8 21.9 20.0 7.0 12.3 9.0 14.0 11.1 11.2 11.3 17.5 9.1 10.3 17.2 13.6 14.8 4.4 11.7 17.1 35.1 9.0 5.3 12.5 13.1 11.6 7.2 24.5 11.3 7.0 11.7 15.5 17.4 12.1 7.2 5.4 22.7 7.1 6.7 8.1 12.8 8.6 16.1 7.5 4.9 2.7 3.7 0.4 2.9 0.6 0.7 0.7 1.1 2.8 0.8 0.6 0.7 7.0 1.3 3.1 1.1 1.0 0.9 4.2 4.5 8.8 4.4 4.4 4.4 4.1 2.6 3.6 3.8 44.7 30.7 22.9 21.2 51.2 7.5 15.9 5.1 12.0 23.9 3.5 2.0 24.5 5.0 5.7 4.2 11.8 21.2 0.0 6.4 16.3 18.3 23.4 24.2 10.9 13.2 9.5 20.2 12.3 35.2 4.0 22.5 28.9 23.6 1.8 16.0 10.0 12.7 13.3 19.8 6.9 5.1 0.0 20.6 22.4 18.5 102.9 36.0 13.8 18.0 56.9 REC8 "kleisin-alpha, REC8L1, Rec8p" ENSG00000100918 "REC8 meiotic recombination protein" O95072 14 24171853-24180257 "Plasma proteins, Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 30.4" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 48.2;Early spermatids: 113.3;Late spermatids: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 6.7;HHSteC: 5.7;MOLT-4: 6.9;SH-SY5Y: 30.2;SuSa: 17.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031727, HPA031729" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031727: AB_10602920, HPA031729: AB_10669915" "prognostic favorable (2.19e-4)" "unprognostic (2.57e-2)" "unprognostic (2.15e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-1)" "unprognostic (5.10e-3)" "unprognostic (1.00e-1)" "unprognostic (1.21e-2)" "unprognostic (3.16e-1)" "unprognostic (1.31e-1)" "prognostic favorable (5.57e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.41e-7)" "unprognostic (8.98e-2)" "unprognostic (2.12e-1)" "unprognostic (1.88e-2)" "unprognostic (6.40e-3)" 2.8 4.6 3.1 2.9 4.6 8.2 1.5 20.3 6.1 3.0 2.7 5.2 9.9 2.0 3.3 3.0 1.5 17.4 30.4 1.6 3.8 3.8 6.3 1.7 3.6 4.0 3.8 5.4 2.2 1.7 0.9 21.4 1.0 10.8 3.2 0.9 8.0 2.1 10.3 1.3 1.4 2.2 3.7 5.1 4.2 8.5 13.3 3.4 22.3 2.0 0.0 4.4 1.7 1.7 2.1 6.2 10.7 6.3 3.3 6.9 1.3 0.0 0.1 6.7 0.0 0.2 0.3 0.3 0.3 0.3 0.6 0.5 0.0 0.7 0.1 0.0 0.0 0.4 0.3 0.2 0.0 0.4 0.6 0.1 0.2 0.3 0.0 5.7 0.1 0.9 3.1 0.3 0.2 0.0 2.6 1.2 0.2 0.0 0.9 0.0 0.1 6.9 1.1 2.1 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.1 30.2 0.0 0.0 0.2 17.5 0.1 0.2 0.2 0.0 0.1 0.2 0.0 1.1 0.3 0.1 0.0 0.1 0.1 2.6 0.1 10.7 6.1 1.2 6.9 2.1 2.2 3.3 3.8 1.6 1.0 3.1 0.1 3.3 6.3 6.2 3.5 1.3 3.1 4.6 20.3 6.1 3.8 3.8 3.8 5.4 10.8 3.4 11.9 13.3 7.0 4.4 1.6 15.5 1.7 22.9 48.2 13.6 26.2 0.0 1.1 5.0 2.2 113.3 4.1 3.5 0.0 2.4 2.8 2.4 1.0 3.5 2.5 2.0 6.4 4.6 4.3 5.9 57.2 4.4 5.6 1.7 1.0 2.3 23.8 3.6 0.0 2.8 23.3 1.6 0.0 1.4 1.9 37.5 1.8 0.3 8.7 1.7 1.8 RECQL "RecQ1, RecQL1" ENSG00000004700 "RecQ like helicase" P46063 12 21468911-21501669 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009743, HPA030960, HPA064259" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: AB_2685230" "unprognostic (9.70e-3)" "unprognostic (2.55e-2)" "unprognostic (1.86e-2)" "unprognostic (6.25e-3)" "unprognostic (2.47e-1)" "unprognostic (1.39e-1)" "unprognostic (8.97e-3)" "unprognostic (1.89e-3)" "unprognostic (8.74e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (3.77e-3)" "unprognostic (3.78e-2)" "unprognostic (2.85e-1)" "unprognostic (1.27e-1)" "unprognostic (1.09e-1)" "unprognostic (2.99e-1)" "unprognostic (3.69e-2)" 32.7 15.8 10.0 22.0 12.7 10.8 18.2 10.9 11.2 18.0 16.3 9.4 11.0 7.5 19.8 14.4 18.7 14.6 14.1 17.9 11.2 7.2 19.6 18.0 19.5 25.7 15.3 7.6 16.0 11.9 8.0 14.8 17.1 12.0 14.0 12.7 6.7 13.1 12.4 15.0 12.4 15.5 20.5 19.5 34.0 12.9 10.8 13.0 27.4 17.4 14.3 25.0 22.6 13.0 19.3 15.2 11.3 20.7 23.1 28.0 13.8 17.2 17.5 13.3 9.8 26.9 33.8 15.4 33.3 28.2 21.5 25.2 19.1 14.4 20.7 12.9 22.7 27.3 12.6 14.2 16.6 30.7 34.6 9.4 25.3 19.4 8.1 10.4 17.5 19.1 18.8 8.6 30.5 22.4 19.8 24.1 14.6 8.8 10.1 28.3 8.4 19.1 20.4 22.1 5.3 11.9 15.8 53.9 16.0 8.3 11.9 3.6 10.6 24.9 6.7 17.5 48.0 17.0 11.2 32.5 30.3 19.7 26.5 30.9 4.1 12.2 45.4 25.6 10.3 22.2 9.3 11.8 11.3 21.9 20.7 21.3 19.3 20.5 21.0 15.2 16.0 13.6 18.8 5.5 23.1 18.8 11.6 28.0 13.8 10.0 12.7 10.9 11.2 11.2 7.2 15.3 7.6 12.0 13.0 20.8 19.7 38.7 12.7 20.9 10.9 7.3 12.7 30.8 25.0 14.0 13.7 9.7 8.3 16.8 0.5 36.0 3.2 0.0 21.6 23.8 30.7 7.0 50.8 11.9 25.0 14.3 9.4 28.3 30.7 2.0 20.4 35.9 28.7 49.5 6.0 17.7 24.4 5.5 35.3 9.5 10.9 12.9 25.8 6.0 8.1 37.5 3.0 41.7 6.9 8.2 RECQL4 RecQ4 ENSG00000160957 "RecQ like helicase 4" 8 144511288-144517845 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.0;lymphoid tissue: 18.9" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 7.1;Spermatocytes: 12.6;Spermatogonia: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 14 "B-cells: 1.9;monocytes: 1.0;T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB017800, HPA025821" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB017800: , HPA025821: AB_1856168" "unprognostic (5.92e-2)" "unprognostic (1.86e-1)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (9.17e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (1.91e-4)" "unprognostic (1.12e-2)" "unprognostic (4.12e-2)" "unprognostic (7.53e-2)" "unprognostic (2.65e-2)" "unprognostic (4.26e-2)" "unprognostic (1.12e-3)" "unprognostic (8.82e-3)" "unprognostic (1.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.34e-1)" 2.0 1.6 2.6 12.3 5.6 21.0 2.8 11.5 3.7 1.8 4.3 1.5 1.6 5.6 2.5 4.9 9.4 1.5 1.9 1.9 2.3 1.7 1.6 1.9 1.6 5.9 1.5 2.2 1.9 3.5 0.3 2.4 2.7 2.2 7.7 1.5 1.4 5.4 0.9 2.1 9.4 4.8 1.1 1.7 4.7 3.0 18.1 1.8 18.9 2.5 5.3 8.0 1.6 1.8 1.9 0.1 0.0 1.0 0.0 1.6 0.2 10.4 18.7 8.7 18.4 0.5 0.9 15.3 10.6 1.9 7.9 6.6 18.4 15.5 7.1 7.1 1.7 4.6 12.7 5.8 4.5 2.2 12.5 22.0 25.7 32.0 13.7 0.1 6.5 21.5 1.1 0.6 8.8 1.8 1.1 2.2 14.6 25.5 9.3 2.7 32.4 23.7 17.7 6.1 8.7 22.4 24.9 6.9 11.9 2.1 11.3 17.3 10.4 14.4 12.1 3.7 2.5 14.7 14.4 2.9 12.8 38.7 15.3 19.5 5.2 5.4 12.1 7.3 20.2 12.8 0.0 0.1 0.0 1.1 1.0 0.0 1.9 0.5 1.1 0.1 0.0 0.9 1.6 0.0 0.0 0.0 0.1 0.0 0.2 2.6 5.6 11.5 3.7 2.3 1.7 1.5 2.2 2.2 1.8 0.0 0.0 2.2 0.4 1.3 2.5 1.6 2.5 0.0 0.0 0.0 3.9 1.2 0.0 0.4 3.1 0.0 0.4 0.0 0.4 7.1 0.8 0.5 0.0 0.6 3.0 0.0 0.0 0.0 0.3 6.2 1.1 0.6 0.0 0.0 1.4 0.2 0.3 0.0 1.4 0.3 1.6 0.0 0.4 12.6 21.1 0.9 1.3 0.0 3.1 0.4 RELT "FLJ14993, TNFRSF19L" ENSG00000054967 "RELT, TNF receptor" Q969Z4 11 73376264-73397474 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Receptor "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 92.2" "Cell type enhanced" "Detected in many" 5 "Macrophages: 37.2;monocytes: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062824, HPA071518" Supported Nucleoplasm NA NA Nucleoplasm "HPA062824: AB_2684875, HPA071518: AB_2686408" "unprognostic (3.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.80e-3)" "unprognostic (9.92e-3)" "unprognostic (1.67e-3)" "unprognostic (1.17e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-1)" "unprognostic (8.42e-2)" "unprognostic (4.13e-2)" "prognostic unfavorable (4.07e-11)" "unprognostic (1.64e-1)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (1.69e-1)" 3.5 2.2 3.5 11.7 8.8 92.2 2.8 3.5 5.7 1.4 2.1 7.4 0.0 2.7 1.9 2.5 3.2 1.6 4.1 5.3 4.0 5.2 2.0 2.0 8.4 18.2 8.3 3.9 1.5 1.6 1.8 3.1 4.1 13.9 1.7 2.0 2.3 4.6 1.3 22.1 2.5 5.6 2.8 14.3 18.1 2.5 3.0 4.6 4.8 1.8 3.9 9.0 3.3 2.1 4.7 6.8 12.1 19.2 0.3 1.1 3.1 5.7 5.8 4.5 4.5 0.5 0.7 5.1 6.4 4.0 7.4 4.5 5.5 2.5 10.6 21.0 4.1 5.9 8.5 2.8 3.1 2.7 6.4 5.4 10.0 7.2 2.0 1.3 9.9 17.6 0.7 1.3 7.8 2.0 1.7 2.6 5.3 7.5 14.1 2.0 5.4 7.1 10.3 4.1 4.5 7.2 14.1 7.9 9.2 1.5 2.5 6.0 5.7 5.4 4.9 6.6 1.1 2.7 8.6 3.6 9.3 6.6 15.4 11.3 4.9 3.9 11.6 5.7 9.8 9.8 0.4 7.0 12.1 0.5 14.3 1.1 4.7 0.6 1.0 6.8 3.7 0.8 0.4 11.6 0.3 19.2 6.8 0.2 3.1 3.5 8.8 3.5 5.7 4.0 5.2 8.3 3.9 13.9 4.6 6.0 2.1 15.9 11.9 23.6 1.9 2.2 0.0 1.4 3.4 0.0 11.8 1.4 0.0 3.5 0.7 2.3 2.1 0.0 0.7 9.4 6.6 7.8 25.3 0.0 20.4 28.6 3.4 0.6 23.5 1.0 0.0 37.2 5.0 30.7 0.6 10.0 4.1 0.6 0.0 0.4 2.0 6.5 7.8 2.7 7.5 15.9 17.6 7.5 1.3 14.8 REPIN1 "AP4, H_DJ0584D14.12, RIP60, Zfp464, ZNF464" ENSG00000214022 "Replication initiator 1" Q9BWE0 7 150368189-150374044 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 126.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 66.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036022 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA036022: AB_10610417" "unprognostic (2.73e-1)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "unprognostic (7.50e-3)" "unprognostic (5.42e-2)" "unprognostic (7.00e-3)" "unprognostic (1.52e-2)" "unprognostic (6.88e-3)" "unprognostic (6.68e-2)" "unprognostic (6.59e-2)" "prognostic favorable (1.12e-4)" "unprognostic (3.40e-2)" "prognostic favorable (5.56e-4)" "prognostic favorable (1.61e-4)" "unprognostic (1.79e-1)" "unprognostic (2.02e-3)" "prognostic favorable (6.41e-4)" 17.0 30.1 16.2 24.9 23.1 25.7 16.9 24.2 21.7 12.0 27.5 21.5 23.2 29.2 15.4 23.6 14.9 17.5 23.6 22.1 15.6 17.1 18.6 36.1 12.3 22.4 21.9 14.3 16.6 34.0 21.5 28.5 10.4 15.6 19.0 20.3 21.9 26.9 23.2 78.4 14.4 27.1 11.4 13.3 23.1 20.6 7.0 18.9 45.4 20.1 20.0 20.3 18.1 15.9 3.6 11.2 3.5 2.1 2.3 3.5 1.2 16.1 19.8 18.8 23.0 4.6 3.3 11.5 8.0 9.9 7.9 6.9 15.3 10.5 18.0 20.4 5.7 13.7 12.1 10.2 3.1 4.0 19.6 15.4 10.5 10.7 19.2 15.3 18.5 17.2 4.3 9.7 4.3 1.0 7.5 11.1 11.0 25.2 11.3 6.5 21.0 25.6 21.1 19.7 10.9 19.7 14.1 21.8 66.9 8.3 28.8 27.7 35.4 12.1 30.5 20.5 8.1 14.9 14.9 11.7 6.1 5.0 6.7 16.1 33.0 12.2 16.4 10.7 16.5 15.0 0.1 2.1 3.5 1.2 1.0 1.9 3.6 2.7 2.3 3.0 3.5 3.5 1.7 2.0 2.3 0.5 11.2 1.1 1.2 16.2 23.1 24.2 21.7 15.6 17.1 21.9 14.3 15.6 18.9 32.8 18.1 23.0 16.6 8.4 59.5 40.5 35.7 16.0 12.5 14.0 39.3 23.1 53.0 32.6 5.8 19.7 43.4 0.0 43.4 10.2 13.5 26.1 24.3 55.7 27.7 76.3 65.4 19.6 14.6 6.3 20.4 14.8 15.1 126.2 53.2 77.2 34.2 24.6 18.7 26.1 52.6 6.5 17.0 8.9 3.2 15.6 21.4 18.5 98.3 16.9 RERGL FLJ22655 ENSG00000111404 "RERG like" Q9H628 12 18080869-18320107 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 32 "Sertoli cells: 161.7;Smooth muscle cells: 159.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 719 "REH: 72.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA041740 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041740: AB_10795694" "unprognostic (3.53e-2)" "unprognostic (7.03e-4)" "unprognostic (6.29e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-2)" "unprognostic (4.39e-2)" "unprognostic (1.10e-2)" "unprognostic (3.14e-2)" "unprognostic (5.51e-2)" "unprognostic (7.26e-2)" "unprognostic (8.47e-2)" "unprognostic (1.25e-1)" "unprognostic (6.76e-3)" "unprognostic (1.96e-1)" "unprognostic (2.39e-2)" "unprognostic (1.66e-2)" 22.4 4.0 5.4 3.2 8.3 0.0 13.0 1.8 8.9 33.4 10.3 4.3 3.5 2.1 16.5 29.2 8.7 19.6 17.3 4.7 7.5 6.1 12.8 0.9 3.1 0.9 9.4 6.0 11.3 1.0 0.8 0.7 0.3 9.0 12.6 12.3 1.6 2.1 14.1 7.7 5.6 6.3 11.8 6.2 1.1 3.9 11.7 4.2 0.4 7.0 8.0 1.1 8.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 8.3 1.8 8.9 7.5 6.1 9.4 6.0 9.0 4.2 0.0 0.0 0.0 0.1 3.9 0.0 3.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 1.9 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.0 0.1 0.0 1.4 0.4 0.0 161.7 159.4 0.1 0.7 2.0 0.1 0.0 0.0 0.3 REV3L "POLZ, REV3" ENSG00000009413 "REV3 like, DNA directed polymerase zeta catalytic subunit" O60673 6 111299028-111483715 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 40.2;ASC TERT1: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064853, HPA069382" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA064853: AB_2685369, HPA069382: AB_2686134" "unprognostic (5.54e-2)" "unprognostic (2.06e-1)" "unprognostic (5.09e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" "unprognostic (8.59e-3)" "unprognostic (4.42e-2)" "unprognostic (1.56e-2)" "unprognostic (8.09e-2)" "unprognostic (1.17e-1)" "unprognostic (6.87e-3)" "unprognostic (1.27e-1)" "unprognostic (4.34e-2)" "unprognostic (2.80e-1)" "unprognostic (1.67e-1)" "unprognostic (1.67e-1)" "unprognostic (1.03e-3)" 21.0 7.1 7.8 8.8 7.3 7.3 15.1 26.0 7.6 31.7 11.0 5.8 14.1 5.4 34.5 18.5 7.6 12.2 7.4 7.1 6.5 6.1 6.5 6.4 10.8 6.3 5.4 5.8 11.3 8.1 7.8 15.1 10.2 6.8 11.4 7.4 8.3 6.9 16.3 17.1 8.2 7.0 18.0 6.9 7.1 8.6 10.3 6.7 10.2 9.2 7.2 5.5 18.3 16.2 5.1 2.8 6.0 2.9 1.7 4.6 1.0 4.7 3.0 5.8 8.8 40.2 30.6 6.4 6.7 11.1 3.7 6.1 5.3 2.9 10.4 4.9 9.7 5.8 4.9 8.5 3.7 6.3 6.1 4.7 6.9 7.6 7.1 5.6 7.2 4.2 19.5 3.4 6.8 10.7 6.4 6.8 5.4 8.8 6.6 7.1 4.4 8.5 1.5 2.0 2.4 5.0 5.5 6.4 3.4 2.8 5.9 7.7 6.1 8.4 3.1 7.2 4.7 3.8 7.8 7.8 5.6 5.2 26.0 7.6 7.0 8.1 9.3 5.4 5.6 7.3 1.9 1.7 3.3 3.3 1.3 4.6 2.8 2.5 3.0 1.7 5.1 1.6 2.8 6.0 1.7 2.9 2.8 1.9 1.0 7.8 7.3 26.0 7.2 6.5 6.1 5.4 5.8 6.8 6.7 44.7 73.8 34.3 19.1 27.1 106.3 31.0 12.7 56.2 45.5 19.2 53.0 18.3 3.3 13.5 30.3 42.0 13.4 0.0 9.9 10.9 62.7 15.8 45.1 12.5 10.9 33.4 57.4 19.0 18.3 11.9 46.6 44.7 20.3 15.4 14.8 74.6 10.1 13.5 36.7 9.2 58.5 38.8 60.6 40.2 68.7 23.5 27.6 22.4 17.7 6.7 RFC1 "A1, MHCBFB, PO-GA, RFC140" ENSG00000035928 "Replication factor C subunit 1" P35251 4 39287456-39366375 "Plasma proteins, Predicted intracellular proteins" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" Neuropathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009520, HPA046116, HPA069306" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115" "unprognostic (8.23e-2)" "unprognostic (2.30e-1)" "prognostic favorable (4.43e-5)" "unprognostic (4.15e-2)" "unprognostic (4.08e-2)" "unprognostic (3.38e-2)" "unprognostic (7.48e-2)" "unprognostic (3.30e-1)" "unprognostic (4.70e-2)" "unprognostic (2.47e-1)" "unprognostic (4.17e-2)" "unprognostic (4.14e-2)" "unprognostic (1.62e-3)" "unprognostic (4.48e-2)" "unprognostic (1.31e-1)" "unprognostic (5.41e-2)" "unprognostic (1.47e-2)" 18.7 24.0 20.2 22.5 24.9 26.8 21.2 19.9 22.7 23.8 17.8 17.1 20.3 12.5 20.7 19.0 19.4 15.8 11.9 15.4 17.9 14.6 23.4 24.9 17.2 26.3 29.0 22.7 26.2 34.1 41.3 30.7 17.6 23.5 20.1 14.5 10.5 17.4 18.9 13.5 17.8 16.0 21.0 32.7 21.6 17.1 12.4 28.9 33.6 22.3 14.6 27.3 25.3 17.4 15.3 13.0 6.4 8.1 10.8 13.5 4.7 15.8 7.2 20.5 16.7 9.9 12.6 10.5 18.4 16.8 18.9 22.5 13.9 16.2 39.2 12.5 12.3 20.3 7.7 18.8 16.0 30.5 7.0 12.8 17.5 13.8 12.7 12.0 24.5 11.7 9.6 12.9 19.1 21.4 15.1 14.6 19.6 17.3 8.3 14.3 6.4 35.9 15.8 12.5 9.9 9.2 28.6 37.4 12.3 8.2 11.1 14.4 14.0 10.8 4.3 13.9 13.4 11.3 13.8 11.1 15.6 19.3 14.4 23.3 11.9 16.1 37.3 12.8 25.7 15.5 6.4 8.1 3.2 13.2 6.2 9.6 12.4 11.4 11.2 6.2 15.3 13.5 11.9 3.7 10.8 7.4 13.0 9.9 4.7 20.2 24.9 19.9 22.7 17.9 14.6 29.0 22.7 23.5 28.9 59.6 101.9 40.2 33.4 18.3 67.9 62.9 30.6 45.5 48.9 54.1 56.9 32.4 61.3 47.2 30.3 54.6 23.3 23.3 57.3 45.5 31.2 43.3 24.4 70.3 26.9 81.0 28.8 55.9 42.4 22.0 75.9 33.8 15.1 37.9 46.9 81.0 46.5 31.6 86.3 63.9 74.7 58.2 24.5 40.8 69.2 18.6 26.9 55.4 43.2 40.9 RFC4 "A1, RFC37" ENSG00000163918 "Replication factor C subunit 4" P35249 3 186789880-186807058 "Plasma proteins, Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 48.3;Spermatocytes: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004557, HPA049123, HPA058507" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736" "unprognostic (2.45e-1)" "prognostic favorable (7.41e-5)" "unprognostic (2.84e-1)" "unprognostic (1.81e-3)" "unprognostic (1.03e-1)" "unprognostic (6.69e-3)" "prognostic unfavorable (6.75e-7)" "unprognostic (5.29e-3)" "unprognostic (1.15e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (7.38e-4)" "unprognostic (5.92e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (1.80e-2)" "unprognostic (4.98e-1)" "unprognostic (6.15e-2)" "unprognostic (2.16e-1)" 7.1 6.9 11.5 14.1 16.0 26.8 10.5 28.0 13.9 8.8 11.6 5.3 5.8 8.2 11.8 7.3 13.0 10.2 7.6 8.0 8.6 6.2 8.2 9.3 6.6 22.1 14.5 9.8 12.7 11.9 6.5 9.0 11.0 12.5 7.3 16.1 5.9 8.1 5.8 8.1 8.7 11.8 13.6 8.4 15.6 9.8 20.3 12.8 28.6 6.4 11.0 25.2 8.3 8.5 11.2 7.7 7.4 10.3 7.0 16.5 6.2 34.8 12.0 28.5 18.2 4.1 4.5 22.5 16.9 10.7 27.0 29.9 17.9 16.7 25.2 39.3 8.1 25.9 18.4 25.1 16.5 33.3 38.0 22.1 25.9 18.4 18.2 3.2 27.3 17.4 3.8 6.0 18.5 14.5 6.0 9.0 39.5 20.1 35.9 18.4 16.6 34.3 25.6 25.2 31.2 16.4 27.2 24.5 34.6 9.7 13.0 27.9 13.9 21.1 23.3 19.1 22.4 39.6 26.2 4.1 16.4 20.7 27.4 50.4 20.1 44.4 83.9 14.4 30.1 21.5 0.0 2.2 7.4 9.8 3.3 9.4 10.6 9.7 10.1 3.9 11.2 9.8 8.9 0.4 7.0 10.3 7.7 16.5 6.2 11.5 16.0 28.0 13.9 8.6 6.2 14.5 9.8 12.5 12.8 0.0 2.1 20.1 13.1 5.4 17.0 6.9 10.2 9.4 7.9 10.4 0.0 26.7 5.0 9.4 18.6 4.5 2.0 23.3 14.4 48.3 5.1 4.1 8.1 2.9 20.0 7.9 1.2 6.7 2.1 7.9 9.8 5.2 1.7 15.4 4.2 12.4 7.9 3.5 7.4 6.7 14.0 6.5 10.3 67.9 38.7 2.6 9.4 8.6 11.5 3.1 RFC5 RFC36 ENSG00000111445 "Replication factor C subunit 5" P40937 12 118013588-118033130 "Plasma proteins, Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041037 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041037: AB_10805834" "unprognostic (9.63e-2)" "prognostic favorable (8.05e-5)" "unprognostic (5.12e-3)" "unprognostic (2.25e-2)" "unprognostic (1.06e-2)" "unprognostic (2.16e-2)" "unprognostic (1.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.35e-3)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (2.30e-4)" "unprognostic (1.44e-1)" "unprognostic (2.15e-1)" "unprognostic (2.70e-1)" "unprognostic (5.06e-1)" 9.4 9.3 9.8 15.1 10.7 30.3 11.7 14.4 12.5 11.4 11.0 10.2 12.6 10.2 12.9 10.8 14.3 12.2 8.4 6.7 15.2 6.5 9.3 13.9 8.4 16.0 7.0 10.1 18.7 12.3 7.3 11.4 9.1 11.0 8.7 14.5 8.5 9.9 12.6 7.3 11.2 11.5 9.0 9.3 11.1 9.8 16.4 9.3 33.4 12.0 11.2 17.0 12.6 10.8 12.9 8.8 14.2 10.4 9.1 14.1 7.9 19.5 21.4 21.0 11.7 5.2 6.1 23.0 14.8 10.1 28.7 21.5 22.0 8.5 23.1 10.5 7.6 17.6 18.8 28.9 14.5 27.1 16.2 24.1 18.1 16.8 14.4 3.1 28.3 13.8 3.2 4.8 21.6 6.9 12.3 11.9 28.5 24.1 8.4 13.4 21.4 35.6 21.4 15.9 11.8 19.7 26.7 25.8 22.0 12.4 17.8 28.2 12.3 25.5 7.1 9.1 12.8 26.3 10.9 5.5 15.4 17.3 21.0 27.8 14.3 18.5 28.3 14.8 20.4 26.1 14.2 6.2 3.9 11.2 10.4 10.0 12.9 13.7 9.8 8.8 11.1 10.7 9.3 6.1 9.1 5.8 7.6 14.1 7.9 9.8 10.7 14.4 12.5 15.2 6.5 7.0 10.1 11.0 9.3 0.0 3.5 0.0 7.8 7.4 3.7 2.6 2.5 17.4 4.5 8.7 2.0 12.7 8.3 7.5 1.3 4.1 2.5 46.7 5.6 22.1 4.3 2.5 5.7 5.8 8.0 1.6 4.1 4.3 2.6 1.7 3.7 4.1 0.0 2.8 5.6 7.8 3.4 3.5 7.8 4.6 6.3 0.0 5.2 12.6 9.3 4.6 7.4 6.9 10.8 1.8 RFESD ENSG00000175449 "Rieske Fe-S domain containing" Q8TAC1 5 95646754-95684773 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 28.3" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 163.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.7;NK-cells: 5.0;T-cells: 12.7" "Cell line enhanced" "Detected in many" "HEL: 21.2;K-562: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016546 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB016546: AB_630417" "unprognostic (1.15e-1)" "unprognostic (5.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.37e-2)" "unprognostic (6.07e-3)" "unprognostic (2.72e-1)" "unprognostic (1.33e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (9.91e-2)" "unprognostic (8.24e-3)" "unprognostic (4.89e-2)" "unprognostic (5.83e-3)" "unprognostic (6.78e-2)" "unprognostic (9.03e-2)" "unprognostic (9.35e-2)" "unprognostic (1.09e-1)" 2.4 3.8 2.8 2.8 5.5 28.3 8.6 4.9 5.1 3.5 2.6 3.1 3.3 1.8 3.1 6.2 3.4 2.8 1.9 5.4 3.8 3.1 3.4 4.4 3.7 3.8 4.5 4.1 4.2 10.7 6.9 9.7 2.9 5.5 4.5 2.2 2.8 8.1 4.9 6.8 9.7 2.3 2.1 8.6 3.7 3.4 16.0 3.9 8.6 4.5 1.4 4.1 3.3 2.9 3.7 1.6 0.3 0.9 5.0 12.7 2.8 1.8 2.9 0.5 1.8 1.9 3.4 0.0 1.0 1.5 1.6 1.7 2.3 2.0 3.0 2.1 0.8 3.9 2.7 2.0 1.5 1.8 4.4 1.7 21.2 2.9 0.8 2.3 1.9 2.2 1.5 2.9 2.1 1.9 1.5 1.6 8.9 39.4 2.3 2.6 1.2 6.2 8.4 2.3 0.8 2.7 3.0 0.3 1.3 0.6 1.1 2.8 2.0 2.8 1.3 0.0 0.2 1.4 1.0 0.8 2.1 1.6 1.5 1.7 2.1 5.0 2.3 1.8 2.3 1.1 0.0 0.7 0.3 3.5 0.9 9.4 3.7 8.5 6.0 1.5 2.9 12.7 7.2 0.0 5.0 0.8 1.6 4.9 2.8 2.8 5.5 4.9 5.1 3.8 3.1 4.5 4.1 5.5 3.9 11.9 3.5 4.5 3.7 2.9 2.2 8.3 0.0 6.7 5.7 1.8 0.0 2.9 1.7 2.0 11.8 1.1 0.1 163.5 1.5 10.4 1.9 1.5 3.5 1.6 3.3 1.6 0.0 2.5 1.0 6.3 1.7 0.8 0.0 3.6 1.0 2.7 2.1 0.0 1.1 2.1 1.2 6.5 1.1 39.4 10.8 5.9 1.7 2.2 1.3 2.5 RFNG ENSG00000169733 "RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" Q9Y644 17 82047902-82051831 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011564, HPA031673" Uncertain Approved Nucleoplasm No No 450000 Nucleoplasm "HPA011564: AB_1079803, HPA031673: AB_2673989" "unprognostic (4.17e-3)" "unprognostic (7.60e-3)" "unprognostic (2.87e-3)" "unprognostic (2.49e-1)" "unprognostic (2.05e-1)" "unprognostic (2.65e-2)" "unprognostic (1.62e-1)" "unprognostic (9.86e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "prognostic favorable (4.81e-4)" "unprognostic (1.20e-1)" "unprognostic (6.96e-3)" "unprognostic (1.77e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (4.14e-2)" 19.5 13.0 13.8 9.3 13.3 11.7 43.8 14.3 13.8 11.4 11.8 9.0 22.7 14.9 13.5 20.9 13.4 16.3 17.0 12.2 11.6 8.7 12.5 34.5 16.7 10.1 11.2 8.0 19.7 26.6 4.1 10.7 8.2 9.9 11.8 4.8 10.6 27.3 20.4 32.6 13.3 12.7 12.9 8.5 8.9 13.2 12.8 10.6 5.7 12.6 10.5 7.6 12.4 12.8 3.4 3.4 4.3 5.0 0.4 6.3 1.5 9.5 9.5 2.8 9.6 7.2 6.3 12.3 8.9 5.2 4.3 3.4 5.8 6.8 2.2 6.4 14.1 8.8 5.3 1.9 7.7 0.9 2.9 10.0 3.2 2.3 23.6 35.5 1.2 7.1 11.5 5.2 7.3 12.5 8.4 8.0 7.5 4.0 8.4 3.4 11.7 7.1 3.3 2.8 6.4 10.0 5.0 3.4 5.0 4.8 5.8 5.0 12.4 3.4 5.8 26.3 3.2 16.1 6.8 3.0 6.8 9.2 6.4 4.8 11.3 2.1 2.3 8.5 2.0 5.8 2.3 5.0 4.3 4.1 1.4 1.5 2.5 2.8 4.3 3.4 3.4 2.8 1.9 2.0 0.4 1.5 2.7 6.3 1.5 13.8 13.3 14.3 13.8 11.6 8.7 11.2 8.0 9.9 10.6 6.0 11.3 5.2 11.2 8.7 28.3 10.0 7.6 4.0 3.4 22.7 23.6 4.8 6.6 7.0 2.9 9.2 17.1 0.0 12.8 2.8 17.9 13.2 1.1 42.9 8.3 11.1 10.9 17.8 9.7 8.5 20.1 6.1 10.1 2.8 13.3 30.4 11.9 17.3 18.7 28.9 24.4 0.0 7.0 17.9 3.1 8.9 3.1 7.5 11.1 7.0 RFX4 ENSG00000111783 "Regulatory factor X4" Q33E94 12 106582907-106762803 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 43.9;testis: 70.5" "Cell type enhanced" "Detected in some" 31 "Early spermatids: 34.1;Late spermatids: 23.0;Spermatocytes: 99.6" "Cancer enriched" "Detected in single" 54 "glioma: 15.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;NK-cell: 1.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 14 "AF22: 33.3" "Low region specificity" "Detected in all" HPA050527 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA050527: AB_2681158" "unprognostic (3.67e-1)" "unprognostic (4.86e-2)" "unprognostic (1.76e-3)" "unprognostic (1.60e-2)" "unprognostic (1.09e-1)" "unprognostic (6.97e-2)" "unprognostic (7.97e-2)" "unprognostic (3.04e-1)" "unprognostic (6.80e-2)" "unprognostic (2.72e-3)" "unprognostic (1.66e-3)" "unprognostic (1.15e-2)" "unprognostic (1.30e-2)" "unprognostic (5.46e-2)" 1.3 1.2 13.8 1.2 14.5 1.2 1.2 7.6 20.6 1.2 1.2 21.0 0.0 1.2 1.2 1.3 1.2 1.3 1.3 1.3 15.7 9.9 1.3 1.2 1.3 1.3 12.0 8.6 1.2 1.4 1.2 8.0 1.2 20.6 1.4 1.2 0.0 1.2 1.3 1.2 1.2 1.3 1.2 43.9 1.2 1.3 70.5 13.7 0.0 1.4 0.0 1.2 1.2 0.1 0.5 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.2 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 13.8 14.5 7.6 13.6 15.7 9.9 12.0 8.6 20.6 13.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 34.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 99.6 3.1 0.0 0.0 0.0 0.0 0.0 RFXANK "ANKRA1, BLS, F14150_1, MGC138628, RFX-B" ENSG00000064490 "Regulatory factor X associated ankyrin containing protein" O14593 19 19192229-19201869 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049157, HPA053330" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049157: AB_2680658, HPA053330: AB_2682114" "unprognostic (3.16e-2)" "unprognostic (6.39e-3)" "unprognostic (1.47e-2)" "unprognostic (1.22e-1)" "unprognostic (5.23e-2)" "unprognostic (4.46e-2)" "unprognostic (1.25e-3)" "unprognostic (3.40e-2)" "unprognostic (3.89e-1)" "unprognostic (1.57e-1)" "unprognostic (2.71e-1)" "unprognostic (1.97e-1)" "unprognostic (1.31e-2)" "unprognostic (3.62e-2)" "unprognostic (3.52e-1)" "unprognostic (2.73e-2)" "unprognostic (2.04e-3)" 16.2 11.0 15.8 19.5 17.8 28.4 15.6 7.6 15.3 19.5 20.1 14.9 17.4 16.9 16.6 20.3 21.8 25.3 12.8 17.7 14.3 12.7 19.0 11.3 14.3 22.5 16.0 10.1 18.8 17.9 12.2 14.0 21.9 13.6 17.7 9.0 16.1 27.0 22.4 32.0 18.7 15.3 11.9 13.0 26.5 16.7 8.5 9.3 49.6 36.6 21.8 23.4 15.1 13.8 25.1 31.7 28.4 18.2 18.3 23.3 15.7 18.6 11.7 8.3 16.6 2.9 8.2 20.9 9.3 9.8 16.0 15.9 9.7 39.1 18.4 23.9 9.6 6.8 13.9 7.1 18.4 7.1 12.6 11.1 14.6 11.9 14.1 30.5 20.8 31.1 15.6 10.9 14.0 10.3 9.8 15.9 18.3 29.1 21.0 8.7 37.4 27.1 27.7 10.0 19.7 26.6 23.0 8.5 32.0 13.2 13.1 6.9 14.4 9.7 12.4 22.8 5.8 17.9 42.6 15.5 8.8 9.3 20.7 14.9 24.3 26.3 27.3 12.7 26.0 16.7 20.5 17.7 28.4 15.1 18.2 12.6 23.6 16.9 16.3 20.0 25.1 17.1 16.5 7.6 18.3 13.3 31.7 23.3 15.7 15.8 17.8 7.6 15.3 14.3 12.7 16.0 10.1 13.6 9.3 29.8 34.6 34.2 28.5 19.6 7.8 3.3 25.5 41.5 14.8 29.6 2.0 50.0 64.6 40.6 4.0 26.3 43.3 23.3 49.9 50.7 21.3 23.9 32.2 13.6 54.2 14.3 35.7 31.3 48.3 7.6 28.1 33.6 20.3 68.5 37.0 24.1 47.4 36.8 18.0 53.8 10.1 38.8 25.9 5.2 17.2 21.5 38.1 28.0 39.4 21.3 RGL2 "HKE1.5, KE1.5, RAB2L" ENSG00000237441 "Ral guanine nucleotide dissociation stimulator like 2" O15211 6 33291654-33299324 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 4.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047039, HPA053444" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047039: AB_2732538, HPA053444: AB_2682153" "unprognostic (4.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.07e-2)" "unprognostic (6.31e-2)" "unprognostic (1.18e-2)" "unprognostic (2.74e-3)" "unprognostic (2.64e-1)" "unprognostic (1.04e-2)" "unprognostic (3.30e-2)" "unprognostic (2.35e-1)" "prognostic favorable (6.16e-4)" "unprognostic (1.27e-1)" "unprognostic (5.00e-2)" "unprognostic (4.84e-2)" "unprognostic (3.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.62e-2)" 12.1 9.2 6.7 10.0 8.4 4.5 6.8 9.4 8.4 8.6 7.0 7.1 15.3 6.7 8.9 9.5 6.5 8.3 9.9 9.1 7.2 3.2 7.5 4.2 9.9 7.2 7.5 4.8 10.7 6.6 4.9 17.1 7.7 8.6 7.5 4.2 7.5 6.8 13.3 19.9 4.6 6.6 6.3 4.9 19.0 7.1 6.4 6.6 4.6 12.8 4.5 6.8 7.5 10.7 0.5 0.7 4.2 0.9 0.7 0.4 0.8 3.6 1.0 4.1 2.1 0.6 0.4 2.0 1.7 1.0 0.5 0.7 0.5 0.9 1.2 6.1 0.3 2.0 0.8 0.8 0.5 0.3 3.0 2.1 2.5 1.0 0.9 0.5 1.8 3.9 0.8 0.5 1.6 0.3 2.6 1.1 1.5 3.1 0.9 0.3 0.7 1.2 2.6 0.1 0.5 1.8 1.2 2.3 1.3 0.8 0.7 3.5 3.4 1.2 2.2 5.2 1.1 1.8 2.1 3.2 2.0 2.9 1.3 4.6 5.1 2.9 3.2 0.6 1.3 3.5 1.6 0.8 2.0 0.4 0.9 0.4 0.5 0.3 0.4 0.7 0.5 0.2 0.3 4.2 0.7 0.2 0.0 0.3 0.8 6.7 8.4 9.4 8.4 7.2 3.2 7.5 4.8 8.6 6.6 14.9 40.4 15.9 31.8 25.2 27.7 22.9 12.7 21.4 30.7 21.0 21.6 22.8 11.6 19.0 3.9 54.2 6.1 0.0 12.7 34.3 17.5 39.0 10.5 10.4 26.5 30.2 27.4 61.4 25.6 10.3 15.5 20.5 16.9 10.8 10.4 20.9 17.4 22.9 13.8 9.7 29.6 25.8 21.7 27.8 16.2 21.2 85.5 20.8 8.3 35.6 RGMB "DRAGON, FLJ90406" ENSG00000174136 "Repulsive guidance molecule BMP co-receptor b" Q6NW40 5 98768650-98798643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 51.6;Mucus-secreting cells: 39.5;Undifferentiated cells: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.3" "Group enriched" "Detected in many" 12 "B-cells: 4.1;T-cells: 8.3" "Cell line enhanced" "Detected in many" "BJ: 68.4;fHDF/TERT166: 37.5;HBF TERT88: 48.5;LHCN-M2: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016993 Approved Nucleoplasm NA NA 150000 Nucleoplasm "HPA016993: AB_1856216" "unprognostic (1.50e-2)" "unprognostic (3.77e-2)" "unprognostic (9.03e-2)" "unprognostic (8.92e-2)" "unprognostic (2.88e-1)" "unprognostic (5.27e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-2)" "unprognostic (8.24e-2)" "unprognostic (2.19e-1)" "unprognostic (3.60e-3)" "unprognostic (9.00e-2)" "unprognostic (3.88e-2)" "unprognostic (3.90e-2)" "unprognostic (6.40e-2)" "unprognostic (4.20e-2)" "unprognostic (3.78e-3)" 8.3 7.2 14.0 9.9 11.7 0.8 14.4 18.0 23.9 8.8 19.7 5.6 9.9 19.0 8.4 5.7 17.7 10.1 8.9 8.8 9.8 14.4 3.9 6.6 10.8 4.1 7.2 13.3 20.1 15.4 9.0 12.3 5.1 11.5 19.2 28.5 6.8 18.4 15.6 23.1 28.1 22.9 10.6 11.6 6.2 34.5 13.3 5.6 1.0 13.5 7.2 7.7 9.7 15.7 4.1 0.1 0.5 0.2 0.3 8.3 1.6 1.8 1.3 19.1 1.7 5.7 9.9 2.6 68.4 30.5 30.5 21.6 0.9 0.8 1.0 2.9 37.5 2.3 1.8 2.2 5.9 48.5 3.4 2.8 0.0 1.6 1.1 2.8 0.1 0.0 8.1 2.0 19.9 6.1 8.2 5.5 3.2 0.0 0.8 35.6 1.7 0.0 0.0 1.5 0.7 4.4 2.8 11.7 1.8 1.1 1.8 8.3 4.2 0.9 2.1 3.2 0.9 1.7 0.0 13.5 19.4 4.0 12.4 31.0 1.8 2.2 1.4 7.3 0.0 4.2 0.0 0.0 0.2 0.3 0.2 1.4 3.1 3.9 1.3 0.1 4.1 8.3 3.9 0.5 0.3 0.0 0.0 5.3 1.6 14.0 11.7 18.0 21.5 9.8 14.4 7.2 13.3 11.5 5.6 14.9 2.6 4.2 12.8 27.5 4.9 13.0 5.1 2.7 1.2 8.7 15.7 3.8 1.7 4.6 51.6 7.4 7.8 0.0 4.5 4.7 13.2 10.6 0.0 7.5 1.7 0.0 20.9 8.6 1.3 12.3 8.3 2.1 11.8 1.0 39.5 1.3 6.6 10.5 6.7 1.2 3.6 0.0 18.6 4.9 12.6 21.3 1.5 0.0 50.0 15.9 RHBDL1 "RHBDL, RRP" ENSG00000103269 "Rhomboid like 1" O75783 16 675666-678268 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 12.0;Cone photoreceptor cells: 11.8;Horizontal cells: 14.3;Rod photoreceptor cells: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 3.4" "Group enriched" "Detected in many" 20 "B-cells: 2.2;NK-cells: 1.3;T-cells: 3.4" "Cell line enhanced" "Detected in many" "HeLa: 9.3;MCF7: 9.8;U-266/70: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030359, HPA030360, HPA046593" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711" "prognostic favorable (8.12e-4)" "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.45e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-2)" "unprognostic (3.27e-2)" "unprognostic (1.94e-1)" "unprognostic (2.78e-1)" "unprognostic (6.60e-3)" "unprognostic (2.74e-2)" "unprognostic (3.97e-2)" "unprognostic (5.63e-3)" "unprognostic (5.89e-2)" "unprognostic (1.27e-1)" "unprognostic (8.30e-3)" "unprognostic (1.49e-2)" 1.7 6.3 10.0 1.1 8.3 2.3 0.7 21.3 14.5 1.3 2.2 1.3 2.2 5.8 1.3 1.7 1.1 1.0 1.2 2.4 8.4 9.9 3.9 1.2 0.8 1.1 5.5 7.2 0.9 6.2 2.2 4.4 1.1 4.6 1.5 1.1 1.5 6.1 2.6 0.8 3.1 5.9 0.7 2.2 0.6 4.5 2.2 1.9 0.7 0.6 0.6 0.5 0.8 0.5 2.2 0.1 0.0 0.0 1.3 3.4 0.7 1.8 2.3 1.3 2.0 1.0 2.7 6.9 0.8 1.3 0.4 0.1 4.8 1.3 0.7 1.6 0.5 0.2 1.2 0.1 0.4 0.0 1.7 8.7 1.0 9.3 1.9 1.0 1.7 1.3 1.8 3.3 0.3 0.0 1.0 0.1 3.1 1.3 1.3 0.1 9.8 0.4 4.7 1.3 2.5 0.7 8.3 1.2 1.8 0.1 1.6 1.7 2.3 1.0 0.5 2.2 0.9 3.6 4.9 0.5 2.8 2.6 0.9 0.6 11.9 1.6 2.3 1.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.4 0.3 0.0 0.5 0.5 0.2 0.0 1.3 0.0 0.1 1.2 0.7 10.0 8.3 21.3 14.5 8.4 9.9 5.5 7.2 4.6 1.9 0.0 0.0 0.0 4.2 1.9 12.0 0.8 0.0 8.1 1.2 0.0 11.8 0.2 0.0 0.7 2.0 0.0 3.9 0.0 0.5 0.2 0.9 1.4 0.0 0.8 0.3 14.3 2.4 0.6 1.2 1.1 1.4 0.0 0.0 0.0 4.5 2.0 1.0 3.6 2.5 7.4 35.2 0.0 0.5 0.7 2.1 1.6 0.2 0.0 4.7 1.6 RHBG SLC42A2 ENSG00000132677 "Rh family B glycoprotein (gene/pseudogene)" Q9H310 1 156369212-156385219 "Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 23.2;kidney: 16.9;ovary: 5.9" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 21.0;Distal tubular cells: 16.6;Early spermatids: 10.7;Late spermatids: 8.6" "Group enriched" "Detected in some" 5 "liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1" "Region enriched" "Detected in some" 15 "cerebellum: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 65 "CACO-2: 4.8;Hep G2: 5.7;RT4: 10.0" "Low region specificity" "Detected in all" "HPA042726, HPA048489" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA042726: AB_2678131, HPA048489: AB_2680417" "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" "unprognostic (4.55e-3)" "unprognostic (5.04e-2)" "unprognostic (2.95e-2)" "unprognostic (3.76e-3)" "unprognostic (2.00e-1)" "unprognostic (1.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.45e-1)" "unprognostic (3.72e-1)" "unprognostic (3.63e-2)" "unprognostic (4.91e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-3)" "prognostic favorable (8.06e-4)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 23.2 0.1 0.3 0.3 0.0 1.0 0.0 0.1 0.0 2.2 0.0 0.0 0.1 0.1 0.1 16.9 3.3 0.1 0.0 0.1 0.1 5.9 0.2 0.0 0.1 0.0 1.5 0.1 0.0 0.0 0.1 0.4 0.1 1.0 0.3 0.0 0.1 0.1 0.1 1.2 0.0 0.0 0.1 1.1 1.2 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 23.2 0.1 0.1 0.1 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 21.0 0.0 0.0 16.6 0.3 10.7 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 4.3 0.1 0.0 0.0 0.0 0.0 8.6 0.3 0.0 0.0 1.0 0.0 1.1 0.1 0.0 0.4 0.9 0.0 0.0 0.0 2.2 0.4 0.4 0.0 0.0 0.0 0.0 RHPN1 "KIAA1929, ODF5, RHPN" ENSG00000158106 "Rhophilin Rho GTPase binding protein 1" Q8TCX5 8 143368887-143384220 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 22.7;Collecting duct cells: 36.6;Cone photoreceptor cells: 29.5;Rod photoreceptor cells: 23.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 6 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "MCF7: 17.0;MOLT-4: 15.3;RPMI-8226: 11.3;T-47d: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024288, HPA024671" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024288: AB_1856274, HPA024671: AB_1856275" "unprognostic (2.04e-1)" "unprognostic (3.71e-1)" "unprognostic (1.54e-2)" "unprognostic (2.20e-1)" "unprognostic (5.82e-2)" "unprognostic (6.38e-2)" "unprognostic (2.07e-3)" "unprognostic (3.12e-1)" "unprognostic (3.57e-1)" "unprognostic (1.02e-1)" "unprognostic (8.27e-3)" "unprognostic (1.23e-1)" "unprognostic (1.16e-2)" "unprognostic (1.24e-3)" "unprognostic (9.92e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-2)" 3.3 3.2 17.9 3.6 11.9 5.9 4.0 2.5 14.3 5.7 2.6 10.8 6.2 1.2 1.1 6.2 1.9 8.0 3.7 1.3 19.4 9.7 9.7 0.9 4.0 4.0 9.0 9.4 0.8 7.8 10.3 14.8 1.4 10.9 3.2 1.3 2.0 6.6 7.2 0.8 5.3 1.9 1.7 8.3 5.6 5.2 2.7 14.1 15.4 14.9 0.5 2.5 2.4 1.2 0.0 0.1 0.0 0.0 0.0 1.0 0.0 1.7 3.0 0.7 2.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 1.2 0.1 6.1 0.0 0.1 0.7 0.0 0.0 0.0 0.3 2.7 0.0 1.9 0.1 0.2 0.1 1.9 0.0 0.5 0.0 0.0 0.5 0.6 7.2 0.6 3.7 0.0 17.0 15.3 1.5 1.1 3.5 8.3 4.2 0.0 11.3 2.8 2.8 4.5 1.7 0.9 5.1 1.0 0.0 27.7 0.0 0.0 0.0 3.2 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.3 0.3 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 11.9 2.5 12.7 19.4 9.7 9.0 9.4 10.9 14.1 6.0 6.9 0.8 2.4 2.3 2.5 0.8 5.1 22.7 4.5 36.6 29.5 1.3 10.0 8.7 4.3 3.6 0.0 0.0 2.4 0.2 1.1 3.3 0.0 0.8 2.8 6.4 21.8 2.5 2.2 7.2 0.3 1.1 6.8 1.8 2.3 11.4 3.3 0.0 1.4 12.9 23.5 0.0 0.7 6.0 7.3 1.3 1.6 3.2 3.0 2.6 RIMS4 "C20orf190, dJ781B1.3" ENSG00000101098 "Regulating synaptic membrane exocytosis 4" Q9H426 20 44751808-44810338 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.8;testis: 14.6" "Cell type enhanced" "Detected in some" 19 "Horizontal cells: 36.5;Peritubular cells: 12.4;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 13.1;MCF7: 8.8;SCLC-21H: 27.1;SH-SY5Y: 13.9;SiHa: 9.4;U-2 OS: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060928 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA060928: AB_2684387" "unprognostic (1.54e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" "unprognostic (9.46e-2)" "unprognostic (2.97e-1)" "unprognostic (1.90e-2)" "unprognostic (4.63e-3)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (4.21e-3)" "unprognostic (1.70e-1)" "unprognostic (8.60e-3)" "unprognostic (3.37e-2)" "unprognostic (1.28e-1)" "unprognostic (7.66e-3)" "unprognostic (2.94e-2)" 1.0 2.1 13.8 0.8 23.3 0.4 1.2 9.6 23.8 11.8 1.2 0.2 0.0 0.6 3.2 2.2 1.3 11.9 1.4 0.6 14.1 7.5 0.6 0.5 1.7 0.6 4.9 8.8 9.5 0.6 0.5 6.0 0.6 4.1 3.2 1.2 1.0 2.0 1.8 1.8 0.5 0.7 4.3 1.3 0.5 2.3 14.6 2.6 0.0 7.5 0.9 1.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.0 1.3 0.0 13.1 0.1 0.0 0.0 5.5 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 8.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 27.1 13.9 9.4 0.0 0.1 0.4 4.1 0.4 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 23.3 9.6 19.0 14.1 7.5 4.9 8.8 4.1 2.6 0.0 0.0 0.0 0.0 0.2 2.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 36.5 1.7 0.0 0.0 2.4 6.6 0.0 0.0 0.0 0.7 0.8 0.1 0.0 12.4 0.0 0.7 25.8 0.0 0.7 4.1 0.1 0.0 0.0 0.0 0.0 RIPOR3 "C20orf175, C20orf176, dJ530I15.2, dJ530I15.3, FAM65C" ENSG00000042062 "RIPOR family member 3" Q96MK2 20 50586108-50691528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 3.0;Collecting duct cells: 3.5;monocytes: 3.6;Proximal tubular cells: 2.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 19.9;ASC TERT1: 9.3;HEL: 29.1;HSkMC: 18.3;K-562: 16.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA051823, HPA054759" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051823: AB_2681626, HPA054759: AB_2682596" "unprognostic (7.23e-2)" "unprognostic (4.17e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.38e-2)" "prognostic favorable (1.66e-5)" "unprognostic (4.96e-4)" "unprognostic (1.32e-1)" "unprognostic (2.66e-2)" "unprognostic (2.18e-1)" "unprognostic (2.88e-2)" "unprognostic (1.13e-1)" "unprognostic (1.10e-3)" "unprognostic (1.98e-1)" "unprognostic (9.21e-3)" "unprognostic (1.67e-2)" "unprognostic (4.58e-2)" 18.9 11.8 4.6 4.2 8.1 22.8 8.1 3.0 5.3 18.6 6.4 2.9 2.4 3.3 14.1 5.7 5.8 13.5 4.3 5.7 4.3 1.1 15.1 7.7 2.9 9.1 5.1 0.9 5.1 2.1 1.5 5.5 2.7 5.2 5.4 2.2 6.3 4.3 1.1 11.7 3.0 5.8 5.8 3.8 4.2 3.2 6.4 6.3 2.7 4.2 2.5 2.6 6.6 24.6 1.1 0.7 1.9 0.3 0.1 1.1 1.0 0.0 0.0 0.5 0.0 19.9 9.3 0.0 0.0 6.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.1 2.3 0.0 0.0 18.3 0.0 0.5 0.0 0.0 0.0 0.0 16.9 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 1.7 0.0 0.0 2.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 1.4 0.1 1.9 1.1 0.3 0.0 1.1 0.8 0.4 0.1 0.8 0.8 0.4 1.1 0.1 0.2 0.7 0.3 1.0 4.6 8.1 3.0 5.3 4.3 1.1 5.1 0.9 5.2 6.3 3.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 3.5 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 RITA1 "C12orf52, FLJ14827, RITA" ENSG00000139405 "RBPJ interacting and tubulin associated 1" Q96K30 12 113185526-113192368 "Predicted intracellular proteins" "Neurogenesis, Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039094, HPA039095, HPA061531" Supported Supported Nucleoplasm No No Nucleoplasm "HPA039094: AB_10671037, HPA039095: AB_2676345, HPA061531: AB_2684554" "unprognostic (7.10e-2)" "unprognostic (4.26e-2)" "unprognostic (2.78e-2)" "unprognostic (3.55e-2)" "unprognostic (2.56e-2)" "unprognostic (6.98e-2)" "prognostic unfavorable (9.79e-4)" "unprognostic (3.47e-2)" "unprognostic (2.92e-2)" "unprognostic (1.77e-1)" "unprognostic (1.30e-2)" "unprognostic (2.02e-1)" "unprognostic (1.98e-1)" "unprognostic (2.59e-3)" "unprognostic (1.44e-1)" "unprognostic (2.93e-1)" "unprognostic (2.01e-1)" 6.7 20.7 14.4 7.9 17.6 7.4 7.7 16.6 29.7 8.4 10.7 7.8 3.4 14.7 7.2 8.2 11.3 16.4 8.3 12.3 13.4 12.9 14.1 24.1 7.5 11.5 11.8 15.0 10.5 9.6 7.3 10.6 5.9 13.2 9.2 7.1 10.5 14.8 10.5 31.4 9.3 15.3 5.6 5.7 8.7 8.0 6.6 7.3 13.0 12.3 12.0 11.1 7.6 6.4 7.8 14.2 24.6 8.9 12.8 10.2 8.0 12.4 16.2 4.2 11.1 5.6 4.3 7.7 8.2 16.8 12.0 9.6 19.1 6.1 23.9 12.8 6.8 10.4 9.6 9.5 10.5 7.1 14.4 13.8 8.1 8.0 12.1 9.3 10.8 6.8 6.7 9.6 11.8 6.7 16.7 9.8 11.8 15.6 4.4 7.1 17.8 12.0 29.3 14.1 10.6 20.5 10.8 4.5 20.1 9.7 17.8 14.1 8.2 10.4 21.7 17.5 5.4 18.2 16.5 6.4 7.7 10.9 8.8 11.5 15.5 12.9 25.7 11.5 9.0 10.7 24.6 8.9 5.7 10.1 4.2 10.2 7.3 9.0 9.1 10.2 7.8 9.0 9.7 0.2 12.8 4.9 14.2 9.5 8.0 14.4 17.6 16.6 29.7 13.4 12.9 11.8 15.0 13.2 7.3 0.0 9.9 15.9 6.3 5.7 8.2 5.6 15.3 13.4 5.7 14.0 3.9 15.5 41.4 14.9 8.7 8.2 21.2 0.0 14.3 13.7 6.6 7.5 0.0 27.7 12.4 14.3 10.9 6.2 7.8 21.2 9.2 2.5 5.0 3.6 14.5 9.5 12.9 12.5 7.8 38.6 5.2 6.5 7.2 3.8 6.7 5.6 8.5 11.4 10.5 6.7 RMC1 "C18orf8, HsT2591, MIC1, WDR98" ENSG00000141452 "Regulator of MON1-CCZ1" Q96DM3 18 23503470-23531807 "Cancer-related genes, Predicted intracellular proteins" Autophagy "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 13.6;monocytes: 15.4;Proximal tubular cells: 14.5;Syncytiotrophoblasts: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043589 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043589: AB_2678568" "unprognostic (6.45e-2)" "unprognostic (6.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.78e-1)" "unprognostic (5.51e-3)" "unprognostic (8.16e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (4.26e-2)" "unprognostic (3.77e-1)" "unprognostic (1.73e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (3.03e-1)" "unprognostic (3.76e-1)" "unprognostic (1.25e-1)" "unprognostic (3.04e-2)" "unprognostic (4.13e-2)" 16.6 14.3 11.6 13.9 13.2 30.1 25.2 15.8 20.5 13.2 17.1 13.1 11.8 20.3 16.4 12.4 15.0 14.4 13.3 12.7 16.6 10.7 20.9 23.8 19.5 24.1 15.4 12.0 14.1 17.3 14.6 23.5 17.5 13.4 13.2 14.1 16.2 16.3 14.2 17.2 16.3 23.1 13.6 14.0 21.9 18.9 26.2 11.6 19.7 13.3 11.0 22.9 16.3 14.8 20.0 27.1 24.1 25.4 19.7 18.0 10.2 8.4 8.7 6.5 11.3 14.9 10.7 8.7 13.3 14.2 17.9 21.4 7.9 5.2 12.7 11.2 11.4 26.0 16.7 16.9 7.5 15.9 13.1 9.6 6.4 6.2 7.9 19.5 16.8 22.9 9.6 11.8 22.1 12.7 10.3 10.5 11.1 10.0 13.7 11.9 10.9 14.0 7.7 3.5 12.1 13.4 11.3 9.8 12.5 9.4 8.2 8.8 11.9 17.2 8.7 10.9 9.4 6.7 10.5 10.1 15.3 4.1 6.1 11.4 21.9 16.5 14.6 15.8 11.5 11.5 24.1 9.9 21.5 15.5 18.4 16.0 19.9 13.8 14.9 12.1 20.0 9.4 11.4 9.6 19.7 25.4 27.1 18.0 10.2 11.6 13.2 15.8 20.5 16.6 10.7 15.4 12.0 13.4 11.6 8.9 13.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.8 7.0 0.0 8.9 5.0 10.1 0.0 0.0 0.0 0.0 10.7 6.5 0.0 0.0 3.5 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 15.4 0.0 0.0 10.2 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 RMND5A "FLJ13910, GID2, GID2A, p44CTLH, RMD5" ENSG00000153561 "Required for meiotic nuclear division 5 homolog A" Q9H871 2 86720173-86778041 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046795, HPA060843" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046795: AB_10963573, HPA060843: AB_2684378" "unprognostic (4.54e-2)" "unprognostic (9.23e-2)" "unprognostic (3.45e-2)" "prognostic unfavorable (3.03e-4)" "unprognostic (2.32e-2)" "unprognostic (4.40e-2)" "unprognostic (1.52e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (1.49e-2)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-2)" "unprognostic (8.34e-3)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "unprognostic (1.56e-1)" 9.8 7.0 11.1 6.5 11.7 15.6 10.1 47.3 19.2 9.0 11.8 8.4 6.8 9.7 11.3 8.4 19.7 8.1 8.9 23.1 12.5 8.5 11.2 25.6 6.9 12.6 9.3 10.0 9.0 9.9 15.8 7.6 9.6 7.0 8.4 13.1 10.3 12.0 7.1 34.2 13.4 9.0 12.0 11.2 8.0 7.2 5.5 5.5 24.1 7.9 10.6 8.1 9.2 12.0 4.6 6.4 20.7 8.7 6.0 8.8 5.1 8.1 4.4 7.8 4.6 10.4 4.6 16.1 3.2 2.7 4.3 4.9 16.1 8.8 28.5 10.0 2.9 5.0 9.8 19.7 6.8 6.7 8.2 15.1 25.1 9.7 14.5 10.5 18.2 8.3 7.0 13.6 4.5 15.8 4.9 7.4 21.2 15.8 16.4 3.4 5.3 16.7 15.6 13.2 9.8 5.7 20.1 24.1 17.9 8.9 9.8 14.5 11.2 7.3 14.8 11.8 11.5 7.4 15.8 7.1 3.0 5.8 5.4 5.0 7.4 7.7 19.6 2.5 22.1 3.4 20.7 8.7 5.4 6.0 6.8 7.1 3.2 4.6 6.7 6.4 4.6 6.4 8.8 19.0 6.0 7.9 5.1 3.1 5.1 11.1 11.7 47.3 19.2 12.5 8.5 9.3 10.0 7.0 5.5 11.9 12.8 15.0 18.5 37.3 19.8 71.8 17.8 18.7 6.8 10.4 5.9 17.5 19.9 11.7 8.4 19.2 33.8 70.0 12.3 16.0 17.9 26.5 8.1 55.5 13.7 22.3 37.9 19.0 33.6 4.7 17.8 17.1 30.4 8.2 48.6 14.1 19.1 31.7 16.3 23.8 15.2 6.5 18.6 16.6 26.7 47.9 20.6 18.5 24.4 21.7 RMND5B "FLJ22318, GID2, GID2B" ENSG00000145916 "Required for meiotic nuclear division 5 homolog B" Q96G75 5 178130996-178150565 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 149.7;Late spermatids: 317.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 56.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047778 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047778: AB_2680153" "unprognostic (2.08e-1)" "unprognostic (6.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.35e-2)" "unprognostic (4.38e-2)" "unprognostic (9.81e-3)" "unprognostic (2.64e-3)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.48e-1)" "prognostic favorable (7.66e-4)" "unprognostic (1.60e-1)" "prognostic favorable (7.22e-8)" "unprognostic (1.77e-2)" "unprognostic (1.41e-1)" "unprognostic (6.43e-2)" "unprognostic (5.78e-2)" 12.2 12.6 11.6 7.3 13.7 7.7 9.7 10.4 18.8 11.4 11.8 16.2 9.1 9.0 16.2 11.8 36.7 12.8 12.5 17.2 11.4 9.0 11.3 13.1 11.5 11.1 14.5 16.7 11.8 16.9 12.8 15.7 11.3 13.0 12.2 8.2 16.1 15.8 11.9 23.4 18.0 11.7 18.7 9.1 10.5 12.0 42.0 9.2 11.2 14.3 13.0 18.2 11.5 14.0 13.2 8.5 22.4 13.8 2.2 12.8 7.2 6.4 10.9 7.5 18.1 9.7 1.0 22.4 5.4 6.1 7.9 9.5 12.8 9.6 14.1 10.8 4.0 9.1 9.0 7.4 11.3 3.1 39.5 9.9 14.4 13.0 6.7 10.3 6.9 5.4 2.0 9.1 5.5 9.4 4.9 8.2 4.9 12.0 10.0 2.6 56.9 5.0 4.2 9.6 8.6 6.8 6.2 5.4 9.7 7.3 10.5 7.7 10.8 7.2 24.8 12.6 6.4 17.3 10.0 5.6 4.8 7.1 4.4 6.7 14.5 13.4 11.6 6.0 7.0 6.5 9.2 9.7 22.4 4.2 11.2 1.8 11.1 8.5 4.8 5.7 13.2 12.8 7.6 6.8 2.2 13.8 8.5 12.5 7.2 11.6 13.7 10.4 18.8 11.4 9.0 14.5 16.7 13.0 9.2 11.9 5.8 15.6 17.3 8.5 46.1 20.9 20.4 4.0 5.7 29.6 49.1 27.9 19.9 17.7 149.7 10.6 18.7 46.7 16.6 24.1 15.3 18.0 4.7 11.9 18.8 46.1 8.6 14.7 10.7 317.0 26.7 11.0 6.8 24.4 13.7 29.1 16.2 13.6 23.7 16.5 53.1 12.9 14.2 79.2 34.1 11.7 37.2 10.0 16.2 17.6 RNASEH2B "AGS2, DLEU8, FLJ11712" ENSG00000136104 "Ribonuclease H2 subunit B" Q5TBB1 13 50909678-51024120 "Disease related genes, Predicted intracellular proteins" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 120.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 68.3;REH: 57.1;THP-1: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040084, HPA041469" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040084: AB_10697714, HPA041469: AB_2677496" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (2.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.59e-1)" "unprognostic (1.16e-1)" "unprognostic (8.33e-2)" "unprognostic (2.79e-2)" "unprognostic (2.50e-2)" "unprognostic (9.63e-3)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "prognostic unfavorable (2.54e-8)" "unprognostic (1.05e-1)" "unprognostic (3.13e-1)" "unprognostic (1.39e-2)" "unprognostic (3.34e-1)" 11.9 10.5 11.3 20.2 14.1 28.3 10.9 11.3 10.9 14.0 15.2 9.4 12.9 8.9 20.0 12.6 11.6 15.8 11.6 14.7 10.0 8.8 9.1 7.9 14.3 25.7 11.8 9.9 14.0 18.0 6.3 12.0 10.6 8.5 15.4 12.4 9.6 12.7 12.9 15.8 8.5 13.9 15.5 10.0 18.5 11.5 16.4 11.3 120.1 15.8 11.0 20.4 15.1 12.2 34.2 31.3 5.5 13.9 12.0 34.5 16.9 7.9 6.6 3.6 7.2 4.8 9.5 8.6 5.7 6.6 8.3 7.0 8.6 12.4 22.8 3.7 5.9 8.0 7.7 11.3 5.3 10.0 8.3 9.2 20.4 4.6 5.0 6.5 37.3 13.5 3.8 6.7 7.3 6.5 7.6 7.3 48.0 11.3 10.9 11.3 3.8 68.3 50.7 11.6 17.3 5.2 57.1 10.6 15.3 6.3 4.7 8.0 11.7 6.9 2.5 7.3 4.8 3.9 51.0 5.2 7.5 6.2 8.8 12.7 14.6 9.6 27.0 1.9 27.9 8.7 0.9 12.6 5.5 11.1 13.9 12.7 34.2 22.1 18.2 18.2 29.0 19.9 18.5 2.1 12.0 11.9 31.3 34.5 16.9 11.3 14.1 11.3 10.9 10.0 8.8 11.8 9.9 8.5 11.3 35.7 22.1 62.1 24.8 16.7 12.9 43.5 20.4 53.5 28.4 15.7 5.9 29.9 24.9 37.0 45.2 13.9 8.1 23.3 44.0 45.2 22.6 20.1 50.8 13.1 86.8 1.6 11.6 16.5 44.7 31.5 25.6 35.6 15.1 89.2 18.7 8.1 26.5 3.5 28.0 22.5 4.7 12.9 24.2 70.7 39.5 18.3 15.0 48.4 36.3 22.0 RNASEH2C "AGS3, AYP1" ENSG00000172922 "Ribonuclease H2 subunit C" Q8TDP1 11 65714005-65720947 "Disease related genes, Predicted intracellular proteins" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065375 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA065375: AB_2685481" "unprognostic (1.61e-1)" "unprognostic (6.84e-2)" "unprognostic (2.06e-1)" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (2.26e-2)" "unprognostic (7.88e-3)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.68e-5)" "unprognostic (1.48e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.72e-2)" "unprognostic (1.84e-1)" "unprognostic (1.67e-2)" "unprognostic (9.99e-2)" 10.3 18.0 16.6 16.6 17.9 29.9 16.2 33.3 21.2 13.4 18.9 13.5 19.8 15.6 19.1 12.6 8.8 15.7 16.0 25.8 14.8 11.4 14.5 10.0 10.6 22.6 20.1 9.6 24.7 17.0 19.7 22.2 10.0 14.5 20.2 7.9 14.6 13.0 22.4 10.9 20.4 14.3 11.5 11.0 25.0 13.6 7.3 19.1 20.0 14.2 12.0 14.4 14.6 17.1 12.6 20.1 3.6 13.5 9.4 10.3 9.4 5.1 6.2 8.5 6.0 7.3 3.4 3.6 3.4 2.4 9.9 7.9 6.5 8.2 10.6 4.0 3.7 12.8 8.4 6.4 5.0 6.5 8.9 18.1 9.4 18.6 3.4 0.7 1.5 10.4 3.7 1.7 8.5 2.6 5.4 4.0 10.9 4.7 13.1 3.7 8.6 17.7 11.9 5.4 2.7 9.0 16.2 4.9 16.6 2.6 3.5 10.9 8.7 1.8 6.8 3.3 2.5 9.9 5.1 3.6 10.0 8.1 7.3 4.7 13.0 4.0 2.3 13.9 8.2 8.5 2.7 13.5 3.6 10.3 9.2 10.2 11.7 6.8 7.6 8.5 12.6 8.6 6.8 2.8 9.4 6.9 20.1 6.7 9.4 16.6 17.9 33.3 16.3 14.8 11.4 20.1 9.6 14.5 19.1 23.8 32.8 96.1 92.8 28.0 25.3 54.6 91.7 34.8 23.9 64.6 7.9 68.7 89.5 55.7 29.6 77.7 75.9 140.2 40.5 92.5 63.1 75.9 64.6 90.4 112.4 22.3 123.3 101.3 90.4 104.8 125.7 55.3 60.8 65.9 45.1 30.6 48.8 66.2 94.0 205.6 23.2 109.9 87.2 53.0 71.1 32.2 173.9 62.3 50.2 83.3 RNF113A "Cwc24, RNF113, ZNF183" ENSG00000125352 "Ring finger protein 113A" O15541 X 119870475-119871827 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA000160, HPA076658" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA000160: AB_1079821, HPA076658: AB_2732319" "unprognostic (2.85e-1)" "unprognostic (4.38e-3)" "unprognostic (5.55e-3)" "unprognostic (2.38e-2)" "unprognostic (1.02e-1)" "unprognostic (1.28e-2)" "unprognostic (3.65e-3)" "unprognostic (2.02e-3)" "unprognostic (6.29e-2)" "unprognostic (2.57e-1)" "unprognostic (6.49e-3)" "unprognostic (1.83e-1)" "prognostic unfavorable (7.93e-4)" "unprognostic (7.99e-2)" "unprognostic (3.19e-1)" "unprognostic (3.91e-2)" "prognostic favorable (6.23e-4)" 11.3 10.7 12.3 14.3 14.9 35.2 12.6 18.6 15.5 11.8 14.6 8.7 14.8 15.0 14.9 12.3 12.7 12.8 11.8 14.2 12.2 14.4 10.9 20.6 12.3 25.1 12.8 11.4 16.4 20.5 7.6 11.4 11.9 11.3 10.5 11.8 11.1 17.6 13.7 12.7 17.6 17.8 9.4 12.9 26.2 13.3 4.0 12.9 25.6 14.2 8.3 21.7 14.0 21.7 33.2 24.4 39.8 25.3 22.9 35.6 26.4 8.1 12.3 5.9 9.2 11.9 8.6 11.5 7.5 13.9 10.0 12.0 10.4 7.2 14.6 14.5 7.5 13.5 10.4 13.6 10.5 7.4 10.6 9.4 8.3 13.6 12.2 16.4 16.8 14.4 10.6 11.6 9.9 14.8 11.3 9.5 9.9 6.2 20.1 9.6 24.8 11.6 20.6 8.1 15.2 17.7 10.6 12.2 22.5 10.2 10.6 7.7 6.8 11.6 17.8 16.4 7.4 4.4 16.0 6.7 9.9 3.3 13.5 14.8 22.7 17.3 13.8 9.1 22.5 6.3 29.1 23.0 39.8 30.4 22.4 30.9 31.5 32.8 32.4 24.4 33.2 34.8 30.9 10.3 22.9 25.3 20.1 35.6 26.4 12.3 14.9 18.6 15.5 12.2 14.4 12.8 11.4 11.3 12.9 8.9 17.9 28.8 13.9 21.6 10.1 7.3 12.7 13.4 14.8 14.0 13.7 15.5 8.3 14.7 0.3 15.7 12.3 0.0 14.5 27.8 14.4 9.7 24.4 12.1 21.6 12.7 4.1 14.7 16.8 0.4 11.2 20.8 25.3 8.2 13.3 12.9 15.4 14.4 9.2 17.3 12.0 6.5 20.3 2.2 5.4 21.3 22.1 50.8 13.9 13.1 RNF20 "BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779" ENSG00000155827 "Ring finger protein 20" Q5VTR2 9 101533851-101563344 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012478, HPA051773" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB012478: , HPA051773: AB_2681604" "unprognostic (7.02e-2)" "unprognostic (2.21e-1)" "unprognostic (9.04e-2)" "unprognostic (2.03e-1)" "unprognostic (3.12e-2)" "unprognostic (1.68e-1)" "unprognostic (1.41e-2)" "unprognostic (2.90e-1)" "unprognostic (2.01e-1)" "unprognostic (5.47e-2)" "unprognostic (7.27e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.64e-6)" "unprognostic (2.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.32e-1)" "unprognostic (9.54e-3)" 16.4 17.1 24.6 17.0 24.9 12.1 17.7 24.4 26.3 18.6 16.4 27.7 15.9 10.1 18.3 18.7 20.4 19.1 13.2 24.1 22.3 22.1 20.5 14.4 14.9 15.5 25.2 20.7 21.1 19.5 31.5 23.1 15.1 30.0 21.6 16.1 16.8 16.2 17.7 32.0 16.3 12.5 23.6 28.8 17.0 13.9 28.2 25.8 21.2 22.0 15.3 18.6 21.1 19.0 13.0 12.5 21.0 23.5 13.8 18.6 10.4 9.7 24.8 14.3 15.7 17.7 14.0 12.2 17.0 13.7 17.1 15.0 15.0 10.4 21.6 9.2 13.1 14.3 24.8 16.6 14.5 17.6 22.5 7.7 11.5 22.7 15.0 13.0 19.8 13.9 13.7 15.6 15.1 19.6 12.9 10.0 8.0 10.9 12.8 18.5 12.7 15.4 5.3 31.6 22.0 12.6 14.9 49.6 10.7 7.0 9.4 15.3 19.3 24.1 12.9 14.0 15.0 11.6 9.4 14.1 15.9 16.0 11.3 14.3 13.9 42.7 11.8 14.0 7.5 19.2 21.0 12.7 19.1 18.6 17.5 14.0 13.0 15.4 13.9 12.5 11.2 16.2 14.9 13.9 13.8 23.5 7.9 11.9 10.4 24.6 24.9 24.4 26.3 22.3 22.1 25.2 20.7 30.0 25.8 23.8 24.5 7.5 8.1 5.7 29.1 42.4 10.2 33.5 26.1 21.0 5.9 13.6 5.0 14.3 26.2 11.3 12.2 0.0 12.1 9.6 11.5 7.2 20.9 16.8 14.4 41.3 23.6 7.4 23.8 15.2 16.7 20.0 10.1 27.9 10.7 27.6 10.2 15.3 22.3 9.1 23.0 32.3 14.4 24.7 15.8 5.1 6.4 16.0 12.0 5.4 RNF208 DKFZP761H1710 ENSG00000212864 "Ring finger protein 208" Q9H0X6 9 137220247-137221581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 21.6;Horizontal cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 12.4;MCF7: 29.7;REH: 23.9;RPMI-8226: 13.2;T-47d: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021256, HPA021429" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021256: AB_1844331, HPA021429: AB_2180654" "unprognostic (2.97e-1)" "unprognostic (7.37e-2)" "unprognostic (1.46e-2)" "unprognostic (6.33e-3)" "unprognostic (9.99e-2)" "unprognostic (2.10e-3)" "unprognostic (3.52e-3)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.95e-2)" "unprognostic (8.42e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.12e-8)" "unprognostic (3.41e-1)" "unprognostic (1.69e-1)" "unprognostic (7.66e-2)" "unprognostic (3.40e-2)" 3.7 7.1 17.3 1.2 13.3 0.7 4.3 10.1 27.4 1.9 1.7 1.5 1.2 2.0 1.7 2.7 4.6 3.4 1.2 6.2 18.1 10.8 3.7 8.1 1.8 3.4 9.4 4.6 1.5 8.8 5.7 3.0 1.2 3.5 4.0 0.6 1.8 11.4 5.5 13.2 6.6 2.4 1.2 3.3 1.8 3.4 3.1 2.1 1.2 2.1 3.2 1.2 2.1 1.3 0.6 0.0 0.8 0.7 0.0 1.2 0.8 0.8 1.5 1.1 1.8 0.7 0.1 3.2 0.4 0.6 0.7 0.7 4.5 2.8 0.4 2.3 0.5 0.1 2.3 2.5 0.1 0.1 1.1 0.9 3.1 5.2 12.4 2.4 0.6 1.1 0.5 0.8 0.7 0.3 2.8 0.7 4.6 4.4 0.2 0.3 29.7 1.6 1.4 1.3 2.9 3.3 23.9 0.2 13.2 0.8 0.1 3.0 10.6 0.3 0.9 0.6 0.6 10.7 2.3 0.3 0.5 0.7 1.1 0.0 0.4 0.4 0.1 1.4 0.2 0.6 0.0 0.4 0.2 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.8 17.3 13.3 10.1 27.4 18.1 10.8 9.4 4.6 3.5 2.1 6.0 2.1 1.5 1.1 0.3 8.2 8.2 5.1 4.0 0.0 7.0 11.8 0.2 21.6 3.9 0.5 1.4 4.0 0.0 1.9 0.2 0.9 1.6 0.0 6.8 1.1 15.9 7.5 1.3 0.3 0.5 1.1 0.0 1.7 1.8 3.9 5.5 3.5 4.2 3.2 8.8 3.2 0.0 0.9 1.7 2.2 1.6 0.2 0.8 3.3 0.7 RNF220 "C1orf164, FLJ10597" ENSG00000187147 "Ring finger protein 220" Q5VTB9 1 44405194-44651724 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 37.2" "Low region specificity" "Detected in all" "HPA027577, HPA027578" Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA027577: AB_2672339, HPA027578: AB_10601482" "unprognostic (3.12e-2)" "unprognostic (1.24e-1)" "unprognostic (3.49e-2)" "unprognostic (2.56e-1)" "unprognostic (2.94e-2)" "unprognostic (6.96e-3)" "prognostic unfavorable (2.35e-6)" "unprognostic (1.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.13e-1)" "unprognostic (2.14e-3)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.51e-2)" "unprognostic (1.98e-1)" "unprognostic (1.37e-3)" "unprognostic (6.46e-2)" 9.8 7.4 20.9 9.6 38.5 12.7 6.7 12.6 40.1 5.4 9.2 40.7 2.7 10.7 8.0 8.8 6.0 9.3 4.5 9.2 33.4 20.9 7.4 5.1 7.4 7.6 49.8 19.8 9.5 8.1 7.0 5.7 8.7 25.8 7.7 5.9 4.2 9.3 7.1 28.4 8.7 8.8 8.0 57.4 7.9 7.6 7.0 49.6 5.0 7.3 4.6 8.0 7.9 5.6 3.6 6.6 2.8 2.3 1.9 4.3 1.4 6.1 2.9 12.6 4.2 4.9 4.5 9.4 7.2 6.7 5.6 8.3 5.0 6.1 11.9 6.4 5.8 8.0 4.0 14.0 5.9 7.6 14.7 12.5 16.3 9.1 8.4 7.9 11.5 8.4 4.9 13.6 6.2 10.0 4.6 3.2 6.3 12.0 5.9 3.5 4.2 11.3 8.7 13.7 6.7 6.6 9.6 7.4 8.5 3.6 3.8 5.7 7.0 6.1 4.3 8.7 4.6 3.2 20.4 4.9 6.0 6.4 5.6 13.3 13.5 12.9 8.5 4.9 37.2 3.5 2.4 2.3 2.8 3.2 1.8 2.4 2.4 1.0 4.3 3.4 3.6 1.9 1.7 1.5 1.9 1.3 6.6 3.2 1.4 20.9 38.5 12.6 30.8 33.4 20.9 49.8 19.8 25.8 49.6 8.9 12.0 15.9 12.3 13.5 23.6 19.4 25.5 4.0 9.1 22.7 23.6 15.6 14.9 16.5 7.9 16.1 22.2 46.7 24.8 20.6 12.8 18.6 10.4 25.9 22.1 22.3 17.3 15.4 25.1 11.8 17.8 12.8 11.8 15.4 22.6 13.2 19.6 20.1 13.1 27.9 17.0 6.5 9.9 27.4 27.9 15.3 8.5 20.0 25.2 12.7 RNF38 ENSG00000137075 "Ring finger protein 38" Q9H0F5 9 36336396-36487548 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 20 "Early spermatids: 442.1;Late spermatids: 1049.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015853 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA015853: AB_1856365" "unprognostic (2.26e-1)" "unprognostic (2.49e-1)" "unprognostic (1.53e-1)" "unprognostic (8.16e-2)" "unprognostic (6.49e-2)" "unprognostic (3.65e-3)" "unprognostic (3.30e-3)" "unprognostic (1.64e-2)" "unprognostic (1.58e-1)" "unprognostic (9.69e-2)" "unprognostic (2.29e-1)" "unprognostic (4.15e-2)" "prognostic favorable (2.90e-6)" "unprognostic (3.88e-2)" "unprognostic (5.94e-2)" "unprognostic (1.46e-1)" "unprognostic (5.39e-2)" 11.9 8.0 13.1 7.7 14.5 20.3 11.1 18.8 17.0 13.6 14.1 12.2 8.1 6.4 16.3 12.9 10.1 11.7 9.6 9.5 10.0 11.1 12.3 6.8 11.7 14.5 9.2 12.3 24.4 12.8 12.2 5.7 21.2 14.0 15.3 10.1 14.4 10.3 12.8 9.6 8.9 10.2 16.9 8.5 11.4 8.7 46.3 10.0 13.1 14.4 4.3 11.1 16.5 13.5 6.2 4.1 12.2 4.3 8.4 8.7 4.2 9.0 5.2 20.0 11.8 9.2 8.5 19.6 5.7 7.1 7.0 9.2 8.7 5.0 13.7 6.0 10.9 9.2 3.6 12.7 6.6 10.8 12.1 5.4 16.5 7.3 8.5 7.1 12.1 15.1 8.7 7.2 8.8 8.6 11.6 17.7 13.6 3.4 13.2 11.3 3.1 12.4 6.4 13.3 6.0 3.7 11.4 9.0 7.5 11.9 10.5 8.3 9.0 6.4 6.5 6.4 24.4 6.2 12.4 17.4 6.7 10.2 3.9 6.7 8.7 18.1 9.7 6.1 10.2 8.5 12.2 4.3 7.2 7.2 4.1 6.0 5.8 6.5 7.6 4.1 6.2 7.0 7.0 8.0 8.4 4.1 3.3 8.7 4.2 13.1 14.5 18.8 17.0 10.0 11.1 9.2 12.3 14.0 10.0 11.9 13.2 7.3 9.1 15.3 13.4 14.1 12.7 2.7 11.4 7.0 17.7 11.6 8.3 9.5 442.1 22.6 12.5 0.0 10.2 9.9 11.0 16.6 5.8 15.7 9.9 25.4 16.1 22.7 20.0 1049.3 30.5 14.5 18.6 6.4 14.6 14.1 11.6 2.9 37.4 13.4 22.6 12.9 15.8 31.6 18.9 13.0 12.5 17.3 10.5 14.0 RNF40 "BRE1B, KIAA0661, RBP95, STARING" ENSG00000103549 "Ring finger protein 40" O75150 16 30761745-30776307 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041330, HPA054227" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA041330: AB_10793872, HPA054227: AB_2682422" "unprognostic (1.61e-1)" "unprognostic (1.74e-2)" "unprognostic (3.06e-1)" "unprognostic (4.87e-2)" "unprognostic (1.21e-1)" "unprognostic (4.01e-1)" "unprognostic (5.97e-3)" "unprognostic (1.56e-1)" "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.16e-2)" "unprognostic (1.91e-2)" "prognostic favorable (8.11e-8)" "unprognostic (9.96e-2)" "unprognostic (1.36e-1)" "unprognostic (6.55e-3)" "unprognostic (6.60e-3)" 21.0 25.2 26.4 21.3 26.5 40.8 20.9 36.8 28.2 25.8 21.0 22.0 18.0 20.1 28.4 17.0 25.6 24.4 21.3 22.8 22.2 17.1 20.0 21.2 20.2 21.9 20.9 18.9 30.5 24.4 44.0 21.6 25.3 19.6 21.4 15.1 20.0 27.3 21.1 20.0 25.5 20.3 18.3 18.6 20.0 19.6 43.1 22.8 23.5 26.8 15.4 20.6 22.5 21.4 7.6 12.0 15.0 14.9 9.9 13.3 12.9 20.3 31.9 19.4 18.4 14.8 15.5 21.2 20.8 16.1 24.1 18.8 25.8 19.0 16.2 30.6 17.8 16.5 22.1 35.3 18.5 18.9 23.2 41.4 15.9 35.0 26.7 19.8 27.4 18.6 14.4 15.5 30.2 17.1 16.1 20.2 14.4 34.8 15.5 14.6 34.0 26.1 25.8 20.2 16.3 19.3 51.9 21.4 31.2 10.6 18.1 32.4 23.8 16.3 20.9 15.1 10.7 32.0 31.2 21.8 27.1 13.8 19.1 23.7 23.2 28.5 32.2 22.5 24.4 27.6 6.2 11.5 14.7 12.9 13.4 13.3 7.6 7.2 9.9 12.0 6.5 5.4 8.3 15.0 9.9 14.9 6.2 6.2 12.9 26.4 26.5 36.8 28.2 22.2 17.1 20.9 18.9 19.6 22.8 11.9 26.4 10.4 10.9 12.4 14.5 2.0 30.6 9.4 11.4 21.0 3.9 13.3 74.6 12.9 18.8 10.9 22.6 0.0 11.6 13.8 11.8 14.0 4.6 18.7 18.7 4.8 13.4 9.8 24.6 16.8 16.7 13.0 16.9 9.0 20.9 16.6 13.6 14.0 16.6 19.9 13.3 12.9 11.2 19.7 9.4 17.2 19.0 13.6 23.6 10.0 RNF44 KIAA1100 ENSG00000146083 "Ring finger protein 44" Q7L0R7 5 176526697-176538025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 100.6;Late spermatids: 305.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038981 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA038981: AB_10674846" "unprognostic (1.85e-1)" "unprognostic (3.07e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.57e-7)" "unprognostic (1.50e-1)" "unprognostic (2.56e-2)" "prognostic unfavorable (8.45e-4)" "unprognostic (1.61e-1)" "unprognostic (4.54e-2)" "unprognostic (5.36e-2)" "unprognostic (5.78e-2)" "unprognostic (1.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-3)" "unprognostic (1.62e-1)" "unprognostic (5.12e-3)" "unprognostic (1.15e-2)" 10.8 12.7 16.5 27.1 17.7 38.5 12.4 27.1 21.6 10.3 14.8 14.3 7.3 20.5 12.6 10.0 17.0 12.1 12.4 10.0 15.7 10.9 15.2 9.3 14.1 34.9 14.6 13.7 17.8 16.0 10.3 11.0 20.6 13.4 12.8 13.5 11.1 15.9 10.8 10.2 20.5 22.2 8.6 14.5 38.1 16.4 14.5 16.1 43.3 17.3 7.5 24.1 14.1 13.3 4.1 1.9 9.4 3.1 3.3 5.5 2.6 3.7 8.6 13.8 12.8 2.7 2.3 37.0 2.2 1.9 1.4 1.9 13.0 8.3 7.2 13.6 1.2 6.7 10.2 6.1 13.1 1.7 27.7 10.8 7.6 7.3 12.0 3.5 8.8 10.6 4.4 10.6 1.6 5.0 4.8 4.0 14.0 8.5 10.8 2.0 13.0 20.5 19.9 18.2 4.9 10.6 8.4 3.6 10.3 5.0 8.8 17.0 20.7 3.3 9.1 12.5 9.5 10.0 17.8 6.6 3.7 5.6 3.0 4.0 13.8 10.3 9.8 1.8 18.3 4.8 0.0 2.7 4.7 5.5 3.1 4.1 3.5 4.2 4.6 1.8 4.1 4.2 5.0 9.4 3.3 2.5 1.9 5.0 2.6 16.5 17.7 27.1 21.6 15.7 10.9 14.6 13.7 13.4 16.1 11.9 29.4 27.6 8.3 35.7 14.8 11.0 17.8 8.1 15.9 12.2 9.8 8.2 6.6 10.2 100.6 18.0 25.7 0.0 13.9 10.1 10.4 14.5 15.1 8.7 13.1 27.0 39.1 15.4 41.2 305.8 18.4 19.0 5.0 7.2 38.5 8.8 18.6 20.1 11.7 8.4 7.7 6.5 7.2 3.4 10.0 43.3 10.1 35.5 34.0 12.3 RNGTT "hCAP, HCE, HCE1" ENSG00000111880 "RNA guanylyltransferase and 5'-phosphatase" O60942 6 88610272-88963721 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA capping, mRNA processing" "Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003750 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003750: AB_1856383" "unprognostic (5.19e-3)" "unprognostic (1.00e-1)" "unprognostic (2.82e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (4.48e-3)" "unprognostic (1.28e-1)" "unprognostic (4.05e-3)" "unprognostic (3.76e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-3)" "unprognostic (9.83e-2)" "unprognostic (6.55e-2)" "unprognostic (1.67e-1)" "unprognostic (8.08e-3)" 9.1 12.1 10.2 19.6 12.2 14.2 9.9 18.5 13.1 10.0 8.1 8.7 7.0 7.4 11.1 7.2 12.5 8.7 7.2 9.6 10.5 16.0 9.4 11.8 9.4 26.3 9.8 6.4 10.4 6.6 12.1 23.1 11.6 11.1 9.8 9.8 9.4 8.4 11.6 10.5 9.0 10.7 10.7 10.7 14.3 7.5 15.0 10.4 28.0 10.0 7.8 28.2 10.9 13.8 18.6 4.4 5.7 4.6 8.0 8.4 4.3 5.7 8.8 13.7 17.5 8.1 8.5 8.2 13.2 8.6 10.7 13.6 10.0 4.4 14.9 10.8 9.4 14.2 7.2 16.0 10.6 19.7 20.2 12.5 19.3 7.9 8.0 6.6 20.7 11.0 5.4 9.3 11.1 10.8 9.2 9.4 8.2 19.1 12.0 15.8 7.6 9.1 14.8 8.2 9.5 7.7 18.0 21.2 8.4 9.6 8.9 8.1 11.6 10.9 6.6 7.2 13.6 7.1 20.8 7.5 8.7 8.0 9.8 17.7 10.9 19.0 8.4 12.8 15.5 15.8 3.5 3.0 5.7 6.4 4.6 6.4 18.6 7.2 7.9 4.4 16.8 8.2 8.4 2.5 8.0 3.9 3.1 6.7 4.3 10.2 12.2 18.5 13.1 10.5 16.0 9.8 6.4 11.1 10.4 0.0 18.1 34.7 7.8 7.3 19.8 9.2 2.5 13.4 18.2 12.2 37.3 8.7 0.0 5.7 4.9 4.7 5.9 0.0 4.3 8.0 7.1 6.8 8.1 8.6 6.7 14.3 8.7 6.2 7.5 3.6 5.5 9.8 3.3 6.4 5.7 8.7 5.6 3.5 7.4 5.8 43.3 6.5 7.5 19.9 21.7 7.5 9.8 13.8 6.3 5.8 RNPC3 "FLJ20008, KIAA1839, RBM40, SNRNP65" ENSG00000185946 "RNA binding region (RNP1, RRM) containing 3" Q96LT9 1 103525691-103555239 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 95.4;Cone photoreceptor cells: 125.7;Rod photoreceptor cells: 145.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052434 Supported Nucleoplasm NA NA Nucleoplasm "HPA052434: AB_2681832" "unprognostic (1.87e-2)" "unprognostic (9.61e-2)" "unprognostic (1.04e-1)" "unprognostic (4.31e-3)" "unprognostic (2.92e-2)" "unprognostic (1.34e-5)" "unprognostic (9.00e-2)" "prognostic favorable (1.53e-4)" "unprognostic (1.94e-2)" "unprognostic (7.61e-2)" "prognostic favorable (7.82e-4)" "prognostic unfavorable (7.70e-4)" "unprognostic (3.65e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-1)" "unprognostic (3.19e-1)" "prognostic favorable (5.25e-4)" 19.8 18.5 42.1 16.7 52.4 15.3 20.7 53.4 41.2 22.3 17.8 19.1 22.2 16.4 24.2 40.7 11.9 25.8 15.4 20.1 33.5 12.7 19.4 10.9 17.0 22.4 25.6 28.6 27.2 29.6 25.1 42.5 9.0 24.4 17.5 16.3 17.2 26.9 18.2 28.9 26.6 19.3 13.8 24.5 20.3 16.1 11.0 33.0 15.5 37.9 14.0 18.3 18.7 18.4 33.6 26.3 61.3 23.1 9.3 19.2 3.2 7.0 5.7 12.3 6.1 7.6 13.5 8.2 9.8 6.5 7.9 11.8 6.1 12.0 13.4 15.7 4.8 4.7 14.3 7.5 7.7 9.3 8.7 14.2 14.0 29.9 6.1 5.4 18.5 12.1 12.4 11.8 6.7 4.7 11.6 7.2 11.7 8.7 15.6 9.0 3.9 10.5 9.4 8.0 6.8 8.7 14.6 11.4 10.5 10.4 7.6 13.1 6.4 6.6 9.2 9.8 7.1 6.2 8.6 9.6 8.6 8.5 4.6 6.3 11.7 3.9 11.8 15.1 14.4 4.3 42.7 23.1 15.3 13.5 10.7 9.8 24.6 16.1 12.2 6.7 33.6 19.2 17.5 61.3 9.3 12.1 26.3 10.7 3.2 42.1 52.4 53.4 41.2 33.5 12.7 25.6 28.6 24.4 33.0 26.8 37.9 11.5 17.0 6.6 95.4 16.9 12.7 62.9 43.3 26.2 125.7 6.4 13.3 8.2 22.1 16.6 19.7 0.0 9.0 3.6 9.1 9.5 19.7 8.6 6.7 58.8 16.3 14.1 21.9 3.6 23.0 16.8 15.1 15.4 16.3 53.0 9.0 12.5 20.1 4.3 145.9 25.8 11.2 18.2 8.1 7.9 9.2 17.5 12.1 11.7 RNPS1 ENSG00000205937 "RNA binding protein with serine rich domain 1" Q15287 16 2253116-2268412 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044014 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA044014: AB_10966286" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (3.46e-1)" "unprognostic (1.49e-3)" "unprognostic (2.92e-1)" "unprognostic (1.47e-1)" "unprognostic (1.18e-3)" "unprognostic (1.96e-1)" "unprognostic (2.76e-1)" "unprognostic (1.15e-1)" "unprognostic (2.30e-1)" "unprognostic (2.93e-2)" "unprognostic (1.04e-1)" "unprognostic (7.13e-3)" "unprognostic (2.38e-1)" "unprognostic (4.64e-2)" "unprognostic (2.27e-1)" 15.5 17.7 25.2 17.4 22.9 42.6 17.1 36.0 34.1 16.4 19.2 19.2 11.5 16.2 20.7 17.0 22.1 21.4 18.3 20.0 23.1 26.7 15.5 18.5 14.8 23.7 20.7 27.4 22.2 17.1 18.3 20.9 26.8 21.7 18.6 14.4 16.7 15.7 20.0 50.9 23.0 15.6 17.8 16.2 19.5 16.6 73.5 13.7 19.5 17.6 29.9 22.8 17.2 15.9 52.4 40.0 30.2 44.3 43.9 48.7 62.1 18.3 28.3 28.2 32.0 16.2 15.4 34.7 20.0 17.2 34.5 30.0 55.0 26.7 37.1 22.9 19.0 19.2 28.5 38.2 27.4 23.1 29.1 50.0 24.5 23.4 35.8 27.6 26.4 29.3 18.5 31.4 27.5 37.5 14.4 26.2 25.2 48.2 38.4 27.0 46.7 64.7 61.7 63.9 22.8 22.8 82.0 28.9 58.8 22.3 12.9 66.6 38.4 25.4 30.6 29.2 14.2 31.0 33.3 16.9 29.8 28.3 26.3 30.9 35.0 47.7 92.6 12.7 29.2 34.9 10.0 37.1 30.2 46.7 42.9 46.1 48.1 45.5 47.6 40.0 52.4 43.5 45.9 11.4 43.9 44.3 33.9 48.7 62.1 25.2 22.9 36.0 34.1 23.1 26.7 20.7 27.4 21.7 13.7 41.7 60.8 131.7 157.1 183.5 110.7 32.3 50.9 40.2 63.7 48.8 131.6 149.8 59.7 107.8 13.7 82.0 69.1 46.7 81.2 199.4 93.8 114.0 102.6 30.8 92.9 92.2 117.0 57.1 53.6 19.1 87.2 74.7 92.8 124.4 85.6 85.3 94.1 70.2 64.7 48.4 116.7 84.1 124.8 116.4 243.4 185.7 135.5 138.5 109.0 172.1 RORB "NR1F2, ROR-BETA, RZRB" ENSG00000198963 "RAR related orphan receptor B" Q92753 9 74497365-74693177 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding, Receptor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.5;cervix, uterine: 20.8" "Group enriched" "Detected in many" 5 "Horizontal cells: 1322.1;Muller glia cells: 409.4" "Group enriched" "Detected in some" 5 "glioma: 2.1;prostate cancer: 2.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HHSteC: 18.3;HSkMC: 10.1;JURKAT: 18.1;MOLT-4: 5.1;SH-SY5Y: 10.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008393 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008393: AB_1079830" "unprognostic (6.89e-3)" "unprognostic (4.06e-3)" "unprognostic (1.38e-1)" "unprognostic (3.97e-1)" "unprognostic (1.34e-1)" "unprognostic (1.05e-3)" "unprognostic (1.28e-1)" "unprognostic (1.18e-2)" "unprognostic (1.07e-1)" "unprognostic (3.07e-1)" "unprognostic (3.52e-1)" "unprognostic (5.46e-2)" "unprognostic (8.81e-8)" "unprognostic (5.97e-3)" "unprognostic (2.17e-2)" "unprognostic (2.26e-2)" "unprognostic (4.00e-2)" 3.1 7.9 8.3 1.2 11.1 1.0 1.4 1.8 35.5 20.8 1.3 2.1 2.2 1.1 8.9 0.9 1.7 1.5 4.5 3.9 5.6 7.0 2.0 1.0 2.0 0.9 4.1 18.7 1.4 1.1 1.1 4.0 10.6 6.1 10.5 1.6 18.7 1.2 11.7 0.9 1.3 1.1 1.7 6.7 1.0 1.6 2.0 3.7 2.2 1.5 0.0 1.5 2.3 2.2 0.2 0.2 1.8 0.2 0.6 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 18.3 0.0 0.5 10.1 0.0 0.0 0.0 0.0 0.0 18.1 0.0 2.8 0.0 0.1 5.1 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.4 2.5 0.0 1.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.6 1.8 0.6 0.1 0.2 0.0 0.0 8.3 11.1 1.8 35.5 5.6 7.0 4.1 18.7 6.1 3.7 0.0 3.7 0.0 0.6 1.4 160.1 11.7 0.0 1.4 0.0 0.0 113.9 0.0 0.0 0.0 5.3 0.6 0.0 0.0 0.0 0.4 5.4 2.3 1.1 0.0 0.6 1322.1 0.0 1.3 0.0 0.5 0.0 1.3 1.7 0.0 0.0 409.4 0.1 0.0 0.0 5.7 181.1 0.0 3.1 0.5 0.1 0.4 0.1 0.8 0.0 0.8 RPA1 "HSSB, REPA1, RF-A, RP-A, RPA70" ENSG00000132383 "Replication protein A1" P27694 17 1829702-1900082 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004563, HPA006914, HPA046497" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004563: AB_628224, HPA006914: AB_1856410, HPA046497: AB_2679675" "unprognostic (1.84e-1)" "unprognostic (1.47e-2)" "unprognostic (7.38e-2)" "unprognostic (1.01e-1)" "unprognostic (7.53e-2)" "unprognostic (6.58e-3)" "prognostic unfavorable (9.00e-9)" "unprognostic (9.59e-2)" "unprognostic (2.20e-1)" "unprognostic (2.69e-1)" "unprognostic (6.03e-3)" "unprognostic (1.75e-2)" "unprognostic (3.37e-2)" "unprognostic (2.19e-1)" "unprognostic (6.57e-2)" "unprognostic (2.62e-1)" "unprognostic (4.52e-2)" 19.8 18.9 17.5 22.2 18.6 15.7 19.6 21.0 19.2 20.1 21.2 17.0 26.7 15.9 23.7 20.1 23.8 23.2 20.6 27.6 15.0 15.6 13.3 15.2 19.2 27.6 19.6 19.8 28.8 17.8 18.8 15.7 15.2 15.0 20.2 16.5 20.9 22.9 23.3 46.1 23.6 18.6 21.7 15.0 18.7 17.0 13.9 17.5 36.7 21.1 24.4 33.1 23.6 19.1 24.6 14.5 23.9 19.7 34.2 27.1 25.2 27.7 28.6 26.0 23.9 13.1 13.3 29.1 22.9 14.3 30.5 31.9 40.4 12.9 39.2 21.6 14.5 11.9 25.9 32.2 19.6 34.4 25.6 37.9 23.7 35.4 16.8 8.7 17.4 21.1 10.8 12.9 30.0 13.2 10.8 22.0 25.3 22.4 22.6 21.3 16.0 37.5 11.2 19.9 19.7 16.7 52.2 13.9 21.3 13.5 19.3 11.2 17.5 32.5 11.5 20.2 19.6 23.4 13.7 17.0 20.7 18.1 24.0 34.6 6.3 16.4 22.6 14.8 27.5 25.8 16.7 11.3 23.9 25.9 16.2 26.3 24.6 27.1 25.7 13.8 15.4 26.8 24.3 5.5 34.2 19.7 14.5 25.0 25.2 17.5 18.6 21.0 19.2 15.0 15.6 19.6 19.8 15.0 17.5 8.9 14.3 22.9 13.7 26.3 17.6 18.2 28.1 18.7 11.4 38.4 3.9 55.5 5.0 16.5 15.8 20.1 15.1 46.7 17.4 61.3 22.4 11.7 33.4 20.3 39.8 35.0 15.0 26.4 37.7 27.5 30.0 18.4 27.0 41.5 20.4 34.7 13.6 3.5 32.5 8.5 17.6 0.0 22.7 13.1 21.4 25.5 36.4 25.5 18.1 8.5 RPA4 HSU24186 ENSG00000204086 "Replication protein A4" Q13156 X 96883908-96885467 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.2" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 6.5;Spermatocytes: 7.6;Syncytiotrophoblasts: 8.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 3.0;HL-60: 3.0" HPA066010 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA066010: AB_2685596" "unprognostic (6.23e-2)" "unprognostic (2.55e-2)" "unprognostic (1.17e-1)" "unprognostic (6.66e-6)" "unprognostic (1.33e-1)" "unprognostic (6.33e-2)" "unprognostic (9.75e-4)" "unprognostic (3.15e-1)" "unprognostic (7.61e-3)" "unprognostic (2.59e-3)" "unprognostic (1.55e-1)" "unprognostic (2.62e-1)" "unprognostic (2.47e-12)" "unprognostic (8.95e-3)" "unprognostic (6.05e-3)" "unprognostic (8.17e-2)" "unprognostic (4.59e-2)" 0.9 0.1 0.0 0.3 0.1 1.0 0.4 0.0 0.1 0.5 0.2 0.4 0.1 0.2 0.3 0.0 0.3 0.6 0.0 0.0 0.1 1.1 0.8 0.2 0.0 0.6 0.1 0.0 0.0 0.8 0.4 0.6 0.4 0.2 0.4 0.3 0.1 0.2 0.1 0.1 0.2 5.2 0.2 0.2 0.4 0.8 1.3 1.4 2.5 2.3 0.0 2.1 0.1 0.0 0.7 0.1 1.1 0.0 0.3 0.0 0.8 0.0 0.4 0.8 1.3 0.3 1.6 0.3 0.6 2.5 0.0 2.4 0.1 0.7 0.0 1.0 0.0 3.0 0.1 0.1 3.0 0.8 0.2 0.1 2.0 0.9 0.0 0.1 1.2 0.0 2.4 2.1 0.4 1.0 1.6 1.1 0.0 1.1 0.0 0.9 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.5 0.4 0.0 0.0 0.7 1.4 0.6 0.6 0.5 0.1 0.0 1.0 0.5 1.8 1.0 0.0 2.3 2.5 1.8 0.9 2.1 1.0 0.4 0.4 0.6 1.3 0.3 0.5 1.4 0.0 1.8 1.4 1.3 0.1 0.0 3.5 0.0 0.1 0.7 0.4 0.0 0.0 0.0 1.2 0.0 0.0 2.9 0.0 0.7 0.8 1.6 1.3 0.0 0.5 0.9 0.9 0.4 0.0 1.9 1.7 0.0 3.5 0.0 2.4 0.4 1.4 0.4 0.0 0.0 2.2 0.2 0.9 3.5 1.4 0.0 1.2 6.5 0.2 7.6 2.5 1.1 8.2 0.0 2.0 0.1 RPP25L "bA296L22.5, C9orf23, MGC29635" ENSG00000164967 "Ribonuclease P/MRP subunit p25 like" Q8N5L8 9 34610486-34612104 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052187, HPA059698" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA052187: AB_2681755, HPA059698: AB_2684106" "unprognostic (1.56e-1)" "unprognostic (1.43e-2)" "unprognostic (7.44e-2)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.78e-1)" "unprognostic (4.78e-2)" "unprognostic (2.56e-1)" "unprognostic (1.66e-1)" "unprognostic (2.53e-2)" "unprognostic (3.39e-2)" "unprognostic (2.44e-1)" "prognostic favorable (3.01e-9)" "unprognostic (4.63e-3)" "unprognostic (6.20e-2)" "unprognostic (3.40e-1)" "prognostic favorable (8.21e-4)" 7.4 10.1 11.1 7.9 13.8 4.9 9.3 8.6 14.0 8.2 18.0 7.2 14.0 15.4 9.9 11.4 13.3 11.8 10.9 19.9 9.8 8.8 11.1 19.9 9.3 10.1 10.1 9.1 11.7 20.4 6.3 7.6 11.0 7.5 14.4 8.2 6.4 15.7 9.5 56.0 9.7 18.4 9.3 7.1 11.4 8.6 10.9 6.1 14.4 14.8 21.9 11.3 11.0 10.4 40.7 30.1 41.5 35.4 32.5 41.7 24.8 18.8 24.6 10.0 9.8 10.3 9.5 10.0 8.1 8.5 13.5 15.5 10.8 12.8 14.6 12.7 4.9 6.3 12.7 15.1 20.4 4.8 29.5 20.3 8.7 18.3 15.8 22.0 8.9 13.3 16.9 19.7 11.2 26.2 11.7 14.1 20.4 13.9 15.7 10.3 20.2 18.6 33.7 9.2 19.3 22.4 16.5 10.6 14.6 14.5 9.9 6.7 3.9 14.9 16.8 9.5 5.2 15.3 15.8 6.4 4.2 12.4 10.2 6.7 7.6 13.3 16.6 12.9 18.7 20.3 41.5 35.4 33.3 25.6 28.8 31.6 34.9 30.2 26.9 30.1 40.7 35.5 33.5 32.9 32.5 33.6 24.5 41.7 24.8 11.1 13.8 8.6 14.0 9.8 8.8 10.1 9.1 7.5 6.1 0.0 13.7 24.8 44.7 9.8 7.9 31.3 28.1 13.4 13.6 19.2 2.0 52.4 84.6 22.9 2.2 12.0 59.6 46.7 17.3 31.1 14.9 29.7 10.3 68.6 28.4 0.0 32.3 26.4 34.1 4.5 20.8 12.1 11.8 25.2 40.0 19.0 18.3 51.8 14.5 51.9 9.3 6.5 17.4 49.2 25.4 12.9 35.0 22.7 46.6 41.5 RPP40 "bA428J1.3, RNASEP1" ENSG00000124787 "Ribonuclease P/MRP subunit p40" O75818 6 4994732-5004063 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035685, HPA035686" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA035685: AB_2674734, HPA035686: AB_10670153" "unprognostic (2.93e-2)" "unprognostic (3.22e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (6.10e-6)" "unprognostic (8.00e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (5.41e-4)" "unprognostic (1.20e-1)" "unprognostic (1.72e-2)" "unprognostic (6.44e-2)" "unprognostic (8.17e-2)" "unprognostic (9.57e-2)" "prognostic unfavorable (7.54e-8)" "unprognostic (1.54e-1)" "unprognostic (5.10e-1)" "unprognostic (4.08e-2)" "unprognostic (2.19e-1)" 6.9 16.8 10.8 7.2 10.7 6.7 11.1 3.5 11.9 6.0 5.5 4.2 6.3 4.6 6.1 6.6 11.9 5.5 4.7 5.5 10.0 8.8 5.6 10.8 3.9 10.1 9.9 5.8 6.2 7.8 5.2 8.6 5.6 9.1 5.3 5.3 1.5 4.0 6.7 7.7 9.8 3.6 7.5 5.3 6.8 4.3 10.5 8.0 6.1 5.6 13.0 8.3 9.1 6.9 7.8 12.3 0.0 11.1 7.9 8.4 5.0 6.4 10.8 3.4 9.7 6.4 8.1 10.9 6.4 3.2 12.3 9.8 14.7 5.0 14.0 28.3 6.6 16.9 6.9 7.0 9.9 11.2 5.3 14.2 8.8 7.0 19.9 7.5 11.3 5.0 6.3 8.5 12.2 12.2 2.7 12.0 12.9 13.9 2.8 8.9 18.4 5.7 19.5 5.7 7.7 17.6 12.2 6.5 25.6 6.2 7.0 12.3 3.6 6.0 5.8 6.4 9.5 10.5 9.4 5.7 16.2 10.9 10.9 14.5 5.0 21.1 11.0 3.0 19.0 8.3 0.0 6.9 0.0 3.4 11.1 5.0 7.8 5.9 4.1 12.3 6.5 8.1 7.2 0.0 7.9 3.5 5.9 8.4 5.0 10.8 10.7 3.5 11.9 10.0 8.8 9.9 5.8 9.1 8.0 0.0 0.6 4.5 7.0 11.0 0.2 3.6 0.0 5.3 4.5 1.8 0.0 11.1 10.0 8.1 5.5 7.0 0.4 0.0 8.1 10.7 6.0 3.1 0.0 5.8 9.9 0.0 2.9 6.7 2.1 2.1 5.2 3.4 8.5 1.8 3.1 1.3 3.9 2.3 4.6 11.7 0.2 0.0 7.2 11.4 26.8 12.9 8.0 1.9 6.8 7.0 RPRD1B "C20orf77, CREPT, dJ1057B20.2, DKFZp434P0735, FLJ44520, K-H, Kub5-Hera, NET60" ENSG00000101413 "Regulation of nuclear pre-mRNA domain containing 1B" Q9NQG5 20 38033546-38127780 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 113.9" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066290, HPA070590, HPA072645" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA066290: AB_2685650, HPA070590: , HPA072645: " "unprognostic (3.14e-2)" "unprognostic (3.30e-1)" "unprognostic (5.38e-2)" "unprognostic (1.18e-3)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (2.68e-2)" "unprognostic (4.84e-2)" "unprognostic (1.03e-1)" "unprognostic (3.20e-2)" "unprognostic (1.14e-1)" "unprognostic (5.25e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "unprognostic (5.77e-2)" "unprognostic (1.36e-2)" "unprognostic (3.47e-1)" 8.8 9.4 7.5 14.5 8.3 20.9 9.6 9.8 10.0 9.0 10.2 12.5 11.4 7.3 12.9 10.7 10.7 11.5 10.4 16.4 7.6 6.5 10.2 113.9 8.9 13.4 7.9 7.6 10.5 16.2 13.7 8.6 9.4 8.3 10.7 8.6 11.0 9.1 15.5 24.3 9.6 10.2 9.6 7.5 10.7 9.1 10.2 7.2 11.4 10.4 8.4 19.3 12.7 9.0 5.5 8.3 7.3 10.7 5.6 8.9 6.3 15.7 7.1 13.6 6.9 8.9 12.3 14.0 11.4 9.2 12.8 11.5 36.5 14.9 13.2 16.7 7.6 12.5 19.0 12.1 18.5 15.3 6.2 6.9 22.3 9.4 18.2 10.7 16.9 7.6 9.6 18.4 13.2 15.4 8.8 8.0 13.5 19.4 10.6 9.7 11.1 25.0 12.1 7.8 16.5 15.1 16.1 27.8 13.3 6.9 13.2 14.9 10.2 19.8 29.6 13.8 8.7 15.8 15.4 9.3 25.9 15.2 9.7 12.5 13.3 12.5 24.3 15.4 9.9 8.5 0.7 8.3 7.3 7.0 9.4 8.9 5.5 6.8 6.3 8.3 5.1 8.7 7.8 6.7 5.6 10.7 4.4 4.0 6.3 7.5 8.3 9.8 10.0 7.6 6.5 7.9 7.6 8.3 7.2 14.9 21.6 13.0 10.6 14.1 16.1 40.8 20.4 20.1 10.3 17.4 17.7 12.4 13.3 6.5 6.3 13.4 11.7 0.0 7.4 10.0 12.1 16.6 12.7 67.0 10.7 17.5 22.5 28.3 18.8 7.9 9.8 10.9 10.1 3.6 20.1 11.4 7.9 10.5 12.4 14.1 16.2 6.5 8.2 12.6 12.0 16.3 13.0 12.8 13.4 13.6 RPS19 "DBA, S19" ENSG00000105372 "Ribosomal protein S19" P39019 19 41859918-41872926 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 546.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063217 Supported Nucleoplasm NA NA 52000 Nucleoplasm "HPA063217: AB_2732699" "unprognostic (8.02e-3)" "unprognostic (9.04e-2)" "unprognostic (5.93e-2)" "unprognostic (1.14e-1)" "unprognostic (7.32e-3)" "unprognostic (1.32e-1)" "unprognostic (2.69e-2)" "unprognostic (9.14e-2)" "unprognostic (1.06e-1)" "unprognostic (6.68e-2)" "unprognostic (5.78e-2)" "unprognostic (9.96e-2)" "prognostic unfavorable (2.32e-8)" "unprognostic (1.16e-1)" "unprognostic (7.55e-2)" "unprognostic (1.58e-1)" "unprognostic (1.72e-2)" 63.2 51.5 41.6 67.3 38.6 116.3 98.2 20.5 36.2 62.3 86.8 29.7 48.4 64.8 89.9 47.7 134.3 75.2 66.9 43.2 31.9 26.5 52.0 110.8 53.6 104.9 48.4 38.1 139.4 121.2 11.7 38.5 69.8 38.4 88.3 53.3 28.9 117.8 41.3 64.7 110.0 62.7 44.9 35.7 110.4 61.4 79.0 36.3 103.3 81.6 95.2 94.4 70.0 138.8 420.3 255.5 23.6 255.6 250.5 376.5 546.5 138.8 201.1 128.9 114.0 168.1 222.6 143.0 108.3 129.4 139.3 124.7 155.6 95.5 205.5 123.1 97.0 67.2 74.0 110.8 184.6 64.9 84.4 204.3 101.3 62.7 159.3 289.1 168.3 105.1 315.1 377.6 83.6 163.2 228.5 139.0 197.4 112.1 143.9 113.3 160.0 154.8 118.8 148.9 395.4 83.6 172.6 103.4 98.8 127.4 150.0 91.9 113.2 59.7 203.9 150.6 203.0 115.1 275.2 107.6 89.8 142.1 59.8 170.2 162.0 169.4 191.3 98.2 145.9 101.9 23.6 116.2 12.4 221.3 206.9 333.3 403.7 329.8 286.1 186.0 420.3 376.5 337.2 17.0 250.5 255.6 255.5 248.1 546.5 41.6 38.6 20.5 36.2 31.9 26.5 48.4 38.1 38.4 36.3 1527.6 2084.4 8605.5 7900.9 11848.7 270.9 645.2 2677.7 1311.6 2599.0 1357.4 119.8 5889.1 2238.2 3795.7 354.1 3914.2 2329.1 1845.5 7458.5 8187.3 3822.9 5482.6 1732.0 2563.4 4139.5 128.7 2143.3 3174.7 4844.3 1450.2 3737.8 5327.2 4322.3 6508.7 4064.5 386.9 6711.2 3300.0 1779.1 2720.9 355.9 1558.7 4061.9 516.1 1479.2 14818.6 5464.6 5600.3 7205.6 6831.8 RPS6KA2 "HU-2, RSK, RSK3" ENSG00000071242 "Ribosomal protein S6 kinase A2" Q15349 6 166409364-166906451 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Horizontal cells: 271.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "eosinophil: 17.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 17.5" "Cell line enhanced" "Detected in many" "ASC diff: 48.4;ASC TERT1: 35.5;HHSteC: 35.9;HSkMC: 31.9;hTERT-HME1: 38.6;hTERT-RPE1: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026243, HPA045061, HPA054237, CAB069428" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425" "unprognostic (8.71e-2)" "unprognostic (3.14e-3)" "unprognostic (7.29e-2)" "unprognostic (1.72e-1)" "unprognostic (3.80e-1)" "unprognostic (2.45e-1)" "unprognostic (6.44e-3)" "unprognostic (8.63e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (8.63e-5)" "unprognostic (8.68e-2)" "unprognostic (4.11e-2)" "prognostic favorable (2.86e-5)" "unprognostic (3.12e-3)" "unprognostic (1.51e-1)" "unprognostic (1.56e-2)" "unprognostic (2.01e-1)" 15.4 6.5 26.8 5.3 35.5 6.9 12.7 12.1 21.5 13.5 7.1 20.3 11.5 4.3 18.3 5.2 14.0 11.9 12.5 40.9 25.0 18.3 9.9 3.3 24.6 10.6 22.4 18.4 20.9 30.2 32.6 18.0 12.1 22.7 10.6 7.4 11.1 9.0 10.5 14.4 7.5 7.2 15.8 37.2 16.5 10.4 5.1 25.7 0.8 24.8 3.5 4.9 15.5 10.2 0.4 3.9 17.5 1.6 3.3 0.6 0.2 1.9 0.0 3.9 5.7 48.4 35.5 0.0 4.1 8.1 2.3 3.2 0.0 1.2 0.2 1.3 14.6 1.8 1.7 2.0 9.0 2.1 0.8 0.5 0.0 8.5 0.1 35.9 0.1 1.6 31.9 6.5 12.5 38.6 70.4 12.6 4.1 0.0 0.0 9.5 0.4 0.1 0.4 1.0 1.9 2.3 0.6 2.0 5.7 2.4 2.1 2.1 15.2 1.4 3.9 5.3 1.0 0.1 3.0 4.6 8.3 0.8 22.8 1.2 1.1 1.7 0.5 5.5 0.2 7.8 0.1 0.5 17.5 0.5 0.7 0.2 0.3 0.5 0.2 0.7 0.4 0.6 0.3 0.4 3.3 1.6 3.9 0.4 0.2 26.8 35.5 12.1 21.5 25.0 18.3 22.4 18.4 22.7 25.7 20.8 34.5 0.0 4.1 4.1 34.9 54.9 22.9 2.7 13.6 34.9 7.9 0.1 10.0 12.8 12.0 47.2 0.5 0.0 20.9 0.2 8.0 9.4 2.3 11.6 7.2 271.7 5.2 38.6 5.0 48.4 4.9 4.7 18.6 3.6 5.5 8.3 22.7 1.4 4.2 4.4 15.4 12.9 6.9 3.2 1.1 3.0 0.2 1.3 1.2 5.8 RPS6KA5 "MSK1, RLPK" ENSG00000100784 "Ribosomal protein S6 kinase A5" O75582 14 90847862-91060636 "Enzymes, Predicted intracellular proteins" "Inflammatory response, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "granulocytes: 86.9;Syncytiotrophoblasts: 93.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 30.1;SK-BR-3: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001274, HPA001780, CAB025458" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB025458: , HPA001274: AB_1079417, HPA001780: AB_2666432" "unprognostic (3.05e-2)" "unprognostic (2.19e-3)" "unprognostic (4.27e-4)" "unprognostic (1.98e-3)" "unprognostic (4.79e-2)" "unprognostic (4.20e-4)" "unprognostic (3.70e-2)" "unprognostic (5.80e-4)" "unprognostic (6.70e-2)" "unprognostic (8.39e-2)" "unprognostic (1.84e-1)" "unprognostic (1.97e-1)" "unprognostic (1.38e-4)" "unprognostic (5.73e-3)" "unprognostic (1.07e-1)" "unprognostic (2.42e-1)" "unprognostic (1.75e-1)" 4.9 2.4 8.3 13.0 21.6 5.8 16.3 32.9 12.2 7.0 11.0 12.0 4.2 9.3 11.8 2.6 11.9 8.9 6.7 6.1 9.0 7.9 4.5 4.1 6.1 7.3 12.8 9.7 10.2 4.9 12.0 6.9 14.9 11.0 8.0 11.7 2.8 8.7 9.9 14.3 6.6 9.8 19.4 17.1 7.4 9.8 5.2 13.7 4.8 8.6 7.8 7.7 11.6 7.3 5.8 2.5 20.0 3.2 8.4 7.1 2.2 1.2 1.7 2.0 1.3 0.0 0.4 8.7 0.7 1.1 2.3 3.4 0.9 2.3 5.9 2.5 2.2 1.6 3.8 1.7 1.7 4.8 0.9 3.1 5.9 1.7 0.2 0.0 5.8 30.1 0.5 3.6 1.4 1.1 0.5 2.5 4.1 0.6 6.7 2.3 2.5 1.8 2.9 0.6 3.7 2.7 3.2 9.6 3.0 2.5 2.2 10.1 3.2 2.5 15.1 8.5 1.8 2.9 1.9 0.5 0.7 1.3 0.6 2.9 2.9 2.8 5.1 1.4 4.3 9.5 10.5 2.7 7.8 3.6 2.1 5.9 4.4 4.8 3.5 2.5 5.8 5.6 3.0 20.0 8.4 3.2 1.0 7.1 2.2 8.3 21.6 32.9 12.2 9.0 7.9 12.8 9.7 11.0 13.7 17.9 27.4 40.7 37.9 35.8 29.4 14.1 12.7 37.5 29.6 7.0 15.7 31.0 0.0 8.9 5.5 19.6 27.6 0.0 4.6 4.7 13.2 25.2 86.9 6.8 6.4 25.4 15.6 14.1 16.1 2.1 13.0 16.9 18.6 2.8 17.9 12.9 3.0 11.5 11.0 2.8 29.2 12.9 27.6 13.1 23.7 40.5 93.5 39.5 18.8 42.3 RPS6KB1 "p70(S6K)-alpha, PS6K, S6K1, STK14A" ENSG00000108443 "Ribosomal protein S6 kinase B1" P23443 17 59893046-59950564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "MCF7: 76.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003838, CAB018346, HPA039442" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: AB_2676510" "unprognostic (2.25e-1)" "unprognostic (4.52e-2)" "unprognostic (1.91e-3)" "unprognostic (1.35e-2)" "unprognostic (9.81e-2)" "unprognostic (1.13e-1)" "unprognostic (3.72e-3)" "unprognostic (1.70e-1)" "unprognostic (5.86e-2)" "unprognostic (1.66e-1)" "unprognostic (3.67e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (5.09e-7)" "unprognostic (3.45e-1)" "unprognostic (2.09e-1)" "unprognostic (3.98e-2)" "unprognostic (1.52e-3)" 18.4 18.3 16.6 23.2 19.5 20.5 18.4 25.7 24.2 18.1 18.2 13.1 18.4 13.1 19.6 16.5 25.4 14.5 14.9 14.2 15.7 12.6 13.5 20.0 14.8 17.3 20.3 17.5 21.6 22.3 24.5 18.9 20.3 17.6 16.7 15.0 10.1 17.3 21.5 50.3 15.8 14.1 19.3 19.8 17.6 17.5 10.7 20.0 17.8 16.8 18.4 22.0 18.5 20.8 8.9 12.8 25.9 11.1 9.4 13.5 8.3 10.9 10.6 9.1 8.6 6.3 9.2 6.9 10.1 9.4 8.9 10.0 8.7 5.5 13.2 12.6 8.4 10.7 5.7 12.0 9.1 14.4 7.3 13.4 9.0 6.9 9.9 9.3 13.9 9.1 9.4 7.0 10.3 7.6 7.4 11.6 8.5 11.9 8.5 6.6 76.1 16.5 5.9 6.1 9.6 8.2 9.8 15.4 12.3 7.4 8.1 6.6 8.0 8.5 5.0 5.4 11.0 9.8 7.7 10.0 8.7 14.5 7.0 13.4 15.4 13.0 14.9 6.6 8.6 6.9 25.9 10.1 9.0 11.4 10.2 13.5 8.9 10.5 13.0 12.8 8.6 12.3 12.9 10.0 9.4 11.1 8.0 9.5 8.3 16.6 19.5 25.7 24.2 15.7 12.6 20.3 17.5 17.6 20.0 20.8 32.2 20.1 17.7 29.3 16.3 13.7 17.8 25.4 38.7 3.5 17.7 20.8 3.3 10.9 2.6 18.8 10.1 0.0 14.1 15.1 21.8 21.4 22.0 12.4 10.6 17.5 12.7 11.1 14.8 2.1 14.7 18.0 10.1 16.2 16.1 11.9 13.7 10.5 17.0 7.2 18.5 25.8 22.8 11.1 13.1 28.0 25.5 20.3 13.4 24.3 RPS6KL1 MGC11287 ENSG00000198208 "Ribosomal protein S6 kinase like 1" Q9Y6S9 14 74903954-74923396 "Enzymes, Predicted intracellular proteins" "Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 67.9;Cone photoreceptor cells: 78.5;Horizontal cells: 38.1;Rod photoreceptor cells: 72.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 2.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.0;plasmacytoid DC: 5.4" "Group enriched" "Detected in many" 26 "B-cells: 2.0;dendritic cells: 5.4;T-cells: 2.0" "Cell line enhanced" "Detected in many" "HMC-1: 13.0;SCLC-21H: 24.9;SK-BR-3: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027451, HPA027794" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027451: AB_10599304, HPA027794: AB_10602098" "unprognostic (2.71e-2)" "unprognostic (9.33e-3)" "unprognostic (3.36e-1)" "unprognostic (1.13e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.49e-4)" "unprognostic (2.06e-1)" "unprognostic (1.54e-1)" "unprognostic (4.09e-3)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.03e-2)" "unprognostic (7.52e-2)" 4.2 7.5 14.7 2.3 13.6 4.2 5.7 18.2 29.1 2.1 4.8 9.0 2.2 3.8 5.1 8.8 5.3 2.5 3.7 10.2 14.3 13.7 2.3 2.1 2.5 2.5 11.1 15.3 1.5 6.7 4.0 10.6 1.4 8.4 2.8 5.6 5.9 3.2 5.4 12.7 1.2 2.8 6.9 8.8 1.7 2.0 11.4 6.8 0.0 3.8 1.2 2.5 1.9 0.8 2.0 5.4 0.1 0.0 0.0 2.0 0.1 2.3 0.3 1.0 3.8 0.1 0.0 4.5 0.4 0.2 1.8 0.5 5.6 1.6 0.0 3.5 0.7 0.5 0.3 1.8 0.3 2.4 0.0 0.8 1.9 0.8 4.2 4.7 2.2 13.0 0.3 3.2 2.0 0.0 0.0 5.9 0.0 2.7 0.7 0.1 7.6 0.0 0.8 0.8 0.7 3.7 1.8 0.0 7.2 1.8 0.0 24.9 3.0 0.3 14.4 2.4 2.0 1.4 1.5 4.0 0.1 0.2 3.1 0.0 10.1 5.3 5.3 1.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 2.0 0.4 0.1 0.0 0.4 1.9 2.0 0.1 0.0 0.0 5.4 0.0 0.1 14.7 13.6 18.2 18.2 14.3 13.7 11.1 15.3 8.4 6.8 0.0 0.0 0.0 1.8 0.7 67.9 5.1 0.0 5.3 0.0 3.5 78.5 1.4 1.7 1.2 6.5 2.6 2.0 0.0 5.3 1.1 1.0 1.6 0.0 2.1 3.0 38.1 6.4 1.3 0.0 5.6 2.0 1.2 3.3 0.0 1.5 4.0 3.1 1.5 2.5 0.8 72.2 6.5 2.7 22.3 15.8 1.1 1.1 1.3 2.5 1.3 RPUSD3 MGC29784 ENSG00000156990 "RNA pseudouridylate synthase domain containing 3" Q6P087 3 9837849-9844602 "Predicted intracellular proteins" "mRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 105.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 77.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037551, HPA037552" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA037551: AB_2675538, HPA037552: AB_10672600" "unprognostic (1.57e-1)" "unprognostic (8.88e-2)" "unprognostic (5.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-2)" "unprognostic (2.35e-1)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.31e-1)" "unprognostic (2.36e-1)" "unprognostic (3.00e-2)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (5.17e-3)" "unprognostic (2.02e-1)" "unprognostic (2.16e-1)" "unprognostic (2.94e-2)" "unprognostic (8.83e-2)" 10.8 18.9 19.5 11.8 25.9 17.0 13.2 21.1 26.5 11.1 14.9 12.9 9.8 16.0 14.0 14.4 19.3 13.9 14.0 20.7 17.2 17.0 16.9 19.5 11.8 14.3 14.4 16.5 14.7 17.5 24.1 17.0 15.2 17.4 13.3 15.6 14.6 12.5 17.5 43.3 18.6 11.9 15.6 10.6 13.2 13.6 36.3 16.4 16.5 15.3 13.9 18.7 15.0 12.2 23.7 22.2 12.4 24.7 37.0 29.7 19.0 9.0 13.5 10.3 6.6 17.4 12.9 77.2 7.8 11.2 13.0 13.8 11.8 9.3 15.6 9.8 8.6 19.2 7.7 22.9 14.0 10.4 12.0 24.0 20.8 12.1 12.6 13.6 12.7 13.2 15.8 19.5 15.1 17.6 10.7 17.1 21.1 15.3 10.9 12.8 21.3 17.3 23.3 11.2 13.2 20.3 12.3 8.5 26.1 14.3 6.8 8.0 6.7 9.8 12.6 21.5 15.5 21.5 13.8 10.1 5.2 9.4 9.1 11.4 16.2 19.3 20.5 11.0 24.2 12.0 12.4 24.7 11.9 22.6 17.6 22.9 23.7 21.2 21.1 22.2 20.0 24.2 21.5 6.0 37.0 12.0 21.3 29.7 19.0 19.5 25.9 21.1 26.5 17.2 17.0 14.4 16.5 17.4 16.4 17.9 8.1 21.6 19.2 7.1 24.2 21.4 12.7 13.4 14.8 14.0 19.6 38.5 39.7 26.0 63.8 13.4 18.8 0.0 27.6 39.4 12.4 15.6 20.7 24.1 33.7 11.1 12.7 23.4 14.3 42.6 19.8 16.7 15.1 26.2 14.4 16.9 22.0 14.4 20.1 35.2 21.2 6.5 18.6 105.6 21.0 11.2 14.4 25.9 26.2 10.1 RRP9 "RNU3IP2, U3-55K" ENSG00000114767 "Ribosomal RNA processing 9, U3 small nucleolar RNA binding protein" O43818 3 51933430-51941941 "Predicted intracellular proteins" "rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038798 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA038798: AB_10672653" "unprognostic (5.57e-2)" "unprognostic (9.47e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-2)" "unprognostic (4.18e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.90e-5)" "unprognostic (1.24e-1)" "unprognostic (2.00e-1)" "unprognostic (1.63e-1)" "unprognostic (2.82e-2)" "unprognostic (8.25e-3)" "unprognostic (2.60e-3)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (4.15e-2)" "unprognostic (5.92e-2)" 18.6 19.4 17.5 17.3 22.9 14.1 15.9 11.0 16.3 15.0 12.7 9.3 11.2 14.4 16.4 8.9 16.5 16.7 15.9 12.7 13.6 9.1 12.0 18.6 13.4 18.7 14.2 18.6 17.4 34.7 12.6 10.6 12.1 12.8 13.8 10.5 8.7 13.2 13.1 30.9 15.7 11.0 14.1 9.5 15.6 12.1 15.3 14.0 11.1 12.7 17.7 13.6 13.9 21.6 12.8 13.1 1.5 9.3 12.9 13.7 7.0 10.6 15.3 7.3 17.5 10.8 6.1 18.7 11.8 6.5 20.1 12.8 26.0 12.2 31.0 5.0 8.3 27.3 9.9 25.4 18.2 8.1 14.1 11.0 21.0 9.1 23.1 21.8 22.8 17.6 12.5 13.5 25.1 23.9 4.9 7.7 11.1 19.8 7.9 8.8 17.0 19.2 22.8 28.9 16.5 39.4 11.9 8.4 23.8 9.7 15.9 9.1 10.7 10.7 12.0 11.4 6.6 6.2 14.9 7.3 14.1 18.8 34.8 48.5 13.6 21.9 29.0 12.5 28.6 22.1 1.5 6.6 0.4 12.8 9.3 13.7 12.8 11.0 11.2 12.4 10.5 8.7 10.4 0.5 12.9 4.5 13.1 8.9 7.0 17.5 22.9 11.0 16.3 13.6 9.1 14.2 18.6 12.8 14.0 0.0 10.9 20.3 16.9 59.3 13.0 3.1 10.2 9.4 9.1 5.2 3.9 23.6 13.3 18.6 5.8 7.5 4.2 0.0 11.8 33.0 17.5 9.1 15.0 7.2 20.5 15.9 8.1 4.9 2.1 3.6 8.1 6.9 20.3 14.4 7.2 10.0 15.4 8.6 8.5 14.9 7.8 6.5 18.9 7.6 26.6 44.2 14.0 10.9 15.3 13.2 RSF1 "HBXAP, p325, RSF-1, XAP8" ENSG00000048649 "Remodeling and spacing factor 1" Q96T23 11 77659996-77821017 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022626, HPA046129, HPA057547, HPA064567" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289" "unprognostic (2.67e-1)" "unprognostic (2.02e-1)" "unprognostic (2.39e-1)" "unprognostic (4.35e-3)" "unprognostic (5.00e-3)" "unprognostic (5.57e-2)" "unprognostic (1.23e-2)" "unprognostic (2.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (6.19e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.71e-1)" "unprognostic (2.22e-1)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" 15.9 20.1 20.4 19.5 23.5 21.1 14.4 32.3 20.0 19.0 14.2 11.0 15.2 8.7 19.3 14.6 13.4 14.1 15.7 13.1 18.7 17.2 14.0 10.9 15.6 13.2 16.2 15.3 26.0 15.6 25.3 27.3 16.9 18.7 16.3 12.0 8.1 13.4 21.3 15.7 13.5 12.7 16.7 15.8 16.2 12.5 21.1 21.8 22.4 21.1 8.4 12.3 21.3 25.8 21.7 18.5 27.7 15.7 13.6 17.1 4.0 10.5 7.1 24.8 13.2 8.4 10.7 9.3 12.5 12.3 10.3 12.7 18.7 14.8 18.0 13.4 8.7 15.9 11.1 14.5 9.3 19.3 12.8 6.5 16.9 10.1 5.0 8.1 16.0 12.1 8.9 7.1 14.0 22.6 12.0 12.9 6.0 27.5 17.1 11.8 7.2 11.2 9.0 14.4 12.7 9.8 18.8 43.1 11.7 5.4 13.8 15.0 15.2 19.2 7.6 7.5 13.5 13.6 8.0 16.1 18.2 15.8 28.4 8.9 10.3 13.2 41.5 4.8 10.9 13.6 21.3 10.7 17.8 17.1 9.9 11.7 18.2 10.3 10.7 8.1 21.7 14.3 14.2 27.7 13.6 15.7 18.5 9.6 4.0 20.4 23.5 32.3 20.0 18.7 17.2 16.2 15.3 18.7 21.8 110.2 97.4 50.0 60.3 80.4 120.3 86.5 48.4 78.9 81.9 69.8 70.7 51.8 39.7 63.9 69.5 87.9 40.1 70.0 48.5 44.1 80.8 77.0 91.4 37.7 39.8 138.2 82.1 72.4 47.5 29.1 117.3 58.4 54.0 85.6 57.6 115.2 62.7 57.7 111.0 31.1 94.9 103.5 72.1 96.0 109.4 73.4 56.4 77.8 54.2 72.5 RSG1 "C1orf89, MGC10731" ENSG00000132881 "REM2 and RAB like small GTPase 1" Q9BU20 1 16231700-16237162 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 5 "Alveolar cells type 2: 3.5;granulocytes: 4.6;Spermatocytes: 3.7;Spermatogonia: 3.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028453 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028453: AB_10601692" "unprognostic (7.52e-2)" "unprognostic (3.22e-1)" "unprognostic (3.61e-2)" "unprognostic (1.34e-2)" "unprognostic (1.05e-2)" "unprognostic (1.25e-2)" "unprognostic (6.12e-3)" "unprognostic (1.11e-1)" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (8.31e-2)" "unprognostic (4.79e-2)" "prognostic favorable (1.36e-10)" "unprognostic (1.45e-2)" "unprognostic (2.36e-1)" "unprognostic (1.56e-1)" "unprognostic (2.16e-2)" 3.2 7.5 14.2 3.7 17.1 5.8 3.3 3.7 9.8 6.0 3.7 3.9 12.6 4.2 5.6 3.2 8.9 11.8 3.8 7.9 10.4 12.0 5.3 3.6 3.2 4.5 9.3 10.5 10.1 8.3 7.9 8.0 4.1 10.4 5.4 3.3 5.7 8.0 7.5 2.1 7.4 3.6 6.1 7.9 5.9 6.6 6.7 7.5 1.7 11.6 0.3 4.0 5.9 3.0 3.2 2.2 4.0 3.5 2.9 6.2 1.4 4.0 11.0 3.4 11.1 2.3 4.2 3.1 4.5 2.9 3.7 1.6 4.0 6.2 8.7 9.2 2.5 7.3 3.3 6.1 5.9 0.4 13.1 5.1 4.3 9.6 0.8 5.7 2.9 7.9 2.2 5.1 4.3 3.9 3.7 3.5 6.7 15.6 3.4 3.0 5.0 3.1 2.1 0.8 4.3 4.3 7.8 0.4 7.0 3.3 2.5 8.2 5.5 1.8 2.8 4.1 2.6 8.4 2.7 3.5 1.1 1.8 2.2 1.5 9.4 3.5 5.0 3.0 6.3 6.2 0.0 1.2 4.0 5.0 3.5 6.2 3.0 3.1 1.4 2.2 3.2 3.0 2.4 1.1 2.9 2.2 0.7 3.2 1.4 14.2 17.1 3.7 9.8 10.4 12.0 9.3 10.5 10.4 7.5 0.0 3.5 0.5 1.5 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 1.7 0.0 0.0 0.8 0.7 2.0 0.0 0.0 2.0 0.7 1.0 4.6 0.8 2.1 0.0 1.2 0.6 1.3 0.9 1.1 0.0 1.7 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.7 3.7 0.3 0.9 0.0 1.2 0.5 RSPH4A "CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B" ENSG00000111834 "Radial spoke head 4 homolog A" Q5TD94 6 116616479-116632985 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8;fallopian tube: 35.9;pituitary gland: 16.7" "Cell type enriched" "Detected in many" 10 "Ciliated cells: 365.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.6" "Group enriched" "Detected in many" 4 "basal ganglia: 9.4;pons and medulla: 19.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 7.6;U-266/84: 5.5" "Low region specificity" "Detected in many" "HPA031196, HPA031197, HPA031198" Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025" "unprognostic (9.83e-4)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" "unprognostic (9.69e-3)" "unprognostic (9.37e-2)" "unprognostic (1.13e-3)" "unprognostic (4.52e-1)" "unprognostic (1.07e-1)" "unprognostic (1.06e-1)" "unprognostic (5.08e-2)" "unprognostic (9.56e-5)" "unprognostic (2.87e-1)" "unprognostic (2.69e-4)" "unprognostic (1.96e-2)" "unprognostic (2.51e-1)" "unprognostic (3.55e-2)" "unprognostic (5.21e-2)" 0.5 0.7 1.8 0.5 9.4 0.9 0.7 1.2 0.9 2.2 0.4 10.2 0.4 0.5 1.9 13.3 0.4 35.9 0.8 0.5 3.0 3.3 0.7 0.4 11.1 0.5 0.5 1.1 13.7 0.6 2.8 16.7 0.3 19.8 0.6 0.4 0.2 0.4 0.5 1.0 0.6 0.4 0.6 0.7 1.0 0.8 6.6 1.8 0.0 1.0 0.0 0.5 0.4 0.1 0.8 0.1 1.3 0.2 0.2 1.0 0.0 0.1 0.2 1.4 3.2 0.1 0.1 0.3 0.4 0.8 0.6 0.8 0.7 1.1 1.0 0.3 0.1 1.2 0.2 0.3 0.6 0.6 0.8 1.1 0.4 0.5 1.2 0.0 0.8 1.1 0.4 0.2 1.0 0.2 0.1 0.0 0.9 0.2 0.1 0.6 0.2 0.7 0.1 0.6 0.1 0.1 0.8 1.6 7.6 3.2 0.4 2.8 1.2 0.2 0.2 0.5 0.3 0.5 0.6 0.5 0.4 0.7 0.5 0.5 0.5 5.5 0.4 0.1 0.4 0.5 1.3 0.2 0.8 1.0 0.1 0.1 0.4 0.3 0.0 0.0 0.8 0.2 0.5 0.0 0.2 0.1 0.1 0.0 0.0 1.8 9.4 1.2 0.7 3.0 3.3 0.5 1.1 19.8 1.8 3.0 4.3 0.0 0.0 0.0 3.0 0.4 0.0 365.4 35.2 0.0 2.0 0.0 1.7 0.4 18.2 0.1 0.0 0.0 0.3 0.1 0.0 0.1 2.3 0.0 0.1 1.6 0.0 2.5 0.0 8.7 0.3 0.0 1.7 0.0 0.0 1.7 0.2 0.0 0.0 0.0 3.2 0.0 0.4 4.4 1.5 0.1 0.2 0.0 0.0 0.0 RSRP1 "C1orf63, DJ465N24.2.1" ENSG00000117616 "Arginine and serine rich protein 1" Q9BUV0 1 25242237-25338213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 353.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058992, HPA067651" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA058992: AB_2683873, HPA067651: AB_2685879" "unprognostic (1.03e-1)" "unprognostic (4.52e-2)" "unprognostic (2.18e-1)" "unprognostic (7.24e-2)" "unprognostic (3.65e-2)" "unprognostic (3.81e-2)" "unprognostic (5.77e-3)" "unprognostic (3.67e-2)" "unprognostic (2.22e-2)" "unprognostic (1.21e-1)" "unprognostic (1.02e-2)" "unprognostic (7.51e-3)" "unprognostic (1.73e-3)" "unprognostic (4.84e-2)" "unprognostic (1.87e-1)" "unprognostic (7.87e-2)" "prognostic favorable (2.91e-5)" 11.3 55.9 13.2 23.7 20.6 21.3 9.4 18.3 16.7 48.3 13.4 17.8 44.2 10.4 19.2 26.0 15.6 14.7 30.3 16.5 16.8 13.6 19.4 17.5 16.3 11.0 31.0 15.6 20.2 22.8 6.7 25.0 17.0 18.6 21.4 6.4 12.7 36.7 36.6 9.9 16.9 12.6 12.0 25.9 15.0 17.3 14.0 21.5 23.1 17.5 10.5 20.9 12.2 21.1 7.7 18.6 39.2 18.0 10.0 10.5 7.7 3.4 9.7 1.5 1.3 8.4 2.2 3.3 3.4 1.3 4.8 5.1 7.5 4.0 2.8 12.3 0.9 1.5 5.6 7.5 0.8 1.3 6.9 5.1 11.2 10.8 9.0 2.4 4.9 5.7 0.8 4.6 1.9 0.2 2.8 2.9 3.7 8.7 27.6 1.3 4.1 1.3 9.4 5.4 7.0 5.6 4.1 3.8 4.1 3.3 0.2 4.7 1.3 2.5 1.7 2.0 0.8 2.0 5.0 4.0 3.0 2.4 2.8 2.1 15.1 13.5 3.1 2.3 12.4 2.2 36.5 18.0 25.5 7.9 11.4 8.2 7.4 8.2 6.4 18.6 7.7 7.9 5.2 39.2 10.0 14.9 11.8 10.5 7.7 13.2 20.6 18.3 16.7 16.8 13.6 31.0 15.6 18.6 21.5 56.6 75.6 125.0 203.5 0.0 95.1 40.3 40.8 108.4 69.4 89.0 133.5 64.6 18.3 33.2 24.1 69.8 353.7 23.3 18.8 45.9 62.1 147.7 216.6 15.7 55.8 79.4 125.4 61.4 67.3 10.1 129.8 97.5 0.0 83.0 125.1 79.6 32.5 277.0 84.8 7.9 146.7 122.9 31.5 64.2 96.5 0.0 101.4 148.1 107.4 174.4 RTCA "RPC, RTC1, RTCD1" ENSG00000137996 "RNA 3'-terminal phosphate cyclase" O00442 1 100266207-100292769 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027982, HPA027990, HPA028151, HPA028331" Uncertain Enhanced Nucleoplasm NA NA 8700 Nucleoplasm "HPA027982: AB_10601769, HPA027990: AB_2672452, HPA028151: AB_10602099, HPA028331: " "unprognostic (4.79e-2)" "unprognostic (1.17e-2)" "unprognostic (3.97e-2)" "unprognostic (3.82e-2)" "unprognostic (6.76e-2)" "unprognostic (4.12e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (9.55e-3)" "unprognostic (3.64e-2)" "unprognostic (1.12e-2)" "unprognostic (2.46e-1)" "unprognostic (8.09e-3)" "unprognostic (3.74e-3)" "unprognostic (2.10e-2)" "unprognostic (1.44e-1)" "unprognostic (3.59e-1)" "unprognostic (2.94e-2)" 20.9 25.0 19.4 17.8 24.9 25.5 20.0 22.6 31.7 14.7 22.9 20.3 19.9 31.7 14.2 26.0 27.0 13.4 19.9 25.5 20.0 21.0 31.7 23.0 16.1 21.8 21.5 20.7 13.3 27.7 21.1 17.2 21.2 33.1 20.9 22.2 14.1 18.5 17.4 35.4 14.6 37.8 15.4 20.5 24.2 21.8 12.2 12.4 25.0 18.3 20.2 20.8 18.7 17.5 9.6 8.0 8.2 19.6 11.0 20.1 7.7 22.0 11.4 11.3 15.2 14.3 23.3 30.9 26.2 12.8 17.1 14.8 18.6 11.1 22.6 19.9 16.6 21.1 11.2 13.8 12.4 20.7 22.6 11.5 14.9 13.0 23.4 22.1 27.1 23.6 18.9 19.6 22.3 29.9 17.0 21.2 16.5 25.6 34.5 25.8 7.3 13.9 21.1 17.3 15.7 22.1 10.0 20.2 9.9 21.0 18.1 9.1 11.4 16.9 24.5 35.8 18.5 5.3 34.8 18.4 16.2 11.3 25.2 31.4 20.0 20.1 18.1 34.0 23.6 9.6 8.2 9.1 7.5 10.8 11.3 13.8 9.6 10.0 12.8 8.0 7.1 9.3 10.5 4.4 11.0 19.6 7.6 20.1 7.7 19.4 24.9 22.6 31.7 20.0 21.0 21.5 20.7 33.1 12.4 6.0 14.4 26.1 13.0 12.0 22.2 49.6 7.6 13.4 10.3 17.4 11.8 48.9 21.6 37.0 11.5 17.5 35.4 0.0 30.2 65.3 13.9 14.2 12.7 15.3 69.5 20.6 18.5 22.7 41.9 6.4 17.8 28.9 15.1 50.5 26.6 20.6 46.7 37.1 12.0 49.6 26.8 6.5 12.3 27.2 14.7 12.8 38.8 32.0 29.7 15.7 RTL5 "KIAA2001, Mar5, Mart5, RGAG4, SIRH8" ENSG00000242732 "Retrotransposon Gag like 5" Q5HYW3 X 72127110-72131901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.2;Ciliated cells: 4.0;Club cells: 3.4;Distal tubular cells: 1.7;granulocytes: 2.3;Hofbauer cells: 3.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.6;AN3-CA: 6.3;SCLC-21H: 7.6;SH-SY5Y: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003652 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003652: AB_1079805" "unprognostic (7.97e-2)" "unprognostic (1.31e-2)" "unprognostic (5.29e-3)" "unprognostic (2.98e-2)" "unprognostic (3.93e-2)" "unprognostic (3.64e-1)" "unprognostic (4.20e-1)" "prognostic favorable (7.30e-4)" "unprognostic (1.62e-1)" "unprognostic (2.82e-1)" "prognostic favorable (3.41e-4)" "unprognostic (4.23e-1)" "unprognostic (4.18e-3)" "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" 5.4 7.2 7.0 2.7 12.5 1.9 7.7 22.7 14.2 4.9 4.5 3.5 6.2 2.8 9.6 10.1 2.6 4.9 6.0 4.0 10.3 8.9 4.4 4.2 5.5 2.4 5.2 11.2 10.5 1.1 7.4 16.3 5.2 6.3 5.7 3.0 3.0 3.7 6.9 2.3 2.1 3.2 6.7 9.5 2.7 5.4 12.4 4.8 0.0 11.7 0.8 2.0 5.5 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 5.6 6.3 1.5 1.8 0.3 2.1 0.8 0.3 0.9 0.4 0.0 0.0 0.9 0.4 1.0 0.0 1.1 0.1 1.1 0.0 0.8 0.2 0.1 0.0 0.1 0.0 0.7 3.4 0.1 0.9 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.6 10.6 0.4 0.0 0.0 2.4 0.2 0.0 0.7 0.8 0.7 1.4 0.0 0.1 0.0 0.0 1.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.0 12.5 22.7 14.2 10.3 8.9 5.2 11.2 6.3 4.8 3.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 0.0 0.0 0.1 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RTP4 "IFRG28, Z3CXXC4" ENSG00000136514 "Receptor transporter protein 4" Q96DX8 3 187368332-187372076 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 27.5;Urothelial cells: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.9;GAMG: 11.9;HDLM-2: 9.8;Karpas-707: 8.1;REH: 7.9;SK-MEL-30: 15.2" "HPA064887, HPA071189" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA064887: AB_2685383, HPA071189: AB_2686357" "unprognostic (1.45e-2)" "unprognostic (2.46e-2)" "unprognostic (1.30e-1)" "unprognostic (1.44e-2)" "unprognostic (6.35e-2)" "unprognostic (3.24e-1)" "unprognostic (2.32e-1)" "unprognostic (3.78e-1)" "unprognostic (1.18e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (6.83e-4)" "unprognostic (1.34e-1)" "unprognostic (5.49e-2)" "unprognostic (3.44e-2)" "unprognostic (2.95e-2)" "prognostic favorable (4.35e-4)" "prognostic favorable (1.45e-4)" 7.7 4.6 3.2 6.9 3.6 0.7 5.9 1.0 3.1 8.1 13.3 6.0 3.8 9.2 6.7 7.1 6.2 11.3 7.6 2.9 3.1 3.0 8.6 8.8 8.0 12.0 3.8 3.0 6.4 9.7 0.3 3.0 5.9 3.3 10.1 6.1 7.7 10.8 5.6 0.9 2.2 23.2 5.2 5.4 13.5 8.0 1.9 1.5 16.8 10.5 4.3 8.6 10.5 4.7 5.1 6.0 4.7 10.5 12.4 16.2 5.6 2.4 0.0 0.0 0.0 1.2 4.2 0.1 0.0 1.0 1.7 1.5 0.0 8.9 1.1 0.0 1.0 11.9 3.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 0.1 1.6 0.0 2.2 1.0 0.0 0.3 0.0 0.3 0.3 0.2 0.0 8.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 7.9 0.0 6.4 2.1 6.4 0.0 0.0 0.0 0.2 15.2 0.1 0.0 3.9 0.1 0.1 0.2 0.0 0.1 6.5 2.1 0.0 0.0 2.2 4.9 4.7 6.9 4.7 10.4 8.5 10.2 5.1 8.3 9.4 6.0 4.8 6.4 7.4 2.1 12.4 10.5 0.1 16.2 5.6 3.2 3.6 1.0 3.1 3.1 3.0 3.8 3.0 3.3 1.5 6.0 5.0 2.7 24.0 1.4 0.0 0.4 12.7 17.4 7.9 5.2 0.0 0.0 13.3 27.5 0.0 7.3 8.0 0.0 8.6 0.1 2.3 9.7 1.1 2.9 5.4 0.0 8.7 9.8 5.9 0.0 2.0 4.0 1.7 3.6 11.3 4.1 12.4 10.5 4.6 2.2 0.0 0.0 1.1 0.0 0.0 1.1 0.2 7.2 7.2 41.4 RTRAF "C14orf166, CGI-99, CLE, CLE7, hCLE1, LCRP369, RLLM1" ENSG00000087302 "RNA transcription, translation and transport factor" Q9Y224 14 51989475-52010691 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 281.4;Distal tubular cells: 261.9;Exocrine glandular cells: 252.9;Extravillous trophoblasts: 296.5;monocytes: 269.7;Proximal tubular cells: 245.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039824 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA039824: AB_10793922" "unprognostic (2.99e-2)" "unprognostic (2.90e-1)" "unprognostic (7.89e-2)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (6.08e-2)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (2.23e-2)" "unprognostic (6.50e-2)" "unprognostic (2.80e-1)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" "unprognostic (3.34e-1)" "unprognostic (5.03e-2)" "unprognostic (5.74e-2)" "unprognostic (1.99e-1)" 41.8 46.1 28.7 43.9 38.7 51.9 78.8 21.0 52.1 28.8 40.2 18.8 44.3 26.9 36.3 45.8 38.7 29.7 41.3 110.7 31.2 25.8 34.5 37.8 44.8 80.0 30.8 31.5 45.4 72.2 25.1 33.7 29.9 39.2 32.1 40.6 21.4 39.5 49.6 95.6 36.5 30.6 58.9 39.1 30.6 46.9 94.7 26.3 54.7 38.6 55.1 44.5 38.6 47.6 37.5 40.3 19.2 35.9 32.0 47.9 37.7 44.4 30.2 52.1 50.4 35.0 46.7 49.9 35.6 39.4 39.5 44.7 32.4 39.4 60.9 38.2 29.5 31.1 35.7 48.5 32.5 51.6 32.8 27.2 23.6 63.0 43.0 56.2 50.2 27.3 35.2 33.8 29.7 49.1 46.1 44.5 57.6 24.3 29.2 38.1 49.5 63.5 63.6 40.5 51.9 51.3 58.0 49.6 28.7 37.9 52.0 36.9 37.6 45.0 81.4 55.6 68.8 54.5 39.9 31.0 43.3 47.6 36.3 44.4 11.0 15.4 61.9 21.3 39.7 49.0 14.3 32.0 19.2 26.9 34.8 33.5 37.5 37.7 32.2 40.3 31.3 35.2 35.1 6.7 32.0 35.9 36.9 47.9 37.7 28.7 38.7 21.0 52.1 31.2 25.8 30.8 31.5 39.2 26.3 41.7 56.3 0.0 0.0 0.0 0.0 0.0 0.0 91.0 71.7 69.8 0.0 281.4 261.9 188.5 0.0 0.0 0.0 0.0 252.9 296.5 0.0 0.0 57.0 0.0 212.6 0.0 0.0 0.0 0.0 0.0 0.0 33.4 0.0 269.7 0.0 0.0 209.0 0.0 0.0 245.9 0.0 0.0 0.0 0.0 0.0 0.0 218.8 0.0 0.0 0.0 RUFY2 "FLJ10063, KIAA1537, RABIP4R, ZFYVE13" ENSG00000204130 "RUN and FYVE domain containing 2" Q8WXA3 10 68341107-68407294 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039792 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039792: AB_10673363" "unprognostic (1.23e-1)" "unprognostic (3.37e-1)" "unprognostic (1.91e-1)" "unprognostic (2.19e-1)" "unprognostic (2.48e-3)" "unprognostic (2.22e-2)" "unprognostic (4.36e-3)" "unprognostic (1.96e-1)" "unprognostic (2.13e-2)" "unprognostic (2.08e-2)" "unprognostic (1.92e-1)" "unprognostic (1.28e-2)" "unprognostic (2.00e-3)" "unprognostic (3.23e-1)" "unprognostic (3.82e-1)" "unprognostic (7.74e-2)" "unprognostic (3.40e-2)" 8.1 7.0 15.5 5.4 16.3 2.6 10.1 34.3 28.7 9.6 6.6 14.8 6.4 4.9 12.1 7.7 8.1 8.9 7.6 6.5 16.9 16.2 8.3 3.2 7.8 5.2 19.1 11.6 15.0 6.9 11.3 11.9 8.3 16.5 10.0 7.9 5.2 6.2 8.3 6.3 6.9 5.7 10.4 32.8 6.4 7.3 5.8 16.3 5.7 9.7 4.8 5.9 8.6 6.4 2.1 1.0 2.3 1.7 6.5 3.0 0.7 9.9 3.6 5.8 7.4 7.9 12.7 3.6 8.6 10.8 9.5 9.7 5.3 9.0 2.9 6.3 13.5 4.4 6.9 2.6 9.2 9.6 1.4 5.9 1.8 2.8 2.6 8.6 2.3 1.2 10.3 9.9 10.9 11.0 13.5 9.8 2.5 3.8 4.8 9.4 4.0 2.3 3.1 2.6 2.9 10.1 3.1 5.2 1.7 8.6 5.7 7.1 6.9 6.0 7.7 4.9 8.0 11.5 3.0 11.4 11.3 8.4 6.4 11.6 5.1 2.6 1.6 10.3 2.6 4.4 1.5 1.0 2.3 1.7 1.4 1.7 1.7 2.2 2.3 0.6 2.1 2.5 3.0 1.2 6.5 1.7 1.0 0.6 0.7 15.5 16.3 34.3 17.7 16.9 16.2 19.1 11.6 16.5 16.3 29.8 10.8 8.3 14.6 6.0 31.0 10.0 0.0 25.4 27.3 24.4 56.9 7.4 1.7 13.7 6.1 20.2 6.2 0.0 11.2 5.0 13.0 12.8 7.0 5.5 5.7 30.2 9.8 20.3 7.8 4.1 22.5 10.9 11.8 10.8 10.9 21.7 13.4 3.5 16.6 8.1 63.6 12.9 14.2 8.4 26.5 7.0 8.0 8.7 6.9 9.5 RUNX1T1 "AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2" ENSG00000079102 "RUNX1 translocation partner 1" Q06455 8 91954967-92103286 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 57.8" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 122.4;Ito cells: 87.8;Leydig cells: 89.2;Peritubular cells: 93.0;Sertoli cells: 64.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 57.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 13.2;fHDF/TERT166: 11.2;HEL: 24.1;HSkMC: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049852, HPA070951" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA049852: AB_2680914, HPA070951: AB_2686326" "unprognostic (2.37e-1)" "unprognostic (1.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.62e-1)" "unprognostic (3.37e-4)" "unprognostic (2.29e-4)" "unprognostic (5.56e-3)" "unprognostic (1.24e-2)" "unprognostic (1.62e-2)" "unprognostic (2.11e-2)" "unprognostic (2.37e-1)" "unprognostic (5.70e-4)" "unprognostic (8.98e-3)" "unprognostic (6.78e-2)" "unprognostic (1.51e-1)" "unprognostic (7.80e-3)" 9.6 4.6 7.7 4.5 11.5 0.4 6.9 57.8 13.0 14.0 7.8 1.1 2.0 2.0 11.8 5.9 4.1 7.7 7.8 12.3 5.8 4.0 2.5 1.3 6.0 2.0 3.6 9.6 7.7 1.8 1.7 8.6 8.7 4.2 4.2 4.0 5.3 4.7 4.1 5.5 3.6 3.6 10.3 3.0 2.9 4.2 5.6 3.7 0.0 5.2 3.3 1.8 5.7 5.9 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.3 3.5 5.1 0.0 5.2 7.9 3.5 5.4 0.0 0.0 13.2 0.0 11.2 0.0 0.0 2.8 0.3 2.3 0.0 2.2 24.1 0.0 0.0 1.4 0.0 0.0 9.7 0.0 5.8 0.3 0.0 7.4 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 4.2 0.0 0.0 0.0 5.7 0.0 0.0 0.8 0.3 0.0 0.6 0.0 2.6 0.0 4.2 0.5 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 7.7 11.5 57.8 13.0 5.8 4.0 3.6 9.6 4.2 3.7 0.0 0.6 0.0 0.1 5.6 122.4 43.1 0.0 0.0 1.2 0.0 15.7 1.1 1.7 0.0 2.0 49.6 0.0 0.0 0.2 0.2 62.1 0.3 1.1 0.5 1.7 33.4 45.7 87.8 4.9 4.0 89.2 0.8 10.1 0.0 0.0 3.9 0.3 0.0 93.0 0.0 7.1 64.7 41.5 3.0 13.0 4.3 0.9 0.0 0.0 0.0 RUNX2 "AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1" ENSG00000124813 "Runt related transcription factor 2" Q13950 6 45328157-45664349 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 67.7;monocytes: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 16.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 18.6;Karpas-707: 29.1;RH-30: 24.3;U-698: 25.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB008374, HPA022040, CAB062561, CAB068226, HPA070715" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: " "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (3.99e-2)" "unprognostic (2.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-1)" "unprognostic (1.23e-1)" "unprognostic (3.70e-2)" "unprognostic (3.18e-1)" "prognostic unfavorable (3.97e-9)" "prognostic unfavorable (2.24e-4)" "unprognostic (5.52e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (6.66e-5)" 3.7 2.1 4.9 13.7 7.0 15.5 5.7 1.0 7.2 13.5 6.0 5.6 7.4 4.1 3.5 2.3 3.4 2.4 6.8 1.8 7.4 3.5 3.9 1.8 5.3 8.6 6.3 3.4 5.0 1.9 1.3 3.8 3.3 7.2 9.5 7.8 5.4 19.8 14.9 2.2 4.9 10.8 3.4 10.5 6.6 6.0 2.1 7.3 6.5 4.2 4.5 11.7 7.3 8.9 0.1 11.4 5.3 0.6 16.0 10.2 0.7 1.6 0.5 0.3 0.0 1.5 4.0 0.0 1.5 3.6 5.1 7.2 0.0 0.9 0.0 1.8 2.1 2.3 2.0 0.0 1.4 9.4 6.1 0.7 0.0 1.1 0.0 8.0 6.3 0.0 10.8 1.1 4.5 5.1 18.6 0.0 2.5 0.0 29.1 9.1 0.4 0.2 11.0 0.3 1.4 0.2 0.0 24.3 0.0 5.0 3.2 0.0 0.0 1.1 0.0 1.8 4.5 1.7 0.5 0.2 5.2 4.2 8.0 5.5 9.2 0.0 25.4 5.9 2.4 2.3 5.3 0.6 3.2 1.2 0.1 10.2 0.1 2.8 3.2 1.8 0.1 0.5 1.5 4.8 16.0 0.1 11.4 2.3 0.7 4.9 7.0 1.0 7.2 7.4 3.5 6.3 3.4 7.2 7.3 0.0 2.4 3.7 14.8 2.5 0.0 1.7 0.0 4.0 4.5 3.5 0.0 0.0 0.0 0.6 67.7 0.3 0.0 0.0 0.2 0.0 2.7 15.7 2.3 0.5 3.8 0.0 0.0 1.8 4.5 13.2 1.1 7.9 6.8 20.8 0.7 0.0 0.4 0.0 2.1 2.2 0.0 6.5 2.5 0.9 0.4 1.4 0.1 17.3 0.0 18.2 RXRB "H-2RIIBP, NR2B2, RCoR-1" ENSG00000204231 "Retinoid X receptor beta" P28702 6 33193588-33200688 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 6.9;GAMG: 9.4;RH-30: 8.6;RT4: 8.1;T-47d: 8.4;U-698: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002003, HPA063653" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB002003: , HPA063653: AB_2685076" "unprognostic (3.51e-1)" "unprognostic (8.46e-2)" "unprognostic (1.94e-1)" "unprognostic (2.22e-2)" "unprognostic (2.00e-2)" "unprognostic (4.71e-3)" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.67e-3)" "unprognostic (8.13e-3)" "unprognostic (9.53e-3)" "unprognostic (8.30e-2)" "unprognostic (1.55e-1)" "unprognostic (6.38e-2)" "unprognostic (8.53e-3)" 24.9 18.9 13.0 14.0 16.1 9.8 16.0 24.7 23.2 22.8 17.1 17.7 17.3 19.0 17.4 56.6 13.7 18.5 17.1 27.7 13.5 12.3 14.1 17.4 16.5 9.8 16.4 15.6 19.1 16.2 3.6 17.5 19.2 15.5 20.1 8.4 16.0 16.2 22.0 19.7 25.5 14.1 28.4 10.4 19.8 13.9 10.4 18.2 18.5 22.0 10.9 24.5 14.0 14.5 1.9 1.4 5.2 1.2 1.9 2.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 6.9 0.0 5.2 4.0 0.0 9.4 3.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 5.2 0.0 0.0 0.2 3.1 0.0 0.0 0.0 8.6 0.0 5.2 8.1 0.0 4.6 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 3.7 0.0 0.0 6.7 5.8 8.4 0.0 0.0 0.0 5.2 0.8 2.9 2.5 0.9 1.8 1.9 2.5 2.4 1.3 0.8 2.4 1.5 1.9 1.9 1.2 1.4 2.5 0.7 13.0 16.1 24.7 23.2 13.5 12.3 16.4 15.6 15.5 18.2 38.7 14.1 14.7 14.6 15.3 25.5 16.1 5.1 9.4 15.9 5.2 19.6 19.4 21.6 16.6 2.2 14.7 19.6 0.0 14.1 13.3 14.6 14.4 10.3 14.9 14.0 17.5 21.1 9.8 14.2 3.2 15.0 8.5 15.1 22.6 20.2 15.7 12.5 17.3 15.2 10.7 19.7 25.8 17.6 14.7 13.6 16.4 24.0 17.9 20.7 11.7 RYBP "AAP1, DEDAF, YEAF1" ENSG00000163602 "RING1 and YY1 binding protein" Q8N488 3 72371825-72446621 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053357 Approved Supported Nucleoplasm NA No Nucleoplasm "HPA053357: AB_2682124" "unprognostic (6.80e-2)" "unprognostic (2.81e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-1)" "unprognostic (7.60e-2)" "unprognostic (1.60e-3)" "unprognostic (1.44e-1)" "unprognostic (1.65e-1)" "unprognostic (1.14e-2)" "unprognostic (2.40e-2)" "unprognostic (3.84e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.50e-5)" "unprognostic (1.89e-1)" "unprognostic (4.24e-1)" "unprognostic (3.09e-2)" "unprognostic (4.22e-1)" 7.7 6.3 9.5 10.5 12.1 8.2 8.6 6.1 13.3 9.7 7.6 23.1 7.7 5.8 13.3 6.8 7.0 7.1 8.2 5.8 10.9 8.6 7.4 10.2 11.3 6.3 20.4 4.2 10.4 6.3 6.4 11.5 15.8 15.8 10.9 7.6 9.0 5.8 8.0 3.4 6.7 9.4 8.8 12.6 9.0 6.0 9.3 26.1 3.8 6.0 5.2 7.1 7.9 6.8 1.6 4.2 8.5 3.0 1.9 1.8 0.8 5.7 3.5 7.4 6.2 8.4 11.9 5.5 5.8 8.6 7.4 8.7 5.3 6.6 4.6 5.0 6.5 10.7 2.5 7.7 5.9 9.6 33.3 4.0 17.9 4.2 5.4 9.0 4.4 6.0 13.2 12.2 9.6 16.3 12.7 4.3 5.9 5.8 15.2 7.8 7.4 5.5 5.2 18.7 10.3 4.9 5.8 5.6 3.5 7.2 8.3 6.5 17.5 10.6 10.0 10.4 14.2 4.5 6.4 4.6 11.2 9.3 7.5 4.9 15.4 13.6 5.2 4.4 9.7 12.1 3.3 1.4 4.7 1.4 2.8 1.4 1.3 1.6 1.2 1.5 1.6 1.8 1.3 8.5 1.9 3.0 4.2 1.8 0.8 9.5 12.1 6.1 13.3 10.9 8.6 20.4 4.2 15.8 26.1 53.6 25.9 40.2 53.6 95.2 67.6 35.5 35.7 32.1 30.7 40.1 15.7 21.9 28.2 17.6 17.9 54.0 40.7 23.3 20.9 26.6 75.6 56.6 67.0 28.7 14.8 36.5 77.9 52.8 44.8 10.5 23.9 39.3 33.7 13.6 41.9 21.1 24.4 32.3 41.1 15.0 40.9 32.3 33.0 37.0 33.1 84.8 156.3 27.7 25.8 52.2 S100A5 S100D ENSG00000196420 "S100 calcium binding protein A5" P33763 1 153537147-153541765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.6;thyroid gland: 9.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Distal tubular cells: 3.3;Extravillous trophoblasts: 7.2" "Group enriched" "Detected in many" 5 "ovarian cancer: 3.7;thyroid cancer: 11.7;urothelial cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "OE19: 24.3;PC-3: 7.1;RPTEC TERT1: 8.6;RT4: 14.2;SCLC-21H: 12.7" "Region enriched" "Detected in single" 85 "olfactory region: 1210.8" "Region enriched" "Detected in single" 30 "olfactory region: 16.8" HPA064184 Approved Nucleoplasm Yes NA Nucleoplasm "HPA064184: AB_2685206" "unprognostic (6.09e-2)" "unprognostic (2.92e-2)" "unprognostic (8.92e-2)" "unprognostic (1.63e-5)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (1.52e-3)" "unprognostic (4.11e-2)" "unprognostic (2.69e-1)" "unprognostic (7.39e-3)" "unprognostic (3.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (9.53e-2)" "unprognostic (5.70e-2)" "unprognostic (4.68e-3)" 0.5 0.1 0.8 2.4 0.2 0.9 0.4 0.2 0.9 0.6 0.3 0.2 0.2 2.3 1.0 0.2 1.3 0.7 1.6 0.2 0.4 0.1 2.3 0.2 3.0 4.6 0.2 0.2 0.2 0.2 0.0 0.4 1.1 0.2 1.5 0.0 0.2 3.8 0.2 0.2 6.0 0.5 0.2 0.2 1.1 1.9 0.2 0.2 1.6 9.1 0.2 2.6 1.8 0.6 0.9 4.6 2.3 1.2 0.0 7.6 1.2 1.5 4.1 0.0 0.0 0.4 0.3 0.3 0.7 0.9 0.5 1.0 0.4 3.0 0.0 2.7 1.5 0.3 1.2 0.1 0.7 0.6 0.3 0.0 1.9 1.5 0.1 0.3 0.0 2.5 0.0 0.8 2.0 0.6 0.3 0.4 0.0 0.5 0.1 2.2 0.1 0.3 0.9 0.1 24.3 7.1 0.0 1.3 0.7 8.6 14.2 12.7 0.0 0.1 6.5 0.6 1.2 0.0 0.4 0.3 0.1 0.9 1.9 1.2 0.0 0.6 0.0 0.4 0.5 0.2 0.0 1.2 2.3 2.0 0.2 7.6 0.9 4.2 2.2 2.8 0.5 2.4 1.1 1.9 0.0 0.6 4.6 6.1 1.2 0.8 0.2 0.2 0.9 0.4 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.2 7.2 0.7 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.3 0.3 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.2 0.0 0.0 0.4 S100P ENSG00000163993 "S100 calcium binding protein P" P25815 4 6693069-6697170 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 89.9;bone marrow: 42.8;stomach 1: 70.0;urinary bladder: 47.6" "Group enriched" "Detected in many" 5 "Syncytiotrophoblasts: 2319.4;Urothelial cells: 3591.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 564.7" "Group enriched" "Detected in some" 41 "basophil: 47.8;eosinophil: 24.8;neutrophil: 89.9" "Lineage enriched" "Detected in many" 68 "granulocytes: 89.9" "Cell line enhanced" "Detected in some" "BEWO: 28.5;Hep G2: 30.0;hTCEpi: 33.4;OE19: 130.4;RT4: 61.3;SK-BR-3: 34.3" "HPA019502, HPA075251" Enhanced Supported Nucleoplasm NA NA 1200000 Nucleoplasm "HPA019502: AB_1856530, HPA075251: " "unprognostic (1.46e-1)" "unprognostic (1.50e-1)" "unprognostic (7.52e-2)" "unprognostic (1.44e-1)" "unprognostic (2.22e-1)" "unprognostic (7.34e-2)" "unprognostic (1.60e-3)" "unprognostic (3.92e-2)" "unprognostic (7.19e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (2.00e-4)" "unprognostic (3.87e-2)" "unprognostic (1.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.24e-2)" "unprognostic (3.65e-1)" "unprognostic (1.12e-2)" 0.1 0.0 0.0 1.1 0.0 42.8 0.0 0.0 0.0 0.3 5.2 0.1 0.0 0.0 23.3 0.3 1.0 0.0 0.0 0.0 0.0 1.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 16.4 4.8 5.4 1.1 0.0 0.0 3.9 0.5 0.1 0.0 4.4 70.0 0.0 0.0 2.5 47.6 5.1 0.0 0.0 89.9 1.3 0.0 0.0 0.4 3.8 2.4 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.4 0.0 0.0 4.7 0.0 0.0 0.0 1.8 0.0 0.0 2.7 30.0 0.0 1.7 0.1 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.4 0.0 3.5 0.0 130.4 4.3 0.0 0.0 0.0 0.0 61.3 0.0 0.0 5.6 34.3 0.0 1.2 0.9 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 47.8 1.3 24.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.9 0.0 0.1 0.0 0.0 0.4 8.9 66.8 2.9 152.0 1.0 0.0 0.8 43.3 224.9 151.2 1.8 0.0 512.0 0.0 0.2 11.8 0.5 133.5 0.0 27.6 604.2 12.6 292.8 30.1 1.1 61.5 0.0 16.0 1.8 14.1 5.6 0.0 3.6 8.5 2.8 160.2 0.0 481.5 254.0 0.0 0.1 0.0 0.0 2.1 0.0 0.2 5.5 2319.4 2.2 48.0 3591.7 SAAL1 FLJ41463 ENSG00000166788 "Serum amyloid A like 1" Q96ER3 11 18069935-18106091 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039003, HPA039004" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA039003: AB_2676303, HPA039004: AB_10673602" "unprognostic (1.13e-1)" "unprognostic (3.00e-1)" "unprognostic (4.35e-1)" "unprognostic (2.37e-2)" "unprognostic (1.88e-1)" "unprognostic (5.76e-2)" "unprognostic (4.10e-3)" "unprognostic (1.53e-2)" "unprognostic (4.75e-2)" "unprognostic (7.26e-2)" "unprognostic (3.36e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.78e-5)" "unprognostic (2.86e-1)" "unprognostic (1.39e-1)" "unprognostic (3.72e-1)" "unprognostic (1.87e-1)" 10.1 10.1 12.5 23.6 11.4 22.5 14.0 17.3 12.5 10.7 13.0 12.9 9.2 11.0 13.2 11.6 11.8 9.9 10.2 10.2 10.0 8.8 10.1 11.3 7.6 18.2 11.7 8.2 12.7 14.4 5.8 16.8 9.6 10.3 9.6 16.9 10.8 10.1 8.7 9.5 9.7 11.2 13.5 9.4 15.1 11.5 17.8 12.9 22.1 8.7 11.5 20.5 11.6 10.5 14.5 17.8 7.4 12.0 8.1 16.2 8.5 10.9 17.2 12.5 17.0 8.5 9.5 10.4 12.4 8.5 19.1 22.7 23.9 4.2 29.9 6.6 6.9 26.6 14.5 23.8 20.1 26.9 13.2 24.8 13.7 10.7 15.1 6.9 23.0 12.2 6.6 9.5 12.2 18.4 7.2 16.1 26.2 20.2 10.1 15.6 15.1 26.6 22.0 16.2 17.1 17.2 26.7 22.0 10.4 10.8 13.1 15.5 14.7 11.2 12.0 14.7 16.6 7.6 10.6 6.5 21.9 15.2 12.4 17.7 4.9 14.9 33.1 9.1 18.5 19.9 7.4 10.5 3.3 11.8 12.0 11.6 14.5 14.0 10.8 17.8 10.2 11.5 11.9 0.5 8.1 11.5 9.0 16.2 8.5 12.5 11.4 17.3 12.5 10.0 8.8 11.7 8.2 10.3 12.9 0.0 9.6 16.1 7.5 4.0 8.6 7.3 2.5 5.3 2.3 1.8 2.0 18.5 5.0 8.2 11.0 7.2 5.5 23.3 8.9 17.5 6.1 3.8 13.9 4.0 14.0 0.0 26.9 6.7 9.1 1.9 7.5 7.9 5.0 10.8 10.7 5.6 6.7 3.5 7.4 5.7 7.2 6.5 11.3 35.1 28.9 4.6 8.7 12.9 14.6 4.7 SALL4 "dJ1112F19.1, ZNF797" ENSG00000101115 "Spalt like transcription factor 4" Q9UJQ4 20 51782331-51802520 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 8.8;testis: 11.7;thyroid gland: 8.6" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 25.4" "Cancer enriched" "Detected in many" 11 "testis cancer: 22.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "NK-cell: 6.3" "Lineage enriched" "Detected in single" 9 "NK-cells: 6.3" "Cell line enhanced" "Detected in some" "AF22: 13.1;AN3-CA: 9.1;BEWO: 17.5;NTERA-2: 31.5;SiHa: 8.0;SuSa: 22.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015291, HPA015791" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "HPA015291: AB_1856548, HPA015791: AB_1856547" "unprognostic (1.30e-1)" "unprognostic (2.35e-2)" "unprognostic (1.11e-1)" "unprognostic (1.09e-3)" "unprognostic (3.55e-2)" "unprognostic (7.43e-2)" "unprognostic (3.63e-2)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (9.23e-2)" "unprognostic (2.50e-2)" "unprognostic (2.39e-2)" "unprognostic (2.42e-8)" "unprognostic (5.90e-3)" "unprognostic (1.82e-1)" "unprognostic (5.00e-5)" "unprognostic (7.41e-2)" 0.3 0.4 0.3 0.3 0.9 1.2 0.3 0.8 0.9 0.4 0.7 0.3 2.2 0.1 0.3 0.8 0.3 0.2 0.3 0.3 0.3 0.1 0.5 1.9 0.3 0.3 0.3 0.3 0.3 4.6 8.8 0.6 0.3 0.9 3.1 0.2 4.5 2.2 0.4 0.3 0.3 0.7 0.3 0.3 0.8 0.3 11.7 0.3 0.3 8.6 0.3 0.3 0.9 0.3 0.1 0.1 0.6 0.1 6.3 0.2 0.0 0.0 0.8 13.1 9.1 0.0 0.0 17.5 0.0 0.1 0.0 0.1 4.5 0.1 0.0 0.1 0.1 0.1 2.2 0.1 0.0 0.1 0.2 0.0 0.0 3.0 0.2 0.1 0.0 1.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 31.5 0.1 0.2 1.2 0.0 0.0 0.0 0.2 3.0 1.6 8.0 0.0 0.7 22.0 0.0 0.5 0.0 0.5 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.6 6.3 0.1 0.1 0.0 0.0 0.3 0.9 0.8 0.9 0.3 0.1 0.3 0.3 0.9 0.3 0.0 1.3 0.0 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.4 1.1 0.0 0.0 0.2 25.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 1.7 0.0 0.0 0.0 0.0 1.0 SAMD10 C20orf136 ENSG00000130590 "Sterile alpha motif domain containing 10" Q9BYL1 20 63974113-63980008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;T-cells: 6.2" "Cell line enhanced" "Detected in many" "HMC-1: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040973 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040973: AB_10794258" "unprognostic (5.89e-3)" "unprognostic (1.16e-3)" "unprognostic (6.27e-2)" "unprognostic (3.19e-1)" "unprognostic (2.28e-1)" "unprognostic (2.84e-3)" "prognostic unfavorable (4.60e-4)" "unprognostic (2.69e-2)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.96e-2)" "unprognostic (1.08e-1)" "unprognostic (5.83e-2)" "unprognostic (4.97e-3)" "unprognostic (4.20e-1)" "unprognostic (1.28e-1)" "unprognostic (6.94e-3)" 2.4 2.8 6.4 6.1 14.5 3.4 5.4 25.7 10.4 2.3 4.4 1.6 9.2 7.3 1.4 3.0 10.3 4.7 8.8 3.2 5.5 5.0 6.5 4.4 3.6 10.1 3.5 3.5 0.5 5.6 5.3 3.3 3.3 3.2 4.8 3.7 2.7 9.7 6.5 1.7 9.3 6.8 1.5 1.9 5.7 10.2 3.2 2.4 5.7 3.1 2.7 12.3 5.4 4.2 2.9 1.0 0.6 0.4 1.0 6.2 1.6 5.9 0.0 2.0 0.2 0.5 0.6 0.1 1.9 1.6 3.9 1.8 5.7 11.6 0.4 4.0 0.9 0.2 8.1 1.9 2.4 2.0 12.1 4.0 2.0 5.9 8.6 0.8 10.0 16.2 0.5 4.4 2.1 0.3 2.9 1.8 4.3 4.8 4.9 0.7 4.5 4.5 9.3 3.2 8.5 9.2 6.3 0.1 10.5 6.4 10.5 2.2 4.7 1.3 11.3 2.4 0.8 7.6 5.0 1.7 1.2 2.8 0.0 0.3 1.0 0.7 3.3 3.8 8.1 1.1 0.0 0.2 0.6 4.9 0.2 2.7 2.9 3.3 2.9 0.6 1.3 5.6 6.2 0.0 1.0 0.4 1.0 2.5 1.6 6.4 14.5 25.7 10.4 5.5 5.0 3.5 3.5 3.2 2.4 3.0 0.0 2.2 2.2 0.9 6.1 2.0 0.0 2.7 1.2 8.7 2.0 2.3 1.7 3.4 0.0 1.0 2.6 0.0 3.0 0.4 0.3 2.6 0.0 0.6 1.1 0.0 4.7 2.5 1.5 0.0 0.0 0.7 1.7 2.8 4.2 2.7 5.2 1.9 0.0 3.1 2.6 0.0 0.8 0.5 1.3 1.6 2.3 4.4 2.2 3.4 SAP30 ENSG00000164105 "Sin3A associated protein 30" O75446 4 173369969-173377532 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022627, HPA059012" Enhanced Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB022627: , HPA059012: AB_2683880" "unprognostic (1.53e-1)" "unprognostic (3.67e-2)" "unprognostic (3.26e-1)" "unprognostic (1.39e-1)" "unprognostic (5.83e-2)" "unprognostic (8.71e-2)" "prognostic unfavorable (1.24e-6)" "unprognostic (4.95e-2)" "unprognostic (7.23e-2)" "unprognostic (3.93e-2)" "unprognostic (4.48e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (1.54e-7)" "unprognostic (3.97e-1)" "unprognostic (5.70e-2)" "unprognostic (1.30e-1)" "unprognostic (2.21e-1)" 16.9 19.8 15.6 19.2 18.3 29.6 13.7 19.4 21.6 13.5 21.9 22.5 11.1 14.3 13.6 15.2 13.0 15.4 13.4 20.1 18.0 14.7 7.6 10.3 13.5 10.5 23.4 13.9 17.3 10.5 6.6 9.2 10.7 15.8 16.3 11.2 15.3 11.8 15.7 10.0 8.0 13.8 19.0 24.2 15.7 28.6 26.8 23.3 10.7 12.1 7.2 9.7 24.9 17.6 0.7 2.9 1.9 4.1 0.0 1.9 0.8 15.5 5.3 15.4 14.9 9.9 6.2 3.4 7.3 6.3 8.2 10.3 2.2 6.3 14.1 3.4 8.5 10.4 3.9 12.4 6.2 6.4 15.8 11.8 18.8 12.8 6.3 9.4 10.8 12.0 10.2 3.0 7.0 7.1 11.7 9.7 10.3 9.7 60.2 10.6 6.6 15.2 12.1 6.8 7.0 10.3 12.4 5.5 10.0 5.0 2.5 12.6 26.6 10.4 10.5 4.7 4.1 4.4 6.4 9.4 5.9 8.0 13.8 16.9 34.0 12.1 13.4 19.2 26.4 16.8 1.3 4.1 0.0 1.9 2.4 0.7 0.4 1.0 1.2 2.9 0.7 0.2 0.6 1.9 0.0 1.3 0.1 1.4 0.8 15.6 18.3 19.4 21.6 18.0 14.7 23.4 13.9 15.8 23.3 0.0 2.9 4.5 6.1 45.9 23.7 25.0 2.5 4.0 3.4 7.0 21.6 2.3 0.0 2.4 12.6 13.1 3.6 23.3 3.1 8.4 19.9 7.4 6.9 7.9 8.2 23.8 18.9 10.4 63.3 2.3 9.5 10.8 32.1 2.8 7.4 48.7 2.5 3.5 6.0 4.5 43.5 51.8 19.5 53.9 9.8 46.3 1.0 5.0 9.7 2.6 SAP30BP "HCNGP, HTRG, HTRP" ENSG00000161526 "SAP30 binding protein" Q9UHR5 17 75667116-75708062 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042382, HPA052943" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042382: AB_10793881, HPA052943: AB_2681995" "unprognostic (6.92e-2)" "unprognostic (8.56e-3)" "unprognostic (1.20e-1)" "unprognostic (5.34e-3)" "unprognostic (2.95e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (4.71e-5)" "unprognostic (1.53e-2)" "unprognostic (2.15e-1)" "unprognostic (8.32e-3)" "unprognostic (1.03e-2)" "unprognostic (3.31e-3)" "prognostic unfavorable (1.98e-4)" "unprognostic (1.31e-1)" "unprognostic (1.88e-1)" "unprognostic (6.06e-2)" "unprognostic (6.58e-2)" 19.2 18.4 28.7 21.7 27.6 28.6 22.1 25.2 31.2 25.3 22.6 39.0 15.4 17.2 25.7 26.5 22.0 22.8 22.0 22.3 29.5 24.9 19.3 23.1 19.6 24.3 29.6 23.9 23.9 21.0 29.2 21.1 25.4 24.7 22.3 22.4 22.6 31.8 26.6 31.2 19.3 19.2 24.5 31.7 24.3 20.1 21.6 25.0 26.1 20.4 15.6 31.0 25.4 21.0 21.3 29.9 21.6 21.4 22.6 25.8 20.1 13.0 15.7 13.2 12.3 13.1 13.8 14.6 13.9 15.4 26.1 27.3 14.4 11.0 14.2 7.5 13.3 24.1 10.2 15.7 15.6 26.9 5.0 17.9 11.1 11.4 15.4 12.9 11.7 9.8 12.9 14.3 20.0 21.3 14.8 36.0 15.1 13.2 11.3 20.6 13.7 19.0 9.8 10.9 19.1 18.6 12.4 19.7 10.7 22.1 11.2 8.9 15.2 12.8 12.7 14.5 21.0 20.4 10.0 13.4 22.8 14.0 10.0 18.4 8.2 3.2 16.8 15.4 8.7 18.2 13.6 21.4 21.2 23.7 17.5 25.8 20.9 21.9 24.2 18.1 21.3 21.7 22.5 21.6 22.6 20.0 29.9 23.0 20.1 28.7 27.6 25.2 31.2 29.5 24.9 29.6 23.9 24.7 25.0 50.6 60.8 45.5 99.7 44.0 18.7 43.6 22.9 76.3 79.6 21.0 11.8 51.1 58.0 63.1 43.1 62.4 47.7 23.3 63.6 54.6 56.3 38.2 74.1 31.8 50.3 9.5 34.4 45.4 38.7 69.2 41.1 51.7 54.0 68.5 33.6 59.7 77.0 45.6 32.5 35.4 14.4 64.7 61.4 29.6 29.0 39.6 80.3 65.0 24.9 96.7 SART3 "KIAA0156, p110, RP11-13G14, TIP110" ENSG00000075856 "Squamous cell carcinoma antigen recognized by T cells 3" Q15020 12 108522580-108561400 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028840, HPA044322" Approved Supported Nucleoplasm No No Nucleoplasm "HPA028840: , HPA044322: AB_2678895" "unprognostic (1.72e-1)" "unprognostic (1.16e-1)" "unprognostic (7.59e-2)" "unprognostic (1.72e-1)" "unprognostic (2.00e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (6.32e-6)" "unprognostic (2.74e-1)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.38e-1)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (1.23e-1)" "unprognostic (1.23e-3)" "unprognostic (7.91e-2)" "unprognostic (1.61e-1)" "unprognostic (6.36e-2)" 18.0 19.0 29.3 30.0 27.6 25.9 19.6 35.7 27.9 22.8 19.1 19.1 19.4 14.7 24.7 19.5 23.7 22.5 19.1 16.2 21.5 19.3 16.1 19.8 18.6 28.7 16.3 26.1 30.2 17.2 28.9 25.8 20.2 19.6 21.6 21.0 19.0 18.6 28.7 43.9 23.3 19.6 20.2 15.7 25.9 18.7 20.5 20.1 36.2 25.5 15.5 30.5 20.9 20.5 11.7 13.0 14.3 10.4 11.4 15.0 9.2 12.6 23.9 21.1 21.9 12.5 10.0 16.9 12.3 16.8 23.4 18.2 21.1 8.8 21.5 7.3 12.3 14.7 12.1 34.4 16.8 21.7 22.9 18.5 29.5 16.0 20.7 19.3 28.1 15.9 14.0 15.2 16.4 24.3 18.6 14.5 20.0 31.5 13.3 14.0 16.7 24.9 24.3 32.3 13.9 25.3 24.3 17.8 19.2 12.3 24.0 21.9 15.2 17.2 6.8 11.1 20.1 18.4 21.0 9.4 13.9 8.8 10.6 11.0 16.9 23.3 29.5 14.2 17.1 18.1 14.3 9.3 10.4 13.5 7.8 15.0 11.7 9.1 12.0 13.0 11.3 14.0 11.2 3.1 11.4 10.4 8.8 13.6 9.2 29.3 27.6 35.7 27.9 21.5 19.3 16.3 26.1 19.6 20.1 17.9 20.3 16.0 15.2 13.1 39.9 15.5 10.2 32.1 29.6 17.4 33.4 18.6 6.6 12.2 30.3 18.5 8.5 0.0 11.0 11.2 14.1 13.5 16.3 11.3 11.5 33.4 12.0 12.9 15.2 25.8 9.5 14.4 15.1 17.2 9.1 25.3 11.4 5.8 16.6 6.2 39.8 32.3 12.6 21.4 29.6 15.7 19.8 17.5 10.9 13.6 SATB2 "FLJ21474, KIAA1034" ENSG00000119042 "SATB homeobox 2" Q9UPW6 2 199269500-199471266 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.1;intestine: 33.2;lymphoid tissue: 11.0" "Group enriched" "Detected in many" 7 "Enterocytes: 72.1;Intestinal endocrine cells: 95.8;Mucus-secreting cells: 76.0;Paneth cells: 48.9;Undifferentiated cells: 85.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 10.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 19.8;K-562: 21.6;THP-1: 29.5" "Group enriched" "Detected in some" 9 "amygdala: 7.9;cerebral cortex: 29.7;hippocampal formation: 19.7" "Group enriched" "Detected in many" 10 "cerebral cortex: 52.6;hippocampal formation: 45.2" "HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB023669: AB_1129287, CAB062562: AB_2665615, CAB067751: AB_2665629, CAB068229: AB_2665628, CAB068230: AB_2665630, CAB068231: AB_2665631, HPA001042: AB_10601711, HPA029543: AB_10959737" "unprognostic (1.77e-2)" "unprognostic (1.90e-1)" "unprognostic (8.53e-3)" "unprognostic (4.77e-2)" "unprognostic (1.07e-1)" "unprognostic (9.39e-3)" "unprognostic (1.80e-1)" "unprognostic (5.54e-3)" "unprognostic (8.26e-2)" "unprognostic (3.75e-1)" "unprognostic (2.04e-2)" "unprognostic (1.13e-1)" "prognostic favorable (5.37e-8)" "unprognostic (1.14e-1)" "unprognostic (2.84e-1)" "unprognostic (7.95e-6)" "unprognostic (1.08e-3)" 2.4 5.0 4.5 11.0 10.0 0.5 2.0 0.5 26.1 2.3 27.9 0.4 0.4 1.4 1.7 1.1 0.9 1.1 1.4 0.7 5.6 1.6 3.6 2.8 0.8 0.6 2.3 15.5 1.9 3.4 3.1 1.1 0.8 4.6 1.9 33.2 0.1 1.5 2.6 2.1 1.7 5.0 2.9 4.9 0.7 1.0 2.4 0.0 0.0 1.6 2.4 1.0 1.6 3.1 0.2 0.0 0.0 0.7 0.0 0.5 0.1 1.2 0.8 8.9 4.1 4.3 5.2 0.6 3.0 4.5 2.2 2.9 0.2 2.9 0.4 0.1 6.6 3.5 0.2 7.0 1.8 3.6 4.5 6.1 19.8 1.7 2.4 0.9 9.0 8.8 2.5 3.3 4.4 2.9 5.8 0.2 3.0 21.6 0.0 6.5 0.4 0.4 11.2 1.6 1.0 1.4 0.8 3.0 0.1 3.4 0.3 1.9 0.0 1.5 0.0 4.6 1.6 1.8 29.5 3.0 16.3 3.0 5.1 8.1 1.3 4.2 13.0 11.2 7.2 12.8 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 4.5 10.0 0.5 26.1 5.6 1.6 2.3 15.5 4.6 0.0 0.0 0.6 0.0 2.4 1.5 1.8 1.4 0.0 0.0 0.0 0.0 3.9 0.1 1.7 0.1 0.8 0.6 72.1 0.0 2.3 0.3 0.3 3.9 0.0 4.0 0.7 0.0 95.8 1.3 2.8 0.9 2.3 1.6 5.0 0.0 76.0 0.8 1.2 48.9 1.1 4.4 0.5 0.0 11.4 4.6 4.2 2.6 0.1 0.0 85.8 1.7 SBNO1 "FLJ10701, FLJ10833, MOP3, Sno" ENSG00000139697 "Strawberry notch homolog 1" A3KN83 12 123289109-123364843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.1" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 294.5;Spermatogonia: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042388 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA042388: AB_10795704" "unprognostic (1.61e-2)" "unprognostic (9.61e-2)" "unprognostic (5.12e-2)" "unprognostic (2.54e-3)" "unprognostic (3.50e-1)" "unprognostic (3.59e-2)" "unprognostic (1.21e-2)" "unprognostic (1.48e-1)" "unprognostic (5.33e-2)" "unprognostic (2.22e-1)" "unprognostic (2.22e-1)" "unprognostic (1.22e-1)" "unprognostic (6.61e-3)" "unprognostic (2.06e-1)" "unprognostic (3.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-2)" 7.6 7.6 12.9 9.8 12.2 21.4 9.0 24.3 15.9 9.4 8.6 6.4 6.9 7.4 10.9 6.4 10.7 9.3 6.4 7.5 11.3 9.2 9.5 11.0 7.4 12.7 12.1 10.9 10.4 9.5 13.7 15.6 11.8 12.2 10.2 9.5 5.3 7.2 9.1 11.2 8.6 10.1 10.0 9.7 9.4 8.7 57.1 12.3 19.5 14.6 4.8 12.0 8.6 10.4 11.6 8.1 13.8 13.5 7.9 14.7 6.7 11.3 22.1 8.9 16.5 12.7 9.9 18.5 10.4 10.4 9.3 7.8 15.6 7.4 24.5 12.5 11.9 10.4 13.5 18.8 11.6 15.4 18.0 7.1 23.8 13.8 12.6 6.5 29.0 20.7 7.8 9.2 13.0 12.8 10.1 9.1 13.6 29.2 8.0 16.0 11.5 16.0 11.7 13.5 9.8 11.5 17.2 13.0 12.6 7.2 29.6 15.1 6.4 18.1 12.8 9.6 10.9 22.2 10.1 12.0 12.6 16.0 14.9 9.2 8.1 17.2 31.3 7.2 17.3 14.2 8.3 8.2 10.9 12.6 9.6 14.7 11.6 12.2 12.5 8.1 9.7 12.0 12.9 13.8 7.9 13.5 7.6 9.4 6.7 12.9 12.2 24.3 15.9 11.3 9.2 12.1 10.9 12.2 12.3 26.8 18.8 38.5 40.3 56.2 86.0 31.1 22.9 37.5 33.0 34.9 74.6 55.8 19.9 28.9 42.5 25.9 21.1 0.0 23.7 43.8 36.7 29.8 28.8 23.6 23.9 60.4 38.6 28.3 35.1 26.7 23.6 31.9 32.1 54.1 22.7 48.9 30.2 17.5 57.0 23.2 55.9 25.8 44.2 294.5 190.1 53.6 88.7 42.7 36.6 41.3 SCAF4 "DKFZp434E098, KIAA1172, SFRS15, SRA4" ENSG00000156304 "SR-related CTD associated factor 4" O95104 21 31671033-31732075 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018319, HPA018668, HPA021504, HPA028807" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927" "unprognostic (9.18e-2)" "unprognostic (1.17e-1)" "unprognostic (9.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (3.99e-3)" "unprognostic (4.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.66e-2)" "unprognostic (3.28e-1)" "unprognostic (6.11e-2)" "unprognostic (1.85e-3)" "unprognostic (2.87e-1)" "unprognostic (7.65e-3)" "unprognostic (1.10e-1)" "unprognostic (2.16e-3)" 18.8 14.9 15.1 32.7 16.3 19.0 18.4 24.0 21.4 19.9 23.2 20.3 12.9 19.4 21.6 17.6 22.3 16.8 22.3 15.4 13.2 11.5 14.0 22.5 19.0 27.1 15.3 11.9 23.9 18.5 23.7 18.1 20.3 14.3 17.6 16.8 17.1 18.4 19.3 23.3 24.2 21.9 16.1 13.3 23.7 17.9 25.6 14.6 44.2 16.5 12.8 26.4 18.9 20.4 14.1 12.0 12.7 13.2 9.6 12.8 8.4 14.0 9.4 18.9 13.7 10.2 7.9 12.9 10.5 11.1 11.1 10.4 17.9 10.2 28.9 6.4 10.2 12.2 8.8 20.5 10.2 12.3 12.9 12.2 23.0 7.3 14.9 11.8 24.5 9.7 8.7 11.6 14.9 12.8 7.1 9.7 11.6 30.4 15.1 9.2 18.9 26.0 17.9 24.3 13.8 8.1 25.8 21.1 9.5 7.7 11.1 13.0 14.1 16.1 12.5 9.1 10.9 9.6 16.5 11.2 11.6 11.2 11.1 10.6 9.8 9.0 33.4 8.3 19.8 10.8 8.2 9.4 12.7 12.8 13.2 12.8 14.1 7.5 12.1 12.0 14.0 8.8 9.5 5.0 9.6 11.4 8.4 6.6 8.4 15.1 16.3 24.0 21.4 13.2 11.5 15.3 11.9 14.3 14.6 6.0 9.7 35.8 31.3 41.4 22.2 7.9 15.3 20.1 12.5 10.4 23.6 14.1 3.3 14.7 7.8 15.8 31.5 23.3 12.1 13.5 20.6 25.6 11.5 19.8 13.5 20.6 19.0 18.4 19.1 2.0 20.4 14.9 32.1 16.2 16.7 15.3 14.7 18.4 13.4 5.0 22.8 12.9 17.5 20.9 22.2 35.9 15.8 20.0 19.6 28.7 SCAF8 "KIAA1116, RBM16" ENSG00000213079 "SR-related CTD associated factor 8" Q9UPN6 6 154733325-154834244 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035601, HPA035602" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035601: AB_2674698, HPA035602: AB_10673220" "unprognostic (4.60e-3)" "unprognostic (3.67e-2)" "unprognostic (7.90e-3)" "unprognostic (2.50e-2)" "unprognostic (6.18e-2)" "unprognostic (1.13e-1)" "unprognostic (1.01e-2)" "unprognostic (3.41e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (6.61e-4)" "unprognostic (3.65e-1)" "unprognostic (2.08e-1)" "unprognostic (9.08e-2)" "unprognostic (2.66e-1)" "unprognostic (1.52e-1)" "unprognostic (2.42e-1)" "unprognostic (1.11e-1)" 27.9 19.1 17.4 32.0 19.1 36.1 27.5 28.1 22.2 30.0 23.4 18.2 20.8 14.2 28.3 21.6 18.5 25.1 21.9 19.3 16.9 13.4 19.8 17.6 19.6 23.5 16.2 15.1 32.6 20.0 33.6 24.1 23.8 14.8 24.4 20.7 17.9 21.9 30.1 28.5 26.9 21.2 23.8 14.3 21.7 19.9 25.4 20.2 42.6 24.7 20.1 22.8 26.1 32.9 5.4 3.3 3.8 6.7 6.1 7.5 2.6 8.5 8.4 24.9 15.0 16.8 17.3 15.3 14.1 19.9 18.7 19.0 13.1 8.7 26.9 11.5 16.2 16.6 11.7 21.9 18.6 25.1 11.7 11.0 24.1 9.1 16.0 19.5 22.2 16.2 18.6 19.8 16.3 25.6 14.5 15.8 11.9 27.9 16.4 17.1 15.6 23.7 15.1 17.3 13.2 6.3 22.8 13.6 14.5 15.8 15.8 15.4 18.0 14.7 19.4 10.7 18.7 12.7 25.9 14.4 10.7 13.0 13.8 14.2 15.4 11.3 29.8 13.3 13.9 16.5 1.2 2.8 3.5 6.0 3.9 5.8 4.8 6.2 5.9 3.3 5.4 6.3 5.6 3.8 6.1 6.7 3.2 7.5 2.6 17.4 19.1 28.1 22.2 16.9 13.4 16.2 15.1 14.8 20.2 23.8 18.6 14.1 10.3 11.2 17.7 31.1 7.6 13.4 9.1 12.2 23.6 9.2 1.7 9.3 2.7 13.5 12.2 0.0 10.2 7.4 13.5 10.4 33.5 10.4 11.2 12.7 12.5 19.6 25.1 4.2 15.3 11.4 10.1 6.4 13.9 14.8 11.9 8.6 11.7 5.3 18.6 25.8 8.2 21.4 22.4 9.4 8.9 10.0 13.6 12.8 SCFD2 "FLJ39514, STXBP1L1" ENSG00000184178 "Sec1 family domain containing 2" Q8WU76 4 52872982-53366075 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036526, HPA036527" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA036526: AB_10673499, HPA036527: AB_2675175" "unprognostic (1.50e-2)" "unprognostic (7.99e-2)" "unprognostic (2.99e-2)" "unprognostic (3.31e-1)" "unprognostic (4.22e-2)" "unprognostic (6.16e-2)" "unprognostic (1.27e-2)" "unprognostic (7.08e-2)" "unprognostic (4.02e-2)" "unprognostic (4.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "prognostic favorable (3.81e-6)" "unprognostic (9.39e-3)" "unprognostic (1.10e-1)" "unprognostic (4.86e-3)" "unprognostic (2.51e-2)" 13.7 19.4 11.0 15.8 15.1 12.5 13.7 7.8 17.6 12.9 11.7 16.2 6.5 10.5 14.2 9.0 16.7 9.9 10.0 11.9 11.5 13.2 13.6 17.2 10.4 12.7 15.7 9.3 13.2 18.3 11.4 15.3 11.2 16.4 8.7 11.8 10.5 13.0 10.4 13.8 13.5 10.7 14.2 13.2 12.7 10.6 5.1 12.4 16.2 10.1 10.2 19.3 10.4 12.1 6.5 15.9 1.4 9.7 13.9 9.5 9.1 6.6 6.2 3.6 8.3 11.9 12.1 4.4 15.5 11.7 5.4 4.6 4.4 8.6 12.7 12.0 29.5 5.7 4.2 11.5 13.5 10.4 3.9 6.7 7.1 6.6 5.3 5.6 8.4 13.1 8.3 8.2 10.4 4.1 5.2 9.1 3.4 12.0 7.4 9.2 7.7 12.4 5.4 2.1 19.1 7.8 7.7 3.3 13.4 6.0 4.5 10.3 5.8 3.5 13.1 6.9 4.3 5.1 4.1 8.4 11.8 7.5 13.3 11.3 8.7 4.7 15.0 8.0 10.5 33.5 0.0 5.6 1.4 7.8 9.7 7.8 6.5 6.4 8.8 15.9 5.7 9.5 8.6 1.2 13.9 9.3 10.3 5.5 9.1 11.0 15.1 7.8 16.9 11.5 13.2 15.7 9.3 16.4 12.4 0.0 1.9 7.5 4.6 3.3 3.3 2.8 15.3 5.3 0.0 3.5 5.9 6.7 1.7 3.5 1.8 3.0 2.2 0.0 4.5 6.2 5.1 2.5 12.7 5.3 4.7 4.8 1.2 3.1 2.7 1.7 6.1 3.9 5.0 0.0 3.0 3.8 2.2 2.9 5.3 5.4 3.2 0.0 3.1 4.3 3.2 4.6 3.5 4.4 4.0 1.8 SCML1 ENSG00000047634 "Scm polycomb group protein like 1" Q9UN30 X 17737449-17754988 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 214.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 17.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 39.9" "HPA035270, HPA035271, HPA061397" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA035270: AB_10672860, HPA035271: AB_10602795, HPA061397: AB_2684503" "unprognostic (6.36e-2)" "unprognostic (5.86e-3)" "unprognostic (3.83e-1)" "unprognostic (3.18e-1)" "unprognostic (1.73e-1)" "unprognostic (5.18e-1)" "unprognostic (2.12e-3)" "unprognostic (9.49e-2)" "unprognostic (8.40e-2)" "unprognostic (2.04e-1)" "unprognostic (3.75e-2)" "unprognostic (7.56e-2)" "unprognostic (1.44e-3)" "unprognostic (2.84e-1)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-3)" 12.6 12.1 5.9 6.7 6.2 3.1 9.6 5.5 7.7 9.6 10.7 6.7 13.5 8.8 10.4 8.3 6.8 7.2 6.2 7.2 6.4 4.6 7.8 30.4 11.9 8.2 5.1 4.1 19.6 7.4 4.1 8.8 10.9 9.5 8.5 8.3 12.7 7.1 15.0 19.5 6.2 8.5 11.1 8.0 7.9 6.0 35.4 4.3 6.3 5.2 7.3 6.1 11.5 7.6 3.5 2.2 0.8 3.2 8.0 17.1 2.1 10.2 2.8 8.8 3.0 8.4 11.1 1.0 10.0 9.7 11.1 14.2 5.8 4.7 0.0 4.4 6.9 7.2 5.9 11.5 7.1 16.5 0.0 22.7 0.8 8.0 11.3 11.3 0.0 5.5 7.4 6.5 14.6 10.9 2.4 0.1 4.0 1.6 0.0 10.1 3.2 0.0 0.0 1.4 7.6 11.1 0.0 4.6 4.6 4.4 2.5 1.8 2.3 4.6 0.0 3.8 5.3 1.6 0.2 5.2 10.7 4.4 39.9 6.5 6.2 5.6 0.0 8.7 0.9 3.0 0.0 1.1 0.7 0.2 2.9 0.2 1.3 2.9 0.3 2.2 3.5 17.1 8.0 0.8 8.0 3.2 0.5 0.4 2.1 5.9 6.2 5.5 7.7 6.4 4.6 5.1 4.1 9.5 4.3 17.9 22.6 10.3 31.8 84.3 54.6 21.8 5.1 8.1 17.0 15.7 64.8 4.1 8.3 4.9 20.6 22.7 19.6 0.0 7.6 1.9 35.3 28.9 10.4 52.5 16.1 36.5 10.9 14.1 12.9 14.8 55.0 17.0 27.0 3.6 17.7 32.4 4.8 21.6 32.2 4.4 85.4 51.8 45.3 214.3 49.6 99.6 4.7 5.7 32.0 23.7 SCML4 dJ47M23.1 ENSG00000146285 "Scm polycomb group protein like 4" Q8N228 6 107704104-107824317 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.3;lymphoid tissue: 24.6" "Group enriched" "Detected in many" 21 "Early spermatids: 71.9;Late spermatids: 104.1;T-cells: 35.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "gdT-cell: 19.5;MAIT T-cell: 18.0;memory CD4 T-cell: 27.3;memory CD8 T-cell: 24.3;naive CD4 T-cell: 26.9;naive CD8 T-cell: 23.9;NK-cell: 17.6" "Group enriched" "Detected in many" 5 "NK-cells: 17.6;T-cells: 27.3" "Cell line enriched" "Detected in some" 5 "HDLM-2: 37.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA063326, HPA065958" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA063326: AB_2684986, HPA065958: AB_2685587" "unprognostic (4.00e-5)" "unprognostic (2.10e-3)" "unprognostic (4.71e-2)" "unprognostic (4.24e-3)" "unprognostic (1.38e-3)" "unprognostic (4.75e-4)" "unprognostic (3.84e-3)" "unprognostic (6.65e-3)" "unprognostic (4.26e-1)" "unprognostic (1.53e-2)" "unprognostic (2.13e-4)" "unprognostic (3.68e-1)" "unprognostic (3.77e-4)" "unprognostic (8.65e-2)" "unprognostic (3.68e-2)" "unprognostic (2.52e-3)" "unprognostic (5.09e-3)" 1.3 0.6 0.5 13.9 0.6 2.7 1.4 0.3 0.5 1.2 5.4 0.3 0.3 10.1 0.9 4.9 1.3 1.2 2.4 0.6 1.7 0.9 1.7 2.7 3.2 24.6 0.4 0.0 0.7 1.4 0.0 3.9 0.3 0.5 1.2 2.1 1.6 5.7 0.0 0.3 0.9 12.4 0.4 0.9 11.5 2.4 10.4 0.2 23.9 1.5 1.3 24.5 2.3 1.3 4.5 0.3 3.6 0.1 17.6 27.3 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 0.0 2.1 19.5 0.0 18.0 4.5 27.3 24.3 0.0 3.5 26.9 23.9 3.6 17.6 0.1 0.3 2.6 9.4 0.5 0.6 0.3 0.5 1.7 0.9 0.4 0.0 0.5 0.2 0.0 0.0 0.9 0.0 1.3 0.0 0.8 0.0 1.4 0.0 0.0 0.0 1.0 0.0 0.6 71.9 0.3 1.0 0.0 0.0 0.0 0.6 0.0 1.1 1.7 0.2 1.6 0.0 1.3 0.0 104.1 0.9 0.8 3.3 1.0 1.6 0.0 0.1 0.3 0.7 0.0 0.0 0.0 1.0 1.1 0.5 0.1 0.1 35.9 2.9 0.0 SCNM1 MGC3180 ENSG00000163156 "Sodium channel modifier 1" Q9BWG6 1 151156664-151170297 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 77.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052439, HPA054324" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052439: AB_2681834, HPA054324: AB_2682451" "unprognostic (1.20e-1)" "unprognostic (4.42e-2)" "unprognostic (6.13e-2)" "unprognostic (7.79e-2)" "unprognostic (8.96e-3)" "unprognostic (1.77e-1)" "unprognostic (4.25e-3)" "unprognostic (1.25e-2)" "unprognostic (1.77e-1)" "prognostic favorable (1.23e-4)" "unprognostic (1.38e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (2.17e-13)" "unprognostic (8.74e-2)" "unprognostic (1.13e-1)" "unprognostic (8.48e-2)" "unprognostic (9.71e-2)" 20.5 15.5 22.2 21.1 21.1 32.9 16.2 17.0 20.0 15.3 16.8 21.0 8.0 16.3 18.4 15.0 19.4 16.5 15.5 16.5 19.8 17.1 19.5 19.8 16.1 34.0 22.9 14.9 16.8 13.5 10.3 12.1 23.6 20.2 17.3 14.7 20.3 16.2 15.2 47.9 21.7 20.5 18.0 22.3 41.8 14.6 14.4 19.4 40.9 16.1 20.1 27.2 21.6 15.6 28.2 61.4 50.9 45.3 28.8 30.1 37.8 13.1 9.2 10.3 12.1 14.5 10.9 17.4 10.4 12.1 25.4 19.9 20.1 12.9 21.0 17.0 11.2 6.6 17.8 12.0 9.6 12.4 13.2 13.3 18.1 13.2 12.8 21.0 24.0 17.8 11.4 18.7 17.8 16.0 11.9 15.3 14.7 14.4 16.1 12.4 32.4 17.0 37.3 26.2 20.5 14.4 23.3 12.4 26.0 13.6 8.8 12.8 20.6 11.8 19.2 23.3 13.4 17.8 77.1 11.2 12.2 11.4 12.6 22.1 20.9 28.4 32.8 12.7 25.5 15.6 50.9 45.3 45.6 20.4 33.7 19.3 28.2 24.8 23.0 60.2 24.7 22.9 19.9 45.7 28.8 21.0 61.4 30.1 37.8 22.2 21.1 17.0 20.0 19.8 17.1 22.9 14.9 20.2 19.4 3.0 17.5 25.9 17.5 23.7 17.9 26.6 12.7 24.1 21.6 27.9 17.7 31.2 46.4 32.0 24.9 23.7 24.2 46.7 27.7 28.6 28.9 12.3 39.3 11.0 62.2 7.9 13.8 18.4 58.4 19.2 28.7 54.1 20.3 52.3 15.5 22.0 32.8 28.1 20.1 28.3 14.5 32.3 33.0 22.8 13.5 15.9 23.0 46.7 16.8 19.6 SCRT2 ZNF898B ENSG00000215397 "Scratch family transcriptional repressor 2" Q9NQ03 20 661596-676179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 17.9;retina: 6.1" "Cell type enriched" "Detected in some" 51 "Horizontal cells: 57.2" "Cancer enriched" "Detected in single" 5 "glioma: 1.0" "Group enriched" "Detected in many" 4 "cerebellum: 8.8;cerebral cortex: 17.9" "Cell type enriched" "Detected in single" 25 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.4" "Group enriched" "Detected in some" 5 "Karpas-707: 4.0;NTERA-2: 3.7;RPMI-8226: 8.1;SCLC-21H: 3.9;SH-SY5Y: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA067697 Approved Nucleoplasm NA NA Nucleoplasm "HPA067697: AB_2685890" "unprognostic (9.71e-2)" "unprognostic (2.03e-1)" "unprognostic (6.97e-2)" "unprognostic (9.70e-2)" "unprognostic (1.70e-1)" 0.3 0.3 0.7 0.3 0.7 0.3 0.3 8.8 17.9 0.3 0.3 0.6 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.7 0.6 0.3 0.3 0.3 0.3 1.9 0.0 0.3 1.3 0.3 0.0 0.4 3.2 0.3 0.3 6.1 0.3 0.3 0.3 0.3 0.3 0.3 1.1 0.6 0.3 0.7 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 8.1 0.0 0.0 3.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.7 8.8 17.9 0.7 0.6 1.9 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 57.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SDK2 "FLJ10832, KIAA1514" ENSG00000069188 "Sidekick cell adhesion molecule 2" Q58EX2 17 73334384-73644089 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 13.6" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 14.2;Horizontal cells: 19.1;Intestinal endocrine cells: 14.3;Late spermatids: 15.3;Spermatocytes: 12.4;Syncytiotrophoblasts: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.7;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 5 "B-cells: 2.7;dendritic cells: 2.3" "Cell line enhanced" "Detected in some" "AF22: 14.7;BEWO: 12.1;RPMI-8226: 4.8;SuSa: 8.1;U-2 OS: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014725 Approved Nucleoplasm NA NA 2000000 Nucleoplasm "HPA014725: AB_2183303" "unprognostic (7.22e-4)" "unprognostic (5.57e-2)" "unprognostic (1.70e-1)" "unprognostic (7.00e-3)" "unprognostic (1.62e-2)" "unprognostic (3.18e-1)" "unprognostic (3.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.98e-1)" "unprognostic (1.49e-1)" "unprognostic (8.80e-4)" "unprognostic (7.69e-2)" "unprognostic (3.89e-2)" "unprognostic (1.44e-2)" "unprognostic (1.38e-1)" "unprognostic (1.37e-2)" "unprognostic (6.64e-2)" 0.4 0.6 2.1 5.3 1.2 0.7 2.6 0.5 2.7 8.9 0.5 0.6 0.0 0.0 3.1 5.1 0.9 3.5 1.4 3.5 1.7 4.1 1.1 0.5 4.2 4.8 1.6 0.0 0.8 0.4 0.0 1.9 3.7 1.9 2.6 0.3 2.2 2.0 1.4 0.4 0.5 0.5 0.3 3.0 3.6 0.6 13.6 0.0 0.1 1.8 1.1 2.9 0.7 7.2 2.7 2.3 0.0 0.0 0.2 0.5 0.0 0.0 2.1 14.7 4.2 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 3.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.5 0.0 4.8 0.0 0.0 3.3 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 4.4 1.8 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 2.7 0.5 0.4 0.0 0.2 0.0 2.3 0.0 0.0 2.1 1.2 0.5 2.5 1.7 4.1 1.6 0.0 1.9 0.0 0.0 2.4 4.5 3.7 0.8 3.5 2.0 0.0 0.0 2.3 0.0 0.0 3.8 0.0 0.2 10.9 0.3 0.0 0.0 0.2 14.2 1.9 2.3 1.1 0.0 0.6 19.1 14.3 0.0 0.0 15.3 0.6 0.0 1.7 1.8 0.2 7.8 0.0 0.0 0.0 0.0 0.6 0.0 0.9 12.4 3.5 0.1 14.9 0.0 0.0 0.3 SEC14L6 ENSG00000214491 "SEC14 like lipid binding 6" B5MCN3 22 30522799-30546682 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 15.4;parathyroid gland: 20.9" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.0;Club cells: 6.8;Collecting duct cells: 12.2;Muller glia cells: 14.0" "Cancer enriched" "Detected in many" 7 "renal cancer: 12.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "K-562: 11.2;RPTEC TERT1: 21.1;SiHa: 6.2" HPA067695 Approved Nucleoplasm NA NA Nucleoplasm "HPA067695: AB_2685889" "unprognostic (3.49e-2)" "unprognostic (4.76e-2)" "unprognostic (4.79e-2)" "unprognostic (4.09e-2)" "unprognostic (3.04e-2)" "unprognostic (1.12e-1)" "unprognostic (7.28e-3)" "unprognostic (3.88e-2)" "unprognostic (3.13e-1)" "unprognostic (3.35e-1)" "unprognostic (1.29e-1)" "unprognostic (9.25e-2)" "unprognostic (8.69e-2)" "unprognostic (8.20e-2)" "unprognostic (2.12e-1)" "unprognostic (2.48e-2)" "unprognostic (6.02e-2)" 0.7 0.7 3.3 0.0 3.6 1.1 2.4 1.1 2.1 2.3 0.0 0.1 2.0 15.4 0.0 0.9 2.8 0.0 2.4 3.4 7.2 0.0 7.9 0.0 4.0 1.7 3.5 20.9 1.8 0.0 1.0 0.0 0.0 1.6 0.0 7.3 0.0 1.3 3.9 0.0 0.6 3.8 0.0 0.1 0.1 0.0 1.2 0.9 2.7 0.8 1.9 2.2 0.3 0.2 0.1 0.9 0.3 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.2 0.5 0.3 1.1 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 2.8 0.3 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.7 0.0 0.1 11.2 0.2 0.0 0.4 0.1 0.4 0.5 0.0 0.1 0.2 0.0 0.1 21.1 0.2 0.2 0.1 6.2 0.1 0.0 0.2 1.7 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.3 0.1 1.9 0.8 0.7 0.6 0.6 1.6 0.7 0.5 0.5 0.2 1.2 0.6 0.9 2.7 1.9 0.7 0.9 2.2 0.3 11.9 8.0 0.0 0.3 0.1 0.0 0.3 5.1 0.0 6.8 12.2 0.0 0.0 1.7 5.1 0.0 0.4 0.0 0.0 0.7 0.0 0.2 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 14.0 1.9 0.0 0.7 2.6 0.3 0.0 0.1 0.5 0.2 0.0 0.1 0.0 0.0 0.1 SECISBP2 SBP2 ENSG00000187742 "SECIS binding protein 2" Q96T21 9 89318506-89359662 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 257.7;Late spermatids: 318.0;Spermatocytes: 306.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044314, HPA054905" Approved Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA044314: AB_10964885, HPA054905: " "unprognostic (1.07e-1)" "unprognostic (4.24e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-2)" "unprognostic (1.24e-1)" "unprognostic (1.21e-1)" "unprognostic (4.00e-1)" "unprognostic (8.80e-2)" "unprognostic (1.35e-2)" "unprognostic (7.18e-2)" "unprognostic (1.92e-2)" "unprognostic (1.16e-1)" "prognostic favorable (8.98e-9)" "unprognostic (5.44e-2)" "unprognostic (1.48e-1)" "unprognostic (1.98e-1)" "unprognostic (4.55e-3)" 17.3 24.8 19.5 23.1 26.6 26.4 30.0 28.3 28.9 22.1 22.5 21.7 19.8 20.5 28.1 26.0 16.7 23.3 17.7 13.4 22.5 15.9 26.8 25.4 30.0 25.6 20.6 16.2 36.7 34.3 26.9 33.9 29.9 21.0 21.0 24.9 21.3 26.8 21.3 32.6 25.8 23.6 21.3 24.7 29.7 23.2 58.2 22.8 26.6 31.5 11.8 23.4 19.9 26.3 14.1 11.7 21.5 9.5 9.1 16.1 5.9 13.4 9.2 25.3 14.6 11.9 13.0 18.3 7.8 9.7 9.4 9.3 5.1 11.4 20.2 6.9 7.3 15.0 17.1 17.0 7.9 8.7 13.3 10.1 9.9 7.2 13.0 10.4 19.8 14.9 8.1 15.0 7.9 9.5 10.4 11.6 27.2 12.6 24.0 8.9 12.5 27.1 10.2 26.2 34.0 9.1 13.1 12.4 13.2 10.5 10.4 18.5 18.2 7.1 15.8 20.5 17.6 14.0 17.2 10.7 9.1 10.6 12.2 12.0 29.3 18.6 8.4 15.9 12.9 13.1 12.2 7.6 12.7 10.4 7.9 10.1 12.9 10.7 10.2 6.7 14.1 16.1 13.5 21.5 9.1 9.5 11.7 12.5 5.9 19.5 26.6 28.3 28.9 22.5 15.9 20.6 16.2 21.0 22.8 41.7 47.6 35.6 60.3 17.3 105.5 15.1 20.4 41.5 39.8 38.4 86.4 55.5 36.5 33.4 257.7 36.0 38.4 23.3 27.3 41.2 27.2 56.9 34.7 33.3 23.6 54.0 35.8 27.0 31.8 318.0 37.2 26.3 20.3 27.9 51.3 45.0 31.3 46.0 24.1 44.6 111.0 32.3 24.5 306.3 193.7 22.2 76.8 43.3 47.0 55.5 SECISBP2L KIAA0256 ENSG00000138593 "SECIS binding protein 2 like" Q93073 15 48988476-49046563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.1" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 183.4;Syncytiotrophoblasts: 594.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039875 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039875: AB_10673365" "unprognostic (7.86e-3)" "unprognostic (2.53e-2)" "unprognostic (1.33e-1)" "unprognostic (3.19e-3)" "unprognostic (9.29e-2)" "unprognostic (5.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (9.58e-3)" "unprognostic (2.16e-1)" "unprognostic (3.08e-2)" "prognostic favorable (5.65e-8)" "unprognostic (1.87e-2)" "unprognostic (1.27e-1)" "unprognostic (2.01e-2)" "unprognostic (2.28e-1)" 13.2 12.6 30.1 8.5 32.2 14.4 14.3 18.1 38.0 15.2 10.8 40.7 12.1 7.2 14.1 17.4 13.2 14.4 11.1 11.1 38.4 23.8 19.3 13.9 27.3 9.5 38.8 24.8 15.5 10.9 42.0 12.7 29.4 36.7 16.3 9.2 8.1 30.8 14.8 10.1 8.3 8.5 11.5 66.1 10.6 13.6 9.9 35.6 6.7 18.2 6.7 9.8 10.8 10.3 14.7 8.1 14.6 6.0 7.8 11.1 4.0 4.7 5.1 11.5 9.6 16.4 12.7 6.8 16.8 14.1 14.3 17.7 5.7 4.3 3.3 8.0 12.8 15.0 4.0 14.4 4.2 16.9 19.2 3.5 9.5 7.4 4.5 8.6 5.2 10.8 10.0 5.5 12.2 6.9 15.2 13.5 8.0 5.7 8.5 16.5 2.0 5.4 5.0 4.1 3.1 4.6 5.5 12.6 13.0 18.4 10.2 2.0 7.8 10.9 20.0 15.9 20.4 5.8 6.1 16.2 12.5 6.0 11.8 7.8 7.0 12.4 6.0 9.9 7.6 16.6 9.3 5.1 14.6 9.0 4.9 8.5 12.2 8.1 6.1 3.6 14.7 11.1 8.7 9.2 7.8 6.0 8.1 5.8 4.0 30.1 32.2 18.1 31.5 38.4 23.8 38.8 24.8 36.7 35.6 107.2 183.4 25.3 14.0 13.2 33.9 35.8 15.3 99.0 61.4 31.4 25.5 71.2 13.3 23.4 8.2 29.2 20.7 0.0 16.3 30.7 28.0 30.9 31.3 22.1 23.2 54.0 9.2 26.4 13.7 6.9 31.1 18.1 43.9 28.9 14.2 35.2 29.3 14.0 34.3 32.1 25.4 6.5 21.7 17.4 27.8 11.8 594.9 17.5 9.9 31.0 SEL1L3 KIAA0746 ENSG00000091490 "SEL1L family member 3" Q68CR1 4 25747427-25863760 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 48.0" "Cell type enhanced" "Detected in many" 4 "Mucus-secreting cells: 74.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 45.9" "Group enriched" "Detected in many" 5 "memory B-cell: 20.8;naive B-cell: 20.8;plasmacytoid DC: 17.9" "Group enriched" "Detected in many" 4 "B-cells: 20.8;dendritic cells: 17.9" "Cell line enhanced" "Detected in many" "Daudi: 65.9;OE19: 49.9;U-698: 43.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 191.0" "HPA040045, HPA058792" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040045: AB_10796116, HPA058792: AB_2683822" "unprognostic (1.01e-2)" "unprognostic (2.03e-1)" "unprognostic (3.06e-3)" "unprognostic (1.44e-2)" "unprognostic (2.43e-3)" "unprognostic (1.80e-1)" "unprognostic (1.26e-2)" "unprognostic (1.39e-1)" "unprognostic (5.33e-2)" "unprognostic (7.24e-2)" "unprognostic (1.11e-1)" "unprognostic (5.11e-1)" "unprognostic (4.77e-2)" "unprognostic (7.21e-3)" "unprognostic (1.32e-1)" "unprognostic (2.28e-2)" "prognostic favorable (4.33e-4)" 5.4 3.3 4.0 36.3 5.6 2.3 3.8 45.9 6.4 13.7 19.3 1.5 1.5 19.3 2.2 18.1 6.2 3.6 22.0 2.4 3.3 2.8 6.9 3.6 14.3 27.7 2.1 1.7 3.1 48.0 10.9 2.9 13.7 3.0 4.2 16.7 12.9 23.1 1.0 1.3 1.7 30.3 3.4 2.1 33.5 24.6 2.2 1.1 2.8 12.5 3.8 46.7 14.8 2.2 20.8 17.9 0.4 0.1 3.7 4.3 1.4 4.8 5.3 3.9 1.3 0.6 0.8 0.6 2.4 6.6 1.8 6.0 3.3 22.7 65.9 11.7 16.6 15.9 3.1 2.9 10.5 2.5 3.5 1.7 0.7 8.8 4.5 17.1 9.0 0.4 1.3 8.5 6.6 2.6 7.5 24.8 1.3 4.3 0.0 1.3 3.7 0.0 0.6 11.4 49.9 4.7 0.3 21.7 9.1 14.5 16.4 9.8 1.9 16.1 0.2 1.6 5.7 0.8 11.2 10.8 0.1 7.9 0.1 6.9 0.4 0.1 43.0 30.0 3.8 4.5 0.4 0.1 0.0 2.8 0.0 3.4 20.8 3.5 3.1 0.7 20.8 1.5 2.4 0.3 3.7 0.1 17.9 4.3 1.4 4.0 5.6 45.9 6.4 3.3 2.8 2.1 1.7 3.0 1.1 11.9 29.0 65.6 3.0 0.8 2.1 1.2 63.7 8.1 55.7 3.5 0.0 23.3 0.0 64.6 46.5 8.4 31.3 23.3 28.5 1.3 1.5 12.0 2.3 1.7 4.6 0.0 11.1 13.5 16.0 58.1 1.4 6.4 8.5 15.4 74.5 32.9 37.4 24.6 0.4 9.7 29.0 0.0 1.4 0.6 2.4 1.4 13.7 26.1 35.6 4.2 SEPHS1 "SPS, SPS1" ENSG00000086475 "Selenophosphate synthetase 1" P49903 10 13317424-13348298 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037645, HPA062118" Enhanced Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037645: AB_10671631, HPA062118: AB_2732676" "unprognostic (8.18e-3)" "unprognostic (1.79e-1)" "unprognostic (1.06e-3)" "unprognostic (2.07e-1)" "unprognostic (3.50e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (2.16e-7)" "unprognostic (2.66e-2)" "unprognostic (1.43e-1)" "unprognostic (2.61e-2)" "prognostic favorable (3.12e-4)" "unprognostic (1.09e-1)" "unprognostic (1.38e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (5.11e-2)" 15.1 21.9 19.8 11.4 18.0 11.5 33.2 17.3 16.2 14.4 16.0 14.6 10.4 11.9 17.5 20.2 15.4 19.1 15.1 16.1 18.3 15.4 30.5 39.1 20.0 24.3 16.3 11.2 19.8 37.3 23.2 16.6 14.2 17.3 14.4 17.6 15.1 20.6 14.0 20.5 11.8 13.0 17.7 16.6 17.9 15.1 13.7 16.1 44.7 29.8 22.2 17.2 14.1 17.0 8.1 13.2 8.7 19.6 12.7 10.9 6.6 27.5 20.1 41.2 39.7 13.7 10.5 19.4 12.3 9.5 26.3 22.4 22.8 26.0 26.9 15.3 14.3 12.7 17.7 43.6 20.3 27.6 40.4 18.0 14.7 15.0 28.8 14.2 19.8 9.4 9.1 14.6 15.3 9.0 12.3 21.2 57.1 19.3 22.0 18.6 36.5 48.9 8.4 68.1 26.1 9.1 38.2 20.1 16.0 14.2 11.2 14.6 27.2 37.7 16.7 16.8 37.5 21.1 21.1 14.1 11.7 22.3 15.2 25.6 16.2 29.9 49.8 9.4 14.8 9.3 8.7 9.7 7.1 7.1 14.5 8.6 8.1 7.3 8.0 11.6 6.3 9.4 8.7 1.5 12.7 19.6 13.2 10.9 6.6 19.8 18.0 17.3 16.2 18.3 15.4 16.3 11.2 17.3 16.1 11.9 12.5 6.0 14.0 15.2 15.5 10.8 17.8 10.7 15.9 21.0 0.0 28.1 28.2 26.2 8.6 19.0 12.4 23.3 26.1 37.4 15.8 15.2 15.1 27.1 18.2 20.6 16.0 16.5 7.5 11.1 13.8 14.2 15.1 7.2 10.4 22.9 27.4 14.0 17.3 32.7 11.3 6.5 20.6 18.2 15.4 14.8 21.4 11.4 14.6 12.1 SEPHS2 "SPS2, SPS2b" ENSG00000179918 "Selenophosphate synthetase 2" Q99611 16 30443631-30446181 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 52.8;liver: 111.2" "Cell type enhanced" "Detected in many" 11 "Distal tubular cells: 326.6;Proximal tubular cells: 285.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 96.4" "Low region specificity" "Detected in all" HPA047931 Approved Approved Nucleoplasm No No Nucleoplasm "HPA047931: AB_2680216" "unprognostic (5.33e-2)" "unprognostic (2.02e-1)" "unprognostic (1.92e-2)" "unprognostic (9.85e-2)" "unprognostic (2.67e-2)" "unprognostic (6.29e-2)" "unprognostic (5.67e-2)" "unprognostic (7.69e-3)" "unprognostic (2.38e-1)" "unprognostic (9.86e-2)" "unprognostic (9.66e-3)" "unprognostic (1.49e-1)" "prognostic favorable (4.35e-8)" "unprognostic (2.24e-2)" "unprognostic (1.35e-1)" "unprognostic (3.25e-2)" "unprognostic (3.62e-2)" 9.0 9.0 4.9 6.9 6.4 4.0 6.7 6.3 8.4 5.3 25.6 5.2 5.5 26.6 7.6 6.1 6.0 6.1 12.6 5.3 5.2 5.1 32.8 111.2 5.8 7.6 5.5 3.8 5.2 10.0 7.3 6.4 7.5 7.7 6.6 13.1 6.2 10.6 4.7 11.1 5.5 52.8 4.9 4.4 10.5 12.1 3.0 4.6 14.1 11.9 6.4 9.5 8.1 4.4 14.6 15.3 20.5 13.7 23.2 18.9 8.9 14.8 13.4 4.8 16.5 14.7 9.4 12.5 10.3 12.7 10.1 12.6 8.3 11.4 21.3 15.9 10.9 9.2 8.3 8.8 9.4 10.3 13.6 27.2 21.3 7.3 39.0 18.6 11.8 96.4 11.9 20.1 9.5 17.7 6.4 9.2 15.8 17.2 13.9 8.9 21.9 17.7 24.4 11.8 11.2 10.2 17.3 8.3 16.3 12.5 13.4 10.1 8.7 8.8 25.8 33.4 10.0 22.6 39.5 7.7 10.6 7.5 10.2 6.2 12.0 19.2 11.1 9.2 22.1 11.8 6.1 12.9 20.5 11.2 11.2 17.1 12.4 15.9 16.1 15.3 14.6 18.9 12.9 12.9 23.2 13.7 10.9 15.1 8.9 4.9 6.4 6.3 8.4 5.2 5.1 5.5 3.8 7.7 4.6 41.7 32.3 26.8 1.1 33.3 0.8 46.2 0.0 21.4 21.6 61.1 0.0 1.1 326.6 80.1 0.0 17.5 13.1 0.0 72.7 0.9 24.9 1.7 30.1 6.7 1.2 0.0 34.0 0.6 2.4 0.0 0.0 34.5 42.2 64.1 1.1 0.2 55.5 3.5 0.0 285.3 0.8 0.0 54.6 0.7 0.7 37.3 1.0 20.8 1.4 0.6 SEPT4 "ARTS, CE5B3, H5, hCDCREL-2, hucep-7, MART, PNUTL2" ENSG00000108387 "Septin 4" O43236 17 58520250-58540818 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 77.8;brain: 94.8" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 2070.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 11.0;hTERT-RPE1: 14.9;SK-MEL-30: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006855, HPA021587, HPA022905" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB006855: , HPA021587: AB_1856686, HPA022905: AB_1856687" "unprognostic (1.12e-1)" "unprognostic (5.54e-2)" "unprognostic (8.36e-3)" "unprognostic (8.01e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-2)" "unprognostic (6.88e-3)" "unprognostic (2.73e-2)" "unprognostic (2.76e-1)" "unprognostic (8.02e-2)" "unprognostic (1.97e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.28e-7)" "unprognostic (6.40e-3)" "unprognostic (1.58e-1)" "unprognostic (8.26e-2)" "unprognostic (8.75e-3)" 14.8 77.8 70.5 2.6 80.0 0.9 7.2 44.3 82.7 4.0 3.3 92.4 0.0 2.7 3.5 3.9 3.2 2.7 8.3 14.3 84.8 49.9 8.5 25.0 9.5 5.9 94.8 32.3 5.4 3.9 4.8 2.4 9.9 49.7 2.5 3.1 10.0 4.4 3.8 4.2 3.9 2.9 6.0 84.0 18.0 2.8 7.3 56.5 0.0 4.5 0.5 3.8 5.1 1.3 1.7 5.5 2.9 5.5 1.4 7.6 5.6 0.0 0.4 0.9 2.6 1.1 0.1 0.4 0.1 0.3 1.6 1.9 0.1 0.1 0.0 3.9 0.6 2.4 0.2 1.4 1.1 0.4 0.1 0.7 0.9 0.2 5.5 11.0 0.1 0.5 5.7 2.2 0.4 2.0 14.9 0.5 1.4 0.0 2.6 0.1 0.0 0.0 0.1 0.5 0.0 0.7 0.1 0.0 1.2 0.0 0.0 2.8 1.6 0.0 0.1 24.2 1.3 0.4 0.3 0.0 0.1 1.2 0.0 1.0 0.8 0.4 0.0 0.9 0.0 0.3 0.0 5.5 1.1 7.6 0.7 2.4 1.7 1.6 2.0 5.5 0.6 2.9 2.3 2.9 1.4 0.0 0.3 1.0 5.6 70.5 80.0 44.3 50.5 84.8 49.9 94.8 32.3 49.7 56.5 0.0 0.6 0.0 0.0 5.5 93.8 45.3 0.0 0.0 0.0 7.0 329.9 3.6 14.9 0.0 62.0 12.7 0.0 23.3 0.0 0.3 7.0 0.0 1.1 20.8 4.7 2070.5 0.0 27.6 2.4 56.2 6.6 1.6 65.8 0.0 0.0 56.1 0.0 0.0 13.1 0.5 325.4 181.1 84.9 3.6 1.7 2.5 3.8 0.0 0.0 0.0 SERTAD4 DJ667H12.2 ENSG00000082497 "SERTA domain containing 4" Q9NUC0 1 210232799-210246631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 36.3" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 14.8;Ciliated cells: 14.7;Extravillous trophoblasts: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 7.4;BEWO: 7.7;SCLC-21H: 7.7;SK-BR-3: 8.8;T-47d: 10.8;U-2 OS: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027344, HPA028514" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA027344: AB_10601770, HPA028514: AB_10611391" "unprognostic (1.75e-2)" "unprognostic (3.92e-2)" "unprognostic (3.83e-2)" "unprognostic (9.74e-2)" "unprognostic (1.98e-2)" "unprognostic (1.27e-1)" "unprognostic (6.46e-2)" "unprognostic (1.03e-1)" "unprognostic (7.74e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-2)" "unprognostic (5.98e-2)" "unprognostic (6.24e-2)" "unprognostic (2.05e-1)" "unprognostic (3.85e-2)" "unprognostic (6.55e-2)" "unprognostic (4.24e-1)" 1.5 1.0 2.3 0.7 7.7 0.1 12.3 2.6 4.3 6.2 6.2 1.5 4.6 1.1 6.2 3.2 15.7 3.2 2.9 4.2 1.8 2.1 2.5 0.2 3.4 0.4 2.8 0.4 2.5 0.2 1.5 1.4 11.7 3.0 3.6 3.3 1.0 36.3 11.1 0.5 5.3 1.1 6.0 2.7 0.3 2.3 0.7 2.1 1.9 3.2 14.6 7.7 1.7 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.2 1.6 0.0 0.8 0.8 7.7 1.9 1.9 1.4 2.6 0.3 0.9 0.0 0.2 0.4 1.2 3.6 0.3 0.6 0.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 1.8 0.3 0.0 0.0 0.0 0.3 1.8 0.0 0.0 5.4 6.0 0.3 0.0 2.5 0.0 1.3 1.3 7.7 6.7 1.2 8.8 0.1 3.2 10.8 0.0 2.4 2.1 9.2 0.1 5.6 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 7.7 2.6 4.3 1.8 2.1 2.8 0.4 3.0 2.1 6.0 3.8 0.0 10.1 14.8 0.5 0.6 2.5 14.7 11.4 8.7 0.0 13.2 6.6 1.6 0.6 1.4 0.0 0.0 3.5 37.9 4.4 2.2 0.0 0.0 1.3 0.0 1.2 1.3 0.0 0.6 0.6 0.6 10.1 0.0 4.3 0.3 5.2 0.0 1.4 0.0 0.2 0.0 0.9 0.0 0.6 4.1 3.7 0.0 3.7 1.8 SETD1B "KIAA1076, KMT2G, Set1B" ENSG00000139718 "SET domain containing 1B" Q9UPS6 12 121804180-121832584 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021667, HPA059412" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021667: AB_1856753, HPA059412: AB_2684006" "unprognostic (1.69e-1)" "unprognostic (2.38e-2)" "unprognostic (6.32e-2)" "unprognostic (3.51e-1)" "unprognostic (2.06e-1)" "unprognostic (2.75e-2)" "unprognostic (5.32e-2)" "unprognostic (1.35e-1)" "unprognostic (1.28e-2)" "unprognostic (5.65e-2)" "unprognostic (1.59e-2)" "unprognostic (1.75e-1)" "unprognostic (7.33e-2)" "unprognostic (1.55e-1)" "unprognostic (1.28e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" 13.8 9.6 9.3 16.8 9.4 22.7 18.1 22.0 11.1 19.6 25.0 7.4 16.0 13.0 27.2 14.8 15.8 21.1 18.2 10.0 8.9 4.6 10.1 10.9 10.9 11.9 5.4 7.4 17.4 14.3 12.1 11.9 12.2 7.1 16.5 6.8 14.4 15.9 31.1 12.9 11.8 15.3 14.7 5.4 14.4 17.8 9.1 7.3 31.1 14.7 8.9 14.7 22.8 14.4 1.3 2.1 3.9 2.0 1.0 2.1 0.8 6.0 12.1 6.4 10.5 6.0 4.1 9.7 5.7 4.7 4.6 2.6 6.8 3.7 4.5 5.3 6.4 2.7 9.5 7.4 4.6 2.6 7.9 9.0 13.9 15.0 5.8 5.1 12.6 11.9 5.0 5.4 6.2 4.9 5.2 4.8 9.0 14.2 3.2 3.1 14.3 18.0 16.7 8.9 2.9 7.4 14.1 4.2 6.4 4.1 12.7 7.9 6.0 13.0 8.7 4.7 4.8 10.8 10.9 8.0 6.5 8.1 9.2 6.3 6.3 3.2 2.7 5.4 7.9 7.4 3.9 0.9 2.0 1.9 2.0 1.3 1.2 1.3 1.8 0.7 1.3 2.1 1.3 3.8 1.0 0.8 2.1 1.3 0.8 9.3 9.4 22.0 11.1 8.9 4.6 5.4 7.4 7.1 7.3 3.0 5.3 2.4 3.2 10.4 12.0 8.3 7.6 0.0 6.8 5.2 7.9 6.5 0.0 4.5 7.5 9.3 5.5 0.0 6.2 5.9 7.4 6.7 3.5 11.9 5.7 11.1 7.0 12.9 21.6 14.4 10.6 5.6 1.7 1.0 7.3 5.3 5.7 9.5 9.6 3.0 8.4 6.5 7.2 12.5 1.0 11.3 11.0 8.5 6.7 6.5 SETD5 FLJ10707 ENSG00000168137 "SET domain containing 5" Q9C0A6 3 9397615-9479240 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Autism, Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017093, HPA035574" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB017093: , HPA035574: AB_2674681" "unprognostic (6.46e-2)" "unprognostic (1.64e-1)" "unprognostic (3.44e-1)" "unprognostic (1.13e-1)" "unprognostic (1.22e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (6.21e-4)" "unprognostic (5.52e-2)" "unprognostic (2.29e-1)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (4.04e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (6.65e-2)" "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (5.15e-3)" 18.9 21.9 33.1 18.2 29.1 13.2 40.9 58.0 38.9 21.7 20.7 15.4 22.1 14.0 24.0 27.0 20.7 22.0 18.4 18.3 29.6 13.8 15.4 22.1 26.5 29.8 23.0 30.1 29.7 22.7 25.6 31.4 23.0 25.1 20.6 20.4 16.7 22.3 22.7 16.6 29.0 19.8 24.1 22.8 22.5 18.7 21.3 26.6 21.0 25.9 14.8 24.2 20.4 37.5 3.7 4.0 4.7 2.0 4.3 4.1 1.0 9.9 12.0 24.7 11.2 14.6 15.2 59.0 9.8 13.3 14.3 16.5 11.9 12.4 21.7 5.9 14.3 12.6 8.3 23.0 13.0 15.8 15.3 11.4 21.2 20.2 11.0 14.9 16.2 14.1 14.7 21.2 21.6 25.7 14.8 15.1 15.4 20.8 14.3 12.2 14.6 14.3 13.5 18.7 7.6 9.7 16.6 19.5 9.6 11.2 16.1 9.9 15.4 14.3 11.8 8.9 23.0 15.8 11.9 17.9 15.1 17.3 8.1 11.7 10.4 13.0 36.2 10.8 11.7 14.1 2.3 2.0 1.7 3.8 1.2 2.5 3.4 2.5 4.1 1.3 3.7 2.4 2.2 4.7 4.3 1.4 4.0 1.0 1.0 33.1 29.1 58.0 38.9 29.6 13.8 23.0 30.1 25.1 26.6 38.7 45.3 34.4 46.5 83.5 109.6 20.7 48.4 56.2 59.1 40.1 108.0 31.2 3.3 31.7 6.2 57.1 35.1 0.0 29.5 33.8 55.5 67.5 46.2 41.4 21.1 52.4 60.0 57.1 28.8 7.5 61.9 31.1 42.2 30.7 47.0 38.4 36.6 45.6 50.5 9.8 62.8 12.9 58.0 37.5 39.3 79.9 47.9 50.7 42.2 63.9 SETD9 "C5orf35, MGC33648" ENSG00000155542 "SET domain containing 9" Q8NE22 5 56909260-56925532 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 23.8" "Group enriched" "Detected in many" 6 "Early spermatids: 523.2;Late spermatids: 284.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049936 Approved Nucleoplasm NA NA Nucleoplasm "HPA049936: " "unprognostic (1.13e-1)" "unprognostic (3.89e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-1)" "unprognostic (2.29e-1)" "unprognostic (7.37e-2)" "unprognostic (8.75e-3)" "unprognostic (2.08e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-2)" "unprognostic (1.49e-1)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" 7.2 2.6 2.3 1.2 4.4 2.4 11.1 1.4 5.2 2.6 4.4 4.7 4.6 4.4 2.7 2.5 2.4 1.9 2.1 7.0 2.1 2.4 5.4 8.8 2.4 5.3 5.3 3.8 2.6 7.3 2.4 2.0 2.6 3.7 4.3 3.3 2.8 5.3 1.2 4.1 1.9 5.2 4.4 3.6 1.8 2.7 23.8 3.2 1.1 4.4 3.4 2.0 2.9 8.1 1.1 2.0 4.3 3.0 1.6 2.9 0.8 4.9 1.8 3.0 3.8 4.6 2.6 5.2 1.4 2.2 2.4 6.1 4.5 5.7 4.5 7.0 2.1 3.1 4.6 3.2 1.8 6.3 3.2 6.7 1.2 1.5 3.7 1.8 1.4 4.3 1.2 2.5 2.2 3.2 3.6 3.9 1.9 3.7 3.3 5.5 7.1 0.7 3.5 4.7 0.0 7.2 4.6 1.9 6.0 2.6 1.7 3.4 5.4 1.2 3.5 5.9 2.0 5.5 3.4 4.2 1.6 7.3 4.6 3.1 3.3 9.5 7.4 2.2 1.3 0.7 1.4 2.3 4.3 1.4 2.0 1.3 0.5 1.6 0.4 2.0 1.1 0.5 0.6 2.7 1.6 3.0 0.8 2.9 0.8 2.3 4.4 1.4 5.2 2.1 2.4 5.3 3.8 3.7 3.2 3.0 2.4 10.3 12.8 15.5 3.0 14.8 10.2 5.3 1.2 7.0 0.0 13.2 48.0 13.9 523.2 6.8 19.6 0.0 15.2 17.3 15.0 18.2 14.9 24.6 13.3 0.0 17.7 9.8 13.9 284.0 9.5 15.7 27.0 11.8 9.2 2.8 8.6 17.5 5.3 36.6 2.9 0.0 10.2 63.8 8.4 13.4 12.0 8.9 12.0 16.4 SETDB2 "C13orf4, CLLD8, CLLL8, KMT1F" ENSG00000136169 "SET domain bifurcated 2" Q96T68 13 49444374-49495003 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Chromatin regulator, Developmental protein, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012190, HPA071677" Approved Approved Nucleoplasm No No Nucleoplasm "CAB012190: AB_2186195, HPA071677: AB_2686430" "unprognostic (1.77e-1)" "unprognostic (1.11e-2)" "unprognostic (1.58e-1)" "unprognostic (3.61e-2)" "unprognostic (4.20e-1)" "unprognostic (3.70e-3)" "unprognostic (3.74e-2)" "unprognostic (3.44e-3)" "unprognostic (7.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.09e-3)" "unprognostic (7.95e-2)" "prognostic favorable (1.92e-7)" "unprognostic (2.83e-2)" "unprognostic (1.64e-1)" "unprognostic (1.95e-1)" "unprognostic (1.85e-1)" 10.2 14.5 9.8 20.5 10.8 9.5 14.1 14.4 12.3 13.0 12.4 8.3 13.6 7.8 13.1 11.6 9.8 9.9 9.7 12.7 8.2 6.9 12.4 11.0 16.3 19.0 7.2 11.1 21.0 15.0 10.8 15.8 7.8 9.5 13.6 11.9 13.5 11.7 10.9 5.5 9.6 11.4 11.3 8.4 19.0 10.7 18.1 8.7 17.3 14.6 3.7 16.6 11.9 10.3 8.4 7.4 4.7 5.4 7.8 10.2 4.5 2.0 1.4 4.3 4.4 6.1 6.9 2.2 5.9 7.4 5.3 5.0 8.7 5.0 25.7 1.2 3.8 4.0 4.2 4.5 4.0 5.2 5.8 3.9 8.9 3.9 5.2 8.6 13.5 5.1 5.3 7.4 4.0 13.4 5.8 4.5 8.3 3.9 3.6 4.8 1.8 5.1 10.1 2.2 5.5 3.4 10.0 5.4 5.4 4.9 1.9 2.2 2.6 2.6 3.7 12.6 3.9 3.1 11.8 2.7 5.1 1.8 6.8 2.4 4.3 6.0 13.6 1.6 11.0 2.3 4.1 4.1 4.7 6.9 5.4 5.8 8.4 7.1 7.1 7.4 8.1 10.2 7.6 1.4 7.8 4.3 5.2 9.4 4.5 9.8 10.8 14.4 12.3 8.2 6.9 7.2 11.1 9.5 8.7 26.8 14.1 32.7 5.3 6.2 12.6 22.4 10.2 13.4 10.3 5.2 25.5 4.8 8.3 3.3 14.7 8.2 6.9 0.0 3.8 2.9 5.1 3.0 5.8 5.9 15.9 12.7 11.1 5.5 19.0 11.1 9.2 17.4 13.5 10.0 6.2 10.8 3.1 2.9 7.8 3.4 29.6 0.0 5.2 18.2 11.8 5.3 2.4 19.1 8.5 2.0 SF1 "ZCCHC25, ZFM1, ZNF162" ENSG00000168066 "Splicing factor 1" Q15637 11 64764606-64778786 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018883 Supported Supported Nucleoplasm NA NA 52000 Nucleoplasm "HPA018883: AB_1856763" "unprognostic (1.24e-1)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (4.01e-2)" "unprognostic (1.50e-1)" "unprognostic (4.35e-1)" "prognostic unfavorable (4.85e-5)" "unprognostic (3.72e-1)" "unprognostic (4.51e-3)" "unprognostic (1.39e-1)" "unprognostic (4.62e-3)" "unprognostic (6.20e-2)" "unprognostic (8.00e-2)" "unprognostic (2.18e-1)" "unprognostic (1.42e-1)" "unprognostic (2.62e-2)" "unprognostic (1.78e-1)" 43.4 36.1 35.7 50.0 37.7 124.4 43.7 61.9 49.0 45.3 41.8 51.8 40.6 38.9 48.2 42.9 39.1 49.2 44.3 39.7 34.3 26.9 38.5 39.3 38.8 54.2 37.8 32.9 66.9 47.2 40.7 43.6 33.7 33.3 47.1 28.1 46.5 47.2 56.4 60.9 47.0 44.8 43.7 28.6 59.6 41.5 65.2 44.6 75.0 45.4 30.9 52.5 39.8 56.1 11.1 12.2 15.9 11.7 9.7 15.5 8.9 35.6 43.4 39.9 34.6 22.4 17.9 47.2 25.6 21.9 34.7 26.9 37.0 40.6 57.3 32.2 28.8 31.8 42.6 45.3 44.6 29.8 42.8 30.7 36.7 28.0 27.3 35.7 39.2 38.2 23.4 23.1 44.0 46.4 20.6 31.1 37.6 54.2 37.4 26.4 38.0 75.4 54.7 54.1 32.3 31.8 64.5 27.7 44.8 23.2 39.8 31.6 41.8 35.9 31.8 35.1 26.7 47.8 41.7 27.0 39.0 35.4 35.7 40.7 43.7 34.4 52.6 34.5 33.7 47.2 3.7 10.5 11.1 15.5 11.7 15.4 11.1 11.6 14.9 10.7 9.4 13.9 14.1 15.9 9.7 10.1 12.2 11.4 8.9 35.7 37.7 61.9 49.0 34.3 26.9 37.8 32.9 33.3 44.6 56.6 87.9 136.8 165.4 163.6 259.4 54.8 84.1 45.5 62.6 52.4 212.1 99.0 31.5 61.5 121.8 127.5 112.6 23.3 63.6 98.9 95.3 151.4 106.1 101.0 85.9 165.3 201.4 128.3 93.7 49.3 145.9 99.3 91.1 90.2 89.1 158.1 70.1 95.1 106.4 46.2 309.2 77.6 131.8 104.4 88.7 160.7 124.4 132.1 95.8 170.1 SF3A2 "Prp11, PRPF11, SAP62, SF3a66" ENSG00000104897 "Splicing factor 3a subunit 2" Q15428 19 2236504-2248679 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042843, HPA049439" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA042843: AB_2678199, HPA049439: AB_2680766" "unprognostic (5.29e-2)" "prognostic favorable (7.16e-4)" "prognostic unfavorable (8.64e-4)" "unprognostic (3.09e-3)" "unprognostic (9.19e-2)" "unprognostic (7.98e-2)" "prognostic unfavorable (3.23e-5)" "unprognostic (1.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.71e-1)" "unprognostic (5.72e-3)" "unprognostic (7.94e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (4.09e-3)" "unprognostic (5.38e-2)" "unprognostic (2.85e-1)" "unprognostic (8.73e-2)" 21.1 12.0 12.1 27.1 16.6 35.7 21.3 25.7 22.3 29.2 19.7 20.5 13.2 29.7 32.5 18.2 22.4 23.7 19.5 13.8 10.9 9.0 15.7 13.5 17.4 28.7 13.5 13.1 39.3 25.1 7.5 17.7 24.9 12.1 22.9 7.0 18.4 29.9 21.6 24.8 36.0 26.0 22.8 12.8 27.9 21.0 45.3 14.6 54.2 19.6 20.3 27.0 30.3 24.2 3.4 4.2 9.3 4.3 2.1 5.5 2.8 26.0 11.5 15.9 15.8 4.6 6.9 27.5 9.0 8.4 14.6 14.1 16.8 9.1 28.4 10.7 7.4 9.6 20.9 15.4 11.7 3.2 21.8 23.5 18.2 11.4 13.7 12.4 22.6 23.6 9.7 10.5 12.6 9.9 7.5 14.3 22.7 21.5 26.9 5.4 14.2 29.5 22.0 31.2 10.5 9.6 49.9 9.0 24.7 6.2 7.6 19.5 32.3 13.8 10.7 11.6 7.1 14.9 26.0 14.2 15.2 16.7 31.6 28.7 30.0 29.6 28.5 11.1 17.7 15.0 1.2 2.9 9.3 5.1 4.3 3.5 2.8 3.9 5.5 2.9 3.4 3.5 3.1 2.9 2.1 2.8 4.2 4.6 2.8 12.1 16.6 25.7 19.6 10.9 9.0 13.5 13.1 12.1 14.6 3.0 5.0 30.0 23.2 34.7 6.8 2.0 7.6 1.4 4.5 10.4 3.9 57.9 21.6 20.6 52.3 20.2 18.8 0.0 8.2 72.3 27.1 10.2 16.1 3.8 28.9 7.9 12.6 28.8 21.4 70.4 42.6 20.0 30.4 18.0 20.0 5.2 9.4 21.6 30.1 16.5 11.9 12.9 17.1 53.5 60.0 22.1 49.3 50.8 23.3 18.2 SF3B5 "MGC3133, SF3b10, Ysf3" ENSG00000169976 "Splicing factor 3b subunit 5" Q9BWJ5 6 144094881-144095573 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054408 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054408: AB_2682479" "unprognostic (1.22e-1)" "unprognostic (7.12e-2)" "unprognostic (4.54e-2)" "unprognostic (6.86e-2)" "unprognostic (1.42e-1)" "unprognostic (3.08e-2)" "unprognostic (1.07e-3)" "unprognostic (1.74e-1)" "unprognostic (6.47e-3)" "unprognostic (1.43e-1)" "unprognostic (1.33e-3)" "unprognostic (2.47e-1)" "unprognostic (3.61e-2)" "unprognostic (1.92e-1)" "unprognostic (2.77e-1)" "unprognostic (1.90e-2)" "unprognostic (1.49e-1)" 31.0 52.5 32.9 34.0 37.2 76.6 41.7 18.6 35.8 36.9 42.6 23.8 45.3 33.1 34.5 42.6 46.9 47.1 39.8 47.7 32.0 31.1 54.4 84.8 30.3 62.4 32.5 26.0 40.9 100.7 22.3 48.4 31.3 28.0 32.1 40.6 26.5 43.1 60.4 47.4 39.8 40.3 33.2 30.6 38.7 33.9 47.3 24.7 56.7 47.7 63.7 43.4 35.3 30.2 42.7 76.4 38.4 80.7 38.6 48.6 68.5 22.6 30.8 35.4 65.4 41.6 47.4 21.1 23.6 39.8 48.6 55.7 32.6 20.8 37.9 42.5 38.3 47.2 27.0 40.6 54.2 34.4 39.1 57.3 41.3 27.5 71.6 40.0 80.4 26.6 48.3 73.3 53.3 53.4 31.5 58.8 52.5 52.9 55.4 43.5 80.5 51.9 72.6 22.7 35.7 37.3 32.4 46.4 38.3 52.8 20.5 48.7 30.8 32.9 40.4 43.9 18.7 29.3 49.5 31.7 25.0 34.2 44.7 50.9 41.7 50.2 35.6 40.5 67.6 30.8 30.6 80.7 38.4 38.4 56.1 47.2 42.7 43.6 45.2 68.8 39.1 43.5 43.3 21.6 38.6 49.8 76.4 48.6 68.5 32.9 37.2 18.6 35.8 32.0 31.1 32.5 26.0 28.0 24.7 83.4 145.5 165.3 123.3 240.9 44.9 77.9 196.1 116.4 94.4 116.9 11.8 202.6 388.0 204.2 171.0 134.9 248.1 210.2 274.2 179.7 208.8 158.9 174.4 239.5 289.2 41.3 257.0 153.4 220.2 84.0 124.8 193.2 239.6 242.5 242.8 104.3 226.1 234.4 102.2 429.7 46.6 103.5 144.3 82.1 55.6 283.4 172.7 200.5 251.5 180.0 SF3B6 "CGI-110, Ht006, P14, SAP14a, SF3B14a" ENSG00000115128 "Splicing factor 3b subunit 6" Q9Y3B4 2 24067584-24076443 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034829, HPA034830" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA034829: AB_10673104, HPA034830: AB_10669680" "unprognostic (6.37e-2)" "unprognostic (1.38e-1)" "unprognostic (3.59e-1)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (5.35e-3)" "prognostic unfavorable (5.57e-5)" "unprognostic (1.74e-2)" "unprognostic (8.75e-2)" "unprognostic (7.41e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (2.80e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (1.28e-1)" "unprognostic (1.42e-2)" "unprognostic (5.44e-2)" "unprognostic (2.91e-1)" 39.4 43.5 39.5 31.0 35.9 72.5 57.1 24.2 35.5 43.7 49.7 30.8 34.6 39.5 41.3 58.6 62.9 36.5 35.4 38.8 35.5 31.5 60.3 64.5 33.1 37.1 35.3 29.2 41.5 43.1 26.4 41.4 49.3 30.8 41.8 45.5 27.1 46.4 36.3 40.8 33.4 62.1 46.0 40.4 42.5 35.8 42.2 34.7 56.9 57.1 63.3 47.3 49.6 42.2 54.1 49.9 71.1 45.6 44.0 62.4 47.4 49.8 24.2 38.9 32.3 30.9 48.2 23.9 38.0 40.6 45.9 47.4 51.6 31.6 37.4 21.5 34.9 47.3 29.8 39.8 47.8 55.8 36.6 47.9 39.5 31.1 44.8 55.6 48.7 24.7 44.6 57.3 46.6 53.6 48.4 45.9 35.2 44.7 28.4 47.8 37.7 36.6 73.7 31.2 62.2 47.8 27.0 53.4 37.1 54.4 28.1 34.8 52.3 21.2 42.1 83.5 34.7 20.5 50.5 27.4 25.3 35.1 26.5 62.1 28.5 36.6 101.1 34.6 81.5 34.9 56.6 43.9 64.9 36.8 45.6 40.5 54.1 46.9 43.9 49.9 40.7 46.4 49.1 71.1 44.0 40.2 45.6 62.4 47.4 39.5 35.9 24.2 35.5 35.5 31.5 35.3 29.2 30.8 34.7 65.5 65.5 119.9 229.6 0.0 50.2 109.1 163.1 143.2 101.2 130.9 15.7 250.0 330.0 180.8 127.3 117.2 210.5 140.2 145.5 328.8 128.0 207.7 98.1 161.7 204.5 17.5 173.1 131.3 129.1 26.7 194.8 118.8 0.0 227.2 200.2 113.5 180.1 263.1 169.7 338.6 53.4 116.4 169.3 210.5 163.8 0.0 227.2 122.2 209.2 366.6 SFMBT1 "DKFZp434L243, RU1, SFMBT" ENSG00000163935 "Scm like with four mbt domains 1" Q9UHJ3 3 52903572-53046750 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 30.2" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 123.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036152, HPA064564" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036152: AB_2674972, HPA064564: AB_2685288" "unprognostic (2.78e-2)" "unprognostic (9.96e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (1.69e-1)" "unprognostic (2.71e-2)" "unprognostic (1.28e-2)" "unprognostic (9.39e-2)" "unprognostic (6.79e-2)" "unprognostic (3.55e-2)" "unprognostic (2.36e-1)" "unprognostic (2.57e-2)" "unprognostic (3.57e-3)" "unprognostic (7.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.19e-2)" "unprognostic (3.55e-2)" 3.1 2.4 5.1 7.0 3.7 5.5 6.8 10.5 5.8 3.2 4.9 3.1 2.7 3.1 2.8 5.2 4.9 3.7 3.8 4.8 4.1 2.4 4.5 6.3 7.3 6.3 2.6 4.3 2.4 11.8 15.1 12.0 3.1 3.1 4.6 5.4 2.9 4.6 2.1 17.7 4.8 4.4 4.1 4.1 5.9 4.2 30.2 2.4 3.9 5.1 2.7 5.6 3.2 12.9 8.2 0.9 10.9 2.1 3.6 5.3 2.4 15.3 4.2 6.9 12.4 1.5 1.1 14.0 3.4 3.2 10.3 12.8 8.6 13.3 7.9 4.0 2.1 11.3 1.3 6.8 4.3 12.5 14.3 4.3 6.6 8.9 3.8 2.4 10.4 6.9 1.0 6.3 7.0 4.8 1.1 1.8 9.1 2.2 11.9 3.4 4.8 6.5 4.2 3.6 5.9 4.5 5.9 6.3 4.4 1.4 16.6 8.1 5.1 14.5 6.0 7.3 0.8 3.9 9.7 1.1 4.6 10.4 7.9 10.4 5.7 19.9 16.9 4.2 4.3 7.7 2.0 2.1 10.9 3.4 1.1 4.5 8.2 5.2 3.1 0.9 6.9 4.8 5.3 3.8 3.6 1.1 0.9 2.5 2.4 5.1 3.7 10.5 5.8 4.1 2.4 2.6 4.3 3.1 2.4 8.9 6.5 14.7 7.5 10.3 13.3 13.7 12.7 13.4 6.8 1.8 43.2 8.8 6.6 6.0 33.8 4.5 6.2 23.3 11.7 8.3 4.2 7.6 9.2 12.4 5.6 7.9 5.8 3.7 5.3 43.6 2.0 5.4 0.0 4.6 8.5 6.0 8.6 8.6 7.1 6.9 21.2 6.5 5.9 123.8 23.2 7.5 4.5 12.5 10.6 4.2 SFPQ "PPP1R140, PSF" ENSG00000116560 "Splicing factor proline and glutamine rich" P23246 1 35176378-35193148 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009886, HPA047513, HPA054689" Enhanced Enhanced Nucleoplasm NA NA 280000 Nucleoplasm "CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574" "prognostic favorable (9.56e-5)" "unprognostic (1.01e-1)" "unprognostic (1.02e-3)" "unprognostic (1.99e-1)" "unprognostic (5.53e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (7.91e-13)" "unprognostic (3.10e-1)" "unprognostic (4.00e-3)" "unprognostic (3.85e-2)" "unprognostic (2.20e-2)" "unprognostic (8.03e-3)" "unprognostic (1.25e-3)" "unprognostic (1.16e-2)" "unprognostic (3.97e-3)" "unprognostic (3.07e-1)" "unprognostic (3.77e-3)" 40.5 35.7 31.5 39.4 31.4 122.5 48.3 53.0 38.5 39.0 31.4 37.8 32.9 30.0 45.3 36.5 45.5 43.0 28.1 34.0 29.1 24.6 36.4 34.2 47.6 48.8 26.3 32.6 59.9 40.2 45.8 46.3 35.5 31.9 35.5 38.0 35.7 39.6 38.0 44.9 42.9 34.1 36.5 32.8 42.4 35.5 37.5 32.9 95.2 35.3 24.1 60.6 35.9 38.6 6.9 11.2 4.4 8.8 4.9 8.9 3.3 36.4 30.5 53.2 30.1 13.1 19.7 49.9 20.0 20.3 34.2 25.0 33.1 26.4 66.6 27.8 23.1 21.4 33.4 57.8 39.1 46.6 35.5 38.4 50.0 32.9 39.3 17.7 52.0 29.8 15.7 15.2 29.6 14.4 15.2 29.7 35.3 56.5 31.8 33.2 31.7 60.8 44.6 63.4 22.0 29.5 61.9 36.1 43.3 33.0 44.3 38.4 42.7 28.8 22.5 28.9 38.9 26.3 37.1 31.6 27.4 40.3 17.9 42.7 36.5 31.0 67.8 19.5 34.5 38.9 2.6 6.5 4.4 7.7 8.8 8.9 6.2 7.6 6.1 5.8 6.9 7.2 7.9 3.4 4.9 6.4 11.2 8.2 3.3 31.5 31.4 53.0 38.5 29.1 24.6 26.3 32.6 31.9 32.9 157.8 233.8 123.2 218.3 317.6 223.2 127.3 68.8 123.1 187.7 104.7 180.6 178.4 69.6 106.2 101.7 173.0 92.7 46.7 119.2 185.7 204.4 133.7 151.3 95.2 121.1 162.1 210.6 114.8 123.3 250.0 132.3 139.5 133.3 108.2 106.4 182.5 126.2 101.2 109.6 66.5 219.0 51.8 200.9 192.3 171.1 286.1 255.5 127.5 133.5 143.0 SGK2 ENSG00000101049 "SGK2, serine/threonine kinase 2" Q9HBY8 20 43558968-43588237 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.1;kidney: 39.1;liver: 32.9" "Cell type enhanced" "Detected in many" 15 "Distal tubular cells: 64.6;Enterocytes: 26.9;Hepatocytes: 26.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.3;CAPAN-2: 8.0;Hep G2: 10.4;OE19: 34.0;RPTEC TERT1: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008859, HPA011387" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008859: AB_2668159, HPA011387: AB_1856744" "unprognostic (1.82e-1)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.86e-1)" "unprognostic (6.27e-2)" "unprognostic (2.98e-4)" "unprognostic (2.05e-2)" "unprognostic (1.35e-1)" "unprognostic (4.30e-2)" "unprognostic (2.60e-1)" "unprognostic (1.05e-1)" "unprognostic (5.72e-4)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (2.56e-1)" "unprognostic (3.11e-2)" "prognostic favorable (5.65e-4)" 11.4 0.7 2.8 4.3 9.9 0.2 3.1 1.0 10.2 1.4 21.3 33.1 0.9 17.8 1.0 19.7 0.7 1.6 7.9 0.7 4.3 2.5 39.1 32.9 0.6 0.5 6.9 5.1 3.2 14.1 0.5 1.7 0.5 13.7 1.4 23.4 0.0 0.9 1.8 0.4 3.2 20.7 1.0 14.2 0.7 11.9 1.0 6.0 0.0 1.0 0.2 0.2 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 8.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 10.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 34.0 0.0 0.0 0.0 0.0 14.7 1.7 0.1 0.4 0.0 0.7 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 9.9 1.0 10.2 4.3 2.5 6.9 5.1 13.7 6.0 0.0 0.0 0.0 0.1 0.1 0.8 2.2 12.7 0.0 0.0 10.4 0.0 3.4 64.6 3.9 0.1 0.1 26.9 0.0 5.4 1.0 0.2 0.1 0.0 26.9 0.6 6.4 1.7 1.3 1.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 2.6 8.4 0.4 15.7 0.8 0.0 0.0 0.0 0.2 0.1 14.3 0.0 5.9 0.1 SGPP1 ENSG00000126821 "Sphingosine-1-phosphate phosphatase 1" Q9BX95 14 63684214-63728039 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 49.4" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 48.8;Kupffer cells: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 23.9;U-698: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053149, HPA064908" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA053149: AB_2682057, HPA064908: AB_2797270" "unprognostic (1.57e-2)" "unprognostic (1.04e-2)" "unprognostic (5.40e-3)" "unprognostic (7.82e-2)" "unprognostic (9.09e-2)" "unprognostic (4.30e-2)" "unprognostic (6.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.64e-1)" "unprognostic (7.41e-2)" "unprognostic (1.51e-1)" "unprognostic (3.27e-1)" "unprognostic (8.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-3)" 10.5 12.1 12.1 15.7 11.6 4.3 7.6 14.3 12.9 9.2 9.6 15.1 3.9 6.2 8.4 10.3 5.7 5.9 8.9 5.5 13.1 12.6 24.7 29.4 10.3 18.5 13.0 7.0 7.4 14.1 15.5 6.4 49.4 11.1 9.0 8.7 6.7 5.7 7.0 4.4 4.8 8.9 7.9 19.6 16.5 5.8 8.2 9.8 15.4 7.8 3.7 19.1 8.6 7.3 3.2 0.5 8.8 3.3 0.5 2.0 0.5 10.5 3.4 1.7 4.8 6.2 5.8 20.3 8.7 6.1 5.4 6.1 1.5 6.0 23.9 2.6 4.4 4.5 11.3 2.7 5.1 8.8 9.3 3.1 2.2 2.0 2.4 7.6 3.9 6.9 4.2 8.3 4.7 7.5 5.5 2.6 4.5 1.2 0.7 7.8 3.9 4.5 0.0 1.1 1.7 7.3 1.1 4.7 1.9 8.6 5.3 1.0 2.8 6.1 5.7 4.5 5.4 7.4 1.4 2.9 7.6 5.2 5.3 4.3 5.7 3.5 31.1 5.5 0.0 3.2 8.8 0.3 2.8 1.0 2.3 1.0 3.2 1.0 0.7 0.5 0.8 1.5 1.1 0.4 0.5 3.3 0.3 2.0 0.5 12.1 11.6 14.3 12.9 13.1 12.6 13.0 7.0 11.1 9.8 11.9 14.4 11.2 4.9 8.7 3.5 3.2 25.5 2.7 3.4 48.8 0.0 19.1 0.0 5.2 1.6 5.4 6.7 0.0 7.7 24.8 16.2 8.0 10.5 37.6 19.7 9.5 17.9 8.0 53.2 0.8 5.8 20.6 16.9 3.6 9.4 7.3 11.2 11.6 15.9 20.9 5.1 6.5 19.4 6.7 2.7 11.8 27.6 7.5 8.1 4.8 SGTA SGT ENSG00000104969 "Small glutamine rich tetratricopeptide repeat containing alpha" O43765 19 2754714-2783371 "Predicted intracellular proteins" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056309 Approved Approved Nucleoplasm NA NA 20000 Nucleoplasm "HPA056309: AB_2683096" "unprognostic (2.31e-2)" "prognostic favorable (9.70e-4)" "unprognostic (1.13e-1)" "prognostic favorable (1.04e-4)" "unprognostic (7.99e-2)" "unprognostic (1.06e-1)" "unprognostic (2.52e-3)" "unprognostic (1.47e-1)" "unprognostic (7.23e-2)" "unprognostic (1.97e-1)" "unprognostic (7.58e-3)" "unprognostic (2.89e-2)" "prognostic favorable (2.35e-4)" "unprognostic (1.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.04e-1)" "unprognostic (3.04e-1)" 19.1 18.6 28.6 16.7 28.8 27.3 15.7 25.8 44.4 17.3 19.3 46.8 21.1 26.8 18.7 18.9 23.9 23.9 16.0 44.6 30.6 24.7 21.6 29.5 15.6 18.9 28.8 27.0 30.2 41.8 14.9 23.9 30.4 27.0 20.4 11.4 22.2 31.9 22.4 62.9 16.2 24.0 18.4 35.7 20.9 19.6 28.9 21.0 33.2 25.0 18.6 15.9 16.6 19.7 16.4 22.5 22.9 29.7 19.6 23.1 19.0 28.4 23.5 21.5 20.6 8.9 9.3 17.9 19.3 13.9 29.7 25.5 37.3 12.9 26.7 15.6 15.0 17.8 20.4 27.2 30.2 11.7 0.1 24.2 15.1 12.3 27.3 21.3 20.6 17.4 15.4 16.2 22.3 20.0 11.7 19.9 22.7 39.1 22.4 14.8 17.3 31.6 22.5 37.3 19.3 22.7 39.7 19.5 30.2 15.9 17.7 40.3 31.2 14.8 21.2 27.5 10.0 25.1 24.8 16.6 19.2 19.8 36.6 34.6 39.0 38.7 32.0 24.7 43.0 29.6 13.4 21.1 20.6 18.5 26.0 21.0 16.4 19.4 20.1 22.5 15.0 15.7 15.4 22.9 19.6 29.7 19.4 23.1 19.0 28.6 28.8 25.8 44.4 30.6 24.7 28.8 27.0 27.0 21.0 8.9 20.7 20.8 21.0 21.1 40.9 41.9 17.8 4.0 10.3 17.4 23.6 45.8 29.9 34.2 66.8 24.8 37.6 0.0 38.9 44.3 23.5 22.7 27.7 21.5 33.6 36.5 30.9 12.9 22.5 34.2 20.4 20.3 18.6 38.7 27.5 40.1 31.5 38.6 25.8 21.7 40.8 12.9 22.8 31.7 20.6 21.5 77.6 17.5 30.2 26.4 SGTB "FLJ39002, Sgt2" ENSG00000197860 "Small glutamine rich tetratricopeptide repeat containing beta" Q96EQ0 5 65665928-65723035 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.8" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 66.7;Muller glia cells: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044689, HPA063674" Enhanced Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044689: AB_10960838, HPA063674: AB_2685084" "unprognostic (9.94e-2)" "unprognostic (2.28e-1)" "unprognostic (9.58e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (5.92e-5)" "unprognostic (4.27e-2)" "unprognostic (2.86e-1)" "unprognostic (2.41e-1)" "unprognostic (1.64e-2)" "unprognostic (5.35e-2)" "unprognostic (2.54e-3)" "unprognostic (6.82e-2)" "unprognostic (1.87e-1)" "unprognostic (6.34e-2)" "unprognostic (3.05e-3)" 5.9 4.0 14.5 9.4 17.1 11.1 4.0 14.0 40.8 4.6 3.2 4.2 0.2 2.4 6.5 3.2 4.3 2.9 4.4 5.6 13.4 13.4 3.8 3.7 5.3 9.3 14.8 11.9 4.4 2.8 3.7 3.9 5.1 16.9 6.8 3.8 3.0 2.4 3.3 3.5 3.1 2.6 7.2 12.2 6.0 2.7 2.8 4.9 3.1 5.8 0.9 6.4 5.1 3.0 1.5 2.4 8.5 6.6 1.0 13.4 3.1 4.7 3.0 5.8 5.9 8.8 11.6 5.7 19.9 6.2 6.7 9.2 4.1 2.0 6.4 10.8 15.4 11.8 4.8 8.3 7.6 10.9 4.8 8.1 2.8 8.4 8.2 22.8 2.1 4.7 8.6 6.7 14.5 19.2 4.7 6.4 5.1 4.8 4.4 10.4 1.7 4.5 3.3 3.9 0.4 1.6 5.4 10.2 6.6 3.0 1.7 9.1 4.9 8.1 1.4 9.3 6.1 2.0 3.2 9.6 8.8 9.5 9.4 4.4 3.5 5.3 8.7 4.5 6.1 3.4 8.5 5.7 1.3 2.9 6.6 2.7 1.5 6.8 3.8 2.4 1.4 7.4 4.2 6.1 1.0 5.5 0.6 13.4 3.1 14.5 17.1 14.0 29.9 13.4 13.4 14.8 11.9 16.9 4.9 14.9 5.6 1.4 2.4 5.7 6.0 3.2 5.1 2.7 6.8 1.8 0.0 1.3 0.0 2.7 1.9 6.8 0.0 0.0 1.7 3.5 7.5 3.6 20.7 3.8 20.5 66.7 1.7 1.8 20.2 1.4 3.7 16.4 11.8 19.0 1.5 59.7 3.6 1.4 3.9 1.8 4.2 12.9 10.8 4.1 4.8 4.0 1.0 10.2 0.6 1.3 SH2B1 "FLJ30542, SH2B" ENSG00000178188 "SH2B adaptor protein 1" Q9NRF2 16 28846600-28874212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060663, HPA076175" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA060663: , HPA076175: AB_2686782" "unprognostic (3.60e-2)" "unprognostic (1.94e-2)" "unprognostic (8.94e-2)" "unprognostic (2.27e-1)" "unprognostic (3.27e-1)" "unprognostic (3.27e-3)" "unprognostic (6.10e-2)" "prognostic favorable (9.40e-4)" "unprognostic (3.94e-2)" "unprognostic (1.18e-1)" "prognostic favorable (4.38e-4)" "unprognostic (1.39e-2)" "prognostic favorable (2.81e-6)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.60e-4)" 18.1 29.5 31.5 22.2 32.0 24.6 19.7 45.0 42.3 23.3 24.1 27.7 32.7 33.6 26.0 21.6 19.4 25.7 22.0 23.6 26.0 22.9 27.0 18.2 18.9 26.0 30.1 36.2 39.7 27.1 50.6 33.1 15.4 25.5 25.4 21.6 29.1 35.3 32.6 37.7 29.5 32.0 20.3 22.2 28.9 21.7 19.9 28.0 17.0 33.1 18.8 18.2 20.9 21.2 4.7 4.7 7.1 3.4 1.7 5.3 2.0 12.9 19.1 14.7 18.9 15.5 13.2 12.3 13.6 7.7 10.8 11.7 12.9 22.1 12.1 19.2 10.9 9.3 20.8 9.6 15.1 6.1 15.6 12.4 10.7 44.1 19.6 11.8 10.7 10.3 18.4 12.4 15.0 6.1 18.4 12.3 12.5 17.0 17.8 14.1 17.8 16.0 16.0 19.0 6.8 7.8 27.2 8.8 20.1 12.4 9.9 16.9 22.8 6.5 19.2 9.9 9.2 15.1 11.6 17.3 12.4 10.5 10.8 10.2 33.9 16.7 13.3 19.3 18.9 12.4 7.1 3.4 2.0 5.3 2.8 5.1 3.9 4.3 3.7 3.0 4.7 3.4 3.1 6.0 1.7 2.7 4.7 4.5 2.0 31.5 32.0 45.0 42.3 26.0 22.9 30.1 36.2 25.5 28.0 6.0 10.7 9.8 15.5 9.6 24.3 15.8 15.3 9.4 14.8 21.0 31.4 13.5 13.3 8.1 1.8 11.7 24.4 0.0 11.3 6.7 11.9 10.3 5.8 4.9 10.7 27.0 26.6 11.1 7.6 3.4 20.4 10.0 3.3 10.8 22.2 16.9 10.5 22.1 22.3 7.0 26.8 25.8 12.2 9.3 11.3 9.7 11.4 10.2 26.5 9.5 SH2B3 "IDDM20, LNK" ENSG00000111252 "SH2B adaptor protein 3" Q9UQQ2 12 111405948-111451623 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ito cells: 49.7;Kupffer cells: 110.0;Macrophages: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 32.3;hTEC/SVTERT24-B: 37.0;U-87 MG: 56.2;WM-115: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005483 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA005483: AB_1079260" "unprognostic (2.77e-1)" "unprognostic (1.74e-1)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" "unprognostic (1.18e-1)" "unprognostic (9.09e-2)" "unprognostic (1.23e-1)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (4.65e-2)" "unprognostic (8.17e-3)" "unprognostic (9.08e-2)" "prognostic unfavorable (6.20e-4)" "unprognostic (2.86e-1)" "unprognostic (3.89e-3)" "unprognostic (1.11e-1)" "unprognostic (2.24e-2)" 17.6 9.0 7.9 13.7 7.9 34.4 19.8 3.8 9.3 8.9 7.5 7.2 3.1 5.3 8.0 7.1 5.6 7.5 12.7 15.3 5.8 5.5 9.2 12.5 17.6 27.8 6.6 4.0 8.2 11.0 4.7 7.6 16.1 5.2 8.4 9.3 8.7 5.0 4.2 10.2 3.6 10.3 9.1 7.8 31.7 5.5 13.3 6.8 9.5 10.2 3.2 11.8 10.0 5.8 1.8 6.1 3.8 10.3 2.3 1.7 1.9 2.3 1.4 1.8 1.9 6.4 9.6 1.2 7.5 20.6 5.7 6.2 2.1 1.3 3.9 5.4 11.4 19.5 0.4 1.4 4.3 9.4 3.3 0.7 13.4 0.6 1.5 6.3 5.8 32.3 5.7 1.0 37.0 3.3 12.8 30.9 3.3 9.6 1.6 20.9 0.8 2.4 11.7 2.8 0.6 5.4 2.4 4.2 2.5 2.7 0.9 1.2 1.3 1.3 0.1 10.7 1.7 0.9 8.4 23.9 5.3 3.0 4.5 12.1 3.6 3.8 4.5 56.2 4.2 42.8 1.1 4.3 1.5 1.6 10.3 1.4 1.8 1.4 1.7 5.9 0.7 1.0 1.3 3.8 2.3 7.6 6.1 0.5 1.9 7.9 7.9 3.8 9.3 5.8 5.5 6.6 4.0 5.2 6.8 3.0 31.9 11.5 1.3 6.1 4.1 14.9 5.1 0.0 2.3 1.8 2.0 0.4 1.7 3.1 9.6 32.1 3.8 0.0 7.5 1.1 9.8 2.4 37.0 9.4 35.5 3.2 3.4 49.7 110.0 4.0 2.6 49.7 15.1 34.3 2.6 0.9 6.9 7.0 3.9 1.4 3.1 0.0 17.6 9.4 4.0 3.6 0.8 11.8 1.7 0.8 SH3BGRL2 ENSG00000198478 "SH3 domain binding glutamate rich protein like 2" Q9UJC5 6 79631283-79703659 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 104.4" "Cell type enhanced" "Detected in many" 4 "Mucus-secreting cells: 75.8;Paneth cells: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 7.4;neutrophil: 2.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.4" "Cell line enhanced" "Detected in many" "CACO-2: 33.0;HEL: 16.8;OE19: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047486 Approved Supported Nucleoplasm NA NA 4700000 Nucleoplasm "HPA047486: AB_2680065" "unprognostic (3.48e-2)" "unprognostic (1.95e-1)" "unprognostic (1.75e-2)" "unprognostic (2.28e-2)" "unprognostic (4.21e-1)" "unprognostic (7.77e-2)" "unprognostic (1.07e-1)" "unprognostic (1.60e-2)" "unprognostic (6.92e-2)" "unprognostic (6.53e-3)" "unprognostic (2.78e-1)" "unprognostic (7.94e-2)" "prognostic favorable (2.24e-4)" "unprognostic (1.60e-1)" "unprognostic (1.51e-1)" "unprognostic (2.11e-2)" "unprognostic (1.33e-1)" 21.0 3.9 11.6 6.5 10.7 1.1 29.3 9.7 18.3 14.6 24.7 2.6 7.9 17.3 9.1 13.0 29.8 9.3 14.2 7.4 12.3 13.8 8.2 27.6 8.0 4.1 14.6 7.8 3.5 11.6 17.9 12.6 14.4 22.4 13.8 24.1 9.6 104.4 6.4 8.3 7.1 17.3 8.2 13.9 3.8 34.1 3.7 2.4 0.4 38.3 11.1 15.0 8.7 12.6 0.0 0.2 7.4 0.3 0.0 1.2 10.8 3.4 0.6 3.2 0.6 2.8 2.4 7.6 0.2 2.3 0.8 1.7 33.0 6.7 0.0 4.8 0.2 0.6 1.6 2.9 3.7 2.8 0.0 4.2 16.8 0.7 6.3 1.2 0.6 0.4 1.3 3.0 2.4 1.4 1.1 9.8 0.0 6.6 0.0 0.2 0.5 0.0 0.0 2.7 40.3 1.1 0.0 0.9 0.0 0.8 11.1 8.5 9.4 0.2 1.0 0.2 4.5 0.1 1.4 5.5 2.2 1.4 0.0 1.9 5.0 2.3 0.0 0.3 0.0 0.7 7.4 0.3 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 1.2 2.7 0.0 0.0 0.2 0.0 10.8 11.6 10.7 9.7 18.3 12.3 13.8 14.6 7.8 22.4 2.4 6.0 19.0 0.9 3.7 1.9 12.6 5.2 66.2 25.4 27.3 21.0 7.9 33.0 0.0 15.1 10.8 29.8 58.0 0.0 11.3 1.9 3.6 27.2 0.0 61.0 3.7 12.7 12.1 35.0 4.1 14.7 0.6 1.1 15.1 1.8 75.8 8.3 14.8 69.1 4.2 8.4 11.7 0.0 5.3 1.7 0.9 0.6 44.1 0.0 59.5 25.7 SH3RF2 "FLJ23654, Hepp1, POSHER, PPP1R39, RNF158" ENSG00000156463 "SH3 domain containing ring finger 2" Q8TEC5 5 145936579-146081791 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Protein phosphatase inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 40.8" "Cell type enriched" "Detected in many" 5 "Late spermatids: 7204.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basal ganglia: 11.5;cerebral cortex: 2.9" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "dendritic cells: 1.4;T-cells: 1.6" "Cell line enhanced" "Detected in many" "CACO-2: 34.6;GAMG: 15.3;hTERT-RPE1: 17.2" "Region enriched" "Detected in single" 14 "basal ganglia: 23.9" "Region enhanced" "Detected in some" "basal ganglia: 14.5" "HPA035903, HPA058119" Uncertain Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA035903: AB_10696515, HPA058119: AB_2683611" "unprognostic (8.90e-3)" "unprognostic (2.00e-3)" "unprognostic (5.11e-3)" "unprognostic (1.66e-2)" "unprognostic (1.45e-3)" "unprognostic (1.47e-2)" "unprognostic (9.96e-3)" "unprognostic (8.22e-2)" "unprognostic (3.92e-1)" "unprognostic (7.37e-3)" "unprognostic (2.44e-3)" "unprognostic (1.66e-1)" "unprognostic (2.98e-2)" "unprognostic (5.21e-2)" "unprognostic (1.46e-1)" "unprognostic (2.64e-2)" "unprognostic (4.13e-3)" 2.6 0.6 1.2 6.2 11.5 0.0 2.9 0.2 2.9 6.4 19.1 0.4 0.4 9.2 2.9 2.2 22.2 3.6 40.8 23.5 0.8 0.3 0.8 4.6 1.9 0.0 0.3 1.1 1.0 14.3 0.0 3.3 0.3 0.1 2.2 8.5 0.9 16.9 1.0 21.7 33.1 21.4 1.2 0.5 0.2 11.9 6.4 0.6 0.6 3.8 19.6 16.1 0.9 10.0 0.0 1.4 0.3 0.1 0.0 1.6 0.3 10.2 2.8 0.1 0.6 0.0 0.0 0.0 0.1 0.8 2.1 0.8 34.6 9.5 0.0 5.4 0.4 15.3 9.5 0.0 11.2 2.0 0.1 0.1 0.0 4.1 4.6 0.6 0.0 0.0 0.1 6.0 3.2 7.6 17.2 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.8 8.5 0.7 0.0 0.1 0.0 4.4 1.0 0.0 0.0 0.6 0.2 0.2 0.5 3.3 0.0 4.9 0.4 8.9 0.7 3.3 0.0 0.0 0.0 5.5 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 1.6 0.7 1.4 0.0 0.0 1.5 0.2 0.0 0.1 0.0 0.8 0.3 1.2 11.5 0.2 2.9 0.8 0.3 0.3 1.1 0.1 0.6 14.9 2.9 0.0 4.5 48.9 0.6 414.9 2.5 2.7 2.3 1.8 0.0 0.0 0.0 6.5 1412.5 1.5 27.7 0.0 7.6 0.0 0.5 1.3 1.1 8.3 0.2 0.0 1.2 0.6 0.0 7204.3 23.9 0.0 8.5 1.0 12.2 1.9 13.6 17.5 32.5 0.6 0.0 12.9 1.4 32.0 16.2 43.7 0.0 0.0 27.1 6.4 SH3RF3 "FLJ00204, POSH2, SH3MD4" ENSG00000172985 "SH3 domain containing ring finger 3" Q8TEJ3 2 109129348-109504632 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 9.0;Horizontal cells: 9.5;Ito cells: 9.2;Sertoli cells: 12.9;Smooth muscle cells: 10.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HHSteC: 14.1;RPMI-8226: 13.4;TIME: 15.6;U-266/84: 18.2" "Low region specificity" "Detected in many" "HPA044822, HPA048444" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA044822: AB_2679103, HPA048444: AB_2680396" "unprognostic (1.97e-1)" "unprognostic (8.84e-3)" "unprognostic (8.04e-2)" "unprognostic (1.91e-1)" "unprognostic (2.55e-1)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (1.76e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (4.57e-2)" "unprognostic (1.95e-1)" "unprognostic (3.54e-2)" "unprognostic (4.94e-2)" "unprognostic (2.72e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-2)" 17.4 5.6 2.7 3.4 4.4 0.6 18.3 1.7 5.4 5.3 3.6 3.3 2.5 1.0 5.5 2.2 3.4 4.8 5.6 6.4 3.0 2.1 2.5 0.8 6.0 2.9 4.3 1.5 3.0 1.8 0.6 2.6 6.5 3.8 3.4 1.6 4.6 2.4 5.9 6.4 2.9 2.3 4.6 2.8 2.0 2.7 4.3 2.9 1.5 3.4 3.6 4.0 4.6 3.4 0.4 0.4 1.8 0.2 0.0 0.6 0.3 0.0 0.0 0.1 1.5 6.4 4.9 0.0 2.8 8.3 2.2 0.8 0.7 0.0 0.0 2.2 2.0 0.5 0.0 0.1 1.2 0.9 0.0 2.8 0.0 0.1 0.0 14.1 0.0 0.0 8.5 2.0 9.7 4.4 1.2 7.8 1.5 0.0 8.0 4.9 0.0 0.0 4.3 0.7 0.0 8.1 1.7 0.0 13.4 0.0 0.0 0.5 1.7 0.0 0.0 0.3 0.1 0.1 0.0 15.6 2.8 8.3 7.9 3.6 2.7 18.2 0.0 0.0 4.2 3.8 0.0 0.2 0.7 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.4 0.6 0.6 1.8 0.0 0.0 0.4 0.0 0.3 2.7 4.4 1.7 3.3 3.0 2.1 4.3 1.5 3.8 2.9 0.0 0.0 0.0 0.2 1.6 0.1 9.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.5 2.0 3.8 0.0 0.0 0.2 0.1 4.1 0.2 0.0 0.0 3.6 9.5 1.7 9.2 3.7 3.6 2.0 0.5 5.0 0.0 0.2 0.8 0.1 0.0 2.8 0.8 0.0 12.9 10.8 0.7 6.6 0.6 0.1 0.0 0.0 0.0 SH3YL1 "DKFZP586F1318, Ray" ENSG00000035115 "SH3 and SYLF domain containing 1" Q96HL8 2 217730-266398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 94.7" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 402.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 65.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030926, HPA030927" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA030926: AB_10670148, HPA030927: AB_10669874" "unprognostic (1.54e-1)" "unprognostic (1.33e-1)" "unprognostic (5.10e-2)" "unprognostic (2.28e-3)" "unprognostic (5.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.46e-1)" "unprognostic (6.57e-3)" "unprognostic (9.25e-2)" "unprognostic (6.40e-2)" "unprognostic (1.71e-2)" "unprognostic (2.81e-1)" "prognostic favorable (7.70e-4)" "unprognostic (1.95e-3)" "unprognostic (1.10e-1)" "unprognostic (1.47e-1)" "unprognostic (3.22e-3)" 3.6 11.7 10.3 8.7 10.1 2.6 16.0 8.7 9.7 9.6 12.9 8.6 16.1 9.8 7.9 12.4 17.4 12.8 22.9 4.1 10.5 8.0 42.5 3.8 14.9 10.4 10.9 11.8 9.9 94.7 13.9 20.7 11.4 7.9 17.7 15.8 7.3 35.3 26.9 3.2 21.5 32.1 7.6 13.1 5.5 23.6 6.0 8.2 5.7 22.5 15.3 14.4 18.0 9.5 7.2 3.3 14.0 2.3 12.4 20.6 5.2 3.6 0.7 4.1 1.8 5.6 5.3 2.7 4.7 5.3 1.8 1.8 9.9 13.9 0.1 2.3 4.1 1.2 15.5 1.0 20.3 1.7 3.1 0.7 0.9 1.1 3.1 4.5 0.4 1.2 5.9 21.0 1.0 3.4 8.8 2.6 5.1 0.2 0.6 3.6 10.7 3.9 2.0 1.3 65.8 0.8 1.8 1.2 0.2 12.6 21.0 1.7 2.8 0.7 19.6 3.3 5.7 13.4 3.1 1.9 0.9 0.2 5.2 2.0 0.5 0.0 0.3 9.0 6.2 3.0 14.0 1.3 1.0 2.6 1.6 8.4 7.2 13.3 6.7 3.3 5.5 20.6 11.9 0.8 12.4 2.3 2.9 16.2 5.2 10.3 10.1 8.7 9.7 10.5 8.0 10.9 11.8 7.9 8.2 53.6 103.8 28.7 161.2 73.5 18.5 5.7 280.2 57.6 78.5 96.0 21.6 132.4 247.1 104.8 113.4 15.7 68.8 0.0 125.5 61.0 27.7 132.4 15.1 6.8 23.1 25.4 47.1 18.4 6.9 92.8 33.9 14.8 69.2 14.4 79.9 7.7 99.4 91.2 38.5 402.5 8.7 25.8 18.6 61.2 23.6 100.7 206.5 17.5 106.3 210.4 SHC3 "N-Shc, NSHC, SHCC" ENSG00000148082 "SHC adaptor protein 3" Q92529 9 89005771-89178767 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 2: 16.0;Bipolar cells: 7.0;Muller glia cells: 6.1" "Cancer enhanced" "Detected in some" "glioma: 5.1" "Group enriched" "Detected in many" 4 "amygdala: 15.7;basal ganglia: 20.8;cerebral cortex: 31.5;hippocampal formation: 14.2;olfactory region: 24.7" "Cell type enriched" "Detected in single" 14 "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 14 "B-cells: 1.4" "Cell line enhanced" "Detected in some" "AF22: 17.1;hTERT-RPE1: 18.9;RT4: 6.3;SH-SY5Y: 6.3;U-87 MG: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031427, HPA046656, HPA072448" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA031427: AB_2673877, HPA046656: AB_2679740, HPA072448: AB_2686521" "unprognostic (6.22e-2)" "unprognostic (5.86e-2)" "unprognostic (1.26e-1)" "unprognostic (2.43e-1)" "unprognostic (1.04e-1)" "unprognostic (9.07e-4)" "unprognostic (2.70e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (3.09e-1)" "unprognostic (2.72e-3)" "unprognostic (7.39e-2)" "unprognostic (1.53e-7)" "unprognostic (8.33e-2)" "unprognostic (1.05e-1)" "unprognostic (9.01e-2)" "unprognostic (9.84e-4)" 1.6 10.8 15.7 0.8 20.8 0.5 1.8 0.8 35.1 7.3 1.2 2.3 0.0 1.1 1.5 1.7 1.5 2.2 2.7 1.0 14.2 4.7 1.4 0.6 6.0 0.8 3.1 24.7 0.7 4.4 10.4 1.0 0.8 5.2 1.5 1.4 0.0 6.4 1.4 0.9 1.8 0.9 1.8 1.5 0.6 0.8 1.0 1.3 0.0 1.3 0.0 0.8 1.7 3.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 17.1 0.0 3.8 1.2 0.0 1.2 3.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.4 0.2 0.0 2.6 0.0 1.7 0.0 18.9 4.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 2.2 0.2 0.2 0.2 0.0 3.5 3.7 6.3 2.3 6.3 0.4 0.0 0.0 0.1 0.0 0.3 2.6 0.7 0.1 1.0 0.1 0.0 0.0 0.0 9.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 20.8 0.8 31.5 14.2 4.7 3.1 24.7 5.2 1.3 0.0 16.0 0.0 0.2 0.1 7.0 0.8 0.0 1.4 1.2 0.0 0.0 0.1 1.7 0.0 0.8 0.1 0.0 0.0 0.8 0.1 1.1 0.0 0.0 0.0 0.2 3.2 0.0 0.0 0.0 0.9 1.4 0.0 1.7 0.0 0.0 6.1 0.1 0.0 3.5 0.3 0.4 0.0 0.8 0.2 0.1 0.5 0.3 0.0 0.0 0.9 SHF ENSG00000138606 "Src homology 2 domain containing F" Q7M4L6 15 45167214-45201175 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 84.3" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 46.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 84.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 50.7;SH-SY5Y: 22.6" "Region enriched" "Detected in all" 5 "cerebellum: 269.9" HPA057381 Approved Nucleoplasm NA NA Nucleoplasm "HPA057381: AB_2683423" "unprognostic (4.05e-2)" "unprognostic (2.02e-3)" "unprognostic (7.59e-2)" "unprognostic (1.54e-1)" "unprognostic (1.88e-2)" "unprognostic (2.18e-1)" "unprognostic (2.38e-1)" "unprognostic (7.61e-2)" "unprognostic (2.18e-1)" "unprognostic (3.50e-2)" "unprognostic (6.88e-2)" "unprognostic (5.12e-2)" "unprognostic (6.89e-2)" "unprognostic (2.83e-2)" "unprognostic (1.17e-1)" "unprognostic (5.09e-3)" "unprognostic (1.83e-2)" 2.9 19.3 6.9 3.3 10.4 0.6 3.3 84.3 14.5 7.3 6.3 3.9 2.2 10.5 8.5 4.0 4.1 6.2 5.3 4.5 5.9 7.2 1.8 18.9 2.9 1.8 4.5 6.7 20.5 2.5 2.5 3.5 1.5 7.1 5.3 4.4 6.3 5.3 5.2 2.6 6.5 7.9 6.3 5.2 2.3 2.9 4.1 3.2 1.6 4.9 2.4 1.8 5.8 5.5 3.3 2.6 2.5 1.9 5.1 4.2 1.5 0.0 0.6 10.0 0.3 0.7 0.4 4.7 1.2 0.8 2.8 4.0 1.4 4.7 0.5 4.0 1.7 2.7 0.8 3.8 0.3 1.3 0.8 1.7 0.3 0.9 9.8 0.4 0.0 3.3 0.9 0.2 0.3 0.0 2.1 2.1 4.9 1.9 0.2 3.9 1.6 2.1 0.3 3.9 1.8 0.2 6.0 7.9 0.2 0.9 0.2 50.7 22.6 0.3 0.3 0.2 3.2 0.5 0.9 0.1 0.3 4.3 0.3 0.1 0.4 0.3 0.4 0.1 0.2 1.5 0.3 1.9 1.2 3.8 1.7 4.2 2.4 1.6 2.4 1.8 3.3 2.2 1.7 2.5 5.1 1.7 2.6 0.3 1.5 6.9 10.4 84.3 12.1 5.9 7.2 4.5 6.7 7.1 3.2 0.0 1.1 0.0 4.9 3.2 46.9 2.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.9 6.1 3.7 4.2 0.0 1.1 0.4 3.0 2.5 2.3 9.7 0.6 9.5 12.5 3.7 1.0 9.8 4.0 2.8 8.5 0.0 8.6 5.7 0.5 5.8 3.9 1.0 4.5 6.5 5.0 4.7 2.7 2.3 0.6 0.7 4.5 7.1 SHQ1 "FLJ10539, Shq1p" ENSG00000144736 "SHQ1, H/ACA ribonucleoprotein assembly factor" Q6PI26 3 72749277-72861914 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 49.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042792 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA042792: AB_10959736" "unprognostic (1.10e-2)" "unprognostic (1.03e-1)" "prognostic favorable (2.83e-4)" "prognostic favorable (6.49e-4)" "unprognostic (2.05e-1)" "unprognostic (4.54e-3)" "unprognostic (9.21e-3)" "unprognostic (3.19e-2)" "unprognostic (8.89e-2)" "unprognostic (6.78e-3)" "unprognostic (3.76e-1)" "unprognostic (5.28e-2)" "unprognostic (7.30e-3)" "unprognostic (3.59e-3)" "unprognostic (3.21e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" 10.5 15.6 6.8 17.2 9.2 11.4 14.8 8.7 9.0 10.1 12.1 9.6 11.9 9.1 15.6 16.7 13.3 15.5 9.7 14.8 8.0 8.0 10.7 10.7 14.8 15.5 15.1 5.9 12.3 17.5 12.2 12.8 7.2 10.4 9.7 12.3 11.0 13.1 13.6 17.5 11.3 10.3 11.4 7.5 12.0 10.7 17.3 7.5 29.8 12.5 10.4 13.4 11.2 17.0 10.1 12.9 3.1 9.7 17.0 14.9 10.4 5.9 8.1 5.5 9.1 7.3 9.1 5.6 10.1 7.2 10.5 11.5 6.3 4.8 10.0 4.9 6.8 8.5 4.9 11.3 9.3 12.8 8.8 9.0 10.3 6.7 7.6 7.5 17.5 8.6 9.2 7.1 15.4 6.3 4.8 9.7 16.3 8.3 6.2 8.4 8.8 49.1 6.1 15.4 18.3 10.4 11.9 8.7 7.5 9.1 7.9 3.4 14.2 9.2 6.6 4.7 7.6 6.7 6.6 6.7 8.4 8.3 13.8 8.6 11.5 23.1 14.9 7.5 14.1 8.3 0.6 8.6 3.1 11.2 9.7 14.9 10.1 12.6 12.0 9.1 9.3 14.3 12.4 0.4 17.0 8.4 12.9 10.2 10.4 6.8 9.2 8.7 9.0 8.0 8.0 15.1 5.9 10.4 7.5 11.9 5.8 1.5 3.7 11.7 7.9 8.1 2.5 17.4 6.8 5.2 0.0 5.4 6.6 7.0 2.8 6.8 3.8 0.0 5.3 6.3 6.6 3.8 15.0 5.7 6.1 3.2 4.1 16.0 4.7 0.9 5.5 5.4 5.0 1.8 6.9 2.9 5.6 3.5 5.3 5.1 4.4 0.0 5.1 7.9 22.7 8.9 4.8 4.9 8.8 4.2 SIK3 "FLJ12240, KIAA0999, L19, QSK" ENSG00000160584 "SIK family kinase 3" 11 116843402-117098437 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 106.0;Late spermatids: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045245, HPA048161" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045245: AB_2679270, HPA048161: AB_2680293" "unprognostic (3.19e-2)" "unprognostic (3.31e-1)" "unprognostic (2.78e-2)" "unprognostic (8.21e-2)" "unprognostic (1.31e-1)" "unprognostic (2.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.33e-2)" "unprognostic (7.63e-2)" "unprognostic (2.46e-2)" "unprognostic (1.28e-3)" "unprognostic (1.89e-1)" "prognostic favorable (1.12e-5)" "unprognostic (1.82e-1)" "unprognostic (6.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.28e-2)" 13.0 12.2 24.7 13.8 36.9 14.3 13.5 24.0 34.4 13.5 16.6 40.5 10.4 10.9 18.6 9.9 13.7 16.6 12.8 16.0 23.7 16.2 13.9 17.6 13.7 11.9 25.8 24.4 22.4 19.5 29.4 18.4 16.3 23.9 11.4 11.7 10.6 11.7 15.6 16.9 11.3 14.0 18.4 17.2 14.2 14.5 26.0 38.0 10.4 22.1 6.9 12.9 14.5 12.9 2.4 1.7 3.9 3.7 1.6 1.8 0.7 7.9 6.1 9.7 10.2 8.4 9.1 15.6 6.0 10.9 4.8 5.4 14.8 9.2 9.4 9.9 11.1 10.6 12.5 8.0 8.7 6.7 25.8 5.1 21.1 6.7 9.1 7.8 7.5 8.3 10.0 5.1 10.2 16.5 6.1 6.4 6.3 10.1 7.0 6.5 2.7 6.7 8.1 5.4 5.4 4.5 8.7 5.6 7.4 6.6 1.5 9.5 7.6 16.3 7.2 3.2 7.8 4.7 8.0 7.3 5.9 7.5 9.8 6.0 5.0 3.6 12.0 5.5 12.4 7.9 3.9 1.1 0.0 1.0 1.5 1.8 0.4 0.9 0.4 1.7 2.4 0.3 0.1 2.6 1.6 3.7 0.1 0.1 0.7 24.7 36.9 24.0 32.2 23.7 16.2 25.8 24.4 23.9 38.0 8.9 26.1 22.2 23.4 23.6 42.8 19.3 12.7 18.7 15.9 5.2 106.0 7.4 5.0 6.7 76.2 16.5 9.7 0.0 6.4 2.6 20.8 17.6 17.3 18.4 6.8 44.5 16.6 14.1 21.4 130.5 9.5 18.7 15.1 4.6 12.0 47.3 7.9 8.6 13.4 5.6 64.0 0.0 20.6 20.4 11.3 21.2 24.8 25.9 10.3 24.3 SIN3A "DKFZP434K2235, KIAA0700" ENSG00000169375 "SIN3 transcription regulator family member A" Q96ST3 15 75369379-75455842 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004506, HPA047213, HPA062123" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (1.48e-1)" "unprognostic (1.27e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-1)" "unprognostic (4.74e-2)" "unprognostic (1.91e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (8.52e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-3)" "unprognostic (7.33e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (3.52e-1)" 21.0 15.4 14.0 19.4 18.5 31.6 20.4 26.3 15.5 26.3 20.2 19.9 15.3 11.8 26.6 16.8 17.7 22.1 15.9 13.4 14.2 11.8 13.6 13.9 17.4 20.7 13.0 14.2 27.6 19.8 23.4 16.8 17.2 13.0 22.9 14.3 23.0 17.6 20.5 18.2 23.5 17.9 24.5 12.8 20.3 16.8 28.5 15.1 48.7 24.0 12.8 26.9 26.0 19.0 9.8 6.5 9.3 8.3 9.7 12.7 6.3 12.9 26.9 24.1 15.8 12.0 12.7 13.9 9.7 15.2 14.4 15.5 14.8 17.7 28.3 10.2 14.4 19.7 23.3 34.9 14.7 15.8 22.8 18.1 26.7 20.5 11.6 9.1 25.3 22.9 15.4 11.4 16.7 17.5 14.9 12.9 20.3 21.0 31.6 11.6 15.1 24.8 16.3 23.4 17.3 11.3 25.1 31.9 17.4 10.3 23.9 19.1 19.0 24.1 10.8 13.5 24.2 16.4 20.1 11.2 17.9 24.2 11.8 14.4 21.8 34.0 30.1 10.6 25.9 9.9 3.3 4.8 6.9 8.5 4.8 12.7 9.3 10.8 10.7 6.5 9.8 11.1 9.5 9.3 9.7 8.3 4.4 9.5 6.3 14.0 18.5 26.3 15.5 14.2 11.8 13.0 14.2 13.0 15.1 32.8 26.7 28.9 21.6 34.9 19.3 12.6 17.8 29.4 31.8 26.2 29.5 18.2 5.0 13.3 6.8 23.9 11.8 0.0 11.0 9.1 23.6 23.5 29.9 14.3 11.4 19.1 16.6 26.4 23.0 3.1 21.3 20.0 10.1 12.6 17.1 17.2 12.3 15.0 19.1 8.4 31.7 12.9 17.6 37.7 41.7 46.4 18.3 22.3 15.9 16.6 SIRT6 ENSG00000077463 "Sirtuin 6" Q8N6T7 19 4174109-4182604 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049729, HPA071776" Supported Supported Nucleoplasm No No Nucleoplasm "HPA049729: AB_2680865, HPA071776: AB_2686445" "unprognostic (4.58e-1)" "unprognostic (3.41e-3)" "unprognostic (1.36e-1)" "prognostic favorable (2.85e-4)" "unprognostic (2.28e-1)" "unprognostic (4.14e-2)" "unprognostic (2.93e-3)" "unprognostic (8.32e-2)" "unprognostic (1.86e-1)" "unprognostic (6.13e-2)" "unprognostic (7.27e-3)" "unprognostic (4.42e-2)" "unprognostic (5.84e-2)" "prognostic favorable (9.13e-4)" "unprognostic (5.17e-2)" "unprognostic (1.63e-1)" "prognostic favorable (2.58e-4)" 9.5 11.7 9.4 14.6 11.5 17.8 8.0 15.2 16.3 9.0 26.3 11.0 14.8 19.3 10.6 11.9 11.1 8.9 9.9 11.4 9.5 9.0 12.1 14.2 8.7 12.7 10.8 8.5 8.1 17.3 9.4 13.4 12.1 8.2 12.0 15.3 10.9 12.1 11.9 10.2 13.0 18.4 8.0 7.9 15.1 15.3 6.6 7.0 14.4 10.7 10.0 11.9 8.1 8.9 10.7 14.1 12.4 16.2 5.1 12.0 8.0 14.1 9.6 4.9 6.1 3.8 3.5 7.6 6.9 5.2 5.9 5.2 6.4 5.4 9.2 7.6 4.6 5.4 9.1 2.7 7.6 0.9 17.3 5.4 3.8 5.1 5.8 8.6 9.7 14.9 4.8 6.0 6.1 3.8 4.7 5.2 8.7 8.4 21.1 3.1 10.7 13.4 10.2 8.3 5.3 8.9 10.5 4.5 10.4 5.6 6.4 6.5 10.5 6.2 5.9 13.3 2.0 5.9 12.9 7.9 6.0 6.1 21.0 10.2 26.7 14.0 10.0 12.0 15.6 7.2 5.2 13.4 11.3 11.6 16.2 6.5 10.5 7.8 9.3 14.1 10.7 6.9 6.5 12.4 5.1 12.5 11.9 12.0 8.0 9.4 11.5 15.2 16.3 9.5 9.0 10.8 8.5 8.2 7.0 11.9 8.2 13.7 8.9 9.2 10.5 2.8 10.2 8.1 9.1 5.2 17.7 19.3 11.6 28.5 1.3 6.6 70.3 0.0 23.0 20.0 8.5 7.5 5.7 6.6 21.6 12.7 25.3 14.1 8.7 1.4 10.6 14.0 5.0 34.3 23.1 10.3 25.4 29.8 7.8 11.6 13.0 0.0 8.5 7.0 9.1 11.0 21.4 10.5 24.3 11.1 SIVA1 "CD27BP, SIVA, Siva-1, Siva-2" ENSG00000184990 "SIVA1 apoptosis inducing factor" O15304 14 104753100-104768494 "Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 82.2" "Low region specificity" "Detected in all" "HPA065398, HPA066693" Supported Nucleoplasm NA NA Nucleoplasm "HPA065398: AB_2685484, HPA066693: AB_2685703" "unprognostic (1.86e-1)" "prognostic favorable (5.95e-4)" "unprognostic (1.61e-1)" "unprognostic (1.51e-1)" "unprognostic (6.89e-2)" "unprognostic (2.27e-1)" "unprognostic (4.77e-3)" "unprognostic (2.89e-1)" "unprognostic (2.17e-2)" "unprognostic (7.19e-3)" "unprognostic (5.85e-3)" "unprognostic (3.21e-2)" "unprognostic (4.94e-2)" "unprognostic (3.06e-2)" "unprognostic (4.08e-1)" "unprognostic (3.51e-1)" "unprognostic (7.43e-2)" 20.4 17.6 16.1 25.2 15.2 53.5 18.2 16.6 16.8 19.2 24.1 11.1 21.7 24.4 19.8 32.2 19.3 19.5 25.5 25.9 13.0 12.5 18.4 34.4 15.5 22.5 16.3 12.9 23.7 50.0 5.8 23.7 17.7 14.1 20.6 5.1 20.3 32.7 28.3 66.5 15.0 25.0 19.8 10.3 21.5 21.6 32.2 14.0 51.6 30.0 29.5 18.0 20.6 32.6 38.4 95.6 46.4 33.4 17.9 38.4 35.6 25.4 38.6 10.6 17.4 3.7 4.6 27.9 13.9 7.7 17.3 15.1 29.4 22.5 24.4 20.9 5.0 11.1 25.3 3.9 14.0 1.3 19.1 38.8 9.7 23.2 35.1 9.2 16.3 16.5 5.7 6.4 7.9 2.4 2.4 9.8 70.6 9.6 13.9 3.9 82.2 55.9 37.1 16.0 15.5 53.6 32.9 21.9 19.3 3.7 22.1 27.6 14.0 19.5 11.8 18.1 1.7 22.6 18.7 10.6 13.8 17.3 33.1 22.6 11.4 12.2 29.5 16.2 19.1 15.6 32.9 27.6 46.4 28.6 31.2 32.1 38.4 34.5 31.1 20.6 36.9 38.4 32.5 26.2 17.9 33.4 95.6 35.7 35.6 16.1 15.2 16.6 16.8 13.0 12.5 16.3 12.9 14.1 14.0 56.6 107.8 116.9 166.9 103.5 33.0 44.5 81.5 165.9 100.1 97.7 11.8 237.3 117.7 67.8 87.6 89.4 120.5 70.0 148.8 291.1 153.0 148.7 142.0 188.9 156.4 36.5 87.5 157.8 74.2 29.2 130.3 100.2 102.9 129.0 130.7 119.2 90.2 121.0 116.7 146.6 37.8 109.9 138.3 289.6 290.9 102.1 232.8 109.3 175.3 150.2 SIX3 HPE2 ENSG00000138083 "SIX homeobox 3" O95343 2 44941898-44946077 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 40.2;parathyroid gland: 32.1;pituitary gland: 30.9;retina: 66.5" "Group enriched" "Detected in some" 18 "Bipolar cells: 197.9;Horizontal cells: 174.8;Muller glia cells: 357.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "basal ganglia: 40.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 34.3;SCLC-21H: 31.9;SH-SY5Y: 12.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 38.7" HPA067988 Approved Nucleoplasm NA NA Nucleoplasm "HPA067988: AB_2685939" "unprognostic (1.19e-3)" "unprognostic (1.05e-2)" "unprognostic (4.76e-1)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.76e-2)" "unprognostic (1.31e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "unprognostic (6.82e-2)" "unprognostic (1.22e-1)" "unprognostic (2.49e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-2)" 0.4 0.4 3.7 0.5 40.2 0.5 0.5 0.7 0.7 1.5 0.4 1.5 0.0 0.5 0.4 0.4 0.5 0.4 0.5 0.4 1.6 7.2 0.4 0.4 0.5 0.5 1.1 2.7 0.4 1.0 32.1 30.9 0.4 0.1 0.4 0.4 66.5 0.4 0.4 1.1 0.5 0.4 0.4 0.0 0.4 0.5 0.8 6.5 0.0 0.4 0.0 0.4 0.4 0.0 1.1 1.1 4.5 2.2 1.9 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.3 0.0 5.9 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 34.3 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 31.9 12.7 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.6 1.2 1.0 1.1 1.7 1.1 1.1 0.8 0.8 1.1 1.3 1.4 1.7 1.9 2.2 1.1 1.3 0.7 3.7 40.2 0.7 0.7 1.6 7.2 1.1 2.7 0.1 6.5 0.0 0.0 0.0 0.0 0.0 197.9 0.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 174.8 1.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 357.8 0.0 0.0 0.0 0.6 13.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 SIX4 AREC3 ENSG00000100625 "SIX homeobox 4" Q9UIU6 14 60709528-60724348 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 20.4;salivary gland: 16.4;skeletal muscle: 19.3" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 9.2;Ciliated cells: 20.1;Cone photoreceptor cells: 19.6;Glandular cells: 15.2;Urothelial cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 20.7;hTERT-RPE1: 15.9;RH-30: 21.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA031794 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031794: AB_10602928" "unprognostic (2.23e-1)" "unprognostic (9.50e-2)" "unprognostic (2.63e-4)" "unprognostic (9.74e-2)" "unprognostic (2.69e-2)" "unprognostic (1.03e-1)" "unprognostic (5.39e-2)" "unprognostic (1.28e-2)" "unprognostic (8.13e-2)" "unprognostic (2.33e-2)" "unprognostic (4.39e-2)" "unprognostic (5.38e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.11e-1)" "unprognostic (1.51e-3)" "unprognostic (1.08e-1)" 2.0 1.5 0.9 0.6 0.9 0.3 4.8 4.3 4.5 3.3 0.7 0.1 3.3 0.4 1.6 1.3 0.5 3.5 1.1 1.5 1.0 1.0 1.4 0.5 2.1 0.2 1.0 2.2 2.9 3.3 20.4 6.3 2.1 3.6 4.0 0.3 0.8 16.4 2.7 19.3 0.5 0.5 0.9 1.8 0.3 2.0 0.7 1.1 0.8 3.9 2.4 1.4 1.7 14.3 0.2 0.1 1.0 0.1 0.3 0.2 0.0 20.7 1.5 1.2 5.6 4.9 6.2 9.8 4.7 7.1 1.4 2.0 1.0 6.6 0.0 3.1 2.3 1.4 7.9 5.6 3.8 3.3 1.6 4.6 0.6 2.1 1.4 1.6 2.1 0.2 2.9 1.8 1.3 6.6 15.9 1.2 0.4 4.1 0.0 7.2 5.2 0.0 0.2 3.6 0.1 8.9 1.3 21.0 0.0 2.5 11.9 3.4 0.3 3.0 4.7 1.2 2.0 6.4 0.1 4.1 4.4 9.7 2.9 4.2 1.4 0.0 0.0 1.5 0.0 0.8 0.3 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.1 1.0 0.3 0.1 0.1 0.0 0.0 0.9 0.9 4.3 4.5 1.0 1.0 1.0 2.2 3.6 1.1 3.0 0.3 0.0 9.2 0.3 0.2 1.6 0.0 20.1 6.8 1.8 19.6 4.7 0.0 0.1 0.0 0.3 0.0 0.0 0.9 3.3 1.9 15.2 1.1 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.3 0.1 1.7 0.0 0.0 1.7 2.7 0.0 1.4 0.3 0.4 0.0 0.3 0.1 0.9 0.5 2.6 0.0 0.0 10.5 SIX6 "OPTX2, Six9" ENSG00000184302 "SIX homeobox 6" O95475 14 60508951-60512850 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cataract, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pituitary gland: 43.3" "Cell type enhanced" "Detected in some" 33 "Cone photoreceptor cells: 27.5;Horizontal cells: 46.1;Muller glia cells: 158.1" "Cancer enriched" "Detected in single" 8 "glioma: 1.0" "Region enriched" "Detected in single" 8 "hypothalamus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "JURKAT: 9.3;MOLT-4: 29.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "hypothalamus: 2.5" HPA001403 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA001403: AB_1079993" "unprognostic (2.76e-1)" "unprognostic (6.14e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-2)" 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.4 0.0 10.6 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 29.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.8 0.8 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 158.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC12A8 CCC9 ENSG00000221955 "Solute carrier family 12 member 8" A0AV02 3 125082636-125212864 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;thyroid gland: 20.5" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 22.7;granulocytes: 18.4;Mucus-secreting cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HHSteC: 18.2;OE19: 17.3;U-2197: 35.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031123 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031123: AB_2301872" "unprognostic (4.74e-2)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (5.91e-3)" "unprognostic (7.35e-3)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (3.76e-2)" "unprognostic (1.01e-1)" "unprognostic (7.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.13e-2)" "prognostic unfavorable (5.56e-4)" "unprognostic (7.18e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-2)" 1.1 1.1 11.1 0.7 19.4 0.0 2.0 0.8 7.0 1.2 3.0 1.7 0.4 4.9 0.4 2.9 3.5 1.7 8.1 0.5 3.8 1.2 2.1 5.7 1.9 0.4 1.0 3.6 0.5 9.0 8.2 1.9 2.2 8.6 2.5 4.1 6.2 10.0 0.4 1.8 1.0 3.4 0.4 1.3 0.4 3.8 4.6 2.0 0.4 20.5 0.4 0.7 1.9 1.7 0.2 0.2 1.8 0.5 0.0 0.2 0.0 8.2 0.0 1.4 0.0 1.7 2.4 4.1 0.4 1.0 0.4 0.9 10.7 3.9 0.0 1.0 3.7 1.4 5.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 18.2 0.0 0.6 4.7 5.0 1.4 0.5 9.7 0.0 0.0 0.0 0.3 0.6 2.2 0.0 0.0 5.7 17.3 0.4 0.0 0.1 0.0 4.2 0.6 2.4 0.0 4.8 5.1 0.1 0.6 9.1 0.2 0.1 0.1 0.7 35.3 0.0 0.1 1.0 2.7 1.7 0.0 0.7 1.8 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 19.4 0.8 7.0 3.8 1.2 1.0 3.6 8.6 2.0 0.0 0.3 0.0 1.1 0.9 0.0 1.0 0.0 0.0 1.2 22.7 0.0 0.3 0.0 3.9 0.2 0.0 2.0 0.0 2.9 6.2 1.3 5.0 18.4 6.4 0.8 0.0 5.2 0.0 0.0 0.0 0.0 0.6 0.0 3.6 28.6 0.0 4.3 2.9 0.0 1.1 0.0 0.0 0.3 0.7 0.4 0.3 2.5 0.0 5.0 0.9 SLC15A4 "PHT1, PTR4" ENSG00000139370 "Solute carrier family 15 member 4" Q8N697 12 128793191-128823983 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 67.3;Late spermatids: 84.4;Muller glia cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 20.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016713 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA016713: AB_1856978" "unprognostic (3.12e-1)" "unprognostic (1.00e-1)" "unprognostic (3.63e-2)" "unprognostic (1.10e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (8.45e-4)" "prognostic unfavorable (6.78e-4)" "unprognostic (5.14e-3)" "unprognostic (6.39e-2)" "unprognostic (1.50e-1)" "unprognostic (2.26e-1)" "unprognostic (2.06e-2)" "prognostic unfavorable (7.56e-6)" "unprognostic (1.28e-1)" "unprognostic (2.06e-1)" "unprognostic (2.34e-2)" "unprognostic (2.57e-1)" 12.7 7.0 6.6 11.4 7.3 17.6 10.7 8.7 10.2 11.6 8.8 16.0 4.2 5.4 17.2 5.7 9.1 12.3 10.0 9.8 8.4 5.0 8.1 20.4 10.9 14.8 13.8 6.6 10.4 8.2 8.4 6.2 8.8 9.7 7.4 5.4 16.1 8.4 8.8 35.1 9.7 8.2 12.2 10.2 12.2 7.9 27.8 10.1 29.7 9.1 7.3 17.8 11.9 10.5 2.0 20.1 12.1 2.4 4.2 5.0 1.7 6.2 10.3 2.6 5.7 23.4 15.2 9.7 10.9 9.2 7.9 9.0 4.6 9.1 22.8 5.7 9.5 7.9 7.1 7.2 6.7 8.6 11.1 6.6 3.1 6.2 8.2 24.4 10.5 3.3 9.8 12.4 6.5 17.2 23.5 5.4 4.6 5.1 14.4 16.0 4.3 5.4 2.7 9.3 6.8 6.0 4.6 5.7 8.8 15.2 8.0 4.7 3.9 4.4 8.4 11.6 7.4 11.3 2.9 8.1 8.7 4.9 4.3 6.6 4.8 10.6 10.5 11.7 7.4 0.1 0.0 1.8 4.4 5.0 2.4 2.5 1.9 0.9 2.9 1.1 2.0 1.0 2.5 12.1 4.2 1.0 20.1 0.4 1.7 6.6 7.3 8.7 10.2 8.4 5.0 13.8 6.6 9.7 10.1 17.9 10.1 9.7 6.1 9.2 10.3 8.3 5.1 0.0 6.8 21.0 11.8 4.5 1.7 21.0 67.3 4.8 5.5 0.0 9.4 4.8 9.8 7.2 11.5 16.3 18.7 14.3 10.4 13.5 21.5 84.4 11.5 18.6 23.6 19.0 4.3 87.4 19.6 4.9 12.7 3.7 15.6 6.5 9.2 8.0 10.6 8.0 3.3 19.2 6.1 6.0 SLC17A9 "C20orf59, FLJ23412, VNUT" ENSG00000101194 "Solute carrier family 17 member 9" Q9BYT1 20 62952647-62969585 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Exocytosis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.7" "Cell type enhanced" "Detected in many" 11 "B-cells: 28.5;Hepatocytes: 35.4;Hofbauer cells: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 7.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 16.0;CACO-2: 14.8;Hep G2: 30.7;NB-4: 16.5;RPMI-8226: 15.9;U-937: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA047470 Approved Nucleoplasm NA NA Nucleoplasm "HPA047470: AB_2680060" "unprognostic (2.65e-3)" "unprognostic (2.13e-1)" "unprognostic (7.08e-2)" "unprognostic (1.97e-1)" "unprognostic (4.33e-3)" "unprognostic (5.33e-2)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (1.00e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "prognostic unfavorable (2.78e-15)" "unprognostic (6.06e-3)" "unprognostic (5.51e-2)" "unprognostic (5.96e-2)" "unprognostic (1.06e-1)" 4.2 1.3 1.6 11.4 3.4 11.9 2.2 0.4 1.4 1.9 4.8 0.6 0.1 6.4 1.7 1.2 1.5 2.1 7.3 1.5 1.5 0.7 1.5 42.7 5.7 6.6 4.8 0.0 1.9 3.4 0.0 2.5 1.9 3.4 1.6 3.8 1.1 3.6 1.2 3.4 0.9 3.9 1.4 3.9 10.5 10.7 0.8 2.9 0.5 1.4 0.5 11.8 5.6 2.4 4.0 4.2 0.0 2.7 7.3 1.3 1.2 0.0 0.0 0.0 0.1 0.1 1.3 0.0 16.0 4.6 5.3 8.4 14.8 0.0 11.5 0.0 12.8 0.0 0.0 2.3 0.0 1.2 0.0 0.0 5.0 0.4 30.7 3.6 9.0 0.0 1.2 0.0 6.3 0.0 0.0 3.4 0.0 0.0 6.7 0.0 0.0 0.3 16.5 0.0 5.7 0.0 11.9 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 1.1 0.0 0.0 0.5 0.0 2.3 0.1 6.2 0.0 19.4 0.0 0.0 1.6 0.0 1.3 2.7 0.9 4.0 0.0 0.6 4.2 3.2 0.0 0.6 0.0 7.3 0.6 0.0 0.1 1.2 1.6 3.4 0.4 1.4 1.5 0.7 4.8 0.0 3.4 2.9 0.0 0.6 28.5 0.0 0.8 0.2 1.2 12.7 0.0 1.2 0.0 0.0 0.3 0.0 0.2 0.6 0.7 1.6 0.0 0.3 0.6 5.8 0.5 4.7 35.4 16.2 0.0 2.9 2.5 4.0 0.0 1.1 9.1 5.0 1.0 7.7 0.0 1.1 0.0 0.7 0.0 0.0 0.0 3.1 0.3 0.9 1.0 0.7 4.1 9.1 0.4 SLC22A18AS "BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS" ENSG00000254827 "Solute carrier family 22 member 18 antisense" Q8N1D0 11 2887780-2903740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 20.1;kidney: 13.4;liver: 13.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 89.5;Paneth cells: 107.4;Proximal tubular cells: 73.1;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 9.1" "Group enriched" "Detected in many" 10 "dendritic cells: 4.9;granulocytes: 5.2;monocytes: 9.1" "Cell line enhanced" "Detected in some" "A549: 7.1;CAPAN-2: 7.0;MCF7: 13.2;OE19: 6.7;SK-MEL-30: 24.5;WM-115: 11.0" HPA068288 Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA068288: AB_2685969" "unprognostic (1.43e-1)" "unprognostic (9.21e-2)" "unprognostic (3.36e-1)" "unprognostic (8.05e-2)" "unprognostic (1.33e-3)" "unprognostic (3.16e-2)" "unprognostic (5.14e-3)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.10e-2)" "unprognostic (1.48e-2)" "unprognostic (9.52e-2)" "unprognostic (1.77e-1)" "unprognostic (2.39e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" 1.4 0.3 0.2 6.0 0.7 0.0 0.6 0.2 2.2 0.5 13.7 0.6 0.2 12.8 0.8 1.2 1.1 0.4 4.9 0.3 0.2 0.3 13.4 13.6 0.6 0.2 1.3 1.5 0.4 0.2 0.0 0.3 2.0 1.6 0.7 9.8 0.2 4.2 0.2 0.4 1.0 20.1 0.6 1.6 0.8 1.4 0.6 0.4 0.2 0.3 1.6 0.3 0.5 0.9 0.0 4.9 5.2 9.1 0.5 0.6 2.7 0.8 7.1 0.1 0.3 0.0 0.0 0.7 0.4 0.3 0.0 0.2 1.6 7.0 0.0 0.6 0.0 0.4 0.4 0.0 0.2 0.0 0.3 0.1 0.0 0.6 4.1 0.5 0.0 0.1 0.1 0.2 0.0 0.4 0.2 0.2 0.4 0.0 0.7 0.0 13.2 0.0 0.3 0.1 6.7 0.3 0.2 0.0 0.6 0.6 0.0 0.1 0.2 0.3 0.3 24.5 0.1 0.0 0.7 1.4 0.0 0.5 0.2 0.1 0.0 0.0 0.1 0.2 1.9 11.0 5.2 9.1 1.6 0.3 5.1 0.1 0.0 0.1 0.3 4.9 0.0 0.0 0.1 2.2 0.5 3.5 0.0 0.6 2.7 0.2 0.7 0.2 2.2 0.2 0.3 1.3 1.5 1.6 0.4 0.0 0.3 1.3 1.1 0.5 0.0 0.1 2.5 0.0 0.0 7.0 0.0 16.4 8.3 0.8 0.0 0.0 89.5 0.0 0.7 8.2 0.8 1.4 1.1 18.4 15.6 0.0 8.7 1.8 4.1 0.0 0.3 5.4 3.3 3.6 25.4 0.0 1.5 107.4 0.0 73.1 0.0 0.0 0.6 0.0 0.2 1.0 67.5 0.0 23.7 2.3 SLC25A30 ENSG00000174032 "Solute carrier family 25 member 30" Q5SVS4 13 45393316-45418455 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 38.0;skeletal muscle: 43.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 39.7;Hepatocytes: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045260 Approved Nucleoplasm NA NA Nucleoplasm "HPA045260: AB_10962505" "unprognostic (9.23e-2)" "unprognostic (9.92e-2)" "unprognostic (1.05e-1)" "unprognostic (4.28e-2)" "unprognostic (1.96e-1)" "unprognostic (2.63e-1)" "unprognostic (1.35e-2)" "unprognostic (3.16e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (5.69e-2)" "unprognostic (1.58e-1)" "prognostic favorable (9.91e-8)" "unprognostic (2.24e-1)" "unprognostic (5.19e-2)" "unprognostic (4.12e-1)" "unprognostic (6.19e-3)" 7.7 6.3 6.2 4.7 5.7 5.3 7.1 3.6 6.3 6.5 4.2 2.1 9.7 2.5 7.7 7.2 5.3 3.9 4.5 38.0 5.8 3.8 24.6 19.5 5.9 9.3 5.4 4.3 10.8 7.5 2.4 5.7 3.4 8.1 8.0 3.5 9.5 6.8 9.1 43.1 4.4 3.5 9.4 7.6 6.1 4.0 5.0 4.9 1.2 6.5 6.7 4.4 6.6 9.0 1.6 5.3 4.3 3.4 1.7 2.7 1.1 2.3 5.1 3.0 13.1 15.4 9.8 1.0 10.9 6.4 9.5 5.7 5.3 6.3 0.0 9.6 11.1 7.0 4.5 7.0 11.0 11.3 7.6 5.7 8.6 3.3 14.1 9.1 12.3 11.7 6.4 7.5 13.9 10.4 11.2 16.4 8.7 5.2 0.0 19.1 2.7 4.5 8.5 4.5 2.7 6.5 11.2 5.1 4.5 20.5 1.9 0.6 3.1 6.1 9.4 8.7 5.5 7.3 16.6 6.0 8.9 5.1 9.8 7.5 2.3 4.5 0.1 9.7 11.7 13.6 0.0 2.8 4.3 2.2 3.4 1.5 1.6 2.2 2.2 4.0 1.5 2.7 1.2 0.0 1.7 1.5 5.3 0.8 1.1 6.2 5.7 3.6 6.3 5.8 3.8 5.4 4.3 8.1 4.9 6.0 2.1 1.5 1.9 11.4 1.7 39.7 10.2 0.0 1.2 14.0 3.9 0.7 19.9 2.2 7.6 4.1 1.4 0.0 1.2 0.8 2.2 2.8 4.7 38.9 3.7 0.0 2.4 7.4 10.0 2.3 4.6 5.9 5.0 6.4 3.9 0.8 2.4 0.0 6.0 22.1 1.1 6.5 2.2 0.0 1.4 5.4 0.5 4.4 3.3 1.1 SLC29A2 "DER12, ENT2, HNP36" ENSG00000174669 "Solute carrier family 29 member 2" Q14542 11 66362521-66372214 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.9" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 1.6;dendritic cells: 1.6;T-cells: 4.1" "Cell line enhanced" "Detected in many" "BEWO: 16.7;CAPAN-2: 21.4;K-562: 16.1;T-47d: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018168 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA018168: AB_1857077" "unprognostic (3.20e-2)" "unprognostic (4.50e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.37e-1)" "unprognostic (5.08e-2)" "unprognostic (5.64e-2)" "unprognostic (1.60e-1)" "unprognostic (1.96e-1)" "unprognostic (2.09e-1)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "prognostic favorable (2.78e-4)" "unprognostic (2.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.13e-1)" "unprognostic (6.38e-3)" 5.4 1.3 2.5 2.8 3.2 1.2 13.2 10.3 5.1 1.9 4.0 3.1 4.8 5.6 1.2 5.2 2.7 3.0 3.2 9.0 2.9 3.3 6.4 1.5 3.4 2.5 3.3 3.5 1.0 7.8 11.3 5.9 3.3 7.0 4.2 2.3 2.2 6.0 6.3 68.9 1.9 4.3 0.9 1.7 2.0 6.6 0.9 2.0 1.6 4.2 18.0 2.5 1.5 2.2 1.6 1.6 0.2 0.1 0.1 4.1 1.2 5.8 4.4 3.5 0.7 0.3 0.0 16.7 0.2 0.0 0.2 0.3 7.0 21.4 2.6 5.5 0.0 1.1 5.9 3.3 4.2 0.0 0.1 9.6 5.7 5.4 0.5 0.7 9.5 0.1 0.3 1.7 0.6 1.9 1.7 0.3 2.0 16.1 0.0 0.0 12.1 0.7 13.4 10.1 7.3 4.6 0.7 0.0 12.1 8.9 4.4 7.1 3.2 0.3 9.2 0.6 0.4 26.0 2.1 0.0 0.1 5.8 0.1 0.0 0.1 0.3 0.2 0.4 0.2 0.2 0.0 0.1 0.0 3.5 0.0 1.1 0.6 2.2 4.1 0.8 1.6 4.1 4.1 0.2 0.1 0.1 1.6 0.4 1.2 2.5 3.2 10.3 5.1 2.9 3.3 3.3 3.5 7.0 2.0 3.0 4.6 1.4 4.4 0.6 2.5 9.7 5.1 5.3 7.9 14.0 11.8 40.5 3.3 4.3 0.0 0.7 2.1 0.0 5.8 12.3 1.0 2.8 4.6 0.5 3.8 4.8 2.4 0.0 0.6 0.0 0.0 0.0 0.0 1.0 8.5 2.3 3.2 3.5 0.4 0.6 3.3 0.0 2.3 0.1 0.2 0.0 11.3 1.3 10.7 2.5 SLC33A1 "ACATN, AT-1, AT1, SPG42" ENSG00000169359 "Solute carrier family 33 member 1" O00400 3 155821024-155854456 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Cataract, Deafness, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042430, HPA060345" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA042430: AB_10806238, HPA060345: AB_2732647" "unprognostic (5.12e-3)" "unprognostic (7.78e-2)" "unprognostic (1.13e-2)" "unprognostic (7.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.73e-2)" "unprognostic (9.57e-2)" "unprognostic (5.65e-2)" "unprognostic (6.61e-2)" "unprognostic (4.36e-2)" "unprognostic (1.19e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-2)" "unprognostic (2.92e-1)" "unprognostic (4.73e-2)" "unprognostic (5.74e-2)" 11.3 17.3 6.5 9.9 8.6 3.1 12.1 9.4 9.4 18.8 13.1 10.5 29.9 11.3 14.0 22.9 11.8 12.3 11.5 12.9 7.8 6.7 19.4 38.3 12.8 13.6 9.4 5.6 13.6 42.4 18.8 24.6 13.9 8.9 15.0 10.5 9.2 26.6 33.9 7.0 9.4 15.2 10.4 8.2 11.9 12.4 8.9 8.8 14.9 26.1 5.8 10.7 10.2 11.6 6.0 16.7 12.1 8.3 6.9 10.8 6.0 14.9 10.4 5.4 6.7 20.0 17.3 10.2 11.2 15.0 13.6 13.4 5.9 16.0 7.7 18.1 9.1 14.2 12.7 9.3 11.0 15.4 10.9 9.6 8.0 5.0 11.6 29.0 8.8 7.1 13.8 22.1 7.2 28.1 15.2 14.9 7.3 6.4 18.6 12.2 9.5 3.5 5.2 5.2 12.6 10.0 4.0 6.0 23.1 13.9 9.5 6.3 5.2 9.4 21.9 19.9 8.0 6.9 11.2 15.4 8.0 4.0 14.7 11.7 21.9 7.7 8.1 11.5 7.2 11.4 12.1 8.3 6.0 9.4 6.5 10.8 6.0 6.8 7.4 10.7 4.1 6.5 6.3 1.8 6.9 6.3 16.7 6.1 6.0 6.5 8.6 9.4 9.4 7.8 6.7 9.4 5.6 8.9 8.8 20.8 20.6 11.9 10.4 7.9 16.4 21.8 22.9 21.4 18.2 10.4 25.5 15.7 5.0 13.3 10.1 11.3 14.8 0.0 13.5 23.4 14.7 16.8 11.5 43.1 17.3 17.5 12.0 18.4 16.2 9.1 17.3 15.9 11.8 14.4 14.7 17.2 15.0 3.5 20.1 15.5 19.9 12.9 17.2 17.2 7.2 8.3 31.5 15.8 12.1 9.1 SLC35E2B ENSG00000189339 "Solute carrier family 35 member E2B" P0CK96 1 1659529-1692728 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045641, HPA062711" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045641: AB_2679402, HPA062711: AB_2684844" "unprognostic (9.00e-2)" "unprognostic (2.13e-1)" "unprognostic (8.74e-3)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "prognostic favorable (7.64e-4)" "unprognostic (1.18e-1)" "unprognostic (4.09e-2)" "unprognostic (5.70e-2)" "unprognostic (5.83e-2)" "unprognostic (2.04e-2)" "unprognostic (2.20e-1)" "unprognostic (2.92e-1)" "unprognostic (2.68e-2)" "unprognostic (6.61e-2)" "unprognostic (2.54e-2)" "prognostic favorable (5.15e-4)" 7.4 9.7 11.3 5.8 9.3 6.4 14.2 15.5 14.5 8.1 15.4 9.7 15.4 12.5 10.2 10.5 6.8 9.0 9.8 5.0 11.7 7.5 7.7 14.2 8.6 18.8 10.0 8.5 15.0 16.6 6.5 14.4 11.0 9.2 9.7 7.3 8.7 12.1 10.2 10.4 10.5 12.1 13.6 7.1 12.8 8.2 3.9 12.6 8.5 9.8 7.2 10.2 7.3 13.0 4.8 8.7 6.8 3.9 4.5 9.5 5.0 6.1 7.7 27.5 19.4 15.4 14.7 6.9 3.4 8.0 4.0 4.1 3.5 8.4 8.3 12.4 16.4 9.9 4.5 10.9 5.9 3.5 11.7 10.3 12.3 13.7 9.9 15.3 11.6 10.0 13.7 13.8 10.7 12.0 21.4 16.8 16.0 14.6 14.9 9.3 3.8 15.2 13.2 9.5 5.1 9.1 12.7 5.8 14.4 9.9 3.4 18.6 23.8 12.7 11.2 20.1 12.5 9.0 15.8 12.4 11.5 6.1 4.9 4.1 12.5 9.6 17.5 9.1 21.1 8.1 1.7 3.9 3.3 8.3 3.5 8.9 4.3 6.8 9.5 2.8 4.8 8.1 6.7 6.8 4.5 2.5 8.7 6.4 5.0 11.3 9.3 15.5 14.5 11.7 7.5 10.0 8.5 9.2 12.6 11.9 27.0 23.5 6.5 6.5 33.6 15.3 35.7 13.4 27.3 3.5 72.6 11.2 0.0 5.0 0.8 18.6 25.2 0.0 5.3 7.3 19.3 8.4 22.0 18.1 8.9 28.6 24.5 30.1 33.0 1.3 28.1 8.0 11.8 6.4 23.6 12.3 4.8 17.5 25.1 2.2 66.3 6.5 9.5 6.1 15.5 8.4 7.3 30.6 26.7 6.7 SLC39A11 C17orf26 ENSG00000133195 "Solute carrier family 39 member 11" Q8N1S5 17 72645949-73092712 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 49.0;Mucus-secreting cells: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 48.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021455 Approved Nucleoplasm NA NA Nucleoplasm "HPA021455: AB_2670710" "unprognostic (2.29e-2)" "unprognostic (2.75e-1)" "unprognostic (1.25e-1)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (1.82e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (3.45e-3)" "unprognostic (2.30e-1)" "unprognostic (1.57e-3)" "unprognostic (5.26e-2)" "unprognostic (1.17e-1)" "unprognostic (4.96e-3)" "unprognostic (3.85e-2)" 10.4 7.4 12.4 7.8 17.9 10.7 10.8 5.3 14.4 9.3 13.3 19.8 6.6 11.5 4.8 9.6 13.0 5.6 8.6 4.2 13.3 6.3 7.9 21.9 8.2 4.8 27.8 6.6 2.8 23.8 3.1 3.8 7.0 15.3 5.3 13.8 6.7 16.6 5.2 3.7 11.2 12.7 5.7 15.7 6.5 27.6 4.1 22.5 6.0 20.6 3.6 8.6 8.3 7.6 6.0 14.9 9.8 16.2 8.7 6.9 6.3 4.3 7.9 0.9 3.8 6.9 5.6 5.4 4.6 4.1 2.1 2.9 2.9 19.7 5.4 4.8 4.7 3.4 3.7 1.3 2.3 3.3 5.8 2.8 5.0 2.1 3.4 4.1 5.3 48.4 4.8 4.5 4.4 2.6 2.3 2.2 2.8 2.6 6.8 2.7 6.1 3.4 11.6 0.7 13.3 3.4 2.3 3.6 4.5 3.5 4.5 2.2 3.1 2.5 18.7 2.8 3.9 12.8 7.4 1.8 4.2 4.0 3.6 2.8 5.5 2.5 3.8 6.9 10.8 2.4 5.5 16.2 9.8 6.9 15.4 4.6 6.0 5.3 5.2 14.9 3.9 3.8 5.2 2.5 8.7 11.9 10.5 6.5 6.3 12.4 17.9 5.3 14.4 13.3 6.3 27.8 6.6 15.3 22.5 0.0 4.6 3.7 4.4 3.9 2.3 2.0 7.6 6.7 7.9 3.5 0.0 4.7 0.0 6.8 19.2 3.6 19.9 23.3 12.3 14.7 3.6 5.1 29.9 25.0 25.0 4.8 8.1 4.3 15.5 49.0 3.7 7.6 10.1 15.4 73.3 3.9 8.3 20.4 3.2 9.8 1.5 12.9 6.1 1.9 2.5 3.9 4.1 3.2 14.7 6.3 SLC4A3 "AE3, SLC2C" ENSG00000114923 "Solute carrier family 4 member 3" P48751 2 219627327-219641980 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 103.6;ovary: 30.2" "Group enriched" "Detected in many" 17 "Cardiomyocytes: 201.0;Horizontal cells: 527.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 36 "myeloid DC: 2.3;plasmacytoid DC: 8.9" "Lineage enriched" "Detected in single" 58 "dendritic cells: 8.9" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063498 Approved Nucleoplasm NA NA Nucleoplasm "HPA063498: AB_2685025" "unprognostic (9.49e-2)" "unprognostic (5.72e-3)" "unprognostic (8.92e-4)" "unprognostic (1.77e-2)" "unprognostic (6.61e-3)" "unprognostic (1.47e-1)" "unprognostic (2.60e-1)" "unprognostic (2.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-1)" "unprognostic (8.15e-3)" "unprognostic (1.97e-1)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.12e-4)" 1.8 5.4 11.8 1.6 22.5 1.2 2.0 8.8 22.0 2.8 1.3 3.0 0.4 1.4 3.4 2.6 2.9 2.7 2.3 103.6 10.4 8.2 1.6 1.0 1.3 1.4 6.5 9.0 30.2 2.7 4.5 9.9 2.5 24.1 4.2 1.1 4.9 3.1 4.3 1.2 1.6 1.3 3.1 1.6 2.6 1.4 4.2 3.5 0.0 1.5 0.0 1.3 1.6 0.9 0.0 8.9 0.0 0.1 0.0 0.0 0.0 6.2 0.2 2.2 6.5 0.4 0.4 4.4 3.9 4.1 5.3 3.8 4.5 3.6 0.0 1.5 1.4 9.2 3.6 1.1 7.1 1.6 0.0 1.0 0.0 0.0 0.1 1.1 0.1 0.3 3.1 6.7 0.0 2.1 13.4 0.0 0.0 0.2 0.0 1.5 2.1 0.0 0.0 3.6 0.2 5.3 0.0 0.0 0.0 3.6 1.5 1.3 6.4 2.5 6.8 3.3 7.5 0.6 1.6 0.0 3.3 5.8 0.0 3.1 0.0 0.0 0.0 2.7 0.0 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 11.8 22.5 8.8 22.0 10.4 8.2 6.5 9.0 24.1 3.5 0.0 0.0 0.0 0.6 0.2 8.9 201.0 0.0 0.0 1.2 1.8 0.0 10.5 1.7 2.8 2.0 0.1 0.0 0.0 1.5 2.5 2.2 0.3 0.0 0.0 1.6 527.6 0.0 0.0 0.0 11.9 14.1 1.1 0.0 1.0 0.0 7.0 1.3 0.0 21.2 0.3 6.7 6.5 1.4 0.5 1.1 0.6 11.6 0.0 0.0 0.0 SLF1 "ANKRD32, BRCTD1, BRCTx, DKFZp564C0469, DKFZp761C121" ENSG00000133302 "SMC5-SMC6 complex localization factor 1" Q9BQI6 5 94618347-94739436 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 104.0;Spermatogonia: 128.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HeLa: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040793, HPA054213" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA040793: AB_10796560, HPA054213: AB_2682419" "unprognostic (7.56e-2)" "unprognostic (1.45e-2)" "unprognostic (2.44e-3)" "unprognostic (1.02e-1)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-5)" "unprognostic (1.23e-2)" "unprognostic (1.43e-2)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.22e-1)" "unprognostic (6.57e-6)" "unprognostic (3.27e-2)" "unprognostic (2.83e-1)" "unprognostic (1.77e-1)" "unprognostic (8.32e-2)" 3.4 3.6 9.8 4.5 14.1 6.3 4.0 17.6 14.7 3.4 4.0 2.1 2.7 4.3 3.7 3.3 3.7 4.8 4.6 4.7 6.1 6.2 3.8 3.1 3.4 6.5 3.1 9.8 6.3 4.7 3.3 7.9 3.4 5.3 3.0 5.2 1.7 3.4 3.1 3.4 7.8 6.7 3.3 5.1 5.9 3.2 14.8 4.8 9.2 4.0 3.4 5.2 3.5 3.4 5.3 1.9 10.8 1.9 1.5 4.6 1.0 3.0 4.1 5.8 5.4 1.8 2.3 3.7 4.8 2.5 5.6 7.8 2.1 4.3 4.9 3.2 1.4 6.9 4.3 4.7 3.9 7.6 1.7 3.9 3.3 34.8 1.8 0.5 1.7 3.7 1.1 1.1 4.9 2.2 1.8 2.3 3.0 3.5 3.0 4.8 2.8 4.6 2.2 6.0 1.7 2.2 2.8 6.5 5.4 1.8 2.4 5.9 5.9 5.9 2.5 2.0 4.8 3.4 4.8 1.6 2.7 3.7 3.8 6.3 2.3 4.7 4.0 4.1 4.8 5.3 1.0 1.9 1.1 2.6 1.5 1.4 3.1 3.9 4.6 1.2 5.3 1.8 2.4 10.8 1.5 1.2 1.9 2.2 1.0 9.8 14.1 17.6 14.7 6.1 6.2 3.1 9.8 5.3 4.8 3.0 5.4 20.2 5.1 0.0 24.2 0.0 2.5 37.5 13.6 5.2 25.5 12.2 1.7 6.4 6.2 7.1 4.2 46.7 6.1 12.5 3.2 2.7 14.0 5.8 6.9 19.1 2.4 10.4 5.4 6.7 5.2 5.1 0.0 4.6 5.4 6.5 7.5 5.5 5.6 9.1 31.0 0.0 0.0 104.0 128.8 0.0 5.1 21.7 5.2 1.6 SLX1A GIYD1 ENSG00000132207 "SLX1 homolog A, structure-specific endonuclease subunit" Q9BQ83 16 30193887-30197561 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.2;intestine: 26.0" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 10.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 44.5" HPA047038 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047038: AB_2679913" "unprognostic (3.46e-2)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (1.84e-1)" "unprognostic (5.60e-2)" "unprognostic (6.04e-2)" "unprognostic (1.88e-1)" "unprognostic (1.41e-1)" "unprognostic (1.75e-1)" "unprognostic (2.67e-1)" "unprognostic (1.26e-6)" "unprognostic (2.52e-1)" "unprognostic (3.21e-1)" "unprognostic (1.53e-1)" "unprognostic (3.86e-1)" 3.4 5.2 2.9 7.7 1.7 7.7 3.7 0.7 1.9 2.0 8.2 26.0 1.6 0.0 5.4 1.0 2.7 4.2 2.7 2.5 7.1 13.1 3.5 5.4 3.0 0.5 6.7 0.9 2.3 2.9 1.8 2.6 2.9 1.5 4.9 3.1 19.6 1.5 2.8 9.5 12.6 0.3 2.1 3.7 3.7 1.9 19.4 35.8 41.6 44.2 17.7 30.6 26.4 15.5 9.8 3.6 3.9 1.0 0.8 22.1 3.5 3.3 1.4 1.4 2.0 11.2 6.4 14.2 2.2 3.9 12.4 1.0 1.8 1.6 11.5 11.3 6.6 3.3 19.3 2.2 7.9 18.1 0.9 3.0 1.2 1.7 2.9 1.3 2.4 5.8 12.4 1.3 15.7 10.2 27.3 11.3 7.2 6.6 30.1 0.6 34.3 3.4 5.0 7.1 19.1 0.0 30.5 7.2 1.2 5.4 6.8 0.0 9.4 10.7 9.3 5.2 44.5 17.1 5.9 10.4 8.2 6.4 5.8 44.2 41.6 23.5 40.9 16.7 19.4 17.6 19.1 35.8 18.1 8.8 14.9 16.1 17.7 32.5 18.3 30.6 26.4 0.0 0.6 0.0 0.9 0.6 0.7 2.0 0.0 0.0 0.0 3.5 0.0 5.1 0.0 5.4 0.2 1.6 4.9 0.0 10.4 1.8 1.5 0.8 0.0 2.5 2.5 0.0 3.5 1.8 7.5 0.0 0.9 3.3 6.8 2.8 3.6 0.2 7.8 5.8 0.0 2.4 0.2 0.0 2.3 0.3 0.4 1.9 3.4 3.8 4.0 0.4 SLX1B "GIYD2, MGC5178" ENSG00000181625 "SLX1 homolog B, structure-specific endonuclease subunit" Q9BQ83 16 29454501-29458219 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.5" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 10.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA047038 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047038: AB_2679913" "unprognostic (2.93e-1)" "unprognostic (1.11e-1)" "unprognostic (2.16e-2)" "unprognostic (5.12e-2)" "unprognostic (7.05e-2)" "unprognostic (1.78e-1)" "unprognostic (7.20e-2)" "unprognostic (2.72e-2)" "unprognostic (2.35e-3)" "unprognostic (3.63e-1)" "unprognostic (1.22e-1)" "unprognostic (3.64e-2)" "unprognostic (2.51e-7)" "unprognostic (4.84e-2)" "unprognostic (1.96e-1)" "unprognostic (4.44e-1)" "unprognostic (5.25e-3)" 4.6 2.9 0.2 3.9 0.5 8.8 4.9 2.0 2.7 5.6 6.6 14.1 5.4 2.7 3.0 4.4 1.1 2.2 0.4 0.5 3.3 11.1 5.7 3.0 0.6 4.2 3.1 3.4 2.2 5.4 4.0 4.6 8.0 5.4 11.2 5.7 13.4 2.9 1.8 6.3 4.7 0.0 6.1 6.6 5.7 3.9 3.2 20.8 26.5 24.7 3.7 6.5 6.7 6.8 5.9 15.4 0.7 3.2 4.6 21.2 6.4 15.0 14.6 12.4 1.6 10.5 17.3 5.6 4.5 2.3 2.6 5.7 9.2 3.5 1.0 4.3 7.1 3.1 9.2 9.9 7.2 2.9 6.1 6.6 9.6 6.5 9.2 16.2 20.4 3.7 7.1 6.8 9.7 1.3 7.2 1.3 15.4 8.6 7.0 12.2 15.5 12.3 4.2 2.5 14.8 2.7 30.2 1.4 2.4 1.4 4.1 10.8 4.9 1.5 2.9 1.1 3.2 20.1 11.0 5.4 5.5 2.1 3.3 24.7 26.5 2.8 20.7 0.8 3.2 2.5 2.8 20.8 2.5 1.2 1.6 14.8 3.7 11.9 1.2 6.5 6.7 0.0 0.3 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.1 1.0 0.0 1.3 0.6 0.4 0.2 0.0 0.5 1.0 0.0 0.0 0.6 1.2 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.8 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.9 0.1 0.1 SMARCA4 "BAF190, BRG1, FLJ39786, hSNF2b, SNF2, SNF2-BETA, SNF2L4, SNF2LB, SWI2" ENSG00000127616 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4" P51532 19 10960825-11079426 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase, Repressor, RNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 219.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB004208 Supported Supported Nucleoplasm NA NA 260000 Nucleoplasm "CAB004208: AB_626762" "unprognostic (2.68e-1)" "unprognostic (4.85e-2)" "unprognostic (1.71e-1)" "unprognostic (3.43e-3)" "unprognostic (1.40e-1)" "unprognostic (6.33e-3)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.19e-2)" "unprognostic (7.29e-2)" "unprognostic (1.73e-2)" "unprognostic (1.97e-1)" "unprognostic (1.15e-2)" "unprognostic (6.80e-3)" "unprognostic (6.83e-3)" "unprognostic (5.44e-2)" "unprognostic (1.01e-1)" "unprognostic (1.29e-1)" 10.3 12.4 15.5 18.0 21.3 20.5 10.9 29.1 28.0 13.2 12.8 16.6 9.7 14.3 16.6 9.4 24.7 15.7 12.8 11.6 14.4 17.7 13.0 9.9 13.0 18.1 17.1 16.8 13.6 13.4 18.1 11.5 14.6 16.1 13.3 9.4 17.3 18.2 12.5 21.9 20.4 12.0 10.6 16.1 13.2 14.5 22.2 12.4 58.2 15.5 10.1 21.5 15.2 12.6 9.8 11.2 8.6 13.5 11.4 13.7 5.9 20.5 1.1 36.7 34.7 7.2 6.1 16.1 14.3 8.6 17.5 13.0 28.7 0.9 48.3 22.2 12.5 0.7 15.1 28.6 17.7 9.7 19.8 21.4 38.4 18.2 33.3 10.9 27.8 19.2 10.2 8.6 14.7 15.2 7.8 15.6 21.1 34.4 18.2 13.7 41.9 46.2 23.9 37.2 10.0 31.1 49.2 23.2 25.0 11.2 26.1 41.8 37.9 15.2 19.6 16.3 12.3 16.6 20.9 20.6 26.1 13.6 23.8 23.6 37.7 41.8 47.9 14.8 26.7 22.1 8.1 8.3 8.6 13.7 9.5 12.2 7.4 10.4 11.6 8.5 9.8 11.4 11.2 5.2 11.4 13.5 11.2 8.8 5.9 15.5 21.3 29.1 28.0 14.4 17.7 17.1 16.8 16.1 12.4 62.5 67.7 32.7 32.8 32.7 82.3 219.1 43.3 46.8 51.2 41.8 66.8 57.1 34.9 75.0 39.4 30.8 34.6 23.3 53.1 46.8 38.0 38.3 29.0 19.2 36.4 95.3 60.6 22.7 21.0 29.3 24.2 23.3 15.1 57.7 37.3 37.2 60.6 38.6 12.7 19.3 63.8 12.9 30.3 93.0 96.0 45.2 51.0 28.4 50.9 40.7 SMARCAD1 "DKFZP762K2015, ETL1, KIAA1122" ENSG00000163104 "SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1" Q9H4L7 4 94207611-94291292 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016737 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA016737: AB_1857271" "unprognostic (5.01e-2)" "unprognostic (5.83e-2)" "unprognostic (2.59e-3)" "unprognostic (1.23e-1)" "unprognostic (8.41e-3)" "unprognostic (9.08e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (2.45e-1)" "unprognostic (3.49e-3)" "unprognostic (3.55e-1)" "unprognostic (2.57e-2)" "unprognostic (7.72e-2)" "unprognostic (2.99e-2)" "unprognostic (1.43e-1)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (3.20e-3)" 12.8 15.4 15.4 22.2 14.6 8.6 20.1 26.7 25.1 15.4 13.6 9.4 14.4 12.6 19.6 17.5 17.2 16.5 13.9 12.9 13.6 14.7 16.6 14.9 21.6 22.8 17.6 11.1 20.8 15.0 17.2 33.0 18.3 14.9 15.4 16.5 10.2 14.9 20.9 11.8 26.5 13.9 15.6 17.9 17.6 13.9 15.3 16.2 42.0 20.2 11.4 17.8 16.0 15.9 5.5 4.3 3.5 3.0 7.5 6.2 2.7 7.4 9.7 30.1 19.7 8.7 14.3 15.6 13.3 12.5 11.1 10.7 8.7 12.2 19.2 9.2 11.4 10.1 6.5 21.2 11.2 16.1 14.7 9.6 13.8 10.5 13.3 12.6 20.1 14.8 14.6 9.3 13.8 17.8 13.8 17.3 16.8 22.8 8.0 16.8 5.9 34.2 10.7 20.9 9.4 4.8 19.9 17.2 9.8 13.0 9.1 17.7 26.2 10.2 17.2 14.6 19.3 8.8 13.6 16.3 14.5 15.5 8.9 10.1 11.3 16.9 23.0 13.6 10.8 17.9 3.5 2.5 0.3 4.6 3.0 4.8 5.5 5.1 4.9 4.3 4.2 5.5 6.2 0.0 7.5 2.9 3.7 4.1 2.7 15.4 14.6 26.7 25.1 13.6 14.7 17.6 11.1 14.9 16.2 11.9 9.9 6.0 5.4 10.4 19.7 12.3 5.1 37.5 34.2 8.7 15.7 11.2 1.7 10.8 1.7 14.3 5.0 0.0 8.7 9.4 10.1 5.8 22.1 11.0 9.3 17.5 8.6 11.1 14.0 1.8 13.3 12.3 3.3 7.2 12.6 9.4 12.3 8.2 17.3 12.7 18.1 6.5 7.2 26.5 34.0 8.4 8.0 16.2 10.9 3.8 SMARCAL1 "HARP, HHARP" ENSG00000138375 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1" Q9NZC9 2 216412414-216483053 "Disease related genes, Predicted intracellular proteins" "Helicase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020337 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA020337: AB_2670410" "unprognostic (4.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.65e-1)" "unprognostic (2.20e-2)" "unprognostic (3.39e-2)" "unprognostic (2.68e-2)" "prognostic unfavorable (5.22e-4)" "unprognostic (4.35e-3)" "unprognostic (3.31e-2)" "unprognostic (2.33e-1)" "unprognostic (1.36e-1)" "unprognostic (7.46e-2)" "unprognostic (2.00e-2)" "unprognostic (2.67e-1)" "unprognostic (1.41e-1)" "unprognostic (1.97e-1)" "unprognostic (3.16e-1)" 14.9 17.2 11.5 15.3 16.0 11.9 14.1 9.8 18.0 16.6 11.8 18.3 13.9 9.2 23.4 11.7 15.2 16.5 13.9 14.9 10.8 13.3 12.2 10.3 11.5 17.5 14.7 13.1 25.1 14.9 18.3 15.8 15.3 15.2 15.8 11.2 14.6 13.9 14.1 14.9 15.2 12.5 15.2 13.9 16.3 12.1 14.7 15.5 30.5 15.1 10.8 21.5 14.7 14.6 8.9 15.9 17.4 14.0 16.6 12.8 7.1 9.4 9.7 13.2 7.7 13.3 15.5 12.7 13.1 13.5 14.0 16.0 15.3 12.1 8.5 13.2 16.2 17.3 7.3 11.4 14.4 18.7 26.2 11.3 24.8 7.7 11.2 13.6 6.7 14.4 10.4 15.3 15.0 14.9 14.6 16.4 13.7 24.4 9.5 15.9 7.1 12.4 15.5 9.5 8.5 5.2 14.3 8.9 5.4 11.0 6.6 11.1 7.2 7.0 5.5 10.9 24.3 7.4 10.8 12.5 17.4 8.0 8.3 7.9 10.8 10.6 7.7 17.6 9.1 12.1 17.4 8.1 11.6 11.1 8.9 10.5 8.9 10.5 12.8 12.7 8.8 8.8 10.6 1.6 16.6 14.0 15.9 12.4 7.1 11.5 16.0 9.8 18.0 10.8 13.3 14.7 13.1 15.2 15.5 6.0 6.7 5.9 3.4 0.8 4.9 3.6 2.5 4.0 2.3 0.0 0.0 8.9 5.0 6.6 10.6 7.0 3.3 0.0 3.4 10.2 4.1 1.6 17.3 3.2 8.6 7.9 3.5 3.1 7.6 9.5 5.8 3.9 1.7 13.6 4.2 4.1 4.1 12.2 8.1 3.0 4.6 12.9 5.1 6.7 3.1 1.1 6.1 7.4 5.6 1.8 SMARCC1 "BAF155, CRACC1, Rsc8, SRG3" ENSG00000173473 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1" Q92922 3 47585272-47782106 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011576, CAB016336, HPA024352, HPA026853" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030" "unprognostic (3.47e-1)" "unprognostic (1.65e-1)" "prognostic favorable (3.34e-4)" "unprognostic (2.54e-1)" "unprognostic (1.83e-2)" "unprognostic (3.70e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (1.33e-2)" "unprognostic (4.28e-3)" "unprognostic (6.92e-2)" "unprognostic (5.53e-2)" "unprognostic (2.78e-2)" "unprognostic (1.66e-2)" "unprognostic (7.99e-2)" "unprognostic (3.84e-1)" "unprognostic (2.31e-2)" "unprognostic (2.45e-1)" 16.5 9.3 14.5 22.6 18.9 16.7 21.8 16.5 17.2 19.3 22.4 19.6 13.1 13.3 20.0 15.2 21.8 12.5 16.4 10.3 13.9 11.3 18.7 15.6 13.6 18.6 18.1 11.3 18.7 25.6 16.4 15.1 28.0 11.7 22.1 20.8 14.5 18.9 16.9 19.8 24.3 17.8 32.6 16.1 18.7 16.6 18.7 18.3 45.0 21.1 12.8 27.7 24.9 27.0 8.2 4.7 4.3 5.4 4.0 8.1 3.9 14.5 7.7 32.4 25.1 7.2 12.5 21.8 11.6 10.9 15.1 15.4 13.8 15.5 34.0 9.4 14.6 8.8 12.5 30.4 18.0 22.2 16.2 18.1 33.3 13.3 18.7 10.9 30.4 15.4 10.4 16.0 17.0 18.9 11.3 17.6 22.9 27.9 11.6 16.2 10.8 39.6 15.9 42.7 14.1 11.9 17.8 18.8 29.9 16.2 19.1 14.5 29.1 18.1 17.7 12.9 23.7 15.4 28.5 14.1 10.1 14.4 11.4 18.9 14.2 18.1 40.6 7.4 28.9 14.2 4.0 3.5 3.4 6.2 5.4 5.6 8.2 6.7 8.1 4.4 6.3 6.4 7.5 4.3 4.0 3.8 4.7 6.3 3.9 14.5 18.9 16.5 17.2 13.9 11.3 18.1 11.3 11.7 18.3 38.7 41.6 33.7 45.3 47.2 27.1 26.6 35.7 33.5 69.4 54.1 35.3 65.8 11.6 61.0 86.4 27.0 20.0 23.3 40.5 94.1 27.3 55.4 23.2 35.0 26.8 19.1 87.9 19.6 24.2 81.6 23.6 30.7 21.9 56.9 60.1 17.9 53.5 20.1 26.9 30.5 30.1 38.8 29.3 55.9 92.0 58.3 60.6 30.5 59.9 48.2 SMARCC2 "BAF170, CRACC2, Rsc8" ENSG00000139613 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2" Q8TAQ2 12 56162983-56189567 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004321, HPA021213, HPA061788" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004321: AB_2286337, HPA021213: AB_1857275, HPA061788: AB_2684608" "unprognostic (7.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.31e-2)" "unprognostic (4.93e-2)" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (1.43e-2)" "unprognostic (1.83e-1)" "unprognostic (1.71e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (1.04e-1)" "unprognostic (2.46e-1)" "unprognostic (1.35e-1)" "unprognostic (2.45e-1)" "unprognostic (6.74e-2)" "unprognostic (8.79e-2)" 25.0 22.2 34.5 17.4 36.5 15.7 22.5 43.7 40.7 24.9 20.4 29.9 17.1 21.5 29.1 16.6 18.2 25.5 18.6 19.0 35.0 22.7 19.8 14.1 21.6 20.9 29.2 24.2 38.4 21.8 36.1 21.1 19.9 27.5 24.6 19.0 26.7 26.1 28.2 32.3 26.8 21.7 27.2 22.6 23.4 20.6 17.7 32.1 21.3 30.2 13.2 23.2 27.5 22.7 8.8 7.0 19.0 12.2 6.2 12.7 9.6 19.6 30.4 32.5 23.4 20.2 21.2 13.5 17.6 18.9 21.3 20.7 17.5 24.7 28.6 17.0 20.5 20.0 22.9 20.9 17.8 19.3 21.8 19.5 45.4 20.6 11.0 10.9 21.3 33.8 19.7 13.4 20.1 10.2 38.5 26.9 22.3 25.8 24.0 19.6 20.6 36.0 19.2 11.0 15.7 20.8 21.4 26.0 22.4 15.9 25.8 24.0 24.9 29.9 20.9 8.1 17.7 35.3 19.0 23.0 18.2 22.3 16.2 12.9 22.8 16.6 20.0 18.9 14.3 19.3 13.7 7.6 19.0 11.9 10.0 12.7 8.6 8.4 8.4 7.0 8.8 6.2 7.8 6.6 6.2 12.2 5.0 8.2 9.6 34.5 36.5 43.7 40.7 35.0 22.7 29.2 24.2 27.5 32.1 62.5 38.7 25.3 36.7 18.2 55.0 23.4 20.4 29.4 47.8 40.1 37.3 16.4 6.6 21.2 1.3 30.1 17.6 0.0 15.7 10.2 22.4 27.0 61.4 14.3 14.3 36.5 21.8 26.4 15.9 2.8 63.9 18.0 18.6 33.3 19.9 50.0 18.7 17.3 51.9 14.2 58.8 19.4 28.4 43.6 29.4 19.7 11.1 32.4 19.9 32.5 SMARCD2 "BAF60B, CRACD2, PRO2451, Rsc6p" ENSG00000108604 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2" Q92925 17 63832081-63843065 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059934, HPA061348" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059934: AB_2684170, HPA061348: AB_2684486" "unprognostic (1.70e-1)" "unprognostic (2.17e-2)" "unprognostic (8.04e-2)" "unprognostic (3.84e-2)" "unprognostic (1.59e-1)" "unprognostic (2.00e-2)" "unprognostic (7.84e-2)" "unprognostic (4.79e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.75e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (1.81e-2)" "unprognostic (1.26e-1)" "unprognostic (1.79e-3)" "unprognostic (6.80e-2)" 22.0 25.0 6.9 23.1 11.5 21.2 25.6 29.0 12.5 21.7 24.6 14.3 36.5 17.8 17.2 25.8 30.7 22.7 25.9 13.4 8.6 5.3 16.0 21.3 20.1 26.5 15.8 8.9 18.0 42.5 17.3 16.1 33.2 10.1 24.2 18.0 15.0 42.9 30.2 11.1 36.3 25.6 22.1 8.9 26.1 26.4 17.7 13.6 40.6 23.3 23.7 28.0 23.7 22.5 11.0 14.5 13.0 11.6 9.1 13.6 6.7 26.2 17.2 4.6 20.8 29.1 47.6 26.0 9.8 14.7 21.7 14.2 20.1 15.2 30.4 5.7 17.7 8.9 18.0 14.9 22.6 13.7 8.1 35.7 20.7 7.0 29.5 23.9 24.3 23.1 37.0 28.3 11.6 10.3 12.9 17.8 22.4 16.3 18.5 12.9 63.6 38.5 26.1 10.7 42.2 19.7 39.4 16.1 35.1 15.7 20.0 17.4 30.9 12.3 50.9 21.1 15.2 47.0 24.3 11.7 13.8 8.3 12.6 16.9 21.7 16.1 20.6 10.8 24.2 10.0 5.4 11.6 10.6 11.5 10.0 7.6 8.8 12.9 12.3 14.5 11.0 8.6 11.6 13.0 9.1 11.5 12.9 13.6 6.7 6.9 11.5 29.0 12.5 8.6 5.3 15.8 8.9 10.1 13.6 26.8 46.8 21.8 16.6 20.4 10.3 5.0 25.5 22.7 27.3 15.7 5.9 43.2 3.3 14.5 0.8 14.6 27.6 0.0 17.0 34.6 23.0 18.1 13.9 72.9 19.3 11.1 31.8 22.1 34.0 2.4 45.8 19.0 13.5 16.2 38.9 16.7 17.7 31.5 29.0 10.0 11.6 32.3 15.0 13.4 17.9 27.1 44.3 13.8 36.8 16.2 SMARCD3 "BAF60C, CRACD3, Rsc6p" ENSG00000082014 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3" Q6STE5 7 151238764-151277896 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 75.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 59.6;Peritubular cells: 83.1;Sertoli cells: 64.7;Smooth muscle cells: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 8.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.6;granulocytes: 3.1;monocytes: 8.8" "Cell line enhanced" "Detected in many" "AN3-CA: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063955, HPA065517" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063955: AB_2685159, HPA065517: AB_2685500" "unprognostic (1.23e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.38e-3)" "unprognostic (4.67e-1)" "unprognostic (1.41e-3)" "unprognostic (2.24e-2)" "unprognostic (3.52e-2)" "unprognostic (1.63e-1)" "unprognostic (3.50e-1)" "unprognostic (2.08e-3)" "unprognostic (9.18e-2)" "unprognostic (1.02e-1)" "unprognostic (2.05e-3)" "unprognostic (1.34e-1)" "unprognostic (3.35e-3)" "unprognostic (1.29e-1)" 9.7 16.0 34.2 4.0 40.3 4.9 9.8 25.4 36.8 12.9 5.6 7.8 7.9 2.9 8.6 11.4 6.7 14.5 10.7 38.5 22.2 24.7 4.9 2.0 8.3 4.0 18.7 18.8 19.2 7.5 6.8 14.7 4.6 13.3 10.8 3.6 7.6 6.6 18.1 75.2 5.7 3.4 10.0 14.1 4.3 4.8 9.0 11.6 0.0 7.4 9.5 2.5 10.1 4.8 0.2 2.6 3.1 8.8 0.0 0.8 2.1 0.3 2.8 9.4 33.3 15.0 6.7 0.7 6.1 6.2 3.6 2.1 2.1 1.9 3.6 2.2 9.6 1.4 0.6 7.5 0.6 1.4 1.1 4.6 0.0 1.9 0.6 12.9 0.1 6.1 15.9 0.8 1.2 0.1 15.7 0.7 9.3 7.2 1.2 19.0 3.8 0.6 4.7 2.9 0.9 1.2 0.2 14.8 0.1 3.2 0.0 5.4 11.0 5.8 1.0 4.4 1.5 0.8 9.3 1.1 2.3 3.7 7.1 2.0 7.9 0.0 3.0 6.6 8.2 10.3 0.6 8.8 0.0 0.2 1.9 0.1 0.2 0.8 0.0 2.6 0.0 0.5 0.8 3.1 0.0 0.4 0.0 0.7 2.1 34.2 40.3 25.4 27.9 22.2 24.7 18.7 18.8 13.3 11.6 6.0 20.8 0.0 31.9 9.5 12.7 59.6 17.8 6.7 5.7 10.4 3.9 0.4 26.6 14.9 1.8 4.7 0.0 0.0 2.1 0.2 19.3 7.3 2.3 0.4 3.4 11.1 3.4 2.5 17.1 8.9 46.9 6.4 6.8 1.0 0.0 23.4 4.3 0.0 83.1 1.7 4.6 64.7 51.5 1.7 9.5 4.1 0.9 0.9 0.0 8.1 SMARCE1 BAF57 ENSG00000073584 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1" Q969G3 17 40624962-40648864 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" Neurogenesis "Chromatin regulator, DNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003916, CAB037318" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB037318: AB_476780, HPA003916: AB_1857279" "unprognostic (7.91e-2)" "unprognostic (2.68e-2)" "unprognostic (2.09e-2)" "unprognostic (8.06e-3)" "unprognostic (1.87e-1)" "unprognostic (2.55e-2)" "unprognostic (4.48e-1)" "unprognostic (1.25e-2)" "unprognostic (2.20e-2)" "unprognostic (1.05e-1)" "unprognostic (2.53e-2)" "unprognostic (2.04e-1)" "unprognostic (9.80e-2)" "unprognostic (5.93e-2)" "unprognostic (7.63e-2)" "unprognostic (1.09e-1)" "unprognostic (1.27e-2)" 25.1 20.2 14.4 17.2 18.8 18.4 20.2 17.0 16.7 37.6 25.1 18.0 12.6 18.4 42.8 19.5 31.0 21.1 20.6 19.6 13.3 12.0 23.0 22.6 20.1 22.3 16.5 14.3 39.5 16.9 13.3 20.4 34.8 15.2 32.4 19.2 17.9 20.6 21.9 32.0 21.3 22.6 33.4 15.8 30.3 19.1 22.0 17.5 53.9 23.8 18.9 25.1 31.2 21.0 40.3 32.0 34.0 30.3 47.2 44.0 39.2 20.7 34.5 42.3 31.5 22.4 32.3 20.8 26.1 36.0 30.7 23.1 22.6 18.0 32.9 37.7 35.2 20.5 28.3 26.2 27.6 36.9 30.8 34.0 23.5 18.6 39.6 22.6 42.9 23.9 28.0 21.8 24.5 35.7 31.0 33.0 26.6 34.2 13.1 29.3 23.3 78.5 8.9 23.6 17.1 17.1 44.0 47.7 25.0 37.0 35.6 33.9 32.8 23.2 67.3 21.7 48.0 40.3 26.9 27.0 25.0 27.5 22.5 32.1 24.6 28.6 49.2 25.4 19.7 38.4 31.8 26.0 34.0 39.1 26.8 40.5 38.4 35.8 40.9 31.3 40.3 30.2 34.9 11.0 47.2 30.3 32.0 44.0 39.2 14.4 18.8 17.0 16.7 13.3 12.0 16.5 14.3 15.2 17.5 44.7 30.1 53.5 36.0 33.9 46.7 46.8 38.2 73.6 60.3 19.2 15.7 85.1 13.3 34.9 18.3 60.7 37.1 23.3 27.8 65.4 59.9 34.1 70.6 38.4 44.7 77.9 92.7 48.5 34.8 7.7 83.7 37.7 23.6 49.5 51.9 65.5 27.8 51.0 77.4 21.6 34.7 38.8 52.6 40.8 46.0 35.0 96.0 60.9 54.8 33.5 SMC1A "DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb" ENSG00000072501 "Structural maintenance of chromosomes 1A" Q14683 X 53374149-53422728 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005499, CAB025404" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB025404: , HPA005499: AB_1080028" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (5.76e-2)" "unprognostic (1.04e-1)" "unprognostic (9.89e-2)" "unprognostic (1.29e-3)" "unprognostic (1.89e-1)" "unprognostic (9.80e-3)" "unprognostic (9.49e-2)" "unprognostic (4.48e-2)" "unprognostic (6.55e-2)" "unprognostic (2.58e-1)" "unprognostic (4.18e-3)" "unprognostic (6.28e-2)" "unprognostic (2.89e-1)" "unprognostic (9.39e-2)" 20.6 14.1 14.6 24.2 28.2 24.6 16.2 33.6 21.7 19.9 18.2 22.0 10.5 16.2 27.5 10.0 22.4 21.7 12.5 16.2 16.8 10.8 19.2 23.5 15.4 30.2 25.2 13.0 21.8 17.2 31.0 18.4 19.5 18.0 13.4 17.3 12.5 16.8 12.9 24.3 16.2 19.7 21.7 21.3 20.1 17.5 10.4 25.8 38.3 16.8 11.1 25.7 22.0 21.3 14.3 15.5 13.7 18.7 15.6 17.8 10.6 28.3 31.8 25.3 21.5 9.3 10.4 14.2 17.2 11.3 21.8 17.7 18.8 16.5 27.7 14.7 11.4 30.1 21.7 45.0 24.8 24.4 23.7 52.5 24.2 36.9 13.1 3.8 34.1 34.8 5.8 6.4 24.4 14.9 5.6 18.8 18.3 35.5 17.9 17.0 17.2 30.7 10.3 37.5 12.3 17.0 33.0 43.6 25.5 9.2 18.7 26.9 22.7 44.9 22.1 9.5 34.6 23.8 13.9 10.5 18.6 19.7 18.3 16.6 11.7 19.8 25.7 10.6 38.8 18.1 6.1 13.8 13.7 17.8 18.7 17.0 12.2 12.0 15.6 15.5 14.3 14.2 10.9 9.4 15.6 17.4 12.9 8.8 10.6 14.6 28.2 33.6 21.7 16.8 10.8 25.2 13.0 18.0 25.8 41.7 29.9 35.6 26.7 21.4 44.7 48.0 30.6 56.2 61.4 19.2 25.5 30.6 6.6 27.7 8.7 31.0 31.4 23.3 23.5 52.5 23.8 28.7 33.6 48.7 42.3 57.2 19.1 19.6 33.4 5.8 35.1 40.8 21.9 37.9 35.3 40.8 26.4 14.0 33.9 20.3 44.9 38.8 37.0 17.9 54.6 21.3 40.5 27.7 41.7 25.8 SMC3 "BAM, bamacan, CSPG6, HCAP, SMC3L1" ENSG00000108055 "Structural maintenance of chromosomes 3" Q9UQE7 10 110567691-110604636 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Sertoli cells: 181.1;Spermatocytes: 507.2;Spermatogonia: 682.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037411, HPA043206" Uncertain Supported Nucleoplasm NA NA 10000000 Nucleoplasm "HPA037411: AB_10671753, HPA043206: AB_2678362" "unprognostic (3.40e-1)" "unprognostic (1.73e-2)" "unprognostic (9.05e-2)" "unprognostic (3.00e-2)" "unprognostic (3.73e-2)" "unprognostic (8.89e-3)" "unprognostic (9.74e-3)" "unprognostic (8.06e-2)" "unprognostic (5.31e-2)" "unprognostic (6.32e-2)" "unprognostic (3.53e-2)" "unprognostic (1.17e-2)" "unprognostic (8.73e-3)" "unprognostic (7.22e-2)" "unprognostic (5.18e-2)" "unprognostic (7.95e-2)" "unprognostic (1.32e-1)" 17.1 13.4 16.8 15.4 22.9 32.7 21.3 37.8 18.0 19.2 15.1 9.9 10.7 13.3 20.1 14.3 19.7 15.6 9.9 11.9 16.7 11.2 16.6 17.2 12.6 23.7 18.6 15.4 26.5 18.4 22.2 36.6 22.9 17.7 14.6 15.1 8.8 15.3 14.3 18.4 18.4 18.8 19.6 22.2 18.1 13.5 32.0 23.2 47.4 19.4 11.4 20.8 20.7 19.7 13.2 11.0 19.1 10.5 15.1 17.7 7.4 27.3 17.1 37.2 26.4 12.4 10.7 16.1 22.2 22.1 20.5 20.2 21.5 23.1 35.6 9.7 14.8 15.8 21.8 26.6 13.4 31.4 29.1 22.9 28.8 21.6 19.3 12.5 40.8 22.3 8.4 11.0 22.7 35.8 19.1 15.1 12.2 22.9 27.6 17.7 14.3 31.4 21.7 25.6 14.6 13.7 26.7 67.4 19.3 12.7 12.2 21.2 24.3 23.9 6.9 18.2 25.4 11.1 20.0 15.4 16.6 26.2 18.6 31.9 16.1 14.3 38.7 14.8 39.5 13.5 19.1 7.7 18.6 13.0 10.5 16.1 13.2 15.1 14.0 8.4 13.1 15.5 15.1 8.4 15.1 8.9 11.0 17.7 7.4 16.8 22.9 37.8 18.0 16.7 11.2 18.6 15.4 17.7 23.2 74.5 53.1 60.6 45.3 53.8 75.4 47.3 28.1 87.0 72.8 52.4 70.7 92.8 21.6 81.3 36.8 60.7 29.7 46.7 39.8 102.4 54.0 32.7 54.4 25.2 51.1 57.2 39.0 35.6 33.5 26.9 106.7 45.1 35.4 99.2 34.6 52.6 45.0 30.8 107.1 25.1 76.1 181.1 50.5 507.2 682.8 56.3 41.1 65.4 42.0 32.5 SMC6 "FLJ22116, SMC6L1" ENSG00000163029 "Structural maintenance of chromosomes 6" Q96SB8 2 17663812-17800242 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 102.7;Spermatocytes: 151.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035057, CAB037186, HPA042733" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "CAB037186: AB_1080031, HPA035057: AB_2674435, HPA042733: AB_2678134" "unprognostic (1.75e-1)" "unprognostic (1.08e-1)" "unprognostic (1.50e-2)" "unprognostic (1.33e-3)" "unprognostic (1.70e-2)" "unprognostic (6.57e-2)" "unprognostic (1.38e-2)" "unprognostic (3.91e-2)" "unprognostic (2.03e-2)" "unprognostic (2.94e-3)" "unprognostic (9.33e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (3.15e-4)" "unprognostic (7.02e-2)" "unprognostic (1.57e-1)" "unprognostic (1.25e-1)" "unprognostic (5.25e-2)" 9.5 5.2 6.9 16.3 10.9 10.0 13.2 10.3 9.5 10.3 10.0 5.6 7.6 7.6 9.2 15.8 16.4 7.8 8.1 9.7 7.1 7.5 10.5 16.8 8.2 17.9 8.9 5.0 9.7 6.8 7.0 29.6 12.2 11.4 8.1 11.8 22.8 14.0 13.5 10.4 12.5 12.5 7.6 9.3 19.4 8.4 28.8 11.3 16.0 8.2 13.8 18.7 8.4 12.6 18.4 17.3 5.0 3.9 4.4 8.8 2.4 21.4 10.8 14.1 11.7 15.3 14.8 14.4 11.5 8.2 7.5 7.3 12.0 8.5 18.8 7.4 10.5 12.4 15.1 16.9 13.5 11.6 22.2 11.1 25.8 6.8 18.0 14.3 17.8 14.0 11.0 9.6 12.0 15.8 9.2 17.1 11.6 28.3 15.7 14.0 8.8 13.7 9.2 19.2 10.8 8.6 16.5 40.1 12.7 7.2 12.0 12.5 13.4 16.7 8.8 12.8 16.4 5.6 8.0 18.5 18.6 7.4 14.4 20.3 11.2 18.0 38.1 9.4 19.7 13.2 1.2 2.4 5.0 5.3 2.6 4.4 15.5 4.1 4.7 3.2 18.4 2.9 4.0 2.0 4.4 3.9 17.3 8.8 2.4 6.9 10.9 10.3 9.5 7.1 7.5 8.9 5.0 11.4 11.3 44.7 12.2 42.7 18.1 16.3 14.4 32.5 12.7 24.1 30.7 5.2 11.8 10.1 10.0 14.1 102.7 13.5 13.4 23.3 10.1 25.1 18.5 10.8 19.7 17.1 15.6 6.4 10.9 15.4 7.3 93.4 20.8 18.7 25.3 22.6 14.5 16.1 13.6 14.4 25.8 13.2 17.4 45.3 27.8 151.3 91.9 12.4 10.4 21.0 18.4 12.9 SMCR8 FLJ34716 ENSG00000176994 "Smith-Magenis syndrome chromosome region, candidate 8" Q8TEV9 17 18315310-18328055 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021557, HPA024646" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021557: AB_1857283, HPA024646: AB_1857284" "unprognostic (1.69e-1)" "unprognostic (2.25e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.07e-1)" "unprognostic (4.34e-3)" "unprognostic (2.11e-3)" "unprognostic (3.02e-2)" "unprognostic (3.18e-1)" "unprognostic (1.48e-2)" "unprognostic (5.09e-3)" "unprognostic (7.11e-2)" "prognostic favorable (1.35e-4)" "unprognostic (9.41e-3)" "unprognostic (4.35e-2)" "unprognostic (1.55e-2)" "unprognostic (9.27e-2)" 10.4 10.0 6.1 11.1 11.4 25.0 10.5 13.9 15.8 8.7 8.5 11.2 10.6 8.0 12.2 6.9 10.4 9.1 7.8 7.3 7.2 6.3 9.6 7.9 10.7 12.4 6.7 5.7 10.8 9.6 14.0 17.1 11.6 9.3 9.7 9.3 12.0 13.6 7.9 13.3 10.4 13.0 7.9 7.1 16.1 10.9 8.8 8.8 15.8 9.5 4.7 15.8 12.5 10.9 1.1 1.2 5.2 2.2 1.1 1.2 0.9 5.8 8.1 4.1 4.7 5.8 3.9 7.5 4.2 5.6 7.4 7.2 12.4 2.5 3.4 3.2 5.1 8.4 7.8 8.0 4.9 6.9 7.0 6.8 6.4 8.1 3.5 6.2 2.5 15.9 4.9 6.4 8.5 5.4 4.9 5.3 5.0 5.3 3.3 4.4 3.5 4.2 3.7 3.9 7.5 3.4 4.7 10.5 5.4 3.4 6.7 2.2 5.0 4.7 6.1 9.0 22.6 12.4 5.1 5.2 4.3 5.2 11.1 5.5 5.0 5.6 1.8 5.9 4.0 4.3 5.2 1.7 1.5 1.0 1.2 0.9 1.1 0.8 1.1 1.2 0.8 1.2 1.1 2.1 1.1 2.2 1.0 0.7 0.9 6.1 11.4 13.9 15.8 7.2 6.3 6.7 5.7 9.3 8.8 6.0 11.2 3.2 2.9 0.3 7.2 2.8 5.1 4.0 10.3 10.4 2.0 3.2 0.0 4.4 2.9 4.5 4.3 0.0 4.7 2.5 3.0 4.9 8.1 4.9 7.5 6.4 3.5 11.1 15.5 1.5 3.7 8.3 0.0 7.2 8.7 2.7 5.5 3.5 3.9 5.7 6.0 0.0 2.8 6.7 7.0 0.5 5.0 5.0 6.3 5.7 SMG1 "ATX, KIAA0421, LIP" ENSG00000157106 "SMG1, nonsense mediated mRNA decay associated PI3K related kinase" Q96Q15 16 18804853-18926454 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Nonsense-mediated mRNA decay" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006870, HPA031623, HPA073972" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006870: AB_1079725, HPA031623: AB_2673962, HPA073972: AB_2686648" "unprognostic (6.34e-2)" "unprognostic (5.88e-2)" "unprognostic (5.98e-2)" "unprognostic (2.66e-1)" "unprognostic (2.44e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (8.32e-3)" "unprognostic (7.28e-2)" "unprognostic (1.05e-1)" "unprognostic (2.61e-2)" "unprognostic (1.15e-1)" "unprognostic (3.17e-2)" "unprognostic (2.45e-2)" 4.7 3.0 2.1 4.5 3.5 11.7 6.2 13.2 3.0 4.4 4.5 3.1 5.4 5.1 5.5 4.0 3.0 4.5 2.3 2.2 4.6 5.4 4.1 6.2 2.3 6.3 4.5 7.2 3.9 3.1 4.2 5.0 4.7 3.3 21.1 14.4 5.0 3.9 3.4 4.5 4.3 4.0 6.0 5.8 5.2 4.9 7.1 4.6 19.1 5.6 2.3 6.1 1.0 23.5 15.8 14.9 10.5 17.1 18.1 11.1 11.0 10.9 12.0 13.5 13.9 8.7 32.5 15.9 15.3 12.7 13.4 17.1 9.6 19.2 20.9 10.7 14.8 13.9 17.7 13.9 19.9 11.7 10.6 16.3 24.9 30.0 11.9 16.8 17.7 22.7 18.1 13.2 12.6 13.7 11.9 15.9 8.6 9.1 15.9 20.1 11.1 10.4 18.5 13.5 10.4 17.1 11.6 12.1 12.8 9.3 12.7 21.2 18.1 12.1 11.1 16.3 9.3 12.0 21.4 12.0 15.5 10.8 19.1 2.5 3.4 6.1 2.8 2.9 3.7 4.0 4.3 2.5 7.1 5.4 4.7 7.6 2.3 5.6 4.6 3.7 1.0 71.5 85.2 53.9 67.9 171.7 51.1 42.5 20.4 48.2 92.1 26.2 70.7 16.8 3.3 19.5 15.5 65.3 48.7 23.3 20.4 15.0 55.9 71.2 38.1 39.9 21.0 39.7 37.7 36.8 38.1 15.4 27.6 61.1 37.1 36.1 38.6 20.1 26.6 57.5 24.8 12.2 43.3 45.3 56.7 45.2 29.8 178.7 25.1 60.7 35.2 83.0 SMG8 "C17orf71, FLJ10587, FLJ23205" ENSG00000167447 "SMG8, nonsense mediated mRNA decay factor" Q8ND04 17 59209400-59215247 "Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 5.3;granulocytes: 5.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024841 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024841: AB_10600790" "unprognostic (2.68e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-3)" "unprognostic (9.91e-2)" "unprognostic (8.59e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.72e-5)" "unprognostic (1.91e-1)" "unprognostic (1.15e-1)" "unprognostic (1.83e-1)" "unprognostic (3.18e-3)" "unprognostic (4.65e-2)" "unprognostic (9.37e-2)" "unprognostic (4.31e-2)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.75e-1)" 14.7 17.9 11.9 9.4 15.1 15.0 13.8 14.5 19.8 12.9 9.6 15.4 14.8 9.2 15.9 11.7 13.9 14.1 8.1 11.5 11.3 13.2 11.6 12.5 9.9 13.6 12.3 13.3 19.0 11.4 13.8 12.8 18.5 16.1 11.7 9.7 13.2 12.7 11.9 13.7 13.3 11.3 11.8 9.8 15.9 11.9 18.3 11.6 24.2 13.3 9.0 15.5 12.0 9.2 7.8 10.8 15.3 17.8 7.0 7.9 6.2 10.5 15.0 11.9 11.8 14.9 12.6 16.0 15.3 15.8 21.6 18.8 10.1 9.4 15.5 24.1 14.6 16.9 12.8 18.9 14.3 20.9 20.5 18.0 17.7 8.7 14.5 17.1 17.2 15.4 16.4 17.7 15.7 11.8 14.4 14.1 9.9 21.4 8.2 14.8 23.4 16.7 8.0 11.6 15.3 14.7 11.2 17.6 14.6 10.2 7.6 10.4 17.0 10.7 5.9 12.7 15.5 18.1 12.2 13.5 8.2 18.7 8.8 13.7 16.5 22.9 18.2 10.4 9.2 13.3 15.3 14.2 6.6 6.7 17.8 7.9 7.8 6.2 6.3 10.8 4.8 6.3 5.6 3.4 7.0 17.6 3.6 5.8 6.2 11.9 15.1 14.5 19.8 11.3 13.2 12.3 13.3 16.1 11.6 3.0 1.6 0.0 0.2 0.6 0.6 0.8 0.0 5.3 2.3 0.0 0.0 0.9 0.0 2.4 0.2 0.5 1.0 0.0 2.3 0.8 0.4 0.2 5.7 0.8 0.7 3.2 1.7 1.3 1.6 0.0 0.9 0.4 0.0 2.8 0.7 0.7 3.0 3.5 0.7 0.5 0.8 0.0 0.4 1.1 0.9 0.5 1.1 1.0 1.2 0.3 SMIM6 C17orf110 ENSG00000259120 "Small integral membrane protein 6" P0DI80 17 75646243-75647977 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 22.0;fallopian tube: 19.1;stomach 1: 26.5;testis: 20.6" "Group enriched" "Detected in many" 4 "Early spermatids: 508.7;Late spermatids: 1038.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 22.0" "Lineage enriched" "Detected in single" 46 "dendritic cells: 22.0" "Cell line enhanced" "Detected in some" "A549: 12.6;CACO-2: 4.1;EFO-21: 9.8;HEL: 7.1;OE19: 11.6;RPTEC TERT1: 4.5" HPA065721 Uncertain Approved Nucleoplasm Yes NA Nucleoplasm "HPA065721: AB_2685546" "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (7.07e-2)" "prognostic favorable (1.49e-4)" "unprognostic (3.42e-1)" "unprognostic (1.22e-2)" "unprognostic (6.53e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-3)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "unprognostic (8.06e-2)" "prognostic favorable (4.09e-4)" "unprognostic (2.77e-1)" "unprognostic (1.38e-1)" "unprognostic (2.58e-2)" "prognostic favorable (1.64e-4)" 0.2 0.1 2.4 0.6 4.1 0.6 0.1 0.6 6.1 1.8 5.3 12.3 3.2 7.9 0.9 2.2 0.2 19.1 15.8 0.1 4.0 2.1 13.5 5.2 1.8 0.3 5.3 4.1 0.4 7.3 1.7 0.1 0.4 5.4 0.3 5.5 0.1 0.2 2.9 0.1 0.2 9.4 0.0 9.1 0.2 26.5 20.6 3.1 0.0 0.1 0.2 0.2 1.1 0.8 0.0 22.0 0.0 0.0 0.4 0.0 0.2 0.7 12.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.1 3.9 0.0 9.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 7.1 0.3 3.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.2 4.5 2.1 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 22.0 0.0 0.2 2.4 4.1 0.6 6.1 4.0 2.1 5.3 4.1 5.4 3.1 3.0 1.9 0.8 3.2 0.1 0.0 0.0 30.6 44.2 6.8 33.2 0.0 0.0 116.0 27.9 508.7 0.1 26.2 0.0 14.7 2.6 0.2 1.8 0.0 5.4 0.6 0.0 189.1 0.0 0.0 1038.8 6.1 1.0 0.0 2.8 36.2 0.0 37.4 84.2 1.8 15.7 0.0 6.5 0.1 4.9 2.1 0.0 3.4 0.0 3.1 8.4 SNAI1 "SLUGH2, SNA, SNAH, SNAIL, SNAIL1" ENSG00000124216 "Snail family transcriptional repressor 1" O95863 20 49982999-49988886 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Endothelial cells: 26.5;Extravillous trophoblasts: 69.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Lineage enriched" "Detected in single" 6 "dendritic cells: 4.1" "Cell line enhanced" "Detected in many" "SiHa: 17.8;TIME: 24.9;WM-115: 16.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB005883, HPA056831, HPA069985, CAB078687" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB005883: AB_443967, CAB078687: AB_2665847, HPA056831: AB_2732606, HPA069985: AB_2732146" "unprognostic (4.60e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (4.76e-4)" "unprognostic (2.60e-2)" "unprognostic (1.15e-2)" "unprognostic (4.22e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (3.34e-3)" "unprognostic (9.85e-3)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.63e-7)" "unprognostic (3.75e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (8.82e-7)" "unprognostic (1.88e-2)" 18.3 8.0 1.8 5.9 3.8 5.5 11.1 2.9 2.7 5.9 3.4 5.8 2.6 1.6 5.4 4.2 4.0 8.2 22.2 11.8 3.1 1.2 5.2 7.2 14.3 5.9 3.1 1.3 6.8 7.0 3.6 4.9 15.9 2.9 6.1 1.3 11.0 3.4 3.8 3.6 3.2 2.3 4.3 6.3 8.1 4.5 4.5 3.6 0.7 18.7 4.1 2.0 10.8 13.9 0.0 4.1 0.0 0.6 0.0 0.0 0.1 0.7 0.6 3.5 0.5 1.1 0.7 7.0 3.0 3.7 0.6 0.4 5.6 0.9 0.4 8.2 5.3 3.6 0.1 1.0 0.0 0.3 0.0 0.7 0.4 1.3 3.3 9.0 0.9 2.8 2.1 0.2 1.3 0.0 9.3 9.0 0.4 4.3 0.1 0.0 1.2 0.1 1.0 4.6 0.5 2.4 1.5 0.9 0.4 4.1 0.0 1.5 3.6 17.8 4.6 0.7 3.1 0.9 4.1 24.9 0.0 4.4 0.0 0.0 0.1 0.1 4.6 1.5 1.3 16.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 1.8 3.8 2.9 2.7 3.1 1.2 3.1 1.3 2.9 3.6 0.0 4.0 3.9 1.1 4.6 0.7 3.6 2.5 1.4 5.7 0.0 0.0 7.5 0.0 1.4 2.2 26.5 1.6 0.0 0.2 69.4 13.4 1.2 1.1 0.0 7.3 3.2 1.7 19.0 5.1 0.4 5.2 14.4 5.0 1.8 3.4 0.8 2.8 1.4 13.4 0.0 0.2 6.5 11.3 1.2 3.2 4.3 11.7 1.3 1.7 0.4 SNAI2 "SLUG, SLUGH, SLUGH1, SNAIL2" ENSG00000019549 "Snail family transcriptional repressor 2" O43623 8 48917604-48921740 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Deafness, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Basal glandular cells: 113.7;Basal keratinocytes: 144.6;Fibroblasts: 122.9;Ito cells: 49.1;Leydig cells: 68.1;Melanocytes: 82.7;Peritubular cells: 63.3;Sertoli cells: 51.8;Smooth muscle cells: 149.4;Suprabasal keratinocytes: 129.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 11 "basophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "ASC diff: 55.8;ASC TERT1: 57.5;HSkMC: 42.4;hTERT-HME1: 39.6;LHCN-M2: 52.5;U-138 MG: 48.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" CAB011671 Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB011671: AB_777968" "unprognostic (3.52e-2)" "unprognostic (3.95e-1)" "unprognostic (1.55e-1)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (1.74e-2)" "unprognostic (1.79e-1)" "unprognostic (1.04e-2)" "unprognostic (4.24e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.83e-4)" "unprognostic (2.38e-1)" "prognostic unfavorable (4.69e-8)" "unprognostic (1.65e-3)" "unprognostic (3.76e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (7.16e-4)" 13.9 6.1 1.0 13.7 1.4 0.0 60.3 4.8 1.8 52.9 7.8 2.0 14.4 2.2 31.3 17.3 15.6 20.7 12.8 12.5 1.0 0.8 17.8 4.8 6.7 14.2 1.9 1.6 27.6 5.8 1.2 2.5 11.5 3.4 34.4 4.6 20.5 11.0 18.8 6.1 21.7 6.3 21.7 3.9 10.6 5.5 9.0 0.9 4.7 6.0 11.6 8.2 22.4 37.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.7 0.1 9.4 0.0 55.8 57.5 0.0 8.7 14.9 8.7 11.9 0.0 3.8 0.0 0.0 10.9 13.0 6.5 0.0 25.6 9.6 0.0 0.1 0.0 2.0 0.0 19.7 0.0 0.0 42.4 26.9 7.3 39.6 1.2 0.2 0.0 0.0 4.0 52.5 0.0 0.0 0.0 0.4 0.0 7.4 0.0 26.6 0.0 0.0 1.5 1.1 0.8 0.7 0.0 13.6 4.4 0.0 0.0 2.3 48.1 1.6 8.0 4.4 0.0 0.0 0.8 16.8 0.0 16.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 4.8 1.8 1.0 0.8 1.9 1.6 3.4 0.9 0.0 0.0 0.0 113.7 144.6 1.1 0.8 0.0 0.0 9.1 0.0 0.0 1.5 0.0 3.4 0.5 9.0 0.0 0.0 2.1 0.4 122.9 18.4 0.0 5.5 1.4 0.0 0.0 49.1 1.0 0.6 68.1 0.8 82.7 0.0 0.0 0.0 5.1 0.0 63.3 0.0 0.1 51.8 149.4 0.2 0.2 129.4 1.8 0.0 0.0 11.1 SNAI3 "SMUC, Zfp293, ZNF293" ENSG00000185669 "Snail family transcriptional repressor 3" Q3KNW1 16 88677682-88686493 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 25.5;skeletal muscle: 33.9" "Cell type enhanced" "Detected in some" 9 "B-cells: 8.0;granulocytes: 9.2;Hofbauer cells: 7.0;Kupffer cells: 14.2;Macrophages: 10.3;T-cells: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NB-4: 14.7;RPMI-8226: 23.2" "Region enhanced" "Detected in single" "basal ganglia: 1.3" "Not detected" "Not detected" HPA071127 Approved Nucleoplasm NA NA Nucleoplasm "HPA071127: AB_2686346" "unprognostic (1.03e-2)" "prognostic favorable (1.39e-4)" "unprognostic (2.20e-2)" "unprognostic (6.19e-4)" "unprognostic (3.05e-1)" "unprognostic (2.85e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (3.24e-2)" "unprognostic (7.79e-2)" "prognostic favorable (3.58e-4)" "unprognostic (9.09e-2)" "unprognostic (1.62e-1)" "unprognostic (8.46e-2)" "unprognostic (6.57e-2)" "unprognostic (1.11e-1)" "unprognostic (7.47e-2)" 0.9 0.8 2.4 6.3 2.3 2.3 0.8 1.9 2.9 1.3 3.4 2.1 0.2 2.2 0.8 1.3 1.3 1.4 2.6 2.4 2.5 1.7 1.3 1.0 5.3 4.5 3.1 0.8 1.5 6.1 2.1 1.0 0.9 2.2 1.6 0.8 1.4 3.6 0.7 33.9 1.1 4.6 1.1 2.4 9.2 3.5 2.1 2.2 2.1 3.0 9.5 13.0 2.7 2.4 4.6 9.2 25.5 7.7 0.5 11.6 5.4 0.2 0.8 0.2 1.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 2.9 0.2 1.9 0.5 0.0 0.7 0.6 0.2 0.2 0.0 0.3 1.1 0.9 0.1 0.9 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.2 1.7 3.6 0.0 2.6 0.1 14.7 0.3 0.3 0.3 3.2 0.2 23.2 0.0 0.4 1.4 0.2 0.6 0.0 0.2 0.4 1.0 1.8 0.3 0.1 0.9 0.2 0.0 0.6 3.3 3.3 0.2 4.0 0.4 2.8 7.7 25.5 6.1 2.9 10.9 4.6 9.9 5.7 9.2 3.8 6.1 3.8 17.1 0.5 0.7 6.5 11.6 5.4 2.4 2.3 1.9 2.4 2.5 1.7 3.1 0.8 2.2 2.2 3.0 0.0 8.0 0.1 0.5 0.2 2.0 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.1 9.2 0.0 7.0 0.0 0.0 0.6 14.2 0.0 0.0 10.3 5.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.8 0.0 1.1 0.3 0.1 10.9 0.0 0.0 SNAPC5 SNAP19 ENSG00000174446 "Small nuclear RNA activating complex polypeptide 5" O75971 15 66490135-66497813 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024379 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA024379: AB_2671552" "unprognostic (4.43e-2)" "unprognostic (1.53e-3)" "unprognostic (4.39e-3)" "unprognostic (4.56e-2)" "unprognostic (3.49e-2)" "unprognostic (2.31e-1)" "unprognostic (1.06e-1)" "unprognostic (8.07e-2)" "unprognostic (1.12e-2)" "unprognostic (3.39e-2)" "unprognostic (3.13e-1)" "unprognostic (6.28e-2)" "unprognostic (1.64e-2)" "unprognostic (1.25e-1)" "unprognostic (2.21e-1)" "unprognostic (9.40e-2)" "unprognostic (5.69e-2)" 16.6 20.7 30.9 17.0 29.8 7.5 16.7 29.1 30.5 13.9 18.7 15.2 15.5 12.6 17.2 33.0 13.4 17.6 13.5 32.2 21.8 26.6 22.2 27.4 15.3 16.3 22.8 25.0 16.8 14.1 28.8 21.6 12.6 20.0 18.7 15.6 15.8 16.0 24.5 34.1 9.4 14.5 19.1 15.6 16.1 14.3 25.2 17.2 14.0 22.1 17.3 17.4 15.7 12.4 26.4 25.2 23.9 28.9 26.9 35.5 19.8 7.0 26.3 9.8 12.0 14.0 13.0 10.5 8.1 11.8 11.1 8.4 15.2 17.1 8.4 23.9 10.3 11.2 15.0 27.3 11.8 11.9 14.5 16.2 11.6 25.9 19.9 16.3 29.0 12.7 11.0 14.3 9.2 23.5 7.9 9.3 16.4 37.1 16.1 7.9 16.6 12.4 10.4 10.5 31.0 11.7 13.4 10.2 31.0 14.4 9.9 12.2 9.2 9.1 17.9 35.8 23.6 17.2 21.2 6.5 9.3 19.0 10.2 15.6 13.3 20.2 14.4 9.7 36.2 19.8 23.9 16.1 23.6 22.5 26.7 30.2 26.4 27.2 30.0 14.3 19.9 35.5 31.5 8.3 26.9 28.9 25.2 30.0 19.8 30.9 29.8 29.1 30.5 21.8 26.6 22.8 25.0 20.0 17.2 20.8 16.3 16.6 14.8 8.4 13.9 46.2 15.3 48.2 21.6 26.2 9.8 29.2 71.3 23.0 93.9 22.4 13.1 23.3 41.7 22.0 17.1 22.3 18.5 43.2 40.4 17.5 13.4 11.1 13.4 80.2 24.7 21.1 25.3 36.9 15.5 11.1 24.5 7.0 26.2 60.2 15.7 0.0 19.8 98.4 31.1 8.4 18.7 26.1 16.2 14.0 SNRNP200 "ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD" ENSG00000144028 "Small nuclear ribonucleoprotein U5 subunit 200" O75643 2 96274336-96305515 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029321 Approved Supported Nucleoplasm NA NA 6600 Nucleoplasm "HPA029321: AB_10604096" "unprognostic (2.63e-2)" "unprognostic (1.45e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (3.89e-4)" "unprognostic (1.50e-1)" "unprognostic (1.09e-1)" "unprognostic (2.48e-3)" "unprognostic (1.01e-1)" "unprognostic (1.75e-1)" "unprognostic (1.74e-1)" "unprognostic (3.10e-1)" "unprognostic (6.46e-2)" "unprognostic (2.61e-2)" "unprognostic (1.82e-1)" "unprognostic (2.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" 26.6 25.2 18.4 28.4 21.9 32.0 26.1 37.2 25.8 24.4 23.6 23.7 20.6 18.4 34.7 22.6 23.4 26.5 22.0 22.0 19.7 12.3 19.0 25.8 22.7 25.1 16.6 18.9 39.3 22.7 49.4 25.2 33.7 18.9 21.3 22.0 25.5 28.3 23.0 39.7 25.3 27.6 28.3 15.8 25.2 23.4 34.3 19.5 57.3 25.3 21.3 31.2 33.7 24.0 8.5 7.7 15.3 7.5 9.1 12.6 6.0 23.1 26.3 35.4 26.5 16.5 14.6 33.3 16.0 19.6 29.4 28.1 47.9 17.0 40.4 25.4 20.5 44.7 18.4 64.9 21.8 30.4 21.8 34.3 51.6 41.9 25.9 10.7 39.5 22.7 15.1 13.6 33.4 28.4 15.5 23.8 23.9 45.1 27.2 16.9 20.2 37.0 11.8 46.0 19.1 25.5 43.8 34.3 25.3 11.4 34.3 39.3 37.4 26.0 22.3 16.6 42.5 21.3 24.7 20.6 24.5 29.7 24.8 23.1 25.3 29.8 50.3 16.6 26.4 26.1 15.3 5.6 7.5 10.1 7.0 12.2 7.8 7.8 12.6 7.3 8.5 7.6 9.3 6.2 9.1 7.5 7.7 8.5 6.0 18.4 21.9 37.2 25.8 19.7 12.3 16.6 18.9 18.9 19.5 41.7 51.7 49.6 23.8 26.3 74.3 30.5 71.4 40.2 45.5 48.8 98.2 36.0 5.0 36.2 22.5 41.7 37.6 23.3 40.2 31.2 30.8 30.4 24.3 42.9 30.8 82.6 44.9 33.2 27.5 10.6 53.2 32.3 16.9 37.9 40.6 92.0 36.3 35.1 51.9 14.6 128.6 64.7 38.7 86.5 54.9 28.9 37.3 66.0 41.3 27.3 SNRNP27 "RY1, U4/U6.U5-27K" ENSG00000124380 "Small nuclear ribonucleoprotein U4/U6.U5 subunit 27" Q8WVK2 2 69893560-69905575 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034541 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA034541: AB_10602408" "unprognostic (2.24e-1)" "unprognostic (6.11e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (4.89e-2)" "unprognostic (1.28e-2)" "unprognostic (1.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.61e-2)" "unprognostic (1.30e-2)" "unprognostic (1.26e-1)" "unprognostic (3.18e-1)" "unprognostic (4.35e-3)" "unprognostic (9.12e-2)" "unprognostic (2.16e-1)" "unprognostic (2.26e-1)" "unprognostic (1.86e-1)" 20.4 24.3 35.1 15.8 28.0 25.9 19.3 25.4 27.3 14.4 12.9 18.3 12.7 12.6 17.2 19.2 13.7 13.7 15.3 27.2 27.5 28.4 17.5 16.9 13.8 20.8 28.7 23.2 16.5 12.7 18.7 26.5 20.6 22.7 17.6 15.0 12.1 14.4 14.4 73.7 14.1 14.6 16.4 31.4 15.1 12.7 9.8 21.9 15.1 18.9 12.3 18.7 15.4 20.1 24.1 26.6 23.6 16.9 19.4 19.7 14.9 10.7 5.8 19.4 12.1 17.2 18.8 15.8 14.8 17.0 20.0 16.4 12.4 12.1 10.7 12.6 11.4 21.4 6.3 12.4 5.8 26.1 12.7 13.3 13.3 6.0 16.0 16.0 16.0 23.5 13.3 14.2 13.5 11.7 17.2 15.6 17.0 17.5 19.2 26.4 5.8 22.6 29.1 14.9 11.6 6.5 18.0 16.5 11.8 23.0 7.0 20.3 16.4 11.1 12.3 16.4 15.5 11.0 13.6 9.9 15.3 20.7 20.8 22.2 11.9 11.4 17.8 13.7 19.8 28.2 22.5 16.9 23.6 16.3 14.8 17.0 24.1 17.7 15.6 13.7 21.0 19.7 19.3 9.0 19.4 14.7 26.6 18.8 14.9 35.1 28.0 25.4 27.3 27.5 28.4 28.7 23.2 22.7 21.9 50.6 38.3 74.4 35.1 43.6 30.5 52.0 45.9 54.9 34.2 59.3 13.7 41.3 63.0 54.7 23.4 36.9 31.8 23.3 47.8 49.9 48.9 30.4 56.8 71.5 49.6 22.3 37.4 52.8 53.1 8.5 47.5 52.7 35.4 43.3 39.6 35.8 50.5 42.1 54.5 41.9 29.5 38.8 46.7 71.9 58.1 40.3 43.9 49.8 34.9 32.9 SNRNP70 "RNPU1Z, RPU1, Snp1, SNRP70, U1-70K" ENSG00000104852 "Small nuclear ribonucleoprotein U1 subunit 70" P08621 19 49085419-49108605 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001718, HPA042050, HPA043516" Supported Enhanced Nucleoplasm NA NA 30000 Nucleoplasm "CAB001718: , HPA042050: AB_2677821, HPA043516: AB_2678523" "unprognostic (2.22e-3)" "unprognostic (5.27e-2)" "unprognostic (9.13e-3)" "unprognostic (1.05e-1)" "unprognostic (6.66e-2)" "unprognostic (2.58e-2)" "unprognostic (4.01e-3)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-1)" "prognostic favorable (4.59e-5)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.12e-5)" "unprognostic (5.18e-3)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "prognostic favorable (5.35e-5)" 46.9 46.5 50.1 65.8 57.0 51.9 29.8 89.6 73.1 36.7 36.2 40.5 46.5 45.8 44.0 38.8 38.9 34.0 35.4 33.3 46.5 34.6 30.6 35.0 29.3 47.6 53.8 49.0 43.3 36.1 37.8 41.8 34.3 43.4 43.0 27.3 26.6 42.7 52.7 73.5 48.1 44.6 28.5 41.5 45.6 45.2 30.5 58.1 34.9 39.8 25.6 37.3 26.9 35.0 5.3 3.2 3.2 3.7 7.9 3.9 1.2 34.5 40.0 28.1 20.1 11.5 7.1 34.5 26.8 16.5 28.1 24.2 24.3 20.4 42.3 25.9 17.3 23.4 30.9 34.8 25.3 20.8 27.7 92.8 38.6 20.1 27.6 6.0 41.7 26.0 9.9 7.0 20.0 13.6 12.7 20.9 20.2 39.5 13.1 16.7 29.9 43.0 66.6 35.6 18.6 34.6 50.0 27.9 24.7 17.1 21.6 24.2 28.7 33.6 18.9 17.8 19.3 20.0 25.1 31.1 20.6 38.7 18.0 42.9 34.9 29.4 51.5 17.4 27.2 19.3 1.5 3.7 3.2 3.6 2.5 2.1 5.3 2.3 1.5 3.2 3.5 3.9 2.3 1.7 7.9 1.9 2.8 2.4 1.2 50.1 57.0 89.6 73.1 46.5 34.6 53.8 49.0 43.4 58.1 17.9 62.4 92.3 143.3 123.9 97.6 25.0 56.0 36.1 47.8 71.5 84.4 155.8 39.7 97.0 14.1 68.1 71.8 23.3 90.8 176.6 99.6 110.3 53.2 72.3 109.6 108.1 113.3 63.3 61.9 12.5 120.6 80.2 65.8 77.5 97.3 96.3 92.5 74.8 104.0 62.4 104.8 122.9 97.6 108.5 89.7 114.3 147.5 77.8 98.4 135.5 SNRPA "Mud1, U1-A, U1A" ENSG00000077312 "Small nuclear ribonucleoprotein polypeptide A" P09012 19 40750637-40765389 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004652, HPA046440, HPA054834" Supported Supported Nucleoplasm NA NA 23000 Nucleoplasm "CAB004652: AB_425687, HPA046440: AB_2679668, HPA054834: AB_2682619" "unprognostic (3.53e-2)" "prognostic favorable (2.50e-4)" "unprognostic (3.78e-2)" "unprognostic (2.10e-1)" "unprognostic (3.30e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (1.34e-5)" "unprognostic (1.03e-1)" "unprognostic (8.04e-2)" "unprognostic (9.08e-3)" "unprognostic (1.81e-1)" "unprognostic (3.38e-2)" "prognostic unfavorable (2.96e-9)" "unprognostic (2.52e-2)" "unprognostic (1.05e-1)" "unprognostic (4.80e-2)" "unprognostic (7.01e-3)" 27.6 25.0 28.1 35.8 30.8 44.0 39.2 28.8 32.6 31.9 31.8 16.7 33.8 31.2 35.2 35.5 32.8 31.3 27.0 23.6 23.4 19.2 26.9 26.6 28.2 56.3 26.9 19.7 44.7 34.8 16.1 30.6 23.4 25.1 32.3 29.0 19.5 29.7 37.4 43.1 26.6 36.2 41.8 36.4 40.4 27.2 30.9 29.8 49.8 35.1 34.0 37.9 33.2 47.4 14.8 29.9 3.8 17.2 14.2 18.2 11.9 35.0 31.1 35.6 28.6 9.5 11.9 30.4 12.1 16.9 32.6 35.5 25.6 29.1 42.9 18.1 16.1 17.0 26.7 35.1 31.5 30.0 23.6 38.3 31.3 25.7 32.0 14.7 35.7 20.7 11.2 7.6 20.9 35.1 18.1 28.6 38.4 34.8 23.6 21.7 28.8 67.2 56.8 38.1 27.7 26.3 58.8 24.7 33.8 21.7 18.7 27.9 28.4 23.8 25.5 19.8 20.5 25.4 33.0 15.6 17.3 31.1 18.3 30.4 26.2 29.1 63.2 17.7 39.5 22.1 1.6 15.1 3.8 16.1 17.2 16.8 14.8 16.5 18.2 29.9 13.9 16.9 15.9 1.4 14.2 8.1 18.3 16.2 11.9 28.1 30.8 28.8 32.6 23.4 19.2 26.9 19.7 25.1 29.8 11.9 17.5 38.8 43.7 31.9 7.3 6.7 10.2 10.7 9.1 24.4 2.0 85.1 36.5 38.9 27.1 32.1 28.5 23.3 42.4 104.6 31.5 29.9 32.3 19.0 53.5 4.8 31.8 26.4 24.7 11.0 34.5 31.3 21.9 53.3 40.3 13.4 36.0 23.0 26.5 26.9 4.0 19.4 25.8 49.2 68.5 29.0 55.5 38.3 59.0 33.6 SNRPB "COD, Sm-B/B', SmB/SmB', snRNP-B, SNRPB1" ENSG00000125835 "Small nuclear ribonucleoprotein polypeptides B and B1" P14678 20 2461634-2470853 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003482, CAB009610, HPA067842" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009610: AB_2193859, HPA003482: AB_1857337, HPA067842: AB_2685909" "unprognostic (2.33e-1)" "unprognostic (3.14e-2)" "unprognostic (5.64e-2)" "unprognostic (2.73e-2)" "unprognostic (9.47e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (1.07e-5)" "unprognostic (5.11e-2)" "unprognostic (3.66e-1)" "unprognostic (4.66e-2)" "unprognostic (7.30e-2)" "unprognostic (4.20e-2)" "unprognostic (2.21e-1)" "unprognostic (2.79e-1)" "unprognostic (1.13e-1)" "unprognostic (9.18e-2)" "unprognostic (9.47e-2)" 26.6 28.5 14.8 41.1 16.4 78.9 29.0 20.8 17.7 26.3 33.6 10.6 26.8 27.1 34.4 30.2 46.7 26.8 29.6 29.2 10.9 9.9 26.2 36.4 29.3 39.5 18.3 16.5 29.5 34.4 14.7 20.7 35.7 16.6 23.9 23.4 16.0 29.6 21.2 43.8 37.9 27.9 23.4 12.3 39.5 26.9 30.3 15.6 60.1 29.3 51.0 39.6 24.7 28.1 57.9 65.0 36.8 56.9 41.7 63.8 63.7 79.9 109.8 39.6 36.4 8.9 16.0 45.0 35.3 26.9 72.9 59.4 127.0 58.2 60.2 22.6 20.5 58.6 59.2 38.2 65.1 36.9 24.7 68.0 41.3 22.1 118.2 31.3 57.2 25.4 18.3 25.3 59.4 26.2 13.8 40.4 51.1 56.8 43.7 29.7 55.3 89.7 91.5 87.7 40.9 53.3 54.6 40.6 72.8 27.2 42.5 42.8 47.0 43.1 58.7 50.4 17.9 54.6 63.1 27.9 43.5 36.6 38.1 78.8 36.5 91.6 90.1 14.7 63.5 44.0 36.8 47.1 35.3 59.4 56.9 49.9 57.6 53.0 52.4 62.4 57.9 43.5 50.5 24.4 41.7 56.4 65.0 63.8 63.7 14.8 16.4 20.8 17.7 10.9 9.9 18.3 16.5 16.6 15.6 41.7 62.5 219.0 273.7 425.2 44.2 16.1 112.1 78.9 95.5 89.0 11.8 311.6 122.7 297.7 13.8 155.8 105.2 46.7 256.3 535.0 176.5 161.5 141.9 50.0 256.0 28.6 136.2 82.3 85.0 16.6 147.3 183.9 180.5 230.0 159.2 57.0 307.2 168.6 116.3 108.3 40.4 155.2 220.0 302.7 322.8 369.9 312.3 182.1 238.2 375.6 SNRPC "U1-C, Yhc1" ENSG00000124562 "Small nuclear ribonucleoprotein polypeptide C" P09234 6 34757406-34773794 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034338, HPA042419, HPA055490" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034338: AB_2295245, HPA042419: AB_2677989, HPA055490: AB_2682833" "unprognostic (1.84e-1)" "unprognostic (3.73e-2)" "unprognostic (1.59e-1)" "unprognostic (2.32e-3)" "unprognostic (1.45e-1)" "unprognostic (3.93e-2)" "prognostic unfavorable (5.65e-4)" "unprognostic (1.48e-2)" "unprognostic (6.16e-2)" "unprognostic (1.16e-3)" "unprognostic (7.71e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (8.20e-5)" "unprognostic (4.39e-2)" "unprognostic (8.64e-2)" "unprognostic (1.52e-1)" "unprognostic (2.62e-2)" 20.9 24.6 28.3 25.5 29.5 56.2 23.5 19.0 26.7 20.3 28.2 19.0 26.9 26.6 28.5 33.7 28.1 32.1 31.6 56.8 24.4 22.4 26.7 34.9 25.3 36.3 27.4 28.3 26.3 62.5 18.5 19.5 27.1 23.8 22.9 24.3 19.7 30.6 26.5 54.9 20.7 27.3 25.0 29.3 28.6 25.5 66.6 26.3 39.8 36.9 47.2 33.7 24.1 21.0 58.6 53.4 32.6 56.7 38.4 58.3 55.5 47.4 29.4 38.7 50.4 21.0 20.5 29.8 27.2 30.0 54.6 46.2 50.6 18.8 53.4 36.5 33.8 38.2 22.9 58.2 40.7 44.5 35.6 61.4 41.2 25.1 69.7 36.5 52.3 26.3 25.3 39.7 55.4 39.5 21.7 34.5 52.2 66.1 31.2 39.3 39.8 62.6 86.6 42.2 70.8 35.9 43.4 32.7 51.3 35.2 20.3 48.0 34.4 24.4 25.2 59.6 26.2 38.7 79.3 22.9 33.6 39.4 27.3 66.2 34.7 90.1 75.1 15.2 91.7 56.9 26.8 43.8 32.6 35.3 50.1 40.4 58.6 43.5 40.4 50.3 51.0 47.4 43.0 7.9 38.4 56.7 53.4 58.3 55.5 28.3 29.5 19.0 26.7 24.4 22.4 27.4 28.3 23.8 26.3 113.2 104.2 62.5 63.3 39.0 23.7 207.1 84.1 131.2 119.4 64.6 23.6 209.0 160.8 134.3 96.2 66.7 54.9 23.3 135.8 171.0 97.6 66.3 77.5 85.5 197.4 27.0 87.2 63.8 66.9 49.1 51.2 87.8 60.8 201.0 86.3 68.5 129.0 73.7 39.3 158.4 33.1 64.7 62.8 146.4 108.6 39.1 94.7 91.6 100.0 62.6 SNRPG Sm-G ENSG00000143977 "Small nuclear ribonucleoprotein polypeptide G" P62308 2 70281362-70293771 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA064152, HPA067814" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA064152: AB_2685199, HPA067814: AB_2685903" "unprognostic (6.42e-2)" "unprognostic (7.89e-2)" "unprognostic (6.10e-2)" "unprognostic (5.42e-2)" "unprognostic (1.29e-1)" "unprognostic (1.11e-3)" "unprognostic (1.75e-3)" "unprognostic (2.28e-2)" "unprognostic (3.60e-3)" "unprognostic (6.19e-2)" "unprognostic (1.00e-2)" "unprognostic (9.14e-2)" "prognostic unfavorable (1.08e-6)" "unprognostic (4.37e-2)" "unprognostic (1.33e-1)" "unprognostic (8.96e-2)" "unprognostic (1.41e-2)" 24.8 40.2 22.8 36.4 26.4 40.3 34.8 16.7 23.1 21.1 34.3 14.3 29.0 25.5 25.4 42.8 40.3 19.5 28.5 33.6 24.0 18.6 35.2 38.9 25.5 36.3 30.5 25.0 22.7 37.7 10.0 29.5 36.1 27.4 22.8 32.8 16.7 38.9 33.2 57.3 17.6 26.0 24.6 34.0 33.8 26.1 33.9 27.9 33.8 28.8 42.2 36.6 22.1 47.3 51.2 69.6 43.1 55.0 33.2 57.2 63.6 48.9 51.4 53.0 30.6 19.1 20.6 47.6 32.2 28.9 42.5 39.6 88.6 32.7 44.0 24.5 25.0 52.2 32.5 52.1 44.4 45.7 40.7 51.0 58.4 35.1 109.4 25.4 73.6 41.9 18.3 25.2 40.0 39.8 17.4 42.7 38.0 77.8 32.5 33.4 58.3 63.8 118.2 57.0 60.5 42.9 43.5 65.2 51.6 60.5 45.7 30.5 27.2 29.8 25.6 35.5 33.7 25.7 60.1 29.3 30.5 58.6 31.9 64.2 25.5 26.5 90.0 27.4 63.3 33.1 31.0 43.8 43.1 40.4 55.0 40.7 51.2 56.0 46.3 51.0 40.9 45.6 53.7 21.9 33.2 54.9 69.6 57.2 63.6 22.8 26.4 16.7 23.1 24.0 18.6 30.5 25.0 27.4 27.9 187.6 179.7 207.0 263.9 265.7 86.8 143.2 165.6 295.8 176.3 191.9 31.4 575.2 452.6 350.1 21.6 194.3 190.4 163.5 341.1 649.7 230.3 272.1 204.8 326.8 339.5 62.0 179.0 173.1 183.0 38.3 162.8 237.5 212.6 352.5 202.6 251.2 356.9 212.7 149.6 501.2 70.3 181.1 181.0 261.1 342.4 278.2 436.2 244.5 250.8 301.5 SNRPN "HCERN3, PWCR, RT-LI, SM-D, SMN, SNRNP-N, SNURF-SNRPN" ENSG00000128739 "Small nuclear ribonucleoprotein polypeptide N" P63162 15 24823637-24978723 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 388.0;Horizontal cells: 314.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 117.7;SuSa: 79.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003482, HPA067842" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003482: AB_1857337, HPA067842: AB_2685909" "unprognostic (9.91e-2)" "unprognostic (1.03e-3)" "unprognostic (2.79e-1)" "unprognostic (1.66e-2)" "unprognostic (3.71e-2)" "unprognostic (2.32e-2)" "unprognostic (1.08e-1)" "unprognostic (2.72e-2)" "unprognostic (9.44e-3)" "unprognostic (1.30e-1)" "unprognostic (1.04e-2)" "unprognostic (6.59e-2)" "prognostic favorable (8.93e-8)" "unprognostic (4.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" "unprognostic (6.74e-2)" 7.9 35.1 62.2 7.8 73.4 5.6 13.0 65.6 74.7 21.4 9.4 18.4 14.2 6.5 11.6 64.8 8.0 22.8 25.9 84.7 55.9 68.3 35.8 12.4 13.0 14.9 51.3 47.4 28.4 20.3 49.8 42.8 6.5 51.6 33.0 6.4 17.3 22.4 29.1 34.9 6.3 7.9 10.9 31.9 13.3 10.3 9.6 21.3 9.9 55.5 6.8 14.1 12.9 7.8 48.6 71.0 23.6 9.6 36.3 73.7 67.3 0.1 21.5 39.4 27.0 23.3 10.6 0.1 7.1 14.6 4.7 8.7 19.9 10.2 0.0 14.0 17.1 7.2 4.0 0.0 20.9 2.7 11.8 0.0 13.0 13.8 21.3 27.6 15.5 11.7 20.1 8.9 10.3 12.2 31.9 14.0 27.7 3.5 0.0 26.9 0.0 31.0 0.2 117.7 0.0 9.1 16.2 14.9 0.0 25.4 32.3 23.3 22.3 0.1 0.5 25.2 79.9 13.9 39.9 9.4 11.9 12.2 0.0 4.2 33.2 17.8 20.4 10.0 10.6 8.9 23.6 9.3 13.7 44.6 9.5 49.9 48.6 55.2 50.6 8.7 45.1 73.7 60.6 2.5 36.3 9.6 71.0 55.4 67.3 62.2 73.4 65.6 74.7 55.9 68.3 51.3 47.4 51.6 21.3 8.9 39.2 89.8 86.5 1.9 173.2 156.1 188.5 45.5 38.7 169.3 49.1 1.2 388.0 144.4 79.6 44.3 9.8 0.0 71.7 1.1 38.2 150.5 61.2 26.3 51.9 314.6 137.0 52.8 26.7 74.6 71.7 25.3 0.0 55.1 35.3 123.5 61.4 31.3 109.6 212.5 75.0 51.8 47.2 58.4 44.8 1.5 1.4 76.2 21.6 54.7 SNX20 "SLIC-1, SLIC1" ENSG00000167208 "Sorting nexin 20" Q7Z614 16 50666300-50681353 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 58.5;lymphoid tissue: 42.5" "Cell type enhanced" "Detected in some" 7 "B-cells: 16.1;Cardiomyocytes: 14.3;Hofbauer cells: 16.3;Kupffer cells: 17.3;Macrophages: 22.2;monocytes: 17.2;Sertoli cells: 12.9;T-cells: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 13.3;HMC-1: 37.2;NB-4: 21.6;RPMI-8226: 9.2;THP-1: 9.7;U-266/70: 12.1;U-937: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043649 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043649: AB_10965697" "unprognostic (1.53e-2)" "prognostic favorable (9.07e-4)" "unprognostic (5.58e-2)" "unprognostic (5.06e-3)" "unprognostic (9.03e-2)" "prognostic favorable (6.56e-4)" "unprognostic (1.97e-1)" "unprognostic (1.26e-2)" "unprognostic (1.78e-2)" "unprognostic (1.04e-1)" "unprognostic (4.06e-2)" "unprognostic (1.84e-1)" "prognostic unfavorable (6.00e-6)" "unprognostic (3.24e-1)" "unprognostic (3.37e-2)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" 2.0 1.4 2.5 12.7 5.7 10.7 1.3 1.2 2.7 1.3 1.7 1.4 0.1 1.8 1.2 2.4 1.7 1.7 3.1 2.7 1.5 1.5 1.9 1.5 5.7 21.1 2.6 0.2 1.1 1.0 0.1 1.1 1.8 3.1 1.8 2.3 1.3 3.0 0.2 0.7 1.4 7.4 1.6 3.0 23.6 2.1 0.6 3.3 42.5 1.5 0.8 22.3 4.7 1.2 5.5 27.9 58.5 30.7 11.1 30.1 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.3 0.0 2.3 0.0 0.0 0.0 3.3 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 1.1 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.0 0.0 12.1 6.3 2.9 0.0 12.9 0.0 58.5 15.1 45.5 10.1 26.6 12.6 5.5 18.0 12.2 27.9 5.2 14.0 9.5 14.1 11.1 30.7 7.7 30.1 15.8 2.5 5.7 1.2 2.7 1.5 1.5 2.6 0.2 3.1 3.3 0.0 0.0 16.1 0.0 0.7 0.0 14.3 2.5 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.4 0.0 4.7 0.0 16.3 1.6 0.0 0.0 17.3 0.0 0.0 22.2 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.5 0.3 22.4 0.0 0.0 SOX10 "DOM, WS2E, WS4" ENSG00000100146 "SRY-box 10" P56693 22 37970686-37987422 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Deafness, Disease mutation, Hirschsprung disease, Kallmann syndrome, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 64.4;salivary gland: 98.4" "Cell type enriched" "Detected in some" 12 "Melanocytes: 33.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 704 "SK-MEL-30: 62.9;WM-115: 90.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003171, HPA068898" Enhanced Supported Nucleoplasm Yes NA Nucleoplasm "CAB003171: AB_2195374, HPA068898: AB_2686054" 3.3 4.0 21.0 3.7 33.1 1.6 18.7 3.2 32.8 3.2 8.1 64.4 0.5 2.9 1.8 2.8 2.8 1.9 3.4 3.9 26.9 15.2 1.7 1.7 1.6 1.6 41.3 13.7 2.4 2.2 1.7 0.7 1.6 24.7 2.3 3.9 22.8 98.4 7.1 1.8 15.8 3.8 3.2 46.6 1.8 2.4 3.1 42.5 0.0 1.7 0.0 1.6 2.5 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 90.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 33.1 3.2 24.6 26.9 15.2 41.3 13.7 24.7 42.5 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.6 0.0 0.0 0.0 0.0 SOX12 SOX22 ENSG00000177732 "SRY-box 12" O15370 20 325595-330224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 53.0;Cone photoreceptor cells: 39.3;Horizontal cells: 30.2;Rod photoreceptor cells: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "B-cells: 1.8;dendritic cells: 1.5;T-cells: 1.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055052, HPA061627" Enhanced Nucleoplasm No No Nucleoplasm "HPA055052: AB_2682685, HPA061627: AB_2684571" "unprognostic (1.02e-1)" "unprognostic (1.33e-2)" "unprognostic (1.18e-3)" "unprognostic (1.30e-3)" "unprognostic (1.81e-3)" "unprognostic (8.80e-2)" "prognostic unfavorable (6.64e-5)" "unprognostic (1.90e-1)" "unprognostic (1.49e-3)" "unprognostic (3.55e-1)" "unprognostic (5.02e-3)" "unprognostic (4.66e-1)" "unprognostic (3.12e-3)" "unprognostic (7.91e-2)" "unprognostic (1.55e-1)" "unprognostic (8.36e-2)" "unprognostic (2.20e-2)" 5.2 7.4 11.0 4.9 10.2 5.4 10.3 27.5 14.1 8.2 7.8 10.1 11.0 4.1 10.9 11.3 5.8 10.2 5.2 6.8 10.9 8.8 8.3 4.7 5.3 5.1 11.3 5.7 14.6 12.6 7.7 7.0 5.0 8.4 8.7 3.0 7.8 8.8 13.8 2.3 9.0 4.8 8.5 6.9 7.6 5.0 8.2 10.9 12.1 8.2 2.0 3.8 7.8 9.0 1.8 1.5 0.3 0.2 0.2 1.3 0.2 3.7 13.2 12.9 8.7 6.3 4.6 3.9 5.2 4.5 4.7 4.7 2.6 3.9 8.4 4.0 6.0 9.9 4.4 9.4 1.7 2.7 4.2 6.5 5.4 5.1 26.3 8.1 7.4 1.4 6.3 5.4 4.0 1.6 7.8 6.2 5.8 12.7 4.4 3.0 9.1 2.5 18.3 21.1 2.1 17.4 13.2 3.3 6.8 6.7 0.4 15.9 18.5 3.5 15.3 19.2 5.6 14.5 10.4 7.0 18.4 18.3 0.5 4.5 12.8 13.4 8.7 3.4 7.4 3.5 0.3 0.2 0.3 0.5 0.1 0.2 1.7 0.6 0.8 0.2 1.8 1.3 1.1 0.1 0.2 0.0 1.5 0.8 0.2 11.0 10.2 27.5 10.7 10.9 8.8 11.3 5.7 8.4 10.9 0.0 2.7 0.8 2.1 3.1 53.0 11.0 5.1 1.4 1.2 7.0 39.3 1.2 13.3 1.1 0.6 3.8 1.1 0.0 0.3 0.4 4.3 2.6 0.0 4.7 1.8 30.2 8.7 8.6 1.9 1.7 9.5 0.7 5.0 0.0 4.0 8.3 0.4 0.0 11.7 4.8 37.2 0.0 5.7 0.9 7.0 1.0 0.6 2.1 3.7 0.3 SOX13 "ICA12, MGC117216, Sox-13" ENSG00000143842 "SRY-box 13" Q9UN79 1 204073115-204127743 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.1" "Group enriched" "Detected in many" 6 "NK-cells: 4.1;T-cells: 2.6" "Cell line enhanced" "Detected in many" "BEWO: 24.0;SK-BR-3: 50.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051790, HPA054843" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051790: AB_2681610, HPA054843: AB_2682622" "unprognostic (4.88e-3)" "unprognostic (6.01e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (4.74e-2)" "unprognostic (2.65e-1)" "unprognostic (3.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.27e-2)" "unprognostic (2.75e-1)" "unprognostic (2.95e-1)" "unprognostic (1.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.48e-3)" "unprognostic (1.04e-1)" "unprognostic (8.20e-2)" "unprognostic (7.98e-2)" "unprognostic (1.92e-1)" 22.2 10.7 11.0 6.9 8.6 0.8 18.4 9.2 9.9 37.0 17.2 14.4 16.1 13.5 30.3 12.4 10.9 22.3 16.4 9.7 11.0 6.9 19.0 12.3 20.5 4.3 13.7 7.0 13.5 12.8 34.2 5.6 27.3 14.3 23.5 8.3 13.7 13.1 18.7 14.2 9.9 16.8 18.2 12.1 8.4 8.2 8.7 13.3 0.1 10.4 7.5 7.0 19.5 19.2 0.0 0.0 0.5 0.0 4.1 2.6 0.3 8.5 5.5 11.9 0.8 11.4 3.4 24.0 3.3 2.0 5.3 3.3 4.6 6.4 0.0 11.0 2.1 1.4 13.9 4.5 4.3 2.5 3.9 2.2 0.0 3.7 5.1 2.6 0.0 5.0 3.5 2.2 3.3 2.9 2.6 7.6 0.1 0.0 0.0 1.1 10.5 0.0 0.0 15.7 13.9 6.7 0.1 4.0 5.2 4.0 19.8 1.8 0.9 3.4 50.1 15.0 11.1 22.3 1.0 4.4 1.2 3.2 5.1 2.3 0.0 0.0 0.0 1.9 0.1 3.1 0.2 0.0 0.5 2.5 0.0 2.6 0.0 1.2 1.4 0.0 0.0 0.0 1.0 0.3 4.1 0.0 0.0 0.0 0.3 11.0 8.6 9.2 9.9 11.0 6.9 13.7 7.0 14.3 13.3 6.0 11.4 0.8 7.9 1.9 0.5 24.3 10.2 1.4 4.5 8.7 0.0 4.3 1.7 2.7 8.5 12.7 12.6 0.0 1.3 5.0 5.0 6.6 16.2 5.9 1.2 0.0 7.5 8.0 0.0 20.2 19.2 0.7 1.7 0.0 5.5 6.3 2.9 7.6 18.4 3.5 0.9 38.8 15.5 0.2 0.7 1.4 1.6 1.9 5.4 5.7 SOX17 ENSG00000164736 "SRY-box 17" Q9H6I2 8 54457935-54460888 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 23 "Endothelial cells: 80.4;Ito cells: 39.3;Melanocytes: 18.6" "Group enriched" "Detected in many" 12 "endometrial cancer: 122.8;ovarian cancer: 96.2;testis cancer: 25.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "EFO-21: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025594, HPA068399" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB025594: , HPA068399: AB_2685981" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" "unprognostic (1.76e-3)" "prognostic favorable (2.76e-4)" "unprognostic (1.01e-1)" "unprognostic (3.85e-2)" "unprognostic (3.34e-2)" "unprognostic (1.28e-1)" "unprognostic (1.39e-2)" "unprognostic (7.90e-2)" "unprognostic (3.62e-2)" "unprognostic (1.18e-1)" "unprognostic (4.98e-2)" "unprognostic (7.28e-3)" "unprognostic (1.12e-1)" "unprognostic (3.76e-1)" "unprognostic (1.88e-1)" 26.7 2.0 1.2 9.1 1.8 0.6 31.3 0.6 2.9 25.7 7.9 1.5 1.0 1.4 23.9 7.1 11.6 23.1 20.2 20.6 1.5 1.3 3.0 2.2 8.7 1.5 2.0 1.0 13.0 1.5 1.7 1.5 9.9 2.3 7.6 1.6 3.6 2.4 3.0 13.3 3.1 3.3 5.9 1.8 15.7 3.7 5.8 0.4 0.8 3.6 6.2 1.3 12.3 5.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.1 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 0.6 2.9 1.5 1.3 2.0 1.0 2.3 0.4 0.0 0.0 0.0 0.1 12.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 80.4 0.0 0.0 0.2 0.1 1.0 0.6 0.0 0.0 0.1 0.0 0.0 39.3 1.6 1.5 2.3 0.0 18.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.1 0.4 0.6 11.8 0.0 0.0 0.0 1.5 SOX18 ENSG00000203883 "SRY-box 18" P35713 20 64047582-64049641 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 53.3" "Group enriched" "Detected in many" 15 "Endothelial cells: 106.0;Ito cells: 165.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 15.5;NB-4: 25.5;REH: 6.1;TIME: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA073703 Approved Nucleoplasm NA NA Nucleoplasm "HPA073703: AB_2686628" "unprognostic (2.51e-1)" "unprognostic (3.23e-1)" "unprognostic (9.98e-3)" "unprognostic (6.30e-2)" "unprognostic (1.07e-1)" "unprognostic (2.88e-2)" "unprognostic (2.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.62e-1)" "unprognostic (3.45e-2)" "unprognostic (1.33e-3)" "unprognostic (1.76e-1)" "unprognostic (1.13e-3)" "unprognostic (9.63e-3)" "unprognostic (1.41e-1)" "unprognostic (2.46e-1)" "unprognostic (5.40e-2)" 53.3 6.2 3.1 9.9 5.0 1.8 27.5 2.5 5.2 18.3 9.4 3.1 4.3 7.4 26.0 10.0 16.4 15.0 15.8 29.7 3.2 3.1 10.1 6.8 29.3 17.7 4.8 2.3 11.2 3.6 4.6 3.2 12.4 6.1 12.3 2.7 13.1 8.1 5.8 20.3 7.9 7.2 7.0 3.4 13.7 7.2 6.9 1.2 2.9 13.8 20.5 5.8 8.4 18.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.8 0.0 2.1 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 15.5 0.0 2.6 0.0 0.0 0.5 0.0 25.5 0.1 0.0 0.2 6.1 0.0 0.4 0.0 1.0 0.4 0.5 0.2 0.0 0.3 0.0 0.4 1.2 7.0 0.1 2.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.0 2.5 5.2 3.2 3.1 4.8 2.3 6.1 1.2 0.0 1.1 3.4 0.1 0.9 0.8 6.2 2.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 8.8 106.0 0.0 0.0 0.0 0.0 0.9 0.2 4.6 0.2 0.1 0.0 0.0 165.7 8.9 2.1 1.1 0.8 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 1.0 1.8 1.5 1.0 0.2 0.0 0.0 0.4 SOX2 ENSG00000181449 "SRY-box 2" P48431 3 181711924-181714436 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 80.1" "Cell type enriched" "Detected in some" 9 "Muller glia cells: 455.6" "Cancer enhanced" "Detected in many" "glioma: 136.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 68.9;HAP1: 29.3;NTERA-2: 56.2;U-251 MG: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045725, HPA062851, HPA071379, CAB079745" Enhanced Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: " "unprognostic (1.80e-2)" "unprognostic (3.18e-3)" "unprognostic (5.69e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-3)" "unprognostic (1.60e-1)" "unprognostic (1.79e-2)" "unprognostic (4.48e-3)" "unprognostic (1.71e-1)" "unprognostic (4.38e-3)" "unprognostic (1.83e-1)" "unprognostic (7.68e-2)" "unprognostic (3.81e-9)" "unprognostic (1.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.12e-2)" 1.8 2.5 30.3 2.0 25.8 1.5 1.6 13.9 80.1 1.8 2.3 24.3 0.0 2.0 1.5 1.8 15.9 5.0 1.8 1.7 36.0 19.2 1.5 1.5 3.4 1.5 19.4 18.5 1.7 1.6 1.5 5.8 1.5 18.6 3.9 2.0 1.0 6.3 1.9 1.6 1.8 2.3 1.7 18.4 1.6 9.7 3.0 22.4 0.0 1.5 2.1 6.9 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 68.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 29.3 0.7 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 56.2 2.9 0.1 0.0 0.1 0.0 7.6 0.1 0.1 0.3 0.0 0.0 0.0 11.9 0.4 0.0 0.0 0.0 1.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 25.8 13.9 20.0 36.0 19.2 19.4 18.5 18.6 22.4 0.0 5.9 0.0 41.2 0.2 3.5 0.4 0.0 52.2 38.7 3.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 4.9 1.1 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.6 0.2 3.3 0.0 0.0 455.6 0.0 0.0 0.0 0.0 8.2 0.0 0.1 1.5 0.2 0.4 0.2 0.0 0.0 7.0 SOX21 SOX25 ENSG00000125285 "SRY-box 21" Q9Y651 13 94709622-94712399 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.2;skin 1: 18.3;stomach 1: 38.7" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 4.7;Suprabasal keratinocytes: 8.0" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 42.6;NTERA-2: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048337, HPA064084" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA048337: AB_2732547, HPA064084: AB_2685187" "unprognostic (3.33e-1)" "prognostic favorable (7.60e-4)" "unprognostic (7.96e-2)" "prognostic favorable (8.79e-5)" "unprognostic (1.54e-2)" "unprognostic (3.87e-1)" "unprognostic (9.02e-2)" "unprognostic (2.11e-1)" "unprognostic (1.50e-1)" "unprognostic (2.90e-2)" "unprognostic (1.93e-1)" "unprognostic (6.05e-2)" "unprognostic (1.11e-1)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" "unprognostic (1.35e-1)" 0.6 0.6 11.0 0.7 10.1 0.6 1.5 2.5 13.2 0.7 0.6 7.5 0.0 0.6 0.7 0.6 8.3 0.7 0.7 0.6 10.9 5.5 0.6 0.6 0.8 0.6 6.0 8.2 0.6 0.6 0.6 0.1 0.6 5.8 1.2 0.6 0.0 1.7 0.6 0.7 18.3 0.6 0.7 6.1 0.6 38.7 0.8 9.8 0.0 0.7 1.0 4.3 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 42.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 3.3 6.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.1 2.5 12.3 10.9 5.5 6.0 8.2 5.8 9.8 0.0 0.0 0.0 1.2 4.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.0 0.0 0.0 0.0 0.7 SOX3 PHP ENSG00000134595 "SRY-box 3" P41225 X 140502985-140505116 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 18.2;testis: 12.4" "Cell type enriched" "Detected in single" 8 "Muller glia cells: 4.3" "Cancer enhanced" "Detected in some" "glioma: 2.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.8;HEK 293: 8.3;NTERA-2: 18.6;SuSa: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054720, HPA075003" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054720: AB_2682584, HPA075003: AB_2686727" "unprognostic (6.04e-2)" "unprognostic (3.75e-1)" "unprognostic (8.62e-3)" "unprognostic (8.03e-2)" "unprognostic (1.57e-1)" "unprognostic (5.27e-3)" 0.3 0.5 2.6 0.3 2.7 0.3 0.3 0.6 2.6 1.5 0.3 5.0 0.0 0.3 0.6 0.3 0.3 18.2 0.3 0.3 2.2 5.0 0.3 0.3 0.3 0.3 2.0 1.8 4.7 0.3 0.4 3.2 0.3 3.6 0.3 0.3 0.5 0.3 0.3 0.4 0.3 0.3 0.3 2.3 0.3 0.3 12.4 0.6 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.7 0.6 2.6 2.2 5.0 2.0 1.8 3.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 SOX5 "L-SOX5, MGC35153" ENSG00000134532 "SRY-box 5" P35711 12 23529500-24562544 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 52.0" "Group enriched" "Detected in many" 4 "Early spermatids: 153.3;Late spermatids: 165.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 4.3;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 6 "B-cells: 4.3" "Cell line enhanced" "Detected in many" "AF22: 12.0;Daudi: 12.0;HDLM-2: 25.2;K-562: 10.9;WM-115: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060499 Supported Nucleoplasm NA NA Nucleoplasm "HPA060499: AB_2684294" "unprognostic (9.11e-4)" "unprognostic (4.64e-3)" "unprognostic (3.23e-1)" "unprognostic (6.83e-2)" "unprognostic (1.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (1.03e-3)" "unprognostic (1.36e-1)" "unprognostic (8.40e-2)" "unprognostic (1.70e-4)" "unprognostic (6.95e-2)" "unprognostic (4.53e-4)" "unprognostic (3.12e-3)" "unprognostic (2.37e-1)" "unprognostic (9.59e-2)" "unprognostic (2.75e-2)" 8.5 2.4 9.2 3.1 5.4 0.7 4.4 3.8 10.5 10.6 2.9 3.0 2.7 1.1 8.7 1.8 2.6 4.5 3.8 3.6 10.0 2.8 2.9 12.9 3.3 4.2 4.1 6.4 9.1 2.5 0.7 6.9 9.9 7.2 2.8 1.8 5.2 4.0 4.9 2.7 7.1 2.7 4.3 5.1 2.5 2.9 52.0 5.5 0.0 3.3 1.6 3.7 2.9 5.4 4.3 0.7 0.1 0.0 0.7 0.1 0.2 0.1 0.1 12.0 0.0 6.8 3.6 0.0 0.1 0.0 0.1 0.4 2.1 0.1 12.0 0.6 0.0 0.0 0.1 6.8 0.0 0.1 25.2 1.7 2.5 0.0 5.6 4.6 0.0 0.1 1.9 0.0 0.6 0.0 1.5 0.0 0.4 10.9 0.5 0.3 0.0 4.6 0.1 3.6 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.5 0.0 0.0 4.9 3.3 0.2 2.4 0.0 0.2 1.6 0.0 1.1 0.3 0.0 0.7 2.7 0.0 10.2 0.1 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.1 0.0 3.7 0.0 0.1 0.1 0.7 0.0 0.7 0.0 0.2 9.2 5.4 3.8 10.5 10.0 2.8 4.1 6.4 7.2 5.5 6.0 8.3 1.3 0.1 11.7 11.5 2.8 2.5 25.4 5.7 3.5 0.0 0.1 0.0 0.1 153.3 1.5 0.0 0.0 0.0 0.1 7.4 0.2 1.1 18.1 0.3 0.0 5.2 4.3 1.2 165.2 9.5 0.0 11.8 10.0 0.0 17.5 0.0 0.0 6.3 0.5 1.8 19.4 11.7 38.4 1.2 10.7 0.2 0.0 0.0 0.1 SOX6 ENSG00000110693 "SRY-box 6" P35712 11 15966449-16739591 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.1;kidney: 28.4" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 221.4;Erythroid cells: 116.8;Muller glia cells: 66.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "neutrophil: 5.4" "Lineage enriched" "Detected in single" 30 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "AF22: 4.4;CACO-2: 5.9;HAP1: 4.9;hTCEpi: 5.6;SK-MEL-30: 5.0;WM-115: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001923, HPA003908" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA001923: AB_1080065, HPA003908: AB_1080063" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-1)" "unprognostic (1.68e-1)" "unprognostic (4.17e-3)" "unprognostic (1.05e-2)" "unprognostic (6.47e-3)" "unprognostic (1.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.89e-4)" "unprognostic (9.08e-2)" "unprognostic (7.37e-3)" "prognostic favorable (6.47e-12)" "unprognostic (9.90e-2)" "unprognostic (5.02e-2)" "unprognostic (1.15e-1)" "unprognostic (3.04e-2)" 1.4 0.9 3.9 0.8 3.5 17.7 0.8 0.8 5.7 1.4 30.5 0.8 2.3 5.0 0.8 4.9 1.6 3.3 6.3 2.5 2.6 2.5 28.4 3.8 2.0 0.8 3.0 0.8 1.7 14.5 0.0 2.9 1.9 0.9 0.8 0.8 1.1 0.8 0.8 8.1 4.5 70.1 0.8 1.4 1.1 0.6 10.3 1.0 0.8 2.8 1.4 0.8 0.8 0.8 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.6 4.4 4.2 0.0 0.0 0.0 0.3 1.4 0.1 0.1 5.9 0.0 0.0 3.8 0.0 0.0 0.1 4.9 1.3 0.0 0.0 0.5 0.0 0.0 0.2 0.7 0.0 0.0 0.0 5.6 0.0 0.1 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 2.2 0.0 0.0 0.1 0.4 0.0 5.0 0.5 0.0 0.0 0.0 2.9 2.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.0 0.0 3.9 3.5 0.8 2.5 2.6 2.5 3.0 0.8 0.9 1.0 3.0 4.6 0.0 4.2 35.6 2.1 18.7 25.5 12.0 5.7 34.9 9.8 1.0 8.3 12.3 221.4 3.5 3.2 116.8 3.3 0.5 16.2 2.6 0.0 2.8 1.0 0.0 7.5 3.7 0.3 43.5 3.1 2.2 33.7 0.0 1.5 66.8 6.2 8.6 2.1 17.2 3.3 0.0 13.3 20.1 3.5 14.1 0.5 0.0 0.9 2.8 SOX8 ENSG00000005513 "SRY-box 8" P57073 16 981808-986979 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 64.9" "Cell type enriched" "Detected in some" 22 "Muller glia cells: 120.0" "Cancer enriched" "Detected in many" 6 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.2;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 23 "T-cells: 2.2" "Cell line enriched" "Detected in some" 5 "RH-30: 51.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041640, HPA058665" Enhanced Nucleoplasm No NA Nucleoplasm "HPA041640: AB_10964357, HPA058665: AB_2683792" "unprognostic (1.40e-2)" "unprognostic (2.56e-3)" "unprognostic (1.59e-1)" "unprognostic (3.10e-2)" "unprognostic (4.58e-2)" "unprognostic (7.16e-3)" "unprognostic (6.05e-3)" "unprognostic (3.01e-2)" "unprognostic (2.53e-1)" "unprognostic (1.16e-1)" "unprognostic (4.53e-3)" "unprognostic (4.46e-2)" "unprognostic (1.20e-3)" "unprognostic (8.50e-2)" "unprognostic (6.18e-2)" "unprognostic (5.47e-1)" "unprognostic (9.09e-2)" 1.6 1.5 18.4 1.8 25.1 1.0 2.5 3.2 64.9 1.2 1.4 20.9 0.0 1.1 1.1 1.1 1.2 1.1 1.5 1.8 22.6 14.5 1.0 1.0 1.0 2.7 26.5 5.4 1.0 1.5 1.0 0.1 1.4 12.0 1.3 1.5 0.9 8.6 1.4 1.3 1.3 1.2 1.2 27.1 1.8 1.7 1.9 30.4 0.0 1.1 0.0 3.1 1.1 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.3 1.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.5 0.7 0.1 0.0 51.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.2 18.4 25.1 3.2 11.8 22.6 14.5 26.5 5.4 12.0 30.4 0.0 0.0 0.0 0.4 0.3 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.2 0.1 2.1 1.4 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 3.1 0.0 1.7 1.0 0.0 120.0 0.1 0.0 1.8 0.0 5.3 0.0 0.8 0.0 4.3 0.9 0.0 0.0 0.0 0.1 SOX9 "CMD1, CMPD1, SRA1" ENSG00000125398 "SRY-box 9" P48436 17 72121020-72126420 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 63.4" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 178.3;Muller glia cells: 170.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 28.5;Hep G2: 34.1;OE19: 26.3;U-251 MG: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001758, CAB022456, CAB068240" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067" "unprognostic (6.92e-2)" "unprognostic (1.73e-2)" "unprognostic (4.47e-3)" "unprognostic (4.43e-2)" "unprognostic (2.55e-2)" "unprognostic (7.96e-3)" "unprognostic (4.32e-3)" "prognostic unfavorable (2.07e-4)" "unprognostic (4.87e-2)" "unprognostic (3.31e-1)" "unprognostic (8.92e-3)" "unprognostic (1.21e-1)" "unprognostic (3.26e-3)" "unprognostic (2.77e-3)" "unprognostic (1.15e-1)" "unprognostic (8.88e-2)" "unprognostic (1.21e-2)" 3.1 2.6 32.2 4.3 31.6 1.1 23.4 20.3 32.4 7.4 14.6 28.4 8.1 16.6 3.5 1.9 7.7 7.4 11.7 9.5 35.5 15.7 11.7 3.9 3.4 1.9 14.6 13.7 1.2 31.9 1.2 7.0 1.4 21.3 21.7 15.7 12.9 63.4 14.4 3.0 13.1 12.9 2.1 15.6 1.3 35.2 25.2 20.2 0.0 17.8 5.3 5.0 1.9 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 6.9 14.3 28.5 1.4 0.4 0.0 1.7 1.5 3.0 1.6 9.6 14.8 0.0 1.1 0.4 16.2 11.2 0.0 6.7 2.8 0.0 0.9 0.0 1.5 34.1 0.1 0.0 0.0 0.2 0.6 3.5 3.3 17.4 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.5 26.3 10.6 0.0 11.6 0.1 12.9 0.7 0.7 0.7 1.4 1.7 0.0 8.1 6.1 0.1 0.0 5.9 15.9 3.1 23.5 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.2 31.6 20.3 26.7 35.5 15.7 14.6 13.7 21.3 20.2 11.9 3.5 2.2 77.1 49.2 1.4 13.8 178.3 26.8 20.5 34.9 0.0 0.2 6.6 53.5 3.4 1.4 28.2 0.0 41.0 0.0 3.8 85.0 4.6 3.9 0.2 0.0 57.4 0.0 0.0 7.1 4.0 2.6 11.8 1.8 90.5 170.2 39.9 21.0 0.4 46.9 6.5 6.5 6.2 12.5 1.5 15.6 0.1 0.5 78.3 71.8 SP1 ENSG00000185591 "Sp1 transcription factor" P08047 12 53380176-53416446 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000330, HPA001853, HPA012292" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000330: AB_2171049, HPA001853: AB_1080069, HPA012292: AB_1857394" "unprognostic (1.12e-1)" "unprognostic (8.52e-3)" "unprognostic (6.11e-2)" "unprognostic (1.24e-1)" "unprognostic (2.03e-1)" "unprognostic (4.64e-3)" "unprognostic (1.08e-2)" "unprognostic (2.53e-1)" "unprognostic (1.01e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (1.43e-4)" "unprognostic (6.38e-2)" "unprognostic (5.14e-2)" "unprognostic (4.05e-2)" "unprognostic (1.37e-1)" "unprognostic (4.77e-2)" "unprognostic (2.12e-2)" 20.7 18.1 8.8 13.9 14.2 17.0 20.1 30.0 14.7 20.9 21.9 17.5 19.3 19.6 25.4 21.2 35.0 20.4 18.7 12.1 14.1 6.8 31.3 14.1 17.6 14.2 18.3 9.7 22.5 17.9 19.0 11.3 19.5 14.4 16.2 20.1 21.5 25.8 19.5 22.0 25.8 30.0 18.4 21.0 19.0 18.8 22.4 15.2 25.8 16.6 17.3 26.6 25.1 21.6 2.7 3.0 11.2 4.2 1.7 2.8 1.4 17.7 19.5 22.4 16.3 18.0 20.8 17.8 12.9 16.6 15.8 14.6 16.2 35.6 24.1 17.1 14.7 10.2 25.8 25.7 17.4 17.7 18.4 14.9 21.2 24.7 8.8 12.6 19.3 18.0 22.0 18.2 16.2 31.6 28.7 16.2 19.3 20.3 35.0 11.6 25.4 28.8 14.8 12.4 13.7 14.7 20.5 21.6 14.3 12.5 32.2 11.8 15.8 26.1 21.9 13.2 18.4 27.5 20.8 15.7 18.6 17.4 13.9 13.7 12.1 13.8 24.1 14.3 16.1 14.9 4.5 4.2 2.5 2.2 2.7 2.8 2.3 2.2 2.1 2.4 2.7 2.4 2.6 11.2 1.7 3.1 3.0 1.6 1.4 8.8 14.2 30.0 14.7 14.1 6.8 18.3 9.7 14.4 15.2 20.8 12.9 13.5 18.3 21.2 11.0 6.7 35.7 12.0 21.6 29.6 7.9 13.5 5.0 15.2 44.6 19.7 33.8 23.3 11.9 13.5 16.5 21.7 5.8 25.9 16.0 15.9 12.1 28.8 37.1 35.5 25.3 17.2 8.5 9.0 29.3 20.6 15.6 17.3 24.4 18.4 9.7 12.9 17.0 27.9 22.6 27.4 17.8 13.1 23.4 40.6 SP110 "IFI41, IFI75" ENSG00000135899 "SP110 nuclear body protein" Q9HB58 2 230167293-230225729 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 65.9" "Cell type enhanced" "Detected in many" 7 "B-cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 40.1" "Low region specificity" "Detected in all" HPA058554 Supported Nucleoplasm No No Nucleoplasm "HPA058554: AB_2683754" "unprognostic (9.72e-2)" "unprognostic (1.15e-2)" "unprognostic (5.02e-2)" "unprognostic (8.33e-4)" "unprognostic (2.93e-1)" "unprognostic (1.80e-1)" "unprognostic (6.65e-2)" "unprognostic (9.44e-2)" "unprognostic (9.68e-2)" "unprognostic (1.46e-2)" "unprognostic (4.11e-3)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.38e-1)" "unprognostic (2.66e-2)" "unprognostic (2.99e-3)" "unprognostic (9.50e-3)" 21.4 8.9 6.5 29.9 12.1 17.6 12.3 3.1 7.5 10.2 8.9 11.6 3.2 7.6 13.5 8.0 11.1 8.1 11.7 8.6 6.0 5.7 10.0 10.4 14.6 43.4 10.7 4.6 12.7 10.0 8.9 13.0 11.2 8.9 12.2 9.4 9.3 10.3 5.4 8.0 7.9 18.6 9.5 12.7 45.2 9.2 4.0 10.3 32.7 8.4 5.7 35.1 14.3 13.2 36.0 21.3 65.9 31.7 13.2 16.5 10.4 3.1 1.7 1.0 1.8 5.6 9.3 3.3 5.9 11.9 28.0 40.1 0.0 4.9 13.4 5.5 6.0 26.5 2.0 3.7 9.1 10.5 12.0 2.2 5.6 2.5 3.3 5.8 8.2 6.8 13.2 4.6 8.1 11.7 5.2 9.6 9.1 1.9 4.8 7.9 1.8 12.3 16.0 3.4 1.5 2.0 7.6 10.0 5.0 22.5 4.3 0.2 2.2 2.2 4.8 11.9 0.4 3.7 7.0 7.1 5.1 3.2 1.2 2.8 5.2 1.7 6.7 5.7 7.8 4.1 18.6 12.0 29.1 14.7 20.4 12.6 36.0 14.1 12.9 10.6 34.5 14.6 15.2 65.9 13.2 31.7 21.3 16.5 10.4 6.5 12.1 3.1 7.5 6.0 5.7 10.7 4.6 8.9 10.3 41.7 22.1 109.7 4.3 8.9 0.2 3.2 7.6 20.1 14.8 10.4 0.0 2.8 11.6 18.1 4.1 15.5 9.2 0.0 24.9 10.5 12.5 3.9 36.9 4.9 23.3 0.0 6.4 18.4 45.6 3.6 10.9 46.0 18.6 25.2 8.7 10.4 21.2 10.2 9.6 10.3 4.5 6.5 10.3 5.2 2.6 8.8 3.9 59.7 5.2 2.6 SP140L ENSG00000185404 "SP140 nuclear body protein like" Q9H930 2 230327184-230403732 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA055864 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055864: AB_2682949" "unprognostic (1.44e-2)" "unprognostic (8.91e-2)" "unprognostic (4.44e-2)" "unprognostic (9.70e-3)" "unprognostic (2.07e-1)" "unprognostic (1.42e-2)" "unprognostic (1.22e-3)" "unprognostic (1.77e-1)" "unprognostic (3.87e-1)" "unprognostic (2.31e-2)" "unprognostic (4.87e-3)" "unprognostic (3.19e-1)" "prognostic unfavorable (5.09e-10)" "unprognostic (9.15e-2)" "unprognostic (7.81e-2)" "unprognostic (9.49e-2)" "unprognostic (2.00e-3)" 11.0 10.5 2.2 24.3 4.6 9.6 9.3 1.0 2.8 11.2 10.0 4.3 8.7 8.5 12.5 12.0 8.4 7.7 9.7 6.0 3.3 2.2 7.7 14.5 12.3 19.3 4.8 1.4 12.3 5.1 1.9 6.1 10.8 4.8 9.1 7.5 5.1 16.0 12.5 5.4 3.5 16.2 9.4 6.7 25.0 6.8 2.8 4.3 15.7 6.3 6.4 22.7 10.5 16.0 21.0 5.1 11.2 7.1 14.5 13.4 6.0 7.7 1.4 1.8 5.6 9.7 10.6 10.3 11.5 13.3 9.7 15.4 0.8 9.0 5.9 12.1 8.9 17.0 1.4 0.0 8.4 15.9 15.4 0.0 10.4 6.2 5.7 18.2 8.5 12.0 8.7 4.5 14.0 9.4 8.1 14.1 9.1 2.5 5.6 17.4 4.2 12.7 11.9 6.5 5.3 4.0 4.5 17.1 4.7 8.8 9.8 0.3 1.8 2.8 5.8 6.4 12.1 8.5 9.2 15.4 8.6 6.3 4.9 8.7 8.2 5.0 8.4 11.4 8.7 15.0 11.2 4.9 2.4 10.4 6.5 12.5 16.9 9.5 8.3 5.1 21.0 13.4 12.0 5.0 14.5 7.1 2.1 5.8 6.0 2.2 4.6 1.0 2.8 3.3 2.2 4.8 1.4 4.8 4.3 29.8 32.3 27.9 13.3 1.6 2.9 3.6 12.7 33.5 21.6 15.7 17.7 8.2 0.0 18.2 11.1 25.1 11.3 0.0 15.9 13.8 7.0 8.3 39.5 8.2 17.4 0.0 3.5 11.1 13.7 3.2 4.0 14.8 5.0 6.4 7.9 2.0 17.5 21.0 7.8 2.9 1.9 6.5 6.9 0.5 1.4 2.3 10.0 28.7 6.6 18.4 SP3 SPR-2 ENSG00000172845 "Sp3 transcription factor" Q02447 2 173906459-173965702 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004580, HPA032145, HPA032146" Supported Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB004580: AB_628274, HPA032145: , HPA032146: AB_2732465" "unprognostic (1.94e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-1)" "unprognostic (2.39e-3)" "unprognostic (2.50e-1)" "unprognostic (4.92e-2)" "unprognostic (5.54e-3)" "unprognostic (6.36e-2)" "unprognostic (2.76e-3)" "unprognostic (3.27e-1)" "unprognostic (5.01e-3)" "unprognostic (1.68e-1)" "prognostic unfavorable (2.46e-5)" "unprognostic (2.78e-1)" "unprognostic (2.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.69e-1)" 29.0 12.3 13.6 29.5 14.7 46.2 27.6 26.0 13.8 29.3 23.3 10.9 19.9 12.5 25.1 23.9 19.9 20.8 16.5 15.6 12.8 11.7 19.5 19.2 20.8 41.4 16.0 12.7 23.1 15.0 26.3 21.0 31.9 13.3 23.5 20.4 14.1 20.5 24.2 20.4 21.3 23.0 20.1 15.0 28.8 14.9 14.2 16.2 73.4 30.7 18.1 27.3 24.0 25.7 9.6 10.2 29.5 9.8 20.0 14.0 9.2 17.6 17.7 34.4 19.6 41.2 38.7 36.2 21.4 32.7 30.6 32.5 27.8 26.0 28.1 17.6 30.7 21.3 17.7 27.7 21.7 43.4 24.4 9.8 29.5 17.0 22.3 20.3 27.0 21.9 28.5 22.9 35.4 30.0 21.6 22.5 23.6 22.0 37.7 28.0 20.5 37.4 18.6 27.3 25.5 17.8 32.0 31.1 21.4 20.7 27.2 30.7 21.1 29.9 15.8 21.2 39.0 12.7 30.4 20.1 30.8 27.2 20.1 20.5 26.3 19.7 38.7 23.3 17.1 29.0 9.6 9.8 13.6 12.5 6.6 13.0 9.6 12.5 12.5 10.2 8.4 14.0 12.0 29.5 20.0 9.0 5.0 12.5 9.2 13.6 14.7 26.0 13.8 12.8 11.7 16.0 12.7 13.3 16.2 17.9 18.5 42.9 29.1 51.2 29.5 16.1 10.2 17.4 15.9 19.2 25.5 27.3 10.0 16.3 2.9 30.3 18.8 23.3 16.6 33.4 36.9 28.4 23.1 31.6 21.9 22.3 29.3 33.7 41.3 4.3 42.0 38.6 40.5 9.0 27.0 30.3 24.2 21.0 34.6 17.3 21.2 19.4 49.1 8.4 26.4 49.8 28.9 37.4 27.7 50.8 SP8 ENSG00000164651 "Sp8 transcription factor" Q8IXZ3 7 20782283-20786886 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "prostate: 14.3" "Cell type enhanced" "Detected in some" 16 "Basal glandular cells: 2.9;Glandular cells: 2.4;Spermatocytes: 1.2;Spermatogonia: 1.6" "Cancer enhanced" "Detected in many" "testis cancer: 7.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.3;HUVEC TERT2: 5.9;NTERA-2: 12.2;PC-3: 20.6" "Group enriched" "Detected in some" 13 "basal ganglia: 15.7;olfactory region: 66.8" "Region enriched" "Detected in some" 11 "olfactory region: 72.4" HPA054006 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA054006: AB_2682340" "unprognostic (1.56e-1)" "unprognostic (1.49e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-1)" "unprognostic (7.90e-4)" "unprognostic (3.46e-1)" "unprognostic (5.49e-1)" "unprognostic (1.73e-2)" "unprognostic (2.42e-2)" "unprognostic (3.38e-1)" "unprognostic (7.44e-2)" 0.1 0.1 2.3 0.1 2.8 0.1 0.2 0.1 3.2 0.3 0.3 1.9 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.5 0.3 0.1 0.2 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.2 0.7 14.3 0.1 0.0 0.1 0.1 0.1 2.4 0.8 0.1 0.2 0.2 0.3 0.5 0.7 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.2 0.0 1.1 0.0 0.0 0.0 4.3 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.8 12.2 0.1 20.6 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.8 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.8 0.1 3.2 2.4 0.5 0.1 1.7 0.7 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 0.0 0.0 0.0 0.0 0.7 SPAG7 "ACRP, FSA-1, MGC20134" ENSG00000091640 "Sperm associated antigen 7" O75391 17 4959226-4967872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024032, HPA052394" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA024032: AB_1857410, HPA052394: AB_2681810" "unprognostic (7.10e-2)" "unprognostic (8.82e-2)" "unprognostic (1.43e-2)" "unprognostic (1.24e-2)" "unprognostic (1.46e-2)" "unprognostic (2.92e-1)" "unprognostic (8.90e-2)" "unprognostic (9.83e-2)" "unprognostic (8.35e-2)" "unprognostic (1.27e-1)" "unprognostic (8.39e-3)" "unprognostic (1.96e-1)" "prognostic favorable (5.79e-5)" "unprognostic (4.66e-3)" "unprognostic (5.51e-2)" "unprognostic (7.07e-3)" "unprognostic (2.72e-2)" 18.1 19.8 23.5 15.7 24.4 15.5 16.1 14.4 30.9 15.9 19.4 10.5 20.0 14.7 23.2 22.9 18.5 27.6 17.0 53.7 20.5 19.4 25.2 24.4 17.9 15.6 19.8 21.8 14.8 19.4 19.4 13.2 24.8 22.6 17.7 15.5 16.6 18.9 20.1 106.4 14.3 17.6 20.1 21.8 17.4 17.7 15.0 12.8 13.9 22.5 47.9 16.0 15.7 15.4 38.0 42.8 30.8 35.5 24.3 41.9 33.2 12.3 27.3 36.1 20.0 25.1 36.6 20.9 24.6 27.9 24.0 18.5 15.9 16.2 15.7 36.3 30.1 16.9 17.8 18.0 37.3 10.9 23.0 16.0 17.0 22.4 22.1 35.1 9.4 25.6 40.1 27.0 20.5 38.5 36.9 30.2 20.4 11.3 16.3 29.2 19.6 17.1 21.0 20.5 17.2 8.8 18.2 22.9 11.2 41.1 15.5 10.2 20.1 20.9 8.4 20.1 19.4 18.1 15.0 29.1 16.4 10.7 8.0 20.0 14.5 11.4 9.6 32.3 13.5 21.1 28.1 35.5 30.8 35.4 29.2 38.4 38.0 33.4 33.0 41.7 31.4 41.9 36.6 9.4 24.3 27.8 42.8 37.2 33.2 23.5 24.4 14.4 30.9 20.5 19.4 19.8 21.8 22.6 12.8 53.6 52.4 68.0 80.5 49.1 57.7 115.7 86.6 87.0 45.5 94.2 43.2 162.3 275.2 131.6 20.1 62.6 81.8 0.0 126.2 143.9 62.5 71.5 70.6 62.5 122.0 87.4 54.9 52.8 58.5 16.1 42.6 80.2 99.5 332.8 62.3 64.8 123.9 74.6 39.6 178.0 53.9 71.1 68.4 48.3 44.6 43.8 193.0 63.3 64.9 81.3 SPATA20 "FLJ21347, SSP411, Tisp78" ENSG00000006282 "Spermatogenesis associated 20" Q8TB22 17 50543058-50555852 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 24 "Early spermatids: 516.6;Late spermatids: 1225.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 27.1;MCF7: 26.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022023, HPA027144, HPA031442" Enhanced Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA022023: AB_1857417, HPA027144: AB_1857418, HPA031442: AB_10610557" "unprognostic (9.27e-3)" "unprognostic (1.90e-1)" "unprognostic (9.60e-2)" "unprognostic (9.74e-3)" "unprognostic (2.63e-3)" "unprognostic (7.23e-2)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (7.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.12e-3)" "unprognostic (4.93e-2)" "unprognostic (6.74e-2)" "unprognostic (1.75e-1)" "unprognostic (2.29e-1)" "unprognostic (2.66e-1)" "prognostic favorable (9.69e-5)" 9.7 29.0 14.9 15.2 13.1 4.6 8.2 17.7 22.8 11.7 13.4 11.4 16.8 9.8 16.0 21.1 10.7 13.5 25.4 36.3 9.8 14.3 15.7 13.1 11.2 8.7 15.0 18.3 20.4 22.4 11.9 10.4 6.9 13.3 15.4 5.8 29.0 18.9 15.0 17.9 8.7 9.9 12.7 13.0 14.1 22.8 62.7 6.8 2.5 22.3 8.5 9.9 13.1 7.9 3.2 8.9 1.1 4.7 9.3 2.6 2.9 3.4 16.0 0.9 10.5 2.4 7.5 2.9 5.9 6.8 2.8 2.2 11.9 5.1 3.7 14.3 4.2 3.1 2.7 0.6 2.9 1.4 5.0 2.3 2.5 3.5 27.1 11.1 0.9 7.4 11.9 3.9 1.5 4.4 3.7 3.6 0.6 0.3 6.9 2.5 26.8 0.0 0.9 1.1 7.3 7.0 1.5 2.5 1.0 13.7 17.0 1.8 4.3 5.2 3.9 6.3 1.1 7.5 0.4 8.1 2.8 8.9 1.6 1.2 13.2 4.0 0.0 5.9 0.5 2.9 0.0 4.5 1.1 2.0 4.7 2.6 3.2 1.5 1.5 8.9 2.2 2.0 2.2 0.3 9.3 4.0 2.0 0.8 2.9 14.9 13.1 17.7 22.8 9.8 14.3 15.0 18.3 13.3 6.8 6.0 5.3 3.4 11.9 9.5 3.4 26.6 17.8 4.0 12.5 22.7 3.9 14.5 23.2 29.1 516.6 10.5 20.1 0.0 34.6 8.5 19.4 14.3 17.3 19.8 30.3 11.1 36.5 9.8 22.6 1225.1 35.4 15.4 20.3 19.0 31.6 24.6 24.1 25.9 35.7 30.1 1.9 6.5 20.6 8.1 10.4 7.8 8.2 10.2 20.5 12.0 SPATS1 "FLJ25442, SPATA8, SRSP1" ENSG00000249481 "Spermatogenesis associated serine rich 1" Q496A3 6 44342660-44377167 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "fallopian tube: 9.0;testis: 33.5" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 17.4;Early spermatids: 25.7;Late spermatids: 6.2" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SK-MEL-30: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA030897, HPA049722" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA030897: AB_2673647, HPA049722: AB_2680861" "unprognostic (2.30e-3)" 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.4 0.3 0.0 1.5 0.0 0.0 0.1 4.8 0.1 9.0 0.0 0.0 0.7 0.7 0.0 0.0 1.5 0.0 0.4 0.0 1.6 0.0 0.2 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 1.0 0.0 0.4 0.7 0.7 0.4 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 SPCS2 KIAA0102 ENSG00000118363 "Signal peptidase complex subunit 2" Q15005 11 74949247-74979031 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013386 Approved Approved Nucleoplasm NA NA 220000 Nucleoplasm "HPA013386: AB_1857426" "unprognostic (2.43e-1)" "unprognostic (7.01e-2)" "unprognostic (1.65e-2)" "unprognostic (7.09e-3)" "unprognostic (9.30e-2)" "unprognostic (2.31e-2)" "unprognostic (7.04e-3)" "unprognostic (9.61e-2)" "unprognostic (8.83e-2)" "unprognostic (2.02e-3)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (5.70e-2)" "unprognostic (1.37e-1)" "unprognostic (8.62e-2)" 21.8 32.8 29.1 25.8 29.2 13.4 28.7 20.0 26.8 36.5 30.4 26.8 49.5 23.2 32.3 61.6 23.3 25.8 21.4 25.2 29.8 27.5 30.0 46.5 24.0 25.3 33.4 33.5 24.0 75.5 41.6 26.7 28.5 32.9 29.2 31.1 18.6 55.9 34.9 26.4 17.2 24.0 24.8 33.4 30.1 26.5 24.2 27.6 20.3 43.9 14.9 38.7 23.8 21.4 78.2 89.7 86.4 45.9 47.9 65.4 71.8 22.3 26.3 35.2 31.5 31.0 20.9 19.2 32.1 31.4 29.6 26.0 51.7 50.8 36.4 40.7 27.1 35.4 41.3 30.4 23.5 37.0 30.0 22.3 36.9 32.0 42.6 35.3 39.1 26.0 18.5 30.7 24.9 41.0 26.1 28.3 26.9 42.4 95.0 26.8 34.0 27.8 25.0 21.5 88.9 25.1 34.7 54.2 82.5 34.1 37.4 28.6 28.7 32.0 43.1 105.2 25.5 41.7 30.0 22.8 33.8 21.0 35.0 28.3 40.6 41.0 67.6 13.9 27.8 34.1 86.4 45.9 41.3 58.3 44.4 65.4 78.2 54.0 55.9 43.4 62.1 41.4 49.6 29.6 47.9 38.2 89.7 50.9 71.8 29.1 29.2 20.0 26.8 29.8 27.5 33.4 33.5 32.9 27.6 80.4 121.2 168.1 276.8 270.4 92.5 52.0 203.8 105.7 150.2 226.8 49.1 294.6 160.8 248.0 23.5 169.0 110.2 186.9 251.0 262.7 270.0 340.7 151.3 327.2 251.3 90.6 120.3 149.8 135.4 21.2 222.9 194.9 494.3 215.6 135.9 198.0 231.8 129.8 183.9 236.3 72.2 168.1 200.5 94.2 127.2 200.6 388.7 197.1 133.3 256.7 SPDYA "Ringo3, SPDY1, SPY1" ENSG00000163806 "Speedy/RINGO cell cycle regulator family member A" Q5MJ70 2 28782517-28850611 "Predicted intracellular proteins" "Cell cycle, DNA damage" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 50 "testis: 93.4" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 226.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 6.1;THP-1: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035162, HPA066214" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA035162: AB_2674501, HPA066214: AB_2685636" "unprognostic (3.41e-2)" "unprognostic (3.20e-3)" "unprognostic (2.45e-1)" "unprognostic (3.53e-2)" "unprognostic (4.21e-2)" "unprognostic (4.04e-3)" "unprognostic (1.10e-4)" "unprognostic (3.04e-3)" "unprognostic (1.95e-2)" "unprognostic (6.54e-3)" "unprognostic (1.45e-1)" "unprognostic (1.99e-2)" "unprognostic (1.66e-13)" "unprognostic (8.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.85e-1)" "unprognostic (5.55e-5)" 0.4 0.7 0.7 0.4 0.8 0.7 0.4 1.8 0.6 0.7 0.4 0.5 0.4 0.6 0.4 0.8 0.4 0.3 0.7 0.4 0.8 0.6 0.5 0.6 0.4 0.7 0.6 0.4 0.9 0.6 0.1 0.8 0.4 0.4 1.0 0.2 0.4 0.6 0.4 0.5 1.8 0.5 0.5 0.5 1.1 0.3 93.4 0.4 0.8 0.7 0.4 0.4 0.6 0.4 0.6 1.4 0.0 0.3 0.6 1.0 0.0 1.0 0.5 1.7 3.8 0.0 0.0 2.1 0.9 0.1 0.3 0.1 1.0 0.8 0.9 1.2 0.0 1.0 2.4 0.4 0.0 0.4 0.5 1.1 0.8 2.2 3.0 0.1 1.1 1.7 0.3 0.2 0.2 0.5 0.9 0.0 0.7 0.5 1.5 0.8 0.4 0.4 6.1 0.5 0.3 0.4 0.8 2.9 0.9 1.1 0.7 1.3 0.8 1.9 2.5 0.7 1.7 0.7 5.7 0.2 3.0 2.3 1.6 1.4 0.9 1.5 1.5 0.8 0.8 0.6 0.0 0.3 0.0 1.0 0.3 0.2 0.5 0.5 0.5 0.1 0.6 0.7 0.8 0.0 0.6 0.2 1.4 0.1 0.0 0.7 0.8 1.8 0.6 0.8 0.6 0.6 0.4 0.4 0.4 3.0 0.3 0.5 0.9 0.2 0.6 0.5 0.0 0.0 1.2 1.8 5.9 0.1 0.0 0.4 42.2 1.1 0.6 0.0 0.4 0.1 0.4 1.2 2.3 0.0 0.3 0.0 0.0 1.8 0.0 22.3 2.3 1.0 0.0 0.0 0.0 0.0 0.8 0.0 2.1 0.0 1.3 6.5 0.2 226.6 2.6 0.1 0.5 0.0 0.3 1.7 SPEN "KIAA0929, MINT, RBM15C, SHARP" ENSG00000065526 "Spen family transcriptional repressor" Q96T58 1 15847864-15940460 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015825, HPA050257" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015825: AB_1856823, HPA050257: AB_2681065" "unprognostic (3.91e-1)" "unprognostic (1.74e-1)" "unprognostic (3.76e-1)" "unprognostic (2.04e-1)" "unprognostic (1.48e-1)" "unprognostic (3.06e-2)" "unprognostic (6.93e-3)" "unprognostic (2.26e-1)" "unprognostic (4.26e-2)" "unprognostic (4.88e-3)" "unprognostic (1.71e-1)" "unprognostic (5.98e-2)" "unprognostic (1.06e-3)" "unprognostic (1.49e-1)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (1.83e-1)" 18.2 11.2 18.2 18.2 22.2 27.2 17.3 38.2 25.9 18.5 13.4 20.7 17.7 11.9 19.0 12.7 16.7 19.4 11.8 13.5 17.6 11.5 14.4 13.2 17.8 16.6 23.4 17.5 31.2 23.9 35.1 17.5 16.2 19.0 14.9 13.3 11.6 16.2 16.2 24.0 22.8 16.0 15.1 22.0 16.5 13.7 13.6 23.3 18.3 20.1 8.7 18.0 17.1 41.9 5.0 2.7 7.7 2.4 1.3 1.7 0.6 12.7 10.8 13.5 10.1 13.6 8.3 7.3 6.6 8.7 7.2 6.1 9.8 10.0 18.0 7.9 13.0 8.5 18.5 12.7 11.8 11.6 16.2 35.2 22.6 9.6 6.2 6.1 18.5 10.8 6.1 8.5 10.7 15.6 6.8 8.2 13.8 23.5 18.6 5.8 7.1 15.3 7.3 6.1 7.4 8.3 14.8 13.2 11.1 4.0 11.5 10.5 10.6 18.6 9.1 7.9 6.4 3.2 9.1 14.7 6.6 8.2 12.8 9.4 11.2 7.3 20.6 6.5 15.0 9.2 7.7 1.5 0.9 1.6 2.4 1.3 1.8 1.7 1.4 0.7 5.0 0.9 1.3 4.2 1.3 1.2 2.7 1.1 0.6 18.2 22.2 38.2 25.9 17.6 11.5 23.4 17.5 19.0 23.3 74.5 74.0 31.3 47.9 93.0 64.6 48.1 20.4 38.8 66.0 5.2 49.1 10.9 3.3 16.9 3.4 55.5 30.7 23.3 15.0 12.0 46.5 43.4 59.1 26.3 13.3 90.6 30.4 13.5 30.8 3.6 25.3 30.1 20.3 25.2 24.4 29.6 18.0 23.2 33.6 6.5 54.5 19.4 54.6 34.9 51.9 88.8 13.2 20.2 18.7 49.2 SPHK2 ENSG00000063176 "Sphingosine kinase 2" Q9NRA0 19 48619291-48630717 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 66.9;Cone photoreceptor cells: 72.6;Rod photoreceptor cells: 83.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049062 Supported Nucleoplasm NA NA Nucleoplasm "HPA049062: " "unprognostic (5.33e-2)" "unprognostic (4.11e-2)" "unprognostic (9.61e-2)" "prognostic unfavorable (5.19e-4)" "unprognostic (2.10e-1)" "unprognostic (7.19e-3)" "unprognostic (3.04e-1)" "unprognostic (4.45e-3)" "unprognostic (7.28e-2)" "unprognostic (2.80e-1)" "prognostic favorable (9.30e-4)" "unprognostic (1.25e-1)" "prognostic favorable (2.59e-5)" "unprognostic (1.18e-2)" "unprognostic (9.97e-2)" "unprognostic (4.21e-2)" "unprognostic (7.06e-2)" 9.3 8.9 12.6 9.9 13.0 5.2 5.1 13.6 22.0 7.2 12.9 13.4 4.9 33.2 7.4 4.2 4.9 7.3 7.8 4.7 22.5 14.8 19.3 15.2 6.1 8.7 26.3 14.9 9.1 7.2 15.0 9.5 4.1 22.3 8.7 6.2 7.2 7.5 8.0 6.1 4.3 22.2 4.9 14.1 8.4 11.3 17.2 13.7 4.0 9.1 3.1 5.3 6.2 12.4 10.4 7.4 12.5 9.4 7.2 7.0 4.2 4.1 11.9 4.4 8.1 4.9 2.0 8.4 4.5 3.8 5.2 6.3 20.3 5.4 7.7 3.1 2.9 3.1 3.1 4.1 3.6 0.7 8.7 9.8 8.5 5.2 7.0 7.7 5.4 9.4 3.7 2.0 3.6 2.5 2.5 2.9 10.5 5.5 6.9 2.6 4.3 12.8 33.8 5.9 3.1 5.8 11.8 3.6 5.0 2.4 2.8 16.1 12.7 4.3 6.8 4.3 2.6 3.7 3.7 4.5 7.5 4.2 5.8 8.9 13.3 15.3 8.5 4.3 6.3 6.7 12.5 8.3 3.6 6.0 9.4 5.9 6.5 4.8 5.8 7.4 10.4 6.6 7.0 3.3 7.2 7.4 6.6 4.6 4.2 12.6 13.0 13.6 22.0 22.5 14.8 26.3 14.9 22.3 13.7 6.0 7.7 5.4 4.8 3.0 66.9 1.0 7.6 2.7 4.5 10.4 72.6 5.9 1.7 5.3 8.2 6.4 28.6 0.0 4.4 5.3 5.2 5.4 4.6 17.3 7.6 42.9 15.5 4.9 10.7 9.0 15.3 6.3 3.3 7.2 9.2 22.9 6.0 11.5 12.0 13.5 83.3 6.5 5.4 18.7 6.4 2.5 3.8 16.6 12.8 3.6 SPI1 "OF, PU.1, SFPI1, SPI-1, SPI-A" ENSG00000066336 "Spi-1 proto-oncogene" P17947 11 47354860-47378576 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 100.3;lymphoid tissue: 70.2" "Group enriched" "Detected in many" 5 "Hofbauer cells: 391.4;Kupffer cells: 374.7;Macrophages: 436.5;monocytes: 317.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 45.4;neutrophil: 24.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 45.4" "Cell line enhanced" "Detected in some" "HEL: 19.2;HL-60: 33.6;HMC-1: 62.7;NB-4: 56.7;THP-1: 44.2;U-698: 17.9;U-937: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004079, HPA044653" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB004079: AB_10692379, HPA044653: AB_2679036" "unprognostic (4.45e-2)" "unprognostic (3.31e-3)" "unprognostic (2.92e-2)" "unprognostic (1.66e-2)" "unprognostic (5.97e-2)" "unprognostic (3.33e-2)" "unprognostic (5.28e-2)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (2.79e-1)" "unprognostic (3.36e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.20e-1)" "unprognostic (4.95e-2)" "unprognostic (2.40e-1)" "unprognostic (4.92e-2)" 24.4 8.1 6.7 35.7 15.2 100.3 9.0 1.5 6.6 3.6 5.2 8.6 0.0 7.6 3.2 6.2 4.0 8.5 7.7 15.7 5.6 5.1 5.8 11.9 37.2 51.1 12.6 1.6 6.1 3.5 0.9 3.6 10.1 9.6 4.5 3.9 3.9 6.4 2.6 3.3 5.0 10.5 7.6 12.1 70.2 5.8 5.4 10.5 9.6 3.7 2.7 16.8 9.1 5.7 1.0 4.6 45.4 9.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 33.6 62.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 56.7 0.0 0.0 0.0 10.3 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 44.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 17.9 0.0 25.0 0.0 3.6 5.4 45.4 0.0 7.8 0.0 1.0 0.0 0.0 4.6 0.8 0.0 0.0 24.8 0.0 9.1 0.2 0.0 1.5 6.7 15.2 1.5 6.6 5.6 5.1 12.6 1.6 9.6 10.5 3.0 0.6 71.3 0.5 9.3 1.5 2.0 7.6 1.4 1.2 5.2 0.0 1.9 16.6 0.0 5.9 2.2 0.3 0.0 0.3 2.5 5.9 0.4 34.5 1.3 391.4 0.0 4.1 11.1 374.7 20.0 1.7 436.5 10.1 317.4 0.1 4.0 0.0 0.0 0.0 1.3 1.0 12.9 2.1 5.5 2.5 8.7 3.5 2.5 0.4 0.4 SPIDR KIAA0146 ENSG00000164808 "Scaffolding protein involved in DNA repair" Q14159 8 47260575-47736306 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA027201, HPA041582" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA027201: AB_10603774, HPA041582: AB_2677563" "unprognostic (5.58e-2)" "unprognostic (2.24e-2)" "unprognostic (2.71e-2)" "unprognostic (7.45e-2)" "unprognostic (4.72e-3)" "unprognostic (7.99e-2)" "unprognostic (3.17e-2)" "unprognostic (2.15e-3)" "unprognostic (2.93e-2)" "prognostic unfavorable (8.91e-4)" "unprognostic (1.74e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (2.04e-6)" "unprognostic (5.30e-1)" "unprognostic (1.97e-1)" "unprognostic (8.43e-2)" "unprognostic (1.35e-2)" 21.1 21.6 24.0 22.4 20.7 15.6 23.8 47.5 32.1 18.2 18.9 15.5 17.1 12.8 29.7 18.9 28.6 19.5 25.1 14.4 20.1 17.5 15.3 16.3 21.4 18.0 15.9 18.7 28.4 20.5 19.4 39.8 21.4 22.4 20.8 18.5 19.9 20.6 15.8 15.7 24.0 15.1 21.4 18.6 23.3 20.2 16.7 15.3 12.7 23.2 10.5 25.2 21.0 24.8 7.9 9.6 5.2 11.1 8.6 11.4 5.5 8.4 14.3 9.0 14.2 10.4 12.8 7.4 10.8 8.0 8.6 12.4 7.7 19.9 17.0 13.0 9.5 8.6 4.6 9.4 8.2 13.0 5.0 8.9 11.8 12.5 14.5 11.2 8.8 7.4 7.0 8.0 6.8 10.3 9.5 6.3 10.7 8.6 6.1 8.5 20.7 16.5 22.0 11.1 18.8 3.5 8.2 5.2 0.9 11.8 31.8 4.6 10.8 16.0 13.4 6.0 9.2 12.8 16.5 11.0 6.9 10.0 8.4 7.3 7.3 12.9 11.9 7.2 12.1 6.6 4.8 11.1 3.5 11.4 7.2 11.3 7.9 5.1 6.9 9.6 7.4 5.7 5.1 5.2 8.6 8.2 1.6 10.0 5.5 24.0 20.7 47.5 32.1 20.1 17.5 15.9 18.7 22.4 15.3 32.8 28.9 6.2 14.3 9.5 10.9 16.1 15.3 25.4 14.8 12.2 17.7 15.1 6.6 7.0 7.4 14.7 6.3 0.0 7.7 9.5 13.0 15.5 11.6 6.8 9.7 12.7 11.1 11.6 29.4 6.6 13.6 18.6 8.5 1.8 11.6 8.2 6.7 8.5 13.8 3.7 10.7 6.5 13.7 22.3 29.5 7.5 13.7 13.8 11.0 15.9 SPIN1 "SPIN, TDRD24" ENSG00000106723 "Spindlin 1" Q9Y657 9 88388419-88478694 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Meiosis, Wnt signaling pathway" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 158.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000162, HPA068784" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA000162: AB_1080079, HPA068784: AB_2686033" "unprognostic (1.53e-1)" "unprognostic (2.29e-1)" "unprognostic (2.74e-1)" "unprognostic (1.01e-1)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (6.11e-2)" "unprognostic (1.19e-2)" "unprognostic (2.08e-2)" "unprognostic (8.96e-2)" "unprognostic (8.78e-2)" "unprognostic (8.32e-2)" "prognostic favorable (8.69e-6)" "unprognostic (4.73e-3)" "unprognostic (1.20e-1)" "unprognostic (1.05e-1)" "unprognostic (1.56e-1)" 12.2 15.0 28.3 9.4 34.2 7.0 19.7 22.6 38.0 34.9 14.4 23.7 10.2 10.4 34.4 44.0 15.5 28.6 17.5 15.6 27.1 28.7 24.9 11.3 14.1 8.3 21.7 27.2 32.2 12.2 28.4 19.6 26.9 26.3 21.6 14.1 16.8 12.9 24.6 3.5 13.4 12.1 25.7 22.0 9.9 11.6 18.5 15.9 12.7 22.9 6.8 9.1 15.4 21.3 4.5 8.1 8.1 4.2 4.2 7.8 4.9 23.6 11.8 19.5 16.5 13.3 15.7 22.9 23.8 22.1 27.3 20.0 8.7 13.8 13.2 14.1 29.1 17.6 36.4 14.5 21.6 31.4 13.8 8.9 6.3 24.9 9.2 12.3 14.3 6.9 13.0 22.6 18.4 26.0 26.9 15.5 16.8 8.0 0.0 30.5 16.3 24.2 6.5 32.1 19.8 11.1 32.5 21.2 4.2 24.6 16.7 27.7 20.8 28.2 17.8 10.4 23.6 13.7 11.4 14.7 18.1 19.3 26.8 16.8 5.5 8.2 11.4 21.9 13.3 16.8 8.1 4.2 6.4 6.7 3.8 7.1 4.5 5.0 6.9 8.1 3.4 7.1 7.8 0.6 4.2 3.3 3.8 4.5 4.9 28.3 34.2 22.6 38.0 27.1 28.7 21.7 27.2 26.3 15.9 47.6 12.5 2.9 22.2 35.5 21.1 34.1 33.1 20.1 19.4 41.8 23.6 24.0 21.6 21.8 158.1 21.1 19.0 23.3 15.9 38.4 35.2 28.1 33.5 15.5 28.0 23.8 39.6 20.3 31.4 87.6 31.1 18.9 20.3 11.8 26.4 39.4 21.2 18.7 41.8 39.9 13.7 25.8 26.2 24.7 65.2 39.1 20.8 10.2 19.5 25.7 SPIN2A "DXF34, SPIN2, TDRD25" ENSG00000147059 "Spindlin family member 2A" Q99865 X 57134530-57137625 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 5.2;Cardiomyocytes: 5.0;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 4.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 5.8;HSkMC: 7.2" "HPA000162, HPA069835" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA000162: AB_1080079, HPA069835: AB_2686211" "unprognostic (3.18e-1)" "unprognostic (1.72e-2)" "unprognostic (7.32e-2)" "unprognostic (1.10e-4)" "unprognostic (1.02e-1)" "unprognostic (2.61e-3)" "unprognostic (1.55e-1)" "unprognostic (4.00e-2)" "unprognostic (1.12e-1)" "unprognostic (4.35e-2)" "unprognostic (8.01e-2)" "unprognostic (1.48e-1)" "unprognostic (7.95e-5)" "unprognostic (3.63e-2)" "unprognostic (8.61e-2)" "unprognostic (2.75e-1)" "unprognostic (5.07e-3)" 1.8 1.4 1.8 2.3 1.6 0.2 1.7 5.0 2.9 2.4 1.5 1.9 2.1 0.7 1.0 1.4 1.7 0.9 1.9 1.9 1.7 1.1 1.5 3.2 1.2 3.2 1.4 1.6 2.7 1.2 2.1 2.0 2.1 1.7 0.5 3.5 1.5 2.2 1.2 2.7 1.9 0.8 2.5 2.1 1.5 2.7 1.4 0.5 0.0 0.8 0.0 0.8 0.2 0.9 1.8 5.0 0.9 0.9 1.0 1.3 1.8 0.7 0.4 0.8 0.9 1.5 0.4 0.8 3.1 0.5 1.2 1.1 1.0 0.4 0.6 0.7 0.8 5.8 0.9 1.7 0.8 1.0 7.2 0.8 0.3 0.3 2.3 0.5 0.8 0.7 2.4 1.0 1.2 0.5 2.3 1.8 0.1 0.8 0.9 1.2 0.7 0.8 0.9 3.2 0.9 0.9 0.5 0.2 1.7 0.9 0.9 0.7 2.6 1.1 1.1 0.6 2.4 0.3 0.3 0.7 2.1 0.9 0.0 0.8 0.0 0.5 0.3 0.8 1.4 0.3 0.5 0.0 0.4 0.7 0.1 0.0 0.0 0.3 0.5 0.7 0.2 0.0 0.3 0.0 0.3 0.2 5.2 5.0 0.0 0.0 0.0 0.0 3.9 0.1 1.7 0.4 0.0 0.7 0.0 0.0 0.0 0.1 1.5 0.5 1.1 0.0 0.2 1.6 0.0 1.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 4.8 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 SPIN2B "SPIN-2, TDRD26" ENSG00000186787 "Spindlin family member 2B" Q9BPZ2 X 57118551-57121546 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA000162, HPA069835" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA000162: AB_1080079, HPA069835: AB_2686211" "unprognostic (3.21e-2)" "unprognostic (7.92e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (8.28e-2)" "unprognostic (2.30e-2)" "unprognostic (8.42e-4)" "unprognostic (1.73e-3)" "unprognostic (2.24e-2)" "prognostic favorable (3.43e-4)" "prognostic favorable (3.39e-4)" "unprognostic (9.04e-3)" "prognostic favorable (1.78e-5)" "unprognostic (3.41e-2)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (2.26e-3)" 8.9 11.8 14.6 11.1 19.4 5.6 16.1 17.0 24.3 13.0 13.9 8.5 9.9 6.4 12.3 16.2 8.5 9.8 12.0 11.5 14.4 17.3 11.1 8.4 9.3 13.1 15.7 15.8 12.2 9.6 11.6 14.3 9.1 14.4 15.9 16.6 8.2 10.6 15.3 12.0 12.1 9.0 18.2 15.1 12.4 11.1 6.3 13.4 8.8 12.5 6.6 11.9 10.9 14.2 10.8 9.4 1.2 6.1 11.3 13.1 8.3 11.6 8.8 10.5 8.0 10.9 12.3 7.1 7.9 5.1 10.3 6.8 11.4 9.8 2.5 13.3 7.2 9.0 1.8 12.2 4.0 10.7 4.6 14.6 7.1 25.9 14.9 8.9 6.0 5.5 10.2 7.7 6.6 6.9 10.1 8.0 6.5 8.6 8.3 10.7 16.7 8.7 10.9 10.3 3.3 9.9 8.5 13.8 10.7 10.9 5.5 7.2 7.4 13.8 3.4 6.8 16.8 7.6 4.2 8.1 8.7 8.4 14.9 4.7 8.3 5.7 7.3 6.8 11.7 4.8 1.2 5.3 0.6 9.0 6.1 13.0 10.8 11.4 12.3 6.5 8.5 13.1 10.5 0.3 11.3 5.5 9.4 13.1 8.3 14.6 19.4 17.0 24.3 14.4 17.3 15.7 15.8 14.4 13.4 17.9 5.3 4.7 6.7 4.7 10.0 8.4 0.0 1.4 1.2 10.4 0.0 6.7 13.3 5.2 0.0 10.5 5.5 0.0 4.6 4.8 9.3 5.0 10.5 2.9 4.4 11.1 11.1 5.5 2.5 0.0 11.2 2.6 8.5 1.8 7.8 5.2 2.9 10.5 17.7 8.5 5.4 25.8 8.6 0.0 0.4 7.9 2.5 10.1 10.5 4.8 SPIN3 TDRD27 ENSG00000204271 "Spindlin family member 3" Q5JUX0 X 56818298-56995827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 7.0;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 17.0" "Low region specificity" "Detected in all" HPA000727 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA000727: AB_2196121" "unprognostic (3.12e-3)" "unprognostic (2.32e-1)" "unprognostic (7.45e-3)" "prognostic unfavorable (3.49e-4)" "unprognostic (1.20e-2)" "unprognostic (1.67e-2)" "unprognostic (6.85e-4)" "prognostic favorable (6.79e-4)" "unprognostic (1.70e-2)" "unprognostic (1.30e-1)" "unprognostic (2.48e-2)" "unprognostic (1.16e-2)" "unprognostic (1.02e-2)" "unprognostic (6.53e-2)" "unprognostic (8.51e-2)" "unprognostic (1.98e-2)" "prognostic favorable (6.30e-4)" 5.7 7.6 10.5 4.8 10.7 0.4 9.4 28.6 14.2 7.8 4.6 7.3 9.2 4.8 10.4 8.3 4.5 7.4 5.5 3.8 9.2 6.6 5.3 5.0 5.4 6.7 6.6 10.3 11.3 10.2 4.4 12.4 4.1 9.6 10.4 7.0 6.5 7.5 7.5 4.2 4.7 6.6 7.6 5.0 6.1 7.5 4.3 8.3 0.3 6.0 1.4 6.9 8.2 6.2 2.7 1.6 3.3 1.5 4.7 4.5 2.2 4.3 6.4 3.6 0.0 7.0 6.2 2.8 3.8 2.0 2.6 3.0 3.7 5.5 0.0 2.6 3.2 7.3 5.1 5.6 2.3 3.2 0.0 1.3 0.5 17.0 2.6 3.8 0.0 4.8 5.4 4.7 2.7 4.3 4.0 1.6 0.0 2.6 8.5 4.4 2.8 0.0 3.5 7.4 2.5 6.1 0.0 3.1 1.7 3.4 5.1 7.3 5.0 4.0 3.9 4.1 5.9 9.7 1.0 1.1 4.4 6.7 7.2 2.0 3.5 2.5 0.0 4.3 0.0 3.3 3.3 1.0 1.9 0.2 1.5 1.7 2.7 3.9 1.6 1.6 0.9 4.5 1.1 0.0 4.7 0.1 0.2 1.0 2.2 10.5 10.7 28.6 13.4 9.2 6.6 6.6 10.3 9.6 8.3 0.0 3.0 0.0 3.6 0.2 2.0 1.0 2.5 1.4 3.4 7.0 0.0 1.9 1.7 3.2 0.0 1.1 0.8 0.0 2.4 1.7 1.8 1.6 1.1 1.1 0.8 1.6 0.0 1.8 1.8 0.0 3.7 1.0 1.7 1.8 0.7 1.0 3.1 0.0 2.5 2.7 2.4 6.5 1.4 0.0 0.0 0.4 0.3 0.0 1.1 2.0 SPRED1 "FLJ33903, PPP1R147" ENSG00000166068 "Sprouty related EVH1 domain containing 1" Q7Z699 15 38252326-38357249 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.3;non-classical monocyte: 4.0" "Lineage enriched" "Detected in many" 4 "monocytes: 4.0" "Cell line enhanced" "Detected in many" "AF22: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042193, HPA061805" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA042193: AB_10794079, HPA061805: AB_2684617" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (2.46e-1)" "prognostic favorable (7.08e-4)" "unprognostic (1.20e-1)" "unprognostic (2.38e-1)" "unprognostic (1.21e-3)" "unprognostic (5.71e-2)" "unprognostic (3.84e-2)" "unprognostic (2.81e-3)" "unprognostic (9.27e-3)" "unprognostic (3.33e-1)" "prognostic unfavorable (7.37e-5)" "prognostic unfavorable (8.29e-5)" "unprognostic (6.04e-2)" "unprognostic (5.77e-2)" "unprognostic (1.01e-1)" 17.6 9.5 21.2 9.5 24.2 1.1 12.4 8.6 24.6 13.9 12.3 14.7 2.9 9.1 12.5 7.2 7.1 8.1 15.3 8.0 18.2 14.0 10.4 6.3 18.9 7.5 16.1 12.9 10.0 5.3 11.7 6.2 15.3 13.8 10.2 12.3 10.2 8.0 10.3 4.1 6.9 9.4 10.6 16.5 9.8 11.5 9.0 13.7 2.3 33.7 5.4 5.5 9.2 11.8 0.0 1.0 0.2 4.0 0.2 0.3 0.1 5.0 4.0 28.8 5.2 10.1 18.5 2.3 12.1 11.8 6.2 7.8 3.5 4.0 0.0 4.5 9.6 4.6 4.1 2.9 7.8 12.2 0.7 0.9 5.8 2.6 3.3 12.4 3.1 16.7 12.0 3.9 11.7 10.9 15.5 4.8 3.1 5.3 5.7 14.6 1.3 1.2 2.3 5.7 17.5 10.4 0.0 6.1 3.2 9.7 8.0 1.3 6.3 3.3 1.6 12.2 4.6 1.3 0.7 8.6 15.1 7.7 9.1 7.1 4.9 3.2 7.6 10.7 1.3 24.1 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.2 0.2 4.0 0.0 0.0 0.1 21.2 24.2 8.6 20.3 18.2 14.0 16.1 12.9 13.8 13.7 92.3 24.0 2.7 22.3 25.1 11.3 6.5 28.1 13.4 18.2 1.8 5.9 1.1 1.7 8.4 29.1 25.0 9.2 0.0 4.3 0.9 23.6 9.9 40.5 3.6 47.9 4.8 6.4 32.5 32.7 6.8 20.1 41.2 27.0 7.2 19.7 23.7 10.0 5.8 28.7 11.1 5.2 6.5 28.6 3.4 3.2 8.4 1.1 2.5 11.7 14.0 SPRTN "C1orf124, DKFZP547N043, DVC1, Spartan" ENSG00000010072 "SprT-like N-terminal domain" Q9H040 1 231337104-231355023 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 80.5;Rod photoreceptor cells: 58.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025073 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA025073: AB_1847695" "unprognostic (2.63e-1)" "unprognostic (5.41e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-1)" "unprognostic (1.56e-2)" "unprognostic (2.00e-1)" "unprognostic (5.69e-3)" "unprognostic (1.72e-1)" "unprognostic (1.33e-2)" "unprognostic (4.75e-3)" "unprognostic (1.26e-1)" "unprognostic (3.25e-1)" "unprognostic (7.51e-3)" "unprognostic (1.19e-1)" "unprognostic (3.21e-2)" "unprognostic (3.60e-2)" "unprognostic (5.35e-2)" 8.0 8.3 7.5 7.7 9.4 16.2 9.0 7.3 10.0 8.4 7.1 12.4 8.2 6.4 8.5 7.2 11.2 7.3 7.3 8.4 7.7 7.1 8.1 9.6 6.1 9.4 9.9 7.1 7.2 6.3 9.0 12.7 12.5 10.9 6.6 6.3 7.1 8.7 7.2 18.5 9.3 7.0 8.1 10.1 9.2 7.3 23.3 9.3 16.1 8.3 10.9 9.6 7.8 7.6 6.7 6.5 13.8 9.1 8.6 10.1 5.0 11.2 9.8 9.0 9.8 8.4 6.0 10.8 10.3 9.0 11.9 10.3 11.1 10.0 10.2 11.1 8.4 4.7 16.8 12.7 10.2 12.8 8.5 22.0 6.3 9.5 7.7 9.0 10.6 9.4 8.1 11.0 12.8 10.5 5.4 11.8 9.2 15.5 10.1 11.7 6.1 11.3 6.2 8.8 13.0 8.4 10.0 11.9 12.1 10.2 8.4 11.3 10.9 10.8 8.6 11.6 4.2 15.5 16.3 8.7 10.3 10.5 14.6 16.3 7.8 8.1 13.9 8.0 9.4 17.3 9.3 6.6 13.0 7.7 9.1 8.7 6.7 7.8 9.1 6.5 5.2 9.3 10.1 13.8 8.6 6.5 6.1 8.1 5.0 7.5 9.4 7.3 10.0 7.7 7.1 9.9 7.1 10.9 9.3 14.9 3.4 13.7 9.7 28.4 22.3 3.9 2.5 16.0 10.3 3.5 80.5 10.5 8.3 7.5 16.8 14.6 9.0 0.0 8.3 9.5 11.2 7.3 26.4 6.4 8.2 14.3 11.5 10.4 6.1 7.8 8.3 10.3 6.8 13.6 6.4 12.4 8.8 5.9 7.4 6.2 58.4 12.9 12.0 47.2 18.5 24.8 12.7 20.3 6.6 14.5 SPRYD4 DKFZp686N0877 ENSG00000176422 "SPRY domain containing 4" Q8WW59 12 56468567-56479707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 58.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 141.7;Proximal tubular cells: 76.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053469 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053469: AB_2682162" "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (8.00e-2)" "prognostic unfavorable (8.85e-5)" "unprognostic (7.76e-2)" "unprognostic (1.20e-1)" "unprognostic (3.06e-3)" "prognostic favorable (4.52e-4)" "unprognostic (5.59e-3)" "unprognostic (1.19e-2)" "unprognostic (3.14e-2)" "unprognostic (9.98e-2)" "unprognostic (1.27e-3)" "unprognostic (1.81e-1)" "unprognostic (1.69e-1)" "unprognostic (3.44e-1)" "unprognostic (1.14e-1)" 3.8 9.6 3.3 6.0 4.6 4.4 6.2 4.2 6.1 3.8 5.1 6.0 6.7 4.2 4.5 6.3 7.1 3.8 7.4 7.2 3.6 3.6 12.0 58.4 3.1 3.5 4.4 4.3 4.9 12.3 5.0 7.0 4.3 3.7 5.2 6.5 5.8 8.2 6.3 10.5 4.6 6.4 4.3 3.3 4.8 5.0 2.6 3.3 3.8 7.6 7.3 6.1 5.2 4.1 4.6 5.0 3.8 3.8 4.8 3.2 2.5 2.8 3.7 3.2 2.5 2.9 1.8 4.4 2.3 2.4 4.9 3.0 3.4 5.0 3.5 3.1 3.0 3.4 4.9 2.7 4.0 3.1 1.7 5.7 5.1 3.8 5.1 2.8 3.5 5.1 4.1 2.6 3.6 2.9 2.6 5.0 2.4 2.7 15.2 4.1 4.6 1.7 2.5 2.1 3.2 4.3 2.1 2.4 7.3 5.2 3.6 3.3 1.5 4.5 5.4 3.4 2.1 9.2 1.0 2.4 2.2 4.0 3.1 1.8 2.6 1.4 1.2 1.8 3.0 2.6 3.8 3.8 2.0 3.0 3.0 3.2 3.8 2.8 3.0 3.3 4.6 3.2 3.2 3.8 4.8 3.2 5.0 1.2 2.5 3.3 4.6 4.2 6.1 3.6 3.6 4.4 4.3 3.7 3.3 0.0 6.1 11.9 15.2 4.2 13.4 14.0 12.7 2.7 3.4 21.0 15.7 33.1 46.4 21.4 1.0 5.8 18.7 23.3 18.6 19.0 6.1 9.3 10.3 141.7 18.2 15.9 16.8 8.0 10.7 0.5 8.3 5.4 5.0 13.6 14.3 10.1 19.6 7.0 9.9 76.7 17.4 0.0 5.1 4.7 9.7 4.5 30.1 5.2 16.1 17.8 SRARP "C1orf64, ERRF, MGC24047" ENSG00000183888 "Steroid receptor associated and regulated protein" Q8NEQ6 1 16004236-16008807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0;breast: 14.7" "Cell type enriched" "Detected in single" 763 "Distal tubular cells: 76.3" "Cancer enhanced" "Detected in some" "breast cancer: 7.7;prostate cancer: 6.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.3" "Group enriched" "Detected in some" 12 "Hep G2: 9.2;SK-BR-3: 16.5;T-47d: 5.3" "Low region specificity" "Detected in all" HPA026676 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA026676: AB_1853866" "unprognostic (8.55e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.68e-6)" "unprognostic (3.32e-2)" "unprognostic (1.09e-2)" "unprognostic (1.45e-2)" "unprognostic (1.41e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.40e-2)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (1.65e-3)" "unprognostic (6.32e-2)" 0.9 1.1 12.8 1.2 19.9 2.2 14.7 7.5 19.3 6.6 0.8 3.5 0.0 1.3 3.8 1.2 1.1 0.8 1.1 1.5 14.1 6.4 2.7 0.9 0.9 1.3 12.8 7.2 1.1 1.1 0.6 0.3 1.0 22.0 2.5 0.8 0.0 8.6 0.8 2.2 2.2 0.9 0.6 7.8 1.1 1.4 1.1 16.6 0.0 3.8 0.0 0.7 1.2 0.3 0.8 0.5 5.3 0.4 1.0 0.6 0.1 0.4 0.1 0.4 0.5 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.1 0.5 0.7 9.2 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.7 0.7 0.0 0.5 0.3 0.4 0.1 0.2 0.2 0.2 0.3 0.2 0.0 0.1 0.5 0.8 0.3 16.5 0.3 0.6 5.3 0.5 0.2 0.6 0.4 0.5 0.1 0.3 0.6 0.3 0.2 0.3 0.7 2.0 0.4 0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.1 0.8 0.6 0.6 5.3 1.0 0.3 0.5 0.2 0.1 12.8 19.9 7.5 19.3 14.1 6.4 12.8 7.2 22.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRF MCM1 ENSG00000112658 "Serum response factor" P11831 6 43171299-43181507 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001819, CAB005416" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB005416: AB_2255249, HPA001819: AB_1079928" "unprognostic (1.44e-3)" "unprognostic (1.09e-1)" "unprognostic (5.39e-3)" "unprognostic (2.66e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-2)" "unprognostic (4.60e-2)" "unprognostic (9.84e-2)" "unprognostic (4.28e-2)" "unprognostic (2.21e-2)" "unprognostic (6.72e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.01e-5)" "unprognostic (5.31e-2)" "unprognostic (1.59e-1)" "unprognostic (5.10e-2)" "unprognostic (1.97e-2)" 17.7 8.1 10.7 15.6 12.3 14.1 12.9 11.6 14.5 24.9 38.1 10.6 17.9 8.1 35.3 14.9 28.2 24.8 23.7 30.6 9.4 6.5 10.5 11.3 13.9 11.8 7.8 6.2 25.6 13.1 13.8 10.1 14.1 7.5 26.9 9.4 15.4 8.7 29.9 29.7 10.2 16.8 47.9 5.4 18.2 20.8 10.0 8.1 16.1 14.9 14.6 13.2 36.0 17.7 1.9 3.7 4.7 2.9 1.1 3.1 1.0 16.6 6.7 15.5 10.2 9.2 7.6 22.9 15.3 12.6 13.3 8.3 17.8 5.0 21.1 14.0 16.3 16.8 13.5 15.8 13.4 11.7 23.2 15.5 19.1 13.1 17.5 17.6 17.8 23.3 13.0 14.7 20.4 15.1 12.6 11.0 18.4 13.5 16.6 10.0 17.9 22.0 15.6 10.8 37.6 8.2 16.9 15.9 7.5 9.7 10.8 9.1 8.3 12.5 9.6 15.1 12.5 9.8 33.2 13.3 15.8 12.1 15.1 26.1 11.6 9.5 35.5 9.8 12.8 10.6 1.7 1.7 2.9 3.1 2.9 2.5 1.9 1.8 2.3 1.8 1.9 1.4 2.4 4.7 1.1 2.3 3.7 2.1 1.0 10.7 12.3 11.6 14.5 9.4 6.5 7.8 6.2 7.5 8.1 35.7 22.7 0.8 54.0 69.3 5.9 70.5 17.8 14.7 22.7 10.4 19.6 7.6 0.0 11.9 2.0 17.6 20.9 23.3 17.1 18.5 16.9 16.7 7.0 42.9 11.0 9.5 98.0 16.5 14.3 1.1 11.5 7.2 23.6 4.6 25.7 8.7 18.4 17.5 27.3 2.8 7.3 12.9 18.4 3.0 3.2 58.5 10.2 6.9 18.3 29.6 SRRT "ARS2, Asr2, serrate" ENSG00000087087 "Serrate, RNA effector molecule" Q9BXP5 7 100875111-100888664 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 199.7;Late spermatids: 241.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042858, HPA058379" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042858: AB_2678201, HPA058379: AB_2683697" "unprognostic (5.83e-2)" "unprognostic (3.72e-3)" "unprognostic (5.89e-2)" "unprognostic (1.77e-1)" "unprognostic (1.45e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (1.90e-5)" "unprognostic (4.36e-2)" "unprognostic (4.99e-3)" "unprognostic (2.35e-2)" "unprognostic (4.25e-3)" "unprognostic (2.74e-2)" "prognostic unfavorable (1.01e-6)" "unprognostic (6.30e-3)" "unprognostic (2.77e-2)" "unprognostic (9.98e-2)" "unprognostic (1.10e-3)" 18.8 25.2 23.0 32.4 26.7 62.8 22.0 43.4 28.2 25.5 20.7 27.6 37.6 24.3 25.9 27.9 26.5 23.0 22.3 19.3 26.0 15.5 24.2 29.6 20.2 36.5 26.7 20.0 31.6 25.7 26.4 32.6 25.2 24.1 30.8 17.2 23.5 32.4 39.1 23.8 44.2 24.3 18.8 17.4 31.8 22.4 67.6 28.9 39.9 27.9 24.3 32.6 18.9 26.2 10.4 9.9 13.2 14.9 6.1 26.1 12.3 24.9 30.0 31.3 30.2 13.4 9.6 28.9 27.8 14.2 28.8 24.8 39.1 28.4 41.7 19.2 20.3 21.4 23.8 37.6 25.0 14.5 36.8 30.8 39.6 34.6 32.1 12.1 51.1 67.9 14.3 9.8 25.6 7.2 13.1 15.6 25.6 34.6 34.0 19.8 43.4 47.1 56.3 32.0 21.6 26.4 44.2 23.9 25.1 18.4 27.7 24.7 23.9 27.4 34.3 18.0 16.7 21.5 31.4 23.5 32.6 31.3 27.4 37.5 21.5 30.6 44.3 18.1 34.2 30.5 4.6 9.2 13.2 19.7 14.9 12.3 8.4 12.9 26.1 9.9 10.4 11.3 15.9 6.8 6.1 10.4 9.0 6.2 12.3 23.0 26.7 43.4 28.2 26.0 15.5 26.7 20.0 24.1 28.9 23.8 51.7 19.3 25.8 34.2 21.3 19.7 15.3 38.8 48.9 15.7 13.7 32.7 6.6 21.3 199.7 19.9 14.2 23.3 27.6 41.8 23.3 18.3 25.5 11.4 23.3 25.4 31.6 9.8 10.5 241.6 31.4 23.9 15.1 29.7 17.9 26.9 21.0 14.4 26.2 9.9 45.7 19.4 29.9 83.4 63.9 38.0 45.3 29.9 26.2 17.0 SRSF1 "ASF, MGC5228, SF2, SF2p33, SFRS1, SRp30a" ENSG00000136450 "Serine and arginine rich splicing factor 1" Q07955 17 58003360-58007346 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013073, HPA061301" Supported Supported Nucleoplasm NA NA 1100000 Nucleoplasm "CAB013073: AB_2533079, HPA061301: AB_2684474" "unprognostic (9.86e-2)" "prognostic favorable (7.00e-4)" "prognostic favorable (4.56e-5)" "unprognostic (8.11e-2)" "unprognostic (2.00e-1)" "unprognostic (3.88e-3)" "prognostic unfavorable (1.64e-6)" "unprognostic (8.28e-2)" "unprognostic (2.60e-3)" "unprognostic (3.07e-2)" "unprognostic (1.98e-1)" "unprognostic (5.48e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (1.02e-2)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (1.59e-2)" 27.0 30.0 25.4 41.0 31.7 19.1 29.9 58.3 32.9 43.8 41.1 26.3 41.7 32.2 44.9 29.3 28.6 43.2 30.2 24.0 23.9 15.8 29.0 30.9 31.4 47.1 34.6 21.6 73.1 28.5 40.8 52.3 28.5 30.1 44.9 32.4 28.7 32.9 31.7 40.7 24.7 38.9 42.2 27.4 38.4 29.2 26.0 32.1 57.0 44.7 30.7 50.7 32.1 44.1 19.8 41.8 16.5 36.1 24.8 23.2 22.3 52.3 46.8 56.5 34.1 15.7 15.9 39.6 48.9 24.6 50.2 45.5 54.6 40.9 89.6 29.9 31.8 31.1 42.2 65.1 52.0 54.4 53.1 45.0 71.3 56.6 51.2 20.2 70.5 38.7 15.4 19.5 47.3 33.5 15.1 32.4 31.0 77.2 31.0 33.7 42.6 83.8 42.0 56.0 35.9 42.3 81.9 55.6 49.6 31.4 44.1 46.6 44.0 39.3 28.6 26.2 24.7 40.6 41.2 42.2 36.5 43.3 27.2 59.4 27.5 54.0 86.1 36.0 60.6 45.5 9.8 27.3 16.5 23.2 36.1 23.1 19.8 17.8 21.8 41.8 14.6 19.5 19.5 12.7 24.8 23.8 21.3 19.2 22.3 25.4 31.7 58.3 32.9 23.9 15.8 34.6 21.6 30.1 32.1 32.8 42.4 89.7 106.8 118.7 59.2 26.2 28.1 41.5 38.7 41.8 29.5 60.7 59.7 56.4 40.6 42.3 58.0 23.3 52.0 95.3 69.1 84.9 58.8 42.3 52.2 49.3 63.2 34.4 54.2 25.9 77.9 51.1 52.3 35.1 65.7 45.0 49.8 75.5 56.6 41.6 79.0 103.5 84.9 82.4 62.6 120.2 50.9 59.6 80.2 105.0 SRSF10 "FUSIP1, FUSIP2, PPP1R149, SFRS13, SFRS13A, SRp38, SRrp40, TASR1, TASR2" ENSG00000188529 "Serine and arginine rich splicing factor 10" O75494 1 23964804-23980927 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053805, HPA053831" Uncertain Supported Nucleoplasm NA Yes 28000 Nucleoplasm "HPA053805: AB_2682269, HPA053831: AB_2682275" "unprognostic (2.49e-1)" "unprognostic (3.10e-1)" "unprognostic (1.34e-2)" "unprognostic (1.77e-1)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (2.05e-2)" "unprognostic (1.68e-3)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.74e-4)" "prognostic unfavorable (1.01e-5)" "unprognostic (2.69e-2)" "unprognostic (1.59e-1)" "unprognostic (2.76e-1)" "unprognostic (2.40e-2)" 34.1 41.8 23.7 34.3 27.1 69.0 34.5 35.5 28.7 35.0 29.2 24.6 35.0 26.8 44.1 34.4 30.6 36.2 24.8 27.1 25.3 21.7 33.0 41.0 32.0 41.6 24.0 22.3 42.8 33.6 29.5 47.9 33.7 24.9 32.5 34.3 23.1 31.1 32.9 30.0 27.1 32.5 30.7 29.8 40.0 31.2 32.4 29.2 73.8 42.9 22.0 41.2 31.4 33.1 51.9 44.1 53.3 50.1 47.7 47.1 41.6 32.1 25.8 44.4 28.1 25.1 21.2 27.8 37.6 16.2 34.9 30.9 26.2 32.2 70.1 24.4 18.0 22.1 28.1 50.5 26.5 44.8 38.2 36.1 42.2 44.6 34.1 19.1 46.2 30.5 13.3 20.5 22.7 22.5 19.7 27.3 25.8 53.9 26.8 29.3 22.8 50.4 33.7 56.7 38.2 25.6 46.3 32.5 35.2 29.2 26.0 32.4 25.3 28.6 25.4 27.6 29.6 27.3 37.3 26.1 29.0 28.3 26.5 36.2 27.1 37.0 56.6 25.0 51.8 31.9 53.3 43.0 44.3 36.4 50.1 45.8 51.9 41.9 42.3 36.4 42.9 47.1 41.6 27.4 47.7 48.9 44.1 46.9 41.6 23.7 27.1 35.5 28.7 25.3 21.7 24.0 22.3 24.9 29.2 104.2 84.9 121.8 101.4 37.8 151.3 50.9 63.7 155.2 142.1 75.0 151.2 94.2 66.3 76.4 85.5 99.4 62.3 23.3 77.4 141.6 73.7 80.8 89.2 54.2 71.8 93.8 117.0 76.1 48.7 91.5 118.2 72.5 25.3 92.0 73.8 132.6 67.9 81.6 104.0 60.5 285.3 103.5 89.5 166.6 159.0 39.6 53.0 96.9 93.0 74.0 SRSF3 "SFRS3, SRp20" ENSG00000112081 "Serine and arginine rich splicing factor 3" P84103 6 36594353-36605600 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012986, HPA056981" Supported Supported Nucleoplasm NA NA 1600000 Nucleoplasm "CAB012986: AB_2533150, HPA056981: AB_2683299" "unprognostic (3.25e-1)" "unprognostic (1.08e-3)" "prognostic favorable (2.56e-4)" "unprognostic (8.19e-2)" "unprognostic (2.06e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (6.22e-5)" "unprognostic (2.92e-2)" "prognostic unfavorable (1.95e-4)" "prognostic favorable (1.37e-4)" "unprognostic (9.61e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (9.88e-2)" "unprognostic (3.33e-2)" "unprognostic (8.33e-2)" "unprognostic (1.06e-2)" 45.3 27.4 37.4 42.1 38.3 69.5 43.5 42.6 39.1 36.4 41.7 32.9 34.0 25.5 37.2 31.8 42.9 40.8 27.4 37.5 33.0 28.1 34.3 36.9 32.3 51.8 35.8 27.0 53.9 31.3 22.4 47.2 37.4 38.1 40.1 46.6 30.1 30.2 33.0 29.2 36.2 35.8 43.1 31.9 36.4 35.2 27.2 36.7 67.5 35.9 46.7 67.0 49.6 38.6 28.0 73.9 12.9 38.0 37.6 37.6 53.9 52.3 35.0 61.8 47.2 23.9 18.8 38.2 37.5 31.5 63.3 48.8 41.1 37.7 88.1 27.1 41.0 41.4 41.6 81.1 59.7 67.7 41.1 49.9 52.9 27.8 46.2 29.2 70.9 44.8 16.6 20.3 41.2 46.1 20.2 48.0 53.7 63.7 37.4 45.9 40.9 87.1 67.2 65.1 61.6 36.8 77.8 59.2 52.8 44.8 43.7 47.8 45.2 41.7 41.0 56.7 46.2 41.5 76.3 31.3 32.4 47.3 32.4 56.3 36.9 54.6 120.8 27.8 66.1 44.9 12.9 38.0 11.5 32.9 36.2 37.1 28.0 31.1 34.5 73.9 24.0 31.4 32.3 3.7 37.6 24.4 43.7 37.6 53.9 37.4 38.3 42.6 39.1 33.0 28.1 35.8 27.0 38.1 36.7 187.6 233.6 318.3 350.5 417.2 149.0 207.3 150.3 167.3 258.2 118.7 51.1 416.8 308.4 279.1 130.6 291.5 222.5 70.0 281.9 659.0 372.0 205.6 389.0 176.1 317.5 93.8 319.4 203.1 270.2 235.9 196.2 343.3 317.2 322.0 216.3 322.7 247.9 247.6 161.9 198.3 123.9 200.5 442.5 331.9 315.7 389.7 439.9 330.0 297.7 236.4 SRSF7 "9G8, AAG3, HSSG1, RBM37, SFRS7, ZCCHC20, ZCRB2" ENSG00000115875 "Serine and arginine rich splicing factor 7" Q16629 2 38743599-38751494 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043850, HPA056926" Supported Enhanced Nucleoplasm NA NA 1400000 Nucleoplasm "HPA043850: AB_10964495, HPA056926: AB_2683277" "unprognostic (2.74e-1)" "unprognostic (1.53e-3)" "unprognostic (1.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.86e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.90e-5)" "unprognostic (3.24e-2)" "unprognostic (2.53e-2)" "unprognostic (2.61e-1)" "unprognostic (3.75e-1)" "unprognostic (4.44e-3)" "prognostic unfavorable (3.18e-8)" "unprognostic (1.02e-2)" "unprognostic (1.87e-1)" "unprognostic (1.72e-1)" "unprognostic (3.07e-3)" 42.2 32.2 32.8 51.1 37.3 76.7 39.2 34.7 38.9 26.8 37.2 21.4 34.8 20.4 34.1 27.3 50.2 36.9 25.9 29.8 26.9 24.6 25.1 34.9 34.3 45.5 37.5 23.8 31.7 38.2 20.4 50.4 34.3 32.8 27.4 37.2 25.0 32.8 32.4 31.7 26.2 37.7 36.6 33.4 34.8 38.8 35.9 33.0 44.1 26.1 38.6 59.2 28.2 40.7 20.9 47.6 8.8 33.4 20.8 22.9 22.3 44.4 38.7 52.0 33.5 16.0 12.7 36.8 38.1 16.4 38.4 31.0 45.6 34.3 72.7 26.1 24.7 35.7 25.1 65.4 46.6 46.3 45.2 40.9 43.8 27.7 46.5 13.6 53.7 31.9 7.5 15.9 26.4 51.1 16.1 31.8 30.4 63.2 29.1 32.5 49.5 68.0 47.6 56.8 51.9 35.5 60.4 43.6 41.2 28.5 43.2 35.7 34.7 36.4 32.2 25.5 34.2 29.4 49.1 27.4 23.3 36.5 19.9 53.0 32.1 48.1 108.6 27.7 56.4 32.0 6.4 23.1 8.8 21.3 33.4 22.9 20.9 16.4 21.0 47.6 14.1 18.6 21.1 2.3 20.8 19.6 28.6 17.4 22.3 32.8 37.3 34.7 38.9 26.9 24.6 37.5 23.8 32.8 33.0 74.5 215.1 214.9 400.1 230.6 113.1 58.5 71.4 103.1 134.2 61.1 111.9 262.6 132.6 156.5 100.6 205.2 175.7 93.5 114.8 395.5 179.8 170.8 309.8 83.0 212.6 114.4 170.8 124.0 110.1 27.4 128.3 171.7 145.1 221.8 114.8 196.9 126.7 138.2 103.3 87.8 205.4 116.4 213.8 249.3 306.4 212.9 209.3 335.6 161.8 319.7 SSB "La, La/SSB, LARP3" ENSG00000138385 "Sjogren syndrome antigen B" P05455 2 169791933-169812064 "Predicted intracellular proteins" RNA-binding "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004643, HPA017287" Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB004643: AB_425691, HPA017287: AB_1852672" "unprognostic (5.58e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "unprognostic (9.05e-3)" "unprognostic (6.60e-2)" "prognostic unfavorable (5.99e-4)" "prognostic unfavorable (8.30e-8)" "unprognostic (1.09e-2)" "unprognostic (1.45e-2)" "unprognostic (9.81e-3)" "unprognostic (3.24e-3)" "unprognostic (2.57e-1)" "prognostic unfavorable (6.17e-6)" "unprognostic (9.92e-2)" "unprognostic (2.43e-1)" "unprognostic (1.21e-3)" "unprognostic (2.38e-2)" 52.4 38.5 39.7 35.1 41.8 43.8 38.2 45.8 48.4 37.8 32.7 18.9 24.2 23.7 34.7 42.4 35.8 31.7 28.9 32.7 37.2 42.9 54.0 44.9 27.0 41.3 36.0 34.3 46.5 21.8 40.3 76.9 39.8 51.1 44.5 28.9 19.8 23.5 35.0 44.6 22.4 30.7 38.2 42.4 45.6 26.6 19.4 35.7 35.9 48.1 30.0 38.1 49.3 29.1 32.4 21.0 22.4 33.2 32.3 38.5 22.5 30.8 18.2 39.4 29.3 42.8 39.8 49.3 38.0 25.4 35.7 33.3 55.0 33.9 69.3 43.5 24.8 32.5 33.2 53.2 33.2 49.1 37.6 43.6 83.0 23.0 52.8 38.3 66.6 31.1 30.5 32.0 45.3 27.1 29.4 39.6 26.2 96.4 16.2 74.7 24.3 44.1 69.9 63.5 29.8 18.7 43.8 42.0 50.0 45.1 34.2 37.7 28.8 30.1 22.5 41.9 40.1 25.8 48.1 35.6 26.1 31.1 26.2 36.5 18.9 36.4 59.1 25.8 62.9 28.3 22.4 16.9 19.8 26.9 27.8 38.5 32.4 38.2 33.9 19.6 27.1 34.9 36.8 2.7 32.3 33.2 21.0 33.9 22.5 39.7 41.8 45.8 48.4 37.2 42.9 36.0 34.3 51.1 35.7 80.4 66.3 99.4 177.0 81.5 115.4 84.5 53.5 274.4 111.5 106.4 25.5 182.8 159.2 164.1 16.1 133.2 32.6 46.7 128.2 168.7 141.2 127.2 195.7 71.0 164.6 128.7 70.2 94.5 76.4 34.1 170.6 138.1 75.9 92.0 78.5 142.4 108.6 38.6 175.7 143.3 76.2 213.4 162.9 173.1 145.9 77.2 138.3 109.7 93.4 140.8 SSBP2 HSPC116 ENSG00000145687 "Single stranded DNA binding protein 2" P81877 5 81413021-81751797 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 89.9" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 139.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 38.3;MOLT-4: 35.5;REH: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020834, HPA068605, HPA071780" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB020834: , HPA068605: AB_2732116, HPA071780: " "unprognostic (4.62e-2)" "unprognostic (1.96e-3)" "unprognostic (1.12e-1)" "unprognostic (1.46e-2)" "unprognostic (1.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.30e-1)" "unprognostic (6.54e-2)" "unprognostic (1.56e-1)" "unprognostic (7.78e-3)" "unprognostic (2.36e-3)" "unprognostic (6.01e-2)" "unprognostic (1.01e-2)" "unprognostic (3.04e-3)" "unprognostic (6.56e-2)" "unprognostic (9.81e-2)" "unprognostic (4.39e-3)" 18.9 11.5 16.3 11.1 24.3 11.0 20.0 49.8 21.3 26.5 18.8 13.6 11.1 5.2 27.0 27.2 21.3 26.4 14.2 26.3 16.1 22.8 10.3 3.2 11.3 15.4 19.9 16.2 33.1 8.7 42.4 31.0 11.7 20.9 16.1 11.7 20.0 14.6 19.5 16.3 19.6 10.3 26.1 20.6 8.9 13.6 6.9 21.5 89.9 12.8 11.7 19.9 19.0 18.5 16.2 8.1 26.2 12.2 25.6 15.2 7.9 1.0 1.9 24.2 13.7 14.0 21.3 1.5 5.0 4.6 4.7 4.9 0.0 2.0 16.7 0.3 5.9 2.3 0.1 6.6 2.7 4.6 7.1 2.8 3.5 4.1 0.0 7.9 1.7 9.3 21.8 23.5 0.8 4.5 10.2 2.0 38.3 2.2 8.2 5.0 2.3 35.5 2.8 3.3 0.0 1.0 53.5 5.5 12.7 2.4 0.9 12.6 11.4 5.3 5.9 1.8 10.2 8.7 4.9 1.3 1.8 3.0 3.5 1.3 8.7 6.7 28.0 6.2 3.1 1.2 20.7 8.6 26.2 2.4 7.6 3.8 9.9 7.7 4.3 8.1 16.2 15.2 5.3 12.5 25.6 12.2 2.6 3.4 7.9 16.3 24.3 49.8 21.3 16.1 22.8 19.9 16.2 20.9 21.5 8.9 18.1 15.4 39.3 31.0 60.9 38.4 7.6 29.4 33.0 27.9 25.5 5.9 14.9 10.5 5.4 19.6 2.3 0.0 8.8 2.8 30.8 11.9 24.3 1.6 16.4 39.7 14.5 18.4 15.4 3.4 35.1 18.7 33.7 5.4 4.7 139.7 6.3 10.2 45.6 4.1 43.9 51.8 68.0 6.3 20.3 31.7 6.2 14.4 3.5 26.4 SSBP3 "CSDP, FLJ10355, SSDP, SSDP1" ENSG00000157216 "Single stranded DNA binding protein 3" Q9BWW4 1 54225432-54413479 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.6" "Lineage enriched" "Detected in many" 6 "T-cells: 6.6" "Cell line enhanced" "Detected in all" "BEWO: 52.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071780 Approved Nucleoplasm NA NA Nucleoplasm "HPA071780: " "unprognostic (1.44e-2)" "prognostic favorable (2.48e-9)" "unprognostic (1.06e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.94e-1)" "unprognostic (1.36e-2)" "unprognostic (1.11e-2)" "unprognostic (6.59e-2)" "unprognostic (3.93e-2)" "unprognostic (3.34e-1)" "unprognostic (7.08e-2)" "unprognostic (1.43e-1)" "unprognostic (6.81e-3)" "unprognostic (2.50e-1)" "unprognostic (6.45e-2)" "unprognostic (2.08e-1)" "unprognostic (1.96e-1)" 12.3 19.9 17.4 11.1 18.8 21.3 12.2 27.8 35.8 24.7 15.7 11.2 12.0 14.5 26.1 7.3 17.2 21.9 17.2 13.1 15.3 13.5 10.6 14.7 10.7 9.6 13.7 21.1 51.9 13.5 6.1 7.8 13.9 11.0 16.4 10.7 12.5 13.6 21.1 13.9 16.7 14.9 16.5 15.1 12.1 26.2 12.8 9.6 40.7 9.9 8.5 9.3 15.4 18.9 0.5 0.7 1.1 0.4 0.3 6.6 1.3 3.9 2.5 22.8 14.4 9.0 5.8 52.8 7.7 6.6 3.2 2.5 4.5 3.5 2.7 14.7 6.8 3.3 12.5 11.3 5.3 3.2 20.3 5.3 26.4 8.3 5.1 8.2 6.9 13.1 10.1 3.9 5.6 1.6 5.6 15.9 16.2 25.8 4.9 3.8 3.7 41.4 8.3 43.6 15.3 11.4 29.6 6.3 10.7 4.4 3.0 34.5 19.5 9.2 18.7 5.0 20.2 9.8 8.0 13.3 6.6 11.6 8.2 5.4 11.1 8.9 6.2 11.0 24.0 2.7 0.0 0.4 1.1 2.3 0.2 2.1 0.5 3.7 3.0 0.7 0.3 6.6 5.2 0.1 0.3 0.4 0.6 0.2 1.3 17.4 18.8 27.8 35.8 15.3 13.5 13.7 21.1 11.0 9.6 11.9 8.9 3.0 36.3 26.4 85.6 15.1 45.9 21.4 13.6 22.7 7.9 45.2 8.3 27.5 29.8 31.7 34.9 46.7 22.5 38.4 36.8 27.8 7.0 84.4 22.8 39.7 107.4 44.2 31.0 27.5 84.8 16.2 21.9 6.4 73.5 53.9 41.6 34.5 128.7 8.9 45.8 25.8 41.2 2.5 14.3 22.6 19.8 9.5 46.0 25.7 SSBP4 ENSG00000130511 "Single stranded DNA binding protein 4" Q9BWG4 19 18418864-18434562 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071780 Approved Nucleoplasm NA NA Nucleoplasm "HPA071780: " "unprognostic (2.81e-2)" "unprognostic (8.47e-3)" "unprognostic (4.94e-1)" "unprognostic (1.14e-1)" "unprognostic (1.52e-1)" "unprognostic (2.44e-2)" "unprognostic (3.38e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-1)" "unprognostic (7.85e-2)" "prognostic favorable (1.01e-4)" "unprognostic (3.32e-2)" "prognostic unfavorable (2.04e-10)" "unprognostic (4.50e-2)" "unprognostic (1.97e-1)" "unprognostic (4.26e-2)" "unprognostic (1.05e-2)" 20.7 15.9 25.4 17.6 39.9 12.2 8.7 16.3 30.1 15.1 12.5 8.0 15.3 16.7 19.9 8.5 8.7 23.2 7.4 8.6 21.1 15.2 9.7 8.2 14.8 16.2 7.7 16.2 15.0 16.1 6.9 28.6 12.7 10.0 13.3 5.0 11.9 12.4 24.1 25.6 11.6 20.1 8.0 5.7 35.5 23.3 12.1 11.4 11.7 11.1 6.9 9.9 7.2 10.3 10.8 5.4 0.5 17.8 3.4 9.4 3.2 11.6 9.0 8.6 15.2 1.6 6.1 12.1 16.4 3.3 3.7 3.9 3.7 13.0 10.3 14.4 3.5 4.0 13.5 2.2 3.0 1.5 11.0 25.2 18.0 11.0 8.3 6.7 8.3 33.2 5.2 2.4 2.3 0.9 5.1 10.9 20.2 36.0 5.1 1.1 17.5 22.1 27.7 7.0 5.5 26.5 15.2 6.9 10.5 5.6 3.7 15.3 26.3 2.5 7.8 21.6 1.7 8.5 19.6 13.8 6.3 16.7 38.2 10.4 7.6 2.2 6.8 16.5 26.2 12.7 0.0 4.3 0.2 9.4 10.8 6.4 10.8 7.9 8.1 5.4 8.7 4.7 8.1 0.5 3.4 17.8 3.4 4.1 3.2 25.4 39.9 16.3 30.1 21.1 15.2 7.7 16.2 10.0 11.4 6.0 18.1 39.5 27.2 15.2 13.5 5.2 7.6 76.3 19.4 50.6 23.6 17.6 21.6 11.4 7.1 33.8 5.6 0.0 18.2 37.9 45.1 23.7 36.9 10.6 31.0 39.7 57.5 23.9 27.9 21.3 54.1 31.1 18.6 8.2 16.9 21.3 11.8 10.5 48.4 17.3 14.1 38.8 35.9 18.2 59.4 12.8 15.8 51.1 17.8 24.0 ST5 "DENND2B, HTS1, p126" ENSG00000166444 "Suppression of tumorigenicity 5" P78524 11 8693351-8910951 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 538.0;Rod photoreceptor cells: 371.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046796 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046796: AB_2679812" "unprognostic (1.88e-3)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (1.88e-2)" "unprognostic (4.17e-2)" "unprognostic (2.46e-1)" "unprognostic (6.42e-2)" "unprognostic (1.17e-1)" "unprognostic (1.72e-1)" "unprognostic (5.56e-2)" "unprognostic (3.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" "unprognostic (8.77e-2)" "unprognostic (1.60e-1)" "unprognostic (1.54e-1)" 9.6 25.4 9.5 14.9 11.9 1.3 11.0 16.3 13.2 45.1 29.3 14.1 20.4 11.9 71.3 22.2 27.0 41.1 22.4 13.9 8.5 7.5 10.8 10.4 11.0 5.9 7.9 9.7 49.5 14.4 6.5 14.8 19.2 11.6 24.5 11.7 28.9 21.0 28.3 8.4 8.4 17.8 51.4 8.5 22.8 22.4 34.5 8.6 4.5 15.8 9.2 8.6 26.5 19.7 1.3 1.6 1.0 5.9 0.0 0.2 0.6 12.4 1.8 20.6 3.4 6.9 7.2 0.9 11.3 36.7 10.9 10.1 2.5 13.5 0.4 6.8 20.4 4.8 12.6 3.8 16.4 4.3 1.7 5.0 0.0 6.4 8.6 10.4 0.0 0.1 24.5 4.6 6.2 8.3 22.6 2.1 2.0 2.6 1.1 17.6 1.3 0.7 0.5 3.0 12.5 3.0 0.4 12.4 0.7 15.2 9.1 3.9 12.2 9.7 12.7 7.8 7.1 2.1 0.4 5.7 5.9 10.0 19.2 8.8 3.0 5.7 0.1 9.8 0.0 11.9 0.0 0.1 0.0 0.1 0.8 0.0 1.3 0.0 0.0 1.6 1.2 0.1 0.1 1.0 0.0 5.9 0.0 0.2 0.6 9.5 11.9 16.3 13.2 8.5 7.5 7.9 9.7 11.6 8.6 11.9 38.5 0.0 42.4 15.8 27.4 4.4 38.2 28.1 40.9 17.4 538.0 3.3 3.3 35.5 32.9 10.1 19.7 23.3 28.3 1.8 23.7 23.4 1.1 9.6 5.2 1.6 16.7 8.6 3.1 23.3 74.5 3.6 23.6 6.4 22.8 94.1 32.0 7.0 93.7 1.5 371.0 64.7 36.4 18.0 16.6 6.8 2.4 0.0 19.8 25.8 ST6GALNAC3 SIAT7C ENSG00000184005 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3" Q8NDV1 1 76074719-76634601 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 23 "Endothelial cells: 21.6;Ito cells: 57.1;Kupffer cells: 11.7;Muller glia cells: 11.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 18.6;HUVEC TERT2: 23.6;SK-MEL-30: 32.2;TIME: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054566, HPA055399" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054566: AB_2682526, HPA055399: AB_2682806" "unprognostic (7.85e-2)" "unprognostic (1.78e-1)" "unprognostic (2.99e-2)" "unprognostic (2.70e-4)" "unprognostic (2.76e-2)" "unprognostic (2.21e-2)" "unprognostic (6.55e-3)" "unprognostic (7.31e-2)" "unprognostic (2.14e-1)" "unprognostic (4.57e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (9.97e-4)" "unprognostic (3.33e-4)" "unprognostic (5.44e-2)" "unprognostic (1.92e-1)" "unprognostic (3.44e-4)" 20.7 2.9 7.0 3.6 13.0 5.3 13.9 3.8 9.7 4.3 4.0 13.4 2.0 1.8 10.7 2.1 3.8 4.2 4.7 7.8 8.8 6.0 14.9 3.9 7.5 5.1 16.3 3.6 4.7 2.2 12.6 4.3 5.7 12.9 2.5 4.7 2.8 2.3 3.5 3.3 1.9 2.7 8.3 19.0 3.0 3.0 1.2 12.5 0.0 23.2 1.5 1.7 5.5 5.2 5.9 3.0 5.2 8.3 0.4 1.9 2.6 0.1 0.0 18.6 0.0 0.3 0.0 0.0 0.0 2.2 0.3 0.2 6.0 0.0 0.3 1.2 0.1 1.2 0.0 0.0 0.2 0.1 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.5 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 1.4 0.0 0.9 0.8 0.0 0.0 0.0 1.4 4.6 0.0 0.0 32.2 4.5 0.0 0.1 10.4 0.1 1.5 0.0 1.7 0.0 0.0 0.0 0.0 4.2 2.8 0.0 8.3 3.7 0.0 2.9 0.0 3.3 0.5 0.8 3.0 5.9 1.9 1.9 5.2 0.4 5.3 0.0 0.0 2.6 7.0 13.0 3.8 9.7 8.8 6.0 16.3 3.6 12.9 12.5 3.0 1.0 1.3 0.1 0.2 3.0 1.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.4 0.8 0.0 0.0 57.1 11.7 0.4 0.0 1.5 5.0 0.0 0.3 11.0 0.2 3.2 0.0 0.0 0.5 0.0 0.3 0.2 0.4 0.4 0.1 0.0 0.0 0.1 STN1 "bA541N10.2, FLJ22559, OBFC1" ENSG00000107960 "STN1, CST complex subunit" Q9H668 10 103882542-103918205 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 30.7;Distal tubular cells: 34.9;Exocrine glandular cells: 68.6;Pancreatic endocrine cells: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037924, HPA037925" Supported Nucleoplasm NA NA Nucleoplasm "HPA037924: AB_10671636, HPA037925: AB_10672469" "unprognostic (1.50e-1)" "unprognostic (4.22e-2)" "unprognostic (2.18e-2)" "unprognostic (5.58e-3)" "unprognostic (6.01e-2)" "unprognostic (1.53e-2)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (5.93e-2)" "unprognostic (1.72e-1)" "unprognostic (1.12e-3)" "unprognostic (3.76e-1)" "prognostic favorable (1.12e-6)" "unprognostic (1.21e-1)" "unprognostic (1.74e-1)" "unprognostic (1.20e-1)" "unprognostic (1.83e-2)" 13.6 21.0 7.4 10.4 12.6 8.8 13.2 10.7 12.7 13.2 10.9 14.4 10.1 9.1 12.9 10.7 35.6 9.9 18.5 25.4 7.9 9.2 18.6 9.6 21.3 15.6 11.6 6.8 17.6 30.1 23.3 15.3 12.9 17.0 13.0 12.8 13.1 17.2 10.8 19.0 11.8 11.0 14.0 11.9 13.4 16.3 26.8 9.1 19.7 13.9 18.2 24.2 18.0 15.9 9.2 14.4 38.5 12.0 23.5 38.4 16.8 13.2 10.5 11.7 9.7 9.8 29.4 4.1 6.8 17.7 8.2 7.5 6.2 21.1 8.5 12.2 8.0 7.7 12.3 4.4 15.5 7.7 12.4 6.6 7.9 3.5 11.6 13.4 6.1 6.4 19.4 25.9 8.1 23.0 21.3 15.8 15.9 4.3 17.3 13.6 10.4 14.2 10.6 2.6 19.2 15.2 11.3 8.4 8.9 20.2 15.6 6.9 8.3 4.7 7.3 12.2 7.3 6.2 5.3 22.5 10.3 7.5 7.2 9.4 24.9 6.9 8.7 15.3 12.9 4.3 10.8 12.0 38.5 24.6 7.7 38.4 9.1 27.3 22.3 14.4 9.2 20.2 23.9 17.6 23.5 7.8 13.2 34.2 16.8 7.4 12.6 10.7 12.7 7.9 9.2 11.6 6.8 17.0 9.1 20.8 18.1 0.0 0.0 0.0 0.0 0.0 0.0 13.4 9.1 8.7 0.0 30.7 34.9 22.7 0.0 0.0 0.0 0.0 68.6 11.3 0.0 0.0 4.7 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 23.4 0.0 0.0 48.9 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 STPG1 "C1orf201, FLJ33340, MAPO2" ENSG00000001460 "Sperm tail PG-rich repeat containing 1" Q5TH74 1 24356999-24416934 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.2" "Group enriched" "Detected in many" 5 "Early spermatids: 225.3;Late spermatids: 476.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA024301 Approved Nucleoplasm NA NA Nucleoplasm "HPA024301: AB_1845634" "unprognostic (2.63e-2)" "unprognostic (3.35e-1)" "unprognostic (1.36e-2)" "prognostic favorable (1.33e-4)" "unprognostic (6.06e-4)" "unprognostic (5.14e-2)" "unprognostic (2.91e-3)" "unprognostic (5.53e-2)" "unprognostic (1.46e-1)" "unprognostic (3.40e-2)" "unprognostic (1.08e-1)" "unprognostic (3.48e-2)" "prognostic favorable (2.31e-4)" "unprognostic (9.14e-2)" "unprognostic (3.93e-2)" "unprognostic (5.21e-2)" "unprognostic (1.42e-1)" 5.5 4.3 6.0 2.6 12.8 1.5 4.2 13.6 23.3 4.7 7.9 12.0 2.4 4.4 4.8 7.1 4.9 20.8 4.2 4.0 6.7 8.7 5.9 1.9 6.2 2.5 6.5 8.0 5.6 4.8 13.0 9.2 1.6 14.2 5.8 6.9 9.9 3.5 4.6 1.5 4.3 5.5 6.4 6.1 2.1 5.1 29.2 7.9 2.5 5.9 1.2 3.4 4.5 3.9 5.2 2.7 1.1 1.4 0.0 4.3 1.9 5.9 3.5 0.5 6.5 4.8 6.9 3.5 8.7 8.4 8.4 8.8 1.5 8.9 0.7 6.0 9.1 7.0 2.4 5.6 6.1 9.7 7.0 5.6 1.0 1.9 1.6 9.8 2.9 1.5 4.1 12.5 12.1 16.0 8.9 6.6 0.0 2.1 0.0 6.3 2.1 0.0 2.4 5.3 6.3 6.0 1.6 0.0 0.2 11.2 2.0 5.4 3.7 4.7 1.8 13.5 5.7 4.8 5.2 4.5 3.0 3.5 1.2 2.5 3.8 3.6 2.1 3.4 0.3 4.8 0.0 0.1 1.1 1.5 1.4 0.2 5.2 1.2 4.3 0.6 3.4 1.4 1.7 0.1 0.0 0.2 2.7 2.5 1.9 6.0 12.8 13.6 23.3 6.7 8.7 6.5 8.0 14.2 7.9 8.9 8.1 2.2 11.4 4.0 12.4 4.8 0.0 65.6 17.0 10.4 13.7 3.8 13.3 6.5 225.3 4.2 16.3 23.3 6.2 7.0 3.8 6.7 11.5 1.3 3.3 9.5 4.6 5.5 1.0 476.4 6.1 4.6 15.1 4.6 5.2 7.4 7.7 10.5 4.2 7.1 16.7 6.5 5.1 14.2 9.4 4.8 3.8 3.9 5.0 51.2 STYX ENSG00000198252 "Serine/threonine/tyrosine interacting protein" Q8WUJ0 14 52730180-52774998 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 77.4;Late spermatids: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040290 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA040290: AB_10963686" "unprognostic (5.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.22e-1)" "unprognostic (9.56e-2)" "unprognostic (2.43e-1)" "unprognostic (2.16e-1)" "unprognostic (2.81e-1)" "unprognostic (2.37e-1)" "unprognostic (3.00e-3)" "unprognostic (1.91e-2)" "unprognostic (3.21e-2)" "unprognostic (2.26e-1)" "unprognostic (1.57e-3)" "unprognostic (6.89e-2)" "unprognostic (6.82e-2)" "unprognostic (2.48e-2)" "unprognostic (6.84e-3)" 12.2 6.4 7.6 14.8 8.3 6.4 19.6 9.9 7.4 9.7 10.1 8.5 8.2 7.1 10.8 6.4 13.2 8.1 9.6 11.5 7.2 5.4 7.5 32.2 12.6 23.5 10.2 5.8 9.7 11.8 7.0 9.4 11.6 7.2 9.9 8.4 7.1 10.2 11.5 26.6 10.9 9.0 15.5 10.0 11.7 11.2 13.9 8.6 16.7 7.7 12.2 14.9 13.4 10.7 7.1 5.4 6.6 6.8 5.4 13.4 6.3 10.5 5.8 8.1 9.6 13.8 19.8 15.4 12.8 9.5 9.4 9.5 8.4 7.8 13.1 10.9 12.0 7.9 8.4 10.0 10.4 16.6 11.6 3.8 6.7 6.5 11.1 11.4 10.6 8.9 14.1 12.7 12.3 12.8 8.4 16.9 11.9 7.9 12.7 12.8 14.5 11.8 7.0 9.7 12.0 12.1 10.1 10.9 7.7 12.2 12.1 1.8 5.4 13.0 8.8 8.3 11.8 21.4 10.8 15.5 16.4 10.5 17.7 7.9 4.7 6.3 8.2 5.3 7.2 13.8 6.6 5.0 4.0 6.8 6.8 9.0 7.1 11.2 9.1 5.4 4.8 13.4 9.9 2.6 5.4 6.1 4.1 12.2 6.3 7.6 8.3 9.9 7.4 7.2 5.4 10.2 5.8 7.2 8.6 6.0 8.6 13.7 9.8 14.7 4.6 19.4 7.6 17.4 9.1 5.2 5.9 11.8 11.6 11.3 77.4 14.3 5.3 0.0 15.9 25.9 11.3 14.4 19.7 51.3 14.2 4.8 4.6 15.4 13.1 67.5 8.9 17.9 3.3 15.4 5.3 6.7 12.5 8.6 10.6 9.2 6.5 25.8 14.0 53.9 23.3 17.1 17.6 20.0 7.5 10.0 SUFU "PRO1280, SUFUH, SUFUXL" ENSG00000107882 "SUFU negative regulator of hedgehog signaling" Q9UMX1 10 102503987-102633535 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Ciliopathy, Disease mutation, Joubert syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 126.0;Late spermatids: 78.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008700 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA008700: AB_1080125" "unprognostic (1.55e-1)" "unprognostic (4.00e-2)" "unprognostic (5.14e-2)" "unprognostic (1.33e-1)" "unprognostic (4.69e-2)" "unprognostic (5.68e-2)" "unprognostic (3.69e-2)" "unprognostic (5.99e-2)" "unprognostic (1.64e-1)" "unprognostic (3.15e-3)" "unprognostic (9.60e-2)" "unprognostic (2.13e-1)" "unprognostic (3.72e-3)" "unprognostic (1.82e-1)" "unprognostic (1.44e-1)" "unprognostic (5.10e-2)" "unprognostic (3.82e-3)" 10.7 12.8 15.0 15.2 12.8 3.9 18.3 23.0 15.3 13.4 10.4 11.3 12.1 7.7 14.4 13.3 14.7 14.2 16.2 11.0 11.8 7.8 10.8 10.0 21.4 20.5 11.9 11.0 18.0 8.9 20.0 7.8 13.9 10.0 15.4 8.8 11.9 12.6 16.7 14.1 23.1 9.4 14.3 10.7 13.1 7.9 21.1 13.1 19.9 6.2 12.7 15.0 15.2 15.0 2.3 4.5 6.2 5.5 2.8 3.1 2.8 6.3 6.7 10.9 15.7 11.3 9.5 5.3 6.6 12.8 9.6 8.7 6.2 4.7 6.5 18.8 7.3 3.9 4.5 13.4 7.3 6.3 4.0 10.4 15.5 3.9 5.9 5.4 5.6 11.2 10.9 5.8 7.1 5.8 17.6 12.3 6.4 3.4 6.0 5.8 5.3 10.6 8.5 3.1 4.1 5.1 11.5 11.8 3.4 6.3 9.5 3.7 5.9 5.2 4.9 5.9 10.5 10.8 3.7 13.5 4.3 6.1 4.5 7.2 4.9 3.2 4.7 5.3 11.0 2.9 4.2 4.5 6.2 2.5 5.5 2.0 2.3 3.1 2.8 4.5 2.1 2.2 2.5 1.1 2.8 5.5 2.5 1.9 2.8 15.0 12.8 23.0 15.3 11.8 7.8 11.9 11.0 10.0 13.1 0.0 3.0 0.9 2.2 2.7 3.4 3.6 0.0 4.0 4.5 3.5 7.9 6.9 1.7 3.9 126.0 4.3 4.0 0.0 2.6 3.1 5.4 1.9 3.5 4.9 10.4 1.6 1.2 12.9 10.2 78.9 4.6 5.6 0.0 7.2 2.2 2.9 3.5 0.0 6.3 4.4 3.9 0.0 3.4 4.2 4.5 5.6 5.8 5.1 2.8 1.1 SUGP1 "DKFZp434E2216, F23858, RBP, SF4" ENSG00000105705 "SURP and G-patch domain containing 1" Q8IWZ8 19 19276018-19320844 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004890 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004890: AB_1079935" "unprognostic (1.08e-1)" "unprognostic (4.51e-3)" "unprognostic (5.21e-2)" "unprognostic (9.88e-2)" "unprognostic (1.87e-1)" "unprognostic (7.34e-3)" "unprognostic (1.67e-2)" "unprognostic (4.90e-3)" "unprognostic (2.14e-2)" "unprognostic (1.26e-1)" "unprognostic (1.37e-3)" "unprognostic (4.25e-2)" "unprognostic (3.52e-2)" "unprognostic (2.06e-3)" "unprognostic (5.51e-2)" "unprognostic (1.50e-2)" "unprognostic (3.42e-3)" 6.8 8.2 14.8 9.2 13.4 5.6 7.0 16.4 17.0 7.3 8.6 9.1 7.8 9.7 9.0 6.9 9.2 8.3 7.1 11.2 12.1 8.7 8.6 8.6 8.3 7.9 11.0 9.1 7.1 10.5 9.0 8.1 6.4 10.3 8.4 6.6 8.2 11.2 8.7 19.7 7.4 8.5 8.5 10.8 8.1 8.7 20.2 10.9 9.8 6.5 6.8 8.8 8.6 6.2 12.9 14.1 14.1 21.9 15.8 17.0 14.4 12.0 2.5 5.9 7.2 5.9 5.7 15.4 8.6 11.4 12.3 8.9 5.6 9.0 11.8 11.8 11.3 7.7 8.3 6.6 10.0 6.0 8.3 5.5 9.8 3.1 4.0 6.9 6.8 10.6 10.9 4.8 10.7 4.5 6.2 8.8 9.0 12.6 6.3 10.1 9.6 17.1 10.4 12.6 12.1 7.8 14.3 8.8 13.5 9.0 5.1 10.1 13.1 8.4 7.1 14.1 6.6 8.1 12.6 14.1 8.8 9.1 11.3 10.5 11.2 11.1 13.6 11.0 9.1 10.9 7.8 14.1 14.1 16.2 16.8 12.6 12.9 12.7 17.0 14.1 11.9 11.9 12.6 12.8 15.8 21.9 13.0 12.4 14.4 14.8 13.4 16.4 17.0 12.1 8.7 11.0 9.1 10.3 10.9 14.9 16.0 8.8 6.7 4.1 11.0 18.7 12.7 6.7 14.8 14.0 3.9 15.8 14.9 12.9 33.1 9.0 13.3 0.0 12.4 11.5 6.1 3.0 9.2 7.3 12.4 1.6 9.2 6.7 6.3 83.0 10.3 10.8 10.1 22.6 9.1 13.8 11.3 11.2 11.7 13.6 7.6 6.5 9.2 27.8 16.4 5.0 14.1 12.8 9.4 3.1 SUPT3H "SPT3, SPT3L" ENSG00000196284 "SPT3 homolog, SAGA and STAGA complex component" O75486 6 44809317-45377953 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 115.4;Late spermatids: 129.6;T-cells: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024371 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA024371: AB_1857660" "unprognostic (5.72e-3)" "unprognostic (7.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.34e-1)" "prognostic favorable (3.55e-4)" "unprognostic (1.07e-2)" "unprognostic (6.15e-5)" "unprognostic (7.46e-2)" "unprognostic (1.75e-1)" "prognostic favorable (1.72e-4)" "unprognostic (1.49e-1)" "unprognostic (2.30e-1)" "unprognostic (2.05e-2)" "unprognostic (3.08e-2)" "unprognostic (1.23e-1)" "unprognostic (8.13e-3)" "unprognostic (4.31e-2)" 6.0 11.2 7.4 6.7 7.1 2.8 6.1 20.3 9.2 9.4 9.6 7.9 11.5 5.1 10.0 11.4 4.7 11.7 6.6 4.4 6.1 4.6 8.5 4.2 6.9 3.9 6.3 7.7 11.7 10.2 11.4 15.4 7.1 8.3 10.4 5.4 7.7 7.6 8.1 3.0 3.8 4.3 7.1 10.1 3.7 5.3 14.8 8.8 6.0 9.5 2.6 4.7 6.6 6.5 1.2 3.3 0.3 0.4 5.0 17.1 5.4 3.7 3.6 11.8 3.2 2.2 8.5 2.1 1.8 2.7 8.7 7.6 5.0 2.1 2.2 2.7 1.8 3.1 0.6 9.4 8.1 9.5 2.2 4.2 1.7 2.2 13.1 5.5 2.2 1.0 5.9 7.2 6.7 10.0 16.0 3.6 5.4 3.6 3.2 6.2 1.9 4.3 6.8 4.4 10.6 1.8 5.4 2.7 1.1 11.9 4.6 4.4 2.8 0.6 0.3 5.3 10.3 2.4 3.1 1.8 2.4 0.1 2.7 4.9 4.3 1.1 9.6 4.3 6.3 2.0 0.3 0.4 0.0 8.5 0.4 13.9 1.1 12.4 10.9 1.3 1.2 17.1 13.4 0.3 5.0 0.4 3.3 5.4 5.4 7.4 7.1 20.3 9.2 6.1 4.6 6.3 7.7 8.3 8.8 3.0 4.5 5.6 13.2 1.5 7.1 2.8 2.5 9.4 6.8 7.0 5.9 9.3 10.0 6.5 115.4 5.8 0.8 0.0 2.8 10.3 4.2 6.5 3.5 2.6 8.1 3.2 8.1 7.4 1.6 129.6 7.2 3.5 5.0 14.4 2.8 2.2 4.1 2.8 4.9 7.7 14.2 12.9 7.2 21.3 17.9 1.1 6.9 33.1 3.3 8.8 SUPT4H1 "Spt4, SPT4H, Supt4a, SUPT4H" ENSG00000213246 "SPT4 homolog, DSIF elongation factor subunit" P63272 17 58345175-58353093 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059748 Approved Nucleoplasm NA NA Nucleoplasm "HPA059748: " "unprognostic (1.32e-1)" "unprognostic (1.04e-2)" "unprognostic (1.69e-1)" "unprognostic (2.43e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-2)" "prognostic unfavorable (7.69e-5)" "unprognostic (6.71e-2)" "unprognostic (7.05e-2)" "unprognostic (2.37e-3)" "unprognostic (1.57e-2)" "unprognostic (9.52e-2)" "unprognostic (1.28e-2)" "unprognostic (1.07e-1)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (2.54e-1)" 33.3 41.5 34.2 29.8 32.0 67.5 37.4 36.0 53.3 35.1 34.9 29.4 23.9 24.3 36.4 32.0 36.2 31.3 27.5 31.7 29.3 26.7 43.1 52.5 29.7 44.5 30.0 27.3 34.8 34.4 25.5 23.1 41.7 33.5 33.0 32.0 33.0 33.5 31.6 37.4 33.7 36.7 30.3 27.9 41.5 30.5 35.1 20.5 44.1 46.2 37.4 35.9 33.4 29.6 17.8 33.2 73.0 41.4 11.9 21.1 41.7 20.8 39.1 20.3 14.4 21.7 18.8 26.7 22.8 23.1 32.1 31.1 11.7 20.2 21.9 40.0 33.4 24.8 12.6 27.0 27.3 39.1 35.3 29.5 32.9 22.7 47.1 20.7 41.5 24.0 26.4 24.4 23.4 22.0 29.5 25.8 25.9 34.8 25.7 25.7 31.1 43.7 29.3 17.5 26.1 32.9 33.5 28.3 21.7 26.6 22.6 17.9 32.2 12.1 10.6 22.8 27.7 28.8 33.1 20.1 27.7 23.6 14.3 28.0 37.4 81.8 30.2 22.8 14.3 18.7 38.3 39.0 46.3 17.4 41.4 17.0 17.8 16.7 18.1 33.2 14.7 13.5 16.3 73.0 11.9 40.4 18.3 21.1 41.7 34.2 32.0 36.0 53.3 29.3 26.7 30.0 27.3 33.5 20.5 11.9 7.8 101.3 56.0 63.4 27.2 35.4 61.1 12.0 4.5 57.6 0.0 120.6 165.8 108.7 26.1 83.9 83.9 46.7 85.3 139.0 71.9 57.7 88.5 94.4 161.8 12.7 65.8 83.4 132.9 30.6 87.8 149.1 104.6 187.6 59.5 85.7 101.4 71.9 88.8 185.1 22.3 38.8 55.1 55.3 44.8 73.1 125.6 97.2 58.1 65.7 SUPT5H "FLJ34157, SPT5, SPT5H" ENSG00000196235 "SPT5 homolog, DSIF elongation factor subunit" O00267 19 39436156-39476670 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029273, CAB034370" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034370: AB_2196394, HPA029273: AB_10603896" "unprognostic (3.96e-2)" "unprognostic (3.51e-1)" "unprognostic (1.32e-2)" "unprognostic (5.53e-3)" "unprognostic (4.19e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (7.00e-5)" "unprognostic (7.30e-2)" "unprognostic (4.35e-1)" "unprognostic (1.68e-2)" "unprognostic (1.94e-2)" "unprognostic (6.42e-2)" "unprognostic (1.37e-3)" "unprognostic (1.74e-1)" "unprognostic (2.68e-1)" "unprognostic (3.32e-1)" "unprognostic (2.38e-1)" 27.7 26.2 39.4 28.9 41.0 64.2 23.5 46.8 50.7 26.2 29.2 34.2 21.0 27.7 33.0 22.3 24.2 26.9 26.7 27.8 34.9 28.6 22.6 28.4 25.5 32.9 28.7 42.3 39.8 34.2 39.3 42.9 26.3 31.3 27.8 21.7 25.7 37.6 27.5 55.9 27.7 29.7 24.4 34.4 30.1 27.9 77.8 37.2 22.2 30.1 17.5 27.9 30.3 31.1 10.8 23.4 25.9 12.2 8.2 8.0 6.9 33.5 54.4 20.1 20.1 19.2 13.5 17.1 29.3 18.6 17.7 19.7 35.5 21.0 40.9 27.7 27.2 14.7 13.2 26.9 19.2 13.9 40.0 26.4 45.8 26.0 21.6 17.5 37.2 31.3 21.5 14.5 22.5 23.2 19.5 16.8 36.2 34.4 21.2 17.4 34.1 27.3 11.3 25.1 28.2 13.8 27.8 29.6 20.8 18.3 55.8 19.1 26.0 34.5 27.6 18.8 17.9 16.8 20.3 35.8 18.0 21.0 22.4 37.3 35.0 56.8 50.4 22.1 21.5 22.1 18.5 12.2 9.6 8.0 6.5 8.0 10.8 5.6 6.5 5.8 8.7 6.4 5.1 25.9 8.2 8.2 23.4 6.0 6.9 39.4 41.0 46.8 50.7 34.9 28.6 28.7 42.3 31.3 37.2 41.7 79.1 45.9 20.1 45.8 45.3 52.6 30.6 68.3 56.9 41.8 80.5 32.5 11.6 31.8 50.0 42.9 54.2 23.3 30.4 37.8 29.7 29.1 44.0 52.8 32.5 46.1 85.6 32.5 25.7 57.1 41.7 36.3 38.8 35.1 48.8 26.7 41.7 38.2 38.9 18.8 55.7 19.4 32.0 67.0 46.5 43.3 45.2 48.4 40.2 24.7 SUPT7L "KIAA0764, SPT7L, STAF65, STAF65gamma" ENSG00000119760 "SPT7 like, STAGA complex gamma subunit" O94864 2 27650812-27663840 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039565, HPA063643" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA039565: AB_10795109, HPA063643: AB_2685070" "unprognostic (1.10e-1)" "unprognostic (1.15e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (7.54e-2)" "unprognostic (3.70e-1)" "prognostic unfavorable (4.46e-7)" "unprognostic (5.15e-2)" "unprognostic (1.43e-3)" "unprognostic (2.27e-2)" "unprognostic (1.97e-3)" "unprognostic (9.75e-3)" "prognostic unfavorable (1.53e-4)" "unprognostic (2.26e-1)" "unprognostic (4.86e-1)" "unprognostic (3.79e-1)" "unprognostic (5.23e-3)" 24.5 27.5 23.5 23.3 39.7 33.9 25.3 38.6 47.6 22.4 21.8 35.6 21.4 25.0 31.4 29.3 20.5 27.3 22.9 31.0 26.6 28.0 25.1 28.5 23.9 27.6 25.8 27.2 33.4 23.9 33.2 39.3 29.6 36.7 26.7 29.0 28.8 19.3 26.0 26.1 18.7 24.8 31.7 23.2 32.5 22.9 19.5 25.9 34.7 29.7 18.4 26.0 21.8 23.1 12.5 17.3 20.2 13.0 18.2 18.1 10.9 18.1 15.8 23.2 17.9 21.3 17.5 27.8 17.7 17.2 16.1 17.4 20.3 20.5 15.9 18.8 18.7 22.7 19.9 20.8 19.7 15.8 18.2 20.1 21.6 22.4 23.0 27.9 17.4 21.3 24.4 24.8 23.8 25.1 29.9 20.8 19.6 24.4 19.2 20.8 12.4 15.0 28.7 15.4 18.2 14.0 14.5 24.8 20.2 20.6 17.1 18.5 24.0 15.9 16.7 29.1 30.9 11.5 15.2 15.9 22.5 16.6 11.2 16.8 34.6 25.1 33.1 17.4 21.7 15.2 20.2 12.4 10.7 16.4 13.0 18.1 9.2 12.8 16.6 17.3 12.5 15.6 14.7 3.3 18.2 11.1 11.6 14.1 10.9 23.5 39.7 38.6 47.6 26.6 28.0 25.8 27.2 36.7 25.9 20.8 17.9 6.7 12.2 7.4 16.9 18.1 12.7 24.1 21.6 21.0 39.3 29.5 18.3 16.2 5.9 16.4 10.5 0.0 12.7 24.6 13.6 9.2 18.5 14.0 21.4 14.3 10.4 14.1 11.5 1.9 12.7 12.4 3.3 14.4 11.5 17.2 14.1 7.0 14.5 15.7 23.9 19.4 14.4 22.4 18.3 7.5 35.4 17.0 12.7 9.5 SUSD1 DKFZP761E1824 ENSG00000106868 "Sushi domain containing 1" Q6UWL2 9 112040785-112175408 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 24.1;monocytes: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 24.9" "Lineage enriched" "Detected in many" 4 "dendritic cells: 24.9" "Cell line enhanced" "Detected in many" "HDLM-2: 22.7;HEL: 25.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048554 Approved Approved Nucleoplasm "Intracellular and membrane" NA NA 530000 Nucleoplasm "HPA048554: AB_2680439" "unprognostic (2.25e-1)" "unprognostic (4.02e-2)" "unprognostic (1.42e-2)" "unprognostic (1.62e-1)" "unprognostic (9.29e-3)" "unprognostic (5.27e-2)" "unprognostic (1.69e-2)" "unprognostic (3.73e-2)" "unprognostic (1.23e-2)" "unprognostic (1.29e-3)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "prognostic favorable (3.63e-6)" "unprognostic (2.14e-3)" "unprognostic (8.38e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" 9.6 13.9 9.1 9.7 13.9 14.1 8.4 3.1 15.3 7.6 10.2 2.7 11.6 8.6 5.7 9.8 4.8 6.7 7.6 11.2 6.1 16.4 15.5 4.4 11.5 15.7 8.3 8.2 3.3 8.1 9.4 8.2 23.3 7.4 5.8 11.4 8.1 10.7 12.8 2.9 3.6 9.9 9.3 5.1 14.5 12.2 5.8 3.5 9.6 5.6 1.4 6.6 13.1 4.6 0.2 24.9 5.8 2.7 1.7 1.6 1.1 1.3 8.5 6.1 0.0 4.5 3.0 19.5 5.4 7.3 7.7 9.9 16.9 11.4 0.1 6.1 9.5 0.5 3.9 2.1 1.0 5.8 22.7 1.8 25.7 6.2 11.4 5.4 6.7 8.3 3.7 0.8 4.3 0.1 5.3 17.9 3.8 13.9 1.1 4.8 1.6 0.9 4.1 2.0 21.0 1.3 5.7 1.4 0.0 1.8 4.5 2.1 5.2 3.0 0.6 0.0 3.5 1.0 7.3 13.6 0.1 2.9 0.8 0.0 0.3 0.3 0.5 5.3 2.6 1.6 3.5 1.4 5.8 1.6 1.6 0.5 0.1 0.4 1.1 1.0 0.2 0.2 1.2 0.5 1.7 2.7 24.9 0.1 1.1 9.1 13.9 3.1 15.3 6.1 16.4 8.3 8.2 7.4 3.5 0.0 4.5 1.5 1.2 0.5 0.0 1.9 2.5 6.7 5.7 12.2 0.0 7.4 0.0 5.6 1.7 2.3 4.7 0.0 6.2 8.8 4.0 1.8 5.7 0.0 14.2 0.0 4.1 10.4 24.1 1.2 0.0 10.8 0.0 18.0 4.5 0.0 8.8 3.5 1.8 1.7 1.6 0.0 3.8 0.3 0.3 0.6 7.2 4.9 5.6 7.3 SYCE2 CESC1 ENSG00000161860 "Synaptonemal complex central element protein 2" Q6PIF2 19 12898786-12919276 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 41.2" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 21.3;Late spermatids: 19.1;Sertoli cells: 25.8;Spermatocytes: 102.1;Spermatogonia: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 4 "NK-cell: 6.3" "Lineage enriched" "Detected in many" 4 "NK-cells: 6.3" "Cell line enhanced" "Detected in many" "EFO-21: 11.7;JURKAT: 10.3;MOLT-4: 10.5;SiHa: 11.5;U-266/70: 12.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA042080, HPA062919" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA042080: AB_10794411, HPA062919: AB_2684905" "unprognostic (3.00e-1)" "prognostic favorable (3.85e-5)" "unprognostic (9.99e-3)" "prognostic unfavorable (9.91e-4)" "unprognostic (1.75e-1)" "unprognostic (3.48e-2)" "unprognostic (2.19e-1)" "unprognostic (1.75e-1)" "unprognostic (1.78e-1)" "unprognostic (8.28e-3)" "unprognostic (1.30e-2)" "unprognostic (8.39e-4)" "unprognostic (1.79e-10)" "unprognostic (7.55e-3)" "unprognostic (9.93e-2)" "unprognostic (1.09e-1)" "unprognostic (7.87e-5)" 0.4 0.4 0.3 0.3 0.4 2.9 0.3 2.0 1.6 0.5 0.4 0.3 0.3 0.2 0.3 0.6 0.3 0.4 0.3 0.3 0.5 0.2 0.3 1.1 0.5 1.0 0.3 0.3 0.8 0.4 0.0 0.4 0.8 0.4 0.6 0.1 0.3 0.6 0.3 0.3 1.1 0.3 0.3 0.4 0.5 0.3 41.2 0.3 2.6 0.4 0.3 0.7 0.5 0.4 0.1 0.2 1.4 0.1 6.3 0.6 0.1 5.6 1.1 2.9 1.8 0.3 0.8 3.2 1.3 0.6 0.8 1.0 0.2 0.8 4.4 11.7 0.8 1.0 1.1 1.0 0.3 0.9 1.6 0.7 1.2 2.5 0.5 0.1 2.8 4.0 0.8 0.2 0.3 0.6 1.4 0.2 10.3 1.1 1.3 0.5 2.3 10.5 1.9 1.9 0.2 3.3 3.2 1.4 1.1 0.5 0.8 2.1 1.4 11.5 0.6 0.6 0.9 2.2 3.0 0.8 0.8 1.5 4.3 0.3 12.1 1.5 4.9 1.0 3.8 5.4 0.0 0.1 1.4 0.2 0.0 0.1 0.0 0.6 0.0 0.2 0.1 0.2 0.4 0.0 6.3 0.0 0.0 0.5 0.1 0.3 0.4 2.0 0.6 0.5 0.2 0.3 0.3 0.4 0.3 0.0 0.0 0.5 0.3 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 21.3 0.1 0.0 0.0 0.3 1.6 0.4 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.6 19.1 2.8 0.0 0.0 0.0 0.0 0.7 0.1 0.0 1.1 0.0 0.2 25.8 0.2 102.1 38.1 0.4 0.2 0.0 0.0 0.1 SYCP2L "C6orf177, dJ62D2.1, NO145" ENSG00000153157 "Synaptonemal complex protein 2 like" Q5T4T6 6 10886831-10979320 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "parathyroid gland: 54.0" "Cell type enhanced" "Detected in some" 10 "Early spermatids: 10.8;granulocytes: 10.4;Spermatogonia: 8.1" "Cancer enhanced" "Detected in single" "testis cancer: 1.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "basophil: 2.9;eosinophil: 5.5;plasmacytoid DC: 7.6" "Group enriched" "Detected in many" 17 "dendritic cells: 7.6;granulocytes: 5.5" "Cell line enhanced" "Detected in some" "HL-60: 9.1;HMC-1: 28.4;K-562: 7.1;NB-4: 9.7;SuSa: 6.0;THP-1: 7.3" HPA034679 Supported Nucleoplasm NA NA Nucleoplasm "HPA034679: AB_10669729" "unprognostic (3.25e-1)" "unprognostic (2.58e-2)" "unprognostic (3.23e-1)" "unprognostic (3.72e-5)" "unprognostic (2.20e-1)" "unprognostic (1.21e-2)" "unprognostic (5.57e-3)" "unprognostic (4.23e-1)" "unprognostic (6.03e-2)" "unprognostic (2.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.04e-1)" "unprognostic (1.21e-3)" "unprognostic (1.07e-2)" "unprognostic (1.86e-1)" "unprognostic (3.85e-2)" "unprognostic (2.74e-2)" 0.9 0.4 0.9 0.8 1.0 0.7 0.7 2.6 1.5 0.5 1.1 0.8 3.7 0.4 1.1 8.9 0.6 0.5 0.7 3.0 0.8 0.7 1.6 0.4 10.1 0.5 1.0 0.5 1.5 5.5 54.0 0.7 4.0 0.6 0.8 0.4 2.9 1.2 0.5 1.9 0.6 0.3 0.5 0.9 0.6 0.4 5.1 0.6 0.7 2.5 0.0 2.2 0.5 0.3 0.0 7.6 5.5 0.3 0.0 0.0 0.0 0.0 0.7 1.4 0.0 0.1 0.0 3.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.1 0.1 4.3 0.0 0.0 0.0 0.0 9.1 28.4 0.0 0.6 0.0 0.0 0.1 0.0 0.3 7.1 0.0 0.0 0.0 2.3 9.7 0.5 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.4 2.5 0.0 2.4 0.0 6.0 0.1 7.3 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.8 2.9 0.1 5.5 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.9 1.0 2.6 1.5 0.8 0.7 1.0 0.5 0.6 0.6 0.0 2.2 0.0 0.0 0.1 2.4 0.3 0.0 1.4 0.0 0.0 0.0 2.1 0.0 0.1 10.8 0.1 0.0 0.0 0.2 1.6 0.3 0.3 10.4 0.0 0.4 3.2 0.0 0.0 0.0 2.3 1.1 0.9 0.0 0.0 0.0 0.5 0.6 0.0 1.4 0.0 0.0 0.0 0.0 3.9 8.1 0.0 1.1 0.0 0.0 0.1 SYN2 "SYNII, SYNIIa, SYNIIb" ENSG00000157152 "Synapsin II" 3 12004402-12191400 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 20 "brain: 72.5" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 14.6;Cone photoreceptor cells: 5.9;Horizontal cells: 12.7;Spermatocytes: 4.9;Spermatogonia: 6.6" "Cancer enhanced" "Detected in many" "glioma: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.5;HEK 293: 3.3;HMC-1: 6.1;NTERA-2: 5.2;SCLC-21H: 4.2;SH-SY5Y: 16.5;SuSa: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037012, CAB079005" Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB079005: , HPA037012: AB_2675431" "unprognostic (1.62e-3)" "unprognostic (1.60e-2)" "unprognostic (7.54e-2)" "unprognostic (9.87e-3)" "unprognostic (1.73e-1)" "unprognostic (3.19e-1)" "unprognostic (6.32e-3)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-4)" "unprognostic (9.94e-2)" "unprognostic (7.35e-2)" "unprognostic (1.78e-2)" 3.7 2.7 28.2 0.7 23.3 0.5 1.4 9.2 72.5 1.0 0.8 0.2 0.0 0.8 1.2 1.2 0.5 0.8 0.7 0.7 15.4 1.4 0.4 0.8 0.5 0.0 33.4 1.5 0.5 1.8 0.0 2.3 15.3 0.7 0.9 0.0 0.9 0.6 0.9 0.9 1.2 1.9 2.2 0.8 1.2 2.4 1.6 0.0 0.5 0.0 0.5 0.5 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 0.7 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 3.5 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 6.1 0.1 0.0 0.1 0.4 0.0 0.5 1.5 0.0 0.4 0.0 0.0 0.0 0.0 5.2 0.1 0.4 0.0 0.0 0.0 0.0 0.2 4.2 16.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.6 1.0 0.0 0.0 0.0 0.0 5.9 1.4 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.5 12.7 0.0 0.0 1.6 1.3 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 2.3 2.6 0.0 0.0 4.9 6.6 0.0 0.7 0.0 0.0 0.1 SYNGAP1 "KIAA1938, RASA5, SYNGAP" ENSG00000197283 "Synaptic Ras GTPase activating protein 1" Q96PV0 6 33419661-33457541 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Autism, Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 21.8;Horizontal cells: 36.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.9" "Group enriched" "Detected in many" 6 "B-cells: 1.5;T-cells: 1.9" "Cell line enhanced" "Detected in many" "AF22: 20.9;HMC-1: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038373 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA038373: AB_10670779" "unprognostic (3.72e-1)" "unprognostic (3.13e-2)" "unprognostic (4.74e-2)" "unprognostic (2.23e-2)" "unprognostic (4.35e-2)" "prognostic favorable (2.80e-4)" "unprognostic (3.66e-2)" "unprognostic (8.65e-2)" "unprognostic (4.02e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-2)" "unprognostic (9.81e-2)" "prognostic unfavorable (1.34e-6)" "unprognostic (9.48e-3)" "unprognostic (1.73e-1)" "unprognostic (1.83e-2)" "unprognostic (2.47e-2)" 4.5 5.0 29.7 11.9 28.6 6.2 4.3 27.2 33.7 7.8 5.9 5.5 2.4 6.0 13.0 5.3 4.2 11.9 6.1 4.4 37.9 7.6 4.0 2.2 5.9 10.3 4.1 38.9 12.8 3.5 10.0 26.1 6.2 7.9 6.3 4.7 3.2 3.7 7.1 2.3 6.2 5.7 11.1 8.7 9.7 4.9 8.7 9.3 8.9 5.6 0.2 7.0 6.9 6.4 1.5 0.1 0.1 0.2 0.0 1.9 0.0 2.0 0.9 20.9 7.7 4.4 4.5 2.7 5.1 3.2 2.8 2.2 8.7 0.9 5.9 1.3 2.4 2.6 3.0 2.6 2.9 2.0 3.4 1.7 14.7 2.3 0.5 2.9 2.2 17.2 3.1 0.9 5.3 2.5 10.8 2.1 4.9 4.6 2.7 2.1 4.4 3.5 3.4 10.5 0.9 2.2 13.8 0.5 2.4 2.1 1.5 5.1 4.1 1.9 3.6 1.6 4.9 7.9 2.1 0.6 6.0 5.9 2.4 0.9 3.2 1.1 4.3 3.4 2.6 1.4 0.0 0.2 0.1 0.3 0.0 0.8 0.1 1.9 0.9 0.0 1.5 0.9 0.2 0.1 0.0 0.1 0.1 0.1 0.0 29.7 28.6 27.2 33.7 37.9 7.6 4.1 38.9 7.9 9.3 0.0 1.3 2.2 1.7 3.2 21.8 1.4 7.6 9.4 4.5 3.5 9.8 0.8 1.7 1.6 4.4 6.2 1.3 0.0 1.2 1.0 8.9 1.5 4.7 0.8 1.6 36.5 9.2 8.6 3.7 1.1 10.6 2.5 3.3 2.8 1.7 5.6 1.7 0.0 12.7 1.9 7.4 19.4 7.8 7.1 6.7 3.8 0.7 12.2 2.8 1.4 TADA3 "ADA3, FLJ20221, FLJ21329, hADA3, NGG1, TADA3L" ENSG00000171148 "Transcriptional adaptor 3" O75528 3 9779860-9793011 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042250 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA042250: AB_10794043" "unprognostic (5.77e-2)" "unprognostic (1.72e-2)" "unprognostic (2.78e-1)" "unprognostic (2.00e-3)" "unprognostic (6.83e-2)" "unprognostic (4.70e-2)" "unprognostic (9.15e-3)" "unprognostic (2.71e-1)" "unprognostic (4.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.47e-2)" "unprognostic (6.56e-2)" "prognostic favorable (5.47e-5)" "unprognostic (1.10e-2)" "unprognostic (2.03e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-3)" 21.9 39.3 37.3 28.1 35.2 22.0 44.2 16.8 43.4 29.7 25.8 23.4 30.6 23.1 29.6 25.5 25.1 35.8 34.2 34.1 33.6 30.3 26.1 34.2 32.1 40.8 29.7 26.2 46.8 21.0 25.8 30.3 18.9 27.5 34.2 21.5 23.0 25.9 34.6 39.0 20.0 24.7 26.1 25.3 25.6 24.9 48.0 21.6 32.7 33.9 22.5 28.5 29.6 27.1 13.3 18.3 46.4 31.2 18.7 23.8 18.1 13.8 14.3 23.3 13.2 21.3 19.6 50.0 13.7 25.7 20.0 25.2 14.8 16.5 15.0 17.3 32.5 25.4 8.3 13.5 19.8 9.2 18.1 14.9 32.8 18.1 15.9 30.4 11.6 55.7 19.9 25.9 28.4 20.7 25.5 13.3 22.3 21.8 18.9 24.5 39.5 11.7 11.3 21.5 18.3 13.8 5.7 11.6 19.2 20.4 13.5 8.8 26.2 12.1 6.6 23.7 13.6 24.5 30.3 18.2 26.7 21.9 13.9 19.7 15.2 16.9 25.6 38.7 21.7 21.1 20.6 15.8 46.4 23.8 24.9 12.1 13.3 17.0 19.4 18.3 12.5 15.2 16.4 20.3 18.7 31.2 11.3 20.7 18.1 37.3 35.2 16.8 43.4 33.6 30.3 29.7 26.2 27.5 21.6 11.9 13.8 35.0 74.0 14.9 28.0 7.5 28.1 6.7 9.1 31.4 13.7 41.7 56.3 55.8 69.5 16.1 57.7 23.3 56.6 44.6 38.5 44.3 47.2 35.9 58.1 23.8 34.1 29.4 41.1 62.8 33.9 37.5 30.4 121.8 57.0 61.9 53.4 59.6 40.3 52.5 22.3 71.1 30.9 64.0 73.4 14.4 30.8 64.3 47.2 48.8 TAF1 "BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250" ENSG00000147133 "TATA-box binding protein associated factor 1" P21675 X 71366239-71532374 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Dystonia, Mental retardation, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 76.6;Erythroid cells: 70.0;Rod photoreceptor cells: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA001075, CAB016283" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB016283: AB_671202, HPA001075: AB_1080179" "unprognostic (2.95e-2)" "unprognostic (1.77e-1)" "unprognostic (6.45e-3)" "unprognostic (1.91e-2)" "unprognostic (1.88e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "prognostic favorable (6.54e-4)" "unprognostic (2.68e-2)" "unprognostic (3.43e-2)" "unprognostic (2.03e-1)" "unprognostic (5.59e-2)" "prognostic unfavorable (6.03e-4)" "unprognostic (1.14e-2)" "unprognostic (1.41e-1)" "unprognostic (1.82e-2)" "unprognostic (2.56e-2)" 20.1 16.2 15.0 17.1 19.8 16.3 17.7 20.7 18.0 20.7 15.5 23.8 17.1 10.0 25.4 17.1 14.4 19.1 16.1 12.9 15.4 12.0 11.9 12.9 13.8 17.8 18.5 16.5 23.9 17.5 25.5 19.3 15.4 17.3 16.9 15.4 20.8 14.5 16.1 19.6 16.8 17.1 18.3 17.2 21.3 15.8 12.2 21.3 19.4 20.1 12.0 18.7 18.4 15.8 5.0 4.7 5.2 4.8 4.2 4.9 1.8 11.4 10.0 11.4 7.7 9.1 15.9 7.1 8.6 8.0 9.0 7.5 7.5 6.9 10.7 7.3 9.5 8.0 10.9 15.9 6.8 11.6 7.1 13.9 12.8 13.1 7.3 6.6 24.2 12.3 9.2 6.9 9.7 18.4 8.1 9.4 8.3 17.3 26.0 9.1 8.1 13.4 10.7 13.1 12.8 13.1 12.3 23.2 13.1 6.1 14.9 6.1 9.4 23.9 8.4 10.5 9.4 6.1 12.9 11.8 10.7 9.0 8.6 5.9 11.2 10.3 13.8 5.9 19.5 7.9 4.4 4.1 1.1 4.4 2.8 3.8 3.0 4.6 4.5 4.7 5.0 4.4 4.9 5.2 4.2 4.8 3.5 3.1 1.8 15.0 19.8 20.7 18.0 15.4 12.0 18.5 16.5 17.3 21.3 29.8 25.3 10.9 8.1 10.5 33.8 14.8 5.1 13.4 34.2 3.5 76.6 6.7 1.7 5.1 2.0 23.9 8.4 70.0 6.0 4.9 10.4 8.4 22.0 12.1 7.7 15.9 10.9 19.0 15.4 1.8 20.4 17.0 5.0 6.4 15.4 18.7 6.4 14.0 20.8 3.6 71.6 0.0 14.2 6.0 8.9 15.2 4.8 13.8 14.6 7.6 TAF10 "TAF2A, TAF2H, TAFII30" ENSG00000166337 "TATA-box binding protein associated factor 10" Q12962 11 6606296-6612667 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 282.6;Late spermatids: 670.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004148, CAB022405" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022405: , HPA004148: AB_1857736" "unprognostic (1.69e-3)" "unprognostic (2.32e-1)" "unprognostic (3.19e-2)" "unprognostic (6.21e-3)" "unprognostic (9.10e-2)" "unprognostic (6.99e-2)" "unprognostic (5.24e-3)" "unprognostic (9.03e-3)" "unprognostic (1.12e-1)" "unprognostic (1.24e-2)" "unprognostic (3.46e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.38e-1)" "unprognostic (2.55e-1)" "unprognostic (9.64e-3)" "unprognostic (3.80e-3)" 23.4 33.7 30.7 25.4 25.6 40.1 28.4 8.8 30.9 21.5 28.8 26.9 28.5 21.9 23.8 53.4 32.6 20.8 32.4 26.9 28.4 22.5 35.6 63.1 28.4 47.2 26.4 15.4 25.7 46.4 26.5 30.5 31.3 17.5 24.3 28.5 18.2 43.6 30.5 46.0 15.7 30.1 20.2 26.0 44.1 24.7 44.2 14.8 55.7 37.6 29.5 37.5 21.8 19.0 9.0 18.5 21.8 11.7 6.1 8.7 3.1 21.8 38.1 23.9 21.0 40.1 39.3 19.2 17.0 37.5 27.7 27.9 27.8 39.6 12.0 22.7 30.3 38.5 18.4 17.3 27.2 27.5 25.2 26.4 17.2 26.1 33.1 65.4 22.7 27.6 45.2 34.8 21.7 45.9 46.9 30.6 37.3 17.7 21.9 43.7 43.1 32.3 20.9 17.3 35.1 29.9 19.0 12.9 21.2 44.6 29.4 17.3 23.6 23.0 26.4 28.5 37.5 18.5 27.0 17.3 18.4 22.3 26.4 23.7 26.7 17.6 19.3 30.6 11.5 29.8 7.9 7.6 8.1 7.6 11.7 7.1 7.8 7.6 8.7 8.2 9.0 7.1 6.1 21.8 6.1 11.5 18.5 8.3 3.1 30.7 25.6 8.8 30.9 28.4 22.5 26.4 15.4 17.5 14.8 3.0 21.8 29.7 47.7 19.1 22.4 42.5 50.9 14.7 14.8 34.9 19.6 41.7 16.6 14.3 282.6 31.3 65.1 0.0 28.5 42.2 26.2 74.6 4.7 49.7 58.2 22.3 33.4 26.4 63.3 670.6 22.7 40.5 25.3 17.2 46.5 43.6 28.8 53.5 18.0 35.3 22.6 0.0 16.7 58.2 30.0 25.5 44.9 44.0 34.8 73.2 TAF15 "hTAFII68, Npl3, RBP56, TAF2N" ENSG00000270647 "TATA-box binding protein associated factor 15" Q92804 17 35713791-35864615 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052059, HPA063647" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052059: AB_2681711, HPA063647: AB_2685072" "unprognostic (1.26e-1)" "unprognostic (2.66e-3)" "unprognostic (1.10e-1)" "unprognostic (1.63e-2)" "unprognostic (1.82e-1)" "unprognostic (1.27e-1)" "unprognostic (8.48e-3)" "unprognostic (4.75e-2)" "unprognostic (8.06e-3)" "unprognostic (2.08e-2)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (1.79e-2)" "unprognostic (1.39e-2)" "unprognostic (5.41e-2)" "unprognostic (3.35e-2)" "unprognostic (2.99e-1)" 14.0 12.9 12.7 15.3 16.2 13.9 11.0 13.7 14.1 10.5 11.7 15.0 13.2 12.7 10.2 11.0 12.6 8.0 11.5 13.1 11.8 9.8 15.0 8.9 19.4 14.7 8.3 10.7 11.3 14.6 18.1 11.1 11.1 11.4 10.1 9.2 9.8 15.3 26.9 14.7 13.4 17.5 15.9 12.7 11.0 11.3 15.5 21.1 9.4 12.8 15.8 12.0 9.8 3.7 3.2 3.8 3.6 4.7 7.2 2.2 29.2 48.1 25.7 24.9 20.6 11.7 16.9 33.4 11.4 15.3 15.0 32.2 21.2 58.2 24.1 21.6 18.3 31.1 34.1 33.7 22.0 16.4 44.7 33.5 34.9 33.7 20.4 54.0 22.5 18.6 17.7 23.1 36.3 17.7 20.6 36.2 31.4 24.1 17.2 34.9 58.8 13.1 15.9 27.3 13.8 35.1 38.3 21.8 19.3 52.6 19.5 19.2 41.6 12.6 13.2 31.4 29.5 18.6 27.7 11.8 25.8 16.9 40.1 22.8 27.8 42.4 23.3 26.7 19.3 3.8 3.5 3.5 4.9 3.4 7.2 3.0 3.5 3.8 2.5 3.7 3.3 3.7 2.0 4.7 3.6 3.2 3.9 2.2 14.9 50.3 37.4 49.0 32.1 54.1 35.5 43.3 50.9 64.8 57.6 39.3 72.7 3.3 35.9 4.6 49.6 37.7 46.7 25.7 39.3 25.9 36.3 54.3 53.9 37.4 57.2 47.1 33.2 42.9 8.9 28.4 36.7 32.1 34.3 49.4 55.6 28.8 28.1 38.2 26.6 42.8 45.3 31.9 60.1 72.8 32.5 65.2 42.4 50.6 42.6 TAF1A "SL1, TAFI48" ENSG00000143498 "TATA-box binding protein associated factor, RNA polymerase I subunit A" Q15573 1 222557902-222589933 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054334 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA054334: AB_2682453" "unprognostic (3.01e-1)" "prognostic unfavorable (9.26e-6)" "unprognostic (7.98e-2)" "unprognostic (9.59e-3)" "unprognostic (1.22e-1)" "unprognostic (8.98e-3)" "unprognostic (3.88e-3)" "unprognostic (3.10e-3)" "unprognostic (4.79e-2)" "unprognostic (2.93e-1)" "unprognostic (3.86e-3)" "unprognostic (2.25e-1)" "unprognostic (2.41e-4)" "unprognostic (8.43e-2)" "unprognostic (1.76e-1)" "unprognostic (2.35e-3)" "unprognostic (9.06e-2)" 7.3 6.9 5.5 8.6 8.2 4.8 6.4 7.6 8.1 7.3 4.7 8.2 5.0 4.8 8.0 6.1 5.9 6.4 5.5 5.6 4.3 6.7 4.2 6.3 5.5 11.5 7.3 3.8 13.7 5.3 5.3 16.9 8.4 8.0 6.6 5.2 6.4 5.5 5.6 2.8 4.1 6.1 6.5 8.9 8.3 6.5 11.7 8.0 6.4 10.0 3.3 10.2 7.4 7.0 10.5 7.1 2.7 3.3 4.0 6.7 2.4 8.4 4.6 12.4 4.3 4.3 3.8 11.0 5.7 4.4 6.9 8.5 4.8 9.3 7.7 11.2 2.0 5.5 8.5 8.2 3.5 9.8 5.0 6.2 4.6 3.7 4.6 4.9 11.1 2.1 2.0 3.8 7.7 9.8 3.3 2.8 5.4 14.0 3.5 9.4 3.1 12.9 7.8 25.0 9.7 13.2 8.0 24.8 7.4 2.9 4.5 7.0 14.8 8.7 5.1 6.0 6.6 2.9 5.6 3.7 7.0 7.0 12.3 14.1 4.3 3.9 10.0 6.2 7.1 9.2 1.5 2.1 2.7 4.6 3.3 6.7 7.3 4.1 4.2 2.0 10.5 4.9 6.0 0.4 4.0 3.2 7.1 3.4 2.4 5.5 8.2 7.6 8.1 4.3 6.7 7.3 3.8 8.0 8.0 0.0 0.6 2.2 5.2 7.6 9.1 1.4 2.5 1.4 1.2 3.5 5.9 6.6 1.7 2.7 1.2 1.5 1.2 0.0 0.6 5.7 6.8 3.7 1.1 2.1 3.9 6.4 1.2 1.8 4.5 0.4 5.2 2.8 0.0 1.8 1.8 3.1 1.1 1.9 2.1 1.3 7.3 6.5 3.1 7.7 10.2 2.5 4.9 3.2 2.8 7.8 TAF4 "TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135" ENSG00000130699 "TATA-box binding protein associated factor 4" O00268 20 61953469-62065810 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008599, CAB031484" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB031484: AB_671207, HPA008599: AB_1080183" "unprognostic (3.38e-2)" "unprognostic (1.21e-2)" "unprognostic (1.38e-1)" "unprognostic (6.29e-2)" "unprognostic (3.14e-1)" "unprognostic (9.67e-2)" "prognostic unfavorable (3.31e-4)" "unprognostic (2.16e-1)" "unprognostic (1.91e-1)" "unprognostic (2.74e-1)" "unprognostic (3.34e-1)" "unprognostic (1.00e-3)" "unprognostic (4.39e-3)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (3.92e-2)" "unprognostic (9.99e-2)" 7.7 11.4 8.5 7.8 9.5 9.8 6.2 16.5 9.6 8.9 9.8 8.5 4.2 10.1 8.5 3.8 7.6 7.0 7.0 4.9 7.7 4.5 6.6 8.9 6.2 7.1 9.6 6.0 16.7 12.4 4.3 6.4 6.8 6.4 6.8 4.6 6.4 6.6 7.6 13.2 7.7 10.4 6.8 5.8 9.7 10.9 17.9 8.7 16.5 6.8 4.3 5.8 7.7 9.9 0.1 0.2 2.7 0.6 0.0 1.4 0.2 5.6 5.3 3.2 3.6 1.5 1.1 6.4 2.8 1.2 4.7 2.5 17.6 4.7 4.6 7.2 1.5 3.5 7.3 2.8 3.3 2.0 3.9 4.1 10.5 5.8 8.1 1.6 5.0 9.5 0.8 3.0 2.1 2.2 1.3 1.8 5.7 8.5 4.1 0.8 6.0 14.0 6.1 4.7 4.0 7.5 13.0 7.3 4.8 1.5 5.2 5.4 4.7 8.5 9.1 2.9 2.4 5.5 6.1 2.3 6.0 8.8 6.0 5.1 5.7 5.3 7.2 3.5 3.0 4.1 0.0 0.6 0.7 0.1 0.2 0.0 0.0 0.3 0.4 0.2 0.1 0.3 0.5 2.7 0.0 0.1 0.1 1.4 0.2 8.5 9.5 16.5 9.6 7.7 4.5 9.6 6.0 6.4 8.7 6.0 16.0 5.6 2.8 6.8 6.2 6.7 5.1 8.1 3.4 5.2 2.0 5.1 0.0 5.1 12.7 4.5 6.8 0.0 3.3 4.2 5.9 5.8 1.1 10.0 4.9 14.3 3.5 5.5 10.7 4.2 8.6 6.1 3.3 1.8 10.9 3.9 5.0 10.5 9.9 4.7 8.6 6.5 8.1 8.9 12.5 8.4 7.0 3.8 9.5 5.6 TAF5 "TAF2D, TAFII100" ENSG00000148835 "TATA-box binding protein associated factor 5" Q15542 10 103367967-103389065 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 25.5" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 27.4;Spermatogonia: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006195, HPA006474" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA006195: AB_1080188, HPA006474: AB_1080185" "unprognostic (3.09e-2)" "unprognostic (2.44e-3)" "unprognostic (2.95e-1)" "unprognostic (3.18e-3)" "unprognostic (3.59e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (5.36e-3)" "unprognostic (2.21e-1)" "unprognostic (1.18e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (1.36e-9)" "prognostic favorable (7.39e-5)" "unprognostic (2.79e-2)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" 5.3 3.6 4.0 5.8 5.9 7.9 6.3 13.8 7.7 5.3 5.8 3.8 3.7 5.5 5.2 3.5 5.0 4.1 3.2 3.4 5.2 3.5 3.5 5.0 3.9 7.6 3.8 3.9 6.1 7.9 3.4 7.5 6.6 6.3 4.2 6.1 2.1 4.4 4.5 5.5 4.7 4.7 4.4 5.4 6.2 4.3 25.5 5.6 14.0 4.4 2.5 7.9 4.1 7.3 3.2 1.3 2.5 1.8 1.1 3.4 0.6 6.7 3.1 7.7 13.9 4.4 3.6 9.0 4.8 5.5 7.0 8.8 6.1 3.5 16.1 2.8 2.5 4.0 6.8 12.9 2.6 8.9 5.9 11.2 7.4 3.6 6.0 2.0 14.2 8.0 1.6 1.9 4.1 4.4 2.9 5.2 7.2 10.5 8.1 4.6 4.4 11.5 18.7 9.4 8.6 4.1 9.8 9.4 4.9 1.9 2.0 5.4 6.0 3.1 2.3 2.8 7.7 2.7 5.9 3.0 4.1 5.2 4.6 8.5 4.6 5.5 9.9 2.3 17.0 2.6 0.6 1.8 2.5 1.5 0.6 1.3 0.4 1.4 2.8 1.0 3.2 3.4 2.0 0.3 1.1 1.1 1.3 3.4 0.6 4.0 5.9 13.8 7.7 5.2 3.5 3.8 3.9 6.3 5.6 6.0 1.6 8.0 4.6 12.8 6.2 2.4 2.5 0.0 3.4 1.8 5.9 3.9 3.3 2.3 13.3 3.6 2.6 0.0 1.9 7.3 3.8 2.9 9.2 2.6 3.2 1.6 2.4 1.8 1.5 10.2 1.7 4.5 1.7 1.0 2.4 1.8 1.6 2.9 2.5 0.6 6.6 0.0 6.9 27.4 43.6 12.4 5.7 5.0 3.3 2.7 TAF6L PAF65A ENSG00000162227 "TATA-box binding protein associated factor 6 like" Q9Y6J9 11 62771303-62787342 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067239 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA067239: AB_2685809" "unprognostic (5.41e-2)" "unprognostic (1.37e-1)" "unprognostic (3.23e-1)" "unprognostic (1.46e-2)" "unprognostic (1.35e-1)" "prognostic favorable (8.98e-5)" "unprognostic (1.03e-1)" "unprognostic (2.47e-1)" "unprognostic (9.37e-2)" "unprognostic (2.83e-3)" "unprognostic (5.45e-3)" "unprognostic (9.65e-2)" "unprognostic (4.38e-2)" "unprognostic (1.63e-3)" "unprognostic (1.04e-1)" "unprognostic (3.66e-1)" "unprognostic (2.61e-3)" 10.7 11.0 9.3 10.0 13.1 8.8 14.0 8.7 14.5 10.4 11.2 13.2 7.0 11.6 12.6 11.8 8.7 9.8 9.0 7.8 8.7 9.1 11.9 19.5 7.2 8.5 12.1 13.1 11.7 13.5 12.4 14.1 12.1 9.6 9.9 6.0 13.8 10.0 9.8 20.6 18.4 8.5 8.8 7.6 12.4 8.6 5.9 10.5 9.8 13.8 8.4 8.1 9.7 7.4 3.1 3.4 3.3 2.7 3.4 3.5 0.8 8.4 7.9 11.3 8.9 5.0 4.2 9.5 6.7 4.9 8.2 6.4 4.7 9.6 11.3 14.9 5.1 7.4 11.1 7.7 7.3 2.5 15.2 16.7 6.0 9.3 7.7 7.1 7.4 11.0 5.6 5.4 6.5 4.3 4.3 6.7 12.2 12.4 8.5 5.1 16.5 11.0 21.5 11.8 4.0 11.4 13.7 7.6 14.5 5.5 5.8 12.1 11.7 6.9 7.3 10.8 5.0 13.0 5.5 6.5 8.2 10.5 13.2 7.8 9.1 15.2 12.8 7.3 5.7 7.6 2.7 2.7 3.3 2.2 2.7 2.5 3.1 1.7 1.7 3.2 2.9 3.5 2.3 0.7 3.4 1.1 3.4 1.3 0.8 9.3 13.1 8.7 14.5 8.7 9.1 12.1 13.1 9.6 10.5 3.0 4.8 7.5 4.0 5.5 7.3 2.4 15.3 4.0 1.2 1.8 0.0 12.6 13.3 4.6 4.6 4.3 8.6 23.3 2.7 7.3 3.9 3.3 0.0 10.5 8.4 3.2 5.1 5.5 8.2 3.2 4.9 6.7 8.5 2.8 6.7 8.7 3.5 7.0 4.6 15.4 5.4 0.0 5.8 1.5 10.0 5.5 16.2 6.9 7.5 3.5 TAF8 "FLJ32821, TAF(II)43, TBN" ENSG00000137413 "TATA-box binding protein associated factor 8" Q7Z7C8 6 42050513-42087461 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031730, HPA031731, HPA031734" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031730: AB_2674016, HPA031731: AB_2674017, HPA031734: AB_10603994" "unprognostic (7.41e-2)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.46e-3)" "unprognostic (3.08e-1)" "unprognostic (2.23e-2)" "unprognostic (2.46e-1)" "unprognostic (3.53e-1)" "unprognostic (2.01e-3)" "unprognostic (6.74e-2)" "unprognostic (8.22e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-2)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (2.42e-2)" "unprognostic (2.26e-2)" 24.7 17.4 11.9 17.1 13.2 25.5 17.4 9.6 15.1 15.6 19.0 15.2 21.4 14.9 16.1 17.6 15.6 11.4 12.1 22.8 11.5 9.9 18.7 14.1 16.2 19.9 15.0 13.2 13.8 14.0 22.3 12.3 19.1 12.4 15.6 13.3 16.4 16.4 19.6 25.5 12.8 14.1 14.7 12.2 20.6 17.2 18.9 12.2 36.0 24.3 11.2 20.1 16.7 15.6 15.4 19.8 19.7 24.6 8.4 13.2 7.3 9.5 10.5 8.7 9.7 9.8 9.1 8.0 4.5 7.8 11.9 12.4 17.9 5.8 14.7 9.7 6.5 12.2 7.2 14.1 9.5 9.3 12.7 13.6 18.5 12.6 8.8 12.1 10.7 13.6 12.4 7.6 8.5 10.8 6.0 13.2 18.3 22.8 15.5 6.6 12.7 9.8 16.3 5.4 25.5 4.9 20.2 10.3 11.2 10.5 7.9 9.0 8.0 8.2 6.4 9.1 7.5 9.7 13.2 12.3 10.7 11.2 4.9 9.1 13.5 13.1 31.1 4.9 11.9 6.0 13.4 12.1 19.7 13.2 12.8 9.3 14.1 12.0 10.3 13.0 15.4 12.5 12.1 15.2 8.4 24.6 19.8 10.1 7.3 11.9 13.2 9.6 15.1 11.5 9.9 15.0 13.2 12.4 12.2 17.9 22.6 10.4 11.0 6.3 15.6 24.5 15.3 9.4 19.4 10.4 29.5 19.6 26.6 8.9 8.2 15.8 9.2 0.0 8.4 6.8 10.4 12.4 18.5 7.4 11.5 20.6 8.6 7.4 14.2 13.8 13.8 10.9 6.8 12.6 11.1 11.7 7.4 7.0 11.0 12.9 23.1 12.9 10.8 7.9 14.5 7.3 18.0 12.8 9.0 11.5 TAF9 "AD-004, CGI-137, MGC1603, MGC3647, MGC5067, TAF2G, TAFII31, TAFII32, TAFIID32" ENSG00000273841 "TATA-box binding protein associated factor 9" Q16594 5 69364743-69370013 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 444.4;Late spermatids: 626.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028930, HPA053429, HPA058961, HPA072658" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028930: AB_2672832, HPA053429: AB_2682148, HPA058961: AB_2683863, HPA072658: " "unprognostic (1.25e-3)" "unprognostic (9.52e-2)" "unprognostic (1.76e-3)" "unprognostic (8.38e-3)" "unprognostic (5.40e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (1.48e-5)" "unprognostic (1.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.66e-1)" "unprognostic (9.45e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (9.20e-4)" "unprognostic (2.58e-1)" "unprognostic (1.97e-1)" "unprognostic (3.02e-2)" "unprognostic (1.79e-1)" 11.3 7.2 6.8 5.5 8.4 16.6 8.8 6.5 9.5 6.7 8.0 4.0 6.3 6.3 5.9 10.0 10.9 5.1 5.7 9.2 5.6 11.5 18.0 6.5 8.2 6.8 6.2 7.3 7.4 4.4 10.8 8.6 9.4 7.1 9.1 4.4 5.2 5.2 11.0 5.3 9.7 6.9 5.7 8.7 6.1 30.1 6.8 10.2 9.8 9.8 9.8 7.8 5.0 24.9 21.8 29.8 28.8 14.9 25.0 31.2 16.9 17.8 11.4 19.1 18.2 23.9 29.8 16.9 25.4 28.4 38.0 18.9 20.8 23.0 12.7 24.2 53.7 12.5 15.2 33.9 37.3 10.4 18.8 18.8 29.7 23.8 44.5 18.5 27.3 28.2 22.5 19.6 44.0 19.9 22.9 21.0 18.8 18.4 26.7 23.3 20.9 29.0 13.6 6.4 14.0 13.6 18.9 26.0 24.1 18.6 18.9 13.5 16.0 9.8 29.2 19.8 15.5 27.3 16.0 11.0 16.8 11.7 27.8 17.1 20.5 28.9 16.1 22.5 12.6 28.4 28.8 29.8 14.9 26.1 22.4 24.9 22.2 18.3 21.8 19.7 25.0 21.4 4.5 14.9 20.6 13.5 23.2 31.2 17.9 30.6 51.1 138.1 154.5 21.2 61.3 43.3 33.5 31.8 22.7 13.7 101.8 76.3 62.8 444.4 55.3 36.5 23.3 69.7 133.9 64.7 69.2 37.0 41.2 94.4 19.1 29.6 34.4 40.6 626.5 60.4 60.8 94.5 53.3 53.5 24.2 76.7 31.6 32.2 66.6 33.1 32.3 93.7 328.5 65.8 142.7 87.4 36.2 61.0 135.9 TAF9B "DN-7, DN7, TAF9L, TAFII31L, TFIID-31" ENSG00000187325 "TATA-box binding protein associated factor 9b" Q9HBM6 X 78129748-78139706 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045275, HPA058961" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045275: AB_10962831, HPA058961: AB_2683863" "unprognostic (3.62e-3)" "prognostic favorable (5.40e-5)" "unprognostic (1.91e-1)" "unprognostic (1.78e-1)" "unprognostic (4.20e-2)" "unprognostic (6.43e-2)" "unprognostic (1.02e-1)" "unprognostic (5.67e-2)" "unprognostic (3.46e-2)" "unprognostic (2.37e-3)" "unprognostic (5.68e-2)" "unprognostic (9.56e-2)" "unprognostic (8.42e-3)" "unprognostic (8.71e-2)" "unprognostic (9.34e-3)" "unprognostic (9.47e-2)" "unprognostic (2.62e-1)" 15.5 12.4 25.6 10.3 23.5 10.7 16.6 20.1 27.5 21.5 15.5 20.2 9.9 6.9 24.8 15.6 20.2 17.4 14.2 23.6 21.6 23.0 19.2 14.4 11.5 11.0 21.2 22.1 17.7 11.6 24.4 19.6 13.6 21.3 21.5 10.9 12.9 10.5 19.2 20.7 12.8 9.3 31.9 23.9 10.6 14.0 10.7 19.2 15.9 20.0 11.3 10.9 22.4 12.4 4.5 4.9 1.4 3.3 10.3 13.3 7.2 10.9 9.5 23.5 10.3 9.2 9.4 3.5 9.8 9.1 16.0 8.9 13.2 19.0 12.6 14.1 10.6 13.0 8.7 35.0 8.1 16.7 19.5 12.2 6.8 13.5 12.1 9.2 10.8 7.6 12.0 4.3 17.5 12.1 10.1 9.6 12.6 14.0 27.2 14.1 16.6 16.9 8.4 27.6 14.4 17.9 14.7 30.6 11.5 10.8 22.2 15.0 14.9 27.3 11.9 10.6 12.8 19.2 7.8 10.2 12.4 18.9 13.5 11.8 11.7 23.7 9.3 21.5 21.8 17.3 0.6 3.1 0.9 5.5 3.3 10.2 4.5 12.5 9.5 4.0 4.4 12.8 9.4 1.4 10.3 2.4 4.9 13.3 7.2 25.6 23.5 20.1 27.5 21.6 23.0 21.2 22.1 21.3 19.2 8.9 5.6 4.7 19.7 13.9 13.5 23.0 5.1 2.7 6.8 19.2 7.9 14.7 6.6 5.9 0.8 15.3 0.9 0.0 7.4 13.7 11.2 13.8 2.3 5.5 5.9 7.9 12.1 13.5 3.8 1.1 9.8 5.0 21.9 9.0 4.4 22.1 3.7 3.4 13.1 13.6 9.0 19.4 22.8 2.9 30.4 7.8 7.1 6.5 3.5 8.6 TAL1 "bHLHa17, SCL, TCL5" ENSG00000162367 "TAL bHLH transcription factor 1, erythroid differentiation factor" P17542 1 47216290-47232220 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 33.1" "Cell type enhanced" "Detected in some" 22 "Endothelial cells: 18.0;Erythroid cells: 93.5;granulocytes: 35.8;Ito cells: 30.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.2;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "HEL: 52.8;HMC-1: 25.4;HUVEC TERT2: 11.0;JURKAT: 21.1;K-562: 16.5;TIME: 12.0" "Region enriched" "Detected in some" 5 "midbrain: 17.1" "Low region specificity" "Detected in many" "CAB017805, HPA047866, HPA073983" Approved Enhanced Nucleoplasm Yes NA Nucleoplasm "CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246" "unprognostic (2.63e-1)" "unprognostic (2.62e-2)" "unprognostic (1.22e-1)" "unprognostic (2.40e-2)" "unprognostic (1.59e-1)" "unprognostic (8.80e-3)" "unprognostic (3.95e-3)" "unprognostic (1.33e-1)" "unprognostic (4.15e-2)" "unprognostic (1.99e-2)" "unprognostic (5.42e-3)" "unprognostic (3.68e-1)" "unprognostic (1.02e-2)" "unprognostic (2.76e-2)" "unprognostic (2.19e-1)" "unprognostic (1.51e-1)" "unprognostic (1.18e-2)" 9.1 2.7 7.0 1.8 5.7 33.1 7.1 1.6 6.9 3.3 2.4 12.0 2.3 1.6 3.7 3.3 2.5 4.1 4.2 3.9 8.8 3.5 4.5 2.4 14.6 2.2 11.1 4.4 1.5 1.3 2.2 2.1 9.8 7.3 2.4 2.4 2.1 1.4 3.0 3.1 2.0 3.3 4.4 9.4 8.5 2.1 1.8 9.2 0.0 6.7 4.1 1.5 2.5 5.5 0.3 0.1 3.2 0.3 0.4 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 52.8 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 11.0 21.1 16.5 0.0 0.0 0.0 8.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.3 0.4 0.1 1.2 0.4 0.1 0.1 0.1 2.2 7.0 5.7 1.6 6.9 8.8 3.5 11.1 4.4 7.3 9.2 0.0 0.0 0.0 0.0 0.8 0.0 1.7 2.5 0.0 2.3 1.8 0.0 0.1 0.0 0.0 4.8 18.0 0.0 93.5 0.0 0.1 0.9 0.0 35.8 0.0 7.9 0.0 0.0 30.7 2.1 10.2 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.4 0.9 0.0 0.0 0.0 0.0 TARDBP "ALS10, TDP-43" ENSG00000120948 "TAR DNA binding protein" Q13148 1 11012344-11026420 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003703, HPA017284" Supported Enhanced Nucleoplasm NA Yes 13000 Nucleoplasm "CAB003703: AB_425904, HPA017284: AB_1857775" "unprognostic (3.72e-3)" "prognostic favorable (1.15e-5)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (8.52e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.20e-7)" "unprognostic (1.06e-1)" "unprognostic (3.41e-3)" "unprognostic (4.75e-3)" "unprognostic (2.24e-1)" "unprognostic (2.54e-2)" "unprognostic (2.27e-3)" "unprognostic (2.27e-1)" "unprognostic (1.87e-1)" "unprognostic (2.86e-1)" "unprognostic (2.71e-2)" 36.1 38.1 52.3 43.3 62.9 31.7 42.8 86.2 61.8 38.7 39.8 47.6 37.5 39.8 45.8 47.2 47.8 37.9 32.4 40.8 49.5 36.7 39.3 48.3 40.2 52.8 59.0 45.2 53.0 39.1 60.2 68.1 44.2 46.5 43.3 52.9 38.4 41.7 45.3 57.1 43.0 43.4 50.5 44.7 46.1 38.1 34.5 62.6 52.2 46.7 38.0 63.5 38.1 47.9 29.4 31.7 16.5 24.8 33.6 31.1 17.0 52.6 36.2 62.1 31.8 33.7 28.4 36.7 36.2 32.0 59.6 44.6 42.7 38.9 70.2 26.6 40.2 35.0 37.8 75.2 42.1 78.6 37.6 36.3 53.2 60.1 56.7 27.6 63.7 35.4 23.1 47.9 41.8 34.3 33.5 42.2 27.7 68.3 39.6 50.4 42.5 46.6 51.7 49.5 50.5 32.4 55.3 49.8 44.6 42.9 39.0 42.4 35.0 49.3 39.1 27.9 47.4 39.1 45.0 38.5 40.0 47.0 32.9 52.0 29.6 36.5 74.3 26.2 64.1 42.4 16.3 19.6 16.5 25.4 24.8 31.1 29.4 26.0 24.6 31.7 21.2 25.9 27.7 7.9 33.6 23.6 22.2 26.8 17.0 52.3 62.9 86.2 61.8 49.5 36.7 59.0 45.2 46.5 62.6 29.8 67.3 58.2 67.5 101.8 36.2 65.0 33.1 64.3 60.3 27.9 27.5 55.0 28.2 39.9 5.6 56.1 37.9 46.7 47.0 69.3 45.5 61.8 39.5 45.1 43.8 35.0 63.7 35.6 47.5 7.8 43.7 40.0 33.7 38.7 45.1 35.8 42.4 31.6 48.4 33.2 37.8 32.3 50.6 50.2 31.1 100.1 61.4 41.7 47.8 60.0 TATDN1 CDA11 ENSG00000147687 "TatD DNase domain containing 1" Q6P1N9 8 124488485-124539458 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023634, HPA053045" Uncertain Supported Nucleoplasm NA NA 2000000 Nucleoplasm "HPA023634: AB_1857779, HPA053045: AB_2682024" "unprognostic (2.19e-3)" "unprognostic (3.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.87e-2)" "unprognostic (1.65e-1)" "unprognostic (1.23e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (1.56e-1)" "unprognostic (1.45e-2)" "prognostic unfavorable (2.53e-4)" "unprognostic (2.50e-1)" "unprognostic (6.33e-3)" "unprognostic (3.44e-2)" "unprognostic (4.30e-2)" "unprognostic (2.24e-1)" "unprognostic (5.12e-2)" 16.6 14.1 16.1 13.0 18.6 9.9 27.4 22.7 18.8 14.9 14.4 11.7 9.9 12.3 16.7 15.3 15.5 16.8 10.1 16.4 14.9 14.4 19.4 17.1 16.3 14.7 22.7 17.0 28.9 34.7 13.2 18.4 10.5 19.4 13.8 16.0 8.1 18.6 11.1 40.4 14.0 11.9 16.9 21.2 8.2 16.3 8.3 18.3 15.1 26.2 14.5 13.3 15.2 13.3 10.5 10.0 13.7 7.2 11.1 18.1 8.9 20.0 14.2 13.6 9.5 12.3 23.3 10.3 11.0 12.2 14.1 13.1 13.9 22.0 15.3 25.0 12.1 10.9 16.6 16.4 16.4 23.4 19.5 10.9 14.1 11.8 12.0 23.4 10.7 5.3 17.4 26.2 20.5 43.4 15.7 11.2 15.0 11.5 10.0 18.7 61.0 16.0 6.7 13.6 41.2 18.4 10.7 10.1 17.1 19.8 14.2 11.4 16.0 12.3 25.1 25.9 13.3 16.8 11.6 8.7 10.0 26.6 18.3 30.0 12.9 19.6 19.2 18.8 19.1 8.6 13.7 7.2 2.8 8.2 6.0 12.7 10.5 12.5 10.1 10.0 10.4 18.1 16.6 1.5 11.1 4.5 7.5 12.9 8.9 16.1 18.6 22.7 18.8 14.9 14.4 22.7 17.0 19.4 18.3 14.9 21.9 35.0 84.7 57.6 17.6 15.3 28.1 22.7 30.7 26.2 13.7 55.3 91.2 43.0 5.1 28.0 20.7 23.3 53.6 54.4 44.2 63.1 19.7 35.5 48.7 15.9 15.5 22.1 39.4 4.7 46.1 38.8 45.5 49.5 34.9 18.4 41.4 24.6 32.5 91.6 17.1 19.4 47.2 30.9 37.3 50.8 49.9 35.5 57.5 61.6 TBKBP1 "KIAA0775, ProSAPiP2" ENSG00000198933 "TBK1 binding protein 1" A7MCY6 17 47694081-47712050 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 13.0;Horizontal cells: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Group enriched" "Detected in many" 5 "granulocytes: 5.7;NK-cells: 2.2;T-cells: 2.8" "Cell line enhanced" "Detected in many" "CACO-2: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062347, HPA064856" Approved Approved Nucleoplasm NA Yes Nucleoplasm "HPA062347: AB_2684744, HPA064856: AB_2685371" "unprognostic (2.14e-3)" "unprognostic (1.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.92e-2)" "unprognostic (2.39e-1)" "unprognostic (3.09e-2)" "unprognostic (3.72e-1)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (3.24e-1)" "prognostic favorable (8.14e-6)" "unprognostic (5.83e-2)" "unprognostic (1.14e-1)" "unprognostic (3.03e-1)" "unprognostic (4.22e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.59e-5)" 12.6 7.8 16.1 8.7 8.4 5.6 6.0 13.5 20.1 11.2 7.3 3.9 5.4 3.1 9.7 5.9 10.9 6.7 7.8 12.2 16.3 14.6 6.3 3.2 7.8 5.3 11.2 15.2 17.9 15.0 9.2 6.4 9.2 8.0 7.4 2.4 12.2 18.2 9.8 30.1 4.6 3.6 12.1 4.2 11.0 5.4 8.5 2.8 2.8 9.1 6.5 6.7 8.0 9.6 0.6 0.5 5.7 0.5 2.2 2.8 0.3 0.2 5.2 9.7 10.3 5.0 5.1 6.3 5.3 5.5 2.6 3.1 32.5 0.8 0.1 5.3 6.5 4.7 0.6 7.6 1.3 1.5 6.3 17.1 13.7 4.6 5.4 11.6 2.6 3.0 10.2 3.5 0.6 0.9 8.2 9.1 3.8 11.8 0.0 1.4 1.4 1.6 12.8 13.5 0.2 3.7 6.1 3.0 5.4 3.3 0.4 8.5 15.8 2.5 0.6 2.7 9.6 5.8 5.9 10.5 8.1 9.6 9.7 0.6 3.6 0.3 6.4 4.7 4.9 2.0 0.0 0.5 0.9 2.8 0.2 1.5 0.0 0.7 2.0 0.5 0.6 0.3 1.0 5.7 2.2 0.0 0.5 0.5 0.3 16.1 8.4 13.5 17.9 16.3 14.6 11.2 15.2 8.0 2.8 0.0 1.4 0.5 3.3 3.5 13.0 2.8 0.0 0.0 1.2 3.5 2.0 0.1 1.7 0.9 5.9 5.2 0.0 0.0 1.5 0.1 3.7 4.7 0.0 1.1 2.7 27.0 5.1 9.8 3.3 4.1 8.1 1.7 1.7 1.0 0.1 4.1 1.1 0.0 8.1 3.7 3.5 0.0 4.2 4.4 5.1 2.6 0.2 1.5 0.0 1.7 TBL1XR1 "C21, DC42, FLJ12894, IRA1, TBLR1" ENSG00000177565 "Transducin beta like 1 X-linked receptor 1" Q9BZK7 3 177019340-177228000 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 71.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019182 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA019182: AB_1857800" "unprognostic (4.11e-2)" "unprognostic (3.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.27e-3)" "prognostic favorable (5.16e-5)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.08e-7)" "unprognostic (3.75e-1)" "unprognostic (4.84e-2)" "unprognostic (3.04e-1)" "unprognostic (3.13e-3)" "unprognostic (2.50e-1)" "prognostic unfavorable (4.25e-5)" "unprognostic (5.83e-2)" "unprognostic (1.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" 20.7 26.0 27.4 24.3 26.8 27.3 20.3 27.5 28.1 28.9 29.9 22.6 15.4 24.0 23.9 20.5 23.8 21.9 22.7 30.3 26.2 20.7 19.9 21.8 30.8 27.8 21.4 25.9 26.5 19.9 30.6 11.3 24.0 19.7 24.4 23.2 24.7 21.3 17.7 21.1 17.8 24.3 21.9 19.6 24.7 21.3 17.4 22.3 28.4 45.6 14.9 32.1 29.1 25.5 7.4 13.3 12.9 4.6 6.8 8.3 4.1 23.9 12.3 16.0 9.0 13.6 14.8 9.6 7.6 11.8 6.6 9.1 14.1 19.9 24.6 35.9 10.9 17.5 14.8 11.9 15.8 13.3 25.8 3.7 13.8 21.0 8.4 11.7 21.9 8.2 21.8 8.2 9.7 24.1 13.0 10.3 17.3 10.3 43.6 8.5 8.6 20.4 3.0 10.1 15.4 8.3 11.7 20.4 26.2 5.9 34.0 5.8 9.2 10.2 8.0 9.5 10.5 29.3 16.8 15.7 10.8 9.1 6.0 16.4 23.8 30.5 71.1 7.3 16.4 12.3 11.4 3.0 3.8 5.8 4.6 5.1 7.3 5.7 6.6 4.0 7.4 5.0 6.4 12.9 6.8 3.9 13.3 8.3 4.1 27.4 26.8 27.5 28.1 26.2 20.7 21.4 25.9 19.7 22.3 68.5 47.1 43.4 46.9 81.4 116.0 84.2 48.4 61.6 62.6 99.5 117.8 22.3 24.9 43.8 5.7 62.9 42.8 23.3 37.3 28.5 65.8 123.0 24.3 58.7 32.8 109.7 81.9 55.9 85.4 5.2 59.2 54.6 62.4 31.5 74.5 41.8 53.4 23.0 68.6 46.2 81.2 45.3 41.5 8.4 53.9 97.7 23.0 49.8 75.7 61.8 TBL1Y TBL1 ENSG00000092377 "Transducin beta like 1 Y-linked" Q9BQ87 Y 6910686-7091683 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 15.1;thyroid gland: 10.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "prostate cancer: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "MAIT T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enriched" "Detected in some" 6 "U-698: 14.5" "HPA050857, HPA060073" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA050857: , HPA060073: AB_2684196" "unprognostic (2.81e-3)" "unprognostic (2.94e-1)" "unprognostic (3.06e-1)" "unprognostic (7.76e-2)" "unprognostic (1.17e-2)" "unprognostic (1.28e-1)" "unprognostic (2.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.24e-2)" 1.0 0.0 0.1 0.2 0.5 0.1 1.0 0.1 0.4 0.0 0.4 0.5 0.0 0.2 0.1 1.5 1.3 0.1 3.8 0.1 0.1 0.2 1.4 3.3 3.0 0.8 0.1 0.0 0.1 15.1 0.0 0.1 0.3 0.7 7.2 0.4 1.6 5.8 0.7 1.3 0.6 0.3 0.1 0.0 0.1 0.7 3.5 0.0 0.1 10.8 2.9 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 2.2 0.0 2.4 1.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.4 0.1 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.0 TBP "GTF2D1, SCA17, TFIID" ENSG00000112592 "TATA-box binding protein" P20226 6 170554302-170572870 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 53.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009442, HPA049805" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009442: AB_632480, HPA049805: AB_2680890" "unprognostic (2.86e-3)" "unprognostic (1.73e-2)" "unprognostic (3.90e-2)" "unprognostic (4.55e-3)" "unprognostic (7.10e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (1.51e-7)" "unprognostic (1.46e-1)" "unprognostic (4.28e-1)" "unprognostic (1.17e-2)" "unprognostic (1.06e-2)" "unprognostic (1.34e-2)" "unprognostic (1.54e-2)" "unprognostic (8.13e-2)" "unprognostic (2.62e-1)" "unprognostic (3.70e-2)" "unprognostic (3.05e-1)" 11.9 12.3 10.2 14.9 15.8 18.4 13.1 18.1 19.3 13.9 12.7 17.5 15.2 11.4 16.1 12.1 13.3 14.0 11.7 11.5 10.3 10.5 12.3 12.4 11.8 16.8 11.5 13.8 17.3 14.0 10.1 13.2 20.0 18.0 13.1 12.1 14.4 13.7 15.5 14.5 14.5 14.7 13.9 11.7 17.7 13.2 51.4 9.9 15.7 13.7 11.7 15.9 13.1 13.1 32.0 26.3 30.8 25.6 19.6 31.9 12.4 7.4 8.4 14.8 18.5 7.9 8.8 13.8 12.3 9.0 11.8 12.3 16.6 7.5 15.5 9.7 9.6 16.7 11.2 18.9 9.9 13.2 17.9 13.0 16.2 9.6 14.4 10.7 18.3 14.0 8.8 11.3 13.9 15.7 9.4 9.0 21.1 27.7 9.8 10.5 11.8 18.8 18.5 15.1 14.7 6.4 16.5 12.0 13.6 8.9 4.0 6.1 14.3 14.3 10.7 9.5 12.8 7.6 23.5 10.4 8.3 11.9 13.6 18.4 14.7 19.7 25.0 11.3 15.8 13.2 30.8 19.9 23.5 25.0 19.4 28.9 30.9 24.3 25.1 18.5 32.0 31.9 26.6 28.6 19.6 25.6 26.3 22.0 12.4 10.2 15.8 18.1 19.3 10.3 10.5 11.5 13.8 18.0 9.9 8.9 8.6 8.3 4.8 4.8 7.5 8.3 15.3 4.0 9.1 12.2 7.9 13.8 3.3 6.2 14.2 8.7 6.2 0.0 4.0 10.9 7.2 7.0 1.1 7.3 9.0 0.0 6.9 13.5 15.6 3.2 10.0 5.1 1.7 4.6 7.4 6.6 5.4 8.4 9.9 5.8 6.4 12.9 5.7 53.3 16.6 5.8 11.3 6.4 7.5 5.3 TBRG1 "FLJ14621, NIAM, TB-5" ENSG00000154144 "Transforming growth factor beta regulator 1" Q3YBR2 11 124622836-124635398 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055645, HPA068022" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055645: AB_2682873, HPA068022: AB_2685942" "unprognostic (1.64e-2)" "unprognostic (3.24e-2)" "unprognostic (7.81e-2)" "unprognostic (1.37e-2)" "unprognostic (9.21e-2)" "unprognostic (3.66e-1)" "unprognostic (1.03e-1)" "unprognostic (4.58e-2)" "unprognostic (1.18e-3)" "unprognostic (1.52e-1)" "unprognostic (7.40e-2)" "unprognostic (3.72e-3)" "unprognostic (1.78e-1)" "unprognostic (1.70e-1)" "unprognostic (1.22e-1)" "unprognostic (3.83e-1)" "unprognostic (7.13e-3)" 13.3 16.0 13.8 15.9 24.8 7.9 9.8 10.3 33.1 9.2 10.9 13.6 8.0 18.7 10.2 14.4 11.0 8.8 11.8 8.7 12.8 9.3 12.9 17.5 14.0 17.1 15.3 18.0 9.4 17.2 11.4 12.7 12.2 15.8 12.9 15.3 8.3 12.1 10.7 18.9 16.0 17.3 9.5 12.2 19.0 15.2 7.4 16.5 7.6 13.4 6.6 16.3 10.8 9.3 24.2 17.7 25.5 19.5 11.1 22.6 9.3 4.9 4.1 4.7 4.2 8.6 6.4 4.4 9.6 5.9 3.2 3.4 7.0 4.1 6.2 5.9 6.6 7.7 8.5 5.5 7.1 5.5 4.3 5.1 24.1 2.1 5.6 7.7 11.5 23.1 6.5 12.7 4.4 6.4 4.9 5.3 6.6 9.2 6.2 7.8 2.5 4.9 9.5 5.8 12.2 6.4 3.2 5.7 3.6 5.6 5.3 3.2 4.9 4.3 6.0 5.7 4.7 9.1 6.8 10.0 8.4 2.7 5.3 5.6 4.7 5.4 6.8 4.4 11.0 5.4 20.5 19.5 25.5 20.4 17.6 15.6 22.5 20.9 17.3 11.5 24.2 22.6 18.0 24.9 11.1 15.5 17.7 19.5 9.3 13.8 24.8 10.3 33.1 12.8 9.3 15.3 18.0 15.8 16.5 41.7 50.4 29.8 40.9 41.0 19.1 20.6 35.7 34.8 46.6 22.7 11.8 28.8 44.7 33.4 41.8 42.9 45.1 23.3 41.6 24.3 42.1 68.1 68.3 58.7 32.8 28.6 27.2 28.3 39.1 4.3 35.1 58.3 32.1 33.3 38.1 26.2 46.7 42.1 31.5 48.0 18.7 25.8 39.2 28.1 22.3 42.0 40.4 49.6 30.4 63.5 TBX18 ENSG00000112837 "T-box 18" O95935 6 84687351-84764519 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 23.3" "Cell type enhanced" "Detected in some" 16 "Basal keratinocytes: 4.8;Fibroblasts: 5.3;Melanocytes: 8.5;Smooth muscle cells: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 26.5;ASC diff: 19.3;ASC TERT1: 20.2;RH-30: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006807 Supported Nucleoplasm NA NA Nucleoplasm "HPA006807: " "unprognostic (8.04e-2)" "unprognostic (7.06e-3)" "unprognostic (9.71e-2)" "unprognostic (2.31e-1)" "unprognostic (4.00e-1)" "unprognostic (1.62e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-1)" "unprognostic (2.57e-1)" "unprognostic (7.92e-2)" "unprognostic (3.50e-1)" "unprognostic (1.12e-1)" "unprognostic (1.88e-14)" "unprognostic (4.81e-5)" "unprognostic (1.86e-1)" "unprognostic (3.07e-3)" "unprognostic (1.78e-1)" 14.5 4.9 1.7 2.1 4.0 0.3 16.1 1.8 3.6 4.4 1.9 4.1 0.5 0.5 2.4 2.1 7.3 2.7 3.6 9.9 3.4 1.8 1.0 0.8 0.7 3.9 6.3 5.5 5.0 1.4 1.3 2.6 4.1 5.0 4.9 1.3 8.9 3.9 2.9 2.5 8.0 2.7 11.1 4.0 0.3 1.0 2.5 1.8 0.0 2.8 2.0 3.0 7.6 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 19.3 20.2 0.0 10.9 5.4 8.3 8.0 0.1 0.0 0.0 0.0 4.5 0.0 1.4 0.0 6.4 6.8 0.0 10.8 0.0 0.0 0.0 2.5 0.0 11.0 8.3 0.6 5.7 12.3 0.0 9.5 0.0 13.7 0.1 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.1 0.0 0.1 0.5 0.0 0.4 4.2 0.7 0.0 14.3 8.4 0.0 2.3 8.4 0.0 0.1 0.0 0.0 5.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.0 1.8 3.6 3.4 1.8 6.3 5.5 5.0 1.8 0.0 0.0 0.0 0.0 4.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 2.6 1.1 0.0 8.5 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 16.7 0.3 1.9 3.9 0.1 0.0 0.0 0.0 TBX5 HOS ENSG00000089225 "T-box 5" Q99593 12 114353931-114408442 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Atrial fibrillation, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 44.5;lung: 14.0;placenta: 19.7" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 62.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hippocampal formation: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 13.1;BJ hTERT+: 29.2;BJ hTERT+ SV40 Large T+: 6.8;BJ hTERT+ SV40 Large T+ RasG12V: 8.3;HAP1: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008786, HPA064683" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008786: AB_10601720, HPA064683: AB_2685320" "unprognostic (3.09e-2)" "unprognostic (1.53e-1)" "unprognostic (3.79e-2)" "unprognostic (2.75e-1)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (8.67e-2)" "unprognostic (3.36e-7)" "unprognostic (2.29e-2)" "unprognostic (1.68e-2)" "unprognostic (7.34e-2)" "unprognostic (4.38e-3)" 2.2 0.1 0.1 0.0 0.1 0.0 3.8 0.8 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.1 6.4 0.1 0.0 44.5 2.2 0.1 0.1 0.1 14.0 1.6 0.1 0.1 0.1 0.1 0.0 0.1 19.7 0.5 5.4 0.0 1.4 0.1 0.0 0.1 0.5 0.1 6.6 0.2 0.1 0.1 0.1 0.0 0.0 1.0 0.0 0.0 6.5 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.1 29.2 6.8 8.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 11.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.2 2.2 0.1 0.1 0.1 0.5 0.0 0.0 1.1 0.0 0.0 0.1 3.6 62.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 TBX6 ENSG00000149922 "T-box 6" O95947 16 30085793-30091887 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.8;lymphoid tissue: 16.3;pancreas: 19.8" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 7.9;Sertoli cells: 6.5;Urothelial cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 9.9;U-266/70: 10.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA062498 Approved Nucleoplasm NA NA Nucleoplasm "HPA062498: AB_2732686" "unprognostic (2.47e-1)" "unprognostic (1.32e-3)" "unprognostic (5.62e-5)" "unprognostic (1.49e-1)" "unprognostic (4.76e-2)" "unprognostic (2.35e-2)" "unprognostic (3.35e-1)" "unprognostic (5.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.29e-1)" "unprognostic (1.77e-2)" "unprognostic (3.87e-1)" "unprognostic (2.76e-2)" "unprognostic (2.95e-1)" "unprognostic (4.21e-2)" "unprognostic (5.05e-3)" "unprognostic (4.26e-2)" 1.2 1.4 1.4 1.0 1.5 0.6 0.9 0.9 1.5 2.7 1.2 0.9 0.9 1.8 0.9 1.0 22.8 1.6 1.3 0.9 1.5 1.0 1.8 1.2 1.2 1.2 1.7 0.9 1.9 19.8 3.2 2.3 0.9 2.1 3.2 0.3 2.3 3.9 2.2 2.8 5.0 1.7 0.9 1.5 1.8 7.8 2.4 1.2 1.6 2.3 5.1 16.3 5.5 8.6 4.4 1.3 3.3 2.6 1.3 1.9 1.1 0.9 1.1 0.6 1.1 1.5 0.8 0.8 0.3 0.2 0.0 0.2 1.3 4.3 1.9 2.3 0.2 0.2 1.3 0.5 0.9 0.0 1.4 0.8 1.2 1.7 0.9 1.1 0.2 2.6 0.3 1.2 0.3 0.5 0.9 0.6 4.2 0.1 4.3 0.1 3.6 0.7 0.5 0.9 5.9 0.9 2.8 0.1 3.1 0.0 9.9 1.4 2.0 0.2 0.9 1.2 0.5 1.8 1.7 0.5 1.2 0.7 0.6 0.0 10.4 2.4 0.3 1.2 1.8 0.4 3.1 2.6 0.8 1.8 2.3 1.2 1.3 0.9 1.3 1.3 4.4 1.9 1.7 3.3 1.3 0.8 1.1 1.8 1.1 1.4 1.5 0.9 1.4 1.5 1.0 1.7 0.9 2.1 1.2 0.0 1.1 0.8 2.9 1.0 1.4 0.4 0.0 1.4 0.0 1.8 7.9 1.4 0.0 0.7 0.0 1.4 0.7 0.0 1.0 0.6 0.6 2.9 0.0 0.2 0.5 0.0 0.0 0.6 1.0 0.0 0.9 1.0 0.0 0.0 0.9 1.9 2.1 1.4 1.1 0.4 3.1 6.5 0.1 1.7 2.3 0.9 1.9 0.0 0.7 6.4 TBXT T ENSG00000164458 "T-box transcription factor T" O15178 6 166157656-166168700 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 12.2;pituitary gland: 5.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 22 "testis cancer: 6.2" "Region enhanced" "Detected in single" "pons and medulla: 3.0" "Group enriched" "Detected in some" 24 "naive B-cell: 2.3;NK-cell: 2.5" "Group enriched" "Detected in many" 24 "B-cells: 2.3;NK-cells: 2.5" "Cell line enriched" "Detected in some" 4 "HeLa: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA003322 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA003322: AB_1080176" "unprognostic (5.68e-2)" "unprognostic (4.59e-2)" "unprognostic (6.21e-3)" "unprognostic (8.64e-3)" "unprognostic (9.34e-3)" 0.3 0.0 0.1 2.0 0.0 0.0 0.1 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 12.2 5.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.4 0.0 1.9 0.0 0.0 1.2 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 18.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.5 0.9 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCEAL1 "p21, pp21, SIIR, WEX9" ENSG00000172465 "Transcription elongation factor A like 1" Q15170 X 103628704-103630953 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Leydig cells: 262.6;Peritubular cells: 364.5;Sertoli cells: 148.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057345, HPA060384, HPA076762" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA057345: , HPA060384: AB_2732648, HPA076762: " "unprognostic (1.98e-2)" "unprognostic (2.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-1)" "unprognostic (5.30e-2)" "unprognostic (1.38e-1)" "unprognostic (5.60e-3)" "unprognostic (6.09e-2)" "unprognostic (2.03e-2)" "unprognostic (9.85e-3)" "unprognostic (6.54e-2)" "unprognostic (4.80e-2)" "unprognostic (2.62e-1)" "unprognostic (2.56e-1)" "unprognostic (5.56e-2)" "unprognostic (8.76e-2)" 10.5 24.7 23.8 9.1 20.8 4.2 19.5 19.9 45.1 29.6 17.1 5.5 29.7 7.3 45.8 20.2 18.4 32.1 17.6 13.5 27.0 18.6 10.6 7.5 10.1 7.8 12.2 25.3 59.1 9.0 13.5 11.2 8.5 19.9 25.4 8.4 6.1 6.4 40.3 22.4 8.1 8.7 49.2 23.5 9.3 13.3 9.3 13.2 3.1 15.5 10.5 4.7 33.9 24.7 18.3 16.6 11.3 8.4 13.4 14.7 8.2 9.5 9.2 5.2 7.2 22.7 15.7 7.0 13.6 13.7 13.3 14.5 4.0 9.5 4.4 14.1 17.5 20.2 9.6 8.7 7.2 9.9 0.0 10.8 6.0 12.9 7.8 10.2 0.0 9.1 19.2 14.0 10.2 5.7 22.1 13.6 5.1 2.2 2.5 26.6 10.5 5.2 0.1 1.7 8.5 15.0 5.4 16.9 0.0 18.3 9.5 7.2 6.1 13.8 6.6 14.9 4.0 6.1 5.6 10.8 9.7 3.5 22.6 6.9 2.5 7.9 0.1 12.7 0.0 9.6 11.3 8.4 0.5 10.4 5.7 14.7 18.3 9.4 8.6 16.6 16.1 12.5 14.3 0.9 13.4 2.3 13.0 8.0 8.2 23.8 20.8 19.9 45.1 27.0 18.6 12.2 25.3 19.9 13.2 14.9 24.5 11.9 44.6 26.4 19.2 25.8 30.6 56.2 44.3 24.4 2.0 27.4 48.0 19.4 1.6 35.2 7.3 0.0 21.7 28.5 38.1 16.0 25.5 17.1 30.3 20.6 26.5 36.8 17.8 4.2 262.6 22.6 18.6 24.4 13.1 29.3 11.5 18.2 364.5 39.9 12.0 148.8 69.3 3.9 7.5 18.6 6.1 17.1 18.1 10.2 TCEAL3 "MGC15737, WEX8" ENSG00000196507 "Transcription elongation factor A like 3" Q969E4 X 103607451-103629690 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 240.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045564, HPA058982" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (2.55e-1)" "unprognostic (2.64e-1)" "unprognostic (2.20e-2)" "unprognostic (1.46e-1)" "unprognostic (1.61e-1)" "unprognostic (1.58e-2)" "unprognostic (2.41e-1)" "prognostic favorable (4.05e-4)" "unprognostic (2.26e-1)" "prognostic favorable (8.33e-4)" "unprognostic (6.35e-3)" "unprognostic (2.30e-1)" "unprognostic (2.22e-3)" "unprognostic (7.19e-3)" "unprognostic (1.79e-1)" "unprognostic (1.53e-1)" "unprognostic (2.64e-1)" 14.8 36.9 36.8 11.0 34.2 9.9 18.3 30.2 47.4 35.0 15.5 24.9 33.7 9.3 42.8 24.9 17.8 27.4 17.9 21.0 33.7 40.7 16.0 5.1 12.5 7.3 43.4 29.1 49.8 22.6 28.3 35.2 13.5 40.3 45.5 7.9 11.9 21.9 55.4 9.7 8.0 8.9 48.3 44.0 18.5 14.5 15.2 23.6 0.8 17.7 4.0 6.4 44.3 23.0 9.6 9.7 4.5 6.9 14.7 12.2 5.3 24.3 2.6 6.6 5.4 23.1 11.8 0.2 36.6 17.3 16.5 22.1 0.0 2.4 0.0 4.5 26.2 29.5 9.6 4.7 14.2 12.1 0.0 1.2 1.8 10.4 0.0 22.2 0.0 8.1 15.2 4.4 11.7 16.7 23.5 11.2 8.5 0.0 7.1 22.4 20.3 1.1 0.1 2.9 0.0 7.0 8.5 4.2 0.1 7.8 4.8 10.2 8.3 1.6 2.1 8.4 3.4 10.0 5.6 14.6 8.7 4.5 17.7 11.2 7.6 3.5 0.0 21.5 0.0 19.0 4.5 6.9 3.8 11.1 3.5 12.2 7.3 9.7 8.8 7.6 9.6 9.7 11.8 1.1 14.7 0.3 9.7 12.2 5.3 36.8 34.2 30.2 31.1 33.7 40.7 43.4 29.1 40.3 23.6 14.9 45.8 12.7 75.4 23.0 50.9 40.8 28.1 71.0 45.5 71.5 17.7 2.8 121.0 35.9 2.5 42.8 1.5 0.0 34.1 1.9 50.3 86.9 94.6 3.4 51.9 17.5 41.8 54.6 26.4 9.3 145.6 40.9 15.1 39.7 22.5 116.7 22.7 8.6 240.8 25.8 28.7 25.8 47.6 2.1 1.5 14.8 2.3 16.0 4.4 34.1 TCEAL5 WEX4 ENSG00000204065 "Transcription elongation factor A like 5" Q5H9L2 X 103273691-103276872 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.4;testis: 45.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 41.1;Muller glia cells: 64.8;Peritubular cells: 33.6" "Cancer enhanced" "Detected in many" "glioma: 13.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 7.5;SH-SY5Y: 23.4" "HPA045564, HPA058982" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (1.30e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (9.09e-4)" "unprognostic (9.68e-2)" "unprognostic (8.75e-4)" "unprognostic (1.21e-1)" "unprognostic (8.11e-2)" "prognostic favorable (8.60e-4)" "unprognostic (1.28e-2)" "unprognostic (1.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.74e-1)" "unprognostic (6.30e-2)" "unprognostic (6.03e-4)" 2.0 11.2 21.9 2.1 31.8 1.3 3.3 32.7 56.4 4.7 2.2 6.6 0.0 1.9 6.0 7.8 1.5 1.6 2.0 2.0 22.3 23.1 1.5 1.3 1.5 1.3 13.0 24.0 5.0 2.1 1.3 23.1 1.3 19.8 3.7 2.0 1.4 2.3 5.4 1.4 1.3 2.4 4.3 11.0 1.3 1.5 45.9 8.4 0.0 3.4 0.0 1.3 2.1 1.1 0.7 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.0 0.2 0.0 0.1 0.0 0.0 21.9 31.8 32.7 31.9 22.3 23.1 13.0 24.0 19.8 8.4 0.0 0.0 0.0 0.3 0.1 41.1 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.6 0.4 0.0 0.0 0.0 0.3 0.6 0.2 0.0 0.0 0.2 1.6 0.0 0.0 0.0 11.5 7.8 0.6 0.0 0.0 0.0 64.8 0.0 0.0 33.6 0.0 5.6 0.0 0.9 2.8 1.7 0.3 0.3 0.0 0.0 0.1 TCEAL6 WEX2 ENSG00000204071 "Transcription elongation factor A like 6" Q6IPX3 X 102140476-102142970 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 14.3;brain: 48.4;pituitary gland: 20.7;testis: 21.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 30.0;Horizontal cells: 14.3" "Cancer enriched" "Detected in single" 9 "glioma: 3.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 1.1;SCLC-21H: 2.0" "HPA045564, HPA058982" Supported Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (5.43e-2)" "unprognostic (6.54e-2)" "unprognostic (1.87e-3)" "unprognostic (6.69e-3)" "unprognostic (1.39e-1)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (3.89e-2)" "unprognostic (1.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.33e-2)" "unprognostic (1.18e-1)" 1.1 14.3 16.6 1.3 15.2 1.0 1.1 31.4 48.4 1.2 1.4 2.5 0.0 1.3 5.3 2.8 1.1 3.2 1.1 1.1 11.3 26.0 1.2 1.0 1.0 1.0 15.2 7.5 6.1 1.3 1.1 20.7 1.0 12.5 1.9 1.3 2.0 3.1 1.9 1.0 1.0 1.3 1.9 7.5 1.0 1.0 21.9 2.8 0.0 1.8 0.0 1.0 1.0 1.7 0.7 0.6 0.1 0.5 1.3 0.7 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.0 0.0 0.7 0.0 0.3 0.1 0.5 0.1 0.5 0.3 0.7 0.4 0.2 0.3 0.5 0.7 0.4 0.6 0.0 1.3 0.0 0.6 0.6 0.6 16.6 15.2 31.4 26.0 11.3 26.0 15.2 7.5 12.5 2.8 0.0 0.0 0.0 0.2 0.1 30.0 4.0 0.0 0.0 0.0 3.5 2.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 14.3 0.0 0.0 0.0 2.6 2.3 0.0 1.7 0.0 0.0 2.0 0.7 0.0 0.7 0.0 4.3 0.0 1.9 1.1 0.8 0.3 0.0 0.0 0.0 0.0 TCEAL7 "MGC23947, WEX5" ENSG00000182916 "Transcription elongation factor A like 7" Q9BRU2 X 103330196-103332326 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 70.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 34.8;Horizontal cells: 46.1;Leydig cells: 40.6;Muller glia cells: 77.7;Peritubular cells: 36.7;Smooth muscle cells: 31.7" "Cancer enriched" "Detected in many" 10 "glioma: 39.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.3" "Lineage enhanced" "Detected in single" "NK-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 23.0;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;GAMG: 31.8;hTEC/SVTERT24-B: 23.0;SCLC-21H: 58.2;U-87 MG: 21.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051507, HPA065080" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA051507: AB_2681512, HPA065080: AB_2685419" "unprognostic (1.09e-2)" "unprognostic (4.36e-2)" "unprognostic (5.54e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (4.52e-2)" "unprognostic (2.17e-1)" "unprognostic (2.23e-1)" "unprognostic (3.26e-2)" "unprognostic (1.12e-1)" "unprognostic (4.18e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (4.31e-4)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.62e-1)" "unprognostic (2.28e-2)" "unprognostic (1.35e-3)" 4.9 22.1 31.7 3.8 33.4 1.0 7.8 33.0 70.4 16.8 6.4 20.1 1.8 3.9 36.4 14.7 5.1 5.4 9.7 9.5 31.1 44.2 4.6 2.6 3.8 2.5 34.4 27.4 23.2 1.3 1.3 14.0 2.5 51.8 10.3 6.9 2.0 2.9 11.3 2.9 1.5 4.9 23.3 45.1 5.0 2.6 3.2 19.4 0.0 3.0 2.2 1.9 7.5 5.7 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 23.0 0.0 10.1 15.6 4.1 3.2 16.9 7.2 20.7 0.0 0.0 0.0 0.0 3.4 31.8 0.0 0.0 0.4 12.5 0.0 0.2 0.1 0.0 0.0 5.1 0.0 0.0 13.1 0.0 23.0 0.0 0.0 7.5 0.0 0.1 0.0 19.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.6 0.0 0.0 0.0 58.2 15.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 10.7 0.4 0.1 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 31.7 33.4 33.0 46.7 31.1 44.2 34.4 27.4 51.8 19.4 0.0 2.2 0.0 5.2 2.3 34.8 14.1 0.0 0.0 1.2 3.5 3.9 1.2 5.0 0.2 0.2 1.9 0.0 0.0 0.0 0.3 6.1 0.9 0.0 0.0 0.5 46.1 0.0 2.5 0.0 1.4 40.6 0.8 8.5 0.0 0.0 77.7 0.5 0.0 36.7 1.0 10.2 12.9 31.7 3.1 0.9 2.8 0.2 0.0 0.0 0.9 TCEAL8 "MGC45400, WEX3" ENSG00000180964 "Transcription elongation factor A like 8" Q8IYN2 X 103252995-103255203 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059115 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059115: AB_2683909" "unprognostic (1.51e-2)" "unprognostic (4.56e-2)" "unprognostic (9.24e-2)" "unprognostic (7.13e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (8.53e-6)" "unprognostic (3.71e-3)" "unprognostic (1.88e-2)" "unprognostic (5.52e-2)" "unprognostic (4.80e-3)" "unprognostic (4.03e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-2)" "unprognostic (3.26e-2)" "unprognostic (7.22e-2)" "unprognostic (9.12e-2)" "unprognostic (9.32e-2)" 24.6 30.9 37.3 16.8 32.5 12.4 30.0 34.5 38.5 34.8 25.1 25.6 25.8 14.9 29.6 67.9 26.7 22.7 27.9 43.9 33.4 32.4 33.9 20.2 20.8 20.6 34.5 25.8 36.7 25.0 32.2 64.5 32.9 39.4 31.6 24.7 26.0 29.7 28.6 8.8 19.8 19.9 31.1 34.6 24.3 21.5 21.0 22.5 30.7 35.2 18.8 20.9 31.7 22.4 17.5 28.7 16.3 9.4 33.3 30.3 15.2 9.7 5.1 23.6 11.3 34.9 59.0 11.4 20.3 31.6 18.3 29.8 4.0 20.3 4.8 13.6 24.1 30.3 6.7 4.0 24.5 24.3 0.1 12.7 22.1 7.0 6.1 21.9 22.1 22.8 40.1 14.7 16.3 0.0 39.5 26.1 14.1 27.2 5.3 46.0 0.0 18.5 9.3 26.3 0.7 10.8 7.6 31.5 1.5 26.2 7.6 12.5 16.6 11.2 3.9 26.3 22.9 7.2 7.8 16.4 11.8 15.2 35.1 6.8 5.3 8.8 0.2 19.1 12.2 18.9 16.3 9.4 5.5 19.7 8.2 23.5 17.5 23.9 21.2 16.9 14.8 26.5 22.8 0.9 33.3 6.2 28.7 30.3 15.2 37.3 32.5 34.5 38.5 33.4 32.4 34.5 25.8 39.4 22.5 47.6 65.5 63.1 70.6 54.0 53.1 66.3 114.7 38.8 45.5 92.5 9.8 163.9 232.1 105.5 3.9 69.9 39.3 23.3 96.4 155.7 110.9 59.3 67.1 92.3 87.5 47.7 75.3 154.1 81.0 6.2 116.5 69.4 114.7 83.8 113.8 74.4 76.7 52.6 114.5 208.3 30.0 84.1 75.7 3.7 4.0 51.9 112.8 60.9 77.5 59.9 TCERG1 "CA150, TAF2S, Urn1" ENSG00000113649 "Transcription elongation regulator 1" O14776 5 146447311-146511961 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064854, HPA069752, HPA069808" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064854: AB_2685370, HPA069752: AB_2686190, HPA069808: AB_2686204" "unprognostic (2.73e-1)" "unprognostic (5.11e-2)" "unprognostic (1.27e-3)" "unprognostic (8.58e-2)" "unprognostic (1.32e-1)" "unprognostic (9.32e-2)" "prognostic unfavorable (5.34e-5)" "unprognostic (1.07e-1)" "unprognostic (3.38e-2)" "unprognostic (2.13e-2)" "unprognostic (2.41e-1)" "unprognostic (1.35e-3)" "prognostic unfavorable (4.70e-11)" "unprognostic (1.52e-2)" "unprognostic (7.76e-2)" "unprognostic (3.98e-2)" "unprognostic (1.24e-3)" 15.7 12.1 16.8 20.9 28.1 34.2 16.7 36.3 22.7 14.2 15.3 13.7 10.1 15.3 19.6 13.9 18.6 17.5 14.8 14.5 16.3 12.7 10.7 10.0 14.7 23.8 12.4 19.1 20.5 12.6 14.4 18.5 17.8 17.2 15.0 16.4 13.0 16.1 19.0 34.9 19.0 15.2 17.5 12.7 16.6 16.8 19.5 14.9 21.9 14.7 14.9 23.9 18.7 16.5 6.5 10.5 2.6 11.6 10.5 8.3 5.8 19.4 14.5 22.5 15.3 6.2 9.8 28.3 14.8 12.0 16.5 19.6 23.3 20.8 33.6 11.1 12.0 11.9 17.5 27.1 18.6 25.3 19.8 21.8 22.2 16.3 14.1 6.6 32.7 17.4 6.8 11.0 15.9 17.5 9.2 14.6 28.7 25.8 12.4 12.6 13.9 28.5 18.5 22.2 11.2 16.5 28.0 26.4 22.4 10.4 15.4 14.6 18.0 16.4 17.6 10.8 14.2 18.6 16.5 16.1 14.4 17.0 12.2 22.8 12.9 14.3 45.3 13.5 28.0 16.1 1.0 6.4 2.6 6.7 9.6 7.9 6.5 7.8 8.3 10.5 6.0 8.2 8.1 0.5 10.5 11.6 5.4 6.9 5.8 16.8 28.1 36.3 22.7 16.3 12.7 12.4 19.1 17.2 14.9 50.6 36.7 36.9 37.7 40.0 54.0 32.3 17.8 40.2 43.3 22.7 58.9 41.0 1.7 22.8 2.2 28.7 13.8 23.3 28.9 50.1 36.0 30.8 35.9 16.6 26.8 33.4 27.1 23.9 27.2 4.1 26.4 26.8 23.6 23.4 32.9 21.2 32.4 24.6 23.0 5.5 36.8 19.4 33.0 77.9 60.0 40.0 36.7 24.9 41.3 51.5 TCF3 "bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, VDIR" ENSG00000071564 "Transcription factor 3" P15923 19 1609290-1652605 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 76.6;REH: 76.2;U-698: 96.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018351, HPA049808, HPA062476" Approved Enhanced Nucleoplasm No No Nucleoplasm "CAB018351: AB_675504, HPA049808: AB_2680892, HPA062476: AB_2684775" "unprognostic (8.82e-2)" "unprognostic (4.74e-2)" "unprognostic (1.26e-2)" "unprognostic (1.25e-1)" "unprognostic (1.91e-2)" "unprognostic (8.25e-3)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.07e-2)" "unprognostic (7.99e-2)" "unprognostic (2.35e-1)" "unprognostic (2.42e-1)" "unprognostic (9.29e-3)" "prognostic unfavorable (1.53e-4)" "unprognostic (4.87e-3)" "unprognostic (1.88e-1)" "unprognostic (3.07e-1)" "unprognostic (8.05e-2)" 13.0 8.8 12.8 31.6 9.8 33.2 17.4 8.3 11.9 15.5 16.2 11.9 9.4 18.1 16.6 11.3 16.7 12.1 19.0 9.4 11.2 6.2 11.9 8.9 13.2 42.0 10.7 6.0 18.2 13.5 6.3 13.9 10.8 11.0 17.1 9.7 12.4 13.6 6.9 11.2 16.7 23.0 8.8 10.4 33.1 14.9 36.0 11.2 63.2 15.9 11.6 38.0 15.2 13.9 11.3 12.1 2.9 2.8 2.3 4.2 1.6 15.9 8.2 22.6 20.3 3.2 8.6 10.1 9.9 7.8 11.4 10.1 16.2 12.6 76.6 11.3 8.1 2.1 16.6 13.8 10.8 6.7 46.4 9.2 7.2 10.3 17.6 7.4 17.6 10.1 5.5 12.5 8.9 6.9 10.2 13.7 28.5 29.6 26.6 7.2 28.2 48.6 17.1 31.4 9.7 8.6 76.2 10.4 17.3 7.7 14.1 21.6 30.3 9.4 9.3 11.5 8.8 11.8 31.4 16.4 15.0 17.8 18.5 16.9 64.8 31.6 96.6 9.8 22.5 13.4 2.9 1.3 0.9 3.5 1.4 3.7 10.8 2.2 3.2 2.7 11.3 3.2 4.2 0.4 2.3 2.8 12.1 2.1 1.6 12.8 9.8 8.3 11.9 11.2 6.2 10.7 6.0 11.0 11.2 6.0 7.8 26.7 4.5 12.4 10.7 8.9 2.5 0.0 10.3 1.8 25.5 3.4 1.7 9.4 6.7 9.5 13.5 0.0 5.9 7.4 11.5 8.0 6.9 3.9 6.7 4.8 15.5 8.6 7.2 3.9 12.7 6.5 10.1 5.4 13.0 9.0 14.7 14.0 9.6 4.5 13.6 19.4 10.5 3.7 15.8 11.5 2.4 8.6 18.4 6.7 TCF7 TCF-1 ENSG00000081059 "Transcription factor 7" P36402 5 134114711-134151865 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 326.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 68.7;Rod photoreceptor cells: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "MAIT T-cell: 10.3;memory CD4 T-cell: 17.8;memory CD8 T-cell: 10.4;naive CD4 T-cell: 35.8;naive CD8 T-cell: 21.8;NK-cell: 14.2" "Group enriched" "Detected in many" 19 "NK-cells: 14.2;T-cells: 35.8" "Cell line enriched" "Detected in many" 6 "MOLT-4: 170.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB019403, HPA058863, HPA070505" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB019403: AB_2199302, HPA058863: AB_2683837, HPA070505: AB_2686275" "unprognostic (3.63e-3)" "unprognostic (1.98e-3)" "unprognostic (1.03e-1)" "unprognostic (5.08e-3)" "unprognostic (1.70e-1)" "unprognostic (6.74e-2)" "unprognostic (1.12e-1)" "unprognostic (6.38e-2)" "unprognostic (2.31e-1)" "unprognostic (1.65e-1)" "unprognostic (5.35e-2)" "unprognostic (2.32e-1)" "unprognostic (3.04e-1)" "unprognostic (1.50e-2)" "unprognostic (2.33e-2)" "unprognostic (1.90e-1)" "unprognostic (4.10e-2)" 1.8 3.6 1.3 21.8 1.5 5.2 3.1 0.9 1.2 2.1 3.3 2.5 2.2 5.6 1.4 16.3 2.7 16.1 2.6 1.6 1.5 1.2 2.7 3.7 4.0 41.8 1.3 1.0 2.5 7.2 0.2 6.1 1.4 4.7 2.9 2.3 3.6 7.9 1.8 0.9 2.9 15.1 0.9 3.3 14.4 3.7 2.4 1.1 326.1 4.4 2.2 32.5 3.3 1.5 1.2 0.1 1.0 0.1 14.2 35.8 6.9 0.0 1.0 1.1 3.9 0.5 2.1 1.5 0.3 0.5 0.1 0.1 8.0 2.5 0.0 1.9 1.7 4.3 0.1 1.7 0.4 0.0 0.3 1.7 0.0 1.1 6.0 0.0 0.0 0.2 0.1 0.0 1.6 0.0 0.7 0.2 29.0 1.0 0.0 0.1 0.0 170.0 0.1 1.2 2.5 1.4 0.2 0.0 0.1 0.4 0.1 0.4 3.4 0.8 0.2 0.2 0.9 0.2 0.9 0.2 11.0 0.0 5.0 0.3 0.1 0.0 0.0 5.8 0.0 0.5 0.7 0.1 1.0 4.4 0.0 10.3 1.2 17.8 10.4 0.0 0.4 35.8 21.8 0.7 14.2 0.0 0.1 2.1 6.9 1.3 1.5 0.9 1.2 1.5 1.2 1.3 1.0 4.7 1.1 3.0 3.4 22.9 24.6 14.0 27.8 2.7 10.2 1.4 0.0 3.5 68.7 20.0 0.0 5.8 2.4 4.7 21.4 0.0 8.9 23.4 10.8 11.6 20.7 3.2 6.4 9.5 12.1 6.7 5.2 1.7 5.8 4.9 10.1 9.0 12.7 8.3 15.8 17.3 4.2 0.8 53.0 0.0 16.9 3.9 9.4 9.9 25.1 47.5 14.4 12.3 TCFL5 "bHLHe82, CHA, E2BP-1, Figlb" ENSG00000101190 "Transcription factor like 5" Q9UL49 20 62841115-62861763 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.9;testis: 55.7" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055223, HPA076419" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA055223: AB_2682745, HPA076419: " "unprognostic (4.05e-2)" "unprognostic (3.14e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (3.24e-4)" "unprognostic (2.78e-1)" "unprognostic (2.72e-3)" "unprognostic (3.95e-2)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "unprognostic (2.79e-1)" "unprognostic (1.14e-1)" "unprognostic (3.88e-1)" "unprognostic (1.54e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-1)" "unprognostic (1.33e-3)" "unprognostic (1.01e-2)" 5.4 3.9 18.6 4.0 18.9 3.7 6.4 4.6 14.8 6.5 4.1 22.5 6.1 3.2 5.7 6.6 6.0 5.9 5.0 5.5 20.0 15.5 5.0 4.6 3.6 4.7 25.4 10.7 8.3 4.8 7.5 3.0 4.8 17.0 4.9 3.8 6.3 4.9 6.3 4.5 10.9 3.5 5.5 32.9 4.1 3.7 55.7 12.0 8.3 14.9 2.1 5.0 4.6 3.2 1.4 1.9 2.9 1.6 1.2 3.2 0.7 12.9 3.9 8.6 9.9 18.6 18.9 7.7 8.4 11.7 16.4 9.2 9.5 8.0 6.6 9.7 7.4 8.8 14.3 8.6 9.5 14.4 4.6 7.2 5.4 11.2 14.0 7.3 7.9 6.6 6.9 14.2 4.6 9.7 7.1 7.4 10.2 6.0 2.5 7.6 15.7 34.7 10.0 5.6 10.8 12.4 19.2 15.1 9.2 4.4 3.8 12.4 6.7 14.9 6.1 22.7 6.3 10.4 14.8 7.9 13.1 8.6 11.4 9.8 6.4 4.3 5.5 7.9 9.9 7.1 0.5 1.6 2.9 3.2 1.5 1.9 1.3 2.3 2.1 1.2 1.4 2.5 1.7 2.8 1.2 1.5 1.9 2.3 0.7 18.6 18.9 4.6 14.8 20.0 15.5 25.4 10.7 17.0 12.0 0.0 1.0 0.0 1.2 9.3 9.2 3.6 2.5 0.0 1.2 7.0 5.9 0.5 1.7 1.2 11.4 3.6 1.4 0.0 1.1 0.8 3.1 1.4 0.0 2.9 0.9 7.9 2.4 3.1 4.4 5.9 7.2 1.7 3.3 1.0 2.4 9.7 0.8 1.9 6.7 1.7 6.7 0.0 2.1 62.7 8.4 12.4 0.2 1.0 2.6 0.9 TEAD1 "AA, TCF13, TEF-1" ENSG00000187079 "TEA domain transcription factor 1" P28347 11 12674591-12944483 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057339, HPA062471" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA057339: AB_2683413, HPA062471: AB_2684773" "unprognostic (1.00e-1)" "unprognostic (2.53e-2)" "unprognostic (8.84e-2)" "unprognostic (9.93e-3)" "unprognostic (2.05e-2)" "unprognostic (4.50e-1)" "unprognostic (1.50e-1)" "unprognostic (1.75e-1)" "unprognostic (1.43e-1)" "unprognostic (4.40e-3)" "unprognostic (8.39e-2)" "unprognostic (4.76e-2)" "unprognostic (1.41e-2)" "unprognostic (7.08e-3)" "unprognostic (2.52e-1)" "unprognostic (3.14e-1)" "unprognostic (2.18e-2)" 16.3 6.6 8.2 6.7 6.6 0.0 23.5 7.8 7.7 13.6 12.6 7.3 9.5 4.1 14.1 7.9 16.4 11.4 10.9 16.5 10.6 4.2 13.1 8.4 8.2 1.9 8.0 4.9 12.1 8.6 25.2 18.5 17.5 7.9 13.9 6.7 11.9 8.8 10.4 41.4 7.5 7.3 21.4 7.2 4.1 9.1 5.9 8.2 0.2 9.6 12.8 5.0 22.2 20.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 22.0 21.9 16.7 19.4 18.4 19.2 28.7 30.4 23.3 23.5 21.9 20.4 19.4 0.1 8.3 36.0 10.4 12.7 19.2 11.4 36.9 0.0 7.5 0.0 36.9 6.3 17.3 0.0 1.7 16.5 5.8 17.1 21.4 18.3 4.7 1.4 9.7 0.0 33.0 4.2 0.0 0.1 6.2 4.5 8.7 0.1 22.6 10.8 15.4 14.1 9.2 10.9 32.1 14.9 18.7 23.6 7.3 1.4 10.4 34.2 27.3 28.1 20.6 3.2 6.6 4.0 13.4 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 6.6 7.8 7.7 10.6 4.2 8.0 4.9 7.9 8.2 83.4 14.2 0.8 28.4 88.3 12.7 55.4 33.1 56.2 40.9 47.1 11.8 18.1 1.7 14.0 5.7 23.3 7.0 0.0 10.9 45.4 42.9 45.8 0.0 35.5 3.2 1.6 44.9 20.9 2.4 5.6 21.9 2.5 23.6 0.0 10.4 29.8 25.0 7.0 22.6 24.5 18.8 6.5 34.0 3.2 26.9 47.9 10.3 0.0 8.7 49.8 TEAD2 "ETF, TEF-4, TEF4" ENSG00000074219 "TEA domain transcription factor 2" Q15562 19 49340595-49362457 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 45.7;Early spermatids: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory B-cell: 4.1;naive B-cell: 5.2" "Lineage enriched" "Detected in single" 27 "B-cells: 5.2" "Cell line enhanced" "Detected in many" "AF22: 42.8;AN3-CA: 46.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066292, HPA069963" Supported Nucleoplasm NA NA Nucleoplasm "HPA066292: AB_2685651, HPA069963: AB_2686222" "unprognostic (2.69e-2)" "unprognostic (1.08e-1)" "unprognostic (2.09e-1)" "unprognostic (1.03e-2)" "unprognostic (8.58e-3)" "unprognostic (4.39e-1)" "prognostic unfavorable (8.66e-4)" "unprognostic (2.91e-1)" "unprognostic (4.47e-3)" "unprognostic (1.11e-1)" "unprognostic (3.96e-3)" "unprognostic (1.24e-1)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" "unprognostic (1.08e-1)" "unprognostic (1.31e-1)" "unprognostic (6.78e-2)" 17.6 8.1 4.5 9.3 4.3 0.0 19.5 2.1 3.4 21.7 21.6 3.9 11.6 3.9 20.2 12.4 12.8 14.4 12.8 25.6 4.1 1.5 11.3 18.3 19.9 8.7 5.6 1.8 25.2 18.1 4.9 4.5 10.5 5.2 19.0 6.3 19.0 10.0 13.6 6.1 4.8 8.1 21.8 7.5 11.8 14.7 10.9 3.2 1.8 9.5 8.9 5.1 16.3 26.4 5.2 0.0 0.0 0.1 0.0 0.1 0.1 3.7 8.8 42.8 46.3 4.6 6.8 7.6 7.0 7.5 8.1 9.5 0.7 2.1 0.3 9.4 11.9 4.1 4.3 11.7 2.4 4.5 0.0 5.4 0.0 8.4 5.8 8.0 0.0 0.1 8.0 5.6 5.5 2.7 16.1 28.8 0.0 6.5 0.0 11.3 4.7 0.0 0.0 14.4 10.8 11.3 0.0 12.9 0.0 7.4 0.0 0.0 26.0 11.8 1.7 3.1 15.3 12.7 1.0 16.9 14.7 9.1 3.1 0.5 0.0 0.0 1.4 0.5 0.1 5.7 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 4.3 2.1 3.4 4.1 1.5 5.6 1.8 5.2 3.2 3.0 2.7 0.0 5.0 3.0 0.0 0.8 7.6 1.4 3.4 12.2 0.0 0.7 1.7 45.7 59.6 26.5 0.0 0.0 22.7 19.4 13.2 6.2 0.0 2.0 0.6 0.0 6.8 18.4 1.2 22.0 14.1 0.6 5.0 0.0 4.5 7.8 25.8 3.5 20.8 0.0 0.4 32.3 24.5 2.5 1.5 1.4 1.0 0.0 5.2 2.4 TEAD4 "EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1" ENSG00000197905 "TEA domain transcription factor 4" Q15561 12 2959330-3040673 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 60.1" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 37.4;Exocrine glandular cells: 32.8;Ito cells: 31.3;Syncytiotrophoblasts: 28.9" "Cancer enriched" "Detected in all" 5 "testis cancer: 78.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 86.2" "Region enriched" "Detected in single" 4 "cerebellum: 3.5" "Low region specificity" "Detected in some" HPA056896 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA056896: AB_2683268" "unprognostic (3.68e-1)" "unprognostic (3.98e-1)" "unprognostic (2.17e-1)" "unprognostic (1.55e-3)" "unprognostic (1.33e-1)" "unprognostic (3.68e-1)" "unprognostic (9.20e-3)" "unprognostic (2.21e-3)" "unprognostic (3.01e-1)" "unprognostic (1.24e-1)" "unprognostic (2.50e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (9.78e-9)" "unprognostic (5.05e-3)" "unprognostic (8.43e-2)" "unprognostic (2.42e-2)" "unprognostic (1.23e-3)" 7.6 1.9 1.2 4.5 1.8 0.5 11.1 2.0 2.5 3.6 3.1 0.7 7.4 3.2 4.4 5.1 4.2 3.1 4.3 9.7 1.4 1.1 9.2 5.5 10.3 5.3 2.4 0.4 4.4 27.5 1.1 1.5 6.8 3.2 3.8 2.9 3.9 3.5 7.1 60.1 6.2 5.2 5.7 1.9 7.2 3.6 2.2 1.4 0.5 16.4 13.3 2.5 3.1 10.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 8.6 12.2 3.1 8.6 0.9 2.1 33.4 6.9 3.7 12.0 6.7 23.2 9.2 0.0 5.4 5.2 8.1 12.4 12.1 86.2 11.2 0.0 9.8 13.7 10.0 20.0 4.6 2.9 2.6 3.0 3.5 10.4 16.1 5.0 10.2 5.5 8.7 0.1 4.1 12.2 0.1 0.0 23.9 11.0 7.2 6.3 17.7 6.7 5.6 3.6 1.8 3.2 8.6 21.6 6.3 23.6 14.6 5.0 11.6 7.0 24.4 4.8 3.6 0.0 0.0 0.0 5.6 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 2.0 2.5 1.4 1.1 2.4 0.4 3.2 1.4 11.9 6.6 0.0 9.5 10.9 0.0 1.7 7.6 1.4 2.3 7.0 0.0 37.4 5.0 11.6 0.1 19.7 6.5 0.0 32.8 12.7 8.2 15.2 5.7 0.0 4.5 0.0 0.0 31.3 1.5 1.3 0.0 0.4 8.5 0.0 3.2 0.0 21.6 0.0 0.4 14.3 0.0 0.0 12.7 0.2 6.4 6.8 28.9 0.0 4.1 3.1 TECPR2 KIAA0329 ENSG00000196663 "Tectonin beta-propeller repeat containing 2" O15040 14 102362963-102502481 "Disease related genes, Predicted intracellular proteins" Autophagy "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 47.1;Rod photoreceptor cells: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 14 "granulocytes: 10.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000658 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA000658: AB_1079191" "unprognostic (6.81e-2)" "unprognostic (1.21e-1)" "unprognostic (3.77e-2)" "unprognostic (2.62e-1)" "unprognostic (4.46e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (5.66e-5)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (1.64e-1)" "unprognostic (5.76e-3)" "unprognostic (3.78e-2)" "prognostic favorable (6.53e-9)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "unprognostic (1.91e-1)" "unprognostic (1.56e-3)" 8.5 7.0 15.4 8.4 19.3 8.3 7.4 13.5 23.3 10.0 8.5 28.3 6.3 6.2 9.6 11.3 8.2 10.7 7.4 11.0 15.9 12.1 7.0 4.6 7.1 6.8 23.6 14.3 10.2 6.9 17.5 8.4 9.1 14.4 9.8 5.5 12.0 15.2 12.5 12.4 6.2 5.6 13.9 16.3 6.6 6.5 16.9 17.3 7.6 8.7 2.6 4.7 9.1 5.6 0.3 0.3 10.5 0.7 0.2 0.5 0.6 3.8 7.9 7.7 6.3 16.0 12.1 4.3 8.8 10.3 8.9 7.5 1.6 2.9 2.9 5.5 9.2 6.6 7.1 5.3 6.6 7.5 10.7 3.5 3.5 4.2 3.4 7.5 1.9 3.4 7.9 5.9 8.0 5.4 8.5 8.7 3.3 1.7 6.7 8.2 7.4 1.7 2.1 2.9 4.0 8.3 4.1 5.4 0.9 4.5 6.6 6.1 5.7 7.6 2.0 4.9 5.2 9.0 2.6 8.9 6.9 1.7 18.4 3.7 7.0 4.1 0.6 6.7 5.1 7.1 0.5 0.7 1.1 0.4 0.5 0.3 0.1 0.3 0.2 0.3 0.3 0.5 0.2 10.5 0.2 0.1 0.2 0.5 0.6 15.4 19.3 13.5 23.3 15.9 12.1 23.6 14.3 14.4 17.3 8.9 5.8 2.4 2.5 1.8 16.7 11.8 5.1 5.3 5.7 3.5 47.1 5.1 5.0 6.3 22.1 5.8 4.7 0.0 6.2 4.9 4.9 3.1 0.0 5.1 4.3 12.7 4.1 8.0 6.5 19.1 13.3 3.6 3.3 5.4 3.0 20.6 6.4 3.4 17.7 5.7 39.8 19.4 5.0 19.9 15.0 1.4 5.0 2.5 4.3 2.8 TEN1 "C17orf106, FLJ39785" ENSG00000257949 "TEN1, CST complex subunit" Q86WV5 17 75979220-76000586 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Exocrine glandular cells: 77.6;monocytes: 64.9;Pancreatic endocrine cells: 72.5;Proximal tubular cells: 75.9;Suprabasal keratinocytes: 46.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065069 Supported Nucleoplasm NA NA Nucleoplasm "HPA065069: AB_2685418" "unprognostic (1.61e-1)" "unprognostic (1.16e-1)" "unprognostic (3.34e-2)" "unprognostic (1.07e-1)" "unprognostic (3.02e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-3)" "unprognostic (2.95e-1)" "unprognostic (2.85e-2)" "unprognostic (9.03e-2)" "unprognostic (8.61e-3)" "unprognostic (3.17e-2)" "unprognostic (1.64e-2)" "unprognostic (1.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.94e-1)" "unprognostic (2.85e-4)" 8.8 12.1 7.3 11.9 9.1 17.2 11.4 9.6 8.6 8.8 11.7 7.7 19.3 14.7 7.2 9.4 17.4 9.9 12.8 6.4 7.1 6.2 11.8 18.5 10.6 17.2 9.4 8.1 8.2 15.6 4.6 11.2 13.0 8.5 13.1 5.5 8.6 20.3 17.5 5.2 21.1 15.8 5.4 6.5 13.0 10.8 7.3 9.7 4.6 10.1 13.6 12.3 15.3 13.5 30.2 28.8 35.5 30.0 22.3 22.6 19.8 9.3 9.4 6.8 8.4 8.3 10.9 19.6 6.6 8.8 10.7 11.0 9.4 16.0 12.0 10.4 7.2 11.5 9.9 4.2 9.2 3.1 6.7 15.0 14.9 11.7 10.0 9.9 9.1 23.6 9.9 12.7 6.0 6.0 9.4 14.1 7.7 6.7 12.1 6.1 16.3 11.4 22.3 6.7 9.5 13.8 11.3 6.4 11.2 13.1 16.6 12.4 22.9 4.8 40.7 7.7 5.4 22.6 14.8 8.4 22.4 13.3 10.0 13.5 14.2 5.3 7.2 11.3 6.9 6.8 35.5 30.0 17.0 22.6 26.6 18.6 30.2 18.3 19.2 26.3 25.8 14.2 16.7 18.1 22.3 14.7 28.8 19.3 19.8 7.3 9.1 9.6 8.6 7.1 6.2 9.4 8.1 8.5 9.7 0.0 3.4 0.0 0.0 34.7 0.0 0.0 0.0 1.4 1.2 5.2 0.0 0.0 33.2 34.8 0.0 0.0 0.0 0.0 77.6 0.1 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.8 28.7 64.9 0.0 0.0 72.5 0.0 0.0 75.9 0.0 0.0 11.3 0.0 0.0 46.0 0.0 0.0 0.0 0.1 TENM3 "KIAA1455, ODZ3, Ten-M3" ENSG00000218336 "Teneurin transmembrane protein 3" Q9P273 4 182143987-182803024 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Bipolar cells: 28.4;Cytotrophoblasts: 88.5;Extravillous trophoblasts: 46.4;Syncytiotrophoblasts: 111.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 24.4;BEWO: 23.3;HDLM-2: 31.7;T-47d: 31.4" "Low region specificity" "Detected in many" HPA047043 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047043: AB_2679914" "unprognostic (5.79e-2)" "unprognostic (3.01e-2)" "unprognostic (6.62e-2)" "unprognostic (4.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (8.28e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (2.31e-2)" "unprognostic (4.85e-2)" "unprognostic (2.54e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (8.59e-2)" "unprognostic (1.07e-2)" "unprognostic (5.25e-4)" 9.5 10.8 11.3 3.7 12.5 1.0 9.3 8.5 17.8 3.9 8.5 1.5 5.7 2.4 6.4 2.6 2.4 2.9 5.3 3.5 11.8 9.4 2.7 1.4 2.4 2.3 3.5 15.4 8.4 3.2 17.0 15.0 24.5 5.4 8.3 2.5 6.4 2.0 8.0 4.3 1.4 2.5 5.2 6.1 4.8 2.2 4.7 2.3 0.8 12.3 1.8 3.0 3.7 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 24.4 0.1 5.0 8.9 23.3 2.8 1.0 2.5 2.2 12.1 6.3 0.0 0.3 18.8 10.6 1.2 5.8 1.2 2.5 31.7 9.7 0.0 0.0 0.0 0.5 0.0 0.0 11.7 0.4 7.9 5.5 5.7 3.5 0.0 0.0 0.1 3.8 0.8 0.0 0.0 7.8 0.0 1.0 0.0 6.3 0.0 0.0 0.0 10.0 9.3 1.4 0.1 0.0 13.8 31.4 1.2 7.6 20.0 14.4 0.0 14.1 0.0 0.0 0.0 10.5 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 12.5 8.5 17.8 11.8 9.4 3.5 15.4 5.4 2.3 0.0 0.0 0.0 0.2 0.3 28.4 3.3 0.0 0.0 0.0 3.5 3.9 88.5 1.7 0.0 8.3 0.3 0.0 0.0 1.5 46.4 3.1 0.2 0.0 0.6 9.0 4.8 5.1 0.6 0.0 1.8 7.8 0.0 1.7 0.0 0.0 11.8 0.6 0.0 2.5 0.1 2.8 0.0 1.0 3.7 7.1 0.0 111.6 0.0 0.0 0.0 TESK2 ENSG00000070759 "Testis-specific kinase 2" Q96S53 1 45343883-45491166 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 13.1;RT4: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027257, HPA063869" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027257: AB_10602477, HPA063869: AB_2685137" "unprognostic (2.95e-1)" "prognostic favorable (2.22e-4)" "unprognostic (3.90e-2)" "unprognostic (5.04e-3)" "unprognostic (6.03e-2)" "unprognostic (1.87e-3)" "unprognostic (3.22e-2)" "unprognostic (1.43e-2)" "unprognostic (5.15e-2)" "unprognostic (2.96e-1)" "unprognostic (2.28e-1)" "unprognostic (2.86e-1)" "unprognostic (4.36e-2)" "unprognostic (2.49e-2)" "unprognostic (1.13e-1)" "unprognostic (4.37e-2)" "unprognostic (2.01e-1)" 5.5 3.3 6.1 5.9 17.4 12.6 9.6 7.8 12.6 7.7 8.4 25.7 4.0 11.9 4.7 5.7 9.1 4.1 3.9 5.8 9.6 5.1 3.5 9.7 5.5 6.0 19.2 4.7 14.4 4.6 6.7 4.1 8.3 13.2 22.1 10.1 7.6 11.2 5.7 10.1 17.1 14.8 4.4 18.7 6.3 5.6 11.7 14.8 4.2 5.1 3.2 7.2 8.2 9.7 7.5 2.0 15.9 5.9 1.1 3.7 2.6 1.6 0.0 0.8 0.0 3.2 1.7 13.1 0.6 4.3 1.9 3.2 3.6 1.5 5.3 0.6 1.6 4.9 2.0 3.4 2.7 1.5 3.7 4.3 3.6 1.8 2.7 1.7 1.2 9.9 1.8 2.9 2.1 3.0 2.9 1.5 7.1 0.6 10.9 1.3 0.6 3.0 2.4 3.4 1.5 1.5 4.4 0.1 1.4 1.7 12.8 0.3 1.4 3.4 6.4 12.2 8.1 10.0 1.5 0.0 0.2 2.0 1.6 1.1 7.2 4.2 1.0 1.0 0.0 0.8 9.4 3.8 10.6 2.4 2.8 1.7 7.5 2.2 1.6 2.0 5.7 3.7 2.1 15.9 1.1 5.9 1.1 1.5 2.6 6.1 17.4 7.8 12.6 9.6 5.1 19.2 4.7 13.2 14.8 0.0 3.2 2.4 6.5 6.9 2.3 1.1 5.1 1.4 3.4 0.0 13.7 6.5 0.0 1.0 18.1 2.9 12.4 0.0 2.3 2.5 2.2 12.9 6.9 5.5 5.9 0.0 4.1 1.3 4.6 5.2 2.6 4.5 3.3 2.8 5.3 1.1 1.0 7.4 1.8 0.6 2.8 6.5 4.7 26.8 5.7 7.4 12.4 4.4 4.9 7.3 TET2 "FLJ20032, KIAA1546" ENSG00000168769 "Tet methylcytosine dioxygenase 2" Q6N021 4 105145875-105279816 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.0" "Lineage enriched" "Detected in all" 4 "granulocytes: 29.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043135 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA043135: AB_10794177" "unprognostic (6.83e-2)" "unprognostic (3.52e-2)" "unprognostic (1.69e-2)" "unprognostic (9.42e-2)" "unprognostic (4.15e-2)" "unprognostic (5.88e-2)" "unprognostic (6.12e-2)" "unprognostic (1.19e-3)" "unprognostic (1.15e-2)" "unprognostic (1.57e-2)" "unprognostic (5.77e-2)" "unprognostic (7.29e-2)" "unprognostic (2.70e-3)" "unprognostic (6.10e-2)" "unprognostic (1.89e-1)" "unprognostic (9.15e-2)" "unprognostic (7.84e-2)" 9.9 6.1 8.7 11.9 11.4 26.3 8.0 4.1 10.0 9.6 7.4 10.1 5.8 8.2 10.1 7.4 16.2 9.2 6.6 6.8 9.0 4.2 6.7 5.5 9.9 9.8 13.7 5.7 8.5 7.0 7.4 29.0 12.4 9.1 6.5 8.0 4.7 13.5 8.2 9.8 16.0 10.2 7.8 15.5 12.9 6.8 3.2 14.6 9.3 7.2 6.9 8.7 9.8 12.3 2.8 5.1 29.0 7.0 2.6 2.1 1.4 4.8 3.1 10.6 10.8 1.9 4.3 4.3 3.5 4.7 5.0 4.9 3.1 6.5 0.5 4.0 4.3 2.4 4.6 10.2 6.1 5.7 6.2 2.7 6.8 6.0 1.1 5.4 15.4 11.3 3.7 8.3 4.8 6.2 8.1 6.6 3.7 7.2 12.7 4.3 3.6 2.5 4.2 2.3 6.4 1.9 7.9 5.3 1.0 4.6 10.2 7.6 6.2 3.8 9.9 0.6 6.0 4.5 11.1 8.5 7.6 6.9 2.2 5.9 8.5 6.1 6.4 4.6 3.8 7.4 10.8 7.0 7.2 2.1 5.5 0.8 2.6 1.2 1.2 5.1 2.8 1.0 1.6 29.0 2.6 6.4 4.5 1.5 1.4 8.7 11.4 4.1 10.0 9.0 4.2 13.7 5.7 9.1 14.6 23.8 26.1 5.6 9.4 12.8 21.1 21.6 7.6 21.4 20.5 8.7 15.7 16.9 6.6 5.6 0.2 12.9 15.8 0.0 6.6 4.8 7.5 10.8 26.6 6.6 13.0 33.4 22.3 9.2 49.2 0.4 7.5 43.4 5.0 11.8 15.9 5.6 6.6 17.3 6.7 2.4 23.8 12.9 8.2 0.2 0.6 31.5 28.6 17.5 12.7 22.5 TEX2 "HT008, KIAA1738, TMEM96" ENSG00000136478 "Testis expressed 2" Q8IWB9 17 64147227-64263301 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 41.1;Late spermatids: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "plasmacytoid DC: 18.1" "Lineage enriched" "Detected in many" 7 "dendritic cells: 18.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020648, HPA057116" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020648: AB_1857908, HPA057116: AB_2683341" "unprognostic (6.13e-2)" "unprognostic (1.35e-1)" "prognostic favorable (3.90e-6)" "unprognostic (1.69e-2)" "unprognostic (3.84e-2)" "unprognostic (8.34e-2)" "unprognostic (6.97e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (2.53e-1)" "unprognostic (8.39e-2)" "unprognostic (1.11e-1)" "unprognostic (7.97e-2)" "unprognostic (7.00e-2)" "unprognostic (1.87e-1)" "unprognostic (4.53e-3)" "unprognostic (5.59e-3)" 11.7 18.1 22.3 5.0 25.1 11.8 14.3 18.9 22.5 14.0 8.8 22.9 4.2 7.3 10.8 8.7 12.6 10.2 15.8 19.2 23.0 20.1 14.6 23.4 10.7 4.1 29.0 13.8 12.0 21.1 27.2 10.7 8.7 20.5 12.3 10.0 46.2 17.7 13.2 28.1 11.1 7.2 10.8 26.3 8.7 9.1 35.7 17.2 4.9 29.3 10.9 4.9 8.1 8.2 0.6 18.1 0.7 2.6 2.6 1.6 1.4 13.2 6.4 4.0 8.2 19.6 11.6 4.9 18.4 20.9 16.8 11.6 6.0 3.3 4.7 4.8 23.3 10.4 6.6 7.2 22.4 19.1 6.8 5.0 31.6 4.4 11.2 7.3 9.1 5.3 8.5 12.4 11.4 23.4 11.9 8.0 8.0 8.6 5.8 12.5 14.9 8.3 4.2 2.3 10.4 11.6 5.1 36.7 6.6 9.7 6.3 6.2 10.2 9.2 23.6 10.1 23.3 11.1 7.9 9.4 15.7 9.2 12.1 10.6 6.0 8.2 3.1 6.2 8.7 14.1 0.0 2.6 0.7 1.4 0.8 1.6 0.3 1.5 1.6 2.5 0.6 1.6 1.5 0.3 2.6 1.5 18.1 1.0 1.4 22.3 25.1 18.9 22.3 23.0 20.1 29.0 13.8 20.5 17.2 3.0 7.2 2.2 5.5 7.8 4.1 28.9 7.6 8.1 5.7 12.2 5.9 2.1 1.7 4.3 41.1 8.7 5.5 0.0 7.1 1.6 6.4 5.5 3.5 28.6 11.1 9.5 11.6 8.6 7.5 38.4 6.1 3.8 6.8 1.8 10.2 6.0 6.1 2.9 12.0 7.9 18.4 0.0 6.1 14.6 9.5 7.9 1.1 2.2 10.6 4.2 TFAP2A "AP-2, AP2TF, TFAP2" ENSG00000137203 "Transcription factor AP-2 alpha" P05549 6 10393186-10419659 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 130.5;retina: 48.1" "Cell type enhanced" "Detected in many" 17 "Cytotrophoblasts: 245.7;Extravillous trophoblasts: 224.5;Syncytiotrophoblasts: 585.5" "Cancer enhanced" "Detected in many" "melanoma: 45.6" "Region enhanced" "Detected in single" "cerebellum: 2.2" "Cell type enriched" "Detected in single" 10 "myeloid DC: 1.0" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.0" "Cell line enhanced" "Detected in many" "AN3-CA: 28.0;HDLM-2: 31.3;hTCEpi: 30.2;SuSa: 31.6" "Region enhanced" "Detected in single" "cerebellum: 4.3" "Region enhanced" "Detected in single" "cerebellum: 8.6" "CAB000326, HPA056871" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000326: AB_667767, HPA056871: AB_2683262" "unprognostic (5.97e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (1.14e-1)" "unprognostic (3.87e-2)" "unprognostic (1.27e-1)" "unprognostic (7.62e-5)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.45e-1)" "unprognostic (2.76e-2)" "unprognostic (3.33e-3)" "unprognostic (2.82e-1)" "unprognostic (1.40e-11)" "unprognostic (1.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.72e-4)" "unprognostic (2.25e-2)" 0.4 0.3 0.3 0.0 0.3 0.0 19.0 2.2 0.5 4.4 0.8 0.0 18.7 0.2 0.5 17.8 18.3 0.4 1.7 0.7 0.3 0.2 6.4 0.2 0.5 0.1 0.2 0.2 0.3 0.3 0.0 0.4 130.5 0.6 5.8 0.2 48.1 19.4 26.7 0.2 36.0 0.4 0.1 0.4 0.2 0.7 1.6 0.0 0.1 0.4 16.6 9.9 2.4 9.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 16.3 6.3 0.0 28.0 0.1 0.0 6.0 12.1 9.3 9.9 9.8 0.6 6.1 0.9 1.6 3.5 5.7 17.5 1.5 20.7 9.5 31.3 15.8 0.1 14.8 0.0 0.0 0.4 0.4 0.0 30.2 0.0 22.0 5.6 0.0 0.3 0.9 0.0 0.1 3.6 0.0 5.1 0.1 1.0 7.8 1.7 1.5 0.6 5.6 6.6 4.1 0.1 14.9 26.2 23.8 31.6 17.3 0.5 0.0 3.0 0.8 2.1 7.6 0.0 1.4 0.2 1.6 0.5 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.2 0.3 0.3 0.2 0.2 0.2 0.6 0.0 0.0 0.0 0.0 37.5 116.1 3.1 2.2 0.0 8.1 15.9 29.6 2.0 245.7 6.6 2.0 4.6 0.8 0.0 0.0 0.3 224.5 5.3 38.8 0.0 0.0 17.7 76.3 1.2 0.0 0.0 2.1 0.6 0.2 118.1 0.0 0.5 2.4 2.2 0.0 0.0 0.2 4.2 0.0 2.1 3.9 11.8 120.9 585.5 0.0 0.4 39.3 TFAP2B AP2-B ENSG00000008196 "Transcription factor AP-2 beta" Q92481 6 50818723-50847613 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "epididymis: 65.5" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 413.2" "Cancer enriched" "Detected in some" 8 "breast cancer: 12.1" "Group enriched" "Detected in some" 41 "cerebellum: 4.7;pons and medulla: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 32.4;SH-SY5Y: 60.4" "Region enhanced" "Detected in some" "cerebellum: 11.2" "Low region specificity" "Detected in many" "HPA034683, HPA062942" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA034683: AB_10670966, HPA062942: AB_2684909" "unprognostic (2.02e-1)" "unprognostic (2.29e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-4)" "unprognostic (9.76e-2)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (4.57e-1)" "unprognostic (6.58e-6)" "unprognostic (1.13e-2)" "unprognostic (1.88e-1)" "unprognostic (7.17e-3)" 0.2 3.0 0.0 0.0 0.0 0.0 9.4 4.7 0.0 0.2 0.2 0.0 8.8 0.0 0.0 65.5 5.8 0.0 0.0 0.1 0.0 0.1 6.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 6.3 0.1 0.0 12.2 7.0 0.6 0.0 6.3 0.0 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 60.4 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.1 0.0 6.3 0.0 0.0 0.0 0.0 0.0 10.4 6.9 0.6 0.0 0.0 0.0 48.8 7.9 10.5 46.4 0.0 11.5 0.3 0.0 0.0 0.0 3.7 0.3 0.0 0.0 0.0 1.0 413.2 0.0 0.0 0.0 0.5 0.0 0.0 101.3 0.0 0.0 2.3 0.0 0.0 0.4 0.7 9.7 0.0 0.0 0.5 0.0 3.8 4.1 0.0 0.0 0.0 TFAP2C "AP2-GAMMA, ERF1, hAP-2g, TFAP2G" ENSG00000087510 "Transcription factor AP-2 gamma" Q92754 20 56629302-56639283 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 53.9;skin 1: 32.5" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 117.7;Cytotrophoblasts: 77.5;Extravillous trophoblasts: 49.1;Suprabasal keratinocytes: 130.6;Syncytiotrophoblasts: 88.3" "Cancer enhanced" "Detected in many" "testis cancer: 54.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "BEWO: 45.8;MCF7: 38.8;SK-BR-3: 73.8;T-47d: 20.6;WM-115: 27.1" "Region enriched" "Detected in single" 13 "olfactory region: 2.9" "Low region specificity" "Detected in many" "CAB016061, CAB016079, HPA055179, HPA057076" Enhanced Supported Nucleoplasm Yes NA Nucleoplasm "CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329" "unprognostic (1.74e-2)" "prognostic favorable (6.90e-4)" "unprognostic (2.24e-2)" "unprognostic (2.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.75e-2)" "unprognostic (2.54e-2)" "unprognostic (8.26e-2)" "unprognostic (2.97e-1)" "unprognostic (1.61e-1)" "unprognostic (3.14e-3)" "unprognostic (2.63e-1)" "unprognostic (9.04e-5)" "unprognostic (2.31e-1)" "unprognostic (1.85e-1)" "unprognostic (6.71e-2)" "unprognostic (3.28e-2)" 1.1 0.3 0.7 0.2 0.4 0.0 16.1 0.4 0.9 17.3 2.4 0.2 7.7 0.0 3.7 3.4 19.6 1.6 2.0 0.4 1.4 0.2 0.7 0.1 2.8 0.0 0.2 0.5 0.3 1.6 0.0 0.6 53.9 0.4 5.7 0.7 1.9 19.7 7.9 1.0 32.5 0.3 0.6 0.4 0.1 0.3 0.7 0.2 0.3 4.2 21.0 10.1 2.1 11.1 0.1 0.2 0.8 0.1 0.2 0.2 0.0 2.9 3.7 0.0 0.0 0.0 0.0 45.8 4.7 8.6 6.0 1.1 0.7 0.0 0.0 0.3 3.1 3.2 10.0 6.4 1.3 4.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 5.1 1.7 1.7 0.0 0.0 1.9 0.0 0.7 0.0 38.8 4.7 0.2 2.2 2.3 4.9 0.0 0.0 1.6 0.0 2.3 1.2 0.0 3.1 73.8 4.8 7.1 20.6 1.0 0.0 3.9 0.1 2.0 3.5 0.0 0.0 0.0 0.9 0.0 27.1 0.4 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.2 0.1 0.2 0.1 0.0 0.7 0.4 0.4 0.9 1.4 0.2 0.2 0.5 0.4 0.2 0.0 7.4 0.0 26.2 117.7 0.4 0.9 0.0 5.3 4.5 8.7 0.0 77.5 0.0 0.2 0.2 1.0 0.0 0.0 0.0 49.1 11.3 18.8 0.0 0.0 6.8 0.0 2.9 1.3 0.3 0.0 0.0 0.9 20.3 0.0 1.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.5 130.6 88.3 0.0 1.7 12.8 TFEB "bHLHe35, TCFEB" ENSG00000112561 "Transcription factor EB" P19484 6 41683978-41736259 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Autophagy, Immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Syncytiotrophoblasts: 100.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 30.2;Daudi: 19.1;OE19: 25.5;U-698: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049532 Supported Nucleoplasm NA NA Nucleoplasm "HPA049532: AB_2680807" "unprognostic (3.63e-3)" "unprognostic (1.51e-3)" "unprognostic (1.75e-2)" "unprognostic (4.48e-3)" "unprognostic (1.95e-1)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (4.22e-3)" "unprognostic (1.39e-2)" "unprognostic (4.13e-2)" "prognostic favorable (4.77e-4)" "unprognostic (2.12e-2)" "prognostic favorable (1.06e-5)" "unprognostic (1.44e-1)" "unprognostic (3.51e-2)" "unprognostic (2.46e-1)" "unprognostic (1.31e-2)" 8.6 6.4 10.2 16.8 20.7 8.9 6.8 8.6 15.0 6.4 10.5 34.4 8.2 6.8 7.1 4.3 9.3 7.2 9.1 19.3 14.6 8.2 12.2 5.0 8.3 24.1 30.0 6.8 6.7 11.4 26.1 14.9 18.5 16.2 10.7 5.3 6.9 18.0 8.6 45.2 7.9 15.5 8.4 27.4 27.3 7.9 2.5 24.0 2.8 11.1 10.9 18.3 10.8 11.1 22.2 8.5 29.0 9.6 0.8 2.6 4.4 1.7 1.8 0.4 7.0 2.4 1.4 30.2 2.7 5.5 2.4 1.8 4.0 2.0 19.1 3.7 2.9 1.8 4.8 1.1 2.8 0.6 17.5 1.9 0.0 6.9 7.3 4.7 0.5 2.6 0.5 5.4 2.8 1.8 5.8 1.8 2.1 2.3 4.7 0.9 1.2 1.1 1.4 0.1 25.5 0.9 12.6 0.2 2.6 4.3 1.4 7.9 2.3 2.3 4.9 0.6 1.8 1.4 9.5 3.8 0.9 1.9 0.1 1.9 12.3 1.9 28.2 1.4 8.1 0.9 0.1 9.6 8.8 2.6 9.3 0.4 22.2 0.7 1.0 8.5 15.1 0.2 0.9 29.0 0.8 6.5 1.7 0.4 4.4 10.2 20.7 8.6 15.0 14.6 8.2 30.0 6.8 16.2 24.0 8.9 9.4 20.8 7.5 12.6 5.8 16.4 12.7 4.0 1.2 12.2 11.8 37.8 18.3 3.0 0.7 7.7 14.0 0.0 6.2 3.4 5.2 6.4 1.1 3.9 25.2 25.4 12.7 8.6 22.7 4.0 3.1 12.9 0.0 4.6 8.4 16.7 6.9 17.3 10.3 2.4 4.7 6.5 6.2 0.5 0.9 12.7 100.7 5.4 7.9 6.0 TFEC "bHLHe34, TCFEC, TFECL" ENSG00000105967 "Transcription factor EC" O14948 7 115935148-116159896 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 22.6" "Group enriched" "Detected in some" 6 "Hofbauer cells: 40.9;Kupffer cells: 42.8;Macrophages: 48.6;Proximal tubular cells: 52.2" "Cancer enhanced" "Detected in many" "renal cancer: 5.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 8.7;myeloid DC: 7.7" "Group enriched" "Detected in many" 32 "B-cells: 4.9;dendritic cells: 7.7;monocytes: 8.7" "Cell line enhanced" "Detected in some" "HEL: 12.3;HUVEC TERT2: 8.6;THP-1: 16.3;TIME: 9.6;U-937: 18.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB032260, HPA063577" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB032260: AB_2202845, HPA063577: AB_2685047" "unprognostic (1.36e-1)" "unprognostic (1.08e-2)" "unprognostic (8.70e-2)" "unprognostic (1.91e-2)" "unprognostic (1.44e-1)" "unprognostic (2.79e-2)" "unprognostic (1.13e-1)" "unprognostic (8.26e-2)" "unprognostic (2.15e-1)" "unprognostic (6.54e-2)" "unprognostic (2.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.05e-3)" "unprognostic (2.92e-1)" "unprognostic (4.14e-2)" "unprognostic (1.51e-1)" "unprognostic (3.60e-2)" 11.2 3.5 5.8 15.4 9.2 12.3 7.6 0.8 4.6 1.8 3.7 1.4 0.6 3.4 1.6 6.1 2.4 2.6 4.2 2.5 6.0 2.1 22.6 2.8 15.7 17.0 13.0 2.2 1.6 1.8 0.4 1.8 3.9 8.8 1.9 3.6 0.8 3.1 0.7 1.2 1.3 11.6 2.6 15.2 16.4 2.3 1.7 9.4 1.6 2.1 1.1 10.0 3.8 1.7 4.9 7.7 0.2 8.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 1.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 16.3 9.6 1.7 0.1 1.0 0.0 4.3 0.0 0.0 0.0 18.5 0.9 0.0 8.7 0.0 0.0 3.7 0.0 4.9 0.0 0.0 7.7 2.1 0.0 0.0 0.2 0.0 0.5 3.9 0.0 1.7 5.8 9.2 0.8 4.6 6.0 2.1 13.0 2.2 8.8 9.4 0.0 2.1 5.0 0.0 0.5 0.0 0.7 2.5 0.0 0.0 3.5 0.0 0.1 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.2 0.3 0.0 2.3 0.0 40.9 0.0 0.0 0.0 42.8 2.7 0.0 48.6 0.0 8.2 0.0 0.0 0.1 0.0 0.0 52.2 0.0 0.0 0.0 0.2 0.4 0.4 0.7 0.0 0.0 0.0 TFPT "amida, FB1, INO80F" ENSG00000105619 "TCF3 fusion partner" P0C1Z6 19 54107013-54115675 "Disease related genes, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 114.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034958, HPA058534" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA034958: AB_10603036, HPA058534: AB_2683745" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (5.13e-4)" "unprognostic (6.56e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.85e-1)" "unprognostic (2.85e-1)" "unprognostic (2.71e-1)" "prognostic favorable (3.13e-4)" "unprognostic (1.80e-2)" "unprognostic (1.15e-1)" "unprognostic (2.00e-2)" "unprognostic (2.61e-1)" "unprognostic (3.43e-1)" "unprognostic (3.66e-2)" 5.9 6.5 33.4 8.9 17.0 7.9 5.1 9.6 22.9 7.9 5.3 8.7 4.3 10.1 5.9 5.3 4.1 5.1 7.1 7.7 24.4 15.5 4.3 3.6 7.9 11.6 18.3 16.1 4.2 4.0 3.3 4.2 6.4 10.8 15.9 2.9 4.8 12.9 5.2 10.8 6.8 10.7 4.7 9.7 14.1 14.5 4.6 12.8 9.6 5.2 3.2 4.8 5.3 3.9 4.4 24.7 5.0 3.9 10.4 13.3 5.5 2.5 2.2 2.2 4.3 0.4 0.8 2.1 2.4 1.8 2.2 2.7 2.6 8.2 2.5 6.0 2.4 1.1 2.7 0.8 1.3 0.7 6.6 11.8 3.0 4.1 3.4 6.3 4.0 6.6 1.7 0.8 1.5 1.1 2.0 3.5 6.2 2.7 3.7 3.5 9.4 7.2 12.7 2.5 4.9 5.0 5.9 1.5 3.4 1.6 11.9 6.0 5.1 0.8 9.7 13.1 0.6 2.5 14.3 8.0 16.5 3.3 1.2 3.4 6.4 6.7 1.9 7.0 11.1 13.9 5.0 3.7 3.6 8.1 3.9 7.7 4.4 11.6 10.7 9.5 4.2 9.0 9.5 2.4 10.4 1.2 24.7 13.3 5.5 33.4 17.0 9.6 22.9 24.4 15.5 18.3 16.1 10.8 12.8 14.9 7.4 21.5 10.2 15.0 9.5 1.6 12.7 6.7 12.5 21.0 2.0 19.5 13.3 17.6 6.1 25.2 20.0 0.0 23.9 22.7 13.1 34.2 15.0 7.4 114.8 0.0 15.0 37.4 28.0 4.0 11.2 38.7 37.1 65.9 29.8 13.4 41.2 17.3 15.9 19.6 9.4 6.5 9.2 6.0 12.3 15.2 21.9 19.7 13.4 9.0 TGIF1 "HPE4, TGIF" ENSG00000177426 "TGFB induced factor homeobox 1" Q15583 18 3411608-3459978 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 533.4;Basal keratinocytes: 319.4;Urothelial cells: 322.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062160 Supported Nucleoplasm NA Yes Nucleoplasm "HPA062160: AB_2684701" "unprognostic (1.11e-2)" "unprognostic (5.20e-2)" "unprognostic (2.40e-1)" "unprognostic (1.97e-1)" "unprognostic (3.57e-3)" "unprognostic (3.10e-2)" "unprognostic (2.75e-1)" "unprognostic (4.34e-2)" "unprognostic (1.94e-2)" "unprognostic (1.96e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (9.60e-2)" "unprognostic (1.12e-2)" "unprognostic (9.81e-2)" "unprognostic (4.60e-1)" "unprognostic (7.07e-2)" "unprognostic (2.48e-3)" 31.9 16.6 6.9 17.2 9.3 11.2 22.0 2.7 6.2 26.8 23.8 15.5 48.4 9.6 32.7 47.3 27.1 24.8 31.4 12.9 6.5 7.2 24.7 33.6 27.9 10.6 8.1 5.9 23.0 20.2 5.3 10.2 49.6 9.9 33.2 22.4 15.3 25.1 29.8 21.2 22.9 16.6 18.5 8.6 23.1 19.8 23.1 9.2 18.1 60.2 11.2 21.0 40.5 29.0 18.2 14.0 20.4 17.3 7.4 27.5 12.7 6.2 28.5 18.7 6.0 19.1 25.8 45.7 12.0 46.0 9.8 12.6 11.2 28.6 0.3 4.0 9.8 33.0 6.4 7.1 13.4 13.0 2.5 3.0 0.8 13.6 21.2 35.9 9.0 7.5 17.9 57.8 17.8 47.5 27.0 20.9 4.3 6.4 0.1 19.2 12.2 5.8 11.0 47.6 22.6 6.3 6.2 8.4 2.0 40.3 30.7 5.2 5.2 31.6 24.8 17.5 32.7 5.7 8.1 8.9 15.4 13.4 18.1 7.5 1.0 0.1 2.8 15.8 3.4 19.3 20.4 17.3 2.9 25.9 6.5 27.5 18.2 21.6 25.2 14.0 12.8 15.5 18.0 7.8 7.4 6.1 1.4 11.4 12.7 6.9 9.3 2.7 6.2 6.5 7.2 8.1 5.9 9.9 9.2 32.8 38.1 22.9 533.4 319.4 0.0 4.8 61.1 58.9 46.6 116.9 0.0 126.0 41.4 90.1 18.0 35.0 23.5 23.3 65.8 139.4 114.7 314.8 67.9 27.2 66.3 1.6 44.5 17.2 38.3 5.0 26.4 53.4 72.6 105.6 69.3 6.0 95.9 60.4 14.5 79.5 0.0 32.3 126.7 5.0 13.2 224.7 125.7 55.4 72.7 322.0 TGIF2LX ENSG00000153779 "TGFB induced factor homeobox 2 like, X-linked" Q8IUE1 X 89921882-89922883 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 13.3" "Group enriched" "Detected in some" 57 "Early spermatids: 59.2;Late spermatids: 39.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SH-SY5Y: 10.2;U-2 OS: 12.0;U-266/84: 18.5" HPA034543 Supported Approved Nucleoplasm No No Nucleoplasm "HPA034543: AB_10603037" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 12.0 0.3 0.0 1.0 18.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 THAP1 "4833431A01Rik, DYT6, FLJ10477" ENSG00000131931 "THAP domain containing 1" Q9NVV9 8 42836674-42843325 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" DNA-binding "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071310 Supported Nucleoplasm No No Nucleoplasm "HPA071310: AB_2686386" "unprognostic (8.99e-3)" "unprognostic (3.97e-3)" "unprognostic (7.15e-3)" "unprognostic (1.87e-2)" "unprognostic (2.55e-1)" "unprognostic (6.38e-2)" "unprognostic (1.20e-1)" "unprognostic (4.03e-1)" "unprognostic (3.91e-2)" "unprognostic (5.95e-2)" "unprognostic (9.43e-2)" "unprognostic (9.19e-2)" "unprognostic (2.94e-2)" "unprognostic (1.28e-1)" "unprognostic (2.82e-1)" "unprognostic (1.95e-1)" "unprognostic (3.16e-2)" 12.7 12.8 12.0 11.5 12.6 12.8 19.7 16.7 12.5 14.3 14.2 9.2 9.8 10.5 13.3 11.7 13.2 13.6 9.3 15.9 12.3 11.6 14.3 15.9 9.7 15.2 12.4 9.4 15.5 11.9 11.6 16.3 12.3 13.4 15.7 10.0 6.8 10.4 11.7 21.8 7.1 15.3 12.8 13.7 16.1 10.7 16.2 14.1 26.4 17.7 8.9 14.5 13.9 30.1 16.1 15.6 23.3 14.9 14.7 24.7 13.8 9.1 8.3 7.8 7.5 11.9 13.6 9.4 12.8 9.8 11.8 10.9 7.1 12.0 11.3 10.5 9.4 17.5 9.6 12.7 10.8 15.1 10.9 9.4 11.0 7.7 8.3 14.7 9.1 11.7 10.6 16.3 13.0 16.9 11.5 15.0 15.4 12.2 13.5 13.7 5.7 21.8 10.6 15.4 15.0 6.7 9.9 14.0 9.0 12.8 7.0 6.3 7.5 14.0 8.8 17.6 10.8 12.4 10.3 9.0 10.4 7.7 13.8 12.7 11.0 11.8 10.9 10.4 12.1 11.3 17.2 14.9 23.3 16.6 12.9 18.1 16.1 19.7 18.4 15.6 13.3 23.4 18.3 17.7 14.7 13.3 7.7 24.7 13.8 12.0 12.6 16.7 12.5 12.3 11.6 12.4 9.4 13.4 14.1 8.9 6.5 22.3 8.0 11.9 10.3 17.9 2.5 13.4 9.1 5.2 0.0 17.8 19.9 15.8 28.0 12.4 8.0 0.0 10.0 19.6 12.1 9.2 16.1 9.9 13.5 22.3 13.7 7.4 10.3 15.2 10.6 9.5 6.8 19.0 6.4 11.8 10.7 3.5 13.1 17.0 8.0 0.0 16.0 27.2 46.2 12.0 6.8 21.8 8.6 6.0 THAP12 "DAP4, P52rIPK, PRKRIR, THAP0" ENSG00000137492 "THAP domain containing 12" O43422 11 76349956-76380971 "Plasma proteins, Predicted membrane proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 25.9;Exocrine glandular cells: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 71.5" "Low region specificity" "Detected in all" HPA008758 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA008758: AB_1855714" "unprognostic (2.79e-1)" "unprognostic (9.79e-2)" "unprognostic (1.16e-3)" "unprognostic (6.47e-2)" "unprognostic (8.85e-3)" "unprognostic (1.23e-1)" "unprognostic (4.03e-3)" "unprognostic (1.08e-1)" "unprognostic (6.68e-3)" "unprognostic (1.48e-1)" "unprognostic (1.57e-2)" "unprognostic (2.65e-2)" "unprognostic (7.98e-2)" "unprognostic (2.06e-1)" "unprognostic (3.95e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-2)" 17.0 15.4 19.4 15.5 16.9 17.1 26.4 28.8 15.5 14.6 14.5 7.1 7.2 11.9 17.9 13.7 12.5 14.9 10.2 20.6 13.6 11.2 17.0 25.3 13.2 18.5 11.7 8.7 15.2 32.3 10.4 16.2 20.1 14.2 12.8 16.3 8.2 12.4 12.6 20.6 9.3 14.5 13.8 12.7 21.9 13.8 14.4 13.4 43.2 16.3 11.6 17.2 11.9 23.3 5.1 2.9 2.0 2.1 7.5 7.7 2.4 10.7 8.7 16.6 9.3 11.3 16.2 10.0 11.2 11.7 14.2 12.6 17.3 11.6 29.5 17.2 10.7 12.4 10.7 20.2 13.3 22.8 22.1 6.4 21.0 6.2 8.0 12.5 26.6 10.5 11.5 17.6 12.6 23.7 8.6 12.2 21.1 24.3 16.7 12.6 11.7 22.9 15.0 6.8 28.9 9.5 17.2 37.9 30.5 8.2 11.5 16.2 10.8 10.9 12.1 5.9 11.6 12.2 10.5 10.9 17.0 27.9 34.5 9.8 14.9 15.7 71.5 4.1 14.9 9.1 1.1 2.1 2.0 6.6 2.1 7.7 4.9 6.9 7.2 2.9 5.1 5.1 6.6 0.6 7.5 2.0 1.3 6.3 2.4 19.4 16.9 28.8 15.5 13.6 11.2 11.7 8.7 14.2 13.4 23.8 25.9 0.0 0.0 0.0 0.0 0.0 0.0 10.7 11.4 10.4 0.0 12.3 11.6 9.5 0.0 0.0 0.0 0.0 22.9 18.1 0.0 0.0 7.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 14.4 0.0 0.0 13.9 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 THAP5 DKFZp313O1132 ENSG00000177683 "THAP domain containing 5" Q7Z6K1 7 108554543-108569750 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 8 "Early spermatids: 374.3;Late spermatids: 414.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043170, HPA051488" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043170: AB_10964500, HPA051488: AB_2681504" "unprognostic (2.53e-2)" "unprognostic (1.91e-1)" "unprognostic (2.88e-1)" "unprognostic (2.05e-1)" "unprognostic (2.68e-2)" "unprognostic (1.51e-1)" "unprognostic (1.79e-1)" "unprognostic (5.84e-2)" "unprognostic (3.33e-2)" "unprognostic (3.94e-1)" "unprognostic (3.67e-2)" "unprognostic (3.20e-1)" "prognostic favorable (8.99e-4)" "unprognostic (6.00e-2)" "unprognostic (3.39e-2)" "unprognostic (5.96e-3)" "unprognostic (2.79e-2)" 12.8 16.9 17.8 13.2 18.9 5.3 16.2 22.9 22.3 16.4 11.3 11.1 16.1 12.1 16.3 16.5 10.0 12.9 9.9 16.5 18.0 17.6 20.4 25.8 12.7 16.1 24.5 18.7 22.5 16.0 22.7 29.4 14.8 20.2 16.8 10.6 8.1 11.5 24.3 19.6 10.3 11.9 12.3 22.3 14.7 12.4 28.9 22.0 19.4 27.9 9.4 16.0 16.7 15.1 16.8 10.5 21.2 11.4 8.9 15.5 6.2 9.2 7.2 9.3 21.0 6.1 8.6 4.9 8.6 9.8 9.6 10.2 3.6 7.8 11.3 15.4 5.9 12.4 4.0 9.5 6.7 12.5 14.5 7.4 8.5 7.5 3.4 13.0 15.1 11.2 5.3 13.2 5.8 13.9 10.2 5.8 12.9 13.2 24.6 9.6 9.3 22.8 6.6 10.9 5.5 7.1 7.2 13.2 26.3 5.8 5.4 10.9 19.3 12.3 14.6 16.8 7.6 6.1 5.7 5.7 18.2 10.0 14.2 10.5 28.5 24.5 20.9 10.0 9.2 16.3 12.4 6.8 10.7 10.0 8.2 13.3 14.6 11.7 9.5 6.1 16.8 15.5 12.9 21.2 8.9 11.4 10.5 8.8 6.2 17.8 18.9 22.9 22.3 18.0 17.6 24.5 18.7 20.2 22.0 14.9 18.1 27.0 11.6 10.9 38.1 25.4 17.8 33.5 15.9 24.4 7.9 11.7 39.7 12.9 374.3 21.4 12.3 23.3 14.6 7.7 14.3 12.6 30.2 22.1 8.3 44.5 15.1 18.4 10.8 414.2 26.2 19.5 33.7 7.2 15.1 47.9 13.0 12.2 26.5 21.5 33.5 25.8 19.6 31.6 24.4 15.7 12.0 21.8 10.6 5.7 THAP8 FLJ32891 ENSG00000161277 "THAP domain containing 8" Q8NA92 19 36034985-36054762 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 19.3;Spermatogonia: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA064056, HPA070139" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064056: AB_2685184, HPA070139: AB_2686230" "unprognostic (1.33e-3)" "unprognostic (2.24e-1)" "unprognostic (8.03e-2)" "unprognostic (1.08e-2)" "unprognostic (3.10e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (9.01e-3)" "unprognostic (3.94e-1)" "unprognostic (1.27e-1)" "prognostic favorable (3.19e-4)" "unprognostic (2.50e-1)" "unprognostic (2.10e-2)" "unprognostic (9.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.48e-2)" "unprognostic (2.48e-1)" 4.6 5.3 9.1 3.9 10.3 1.3 3.3 6.0 8.7 5.7 11.2 10.1 3.9 4.9 6.4 6.3 5.2 6.8 6.5 4.8 6.5 6.6 5.4 5.6 4.6 4.3 8.5 8.1 6.3 3.4 5.6 6.1 6.4 9.9 5.6 4.1 3.6 5.7 7.5 12.7 8.5 5.0 7.5 9.0 5.0 4.8 15.8 13.3 10.1 5.2 2.6 3.5 7.8 5.0 5.9 6.2 10.4 9.3 7.0 8.4 5.3 2.5 7.9 3.9 3.3 10.5 6.6 2.8 2.3 4.1 4.6 7.6 3.5 2.0 3.8 8.1 3.6 4.7 1.3 2.3 2.9 1.7 2.9 1.9 2.4 2.0 4.0 12.0 1.1 2.3 5.5 4.5 3.1 1.8 5.5 2.3 7.4 2.2 4.7 4.7 4.9 3.1 3.1 3.6 4.8 2.9 3.0 1.3 3.6 3.9 2.4 6.9 5.2 4.0 3.3 2.4 5.5 3.5 1.7 1.5 6.5 4.2 3.4 1.8 3.9 3.3 2.7 6.9 2.3 3.9 10.4 8.6 9.5 7.2 9.3 8.1 5.9 7.5 7.2 6.2 4.9 6.1 8.4 4.0 7.0 8.0 6.2 7.0 5.3 9.1 10.3 6.0 8.7 6.5 6.6 8.5 8.1 9.9 13.3 3.0 3.0 2.7 1.0 1.0 2.1 3.1 5.1 0.0 2.3 7.0 2.0 9.3 1.7 4.0 1.8 1.6 2.6 0.0 0.5 4.0 3.3 0.9 5.7 2.9 13.5 3.2 6.3 2.5 5.1 3.9 1.7 1.8 1.7 5.4 1.3 4.3 3.7 1.5 3.9 7.4 2.2 0.0 2.5 19.3 19.8 1.9 8.8 3.2 2.3 1.0 THEMIS2 "C1orf38, ICB-1" ENSG00000130775 "Thymocyte selection associated family member 2" Q5TEJ8 1 27872543-27886685 "Predicted intracellular proteins" "Immunity, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 72.0;bone marrow: 72.3;lymphoid tissue: 73.0" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 60.6;Kupffer cells: 120.5;Macrophages: 117.1;monocytes: 154.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 43.6;granulocytes: 72.0;monocytes: 62.6" "Cell line enhanced" "Detected in many" "Karpas-707: 48.2;U-266/70: 37.4;U-937: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027513, HPA031096" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA027513: , HPA031096: AB_10599254" "unprognostic (7.38e-2)" "unprognostic (6.56e-2)" "unprognostic (5.07e-2)" "unprognostic (1.99e-3)" "unprognostic (4.51e-2)" "unprognostic (5.56e-3)" "unprognostic (4.13e-1)" "unprognostic (8.21e-2)" "unprognostic (1.77e-2)" "unprognostic (3.05e-2)" "unprognostic (1.38e-2)" "unprognostic (8.96e-2)" "unprognostic (7.21e-3)" "unprognostic (5.07e-2)" "unprognostic (1.42e-2)" "unprognostic (2.24e-3)" "unprognostic (4.52e-3)" 13.4 5.2 4.3 27.2 7.2 72.3 5.8 0.9 4.6 3.6 7.2 10.7 0.3 4.1 3.0 6.6 4.6 5.4 9.5 6.5 7.1 4.6 5.9 7.5 22.1 39.0 11.5 2.7 3.8 2.7 1.0 2.7 7.1 7.8 2.8 4.2 6.0 6.0 1.8 2.3 2.3 12.7 6.0 16.4 73.0 4.8 9.9 6.7 12.5 5.3 1.1 25.2 7.8 3.3 6.5 43.6 72.0 62.6 8.5 11.3 40.5 3.2 0.1 1.2 0.2 4.1 5.7 0.5 0.6 7.0 10.3 14.6 0.4 0.8 4.5 0.4 2.2 5.7 0.4 1.8 0.4 1.6 0.6 0.4 6.3 0.1 0.9 8.2 7.8 10.3 2.9 0.1 5.3 0.0 0.5 3.9 0.3 8.8 48.2 0.7 2.1 0.3 6.8 4.1 0.1 0.7 1.4 4.6 7.9 3.0 0.1 0.0 1.8 0.0 0.2 9.0 0.7 0.1 6.9 2.4 0.6 0.0 2.0 0.1 37.4 2.1 0.3 11.6 21.9 0.1 4.4 54.1 47.1 11.3 62.6 10.3 6.5 8.2 9.1 43.6 2.9 7.1 7.3 72.0 8.5 60.9 17.7 7.9 40.5 4.3 7.2 0.9 4.6 7.1 4.6 11.5 2.7 7.8 6.7 3.0 30.7 30.5 1.4 2.9 0.3 0.5 5.1 1.4 5.7 0.0 0.0 0.6 0.0 0.5 0.9 2.2 0.0 0.0 7.5 1.0 1.8 2.2 12.7 0.8 60.6 0.0 10.3 5.5 120.5 3.6 0.6 117.1 16.9 154.1 0.1 0.0 7.4 0.0 0.4 0.3 0.2 0.0 0.5 0.7 1.9 1.0 2.1 49.0 0.0 3.8 THOC2 "CXorf3, dJ506G2.1, MRX12, MRX35, THO2" ENSG00000125676 "THO complex 2" Q8NI27 X 123600561-123733056 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047921 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA047921: AB_10960388" "unprognostic (2.12e-2)" "unprognostic (5.64e-2)" "unprognostic (3.49e-1)" "unprognostic (3.74e-2)" "unprognostic (2.22e-2)" "unprognostic (3.08e-1)" "prognostic unfavorable (5.77e-5)" "unprognostic (1.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.24e-2)" "unprognostic (3.24e-1)" "unprognostic (6.29e-2)" "unprognostic (4.27e-3)" "unprognostic (6.43e-3)" "unprognostic (1.05e-1)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" 25.9 22.7 25.2 23.3 28.2 21.6 26.6 36.0 29.8 30.1 22.5 17.8 24.8 22.5 27.4 39.8 24.7 21.6 19.9 17.7 25.2 19.2 28.0 20.3 24.0 29.4 28.9 21.9 30.1 23.6 28.3 45.4 22.8 24.9 26.3 23.4 17.2 18.9 24.6 20.6 29.0 31.1 27.0 31.7 27.4 20.0 15.2 29.7 45.3 26.2 20.7 26.3 27.0 21.2 13.5 15.2 9.7 12.7 11.7 16.0 8.2 21.2 17.8 22.8 24.6 16.8 16.2 12.3 14.5 14.4 16.1 21.6 12.4 21.9 21.8 16.7 15.9 15.5 16.3 27.6 10.8 27.4 20.7 25.0 30.5 24.9 16.9 15.7 35.2 21.8 32.0 13.6 18.4 21.3 14.1 14.8 33.4 45.6 19.9 16.2 22.4 30.3 34.6 12.7 28.9 17.6 30.9 14.3 18.0 25.2 24.1 17.6 15.7 40.7 11.3 13.5 19.1 11.2 21.6 15.3 14.5 7.5 20.6 24.4 13.8 20.2 18.8 13.0 31.6 15.8 9.6 9.2 9.7 13.4 12.4 15.6 12.3 14.6 14.4 8.9 13.5 16.0 15.4 5.6 11.7 12.7 15.2 11.1 8.2 25.2 28.2 36.0 29.8 25.2 19.2 28.9 21.9 24.9 29.7 128.1 126.8 63.2 59.8 74.0 64.6 45.3 17.8 91.0 105.8 61.1 149.2 37.4 10.0 44.3 3.8 61.2 57.2 46.7 44.2 29.9 59.6 56.4 77.5 31.4 34.3 50.9 64.8 51.5 45.7 5.4 86.3 57.9 28.7 73.1 47.7 39.1 39.9 35.1 85.9 22.2 106.7 122.9 70.0 45.4 36.7 67.2 36.5 61.8 46.1 67.0 THOC5 "C22orf19, Fmip, fSAP79, KIAA0983, PK1.3" ENSG00000100296 "THO complex 5" Q13769 22 29505879-29555216 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 98.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048402 Supported Nucleoplasm NA NA Nucleoplasm "HPA048402: AB_2680387" "unprognostic (1.16e-1)" "unprognostic (3.05e-1)" "unprognostic (7.77e-2)" "unprognostic (2.27e-2)" "unprognostic (7.20e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (3.76e-6)" "unprognostic (6.34e-2)" "unprognostic (5.54e-2)" "unprognostic (2.55e-1)" "unprognostic (2.45e-1)" "unprognostic (8.81e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (9.53e-2)" "unprognostic (1.24e-1)" "unprognostic (1.24e-1)" "unprognostic (2.97e-1)" 16.8 11.3 10.2 12.2 16.4 14.7 15.1 14.7 26.8 16.5 29.7 20.0 11.6 10.2 30.3 12.9 17.1 19.9 15.6 20.4 10.8 7.2 12.9 12.1 13.3 12.5 12.5 12.1 20.4 13.6 12.4 14.8 10.7 18.9 16.6 12.9 16.8 15.4 19.8 35.7 12.2 15.1 26.7 10.9 14.1 18.7 21.1 14.9 18.8 10.7 9.4 15.9 25.7 16.4 7.5 10.0 25.0 13.1 5.6 10.5 7.2 15.9 10.9 10.0 29.9 19.0 15.6 12.7 30.2 17.9 26.8 26.8 17.5 7.2 9.9 11.8 24.0 16.0 14.4 14.3 16.2 26.4 11.3 14.8 16.2 15.4 19.7 12.9 36.9 13.9 16.2 15.2 26.4 20.5 22.0 19.6 9.9 18.4 10.2 16.6 17.8 11.4 11.5 20.8 13.7 8.5 16.8 24.1 12.2 9.8 12.2 20.5 33.1 16.8 13.5 18.3 13.8 7.6 13.2 13.4 47.5 27.8 11.1 19.6 16.2 15.4 24.2 15.8 15.4 20.1 3.8 9.0 22.0 8.8 11.3 8.8 7.5 7.3 6.4 10.0 6.1 7.8 7.1 25.0 5.6 13.1 2.4 10.5 7.2 10.2 16.4 14.7 26.8 10.8 7.2 12.5 12.1 18.9 14.9 20.8 9.3 4.5 6.7 4.7 11.6 14.7 7.6 13.4 7.9 3.5 19.6 17.1 11.6 18.7 35.0 10.5 9.5 0.0 12.7 19.6 9.2 7.0 10.5 6.7 12.8 7.9 8.6 6.2 7.6 98.6 11.8 8.6 8.5 14.4 4.9 7.3 14.4 7.0 12.0 14.0 24.9 0.0 15.9 40.3 17.6 5.4 14.5 11.3 10.5 4.5 THRSP "Lpgp, LPGP1, S14, SPOT14, THRP" ENSG00000151365 "Thyroid hormone responsive" Q92748 11 78063861-78068351 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 62.0;liver: 92.5;salivary gland: 45.6" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 65.3" "Cancer enhanced" "Detected in many" "liver cancer: 44.1" "Region enriched" "Detected in single" 10 "cerebellum: 1.0" "Cell type enhanced" "Detected in some" "NK-cell: 1.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 13 "ASC diff: 42.5" "Low region specificity" "Detected in all" HPA040642 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040642: AB_10794878" "unprognostic (1.19e-1)" "unprognostic (2.88e-1)" "unprognostic (2.84e-1)" "unprognostic (2.73e-2)" "unprognostic (3.07e-1)" "unprognostic (9.91e-3)" "unprognostic (1.59e-2)" "unprognostic (9.60e-2)" "unprognostic (1.07e-2)" "unprognostic (8.23e-2)" "unprognostic (1.68e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (9.64e-2)" "unprognostic (1.57e-1)" "prognostic favorable (3.28e-4)" "unprognostic (1.69e-3)" 62.0 1.6 0.0 18.3 0.0 0.0 22.7 1.0 0.0 0.0 12.2 0.0 2.8 0.0 0.1 1.2 0.1 0.3 16.5 11.7 0.0 0.0 2.1 92.5 0.0 2.9 0.1 0.0 0.0 1.1 0.3 0.0 0.0 0.1 0.0 0.1 0.2 45.6 2.0 9.3 7.2 1.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 1.6 4.3 0.3 5.7 0.3 0.5 0.1 0.0 0.2 1.5 1.0 0.0 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.5 0.1 0.5 0.2 1.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 65.3 0.0 0.0 0.0 0.6 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 THUMPD2 "C2orf8, MGC2454" ENSG00000138050 "THUMP domain containing 2" Q9BTF0 2 39736060-39779267 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043042, HPA058025" Approved Uncertain Nucleoplasm Yes No Nucleoplasm "HPA043042: AB_10964424, HPA058025: " "unprognostic (6.30e-2)" "unprognostic (9.12e-3)" "unprognostic (2.48e-2)" "unprognostic (4.62e-3)" "unprognostic (2.16e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.22e-1)" "unprognostic (2.31e-2)" "unprognostic (1.30e-1)" "unprognostic (2.72e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (7.27e-5)" "unprognostic (2.17e-1)" "unprognostic (1.61e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-3)" 6.9 7.1 6.3 8.2 7.4 13.3 9.3 21.1 7.9 8.5 6.0 5.0 4.5 7.7 12.0 6.8 9.2 4.3 5.1 8.7 6.0 6.8 7.9 7.3 5.8 9.4 7.1 5.0 10.8 5.9 5.4 19.7 4.3 6.7 6.9 5.1 6.4 6.0 6.4 14.5 5.8 6.5 6.4 5.5 6.6 6.7 3.8 6.4 13.5 7.8 5.1 9.3 6.0 9.6 6.1 9.9 0.3 4.5 8.6 5.2 3.1 9.2 6.0 2.1 8.9 2.9 4.7 4.7 3.9 4.3 4.3 4.7 7.5 6.9 11.9 4.3 2.8 9.9 3.3 11.5 6.7 5.0 14.6 13.8 8.7 4.2 7.3 6.5 10.2 5.4 4.9 4.3 4.1 1.6 4.6 6.4 2.7 9.4 4.1 8.3 3.1 8.8 8.6 0.2 16.9 4.2 6.7 7.8 7.0 4.6 5.5 9.0 6.6 3.3 8.4 5.9 0.7 3.7 5.7 3.9 7.2 6.2 3.2 8.1 6.6 7.6 12.5 4.2 16.3 5.5 0.0 4.5 0.2 3.3 3.2 3.9 6.1 5.2 3.4 5.5 4.7 4.8 4.2 0.3 8.6 2.1 9.9 4.2 3.1 6.3 7.4 21.1 7.9 6.0 6.8 7.1 5.0 6.7 6.4 23.8 19.4 14.8 22.9 12.7 22.1 20.6 7.6 13.4 25.0 14.0 17.7 10.0 16.6 15.0 1.9 11.7 7.3 0.0 12.0 11.4 8.6 13.8 6.9 7.6 9.5 6.4 9.2 9.8 12.4 2.8 25.9 10.6 5.0 7.2 8.4 11.5 13.2 13.3 24.1 11.5 18.3 6.5 12.2 8.9 16.9 11.8 5.7 10.2 11.8 22.1 TICRR "C15orf42, FLJ41618, MGC45866, SLD3, Treslin" ENSG00000140534 "TOPBP1 interacting checkpoint and replication regulator" Q7Z2Z1 15 89575482-89631056 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 9.0;lymphoid tissue: 21.7;tongue: 9.5" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 1.6;Extravillous trophoblasts: 4.8;Spermatogonia: 5.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046746, HPA049454" Supported Nucleoplasm NA Yes Nucleoplasm "HPA046746: AB_2732533, HPA049454: AB_2680773" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (3.41e-1)" "unprognostic (1.10e-1)" "unprognostic (6.22e-5)" "unprognostic (7.73e-3)" "prognostic unfavorable (2.87e-6)" "unprognostic (1.64e-1)" "unprognostic (1.31e-4)" "unprognostic (5.87e-2)" "unprognostic (0.00e+0)" "unprognostic (3.54e-2)" "unprognostic (7.38e-2)" "unprognostic (4.53e-2)" "unprognostic (3.59e-2)" 0.9 0.4 0.3 3.5 0.4 6.9 0.6 0.1 0.4 1.0 2.5 0.1 0.1 2.2 1.0 0.1 9.0 0.7 0.5 0.3 0.2 0.3 0.3 0.2 0.7 2.9 0.4 0.1 0.9 0.1 0.0 0.3 3.9 0.1 0.5 2.6 0.2 1.2 0.1 0.1 1.0 3.2 0.4 0.2 2.9 0.9 7.7 0.1 21.7 0.4 9.5 12.2 0.8 2.3 0.0 0.0 0.0 0.4 0.0 0.7 0.0 7.1 9.8 12.8 7.3 0.5 1.0 7.2 5.2 2.4 7.4 7.8 10.7 5.5 9.5 2.8 1.7 6.2 14.3 17.5 4.6 6.8 4.8 16.9 14.2 9.5 5.6 0.0 10.1 5.2 0.3 0.3 6.0 4.5 1.1 3.6 8.5 13.5 11.1 4.3 6.7 8.8 8.6 8.5 7.1 5.1 12.7 11.5 7.7 1.7 10.2 5.5 5.4 12.5 7.1 2.1 9.8 5.3 6.8 2.2 8.1 10.2 16.4 10.7 2.6 5.0 8.2 2.8 8.6 4.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.4 0.1 0.3 0.2 0.3 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.8 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.7 0.1 0.8 0.0 0.3 0.1 TIMELESS "hTIM, TIM, TIM1" ENSG00000111602 "Timeless circadian regulator" Q9UNS1 12 56416373-56449403 "Predicted intracellular proteins" "Biological rhythms, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 30.7;Spermatogonia: 22.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 9.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA060655 Enhanced Supported Nucleoplasm No No Nucleoplasm "HPA060655: AB_2684338" "unprognostic (3.94e-2)" "unprognostic (1.10e-2)" "unprognostic (1.29e-2)" "unprognostic (2.18e-2)" "unprognostic (2.36e-1)" "unprognostic (3.06e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.06e-5)" "unprognostic (7.03e-2)" "unprognostic (2.53e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.61e-5)" "unprognostic (9.47e-3)" "unprognostic (1.72e-1)" "unprognostic (1.92e-2)" "unprognostic (5.01e-2)" 4.5 6.1 3.3 13.4 9.9 19.2 13.9 4.8 8.7 5.5 6.6 5.3 6.7 5.9 5.9 4.9 10.9 4.1 3.9 3.1 4.4 3.0 5.8 14.0 6.0 14.3 9.2 2.6 3.4 7.8 7.3 9.8 10.7 6.7 4.8 8.8 7.8 6.3 3.7 5.2 5.4 7.9 5.6 7.0 10.8 5.9 7.8 6.6 30.4 6.5 4.8 17.3 5.9 5.8 9.1 2.0 0.6 2.5 2.4 3.0 1.7 12.7 29.5 37.6 17.4 3.4 3.4 21.3 13.9 8.4 19.8 15.7 14.9 18.8 37.0 14.1 8.0 10.0 10.9 27.4 10.8 18.3 17.5 15.4 28.3 15.8 10.9 1.7 21.3 21.1 2.4 3.4 14.2 8.6 5.4 10.5 22.5 26.3 33.4 16.6 24.9 30.1 16.6 26.6 16.1 12.4 30.3 19.2 18.1 7.7 16.3 29.0 20.0 25.9 14.7 4.1 16.2 25.9 16.8 6.2 15.5 15.6 14.1 11.3 12.6 16.1 20.7 7.2 13.1 18.5 0.1 1.0 0.6 3.0 2.5 0.6 5.7 1.9 2.1 1.6 9.1 1.5 0.6 0.3 2.4 1.7 2.0 2.6 1.7 3.3 9.9 4.8 8.7 4.4 3.0 9.2 2.6 6.7 6.6 0.0 5.3 6.0 2.6 3.0 30.7 1.4 2.5 4.0 10.3 7.0 2.0 9.0 0.0 4.0 4.3 5.8 1.0 0.0 4.9 18.9 1.9 3.1 5.7 9.6 7.2 6.4 1.7 4.3 3.3 2.2 1.1 5.4 0.0 5.4 3.4 5.2 3.5 0.0 1.1 1.9 17.1 0.0 1.2 1.1 22.8 1.3 7.7 4.3 6.5 2.6 TKT ENSG00000163931 Transketolase P29401 3 53224707-53256052 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 216.3" "Cell type enhanced" "Detected in all" 5 "Kupffer cells: 587.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "classical monocyte: 63.0;eosinophil: 41.5;intermediate monocyte: 31.0;myeloid DC: 32.5;neutrophil: 60.1;non-classical monocyte: 35.5" "Group enriched" "Detected in all" 8 "dendritic cells: 32.5;granulocytes: 60.1;monocytes: 63.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029480, HPA029481" Enhanced Enhanced Nucleoplasm NA NA 190000000 Nucleoplasm "HPA029480: AB_10599307, HPA029481: AB_10601895" "unprognostic (5.05e-2)" "unprognostic (3.34e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-2)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (7.21e-6)" "unprognostic (6.78e-2)" "unprognostic (1.70e-1)" "unprognostic (4.73e-2)" "unprognostic (3.06e-3)" "unprognostic (1.36e-2)" "unprognostic (2.08e-1)" "unprognostic (2.99e-1)" "unprognostic (1.07e-1)" "unprognostic (3.29e-1)" "unprognostic (9.90e-3)" 53.6 37.0 21.2 24.1 26.0 216.3 70.1 18.1 24.3 19.0 24.3 21.1 9.9 31.8 16.9 9.5 60.4 21.8 36.5 15.3 19.4 23.0 51.9 27.4 50.1 45.6 33.4 16.0 35.2 69.9 22.5 16.9 29.8 28.7 25.2 19.6 17.5 21.0 21.6 5.2 16.8 22.5 34.5 28.2 45.6 24.5 10.8 23.3 44.8 67.7 37.9 25.1 58.2 57.3 6.8 32.5 60.1 63.0 4.7 5.7 37.6 31.4 159.3 22.8 25.3 50.9 62.2 46.6 21.3 37.0 37.0 35.4 44.0 81.1 39.6 10.3 31.1 71.5 45.6 39.5 80.3 11.0 13.2 21.9 26.4 111.4 66.0 62.3 32.2 17.8 45.0 46.2 44.2 22.8 101.2 46.5 33.7 18.7 17.3 15.0 38.5 33.6 36.1 77.4 61.4 38.5 20.3 10.4 73.6 57.8 53.5 14.8 11.0 39.7 63.6 38.3 72.9 19.8 44.6 34.8 11.4 17.7 33.7 40.7 10.0 18.7 23.7 25.0 32.7 21.2 7.0 63.0 41.5 3.0 31.0 3.8 6.8 4.4 3.4 32.5 3.5 4.6 3.4 60.1 4.7 35.5 5.5 5.7 37.6 21.2 26.0 18.1 24.3 19.4 23.0 33.4 16.0 28.7 23.3 125.0 107.1 122.7 318.5 70.5 32.5 12.0 68.8 60.2 69.4 59.3 27.5 317.9 68.0 167.6 5.0 48.1 125.0 23.3 233.6 204.0 47.6 102.3 61.2 73.1 233.2 35.0 50.5 56.4 587.5 2.7 145.6 247.7 72.6 160.5 113.7 78.1 222.7 69.1 100.4 170.5 36.1 51.8 72.1 14.1 21.1 58.6 345.9 84.1 213.7 357.0 TLE1 "ESG, ESG1, GRG1" ENSG00000196781 "Transducin like enhancer of split 1" Q04724 9 81583683-81689305 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 116.4;Spermatogonia: 119.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011482, HPA071396" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB011482: AB_443210, HPA071396: AB_2686392" "unprognostic (5.86e-2)" "unprognostic (2.59e-1)" "unprognostic (3.71e-1)" "unprognostic (8.49e-2)" "unprognostic (2.62e-1)" "unprognostic (4.18e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-3)" "unprognostic (3.59e-2)" "unprognostic (3.75e-2)" "unprognostic (4.95e-2)" "unprognostic (3.65e-1)" "prognostic favorable (8.07e-4)" "unprognostic (2.56e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (7.60e-4)" "unprognostic (4.09e-1)" 26.4 20.1 27.5 12.2 23.1 24.3 23.0 20.3 22.0 25.7 15.2 9.7 13.8 4.0 22.8 19.2 12.7 18.6 19.3 8.1 31.8 9.3 8.6 33.9 9.1 18.8 14.0 20.0 18.1 37.2 5.6 7.9 12.1 14.2 14.6 12.5 13.3 29.0 18.1 54.1 11.8 11.9 20.1 10.5 22.6 15.4 15.0 20.5 2.1 11.0 15.3 8.3 12.9 24.7 6.9 2.0 8.7 0.1 4.9 3.5 0.6 22.9 15.6 15.1 0.0 16.1 9.0 33.6 1.4 4.2 2.5 3.7 2.4 8.5 0.0 15.3 9.6 21.5 12.7 0.2 7.4 2.7 0.0 14.4 0.0 3.2 24.1 9.2 0.0 0.4 4.3 16.6 8.7 17.5 7.6 10.8 6.7 0.0 7.7 8.8 24.5 2.7 0.1 29.6 12.9 9.3 21.3 12.7 1.7 16.0 11.4 8.7 10.9 1.2 12.4 7.5 15.7 9.4 10.7 9.2 6.8 7.5 3.6 10.7 0.2 0.0 0.5 9.6 0.0 12.6 8.7 0.0 5.0 2.5 0.0 3.5 6.9 0.2 1.0 0.6 6.6 0.0 0.2 0.0 4.9 0.1 2.0 0.0 0.6 27.5 23.1 20.3 22.0 31.8 9.3 14.0 20.0 14.2 20.5 0.0 6.2 33.3 18.3 48.4 28.0 5.3 40.8 18.7 13.6 14.0 15.7 52.9 13.3 37.5 0.7 37.2 25.3 0.0 20.3 62.7 23.8 31.9 0.0 54.2 6.9 15.9 27.6 23.9 3.5 2.4 21.0 8.2 43.9 13.6 21.1 35.7 43.9 31.7 32.2 2.5 6.3 116.4 40.6 1.6 119.9 38.1 42.4 26.1 31.2 27.2 TLE3 "ESG, ESG3, GRG3, HsT18976, KIAA1547" ENSG00000140332 "Transducin like enhancer of split 3" Q04726 15 70047790-70098176 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 116.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 27.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 27.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054116 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA054116: AB_2682386" "unprognostic (5.57e-2)" "prognostic favorable (2.09e-5)" "unprognostic (5.18e-2)" "unprognostic (5.13e-2)" "unprognostic (1.15e-1)" "unprognostic (4.05e-2)" "unprognostic (1.35e-2)" "unprognostic (5.53e-2)" "unprognostic (6.74e-2)" "unprognostic (3.11e-2)" "unprognostic (1.72e-1)" "unprognostic (6.07e-2)" "unprognostic (4.90e-2)" "unprognostic (2.43e-1)" "unprognostic (6.71e-2)" "unprognostic (6.29e-2)" "unprognostic (2.74e-1)" 18.7 5.5 10.1 28.8 6.3 62.9 13.1 6.1 11.2 16.0 16.5 10.4 14.2 16.5 9.9 9.2 24.1 8.6 11.3 8.6 8.6 6.9 10.9 13.8 16.8 15.4 7.6 5.7 12.3 14.7 5.2 9.2 34.4 9.5 19.4 7.2 11.3 15.7 18.1 7.6 21.6 27.4 7.5 12.5 20.9 14.1 18.4 6.5 30.7 14.8 12.8 28.0 10.2 15.8 6.0 4.8 27.1 2.7 1.5 2.0 0.8 2.9 9.4 5.8 8.3 4.7 4.4 30.6 1.0 2.1 1.3 0.9 13.0 8.5 7.7 12.9 1.0 1.8 5.3 14.5 5.3 1.4 10.9 17.8 12.6 19.2 2.3 4.5 4.2 19.8 7.6 2.1 4.8 3.8 8.0 6.8 18.1 9.5 35.4 2.2 8.1 14.3 10.8 5.2 2.4 9.7 13.4 5.1 8.9 2.4 17.6 7.4 10.8 23.4 10.7 10.5 7.9 11.9 9.2 4.4 3.9 7.6 11.5 6.6 33.7 21.3 13.3 5.6 13.0 9.4 1.3 2.7 1.3 1.1 2.6 1.0 6.0 1.5 1.4 1.6 2.9 1.6 2.0 27.1 1.5 2.7 4.8 0.9 0.8 10.1 6.3 6.1 8.7 8.6 6.9 7.6 5.7 9.5 6.5 11.9 29.6 50.2 43.6 102.2 21.8 9.0 5.1 9.4 18.2 59.3 29.5 21.7 6.6 11.4 32.7 16.3 38.3 23.3 4.8 49.1 25.2 38.0 50.9 20.2 34.5 0.0 27.6 27.6 44.2 62.0 13.0 43.9 33.7 21.6 27.2 29.6 7.4 24.6 17.3 10.3 3.6 0.0 28.1 4.7 26.5 116.1 68.9 13.8 28.6 28.4 TLE4 "E(spI), ESG, GRG4" ENSG00000106829 "Transducin like enhancer of split 4" Q04727 9 79571773-79726882 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 66.2" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 722.1;Late spermatids: 937.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 33.0;BJ hTERT+: 32.9;BJ hTERT+ SV40 Large T+: 31.0;fHDF/TERT166: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065357 Supported Nucleoplasm NA NA Nucleoplasm "HPA065357: AB_2685479" "unprognostic (6.68e-2)" "unprognostic (8.50e-3)" "unprognostic (2.13e-3)" "unprognostic (2.92e-1)" "unprognostic (1.91e-1)" "unprognostic (9.79e-2)" "unprognostic (1.24e-2)" "unprognostic (4.83e-1)" "unprognostic (2.83e-1)" "unprognostic (1.62e-1)" "unprognostic (9.94e-3)" "unprognostic (1.04e-1)" "prognostic favorable (6.94e-4)" "unprognostic (1.49e-1)" "unprognostic (3.04e-1)" "unprognostic (2.02e-1)" "unprognostic (1.82e-1)" 6.1 11.6 11.6 11.6 25.3 40.0 6.9 22.5 21.2 7.4 7.3 28.8 3.6 6.0 11.4 5.5 12.8 10.3 13.0 6.2 14.7 11.3 5.6 4.4 8.9 10.8 28.9 15.0 26.1 5.3 14.0 45.2 14.6 20.4 4.9 8.6 8.6 7.5 7.1 23.8 13.5 8.0 11.2 31.2 12.4 10.5 66.2 30.3 18.8 8.1 5.1 14.2 12.2 9.3 1.2 2.2 17.3 4.7 2.3 4.8 2.0 0.0 5.9 24.1 0.1 4.4 3.7 7.4 33.0 32.9 31.0 12.3 0.8 3.4 2.7 0.0 51.5 4.5 6.9 1.6 5.8 15.0 11.8 10.2 0.0 2.9 0.1 4.7 7.0 4.3 4.2 4.3 8.8 1.7 8.8 8.0 4.7 0.5 7.2 10.3 0.2 9.1 3.0 7.6 4.2 1.5 8.3 12.7 2.3 1.9 0.9 9.9 14.7 4.6 0.6 0.0 11.8 0.0 8.1 11.5 12.0 0.0 0.2 1.6 4.7 7.6 3.5 4.2 6.1 5.5 17.3 3.4 12.9 3.9 4.7 4.8 1.1 2.1 2.9 2.2 1.2 1.2 2.1 9.2 2.3 3.6 0.8 0.5 2.0 11.6 25.3 22.5 21.2 14.7 11.3 28.9 15.0 20.4 30.3 6.0 20.8 54.1 48.8 107.4 74.6 15.3 61.1 24.1 25.0 14.0 119.8 55.1 3.3 11.6 722.1 49.7 119.6 0.0 19.5 58.1 45.9 27.8 20.7 12.8 42.0 206.6 24.2 36.8 152.5 937.0 97.8 71.8 40.5 27.9 68.5 23.4 25.3 203.4 43.9 15.3 271.5 71.1 60.8 39.3 150.1 79.4 54.3 87.1 54.2 84.6 TLK1 "KIAA0137, PKU-BETA" ENSG00000198586 "Tousled like kinase 1" Q9UKI8 2 170990823-171231314 "Enzymes, Predicted intracellular proteins" "Cell cycle, DNA damage" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016043 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA016043: AB_1858027" "unprognostic (2.13e-2)" "unprognostic (3.87e-1)" "unprognostic (7.36e-2)" "unprognostic (6.00e-3)" "unprognostic (2.00e-1)" "unprognostic (6.78e-2)" "unprognostic (2.47e-2)" "unprognostic (7.60e-2)" "unprognostic (1.61e-1)" "unprognostic (5.26e-2)" "unprognostic (2.57e-1)" "unprognostic (1.11e-1)" "unprognostic (6.13e-2)" "unprognostic (2.08e-1)" "unprognostic (1.55e-1)" "unprognostic (2.63e-1)" "unprognostic (1.53e-1)" 13.8 20.1 22.0 32.9 21.0 14.4 26.2 18.3 23.2 19.6 20.2 8.4 22.3 13.7 16.1 16.1 14.1 14.4 16.2 12.7 20.6 19.3 19.5 21.4 22.1 33.7 21.7 20.8 21.5 19.8 37.8 21.0 36.0 18.3 18.0 18.2 10.8 16.4 30.3 18.6 15.4 18.9 20.5 18.7 26.0 19.9 24.2 12.2 28.0 25.7 11.1 21.7 21.9 19.1 10.5 5.3 11.3 5.5 9.5 12.3 6.6 8.6 8.5 12.3 9.6 8.8 8.8 13.6 12.1 17.6 12.2 10.2 11.7 14.2 18.0 9.9 18.1 13.2 7.4 15.6 13.5 13.4 21.4 7.8 20.8 10.6 15.1 9.5 26.3 10.5 9.6 13.8 24.2 16.0 13.0 13.3 11.6 21.3 15.4 7.3 10.8 22.1 8.4 11.3 8.4 4.8 16.7 14.9 18.6 10.0 16.7 14.0 10.9 13.1 9.3 8.9 8.7 7.6 9.2 18.1 10.9 13.4 7.1 9.4 12.9 21.7 32.7 13.5 10.9 10.9 11.3 3.9 6.5 6.6 3.0 9.1 10.5 10.7 7.2 3.5 10.5 12.3 8.1 5.0 9.5 5.5 5.3 10.0 6.6 22.0 21.0 18.3 23.2 20.6 19.3 21.7 20.8 18.3 12.2 47.6 23.8 55.6 30.2 36.7 31.7 26.5 28.1 33.5 29.6 48.8 56.9 70.8 74.6 24.8 57.8 27.4 38.0 23.3 28.2 44.9 25.5 42.8 26.5 30.0 23.9 42.9 23.0 12.3 25.7 21.5 40.0 26.9 35.4 15.4 31.6 25.5 28.4 34.8 42.1 38.3 72.6 0.0 28.8 29.9 22.6 34.3 146.2 48.0 28.0 31.4 TLX2 "Enx, HOX11L1, NCX, Tlx2" ENSG00000115297 "T cell leukemia homeobox 2" O43763 2 74513463-74517147 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.0;brain: 4.3;retina: 3.8" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 19.6;Rod photoreceptor cells: 16.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "SH-SY5Y: 38.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA062254 Approved Nucleoplasm NA NA Nucleoplasm "HPA062254: AB_2684727" "unprognostic (7.30e-2)" "unprognostic (3.03e-4)" "unprognostic (9.54e-4)" "unprognostic (2.86e-2)" "unprognostic (2.33e-1)" "unprognostic (1.69e-2)" "unprognostic (6.77e-2)" "unprognostic (1.36e-1)" "unprognostic (9.00e-2)" "unprognostic (3.91e-2)" "unprognostic (1.39e-1)" "unprognostic (5.40e-1)" "unprognostic (3.92e-7)" "unprognostic (2.51e-1)" "unprognostic (6.86e-2)" "unprognostic (5.04e-2)" "unprognostic (1.18e-1)" 0.1 8.0 1.7 1.7 4.0 0.2 0.1 0.8 4.3 0.1 2.7 0.0 0.0 1.9 0.1 0.1 0.5 0.1 0.6 0.1 0.4 0.7 0.1 0.1 0.1 0.5 0.8 0.0 0.1 0.6 0.5 0.0 0.2 3.5 0.1 0.7 3.8 0.1 0.1 0.1 0.4 2.5 0.2 0.3 0.2 0.9 3.3 0.6 2.5 0.1 0.0 0.3 2.1 0.4 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 2.0 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.3 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.0 0.8 4.3 0.4 0.7 0.8 0.0 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.5 0.0 0.0 1.7 3.2 0.0 0.0 0.0 0.0 0.0 TLX3 "HOX11L2, RNX" ENSG00000164438 "T cell leukemia homeobox 3" O43711 5 171309284-171312134 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "brain: 46.6" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 5.2" "Cancer enhanced" "Detected in some" "cervical cancer: 1.7" "Region enriched" "Detected in some" 22 "cerebellum: 46.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 24.6" "Region enriched" "Detected in single" 7 "cerebellum: 2.5" "Region enriched" "Detected in some" 10 "cerebellum: 48.1" "HPA030504, HPA060957, HPA069359" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130" "unprognostic (3.52e-2)" "unprognostic (2.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.11e-1)" "unprognostic (9.80e-2)" "unprognostic (2.76e-2)" "unprognostic (4.48e-2)" 0.4 0.5 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 TMEM100 "FLJ10970, FLJ37856" ENSG00000166292 "Transmembrane protein 100" Q9NV29 17 55719627-55732121 "Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 52.8;lung: 99.5" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 20.4;Leydig cells: 37.7;Peritubular cells: 49.5;Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 18.1;ASC TERT1: 12.3;HHSteC: 28.0;HSkMC: 12.9;U-87 MG: 8.5;WM-115: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055936 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA055936: AB_2682975" "unprognostic (1.35e-1)" "unprognostic (2.75e-1)" "unprognostic (1.57e-1)" "unprognostic (4.02e-2)" "unprognostic (6.78e-3)" "unprognostic (3.07e-1)" "prognostic favorable (2.67e-5)" "unprognostic (5.74e-2)" "unprognostic (1.87e-2)" "unprognostic (4.66e-1)" "unprognostic (1.89e-2)" "unprognostic (8.11e-3)" "prognostic unfavorable (1.32e-4)" "unprognostic (4.91e-3)" "unprognostic (1.12e-1)" "unprognostic (2.07e-2)" "unprognostic (1.26e-3)" 24.7 2.0 3.4 1.5 3.9 0.0 52.8 0.7 5.3 5.1 10.5 0.7 8.8 2.7 1.6 16.7 4.6 3.6 4.8 5.8 1.6 2.8 1.2 5.8 99.5 1.5 3.4 0.6 10.1 1.9 0.0 3.3 23.5 2.6 7.4 5.1 2.6 2.2 11.7 7.0 1.3 6.6 5.2 1.4 2.3 10.7 3.9 0.6 0.5 3.8 3.7 1.3 5.3 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 18.1 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 28.0 0.0 0.0 12.9 0.0 0.9 0.1 0.1 0.0 0.2 0.5 0.1 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 1.2 2.4 0.0 0.5 0.0 0.1 8.5 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.9 0.7 1.7 1.6 2.8 3.4 0.6 2.6 0.6 0.0 5.1 0.0 0.3 2.3 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 14.1 0.0 0.0 0.0 0.0 20.4 0.1 1.1 13.9 0.1 0.0 0.0 7.4 0.0 0.0 37.7 0.6 6.8 0.0 0.0 0.0 0.2 0.0 49.5 0.5 0.0 32.3 12.2 0.0 0.0 2.3 0.1 0.0 0.0 0.1 TMEM184A "MGC9712, SDMG1" ENSG00000164855 "Transmembrane protein 184A" Q6ZMB5 7 1542235-1560821 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.2;intestine: 39.3" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 57.2;Mucus-secreting cells: 31.0;Paneth cells: 31.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 15.2;RT4: 17.3;SCLC-21H: 17.8;SK-BR-3: 27.6;T-47d: 24.4" "Low region specificity" "Detected in many" "HPA053790, HPA071312" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA053790: AB_2682263, HPA071312: AB_2686387" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.38e-1)" "unprognostic (4.41e-3)" "unprognostic (1.07e-1)" "unprognostic (2.36e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-1)" "unprognostic (1.31e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (5.47e-2)" 0.4 0.1 0.2 3.5 0.2 0.1 1.6 0.2 0.3 8.6 15.6 0.2 8.0 15.1 1.7 2.9 40.2 4.4 9.6 0.2 0.2 0.1 5.3 18.0 1.5 0.2 0.2 0.3 0.9 24.7 3.1 5.4 14.3 0.4 5.1 4.0 0.3 10.3 12.0 2.3 17.9 39.3 1.2 0.2 0.2 7.5 3.8 0.2 0.5 0.3 22.9 31.9 10.0 15.8 0.8 0.8 2.0 0.5 0.4 0.5 0.0 9.7 6.6 0.0 0.0 0.0 0.0 2.2 0.3 0.1 0.4 0.0 8.9 11.7 0.2 3.4 0.1 3.6 7.5 0.0 4.4 0.1 0.1 0.2 0.0 6.0 4.0 0.1 0.0 0.0 0.0 4.3 0.1 3.9 0.2 0.0 2.9 0.1 0.0 0.0 15.2 0.0 0.0 0.3 6.0 8.6 0.2 0.0 4.7 3.3 17.3 17.8 0.0 2.9 27.6 0.0 0.2 24.4 0.0 0.0 0.0 3.7 4.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.2 0.5 0.1 0.3 0.2 0.3 0.2 0.1 0.8 0.4 0.3 2.0 0.4 0.2 0.8 0.3 0.0 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.3 0.4 0.2 3.0 4.1 0.8 5.3 3.5 0.9 2.5 17.8 13.4 10.3 8.7 0.0 6.6 1.7 11.9 0.0 0.7 57.2 0.0 9.6 7.7 1.3 11.9 1.1 12.4 0.7 0.0 6.9 0.0 1.2 0.0 0.0 1.7 0.0 1.0 31.0 0.0 12.3 31.6 0.0 3.8 0.4 0.0 1.0 0.0 0.0 8.2 14.1 0.0 13.3 11.3 TMEM189-UBE2V1 "CROC-1B, Kua-UEV" ENSG00000124208 "TMEM189-UBE2V1 readthrough" 20 50081124-50153637 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 4.5;Ciliated cells: 9.4;Club cells: 9.1;granulocytes: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA052535, HPA053186" Supported Nucleoplasm NA NA Nucleoplasm "HPA052535: AB_2681863, HPA053186: AB_2682073" "unprognostic (3.69e-1)" "unprognostic (1.27e-1)" "unprognostic (2.41e-3)" "unprognostic (2.71e-2)" "unprognostic (1.52e-1)" "unprognostic (6.05e-3)" "unprognostic (2.40e-1)" "unprognostic (8.19e-2)" 9.2 4.4 4.6 7.5 9.7 1.2 5.1 6.1 7.1 4.3 3.9 14.2 6.8 2.0 4.7 3.0 5.9 2.9 3.1 3.9 4.4 4.5 3.4 8.4 5.0 3.6 14.0 3.0 4.3 9.1 5.5 4.3 15.0 8.3 3.8 1.6 2.0 3.7 4.6 8.4 4.0 4.4 4.8 7.9 4.6 7.6 12.2 10.2 3.5 3.2 4.0 5.6 4.5 3.5 6.1 9.1 11.3 15.3 8.0 8.7 9.9 3.4 5.8 2.1 5.4 8.9 6.1 6.4 5.9 3.9 8.1 4.6 12.4 7.3 1.7 8.2 3.2 7.4 14.9 3.2 6.6 1.4 0.8 1.1 2.5 10.2 7.5 4.1 4.3 4.6 6.1 12.2 6.0 2.2 0.6 8.0 0.8 4.1 5.2 3.6 4.2 3.2 0.4 1.5 1.3 1.4 3.1 1.7 2.9 2.3 9.4 3.3 1.5 2.8 12.3 2.6 0.1 2.6 4.0 12.4 9.5 3.6 2.6 3.8 1.3 1.7 0.6 4.2 1.1 6.2 7.5 9.4 11.3 8.7 13.5 7.6 4.1 7.9 8.6 9.1 6.1 7.4 7.8 1.3 8.0 15.3 5.5 8.2 9.9 4.6 9.7 6.1 7.1 4.4 4.5 14.0 3.0 8.3 10.2 8.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 9.4 9.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM220 ENSG00000187824 "Transmembrane protein 220" Q6QAJ8 17 10699015-10730316 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 58.2" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 146.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047680 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047680: " "unprognostic (1.71e-2)" "unprognostic (4.60e-2)" "unprognostic (6.31e-3)" "unprognostic (4.04e-3)" "unprognostic (1.05e-3)" "unprognostic (1.84e-4)" "prognostic favorable (2.23e-5)" "unprognostic (4.58e-2)" "unprognostic (4.96e-3)" "unprognostic (2.81e-1)" "prognostic favorable (1.72e-4)" "unprognostic (2.97e-1)" "unprognostic (4.34e-3)" "unprognostic (2.25e-1)" "unprognostic (2.63e-2)" "unprognostic (7.80e-3)" "unprognostic (5.97e-2)" 6.5 7.4 4.5 2.4 4.6 3.3 7.8 1.3 2.8 4.7 6.1 3.8 14.3 8.1 4.9 11.1 3.3 3.9 10.1 6.3 3.8 2.4 6.4 58.2 4.6 3.1 2.9 1.2 4.8 6.0 2.4 2.4 1.7 4.9 12.0 2.8 6.6 3.5 18.5 4.1 3.7 15.4 5.4 2.5 4.7 7.1 17.2 3.5 0.6 9.4 2.6 2.4 4.1 3.4 11.6 2.9 2.3 2.5 4.5 9.0 1.9 0.5 3.5 1.3 8.3 5.2 5.2 1.0 6.9 7.3 4.7 6.8 0.0 0.3 1.2 0.5 4.3 0.4 0.4 3.4 0.6 3.5 0.4 1.5 0.5 0.2 2.9 7.6 0.9 0.8 3.4 0.4 1.5 0.3 1.0 2.2 3.0 0.4 0.3 3.0 0.4 1.1 1.5 5.0 0.4 0.0 4.8 0.2 0.6 11.1 0.2 0.5 6.0 0.3 0.1 0.7 1.9 0.4 1.8 4.8 0.4 1.3 2.6 0.4 0.8 0.3 0.3 4.9 1.4 0.6 1.4 2.5 2.3 0.9 1.8 1.1 4.2 2.2 1.3 2.9 11.6 9.0 6.1 2.1 4.5 0.8 2.3 0.4 1.9 4.5 4.6 1.3 2.8 3.8 2.4 2.9 1.2 4.9 3.5 3.0 8.3 5.6 13.2 8.5 1.5 8.8 56.0 8.1 11.4 17.4 7.9 10.1 18.3 13.7 72.2 7.9 60.8 23.3 20.8 20.6 12.0 37.1 39.3 146.5 20.4 0.0 2.9 10.4 11.8 12.5 16.7 5.4 23.6 6.4 15.2 44.1 14.9 28.8 9.2 20.3 22.1 19.4 9.6 52.0 7.5 6.9 3.8 2.5 10.0 21.1 TMEM233 IFITMD2 ENSG00000224982 "Transmembrane protein 233" B4DJY2 12 119593459-119643066 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 88.0" "Cell type enriched" "Detected in some" 4 "granulocytes: 76.3" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 12.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 11.5;hTERT-RPE1: 4.7;RH-30: 6.1;U-2197: 9.2;U-87 MG: 37.0" "Not detected" "Not detected" "HPA047506, HPA075435" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047506: AB_10963068, HPA075435: " "unprognostic (1.46e-2)" "unprognostic (1.16e-2)" "unprognostic (1.39e-3)" "unprognostic (1.03e-2)" "unprognostic (1.99e-3)" "unprognostic (1.71e-2)" "unprognostic (5.86e-2)" "unprognostic (1.55e-2)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (4.41e-2)" "unprognostic (6.06e-2)" "unprognostic (3.10e-3)" "unprognostic (2.94e-1)" "unprognostic (4.38e-2)" "unprognostic (3.66e-1)" 0.6 0.3 0.8 0.0 0.4 0.0 0.6 0.1 8.8 0.2 0.2 0.0 0.0 0.1 0.9 0.6 0.2 0.2 1.0 0.7 0.2 0.5 0.5 0.3 0.6 0.2 0.1 1.4 0.6 0.1 1.7 0.4 0.0 0.4 0.4 0.1 0.7 0.5 0.3 88.0 0.1 0.2 0.5 0.3 0.2 0.2 0.2 0.0 0.1 11.1 5.2 0.3 0.4 1.8 0.3 0.3 0.7 0.1 0.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 11.5 0.0 4.7 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.2 0.3 0.3 0.2 0.0 0.3 0.2 0.5 0.7 0.6 0.1 0.3 0.1 0.1 0.8 0.4 0.1 1.5 0.2 0.5 0.1 1.4 0.4 0.0 3.0 1.4 0.0 0.3 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 7.2 6.8 0.0 0.0 7.8 0.0 0.4 0.3 76.3 0.0 0.1 7.9 0.0 18.4 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 2.1 0.0 0.2 2.3 0.2 0.1 0.1 0.0 0.0 0.2 TMEM250 "bA83N9.1, C9orf69" ENSG00000238227 "Transmembrane protein 250" H0YL14 9 136114581-136118863 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 14.0;Cytotrophoblasts: 14.7;Extravillous trophoblasts: 18.7;Hofbauer cells: 13.1;Pancreatic endocrine cells: 13.9;Proximal tubular cells: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066070 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA066070: AB_2685608" "unprognostic (2.79e-2)" "unprognostic (3.47e-1)" "unprognostic (1.34e-2)" "prognostic favorable (1.09e-4)" "unprognostic (4.99e-2)" "unprognostic (2.34e-2)" "unprognostic (4.34e-2)" "unprognostic (1.27e-3)" "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (6.31e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-2)" "unprognostic (9.33e-3)" "unprognostic (1.09e-2)" "unprognostic (2.41e-2)" "unprognostic (1.64e-1)" 16.4 11.4 16.1 15.0 19.4 5.5 25.3 13.8 28.4 12.4 19.3 9.2 8.2 22.5 12.2 10.9 22.2 14.2 13.8 10.7 17.1 9.5 13.0 17.6 15.2 15.2 9.4 14.2 15.9 12.7 9.4 10.1 15.2 9.8 13.4 11.4 7.4 18.3 13.0 33.9 26.8 18.9 14.1 7.7 14.0 17.3 12.8 10.0 15.4 11.2 12.9 12.0 13.2 11.8 3.0 4.6 5.3 6.3 4.7 9.9 3.0 11.0 21.0 8.2 12.2 11.7 10.7 25.7 13.3 9.6 8.1 5.8 11.9 16.2 8.2 15.7 14.2 12.9 28.4 5.8 9.4 2.5 35.3 11.1 6.9 21.9 8.3 16.3 12.5 9.0 9.6 18.1 8.7 9.2 10.4 12.8 8.2 15.5 8.7 7.0 25.5 15.2 10.1 18.2 19.4 23.0 6.2 11.4 13.5 8.8 8.1 14.2 10.8 14.4 10.0 11.4 5.1 9.1 18.9 14.4 14.2 6.3 18.5 14.7 5.1 4.9 4.9 14.2 9.0 13.3 4.9 4.6 2.7 9.9 6.2 7.4 3.0 7.6 8.3 4.6 2.4 3.7 6.9 5.3 4.7 6.3 3.0 3.8 3.0 16.1 19.4 13.8 28.4 17.1 9.5 9.4 14.2 9.8 10.0 6.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 14.0 0.0 14.7 3.3 10.6 0.0 0.0 0.0 0.0 9.1 18.7 0.0 0.0 2.3 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 6.4 0.0 0.0 13.9 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 TMEM255B "FAM70B, MGC20579" ENSG00000184497 "Transmembrane protein 255B" Q8WV15 13 113759240-113816995 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Endothelial cells: 51.3;granulocytes: 39.2;Ito cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 7 "granulocytes: 17.0;monocytes: 4.8" "Cell line enhanced" "Detected in many" "HMC-1: 15.7;HUVEC TERT2: 20.4;PC-3: 20.7;RPMI-8226: 13.2;TIME: 19.1;U-87 MG: 21.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA043334 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043334: AB_10795982" "unprognostic (2.20e-1)" "unprognostic (2.57e-3)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (4.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.13e-1)" "unprognostic (1.99e-1)" "unprognostic (4.49e-3)" "unprognostic (3.00e-2)" "unprognostic (9.39e-2)" "prognostic unfavorable (4.12e-5)" "unprognostic (4.65e-2)" "unprognostic (1.84e-1)" "unprognostic (4.00e-1)" "unprognostic (2.83e-1)" 18.5 6.6 3.9 7.1 4.5 1.5 11.8 2.0 4.7 11.1 3.9 2.3 4.3 3.5 10.1 5.3 3.9 6.6 7.5 7.3 6.5 3.7 9.0 6.6 11.7 7.9 5.4 2.1 4.6 4.7 3.1 8.0 2.4 6.1 8.8 3.2 3.3 3.8 5.1 4.6 6.0 4.5 10.4 4.9 9.5 4.4 4.6 4.0 0.1 12.4 2.4 3.7 8.1 29.9 1.5 1.3 17.0 4.8 0.0 0.0 1.0 5.3 0.0 0.3 0.0 1.5 0.0 0.0 2.5 5.7 2.9 1.8 0.2 0.1 0.1 0.0 3.9 6.8 0.8 0.5 0.3 1.2 0.0 0.6 0.1 0.2 0.0 0.9 1.4 15.7 1.1 1.3 6.3 2.4 8.4 20.4 0.3 0.0 0.1 6.3 0.1 0.7 0.4 0.6 0.8 20.7 0.9 0.4 13.2 2.9 0.2 1.2 2.8 0.1 0.7 0.0 0.6 0.3 4.2 19.1 0.8 5.8 0.3 0.9 0.0 0.0 1.0 21.8 1.4 0.1 17.0 4.8 0.6 0.0 4.5 0.0 0.8 0.0 0.0 1.3 1.5 0.0 0.0 2.2 0.0 3.2 0.0 0.0 1.0 3.9 4.5 2.0 4.7 6.5 3.7 5.4 2.1 6.1 4.0 6.0 7.4 0.5 1.1 5.3 0.7 6.7 0.0 0.0 0.0 1.8 0.0 0.0 1.7 8.3 0.6 51.3 0.0 23.3 1.5 0.1 3.7 1.3 39.2 0.4 11.0 0.0 1.2 111.1 17.8 0.4 7.2 14.4 8.5 4.6 0.0 0.5 1.5 0.0 2.8 0.0 0.7 6.5 4.1 1.4 17.0 4.1 0.0 0.0 0.4 0.6 TMEM38A "MGC3169, TRIC-A" ENSG00000072954 "Transmembrane protein 38A" Q9H6F2 19 16661127-16690029 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 158.8" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 21.6;Cardiomyocytes: 22.4;Cone photoreceptor cells: 80.5;Peritubular cells: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 20.3" "Cell line enhanced" "Detected in many" "Daudi: 12.1;U-266/70: 12.2;U-698: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048100, HPA050463" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA048100: , HPA050463: AB_2681137" "unprognostic (1.56e-1)" "unprognostic (1.04e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-1)" "unprognostic (2.99e-1)" "unprognostic (3.49e-1)" "prognostic favorable (2.78e-5)" "unprognostic (2.94e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.99e-10)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (4.50e-3)" "unprognostic (1.96e-2)" 1.3 1.6 3.6 1.1 7.9 2.3 1.2 5.1 12.2 1.3 1.4 2.1 3.1 1.3 1.1 6.6 3.5 1.8 1.0 5.4 3.0 3.8 2.0 2.7 2.1 1.3 5.2 3.7 1.2 1.3 1.7 2.2 0.9 4.8 2.9 1.5 8.3 2.7 2.4 158.8 1.0 1.1 1.1 1.9 1.0 5.3 1.6 1.4 0.0 1.8 30.1 1.9 1.1 0.4 3.9 0.5 20.3 2.9 2.1 0.5 0.6 3.0 0.6 0.8 4.7 2.6 0.3 0.4 1.1 0.6 0.7 1.5 0.9 4.4 12.1 1.9 0.2 4.2 2.5 6.2 1.3 0.7 0.8 1.8 0.0 1.8 1.0 0.7 0.1 0.2 1.1 4.8 0.9 0.5 3.6 0.3 2.2 0.1 1.1 0.5 4.6 0.1 1.2 1.2 11.3 7.2 6.3 1.1 3.2 4.6 2.3 7.8 5.4 3.3 0.4 1.5 0.4 2.3 1.0 0.0 0.9 2.3 2.9 0.5 12.2 8.8 20.3 1.1 7.2 0.9 20.3 2.9 8.2 0.0 1.1 0.0 2.8 0.4 0.0 0.2 3.9 0.1 0.1 1.6 2.1 0.7 0.5 0.5 0.6 3.6 7.9 5.1 12.2 3.0 3.8 5.2 3.7 4.8 1.4 3.0 1.0 0.8 2.8 1.0 21.6 22.4 0.0 1.4 1.2 0.0 80.5 0.0 1.7 3.1 0.0 3.3 0.7 0.0 2.2 0.1 2.1 3.6 0.0 6.7 0.4 12.7 4.1 8.0 5.6 0.5 9.8 0.0 3.3 0.0 5.8 12.1 7.1 0.0 21.2 1.0 10.2 0.0 2.8 0.5 0.4 0.3 0.1 0.0 2.4 0.9 TMEM45B "BC016153, FLJ40787" ENSG00000151715 "Transmembrane protein 45B" Q96B21 11 129815819-129860003 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 106.6" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 253.0;Paneth cells: 150.7;Undifferentiated cells: 102.5;Urothelial cells: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 3.6;naive CD4 T-cell: 4.3;neutrophil: 13.1" "Group enriched" "Detected in many" 12 "granulocytes: 13.1;T-cells: 4.3" "Group enriched" "Detected in some" 5 "OE19: 82.8;RT4: 33.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015474, HPA015878" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA015474: , HPA015878: AB_2205046" "unprognostic (4.92e-3)" "unprognostic (7.94e-2)" "unprognostic (5.98e-2)" "unprognostic (1.81e-1)" "unprognostic (5.44e-3)" "unprognostic (7.11e-2)" "unprognostic (1.17e-1)" "unprognostic (6.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.02e-3)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (1.42e-2)" "unprognostic (2.24e-1)" "unprognostic (1.68e-2)" "unprognostic (1.52e-1)" 0.2 0.2 0.6 9.0 0.9 0.0 4.0 0.3 0.7 6.6 50.3 0.5 1.7 40.4 1.2 4.1 29.5 6.5 9.3 0.4 1.2 0.6 9.6 13.2 4.5 1.9 0.4 0.7 1.4 3.1 0.0 2.9 1.2 2.3 4.0 29.0 0.3 7.3 2.4 0.2 10.9 106.6 1.5 0.5 0.6 7.4 0.7 0.2 0.5 9.1 21.9 19.9 9.4 10.9 0.6 0.4 13.1 0.6 0.7 4.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 9.7 4.2 0.0 1.8 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.5 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.0 82.8 12.6 0.0 0.0 0.6 5.4 33.4 1.0 0.1 0.0 2.7 0.0 0.0 9.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.6 0.1 0.3 0.2 0.3 0.2 3.6 0.9 0.0 0.6 4.3 0.7 13.1 0.7 0.2 0.4 0.6 1.3 0.6 0.9 0.3 0.7 1.2 0.6 0.4 0.7 2.3 0.2 17.9 8.4 0.5 10.0 3.0 0.0 0.6 22.9 68.3 21.6 43.6 0.0 4.0 11.6 20.5 0.2 0.3 253.0 0.0 7.3 0.6 0.9 18.6 2.3 2.6 0.5 0.0 53.3 0.0 1.6 0.0 0.3 1.9 3.3 0.0 64.7 0.0 32.6 150.7 0.0 1.2 0.3 0.0 1.0 0.0 0.0 18.2 0.3 0.7 102.5 96.6 TMEM69 "C1orf154, FLJ21029" ENSG00000159596 "Transmembrane protein 69" Q5SWH9 1 45687214-45694443 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026993 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA026993: AB_10601824" "prognostic favorable (2.24e-4)" "unprognostic (2.47e-1)" "unprognostic (5.25e-2)" "unprognostic (1.85e-2)" "unprognostic (2.40e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.66e-8)" "unprognostic (4.05e-2)" "unprognostic (1.59e-3)" "unprognostic (5.17e-2)" "unprognostic (3.98e-3)" "unprognostic (1.98e-1)" "unprognostic (1.14e-3)" "unprognostic (1.49e-2)" "unprognostic (1.96e-1)" "unprognostic (4.41e-3)" "unprognostic (3.65e-2)" 6.0 9.0 7.0 5.8 11.0 2.6 12.2 6.8 13.8 5.3 7.5 7.3 2.9 8.3 5.6 9.9 12.1 6.0 5.6 11.6 6.3 6.2 8.4 7.6 8.3 8.8 6.9 5.0 8.9 7.8 10.7 5.5 6.8 10.8 7.0 8.4 4.7 7.9 5.7 8.2 7.7 8.2 6.2 9.1 7.8 5.7 12.1 9.4 10.1 7.5 8.8 9.3 8.4 11.1 8.7 10.9 5.4 15.6 4.6 8.2 6.1 13.1 3.2 9.1 7.4 7.0 9.0 22.4 8.6 10.2 14.6 14.2 9.0 6.9 16.0 6.0 8.2 10.8 17.8 7.3 19.6 15.0 11.1 8.5 32.6 8.0 9.7 12.4 15.6 16.1 10.5 20.4 13.4 8.5 9.4 11.9 15.4 19.5 11.1 9.1 4.8 8.6 11.2 21.7 8.0 8.8 13.5 8.3 16.2 15.4 14.0 10.6 9.5 9.1 24.6 14.7 16.6 12.8 16.0 8.9 6.7 11.5 14.8 10.3 8.9 11.0 12.2 9.4 11.7 9.8 5.0 12.2 5.0 5.1 12.7 6.4 8.7 7.2 5.7 10.9 8.3 8.2 6.3 5.4 4.6 15.6 6.8 6.8 6.1 7.0 11.0 6.8 13.8 6.3 6.2 6.9 5.0 10.8 9.4 0.0 12.2 15.7 21.6 17.9 11.2 7.9 7.6 13.4 17.0 17.4 0.0 53.1 36.5 19.2 1.5 11.6 17.1 0.0 15.4 28.9 13.5 20.5 5.8 12.5 33.1 6.4 23.1 14.1 39.0 3.0 17.3 26.0 16.9 12.6 21.0 12.4 13.5 10.5 12.0 27.2 10.5 12.9 8.6 18.4 14.9 22.7 49.9 14.9 23.6 18.4 TMEM92 FLJ33318 ENSG00000167105 "Transmembrane protein 92" Q6UXU6 17 50271406-50281485 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 74.7" "Cell type enhanced" "Detected in many" 15 "Pancreatic endocrine cells: 31.5;Urothelial cells: 92.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "neutrophil: 5.5" "Lineage enriched" "Detected in single" 21 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "A549: 9.1;CACO-2: 15.5;CAPAN-2: 14.8;EFO-21: 30.9;OE19: 17.9;SuSa: 20.9" "Low region specificity" "Detected in all" "HPA063009, HPA069820" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063009: AB_2684921, HPA069820: AB_2686208" "unprognostic (3.54e-3)" "unprognostic (2.39e-2)" "unprognostic (9.85e-2)" "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "prognostic unfavorable (8.35e-4)" "unprognostic (4.37e-3)" "unprognostic (2.45e-2)" "unprognostic (1.11e-1)" "unprognostic (4.39e-1)" "unprognostic (3.88e-3)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (7.81e-2)" 0.2 0.1 0.3 1.9 0.3 0.4 0.3 0.3 0.3 3.3 27.9 0.3 0.1 23.3 1.2 0.3 1.0 0.7 11.7 0.1 0.8 0.3 0.4 10.2 6.1 0.1 0.3 0.2 2.4 1.2 0.0 0.1 0.3 0.9 1.2 1.8 1.1 4.3 1.2 0.1 0.2 74.7 0.4 0.4 0.3 17.9 0.5 0.3 0.1 0.1 0.4 1.6 2.2 3.7 0.1 0.2 5.5 0.1 0.0 0.0 0.0 0.9 9.1 0.2 0.0 0.0 0.4 2.0 0.2 0.3 0.0 0.0 15.5 14.8 0.0 30.9 0.6 3.5 0.0 0.2 1.7 0.0 2.4 0.1 0.0 0.9 1.5 0.1 0.1 0.1 0.1 1.7 0.1 0.5 1.4 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.2 3.4 17.9 4.0 0.2 0.0 3.8 3.3 0.0 0.0 0.0 0.0 0.1 0.0 20.9 1.9 0.5 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.3 0.8 0.3 0.3 0.2 0.9 0.3 3.0 17.1 0.0 6.4 0.5 0.0 0.1 22.9 2.7 1.2 7.0 0.0 0.0 0.0 6.2 0.0 0.0 8.0 0.0 17.8 1.2 1.0 16.8 0.0 11.3 0.4 0.0 5.2 1.8 0.3 0.0 0.0 0.0 0.0 1.8 20.4 0.0 31.5 16.4 0.0 0.0 0.0 0.0 0.1 0.1 1.7 0.9 0.0 0.0 14.9 92.2 TMEM98 DKFZP564K1964 ENSG00000006042 "Transmembrane protein 98" Q9Y2Y6 17 32927910-32945106 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 96.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 7.9" "Lineage enriched" "Detected in single" 12 "dendritic cells: 7.9" "Cell line enhanced" "Detected in many" "CACO-2: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040473, HPA053385" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA040473: AB_10794876, HPA053385: AB_2682134" "unprognostic (1.55e-2)" "unprognostic (5.15e-2)" "unprognostic (4.36e-3)" "unprognostic (7.20e-2)" "unprognostic (1.19e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (8.14e-4)" "prognostic favorable (7.10e-4)" "unprognostic (6.38e-2)" "unprognostic (2.22e-1)" "unprognostic (3.41e-1)" "unprognostic (9.18e-3)" "prognostic favorable (3.85e-4)" "unprognostic (5.16e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-2)" "unprognostic (2.58e-1)" 15.5 15.9 11.8 7.1 36.8 0.9 13.3 6.5 28.3 21.6 26.1 55.5 5.6 29.7 30.5 23.0 8.2 29.6 27.7 13.5 17.0 9.4 10.8 7.7 17.0 3.1 50.4 18.5 60.2 25.7 6.3 7.4 8.0 40.8 24.7 28.7 96.8 14.8 7.4 2.6 7.1 34.0 19.0 37.1 5.7 29.7 9.7 37.7 0.6 14.2 7.4 3.5 15.6 13.3 0.5 7.9 0.6 0.1 0.2 0.6 0.1 1.5 5.8 25.2 0.0 34.6 31.2 0.2 24.4 33.1 13.0 28.0 58.9 1.7 0.3 0.3 30.6 0.4 0.2 16.0 6.4 7.6 5.1 19.7 0.9 0.0 26.1 16.0 0.0 0.3 26.0 6.5 16.3 2.6 7.0 33.4 8.7 16.0 0.0 35.2 0.0 0.0 0.1 16.7 17.5 9.0 0.0 23.6 0.1 2.9 10.4 2.1 34.8 0.5 0.0 19.0 16.7 7.9 0.0 27.3 18.5 17.4 0.2 0.0 2.0 0.8 0.0 9.4 0.0 9.9 0.5 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.6 0.0 0.5 0.1 0.2 0.6 0.2 0.1 7.9 0.1 0.1 11.8 36.8 6.5 28.3 17.0 9.4 50.4 18.5 40.8 37.7 38.7 19.0 0.0 70.6 22.2 1.7 10.9 73.9 40.2 30.7 43.6 0.0 8.6 5.0 78.8 13.2 5.7 130.7 0.0 58.1 7.3 109.2 105.0 3.5 8.5 5.0 0.0 94.1 22.1 0.6 9.5 111.7 2.8 42.2 0.0 153.0 80.2 76.7 84.2 142.5 30.0 4.4 64.7 32.5 36.8 26.0 11.0 5.9 3.5 154.7 59.9 TMPRSS5 "MGC141886, MGC148044" ENSG00000166682 "Transmembrane serine protease 5" Q9H3S3 11 113687546-113706373 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 24.0;salivary gland: 15.0;skeletal muscle: 6.0" "Cell type enhanced" "Detected in some" 14 "Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Horizontal cells: 4.8;Muller glia cells: 3.4" "Cancer enhanced" "Detected in some" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.3;CAPAN-2: 7.1;WM-115: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010992 Approved Nucleoplasm NA NA Nucleoplasm "HPA010992: AB_1858152" "unprognostic (1.53e-2)" "unprognostic (3.81e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (2.99e-3)" "unprognostic (3.08e-1)" "unprognostic (5.19e-3)" "unprognostic (8.49e-2)" "unprognostic (8.13e-2)" "unprognostic (3.38e-2)" "unprognostic (1.96e-3)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (4.04e-3)" 2.1 1.7 10.8 1.0 24.0 3.2 2.2 2.1 14.8 1.2 1.0 21.6 0.0 1.0 1.2 0.9 1.8 1.1 2.2 1.2 11.5 5.7 0.9 0.9 0.9 1.1 11.6 12.7 1.4 1.2 0.6 1.5 1.2 16.5 1.2 1.3 0.9 15.0 1.4 6.0 2.7 0.7 1.2 16.9 1.1 2.4 2.3 8.8 0.0 1.1 0.4 1.3 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.8 4.3 2.5 0.5 0.4 0.6 1.2 0.5 0.6 0.9 2.5 7.1 0.3 3.2 0.5 0.8 0.8 0.3 0.4 0.3 0.4 1.3 1.0 0.6 0.0 0.3 1.0 0.8 0.6 0.6 0.5 1.2 0.5 0.8 1.7 0.8 0.5 0.9 0.0 0.8 1.2 0.5 4.3 0.2 0.9 0.5 0.0 0.7 0.4 0.6 1.0 0.5 0.1 3.5 0.6 0.5 0.5 0.5 0.9 1.7 0.6 0.7 0.5 0.2 0.1 0.4 0.9 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 24.0 2.1 12.3 11.5 5.7 11.6 12.7 16.5 8.8 0.0 0.0 0.0 0.2 0.2 0.5 0.4 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.4 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.1 TNFAIP8 "GG2-1, MDC-3.13, SCC-S2" ENSG00000145779 "TNF alpha induced protein 8" O95379 5 119268692-119399688 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 73.4;lymphoid tissue: 83.1" "Cell type enhanced" "Detected in many" 6 "granulocytes: 208.8;monocytes: 266.9;Syncytiotrophoblasts: 244.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 44.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA054434, HPA057089" Uncertain Enhanced Nucleoplasm No Yes 270000 Nucleoplasm "HPA054434: AB_2682487, HPA057089: AB_2683331" "prognostic favorable (2.45e-4)" "unprognostic (6.06e-2)" "unprognostic (9.81e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" "unprognostic (1.08e-1)" "unprognostic (2.86e-3)" "unprognostic (4.92e-1)" "unprognostic (1.55e-1)" "unprognostic (4.45e-2)" "unprognostic (5.81e-3)" "unprognostic (4.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.88e-3)" "unprognostic (1.64e-1)" "unprognostic (1.73e-2)" 21.1 2.1 1.6 49.9 3.0 17.8 18.9 1.5 1.7 11.3 8.0 1.6 4.7 4.3 9.7 9.2 15.0 4.6 9.7 8.5 1.8 1.7 8.7 8.4 22.0 71.3 2.9 1.8 4.2 12.5 5.2 1.7 36.1 12.2 11.8 5.5 4.2 13.7 5.8 2.2 14.4 21.4 6.9 3.6 37.5 13.1 4.7 2.2 83.1 9.3 8.6 41.1 12.7 12.8 50.3 25.2 73.4 19.7 19.7 54.4 36.5 7.5 5.3 2.8 4.6 6.1 5.1 26.0 4.2 11.4 3.2 6.6 2.9 8.8 14.2 1.3 4.7 5.1 10.8 2.3 12.8 4.5 15.5 4.9 22.5 11.9 4.9 2.9 27.1 25.0 5.7 12.1 9.6 4.6 6.2 4.3 28.3 8.7 44.5 4.4 2.9 23.0 35.4 4.3 4.4 2.5 7.0 12.6 20.6 12.8 15.2 1.5 2.2 15.8 3.1 1.5 9.7 2.7 31.0 2.1 5.8 2.2 4.0 4.9 21.9 24.0 28.6 6.7 29.0 3.4 73.4 18.6 55.3 22.6 19.7 43.9 50.3 45.5 33.2 25.2 44.2 54.4 34.9 10.6 19.7 14.8 12.1 34.8 36.5 1.6 3.0 1.5 1.7 1.8 1.7 2.9 1.8 12.2 2.2 8.9 16.0 115.2 57.1 142.5 0.1 8.9 15.3 48.2 25.0 17.4 0.0 133.6 14.9 46.4 1.9 18.9 1.3 0.0 87.0 135.2 42.9 45.5 208.8 0.5 45.7 0.0 1.2 6.2 52.3 1.1 2.0 76.8 35.4 266.9 7.6 3.9 105.8 2.9 1.8 11.0 0.5 45.3 34.0 0.4 14.9 104.3 244.7 119.6 3.8 58.5 TNFRSF10A "Apo2, CD261, DR4, TRAILR-1, TRAILR1" ENSG00000104689 "TNF receptor superfamily member 10a" O00220 8 23190452-23225126 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 24.0;Urothelial cells: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA050958, HPA054475" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050958: AB_2681290, HPA054475: AB_2682500" "unprognostic (3.66e-1)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (4.89e-2)" "unprognostic (9.44e-2)" "unprognostic (8.39e-2)" "unprognostic (5.32e-2)" "unprognostic (2.18e-2)" "unprognostic (2.72e-1)" "unprognostic (4.48e-2)" "prognostic unfavorable (1.00e-4)" "unprognostic (1.49e-1)" "unprognostic (1.99e-3)" "unprognostic (1.91e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-1)" "unprognostic (2.87e-1)" 11.9 4.0 2.1 13.0 3.4 8.4 9.7 2.0 2.8 6.0 10.9 1.4 4.5 5.9 5.3 5.6 13.6 4.1 12.7 6.3 2.2 2.0 10.9 10.6 11.0 12.4 3.0 0.7 2.7 12.9 3.6 1.8 6.9 4.0 5.1 7.2 2.1 8.2 4.3 3.8 7.1 10.2 3.8 2.9 13.2 6.1 2.6 3.0 9.5 5.8 14.9 25.4 6.7 8.7 13.2 4.5 3.8 4.3 3.9 13.9 4.2 8.0 14.5 0.7 0.0 0.5 3.0 0.0 1.6 1.0 0.8 2.4 11.2 14.2 18.6 19.0 1.0 4.1 15.3 13.1 20.8 1.4 4.6 0.1 9.8 8.8 6.3 7.5 5.2 9.4 5.0 17.2 18.5 16.0 2.5 9.8 0.6 15.1 6.7 3.9 6.3 0.2 3.3 10.1 14.3 8.9 0.1 0.0 13.4 11.1 17.4 0.4 0.5 4.1 10.3 0.0 3.2 5.5 4.0 13.8 0.0 0.1 0.8 0.0 7.9 11.1 14.4 0.1 1.7 0.2 2.0 4.3 3.8 3.8 1.9 10.3 10.4 12.3 7.7 4.5 13.2 12.1 7.0 0.5 3.9 1.7 0.0 13.9 4.2 2.1 3.4 2.0 2.8 2.2 2.0 3.0 0.7 4.0 3.0 3.0 8.3 6.4 16.2 20.9 0.1 0.8 12.7 6.7 19.4 10.4 0.0 0.1 0.0 9.2 0.0 11.8 6.2 0.0 3.5 0.4 1.3 10.0 7.0 4.0 3.0 0.0 2.4 1.3 2.1 0.0 0.0 7.1 3.3 1.8 6.0 0.0 14.3 7.4 0.0 2.4 0.0 0.0 1.1 0.0 0.2 24.0 0.0 2.9 6.3 27.1 TNRC6C "FLJ20015, KIAA1582" ENSG00000078687 "Trinucleotide repeat containing 6C" Q9HCJ0 17 77959240-78108835 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 119.8;Cone photoreceptor cells: 223.8;Rod photoreceptor cells: 142.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "basophil: 12.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 12.9" "Cell line enhanced" "Detected in many" "MOLT-4: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022007, HPA062051" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA022007: AB_2670877, HPA062051: AB_2684670" "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-3)" "unprognostic (2.66e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (2.89e-3)" "unprognostic (2.59e-1)" "unprognostic (7.83e-2)" "prognostic favorable (6.56e-5)" "unprognostic (1.36e-1)" "unprognostic (1.17e-2)" "unprognostic (1.07e-1)" "unprognostic (1.84e-1)" "unprognostic (3.04e-1)" "unprognostic (5.70e-2)" 5.5 3.6 8.9 7.4 15.1 3.6 5.1 13.3 13.8 6.0 3.8 14.5 4.4 2.3 6.9 7.6 3.1 6.9 4.7 6.9 8.5 7.6 3.3 3.4 4.2 7.5 13.3 6.3 9.1 4.4 6.1 7.6 1.9 12.2 6.1 3.0 10.9 6.0 4.9 11.1 3.3 3.8 5.6 7.5 6.0 3.6 13.2 14.3 3.4 4.1 6.1 5.5 3.6 4.1 1.1 0.7 12.9 0.3 3.1 2.7 0.5 3.1 3.0 5.4 5.8 2.3 1.8 0.0 4.8 4.0 3.4 2.8 3.1 0.9 0.0 2.0 3.6 2.4 0.3 4.0 0.1 2.1 2.5 4.1 11.1 1.0 3.5 2.1 2.6 5.7 1.5 1.5 1.3 3.2 1.5 7.1 11.0 2.1 5.6 3.5 4.2 24.9 1.4 2.8 1.4 2.2 3.3 10.9 2.1 0.8 4.5 6.7 12.3 5.7 7.4 2.6 2.8 5.6 3.9 5.2 7.6 2.6 3.9 5.8 4.3 0.7 3.2 2.1 4.1 5.4 12.9 0.3 1.3 1.9 0.2 2.2 1.0 2.1 2.0 0.2 1.1 2.3 2.7 1.2 3.1 0.3 0.7 0.9 0.5 8.9 15.1 13.3 12.5 8.5 7.6 13.3 6.3 12.2 14.3 26.8 26.7 6.1 8.5 19.6 119.8 26.0 30.6 6.7 9.1 8.7 223.8 0.1 1.7 6.2 7.2 25.7 5.3 23.3 5.1 0.3 19.5 13.9 22.0 15.5 2.0 69.9 38.3 29.4 12.9 5.3 47.5 6.1 15.1 2.8 9.0 33.0 6.8 3.5 40.3 4.3 142.8 0.0 31.6 23.5 19.9 12.4 0.2 36.3 5.9 3.8 TOGARAM1 "crescerin, Crescerin-1, FAM179B, KIAA0423" ENSG00000198718 "TOG array regulator of axonemal microtubules 1" Q9Y4F4 14 44962208-45074431 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 71.0;Club cells: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050849, HPA053559" Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA050849: AB_2681257, HPA053559: AB_2682190" "unprognostic (2.91e-1)" "unprognostic (4.07e-2)" "unprognostic (2.04e-2)" "unprognostic (1.05e-2)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (2.67e-2)" "unprognostic (2.69e-1)" "unprognostic (1.21e-1)" "unprognostic (5.63e-2)" "unprognostic (6.49e-2)" "prognostic favorable (8.38e-4)" "unprognostic (1.62e-1)" "unprognostic (2.15e-1)" "unprognostic (3.02e-2)" "unprognostic (1.60e-1)" 6.9 11.6 13.6 7.0 17.5 6.0 9.0 16.3 34.4 12.3 6.7 10.0 9.8 4.8 10.3 9.9 8.1 17.5 8.3 13.7 14.5 10.5 14.0 8.0 12.9 8.4 13.1 17.0 13.9 11.1 15.5 20.1 9.9 11.0 9.9 6.6 6.8 7.8 11.5 19.1 6.5 5.9 9.2 13.0 7.1 6.4 9.3 12.5 9.1 15.4 5.2 6.7 8.6 6.7 1.7 1.8 6.9 1.0 1.9 1.4 0.8 3.1 5.1 5.0 1.3 11.4 13.6 3.5 4.4 9.7 8.5 10.2 2.1 3.4 2.9 5.1 7.1 4.4 5.9 9.0 2.8 9.6 2.6 3.3 2.4 2.7 2.5 8.4 4.2 2.6 7.8 5.3 4.6 8.3 10.2 6.7 1.6 1.7 3.5 8.8 4.7 5.4 2.3 1.7 4.6 4.0 2.7 12.2 2.0 8.1 11.0 5.2 2.0 5.2 7.9 7.9 5.5 5.8 3.4 5.0 5.8 4.5 7.5 3.2 3.5 2.4 3.4 3.3 0.8 4.9 6.9 1.0 2.2 1.1 0.9 1.3 1.0 1.4 1.1 1.3 1.7 1.4 0.9 0.1 1.9 0.9 1.8 1.4 0.8 13.6 17.5 16.3 34.4 14.5 10.5 13.1 17.0 11.0 12.5 14.9 12.2 0.0 0.0 0.0 0.0 0.0 0.0 71.0 37.5 15.7 0.0 8.3 1.7 8.9 0.0 0.0 0.0 0.0 5.0 6.5 0.0 0.0 9.3 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 11.8 0.0 0.0 7.4 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 TOP2B ENSG00000077097 "DNA topoisomerase II beta" Q02880 3 25597905-25664907 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "Autism spectrum disorder, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 106.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004601, HPA024120, HPA050441" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127" "unprognostic (2.90e-2)" "unprognostic (5.17e-2)" "unprognostic (7.21e-3)" "unprognostic (2.42e-1)" "unprognostic (1.60e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.86e-7)" "unprognostic (7.86e-2)" "unprognostic (1.89e-1)" "unprognostic (2.84e-1)" "unprognostic (7.14e-2)" "unprognostic (1.08e-1)" "prognostic favorable (2.43e-4)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" "unprognostic (1.49e-1)" "unprognostic (7.93e-2)" 19.3 18.8 23.4 23.1 29.7 26.5 21.1 48.4 33.5 24.1 22.4 21.1 18.9 17.1 29.6 25.6 21.1 20.6 20.7 22.7 22.0 19.9 20.3 18.4 17.7 28.2 21.0 28.5 26.8 17.2 43.0 21.6 22.3 26.4 24.7 20.8 17.6 21.3 22.3 31.3 20.9 19.3 24.4 23.4 24.6 20.1 11.3 22.7 60.2 28.3 20.7 27.3 34.8 21.5 5.5 5.6 5.3 4.6 7.8 7.2 2.2 10.7 11.1 24.6 30.1 8.2 10.4 9.8 10.4 13.4 9.7 10.6 5.7 8.5 33.3 7.3 15.0 6.0 9.1 20.3 11.6 16.3 15.9 10.9 50.4 13.8 9.5 5.8 39.4 27.0 7.4 5.8 10.8 9.5 9.8 15.7 22.8 16.9 16.4 12.4 11.9 25.5 9.7 18.6 7.2 8.5 106.6 13.8 15.4 8.7 37.9 12.4 21.5 15.5 11.1 9.5 14.8 11.5 35.3 15.0 13.5 10.5 10.7 11.1 25.4 14.4 35.3 8.8 29.5 8.9 4.2 2.9 5.3 6.3 3.3 6.9 4.3 6.1 6.4 4.3 5.5 7.2 6.4 2.0 7.8 4.6 5.6 4.4 2.2 23.4 29.7 48.4 33.5 22.0 19.9 21.0 28.5 26.4 22.7 59.6 57.9 25.1 36.1 34.8 53.5 109.0 43.3 34.8 40.9 24.4 53.0 41.2 11.6 29.3 2.9 32.2 17.7 23.3 28.8 20.8 35.0 47.5 31.4 33.5 23.1 57.2 57.0 21.5 40.9 4.8 36.2 38.8 21.9 21.6 32.6 46.4 32.0 17.5 31.5 21.9 89.3 32.3 36.7 66.2 27.0 33.0 39.0 45.0 37.9 57.7 TOP3B ENSG00000100038 "DNA topoisomerase III beta" O95985 22 21957025-21982816 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072114 Approved Nucleoplasm NA NA Nucleoplasm "HPA072114: " "unprognostic (1.03e-1)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (3.37e-1)" "unprognostic (5.04e-2)" "unprognostic (2.27e-1)" "unprognostic (3.93e-1)" "unprognostic (2.15e-2)" "unprognostic (2.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.29e-2)" "unprognostic (1.96e-2)" "unprognostic (1.69e-2)" "unprognostic (1.21e-1)" "unprognostic (3.53e-2)" "unprognostic (1.11e-4)" 10.4 11.7 12.1 16.1 17.4 20.8 10.9 17.2 17.1 12.5 11.0 16.9 14.9 15.4 16.1 11.0 14.2 11.0 11.2 10.1 12.7 5.5 13.4 15.3 12.7 17.0 18.7 6.5 20.2 12.1 13.5 21.0 12.1 16.2 15.6 14.9 14.1 13.3 13.3 13.4 17.5 16.1 14.5 17.4 23.6 11.8 11.1 16.9 13.1 14.2 5.7 18.9 10.5 14.3 9.0 8.8 2.7 6.8 6.1 9.3 5.2 9.7 9.3 19.1 7.6 7.1 5.9 11.9 6.5 8.1 15.0 13.3 10.1 4.2 13.4 4.9 6.7 6.3 17.9 8.6 11.5 12.1 6.8 20.6 10.5 12.0 10.4 9.6 14.3 6.9 2.9 17.6 12.4 6.0 8.7 12.5 7.8 49.2 7.3 7.0 9.9 8.9 11.1 7.8 7.1 8.9 14.1 12.7 2.1 7.4 13.0 12.5 9.1 7.9 7.1 6.0 8.0 5.5 9.2 9.0 6.2 13.0 5.8 7.9 10.8 8.8 12.7 4.8 8.7 6.4 2.5 6.7 2.7 9.3 6.8 6.5 7.5 5.8 6.5 7.4 9.0 5.9 5.7 2.3 6.1 3.8 8.8 6.7 5.2 12.1 17.4 17.2 17.1 12.7 5.5 18.7 6.5 16.2 16.9 0.0 1.6 4.7 2.3 1.5 4.5 0.0 12.7 5.3 1.2 3.5 9.8 4.1 1.7 4.1 0.9 2.5 4.1 0.0 3.7 3.0 2.8 3.6 1.1 4.4 3.5 1.6 4.6 7.4 3.7 1.1 9.8 2.7 5.0 2.8 3.9 2.4 5.2 3.5 7.1 2.2 5.3 6.5 1.4 5.4 4.7 1.4 3.3 5.7 5.6 2.5 TOPBP1 "KIAA0259, TOP2BP1" ENSG00000163781 "DNA topoisomerase II binding protein 1" Q92547 3 133598175-133662380 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 79.9;Spermatocytes: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022451, HPA036738, HPA036739" Approved Supported Nucleoplasm No No Nucleoplasm "CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281" "unprognostic (7.72e-2)" "unprognostic (8.54e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.05e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (4.66e-5)" "unprognostic (8.03e-2)" "unprognostic (3.98e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (1.88e-4)" "unprognostic (2.74e-3)" "unprognostic (8.65e-3)" "unprognostic (7.97e-2)" "unprognostic (2.52e-1)" "unprognostic (7.64e-2)" "unprognostic (1.60e-1)" 13.0 8.2 9.7 16.1 11.7 32.9 17.2 14.4 13.8 9.6 10.8 5.4 8.2 9.7 11.5 10.3 15.0 9.7 8.8 12.1 9.2 7.8 7.4 8.6 10.2 21.3 8.8 9.2 11.0 12.6 10.0 9.8 14.0 10.7 9.5 14.0 5.1 12.0 7.2 10.8 13.6 13.0 11.0 13.1 18.9 10.9 24.6 8.8 38.0 10.3 11.5 20.9 11.0 11.1 2.8 3.1 6.1 2.7 3.0 4.4 1.2 16.0 10.0 16.3 13.2 3.1 4.1 12.2 12.5 10.0 15.5 20.1 13.9 10.2 29.1 11.1 9.1 18.8 18.7 23.4 8.3 24.0 17.6 10.4 27.3 14.5 8.5 3.0 29.1 21.6 4.8 5.2 15.2 9.1 5.8 10.6 17.3 16.9 20.9 12.2 11.0 28.5 15.5 13.4 18.4 8.5 19.3 20.3 21.2 5.5 11.1 15.5 17.2 15.4 8.5 12.9 16.6 14.2 27.2 7.3 16.4 14.9 16.6 13.7 12.6 18.9 56.1 9.7 15.6 14.4 4.6 2.0 6.1 2.2 2.7 3.3 2.8 2.3 2.2 2.0 1.9 2.2 2.3 2.4 3.0 1.5 3.1 4.4 1.2 9.7 11.7 14.4 13.8 9.2 7.8 8.8 9.2 10.7 8.8 20.8 24.5 14.2 6.9 11.0 14.7 7.9 15.3 12.0 30.7 10.4 2.0 15.8 8.3 9.3 56.8 13.2 6.5 23.3 11.5 18.3 8.0 7.5 7.0 8.6 9.8 3.2 6.9 7.4 11.9 79.9 9.5 14.0 8.5 20.8 10.1 10.4 11.7 10.5 9.2 5.0 8.5 12.9 5.2 68.9 51.3 10.0 11.7 13.8 12.4 8.8 TOPORS "LUN, RP31, TP53BPL" ENSG00000197579 "TOP1 binding arginine/serine rich protein" Q9NS56 9 32540544-32552553 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, Ubl conjugation pathway" Transferase "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 148.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 33.4" "Cell line enhanced" "Detected in all" "HEL: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060640, HPA065661" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA060640: AB_2684334, HPA065661: AB_2685527" "unprognostic (1.75e-1)" "unprognostic (1.73e-1)" "unprognostic (1.20e-2)" "unprognostic (1.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "unprognostic (1.37e-2)" "unprognostic (9.94e-2)" "prognostic favorable (7.07e-4)" "unprognostic (2.70e-1)" "unprognostic (3.61e-1)" "prognostic favorable (6.64e-6)" "unprognostic (1.22e-1)" "unprognostic (5.95e-2)" "unprognostic (3.13e-1)" "unprognostic (2.92e-1)" 16.0 12.5 12.7 8.5 16.0 22.9 13.7 18.6 15.1 14.0 12.2 9.6 9.5 8.8 12.9 11.4 13.1 10.5 11.7 9.3 15.9 9.6 14.6 17.4 10.6 10.0 20.1 5.2 17.5 13.2 19.6 19.5 17.9 14.8 13.1 10.3 9.2 11.0 10.8 10.9 10.2 16.8 12.3 17.8 12.4 10.7 18.9 15.0 15.5 15.6 9.8 10.5 16.3 16.0 5.2 4.9 33.4 5.9 7.1 7.4 3.4 8.2 7.6 10.5 9.2 12.9 11.7 6.7 10.5 9.9 8.7 10.2 4.7 4.2 13.4 6.1 10.5 7.7 5.5 12.4 11.9 12.3 11.1 6.8 45.2 13.3 5.9 8.0 12.8 12.5 9.4 13.4 12.6 8.9 10.9 10.6 10.2 7.8 7.0 14.2 4.4 11.4 23.6 14.0 6.1 7.8 11.8 9.4 6.0 11.7 8.7 5.2 8.4 10.5 5.7 6.8 12.4 5.8 7.3 11.1 9.6 9.8 5.0 7.7 4.9 7.8 14.5 8.9 7.4 4.3 14.6 4.9 10.0 5.0 4.6 5.4 4.6 5.4 5.8 4.9 5.2 7.4 7.2 33.4 7.1 5.9 4.0 6.3 3.4 12.7 16.0 18.6 15.1 15.9 9.6 20.1 5.2 14.8 15.0 50.6 20.6 26.5 37.9 41.9 48.4 16.8 28.1 18.7 38.7 24.4 35.3 25.9 16.6 21.0 148.7 37.9 22.0 0.0 16.2 14.5 27.8 32.6 40.5 20.2 15.7 52.4 44.0 22.1 16.6 13.0 30.8 27.2 18.6 27.9 18.4 48.5 18.7 22.9 30.8 19.1 38.4 19.4 37.1 51.9 49.7 41.7 42.4 34.1 19.0 41.6 TOR4A "C9orf167, FLJ20245" ENSG00000198113 "Torsin family 4 member A" Q9NXH8 9 137277749-137282641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Undifferentiated cells: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 22.9;TIME: 20.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044913 Enhanced Approved Nucleoplasm NA NA 1500000 Nucleoplasm "HPA044913: AB_10965030" "unprognostic (1.95e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.99e-1)" "unprognostic (3.56e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (5.42e-3)" "unprognostic (1.69e-1)" "unprognostic (1.47e-1)" "unprognostic (1.11e-2)" "unprognostic (2.24e-1)" "unprognostic (5.20e-2)" "unprognostic (2.00e-3)" "unprognostic (4.39e-3)" "unprognostic (7.93e-3)" "unprognostic (2.56e-1)" 8.7 3.0 1.6 9.1 3.1 3.2 3.8 0.6 1.7 6.0 12.9 2.8 7.6 12.5 5.0 4.7 8.4 4.6 23.2 12.4 1.5 1.3 8.0 6.6 14.8 7.5 2.8 1.1 9.4 4.0 0.4 2.1 4.9 2.3 3.4 5.8 5.5 1.8 9.7 1.8 2.0 14.5 1.9 2.4 19.4 15.6 1.9 2.0 2.9 5.0 1.4 13.3 4.5 3.9 0.9 1.6 3.7 3.5 0.7 0.7 0.9 8.0 10.6 0.0 0.3 0.1 0.8 0.8 13.4 9.2 6.2 3.3 1.3 15.3 0.8 18.9 4.7 0.4 16.7 0.0 4.4 2.1 0.6 0.7 8.8 7.3 7.1 13.4 3.8 22.9 0.5 4.7 1.2 2.4 7.1 8.4 0.0 13.2 1.0 1.0 0.8 0.0 10.6 1.3 8.7 11.9 2.1 2.9 5.4 7.4 0.0 0.4 0.1 9.7 0.1 0.2 0.3 0.8 11.9 20.5 0.3 7.4 1.4 2.2 0.1 0.5 5.1 2.3 3.5 3.0 1.6 2.3 3.7 0.5 2.1 0.6 0.7 0.4 0.1 1.6 0.9 0.0 0.1 1.4 0.7 3.5 0.2 0.7 0.9 1.6 3.1 0.6 1.7 1.5 1.3 2.8 1.1 2.3 2.0 0.0 5.1 3.9 2.1 2.4 0.0 5.6 25.5 1.4 2.3 12.2 0.0 0.1 0.0 9.4 0.1 3.8 20.6 0.0 1.9 0.1 0.9 1.4 10.3 0.8 12.7 0.0 6.9 26.4 25.2 0.0 2.3 8.2 0.0 11.8 23.9 0.8 14.0 24.9 3.9 0.4 0.5 19.4 3.1 0.0 0.9 2.0 0.0 2.2 28.7 10.8 TOX2 "C20orf100, dJ1108D11.2, GCX-1" ENSG00000124191 "TOX high mobility group box family member 2" Q96NM4 20 43914864-44069616 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 77.2" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 21.1;Ito cells: 39.3;Late spermatids: 14.0;Smooth muscle cells: 12.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 9.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 45.8;PC-3: 20.5;U-266/70: 29.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049900, HPA058396" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA049900: AB_2680942, HPA058396: AB_2683704" "unprognostic (2.15e-2)" "unprognostic (1.82e-2)" "unprognostic (8.97e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.33e-1)" "unprognostic (1.01e-1)" "unprognostic (7.53e-3)" "unprognostic (6.29e-2)" "unprognostic (1.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.75e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (7.45e-8)" "unprognostic (1.60e-1)" "unprognostic (2.00e-1)" "unprognostic (7.60e-2)" "unprognostic (3.12e-1)" 7.0 4.4 8.0 9.9 5.2 2.4 4.8 0.8 14.5 6.7 4.8 2.6 3.5 2.3 3.6 3.5 12.2 3.0 4.7 2.0 7.8 20.6 2.4 4.1 20.1 19.2 13.7 7.0 1.8 2.7 17.3 14.9 4.6 7.3 9.9 4.2 3.0 2.4 5.3 0.8 2.9 5.3 12.0 4.5 7.1 5.7 17.6 2.0 77.2 4.8 2.4 11.8 9.7 6.5 0.1 3.7 9.7 0.3 1.9 2.0 0.2 4.5 5.7 1.8 0.3 2.0 5.8 0.0 5.7 2.4 3.6 4.5 0.0 1.8 0.0 8.3 6.5 16.3 2.3 1.4 0.1 3.3 7.3 1.5 0.0 0.4 0.0 45.8 0.0 8.7 15.7 6.8 12.7 0.6 11.6 4.4 4.2 0.0 5.4 2.2 4.8 1.7 1.6 1.4 0.1 20.5 0.0 4.4 7.5 0.0 0.5 2.0 15.5 1.0 0.0 7.3 0.2 0.0 3.9 5.4 0.0 3.6 0.1 0.0 29.6 6.4 3.9 7.5 0.0 12.1 0.0 0.3 9.7 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.1 0.2 0.1 1.0 1.9 0.0 3.7 2.0 0.2 8.0 5.2 0.8 14.5 7.8 20.6 13.7 7.0 7.3 2.0 0.0 1.1 4.5 0.7 0.9 0.4 0.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 8.7 0.0 0.0 0.2 0.1 0.6 0.3 0.0 0.8 1.1 3.2 0.0 39.3 4.3 14.0 1.7 0.0 1.7 0.0 0.0 4.3 0.1 0.0 0.7 0.0 0.0 0.0 12.6 1.1 1.4 1.1 0.2 3.2 0.6 0.3 TP53 "LFS1, p53" ENSG00000141510 "Tumor protein p53" P04637 17 7661779-7687550 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 102.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, HPA051244: AB_2681403, HPA063532: " "unprognostic (2.29e-2)" "unprognostic (8.83e-3)" "unprognostic (1.26e-2)" "prognostic favorable (1.35e-4)" "unprognostic (9.95e-2)" "unprognostic (4.00e-2)" "unprognostic (2.79e-3)" "unprognostic (4.99e-2)" "unprognostic (2.75e-2)" "unprognostic (2.55e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (1.86e-3)" "unprognostic (7.89e-3)" "unprognostic (8.05e-2)" "unprognostic (2.74e-1)" "unprognostic (1.08e-1)" 18.5 11.1 6.0 28.6 6.8 9.0 17.5 2.5 7.3 18.5 14.6 6.8 8.3 9.7 20.3 15.0 25.3 16.7 22.6 8.1 5.0 3.8 10.6 20.8 11.2 26.0 6.6 3.1 33.8 13.8 4.9 6.0 22.8 6.9 16.5 14.5 9.9 15.3 16.1 12.5 24.6 14.0 12.8 6.2 24.2 12.0 14.1 6.9 102.6 13.2 23.5 31.2 16.9 15.0 15.2 19.6 2.2 14.1 11.0 11.3 8.2 19.4 36.0 19.7 14.2 9.2 11.0 20.8 7.0 15.8 19.4 24.6 1.0 10.0 45.8 31.9 13.8 18.9 43.0 28.5 19.3 18.2 10.2 19.1 18.5 20.2 17.1 27.7 0.4 9.6 13.9 22.5 9.4 26.1 11.2 19.0 6.2 0.9 1.8 9.9 34.6 31.1 22.7 19.8 2.5 0.7 60.4 13.9 15.9 14.5 21.6 11.7 20.3 23.1 15.6 5.9 10.2 27.0 1.7 24.6 23.3 7.7 0.3 11.8 12.1 8.8 19.7 6.0 2.4 19.6 0.8 13.3 2.2 9.1 14.1 11.1 15.2 9.4 10.2 19.6 14.5 9.9 10.8 1.7 11.0 11.9 17.9 11.3 8.2 6.0 6.8 2.5 6.4 5.0 3.8 6.6 3.1 6.9 6.9 8.9 10.9 24.4 8.9 25.4 2.3 2.0 22.9 8.1 12.5 19.2 0.0 30.5 8.3 19.1 7.8 19.6 10.2 0.0 15.7 35.3 17.1 11.3 1.1 16.1 21.7 0.0 29.6 20.3 27.8 2.1 21.3 14.4 11.8 15.4 37.2 6.1 19.5 0.0 15.9 6.5 2.2 12.9 20.1 0.5 4.2 28.7 18.8 15.7 50.6 7.4 TP63 "EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L" ENSG00000073282 "Tumor protein p63" Q9H3D4 3 189631416-189897279 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 83.2;skin 1: 54.2" "Group enriched" "Detected in many" 12 "Basal keratinocytes: 244.6;Suprabasal keratinocytes: 247.4" "Group enriched" "Detected in many" 11 "cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HaCaT: 23.8;HBEC3-KT: 45.6;hTCEpi: 34.6;hTERT-HME1: 33.1;RT4: 50.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000083, HPA006288, HPA006289, HPA007009, HPA007010" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336" "prognostic favorable (1.07e-4)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "unprognostic (3.02e-1)" "unprognostic (4.38e-2)" "unprognostic (3.50e-1)" "unprognostic (1.29e-1)" "unprognostic (5.17e-2)" "unprognostic (2.78e-1)" "unprognostic (5.37e-2)" "unprognostic (2.09e-3)" "unprognostic (1.54e-1)" "unprognostic (1.87e-5)" "unprognostic (1.86e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (2.74e-3)" 2.9 0.1 0.2 0.7 0.1 0.0 7.2 0.1 0.2 9.5 0.1 0.1 5.7 0.0 0.3 8.0 33.7 0.3 0.0 0.2 0.1 0.1 0.4 0.1 1.2 0.2 0.1 0.2 0.1 0.1 0.0 0.3 7.8 0.8 9.6 0.0 0.3 9.0 7.8 83.2 54.2 0.1 2.7 0.6 0.1 0.1 1.2 0.0 9.0 0.4 36.7 26.1 9.6 19.2 3.7 1.3 3.0 0.9 1.2 1.2 0.2 0.6 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 23.8 0.0 45.6 0.0 0.3 0.0 0.5 0.3 0.1 0.0 0.0 0.1 0.0 34.6 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 50.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 0.3 0.1 0.0 0.2 2.0 0.4 1.1 0.9 0.5 0.7 3.7 1.2 1.0 0.4 1.7 0.8 0.7 3.0 1.2 0.9 1.3 0.8 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.8 0.0 0.0 4.0 0.0 20.4 244.6 0.0 0.6 0.0 1.4 5.7 0.0 0.0 18.7 0.0 0.2 0.7 0.3 0.0 0.0 0.2 1.8 1.0 2.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.5 1.0 0.0 0.0 1.2 0.0 1.1 0.0 0.0 0.0 0.5 0.3 2.6 247.4 7.4 0.0 0.0 10.1 TPBG "5T4, 5T4-AG" ENSG00000146242 "Trophoblast glycoprotein" Q13641 6 82363206-82370828 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 67.5;Urothelial cells: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 3.2" "Lineage enriched" "Detected in single" 16 "T-cells: 3.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.9;hTCEpi: 30.5;hTEC/SVTERT24-B: 27.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010554 Enhanced Approved Nucleoplasm NA NA 330000 Nucleoplasm "HPA010554: AB_1858206" "unprognostic (3.03e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (6.68e-4)" "unprognostic (1.06e-1)" "unprognostic (4.52e-3)" "unprognostic (7.47e-3)" "unprognostic (8.55e-2)" "unprognostic (3.55e-3)" "unprognostic (8.39e-2)" "unprognostic (3.42e-2)" "unprognostic (8.02e-2)" "unprognostic (4.94e-1)" "unprognostic (3.77e-1)" "unprognostic (7.46e-2)" "unprognostic (1.06e-1)" "unprognostic (1.54e-1)" "unprognostic (5.57e-2)" 10.2 2.9 0.4 4.8 15.7 1.2 10.2 0.0 8.8 22.0 4.6 1.9 12.1 4.2 12.6 4.6 35.2 8.4 9.3 5.3 0.7 2.0 6.6 1.7 4.1 3.0 4.3 1.4 5.8 4.8 4.1 11.2 16.9 17.6 14.1 4.6 5.1 11.5 9.4 2.6 12.6 4.9 16.2 4.5 5.7 6.2 3.3 7.9 4.2 13.0 6.8 4.5 22.9 25.5 0.0 0.0 0.0 0.1 0.0 3.2 0.0 4.5 6.8 2.5 5.0 9.1 13.1 4.3 21.4 24.9 4.3 5.9 0.8 6.4 0.0 2.3 11.7 12.1 8.9 2.8 11.7 4.6 0.0 3.6 2.6 3.3 0.2 7.4 0.2 2.2 8.3 30.5 27.9 10.4 3.9 1.0 0.2 0.4 0.0 1.1 9.3 0.0 0.0 2.9 2.0 5.4 0.0 4.8 0.0 6.3 6.4 1.2 3.9 4.7 6.8 0.0 4.9 11.3 0.9 3.1 3.7 3.7 7.9 4.6 0.0 0.0 0.0 18.2 0.3 3.9 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 15.7 0.0 8.8 0.7 2.0 4.3 1.4 17.6 7.9 11.9 6.2 0.0 63.5 60.3 0.1 2.0 12.7 5.3 18.2 52.4 0.0 36.6 0.0 30.7 6.2 17.9 2.6 0.0 40.7 67.5 22.6 45.6 0.0 0.0 3.2 1.6 1.2 6.7 1.2 4.1 11.8 4.0 16.9 0.0 16.1 1.7 26.7 16.4 5.6 0.4 0.2 32.3 19.1 1.9 5.3 27.4 55.2 2.9 9.7 71.2 TPRG1 "FAM79B, FLJ41238, FLJ43694" ENSG00000188001 "Tumor protein p63 regulated 1" Q6ZUI0 3 188947214-189325304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.3;lymphoid tissue: 32.9" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 35.7;Early spermatids: 102.2" "Cancer enhanced" "Detected in many" "breast cancer: 7.0" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.8;Karpas-707: 4.5;OE19: 21.7;U-266/70: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA044751, HPA060187" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA044751: AB_2679073, HPA060187: AB_2684217" "prognostic favorable (5.43e-4)" "unprognostic (8.71e-3)" "unprognostic (2.10e-3)" "unprognostic (2.36e-2)" "unprognostic (3.84e-3)" "unprognostic (1.33e-3)" "unprognostic (1.55e-2)" "unprognostic (9.88e-2)" "unprognostic (2.66e-1)" "unprognostic (2.71e-1)" "unprognostic (1.40e-2)" "unprognostic (3.79e-1)" "unprognostic (3.52e-8)" "unprognostic (8.50e-2)" "unprognostic (9.53e-2)" "unprognostic (1.38e-1)" "unprognostic (3.73e-2)" 16.1 1.0 0.3 0.9 0.8 0.0 14.4 1.7 0.8 19.7 1.2 0.1 1.0 0.0 5.0 1.6 43.3 5.2 1.6 2.4 0.2 0.2 0.6 5.1 2.7 0.3 0.3 0.5 1.9 0.3 0.0 0.8 1.0 0.5 2.5 0.0 0.8 3.7 0.7 5.0 14.5 0.5 1.9 0.3 0.7 0.4 2.6 0.3 7.9 0.8 25.5 32.9 2.3 17.8 0.2 0.7 1.3 2.3 0.0 6.3 1.3 0.8 0.2 0.3 0.0 2.0 1.7 0.0 0.0 0.0 0.0 0.1 1.0 2.1 1.2 3.3 0.1 0.5 0.2 0.0 0.0 0.0 8.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.4 0.0 0.0 0.5 0.0 0.0 0.0 4.5 0.2 0.3 0.0 0.0 0.6 21.7 0.3 0.0 0.0 1.5 0.0 1.7 0.0 0.0 0.2 0.5 0.0 0.7 3.9 0.6 0.0 0.1 0.3 0.0 0.3 4.2 3.3 0.3 0.1 0.0 0.1 0.0 2.3 0.0 6.0 1.8 0.9 0.2 4.9 6.3 0.7 0.0 1.0 2.5 1.3 0.0 1.6 0.1 5.4 1.3 0.3 0.8 1.7 0.8 0.2 0.2 0.3 0.5 0.5 0.3 35.7 1.7 5.7 16.1 4.9 0.2 0.7 0.0 1.4 10.3 0.0 0.0 0.3 0.0 0.3 102.2 0.7 0.0 0.0 0.5 0.2 1.4 1.5 1.1 6.6 5.0 0.0 0.0 0.0 1.9 7.8 6.6 2.2 0.0 0.0 0.0 0.0 4.6 0.0 2.8 0.0 0.0 0.0 0.7 1.2 1.1 5.1 0.2 13.4 0.2 5.1 TRAF1 EBI6 ENSG00000056558 "TNF receptor associated factor 1" Q13077 9 120902393-120929173 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 15 "monocytes: 550.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 2.8;T-cells: 11.1" "Group enriched" "Detected in many" 6 "HDLM-2: 35.9;WM-115: 45.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001852, CAB009593" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB009593: , HPA001852: AB_1080344" "unprognostic (1.45e-3)" "unprognostic (4.51e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-3)" "unprognostic (2.32e-2)" "unprognostic (1.48e-3)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (1.02e-2)" "unprognostic (1.39e-1)" "prognostic favorable (2.19e-5)" "unprognostic (3.23e-1)" "prognostic unfavorable (4.42e-5)" "unprognostic (1.85e-3)" "unprognostic (5.70e-3)" "unprognostic (2.64e-1)" "unprognostic (9.87e-3)" 5.4 8.6 9.5 21.6 20.5 8.7 5.7 4.7 13.7 5.3 6.5 17.5 9.2 4.3 6.6 7.4 5.2 6.7 8.6 7.5 11.4 5.5 7.8 4.9 7.4 33.1 14.8 11.2 10.9 3.9 5.3 11.0 3.6 12.5 10.0 5.0 9.4 10.3 7.2 2.4 8.2 8.9 7.8 7.6 15.5 6.6 3.1 19.1 3.5 7.9 2.2 24.0 9.0 10.0 0.2 2.8 0.0 0.4 1.4 11.1 2.0 1.2 0.8 0.1 0.0 1.5 3.7 0.0 0.3 2.0 0.6 1.1 0.1 0.7 2.4 0.4 0.4 6.0 0.5 0.2 0.1 0.7 35.9 0.0 0.2 0.8 0.1 1.1 0.1 2.8 1.8 1.9 2.3 1.7 0.7 0.3 0.7 0.0 4.9 0.3 0.1 0.0 1.0 0.4 0.5 0.1 0.6 0.6 4.9 0.2 0.1 0.4 0.0 0.3 0.1 0.1 1.1 0.3 0.4 0.3 0.5 0.3 2.0 6.4 3.8 1.3 1.2 1.2 0.2 45.4 0.0 0.3 0.0 3.6 0.4 6.4 0.2 8.8 7.4 0.4 0.2 2.7 4.0 0.0 1.4 0.3 2.8 11.1 2.0 9.5 20.5 4.7 13.7 11.4 5.5 14.8 11.2 12.5 19.1 6.0 0.0 6.7 4.1 8.7 0.3 2.3 2.5 0.0 6.8 3.5 17.7 0.0 1.7 24.7 0.5 2.7 0.5 0.0 1.6 0.0 2.8 2.0 36.8 1.8 2.8 0.0 1.7 0.6 3.4 0.6 1.7 14.8 6.8 550.0 0.5 1.0 9.9 0.0 1.8 0.7 6.6 0.0 5.1 1.4 0.5 9.2 0.0 25.9 0.6 1.7 TRANK1 "KIAA0342, LBA1" ENSG00000168016 "Tetratricopeptide repeat and ankyrin repeat containing 1" O15050 3 36826820-36945098 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 42.3" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 14.9;Enterocytes: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 42.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 42.3" "Cell line enhanced" "Detected in many" "Daudi: 38.8;HMC-1: 15.6" "Low region specificity" "Detected in all" HPA035508 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035508: AB_10671105" "unprognostic (7.11e-3)" "unprognostic (1.55e-2)" "unprognostic (3.05e-2)" "unprognostic (2.34e-1)" "unprognostic (4.84e-2)" "unprognostic (2.04e-3)" "unprognostic (9.13e-2)" "unprognostic (3.22e-1)" "unprognostic (1.76e-1)" "unprognostic (8.59e-2)" "unprognostic (3.83e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (1.82e-3)" "unprognostic (1.07e-3)" 4.1 3.6 4.5 10.4 11.2 6.9 4.7 21.5 12.0 8.5 14.2 1.7 3.1 8.6 12.3 4.5 3.1 19.3 7.3 4.1 3.3 3.9 3.2 7.9 6.2 13.9 2.9 6.6 9.0 2.8 5.0 3.8 3.7 6.0 7.9 10.9 4.4 4.9 5.0 2.6 2.9 23.1 10.5 3.2 9.9 6.0 2.9 1.7 15.1 5.8 1.1 16.2 9.8 6.0 5.2 0.5 42.3 1.3 2.8 5.7 0.9 0.7 0.9 0.2 0.0 2.4 9.7 0.0 0.7 5.1 2.3 4.5 0.0 3.9 38.8 1.6 2.9 7.7 0.2 0.1 0.5 0.4 1.9 0.0 6.3 2.6 0.0 3.1 1.7 15.6 3.2 2.0 1.7 0.1 0.5 2.8 4.2 5.0 5.6 1.7 0.0 4.9 0.7 0.2 0.0 1.0 1.4 0.1 0.7 0.8 1.7 0.3 0.0 3.9 1.0 0.3 0.4 0.6 2.2 1.9 1.8 0.7 0.1 0.6 5.5 1.1 8.6 0.3 1.4 0.2 2.5 0.6 3.9 5.6 0.9 4.2 4.0 4.8 5.7 0.5 5.2 4.4 4.2 42.3 2.8 1.3 0.0 4.0 0.9 4.5 11.2 21.5 12.0 3.3 3.9 2.9 6.6 6.0 1.7 14.9 5.6 3.9 1.2 0.7 1.1 2.4 2.5 5.3 4.5 3.5 2.0 1.0 0.0 2.2 0.2 3.3 15.2 0.0 1.6 1.1 3.0 1.9 5.8 13.9 4.2 0.0 5.2 6.2 6.3 0.0 4.0 3.6 5.0 1.0 8.8 1.4 3.0 12.2 5.6 0.6 0.7 0.0 1.7 0.2 0.2 0.6 0.6 13.8 3.8 1.4 TRIB3 "C20orf97, dJ1103G7.3, TRB3" ENSG00000101255 "Tribbles pseudokinase 3" Q96RU7 20 362835-397559 "Enzymes, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 39.0;salivary gland: 47.5" "Cell type enhanced" "Detected in many" 8 "Ductal cells: 49.9;Hepatocytes: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 88.9;hTCEpi: 55.1;hTERT-HME1: 64.0;SK-MEL-30: 80.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015272, HPA055442" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA015272: AB_1858269, HPA055442: AB_2682818" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (1.57e-1)" "unprognostic (2.25e-3)" "unprognostic (1.92e-1)" "prognostic unfavorable (1.70e-4)" "prognostic unfavorable (6.75e-5)" "unprognostic (1.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.24e-1)" "unprognostic (7.95e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.07e-13)" "unprognostic (7.62e-2)" "unprognostic (2.79e-2)" "unprognostic (2.31e-1)" "unprognostic (4.05e-3)" 4.8 8.7 1.6 2.8 1.5 9.7 6.0 3.8 4.2 2.5 1.8 1.2 3.6 1.0 2.1 3.1 9.8 1.1 2.7 3.0 1.4 2.0 3.3 39.0 8.2 7.3 1.0 2.4 4.4 13.8 2.0 10.5 6.2 1.6 3.9 1.6 3.7 47.5 5.3 1.5 6.5 2.5 1.3 0.7 7.9 4.4 2.7 0.6 6.7 27.2 4.1 7.0 2.7 5.3 15.5 4.7 3.3 4.4 6.6 11.4 5.1 11.1 5.7 0.7 1.6 1.9 2.5 4.8 3.3 8.9 3.2 6.6 11.7 5.6 4.8 3.3 3.0 14.3 9.0 3.1 14.9 2.9 1.8 2.2 3.7 1.2 19.1 88.9 9.4 1.8 10.3 55.1 6.0 64.0 2.2 6.1 12.2 12.9 21.7 0.3 10.4 0.5 11.4 1.7 16.5 18.5 2.1 0.9 10.4 3.7 4.5 2.1 3.3 0.7 27.1 80.8 1.0 7.8 25.0 3.5 1.7 3.0 0.0 5.1 7.6 9.8 8.6 1.5 8.3 6.1 2.5 4.4 1.0 10.0 3.4 7.1 15.5 9.3 11.4 4.7 10.2 10.7 7.6 3.3 6.6 1.7 2.1 6.4 5.1 1.6 1.5 3.8 4.2 1.4 2.0 1.0 2.4 1.6 0.6 3.0 1.0 7.6 7.2 6.1 3.8 1.2 10.2 2.7 1.2 1.8 3.9 13.1 0.0 49.9 0.0 5.8 0.0 23.3 19.2 4.3 1.5 10.5 4.7 25.3 5.6 0.0 1.2 8.0 2.1 0.0 1.7 4.0 6.8 1.8 6.5 0.5 23.3 2.3 1.4 0.0 6.7 6.5 4.1 1.9 2.2 4.6 5.9 5.0 0.6 4.8 TRIM21 "RNF81, Ro/SSA, RO52, SSA1" ENSG00000132109 "Tripartite motif containing 21" P19474 11 4384897-4393696 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "DNA-binding, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 72.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004566, HPA005673" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB004566: AB_628286, HPA005673: AB_1080090" "prognostic favorable (4.83e-5)" "unprognostic (4.55e-2)" "unprognostic (3.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.20e-1)" "unprognostic (5.04e-2)" "unprognostic (1.27e-1)" "unprognostic (2.49e-2)" "unprognostic (3.31e-1)" "unprognostic (1.82e-2)" "unprognostic (6.27e-2)" "unprognostic (4.69e-2)" "prognostic favorable (2.26e-6)" "unprognostic (9.12e-3)" 18.2 12.1 4.9 13.7 6.5 15.0 9.8 2.5 6.4 15.0 11.7 6.4 6.0 12.5 11.6 10.3 14.6 10.4 10.8 8.5 5.0 5.3 12.9 14.9 14.6 21.4 6.8 4.0 17.4 10.7 4.3 9.9 19.9 8.6 18.0 12.0 8.5 11.9 8.6 4.5 6.9 21.8 12.0 4.7 28.3 13.5 6.0 4.7 21.5 19.1 6.8 17.0 11.6 13.5 10.9 22.0 72.4 27.5 14.5 19.5 28.6 5.7 6.8 3.4 3.2 7.1 10.7 4.8 7.4 14.0 29.4 32.6 3.1 16.8 8.8 3.4 10.9 30.4 8.3 6.0 11.3 9.1 14.8 6.7 13.6 3.9 2.8 15.8 16.0 13.6 10.4 6.8 5.9 4.1 10.7 17.9 7.7 4.2 9.7 9.7 5.1 8.4 11.8 2.9 6.6 3.5 5.9 4.5 4.9 11.6 5.4 0.0 1.5 6.1 6.8 8.2 5.8 2.3 11.0 16.1 7.2 5.6 3.7 2.7 5.1 4.0 5.6 6.5 12.7 5.1 18.8 26.9 60.1 19.3 27.5 16.8 10.5 16.6 17.1 22.0 10.9 14.9 15.7 72.4 14.5 24.4 7.4 19.5 28.6 4.9 6.5 2.5 6.4 5.0 5.3 6.8 4.0 8.6 4.7 8.9 4.6 4.7 4.4 1.8 0.5 2.5 5.1 10.7 11.4 5.2 0.0 5.5 6.6 10.3 0.0 6.2 6.7 0.0 7.4 7.2 2.8 3.4 11.6 7.6 8.6 1.6 2.4 9.8 11.0 0.4 4.0 7.2 1.7 10.0 6.9 1.4 9.9 5.8 6.7 3.1 0.0 12.9 4.2 0.3 0.4 1.5 7.6 8.3 4.8 2.8 TRIM24 "hTIF1, RNF82, TIF1, Tif1a" ENSG00000122779 "Tripartite motif containing 24" O15164 7 138460334-138589993 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 43.3;HMC-1: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043495, HPA061717" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA043495: AB_10962915, HPA061717: AB_2684592" "unprognostic (2.40e-1)" "unprognostic (9.52e-3)" "unprognostic (2.23e-1)" "unprognostic (3.96e-2)" "unprognostic (1.20e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.94e-4)" "prognostic favorable (6.57e-4)" "unprognostic (4.01e-2)" "unprognostic (8.93e-2)" "unprognostic (2.53e-1)" "unprognostic (2.02e-1)" "unprognostic (4.62e-2)" "unprognostic (1.62e-1)" "unprognostic (2.25e-2)" "unprognostic (5.54e-2)" "unprognostic (6.34e-2)" 10.3 31.4 10.4 11.2 10.6 8.8 8.8 8.5 10.7 9.4 9.2 14.6 5.7 9.4 9.0 8.5 11.3 7.0 10.3 9.7 8.4 8.5 9.6 21.5 10.7 8.5 10.5 8.0 29.9 11.6 20.7 7.3 13.5 8.4 13.6 9.1 7.5 10.1 7.1 16.0 9.8 14.1 9.4 8.0 8.5 10.8 24.1 11.3 34.8 8.8 9.2 8.9 11.3 11.2 1.3 1.9 3.7 2.5 2.2 2.7 0.8 4.2 5.2 43.3 12.5 2.9 2.7 3.3 3.9 4.2 3.1 3.0 8.2 3.9 8.1 3.9 3.8 6.4 2.3 21.0 3.3 4.6 6.2 5.2 17.9 3.9 25.2 3.9 13.9 58.5 2.4 3.5 2.6 4.1 2.2 7.3 4.5 20.2 5.0 3.7 8.2 23.7 12.6 16.5 22.1 4.7 18.8 5.1 6.8 6.9 12.6 9.0 20.5 7.3 6.6 2.1 15.7 4.5 9.2 3.1 3.6 3.0 6.3 5.4 4.6 5.0 13.8 6.0 9.2 5.2 1.1 2.3 3.6 2.2 2.5 0.4 0.9 1.9 1.2 1.9 1.3 1.8 2.0 3.7 2.2 1.1 1.4 2.7 0.8 10.4 10.6 8.5 9.7 8.4 8.5 10.5 8.0 8.4 11.3 47.6 42.2 4.5 11.6 12.4 13.3 38.8 15.3 17.4 20.5 7.0 15.7 25.9 5.0 6.3 45.5 13.2 8.0 0.0 10.6 11.7 11.8 10.1 38.3 28.4 9.2 38.1 9.7 14.1 11.2 28.3 13.0 12.4 13.5 4.6 8.2 28.0 10.1 9.3 15.2 7.7 20.8 12.9 9.9 43.1 8.5 10.3 18.5 10.2 15.5 12.2 TRIM28 "KAP1, PPP1R157, RNF96, TF1B, TIF1B" ENSG00000130726 "Tripartite motif containing 28" Q13263 19 58544091-58550722 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 221.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010066, HPA064033" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 140000 Nucleoplasm "CAB010066: AB_2209905, HPA064033: AB_2685179" "unprognostic (2.76e-1)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (1.85e-6)" "unprognostic (1.20e-2)" "unprognostic (2.10e-2)" "unprognostic (2.66e-1)" "unprognostic (4.92e-3)" "unprognostic (9.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.67e-2)" "unprognostic (7.34e-2)" "unprognostic (4.22e-1)" "unprognostic (3.28e-2)" 24.2 26.4 17.9 40.1 20.6 52.2 30.6 34.5 26.3 46.7 36.5 26.2 26.2 26.8 43.3 30.0 34.1 34.5 38.5 28.4 18.5 16.4 27.3 42.3 29.5 38.1 29.2 22.7 69.3 47.0 30.7 25.7 45.6 22.8 37.6 18.5 21.5 31.8 32.4 56.5 41.2 27.5 38.4 17.9 34.9 32.9 48.1 23.1 119.9 50.6 33.5 33.5 34.0 46.4 13.7 14.6 5.0 7.6 16.0 16.9 6.3 36.5 78.7 42.3 31.2 18.5 14.2 47.2 24.0 21.8 23.5 18.0 54.8 30.8 40.2 15.9 20.7 43.6 25.1 47.8 34.6 15.4 20.6 221.1 69.2 35.7 43.6 19.7 43.9 44.5 19.2 19.3 30.0 23.5 19.8 21.9 47.6 33.6 22.7 21.6 54.1 61.3 54.1 29.6 37.7 50.7 58.2 25.6 43.2 21.0 60.7 42.4 33.2 25.1 32.7 13.4 13.1 22.4 42.7 20.2 55.3 21.9 12.0 43.0 29.3 47.7 45.0 25.0 32.8 35.0 1.3 7.1 5.0 8.9 7.6 11.6 11.5 12.8 12.3 9.0 13.7 16.9 15.1 3.8 16.0 4.9 14.6 8.2 6.3 17.9 20.6 34.5 26.3 18.5 16.4 29.2 22.7 22.8 23.1 11.9 15.2 37.3 46.8 57.1 60.0 8.4 40.8 8.1 17.0 31.4 25.5 50.7 19.9 38.6 75.8 40.5 45.0 0.0 47.9 51.6 41.1 44.2 21.8 31.0 40.2 52.4 62.0 26.4 32.9 81.1 60.9 36.2 27.0 29.7 61.8 50.0 49.3 45.6 38.9 32.1 31.8 58.2 46.4 124.7 74.6 53.1 46.9 30.5 58.1 39.7 TRIM35 "HLS5, KIAA1098, MAIR" ENSG00000104228 "Tripartite motif containing 35" Q9UPQ4 8 27284887-27311319 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3;Ito cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019647 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA019647: AB_1858291" "unprognostic (7.67e-3)" "unprognostic (6.53e-2)" "unprognostic (1.61e-2)" "unprognostic (9.64e-3)" "unprognostic (9.35e-2)" "prognostic favorable (1.38e-4)" "unprognostic (8.79e-2)" "unprognostic (8.02e-2)" "unprognostic (5.72e-2)" "unprognostic (2.30e-1)" "unprognostic (1.12e-1)" "unprognostic (4.86e-2)" "prognostic favorable (5.59e-7)" "unprognostic (1.74e-2)" "unprognostic (1.69e-1)" "unprognostic (3.99e-2)" "unprognostic (1.92e-1)" 10.6 7.2 5.7 8.1 8.9 8.6 17.7 5.7 12.9 8.2 7.9 8.7 17.3 7.2 10.2 6.6 11.7 8.2 6.3 6.9 10.9 5.9 11.3 14.6 8.4 12.7 7.3 7.3 8.7 11.6 6.8 5.1 7.1 7.0 8.3 5.4 5.4 23.4 27.7 5.8 32.7 7.3 9.7 12.6 7.8 6.8 10.4 6.6 10.2 6.1 7.4 9.0 8.6 10.8 5.2 5.9 8.7 3.0 7.8 12.8 4.8 9.0 6.5 3.8 4.9 38.1 9.5 8.8 5.5 4.3 5.1 5.5 9.2 1.8 8.0 5.7 6.0 4.5 9.0 5.4 10.6 3.9 4.5 4.1 7.9 5.1 7.8 9.9 4.2 6.8 13.7 24.1 7.2 14.4 2.7 5.0 7.7 5.5 9.0 4.1 4.6 14.2 5.9 6.6 5.8 5.3 7.2 4.9 6.9 3.5 7.1 6.5 6.2 4.6 4.4 7.6 3.8 2.8 6.9 5.9 4.7 9.7 14.7 5.3 4.1 4.3 5.9 6.7 6.3 4.5 8.7 2.8 3.4 8.6 2.7 9.7 5.2 11.2 9.5 3.5 3.7 7.7 11.3 1.1 7.8 3.0 5.9 12.8 4.8 5.7 8.9 5.7 12.9 10.9 5.9 7.3 7.3 7.0 6.6 3.0 5.0 2.2 5.6 18.5 3.3 3.6 7.6 0.0 4.5 12.2 5.9 3.0 0.0 3.5 0.6 4.7 3.4 23.3 4.5 2.1 3.8 3.7 5.7 17.4 2.5 4.8 2.4 25.8 8.4 0.4 11.8 4.1 6.8 5.4 2.8 2.2 4.1 0.0 10.3 5.0 3.6 0.0 5.2 1.4 4.3 19.4 1.3 5.0 3.0 2.7 TRIM66 "C11orf29, KIAA0298, TIF1D" ENSG00000166436 "Tripartite motif containing 66" O15016 11 8612037-8682694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 38.1;Late spermatids: 22.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027420 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA027420: AB_1858316" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (2.43e-1)" "unprognostic (7.54e-2)" "unprognostic (3.99e-2)" "unprognostic (1.37e-3)" "unprognostic (8.01e-2)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (6.79e-2)" "prognostic favorable (8.89e-4)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.96e-4)" "unprognostic (1.67e-1)" "unprognostic (4.26e-1)" "unprognostic (4.67e-2)" "unprognostic (4.31e-1)" 5.6 8.0 4.1 7.0 12.1 4.5 8.3 10.5 11.3 4.9 6.0 12.5 13.2 6.1 9.9 19.4 6.7 5.7 6.1 3.2 4.4 5.2 5.6 12.9 4.8 8.6 3.5 5.8 5.5 11.3 7.8 17.3 4.1 8.3 5.6 8.3 9.3 5.7 11.3 5.7 19.9 6.9 6.3 5.3 7.7 6.4 19.8 3.7 8.8 9.2 4.5 12.3 5.9 5.3 2.5 3.8 0.9 3.5 1.9 3.3 0.7 5.8 5.3 3.2 11.6 7.1 5.4 4.0 3.6 4.1 2.5 3.3 6.8 11.1 5.7 2.4 3.1 2.3 7.7 3.5 3.1 3.1 6.6 2.7 5.4 8.5 3.7 2.9 4.4 4.5 8.4 3.2 2.2 7.4 2.8 3.3 14.7 3.0 6.1 3.3 6.4 2.3 3.7 1.7 2.9 4.9 3.3 2.5 2.3 3.7 7.1 2.4 2.3 5.2 3.6 2.4 3.4 4.8 1.1 2.6 4.9 4.5 2.7 3.1 2.6 3.9 7.2 3.3 5.2 2.7 0.1 1.4 0.9 1.9 0.4 1.2 1.5 2.1 2.5 2.0 2.5 1.9 3.3 0.7 1.9 3.5 3.8 1.4 0.7 4.1 12.1 10.5 11.3 4.4 5.2 3.5 5.8 8.3 3.7 3.0 3.5 2.2 2.3 1.5 8.8 1.7 7.6 2.7 5.7 5.2 11.8 2.8 0.0 3.2 38.1 1.7 4.2 0.0 2.8 1.5 2.0 1.4 1.1 7.4 2.2 11.1 5.8 5.5 2.4 22.4 1.7 2.7 0.0 5.4 3.3 5.8 3.2 3.5 2.1 1.5 9.2 12.9 1.1 10.2 6.6 1.0 1.1 2.5 4.1 0.9 TRIP13 16E1BP ENSG00000071539 "Thyroid hormone receptor interactor 13" Q15645 5 892643-919357 "Disease related genes, Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.4;testis: 52.9" "Group enriched" "Detected in many" 5 "Ciliated cells: 109.7;Early spermatids: 114.7;Late spermatids: 165.0;Spermatocytes: 66.2;Spermatogonia: 77.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005727, HPA053093" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA005727: AB_10603220, HPA053093: AB_2682042" "unprognostic (1.65e-2)" "unprognostic (1.65e-1)" "unprognostic (8.59e-2)" "prognostic unfavorable (3.93e-4)" "unprognostic (2.34e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.30e-6)" "unprognostic (4.44e-3)" "unprognostic (1.73e-3)" "prognostic favorable (1.39e-4)" "unprognostic (4.25e-2)" "unprognostic (2.24e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.04e-2)" "unprognostic (1.99e-1)" "unprognostic (1.31e-1)" "unprognostic (3.34e-1)" 1.5 0.9 1.7 8.6 1.2 3.4 1.7 0.6 1.6 1.6 2.7 0.4 1.4 2.4 1.6 1.9 5.3 4.9 2.4 1.2 1.4 1.7 1.3 0.8 1.5 4.7 0.6 0.6 2.1 1.0 0.0 1.9 2.8 1.0 1.0 4.5 0.4 1.3 1.0 0.6 1.4 2.5 2.5 0.7 3.8 1.4 52.9 0.3 16.4 0.5 8.8 6.3 1.1 1.8 2.7 2.3 0.0 0.3 3.3 4.8 0.9 19.5 22.6 14.7 20.8 1.3 3.3 15.4 20.6 10.3 32.8 30.8 21.2 13.5 17.6 14.8 12.1 28.5 14.3 31.1 14.7 41.0 26.3 24.2 12.3 42.5 15.4 0.3 19.9 7.3 1.4 1.0 27.3 11.9 3.4 16.0 14.2 18.0 15.6 22.3 13.3 19.3 16.5 16.1 11.5 19.7 11.6 27.3 32.8 8.7 10.5 14.6 15.0 31.3 11.3 6.0 13.3 21.8 9.3 8.1 17.5 21.7 14.2 22.9 9.2 20.0 19.1 10.3 22.8 19.0 0.0 0.1 0.0 1.0 0.1 0.5 2.7 1.4 1.9 0.3 2.1 0.6 0.2 0.0 3.3 0.3 2.3 4.8 0.9 1.7 1.2 0.6 1.6 1.4 1.7 0.6 0.6 1.0 0.3 0.0 1.4 3.7 3.5 3.1 0.6 0.2 0.0 109.7 4.5 0.0 0.0 3.6 0.0 3.1 114.7 1.4 0.8 0.0 1.6 20.1 1.9 2.1 5.7 0.2 6.2 3.2 4.1 3.1 1.5 165.0 2.0 3.2 0.0 1.8 2.4 0.8 1.8 1.5 2.1 1.0 0.7 6.5 0.3 66.2 77.5 1.3 2.9 4.3 2.8 2.0 TRIR "C19orf43, fSAP18, MGC2803, TERCIR" ENSG00000123144 "Telomerase RNA component interacting RNase" Q9BQ61 19 12730640-12734775 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 325.2;Exocrine glandular cells: 329.0;Extravillous trophoblasts: 428.3;monocytes: 432.0;Pancreatic endocrine cells: 322.0;Proximal tubular cells: 402.3;Syncytiotrophoblasts: 484.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059965 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059965: AB_2684182" "unprognostic (5.57e-2)" "unprognostic (2.73e-3)" "unprognostic (3.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.48e-2)" "unprognostic (1.99e-1)" "unprognostic (3.17e-3)" "unprognostic (1.93e-2)" "unprognostic (1.74e-1)" "unprognostic (9.33e-3)" "unprognostic (2.43e-3)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (4.84e-2)" "unprognostic (1.30e-1)" "unprognostic (2.63e-3)" "unprognostic (1.02e-2)" 58.6 48.6 51.6 64.7 48.9 62.7 53.7 46.3 51.2 61.9 66.0 33.6 45.5 46.8 49.7 68.4 60.0 37.8 59.2 51.5 45.8 41.4 49.1 97.1 45.4 51.8 47.1 39.3 62.3 53.8 31.4 40.2 62.1 31.3 60.4 40.4 36.7 55.6 48.0 77.3 42.5 55.6 47.6 45.1 65.1 48.4 45.8 32.6 87.1 59.5 39.0 59.1 62.2 80.7 24.7 13.6 33.8 10.9 10.6 16.1 5.6 44.5 24.1 30.2 22.3 24.4 26.0 29.2 38.0 23.4 29.2 28.6 31.8 15.7 35.4 49.8 22.5 23.9 30.9 30.2 24.1 23.7 40.2 58.2 23.7 27.4 51.6 23.8 34.1 45.0 26.3 29.7 22.2 17.8 24.6 27.6 25.7 32.7 14.8 26.9 96.4 56.5 80.4 34.4 26.0 68.6 49.2 23.7 35.4 34.1 30.5 34.3 45.8 26.0 26.7 42.7 20.8 23.2 52.6 28.5 35.2 28.2 54.7 48.5 49.6 53.2 39.5 29.8 41.7 24.6 8.0 10.9 33.8 11.4 9.3 13.3 24.7 14.8 14.6 9.7 17.5 14.0 12.5 21.0 10.6 8.7 13.6 16.1 5.6 51.6 48.9 46.3 51.2 45.8 41.4 47.1 39.3 31.3 32.6 65.5 65.4 0.0 0.0 0.0 0.0 0.0 0.0 56.2 62.6 174.5 0.0 325.2 230.5 276.3 0.0 0.0 0.0 0.0 329.0 428.3 0.0 0.0 23.3 0.0 314.8 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.0 432.0 0.0 0.0 322.0 0.0 0.0 402.3 0.0 0.0 0.0 0.0 0.0 0.0 484.5 0.0 0.0 0.0 TRMO "C9orf156, HSPC219" ENSG00000136932 "TRNA methyltransferase O" Q9BU70 9 97904489-97922570 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021281, HPA052197" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA021281: AB_2670649, HPA052197: AB_2681758" "unprognostic (2.53e-1)" "unprognostic (5.66e-2)" "unprognostic (2.13e-1)" "unprognostic (1.63e-3)" "unprognostic (1.12e-1)" "unprognostic (6.28e-2)" "unprognostic (1.08e-2)" "unprognostic (7.27e-3)" "unprognostic (1.64e-1)" "unprognostic (8.67e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-2)" "prognostic favorable (4.81e-10)" "unprognostic (1.97e-1)" "unprognostic (1.78e-1)" "unprognostic (1.74e-2)" "unprognostic (4.39e-2)" 12.2 15.9 13.6 22.5 14.2 20.4 19.3 15.9 14.9 13.5 10.0 19.2 14.9 9.4 15.1 17.3 12.9 15.0 10.6 9.1 13.0 12.3 13.9 17.6 17.9 23.0 14.2 16.3 13.9 13.7 15.7 26.7 10.4 13.3 14.0 11.6 13.4 19.7 11.7 14.1 15.0 14.8 10.1 15.0 20.8 12.8 18.2 14.2 22.8 26.1 10.3 19.1 11.9 10.7 15.8 13.4 28.8 13.7 11.9 25.8 12.0 14.9 9.6 5.2 6.3 6.5 5.4 9.0 7.7 8.8 12.2 9.2 13.3 10.9 9.5 5.3 7.4 13.8 14.2 8.4 6.1 9.6 11.2 6.9 7.6 11.6 11.8 13.6 14.7 12.8 9.5 13.6 6.6 5.7 7.4 5.4 7.6 12.2 12.1 8.4 21.7 6.2 10.2 7.2 16.3 10.8 7.6 11.5 6.9 11.4 12.2 9.4 8.2 5.8 12.2 12.4 4.6 5.3 8.2 8.1 6.8 6.8 14.1 11.5 13.4 9.5 4.8 7.1 7.7 5.9 20.1 12.8 28.8 12.9 13.7 15.9 11.9 19.8 15.5 13.4 15.8 25.8 17.9 20.9 11.9 9.1 7.8 20.2 12.0 13.6 14.2 15.9 14.9 13.0 12.3 14.2 16.3 13.3 14.2 11.9 4.0 7.8 13.4 0.0 8.7 0.0 7.6 10.7 12.5 5.2 0.0 7.7 6.6 7.8 27.5 3.7 2.6 0.0 8.5 6.1 4.1 4.9 0.0 6.4 9.5 6.4 2.4 3.1 8.9 10.5 4.6 2.8 0.0 8.2 7.0 11.6 8.4 7.0 6.7 7.0 4.2 6.5 0.0 14.8 14.5 0.0 15.3 10.2 4.9 6.4 TRMT44 "C4orf23, FLJ35725, METTL19, TRM44" ENSG00000155275 "TRNA methyltransferase 44 homolog" Q8IYL2 4 8436140-8493531 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045461 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045461: AB_10961276" "unprognostic (1.50e-1)" "unprognostic (1.65e-3)" "unprognostic (3.47e-1)" "unprognostic (1.01e-2)" "unprognostic (2.06e-1)" "unprognostic (1.34e-2)" "unprognostic (1.75e-1)" "unprognostic (1.78e-2)" "unprognostic (3.46e-1)" "unprognostic (8.13e-2)" "unprognostic (3.44e-3)" "unprognostic (2.69e-3)" "unprognostic (1.49e-1)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (6.76e-2)" "unprognostic (8.34e-3)" 11.5 7.6 13.3 7.3 17.5 13.1 15.4 20.3 16.2 10.1 9.2 14.1 10.1 7.1 16.3 10.7 13.6 12.3 8.6 9.8 12.1 6.3 7.1 8.9 8.8 9.8 12.2 14.7 17.1 9.7 11.3 10.9 10.2 8.7 10.8 7.2 9.4 12.4 8.7 11.5 17.2 7.6 9.7 6.7 8.1 11.3 15.8 13.8 7.8 9.9 9.0 10.7 10.8 11.4 2.1 2.1 0.4 2.1 0.8 3.0 0.5 5.6 6.0 7.4 8.8 8.0 7.8 16.2 6.8 4.8 8.9 8.0 7.3 8.1 7.7 3.3 2.7 7.2 4.3 10.8 6.6 7.9 3.9 5.3 7.2 9.3 5.7 6.9 12.4 6.0 4.7 9.1 6.8 7.5 7.6 9.5 5.3 11.0 8.4 5.6 3.7 10.3 9.1 8.5 7.2 9.0 7.7 8.0 4.9 7.7 6.9 8.1 5.6 4.4 4.0 5.9 8.8 3.6 4.8 5.6 5.5 3.0 5.1 10.4 9.8 6.1 7.1 6.1 11.7 5.3 0.4 1.2 0.1 2.3 1.2 1.6 0.8 2.1 2.5 2.1 2.1 3.0 0.9 0.2 0.8 2.1 1.7 0.2 0.5 13.3 17.5 20.3 16.2 12.1 6.3 12.2 14.7 8.7 13.8 8.9 5.3 2.2 3.7 6.1 7.8 2.6 12.7 5.3 2.3 7.0 23.6 8.6 5.0 4.2 3.0 3.9 2.3 0.0 3.9 5.3 5.1 3.9 4.7 2.9 4.0 3.2 1.7 3.1 4.6 1.4 5.5 2.9 1.7 4.6 2.3 3.2 3.6 2.5 3.5 2.2 10.9 0.0 1.8 6.2 6.1 5.1 13.6 3.2 2.8 7.0 TRPS1 "GC79, LGCR" ENSG00000104447 "Transcriptional repressor GATA binding 1" Q9UHF7 8 115408496-115809673 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 65.9" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 77.5;Late spermatids: 117.5" "Cancer enriched" "Detected in many" 8 "breast cancer: 49.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 8.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 13.7;SK-BR-3: 23.4;T-47d: 73.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060380, HPA071767" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA060380: AB_2684270, HPA071767: AB_2732185" "unprognostic (4.34e-2)" "unprognostic (4.65e-2)" "unprognostic (1.73e-2)" "unprognostic (2.57e-1)" "unprognostic (1.87e-1)" "prognostic favorable (9.42e-4)" "unprognostic (2.23e-3)" "unprognostic (2.08e-1)" "unprognostic (9.31e-2)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.16e-4)" "unprognostic (3.02e-1)" "unprognostic (2.17e-2)" "unprognostic (1.93e-2)" "unprognostic (1.64e-1)" "unprognostic (1.78e-2)" "unprognostic (3.07e-3)" 6.7 4.5 11.4 6.8 12.0 8.2 65.9 7.0 8.9 16.8 7.7 7.5 9.2 2.0 11.7 6.8 16.3 7.2 11.7 5.9 14.0 4.3 9.8 3.3 6.5 5.9 8.7 8.1 6.8 2.4 9.1 9.7 4.0 10.8 11.7 4.1 4.1 16.0 10.6 4.1 13.5 3.6 12.6 20.6 5.2 4.7 13.2 8.6 1.8 7.2 14.8 9.2 9.6 17.6 1.8 3.1 1.6 8.5 1.8 2.1 1.3 0.8 0.1 1.7 0.0 1.6 6.2 0.1 1.4 3.3 0.9 1.6 0.1 1.4 0.7 0.0 3.7 0.8 0.0 6.8 1.2 1.1 0.0 2.0 0.0 2.8 0.0 2.2 0.0 0.0 2.9 1.3 2.6 4.8 2.7 0.8 0.1 0.3 11.3 1.8 13.7 0.0 0.0 0.3 0.3 1.4 0.0 0.0 8.6 1.5 0.0 1.5 1.2 0.7 23.4 0.9 0.9 73.3 0.6 0.0 4.1 2.1 1.2 2.8 3.0 0.0 1.3 4.4 0.0 2.7 0.0 8.5 0.0 1.7 3.5 2.0 1.0 2.1 2.0 3.1 1.8 1.9 1.8 1.6 1.8 2.5 1.1 0.8 1.3 11.4 12.0 7.0 8.9 14.0 4.3 8.7 8.1 10.8 8.6 6.0 4.0 11.5 20.1 8.4 6.6 3.5 5.1 0.0 3.4 17.4 41.2 0.1 10.0 2.3 77.5 4.5 0.0 0.0 2.5 0.1 11.8 17.3 12.7 0.9 14.3 0.0 0.0 3.1 46.8 117.5 23.3 45.2 20.3 2.8 0.0 10.0 1.9 0.0 26.5 20.3 36.6 6.5 24.5 1.7 9.4 10.9 0.2 11.5 0.0 8.9 TSEN34 "LENG5, SEN34, SEN34L" ENSG00000170892 "TRNA splicing endonuclease subunit 34" Q9BSV6 19 54189938-54194536 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Disease mutation, Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 24.8" "Group enriched" "Detected in many" 6 "granulocytes: 24.8;monocytes: 8.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041111, HPA048208" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA041111: AB_10794263, HPA048208: AB_2680313" "unprognostic (3.24e-2)" "unprognostic (2.95e-2)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (3.48e-2)" "unprognostic (4.82e-2)" "prognostic unfavorable (1.44e-7)" "unprognostic (2.38e-1)" "unprognostic (7.35e-2)" "unprognostic (1.51e-1)" "unprognostic (5.04e-3)" "unprognostic (8.98e-2)" "unprognostic (4.55e-3)" "unprognostic (2.02e-3)" "unprognostic (1.81e-1)" "unprognostic (2.81e-1)" "unprognostic (1.12e-1)" 12.3 28.0 10.4 10.8 10.2 8.2 15.4 4.0 12.8 19.8 19.5 9.4 19.2 3.0 17.3 23.4 20.2 25.3 18.1 20.0 8.8 9.8 15.4 20.0 13.4 18.2 8.7 8.9 31.8 27.3 19.2 14.3 22.0 8.7 23.2 12.3 15.7 17.8 29.5 15.7 14.7 9.8 18.6 7.8 18.0 13.0 27.3 7.7 12.9 28.5 19.6 14.9 19.8 15.5 1.4 2.6 24.8 8.1 0.8 2.4 1.5 29.2 4.3 11.9 17.0 7.1 14.4 13.0 3.6 7.4 8.8 8.3 2.2 4.2 2.2 1.0 5.7 15.3 20.6 16.2 21.5 6.5 7.6 24.6 2.6 0.8 2.4 6.7 0.8 3.6 23.2 9.9 6.0 7.1 7.4 18.1 0.0 5.9 1.4 18.8 3.6 1.5 0.0 2.7 18.6 3.2 7.3 8.1 1.0 25.5 2.5 0.6 6.9 0.8 21.8 8.0 7.7 17.3 2.1 1.2 0.0 12.3 12.8 22.4 8.3 8.0 2.1 21.3 1.3 13.5 4.1 8.1 17.8 0.9 3.3 1.8 1.0 1.3 2.4 2.3 1.4 2.3 0.9 24.8 0.8 5.2 2.6 0.7 1.5 10.4 10.2 4.0 12.8 8.8 9.8 8.7 8.9 8.7 7.7 11.9 20.1 13.7 83.2 65.4 36.0 10.5 50.9 33.5 6.8 41.8 27.5 85.1 81.2 59.2 19.5 32.8 50.1 0.0 52.3 87.0 54.1 67.1 26.5 33.9 49.4 15.9 73.7 33.7 31.5 13.0 62.7 44.3 43.9 23.4 79.0 62.4 50.8 51.8 62.6 85.1 41.1 58.2 56.2 46.1 66.6 61.4 92.8 29.7 61.7 51.5 TSEN54 "SEN54, SEN54L" ENSG00000182173 "TRNA splicing endonuclease subunit 54" Q7Z6J9 17 75516060-75524739 "Disease related genes, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Disease mutation, Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 79.7;T-cells: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024543, HPA053097" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA024543: , HPA053097: AB_2682043" "unprognostic (3.52e-2)" "unprognostic (2.52e-3)" "unprognostic (9.60e-3)" "unprognostic (2.55e-3)" "unprognostic (1.81e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (8.06e-6)" "unprognostic (2.33e-2)" "unprognostic (8.37e-2)" "unprognostic (9.04e-2)" "prognostic favorable (2.62e-5)" "unprognostic (7.26e-3)" "unprognostic (5.01e-2)" "prognostic favorable (7.78e-5)" "unprognostic (8.69e-2)" "unprognostic (2.03e-2)" "prognostic favorable (8.54e-4)" 6.2 7.9 8.1 9.7 11.0 12.9 7.1 24.6 9.0 8.0 12.4 10.9 8.6 18.9 7.2 6.1 12.8 9.1 27.0 4.9 12.2 5.0 12.3 9.8 9.5 10.4 15.8 9.4 7.3 21.6 7.6 10.7 5.9 11.7 11.0 7.3 4.7 13.6 11.5 7.9 19.5 17.3 7.4 9.5 15.2 17.4 7.4 10.5 10.9 10.4 8.6 13.1 8.5 8.9 4.6 10.5 7.5 3.4 17.0 34.0 9.6 14.9 17.1 4.8 9.7 1.6 1.9 12.7 3.9 2.5 8.0 6.4 20.2 12.3 19.3 5.2 1.5 5.6 13.9 6.2 5.8 3.6 5.1 22.5 14.8 10.5 12.5 4.0 6.0 30.5 2.3 7.5 3.6 3.3 1.8 5.4 12.3 17.4 6.9 2.3 26.0 19.8 17.3 6.5 14.4 17.1 14.6 15.2 14.3 4.3 8.3 16.3 12.6 8.6 23.2 6.2 6.7 16.5 8.6 2.6 8.5 13.4 10.6 8.2 17.0 7.8 10.3 4.7 19.7 3.9 7.5 1.6 5.0 34.0 3.4 22.5 4.6 13.8 25.2 3.9 2.9 11.1 21.2 0.2 17.0 3.2 10.5 7.7 9.6 8.1 11.0 24.6 9.0 12.2 5.0 15.8 9.4 11.7 10.5 8.9 8.1 6.7 11.3 23.5 13.9 2.0 10.2 2.7 7.9 8.7 3.9 10.6 10.0 14.6 4.6 8.7 16.8 0.0 15.1 14.6 8.9 7.7 79.7 7.7 11.2 30.2 18.0 6.2 4.6 4.2 4.4 4.5 15.1 17.2 15.7 15.2 12.5 16.7 7.1 9.8 6.8 12.9 8.7 15.8 26.0 21.2 6.3 62.1 19.6 7.3 TSHZ1 "NY-CO-33, SDCCAG33, TSH1" ENSG00000179981 "Teashirt zinc finger homeobox 1" Q6ZSZ6 18 75210755-75289950 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Peritubular cells: 176.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 27.9" "Region enriched" "Detected in many" 5 "olfactory region: 81.2" "Low region specificity" "Detected in all" HPA006982 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA006982: AB_1079886" "unprognostic (2.02e-1)" "unprognostic (2.61e-2)" "unprognostic (4.03e-1)" "unprognostic (5.89e-2)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (1.24e-1)" "unprognostic (4.12e-2)" "unprognostic (9.05e-2)" "unprognostic (5.64e-2)" "unprognostic (1.69e-1)" "unprognostic (3.43e-3)" "unprognostic (1.26e-1)" "unprognostic (8.00e-2)" "prognostic unfavorable (1.71e-5)" "unprognostic (3.42e-3)" 16.2 9.4 13.8 10.3 16.8 3.6 25.6 25.9 23.2 20.9 22.4 8.5 9.3 15.3 13.1 11.3 11.7 19.0 11.9 13.6 11.9 9.2 13.9 9.3 9.3 10.0 9.9 7.7 41.6 8.9 12.6 18.5 32.1 12.7 10.8 10.8 13.7 13.3 13.6 9.4 12.0 17.5 13.5 19.0 10.2 11.5 8.7 7.9 14.3 9.7 5.2 6.2 14.7 19.9 1.2 1.7 1.2 1.2 3.2 5.1 1.4 3.3 4.0 1.4 8.2 12.4 6.0 1.4 15.3 14.5 2.5 4.9 2.0 8.2 6.7 2.0 13.9 2.9 3.0 1.8 4.4 0.9 27.9 15.1 5.2 9.3 2.6 3.2 12.2 6.1 6.0 4.7 2.1 4.2 4.0 6.5 7.9 2.9 12.1 4.2 3.2 8.7 6.9 0.5 3.9 5.0 8.0 4.2 8.0 4.9 2.4 10.4 7.9 4.3 5.6 4.2 0.6 1.3 6.4 4.9 5.7 3.9 3.9 2.4 4.0 9.5 5.5 5.5 10.4 5.1 0.0 1.2 1.2 4.8 0.5 3.4 1.0 2.4 4.2 1.7 1.2 3.7 5.1 0.8 3.2 0.5 1.7 1.0 1.4 13.8 16.8 25.9 23.2 11.9 9.2 9.9 7.7 12.7 7.9 11.9 12.3 6.2 4.8 15.0 42.4 21.6 22.9 12.0 10.3 3.5 2.0 3.7 3.3 4.4 1.0 26.9 17.4 0.0 8.8 1.7 35.1 6.4 6.9 18.1 5.4 11.1 16.3 18.4 12.9 2.4 59.8 10.0 8.5 1.8 17.0 16.6 3.3 10.5 176.0 16.7 10.9 25.8 11.8 0.7 4.9 11.5 3.0 15.8 16.4 5.2 TSPAN13 "NET-6, TM4SF13" ENSG00000106537 "Tetraspanin 13" O95857 7 16753535-16784536 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 461.6;Mucus-secreting cells: 362.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 24.7;plasmacytoid DC: 51.3" "Group enriched" "Detected in many" 41 "B-cells: 24.7;dendritic cells: 51.3" "Cell line enhanced" "Detected in many" "OE19: 74.3;SCLC-21H: 34.3;SK-BR-3: 49.6;T-47d: 92.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007426 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA007426: AB_10603137" "unprognostic (3.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.56e-5)" "unprognostic (2.63e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (5.69e-2)" "unprognostic (6.63e-2)" "prognostic favorable (2.20e-4)" "unprognostic (1.50e-1)" "unprognostic (3.07e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" 20.8 24.2 17.7 7.6 24.9 6.2 25.6 10.7 33.0 18.6 23.6 3.0 21.0 25.2 5.9 12.3 8.8 5.7 16.0 6.8 14.5 21.7 3.3 22.2 53.4 14.8 12.0 15.9 2.1 55.2 4.6 48.0 19.0 14.0 15.1 29.1 8.5 49.1 19.2 4.1 4.7 27.8 5.9 3.6 12.9 31.3 3.1 3.4 3.6 13.0 7.1 18.5 12.1 10.6 24.7 51.3 0.9 0.0 0.8 0.0 1.2 7.1 5.9 7.6 8.0 0.9 0.0 2.1 15.4 2.5 0.4 0.7 20.8 11.1 0.2 3.9 5.5 1.9 11.1 8.7 12.9 3.4 0.2 9.4 3.0 2.4 2.2 2.1 0.2 0.6 0.9 5.6 0.8 0.9 4.4 4.7 3.2 10.0 0.0 0.4 20.4 0.4 0.4 5.3 74.3 7.2 8.2 0.0 7.4 24.0 13.6 34.3 5.2 2.8 49.6 0.7 11.3 92.8 0.8 0.4 0.2 2.7 0.2 5.0 4.5 0.1 0.1 7.1 0.1 10.8 0.1 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.2 24.7 0.0 0.0 0.9 0.8 0.0 51.3 0.0 1.2 17.7 24.9 10.7 33.0 14.5 21.7 12.0 15.9 14.0 3.4 461.6 65.1 58.0 67.1 37.8 65.4 15.8 38.2 25.4 58.0 27.9 7.9 258.0 6.6 62.2 1.0 52.8 83.8 46.7 178.4 88.6 42.3 128.5 9.2 25.9 34.7 14.3 103.4 9.8 15.8 1.8 0.6 4.3 30.4 105.6 362.8 2.3 99.4 94.7 0.7 0.7 7.4 32.3 10.8 0.7 16.8 34.6 168.2 8.7 117.0 107.7 TSPAN17 "FBX23, FBXO23, TM4SF17" ENSG00000048140 "Tetraspanin 17" Q96FV3 5 176647387-176659054 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030447 Approved Nucleoplasm NA NA Nucleoplasm "HPA030447: AB_2673484" "unprognostic (1.70e-2)" "unprognostic (7.92e-2)" "unprognostic (2.91e-1)" "unprognostic (3.47e-2)" "unprognostic (3.97e-2)" "unprognostic (3.71e-3)" "unprognostic (1.21e-3)" "unprognostic (3.82e-1)" "unprognostic (2.30e-1)" "unprognostic (3.60e-1)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.41e-2)" "unprognostic (7.11e-3)" "unprognostic (2.32e-1)" "unprognostic (4.50e-1)" "unprognostic (1.46e-1)" 11.1 29.3 18.7 12.8 12.6 39.1 14.7 18.3 20.9 8.7 14.7 7.1 12.4 13.1 9.0 10.5 16.6 11.2 16.8 16.5 13.3 10.4 16.4 15.0 13.5 19.8 9.2 9.2 8.6 30.5 12.3 19.5 10.3 10.4 12.4 11.8 9.1 11.7 15.8 30.2 11.2 14.6 11.7 6.6 15.7 15.3 18.4 11.2 3.4 11.9 13.7 15.8 14.5 9.4 2.6 3.1 0.8 4.9 3.7 9.3 3.4 16.0 16.3 10.9 19.9 15.2 13.1 17.0 12.1 17.7 17.9 17.9 4.9 18.5 7.2 22.1 20.8 37.0 12.3 5.4 28.1 11.0 53.0 11.4 2.7 7.1 5.8 13.9 5.8 10.1 15.5 15.9 14.2 8.7 12.2 24.5 5.6 13.5 7.8 18.1 26.5 1.2 2.5 8.8 15.7 17.9 6.1 9.3 4.0 16.8 11.9 16.6 11.7 13.1 15.3 16.3 9.5 12.5 7.4 18.9 19.5 20.3 14.6 15.1 4.4 5.7 3.1 21.3 12.4 11.3 0.0 3.1 0.8 5.4 3.1 4.3 1.6 4.1 8.8 3.1 2.6 2.9 3.9 0.5 3.7 4.9 0.8 9.3 3.4 18.7 12.6 18.3 20.9 13.3 10.4 9.2 9.2 10.4 11.2 11.9 9.8 8.2 9.5 2.6 9.7 12.3 12.7 1.4 5.7 10.4 11.8 0.8 5.0 32.2 0.8 7.9 26.0 23.3 49.2 16.3 9.1 11.8 0.0 11.6 13.6 1.6 13.8 12.3 8.9 0.4 6.4 8.6 6.8 14.4 19.4 6.5 35.7 19.5 6.7 11.0 24.8 0.0 8.6 1.1 2.4 4.6 1.0 13.1 20.4 11.9 TSPAN2 "FLJ12082, TSN2, TSPAN-2" ENSG00000134198 "Tetraspanin 2" O60636 1 115048011-115089500 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 44.6" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 22.5;Intestinal endocrine cells: 37.7;Smooth muscle cells: 20.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "pons and medulla: 11.9" "Cell type enhanced" "Detected in many" "neutrophil: 35.0" "Group enriched" "Detected in many" 4 "granulocytes: 35.0;NK-cells: 25.9" "Cell line enhanced" "Detected in many" "EFO-21: 35.1;hTERT-RPE1: 9.8;U-937: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015640, HPA073306" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015640: AB_1858405, HPA073306: " "unprognostic (4.56e-2)" "unprognostic (6.86e-2)" "unprognostic (2.60e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (1.57e-3)" "unprognostic (1.64e-1)" "unprognostic (9.73e-6)" "unprognostic (6.06e-3)" "unprognostic (3.07e-2)" "unprognostic (4.74e-2)" "unprognostic (7.66e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (8.48e-7)" "unprognostic (5.40e-2)" "unprognostic (1.59e-1)" "unprognostic (1.48e-3)" "unprognostic (7.80e-3)" 3.7 0.6 1.1 4.7 2.5 9.6 3.2 0.9 2.0 20.1 31.0 1.5 8.9 2.5 30.6 6.9 12.3 14.2 10.6 6.1 1.1 2.6 4.0 0.6 3.0 1.5 1.9 1.9 6.5 2.0 6.4 2.0 1.5 11.9 15.2 6.2 1.9 2.2 15.7 2.0 1.6 7.0 44.6 1.6 2.2 10.0 4.4 0.8 2.6 4.0 4.9 0.9 25.4 7.0 0.2 1.2 35.0 2.9 25.9 7.4 3.8 8.5 0.1 0.7 0.0 0.0 0.1 0.0 1.4 0.5 1.4 2.2 1.7 5.2 0.0 35.1 1.9 1.9 1.2 1.1 0.0 1.5 1.7 0.7 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 9.8 0.0 6.9 0.0 0.5 0.0 0.4 4.6 0.7 8.0 1.7 0.9 0.0 0.5 0.0 0.2 3.2 1.8 2.9 2.1 0.9 0.1 4.9 0.1 0.3 0.1 0.1 3.4 0.2 8.0 7.3 0.2 0.0 0.0 15.4 3.8 27.8 2.9 16.6 5.9 0.0 1.9 0.2 7.0 7.4 1.2 0.1 1.2 6.0 35.0 25.9 0.0 1.2 0.9 3.8 1.1 2.5 0.9 2.0 1.1 2.6 1.9 1.9 11.9 0.8 0.0 1.1 0.0 22.5 7.1 0.2 9.2 0.0 10.7 2.3 10.4 0.0 0.1 0.0 16.3 10.8 15.0 0.0 0.0 2.2 3.1 3.1 10.9 0.0 0.0 0.6 0.0 37.7 5.5 0.8 2.7 0.6 0.9 3.3 0.0 0.8 0.0 7.7 0.0 2.8 1.0 0.4 6.5 20.2 0.1 0.9 2.4 0.2 5.0 1.0 9.2 TSPAN32 "PHEMX, TSSC6" ENSG00000064201 "Tetraspanin 32" Q96QS1 11 2301997-2318200 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.3;bone marrow: 17.5;heart muscle: 11.9;lymphoid tissue: 11.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 10.7;Cardiomyocytes: 13.4;granulocytes: 29.0;Macrophages: 13.0;T-cells: 23.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "HEL: 15.8;HL-60: 6.9;NB-4: 5.7;THP-1: 6.1;U-937: 9.6" "Low region specificity" "Detected in many" HPA024135 Uncertain Approved Nucleoplasm NA NA 37000 Nucleoplasm "HPA024135: AB_1858409" "unprognostic (7.50e-3)" "unprognostic (4.88e-4)" "unprognostic (1.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.45e-3)" "unprognostic (2.10e-4)" "unprognostic (7.72e-3)" "unprognostic (8.25e-3)" "unprognostic (9.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.02e-1)" "unprognostic (2.28e-7)" "unprognostic (1.07e-1)" "unprognostic (4.20e-1)" "unprognostic (4.35e-1)" "unprognostic (8.13e-2)" 1.2 0.4 0.3 6.3 0.5 17.5 0.5 0.4 1.0 1.3 1.3 2.1 0.0 0.2 1.6 1.6 0.9 0.6 1.4 11.9 0.3 0.4 0.9 0.8 3.1 5.1 0.5 0.3 0.8 0.4 0.0 0.4 0.9 0.5 1.2 0.1 1.7 5.6 0.9 0.3 0.5 1.1 1.8 0.8 5.8 1.4 0.4 1.1 7.4 0.5 2.1 11.5 1.0 0.8 1.1 14.9 17.9 19.3 25.3 13.2 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 15.8 0.0 0.1 0.7 6.9 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 9.6 0.0 17.9 15.2 2.0 13.0 17.9 8.1 1.1 4.7 11.1 14.9 0.6 3.7 13.2 8.4 25.3 19.3 0.7 5.8 9.5 0.3 0.5 0.4 1.0 0.3 0.4 0.5 0.3 0.5 1.1 0.0 10.7 2.7 0.0 0.8 0.0 13.4 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.9 0.0 29.0 0.0 4.4 0.0 0.0 0.0 6.6 3.5 0.9 13.0 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.5 0.0 23.5 0.0 0.0 TSR1 FLJ10534 ENSG00000167721 "TSR1, ribosome maturation factor" Q2NL82 17 2322503-2337507 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024434, HPA053087" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024434: AB_1858413, HPA053087: AB_2682040" "unprognostic (1.45e-2)" "unprognostic (1.43e-2)" "unprognostic (1.36e-1)" "unprognostic (1.53e-1)" "unprognostic (4.76e-2)" "unprognostic (2.74e-1)" "unprognostic (1.95e-3)" "unprognostic (9.80e-3)" "unprognostic (6.16e-2)" "unprognostic (2.38e-1)" "unprognostic (6.74e-2)" "unprognostic (1.60e-2)" "unprognostic (8.61e-2)" "unprognostic (1.40e-1)" "unprognostic (5.60e-2)" "unprognostic (1.70e-2)" "unprognostic (9.46e-3)" 15.6 11.8 11.2 14.0 14.1 11.8 14.7 12.5 15.9 10.3 12.8 12.1 11.7 7.9 15.9 10.8 20.0 12.5 10.5 14.8 11.5 9.3 10.6 18.5 9.8 13.3 13.3 12.7 14.5 23.8 14.2 9.6 13.7 11.1 12.6 12.9 10.5 12.8 15.7 42.2 16.2 9.8 20.1 10.6 11.6 12.7 18.3 11.4 14.4 10.7 25.0 15.4 14.2 12.3 8.3 11.4 1.4 10.7 5.6 11.8 5.7 26.8 27.7 12.9 26.0 10.5 12.3 27.2 21.2 11.7 12.9 9.9 44.1 11.2 27.3 19.6 16.6 12.3 23.1 27.8 24.6 16.6 12.9 32.9 20.1 22.3 20.3 14.6 18.6 14.7 12.4 15.4 24.8 28.5 14.1 12.5 14.9 26.5 15.3 15.9 15.5 18.4 9.0 31.8 19.1 16.7 19.9 17.7 19.1 15.9 16.9 9.4 20.9 18.5 14.4 14.5 12.8 13.5 8.1 13.9 18.2 15.3 22.1 40.4 11.5 15.0 16.8 17.8 21.2 22.6 1.4 6.7 1.4 8.9 10.7 11.8 7.5 7.2 7.6 11.4 8.3 7.6 9.0 1.1 5.6 10.3 4.3 8.7 5.7 11.2 14.1 12.5 15.9 11.5 9.3 13.3 12.7 11.1 11.4 29.8 30.6 20.8 29.5 30.6 17.1 16.9 15.3 30.8 42.1 14.0 17.7 25.6 3.3 19.5 61.9 13.5 3.3 0.0 14.2 34.6 17.5 16.0 41.6 12.1 14.1 17.5 9.9 11.1 8.6 57.0 12.0 12.2 15.1 19.0 10.1 11.2 18.8 7.0 11.3 9.8 18.9 19.4 24.7 23.8 50.8 36.0 20.3 12.2 14.4 26.7 TSTD2 "C9orf97, PP4189" ENSG00000136925 "Thiosulfate sulfurtransferase like domain containing 2" Q5T7W7 9 97600080-97633575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022537, HPA024241, HPA064304" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA022537: AB_1845850, HPA024241: AB_1845851, HPA064304: AB_2685238" "unprognostic (7.24e-2)" "unprognostic (5.56e-2)" "unprognostic (1.88e-1)" "unprognostic (2.98e-1)" "unprognostic (4.18e-2)" "unprognostic (1.39e-2)" "unprognostic (1.38e-1)" "unprognostic (7.07e-2)" "unprognostic (1.10e-1)" "unprognostic (1.23e-3)" "unprognostic (9.67e-2)" "unprognostic (1.51e-1)" "prognostic favorable (5.75e-4)" "unprognostic (2.21e-2)" "unprognostic (5.31e-2)" "unprognostic (1.12e-1)" "unprognostic (1.10e-1)" 11.9 11.8 11.9 7.4 11.6 3.3 12.1 18.9 15.1 14.2 12.4 14.9 10.6 6.9 14.8 10.6 10.0 12.7 11.0 14.9 9.8 8.4 12.8 14.4 11.0 8.9 12.4 9.5 17.2 15.7 19.8 17.0 13.9 12.5 12.2 11.3 11.1 10.2 13.1 21.1 9.2 9.7 14.4 13.8 8.7 11.2 11.6 12.4 10.6 16.2 12.1 12.0 14.4 9.7 6.2 6.5 5.2 7.0 11.2 10.4 5.3 10.9 8.6 13.8 8.9 9.3 7.8 12.1 7.2 8.8 9.9 10.4 8.5 3.6 11.4 3.5 9.1 11.9 15.1 12.3 7.0 11.2 7.6 5.5 7.8 9.9 6.4 10.9 11.5 10.3 10.3 12.0 9.6 17.0 9.0 7.5 11.9 13.9 8.6 8.5 5.3 13.6 5.7 11.3 14.0 8.4 11.3 20.4 5.9 6.8 5.0 10.0 7.8 9.2 6.4 8.4 11.1 4.9 6.5 7.9 8.6 8.3 10.1 8.1 12.3 16.1 5.9 7.2 5.8 6.2 4.3 3.9 5.2 6.4 7.0 10.4 5.8 6.4 7.7 6.5 6.2 7.2 6.9 1.6 11.2 5.2 2.9 3.6 5.3 11.9 11.6 18.9 15.1 9.8 8.4 12.4 9.5 12.5 12.4 17.9 11.7 7.8 3.6 1.4 25.8 15.2 7.6 21.4 23.9 1.8 23.6 5.9 14.9 7.4 15.6 6.7 4.9 23.3 6.3 3.6 5.4 4.5 19.7 11.6 4.6 20.6 18.4 6.2 5.7 5.9 7.5 3.5 5.0 4.6 5.1 12.0 9.0 4.3 9.9 6.4 20.3 19.4 5.4 19.0 25.6 3.6 9.2 5.3 4.9 3.3 TTC12 "FLJ13859, FLJ20535, TPARM" ENSG00000149292 "Tetratricopeptide repeat domain 12" Q9H892 11 113314529-113383544 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.8" "Group enriched" "Detected in many" 6 "Ciliated cells: 78.9;Early spermatids: 130.7;Late spermatids: 140.2;Spermatocytes: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038542, HPA038543, HPA061364" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA038542: AB_2676072, HPA038543: AB_10674686, HPA061364: AB_2684492" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" "prognostic favorable (3.14e-4)" "prognostic favorable (2.48e-5)" "unprognostic (2.11e-2)" "unprognostic (3.27e-1)" "unprognostic (1.13e-3)" "unprognostic (3.33e-3)" "unprognostic (7.67e-2)" "unprognostic (1.57e-1)" "unprognostic (6.03e-2)" "unprognostic (5.46e-2)" "prognostic favorable (5.95e-5)" "unprognostic (3.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.26e-1)" "unprognostic (1.35e-2)" 3.1 6.1 3.8 8.8 5.2 1.3 8.1 3.1 4.4 9.0 4.7 7.3 16.3 2.8 10.8 14.9 4.3 13.1 6.8 5.4 3.5 4.5 7.2 4.4 4.9 9.8 3.9 2.1 6.9 5.1 17.5 25.7 3.4 5.7 9.8 5.1 10.0 9.5 13.1 3.5 4.7 4.2 11.5 4.0 4.2 4.6 44.8 4.7 2.5 12.1 5.9 8.4 7.2 4.6 6.4 4.0 3.1 1.8 2.9 5.7 2.2 3.8 2.4 5.9 6.2 4.3 5.4 3.5 3.5 6.7 4.8 4.6 2.9 10.6 2.0 5.2 0.1 3.9 8.3 0.0 17.0 7.1 2.2 2.7 0.8 7.7 4.3 8.7 0.0 1.4 5.9 6.7 0.0 10.4 9.1 3.4 0.0 3.5 1.4 8.5 4.8 0.0 0.7 3.8 13.3 4.5 0.0 1.0 3.6 8.7 2.8 5.2 7.0 18.2 6.6 3.5 8.4 11.6 2.4 1.2 0.8 4.2 3.6 6.1 1.2 2.0 0.1 4.0 0.4 0.0 0.0 1.8 3.0 3.5 1.8 5.4 4.5 4.7 3.8 4.0 6.4 5.7 5.0 3.1 2.9 1.8 3.3 1.8 2.2 3.8 5.2 3.1 4.4 3.5 4.5 3.9 2.1 5.7 4.7 0.0 4.8 0.5 3.5 1.1 6.7 5.4 7.6 78.9 18.2 5.2 2.0 6.2 5.0 4.9 130.7 1.6 2.6 0.0 4.2 1.5 2.9 2.5 2.3 2.0 2.3 1.6 4.6 0.6 0.6 140.2 3.1 1.2 1.7 1.0 3.2 5.6 4.3 2.6 3.5 7.2 8.7 6.5 1.7 51.6 5.1 1.5 2.3 0.5 3.6 1.8 TTC13 FLJ22584 ENSG00000143643 "Tetratricopeptide repeat domain 13" Q8NBP0 1 230906243-230978875 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018022, HPA051558" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018022: AB_2211524, HPA051558: AB_2681534" "unprognostic (2.68e-1)" "unprognostic (1.64e-1)" "unprognostic (3.42e-1)" "unprognostic (9.59e-3)" "unprognostic (8.10e-2)" "prognostic favorable (7.66e-4)" "unprognostic (2.60e-2)" "unprognostic (5.40e-3)" "unprognostic (1.97e-1)" "unprognostic (1.80e-2)" "prognostic favorable (4.59e-5)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.60e-11)" "unprognostic (4.48e-2)" "unprognostic (3.01e-1)" "unprognostic (5.96e-2)" "unprognostic (7.54e-3)" 10.5 7.1 8.9 16.6 26.7 13.1 9.6 11.2 12.4 7.3 13.6 12.5 8.6 10.5 9.3 9.2 8.5 9.2 8.9 7.0 9.9 7.9 6.9 9.0 12.2 23.4 13.3 9.3 8.2 13.7 13.5 15.5 9.9 12.6 8.1 21.6 7.9 9.6 9.5 15.6 12.8 15.6 8.4 14.7 21.3 15.6 3.9 13.7 18.4 9.8 6.2 18.9 8.0 9.1 4.2 10.8 7.6 7.7 11.9 10.0 5.1 7.6 7.8 7.7 14.9 7.2 4.7 15.8 11.2 8.8 6.3 7.1 11.4 8.3 14.1 10.3 6.7 6.3 12.3 5.0 4.1 4.2 15.7 15.4 4.2 8.3 7.7 7.6 8.6 3.9 4.1 7.3 5.9 5.5 6.3 11.1 6.1 4.4 8.2 5.8 3.9 4.5 8.2 8.7 25.5 9.7 7.4 11.0 19.6 6.6 5.3 10.6 9.2 8.5 8.8 14.9 3.5 9.4 11.2 5.6 7.5 1.0 10.0 19.7 10.2 16.7 4.3 7.3 5.5 12.2 7.6 7.6 6.8 10.0 5.8 6.8 4.2 7.0 8.2 10.8 3.9 5.7 6.8 2.9 11.9 7.7 7.4 5.4 5.1 8.9 26.7 11.2 12.4 9.9 7.9 13.3 9.3 12.6 13.7 6.0 9.0 9.9 1.2 3.0 4.0 2.5 0.0 0.0 4.5 1.8 5.9 3.7 1.7 4.4 1.4 4.5 2.6 0.0 7.5 4.4 2.8 1.5 9.2 5.9 4.6 11.1 5.8 2.5 7.0 1.7 2.6 7.1 1.7 1.0 10.7 4.0 3.5 8.6 6.3 1.1 10.0 6.5 3.9 2.3 2.4 2.4 1.4 12.8 7.0 1.0 TTC14 "FLJ00166, KIAA1980" ENSG00000163728 "Tetratricopeptide repeat domain 14" Q96N46 3 180602130-180617828 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009295 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA009295: AB_1858425" "unprognostic (2.72e-1)" "unprognostic (4.85e-1)" "unprognostic (1.11e-1)" "unprognostic (1.59e-2)" "unprognostic (1.48e-2)" "unprognostic (1.54e-1)" "unprognostic (2.43e-2)" "unprognostic (1.39e-1)" "unprognostic (1.91e-2)" "unprognostic (2.01e-1)" "unprognostic (3.63e-1)" "unprognostic (2.22e-3)" "unprognostic (2.27e-3)" "unprognostic (1.95e-1)" "unprognostic (2.08e-1)" "unprognostic (8.07e-2)" "unprognostic (2.33e-3)" 17.2 20.3 30.0 30.4 32.0 23.1 20.5 18.2 32.4 22.8 20.8 15.8 25.6 19.3 29.0 37.9 12.7 25.2 16.9 16.8 25.6 15.4 22.3 14.1 18.6 30.7 22.8 28.7 41.9 24.3 33.7 49.0 18.0 22.1 26.4 19.0 15.9 15.5 28.7 11.9 17.8 20.7 17.5 23.8 25.7 19.8 16.6 24.3 41.1 35.2 11.1 23.0 20.3 23.4 14.2 18.2 17.1 13.7 14.3 15.0 5.9 8.7 7.0 11.0 6.4 15.0 12.9 10.5 12.7 10.3 9.3 15.3 9.6 11.8 13.3 13.7 9.1 21.0 12.7 10.3 6.7 12.5 24.4 10.4 12.4 16.2 22.3 11.1 13.2 11.5 16.6 13.1 9.2 4.6 15.3 7.3 17.0 5.2 2.6 10.4 2.5 10.0 1.0 7.8 11.2 14.2 11.8 6.9 14.1 5.3 6.7 9.4 9.3 12.2 6.2 12.0 11.9 22.7 12.9 11.5 18.9 9.7 8.5 23.4 19.9 30.2 29.7 9.0 16.8 8.2 17.1 9.8 10.4 11.6 10.7 14.1 14.2 12.2 11.4 7.4 12.5 15.0 11.9 7.8 14.3 13.7 18.2 10.4 5.9 30.0 32.0 18.2 32.4 25.6 15.4 22.8 28.7 22.1 24.3 8.9 32.3 41.3 27.4 15.8 104.5 11.7 48.4 33.5 31.8 62.8 110.0 27.3 3.3 22.4 5.0 35.9 27.6 0.0 28.2 16.2 30.9 22.4 58.8 23.5 20.7 76.3 37.5 39.9 24.9 4.0 85.7 28.0 28.7 28.9 19.8 67.7 26.1 30.8 76.4 5.6 125.3 84.1 27.8 33.0 28.7 13.4 20.6 50.7 18.3 18.0 TTC21A "IFT139A, STI2" ENSG00000168026 "Tetratricopeptide repeat domain 21A" Q8NDW8 3 39107704-39138903 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 51.9" "Group enriched" "Detected in many" 4 "Ciliated cells: 41.5;Early spermatids: 60.9;Late spermatids: 68.3;Spermatocytes: 73.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0;naive B-cell: 2.7" "Group enriched" "Detected in many" 6 "B-cells: 2.7;monocytes: 1.7" "Cell line enhanced" "Detected in some" "Karpas-707: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035510, HPA035511" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA035510: AB_2674659, HPA035511: AB_10671514" "unprognostic (1.85e-3)" "unprognostic (6.95e-3)" "unprognostic (7.74e-3)" "prognostic favorable (1.79e-4)" "unprognostic (1.55e-1)" "unprognostic (1.58e-5)" "unprognostic (2.29e-2)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.15e-1)" "unprognostic (3.01e-4)" "unprognostic (2.19e-2)" "unprognostic (1.29e-3)" "unprognostic (6.54e-2)" "unprognostic (3.35e-1)" "unprognostic (9.76e-2)" "unprognostic (3.91e-4)" 0.9 0.8 2.5 2.2 4.1 0.7 0.8 1.0 2.9 0.9 0.9 2.2 1.9 0.9 1.8 3.0 0.9 2.0 0.7 0.9 2.4 0.8 0.9 0.9 1.0 1.0 0.9 3.6 1.0 2.1 0.9 7.0 0.7 2.9 0.9 0.7 1.4 1.0 0.8 1.0 0.9 0.8 0.6 0.9 0.8 0.9 51.9 1.9 0.0 0.9 0.0 1.6 0.8 0.9 2.7 0.3 0.3 1.7 0.0 0.0 0.1 0.6 1.1 0.3 0.7 0.0 0.7 0.9 1.2 0.9 0.9 0.5 0.0 0.6 2.6 0.0 0.4 0.2 0.5 0.4 1.7 0.2 1.1 0.5 0.1 1.1 0.0 1.3 1.0 0.8 0.9 0.9 0.0 1.3 1.1 0.0 0.7 0.0 3.8 0.0 1.2 0.1 0.4 0.1 0.0 0.0 0.2 0.2 0.4 0.0 1.1 1.3 0.5 1.2 3.0 1.3 0.3 2.9 0.1 0.6 0.3 0.5 2.5 0.5 2.7 0.3 0.2 1.0 0.0 0.6 0.0 0.5 0.0 0.0 1.7 0.0 2.0 0.0 0.0 0.3 2.7 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 2.5 4.1 1.0 2.9 2.4 0.8 0.9 3.6 2.9 1.9 0.0 4.0 3.2 3.9 0.6 3.8 5.6 2.5 41.5 5.7 1.8 7.9 1.2 0.0 1.3 60.9 1.8 2.0 0.0 1.6 1.5 1.7 1.9 1.1 1.0 1.3 4.8 4.1 3.7 1.8 68.3 6.6 2.1 3.3 1.0 2.2 3.1 1.4 2.5 5.6 0.8 13.9 6.5 2.3 73.9 3.4 0.5 3.1 1.3 1.9 2.1 TTC24 ENSG00000187862 "Tetratricopeptide repeat domain 24" A2A3L6 1 156579727-156586770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 13.3;lymphoid tissue: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 13.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 12.4;MOLT-4: 3.7;REH: 13.9;U-698: 2.7" HPA029799 Approved Nucleoplasm NA NA Nucleoplasm "HPA029799: AB_10601684" "unprognostic (2.43e-3)" "unprognostic (5.61e-5)" "unprognostic (5.86e-2)" "unprognostic (1.39e-1)" "unprognostic (2.62e-1)" "unprognostic (4.48e-6)" "unprognostic (6.26e-2)" "unprognostic (1.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.20e-1)" "unprognostic (4.42e-1)" "unprognostic (7.96e-2)" "unprognostic (4.87e-9)" "unprognostic (1.07e-2)" "unprognostic (5.19e-2)" "unprognostic (2.22e-2)" "unprognostic (9.76e-4)" 0.2 0.0 0.2 2.7 0.3 2.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.2 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 8.4 0.2 0.2 0.2 0.2 0.0 3.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.6 0.0 2.6 0.2 0.2 5.1 0.4 0.2 0.2 1.4 0.2 0.2 7.5 0.2 0.2 2.2 13.3 0.3 0.0 3.8 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 3.7 0.6 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.0 1.1 0.1 2.2 0.2 1.9 0.3 3.8 0.0 13.3 0.0 0.6 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 TTC36 HBP21 ENSG00000172425 "Tetratricopeptide repeat domain 36" A6NLP5 11 118527472-118531197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 53.9" "Group enriched" "Detected in some" 12 "Hepatocytes: 410.0;Proximal tubular cells: 138.6" "Group enriched" "Detected in some" 7 "breast cancer: 5.0;liver cancer: 12.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038731 Enhanced Uncertain Nucleoplasm NA NA 20000 Nucleoplasm "HPA038731: AB_10672651" "unprognostic (1.57e-3)" "unprognostic (2.58e-3)" "unprognostic (1.16e-1)" "unprognostic (6.50e-2)" "unprognostic (1.02e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.81e-5)" "unprognostic (6.32e-2)" "unprognostic (8.80e-2)" "unprognostic (6.14e-2)" "unprognostic (4.77e-3)" "unprognostic (3.38e-2)" "unprognostic (5.77e-7)" "unprognostic (5.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.59e-1)" "unprognostic (8.95e-3)" 2.9 0.4 0.2 0.4 0.3 0.0 3.7 0.6 0.2 0.1 5.5 0.1 0.1 3.4 0.3 8.3 0.1 0.1 0.6 0.7 0.1 0.2 3.2 53.9 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.5 0.1 0.1 0.2 0.0 0.1 1.0 0.6 0.4 0.1 2.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.8 2.4 0.0 0.0 0.7 0.5 0.0 0.2 0.2 0.2 0.8 0.0 0.0 2.7 0.4 0.0 0.0 0.0 0.2 0.5 0.3 1.7 0.0 0.0 0.8 0.1 0.0 0.0 1.5 2.0 0.1 0.1 0.5 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.8 0.2 0.0 0.0 0.5 0.0 0.5 0.0 2.7 0.6 0.5 1.3 0.0 0.0 0.7 1.7 0.6 12.4 0.0 0.1 2.2 0.0 0.3 0.0 0.9 0.0 0.2 1.1 1.4 1.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.8 0.2 0.3 0.2 0.1 0.5 0.0 0.0 0.7 0.0 2.4 0.0 0.0 0.2 0.3 0.6 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 4.3 0.6 0.2 0.0 0.3 7.6 0.0 0.0 12.2 0.0 0.8 14.9 0.3 0.0 0.0 1.7 23.3 0.4 0.2 0.0 3.0 0.0 410.0 0.1 0.0 2.4 10.4 11.0 0.0 0.3 0.0 0.0 1.0 2.6 0.5 0.3 0.2 0.0 138.6 0.7 0.0 0.1 0.2 0.0 0.1 1.7 0.0 1.0 1.0 TTC39C "C18orf17, FLJ33761, HsT2697" ENSG00000168234 "Tetratricopeptide repeat domain 39C" Q8N584 18 23992773-24135610 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 92.2" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 120.1;Hepatocytes: 148.6;Late spermatids: 236.0;Rod photoreceptor cells: 233.7" "Cancer enhanced" "Detected in all" "liver cancer: 19.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 35.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065705, HPA065713" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA065705: AB_2685538, HPA065713: AB_2685542" "prognostic favorable (1.48e-4)" "unprognostic (6.37e-2)" "unprognostic (3.66e-1)" "unprognostic (9.97e-2)" "unprognostic (4.37e-2)" "unprognostic (2.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.30e-3)" "unprognostic (2.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.60e-5)" "unprognostic (2.32e-1)" "unprognostic (3.51e-1)" "unprognostic (8.94e-3)" "unprognostic (4.48e-3)" 9.0 14.2 6.2 12.0 4.9 17.7 10.9 5.1 12.2 8.7 6.3 2.4 1.5 5.1 9.8 6.5 9.4 9.0 17.2 3.9 5.3 2.7 3.3 92.2 7.1 14.1 2.2 6.7 5.9 9.8 1.3 13.4 1.5 6.2 9.7 4.6 20.8 11.8 3.9 4.7 24.2 6.2 5.3 2.2 6.7 6.1 14.3 1.0 12.0 3.7 5.7 20.9 8.3 9.3 5.2 8.8 0.5 1.9 5.7 35.5 4.2 6.6 4.9 3.3 2.2 21.1 22.3 12.1 9.5 21.8 7.6 7.8 0.6 3.7 10.9 9.4 16.6 5.7 8.3 6.5 8.3 6.1 16.3 6.7 3.2 23.9 12.3 4.1 17.1 8.5 18.0 11.3 4.3 6.1 14.1 0.5 7.9 0.1 0.1 4.8 5.1 2.8 5.2 8.2 2.9 12.7 15.7 5.0 4.2 7.9 10.1 8.8 7.0 18.4 6.1 5.8 3.6 4.8 6.3 4.2 6.7 5.0 5.1 4.8 0.2 0.0 15.9 9.0 17.9 4.5 0.5 1.9 0.0 11.2 1.9 28.8 5.2 24.9 14.0 2.5 3.3 10.7 9.0 0.5 5.7 1.5 8.8 35.5 4.2 6.2 4.9 5.1 12.2 5.3 2.7 2.2 6.7 6.2 1.0 0.0 4.3 22.3 15.8 40.9 14.4 3.1 53.5 12.0 2.3 7.0 43.2 0.5 0.0 9.7 120.1 3.0 2.2 0.0 10.1 12.5 12.4 19.8 2.3 148.6 11.3 12.7 4.1 4.9 24.7 236.0 10.3 20.8 13.5 1.8 9.0 20.5 8.2 0.0 7.4 1.1 233.7 0.0 8.3 23.8 1.7 75.3 0.5 59.9 4.6 16.7 TTC5 Strap ENSG00000136319 "Tetratricopeptide repeat domain 5" Q8N0Z6 14 20256558-20305994 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045008, HPA054198" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA045008: AB_10960209, HPA054198: AB_2682414" "unprognostic (2.19e-3)" "unprognostic (1.00e-1)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.39e-2)" "unprognostic (6.48e-2)" "unprognostic (8.15e-2)" "unprognostic (6.82e-2)" "unprognostic (4.68e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-2)" "unprognostic (3.29e-1)" "prognostic favorable (8.54e-4)" "unprognostic (3.01e-1)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (5.07e-2)" 5.6 7.2 11.2 4.6 13.1 5.7 8.7 9.6 11.7 7.6 4.9 7.3 3.1 4.9 8.7 7.6 5.5 13.0 5.0 4.2 10.5 10.0 8.2 3.3 5.8 6.5 6.9 7.2 7.9 7.6 15.3 12.3 5.5 9.2 8.9 5.5 5.2 6.9 7.3 2.8 7.6 4.8 6.7 6.0 5.2 5.5 5.7 9.0 6.5 11.1 2.5 7.6 5.6 6.0 7.1 5.2 6.7 6.0 6.5 6.8 4.9 3.9 6.5 8.1 0.8 6.0 8.8 4.4 5.2 6.1 7.9 8.2 3.0 9.2 8.5 3.3 5.5 4.1 3.4 7.8 3.6 12.3 7.4 3.0 7.1 2.9 5.1 6.0 12.8 4.4 5.3 8.2 6.9 9.0 7.2 7.7 6.3 5.0 4.3 7.8 5.5 7.5 5.4 6.7 6.6 6.2 4.0 5.9 6.2 7.0 4.3 2.8 5.4 5.9 6.3 3.6 3.5 5.0 6.3 7.9 3.1 5.1 4.2 2.8 6.2 5.5 10.7 2.5 5.5 7.3 2.5 4.7 6.7 6.8 4.8 5.8 6.5 5.0 5.5 5.2 7.1 5.3 6.4 2.0 6.5 6.0 3.7 5.8 4.9 11.2 13.1 9.6 11.7 10.5 10.0 6.9 7.2 9.2 9.0 11.9 7.4 12.6 8.6 5.7 14.7 3.9 12.7 21.4 4.5 17.4 15.7 15.9 10.0 8.9 1.2 10.9 2.4 0.0 5.7 10.8 9.4 4.6 11.5 4.7 13.2 4.8 8.6 10.4 9.1 1.9 9.5 7.9 6.8 9.0 6.1 10.6 5.6 3.5 9.2 11.0 19.9 6.5 11.1 24.0 36.1 7.5 3.9 14.9 7.8 5.5 TTC9C MGC29649 ENSG00000162222 "Tetratricopeptide repeat domain 9C" Q8N5M4 11 62728069-62740293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055169 Approved Approved Nucleoplasm NA Yes Nucleoplasm "HPA055169: AB_2682724" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (2.71e-2)" "unprognostic (7.23e-3)" "unprognostic (2.17e-1)" "unprognostic (6.56e-3)" "unprognostic (1.86e-3)" "unprognostic (1.52e-1)" "unprognostic (5.66e-2)" "unprognostic (6.90e-3)" "unprognostic (1.33e-3)" "unprognostic (1.57e-1)" "prognostic unfavorable (4.67e-7)" "prognostic favorable (4.15e-5)" "unprognostic (7.49e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-2)" 17.1 19.0 23.4 20.9 24.2 6.5 18.4 26.2 29.3 19.1 19.3 15.8 21.2 25.0 22.9 21.6 18.0 22.6 18.7 13.2 21.5 22.6 20.9 17.2 16.4 28.2 20.4 20.0 32.9 22.3 12.3 18.3 23.1 22.3 18.5 18.8 16.7 21.6 20.0 21.1 24.4 18.2 19.0 17.0 23.2 18.4 17.0 17.5 31.1 24.3 13.3 27.9 21.3 18.0 25.2 20.2 31.0 23.9 16.8 22.7 14.0 20.2 17.5 14.6 14.3 20.1 24.4 10.8 20.8 21.4 25.7 21.2 15.5 20.2 15.4 39.8 14.6 22.3 18.4 21.6 6.5 20.0 40.1 10.8 17.0 25.6 18.6 23.1 11.4 19.0 16.1 13.9 20.8 21.1 18.6 18.8 18.6 12.3 15.6 24.4 14.8 18.1 24.3 12.4 16.5 13.9 14.4 18.6 23.3 16.2 8.0 12.8 10.5 18.0 16.0 25.2 13.5 21.0 11.0 16.2 26.3 15.3 29.0 14.9 16.4 24.6 17.1 14.3 8.8 13.6 31.0 23.9 23.1 14.4 21.3 11.0 25.2 15.4 14.2 20.2 22.6 15.4 13.9 15.3 16.8 13.8 20.2 22.7 14.0 23.4 24.2 26.2 29.3 21.5 22.6 20.4 20.0 22.3 17.5 14.9 10.4 25.9 12.6 26.3 17.1 7.0 7.6 13.4 15.9 17.4 7.9 29.1 23.2 20.0 18.9 21.4 16.9 0.0 13.1 36.2 23.8 13.9 8.1 7.8 33.4 27.0 5.8 13.5 24.8 15.9 26.2 19.0 15.1 42.3 12.6 13.2 18.1 18.2 25.8 20.6 16.8 32.3 18.4 27.7 26.6 29.1 19.9 20.8 15.3 17.6 TXNRD1 "GRIM-12, Trxr1, TXNR" ENSG00000198431 "Thioredoxin reductase 1" Q16881 12 104215779-104350305 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 272.3;Urothelial cells: 489.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 144.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001395, CAB004607, CAB015834, HPA043871" Approved Supported Nucleoplasm NA NA 5900000 Nucleoplasm "CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709" "unprognostic (2.52e-2)" "unprognostic (1.16e-1)" "unprognostic (5.48e-2)" "unprognostic (1.01e-1)" "unprognostic (3.15e-1)" "unprognostic (1.94e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.55e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (6.42e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (2.13e-1)" "unprognostic (1.27e-1)" "unprognostic (1.18e-2)" "unprognostic (8.80e-2)" 19.1 79.2 14.1 15.6 16.9 22.6 18.5 11.1 13.7 13.0 21.8 9.7 19.7 23.5 23.5 14.7 16.7 19.0 23.2 32.4 11.0 11.7 25.3 19.6 29.3 18.1 12.0 10.9 16.4 7.9 10.5 16.2 30.8 16.4 25.3 19.1 18.1 10.6 26.5 30.0 5.7 17.0 99.6 10.9 14.9 24.2 14.8 8.9 15.6 16.5 16.9 13.2 73.2 72.0 8.1 14.2 37.6 16.2 8.3 10.2 8.7 22.2 103.7 12.1 11.3 58.1 32.6 42.0 41.4 26.2 18.7 19.4 10.9 33.2 16.7 19.3 144.9 70.2 7.8 23.8 15.9 22.2 8.1 10.3 14.1 81.4 46.1 93.3 21.9 15.4 18.5 16.4 41.4 13.2 57.6 64.1 23.0 19.3 7.9 28.0 10.7 22.4 10.0 11.6 44.8 106.9 22.3 8.4 14.5 21.8 12.3 18.8 11.4 33.5 53.0 33.0 23.9 12.5 13.0 85.6 9.2 19.1 20.6 33.9 8.7 17.0 25.1 19.3 12.2 54.4 33.0 10.6 24.7 9.1 14.0 10.2 8.1 8.4 9.0 14.2 5.2 7.6 6.6 37.6 8.3 16.2 9.2 7.1 8.7 14.1 16.9 11.1 11.2 11.0 11.7 12.0 10.9 16.4 8.9 59.6 55.0 27.6 272.3 92.4 28.0 55.7 38.2 104.4 96.7 15.7 21.6 22.9 34.9 73.1 34.3 40.9 44.4 23.3 68.7 28.0 34.6 217.3 50.9 45.7 36.8 27.0 19.7 50.3 37.2 13.4 63.0 64.0 18.6 55.9 17.9 23.3 183.4 20.3 27.6 28.5 19.7 0.0 58.8 11.6 28.8 63.7 42.9 23.5 24.1 489.6 U2AF1 "RN, RNU2AF1, U2AF35, U2AFBP" ENSG00000160201 "U2 small nuclear RNA auxiliary factor 1" Q01081 21 43092956-43107587 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Basal keratinocytes: 437.9;Melanocytes: 192.3;Suprabasal keratinocytes: 379.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044833, HPA052083" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044833: AB_10960990, HPA052083: AB_2681720" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (5.98e-2)" "unprognostic (2.87e-2)" "unprognostic (1.36e-1)" "unprognostic (8.06e-2)" "unprognostic (2.76e-2)" "unprognostic (4.29e-4)" "unprognostic (4.81e-4)" "unprognostic (3.42e-2)" "unprognostic (2.31e-3)" "unprognostic (8.85e-2)" "unprognostic (2.14e-6)" "unprognostic (1.08e-1)" "unprognostic (1.40e-2)" "unprognostic (1.72e-1)" "unprognostic (1.26e-2)" 20.0 15.1 20.8 19.2 21.1 48.5 61.0 25.6 20.8 16.1 21.5 9.7 12.3 17.6 28.8 26.5 19.3 27.6 17.1 19.5 19.7 15.8 14.6 17.1 35.2 33.5 25.7 2.9 22.1 48.3 15.3 27.8 21.2 20.8 23.9 13.7 9.6 44.5 19.8 33.0 16.6 20.4 38.7 23.9 21.0 17.5 33.9 22.7 20.6 27.3 26.5 20.0 22.9 31.7 58.4 82.8 81.2 54.1 33.1 55.5 53.8 25.3 27.8 15.1 11.4 8.9 6.4 35.5 22.0 15.3 18.0 16.1 64.6 9.3 43.4 12.0 14.3 24.7 12.4 31.6 23.4 9.3 34.0 71.5 70.2 14.2 24.3 21.7 30.2 17.3 8.8 14.4 29.1 18.6 6.5 14.8 26.6 38.5 19.6 12.5 47.7 24.9 33.5 32.1 21.7 32.1 41.2 14.6 21.8 12.0 10.7 23.0 17.6 23.6 14.3 11.7 4.3 17.4 17.6 18.5 15.0 20.4 13.5 23.0 26.3 30.9 35.9 14.4 55.6 23.1 48.4 52.6 50.9 42.2 52.5 41.4 55.9 46.4 42.1 54.1 58.4 46.4 44.8 81.2 33.1 54.1 82.8 55.5 53.8 20.8 21.1 25.6 20.8 19.7 15.8 25.7 2.9 20.8 22.7 17.9 17.8 8.9 29.0 437.9 21.8 2.8 7.6 21.4 27.3 1.8 41.2 16.3 1.7 4.5 1.9 22.2 22.9 0.0 5.1 15.6 26.8 31.7 26.7 17.8 19.6 17.5 17.5 28.8 21.4 2.0 17.0 27.1 192.3 2.8 16.7 13.0 4.0 17.5 21.2 2.8 59.6 6.5 29.2 14.4 17.7 379.0 19.9 20.0 22.2 30.1 U2AF1L4 "MGC33901, U2AF1L3, U2af26" ENSG00000161265 "U2 small nuclear RNA auxiliary factor 1 like 4" Q8WU68 19 35742464-35745445 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA052083, HPA061644" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA052083: AB_2681720, HPA061644: AB_2684574" "prognostic favorable (2.44e-4)" "unprognostic (1.31e-1)" "unprognostic (2.39e-3)" "unprognostic (1.31e-2)" "unprognostic (2.35e-1)" "prognostic favorable (2.58e-5)" "unprognostic (3.95e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.67e-2)" "prognostic favorable (8.58e-5)" "unprognostic (8.44e-2)" "prognostic unfavorable (9.73e-5)" "unprognostic (1.06e-1)" "unprognostic (7.21e-2)" "unprognostic (1.92e-1)" "prognostic favorable (7.05e-4)" 5.3 9.7 12.1 4.5 15.0 4.6 4.5 9.3 12.5 4.8 5.7 8.7 8.0 2.7 5.7 6.0 4.9 6.1 5.1 24.3 11.1 10.2 7.0 4.4 4.7 2.8 9.5 10.3 10.7 4.7 11.7 6.6 5.8 8.7 6.7 2.8 10.9 2.5 9.1 19.8 3.4 5.8 6.8 8.5 5.0 4.1 10.7 6.0 2.7 7.4 4.3 5.3 4.2 3.1 9.2 8.4 2.2 3.2 0.8 9.9 5.2 3.7 13.6 1.8 3.2 0.0 1.7 3.1 3.4 3.5 8.7 8.6 5.4 3.1 1.6 6.7 7.8 7.8 1.9 6.9 5.3 5.4 10.4 1.0 1.7 3.4 5.8 10.9 2.5 5.6 2.0 2.3 3.6 2.1 3.2 1.6 4.9 4.1 4.7 5.5 8.0 7.6 2.6 3.0 9.0 2.4 1.9 3.2 0.0 2.0 0.6 4.6 4.5 5.0 3.3 0.9 4.9 3.8 5.0 2.9 5.5 2.4 1.2 5.6 5.5 6.4 3.5 3.6 5.7 6.6 0.0 2.1 1.5 3.1 3.2 3.0 9.2 6.0 5.9 2.0 6.9 9.0 8.6 2.2 0.8 2.4 8.4 9.9 5.2 12.1 15.0 9.3 12.3 11.1 10.2 9.5 10.3 8.7 6.0 17.9 23.1 37.4 12.7 9.2 24.6 4.4 5.1 8.1 5.7 8.7 13.7 13.1 23.2 9.0 9.3 13.6 20.3 23.3 11.0 8.2 16.2 10.7 33.7 13.2 17.4 19.1 12.1 9.8 13.9 11.0 14.4 21.2 28.7 36.9 12.1 10.3 8.1 23.0 11.7 22.6 28.0 12.9 12.8 37.9 13.4 7.8 24.7 42.6 10.1 10.7 U2AF1L5 ENSG00000275895 "U2 small nuclear RNA auxiliary factor 1 like 5" P0DN76 21 6484623-6499261 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 74.4" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 20.7;Ciliated cells: 18.7;Club cells: 26.1;granulocytes: 27.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044833, HPA052083" Supported Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044833: AB_10960990, HPA052083: AB_2681720" "unprognostic (6.54e-2)" "unprognostic (2.42e-1)" "unprognostic (2.75e-2)" "unprognostic (8.31e-3)" "unprognostic (2.80e-1)" "unprognostic (5.99e-2)" "unprognostic (2.02e-1)" "unprognostic (4.54e-2)" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (1.70e-1)" "unprognostic (3.42e-2)" "unprognostic (5.39e-3)" "unprognostic (3.14e-1)" "unprognostic (2.79e-2)" "unprognostic (5.98e-2)" "unprognostic (8.20e-2)" 4.7 5.3 0.5 5.3 6.4 7.0 6.2 6.2 21.0 4.7 6.0 7.3 6.8 3.7 9.5 8.6 8.9 4.5 8.5 8.2 3.0 7.4 5.8 6.6 6.0 0.5 12.0 11.9 8.5 3.9 0.5 14.9 6.4 4.0 6.5 8.1 12.8 5.3 4.3 4.2 3.5 11.0 4.6 5.0 3.2 11.2 0.8 10.6 14.2 0.5 11.4 4.2 7.7 40.6 63.8 74.4 41.8 33.3 47.6 47.0 25.6 10.6 55.2 24.0 15.4 14.1 24.6 15.3 18.2 29.6 20.5 39.0 17.3 57.8 13.2 21.2 32.7 17.9 44.6 22.0 42.8 11.4 4.2 74.1 24.9 48.4 25.4 80.5 25.8 10.7 13.7 19.8 21.3 15.0 27.1 27.3 58.3 33.7 30.1 24.7 56.1 51.0 57.5 41.5 3.4 88.1 30.3 33.2 33.6 39.1 29.0 19.3 27.0 27.3 27.3 13.9 19.2 45.1 24.0 21.5 28.9 11.4 33.8 41.1 34.6 67.0 19.4 49.1 29.3 35.8 41.8 36.9 29.9 34.6 36.4 37.9 38.7 35.2 43.5 40.6 43.8 37.0 74.4 33.3 26.1 63.8 47.6 47.0 11.9 20.7 0.5 1.5 0.0 0.1 0.0 2.5 18.7 26.1 0.0 0.0 1.3 1.7 4.2 0.6 0.0 0.2 0.0 6.1 1.5 0.8 2.9 27.9 0.8 0.9 0.0 2.4 1.8 0.6 0.0 0.3 1.3 0.0 4.6 1.9 0.4 5.4 2.3 1.1 1.3 0.4 0.0 0.0 1.7 1.9 0.0 1.7 0.0 1.7 1.1 U2SURP "fSAPa, SR140" ENSG00000163714 "U2 snRNP associated SURP domain containing" O15042 3 142964497-143060546 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037545, HPA037546, HPA061407" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA037545: AB_10672598, HPA037546: AB_2675535, HPA061407: AB_2684506" "unprognostic (2.01e-1)" "unprognostic (9.78e-2)" "unprognostic (8.09e-2)" "prognostic unfavorable (8.44e-4)" "unprognostic (3.11e-2)" "unprognostic (4.30e-2)" "prognostic unfavorable (3.15e-5)" "unprognostic (3.72e-2)" "unprognostic (1.98e-2)" "unprognostic (9.61e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (2.85e-3)" "prognostic unfavorable (8.86e-7)" "unprognostic (6.71e-2)" "unprognostic (2.19e-1)" "unprognostic (3.12e-1)" "prognostic favorable (6.78e-4)" 21.2 17.7 21.3 17.6 30.8 48.2 24.0 29.7 27.9 26.3 20.3 18.8 18.0 12.9 24.3 22.2 22.3 19.2 12.7 16.6 18.4 16.4 17.8 22.1 17.9 26.8 24.5 24.8 28.4 22.8 22.3 39.6 21.7 25.8 21.2 20.7 19.2 18.6 15.8 26.4 21.9 22.1 26.0 26.6 23.5 18.3 19.2 27.3 32.3 21.2 16.5 24.5 23.2 19.0 33.8 31.2 19.9 25.7 18.4 26.6 11.3 38.0 12.8 14.3 9.6 7.6 7.1 24.9 17.2 11.1 19.9 14.9 17.0 11.7 44.0 18.5 11.1 38.2 13.8 29.4 15.3 22.8 11.9 20.6 47.7 11.8 13.5 7.9 46.2 18.0 8.6 7.7 15.4 19.7 8.9 10.7 28.2 29.3 14.1 9.2 10.7 22.9 20.2 23.1 12.2 12.0 23.4 28.1 18.4 10.0 24.1 18.5 10.8 34.6 11.4 20.2 15.5 20.3 20.0 11.7 10.8 12.7 8.4 27.6 16.9 21.6 75.4 8.6 16.8 14.8 18.9 19.7 18.3 25.2 18.6 22.0 31.7 23.1 22.3 15.4 33.8 26.6 22.8 19.9 18.4 25.7 31.2 22.1 11.3 21.3 30.8 29.7 27.9 18.4 16.4 24.5 24.8 25.8 27.3 110.2 113.9 58.8 76.8 54.0 118.7 107.4 50.9 109.7 113.7 59.3 62.8 66.9 44.7 59.1 24.0 69.2 40.4 23.3 69.1 74.2 66.7 59.6 93.8 51.4 53.1 87.4 53.0 59.5 57.8 14.6 100.7 82.2 49.0 103.6 66.5 100.5 72.4 56.1 75.0 46.0 116.0 77.6 76.2 174.5 202.9 56.7 66.1 72.6 70.6 61.5 UBA1 "A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X" ENSG00000130985 "Ubiquitin like modifier activating enzyme 1" P22314 X 47190861-47215128 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000289, HPA001506, CAB019435, CAB073410" Approved Supported Nucleoplasm NA NA 16000000 Nucleoplasm "CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305" "unprognostic (7.18e-3)" "unprognostic (1.52e-1)" "unprognostic (7.54e-2)" "unprognostic (2.40e-1)" "unprognostic (9.29e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (6.10e-5)" "unprognostic (7.22e-2)" "unprognostic (2.42e-3)" "unprognostic (3.43e-2)" "unprognostic (8.50e-3)" "unprognostic (2.17e-3)" "unprognostic (1.85e-3)" "unprognostic (1.13e-1)" "unprognostic (5.38e-2)" "prognostic favorable (1.78e-4)" "unprognostic (1.21e-2)" 45.6 63.0 56.0 47.2 50.6 42.0 38.3 58.1 75.7 48.0 39.3 55.9 44.9 36.3 52.9 34.1 59.4 56.0 39.9 48.7 49.5 39.9 51.1 60.0 42.0 48.2 47.7 62.3 57.6 34.9 78.8 55.5 39.1 47.6 40.2 35.5 41.0 47.5 45.7 77.7 56.1 37.9 59.4 35.5 53.4 38.7 36.0 48.6 52.7 65.0 43.9 54.0 39.2 52.7 28.9 30.6 32.6 36.0 25.6 29.0 24.1 46.0 47.9 54.8 83.2 37.5 34.2 24.2 30.7 32.7 44.2 36.0 38.0 35.2 34.4 20.4 61.4 65.4 44.6 68.7 65.3 32.4 28.5 69.8 21.5 53.1 30.5 26.4 36.2 46.5 32.1 34.2 64.2 50.1 31.6 57.8 41.4 23.3 30.9 43.8 58.4 34.1 32.0 58.4 27.9 74.9 39.8 38.3 58.5 35.3 49.7 35.5 26.7 91.4 44.5 20.4 61.4 61.8 22.6 42.2 33.2 38.5 47.7 28.6 21.2 22.0 49.1 34.1 25.9 39.6 17.4 27.0 27.4 29.0 36.0 25.4 28.9 24.0 25.9 30.6 22.0 19.1 23.4 32.6 25.6 32.8 20.8 28.2 24.1 56.0 50.6 58.1 75.7 49.5 39.9 47.7 62.3 47.6 48.6 47.6 32.5 35.6 30.6 29.9 25.4 44.0 71.4 29.4 29.6 78.5 15.7 42.1 29.9 67.7 29.3 28.1 83.5 23.3 78.8 52.0 36.1 52.8 17.4 40.8 53.6 11.1 55.2 46.1 45.1 41.8 39.1 34.8 18.6 66.7 64.2 20.0 108.7 57.9 61.9 49.5 24.4 38.8 40.3 8.8 19.6 36.8 59.5 26.6 52.5 48.1 UBA2 "ARX, FLJ13058, HRIHFB2115, SAE2" ENSG00000126261 "Ubiquitin like modifier activating enzyme 2" Q9UBT2 19 34428352-34471251 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Sertoli cells: 265.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041436 Supported Supported Nucleoplasm NA NA 9400000 Nucleoplasm "HPA041436: AB_2677479" "unprognostic (2.37e-1)" "unprognostic (3.17e-1)" "unprognostic (2.13e-2)" "unprognostic (1.36e-3)" "unprognostic (6.39e-3)" "unprognostic (8.72e-3)" "prognostic unfavorable (3.76e-4)" "unprognostic (1.96e-2)" "unprognostic (2.14e-2)" "unprognostic (1.21e-1)" "unprognostic (2.58e-1)" "unprognostic (2.65e-2)" "prognostic unfavorable (8.02e-4)" "unprognostic (1.63e-2)" "unprognostic (2.11e-2)" "unprognostic (2.00e-1)" "unprognostic (1.88e-1)" 49.2 23.5 25.1 29.5 28.4 30.6 70.9 44.3 30.4 26.5 25.4 20.7 24.0 17.8 32.3 24.2 27.4 25.1 23.7 31.0 25.6 27.7 22.8 25.5 24.5 37.8 26.9 23.2 30.3 29.4 28.8 26.8 39.1 25.1 25.1 23.9 20.7 20.9 31.5 56.3 29.2 20.4 28.8 27.4 28.6 20.9 56.7 19.9 55.9 25.9 27.1 34.4 29.2 38.9 8.6 10.8 7.7 6.2 8.5 13.0 3.6 28.9 42.4 43.5 18.0 23.6 19.3 17.8 22.6 19.5 29.3 32.8 36.3 17.7 54.2 35.0 18.4 18.2 11.8 46.0 17.6 41.4 38.8 31.1 57.5 21.7 36.2 30.5 45.6 25.0 13.9 22.5 20.7 36.5 19.7 22.9 23.4 56.9 30.8 25.7 28.9 35.1 25.3 32.6 45.3 14.7 28.0 30.0 24.1 20.6 30.3 37.0 36.3 20.6 19.0 30.4 29.6 13.6 56.0 14.8 33.0 23.0 21.0 40.5 32.5 46.1 52.5 20.9 34.9 29.0 5.9 4.8 7.7 8.4 5.0 11.2 8.5 10.5 12.1 6.0 8.6 13.0 10.4 0.6 8.5 6.2 10.8 8.0 3.6 25.1 28.4 44.3 30.4 25.6 27.7 26.9 23.2 25.1 19.9 23.8 33.6 45.4 55.0 77.3 59.3 31.9 22.9 29.4 30.7 17.4 39.3 60.6 28.2 38.5 10.7 46.7 15.5 23.3 36.4 83.5 49.3 42.2 38.1 23.6 41.7 44.5 44.2 20.3 31.3 18.0 40.3 35.2 72.6 45.1 28.5 45.3 35.2 21.0 49.8 28.3 35.0 265.1 176.3 193.3 196.1 81.2 77.6 35.2 44.9 68.2 UBE2E1 UbcH6 ENSG00000170142 "Ubiquitin conjugating enzyme E2 E1" P51965 3 23805903-23891316 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030445, CAB073413" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB073413: , HPA030445: AB_10669599" "unprognostic (7.50e-2)" "unprognostic (2.78e-2)" "unprognostic (7.91e-3)" "unprognostic (7.13e-2)" "unprognostic (6.74e-3)" "unprognostic (1.74e-1)" "prognostic unfavorable (9.97e-7)" "unprognostic (3.69e-2)" "unprognostic (3.53e-2)" "unprognostic (1.34e-2)" "unprognostic (5.36e-3)" "unprognostic (2.70e-2)" "unprognostic (2.40e-2)" "unprognostic (1.94e-1)" "unprognostic (2.94e-1)" "unprognostic (2.75e-1)" "unprognostic (1.93e-1)" 32.0 28.1 50.8 34.7 44.4 56.1 52.6 38.7 43.4 41.9 40.6 32.4 27.5 23.9 35.3 35.6 57.9 29.5 29.9 58.5 47.3 43.2 33.6 34.0 34.9 44.9 52.0 36.9 36.5 32.0 41.6 22.5 44.5 38.1 38.5 37.8 23.2 30.3 36.4 52.2 33.3 25.8 44.1 55.6 36.3 29.9 24.3 43.3 33.8 41.4 38.0 47.3 52.2 46.3 6.7 7.6 6.8 9.1 7.0 7.2 4.1 33.9 21.4 33.7 16.8 20.6 30.1 29.5 25.7 40.0 28.9 38.8 16.1 37.6 30.1 21.8 24.8 24.6 11.0 39.8 31.8 37.9 36.3 44.5 41.5 16.1 19.6 29.7 40.9 22.1 28.4 30.0 36.8 49.5 34.0 45.9 21.1 29.0 33.5 23.1 17.5 28.7 44.5 49.5 18.7 54.9 32.0 14.8 86.5 45.0 24.3 9.8 35.1 23.0 21.4 37.0 35.2 24.0 54.1 29.8 21.2 26.3 15.7 19.1 28.0 16.5 59.5 22.9 39.3 16.4 2.4 8.4 6.8 4.5 9.1 6.5 6.5 5.4 3.8 7.3 6.7 7.2 4.3 3.3 7.0 5.8 7.6 3.9 4.1 50.8 44.4 38.7 43.4 47.3 43.2 52.0 36.9 38.1 43.3 41.7 28.2 30.6 52.3 64.2 26.4 54.9 28.1 46.8 28.4 17.4 3.9 83.0 48.0 80.0 20.6 53.7 35.4 0.0 68.5 82.1 57.3 58.6 40.3 19.1 88.2 19.1 44.5 42.4 63.6 39.3 37.7 75.5 92.8 111.0 36.1 49.9 62.2 59.6 45.6 32.6 20.9 51.8 80.2 36.3 62.2 78.9 60.3 35.4 44.6 59.6 UBE2E2 "FLJ25157, UbcH8" ENSG00000182247 "Ubiquitin conjugating enzyme E2 E2" Q96LR5 3 23203020-23591793 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 15.2;intermediate monocyte: 17.8;memory B-cell: 12.3;myeloid DC: 20.9;naive B-cell: 14.8;non-classical monocyte: 18.3;plasmacytoid DC: 27.1" "Group enriched" "Detected in many" 6 "B-cells: 14.8;dendritic cells: 27.1;monocytes: 18.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003303, HPA028872, HPA030445, CAB073417" Approved Approved Nucleoplasm No No Nucleoplasm "CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599" "unprognostic (2.20e-1)" "unprognostic (2.30e-1)" "unprognostic (1.52e-2)" "unprognostic (3.68e-3)" "unprognostic (3.74e-2)" "unprognostic (1.70e-1)" "unprognostic (9.19e-3)" "unprognostic (3.11e-3)" "unprognostic (1.32e-1)" "unprognostic (1.20e-1)" "unprognostic (4.20e-1)" "unprognostic (4.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.44e-2)" "unprognostic (2.68e-2)" "unprognostic (3.11e-2)" "unprognostic (6.11e-3)" 22.7 11.4 19.2 12.0 23.3 7.6 15.9 18.8 32.7 22.4 14.5 20.8 7.5 5.9 17.7 31.9 19.7 12.0 18.5 23.4 21.3 21.8 19.1 15.8 16.7 17.7 14.1 19.7 19.0 9.8 15.5 14.4 9.0 20.9 18.2 6.4 8.4 11.2 17.0 32.0 14.8 7.2 22.4 17.6 15.9 11.1 17.8 13.3 14.8 16.8 11.1 14.5 17.0 16.2 14.8 27.1 0.4 18.3 0.8 3.6 5.2 17.1 6.2 16.3 0.3 14.5 16.2 14.8 10.8 18.5 10.2 14.4 1.7 14.1 14.9 7.5 9.5 14.1 1.7 11.8 16.9 13.2 0.1 11.9 0.0 7.3 2.0 10.4 0.0 12.0 12.8 17.8 14.7 24.8 10.5 9.8 11.8 0.8 15.9 9.2 2.7 7.8 3.3 11.6 9.8 9.0 16.4 6.3 17.1 10.0 0.4 4.2 8.7 11.9 7.0 0.2 12.3 15.0 9.9 8.5 10.1 14.3 6.7 12.2 15.3 5.0 22.0 9.5 6.7 2.8 0.0 15.2 0.0 0.2 17.8 0.3 12.3 0.5 0.2 20.9 14.8 3.6 1.3 0.4 0.8 18.3 27.1 0.2 5.2 19.2 23.3 18.8 32.7 21.3 21.8 14.1 19.7 20.9 13.3 20.8 9.8 36.3 10.5 22.8 22.7 32.7 20.4 5.3 4.5 29.6 15.7 28.0 58.0 12.3 17.6 20.4 0.0 0.0 25.6 33.5 29.3 47.2 0.0 38.4 44.7 30.2 1.7 14.7 43.5 12.0 36.5 55.4 74.2 35.1 0.7 10.9 13.5 0.3 49.8 98.2 2.9 32.3 50.9 33.5 99.2 36.9 32.3 2.5 0.5 5.1 UBE2V1 "CROC-1, CROC1, UBE2V, UEV-1, UEV1A" ENSG00000244687 "Ubiquitin conjugating enzyme E2 V1" Q13404 20 50081124-50115959 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 76.3;Club cells: 55.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA052535, HPA053186" Enhanced Nucleoplasm NA NA 4000000 Nucleoplasm "HPA052535: AB_2681863, HPA053186: AB_2682073" "unprognostic (1.39e-1)" "unprognostic (3.13e-3)" "unprognostic (1.52e-1)" "unprognostic (1.01e-3)" "unprognostic (2.16e-1)" "unprognostic (2.00e-2)" "unprognostic (2.81e-3)" "unprognostic (4.35e-2)" "unprognostic (3.48e-2)" "unprognostic (5.32e-2)" "unprognostic (2.02e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (4.58e-5)" "unprognostic (2.58e-2)" "unprognostic (1.95e-1)" "unprognostic (1.31e-1)" "unprognostic (1.01e-1)" 35.2 35.3 44.9 31.7 52.4 25.6 29.7 36.9 61.7 27.4 37.7 33.8 19.3 34.2 29.1 32.7 43.6 27.4 28.7 38.1 37.5 39.3 39.2 61.8 34.1 36.8 36.4 33.3 37.2 60.8 36.7 23.2 45.9 44.7 30.3 37.3 38.7 38.6 35.0 46.0 37.8 40.1 43.7 29.0 40.2 33.3 23.2 23.2 35.0 30.2 32.0 50.7 49.0 31.7 37.4 40.1 33.9 39.1 54.2 57.4 70.2 29.8 18.7 35.3 21.1 29.0 50.0 19.6 34.0 33.6 72.4 34.9 93.2 22.5 29.1 31.5 44.0 31.5 26.5 25.8 46.6 63.1 20.3 16.3 28.4 14.0 41.2 26.2 34.6 23.1 39.8 28.1 35.6 23.7 40.9 48.8 24.1 35.4 17.7 40.4 20.1 31.1 27.5 24.6 40.0 33.1 17.2 40.3 26.5 49.9 21.5 20.7 25.0 34.6 60.5 25.6 36.9 23.2 31.4 42.3 40.2 37.2 34.0 27.3 17.6 22.6 23.6 43.8 18.1 27.8 25.5 39.1 33.9 56.6 38.5 57.4 37.4 47.0 53.9 40.1 31.0 48.3 52.4 13.8 54.2 33.0 31.6 44.4 70.2 44.9 52.4 36.9 61.7 37.5 39.3 36.4 33.3 44.7 23.2 47.6 19.1 17.1 2.6 5.3 4.5 6.9 12.7 76.3 55.7 10.4 5.9 5.2 19.9 9.5 14.5 6.3 7.4 0.0 9.7 4.6 4.1 2.1 33.7 11.0 6.1 0.0 9.8 16.5 20.0 15.2 7.2 7.7 8.5 19.8 4.2 3.0 15.6 7.0 4.6 12.6 4.9 6.5 5.0 10.3 6.4 7.4 5.9 10.2 4.3 3.5 UBE2V2 "DDVit-1, DDVIT1, EDAF-1, EDPF-1, EDPF1, MMS2, UEV-2, UEV2" ENSG00000169139 "Ubiquitin conjugating enzyme E2 V2" Q15819 8 48008400-48064708 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052535, HPA053186" Supported Nucleoplasm NA NA 1500000 Nucleoplasm "HPA052535: AB_2681863, HPA053186: AB_2682073" "unprognostic (3.50e-3)" "unprognostic (3.27e-1)" "unprognostic (1.53e-1)" "unprognostic (3.07e-2)" "unprognostic (1.69e-1)" "unprognostic (5.83e-2)" "unprognostic (2.94e-3)" "unprognostic (1.21e-2)" "unprognostic (1.65e-3)" "unprognostic (4.97e-2)" "unprognostic (1.77e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (4.96e-6)" "unprognostic (1.42e-1)" "unprognostic (1.42e-1)" "unprognostic (2.45e-1)" "unprognostic (9.62e-2)" 22.4 28.3 38.8 19.3 34.5 12.5 23.1 28.3 51.1 17.9 22.8 13.8 12.9 22.0 21.7 17.8 31.8 15.3 17.7 14.6 40.5 41.7 22.7 37.8 14.6 22.5 40.1 43.4 16.5 12.3 19.2 36.4 21.4 48.5 22.5 23.7 13.0 13.8 21.0 29.3 15.9 20.4 24.6 26.7 14.3 19.0 20.5 20.6 20.8 24.0 18.5 24.1 25.0 17.2 37.9 42.2 34.6 40.1 51.7 49.4 42.8 31.5 18.4 41.1 22.7 22.6 25.4 14.5 33.1 23.3 33.6 29.5 23.2 24.7 38.9 19.5 31.6 28.7 19.1 37.3 31.0 45.2 13.2 26.1 34.9 22.5 19.2 28.3 18.9 10.5 23.9 32.5 27.0 43.2 25.5 28.2 33.4 42.6 24.2 42.3 24.1 60.5 36.9 38.1 47.2 12.2 30.4 18.2 19.1 35.7 25.6 45.1 29.5 27.9 24.8 29.1 32.1 41.7 25.4 15.5 28.5 26.0 25.4 30.7 24.3 41.0 48.8 37.0 33.6 30.1 30.6 35.9 34.6 31.0 40.1 37.0 37.9 38.8 37.8 42.2 32.8 39.1 43.8 22.3 51.7 38.2 35.1 49.4 42.8 38.8 34.5 28.3 51.1 40.5 41.7 40.1 43.4 48.5 20.6 44.7 25.9 50.8 66.9 40.2 91.0 49.4 28.1 37.5 27.3 48.8 15.7 87.6 109.5 74.8 42.0 43.3 32.6 23.3 77.1 128.9 61.8 54.4 50.7 44.8 79.3 76.3 31.0 30.1 41.4 22.1 52.0 50.8 35.4 85.6 45.1 79.9 73.1 57.1 68.9 99.0 48.9 58.2 102.9 123.8 75.9 49.9 125.2 39.8 54.9 64.8 UBN2 "FLJ25778, KIAA2030" ENSG00000157741 "Ubinuclein 2" Q6ZU65 7 139230356-139308236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 109.8;Late spermatids: 132.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 9.0;NK-cell: 3.4" "Group enriched" "Detected in many" 5 "granulocytes: 9.0;NK-cells: 3.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019743, HPA020122, HPA020124" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019743: AB_1848851, HPA020122: AB_1848847, HPA020124: AB_2212202" "unprognostic (1.96e-1)" "unprognostic (2.49e-1)" "unprognostic (2.48e-2)" "unprognostic (1.44e-2)" "unprognostic (2.41e-1)" "prognostic favorable (4.49e-4)" "unprognostic (1.24e-3)" "unprognostic (1.22e-2)" "unprognostic (1.30e-3)" "unprognostic (9.88e-2)" "unprognostic (1.65e-1)" "unprognostic (4.96e-2)" "unprognostic (3.65e-2)" "unprognostic (4.54e-3)" "unprognostic (2.95e-1)" "unprognostic (2.91e-2)" "unprognostic (1.05e-2)" 5.4 7.8 11.9 5.3 13.0 10.4 9.7 20.8 13.7 7.6 5.9 8.7 12.6 5.0 10.0 14.1 7.0 7.3 5.7 5.8 11.5 6.9 6.3 7.0 6.0 5.1 10.2 7.6 11.5 10.7 10.5 16.9 6.2 8.6 8.2 6.9 8.1 8.1 12.7 11.1 18.6 5.9 7.9 8.4 6.3 6.3 25.5 9.7 6.9 10.4 3.1 5.2 6.4 13.6 1.2 1.2 9.0 1.0 3.4 0.8 0.1 3.9 3.7 6.1 7.6 4.9 4.5 4.7 2.3 3.4 2.1 2.5 4.5 3.9 6.7 4.3 2.8 5.2 3.7 7.8 1.9 3.7 3.4 4.5 5.0 6.7 4.9 2.8 9.7 3.9 3.1 5.5 2.7 4.4 3.8 4.0 3.6 11.6 5.2 2.7 6.0 7.0 11.3 8.7 4.0 2.7 4.0 5.7 4.7 2.9 2.9 10.1 7.3 7.0 4.9 3.3 6.0 3.1 6.5 4.5 2.6 3.0 3.8 2.9 6.0 6.6 11.8 4.2 5.9 3.8 9.0 1.0 0.1 0.5 0.5 0.4 1.0 0.5 0.6 0.3 1.2 0.8 0.5 1.0 3.4 0.4 1.2 0.3 0.1 11.9 13.0 20.8 13.7 11.5 6.9 10.2 7.6 8.6 9.7 6.0 20.5 7.1 15.7 20.7 52.5 24.3 15.3 29.4 15.9 21.0 88.4 7.1 6.6 6.4 109.8 13.8 13.1 23.3 6.1 7.6 17.4 29.6 11.5 16.8 6.2 42.9 22.4 16.5 14.0 132.0 20.8 13.4 8.5 4.6 16.7 25.5 8.4 14.7 20.1 7.9 57.3 19.4 21.5 26.9 30.1 25.2 12.2 8.7 12.1 18.6 UBOX5 "KIAA0860, RNF37, Ubce7ip5, UIP5" ENSG00000185019 "U-box domain containing 5" O94941 20 3107573-3160196 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028871 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028871: AB_10603140" "unprognostic (4.11e-2)" "unprognostic (2.01e-2)" "unprognostic (1.77e-1)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "prognostic favorable (4.52e-5)" "unprognostic (2.58e-2)" "unprognostic (1.02e-1)" "unprognostic (3.11e-2)" "unprognostic (1.61e-1)" "prognostic favorable (1.80e-5)" "unprognostic (4.02e-2)" "unprognostic (9.71e-3)" "unprognostic (3.33e-1)" "unprognostic (5.58e-2)" "unprognostic (1.07e-2)" "unprognostic (1.61e-2)" 10.1 9.9 9.6 10.0 13.0 17.7 15.4 14.9 16.3 11.6 12.7 12.3 9.0 8.6 14.1 8.8 11.2 13.9 8.8 10.8 10.0 9.1 13.7 12.2 10.1 19.6 10.0 10.2 15.2 17.8 12.8 11.6 11.1 11.9 11.8 8.8 9.5 13.2 13.6 34.1 16.3 10.7 12.2 7.9 10.4 10.8 15.1 9.3 14.9 10.4 11.1 11.5 12.8 9.7 8.7 7.0 11.4 7.0 7.5 8.4 5.5 6.3 6.5 5.2 3.3 6.8 3.8 2.7 5.4 4.9 6.5 6.5 6.1 5.5 4.8 2.1 4.5 7.5 8.8 3.4 8.1 4.0 1.4 2.9 8.3 2.0 5.7 5.5 3.5 3.3 4.9 6.1 5.2 6.7 5.3 4.2 4.0 6.8 4.7 3.8 4.2 7.1 5.2 4.0 6.7 3.9 4.8 6.5 3.4 4.1 6.6 6.4 6.2 3.4 20.0 4.2 4.2 8.5 2.6 4.7 4.4 2.8 4.8 4.3 6.4 9.3 4.3 2.4 3.6 3.1 11.1 7.0 11.4 7.1 7.0 7.3 8.7 8.0 5.8 7.0 6.8 8.4 8.1 11.4 7.5 5.9 5.6 7.6 5.5 9.6 13.0 14.9 16.3 10.0 9.1 10.0 10.2 11.9 9.3 11.9 5.9 4.4 3.4 1.6 6.8 1.0 2.5 1.4 2.3 0.0 5.9 6.2 0.0 3.2 1.1 2.2 4.0 0.0 3.7 3.3 3.3 4.1 2.3 3.8 4.3 6.4 9.8 6.2 4.8 1.2 6.4 2.9 3.3 5.4 5.1 3.9 3.6 3.5 3.5 4.4 4.7 6.5 2.0 8.6 4.2 2.0 8.5 2.9 5.0 5.6 UBP1 LBP-1a ENSG00000153560 "Upstream binding protein 1" Q9NZI7 3 33388336-33441371 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003967 Supported Nucleoplasm NA NA Nucleoplasm "HPA003967: AB_10601829" "unprognostic (3.11e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.81e-4)" "unprognostic (4.64e-2)" "unprognostic (9.35e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (9.45e-4)" "unprognostic (6.67e-3)" "unprognostic (3.92e-2)" "unprognostic (1.11e-2)" "unprognostic (2.01e-1)" "unprognostic (7.48e-3)" "unprognostic (1.23e-1)" "unprognostic (3.14e-2)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" "unprognostic (1.88e-2)" 19.3 18.7 22.6 25.0 30.7 14.8 19.9 39.1 28.8 21.0 26.4 14.8 20.0 21.1 26.1 20.3 24.6 19.7 22.5 21.9 16.5 17.0 15.9 23.1 21.7 29.2 13.6 22.1 22.2 23.6 20.1 26.0 15.7 15.4 21.5 25.5 20.4 18.1 30.3 14.6 18.7 23.4 36.3 15.0 25.1 22.6 13.8 17.8 36.0 20.9 16.6 30.3 28.0 30.9 2.8 5.7 6.5 5.2 4.9 6.3 3.6 17.7 21.7 16.7 27.6 25.5 18.8 8.2 21.5 23.9 25.7 26.3 20.9 15.8 33.4 12.7 31.2 18.5 12.4 49.9 25.0 31.8 18.2 15.3 35.8 21.1 25.0 17.9 26.0 15.5 15.4 20.7 24.9 25.3 21.1 30.7 18.5 32.6 18.4 24.7 16.7 20.5 15.4 39.8 14.2 22.5 21.7 12.3 30.9 18.2 26.8 11.6 13.8 17.0 29.5 18.6 23.2 22.4 31.8 25.5 22.8 17.6 25.6 29.7 14.8 26.5 34.3 19.6 30.2 16.8 6.5 3.9 3.7 5.3 4.0 5.0 2.8 5.3 5.2 5.7 2.1 6.3 5.1 1.0 4.9 5.2 4.8 3.3 3.6 22.6 30.7 39.1 28.8 16.5 17.0 13.6 22.1 15.4 17.8 6.0 18.1 9.1 7.5 22.7 22.6 26.4 22.9 5.3 6.8 10.4 13.7 6.5 3.3 10.8 1.3 21.5 18.7 23.3 12.5 8.2 13.8 14.7 2.3 34.5 13.3 22.3 11.6 18.4 30.1 1.6 9.2 20.9 25.3 17.2 27.8 7.5 12.2 14.0 16.6 9.1 17.0 12.9 17.6 12.2 12.6 27.1 4.6 14.6 24.3 11.5 UBQLN4 "A1U, C1orf6, UBIN" ENSG00000160803 "Ubiquilin 4" Q9NRR5 1 156035301-156053794 "Predicted intracellular proteins, Transporters" "Autophagy, DNA damage, DNA repair" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061797 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA061797: AB_2684613" "unprognostic (3.91e-2)" "unprognostic (2.01e-2)" "unprognostic (1.95e-1)" "unprognostic (1.29e-3)" "unprognostic (1.52e-2)" "unprognostic (6.75e-2)" "unprognostic (1.58e-3)" "unprognostic (5.48e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-2)" "unprognostic (1.91e-2)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "unprognostic (7.25e-3)" "unprognostic (7.65e-2)" "unprognostic (4.73e-1)" "unprognostic (1.57e-1)" 7.1 6.7 13.8 7.4 19.9 3.9 12.4 23.1 25.2 9.9 7.8 6.5 4.2 7.2 11.9 8.9 11.6 10.2 6.2 9.3 17.7 9.7 7.9 10.2 8.5 7.3 15.0 18.7 15.1 14.1 10.6 3.6 8.4 12.4 8.9 8.8 6.4 12.4 11.8 24.3 11.6 7.4 13.1 8.7 6.8 9.4 6.9 13.7 7.9 6.8 6.6 8.9 8.2 8.4 1.9 2.0 9.7 1.2 1.7 3.2 1.1 16.2 19.6 18.8 18.4 12.9 8.0 18.6 13.7 7.6 13.8 10.4 17.6 14.8 27.7 12.6 12.5 7.5 18.3 19.0 14.8 13.2 23.3 20.1 15.2 11.2 16.9 8.3 16.3 28.8 6.0 19.1 19.0 15.5 12.2 16.4 8.9 28.4 15.5 12.4 20.0 17.9 16.5 25.8 41.9 18.3 23.0 13.9 27.4 11.2 16.5 13.9 40.2 13.8 34.3 14.1 19.1 33.1 18.0 15.8 12.8 17.0 13.0 14.7 34.5 27.4 30.2 7.8 16.5 17.9 9.7 1.1 0.6 2.5 1.2 3.2 1.9 2.0 2.7 0.9 1.5 1.5 2.1 0.0 1.7 0.2 2.0 1.6 1.1 13.8 19.9 23.1 25.2 17.7 9.7 15.0 18.7 12.4 13.7 6.0 4.0 4.5 7.5 11.8 5.9 4.3 15.3 2.7 4.5 22.7 5.9 7.1 3.3 10.9 0.7 6.8 6.6 0.0 9.3 8.1 7.9 16.4 1.1 19.4 8.6 6.4 10.3 9.8 7.2 2.3 6.1 7.4 16.9 17.2 9.7 6.1 11.1 5.8 8.5 9.2 5.2 0.0 8.0 3.6 5.1 12.8 6.9 5.7 13.3 10.5 UBR7 C14orf130 ENSG00000012963 "Ubiquitin protein ligase E3 component n-recognin 7 (putative)" Q8N806 14 93207056-93229215 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 246.4;Late spermatids: 271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000861 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA000861: AB_1078321" "unprognostic (9.60e-2)" "unprognostic (5.12e-3)" "unprognostic (1.11e-1)" "unprognostic (9.20e-2)" "unprognostic (3.30e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (8.12e-5)" "unprognostic (1.14e-1)" "unprognostic (9.83e-2)" "unprognostic (1.04e-2)" "unprognostic (4.30e-2)" "unprognostic (5.94e-2)" "prognostic favorable (9.76e-5)" "unprognostic (3.61e-2)" "unprognostic (2.91e-1)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" 14.1 12.3 16.4 12.5 22.9 17.0 17.5 20.0 25.8 17.1 15.7 17.7 11.3 11.1 14.9 13.4 14.8 13.7 11.9 19.0 14.2 12.8 15.3 13.2 11.9 18.0 14.0 17.1 17.0 20.4 28.2 11.5 11.4 13.3 13.9 17.1 13.6 13.7 14.9 19.9 15.2 12.7 14.1 16.9 13.8 14.1 21.1 14.3 31.9 15.4 12.9 23.3 13.4 13.3 18.1 10.7 15.8 9.5 11.5 16.5 8.2 6.5 8.7 13.5 11.2 6.3 6.8 4.8 13.8 9.8 15.4 11.7 6.3 7.4 15.5 11.6 7.0 6.7 7.9 14.4 7.7 15.8 12.0 7.8 11.2 9.4 6.0 2.9 16.4 12.6 4.1 5.4 8.5 5.4 5.7 8.6 14.9 10.4 15.6 14.7 19.1 26.6 9.0 6.2 17.2 15.9 20.5 24.1 8.5 5.2 10.7 16.9 12.1 9.9 8.3 4.1 8.3 15.0 11.3 6.5 11.3 6.1 9.7 14.2 18.1 27.7 16.0 9.9 12.7 9.6 15.8 7.3 11.8 12.7 9.1 13.3 18.1 11.4 11.7 7.8 14.8 10.0 10.6 11.5 11.5 9.5 10.7 16.5 8.2 16.4 22.9 20.0 25.8 14.2 12.8 14.0 17.1 13.3 14.3 14.9 5.4 14.3 6.6 17.6 5.8 15.3 10.2 2.7 10.3 10.4 9.8 7.8 10.0 8.8 246.4 8.2 9.2 23.3 11.2 13.2 10.2 4.3 4.7 10.4 11.8 3.2 5.2 14.1 10.1 271.2 8.6 8.5 13.5 7.2 7.6 12.6 8.2 5.8 11.7 7.0 13.4 6.5 10.7 34.9 27.7 11.8 5.5 10.7 10.7 3.3 UBXN2B p37 ENSG00000215114 "UBX domain protein 2B" Q14CS0 8 58411264-58451501 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 27.6" "Group enriched" "Detected in all" 5 "granulocytes: 27.6;monocytes: 7.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045278 Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA045278: AB_10963578" "unprognostic (1.98e-3)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (2.15e-3)" "unprognostic (1.63e-1)" "unprognostic (2.22e-1)" "unprognostic (2.46e-1)" "unprognostic (8.71e-2)" "unprognostic (3.36e-1)" "unprognostic (5.97e-2)" "unprognostic (1.58e-2)" "unprognostic (1.54e-1)" "unprognostic (6.48e-3)" "unprognostic (1.26e-1)" "unprognostic (8.22e-2)" "unprognostic (2.00e-1)" "unprognostic (1.42e-2)" 9.6 11.7 20.2 14.1 18.8 17.8 13.9 27.2 25.4 8.9 11.1 9.8 7.4 9.3 10.4 14.0 8.4 10.9 10.7 12.0 25.5 13.3 19.6 22.7 12.1 11.6 16.0 20.0 12.0 11.4 22.0 11.7 9.1 14.7 12.3 11.6 6.7 15.0 11.2 12.1 7.8 9.3 14.4 19.7 14.9 10.8 11.1 16.9 11.7 17.7 6.5 11.2 11.4 13.1 2.3 3.6 27.6 7.3 3.0 3.2 3.0 7.1 14.7 10.9 13.3 2.0 1.3 8.1 4.3 7.8 5.6 7.0 5.5 15.8 8.6 9.3 5.2 14.3 7.2 15.9 7.6 7.5 7.9 8.1 10.0 13.2 7.5 8.3 8.8 9.7 3.6 12.2 3.0 12.3 12.7 6.4 12.4 7.3 15.2 4.7 7.0 15.7 9.9 15.4 24.0 3.0 9.4 5.2 7.7 17.1 10.6 4.7 16.5 7.3 7.9 12.3 11.2 15.7 11.0 1.4 5.1 11.0 8.8 9.0 8.0 9.3 12.0 13.5 8.4 5.9 7.0 7.1 12.3 2.8 6.9 3.1 2.3 2.7 2.4 3.6 2.1 3.1 2.9 27.6 3.0 7.3 2.0 3.2 3.0 20.2 18.8 27.2 25.4 25.5 13.3 16.0 20.0 14.7 16.9 8.9 8.3 17.9 8.9 5.0 14.8 17.1 5.1 5.3 5.7 10.4 21.6 13.5 8.3 10.6 27.9 5.3 12.7 0.0 9.6 13.2 6.8 12.6 23.1 16.3 20.8 11.1 11.5 5.5 30.4 45.3 9.8 28.9 8.5 5.4 8.7 10.9 9.0 7.0 13.8 24.3 26.1 0.0 7.6 17.2 14.7 5.8 7.2 10.1 10.4 7.3 UBXN7 "KIAA0794, UBXD7" ENSG00000163960 "UBX domain protein 7" O94888 3 196347662-196432474 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048441, HPA049442" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA048441: AB_2680394, HPA049442: AB_2680769" "unprognostic (8.36e-3)" "unprognostic (4.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-3)" "unprognostic (1.05e-1)" "unprognostic (6.64e-2)" "unprognostic (5.12e-3)" "unprognostic (1.49e-1)" "unprognostic (9.60e-2)" "unprognostic (6.45e-2)" "unprognostic (2.11e-2)" "unprognostic (2.91e-2)" "unprognostic (2.52e-2)" "unprognostic (1.78e-1)" "unprognostic (3.40e-1)" "unprognostic (7.58e-2)" "unprognostic (1.32e-1)" 13.8 12.7 14.0 11.2 17.6 29.9 13.3 30.4 16.3 14.5 13.1 19.2 13.5 9.0 17.3 14.3 13.4 14.4 9.9 9.6 15.6 12.1 11.4 10.4 13.3 13.3 16.3 12.9 21.4 12.9 23.1 23.4 14.9 16.2 12.4 11.5 11.4 12.8 13.3 10.3 17.5 12.9 13.4 14.0 13.5 10.8 17.9 19.0 24.7 13.2 6.7 13.6 13.9 17.2 9.6 6.3 10.4 6.5 7.6 9.5 2.8 15.1 4.4 18.9 10.0 9.9 17.5 7.9 12.7 8.4 7.3 6.7 12.4 6.6 14.1 26.1 8.5 9.7 12.3 14.1 7.6 13.6 5.8 8.7 22.7 10.3 6.7 7.6 11.2 7.3 10.4 8.6 10.2 12.8 13.1 11.7 10.4 10.7 9.9 8.5 6.6 11.7 6.1 11.0 6.3 6.1 13.6 14.2 9.6 6.0 6.4 12.9 9.7 19.7 5.7 10.1 15.8 15.3 9.6 14.7 8.5 7.5 7.5 13.5 13.5 18.5 20.7 7.7 13.3 6.1 10.2 5.9 8.9 6.1 4.9 5.8 9.6 5.4 4.0 6.3 7.5 9.5 8.3 10.4 7.6 6.5 2.9 8.7 2.8 14.0 17.6 30.4 16.3 15.6 12.1 16.3 12.9 16.2 19.0 41.7 16.8 11.7 12.6 42.0 34.6 16.1 15.3 25.4 23.9 19.2 66.8 14.0 5.0 9.9 30.5 22.2 11.2 0.0 8.7 8.8 21.7 21.2 8.1 10.5 11.1 30.2 44.6 21.5 20.6 19.6 27.6 19.9 21.9 15.4 16.7 21.5 10.8 8.6 26.5 9.4 45.6 32.3 20.8 29.8 21.3 47.8 15.8 27.3 15.5 14.1 UCK2 UMPK ENSG00000143179 "Uridine-cytidine kinase 2" Q9BZX2 1 165827531-165911618 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.8" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057128 Approved Nucleoplasm NA NA Nucleoplasm "HPA057128: AB_2683346" "unprognostic (5.37e-2)" "unprognostic (1.75e-2)" "unprognostic (2.51e-1)" "unprognostic (1.20e-2)" "unprognostic (4.54e-2)" "unprognostic (6.83e-3)" "prognostic unfavorable (9.22e-8)" "prognostic unfavorable (4.98e-4)" "prognostic unfavorable (6.70e-4)" "unprognostic (3.04e-2)" "unprognostic (1.49e-1)" "unprognostic (1.13e-2)" "prognostic unfavorable (5.12e-13)" "unprognostic (2.49e-3)" "unprognostic (1.14e-1)" "unprognostic (2.01e-3)" "unprognostic (1.83e-1)" 12.5 7.1 6.5 11.1 8.6 11.6 17.5 16.9 9.6 9.3 18.4 8.9 11.0 15.3 10.1 15.3 20.5 8.8 9.0 9.6 6.4 6.6 6.6 14.6 11.1 10.3 10.5 6.6 7.5 17.6 7.9 9.4 65.8 11.2 8.1 19.9 5.0 16.1 9.9 20.9 15.0 24.8 10.0 8.2 7.7 13.2 7.2 7.9 13.1 6.4 12.4 12.3 9.0 11.1 3.4 14.7 0.8 5.6 3.4 3.9 2.0 25.2 26.3 14.2 12.7 7.3 12.2 23.1 27.9 20.6 29.8 34.0 24.9 27.8 12.5 19.9 17.3 12.1 20.8 26.6 32.8 26.7 22.9 22.4 14.5 22.6 25.6 18.2 28.3 11.1 11.5 16.9 56.2 35.0 7.2 19.6 24.1 38.3 18.0 26.7 18.3 25.1 18.2 38.9 35.2 25.5 11.5 15.6 42.5 13.8 16.5 21.4 25.3 19.9 39.4 19.3 28.3 24.3 27.0 20.4 16.7 23.3 18.9 29.5 24.2 36.0 46.3 14.4 18.8 12.7 0.8 5.6 0.1 1.8 3.7 3.9 3.4 1.7 2.4 14.7 3.4 0.0 1.4 0.2 3.4 3.2 14.0 2.2 2.0 6.5 8.6 16.9 9.6 6.4 6.6 10.5 6.6 11.2 7.9 0.0 1.4 3.0 24.7 20.4 4.3 4.1 12.7 1.4 4.5 8.7 0.0 1.2 6.6 15.0 94.9 15.3 22.2 0.0 19.1 46.9 11.0 10.1 0.0 4.9 11.9 0.0 6.4 4.9 3.5 31.3 6.1 7.1 10.1 17.2 13.7 4.0 38.8 14.4 3.2 5.8 4.2 0.0 9.0 5.2 11.5 26.0 22.1 4.8 18.3 20.9 UGDH ENSG00000109814 "UDP-glucose 6-dehydrogenase" O60701 4 39498755-39528311 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 125.8" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 293.1;Hepatocytes: 215.1;Pancreatic endocrine cells: 205.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 85.7;Hep G2: 99.2;U-2197: 61.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034444, HPA036656, HPA036657" Enhanced Supported Nucleoplasm Yes No 42000 Nucleoplasm "CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360" "unprognostic (1.22e-2)" "unprognostic (1.62e-1)" "unprognostic (2.73e-2)" "unprognostic (3.96e-2)" "unprognostic (5.54e-2)" "unprognostic (1.63e-1)" "unprognostic (8.78e-3)" "unprognostic (6.07e-2)" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (9.81e-3)" "unprognostic (6.86e-2)" "prognostic unfavorable (5.51e-10)" "unprognostic (2.48e-1)" "unprognostic (2.04e-1)" "unprognostic (1.66e-1)" "unprognostic (4.97e-2)" 25.9 11.3 4.4 24.7 3.2 0.2 12.7 4.0 3.1 13.0 29.3 3.8 10.2 13.7 11.5 9.7 22.9 9.9 12.9 10.1 3.6 3.5 28.2 125.8 13.5 4.7 4.0 2.2 20.6 24.9 5.1 4.7 26.8 5.3 13.2 23.3 7.5 8.2 7.3 7.5 5.5 24.2 17.7 3.7 3.3 14.1 5.0 3.8 1.7 16.7 12.7 7.1 30.2 24.1 12.0 12.3 17.1 12.0 21.8 22.4 10.2 4.9 85.7 9.4 12.3 30.9 34.4 7.9 16.3 19.4 16.1 14.8 12.0 18.5 3.1 10.2 22.6 14.8 5.1 9.8 4.6 16.9 4.0 1.7 3.5 11.1 99.2 12.2 4.3 3.5 11.5 2.5 27.6 8.7 13.0 10.3 2.5 4.6 2.6 11.1 14.6 4.2 4.7 7.6 32.4 6.3 7.2 14.6 3.1 8.9 19.7 4.8 7.1 10.0 5.9 6.8 7.2 3.3 3.6 12.0 16.6 7.7 61.6 7.8 6.0 4.3 3.1 14.0 3.6 8.6 17.1 12.0 10.9 14.3 10.6 22.4 10.9 11.4 14.8 10.7 12.0 9.8 12.0 2.3 21.8 6.1 12.3 7.3 10.2 4.4 3.2 4.0 3.0 3.6 3.5 4.0 2.2 5.3 3.8 23.8 22.2 19.5 56.0 103.1 7.7 7.3 22.9 72.3 30.7 19.2 13.7 18.5 59.7 44.3 0.9 20.2 111.9 0.0 293.1 59.3 101.2 100.0 35.7 215.1 16.1 9.5 108.6 23.4 18.5 0.9 30.8 17.2 28.7 26.2 69.3 5.2 205.5 85.2 27.3 54.9 8.6 32.3 92.4 2.4 4.0 35.0 24.3 11.5 88.0 69.0 UHRF1 "FLJ21925, ICBP90, Np95, RNF106, TDRD22" ENSG00000276043 "Ubiquitin like with PHD and ring finger domains 1" Q96T88 19 4903080-4962154 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 75.6" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 5.8;Hofbauer cells: 7.5;Spermatogonia: 6.9" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.2" "Group enriched" "Detected in many" 4 "dendritic cells: 8.2;T-cells: 4.2" "Cell line enhanced" "Detected in many" "MOLT-4: 63.9;REH: 145.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA049408, HPA055446" Enhanced Supported Nucleoplasm No Yes Nucleoplasm "HPA049408: AB_2756317, HPA055446: AB_2732597" "unprognostic (3.83e-2)" "unprognostic (6.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (4.30e-2)" "prognostic unfavorable (6.81e-4)" "unprognostic (2.82e-1)" "prognostic unfavorable (4.52e-5)" "unprognostic (2.33e-3)" "unprognostic (0.00e+0)" "unprognostic (3.75e-3)" "unprognostic (2.45e-1)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" 0.7 0.0 0.7 8.2 3.7 16.5 0.7 0.3 4.2 0.3 1.5 1.6 0.0 2.1 0.3 0.2 2.0 0.0 1.0 0.9 1.2 0.1 0.1 0.3 10.0 4.3 0.7 0.3 0.6 0.0 0.0 1.0 1.4 0.0 1.4 0.0 0.0 0.0 0.3 1.9 2.2 0.8 0.7 2.2 1.9 3.1 4.0 75.6 0.0 4.0 6.6 1.1 0.0 0.4 8.2 1.5 0.4 0.9 4.2 0.9 15.9 11.6 17.5 12.4 0.5 2.0 2.8 13.0 6.2 13.6 13.2 13.8 8.1 9.1 3.2 5.7 4.9 8.0 12.0 7.0 9.6 14.7 13.7 7.8 10.8 14.7 0.2 19.3 11.9 1.0 0.5 7.3 1.9 2.1 4.0 14.4 11.2 10.5 8.1 12.5 63.9 11.8 7.8 5.8 12.5 145.0 39.1 6.6 3.7 11.7 13.0 10.3 10.2 5.6 1.8 2.9 10.1 18.4 5.0 14.4 11.7 18.6 15.7 4.5 4.6 26.8 8.3 18.8 18.3 0.6 0.4 0.2 1.1 0.1 0.1 0.3 1.5 1.9 2.2 0.4 0.4 1.5 1.5 0.9 0.3 8.2 4.2 0.9 0.0 0.0 1.5 0.6 0.0 2.6 1.6 2.5 1.4 1.2 0.0 0.0 1.7 0.0 1.7 2.5 0.0 0.9 0.0 0.3 5.8 0.5 0.5 0.0 0.6 7.5 3.2 0.0 0.0 2.1 0.9 0.6 0.7 0.0 2.8 1.5 0.5 2.6 1.9 0.4 0.0 0.8 0.0 1.5 4.2 6.9 0.0 1.1 0.0 4.7 0.7 UHRF2 "MGC33463, NIRF, RNF107, TDRD23, URF2" ENSG00000147854 "Ubiquitin like with PHD and ring finger domains 2" Q96PU4 9 6413151-6507054 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026633, HPA026697" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA026633: AB_2732431, HPA026697: AB_2732432" "unprognostic (1.08e-1)" "unprognostic (1.13e-1)" "unprognostic (1.52e-1)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (8.40e-2)" "unprognostic (4.35e-3)" "unprognostic (4.12e-2)" "unprognostic (1.53e-1)" "unprognostic (4.17e-2)" "unprognostic (1.73e-1)" "unprognostic (5.69e-3)" "unprognostic (2.14e-2)" "unprognostic (6.21e-2)" "unprognostic (8.77e-2)" "unprognostic (7.42e-2)" "unprognostic (1.50e-1)" 14.1 12.9 10.6 25.4 12.2 49.1 19.0 24.8 11.8 18.6 15.6 12.7 17.6 7.9 17.5 15.1 13.3 12.0 11.9 11.3 10.2 10.6 10.1 9.8 13.5 19.3 12.3 10.5 18.9 14.5 12.7 12.7 14.6 11.4 19.3 12.0 10.7 13.0 16.4 15.7 11.0 12.0 17.1 12.2 14.1 11.6 10.6 14.8 40.3 15.2 10.2 19.8 18.7 18.2 5.1 2.5 7.5 1.4 1.2 3.6 1.2 6.7 7.7 11.1 4.7 9.1 13.2 8.1 15.6 9.6 9.8 17.2 4.9 4.9 10.3 3.4 7.7 9.1 4.4 10.2 9.1 15.0 18.7 4.7 18.0 15.0 7.8 7.5 8.4 6.1 5.9 5.9 7.6 18.8 18.8 38.2 10.6 1.7 10.1 23.1 2.3 14.1 32.7 4.3 9.9 5.7 16.0 5.1 3.6 7.3 4.6 10.0 3.9 6.7 4.5 9.7 14.1 5.6 16.9 32.2 10.5 3.8 4.3 13.0 2.7 8.0 12.1 5.1 7.4 4.1 7.5 1.1 4.3 2.3 0.9 1.7 3.5 3.6 1.8 0.7 5.1 2.3 3.0 1.3 1.2 1.4 2.5 3.5 1.2 10.6 12.2 24.8 11.8 10.2 10.6 12.3 10.5 11.4 14.8 6.0 11.8 25.0 9.7 19.2 22.6 42.0 5.1 5.3 9.1 12.2 29.5 10.8 1.7 5.1 16.0 20.4 8.1 23.3 3.4 8.5 12.4 13.9 17.3 11.3 9.2 27.0 6.8 15.4 11.7 5.9 17.8 11.0 20.3 6.4 12.4 6.7 6.0 12.9 13.8 5.1 34.9 12.9 13.7 37.2 17.2 16.7 4.9 13.8 11.3 7.1 UMAD1 "RPA3-AS1, RPA3OS" ENSG00000219545 "UBAP1-MVB12-associated (UMA) domain containing 1" 7 7640711-7968020 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044806 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA044806: AB_10961141" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (1.68e-1)" "unprognostic (1.23e-1)" "unprognostic (9.08e-3)" "unprognostic (9.24e-2)" "unprognostic (6.86e-3)" "unprognostic (4.87e-1)" "unprognostic (2.56e-1)" "unprognostic (6.57e-2)" "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "prognostic favorable (1.73e-8)" "unprognostic (6.66e-3)" "unprognostic (8.34e-2)" "unprognostic (7.69e-2)" "unprognostic (3.58e-1)" 4.1 8.7 7.0 6.5 8.5 3.8 6.7 6.8 8.8 4.2 6.1 5.3 9.6 7.6 6.2 7.8 4.2 5.0 5.1 6.6 5.5 8.7 7.0 6.6 6.9 7.5 8.3 7.2 18.7 12.5 17.0 4.2 8.1 10.0 5.8 6.1 11.4 11.9 3.5 2.6 8.1 6.3 7.3 5.1 11.6 2.4 6.3 8.6 12.9 3.5 6.3 7.1 8.4 17.0 9.7 27.4 13.0 10.1 22.0 10.9 14.1 10.5 5.4 6.2 7.8 9.2 6.2 8.8 10.1 6.9 10.6 4.4 10.6 7.7 9.3 5.4 28.0 9.2 6.1 8.8 8.7 5.8 4.7 4.2 8.0 5.1 8.7 7.7 9.9 8.7 11.1 10.0 7.7 8.1 4.2 10.2 8.6 23.9 9.1 11.5 7.0 4.2 9.7 9.5 8.8 7.8 12.7 12.3 12.6 6.5 2.2 8.9 12.3 15.9 12.4 16.7 12.4 9.5 4.6 7.1 16.7 13.9 8.8 17.2 18.8 8.9 16.0 11.1 21.8 22.8 9.7 24.6 12.1 12.4 15.0 17.0 17.3 15.1 8.1 16.2 20.5 15.3 27.4 10.1 13.0 9.7 22.0 10.9 23.8 11.0 5.3 24.5 0.0 6.5 10.1 12.7 17.4 18.2 14.0 13.7 14.4 33.2 7.4 6.3 6.0 11.2 0.0 12.8 17.6 9.6 27.0 14.0 8.9 14.4 14.3 5.8 4.9 9.8 2.8 12.4 9.3 0.0 7.2 14.3 11.3 9.3 11.0 7.4 26.2 9.4 25.8 7.4 3.0 4.6 0.0 17.7 10.2 9.9 19.2 UNC93B1 UNC93 ENSG00000110057 "Unc-93 homolog B1, TLR signaling regulator" Q9H1C4 11 67991104-68004982 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 28.6" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 87.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "CAPAN-2: 31.3;RPMI-8226: 87.0;SK-BR-3: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038716, HPA038717, HPA042803" Approved Approved Nucleoplasm No No Nucleoplasm "HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176" "unprognostic (3.32e-2)" "unprognostic (1.75e-1)" "unprognostic (3.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (7.66e-2)" "unprognostic (1.29e-2)" "unprognostic (9.36e-2)" "unprognostic (5.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.76e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.73e-2)" "unprognostic (1.85e-2)" "unprognostic (7.05e-3)" "unprognostic (5.23e-3)" 8.0 2.7 5.7 9.7 7.4 9.2 5.0 6.2 7.0 4.7 11.9 5.3 6.9 11.8 2.3 5.7 5.5 4.1 13.9 4.6 8.7 6.0 5.9 7.1 13.4 20.8 3.6 0.4 3.0 5.2 0.8 3.3 6.7 2.7 5.3 1.2 5.0 12.3 9.0 6.1 3.7 16.9 2.7 3.5 28.6 10.7 4.1 2.2 2.6 5.3 2.4 13.3 5.9 2.8 2.5 13.6 5.7 6.6 1.8 0.2 0.9 4.5 8.2 0.6 3.3 1.8 0.6 7.1 2.0 1.8 3.2 2.9 0.6 31.3 10.0 7.8 0.9 2.7 10.9 0.2 1.7 0.1 3.5 2.3 1.0 2.6 1.5 2.8 7.1 5.7 1.5 1.8 0.9 0.3 1.2 0.6 1.5 0.7 4.7 0.5 4.3 0.0 5.6 1.5 11.0 4.4 5.9 0.0 87.0 2.8 2.5 0.9 1.4 3.4 23.4 4.5 0.2 8.7 9.3 2.2 2.1 3.1 3.1 0.2 3.3 4.4 1.6 4.0 7.3 2.5 0.1 3.6 5.7 0.1 6.6 0.2 2.4 0.2 0.2 4.7 2.5 0.0 0.0 3.1 1.8 6.6 13.6 0.0 0.9 5.7 7.4 6.2 7.0 8.7 6.0 3.6 0.4 2.7 2.2 8.9 7.8 29.4 21.8 3.5 0.0 1.6 35.7 36.1 6.8 15.7 0.0 9.0 1.7 33.6 0.6 5.8 24.2 0.0 20.5 41.1 8.3 14.1 6.9 4.0 87.3 4.8 4.1 5.5 53.9 0.0 4.0 51.3 21.9 53.3 14.2 4.8 34.0 21.0 3.9 5.7 0.3 0.0 4.2 0.0 0.9 5.6 6.1 9.6 18.7 30.4 UNCX Uncx4.1 ENSG00000164853 "UNC homeobox" A6NJT0 7 1232907-1237318 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 44.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 20 "cerebellum: 44.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "NB-4: 47.2" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Region enriched" "Detected in many" 8 "cerebellum: 19.3" HPA063294 Approved Nucleoplasm NA NA Nucleoplasm "HPA063294: AB_2684977" "unprognostic (1.15e-1)" "unprognostic (9.71e-2)" 0.1 0.1 0.0 0.2 0.0 0.1 0.1 44.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 3.5 0.1 0.1 0.1 0.9 0.0 0.1 0.1 0.1 0.3 0.1 2.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 1.1 0.9 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UPF1 "HUPF1, KIAA0221, NORF1, pNORF1, RENT1, smg-2" ENSG00000005007 "UPF1, RNA helicase and ATPase" Q92900 19 18831938-18868236 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Nonsense-mediated mRNA decay" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019587, HPA020857" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA019587: AB_1856174, HPA020857: AB_1856175" "unprognostic (1.03e-1)" "unprognostic (2.58e-2)" "unprognostic (3.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.66e-1)" "unprognostic (7.77e-2)" "unprognostic (2.09e-1)" "unprognostic (7.98e-2)" "prognostic unfavorable (2.72e-4)" "unprognostic (2.94e-1)" "unprognostic (3.31e-1)" "unprognostic (3.71e-3)" "prognostic favorable (2.97e-6)" "unprognostic (4.48e-2)" "unprognostic (1.71e-1)" "unprognostic (8.90e-3)" "unprognostic (1.01e-2)" 22.5 22.4 18.0 22.4 19.9 23.2 20.4 40.9 25.4 21.5 20.0 24.5 27.8 21.9 24.9 16.7 23.4 19.6 27.0 19.2 14.6 13.5 17.3 20.8 20.5 23.4 20.3 19.3 23.6 42.7 38.1 21.1 28.7 17.7 22.4 11.4 17.9 36.3 25.3 27.9 26.4 20.3 20.1 15.9 23.7 23.7 46.9 20.8 24.9 25.9 13.0 22.9 25.4 24.4 0.9 1.3 4.7 2.3 2.6 1.1 0.8 23.8 15.9 11.2 13.3 17.4 11.4 36.8 20.3 12.6 19.7 15.5 30.5 21.7 21.5 27.0 12.7 10.5 24.1 15.7 22.1 7.5 11.4 30.9 23.6 14.4 19.5 15.0 26.1 14.2 12.7 16.1 15.3 16.7 11.3 12.5 18.8 29.6 20.9 10.4 26.0 30.3 16.4 18.6 16.6 39.0 24.3 18.1 20.1 8.7 21.6 23.8 18.3 18.6 21.2 10.9 9.4 12.7 16.8 17.5 17.6 12.3 21.5 22.6 13.5 10.4 33.2 12.5 25.2 19.4 0.0 1.7 3.0 0.8 0.9 0.7 0.4 1.1 0.2 1.3 0.9 0.7 0.5 4.7 2.6 2.3 0.6 0.5 0.8 18.0 19.9 40.9 25.4 14.6 13.5 20.3 19.3 17.7 20.8 20.8 12.8 14.5 11.7 14.0 27.5 13.7 15.3 12.0 7.9 26.2 13.7 13.9 0.0 10.0 8.4 14.3 22.7 0.0 8.4 12.1 8.6 15.5 0.0 20.2 11.9 35.0 20.7 14.7 16.1 6.3 13.6 11.0 11.8 9.0 23.0 19.7 13.5 17.3 18.0 9.1 19.2 12.9 9.2 19.3 19.8 16.3 17.2 8.9 19.6 24.2 UPP1 "UDRPASE, UP, UPASE, UPP" ENSG00000183696 "Uridine phosphorylase 1" Q16831 7 48088628-48108733 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 206.2;Macrophages: 205.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 26.4;hTERT-HME1: 103.9;SK-MEL-30: 24.1;WM-115: 23.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054040, HPA055394" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "HPA054040: AB_2682352, HPA055394: AB_2682805" "unprognostic (1.16e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (5.96e-2)" "unprognostic (1.01e-1)" "unprognostic (3.21e-3)" "unprognostic (6.36e-2)" "unprognostic (1.78e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.81e-2)" "unprognostic (1.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.59e-1)" "unprognostic (1.52e-3)" "unprognostic (2.95e-2)" "unprognostic (1.30e-1)" "unprognostic (1.30e-1)" "unprognostic (1.39e-1)" 16.7 8.4 2.8 12.6 4.2 17.6 7.1 5.7 3.8 10.3 8.0 1.7 2.1 7.5 2.8 4.2 37.7 3.3 8.5 7.0 2.3 3.3 12.4 9.1 18.3 17.4 5.8 1.4 2.9 5.8 2.4 5.0 28.9 5.5 3.0 7.6 2.9 7.5 2.1 5.1 2.0 9.7 5.2 3.9 13.9 2.5 1.8 4.8 1.2 6.2 34.0 19.4 7.9 19.6 0.6 8.2 15.7 22.0 5.7 19.7 16.0 6.5 7.9 0.8 1.6 2.7 1.2 8.1 3.2 4.5 4.1 5.1 3.3 3.2 0.0 1.2 2.6 26.4 4.6 1.5 13.1 2.7 1.3 1.4 0.2 1.9 1.3 2.4 0.2 0.5 1.6 6.4 1.9 103.9 1.9 2.7 0.2 0.4 3.9 2.2 0.7 0.0 1.1 3.1 1.1 6.9 0.0 1.7 1.7 9.5 3.4 0.7 0.7 3.3 0.9 24.1 8.9 0.8 0.2 3.8 9.7 8.3 2.6 8.2 7.5 10.0 1.1 9.8 1.0 23.6 15.7 22.0 15.1 19.7 16.7 12.5 0.2 12.6 13.5 8.2 0.6 13.0 12.0 9.1 5.7 15.9 0.7 11.2 16.0 2.8 4.2 5.7 3.8 2.3 3.3 5.8 1.4 5.5 4.8 17.9 64.1 14.6 17.3 41.6 27.8 10.4 22.9 8.1 13.6 10.4 31.4 6.0 59.7 36.9 0.6 58.5 53.1 0.0 35.8 206.2 39.5 10.1 24.4 15.1 111.9 15.9 12.5 78.5 137.0 1.5 4.9 205.8 82.7 43.3 11.6 13.5 73.7 52.6 2.1 15.4 28.8 6.5 33.0 0.0 3.0 26.1 65.8 46.7 13.3 29.6 USB1 "C16orf57, FLJ13154, HVSL1, Mpn1" ENSG00000103005 "U6 snRNA biogenesis phosphodiesterase 1" Q9BQ65 16 57999546-58021618 "Disease related genes, Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041791, HPA059854" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA041791: AB_10793933, HPA059854: AB_2684143" "unprognostic (2.79e-1)" "unprognostic (3.84e-2)" "unprognostic (1.21e-2)" "unprognostic (9.65e-2)" "unprognostic (2.03e-1)" "unprognostic (2.23e-3)" "prognostic unfavorable (6.69e-7)" "unprognostic (4.30e-3)" "unprognostic (2.92e-1)" "unprognostic (4.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (2.18e-1)" "unprognostic (1.56e-1)" "unprognostic (1.06e-3)" "unprognostic (5.04e-2)" 23.7 26.3 19.5 28.7 20.3 29.0 16.1 8.2 30.5 17.4 19.1 16.8 10.3 15.2 19.1 18.6 16.6 14.7 16.1 22.4 19.9 21.4 18.0 47.5 19.6 20.6 19.0 16.5 18.4 16.6 18.5 13.7 18.8 26.1 16.5 20.8 13.4 14.3 21.3 13.5 16.1 16.8 26.7 14.2 27.6 18.5 18.1 15.5 18.5 21.8 14.3 21.7 25.4 19.3 6.2 16.7 50.0 26.5 12.8 18.5 9.0 18.0 38.0 13.0 24.6 16.9 11.9 20.5 15.2 20.5 24.5 17.5 24.6 10.9 11.2 20.3 22.6 21.9 13.5 20.5 32.7 35.3 10.6 11.5 13.9 15.7 35.5 19.3 18.3 40.9 17.0 19.6 31.2 18.3 16.2 26.8 24.4 18.6 5.5 20.5 19.1 16.8 21.2 21.5 16.4 31.1 16.9 11.7 18.6 17.4 22.2 6.3 14.8 40.0 10.5 9.6 21.5 5.2 18.7 28.8 14.5 21.4 15.4 20.8 8.4 12.2 20.5 17.4 17.6 17.6 25.2 18.0 25.0 18.5 20.3 12.1 6.2 10.9 14.1 16.7 4.3 6.8 12.1 50.0 12.8 26.5 7.3 13.1 9.0 19.5 20.3 8.2 30.5 19.9 21.4 19.0 16.5 26.1 15.5 0.0 11.6 11.0 14.3 16.1 2.7 10.5 17.8 8.1 5.7 8.7 3.9 26.4 10.0 36.0 0.9 11.3 16.6 0.0 40.5 46.4 16.0 12.5 16.1 12.1 37.6 6.4 12.1 22.1 22.1 1.3 7.5 20.9 13.5 44.1 13.9 5.7 40.0 14.8 11.0 11.6 3.1 6.5 18.4 9.8 18.8 11.4 17.2 25.5 8.9 12.6 USF1 "bHLHb11, MLTFI, UEF" ENSG00000158773 "Upstream transcription factor 1" P22415 1 161039251-161045977 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001480, HPA036233, HPA036535" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB001480: AB_2213986, HPA036233: AB_2675012, HPA036535: AB_2675178" "unprognostic (3.66e-2)" "unprognostic (2.79e-2)" "unprognostic (9.12e-3)" "unprognostic (2.17e-1)" "unprognostic (9.40e-2)" "prognostic favorable (8.70e-4)" "unprognostic (1.59e-3)" "unprognostic (2.94e-2)" "unprognostic (3.57e-1)" "unprognostic (1.03e-3)" "unprognostic (3.05e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (6.01e-12)" "unprognostic (1.24e-3)" "unprognostic (3.29e-1)" "unprognostic (4.08e-1)" "prognostic favorable (1.95e-5)" 15.4 17.0 21.6 16.9 24.4 14.3 13.8 31.0 27.6 15.2 17.6 15.6 15.6 17.7 15.1 15.5 12.6 17.1 16.2 17.4 21.6 22.1 15.2 19.1 16.7 23.8 19.7 19.4 17.2 9.8 19.0 12.3 17.3 17.1 14.4 18.0 14.7 13.8 19.0 27.4 14.6 17.8 18.0 18.3 26.7 13.7 8.5 18.7 21.9 16.1 13.5 30.3 18.5 13.8 3.9 5.7 8.6 4.7 2.0 4.0 2.0 8.2 12.6 15.1 17.5 20.4 11.7 20.3 7.0 15.1 21.8 17.0 8.8 10.5 10.7 14.8 11.5 9.5 10.4 17.8 11.0 12.3 9.9 10.5 9.2 10.5 9.2 11.9 12.8 12.9 9.5 11.1 15.7 12.8 13.9 20.3 18.4 15.1 11.6 13.6 9.7 19.7 14.0 31.1 18.1 16.5 17.2 11.8 13.0 10.8 13.3 8.5 16.4 12.7 16.5 8.8 22.8 13.7 41.8 11.9 10.9 6.9 6.6 11.2 9.8 12.4 17.0 9.4 12.5 8.3 4.7 4.7 2.7 4.0 4.5 2.4 3.4 2.5 2.9 5.4 3.9 2.7 2.6 8.6 2.0 4.2 5.7 2.7 2.0 21.6 24.4 31.0 27.6 21.6 22.1 19.7 19.4 17.1 18.7 6.0 8.6 3.2 0.6 2.1 3.6 0.7 0.0 8.1 2.3 3.5 2.0 1.9 1.7 1.6 0.3 1.9 6.3 0.0 1.2 3.3 1.8 1.0 10.5 0.4 2.8 4.8 2.9 0.0 1.9 0.0 0.3 3.2 5.0 2.8 2.7 2.0 2.1 7.0 0.0 2.5 3.4 6.5 1.4 0.5 0.4 1.6 2.9 4.6 3.2 1.3 USP1 ENSG00000162607 "Ubiquitin specific peptidase 1" O94782 1 62436297-62451804 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.6" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 281.4;Spermatogonia: 214.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028387, HPA028440" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028387: AB_2672578, HPA028440: AB_10603000" "unprognostic (1.22e-1)" "unprognostic (5.36e-2)" "unprognostic (1.78e-3)" "unprognostic (4.05e-3)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (6.72e-2)" "unprognostic (1.11e-2)" "unprognostic (5.32e-2)" "unprognostic (3.33e-3)" "unprognostic (3.99e-2)" "unprognostic (2.76e-2)" "unprognostic (9.61e-3)" "unprognostic (5.70e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" 11.6 9.0 11.3 17.2 10.7 29.3 15.9 20.6 14.2 19.2 13.3 7.8 8.0 10.8 15.1 12.0 15.6 13.8 8.9 9.0 11.5 9.6 11.8 9.3 11.7 19.2 14.2 9.6 26.7 12.7 14.8 18.4 13.6 10.9 14.8 13.9 7.6 12.7 13.5 11.7 12.3 13.3 15.8 15.5 18.1 11.6 31.6 11.8 70.6 15.0 13.3 20.1 16.5 16.5 14.7 11.8 23.4 12.4 15.5 16.3 9.2 22.3 6.6 27.8 15.0 6.2 7.5 15.4 21.5 14.7 26.8 29.3 11.1 10.9 40.4 15.6 12.0 24.0 13.0 22.7 14.8 37.5 20.2 16.4 33.2 22.9 11.6 6.8 35.5 16.8 4.0 9.7 24.2 18.3 7.3 12.6 27.5 24.0 35.3 18.8 10.0 36.3 13.7 24.4 13.4 13.7 34.5 47.1 25.0 10.0 16.7 28.7 16.1 24.3 19.9 23.5 19.4 11.4 21.7 8.7 20.7 22.5 30.2 30.1 14.0 19.5 46.4 14.0 28.4 18.5 17.4 9.5 23.4 12.6 9.6 16.3 14.7 15.0 12.7 11.4 10.7 14.3 11.9 16.9 15.5 12.4 11.8 13.6 9.2 11.3 10.7 20.6 14.2 11.5 9.6 14.2 9.6 10.9 11.8 44.7 25.6 45.4 30.6 55.3 44.0 29.7 20.4 56.2 43.3 15.7 21.6 30.6 16.6 26.4 117.0 37.9 12.9 0.0 29.7 56.2 38.1 45.1 26.6 15.8 26.9 33.4 8.1 23.4 28.2 52.6 46.3 31.1 25.3 53.3 29.2 47.5 22.4 7.0 38.5 13.5 78.0 51.8 47.7 281.4 214.8 56.2 27.6 46.5 30.4 28.8 USP12 USP12L1 ENSG00000152484 "Ubiquitin specific peptidase 12" O75317 13 27066142-27171896 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007288, HPA059492" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA007288: AB_1080531, HPA059492: " "unprognostic (6.72e-3)" "unprognostic (2.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" "unprognostic (5.85e-2)" "unprognostic (1.79e-1)" "unprognostic (3.39e-1)" "unprognostic (8.38e-2)" "unprognostic (8.77e-2)" "unprognostic (2.20e-1)" "unprognostic (3.06e-2)" "unprognostic (1.22e-2)" "unprognostic (1.40e-1)" "unprognostic (2.91e-1)" "unprognostic (6.77e-2)" "unprognostic (1.73e-1)" 15.7 10.4 18.3 23.3 17.8 46.0 15.6 16.6 18.3 12.1 30.6 16.1 8.8 13.0 15.3 11.6 23.5 9.5 14.5 11.3 19.3 15.9 18.3 27.9 19.9 19.6 20.5 7.5 12.0 13.4 10.7 16.2 14.8 12.4 17.5 19.1 10.1 8.9 9.5 9.8 17.3 33.0 43.8 18.5 16.5 14.7 11.0 13.1 8.4 12.0 6.6 18.5 42.8 24.2 4.6 3.0 5.3 2.1 2.3 3.6 1.2 12.1 7.6 14.6 7.6 9.8 12.6 5.2 17.1 12.1 9.5 7.1 13.8 19.1 17.3 8.6 13.5 23.1 7.5 9.5 9.9 20.4 27.9 8.2 26.7 9.9 9.7 12.4 15.4 18.8 7.8 14.6 10.7 12.4 12.1 21.9 12.0 8.9 8.4 19.7 7.1 9.4 20.6 10.5 15.6 13.5 10.8 18.7 4.1 18.8 8.6 16.2 9.8 14.7 12.4 13.8 19.1 5.8 15.0 25.8 10.0 9.6 21.3 15.5 6.5 7.2 12.3 16.8 9.2 11.1 0.0 1.2 5.3 1.5 1.3 2.5 3.2 2.4 2.0 1.6 4.6 1.6 1.7 1.2 2.3 2.1 3.0 3.6 1.2 18.3 17.8 16.6 15.5 19.3 15.9 20.5 7.5 12.4 13.1 26.8 25.1 15.1 22.9 81.5 21.6 22.6 10.2 16.0 10.3 22.7 37.3 12.2 24.9 11.8 16.7 31.9 32.8 46.7 14.0 5.6 31.0 29.2 12.7 22.2 12.6 27.0 20.1 17.2 15.8 8.2 7.2 23.3 37.1 44.1 23.6 10.9 19.7 25.8 6.0 15.7 29.9 32.3 45.3 2.5 8.9 69.1 9.2 13.8 20.4 30.3 USP26 ENSG00000134588 "Ubiquitin specific peptidase 26" Q9BXU7 X 133024631-133097109 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 3.8" "Cell type enriched" "Detected in single" 14 "Spermatogonia: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "HPA000424, HPA027310" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA000424: , HPA027310: " "unprognostic (7.92e-4)" "unprognostic (3.59e-2)" "unprognostic (1.99e-2)" "unprognostic (2.08e-1)" 0.1 0.1 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.4 0.1 0.1 0.1 0.1 0.1 3.8 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.3 0.0 0.0 0.5 0.4 0.5 0.4 0.1 0.1 0.2 0.2 0.7 0.1 0.2 0.1 0.7 0.1 0.1 0.0 0.1 0.7 0.1 0.2 0.3 1.0 0.3 1.0 0.3 0.1 0.1 0.0 1.5 0.6 0.4 0.1 0.3 0.1 0.4 0.4 0.4 0.2 0.2 0.1 0.8 0.4 0.2 0.3 0.4 0.1 0.0 0.9 0.5 0.5 0.2 0.1 0.1 0.2 1.0 0.1 0.7 0.3 0.9 0.1 0.3 0.4 0.9 0.3 0.1 0.2 0.4 0.3 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.0 0.0 0.0 USP34 "KIAA0570, KIAA0729" ENSG00000115464 "Ubiquitin specific peptidase 34" Q70CQ2 2 61187463-61470769 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 235.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025815, HPA070764" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA025815: AB_1858681, HPA070764: AB_2686308" "unprognostic (4.04e-2)" "unprognostic (8.21e-3)" "unprognostic (5.08e-2)" "unprognostic (3.14e-2)" "unprognostic (4.13e-2)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (2.66e-1)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "unprognostic (8.91e-2)" "unprognostic (4.62e-2)" "unprognostic (9.58e-2)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (6.34e-2)" "unprognostic (7.01e-2)" 17.2 19.6 31.8 37.2 25.6 24.8 28.3 77.1 35.5 22.5 22.7 14.4 31.1 11.4 22.2 44.5 18.6 17.5 20.0 16.9 30.5 24.0 20.5 21.5 29.7 34.2 22.0 21.2 24.7 17.2 33.5 40.3 13.4 22.0 22.7 21.5 21.2 16.9 45.2 27.0 31.6 21.0 22.7 20.8 24.8 19.3 26.4 25.3 21.7 23.2 13.9 33.5 19.1 16.7 6.0 5.8 3.4 4.6 5.2 7.5 2.3 16.8 12.1 15.7 16.3 29.9 20.1 13.2 10.4 14.7 9.3 8.9 16.9 6.5 40.0 11.1 22.4 9.9 9.3 12.4 13.7 17.4 14.3 9.8 24.2 11.7 27.2 25.2 17.9 15.4 21.9 17.8 17.0 25.4 22.8 19.6 11.4 16.5 13.0 20.7 15.8 11.8 26.1 10.6 17.2 9.6 12.7 19.2 10.7 27.5 20.7 13.0 13.9 16.4 12.2 17.9 21.0 6.4 13.0 17.5 14.8 19.7 8.7 13.6 15.1 7.4 42.0 13.9 16.7 12.6 3.4 2.0 2.8 7.5 2.2 6.7 5.1 5.1 5.5 1.8 6.0 5.8 7.5 3.4 5.2 4.6 5.8 4.5 2.3 31.8 25.6 77.1 35.5 30.5 24.0 22.0 21.2 22.0 25.3 59.6 60.6 35.3 50.1 54.3 132.9 41.8 56.0 33.5 59.1 31.4 235.6 26.6 8.3 35.4 108.3 51.2 38.6 0.0 29.1 19.8 45.2 63.1 31.2 36.3 19.7 101.7 46.7 23.4 40.3 105.2 52.6 41.4 38.8 30.7 32.2 62.5 38.7 38.4 62.9 18.3 185.3 25.8 46.7 97.9 106.7 53.6 44.6 40.8 31.2 57.6 USP39 "CGI-21, SAD1, SNRNP65" ENSG00000168883 "Ubiquitin specific peptidase 39" Q53GS9 2 85602856-85649282 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034823, HPA077350" Supported Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA034823: AB_10602488, HPA077350: " "unprognostic (1.10e-2)" "unprognostic (3.31e-3)" "unprognostic (1.83e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.46e-3)" "unprognostic (3.67e-2)" "prognostic unfavorable (2.84e-6)" "unprognostic (1.10e-2)" "unprognostic (1.69e-1)" "unprognostic (1.89e-1)" "unprognostic (5.17e-3)" "unprognostic (3.14e-2)" "prognostic unfavorable (4.05e-7)" "unprognostic (3.95e-3)" "unprognostic (2.25e-1)" "unprognostic (2.52e-2)" "unprognostic (2.52e-1)" 19.0 15.1 14.5 23.5 16.8 30.4 18.3 14.9 20.8 20.2 24.1 18.7 11.8 14.7 22.1 24.1 20.7 16.8 20.6 25.5 13.7 13.7 17.8 20.8 18.5 20.8 15.2 14.5 19.2 15.0 17.7 13.7 28.0 15.8 21.6 20.5 18.0 17.2 20.0 44.2 20.2 17.8 19.0 15.0 21.0 18.1 17.2 13.0 56.5 24.7 23.9 27.0 23.0 26.0 25.3 28.8 29.8 29.7 26.4 37.3 28.2 22.1 22.5 23.1 25.3 16.8 13.2 25.9 18.7 17.7 27.9 24.9 36.0 16.0 26.2 17.7 17.5 20.6 16.0 44.2 20.2 35.4 26.3 28.0 32.5 13.6 31.7 16.6 39.5 22.3 9.3 16.2 21.4 19.3 13.1 22.2 27.7 39.8 15.5 20.4 25.7 38.8 29.7 30.5 27.0 21.0 35.9 49.5 19.9 14.9 17.3 21.3 17.2 11.7 19.2 16.1 19.7 12.9 19.3 14.2 17.3 21.6 20.5 30.9 13.7 25.3 28.1 14.7 41.7 20.6 28.0 25.5 29.8 30.3 29.7 35.2 24.3 31.8 31.2 28.8 25.3 31.4 28.5 16.4 26.4 26.9 22.5 37.3 28.2 14.5 16.8 14.9 20.8 13.7 13.7 15.2 14.5 15.8 13.0 17.9 18.5 11.5 13.7 18.2 7.6 16.2 7.6 17.4 18.2 12.2 7.9 50.4 18.3 16.6 21.7 16.1 10.2 0.0 16.4 24.7 19.3 13.0 16.2 12.5 22.0 4.8 11.6 17.2 10.4 9.4 17.8 16.8 18.6 23.4 14.3 14.0 15.5 8.6 17.7 12.4 10.3 0.0 16.7 17.4 16.8 14.2 29.9 20.3 14.6 13.4 USP42 FLJ12697 ENSG00000106346 "Ubiquitin specific peptidase 42" Q9H9J4 7 6104884-6161564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 70.7;Spermatocytes: 67.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064800 Approved Nucleoplasm NA NA Nucleoplasm "HPA064800: AB_2685355" "unprognostic (1.48e-2)" "unprognostic (1.47e-1)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-1)" "unprognostic (1.19e-2)" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (2.82e-1)" "unprognostic (6.21e-3)" "unprognostic (2.47e-2)" "unprognostic (3.17e-3)" "unprognostic (3.14e-2)" "unprognostic (3.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.66e-1)" 6.7 5.6 5.7 5.7 9.5 19.8 7.2 14.1 10.6 8.5 7.4 10.4 5.5 8.1 14.1 7.0 6.9 8.1 6.5 5.4 5.8 6.0 7.4 7.1 7.3 6.5 6.7 4.9 10.6 11.7 10.5 10.9 8.2 6.2 7.4 6.5 8.9 6.6 6.3 7.4 9.2 9.2 8.7 9.9 7.8 6.7 25.2 8.1 14.3 7.7 6.2 8.3 7.6 6.9 1.9 2.2 3.3 2.4 1.9 4.3 0.8 8.4 6.3 11.4 11.1 6.6 5.0 7.8 4.6 5.9 5.4 5.4 4.4 4.5 10.1 3.0 5.7 8.0 7.9 9.5 5.0 5.9 2.4 7.4 4.6 5.4 4.5 5.6 10.8 5.3 5.9 6.0 5.8 7.5 5.0 6.6 8.5 17.8 6.8 3.6 7.5 6.5 12.1 12.9 4.4 4.8 12.4 8.9 6.9 5.1 4.5 8.8 15.5 5.8 12.2 3.6 10.9 5.6 5.6 5.5 4.9 18.1 6.1 5.4 6.1 5.1 8.8 4.1 6.6 9.5 2.3 1.1 3.3 2.1 2.4 3.0 1.9 2.6 1.3 1.1 1.1 1.7 4.3 1.4 1.9 1.2 2.2 1.8 0.8 5.7 9.5 14.1 10.6 5.8 6.0 6.7 4.9 6.2 8.1 11.9 6.5 11.5 16.3 35.9 18.1 6.9 0.0 10.7 6.8 1.8 21.6 7.3 0.0 9.4 70.7 12.2 12.5 0.0 8.9 6.5 8.5 16.7 9.2 7.8 7.2 20.6 10.3 14.7 7.0 32.5 13.3 11.5 10.1 6.4 14.6 11.3 10.2 7.0 12.0 4.2 17.9 12.9 11.3 67.4 32.6 36.3 22.4 12.1 11.3 13.5 UTP11 "CGI-94, UTP11L" ENSG00000183520 "UTP11, small subunit processome component" Q9Y3A2 1 38009258-38024824 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 74.7" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 54.9;Exocrine glandular cells: 58.5;Pancreatic endocrine cells: 60.3;Syncytiotrophoblasts: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045830 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045830: AB_10969917" "unprognostic (1.95e-1)" "unprognostic (2.23e-1)" "unprognostic (1.52e-1)" "unprognostic (3.18e-2)" "unprognostic (7.29e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (7.44e-8)" "unprognostic (3.51e-1)" "unprognostic (2.99e-2)" "unprognostic (1.66e-3)" "unprognostic (1.40e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (1.42e-8)" "unprognostic (1.39e-2)" "unprognostic (2.44e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-1)" 11.3 12.4 9.1 9.6 8.4 9.3 9.7 7.5 11.3 10.6 12.1 6.0 6.9 7.3 11.4 9.1 13.8 9.8 8.6 11.5 12.9 9.5 9.1 13.1 7.4 8.6 9.3 8.7 10.7 11.5 6.6 10.2 11.4 11.2 12.9 8.7 6.7 10.0 8.8 74.7 9.4 7.6 19.7 10.9 10.2 10.4 9.3 5.7 10.5 8.1 26.1 10.6 22.6 10.9 12.9 18.7 9.6 22.5 21.9 17.7 12.3 15.0 9.1 16.0 15.6 12.0 16.4 14.6 17.1 16.3 23.2 21.4 13.4 18.9 25.2 16.1 13.8 11.4 13.2 18.1 15.0 29.1 18.9 16.6 29.3 12.3 11.7 16.2 29.2 19.3 15.1 9.7 25.6 22.4 14.5 18.5 19.3 33.5 13.7 26.2 10.7 22.6 30.2 38.9 16.9 12.2 20.1 34.2 23.4 15.2 14.7 21.2 17.6 15.0 13.0 27.5 17.6 11.8 18.0 13.6 15.9 19.2 17.3 32.5 13.1 25.6 21.3 21.3 32.1 19.5 8.4 18.9 9.6 16.9 20.5 17.7 10.5 13.5 14.0 18.7 12.9 12.4 15.0 5.7 21.9 22.5 18.0 15.6 12.3 9.1 8.4 7.5 11.3 12.9 9.5 9.3 8.7 11.2 5.7 32.8 35.8 0.0 0.0 0.0 0.0 0.0 0.0 46.8 38.7 24.4 0.0 47.4 33.2 54.9 0.0 0.0 0.0 0.0 58.5 41.6 0.0 0.0 23.3 0.0 47.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 33.3 0.0 0.0 60.3 0.0 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.0 65.1 0.0 0.0 0.0 UVSSA KIAA1530 ENSG00000163945 "UV stimulated scaffold protein A" "Q2YD98, Q8N1N5" 4 1347266-1395992 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050824, HPA053496" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050824: AB_2681251, HPA053496: AB_2682170" "unprognostic (6.40e-3)" "unprognostic (4.91e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-2)" "unprognostic (1.67e-1)" "unprognostic (3.85e-4)" "unprognostic (1.89e-1)" "unprognostic (4.80e-2)" "unprognostic (1.38e-1)" "unprognostic (4.88e-2)" "unprognostic (2.12e-3)" "unprognostic (3.92e-3)" "prognostic unfavorable (1.90e-4)" "unprognostic (2.76e-3)" "unprognostic (5.19e-2)" "unprognostic (1.02e-2)" "prognostic favorable (6.87e-4)" 6.5 7.1 5.7 8.0 10.8 11.8 8.1 7.2 7.1 6.1 7.6 10.6 10.9 9.7 10.0 11.4 6.8 10.7 5.5 4.8 8.0 3.4 5.8 6.3 9.4 7.6 7.8 4.3 9.5 13.4 6.7 19.0 9.4 7.0 6.7 5.6 9.6 11.1 6.7 8.7 19.6 8.7 7.2 8.4 9.9 8.9 22.2 7.6 7.1 11.5 3.1 7.3 9.3 7.0 1.5 2.4 3.6 2.1 8.2 1.6 1.5 4.3 6.8 6.3 6.6 9.8 9.7 5.9 3.9 3.0 3.1 2.5 4.6 7.3 2.6 7.5 3.3 7.5 4.6 3.6 4.6 2.6 4.5 2.2 6.4 8.7 7.0 2.6 3.9 8.5 2.9 8.8 3.3 3.8 3.7 5.1 6.1 6.5 8.9 3.8 3.1 6.3 9.1 6.7 2.6 6.1 5.7 3.1 3.8 2.7 5.9 4.8 6.3 2.7 3.5 4.7 5.9 9.1 2.2 10.8 11.9 3.0 4.5 6.4 15.8 9.0 5.8 9.0 4.9 7.3 0.2 1.8 1.7 1.6 1.1 1.0 1.2 1.3 1.5 2.4 1.5 1.3 0.9 3.6 8.2 2.1 1.4 0.6 1.5 5.7 10.8 7.2 7.1 8.0 3.4 7.8 4.3 7.0 7.6 6.0 25.8 3.7 4.3 4.8 13.8 3.1 7.6 21.4 9.1 15.7 39.3 2.6 3.3 6.5 3.9 5.3 8.8 0.0 7.4 2.5 4.8 4.7 8.1 9.0 5.7 28.6 5.8 6.2 5.9 5.1 4.9 8.5 5.0 6.4 8.0 12.9 7.5 5.7 3.5 3.6 28.3 0.0 4.7 22.1 8.3 5.4 3.1 5.9 5.5 3.1 VEZF1 "DB1, ZNF161" ENSG00000136451 "Vascular endothelial zinc finger 1" Q14119 17 57971547-57988259 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027520, HPA048315" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027520: AB_10602680, HPA048315: AB_2680353" "unprognostic (7.24e-2)" "unprognostic (3.18e-1)" "prognostic favorable (6.14e-5)" "unprognostic (2.12e-2)" "unprognostic (3.85e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (6.46e-4)" "unprognostic (2.71e-2)" "unprognostic (1.65e-1)" "unprognostic (4.72e-2)" "unprognostic (4.97e-2)" "unprognostic (5.15e-2)" "unprognostic (3.28e-3)" "unprognostic (1.45e-1)" "unprognostic (7.67e-2)" "unprognostic (8.67e-2)" "unprognostic (3.03e-2)" 18.3 26.6 21.2 18.6 29.2 38.6 27.9 24.0 24.2 27.4 31.2 32.4 21.4 15.9 34.0 16.9 21.1 32.4 20.3 24.1 23.6 14.5 23.8 13.4 23.6 21.2 32.2 16.4 28.7 22.6 19.8 26.1 21.2 24.6 26.2 19.2 22.6 23.5 26.1 51.7 13.5 21.2 29.7 21.6 20.6 22.4 16.5 37.2 39.8 31.3 19.6 15.6 29.7 36.4 13.9 17.5 26.2 26.0 25.3 18.2 11.9 19.3 22.0 42.3 14.7 10.9 15.5 14.7 16.1 23.4 20.3 18.5 10.5 20.6 10.0 27.5 17.9 18.8 11.2 16.9 18.4 27.7 28.0 13.2 18.5 17.4 12.4 13.8 16.2 16.6 11.0 23.1 13.1 25.0 28.5 19.6 13.7 13.8 14.0 20.6 7.4 26.2 8.8 14.5 17.3 25.8 20.1 33.1 7.7 12.5 18.5 17.6 33.1 15.7 7.2 23.6 18.5 41.2 16.7 19.2 28.8 29.3 17.8 26.1 14.6 11.5 15.4 20.0 14.4 36.6 21.6 13.8 26.2 17.0 17.1 17.5 12.0 14.0 18.2 16.5 13.9 17.8 15.8 24.1 25.3 26.0 17.5 13.1 11.9 21.2 29.2 24.0 24.2 23.6 14.5 32.2 16.4 24.6 37.2 77.4 48.7 19.9 33.3 32.2 65.0 85.3 40.8 66.9 51.2 24.4 62.8 14.1 21.6 30.9 18.8 40.5 18.7 0.0 31.8 14.2 34.8 46.0 54.4 17.8 19.0 31.8 47.0 34.4 37.2 28.5 33.4 41.5 40.5 19.8 30.2 41.2 25.1 21.0 26.2 23.7 61.8 51.8 39.1 37.7 21.3 18.3 16.6 23.0 23.5 32.0 VGLL1 "TDU, TONDU" ENSG00000102243 "Vestigial like family member 1" Q99990 X 136532152-136556807 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 124.6" "Group enriched" "Detected in some" 11 "Cytotrophoblasts: 1053.7;Extravillous trophoblasts: 494.4;Syncytiotrophoblasts: 1495.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 47.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 25.3;BEWO: 39.0;CAPAN-2: 14.2;RT4: 67.0;SK-BR-3: 65.8" "Low region specificity" "Detected in all" "HPA042403, HPA064616" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA042403: AB_2677980, HPA064616: AB_2685300" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (4.54e-4)" "unprognostic (5.16e-2)" "unprognostic (1.80e-1)" "unprognostic (4.28e-1)" "unprognostic (6.14e-3)" "unprognostic (1.92e-3)" "unprognostic (1.37e-2)" "unprognostic (5.53e-2)" "unprognostic (3.05e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 2.6 0.1 0.1 0.5 0.1 0.1 0.2 0.0 0.1 0.7 1.4 0.4 0.3 0.1 0.1 0.0 3.7 0.1 0.9 0.1 0.1 0.1 0.2 0.6 0.0 1.3 124.6 0.1 2.8 0.0 0.1 5.0 2.3 0.1 0.1 0.1 0.6 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.7 19.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 3.8 14.2 0.0 0.0 0.0 0.0 1.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 67.0 0.0 0.0 0.0 65.8 0.0 2.8 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 20.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.0 4.5 34.9 0.0 1053.7 0.0 1.3 0.0 0.0 0.0 0.0 0.2 494.4 0.0 2.2 1.1 0.0 93.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1495.8 0.0 0.0 9.8 VPS33A ENSG00000139719 "VPS33A, CORVET/HOPS core subunit" Q96AX1 12 122229564-122266521 "Disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease mutation, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038701 Approved Nucleoplasm NA NA Nucleoplasm "HPA038701: AB_10673473" "unprognostic (3.98e-2)" "unprognostic (2.90e-2)" "unprognostic (4.07e-2)" "unprognostic (4.61e-3)" "unprognostic (2.00e-1)" "unprognostic (2.14e-1)" "prognostic unfavorable (9.11e-5)" "unprognostic (2.17e-1)" "unprognostic (1.47e-1)" "unprognostic (2.40e-1)" "unprognostic (3.44e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.29e-4)" "unprognostic (4.63e-2)" "unprognostic (7.65e-2)" "prognostic favorable (2.41e-4)" "unprognostic (1.09e-2)" 10.4 15.2 13.4 13.6 17.3 12.6 12.7 17.3 19.9 9.6 13.7 14.2 10.5 11.7 11.7 16.8 10.5 12.8 10.4 9.5 13.6 14.4 12.6 12.5 10.8 14.9 13.7 16.8 12.9 11.4 14.7 19.3 17.3 16.8 10.8 11.7 13.0 11.5 14.5 17.1 14.3 11.8 13.6 13.4 16.6 11.2 16.3 9.9 16.1 10.4 9.1 15.8 11.3 11.6 11.6 11.7 21.3 13.7 13.1 17.4 9.6 7.9 10.6 10.9 4.3 8.4 6.5 12.6 7.3 8.0 12.8 8.1 17.3 4.0 8.9 6.2 4.9 9.0 6.8 19.5 7.7 11.1 11.9 10.5 9.1 7.3 15.0 10.8 12.3 9.9 7.2 6.5 9.0 7.3 10.6 8.3 9.8 20.4 4.6 8.3 9.0 5.9 12.7 15.7 6.5 11.4 10.4 10.0 10.5 5.4 8.4 7.9 12.1 15.3 4.6 14.1 11.7 19.7 8.3 5.4 5.8 9.2 10.9 6.7 14.4 31.1 13.9 9.2 8.0 7.9 21.3 11.2 17.9 11.8 12.2 10.6 11.6 13.4 12.5 11.7 9.2 9.6 11.1 9.5 13.1 13.7 7.4 17.4 9.6 13.4 17.3 17.3 19.9 13.6 14.4 13.7 16.8 16.8 9.9 8.9 3.8 8.5 4.0 2.9 15.7 5.9 5.1 13.4 3.4 7.0 9.8 18.5 3.3 12.0 15.9 4.5 7.0 0.0 10.9 17.9 3.5 2.2 13.9 7.7 18.2 3.2 17.2 8.6 8.1 9.7 7.5 11.0 3.3 22.6 6.9 12.1 12.1 7.4 10.6 9.5 15.1 19.4 5.2 34.2 29.0 2.6 18.1 12.9 7.3 1.7 VRTN "C14orf115, FLJ10811, vertnin" ENSG00000133980 "Vertebrae development associated" Q9H8Y1 14 74303069-74360008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.9;lymphoid tissue: 4.5;testis: 5.8" "Cell type enhanced" "Detected in single" 25 "Spermatocytes: 1.9" "Cancer enriched" "Detected in single" 40 "testis cancer: 15.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NTERA-2: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA001460 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA001460: AB_1078318" "unprognostic (1.20e-1)" "unprognostic (4.31e-2)" "unprognostic (1.37e-1)" "unprognostic (5.98e-2)" "unprognostic (1.35e-1)" "unprognostic (3.78e-2)" "unprognostic (1.66e-1)" "unprognostic (1.77e-1)" 0.1 0.1 0.1 2.2 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.6 0.0 4.9 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 4.5 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.1 0.2 0.2 5.8 0.0 0.0 0.1 0.0 1.9 0.1 0.1 0.8 1.2 1.4 0.5 0.8 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.5 0.3 0.3 0.2 0.3 0.2 0.5 0.2 0.8 0.3 0.4 1.4 0.8 0.5 1.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 VSIG10L ENSG00000186806 "V-set and immunoglobulin domain containing 10 like" Q86VR7 19 51331536-51342124 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 70.9;lymphoid tissue: 52.2;salivary gland: 72.9;tongue: 37.6" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 9.5;Melanocytes: 5.0;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 5.9;OE19: 13.7;T-47d: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA060453, HPA066745" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA060453: AB_2684280, HPA066745: AB_2685712" "unprognostic (1.70e-2)" "unprognostic (1.95e-2)" "unprognostic (1.30e-2)" "unprognostic (2.98e-3)" "unprognostic (1.08e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (8.75e-4)" "unprognostic (2.40e-3)" "unprognostic (2.78e-1)" "unprognostic (9.87e-2)" "unprognostic (2.62e-2)" "unprognostic (1.87e-1)" "unprognostic (2.90e-4)" "unprognostic (1.42e-2)" "unprognostic (8.51e-2)" "unprognostic (7.74e-2)" "unprognostic (5.19e-3)" 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.1 9.8 0.1 0.0 2.0 0.1 0.6 0.0 70.9 0.0 0.9 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 1.2 0.1 0.0 72.9 2.6 0.2 4.9 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 37.6 52.2 0.1 10.8 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.1 1.2 0.1 0.5 0.5 0.1 0.2 0.1 0.1 0.0 0.1 0.4 0.9 0.7 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.7 0.1 0.2 5.9 0.0 0.0 1.0 0.0 0.7 0.2 0.0 0.0 0.0 0.3 0.5 1.7 0.0 0.5 0.0 0.1 0.8 13.7 0.6 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.2 10.8 0.0 0.1 0.0 0.2 0.9 0.0 1.4 0.9 0.1 0.7 0.2 0.3 0.0 0.6 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 1.1 0.6 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.1 0.4 0.7 0.0 0.0 0.7 1.4 0.9 1.1 1.0 4.0 9.5 1.2 1.3 3.2 0.0 2.0 1.8 5.0 1.8 0.6 1.2 0.4 0.2 3.9 0.8 0.4 6.5 1.0 0.5 2.2 0.4 0.5 0.0 0.4 0.3 VSIG2 "CTH, CTXL" ENSG00000019102 "V-set and immunoglobulin domain containing 2" Q96IQ7 11 124747472-124752238 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 38.2;stomach 1: 105.5" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 296.5;Mucus-secreting cells: 283.0;Paneth cells: 482.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "OE19: 98.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035919, HPA050147" Enhanced Approved Nucleoplasm NA NA 81000 Nucleoplasm "HPA035919: AB_10669981, HPA050147: AB_2681032" "unprognostic (1.64e-3)" "unprognostic (1.21e-1)" "unprognostic (1.10e-2)" "unprognostic (1.90e-1)" "unprognostic (2.00e-1)" "unprognostic (2.18e-3)" "unprognostic (2.16e-1)" "unprognostic (2.22e-2)" "unprognostic (3.47e-3)" "unprognostic (2.02e-1)" "unprognostic (6.01e-2)" "unprognostic (2.78e-2)" "unprognostic (2.99e-2)" "unprognostic (2.61e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.36e-2)" 1.3 0.1 0.3 11.2 0.4 0.2 3.3 0.3 0.5 5.2 23.5 0.7 0.3 0.7 1.0 0.8 8.6 2.9 38.2 0.6 0.3 0.2 1.6 0.7 25.3 0.3 0.3 0.3 2.2 0.4 0.0 0.3 0.7 0.5 18.5 24.3 0.4 12.4 0.8 0.3 0.3 2.0 3.5 0.3 0.3 105.5 1.2 0.3 0.3 28.9 3.1 5.3 26.0 14.7 0.3 1.4 0.6 3.8 0.8 2.1 2.7 0.0 0.0 1.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 1.7 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 98.4 0.8 0.0 0.8 0.0 0.0 16.0 0.0 0.2 0.0 1.0 0.0 0.1 0.1 0.5 0.9 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.0 3.8 0.0 0.0 0.6 1.6 0.0 1.8 0.3 1.4 0.3 2.0 1.6 0.6 0.8 0.5 0.0 2.1 2.7 0.3 0.4 0.3 0.5 0.3 0.2 0.3 0.3 0.5 0.3 116.1 39.3 0.0 14.5 0.7 0.6 0.4 76.5 17.4 43.3 3.5 0.0 0.0 1.7 4.7 0.0 4.5 296.5 0.0 82.7 0.0 0.5 69.3 1.1 0.0 0.1 0.0 64.2 4.3 0.3 0.0 1.4 2.3 3.3 0.0 283.0 0.0 152.0 482.9 0.0 0.0 0.0 0.0 4.4 0.3 0.4 0.4 0.0 0.0 145.8 135.8 VSIR "B7-H5, B7H5, C10orf54, GI24, PD-1H, SISP1, VISTA" ENSG00000107738 "V-set immunoregulatory receptor" Q9H7M9 10 71747559-71773498 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 111.3" "Cell type enhanced" "Detected in many" 19 "Cytotrophoblasts: 279.2;Extravillous trophoblasts: 255.7;monocytes: 118.2;Syncytiotrophoblasts: 566.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 111.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.5;HaCaT: 20.2;HMC-1: 33.8;U-937: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007968 Approved Nucleoplasm NA NA 360000 Nucleoplasm "HPA007968: AB_1845518" "unprognostic (1.19e-1)" "unprognostic (1.76e-3)" "unprognostic (1.64e-1)" "unprognostic (6.67e-2)" "unprognostic (9.29e-2)" "unprognostic (2.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (1.02e-2)" "unprognostic (6.82e-2)" "unprognostic (8.70e-2)" "unprognostic (2.57e-3)" "unprognostic (2.72e-1)" "prognostic unfavorable (6.93e-4)" "unprognostic (2.37e-3)" "unprognostic (3.29e-1)" 20.8 5.7 13.3 23.4 14.8 55.3 30.4 3.4 10.2 10.7 12.9 10.5 5.4 16.6 14.7 8.8 13.7 15.0 10.8 13.6 13.0 9.8 5.8 4.1 20.1 60.0 12.4 7.2 17.5 4.4 2.4 3.8 48.2 11.8 11.0 7.1 8.1 8.6 8.7 4.7 9.1 16.3 12.7 11.1 55.1 10.2 6.4 11.8 4.6 7.7 10.1 17.6 14.1 24.8 1.9 24.4 111.3 44.9 5.8 11.7 40.1 3.3 6.5 0.0 0.1 3.5 2.9 3.1 1.2 7.9 1.5 2.6 2.6 26.5 0.2 1.7 11.2 0.0 20.2 0.0 0.7 0.4 0.1 0.0 4.4 1.4 0.2 4.9 0.7 33.8 2.4 0.8 0.2 0.1 2.3 0.5 0.6 0.1 2.5 0.9 0.1 0.7 5.5 0.0 5.0 1.3 0.0 0.3 1.5 0.0 1.5 0.0 0.1 1.7 1.3 1.2 0.4 0.1 9.5 1.7 0.0 0.0 5.4 0.0 1.8 0.9 0.0 0.1 29.5 0.1 22.0 42.3 81.0 8.9 40.5 11.7 1.8 8.9 8.4 24.4 1.9 8.3 8.3 111.3 5.8 44.9 6.4 8.8 40.1 13.3 14.8 3.4 10.2 13.0 9.8 12.4 7.2 11.8 11.8 26.8 11.6 0.0 0.0 0.0 0.0 0.0 0.0 6.7 11.4 10.4 0.0 279.2 0.0 37.3 0.0 0.0 0.0 0.0 9.6 255.7 0.0 0.0 29.1 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 118.2 0.0 0.0 36.4 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 566.7 0.0 0.0 0.0 WAC "BM-016, FLJ31290, MGC10753, PRO1741, Wwp4" ENSG00000095787 "WW domain containing adaptor with coiled-coil" Q9BTA9 10 28532493-28623112 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036528, HPA042609, HPA074604" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036528: AB_10670839, HPA042609: AB_2678076, HPA074604: " "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.80e-1)" "unprognostic (4.53e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (9.27e-6)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" "unprognostic (3.60e-1)" "unprognostic (2.07e-1)" "unprognostic (2.90e-1)" "unprognostic (1.82e-2)" "unprognostic (1.23e-1)" "unprognostic (3.13e-2)" "unprognostic (6.63e-2)" "unprognostic (1.36e-1)" 30.6 25.2 36.5 29.8 40.9 59.3 30.4 83.3 46.0 30.4 36.5 27.8 26.9 24.9 33.3 30.6 29.0 28.3 25.9 40.8 37.4 31.6 32.2 28.7 29.4 32.9 36.4 35.5 39.6 33.8 41.8 44.2 34.8 35.4 32.3 28.8 21.2 27.0 31.7 31.8 28.9 27.5 36.4 38.1 33.5 27.3 28.1 41.0 30.1 36.5 18.3 36.6 40.3 78.9 15.0 14.9 19.9 20.6 23.0 17.6 9.7 31.3 20.1 41.3 25.2 34.1 32.9 29.1 30.5 24.2 35.8 41.1 28.5 35.1 41.8 22.1 28.1 28.2 30.6 33.5 23.0 39.6 42.9 27.7 44.3 22.5 22.3 39.8 21.5 34.8 28.3 44.3 39.2 34.7 35.4 31.5 33.7 39.0 39.0 29.8 24.2 47.7 18.9 23.9 24.4 10.4 34.6 57.0 28.0 25.6 18.3 41.5 31.2 25.3 33.6 45.9 34.6 25.5 34.5 26.1 22.8 28.3 24.6 26.9 21.1 18.7 45.4 24.1 41.0 20.0 14.6 12.1 12.4 14.6 20.6 17.6 15.0 13.2 16.8 14.9 13.6 15.0 13.6 19.9 23.0 15.9 11.3 14.2 9.7 36.5 40.9 83.3 46.0 37.4 31.6 36.4 35.5 35.4 41.0 86.4 62.7 75.1 84.6 156.4 108.3 98.2 58.6 34.8 55.7 38.4 90.3 50.1 26.6 39.8 80.4 72.4 67.2 0.0 40.9 51.4 74.3 94.2 54.3 51.3 46.5 101.7 66.7 68.2 99.9 76.5 76.8 83.5 72.6 38.7 70.0 65.8 47.1 63.3 77.8 50.0 84.7 58.2 80.8 79.1 54.1 160.8 82.8 82.8 62.6 118.0 WASHC4 "KIAA1033, SWIP" ENSG00000136051 "WASH complex subunit 4" Q2M389 12 105107324-105169134 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 41.8;Hofbauer cells: 44.7;monocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045666, HPA046737" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045666: AB_2679411, HPA046737: AB_2679778" "unprognostic (2.68e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (4.85e-2)" "unprognostic (2.76e-1)" "unprognostic (1.10e-1)" "unprognostic (4.41e-1)" "unprognostic (9.79e-3)" "unprognostic (1.32e-2)" "unprognostic (3.14e-2)" "unprognostic (1.24e-2)" "unprognostic (1.81e-1)" "unprognostic (1.49e-2)" "unprognostic (2.96e-1)" "unprognostic (4.61e-2)" "unprognostic (1.87e-1)" "unprognostic (1.03e-1)" "unprognostic (3.86e-2)" 26.2 22.1 14.4 22.8 18.1 16.0 20.2 14.8 16.8 20.8 16.2 16.4 21.1 11.5 22.3 18.0 15.9 15.3 18.2 13.3 14.3 11.9 25.6 28.5 19.4 31.5 18.7 11.9 21.7 19.6 20.7 30.1 23.8 24.0 18.5 14.8 14.6 17.5 18.0 18.0 24.3 21.9 18.2 22.1 36.5 14.3 9.9 17.4 21.3 17.9 12.2 29.8 16.7 18.9 11.4 7.9 11.0 20.9 5.3 3.6 4.3 10.0 12.2 10.9 7.9 25.6 25.5 13.0 15.6 18.1 18.4 17.0 8.6 5.8 22.7 8.7 26.2 11.8 9.4 9.2 9.6 14.8 8.2 7.0 4.6 11.3 7.1 17.2 12.9 9.0 20.4 11.3 16.6 13.4 19.7 29.7 8.1 9.2 8.1 19.9 5.1 7.2 13.4 13.1 7.1 10.2 13.7 14.8 7.1 24.4 11.8 7.0 8.8 16.2 11.5 16.0 14.4 8.5 13.9 36.1 22.3 6.1 14.1 10.2 10.6 10.0 18.4 15.7 11.4 22.3 9.9 10.2 5.9 2.1 12.4 3.1 11.4 3.4 2.8 7.9 9.0 3.6 3.4 11.0 5.3 20.9 4.0 2.3 4.3 14.4 18.1 14.8 16.8 14.3 11.9 18.7 11.9 24.0 17.4 32.8 18.7 0.0 0.0 0.0 0.0 0.0 0.0 32.1 21.6 41.8 0.0 19.1 16.6 22.0 0.0 0.0 0.0 0.0 19.0 23.9 0.0 0.0 24.4 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 46.9 0.0 0.0 22.7 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 WASHC5 "KIAA0196, SPG8" ENSG00000164961 "WASH complex subunit 5" Q12768 8 125024260-125091840 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 17.5;Exocrine glandular cells: 14.9;Hofbauer cells: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034216, CAB034219, HPA064649, HPA070916" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: AB_2685312, HPA070916: AB_2686322" "unprognostic (1.98e-3)" "unprognostic (3.75e-2)" "unprognostic (8.40e-2)" "unprognostic (3.89e-3)" "unprognostic (2.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.74e-5)" "unprognostic (2.54e-2)" "unprognostic (3.54e-1)" "unprognostic (5.69e-2)" "unprognostic (9.10e-3)" "unprognostic (1.53e-1)" "unprognostic (9.39e-3)" "unprognostic (5.95e-2)" "unprognostic (2.17e-1)" "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" 21.7 28.1 16.7 17.3 25.1 18.5 20.1 17.1 23.7 18.7 18.2 38.0 13.0 17.9 22.2 16.5 19.6 15.8 18.0 17.1 16.9 15.2 23.2 18.2 16.8 23.0 22.8 16.4 16.5 17.1 25.9 26.4 22.0 28.7 18.3 20.7 17.9 22.6 17.3 23.1 18.6 16.8 20.7 24.5 19.6 18.3 9.3 22.5 25.0 23.9 17.8 20.6 20.4 16.0 8.4 16.0 9.7 21.5 13.5 13.5 9.6 15.7 18.6 10.2 12.5 23.3 25.0 6.7 16.9 26.1 18.0 19.2 6.9 17.1 14.1 12.1 22.1 10.5 12.4 16.6 15.5 23.7 18.6 9.3 19.0 11.5 9.0 22.7 5.8 19.3 24.8 10.3 14.8 13.0 13.8 20.6 12.5 10.9 14.6 21.8 34.4 17.2 4.6 9.7 26.5 18.9 11.7 9.2 14.4 13.7 19.8 5.4 10.8 19.8 44.8 15.7 11.1 19.3 10.1 17.9 9.8 21.8 16.2 15.0 13.1 12.0 12.7 26.0 11.0 13.6 7.7 13.7 9.7 11.8 16.8 12.5 8.4 11.3 11.9 16.0 8.1 9.1 12.5 4.8 13.5 21.5 5.8 13.5 9.6 16.7 25.1 17.1 23.7 16.9 15.2 22.8 16.4 28.7 22.5 3.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 8.1 9.1 10.4 0.0 11.0 5.0 10.4 0.0 0.0 0.0 0.0 14.9 8.8 0.0 0.0 8.1 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 10.0 0.0 0.0 12.8 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 WBP11 "NPWBP, PPP1R165, SIPP1" ENSG00000084463 "WW domain binding protein 11" Q9Y2W2 12 14784579-14803540 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039710, HPA040037, HPA046403, HPA049126" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039710: AB_2676638, HPA040037: AB_10796115, HPA046403: AB_2679654, HPA049126: AB_2680644" "unprognostic (4.40e-2)" "unprognostic (1.58e-1)" "unprognostic (4.16e-2)" "unprognostic (1.39e-2)" "unprognostic (1.55e-1)" "unprognostic (4.15e-2)" "prognostic unfavorable (9.40e-4)" "unprognostic (5.67e-3)" "unprognostic (3.30e-2)" "unprognostic (2.68e-1)" "unprognostic (9.69e-2)" "unprognostic (1.68e-1)" "unprognostic (2.96e-3)" "unprognostic (6.11e-2)" "unprognostic (3.07e-1)" "unprognostic (1.94e-1)" "unprognostic (4.09e-2)" 27.0 30.8 32.7 22.8 40.7 59.5 25.9 25.6 34.2 21.4 21.9 28.8 10.7 17.5 27.5 20.5 23.4 27.3 19.3 32.9 28.1 25.3 23.5 25.1 25.4 27.3 24.0 29.7 29.4 23.1 29.7 21.8 28.2 29.3 25.1 24.9 23.0 23.2 21.6 46.7 28.7 23.1 24.6 29.1 31.1 23.6 39.2 25.8 25.7 26.5 20.4 30.6 26.4 20.9 15.4 11.4 10.5 16.7 15.9 19.8 11.3 16.2 14.6 17.3 32.9 11.6 11.1 31.2 13.4 11.3 20.5 20.7 26.4 20.2 20.3 8.7 12.1 17.6 13.5 26.6 17.7 25.3 35.9 17.8 29.6 16.1 16.0 11.6 27.6 16.3 10.8 14.1 22.9 17.2 11.2 16.3 19.3 18.8 10.8 16.2 15.7 25.7 14.8 55.6 11.3 9.3 22.0 27.4 12.7 14.7 22.4 9.2 18.8 17.9 15.0 14.1 43.1 8.0 18.3 12.0 14.3 22.0 12.6 22.9 9.5 13.2 37.4 15.0 13.8 19.0 9.5 12.1 10.5 17.2 16.7 18.9 15.4 16.6 17.3 11.4 13.8 19.8 17.9 7.4 15.9 16.5 8.2 17.2 11.3 32.7 40.7 25.6 34.2 28.1 25.3 24.0 29.7 29.3 25.8 53.6 55.4 61.2 69.4 48.8 41.1 94.8 61.1 100.4 67.1 34.9 45.2 49.7 36.5 51.5 59.9 46.9 28.6 70.0 51.9 78.0 44.6 45.4 101.8 36.5 41.5 41.3 37.9 44.2 29.8 44.4 42.0 44.2 33.7 132.6 33.1 45.0 42.9 17.5 30.8 39.1 49.6 58.2 50.2 136.2 151.1 48.7 63.5 59.6 38.4 55.9 WDHD1 "AND-1, CHTF4, CTF4" ENSG00000198554 "WD repeat and HMG-box DNA binding protein 1" O75717 14 54938950-55027105 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.1" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 10.6;Spermatogonia: 20.5" "Cancer enhanced" "Detected in all" "testis cancer: 23.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000632, HPA001122" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000632: , HPA001122: AB_1080589" "unprognostic (1.88e-1)" "unprognostic (1.21e-1)" "unprognostic (1.98e-2)" "unprognostic (2.25e-3)" "unprognostic (1.20e-1)" "unprognostic (6.85e-3)" "unprognostic (2.33e-4)" "unprognostic (5.52e-3)" "unprognostic (7.28e-3)" "unprognostic (8.05e-3)" "prognostic unfavorable (9.24e-4)" "unprognostic (5.11e-2)" "unprognostic (2.67e-4)" "unprognostic (8.31e-3)" "unprognostic (1.50e-1)" "unprognostic (3.49e-2)" "unprognostic (2.36e-2)" 5.0 2.8 6.3 6.6 7.5 10.8 3.8 7.2 4.6 3.7 4.9 2.7 0.6 3.2 4.2 2.9 7.0 4.0 2.3 2.3 3.2 2.3 2.8 2.1 2.9 8.9 3.3 2.5 4.1 2.0 3.0 1.9 6.0 4.4 2.1 7.3 2.6 3.0 2.2 2.0 4.5 3.6 4.6 2.8 4.6 2.8 8.8 3.5 21.1 2.1 6.4 11.2 3.6 4.3 4.8 1.8 4.3 0.9 4.3 4.6 1.6 16.0 10.4 20.6 9.0 2.0 4.9 12.0 15.6 6.7 12.6 15.5 6.9 10.8 18.4 8.0 4.4 9.1 13.7 30.6 9.0 26.6 12.3 5.3 12.1 10.1 6.6 0.8 22.8 9.3 2.5 1.6 15.6 6.1 3.0 8.2 12.0 15.1 9.3 12.1 8.9 21.4 4.5 16.3 8.6 10.8 20.1 29.6 7.1 3.6 10.8 12.0 8.4 16.6 4.2 5.4 15.7 11.3 4.6 5.3 16.1 19.1 11.7 13.2 2.8 5.7 24.6 7.3 11.3 12.6 4.3 0.8 1.4 2.3 0.6 3.2 3.0 2.7 3.3 1.4 4.8 3.3 4.6 1.2 4.3 0.9 1.8 3.9 1.6 6.3 7.5 7.2 4.6 3.2 2.3 3.3 2.5 4.4 3.5 0.0 1.3 2.9 1.5 3.4 2.1 1.5 0.0 4.0 5.7 3.5 0.0 5.8 0.0 1.8 0.5 1.0 0.5 0.0 0.9 8.0 3.1 0.5 0.0 0.8 3.4 3.2 0.0 1.3 1.6 0.8 0.0 2.0 1.7 1.8 2.5 1.5 1.0 0.0 2.8 1.9 3.3 0.0 3.3 10.6 20.5 2.0 2.2 0.0 3.1 0.9 WDR18 Ipi3 ENSG00000065268 "WD repeat domain 18" Q9BV38 19 984271-998438 "Plasma proteins, Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050193, HPA050200" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050193: AB_2681047, HPA050200: AB_2681049" "unprognostic (7.94e-2)" "unprognostic (3.08e-1)" "unprognostic (2.51e-1)" "unprognostic (2.13e-3)" "unprognostic (8.58e-2)" "unprognostic (2.03e-1)" "unprognostic (7.14e-2)" "unprognostic (4.88e-2)" "unprognostic (6.69e-2)" "unprognostic (2.70e-1)" "unprognostic (6.74e-3)" "unprognostic (1.43e-2)" "unprognostic (2.86e-2)" "unprognostic (1.60e-2)" "unprognostic (2.50e-1)" "unprognostic (3.07e-1)" "unprognostic (2.35e-1)" 13.1 16.5 13.4 16.7 14.5 14.0 11.1 24.0 20.5 10.9 14.3 14.4 12.2 16.9 11.4 17.4 18.8 11.5 11.7 14.9 12.0 11.6 17.9 23.4 11.0 18.7 12.4 8.2 16.1 32.2 10.5 14.6 15.1 10.3 14.4 6.8 14.3 19.5 15.1 28.7 16.9 15.5 10.6 9.8 14.0 17.0 15.2 9.2 22.7 13.1 20.9 16.8 11.0 10.8 22.9 40.7 6.2 28.1 18.4 21.3 22.3 18.9 18.6 5.9 9.9 5.7 5.2 23.0 8.5 5.1 10.9 8.2 20.7 6.7 22.4 10.1 13.0 1.2 15.6 16.1 18.6 4.3 11.7 24.9 10.8 11.2 25.6 13.3 23.3 10.3 6.8 9.9 6.5 15.4 5.5 9.8 11.1 23.9 8.9 4.0 20.0 17.3 32.9 33.0 13.7 11.8 32.6 13.4 35.0 6.9 12.1 21.9 20.4 8.1 7.0 8.3 4.3 16.4 14.1 9.5 12.0 14.4 23.5 13.4 28.2 24.0 10.9 10.4 14.6 12.7 4.0 27.4 6.2 19.7 28.1 19.2 19.9 19.9 21.1 40.7 22.9 20.0 18.2 1.2 18.4 22.1 25.5 21.3 22.3 13.4 14.5 24.0 20.5 12.0 11.6 12.4 8.2 10.3 9.2 8.9 15.4 24.7 23.5 17.2 26.2 11.3 10.2 17.4 12.5 29.6 21.6 78.7 59.7 51.0 27.4 16.3 19.1 0.0 47.1 135.7 17.5 21.9 16.1 36.8 40.6 25.4 31.0 23.4 19.8 25.5 14.4 17.7 15.1 63.1 28.4 30.2 40.9 21.0 15.2 108.1 20.6 12.9 18.9 34.1 29.9 17.8 50.2 23.6 44.1 23.7 WDR19 "DYF-2, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp" ENSG00000157796 "WD repeat domain 19" Q8NEZ3 4 39182404-39285810 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 41.1" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 41.5;Spermatocytes: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 25.4;ASC TERT1: 28.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039616, HPA058847" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039616: AB_10796331, HPA058847: AB_2683834" "unprognostic (1.80e-1)" "unprognostic (9.32e-2)" "unprognostic (6.40e-2)" "unprognostic (5.69e-2)" "unprognostic (1.37e-1)" "unprognostic (1.26e-3)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.06e-1)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "prognostic favorable (2.70e-4)" "prognostic unfavorable (8.58e-4)" "unprognostic (3.52e-2)" "unprognostic (2.40e-2)" "unprognostic (5.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.56e-2)" 8.5 7.6 8.1 4.8 12.9 3.4 9.2 21.0 14.5 13.2 7.8 5.7 7.8 1.9 15.5 11.2 5.4 20.9 8.6 5.1 11.7 4.1 8.6 7.0 8.6 4.4 6.0 11.0 19.0 6.6 10.1 41.1 6.3 14.6 8.1 4.3 6.9 7.6 8.2 3.1 6.0 5.7 9.5 9.7 4.3 8.0 12.7 7.3 6.8 17.1 3.8 5.0 9.9 8.9 3.9 1.1 1.5 2.0 2.3 2.4 0.8 3.2 2.3 5.5 6.6 25.4 28.5 2.5 4.3 9.7 4.5 6.0 1.4 3.7 5.3 2.1 4.1 9.7 1.9 5.4 2.8 5.0 0.3 3.9 1.0 4.4 2.7 7.9 5.2 1.4 17.3 6.1 6.0 3.8 12.5 5.4 5.4 4.7 5.3 5.4 1.1 3.5 3.6 1.8 1.9 2.6 4.3 5.6 2.4 3.7 1.3 6.1 5.6 4.2 1.4 2.8 6.9 2.8 1.9 3.9 4.4 3.0 9.7 4.2 3.9 3.6 3.7 6.6 1.5 2.0 0.7 1.2 0.9 1.7 2.0 1.3 3.4 2.1 2.4 1.1 3.9 2.1 2.1 1.5 2.3 1.7 0.7 1.4 0.8 8.1 12.9 21.0 14.5 11.7 4.1 6.0 11.0 14.6 7.3 11.9 5.7 3.2 4.9 4.2 7.6 3.8 2.5 41.5 12.5 17.4 9.8 1.0 0.0 4.5 3.0 4.5 0.0 0.0 3.1 2.0 5.6 3.1 2.3 10.6 2.7 23.8 2.4 4.3 1.9 2.6 15.3 2.9 1.7 1.0 2.2 7.3 2.9 0.0 17.7 3.4 22.5 0.0 3.8 30.3 10.2 4.1 1.1 1.0 1.0 1.8 WDR25 "C14orf67, MGC4645" ENSG00000176473 "WD repeat domain 25" Q64LD2 14 100376418-100530303 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003113 Uncertain Approved Nucleoplasm "Secreted to blood" NA NA Nucleoplasm "HPA003113: AB_2215263" "unprognostic (5.31e-2)" "unprognostic (5.76e-3)" "unprognostic (2.28e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (7.36e-4)" "unprognostic (1.79e-2)" "unprognostic (6.62e-2)" "unprognostic (3.94e-3)" "unprognostic (2.44e-2)" "unprognostic (1.37e-2)" "prognostic favorable (3.89e-5)" "unprognostic (1.01e-2)" "unprognostic (1.73e-1)" "unprognostic (7.30e-2)" "unprognostic (7.51e-2)" 6.9 10.9 10.8 5.0 13.5 7.9 9.5 14.4 14.8 15.2 8.3 11.2 5.4 6.8 11.1 9.4 7.6 14.0 7.2 7.6 10.8 9.4 7.6 9.0 7.5 6.8 8.6 13.3 11.0 16.2 7.7 13.4 7.2 9.4 9.2 5.7 10.9 11.9 9.7 11.4 6.1 5.8 7.3 7.5 6.8 8.4 15.0 11.3 6.4 17.3 4.4 6.6 7.4 6.6 9.9 11.9 19.5 13.9 4.2 10.8 10.0 3.3 5.9 4.1 15.2 6.7 6.3 3.4 6.2 9.9 7.2 7.3 2.7 6.3 4.8 7.8 5.1 2.0 6.0 3.9 7.6 3.8 4.7 2.8 3.2 6.7 4.6 12.3 3.7 3.7 9.4 9.0 5.2 7.9 6.3 5.2 5.8 3.9 7.1 4.7 12.7 5.5 4.2 3.2 4.0 10.5 4.0 5.8 3.3 5.5 2.7 9.7 10.2 5.0 1.9 8.3 4.1 7.0 1.3 8.8 2.7 3.2 10.6 3.5 4.8 2.4 2.4 9.6 2.8 5.2 19.5 13.9 19.5 7.5 11.8 7.8 9.9 10.0 8.0 11.9 7.2 10.8 7.9 7.3 4.2 12.4 9.2 9.7 10.0 10.8 13.5 14.4 14.8 10.8 9.4 8.6 13.3 9.4 11.3 0.0 5.4 3.4 3.8 2.9 8.0 2.0 0.0 9.4 3.4 3.5 9.8 7.2 8.3 9.6 8.2 6.7 5.9 0.0 29.6 4.1 6.6 2.6 3.5 7.2 5.9 4.8 5.2 5.5 4.4 4.2 6.4 3.5 5.0 5.4 6.1 12.1 13.6 3.5 10.6 13.5 15.2 12.9 8.0 10.9 15.2 2.6 5.8 5.3 6.8 1.8 WDR27 MGC43690 ENSG00000184465 "WD repeat domain 27" A2RRH5 6 169457212-169702048 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037497, HPA037498" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037497: AB_10671503, HPA037498: AB_2675509" "unprognostic (2.10e-1)" "unprognostic (8.66e-3)" "unprognostic (1.32e-1)" "unprognostic (1.78e-2)" "unprognostic (8.59e-2)" "unprognostic (1.98e-3)" "unprognostic (3.81e-3)" "unprognostic (2.59e-2)" "unprognostic (1.83e-1)" "unprognostic (8.63e-2)" "unprognostic (2.43e-2)" "unprognostic (3.62e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (3.15e-2)" "unprognostic (2.19e-1)" "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" 6.7 8.0 8.6 11.8 9.2 7.0 9.3 10.1 10.9 9.9 7.9 10.3 7.1 8.1 17.2 10.2 8.9 13.4 8.1 5.0 6.1 4.1 7.2 6.3 6.6 8.2 5.9 5.1 18.2 8.5 8.4 9.9 5.9 7.2 9.2 6.3 8.4 11.2 5.9 5.9 7.5 8.6 9.1 4.7 7.8 7.7 21.5 8.6 7.6 12.7 4.2 9.0 10.2 10.8 4.7 2.1 1.5 1.1 0.7 6.0 1.2 4.4 6.3 15.8 8.9 4.7 6.2 7.9 6.1 1.5 2.9 4.5 8.4 6.6 4.5 4.7 1.9 6.3 9.1 5.0 4.3 4.5 6.0 8.9 8.5 11.3 5.4 3.4 4.7 1.3 6.1 3.8 3.9 4.6 7.5 5.8 9.2 19.8 9.3 4.8 6.7 3.0 11.7 7.4 4.8 5.5 7.9 5.5 6.6 3.7 4.0 9.0 10.8 5.0 3.6 3.8 5.6 4.4 8.0 5.6 4.3 5.4 6.3 7.1 8.8 3.5 10.0 5.3 9.3 7.4 0.2 1.1 1.5 1.9 0.7 3.2 2.1 2.0 2.5 1.1 4.7 6.0 1.7 0.5 0.7 0.5 2.1 1.2 1.2 8.6 9.2 10.1 10.9 6.1 4.1 5.9 5.1 7.2 8.6 8.9 3.8 5.6 5.1 1.9 12.7 3.2 7.6 14.7 3.4 12.2 5.9 4.2 0.0 2.2 21.5 5.8 3.3 0.0 1.3 2.3 4.5 3.7 3.5 3.9 1.9 20.6 4.1 11.1 1.3 6.8 7.5 2.5 3.3 1.0 4.2 7.0 1.7 5.1 9.2 1.3 13.8 0.0 2.7 14.9 9.4 1.0 1.6 4.4 6.0 4.7 WDR5 "CFAP89, SWD3" ENSG00000196363 "WD repeat domain 5" P61964 9 134135365-134159968 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047182 Supported Nucleoplasm NA NA Nucleoplasm "HPA047182: AB_2679971" "unprognostic (9.28e-2)" "unprognostic (1.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.73e-1)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" "unprognostic (1.05e-3)" "unprognostic (2.26e-3)" "unprognostic (1.22e-1)" "unprognostic (1.05e-1)" "unprognostic (4.31e-3)" "unprognostic (4.63e-2)" "unprognostic (7.06e-2)" "unprognostic (5.91e-3)" "unprognostic (1.47e-1)" "unprognostic (3.22e-2)" "unprognostic (2.88e-2)" 14.0 14.3 18.5 18.5 18.1 17.2 27.8 23.1 19.4 14.8 14.3 11.5 13.2 17.5 18.5 12.4 21.0 15.6 13.6 12.4 12.3 10.8 11.8 20.8 13.0 16.0 14.4 15.4 19.1 21.4 16.2 17.6 14.7 12.7 13.3 14.3 10.2 16.9 19.6 32.9 20.5 16.9 13.9 10.0 13.7 15.4 41.6 14.2 19.6 14.3 18.5 17.4 15.2 22.9 7.1 11.3 1.8 10.5 5.3 8.5 7.0 15.3 18.9 18.1 20.6 9.9 11.0 28.7 15.6 10.4 21.4 14.7 22.0 12.7 24.6 10.0 12.7 18.8 38.5 24.5 16.0 17.5 16.4 16.7 14.1 29.6 17.7 10.6 31.6 14.9 10.5 15.2 15.9 19.7 8.8 14.1 24.6 26.3 13.8 14.8 41.1 27.0 26.0 23.0 35.1 23.9 29.6 36.8 23.2 10.5 15.1 30.4 15.8 23.5 18.5 10.4 12.6 25.4 27.9 12.2 22.0 20.2 20.1 25.1 7.2 13.8 26.6 12.7 21.6 17.6 1.0 10.5 1.8 8.1 6.6 8.0 5.4 8.1 8.2 11.3 7.1 8.5 6.4 0.9 5.3 5.4 9.4 7.1 7.0 18.5 18.1 23.1 19.4 12.3 10.8 14.4 15.4 12.7 14.2 8.9 7.5 7.5 12.0 10.5 7.9 8.0 12.7 0.0 3.4 5.2 21.6 21.3 8.3 14.6 127.2 6.3 12.9 0.0 17.9 35.3 10.3 12.8 9.2 17.8 16.7 7.9 6.3 6.2 7.0 22.2 10.6 8.9 5.0 7.2 11.4 6.3 14.6 8.6 11.0 8.4 7.1 6.5 10.1 32.9 42.2 14.3 14.9 8.5 18.3 14.1 WDR75 "FLJ12519, NET16, UTP17" ENSG00000115368 "WD repeat domain 75" Q8IWA0 2 189441433-189475565 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038199 Approved Nucleoplasm NA NA Nucleoplasm "HPA038199: AB_10674548" "unprognostic (1.23e-1)" "unprognostic (7.34e-2)" "unprognostic (3.31e-1)" "unprognostic (1.54e-1)" "unprognostic (4.22e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.50e-8)" "unprognostic (1.49e-1)" "unprognostic (2.46e-3)" "unprognostic (1.93e-2)" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.15e-11)" "unprognostic (1.34e-1)" "unprognostic (7.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-2)" 24.8 23.8 15.4 20.7 20.4 17.7 25.5 25.5 25.6 26.8 16.4 16.1 18.4 15.1 25.5 27.3 20.1 21.7 15.6 14.9 16.5 17.0 21.6 18.5 13.7 25.2 20.0 17.5 28.9 22.4 19.0 21.7 17.5 20.7 18.5 19.5 13.9 15.4 14.5 16.7 22.6 17.4 20.9 23.6 24.1 17.6 18.2 24.2 28.9 15.5 25.3 24.0 24.8 19.2 8.1 9.9 3.3 7.8 7.8 13.7 5.6 13.2 12.8 16.2 20.3 17.8 18.9 20.2 28.3 12.5 31.0 24.1 27.0 14.5 29.2 16.0 8.5 12.2 18.9 31.0 18.3 30.5 19.2 14.5 39.0 23.4 19.9 16.8 42.1 19.1 15.6 15.4 22.2 31.2 13.0 20.3 16.2 37.9 16.6 20.5 14.3 19.5 28.1 39.2 15.2 35.3 18.5 26.5 22.8 15.1 16.6 15.9 16.2 18.0 16.2 14.1 27.8 15.0 17.7 19.3 18.3 20.3 14.2 20.5 18.4 29.5 35.7 13.1 19.2 15.5 1.3 5.2 3.3 8.0 7.8 13.7 8.1 8.2 10.5 9.9 6.8 10.8 9.5 0.0 7.8 5.0 5.4 10.4 5.6 15.4 20.4 25.5 25.6 16.5 17.0 20.0 17.5 20.7 24.2 26.8 13.1 8.1 18.3 15.0 6.0 15.4 2.5 10.7 7.9 1.8 7.9 16.5 10.0 12.6 1.4 13.1 5.1 0.0 14.5 13.3 11.8 6.5 4.7 7.8 9.4 15.9 8.6 9.8 30.6 2.1 16.7 8.6 13.5 4.6 10.6 4.4 13.8 8.6 14.9 11.0 8.8 19.4 15.5 28.4 27.9 9.8 14.4 13.1 10.4 14.7 WDR92 "FLJ31741, Monad" ENSG00000243667 "WD repeat domain 92" Q96MX6 2 68122936-68157560 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 48.2;Cone photoreceptor cells: 45.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035335, HPA035336" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035335: AB_10959456, HPA035336: AB_10964348" "unprognostic (3.55e-2)" "unprognostic (3.42e-3)" "unprognostic (6.80e-2)" "unprognostic (1.69e-2)" "unprognostic (1.31e-1)" "unprognostic (3.20e-2)" "unprognostic (3.76e-3)" "unprognostic (2.51e-2)" "unprognostic (1.34e-1)" "unprognostic (2.01e-1)" "unprognostic (4.91e-2)" "unprognostic (3.61e-1)" "unprognostic (3.56e-3)" "unprognostic (9.86e-2)" "unprognostic (7.23e-2)" "unprognostic (4.07e-1)" "unprognostic (3.15e-2)" 9.5 12.4 16.6 12.8 26.5 5.2 12.3 19.8 17.3 9.2 10.0 12.3 6.5 9.2 11.1 23.7 10.5 16.2 7.8 12.7 12.2 10.7 8.7 9.8 8.3 12.9 8.7 7.9 11.3 13.5 15.8 17.1 8.2 15.0 12.2 11.9 10.9 10.8 12.4 15.4 14.9 8.6 16.2 9.5 11.1 9.2 12.8 12.3 10.2 12.9 12.2 12.1 10.1 10.2 8.8 7.9 1.9 4.1 9.0 8.5 4.8 14.4 10.3 11.6 11.9 13.3 13.9 10.4 13.2 9.1 11.3 11.8 8.0 12.3 17.9 4.7 9.0 15.9 14.7 12.0 8.1 14.5 11.8 14.5 17.2 12.7 8.0 6.7 19.1 5.2 8.7 10.5 9.4 8.2 12.2 11.0 14.1 13.0 10.8 12.6 9.1 12.5 16.7 12.2 13.4 12.3 14.9 16.0 13.9 11.3 8.2 12.9 10.9 8.6 15.2 11.4 12.1 11.8 12.0 13.7 18.0 8.1 11.5 11.4 7.6 11.1 11.7 18.8 18.8 9.2 0.7 3.9 1.9 5.7 4.1 7.7 8.8 6.1 6.3 4.6 8.5 8.0 8.5 1.6 9.0 2.7 7.9 5.9 4.8 16.6 26.5 19.8 17.3 12.2 10.7 8.7 7.9 15.0 12.3 3.0 7.5 12.4 4.4 3.1 22.3 3.1 0.0 48.2 13.6 5.2 45.2 11.9 1.7 6.6 4.7 5.8 1.0 23.3 5.7 7.3 5.3 2.5 12.7 5.0 6.2 11.1 0.0 3.7 1.6 2.2 7.2 4.0 1.7 5.4 3.0 10.1 5.1 3.5 8.9 6.3 21.5 6.5 4.1 27.1 14.3 3.6 4.2 4.1 7.3 1.7 WIPF2 "WICH, WIRE" ENSG00000171475 "WAS/WASL interacting protein family member 2" Q8TF74 17 40219304-40284136 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024000, HPA024001, HPA024467" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA024000: AB_1858840, HPA024001: AB_1858841, HPA024467: AB_1858842" "unprognostic (1.90e-1)" "unprognostic (1.02e-1)" "unprognostic (2.59e-1)" "unprognostic (6.07e-2)" "unprognostic (2.63e-2)" "unprognostic (1.83e-1)" "unprognostic (5.18e-3)" "unprognostic (1.92e-1)" "unprognostic (2.05e-1)" "unprognostic (8.51e-3)" "unprognostic (2.05e-2)" "unprognostic (4.34e-2)" "unprognostic (1.32e-3)" "unprognostic (4.12e-1)" "unprognostic (7.51e-2)" "unprognostic (5.28e-2)" "unprognostic (9.23e-2)" 13.0 9.4 21.0 11.5 21.6 18.8 10.7 23.0 27.4 12.8 17.3 15.8 11.1 14.8 13.2 11.7 18.9 11.9 12.4 7.9 22.3 16.8 15.6 9.4 15.4 9.5 16.7 18.5 10.3 13.7 19.3 10.6 14.5 16.1 11.0 17.1 9.4 12.2 13.4 7.6 18.8 16.2 15.0 13.8 14.1 15.8 9.5 17.7 8.3 11.2 8.1 13.3 12.4 20.4 4.3 4.1 11.4 3.2 3.8 5.3 1.5 11.3 17.2 7.5 7.0 7.9 8.3 7.4 10.0 7.0 9.1 9.7 8.4 9.7 6.5 11.3 11.8 11.3 19.2 6.3 7.5 12.4 11.5 7.7 7.0 8.5 10.0 8.0 9.1 8.0 6.6 9.7 9.6 10.8 9.8 8.8 7.0 6.6 6.0 8.7 6.4 9.0 4.6 4.5 8.2 5.4 5.8 9.0 6.4 9.7 17.7 9.2 6.5 17.9 48.6 6.5 13.4 16.5 5.7 12.7 6.2 9.4 11.8 11.2 6.9 10.4 6.8 13.7 4.9 9.2 6.8 3.2 3.5 5.3 2.9 4.6 4.3 3.2 3.4 2.4 3.7 3.7 3.3 11.4 3.8 3.2 4.1 3.8 1.5 21.0 21.6 23.0 27.4 22.3 16.8 16.7 18.5 16.1 17.7 62.5 30.4 19.3 28.3 38.2 34.5 10.4 40.8 17.4 17.0 43.6 43.2 41.5 11.6 25.9 2.1 31.3 67.0 0.0 31.5 23.9 26.2 34.4 38.0 20.9 26.2 39.7 45.4 40.5 36.8 2.5 18.7 21.8 15.1 19.8 27.8 24.3 38.9 54.5 24.4 21.7 17.3 38.8 24.7 17.3 35.4 60.3 56.3 25.4 30.7 64.6 WRNIP1 "bA420G6.2, FLJ22526, WHIP" ENSG00000124535 "Werner helicase interacting protein 1" Q96S55 6 2765414-2786952 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031752, HPA031753" Enhanced Approved Nucleoplasm No No Nucleoplasm "HPA031752: AB_10603004, HPA031753: AB_2674028" "unprognostic (5.52e-2)" "unprognostic (5.95e-2)" "unprognostic (6.83e-3)" "unprognostic (8.35e-3)" "unprognostic (7.66e-2)" "unprognostic (7.10e-2)" "unprognostic (5.63e-3)" "unprognostic (3.40e-2)" "unprognostic (1.39e-2)" "unprognostic (1.73e-2)" "unprognostic (1.81e-1)" "unprognostic (6.29e-2)" "unprognostic (2.28e-1)" "unprognostic (2.37e-1)" "unprognostic (2.61e-2)" "unprognostic (1.85e-1)" "unprognostic (2.29e-1)" 15.4 23.1 29.9 19.8 32.1 31.2 22.4 42.5 33.5 22.2 21.9 23.3 25.7 17.7 19.8 29.7 32.8 28.0 24.7 28.8 30.9 30.1 23.3 25.8 21.2 23.4 27.4 26.2 23.2 37.4 39.2 31.2 32.3 21.3 22.5 22.6 23.9 34.6 22.0 29.0 27.8 19.6 18.5 20.2 20.7 19.3 24.6 24.2 34.1 31.6 36.0 25.3 18.8 29.2 3.4 4.2 9.1 2.8 3.7 6.5 2.3 31.5 15.9 16.2 26.5 17.2 14.9 21.6 14.5 20.4 26.8 26.7 25.1 14.8 28.4 39.7 18.7 29.1 24.6 26.5 29.2 26.2 28.3 29.1 29.7 18.1 39.2 19.6 18.6 20.6 15.1 23.9 24.6 26.8 18.7 33.9 27.0 22.6 10.3 19.5 30.9 27.5 33.8 13.9 21.8 19.8 22.0 23.7 28.8 28.4 19.5 49.0 14.0 17.2 17.5 33.8 26.7 22.5 21.0 18.4 20.1 15.2 17.4 35.1 13.3 23.1 22.1 7.9 20.3 27.2 9.1 2.6 3.4 6.5 2.8 2.1 3.4 4.7 4.8 2.1 2.4 5.5 5.2 1.1 3.7 1.4 4.2 6.5 2.3 29.9 32.1 42.5 33.5 30.9 30.1 27.4 26.2 21.3 24.2 17.9 10.5 3.7 10.8 28.8 23.9 17.3 35.7 21.4 7.9 10.4 7.9 26.5 3.3 12.6 42.1 18.0 18.7 0.0 11.8 20.2 14.8 14.5 9.2 21.9 11.1 7.9 38.2 30.1 13.8 11.0 20.8 12.7 20.3 7.2 24.1 18.0 15.9 11.5 20.8 11.3 16.5 6.5 11.8 21.4 24.7 28.1 21.3 4.5 23.0 13.2 WSCD2 KIAA0789 ENSG00000075035 "WSC domain containing 2" Q2TBF2 12 108129471-108250537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;seminal vesicle: 18.2;thyroid gland: 21.8" "Group enriched" "Detected in some" 10 "Bipolar cells: 35.7;Horizontal cells: 20.6" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.6" "Region enhanced" "Detected in all" "cerebellum: 44.0" "Cell type enhanced" "Detected in single" "T-reg: 2.5" "Lineage enhanced" "Detected in single" "T-cells: 2.5" "Cell line enriched" "Detected in some" 21 "RT4: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013346, HPA048133" Approved Uncertain Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA013346: AB_1858865, HPA048133: AB_2797236" "unprognostic (1.50e-1)" "unprognostic (1.64e-3)" "unprognostic (1.50e-2)" "unprognostic (4.27e-3)" "unprognostic (1.68e-1)" "unprognostic (3.43e-1)" "unprognostic (1.80e-2)" "unprognostic (3.43e-3)" "unprognostic (3.03e-2)" "unprognostic (3.05e-1)" "unprognostic (3.15e-1)" "unprognostic (7.43e-2)" "unprognostic (5.99e-2)" "unprognostic (3.73e-2)" "unprognostic (2.11e-1)" "unprognostic (2.32e-3)" "unprognostic (7.62e-3)" 1.4 1.2 6.5 0.5 12.5 0.4 1.0 44.0 15.2 5.4 1.7 1.6 0.0 0.7 6.9 3.0 3.8 2.0 0.5 0.5 10.0 3.0 1.3 0.4 0.8 0.5 1.3 6.0 0.6 2.1 0.4 0.9 0.6 1.9 6.0 0.7 9.9 0.5 18.2 0.5 0.6 0.9 9.2 1.5 0.5 2.0 0.6 2.0 0.0 21.8 0.2 0.5 3.0 0.9 0.8 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 6.5 12.5 44.0 15.2 10.0 3.0 1.3 6.0 1.9 2.0 0.0 0.0 0.5 0.0 0.1 35.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.6 0.0 1.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 WT1 "AWT1, GUD, NPHS4, WAGR, WIT-2" ENSG00000184937 "Wilms tumor 1" P19544 11 32387775-32435630 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 69.0;fallopian tube: 34.5;ovary: 53.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 19.2;Late spermatids: 5.9;Leydig cells: 7.8;Sertoli cells: 6.5" "Cancer enriched" "Detected in many" 14 "ovarian cancer: 55.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 13.5;HMC-1: 17.4;K-562: 12.2;NB-4: 32.6;THP-1: 15.6" "Region enhanced" "Detected in single" "pons and medulla: 0.5" "Not detected" "Not detected" "CAB000327, HPA035717, HPA053848" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: AB_2682279" "unprognostic (3.09e-3)" "unprognostic (9.97e-4)" "unprognostic (3.32e-1)" "unprognostic (8.24e-3)" "unprognostic (5.20e-2)" "unprognostic (1.98e-3)" "unprognostic (2.94e-2)" "unprognostic (1.59e-2)" "unprognostic (1.23e-2)" "unprognostic (4.15e-2)" "unprognostic (1.86e-2)" "unprognostic (1.36e-1)" "unprognostic (1.31e-10)" "unprognostic (2.65e-3)" "unprognostic (1.87e-1)" "unprognostic (1.96e-3)" "unprognostic (1.30e-2)" 10.3 0.0 0.2 1.8 0.6 0.0 0.2 0.2 0.5 20.3 1.5 0.2 3.7 0.0 69.0 9.3 0.4 34.5 0.8 2.1 0.9 0.0 5.3 0.2 0.8 0.5 0.2 0.2 53.4 0.2 0.0 0.2 6.9 0.3 0.9 0.0 0.2 0.2 4.2 0.2 0.0 0.4 23.7 0.2 14.6 0.0 24.5 0.2 0.2 0.3 0.2 0.2 1.3 4.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 4.7 13.5 0.0 1.2 3.8 9.0 17.4 0.0 0.0 2.8 0.0 0.0 0.0 2.8 12.2 0.1 2.7 0.0 7.9 32.6 0.7 0.0 3.8 1.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.8 15.6 0.1 0.0 2.4 0.0 0.3 0.0 0.0 0.0 0.1 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.6 0.2 0.5 0.9 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 19.2 0.0 0.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.3 0.0 0.0 2.5 0.0 5.9 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 0.0 6.5 0.0 1.9 0.9 0.0 0.7 0.0 0.0 0.1 XAGE1A "CT12.1a, GAGED2, XAGE-1, XAGE1" ENSG00000204379 "X antigen family member 1A" Q9HD64 X 52495676-52500812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 28.7" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 9.3;Spermatogonia: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 74.6;NB-4: 72.7;THP-1: 74.6;U-2 OS: 54.5;U-266/70: 35.5;U-266/84: 96.5;U-937: 59.9" HPA046363 Approved Nucleoplasm NA NA Nucleoplasm "HPA046363: " 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 74.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 72.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.5 0.0 0.1 0.2 0.0 5.1 74.6 0.0 0.0 54.5 0.0 10.4 35.5 96.5 0.1 0.0 59.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 XAGE1B CT12.1b ENSG00000204382 "X antigen family member 1B" Q9HD64 X 52512077-52520803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 28.8" "Cell type enhanced" "Detected in single" 28 "Spermatogonia: 1.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 19 "dendritic cells: 4.7" "Cell line enhanced" "Detected in some" "HMC-1: 78.4;NB-4: 76.2;THP-1: 74.1;U-2 OS: 56.8;U-266/70: 35.7;U-266/84: 97.4;U-937: 60.9" HPA046363 Approved Nucleoplasm NA NA Nucleoplasm "HPA046363: " 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.3 0.0 0.0 0.0 4.7 0.0 0.2 0.0 0.0 0.0 0.3 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 78.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.1 76.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.6 0.0 0.2 0.3 0.0 5.3 74.1 0.0 0.0 56.8 0.0 10.5 35.7 97.4 0.1 0.0 60.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.0 0.0 0.0 0.0 0.0 XPO5 KIAA1291 ENSG00000124571 "Exportin 5" Q9HAV4 6 43522330-43576075 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport" "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 27.2;Spermatogonia: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012357, HPA018402, HPA023959, HPA029909" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245" "unprognostic (6.98e-2)" "unprognostic (4.34e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (4.94e-7)" "unprognostic (6.16e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (3.98e-8)" "unprognostic (4.78e-1)" "unprognostic (4.72e-3)" "unprognostic (1.72e-1)" "unprognostic (4.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-2)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (9.48e-2)" "unprognostic (5.66e-3)" 11.5 12.2 9.5 10.8 14.0 9.0 10.8 14.6 15.4 9.6 8.8 11.5 8.3 7.8 12.0 12.0 16.7 9.8 7.5 8.9 8.0 7.3 10.0 13.1 9.4 10.0 9.5 8.0 11.9 19.7 17.7 16.1 9.5 9.4 10.5 11.5 9.7 12.9 10.6 14.9 15.3 8.6 12.3 8.0 9.9 11.2 42.3 9.7 18.3 16.7 8.5 13.7 10.5 10.4 3.7 5.9 3.6 11.7 8.4 6.8 4.4 15.6 9.4 15.7 31.6 8.2 6.9 14.6 8.2 5.8 16.2 11.8 25.8 5.5 21.3 10.7 7.8 15.3 13.5 26.1 11.9 18.3 15.4 20.7 20.6 11.3 18.7 11.8 22.7 11.0 5.0 12.4 17.0 26.6 5.8 11.5 15.3 44.1 16.8 10.9 19.2 17.1 11.3 16.8 43.1 9.6 18.7 16.7 15.9 9.3 12.3 32.5 13.4 11.4 10.5 14.6 14.4 12.1 18.3 9.6 12.0 14.3 11.4 17.2 10.7 11.7 41.9 4.3 19.9 12.8 0.0 5.0 3.6 6.3 6.4 5.8 3.7 5.6 6.8 5.9 3.4 4.5 5.9 0.5 8.4 11.7 1.8 5.5 4.4 9.5 14.0 14.6 15.4 8.0 7.3 9.5 8.0 9.4 9.7 6.0 3.5 3.0 4.4 7.9 10.8 5.4 2.5 5.3 1.2 10.4 7.9 4.2 1.7 6.5 9.2 4.5 3.3 0.0 6.6 5.6 6.4 6.0 11.5 4.0 5.5 20.6 13.8 1.8 6.5 10.2 3.7 4.0 1.7 2.8 6.6 4.1 6.4 0.0 7.8 4.2 13.7 0.0 4.4 27.2 26.3 6.1 3.7 3.2 6.4 5.2 XRCC1 RCC ENSG00000073050 "X-ray repair cross complementing 1" P18887 19 43543040-43580473 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005427, HPA006717" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB005427: AB_2215661, HPA006717: AB_1858896" "unprognostic (1.10e-2)" "unprognostic (3.51e-3)" "unprognostic (4.59e-1)" "unprognostic (2.81e-2)" "unprognostic (4.08e-1)" "unprognostic (2.68e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (5.07e-2)" "unprognostic (3.12e-1)" "unprognostic (7.51e-2)" "unprognostic (3.00e-2)" "unprognostic (9.54e-2)" "unprognostic (1.07e-1)" "unprognostic (2.28e-1)" "unprognostic (9.34e-3)" "unprognostic (2.20e-2)" "unprognostic (5.69e-2)" 16.6 17.5 20.8 18.7 22.4 22.4 16.9 23.6 22.7 20.3 17.4 19.2 18.0 13.6 23.8 18.9 20.2 24.9 16.9 15.7 16.5 16.3 16.3 10.4 16.3 22.8 15.8 21.1 34.2 22.1 19.4 32.0 19.7 15.7 16.7 12.6 21.8 16.4 19.2 18.8 20.4 14.2 18.8 15.3 19.5 17.2 25.0 17.9 38.9 21.5 12.0 21.6 18.1 17.2 14.2 13.6 20.3 14.2 10.6 17.7 12.9 25.6 21.1 25.0 22.3 12.2 11.5 13.3 14.4 16.3 19.0 20.8 13.2 18.7 19.3 18.3 12.7 18.8 13.3 14.9 16.5 11.3 21.3 15.4 24.7 20.6 15.3 12.3 13.9 21.5 13.3 11.4 24.0 12.1 23.2 17.1 22.9 15.5 19.7 16.8 21.2 28.7 25.1 7.8 20.0 9.3 24.2 15.6 11.1 16.2 20.5 20.7 13.1 17.9 17.5 8.6 13.5 16.5 34.1 9.6 25.2 19.7 7.5 17.9 21.7 20.9 14.2 20.4 12.6 27.3 20.3 14.2 16.8 12.9 13.4 14.6 14.2 16.1 17.7 13.6 12.6 14.0 12.8 16.3 10.6 8.3 10.5 16.2 12.9 20.8 22.4 23.6 22.7 16.5 16.3 15.8 21.1 15.7 17.9 14.9 9.8 9.7 6.8 5.5 11.0 7.4 2.5 48.2 11.4 7.0 5.9 25.8 16.6 12.7 22.1 9.0 7.3 0.0 10.1 16.2 11.7 4.1 19.6 4.9 18.6 4.8 13.1 9.2 19.5 13.6 9.5 11.8 13.5 14.4 13.0 7.3 11.2 8.6 12.0 11.8 11.3 6.5 8.3 19.0 12.9 6.1 16.7 17.5 13.3 2.4 XRCC3 ENSG00000126215 "X-ray repair cross complementing 3" O43542 14 103697609-103715504 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 30.3" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 6.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062422, HPA068953" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA062422: AB_2684757, HPA068953: AB_2686062" "unprognostic (2.52e-2)" "unprognostic (1.81e-3)" "unprognostic (6.75e-2)" "unprognostic (4.01e-2)" "unprognostic (4.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.53e-4)" "unprognostic (2.93e-2)" "unprognostic (4.67e-2)" "unprognostic (1.58e-2)" "unprognostic (4.46e-2)" "unprognostic (2.53e-2)" "unprognostic (3.52e-7)" "unprognostic (1.27e-1)" "unprognostic (1.57e-1)" "unprognostic (8.84e-2)" "unprognostic (3.72e-2)" 5.4 3.3 8.1 15.1 7.3 22.0 5.4 11.3 8.0 5.5 5.8 6.5 4.6 5.4 6.4 5.1 8.5 6.1 5.3 4.4 6.9 2.6 4.1 3.8 6.0 11.1 7.3 5.4 7.0 7.8 2.1 4.4 5.6 6.8 7.7 6.2 5.3 11.1 2.9 8.9 30.3 7.0 2.3 5.3 13.5 6.8 10.1 5.0 17.6 5.6 6.7 14.2 5.3 9.0 4.5 2.0 3.0 3.3 2.5 3.9 3.6 12.7 23.3 12.8 15.9 1.1 3.3 23.3 14.1 4.7 20.0 21.6 12.9 20.5 20.3 12.2 2.9 15.9 20.4 14.0 21.0 12.3 12.5 14.5 19.8 11.4 11.9 2.0 17.7 12.9 2.5 2.1 17.6 11.2 4.2 8.1 20.7 12.2 12.5 10.3 27.8 30.7 14.0 11.0 18.7 16.6 25.0 18.5 8.0 4.4 17.6 12.7 10.5 16.6 9.0 5.8 7.4 14.2 13.9 7.0 10.4 12.2 33.0 15.4 10.7 9.7 25.2 6.5 14.7 15.9 2.6 1.6 3.0 3.8 3.3 3.9 4.5 3.3 3.2 2.0 4.0 3.3 2.2 1.2 2.5 2.5 1.4 2.5 3.6 8.1 7.3 11.3 8.0 6.9 2.6 7.3 5.4 6.8 5.0 0.0 0.0 1.9 2.1 1.3 1.5 0.2 2.5 1.4 3.4 0.0 2.0 6.8 1.7 1.4 0.4 0.9 2.0 0.0 1.6 4.5 0.4 1.4 0.0 0.4 3.8 3.2 1.2 0.0 0.0 1.5 0.3 1.5 0.0 1.8 5.0 1.3 1.4 3.5 1.1 0.0 2.1 0.0 0.9 3.4 5.7 1.1 2.6 0.0 5.0 0.7 XRCC4 ENSG00000152422 "X-ray repair cross complementing 4" Q13426 5 83077498-83353787 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Pancreatic endocrine cells: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 37.1" "Low region specificity" "Detected in all" "HPA006801, HPA051538" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006801: AB_1858899, HPA051538: AB_2681526" "prognostic unfavorable (1.80e-5)" "unprognostic (3.05e-2)" "unprognostic (5.12e-2)" "unprognostic (3.91e-3)" "unprognostic (1.55e-1)" "unprognostic (1.69e-1)" "unprognostic (1.44e-3)" "unprognostic (2.23e-2)" "unprognostic (2.19e-2)" "unprognostic (5.77e-2)" "unprognostic (2.38e-2)" "unprognostic (8.24e-2)" "unprognostic (4.46e-2)" "unprognostic (1.79e-1)" "unprognostic (1.97e-1)" "unprognostic (2.34e-1)" "unprognostic (6.91e-2)" 8.8 9.4 8.1 12.9 10.1 5.9 9.4 4.8 10.2 5.3 9.1 7.2 5.4 11.4 8.3 7.7 10.1 6.2 8.1 13.0 8.5 6.6 12.2 8.1 7.6 11.7 8.7 5.8 5.8 4.9 4.0 9.5 11.3 11.5 6.3 8.8 3.7 7.2 7.1 5.3 5.7 15.4 5.9 9.5 14.6 6.4 12.5 8.8 20.6 7.4 9.7 12.9 8.7 5.8 7.4 10.3 12.3 19.1 11.5 7.0 6.8 8.6 6.9 8.4 7.5 4.8 7.0 8.0 8.3 6.9 9.2 10.8 5.8 12.9 12.4 6.2 6.6 13.2 7.6 5.6 18.8 15.2 5.7 7.0 6.4 5.2 7.3 3.2 7.1 10.4 4.8 8.6 11.9 6.7 9.4 7.3 8.2 4.6 5.8 10.5 7.0 13.0 9.2 4.7 5.3 10.2 10.9 37.1 12.4 8.5 4.0 5.5 7.1 5.2 3.9 10.5 7.4 7.9 11.6 4.5 5.0 10.7 5.3 11.0 4.7 6.9 15.3 9.0 12.9 8.0 12.1 13.5 9.2 4.7 19.1 4.9 7.4 5.2 5.2 10.3 6.3 7.0 5.6 12.3 11.5 17.8 7.6 5.6 6.8 8.1 10.1 4.8 10.2 8.5 6.6 8.7 5.8 11.5 8.8 14.9 5.6 12.8 11.2 4.7 4.3 12.3 5.1 10.7 12.5 5.2 0.0 15.8 13.3 15.0 7.8 7.5 6.8 0.0 24.8 33.3 10.1 4.9 10.4 4.9 17.2 1.6 0.0 11.6 20.2 3.6 7.2 25.5 8.5 14.4 6.9 7.5 43.1 4.9 6.7 16.5 3.8 0.0 7.2 24.9 25.3 3.9 10.0 10.9 5.2 8.4 XRCC5 "KARP-1, KU80, Ku86, KUB2" ENSG00000079246 "X-ray repair cross complementing 5" P13010 2 216107464-216206303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004468, HPA025813, HPA064685" Supported Enhanced Nucleoplasm NA NA 140000 Nucleoplasm "CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: AB_2685322" "unprognostic (4.23e-2)" "unprognostic (1.75e-1)" "unprognostic (9.07e-3)" "unprognostic (3.44e-3)" "unprognostic (2.44e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (2.10e-7)" "unprognostic (4.42e-3)" "unprognostic (1.38e-1)" "unprognostic (1.06e-1)" "unprognostic (3.38e-3)" "unprognostic (1.96e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-1)" "unprognostic (2.88e-2)" "unprognostic (3.58e-2)" "unprognostic (6.01e-2)" 53.7 47.6 35.2 47.0 56.8 47.0 56.6 47.0 59.7 51.2 44.3 45.2 39.5 39.5 62.9 43.8 61.1 51.7 41.2 43.7 38.6 36.4 62.4 67.1 43.8 56.2 41.8 45.2 58.7 46.7 63.0 56.1 54.3 58.3 46.0 53.5 36.1 49.4 47.9 65.0 54.7 46.5 49.7 44.2 60.5 47.9 36.9 38.0 112.4 64.2 55.6 65.5 56.5 47.7 38.6 51.5 60.9 61.3 50.4 54.0 82.3 38.8 33.0 74.1 39.6 32.9 37.8 44.8 46.3 47.9 53.5 57.7 70.8 38.7 37.6 37.8 40.4 46.9 34.8 72.8 56.1 82.6 35.8 50.1 81.6 52.2 66.1 40.9 72.6 40.0 34.4 30.0 62.8 27.5 38.3 63.1 46.5 51.5 34.4 69.7 37.4 81.1 36.7 86.1 39.4 29.5 71.4 65.5 31.1 57.6 44.3 65.0 54.8 37.2 27.6 33.3 78.1 33.9 54.5 45.4 50.4 42.4 32.9 52.3 41.7 50.5 84.0 39.2 57.0 49.4 60.9 51.5 51.8 50.2 54.0 54.0 38.6 49.1 50.9 51.5 37.5 49.9 49.8 59.4 50.4 61.3 31.4 49.3 82.3 35.2 56.8 47.0 59.7 38.6 36.4 41.8 45.2 58.3 38.0 98.3 108.3 82.7 152.6 101.0 129.3 138.8 101.9 165.9 152.4 96.0 43.2 176.4 82.9 239.3 65.8 131.5 70.4 70.0 206.2 196.4 122.7 101.3 140.1 177.3 138.8 84.2 128.0 77.3 91.0 17.1 94.0 132.7 65.8 380.5 79.8 130.6 194.7 63.1 121.6 110.9 102.9 109.9 137.9 221.2 164.2 105.1 138.4 124.6 99.6 138.1 XRCC6 "D22S671, D22S731, G22P1, KU70, ML8" ENSG00000196419 "X-ray repair cross complementing 6" P12956 22 41621119-41664048 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004254, HPA047549, HPA062226" Enhanced Enhanced Nucleoplasm No No 24000 Nucleoplasm "CAB004254: AB_628453, HPA047549: AB_2680085, HPA062226: AB_2684716" "unprognostic (5.55e-2)" "unprognostic (2.39e-2)" "unprognostic (1.82e-3)" "unprognostic (2.39e-1)" "unprognostic (2.47e-2)" "unprognostic (9.17e-2)" "unprognostic (1.16e-3)" "unprognostic (2.32e-2)" "unprognostic (2.21e-1)" "unprognostic (2.11e-1)" "unprognostic (1.89e-2)" "unprognostic (1.33e-1)" "unprognostic (2.06e-3)" "unprognostic (1.22e-1)" "unprognostic (2.28e-1)" "unprognostic (4.77e-2)" "unprognostic (7.95e-2)" 49.2 67.9 44.4 47.8 54.3 62.3 49.7 44.5 57.5 51.2 51.3 39.5 44.1 44.7 59.9 41.0 68.6 52.4 35.2 63.0 59.3 39.2 50.1 61.6 48.1 66.9 37.2 50.6 61.5 44.0 48.4 53.1 63.5 51.5 46.1 56.4 39.7 59.2 52.1 100.9 58.6 46.9 58.2 68.4 54.4 50.8 113.6 34.2 83.8 49.5 59.2 70.9 51.4 50.1 51.9 63.7 42.7 57.0 46.6 62.6 96.7 62.2 45.0 62.6 54.5 38.2 34.1 49.4 45.4 54.7 95.6 78.9 66.0 39.5 100.5 38.2 55.1 43.0 46.9 86.5 56.9 96.4 55.9 108.6 53.9 55.1 65.4 34.6 127.2 62.4 30.8 39.3 59.7 32.9 38.4 59.4 43.8 52.6 42.7 61.5 68.6 66.1 47.5 57.5 132.4 53.3 75.7 65.9 79.8 54.0 46.7 29.2 20.9 73.9 39.4 52.4 49.3 45.3 51.5 41.9 47.8 66.5 42.0 59.6 42.4 74.0 102.5 44.8 50.5 56.4 24.5 50.1 42.7 51.1 57.0 53.5 51.9 56.8 55.8 63.7 48.2 62.6 55.8 13.5 46.6 55.5 37.7 61.8 96.7 44.4 54.3 44.5 57.5 59.3 39.2 37.2 50.6 51.5 34.2 89.3 116.9 114.6 165.5 110.1 101.4 76.4 96.8 104.4 113.7 78.5 58.9 380.2 140.9 149.3 68.8 107.6 88.2 46.7 159.8 266.0 133.6 98.3 115.6 92.4 150.7 82.6 94.6 71.8 90.4 42.8 117.3 120.1 84.4 217.4 92.7 138.2 128.0 107.8 119.2 113.5 75.0 161.7 129.7 482.0 292.1 89.3 302.9 130.7 133.6 112.7 YAF2 ENSG00000015153 "YY1 associated factor 2" Q8IY57 12 42157104-42238349 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 8 "Cardiomyocytes: 1091.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 45.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026867 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA026867: AB_1858911" "unprognostic (1.41e-1)" "unprognostic (2.24e-1)" "unprognostic (9.30e-2)" "unprognostic (3.06e-1)" "unprognostic (2.06e-2)" "unprognostic (4.12e-1)" "unprognostic (7.10e-3)" "unprognostic (2.70e-1)" "unprognostic (2.86e-3)" "unprognostic (2.44e-2)" "unprognostic (3.58e-2)" "unprognostic (5.57e-2)" "unprognostic (4.57e-2)" "unprognostic (3.42e-1)" "unprognostic (2.33e-1)" "unprognostic (5.76e-2)" "unprognostic (1.20e-2)" 11.2 11.4 15.6 7.6 14.2 9.7 10.0 16.3 19.7 11.0 7.9 8.4 6.9 7.2 10.9 11.1 8.5 7.8 10.1 39.4 12.9 13.3 10.5 19.2 8.4 12.4 13.2 11.3 11.0 7.6 7.4 14.6 10.2 14.5 9.3 8.3 8.1 7.1 10.0 43.9 6.5 8.9 11.6 10.8 11.3 7.0 7.8 9.1 12.7 11.9 8.3 10.5 11.2 9.1 13.6 10.8 32.6 9.8 14.2 14.1 5.2 7.0 5.3 8.2 6.0 10.4 9.5 4.7 9.1 9.3 8.7 8.0 7.4 5.5 4.5 7.6 8.3 3.4 5.5 8.0 5.9 11.9 10.6 8.8 9.7 2.9 3.8 6.2 9.1 6.1 6.7 8.6 6.7 13.7 8.6 8.6 4.7 9.5 10.2 10.8 3.4 9.8 12.1 1.8 8.2 5.8 6.8 9.5 6.4 10.8 4.7 5.9 8.3 7.6 9.3 7.9 3.9 6.0 7.4 8.1 7.8 6.1 8.9 4.7 9.4 11.9 14.8 8.2 45.4 2.9 17.9 9.3 15.1 10.9 9.8 11.1 11.2 10.3 12.4 6.9 13.6 8.3 8.6 32.6 14.2 8.9 10.8 14.1 5.2 15.6 14.2 16.3 16.7 12.9 13.3 13.2 11.3 14.5 9.1 20.8 12.0 51.1 37.6 51.6 71.2 1091.6 33.1 21.4 30.7 19.2 80.5 35.9 53.0 28.7 25.4 49.0 20.6 23.3 39.3 18.5 47.4 31.2 70.3 92.4 24.5 136.7 37.3 53.4 36.4 11.8 53.8 38.8 40.5 40.5 25.8 71.4 31.6 23.0 72.2 37.2 98.7 103.5 54.7 30.7 29.6 44.7 37.9 58.6 23.0 27.3 YBEY C21orf57 ENSG00000182362 "YbeY metallopeptidase (putative)" P58557 21 46286337-46297751 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.3" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 253.1;Late spermatids: 197.2;Spermatocytes: 177.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016593, HPA018162" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA016593: AB_1845698, HPA018162: AB_1845699" "prognostic favorable (5.54e-4)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "unprognostic (7.24e-3)" "unprognostic (4.81e-1)" "unprognostic (2.78e-2)" "unprognostic (7.99e-2)" "unprognostic (1.95e-1)" "unprognostic (1.72e-1)" "unprognostic (8.87e-2)" "unprognostic (1.66e-3)" "unprognostic (2.95e-1)" "unprognostic (1.51e-2)" "unprognostic (7.50e-2)" "unprognostic (7.48e-2)" "unprognostic (1.94e-1)" "unprognostic (3.64e-3)" 7.0 8.3 9.5 8.9 10.3 4.1 10.9 8.9 12.1 7.6 11.1 11.6 10.1 8.9 6.6 12.0 5.9 8.2 6.8 8.1 9.0 9.1 8.8 11.0 10.1 10.9 11.4 10.5 8.2 11.3 10.1 10.0 4.7 9.2 10.4 9.7 7.3 10.5 9.6 11.5 9.4 12.4 6.3 13.6 7.0 6.8 58.3 8.5 6.8 7.5 12.7 10.6 6.3 6.4 21.8 16.0 14.8 7.8 12.7 16.8 6.8 10.1 8.9 7.6 9.2 5.8 22.4 7.4 6.9 10.4 6.9 8.4 4.7 1.7 12.9 6.1 7.1 3.6 3.3 3.2 3.2 6.3 12.2 12.8 3.7 5.8 1.8 16.8 4.1 0.4 15.4 13.9 5.4 11.3 9.0 4.4 6.4 8.8 15.5 8.0 8.6 8.1 5.4 22.3 3.8 9.3 17.2 3.6 24.7 14.0 4.7 5.6 9.9 9.4 4.3 18.6 2.6 2.2 3.7 5.4 6.6 2.4 5.3 4.5 19.4 34.3 22.2 12.0 4.6 4.0 14.8 6.1 4.6 9.6 6.8 9.3 21.8 11.6 11.7 6.9 15.5 11.4 13.0 2.1 12.7 7.8 16.0 16.8 6.8 9.5 10.3 8.9 12.1 9.0 9.1 11.4 10.5 9.2 8.5 3.0 6.1 22.7 30.1 41.1 13.0 19.0 15.3 10.7 13.6 17.4 7.9 14.0 54.7 31.5 253.1 18.0 46.6 0.0 67.1 20.6 27.3 31.8 11.5 43.2 21.8 15.9 30.8 22.1 27.5 197.2 37.7 32.3 37.1 17.2 53.4 14.0 43.0 49.1 23.0 56.4 21.1 6.5 27.0 177.3 30.9 52.9 8.0 22.4 53.3 31.2 YDJC ENSG00000161179 "YdjC chitooligosaccharide deacetylase homolog" A8MPS7 22 21628089-21630064 "Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061005 Approved Nucleoplasm NA NA Nucleoplasm "HPA061005: AB_2684412" "unprognostic (5.34e-2)" "unprognostic (2.30e-1)" "unprognostic (3.96e-1)" "unprognostic (2.29e-1)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (9.84e-4)" "unprognostic (9.35e-2)" "unprognostic (7.08e-2)" "unprognostic (8.09e-3)" "unprognostic (1.24e-1)" "unprognostic (9.86e-2)" "unprognostic (4.90e-3)" "unprognostic (1.07e-1)" "unprognostic (2.25e-1)" "unprognostic (9.60e-2)" "prognostic favorable (8.98e-5)" 5.0 6.5 8.1 12.4 6.9 4.0 4.9 5.8 12.3 9.4 9.8 6.0 6.9 10.3 5.4 5.8 9.4 8.3 7.0 3.5 8.6 5.7 12.4 10.2 5.3 13.3 5.9 3.8 7.9 19.2 9.2 4.4 7.3 5.8 7.1 6.2 4.3 8.2 6.1 4.6 8.1 11.8 4.5 5.9 10.2 7.4 4.2 3.8 10.3 14.6 7.5 13.8 7.1 5.5 20.4 18.1 11.6 15.4 21.4 16.0 11.7 3.8 0.9 0.1 0.3 1.2 0.9 4.4 1.7 1.0 1.0 1.7 0.3 1.5 3.8 6.4 0.0 1.0 3.4 1.2 2.9 1.6 3.3 13.0 5.4 0.7 4.7 1.6 9.6 4.1 1.4 5.9 0.8 7.5 1.1 2.9 5.8 39.8 0.7 0.7 4.0 3.5 13.6 1.5 11.0 7.3 2.4 0.0 3.8 7.1 2.0 5.1 3.2 1.6 2.5 3.5 0.0 3.4 4.6 2.4 0.4 4.8 1.0 2.2 7.4 4.2 3.5 0.4 2.9 0.8 7.6 15.4 11.6 11.1 13.6 11.2 18.1 15.8 12.1 18.1 20.4 13.8 12.6 5.6 21.4 9.7 12.3 16.0 11.7 8.1 6.9 5.8 12.3 8.6 5.7 5.9 3.8 5.8 3.8 6.0 8.0 46.3 34.3 22.1 4.4 3.2 17.8 4.0 3.4 41.8 0.0 36.6 33.2 53.1 17.0 14.7 35.8 0.0 37.1 56.3 10.3 33.7 11.5 13.0 26.8 3.2 15.5 3.7 14.1 3.2 9.8 24.8 13.5 70.3 27.8 5.3 44.3 33.4 6.3 52.1 4.7 19.4 8.2 13.0 32.4 19.8 19.3 33.0 35.4 36.1 YEATS2 "FLJ10201, FLJ12841, FLJ13308, KIAA1197" ENSG00000163872 "YEATS domain containing 2" Q9ULM3 3 183697818-183812625 "Predicted intracellular proteins" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045891 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045891: AB_10961271" "unprognostic (1.57e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (3.40e-3)" "unprognostic (1.14e-1)" "unprognostic (7.49e-2)" "prognostic unfavorable (4.82e-6)" "unprognostic (2.44e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-1)" "unprognostic (8.33e-3)" "unprognostic (1.65e-3)" "prognostic unfavorable (6.90e-9)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "unprognostic (2.08e-2)" 11.1 8.5 17.9 18.9 21.0 20.4 13.1 27.2 22.7 13.7 12.8 17.9 4.9 9.0 16.0 8.5 13.1 17.5 10.9 10.7 15.5 14.9 10.5 5.9 16.1 19.1 14.1 17.8 25.8 8.9 18.1 20.2 17.9 14.9 14.2 11.6 12.8 12.5 12.9 8.4 13.6 10.7 19.6 16.2 13.6 9.8 13.0 15.0 21.7 16.2 5.1 18.5 15.0 14.3 2.6 2.8 10.5 8.0 1.5 2.7 2.3 18.9 5.7 16.9 7.5 8.3 12.3 18.8 11.3 8.8 16.9 19.9 14.0 6.9 17.4 21.0 9.9 26.2 12.2 16.4 10.9 17.3 14.2 9.7 17.6 6.2 6.8 12.8 13.0 10.2 8.4 8.5 12.1 14.7 16.9 17.1 18.1 6.9 14.7 12.6 5.1 18.8 10.1 15.2 6.9 11.4 26.8 15.9 20.9 6.8 8.4 16.4 11.7 8.4 28.8 14.9 14.9 14.2 9.0 14.4 15.6 11.4 7.8 12.6 14.1 11.0 29.6 12.1 13.1 11.0 0.1 6.0 1.6 2.7 2.5 1.9 2.6 2.3 1.9 2.0 1.8 1.9 2.1 10.5 1.5 8.0 2.8 0.9 2.3 17.9 21.0 27.2 22.7 15.5 14.9 14.1 17.8 14.9 15.0 32.8 2.9 7.6 2.7 1.8 18.1 8.7 2.5 9.4 5.7 5.2 9.8 3.9 0.0 5.5 1.9 9.5 4.0 0.0 3.5 7.5 4.3 4.8 6.9 2.1 6.0 12.7 8.2 8.0 8.4 2.1 9.2 5.8 1.7 2.8 5.8 6.1 6.9 0.0 8.9 0.8 16.5 0.0 4.1 1.9 14.3 3.0 1.7 3.2 4.3 2.1 ZBED4 KIAA0637 ENSG00000100426 "Zinc finger BED-type containing 4" O75132 22 49853842-49890078 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045341 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA045341: AB_2679295" "unprognostic (3.82e-2)" "unprognostic (6.39e-2)" "unprognostic (7.22e-3)" "unprognostic (4.43e-2)" "unprognostic (7.90e-2)" "unprognostic (2.42e-1)" "unprognostic (2.48e-3)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "unprognostic (8.74e-3)" "unprognostic (9.44e-2)" "unprognostic (2.43e-2)" "unprognostic (1.27e-1)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.53e-2)" "unprognostic (5.20e-2)" 5.5 4.6 5.9 11.3 7.5 15.0 7.3 11.7 7.5 5.8 9.1 8.9 2.8 8.5 6.7 6.4 11.5 6.0 7.1 4.8 5.1 4.7 7.2 8.0 8.0 11.4 5.4 3.8 6.8 16.5 5.6 6.4 6.6 4.9 6.1 8.0 5.8 11.1 3.7 8.5 8.0 8.5 5.2 6.5 9.5 7.2 8.8 5.3 29.7 6.2 5.4 10.9 6.9 5.9 1.6 2.5 1.6 1.4 6.7 4.1 1.5 9.3 8.3 15.9 12.7 4.9 5.4 9.9 5.5 4.6 6.1 5.6 8.5 4.2 18.4 3.9 5.8 6.4 10.7 11.2 7.1 6.6 7.2 13.7 10.5 8.4 8.0 7.2 22.3 15.2 5.1 10.8 6.6 10.2 6.1 8.1 18.0 11.2 8.8 7.2 7.4 18.4 10.6 8.7 8.1 5.9 22.2 14.5 11.1 6.5 9.4 8.5 16.8 5.4 16.2 11.0 10.4 7.6 12.8 9.3 8.4 13.3 4.9 7.7 8.9 5.5 16.8 5.0 10.0 9.8 0.7 0.9 1.6 2.2 1.4 4.1 1.6 2.2 2.3 2.4 1.1 2.7 2.1 0.6 6.7 1.4 2.5 1.6 1.5 5.9 7.5 11.7 7.5 5.1 4.7 5.4 3.8 4.9 5.3 0.0 6.2 8.3 4.1 4.5 8.2 6.5 7.6 2.7 10.3 5.2 13.7 3.2 3.3 8.2 4.2 5.0 5.2 0.0 6.1 5.3 4.3 7.4 0.0 5.4 6.0 12.7 12.1 7.4 9.1 3.6 2.8 4.8 0.0 2.8 9.6 2.3 10.3 7.0 3.9 2.1 9.3 6.5 5.0 3.2 5.3 3.3 2.7 7.5 9.3 5.7 ZBED8 "Buster3, C5orf54" ENSG00000221886 "Zinc finger BED-type containing 8" Q8IZ13 5 160393148-160400097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 9.4;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045445, HPA055817" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045445: AB_10959608, HPA055817: AB_2682933" "unprognostic (1.51e-1)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (8.40e-2)" "unprognostic (7.04e-3)" "unprognostic (7.50e-2)" "unprognostic (1.47e-5)" "unprognostic (6.52e-2)" "unprognostic (1.05e-2)" "unprognostic (5.65e-2)" "prognostic favorable (3.72e-4)" "unprognostic (1.16e-1)" "unprognostic (7.44e-2)" "unprognostic (9.74e-2)" "unprognostic (9.25e-2)" "unprognostic (2.50e-1)" "unprognostic (9.96e-3)" 3.6 8.1 10.4 1.9 12.4 0.6 6.7 20.1 8.8 11.1 6.3 9.9 5.2 2.9 10.5 13.5 3.8 9.4 4.4 6.8 7.9 6.6 6.7 2.5 4.2 2.5 14.2 6.4 18.8 4.4 6.3 21.7 7.6 9.7 8.3 3.5 5.6 7.9 10.3 4.1 4.8 2.8 8.2 9.5 3.6 4.6 7.0 12.5 2.1 9.5 1.5 3.1 5.5 9.0 0.8 2.9 1.1 3.1 3.3 2.4 1.6 5.5 4.4 10.9 9.5 8.7 6.4 4.5 4.8 4.5 5.9 8.9 3.9 4.4 4.6 9.2 1.6 13.9 6.0 6.2 2.8 7.9 4.7 6.2 2.9 6.4 5.0 3.3 1.9 3.7 2.5 5.9 4.3 2.9 5.4 3.0 3.9 2.0 4.4 6.2 2.2 1.7 3.1 2.6 2.3 4.7 2.3 12.6 3.0 2.7 1.6 11.2 3.8 6.3 1.8 5.2 4.5 4.2 1.9 2.1 8.8 5.9 2.7 3.9 4.0 6.8 1.1 6.3 2.8 8.6 0.0 2.4 1.1 2.4 1.9 1.4 0.8 2.2 1.7 2.9 0.6 1.7 1.3 0.3 3.3 3.1 2.6 0.0 1.6 10.4 12.4 20.1 8.8 7.9 6.6 14.2 6.4 9.7 12.5 0.0 0.3 0.0 0.7 0.0 4.6 2.4 0.0 9.4 1.2 1.8 2.0 3.5 1.7 1.1 0.8 1.5 0.0 0.0 0.4 1.2 0.9 0.8 0.0 0.0 1.2 3.2 0.0 0.6 1.2 0.0 6.1 0.0 0.0 1.8 0.6 5.8 0.7 0.0 5.3 1.0 3.9 12.9 0.5 1.6 4.9 0.0 1.1 0.0 0.6 0.3 ZBTB1 "KIAA0997, ZNF909" ENSG00000126804 "Zinc finger and BTB domain containing 1" Q9Y2K1 14 64503712-64533690 "Predicted intracellular proteins, Transcription factors" "Differentiation, DNA damage, DNA repair, Immunity, Innate immunity, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050516, HPA054552, HPA075151" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050516: AB_2681153, HPA054552: , HPA075151: " "unprognostic (4.09e-1)" "unprognostic (3.68e-1)" "unprognostic (1.08e-1)" "unprognostic (9.51e-2)" "unprognostic (1.28e-1)" "prognostic favorable (4.92e-4)" "unprognostic (1.11e-3)" "unprognostic (9.43e-2)" "unprognostic (6.64e-2)" "unprognostic (2.00e-1)" "unprognostic (9.65e-2)" "unprognostic (6.63e-2)" "unprognostic (3.34e-2)" "unprognostic (6.26e-2)" "unprognostic (2.23e-1)" "unprognostic (2.58e-1)" "unprognostic (3.27e-2)" 19.5 13.0 15.4 19.2 17.9 47.2 34.4 15.6 23.5 15.3 14.6 9.0 13.7 10.8 15.3 18.4 13.6 16.3 14.0 15.0 18.0 11.3 15.8 14.1 20.2 27.1 24.6 9.3 16.4 17.8 19.1 19.2 16.7 15.7 19.6 14.8 10.2 16.4 17.8 18.4 22.2 18.4 16.2 22.3 26.2 14.9 7.2 20.3 39.0 18.9 11.6 22.4 16.0 25.4 12.1 10.9 25.6 13.4 15.1 18.8 11.3 24.6 8.3 18.7 11.6 19.4 23.5 19.2 10.7 16.1 10.2 13.0 8.0 17.6 23.8 10.8 15.2 8.0 17.5 9.0 10.7 14.0 35.1 6.1 11.6 15.2 6.7 12.2 9.6 17.0 30.1 18.8 7.0 10.6 22.5 11.7 15.4 5.7 16.4 18.8 18.8 16.5 9.7 7.8 12.8 12.5 14.9 11.5 9.1 17.8 30.1 13.1 10.5 17.6 13.3 14.3 18.9 12.8 12.4 15.5 17.1 11.6 8.1 7.4 20.6 8.8 26.7 17.2 9.2 11.1 25.6 10.4 16.6 15.1 9.9 17.3 12.1 13.5 16.7 10.9 11.3 14.0 16.8 8.0 15.1 13.4 6.9 18.8 11.3 15.4 17.9 15.6 23.5 18.0 11.3 24.6 9.3 15.7 20.3 14.9 10.1 27.6 14.0 28.2 10.6 11.2 5.1 18.7 13.6 8.7 11.8 6.5 8.3 11.2 74.1 18.8 6.5 23.3 7.5 11.5 26.8 12.8 27.7 6.8 14.0 6.4 21.2 12.9 20.8 26.6 14.7 28.1 28.7 6.4 12.0 8.7 13.0 9.5 17.3 4.4 8.2 6.5 31.2 2.3 4.3 21.1 6.5 20.0 10.0 18.0 ZBTB10 "FLJ12752, RINZF" ENSG00000205189 "Zinc finger and BTB domain containing 10" Q96DT7 8 80485619-80526265 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021554, HPA050569" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021554: AB_1858937, HPA050569: AB_2681179" "unprognostic (7.97e-2)" "unprognostic (3.53e-1)" "unprognostic (2.26e-1)" "unprognostic (6.67e-2)" "unprognostic (9.28e-2)" "unprognostic (8.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" "unprognostic (4.86e-1)" "unprognostic (3.66e-2)" "unprognostic (2.15e-1)" "prognostic favorable (3.52e-4)" "unprognostic (4.65e-3)" "unprognostic (2.40e-1)" "unprognostic (7.15e-2)" "unprognostic (2.63e-2)" 12.4 8.2 6.3 8.4 6.8 21.3 14.1 13.5 8.0 11.3 6.9 6.1 8.6 2.0 14.5 9.1 5.7 12.2 7.4 9.0 5.6 5.3 10.7 18.4 11.5 9.7 7.5 3.3 18.8 16.2 9.4 7.2 22.8 6.4 17.6 8.0 7.9 8.7 6.8 17.3 3.8 4.3 14.0 7.6 6.6 6.6 12.1 6.3 14.6 10.3 7.5 4.1 19.2 13.4 2.1 3.6 0.6 0.8 2.0 1.5 0.2 0.0 2.4 12.5 6.3 5.5 4.2 16.9 2.2 0.0 1.8 1.8 5.2 1.9 7.1 6.5 3.4 5.4 0.6 9.7 3.0 2.1 0.0 15.9 3.7 1.6 4.1 3.2 1.3 1.7 4.0 2.9 2.2 6.3 1.5 4.5 6.1 3.3 14.1 1.5 3.8 7.0 3.2 3.1 0.7 3.8 8.2 6.8 2.4 5.2 7.1 7.3 8.6 2.9 28.6 8.4 14.9 5.4 5.1 5.7 4.3 8.1 0.0 2.0 4.2 2.0 8.1 1.6 0.0 5.3 0.6 0.2 0.0 0.8 0.3 0.9 1.1 0.7 0.9 0.7 2.1 1.5 1.4 0.0 2.0 0.8 3.6 0.0 0.2 6.3 6.8 13.5 5.5 5.6 5.3 7.5 3.3 6.4 6.3 23.8 14.2 14.3 11.0 25.2 12.9 29.0 17.8 22.7 14.8 12.2 15.7 30.3 3.3 11.0 53.3 23.8 20.6 0.0 6.0 31.5 26.2 72.3 9.2 28.4 11.2 30.2 58.0 12.9 14.8 24.7 17.8 11.5 47.2 15.4 32.3 19.3 8.4 5.8 19.8 11.1 8.2 25.8 36.5 14.4 10.6 11.0 88.0 17.9 29.2 10.7 ZBTB11 "ZNF-U69274, ZNF913" ENSG00000066422 "Zinc finger and BTB domain containing 11" O95625 3 101648889-101677495 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015328, HPA024138" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015328: AB_1858938, HPA024138: AB_1858939" "unprognostic (3.25e-3)" "unprognostic (9.62e-2)" "unprognostic (4.92e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (2.86e-2)" "unprognostic (7.04e-2)" "unprognostic (1.17e-3)" "unprognostic (4.77e-1)" "unprognostic (6.65e-3)" "unprognostic (1.75e-1)" "unprognostic (1.41e-1)" "unprognostic (1.45e-2)" "unprognostic (5.64e-2)" "unprognostic (2.91e-1)" "unprognostic (1.89e-1)" "unprognostic (5.90e-2)" "unprognostic (2.09e-1)" 11.6 11.0 14.8 14.8 16.5 44.0 13.7 21.9 16.0 14.1 11.9 8.5 8.4 11.4 13.6 10.4 14.1 10.9 10.5 9.1 12.3 12.4 10.5 12.9 14.2 16.6 11.2 12.9 15.0 16.4 19.1 14.3 14.2 14.3 13.0 10.8 7.1 15.2 13.2 16.2 16.6 12.7 12.3 13.5 16.6 11.7 13.7 13.6 28.7 13.6 10.2 16.4 14.4 22.3 6.8 8.0 9.6 11.6 5.2 9.0 4.6 9.8 11.0 7.3 9.7 11.4 11.2 12.8 9.7 9.4 8.8 9.7 9.9 6.8 11.9 7.9 7.2 8.1 12.2 10.8 10.8 15.8 12.4 7.7 26.5 10.2 9.1 8.8 18.6 9.7 9.0 14.0 8.1 18.9 8.0 8.6 13.8 15.1 14.6 9.4 12.0 16.3 8.3 6.9 10.4 16.3 13.4 11.4 14.4 8.2 11.7 21.4 7.9 12.5 10.3 12.8 4.8 13.1 10.2 9.8 13.6 10.1 5.6 9.6 16.8 13.9 22.3 8.5 12.3 9.6 9.6 6.3 7.0 6.8 8.2 9.0 5.4 5.8 7.5 8.0 6.8 6.8 5.6 4.3 5.2 11.6 4.8 6.3 4.6 14.8 16.5 21.9 16.0 12.3 12.4 11.2 12.9 14.3 13.6 29.8 14.4 13.7 18.0 41.2 12.0 10.8 12.7 24.1 26.1 1.8 31.4 8.2 0.0 5.5 2.6 16.7 9.1 0.0 4.8 6.6 21.6 14.6 8.1 8.9 6.8 20.6 19.4 15.4 25.9 2.3 7.8 20.4 18.6 8.2 10.2 11.7 6.7 3.5 13.4 4.8 22.8 6.5 16.2 16.1 19.3 42.9 14.1 22.4 9.5 20.4 ZBTB12 "C6orf46, D6S59E, G10, NG35" ENSG00000204366 "Zinc finger and BTB domain containing 12" Q9Y330 6 31899607-31901992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 3.9;Horizontal cells: 3.2;Rod photoreceptor cells: 1.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047161, HPA070639" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA047161: AB_2679962, HPA070639: " "unprognostic (2.05e-1)" "unprognostic (3.15e-2)" "unprognostic (3.77e-1)" "unprognostic (2.93e-1)" "unprognostic (1.24e-1)" "unprognostic (8.92e-2)" "unprognostic (1.26e-3)" "unprognostic (1.55e-1)" "unprognostic (5.22e-2)" "unprognostic (8.16e-2)" "unprognostic (2.58e-1)" "unprognostic (5.41e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.87e-1)" "unprognostic (2.11e-1)" "unprognostic (6.39e-2)" "unprognostic (8.98e-3)" 2.2 3.2 5.0 3.4 4.6 1.8 3.0 4.5 5.5 5.3 2.7 7.4 5.7 4.8 5.7 2.3 2.9 5.3 2.6 2.8 5.5 3.6 1.6 1.4 2.2 2.5 8.6 2.9 7.4 2.2 2.5 2.1 2.3 4.0 6.5 1.2 3.2 4.5 2.4 3.3 1.8 3.7 7.3 4.7 3.2 3.3 2.4 9.9 3.5 6.5 1.8 1.6 4.4 6.7 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.0 2.7 6.2 5.4 1.2 1.4 0.5 1.1 1.1 2.2 1.6 2.1 2.9 2.7 2.6 1.3 4.3 0.7 3.1 2.1 0.9 7.1 8.5 2.3 0.0 4.2 2.2 8.8 4.2 1.2 0.8 0.9 1.7 3.1 0.1 3.1 2.6 1.6 1.3 2.8 4.5 6.3 6.4 1.5 1.0 9.9 1.3 0.0 1.3 1.6 3.4 11.4 1.1 0.6 3.1 1.5 0.0 2.7 0.9 3.4 1.1 1.5 0.1 2.3 8.3 2.8 1.5 0.9 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.0 4.6 4.5 5.1 5.5 3.6 8.6 2.9 4.0 9.9 0.0 0.0 0.0 0.0 0.0 0.8 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ZBTB21 "KIAA1227, ZNF295" ENSG00000173276 "Zinc finger and BTB domain containing 21" Q9ULJ3 21 41986831-42010387 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 53.2;Suprabasal keratinocytes: 55.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024655, HPA031757, HPA031758" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA024655: AB_1859171, HPA031757: AB_2674031, HPA031758: AB_2674032" "unprognostic (1.16e-2)" "unprognostic (3.51e-2)" "unprognostic (8.79e-2)" "unprognostic (1.79e-1)" "unprognostic (5.88e-2)" "unprognostic (4.61e-2)" "unprognostic (6.03e-3)" "unprognostic (2.19e-2)" "unprognostic (2.67e-1)" "unprognostic (6.21e-3)" "unprognostic (2.67e-2)" "unprognostic (4.59e-2)" "unprognostic (1.35e-3)" "unprognostic (1.81e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-3)" "unprognostic (4.02e-1)" 13.1 41.0 11.0 6.8 12.9 39.2 11.8 11.5 14.4 10.3 7.5 8.3 7.4 4.9 15.4 9.2 8.0 11.4 13.8 9.4 9.6 7.3 8.0 19.6 10.3 5.8 8.3 6.2 19.6 10.7 20.9 11.7 18.3 8.8 9.6 6.2 6.8 8.5 8.6 5.3 13.8 7.6 9.9 8.9 8.7 8.9 13.1 10.4 10.1 12.1 6.4 7.1 10.7 14.5 4.9 5.0 5.0 6.2 1.3 5.9 2.4 6.5 5.2 5.1 5.8 7.3 5.7 5.0 6.1 8.8 5.9 9.0 6.2 3.3 11.7 2.8 6.1 10.6 5.0 7.5 4.3 9.6 6.1 7.4 1.3 5.3 3.7 5.6 4.5 2.8 3.2 9.3 8.2 10.8 2.6 3.3 6.4 7.6 20.4 4.1 9.6 12.2 2.2 5.1 4.8 6.5 5.2 5.8 13.6 2.6 5.3 7.3 4.3 8.5 12.8 5.9 2.7 4.5 2.1 3.7 8.7 4.9 6.0 6.0 32.6 28.5 11.0 11.4 7.6 5.6 0.2 4.9 2.4 3.7 6.0 4.2 4.9 4.0 2.9 5.0 4.5 5.9 4.3 5.0 1.3 6.2 4.3 2.6 2.4 11.0 12.9 11.5 14.4 9.6 7.3 8.3 6.2 8.8 10.4 6.0 37.9 18.5 32.4 53.2 12.5 3.7 2.5 16.0 15.9 7.0 2.0 5.7 10.0 4.7 11.1 17.4 4.9 0.0 4.3 4.2 27.2 23.1 16.1 17.8 5.5 30.2 4.1 9.2 7.6 4.1 3.7 12.2 33.7 5.4 8.7 9.4 3.7 6.0 9.9 4.4 13.6 6.5 19.6 15.2 11.1 55.3 8.1 10.7 5.1 16.2 ZBTB22 "BING1, fru, fruitless, ZBTB22A, ZNF297, ZNF297A" ENSG00000236104 "Zinc finger and BTB domain containing 22" O15209 6 33314406-33317942 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043848 Approved Nucleoplasm No No Nucleoplasm "HPA043848: AB_10961146" "unprognostic (1.32e-1)" "unprognostic (2.87e-1)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (2.82e-1)" "unprognostic (1.31e-1)" "unprognostic (1.55e-2)" "unprognostic (2.06e-1)" "unprognostic (6.88e-2)" "unprognostic (4.98e-2)" "unprognostic (1.81e-1)" "unprognostic (6.54e-3)" "unprognostic (1.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.66e-2)" "unprognostic (9.32e-3)" 7.0 15.4 9.5 5.7 11.0 4.9 8.3 9.0 18.1 11.0 8.0 9.4 6.4 12.0 12.5 20.9 11.6 9.9 11.0 10.1 11.6 7.2 8.8 6.8 10.6 12.4 7.4 14.9 14.8 20.3 37.6 8.2 15.9 8.7 9.2 9.7 8.8 8.8 11.3 7.8 13.1 10.1 11.0 7.7 10.7 8.5 7.5 6.4 7.2 14.9 3.0 8.9 9.9 9.7 1.8 1.8 3.3 1.7 0.6 3.2 0.8 0.2 0.3 7.2 3.7 7.2 3.8 4.3 5.4 8.8 7.2 6.3 0.1 3.3 2.0 4.1 11.7 9.5 0.5 0.3 3.9 4.5 7.3 4.4 6.3 5.6 2.4 0.0 2.0 3.0 12.7 12.9 0.2 3.3 8.4 0.6 5.3 1.3 8.2 3.1 4.6 3.7 6.5 0.0 0.3 1.5 0.4 0.0 4.5 5.3 0.3 7.9 0.4 0.6 0.3 3.3 4.5 0.6 0.3 10.4 3.5 4.8 0.1 0.1 3.5 3.8 2.2 5.7 1.9 5.0 2.0 0.8 3.3 1.3 1.7 0.4 1.8 1.6 1.0 1.1 1.6 3.2 0.8 1.5 0.6 0.7 1.8 0.4 0.8 9.5 11.0 9.0 18.1 11.6 7.2 7.4 14.9 8.7 6.4 0.0 5.3 3.7 13.4 5.7 18.8 3.8 2.5 0.0 2.3 7.0 7.9 5.7 19.9 9.1 0.9 6.7 5.4 0.0 6.3 3.7 6.2 8.5 3.5 1.6 4.7 19.1 7.5 5.5 5.4 1.1 8.6 4.6 1.7 16.2 7.8 14.7 5.6 7.0 6.0 6.2 17.6 12.9 5.0 1.4 1.3 6.5 8.5 6.9 5.9 11.6 ZBTB25 "C14orf51, KUP, ZNF46" ENSG00000089775 "Zinc finger and BTB domain containing 25" P24278 14 64449106-64505213 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054699 Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054699: AB_2682579" "unprognostic (1.13e-2)" "unprognostic (1.86e-1)" "unprognostic (1.16e-1)" "unprognostic (1.64e-2)" "unprognostic (1.82e-2)" "unprognostic (1.11e-3)" "unprognostic (5.32e-3)" "unprognostic (4.21e-2)" "unprognostic (2.26e-1)" "unprognostic (7.33e-2)" "unprognostic (1.70e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (3.56e-6)" "unprognostic (3.29e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-2)" "unprognostic (1.04e-1)" 12.1 12.0 16.5 18.4 19.2 14.6 18.1 17.1 15.2 12.3 12.6 13.9 7.7 8.1 13.3 18.8 8.3 14.6 11.9 20.0 13.0 10.8 10.1 12.4 12.5 28.0 15.4 12.9 16.3 12.9 18.1 18.6 9.5 14.7 12.9 11.3 13.2 9.0 12.8 19.2 15.9 14.1 13.2 18.5 17.0 11.1 11.5 18.1 31.8 19.2 7.8 22.7 20.0 14.0 6.4 2.9 2.8 2.4 6.3 11.5 6.3 15.1 6.7 4.5 4.5 6.5 8.1 8.8 2.6 4.7 4.3 5.7 3.2 10.6 11.3 3.1 4.3 5.5 14.0 4.4 4.4 5.3 11.7 1.4 2.6 10.0 1.4 7.4 1.8 6.0 10.3 4.3 4.3 8.5 9.3 3.9 10.9 1.5 18.7 5.1 6.5 6.4 2.7 2.3 5.4 7.0 4.9 4.8 4.8 5.0 7.2 4.3 4.7 5.6 4.3 3.5 4.3 5.4 1.4 4.2 6.0 9.1 2.8 4.0 16.5 3.8 5.2 8.9 2.3 4.4 2.8 2.4 1.5 6.9 1.6 9.0 6.4 9.7 6.6 1.6 4.3 11.5 11.2 2.6 6.3 1.3 2.9 8.3 6.3 16.5 19.2 17.1 15.2 13.0 10.8 15.4 12.9 14.7 18.1 6.0 8.8 17.7 6.8 7.0 17.8 16.1 7.6 13.4 5.7 7.0 17.7 6.4 8.3 6.5 44.5 7.7 1.8 0.0 5.7 8.0 5.6 6.6 5.8 8.9 9.5 7.9 3.4 7.4 8.2 36.7 12.4 11.3 16.9 4.6 2.7 8.6 6.0 3.2 10.3 5.8 21.2 0.0 7.2 10.7 11.7 7.3 3.3 24.9 3.9 4.7 ZBTB34 "KIAA1993, MGC24652, ZNF918" ENSG00000177125 "Zinc finger and BTB domain containing 34" Q8NCN2 9 126860665-126885878 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023893 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA023893: AB_2219180" "unprognostic (2.96e-2)" "unprognostic (1.83e-1)" "unprognostic (2.72e-3)" "unprognostic (6.59e-3)" "unprognostic (8.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.96e-2)" "unprognostic (5.15e-2)" "unprognostic (9.32e-3)" "unprognostic (3.94e-2)" "unprognostic (2.55e-2)" "unprognostic (3.23e-2)" "unprognostic (9.71e-2)" "unprognostic (3.69e-2)" "unprognostic (2.01e-2)" 9.4 5.0 9.7 7.1 12.0 21.8 6.7 15.6 13.2 5.8 6.1 9.0 4.7 5.2 9.4 5.8 6.0 6.4 6.9 5.3 10.0 5.2 6.1 5.4 9.8 8.9 12.2 6.5 6.7 6.3 7.9 7.0 11.4 11.5 5.9 5.3 8.9 7.3 5.8 6.1 7.5 6.8 5.6 10.2 10.6 6.6 5.2 10.3 8.9 7.2 2.2 7.7 6.4 10.8 0.7 1.0 4.5 1.0 1.2 0.8 0.4 2.5 3.4 10.2 4.2 8.0 8.0 14.1 3.1 4.6 3.7 4.1 8.2 4.8 4.9 3.4 3.3 3.4 7.9 12.2 3.1 3.7 5.1 5.1 5.6 9.1 4.3 5.6 7.6 9.3 7.0 5.0 4.3 5.0 4.8 4.9 8.7 11.8 3.9 3.5 3.6 4.9 6.4 8.8 4.9 2.6 9.3 11.7 5.0 4.8 3.8 3.2 11.0 4.1 3.7 5.6 9.6 3.6 11.5 5.1 3.4 6.3 4.8 3.4 7.0 8.1 4.2 3.1 6.4 3.2 2.3 1.0 3.0 0.8 0.4 0.8 0.6 0.3 0.3 0.8 0.7 0.8 0.4 4.5 1.2 0.6 1.0 0.1 0.4 9.7 12.0 15.6 13.2 10.0 5.2 12.2 6.5 11.5 10.3 3.0 5.8 0.0 2.3 4.7 6.2 2.0 0.0 1.4 3.4 1.8 5.9 3.3 1.7 2.3 6.3 4.5 3.3 0.0 1.4 2.4 4.9 3.8 0.0 3.4 6.5 7.9 1.7 4.9 11.3 15.3 6.4 6.9 5.0 1.8 3.8 1.9 2.6 4.8 0.7 1.9 11.9 0.0 4.2 4.2 2.5 7.2 2.7 1.5 2.3 4.6 ZBTB38 "CIBZ, FLJ35036, PPP1R171, ZNF921" ENSG00000177311 "Zinc finger and BTB domain containing 38" Q8NAP3 3 141324213-141449792 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 52.0;RPMI-8226: 75.3;U-266/70: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014865, HPA059378" Enhanced Nucleoplasm No No Nucleoplasm "HPA014865: AB_2732412, HPA059378: AB_2683998" "unprognostic (1.78e-1)" "unprognostic (3.18e-1)" "unprognostic (2.97e-3)" "unprognostic (1.93e-1)" "unprognostic (2.78e-1)" "unprognostic (2.84e-2)" "unprognostic (4.01e-2)" "unprognostic (7.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.38e-1)" "unprognostic (2.01e-3)" "unprognostic (4.53e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (1.29e-2)" "unprognostic (1.04e-1)" 18.4 27.6 19.6 16.3 26.5 5.4 20.2 50.9 30.1 28.0 23.2 11.6 15.5 14.9 36.1 11.1 14.4 20.1 25.4 21.7 16.3 12.5 18.8 13.2 20.1 16.7 17.6 21.0 21.3 17.3 43.5 21.8 19.9 18.3 19.7 21.9 13.4 22.8 21.3 56.7 11.1 20.4 30.1 18.7 11.8 17.1 17.4 20.1 2.6 20.3 9.4 19.5 25.7 24.5 11.4 5.1 13.6 5.3 14.8 17.8 6.7 10.7 16.0 1.9 3.8 17.2 16.3 2.5 17.4 21.0 16.9 24.7 8.3 6.3 0.3 7.2 15.1 13.2 3.1 2.1 14.7 38.7 10.4 3.0 3.0 15.3 4.8 19.3 0.2 4.5 12.2 8.7 17.9 36.4 27.7 12.9 0.3 3.2 52.0 19.1 1.1 0.2 0.6 1.9 3.0 2.0 0.2 5.5 75.3 10.9 6.7 0.7 2.7 25.5 2.5 9.2 3.4 5.2 2.7 31.0 13.8 3.5 26.8 8.1 51.9 30.2 3.8 23.7 0.3 7.6 13.6 3.4 9.4 17.8 5.3 13.3 11.4 11.7 17.7 5.1 5.1 9.1 14.7 4.0 14.8 4.2 2.5 15.3 6.7 19.6 26.5 50.9 30.1 16.3 12.5 17.6 21.0 18.3 20.1 71.5 54.7 23.8 31.7 18.1 86.6 104.9 66.2 48.2 69.4 55.8 70.7 27.6 24.9 35.6 201.9 74.9 41.3 0.0 27.8 12.6 45.6 45.5 64.9 27.0 27.6 133.5 34.5 48.5 19.7 97.7 65.3 39.9 37.1 95.6 43.1 55.0 48.7 28.8 96.9 39.2 66.4 116.4 91.0 7.2 10.0 16.3 104.5 67.8 69.1 34.1 ZBTB40 "KIAA0478, ZNF923" ENSG00000184677 "Zinc finger and BTB domain containing 40" Q9NUA8 1 22451851-22531157 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042386 Approved Nucleoplasm NA NA Nucleoplasm "HPA042386: AB_10794649" "unprognostic (2.78e-1)" "unprognostic (3.39e-1)" "unprognostic (2.29e-1)" "unprognostic (5.17e-2)" "unprognostic (6.91e-2)" "prognostic favorable (2.01e-4)" "prognostic unfavorable (7.78e-8)" "unprognostic (8.11e-2)" "unprognostic (1.64e-2)" "unprognostic (2.44e-2)" "prognostic favorable (4.12e-5)" "unprognostic (1.52e-1)" "unprognostic (6.74e-2)" "unprognostic (1.98e-2)" "unprognostic (9.51e-2)" "unprognostic (6.66e-2)" "unprognostic (3.34e-2)" 14.1 21.0 8.3 13.5 12.3 11.2 10.8 18.0 12.6 13.9 11.7 14.1 10.9 10.6 21.5 10.5 8.8 13.1 11.9 8.4 9.6 6.4 11.7 8.2 11.5 17.8 12.9 7.3 15.3 15.5 19.0 31.6 8.5 11.6 13.6 11.6 13.5 14.6 10.6 12.7 11.5 18.1 14.4 12.8 23.2 12.5 9.2 13.0 16.6 14.4 6.8 19.5 12.9 14.8 2.5 1.7 1.6 2.1 7.6 3.0 0.8 7.0 8.0 13.3 14.0 10.0 8.4 12.0 6.1 6.7 9.4 10.3 7.2 8.7 8.2 7.3 7.3 7.7 9.1 13.5 6.5 11.3 10.8 11.3 17.4 15.2 8.5 8.7 10.2 16.9 7.0 9.7 12.5 9.6 7.4 8.1 11.7 18.5 0.1 7.7 5.2 6.9 13.0 8.0 5.9 6.7 11.8 10.4 9.3 4.7 7.6 11.2 9.2 11.5 8.5 4.9 8.6 16.1 8.7 9.9 11.6 9.6 11.9 6.0 5.7 7.5 8.4 7.0 12.8 8.3 1.6 1.0 0.6 2.4 2.1 3.0 1.8 1.9 2.0 1.7 2.5 1.9 2.3 0.4 7.6 1.0 1.1 2.7 0.8 8.3 12.3 18.0 12.6 9.6 6.4 12.9 7.3 11.6 13.0 11.9 14.7 11.3 3.1 5.0 13.1 11.0 10.2 6.7 15.9 1.8 29.5 4.2 1.7 4.9 3.6 6.3 3.4 0.0 6.4 3.7 4.7 4.3 15.1 2.9 4.1 11.1 15.5 4.9 4.5 4.7 5.5 4.5 13.5 0.0 5.2 8.2 5.8 7.0 6.3 1.9 23.1 12.9 5.2 5.9 8.5 3.6 2.4 5.1 5.1 2.4 ZBTB42 ZNF925 ENSG00000179627 "Zinc finger and BTB domain containing 42" B2RXF5 14 104800596-104804712 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 25.8" "Cell type enhanced" "Detected in many" 4 "Club cells: 11.4;Exocrine glandular cells: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 8.4" "Lineage enriched" "Detected in single" 8 "granulocytes: 8.4" "Cell line enhanced" "Detected in many" "HDLM-2: 13.5;MCF7: 22.8;T-47d: 18.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA066961 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA066961: AB_2685756" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (8.68e-2)" "unprognostic (1.59e-1)" "unprognostic (6.99e-2)" "unprognostic (6.67e-2)" "unprognostic (6.17e-3)" "unprognostic (2.56e-1)" "unprognostic (4.35e-1)" "unprognostic (2.70e-2)" "unprognostic (1.63e-1)" "unprognostic (3.42e-1)" "prognostic favorable (2.30e-9)" "unprognostic (1.34e-1)" "unprognostic (2.75e-1)" "unprognostic (1.58e-3)" "unprognostic (5.45e-2)" 4.8 4.1 1.1 2.4 1.3 0.1 3.8 0.7 1.2 4.5 4.7 0.9 7.7 3.9 2.6 6.2 5.4 5.6 10.1 4.1 0.8 0.6 4.8 9.9 9.0 4.6 1.2 0.6 5.1 25.8 2.0 1.7 2.4 1.7 7.5 2.1 3.2 10.6 7.3 6.9 2.8 5.2 1.5 1.3 2.9 6.6 2.4 0.3 3.7 6.7 4.5 4.8 3.1 2.3 0.8 0.7 8.4 0.3 0.2 0.9 0.3 0.9 3.0 0.9 3.7 0.7 0.8 3.9 1.3 1.4 2.4 2.2 1.9 3.6 0.3 2.7 1.3 1.6 4.1 0.8 1.3 0.4 13.5 0.9 1.2 1.6 2.2 1.2 0.3 7.4 1.5 1.5 0.9 0.5 1.7 1.0 2.7 2.0 2.0 0.4 22.8 2.4 1.9 0.6 6.1 2.9 3.5 0.2 1.8 1.8 5.9 4.2 1.8 1.0 5.6 2.4 0.9 18.9 1.4 1.7 0.9 2.2 0.2 0.4 2.3 1.2 0.2 3.1 1.3 2.0 0.0 0.3 8.4 0.5 0.1 0.9 0.8 0.7 0.1 0.1 0.6 0.5 0.8 0.1 0.2 0.1 0.7 0.6 0.3 1.1 1.3 0.7 1.2 0.8 0.6 1.2 0.6 1.7 0.3 3.0 9.4 0.0 4.0 0.3 0.4 3.8 10.2 1.4 11.4 0.0 0.0 0.9 3.3 3.6 1.9 1.6 3.1 0.0 11.3 1.4 0.6 5.6 0.0 6.4 0.9 0.0 5.2 1.8 3.7 0.0 0.6 1.0 1.7 0.0 7.3 2.6 7.2 2.9 0.4 3.5 0.3 0.0 1.4 0.6 3.6 0.1 0.7 0.0 3.3 4.0 ZBTB44 "BTBD15, HSPC063, ZNF851" ENSG00000196323 "Zinc finger and BTB domain containing 44" Q8NCP5 11 130226677-130314686 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052589 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA052589: AB_2681874" "unprognostic (4.04e-2)" "unprognostic (1.33e-1)" "unprognostic (8.03e-2)" "unprognostic (7.60e-2)" "unprognostic (4.13e-2)" "unprognostic (5.63e-2)" "unprognostic (2.19e-1)" "unprognostic (2.47e-2)" "unprognostic (1.93e-2)" "unprognostic (3.56e-2)" "unprognostic (1.38e-3)" "unprognostic (3.34e-1)" "unprognostic (8.45e-3)" "unprognostic (6.39e-2)" "unprognostic (2.19e-1)" "unprognostic (1.43e-1)" "unprognostic (1.78e-2)" 14.6 14.1 27.8 10.6 22.3 10.6 21.2 42.4 29.0 13.5 12.1 11.8 22.0 9.2 13.1 18.4 13.7 15.4 9.6 13.6 25.4 9.4 27.4 14.7 15.2 15.3 17.4 17.4 18.4 13.7 24.2 14.7 12.9 16.9 12.5 10.6 8.5 16.7 19.2 38.8 15.6 12.4 10.2 11.8 14.1 11.8 34.2 21.8 28.2 14.6 8.4 16.3 16.5 28.6 3.5 4.1 5.8 2.2 3.7 5.8 1.1 6.7 4.5 6.8 6.5 9.7 9.3 7.7 4.3 6.7 3.5 4.5 7.4 21.0 22.6 21.4 6.6 9.6 7.2 9.5 8.3 6.1 18.2 5.8 32.3 5.1 4.7 5.5 17.0 24.9 6.0 9.6 6.2 13.6 8.1 5.5 12.2 9.6 33.4 4.2 4.8 15.1 11.0 6.2 9.9 7.5 10.5 6.1 7.6 10.0 5.9 14.3 6.2 12.7 7.9 3.2 6.6 15.1 12.8 6.3 7.9 7.0 3.9 4.6 6.2 9.0 19.3 2.0 21.1 6.6 2.2 1.8 2.3 5.8 2.2 3.7 3.0 3.4 3.4 2.1 3.5 2.8 3.3 5.8 3.7 1.6 4.1 3.9 1.1 27.8 22.3 42.4 29.0 25.4 9.4 17.4 17.4 16.9 21.8 23.8 29.6 39.5 29.4 64.1 42.4 36.1 45.9 17.4 20.5 73.3 55.0 26.8 16.6 19.9 44.5 29.3 14.8 46.7 17.7 14.9 37.6 40.5 10.3 39.9 13.2 19.1 18.6 38.1 33.7 39.7 68.1 24.4 21.9 6.4 27.5 21.6 20.9 11.5 74.3 67.0 37.1 38.8 25.8 78.2 59.9 71.8 22.4 39.5 34.6 33.9 ZBTB46 "BTBD4, BZEL, FLJ13502, RINZF, ZNF340" ENSG00000130584 "Zinc finger and BTB domain containing 46" Q86UZ6 20 63743666-63831244 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 17.7;Ito cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "myeloid DC: 3.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.4" "Cell line enhanced" "Detected in many" "NB-4: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013997 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA013997: AB_1858961" "unprognostic (1.11e-1)" "unprognostic (1.96e-3)" "unprognostic (1.30e-4)" "unprognostic (3.13e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-2)" "unprognostic (9.33e-2)" "unprognostic (9.87e-2)" "unprognostic (1.92e-1)" "unprognostic (1.38e-1)" "prognostic favorable (2.17e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (3.54e-1)" "unprognostic (4.07e-2)" "unprognostic (6.70e-2)" "unprognostic (2.12e-1)" 9.2 4.6 6.3 3.8 4.3 2.3 6.0 24.2 6.1 8.1 1.9 2.6 3.2 2.2 9.9 8.0 2.3 6.7 4.4 10.1 4.3 3.8 7.3 3.6 6.4 5.7 4.3 3.0 12.4 6.2 3.4 8.8 7.1 5.3 3.8 1.3 9.4 5.1 6.6 7.3 2.9 3.0 3.3 2.5 14.8 2.4 3.5 2.7 1.8 8.5 4.4 2.0 4.0 10.7 0.2 3.4 0.3 0.6 0.7 0.7 0.2 2.5 2.5 8.6 2.8 0.4 0.9 4.7 1.2 2.9 0.5 0.3 5.9 6.7 0.4 9.1 0.1 3.2 2.5 0.5 0.1 0.4 0.9 2.3 0.5 2.5 5.4 2.0 0.8 1.5 0.5 0.1 0.1 0.0 1.3 0.8 0.3 3.2 0.8 1.6 6.2 0.4 11.8 1.5 3.3 5.4 3.2 4.2 3.6 0.5 1.7 8.6 2.6 2.1 5.2 0.8 4.9 6.4 8.1 0.7 7.3 4.1 3.5 1.4 1.8 4.9 0.8 1.3 1.7 1.3 0.0 0.4 0.2 0.6 0.6 0.3 0.2 0.4 0.6 3.4 0.0 0.4 0.4 0.3 0.7 0.2 0.1 0.7 0.2 6.3 4.3 24.2 6.1 4.3 3.8 4.3 3.0 5.3 2.7 0.0 0.6 0.0 1.1 0.3 4.2 9.0 2.5 0.0 2.3 1.8 17.7 3.5 0.0 1.4 0.4 7.5 0.0 0.0 0.5 0.7 2.5 1.9 2.3 0.0 2.6 1.6 1.2 33.2 5.4 0.9 7.5 2.5 1.7 2.8 0.0 3.8 1.8 0.0 8.1 1.1 9.0 0.0 1.8 0.5 1.7 0.4 3.1 0.0 0.1 1.6 ZBTB47 "DKFZp434N0615, KIAA1190, ZNF651" ENSG00000114853 "Zinc finger and BTB domain containing 47" Q9UFB7 3 42653684-42665854 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 28.1;skeletal muscle: 33.1" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 7.9;Early spermatids: 9.9;Melanocytes: 8.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 33.9;fHDF/TERT166: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074057 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA074057: AB_2686657" "unprognostic (1.03e-1)" "unprognostic (1.15e-2)" "unprognostic (8.23e-2)" "unprognostic (3.99e-3)" "unprognostic (3.74e-2)" "unprognostic (1.95e-2)" "unprognostic (2.07e-1)" "unprognostic (1.23e-1)" "unprognostic (2.74e-1)" "unprognostic (2.00e-2)" "unprognostic (4.86e-2)" "unprognostic (8.99e-2)" "prognostic favorable (7.96e-5)" "unprognostic (5.77e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (7.10e-2)" 5.8 3.3 11.4 3.1 18.0 0.5 2.8 3.3 11.3 4.8 4.4 15.7 0.7 1.1 5.4 1.5 4.4 3.1 4.4 28.1 16.1 4.7 1.2 2.0 2.6 2.1 8.6 9.1 5.0 4.5 2.7 3.0 2.1 6.3 4.8 1.0 2.9 7.6 6.2 33.1 2.8 1.4 5.8 12.8 1.7 3.0 3.1 16.7 0.7 5.2 4.2 1.6 3.7 3.3 0.0 0.9 2.8 1.6 0.3 0.3 0.4 3.6 3.3 2.0 1.3 33.9 13.2 0.7 8.8 7.6 3.9 2.8 0.7 1.5 0.0 3.6 18.0 1.4 0.9 0.5 3.4 0.8 0.0 4.4 2.2 9.5 0.8 10.4 0.0 3.0 14.1 6.2 4.9 4.3 10.0 4.2 0.0 2.0 2.6 7.7 0.9 0.1 0.3 1.1 0.1 2.2 2.7 3.9 1.0 2.1 0.8 2.3 3.8 4.1 0.7 3.3 0.9 4.6 4.8 9.5 8.1 4.7 7.8 3.5 0.1 0.0 0.0 7.4 2.6 2.4 0.0 1.6 0.1 0.3 1.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 2.8 0.3 0.9 0.0 0.0 0.4 11.4 18.0 3.3 9.3 16.1 4.7 8.6 9.1 6.3 16.7 0.0 0.6 0.0 1.2 3.5 4.8 7.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.6 9.9 1.5 0.0 0.0 1.1 0.1 3.0 1.1 4.6 0.5 1.2 0.0 0.0 1.8 1.8 1.4 3.1 1.3 8.5 1.0 0.0 6.6 0.7 0.2 2.8 0.6 1.7 0.0 5.6 0.0 0.2 2.8 0.1 0.0 0.0 1.0 ZBTB7A "DKFZp547O146, FBI-1, LRF, pokemon, ZBTB7, ZNF857A" ENSG00000178951 "Zinc finger and BTB domain containing 7A" O95365 19 4044364-4066945 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037214, CAB037285, HPA046387" Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB037214: AB_609875, CAB037285: AB_609874, HPA046387: AB_2679648" "unprognostic (8.88e-2)" "unprognostic (1.21e-1)" "unprognostic (3.02e-1)" "prognostic favorable (6.50e-6)" "unprognostic (7.54e-2)" "unprognostic (3.65e-3)" "unprognostic (3.71e-2)" "unprognostic (1.12e-1)" "unprognostic (1.56e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (2.99e-4)" "unprognostic (3.75e-1)" "prognostic favorable (1.34e-6)" "prognostic favorable (1.79e-4)" "unprognostic (2.01e-1)" "unprognostic (4.25e-1)" "unprognostic (1.36e-2)" 19.6 13.6 18.1 14.3 19.5 17.5 13.6 26.3 26.6 15.2 23.3 14.3 16.0 27.1 16.7 10.6 29.8 12.6 21.1 11.1 20.6 10.4 11.6 12.2 13.7 14.2 13.2 11.6 12.0 12.1 16.2 11.4 12.9 16.8 14.2 11.6 12.4 16.3 14.0 32.0 21.9 22.7 14.2 10.2 19.5 29.2 5.6 13.2 12.4 10.6 15.8 20.5 17.7 16.0 2.9 2.2 4.9 3.7 2.8 2.2 0.5 17.5 8.7 1.5 5.5 12.4 12.8 6.1 12.7 8.0 3.7 3.9 3.1 7.8 8.2 8.5 9.7 5.1 15.6 2.0 6.4 3.3 15.1 8.6 4.9 6.2 4.2 8.4 7.1 17.4 7.0 10.7 5.2 5.2 7.8 4.2 3.9 9.3 7.7 4.2 12.3 8.4 4.9 3.8 8.3 11.0 6.3 4.6 8.2 5.9 7.7 6.7 5.1 7.9 18.0 7.7 1.4 10.1 12.2 12.6 14.0 6.5 18.7 16.4 15.5 6.6 4.7 17.6 7.3 8.9 1.6 2.8 0.8 2.2 3.7 1.8 2.9 1.3 1.7 0.8 1.9 1.0 2.0 4.9 2.8 2.9 2.2 0.9 0.5 18.1 19.5 26.3 26.6 20.6 10.4 13.2 11.6 16.8 13.2 38.7 38.6 34.0 57.5 78.6 100.0 23.6 79.0 18.7 21.6 40.1 51.1 18.0 23.2 18.6 4.0 41.1 124.6 23.3 17.5 8.9 23.5 73.0 25.5 59.6 21.6 151.0 46.0 63.8 54.1 4.4 40.9 49.9 35.4 16.2 105.5 27.3 24.2 77.7 46.3 15.9 69.0 32.3 43.4 3.8 1.7 99.5 45.0 54.2 87.3 93.1 ZBTB7B "c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B" ENSG00000160685 "Zinc finger and BTB domain containing 7B" O15156 1 155002630-155018522 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 54.0" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 141.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006811, HPA025820" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006811: AB_1859046, HPA025820: AB_1859045" "unprognostic (5.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (4.36e-2)" "unprognostic (2.43e-1)" "unprognostic (4.95e-3)" "unprognostic (9.55e-2)" "unprognostic (1.41e-1)" "unprognostic (3.72e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.46e-2)" "unprognostic (5.35e-2)" "unprognostic (1.11e-2)" "unprognostic (1.82e-1)" "unprognostic (1.61e-1)" "unprognostic (1.53e-2)" 9.4 11.1 3.0 8.8 4.7 11.6 11.1 4.0 4.9 9.5 33.7 11.3 22.3 27.3 5.4 4.5 29.1 5.9 13.2 6.4 4.3 2.1 9.3 19.1 10.5 6.3 8.0 4.3 6.2 18.2 5.1 6.4 11.3 5.9 9.9 8.1 9.6 19.1 18.6 11.8 33.3 54.0 5.4 5.6 10.3 11.2 3.8 7.3 1.8 14.3 11.2 16.0 8.6 12.4 2.0 2.3 5.7 3.4 1.5 2.5 4.3 7.5 13.5 1.2 4.1 6.2 3.5 16.6 5.2 6.2 5.5 6.4 9.0 11.0 3.3 9.4 5.8 4.3 11.5 3.8 7.3 1.1 18.0 4.3 5.5 22.5 6.0 9.1 4.2 15.2 4.6 26.2 7.5 9.3 7.4 4.3 0.5 7.8 15.3 3.1 14.3 0.1 9.4 4.1 12.1 11.2 3.1 0.9 20.7 8.2 7.9 7.7 7.9 10.0 26.8 4.2 5.3 16.7 14.1 3.6 3.6 6.3 7.0 4.3 18.2 11.1 3.5 8.3 14.0 4.0 0.9 3.2 2.9 1.5 3.4 0.5 1.6 2.0 0.9 2.3 2.0 1.7 0.5 5.7 1.5 2.9 0.2 2.5 4.3 3.0 4.7 4.0 4.9 4.3 2.1 8.0 4.3 5.9 7.3 8.9 0.0 4.7 8.4 31.3 14.0 1.4 20.4 0.0 1.2 5.2 2.0 9.2 10.0 11.9 2.2 4.1 141.0 0.0 13.0 12.8 5.6 21.8 5.7 23.7 12.7 15.9 6.4 4.9 30.8 5.6 8.3 16.2 15.1 6.4 27.3 5.1 14.5 48.0 6.7 8.9 9.8 0.0 6.3 0.4 1.2 46.9 23.0 7.4 33.0 16.9 ZC3H3 "KIAA0150, ZC3HDC3" ENSG00000014164 "Zinc finger CCCH-type containing 3" Q8IXZ2 8 143437655-143541453 "Predicted intracellular proteins" "mRNA transport, Transport" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023658, HPA050577" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA023658: AB_1858973, HPA050577: " "unprognostic (1.15e-1)" "unprognostic (7.74e-2)" "unprognostic (1.87e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (4.06e-4)" "unprognostic (2.18e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-2)" "unprognostic (3.69e-1)" "unprognostic (3.32e-1)" "prognostic unfavorable (4.38e-7)" "unprognostic (3.59e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "unprognostic (2.18e-1)" 11.9 7.9 9.9 10.1 11.1 28.0 9.1 17.3 16.6 6.3 7.5 11.9 9.8 20.8 9.4 4.4 9.2 7.6 7.1 6.0 7.9 4.5 12.6 26.9 9.3 8.5 7.3 8.7 8.6 10.1 5.7 6.4 8.8 8.5 7.9 3.6 9.1 12.0 7.7 15.1 10.9 16.5 10.0 5.0 13.4 11.8 23.2 7.4 13.8 9.4 7.0 9.1 8.0 7.7 5.2 5.3 13.4 8.1 2.9 9.2 6.7 7.6 11.4 3.6 8.6 2.2 2.6 10.1 4.4 3.2 5.7 4.7 6.1 7.1 5.5 8.1 3.6 3.1 8.8 2.9 4.6 1.2 11.9 10.2 7.0 6.9 9.6 5.5 3.4 6.2 5.9 4.3 4.7 3.3 2.6 4.1 5.4 11.5 10.2 2.3 19.9 16.2 6.5 6.6 6.3 18.6 9.4 2.9 17.2 4.0 4.7 9.3 6.1 8.7 7.6 4.7 2.0 12.2 6.4 5.6 5.0 15.3 10.9 7.6 9.3 6.2 4.7 6.5 8.2 5.4 9.1 6.3 8.6 6.2 8.1 7.3 5.2 7.1 7.5 5.3 4.7 9.2 7.3 13.4 2.9 5.0 4.5 5.1 6.7 9.9 11.1 17.3 16.6 7.9 4.5 7.3 8.7 8.5 7.4 0.0 2.9 5.6 3.1 6.3 6.7 1.2 0.0 0.0 1.2 5.2 7.9 6.8 1.7 5.6 4.9 3.6 12.7 0.0 6.4 7.5 5.6 3.5 5.7 12.2 7.3 4.8 10.3 2.5 7.3 5.8 4.9 8.1 3.3 8.2 7.9 5.6 5.9 0.0 5.3 8.8 7.0 12.9 2.1 12.7 14.0 7.5 10.3 5.1 7.4 4.8 ZCCHC8 DKFZp434E2220 ENSG00000033030 "Zinc finger CCHC-type containing 8" Q6NZY4 12 122471600-122501073 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cone photoreceptor cells: 117.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037483, HPA037484" Supported Enhanced Nucleoplasm NA NA 130000 Nucleoplasm "HPA037483: AB_10671502, HPA037484: AB_10672485" "unprognostic (1.96e-3)" "unprognostic (8.48e-2)" "unprognostic (5.55e-2)" "unprognostic (5.24e-2)" "unprognostic (2.44e-1)" "unprognostic (6.30e-3)" "unprognostic (1.33e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (7.40e-4)" "unprognostic (1.03e-1)" "unprognostic (6.95e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (5.36e-4)" "unprognostic (8.86e-2)" "unprognostic (2.88e-1)" "unprognostic (2.55e-2)" "unprognostic (1.48e-2)" 13.6 11.9 12.8 15.0 14.2 44.3 13.9 25.5 17.6 15.8 11.7 9.6 19.3 11.1 16.0 10.9 14.3 13.7 9.5 9.0 11.7 6.3 10.6 14.0 11.9 12.2 12.4 7.2 17.3 16.4 14.2 21.8 13.2 9.9 13.3 10.9 10.4 13.6 15.1 21.7 14.9 13.9 14.0 12.8 14.5 13.8 14.5 14.4 19.5 15.8 10.5 17.3 14.6 13.3 10.5 6.8 9.0 8.8 10.0 12.5 5.4 11.6 11.5 17.1 17.6 7.5 10.4 21.8 14.0 9.6 18.8 14.5 10.9 10.1 21.4 9.5 6.0 10.2 14.4 19.1 8.9 16.0 17.3 11.0 13.2 12.7 9.7 18.1 22.7 14.3 8.3 13.5 11.8 16.3 15.5 10.0 20.3 19.1 12.9 9.1 7.5 16.2 17.5 15.4 8.7 13.1 17.9 14.1 16.7 9.1 6.7 12.0 12.9 16.5 8.6 19.0 17.6 15.7 17.2 10.1 11.8 11.6 10.3 14.0 13.8 8.0 28.4 6.2 14.1 6.8 9.0 7.2 4.7 8.9 8.6 8.9 10.5 9.9 10.6 6.8 9.4 11.0 9.0 5.7 10.0 8.8 6.6 12.5 5.4 12.8 14.2 25.5 17.6 11.7 6.3 12.4 7.2 9.9 14.4 29.8 16.9 24.1 26.0 18.2 28.5 8.1 20.4 18.7 37.5 8.7 117.8 14.9 1.7 9.8 63.3 15.8 12.7 23.3 8.3 14.2 15.5 18.3 18.5 13.4 11.2 14.3 18.8 10.4 12.3 37.2 13.8 18.1 15.1 17.2 14.0 16.4 12.1 11.5 13.8 5.7 66.5 6.5 17.5 31.1 11.9 22.5 27.0 17.0 14.0 19.2 ZDHHC23 MGC42530 ENSG00000184307 "Zinc finger DHHC-type containing 23" Q8IYP9 3 113947901-113965401 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.8" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 20.4;Late spermatids: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.7;naive B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016808 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA016808: AB_1859002" "unprognostic (2.10e-3)" "unprognostic (2.86e-1)" "unprognostic (4.48e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.49e-1)" "unprognostic (3.98e-3)" "unprognostic (1.37e-2)" "unprognostic (2.48e-1)" "unprognostic (3.19e-1)" "unprognostic (6.63e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-2)" "prognostic favorable (1.48e-7)" "unprognostic (2.58e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (5.90e-4)" "unprognostic (3.29e-3)" 1.0 0.8 6.3 2.1 5.9 0.4 1.9 2.7 10.4 1.4 7.7 0.9 2.2 6.0 1.5 1.6 1.7 2.1 1.8 1.3 8.9 1.9 4.7 3.2 2.4 2.7 0.9 4.7 1.1 4.4 8.2 3.5 0.4 1.4 1.8 9.9 1.2 4.9 1.4 1.2 2.9 5.4 0.7 0.9 1.9 5.0 25.8 0.6 0.8 5.5 0.9 2.8 1.7 1.5 2.7 1.1 0.5 0.0 0.0 0.5 0.1 13.1 3.3 0.4 7.8 1.2 0.2 11.5 5.2 1.6 1.0 1.6 5.4 8.9 6.1 4.6 3.0 8.6 8.7 10.0 1.4 1.7 3.6 4.6 5.6 4.8 3.3 0.4 6.2 5.2 0.2 1.7 0.2 0.6 1.2 0.8 6.5 0.0 3.6 0.1 7.6 5.1 0.4 2.4 13.6 3.7 0.9 4.5 5.0 5.6 6.5 13.7 3.5 4.0 13.5 2.6 3.2 8.1 2.1 0.2 3.8 7.6 0.8 2.3 4.0 5.2 9.8 3.2 4.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.1 0.0 1.7 0.1 0.0 0.5 0.0 0.0 1.1 0.1 0.1 6.3 5.9 2.7 10.4 8.9 1.9 0.9 4.7 1.4 0.6 0.0 1.0 5.9 1.6 2.7 1.8 1.2 10.2 5.3 2.3 15.7 7.9 0.6 0.0 2.1 20.4 1.4 15.7 0.0 1.6 1.2 0.6 3.5 0.0 5.4 0.4 0.0 13.3 1.8 0.3 26.8 1.1 1.2 3.3 1.0 12.2 3.8 0.7 9.5 0.0 3.4 0.7 0.0 0.3 11.6 1.9 2.4 0.2 0.0 11.4 1.7 ZFAND6 "AWP1, ZA20D3, ZFAND5B" ENSG00000086666 "Zinc finger AN1-type containing 6" Q6FIF0 15 80059568-80138393 "Predicted intracellular proteins" "Apoptosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034845, HPA052746, HPA077824" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA034845: AB_10671234, HPA052746: , HPA077824: " "unprognostic (2.04e-1)" "unprognostic (2.25e-2)" "unprognostic (3.26e-1)" "unprognostic (2.31e-1)" "unprognostic (1.29e-1)" "unprognostic (3.70e-2)" "unprognostic (4.26e-2)" "unprognostic (1.03e-1)" "unprognostic (4.91e-2)" "unprognostic (1.22e-1)" "unprognostic (1.74e-2)" "unprognostic (6.48e-3)" "unprognostic (4.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.45e-1)" "unprognostic (1.55e-1)" "prognostic favorable (8.20e-4)" 34.3 33.9 22.8 28.5 20.9 26.3 39.7 23.7 20.1 22.2 26.0 16.1 21.3 20.5 28.7 33.3 30.9 21.6 21.7 33.9 23.0 22.2 33.0 55.0 27.1 34.2 22.3 17.2 22.8 22.3 22.9 27.1 33.6 21.2 24.1 23.7 23.9 23.5 20.7 55.2 19.8 33.7 33.1 29.0 34.4 22.1 56.0 21.9 25.0 47.2 28.7 30.1 27.5 19.5 44.9 20.2 79.2 31.1 15.5 21.0 23.6 20.3 42.3 31.5 18.0 32.5 25.9 30.0 24.3 33.9 21.3 29.2 14.8 35.7 22.6 31.6 24.8 20.8 16.7 33.4 24.3 22.8 13.7 28.9 54.1 20.2 20.9 38.1 19.2 35.8 22.9 31.9 23.5 32.0 29.4 31.9 19.7 21.5 17.9 23.2 21.5 15.1 19.1 19.7 18.3 14.3 12.5 27.9 51.5 52.8 34.2 6.5 18.7 20.9 24.3 61.4 40.9 23.9 27.9 29.4 22.4 18.3 14.4 23.5 24.0 47.0 26.5 23.3 33.4 15.6 79.2 17.6 54.6 19.7 22.8 17.1 44.9 18.0 18.9 20.2 29.6 19.0 21.0 42.7 15.5 31.1 17.5 17.2 23.6 22.8 20.9 23.7 20.1 23.0 22.2 22.3 17.2 21.2 21.9 50.6 65.5 114.2 120.6 132.8 41.4 77.8 94.3 120.5 39.8 71.5 39.3 106.7 169.1 90.4 449.7 71.9 71.9 93.5 86.9 109.2 74.4 154.0 101.7 120.4 124.0 30.2 79.3 74.3 105.4 383.1 49.2 110.5 118.1 216.4 74.2 71.0 95.0 87.7 59.1 180.4 74.0 90.5 76.2 235.8 150.3 148.0 328.5 96.4 55.7 161.1 ZFHX3 "ATBF1, ZNF927" ENSG00000140836 "Zinc finger homeobox 3" Q15911 16 72782885-73891871 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Myogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Smooth muscle cells: 198.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059353 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA059353: AB_2683987" "prognostic unfavorable (1.55e-4)" "unprognostic (3.57e-2)" "unprognostic (1.68e-1)" "unprognostic (2.03e-2)" "unprognostic (2.81e-2)" "unprognostic (3.12e-1)" "unprognostic (4.24e-2)" "unprognostic (6.36e-2)" "unprognostic (9.94e-3)" "unprognostic (2.85e-1)" "unprognostic (1.06e-1)" "unprognostic (4.16e-2)" "prognostic favorable (1.37e-5)" "unprognostic (6.76e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (2.15e-2)" 7.9 6.0 2.5 2.3 4.6 1.1 11.3 1.5 4.1 7.5 7.7 5.4 14.5 2.0 7.4 7.3 4.5 4.9 18.2 4.9 4.3 4.8 4.4 6.5 6.1 1.4 4.0 2.6 4.4 5.7 23.8 6.3 8.1 5.5 12.0 3.5 10.5 5.0 19.5 16.9 3.6 3.6 15.5 9.7 3.9 5.0 2.3 5.2 0.5 10.8 4.0 1.0 16.7 14.7 0.8 1.0 0.2 1.6 2.5 0.1 0.2 4.4 7.9 12.9 10.7 4.8 6.1 13.3 3.4 3.7 2.2 2.5 9.0 2.5 1.9 6.0 6.4 3.0 3.1 8.1 4.0 3.0 7.8 2.0 0.3 10.8 12.8 4.4 1.3 3.2 2.2 2.4 6.4 5.8 2.0 4.1 0.9 0.9 0.5 5.4 9.2 0.4 2.6 2.3 2.3 1.3 5.9 3.5 0.6 3.5 7.5 9.6 3.4 6.0 1.9 4.3 6.2 2.6 0.6 8.8 5.4 6.4 5.7 4.5 4.9 1.6 1.4 2.6 1.2 4.1 0.2 1.6 0.2 0.1 0.9 0.1 0.5 0.0 0.0 0.7 0.8 0.0 0.1 0.2 2.5 1.1 1.0 0.1 0.2 2.5 4.6 1.5 4.1 4.3 4.8 4.0 2.6 5.5 5.2 65.5 26.1 8.1 52.4 15.0 87.0 16.5 43.3 32.1 48.9 45.4 21.6 35.9 5.0 23.2 1.9 28.2 6.0 0.0 20.2 18.1 50.1 96.3 20.7 30.0 55.1 22.3 25.8 42.4 67.6 1.3 9.8 55.4 20.3 24.4 18.0 18.0 20.8 21.0 18.7 6.1 31.2 122.9 198.8 3.4 17.7 15.1 51.9 3.2 29.3 41.2 ZFP1 "FLJ34243, ZNF475" ENSG00000184517 "ZFP1 zinc finger protein" Q6P2D0 16 75148492-75172236 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044916, HPA062910" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044916: AB_2679144, HPA062910: AB_2684902" "unprognostic (1.39e-2)" "unprognostic (1.84e-1)" "unprognostic (1.36e-2)" "unprognostic (1.38e-1)" "prognostic favorable (4.24e-5)" "unprognostic (1.36e-2)" "unprognostic (4.34e-2)" "unprognostic (2.99e-1)" "unprognostic (1.50e-1)" "unprognostic (4.43e-2)" "unprognostic (1.20e-1)" "unprognostic (1.13e-2)" "unprognostic (1.24e-3)" "prognostic unfavorable (9.80e-4)" "unprognostic (5.55e-1)" "unprognostic (6.64e-2)" "unprognostic (2.08e-1)" 6.0 5.9 13.7 4.6 14.8 4.1 7.4 14.8 19.0 8.6 6.6 8.9 5.9 4.2 9.1 5.6 5.2 7.1 6.6 7.1 12.8 9.9 7.8 23.2 6.1 6.7 10.2 10.0 11.4 4.9 11.9 7.1 7.1 12.8 6.7 5.0 5.0 3.6 7.8 7.4 4.8 4.0 9.5 10.7 5.1 4.5 7.6 9.4 18.1 11.6 3.7 7.4 6.8 5.0 3.6 1.9 3.0 3.2 4.4 4.7 2.2 2.5 5.3 7.4 6.8 4.2 5.7 3.0 3.1 3.6 7.0 8.4 4.3 1.9 10.7 3.5 2.5 2.7 3.3 6.8 4.5 7.8 5.6 4.3 3.8 2.0 3.1 3.8 3.7 12.5 3.9 4.4 4.9 6.5 7.0 4.5 10.1 4.6 2.3 5.0 9.7 13.0 3.5 2.4 2.0 2.1 12.2 3.3 3.4 2.9 2.1 7.7 6.0 7.8 2.2 2.8 2.0 5.0 3.0 3.1 6.4 6.7 2.9 3.4 9.5 9.0 23.9 3.0 5.2 4.7 3.0 1.7 0.7 4.3 3.2 4.6 3.4 2.9 4.7 1.9 3.6 3.9 4.1 0.1 4.4 1.4 0.8 4.4 2.2 13.7 14.8 14.8 19.0 12.8 9.9 10.2 10.0 12.8 9.4 6.0 3.7 2.4 2.0 4.7 4.6 3.1 2.5 2.7 2.3 1.8 0.0 2.3 1.7 2.9 3.5 3.9 0.4 0.0 1.9 2.1 4.7 1.4 1.1 10.6 1.8 12.7 6.9 2.5 4.6 4.3 3.1 1.6 1.7 2.8 0.9 6.5 1.6 0.0 3.9 3.4 2.9 0.0 6.1 17.0 8.2 5.1 3.4 4.5 1.7 2.0 ZFP64 "dJ548G19.1, dJ831D17.1, FLJ10734, FLJ12628, ZNF338" ENSG00000020256 "ZFP64 zinc finger protein" "Q9NPA5, Q9NTW7" 20 52051663-52204308 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035112, HPA058387" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA035112: AB_10672859, HPA058387: AB_2683702" "unprognostic (3.86e-2)" "unprognostic (8.84e-2)" "unprognostic (2.34e-1)" "unprognostic (4.61e-3)" "unprognostic (9.22e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.86e-7)" "unprognostic (4.68e-2)" "unprognostic (5.49e-2)" "unprognostic (3.35e-1)" "unprognostic (1.66e-1)" "unprognostic (1.03e-1)" "unprognostic (1.35e-3)" "unprognostic (2.22e-2)" "unprognostic (2.30e-1)" "unprognostic (2.29e-1)" "unprognostic (1.38e-2)" 9.4 12.1 11.5 10.6 14.5 9.7 10.1 11.6 18.7 12.7 13.2 14.5 12.6 13.3 14.4 9.7 16.3 13.9 15.0 9.4 10.5 10.3 10.9 11.8 9.1 12.1 10.2 11.9 16.7 10.9 14.8 11.5 8.8 11.6 16.5 11.5 15.1 13.7 12.3 9.4 22.3 13.0 11.0 11.1 11.6 11.9 12.8 9.2 22.9 14.3 12.5 16.7 13.6 13.6 8.6 6.7 12.4 6.6 7.8 7.8 4.3 19.7 11.1 8.6 20.6 4.4 8.0 12.4 6.7 10.1 15.0 12.7 10.5 8.2 8.7 13.6 12.2 12.6 26.8 7.0 15.2 9.4 3.6 21.7 5.2 19.9 11.3 12.1 5.9 3.9 7.0 23.3 7.6 8.8 7.8 10.3 9.5 6.2 11.5 3.8 8.3 8.0 5.0 8.6 10.9 8.5 8.9 4.5 8.7 7.1 8.0 8.9 10.4 13.2 16.7 12.8 7.5 11.2 7.1 6.7 10.6 15.8 11.6 4.3 12.3 11.1 7.1 10.3 5.9 7.1 7.4 5.4 12.4 7.8 3.1 5.7 8.6 5.9 6.1 6.7 6.0 6.8 6.4 3.2 7.8 6.6 6.5 5.3 4.3 11.5 14.5 11.6 18.7 10.5 10.3 10.2 11.9 11.6 9.2 3.0 3.5 2.2 4.3 7.7 5.0 3.9 0.0 4.0 1.2 0.0 2.0 3.7 6.6 6.9 4.9 3.5 4.4 0.0 5.0 7.1 4.3 3.1 6.9 5.0 3.5 1.6 6.4 11.1 3.8 8.0 6.1 2.2 3.3 1.8 10.2 2.3 4.7 3.5 6.7 3.8 4.8 6.5 5.1 9.1 2.1 11.7 1.0 4.4 8.4 2.5 ZFP69 "FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A" ENSG00000187815 "ZFP69 zinc finger protein" Q49AA0 1 40477215-40496343 "Predicted intracellular proteins, Transcription factors" "Lipid metabolism, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 6.0;Early spermatids: 5.9;Spermatogonia: 4.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "THP-1: 36.3" "Low region specificity" "Detected in many" "HPA027808, HPA054942" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA027808: AB_10601031, HPA054942: AB_2682644" "unprognostic (1.07e-2)" "unprognostic (6.00e-2)" "unprognostic (7.58e-3)" "unprognostic (4.15e-2)" "unprognostic (1.52e-1)" "prognostic favorable (9.31e-4)" "unprognostic (7.21e-3)" "unprognostic (1.72e-1)" "unprognostic (8.40e-3)" "unprognostic (6.34e-3)" "unprognostic (2.31e-1)" "unprognostic (4.46e-2)" "prognostic unfavorable (5.00e-6)" "unprognostic (1.05e-1)" "unprognostic (3.14e-2)" "unprognostic (5.98e-2)" "unprognostic (2.81e-1)" 5.1 3.4 8.3 5.8 8.5 4.1 5.1 6.8 5.8 4.7 5.3 7.5 5.1 4.4 5.6 5.6 4.4 5.2 8.9 7.3 6.7 5.6 3.7 4.7 5.6 6.3 9.0 2.4 6.8 6.7 8.1 3.1 5.3 8.6 5.6 4.9 3.9 4.9 6.0 1.2 6.7 4.9 9.7 8.7 6.9 4.8 8.4 8.4 9.4 5.2 2.9 6.8 6.1 14.3 1.1 0.6 0.1 0.5 4.8 2.0 0.6 3.3 0.0 2.0 2.6 2.5 2.6 3.4 1.8 2.1 2.8 3.3 1.8 2.6 6.0 2.4 2.9 3.7 2.7 3.8 1.6 3.3 5.4 2.6 4.4 3.0 2.9 2.0 0.1 4.8 2.6 4.0 1.9 2.9 0.9 1.6 0.1 2.5 0.0 1.6 1.7 4.5 5.6 3.8 0.3 0.0 2.5 7.1 2.8 1.5 2.5 2.6 4.2 3.1 2.9 5.1 3.2 0.0 36.3 0.7 1.3 2.6 3.6 0.2 0.1 4.6 3.8 2.4 0.9 3.5 0.0 0.5 0.1 1.6 0.2 2.0 1.1 1.2 1.9 0.6 0.6 0.6 2.0 0.1 4.8 0.4 0.0 0.6 0.6 8.3 8.5 6.8 5.8 6.7 5.6 9.0 2.4 8.6 8.4 6.0 0.0 0.9 0.3 0.9 1.3 1.2 0.0 1.4 0.0 0.0 0.0 1.0 1.7 1.3 5.9 1.8 0.3 0.0 1.2 1.2 0.7 0.2 0.0 0.9 1.1 0.0 0.0 0.6 1.5 2.5 1.1 1.4 1.7 1.8 1.4 1.6 0.8 0.0 1.8 0.5 0.8 0.0 0.5 2.7 4.6 0.4 0.2 0.7 1.4 0.1 ZFPM2 "FOG2, hFOG-2, ZC2HC11B, ZNF89B" ENSG00000169946 "Zinc finger protein, FOG family member 2" Q8WW38 8 104590733-105804532 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Gonadal differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.0;ovary: 37.8" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 18.3;Early spermatids: 43.3;Late spermatids: 22.7;Leydig cells: 22.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 67.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.4;ASC diff: 5.6;BJ hTERT+: 13.9;HHSteC: 10.1;hTEC/SVTERT24-B: 5.7;HUVEC TERT2: 10.6;K-562: 5.7;TIME: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004094 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA004094: AB_1859058" "unprognostic (4.48e-2)" "unprognostic (3.24e-2)" "unprognostic (7.77e-3)" "unprognostic (1.36e-2)" "unprognostic (3.51e-1)" "unprognostic (1.53e-1)" "unprognostic (8.37e-2)" "unprognostic (8.35e-3)" "unprognostic (1.97e-2)" "unprognostic (1.04e-1)" "unprognostic (1.97e-1)" "unprognostic (5.74e-2)" "unprognostic (1.69e-6)" "unprognostic (4.10e-3)" "unprognostic (5.41e-2)" "unprognostic (1.63e-4)" "unprognostic (2.61e-2)" 10.7 3.8 7.9 3.9 2.7 0.6 15.4 67.0 8.2 8.4 4.2 0.7 2.0 1.1 16.6 7.3 5.5 14.2 6.8 11.2 14.8 3.5 1.8 3.5 5.6 8.2 3.4 4.9 37.8 1.4 1.2 2.5 5.0 9.3 3.3 2.9 0.9 1.5 2.9 23.3 2.0 2.3 19.8 3.5 3.5 3.5 4.9 2.0 0.0 8.0 6.5 2.1 7.6 9.9 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 6.4 0.0 5.6 1.8 0.0 0.5 13.9 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 5.0 1.6 0.0 0.0 10.1 0.0 0.0 0.6 0.0 5.7 0.0 1.9 10.6 0.0 5.7 0.0 1.4 0.0 1.4 0.0 0.2 0.1 1.5 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.5 4.4 0.0 6.4 0.3 0.9 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 2.7 67.0 8.2 14.8 3.5 3.4 4.9 9.3 2.0 0.0 1.1 0.0 0.2 3.2 0.6 18.3 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 43.3 6.2 0.0 0.0 0.0 0.1 8.7 0.4 0.0 0.0 0.3 7.9 0.0 8.6 0.0 22.7 22.2 0.0 1.7 1.0 0.0 0.0 0.1 0.0 12.7 0.0 0.6 6.5 3.1 0.7 1.4 2.5 0.3 0.0 0.0 0.3 ZFR "SPG71, ZFR1" ENSG00000056097 "Zinc finger RNA binding protein" Q96KR1 5 32354350-32444761 "Predicted intracellular proteins" "Developmental protein, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016666 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA016666: AB_1859060" "unprognostic (7.45e-3)" "unprognostic (8.46e-2)" "unprognostic (4.07e-3)" "unprognostic (4.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.38e-1)" "unprognostic (1.47e-2)" "unprognostic (6.42e-2)" "unprognostic (1.58e-1)" "unprognostic (3.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.47e-2)" "unprognostic (5.46e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" 22.5 24.2 36.0 16.9 42.8 21.7 22.1 37.3 40.7 23.6 19.4 29.9 11.7 15.0 23.9 18.7 21.8 23.9 19.6 27.6 36.2 27.6 25.1 20.2 15.8 19.8 32.1 28.3 33.5 21.2 33.0 26.5 28.7 29.4 22.6 19.0 16.1 21.1 21.9 37.4 15.1 20.3 22.9 36.3 17.4 16.9 23.6 38.6 20.0 28.6 11.3 20.7 24.1 23.5 14.6 14.2 23.4 20.0 18.7 15.9 10.5 16.1 24.1 28.3 17.6 31.3 23.0 24.8 25.0 21.2 26.6 19.1 24.0 14.4 23.8 16.4 24.4 34.8 12.7 36.7 17.7 37.5 22.4 20.6 29.1 26.0 23.5 27.5 29.8 24.0 21.8 22.3 28.1 51.7 24.2 20.0 11.8 29.1 20.1 27.1 12.2 26.0 12.6 20.8 17.1 18.1 21.3 38.1 13.0 19.9 26.7 15.8 16.7 37.2 21.7 22.3 20.9 13.5 36.9 22.5 26.5 24.8 19.4 20.8 10.0 17.6 26.9 19.5 24.1 32.0 23.4 12.7 15.7 13.8 20.0 15.9 14.6 13.3 14.0 14.2 11.6 12.9 12.9 8.2 18.7 19.2 7.7 12.2 10.5 36.0 42.8 37.3 35.7 36.2 27.6 32.1 28.3 29.4 38.6 47.6 46.0 30.2 44.4 23.1 60.3 96.3 38.2 68.3 79.6 29.6 21.6 33.4 41.4 44.6 35.2 42.5 25.7 0.0 31.4 27.3 40.7 54.7 73.0 33.5 28.7 73.1 37.9 35.6 32.1 25.8 49.2 33.2 28.7 49.5 24.0 69.5 39.3 40.1 57.3 32.7 51.9 38.8 44.8 101.1 71.8 21.5 46.5 37.3 30.0 46.1 ZFR2 KIAA1086 ENSG00000105278 "Zinc finger RNA binding protein 2" Q9UPR6 19 3804024-3869032 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0;pituitary gland: 19.8;testis: 20.3" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 29.9;Cone photoreceptor cells: 25.5;Early spermatids: 21.1;Horizontal cells: 30.2;Rod photoreceptor cells: 35.3;Spermatocytes: 26.9" "Cancer enhanced" "Detected in some" "cervical cancer: 2.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "HMC-1: 17.8;NTERA-2: 30.6;SiHa: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043275, HPA055678" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043275: , HPA055678: AB_2682883" "unprognostic (1.74e-3)" "unprognostic (2.32e-3)" "unprognostic (4.05e-3)" "unprognostic (1.51e-2)" "unprognostic (6.60e-3)" "unprognostic (5.47e-4)" "unprognostic (9.12e-2)" "unprognostic (3.87e-2)" "unprognostic (1.18e-2)" "unprognostic (4.92e-2)" "unprognostic (1.97e-3)" "unprognostic (4.29e-2)" "unprognostic (3.58e-1)" "unprognostic (3.58e-1)" "unprognostic (5.81e-2)" "unprognostic (9.20e-2)" "unprognostic (2.18e-2)" 1.0 6.8 13.0 1.2 17.0 1.3 1.3 2.2 16.9 1.5 0.9 1.9 0.0 0.9 0.9 0.8 0.8 2.4 1.2 1.1 7.6 12.2 0.9 0.9 1.4 1.1 4.9 10.9 1.0 1.7 0.8 19.8 0.8 7.4 1.3 1.0 5.7 1.2 1.1 0.9 1.2 1.4 0.8 3.9 1.3 1.3 20.3 2.3 0.0 1.2 0.0 1.4 0.8 0.2 0.9 0.2 1.5 0.2 1.7 4.5 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 30.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.6 9.0 0.0 0.5 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.5 0.2 0.2 3.4 0.0 4.5 0.2 2.6 1.9 0.0 0.9 3.9 3.4 0.5 1.7 0.0 0.2 0.8 1.4 13.0 17.0 2.2 15.0 7.6 12.2 4.9 10.9 7.4 2.3 0.0 0.6 0.0 0.5 0.9 29.9 1.1 0.0 2.7 0.0 0.0 25.5 0.0 0.0 0.3 21.1 0.5 0.0 0.0 0.2 0.1 0.2 0.4 1.1 0.0 0.1 30.2 0.0 0.0 0.0 7.5 0.9 0.0 1.7 0.0 0.0 4.0 0.3 0.0 0.0 0.2 35.3 0.0 0.3 26.9 14.1 0.1 0.0 2.2 0.0 0.4 ZHX1 ENSG00000165156 "Zinc fingers and homeoboxes 1" Q9UKY1 8 123248451-123275541 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Horizontal cells: 138.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055357 Supported Nucleoplasm No No Nucleoplasm "HPA055357: AB_2682793" "unprognostic (4.36e-3)" "unprognostic (6.73e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (6.09e-4)" "unprognostic (8.73e-3)" "unprognostic (5.61e-2)" "unprognostic (9.22e-2)" "unprognostic (1.51e-1)" "unprognostic (2.01e-1)" "unprognostic (6.00e-2)" "unprognostic (7.97e-2)" "unprognostic (1.44e-1)" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.51e-1)" "unprognostic (1.30e-2)" "unprognostic (1.76e-2)" 21.1 12.6 23.9 9.4 23.1 9.4 16.8 21.8 22.5 18.8 13.9 13.3 19.0 14.8 14.7 14.3 30.7 15.7 12.5 12.3 23.6 18.7 19.0 31.0 11.6 9.3 20.3 16.2 18.1 13.9 28.6 25.2 11.6 18.8 17.3 12.3 10.6 15.6 18.8 14.4 21.8 19.9 16.8 23.8 14.1 11.8 8.0 24.4 13.1 31.2 10.7 11.8 16.4 24.3 4.4 5.8 4.0 14.5 7.5 6.3 3.3 10.1 4.6 6.4 7.5 12.4 10.4 4.1 12.3 6.9 9.2 10.7 8.1 4.4 15.4 16.6 14.9 4.1 7.0 18.1 11.4 11.7 30.5 9.3 24.9 10.7 4.8 8.4 9.1 12.1 7.8 12.9 12.5 10.7 7.9 7.1 7.4 29.1 12.3 13.6 30.8 20.9 4.0 1.7 21.4 9.8 10.8 5.8 11.0 8.1 23.3 31.1 11.6 14.1 40.0 4.8 3.9 16.3 10.5 6.7 14.7 19.4 11.7 8.2 11.5 31.6 17.4 9.9 17.1 4.0 1.7 4.3 4.0 4.9 7.6 6.0 4.1 6.1 4.3 5.8 4.4 5.9 6.1 1.5 7.5 14.5 3.3 6.3 3.3 23.9 23.1 21.8 22.5 23.6 18.7 20.3 16.2 18.8 24.4 23.8 21.7 12.3 21.5 33.0 40.1 27.9 22.9 21.4 30.7 19.2 45.2 8.4 26.6 14.5 8.8 27.5 25.3 23.3 19.3 5.3 27.2 19.1 27.7 58.6 13.1 138.2 41.6 22.1 21.6 14.7 43.1 17.9 25.3 12.6 24.2 40.4 14.6 30.6 60.5 28.8 31.1 38.8 27.2 26.2 22.2 54.6 8.0 17.3 20.2 21.3 ZHX2 KIAA0854 ENSG00000178764 "Zinc fingers and homeoboxes 2" Q9Y6X8 8 122781394-122974512 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 24.1;REH: 25.8;U-698: 24.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006769, HPA006996" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006769: AB_10669919, HPA006996: AB_10670555" "unprognostic (8.28e-2)" "unprognostic (3.80e-3)" "unprognostic (6.48e-2)" "unprognostic (6.90e-2)" "unprognostic (8.19e-3)" "unprognostic (3.61e-2)" "unprognostic (2.03e-2)" "unprognostic (2.68e-2)" "unprognostic (1.35e-1)" "unprognostic (4.80e-2)" "unprognostic (2.25e-1)" "unprognostic (1.36e-1)" "unprognostic (7.29e-2)" "unprognostic (2.03e-2)" "unprognostic (1.70e-1)" "unprognostic (7.61e-3)" "unprognostic (3.04e-1)" 11.3 12.4 14.6 26.2 14.8 7.1 12.7 11.1 16.2 15.1 8.2 22.2 9.8 6.0 15.8 10.6 10.8 17.7 13.9 16.3 16.0 9.8 9.7 15.9 13.2 26.8 19.3 10.3 31.5 20.3 10.1 13.5 7.1 12.4 16.9 7.7 12.7 13.4 15.2 31.1 9.3 11.7 13.6 14.3 15.9 8.3 5.2 20.0 17.9 15.3 10.9 24.7 17.7 11.3 12.2 5.4 9.6 1.9 6.9 7.5 3.2 2.6 1.3 7.7 1.5 3.8 1.2 0.0 1.6 5.1 1.8 2.4 0.3 8.9 24.1 6.7 5.3 1.4 2.2 5.1 3.1 2.0 10.8 3.4 11.2 1.7 8.5 4.1 2.7 3.5 3.3 3.7 1.7 9.1 8.7 2.0 4.4 0.4 8.5 2.1 7.6 2.5 2.4 4.2 1.4 1.8 25.8 4.2 1.9 8.5 6.8 3.3 1.9 6.5 19.2 3.2 5.4 3.3 6.0 3.5 1.4 3.7 1.7 3.4 2.2 0.0 24.7 1.4 2.1 2.3 9.6 1.0 5.2 6.9 1.3 7.2 12.2 5.0 6.7 1.2 11.0 7.5 5.9 5.1 6.9 1.9 5.4 5.1 3.2 14.6 14.8 11.1 12.8 16.0 9.8 19.3 10.3 12.4 20.0 6.0 2.9 16.4 4.3 4.8 2.4 8.9 12.7 2.7 1.2 8.7 0.0 0.4 3.3 9.4 7.5 6.7 3.1 0.0 5.5 0.2 7.8 11.8 8.1 9.9 1.7 4.8 4.1 7.4 5.4 1.9 9.8 2.5 10.1 5.4 4.8 12.8 7.0 3.5 18.4 3.7 0.7 0.0 18.1 0.5 0.1 7.8 1.1 15.2 3.4 7.8 ZHX3 "KIAA0395, TIX1" ENSG00000174306 "Zinc fingers and homeoboxes 3" Q9H4I2 20 41178448-41317672 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046498 Supported Nucleoplasm NA NA Nucleoplasm "HPA046498: AB_2679676" "unprognostic (6.26e-2)" "unprognostic (1.41e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.40e-2)" "unprognostic (4.50e-2)" "unprognostic (2.29e-1)" "unprognostic (3.88e-1)" "unprognostic (3.42e-1)" "unprognostic (7.25e-3)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.53e-5)" "unprognostic (3.06e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (7.52e-4)" "prognostic unfavorable (1.84e-5)" 15.7 18.6 19.8 7.9 24.7 4.1 19.3 26.8 27.6 13.7 13.9 18.2 7.0 10.6 13.1 7.8 16.8 12.1 10.6 12.8 21.1 13.9 33.2 13.2 11.3 8.0 17.0 16.9 20.4 14.4 22.7 10.5 6.4 15.8 11.1 10.3 13.7 6.1 15.6 29.7 11.4 10.5 20.1 17.7 5.1 13.1 26.6 20.3 4.4 23.2 7.8 6.1 15.7 17.4 3.1 0.9 1.6 0.9 2.3 1.8 0.5 9.4 2.7 2.9 6.1 23.6 25.4 3.3 13.3 15.3 12.4 8.4 4.8 1.2 6.6 6.5 24.9 3.3 3.0 3.4 16.8 13.3 1.8 3.0 2.7 3.7 3.6 9.7 3.1 3.5 15.5 8.2 9.3 12.1 8.4 5.3 5.0 2.5 4.6 16.6 18.9 4.9 1.8 1.2 4.4 10.0 2.4 8.1 2.6 17.0 2.8 10.1 3.6 8.8 5.2 3.2 2.6 5.0 4.4 8.5 31.1 4.7 10.9 6.5 5.3 3.2 2.9 12.8 4.7 4.9 0.3 0.7 1.6 1.2 0.4 1.7 2.4 0.9 0.8 0.9 3.1 1.8 1.7 0.5 2.3 0.9 0.6 1.1 0.5 19.8 24.7 26.8 21.9 21.1 13.9 17.0 16.9 15.8 20.3 17.9 13.1 5.2 3.0 2.6 16.1 10.1 15.3 2.7 6.8 21.0 3.9 0.5 10.0 3.6 77.4 7.3 6.6 0.0 2.2 2.5 8.7 2.0 1.1 25.9 2.5 38.1 14.3 15.4 4.3 27.7 17.3 3.3 1.7 1.0 4.4 29.4 3.4 0.0 23.0 17.4 6.9 25.8 7.2 9.8 4.4 3.1 0.3 0.9 3.8 1.8 ZIC1 "ZIC, ZNF201" ENSG00000152977 "Zic family member 1" Q15915 3 147393422-147510293 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 124.7" "Cell type enhanced" "Detected in some" 14 "Hepatocytes: 4.4;Leydig cells: 1.4;Muller glia cells: 4.2;Peritubular cells: 1.4;Rod photoreceptor cells: 1.5" "Cancer enhanced" "Detected in many" "glioma: 9.5" "Region enriched" "Detected in all" 8 "cerebellum: 124.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "AF22: 62.2" "Region enhanced" "Detected in many" "cerebellum: 232.6" "Region enriched" "Detected in many" 9 "cerebellum: 491.0" HPA004098 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA004098: AB_1859065" "unprognostic (1.33e-2)" "unprognostic (1.82e-1)" "unprognostic (4.01e-2)" "unprognostic (2.36e-1)" "unprognostic (9.32e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-2)" "unprognostic (2.19e-1)" "unprognostic (5.01e-1)" "unprognostic (2.61e-7)" "unprognostic (2.95e-3)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" 0.7 0.6 1.5 0.5 8.6 0.5 0.8 124.7 25.5 0.5 0.7 12.3 0.0 0.9 0.6 3.8 1.0 0.5 0.8 0.5 6.2 5.2 0.5 7.3 0.7 0.7 5.2 8.0 0.9 0.5 0.6 0.6 0.5 15.3 0.5 0.7 3.0 0.5 0.6 7.4 4.1 1.9 0.5 10.0 0.5 0.5 1.0 4.5 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 62.2 0.0 6.5 7.2 3.5 4.0 4.8 4.3 3.6 0.0 0.0 0.0 3.2 0.3 3.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.1 0.0 0.2 0.0 0.0 1.0 0.0 3.8 15.0 0.0 0.0 0.1 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 3.6 0.0 0.0 0.0 0.0 6.5 0.0 10.1 3.8 0.0 0.0 0.0 4.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 8.6 124.7 5.2 6.2 5.2 5.2 8.0 15.3 4.5 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 1.4 0.0 1.5 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 ZIC3 "HTX, HTX1, ZNF203" ENSG00000156925 "Zic family member 3" O60481 X 137566142-137577691 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 50.6" "Cell type enhanced" "Detected in some" 27 "Muller glia cells: 7.1;Rod photoreceptor cells: 1.1;Spermatocytes: 1.4;Spermatogonia: 2.7" "Cancer enriched" "Detected in single" 14 "testis cancer: 5.0" "Region enriched" "Detected in all" 8 "cerebellum: 50.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 35 "AF22: 24.0;NTERA-2: 26.7;SuSa: 16.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052936, HPA069523" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA052936: AB_2681993, HPA069523: AB_2732136" "unprognostic (3.55e-5)" "unprognostic (3.82e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" 0.3 0.2 1.4 0.4 2.5 1.1 0.4 50.6 5.8 0.3 0.4 2.7 0.0 0.5 0.5 0.2 0.3 0.3 0.4 0.3 1.9 2.2 0.3 0.3 0.4 0.4 2.4 1.2 0.4 0.5 0.4 1.1 0.4 6.1 0.5 0.3 3.9 0.7 0.3 0.5 0.8 0.5 0.2 1.9 0.5 0.4 3.9 2.2 0.0 0.5 0.0 0.4 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 26.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 16.2 0.3 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 2.5 50.6 2.6 1.9 2.2 2.4 1.2 6.1 2.2 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.4 2.7 0.0 0.0 0.0 0.0 0.0 ZKSCAN3 "ZF47, Zfp47, ZNF306, ZNF309, ZSCAN35" ENSG00000189298 "Zinc finger with KRAB and SCAN domains 3" Q9BRR0 6 28349914-28369177 "Predicted intracellular proteins, Transcription factors" "Autophagy, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA009637, HPA060116" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA009637: AB_2668244, HPA060116: AB_2732641" "unprognostic (2.71e-2)" "unprognostic (1.94e-1)" "unprognostic (8.12e-2)" "unprognostic (2.67e-1)" "prognostic favorable (4.93e-4)" "unprognostic (6.42e-2)" "unprognostic (4.63e-3)" "unprognostic (2.50e-2)" "unprognostic (8.65e-2)" "unprognostic (4.37e-3)" "unprognostic (7.09e-3)" "unprognostic (1.29e-1)" "unprognostic (8.20e-2)" "unprognostic (2.73e-1)" "unprognostic (2.00e-1)" "unprognostic (2.41e-2)" "unprognostic (3.10e-3)" 6.7 8.7 5.8 10.3 9.0 2.4 8.8 11.8 10.3 9.3 9.3 12.3 7.2 4.9 11.2 10.5 6.4 8.6 7.5 6.0 6.3 4.9 7.6 7.2 6.8 6.6 7.1 8.9 12.9 7.3 14.4 13.5 8.7 10.6 9.6 8.8 8.7 7.6 10.2 5.1 8.2 7.2 10.5 9.0 9.3 8.8 7.1 8.1 14.9 9.7 3.8 8.3 9.3 8.4 4.8 4.2 9.6 4.0 3.1 4.9 2.1 3.1 1.9 7.5 13.4 6.8 4.8 2.8 2.8 3.1 4.8 6.4 2.5 1.8 4.9 6.6 3.0 5.2 4.3 8.2 3.7 4.9 4.5 3.4 6.4 4.9 4.1 4.8 6.3 2.1 4.3 3.3 5.3 4.5 5.7 7.6 6.3 16.1 3.2 5.7 1.0 3.2 6.1 3.4 1.8 2.0 9.1 5.8 7.0 5.0 2.3 6.0 6.7 5.0 2.7 4.5 10.3 3.8 6.4 4.5 5.1 3.3 3.3 3.5 4.2 6.3 4.5 1.7 8.4 3.4 3.0 2.4 9.6 4.8 4.0 4.9 4.7 3.2 3.7 3.2 4.8 3.0 4.9 3.1 3.1 2.4 4.2 4.2 2.1 5.8 9.0 11.8 10.3 6.3 4.9 7.1 8.9 10.6 8.1 0.0 4.3 0.0 0.4 0.5 1.1 1.6 0.0 4.0 0.0 3.5 7.9 2.2 0.0 1.1 0.6 2.1 1.0 0.0 0.9 1.7 1.0 0.5 2.3 1.5 1.7 0.0 0.0 4.9 4.3 1.5 2.6 1.0 0.0 2.8 2.2 2.2 1.9 0.0 1.4 1.4 1.9 0.0 0.9 0.7 1.1 0.3 0.8 1.9 2.3 0.3 ZKSCAN4 "FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36" ENSG00000187626 "Zinc finger with KRAB and SCAN domains 4" Q969J2 6 28244623-28252224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 9.4;Spermatocytes: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA009637 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA009637: AB_2668244" "unprognostic (4.29e-2)" "unprognostic (2.88e-1)" "unprognostic (1.04e-1)" "unprognostic (5.01e-2)" "unprognostic (4.23e-3)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.90e-6)" "prognostic favorable (5.04e-4)" "unprognostic (8.73e-3)" "unprognostic (1.80e-2)" "unprognostic (7.20e-2)" "unprognostic (5.13e-2)" "unprognostic (2.13e-2)" "unprognostic (1.62e-1)" "unprognostic (6.07e-2)" "unprognostic (9.70e-2)" "unprognostic (7.36e-3)" 5.9 6.1 5.8 5.2 8.9 2.7 7.5 13.2 8.3 6.5 5.7 7.5 6.8 6.3 8.5 6.9 5.7 6.7 5.3 4.1 5.6 4.2 5.8 6.0 5.2 10.4 4.9 5.3 8.4 9.4 7.2 7.3 7.3 5.7 6.0 6.7 6.2 6.5 6.9 3.5 6.4 7.1 5.2 6.8 16.1 5.3 15.8 7.3 16.1 5.5 2.4 10.4 6.7 6.4 5.9 12.8 9.3 5.9 6.8 9.1 4.4 3.4 2.6 6.3 9.3 7.4 7.2 6.6 4.2 6.7 6.6 6.6 3.8 3.0 8.4 8.0 5.1 4.1 3.9 6.7 5.7 6.6 3.9 6.2 7.2 5.4 5.2 5.2 13.9 6.1 8.3 6.7 5.9 5.5 7.5 6.5 7.3 7.2 1.8 5.1 3.6 8.1 14.1 4.9 1.5 4.8 7.8 8.5 5.2 3.5 2.6 8.6 7.1 3.6 4.2 7.1 6.7 4.0 6.1 4.3 6.7 4.0 3.6 4.3 5.5 5.2 4.0 2.1 13.5 4.1 9.3 5.7 5.9 6.1 4.7 7.0 5.9 6.0 5.9 9.9 5.1 9.1 8.1 7.4 6.8 5.9 12.8 5.4 4.4 5.8 8.9 13.2 8.3 5.6 4.2 4.9 5.3 5.7 7.3 0.0 0.3 2.0 0.2 0.3 1.3 1.2 2.5 0.0 3.4 1.8 2.0 2.9 0.0 2.4 5.2 1.1 1.5 0.0 1.8 2.3 1.4 0.3 2.3 0.9 4.0 1.6 3.4 4.3 9.4 5.6 2.6 2.3 1.7 1.8 1.3 2.0 1.6 3.1 3.5 1.4 1.8 0.0 0.9 17.1 1.9 0.3 0.9 2.2 2.8 0.3 ZMAT1 KIAA1789 ENSG00000166432 "Zinc finger matrin-type 1" Q5H9K5 X 101882288-101932031 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "epididymis: 38.7" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 12.6;U-266/70: 6.3" "Low region specificity" "Detected in all" HPA012827 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA012827: AB_1859070" "unprognostic (9.30e-2)" "unprognostic (4.13e-2)" "unprognostic (2.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.08e-1)" "unprognostic (1.08e-5)" "unprognostic (1.20e-3)" "unprognostic (2.22e-2)" "unprognostic (3.70e-2)" "unprognostic (6.09e-2)" "prognostic favorable (1.72e-5)" "unprognostic (6.33e-3)" "unprognostic (1.72e-2)" "unprognostic (3.05e-1)" "unprognostic (5.28e-2)" "unprognostic (2.21e-1)" "unprognostic (1.38e-2)" 6.1 13.0 11.4 9.9 12.4 10.0 9.9 7.1 12.8 5.0 4.9 16.5 7.0 4.0 7.4 38.7 3.0 7.3 7.2 7.6 11.1 9.6 9.6 6.5 10.8 10.9 10.2 11.4 11.9 7.3 14.5 31.4 2.3 9.2 9.3 3.4 13.6 7.9 14.2 5.1 4.3 5.4 8.3 12.0 10.7 4.1 5.9 11.3 7.0 18.8 3.2 7.5 3.3 3.7 3.7 3.2 2.6 1.1 0.6 1.6 0.6 0.4 0.0 1.5 1.5 0.0 0.0 0.2 0.6 0.1 0.0 0.7 0.0 1.8 2.7 0.2 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.4 0.8 0.0 0.0 0.0 0.3 0.3 1.1 2.8 0.0 12.6 1.0 0.0 0.1 0.2 1.9 0.0 0.2 2.1 0.0 0.1 3.4 0.0 0.6 1.7 1.0 0.0 0.1 1.7 2.2 3.1 3.1 0.9 0.0 0.0 0.1 6.3 0.4 0.0 0.6 3.0 0.9 2.6 1.1 1.7 0.9 0.4 1.6 2.0 1.3 1.4 0.2 3.7 1.6 1.4 0.8 0.6 0.7 3.2 0.6 0.6 11.4 12.4 7.1 12.8 11.1 9.6 10.2 11.4 9.2 11.3 14.9 34.0 4.5 5.8 3.7 34.3 22.7 5.1 22.7 26.1 14.0 41.2 0.0 3.3 3.2 8.5 10.8 1.1 23.3 2.5 0.0 5.4 9.2 15.1 9.0 3.1 15.9 9.9 12.3 6.1 7.5 1.7 9.3 6.8 8.2 2.9 38.4 1.6 1.4 1.1 3.7 54.5 0.0 8.6 10.3 9.7 2.5 0.1 8.7 2.1 4.1 ZMAT3 "FLJ12296, MGC10613, PAG608, WIG-1, WIG1" ENSG00000172667 "Zinc finger matrin-type 3" Q9HA38 3 179017223-179072279 "Predicted intracellular proteins" "Apoptosis, DNA damage, Growth regulation, Protein transport, Translocation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 150.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 28.8;LHCN-M2: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027569, HPA028671, HPA054356" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA027569: AB_2732438, HPA028671: AB_2672725, HPA054356: AB_2682460" "unprognostic (3.53e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-1)" "unprognostic (1.46e-1)" "unprognostic (1.46e-1)" "unprognostic (1.88e-1)" "unprognostic (4.81e-2)" "unprognostic (3.57e-2)" "unprognostic (1.45e-1)" "unprognostic (4.37e-2)" "unprognostic (6.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.85e-2)" "unprognostic (7.09e-2)" "unprognostic (2.51e-1)" "unprognostic (3.91e-2)" "unprognostic (1.46e-2)" 7.1 11.9 18.8 7.1 19.7 4.4 8.3 7.5 27.3 9.1 8.4 9.6 4.4 4.9 8.5 8.6 10.0 8.2 12.6 8.6 15.8 17.1 9.1 16.2 8.2 9.2 16.9 13.3 7.0 7.3 15.7 10.1 7.8 17.4 8.6 12.6 7.1 7.6 11.5 5.5 8.4 5.4 15.5 14.4 9.2 7.2 4.6 9.4 15.7 10.6 3.2 8.6 9.4 6.7 3.6 1.8 3.9 3.3 4.0 5.8 1.3 2.0 1.4 4.5 2.6 21.7 24.8 10.4 8.0 12.4 1.2 1.5 1.8 1.2 8.5 4.1 13.1 1.8 1.9 1.5 8.8 2.7 6.1 2.4 3.5 2.8 5.7 17.3 3.9 5.6 28.8 16.6 2.9 5.8 19.1 17.1 2.4 1.9 1.0 31.8 2.0 3.3 0.7 2.0 2.8 1.1 3.6 4.1 1.8 6.9 4.0 0.9 4.7 2.5 2.3 2.7 8.8 2.8 1.7 19.1 18.4 6.8 3.1 3.7 1.0 0.9 3.5 11.0 0.5 12.5 3.4 1.8 3.9 4.8 1.3 2.7 2.3 3.5 3.9 1.7 3.6 5.8 4.2 2.3 4.0 3.3 1.8 2.5 1.3 18.8 19.7 7.5 22.3 15.8 17.1 16.9 13.3 17.4 9.4 50.6 150.5 11.0 9.5 35.1 19.2 17.1 33.1 33.5 54.6 33.2 23.6 6.8 6.6 13.0 0.7 12.3 11.6 0.0 18.0 2.5 17.4 17.4 37.1 30.0 15.3 58.8 20.1 19.0 40.6 1.5 18.7 15.1 49.0 47.7 10.0 11.8 21.3 12.9 27.3 14.6 10.8 38.8 27.2 7.1 12.8 32.0 3.7 20.8 8.3 9.2 ZMAT5 "SNRNP20, ZC3H19" ENSG00000100319 "Zinc finger matrin-type 5" Q9UDW3 22 29730956-29767011 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004858 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA004858: AB_1080657" "unprognostic (2.14e-1)" "unprognostic (8.03e-3)" "unprognostic (1.23e-1)" "unprognostic (1.19e-2)" "unprognostic (1.02e-1)" "unprognostic (5.47e-3)" "unprognostic (6.04e-3)" "unprognostic (5.69e-2)" "unprognostic (5.75e-2)" "unprognostic (3.71e-2)" "unprognostic (2.04e-1)" "unprognostic (2.15e-2)" "unprognostic (1.03e-1)" "unprognostic (1.52e-1)" "unprognostic (2.65e-1)" "unprognostic (2.62e-1)" "unprognostic (4.10e-2)" 10.6 20.3 18.7 10.6 21.5 13.4 11.9 11.8 20.2 13.2 12.2 16.4 24.9 12.9 13.8 22.2 15.5 22.4 11.1 20.4 16.7 14.4 14.7 18.4 14.0 13.9 17.1 16.9 16.5 20.9 18.4 8.5 8.9 16.7 14.0 7.9 13.5 19.2 19.2 34.2 13.0 10.8 14.7 17.0 15.0 13.8 13.3 15.0 16.0 21.3 11.9 12.5 13.2 12.2 26.8 34.1 42.2 41.8 26.0 26.8 28.3 10.1 12.9 11.4 21.9 14.3 16.0 5.2 11.1 14.0 16.9 20.8 11.0 6.4 6.9 11.3 11.8 13.0 9.5 9.7 11.6 11.3 22.2 21.1 26.6 6.5 20.4 26.8 12.1 8.8 13.9 17.9 21.6 13.2 14.4 17.8 11.0 6.9 15.3 14.0 15.0 17.3 12.7 4.2 19.8 15.1 21.0 20.3 18.4 13.4 6.2 8.9 16.4 10.5 13.2 15.6 6.7 19.8 17.1 11.3 23.3 11.7 15.6 16.5 14.2 11.3 11.4 17.8 14.7 16.3 20.7 39.9 42.2 22.8 41.8 22.8 26.8 23.8 23.6 34.1 24.4 20.9 24.6 32.4 26.0 40.7 26.4 26.8 28.3 18.7 21.5 11.8 20.2 16.7 14.4 17.1 16.9 16.7 15.0 14.9 21.0 14.0 18.0 8.5 11.8 1.2 17.8 14.7 10.3 14.0 17.7 19.0 28.2 29.5 0.6 11.9 18.2 23.3 23.7 15.0 17.5 10.8 33.4 11.5 39.9 4.8 13.8 12.3 23.0 1.5 14.7 22.5 11.8 34.3 16.9 24.6 26.5 17.3 20.5 30.5 16.7 32.3 19.6 8.6 23.8 10.3 11.8 23.5 13.6 16.0 ZMYM3 "DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261" ENSG00000147130 "Zinc finger MYM-type containing 3" Q14202 X 71239624-71255146 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003211, HPA075255" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003211: AB_1080661, HPA075255: AB_2732287" "unprognostic (2.17e-1)" "unprognostic (1.73e-1)" "unprognostic (1.31e-1)" "unprognostic (7.69e-3)" "unprognostic (2.03e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (5.18e-4)" "unprognostic (5.03e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-2)" "unprognostic (4.07e-2)" "unprognostic (1.17e-1)" "unprognostic (2.93e-1)" "unprognostic (2.73e-1)" "unprognostic (5.50e-2)" "unprognostic (4.42e-2)" "unprognostic (1.30e-3)" 7.3 23.7 22.5 7.9 20.6 6.2 7.9 16.6 22.7 10.8 10.4 13.6 10.3 7.0 14.0 19.2 8.0 19.8 11.3 9.3 19.5 14.6 10.6 9.6 10.8 10.9 16.8 20.6 36.8 8.2 15.3 14.4 7.8 14.0 14.3 8.0 10.5 11.2 18.0 9.5 11.1 8.8 14.8 14.1 12.1 9.0 15.9 17.3 13.9 12.6 6.4 10.4 11.9 10.0 9.4 13.5 6.8 7.3 6.0 6.8 5.0 7.1 13.1 31.8 16.8 9.3 9.4 8.1 6.6 9.9 14.3 13.5 14.4 10.8 18.0 16.5 11.8 13.0 6.7 27.1 10.0 10.9 6.0 14.5 15.7 11.6 12.8 4.3 14.6 9.8 11.0 5.8 10.4 6.5 25.6 12.0 14.6 18.0 10.0 10.5 11.8 17.5 18.7 31.6 8.8 11.5 22.0 9.7 13.3 10.6 8.7 15.2 10.5 11.2 7.0 6.5 24.2 10.3 9.6 9.2 7.1 13.2 10.3 5.9 9.1 5.4 15.4 8.6 20.0 7.8 6.8 7.3 5.6 6.1 6.3 6.8 9.4 6.8 5.6 6.4 9.0 6.0 5.9 0.5 6.0 5.1 13.5 6.3 5.0 22.5 20.6 16.6 22.7 19.5 14.6 16.8 20.6 14.0 17.3 11.9 11.0 1.7 2.2 3.4 12.7 7.3 7.6 2.7 15.9 29.6 9.8 6.9 1.7 5.6 1.0 7.2 3.9 0.0 7.7 5.0 5.1 1.7 2.3 13.1 8.3 12.7 4.6 5.5 11.1 3.1 12.7 6.3 3.3 12.6 8.2 11.6 6.5 10.2 21.9 11.8 7.1 6.5 4.4 1.4 3.6 3.3 3.5 4.3 8.2 1.3 ZMYM6 "Buster2, MYM, ZBED7, ZNF198L4, ZNF258" ENSG00000163867 "Zinc finger MYM-type containing 6" O95789 1 34986165-35031968 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011004, HPA071865" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011004: AB_1859075, HPA071865: AB_2686464" "prognostic favorable (1.30e-5)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (3.06e-2)" "unprognostic (3.92e-2)" "unprognostic (2.11e-6)" "unprognostic (1.77e-3)" "unprognostic (4.83e-3)" "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.70e-2)" "unprognostic (9.29e-2)" "unprognostic (7.15e-2)" "unprognostic (2.28e-1)" "unprognostic (1.72e-1)" "unprognostic (4.84e-3)" 12.8 14.7 9.4 13.3 15.9 21.3 11.6 16.3 16.0 10.7 10.9 14.6 9.8 11.0 13.3 13.6 12.8 11.7 10.7 10.8 8.6 8.3 11.7 9.7 12.2 14.9 13.8 10.2 15.9 11.5 13.7 33.7 7.9 17.0 11.0 12.9 12.5 12.9 11.0 8.0 13.6 15.3 11.9 16.7 20.1 11.6 14.9 10.1 16.2 15.4 8.4 14.7 12.5 11.2 10.1 12.3 9.0 9.3 6.5 9.3 4.3 9.3 5.1 9.4 8.9 10.7 13.5 5.8 7.8 11.7 9.5 10.3 4.0 10.3 13.0 8.4 11.5 6.4 9.2 10.4 8.3 11.6 8.9 6.1 11.4 7.4 5.4 9.4 15.8 13.4 11.3 11.9 10.4 8.7 7.2 10.5 10.3 17.5 14.2 9.4 3.1 7.3 10.7 9.4 5.3 8.3 10.3 12.4 7.3 7.8 7.3 9.8 9.1 9.1 8.6 10.7 9.7 5.7 8.8 10.7 11.8 8.7 12.4 11.5 8.8 13.4 9.5 12.0 15.2 9.4 4.6 9.3 9.0 9.3 7.5 8.1 8.1 6.4 5.3 8.3 10.1 9.1 6.1 4.9 6.5 9.1 12.3 6.8 4.3 9.4 15.9 16.3 16.0 8.6 8.3 13.8 10.2 17.0 10.1 11.9 13.9 8.8 4.6 5.4 12.2 13.7 10.2 6.7 6.8 15.7 19.6 3.1 5.0 5.1 1.3 5.2 7.3 0.0 4.7 2.8 5.4 3.5 9.3 6.8 6.8 12.7 3.5 6.7 21.1 1.1 7.8 15.2 1.7 11.8 7.1 7.7 4.7 6.8 10.6 5.8 18.2 12.9 8.2 13.4 17.7 5.6 4.5 6.9 7.9 5.4 ZMYND11 BS69 ENSG00000015171 "Zinc finger MYND-type containing 11" Q15326 10 134465-254637 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015816 Supported Nucleoplasm NA NA Nucleoplasm "HPA015816: AB_1845427" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (3.00e-1)" "unprognostic (1.12e-1)" "unprognostic (9.12e-2)" "unprognostic (2.33e-2)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (1.80e-2)" "unprognostic (3.73e-2)" "unprognostic (4.47e-3)" "unprognostic (6.35e-2)" "prognostic favorable (4.76e-7)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (9.04e-2)" "unprognostic (1.42e-1)" 19.9 19.6 35.7 12.8 35.0 5.1 23.9 38.0 32.5 26.4 26.9 27.3 18.5 15.4 28.8 24.8 23.0 21.8 18.5 28.7 34.1 27.7 26.9 17.8 19.7 12.0 33.3 26.2 30.0 24.2 63.6 24.0 17.6 27.5 28.0 17.9 17.0 21.6 30.2 29.1 16.2 15.4 49.2 38.0 15.5 19.5 15.9 28.9 7.1 46.0 13.4 12.4 31.3 29.6 4.4 4.0 16.2 2.8 12.3 10.7 4.3 23.8 25.4 20.7 16.5 23.4 22.8 12.5 24.4 14.2 17.3 16.3 15.2 24.0 0.0 7.8 30.5 5.5 14.4 11.3 17.5 22.2 9.4 9.2 26.2 13.8 16.3 25.5 7.1 14.8 15.8 22.8 16.8 15.6 22.3 21.4 12.6 7.0 17.4 28.5 29.2 11.0 9.6 6.5 25.8 4.4 10.5 13.4 12.5 21.9 28.1 9.2 17.0 27.0 32.1 12.6 12.2 28.9 13.8 27.7 17.4 6.1 34.0 18.4 14.0 17.7 1.7 17.3 13.4 11.6 9.8 2.0 16.2 10.7 2.8 9.5 4.4 7.7 10.7 3.1 3.0 8.3 8.3 0.9 12.3 1.2 4.0 7.2 4.3 35.7 35.0 38.0 31.4 34.1 27.7 33.3 26.2 27.5 28.9 56.6 41.4 13.5 22.3 23.0 34.4 88.2 28.1 30.8 43.3 31.4 11.8 12.6 43.1 24.9 22.3 40.7 12.7 0.0 27.4 5.0 32.9 37.2 44.0 24.9 12.0 19.1 24.9 27.0 21.8 20.1 36.2 14.0 23.6 9.0 27.6 64.0 24.4 10.5 52.6 34.6 19.8 12.9 40.1 22.4 25.8 24.3 10.4 17.9 17.9 21.6 ZNF134 pHZ-15 ENSG00000213762 "Zinc finger protein 134" P52741 19 57614233-57624723 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009064 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA009064: AB_1080668" "unprognostic (3.60e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.88e-1)" "unprognostic (4.29e-2)" "unprognostic (9.62e-2)" "prognostic unfavorable (5.21e-4)" "unprognostic (6.34e-2)" "unprognostic (1.35e-1)" "unprognostic (4.34e-2)" "unprognostic (1.48e-1)" "unprognostic (3.39e-2)" "unprognostic (1.17e-2)" "prognostic favorable (2.61e-4)" "unprognostic (1.56e-2)" "unprognostic (3.40e-1)" "unprognostic (2.52e-2)" "unprognostic (1.34e-1)" 10.8 12.6 12.7 9.4 17.7 18.9 13.7 26.2 14.6 11.3 12.4 10.6 10.9 6.4 13.9 11.6 11.5 12.2 9.5 11.5 11.3 9.3 10.6 8.8 10.6 12.2 10.9 13.4 14.5 8.7 24.4 18.9 14.1 13.7 13.8 8.5 12.1 12.1 16.0 13.5 15.3 10.8 14.6 10.0 13.1 10.8 14.2 9.9 17.1 15.3 8.4 14.9 15.9 9.7 10.2 5.1 8.0 4.6 12.9 9.8 5.8 1.6 4.4 10.6 5.7 4.7 6.5 5.4 5.0 7.5 6.7 3.4 1.4 1.9 3.3 3.2 5.6 5.1 1.4 4.8 8.4 11.6 0.0 22.4 10.4 4.4 4.1 7.0 6.8 7.8 8.6 8.4 5.1 11.5 8.9 4.5 5.5 1.3 3.9 10.0 2.4 13.5 2.9 14.8 1.0 9.5 8.0 15.6 5.2 5.0 14.3 8.5 10.0 7.5 3.3 4.9 12.2 4.6 5.5 5.8 10.1 4.4 2.3 6.0 10.5 13.9 4.9 5.3 1.2 6.6 1.9 4.6 8.0 7.3 3.3 9.8 10.2 7.7 7.9 5.1 9.5 9.0 9.0 3.8 12.9 3.5 3.8 4.7 5.8 12.7 17.7 26.2 14.6 11.3 9.3 10.9 13.4 13.7 9.9 8.9 2.6 11.2 10.5 4.7 8.3 9.3 10.2 5.3 5.7 3.5 11.8 7.8 6.6 7.2 0.5 6.4 1.2 0.0 3.2 3.3 5.0 8.1 5.8 4.3 4.6 7.9 1.2 5.5 4.1 0.9 6.6 4.7 3.3 7.2 4.8 9.1 3.0 3.5 13.8 4.0 10.4 6.5 7.2 0.9 14.3 6.8 13.6 9.6 3.8 12.6 ZNF140 pHZ-39 ENSG00000196387 "Zinc finger protein 140" P52738 12 133079838-133107544 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003655, HPA048332" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA003655: , HPA048332: AB_2680362" "unprognostic (1.88e-1)" "unprognostic (3.23e-1)" "unprognostic (3.17e-1)" "unprognostic (7.00e-2)" "unprognostic (2.90e-2)" "unprognostic (3.95e-1)" "unprognostic (2.02e-1)" "unprognostic (2.23e-2)" "unprognostic (2.24e-3)" "unprognostic (2.35e-1)" "unprognostic (1.21e-2)" "unprognostic (5.76e-3)" "unprognostic (7.67e-2)" "unprognostic (8.23e-2)" "unprognostic (8.08e-2)" "unprognostic (1.96e-2)" "unprognostic (9.13e-3)" 13.0 12.5 8.8 8.3 11.8 5.4 14.7 15.5 12.7 14.4 9.4 11.1 12.7 11.5 16.6 13.9 10.7 13.8 10.6 10.4 11.0 8.2 11.4 10.9 9.0 14.0 12.2 10.0 18.1 14.4 9.6 23.5 9.9 9.2 14.4 7.4 9.4 12.9 12.5 9.6 13.5 9.6 15.5 8.8 10.0 10.3 10.2 10.2 15.0 17.6 9.3 13.4 10.8 11.6 13.7 9.4 14.9 8.7 14.2 18.8 8.0 4.4 3.7 7.8 0.2 4.8 8.2 8.3 4.2 2.3 2.9 3.0 2.5 2.1 1.8 7.1 4.8 3.7 4.0 4.1 3.0 3.6 0.2 5.1 5.1 4.7 4.0 8.6 4.5 9.4 9.0 7.6 5.1 13.4 9.2 5.7 7.2 2.5 2.2 7.1 6.2 9.4 10.0 7.8 2.1 2.6 7.3 1.0 4.8 5.4 8.0 7.1 10.1 8.2 4.9 4.9 4.3 7.7 8.2 8.3 0.7 5.2 4.1 2.6 2.3 0.0 4.0 0.8 4.9 4.5 10.2 5.5 14.9 10.8 8.7 14.8 13.7 12.5 12.5 9.4 10.8 18.8 14.0 9.8 14.2 5.3 4.9 13.8 8.0 8.8 11.8 15.5 12.7 11.0 8.2 12.2 10.0 9.2 10.2 0.0 16.0 5.6 10.1 6.4 7.1 6.1 2.5 10.7 19.4 0.0 9.8 7.2 11.6 8.3 9.2 6.4 4.7 0.0 5.2 6.2 7.4 7.7 7.0 3.9 5.0 6.4 13.2 9.2 5.4 3.6 8.3 5.6 8.5 2.8 6.3 8.3 5.8 8.5 7.8 7.9 6.7 0.0 6.6 18.8 11.3 5.3 12.5 9.6 5.9 8.4 ZNF180 HHZ168 ENSG00000167384 "Zinc finger protein 180" Q9UJW8 19 44474428-44500524 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028979, HPA028980" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA028979: AB_10600328, HPA028980: AB_10611524" "unprognostic (2.25e-1)" "unprognostic (5.53e-2)" "unprognostic (8.34e-3)" "unprognostic (1.37e-2)" "unprognostic (1.82e-1)" "unprognostic (7.13e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-2)" "unprognostic (4.09e-3)" "unprognostic (1.33e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (2.37e-2)" "unprognostic (6.49e-2)" "unprognostic (2.21e-1)" "unprognostic (2.02e-2)" "unprognostic (3.38e-3)" 8.2 8.6 7.3 10.0 9.1 6.7 10.5 13.4 8.7 10.3 7.7 7.1 10.4 8.8 11.1 6.3 7.5 9.7 8.0 5.9 6.8 5.6 9.4 9.5 7.0 10.7 6.9 5.1 11.9 8.0 16.4 13.7 7.5 8.7 12.3 8.7 6.7 7.4 11.6 6.0 8.8 10.7 7.7 6.6 12.8 7.7 8.1 8.3 17.7 11.2 7.2 8.6 8.2 8.7 6.0 3.8 6.5 3.4 3.6 9.6 3.0 8.3 2.4 10.3 7.1 2.2 4.2 6.9 4.2 4.4 6.8 8.3 4.5 1.6 1.1 5.3 5.9 6.1 2.2 5.9 10.1 8.6 8.5 4.4 10.2 2.7 3.0 2.2 12.6 6.1 4.5 3.9 4.7 5.7 6.8 5.0 4.0 5.0 7.1 5.4 1.6 6.4 4.2 6.2 7.3 4.7 4.5 5.3 5.5 6.9 15.0 8.7 6.8 8.1 7.3 4.5 6.7 4.4 10.5 4.0 12.4 5.5 1.4 6.8 1.9 5.7 3.8 4.1 5.5 6.2 5.8 3.4 6.5 3.5 2.4 4.6 5.4 4.5 5.5 3.8 6.0 5.8 5.4 2.9 3.6 2.7 1.8 9.6 3.0 7.3 9.1 13.4 8.7 6.8 5.6 6.9 5.1 8.7 8.3 6.0 1.0 0.9 1.6 2.3 6.4 4.1 0.0 5.3 4.5 1.8 3.9 4.5 6.6 3.2 4.8 2.1 2.1 23.3 3.7 2.8 2.4 2.0 1.1 2.9 2.8 1.6 4.1 7.4 3.8 0.9 2.6 2.2 5.0 2.8 4.5 5.6 3.2 5.7 4.2 2.9 4.6 6.5 3.1 2.4 5.3 1.1 2.6 5.7 4.3 1.4 ZNF181 "HHZ181, MGC44316" ENSG00000197841 "Zinc finger protein 181" Q2M3W8 19 34734155-34745378 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA043701, HPA062305" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043701: AB_10960859, HPA062305: AB_2684743" "unprognostic (2.00e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-4)" "unprognostic (1.06e-1)" "unprognostic (4.83e-3)" "unprognostic (5.60e-2)" "unprognostic (2.28e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.01e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.06e-1)" "unprognostic (6.52e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (9.34e-2)" "prognostic favorable (5.45e-4)" 8.5 12.1 13.4 7.2 14.2 3.9 13.0 20.8 15.1 11.1 12.0 9.4 12.7 11.7 11.6 8.1 8.3 11.4 8.9 17.0 12.4 10.1 11.2 17.2 9.7 8.3 17.4 11.2 22.8 15.7 16.3 19.3 6.7 13.7 12.2 8.9 6.9 9.3 13.9 25.5 5.7 13.6 10.6 14.6 11.2 9.8 8.3 15.8 11.0 13.1 10.1 10.7 11.8 9.3 12.0 5.8 5.4 12.1 8.4 16.1 5.6 3.6 6.1 7.4 9.6 12.0 9.3 2.2 4.4 8.0 5.0 5.8 4.2 3.9 5.8 12.8 7.0 6.7 3.5 5.0 5.0 3.8 12.0 5.1 10.9 7.5 5.9 14.2 6.4 3.8 7.4 8.1 3.5 6.9 12.3 4.7 12.6 8.7 0.2 9.8 2.6 12.4 4.3 4.7 8.4 5.0 8.5 9.0 7.3 6.8 4.4 5.0 9.4 9.9 2.7 10.0 6.3 5.7 10.0 6.6 12.8 6.4 3.1 4.8 9.0 13.1 4.8 5.1 1.6 6.4 2.6 3.6 5.4 7.5 5.0 7.7 7.5 10.2 10.2 5.1 12.0 16.1 11.4 0.7 8.4 12.1 5.8 6.2 5.6 13.4 14.2 20.8 15.1 12.4 10.1 17.4 11.2 13.7 15.8 14.9 4.0 0.5 3.6 1.4 15.3 38.2 0.0 24.1 13.6 5.2 3.9 2.6 14.9 4.6 1.7 6.0 4.7 0.0 4.4 0.9 3.9 2.4 2.3 6.7 3.2 12.7 4.1 6.7 4.7 1.8 8.6 5.0 5.0 1.8 6.6 13.2 2.4 5.7 11.3 6.7 13.1 0.0 6.6 12.7 9.6 0.6 0.9 5.7 4.7 0.9 ZNF182 "HHZ150, KOX14, Zfp182, ZNF21" ENSG00000147118 "Zinc finger protein 182" P17025 X 47974851-48003978 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059574 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059574: AB_2684068" "unprognostic (1.86e-1)" "unprognostic (9.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" "unprognostic (4.45e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.88e-3)" "unprognostic (6.88e-2)" "unprognostic (8.81e-2)" "unprognostic (3.53e-3)" "unprognostic (2.42e-2)" "prognostic unfavorable (2.42e-5)" "unprognostic (1.01e-1)" "unprognostic (9.49e-2)" "unprognostic (8.59e-2)" "prognostic favorable (1.55e-7)" 6.8 6.9 10.2 7.3 15.2 8.7 8.8 22.1 12.9 8.3 6.5 7.1 5.4 5.7 8.1 9.7 4.7 7.6 6.5 5.0 9.1 6.4 7.7 7.3 7.0 11.9 10.2 7.1 9.9 9.4 11.0 16.9 6.7 9.9 8.4 7.1 4.7 6.1 7.7 4.2 7.3 7.9 6.1 7.7 12.6 7.3 5.8 12.9 16.1 13.2 3.5 12.1 7.0 8.7 7.9 4.3 7.4 8.5 4.9 9.0 4.4 3.6 4.8 6.2 5.9 3.5 4.0 2.4 4.7 5.6 6.9 8.3 3.7 4.9 9.4 3.5 3.0 6.4 4.5 10.1 2.7 8.4 6.6 5.9 4.7 6.2 4.8 4.4 8.7 7.7 3.4 5.8 5.8 7.0 8.2 4.1 9.3 4.0 7.0 6.3 2.7 6.7 15.6 9.7 2.4 5.7 5.7 11.6 10.3 6.0 2.5 5.7 7.8 7.6 2.5 4.4 14.1 6.2 7.6 4.1 5.5 6.0 7.8 3.9 9.3 7.6 7.3 3.8 7.4 3.6 3.1 3.4 7.0 6.2 3.4 7.0 7.9 5.6 5.7 4.3 5.6 9.0 7.5 7.4 4.9 8.5 3.2 5.2 4.4 10.2 15.2 22.1 12.9 9.1 6.4 10.2 7.1 9.9 12.9 11.9 6.5 3.7 0.7 0.2 6.3 2.7 2.5 4.0 2.3 1.8 2.0 1.8 0.0 2.3 0.3 1.4 0.7 0.0 1.6 1.1 1.4 1.0 0.0 2.1 1.4 1.6 7.5 4.9 4.6 0.0 2.3 3.3 3.3 3.6 4.4 3.8 2.5 1.4 1.8 1.9 2.7 0.0 1.3 3.0 2.0 1.0 0.7 2.5 2.3 0.9 ZNF184 ENSG00000096654 "Zinc finger protein 184" Q99676 6 27450743-27473118 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003226, HPA064793" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA003226: AB_2218705, HPA064793: AB_2732722" "unprognostic (8.86e-2)" "unprognostic (5.55e-2)" "unprognostic (2.27e-3)" "unprognostic (1.70e-1)" "unprognostic (4.99e-3)" "unprognostic (6.04e-2)" "unprognostic (1.99e-2)" "unprognostic (1.74e-2)" "unprognostic (1.17e-2)" "prognostic favorable (4.41e-5)" "unprognostic (2.59e-1)" "unprognostic (5.64e-2)" "unprognostic (2.77e-2)" "unprognostic (1.30e-1)" "unprognostic (1.05e-1)" "unprognostic (2.31e-2)" "unprognostic (5.79e-3)" 5.8 5.3 9.9 6.0 12.5 11.3 8.5 10.8 23.4 10.2 6.7 8.6 3.4 5.1 8.5 6.6 6.4 7.1 6.2 4.7 11.8 6.0 10.7 5.2 6.1 8.7 11.5 14.1 9.9 6.0 11.7 9.2 4.5 8.7 7.0 7.1 3.4 7.0 7.1 6.4 8.7 6.0 6.9 10.9 7.4 6.5 13.3 9.9 14.1 8.9 3.7 9.7 7.7 6.8 7.7 4.2 8.1 3.8 7.2 12.0 4.1 4.2 1.3 7.4 13.3 5.3 4.0 2.4 4.1 5.6 4.9 7.5 2.4 2.5 7.7 7.1 2.7 3.3 2.6 6.5 2.6 7.1 7.4 4.0 9.2 4.8 3.3 2.8 10.9 6.6 2.9 4.1 3.5 3.7 5.8 5.2 11.9 7.0 14.3 8.0 2.1 17.5 9.3 4.3 2.3 3.0 23.1 10.3 11.4 3.4 3.9 12.6 6.1 4.7 4.1 6.1 3.8 4.7 9.5 3.5 7.5 4.9 3.3 4.7 6.6 11.0 14.5 1.6 12.8 7.3 2.2 2.8 8.1 8.9 3.8 12.0 7.7 9.4 8.5 4.2 6.6 7.1 9.0 1.5 7.2 2.9 2.6 10.5 4.1 9.9 12.5 10.8 23.4 11.8 6.0 11.5 14.1 8.7 9.9 6.0 7.2 4.5 3.0 3.7 2.1 3.3 2.5 8.1 7.9 1.8 2.0 3.5 6.6 2.0 23.7 4.2 1.3 0.0 2.6 2.5 3.1 3.8 4.7 1.6 2.5 9.5 6.8 3.1 3.5 9.2 3.1 3.1 1.7 1.8 5.0 2.7 2.2 2.8 3.5 3.1 4.1 0.0 5.6 11.2 5.7 3.9 2.4 6.9 3.7 4.2 ZNF197 "D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41" ENSG00000186448 "Zinc finger protein 197" O14709 3 44584888-44648471 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 8.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054567 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA054567: AB_2682527" "unprognostic (1.06e-1)" "unprognostic (6.35e-2)" "unprognostic (6.10e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-2)" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (7.49e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.49e-2)" "unprognostic (3.14e-1)" "unprognostic (7.83e-2)" "unprognostic (1.23e-1)" "unprognostic (2.85e-2)" 9.9 9.9 14.0 12.4 16.1 4.2 12.7 23.7 15.4 13.5 10.9 8.6 18.3 8.9 13.6 13.4 8.3 11.0 9.2 9.8 13.2 12.4 10.2 12.8 9.4 9.7 15.0 14.0 18.4 10.2 17.8 23.5 11.1 16.0 13.7 11.1 9.2 9.0 19.8 18.2 10.8 8.8 17.6 18.3 10.1 9.2 10.1 16.2 11.8 15.9 8.9 9.6 12.0 15.7 2.7 3.2 0.9 8.4 2.5 1.7 0.7 3.0 1.4 14.0 4.5 7.9 8.6 0.4 6.2 7.9 5.4 5.8 3.0 2.6 3.0 3.7 5.2 3.1 2.1 7.1 5.4 6.1 0.7 1.7 12.7 5.3 2.1 7.6 10.2 3.3 9.1 8.1 5.8 9.8 7.9 3.8 4.4 7.9 5.0 8.7 0.7 5.8 6.7 9.2 3.3 4.4 1.9 10.1 3.7 5.7 3.7 6.0 10.1 5.8 2.7 8.4 7.9 7.8 8.8 4.4 6.0 4.3 8.4 5.1 6.5 7.5 2.0 4.7 3.1 5.9 0.6 1.4 0.9 1.5 0.6 1.5 1.1 1.4 1.4 1.9 2.7 1.7 1.0 0.9 2.5 8.4 3.2 1.5 0.7 14.0 16.1 23.7 14.7 13.2 12.4 15.0 14.0 16.0 16.2 14.9 5.4 3.7 4.2 2.3 11.8 10.1 2.5 5.3 14.8 0.0 7.9 1.0 1.7 6.4 11.8 4.5 4.5 0.0 7.7 0.5 4.3 4.0 3.5 6.7 4.0 15.9 5.8 5.5 3.5 2.2 5.2 3.6 5.0 7.2 6.5 12.2 5.8 7.0 4.9 3.7 8.9 6.5 4.2 10.8 5.3 3.0 0.3 5.2 5.0 2.6 ZNF205 "Zfp13, ZNF210" ENSG00000122386 "Zinc finger protein 205" O95201 16 3112560-3120517 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001791 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA001791: AB_1080688" "unprognostic (8.46e-2)" "unprognostic (1.57e-1)" "unprognostic (1.94e-2)" "unprognostic (5.72e-2)" "unprognostic (3.51e-1)" "unprognostic (2.28e-2)" "unprognostic (1.98e-3)" "unprognostic (4.14e-2)" "unprognostic (1.02e-1)" "unprognostic (6.71e-2)" "unprognostic (7.26e-2)" "unprognostic (6.17e-2)" "unprognostic (4.15e-2)" "unprognostic (3.46e-2)" "unprognostic (8.41e-2)" "unprognostic (9.43e-2)" "unprognostic (9.19e-3)" 10.7 10.6 11.4 7.0 13.6 3.5 9.8 16.4 16.8 11.8 11.1 14.2 17.2 13.9 13.0 9.3 10.6 14.2 14.9 12.9 11.5 10.1 13.6 12.4 10.3 5.3 13.0 12.1 17.2 18.3 16.5 10.9 11.0 12.0 12.9 6.1 10.2 15.4 14.8 30.6 19.0 11.1 9.7 9.0 9.0 11.5 5.6 14.3 1.4 14.4 9.0 4.6 8.2 12.4 0.6 0.3 1.5 0.5 2.7 2.4 0.6 7.6 9.2 8.8 14.1 3.5 4.7 12.1 6.4 6.7 8.4 10.4 4.9 7.3 0.3 8.4 4.0 5.4 11.9 7.7 6.6 4.0 2.0 15.5 3.2 12.8 6.2 7.9 0.4 1.8 5.1 10.4 8.0 5.5 8.7 9.6 0.2 6.8 5.8 4.2 12.9 0.1 0.3 9.3 5.0 7.6 0.4 11.1 6.9 4.9 4.3 12.5 10.9 6.6 14.3 9.3 4.8 10.1 2.8 5.5 8.5 9.8 8.2 9.0 0.1 5.8 0.3 3.7 0.4 7.1 0.0 0.5 1.5 2.1 0.4 1.8 0.4 0.7 1.9 0.3 0.6 1.8 2.4 0.2 2.7 0.0 0.2 1.1 0.6 11.4 13.6 16.4 16.8 11.5 10.1 13.0 12.1 12.0 14.3 0.0 0.0 2.4 3.8 5.0 7.3 1.1 10.2 0.0 0.0 5.2 3.9 7.8 5.0 10.5 0.7 5.6 15.6 0.0 11.8 12.1 5.6 2.9 4.6 8.3 7.6 6.4 9.9 7.4 4.6 0.9 15.8 2.5 5.0 5.4 13.2 8.5 11.9 7.0 18.4 12.2 8.2 25.8 5.8 1.7 1.1 4.8 4.0 0.0 12.0 1.6 ZNF207 ENSG00000010244 "Zinc finger protein 207" O43670 17 32350117-32381886 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017013, HPA063908" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA017013: AB_1859124, HPA063908: AB_2685149" "unprognostic (8.40e-3)" "unprognostic (1.84e-1)" "prognostic favorable (2.81e-4)" "unprognostic (7.57e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.30e-8)" "unprognostic (2.68e-1)" "unprognostic (4.75e-3)" "unprognostic (8.53e-2)" "unprognostic (5.18e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.17e-8)" "unprognostic (1.28e-2)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" 41.0 36.7 29.7 42.6 29.9 101.0 37.1 51.0 35.2 40.1 33.2 39.1 31.0 26.9 44.3 37.5 61.0 35.4 29.5 32.5 25.8 24.4 33.3 33.7 40.3 45.6 35.4 25.5 43.9 31.3 38.4 53.1 52.5 28.4 32.5 41.3 37.7 42.1 31.4 42.4 39.7 34.9 39.0 41.4 41.8 34.7 32.7 33.8 74.9 35.6 46.5 60.4 42.0 43.1 28.3 45.7 39.6 39.1 36.9 38.8 35.6 37.8 46.6 50.5 28.4 27.1 29.3 40.5 38.0 53.6 54.1 48.7 44.3 36.3 52.2 29.4 46.6 42.0 39.2 65.1 46.0 61.2 26.8 43.6 53.5 42.7 45.5 28.4 67.7 49.2 33.8 27.7 37.9 21.2 30.5 49.9 26.6 54.2 40.3 51.8 34.6 54.1 31.8 43.5 36.3 26.6 48.7 45.3 48.7 44.6 74.1 35.4 39.5 35.7 26.3 33.5 45.2 47.5 40.3 35.2 30.6 36.4 31.0 51.3 34.5 51.1 83.4 26.1 32.2 47.3 39.6 34.2 34.3 33.0 38.4 34.1 28.3 30.4 30.3 45.7 22.1 25.7 29.3 17.7 36.9 39.1 21.6 38.8 35.6 29.7 29.9 51.0 35.2 25.8 24.4 35.4 25.5 28.4 33.8 74.5 102.5 74.9 153.6 132.7 131.5 29.5 58.6 99.0 149.0 61.1 212.1 105.3 46.4 78.7 38.1 90.4 96.3 46.7 92.1 139.6 97.2 143.7 71.8 51.6 86.8 95.3 111.3 88.4 95.4 18.3 99.2 106.7 52.3 121.8 73.1 61.6 105.4 86.5 91.9 39.8 151.1 122.9 93.9 117.2 108.3 129.7 149.4 101.5 89.7 220.0 ZNF212 C2H2-150 ENSG00000170260 "Zinc finger protein 212" Q9UDV6 7 149239651-149255609 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049807, HPA054178" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA049807: AB_2680891, HPA054178: AB_2682406" "unprognostic (1.07e-2)" "unprognostic (6.31e-2)" "unprognostic (6.77e-3)" "unprognostic (3.66e-3)" "unprognostic (6.48e-2)" "unprognostic (2.79e-3)" "unprognostic (5.55e-3)" "unprognostic (8.75e-3)" "unprognostic (1.37e-3)" "unprognostic (1.15e-1)" "unprognostic (4.32e-3)" "unprognostic (2.46e-1)" "unprognostic (2.30e-1)" "unprognostic (4.75e-2)" "unprognostic (2.99e-1)" "unprognostic (1.60e-2)" "unprognostic (1.59e-1)" 7.3 10.9 8.0 11.7 8.8 16.3 11.2 12.0 13.0 13.0 12.4 11.5 13.1 14.2 14.4 12.6 19.1 11.4 11.9 6.6 9.3 6.7 9.4 12.8 7.4 11.0 7.0 11.8 13.7 10.8 13.0 10.4 19.5 10.5 12.2 7.7 10.9 16.7 12.8 9.7 16.5 13.0 8.1 7.3 15.0 9.1 20.5 7.8 21.8 11.2 6.7 12.9 9.6 15.8 5.8 5.7 9.4 4.5 10.5 9.1 2.7 8.3 8.3 10.2 12.8 7.2 5.9 11.3 5.1 7.7 9.2 9.3 7.0 10.7 11.0 7.9 5.0 7.4 7.7 7.5 8.3 7.6 8.4 13.4 6.0 5.9 5.8 5.5 9.9 7.5 6.7 9.6 6.3 6.7 5.7 5.4 13.6 11.0 8.5 5.3 11.9 17.8 20.3 13.4 6.6 10.0 12.2 7.0 11.9 5.7 7.0 10.3 16.8 7.7 7.6 7.4 6.4 4.5 10.6 4.5 9.3 2.6 11.8 9.2 19.7 8.6 9.9 12.2 9.0 8.4 0.0 4.5 9.4 7.0 3.8 6.8 5.7 5.2 5.8 5.7 5.8 9.1 7.5 2.6 10.5 4.4 5.0 7.5 2.7 8.0 8.8 12.0 13.0 9.3 6.7 7.0 11.8 10.5 7.8 6.0 3.5 5.9 2.6 8.7 6.7 2.4 5.1 4.0 0.0 0.0 3.9 8.1 3.3 4.7 1.5 3.8 6.6 0.0 3.4 8.1 2.8 3.7 2.3 5.9 3.6 9.5 6.4 3.1 4.0 0.0 5.8 2.9 1.7 6.4 6.0 5.8 4.1 0.0 5.6 2.4 8.5 12.9 1.7 13.4 18.6 7.5 12.6 6.5 6.3 3.3 ZNF219 ENSG00000165804 "Zinc finger protein 219" Q9P2Y4 14 21090046-21104722 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030761, HPA056168" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA030761: AB_2673598, HPA056168: AB_2683052" "unprognostic (9.82e-3)" "unprognostic (4.50e-3)" "unprognostic (3.35e-1)" "unprognostic (1.11e-3)" "unprognostic (4.49e-2)" "unprognostic (1.96e-1)" "unprognostic (2.54e-1)" "unprognostic (6.79e-2)" "unprognostic (2.62e-2)" "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.80e-3)" "unprognostic (6.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.56e-2)" "unprognostic (2.35e-2)" 20.9 26.9 11.6 7.9 7.8 4.5 50.2 22.3 12.7 18.1 26.7 5.0 31.7 23.8 15.9 13.6 20.3 10.1 20.1 22.6 10.4 9.4 12.1 10.5 16.7 10.8 13.2 4.8 18.8 13.2 16.1 8.9 7.4 13.1 14.1 11.8 11.3 22.5 27.4 16.4 38.8 26.7 22.6 4.3 5.8 12.1 8.0 4.8 15.3 11.8 20.0 7.3 20.8 17.4 0.5 2.1 2.8 0.4 0.7 1.3 0.2 3.4 11.8 15.2 22.2 2.1 2.0 21.8 4.4 6.7 2.2 3.5 6.8 7.9 5.2 3.3 1.6 2.5 26.1 4.8 13.9 1.5 10.6 5.1 3.1 16.8 14.2 1.3 0.6 4.9 3.0 11.8 3.6 6.7 3.0 2.7 4.9 2.9 1.6 1.2 9.6 6.9 4.9 21.5 6.7 2.5 14.6 2.5 1.3 1.7 19.4 17.4 15.6 6.0 3.5 3.2 3.3 4.3 1.8 0.5 2.7 12.3 6.7 1.7 2.8 1.7 1.1 1.7 2.6 5.3 0.0 0.4 0.1 1.3 0.1 0.1 0.2 0.3 0.6 0.2 0.5 0.6 0.5 2.8 0.7 0.0 2.1 0.1 0.2 11.6 7.8 22.3 11.8 10.4 9.4 13.2 4.8 13.1 4.8 3.0 12.5 1.4 11.5 13.2 34.2 6.5 10.2 2.7 1.2 3.5 25.5 8.0 1.7 7.4 9.9 5.3 22.0 0.0 9.6 0.8 6.6 6.8 14.9 7.8 6.8 11.1 7.5 6.7 9.1 2.9 9.2 5.3 8.5 0.0 15.4 25.4 7.5 5.8 11.7 6.8 24.9 12.9 11.3 2.6 3.1 13.7 10.4 4.3 25.2 12.0 ZNF22 "HKR-T1, KOX15, Zfp422, ZNF422" ENSG00000165512 "Zinc finger protein 22" P17026 10 45000475-45005326 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA016736, HPA054893" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA016736: AB_1859133, HPA054893: AB_2682632" "unprognostic (2.87e-2)" "unprognostic (1.10e-1)" "unprognostic (2.65e-1)" "unprognostic (5.77e-2)" "unprognostic (3.50e-3)" "unprognostic (3.42e-2)" "unprognostic (4.77e-2)" "unprognostic (2.01e-1)" "unprognostic (1.01e-3)" "unprognostic (9.31e-3)" "unprognostic (2.94e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.11e-5)" "prognostic unfavorable (8.06e-4)" "unprognostic (1.39e-1)" "unprognostic (9.96e-2)" "unprognostic (4.58e-2)" 28.5 7.9 15.3 14.5 14.0 12.4 38.6 13.5 13.7 15.7 12.1 9.9 14.7 10.8 18.0 14.0 11.4 15.1 10.5 14.7 14.2 13.0 17.0 22.8 14.1 19.9 14.9 10.2 21.6 29.2 5.5 11.1 22.6 13.6 18.1 12.5 10.2 12.9 11.9 14.0 6.2 13.1 13.9 15.6 17.8 12.4 9.0 14.5 40.1 25.4 11.7 19.1 12.2 12.1 19.8 24.7 13.4 10.9 25.2 25.2 13.6 11.5 1.8 16.2 10.0 8.6 6.2 0.1 5.4 11.1 13.9 15.1 6.4 9.7 11.9 8.9 8.0 3.1 1.9 15.5 5.7 19.8 7.4 0.2 12.4 3.0 0.0 18.0 24.0 4.3 11.0 8.4 5.7 0.2 0.1 21.9 32.6 16.2 21.6 10.9 0.3 44.6 36.3 9.7 6.6 3.2 32.9 22.5 16.8 10.8 9.7 15.7 13.5 4.9 9.9 8.0 15.5 2.1 24.1 12.1 10.2 18.8 7.1 18.1 12.4 12.1 11.4 6.5 0.9 10.8 8.0 10.9 13.4 21.0 10.3 25.2 16.0 13.7 21.6 14.3 19.8 18.9 23.1 1.1 25.2 6.5 24.7 7.7 13.6 15.3 14.0 13.5 13.7 14.2 13.0 14.9 10.2 13.6 14.5 26.8 20.6 39.5 55.7 17.1 32.7 8.9 53.5 41.5 30.7 31.4 9.8 60.0 48.0 50.3 2.7 58.3 4.5 46.7 37.4 50.1 50.3 45.8 31.3 47.9 42.0 36.5 38.4 77.3 24.7 2.4 41.1 26.9 18.6 74.9 34.1 47.6 36.1 10.5 48.1 37.2 30.4 32.3 36.2 37.5 34.5 11.5 44.5 30.5 34.2 25.9 ZNF225 ENSG00000256294 "Zinc finger protein 225" Q9UK10 19 44112181-44134816 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 18.9" HPA073778 Approved Nucleoplasm NA NA Nucleoplasm "HPA073778: AB_2686634" "unprognostic (1.52e-1)" "unprognostic (8.99e-2)" "unprognostic (1.36e-1)" "unprognostic (1.65e-1)" "unprognostic (1.45e-2)" "unprognostic (1.59e-2)" "unprognostic (9.03e-2)" "unprognostic (7.54e-2)" "unprognostic (1.26e-2)" "unprognostic (6.82e-2)" "unprognostic (7.18e-3)" "unprognostic (5.67e-2)" "unprognostic (7.54e-2)" "unprognostic (1.84e-1)" "unprognostic (6.60e-2)" "unprognostic (5.90e-2)" "unprognostic (3.17e-4)" 6.0 8.3 8.7 4.9 8.5 4.1 16.0 15.8 8.8 8.4 5.6 10.8 9.9 4.7 7.9 5.1 5.8 6.4 5.5 5.9 7.6 5.1 6.0 6.3 5.3 7.3 10.2 6.0 10.3 6.2 7.9 11.0 6.2 8.7 6.9 4.8 7.4 6.2 7.1 4.6 6.0 6.1 6.5 7.3 8.2 5.5 21.4 9.9 11.8 7.8 2.0 7.1 6.5 6.0 6.7 6.4 11.4 6.7 6.0 7.6 3.3 2.6 4.3 5.6 6.5 8.5 7.6 1.3 4.3 6.6 5.1 6.7 2.6 1.6 1.1 3.3 4.7 3.0 2.3 5.1 3.2 4.6 2.6 4.9 7.7 5.5 2.4 4.9 4.7 7.4 7.1 3.9 4.6 7.5 8.8 5.0 3.5 2.2 1.4 4.4 0.8 3.4 3.4 5.1 1.9 4.4 2.9 7.8 2.5 5.1 5.3 3.4 5.9 7.8 18.9 2.2 6.0 2.1 8.1 5.0 4.8 5.0 2.3 2.9 6.2 3.7 0.8 2.3 2.8 4.2 11.4 4.7 7.4 5.3 6.7 5.2 5.0 4.1 4.0 6.4 6.7 7.6 5.5 1.2 6.0 2.7 2.8 5.3 3.3 8.7 8.5 15.8 8.8 7.6 5.1 10.2 6.0 8.7 9.9 0.0 1.7 0.8 0.6 0.2 4.2 1.2 0.0 2.7 2.3 1.8 0.0 1.7 3.3 1.1 4.8 1.6 0.7 0.0 1.2 0.9 1.4 0.3 0.0 1.6 1.3 6.4 1.2 3.1 4.4 1.9 2.6 1.1 0.0 0.0 0.6 3.2 1.1 2.0 1.8 0.8 3.7 0.0 0.5 3.9 2.0 0.4 0.2 2.2 1.0 0.3 ZNF233 FLJ38032 ENSG00000159915 "Zinc finger protein 233" A6NK53 19 44259880-44275317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 25.2" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 23.3;Spermatocytes: 8.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 10.7;U-266/84: 10.0" HPA020975 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA020975: AB_1859145" "unprognostic (2.26e-1)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (4.78e-1)" "unprognostic (1.60e-1)" "unprognostic (3.72e-2)" "unprognostic (7.37e-3)" "unprognostic (2.77e-2)" "unprognostic (9.07e-3)" "unprognostic (1.48e-1)" "unprognostic (4.20e-3)" "unprognostic (1.65e-1)" "unprognostic (6.28e-3)" "unprognostic (6.88e-2)" "unprognostic (3.47e-2)" "unprognostic (2.71e-4)" "unprognostic (1.55e-1)" 0.6 2.3 4.4 2.1 6.3 3.9 2.5 10.9 8.5 1.3 4.3 0.8 0.2 1.9 0.9 2.8 1.4 2.2 1.8 4.8 4.1 5.0 2.1 0.8 1.2 2.3 3.3 6.1 1.2 1.6 3.1 11.2 2.2 6.2 4.8 2.2 2.1 1.6 2.3 2.5 3.8 1.8 1.6 3.4 2.2 2.1 25.2 2.4 3.3 3.5 2.7 1.0 1.6 0.8 4.7 3.9 3.3 1.2 3.4 2.2 0.5 0.7 2.7 3.1 3.1 3.2 0.6 1.3 1.2 0.8 1.0 1.8 2.8 3.3 1.2 2.9 0.8 1.5 1.3 0.1 0.7 1.1 0.6 3.8 1.9 3.5 2.9 2.2 1.3 1.3 0.7 0.5 0.7 1.9 4.3 1.3 1.4 1.3 5.9 0.2 1.6 1.0 1.0 3.2 0.6 0.8 2.0 0.4 2.4 0.7 2.4 4.3 6.4 1.2 0.8 2.1 5.7 5.1 1.5 0.8 1.3 0.8 0.9 0.8 10.7 10.0 2.2 4.4 1.3 1.4 3.3 1.0 0.9 1.6 1.1 1.5 2.7 1.4 1.1 0.5 4.7 2.0 2.2 2.4 3.4 1.2 3.9 2.1 0.5 4.4 6.3 10.9 8.5 4.1 5.0 3.3 6.1 6.2 2.4 0.0 0.3 0.0 0.1 0.0 3.7 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 23.3 0.0 0.4 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.5 0.0 1.2 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.7 0.0 4.2 0.0 0.1 8.7 1.9 0.0 0.0 0.0 0.3 0.0 ZNF235 "ANF270, HZF6, ZFP93, ZNF270" ENSG00000159917 "Zinc finger protein 235" Q14590 19 44228729-44305046 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045582 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045582: AB_10963792" "unprognostic (2.11e-2)" "unprognostic (1.67e-1)" "unprognostic (1.11e-2)" "unprognostic (9.91e-3)" "unprognostic (2.04e-2)" "unprognostic (1.23e-4)" "unprognostic (4.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.49e-2)" "unprognostic (3.37e-1)" "unprognostic (1.46e-5)" "unprognostic (1.20e-2)" "unprognostic (1.36e-1)" "unprognostic (2.87e-1)" "unprognostic (1.10e-2)" "unprognostic (2.65e-3)" "unprognostic (3.38e-2)" 5.6 4.8 8.1 6.6 10.4 1.8 8.1 13.9 10.3 6.1 7.7 10.7 10.1 5.0 13.2 6.5 5.2 7.1 4.9 6.9 7.8 7.5 6.7 5.5 6.6 7.4 8.5 4.1 8.1 6.2 10.1 9.0 7.3 9.4 7.7 6.0 6.9 5.8 8.2 6.5 4.4 6.4 6.9 7.1 8.2 5.3 6.8 8.5 10.7 9.1 2.9 9.3 6.2 5.9 10.9 8.3 14.5 3.7 5.6 7.5 2.4 2.0 3.2 6.4 6.4 4.8 2.9 2.4 1.2 3.8 2.3 2.8 2.0 3.5 3.4 3.2 2.4 3.6 1.7 5.6 2.6 2.8 0.0 6.9 7.3 4.9 2.9 3.9 4.1 4.4 2.9 3.5 2.6 3.1 4.0 3.8 6.3 1.7 0.0 2.5 1.6 6.7 0.8 7.6 3.5 2.0 3.3 6.1 2.9 4.6 5.0 4.6 13.0 3.4 4.1 3.0 6.7 3.2 5.0 4.4 2.1 3.0 0.6 1.4 7.8 7.8 2.4 1.8 1.1 3.4 14.5 3.7 3.6 6.8 3.0 4.7 6.9 5.1 5.8 2.7 10.9 7.5 6.5 2.0 5.6 2.9 8.3 3.7 2.4 8.1 10.4 13.9 10.3 7.8 7.5 8.5 4.1 9.4 8.5 0.0 0.0 2.7 0.6 0.5 1.7 1.9 2.5 0.0 0.0 0.0 5.9 1.2 0.0 0.9 0.9 1.4 1.1 0.0 0.0 0.4 0.7 0.8 2.3 0.9 1.2 1.6 0.0 2.5 1.8 0.0 0.6 1.3 1.7 0.0 0.7 1.2 0.4 2.8 3.2 0.4 1.6 0.0 1.9 2.6 4.8 0.5 1.3 3.9 1.0 0.1 ZNF24 "KOX17, Zfp191, ZNF191, ZSCAN3" ENSG00000172466 "Zinc finger protein 24" P17028 18 35332212-35345482 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024062, CAB025642" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB025642: , HPA024062: AB_1859150" "unprognostic (1.19e-1)" "unprognostic (3.25e-1)" "unprognostic (1.16e-3)" "unprognostic (2.42e-2)" "unprognostic (2.09e-1)" "unprognostic (1.49e-2)" "unprognostic (3.12e-2)" "unprognostic (2.79e-2)" "unprognostic (6.01e-2)" "unprognostic (7.69e-2)" "unprognostic (5.68e-2)" "unprognostic (2.44e-2)" "prognostic favorable (1.44e-4)" "unprognostic (5.25e-2)" "unprognostic (1.74e-2)" "unprognostic (9.27e-2)" "unprognostic (5.30e-3)" 17.2 19.5 26.9 17.7 39.8 17.9 30.5 33.5 33.3 19.7 17.8 31.9 15.5 16.9 20.6 19.7 16.3 16.7 15.4 17.0 28.3 20.0 20.8 25.7 18.9 22.2 44.8 21.5 23.2 21.6 31.4 32.6 19.6 28.4 22.5 18.5 14.5 20.1 16.6 26.8 13.7 18.8 18.1 37.3 20.4 20.6 16.1 42.8 27.4 28.6 14.5 21.5 18.0 15.1 23.7 21.8 31.0 20.3 15.5 19.1 10.9 8.6 8.8 28.2 14.7 12.0 13.0 7.9 11.9 13.5 14.8 17.1 5.6 7.2 19.9 13.5 9.9 11.9 16.2 20.7 11.2 25.6 18.0 11.3 14.2 17.6 12.0 12.6 29.9 23.0 10.9 19.4 13.2 14.4 17.1 14.0 12.6 21.4 12.9 15.3 10.3 22.7 12.8 14.6 5.8 6.0 17.1 18.3 15.8 14.9 20.2 24.1 20.7 14.6 13.7 25.5 15.3 12.8 22.9 11.8 21.4 9.6 5.0 11.8 32.9 26.4 20.3 11.9 12.3 19.4 18.6 15.6 17.6 19.0 14.9 18.6 23.1 19.1 16.2 14.2 23.7 18.7 17.1 31.0 15.5 20.3 21.8 14.1 10.9 26.9 39.8 33.5 33.3 28.3 20.0 44.8 21.5 28.4 42.8 53.6 50.0 42.5 56.3 29.2 56.6 41.7 35.7 62.9 64.8 24.4 41.2 34.7 23.2 38.6 86.9 37.9 27.3 0.0 36.0 25.2 35.1 59.8 41.7 43.2 30.2 74.7 53.4 40.5 31.6 19.7 50.3 37.6 21.9 30.7 37.6 91.6 37.1 37.1 47.0 28.5 80.2 45.3 29.9 45.6 53.9 28.4 59.2 44.5 29.2 61.8 ZNF248 bA162G10.3 ENSG00000198105 "Zinc finger protein 248" Q8NDW4 10 37776526-37858106 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 46.4;Cone photoreceptor cells: 45.2;Horizontal cells: 39.7;Rod photoreceptor cells: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018237, HPA018287, HPA018455" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018237: AB_2669815, HPA018287: AB_2669829, HPA018455: AB_2669869" "unprognostic (6.25e-3)" "unprognostic (1.16e-2)" "unprognostic (3.75e-2)" "unprognostic (3.15e-2)" "unprognostic (3.20e-2)" "unprognostic (6.51e-3)" "unprognostic (2.50e-4)" "prognostic favorable (1.04e-4)" "unprognostic (6.37e-3)" "unprognostic (2.05e-2)" "prognostic favorable (1.22e-4)" "prognostic unfavorable (6.71e-4)" "prognostic unfavorable (2.25e-4)" "unprognostic (2.70e-1)" "unprognostic (1.62e-1)" "unprognostic (9.51e-2)" "unprognostic (8.68e-3)" 5.1 7.7 11.0 6.4 18.3 0.7 8.2 29.8 16.2 11.7 14.0 9.5 11.4 5.7 16.1 15.5 6.1 12.6 7.0 8.0 11.5 10.3 6.3 4.9 6.4 6.3 11.2 12.7 14.1 5.8 17.7 23.8 6.7 11.4 13.5 9.6 8.4 7.4 18.1 7.9 7.4 6.8 12.3 7.7 7.4 6.7 7.0 13.3 3.1 14.2 4.6 6.7 8.0 8.9 6.7 3.8 1.4 1.8 4.0 8.9 3.0 5.4 4.6 1.0 12.9 9.3 7.9 5.7 5.6 2.9 5.8 6.3 5.6 6.9 7.2 4.9 3.9 4.4 6.9 7.4 4.0 5.1 12.5 8.2 8.9 9.5 6.8 4.7 7.3 6.1 3.2 7.6 3.0 2.5 11.7 5.3 7.9 3.8 5.2 8.5 2.6 7.4 4.8 3.9 3.6 24.9 6.9 13.1 5.1 7.2 2.7 5.4 10.4 4.8 2.7 3.2 8.4 7.1 2.1 5.2 5.3 5.7 4.2 3.4 8.2 8.6 6.0 7.1 9.8 2.5 1.1 1.8 1.4 5.7 1.2 6.2 5.8 5.1 4.8 3.8 6.7 8.9 7.6 0.2 4.0 1.6 3.5 2.6 3.0 11.0 18.3 29.8 16.2 11.5 10.3 11.2 12.7 11.4 13.3 11.9 11.8 6.6 7.0 1.8 46.4 19.3 10.2 6.7 9.1 5.2 45.2 5.0 6.6 3.3 0.6 5.6 4.0 0.0 1.4 2.6 8.5 4.5 4.7 3.9 3.7 39.7 5.2 5.5 1.3 1.5 9.2 2.8 1.7 3.6 4.0 22.6 3.4 3.6 11.3 3.3 40.3 0.0 10.3 8.4 10.8 2.4 2.2 3.3 4.9 3.7 ZNF251 ENSG00000198169 "Zinc finger protein 251" Q9BRH9 8 144720907-144756417 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018290 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA018290: AB_1859153" "unprognostic (1.16e-3)" "unprognostic (1.50e-1)" "unprognostic (1.47e-1)" "unprognostic (1.77e-1)" "unprognostic (6.87e-2)" "unprognostic (1.20e-1)" "unprognostic (4.26e-3)" "unprognostic (3.04e-2)" "unprognostic (2.53e-1)" "unprognostic (2.30e-1)" "unprognostic (5.75e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (1.42e-9)" "unprognostic (5.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-1)" "unprognostic (2.33e-3)" 10.1 6.7 14.1 8.6 11.8 4.0 10.5 26.0 12.5 13.1 9.9 12.0 8.5 8.7 14.3 25.9 6.4 11.3 11.2 7.9 10.2 9.2 9.8 6.6 8.4 10.8 10.5 9.6 13.8 9.0 17.6 15.1 10.2 10.0 11.8 12.0 9.8 12.0 14.2 11.5 8.8 9.6 11.1 8.7 11.4 10.8 12.0 12.8 9.9 19.6 6.1 10.0 9.5 10.4 2.6 2.4 2.3 0.9 2.7 3.7 1.5 5.0 1.9 11.3 4.2 5.5 8.7 1.2 6.7 3.9 3.6 7.0 1.1 5.2 5.8 4.8 5.4 3.0 7.7 3.4 3.7 7.0 3.5 3.3 6.2 16.1 1.3 4.7 1.0 3.4 7.7 4.7 2.7 3.6 11.5 3.1 9.6 4.3 1.7 2.5 0.3 5.7 0.6 4.8 1.8 0.0 8.3 1.6 2.5 1.0 2.2 5.6 4.4 5.7 1.8 4.5 6.3 4.2 1.9 1.7 5.0 10.6 6.5 4.6 3.9 1.0 6.5 4.3 2.0 2.6 0.0 0.2 2.3 1.8 0.6 3.3 1.4 2.8 3.0 2.4 2.6 3.7 1.2 0.1 2.7 0.9 1.4 2.5 1.5 14.1 11.8 26.0 12.5 10.2 9.2 10.5 9.6 10.0 12.8 0.0 4.0 0.5 3.3 1.9 4.9 2.9 2.5 8.1 14.8 1.8 5.9 1.6 5.0 1.4 14.3 5.7 1.3 0.0 1.4 1.1 2.7 3.2 1.1 1.0 1.3 4.8 1.2 0.6 3.8 5.8 7.2 2.6 1.7 3.6 2.1 3.1 1.6 1.5 4.2 2.4 5.7 12.9 2.1 8.7 11.1 2.8 1.1 3.5 1.7 1.7 ZNF256 BMZF-3 ENSG00000152454 "Zinc finger protein 256" Q9Y2P7 19 57940833-57947675 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 23.8" HPA055390 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA055390: AB_2682803" "unprognostic (2.47e-2)" "unprognostic (3.43e-2)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (2.95e-2)" "unprognostic (1.42e-1)" "unprognostic (3.03e-1)" "unprognostic (3.38e-1)" "unprognostic (3.49e-3)" "unprognostic (2.32e-2)" "unprognostic (4.73e-3)" "unprognostic (2.83e-2)" "unprognostic (6.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-1)" "unprognostic (1.27e-1)" "unprognostic (3.28e-3)" 7.4 5.1 8.4 6.7 12.2 16.6 11.0 22.7 11.3 5.9 6.6 7.2 5.8 4.4 8.2 8.8 6.1 8.8 5.4 11.2 7.4 4.1 6.1 3.7 6.8 8.8 7.9 8.3 11.2 4.6 8.7 9.8 8.7 7.4 7.9 5.8 8.6 7.0 8.4 9.4 13.5 7.3 7.6 5.7 9.5 5.4 8.4 7.4 7.1 8.8 4.9 9.8 7.0 6.0 7.5 5.4 1.7 4.5 4.6 8.9 3.0 2.7 0.9 7.0 7.1 1.5 2.5 6.1 2.3 2.5 3.8 2.6 0.5 1.6 0.0 2.2 3.1 6.0 0.3 1.6 5.4 6.3 0.0 23.8 6.7 0.0 1.8 2.8 0.0 5.6 4.9 1.5 2.8 0.0 4.0 2.3 6.6 0.5 0.0 4.0 0.6 9.2 0.0 8.5 0.2 6.0 3.0 8.8 4.2 2.8 12.1 3.6 5.2 0.0 2.2 1.7 9.1 5.3 2.2 0.9 7.9 4.8 0.0 4.7 3.3 3.2 12.2 0.2 0.0 3.4 1.7 1.3 1.6 4.5 4.5 8.2 6.6 7.8 6.9 5.4 7.5 7.7 8.9 0.6 4.6 4.0 2.6 6.2 3.0 8.4 12.2 22.7 11.3 7.4 4.1 7.9 8.3 7.4 7.4 0.0 0.0 2.0 4.4 2.4 4.0 2.5 2.5 5.3 0.0 1.8 0.0 2.9 3.3 2.7 0.2 2.8 0.5 0.0 0.7 1.4 1.6 2.1 0.0 0.6 1.1 1.6 1.2 0.6 0.6 0.0 1.7 0.3 0.0 2.8 0.9 4.0 0.7 0.0 0.4 0.7 6.8 0.0 1.4 1.6 8.1 3.0 2.2 3.3 1.2 3.4 ZNF264 KIAA0412 ENSG00000083844 "Zinc finger protein 264" O43296 19 57191500-57222846 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046330 Approved Nucleoplasm NA NA Nucleoplasm "HPA046330: " "unprognostic (2.19e-1)" "unprognostic (2.33e-1)" "unprognostic (9.26e-2)" "unprognostic (1.08e-3)" "unprognostic (3.60e-1)" "unprognostic (1.25e-2)" "unprognostic (1.23e-1)" "unprognostic (2.75e-1)" "unprognostic (9.92e-2)" "unprognostic (2.70e-1)" "unprognostic (2.19e-3)" "unprognostic (5.96e-2)" "unprognostic (2.16e-2)" "unprognostic (4.39e-2)" "unprognostic (2.04e-1)" "unprognostic (3.36e-1)" "unprognostic (1.65e-2)" 10.4 10.7 8.1 10.2 12.4 12.1 14.5 15.0 11.2 12.2 8.2 10.9 17.6 8.0 13.2 10.1 11.3 12.2 8.9 7.2 8.3 5.2 10.5 11.6 14.2 13.5 12.4 10.2 15.6 21.2 14.7 13.7 11.3 10.0 10.5 8.0 9.6 12.8 13.5 8.3 11.6 12.9 10.6 9.0 17.3 13.4 15.9 11.1 16.3 13.1 10.4 11.6 11.3 10.6 6.6 3.3 7.1 2.8 4.1 6.6 2.0 7.1 5.1 5.9 4.6 4.2 5.9 2.4 4.2 6.6 5.8 10.5 3.5 5.8 2.3 2.9 5.9 4.8 7.7 0.0 5.8 8.4 0.1 21.1 9.6 8.0 2.7 5.0 1.8 9.1 6.1 3.2 7.2 16.8 4.9 5.5 5.7 0.1 0.2 5.2 0.0 7.9 2.4 3.8 2.0 12.9 2.9 7.5 7.7 4.7 10.0 6.6 4.4 8.5 2.6 3.3 5.2 4.7 4.6 8.1 7.7 6.7 2.3 6.0 10.4 12.3 7.3 5.9 0.1 3.2 1.5 1.8 7.1 3.6 2.7 2.5 6.6 5.1 3.5 2.3 3.8 6.6 6.3 1.7 4.1 2.8 3.3 3.6 2.0 8.1 12.4 15.0 11.2 8.3 5.2 12.4 10.2 10.0 11.1 14.9 20.2 17.9 9.2 1.3 20.1 7.4 30.6 8.1 12.5 15.7 29.5 5.8 6.6 10.0 20.8 12.5 8.8 0.0 13.5 7.4 4.7 13.1 8.1 11.9 11.3 30.2 15.5 26.4 17.2 14.4 9.2 7.2 0.0 8.2 12.0 11.1 12.0 2.9 14.9 9.2 19.8 25.8 5.9 18.1 16.2 1.1 4.1 14.0 9.9 13.7 ZNF267 HZF2 ENSG00000185947 "Zinc finger protein 267" Q14586 16 31873758-31917357 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 94.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003866 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003866: AB_1080698" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (4.84e-2)" "unprognostic (6.24e-2)" "unprognostic (5.60e-3)" "unprognostic (8.64e-2)" "unprognostic (6.73e-2)" "unprognostic (1.31e-1)" "unprognostic (3.60e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (1.58e-6)" "unprognostic (2.34e-1)" "unprognostic (3.34e-2)" "unprognostic (3.95e-1)" "unprognostic (8.21e-2)" 19.3 5.1 5.4 21.3 7.2 23.8 9.9 8.2 7.5 10.7 9.8 3.9 1.3 7.3 7.3 7.8 14.6 6.4 10.6 6.6 5.4 5.3 9.2 6.8 21.7 20.4 7.0 5.1 8.2 6.1 7.5 7.1 10.5 7.7 8.6 7.7 3.4 10.3 4.3 10.8 5.7 11.2 6.3 11.1 31.1 6.8 9.6 8.0 20.0 7.9 11.0 18.4 12.3 8.7 9.6 8.3 34.8 11.5 6.9 8.9 5.0 5.1 5.3 5.5 4.3 3.9 4.7 16.7 4.3 7.1 6.0 9.1 10.5 8.3 9.0 7.8 3.4 5.9 6.7 8.8 6.8 11.5 13.8 7.4 9.4 3.3 9.5 3.6 10.0 22.3 6.5 4.7 8.4 6.2 4.3 8.4 7.2 15.1 22.3 8.1 7.1 6.8 6.7 5.1 4.0 3.3 6.8 15.4 8.1 6.8 23.0 1.8 2.7 6.6 5.8 6.1 10.0 3.5 14.2 10.2 5.9 5.2 5.1 7.1 12.7 6.9 9.5 7.7 8.3 3.5 13.8 10.8 14.4 5.8 10.8 8.5 9.6 7.7 5.8 8.3 6.8 6.0 7.2 34.8 6.9 11.5 4.9 8.9 5.0 5.4 7.2 8.2 7.5 5.4 5.3 7.0 5.1 7.7 8.0 8.9 10.1 20.4 34.3 28.3 4.3 5.2 5.1 20.1 11.4 3.5 0.0 12.4 6.6 15.6 9.8 23.3 4.6 0.0 17.4 8.6 20.6 27.4 59.9 2.0 19.4 11.1 7.5 9.2 23.5 5.2 5.5 52.4 13.5 94.6 4.9 3.1 30.8 5.8 3.2 10.0 3.9 0.0 13.7 15.8 29.5 22.3 7.0 23.0 3.8 46.4 ZNF273 HZF9 ENSG00000198039 "Zinc finger protein 273" Q14593 7 64870172-64930966 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 95.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA077549 Approved Nucleoplasm NA NA Nucleoplasm "HPA077549: AB_2732352" "unprognostic (7.01e-2)" "unprognostic (3.10e-1)" "unprognostic (1.80e-2)" "unprognostic (5.87e-4)" "unprognostic (1.83e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-2)" "unprognostic (1.65e-2)" "unprognostic (2.02e-5)" "unprognostic (2.54e-1)" "unprognostic (5.76e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (1.04e-2)" "unprognostic (3.14e-1)" "unprognostic (9.48e-2)" "unprognostic (1.85e-2)" 2.8 1.5 1.9 1.7 4.1 5.5 4.8 8.6 3.7 3.5 1.5 2.1 1.0 1.4 2.6 0.7 2.9 3.4 0.9 1.7 2.7 1.6 1.7 1.8 1.8 5.0 4.4 2.6 3.7 1.7 0.9 2.8 2.1 5.2 1.9 1.9 0.0 1.8 1.7 1.9 12.1 1.6 1.4 2.6 3.8 1.7 9.2 5.1 11.5 5.8 4.2 3.5 2.2 1.8 3.2 1.8 5.0 0.7 0.7 2.5 1.0 2.2 1.6 3.6 5.2 0.5 1.2 3.0 1.0 0.7 1.5 2.8 2.5 2.0 5.9 3.2 0.4 2.8 0.7 7.2 1.4 1.2 2.9 2.6 3.1 0.9 0.8 0.2 3.1 2.1 0.8 0.9 2.5 2.4 1.1 1.4 8.8 8.3 2.2 1.8 2.0 6.5 3.1 7.1 1.2 2.5 6.9 5.6 3.5 0.8 1.3 3.3 3.4 2.8 1.4 1.6 7.3 2.6 4.2 0.7 1.8 1.9 1.3 2.1 2.2 2.9 8.7 0.5 3.0 1.3 5.0 0.6 3.1 1.0 0.7 1.9 3.2 2.1 1.4 1.7 2.4 1.7 2.5 1.0 0.7 0.5 1.8 2.2 1.0 1.9 4.1 8.6 3.7 2.7 1.6 4.4 2.6 5.2 5.1 3.0 2.9 8.7 5.1 22.1 5.3 3.7 2.5 95.0 13.6 1.8 0.0 5.2 6.6 2.6 20.2 8.0 0.3 23.3 2.5 10.4 7.5 3.1 3.5 0.8 3.1 4.8 0.0 6.7 4.3 8.2 5.8 3.7 5.0 3.6 1.7 2.9 2.6 5.8 3.2 1.1 2.6 0.0 3.3 16.7 7.9 16.6 2.4 7.2 3.3 2.5 ZNF280A "3'OY11.1, SUHW1, ZNF280, ZNF636" ENSG00000169548 "Zinc finger protein 280A" P59817 22 22513736-22520270 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.6;epididymis: 5.6;retina: 2.2" "Cell type enhanced" "Detected in some" 30 "Melanocytes: 1.7;Syncytiotrophoblasts: 4.2" "Cancer enhanced" "Detected in some" "melanoma: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;EFO-21: 1.9;K-562: 13.0;SK-MEL-30: 3.5" "Not detected" "Not detected" HPA044475 Approved Nucleoplasm NA NA Nucleoplasm "HPA044475: AB_10960420" "unprognostic (7.53e-2)" "unprognostic (3.76e-2)" "unprognostic (1.26e-1)" "unprognostic (2.56e-2)" "unprognostic (3.14e-1)" "unprognostic (1.78e-2)" "unprognostic (3.29e-1)" "unprognostic (4.65e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" 0.0 5.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.1 5.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.0 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.2 0.0 1.0 0.0 0.1 1.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 13.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.5 0.3 0.5 0.2 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.2 0.0 0.0 0.0 ZNF280B "5'OY11.1, SUHW2, ZNF279, ZNF632" ENSG00000275004 "Zinc finger protein 280B" Q86YH2 22 22484421-22509154 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 12.4;testis: 19.2" "Group enriched" "Detected in many" 14 "Early spermatids: 147.7;Late spermatids: 74.6;Spermatocytes: 65.0;Spermatogonia: 149.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 13.1;U-2 OS: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059519 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059519: AB_2684050" "unprognostic (7.32e-2)" "unprognostic (2.99e-2)" "unprognostic (1.12e-1)" "unprognostic (2.00e-1)" "unprognostic (2.09e-2)" "unprognostic (1.00e-1)" "unprognostic (2.65e-1)" "unprognostic (2.08e-2)" "unprognostic (2.03e-1)" "unprognostic (1.14e-2)" "unprognostic (2.85e-3)" "unprognostic (1.10e-1)" "unprognostic (5.42e-2)" "unprognostic (3.34e-2)" "unprognostic (4.80e-1)" "unprognostic (2.44e-2)" "unprognostic (5.34e-2)" 0.3 2.1 4.3 0.9 5.5 0.6 0.5 3.9 6.8 0.7 0.5 1.6 0.0 0.4 1.5 1.3 0.5 1.2 0.6 0.8 1.8 0.5 0.3 0.5 1.2 1.7 3.2 2.5 0.7 2.0 5.6 0.5 6.6 1.3 0.7 3.5 0.5 1.4 0.8 0.6 0.6 1.1 2.2 1.1 0.6 19.2 1.2 0.0 2.3 0.0 1.2 0.6 0.0 3.3 3.1 12.4 6.4 6.8 5.4 2.0 0.0 1.9 2.2 0.0 0.0 0.0 2.9 0.4 0.0 0.0 0.0 1.1 0.8 2.0 2.1 0.0 1.8 0.0 1.8 0.3 0.0 0.0 3.5 2.3 0.4 2.7 1.6 1.6 3.0 0.9 0.0 1.8 0.0 0.3 1.9 2.2 13.1 0.8 0.7 0.0 2.0 1.1 1.6 0.9 0.4 1.7 0.0 0.2 0.6 0.0 1.2 1.6 0.0 0.0 0.7 2.0 0.0 1.4 0.8 3.3 6.9 0.7 0.0 1.2 1.2 1.2 2.0 1.5 0.1 12.4 2.3 3.8 2.9 3.3 5.4 3.1 3.6 3.1 2.0 3.3 4.5 4.9 5.9 6.8 6.4 3.1 3.5 2.0 0.0 1.1 2.7 0.5 0.1 6.6 1.2 5.1 0.0 1.2 0.0 3.9 0.1 0.0 1.9 147.7 0.3 0.0 0.0 3.0 0.2 0.5 0.6 0.0 0.0 2.4 4.8 2.9 2.5 0.6 74.6 2.3 0.4 5.0 2.8 0.9 6.0 2.1 0.0 6.7 2.9 7.9 6.5 0.3 65.0 149.7 0.0 0.2 0.5 1.2 0.0 ZNF281 ZBP-99 ENSG00000162702 "Zinc finger protein 281" Q9Y2X9 1 200404940-200410056 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051228 Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051228: AB_2681396" "unprognostic (3.13e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.50e-1)" "unprognostic (8.99e-3)" "unprognostic (1.23e-1)" "unprognostic (5.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" "unprognostic (3.71e-3)" "unprognostic (8.30e-2)" "unprognostic (3.69e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (2.60e-5)" "unprognostic (1.26e-2)" "unprognostic (4.86e-1)" "unprognostic (6.19e-2)" "unprognostic (1.83e-1)" 8.4 5.7 8.8 11.4 18.3 31.2 8.8 22.4 13.1 8.5 7.9 9.1 4.0 6.2 8.8 4.6 4.6 6.8 11.3 5.2 10.5 9.2 8.1 22.9 9.1 11.4 17.3 8.1 6.7 7.6 7.0 8.7 10.3 12.0 6.1 5.0 4.1 6.4 5.1 7.8 3.1 7.3 9.8 11.2 11.4 7.5 10.0 19.9 19.9 5.9 4.8 12.3 8.8 10.2 7.1 5.3 24.5 5.4 4.7 9.3 2.2 11.0 10.8 15.1 7.0 6.0 8.3 13.2 11.6 18.3 11.7 11.1 10.6 8.7 15.9 6.9 13.2 13.7 7.5 16.2 10.8 14.0 17.1 9.9 12.7 8.2 10.9 6.6 11.6 7.3 8.0 12.1 12.6 13.8 14.9 10.5 8.7 18.3 2.6 11.8 5.2 11.9 7.3 35.1 3.4 9.8 11.3 10.5 9.5 12.0 5.6 5.3 14.1 11.5 7.7 10.1 24.8 15.4 8.5 14.2 21.9 16.4 5.0 12.3 9.9 9.6 20.4 11.6 9.2 11.6 8.4 5.1 18.4 6.6 5.4 6.7 7.1 5.7 6.9 5.1 6.5 9.3 8.1 24.5 4.7 4.9 5.3 6.7 2.2 8.8 18.3 22.4 13.1 10.5 9.2 17.3 8.1 12.0 19.9 59.6 29.3 27.2 21.7 42.7 47.6 12.9 30.6 17.4 23.9 26.2 27.5 11.5 11.6 18.9 2.1 26.6 10.7 23.3 9.2 25.2 20.8 19.3 5.8 62.2 18.0 17.5 25.7 28.3 42.5 0.9 9.2 21.8 21.9 16.2 10.4 17.4 14.8 13.1 7.4 15.8 32.4 12.9 20.8 46.8 38.7 19.8 10.3 27.4 10.6 13.6 ZNF283 ENSG00000167637 "Zinc finger protein 283" Q8N7M2 19 43827292-43852017 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 19.7;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 34.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 22.6" "Low region specificity" "Detected in all" HPA072977 Approved Nucleoplasm NA NA Nucleoplasm "HPA072977: AB_2686563" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (3.05e-2)" "unprognostic (1.54e-1)" "unprognostic (5.42e-2)" "unprognostic (1.05e-3)" "unprognostic (6.49e-2)" "unprognostic (8.47e-2)" "unprognostic (3.08e-2)" "unprognostic (3.84e-1)" "unprognostic (1.16e-2)" "unprognostic (8.18e-3)" "unprognostic (4.93e-2)" "unprognostic (1.92e-1)" "unprognostic (6.88e-2)" "unprognostic (1.26e-1)" "unprognostic (4.63e-2)" 5.4 6.5 9.1 4.5 12.3 2.6 10.6 18.7 12.7 6.7 6.4 9.1 6.7 6.5 11.5 9.2 7.1 9.0 6.4 10.9 11.8 8.2 6.6 4.6 5.2 6.4 14.7 11.9 11.3 5.8 12.1 17.6 6.6 11.1 9.2 8.5 6.9 7.4 6.4 6.0 8.9 6.9 7.6 15.0 7.2 7.8 3.6 15.7 6.4 10.5 5.1 6.5 6.5 7.6 5.3 4.6 11.9 4.2 7.0 5.1 2.2 6.6 4.8 4.8 9.3 4.5 8.1 4.2 3.8 4.9 4.5 6.4 3.9 3.3 0.1 2.9 6.3 5.6 6.1 6.2 4.8 7.3 1.6 7.8 5.7 8.2 2.8 3.2 3.3 4.2 6.1 6.2 5.6 6.9 5.9 3.8 2.0 6.4 1.8 5.9 3.2 1.8 2.8 4.5 3.3 2.9 0.0 3.5 1.6 3.9 8.8 5.6 7.9 7.6 5.2 3.3 4.7 2.8 6.0 4.1 6.7 22.6 3.5 4.7 5.0 4.8 0.4 2.9 0.4 4.6 6.7 4.2 3.9 4.3 3.1 5.0 4.5 4.2 2.7 3.0 5.3 5.1 3.5 11.9 7.0 2.9 4.6 4.3 2.2 9.1 12.3 18.7 12.7 11.8 8.2 14.7 11.9 11.1 15.7 8.9 19.7 0.8 2.1 2.2 10.3 4.5 2.5 4.0 10.3 0.0 21.6 2.5 6.6 2.4 1.1 2.8 2.4 0.0 1.6 1.7 2.8 1.7 3.5 1.0 2.1 6.4 5.8 6.2 2.2 0.0 2.3 2.8 1.7 3.6 3.3 3.6 2.0 3.4 3.2 1.1 34.1 0.0 3.3 1.5 4.1 1.4 2.4 1.3 4.0 2.2 ZNF3 "A8-51, FLJ20216, HF.12, KOX25, PP838, Zfp113" ENSG00000166526 "Zinc finger protein 3" P17036 7 100064033-100082548 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003719 Supported Supported Approved Nucleoplasm No No Nucleoplasm "HPA003719: AB_1080701" "unprognostic (5.92e-2)" "unprognostic (3.82e-2)" "unprognostic (1.00e-1)" "unprognostic (1.01e-1)" "unprognostic (3.19e-2)" "unprognostic (2.76e-2)" "unprognostic (1.10e-1)" "prognostic favorable (5.73e-4)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.65e-1)" "unprognostic (2.50e-3)" "unprognostic (7.54e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-3)" "unprognostic (1.24e-1)" "unprognostic (3.41e-2)" "prognostic favorable (2.20e-4)" 16.1 12.8 12.8 9.8 16.8 20.7 19.2 18.3 22.6 18.6 16.4 39.5 16.6 19.3 23.9 20.5 15.2 33.9 11.6 11.5 14.8 11.2 15.0 19.3 11.7 11.1 20.8 11.1 22.5 18.9 17.9 17.8 13.3 21.1 15.6 17.8 19.7 16.4 16.3 18.9 15.4 22.1 14.6 18.0 15.6 16.0 11.8 21.9 21.4 17.6 11.1 16.6 16.7 15.5 16.2 11.2 17.9 12.2 17.3 17.2 9.4 6.2 7.0 19.3 27.6 9.8 7.7 11.3 8.0 9.1 12.2 10.4 8.7 9.4 9.0 14.6 7.6 9.9 8.5 14.2 8.7 10.0 9.9 12.0 7.3 9.1 11.9 11.6 13.0 6.9 9.5 10.9 8.1 19.1 13.5 10.8 13.4 20.3 14.3 11.0 16.8 30.5 13.1 26.6 11.3 12.8 13.1 15.6 22.3 10.9 12.4 21.7 30.2 9.3 27.9 12.4 19.1 8.2 13.2 8.3 15.2 10.9 10.8 10.3 19.2 21.7 17.9 7.7 11.7 14.2 12.3 9.8 17.9 14.2 9.6 17.2 13.3 12.5 14.9 9.9 16.2 14.2 15.5 4.1 17.3 12.2 11.2 11.5 9.4 12.8 16.8 18.3 22.6 14.8 11.2 20.8 11.1 21.1 21.9 11.9 35.9 12.2 8.4 6.8 16.1 9.8 25.5 38.8 14.8 3.5 15.7 10.4 6.6 16.8 1.1 14.6 19.7 0.0 9.6 5.9 8.5 10.1 15.0 12.4 5.7 17.5 25.2 10.4 12.0 1.1 14.1 6.0 3.3 11.8 17.4 20.5 13.3 17.5 14.2 10.6 18.3 6.5 7.3 10.3 17.4 7.9 8.7 11.8 15.8 7.4 ZNF317 ENSG00000130803 "Zinc finger protein 317" Q96PQ6 19 9140380-9163424 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042075, HPA048625" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042075: AB_10796471, HPA048625: AB_2680464" "unprognostic (3.81e-1)" "unprognostic (3.11e-2)" "unprognostic (3.90e-1)" "unprognostic (1.63e-1)" "unprognostic (2.98e-2)" "unprognostic (6.07e-3)" "unprognostic (7.70e-2)" "unprognostic (6.17e-2)" "unprognostic (3.89e-2)" "unprognostic (1.72e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-1)" "unprognostic (1.67e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-1)" "unprognostic (3.36e-1)" "unprognostic (2.42e-3)" 14.6 17.2 18.4 22.8 19.4 36.1 30.3 22.0 24.1 15.6 17.2 22.1 12.4 17.9 19.4 19.5 17.8 17.2 16.9 13.1 18.3 16.1 17.5 20.5 17.1 22.2 19.7 15.2 18.8 21.5 22.0 19.9 14.5 14.6 18.2 17.1 17.9 15.3 18.5 14.3 22.0 17.8 16.9 17.0 25.7 18.0 8.7 19.4 27.0 17.0 11.2 23.4 16.2 15.5 19.0 14.4 14.5 15.0 21.7 20.9 12.9 8.6 7.4 8.1 10.8 8.1 7.9 7.0 7.3 11.4 10.0 12.2 8.3 4.6 14.7 9.4 7.5 11.9 8.8 13.2 12.3 13.1 12.1 17.8 12.8 6.7 9.2 11.1 13.5 13.4 9.4 16.8 11.4 19.9 8.7 8.7 13.2 12.0 17.1 10.0 7.2 17.0 43.6 15.1 9.2 15.9 12.1 10.2 11.8 8.7 14.7 14.0 9.6 10.1 9.0 11.3 7.3 6.7 14.4 7.7 7.1 6.5 16.1 9.6 21.6 20.6 16.7 6.9 12.0 9.1 13.9 14.1 14.5 13.6 15.0 20.9 19.0 17.9 15.4 14.4 16.0 17.1 18.5 8.8 21.7 11.9 13.2 20.8 12.9 18.4 19.4 22.0 24.1 18.3 16.1 19.7 15.2 14.6 19.4 8.9 12.0 9.8 6.8 6.5 6.5 5.9 12.7 12.0 12.5 5.2 5.9 4.4 3.3 4.6 0.6 7.1 5.7 0.0 5.5 4.3 5.2 7.0 12.8 9.8 7.0 7.9 6.9 5.5 12.7 1.3 3.4 9.5 5.0 3.6 7.2 4.0 6.8 3.5 3.5 7.7 4.8 0.0 5.2 2.1 1.1 5.6 9.2 13.8 9.2 8.9 ZNF319 "KIAA1388, Zfp319" ENSG00000166188 "Zinc finger protein 319" Q9P2F9 16 57994668-58000453 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 9.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052584 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052584: AB_2681873" "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.66e-1)" "unprognostic (3.83e-2)" "unprognostic (3.82e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (7.63e-2)" "unprognostic (1.15e-1)" "unprognostic (4.87e-2)" "prognostic favorable (5.87e-5)" "unprognostic (8.69e-2)" "unprognostic (3.72e-3)" "unprognostic (4.49e-1)" "unprognostic (1.82e-1)" "unprognostic (3.53e-2)" "unprognostic (5.80e-2)" 8.0 8.4 7.6 7.5 7.7 21.3 7.1 11.2 15.0 11.0 8.0 10.6 5.1 6.7 12.0 8.0 6.1 9.7 10.6 6.7 7.3 8.2 7.8 5.7 8.5 10.4 7.1 6.2 13.7 10.6 17.1 7.0 9.4 9.4 8.7 4.3 11.2 8.6 10.8 8.9 6.9 6.6 8.8 6.4 13.9 6.5 6.1 6.0 16.9 19.8 5.6 10.2 11.2 6.2 1.6 2.9 7.4 2.6 1.8 5.3 2.5 4.9 13.5 6.7 9.0 6.2 7.6 5.6 7.1 7.0 6.9 3.4 5.3 2.9 8.4 13.0 6.8 5.6 5.5 5.5 7.6 4.2 3.6 5.3 3.1 5.8 6.3 12.3 4.0 10.7 11.1 9.0 5.5 12.0 6.6 4.3 6.2 6.6 1.4 5.7 4.3 7.7 6.9 3.7 2.4 13.5 13.7 4.5 8.3 4.5 12.8 4.8 5.1 11.8 4.4 4.5 4.8 1.6 6.0 8.4 5.4 3.2 2.7 5.4 7.6 3.2 6.5 4.0 4.2 5.8 0.0 2.6 7.4 5.3 1.9 3.6 1.6 2.8 3.7 2.9 1.6 1.9 3.0 4.8 1.8 1.5 1.1 2.3 2.5 7.6 7.7 11.2 15.0 7.3 8.2 7.1 6.2 9.4 6.0 3.0 4.3 0.0 0.5 0.8 2.0 5.1 5.1 4.0 1.2 0.0 0.0 1.4 3.3 2.1 0.2 1.6 1.0 0.0 2.5 0.9 1.6 0.6 1.1 1.6 1.9 0.0 4.7 4.9 9.1 0.0 2.8 1.2 0.0 1.0 1.4 2.8 2.7 0.0 3.2 1.0 2.9 0.0 1.0 1.9 0.7 1.1 0.2 2.5 1.3 0.0 ZNF329 FLJ12586 ENSG00000181894 "Zinc finger protein 329" Q86UD4 19 58126252-58155110 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044373, HPA077958" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044373: AB_10966569, HPA077958: " "unprognostic (3.24e-1)" "unprognostic (1.36e-1)" "unprognostic (2.36e-1)" "unprognostic (6.01e-2)" "unprognostic (2.58e-1)" "unprognostic (6.53e-3)" "unprognostic (1.27e-2)" "unprognostic (1.28e-1)" "unprognostic (1.80e-2)" "unprognostic (1.29e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-3)" "prognostic favorable (8.58e-9)" "unprognostic (9.23e-2)" "unprognostic (1.37e-2)" "unprognostic (1.78e-2)" "unprognostic (2.52e-1)" 7.1 7.2 9.2 5.2 11.7 10.3 11.7 15.9 14.7 10.8 6.9 8.1 5.7 3.5 10.6 10.7 5.6 10.5 7.0 6.7 9.2 10.0 11.8 8.0 6.9 6.8 8.5 6.7 11.2 5.4 20.4 10.7 7.9 10.6 10.1 6.1 9.7 7.1 9.1 2.7 7.2 5.9 9.6 6.5 8.2 6.1 23.7 7.6 8.6 11.3 3.5 8.0 8.7 15.1 8.0 5.0 6.4 1.7 5.3 7.6 2.2 3.2 1.7 7.7 13.3 6.2 6.4 0.1 4.2 8.9 4.6 3.5 1.4 2.5 2.0 2.3 7.5 2.8 1.1 1.3 5.8 5.7 1.5 10.3 6.6 2.3 2.4 6.0 3.9 6.4 6.6 6.2 4.5 9.3 7.4 6.0 4.7 1.6 8.8 6.6 1.1 6.8 2.4 5.8 1.7 5.6 3.7 7.6 2.0 4.9 6.6 5.1 4.8 6.7 0.8 3.3 10.4 7.7 2.2 3.6 12.1 3.3 1.1 0.0 5.2 15.4 4.9 2.6 0.1 6.9 4.8 1.6 6.4 2.5 1.7 4.4 5.8 4.8 4.3 2.1 8.0 7.6 4.6 4.9 5.3 1.1 5.0 2.1 2.2 9.2 11.7 15.9 14.7 9.2 10.0 8.5 6.7 10.6 7.6 3.0 0.3 0.0 2.1 1.4 11.9 4.0 7.6 1.4 3.4 3.5 5.9 1.9 1.7 2.0 1.1 3.8 0.5 0.0 1.4 1.1 1.8 1.5 2.3 3.4 1.3 7.9 2.4 3.7 1.3 1.3 2.6 1.7 0.0 0.0 1.6 5.6 0.9 0.2 1.4 1.7 7.5 0.0 1.9 5.8 6.1 1.4 1.3 4.4 1.4 1.4 ZNF331 "RITA, ZNF361, ZNF463" ENSG00000130844 "Zinc finger protein 331" Q9NQX6 19 53520981-53580269 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 66.4;ovary: 86.4" "Cell type enhanced" "Detected in many" 7 "granulocytes: 234.6;Smooth muscle cells: 196.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 36.4;RT4: 27.8" "Low region specificity" "Detected in all" HPA063157 Approved Nucleoplasm NA NA Nucleoplasm "HPA063157: AB_2684951" "unprognostic (2.19e-1)" "unprognostic (1.79e-1)" "unprognostic (5.18e-2)" "unprognostic (1.55e-2)" "unprognostic (4.24e-1)" "unprognostic (8.16e-2)" "unprognostic (7.62e-3)" "unprognostic (3.25e-2)" "unprognostic (1.84e-2)" "unprognostic (4.40e-2)" "unprognostic (5.68e-3)" "unprognostic (2.69e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (6.74e-2)" 19.1 66.4 6.8 9.0 8.2 18.6 10.5 11.4 9.5 9.4 5.3 8.4 8.9 2.1 9.5 11.6 4.9 19.5 23.8 15.5 5.1 7.7 6.6 6.1 15.6 4.0 6.8 5.5 86.4 9.9 11.3 29.0 23.3 7.2 10.2 4.2 9.9 4.7 31.5 6.3 5.2 4.8 8.5 9.1 4.5 6.3 8.1 6.0 3.8 7.8 4.4 4.8 25.7 9.2 8.1 4.1 6.5 7.4 4.6 14.7 5.2 0.1 5.1 10.3 11.8 8.0 5.9 17.2 7.3 6.5 5.6 10.2 5.5 2.6 4.1 1.9 4.3 2.6 3.0 7.4 5.5 10.0 0.0 36.4 5.1 8.7 3.3 5.8 3.2 7.2 5.9 3.6 6.2 3.0 3.1 2.5 6.4 0.2 1.6 5.5 3.6 7.2 6.8 4.6 0.1 7.6 8.9 6.5 4.2 3.3 27.8 7.3 7.4 3.4 9.7 2.4 21.4 1.7 2.9 2.6 7.9 7.0 4.6 4.8 20.3 13.2 7.7 0.1 0.4 6.1 0.5 4.9 6.5 8.7 3.8 13.4 8.1 9.4 8.8 3.6 8.1 14.7 9.7 0.7 4.6 7.4 4.1 9.4 5.2 6.8 8.2 11.4 9.5 5.1 7.7 6.8 5.5 7.2 6.0 17.9 70.7 15.9 15.3 39.8 52.9 16.5 7.6 17.4 20.5 73.3 27.5 32.9 8.3 2.9 128.2 19.9 2.1 0.0 3.6 30.4 36.8 11.9 234.6 3.9 60.1 28.6 22.5 14.7 33.7 61.5 22.5 79.8 43.9 3.6 5.1 25.1 2.3 3.5 18.4 3.7 35.8 0.0 196.7 34.4 19.8 44.3 37.2 74.7 3.2 9.4 ZNF333 KIAA1806 ENSG00000160961 "Zinc finger protein 333" Q96JL9 19 14689801-14733746 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043973, HPA054680" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043973: AB_10961277, HPA054680: AB_2682571" "unprognostic (8.16e-2)" "unprognostic (2.80e-4)" "unprognostic (5.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-2)" "unprognostic (1.45e-3)" "unprognostic (2.98e-2)" "unprognostic (2.17e-3)" "unprognostic (2.12e-2)" "unprognostic (1.46e-1)" "unprognostic (4.87e-3)" "unprognostic (3.46e-2)" "unprognostic (1.32e-5)" "unprognostic (4.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.62e-1)" "unprognostic (7.06e-3)" 10.7 8.1 8.8 7.8 11.3 12.2 9.4 16.2 12.1 11.4 9.9 14.3 7.0 4.5 16.5 11.0 5.3 10.8 6.6 6.3 8.6 6.9 5.8 4.9 8.7 7.3 16.8 9.8 15.3 9.1 8.2 7.5 7.4 10.3 8.8 5.9 10.3 5.7 8.5 14.5 7.7 6.5 11.6 9.6 13.0 6.7 8.8 12.8 6.7 6.9 4.3 6.6 9.5 8.8 2.7 4.9 7.9 5.0 13.5 5.4 2.4 1.5 0.9 5.8 7.8 8.4 7.9 2.2 3.5 4.9 3.1 4.5 0.4 1.4 2.4 4.0 4.6 1.0 1.5 2.0 1.4 4.6 5.6 1.5 9.9 2.1 2.4 6.9 4.0 5.7 7.3 3.9 2.9 8.2 4.3 4.5 3.0 2.0 4.8 3.9 0.8 2.6 9.5 2.3 3.3 1.8 3.7 3.3 2.3 3.0 2.1 3.2 6.2 3.2 0.4 5.7 2.5 1.5 6.7 7.2 5.3 2.4 8.5 3.7 2.3 1.0 2.5 5.5 6.9 6.2 7.9 4.0 6.0 4.0 5.0 5.4 2.6 3.6 3.0 4.9 2.7 4.1 3.6 7.0 13.5 4.3 2.4 3.0 2.4 8.8 11.3 16.2 12.1 8.6 6.9 16.8 9.8 10.3 12.8 6.0 8.3 1.7 5.0 2.7 12.5 2.7 0.0 4.0 2.3 3.5 3.9 2.5 1.7 2.2 4.6 6.5 1.1 0.0 2.6 2.1 5.9 3.7 16.1 1.8 4.4 7.9 2.4 6.7 9.9 2.5 9.2 6.5 1.7 4.6 1.0 5.2 2.1 2.5 8.5 1.3 17.7 12.9 6.2 10.8 6.8 2.4 1.1 4.9 2.2 3.1 ZNF335 "bA465L10.2, NIF-1" ENSG00000198026 "Zinc finger protein 335" Q9H4Z2 20 45948653-45972172 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063999, HPA071230" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063999: AB_2685170, HPA071230: AB_2686369" "unprognostic (1.50e-1)" "unprognostic (8.05e-2)" "unprognostic (8.29e-3)" "unprognostic (7.85e-2)" "unprognostic (1.35e-2)" "prognostic favorable (4.48e-4)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.74e-2)" "unprognostic (1.01e-1)" "unprognostic (7.91e-2)" "unprognostic (1.30e-3)" "prognostic unfavorable (7.04e-4)" "prognostic unfavorable (2.77e-5)" "unprognostic (4.10e-1)" "unprognostic (1.94e-1)" "unprognostic (2.44e-1)" "unprognostic (2.88e-3)" 10.5 8.3 12.0 12.2 13.6 28.8 10.7 17.9 15.7 10.5 10.3 9.7 4.0 11.5 14.2 5.2 11.2 12.3 8.2 7.0 10.7 5.0 8.6 7.8 10.4 15.0 8.1 11.6 15.2 10.5 13.2 10.4 13.7 8.2 10.7 6.7 8.4 12.0 9.2 12.3 22.9 13.5 7.9 7.6 13.9 10.6 16.5 10.1 19.4 14.9 8.8 12.0 11.4 9.5 3.7 3.6 5.0 4.5 8.9 7.3 3.5 9.1 9.3 8.3 9.0 4.4 5.6 17.7 8.2 5.7 8.2 5.9 20.1 10.3 11.0 12.2 8.0 7.5 13.2 8.0 12.3 3.7 7.5 10.9 9.1 13.6 10.6 6.9 11.8 15.6 9.0 10.5 10.7 7.7 5.9 7.0 11.6 8.6 14.8 5.6 18.6 13.9 11.5 5.7 6.2 15.4 11.5 5.5 9.2 7.2 14.4 8.4 7.4 12.2 17.2 8.6 5.2 13.0 9.8 7.3 17.7 7.7 11.2 11.1 17.3 8.8 11.4 14.3 7.4 9.7 2.4 3.5 5.0 7.3 4.5 3.7 3.3 3.6 4.9 3.6 3.7 3.1 3.4 3.6 8.9 3.6 2.5 3.6 3.5 12.0 13.6 17.9 15.7 10.7 5.0 8.1 11.6 8.2 10.1 11.9 15.9 11.8 11.4 16.7 17.4 2.8 2.5 1.4 4.5 1.8 25.5 7.2 0.0 3.9 22.2 8.3 13.7 0.0 5.1 7.0 7.8 9.9 6.9 5.7 5.3 12.7 20.6 7.4 6.4 17.7 6.9 10.2 8.5 2.8 9.2 5.8 6.6 10.5 4.9 1.9 11.1 0.0 8.6 3.7 8.3 19.6 10.0 16.2 9.1 11.4 ZNF343 MGC10715 ENSG00000088876 "Zinc finger protein 343" Q6P1L6 20 2481817-2524702 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA030587, HPA052438" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA030587: AB_10603246, HPA052438: AB_2681833" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (6.75e-3)" "unprognostic (3.83e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.38e-6)" "unprognostic (9.26e-2)" "unprognostic (3.03e-2)" "unprognostic (2.06e-1)" "unprognostic (4.88e-1)" "unprognostic (5.60e-2)" "prognostic unfavorable (4.53e-5)" "unprognostic (1.65e-1)" "unprognostic (3.71e-1)" "unprognostic (3.41e-2)" "unprognostic (9.53e-2)" 11.6 8.6 10.4 8.0 11.9 3.9 12.4 20.6 15.0 10.6 12.3 10.7 8.5 5.1 13.9 18.0 8.9 10.6 8.1 7.8 10.0 7.1 9.3 8.0 9.4 9.9 9.1 7.6 12.7 12.8 17.2 10.9 9.4 10.4 10.2 10.1 9.0 8.7 10.4 13.8 11.3 7.5 13.0 9.1 8.2 8.9 7.5 9.5 5.4 11.4 6.6 9.8 11.3 12.9 8.9 5.3 4.5 3.9 1.8 7.6 3.0 9.6 10.4 7.0 7.7 8.1 8.4 2.5 6.7 7.6 8.4 8.7 5.4 5.7 12.4 2.6 6.8 9.6 9.2 10.8 12.3 10.9 3.3 5.3 8.0 4.6 10.7 7.3 4.8 3.0 7.6 12.4 10.1 16.3 8.8 8.2 9.7 10.4 6.3 7.9 3.4 10.3 3.2 7.1 8.4 11.1 8.5 9.5 7.4 4.2 2.6 8.2 13.1 8.5 14.0 8.0 6.0 4.9 4.1 5.3 11.6 5.3 8.4 7.7 12.9 20.6 6.4 3.1 6.6 6.7 0.6 3.9 4.5 5.1 3.8 5.4 7.0 6.3 4.4 3.9 8.9 5.8 7.6 3.3 1.8 3.4 5.3 5.7 3.0 10.4 11.9 20.6 15.0 10.0 7.1 9.1 7.6 10.4 9.5 3.0 1.0 2.4 1.3 1.8 4.5 1.6 0.0 1.4 3.4 1.8 0.0 2.0 1.7 1.9 0.6 2.1 1.1 0.0 0.8 1.1 2.1 1.2 1.1 2.4 1.2 7.9 2.9 1.8 1.0 0.0 3.7 1.2 1.7 1.0 2.0 2.7 1.9 0.0 2.8 2.5 2.9 0.0 3.1 3.9 3.3 1.9 0.7 1.5 1.8 1.3 ZNF346 "JAZ, Zfp346" ENSG00000113761 "Zinc finger protein 346" Q9UL40 5 177022696-177081189 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018485 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA018485: AB_1859213" "unprognostic (1.89e-1)" "unprognostic (4.25e-2)" "unprognostic (5.71e-3)" "prognostic unfavorable (9.54e-5)" "unprognostic (9.85e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.88e-7)" "unprognostic (2.69e-2)" "unprognostic (1.45e-2)" "unprognostic (2.13e-1)" "prognostic favorable (1.20e-4)" "unprognostic (5.11e-2)" "unprognostic (7.86e-2)" "unprognostic (8.60e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (1.44e-2)" 9.0 12.1 17.0 14.8 21.3 10.6 12.4 26.8 21.6 13.2 10.7 15.2 11.2 9.1 17.4 16.0 13.8 16.9 10.0 11.4 14.7 14.3 11.5 10.1 8.9 13.2 10.9 19.3 27.0 12.5 16.1 19.0 10.0 13.6 13.0 10.7 14.7 11.1 15.1 16.7 14.7 9.2 18.0 10.5 13.1 9.7 16.8 12.5 15.8 19.6 9.1 17.4 10.8 12.1 7.3 4.0 5.9 3.7 17.0 8.5 4.5 4.2 7.2 12.8 17.5 6.7 6.9 10.3 7.3 7.9 12.3 13.6 9.8 6.6 11.0 8.3 7.5 10.6 5.9 12.4 11.7 11.9 33.8 10.1 7.5 9.0 8.6 8.0 12.4 7.1 6.8 7.1 11.8 8.6 7.4 13.8 13.1 8.9 7.1 5.7 13.7 16.4 6.2 5.7 5.5 12.9 17.6 8.9 5.1 8.5 5.1 16.3 7.0 9.5 6.9 6.0 6.6 9.6 6.7 7.8 9.9 7.7 6.6 8.0 6.3 6.9 12.9 4.0 10.6 8.1 0.3 3.7 5.9 8.5 3.5 5.4 5.1 5.9 5.5 4.0 7.3 7.5 7.5 3.9 17.0 3.5 3.6 5.6 4.5 17.0 21.3 26.8 21.6 14.7 14.3 10.9 19.3 13.6 12.5 0.0 5.9 6.1 2.8 2.6 11.8 3.4 7.6 0.0 3.4 5.2 5.9 7.9 8.3 5.2 2.1 6.3 2.8 0.0 5.0 4.6 3.9 1.0 2.3 3.2 4.9 7.9 4.6 3.7 2.7 4.0 4.6 2.2 3.3 3.6 3.2 8.4 3.4 2.6 6.0 3.6 6.1 0.0 4.2 10.8 10.2 4.3 2.7 5.2 2.8 1.6 ZNF35 "HF.10, HF10, Zfp105" ENSG00000169981 "Zinc finger protein 35" P13682 3 44648727-44660791 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051859, HPA054738" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051859: AB_2681642, HPA054738: AB_2682588" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (1.77e-2)" "unprognostic (1.41e-1)" "unprognostic (8.91e-3)" "unprognostic (9.91e-2)" "unprognostic (6.68e-2)" "unprognostic (1.48e-1)" "unprognostic (2.01e-2)" "unprognostic (4.54e-2)" "unprognostic (1.47e-2)" "unprognostic (1.69e-2)" "unprognostic (9.08e-3)" "unprognostic (1.23e-1)" "unprognostic (8.64e-2)" "unprognostic (1.60e-3)" "unprognostic (3.30e-1)" 8.8 5.9 8.3 6.2 10.4 6.2 8.2 8.7 11.5 8.1 8.3 8.4 7.2 5.2 10.8 11.0 8.8 6.4 6.8 7.9 7.3 6.3 10.2 4.5 7.1 5.3 8.2 7.0 6.4 6.3 8.4 15.3 5.9 10.8 8.7 6.6 7.7 7.2 8.8 8.1 7.9 7.6 12.0 8.5 11.9 7.4 17.7 7.5 3.9 7.9 8.4 8.8 8.3 7.0 4.0 3.9 1.5 4.0 4.6 2.4 1.9 3.1 2.4 6.3 8.0 4.1 3.3 1.2 3.8 5.4 6.8 6.5 4.2 1.4 2.7 1.7 5.3 3.0 2.3 0.3 5.5 7.1 0.0 2.2 9.0 4.4 0.2 3.8 8.9 6.9 3.4 4.3 6.1 5.5 3.3 5.4 0.1 6.0 2.6 7.4 2.0 0.2 2.9 13.9 2.3 6.7 0.1 6.7 4.7 3.6 8.9 3.5 9.0 4.9 3.0 0.8 5.4 8.0 5.6 5.5 7.3 5.3 3.9 7.6 7.2 11.0 1.5 6.2 4.4 5.6 0.0 3.8 1.5 2.2 4.0 1.4 3.6 0.6 2.4 3.9 4.0 1.1 1.2 0.2 4.6 3.7 1.6 0.2 1.9 8.3 10.4 8.7 11.5 7.3 6.3 8.2 7.0 10.8 7.5 6.0 8.3 6.1 3.3 2.5 4.5 2.8 5.1 5.3 3.4 1.8 0.0 0.2 1.7 6.5 8.0 4.9 1.6 0.0 7.6 0.1 2.6 2.8 0.0 0.4 3.3 6.4 2.4 4.3 4.0 4.9 1.1 3.8 1.7 3.6 1.5 4.3 7.5 2.0 4.2 2.4 6.2 0.0 3.1 15.4 9.6 2.5 0.3 2.2 2.3 3.0 ZNF354B "FLJ25008, KID2" ENSG00000178338 "Zinc finger protein 354B" Q96LW1 5 178859953-178888122 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029056 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA029056: AB_10603006" "unprognostic (2.15e-1)" "unprognostic (2.45e-2)" "unprognostic (1.73e-1)" "unprognostic (4.19e-2)" "unprognostic (5.24e-1)" "prognostic favorable (9.52e-4)" "unprognostic (2.88e-4)" "unprognostic (6.72e-2)" "unprognostic (1.26e-3)" "unprognostic (1.11e-3)" "unprognostic (6.22e-2)" "unprognostic (1.80e-2)" "prognostic unfavorable (1.30e-5)" "unprognostic (2.25e-1)" "unprognostic (5.51e-2)" "unprognostic (2.32e-2)" "unprognostic (3.15e-3)" 14.2 8.8 13.1 9.4 15.3 5.4 15.0 22.8 13.3 14.5 11.7 8.1 9.3 8.9 14.2 10.0 8.6 10.7 9.2 7.3 13.7 5.6 10.0 7.4 9.8 10.3 15.8 7.7 13.0 13.0 15.8 20.4 28.6 11.2 13.3 8.1 4.7 10.7 11.7 12.9 10.7 9.8 9.7 11.6 12.4 10.1 7.3 16.3 12.8 15.5 8.3 9.5 11.6 11.9 8.1 3.8 2.6 3.3 2.2 5.9 1.6 4.4 3.5 6.6 14.9 6.5 6.4 16.8 5.5 5.1 5.4 6.3 4.4 8.0 0.0 6.1 4.9 7.5 9.2 8.3 9.2 6.7 0.0 6.8 5.1 11.6 3.2 5.6 0.1 3.6 5.8 5.7 4.4 6.9 8.3 4.8 7.8 4.2 0.0 5.8 4.9 8.1 11.6 3.5 2.1 4.7 7.8 3.6 4.9 4.7 5.4 7.4 7.7 6.7 6.0 4.3 6.7 5.3 8.9 5.6 9.6 8.7 3.4 4.1 3.3 4.7 0.2 0.6 0.0 5.0 2.6 3.3 1.3 5.9 1.9 5.4 4.8 4.2 3.3 2.8 8.1 5.1 5.1 0.9 2.2 2.2 3.8 3.5 1.6 13.1 15.3 22.8 13.3 13.7 5.6 15.8 7.7 11.2 16.3 8.9 4.5 0.0 6.0 4.0 6.2 6.9 5.1 8.1 9.1 7.0 7.9 15.2 0.0 3.9 0.4 9.0 1.1 0.0 1.9 5.0 3.8 4.3 0.0 1.9 4.3 11.1 0.0 7.4 3.4 0.0 4.6 5.4 0.0 1.0 2.4 4.3 2.0 0.0 4.9 1.5 6.2 0.0 5.6 6.9 10.9 4.6 28.9 4.4 1.9 2.8 ZNF354C KID3 ENSG00000177932 "Zinc finger protein 354C" Q86Y25 5 179060415-179083537 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 10.1;Horizontal cells: 15.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030904, HPA068570" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA030904: AB_10603842, HPA068570: " "unprognostic (1.55e-1)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (6.56e-4)" "unprognostic (4.76e-1)" "unprognostic (2.40e-3)" "unprognostic (2.61e-2)" "unprognostic (2.83e-2)" "unprognostic (1.01e-3)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (5.57e-2)" "unprognostic (1.62e-1)" "unprognostic (2.46e-2)" "unprognostic (1.61e-1)" "unprognostic (4.00e-2)" "unprognostic (2.83e-1)" 6.4 4.9 6.6 4.6 7.9 1.2 8.2 12.9 8.9 9.3 7.4 7.7 6.5 2.6 10.6 4.1 5.6 7.8 5.4 5.6 7.7 3.4 4.6 3.0 6.6 6.5 9.4 5.3 15.0 5.3 3.4 3.5 6.5 6.7 9.0 3.5 5.7 4.3 7.3 5.5 4.1 5.1 8.8 5.7 6.4 5.3 4.5 9.3 5.5 9.8 3.1 6.8 6.5 10.5 1.3 0.9 0.8 2.0 1.5 3.3 1.5 0.8 1.2 9.7 15.6 5.1 8.3 0.0 4.4 3.8 4.8 5.6 0.0 1.9 0.0 5.3 4.7 8.2 3.0 0.0 1.5 9.3 0.0 0.1 0.0 0.4 0.0 4.9 0.0 2.2 6.2 1.4 4.8 0.0 1.5 2.3 0.0 0.1 0.0 5.7 0.5 8.9 0.0 6.9 0.7 0.0 0.0 0.0 0.0 1.8 0.4 6.0 10.1 6.9 0.1 4.6 4.4 4.1 3.6 2.9 0.0 6.5 4.2 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.8 0.5 0.5 2.2 0.9 2.2 1.3 2.9 2.0 0.9 1.3 3.3 2.8 0.0 1.5 2.0 0.1 1.7 1.5 6.6 7.9 12.9 8.4 7.7 3.4 9.4 5.3 6.7 9.3 3.0 1.9 0.0 0.7 0.8 10.1 5.3 2.5 1.4 3.4 0.0 0.0 1.8 0.0 0.9 0.4 2.4 0.0 0.0 0.8 1.0 2.6 0.5 1.1 0.5 1.3 15.9 0.0 6.2 0.6 0.0 2.8 2.0 1.7 0.0 0.4 5.6 0.6 0.0 5.3 0.5 5.1 6.5 1.9 2.5 1.0 0.6 0.5 0.5 0.4 0.1 ZNF358 "FLJ10390, ZFEND" ENSG00000198816 "Zinc finger protein 358" Q9NW07 19 7515292-7521026 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 103.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030887, HPA063624" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA030887: AB_10602688, HPA063624: AB_2685064" "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (1.34e-2)" "unprognostic (1.59e-2)" "unprognostic (9.89e-3)" "unprognostic (7.82e-2)" "unprognostic (7.40e-2)" "unprognostic (3.54e-1)" "unprognostic (1.30e-1)" "unprognostic (6.52e-2)" "prognostic favorable (2.50e-4)" "unprognostic (4.30e-1)" "unprognostic (4.48e-1)" "unprognostic (4.11e-2)" "unprognostic (2.00e-1)" "unprognostic (9.72e-2)" "unprognostic (3.60e-2)" 23.7 21.1 33.6 7.9 26.1 2.1 31.6 21.4 54.7 30.1 26.1 20.2 17.5 19.2 22.4 19.5 18.0 27.9 20.9 36.4 29.1 22.5 17.4 17.9 14.4 6.8 24.9 20.2 46.1 25.0 21.1 17.7 12.2 15.0 23.1 12.6 19.1 32.3 30.8 95.9 11.7 18.0 24.9 16.8 13.8 18.3 8.5 18.3 4.4 27.3 13.5 7.7 24.7 24.3 2.6 1.4 4.6 1.8 0.7 2.4 0.7 10.3 7.0 13.2 21.0 28.4 31.6 11.3 3.9 25.7 18.0 15.9 3.0 7.4 0.0 15.3 21.0 2.8 4.1 5.4 10.0 5.8 0.0 11.6 2.0 8.6 4.2 31.2 0.3 0.1 27.5 19.0 8.5 7.4 27.0 18.8 0.0 5.2 0.0 15.8 5.1 0.0 7.5 13.5 4.3 12.4 11.5 7.1 1.1 9.4 4.5 14.7 29.3 4.9 4.1 14.1 8.9 3.1 5.5 8.8 11.6 8.5 17.2 5.9 14.1 7.6 0.0 10.7 0.0 16.0 4.6 1.7 1.1 1.8 1.8 1.3 0.4 0.6 1.0 0.9 2.6 1.4 2.4 0.0 0.7 0.4 1.4 0.0 0.7 33.6 26.1 21.4 54.7 29.1 22.5 24.9 20.2 15.0 18.3 8.9 12.0 3.0 9.8 6.9 20.2 103.8 12.7 1.4 3.4 15.7 13.7 2.5 5.0 11.1 4.1 17.6 35.9 0.0 14.4 4.4 16.5 10.0 14.9 38.9 8.8 47.7 35.1 29.4 15.9 4.7 35.1 7.1 5.0 2.8 27.3 32.3 15.6 17.5 35.0 24.2 15.2 12.9 19.8 0.5 0.7 3.1 2.5 3.9 19.2 10.4 ZNF367 FLJ33970 ENSG00000165244 "Zinc finger protein 367" Q7RTV3 9 96385941-96418329 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.8;lymphoid tissue: 21.5" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 8.9;Sertoli cells: 6.5;Spermatocytes: 7.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 7 "T-cells: 1.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015319, HPA015785" Uncertain Supported Nucleoplasm NA Yes Nucleoplasm "HPA015319: AB_2669185, HPA015785: AB_2217750" "unprognostic (5.91e-2)" "unprognostic (2.78e-3)" "unprognostic (2.17e-2)" "unprognostic (1.11e-2)" "unprognostic (2.36e-1)" "unprognostic (4.57e-3)" "unprognostic (7.76e-3)" "unprognostic (1.60e-3)" "unprognostic (4.35e-2)" "unprognostic (3.01e-1)" "unprognostic (3.78e-3)" "unprognostic (2.71e-2)" "unprognostic (4.88e-3)" "unprognostic (3.23e-3)" "unprognostic (1.72e-1)" "prognostic favorable (2.34e-4)" "unprognostic (2.28e-1)" 2.7 1.2 2.1 8.9 4.6 23.8 4.4 2.9 3.9 2.2 4.9 2.9 1.7 3.2 1.3 2.1 4.5 1.3 3.0 4.6 2.5 2.1 3.3 12.0 2.6 4.7 4.4 2.0 2.2 1.8 3.9 0.6 3.7 3.8 1.4 3.8 2.1 3.2 0.6 3.9 3.9 3.2 2.6 4.3 3.4 2.4 9.6 4.3 21.5 1.3 6.5 5.0 2.1 2.5 0.1 0.2 0.1 0.2 0.1 1.8 0.7 13.3 5.5 5.4 4.9 2.1 3.0 7.4 18.7 11.1 9.3 11.2 3.4 9.5 10.2 8.0 8.9 7.0 16.5 6.3 6.8 11.1 11.1 5.5 7.4 10.6 2.8 0.0 10.3 9.1 0.5 0.4 7.5 3.8 2.0 3.4 7.2 6.7 24.9 11.9 8.9 15.8 8.5 3.7 14.8 9.1 8.0 27.6 6.2 2.7 9.0 9.6 6.7 8.2 9.9 5.7 4.6 5.2 9.2 3.0 15.4 8.8 14.1 14.1 9.7 16.4 4.2 9.3 9.1 12.9 0.0 0.0 0.1 1.2 0.0 0.8 0.0 0.8 1.2 0.2 0.1 1.1 1.3 0.0 0.1 0.2 0.1 1.8 0.7 2.1 4.6 2.9 3.9 2.5 2.1 4.4 2.0 3.8 4.3 0.0 0.0 2.2 1.0 8.9 0.6 2.2 0.0 0.0 1.2 0.0 0.0 1.6 0.0 0.4 0.6 0.6 0.6 0.0 1.0 3.5 1.7 0.4 0.0 3.9 1.7 0.0 0.0 1.3 2.5 0.6 0.6 1.5 3.3 0.0 1.9 0.5 0.5 0.0 0.7 2.2 1.5 6.5 2.5 7.2 1.4 5.6 0.7 2.5 2.5 0.1 ZNF384 "CAGH1A, CIZ, NMP4, NP, TNRC1" ENSG00000126746 "Zinc finger protein 384" Q8TF68 12 6666477-6689572 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004051 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA004051: AB_1859228" "unprognostic (1.90e-1)" "unprognostic (5.11e-3)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (1.79e-1)" "unprognostic (3.04e-2)" "unprognostic (1.87e-2)" "unprognostic (9.94e-2)" "unprognostic (1.35e-2)" "unprognostic (2.57e-2)" "unprognostic (3.51e-2)" "unprognostic (4.25e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.22e-1)" "unprognostic (2.06e-1)" "unprognostic (8.13e-2)" 20.5 22.8 18.9 30.9 19.9 33.4 22.1 36.1 23.0 23.2 23.3 19.5 16.8 22.1 29.8 17.6 21.1 24.2 25.3 16.1 16.0 10.8 20.7 19.9 19.7 21.9 19.7 17.7 31.3 25.8 25.8 20.5 23.9 14.8 22.7 21.4 18.6 22.4 20.6 22.7 24.1 29.4 24.8 14.2 33.6 21.3 20.5 18.7 39.7 27.0 17.5 29.7 25.2 28.9 10.2 11.1 14.2 13.3 15.6 17.3 7.3 10.5 20.3 25.0 16.7 17.7 12.6 33.6 15.3 14.3 14.9 15.9 22.2 22.7 25.0 5.8 17.2 21.6 14.3 18.4 14.1 17.0 45.1 16.7 28.6 26.9 11.5 12.5 27.1 21.2 13.8 13.7 18.3 28.6 28.1 12.8 17.7 14.9 8.7 16.2 16.4 24.4 17.5 48.4 19.3 8.9 24.3 26.8 9.6 13.2 28.5 7.8 25.3 15.9 21.3 13.7 44.0 5.6 22.5 15.9 16.4 22.9 12.8 18.0 12.1 11.4 45.6 16.1 9.8 18.5 3.3 8.0 14.2 17.3 9.7 13.8 10.2 11.0 13.6 11.1 8.8 10.8 12.1 14.2 15.6 13.3 7.4 13.2 7.3 18.9 19.9 36.1 23.0 16.0 10.8 19.7 17.7 14.8 18.7 0.0 8.3 8.0 2.9 7.0 4.7 2.3 12.7 4.0 3.4 1.8 9.8 5.8 0.0 3.8 3.4 5.8 9.7 0.0 4.3 4.4 6.1 4.4 5.7 5.8 6.1 0.0 3.5 9.2 14.1 1.8 7.8 7.2 5.0 6.4 13.6 6.0 5.7 14.1 8.1 3.1 7.6 0.0 3.4 6.7 6.3 8.5 6.1 10.2 11.2 3.8 ZNF41 "MGC8941, MRX89" ENSG00000147124 "Zinc finger protein 41" P51814 X 47445879-47482946 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 5.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069102 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA069102: AB_2686086" "unprognostic (9.63e-2)" "unprognostic (1.94e-1)" "unprognostic (3.12e-2)" "unprognostic (5.72e-2)" "unprognostic (6.87e-2)" "prognostic favorable (8.32e-4)" "unprognostic (3.72e-1)" "unprognostic (5.66e-2)" "unprognostic (6.01e-2)" "unprognostic (3.17e-2)" "unprognostic (1.51e-1)" "unprognostic (4.23e-2)" "prognostic favorable (6.95e-4)" "unprognostic (1.95e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.92e-3)" 8.8 8.0 8.5 11.8 12.2 2.4 10.2 15.2 12.1 10.6 9.5 8.4 8.6 6.8 8.6 9.4 8.3 7.2 9.8 15.2 8.9 7.9 8.8 8.8 8.8 9.4 8.9 8.6 8.8 10.1 20.0 13.8 7.9 9.3 9.3 11.5 7.1 11.0 8.4 26.7 7.6 9.1 9.8 7.9 10.7 8.5 4.3 11.1 12.8 11.5 9.2 11.5 9.7 8.5 6.9 6.5 4.8 6.2 5.6 7.9 4.0 6.0 6.6 5.5 14.0 6.8 7.6 3.8 8.3 7.0 7.2 8.3 3.7 6.6 8.7 4.6 10.9 9.3 9.5 12.4 5.7 9.1 13.7 4.7 2.1 9.2 2.3 4.7 8.6 7.8 5.5 7.3 8.2 10.8 6.5 6.6 7.3 6.2 9.5 9.0 9.0 8.9 4.7 9.3 5.5 10.4 8.3 7.2 8.9 5.5 10.3 7.6 7.8 12.2 9.6 4.8 6.8 10.0 4.8 9.8 7.7 6.0 15.5 5.9 6.9 9.3 9.4 6.6 17.3 8.2 1.4 4.7 4.8 6.5 6.2 7.9 4.9 5.9 7.2 6.5 6.9 6.7 6.1 1.1 5.6 3.0 4.3 4.8 4.0 8.5 12.2 15.2 12.1 8.9 7.9 8.9 8.6 9.3 11.1 3.0 3.8 0.0 1.9 0.6 3.4 3.6 0.0 2.7 1.2 0.0 0.0 0.2 1.7 1.2 0.0 2.1 1.7 0.0 1.2 0.6 1.0 1.2 1.1 1.6 0.9 0.0 0.0 5.5 1.2 0.0 0.9 2.0 1.7 0.0 1.6 1.6 1.4 3.4 0.7 0.7 3.3 0.0 1.2 1.1 1.5 0.1 0.7 0.8 1.7 1.7 ZNF417 MGC34079 ENSG00000173480 "Zinc finger protein 417" Q8TAU3 19 57900296-57916610 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Club cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 34.1" "HPA042125, HPA043288, HPA056213" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (1.28e-1)" "unprognostic (3.74e-2)" "unprognostic (8.93e-2)" "unprognostic (1.63e-2)" "unprognostic (1.85e-1)" "unprognostic (5.76e-2)" "unprognostic (2.59e-3)" "unprognostic (2.34e-1)" "unprognostic (7.65e-3)" "unprognostic (5.33e-2)" "unprognostic (7.63e-2)" "unprognostic (1.01e-1)" "unprognostic (1.93e-2)" "unprognostic (8.75e-2)" "prognostic favorable (3.48e-4)" 7.4 8.8 12.3 11.8 11.8 10.2 16.6 18.5 12.8 15.1 10.1 11.8 16.8 7.0 10.7 38.9 7.9 10.3 11.4 9.5 11.7 10.4 9.4 11.0 9.1 12.8 13.3 12.3 12.7 9.4 14.2 23.8 10.8 10.2 12.7 10.5 12.3 14.2 13.9 6.2 21.5 13.1 10.3 10.1 12.7 10.7 8.0 13.4 14.9 16.1 5.6 16.3 9.1 9.8 6.8 5.8 9.7 3.8 3.6 7.6 2.7 4.1 6.2 10.2 7.0 10.3 9.9 8.7 5.1 7.5 4.8 4.0 6.7 2.4 8.6 2.8 7.5 3.7 2.8 6.4 6.9 13.5 1.6 34.1 9.2 14.2 6.3 7.0 8.5 10.0 7.2 7.2 4.7 6.3 9.1 6.1 7.1 2.8 0.5 9.9 3.9 9.2 4.1 5.9 2.8 6.4 7.2 12.3 6.2 4.8 18.7 9.5 6.2 6.8 4.6 1.6 11.1 4.9 7.1 4.1 12.2 5.3 2.7 5.1 9.6 15.2 7.3 5.1 3.4 5.7 9.7 3.6 7.9 5.0 3.8 5.9 5.1 5.7 4.9 2.8 6.8 7.6 5.5 6.3 3.6 2.8 5.8 4.4 2.7 12.3 11.8 18.5 12.8 11.7 10.4 13.3 12.3 10.2 13.4 6.0 0.6 0.5 1.0 0.7 4.2 2.4 2.5 2.7 7.9 0.0 0.0 0.8 0.0 0.9 0.4 2.2 0.9 0.0 1.2 0.7 0.8 1.4 4.6 1.7 0.9 1.6 5.8 3.1 1.6 0.0 2.3 1.5 0.0 0.0 1.6 1.1 0.4 0.0 1.4 1.1 3.6 6.5 0.9 1.2 2.1 1.1 0.7 0.0 1.7 1.3 ZNF418 "FLJ31551, KIAA1956" ENSG00000196724 "Zinc finger protein 418" Q8TF45 19 57921884-57935393 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 7.7;Ciliated cells: 8.1;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 13.2;SuSa: 9.5;T-47d: 8.2" "HPA043800, HPA053762, HPA072145" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (4.41e-2)" "unprognostic (3.20e-1)" "unprognostic (1.91e-1)" "unprognostic (4.27e-1)" "unprognostic (2.21e-2)" "unprognostic (1.44e-2)" "unprognostic (1.62e-1)" "unprognostic (2.20e-1)" "unprognostic (2.96e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-3)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.63e-2)" "unprognostic (4.77e-2)" "unprognostic (1.66e-1)" "unprognostic (1.29e-1)" "unprognostic (1.36e-3)" 3.0 4.5 9.4 4.2 13.4 2.7 9.3 25.8 11.8 4.4 6.0 16.0 9.4 1.6 6.4 8.6 3.1 7.5 5.5 13.2 9.8 6.3 5.7 3.2 5.4 7.5 14.5 10.2 10.3 6.9 14.8 10.0 8.7 9.9 7.7 2.5 5.8 5.0 9.2 4.6 13.7 3.6 6.5 9.7 7.4 5.3 8.2 11.9 3.5 9.9 1.0 6.8 5.8 4.3 8.5 2.9 1.9 2.1 5.9 3.0 1.1 0.4 2.0 13.2 4.2 2.1 4.5 1.5 3.7 1.3 3.0 0.2 0.3 1.4 0.5 2.7 2.3 4.0 1.2 0.0 3.3 3.6 0.3 1.1 0.2 0.9 0.2 1.2 0.4 2.7 3.7 1.0 3.7 0.0 0.0 0.6 1.1 1.0 0.9 2.5 0.5 0.7 0.5 6.8 0.1 0.5 0.5 1.0 4.4 2.6 1.6 0.2 0.6 0.1 2.4 0.1 9.5 8.2 1.4 0.0 0.8 0.6 0.5 0.7 2.2 5.2 3.3 0.4 1.5 2.6 1.9 0.8 0.7 0.3 2.1 0.8 5.0 1.8 1.2 1.7 8.5 3.0 0.8 1.1 5.9 0.7 2.9 0.0 1.1 9.4 13.4 25.8 11.8 9.8 6.3 14.5 10.2 9.9 11.9 0.0 1.1 0.5 0.8 0.3 3.9 7.7 2.5 8.1 1.2 0.0 3.9 1.0 1.7 1.1 0.1 1.6 0.0 0.0 0.5 0.5 0.9 1.1 5.7 0.5 0.7 3.2 0.0 1.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 4.0 0.2 0.0 1.4 0.7 5.4 12.9 0.9 1.0 6.4 0.4 0.7 0.5 0.0 0.7 ZNF420 FLJ32191 ENSG00000197050 "Zinc finger protein 420" Q8TAQ5 19 37007857-37130314 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA059675 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059675: AB_2684101" "unprognostic (1.00e-2)" "unprognostic (5.00e-2)" "unprognostic (2.30e-2)" "unprognostic (5.40e-3)" "prognostic favorable (3.57e-5)" "unprognostic (7.94e-2)" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (7.14e-3)" "unprognostic (1.64e-1)" "unprognostic (5.24e-2)" "unprognostic (7.59e-2)" "prognostic favorable (1.83e-4)" "unprognostic (2.42e-1)" "unprognostic (7.23e-2)" "unprognostic (7.35e-3)" "unprognostic (1.63e-2)" 6.0 7.4 9.3 6.6 12.6 2.2 9.7 21.2 12.1 9.2 6.6 6.1 5.8 4.2 8.6 6.9 5.8 9.7 4.9 5.7 10.6 7.9 7.4 5.5 4.7 7.6 12.5 7.7 14.8 5.3 12.5 16.0 5.6 10.0 7.6 4.5 4.6 5.6 7.3 8.4 6.2 4.9 9.7 8.7 7.0 5.3 15.5 10.6 9.3 12.3 3.1 7.9 5.8 8.6 10.7 4.8 5.8 3.4 11.1 11.8 5.1 0.0 7.0 6.5 6.8 6.0 3.9 3.6 4.1 4.3 4.9 7.5 1.4 1.4 3.3 8.7 2.8 3.1 1.2 6.4 2.1 5.6 10.8 5.3 7.3 4.2 2.7 6.2 5.9 3.3 4.0 4.7 5.0 3.5 5.5 2.7 5.6 4.1 0.3 5.5 2.3 10.2 2.3 7.4 2.6 4.1 5.8 13.6 7.0 2.7 4.4 9.2 10.5 6.2 2.5 3.3 4.9 4.1 5.2 3.0 5.0 7.9 4.6 4.9 10.1 12.6 8.1 0.0 1.2 4.4 1.8 2.5 5.8 9.0 3.4 9.7 8.7 10.1 9.4 4.8 10.7 10.5 11.3 0.4 11.1 3.3 2.5 11.8 5.1 9.3 12.6 21.2 12.1 10.6 7.9 12.5 7.7 10.0 10.6 11.9 11.3 1.7 2.4 8.9 20.3 4.8 2.5 9.4 7.9 3.5 0.0 7.5 6.6 3.2 25.4 5.6 1.4 0.0 1.1 3.5 4.5 3.4 12.7 3.8 3.6 15.9 5.8 8.6 3.8 24.2 8.9 2.2 6.8 1.8 2.7 6.0 1.7 3.5 8.9 3.7 8.8 25.8 6.1 14.0 7.0 7.5 3.3 7.9 4.0 1.8 ZNF423 "Ebfaz, JBTS19, KIAA0760, NPHP14, OAZ, Roaz, Zfp104" ENSG00000102935 "Zinc finger protein 423" Q2M1K9 16 49487524-49857919 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Late spermatids: 47.7;Leydig cells: 25.6;Peritubular cells: 51.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.6" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.6" "Cell line enhanced" "Detected in some" "AF22: 24.7;NTERA-2: 12.6;REH: 10.7;SCLC-21H: 13.4;SH-SY5Y: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015258, HPA065820" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015258: , HPA065820: AB_2685563" "unprognostic (2.81e-1)" "unprognostic (1.18e-1)" "unprognostic (1.19e-1)" "unprognostic (2.68e-1)" "unprognostic (2.86e-1)" "unprognostic (8.65e-3)" "unprognostic (3.37e-2)" "unprognostic (4.84e-2)" "unprognostic (1.14e-1)" "unprognostic (2.77e-1)" "unprognostic (9.13e-2)" "unprognostic (8.97e-2)" "unprognostic (1.22e-1)" "unprognostic (6.64e-3)" "unprognostic (8.25e-2)" "unprognostic (2.92e-2)" "unprognostic (5.84e-2)" 10.8 4.1 10.3 3.0 8.8 0.9 7.3 9.1 9.0 14.3 4.8 7.7 6.8 2.2 10.0 9.4 6.7 14.0 9.3 9.1 8.8 9.5 1.9 1.5 6.7 3.7 8.6 7.2 13.6 4.2 5.3 4.7 5.8 7.5 12.2 4.0 14.5 4.0 13.8 28.7 2.4 3.3 9.3 5.6 2.2 2.6 7.1 7.7 0.0 4.9 11.0 2.2 5.3 7.1 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 24.7 1.3 2.0 0.3 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.7 0.2 0.0 1.6 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.8 0.2 12.6 0.0 0.0 10.7 0.0 0.0 0.0 0.7 13.4 40.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.4 7.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 10.3 8.8 9.1 8.8 8.8 9.5 8.6 7.2 7.5 7.7 0.0 0.0 0.0 0.2 2.4 8.0 2.8 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.2 14.5 9.1 0.4 0.0 0.2 0.6 10.8 0.1 0.0 0.8 0.6 0.0 0.0 12.9 0.3 47.7 25.6 0.2 1.7 0.0 1.3 7.5 0.2 0.0 51.2 0.0 1.0 0.0 6.4 0.5 0.6 1.5 0.2 0.0 0.4 0.0 ZNF425 ENSG00000204947 "Zinc finger protein 425" Q6IV72 7 149102784-149126346 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 5.0;Horizontal cells: 6.4;Peritubular cells: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA020087 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA020087: AB_2670358" "unprognostic (4.27e-1)" "unprognostic (1.28e-1)" "unprognostic (7.40e-4)" "unprognostic (9.97e-2)" "unprognostic (1.19e-1)" "unprognostic (1.35e-2)" "unprognostic (8.18e-2)" "unprognostic (2.63e-2)" "unprognostic (1.25e-2)" "unprognostic (2.14e-1)" "unprognostic (8.21e-4)" "unprognostic (3.09e-1)" "unprognostic (1.25e-4)" "unprognostic (3.04e-2)" "unprognostic (2.32e-1)" "unprognostic (5.19e-3)" "unprognostic (1.58e-2)" 1.5 3.1 7.2 3.7 7.4 1.4 4.0 7.7 9.6 4.9 3.7 10.8 2.1 2.3 5.2 5.2 4.8 5.5 4.1 2.0 7.9 5.3 4.3 2.4 2.3 1.9 6.2 9.3 9.0 3.4 8.2 3.0 1.6 7.8 4.6 1.8 4.7 3.8 5.5 7.5 5.6 1.9 5.6 4.8 2.2 3.3 3.1 6.2 3.3 4.6 1.6 2.6 3.8 3.0 4.3 4.5 4.3 1.5 6.1 5.4 1.6 1.9 2.5 5.2 4.4 7.8 2.3 3.0 2.8 4.8 1.5 1.8 0.7 2.6 2.2 4.1 2.2 2.1 2.7 0.9 1.4 0.7 1.6 2.0 2.6 3.1 1.2 4.4 1.3 1.2 4.6 2.4 1.5 2.9 4.4 0.8 3.5 2.0 2.3 5.3 9.0 3.4 4.0 12.2 2.8 4.7 3.7 2.7 1.3 3.4 2.7 2.3 4.3 2.8 3.5 6.5 3.5 2.3 3.8 0.9 3.5 0.5 3.9 0.8 4.5 2.8 1.8 2.9 0.8 2.9 4.3 1.4 2.8 3.9 1.5 5.3 3.0 3.3 2.8 1.3 4.3 4.9 5.4 3.5 6.1 0.9 4.5 3.9 1.6 7.2 7.4 7.7 9.6 7.9 5.3 6.2 9.3 7.8 6.2 0.0 1.3 0.0 0.7 0.2 3.1 1.4 0.0 2.7 1.2 3.5 0.0 0.7 5.0 1.3 0.6 0.3 0.5 0.0 0.4 0.6 0.6 0.8 0.0 0.6 0.4 6.4 1.2 0.0 0.0 0.0 4.0 0.0 0.0 2.8 0.9 4.3 0.6 0.0 4.9 0.8 1.1 0.0 1.2 2.3 3.6 0.3 0.8 0.0 0.6 0.4 ZNF426 MGC2663 ENSG00000130818 "Zinc finger protein 426" Q9BUY5 19 9523224-9538645 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029342 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA029342: AB_10603007" "unprognostic (3.64e-1)" "unprognostic (1.52e-1)" "unprognostic (1.31e-1)" "unprognostic (1.65e-2)" "unprognostic (6.62e-2)" "prognostic favorable (3.74e-4)" "unprognostic (4.34e-2)" "unprognostic (1.77e-2)" "unprognostic (4.75e-3)" "unprognostic (1.05e-3)" "unprognostic (8.89e-3)" "unprognostic (7.41e-3)" "prognostic favorable (2.57e-6)" "unprognostic (1.05e-1)" "unprognostic (3.17e-2)" "unprognostic (2.49e-1)" "prognostic favorable (1.81e-4)" 8.0 7.0 6.5 5.0 8.9 6.7 9.3 13.5 8.8 10.9 7.8 7.5 7.2 3.9 10.3 7.2 28.2 8.5 5.9 7.1 8.0 4.5 6.6 3.1 6.8 7.2 6.4 5.4 12.8 5.8 9.1 7.9 7.3 7.0 8.4 5.4 7.8 8.8 7.7 6.7 6.6 5.6 10.5 8.0 5.9 6.7 7.9 7.3 9.9 9.1 6.7 7.4 11.1 11.9 8.8 4.4 9.8 6.7 8.7 12.7 3.9 4.4 1.5 9.2 9.7 6.2 8.2 5.2 5.8 8.7 7.7 9.5 2.0 2.1 4.5 4.7 5.6 5.4 3.8 9.5 6.7 11.7 2.1 7.3 18.7 7.6 3.4 5.6 0.6 6.1 10.4 5.9 8.6 12.4 8.5 8.3 7.9 7.4 0.5 7.4 0.4 10.7 9.1 11.5 1.0 3.6 5.8 11.4 4.7 4.3 11.7 5.2 7.0 9.7 3.5 7.9 8.3 4.8 4.4 6.7 11.0 6.4 4.8 6.1 5.3 7.4 3.9 1.6 0.3 7.8 9.8 3.9 6.9 11.2 5.6 9.9 8.6 8.7 10.9 4.4 8.8 12.7 11.9 8.3 8.7 6.7 4.1 8.1 3.9 6.5 8.9 13.5 8.8 8.0 4.5 6.4 5.4 7.0 7.3 26.8 34.0 5.4 13.4 3.1 22.8 8.7 2.5 24.1 19.4 7.0 19.6 10.8 18.3 9.4 24.1 12.7 3.2 23.3 3.5 8.2 7.7 12.5 26.7 2.5 6.6 35.0 3.5 12.3 7.6 4.9 15.8 7.4 3.3 10.0 5.9 22.7 5.7 3.5 20.8 5.0 18.2 6.5 8.8 12.5 9.8 2.5 11.9 12.5 6.9 16.1 ZNF429 ENSG00000197013 "Zinc finger protein 429" Q86V71 19 21496682-21556270 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004139 Approved Nucleoplasm NA NA Nucleoplasm "HPA004139: AB_2667147" "unprognostic (1.06e-1)" "unprognostic (1.88e-1)" "unprognostic (2.77e-1)" "unprognostic (1.75e-2)" "unprognostic (1.45e-2)" "unprognostic (3.13e-1)" "unprognostic (3.39e-2)" "unprognostic (1.95e-2)" "unprognostic (2.19e-1)" "prognostic favorable (1.96e-8)" "prognostic favorable (7.30e-4)" "unprognostic (5.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.91e-2)" "unprognostic (2.94e-2)" "unprognostic (2.19e-1)" "unprognostic (1.48e-1)" 6.3 14.3 12.0 4.8 13.1 4.3 11.2 15.3 14.2 10.2 6.7 12.3 10.3 5.4 7.5 12.4 6.2 10.8 5.6 4.9 9.6 7.6 11.3 11.1 6.4 9.0 12.6 8.6 14.3 14.3 17.7 24.1 7.4 12.3 8.7 8.9 8.4 9.3 8.2 5.2 11.0 6.2 5.7 9.1 10.6 8.4 11.3 12.9 7.5 16.6 5.1 7.5 7.8 7.5 7.2 2.7 10.4 2.4 9.2 9.5 2.8 0.3 0.9 5.2 6.1 3.6 3.7 4.7 2.7 2.0 3.8 5.8 0.6 3.3 4.4 7.6 1.8 3.3 1.4 3.0 1.2 7.5 1.3 3.6 0.8 0.7 1.6 1.9 4.6 1.8 3.3 1.8 2.3 0.7 3.5 0.2 7.0 7.2 0.9 5.9 3.2 11.0 2.9 5.3 0.1 1.7 5.0 2.9 1.8 4.2 5.2 8.6 3.5 0.2 0.2 1.8 10.8 6.1 2.9 0.6 0.5 1.1 4.3 2.0 0.7 3.6 5.9 0.3 0.4 1.7 10.0 1.8 8.4 4.9 2.2 5.3 7.2 6.8 6.5 1.6 6.4 9.5 8.6 10.4 9.2 2.4 2.7 4.1 2.8 12.0 13.1 15.3 14.2 9.6 7.6 12.6 8.6 12.3 12.9 26.8 9.9 1.5 5.8 2.5 13.6 4.8 5.1 17.4 14.8 7.0 5.9 7.7 18.3 6.3 27.6 5.0 4.0 0.0 4.4 6.1 5.8 5.1 3.5 5.4 3.0 3.2 6.4 6.7 2.1 3.9 10.6 4.3 5.0 1.8 5.6 10.0 5.0 6.2 5.6 10.6 7.6 19.4 5.1 14.2 16.8 1.8 5.7 10.2 5.8 3.1 ZNF432 KIAA0798 ENSG00000256087 "Zinc finger protein 432" O94892 19 52031379-52095738 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 25.4;Rod photoreceptor cells: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA052082, HPA060274, HPA065606" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052082: AB_2681719, HPA060274: AB_2684238, HPA065606: AB_2685518" "unprognostic (1.62e-1)" "unprognostic (2.34e-1)" "unprognostic (1.92e-1)" "unprognostic (7.04e-3)" "unprognostic (1.08e-2)" "unprognostic (2.41e-3)" "unprognostic (3.19e-2)" "unprognostic (2.56e-1)" "unprognostic (6.92e-2)" "unprognostic (1.83e-1)" "unprognostic (3.14e-2)" "unprognostic (5.49e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (1.90e-1)" "prognostic favorable (4.11e-5)" 8.6 9.8 8.4 5.9 12.5 9.4 9.6 11.0 9.1 14.3 5.9 4.5 6.4 6.4 8.3 12.8 7.2 7.9 5.2 7.0 9.8 5.9 10.1 4.3 6.0 5.6 7.8 7.3 10.8 19.0 8.5 15.5 6.3 8.8 17.4 6.2 7.3 7.5 6.9 4.2 9.7 8.6 6.4 10.8 8.3 6.9 9.3 11.2 8.9 14.0 4.2 5.6 8.2 7.2 5.6 3.0 4.1 4.1 2.5 5.7 2.9 4.3 3.6 9.0 13.2 5.5 6.8 3.0 4.9 4.2 3.8 6.3 2.9 2.6 3.2 1.7 5.6 4.2 3.2 4.5 5.1 6.5 3.1 11.3 8.8 8.2 5.4 2.6 0.0 8.2 7.4 3.6 5.3 7.6 7.2 5.1 3.6 2.6 13.2 7.0 2.3 8.8 5.1 3.3 2.2 5.7 4.4 8.9 4.8 5.4 19.5 5.2 4.9 7.7 4.2 2.6 6.2 4.0 3.9 6.5 3.6 5.1 3.6 5.0 6.6 9.0 6.9 6.8 0.8 6.0 2.7 3.6 4.1 5.1 4.1 3.6 5.6 3.1 3.4 3.0 4.9 5.7 4.0 3.8 2.5 2.1 2.3 3.7 2.9 8.4 12.5 11.0 9.1 9.8 5.9 7.8 7.3 8.8 11.2 14.9 10.6 2.4 2.9 1.8 9.5 5.2 2.5 13.4 18.2 8.7 15.7 2.1 3.3 2.7 12.2 4.1 2.1 0.0 1.4 5.1 3.7 3.8 11.6 0.8 2.0 25.4 9.8 4.3 4.6 9.0 3.4 2.5 3.3 2.8 4.6 6.2 1.4 5.1 4.2 2.2 29.8 6.5 3.3 8.0 7.5 1.9 4.1 3.2 3.0 2.1 ZNF439 DKFZp571K0837 ENSG00000171291 "Zinc finger protein 439" Q8NDP4 19 11848726-11883750 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 49.1;Rod photoreceptor cells: 47.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 15.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 12.9;U-138 MG: 13.8" HPA047845 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (4.83e-2)" "unprognostic (3.55e-3)" "unprognostic (2.93e-2)" "unprognostic (1.19e-3)" "unprognostic (8.26e-3)" "unprognostic (7.54e-2)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "unprognostic (9.66e-4)" "unprognostic (1.00e-1)" "unprognostic (8.68e-2)" "unprognostic (2.40e-1)" "unprognostic (8.19e-2)" "unprognostic (4.94e-2)" "unprognostic (1.29e-2)" 3.4 4.7 11.0 8.6 13.2 6.2 9.9 19.7 10.7 6.2 6.0 9.2 6.6 2.3 7.4 9.0 4.3 5.2 4.4 5.5 8.8 5.3 8.0 1.9 6.7 11.2 15.7 10.5 11.4 6.1 27.3 16.8 8.8 11.8 8.2 6.8 5.8 7.0 8.1 1.8 13.1 10.0 4.9 9.7 12.4 5.1 8.5 12.8 13.7 10.0 2.3 12.4 9.0 8.1 8.6 2.5 15.9 2.8 1.9 5.3 1.9 0.1 0.0 3.6 10.6 0.3 0.3 0.0 4.5 1.6 5.4 3.7 2.5 0.2 3.8 1.9 2.4 1.6 0.1 0.0 0.3 6.4 0.0 0.1 3.7 0.0 1.5 1.1 0.0 3.7 1.1 0.3 1.1 0.0 2.4 0.0 3.6 0.7 0.0 0.3 0.3 5.1 12.9 4.5 0.0 1.0 6.1 1.0 0.0 4.0 2.2 6.6 7.1 0.0 0.1 4.6 4.0 2.8 8.4 0.0 13.8 1.3 1.2 2.6 5.3 8.2 8.6 0.2 0.0 3.7 15.9 0.5 4.8 1.7 1.4 2.1 8.6 2.8 1.7 2.5 7.6 5.3 2.9 1.5 1.9 2.8 2.4 1.1 1.9 11.0 13.2 19.7 10.7 8.8 5.3 15.7 10.5 11.8 12.8 3.0 7.2 15.7 1.8 0.5 27.0 3.1 12.7 6.7 10.3 0.0 49.1 24.1 3.3 6.9 3.6 4.7 4.1 0.0 1.6 17.8 3.1 2.5 28.9 0.0 3.5 15.9 5.8 7.4 1.6 2.8 4.0 3.1 5.0 1.0 2.4 12.5 2.5 3.2 7.4 1.9 47.8 12.9 3.8 15.6 6.6 1.6 11.3 8.5 2.1 1.4 ZNF440 FLJ37933 ENSG00000171295 "Zinc finger protein 440" Q8IYI8 19 11814284-11835201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 12.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 20.1" HPA047845 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (2.48e-1)" "unprognostic (8.96e-3)" "unprognostic (1.34e-1)" "unprognostic (4.40e-2)" "unprognostic (2.45e-3)" "unprognostic (1.24e-3)" "unprognostic (1.03e-1)" "unprognostic (3.13e-2)" "unprognostic (9.05e-2)" "unprognostic (4.64e-3)" "unprognostic (1.33e-1)" "prognostic unfavorable (3.57e-4)" "prognostic favorable (1.18e-4)" "unprognostic (9.81e-3)" "unprognostic (2.22e-1)" "unprognostic (3.80e-2)" "prognostic favorable (9.88e-4)" 8.5 6.3 5.2 6.4 7.7 7.8 9.5 12.7 9.1 10.1 13.0 4.5 9.2 7.5 11.0 8.6 15.2 19.6 6.0 4.9 10.4 4.4 9.1 5.8 10.7 5.9 5.2 5.7 10.7 8.5 19.2 9.5 21.2 11.1 12.4 15.2 5.4 11.0 10.6 5.4 20.4 11.7 6.0 7.9 7.2 11.4 9.0 6.1 6.6 8.7 9.2 7.0 19.1 10.7 1.8 2.4 12.1 3.6 3.8 2.4 1.0 5.1 0.0 5.9 7.2 4.5 4.0 15.6 3.7 3.0 4.4 3.9 5.5 4.5 2.9 3.6 3.3 2.2 6.5 3.0 7.0 6.2 0.2 2.0 4.1 3.3 4.4 2.2 0.0 9.4 2.3 4.8 2.8 0.8 3.1 2.5 4.0 15.2 0.3 5.1 2.2 3.6 5.3 4.5 1.8 4.7 3.0 7.7 1.2 3.2 20.1 3.4 2.7 5.7 2.4 4.1 6.6 10.3 7.9 2.6 10.2 2.1 7.4 3.2 5.5 3.9 3.9 4.8 2.6 3.7 12.1 1.9 2.4 1.7 1.2 2.0 1.4 2.1 1.9 2.4 1.8 1.5 2.4 3.6 3.8 3.6 1.5 2.4 1.0 5.2 7.7 12.7 9.1 10.4 4.4 5.2 5.7 11.1 6.1 14.9 6.4 0.9 9.2 2.6 5.3 2.5 2.5 83.0 20.5 8.7 33.4 23.6 3.3 3.1 16.5 3.6 15.4 0.0 3.2 15.6 2.3 6.2 10.4 1.1 3.9 6.4 6.4 4.3 4.4 3.6 2.6 3.3 3.3 1.0 9.5 2.2 4.2 12.4 1.8 1.3 12.4 0.0 3.8 9.3 2.5 4.3 24.9 4.9 11.5 8.4 ZNF45 ZNF13 ENSG00000124459 "Zinc finger protein 45" Q02386 19 43912629-43935278 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038611, HPA075124" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA038611: AB_10669544, HPA075124: AB_2686735" "unprognostic (1.67e-2)" "unprognostic (4.84e-1)" "unprognostic (1.07e-2)" "unprognostic (1.84e-3)" "unprognostic (1.23e-1)" "unprognostic (9.31e-2)" "unprognostic (5.34e-2)" "unprognostic (1.04e-1)" "unprognostic (1.60e-3)" "unprognostic (1.91e-1)" "unprognostic (7.68e-3)" "unprognostic (5.17e-3)" "unprognostic (5.17e-3)" "unprognostic (1.67e-1)" "unprognostic (1.66e-1)" "unprognostic (4.43e-2)" "unprognostic (5.82e-2)" 11.8 12.0 7.5 7.8 9.0 8.2 10.9 17.9 10.0 12.9 9.3 12.2 7.2 8.4 12.1 8.8 8.2 10.5 8.0 7.3 11.3 7.2 9.8 8.7 8.9 10.9 9.7 5.4 14.4 7.7 18.3 13.7 8.9 10.3 11.4 9.5 11.1 9.9 16.8 8.8 8.8 9.8 10.0 7.4 14.8 8.5 6.1 11.4 22.1 14.9 6.6 11.5 10.7 8.8 8.4 6.6 7.4 5.7 8.4 11.9 5.4 6.2 8.4 12.1 10.8 5.9 5.2 4.2 8.2 9.0 8.6 13.2 4.1 2.6 9.1 5.1 5.1 6.7 3.6 9.1 6.0 10.9 7.7 9.7 13.6 7.2 3.6 5.5 13.3 9.2 5.2 6.0 6.3 5.6 8.6 6.8 3.2 4.2 3.7 9.2 2.9 7.8 3.4 14.2 5.9 3.6 6.5 12.0 3.3 5.3 14.0 8.3 13.7 11.5 4.7 3.9 8.1 4.9 8.8 7.1 9.6 14.1 4.0 7.4 15.2 24.5 10.2 4.1 5.2 11.1 3.8 5.0 7.4 8.0 4.6 11.9 8.4 7.7 8.4 6.6 6.3 10.8 7.3 1.5 8.4 5.7 4.4 8.1 5.4 7.5 9.0 17.9 10.0 11.3 7.2 9.7 5.4 10.3 11.4 3.0 1.7 5.2 0.8 1.3 1.3 2.0 0.0 5.3 4.5 0.0 5.9 1.7 0.0 2.3 0.1 1.5 2.0 0.0 1.4 0.9 1.5 1.9 0.0 1.8 2.4 3.2 2.4 1.3 2.2 0.2 1.7 2.3 1.7 1.0 3.4 1.3 1.1 0.0 4.6 1.6 1.9 19.4 0.9 0.9 1.7 1.4 1.0 2.5 2.2 1.2 ZNF451 "COASTER, dJ417I1.1, KIAA0576, KIAA1702" ENSG00000112200 "Zinc finger protein 451" Q9Y4E5 6 57086844-57170307 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 214.0;Late spermatids: 315.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028838 Approved Nucleoplasm NA NA Nucleoplasm "HPA028838: AB_10603330" "unprognostic (5.95e-2)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (1.81e-1)" "unprognostic (9.00e-3)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (6.87e-3)" "unprognostic (1.38e-2)" "unprognostic (1.27e-3)" "unprognostic (9.09e-2)" "unprognostic (6.42e-2)" "unprognostic (1.11e-3)" "unprognostic (2.11e-1)" "unprognostic (2.50e-1)" "unprognostic (2.13e-3)" "unprognostic (6.17e-2)" 13.2 17.8 14.2 10.8 30.9 61.8 14.4 23.3 21.2 13.8 12.8 15.5 11.6 8.8 14.9 16.1 11.7 12.0 11.2 11.2 15.4 13.0 11.9 13.3 13.5 15.2 20.5 13.9 14.3 11.9 14.5 27.6 18.0 20.3 14.9 10.8 8.8 11.3 11.8 11.2 12.3 12.0 18.9 21.1 15.5 12.9 27.5 21.0 16.5 16.6 7.8 14.1 14.9 12.9 14.2 14.2 19.3 10.0 7.7 12.3 6.8 9.3 5.1 12.9 7.9 12.3 15.9 12.4 10.4 13.1 12.7 13.8 11.7 4.7 10.3 6.9 11.5 15.1 8.9 12.6 11.6 20.6 8.3 8.9 26.7 9.3 10.8 9.4 14.8 11.6 11.2 11.8 14.0 17.7 9.4 12.4 14.8 35.6 10.0 10.8 6.8 18.5 12.8 7.0 7.2 5.7 12.7 16.5 9.6 8.4 16.1 15.3 10.3 11.3 7.5 12.3 15.9 9.0 14.3 8.1 12.8 13.2 16.4 12.1 9.7 16.2 21.0 11.2 18.4 6.3 19.3 10.0 9.7 10.8 8.3 10.6 9.6 9.3 6.4 10.6 14.2 12.3 9.4 5.0 7.7 8.5 14.2 7.2 6.8 14.2 30.9 23.3 21.2 15.4 13.0 20.5 13.9 20.3 21.0 23.8 28.0 21.7 12.6 50.0 55.6 22.7 28.1 36.1 25.0 29.6 70.7 34.1 8.3 12.4 214.0 28.6 18.6 116.8 11.9 26.4 47.4 21.6 40.6 25.6 15.7 46.1 35.3 49.7 29.7 315.8 34.8 30.7 32.1 10.0 21.2 32.3 15.3 11.5 38.9 11.0 66.7 6.5 38.5 46.0 30.2 37.4 11.0 24.9 21.0 14.7 ZNF460 "HZF8, ZNF272" ENSG00000197714 "Zinc finger protein 460" Q14592 19 57280051-57293569 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 17.3" "HPA053004, HPA066506" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053004: AB_2682012, HPA066506: AB_2685681" "unprognostic (2.57e-1)" "unprognostic (1.72e-1)" "unprognostic (1.28e-2)" "unprognostic (3.65e-2)" "unprognostic (1.58e-2)" "unprognostic (3.20e-1)" "unprognostic (8.04e-2)" "unprognostic (2.52e-1)" "unprognostic (2.19e-1)" "unprognostic (2.86e-1)" "unprognostic (2.89e-2)" "unprognostic (1.68e-1)" "unprognostic (1.32e-1)" "unprognostic (2.12e-1)" "unprognostic (1.62e-1)" "unprognostic (2.08e-2)" "unprognostic (4.10e-2)" 9.5 23.2 7.7 6.2 12.0 24.7 9.2 9.4 10.1 6.8 5.6 12.7 7.5 3.6 6.5 5.4 7.7 5.7 6.5 8.7 7.4 5.0 7.0 8.5 7.9 5.5 14.6 7.0 13.2 6.5 10.3 13.0 8.0 8.6 7.0 4.8 6.4 8.3 7.3 8.7 9.6 5.1 7.4 10.8 7.8 5.9 9.6 10.7 5.9 8.3 6.7 8.6 5.9 7.5 5.4 0.4 3.4 2.8 2.0 3.6 1.6 1.6 2.4 1.9 2.7 2.0 1.7 5.0 1.1 1.5 1.2 3.7 3.0 0.9 2.3 1.1 1.3 1.1 1.1 2.6 1.3 2.1 1.8 5.0 2.3 1.8 1.5 2.2 3.9 2.6 0.9 2.3 3.2 3.7 1.0 0.8 2.6 2.2 17.3 1.4 1.2 2.4 0.6 2.7 1.2 2.4 1.7 2.7 1.1 0.8 3.1 2.5 1.3 2.7 1.4 1.6 1.3 1.2 2.7 1.1 3.7 4.3 0.5 2.1 7.5 3.2 4.0 1.3 1.5 1.1 0.0 1.2 2.6 2.2 2.8 2.3 2.3 1.7 1.2 0.4 5.4 3.6 1.5 3.4 2.0 1.9 0.2 2.7 1.6 7.7 12.0 9.4 10.1 7.4 5.0 14.6 7.0 8.6 10.7 3.0 1.0 1.7 2.8 2.7 3.9 4.2 0.0 2.7 2.3 0.0 0.0 1.2 0.0 1.2 2.2 2.7 0.4 0.0 0.3 1.7 1.7 2.8 0.0 1.5 0.9 7.9 0.0 7.4 3.0 0.0 1.7 1.8 1.7 3.6 0.6 2.9 1.6 0.0 1.4 0.8 3.2 0.0 5.7 2.8 1.2 2.0 2.2 1.3 0.8 3.4 ZNF462 "DKFZP762N2316, KIAA1803, Zfp462" ENSG00000148143 "Zinc finger protein 462" Q96JM2 9 106863097-107013634 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022283 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA022283: AB_2220602" "unprognostic (4.22e-2)" "unprognostic (3.89e-2)" "unprognostic (2.60e-2)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (2.28e-1)" "unprognostic (2.04e-2)" "unprognostic (2.01e-1)" "unprognostic (3.62e-2)" "unprognostic (1.84e-2)" "unprognostic (2.16e-1)" "unprognostic (6.04e-2)" "prognostic favorable (6.19e-4)" "unprognostic (2.96e-2)" "unprognostic (1.68e-1)" "unprognostic (9.00e-2)" "unprognostic (1.33e-2)" 4.8 11.9 10.4 5.0 11.0 0.8 6.4 25.4 9.5 10.4 6.5 13.2 7.7 2.3 13.3 5.1 10.7 9.1 6.0 8.6 10.6 6.6 5.6 2.9 5.3 1.8 8.1 7.8 11.5 2.1 18.1 10.0 5.6 10.0 11.4 6.4 8.1 12.6 11.9 22.1 11.2 3.3 10.8 9.7 4.8 3.3 9.1 9.8 1.5 11.7 5.4 2.5 5.6 9.3 0.4 0.5 1.1 0.6 1.8 1.7 0.3 3.2 7.6 15.2 10.4 5.1 3.8 2.2 2.0 2.9 2.0 2.2 9.3 3.3 0.0 5.7 2.1 9.3 5.1 9.8 9.0 2.5 0.1 1.3 0.0 2.5 0.0 2.0 1.6 0.3 3.5 4.1 4.5 12.5 5.4 1.0 4.0 0.0 4.2 5.5 5.7 1.8 0.1 11.6 0.0 7.4 0.0 10.2 0.2 5.8 2.8 7.0 8.0 3.8 0.1 3.3 10.1 7.8 0.0 1.0 2.6 9.0 5.9 6.3 0.0 0.1 0.1 4.3 0.2 9.3 1.1 0.2 0.3 0.7 0.4 1.2 0.3 0.7 0.3 0.3 0.4 1.7 0.5 0.7 1.8 0.6 0.5 0.3 0.3 10.4 11.0 25.4 7.7 10.6 6.6 8.1 7.8 10.0 9.8 20.8 23.2 1.3 10.3 29.9 56.8 21.4 20.4 13.4 12.5 7.0 29.5 9.6 5.0 6.7 52.2 23.3 6.3 0.0 2.3 4.1 10.4 13.6 16.2 0.0 1.6 17.5 16.1 39.3 1.0 10.4 13.6 1.3 11.8 3.6 19.9 20.3 4.8 0.0 25.5 14.7 38.6 25.8 19.8 1.2 12.8 10.0 2.6 0.0 16.8 6.4 ZNF471 "KIAA1396, Z1971" ENSG00000196263 "Zinc finger protein 471" Q9BX82 19 56507843-56530221 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 17.3;Ciliated cells: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 9.5;hTERT-RPE1: 13.8;SuSa: 10.4" "Low region specificity" "Detected in all" HPA066695 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA066695: AB_2685704" "unprognostic (2.89e-2)" "unprognostic (2.79e-4)" "unprognostic (1.58e-1)" "unprognostic (2.90e-2)" "unprognostic (2.22e-1)" "unprognostic (2.42e-3)" "unprognostic (1.45e-1)" "unprognostic (8.44e-2)" "unprognostic (1.01e-2)" "unprognostic (4.14e-2)" "unprognostic (4.47e-4)" "unprognostic (9.36e-2)" "prognostic favorable (2.37e-4)" "unprognostic (3.84e-3)" "unprognostic (1.08e-1)" "unprognostic (7.89e-2)" "unprognostic (3.44e-3)" 5.8 7.2 18.5 4.1 18.5 3.0 7.8 23.1 19.3 7.8 8.2 11.2 5.9 2.1 14.2 17.8 5.4 9.8 7.4 5.8 17.4 7.5 5.5 2.6 6.2 3.2 12.2 13.3 24.7 3.9 16.3 10.9 6.6 15.1 9.3 5.1 4.6 6.5 8.5 4.9 10.1 3.2 10.4 11.5 4.6 4.5 8.7 21.3 1.6 10.6 3.1 2.2 6.7 9.9 3.1 1.6 5.4 1.3 3.0 2.1 0.3 0.5 0.5 5.4 0.8 4.5 5.1 0.6 4.9 1.8 2.2 2.0 0.8 0.8 0.8 3.3 5.2 4.4 0.5 0.7 0.4 2.2 1.1 2.0 3.9 1.3 0.6 4.4 1.1 3.5 9.5 1.8 2.9 0.2 13.8 0.2 0.6 1.2 1.7 2.5 0.6 0.5 0.7 1.4 0.4 2.1 0.6 3.5 0.5 3.9 4.1 0.9 3.2 0.5 0.2 0.2 10.4 0.7 0.8 0.8 8.4 3.7 0.9 3.7 1.3 1.2 0.5 0.7 0.6 0.6 3.9 1.3 0.9 1.9 1.0 1.5 1.2 1.7 1.2 0.7 3.1 1.7 2.1 5.4 3.0 1.0 1.6 1.0 0.3 18.5 18.5 23.1 19.3 17.4 7.5 12.2 13.3 15.1 21.3 17.9 17.3 0.0 2.3 0.6 9.8 9.3 2.5 17.4 12.5 5.2 5.9 1.0 3.3 1.3 5.3 6.7 0.9 0.0 0.8 0.3 2.6 2.8 2.3 0.8 0.4 6.4 1.2 6.2 0.6 2.5 4.6 1.9 1.7 1.0 0.7 11.3 0.7 0.0 6.7 1.1 9.1 6.5 3.1 7.1 7.5 0.5 0.7 0.0 1.0 1.4 ZNF473 "DKFZP434N043, HZFP100, KIAA1141" ENSG00000142528 "Zinc finger protein 473" Q8WTR7 19 50025714-50053414 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.6" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 63.5;Spermatocytes: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA004191, HPA073309" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004191: AB_2667168, HPA073309: AB_2686594" "unprognostic (7.47e-3)" "unprognostic (3.57e-2)" "unprognostic (2.47e-1)" "unprognostic (3.40e-1)" "unprognostic (4.27e-1)" "unprognostic (8.00e-3)" "prognostic unfavorable (3.72e-4)" "unprognostic (1.31e-3)" "unprognostic (6.44e-3)" "unprognostic (1.42e-1)" "unprognostic (1.70e-2)" "unprognostic (3.22e-3)" "unprognostic (8.49e-2)" "unprognostic (1.60e-1)" "unprognostic (3.93e-2)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" 3.8 3.7 4.4 3.8 6.5 3.8 4.8 9.7 5.8 4.1 3.7 4.6 3.7 2.9 5.9 4.4 3.8 10.1 3.4 3.0 5.1 4.3 3.8 4.1 4.0 3.7 5.9 3.2 4.8 4.8 4.0 7.7 3.1 7.3 5.1 3.3 2.7 3.4 5.6 4.9 3.8 3.0 5.1 5.0 6.4 3.3 38.6 7.7 2.6 5.2 3.3 4.5 3.7 18.6 12.4 5.6 5.0 7.9 2.4 11.6 4.6 9.4 6.4 10.1 8.4 3.8 4.7 5.7 8.9 5.2 12.7 11.9 12.3 6.3 14.4 3.4 5.1 4.7 7.1 12.7 5.9 16.3 10.3 12.0 14.8 5.6 5.7 4.7 10.6 8.8 4.8 11.0 13.3 17.6 5.2 4.2 8.7 20.9 13.2 6.4 4.1 8.1 5.0 7.1 14.7 9.9 10.4 14.0 6.3 4.2 10.4 8.3 9.4 12.6 6.9 6.2 7.0 6.2 9.8 2.0 17.7 9.0 3.4 8.9 6.1 14.4 12.3 4.2 8.4 14.3 2.2 5.5 2.9 7.2 7.9 7.3 12.4 7.2 8.8 5.4 10.2 9.2 11.6 5.0 2.4 3.5 5.6 3.9 4.6 4.4 6.5 9.7 5.8 5.1 4.3 5.9 3.2 7.3 7.7 0.0 1.7 2.7 2.3 4.0 0.7 2.1 0.0 13.4 1.2 0.0 0.0 2.0 3.3 2.1 63.5 2.8 1.7 0.0 2.8 2.5 2.4 2.8 0.0 1.0 1.9 0.0 1.7 8.6 2.1 16.0 3.4 1.6 1.7 2.8 2.7 1.7 3.2 2.0 3.5 1.5 3.7 12.9 2.9 38.6 20.2 4.1 1.6 3.2 1.8 1.4 ZNF512 KIAA1805 ENSG00000243943 "Zinc finger protein 512" Q96ME7 2 27582969-27623215 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031430 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031430: AB_10603844" "prognostic favorable (9.79e-4)" "unprognostic (4.19e-2)" "unprognostic (1.87e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.33e-1)" "unprognostic (3.07e-2)" "unprognostic (7.75e-3)" "prognostic favorable (5.08e-9)" "unprognostic (6.08e-2)" "unprognostic (2.33e-1)" "prognostic favorable (5.19e-4)" "unprognostic (1.10e-2)" "unprognostic (8.09e-3)" "unprognostic (4.44e-2)" "unprognostic (1.85e-1)" "unprognostic (5.66e-2)" "unprognostic (5.60e-3)" 11.0 12.8 12.0 13.3 19.9 5.2 15.6 18.5 22.4 18.1 14.8 20.4 12.1 7.4 23.7 14.7 9.9 20.8 12.3 12.0 11.0 14.3 12.1 6.7 12.9 14.5 12.1 15.4 33.7 8.1 28.0 27.6 12.1 18.8 17.8 11.7 18.7 11.3 19.1 7.2 6.8 12.5 17.4 14.2 15.0 11.0 12.0 11.6 21.3 19.6 6.6 15.8 17.2 14.0 9.6 6.3 14.6 5.2 17.0 14.6 8.5 11.6 10.3 21.4 9.5 10.6 12.1 0.0 5.8 8.2 11.0 13.0 7.9 7.4 10.2 6.5 6.6 9.1 4.0 18.9 5.4 11.7 9.4 15.2 21.3 8.4 12.0 8.2 13.8 9.7 11.0 6.0 8.5 2.5 8.8 17.4 17.9 18.4 7.5 16.1 1.4 1.4 10.6 14.8 7.7 0.0 23.2 30.2 8.8 7.8 3.2 21.0 20.9 5.5 3.5 16.2 10.7 4.3 8.0 14.3 3.9 9.4 3.9 7.5 7.6 5.3 17.6 5.8 17.3 7.9 14.6 4.2 7.3 8.7 5.2 11.7 9.6 10.9 12.4 6.3 8.0 14.6 12.2 1.2 17.0 4.1 4.5 7.5 8.5 12.0 19.9 18.5 22.4 11.0 14.3 12.1 15.4 18.8 11.6 8.9 13.9 9.3 8.3 3.4 20.9 14.5 7.6 9.4 9.1 17.4 15.7 1.4 8.3 5.9 8.4 10.5 1.8 0.0 1.6 0.9 8.0 7.3 5.8 3.9 4.5 17.5 8.6 11.6 6.0 5.4 13.8 5.5 1.7 4.6 5.5 16.6 3.2 0.0 16.3 2.9 13.9 19.4 11.7 8.9 7.9 2.6 1.0 8.2 4.9 6.7 ZNF512B "GM632, MGC149845, MGC149846" ENSG00000196700 "Zinc finger protein 512B" Q96KM6 20 63956702-63969865 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 20.1;Cone photoreceptor cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006688, HPA008731" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006688: AB_10963053, HPA008731: " "unprognostic (7.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.40e-3)" "unprognostic (7.19e-3)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (5.30e-3)" "unprognostic (2.38e-2)" "unprognostic (3.04e-1)" "unprognostic (1.13e-1)" "unprognostic (6.99e-3)" "unprognostic (5.03e-3)" "unprognostic (2.12e-1)" "unprognostic (7.72e-2)" "unprognostic (5.52e-2)" "unprognostic (1.95e-3)" "unprognostic (3.72e-2)" 7.5 8.2 11.0 6.3 13.3 6.2 5.6 14.3 16.7 7.4 3.6 9.9 6.1 5.3 9.3 9.0 10.1 8.5 7.5 8.3 11.0 8.5 9.6 18.5 7.1 7.0 8.8 10.5 11.3 14.4 13.6 10.3 10.4 8.4 8.5 1.7 9.9 15.5 10.5 11.2 14.3 5.8 7.8 6.4 9.3 8.5 8.8 6.5 6.2 10.7 5.8 8.8 6.2 6.7 0.6 0.4 0.0 0.1 1.4 1.1 0.3 5.4 9.2 10.4 11.0 4.6 3.4 9.5 7.9 6.2 23.8 7.8 17.9 9.2 3.6 19.4 6.8 4.4 7.0 7.8 11.7 5.7 5.8 11.2 8.8 12.9 17.0 7.4 4.7 10.6 7.2 9.7 8.2 4.7 6.3 7.3 16.2 12.2 5.5 4.7 13.0 23.0 10.3 7.2 7.0 12.1 10.6 0.9 10.7 4.3 9.2 15.2 8.9 6.5 10.8 5.2 5.2 22.7 11.5 10.2 22.9 3.5 5.7 6.7 13.2 6.3 10.0 8.2 0.0 9.7 0.0 0.1 0.0 1.1 0.0 0.1 0.1 1.0 0.1 0.4 0.6 1.1 1.0 0.0 1.4 0.0 0.4 0.0 0.3 11.0 13.3 14.3 16.7 11.0 8.5 8.8 10.5 8.4 6.5 3.0 6.4 3.2 2.9 4.7 20.1 1.7 7.6 1.4 5.7 1.8 21.6 6.2 1.7 3.2 0.1 3.0 0.3 0.0 5.2 2.6 4.5 2.5 0.0 15.3 3.2 12.7 5.8 8.6 1.3 1.0 6.1 0.7 5.0 1.8 0.5 8.0 2.8 0.0 6.3 4.1 10.5 0.0 3.4 3.0 4.8 6.0 4.2 2.9 1.3 2.4 ZNF517 ENSG00000197363 "Zinc finger protein 517" Q6ZMY9 8 144798876-144811169 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 14.0" HPA055337 Approved Nucleoplasm NA NA Nucleoplasm "HPA055337: AB_2682788" "unprognostic (9.54e-3)" "unprognostic (4.72e-2)" "unprognostic (3.20e-2)" "unprognostic (3.06e-2)" "unprognostic (1.81e-1)" "unprognostic (1.55e-2)" "unprognostic (2.22e-2)" "unprognostic (3.13e-1)" "unprognostic (4.83e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.66e-4)" "unprognostic (1.83e-1)" "unprognostic (4.23e-2)" "unprognostic (2.75e-1)" "unprognostic (2.40e-1)" "unprognostic (1.38e-1)" "unprognostic (9.57e-2)" 2.9 6.5 5.3 3.1 4.5 1.5 8.5 7.3 8.6 3.3 3.0 2.7 5.3 3.6 5.6 3.1 3.2 4.1 3.2 5.8 6.8 3.2 3.9 3.2 4.6 6.5 5.6 6.1 7.5 3.8 4.5 3.9 4.4 4.2 3.7 0.5 5.4 6.9 1.9 9.6 10.5 4.5 1.4 4.1 4.3 3.6 3.6 4.4 3.0 4.1 1.4 1.4 4.1 2.8 4.1 1.1 0.5 2.4 1.4 2.2 1.2 2.1 3.9 6.6 6.4 1.0 2.0 3.4 1.9 0.5 0.4 0.3 1.3 2.3 1.2 4.6 0.6 2.8 2.1 0.3 0.7 0.9 4.6 1.7 2.7 2.1 14.0 2.5 0.6 2.8 1.4 1.7 0.3 1.3 3.7 1.5 3.4 3.1 1.8 1.1 3.4 2.7 1.6 4.6 4.2 4.4 3.9 2.0 0.9 0.6 2.6 2.9 8.4 5.3 2.1 2.0 3.4 5.4 2.4 1.8 4.4 6.9 2.3 1.9 3.0 0.5 0.8 4.8 1.1 3.6 0.4 1.2 0.0 1.8 2.4 1.5 4.1 1.7 1.2 1.1 0.7 1.4 1.2 0.5 1.4 1.4 0.5 2.2 1.2 5.3 4.5 7.3 8.6 6.8 3.2 5.6 6.1 4.2 4.4 0.0 0.3 0.0 5.0 0.5 3.6 2.8 5.1 0.0 1.2 0.0 7.9 0.6 1.7 0.8 1.2 1.1 1.0 0.0 0.4 0.5 0.8 1.2 0.0 1.7 1.3 3.2 1.2 3.1 1.6 0.0 0.9 1.3 0.0 0.0 1.0 2.3 0.7 0.0 1.1 2.2 3.7 0.0 1.4 3.0 2.6 1.0 0.3 1.0 0.8 4.4 ZNF518A "KIAA0335, ZNF518" ENSG00000177853 "Zinc finger protein 518A" Q6AHZ1 10 96129715-96205288 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029049 Approved Nucleoplasm Yes No Nucleoplasm "HPA029049: AB_2672885" "unprognostic (1.48e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-2)" "unprognostic (4.66e-2)" "unprognostic (7.61e-2)" "unprognostic (3.38e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-2)" "unprognostic (6.02e-1)" "unprognostic (2.97e-1)" "unprognostic (1.09e-3)" "unprognostic (8.38e-3)" "unprognostic (1.43e-1)" "unprognostic (3.06e-1)" "unprognostic (3.09e-2)" "unprognostic (1.16e-3)" 3.5 2.8 4.8 4.6 5.9 6.1 6.9 7.1 5.6 5.7 6.4 6.5 5.9 4.4 6.0 7.7 3.8 4.0 4.4 2.8 4.1 6.1 4.0 4.2 4.9 8.1 4.5 7.3 4.8 5.0 15.1 5.8 7.7 5.6 6.6 4.6 3.4 4.2 2.2 5.3 8.7 5.6 7.1 5.0 6.1 15.0 5.5 12.2 7.3 3.9 5.4 4.0 4.2 4.4 4.8 11.0 7.9 3.9 5.6 2.3 2.8 6.4 7.2 0.0 3.7 4.2 8.7 3.0 1.7 3.3 3.4 6.0 6.9 10.4 2.9 1.9 4.7 4.1 8.2 2.9 3.0 4.8 4.4 15.6 2.2 9.8 3.2 16.9 9.5 2.7 7.1 3.4 5.6 2.4 3.9 12.3 13.3 7.0 3.2 2.8 9.9 10.3 11.1 3.1 0.4 11.2 8.2 4.2 3.9 5.8 2.1 5.1 4.2 4.0 3.1 12.5 4.8 10.8 2.5 1.6 6.1 2.1 3.2 6.5 16.4 6.1 1.1 13.0 1.6 11.0 4.5 5.4 3.2 4.8 5.1 4.4 3.9 3.2 2.8 4.1 5.6 3.8 4.5 3.9 7.9 4.8 4.0 2.3 53.6 26.2 21.5 15.3 0.0 58.9 23.0 20.4 18.7 27.3 38.4 41.2 35.7 16.6 19.5 13.8 17.3 38.1 0.0 22.4 24.4 8.2 20.6 9.2 25.2 24.3 71.5 58.8 36.2 28.9 11.8 32.5 31.3 0.0 13.6 31.2 37.1 25.4 45.6 23.7 14.8 61.0 19.4 12.2 64.6 88.8 0.0 36.6 27.7 30.2 15.4 ZNF518B KIAA1729 ENSG00000178163 "Zinc finger protein 518B" Q9C0D4 4 10439874-10457410 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031215, HPA031216" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031215: AB_10600200, HPA031216: AB_10601449" "unprognostic (2.69e-1)" "unprognostic (1.68e-1)" "unprognostic (2.89e-1)" "unprognostic (7.74e-3)" "unprognostic (2.11e-1)" "unprognostic (7.99e-2)" "unprognostic (1.01e-1)" "unprognostic (4.91e-2)" "unprognostic (3.39e-2)" "unprognostic (3.07e-1)" "unprognostic (2.24e-1)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (1.27e-1)" "unprognostic (5.44e-2)" "unprognostic (1.02e-1)" "unprognostic (1.89e-3)" 11.2 9.6 9.4 10.5 12.2 6.1 12.9 16.0 13.2 11.4 10.3 6.0 9.6 6.4 10.4 11.4 7.7 8.3 7.8 11.0 9.3 9.9 6.2 4.2 7.5 12.6 7.5 7.6 15.8 5.7 10.5 12.7 13.1 8.3 12.7 5.4 9.3 12.1 13.5 12.1 6.5 11.4 10.0 6.4 11.1 7.9 15.1 4.7 19.5 14.1 7.3 14.8 10.7 11.5 9.5 4.5 11.8 5.3 6.8 4.8 2.3 4.9 3.4 13.2 3.8 1.7 2.6 0.0 5.8 1.4 3.6 4.3 0.0 0.0 0.0 5.9 8.4 10.2 0.1 3.0 6.4 8.0 0.0 5.5 16.0 0.0 0.0 7.7 0.0 7.1 7.5 3.8 5.7 0.0 7.4 12.2 12.0 17.2 0.0 2.9 0.0 10.8 0.4 12.8 2.5 7.7 9.3 5.6 1.8 0.1 7.0 9.9 2.9 2.7 0.0 1.8 11.0 2.1 4.3 9.2 0.0 12.1 0.0 5.4 6.8 5.0 9.4 0.7 0.9 0.7 2.8 2.5 11.8 2.9 2.6 3.8 9.5 4.6 3.3 4.5 5.2 4.8 4.4 6.5 6.8 5.3 1.5 3.4 2.3 9.4 12.2 16.0 13.2 9.3 9.9 7.5 7.6 8.3 4.7 3.0 4.6 4.2 17.0 14.2 9.2 23.8 5.1 5.3 10.3 0.0 9.8 7.9 3.3 2.4 10.3 12.6 4.2 0.0 3.3 7.4 6.7 17.5 16.1 1.6 7.7 11.1 1.2 9.2 8.2 15.2 15.0 5.0 1.7 4.6 2.7 8.3 1.9 2.9 20.1 1.0 10.6 0.0 6.2 12.3 8.3 12.4 7.7 5.7 3.0 15.8 ZNF521 "EHZF, Evi3" ENSG00000198795 "Zinc finger protein 521" Q96K83 18 25061926-25352190 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.1" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 27.9;Endothelial cells: 22.4;Horizontal cells: 14.3;Ito cells: 14.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 69.1" "Group enriched" "Detected in some" 5 "basophil: 8.8;plasmacytoid DC: 9.8" "Group enriched" "Detected in many" 5 "dendritic cells: 9.8;granulocytes: 8.8" "Cell line enhanced" "Detected in many" "AF22: 32.0;fHDF/TERT166: 15.0;HUVEC TERT2: 21.9;THP-1: 17.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 105.4" "HPA023056, HPA023849" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA023056: AB_1859315, HPA023849: AB_1859316" "unprognostic (8.80e-3)" "unprognostic (9.68e-2)" "unprognostic (2.05e-1)" "unprognostic (3.40e-2)" "unprognostic (5.43e-2)" "unprognostic (3.73e-3)" "unprognostic (1.52e-3)" "unprognostic (6.17e-2)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (8.18e-2)" "unprognostic (1.83e-1)" "unprognostic (1.19e-3)" "unprognostic (1.16e-3)" "unprognostic (2.43e-1)" "unprognostic (2.52e-3)" "unprognostic (7.82e-4)" 9.2 11.3 5.2 2.8 7.0 1.9 9.1 69.1 11.5 11.0 3.4 9.1 4.7 1.7 19.8 5.9 3.8 9.0 10.0 7.0 5.8 5.1 3.1 1.2 6.4 4.0 8.4 2.8 20.5 1.4 1.4 16.8 8.0 12.2 4.4 3.5 6.7 8.7 3.0 3.8 4.6 3.2 13.3 12.2 18.5 2.4 3.4 8.9 0.5 5.3 6.9 2.6 7.4 5.4 0.0 9.8 8.8 0.1 1.7 0.0 0.1 0.0 0.0 32.0 0.0 5.1 9.0 0.1 4.6 6.7 1.6 1.0 0.0 0.0 0.0 0.0 15.0 0.0 0.1 0.0 0.0 1.3 0.0 1.9 6.3 0.3 0.2 0.9 0.0 9.6 11.1 0.0 0.1 0.0 0.0 21.9 7.6 0.1 0.0 2.8 0.0 4.1 0.0 2.2 0.0 0.0 0.0 7.2 0.5 0.0 0.0 4.1 2.6 0.4 0.0 0.0 3.0 0.0 17.8 12.4 12.7 1.0 3.7 0.7 0.0 0.0 0.1 4.8 0.0 10.4 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 9.8 0.0 0.1 5.2 7.0 69.1 4.3 5.8 5.1 8.4 2.8 12.2 8.9 0.0 4.8 0.0 0.1 3.3 27.9 9.1 0.0 2.7 1.2 0.0 2.0 0.0 0.0 0.0 1.6 22.4 0.0 0.0 0.0 0.0 7.2 0.2 12.7 0.0 0.1 14.3 1.2 14.1 1.6 3.6 9.2 0.9 13.5 0.0 0.0 0.7 0.0 0.0 7.4 3.1 2.7 0.0 3.3 0.1 1.5 3.9 0.1 0.0 0.0 0.1 ZNF524 MGC23143 ENSG00000171443 "Zinc finger protein 524" Q96C55 19 55600022-55603138 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050981 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA050981: AB_2681298" "unprognostic (6.69e-2)" "unprognostic (1.23e-2)" "unprognostic (5.70e-2)" "unprognostic (4.27e-3)" "unprognostic (2.88e-2)" "unprognostic (3.63e-2)" "unprognostic (1.30e-2)" "unprognostic (5.13e-2)" "unprognostic (2.99e-1)" "unprognostic (2.02e-1)" "unprognostic (1.35e-1)" "unprognostic (2.13e-1)" "unprognostic (8.26e-2)" "unprognostic (1.02e-2)" "unprognostic (3.84e-1)" "unprognostic (1.59e-2)" "prognostic favorable (4.98e-8)" 10.4 7.9 7.9 9.9 8.2 9.4 36.6 6.9 10.3 7.1 10.9 5.5 15.8 15.8 7.9 13.6 12.8 8.7 16.2 9.6 7.5 4.4 8.4 10.8 10.5 14.1 12.2 4.8 7.1 31.4 5.4 7.8 5.4 7.5 10.6 4.5 4.5 22.9 13.8 32.1 13.8 12.3 6.4 8.1 11.8 13.3 4.0 9.5 7.9 12.9 12.1 5.9 8.4 16.5 13.2 16.5 16.4 21.2 10.1 19.1 12.4 8.7 8.8 1.3 6.1 4.0 8.5 10.0 5.7 3.4 3.7 3.7 2.6 10.2 4.5 3.3 3.2 2.1 7.1 0.8 4.3 0.5 13.2 22.3 5.4 4.9 4.6 10.0 3.4 7.0 7.0 10.3 3.0 3.1 3.8 6.8 5.8 5.0 9.2 1.9 5.1 3.4 7.5 1.5 8.5 10.0 4.5 3.1 13.3 4.7 5.0 6.2 3.9 5.6 8.1 6.3 1.1 3.8 11.6 5.8 3.1 5.4 6.0 7.4 4.0 4.7 2.1 8.6 9.0 4.2 11.5 21.2 16.4 12.7 18.3 11.7 11.6 13.2 12.2 16.5 13.2 15.8 8.6 13.4 10.1 12.1 5.1 19.1 12.4 7.9 8.2 6.9 10.3 7.5 4.4 12.2 4.8 7.5 9.5 6.0 13.1 16.6 18.3 22.3 9.0 9.6 15.3 5.3 5.7 7.0 5.9 18.6 14.9 22.8 2.1 23.4 69.5 0.0 45.9 15.9 12.5 14.5 10.3 20.3 34.9 6.4 22.4 33.7 61.7 3.6 16.7 26.7 28.7 19.0 48.1 7.2 32.4 49.5 20.5 25.8 6.4 19.4 15.1 0.9 4.1 31.1 21.4 30.8 43.9 16.6 ZNF529 KIAA1615 ENSG00000186020 "Zinc finger protein 529" Q6P280 19 36534774-36605276 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA031311 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031311: AB_10604158" "unprognostic (2.19e-2)" "unprognostic (4.89e-2)" "unprognostic (8.51e-2)" "unprognostic (7.94e-2)" "unprognostic (1.83e-3)" "unprognostic (2.61e-3)" "unprognostic (8.67e-2)" "unprognostic (1.30e-2)" "unprognostic (3.84e-3)" "unprognostic (7.10e-2)" "unprognostic (1.05e-3)" "unprognostic (6.61e-3)" "unprognostic (3.37e-2)" "unprognostic (1.45e-2)" "unprognostic (1.00e-1)" "unprognostic (9.64e-2)" "prognostic favorable (1.39e-5)" 9.0 11.8 13.8 11.6 22.4 15.9 12.4 22.6 18.3 9.5 7.6 16.0 8.1 6.5 14.4 12.7 6.2 13.3 8.5 11.7 13.4 12.2 7.1 8.1 9.2 13.4 20.4 16.5 15.5 6.1 17.0 17.2 10.3 16.0 10.5 7.1 9.0 6.9 8.1 8.5 13.7 8.0 10.2 16.9 11.4 7.1 16.7 18.4 15.3 12.2 3.7 12.4 7.4 8.6 5.3 2.7 6.3 2.1 3.9 6.3 2.4 3.7 7.6 10.6 12.3 6.3 7.7 4.8 5.7 3.5 3.7 7.9 3.8 2.9 9.1 7.7 5.2 4.0 1.7 8.6 3.4 6.5 13.0 9.4 11.8 5.1 2.6 7.3 8.9 7.1 8.6 5.6 4.6 7.6 6.2 3.0 7.4 5.2 0.7 7.6 1.2 9.5 3.4 7.6 0.1 2.9 2.8 7.6 4.9 3.4 8.4 5.3 10.6 7.5 3.1 2.8 5.0 3.6 6.5 5.6 8.0 5.2 5.1 6.9 12.6 6.3 8.9 0.2 3.0 5.2 6.3 2.1 2.6 4.4 1.4 6.3 5.3 5.0 4.9 2.2 4.9 5.7 4.5 1.0 3.9 1.4 2.7 5.6 2.4 13.8 22.4 22.6 18.3 13.4 12.2 20.4 16.5 16.0 18.4 3.0 3.5 6.5 4.7 8.8 19.0 14.3 2.5 5.3 6.8 7.0 23.6 2.9 5.0 3.0 3.4 6.8 1.4 23.3 1.4 2.5 6.2 5.9 2.3 6.8 3.3 71.5 2.9 5.5 2.6 1.4 6.1 5.3 5.0 0.0 3.2 8.2 1.9 2.9 6.3 3.4 22.6 0.0 7.5 14.9 10.5 8.0 2.7 10.0 2.5 5.5 ZNF543 DKFZp434H055 ENSG00000178229 "Zinc finger protein 543" Q08ER8 19 57320509-57330776 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA046330 Approved Nucleoplasm NA NA Nucleoplasm "HPA046330: " "unprognostic (9.20e-2)" "unprognostic (8.89e-2)" "unprognostic (2.60e-2)" "unprognostic (1.51e-1)" "unprognostic (1.45e-1)" "unprognostic (4.71e-1)" "unprognostic (2.45e-2)" "unprognostic (9.86e-2)" "unprognostic (1.01e-1)" "unprognostic (6.55e-2)" "unprognostic (2.44e-2)" "unprognostic (7.47e-2)" "prognostic favorable (2.03e-5)" "unprognostic (1.94e-1)" "unprognostic (1.10e-1)" "unprognostic (2.05e-1)" "unprognostic (2.84e-2)" 6.2 6.0 6.6 4.0 10.1 5.0 8.0 18.1 10.3 5.7 5.3 7.4 7.1 2.3 6.5 5.4 7.7 6.9 4.7 5.2 7.0 4.0 5.1 3.9 5.1 6.5 8.4 5.8 14.8 5.7 10.0 10.8 8.1 7.2 6.4 3.5 7.5 6.8 7.3 6.7 8.9 4.8 6.2 7.7 7.2 4.9 11.0 8.0 15.8 7.9 2.4 8.0 6.5 5.1 6.4 3.6 7.3 3.5 5.2 5.6 3.5 3.3 4.5 4.2 6.6 3.7 3.3 5.1 2.0 3.6 3.8 6.8 1.4 2.0 5.4 2.8 2.7 2.5 1.9 3.6 3.7 5.0 2.4 9.7 5.2 4.7 4.1 4.1 5.0 3.5 3.6 3.9 3.0 6.3 3.2 2.9 6.3 2.8 1.0 2.8 0.4 5.8 1.6 3.8 0.3 3.5 5.5 6.4 5.7 2.5 8.2 7.8 5.5 5.7 2.3 3.9 3.9 2.8 4.7 2.8 5.6 4.0 1.1 3.7 8.1 5.3 6.2 2.7 2.3 2.9 2.2 3.4 7.3 3.8 3.2 4.9 6.0 4.1 5.6 3.6 6.4 5.0 4.9 3.6 5.2 3.5 2.4 2.1 3.5 6.6 10.1 18.1 10.3 7.0 4.0 8.4 5.8 7.2 8.0 3.0 0.3 0.5 1.1 2.4 4.2 1.4 2.5 0.0 2.3 0.0 5.9 2.4 5.0 1.4 12.4 2.9 0.2 0.0 0.4 1.2 0.9 1.6 2.3 1.0 1.3 6.4 0.0 1.3 0.6 8.6 1.4 2.0 1.7 0.0 1.3 3.9 0.2 0.0 2.1 0.6 4.9 6.5 1.4 2.3 1.9 2.3 1.8 1.8 1.1 1.3 ZNF544 AF020591 ENSG00000198131 "Zinc finger protein 544" Q6NX49 19 58228594-58277495 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 52.3" "Low region specificity" "Detected in all" HPA002732 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA002732: AB_1080735" "unprognostic (5.28e-2)" "unprognostic (9.71e-2)" "unprognostic (3.28e-1)" "unprognostic (1.24e-2)" "unprognostic (4.32e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.04e-5)" "unprognostic (3.61e-3)" "prognostic unfavorable (3.65e-5)" "unprognostic (4.94e-2)" "unprognostic (2.31e-2)" "unprognostic (8.87e-2)" "unprognostic (1.42e-2)" "unprognostic (3.68e-1)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (2.49e-1)" 7.0 10.2 14.0 12.7 12.9 6.8 12.8 20.6 14.4 11.7 8.0 10.7 5.4 4.3 18.3 31.2 10.8 20.1 9.4 13.9 12.0 12.2 10.2 7.3 7.2 9.7 12.6 13.7 12.6 12.1 22.8 19.1 9.9 11.1 10.1 8.5 16.2 8.7 9.6 3.7 11.7 7.4 10.4 13.0 10.2 8.8 19.6 12.0 13.9 16.5 8.9 12.0 10.4 7.9 11.7 8.4 12.5 3.8 14.4 11.1 5.4 15.5 6.1 4.2 4.7 4.5 7.7 10.3 7.4 3.4 14.1 9.9 5.3 6.8 20.7 3.6 8.8 0.0 5.3 5.1 16.3 19.8 9.6 52.3 15.8 12.2 2.5 12.5 9.5 12.7 5.3 24.2 9.6 26.8 13.5 12.4 0.1 8.9 0.0 8.2 4.9 19.9 6.6 9.7 3.3 2.9 6.9 4.7 16.0 9.6 24.5 23.0 0.0 8.9 4.5 3.2 7.7 6.5 6.9 10.4 2.6 9.2 2.7 8.4 18.1 35.3 0.0 0.0 0.0 6.4 2.3 2.3 12.5 7.6 3.8 7.0 9.3 6.8 9.6 5.3 11.7 8.3 11.1 2.8 14.4 0.9 8.4 5.5 5.4 14.0 12.9 20.6 14.4 12.0 12.2 12.6 13.7 11.1 12.0 6.0 9.9 20.6 9.3 5.3 24.8 10.6 17.8 16.0 20.5 7.0 43.2 13.7 16.6 6.3 33.3 7.2 4.7 0.0 3.8 8.6 5.8 10.4 10.4 6.6 11.2 20.6 11.1 7.4 4.6 46.6 5.2 5.1 8.5 1.8 5.7 18.3 6.7 0.0 3.5 6.8 35.7 19.4 5.1 46.0 26.2 6.8 9.8 12.2 7.6 10.1 ZNF552 FLJ21603 ENSG00000178935 "Zinc finger protein 552" Q9H707 19 57803841-57814913 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "breast cancer: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 20.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 20.5" "Cell line enhanced" "Detected in many" "RT4: 23.0;T-47d: 37.1" "HPA043800, HPA053762, HPA072145" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "prognostic favorable (4.57e-4)" "unprognostic (2.09e-1)" "prognostic favorable (2.66e-4)" "unprognostic (9.03e-2)" "unprognostic (9.89e-2)" "prognostic favorable (9.96e-4)" "unprognostic (3.03e-2)" "unprognostic (1.29e-3)" "unprognostic (3.36e-3)" "unprognostic (6.72e-2)" "unprognostic (1.93e-1)" "unprognostic (1.18e-1)" "unprognostic (2.24e-3)" "unprognostic (2.41e-2)" "unprognostic (9.01e-2)" "unprognostic (3.09e-1)" "unprognostic (2.04e-3)" 2.9 3.3 3.4 14.7 2.8 5.9 22.2 5.4 3.8 8.4 10.1 4.6 6.5 5.6 8.4 6.0 7.1 4.5 7.8 4.0 2.8 2.2 12.3 5.5 5.7 8.0 3.8 1.2 4.8 5.9 3.8 5.7 11.9 4.7 12.9 10.0 5.2 22.4 14.7 7.2 7.7 10.2 4.3 3.0 6.5 14.2 3.5 2.7 6.7 3.9 2.6 6.3 28.7 11.1 3.4 1.8 20.5 2.7 1.9 3.7 1.8 3.0 1.9 2.2 3.8 1.7 1.0 16.3 1.1 1.5 2.6 1.6 5.1 4.9 4.3 2.1 2.2 0.6 2.9 4.5 3.3 3.5 1.8 8.6 1.5 4.2 3.8 4.1 4.7 2.2 2.0 6.0 1.8 2.0 1.5 3.3 4.6 3.0 1.4 1.6 2.7 2.0 1.3 3.4 3.7 4.1 4.0 2.7 4.4 7.4 23.0 2.7 2.1 5.5 12.3 2.6 6.3 37.1 2.0 2.5 2.3 2.4 1.4 2.0 6.2 4.1 3.5 1.8 3.5 1.3 1.2 2.7 5.5 2.2 2.5 2.1 2.8 2.9 3.5 1.3 3.4 3.7 3.2 20.5 1.9 1.0 1.8 2.2 1.8 3.4 2.8 5.4 3.8 2.8 2.2 3.8 1.2 4.7 2.7 11.9 1.9 5.9 15.6 2.3 5.1 1.3 17.8 22.7 10.3 19.2 2.0 16.8 21.6 5.6 3.3 2.3 9.7 0.0 1.6 5.8 2.7 9.4 8.1 3.4 4.3 3.2 8.1 5.5 2.2 0.9 2.6 3.2 1.7 1.0 9.3 2.0 2.6 9.1 2.1 3.6 13.3 6.5 2.1 2.7 4.1 2.4 17.8 5.7 7.8 11.2 ZNF556 FLJ11637 ENSG00000172000 "Zinc finger protein 556" Q9HAH1 19 2867335-2883445 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.6;brain: 22.3;ovary: 11.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 12.2;Ciliated cells: 8.1;Club cells: 9.1;granulocytes: 7.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 16 "cerebellum: 22.3" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 14.6" "Lineage enriched" "Detected in many" 11 "dendritic cells: 14.6" "Cell line enhanced" "Detected in some" "CACO-2: 7.2;HBEC3-KT: 7.7;Hep G2: 12.1;RH-30: 18.0;THP-1: 6.5" HPA060593 Approved Nucleoplasm NA NA Nucleoplasm "HPA060593: AB_2684328" "unprognostic (1.36e-1)" "unprognostic (9.07e-2)" "unprognostic (2.70e-3)" "unprognostic (1.01e-1)" "unprognostic (1.58e-1)" "unprognostic (1.98e-2)" "unprognostic (3.12e-3)" "unprognostic (3.23e-1)" "unprognostic (4.81e-1)" "unprognostic (2.17e-1)" "unprognostic (6.14e-4)" "unprognostic (2.85e-1)" "unprognostic (2.61e-2)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (5.26e-3)" "unprognostic (5.54e-3)" 0.3 0.2 0.5 0.3 0.5 1.0 0.5 22.3 0.5 0.7 0.3 0.0 1.7 0.1 1.6 0.7 3.1 4.2 0.8 0.2 0.4 0.3 2.6 0.1 0.4 0.3 0.4 0.1 11.3 2.6 0.4 1.6 0.8 1.3 0.4 0.1 0.1 1.0 0.1 4.5 0.7 0.2 0.3 0.5 0.3 0.3 3.5 0.0 0.6 0.2 8.7 0.9 0.2 0.2 0.4 14.6 1.2 0.2 0.6 0.2 0.1 1.9 0.3 0.0 3.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.2 0.1 2.4 1.2 0.1 0.0 0.1 0.0 7.7 0.0 0.1 0.0 0.1 3.2 12.1 0.1 0.2 3.8 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 2.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 18.0 1.5 0.0 0.3 0.1 2.9 0.0 0.3 0.0 0.1 3.7 6.5 0.0 0.1 0.1 4.7 0.1 2.1 3.9 0.1 0.2 0.1 0.1 1.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.2 0.2 1.2 0.6 0.1 14.6 0.1 0.1 0.5 0.5 22.3 0.5 0.4 0.3 0.4 0.1 1.3 0.0 3.0 12.2 0.0 2.3 0.3 2.2 0.4 0.0 8.1 9.1 3.5 2.0 0.4 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.2 0.5 1.5 7.0 0.0 0.2 3.2 0.0 1.3 1.2 0.0 0.6 1.4 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.6 4.6 0.0 0.5 5.6 4.7 0.1 0.2 0.8 0.0 1.6 ZNF561 MGC45408 ENSG00000171469 "Zinc finger protein 561" Q8N587 19 9604680-9621399 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA055332, HPA062397" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055332: AB_2682786, HPA062397: AB_2684751" "unprognostic (6.68e-2)" "unprognostic (1.26e-1)" "unprognostic (6.86e-3)" "unprognostic (3.43e-2)" "unprognostic (1.18e-2)" "unprognostic (3.63e-3)" "unprognostic (9.92e-2)" "unprognostic (2.53e-2)" "unprognostic (9.54e-2)" "prognostic favorable (1.31e-4)" "unprognostic (9.21e-2)" "unprognostic (3.34e-2)" "prognostic favorable (1.16e-4)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (3.27e-3)" "unprognostic (2.85e-3)" 11.7 11.7 7.5 9.1 8.8 7.7 14.6 11.2 8.2 14.5 11.5 10.4 21.9 6.6 18.6 14.9 21.5 16.3 11.1 9.1 7.0 6.4 11.3 10.7 10.8 13.4 9.6 6.2 18.1 16.9 13.1 18.3 8.8 7.4 19.2 11.4 9.6 13.3 15.9 10.3 15.7 10.6 22.2 8.5 10.4 11.6 7.7 11.7 16.4 20.6 11.7 12.2 26.1 14.3 7.2 6.6 9.3 8.5 2.7 10.9 5.7 7.6 3.0 17.0 13.3 14.8 17.6 15.3 10.0 13.4 12.5 14.2 5.6 3.4 6.8 7.4 9.9 7.3 4.3 11.4 19.2 13.1 9.5 12.1 8.6 6.4 9.7 8.6 11.3 8.7 11.3 30.3 9.3 12.2 20.0 15.7 5.0 9.9 9.2 15.6 3.6 4.8 11.9 14.1 6.4 9.6 5.7 8.5 7.4 11.4 28.1 10.9 11.0 0.2 6.2 7.8 17.3 7.9 7.5 4.9 13.6 4.7 9.6 9.7 11.2 15.7 9.4 6.7 2.9 9.1 5.0 8.5 9.3 8.5 8.2 10.9 4.8 6.6 7.6 6.6 7.2 9.6 7.2 5.5 2.7 4.2 5.9 6.3 5.7 7.5 8.8 11.2 8.2 7.0 6.4 9.6 6.2 7.4 11.7 0.0 6.5 5.1 21.6 12.2 9.2 9.0 7.6 28.1 9.1 14.0 5.9 6.9 3.3 10.1 5.2 7.1 6.9 0.0 5.7 6.5 5.6 10.8 7.0 6.4 9.6 9.5 10.9 10.4 10.3 5.2 10.6 7.0 3.3 5.4 6.7 6.0 7.4 7.0 12.4 6.8 11.0 6.5 5.6 7.2 9.8 19.6 5.4 7.5 6.8 25.5 ZNF562 FLJ20079 ENSG00000171466 "Zinc finger protein 562" Q6V9R5 19 9641808-9675086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA055332, HPA062397" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055332: AB_2682786, HPA062397: AB_2684751" "unprognostic (2.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.85e-3)" "unprognostic (1.62e-1)" "unprognostic (2.02e-2)" "prognostic favorable (4.17e-4)" "unprognostic (4.44e-2)" "unprognostic (2.14e-1)" "unprognostic (7.88e-2)" "unprognostic (2.96e-3)" "unprognostic (1.81e-1)" "unprognostic (4.07e-2)" "unprognostic (1.81e-2)" "unprognostic (1.62e-3)" "unprognostic (9.44e-2)" "unprognostic (3.82e-2)" "unprognostic (1.13e-3)" 12.3 11.2 13.9 11.3 15.8 11.6 21.4 20.5 15.2 11.8 15.0 13.5 20.9 9.8 14.6 10.9 26.1 12.0 12.1 11.4 13.4 10.9 11.1 12.2 12.9 10.2 14.9 11.9 13.7 15.5 13.8 22.6 11.1 14.3 13.1 15.0 9.0 15.7 23.4 7.0 12.9 10.6 15.1 16.1 14.0 11.5 6.3 16.8 10.9 11.8 9.4 13.3 16.6 14.5 6.4 8.5 5.5 9.6 6.5 7.9 2.6 8.3 6.6 9.7 17.8 5.8 4.7 0.5 7.9 6.1 8.8 9.1 4.9 4.6 7.5 8.2 6.3 7.5 6.4 11.7 9.7 11.6 8.8 9.2 27.6 6.7 5.1 5.8 10.1 20.6 8.3 7.2 11.1 18.5 5.5 9.3 6.8 13.3 13.4 8.3 4.2 10.0 3.0 12.4 5.5 4.7 3.9 10.6 3.9 4.1 22.2 10.6 6.9 12.8 5.2 6.3 7.9 7.5 8.5 8.7 16.5 5.6 7.5 10.6 11.8 25.9 12.7 2.3 0.6 8.1 4.1 6.2 5.5 7.0 9.6 7.9 6.3 5.6 4.3 8.5 6.4 5.8 7.1 2.4 6.5 9.2 5.1 4.0 2.6 13.9 15.8 20.5 15.2 13.4 10.9 14.9 11.9 14.3 16.8 8.9 21.0 11.3 31.2 5.7 30.2 7.8 22.9 6.7 18.2 24.4 68.7 13.3 16.6 17.2 6.0 12.4 22.9 0.0 7.6 13.8 12.1 31.0 12.7 12.1 10.8 27.0 23.0 16.5 26.6 11.0 11.2 14.8 6.8 11.8 14.8 13.2 18.0 17.3 12.7 6.8 28.1 0.0 9.2 14.2 11.4 8.8 16.2 12.8 15.2 55.8 ZNF566 "FLJ14779, MGC12515" ENSG00000186017 "Zinc finger protein 566" Q969W8 19 36445119-36489902 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 33.4;Horizontal cells: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023456 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA023456: AB_2221143" "unprognostic (1.68e-1)" "unprognostic (6.34e-2)" "unprognostic (7.77e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (3.89e-3)" "unprognostic (5.71e-4)" "unprognostic (1.74e-1)" "unprognostic (3.21e-2)" "unprognostic (1.92e-2)" "unprognostic (7.56e-2)" "unprognostic (8.19e-4)" "unprognostic (7.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (9.48e-2)" "unprognostic (3.00e-1)" "unprognostic (5.47e-3)" 8.2 8.2 10.4 7.2 11.4 5.9 9.0 22.7 14.2 8.7 7.0 9.4 5.8 6.7 12.1 10.3 6.1 9.7 6.2 8.1 10.9 11.7 8.8 8.4 7.9 9.1 11.6 11.8 14.3 6.3 10.4 14.0 5.5 12.7 8.1 5.9 11.6 6.3 7.2 7.3 8.5 6.4 9.1 10.7 7.6 6.0 5.1 13.8 5.1 10.3 5.3 8.9 8.4 6.1 8.1 2.8 5.6 1.6 4.6 8.6 3.2 3.6 8.7 10.1 11.1 7.6 7.7 7.0 7.0 6.0 8.9 9.4 3.6 1.5 6.8 7.7 4.5 4.0 2.5 9.0 2.5 10.2 11.0 6.9 6.9 6.0 3.1 5.6 7.4 8.3 6.6 3.7 4.7 7.5 4.2 3.4 7.2 10.0 0.2 6.0 5.7 9.5 3.8 12.1 6.3 3.8 6.3 8.0 4.6 2.7 7.0 9.4 14.3 8.4 4.9 6.7 5.0 4.3 10.1 3.8 7.7 10.6 3.3 6.7 2.9 7.7 9.4 0.4 4.9 10.1 5.6 1.5 1.9 5.3 1.4 8.6 8.1 6.5 6.5 2.8 6.1 7.9 8.0 1.4 4.6 1.6 2.0 6.7 3.2 10.4 11.4 22.7 14.2 10.9 11.7 11.6 11.8 12.7 13.8 8.9 7.7 3.7 3.7 3.0 20.8 8.7 5.1 4.0 10.3 5.2 33.4 5.6 10.0 4.0 1.7 7.1 2.3 0.0 2.2 2.9 7.6 4.4 2.3 4.7 3.7 30.2 2.9 9.2 2.8 0.4 7.8 4.3 10.1 1.0 4.3 7.5 1.9 5.9 13.8 5.4 20.7 19.4 8.5 6.5 4.2 2.9 1.6 9.5 4.6 2.6 ZNF568 DKFZp686B0797 ENSG00000198453 "Zinc finger protein 568" Q3ZCX4 19 36916329-36998700 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024541, HPA052061" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA024541: , HPA052061: AB_2681713" "unprognostic (3.62e-2)" "unprognostic (2.73e-1)" "unprognostic (9.97e-2)" "unprognostic (1.99e-3)" "unprognostic (5.07e-2)" "unprognostic (2.81e-2)" "unprognostic (8.64e-2)" "unprognostic (2.65e-2)" "unprognostic (5.83e-5)" "unprognostic (1.75e-1)" "unprognostic (1.76e-2)" "unprognostic (1.16e-1)" "unprognostic (2.05e-5)" "unprognostic (2.03e-2)" "unprognostic (1.81e-1)" "unprognostic (5.06e-3)" "unprognostic (9.98e-3)" 6.9 11.3 11.8 5.6 14.7 5.9 9.2 30.4 13.4 11.3 7.3 10.5 6.3 4.5 12.3 8.1 5.9 10.3 5.6 8.9 11.5 13.0 7.8 5.5 6.9 6.5 15.0 9.8 16.3 6.8 14.4 24.6 8.4 13.7 8.5 5.0 8.1 8.6 9.0 8.5 6.8 5.2 10.6 13.0 9.3 7.0 9.5 16.3 6.4 13.2 7.6 7.0 7.6 7.3 8.7 3.0 12.8 2.3 7.1 10.1 3.1 0.2 4.5 7.4 2.4 6.9 7.7 2.3 6.2 6.2 5.2 7.1 0.2 2.6 0.3 7.4 7.7 3.8 1.2 0.1 3.6 5.4 1.0 5.3 2.3 0.6 0.8 8.8 0.2 5.9 10.0 4.3 5.2 0.1 6.5 2.7 3.3 0.4 0.9 7.6 0.3 1.6 1.2 6.0 0.0 0.3 0.6 5.4 2.4 4.9 9.8 7.3 9.4 0.3 0.2 5.5 7.5 6.0 1.0 5.2 3.6 10.2 5.8 4.2 8.7 10.6 5.4 0.2 0.2 11.3 12.8 1.9 6.5 8.4 1.5 7.6 8.7 7.9 7.0 3.0 7.6 10.1 8.0 1.6 7.1 2.3 2.9 6.7 3.1 11.8 14.7 30.4 13.4 11.5 13.0 15.0 9.8 13.7 16.3 3.0 6.5 2.2 2.8 4.5 17.6 5.0 5.1 6.7 2.3 8.7 13.7 4.3 3.3 6.1 21.7 6.0 0.4 0.0 3.3 3.3 6.4 3.4 16.1 1.0 3.0 38.1 0.0 4.9 1.0 14.8 6.1 3.5 1.7 3.6 1.1 8.1 2.2 0.0 9.2 4.0 16.4 6.5 5.7 9.9 12.4 3.6 2.4 6.7 1.2 2.4 ZNF570 FLJ30791 ENSG00000171827 "Zinc finger protein 570" Q96NI8 19 37467585-37488652 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 40.9;Horizontal cells: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028881 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA028881: AB_10603938" "unprognostic (2.93e-2)" "unprognostic (1.55e-1)" "unprognostic (3.71e-2)" "unprognostic (1.24e-1)" "unprognostic (1.70e-2)" "unprognostic (1.28e-2)" "unprognostic (3.32e-2)" "unprognostic (1.23e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (6.54e-2)" "unprognostic (4.59e-2)" "prognostic favorable (4.06e-5)" "unprognostic (5.30e-2)" "unprognostic (2.85e-2)" "unprognostic (3.12e-2)" "unprognostic (2.20e-3)" 7.4 5.8 7.6 3.7 8.8 4.3 6.7 8.2 9.8 6.1 4.7 6.7 3.0 4.4 7.1 4.9 5.2 4.9 5.0 5.4 6.6 5.7 6.7 4.0 4.6 5.6 9.3 6.2 8.3 4.5 13.6 8.0 4.8 8.3 6.8 2.9 4.5 5.0 5.3 4.9 4.1 4.0 5.4 9.0 6.9 4.7 14.7 10.0 7.2 7.5 4.9 5.4 5.7 7.8 3.7 2.0 3.9 3.3 4.7 5.6 2.3 1.9 2.7 3.7 10.9 5.0 6.3 1.8 3.9 2.0 3.7 5.0 0.0 0.8 0.5 5.2 2.8 2.2 0.4 3.1 2.4 4.5 2.2 2.2 2.5 0.3 1.2 3.4 0.2 5.5 5.3 2.2 2.5 0.1 3.4 3.6 4.4 0.4 0.2 3.8 0.8 6.1 1.9 2.4 0.1 1.1 1.1 3.8 2.0 3.0 3.1 3.4 7.0 0.0 0.1 1.2 4.8 2.2 2.8 1.8 1.5 2.8 2.4 2.7 6.1 5.3 2.8 0.0 0.3 2.9 1.4 1.9 2.3 3.6 3.3 2.9 3.6 5.6 2.4 1.9 3.7 5.0 5.0 3.9 4.7 1.4 2.0 3.4 2.3 7.6 8.8 8.2 9.8 6.6 5.7 9.3 6.2 8.3 10.0 6.0 0.3 2.2 1.7 1.4 5.9 10.9 5.1 5.3 4.5 1.8 9.8 2.1 8.3 4.6 40.9 4.3 1.0 0.0 3.3 6.2 3.0 1.7 5.8 2.1 2.8 30.2 5.8 5.5 3.2 5.4 4.6 2.5 5.0 1.8 1.5 6.2 2.7 0.0 9.2 3.5 6.6 0.0 3.6 10.2 7.2 0.4 1.1 4.3 2.1 0.9 ZNF579 FLJ35453 ENSG00000218891 "Zinc finger protein 579" Q8NAF0 19 55576770-55580845 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 28.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062812 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA062812: AB_2684873" "unprognostic (1.76e-2)" "unprognostic (1.43e-2)" "unprognostic (4.09e-2)" "unprognostic (9.08e-2)" "unprognostic (2.87e-1)" "unprognostic (5.95e-2)" "unprognostic (4.79e-2)" "unprognostic (2.87e-2)" "unprognostic (5.39e-2)" "unprognostic (1.71e-1)" "unprognostic (5.85e-3)" "unprognostic (1.68e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (5.27e-2)" "unprognostic (3.46e-1)" "unprognostic (1.57e-1)" "unprognostic (4.08e-3)" 9.6 7.0 9.0 5.9 11.2 7.5 8.8 27.5 19.5 10.3 8.5 13.4 10.9 8.3 12.6 13.7 8.2 13.6 14.5 10.2 7.8 8.9 11.3 8.6 10.4 8.2 8.0 6.3 13.4 12.4 6.8 10.3 5.2 9.7 10.4 5.3 10.6 9.8 10.6 33.0 11.8 6.5 8.2 7.1 8.2 17.6 5.7 7.6 8.5 14.6 8.3 6.6 10.9 9.8 1.9 1.8 0.9 1.7 0.6 1.3 0.2 5.1 10.4 5.7 5.8 9.4 6.5 7.3 10.2 2.7 5.6 6.1 3.5 6.3 8.5 4.1 6.0 1.9 5.0 3.3 5.5 5.8 1.5 28.6 5.1 17.8 6.4 9.6 3.2 4.5 16.3 6.3 4.3 4.5 12.7 3.1 3.2 10.2 2.9 11.0 6.6 4.4 4.2 5.1 2.7 16.5 8.0 5.3 3.4 7.5 9.6 6.9 10.1 6.8 5.3 4.8 11.5 2.7 4.3 6.9 7.4 7.2 2.3 6.1 7.7 6.4 4.6 3.9 5.0 3.6 0.5 1.7 0.2 0.8 0.6 0.4 0.4 0.3 0.9 1.8 1.9 1.3 0.5 0.9 0.6 0.5 1.8 0.8 0.2 9.0 11.2 27.5 19.5 7.8 8.9 8.0 6.3 9.7 7.6 3.0 7.0 3.4 6.4 3.0 11.2 4.2 17.8 2.7 1.2 5.2 11.8 0.7 3.3 4.3 0.0 5.6 2.3 0.0 4.1 0.7 3.1 7.3 4.6 5.5 4.5 14.3 10.9 12.3 4.1 0.0 7.8 3.0 3.3 1.0 6.9 14.8 5.3 0.0 11.7 9.1 7.4 12.9 3.3 0.3 0.9 2.9 0.3 1.3 5.3 7.8 ZNF580 ENSG00000213015 "Zinc finger protein 580" Q9UK33 19 55635016-55643469 "Predicted intracellular proteins, Transcription factors" "Chemotaxis, Inflammatory response, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HEK 293: 78.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054058 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA054058: AB_2682360" "unprognostic (1.36e-2)" "unprognostic (5.13e-3)" "unprognostic (2.47e-3)" "unprognostic (3.80e-2)" "unprognostic (1.72e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.63e-4)" "unprognostic (3.54e-2)" "unprognostic (3.07e-1)" "unprognostic (6.21e-2)" "prognostic favorable (2.36e-5)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.79e-6)" "unprognostic (1.43e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-1)" "unprognostic (3.46e-3)" 32.8 23.6 24.5 25.5 23.4 17.2 19.1 28.7 28.2 23.4 25.2 23.1 36.4 19.8 32.2 39.5 18.2 25.8 25.5 17.2 23.1 21.7 23.3 8.7 17.1 24.2 19.1 22.0 33.0 24.1 37.8 38.2 13.7 19.9 31.3 16.2 23.0 31.7 34.2 20.9 19.4 20.0 32.4 17.3 30.1 24.9 10.7 20.9 23.0 35.4 10.8 21.6 25.8 21.1 12.8 4.1 10.5 9.2 2.9 3.3 1.5 4.7 8.9 8.2 5.3 9.1 5.1 3.2 6.4 7.6 10.0 12.5 1.5 4.6 3.4 1.8 9.3 2.2 3.9 5.4 5.8 7.8 10.9 78.3 6.4 8.4 4.2 12.1 3.1 14.6 11.0 6.2 4.8 9.3 13.3 6.9 8.8 6.3 9.6 8.3 1.5 14.1 4.6 4.2 3.1 11.5 12.8 2.9 14.2 11.3 5.6 9.1 11.2 4.5 4.5 5.8 4.6 3.8 3.3 8.6 5.5 8.3 3.7 3.5 19.4 5.2 8.5 3.0 4.9 5.2 4.4 3.4 10.5 1.2 4.8 1.3 8.2 2.7 2.7 3.6 12.8 3.3 2.8 6.2 2.9 9.2 4.1 2.1 1.5 24.5 23.4 28.7 28.2 23.1 21.7 19.1 22.0 19.9 20.9 8.9 8.9 35.7 31.8 16.6 31.0 8.9 33.1 1.4 5.7 54.1 3.9 23.6 64.6 36.4 2.7 31.8 25.8 0.0 48.6 17.3 31.7 34.7 19.5 9.5 22.2 19.1 64.7 40.5 25.4 4.3 55.0 28.0 37.1 45.9 23.8 26.9 38.3 28.1 66.4 55.9 16.6 38.8 37.1 7.9 12.1 14.8 15.9 20.2 26.9 27.6 ZNF587 "FLJ14710, FLJ20813, UBF-fl, ZF6" ENSG00000198466 "Zinc finger protein 587" Q96SQ5 19 57849857-57865112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 29.4" "HPA042125, HPA043288, HPA056213" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069" "unprognostic (1.61e-2)" "unprognostic (5.39e-2)" "unprognostic (3.92e-2)" "unprognostic (1.91e-1)" "unprognostic (2.42e-1)" "unprognostic (2.12e-2)" "unprognostic (6.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.60e-3)" "unprognostic (1.43e-1)" "unprognostic (2.29e-1)" "unprognostic (6.84e-3)" "prognostic unfavorable (7.98e-4)" "unprognostic (1.59e-1)" "unprognostic (2.11e-1)" "unprognostic (7.30e-2)" "unprognostic (3.68e-3)" 7.4 6.3 11.8 17.8 11.2 9.4 13.5 11.0 10.5 7.7 20.0 10.1 16.7 11.6 9.4 13.0 7.8 7.7 13.4 7.5 7.6 6.6 9.0 7.5 7.7 7.5 11.2 9.5 10.0 11.2 8.9 14.7 10.7 7.8 12.4 18.8 7.5 15.0 9.3 7.7 8.2 25.1 7.6 6.8 8.1 13.2 5.1 9.5 17.0 10.5 2.6 13.1 9.2 9.0 3.6 2.0 6.0 2.0 1.7 2.4 1.0 5.5 6.7 5.9 5.0 5.7 7.9 7.6 5.6 6.7 7.9 6.6 8.7 4.1 6.0 2.9 5.2 3.3 4.2 9.9 8.5 15.1 3.7 20.9 9.0 17.4 5.4 3.7 9.0 7.4 7.7 3.7 8.4 7.7 7.2 8.4 5.9 9.2 5.1 5.6 2.6 5.4 2.8 2.5 2.1 6.0 5.3 5.9 3.2 5.0 29.4 8.2 4.2 7.6 5.7 2.3 7.9 5.8 4.9 4.4 7.6 4.6 2.4 7.0 10.2 7.4 5.7 3.7 4.1 4.3 6.0 1.8 1.9 1.8 1.6 2.1 1.9 1.9 1.6 1.3 3.6 2.1 2.4 5.1 1.7 2.0 2.0 1.7 1.0 11.8 11.2 11.0 10.5 7.6 6.6 11.2 9.5 7.8 9.5 3.0 5.0 6.0 10.8 8.1 19.4 6.9 25.5 13.4 6.8 7.0 29.5 9.3 10.0 7.9 7.4 6.0 12.0 0.0 3.1 9.3 8.4 12.6 12.7 6.6 5.6 19.1 22.4 11.6 5.1 1.0 4.4 5.5 0.0 3.6 19.3 8.4 6.0 14.4 8.5 6.1 23.9 0.0 5.1 3.7 7.6 5.8 8.5 6.9 14.1 13.3 ZNF587B ENSG00000269343 "Zinc finger protein 587B" E7ETH6 19 57819741-57846238 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 29.1" "HPA043800, HPA053762, HPA072145" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (4.13e-3)" "unprognostic (1.43e-1)" "unprognostic (1.36e-1)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (5.69e-2)" "unprognostic (3.22e-3)" "unprognostic (3.80e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (5.47e-2)" "unprognostic (2.47e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (1.16e-1)" "unprognostic (3.57e-2)" "unprognostic (2.94e-1)" "unprognostic (7.48e-2)" "unprognostic (8.70e-2)" 7.6 7.1 5.0 15.0 7.9 19.4 14.1 8.9 6.5 7.8 10.4 6.6 12.4 12.6 13.6 10.7 9.4 9.1 10.7 6.4 5.4 3.3 8.9 14.6 9.3 10.9 6.2 5.5 10.9 17.2 13.3 14.5 8.2 5.7 10.1 11.5 7.6 19.5 16.7 12.7 14.5 12.6 10.2 3.7 15.5 10.3 11.8 7.4 8.0 10.2 7.1 13.1 10.8 7.0 4.5 3.7 5.0 5.3 3.2 6.3 4.5 4.8 13.0 5.8 12.0 1.4 1.5 6.2 3.6 3.1 4.4 2.6 7.8 7.3 9.9 2.1 5.4 2.0 3.8 5.0 13.2 10.0 1.6 11.6 7.0 10.6 8.4 5.1 12.3 7.1 5.0 2.7 5.8 6.2 1.1 3.4 6.9 8.1 4.8 2.5 5.3 5.7 2.1 14.7 4.9 6.0 4.8 5.1 4.5 5.3 29.1 3.4 5.5 4.0 5.9 3.4 9.5 7.8 5.2 4.6 5.1 5.8 1.0 5.5 6.4 5.1 7.8 4.2 3.8 5.6 5.0 5.3 2.5 3.9 5.3 4.8 4.5 4.4 4.9 3.2 4.4 6.3 5.3 2.4 3.2 2.9 3.7 3.0 4.5 5.0 7.9 8.9 6.5 5.4 3.3 6.2 5.5 5.7 7.4 6.0 1.0 4.2 2.9 2.9 3.6 2.8 5.1 2.7 7.9 0.0 0.0 2.9 1.7 3.2 3.6 2.8 1.1 0.0 1.7 2.7 1.0 2.6 0.0 2.4 1.2 3.2 4.1 5.5 2.1 1.0 0.6 3.2 1.7 0.0 3.3 0.8 1.7 0.0 0.7 2.5 3.2 6.5 0.5 3.8 4.7 3.3 2.1 1.5 2.8 2.6 ZNF589 SZF1 ENSG00000164048 "Zinc finger protein 589" Q86UQ0 3 48241100-48299253 "Predicted intracellular proteins, Transcription factors" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 15.2;Cone photoreceptor cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HAP1: 23.4;NTERA-2: 37.1" HPA003145 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA003145: AB_1080738" "unprognostic (2.49e-3)" "prognostic favorable (2.50e-4)" "unprognostic (9.14e-2)" "unprognostic (7.34e-3)" "unprognostic (1.18e-1)" "prognostic favorable (1.71e-4)" "unprognostic (3.01e-5)" "prognostic favorable (6.45e-5)" "unprognostic (2.64e-2)" "unprognostic (9.67e-2)" "prognostic favorable (1.21e-4)" "unprognostic (8.02e-2)" "unprognostic (1.46e-1)" "unprognostic (1.32e-2)" "unprognostic (3.45e-2)" "unprognostic (9.57e-3)" "unprognostic (2.19e-2)" 6.6 9.8 15.5 10.2 17.0 5.2 7.4 42.8 16.2 7.7 7.2 10.4 7.6 4.5 8.4 22.6 9.4 8.3 5.4 6.0 13.5 6.6 6.3 3.5 9.0 12.9 18.2 7.9 16.1 6.4 9.9 16.3 3.5 14.0 20.8 7.5 10.7 9.6 18.1 6.4 11.0 14.4 9.2 13.9 22.8 7.0 5.8 14.9 5.7 18.8 3.3 13.0 7.2 9.6 4.0 13.3 1.8 3.1 1.3 5.1 2.2 2.3 1.6 6.8 5.6 8.8 4.7 8.6 2.1 1.8 2.8 3.6 3.5 3.2 9.2 1.8 2.5 2.1 2.0 23.4 5.8 2.1 5.8 5.4 10.9 6.6 2.7 1.6 2.4 3.0 1.5 3.9 3.2 2.3 2.9 4.8 7.2 7.7 2.1 1.5 2.2 3.4 2.0 37.1 2.0 3.6 1.6 2.5 3.4 2.0 2.3 2.3 4.9 1.7 2.0 6.9 10.6 2.9 3.9 7.6 1.6 3.2 3.6 1.4 4.8 5.9 7.5 1.7 6.7 4.8 1.1 2.8 1.8 3.8 2.4 4.4 4.0 4.4 4.9 2.8 2.7 5.1 4.9 1.5 1.3 3.1 13.3 3.8 2.2 15.5 17.0 42.8 16.2 13.5 6.6 18.2 7.9 14.0 14.9 0.0 4.8 0.8 1.0 1.0 15.2 3.0 0.0 2.7 3.4 8.7 19.6 1.9 3.3 1.2 1.3 2.1 1.3 0.0 0.9 0.9 1.8 0.8 0.0 1.0 3.1 1.6 1.7 1.8 3.7 1.5 2.0 4.6 1.7 0.0 2.3 4.8 0.7 1.4 4.2 1.4 11.0 6.5 1.9 0.6 2.7 1.1 0.0 2.5 2.3 0.7 ZNF592 "CAMOS, KIAA0211, SCAR5" ENSG00000166716 "Zinc finger protein 592" Q92610 15 84748635-84806432 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020332, HPA021600" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020332: AB_1859365, HPA021600: AB_1859364" "unprognostic (2.83e-1)" "unprognostic (1.90e-1)" "unprognostic (2.48e-2)" "unprognostic (2.35e-2)" "unprognostic (1.15e-1)" "unprognostic (7.63e-2)" "unprognostic (4.15e-1)" "unprognostic (2.26e-1)" "unprognostic (1.13e-1)" "unprognostic (5.04e-1)" "unprognostic (7.98e-2)" "unprognostic (2.84e-1)" "unprognostic (4.80e-3)" "unprognostic (3.64e-1)" "unprognostic (6.62e-2)" "unprognostic (3.90e-1)" "unprognostic (2.62e-1)" 16.8 15.0 19.0 19.8 20.0 20.5 22.5 20.4 20.6 17.3 16.4 22.7 16.6 17.0 21.5 17.8 12.9 19.0 14.7 16.4 18.6 13.4 15.7 17.5 15.8 21.0 22.5 12.0 26.9 23.5 23.3 18.4 13.0 16.8 15.2 15.9 16.1 14.9 15.8 31.3 21.2 17.9 17.7 19.1 20.0 13.8 17.8 21.0 23.9 16.7 15.9 19.7 14.7 21.3 3.7 3.4 6.6 3.5 2.3 3.3 1.7 7.1 12.1 11.3 6.3 12.6 8.5 12.4 5.0 7.2 8.4 6.7 11.5 8.5 10.4 6.5 11.3 7.2 13.2 17.3 7.2 5.9 8.3 10.3 12.0 12.0 10.1 7.7 9.7 9.6 9.2 10.2 6.5 10.8 10.0 7.2 7.3 11.8 6.6 8.7 11.0 6.5 11.9 10.2 6.8 4.8 9.6 10.1 9.1 8.8 14.6 10.2 11.1 11.5 10.4 8.2 16.4 5.8 20.8 10.2 12.5 7.3 6.9 9.5 7.6 8.0 11.3 7.9 14.5 7.2 0.0 3.1 2.2 3.3 3.5 1.3 3.7 2.1 3.1 3.4 3.7 2.8 2.4 6.6 2.3 3.2 2.7 1.8 1.7 19.0 20.0 20.4 20.6 18.6 13.4 22.5 12.0 16.8 21.0 8.9 13.8 6.2 3.9 7.4 8.9 4.6 7.6 2.7 5.7 3.5 7.9 4.4 0.0 6.6 6.6 7.1 13.7 0.0 6.9 6.2 7.7 4.8 3.5 13.7 9.8 3.2 7.5 12.3 13.6 7.6 4.4 8.8 6.8 8.2 9.1 4.4 8.3 10.8 9.2 5.4 8.2 6.5 5.1 10.5 10.4 6.1 4.0 6.9 9.2 4.1 ZNF594 KIAA1871 ENSG00000180626 "Zinc finger protein 594" Q96JF6 17 5179536-5191883 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 14.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA060283, HPA067178, HPA069360, HPA074493, HPA077596" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA060283: AB_2732645, HPA067178: AB_2685796, HPA069360: AB_2732131, HPA074493: , HPA077596: " "unprognostic (6.67e-2)" "unprognostic (1.07e-2)" "unprognostic (6.93e-2)" "unprognostic (7.92e-3)" "unprognostic (1.11e-1)" "unprognostic (8.24e-3)" "unprognostic (3.36e-2)" "unprognostic (1.32e-1)" "unprognostic (6.67e-2)" "unprognostic (1.86e-1)" "unprognostic (1.33e-5)" "unprognostic (4.09e-3)" "unprognostic (1.08e-1)" "unprognostic (1.08e-1)" "unprognostic (4.99e-1)" "unprognostic (5.21e-2)" "unprognostic (6.59e-2)" 4.0 6.2 11.8 8.4 11.2 1.3 8.8 13.8 13.4 7.5 6.3 8.0 5.3 3.1 9.3 8.4 4.2 8.3 4.2 4.9 8.9 5.9 6.7 3.8 4.1 10.1 13.6 6.6 19.8 6.0 15.3 15.9 5.8 9.2 9.6 5.1 6.0 6.5 10.2 6.7 3.8 6.8 6.0 8.3 8.4 5.2 7.8 11.1 11.9 10.2 2.1 10.2 6.6 5.6 5.9 4.5 1.1 1.0 2.4 5.2 1.0 5.5 2.5 10.7 8.3 1.7 1.9 8.9 3.8 1.9 6.8 6.5 7.0 2.0 12.6 6.0 3.0 5.0 6.2 6.8 0.2 8.7 6.7 6.9 4.1 8.8 3.5 2.4 0.0 4.1 1.4 1.1 4.0 0.0 1.8 0.7 7.5 1.6 3.2 2.3 5.3 3.4 1.7 4.8 0.9 3.4 7.3 9.0 1.7 1.9 1.5 6.3 8.4 2.9 1.5 5.7 4.9 3.4 3.0 0.1 0.1 3.8 3.4 2.7 2.1 4.1 3.0 0.6 0.0 4.1 0.4 0.8 1.1 3.2 1.0 2.3 3.5 3.3 2.9 1.0 5.9 5.2 3.4 0.4 2.4 0.9 4.5 4.4 1.0 11.8 11.2 13.8 13.4 8.9 5.9 13.6 6.6 9.2 11.1 6.0 3.8 1.4 1.2 1.0 9.4 4.2 7.6 6.7 4.5 5.2 5.9 1.0 6.6 1.3 0.6 1.0 0.0 0.0 1.0 0.6 0.9 0.8 3.5 0.8 0.8 14.3 1.2 3.7 2.2 2.6 3.1 0.0 0.0 1.8 0.9 8.2 0.7 1.1 2.5 0.6 9.8 0.0 1.0 2.3 3.8 0.3 0.2 0.8 1.2 0.4 ZNF606 "FLJ14260, KIAA1852, ZNF328" ENSG00000166704 "Zinc finger protein 606" Q8WXB4 19 57977053-58003349 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 29.4;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041712, HPA043584" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA041712: AB_10960410, HPA043584: AB_2678565" "unprognostic (1.05e-2)" "unprognostic (1.05e-1)" "unprognostic (4.09e-2)" "unprognostic (3.76e-2)" "unprognostic (4.92e-2)" "unprognostic (6.21e-2)" "unprognostic (1.10e-1)" "unprognostic (6.83e-2)" "unprognostic (3.48e-3)" "unprognostic (4.26e-2)" "unprognostic (1.29e-3)" "unprognostic (4.09e-2)" "unprognostic (1.03e-1)" "unprognostic (5.00e-2)" "unprognostic (3.21e-2)" "unprognostic (4.01e-2)" "prognostic favorable (4.75e-6)" 6.9 7.1 13.0 7.1 12.8 5.5 12.8 18.2 11.6 9.6 7.8 12.8 11.3 8.6 11.1 14.6 6.6 14.0 9.8 6.7 15.0 6.9 9.0 6.9 7.7 11.2 16.9 8.2 14.6 8.3 18.9 18.1 6.7 12.3 12.4 7.2 10.2 11.1 10.0 9.9 11.0 10.3 9.2 10.8 12.9 10.0 8.9 11.7 20.1 17.8 6.3 9.8 9.2 7.7 9.8 7.9 9.1 3.0 6.3 8.5 2.4 1.4 2.6 11.3 9.5 3.4 4.8 8.2 3.4 1.2 3.4 2.1 3.3 4.0 2.2 2.7 2.3 3.7 3.4 1.4 3.3 4.6 0.0 20.2 5.5 0.9 3.1 2.7 0.0 4.5 5.7 1.7 2.9 1.7 5.3 2.4 6.6 2.8 0.1 4.3 1.3 7.3 1.3 6.9 1.7 4.9 8.2 4.2 3.2 3.6 6.9 10.6 7.1 6.1 0.2 2.5 5.7 5.5 5.2 2.8 2.7 4.0 1.1 1.1 6.7 7.2 1.6 0.2 0.6 3.5 9.1 3.0 7.4 3.0 2.4 4.1 8.3 4.8 3.4 2.6 9.8 8.5 4.7 7.8 6.3 2.6 7.9 3.2 2.4 13.0 12.8 18.2 11.6 15.0 6.9 16.9 8.2 12.3 11.7 6.0 5.6 2.7 2.9 0.9 13.6 5.7 0.0 29.4 5.7 12.2 23.6 2.9 3.3 2.6 2.0 4.3 2.0 0.0 1.4 0.8 1.9 4.0 4.7 1.6 1.7 11.1 0.0 6.2 0.8 0.0 7.5 2.0 0.0 1.0 2.6 8.4 1.7 3.1 3.2 1.8 25.5 6.5 2.3 5.9 10.2 1.8 2.9 3.5 2.3 3.0 ZNF607 "FLJ14802, MGC13071" ENSG00000198182 "Zinc finger protein 607" Q96SK3 19 37696363-37719790 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 25.9;Late spermatids: 20.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA049465, HPA055018" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049465: AB_2680778, HPA055018: AB_2682674" "unprognostic (6.70e-2)" "unprognostic (8.00e-2)" "unprognostic (1.77e-3)" "unprognostic (2.69e-3)" "unprognostic (1.58e-1)" "unprognostic (9.23e-2)" "unprognostic (9.86e-3)" "unprognostic (2.15e-1)" "unprognostic (4.86e-2)" "unprognostic (1.95e-1)" "unprognostic (1.80e-3)" "unprognostic (1.68e-1)" "unprognostic (6.43e-3)" "unprognostic (3.86e-1)" "unprognostic (4.30e-2)" "unprognostic (5.03e-2)" "prognostic favorable (5.23e-5)" 3.1 5.4 8.1 4.2 9.0 1.4 7.7 14.9 9.4 5.9 4.9 9.8 4.6 3.9 9.0 8.0 5.6 10.8 4.2 5.6 7.0 6.6 5.9 1.6 4.7 5.6 12.3 7.2 12.2 5.0 14.0 12.3 6.1 9.3 7.2 4.9 6.7 4.4 6.2 4.4 7.9 4.6 8.4 11.3 5.5 5.5 13.9 8.7 7.3 9.1 2.4 7.2 5.5 6.0 5.7 3.0 2.8 0.4 3.8 5.3 1.5 5.1 5.3 8.4 8.8 4.6 5.3 5.9 3.7 3.7 3.5 6.3 8.1 2.9 7.2 5.6 4.0 4.6 2.6 8.2 2.8 5.3 3.6 8.4 3.5 4.5 4.4 3.7 0.1 2.2 3.5 5.6 4.2 4.0 5.1 1.8 4.8 7.3 0.0 3.8 4.4 7.0 3.9 9.9 3.6 2.2 3.4 13.0 1.9 3.7 6.7 2.4 7.6 0.2 2.2 0.7 6.4 5.9 0.6 0.4 2.6 1.8 3.0 4.3 7.3 7.9 10.2 0.1 0.0 3.3 0.0 0.4 2.8 2.7 0.3 1.7 5.7 4.2 5.3 1.5 4.2 3.6 4.4 0.0 3.8 0.4 3.0 1.5 1.5 8.1 9.0 14.9 9.4 7.0 6.6 12.3 7.2 9.3 8.7 3.0 0.3 0.0 0.7 1.1 2.5 3.0 0.0 8.1 2.3 1.8 2.0 1.9 0.0 1.5 25.9 1.4 0.7 0.0 1.1 2.1 0.9 0.9 0.0 0.4 1.2 1.6 0.0 1.3 0.0 20.8 0.9 1.0 3.3 1.0 1.7 2.0 0.7 0.0 1.8 1.0 1.3 0.0 1.3 2.9 5.3 1.0 0.7 1.3 1.2 0.7 ZNF610 FLJ36040 ENSG00000167554 "Zinc finger protein 610" Q8N9Z0 19 52336245-52367778 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Early spermatids: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 11.7" "HPA055771, HPA078134" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA055771: AB_2682914, HPA078134: AB_2732372" "unprognostic (1.13e-1)" "unprognostic (5.48e-3)" "unprognostic (1.52e-1)" "unprognostic (8.75e-2)" "unprognostic (3.65e-2)" "unprognostic (1.27e-1)" "unprognostic (3.34e-1)" "unprognostic (2.84e-1)" "unprognostic (1.83e-1)" "prognostic favorable (3.38e-4)" "unprognostic (5.54e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.05e-7)" "unprognostic (2.46e-2)" "unprognostic (1.11e-2)" "unprognostic (1.88e-2)" "unprognostic (5.73e-3)" 2.3 4.8 7.9 2.1 11.9 0.8 5.5 11.0 9.7 5.5 3.0 6.9 3.3 1.5 5.1 11.7 2.1 7.4 4.3 4.2 7.6 7.7 5.9 1.0 3.3 2.6 7.5 7.2 14.3 2.9 7.5 6.8 4.5 10.0 7.6 2.9 5.7 2.2 4.1 1.9 1.6 1.8 4.4 8.5 4.1 2.7 18.1 7.3 3.6 7.7 0.2 2.1 3.6 2.4 3.6 1.5 4.0 0.5 2.5 4.8 1.6 0.2 0.0 6.0 4.9 4.0 3.4 4.6 1.8 3.3 1.1 3.3 0.0 0.4 0.4 3.7 0.8 7.4 0.2 0.0 0.0 2.8 0.1 2.9 0.1 0.3 0.2 4.8 0.0 1.5 4.6 0.1 1.2 0.2 2.9 3.4 3.3 0.3 0.2 5.4 1.2 3.1 0.9 5.7 0.0 0.4 2.2 4.5 0.6 2.1 4.3 7.5 4.3 0.1 0.4 1.8 8.9 3.6 2.6 2.7 0.3 2.0 0.1 2.3 0.2 11.7 0.0 0.0 0.1 2.3 4.0 0.5 1.1 2.9 0.1 4.4 2.5 2.4 2.3 1.4 3.6 4.8 2.0 1.4 2.5 0.1 1.5 3.2 1.6 7.9 11.9 11.0 9.7 7.6 7.7 7.5 7.2 10.0 7.3 0.0 0.3 0.0 0.8 0.0 2.9 2.6 2.5 2.7 3.4 3.5 3.9 1.2 5.0 1.6 28.1 1.1 0.0 0.0 0.0 1.4 0.8 0.9 2.3 0.0 0.5 0.0 0.0 0.6 0.8 7.0 0.9 0.0 1.7 0.0 0.0 3.8 0.2 0.0 1.1 0.6 2.4 6.5 0.4 5.0 2.3 0.3 0.6 0.0 0.4 0.3 ZNF618 "KIAA1952, NEDD10" ENSG00000157657 "Zinc finger protein 618" Q5T7W0 9 113876282-114056591 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 20.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023116, HPA061732" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA023116: AB_10964204, HPA061732: AB_2684596" "unprognostic (1.92e-1)" "unprognostic (3.22e-2)" "unprognostic (2.29e-2)" "unprognostic (4.17e-3)" "prognostic unfavorable (6.34e-4)" "unprognostic (3.07e-1)" "unprognostic (1.04e-1)" "unprognostic (3.61e-1)" "unprognostic (6.43e-2)" "unprognostic (2.38e-2)" "unprognostic (1.56e-2)" "unprognostic (8.24e-2)" "prognostic favorable (5.22e-7)" "unprognostic (4.57e-2)" "unprognostic (2.79e-1)" "unprognostic (1.04e-1)" "unprognostic (3.51e-2)" 5.2 7.5 5.0 8.1 5.2 3.4 6.1 19.2 5.0 9.3 3.6 5.4 4.0 3.3 11.5 7.3 3.5 8.4 12.1 3.1 4.3 3.8 13.3 8.2 5.2 3.0 2.8 3.3 15.0 13.3 15.8 11.6 3.2 4.8 5.9 2.5 14.5 6.0 4.8 3.1 3.4 2.6 6.9 2.7 5.4 6.4 5.6 2.4 5.6 10.9 2.6 3.0 4.3 6.6 1.3 4.3 4.0 0.9 2.8 0.9 0.9 4.4 13.6 20.4 8.9 4.9 5.8 1.0 2.9 4.8 5.9 5.2 0.1 3.2 2.4 2.8 5.0 1.6 0.1 10.2 5.0 2.3 0.0 4.0 0.0 1.0 0.0 3.7 2.6 4.6 5.6 2.0 6.2 1.4 5.4 14.8 0.3 0.0 0.0 2.6 7.2 0.1 3.3 10.1 0.3 3.0 18.8 11.9 0.0 6.3 4.9 6.3 15.0 8.3 5.3 5.4 6.1 0.4 5.3 12.0 7.9 6.3 4.4 3.5 0.0 0.0 0.0 0.6 4.0 5.5 4.0 0.9 0.6 0.9 0.5 0.3 0.0 0.1 0.8 3.4 1.3 0.7 0.5 0.0 2.8 0.7 4.3 0.0 0.9 5.0 5.2 19.2 5.0 4.3 3.8 2.8 3.3 4.8 2.4 3.0 10.4 0.8 4.7 1.8 14.0 2.4 28.1 2.7 4.5 10.4 3.9 0.2 6.6 11.5 5.1 3.0 0.0 0.0 7.0 0.2 5.8 2.0 20.7 7.8 3.6 55.6 2.4 12.3 3.3 3.3 14.1 6.0 0.0 18.0 1.4 9.1 9.6 1.9 14.5 8.4 1.1 25.8 11.3 0.1 13.2 3.1 0.2 2.2 2.3 1.6 ZNF623 KIAA0628 ENSG00000183309 "Zinc finger protein 623" O75123 8 143636013-143656418 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 13.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044372 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044372: AB_10966790" "unprognostic (1.06e-3)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.44e-1)" "unprognostic (8.67e-2)" "unprognostic (4.00e-3)" "unprognostic (6.95e-2)" "unprognostic (2.71e-1)" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-1)" "unprognostic (2.08e-1)" "unprognostic (1.82e-1)" "unprognostic (5.21e-2)" "unprognostic (8.03e-2)" 9.4 8.7 10.4 10.2 14.1 5.3 11.3 18.2 16.7 14.5 10.7 12.2 10.3 12.1 15.0 11.2 10.3 10.8 10.5 10.0 9.6 9.1 8.1 8.6 10.1 10.9 8.8 14.5 17.7 10.4 9.5 9.9 8.6 11.9 12.4 9.8 8.5 12.0 8.5 11.7 14.0 12.0 12.0 8.3 10.7 8.6 11.2 10.2 12.3 12.6 6.5 11.4 11.7 12.5 2.9 1.3 13.5 3.6 2.0 3.3 1.1 3.3 4.8 3.8 6.1 4.1 6.7 3.5 1.9 3.8 4.1 0.7 3.0 6.0 1.3 2.7 7.1 7.0 2.3 5.8 1.9 3.7 5.5 2.2 7.9 7.7 1.7 3.4 1.3 2.2 3.6 4.6 2.2 10.9 5.5 3.5 7.3 7.7 5.4 4.8 8.9 7.8 2.0 4.5 6.4 17.5 4.5 1.9 8.4 3.1 2.9 5.9 7.5 19.3 4.2 5.2 6.2 6.6 5.0 1.0 7.4 1.2 1.1 2.0 1.5 1.7 4.5 3.4 2.3 4.3 13.5 1.0 3.5 2.6 1.3 1.4 2.7 1.7 1.3 1.3 2.9 3.3 2.5 1.8 2.0 3.6 1.2 1.8 1.1 10.4 14.1 18.2 16.7 9.6 9.1 8.8 14.5 11.9 10.2 6.0 4.6 5.4 3.1 1.4 5.7 9.3 10.2 1.4 1.2 7.0 5.9 5.0 3.3 5.4 3.0 4.5 4.3 0.0 3.2 4.9 3.1 3.1 1.1 5.1 4.8 14.3 5.2 7.4 8.7 2.8 7.8 2.8 3.3 7.2 5.0 7.4 3.9 0.0 13.1 3.7 6.8 19.4 2.0 5.9 12.2 2.3 4.0 4.4 5.0 1.6 ZNF628 "ZEC, Zfp628" ENSG00000197483 "Zinc finger protein 628" Q5EBL2 19 55476332-55484487 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 25.5;Late spermatids: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044451 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044451: AB_10962507" "unprognostic (8.70e-2)" "unprognostic (5.08e-1)" "unprognostic (8.30e-2)" "unprognostic (1.81e-1)" "unprognostic (4.65e-2)" "unprognostic (2.35e-2)" "unprognostic (2.13e-2)" "unprognostic (5.19e-2)" "unprognostic (3.10e-1)" "unprognostic (7.15e-2)" "unprognostic (4.58e-3)" "unprognostic (3.23e-2)" "unprognostic (1.06e-1)" "unprognostic (1.42e-1)" "unprognostic (2.66e-1)" "unprognostic (3.49e-2)" "unprognostic (4.88e-3)" 6.8 4.7 3.6 6.0 5.0 9.8 5.0 4.1 10.5 5.5 5.8 5.2 5.6 8.4 6.9 4.7 5.0 5.7 4.8 4.3 2.4 2.4 5.4 10.0 5.5 5.4 1.9 4.9 7.6 6.8 2.8 5.9 6.9 4.6 6.2 2.0 5.4 5.7 5.0 15.0 7.3 7.0 4.9 2.0 7.2 8.0 20.8 2.1 12.1 5.0 5.0 7.5 6.2 4.4 0.6 1.0 0.5 2.3 0.4 1.0 0.3 6.7 4.2 1.0 2.9 0.5 1.3 8.2 4.7 0.9 1.7 1.3 2.6 2.9 6.3 4.6 0.8 1.3 3.9 0.5 2.8 0.2 6.5 15.9 4.4 3.8 2.3 1.8 3.4 11.4 1.0 1.8 1.2 0.7 0.8 1.2 3.8 6.5 3.4 0.6 4.5 4.9 2.3 4.5 1.9 8.4 9.2 1.6 6.0 1.4 4.2 5.2 5.7 3.5 4.0 5.9 0.3 4.0 5.3 2.9 3.0 4.5 3.0 4.8 8.0 6.9 4.9 3.9 2.5 2.9 0.0 0.7 0.5 0.7 0.2 0.5 0.6 1.0 0.6 0.7 0.2 0.3 0.4 0.5 0.4 2.3 1.0 0.0 0.3 3.6 5.0 4.1 10.5 2.4 2.4 1.9 4.9 4.6 2.1 0.0 1.4 5.9 6.4 4.4 4.5 2.0 2.5 0.0 0.0 3.5 3.9 2.9 8.3 2.3 25.5 2.1 5.5 0.0 3.1 2.6 2.8 3.5 13.8 2.6 2.8 4.8 6.9 2.5 1.8 72.4 5.2 2.9 3.3 0.0 4.5 3.8 4.1 5.1 4.2 2.8 2.7 12.9 3.2 4.2 3.6 4.0 4.6 3.8 4.2 4.3 ZNF639 "ANC-2H01, ZASC1" ENSG00000121864 "Zinc finger protein 639" Q9UID6 3 179322991-179338583 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049023, HPA052163" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA049023: AB_2680603, HPA052163: AB_2681747" "unprognostic (5.64e-2)" "unprognostic (6.16e-2)" "unprognostic (8.15e-2)" "unprognostic (1.33e-2)" "prognostic favorable (5.45e-5)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.13e-4)" "unprognostic (7.74e-2)" "unprognostic (1.05e-2)" "unprognostic (2.16e-3)" "unprognostic (4.70e-3)" "unprognostic (4.58e-2)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "unprognostic (7.82e-2)" "unprognostic (1.33e-2)" "unprognostic (1.56e-1)" 19.4 17.2 18.4 12.4 18.0 36.7 28.5 25.4 25.8 24.0 23.7 18.3 15.9 12.7 24.6 20.0 18.8 21.7 14.8 22.1 17.7 15.8 18.8 19.2 17.3 27.5 17.0 17.0 25.6 21.4 31.1 25.2 16.3 19.4 23.6 16.9 19.5 19.6 21.5 23.5 12.3 16.7 23.4 17.2 23.1 17.4 13.3 19.1 25.9 36.4 15.3 17.5 25.1 22.8 4.0 1.7 4.6 2.3 4.5 5.7 1.6 25.6 6.1 11.9 14.6 10.8 13.3 11.7 12.3 18.7 20.5 18.6 10.1 10.4 30.0 18.7 15.2 25.0 9.8 18.3 16.5 25.9 27.4 13.9 30.5 8.9 10.1 18.9 24.1 11.5 10.6 17.5 10.5 24.7 15.4 13.9 20.2 18.5 16.3 16.1 13.1 24.9 10.7 19.8 18.4 14.1 24.0 12.3 36.0 12.7 10.6 21.9 13.2 12.3 13.7 15.9 10.5 34.9 19.1 11.3 14.0 14.7 11.0 31.3 6.5 5.8 56.1 10.3 18.7 9.6 4.6 2.3 2.2 3.5 1.5 3.2 4.0 5.7 5.6 1.7 3.6 4.9 4.7 1.6 4.5 0.9 0.8 4.6 1.6 18.4 18.0 25.4 25.8 17.7 15.8 17.0 17.0 19.4 19.1 17.9 13.2 12.1 24.6 18.5 20.3 16.8 7.6 6.7 10.3 14.0 51.1 12.4 28.2 10.4 16.8 19.4 7.4 0.0 8.5 9.5 17.9 24.8 9.3 14.1 8.6 15.9 18.0 20.9 14.2 6.6 22.7 13.0 13.5 12.6 16.3 17.5 8.8 7.0 22.6 17.0 41.5 25.8 17.5 24.5 20.2 15.3 2.9 10.9 11.3 20.3 ZNF641 FLJ31295 ENSG00000167528 "Zinc finger protein 641" Q96N77 12 48337180-48351414 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035189 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA035189: AB_10603333" "unprognostic (1.79e-1)" "unprognostic (1.85e-1)" "unprognostic (2.70e-2)" "unprognostic (9.82e-3)" "unprognostic (3.71e-2)" "unprognostic (1.08e-2)" "unprognostic (1.90e-2)" "unprognostic (1.35e-3)" "unprognostic (7.82e-3)" "prognostic favorable (3.91e-4)" "prognostic favorable (8.30e-5)" "unprognostic (3.67e-1)" "unprognostic (2.68e-2)" "unprognostic (7.61e-2)" "unprognostic (1.51e-1)" "unprognostic (5.76e-2)" "unprognostic (7.85e-3)" 10.6 28.6 11.9 11.1 10.8 6.4 10.4 11.3 17.1 14.6 9.2 11.8 7.3 10.1 15.3 10.9 7.8 12.5 13.0 11.4 13.1 8.7 10.9 10.4 13.9 12.4 9.5 17.9 25.6 16.0 17.2 12.2 15.2 13.6 11.0 9.1 11.8 9.7 11.5 22.5 6.2 9.3 19.2 12.6 14.8 10.1 12.1 9.5 14.6 15.6 8.1 13.6 12.7 12.5 1.2 4.7 9.7 5.0 6.4 4.3 2.9 3.1 4.0 8.1 13.8 7.3 2.0 5.8 7.1 5.1 3.8 2.5 9.1 8.0 5.4 10.5 6.7 7.1 4.8 2.9 4.9 1.3 13.8 5.1 9.7 7.3 2.2 7.6 11.5 13.6 3.1 7.2 2.8 6.0 6.5 3.6 8.0 9.3 5.6 3.6 3.5 4.5 4.0 1.7 3.1 2.2 3.0 8.1 4.2 6.3 14.3 3.3 5.0 8.7 3.7 5.1 7.1 8.8 11.7 1.5 4.2 7.1 4.6 3.5 6.6 5.9 4.4 2.7 12.3 4.4 1.9 4.1 8.6 4.3 3.9 2.6 0.7 2.5 4.0 4.7 1.2 2.3 4.0 9.7 6.4 5.0 1.9 1.3 2.9 11.9 10.8 11.3 17.1 13.1 8.7 9.5 17.9 13.6 9.5 6.0 17.3 7.4 12.9 2.7 12.1 7.7 12.7 6.7 6.8 7.0 9.8 1.1 6.6 7.1 1.3 9.6 3.9 0.0 8.8 0.7 6.7 4.7 3.5 6.4 6.8 17.5 5.2 18.4 16.2 1.9 14.4 13.6 0.0 2.8 1.8 15.3 6.8 0.0 22.6 3.7 16.8 19.4 9.8 5.9 5.3 1.9 0.5 12.8 2.4 5.4 ZNF652 KIAA0924 ENSG00000198740 "Zinc finger protein 652" Q9Y2D9 17 49289206-49362473 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044408 Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA044408: AB_2678932" "unprognostic (1.33e-2)" "unprognostic (5.54e-2)" "unprognostic (1.15e-1)" "prognostic favorable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (7.31e-3)" "unprognostic (2.34e-1)" "unprognostic (4.52e-2)" "unprognostic (1.13e-2)" "unprognostic (2.75e-1)" "unprognostic (4.09e-3)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (3.90e-2)" "unprognostic (1.30e-2)" 6.4 6.2 8.5 6.3 23.7 9.7 16.0 8.4 14.5 7.0 8.5 17.1 8.2 5.2 6.8 4.6 5.6 5.5 6.4 5.4 9.6 5.6 5.9 8.0 7.3 6.1 28.3 6.5 7.6 7.4 10.0 7.6 6.5 13.0 6.8 6.4 6.0 12.6 8.2 19.9 11.0 7.0 7.9 15.6 8.6 7.8 9.9 23.4 5.1 8.2 1.5 6.6 8.0 6.7 2.7 2.3 6.2 2.1 1.4 1.8 0.6 4.8 4.0 3.4 4.6 3.4 2.3 4.7 1.9 3.2 2.6 2.7 7.0 3.1 10.5 5.8 3.9 1.7 3.3 3.8 3.9 4.0 4.3 3.1 4.3 5.6 3.9 1.6 3.7 6.4 2.8 2.2 2.2 3.8 1.6 2.6 5.7 3.7 9.8 2.1 6.4 5.1 1.1 3.9 2.3 2.8 4.0 8.4 4.3 1.9 7.1 7.1 4.6 3.5 3.4 4.2 5.2 7.3 4.2 4.5 7.2 6.3 3.2 2.9 11.2 9.0 8.2 3.7 2.6 2.7 3.0 1.6 2.4 1.5 0.8 1.8 1.3 1.1 1.5 1.2 2.7 1.0 1.1 6.2 1.4 2.1 2.3 0.6 0.6 8.5 23.7 8.4 14.5 9.6 5.6 28.3 6.5 13.0 23.4 17.9 13.7 32.2 11.8 14.5 48.4 14.2 28.1 18.7 15.9 27.9 60.9 18.4 11.6 14.9 15.4 19.7 13.4 23.3 17.0 14.6 17.3 19.8 4.7 36.8 11.4 41.3 11.6 25.8 30.8 10.9 44.8 15.0 25.3 6.4 23.9 31.2 15.3 21.0 41.8 12.4 48.2 0.0 19.8 50.7 30.3 21.2 11.2 29.4 20.8 9.7 ZNF653 Zip67 ENSG00000161914 "Zinc finger protein 653" Q96CK0 19 11483427-11505923 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 11.5;Late spermatids: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023631, HPA023635" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA023631: AB_2671269, HPA023635: AB_10603940" "unprognostic (1.21e-1)" "unprognostic (5.23e-2)" "prognostic unfavorable (8.37e-4)" "prognostic favorable (4.15e-4)" "unprognostic (9.75e-2)" "unprognostic (1.67e-3)" "unprognostic (1.11e-1)" "unprognostic (2.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.14e-3)" "unprognostic (1.29e-3)" "unprognostic (1.12e-1)" "unprognostic (7.91e-3)" "unprognostic (1.43e-2)" "unprognostic (3.09e-2)" "unprognostic (3.15e-1)" "prognostic favorable (8.74e-4)" 5.5 8.5 7.5 6.3 9.0 3.8 4.7 19.1 9.6 4.4 5.1 3.5 3.1 3.9 4.3 2.0 4.2 5.3 5.0 4.2 8.5 7.3 4.9 5.6 3.3 4.7 5.0 3.5 5.7 7.9 6.6 5.1 4.0 5.1 5.3 2.4 2.4 5.3 4.1 4.2 8.4 5.7 4.7 3.8 4.1 3.9 13.2 5.7 7.2 6.6 5.7 6.8 6.9 17.2 0.5 1.0 0.5 0.1 0.1 2.4 0.1 9.9 8.2 6.4 5.5 1.7 1.3 4.6 3.8 3.2 5.5 5.1 5.7 4.4 6.9 4.8 4.2 5.9 4.5 4.9 3.8 2.8 7.2 6.3 4.5 6.1 6.6 1.8 5.8 7.7 3.9 4.9 5.2 4.2 5.3 4.2 6.1 6.3 10.5 3.2 14.1 8.0 13.5 6.9 5.6 6.3 7.0 4.2 8.9 6.1 8.4 7.3 10.8 2.5 4.3 4.8 3.0 4.3 3.9 5.2 8.0 5.2 8.8 9.0 13.6 20.3 4.8 7.0 8.0 4.5 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.5 0.2 0.0 0.5 0.1 0.0 1.0 2.4 0.1 7.5 9.0 19.1 9.6 8.5 7.3 5.0 3.5 5.1 5.7 0.0 0.0 4.7 3.3 2.9 4.1 1.6 0.0 0.0 0.0 1.8 5.9 1.0 0.0 4.1 11.5 1.1 3.1 0.0 4.5 1.0 1.3 2.2 4.6 2.8 0.9 1.6 4.6 3.1 1.9 19.8 1.7 0.6 0.0 4.6 3.3 4.5 3.9 0.0 2.1 2.4 3.7 0.0 1.4 7.1 2.7 2.4 1.4 1.9 2.2 2.0 ZNF658 "DKFZp572C163, FLJ32813, MGC35232" ENSG00000274349 "Zinc finger protein 658" Q5TYW1 9 66856426-66932141 "Predicted intracellular proteins, Transcription factors" "Ribosome biogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 20.9" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 12.0;Distal tubular cells: 13.3;Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in some" 11 "neutrophil: 20.9" "Lineage enriched" "Detected in many" 11 "granulocytes: 20.9" "Low cell line specificity" "Detected in many" "HPA047730, HPA048668" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA047730: AB_2680136, HPA048668: AB_2680487" "unprognostic (9.54e-2)" "unprognostic (1.60e-1)" "unprognostic (9.06e-3)" "unprognostic (1.97e-1)" "unprognostic (1.02e-1)" "unprognostic (3.32e-2)" "unprognostic (1.45e-1)" "unprognostic (1.38e-2)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (2.75e-3)" "unprognostic (8.04e-2)" "unprognostic (1.18e-4)" "unprognostic (2.68e-2)" "unprognostic (6.99e-2)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" 0.5 0.8 0.1 0.0 2.8 1.4 1.6 0.6 0.3 1.5 0.8 1.4 1.8 0.1 1.8 1.5 0.5 0.9 0.5 3.5 1.1 2.4 0.1 1.8 0.7 1.6 1.4 1.9 4.5 0.0 0.9 1.1 0.6 1.2 2.1 0.9 0.9 1.3 0.4 20.9 0.5 1.8 1.4 0.1 2.8 4.8 4.7 8.8 4.8 5.8 3.6 2.2 4.1 3.1 3.4 0.4 2.2 6.4 2.5 2.1 3.3 7.6 3.7 4.4 3.3 0.2 2.3 1.0 4.0 1.0 5.3 4.0 2.4 4.5 9.8 3.0 4.4 6.4 6.0 4.3 1.3 1.3 3.9 1.6 3.2 2.0 4.0 2.0 8.2 0.3 7.5 2.3 3.3 7.3 6.8 4.1 3.5 1.9 3.4 5.1 2.7 10.3 1.3 4.0 5.1 3.5 2.7 0.8 3.7 1.6 1.8 1.4 4.2 0.5 0.5 1.5 0.6 0.4 0.1 0.6 0.9 0.8 0.2 1.3 1.4 0.7 20.9 1.8 0.4 0.4 0.5 0.1 3.0 2.7 0.5 1.0 0.8 6.4 3.2 0.0 12.0 3.4 0.0 0.0 2.3 13.3 0.9 0.6 0.7 0.9 0.0 0.6 0.7 0.9 0.7 1.1 2.4 1.6 9.5 0.0 0.6 1.3 0.9 2.8 0.1 0.0 0.0 1.8 4.9 0.8 0.0 4.9 4.8 3.9 0.0 0.5 2.6 2.0 1.8 0.8 0.0 1.2 0.9 ZNF664 "DKFZp761B128, ZFOC1, ZNF176" ENSG00000179195 "Zinc finger protein 664" Q8N3J9 12 123971845-124015439 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 134.6;Late spermatids: 216.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047846 Approved Nucleoplasm NA NA Nucleoplasm "HPA047846: AB_2680179" "unprognostic (4.16e-2)" "unprognostic (1.32e-1)" "unprognostic (5.75e-3)" "unprognostic (1.90e-2)" "unprognostic (8.12e-2)" "unprognostic (3.79e-1)" "unprognostic (2.49e-3)" "unprognostic (3.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-1)" "unprognostic (2.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.16e-3)" "unprognostic (7.13e-2)" "unprognostic (1.24e-1)" "unprognostic (1.85e-2)" "unprognostic (1.85e-2)" 22.9 15.0 38.3 11.3 34.5 5.3 29.4 26.9 24.8 23.0 25.5 34.2 26.0 36.6 18.9 35.3 14.4 27.3 16.1 22.4 39.2 30.7 29.3 21.0 20.6 10.4 46.7 20.1 15.2 28.2 72.1 33.4 17.0 28.7 21.1 28.3 22.2 31.2 21.1 21.3 8.9 39.8 14.6 61.8 11.1 20.1 12.0 30.0 10.1 43.9 11.0 13.2 15.3 17.5 2.4 1.0 0.5 0.6 1.7 4.3 1.7 25.0 17.6 28.2 29.4 22.2 16.9 24.0 14.7 20.0 15.3 12.6 21.8 13.8 24.7 18.0 19.9 11.0 22.1 40.3 18.1 28.4 20.8 29.1 38.4 23.0 18.4 26.7 23.1 21.2 10.7 40.6 15.9 26.2 36.1 24.3 24.3 23.4 10.5 13.6 19.2 22.8 10.6 26.4 24.8 38.3 19.9 27.5 14.9 33.2 41.4 58.6 42.5 25.3 27.1 24.8 24.6 48.3 12.3 15.8 13.3 21.6 18.7 15.2 14.5 18.0 19.5 23.1 16.3 20.4 0.2 0.6 0.5 2.8 0.3 4.3 1.9 2.2 2.4 1.0 2.4 2.7 2.2 0.3 1.7 0.0 0.8 3.8 1.7 38.3 34.5 26.9 24.8 39.2 30.7 46.7 20.1 28.7 30.0 23.8 40.2 18.0 12.5 11.2 23.4 54.0 33.1 56.2 40.9 19.2 19.6 7.7 24.9 30.5 134.6 18.0 68.9 0.0 27.3 7.3 27.4 34.5 12.7 38.4 10.7 30.2 42.1 17.2 14.3 216.3 21.6 7.0 20.3 3.6 59.6 29.4 34.9 45.6 16.3 22.7 30.2 19.4 18.6 21.1 25.1 7.8 8.4 10.1 48.2 15.8 ZNF667 FLJ14011 ENSG00000198046 "Zinc finger protein 667" Q5HYK9 19 56439325-56478065 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 27.9;Cone photoreceptor cells: 23.6;Horizontal cells: 30.2;Rod photoreceptor cells: 28.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 10.1;hTERT-RPE1: 15.1;U-138 MG: 12.7" "Low region specificity" "Detected in all" "HPA030731, HPA046673" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030731: AB_2673584, HPA046673: AB_2679746" "unprognostic (6.10e-2)" "unprognostic (7.87e-3)" "unprognostic (2.91e-2)" "unprognostic (4.81e-2)" "unprognostic (6.38e-2)" "unprognostic (2.26e-3)" "unprognostic (8.55e-2)" "unprognostic (5.37e-2)" "unprognostic (1.05e-1)" "unprognostic (5.67e-2)" "unprognostic (3.77e-4)" "unprognostic (1.22e-1)" "unprognostic (4.09e-2)" "unprognostic (8.34e-3)" "unprognostic (3.54e-2)" "unprognostic (7.62e-2)" "unprognostic (1.55e-2)" 2.4 7.7 8.0 1.7 18.2 6.2 6.8 12.1 16.1 4.7 2.6 5.3 1.8 1.6 6.4 11.6 2.4 6.3 4.3 4.0 10.2 9.9 4.1 1.3 2.1 2.4 6.5 8.3 11.1 3.5 6.1 18.9 3.0 9.7 5.6 0.9 3.2 4.5 4.5 2.0 2.9 1.1 5.6 6.6 2.4 1.8 5.9 5.3 2.9 12.6 0.6 1.8 3.7 4.2 6.2 2.2 0.4 0.0 4.5 3.7 0.6 0.1 0.2 8.7 0.1 0.0 0.0 0.2 3.7 2.8 3.4 2.7 0.2 0.1 0.4 5.2 1.3 5.2 0.1 0.0 0.1 5.2 0.0 1.9 10.1 0.1 0.2 2.7 5.9 4.6 5.6 0.1 0.7 0.0 15.1 0.0 0.3 0.0 0.3 2.6 0.2 0.1 0.2 6.3 0.1 1.7 0.0 3.3 7.0 3.4 0.5 0.2 5.1 0.2 0.1 0.0 8.1 2.4 0.0 0.0 12.7 3.4 0.2 6.5 0.2 5.4 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 1.2 0.4 0.3 0.3 6.2 1.5 3.7 0.4 4.5 0.0 2.2 0.0 0.6 8.0 18.2 12.1 14.4 10.2 9.9 6.5 8.3 9.7 5.3 0.0 0.0 0.0 5.6 3.0 27.9 4.5 0.0 5.3 4.5 5.2 23.6 0.1 0.0 2.7 2.1 3.6 0.0 0.0 0.2 0.0 5.3 3.6 9.2 0.0 0.2 30.2 1.2 1.8 0.0 1.6 4.9 0.6 3.3 0.0 0.0 9.3 0.5 0.0 6.7 1.2 28.2 0.0 3.0 7.7 14.4 3.6 0.1 0.0 0.0 2.5 ZNF671 FLJ23506 ENSG00000083814 "Zinc finger protein 671" Q8TAW3 19 57719751-57727624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 7.8;Rod photoreceptor cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 10.4" "Low region specificity" "Detected in all" "HPA046099, HPA056043" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046099: AB_10962484, HPA056043: " "prognostic favorable (2.20e-4)" "unprognostic (4.16e-3)" "unprognostic (6.02e-2)" "unprognostic (5.91e-3)" "unprognostic (8.76e-2)" "unprognostic (3.97e-3)" "unprognostic (6.12e-2)" "unprognostic (5.56e-3)" "unprognostic (8.26e-3)" "unprognostic (2.04e-1)" "prognostic favorable (3.57e-4)" "unprognostic (2.14e-1)" "unprognostic (1.92e-3)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.02e-1)" "unprognostic (4.22e-1)" 3.3 7.9 9.1 6.3 10.1 5.6 6.6 28.5 10.4 5.4 6.7 4.5 4.5 2.7 3.3 8.4 3.2 6.9 4.2 8.1 9.0 6.7 6.2 3.3 5.6 13.2 8.0 7.5 5.4 4.1 16.1 11.3 5.9 7.9 6.6 3.7 7.8 4.5 9.4 10.3 3.2 7.1 6.6 9.0 15.1 3.8 7.1 8.9 15.6 10.4 1.1 12.1 6.2 2.5 22.2 11.0 13.7 10.0 13.9 19.4 10.9 0.1 0.2 2.4 0.0 0.4 0.1 0.0 2.7 1.6 5.4 1.9 0.3 0.4 5.5 0.9 3.9 1.7 0.1 2.0 2.2 6.3 6.0 3.9 0.1 0.9 0.0 4.7 0.0 8.1 7.0 1.6 3.4 1.8 6.2 0.8 5.9 0.8 2.7 4.7 0.1 10.4 0.1 3.5 0.0 5.6 4.1 7.5 3.3 2.0 0.2 0.2 0.0 0.0 0.1 3.6 6.3 1.6 7.7 0.0 0.6 2.9 0.0 2.0 4.9 0.1 3.0 0.6 1.3 1.8 12.1 7.6 13.7 6.4 7.0 16.7 17.2 13.3 11.0 11.0 22.2 19.4 15.5 5.6 13.9 10.0 10.0 13.1 10.9 9.1 10.1 28.5 10.4 9.0 6.7 8.0 7.5 7.9 8.9 0.0 1.1 0.9 0.6 0.6 5.3 4.8 2.5 0.0 1.2 3.5 0.0 1.8 1.7 2.6 0.1 1.0 0.0 0.0 0.0 0.9 1.0 0.5 2.3 1.0 3.3 6.4 0.0 1.3 1.6 0.4 0.0 1.6 1.7 1.8 0.0 7.8 0.5 0.0 0.4 1.3 6.8 0.0 0.4 5.6 4.5 0.4 0.7 4.3 0.3 0.1 ZNF672 FLJ22301 ENSG00000171161 "Zinc finger protein 672" Q499Z4 1 248838210-248849517 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055779, HPA062506" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA055779: AB_2682917, HPA062506: AB_2684786" "unprognostic (1.64e-2)" "unprognostic (3.45e-2)" "unprognostic (8.96e-2)" "unprognostic (2.92e-2)" "unprognostic (2.50e-1)" "unprognostic (9.54e-3)" "unprognostic (7.42e-3)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (2.40e-2)" "prognostic favorable (7.51e-4)" "unprognostic (9.03e-2)" "unprognostic (1.16e-2)" "unprognostic (1.99e-2)" "unprognostic (2.69e-1)" "unprognostic (8.35e-3)" "prognostic favorable (1.79e-5)" 11.3 12.5 11.1 16.4 13.6 15.1 12.1 18.6 15.3 10.2 13.0 17.3 15.0 13.8 12.1 10.7 15.9 11.3 13.3 20.1 11.4 10.2 14.8 27.5 13.6 16.7 14.1 7.5 12.0 14.1 20.4 14.1 16.1 12.4 18.7 11.1 15.1 24.1 14.8 46.6 13.3 16.8 11.3 11.2 16.0 12.7 12.4 14.5 28.1 21.7 21.0 17.3 14.5 10.4 14.5 20.8 9.6 13.4 10.5 8.0 10.3 10.2 11.7 9.6 10.7 5.4 3.8 18.1 9.8 5.3 6.9 7.6 6.4 10.8 11.6 10.1 6.4 5.4 10.1 5.2 7.2 4.6 16.8 2.9 17.7 10.8 8.6 7.0 7.7 13.7 4.2 6.0 9.2 6.6 5.7 6.5 8.0 21.5 9.7 4.9 7.4 13.6 7.7 11.0 11.8 19.9 25.7 9.1 9.1 7.2 8.5 14.1 12.4 8.7 13.3 8.6 6.0 7.7 15.8 5.5 9.8 5.8 6.5 19.8 29.1 10.9 6.8 9.1 13.6 8.0 7.6 13.3 9.6 8.0 13.4 6.7 10.8 5.7 7.9 20.8 14.5 6.3 5.6 8.1 10.5 12.4 11.7 6.5 10.3 11.1 13.6 18.6 15.3 11.4 10.2 14.1 7.5 12.4 14.5 3.0 17.5 21.4 22.4 11.6 21.0 16.9 7.6 5.3 4.5 15.7 11.8 28.2 18.3 16.4 6.2 12.1 18.8 0.0 9.4 16.4 10.8 20.5 28.7 14.8 15.4 9.5 17.3 5.5 15.2 8.9 5.2 14.1 11.8 12.6 16.6 19.2 12.1 17.3 5.3 13.5 30.2 6.5 9.9 22.9 13.6 12.8 59.6 13.8 15.2 19.9 ZNF674 "MRX92, ZNF673B" ENSG00000251192 "Zinc finger protein 674" Q2M3X9 X 46497727-46545457 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 8.9;Horizontal cells: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031026, HPA065295" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031026: AB_10602690, HPA065295: AB_2685456" "unprognostic (6.11e-4)" "unprognostic (1.97e-2)" "unprognostic (2.16e-1)" "unprognostic (9.30e-2)" "unprognostic (1.54e-2)" "unprognostic (3.39e-2)" "unprognostic (6.41e-5)" "unprognostic (2.74e-4)" "unprognostic (5.68e-2)" "unprognostic (2.43e-2)" "unprognostic (2.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (3.25e-4)" "unprognostic (8.45e-4)" 6.7 5.1 5.7 4.0 10.1 3.8 5.5 12.6 9.8 4.7 4.5 6.8 1.9 4.2 6.3 6.5 4.1 3.7 4.9 4.9 5.7 6.3 5.6 8.1 4.3 5.1 6.4 5.8 7.2 7.4 4.8 11.2 4.5 9.6 8.2 5.1 6.8 4.5 5.7 5.0 5.4 4.6 6.9 6.8 5.8 3.9 3.7 7.0 6.0 6.9 1.8 4.6 4.5 5.1 2.3 2.5 5.8 3.5 1.9 2.7 2.1 2.6 3.4 3.4 4.2 3.1 3.1 3.3 2.8 3.9 3.7 3.9 2.2 2.2 2.9 1.8 4.8 6.6 2.5 4.5 3.4 4.1 2.4 2.9 1.3 3.6 1.9 4.1 3.1 5.3 2.9 5.5 2.7 8.9 3.8 2.9 5.0 1.5 4.4 3.3 1.7 3.1 1.4 5.4 0.8 3.2 1.5 5.7 3.3 2.5 1.1 1.3 2.9 4.3 1.4 8.9 9.8 3.6 2.2 2.5 4.7 5.4 2.9 2.6 5.1 4.5 1.3 2.0 1.6 4.7 2.5 2.2 2.9 1.9 3.5 2.0 2.3 2.7 1.5 2.1 1.4 2.2 2.3 5.8 1.9 0.8 2.5 2.2 2.1 5.7 10.1 12.6 9.8 5.7 6.3 6.4 5.8 9.6 7.0 8.9 2.6 0.5 2.8 1.6 7.3 3.3 0.0 4.0 4.5 1.8 0.0 0.7 0.0 0.7 0.0 1.9 0.9 0.0 0.4 0.6 1.1 2.3 2.3 1.8 0.9 12.7 0.0 2.5 2.1 0.0 0.3 1.1 0.0 1.0 0.9 2.9 1.3 0.9 1.8 0.6 5.4 0.0 1.2 0.7 3.2 1.5 0.3 1.7 0.7 1.7 ZNF680 FLJ90430 ENSG00000173041 "Zinc finger protein 680" Q8NEM1 7 64519884-64563106 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003173 Approved Nucleoplasm NA NA Nucleoplasm "HPA003173: AB_1080744" "unprognostic (1.65e-1)" "unprognostic (3.21e-2)" "unprognostic (6.88e-2)" "unprognostic (7.41e-2)" "unprognostic (1.52e-3)" "unprognostic (3.62e-2)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (1.07e-2)" "unprognostic (1.20e-1)" "unprognostic (2.46e-1)" "unprognostic (5.72e-2)" "unprognostic (1.35e-1)" "unprognostic (8.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.26e-1)" "unprognostic (8.05e-3)" 6.4 15.8 18.7 4.2 24.4 2.6 15.4 37.0 23.7 7.7 4.4 7.1 3.3 3.4 5.9 7.0 4.4 6.2 6.2 12.1 20.0 10.8 9.8 21.6 5.7 6.9 23.4 14.6 13.1 5.8 4.0 10.0 5.3 19.9 12.0 6.2 3.9 5.4 6.8 11.6 6.6 3.9 7.1 25.9 7.3 7.0 4.7 24.4 5.4 28.5 6.6 6.0 6.8 5.2 4.3 1.7 4.2 1.3 8.3 4.4 1.7 3.7 2.2 8.8 10.6 4.4 5.0 5.6 3.1 2.5 5.6 7.0 3.0 7.3 7.1 7.6 2.9 6.3 2.6 7.2 3.3 9.1 1.3 5.1 5.4 4.3 2.7 1.9 7.1 4.9 3.3 4.0 4.9 5.5 7.0 5.2 10.1 9.7 0.0 7.6 2.9 11.0 11.5 10.4 3.3 2.7 8.7 9.0 21.4 7.7 12.2 7.2 9.7 9.2 8.7 3.2 17.4 8.8 3.1 2.8 6.8 3.4 3.2 5.2 6.3 8.1 20.2 0.3 6.6 5.9 4.2 1.0 1.1 3.0 1.3 2.5 4.3 4.1 3.5 1.7 3.4 4.4 4.0 0.5 8.3 1.1 1.4 1.2 1.7 18.7 24.4 37.0 23.7 20.0 10.8 23.4 14.6 19.9 24.4 11.9 3.2 9.9 9.2 3.8 11.2 11.6 20.4 2.7 12.5 24.4 3.9 10.0 8.3 7.5 0.8 8.7 2.2 0.0 8.0 8.8 9.1 11.1 6.9 17.4 4.4 1.6 0.0 26.4 12.4 1.3 25.6 5.6 6.8 8.2 4.3 22.8 5.2 3.5 20.8 5.6 9.0 19.4 6.9 11.1 15.1 4.5 5.9 10.2 4.5 8.1 ZNF687 KIAA1441 ENSG00000143373 "Zinc finger protein 687" Q8N1G0 1 151281618-151292180 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 13.1;neutrophil: 9.6" "Group enriched" "Detected in many" 6 "granulocytes: 13.1;monocytes: 4.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021193, HPA023948" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021193: AB_1859415, HPA023948: AB_2671380" "unprognostic (2.23e-1)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (9.64e-3)" "unprognostic (2.44e-2)" "unprognostic (7.82e-2)" "unprognostic (2.62e-2)" "unprognostic (1.56e-1)" "unprognostic (1.39e-1)" "unprognostic (9.91e-2)" "unprognostic (8.69e-3)" "unprognostic (2.10e-1)" "unprognostic (5.82e-3)" "unprognostic (1.36e-1)" "unprognostic (1.41e-1)" "unprognostic (8.54e-2)" "unprognostic (7.99e-2)" 9.8 13.6 9.9 10.7 11.4 36.1 10.6 16.1 21.0 13.6 17.3 17.1 10.9 11.7 13.5 12.9 12.9 13.2 12.8 10.0 9.2 9.7 13.0 14.4 10.2 14.8 9.4 10.7 16.6 21.4 23.0 16.4 13.5 10.6 13.3 8.1 17.6 16.2 13.3 12.5 14.1 15.2 11.4 9.6 17.9 12.5 22.5 9.8 19.6 14.0 8.3 15.4 13.9 9.9 1.3 0.9 13.1 4.1 0.5 0.9 1.0 9.4 14.3 13.2 8.0 7.4 6.3 18.3 5.3 8.4 8.9 8.9 11.2 12.4 8.1 13.1 7.7 9.6 14.7 11.5 9.8 4.0 12.0 12.6 7.7 11.5 12.7 8.2 8.7 11.3 9.9 10.0 7.4 7.9 7.9 5.9 9.1 12.0 14.4 4.9 28.1 12.2 10.5 17.9 12.2 10.8 10.9 10.8 14.7 7.4 13.9 12.3 19.6 13.2 15.6 12.7 12.9 20.6 19.0 5.7 7.1 8.3 9.2 7.6 18.0 15.1 19.8 9.1 5.9 9.0 0.4 1.8 13.1 0.6 2.2 0.7 1.1 0.6 0.6 0.9 1.3 0.8 0.9 9.6 0.5 4.1 0.8 0.4 1.0 9.9 11.4 16.1 21.0 9.2 9.7 9.4 10.7 10.6 9.8 3.0 5.8 1.9 3.0 4.1 6.4 1.2 7.6 1.4 1.2 1.8 9.8 5.7 3.3 5.1 1.6 2.5 5.9 0.0 5.1 4.2 4.1 3.5 0.0 4.0 4.5 7.9 2.4 4.3 3.8 2.1 5.8 4.3 0.0 5.4 6.5 6.1 6.4 2.9 6.7 3.3 10.6 12.9 2.2 8.6 8.6 3.0 7.9 3.3 7.5 4.1 ZNF69 Cos5 ENSG00000198429 "Zinc finger protein 69" Q9UC07 19 11887784-11914329 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 15.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 13.1" HPA047845 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.08e-1)" "unprognostic (4.58e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.55e-4)" "unprognostic (2.45e-2)" "unprognostic (1.21e-2)" "unprognostic (3.47e-2)" "unprognostic (1.37e-2)" "unprognostic (3.08e-3)" "unprognostic (3.97e-2)" "unprognostic (2.09e-1)" "unprognostic (4.83e-3)" "unprognostic (4.12e-2)" "unprognostic (2.54e-1)" "unprognostic (1.26e-1)" "unprognostic (7.97e-2)" "unprognostic (1.93e-2)" 3.8 7.7 4.3 10.6 4.9 3.5 14.3 6.7 5.4 7.9 10.9 3.5 5.4 3.4 6.3 4.6 2.9 8.3 7.8 7.1 6.1 3.6 14.0 11.8 7.1 7.1 4.5 1.6 11.1 11.0 22.7 4.9 4.5 7.1 7.4 11.6 5.7 5.9 4.1 2.5 2.1 5.2 12.1 6.3 4.2 12.7 11.1 4.8 9.4 6.3 1.9 3.0 7.8 13.8 1.0 2.4 11.0 2.3 3.3 4.8 2.0 5.0 0.2 13.1 7.3 1.4 0.1 4.5 7.6 5.3 4.2 5.2 3.4 2.0 3.2 4.5 4.4 3.2 0.1 0.0 2.9 4.3 0.0 0.1 1.5 0.1 7.5 1.1 0.0 3.1 2.1 0.0 1.5 0.1 2.1 0.1 4.6 0.0 0.2 8.7 0.0 3.9 0.6 8.1 0.4 0.0 0.1 3.0 0.1 9.6 3.4 1.2 3.6 0.0 0.2 1.9 6.7 6.7 2.0 0.3 3.4 2.2 3.4 4.2 3.5 3.2 0.0 0.1 0.0 10.6 11.0 2.1 1.5 2.6 2.3 2.5 1.0 1.8 1.1 2.4 0.7 4.7 4.8 0.8 3.3 1.2 1.7 1.2 2.0 4.3 4.9 6.7 5.4 6.1 3.6 4.5 1.6 7.1 4.8 3.0 7.5 0.0 1.3 0.2 0.7 2.4 15.3 5.3 6.8 5.2 0.0 3.1 3.3 4.5 6.8 1.8 2.0 0.0 3.1 2.8 1.3 1.0 7.0 9.6 2.5 0.0 0.0 3.7 2.7 12.7 2.3 3.6 5.0 0.0 5.6 0.5 8.4 3.5 1.8 8.6 0.2 12.9 1.0 2.7 1.5 0.1 1.6 2.9 5.9 2.6 ZNF697 MGC45731 ENSG00000143067 "Zinc finger protein 697" Q5TEC3 1 119619422-119647773 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-MEL-30: 24.8;WM-115: 25.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049933 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049933: AB_2680958" "unprognostic (2.57e-1)" "unprognostic (7.02e-3)" "unprognostic (4.32e-2)" "unprognostic (2.45e-2)" "unprognostic (3.38e-1)" "unprognostic (9.79e-3)" "unprognostic (1.20e-3)" "unprognostic (1.30e-3)" "unprognostic (2.82e-1)" "unprognostic (1.45e-1)" "unprognostic (5.09e-2)" "unprognostic (1.14e-1)" "prognostic favorable (6.20e-5)" "unprognostic (1.19e-2)" "unprognostic (6.48e-2)" "unprognostic (3.53e-2)" "unprognostic (3.36e-1)" 6.1 4.1 4.5 1.7 5.2 1.0 5.0 1.6 6.9 2.0 2.8 0.7 3.5 2.1 3.1 3.4 1.2 2.0 2.0 6.3 1.8 1.2 11.1 5.3 6.5 0.6 2.1 6.6 3.3 7.3 4.2 6.4 9.7 3.8 6.2 1.9 1.0 10.8 1.3 2.9 2.3 1.9 4.4 1.5 2.3 2.5 5.0 1.2 0.5 4.6 2.2 0.7 2.4 1.5 0.0 0.6 0.3 1.5 0.0 0.1 0.3 1.1 0.6 3.0 1.0 4.0 4.5 4.1 5.3 7.4 3.1 2.9 1.8 0.2 0.0 1.8 2.9 2.4 1.3 2.3 5.2 7.4 0.0 2.3 1.9 1.1 3.5 7.7 1.2 1.3 7.5 1.5 7.0 15.0 3.4 6.1 1.7 1.7 0.2 1.4 0.9 0.0 0.9 15.9 1.0 1.7 0.0 7.3 0.1 1.4 2.7 0.6 4.1 1.2 1.3 24.8 9.9 0.6 1.8 14.0 5.2 6.6 3.6 9.1 0.7 1.1 0.0 7.4 1.4 25.4 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 4.5 5.2 1.6 6.9 1.8 1.2 2.1 6.6 3.8 1.2 0.0 0.3 0.0 1.5 1.9 0.9 8.6 0.0 0.0 2.3 1.8 0.0 6.5 3.3 1.7 1.3 3.5 1.0 0.0 0.7 1.7 4.8 4.5 0.0 3.0 2.3 0.0 2.4 4.9 6.5 2.2 4.4 2.2 5.0 0.0 2.2 1.9 1.9 2.0 6.0 5.3 0.8 6.5 2.1 0.2 0.4 1.6 16.6 0.0 1.4 0.9 ZNF700 DKFZp434I1610 ENSG00000196757 "Zinc finger protein 700" Q9H0M5 19 11925068-11950773 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA047845 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.92e-1)" "unprognostic (1.20e-2)" "unprognostic (3.99e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.27e-4)" "unprognostic (8.63e-2)" "unprognostic (8.68e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (9.02e-2)" "unprognostic (7.44e-2)" "prognostic unfavorable (1.75e-4)" "prognostic unfavorable (2.01e-5)" "unprognostic (8.38e-2)" "unprognostic (2.24e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.53e-5)" 10.2 10.3 7.7 22.2 9.6 19.7 21.6 10.2 8.9 8.3 11.3 5.7 13.6 8.4 9.5 12.7 11.8 8.6 13.9 6.8 7.2 3.8 13.6 16.7 13.5 14.6 8.6 5.4 13.1 23.7 13.4 12.4 6.9 7.4 12.0 15.2 7.2 15.8 11.5 5.1 21.8 15.3 14.4 7.1 20.7 11.3 17.3 8.5 10.3 11.2 6.7 14.7 10.8 13.4 6.9 6.4 9.5 8.1 7.2 8.3 3.8 6.5 0.3 7.1 7.3 4.5 5.0 7.2 7.0 6.1 6.3 8.4 5.5 3.3 8.7 6.2 4.5 4.3 5.2 5.8 5.1 8.8 4.9 3.1 8.9 6.5 4.9 3.8 12.6 13.3 4.1 6.1 5.4 6.1 4.3 3.9 5.8 10.0 19.6 9.1 5.4 6.9 11.7 7.3 3.9 6.5 5.9 9.4 6.7 9.0 7.6 4.2 5.1 6.4 4.3 8.2 6.8 7.3 14.5 5.6 16.3 4.2 11.1 8.0 13.6 7.2 9.2 4.3 10.4 5.3 9.5 4.6 9.0 6.9 5.2 7.8 6.9 5.7 8.3 6.4 4.4 5.5 6.9 7.3 7.2 8.1 4.1 6.4 3.8 7.7 9.6 10.2 8.9 7.2 3.8 8.6 5.4 7.4 8.5 8.9 10.2 6.7 1.7 2.7 2.3 3.6 10.2 4.0 10.3 1.8 2.0 4.3 1.7 4.6 0.4 3.6 5.2 0.0 4.0 3.9 1.7 1.7 15.1 7.2 3.8 0.0 2.9 6.2 7.5 0.9 4.0 4.6 5.0 1.0 6.8 2.0 4.9 8.6 1.8 1.3 4.1 0.0 5.1 10.6 6.4 1.5 3.1 5.1 8.1 1.1 ZNF704 "FLJ16218, Gig1" ENSG00000164684 "Zinc finger protein 704" Q6ZNC4 8 80628451-80874781 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.6" "Lineage enriched" "Detected in single" 5 "monocytes: 1.6" "Cell line enhanced" "Detected in many" "HaCaT: 30.7;RH-30: 19.9;SH-SY5Y: 25.4;SK-BR-3: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024285, HPA024302" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA024285: AB_2219847, HPA024302: AB_1859427" "unprognostic (5.23e-2)" "unprognostic (1.39e-1)" "unprognostic (2.27e-1)" "unprognostic (3.39e-3)" "unprognostic (6.86e-2)" "unprognostic (1.05e-1)" "unprognostic (1.81e-1)" "unprognostic (1.34e-1)" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (7.02e-2)" "unprognostic (1.26e-1)" "prognostic favorable (4.02e-4)" "unprognostic (1.68e-2)" "unprognostic (1.62e-1)" "unprognostic (2.58e-1)" "unprognostic (9.90e-2)" 9.7 5.6 10.4 5.5 12.5 0.9 15.9 25.4 11.6 20.2 7.3 11.9 7.2 2.9 19.2 7.6 3.2 13.7 8.5 11.7 9.5 6.3 9.5 3.9 9.4 1.5 11.8 6.1 20.8 19.5 22.7 2.9 5.1 10.5 10.6 6.3 6.9 13.6 13.3 5.9 5.2 4.8 7.5 9.2 3.2 5.8 7.3 14.6 12.0 6.2 5.9 1.3 8.6 13.9 0.0 0.0 0.3 1.6 0.2 0.1 0.0 0.0 1.1 4.9 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.5 0.8 0.0 1.9 0.0 0.4 30.7 0.4 0.8 0.0 0.0 5.2 1.8 2.2 4.0 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.0 2.0 0.2 0.0 0.1 0.0 3.1 4.5 0.0 0.4 2.6 0.4 3.2 19.9 0.0 0.0 10.7 6.3 25.4 0.9 31.1 9.2 1.7 4.9 0.6 0.1 0.0 5.2 0.1 1.0 0.0 0.0 0.1 0.3 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 1.6 0.0 0.0 0.0 10.4 12.5 25.4 11.6 9.5 6.3 11.8 6.1 10.5 14.6 47.6 20.4 0.8 22.3 16.5 21.9 32.0 17.8 20.1 27.3 24.4 0.0 7.0 5.0 14.9 20.7 18.8 15.6 0.0 21.0 4.6 16.7 31.5 26.6 9.6 2.6 19.1 13.3 27.0 5.1 34.8 30.5 2.0 30.4 0.0 25.3 14.6 10.5 14.0 24.1 14.6 2.5 12.9 17.6 1.8 1.3 4.4 2.4 0.5 18.9 29.8 ZNF707 ENSG00000181135 "Zinc finger protein 707" Q96C28 8 143684452-143713898 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044991 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA044991: AB_10961134" "unprognostic (5.12e-2)" "unprognostic (5.65e-2)" "unprognostic (3.86e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (1.73e-1)" "unprognostic (5.91e-2)" "unprognostic (2.94e-2)" "unprognostic (1.65e-1)" "unprognostic (8.66e-2)" "unprognostic (1.11e-1)" "unprognostic (6.98e-2)" "unprognostic (5.07e-2)" "unprognostic (2.30e-2)" "unprognostic (1.14e-2)" "unprognostic (5.23e-1)" "unprognostic (2.47e-2)" "unprognostic (4.08e-2)" 5.4 5.4 6.6 6.2 7.5 5.7 6.0 6.6 8.0 5.5 5.1 7.0 10.4 6.2 6.1 7.1 6.3 6.2 5.8 3.9 6.6 3.4 6.1 5.5 7.7 9.4 10.3 5.1 5.7 8.3 9.2 7.9 4.7 5.5 7.0 3.6 6.5 7.5 6.7 3.8 13.0 8.0 6.7 6.5 13.2 5.8 11.0 7.3 7.7 8.8 5.0 7.8 6.9 5.8 1.1 1.4 1.7 1.0 4.2 2.4 1.0 3.8 3.9 4.2 5.2 4.1 3.6 5.8 4.0 3.3 5.0 3.0 2.9 5.4 3.7 5.1 2.1 2.3 4.3 4.4 4.6 3.1 5.6 2.0 7.5 9.7 4.4 3.5 2.3 4.2 4.0 5.8 6.3 4.8 4.2 3.7 4.2 4.2 2.7 1.5 7.7 5.5 3.0 0.1 4.4 9.7 4.9 2.9 3.7 3.1 4.1 3.8 4.7 8.6 5.9 3.6 3.4 7.1 4.7 6.8 3.2 10.0 3.9 4.9 4.4 2.7 1.3 4.6 4.5 2.9 1.0 1.0 1.5 2.4 0.7 1.7 1.1 1.3 2.1 0.7 1.0 1.3 1.9 1.7 4.2 0.7 1.4 1.7 1.0 6.6 7.5 6.6 8.0 6.6 3.4 10.3 5.1 5.5 7.3 0.0 1.0 0.8 2.3 2.5 2.8 1.6 0.0 1.4 2.3 3.5 0.0 1.8 3.3 1.7 14.3 0.8 1.8 0.0 1.2 2.0 1.3 1.9 1.1 0.5 1.7 1.6 0.0 3.7 2.1 4.5 1.1 2.5 0.0 5.4 1.8 0.9 1.7 2.8 2.1 1.0 3.3 6.5 1.4 2.9 2.5 2.8 2.2 5.0 1.4 1.8 ZNF709 FLJ38281 ENSG00000242852 "Zinc finger protein 709" Q8N972 19 12461184-12513854 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 26.6" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 31.1;Late spermatids: 26.0;Spermatocytes: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045573, HPA053153" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045573: AB_2679370, HPA053153: AB_2682060" "unprognostic (2.27e-1)" "unprognostic (7.40e-4)" "unprognostic (3.53e-2)" "unprognostic (3.01e-2)" "unprognostic (1.11e-1)" "unprognostic (1.24e-2)" "unprognostic (4.19e-3)" "unprognostic (2.58e-4)" "unprognostic (6.76e-2)" "unprognostic (1.22e-2)" "unprognostic (1.39e-3)" "unprognostic (1.93e-1)" "unprognostic (5.66e-3)" "unprognostic (1.71e-1)" "unprognostic (3.19e-2)" "unprognostic (2.13e-1)" "unprognostic (8.53e-5)" 3.4 3.0 7.8 4.8 8.4 2.0 5.1 12.7 7.3 5.0 2.7 3.2 5.6 0.7 5.5 5.3 2.4 6.6 2.4 3.6 6.2 5.4 5.4 2.0 3.0 2.7 3.8 4.6 8.4 4.1 6.2 8.0 3.5 4.9 5.7 2.1 3.3 3.4 4.5 2.5 2.8 2.7 5.1 5.5 4.0 2.6 26.6 5.0 7.2 8.5 0.0 4.0 4.1 4.5 2.0 1.3 3.5 1.1 5.5 4.4 1.0 1.9 0.0 6.3 7.7 1.2 1.8 1.0 1.9 2.2 2.1 2.3 1.7 0.2 1.8 1.3 2.0 0.6 1.3 3.4 1.3 2.4 0.3 0.9 1.6 1.1 1.2 2.5 0.4 2.7 1.0 0.6 1.2 0.0 3.0 1.4 2.4 1.0 0.2 2.7 3.5 4.0 2.2 2.1 0.7 2.0 2.2 6.1 5.7 2.2 3.0 2.9 4.0 0.0 0.3 0.8 2.9 1.5 1.0 0.0 3.3 0.7 1.4 1.3 3.4 4.8 2.6 0.0 0.0 1.5 3.5 0.4 0.1 2.0 0.1 3.1 1.7 3.3 2.1 0.9 2.0 4.4 3.1 0.1 5.5 1.1 1.3 1.8 1.0 7.8 8.4 12.7 7.3 6.2 5.4 3.8 4.6 4.9 5.0 0.0 0.3 0.0 0.1 0.3 0.5 0.3 0.0 0.0 1.2 1.8 0.0 0.4 0.0 0.4 31.1 0.1 0.0 0.0 0.3 0.2 0.4 0.4 0.0 0.0 0.4 0.0 0.0 1.3 1.0 26.0 0.9 0.2 0.0 0.0 0.6 1.5 0.2 0.0 0.7 0.7 2.1 6.5 0.3 7.2 1.7 0.5 0.2 0.0 0.0 0.1 ZNF711 "CMPX1, dJ75N13.1, MRX97, Zfp711, ZNF4, ZNF5, ZNF6" ENSG00000147180 "Zinc finger protein 711" Q9Y462 X 85244032-85273362 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 38.6" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 17.7;Spermatogonia: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.6;naive B-cell: 3.6" "Group enriched" "Detected in many" 7 "B-cells: 3.6;T-cells: 1.3" "Cell line enhanced" "Detected in many" "AF22: 16.8;AN3-CA: 13.1;HAP1: 24.2;HEK 293: 22.3;Karpas-707: 14.9;RH-30: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030654 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA030654: AB_10670561" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (8.07e-2)" "unprognostic (5.51e-3)" "unprognostic (1.75e-2)" "unprognostic (9.11e-3)" "unprognostic (7.40e-3)" "unprognostic (1.37e-2)" "unprognostic (2.96e-1)" "unprognostic (2.50e-3)" "unprognostic (3.25e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (5.72e-2)" "unprognostic (6.62e-3)" 1.4 13.6 11.6 2.1 11.9 5.8 5.4 10.8 19.2 5.9 2.4 4.4 0.0 3.0 8.9 2.9 2.1 4.7 4.0 3.8 11.1 8.3 5.1 0.7 1.9 2.2 6.5 8.1 9.3 4.3 1.5 16.0 7.1 12.6 4.1 1.9 3.3 4.0 2.8 1.6 11.2 4.2 3.4 9.8 4.5 2.8 38.6 9.5 14.4 4.2 1.6 2.5 3.0 2.5 3.6 0.2 0.0 0.0 0.3 1.3 0.3 0.0 1.5 16.8 13.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 3.5 1.4 0.0 0.6 0.2 2.7 0.3 24.2 0.0 0.0 0.0 22.3 7.7 0.4 0.9 0.6 0.0 0.2 1.6 0.2 0.0 3.1 0.0 0.1 7.5 2.3 14.9 2.9 0.8 13.0 0.0 8.2 1.4 0.3 0.0 20.4 0.0 0.0 1.2 4.9 12.7 0.0 0.4 0.0 10.3 2.2 2.1 0.0 0.0 5.5 0.0 0.0 5.6 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.1 0.4 0.1 3.6 1.3 0.8 0.0 0.3 0.0 0.2 0.0 0.3 11.6 11.9 10.8 15.1 11.1 8.3 6.5 8.1 12.6 9.5 3.0 0.6 1.5 6.8 10.6 8.7 2.4 2.5 1.4 2.3 1.8 0.0 0.3 5.0 1.6 2.0 2.3 0.5 0.0 0.4 0.2 5.2 2.5 0.0 0.0 0.3 3.2 17.7 3.7 1.2 4.0 2.8 0.7 5.0 0.0 1.0 10.0 0.7 1.7 3.5 1.9 1.3 0.0 6.2 5.2 25.4 8.0 0.2 0.0 1.1 2.5 ZNF727 ZNF727P ENSG00000214652 "Zinc finger protein 727" A8MUV8 7 64045443-64078549 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 13.7" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 1.9;Distal tubular cells: 3.3;Early spermatids: 1.8;Horizontal cells: 1.6;Late spermatids: 1.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "T-47d: 13.1" "HPA051027, HPA061215" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051027: , HPA061215: AB_2684452" "unprognostic (5.87e-2)" "unprognostic (3.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.75e-3)" "unprognostic (1.36e-2)" "unprognostic (1.80e-1)" "unprognostic (3.86e-2)" "unprognostic (1.56e-1)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (2.54e-1)" "unprognostic (4.04e-2)" "unprognostic (5.73e-4)" "unprognostic (8.70e-2)" "unprognostic (6.36e-2)" "unprognostic (8.61e-2)" 2.6 1.6 2.7 0.9 10.6 0.3 5.4 3.9 7.4 5.2 1.7 5.8 0.0 0.6 5.9 3.1 2.0 4.7 1.6 2.2 4.7 3.1 0.5 1.9 1.2 5.3 2.5 9.1 2.0 1.1 13.7 0.3 7.2 4.9 2.0 3.1 2.2 3.3 1.2 2.0 1.0 3.7 4.2 1.6 2.0 5.5 6.1 0.0 8.7 0.0 0.9 2.6 3.9 1.1 0.4 0.0 0.4 0.4 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.0 13.1 0.0 0.0 0.0 1.6 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.4 1.1 1.0 0.7 0.0 0.4 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 ZNF736 ENSG00000234444 "Zinc finger protein 736" B4DX44 7 64307459-64354860 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 36.3;Late spermatids: 47.2;Rod photoreceptor cells: 44.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051027, HPA061215" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051027: , HPA061215: AB_2684452" "unprognostic (2.41e-1)" "unprognostic (2.71e-2)" "unprognostic (1.17e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (4.14e-1)" "unprognostic (1.24e-1)" "unprognostic (1.20e-3)" "unprognostic (4.89e-2)" "unprognostic (2.51e-2)" "unprognostic (2.11e-2)" "unprognostic (2.01e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (2.26e-1)" "unprognostic (9.63e-2)" "unprognostic (5.28e-2)" "unprognostic (2.22e-3)" "prognostic favorable (8.65e-4)" 7.1 5.4 8.5 8.2 17.4 17.0 12.9 8.3 19.8 7.7 5.5 7.8 4.7 3.9 8.4 9.8 5.4 7.7 6.3 5.3 7.5 6.0 8.2 3.7 7.4 14.0 5.5 8.2 13.1 7.5 6.2 7.6 5.4 13.8 8.6 6.1 11.5 7.7 5.7 4.2 13.1 8.5 6.3 5.8 10.1 6.2 16.8 7.0 17.1 10.6 2.0 11.4 6.1 7.4 4.7 3.5 2.8 2.1 0.3 2.4 1.0 0.5 0.2 4.6 15.9 1.7 3.1 4.7 2.5 0.1 3.3 5.4 1.2 2.6 11.9 3.8 2.1 4.5 2.0 3.5 1.0 5.3 0.2 3.3 4.8 1.4 0.1 1.7 2.1 6.9 2.5 1.0 3.8 0.1 1.6 0.4 7.0 5.7 2.6 4.6 3.0 7.2 11.3 8.9 0.1 0.9 6.2 7.2 5.8 4.1 7.0 5.0 7.3 5.7 4.1 1.5 9.1 11.3 8.8 0.3 5.2 3.7 1.3 3.0 3.1 4.3 14.5 0.1 2.6 0.1 0.0 1.9 2.8 1.5 1.8 1.1 4.7 2.3 1.3 2.1 4.5 2.4 1.9 0.4 0.3 2.1 3.5 1.0 1.0 8.5 17.4 8.3 19.8 7.5 6.0 5.5 8.2 13.8 7.0 6.0 4.8 7.7 2.1 3.4 14.4 2.8 10.2 1.4 4.5 5.2 11.8 3.0 5.0 3.3 36.3 4.3 1.3 0.0 1.9 2.6 3.1 2.5 0.0 2.9 3.1 7.9 1.2 6.2 5.3 47.2 2.3 6.4 3.3 1.8 4.7 6.8 1.9 2.9 2.8 3.4 44.8 0.0 2.0 6.3 6.5 3.4 2.3 4.4 2.8 1.7 ZNF740 Zfp740 ENSG00000139651 "Zinc finger protein 740" Q8NDX6 12 53180700-53195141 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035691 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035691: AB_10669777" "unprognostic (2.31e-1)" "unprognostic (3.40e-1)" "unprognostic (1.61e-1)" "unprognostic (2.12e-3)" "unprognostic (2.86e-2)" "unprognostic (3.20e-2)" "unprognostic (4.19e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (4.88e-2)" "unprognostic (2.36e-3)" "unprognostic (7.92e-2)" "unprognostic (8.89e-3)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (1.72e-1)" "unprognostic (2.30e-2)" 12.5 13.9 12.5 13.6 14.9 6.5 14.0 23.8 17.6 13.8 13.1 13.8 18.1 11.1 17.2 15.7 13.2 16.3 11.1 8.0 17.2 10.1 12.9 11.4 11.6 18.1 16.5 11.8 18.3 16.3 21.2 13.2 11.5 13.0 14.2 12.2 11.8 13.8 16.0 10.1 13.6 14.7 12.6 10.5 18.1 12.4 7.1 13.8 19.0 15.9 7.4 20.1 11.9 16.9 1.7 1.6 2.9 0.8 4.6 2.0 0.7 4.7 6.4 11.4 7.3 11.5 8.6 4.3 5.0 9.4 8.1 7.1 5.4 7.6 11.0 7.6 5.7 3.9 7.8 8.2 5.9 8.3 8.3 8.9 12.2 8.5 4.8 8.4 11.1 7.7 10.8 11.8 6.4 9.7 13.5 6.5 11.6 8.0 22.3 4.2 5.5 8.7 6.0 5.6 4.5 7.8 8.9 8.8 17.8 4.6 6.7 8.8 9.8 8.5 7.2 8.4 5.6 10.3 11.5 5.9 4.3 5.9 4.8 3.6 10.9 4.7 6.0 6.6 6.3 5.3 2.9 0.8 1.4 1.6 0.4 1.1 1.6 1.4 2.0 0.7 1.7 1.9 1.9 0.2 4.6 0.4 1.6 1.7 0.7 12.5 14.9 23.8 17.6 17.2 10.1 16.5 11.8 13.0 13.8 3.0 12.4 4.2 1.9 5.5 7.6 5.1 5.1 5.3 2.3 1.8 5.9 2.7 1.7 3.4 1.0 5.2 4.0 0.0 3.9 1.5 4.6 3.3 7.0 3.9 2.9 4.8 8.1 4.3 6.1 0.9 5.8 2.9 1.7 2.8 5.7 5.8 4.6 7.0 5.6 3.7 6.6 19.4 9.0 1.7 3.1 4.0 2.1 2.5 6.0 2.6 ZNF763 ZNF440L ENSG00000197054 "Zinc finger protein 763" Q0D2J5 19 11965037-11980381 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 9.7" HPA047845 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (4.09e-3)" "unprognostic (6.15e-4)" "unprognostic (1.28e-1)" "unprognostic (1.54e-2)" "unprognostic (6.15e-2)" "unprognostic (1.43e-4)" "unprognostic (1.43e-1)" "unprognostic (8.26e-3)" "unprognostic (9.36e-3)" "unprognostic (1.93e-2)" "unprognostic (1.17e-3)" "unprognostic (1.43e-1)" "unprognostic (6.07e-6)" "unprognostic (1.47e-1)" "unprognostic (3.08e-1)" "unprognostic (1.11e-1)" "unprognostic (8.89e-3)" 7.0 5.2 3.6 4.1 6.6 3.0 9.1 5.5 5.4 7.3 9.0 5.6 6.8 4.8 8.3 5.4 5.1 6.0 4.5 9.7 4.0 3.3 11.1 3.6 7.1 6.3 5.5 3.5 12.6 7.6 12.4 7.5 8.6 5.6 9.5 5.7 9.2 6.5 10.3 4.9 4.7 7.1 6.2 4.6 9.4 5.5 7.1 7.1 8.0 14.3 3.9 6.5 7.3 7.6 8.0 3.2 11.1 4.8 4.9 4.2 2.1 0.4 0.0 2.9 3.1 1.8 0.8 9.7 2.6 2.4 2.2 2.2 1.0 0.6 3.0 2.5 2.0 0.7 0.8 0.0 1.5 1.0 0.4 0.1 1.2 0.1 0.1 0.4 1.6 3.3 4.2 2.0 0.5 0.3 0.7 0.4 4.6 0.4 1.3 2.2 0.3 3.4 0.8 1.3 0.3 0.3 0.2 0.1 1.0 4.4 2.7 0.5 1.2 0.2 0.1 0.6 5.6 5.6 1.8 0.4 3.0 0.1 2.5 0.7 4.5 5.7 0.9 0.7 0.6 0.4 11.1 1.9 5.7 3.1 2.5 2.3 3.4 2.8 4.2 3.2 8.0 3.5 3.8 10.5 4.9 4.8 2.5 1.5 2.1 3.6 6.6 5.5 5.4 4.0 3.3 5.5 3.5 5.6 7.1 3.0 4.5 0.0 0.4 0.1 2.8 0.6 0.0 2.7 4.5 0.0 9.8 4.3 1.7 0.6 3.7 0.0 0.8 0.0 0.3 1.6 0.5 0.5 1.1 0.8 1.1 0.0 1.2 0.0 1.0 0.0 1.4 0.0 0.0 1.0 2.2 2.9 0.3 0.0 1.8 1.3 6.1 0.0 0.3 2.8 1.4 0.0 1.5 0.0 0.9 0.1 ZNF777 KIAA1285 ENSG00000196453 "Zinc finger protein 777" Q9ULD5 7 149431363-149461123 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "placenta: 65.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003252 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003252: AB_1080755" "unprognostic (7.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (3.37e-2)" "unprognostic (4.78e-2)" "unprognostic (6.64e-2)" "unprognostic (5.87e-3)" "unprognostic (4.52e-2)" "unprognostic (1.10e-1)" "unprognostic (6.15e-2)" "unprognostic (5.17e-3)" "unprognostic (2.64e-1)" "unprognostic (4.00e-2)" "unprognostic (6.33e-2)" "unprognostic (1.68e-1)" "unprognostic (8.23e-2)" "unprognostic (5.72e-2)" 5.0 4.3 5.5 4.1 8.8 6.9 4.9 7.1 9.3 5.2 5.2 5.4 3.5 4.5 7.3 3.5 4.1 6.5 3.5 4.7 5.3 5.1 3.8 4.4 4.4 4.7 4.3 5.3 9.1 6.6 6.6 5.9 65.7 6.6 5.8 3.3 5.0 7.3 5.8 10.6 7.3 4.4 5.4 6.2 6.0 4.9 4.2 3.5 3.5 5.2 4.8 3.9 6.2 5.0 0.4 0.2 0.6 0.3 0.1 1.5 0.1 10.2 12.7 8.6 12.4 6.4 5.2 11.0 6.6 7.0 9.0 7.8 7.9 6.6 6.5 13.4 7.5 5.6 6.8 8.3 10.1 5.0 10.5 12.7 6.4 3.6 7.8 10.9 9.0 9.3 6.1 11.6 7.3 10.7 4.8 4.8 8.9 20.5 0.0 5.1 13.2 18.9 12.3 10.4 4.6 7.5 15.7 4.4 13.6 5.6 8.0 9.3 13.1 11.4 11.8 11.0 3.3 5.5 15.1 7.5 7.6 3.0 14.9 10.8 6.2 5.4 3.0 5.7 6.2 9.7 0.0 0.3 0.0 0.5 0.3 0.1 0.3 0.4 0.4 0.0 0.4 0.1 1.5 0.6 0.1 0.1 0.2 0.0 0.1 5.5 8.8 7.1 9.3 5.3 5.1 4.3 5.3 6.6 3.5 0.0 1.7 1.5 1.4 1.0 6.9 2.3 2.5 1.4 0.0 1.8 5.9 1.8 0.0 0.7 2.1 1.6 1.5 0.0 0.9 2.8 1.1 2.0 0.0 5.0 1.3 1.6 1.7 2.5 2.8 2.5 2.6 1.1 0.0 0.0 3.1 4.9 1.0 2.9 3.2 1.4 5.4 0.0 1.4 0.6 4.7 1.6 3.2 2.2 2.6 0.9 ZNF781 FLJ37549 ENSG00000196381 "Zinc finger protein 781" Q8N8C0 19 37667751-37692322 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 57.2;Late spermatids: 45.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "B-cells: 1.0;T-cells: 3.2" "Cell line enhanced" "Detected in many" "AN3-CA: 4.7;ASC diff: 4.7;HSkMC: 4.6;SH-SY5Y: 4.6;U-266/84: 5.4" HPA062512 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA062512: AB_2684788" "unprognostic (3.01e-1)" "unprognostic (8.26e-2)" "unprognostic (3.03e-1)" "unprognostic (2.86e-2)" "unprognostic (1.90e-2)" "unprognostic (5.82e-2)" "unprognostic (1.76e-3)" "unprognostic (2.68e-2)" "unprognostic (1.58e-1)" "unprognostic (1.86e-1)" "unprognostic (1.84e-3)" "unprognostic (1.67e-1)" "unprognostic (1.23e-2)" "unprognostic (2.11e-2)" "unprognostic (8.12e-2)" "unprognostic (2.66e-2)" "unprognostic (1.04e-1)" 4.9 5.3 5.7 4.6 12.9 0.5 2.9 15.8 13.6 4.3 4.5 3.8 1.9 1.6 7.3 4.8 2.2 4.8 3.1 6.5 5.8 5.8 2.6 1.3 3.7 3.5 6.1 6.8 9.8 1.3 4.8 7.4 5.0 7.6 4.5 3.1 3.8 1.5 5.2 1.5 2.0 2.4 8.5 9.6 5.0 2.2 4.8 5.5 0.6 5.3 1.3 2.5 4.7 5.4 1.0 0.1 0.1 0.2 0.0 3.2 0.7 0.0 0.0 1.9 4.7 4.7 1.0 1.0 1.7 0.0 1.7 1.2 0.2 0.0 0.2 0.0 1.1 3.0 0.0 0.1 0.0 2.0 0.0 0.1 0.1 0.0 2.0 2.3 0.0 0.1 4.6 0.0 1.3 0.1 0.6 0.4 0.2 0.9 0.0 0.0 0.0 1.2 1.0 0.5 0.0 0.0 0.0 3.3 0.0 0.7 1.2 0.0 4.6 0.0 0.0 0.0 2.4 2.2 0.1 0.0 0.2 0.0 0.0 1.1 1.5 5.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 1.1 0.4 1.8 2.5 0.1 1.0 2.6 3.2 0.1 0.0 0.0 0.1 0.8 0.7 5.7 12.9 15.8 13.6 5.8 5.8 6.1 6.8 7.6 5.5 0.0 1.1 1.3 0.5 0.5 6.1 12.9 2.5 0.0 0.0 0.0 19.6 5.8 0.0 0.8 57.2 4.5 0.0 0.0 0.0 3.4 1.6 0.1 3.5 0.0 3.0 3.2 7.5 11.6 1.5 45.4 4.4 0.0 1.7 0.0 0.0 5.5 0.1 0.0 6.3 0.2 7.8 12.9 6.6 14.8 3.2 0.0 1.1 1.3 0.0 0.0 ZNF784 MGC75238 ENSG00000179922 "Zinc finger protein 784" Q8NCA9 19 55620742-55624601 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 39.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059676 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059676: AB_2684102" "unprognostic (4.67e-2)" "unprognostic (8.13e-2)" "unprognostic (4.03e-1)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-1)" "unprognostic (9.44e-2)" "unprognostic (4.74e-1)" "unprognostic (1.26e-1)" "unprognostic (9.11e-3)" "unprognostic (4.86e-2)" "unprognostic (3.48e-3)" "unprognostic (3.87e-1)" "unprognostic (7.93e-2)" "unprognostic (5.10e-2)" "prognostic favorable (1.02e-4)" 5.9 5.6 2.9 7.4 3.2 5.7 4.9 5.2 5.0 7.5 9.3 3.3 4.1 8.6 7.9 8.0 4.9 6.7 7.0 9.1 2.8 2.3 5.8 7.3 10.4 3.5 2.7 3.2 9.7 15.0 6.0 5.5 4.9 3.9 7.9 3.8 5.8 5.9 5.8 39.1 4.9 11.2 10.4 2.6 6.5 5.8 3.6 2.6 3.2 7.3 16.1 6.1 6.7 4.5 1.4 1.6 2.9 2.0 1.4 1.3 0.6 4.5 6.4 6.1 3.2 2.3 3.2 5.7 4.8 3.0 2.8 3.7 3.3 5.1 5.5 4.2 3.4 2.1 2.5 1.7 4.2 2.0 3.0 17.1 5.2 5.0 4.0 4.7 4.2 5.5 4.3 4.6 2.3 3.0 4.4 1.8 7.9 6.0 5.7 4.2 4.4 3.2 4.8 5.9 3.5 14.2 6.1 4.1 6.1 5.0 11.7 6.8 9.1 7.9 3.7 2.1 4.2 4.0 7.5 5.5 3.2 3.0 1.9 3.9 6.6 2.7 3.2 4.9 3.2 2.7 0.0 2.0 2.9 0.8 1.8 0.6 1.0 0.8 0.8 1.6 1.4 0.8 1.3 1.1 1.4 1.5 1.2 0.1 0.6 2.9 3.2 5.2 5.0 2.8 2.3 2.7 3.2 3.9 2.6 0.0 9.0 3.2 3.6 0.8 5.4 11.3 5.1 2.7 2.3 0.0 2.0 4.3 3.3 3.2 1.9 2.0 9.3 0.0 3.6 2.3 1.0 2.0 2.3 5.4 3.0 7.9 5.2 1.8 1.9 0.0 3.7 1.3 0.0 4.6 5.1 4.1 4.0 7.0 2.5 4.3 9.5 12.9 2.0 0.7 1.9 1.1 8.5 2.1 5.2 3.4 ZNF789 ENSG00000198556 "Zinc finger protein 789" Q5FWF6 7 99472841-99503650 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029500, HPA050793" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029500: AB_10603009, HPA050793: AB_2681240" "unprognostic (6.84e-3)" "unprognostic (5.75e-2)" "unprognostic (5.71e-2)" "unprognostic (2.49e-2)" "unprognostic (3.08e-1)" "unprognostic (2.90e-2)" "unprognostic (1.25e-3)" "unprognostic (4.38e-3)" "unprognostic (5.16e-2)" "unprognostic (1.56e-1)" "prognostic favorable (7.14e-4)" "unprognostic (1.58e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (6.63e-2)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" "prognostic favorable (5.31e-6)" 6.1 5.5 11.0 15.9 10.0 11.6 9.2 31.9 14.4 6.1 9.2 9.2 11.0 15.1 10.9 12.8 5.0 7.8 6.6 4.0 10.0 8.5 9.0 8.1 6.5 10.5 6.8 9.8 8.9 7.8 6.3 13.3 4.6 7.6 16.4 12.5 14.8 10.3 13.8 8.9 13.3 12.6 8.5 8.6 11.2 8.4 17.6 8.1 8.4 9.3 4.8 10.1 4.1 5.6 3.9 14.2 2.0 1.6 4.1 7.0 2.1 11.2 3.8 6.2 11.2 1.8 2.1 8.6 5.8 2.2 3.5 7.7 6.4 7.7 8.6 4.9 2.6 4.1 5.7 3.5 3.3 4.9 3.9 6.0 6.5 10.6 10.8 3.1 4.4 14.9 2.3 3.0 7.5 3.3 2.3 3.7 11.1 9.7 8.4 3.2 10.7 5.3 11.9 6.3 5.3 6.0 7.0 5.9 9.0 4.6 3.5 6.2 6.8 4.1 11.2 6.5 3.7 3.0 7.0 6.9 6.7 8.2 10.0 5.6 5.1 7.0 10.8 10.6 8.0 7.2 2.0 1.6 1.5 2.7 1.1 2.9 2.7 3.4 2.9 5.6 3.9 7.0 4.2 0.4 4.1 1.4 14.2 5.3 2.1 11.0 10.0 31.9 14.4 10.0 8.5 6.8 9.8 7.6 8.1 0.0 4.6 4.2 3.8 4.8 17.5 1.7 2.5 6.7 4.5 1.8 13.7 4.0 1.7 3.6 21.1 5.6 4.7 23.3 4.8 3.0 3.4 2.5 3.5 2.9 5.6 6.4 5.2 0.6 4.4 6.4 3.1 6.6 6.8 2.8 5.1 10.9 3.5 4.5 4.2 3.4 13.5 0.0 4.2 10.6 3.8 4.5 1.8 4.8 5.6 3.0 ZNF791 FLJ90396 ENSG00000173875 "Zinc finger protein 791" Q3KP31 19 12610918-12633840 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021537 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA021537: AB_2670741" "unprognostic (1.95e-1)" "unprognostic (4.88e-3)" "unprognostic (1.73e-2)" "unprognostic (7.58e-2)" "unprognostic (2.30e-2)" "unprognostic (1.04e-3)" "unprognostic (6.86e-2)" "prognostic favorable (9.07e-4)" "unprognostic (1.88e-2)" "unprognostic (1.59e-2)" "unprognostic (3.38e-2)" "unprognostic (1.73e-2)" "unprognostic (2.57e-2)" "unprognostic (2.77e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-2)" "prognostic favorable (1.39e-5)" 16.7 12.0 11.9 18.0 15.4 22.5 18.6 30.3 17.1 20.0 15.0 12.7 14.1 10.9 16.6 16.3 14.0 15.4 10.1 13.0 11.5 10.9 13.4 11.9 17.0 15.8 14.7 12.5 21.5 15.3 20.2 32.1 13.4 15.5 16.6 13.4 11.8 15.5 18.2 15.9 17.1 15.3 17.9 16.0 16.6 13.8 7.0 13.8 14.4 25.4 8.9 19.6 23.7 18.1 11.6 10.5 9.7 3.8 10.9 8.3 2.6 6.9 3.9 7.5 7.4 9.3 12.0 6.5 9.0 9.9 6.7 8.2 4.8 4.2 1.6 8.7 9.3 4.0 6.6 7.3 8.5 11.2 4.7 7.6 6.9 9.5 6.7 7.6 8.9 7.7 10.3 9.8 8.0 13.0 10.5 7.0 4.5 7.9 11.2 8.3 11.1 5.5 3.4 8.6 3.9 11.7 4.0 12.3 5.7 6.7 13.4 8.3 10.0 8.0 6.5 8.5 9.3 6.5 7.7 8.7 13.5 5.7 11.7 7.2 16.8 20.0 4.9 9.2 7.0 7.9 9.7 3.3 5.2 7.0 2.1 7.2 7.4 6.3 8.0 3.0 11.6 7.4 8.3 5.6 10.9 3.8 10.5 5.4 2.6 11.9 15.4 30.3 17.1 11.5 10.9 14.7 12.5 15.5 13.8 11.9 23.3 34.0 30.3 26.0 68.5 16.8 25.5 29.4 23.9 17.4 92.3 25.1 16.6 20.7 4.3 43.4 26.2 0.0 15.2 15.5 23.7 31.2 9.2 26.0 12.2 33.4 35.6 47.3 15.5 1.8 36.2 24.5 13.5 9.0 24.2 38.4 21.5 11.5 36.7 9.2 75.6 38.8 33.9 11.2 13.7 24.2 32.7 38.4 20.6 29.8 ZNF805 ENSG00000204524 "Zinc finger protein 805" Q5CZA5 19 57240685-57255135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046330, HPA058895" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046330: , HPA058895: AB_2683846" "unprognostic (2.18e-1)" "unprognostic (1.10e-1)" "unprognostic (8.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.22e-1)" "unprognostic (2.62e-3)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.20e-1)" "unprognostic (1.95e-1)" "unprognostic (1.58e-2)" "unprognostic (3.51e-1)" "unprognostic (3.68e-2)" "unprognostic (7.16e-3)" "unprognostic (1.64e-1)" 8.4 8.8 3.6 5.5 7.2 18.5 9.6 4.8 9.4 6.6 6.1 8.3 5.8 3.9 9.1 6.4 6.6 6.0 5.9 6.3 3.4 3.5 5.4 6.2 6.8 5.1 6.4 5.2 10.2 7.2 9.8 9.0 7.5 5.8 6.2 5.7 6.8 7.9 5.8 9.0 7.7 6.3 7.2 5.2 7.2 6.1 8.6 5.9 9.2 6.7 2.4 7.4 7.1 11.6 3.9 2.1 5.3 1.8 5.6 4.9 2.4 2.4 3.7 3.6 4.8 6.6 4.9 4.5 2.3 5.4 4.0 7.9 3.1 2.2 4.6 1.8 5.6 2.5 1.5 4.0 3.9 7.1 2.4 10.0 4.7 3.0 3.0 5.9 4.2 4.7 6.1 4.9 5.2 9.0 3.6 3.7 5.0 1.7 6.2 2.8 1.7 5.1 1.5 3.0 2.1 4.2 2.5 7.7 4.0 2.6 7.8 3.8 3.8 6.2 3.5 3.6 5.1 2.4 4.2 4.1 5.7 3.9 2.6 2.7 6.2 4.3 4.5 3.6 2.3 3.1 0.0 1.8 5.3 3.8 0.5 4.9 3.9 3.3 4.8 2.1 1.7 3.3 3.1 2.0 5.6 0.9 1.5 3.6 2.4 3.6 7.2 4.8 9.4 3.4 3.5 6.4 5.2 5.8 5.9 3.0 0.3 0.0 1.8 1.4 5.4 1.6 0.0 1.4 0.0 1.8 7.9 0.9 1.7 1.2 1.8 2.1 0.4 0.0 1.0 1.4 1.0 1.9 4.6 0.0 0.8 3.2 1.2 1.3 0.6 0.0 1.1 0.7 0.0 0.0 1.2 1.9 1.2 0.0 0.7 0.5 5.4 0.0 2.7 4.7 2.8 1.0 1.9 0.7 0.6 2.3 ZNF814 ENSG00000204514 "Zinc finger protein 814" B7Z6K7 19 57848731-57889074 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 21.5;U-266/84: 19.8" "HPA043800, HPA053762, HPA072145" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (3.74e-2)" "unprognostic (1.24e-1)" "unprognostic (4.53e-2)" "unprognostic (3.29e-2)" "unprognostic (6.01e-2)" "unprognostic (2.12e-2)" "unprognostic (1.03e-1)" "unprognostic (4.69e-2)" "unprognostic (6.78e-4)" "unprognostic (5.05e-3)" "unprognostic (2.41e-4)" "unprognostic (1.56e-2)" "unprognostic (4.99e-4)" "unprognostic (3.94e-1)" "unprognostic (2.33e-1)" "unprognostic (1.08e-1)" "unprognostic (1.54e-5)" 5.6 13.3 11.6 9.0 11.0 12.6 12.2 19.2 10.8 6.4 10.0 4.4 15.7 9.7 5.6 10.5 5.2 12.5 9.8 9.5 11.5 10.3 15.0 11.7 5.9 11.1 9.1 8.4 7.8 6.7 10.9 16.2 9.7 7.7 11.4 7.3 16.1 9.0 18.4 18.6 13.3 12.7 9.0 7.3 13.8 5.5 14.0 5.6 18.7 23.0 4.0 11.5 6.6 5.0 21.2 15.3 5.0 5.0 12.8 13.6 4.5 0.9 2.4 7.3 10.8 0.8 0.7 1.8 2.7 1.8 3.0 0.4 1.3 1.0 5.5 1.8 2.5 2.9 0.8 0.5 5.9 3.8 0.8 4.9 4.1 3.3 1.3 3.3 4.7 5.1 4.9 5.2 1.2 1.1 4.8 0.9 1.9 1.0 2.0 4.6 0.9 15.4 2.1 21.5 0.5 3.1 1.7 0.8 9.7 2.4 3.9 2.8 7.8 0.9 1.8 3.7 16.4 5.3 1.4 1.3 6.8 2.3 1.5 1.2 6.4 19.8 13.9 1.4 2.5 8.1 2.2 4.5 5.0 3.2 5.0 8.2 19.4 8.4 6.9 6.6 21.2 13.6 11.0 2.7 12.8 2.9 15.3 2.1 4.5 11.6 11.0 19.2 10.8 11.5 10.3 9.1 8.4 7.7 5.6 0.0 1.0 19.5 6.3 6.1 21.1 12.0 15.3 10.7 10.3 12.2 45.2 11.4 14.9 6.7 32.9 7.0 5.4 0.0 1.2 16.8 7.2 7.8 16.1 12.3 10.7 19.1 4.7 15.4 3.4 16.6 3.7 9.3 10.1 6.4 3.8 7.5 1.1 21.5 6.7 37.9 32.5 19.4 4.2 8.4 11.7 11.4 9.7 8.7 13.9 10.7 ZNF816-ZNF321P ZNF816-ZNF321 ENSG00000221874 "ZNF816-ZNF321P readthrough" 19 52928475-52962823 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 8.1;Syncytiotrophoblasts: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "RT4: 14.2" HPA051271 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051271: AB_2681415" "unprognostic (4.18e-2)" 2.4 1.7 1.7 3.4 3.6 2.1 4.3 1.7 2.6 4.6 4.7 1.5 5.8 0.7 2.8 4.5 3.6 4.7 4.4 2.2 1.8 1.2 4.2 1.5 3.2 1.7 4.7 0.9 4.2 2.7 2.1 5.4 4.5 2.4 8.5 7.5 1.5 3.0 4.4 1.2 2.4 3.0 3.4 4.0 5.0 4.9 2.0 3.9 9.3 4.6 2.2 2.7 6.3 4.2 0.9 0.0 0.0 0.1 1.6 0.7 0.0 0.5 0.0 1.3 0.4 0.7 0.2 0.7 0.0 0.4 0.8 1.0 0.0 0.4 1.3 0.4 0.5 1.3 0.1 1.2 0.2 0.0 0.8 1.5 0.5 0.2 1.6 1.1 0.0 0.3 0.8 0.0 1.4 0.0 0.4 0.7 0.0 1.3 0.0 0.3 0.2 0.0 0.0 0.2 0.0 1.1 0.4 0.1 0.1 0.5 14.2 0.7 0.2 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.5 0.8 2.2 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.7 0.3 0.0 1.6 0.0 0.0 0.0 0.0 1.7 3.6 1.7 2.6 1.8 1.2 4.7 0.9 2.4 3.9 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 8.1 3.3 3.2 1.6 0.4 3.1 0.0 3.1 5.3 0.6 2.3 4.6 0.4 3.3 0.0 0.0 1.3 1.8 0.9 0.3 0.0 0.0 3.6 3.0 0.0 2.8 3.4 0.7 0.6 0.0 0.0 0.3 0.4 1.8 0.0 9.4 1.0 3.3 4.7 ZNF827 ENSG00000151612 "Zinc finger protein 827" Q17R98 4 145757627-145938635 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 12.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 23.5;WM-115: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021166 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA021166: AB_2670608" "unprognostic (2.75e-2)" "unprognostic (3.46e-3)" "unprognostic (2.79e-1)" "unprognostic (3.64e-1)" "unprognostic (3.90e-2)" "unprognostic (2.40e-2)" "unprognostic (3.77e-1)" "unprognostic (3.57e-1)" "unprognostic (1.57e-1)" "unprognostic (3.90e-2)" "unprognostic (7.64e-2)" "unprognostic (3.47e-1)" "unprognostic (1.64e-3)" "unprognostic (9.46e-2)" "unprognostic (7.85e-2)" "unprognostic (4.03e-2)" "unprognostic (1.88e-2)" 3.8 9.5 8.2 9.6 15.6 3.9 6.5 37.3 12.3 6.0 7.1 8.1 7.7 8.1 10.7 6.5 3.8 8.3 6.3 7.0 5.9 5.8 6.3 1.1 4.7 6.4 5.8 8.2 11.0 4.3 14.9 28.3 2.2 7.4 26.3 6.4 4.3 28.1 9.3 24.9 3.4 10.0 11.4 13.0 5.5 6.3 4.5 9.5 14.0 10.9 3.3 7.7 10.2 5.0 1.9 2.6 5.4 0.0 12.3 3.4 1.2 2.7 4.4 8.0 5.2 3.5 3.9 0.0 4.6 4.4 3.6 2.8 2.2 7.2 0.7 1.6 8.4 3.2 1.7 4.6 3.5 3.8 5.6 2.2 2.2 4.3 2.5 3.7 1.6 0.0 5.3 3.2 2.8 7.9 7.8 6.4 1.2 0.4 4.4 3.0 0.0 2.4 0.1 3.9 0.0 5.8 7.2 4.2 1.4 3.8 4.1 7.3 6.7 4.0 6.9 10.4 4.4 3.1 0.1 23.5 9.6 7.8 0.6 5.3 3.1 0.2 3.0 3.1 9.0 36.4 5.4 0.0 0.0 3.3 0.0 0.9 1.5 1.2 3.1 0.0 1.9 2.1 3.4 0.0 12.3 0.0 2.6 0.1 1.2 8.2 15.6 37.3 12.3 5.9 5.8 5.8 8.2 7.4 9.5 11.9 13.7 4.2 7.6 5.7 12.7 18.9 2.5 10.7 11.4 22.7 9.8 2.1 3.3 8.9 11.8 4.3 10.3 0.0 6.3 0.4 6.6 19.8 2.3 1.3 1.1 17.5 24.8 7.4 1.2 5.8 8.3 1.0 1.7 1.0 19.5 4.8 10.4 3.5 15.9 9.8 1.1 6.5 4.7 1.6 1.7 4.3 1.1 6.4 18.6 9.5 ZNF83 "FLJ11015, HPF1, ZNF816B" ENSG00000167766 "Zinc finger protein 83" P51522 19 52594060-52690496 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA025970 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA025970: AB_1859463" "unprognostic (6.38e-2)" "unprognostic (1.55e-1)" "unprognostic (1.73e-2)" "unprognostic (1.78e-1)" "unprognostic (1.18e-1)" "prognostic favorable (3.83e-4)" "unprognostic (3.38e-3)" "unprognostic (3.67e-1)" "prognostic unfavorable (9.20e-4)" "prognostic favorable (9.06e-4)" "unprognostic (6.08e-2)" "unprognostic (3.85e-3)" "prognostic unfavorable (3.13e-5)" "unprognostic (2.81e-2)" "unprognostic (1.14e-1)" "unprognostic (3.33e-1)" "prognostic favorable (6.92e-6)" 13.1 19.0 14.5 16.2 66.8 14.6 22.3 42.6 20.2 21.6 16.4 11.7 41.4 8.4 23.3 54.0 11.4 27.2 16.0 11.1 17.2 11.5 26.0 4.0 12.9 18.5 25.7 12.5 34.5 11.8 22.3 29.4 44.2 21.9 25.5 14.0 11.0 11.8 32.6 5.8 16.2 12.3 21.0 20.4 19.0 14.7 9.8 24.4 16.9 24.3 8.1 15.9 15.9 34.3 9.9 4.3 8.5 4.9 12.8 9.3 3.7 8.7 0.4 12.5 9.0 11.3 22.9 7.0 13.6 9.4 8.2 11.2 3.4 7.6 9.1 7.1 9.2 6.1 3.9 7.5 9.0 11.5 1.3 8.7 7.7 7.8 4.3 9.3 5.4 10.8 18.4 11.4 6.9 34.4 29.1 9.2 10.3 8.4 7.5 13.5 5.9 7.6 9.4 3.5 1.5 8.6 7.7 10.7 6.1 21.0 17.6 7.3 5.9 8.7 8.6 3.4 21.1 9.1 5.7 12.5 8.3 5.1 4.2 13.9 0.8 8.0 12.6 0.4 5.8 6.6 4.4 3.6 8.5 7.6 3.9 7.8 6.9 8.9 9.3 4.3 9.9 7.6 8.7 3.3 12.8 4.9 2.9 4.3 3.7 14.5 66.8 42.6 20.2 17.2 11.5 25.7 12.5 21.9 24.4 32.8 21.2 4.2 45.7 9.2 27.1 12.9 7.6 28.1 33.0 38.4 33.4 40.1 16.6 16.3 20.0 24.8 7.0 0.0 6.1 16.9 23.5 72.4 34.8 1.3 11.8 46.1 10.4 16.0 4.9 11.1 39.4 15.8 28.7 9.0 14.0 14.3 8.5 17.5 32.5 17.0 38.2 6.5 16.6 13.0 14.7 8.4 53.5 19.2 6.5 63.1 ZNF830 "CCDC16, MGC20398, OMCG1" ENSG00000198783 "Zinc finger protein 830" Q96NB3 17 34961530-34963775 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024754, HPA027211" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA024754: AB_1859464, HPA027211: AB_1859465" "unprognostic (2.87e-1)" "unprognostic (3.86e-2)" "unprognostic (2.47e-1)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "unprognostic (8.70e-2)" "unprognostic (2.37e-2)" "unprognostic (6.39e-2)" "unprognostic (6.39e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.01e-4)" "unprognostic (2.01e-2)" "unprognostic (5.63e-2)" "unprognostic (1.55e-1)" "unprognostic (8.22e-2)" "unprognostic (8.63e-2)" 11.7 11.5 14.2 13.8 17.6 15.4 13.6 26.9 20.0 15.1 13.9 14.0 9.7 13.4 16.1 11.4 14.1 14.8 12.6 9.2 13.1 10.5 12.9 15.7 10.8 19.6 20.5 11.3 21.4 20.2 11.2 12.5 16.9 18.7 13.4 10.3 10.7 12.7 11.4 11.2 13.0 16.6 17.9 11.9 24.1 13.7 15.0 16.3 20.6 17.5 9.6 17.9 12.9 12.0 10.1 9.8 26.7 8.3 10.1 19.3 8.1 5.7 11.2 10.1 9.4 10.9 8.4 7.0 7.0 7.1 9.2 9.2 8.4 7.8 10.4 6.5 6.8 9.6 13.5 10.8 6.4 10.4 6.2 14.7 12.2 11.0 10.4 11.1 18.2 17.5 8.2 15.0 7.7 15.1 9.3 8.3 12.9 17.5 15.4 8.3 4.3 16.5 20.5 6.7 7.7 5.5 11.2 13.8 13.7 8.5 7.8 12.1 10.3 6.8 4.3 10.9 10.3 9.9 20.0 8.6 9.8 7.1 7.1 12.1 17.1 13.0 14.0 8.4 9.8 8.7 14.6 8.3 26.7 11.9 8.2 11.7 9.2 12.6 12.8 9.1 10.1 19.3 15.2 8.1 10.1 5.7 9.8 11.1 8.1 14.2 17.6 26.9 20.0 13.1 10.5 20.5 11.3 18.7 16.3 35.7 24.2 16.6 37.9 21.3 19.4 6.7 20.4 14.7 35.2 12.2 13.7 20.5 29.9 16.2 3.2 16.9 20.3 0.0 11.5 14.6 19.2 21.3 16.2 9.6 12.7 9.5 17.7 13.5 9.4 2.0 24.7 16.0 20.3 11.8 15.4 19.3 12.1 24.6 25.8 16.5 28.7 25.8 20.2 40.6 45.4 21.1 22.3 29.4 17.6 32.7 ZNF84 HPF2 ENSG00000198040 "Zinc finger protein 84" P51523 12 133037292-133063304 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA028860 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028860: AB_10604102" "unprognostic (2.39e-1)" "unprognostic (5.11e-3)" "unprognostic (3.09e-2)" "unprognostic (8.66e-2)" "unprognostic (8.16e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (5.96e-3)" "unprognostic (9.73e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-2)" "unprognostic (3.24e-3)" "unprognostic (8.61e-3)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" "unprognostic (3.48e-2)" "unprognostic (7.30e-3)" 9.7 9.6 19.6 10.0 22.2 8.1 18.6 26.1 21.6 16.3 11.3 16.9 11.8 7.8 20.1 25.3 7.8 17.7 12.1 10.0 17.9 15.9 12.1 11.0 11.5 13.3 25.2 17.9 23.6 11.7 18.3 31.5 12.4 20.6 16.3 13.6 9.8 10.4 15.1 8.8 13.3 10.1 19.6 21.0 12.7 10.6 12.2 23.2 12.4 20.0 11.1 14.8 13.8 10.8 9.6 7.4 4.3 4.9 9.1 12.5 4.9 8.7 7.1 21.6 12.9 8.6 14.4 16.5 8.2 7.6 6.7 6.1 4.3 2.6 10.7 7.8 7.5 8.0 4.2 8.2 6.6 9.6 3.0 13.3 16.1 8.6 6.3 10.5 17.8 7.1 10.1 8.9 9.3 10.4 22.6 10.0 8.2 7.9 5.0 16.4 5.5 11.9 17.3 25.3 3.4 6.6 16.4 10.0 7.2 9.3 19.4 17.3 19.0 16.3 4.6 6.7 12.8 15.9 11.7 13.2 7.4 7.6 6.6 5.8 2.8 0.0 23.8 4.5 13.9 8.2 1.4 3.8 4.3 8.4 4.9 12.3 9.6 9.2 10.7 5.8 8.4 12.5 10.2 0.8 9.1 3.4 7.4 4.9 4.9 19.6 22.2 26.1 21.6 17.9 15.9 25.2 17.9 20.6 23.2 8.9 11.1 9.4 11.6 2.7 18.2 22.9 7.6 28.1 12.5 15.7 5.9 8.4 3.3 10.9 11.7 15.3 3.3 0.0 6.2 5.0 9.7 9.1 12.8 6.7 9.0 19.1 9.2 13.5 7.3 10.4 12.4 7.1 1.7 2.8 9.1 15.2 9.0 8.2 14.2 9.2 16.6 12.9 7.8 9.0 21.6 2.4 5.4 6.9 6.9 8.0 ZNF85 "HPF4, HTF1" ENSG00000105750 "Zinc finger protein 85" Q03923 19 20923222-20950697 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 69.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA044760 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA044760: AB_10960412" "unprognostic (1.26e-2)" "unprognostic (1.92e-1)" "unprognostic (4.69e-2)" "prognostic unfavorable (5.20e-5)" "unprognostic (1.98e-2)" "unprognostic (4.27e-2)" "unprognostic (2.01e-2)" "unprognostic (1.31e-1)" "unprognostic (2.01e-4)" "prognostic favorable (6.45e-6)" "unprognostic (2.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.75e-2)" "unprognostic (2.05e-1)" "unprognostic (2.24e-1)" "unprognostic (3.90e-3)" "unprognostic (6.01e-2)" 5.2 8.4 4.3 7.0 7.0 7.7 8.4 24.7 7.1 5.3 3.4 3.3 7.8 1.0 5.5 3.4 4.8 4.3 3.4 4.9 4.3 3.6 4.9 1.9 3.4 7.8 3.9 5.4 8.9 13.1 6.3 3.5 6.5 5.2 4.7 4.6 3.4 5.1 6.8 1.7 5.4 4.0 4.9 6.3 6.9 7.8 22.8 5.0 15.4 11.7 4.4 8.7 4.7 4.5 8.5 3.2 4.4 3.9 7.6 4.6 2.3 0.8 0.4 9.7 8.3 3.8 3.4 7.6 7.1 2.5 9.6 9.9 0.0 4.3 8.7 8.2 1.7 3.9 0.8 0.1 5.4 10.6 0.3 4.4 2.4 0.9 0.6 0.7 0.1 1.8 1.5 1.8 4.6 6.5 1.7 2.9 9.4 0.1 3.6 5.5 2.9 13.6 5.4 7.2 0.0 8.0 7.6 14.8 4.1 3.4 8.2 6.3 4.8 0.1 0.3 1.3 9.1 4.2 7.1 2.0 4.6 1.3 12.3 7.6 4.6 11.1 9.7 0.2 0.1 3.9 0.8 1.2 4.4 3.4 3.9 2.8 8.5 3.8 2.6 2.7 6.8 4.6 3.8 4.0 7.6 2.5 3.2 4.3 2.3 4.3 7.0 24.7 7.1 4.3 3.6 3.9 5.4 5.2 5.0 3.0 1.7 9.5 2.8 0.7 4.5 3.1 0.0 4.0 2.3 5.2 0.0 7.6 1.7 5.2 69.1 6.9 0.1 0.0 5.4 11.6 3.1 2.0 11.5 0.0 7.1 3.2 0.0 3.7 0.6 10.5 2.8 5.9 5.0 7.2 2.4 3.2 4.1 2.3 3.5 1.7 1.9 19.4 1.4 16.9 13.6 1.3 6.3 5.2 1.5 1.8 ZNF850 ZNF850P ENSG00000267041 "Zinc finger protein 850" A8MQ14 19 36714383-36772825 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 17.9" "Cell type enhanced" "Detected in many" 5 "Ito cells: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 14.7" HPA029299 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029299: AB_2672987" "unprognostic (1.35e-2)" "unprognostic (5.54e-2)" "unprognostic (3.85e-2)" "unprognostic (1.38e-3)" "unprognostic (7.78e-2)" "unprognostic (6.63e-2)" "unprognostic (1.65e-3)" "unprognostic (1.68e-1)" "unprognostic (1.21e-2)" "unprognostic (1.25e-1)" "unprognostic (3.00e-2)" "unprognostic (5.56e-2)" "unprognostic (4.11e-3)" "unprognostic (1.77e-1)" "unprognostic (7.49e-2)" "unprognostic (4.49e-2)" "unprognostic (7.37e-3)" 4.0 3.4 2.6 3.0 4.2 11.5 3.3 8.7 3.1 5.1 2.4 3.4 1.6 1.9 5.6 2.6 2.8 2.9 3.2 4.6 2.5 1.7 2.0 2.8 3.0 4.0 5.9 0.7 5.9 4.1 3.2 6.4 17.9 3.2 3.4 2.9 3.0 2.3 2.2 1.9 3.2 2.9 2.3 3.5 3.6 2.7 6.7 3.8 7.0 2.6 1.0 2.9 5.0 4.4 6.8 3.5 6.0 3.8 3.8 6.0 5.1 0.3 1.7 3.7 5.8 0.8 0.3 7.2 2.4 1.3 1.4 2.1 1.3 0.4 1.2 5.1 0.4 7.8 0.8 2.6 0.5 2.7 0.6 2.1 14.7 0.2 1.1 1.0 1.8 8.4 1.1 0.1 2.4 0.0 0.5 1.4 1.8 3.8 0.8 3.7 0.8 2.6 1.8 10.8 0.6 1.0 1.6 7.3 0.9 0.6 7.4 2.5 4.0 3.8 0.2 0.6 5.4 1.5 3.3 3.0 3.7 5.8 2.1 3.6 1.5 2.6 3.2 0.0 0.8 5.7 4.2 3.4 2.4 3.9 3.6 5.0 6.8 4.8 3.2 3.2 5.4 5.7 6.0 6.0 3.8 3.8 3.5 3.2 5.1 2.6 4.2 8.7 3.1 2.5 1.7 5.9 0.7 3.2 3.8 0.0 0.0 0.9 1.1 1.9 1.1 2.4 2.5 0.0 0.0 3.5 0.0 3.0 0.0 1.1 6.1 2.1 0.0 0.0 0.6 3.8 2.6 0.5 0.0 1.8 1.1 4.8 0.0 8.6 2.7 3.6 1.1 1.1 3.3 0.0 2.9 1.3 0.5 0.0 0.4 0.4 0.0 0.0 1.4 2.6 2.5 3.0 2.4 0.9 0.6 0.9 ZNF879 DKFZp686E2433 ENSG00000234284 "Zinc finger protein 879" B4DU55 5 179023752-179035064 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 11.8;Spermatocytes: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.4;BEWO: 12.4" "Low region specificity" "Detected in all" HPA068608 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA068608: AB_2686010" "unprognostic (3.20e-2)" "unprognostic (5.24e-3)" "unprognostic (7.33e-2)" "unprognostic (1.49e-3)" "unprognostic (1.59e-1)" "unprognostic (1.61e-3)" "unprognostic (5.83e-2)" "unprognostic (8.80e-3)" "unprognostic (3.19e-3)" "unprognostic (6.04e-2)" "unprognostic (5.69e-4)" "unprognostic (1.07e-1)" "unprognostic (4.61e-2)" "unprognostic (2.10e-1)" "unprognostic (3.79e-1)" "unprognostic (4.72e-2)" "unprognostic (5.17e-3)" 5.9 4.0 5.5 5.3 7.2 1.9 6.6 13.5 8.0 6.1 5.8 6.3 4.9 2.9 7.3 5.5 5.0 6.2 4.0 6.3 7.4 4.7 5.9 3.6 4.7 7.2 7.0 5.7 10.2 4.9 8.4 7.6 6.7 6.1 7.7 3.0 4.4 5.2 8.1 7.9 8.2 5.2 5.6 6.9 7.1 4.6 14.5 10.7 12.1 9.1 2.5 7.9 6.2 5.0 5.4 4.4 13.1 4.9 6.0 9.1 3.7 0.0 4.1 3.7 11.4 3.6 2.8 12.4 2.0 3.0 5.0 6.2 3.8 2.1 3.0 2.9 1.9 5.7 1.7 0.0 2.3 4.0 0.0 0.3 0.0 2.6 0.7 5.9 0.0 5.8 2.7 2.2 2.8 1.4 2.3 1.7 3.0 0.6 0.0 4.0 2.0 3.4 1.2 4.2 1.5 1.0 3.1 1.3 0.4 3.7 3.3 1.6 3.8 3.9 0.6 5.3 5.9 5.6 3.4 1.6 2.3 4.3 2.6 0.5 0.0 0.0 4.7 0.0 0.0 3.0 13.1 4.9 4.7 6.3 4.1 6.5 5.2 5.8 5.3 4.4 5.4 9.1 7.1 0.1 6.0 3.9 2.8 6.7 3.7 5.5 7.2 13.5 8.0 7.4 4.7 7.0 5.7 6.1 10.7 6.0 0.6 0.0 1.3 0.5 8.0 1.6 2.5 1.4 0.0 5.2 11.8 2.9 5.0 1.5 2.2 2.2 0.8 0.0 0.7 1.5 1.3 1.4 2.3 0.9 1.9 9.5 1.2 1.8 2.6 2.0 1.4 1.5 0.0 0.0 0.1 4.5 0.8 0.0 2.1 1.1 5.3 6.5 1.2 11.3 8.5 1.0 3.5 1.3 0.6 1.0 ZNF92 "HPF12, TF12" ENSG00000146757 "Zinc finger protein 92" Q03936 7 65373799-65401135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 34.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003173 Approved Nucleoplasm NA NA Nucleoplasm "HPA003173: AB_1080744" "unprognostic (1.07e-1)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "unprognostic (2.13e-1)" "unprognostic (8.53e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (6.56e-4)" "unprognostic (5.48e-3)" "unprognostic (1.30e-2)" "unprognostic (3.86e-2)" "unprognostic (5.83e-2)" "unprognostic (1.40e-2)" "unprognostic (1.24e-1)" "unprognostic (9.65e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.50e-3)" 6.7 9.3 9.6 13.7 13.0 20.8 16.3 24.4 11.9 8.3 6.2 5.0 6.1 6.1 5.7 7.2 11.2 5.4 6.3 4.6 9.6 8.9 7.9 5.6 5.7 14.8 12.1 8.6 8.8 6.9 7.7 13.4 5.7 12.6 6.6 7.0 2.5 6.9 6.6 4.7 4.9 10.1 3.9 18.5 14.8 7.6 7.6 15.7 26.0 9.4 5.1 14.0 8.3 5.7 10.7 2.3 5.6 2.7 9.4 6.0 2.2 4.5 3.1 13.7 13.5 3.5 4.2 6.5 3.8 2.8 4.2 6.1 5.7 6.8 17.7 7.4 2.1 6.3 4.5 10.6 2.6 6.9 6.6 7.1 7.9 1.7 5.6 1.2 9.5 7.6 3.6 2.3 3.8 2.9 5.7 5.1 9.4 10.3 7.3 6.0 1.3 14.0 10.8 18.5 4.8 4.2 12.8 8.0 6.0 4.6 9.2 11.7 8.9 5.8 9.1 4.3 13.9 6.5 13.0 3.7 4.9 4.4 2.9 5.4 4.6 4.1 25.7 3.2 7.7 4.3 5.6 1.6 4.0 2.7 2.1 5.7 10.7 4.2 4.1 2.3 9.2 5.1 5.2 1.3 9.4 2.7 2.2 6.0 2.2 9.6 13.0 24.4 11.9 9.6 8.9 12.1 8.6 12.6 15.7 8.9 0.6 34.0 6.2 4.9 7.6 3.4 5.1 1.4 7.9 5.2 0.0 5.3 10.0 6.3 1.0 5.8 2.6 0.0 4.2 4.4 5.1 6.3 11.5 2.1 3.7 4.8 6.9 6.2 5.4 1.7 6.6 6.8 5.0 9.0 7.2 7.7 6.3 7.0 6.0 3.5 4.8 0.0 5.7 19.6 24.5 3.3 4.1 7.9 4.7 7.0 ZNHIT1 "CG1I, H_DJ0747G18.14, ZNFN4A1" ENSG00000106400 "Zinc finger HIT-type containing 1" O43257 7 101217668-101224190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 796.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019043 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA019043: AB_1859481" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.52e-3)" "unprognostic (1.24e-1)" "unprognostic (4.26e-2)" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (3.72e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-2)" "unprognostic (1.05e-2)" "unprognostic (2.02e-2)" "unprognostic (2.10e-3)" "unprognostic (1.98e-1)" "unprognostic (2.01e-1)" "unprognostic (3.36e-1)" "unprognostic (7.24e-3)" 24.6 21.0 29.4 18.7 26.9 18.3 23.6 11.7 20.8 21.1 24.5 16.6 29.4 24.5 15.0 29.4 21.1 23.2 29.8 26.9 24.7 19.4 27.7 77.2 14.1 18.5 27.9 17.2 13.2 34.7 17.2 17.3 19.9 18.7 17.4 16.2 12.0 29.3 29.9 32.7 16.2 23.4 15.0 28.0 18.4 22.7 13.1 17.6 21.0 27.3 24.0 14.1 14.7 20.9 27.9 42.8 45.5 47.1 22.4 39.7 45.9 14.1 14.6 9.6 18.4 17.8 23.0 9.4 17.5 17.3 17.2 17.1 14.5 16.5 10.1 23.4 19.1 14.9 12.0 8.7 24.3 7.4 10.5 33.7 5.5 12.8 17.3 22.7 11.2 11.9 21.5 29.5 15.2 7.4 14.6 25.1 15.2 17.4 16.8 14.6 42.1 18.4 60.9 18.4 22.9 36.8 9.8 7.5 31.1 23.0 6.7 11.9 26.9 13.2 23.9 28.9 11.3 6.2 13.8 19.1 16.2 14.2 27.9 12.4 13.6 17.2 12.2 15.6 19.8 21.6 42.0 47.1 45.5 27.4 42.5 28.9 27.4 30.5 27.5 40.6 27.9 24.7 26.5 39.1 22.4 40.8 42.8 39.7 45.9 29.4 26.9 11.7 20.8 24.7 19.4 27.9 17.2 18.7 17.6 86.4 76.3 87.8 100.5 89.4 29.5 69.6 216.6 103.1 83.0 181.5 15.7 165.9 306.7 174.5 18.7 143.6 325.7 93.5 222.5 162.7 150.6 101.7 77.3 796.2 180.7 11.1 231.8 154.1 203.1 46.0 125.1 115.6 123.2 212.8 211.4 63.3 222.4 336.6 117.4 541.3 29.9 148.8 103.2 50.5 36.9 101.9 136.7 113.6 219.4 110.3 ZPLD1 ENSG00000170044 "Zona pellucida like domain containing 1" Q8TCW7 3 102099244-102479841 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.0;gallbladder: 6.7;kidney: 2.6" "Cell type enhanced" "Detected in some" 18 "Cholangiocytes: 7.6;Ductal cells: 2.6;Late spermatids: 3.6;Muller glia cells: 11.4;Pancreatic endocrine cells: 3.1" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 8 "non-classical monocyte: 3.0" "Lineage enriched" "Detected in single" 11 "monocytes: 3.0" "Cell line enriched" "Detected in some" 8 "RPTEC TERT1: 12.4" "Region enriched" "Detected in single" 7 "olfactory region: 3.4" "Low region specificity" "Detected in all" HPA077519 Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA077519: AB_2732349" "unprognostic (2.49e-1)" "unprognostic (2.83e-3)" "unprognostic (6.38e-3)" "unprognostic (1.88e-1)" "unprognostic (5.02e-2)" "unprognostic (1.37e-2)" "unprognostic (2.68e-1)" "unprognostic (2.63e-1)" "unprognostic (4.63e-1)" "unprognostic (2.89e-4)" "unprognostic (4.59e-2)" "unprognostic (1.05e-3)" "unprognostic (1.97e-2)" "unprognostic (9.65e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 2.5 1.0 0.0 0.0 0.2 6.7 0.3 0.0 0.6 2.6 0.3 0.0 0.0 0.3 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 1.3 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 12.4 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 11.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 ZRANB2 "ZIS, ZIS1, ZIS2, ZNF265" ENSG00000132485 "Zinc finger RANBP2-type containing 2" O95218 1 71063291-71081297 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053960, HPA061949, HPA063298" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979" "unprognostic (2.10e-1)" "unprognostic (7.54e-2)" "unprognostic (4.15e-3)" "unprognostic (8.11e-2)" "unprognostic (1.04e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (7.29e-5)" "unprognostic (4.25e-3)" "unprognostic (1.24e-2)" "unprognostic (7.79e-2)" "unprognostic (4.54e-2)" "prognostic unfavorable (5.70e-4)" "prognostic unfavorable (1.57e-8)" "unprognostic (3.96e-2)" "unprognostic (8.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.84e-3)" 26.4 27.4 39.8 31.1 42.2 35.1 34.4 54.1 48.6 39.3 28.8 19.6 33.3 23.4 48.3 45.6 20.2 30.6 20.3 27.5 33.5 30.6 20.1 19.5 26.7 37.8 34.1 40.5 39.5 23.9 23.1 77.5 24.6 32.0 30.5 29.3 17.5 25.1 33.2 54.4 27.9 24.9 35.1 42.2 26.2 23.6 31.6 38.0 40.0 32.8 24.3 30.9 32.8 25.6 31.4 34.0 32.1 16.3 20.9 30.8 13.8 23.7 8.6 35.6 20.5 13.9 24.0 20.3 29.1 16.0 25.6 32.7 16.1 15.4 49.3 25.8 17.9 24.1 15.0 30.1 18.1 38.4 34.8 21.7 42.8 33.8 13.4 20.7 46.6 17.5 18.2 22.7 24.9 21.5 29.0 21.5 25.5 44.7 26.4 19.5 8.1 38.1 15.1 36.3 14.2 16.9 43.4 26.6 28.9 16.5 20.3 26.5 16.8 24.8 16.7 24.8 19.4 20.5 20.5 28.8 18.9 18.1 14.8 28.7 21.8 27.0 54.2 27.9 43.5 26.5 32.1 16.3 14.2 22.2 15.0 25.1 30.6 23.6 21.3 12.4 31.4 30.8 24.2 14.6 20.9 14.8 34.0 22.0 13.8 39.8 42.2 54.1 48.6 33.5 30.6 34.1 40.5 32.0 38.0 92.3 128.7 70.6 66.5 45.0 171.8 89.9 58.6 91.0 72.8 47.1 121.7 45.9 41.4 45.1 111.6 51.1 53.4 23.3 58.7 46.6 56.3 44.1 84.4 36.4 38.8 201.8 70.2 51.0 27.2 20.7 171.7 52.0 45.5 50.5 41.0 144.1 55.6 45.6 108.5 30.6 205.0 116.4 59.5 149.3 96.0 40.7 53.1 60.9 36.0 49.3 ZRANB3 DKFZP434B1727 ENSG00000121988 "Zinc finger RANBP2-type containing 3" Q5FWF4 2 135136916-135531236 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035234 Supported Nucleoplasm NA NA Nucleoplasm "HPA035234: AB_2674530" "unprognostic (6.98e-2)" "unprognostic (2.04e-1)" "unprognostic (1.01e-1)" "unprognostic (2.52e-3)" "unprognostic (4.09e-1)" "unprognostic (1.33e-1)" "unprognostic (1.09e-1)" "unprognostic (1.06e-1)" "unprognostic (3.53e-3)" "unprognostic (1.74e-1)" "unprognostic (3.58e-2)" "unprognostic (4.68e-2)" "unprognostic (2.77e-4)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (2.00e-2)" "unprognostic (9.88e-2)" 3.5 6.3 5.5 4.9 7.0 5.2 5.4 7.7 7.9 5.4 3.3 4.1 3.9 2.6 5.4 6.0 3.3 5.4 3.9 4.0 4.7 5.2 4.4 6.3 2.9 4.3 6.0 5.4 7.2 6.1 7.3 15.6 4.3 5.7 5.4 4.7 5.6 3.1 4.0 7.6 3.0 3.0 7.2 4.9 4.0 3.1 12.6 6.6 10.7 6.7 3.0 4.8 4.2 3.6 3.0 1.9 1.4 0.8 1.7 3.5 0.9 3.4 3.2 5.3 4.0 2.9 5.8 5.0 4.3 3.9 4.3 4.7 6.3 3.1 7.4 5.9 3.9 2.2 3.7 8.5 4.4 6.2 10.5 4.7 8.3 2.1 12.1 2.8 7.3 2.9 5.0 4.7 4.0 11.4 5.0 5.1 5.5 9.7 3.2 3.8 4.9 7.0 4.9 3.2 3.1 4.9 6.8 4.3 3.0 6.2 1.9 6.5 8.5 4.2 1.7 3.4 5.1 4.2 3.1 3.3 3.5 2.8 2.0 4.0 2.4 4.6 8.4 4.3 5.3 3.9 0.6 0.8 1.4 1.6 0.8 3.5 3.0 1.5 1.3 1.9 1.5 1.4 1.5 0.9 1.7 0.3 0.8 0.4 0.9 5.5 7.0 7.7 7.9 4.7 5.2 6.0 5.4 5.7 6.6 3.0 1.0 4.9 3.9 1.1 5.0 2.8 2.5 1.4 4.5 0.0 7.9 4.7 0.0 1.7 9.7 0.9 0.1 0.0 0.8 6.9 4.5 1.8 0.0 6.4 2.3 4.8 1.7 2.5 0.3 2.1 2.8 1.3 0.0 3.6 1.3 3.4 1.8 1.4 2.1 2.9 7.5 0.0 2.4 11.8 9.6 1.9 3.2 1.7 2.6 2.8 ZSCAN16 "dJ265C24.3, FLJ22191, ZNF392, ZNF435" ENSG00000196812 "Zinc finger and SCAN domain containing 16" Q9H4T2 6 28124560-28130082 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007290 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA007290: AB_1080721" "unprognostic (1.50e-1)" "prognostic favorable (5.73e-4)" "unprognostic (3.29e-2)" "unprognostic (8.93e-2)" "unprognostic (3.05e-3)" "unprognostic (1.00e-2)" "unprognostic (3.07e-2)" "prognostic favorable (3.19e-4)" "unprognostic (1.23e-2)" "prognostic favorable (1.14e-5)" "unprognostic (2.50e-1)" "unprognostic (1.98e-1)" "unprognostic (2.50e-1)" "unprognostic (1.55e-2)" "unprognostic (2.14e-1)" "unprognostic (3.37e-3)" "prognostic favorable (3.41e-5)" 5.3 6.7 7.6 7.8 8.9 3.5 9.3 26.4 7.7 5.4 9.0 5.5 12.7 11.0 6.0 9.6 6.1 5.4 6.3 3.7 6.9 5.4 9.5 6.9 6.2 11.3 8.0 5.9 4.6 8.3 11.2 11.9 2.8 7.8 7.5 12.0 4.3 10.4 9.9 5.1 8.8 13.0 6.2 10.1 13.4 9.1 3.2 9.3 11.7 7.5 4.2 11.2 7.2 5.4 10.0 11.0 30.5 6.3 9.9 10.7 4.8 0.0 7.2 9.3 6.8 2.6 0.6 7.6 2.5 5.3 6.6 7.1 5.0 4.7 7.1 6.7 2.3 4.6 5.6 6.4 3.6 6.2 10.2 8.9 7.4 5.8 6.9 4.1 5.4 6.3 0.8 6.1 5.5 3.0 7.0 12.0 0.2 1.0 6.1 1.7 7.9 0.0 8.6 1.9 6.0 4.4 8.8 7.1 9.8 7.7 10.2 12.6 13.9 1.2 7.7 8.7 6.3 10.1 2.6 3.7 2.5 5.7 3.7 6.4 3.1 9.8 1.9 1.1 2.7 1.3 30.5 4.9 5.4 8.1 6.3 10.7 10.0 7.2 6.2 5.0 8.1 8.8 7.1 8.9 9.9 6.1 11.0 7.7 4.8 7.6 8.9 26.4 7.7 6.9 5.4 8.0 5.9 7.8 9.3 6.0 1.6 1.4 0.6 1.5 3.8 1.4 5.1 9.4 4.5 7.0 3.9 2.0 5.0 10.1 2.5 3.5 5.6 0.0 11.1 1.0 0.7 0.9 2.3 1.8 1.8 1.6 1.7 3.1 4.6 0.9 0.6 4.0 1.7 5.4 4.7 3.1 8.2 6.8 3.2 5.8 5.5 0.0 1.1 0.7 5.1 1.1 1.5 8.2 7.7 0.6 ZSCAN18 "FLJ12895, ZNF447" ENSG00000121413 "Zinc finger and SCAN domain containing 18" Q8TBC5 19 58083838-58118427 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 49.8;SCLC-21H: 23.8" HPA024318 Supported Approved Nucleoplasm No No Nucleoplasm "HPA024318: AB_1859494" "unprognostic (1.85e-2)" "unprognostic (3.48e-2)" "unprognostic (7.07e-2)" "unprognostic (6.45e-3)" "unprognostic (1.28e-1)" "unprognostic (1.22e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (2.24e-1)" "unprognostic (8.27e-2)" "unprognostic (2.59e-3)" "unprognostic (1.59e-1)" "prognostic favorable (3.95e-7)" "unprognostic (3.68e-2)" "unprognostic (7.23e-2)" "unprognostic (3.70e-1)" "unprognostic (9.04e-2)" 18.1 18.1 26.7 10.4 34.3 5.3 11.8 27.9 47.7 20.5 17.1 20.8 16.0 8.7 26.2 20.3 13.4 33.9 18.6 28.9 27.0 33.7 19.3 7.3 15.0 12.2 23.7 31.1 31.8 16.8 23.7 28.0 15.1 21.1 21.1 6.0 17.7 18.2 27.5 15.9 9.9 10.0 29.0 20.7 17.0 12.9 20.0 18.3 7.4 28.9 8.7 6.1 15.9 14.6 4.6 2.3 3.9 0.8 2.2 2.4 0.7 0.0 0.4 5.2 13.4 0.6 0.8 12.9 3.3 0.1 4.3 0.7 0.0 3.1 1.2 7.6 4.6 5.2 0.0 0.4 2.5 4.6 0.0 49.8 0.1 0.0 0.0 9.2 0.0 10.1 7.9 0.1 3.3 0.0 5.4 0.2 3.1 0.0 0.6 6.5 0.0 6.9 2.5 8.5 0.0 0.0 8.2 0.0 0.6 4.2 10.2 23.8 5.7 0.0 0.2 0.0 4.8 15.6 0.0 0.0 0.2 6.2 5.8 0.0 5.9 17.1 0.0 0.0 0.0 4.0 2.0 0.5 3.5 0.4 0.3 2.1 1.7 1.7 1.8 0.9 4.6 2.4 2.2 3.9 2.2 0.8 2.3 0.1 0.7 26.7 34.3 27.9 31.4 27.0 33.7 23.7 31.1 21.1 18.3 14.9 24.0 31.8 44.4 10.8 77.2 38.7 20.4 28.1 37.5 40.1 31.4 38.9 13.3 19.4 41.6 32.5 3.6 0.0 5.1 7.1 18.3 35.8 23.1 3.8 8.0 106.5 25.4 20.3 1.3 55.0 37.2 6.5 10.1 9.0 12.0 72.0 6.3 11.5 55.2 9.1 103.9 19.4 25.8 25.1 26.9 10.7 54.9 14.6 9.9 29.4 ZSCAN20 "KOX29, ZNF31, ZNF360" ENSG00000121903 "Zinc finger and SCAN domain containing 20" P17040 1 33472645-33496507 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 15.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017933 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA017933: AB_1859028" "unprognostic (1.52e-1)" "unprognostic (1.10e-2)" "unprognostic (1.27e-1)" "unprognostic (6.75e-3)" "unprognostic (9.28e-2)" "unprognostic (3.03e-3)" "unprognostic (1.77e-6)" "unprognostic (3.13e-1)" "unprognostic (6.94e-2)" "unprognostic (4.05e-2)" "unprognostic (2.96e-1)" "unprognostic (1.25e-1)" "unprognostic (1.53e-1)" "unprognostic (2.03e-1)" "unprognostic (2.92e-2)" "unprognostic (4.43e-2)" "unprognostic (1.74e-2)" 3.8 4.2 4.7 2.5 7.1 1.0 4.4 6.1 8.2 4.4 4.1 7.7 4.5 8.4 7.4 3.2 3.6 4.4 3.6 6.1 4.3 2.9 3.9 3.0 3.2 2.1 4.3 5.7 7.8 4.0 11.2 8.6 4.0 5.7 4.2 4.4 5.1 5.0 5.5 3.4 2.9 6.6 5.9 4.2 3.1 4.3 6.1 7.6 3.9 4.4 2.7 3.2 4.9 8.5 0.8 1.7 0.7 2.2 1.0 3.0 0.6 3.7 2.8 6.5 4.5 5.2 5.4 4.4 4.7 4.7 6.3 5.1 2.9 4.9 2.8 2.6 4.9 3.8 4.7 5.4 2.5 6.6 0.0 6.1 5.7 6.2 2.4 5.0 3.2 2.1 3.8 4.5 6.7 5.5 5.8 4.9 4.7 3.8 3.6 5.6 1.3 2.4 2.0 5.4 3.5 1.6 2.7 7.6 1.1 3.5 3.2 2.6 3.8 3.5 3.9 5.1 9.1 2.6 3.6 4.4 5.6 4.0 5.0 6.6 4.8 3.0 1.3 5.8 1.0 3.7 0.2 2.2 0.0 1.3 1.0 2.1 0.3 0.4 0.9 1.7 0.8 1.9 3.0 0.7 1.0 1.0 1.2 0.8 0.6 4.7 7.1 6.1 8.2 4.3 2.9 4.3 5.7 5.7 7.6 0.0 2.2 0.0 0.5 0.0 1.5 1.6 2.5 1.4 0.0 0.0 3.9 0.7 0.0 0.9 15.3 0.6 0.4 0.0 0.2 0.7 0.7 0.5 1.1 0.0 0.6 0.0 1.2 1.3 0.3 1.3 1.1 0.0 0.0 1.8 0.5 0.6 0.7 0.9 1.8 0.4 2.0 0.0 1.0 2.5 1.1 0.0 0.2 0.0 0.4 0.4 ZSCAN9 "PRD51, ZNF193" ENSG00000137185 "Zinc finger and SCAN domain containing 9" O15535 6 28224886-28233482 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054512, HPA059951" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA054512: AB_2682511, HPA059951: AB_2684176" "unprognostic (1.67e-1)" "unprognostic (5.32e-2)" "unprognostic (2.68e-1)" "unprognostic (2.04e-1)" "unprognostic (1.32e-2)" "unprognostic (5.24e-3)" "prognostic unfavorable (3.49e-4)" "unprognostic (5.69e-2)" "unprognostic (4.53e-2)" "unprognostic (3.18e-2)" "unprognostic (1.55e-2)" "unprognostic (6.14e-3)" "prognostic unfavorable (1.21e-6)" "unprognostic (1.74e-2)" "unprognostic (1.51e-2)" "unprognostic (2.51e-1)" "prognostic favorable (1.16e-5)" 12.2 11.0 7.9 12.7 11.9 10.1 16.1 21.2 13.1 17.2 12.7 14.8 13.0 10.2 22.7 15.9 10.4 11.4 14.2 10.2 8.2 9.6 13.0 9.3 10.6 10.5 10.2 7.1 16.0 12.5 13.6 22.4 12.6 11.2 15.8 17.4 12.9 12.3 14.6 8.9 6.9 14.5 17.9 11.9 16.8 11.7 20.1 13.5 4.1 14.5 7.4 11.1 12.2 16.7 5.7 5.6 5.6 4.0 13.0 4.4 2.6 6.8 4.6 16.3 19.3 6.4 6.9 6.0 8.4 7.1 8.1 9.3 4.3 3.5 0.0 12.8 5.3 8.2 4.8 7.9 7.7 9.5 4.5 6.7 10.5 9.3 7.9 8.1 12.3 8.7 5.8 12.2 6.9 10.6 12.6 10.5 0.0 15.5 5.8 12.0 4.0 0.0 20.2 6.0 3.0 5.4 6.4 11.4 7.1 10.2 9.7 14.1 19.4 7.4 5.7 10.0 12.7 6.9 8.4 8.8 16.9 11.7 3.9 14.4 13.2 13.3 2.8 3.5 15.2 9.6 4.8 4.0 5.6 4.4 2.0 3.4 5.7 1.5 3.2 5.6 5.2 0.5 0.9 1.6 13.0 0.9 2.9 1.1 2.6 7.9 11.9 21.2 13.1 8.2 9.6 10.2 7.1 11.2 13.5 8.9 2.2 3.2 4.4 0.8 6.6 3.4 12.7 5.3 12.5 3.5 0.0 3.9 1.7 7.6 14.8 3.6 3.5 0.0 5.5 2.9 3.5 3.6 5.7 1.7 4.5 6.4 5.2 3.7 5.7 2.5 3.4 4.9 3.3 1.8 5.9 4.5 5.2 5.8 4.6 3.7 5.5 6.5 5.0 19.1 12.3 1.0 10.1 2.2 7.0 2.0 ZSWIM9 "C19orf68, LOC374920" ENSG00000185453 "Zinc finger SWIM-type containing 9" Q86XI8 19 48170692-48197620 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 5 "Alveolar cells type 2: 4.3;Cytotrophoblasts: 4.5;Exocrine glandular cells: 5.0;Hofbauer cells: 4.3;Pancreatic endocrine cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061028 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA061028: AB_2684419" "unprognostic (1.59e-1)" "unprognostic (2.76e-1)" "unprognostic (5.79e-3)" "unprognostic (1.65e-1)" "unprognostic (8.49e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.35e-5)" "unprognostic (1.26e-1)" "unprognostic (2.93e-1)" "unprognostic (6.96e-2)" "unprognostic (3.19e-3)" "unprognostic (2.20e-2)" "prognostic favorable (2.44e-4)" "unprognostic (3.59e-1)" "unprognostic (2.64e-1)" "unprognostic (7.07e-2)" "unprognostic (1.03e-1)" 6.8 3.9 11.6 4.2 15.5 4.3 9.8 5.7 10.0 6.0 4.4 8.1 4.5 4.6 9.6 2.0 6.5 4.2 5.5 5.1 10.1 10.2 4.5 3.3 3.8 4.7 9.9 4.8 8.1 5.0 6.2 2.8 3.6 6.6 4.7 2.8 3.9 5.9 5.6 16.2 5.3 5.0 11.1 7.6 5.4 4.2 3.2 6.0 1.2 5.2 1.5 4.2 6.1 8.6 1.2 0.4 0.5 0.4 0.2 1.6 0.1 9.3 10.5 6.3 4.7 4.1 2.3 5.7 7.3 3.9 3.4 3.9 1.7 3.0 7.6 3.5 3.4 4.3 7.8 2.1 4.4 3.8 11.3 7.8 4.8 6.7 4.3 4.4 4.2 4.0 2.5 3.6 5.0 6.0 6.1 3.4 6.1 1.1 4.1 2.2 5.0 4.6 18.2 3.9 8.8 6.7 8.8 5.6 2.0 2.3 7.7 4.4 5.4 10.1 3.2 4.8 4.0 4.4 6.6 8.7 4.0 7.4 3.4 7.9 6.8 6.8 4.6 2.4 6.2 5.2 0.1 0.4 0.1 0.9 0.4 0.2 1.2 0.4 1.6 0.3 0.4 1.0 0.6 0.5 0.2 0.4 0.4 0.0 0.1 11.6 15.5 5.7 9.6 10.1 10.2 9.9 4.8 6.6 6.0 3.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 3.5 0.0 4.5 3.3 3.8 0.0 0.0 0.0 0.0 5.0 2.3 0.0 0.0 2.3 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 4.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 ZXDA ZNF896 ENSG00000198205 "Zinc finger, X-linked, duplicated A" P98168 X 57906708-57910820 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 8.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA043789 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043789: AB_2678673" "unprognostic (1.53e-1)" "unprognostic (3.71e-1)" "unprognostic (1.01e-1)" "unprognostic (3.61e-3)" "unprognostic (1.65e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-1)" "unprognostic (4.22e-3)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.85e-3)" "unprognostic (6.50e-2)" "prognostic favorable (8.55e-4)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (1.15e-1)" "unprognostic (3.27e-2)" 3.5 2.5 1.9 1.4 2.4 3.1 3.5 2.8 2.9 3.3 2.2 1.1 3.6 2.1 1.5 4.3 2.1 2.4 1.9 2.2 2.3 1.6 2.0 3.1 1.6 6.3 3.3 3.7 2.4 0.7 3.3 1.4 2.6 2.9 3.4 2.9 2.4 2.6 1.9 3.5 2.8 0.5 3.6 2.8 2.9 2.4 0.9 0.4 0.0 0.2 1.7 2.3 0.2 2.8 2.5 0.8 3.0 3.0 4.6 2.1 1.6 3.0 2.2 2.5 0.5 2.3 6.3 4.3 4.3 2.5 2.6 3.0 4.0 1.9 5.0 4.7 0.8 2.4 0.0 5.1 0.0 0.3 3.7 6.8 3.3 6.6 3.7 3.7 3.8 0.9 0.2 4.2 2.2 3.1 1.1 3.3 0.6 2.3 3.3 2.4 1.9 1.7 2.4 0.4 2.8 3.6 2.5 2.4 4.2 3.5 2.2 3.0 3.8 8.3 1.1 1.8 0.0 0.0 3.3 2.5 2.7 2.3 0.0 0.2 0.0 2.3 0.2 0.8 0.2 0.6 1.0 0.2 0.9 1.5 0.2 0.0 1.7 0.2 0.4 1.3 0.2 0.0 0.3 1.5 4.2 8.2 2.4 1.3 2.5 1.4 1.2 1.8 3.9 0.7 0.0 1.4 0.0 2.3 0.4 0.0 0.7 0.6 1.3 1.8 1.1 0.8 1.0 3.2 1.2 1.3 1.5 0.0 2.3 1.0 3.3 1.0 1.2 1.3 0.9 0.0 1.1 1.3 2.1 0.0 2.2 0.0 0.3 5.6 0.7 0.0 1.2 2.2 ZXDB ZNF905 ENSG00000198455 "Zinc finger, X-linked, duplicated B" P98169 X 57591652-57597545 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 28.2;Suprabasal keratinocytes: 33.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 24.7" HPA043789 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043789: AB_2678673" "unprognostic (1.87e-1)" "unprognostic (3.22e-1)" "unprognostic (1.88e-1)" "unprognostic (8.61e-3)" "unprognostic (4.29e-2)" "unprognostic (2.80e-1)" "unprognostic (7.15e-2)" "unprognostic (1.98e-1)" "unprognostic (4.36e-1)" "unprognostic (9.04e-2)" "unprognostic (6.73e-2)" "unprognostic (2.16e-2)" "unprognostic (1.17e-3)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (4.02e-3)" "unprognostic (2.87e-3)" 2.6 2.1 2.4 1.9 3.0 5.1 3.4 6.3 3.4 3.5 2.5 1.6 4.0 2.0 2.1 4.1 2.8 2.3 2.4 3.2 2.4 11.2 2.3 2.9 2.3 4.5 4.3 5.3 1.9 1.4 3.6 2.5 2.8 3.1 3.6 3.9 2.9 4.2 2.4 2.9 3.2 0.5 3.8 2.9 4.1 2.3 1.3 1.3 0.0 0.6 0.5 2.4 0.3 3.7 4.4 2.9 3.9 5.0 4.9 4.0 2.7 3.3 2.2 2.3 1.8 2.7 3.2 4.0 4.8 3.6 4.2 8.3 14.2 4.3 8.0 4.5 1.8 5.8 5.0 6.4 3.0 2.0 4.3 24.7 5.6 15.3 4.8 6.6 3.6 2.0 3.5 5.9 2.6 2.6 2.5 11.6 1.5 5.6 3.4 10.6 1.8 3.0 6.0 2.4 4.6 5.4 3.9 4.1 6.8 4.0 3.4 5.7 4.8 9.5 4.1 2.7 0.0 1.4 4.4 3.4 2.6 2.2 0.0 0.3 0.0 1.5 0.5 1.3 1.3 1.1 2.4 0.4 1.2 2.1 1.1 0.0 0.5 0.6 1.3 0.9 0.3 6.0 1.6 5.2 9.6 28.2 3.9 5.3 10.2 2.7 3.4 1.8 0.0 1.9 3.3 2.4 0.0 3.6 2.3 0.0 3.0 1.2 5.0 10.9 0.0 11.4 1.0 6.4 0.0 3.7 2.7 0.0 4.6 1.5 6.8 1.8 6.1 1.2 3.1 0.0 5.3 2.8 2.9 0.0 3.8 0.0 0.0 33.2 2.4 2.2 3.7 12.4 ZYG11A ZYG11 ENSG00000203995 "Zyg-11 family member A, cell cycle regulator" Q6WRX3 1 52842511-52894998 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 21.2;thyroid gland: 8.1" "Cell type enhanced" "Detected in some" 18 "Glandular cells: 1.7;Spermatocytes: 3.4;Spermatogonia: 6.9" "Cancer enriched" "Detected in many" 7 "testis cancer: 11.1" "Region enhanced" "Detected in single" "pons and medulla: 2.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 10.6;hTEC/SVTERT24-B: 10.3;K-562: 9.9;SiHa: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030378, HPA030379" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030378: AB_10604159, HPA030379: AB_2673451" "unprognostic (7.94e-2)" "unprognostic (6.71e-3)" "unprognostic (1.04e-2)" "unprognostic (4.06e-3)" "unprognostic (1.59e-2)" "unprognostic (1.00e-4)" "unprognostic (1.87e-1)" "unprognostic (2.34e-1)" "unprognostic (4.56e-2)" "unprognostic (2.06e-2)" "unprognostic (4.01e-2)" "unprognostic (1.01e-1)" "unprognostic (6.15e-3)" "unprognostic (2.95e-1)" "unprognostic (1.21e-1)" "unprognostic (3.07e-1)" "unprognostic (1.02e-1)" 0.3 0.1 0.2 3.0 0.2 0.4 1.4 0.7 0.1 0.6 0.2 0.1 0.8 0.4 0.1 3.0 1.7 0.1 0.4 0.9 0.1 0.3 6.4 3.1 0.1 1.0 0.1 0.0 0.6 0.3 0.6 0.5 1.0 2.2 1.7 0.2 1.0 0.5 0.0 0.3 0.6 0.3 0.5 1.3 0.3 0.1 21.2 0.0 0.9 8.1 1.3 5.6 0.5 1.1 1.0 0.8 3.1 0.6 0.9 0.7 0.2 0.0 1.9 0.3 0.0 0.0 0.0 4.4 1.2 1.3 5.7 4.6 0.1 0.1 0.0 3.0 1.7 0.0 0.1 3.8 0.1 6.8 0.3 7.3 0.0 10.6 0.0 2.8 0.0 0.9 0.0 0.3 10.3 0.1 0.3 1.3 0.1 9.9 5.5 0.2 5.3 0.0 5.3 1.4 0.0 1.0 0.0 1.3 4.7 3.6 0.2 1.5 2.2 10.3 0.5 0.0 4.6 5.8 2.9 0.1 0.0 0.1 0.0 0.0 2.8 4.5 0.1 0.0 0.1 0.8 1.8 0.6 0.8 0.5 0.3 0.3 0.7 0.5 0.5 0.1 1.0 0.6 0.7 3.1 0.9 0.3 0.8 0.4 0.2 0.2 0.2 0.7 0.1 0.1 0.3 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 1.7 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 1.3 0.0 0.0 3.4 6.9 0.1 0.2 0.0 0.0 0.3